PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Angarita, FA; Acuna, SA; Torregrosa, L; Tawil, M; Escallon, J; Ruiz, A				Angarita, F. A.; Acuna, S. A.; Torregrosa, L.; Tawil, M.; Escallon, J.; Ruiz, A.			Perioperative variables associated with surgical site infection in breast cancer surgery	JOURNAL OF HOSPITAL INFECTION			English	Article						Breast cancer; Breast surgery; Surgical site infection	WOUND-INFECTION; ANTIBIOTIC-PROPHYLAXIS; PREOPERATIVE IRRADIATION; ADJUVANT CHEMOTHERAPY; RISK-FACTORS; COMPLICATIONS; MASTECTOMY; DETERMINANTS; RECONSTRUCTION; MORBIDITY	Despite the fact that breast operations are usually categorized as clean procedures, higher surgical site infection (SSI) rates are reported. This study aimed to determine the perioperative variables related to SSI in breast cancer patients. Medical records of breast cancer patients undergoing surgery between January 2005 and August 2007 at a university based hospital were reviewed. Preoperative, intraoperative, and postoperative clinical data from 199 patients were extracted and analysed. Overall, the SSI rate was 19.1% (38 cases). SSI was associated with a high body mass index (P = 0.001), history of diabetes mellitus (P < 0.0001), smoking (P < 0.0001), or active skin disorders (P < 0.0001). Other SSI-related variables included a tumour at an advanced clinical stage (P = 0.003) and neoadjuvant therapy (P = 0.003). Breast-conserving operations were less frequently associated with SSI than were radical procedures (mastectomy alone and mastectomy followed by immediate reconstruction) (P = 0.0001). (C) 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.	[Angarita, F. A.; Acuna, S. A.; Torregrosa, L.; Tawil, M.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Surg, Bogota, Colombia; [Torregrosa, L.; Tawil, M.] Ctr Javeriano Oncol, Breast & Soft Tissue Clin, Bogota, Colombia; [Escallon, J.] Mt Sinai Hosp, Dept Surg, Toronto, ON M5G 1X5, Canada; [Ruiz, A.] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia		Acuna, SA (corresponding author), Toronto Gen Res Inst, Div Expt Therapeut, Room 4-425,67 Coll St, Toronto, ON M5G 2M1, Canada.	sacuna@uhnresearch.ca	Acuna, Sergio A./H-7783-2013; Ruiz, Alvaro/AAD-5422-2019; Angarita, Fernando A./AAI-9245-2020	Acuna, Sergio A./0000-0002-6266-2136; Ruiz, Alvaro/0000-0001-6528-4268; Angarita, Fernando A./0000-0002-8546-7309; Torregrosa Almonacid, Lilian/0000-0002-5392-7083	Breast and Soft Tissue Clinic, Pontificia Universidad Javeriana	Breast and Soft Tissue Clinic, Pontificia Universidad Javeriana	This project was funded by the Breast and Soft Tissue Clinic, Pontificia Universidad Javeriana.	Alderman AK, 2002, PLAST RECONSTR SURG, V109, P2265, DOI 10.1097/00006534-200206000-00015; ANGARITA FA, 2010, BREAST CANC     0903; Angarita Fernando Andrés, 2010, rev. colomb. cir., V25, P19; Azzawi K, 2010, PLAST RECONSTR SURG, V126, P1, DOI 10.1097/PRS.0b013e3181da8699; Bertin ML, 1998, AM J INFECT CONTROL, V26, P61, DOI 10.1016/S0196-6553(98)70062-8; BROADWATER JR, 1991, ANN SURG, V213, P126, DOI 10.1097/00000658-199102000-00006; Bundred N, 1998, BRIT MED J, V317, P1275, DOI 10.1136/bmj.317.7168.1275; Canavese G, 1997, EUR J SURG ONCOL, V23, P10, DOI 10.1016/S0748-7983(97)80135-7; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; CHEN J, 1991, J HOSP INFECT, V17, P61, DOI 10.1016/0195-6701(91)90078-M; COELLO R, 1993, J HOSP INFECT, V25, P239, DOI 10.1016/0195-6701(93)90110-L; CRUSE PJE, 1980, SURG CLIN N AM, V60, P27; D'Amico DF, 2001, J CHEMOTHERAPY, V13, P108, DOI 10.1179/joc.2001.13.Supplement-2.108; ELDIN AB, 1989, EUR J SURG ONCOL, V15, P486; Felippe WAB, 2007, WORLD J SURG, V31, P2293, DOI 10.1007/s00268-007-9248-3; FUREY PC, 1994, J SURG ONCOL, V55, P194, DOI 10.1002/jso.2930550313; Hall JC, 2000, J HOSP INFECT, V46, P165, DOI [10.1053/jhin.2000.0834, 10.1016/S0195-6701(00)90834-X]; HAYES JA, 1984, AUST NZ J SURG, V54, P25, DOI 10.1111/j.1445-2197.1984.tb06680.x; HE XD, 2010, MED ONCOL       0909; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; HUANG E, 2000, INT J RADIAT ONCOL, V2, P1225; KEIDAN RD, 1990, AM SURGEON, V56, P440; LAWRENCE WT, 1986, SURGERY, V100, P9; Lefebvre D, 2000, PRESSE MED, V29, P1927; Lipshy KA, 1996, ANN SURG ONCOL, V3, P290, DOI 10.1007/BF02306285; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Mortenson MM, 2004, ARCH SURG-CHICAGO, V139, P988, DOI 10.1001/archsurg.139.9.988; Nieto A, 2002, Zentralbl Gynakol, V124, P429, DOI 10.1055/s-2002-38129; Olsen MA, 2008, J AM COLL SURGEONS, V207, P326, DOI 10.1016/j.jamcollsurg.2008.04.021; Olsen MA, 2008, ARCH SURG-CHICAGO, V143, P53, DOI 10.1001/archsurg.2007.11; Peled AW, 2010, ARCH SURG-CHICAGO, V145, P880, DOI 10.1001/archsurg.2010.163; Pittet B, 2005, LANCET INFECT DIS, V5, P94, DOI 10.1016/S1473-3099(05)01281-8; PLATT R, 1992, J INFECT DIS, V166, P556, DOI 10.1093/infdis/166.3.556; Rey JE, 2005, AM J INFECT CONTROL, V33, P126, DOI 10.1016/j.ajic.2004.05.004; Ringberg A, 1999, EUR J SURG ONCOL, V25, P470, DOI 10.1053/ejso.1999.0681; ROTSTEIN C, 1992, INFECT CONT HOSP EP, V13, P207; Ruvalcaba-Limon E, 2006, BREAST CANCER RES TR, V95, P147, DOI 10.1007/s10549-005-9058-y; SAUTER ER, 1993, WORLD J SURG, V17, P237, DOI 10.1007/BF01658934; SAY CC, 1974, SURG GYNECOL OBSTET, V138, P370; SELTZER MH, 1995, INT SURG, V80, P79; Simpson SA, 2007, J AM COLL SURGEONS, V205, P463, DOI 10.1016/j.jamcollsurg.2007.03.030; Skinner KA, 1997, AM J SURG, V174, P705, DOI 10.1016/S0002-9610(97)00198-0; Tejirian T, 2006, J AM COLL SURGEONS, V203, P729, DOI 10.1016/j.jamcollsurg.2006.07.013; TEJLER G, 1985, BRIT J SURG, V72, P542, DOI 10.1002/bjs.1800720714; Tran CL, 2003, AM SURGEON, V69, P852; Vilar-Compte D, 2004, WORLD J SURG, V28, P242, DOI 10.1007/s00268-003-7193-3; Weiss CA, 1999, ARCH SURG-CHICAGO, V134, P1041, DOI 10.1001/archsurg.134.10.1041; Witt A, 2003, OBSTET GYNECOL, V101, P745, DOI 10.1016/S0029-7844(03)00044-9; [No title captured], DOI DOI 10.1002/14651858.CD005360.PUB2	49	28	30	2	10	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	DEC	2011	79	4					328	332		10.1016/j.jhin.2011.08.006	http://dx.doi.org/10.1016/j.jhin.2011.08.006			5	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	846QL	22054593				2022-09-04	WOS:000296918200010
J	Oppedal, K; Borda, MG; Ferreira, D; Westman, E; Aarsland, D				Oppedal, Ketil; Borda, Miguel G.; Ferreira, Daniel; Westman, Eric; Aarsland, Dag		European DLB Consortium	European DLB consortium: diagnostic and prognostic biomarkers in dementia with Lewy bodies, a multicenter international initiative	NEURODEGENERATIVE DISEASE MANAGEMENT			English	Editorial Material						biomarkers; dementia with Lewy bodies; diagnosis; E-DLB; European DLB consortium	ALZHEIMERS-DISEASE; COGNITIVE DECLINE		[Oppedal, Ketil; Borda, Miguel G.; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [Borda, Miguel G.] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Oppedal, Ketil] Stavanger Univ Hosp, Dept Radiol, Stavanger, Norway; [Oppedal, Ketil] Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway; [Borda, Miguel G.] Pontificia Univ Javeriana, Semillero Neurociencias & Envejecimiento, Ageing Inst, Med Sch, Bogota, Colombia; [Ferreira, Daniel; Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, Div Clin Geriatr, Stockholm, Sweden; [Westman, Eric] Kings Coll London, Dept Neuroimaging, Ctr Neuroimaging Sci, Inst Psychiat Psychol & Neurosci, London, England; [Aarsland, Dag] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England		Oppedal, K (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway.; Oppedal, K (corresponding author), Stavanger Univ Hosp, Dept Radiol, Stavanger, Norway.; Oppedal, K (corresponding author), Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway.	ketil.oppedal@gmail.com	Westman, Eric/H-5771-2011; Borda, Miguel Germán/AAK-9029-2020; Ferreira, Daniel/L-8974-2014; Borda, Miguel German/AHB-5593-2022	Westman, Eric/0000-0002-3115-2977; Borda, Miguel Germán/0000-0001-5832-0603; Ferreira, Daniel/0000-0001-9522-4338; Borda, Miguel German/0000-0001-5832-0603; Oppedal, Ketil/0000-0002-8981-331X	AstraZeneca; H. Lundbeck; Novartis Pharmaceuticals; GE Health; Western Norway Regional Health Authority [912152]; Swedish Foundation for Strategic Research (SSF); Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro); Swedish Research Council (VR); Ake Wiberg foundation; Hjarnfonden; Alzheimerfonden; Demensfonden; Birgitta och Sten Westerberg	AstraZeneca(AstraZeneca); H. Lundbeck; Novartis Pharmaceuticals(Novartis); GE Health(General ElectricGE Healthcare); Western Norway Regional Health Authority; Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro); Swedish Research Council (VR)(Swedish Research Council); Ake Wiberg foundation; Hjarnfonden; Alzheimerfonden; Demensfonden; Birgitta och Sten Westerberg	D Aarsland has received research support and/or honoraria from AstraZeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and served as paid consultant for H. Lundbeck, Eisai and Evonik. K Oppedal is funded by The Western Norway Regional Health Authority by postdoc-grant 912152. D Ferreira and E Westman are supported by the Swedish Foundation for Strategic Research (SSF); the Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro); the Swedish Research Council (VR); the Ake Wiberg foundation; Hjarnfonden; Alzheimerfonden; Demensfonden; and Birgitta och Sten Westerberg. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Aarsland D, 2008, DEMENT GERIATR COGN, V26, P445, DOI 10.1159/000165917; Abdelnour C, 2016, MOVEMENT DISORD, V31, P1203, DOI 10.1002/mds.26668; Biundo R, 2016, J NEURAL TRANSM, V123, P431, DOI 10.1007/s00702-016-1517-6; Bonanni L, 2016, J ALZHEIMERS DIS, V54, P1649, DOI 10.3233/JAD-160435; Di Censo R, 2020, J NEUROL NEUROSUR PS, V91, P109, DOI 10.1136/jnnp-2019-320980; Galvin JE, 2010, PARKINSONISM RELAT D, V16, P388, DOI 10.1016/j.parkreldis.2010.03.007; Jones SAV, 2014, PSYCHOL MED, V44, P673, DOI 10.1017/S0033291713000494; Kane JPM, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0350-6; Kramberger MG, 2017, J ALZHEIMERS DIS, V57, P787, DOI 10.3233/JAD-161109; McKeith I, 2007, LANCET NEUROL, V6, P305, DOI 10.1016/S1474-4422(07)70057-1; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Morbelli S, 2019, ANN NEUROL, V85, P715, DOI 10.1002/ana.25453; Mueller C, 2017, LANCET NEUROL, V16, P390, DOI 10.1016/S1474-4422(17)30074-1; Oppedal K, 2019, ALZHEIMERS DEMENT, V15, P400, DOI 10.1016/j.jalz.2018.09.011; Rizzi L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/908915; Rongve A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43458-2; Ferreira CMS, 2019, IEEE INT CONF MOB CL, P24, DOI 10.1109/MobileCloud.2019.00011; Van Steenoven I, 2016, J ALZHEIMERS DIS, V54, P287, DOI 10.3233/JAD-160322; Walker Z, 2015, LANCET, V386, P1683, DOI 10.1016/S0140-6736(15)00462-6; Yoshita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120540; Zhu CW, 2008, ALZHEIMERS DEMENT, V4, P280, DOI 10.1016/j.jalz.2008.02.008	21	11	11	0	1	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1758-2024	1758-2032		NEURODEGENER DIS MAN	Neurodegener. Dis. Manag.	OCT	2019	9	5					247	250		10.2217/nmt-2019-0016	http://dx.doi.org/10.2217/nmt-2019-0016			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	JQ3AO	31580225				2022-09-04	WOS:000498821700001
J	Faccini-Martinez, AA; Ramirez-Hernandez, A; Forero-Becerra, E; Cortes-Vecino, JA; Escandon, P; Rodas, JD; Palomar, AM; Portillo, A; Oteo, JA; Hidalgo, M				Faccini-Martinez, Alvaro A.; Ramirez-Hernandez, Alejandro; Forero-Becerra, Elkin; Cortes-Vecino, Jesus A.; Escandon, Patricia; Rodas, Juan D.; Palomar, Ana M.; Portillo, Aranzazu; Oteo, Jose A.; Hidalgo, Marylin			Molecular Evidence of Different Rickettsia Species in Villeta, Colombia	VECTOR-BORNE AND ZOONOTIC DISEASES			English	Article						Rickettsia; Ticks; Fleas; PCR; Colombia	SPOTTED-FEVER GROUP; GENOTYPIC IDENTIFICATION; IXODES-RICINUS; TICKS; AMBLYOMMII; BRAZIL; STATE; FELIS; SPAIN; FLEAS	The aim of this work was to detect and identify Rickettsia species in ticks collected in rural areas of Villeta, Colombia. Tick specimens were collected from domestic animals and walls of houses in five rural villages of Villeta town and from humans in Naranjal village (same town). Moreover, a flea collected from the same area was also processed. DNA was extracted and tested by conventional, semi-nested, and nested PCR reactions targeting rickettsial genes. In the ticks collected from humans from Naranjal village, a nymph of Amblyomma cajennense sensu lato was amplified using primers for ompA and sequenced (100% identity with "Candidatus Rickettsia amblyommii''). Last, three amplicons from the Ctenocephalides felis flea, corresponding to gltA, ompB, and 16S rRNA genes, showed high identity with R. felis (98.5%, 97.3%, and 99.2%, respectively) and "Candidatus Rickettsia asemboensis'' (99.7% and 100%, respectively). To our knowledge, these results correspond to the first molecular detection in Colombia of "Candidatus Rickettsia amblyommii'' and "Ca. Rickettsia asemboensis'' in fleas.	[Faccini-Martinez, Alvaro A.; Hidalgo, Marylin] Pontificia Univ Javeriana, Dept Microbiol, Fac Sci, Bldg 50,Carrera 7a 43-82, Bogota, Colombia; [Ramirez-Hernandez, Alejandro; Cortes-Vecino, Jesus A.] Univ Nacl Colombia, Vet Parasitol Res Grp, Bogota, Colombia; [Forero-Becerra, Elkin] Univ Fed Vicosa, Dept Vet Med, Vicosa, MG, Brazil; [Escandon, Patricia] Inst Nacl Salud, Microbiol Grp, Bogota, Colombia; [Rodas, Juan D.] Univ Antioquia, CENTAURO Res Grp, Medellin, Colombia; [Palomar, Ana M.; Portillo, Aranzazu; Oteo, Jose A.] Hosp San Pedro CIBIR, Dept Infect Dis, Ctr Rickettsioses & Arthropod Borne Dis, Logrono, Spain		Hidalgo, M (corresponding author), Pontificia Univ Javeriana, Dept Microbiol, Fac Sci, Bldg 50,Carrera 7a 43-82, Bogota, Colombia.	hidalgo.m@javeriana.edu.co	Palomar, Ana M/ABF-7245-2020; Rodas, Juan David/AAM-6382-2020; Hernandez, Alejandro Ramirez/U-1567-2019; Oteo, Jose A./AAB-3134-2020; GONZALEZ, JUAN DAVID RODAS/AAU-7011-2020; Hidalgo, Marylin/AAF-5736-2019; Portillo, Arantza/ABH-7807-2020	Palomar, Ana M/0000-0002-5461-5874; Hernandez, Alejandro Ramirez/0000-0001-8689-5930; Oteo, Jose A./0000-0001-7080-6542; GONZALEZ, JUAN DAVID RODAS/0000-0002-7054-9918; Portillo, Arantza/0000-0002-2055-1825; Cortes-Vecino, Jesus A./0000-0003-2641-604X; Faccini-Martinez, Alvaro A./0000-0002-1127-0132; Hidalgo, Marylin/0000-0001-8960-0616	research project "Caracterizacion de factores climaticos y ecologicos de una especie de garrapata y su relacion con la epidemiologia de la rickettsiosis en un area endemica" [PPTA 4344]; COLCIENCIAS [111549326228, 120351929098]	research project "Caracterizacion de factores climaticos y ecologicos de una especie de garrapata y su relacion con la epidemiologia de la rickettsiosis en un area endemica"; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	Pontificia Universidad Javeriana; research project "Caracterizacion de factores climaticos y ecologicos de una especie de garrapata y su relacion con la epidemiologia de la rickettsiosis en un area endemica" (ID code PPTA 4344). The authors thank Claudia Cuervo for bioinformatics assistance. The study was partially supported by COLCIENCIAS (codes 111549326228 and 120351929098).	Barros-Battesti D.M.B., 2006, CARRAPATOS IMPORTANC; Bermudez SE, 2009, J MED ENTOMOL, V46, P856, DOI 10.1603/033.046.0417; Choi YJ, 2005, EMERG INFECT DIS, V11, P237, DOI 10.3201/eid1102.040603; Hidalgo M, 2007, EMERG INFECT DIS, V13, P1058, DOI 10.3201/eid1307.060537; Hun L, 2011, VECTOR-BORNE ZOONOT, V11, P1395, DOI 10.1089/vbz.2011.0641; Labruna MB, 2004, J MED ENTOMOL, V41, P1073, DOI 10.1603/0022-2585-41.6.1073; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Marquez FJ, 1998, AM J TROP MED HYG, V58, P570, DOI 10.4269/ajtmh.1998.58.570; Oteo JA, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0455-0; Portillo A, 2005, ANN NY ACAD SCI, V1063, P333, DOI 10.1196/annals.1355.053; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Sahni SK, 2013, FUTURE MICROBIOL, V8, P1265, DOI 10.2217/fmb.13.102; Wall R., 2001, VET ECTOPARASITES BI; WEBB L, 1990, J CLIN MICROBIOL, V28, P530, DOI 10.1128/JCM.28.3.530-534.1990; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	16	30	33	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-3667	1557-7759		VECTOR-BORNE ZOONOT	Vector-Borne Zoonotic Dis.	FEB	2016	16	2					85	87		10.1089/vbz.2015.1841	http://dx.doi.org/10.1089/vbz.2015.1841			3	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	DK9QQ	26789730				2022-09-04	WOS:000375266700003
J	Cardenas, D; Velez, G; Orfao, A; Herrera, MV; Solano, J; Olaya, M; Uribe, AM; Saavedra, C; Duarte, M; Rodriguez, M; Lopez, M; Fiorentino, S; Quijano, S				Cardenas, D.; Velez, G.; Orfao, A.; Herrera, M. V.; Solano, J.; Olaya, M.; Uribe, A. M.; Saavedra, C.; Duarte, M.; Rodriguez, M.; Lopez, M.; Fiorentino, S.; Quijano, S.			Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						diffuse large B cell lymphoma; EBV; memory and effector T lymphocytes; soluble cytokines; TCR-V beta repertoire	V-BETA REPERTOIRE; ACUTE INFECTIOUS-MONONUCLEOSIS; PERIPHERAL-BLOOD; VIRAL-INFECTION; IMMUNE-RESPONSE; HEALTHY-ADULTS; FLOW-CYTOMETRY; TUMOR-VIRUS; IN-VIVO; MEMORY	Epstein-Barr virus (EBV) is a persistent virus with oncogenic capacity that has been implicated in the development of aggressive B cell lymphomas, primarily in immunosuppressed individuals, although it can be present in immunocompetent individuals. Changes in the function and clonal diversity of T lymphocytes might be implied by viral persistence and lymphoma development. The aim of the present study was to evaluate the frequency, phenotype, function and clonotypical distribution of EBV-specific T cells after peripheral blood stimulation with a virus lysate in newly diagnosed patients with diffuse large B cell lymphoma (DLBCL) aged more than 50 years without prior histories of clinical immunosuppression compared with healthy controls. Our results showed impaired EBV-specific immune responses among DLBCL patients that were associated primarily with decreased numbers of central and effector memory CD8(+) T lymphocytes. In contrast to healthy controls, only a minority of the patients showed CD4(+)/tumour necrosis factor (TNF)-(+) T cells expressing T cell receptor (TCR)-V17 and CD8(+)/TNF-(+) T cells with TCR-V52, V9 and V18 in response to EBV. Notably, the production of TNF- was undetectable among TCR-V53(+), V11(+), V12(+), V16(+) and V23(+) CD8(+) T cells. In addition, we observed decreased numbers of CD4(+)/TNF-(+) and CD8(+)/TNF-(+), CD8(+)/interleukin (IL)-2(+) and CD8(+)/TNF-(+)/IL-2(+) T lymphocytes in the absence of T cells capable of producing TNF-, IL-2 and IFN- after EBV stimulation simultaneously. Moreover, DLBCL patients displayed higher IL-10 levels both under baseline conditions and after EBV stimulation. These findings were also observed in patients with positive EBV viral loads. Prospective studies including a large number of patients are needed to confirm these findings.	[Cardenas, D.; Velez, G.; Fiorentino, S.; Quijano, S.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Grp Inmunobiol & Biol Celular, Bogota, Colombia; [Orfao, A.] Univ Salamanca, Serv Gen Citometria, E-37008 Salamanca, Spain; [Orfao, A.] Univ Salamanca, Dept Med, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain; [Orfao, A.] Univ Salamanca, IBSAL, CSIC USAL, E-37008 Salamanca, Spain; [Herrera, M. V.; Solano, J.] Hosp Univ San Ignacio, Ctr Oncol Javeriano, Serv Hematol, Bogota, Colombia; [Olaya, M.; Uribe, A. M.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Patol, Bogota, Colombia; [Saavedra, C.] Fdn Santa Fe De Bogota, Grp Patol, Bogota, Colombia; [Duarte, M.; Rodriguez, M.] Fdn Santa Fe De Bogota, Serv Hematol, Bogota, Colombia; [Lopez, M.] Fdn Cardiovasc Colombia, Floridablanca, Colombia		Quijano, S (corresponding author), Pontificia Univ Javeriana Bogota Colombia, Dept Microbiol, Cra 7 43-82,Edificio 50,Oficina 307, Bogota, Colombia.	squijano@javeriana.edu.co	Quijano, Sandra/AAF-2945-2019; Orfao, Alberto/B-5801-2017; fiorentino, susana/R-8700-2016; Lopez, Marcos/AAQ-9872-2021; OLAYA-C, MERCEDES/AGC-7209-2022	fiorentino, susana/0000-0002-4664-0682; OLAYA-C, MERCEDES/0000-0002-7147-425X; Cardenas, Denny/0000-0002-2881-8504; Quijano, Sandra/0000-0003-4452-9291; Solano Vega, Julio Cesar/0000-0002-5150-3041	Pontificia Universidad Javeriana Bogota, Colombia [ID. 4149, ID. 3128]	Pontificia Universidad Javeriana Bogota, Colombia	This study was supported by the following grants: ID. 4149 and ID. 3128 from the Pontificia Universidad Javeriana Bogota, Colombia. The authors thank Adriana Plata and Yubelly Avello of Fundacion Santa Fe de Bogota for their technical support with in-situ hybridization.	Annels NE, 2000, J IMMUNOL, V165, P4831, DOI 10.4049/jimmunol.165.9.4831; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Bingler MA, 2008, AM J TRANSPLANT, V8, P442, DOI 10.1111/j.1600-6143.2007.02080.x; Cader FZ, 2010, CANCER TREAT REV, V36, P348, DOI 10.1016/j.ctrv.2010.02.011; Callan MFC, 2000, J CLIN INVEST, V106, P1251, DOI 10.1172/JCI10590; Callan MFC, 1998, EUR J IMMUNOL, V28, P4382, DOI 10.1002/(SICI)1521-4141(199812)28:12<4382::AID-IMMU4382>3.0.CO;2-Z; Sierra DC, 2014, CLIN EXP IMMUNOL, V177, P320, DOI 10.1111/cei.12337; Castillo JJ, 2011, ONCOLOGIST, V16, P87, DOI 10.1634/theoncologist.2010-0213; Crough T, 2005, EUR J IMMUNOL, V35, P139, DOI 10.1002/eji.200425548; Crucian BE, 2001, J IMMUNOL METHODS, V247, P35, DOI 10.1016/S0022-1759(00)00326-4; Darrah PA, 2010, J EXP MED, V207, P1421, DOI 10.1084/jem.20092532; Dolcetti R, 2015, SEMIN CANCER BIOL, V34, P58, DOI 10.1016/j.semcancer.2015.04.006; Guerreiro M, 2010, EUR J IMMUNOL, V40, P1566, DOI 10.1002/eji.200940000; Gulley ML, 2008, J MOL DIAGN, V10, P279, DOI 10.2353/jmoldx.2008.080023; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Hartmann EM, 2008, HEMATOL ONCOL CLIN N, V22, P807, DOI 10.1016/j.hoc.2008.07.004; Hislop AD, 2001, J IMMUNOL, V167, P2019, DOI 10.4049/jimmunol.167.4.2019; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Huh Jooryung, 2012, Korean J Hematol, V47, P92, DOI 10.5045/kjh.2012.47.2.92; Iancu EM, 2009, J IMMUNOL, V183, P319, DOI 10.4049/jimmunol.0803647; Jaffe ES, 2009, HEMATOLOGY AM SOC HE, V2009, P523, DOI [10.1182/asheducation-2009.1.523, DOI 10.1182/ASHEDUCATION-2009.1.523, 10.1182/asheducation.V2009.1.523.0010523]; Klein G, 2010, BIOCHEM BIOPH RES CO, V396, P67, DOI 10.1016/j.bbrc.2010.02.146; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li H, 2003, CLIN IMMUNOL, V107, P160, DOI 10.1016/S1521-6616(03)00043-3; Lima M, 2003, BLOOD CELL MOL DIS, V30, P1, DOI 10.1016/S1079-9796(03)00014-7; Macedo C, 2011, J IMMUNOL, V186, P5854, DOI 10.4049/jimmunol.1001024; Makedonas G, 2006, SPRINGER SEMIN IMMUN, V28, P209, DOI 10.1007/s00281-006-0025-4; Marshall NA, 2003, J IMMUNOL, V170, P6183, DOI 10.4049/jimmunol.170.12.6183; Munz C, 2008, SEMIN CANCER BIOL, V18, P381, DOI 10.1016/j.semcancer.2008.10.002; Ng SB, 2009, ADV ANAT PATHOL, V16, P40, DOI 10.1097/PAP.0b013e3181916029; Ning RJ, 2011, IMMUNOLOGY, V134, P161, DOI 10.1111/j.1365-2567.2011.03476.x; Orfao A., 2003, CURR PROTOC CYTOM, V9, P1; Ouaguia L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/564296; Perez-Andres M, 2006, CANCER-AM CANCER SOC, V106, P1296, DOI 10.1002/cncr.21746; Piriou E, 2005, BLOOD, V106, P3166, DOI 10.1182/blood-2005-01-0432; Rodriguez-Caballero A, 2004, LAB INVEST, V84, P1387, DOI 10.1038/labinvest.3700162; Rodriguez-Caballero A, 2007, CYTOM PART B-CLIN CY, V72B, P371, DOI 10.1002/cyto.b.20187; Rossi M, 2012, ADV HEMATOL, V2012, P1; Rymkiewicz PD, 2012, IMMUNOL RES, V53, P235, DOI 10.1007/s12026-012-8289-3; Said J, 2009, ADV ANAT PATHOL, V16, P216, DOI 10.1097/PAP.0b013e3181a9d5d2; Sallusto F, 1999, NATURE, V402, P34; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sehrawat S, 2011, J LEUKOCYTE BIOL, V90, P1079, DOI 10.1189/jlb.0611271; Silins SL, 1996, J EXP MED, V184, P1815, DOI 10.1084/jem.184.5.1815; Smithey MJ, 2012, J IMMUNOL, V189, P5356, DOI 10.4049/jimmunol.1201867; Tan H, 2010, HEMATOLOGY, V15, P81, DOI 10.1179/102453310X12583347009856; Thorley-Lawson DA, 2005, J ALLERGY CLIN IMMUN, V116, P251, DOI 10.1016/j.jaci.2005.05.038; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; van Baarle D, 2001, BLOOD, V98, P146, DOI 10.1182/blood.V98.1.146; Vanhoutte VJ, 2009, IMMUNOLOGY, V127, P577, DOI 10.1111/j.1365-2567.2008.03035.x; vansden Beemd R, 2000, CYTOMETRY, V40, P336; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Waldrop SL, 1998, J IMMUNOL, V161, P5284; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Wynn KK, 2010, IMMUNOL CELL BIOL, V88, P125, DOI 10.1038/icb.2009.74	58	16	16	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	NOV	2015	182	2					173	183		10.1111/cei.12682	http://dx.doi.org/10.1111/cei.12682			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT6WY	26174440	Green Published			2022-09-04	WOS:000362955000008
J	Gutierrez-Malaxechebarria, AM; Prime, S; Revillion, C				Gutierrez-Malaxechebarria, Alvaro-Martin; Prime, Simon; Revillion, Christophe			Irrigated Family Farming Panorama in the Latin-American Highlands	CUADERNOS DE DESARROLLO RURAL			English	Article						Irrigation; family farming; highlands; cartography; Latin America; Irrigation; family farms; private plot agriculture; agricultural mapping	ANDEAN IRRIGATION; WATER; RIGHTS; MAP	Although there are statistics and general cartography on irrigation systems in Latin America, this information does not permit to identify the irrigated family farming zones located in the highland areas. In this article we locate and quantify those zones through the use of cartographic methods that helped to identify the zones that meet three requirements: 1) they are irrigated areas; 2) they are located in zones above 1000 m; 3) Their rural population density is higher than 50 inhabitants per km2. The results confirm a wide presence of this type of systems in all Latin-American sub-regions. Nevertheless, due to the restrictions of quality and updating of the information from the available sources, the results given in the present document must be taken as a guideline.	[Gutierrez-Malaxechebarria, Alvaro-Martin] Pontificia Univ Javeriana, Bogota, Colombia; [Prime, Simon] Univ Toulouse 2, GEODE, Mirail, France; [Revillion, Christophe] IRD, UMR Espace Dev, Montpellier, France		Gutierrez-Malaxechebarria, AM (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.	malaxechebarria@yahoo.com; simon.prime@inbox.com; christophe.revillion@ird.fr	Kubrak, Snizhana/C-1469-2018	Kubrak, Snizhana/0000-0003-4236-1528; Gutierrez-Malaxechebarria, Alvaro-Martin/0000-0002-2306-1610; Revillion, Christophe/0000-0002-3896-2083	research projects : "Impacto economico del riego informal en los sistemas de produccion agropecuarios de ladera de la region Andina Colombiana"; Pontificia Universidad Javeriana [M08H01, C09H02]	research projects : "Impacto economico del riego informal en los sistemas de produccion agropecuarios de ladera de la region Andina Colombiana"; Pontificia Universidad Javeriana	This article was supported by the following research projects : "Impacto economico del riego informal en los sistemas de produccion agropecuarios de ladera de la region Andina Colombiana", financed by the Pontificia Universidad Javeriana's academic vice-rectory and research projects that were partly developed through the projects ECOS - Nord no M08H01 "Transformations territoriales et irrigation paysanne dans les vallees de Puebla (Mexique)" (2009-2011) and ECOS - Nord no C09H02: "Les relations entre systemes de production et ecosystemes dans les Andes Colombiennes", 2009-2011. We thank Jaime Forero Alvarez, Alexandra Angeliaume-Des Camps and Jean Christian Tulet, who reviewed and commented this work. Special thanks to Sonia Patricia Hernandez Ocampo, who translated it into English.	Angeliaume-Descamps A., 2012, MODELES IRRIGATION P; Angeliaume-Descamps A., 2011, J GEOGR TRO IN PRESS; [Anonymous], 2009, CAHIERS OUTRE MER, P439; [Anonymous], [No title captured]; [Anonymous], 1994, RESUMENES COMUNICACI, P99; [Anonymous], 2001, INT J WATER, V1, P3; [Anonymous], 2010, REV ESPANOLA ANTROPO, V40, P197; Boelens R, 2009, ANU ESTUD AM, V66, P23; Boelens R, 2009, DEV CHANGE, V40, P307, DOI 10.1111/j.1467-7660.2009.01516.x; Carmagnani Marcello, 2008, Prob. Des, V39, P11; CGIAR-SCI, 2008, SRTM 90M DEM DIG EL; Chiriboga M., 1999, DESARROLLO SOSTENIBL; Cremers L, 2005, NAT RESOUR FORUM, V29, P37, DOI 10.1111/j.1477-8947.2005.00111.x; De Vos H, 2006, INT J WATER RESOUR D, V22, P37, DOI 10.1080/07900620500405049; FAO, 2010, 31 REG C LAT AM CAR; FAO Food and Agriculture Organization, 2000, RIEG AM LAT CAR CIFR; FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS (FAO), 2007, PIR 0 2 DIETH 6 METH, P1; Food and Agriculture Organization of the United Nations (FAO), 2012, AQUASTAT DAT; Gender and Water Alliance, 2007, GEN AG AGR IRR GUIA; Girard S, 2005, M PPEMONDE, P12; Godoy R, 1998, J ANTHROPOL RES, V54, P351, DOI 10.1086/jar.54.3.3630652; Gutierrez-Malaxechebarria A., 2011, 7 SEM INT DES RUR BO; Jauregui P., 2005, EFECTOS RIEGO INGREG; Le Goulven P., 1993, PERFORMANCE MEASUREM, P264; Leiva AJ, 2008, WORLD DEV, V36, P2663, DOI 10.1016/j.worlddev.2007.12.004; Maldonado Rojas T., 2000, TRANSFERENCIA SISTEM, P44; Palerm-Viqueira J, 2010, WATER POLICY, V12, P779, DOI 10.2166/wp.2010.110; PASSOS Eduardo, 2006, PASSAGENS, P13; Prime S., 2010, 6 C EUR CEISAL IND D; Ramirez J., 1999, AJUSTE ESTRUCTURAL E; Ruf T., 1999, IRRIGATION MONTAGNE; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Siebert S, 2007, GLOBAL MAP IRRIGATIO; Smith L. D., 2002, REFORMA DESCENTRALIZ; Thenkabail PS, 2009, INT J REMOTE SENS, V30, P3679, DOI 10.1080/01431160802698919; UN FAO, 2007, GEONETWORK OP SOURC; van der Zee J. J., 2002, IMPACT FARM WATER SU; Vanacker V, 2003, CATENA, V51, P329, DOI 10.1016/S0341-8162(02)00172-8; World Bank, 2007, RAPP DEV MOND 2008 A, P27; World Water Assessment Programme, 2009, 3 UNESCO WORLD WAT A, DOI [10.3390/w3020618, DOI 10.3390/W3020618]; Zimmerer KS, 2010, PROF GEOGR, V62, P335, DOI 10.1080/00330124.2010.483631; Zimmerer KS, 2000, ECUMENE, V7, P150, DOI 10.1177/096746080000700202	42	4	5	0	6	PONTIFICIA UNIV JAVERIANA, FAC EDUC	BOGOTA	CARRERA 7MA N 42-27 EDIFICIO LORENZO URIBE S J-SEGUNDO PISO, BOGOTA, DC 00000, COLOMBIA	0122-1450			CUAD DESARRO RURAL	Cuad. Desarro. Rural		2013	10	70			SI		93	114						22	Agriculture, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	273RA					2022-09-04	WOS:000328552800004
J	Ordonez-Blanco, IT; Martinez-Vernaza, S; Blair, KJ; Quiroga, C; Lowenstein, E; Amaya, LJL; Clark, J; Lake, JE; Valderrama-Beltran, SL				Ordonez-Blanco, I. Tatiana; Martinez-Vernaza, Samuel; Blair, Kevin J.; Quiroga, Camilo; Lowenstein, Ellen; Lombana Amaya, Luis J.; Clark, Jesse; Lake, Jordan E.; Valderrama-Beltran, Sandra Liliana			Anal cytology screening in men who have sex with men with HIV at a university hospital in Bogota, Colombia	INTERNATIONAL JOURNAL OF STD & AIDS			English	Article						Anus neoplasms; human immunodeficiency virus; men who have sex with men; cancer screening	INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS; CANCER	Background: Risk of anal squamous cell carcinoma (anal cancer) is greater among men who have sex with men (MSM) living with human immunodeficiency virus (HIV). We describe the frequency of and factors associated with abnormal anal cytology results in Colombian MSM living with HIV. Methods: This retrospective observational cohort study included MSM >= 18 years old living with HIV screened with anal cytology at Hospital Universitario San Ignacio in Bogota, Colombia between January 2019 and February 2020. A multivariable log-binomial regression model estimated associations with abnormal anal cytology. Results: A total of 211 patients were included. Mean age was 35.6 years. Sixty-eight (32.3%) had an abnormal anal cytology result: ASC-US 33.8% (n = 23); LSIL 60.3% (n = 41); and HSIL 5.9% (n = 4). MSM with an STI diagnosis in the previous 12 months (RR 1.48, [95% CI 1.03-2.12], p = 0.032) or with a CD4(+) T cell count <200 (RR 2.08 [95% CI 1.16-3.73], p = 0.014) were significantly more likely to have abnormal anal cytology. Conclusions: These data provide crucial information to guide scale up of anal cancer screening at select centers in Colombia. Our results also suggest STI prevention efforts and improved virological control among MSM living with HIV may have the secondary benefit of reducing the risk of anal cancer.	[Ordonez-Blanco, I. Tatiana; Martinez-Vernaza, Samuel; Quiroga, Camilo; Lowenstein, Ellen; Valderrama-Beltran, Sandra Liliana] Hosp Univ San Ignacio, Dept Med Interna, Unidad Infectol, Bogota, Colombia; [Ordonez-Blanco, I. Tatiana; Quiroga, Camilo; Lombana Amaya, Luis J.; Valderrama-Beltran, Sandra Liliana] Pontificia Univ Javeriana, Fac Med, Grp Invest Enfermedades Infecciosas, HUSI PUJ, Bogota, Colombia; [Blair, Kevin J.] Univ Calif Los Angeles UCLA, Dept Surg, Los Angeles, CA USA; [Blair, Kevin J.; Clark, Jesse] UCLA, Dept Med, Div Infect Dis, South Amer Program HIV Prevent Res SAPHIR, Los Angeles, CA USA; [Lombana Amaya, Luis J.] Hosp Univ San Ignacio, Dept Cirugia Gen, Bogota, Colombia; [Lake, Jordan E.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX USA; [Valderrama-Beltran, Sandra Liliana] Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia		Ordonez-Blanco, IT (corresponding author), Hosp Univ San Ignacio, Unidad Infectol, Carrera 7 40-62, Bogota 11131, Colombia.	tatianaordonezblanco@gmail.com		Clark, Jesse/0000-0001-5862-6530	University of California Los Angeles' South American Program in HIV Prevention Research (SAPHIR) NIMH grant [R25MH087222]; UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant [P30MH58107]; HUSI	University of California Los Angeles' South American Program in HIV Prevention Research (SAPHIR) NIMH grant; UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant; HUSI	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was partially funded by the University of California Los Angeles' South American Program in HIV Prevention Research (SAPHIR) NIMH grant R25MH087222. This work was also supported by the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant P30MH58107. Additionally, HUSI financially supported this project by protecting the time of each investigator.	Alvarez C., 2014, GUIA PRACTICA CLIN G, P46; [Anonymous], WORLD FACTBOOK COLOM; Apaydin KZ, 2018, J COMMUN HEALTH, V43, P792, DOI 10.1007/s10900-018-0486-0; Bean SM, 2010, LABMEDICINE, V41, P168, DOI 10.1309/LMHYS464MYWZOXFW; Blair KJ, 2021, J SURG RES, V267, P374, DOI 10.1016/j.jss.2021.05.037; Boldrini NAT., 2018, PLOS ONE, V13, P1; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; CATAÑO JUAN, 2006, Infect., V10, P214; Centers for Disease Control, 2014, MMWR-MORBID MORTAL W, V63, P29; Conley LJ, 2016, J INFECT DIS, V213, P351, DOI 10.1093/infdis/jiv408; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Fondo Colombiano de Enfermedades de Alto Costo Cuenta de Alto Costo [CAC], 2021, SIT VIH SIDA COL; Gilbert M, 2011, SEX TRANSM DIS, V38, P964, DOI 10.1097/OLQ.0b013e318222899d; Gimenez Felicidad, 2011, Arq. Gastroenterol., V48, P136, DOI 10.1590/S0004-28032011000200010; Goldstone SE, 2008, DIS COLON RECTUM, V51, P1130, DOI 10.1007/s10350-008-9306-4; Goncalves JCN, 2019, DIS COLON RECTUM, V62, P112, DOI 10.1097/DCR.0000000000001231; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Koskan AM, 2019, CANCER CAUSE CONTROL, V30, P989, DOI 10.1007/s10552-019-01209-8; Maia LB, 2014, DIAGN CYTOPATHOL, V42, P840, DOI 10.1002/dc.23130; Palefsky JM, 1998, J ACQ IMMUN DEF SYND, V17, P314, DOI 10.1097/00042560-199804010-00004; Palefsky JM, 2012, SEX HEALTH, V9, P580, DOI 10.1071/SH12045; Panel de expertos de GeSIDA, 2019, GUIA PRACT CLIN TUM; Revollo B, 2020, CLIN INFECT DIS, V71, P390, DOI 10.1093/cid/ciz831; Rosa-Cunha I, 2010, AIDS PATIENT CARE ST, V24, P533, DOI 10.1089/apc.2010.0032; Mendoza MLR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131040; Siddharthan RV, 2019, ANN GASTROENTEROL, V32, P257, DOI 10.20524/aog.2019.0364; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Stewart DB, 2018, DIS COLON RECTUM, V61, P755, DOI 10.1097/DCR.0000000000001114; The ANCHORstudy.org, 2021, TREAT AN CANC PREC L, P2; van Schalkwyk C, 2019, SEX TRANSM INFECT, V95, P122, DOI 10.1136/sextrans-2018-053558; Wang CCJ, 2019, CANCER TREAT RES, V177, P183, DOI 10.1007/978-3-030-03502-0_7; World health organization, 2021, GLOBAL CANC OBSERVAT, P2; Zhang XJ, 2013, AIDS BEHAV, V17, P1129, DOI 10.1007/s10461-011-0085-x	33	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0956-4624	1758-1052		INT J STD AIDS	Int. J. STD AIDS	JUN	2022	33	7					701	708	09564624221097742	10.1177/09564624221097742	http://dx.doi.org/10.1177/09564624221097742		APR 2022	8	Immunology; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases	2A5ZU	35491739				2022-09-04	WOS:000789231300001
J	Garcia-Cifuentes, E; Marquez, I; Vasquez, D; Aguillon, D; Borda, MG; Lopera, F; Cano-Gutierrez, C				Garcia-Cifuentes, Elkin; Marquez, Isabel; Vasquez, Daniel; Aguillon, David; Borda, Miguel G.; Lopera, Francisco; Cano-Gutierrez, Carlos			The Role of Gait Speed in Dementia: A Secondary Analysis from the SABE Colombia Study	DEMENTIA AND GERIATRIC COGNITIVE DISORDERS			English	Article						Dementia; Frailty; Older adults	MILD COGNITIVE IMPAIRMENT; MIDDLE-INCOME COUNTRIES; ALCOHOL-CONSUMPTION; INCIDENT DEMENTIA; ALZHEIMER-DISEASE; RISK SYNDROME; MOTOR; PREVALENCE; ASSOCIATION; DYSFUNCTION	Introduction: Gait speed (GS) is a predictor of negative outcomes in older adults and in those in risk to develop cognitive impairment; as such, it has been associated with dementia. Studies in Latin-American older adults showing this association are scarce. This study aimed to evaluate the relationship between GS and dementia in a representative sample of Colombian older adults. Methods: This study is a secondary analysis from the Survey on Health, Well-Being, and Aging, SABE (from initials in Spanish: Salud, Bienestar & Envejecimiento) Colombia's survey conducted in 2015 with a sample of 23,694 elderly adults aged 60 years or older. Results: A total of 19,470 participants from the SABE Colombia survey were available for analysis. The multivariate analysis shows that dementia was associated with slow GS (PR 2.39; CI 1.91-3.01) independently to the other variables (p < 0.001). Similarly, GS as a continuous variable shows a statistically significant association with dementia in the adjusted analysis (OR 0.06; CI 0.04-0.09; p < 0.001). Conclusion: Dementia was associated with slow GS. This finding provides evidence to include GS as a complementary parameter in the assessment of Colombian elderly adults.	[Garcia-Cifuentes, Elkin; Marquez, Isabel; Borda, Miguel G.; Cano-Gutierrez, Carlos] Pontificia Univ Javeriana, Inst Envejecimiento, Fac Med, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Garcia-Cifuentes, Elkin; Vasquez, Daniel; Aguillon, David; Lopera, Francisco] Univ Antioquia, Fac Med, Grp Neurociencias, Medellin, Colombia; [Vasquez, Daniel] Univ CES, Grp Invest Epidemiol & Bioestadist, Medellin, Colombia; [Aguillon, David] Univ Antioquia, Fac Med, Grp Neuropsicol & Conducta, Medellin, Colombia; [Borda, Miguel G.] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [Borda, Miguel G.] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Cano-Gutierrez, Carlos] Hosp Univ San Ignacio, Serv Geriatria, Bogota, Colombia		Garcia-Cifuentes, E (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Sch Med, Carrera 7 40-62, Bogota 110231, Colombia.	elkingarciaci@gmail.com	LOPERA, FRANCISCO/AAR-5968-2021; Garcia-Cifuentes, Elkin/AAC-6077-2021; Borda, Miguel German/AHB-5593-2022	Garcia-Cifuentes, Elkin/0000-0003-4214-0266; Borda, Miguel German/0000-0001-5832-0603; Vasquez, Daniel/0000-0002-2586-162X; Cano-Gutierrez, Carlos/0000-0001-5680-7880	Administrative Department of Science, Technology, and Innovation (Colciencias); Ministry of Health and Social Protection of Colombia [764]	Administrative Department of Science, Technology, and Innovation (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Ministry of Health and Social Protection of Colombia	The database used of this study is part of a larger project funded by the Administrative Department of Science, Technology, and Innovation (Colciencias) and the Ministry of Health and Social Protection of Colombia (SABE Study 2015, ID No. 764).	Aggarwal NT, 2006, ARCH NEUROL-CHICAGO, V63, P1763, DOI 10.1001/archneur.63.12.1763; Aguilar-Navarro SG, 2019, J NUTR HEALTH AGING, V23, P227, DOI 10.1007/s12603-019-1160-7; Albala C, 2005, REV PANAM SALUD PUBL, V17, P307, DOI 10.1590/S1020-49892005000500003; Allan LM, 2005, J AM GERIATR SOC, V53, P1681, DOI 10.1111/j.1532-5415.2005.53552.x; Allet L, 2010, DIABETOLOGIA, V53, P458, DOI 10.1007/s00125-009-1592-4; Annweiler C, 2013, BRAIN, V136, P859, DOI 10.1093/brain/aws373; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Ayers E, 2019, J ALZHEIMERS DIS, V71, pS95, DOI 10.3233/JAD-181227; Bender F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9521; Bragatto Vanessa Santa Rosa, 2017, Fisioter. mov., V30, P849, DOI 10.1590/1980-5918.030.004.ar03; Bramell-Risberg E, 2005, DEMENT GERIATR COGN, V20, P298, DOI 10.1159/000088335; Clare L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002245; Darwish H, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00277; De La Monte SM, 2014, HUMAN ALCOHOL RELATE; Downer B, 2015, AM J ALZHEIMERS DIS, V30, P364, DOI 10.1177/1533317514549411; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Gomez JF, 2013, COLOMB MEDICA, V44, P165; Alves DJF, 2017, J STRENGTH COND RES, V31, P3235, DOI 10.1519/JSC.0000000000002182; Ganguli M, 2005, NEUROLOGY, V65, P1210, DOI 10.1212/01.wnl.0000180520.35181.24; Garcia-Pinillos F, 2016, PSYCHOGERIATRICS, V16, P165, DOI 10.1111/psyg.12133; Gomez Diez FJ, 2016, COMUN HOMBRE, P1; Grant RL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7450; Gray WK, 2016, J AM GERIATR SOC, V64, P806, DOI 10.1111/jgs.14069; Hackett RA, 2018, J AM GERIATR SOC, V66, P1670, DOI 10.1111/jgs.15312; Hausdorff JM, 2013, J GERONTOL A-BIOL, V68, P409, DOI 10.1093/gerona/glt002; Hornyak V, 2012, TOP GERIATR REHABIL, V28, P27, DOI 10.1097/TGR.0b013e318233e75b; Inzitari M, 2007, NEUROEPIDEMIOLOGY, V29, P156, DOI 10.1159/000111577; Kim OY, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110407; Kiselev J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225026; Kuspinar A, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-1431-5; Lallart E, 2014, J NEURAL TRANSM, V121, P443, DOI 10.1007/s00702-013-1111-0; Lopera F, 1997, JAMA-J AM MED ASSOC, V277, P793, DOI 10.1001/jama.277.10.793; Luck T, 2012, AM J GERIAT PSYCHIAT, V20, P943, DOI 10.1097/JGP.0b013e31825c09bc; Malmstrom TK, 2014, J AM GERIATR SOC, V62, P721, DOI 10.1111/jgs.12735; Ministerio de Salud y Proteccion Social, 2015, EST NAC SAL BIEN ENV; Montero-Odasso M, 2018, J AM GERIATR SOC, V66, P1676, DOI 10.1111/jgs.15341; Montero-Odasso M, 2017, JAMA NEUROL, V74, P1380, DOI 10.1001/jamaneurol.2017.2880; Montero-Odasso M, 2017, J ALZHEIMERS DIS, V59, P707, DOI 10.3233/JAD-170149; Montero-Odasso M, 2014, J GERONTOL A-BIOL, V69, P1415, DOI 10.1093/gerona/glu155; Montero-Odasso M, 2014, NEUROL SCI, V35, P601, DOI 10.1007/s10072-013-1613-4; Montero-Odasso M, 2012, ARCH PHYS MED REHAB, V93, P293, DOI 10.1016/j.apmr.2011.08.026; Montero-Odasso Manuel, 2009, BMC Geriatr, V9, P41, DOI 10.1186/1471-2318-9-41; Nitrini R, 2009, INT PSYCHOGERIATR, V21, P622, DOI 10.1017/S1041610209009430; Norris ET, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5195-7; Oliveira Louise Makarem, 2019, Dement. neuropsychol., V13, P133, DOI 10.1590/1980-57642018dn13-020001; Piguet O, 2006, EUR ARCH PSY CLIN N, V256, P504, DOI 10.1007/s00406-006-0671-5; Plassman BL, 2009, ANN INTERN MED; Prince M., 2015, WORLD ALZHEIMER REPO, V17, P2016; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Prince M, 2012, LANCET, V380, P50, DOI 10.1016/S0140-6736(12)60399-7; Pritchard JM, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0623-0; Aguilar LR, 2019, ALZHEIMERS DEMENT, V15, P709, DOI 10.1016/j.jalz.2018.12.010; Ramirez-Velez R, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00052; Sakurai R, 2019, J GERONTOL A-BIOL, V74, P698, DOI 10.1093/gerona/gly084; Sala G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225006; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Sekhon H, 2019, GEROSCIENCE, V41, P409, DOI 10.1007/s11357-019-00093-z; Tian Q, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.21636; van Kan GA, 2012, J GERONTOL A-BIOL, V67, P425, DOI 10.1093/gerona/glr177; Verghese J, 2019, ALZHEIMERS DEMENT, V15, P870, DOI 10.1016/j.jalz.2019.03.011; Verghese J, 2014, NEUROLOGY, V83, P718, DOI 10.1212/WNL.0000000000000717; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Williams Michael A, 2016, Continuum (Minneap Minn), V22, P579, DOI 10.1212/CON.0000000000000305; Wirtshafter HS, 2019, CURR BIOL, V29, P3177, DOI 10.1016/j.cub.2019.07.089	64	4	4	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1420-8008	1421-9824		DEMENT GERIATR COGN	Dement. Geriatr. Cogn. Disord.	APR	2021	49	6					565	572		10.1159/000510494	http://dx.doi.org/10.1159/000510494		NOV 2020	8	Geriatrics & Gerontology; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology; Psychiatry	RN4LM	33207340				2022-09-04	WOS:000590578700001
J	Martin-Flores, N; Fernandez-Santiago, R; Antonelli, F; Cerquera, C; Moreno, V; Marti, MJ; Ezquerra, M; Malagelada, C				Martin-Flores, Nuria; Fernandez-Santiago, Ruben; Antonelli, Francesa; Cerquera, Catalina; Moreno, Veronica; Josep Marti, Maria; Ezquerra, Mario; Malagelada, Cristina			MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson's Disease Patients	MOLECULAR NEUROBIOLOGY			English	Article						mTOR; L-DOPA; Dyskinesia; Single nucleotide polymorphism; Parkinson's disease; Epistasia	SYNAPTIC PLASTICITY; SIGNALING PATHWAYS; RAPAMYCIN; PROTEIN; GROWTH; MOTOR; PHOSPHORYLATION; TRANSLATION; ASSOCIATION; PROTEASOME	Dyskinesia induced by L-DOPA administration (LID) is one of the most invalidating adverse effects of the gold standard treatment restoring dopamine transmission in Parkinson's disease (PD). However, LID manifestation in parkinsonian patients is variable and heterogeneous. Here, we performed a candidate genetic pathway analysis of the mTOR signaling cascade to elucidate a potential genetic contribution to LID susceptibility, since mTOR inhibition ameliorates LID in PD animal models. We screened 64 single nucleotide polymorphisms (SNPs) mapping to 57 genes of the mTOR pathway in a retrospective cohort of 401 PD cases treated with L-DOPA (70 PD with moderate/severe LID and 331 with no/mild LID). We performed classic allelic, genotypic, and epistatic analyses to evaluate the association of individual or combinations of SNPs with LID onset and with LID severity after initiation of L-DOPA treatment. As for the time to LID onset, we found significant associations with SNP rs1043098 in the EIF4EBP2 gene and also with an epistatic interaction involving EIF4EBP2 rs1043098, RICTOR rs2043112, and PRKCA rs4790904. For LID severity, we found significant association with HRAS rs12628 and PRKN rs1801582 and also with a four-loci epistatic combination involving RPS6KB1 rs1292034, HRAS rs12628, RPS6KA2 rs6456121, and FCHSD1 rs456998. These findings indicate that the mTOR pathway contributes genetically to LID susceptibility. Our study could help to identify the most susceptible PD patients to L-DOPA in order to prevent the appearance of early and/or severe LID in a future. This information could also be used to stratify PD patients in clinical trials in a more accurate way.	[Martin-Flores, Nuria; Malagelada, Cristina] Univ Barcelona, Fac Med, Dept Biomed, Unit Biochem, E-08036 Barcelona, Catalonia, Spain; [Martin-Flores, Nuria; Malagelada, Cristina] Univ Barcelona, Inst Neurociencies, E-08036 Barcelona, Catalonia, Spain; [Fernandez-Santiago, Ruben; Josep Marti, Maria; Ezquerra, Mario] IDIBAPS Inst Invest Biomed August Pi i Sunyer, Barcelona 08036, Catalonia, Spain; [Fernandez-Santiago, Ruben; Antonelli, Francesa; Cerquera, Catalina; Moreno, Veronica; Josep Marti, Maria; Ezquerra, Mario] Hosp Clin Barcelona, Neurol Serv, Barcelona, Catalonia, Spain; [Fernandez-Santiago, Ruben; Josep Marti, Maria; Ezquerra, Mario] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Cerquera, Catalina] Pontificia Univ Javeriana, Med Sch, Hosp Univ San Ignacio, Neurol Unit, Bogota, Colombia		Malagelada, C (corresponding author), Univ Barcelona, Fac Med, Dept Biomed, Unit Biochem, E-08036 Barcelona, Catalonia, Spain.; Malagelada, C (corresponding author), Univ Barcelona, Inst Neurociencies, E-08036 Barcelona, Catalonia, Spain.	cristina.malagelada@ub.edu	Malagelada, Cristina/X-6065-2019; Fernández‐Santiago, Rubén/K-3808-2014; Trabalon, Mario Ezquerra/E-3723-2019; Flores, Nuria Martin/X-7990-2019	Malagelada, Cristina/0000-0001-7185-436X; Fernández‐Santiago, Rubén/0000-0002-4582-0702; Trabalon, Mario Ezquerra/0000-0003-3246-6641; Flores, Nuria Martin/0000-0003-2537-751X; Cerquera, Catalina/0000-0002-3874-0261				Angliker Nico, 2013, Bioarchitecture, V3, P113, DOI 10.4161/bioa.26497; [Anonymous], RECENT DEV PARKINSOS; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bastide MF, 2015, PROG NEUROBIOL, V132, P96, DOI 10.1016/j.pneurobio.2015.07.002; Bockaert J, 2015, PHYSIOL REV, V95, P1157, DOI 10.1152/physrev.00038.2014; Calabresi P, 2007, PARKINSONISM RELAT D, V13, pS259, DOI 10.1016/S1353-8020(08)70013-0; Cao HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056516; Charbonnier-Beaupel F, 2015, J NEUROSCI, V35, P96, DOI 10.1523/JNEUROSCI.5231-13.2015; Cheshire P, 2014, NEURODEGENER DIS, V13, P24, DOI 10.1159/000351097; Chondrogiorgi M, 2014, EUR J NEUROL, V21, P433, DOI 10.1111/ene.12318; Comi C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020242; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Decressac M, 2013, J PARKINSON DIS, V3, P13, DOI 10.3233/JPD-120155; Devos D, 2014, PARKINSONISM RELAT D, V20, P170, DOI 10.1016/j.parkreldis.2013.10.017; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Fahn S, 1998, J NEUROL, V245, pP15, DOI 10.1007/PL00007742; Fahn S, 2008, PARKINSON'S DISEASE: MOLECULAR AND THERAPEUTIC INSIGHTS FROM MODEL SYSTEMS, P3; Fernandez-Santiago R, 2016, NEUROLOGY, V86, P1072, DOI 10.1212/WNL.0000000000002304; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Helton TD, 2008, P NATL ACAD SCI USA, V105, P19492, DOI 10.1073/pnas.0802280105; Holmans P, 2013, HUM MOL GENET, V22, P1039, DOI 10.1093/hmg/dds492; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jankovic J, 2005, MOVEMENT DISORD, V20, pS11, DOI 10.1002/mds.20458; Kaplan N, 2014, J MOL NEUROSCI, V53, P183, DOI 10.1007/s12031-014-0276-9; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Malagelada C, 2006, J NEUROSCI, V26, P9996, DOI 10.1523/JNEUROSCI.3292-06.2006; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Mandel SA, 2013, Google Patents, Patent No. [US20130217028A1, 0217028]; Mas S, 2015, EUR NEUROPSYCHOPHARM, V25, P51, DOI 10.1016/j.euroneuro.2014.11.011; Motsinger AA, 2006, GENET EPIDEMIOL, V30, P546, DOI 10.1002/gepi.20166; Nadjar A, 2009, PROG NEUROBIOL, V87, P1, DOI 10.1016/j.pneurobio.2008.09.013; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pardo OE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00191; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Polakiewicz RD, 1998, J BIOL CHEM, V273, P23534, DOI 10.1074/jbc.273.36.23534; Reijmerink NE, 2010, ALLERGY, V65, P199, DOI 10.1111/j.1398-9995.2009.02111.x; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shen YD, 2016, AUTISM RES, V9, P436, DOI 10.1002/aur.1540; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Tain LS, 2009, FLY, V3, P278, DOI 10.4161/fly.10309; Wang LJ, 2001, J BIOL CHEM, V276, P32670, DOI 10.1074/jbc.M102776200; Zai CC, 2013, J PSYCHIATR RES, V47, P1760, DOI 10.1016/j.jpsychires.2013.07.025; Zhang YY, 2013, J NEUROSCI, V33, P11655, DOI 10.1523/JNEUROSCI.0288-13.2013	55	10	10	4	18	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2019	56	3					2092	2100		10.1007/s12035-018-1219-1	http://dx.doi.org/10.1007/s12035-018-1219-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN4OP	29992529				2022-09-04	WOS:000460163700041
J	Lino, A; Fonseca, C; Rojas, D; Fischer, E; Pereira, MJR				Lino, Ana; Fonseca, Carlos; Rojas, Danny; Fischer, Erich; Ramos Pereira, Maria Joao			A meta-analysis of the effects of habitat loss and fragmentation on genetic diversity in mammals	MAMMALIAN BIOLOGY			English	Review						Allelic diversity; Habitat loss; Heterozygosity; Inbreeding; Mammals	FILE-DRAWER PROBLEM; BODY-SIZE; INBREEDING AVOIDANCE; FOREST; POPULATION; FLOW; DIFFERENTIATION; CONSEQUENCES; RECOGNITION; SENSITIVITY	Human activities have led to global changes with direct consequences for biodiversity. For this reason, special concerns have arisen, particularly in respect to global threats such as habitat loss and fragmentation, because they decrease population size, promote the loss of species genetic diversity, contract species geographical distribution and facilitate species loss. Interest in the genetic consequences related to habitat changes has increased in the last decades, so it became crucial to understand how genetic diversity changes due to habitat loss and fragmentation and if the degree of genetic losses is related with species traits. Thus, we conduct a meta-analysis to test if genetic diversity of mammalian populations that live in fragments is lower than those living in continuous habitats and we also explore which species traits could be related with the observed patterns. Through this meta-analysis we detected an overall decrease in allelic diversity, allelic richness, observed heterozygosity and expected heterozygosity in mammalian species that live in situations of high habitat fragmentation. However, not all species are affected the same way. We found that species with larger body mass are the most negatively affected by fragmentation; terrestrial and arboreal mammals are more negatively affected than flying species; herbivores suffer consistent negative effect of fragmentation in the four genetic measures analysed; and forest-dependent species are the most susceptible to the negative effects of fragmentation. We expected to detect an increase in inbreeding coefficients in fragments when compared to continuous habitats; however, this pattern did not arise, probably because time since fragmentation was not enough and/or species have ways to avoid inbreeding. The patterns here described allow a better understanding of which mammalian species are more susceptible to the negative effects of habitat loss and fragmentation, potentially giving support for the conservation and management of their populations. (C) 2018 Deutsche Gesellschaft fur Saugetierkunde. Published by Elsevier GmbH. All rights reserved.	[Lino, Ana; Fonseca, Carlos; Rojas, Danny; Ramos Pereira, Maria Joao] Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3810193 Aveiro, Portugal; [Lino, Ana; Fonseca, Carlos; Rojas, Danny; Ramos Pereira, Maria Joao] Univ Aveiro, Ctr Environm & Marine Studies CESAM, Campus Univ Santiago, P-3810193 Aveiro, Portugal; [Rojas, Danny] SUNY Stony Brook, Dept Ecol & Evolut, 650 Life Sci Bldg, Stony Brook, NY 11794 USA; [Rojas, Danny] Pontificia Univ Javeriana Cali, Dept Nat Sci & Math, Cali, Colombia; [Fischer, Erich] Univ Fed Mato Grosso do Sul, Inst Biociencias, BR-79070900 Campo Grande, Brazil; [Ramos Pereira, Maria Joao] Univ Fed Rio Grande do Sul, Inst Biosci, Dept Zool, Av Bento Goncalves 9500, BR-91540000 Porto Alegre, RS, Brazil		Lino, A (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3810193 Aveiro, Portugal.; Lino, A (corresponding author), Univ Aveiro, Ctr Environm & Marine Studies CESAM, Campus Univ Santiago, P-3810193 Aveiro, Portugal.	ana.lino@ua.pt; cfonseca@ua.pt; rojasmartin.cu@gmail.com; erich.fischer@ufms.br; maria.joao@ufrgs.br	Rojas, Danny/A-7961-2011; Fonseca, Carlos MMS/D-9744-2011; Fischer, Erich Arnold/I-1472-2012; Pereira, Maria João Ramos/AAH-9411-2021	Rojas, Danny/0000-0002-5835-0324; Fonseca, Carlos MMS/0000-0001-6559-7133; Fischer, Erich Arnold/0000-0001-8722-9876; Pereira, Maria João Ramos/0000-0002-9365-5166	University of Aveiro (Department of Biology); FCT/MEC [UID/AMB/50017]; FEDER within the PT2020 Partnership Agreement; Foundation for Science and Technology, Portugal [SFRH/BD/52566/2014, SFRH/BPD/97707/2013]; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul [PAPOS/44/2014]; National Council for Scientific and Technological Development, Brazil [307016/2015-3]	University of Aveiro (Department of Biology); FCT/MEC; FEDER within the PT2020 Partnership Agreement; Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); National Council for Scientific and Technological Development, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank to University of Aveiro (Department of Biology) and FCT/MEC for the financial support to CESAM RU (UID/AMB/50017) through national funds and co-financed by the FEDER, within the PT2020 Partnership Agreement. A.L. and D.R. were supported by Foundation for Science and Technology, Portugal (wwwict. pt), fellowships SFRH/BD/52566/2014 and SFRH/BPD/97707/2013, respectively. E.F. and MJ.R.P. were supported by Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (http://funclectlecies,neti), PAPOS/44/2014, and E.F. by National Council for Scientific and Technological Development, Brazil (http://cnowbri), Research Grant 307016/2015-3. We also thank Josh Nightingale for the thorough revision of our paper.	Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; [Anonymous], 2006, MAMIFEROS BRASIL; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Athrey G, 2012, EVOL APPL, V5, P540, DOI 10.1111/j.1752-4571.2011.00233.x; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Biedermann R, 2003, GLOBAL ECOL BIOGEOGR, V12, P381, DOI 10.1046/j.1466-822X.2003.00048.x; Blackburn TM, 1999, ADV ECOL RES, V28, P181, DOI 10.1016/S0065-2504(08)60033-1; COCKBURN A, 1985, ANIM BEHAV, V33, P908, DOI 10.1016/S0003-3472(85)80025-7; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Didham RK, 2012, OIKOS, V121, P161, DOI 10.1111/j.1600-0706.2011.20273.x; Dietz G, 2014, OPENMEE SOFTWARE ECO; Driscoll DA, 2013, TRENDS ECOL EVOL, V28, P605, DOI 10.1016/j.tree.2013.06.010; Dutta T, 2013, EVOL APPL, V6, P949, DOI 10.1111/eva.12078; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Gibbs JP, 2001, BIOL CONSERV, V100, P15, DOI 10.1016/S0006-3207(00)00203-2; GUREVITCH J, 2001, DESIGN ANAL ECOLOGIC, P347; Hanski I, 2015, J BIOGEOGR, V42, P989, DOI 10.1111/jbi.12478; Harris RJ, 2002, ANN ZOOL FENN, V39, P275; Harrison F, 2011, METHODS ECOL EVOL, V2, P1, DOI 10.1111/j.2041-210X.2010.00056.x; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Hoglund J, 2009, EVOLUTIONARY CONSERVATION GENETICS, P1; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; IUCN, 2017, IUCN LIST THREAT SPE; Joricheva J, 2013, HDB METAANALYSIS ECO; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Koskimaki J, 2014, POPUL ECOL, V56, P341, DOI 10.1007/s10144-013-0411-4; Lancaster ML, 2016, LANDSCAPE ECOL, V31, P655, DOI 10.1007/s10980-015-0271-8; Lindenmayer DB, 2007, TRENDS ECOL EVOL, V22, P127, DOI 10.1016/j.tree.2006.11.006; MAC ARTHUR ROBERT H., 1967; MILLS LS, 1995, CONSERV BIOL, V9, P395, DOI 10.1046/j.1523-1739.1995.9020395.x; Montgelard C, 2014, MAMMALIA, V78, P139, DOI 10.1515/mammalia-2012-0142; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Murphy GEP, 2014, ECOL EVOL, V4, P91, DOI 10.1002/ece3.909; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Parr LA, 2010, J COMP PSYCHOL, V124, P343, DOI 10.1037/a0020545; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Potter S, 2012, CONSERV GENET, V13, P937, DOI 10.1007/s10592-012-0342-1; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Puttker T, 2008, STUD NEOTROP FAUNA E, V43, P11, DOI 10.1080/01650520701553651; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Quesnelle PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090926; Quin DG, 2010, COMP BIOCHEM PHYS A, V155, P336, DOI 10.1016/j.cbpa.2009.11.014; R Development Core Team, 2008, R LANG ENV STAT COMP; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1111/j.0014-3820.2005.tb01004.x; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Struebig MJ, 2011, ECOL LETT, V14, P582, DOI 10.1111/j.1461-0248.2011.01623.x; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; Thornton DH, 2011, ECOL APPL, V21, P2324, DOI 10.1890/10-2124.1; Tucker MA, 2018, SCIENCE, V359, P466, DOI 10.1126/science.aam9712; Vetter D, 2011, ECOGRAPHY, V34, P1, DOI 10.1111/j.1600-0587.2010.06453.x; Villard MA, 2014, J APPL ECOL, V51, P309, DOI 10.1111/1365-2664.12190; Waits LP, 2016, LANDSCAPE GENETICS: CONCEPTS, METHODS, APPLICATIONS, P199; Wellesley-Whitehouse H, 1983, AUSTR MUSEUM COMPLET, P371; Williams BL, 2003, MOL ECOL, V12, P11, DOI 10.1046/j.1365-294X.2003.01700.x	60	35	37	14	87	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1616-5047	1618-1476		MAMM BIOL	Mamm. Biol.	JAN	2019	94						69	76		10.1016/j.mambio.2018.09.006	http://dx.doi.org/10.1016/j.mambio.2018.09.006			8	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	HK7JX					2022-09-04	WOS:000458165800011
J	Restrepo, LF				Restrepo, Luis Fernando			CELEBRITY AUTHORS, HUMANITARIAN NARRATIVES, AND THE ROLE OF LITERATURE IN WORLD CRISES TODAY: THE MEDECINS SANS FRONTIERS' NEWSPAPER CHRONICLES TESTIGOS DEL HORROR (WITNESS OF HORROR)	COMPARATIVE LITERATURE STUDIES			English	Article						humanitarianism; chronicle; public intellectuals; human rights; empathy; world crises		This article examines a series of chronicles on contemporary world crises commissioned by Medecins sans Frontiers to eight well-known Hispanic writers and a photojournalist published by El Pais and followed by an exhibition at multiple Instituto Cervantes sites. Seeking to assist vulnerable populations across the globe, the series turned to the authors' prestige as public intellectuals and creativity to appeal to the international community for support. Literature's potential to generate empathy and express solidarity is viewed with some healthy skepticism, arguing that despite their urgent and evident need, a critical view of top-down humanitarian campaigns is necessary. In regards to literature in particular, this article suggests that solidarity projects must address the contradictory elements of humanitarian narratives and their mise en scene of suffering to be effective. Focusing on the chronicle as a genre, this article examines the aura of the author as a public intellectual, the aesthetic mediation of suffering, and the appeal to a metropolitan readership. As a mass media project and exhibition, Witness of Horror also sheds light into the institutional frameworks and practices that mediate literature's efforts to intervene in and remedy world crises today.	[Restrepo, Luis Fernando] Univ Arkansas, Spanish, Fayetteville, AR 72701 USA; [Restrepo, Luis Fernando] Univ Arkansas, Comparat Literature & Cultural Studies Program, Fayetteville, AR 72701 USA; [Restrepo, Luis Fernando] Univ Javeriana, Bogota, Colombia; [Restrepo, Luis Fernando] Univ Antioquia, Medellin, Colombia; [Restrepo, Luis Fernando] Univ EAFIT, Medellin, Colombia; [Restrepo, Luis Fernando] Univ Buenos Aires, Buenos Aires, DF, Argentina		Restrepo, LF (corresponding author), Univ Arkansas, Spanish, Fayetteville, AR 72701 USA.; Restrepo, LF (corresponding author), Univ Arkansas, Comparat Literature & Cultural Studies Program, Fayetteville, AR 72701 USA.; Restrepo, LF (corresponding author), Univ Javeriana, Bogota, Colombia.							[Anonymous], STAT YB; [Anonymous], INT ACT REP 2016, P92; Belloni R, 2007, REV INT STUD, V33, P451, DOI 10.1017/S0260210507007607; Bloom P., 2016, EMPATHY CASE RATIONA; Butler J., 2009, FRAMES WAR IS LIFE G; Chouliariaki Lilie, 2013, IRONIC SPECTATOR SOL; Das V, 1996, DAEDALUS, V125, P67; Fassin D, 2012, HUMANITARIAN REASON: A MORAL HISTORY OF THE PRESENT, P1; Gonzalez Anibal, 2002, CONT MEXICAN CHRONIC, P157; Hunt Lynn, 2007, INVENTING HUMAN RIGH; Jaramillo Agudelo Dario, 2012, ANTOLOGIA CRONICA LA; Kraniauskas J., 1997, MEXICAN POSTCARDS; Laqueur TW, 2009, HUMANITARIANISM AND SUFFERING: THE MOBILIZATION OF EMPATHY, P31; Laqueur Thomas W., 1989, NEW CULTURAL HIST, P176, DOI DOI 10.1525/J.CTT1PPFH6; Llosa, 2012, TESTIGOS DEL HORROR; Llosa Mario Vargas, 2011, TESTIGOS DEL OLVIDO; Lopez Ana Cristina Velez, 2009, PAIS SEMANAL 2009 20; Lopez Ana Cristina Velez, 2016, NARRATIVAS VILO ENTR, P153; Lopez Ana Cristina Velez, 2010, PAIS SEMANAL 2009 20; Mitchell K, 2016, GLOBAL NETW, V16, P288, DOI 10.1111/glob.12114; Nussbaum Martha, 2001, UPHEAVALS THOUGHT IN, P302; Rorty Richard, 1996, HUMAN RIGHTS OXFORD, P111; Scarry Elaine, 1996, LOVE COUNTRY DEBATIN, P98; Slaughter JR, 2009, HUMANITARIANISM AND SUFFERING: THE MOBILIZATION OF EMPATHY, P88; Sontag Susan, 2003, REGARDING PAIN OTHER, P95	25	1	1	0	3	PENN STATE UNIV PRESS	UNIVERSITY PK	820 NORTH UNIV DRIVE, U S B 1, STE C, UNIVERSITY PK, PA 16802 USA	0010-4132	1528-4212		COMP LITERATURE STUD	Comp. Lit. Stud.		2018	55	2			SI		345	360						16	Literature	Arts &amp; Humanities Citation Index (A&amp;HCI)	Literature	GP7SP					2022-09-04	WOS:000441108200006
J	Neganova, ME; Klochkov, SG; Petrova, LN; Shevtsova, EF; Afanasieva, SV; Chudinova, ES; Fisenko, VP; Bachurin, SO; Barreto, GE; Aliev, G				Neganova, Margarita E.; Klochkov, Sergey G.; Petrova, Ludmila N.; Shevtsova, Elena F.; Afanasieva, Svetlana V.; Chudinova, Ekaterina S.; Fisenko, Vladimir P.; Bachurin, Sergey O.; Barreto, George E.; Aliev, Gjumrakch			Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Alkaloids; antioxidant; lipid peroxidation; neurodegenerative diseases; neuroprotection; securinine; beta-amyloid	ALZHEIMERS-DISEASE; PARKINSON DISEASE; OXIDATIVE STRESS; ANTIOXIDANTS; CYTOTOXICITY; MECHANISMS; ROTENONE	Background: Oxidative stress and amyloid deposition are tightly interconnected pathological features of Alzheimer disease. In this respect, both amyloid production and aggregation may be stimulated by oxidative stress and also the increase of pathogenic beta-amyloid and its aggregated form lead to oxidative stress progression. Therefore, the search for potential drugs with both antioxidant and antiaggregation properties are of great interest. Methods: In this study, we described the stereospecific synthesis of alkaloid securinine aminoderivatives. Results: We showed that the newly synthesized compounds possess antioxidant and metal-chelating properties. Indeed, we report that one compound has inhibitory effects towards beta-amyloid aggregation. Conclusion: Based on these results, aminoderivatives of securinine scaffold are promising compounds for development of new drugs for the treatment of neurodegenerative diseases.	[Neganova, Margarita E.; Klochkov, Sergey G.; Petrova, Ludmila N.; Shevtsova, Elena F.; Afanasieva, Svetlana V.; Chudinova, Ekaterina S.; Bachurin, Sergey O.; Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka, Russia; [Fisenko, Vladimir P.] IM Sechenov First Moscow State Med Univ, Moscow, Russia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Univ Atlanta, Healthcare Adm, Johns Creek, GA 30097 USA		Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA.	aliev03@gmail.com	Shevtsova, Elena/G-6288-2017; Sergey, Bachurin/I-1708-2018; Barreto, George E./AAD-7420-2020; Klochkov, S. G./F-4087-2017; Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./B-5747-2014; Neganova, Margarita E/L-8499-2017	Barreto, George E./0000-0002-6644-1971; Klochkov, S. G./0000-0002-0299-9183; Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Elena, Shevtsova/0000-0003-2887-1185	Russian Scientific Foundation [14-23-00160]; Russian Science Foundation [17-23-00013] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work supported by the Russian Scientific Foundation (www.rscf.ru, Grant No. 14-23-00160 for 2014-2016: Directed design, synthesis, and study of biological activity of multi-target compounds as innovative drugs for treatment of neurodegenerative diseases).	Moneim AEA, 2015, CURR ALZHEIMER RES, V12, P335, DOI 10.2174/1567205012666150325182702; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Blach-Olszewska Z, 2015, CURR PHARM DESIGN, V21, P3582, DOI 10.2174/1381612821666150710144829; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Cohen T, 2006, BIOCHEMISTRY-US, V45, P4727, DOI 10.1021/bi051525c; Copperman R, 1973, Pa Med, V76, P36; De Andrade DVG, 2008, BRAIN RES, V1198, P188, DOI 10.1016/j.brainres.2008.01.006; de Oliveira DM, 2011, HUM EXP TOXICOL, V30, P1382, DOI 10.1177/0960327110389837; de Oliveria DM, 2009, NEUROCHEM RES, V34, P215, DOI 10.1007/s11064-008-9749-y; ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jurado-Coronel JC, 2016, CNS NEUROL DISORD-DR, V15, P292, DOI 10.2174/1871527315666160202125519; Klochkov SG, 2008, CHEM NAT COMPD+, V44, P197, DOI 10.1007/s10600-008-9013-3; Klochkov SG, 2014, CHEM NAT COMPD+, V50, P583, DOI 10.1007/s10600-014-1026-5; Klochkov SG, 2014, PHARM CHEM J+, V48, P15, DOI 10.1007/s11094-014-1035-5; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Mashkovskii MD, 1988, LEKARSTVENNYE SREDST, V1, P524; Neganova ME, 2011, NEUROCHEM J+, V5, P208, DOI 10.1134/S1819712411030056; Neganova ME, 2016, CNS NEUROL DISORD-DR, V15, P102, DOI 10.2174/1871527314666150821111812; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ono K, 2006, BBA-MOL BASIS DIS, V1762, P575, DOI 10.1016/j.bbadis.2006.03.002; Perez CA, 2009, J INORG BIOCHEM, V103, P326, DOI 10.1016/j.jinorgbio.2008.11.003; Santos G, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00097; Xu L, 2004, NEUROL RES, V26, P792, DOI 10.1179/016164104225014148	25	8	9	1	19	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2017	16	3					351	355		10.2174/1871527315666161107090525	http://dx.doi.org/10.2174/1871527315666161107090525			5	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	FA3BR	27823572				2022-09-04	WOS:000405316600014
J	Albert, RM; Bamford, MK; Stanistreet, I; Stollhofen, H; Rivera-Rondon, C; Rodriguez-Cintas, A				Albert, R. M.; Bamford, M. K.; Stanistreet, I.; Stollhofen, H.; Rivera-Rondon, C.; Rodriguez-Cintas, A.			Vegetation landscape at DK locality, Olduvai Gorge, Tanzania	PALAEOGEOGRAPHY PALAEOCLIMATOLOGY PALAEOECOLOGY			English	Article						Pleistocene; Eastern Africa; Olduvai Gorge; Palaeoenvironment; Phytoliths; Diatoms	LOWERMOST-BED-II; HOMINID LAND-USE; TUFF IF; PHYTOLITHS; PLIOPLEISTOCENE; ASSEMBLAGES; BASIN; CLASSIFICATION; PALEOECOLOGY; MACROPLANTS	The Olduvai Gorge palaeoanthropological site, in northern Tanzania, encompasses about two million years of earth history. The sedimentary facies of Palaeolake Olduvai have been used to reconstruct lake transgressions and regressions, up to total drying out, interpreted to reflect wet/dry climate cycles. Although multidisciplinary research has been conducted during the past decades to reconstruct the palaeoenvironments and palaeolandscapes of the Gorge, very few focused on the DK site located about 2 km farther east in the Gorge. We present here a vegetation study at DK for Bed I, the oldest stratum, based upon the phytolith and diatom recovery of the basalt lava to Tuff IB stratigraphic interval. These results have been analysed in relation to the different fades in which they occur: sandy diamictite, sandstone, sandy waxy claystone, waxy claystone, and sandy diatomite. The phytolith results from diamictite samples indicate a similar vegetation composition during these more arid periods. Conversely, waxy claystone and sandy waxy daystone samples show a higher diversity in the vegetation composition. The diatoms were indicative of a fresh water pool environment Thus the DK site would have provided plant foods for hominins, such as fruits from trees and shrubs and starch-rich rhizomes and tubers from sedges and reeds. Overall, the results at DK site present a different vegetation landscape in comparison to previously published phytolith results from other Olduvai stratigraphic levels and regions. (C) 2015 Elsevier B.V. All rights reserved.	[Albert, R. M.] ICREA, San Sebastian, Spain; [Albert, R. M.; Bamford, M. K.; Rodriguez-Cintas, A.] Univ Barcelona, ERAAUB, Dept Prehist Ancient Hist & Archaeol, Barcelona 08001, Spain; [Albert, R. M.; Bamford, M. K.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Stanistreet, I.] Univ Liverpool, Dept Earth Ocean & Ecol Sci, Liverpool L69 3GP, Merseyside, England; [Stollhofen, H.] Univ Erlangen Nurnberg, GeoZentrum Nordbayem, D-91054 Erlangen, Germany; [Rivera-Rondon, C.] Pontificia Univ Javeriana, Dept Biol, UNESIS, Bogota, Colombia		Albert, RM (corresponding author), Univ Barcelona, Fac Geog & Hist, Dept Prehist Ancient Hist & Archaeol, C Montalegre 6-8, Barcelona 08001, Spain.	rmalbert@ub.edu	Rodríguez-Cintas, Ágata/F-3467-2016; Albert, Rosa Maria/F-2937-2016; Rivera-Rondon, Carlos A/B-6162-2014	Rodríguez-Cintas, Ágata/0000-0002-3475-8261; Albert, Rosa Maria/0000-0003-1722-9445; Rivera-Rondon, Carlos A/0000-0001-5025-6141; Stollhofen, Harald/0000-0002-2782-3440	Spanish Ministry of Science and Innovation [HAR2010-15967, HAR2013-42054-P]; AGAUR from the Catalan Government [SGR2009-1418]; PAST (Palaeontological Scientific Trust, South Africa) [OLAPP 2014, OLAPP 2013]; German Science Foundation (DFG) [STO 275/9-1]; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Spanish Government); AGAUR from the Catalan Government; PAST (Palaeontological Scientific Trust, South Africa); German Science Foundation (DFG)(German Research Foundation (DFG)); ICREA(ICREA)	We thank reviewers for the helpful suggestions provided. We thank COSTECH and the Department of Antiquities, Tanzania for permission to carry out research at Olduvai Gorge, and the Ngorongoro Conservation for allowing access to the site, the excavators for assistance in the field, and members of OLAPP for useful discussions. Spanish financial support came from the Spanish Ministry of Science and Innovation (HAR2010-15967, HAR2013-42054-P) as well as from AGAUR from the Catalan Government SGR2009-1418 for GEPEG. Financial support for fieldwork was gratefully received from PAST (Palaeontological Scientific Trust, South Africa) (OLAPP 2014 and OLAPP 2013) for MKB and IGS and from the German Science Foundation (DFG grant STO 275/9-1) to HS.	Albert R. M., 2015, RECONSTRUCTION ANCIE; Albert R. M., 2011, PHYTOLITH CORE PHYTO; Albert RM, 2006, QUATERN INT, V148, P78, DOI 10.1016/j.quaint.2005.11.026; Albert RM, 2001, PHYTOLITHS: APPLICATIONS IN EARTH SCIENCES AND HUMAN HISTORY, P251; Albert RM, 2012, GEOARCHAEOLOGY, V27, P363, DOI 10.1002/gea.21413; Alexandre A, 1997, PALAEOGEOGR PALAEOCL, V136, P213, DOI 10.1016/S0031-0182(97)00089-8; [Anonymous], 2013, EDDI EUROPEAN DIATOM; Ashley G.M., 2002, SEDIMENTATION CONTIN, V73, P107, DOI DOI 10.2110/PEC.02.73.0107; Ashley GM, 2009, PALAEOGEOGR PALAEOCL, V272, P1, DOI 10.1016/j.palaeo.2008.10.016; Bamford MK, 2008, PALAEOGEOGR PALAEOCL, V257, P280, DOI 10.1016/j.palaeo.2007.09.003; Bamford MK, 2012, J HUM EVOL, V63, P351, DOI 10.1016/j.jhevol.2011.07.001; Bamford MK, 2006, QUATERN INT, V148, P95, DOI 10.1016/j.quaint.2005.11.027; Bamford MK, 2005, QUATERN INT, V129, P15, DOI 10.1016/j.quaint.2004.04.003; Barboni D, 1999, PALAEOGEOGR PALAEOCL, V152, P87, DOI 10.1016/S0031-0182(99)00045-0; Barboni D, 2007, PALAEOGEOGR PALAEOCL, V246, P454, DOI 10.1016/j.palaeo.2006.10.012; Barboni D, 2014, QUATERN INT, V322, P264, DOI 10.1016/j.quaint.2014.01.016; Barboni D, 2010, QUATERNARY RES, V74, P344, DOI 10.1016/j.yqres.2010.09.005; Barboni D, 2009, REV PALAEOBOT PALYNO, V158, P29, DOI 10.1016/j.revpalbo.2009.07.002; BLUMENSCHINE RJ, 1989, J HUM EVOL, V18, P345, DOI 10.1016/0047-2484(89)90036-5; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Blumenschine RJ, 1998, J HUM EVOL, V34, P565, DOI 10.1006/jhev.1998.0216; BLUMENSCHINE RJ, 1991, J HUM EVOL, V21, P451, DOI 10.1016/0047-2484(91)90095-D; Blumenschine RJ, 2012, J HUM EVOL, V63, P384, DOI 10.1016/j.jhevol.2011.05.003; Bonnefille R., 1984, NATL GEOGRAPHIC SOC, V17, P227; Brochu CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009333; CALJON AG, 1991, HYDROBIOLOGIA, V226, P179, DOI 10.1007/BF00006859; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Cordova CE, 2013, QUATERN INT, V287, P121, DOI 10.1016/j.quaint.2012.04.022; Deino AL, 2012, J HUM EVOL, V63, P251, DOI 10.1016/j.jhevol.2012.05.004; Honaine MF, 2009, AUST J BOT, V57, P512, DOI 10.1071/BT09041; Ficken KJ, 2002, PALAEOGEOGR PALAEOCL, V177, P137, DOI 10.1016/S0031-0182(01)00356-X; Fisher Erich C., 2013, Paleoanthropology, P104; FREDLUND GG, 1994, J BIOGEOGR, V21, P321, DOI 10.2307/2845533; GASSE F, 1995, PALAEOGEOGR PALAEOCL, V117, P31, DOI 10.1016/0031-0182(94)00122-O; GASSE F, 1983, Revue d'Hydrobiologie Tropicale, V16, P3; GASSE F, 1983, HYDROBIOLOGIA, V103, P85, DOI 10.1007/BF00028433; Gasse F., 1980, REV ALGOLOGIQUE MEMO, P249; Ghosh R, 2011, PALAEOGEOGR PALAEOCL, V311, P93, DOI 10.1016/j.palaeo.2011.08.009; Hay R., 1976, GEOLOGY OLDUVAI GORG, DOI DOI 10.1525/9780520334229; Iriarte J, 2006, QUATERNARY RES, V65, P20, DOI 10.1016/j.yqres.2005.05.005; KAPPELMAN J, 1984, PALAEOGEOGR PALAEOCL, V48, P171, DOI 10.1016/0031-0182(84)90043-9; Katz O, 2010, J ARCHAEOL SCI, V37, P1557, DOI 10.1016/j.jas.2010.01.016; Krammer K., 2004, SUSSWASSERFLORA MITT, V2/4, P468; Krammer K., 1991, SUSSWASSERFLORA MITT, V3/2, P576; Lange-Bertalot H., 2001, DIATOMS EUROPE, VVolume 2, P526; Leakey M.D., 1971, OLDUVAI GORGE EXCAVA, V3; Liutkus CM, 2003, J SEDIMENT RES, V73, P691, DOI 10.1306/021303730691; LIVINGSTONE DA, 1980, QUATERNARY RES, V13, P392, DOI 10.1016/0033-5894(80)90065-4; Lu HY, 2003, DIVERS DISTRIB, V9, P73, DOI 10.1046/j.1472-4642.2003.00166.x; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Albert RM, 2012, J HUM EVOL, V63, P342, DOI 10.1016/j.jhevol.2011.05.010; Albert RM, 2009, QUATERN INT, V193, P41, DOI 10.1016/j.quaint.2007.06.008; McHenry LJ, 2012, J HUM EVOL, V63, P284, DOI 10.1016/j.jhevol.2011.04.010; Mercader J, 2009, ANN BOT-LONDON, V104, P91, DOI 10.1093/aob/mcp097; Mulholland SC, 1992, PHYTOLITH SYSTEMATIC; Njau J.K., 2012, P INT S AFR CRAD HUM, P147; PETERS CR, 1995, J HUM EVOL, V29, P321, DOI 10.1006/jhev.1995.1062; Piperno DR, 2006, PHYTOLITHS COMPREHEN; PLUMMER TW, 1994, J HUM EVOL, V27, P47, DOI 10.1006/jhev.1994.1035; Potts, 1988, EARLY HOMINID ACTIVI; POTTS R, 1984, AM SCI, V72, P338; ROSEN AM, 1994, J ARCHAEOL SCI, V21, P125, DOI 10.1006/jasc.1994.1013; Runge F, 1999, REV PALAEOBOT PALYNO, V107, P23, DOI 10.1016/S0034-6667(99)00018-4; Sage R.F., 1999, C4 PLANT BIOL, P596; SANGSTER AG, 1969, ANN BOT-LONDON, V33, P315, DOI 10.1093/oxfordjournals.aob.a084285; Stanistreet IG, 2012, J HUM EVOL, V63, P300, DOI 10.1016/j.jhevol.2012.03.001; Stollhofen H, 2008, PALAEOGEOGR PALAEOCL, V259, P382, DOI 10.1016/j.palaeo.2007.09.024; TIESZEN LL, 1979, OECOLOGIA, V37, P337, DOI 10.1007/BF00347910; Tsartsidou G, 2007, J ARCHAEOL SCI, V34, P1262, DOI 10.1016/j.jas.2006.10.017; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Watling J, 2013, QUATERN INT, V287, P162, DOI 10.1016/j.quaint.2012.10.030; Zeeb Barabara A., 2001, Developments in Paleoenvironmental Research, V3, P203	72	24	24	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-0182	1872-616X		PALAEOGEOGR PALAEOCL	Paleogeogr. Paleoclimatol. Paleoecol.	MAY 15	2015	426						34	45		10.1016/j.palaeo.2015.02.022	http://dx.doi.org/10.1016/j.palaeo.2015.02.022			12	Geography, Physical; Geosciences, Multidisciplinary; Paleontology	Science Citation Index Expanded (SCI-EXPANDED)	Physical Geography; Geology; Paleontology	CG8ZA					2022-09-04	WOS:000353603000004
J	Lopez-Leon, S; Gonzalez-Giraldo, Y; Wegman-Ostrosky, T; Forero, DA				Lopez-Leon, Sandra; Gonzalez-Giraldo, Yeimy; Wegman-Ostrosky, Talia; Forero, Diego A.			Molecular genetics of substance use disorders: An umbrella review	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Review						Substance use disorder; Drug dependence; Addiction; Alcohol; Tobacco; Cannabis; Cocaine; Opioids and methamphetamine; Meta-analyses; Genomic studies	GENOME-WIDE ASSOCIATION; METAANALYSIS; ALCOHOL; CANNABIS; SUSCEPTIBILITY; HERITABILITY; DEPENDENCE; AUTS2; DRUG	Background: Substance use disorders (SUD) are a category of psychiatric disorders with a large epidemiological and societal impact around the world. In the last decades, a large number of genetic studies have been published for SUDs. Methods: With the objective of having an overview and summarizing the evidence published up to date, we carried out an umbrella review of all the meta-analyses of genetic studies for the following substances: alcohol, tobacco, cannabis, cocaine, opioids, heroin and methamphetamines. Meta-analyses for candidate gene studies and genome-wide association studies (GWAS) were included. Results: Alcohol and tobacco were the substances with the largest number of meta-analyses, and cannabis, opioids and cocaine the least studied. The following genes were associated with two or more SUDs: OPRM1, DRD2, DRD4, BDNF and SL6A4. The only genes that had an OR higher than two were the SLC6A4 for all addictions, the ADH1B for alcohol dependence, and BDNF for methamphetamine dependence. GWAS confirmed the possible role of CHRNA5 gene in nicotine dependence and identified novel candidate genes in other SUDs, such as FOXP2, PEX and, AUTS2, which need further functional analyses. Conclusions: This umbrella review summarizes the evidence of 16 years of research on the genetics of SUDs and provides a broad and detailed overview of results from more than 150 meta-analyses for SUD. The results of this umbrella review will guide the need for future genetic studies geared toward understanding, preventing and treating SUDs.	[Lopez-Leon, Sandra] Novartis Pharmaceut, Drug Dev, E Hanover, NJ USA; [Gonzalez-Giraldo, Yeimy] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Wegman-Ostrosky, Talia] Inst Nacl Cancerol INCan, Basic Res Subdirect, Mexico City, DF, Mexico; [Forero, Diego A.] Fdn Univ Area Andina, Sch Hlth & Sport Sci, Hlth & Sport Sci Res Grp, Bogota, Colombia; [Forero, Diego A.] Fdn Univ Area Andina, Sch Hlth & Sport Sci, MSc Program Epidemiol, Bogota, Colombia; [Gonzalez-Giraldo, Yeimy] Univ Antonio Narino, Ctr Psychosocial Studies Latin Amer & Caribbean, Bogota, Colombia		Lopez-Leon, S (corresponding author), Novartis Pharmaceut, E Hanover, NJ 07936 USA.	Sandra.lopez@novartis.com	Gonzalez, Yeimy/Y-1975-2019; González-Giraldo, Yeimy/Q-5652-2018	Gonzalez, Yeimy/0000-0002-2527-218X; González-Giraldo, Yeimy/0000-0002-2527-218X; Lopez Leon, Sandra/0000-0001-7504-3441	Pontificia Universidad Javeriana; Colciencias	Pontificia Universidad Javeriana; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	YGG was supported by a post-doctoral fellowship at Pontificia Universidad Javeriana. DAF has been previously supported by grants from Colciencias. We would like to thank Alejandro Lafuente for creating the ideogram in Fig. 2.	Adkins DE, 2015, TWIN RES HUM GENET, V18, P335, DOI 10.1017/thg.2015.36; Agrawal A, 2018, MOL PSYCHIATR, V23, P1293, DOI 10.1038/mp.2017.200; Agrawal A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.54; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Balhara YPS, 2017, J ADDICT NURS, V28, P11, DOI 10.1097/JAN.0000000000000155; Bedogni F, 2010, GENE EXPR PATTERNS, V10, P9, DOI 10.1016/j.gep.2009.11.005; Belbasis L, 2015, LANCET NEUROL, V14, P263, DOI 10.1016/S1474-4422(14)70267-4; Belin D, 2016, GENES BRAIN BEHAV, V15, P74, DOI 10.1111/gbb.12265; Berrettini W, 2017, DIALOGUES CLIN NEURO, V19, P229; Brazel DM, 2019, BIOL PSYCHIAT, V85, P946, DOI 10.1016/j.biopsych.2018.11.024; Cabana-Dominguez J, 2019, PROG NEURO-PSYCHOPH, V94, DOI 10.1016/j.pnpbp.2019.109667; Day E, 2018, DRUG ALCOHOL REV, V37, P283, DOI 10.1111/dar.12580; Degenhardt L, 2018, LANCET PSYCHIAT, V5, P987, DOI 10.1016/S2215-0366(18)30337-7; Ducci F, 2012, PSYCHIAT CLIN N AM, V35, P495, DOI 10.1016/j.psc.2012.03.010; Fan YJ, 2016, AM J MED GENET A, V170, P515, DOI 10.1002/ajmg.a.37454; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Forero DA, 2020, AM J DRUG ALCOHOL AB, V46, P22, DOI 10.1080/00952990.2019.1636384; Forero DA, 2016, J MED GENET, V53, P438, DOI 10.1136/jmedgenet-2015-103631; Fusar-Poli P, 2018, EVID-BASED MENT HEAL, V21, P95, DOI 10.1136/ebmental-2018-300014; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Gomez-Coronado N, 2018, J AFFECT DISORDERS, V241, P388, DOI 10.1016/j.jad.2018.08.041; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Grant BF, 2016, JAMA PSYCHIAT, V73, P39, DOI 10.1001/jamapsychiatry.2015.2132; Hasin DS, 2013, AM J PSYCHIAT, V170, P834, DOI 10.1176/appi.ajp.2013.12060782; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hiroi N, 2005, MOL PSYCHIATR, V10, P336, DOI 10.1038/sj.mp.4001622; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; Johnson EC, 2020, LANCET PSYCHIAT, V7, P1032, DOI 10.1016/S2215-0366(20)30339-4; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P674, DOI 10.1001/archpsyc.65.6.674; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P261, DOI 10.1001/archpsyc.57.3.261; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Mahna D, 2018, MUTAT RES-REV MUTAT, V777, P19, DOI 10.1016/j.mrrev.2018.06.002; McCance-Katz E, 2019, UDOHAHS NATL SURVEY; Moher David, 2009, Ann Intern Med, V151, P264, DOI 10.1136/bmj.b2535; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; MULLIGAN MK, 2019, PLOS MED, V1162, P129, DOI DOI 10.1007/978-3-030-21737-2_7; NAKAJIMA M, 1996, INT J SURG, V24, P1212; NELSON EC, 2016, ADV EXP MED BIOL, V21, P608, DOI DOI 10.1038/MP.2015.102; Patrinos D.A, 2020, GENOME PLASTICITY HL, P191; Peacock A, 2018, ADDICTION, V113, P1905, DOI 10.1111/add.14234; Peng Q, 2021, ADDICT BIOL, V26, DOI 10.1111/adb.12877; Peng Q, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0397-6; Vieira CMP, 2019, MOL MED REP, V19, P1423, DOI 10.3892/mmr.2018.9792; PIERCE RC, 2018, ADDICTION, V43, P1471, DOI DOI 10.1038/S41386-018-0008-X; PROMWORMLEY EC, 2017, TRANSL PSYCHIAT, V180, P241, DOI DOI 10.1016/J.DRUGALCDEP.2017.06.040; Quality Cf.B.H.Sa, 2018, 2017 NAT SURV DRUG U; Sanchez-Roige S, 2020, NAT NEUROSCI, V23, P475, DOI 10.1038/s41593-020-0609-7; SAUNDERS JB, 2017, DRUG ALCOHOL DEPEN, V30, P227; SCHUMANN G, 2016, CURR OPIN PSYCHIATR, V113, P14372; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Schwantes-An TH, 2016, BEHAV GENET, V46, P151, DOI 10.1007/s10519-015-9737-3; SHARP BM, 2019, P NATL ACAD SCI USA, V50, P2164, DOI DOI 10.1111/EJN.14171; SHERVA R, 2016, BMJ-BRIT MED J, V73, P472; SMOLLER JW, 2019, EUR J NEUROSCI, V24, P409, DOI DOI 10.1038/S41380-017-0010-4; Sulovari A, 2018, PHARMACOGENOMICS J, V18, P398, DOI 10.1038/tpj.2017.35; VAUGHN MG, 2019, MOL PSYCHIATR, V27, P62, DOI DOI 10.1016/J.COPSYC.2018.08.008; Verhulst B, 2015, PSYCHOL MED, V45, P1061, DOI 10.1017/S0033291714002165; Verweij KJH, 2013, ADDICT BIOL, V18, P846, DOI 10.1111/j.1369-1600.2012.00478.x; WARE JJ, 2011, ADDICT BIOL, V13, P1167, DOI DOI 10.1093/NTR/NTR118; WHITEFORD HA, 2015, MOL MED REP, V10, DOI DOI 10.1371/JOURNAL.PONE.0116820; Zhou H, 2020, JAMA PSYCHIAT, V77, P1072, DOI 10.1001/jamapsychiatry.2020.1206; Zhou H, 2020, NAT NEUROSCI, V23, P809, DOI 10.1038/s41593-020-0643-5; Zou ZL, 2017, ADV EXP MED BIOL, V1010, P21, DOI 10.1007/978-981-10-5562-1_2	64	15	15	4	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	MAY	2021	124						358	369		10.1016/j.neubiorev.2021.01.019	http://dx.doi.org/10.1016/j.neubiorev.2021.01.019		FEB 2021	12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	RB3HW	33556390				2022-09-04	WOS:000632006500010
J	Vesga-Jimenez, DJ; Hidalgo-Lanussa, O; Baez-Jurado, E; Echeverria, V; Ashraf, GM; Sahebkar, A; Barreto, GE				Vesga-Jimenez, Diego J.; Hidalgo-Lanussa, Oscar; Baez-Jurado, Eliana; Echeverria, Valentina; Ashraf, Ghulam Md; Sahebkar, Amirhossein; Barreto, George E.			Raloxifene attenuates oxidative stress and preserves mitochondrial function in astrocytic cells upon glucose deprivation	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						astrocytes; glucose deprivation; mitochondria; neuroprotection; raloxifene	ESTROGEN-RECEPTOR MODULATORS; TRAUMATIC BRAIN-INJURY; INDUCED UP-REGULATION; GLUTAMATE TRANSPORTERS; GROWTH-FACTORS; 17-BETA-ESTRADIOL; METABOLISM; ASTROGLIA; MECHANISM; RAT	Oxidative stress and mitochondrial dysfunction induced by metabolic insults are both hallmarks of various neurological disorders, whereby neuronal cells are severely affected by decreased glucose supply to the brain. Likely injured, astrocytes are important for neuronal homeostasis and therapeutic strategies should be directed towards improving astrocytic functions to improve brain's outcome. In the present study, we aimed to assess the actions of raloxifene, a selective estrogen receptor modulator in astrocytic cells under glucose deprivation. Our findings indicated that pretreatment with 1 mu M raloxifene results in an increase in cell viability and attenuated nuclei fragmentation. Raloxifene's actions also rely on the reduction of oxidative stress and preservation of mitochondrial function in glucose-deprived astrocytic cells, suggesting the possible direct effects of this compound on mitochondria. In conclusion, our results demonstrate that raloxifene's protective actions might be mediated in part by astrocytes in the setting of a metabolic insult.	[Vesga-Jimenez, Diego J.; Hidalgo-Lanussa, Oscar; Baez-Jurado, Eliana; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Cra 7 40-62, Bogota, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Concepcion, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Cra 7 40-62, Bogota, Colombia.	gsampaio@javeriana.edu.co	Valentina Echeverria Moran, BCh/E-7765-2013; Sahebkar, Amirhossein/B-5124-2018; Ashraf, Ghulam Md/H-9485-2012; Barreto, George E./AAD-7420-2020	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Vesga Jimenez, Diego Julian/0000-0003-1531-3862; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X				Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Avila MF, 2013, CELL BIOL INT, V37, P521, DOI 10.1002/cbin.10058; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Bourque M, 2014, NEUROBIOL AGING, V35, P2347, DOI 10.1016/j.neurobiolaging.2014.03.017; Cabezas R, 2016, MED CHEM, V12, P204, DOI 10.2174/1573406411666151019120444; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dhandapani KM, 2007, EXP GERONTOL, V42, P70, DOI 10.1016/j.exger.2006.06.032; Dwyer D, 2002, GLUCOSE METABOLISM B; Giatti S., 2018, PROGR NEUROBIOLOGY; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Osmanova S, 2011, IRAN J REPROD MED, V9, P295; Paradies G, 2014, ANTIOXID REDOX SIGN, V20, P1925, DOI 10.1089/ars.2013.5280; Paradies G, 2009, CELL CALCIUM, V45, P643, DOI 10.1016/j.ceca.2009.03.012; Pottoo F. H., 2018, MOL NEUROBIOLOGY; Richardson TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034600; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Vega-Vela NE, 2017, MOL NEUROBIOL, V54, P4996, DOI 10.1007/s12035-016-0045-6; Zhao LQ, 2005, BRAIN RES REV, V49, P472, DOI 10.1016/j.brainresrev.2005.01.009; Zhao TZ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.449	29	10	10	1	38	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	MAR	2019	234	3					2051	2057		10.1002/jcp.27481	http://dx.doi.org/10.1002/jcp.27481			7	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	HC2FU	30246411				2022-09-04	WOS:000451618500011
J	Baez, S; Santamaria-Garcia, H; Ibanez, A				Baez, Sandra; Santamaria-Garcia, Hernando; Ibanez, Agustin			Disarming Ex-Combatants' Minds: Toward Situated Reintegration Process in Post-conflict Colombia	FRONTIERS IN PSYCHOLOGY			English	Article						collective violence; armed conflict; reintegration process; post-conflict Colombia; ex-combatants	POSTTRAUMATIC-STRESS-DISORDER; GULF-WAR VETERANS; MENTAL-HEALTH; SOCIAL COGNITION; VIOLENT BEHAVIOR; APPETITIVE AGGRESSION; CONTROLLED-TRIAL; LIFE STRESS; INTERGROUP; EXPOSURE	Collective violence in the context of armed conflict impacts the economy, health systems, and social stability of affected countries. This is considered a complex phenomenon with interwoven biological, psychological, social, cultural, and political factors. However, most of the research on this topic still lacks suitable established integrative approaches to assess multilevel perspectives. Social, cognitive and affective mental processes (SCAMP) are critical factors that should be considered in multilevel approaches. In this article, we critically discuss some of the classically isolated approaches used in violence research, the absence of successful interventions for ex-combatants reintegration, and the specific neglect of SCAMP in these interventions. We present the case of post-conflict Colombia as a unique opportunity to study the different roots of collective violence, and we call for a more robust and situated approach to understanding of and intervention in this multifaceted phenomenon. In addition, we suggest a two-stage approach for addressing ex-combatants' reintegration programs, which considers the situated nature of post-conflict scenarios and the urgent need for evidence-based interventions. This approach focuses on the comprehensive scientific assessment of specific factors involved in violence exposure and the subsequent design of successful interventions. The implementation of this approach will contribute to the effective reintegration of individuals who have been exposed to extreme violence for more than 50 years.	[Baez, Sandra] Univ Andes, Dept Psicol, Bogota, Colombia; [Santamaria-Garcia, Hernando] Intellectus Hosp Univ San Ignacio, Ctr Memoria & Cognic, Bogota, Colombia; [Santamaria-Garcia, Hernando] Pontificia Univ Javeriana, Physiol & Psychiat, Bogota, Colombia; [Ibanez, Agustin] Favaloro Univ, INECO Fdn, Inst Cognit & Translat Neurosci, Lab Expt Psychol & Neurosci, Buenos Aires, DF, Argentina; [Ibanez, Agustin] Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [Ibanez, Agustin] Univ Adolfo Ibanez, Sch Psychol, Ctr Social & Cognit Neurosci, Santiago, Chile; [Ibanez, Agustin] Univ Autonoma Caribe, Barranquilla, Colombia; [Ibanez, Agustin] ARC Ctr Excellence Cognit & Disorders, Sydney, NSW, Australia		Ibanez, A (corresponding author), Favaloro Univ, INECO Fdn, Inst Cognit & Translat Neurosci, Lab Expt Psychol & Neurosci, Buenos Aires, DF, Argentina.; Ibanez, A (corresponding author), Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina.; Ibanez, A (corresponding author), Univ Adolfo Ibanez, Sch Psychol, Ctr Social & Cognit Neurosci, Santiago, Chile.; Ibanez, A (corresponding author), Univ Autonoma Caribe, Barranquilla, Colombia.; Ibanez, A (corresponding author), ARC Ctr Excellence Cognit & Disorders, Sydney, NSW, Australia.	aibanez@ineco.org.ar	Ibanez, Agustin/H-7976-2015; Baez, Sandra/ABC-7150-2020	Ibanez, Agustin/0000-0001-6758-5101; Santamaria Garcia, Hernando/0000-0001-9422-3579	CONICET; CONICYT/FONDECYT Regular [1170010]; FONDAP [15150012]; INECO Foundation; Global Brain Health Institute (GBHI-UCSF); FONCyT-PICT [2017-1818, 2017-1820]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICYT/FONDECYT Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP; INECO Foundation; Global Brain Health Institute (GBHI-UCSF); FONCyT-PICT(ANPCyTFONCyT)	This work was partially supported by grants from CONICET, CONICYT/FONDECYT Regular (1170010), FONCyT-PICT 2017-1818, FONCyT-PICT 2017-1820, FONDAP 15150012, the INECO Foundation, and Global Brain Health Institute (GBHI-UCSF).	Amnesty International, 2018, AMN INT REP 2017 18; Augsburger M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01756; Baez S, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0118; Valencia JGB, 2017, ANDAMIOS, V14, P59; Bennett S, 2005, AGGRESS VIOLENT BEH, V10, P263, DOI 10.1016/j.avb.2004.07.001; Benyamini Y, 2005, SOC SCI MED, V61, P1267, DOI 10.1016/j.socscimed.2005.01.023; Berk R, 2017, J EXP CRIMINOL, V13, P193, DOI 10.1007/s11292-017-9286-2; Berk RA, 2016, J EMPIR LEGAL STUD, V13, P94, DOI 10.1111/jels.12098; Berk RA, 2013, CRIMINOL PUBLIC POL, V12, P513, DOI 10.1111/1745-9133.12047; Betancourt TS, 2010, CHILD DEV, V81, P1077, DOI 10.1111/j.1467-8624.2010.01455.x; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Bornemann B, 2017, PSYCHOPHYSIOLOGY, V54, P469, DOI 10.1111/psyp.12790; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Bowd R, 2013, J INTERV STATEBUILD, V7, P453, DOI 10.1080/17502977.2012.727537; Bruneau EG, 2010, NEUROIMAGE, V52, P1704, DOI 10.1016/j.neuroimage.2010.05.057; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Chester DS, 2016, SOC COGN AFFECT NEUR, V11, P1173, DOI 10.1093/scan/nsv082; Cikara M, 2011, PSYCHOL SCI, V22, P306, DOI 10.1177/0956797610397667; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; DeSteno D, 2004, PSYCHOL SCI, V15, P319, DOI 10.1111/j.0956-7976.2004.00676.x; Doehrmann O, 2013, JAMA PSYCHIAT, V70, P87, DOI 10.1001/2013.jamapsychiatry.5; Elbert T, 2018, CURR OPIN PSYCHOL, V19, P135, DOI 10.1016/j.copsyc.2017.03.016; Elbogen EB, 2013, J NERV MENT DIS, V201, P872, DOI 10.1097/NMD.0b013e3182a6e76b; Flores TE, 2018, CONFLICT MANAG PEACE, V35, P581, DOI 10.1177/0738894218787786; Gane, 2006, INT SOC SCI J, V58, P41, DOI [10.1111/j.1468-2451.2009.01687.x, DOI 10.1111/J.1468-2451.2009.01687.X]; Ginzburg K, 2011, PSYCHOL MED, V41, P353, DOI 10.1017/S0033291710000528; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Goldstein-Piekarski AN, 2016, P NATL ACAD SCI USA, V113, P11955, DOI 10.1073/pnas.1606671113; Harenski CL, 2010, J ABNORM PSYCHOL, V119, P863, DOI 10.1037/a0020979; Hecker T, 2013, J TRAUMA STRESS, V26, P142, DOI 10.1002/jts.21770; Hermenau K, 2013, J AGGRESS MALTREAT T, V22, P916, DOI 10.1080/10926771.2013.824057; Hoaken PNS, 2007, AGGRESSIVE BEHAV, V33, P412, DOI 10.1002/ab.20194; Hodson G, 2007, PSYCHOL SCI, V18, P691, DOI 10.1111/j.1467-9280.2007.01962.x; Humphreys M, 2007, J CONFLICT RESOLUT, V51, P531, DOI 10.1177/0022002707302790; Ibanez A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00188; Ibanez A, 2009, J THEOR SOC BEHAV, V39, P81, DOI 10.1111/j.1468-5914.2008.00391.x; Ikin JF, 2007, BRIT J PSYCHIAT, V190, P475, DOI 10.1192/bjp.bp.106.025684; Ismail K, 2002, BMJ-BRIT MED J, V325, P576, DOI 10.1136/bmj.325.7364.576; Jusyte A, 2017, EUR ARCH PSY CLIN N, V267, P257, DOI 10.1007/s00406-016-0727-0; Kandalaft MR, 2013, J AUTISM DEV DISORD, V43, P34, DOI 10.1007/s10803-012-1544-6; Kearney DJ, 2016, AM J MED, V129, P204, DOI 10.1016/j.amjmed.2015.09.015; Klimecki OM, 2013, CEREB CORTEX, V23, P1552, DOI 10.1093/cercor/bhs142; Kobach A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01755; Kobach A, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01518; Kok BE, 2017, JAMA PSYCHIAT, V74, P126, DOI 10.1001/jamapsychiatry.2016.3360; LeGrand CC, 2017, CAN J LAT AM CARIBB, V42, P259, DOI 10.1080/08263663.2017.1378381; Leiberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017798; Levy J, 2016, P NATL ACAD SCI USA, V113, P13696, DOI 10.1073/pnas.1612903113; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; Lindenmayer JP, 2013, SCHIZOPHRENIA BULL, V39, P507, DOI 10.1093/schbul/sbs120; Maguen S, 2011, J ANXIETY DISORD, V25, P563, DOI 10.1016/j.janxdis.2011.01.003; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434; McFall M, 1999, J TRAUMA STRESS, V12, P501, DOI 10.1023/A:1024771121189; Meyer-Parlapanis D, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01972; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Molenberghs P, 2016, CEREB CORTEX, V26, P225, DOI 10.1093/cercor/bhu195; Muchembled A., 2010, HIST VIOLENCE; Mullins S., 2010, DYNAMICS ASYMMETRIC, V3, P162; Nandi C, 2015, EUR J PSYCHOTRAUMATO, V6, DOI [10.3402/ejpt.v6.26553, 10.3402/ejpt.v6.26995]; Odenwald Michael, 2007, Confl Health, V1, P10, DOI 10.1186/1752-1505-1-10; Odenwald M, 2007, PLOS MED, V4, P1959, DOI 10.1371/journal.pmed.0040341; Pflueger MO, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0447-4; Poldrack RA, 2018, TRENDS COGN SCI, V22, P111, DOI 10.1016/j.tics.2017.11.003; Raine A., 2013, ANATOMY VIOLENCE BIO; Ready DJ, 2008, J TRAUMA STRESS, V21, P150, DOI 10.1002/jts.20326; Reardon S, 2018, NATURE, V557, P19, DOI 10.1038/d41586-018-04976-7; Richeson JA, 2003, NAT NEUROSCI, V6, P1323, DOI 10.1038/nn1156; Roberts DL, 2014, BRIT J CLIN PSYCHOL, V53, P281, DOI 10.1111/bjc.12044; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Statistique Canada, 2018, LIGNES DIRECTRICES U; Thrasher J, 2018, HUM NATURE-INT BIOS, V29, P371, DOI 10.1007/s12110-018-9324-4; Toomey R, 2007, BRIT J PSYCHIAT, V190, P385, DOI 10.1192/bjp.bp.105.019539; Trujillo S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00510; Valk SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700489; Viding E, 2014, CURR BIOL, V24, pR871, DOI 10.1016/j.cub.2014.06.055; Weierstall R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050891; Yaganeh Z, 2014, J PRACT CLIN PSYCHOL, V4, P17	77	9	9	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	JAN 29	2019	10								73	10.3389/fpsyg.2019.00073	http://dx.doi.org/10.3389/fpsyg.2019.00073			17	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	HJ5BW	30761041	Green Published, gold			2022-09-04	WOS:000457194300001
J	Fernandez, N; Perez, J; Monterrey, P; Poletta, FA; Bagli, DJ; Lorenzo, AJ; Zarante, I				Fernandez, Nicolas; Perez, Jaime; Monterrey, Pedro; Poletta, Fernando A.; Bagli, Darius J.; Lorenzo, Armando J.; Zarante, Ignacio			ECLAMC Study: prevalence patterns of hypospadias in South America: multi-national analysis over a 24-year period	INTERNATIONAL BRAZ J UROL			English	Article						Hypospadias; Prevalence; Epidemiology	CONGENITAL-MALFORMATIONS; ABNORMALITIES; TRENDS	Objective: To evaluate prevalence trends of hypospadias in South-America it is essential to perform multicenter and multinational studies with the same methodology. Herein we present systematic data as part of an international multicenter initiative evaluating congenital malformations in South America over a 24-year period. Materials and Methods: A nested case-control study was conducted using the Latin American Collaborative Study of Congenital Malformations (ECLAMC), between January 1989 and December 2012. Cases were stratified as isolated (IH) and non-isolated hypospadias (NIH). Global prevalence was calculated and discriminated by country. Associations between birth weight and gestational age, and NIH distribution by associated abnormality and severity of hypospadias, were analyzed. Results: A total of 159 hospitals from six countries participated, reporting surveillance on 4.020.384 newborns. A total of 4.537 hypospadias cases were detected, with a global prevalence of 11.3/10.000 newborns. Trend analyses showed in Chile, Brazil and Uruguay a statistically significant increase in prevalence. Analysis of severity and associated anomalies did not to find an association for distal cases, but did for proximal (RR= 1.64 [95% CI=1.33-2.03]). Conclusion: This is one of only a few Latin American multicenter studies reporting on the epidemiology of hypospadias in South America in the last two decades. Our data adds to evidence suggesting an increase in some countries in the region at different times. There were also variations in prevalence according to severity. This study adds to literature describing associated anomalies at a hospital-based level.	[Fernandez, Nicolas; Perez, Jaime] Pontificia Univ Javeriana, Dept Urol, Hosp Univ San Ignacio, Bogota, Colombia; [Fernandez, Nicolas; Zarante, Ignacio] Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; [Monterrey, Pedro] Rosario Univ, Dept Matemat, Bogota, Colombia; [Poletta, Fernando A.] Ctr Educ Med & Invest Clin CEMIC CONICET, ECLAMC Estudio Colaborat Latinoamer Malformac Con, Buenos Aires, DF, Argentina; [Poletta, Fernando A.] Inst Nacl Genet Med Populac INaGeMP, Rio De Janeiro, Brazil; [Bagli, Darius J.; Lorenzo, Armando J.] Hosp Sick Children, Dept Surg, Div Urol, Toronto, ON, Canada; [Bagli, Darius J.; Lorenzo, Armando J.] Univ Toronto, Toronto, ON, Canada		Fernandez, N (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Ak 7 19141, Bogota, Colombia.	fernandez.j@javeriana.edu.co	Zarante, Ignacio/L-6467-2017; Zarante, Ignacio/AAL-6215-2021; Monterrey, Pedro/H-1754-2016	Zarante, Ignacio/0000-0002-0729-6866; Zarante, Ignacio/0000-0002-0729-6866; Monterrey, Pedro/0000-0002-2113-5639; Perez Nino, Jaime/0000-0002-2231-4321; Poletta, Fernando/0000-0002-6102-8416				Agopian AJ, 2013, AM J MED GENET A, V161A, P977, DOI 10.1002/ajmg.a.35815; Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; Fernandez N, 2012, J PEDIATR UROL, V8, P121, DOI 10.1016/j.jpurol.2011.07.005; Fleiss J, 2003, STAT METHODS RATES P, P192; Gallentine ML, 2001, UROLOGY, V57, P788, DOI 10.1016/S0090-4295(00)01105-5; Kalfa N, 2010, UROL CLIN N AM, V37, P159, DOI 10.1016/j.ucl.2010.03.010; KALLEN B, 1988, TERATOLOGY, V38, P45, DOI 10.1002/tera.1420380107; LEUNG TJ, 1985, AM J MED GENET, V21, P39, DOI 10.1002/ajmg.1320210106; Li YH, 2012, BIRTH DEFECTS RES A, V94, P36, DOI 10.1002/bdra.22854; Lund L, 2009, EUR UROL, V56, pE41, DOI 10.1016/j.eururo.2009.06.031; Lund L, 2009, EUR UROL, V55, P1022, DOI 10.1016/j.eururo.2009.01.005; Monlleo IL, 2012, J PEDIAT-BRAZIL, V88, P489, DOI [10.2223/JPED.2237, 10.1590/S0021-75572012000600008]; NETO RM, 1981, AM J MED GENET, V10, P5, DOI 10.1002/ajmg.1320100103; Nordenvall AS, 2014, J UROLOGY, V191, P783, DOI 10.1016/j.juro.2013.09.058; Oliva A, 2008, CAD SAUDE PUBLICA, V24, P785, DOI 10.1590/S0102-311X2008000400008; Paulozzi LJ, 1997, PEDIATRICS, V100, P831, DOI 10.1542/peds.100.5.831; Sharpe RM, 2006, BEST PRACT RES CL EN, V20, P91, DOI 10.1016/j.beem.2005.09.005; Zarante I, 2010, BIOMEDICA, V30, P65, DOI 10.7705/biomedica.v30i1.154	20	8	10	0	1	BRAZILIAN SOC UROL	RIO DE JANEIRO	RUA BAMBINA, 153, RIO DE JANEIRO, 2251-050, BRAZIL	1677-5538	1677-6119		INT BRAZ J UROL	Int. Braz J Urol	MAR-APR	2017	43	2					325	334		10.1590/S1677-5538.IBJU.2016.0002	http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0002			10	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	EN4UR	27802003	Green Published, Green Submitted, gold			2022-09-04	WOS:000396002900021
J	Ghosh, B; Ramos-Mejia, M; Machado, RC; Yuana, SL; Schiller, K				Ghosh, Bipashyee; Ramos-Mejia, Monica; Machado, Rafael Carvalho; Yuana, Suci Lestari; Schiller, Katharina			Decolonising transitions in the Global South: Towards more epistemic diversity in transitions research	ENVIRONMENTAL INNOVATION AND SOCIETAL TRANSITIONS			English	Article						Sustainability transitions; Global South; Decolonialisation; Epistemic diversity; Just transitions; Participatory research	SUSTAINABILITY TRANSITIONS	Research on sustainability transitions in the Global South has evolved since its inception a decade ago. Yet, many issues concerning the hegemony of Western knowledge systems and practices continue to impact research on transitions in the Global South. This viewpoint suggests several ways to address these issues through decolonialising transitions research: namely through acknowledging everyday struggles faced in the Global South, explicitly addressing questions of power, informal institutions, inequality and injustice that permeate transitions in the Global South and integrating truly participatory research methods that value research 'subjects' and embrace the transformative activities and communities of practices. Drawing on half a decade of formal and informal knowledges exchanges led by "Transitions in the Global South" thematic group of STRN, it is time for our community to embrace a fresh and alternative approach to understanding, mainstreaming and implementing transitions in the Global South.	[Ghosh, Bipashyee] Univ Sussex, Business Sch, Sci Policy Res Unit SPRU, Brighton BN1 9SL, E Sussex, England; [Ramos-Mejia, Monica] Pontificia Univ Javeriana, Bogota, Colombia; [Machado, Rafael Carvalho] Univ Posit, Curitiba, Parana, Brazil; [Yuana, Suci Lestari] Univ Utrecht, Copernicus Inst Sustainable Dev, Utrecht, Netherlands; [Yuana, Suci Lestari] Univ Gadjah Mada, Fac Social & Polit Sci, Yogyakarta, Indonesia; [Schiller, Katharina] Fraunhofer Inst Syst & Innovat Res ISI, Karlsruhe, Germany		Ghosh, B (corresponding author), Univ Sussex, Business Sch, Sci Policy Res Unit SPRU, Brighton BN1 9SL, E Sussex, England.	B.Ghosh@sussex.ac.uk	Yuana, Suci Lestari/GOV-3796-2022	Yuana, Suci Lestari/0000-0002-7545-0714; Schiller, Katharina Josefa Friedhilde/0000-0003-2196-1719				Berkhout F, 2010, ENVIRON SCI POLICY, V13, P261, DOI 10.1016/j.envsci.2010.03.010; Cooke B., 2001, Participation: the new tyranny?; Dia M., 1996, Africa's management in the 1990s and beyond: reconciling indigenous and transplanted institutions.; Doyon A, 2021, ENERGY RES SOC SCI, V81, DOI 10.1016/j.erss.2021.102255; Escobar A, 1995, ENCOUNTERING DEV MAK; Escobar A, 2015, SUSTAIN SCI, V10, P451, DOI 10.1007/s11625-015-0297-5; Frediani AA, 2014, J HUM DEV CAPABIL, V15, P1, DOI 10.1080/19452829.2013.879014; Fry Tony, 2017, DESIGN PHILOS PAPERS, V15, P3, DOI DOI 10.1080/14487136.2017.1303242; Ghosh B, 2022, ENVIRON PLAN C-POLIT, V40, P318, DOI 10.1177/23996544211027583; Ghosh B, 2019, ENERGY RES SOC SCI, V51, P82, DOI 10.1016/j.erss.2018.12.001; Gille Z, 2010, GLOB SOC, V24, P9, DOI 10.1080/13600820903431953; Hayward B, 2019, ANNU REV ENV RESOUR, V44, P157, DOI 10.1146/annurev-environ-101718-033119; Hickel J, 2020, ECOL ECON, V167, DOI 10.1016/j.ecolecon.2019.05.011; Jehlicka P, 2019, CAN J DEV STUD, V40, P511, DOI 10.1080/02255189.2018.1498325; Kanger L, 2019, ENVIRON INNOV SOC TR, V32, P7, DOI 10.1016/j.eist.2018.07.006; Kohler J, 2019, ENVIRON INNOV SOC TR, V31, P1, DOI 10.1016/j.eist.2019.01.004; Land & Water Australia,, 2008, REST LANDSC CONF SUM; Onyango J, 2020, WE DECOLONISERESEARC; Pinet M., 2019, OVERSEAS DEV I, V2019; Pols, 2021, DILEMMAS ENERGY TRAN, P182; Ramos-Mejia M, 2018, ENVIRON SCI POLICY, V84, P217, DOI 10.1016/j.envsci.2017.03.010; Rosa MC, 2016, EUR J SOC THEORY, V19, P485, DOI 10.1177/1368431015613714; Silvonen Jussi, 2004, DEV INTERVENTION ACT; Sunio V, 2021, TRANSPORT RES D-TR E, V96, DOI 10.1016/j.trd.2021.102887; Tambelli C.N., 2019, SMART CITIES BREVE I; Wieczorek AJ, 2018, ENVIRON SCI POLICY, V84, P204, DOI 10.1016/j.envsci.2017.08.008; Yang KJ, 2022, REG STUD, V56, P751, DOI 10.1080/00343404.2021.1903412; Yap XS, 2019, RES POLICY, V48, P1030, DOI 10.1016/j.respol.2018.10.002; Yuana SL, 2020, ENVIRON INNOV SOC TR, V37, P156, DOI 10.1016/j.eist.2020.08.009	29	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2210-4224	2210-4232		ENVIRON INNOV SOC TR	Environ. Innov. Soc. Trans.	DEC	2021	41				SI		106	109		10.1016/j.eist.2021.10.029	http://dx.doi.org/10.1016/j.eist.2021.10.029		NOV 2021	4	Environmental Sciences; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology	XO8NF					2022-09-04	WOS:000730434700025
J	Bernal-Ramirez, J; Diaz-Vesga, MC; Talamilla, M; Mendez, A; Quiroga, C; Garza-Cervantes, JA; Lazaro-Alfaro, A; Jerjes-Sanchez, C; Henriquez, M; Garcia-Rivas, G; Pedrozo, Z				Bernal-Ramirez, Judith; Diaz-Vesga, Magda C.; Talamilla, Matias; Mendez, Andrea; Quiroga, Clara; Garza-Cervantes, Javier A.; Lazaro-Alfaro, Anay; Jerjes-Sanchez, Carlos; Henriquez, Mauricio; Garcia-Rivas, Gerardo; Pedrozo, Zully			Exploring Functional Differences between the Right and Left Ventricles to Better Understand Right Ventricular Dysfunction	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Review							PULMONARY ARTERIAL-HYPERTENSION; MONOCROTALINE-INDUCED PULMONARY; RENIN-ANGIOTENSIN SYSTEM; HEART-FAILURE; CARDIAC-HYPERTROPHY; RHO-KINASE; SARCOPLASMIC-RETICULUM; PREVENTS PROGRESSION; EJECTION FRACTION; GENE-EXPRESSION	The right and left ventricles have traditionally been studied as individual entities. Furthermore, modifications found in diseased left ventricles are assumed to influence on right ventricle alterations, but the connection is poorly understood. In this review, we describe the differences between ventricles under physiological and pathological conditions. Understanding the mechanisms that differentiate both ventricles would facilitate a more effective use of therapeutics and broaden our knowledge of right ventricle (RV) dysfunction. RV failure is the strongest predictor of mortality in pulmonary arterial hypertension, but at present, there are no definitive therapies directly targeting RV failure. We further explore the current state of drugs and molecules that improve RV failure in experimental therapeutics and clinical trials to treat pulmonary arterial hypertension and provide evidence of their potential benefits in heart failure.	[Bernal-Ramirez, Judith; Garza-Cervantes, Javier A.; Lazaro-Alfaro, Anay; Jerjes-Sanchez, Carlos; Garcia-Rivas, Gerardo] Tecnol Monterrey, Escuela Med & Ciencias Salud, Ave Morones Prieto 3000, Monterrey 64710, NL, Mexico; [Diaz-Vesga, Magda C.; Talamilla, Matias; Mendez, Andrea; Henriquez, Mauricio; Pedrozo, Zully] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago, Chile; [Diaz-Vesga, Magda C.; Quiroga, Clara; Pedrozo, Zully] Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis, Santiago, Chile; [Diaz-Vesga, Magda C.; Quiroga, Clara; Pedrozo, Zully] Univ Chile, Fac Med, Santiago, Chile; [Diaz-Vesga, Magda C.; Pedrozo, Zully] Univ Chile, Fac Med, Ctr Estudios Ejercicio Metab & Canc CEMC, Santiago, Chile; [Diaz-Vesga, Magda C.; Mendez, Andrea; Henriquez, Mauricio; Pedrozo, Zully] Univ Chile, Red Estudio Enfermedades Cardiopulmonares Alta, Santiago, Chile; [Diaz-Vesga, Magda C.] Pontificia Univ Javeriana Cali, Grp Invest Ciencias Basicas & Clin Salud, Cali, Colombia; [Mendez, Andrea] Univ Amer, Escuela Kinesiol, Fac Salud & Ciencias Sociales, Campus Providencia, Providencia, Chile; [Mendez, Andrea] Univ Amer, Fac Salud & Ciencias Soci, Ctr Invest & Innovac Biopsicosocial Enfermedades, Providencia, Chile; [Quiroga, Clara] Pontificia Univ Catolica Chile, Fac Med, Div Enfermedades Cardiovasc, Santiago, Chile; [Garcia-Rivas, Gerardo] Hosp Zambrano Hell, Ctr Invest Biomed, Tecnol Monterrey, San Pedro Garza Garcia 66278, NL, Mexico		Garcia-Rivas, G (corresponding author), Tecnol Monterrey, Escuela Med & Ciencias Salud, Ave Morones Prieto 3000, Monterrey 64710, NL, Mexico.; Pedrozo, Z (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago, Chile.; Pedrozo, Z (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis, Santiago, Chile.; Pedrozo, Z (corresponding author), Univ Chile, Fac Med, Santiago, Chile.; Pedrozo, Z (corresponding author), Univ Chile, Fac Med, Ctr Estudios Ejercicio Metab & Canc CEMC, Santiago, Chile.; Pedrozo, Z (corresponding author), Univ Chile, Red Estudio Enfermedades Cardiopulmonares Alta, Santiago, Chile.; Garcia-Rivas, G (corresponding author), Hosp Zambrano Hell, Ctr Invest Biomed, Tecnol Monterrey, San Pedro Garza Garcia 66278, NL, Mexico.	judithb.rmz@gmail.com; magdiaz@ug.uchile.cl; matiastalamilla@ug.uchile.cl; andreamg.kine@gmail.com; clquiroga@uc.cl; jav.garza@tec.mx; a.lazaro@tec.mx; carlos.jerjes@udicem.org; mauricioh@uchile.cl; gdejesus@itesm.mx; zpedrozo@uchile.cl	Garcia-Rivas, Gerardo/A-9691-2011	Garcia-Rivas, Gerardo/0000-0003-4731-3293; Quiroga, Clara/0000-0002-0251-4772; Jerjes - Sanchez, Carlos/0000-0003-3222-7405; Diaz Vesga, Magda Carolina/0000-0002-7807-2050; Garza-Cervantes, Javier A./0000-0002-0542-5417	Tecnologico de Monterrey, a CONACYT doctoral fellowship [492122]; CONACYT [256577, 258197]; Fronteras de la Ciencia Grant [0682]; Ciencia Basica [A1-S-43883]; Agencia Nacional de Investigacion y Desarrollo (ANID) grants Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT, Chile [1180613, 1211270]; ANID [21191341]; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias, FONDAP, ACCDiS, Chile [15130011]; U-Redes Generacion, Vicerrectoria de Investigacion y Desarrollo, Universidad de Chile, Chile [URG-035/1]; Puente-ICBM 2019	Tecnologico de Monterrey, a CONACYT doctoral fellowship; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fronteras de la Ciencia Grant; Ciencia Basica; Agencia Nacional de Investigacion y Desarrollo (ANID) grants Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT, Chile; ANID; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias, FONDAP, ACCDiS, Chile; U-Redes Generacion, Vicerrectoria de Investigacion y Desarrollo, Universidad de Chile, Chile; Puente-ICBM 2019	The authors wish to acknowledge the financial support of Tecnologico de Monterrey, a CONACYT doctoral fellowship (Grant 492122 to J.B.R.). This work was supported by grants from the CONACYT (256577 to G.G.R. and 258197 to C.J.S.), Fronteras de la Ciencia Grant (0682 to G.G.R.), and Ciencia Basica (A1-S-43883 to G.G.R.); Agencia Nacional de Investigacion y Desarrollo (ANID) grants Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT, Chile (1180613 to Z.P. and 1211270 to C.Q. and Z.P.) and ANID fellowship (21191341 to M.C.D.); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias, FONDAP, ACCDiS, Chile (15130011 to C.Q., and Z.P.); U-Redes Generacion, Vicerrectoria de Investigacion y Desarrollo, Universidad de Chile, Chile, (URG-035/1 to M.H., and Z.P.); and Puente-ICBM 2019 (to M.H.).	Adao R, 2019, CLIN EXP PHARMACOL P, V46, P255, DOI 10.1111/1440-1681.13043; Altin SE, 2012, PROG CARDIOVASC DIS, V55, P229, DOI 10.1016/j.pcad.2012.07.010; An X, 2020, J TRADIT CHIN MED, V40, P992, DOI 10.19852/j.cnki.jtcm.2020.06.010; Anaruma CP, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2019.116955; Andersen S, 2019, PULM CIRC, V9, DOI 10.1177/2045894019848659; Antigny F, 2020, ARCH CARDIOVASC DIS, V113, P70, DOI 10.1016/j.acvd.2019.10.009; Bageghni SA, 2018, FASEB J, V32, P4941, DOI 10.1096/fj.201701455RR; BASSANI RA, 1994, J PHYSIOL-LONDON, V476, P295, DOI 10.1113/jphysiol.1994.sp020131; Belin RJ, 2011, PFLUG ARCH EUR J PHY, V462, P795, DOI 10.1007/s00424-011-1024-4; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Bernal-Ramirez J, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/9912434; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Boehm M, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0604-x; Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC; BROOKS WW, 1987, J MOL CELL CARDIOL, V19, P433, DOI 10.1016/S0022-2828(87)80395-4; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Bryce YC, 2019, INSIGHTS IMAGING, V10, DOI 10.1186/s13244-019-0695-9; Buckberg G, 2014, J THORAC CARDIOV SUR, V148, P3166, DOI 10.1016/j.jtcvs.2014.05.044; Bueno-Orovio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052234; Bursi F, 2012, J AM COLL CARDIOL, V59, P222, DOI 10.1016/j.jacc.2011.06.076; Cacciapuoti F, 2014, AM J CARDIOVASC DIS, V4, P1; Calloe K, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13787; Casis O, 1998, LIFE SCI, V63, P391, DOI 10.1016/S0024-3205(98)00287-2; Chelladurai P, 2021, BRIT J PHARMACOL, V178, P54, DOI 10.1111/bph.14932; Chin KM, 2005, CORONARY ARTERY DIS, V16, P13, DOI 10.1097/00019501-200502000-00003; Chou IP, 2014, ENDOCR RES, V39, P173, DOI 10.3109/07435800.2013.879165; Chouvarine P, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102232; Chowdhury B, 2020, BIOCHEM BIOPH RES CO, V524, P50, DOI 10.1016/j.bbrc.2020.01.015; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Cordeiro Jonathan M, 2016, Front Biosci (Schol Ed), V8, P143; Correia-Pinto J, 2009, BASIC RES CARDIOL, V104, P535, DOI 10.1007/s00395-009-0017-3; Cowan BR, 2009, CURR HYPERTENS REP, V11, P167, DOI 10.1007/s11906-009-0030-9; Crystal GJ, 2018, ANESTHESIOLOGY, V128, P202, DOI 10.1097/ALN.0000000000001891; Dang ZC, 2020, J ETHNOPHARMACOL, V250, DOI 10.1016/j.jep.2019.112470; de Man FS, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00255-2019; Degadu O, 2018, RIGHT VENTRICULAR PH, P1; DiDiego JM, 1996, AM J PHYSIOL-HEART C, V271, pH548, DOI 10.1152/ajpheart.1996.271.2.H548; Falcao-Pires I, 2009, AM J PHYSIOL-HEART C, V296, pH2007, DOI 10.1152/ajpheart.00089.2009; Fang YH, 2012, J MOL MED, V90, P31, DOI 10.1007/s00109-011-0804-9; Ferguson BS, 2013, P NATL ACAD SCI USA, V110, P9806, DOI 10.1073/pnas.1301509110; Fernandez-Sada E, 2014, BRIT J PHARMACOL, V171, P4207, DOI 10.1111/bph.12684; Friehs I, 2013, AM J PHYSIOL-HEART C, V304, pH697, DOI 10.1152/ajpheart.00802.2012; Galie N, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01889-2018; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gallo S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092164; Gao XJ, 2020, J CARDIOVASC PHARM, V75, P545, DOI 10.1097/FJC.0000000000000815; Ghio S, 2020, HEART FAIL REV, V25, P85, DOI 10.1007/s10741-019-09810-4; Gomez AM, 2013, CURR VASC PHARMACOL, V11, P497, DOI 10.2174/1570161111311040013; Gorr MW, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14344; Guazzi M, 2017, J AM COLL CARDIOL, V69, P1718, DOI 10.1016/j.jacc.2017.01.051; GUIHA NH, 1974, AM J CARDIOL, V33, P254, DOI 10.1016/0002-9149(74)90284-7; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Heger J, 2016, BRIT J PHARMACOL, V173, P3, DOI 10.1111/bph.13344; Heitmeier T, 2020, CARDIOVASC RES, V116, P406, DOI 10.1093/cvr/cvz103; Hemnes A, 2020, PULM CIRC, V10, DOI 10.1177/2045894020957234; Heresi GA, 2012, EUR RESPIR J, V39, P939, DOI 10.1183/09031936.00067011; Herpel E, 2005, VIRCHOWS ARCH, V446, P369, DOI 10.1007/s00428-004-1177-z; Hessel M, 2009, CELL PHYSIOL BIOCHEM, V24, P201, DOI 10.1159/000233246; Hsu S, 2018, CIRCULATION, V137, P2360, DOI 10.1161/CIRCULATIONAHA.117.033147; Huertas A, 2020, CARDIOVASC RES, V116, P885, DOI 10.1093/cvr/cvz308; Hwang HV, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.017835; Iglesias-Garriz I, 2012, REV CARDIOVASC MED, V13, pE62, DOI 10.3909/ricm0602; Ihenacho UK, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.660095; Ikeda S, 2014, ARTERIOSCL THROM VAS, V34, P1260, DOI 10.1161/ATVBAHA.114.303320; ISNER JM, 1978, AM J CARDIOL, V42, P885, DOI 10.1016/0002-9149(78)90672-0; Karim T.A., 2019, MITOCHONDRIAL RESP S, DOI [10.26124/mitofit, DOI 10.26124/MITOFIT]; Kemdem A, 2020, ACTA CARDIOL, V75, P544, DOI 10.1080/00015385.2019.1634333; Keranov S, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.01192-2019; Kerkela Risto, 2006, Curr Heart Fail Rep, V3, P14, DOI 10.1007/s11897-006-0026-6; Kim JJ, 2013, AM J PHYSIOL-HEART C, V304, pH848, DOI 10.1152/ajpheart.00787.2012; Knollmann BC, 2001, J CARDIOVASC ELECTR, V12, P1286, DOI 10.1046/j.1540-8167.2001.01286.x; Kojonazarov B, 2017, AM J RESP CELL MOL, V57, P603, DOI 10.1165/rcmb.2016-0374OC; Kondo RP, 2006, J PHYSIOL-LONDON, V571, P131, DOI 10.1113/jphysiol.2005.101428; Konstam MA, 2018, CIRCULATION, V137, pE578, DOI 10.1161/CIR.0000000000000560; Kreymborg KG, 2010, J MOL CELL CARDIOL, V49, P598, DOI 10.1016/j.yjmcc.2010.07.014; KRUG H, 1987, ACTA HISTOCHEM, V82, P115, DOI 10.1016/S0065-1281(87)80063-6; Lacerda D, 2020, APPL PHYSIOL NUTR ME, V45, P987, DOI 10.1139/apnm-2019-0864; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Lee DS, 2018, KOREAN CIRC J, V48, P1135, DOI 10.4070/kcj.2018.0061; Legchenko E, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao0303; Leong ZP, 2018, VASC PHARMACOL, V100, P41, DOI 10.1016/j.vph.2017.10.006; Levin T., RIGHT VENTRICULAR MY; Liang JS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/742536; Lipczynska M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180629; Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Lu LQ, 2017, INT J CARDIOL, V230, P164, DOI 10.1016/j.ijcard.2016.11.215; MacIver DH, 2012, EXP CLIN CARDIOL, V17, P5; Mamazhakypov Argen, 2020, Pulmonary Circulation, V10, p2045894020947283, DOI 10.1177/2045894020947283; Matthews JC, 2008, CURR CARDIOL REV, V4, P49, DOI 10.2174/157340308783565384; Mazurek JA, 2017, PULM CIRC, V7, P361, DOI 10.1177/2045893217694175; Melenovsky V, 2014, EUR HEART J, V35, P3452, DOI 10.1093/eurheartj/ehu193; Meurs KM, 2006, HUM GENET, V120, P111, DOI 10.1007/s00439-006-0193-2; Minegishi S, 2011, INT HEART J, V52, P56, DOI 10.1536/ihj.52.56; Munch G, 2000, J MOL MED-JMM, V78, P352, DOI 10.1007/s001090000122; Nagendran J, 2008, J THORAC CARDIOV SUR, V136, P168, DOI 10.1016/j.jtcvs.2008.01.040; Nagwekar J, 2014, BIOCHEMISTRY-US, V53, P7641, DOI 10.1021/bi501175s; Nagwekar J., 2018, MED PHOTONICS, V27, P1, DOI [10.1016/j.medpho.2016.07.001, DOI 10.1016/J.MEDPHO.2016.07.001]; Nochioka K, 2018, JAMA CARDIOL, V3, P939, DOI 10.1001/jamacardio.2018.2454; Nogueira-Ferreira R, 2019, J PHYSIOL BIOCHEM, V75, P561, DOI 10.1007/s13105-019-00705-4; OKEN DE, 1957, CIRC RES, V5, P357, DOI 10.1161/01.RES.5.4.357; Olgar Y, 2017, CELL CALCIUM, V67, P81, DOI 10.1016/j.ceca.2017.09.002; Omura J, 2020, CIRCULATION, V142, P1464, DOI 10.1161/CIRCULATIONAHA.120.047626; Ooi JYY, 2015, EPIGENETICS-US, V10, P418, DOI 10.1080/15592294.2015.1024406; Overbeek MJ, 2010, INT J RHEUMATOL, V2010, DOI 10.1155/2010/604615; Pandit SV, 2011, HEART RHYTHM, V8, P1732, DOI 10.1016/j.hrthm.2011.06.028; Pang WY, 2021, J THROMB THROMBOLYS, V52, P48, DOI 10.1007/s11239-020-02329-8; Parikh VN, 2018, AM J PHYSIOL-HEART C, V315, pH348, DOI 10.1152/ajpheart.00693.2017; Park HK, 2001, PHARMACOL RES, V43, P265, DOI 10.1006/phrs.2000.0777; Paulin R, 2015, CIRC RES, V116, P56, DOI 10.1161/CIRCRESAHA.115.303910; Penny DJ, 2016, PEDIATR CRIT CARE ME, V17, pS112, DOI 10.1097/PCC.0000000000000794; PERREAULT CL, 1990, CIRC RES, V67, P707, DOI 10.1161/01.RES.67.3.707; Piao L, 2013, J MOL MED, V91, P1185, DOI 10.1007/s00109-013-1064-7; Pradhan NM, 2020, CRIT CARE CLIN, V36, P141, DOI 10.1016/j.ccc.2019.08.011; Prins KW, 2018, J HEART LUNG TRANSPL, V37, P376, DOI 10.1016/j.healun.2017.08.011; Radu-Ionita F., 2018, RIGHT HEART PATHOLOG, P3; Rai N, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3293584; Rain S, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002636; Rain S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000716; Rajagopalan V, 2013, AM J PHYSIOL-HEART C, V305, pH551, DOI 10.1152/ajpheart.00771.2012; Ramanathan C, 2006, P NATL ACAD SCI USA, V103, P6309, DOI 10.1073/pnas.0601533103; RAMESH V, 1995, AM J PHYSIOL-HEART C, V269, pH778, DOI 10.1152/ajpheart.1995.269.3.H778; Rawat DK, 2014, HYPERTENSION, V64, P1266, DOI 10.1161/HYPERTENSIONAHA.114.03261; Reddy S, 2012, PHYSIOL GENOMICS, V44, P562, DOI 10.1152/physiolgenomics.00163.2011; Roe AT, 2017, CARDIOVASC RES, V113, P1161, DOI 10.1093/cvr/cvx087; Rohm I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112371; Rol N, 2019, CARDIOVASC RES, V115, P432, DOI 10.1093/cvr/cvy186; Rosenkranz S, 2016, EUR HEART J, V37, P942, DOI 10.1093/eurheartj/ehv512; Ryan JJ, 2015, CAN J CARDIOL, V31, P391, DOI 10.1016/j.cjca.2015.01.023; Ryan JJ, 2014, CIRC RES, V115, P176, DOI 10.1161/CIRCRESAHA.113.301129; Saadane N, 1999, BRIT J PHARMACOL, V127, P1165, DOI 10.1038/sj.bjp.0702676; Sabourin J, 2018, J MOL CELL CARDIOL, V118, P208, DOI 10.1016/j.yjmcc.2018.04.003; Sacks D, 2018, INT J STROKE, V13, P612, DOI [10.1177/1747493018778713, 10.1016/j.jvir.2017.11.026]; Santos-Ribeiro D, 2016, ARCH CARDIOVASC DIS, V109, P550, DOI 10.1016/j.acvd.2016.03.004; Sanz J, 2019, J AM COLL CARDIOL, V73, P1463, DOI 10.1016/j.jacc.2018.12.076; Sathish V, 2006, AM J PHYSIOL-HEART C, V291, pH88, DOI 10.1152/ajpheart.01372.2005; Schmuck EG, 2019, AM J PHYSIOL-HEART C, V316, pH1005, DOI 10.1152/ajpheart.00091.2018; Schreckenberg R, 2015, ANTIOXID REDOX SIGN, V23, P1220, DOI 10.1089/ars.2014.6139; Seta Y, 1996, J Card Fail, V2, P243, DOI 10.1016/S1071-9164(96)80047-9; Sharov VG, 1998, J MOL CELL CARDIOL, V30, P1757, DOI 10.1006/jmcc.1998.0739; Sidebotham D., 2007, CARDIOTHORACIC CRITI, P374, DOI [10.1016/B978-075067572-7.50027-8 2-s2.0-84882542845, DOI 10.1016/B978-075067572-7.50027-82-S2.0-84882542845]; Simon MA, 2013, NAT REV CARDIOL, V10, P204, DOI 10.1038/nrcardio.2013.12; SINGH S, 1981, CIRC RES, V49, P434, DOI 10.1161/01.RES.49.2.434; Starr I, 1943, AM HEART J, V26, P291, DOI 10.1016/S0002-8703(43)90325-4; Sun XQ, 2017, CARDIOVASC RES, V113, P1441, DOI 10.1093/cvr/cvx159; Sviglerova J, 2012, EXP BIOL MED, V237, P1056, DOI 10.1258/ebm.2012.012045; Tian L, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00828; Torbicki A, 2003, CIRCULATION, V108, P844, DOI 10.1161/01.CIR.0000084544.54513.E2; Tsuji Y, 2006, CIRCULATION, V113, P345, DOI 10.1161/CIRCULATIONAHA.105.552968; Turck P, 2018, BIOMED PHARMACOTHER, V103, P182, DOI 10.1016/j.biopha.2018.04.001; Turkoglu S, 2008, CAN J CARDIOL, V24, P793, DOI 10.1016/S0828-282X(08)70687-1; van Nieuwenhoven FA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16201-y; Van Tassell BW, 2016, J CARDIOVASC PHARM, V67, P544, DOI 10.1097/FJC.0000000000000378; Vazquez-Garza E, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1841527; Ventetuolo Corey E, 2014, Ann Am Thorac Soc, V11, P811, DOI 10.1513/AnnalsATS.201312-446FR; Volders PGA, 1999, CIRCULATION, V99, P206, DOI 10.1161/01.CIR.99.2.206; Wang YD, 2019, INT J CARDIOVAS IMAG, V35, P441, DOI 10.1007/s10554-018-1468-0; WATANABE T, 1983, CIRC RES, V52, P280, DOI 10.1161/01.RES.52.3.280; Watts JA, 2006, J MOL CELL CARDIOL, V41, P296, DOI 10.1016/j.yjmcc.2006.05.011; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396; Weng LQ, 2014, ACTA PHARMACOL SIN, V35, P1005, DOI 10.1038/aps.2014.45; Wilkins Martin, 2020, Glob Cardiol Sci Pract, V2020, pe202007, DOI 10.21542/gcsp.2020.7; Wu D, 2017, DNA CELL BIOL, V36, P611, DOI 10.1089/dna.2016.3574; Yancy CW, 2016, J CARD FAIL, V22, P659, DOI 10.1016/j.cardfail.2016.07.001; Yildiz M, 2020, PROG CARDIOVASC DIS, V63, P10, DOI 10.1016/j.pcad.2019.11.009; Zhou LC, 2016, J MOL ENDOCRINOL, V57, pR143, DOI 10.1530/JME-16-0086	167	0	0	3	7	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.	AUG 30	2021	2021								9993060	10.1155/2021/9993060	http://dx.doi.org/10.1155/2021/9993060			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	UP4RA	34497685	Green Published, gold			2022-09-04	WOS:000695368200002
J	Cariello, AN; Perrin, PB; Rodriguez-Agudelo, Y; Plaza, SLO; Quijano-Martinez, MC; Arango-Lasprilla, JC				Cariello, Annahir N.; Perrin, Paul B.; Rodriguez-Agudelo, Yaneth; Olivera Plaza, Silvia Leonor; Cristina Quijano-Martinez, Maria; Carlos Arango-Lasprilla, Juan			A Multi-Site Study of Traumatic Brain Injury in Mexico and Colombia: Longitudinal Mediational and Cross-Lagged Models of Family Dynamics, Coping, and Health-Related Quality of Life	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; health-related quality of life; family dynamics; coping	COHERENCE; SENSE; DISABILITY; REHABILITATION; INDIVIDUALS; CAREGIVERS; VALIDITY; NEEDS; SATISFACTION; RELIABILITY	Latin America has high rates of traumatic brain injury (TBI), yet reduced mental and physical health outcomes due to limited rehabilitation services. To understand the psychosocial adjustment process in TBI patients in Latin America, the incorporation of cultural values including family-based variables is imperative. The current study examined relations among healthy family dynamics, coping, and mental and physical health related quality of life (HRQL) among a sample of TBI patients across three sites and two countries over the first 4 months post-injury. A sample of 109 acute TBI patients from Mexico and Colombia were recruited, and a series of longitudinal mediation and cross-lag panel analyses were run. Mental and physical HRQL were positively associated with each other, as well as healthy family dynamics and coping. Coping partially mediated the effects of healthy family dynamics on both mental and physical HRQL. Family dynamics showed the strongest cross-lag relationships with coping going from 2 months to 4 months. Similarly, coping showed the strongest cross-lag relationships with both mental and physical HRQL going from baseline to 2 months. Results provide empirical support for the importance of a rehabilitation workforce that has been trained in and can effectively implement family-based interventions for individuals with TBI in Latin America.	[Cariello, Annahir N.; Perrin, Paul B.] Virginia Commonwealth Univ, 907 Floyd Ave, Richmond, VA 23284 USA; [Rodriguez-Agudelo, Yaneth] Natl Inst Neurol & Neurosurg, Neuropsychol Dept, Mexico City 14269, DF, Mexico; [Olivera Plaza, Silvia Leonor] Univ Surcolombiana, Grp Invest Carlos Finlay, Neiva, Huila, Colombia; [Cristina Quijano-Martinez, Maria] Pontificia Univ Javeriana Cali, Dept Social Sci, Cali, Colombia; [Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp Barakaldo, BioCruces Bizkaia Hlth Res Inst, Baracaldo 48903, Spain; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain; [Carlos Arango-Lasprilla, Juan] Univ Basque Country, Dept Cell Biol & Histol, UPV EHU, Leioa 48940, Biscay, Spain		Arango-Lasprilla, JC (corresponding author), Cruces Univ Hosp Barakaldo, BioCruces Bizkaia Hlth Res Inst, Baracaldo 48903, Spain.; Arango-Lasprilla, JC (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain.; Arango-Lasprilla, JC (corresponding author), Univ Basque Country, Dept Cell Biol & Histol, UPV EHU, Leioa 48940, Biscay, Spain.	carielloa@mymail.vcu.edu; pperrin@vcu.edu; yaneth_r@hotmail.com; silvileo06@hotmail.com; mcquijano@javerianacaliedu.co; jcalasprilla@gmail.com	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X	Fogarty International Center of the National Institutes of Health [R21TW009746]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by grant #R21TW009746 from Fogarty International Center of the National Institutes of Health.	Aarons GA, 2007, FAM PROCESS, V46, P557, DOI 10.1111/j.1545-5300.2007.00232.x; Alvis-Miranda H R, 2013, PANAM J TRAUMA CRIT, V2, P134; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Andren S, 2008, J CLIN NURS, V17, P790, DOI 10.1111/j.1365-2702.2007.02066.x; [Anonymous], **NON-TRADITIONAL**; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Antonovsky A.., 1987, UNRAVELING MYSTERY H; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Ayuso-Mateos JL, 1999, ACTA PSYCHIAT SCAND, V99, P26, DOI 10.1111/j.1600-0447.1999.tb05381.x; Briceno-Leon R., 1999, P WORKSH RIS VIOL CR, P6; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Coy AE, 2013, ARCH PHYS MED REHAB, V94, P362, DOI 10.1016/j.apmr.2012.08.210; DEJONG G, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199003000-00004; Elnasseh Aaliah G, 2016, Int J Alzheimers Dis, V2016, P2386728, DOI 10.1155/2016/2386728; Feigin R, 1998, MARRIAGE FAM REV, V27, P71, DOI 10.1300/J002v27n01_06; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Garcia-Moya I, 2012, SCAND J PUBLIC HEALT, V40, P333, DOI 10.1177/1403494812449924; Gison A, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0193-0; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Hsieh MY, 2012, DISABIL REHABIL, V34, P408, DOI 10.3109/09638288.2011.607219; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Julio Csar C.M.C., 2008, VIGILANCIA EPIDEMIOL, V26, P1; Jurkovich GJ, 1999, J TRAUMA, V47, pS46, DOI 10.1097/00005373-199909001-00011; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kirchner T, 2010, EUR PSYCHIAT, V25, P479, DOI 10.1016/j.eurpsy.2010.04.003; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Kouneski E., 2002, TWIN CITIES MN U MIN, V1, P1; Kreutzer J.S., 1990, COMMUNITY INTEGR TRA, P249; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Lammel J. A., 2003, THESIS; Lehan TJ, 2012, NEUROREHABILITATION, V30, P75, DOI 10.3233/NRE-2012-0729; Lopez Rebecca A, 2005, J Immigr Health, V7, P23, DOI 10.1007/s10903-005-1387-8; Marin G., 1991, RES HISPANIC POPULAT; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; MINUCHIN S, 1975, ARCH GEN PSYCHIAT, V32, P1031; Niemann Y.F., 2004, HDB CHICANA PSYCHOL, P79; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Petersen C, 2005, PROG BRAIN RES, V150, P545, DOI 10.1016/S0079-6123(05)50038-4; POLINDER S, 2015, POPUL HEALTH METR, V0013; Ramachandran A, 2017, WORLD J SURG, V41, P2224, DOI 10.1007/s00268-017-4013-8; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rena F, 1996, SOC SCI MED, V43, P163, DOI 10.1016/0277-9536(95)00358-4; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Snell DL, 2017, DISABIL REHABIL, V39, P1968, DOI 10.1080/09638288.2016.1213895; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Stalp M, 2002, J TRAUMA, V52, P1160, DOI 10.1097/00005373-200206000-00023; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Virues-Ortega J, 2007, MED CLIN-BARCELONA, V128, P486, DOI 10.1157/13100935; Webster G, 1999, BRAIN INJURY, V13, P593; Yody BB, 2000, J HEAD TRAUMA REHAB, V15, P1041, DOI 10.1097/00001199-200008000-00006	57	4	4	3	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	SEP	2020	17	17							6045	10.3390/ijerph17176045	http://dx.doi.org/10.3390/ijerph17176045			16	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	NO9ML	32825253	Green Published, gold			2022-09-04	WOS:000569810000001
J	Losanno, D; Calabrese, A; Madera-Sierra, IE; Spizzuoco, M; Marulanda, J; Thomson, P; Serino, G				Losanno, D.; Calabrese, A.; Madera-Sierra, I. E.; Spizzuoco, M.; Marulanda, J.; Thomson, P.; Serino, G.			Recycled versus Natural-Rubber Fiber-Reinforced Bearings for Base Isolation: Review of the Experimental Findings	JOURNAL OF EARTHQUAKE ENGINEERING			English	Review						Fiber-reinforced isolators; recycled rubber; natural rubber; shaking-table tests; unbonded bearings; low-cost isolators	ELASTOMERIC ISOLATORS; HORIZONTAL STIFFNESS; SEISMIC ISOLATORS; LOW-COST; INSTABILITY	Over the last decade, significant efforts have been dedicated to develop novel low-cost seismic protection systems that could be used on a large scale in developing regions of the world. In the attempt of reducing the cost of conventional base isolation devices, the feasibility of using flexible reinforcements to replace the steel sheets of traditional steel-reinforced elastomeric isolators (SREIs) has been validated. It has also been verified that these bearings can be installed in unbonded configurations. Previous research has verified the performance of fiber-reinforced elastomeric isolators in unbounded configuration (U-FREIs) using recycled elastomers. The use of recycled rubber to manufacture U-FREIs is very appealing because of its low-cost and its limited environmental impact. In this paper a thorough comparison of the performance of natural-rubber unbounded fiber-reinforced elastomeric isolators (NU-FREIs) and that of recycled rubber bearings (RU-FREIs) is proposed. To this end, the paper discusses the manufacturing and the main features of the two different technologies, as well as the results of experimental tests on the devices and small-scale structures tested on a shaking-table. Overall, the performance of NU-FREIs was found to be better than that of RU-FREIs. Nevertheless, recycled rubber devices are very promising when it comes to protecting non-engineered constructions from moderate to high seismic inputs at a fraction of the cost of conventional technologies.	[Losanno, D.] Natl Res Council Italy, Construct Technol Inst, Milan, Italy; [Losanno, D.; Spizzuoco, M.; Serino, G.] Univ Federico II, Dept Struct Engn & Architecture, Via Claudio 21, Naples, Italy; [Calabrese, A.] Calif State Univ Long Beach, Dept Civil Engn & Construct Engn Management, Long Beach, CA 90840 USA; [Madera-Sierra, I. E.] Pontificia Univ Javeriana Cali, Dept Ingn Civil & Ind, Santiago De Cali, Colombia; [Marulanda, J.; Thomson, P.] Univ Valle, Escuela Ingn Civil & Geomat, Santiago De Cali, Colombia		Spizzuoco, M (corresponding author), Univ Federico II, Dept Struct Engn & Architecture, Via Claudio 21, Naples, Italy.	spizzuoc@unina.it		Calabrese, Andrea/0000-0001-7441-9275; Thomson, Peter/0000-0002-9404-0710	STAR 2017 LO-CO-ISO project of the University of Naples Federico II; Foundation "Compagnia di San Paolo"; Universidad Javeriana - Cali (Programa Institucional para el Desarrollo y Fortalecimiento de la Investigacion 2019); COLCIENCIAS [617/2013]; Universidad del Valle	STAR 2017 LO-CO-ISO project of the University of Naples Federico II; Foundation "Compagnia di San Paolo"(Compagnia di San Paolo); Universidad Javeriana - Cali (Programa Institucional para el Desarrollo y Fortalecimiento de la Investigacion 2019); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad del Valle	The research by the corresponding author was funded by the STAR 2017 LO-CO-ISO project of the University of Naples Federico II and the Foundation "Compagnia di San Paolo". The research was also supported by the Universidad del Valle and the Universidad Javeriana - Cali (Programa Institucional para el Desarrollo y Fortalecimiento de la Investigacion 2019). The third author would like to acknowledge the scholarship for Colombian Doctoral Formation No. 617/2013, provided by COLCIENCIAS.	Ambraseys N, 2002, ENV CLIMATE PROGRAM; [Anonymous], 2011, LOW COST STRUCT BEAR; Calabrese A, 2019, ENG STRUCT, V192, P126, DOI 10.1016/j.engstruct.2019.04.076; Calabrese A, 2015, STRUCT CONTROL HLTH, V22, P107, DOI 10.1002/stc.1663; Charleson A. W., 2006, 8 US NAT C EARTHQ EN; Habieb AB, 2019, SOIL DYN EARTHQ ENG, V120, P127, DOI 10.1016/j.soildyn.2019.01.022; Harris H.G., 1999, STRUCTURAL MODELING; Iervolino I, 2010, B EARTHQ ENG, V8, P339, DOI 10.1007/s10518-009-9146-1; Kelly J. M., 2012, 2012101 PEER U CAL, P110; Kelly J. M., 2002, 200211 PEER U CAL, P106; Kelly JM, 2011, MECHANICS OF RUBBER BEARINGS FOR SEISMIC AND VIBRATION ISOLATION, P1, DOI 10.1002/9781119971870; Kelly JM, 1999, J SEISMOL EARTHQ ENG, V2; Konstantinidis D., 2014, 10 US NATL C EARTHQU; Losanno D, 2019, SOIL DYN EARTHQ ENG, V119, P488, DOI 10.1016/j.soildyn.2017.12.017; Losanno D, 2020, ENG STRUCT, V209, DOI 10.1016/j.engstruct.2019.110003; Losanno D, 2019, STRUCT CONTROL HLTH, V26, DOI 10.1002/stc.2386; Losanno D, 2019, COMPOS STRUCT, V212, P66, DOI 10.1016/j.compstruct.2019.01.026; Madera Sierra Ingrid E., 2019, J. appl. res. technol, V17, P44; Sierra IEM, 2019, ENG STRUCT, V183, P894, DOI 10.1016/j.engstruct.2019.01.037; Magliulo G, 2014, B EARTHQ ENG, V12, P1657, DOI 10.1007/s10518-013-9567-8; Minke G., 1984, P INT S EARTHQ REL L, P105; Naghshineh AK, 2014, EARTHQ ENG STRUCT D, V43, P301, DOI 10.1002/eqe.2345; NTC, 2008, GAZZETTA UFFICI 0204; Osgooei PM, 2014, COMPOS STRUCT, V113, P164, DOI 10.1016/j.compstruct.2014.02.033; Paulay T., 1977, INT J HOUS SCI APPL, V1, P293; Pauletta M, 2015, ENG STRUCT, V102, P358, DOI 10.1016/j.engstruct.2015.08.019; Russo G, 2013, ENG STRUCT, V52, P422, DOI 10.1016/j.engstruct.2013.02.034; Russo G, 2013, ENG STRUCT, V48, P70, DOI 10.1016/j.engstruct.2012.08.031; Spizzuoco M, 2014, ENG STRUCT, V76, P99, DOI 10.1016/j.engstruct.2014.07.001; Ngo TV, 2017, EARTHQ ENG STRUCT D, V46, P1747, DOI 10.1002/eqe.2879; Toopchi-Nezhad H, 2014, STRUCT ENG MECH, V49, P395, DOI 10.12989/sem.2014.49.3.395; Toopchi-Nezhad H, 2009, EARTHQ ENG STRUCT D, V45, P421; Toopchi-Nezhad H, 2008, STRUCT CONTROL HLTH, V15, P876, DOI 10.1002/stc.225; Toopchi-Nezhad H, 2008, J STRUCT ENG, V134, P1627, DOI 10.1061/(ASCE)0733-9445(2008)134:10(1627); Toopchi-Nezhad H, 2011, COMPOS STRUCT, V93, P850, DOI 10.1016/j.compstruct.2010.07.009; Toopchi-Nezhad H, 2009, J COMPOS MATER, V43, P1569, DOI 10.1177/0021998308106322; Van Engelen NC, 2019, SOIL DYN EARTHQ ENG, V125, DOI 10.1016/j.soildyn.2019.03.035; Van Engelen NC, 2015, STRUCT CONTROL HLTH, V22, P417, DOI 10.1002/stc.1682	38	13	13	3	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1363-2469	1559-808X		J EARTHQ ENG	J. Earthqu. Eng.	MAR 12	2022	26	4					1921	1940		10.1080/13632469.2020.1748764	http://dx.doi.org/10.1080/13632469.2020.1748764		APR 2020	20	Engineering, Civil; Engineering, Geological; Geosciences, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Geology	ZY9GR					2022-09-04	WOS:000527011200001
J	Jury, N; Abarzua, S; Diaz, I; Guerra, MV; Ampuero, E; Cubillos, P; Martinez, P; Herrera-Soto, A; Arredondo, C; Rojas, F; Manterola, M; Rojas, A; Montecino, M; Varela-Nallar, L; van Zundert, B				Jury, Nur; Abarzua, Sebastian; Diaz, Ivan; Guerra, Miguel V.; Ampuero, Estibaliz; Cubillos, Paula; Martinez, Pablo; Herrera-Soto, Andrea; Arredondo, Cristian; Rojas, Fabiola; Manterola, Marcia; Rojas, Adriana; Montecino, Martin; Varela-Nallar, Lorena; van Zundert, Brigitte			Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice	CLINICAL EPIGENETICS			English	Article						ALS; FTD; Brain; Astrocyte; Neuron; Memory	HISTONE H3; HEXANUCLEOTIDE REPEAT; RNA FOCI; GENE-EXPRESSION; MOUSE MODEL; LYSINE 9; CHROMATIN; METHYLATION; EXPANSION; ALS	Background Hexanucleotide repeat expansions of the G(4)C(2) motif in a non-coding region of the C9ORF72 gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Tissues from C9ALS/FTD patients and from mouse models of ALS show RNA foci, dipeptide-repeat proteins, and notably, widespread alterations in the transcriptome. Epigenetic processes regulate gene expression without changing DNA sequences and therefore could account for the altered transcriptome profiles in C9ALS/FTD; here, we explore whether the critical repressive marks H3K9me2 and H3K9me3 are altered in a recently developed C9ALS/FTD BAC mouse model (C9BAC). Results Chromocenters that constitute pericentric constitutive heterochromatin were visualized as DAPI- or Nucblue-dense foci in nuclei. Cultured C9BAC astrocytes exhibited a reduced staining signal for H3K9me3 (but not for H3K9me2) at chromocenters that was accompanied by a marked decline in the global nuclear level of this mark. Similar depletion of H3K9me3 at chromocenters was detected in astrocytes and neurons of the spinal cord, motor cortex, and hippocampus of C9BAC mice. The alterations of H3K9me3 in the hippocampus of C9BAC mice led us to identify previously undetected neuronal loss in CA1, CA3, and dentate gyrus, as well as hippocampal-dependent cognitive deficits. Conclusions Our data indicate that a loss of the repressive mark H3K9me3 in astrocytes and neurons in the central nervous system of C9BAC mice represents a signature during neurodegeneration and memory deficit of C9ALS/FTD.	[Jury, Nur; Abarzua, Sebastian; Diaz, Ivan; Guerra, Miguel V.; Ampuero, Estibaliz; Cubillos, Paula; Martinez, Pablo; Arredondo, Cristian; Rojas, Fabiola; Montecino, Martin; Varela-Nallar, Lorena; van Zundert, Brigitte] Univ Andres Bello, Fac Med, Inst Biomed Sci ICB, Santiago, Chile; [Jury, Nur; Abarzua, Sebastian; Diaz, Ivan; Guerra, Miguel V.; Ampuero, Estibaliz; Cubillos, Paula; Martinez, Pablo; Herrera-Soto, Andrea; Arredondo, Cristian; Rojas, Fabiola; Montecino, Martin; Varela-Nallar, Lorena; van Zundert, Brigitte] Univ Andres Bello, Fac Life Sci, Santiago, Chile; [Jury, Nur; Abarzua, Sebastian; Diaz, Ivan; Ampuero, Estibaliz; Cubillos, Paula; Martinez, Pablo; Arredondo, Cristian; Rojas, Fabiola; van Zundert, Brigitte] Pontificia Univ Catolica Chile, Fac Biol Sci, CARE Biomed Res Ctr, Santiago, Chile; [Abarzua, Sebastian; Montecino, Martin] FONDAP Ctr Genome Regulat, Santiago, Chile; [Ampuero, Estibaliz] Univ Autonoma Chile, Fac Hlth Sci, Santiago, Chile; [Manterola, Marcia] Univ Chile, Fac Med, Program Human Genet, ICBM, Santiago, Chile; [Rojas, Adriana] Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia		Varela-Nallar, L; van Zundert, B (corresponding author), Univ Andres Bello, Fac Med, Inst Biomed Sci ICB, Santiago, Chile.; Varela-Nallar, L; van Zundert, B (corresponding author), Univ Andres Bello, Fac Life Sci, Santiago, Chile.	lorena.varela@unab.cl; bvanzundert@unab.cl	Varela-Nallar, Lorena/AAV-3304-2021	Ampuero, Estibaliz/0000-0001-5543-1594; Rojas, Adriana/0000-0001-8528-4433; Martinez Contreras, Pablo/0000-0003-3496-4652	FONDECYT [1181645, 1190461]; CONICYT PIA/BASAL [AFB 170005 CARE UC]; ALS Association [20-DDC-497]; FightMND; Nucleus UNAB [DI-4-17/N]; FONDAP [15090007]; CONICYT [201161486, 21151265, 21151563]; FBR [4171-PUJ8253]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT PIA/BASAL(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); ALS Association; FightMND; Nucleus UNAB; FONDAP; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FBR	Grants from FONDECYT (1181645, BvZ; 1190461, LVN), CONICYT PIA/BASAL (AFB 170005 CARE UC, BvZ), The ALS Association 20-DDC-497 (BvZ), FightMND (BvZ), Nucleus UNAB (DI-4-17/N, BvZ, LVN); FONDAP (15090007, MMo), CONICYT (201161486, NJ; 21151265, SA; 21151563, PM), and FBR 4171-PUJ8253 (AR).	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Belzil VV, 2016, ACTA NEUROPATHOL, V132, P487, DOI 10.1007/s00401-016-1587-4; Belzil VV, 2014, BRAIN RES, V1584, P15, DOI 10.1016/j.brainres.2014.02.015; Belzil VV, 2013, ACTA NEUROPATHOL, V126, P895, DOI 10.1007/s00401-013-1199-1; Bustos FJ, 2017, BRAIN, V140, P3252, DOI 10.1093/brain/awx272; Chen P, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150064; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Esanov R, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0185-9; Espana-Agusti J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02245-1; Fritz E, 2013, J NEUROPHYSIOL, V109, P2803, DOI 10.1152/jn.00500.2012; Frost B, 2014, NAT NEUROSCI, V17, P357, DOI 10.1038/nn.3639; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Harr JC, 2016, EMBO REP, V17, P139, DOI 10.15252/embr.201541809; Hayes LR, 2016, NEURON, V90, P427, DOI 10.1016/j.neuron.2016.04.026; Hernandez-Ortega K, 2016, BRAIN PATHOL, V26, P593, DOI 10.1111/bpa.12335; Hewitson TD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00307; Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Linhoff MW, 2015, CELL, V163, P246, DOI 10.1016/j.cell.2015.09.002; Liu EY, 2014, ACTA NEUROPATHOL, V128, P525, DOI 10.1007/s00401-014-1286-y; Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005; Mansuroglu Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep33047; Masala A, 2018, NEUROSCIENCE, V390, P1, DOI 10.1016/j.neuroscience.2018.08.009; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; McMillan CT, 2015, NEUROLOGY, V84, P1622, DOI 10.1212/WNL.0000000000001495; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nakata H, 2019, ANAT SCI INT, V94, P1, DOI 10.1007/s12565-018-0455-9; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; O'Rourke JG, 2015, NEURON, V88, P892, DOI 10.1016/j.neuron.2015.10.027; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Peters OM, 2015, NEURON, V88, P902, DOI 10.1016/j.neuron.2015.11.018; Poleshko A, 2019, ELIFE, V8, DOI 10.7554/eLife.49278; Politz JCR, 2013, NUCLEUS-AUSTIN, V4, P153, DOI 10.4161/nucl.24999; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rojas F, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00203, 10.3389/fncel.2015.00203]; Rojas F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00024; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Sun WY, 2018, NAT NEUROSCI, V21, P1038, DOI 10.1038/s41593-018-0194-1; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Terranova R, 2005, EXP CELL RES, V310, P344, DOI 10.1016/j.yexcr.2005.07.031; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Ugarte F, 2015, STEM CELL REP, V5, P728, DOI 10.1016/j.stemcr.2015.09.009; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Varcianna A, 2019, EBIOMEDICINE, V40, P626, DOI 10.1016/j.ebiom.2018.11.067; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Wijchers PJ, 2015, GENOME RES, V25, P958, DOI 10.1101/gr.186643.114; Xi ZR, 2014, NEUROLOGY, V83, P1476, DOI 10.1212/WNL.0000000000000886; Yokoyama Jennifer S, 2014, Am J Neurodegener Dis, V3, P1; Zeller P, 2017, COLD SH Q B, V82, P15, DOI 10.1101/sqb.2017.82.033662; Zeller P, 2016, NAT GENET, V48, P1385, DOI 10.1038/ng.3672; Zhang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167454; Zhang YJ, 2019, SCIENCE, V363, P707, DOI 10.1126/science.aav2606; Zhang YM, 2018, REPROD TOXICOL, V79, P124, DOI 10.1016/j.reprotox.2018.06.006; Zheng Y, 2019, BRAIN, V142, P787, DOI 10.1093/brain/awy354	67	13	13	1	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1868-7075	1868-7083		CLIN EPIGENETICS	Clin. Epigenetics	FEB 18	2020	12	1							32	10.1186/s13148-020-0816-9	http://dx.doi.org/10.1186/s13148-020-0816-9			15	Oncology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Genetics & Heredity	KQ8VV	32070418	gold, Green Published			2022-09-04	WOS:000517200400003
J	Ramirez, NA; Giovanella, L; Romero, RV; Silva, HT; de Almeida, PF; Rios, G; Goede, H; Oliveira, S				Acosta Ramirez, Naydu; Giovanella, Ligia; Vega Romero, Roman; Tejerina Silva, Herland; de Almeida, Patty Fidelis; Rios, Gilberto; Goede, Hedwig; Oliveira, Suelen			Mapping primary health care renewal in South America	FAMILY PRACTICE			English	Article						Comprehensive health care; health care reform; primary health care; social participation; South America; universal coverage		Background. Primary health care (PHC) renewal processes are currently ongoing in South America (SA), but their characteristics have not been systematically described. Objective. The study aimed to describe and contrast the PHC approaches being implemented in SA to provide knowledge of current conceptions, models and challenges. Methods. This multiple case study used a qualitative approach with technical visits to health ministries in order to apply key-informant interviews of 129 PHC national policy makers and 53 local managers, as well as field observation of 57 selected PHC providers and document analysis, using a common matrix for data collection and analysis. PHC approaches were analysed by triangulating sources using the following categories: PHC philosophy and conception, service provision organization, intersectoral collaboration and social participation. Results. Primary health care models were identified in association with existing health system types and the dynamics of PHC renewal in each country. A neo-selective model was found in three countries where coverage is segmented by private and public regimes; here, individual and collective care are separated. A comprehensive approach similar to the Alma-Ata model was found in seven countries where the public sector predominates and individual, family and community care are coordinated under the responsibility of the same health care team. Conclusions. The process of implementing a renewed PHC approach is affected by how health systems are funded and organized. Both models face many obstacles. In addition, care system organization, intersectoral coordination and social participation are weak in most of the countries.	[Acosta Ramirez, Naydu] Pontificia Univ Javeriana, Dept Publ Hlth, Cali, Colombia; [Giovanella, Ligia; Vega Romero, Roman] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Dept Adm & Planning Hlth, Rio De Janeiro, Brazil; [Vega Romero, Roman] Pontificia Univ Javeriana, Publ Hlth Inst, Bogota, Colombia; [Tejerina Silva, Herland] Univ Mayor San Andres, Fac Med, La Paz, Bolivia; [de Almeida, Patty Fidelis] Univ Fed Fluminense, Dept Hlth Planning, Niteroi, RJ, Brazil; [Rios, Gilberto] Univ Republica, Fac Med, Montevideo, Uruguay; [Goede, Hedwig] Goede Publ Hlth Cons Bur, Paramaribo, Suriname; [Oliveira, Suelen] Ctr ABEU Univ, Fac Psychol, Rio De Janeiro, Brazil		Ramirez, NA (corresponding author), Pontificia Univ Javeriana, Fac Ciencias Salud, Calle 18 118-250, Cali, Colombia.	naydu.acosta@javerianacali.edu.co	ACOSTA, NAYDU/AEJ-0051-2022	ACOSTA, NAYDU/0000-0002-6246-560X; Fidelis de Almeida, Patty/0000-0003-1676-3574; Tejerina, Herland/0000-0002-8844-0865	South American Institute of Government in Health (ISAGS); Health Council of UNASUR [06/2012]	South American Institute of Government in Health (ISAGS); Health Council of UNASUR	South American Institute of Government in Health (ISAGS). Resolution 06/2012 of the Health Council of UNASUR	Acosta Ramirez N, 2014, MAPEO ANALISIS MODEL; Ramirez NA, 2011, CAD SAUDE PUBLICA, V27, P1875, DOI 10.1590/S0102-311X2011001000002; Almeida P, 2014, MAPEAMENTO ANALISE M; Amezcua Manuel, 2002, Rev. Esp. Salud Publica, V76, P423, DOI 10.1590/s1135-57272002000500005; [Anonymous], 2011, SOC PAN LAT AM 2011; Conill Eleonor Minho, 2010, Rev. Bras. Saude Mater. Infant., V10, ps14, DOI 10.1590/S1519-38292010000500002; Giovanella L., 2015, ATENCION PRIMARIA SA; Giovanella L, 2012, SISTEMAS SALUD SURAM; Giovanella Ligia, 2015, Saúde debate, V39, P300, DOI 10.1590/0103-110420151050002002; Goede H., 2014, MAPPING ANAL PRIMARY; Labonté Ronald, 2009, Rev. Gerenc. Polit. Salud, V8, P14; Macinko J, 2009, J AMBUL CARE MANAG, V32, P150, DOI 10.1097/JAC.0b013e3181994221; Organizacion Panamericana de la Salud, 2012, SAL AM PAN REG PERF; PAHO, IND BAS SAL IN REG D; Rios G, 2014, MAPEO ANALISIS MODEL; Rovere Mario, 2012, Saúde debate, V36, P327; Silva H., 2014, INFILTRADOS CRNICA C; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Tejerina HT, 2009, MED SOC, V4, P273; Vega Romero R, 2014, MAPEO ANALISIS MODEL	20	9	13	4	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0263-2136	1460-2229		FAM PRACT	Fam. Pr.	JUN	2016	33	3					261	267		10.1093/fampra/cmw013	http://dx.doi.org/10.1093/fampra/cmw013			7	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR9VJ	27006410	Bronze			2022-09-04	WOS:000380243900009
J	Sack, J; Goldstein, A; Charpak, N; Rozin, A; Ruiz-Pelaez, JG; de Calume, ZF; Charpak, Y; Weller, A				Sack, J; Goldstein, A; Charpak, N; Rozin, A; Ruiz-Pelaez, JG; de Calume, ZF; Charpak, Y; Weller, A			Postpartum maternal hyperthyrotropinemia in an area in which iodine supplementation is required	THYROID			English	Article							KANGAROO MOTHER CARE; THYROID-FUNCTION; PRETERM INFANTS; DEFICIENCY DISORDERS; CONTROLLED TRIAL; SUDANESE WOMEN; PREGNANCY; HYPOTHYROIDISM	Mild maternal hypothyroidism during pregnancy can adversely affect infant development. We studied thyrotropin (TSH) levels in mothers of premature and low-birth-weight infants in Colombia, where iodized salt supplements the diet to correct iodine deficiency. The additional impact of salt restriction in mothers with hypertensive disorders was examined. Blood was spotted on filter paper from 404 mothers and their infants. Using radioimmunoassay (RIA), TSH was measured in the mothers, and TSH and thyroxine in their infants at three postpartum times. Initially, mothers had high TSH levels (i.e., TSH > 10 mU/L in half the mothers at the first assessment). Fourteen days later, only 9.3%, and at calculated term 7.5% were greater than 10 mU/L. Maternal TSH levels correlated with infant birth weight and gestational age (r = 0.47, and r = 0.49, p < 0.01). Initial TSH values were higher in salt restricted (20.1 +/- 2 mU/L, n = 76) versus control mothers (14.6 +/- 0.85, n = 328, p < 0.01), dropping dramatically in both groups 14 days later (to 3.4 +/- 0.7 mU/L vs. 2.8 +/- 0.4 mU/L) and at calculated term (2.8 +/-0.4 mU/L vs. 2.3 +/- 0.6 mU/L). Increased maternal TSH levels during pregnancy in an iodine-deficient area may be aggravated by salt restriction. Monitoring TSH and supplementing iodine or thyroxine are recommended in pregnancy, especially if dietary salt restriction is prescribed.	Chaim Sheba Med Ctr, Dept Pediat, IL-52621 Tel Hashomer, Israel; Sackler Sch Med, Tel Hashomer, Israel; Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; ISS, World Lab, Programme Madre Canguro, Bogota, Colombia; Univ Javeriana, Fac Med, Clin Epidemiol Unit, Bogota, Colombia; EVAL Inst, Paris, France		Sack, J (corresponding author), Chaim Sheba Med Ctr, Dept Pediat, IL-52621 Tel Hashomer, Israel.	weller@mail.biu.ac.il	Weller, Aron/AAU-3074-2020; Ruiz, Juan Gabriel/AAZ-5882-2021	Weller, Aron/0000-0002-0663-4384; Ruiz, Juan Gabriel/0000-0003-3088-5834; charpak, nathalie/0000-0001-6697-5837; Goldstein, Abraham/0000-0002-9349-0621				ABOULKHAIR SA, 1964, CLIN SCI, V27, P195; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; BLOT I, 1999, CURR OPIN HEMATOL, V6, P66; CAO XY, 1994, NEW ENGL J MED, V331, P1739, DOI 10.1056/NEJM199412293312603; Charpak N, 1997, PEDIATRICS, V100, P682, DOI 10.1542/peds.100.4.682; Charpak N, 2001, PEDIATRICS, V108, P1072, DOI 10.1542/peds.108.5.1072; Dunn JT, 2001, J CLIN ENDOCR METAB, V86, P2360, DOI 10.1210/jc.86.6.2360; Dunn JT, 1998, J CLIN ENDOCR METAB, V83, P3398, DOI 10.1210/jc.83.10.3398; ELDAR D, 1990, HORM RES, V34, P219, DOI 10.1159/000181829; Elnagar B, 1998, EUR J CLIN NUTR, V52, P351, DOI 10.1038/sj.ejcn.1600563; Eltom A, 2000, EUR J CLIN NUTR, V54, P429, DOI 10.1038/sj.ejcn.1600992; FISHER DA, 1983, CLIN PERINATOL, V10, P615, DOI 10.1016/S0095-5108(18)30954-0; Gaitan E, 1983, Ecol Dis, V2, P295; Glinoer D, 1999, THYROID, V9, P631, DOI 10.1089/thy.1999.9.631; GLINOER D, 1995, J CLIN ENDOCR METAB, V80, P258, DOI 10.1210/jc.80.1.258; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; HETZEL BS, 1983, LANCET, V2, P1126; Koutras DA, 2000, ANN NY ACAD SCI, V900, P77; Kung AWC, 1997, CLIN ENDOCRINOL, V46, P315, DOI 10.1046/j.1365-2265.1997.1310960.x; LAO TT, 1990, BRIT J OBSTET GYNAEC, V97, P71, DOI 10.1111/j.1471-0528.1990.tb01719.x; Linder N, 1997, J PEDIATR-US, V131, P434, DOI 10.1016/S0022-3476(97)80071-6; MORREALE DE, 2000, J CLIN ENDOCR METAB, V85, P3975, DOI DOI 10.1210/JCEM.85.11.6961; PHAROAH POD, 1984, CLIN ENDOCRINOL, V21, P265, DOI 10.1111/j.1365-2265.1984.tb03468.x; Utiger RD, 1999, NEW ENGL J MED, V341, P601, DOI 10.1056/NEJM199908193410809; Vermiglio F, 1999, THYROID, V9, P19, DOI 10.1089/thy.1999.9.19; Vulsma T, 2001, LANCET, V357, P1145, DOI 10.1016/S0140-6736(00)04381-6; Weller A, 2002, HORM RES, V57, P22, DOI 10.1159/000057942	27	4	5	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	OCT	2003	13	10					959	964		10.1089/105072503322511364	http://dx.doi.org/10.1089/105072503322511364			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	739MZ	14611705				2022-09-04	WOS:000186352200008
J	Cortes-Ortiz, L; Bermingham, E; Rico, C; Rodriguez-Luna, E; Sampaio, I; Ruiz-Garcia, M				Cortes-Ortiz, L; Bermingham, E; Rico, C; Rodriguez-Luna, E; Sampaio, I; Ruiz-Garcia, M			Molecular systematics and biogeography of the Neotropical monkey genus, Alouatta	MOLECULAR PHYLOGENETICS AND EVOLUTION			English	Review						mitochondrial DNA; Andes mountains; Panama Isthmus; riverine barriers; calmodulin; recombination activating gene 1; Ateles; Brachyteles; molecular clock	RED HOWLER MONKEY; WORLD MONKEYS; MITOCHONDRIAL-DNA; PHYLOGENETIC-RELATIONSHIPS; DISPERSAL PATTERNS; RIVERINE BARRIERS; PLATYRRHINI; PRIMATES; NUCLEAR; SPECIATION	We take advantage of the broad distribution of howler monkeys from Mexico to Argentina to provide a historical biogeographical analysis on a regional scale that encompasses the entire Neotropics. The phylogenetic relationships among 9 of the 10 recognized Alouatta species were inferred using three mitochondrial and two nuclear genes. The nuclear gene regions provided no phylogenetic resolution among howler monkey species, and were characterized by very low levels of sequence divergence between Alouatta and the Ateles outgroup. The mtDNA genes, on the other hand, produced a well-resolved phylogeny, which indicated that the earliest split among howler monkeys separated cis- and trans-Andean clades. Eight monophyletic mtDNA haplotype clades were identified, representing six named species in South America, including Alouatta seniculus, Alouatta sara, Alouatta macconelli, Alouatta caraya, Alouatta belzebul, and Alouatta guariba, and two in Mesoamerica, Alouatta pigra and Alouatta palliata. Molecular clock-based estimates of branching times indicated that contemporary howler monkey species originated in the late Miocene and Pliocene, not the Pleistocene. The causes of Alouatta diversification were more difficult to pin down, although we posit that the initial cis-, trans-Andean split in the genus was caused by the late Miocene completion of the northern Andes. Riverine barriers to dispersal and putative forest refuges can neither be discounted nor distinguished as causes of speciation in many cases, and one, the other or both have likely played a role in the diversification of South American howler monkeys. Finally, we estimated the separation of Mesoamerican A. pigra and A. palliata at 3 Ma, which corresponds to the completion date of the Panama Isthmus promoting a role for this earth history event in the speciation of Central American howler monkeys. (C) 2002 Elsevier Science (USA). All rights reserved.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Smithsonian Trop Res Inst, Naos Labs, Unit 0948, APO, AA 34002 USA; Univ Veracruzana, Inst Neuroetol, Jalapa, Veracruz, Mexico; Fed Univ Para, BR-66059 Belem, Para, Brazil; Pontificia Univ Javeriana, Bogota, Colombia		Cortes-Ortiz, L (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	cortesl@naos.si.edu	Rico, Ciro/K-5725-2015; Ruiz-Garcia, Manuel/AAF-8191-2019; SAMPAIO, IRACILDA/J-6514-2012; Rico, Ciro/P-9750-2019	Rico, Ciro/0000-0002-0822-336X; SAMPAIO, IRACILDA/0000-0002-2137-4656; Rico, Ciro/0000-0002-0822-336X				ARMADA JLA, 1987, AM J PRIMATOL, V13, P283, DOI 10.1002/ajp.1350130306; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Bailey WJ, 1992, MOL PHYLOGENET EVOL, V1, P97, DOI 10.1016/1055-7903(92)90024-B; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bigarella J.J., 1982, P27; BROCKETT RC, 2000, NEOTROPICAL PRIMATES, V8, P1; Brown K.S. Jr, 1982, P255; Brown W.M., 1983, P62; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; CARPENTER C. R., 1934, COMPAR PSYCHOL MONOGR, V10, P1; Castroviejo Santiago, 1997, P1; CLARKE MR, 1986, AM J PRIMATOL, V11, P79, DOI 10.1002/ajp.1350110108; Coates Anthony G., 1996, P21; COLINVAUX P, 1997, CENTRAL AM NATURAL C, P123; Colinvaux Paul A., 1996, P359; Collins AC, 2000, INT J PRIMATOL, V21, P421, DOI 10.1023/A:1005487802312; Collins AC, 2001, MOL PHYLOGENET EVOL, V19, P67, DOI 10.1006/mpev.2000.0917; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Consigliere S, 1998, AM J PRIMATOL, V46, P119, DOI 10.1002/(SICI)1098-2345(1998)46:2<119::AID-AJP2>3.0.CO;2-Z; Cortes-Ortiz L, 1998, THESIS U VERACRUZANA; Crockett C.M., 1987, P54; Crockett Carolyn M., 1993, P104; Crockett CM, 1998, INT J PRIMATOL, V19, P549, DOI 10.1023/A:1020316607284; Cropp S, 2000, MOL PHYLOGENET EVOL, V16, P350, DOI 10.1006/mpev.2000.0814; Duda TF, 1999, P NATL ACAD SCI USA, V96, P10272, DOI 10.1073/pnas.96.18.10272; DUNLAP SS, 1985, AM J PHYS ANTHROPOL, V68, P499, DOI 10.1002/ajpa.1330680406; Edwards SV, 2000, EVOLUTION, V54, P1839; Endler J.A., 1977, Monographs in Population Biology, pi; ENGLER JA, 1982, BIOL DIVERSIFICATION, P641; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Ford S.M., 1986, P73; Frantzen MAJ, 1998, MOL ECOL, V7, P1423, DOI 10.1046/j.1365-294x.1998.00449.x; FROHELICH JW, 1987, PRIMATE CONSERVATION, V8, P58; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; GINGERICH PD, 1984, YEARB PHYS ANTHROPOL, V27, P57; GLANDER KE, 1992, INT J PRIMATOL, V13, P415, DOI 10.1007/BF02547826; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Griffiths CS, 1997, MOL PHYLOGENET EVOL, V7, P352, DOI 10.1006/mpev.1997.0404; Groves C. P., 2001, PRIMATE TAXONOMY; Haffer J., 1982, P6; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Haffer J., 1974, Publications Nuttall Orn Club, VNo. 14, P1; HAFFER J, 1975, AVIFAUNA NW COLOMBIA; Haffer J, 1993, BIOGEOGRAPHICA, V69, P15; HAFFER J, 1992, B MUS PARA EM ILIO Z, V8, P127; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hershkovitz P., 1949, Proceedings of the United States National Museum, V98, P323; Hill WCO, 1962, PRIMATES COMP ANAT B; Hoelzer GA, 1997, EVOLUTION, V51, P622, DOI 10.1111/j.1558-5646.1997.tb02451.x; Horovitz I, 1995, MOL PHYLOGENET EVOL, V4, P448, DOI 10.1006/mpev.1995.1041; Huelsenbeck JP, 2000, GENETICS, V154, P1879; Jones OL, 1998, COLON LAT AM HIST R, V7, P1; KAY RF, 1990, J HUM EVOL, V19, P175, DOI 10.1016/0047-2484(90)90016-5; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; LAWRENCE BARBARA, 1933, BULL MUS COMP ZOOL, V75, P313; LIMA MMC, 1991, CYTOGENET CELL GENET, V57, P151, DOI 10.1159/000133135; Lopez JV, 1997, MOL BIOL EVOL, V14, P277, DOI 10.1093/oxfordjournals.molbev.a025763; Lundberg John G., 1998, P13; MADISON WP, 1997, MACCLADE VERSION 3 0; Mayr E, 1963, ANIMAL SPECIES EVOLU; Meireles CM, 1999, MOL PHYLOGENET EVOL, V12, P10, DOI 10.1006/mpev.1998.0574; Meireles CM, 1999, GENET MOL BIOL, V22, P337, DOI 10.1590/S1415-47571999000300009; Minezawa M., 1985, KYOTO U OVERSEAS RES, V5, P7; MUDRY M, 1994, PROMETAPHASE CHROMOS; Mundy NI, 2000, MOL BIOL EVOL, V17, P1075, DOI 10.1093/oxfordjournals.molbev.a026388; Ostro LET, 2001, INT J PRIMATOL, V22, P733, DOI 10.1023/A:1012013315920; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Palumbi SR., 1991, SIMPLE FOOLS GUIDE P; Palumbi Stephen R., 1996, P205; Pastorini J, 2001, MOL PHYLOGENET EVOL, V19, P45, DOI 10.1006/mpev.2000.0904; PATTON JL, 1992, EVOLUTION, V46, P174, DOI 10.1111/j.1558-5646.1992.tb01992.x; PATTON JL, 1994, EVOLUTION, V48, P1314, DOI 10.1111/j.1558-5646.1994.tb05315.x; PATTON JL, 1997, ENDLESS FORMS SPECIE; Peres CA, 1996, FOLIA PRIMATOL, V67, P113, DOI 10.1159/000157213; Pope TR, 2000, BEHAV ECOL SOCIOBIOL, V48, P253, DOI 10.1007/s002650000236; POPE TR, 1992, EVOLUTION, V46, P1112, DOI 10.1111/j.1558-5646.1992.tb00623.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ron SR, 2000, BIOL J LINN SOC, V71, P379, DOI 10.1111/j.1095-8312.2000.tb01265.x; Rosenberger A.L., 1981, P9; ROSENBERGER AL, 1984, J HUM EVOL, V13, P737, DOI 10.1016/S0047-2484(84)80023-8; RUIZGARCIA M, IN PRESS AM J PRIMAT; Rylands AB, 1998, INT J PRIMATOL, V19, P879, DOI 10.1023/A:1020349514553; Rylands AB, 1996, ADAPTIVE RAD NEOTROP; Rylands Anthony B., 2000, Neotropical Primates, V8, P61; Rylands Anthony B., 1995, Neotropical Primates, V3, P113; SALO J, 1986, NATURE, V322, P254, DOI 10.1038/322254a0; Sambrook J., 1989, MOL CLONING LAB MANU; Sampaio I, 1996, PRIMATES, V37, P65, DOI 10.1007/BF02382921; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schneider H, 1996, AM J PHYS ANTHROPOL, V100, P153, DOI 10.1002/(SICI)1096-8644(199606)100:2<153::AID-AJPA1>3.0.CO;2-Z; SCHNEIDER H, 1993, MOL PHYLOGENET EVOL, V2, P225, DOI 10.1006/mpev.1993.1022; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SMITH JD, 1970, J MAMMAL, V51, P358, DOI 10.2307/1378486; STANYON R, 1995, AM J PRIMATOL, V35, P171, DOI 10.1002/ajp.1350350302; Stehli F.G., 1985, GREAT AM BIOTIC INTE; Swofford DL, 2011, PAUP PHYLOGENETIC AN; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/oxfordjournals.molbev.a040023]; TOLEDO VM, 1980, BIOL DIVERSIFICATION, P93; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Vassart M, 1996, J HERED, V87, P331, DOI 10.1093/oxfordjournals.jhered.a023008; von Dornum M, 1999, MOL PHYLOGENET EVOL, V11, P459, DOI 10.1006/mpev.1998.0582; Wallace, 1852, P ZOOL SOC LOND, V20, P107, DOI [10.1080/037454809494374, DOI 10.1080/037454809494374]; Webb S.D., 1984, Journal of Vertebrate Paleontology, V4, P237; Webb S. David, 1997, P97; Webb S. David, 1996, P335; WHITMORE TC, 1987, OXFORD MONOGRAPHS BI, V3; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122	112	206	222	2	64	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1055-7903	1095-9513		MOL PHYLOGENET EVOL	Mol. Phylogenet. Evol.	JAN	2003	26	1					64	81	PII S1055-7903(02)00308-1	10.1016/S1055-7903(02)00308-1	http://dx.doi.org/10.1016/S1055-7903(02)00308-1			18	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	634GA	12470939				2022-09-04	WOS:000180330600008
J	Martins, AMG; Sampaio, I; Silva, A; Boubli, J; Hrbek, T; Farias, I; Ruiz-Garcia, M; Schneider, H				Martins-Junior, Antonio M. G.; Sampaio, Iracilda; Silva, Artur; Boubli, Jean; Hrbek, Tomas; Farias, Izeni; Ruiz-Garcia, Manuel; Schneider, Horacio			Out of the shadows: Multilocus systematics and biogeography of night monkeys suggest a Central Amazonian origin and a very recent widespread southeastward expansion in South America	MOLECULAR PHYLOGENETICS AND EVOLUTION			English	Article						Andean uplift; Aotus; Molecular systematics; Owl monkeys; Phylogeography	OWL MONKEYS; GENUS AOTUS; UPLIFT HISTORY; MIDDLE MIOCENE; LA-VENTA; EVOLUTION; CHROMOSOME; DIVERSIFICATION; PLATYRRHINI; DIVERSITY	Night monkeys (Aotus, Cebidae) are a widely distributed genus of Neotropical primates with a poorly understood taxonomy and biogeography. The number of species in the genus varies from one to nine, depending on the author, and there are at least 18 known karyotypes, varying from 2n = 46 to 2n = 58. Historically, night monkeys are divided into two species groups: red- and grey-necked groups from south and north of the AmazonSolimo similar to es River, respectively. Here, we used 10 nuclear and 10 mitochondrial molecular markers from a wide taxonomic and geographic sample to infer phylogeny, divergence times, and biogeography of the genus. For phylogenetic reconstruction we used Maximum Likelihood (ML) and Bayesian Inferences (BI). Biogeographic models were generated using the 'BioGeoBEARS' software. We found support for nine taxa of Aotus and rejected the existence of monophyletic "red necked" and "grey necked" species groups. We suggest a taxonomic reclassification of the genus, which is better represented by two clades named northern group, which contains Aotus miconax, A. nancymae, A. trivirgatus, A. vociferans, A. lemurinus, A. griseimembra, A. zonalis, and A. brumbacki, and southern group, which contains A. nigriceps, A. boliviensis, A. infulatus, and A. azarae. The results suggest that the most recent common ancestor of all species of Aotus arose in the central Amazon basin in the Early Pliocene. The evolutionary history of night monkeys was guided by dispersal, vicariance and founder events. The end of the Andean uplift and the subsequent changes in the Amazon landscape, as well as the Amazon-Solimo similar to es and Tapaj ' os rivers may have played an important role in the origin and diversification of Aotus, respectively. However, most of the Amazonian rivers seem not to have been geographical barriers to dispersal of night monkeys. The herein named southern group is fruit of a very recent diversification guided by dispersal, crossing the Tapaj ' os, Xingu, Tocantins, and Guapore rivers and reaching the Cerrado in the last 1.6 My.	[Martins-Junior, Antonio M. G.; Sampaio, Iracilda; Schneider, Horacio] Univ Fed Para, Inst Estudos Costeiros, BR-68600000 Braganca, Para, Brazil; [Martins-Junior, Antonio M. G.] Inst Fed Para, Lab Genet Evolucao & Bioinformat, BR-68455695 Tucurui, Brazil; [Silva, Artur] Univ Fed Para, Ctr Genom & Biol Sistemas, Lab Genom & Bioinformat, Belem, Para, Brazil; [Boubli, Jean] Univ Salford, Sch Environm & Life Sci, Salford, Lancs, England; [Hrbek, Tomas; Farias, Izeni] Univ Fed Amazonas, Lab Genet & Evolucao Anim, BR-69080900 Manaus, Amazonas, Brazil; [Ruiz-Garcia, Manuel] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol & Biol Evolut, Bogota, Colombia; [Hrbek, Tomas] Trinity Univ, Biol Dept, San Antonio, TX 78212 USA		Martins, AMG (corresponding author), Inst Fed Para, Lab Genet Evolut & Bioinformat, Tucurui, Brazil.	antonio.martins@ifpa.edu; ira@ufpa.br; asilva@ufpa.br; jeanpboubli@gmail.com; tomas@evoamazon.net; izeni@evoamazon.net; mruiz@javeriana.edu.co; horacio@ufpa.br	Hrbek, Tomas/J-6988-2012	Hrbek, Tomas/0000-0003-3239-7068; Ruiz-Garcia, Manuel/0000-0003-2820-2950	CAPES-PROAM, Brazil [3296/2013]; CNPq, Brazil [306233/2009-6, 473341/2010-7, 305645/2009-9]; CNPq/FAPEAM SISBIOTA Program, Brazil [563348/2010-0]	CAPES-PROAM, Brazil; CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/FAPEAM SISBIOTA Program, Brazil	This work was supported by funds provided by CAPES-PROAM 3296/2013, Brazil, CNPq, Brazil (grants 306233/2009-6 to IS, and 473341/2010-7 and 305645/2009-9 to HS), and CNPq/FAPEAM SISBIOTA Program, Brazil (No. 563348/2010-0).	Alfaro JWL, 2015, MOL PHYLOGENET EVOL, V82, P518, DOI 10.1016/j.ympev.2014.09.027; Alfaro JWL, 2015, MOL PHYLOGENET EVOL, V82, P436, DOI 10.1016/j.ympev.2014.09.004; AQUINO R, 1988, AM J PRIMATOL, V14, P375, DOI 10.1002/ajp.1350140407; ASHLEY MV, 1995, INT J PRIMATOL, V16, P793, DOI 10.1007/BF02735720; Babb PL, 2011, AM J PHYS ANTHROPOL, V146, P209, DOI 10.1002/ajpa.21567; Baker PA, 2015, QUATERNARY SCI REV, V124, P31, DOI 10.1016/j.quascirev.2015.06.011; Boubli J.P., 2018, How many pygmy marmoset (Cebuella Gray, 1870) species are there; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BRUMBACK RA, 1971, FOLIA PRIMATOL, V15, P264, DOI 10.1159/000155384; BRUMBACK RA, 1973, FOLIA PRIMATOL, V20, P106, DOI 10.1159/000155571; Burgos J.D.Z., 2006, THESIS U PAUL SABATI; Byrne H, 2018, ZOOL SCR, V47, P499, DOI 10.1111/zsc.12300; Byrne H, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0142-4; Campbell KE, 2006, PALAEOGEOGR PALAEOCL, V239, P166, DOI 10.1016/j.palaeo.2006.01.020; Carneiro L, 2018, MOL PHYLOGENET EVOL, V120, P375, DOI 10.1016/j.ympev.2017.11.019; Choleva L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080641; Cracraft J., 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI [10.2307/40168278, DOI 10.2307/40168278]; Defler Thomas R., 2001, Neotropical Primates, V9, P37; Defler Thomas R., 2007, Primate Conservation, V22, P55, DOI 10.1896/052.022.0104; Drummond A.J., 2012, Mol. Biol. Evol., V29, P1969; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandez-Duque E, 2006, FOLIA PRIMATOL, V77, P123, DOI 10.1159/000089699; Fernandez-Duque E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012572; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Ford Susan M., 1994, P1; GALBREATH GJ, 1983, AM J PRIMATOL, V4, P245, DOI 10.1002/ajp.1350040303; Garver JI, 2005, J GEOL, V113, P117, DOI 10.1086/427664; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Martins AMG, 2018, GENET MOL BIOL, V41, P699, DOI [10.1590/1678-4685-GMB-2017-0012, 10.1590/1678-4685-gmb-2017-0012]; Graham A, 2001, AM J BOT, V88, P1545, DOI 10.2307/3558398; Gregory-Wodzicki KM, 1998, J S AM EARTH SCI, V11, P533, DOI 10.1016/S0895-9811(98)00031-5; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Groves C., 2001, SMITHSONIAN SERIES C, P1; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HERSHKOVITZ P, 1970, Folia Primatologica, V12, P1, DOI 10.1159/000155278; HERSHKOVITZ P, 1983, AM J PRIMATOL, V4, P209, DOI 10.1002/ajp.1350040302; Hershkovitz P., 1949, Proceedings of the United States National Museum, V98, P323; Hooghiemstra H, 2006, ANN MO BOT GARD, V93, P297, DOI 10.3417/0026-6493(2006)93[297:TPROCI]2.0.CO;2; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hoorn C, 2015, SCIENCE, V348, P186, DOI 10.1126/science.aab0099; Insel N, 2010, CLIM DYNAM, V35, P1477, DOI 10.1007/s00382-009-0637-1; Insel N, 2012, EARTH PLANET SC LETT, V317, P262, DOI 10.1016/j.epsl.2011.11.039; Kay RF, 1998, AM J PRIMATOL, V45, P317, DOI 10.1002/(SICI)1098-2345(1998)45:4<317::AID-AJP1>3.0.CO;2-Z; KAY RF, 1987, J HUM EVOL, V16, P173, DOI 10.1016/0047-2484(87)90075-3; KAY RF, 1994, AM J PHYS ANTHROPOL, V95, P333, DOI 10.1002/ajpa.1330950305; Kay RF, 2015, MOL PHYLOGENET EVOL, V82, P358, DOI 10.1016/j.ympev.2013.12.002; Kiesling NMJ, 2015, MOL PHYLOGENET EVOL, V82, P386, DOI 10.1016/j.ympev.2014.03.027; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Latrubesse EM, 2010, EARTH-SCI REV, V99, P99, DOI 10.1016/j.earscirev.2010.02.005; Lima MGM, 2018, MOL PHYLOGENET EVOL, V124, P137, DOI 10.1016/j.ympev.2018.02.023; Lima MGM, 2017, J BIOGEOGR, V44, P810, DOI 10.1111/jbi.12945; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Ma N.S.F., 1983, Aotus. J. Hered., V74, P27; MA NSF, 1980, J HERED, V71, P336, DOI 10.1093/oxfordjournals.jhered.a109382; MA NSF, 1985, AM J PRIMATOL, V9, P333, DOI 10.1002/ajp.1350090409; MA NSF, 1976, AM J PHYS ANTHROPOL, V45, P191, DOI 10.1002/ajpa.1330450205; MA NSF, 1976, LAB ANIM SCI, V26, P1022; MA NSF, 1977, J HERED, V68, P409; MA NSF, 1981, AM J PHYS ANTHROPOL, V54, P293, DOI 10.1002/ajpa.1330540302; MA NSF, 1978, J MED PRIMATOL, V7, P146; Marivaux L, 2016, J HUM EVOL, V97, P159, DOI 10.1016/j.jhevol.2016.05.011; Matzke NJ, 2014, SYST BIOL, V63, P951, DOI 10.1093/sysbio/syu056; Matzke NJ., 2013, BIOGEOBEARS BIOGEOGR; Menezes AN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-248; Mller K., 2010, PHYDE PHYLOGENETIC D; Mora A, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P38; Ogilvie HA, 2017, MOL BIOL EVOL, V34, P2101, DOI 10.1093/molbev/msx126; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; PIECZARKA JC, 1988, AM J PRIMATOL, V14, P255, DOI 10.1002/ajp.1350140306; PIECZARKA JC, 1993, PRIMATES, V34, P197, DOI 10.1007/BF02381390; PIECZARKA JC, 1992, PRIMATES, V33, P239, DOI 10.1007/BF02382753; Pinto Thieres, 2016, Check List, V12, P1952; Plautz HL, 2009, MOL PHYLOGENET EVOL, V51, P382, DOI 10.1016/j.ympev.2009.01.005; Poulsen CJ, 2010, SCIENCE, V328, P490, DOI 10.1126/science.1185078; Rambaut A., 2018, TRACER V17; Ramrez-Cerqueira J, 1983, RESMENES COMUNICACIO, P146; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Nogueira ACR, 2013, J S AM EARTH SCI, V46, P89, DOI 10.1016/j.jsames.2013.05.004; ROSENBERGER AL, 1991, INT J PRIMATOL, V12, P291, DOI 10.1007/BF02547590; Rosenberger Alfred L., 2009, P69, DOI 10.1007/978-0-387-78705-3_4; Ruiz-Garca M., 2013, J PRIMATOL, V2; Ruiz-Garca M., 2016, MOL POPULATION GENET, P287; Ruiz-Garcia M, 2018, J MAMM EVOL, V25, P213, DOI 10.1007/s10914-016-9375-4; Ruiz-Garcia M, 2011, INT J PRIMATOL, V32, P1218, DOI 10.1007/s10764-011-9539-2; Savagian A, 2017, INT J PRIMATOL, V38, P80, DOI 10.1007/s10764-016-9946-5; SCHNEIDER MPC, 1989, INT J PRIMATOL, V10, P363, DOI 10.1007/BF02737422; Sequeira F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-264; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAKAI M, 1994, J HUM EVOL, V27, P329, DOI 10.1006/jhev.1994.1049; Torres OM, 1998, AM J PRIMATOL, V44, P255, DOI 10.1002/(SICI)1098-2345(1998)44:4<255::AID-AJP2>3.0.CO;2-V; WRIGHT PC, 1978, FOLIA PRIMATOL, V29, P43, DOI 10.1159/000155825; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	94	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1055-7903	1095-9513		MOL PHYLOGENET EVOL	Mol. Phylogenet. Evol.	MAY	2022	170								107426	10.1016/j.ympev.2022.107426	http://dx.doi.org/10.1016/j.ympev.2022.107426			13	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	1D8HA	35131419				2022-09-04	WOS:000794035900008
J	Gonzalez-Rojas, MF; Darragh, K; Robles, J; Linares, M; Schulz, S; McMillan, WO; Jiggins, CD; Pardo-Diaz, C; Salazar, C				Gonzalez-Rojas, M. F.; Darragh, K.; Robles, J.; Linares, M.; Schulz, S.; McMillan, W. O.; Jiggins, C. D.; Pardo-Diaz, C.; Salazar, C.			Chemical signals act as the main reproductive barrier between sister and mimetic Heliconius butterflies	PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES			English	Article						Heliconius; chemical signatures; mate choice; speciation; reproductive isolation	APHRODISIAC PHEROMONES; CUTICULAR HYDROCARBONS; SEXUAL ISOLATION; MATE CHOICE; EVOLUTION; CUES; SPECIATION; ODOR; LEPIDOPTERA; COLEOPTERA	Colour pattern is the main trait that drives mate recognition between Heliconius species that are phylogenetically close. However, when this cue is compromised such as in cases of mimetic, sympatric and closely related species, alternative mating signals must evolve to ensure reproductive isolation and species integrity. The closely related species Heliconius melpomene malleti and H. timareta florencia occur in the same geographical region, and despite being co-mimics, they display strong reproductive isolation. In order to test which cues differ between species, and potentially contribute to reproductive isolation, we quantified differences in the wing phenotype and the male chemical profile. As expected, the wing colour pattern was indistinguishable between the two species, while the chemical profile of the androconial and genital males' extracts showed marked differences. We then conducted behavioural experiments to study the importance of these signals in mate recognition by females. In agreement with our previous results, we found that chemical blends and not wing colour pattern drive the preference of females for conspecific males. Also, experiments with hybrid males and females suggested an important genetic component for both chemical production and preference. Altogether, these results suggest that chemicals are the major reproductive barrier opposing gene flow between these two sister and co-mimic species.	[Gonzalez-Rojas, M. F.; Linares, M.; Pardo-Diaz, C.; Salazar, C.] Univ Rosario, Fac Nat Sci & Math, Dept Biol, Bogota 111221, Colombia; [Darragh, K.; Jiggins, C. D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, Cambs, England; [Robles, J.] Pontificia Univ Javeriana, Dept Chem, Bogota, Colombia; [Schulz, S.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, Braunschweig, Germany; [McMillan, W. O.] Smithsonian Trop Res Inst, Panama City, Panama		Salazar, C (corresponding author), Univ Rosario, Fac Nat Sci & Math, Dept Biol, Bogota 111221, Colombia.	camilo.salazar@urosario.edu.co	Jiggins, Chris/T-4296-2019; C, Salazar/A-1647-2010	Jiggins, Chris/0000-0002-7809-062X; C, Salazar/0000-0001-9217-6588; Robles, Jorge/0000-0002-6782-5619; Schulz, Stefan/0000-0002-4810-324X	COLCIENCIAS [FP44842-5-2017]; Universidad del Rosario [QFN-DG001]; Deutsche Forschungsgemeinschaft (DFG) [Schu984/12-1]; European Research Council [339873]	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad del Rosario; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This study was funded by COLCIENCIAS (grant no. FP44842-5-2017) and Universidad del Rosario (grant no. QFN-DG001). We thank ANLA-Colombia for granting us the collection permit no. 530. S.S. thanks the Deutsche Forschungsgemeinschaft (DFG; grant no. Schu984/12-1). C.D.J. was funded by the European Research Council (grant no. 339873 Speciation Genetics).	ALDRICH JR, 1976, J INSECT PHYSIOL, V22, P1201, DOI 10.1016/0022-1910(76)90094-9; Alves H, 2010, BEHAV GENET, V40, P694, DOI 10.1007/s10519-010-9364-y; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bay RA, 2017, CURR BIOL, V27, P3344, DOI 10.1016/j.cub.2017.09.037; Bookstein F. L., 1991, MORPHOMETRICS TOOLS; Brand P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14162-6; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; Buellesbach J, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-018-0263-z; Burdfield-Steel E, 2018, J INSECT SCI, V18, DOI 10.1093/jisesa/iey020; Byers KJRP, 2020, EVOLUTION, V74, P349, DOI 10.1111/evo.13922; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Chazot N, 2016, EVOLUTION, V70, P181, DOI 10.1111/evo.12842; Chenoweth SF, 2006, NAT REV GENET, V7, P681, DOI 10.1038/nrg1924; Combs PA, 2018, CURR BIOL, V28, P3969, DOI 10.1016/j.cub.2018.10.036; Conner WE, 2016, PHEROMONE COMMUNICATION IN MOTHS: EVOLUTION, BEHAVIOR, AND APPLICATION, P191; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; Coyne JA, 2004, SPECIATION; Darragh K, 2020, ECOL EVOL, V10, P3895, DOI 10.1002/ece3.6079; Darragh K, 2019, ECOL ENTOMOL, V44, P397, DOI 10.1111/een.12716; Darragh K, 2017, PEERJ, V5, DOI 10.7717/peerj.3953; Dorai-Raj S, 2014, BINOM BINOMIAL CONDE; DUSSOURD DE, 1991, P NATL ACAD SCI USA, V88, P9224, DOI 10.1073/pnas.88.20.9224; Estrada C, 2010, ANIM BEHAV, V80, P231, DOI 10.1016/j.anbehav.2010.04.023; Estrada C, 2010, P ROY SOC B-BIOL SCI, V277, P407, DOI 10.1098/rspb.2009.1476; Fox J., 2019, R COMPANION APPL REG, V3rd edition; Giraldo N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-324; Grillet M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00224; GRULA JW, 1980, J CHEM ECOL, V6, P241, DOI 10.1007/BF00987543; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartlieb Elke, 1999, P315; Hench K, 2019, NAT ECOL EVOL, V3, P657, DOI 10.1038/s41559-019-0814-5; Hummel HE, 2012, TECHNIQUES PHEROMONE; Jiggins CD, 2001, EVOLUTION, V55, P1631, DOI 10.1111/j.0014-3820.2001.tb00682.x; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; KAYE H, 1989, ANIM BEHAV, V37, P563, DOI 10.1016/0003-3472(89)90035-3; Keller-Costa T, 2015, GEN COMP ENDOCR, V221, P64, DOI 10.1016/j.ygcen.2015.01.001; Kost S, 2016, EVOLUTION, V70, P1418, DOI 10.1111/evo.12940; Kozak KM, 2015, SYST BIOL, V64, P505, DOI 10.1093/sysbio/syv007; Larsdotter-Mellstrom H, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00068; Lofstedt C., 1991, Chemoecology, V2, P20, DOI 10.1007/BF01240662; Lofstedt C, 2016, PHEROMONE COMMUNICATION IN MOTHS: EVOLUTION, BEHAVIOR, AND APPLICATION, P43; Mallet J, 1998, ENDLESS FORMS, P390; Mann F, 2017, J CHEM ECOL, V43, P843, DOI 10.1007/s10886-017-0867-3; Mas F, 2005, J CHEM ECOL, V31, P2747, DOI 10.1007/s10886-005-7570-5; Merot C, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0335; Merot C, 2015, EVOLUTION, V69, P2891, DOI 10.1111/evo.12789; Merot C, 2013, BIOL J LINN SOC, V109, P830, DOI 10.1111/bij.12091; Merrill RM, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2005902; Merrill RM, 2014, ECOL EVOL, V4, P911, DOI 10.1002/ece3.996; MEYER HJ, 1967, ANN ENTOMOL SOC AM, V60, P858, DOI 10.1093/aesa/60.4.858; Moore B.P., 1990, Chemoecology, V1, P43, DOI 10.1007/BF01325227; Moore PJ, 1997, NATURE, V389, P25, DOI 10.1038/37888; Morgan ED, 2010, BIOSYNTHESIS IN INSECTS: ADVANCED EDITION, P1; Muller F., 1879, T ENTOMOL SOC LOND, V1879, P20; Nieberding CM, 2012, ECOL LETT, V15, P415, DOI 10.1111/j.1461-0248.2012.01748.x; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Peterson MA, 2007, CHEMOECOLOGY, V17, P87, DOI 10.1007/s00049-007-0366-z; PHELAN PL, 1987, SCIENCE, V235, P205, DOI 10.1126/science.235.4785.205; Poulton E. B., 1890, COLOURS ANIMALS THEI; R Core Team, 2022, R LANG ENV STAT COMP; Rohlf F.J, 2017, TPSDIG DIGITIZE LAND; ROTHSCHILD M, 1984, BIOL J LINN SOC, V23, P375, DOI 10.1111/j.1095-8312.1984.tb00153.x; Sanchez AP, 2015, EVOLUTION, V69, P1619, DOI 10.1111/evo.12679; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulz S, 2008, J CHEM ECOL, V34, P82, DOI 10.1007/s10886-007-9393-z; Schwander T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-151; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Seenivasagan T, 2009, PARASITOL RES, V104, P827, DOI 10.1007/s00436-008-1263-2; Shahandeh MP, 2018, EVOLUTION, V72, P123, DOI 10.1111/evo.13389; Shine R, 2003, BEHAV ECOL SOCIOBIOL, V54, P162, DOI 10.1007/s00265-003-0620-5; Simmons LW, 2003, ANIM BEHAV, V66, P677, DOI 10.1006/anbe.2003.2240; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Smadja CM, 2011, MOL ECOL, V20, P5123, DOI 10.1111/j.1365-294X.2011.05350.x; SMITH BH, 1983, P NATL ACAD SCI-BIOL, V80, P4551, DOI 10.1073/pnas.80.14.4551; Snellings Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23189-6; Southcott L, 2018, ETHOLOGY, V124, P862, DOI 10.1111/eth.12818; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; Tregenza T, 2000, EVOLUTION, V54, P574, DOI 10.1111/j.0014-3820.2000.tb00060.x; Van Belleghem SM, 2018, METHODS ECOL EVOL, V9, P390, DOI 10.1111/2041-210X.12853; VANEWRIGHT RI, 1993, PHILOS T R SOC B, V340, P197, DOI 10.1098/rstb.1993.0058; Vanjari S, 2015, MALE SEX PHEROMONE C, DOI [10.1101/033506, DOI 10.1101/033506]; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wicker-Thomas C, 2011, ANN SOC ENTOMOL FR, V47, P55, DOI 10.1080/00379271.2011.10697696; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yildizhan S, 2009, CHEMBIOCHEM, V10, P1666, DOI 10.1002/cbic.200900183; Zelditch ML., 2004, GEOMETRIC MORPHOMETR	86	14	14	2	7	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	0962-8452	1471-2954		P ROY SOC B-BIOL SCI	Proc. R. Soc. B-Biol. Sci.	MAY 13	2020	287	1926								10.1098/rspb.2020.0587	http://dx.doi.org/10.1098/rspb.2020.0587			9	Biology; Ecology; Evolutionary Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Environmental Sciences & Ecology; Evolutionary Biology	LY3SC	32370676	Green Published, hybrid, Green Submitted			2022-09-04	WOS:000540446700001
J	Quijano, SM; Torres, MM; Vasquez, LE; Cuellar, GE; Romero, ML; Martin, EL; Linares, A; Castano, S; Sarmiento, IC; Cabrera, E; Uribe, GI; Andrade, RE; Saavedra, CE				Milena Quijano, Sandra; Mercedes Torres, Maria; Edith Vasquez, Liliana; Elizabeth Cuellar, Gina; Liliana Romero, Martha; Liliana Martin, Edna; Linares, Adriana; Castano, Silverio; Cristina Sarmiento, Isabel; Cabrera, Edgar; Ines Uribe, Gloria; Enrique Andrade, Rafael; Eugenio Saavedra, Carlos			Correlation of the t(9;22), t(12;21), and DNA hyperdiploid content with immunophenotype and proliferative rate of leukemic B-cells of pediatric patients with B-cell acute lymphoblastic leukemia	BIOMEDICA			Spanish	Article						Leukemia; lymphoblastic; flow cytometry; bone marrow	MINIMAL-RESIDUAL-DISEASE; BONE-MARROW; CYTOGENETIC ABNORMALITIES; FLOW-CYTOMETRY; DIAGNOSIS; ASSOCIATION; PATTERNS; CHILDREN; FUSION	Introduction: Between 60 and 80% of patients with B-cell acute lymphoblastic leukemia show genetic abnormalities which influence the prognosis of the disease and the biology of the tumor. Objective: To analyze different genetic abnormalities in acute B lymphoblastic leukemia in children, its relationship with the immunophenotype and the proliferative rate compared with normal B cell precursors. Materials and methods: We assessed immunophenotype, DNA content and proliferative rate in 44 samples by flow cytometry, and translocations t(9; 22), t(12; 21), t(4; 11), and t(1; 19) by RT-PCR. Using a hierarchical cluster analysis, we identified some immunophenotypic patterns associated to genetic abnormalities when compared with normal B cell precursors. Results: DNA quantification showed that 21% of the cases had high hyperdiploidy and 47.7% has low hyperdiploidy. The presence of hyperdiploidy was associated with increased tumor proliferation and aberrant immunophenotypes, including abnormal expression of CD10, TdT, CD38, and CD45 and an increased size of the lymphoblasts. The presence of t(9; 22) and t(12; 21) discriminates normal cells from tumor cells with aberrant immunophenotype in the expression of CD19, CD22, CD13, CD33, CD38, CD34, and CD45. Conclusions: The aberrant immunophenotype profile detected in neoplastic cells along with abnormalities in the proliferative rate were significantly associated with DNA hyperdiploidy and clearly distinguished lymphoblasts with t(9; 22) and t(12; 21) from normal B cell precursors. The identification of these parameters is useful as a tool for classification and monitoring of these patients.	[Milena Quijano, Sandra] Pontificia Univ Javeriana, Dept Microbiol, Bogota, DC, Colombia; [Milena Quijano, Sandra; Edith Vasquez, Liliana; Elizabeth Cuellar, Gina; Liliana Romero, Martha; Liliana Martin, Edna; Enrique Andrade, Rafael; Eugenio Saavedra, Carlos] Fdn Santa Fe Bogota, Dept Patol, Bogota, DC, Colombia; [Mercedes Torres, Maria; Liliana Romero, Martha] Univ Los Andes, Dept Ciencias Biol, Lab Genet Humana, Bogota, DC, Colombia; [Liliana Romero, Martha] Univ Paris Diderot, Pathol Lab, Paris, France; [Linares, Adriana; Castano, Silverio] Univ Nacl Colombia, Fac Med, Dept Pediat Oncohematol Pediat, Bogota, DC, Colombia; [Linares, Adriana; Castano, Silverio; Cristina Sarmiento, Isabel; Cabrera, Edgar; Ines Uribe, Gloria] Fdn Hosp La Misericordia, Serv Oncohematol Pediat, Bogota, DC, Colombia		Saavedra, CE (corresponding author), Fdn Santa Fe Bogota, Grp Patol, Calle 119 7-75,2nd Piso, Bogota, DC, Colombia.	celamsaa54@yahoo.es	Quijano, Sandra/AAF-2945-2019	Quijano, Sandra/0000-0003-4452-9291; Torres, Maria/0000-0001-7033-0097				Acevedo S, 2000, MEDICINA-BUENOS AIRE, V60, P87; Campana D, 2009, SEMIN HEMATOL, V46, P100, DOI 10.1053/j.seminhematol.2008.09.001; Cocco C, 2011, CYTOKINE GROWTH F R, V22, P149, DOI 10.1016/j.cytogfr.2011.05.003; Coustan-Smith E, 2011, BLOOD, V117, P6267, DOI 10.1182/blood-2010-12-324004; Craig FE, 2008, BLOOD, V111, P3941, DOI 10.1182/blood-2007-11-120535; Faderl S, 2010, CANCER-AM CANCER SOC, V116, P1165, DOI 10.1002/cncr.24862; Gallego MS, 2011, ARCH ARGENT PEDIATR, V109, P339, DOI 10.5546/aap.2011.339; HARRIS MB, 1992, BLOOD, V79, P3316; Hazlehurst LA, 2009, CANCER CONTROL, V16, P100, DOI 10.1177/107327480901600202; KASPERS GJL, 1995, BLOOD, V85, P751, DOI 10.1182/blood.V85.3.751.bloodjournal853751; King RL, 2011, AM J CLIN PATHOL, V135, P921, DOI 10.1309/AJCPJCW6BY0CNIHD; Lanasa MC, 2010, HEMATOL-AM SOC HEMAT, P70, DOI 10.1182/asheducation-2010.1.70; Lemez P, 2010, EUR J HAEMATOL, V85, P300, DOI 10.1111/j.1600-0609.2010.01493.x; LOOK AT, 1985, BLOOD, V65, P1079; Mateo G, 2005, CLIN CANCER RES, V11, P3661, DOI 10.1158/1078-0432.CCR-04-1489; McGregor S, 2012, SEMIN DIAGN PATHOL, V29, P2, DOI 10.1053/j.semdp.2011.07.004; Obro NF, 2012, HAEMATOL-HEMATOL J, V97, P137, DOI 10.3324/haematol.2011.051383; Onciu M, 2009, HEMATOL ONCOL CLIN N, V23, P655, DOI 10.1016/j.hoc.2009.04.009; Orfao A, 2004, CYTOM PART A, V58A, P62, DOI 10.1002/cyto.a.10104; Paiva B, 2009, HAEMATOL-HEMATOL J, V94, P1599, DOI 10.3324/haematol.2009.009100; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Perez-Vera P, 2011, BONE MARROW RES, DOI 10.1155/2011/502751; Pineros M, 2007, REV COLOMB CANCEROL, V11, P219; Porwit-MacDonald A, 2000, LEUKEMIA, V14, P816, DOI 10.1038/sj.leu.2401741; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Pui CH, 2010, J FORMOS MED ASSOC, V109, P777, DOI 10.1016/S0929-6646(10)60123-4; Quijano S, 2008, BLOOD, V111, P5130, DOI 10.1182/blood-2007-10-119289; Quijano S, 2008, CYTOM PART B-CLIN CY, V74B, P139, DOI 10.1002/cyto.b.20390; Raimondi SC, 2006, CANCER GENET CYTOGEN, V169, P50, DOI 10.1016/j.cancergencyto.2006.04.006; Roa-Higuera Diana Carolina, 2010, Univ. Sci., V15, P206; Saavedra C, 2010, BIOMEDICA S, V30, P11; San Miguel JF, 2006, EUR J CANCER, V42, P1510, DOI 10.1016/j.ejca.2005.11.039; Seegmiller AC, 2009, AM J CLIN PATHOL, V132, P940, DOI 10.1309/AJCP8G5RMTWUEMUU; SHANKEY TV, 1993, CYTOMETRY, V14, P472, DOI 10.1002/cyto.990140503; SMETS LA, 1985, BRIT J HAEMATOL, V61, P113, DOI 10.1111/j.1365-2141.1985.tb04066.x; Swerdlow SH, 2008, WHO CLASSIFICATION T, P167; Torres J, 2002, THESIS PONTIFICIA U; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Wetzler M, 2004, BRIT J HAEMATOL, V124, P275, DOI 10.1046/j.1365-2141.2003.04736.x; WHITEHEAD VM, 1992, BLOOD, V80, P1316; Yokota A, 2010, LEUKEMIA RES, V34, P793, DOI 10.1016/j.leukres.2009.08.034	43	2	2	0	2	INST NACIONAL SALUD	BOGOTA D C	AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C, 00000, COLOMBIA	0120-4157	2590-7379		BIOMEDICA	Biomedica		2013	33	3					468	486		10.7705/biomedica.v33i3.1441	http://dx.doi.org/10.7705/biomedica.v33i3.1441			19	Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Tropical Medicine	291GV	24652183	gold			2022-09-04	WOS:000329817100016
J	Florez, C; Parra-Izquierdo, V; Bautista-Molano, W; Chamorro-Melo, YM; Beltran-Ostos, A; Jaimes, D; De Avila, J; Ramos-Casallas, A; Acero-M, D; Bello-Gualtero, JM; Gutierrez-Sanchez, J; Tena, CFP; Chila, L; Chalem, P; Romero-Sanchez, C				Florez, C.; Parra-Izquierdo, V.; Bautista-Molano, W.; Chamorro-Melo, Y. M.; Beltran-Ostos, A.; Jaimes, D.; De Avila, J.; Ramos-Casallas, A.; Acero-M, D.; Bello-Gualtero, J. M.; Gutierrez-Sanchez, J.; Tena, C. F. Pacheco; Chila, L.; Chalem, P.; Romero-Sanchez, C.			CHROMOENDOSCOPY AND MAGNIFICATION COLONOSCOPY: ANALYSIS OF THE MUCOSA OF THE COLON AND ILEUM IN PATIENTS WITH SPONDYLOARTRHITIS AND GASTROINTESTINAL SYMPTOMS WITHOUT INFLAMMATORY BOWEL DISEASE	ANNALS OF THE RHEUMATIC DISEASES			English	Meeting Abstract	Annual European Congress of Rheumatology (EULAR)	JUN 03, 2020	ELECTR NETWORK						[Florez, C.; Parra-Izquierdo, V.] Grastroadv SAS, Bogota, Colombia; [Florez, C.; Parra-Izquierdo, V.; Bautista-Molano, W.; De Avila, J.; Ramos-Casallas, A.; Chila, L.; Romero-Sanchez, C.] Univ Bosque, Sch Dent, Cellular & Immunol Grp INMUBO, Bogota, Colombia; [Bautista-Molano, W.; Acero-M, D.] Univ Militar Nueva Granada, Clin Immunol Grp, Bogota, Colombia; [Chamorro-Melo, Y. M.; Bello-Gualtero, J. M.; Gutierrez-Sanchez, J.; Romero-Sanchez, C.] Hosp Militar Cent, Rheumatol & Immunol Dept, Sch Med, Bogota, Colombia; [Beltran-Ostos, A.] Hosp Mil, Subdirecc Docencia & Invest, Bogota, Colombia; [Jaimes, D.] Clin IPS, Bogota, Colombia; [Tena, C. F. Pacheco] Invest & Biomed Chihuahua, Chihuahua, Mexico; [Chalem, P.] Pontificia Univ Javeriana, Inst Genet Humana, Fac Med, Bogota, Colombia						Francisco Jose de Caldas-COLCIENCIAS [130877757442]; Universidad El Bosque [PCI-2018-10091]; Hospital Militar Central [2017023]	Francisco Jose de Caldas-COLCIENCIAS; Universidad El Bosque; Hospital Militar Central	The Government Institute of Science, Technology, and Innovation, Francisco Jose de Caldas-COLCIENCIAS(Grant No. 130877757442). Universidad El Bosque (PCI-2018-10091), Hospital Militar Central (Grant 2017023), Clinicos IPS, Gastroadvanced, Fundacion Instituto de Reumatologia Fernando Chalem-Bogota, Colombia and Biomedicina de Chihuahua, Mexico		0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	JUN	2020	79			1		SAT0388	1138	1139		10.1136/annrheumdis-2020-eular.3943	http://dx.doi.org/10.1136/annrheumdis-2020-eular.3943			2	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rheumatology	MU8GE		Bronze			2022-09-04	WOS:000555905003462
J	Aschner, P; Munoz, OM; Giron, D; Garcia, OM; Fernandez, DG; Casas, LA; Bohorquez, LF; Arango, CM; Carvajal, L; Ramirez, DA; Sarmiento, JG; Colon, CA; Correa, NF; Alarcon, P; Bustamante, AA				Pablo Aschner, M.; Mauricio Munoz Va, Oscar; Giron C, Diana; Milena Garcia M, Olga; Gerardo Fernandez A, Daniel; Angela Casas, Luz; Fernanda Bohorquez, Luisa; Maria Arango T, Clara; Carvajal, Liliana; Amanda Ramirez, Doris; Guillermo Sarmiento, Juan; Alejandro Colon, Cristian; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro			Colombian Clinical Practice Guideline for Treatment of Type 2 Diabetes Mellitus: First Line Treatment Failure	UNIVERSITAS MEDICA			Spanish	Article						type 2 diabetes mellitus; metformin; treatment failure; clinical practice guidelines	METFORMIN; METAANALYSIS; INHIBITORS; MANAGEMENT; EVENTS	Introduction:. ere are different options to treat type 2 diabetes (DMT2) patients who began treatment with metformin and have not reached therapeutic golds. It is imperative to define rules to choose the best option, in these patients, as in those who have not achieved an optimal control under combined therapy. Aim: To define the best option between sulfonylureas, thiazolidinediones, DPP4 inhibitors, GLP-1 agonist or basal insulin, as second or third line treatment, in patients with DMT2 who have not reached therapeutic golds with metformin or combined therapy. Methods: A clinical practice guide has been developed following the broad outline of the methodological guide from the Colombian Ministry of Health and Social Welfare, with the aim of systematically gathering scientific evidence and formulating recommendations using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology. Conclusions: In patients with DMT2 who did not reach their therapeutic goal with metformin as a monotherapy (Hb1Ac <7%), addition of a second oral antidiabetic medication is recommended. it is recommended as a first step to add a DPP-4 inhibitor. It is suggested to add a SGLT2 inhibitor or a sulfonylurea having low risk of hypoglycemia as acceptable options. It is suggested to add basal insulin as a third antidiabetic medication if the combination of two pharmacological treatments does not enable the patient to reach and maintain the HbA1c goal. It is suggested to add a GLP-1 agonist if therapeutic failure appears in patients who remain obese (BMI >= 30 kg/m(2)), considering its potential to reduce weight.	[Pablo Aschner, M.; Mauricio Munoz Va, Oscar; Milena Garcia M, Olga; Gerardo Fernandez A, Daniel; Guillermo Sarmiento, Juan; Alejandro Colon, Cristian; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro] Hosp Univ San Ignacio, Bogota, Colombia; [Pablo Aschner, M.; Mauricio Munoz Va, Oscar; Giron C, Diana; Milena Garcia M, Olga; Gerardo Fernandez A, Daniel; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro] Pontificia Univ Javeriana, Bogota, Colombia; [Angela Casas, Luz] Univ Valle, Cali, Colombia; [Fernanda Bohorquez, Luisa; Amanda Ramirez, Doris] Univ Nacl Colombia, Bogota, Colombia; [Maria Arango T, Clara] Univ Antioquia, Medellin, Colombia; [Carvajal, Liliana] Asociac Colombiana Diabet, Bogota, Colombia		Munoz, OM (corresponding author), Hosp Univ San Ignacio, Bogota, Colombia.; Munoz, OM (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.	o.munoz@javeriana.edu.co	Muñoz, Oscar/Q-2906-2019; Girón, Diana/ABC-1451-2021	Muñoz, Oscar/0000-0001-5401-0018; 				Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Asociacion Latinoamericana de Diabetes, 2013, REV ALAD; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2013, CAN J DIABETES, V37, pS1, DOI DOI 10.1016/J.JCJD.2013.01.009; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gross JL, 2011, ANN INTERN MED, V154, P672, DOI 10.7326/0003-4819-154-10-201105170-00007; Handelsman Y, 2011, DIABETES CARE, P1; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Li Ling, 2014, BMJ, V348, pg2366, DOI 10.1136/bmj.g2366; Lincoff A, 2014, JAMA-J AM MED ASSOC, V298, P1180; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; Monami M, 2014, NUTR METAB CARDIOVAS, V24, P689, DOI 10.1016/j.numecd.2014.01.017; Phung OSJ., 2014, JAMA-J AM MED ASSOC, V303, P1410; Riethof M, 2012, ICSI HLTH CARE GUIDE; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Zhang F, 2013, ENDOCRINE, V44, P648, DOI 10.1007/s12020-013-9970-6; Zhang Q, 2014, DIABETES RES CLIN PR, V105, P313, DOI 10.1016/j.diabres.2014.06.006; Zintzaras E, 2014, CLIN THER, P1	19	0	0	1	9	PONTIFICIA UNIV JAVERIANA, FAC MEDICINA	BOGOTA	HOSPITAL SAN IGNACIO, CARRERA 7A, 40-62 PISO 5, BOGOTA, CUND 00000, COLOMBIA	0041-9095	2011-0839		UNIV MED	Univ. Med.		2017	58	4								10.11144/Javeriana.umed58-4.dm	http://dx.doi.org/10.11144/Javeriana.umed58-4.dm			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FV6HC					2022-09-04	WOS:000424681100002
J	Mendez, H; Heimel, G; Opitz, A; Sauer, K; Barkowski, P; Oehzelt, M; Soeda, J; Okamoto, T; Takeya, J; Arlin, JB; Balandier, JY; Geerts, Y; Koch, N; Salzmann, I				Mendez, Henry; Heimel, Georg; Opitz, Andreas; Sauer, Katrein; Barkowski, Patrick; Oehzelt, Martin; Soeda, Junshi; Okamoto, Toshihiro; Takeya, Jun; Arlin, Jean-Baptiste; Balandier, Jean-Yves; Geerts, Yves; Koch, Norbert; Salzmann, Ingo			Doping of Organic Semiconductors: Impact of Dopant Strength and Electronic Coupling	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						doping; electronic structure; semiconductors; UV/Vis spectroscopy	CHARGE-TRANSPORT; HIGH-PERFORMANCE; DERIVATIVES; COMPLEXES; TETRAFLUOROTETRACYANOQUINODIMETHANE; PHTHALOCYANINE; POLYMERS; LAYERS; ANION		[Mendez, Henry; Heimel, Georg; Opitz, Andreas; Sauer, Katrein; Barkowski, Patrick; Oehzelt, Martin; Koch, Norbert; Salzmann, Ingo] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Oehzelt, Martin; Koch, Norbert] Helmholtz Zentrum Berlin Mat & Energie BESSY II, D-12489 Berlin, Germany; [Soeda, Junshi; Okamoto, Toshihiro; Takeya, Jun] Osaka Univ, ISIR, Osaka 5670047, Japan; [Arlin, Jean-Baptiste; Balandier, Jean-Yves; Geerts, Yves] ULB, B-1050 Brussels, Belgium; [Mendez, Henry] Pontificia Univ Javeriana, Dept Fis, Bogota, Colombia		Heimel, G (corresponding author), Humboldt Univ, Inst Phys, Brook Taylor Str 6, D-12489 Berlin, Germany.	georg.heimel@physik.hu-berlin.de; ingo.salzmann@physik.hu-berlin.de	Koch, Norbert/J-4057-2012; Mendez, Henry/J-6819-2014; Salzmann, Ingo/AAP-3378-2020; Oehzelt, Martin/C-8696-2011; Okamoto, Toshihiro/N-3303-2013; Salzmann, Ingo/F-9702-2011; Opitz, Andreas/L-7700-2015	Koch, Norbert/0000-0002-6042-6447; Salzmann, Ingo/0000-0001-9977-3422; Oehzelt, Martin/0000-0002-9646-6889; Okamoto, Toshihiro/0000-0002-4783-0621; Salzmann, Ingo/0000-0001-9977-3422; Opitz, Andreas/0000-0002-3214-8398	Academic Vice-Rectorate of Pontificia Universidad Javeriana (Colombia); Katholischer Akademischer Auslander Dienst (KAAD); ARC program of the Communaute francaise de Belgique [20061]	Academic Vice-Rectorate of Pontificia Universidad Javeriana (Colombia); Katholischer Akademischer Auslander Dienst (KAAD); ARC program of the Communaute francaise de Belgique	We thank Paul Zybarth and Timo Florian (HU Berlin), Wolfgang Caliebe (DESY-HASYLAB), and Roland Resel and Alexander Pichler (TU Graz, Austria) for experimental support, Gunter Wagner (Leibniz Institut fur Kristallzuchtung) for film-thickness measurements, and Armin Moser (TU Graz, Austria) for providing the software package PyGid. This research was financially supported by the Academic Vice-Rectorate of Pontificia Universidad Javeriana (Colombia) and the Katholischer Akademischer Auslander Dienst (KAAD) (H.M.), as well as by the ARC program of the Communaute francaise de Belgique (grant no. 20061 to Y.G., J.Y.B., J.B.A.).	Aziz EE, 2007, ADV MATER, V19, P3257, DOI 10.1002/adma.200700926; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Duong DT, 2013, ORG ELECTRON, V14, P1330, DOI 10.1016/j.orgel.2013.02.028; Ebata H, 2007, J AM CHEM SOC, V129, P15732, DOI 10.1021/ja074841i; EMGE TJ, 1981, MOL CRYST LIQ CRYST, V65, P161, DOI 10.1080/00268948108082132; Gao WY, 2003, J PHYS-CONDENS MAT, V15, pS2757, DOI 10.1088/0953-8984/15/38/014; Gao WY, 2003, J APPL PHYS, V94, P359, DOI 10.1063/1.1577400; Gao WY, 2001, APPL PHYS LETT, V79, P4040, DOI 10.1063/1.1424067; Ha SD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195410; Harada K, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3456394; Harada K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.195212; Heimel G, 2012, AIP CONF PROC, V1456, P148, DOI 10.1063/1.4730654; Izawa T, 2008, ADV MATER, V20, P3388, DOI 10.1002/adma.200800799; Kanai K, 2009, APPL PHYS A-MATER, V95, P309, DOI 10.1007/s00339-008-5021-1; Kleemann H, 2012, ORG ELECTRON, V13, P58, DOI 10.1016/j.orgel.2011.09.027; Lussem B, 2013, PHYS STATUS SOLIDI A, V210, P9, DOI 10.1002/pssa.201228310; Meerheim R, 2011, J APPL PHYS, V109, DOI 10.1063/1.3590142; MELBY LR, 1962, J AM CHEM SOC, V84, P3374, DOI 10.1021/ja00876a029; Olthof S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176601; Parthasarathy G, 2001, J APPL PHYS, V89, P4986, DOI 10.1063/1.1359161; Pfeiffer M., 1999, ADV SOLID STATE PHYS, V39, P77; Pingel P, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3701729; Pingel P, 2010, J PHYS CHEM LETT, V1, P2037, DOI 10.1021/jz100492c; Qi YB, 2009, J AM CHEM SOC, V131, P12530, DOI 10.1021/ja904939g; Reineke S, 2009, NATURE, V459, P234, DOI 10.1038/nature08003; Salzmann I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.035502; Shimizu T, 1999, INORG CHIM ACTA, V296, P278, DOI 10.1016/S0020-1693(99)00358-8; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Tietze ML, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035320; Uemura T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.111501; Walzer K, 2007, CHEM REV, V107, P1233, DOI 10.1021/cr050156n; Weichsel C, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.075204; YAMAMOTO Y, 1979, J PHYS SOC JPN, V47, P1887, DOI 10.1143/JPSJ.47.1887; ZANON I, 1983, J PHYS CHEM-US, V87, P3657, DOI 10.1021/j100242a018	34	157	158	6	215	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851			ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	JUL 22	2013	52	30					7751	7755		10.1002/anie.201302396	http://dx.doi.org/10.1002/anie.201302396			5	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	184NE	23784880				2022-09-04	WOS:000321896800028
J	Barboza-Palomino, M; Salas, G; Vega-Arce, M; Caycho-Rodriguez, T; Ventura-Leon, J; Flores-Kanter, PE; Salas-Blas, E; Landa-Barzola, M; Lopez-Lopez, W				Barboza-Palomino, Miguel; Salas, Gonzalo; Vega-Arce, Maribel; Caycho-Rodriguez, Tomas; Ventura-Leon, Jose; Ezequiel Flores-Kanter, Pablo; Salas-Blas, Edwin; Landa-Barzola, Manuel; Lopez-Lopez, Wilson			Thirty Years of Psicothema: A Bibliometric Analysis (1989-2018)	PSICOTHEMA			English	Article						Bibliometric analysis; bibliometric indices; Psicothema; scientific cooperation	PSYCHOLOGY; COLLABORATION; PSICOLOGIA; JOURNALS	Background: This study presents a bibliometric analysis of Psicothema as a commemoration for its 30 years of publishing (1989-2018). Methods: A year-, sex-, and publication language-based analysis of the journal's characteristics was carried out based on the sample of 2,396 publications. Based on that data, Lotka's law was assessed, Lawani and Subramanyam indices and cooperation networks were estimated, the Pratt index was calculated, the concentration of papers according to thematic areas and research methods was described, and citations and impact indicators were obtained according to the original articles indexed in Web of Science (1993-2018). Results: The results indicated greater participation by male authors, increased publication in English, compliance with Lotka's law, and a greater inter-institutional contribution in recent decades. There was a higher percentage of methodology/psychometrics-related work, and most of these publications used quantitative methods. The impact factor and the amount of citations reached its peak in 2018. Conclusion: The characteristics of Psicothema, which is a model of scientific communication of psychology in the international context, are discussed in this study.	[Barboza-Palomino, Miguel; Caycho-Rodriguez, Tomas; Ventura-Leon, Jose] Univ Privada Norte, Lima, Peru; [Salas, Gonzalo; Vega-Arce, Maribel] Univ Catolica Maule, Talca, Chile; [Ezequiel Flores-Kanter, Pablo] Univ Siglo 21, Cordoba, Argentina; [Salas-Blas, Edwin] Univ San Martin Porres, Chiclayo, Peru; [Landa-Barzola, Manuel] Univ Cesar Vallejo, Trujillo, Peru; [Lopez-Lopez, Wilson] Pontificia Univ Javeriana, Bogota, Colombia		Barboza-Palomino, M (corresponding author), Univ Privada Norte, Fac Ciencias Salud, Lima 1122, Peru.	mbarbozapalomino@outlook.com.pe	López López, Wilson/AAV-8032-2021; Flores-Kanter, Pablo Ezequiel/J-1441-2017; Ventura Leon, Jose Luis/E-4060-2017	López López, Wilson/0000-0002-2964-0402; Flores-Kanter, Pablo Ezequiel/0000-0002-6712-779X; Barboza Palomino, Miguel/0000-0001-8045-5491; Caycho, Tomas/0000-0002-5349-7570; Ventura Leon, Jose Luis/0000-0003-2996-4244				Alfaro E, 2019, REV INVESTIG EDUC, V17, P179; Allik J, 2013, J CROSS CULT PSYCHOL, V44, P657, DOI 10.1177/0022022112461941; Alonso-Arbiol I, 2010, EUR J PSYCHOL ASSESS, V26, P238, DOI 10.1027/1015-5759/a000032; Anglada-Tort M., 2019, MUSIC SCI, V2, P1, DOI 10.1177/2059204318811786.; Arik E, 2013, J SCIENTOMETR RES, V2, P173, DOI 10.4103/2320-0057.135407; Ato M, 2013, AN PSICOL-SPAIN, V29, P1038, DOI 10.6018/analesps.29.3.178511; Bar-On R, 2006, PSICOTHEMA, V18, P13; Gimenez-Espert MD, 2019, J ADV NURS, V75, P543, DOI 10.1111/jan.13868; Kanter PEF, 2017, INTERDISCIPLINARIA, V34, P25, DOI 10.16888/interd.2017.34.1.2; Rodriguez AG, 2018, REV IBEROAM PSICOL E, V13, P33; Gaviria-Marin M, 2018, J KNOWL MANAG, V22, P1655, DOI 10.1108/JKM-10-2017-0497; Gonzalez-Alcaide G, 2010, PSICOTHEMA, V22, P41; Hall KL, 2018, AM PSYCHOL, V73, P532, DOI 10.1037/amp0000319; Kozlowski SWJ, 2017, J APPL PSYCHOL, V102, P237, DOI 10.1037/apl0000192; LAWANI SM, 1981, LIBRI, V31, P294; LAWANI SM, 1986, SCIENTOMETRICS, V9, P13, DOI 10.1007/BF02016604; Lopez-Lopez W., 2019, UNIV PSYCHOL, V18, P1; Martinez-Lopez FJ, 2018, EUR J MARKETING, V52, P439, DOI 10.1108/EJM-11-2017-0853; Montero I, 2007, INT J CLIN HLTH PSYC, V7, P847; Morgado-Gallardo Katherine, 2018, Suma Psicol., V25, P90, DOI 10.14349/sumapsi.2018.v25.n2.1; Muniz J, 2013, PSICOTHEMA, V25, P151, DOI 10.7334/psicothema2013.24; Osca-Lluch J, 2017, AN PSICOL-SPAIN, V33, P356, DOI 10.6018/analesps.33.2.249891; Polanco F., 2017, REV INTERAM PSICOL, V51, P297, DOI [10.30849/rip/ijp.v51i3.910, DOI 10.30849/RIP/IJP.V51I3.910]; PRATT AD, 1977, J AM SOC INFORM SCI, V28, P285, DOI 10.1002/asi.4630280508; Quevedo-Blasco R, 2013, PSICOTHEMA, V25, P93, DOI 10.7334/psicothema2012.282; Rodriguez SM, 1998, PSICOTHEMA, V10, P23; Sáez-Ibáñez Ángeles, 2018, Rev. psicol., V27, P61, DOI 10.5354/0719-0581.2019.52315; Sahoo S., 2019, J INDIAN LIB ASS, V54, P101; Salas G, 2019, REV LAT AM PSICOL, V51, P123, DOI 10.14349/rlp.2019.v51.n2.7; Salas G, 2018, ACTA COLOMB PSICOL, V21, P13, DOI [10.14718/ACP.2018.21.2.2, 10.14718/acp.2018.21.2.2]; Salas Gonzalo, 2017, Psykhe, V26, P1, DOI 10.7764/psykhe.26.1.1205; Sanchez FJ, 2010, PSYCHOL MEN MASCULIN, V11, P161, DOI 10.1037/a0018033; Senel E, 2017, J EUR ACAD DERMATOL, V31, P518, DOI 10.1111/jdv.13897; SUBRAMANYAM K, 1983, J INFORM SCI, V6, P33, DOI 10.1177/016555158300600105; Thelwall M, 2008, J INF SCI, V34, P605, DOI 10.1177/0165551507087238; Urbizagástegui Alvarado Rubén, 2005, Inf. cult. soc., P51; Walters GD, 2011, J AM SOC INF SCI TEC, V62, P1629, DOI 10.1002/asi.21560; Wei GY, 2019, J ECON SURV, V33, P25, DOI 10.1111/joes.12260; Yinhue M. S., 2018, REV CONCIENCIA EPG, V3, P75, DOI [10.32654/CONCIENCIAEPG.3-2.6, DOI 10.32654/CONCIENCIAEPG.3-2.6]; Zych I, 2011, INT J CLIN HLTH PSYC, V11, P549	40	1	1	4	20	COLEGIO OFICIAL DE PSICOLOGOS DE ASTURIAS	OVIEDO	ILDEFONSO S. DEL RIO, 4-1 B, 33001 OVIEDO, SPAIN	0214-9915	1886-144X		PSICOTHEMA	Psicothema	NOV	2020	32	4					459	468		10.7334/psicothema2020.145	http://dx.doi.org/10.7334/psicothema2020.145			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	OF4YR	33073751				2022-09-04	WOS:000581215700001
J	Bankins, S; Griep, Y; Hansen, SD				Bankins, Sarah; Griep, Yannick; Hansen, Samantha D.			Charting directions for a new research era: addressing gaps and advancing scholarship in the study of psychological contracts	EUROPEAN JOURNAL OF WORK AND ORGANIZATIONAL PSYCHOLOGY			English	Article						Psychological contract; future of work; psychological contract dynamics; psychological contract counterparties; psychological contract context	BREACH; VIOLATION; MODEL; OUTCOMES	The nature of work and the contexts in which firms operate have changed significantly in the many decades since the study of psychological contracts (PCs) at work began in earnest. These changes have altered the contours of the traditional employer-employee relationship and are key motivators of this Special Issue. We seek to chart new directions for PC research over the next decade by widening the theoretical and methodological lenses used to explore PC processes. In the introductory editorial we briefly outline the PC construct, overview the collected papers, and discuss the next exciting wave of PC research (exploring PC dynamics, PC counterparties, and the PC context) inspired by this collection.	[Bankins, Sarah] Macquarie Univ, Macquarie Business Sch, Sydney, NSW, Australia; [Griep, Yannick] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands; [Griep, Yannick] Stockholm Univ, Stress Res Inst, Div Epidmiol, Stockholm, Sweden; [Griep, Yannick] Pontificia Univ Javeriana, Fac Ciencias Econ & Adm, Bogota, Colombia; [Hansen, Samantha D.] Univ Toronto Scarborough, Dept Management, Toronto, ON, Canada; [Hansen, Samantha D.] Rotman Sch Management, Toronto, ON, Canada		Bankins, S (corresponding author), Macquarie Univ, Macquarie Business Sch, Sydney, NSW, Australia.	sarah.bankins@mq.edu.au		Bankins, Sarah/0000-0003-2290-3086				Alcover CM, 2017, ORGAN PSYCHOL REV, V7, P4, DOI 10.1177/2041386616628333; Argyris C., 1960, UNDERSTANDING ORG BE; Bankins S, 2020, EUR J WORK ORGAN PSY, V29, P215, DOI 10.1080/1359432X.2019.1620328; Bankins S, 2015, J ORGAN BEHAV, V36, P1071, DOI 10.1002/job.2007; Baruch Y, 2019, ACAD MANAG ANN, V13, P84, DOI 10.5465/annals.2016.0103; Baruch Y, 2016, EUR J WORK ORGAN PSY, V25, P459, DOI 10.1080/1359432X.2015.1113168; Blau P.M., 1964, SOCIAL EXCHANGE THEO, V34, P193, DOI 10.1111/j.1475-682X.1964.tb00583.x; Bordia P, 2017, J MANAGE, V43, P1447, DOI 10.1177/0149206314556317; Bordia P, 2010, J MANAGE, V36, P1578, DOI 10.1177/0149206310378366; Conway N., 2005, UNDERSTANDING PSYCHO, DOI [10.1093/acprof:oso/9780199280643.001.0001, DOI 10.1093/ACPROF:OSO/9780199280643.001.0001]; Cooper CL, 2002, OCCUP ENVIRON MED, V59, P355, DOI 10.1136/oem.59.6.355; Coyle-Shapiro J, 2000, J MANAGE STUD, V37, P903, DOI 10.1111/1467-6486.00210; Coyle-Shapiro JAM, 2019, ANNU REV ORGAN PSYCH, V6, P145, DOI 10.1146/annurev-orgpsych-012218-015212; Deng H, 2018, J APPL PSYCHOL, V103, P561, DOI 10.1037/apl0000272; Garcia PRJM, 2018, J ORGAN BEHAV, V39, P326, DOI 10.1002/job.2222; GOULDNER AW, 1960, AM SOCIOL REV, V25, P161, DOI 10.2307/2092623; Griep Y., 2019, HDB RES PSYCHOL CONT, P397, DOI [10.4337/9781788115681, DOI 10.4337/9781788115681]; Griep Y, 2018, J OCCUP ORGAN PSYCH, V91, P421, DOI 10.1111/joop.12201; Griep Y, 2018, J VOCAT BEHAV, V104, P141, DOI 10.1016/j.jvb.2017.10.013; Guest D, 2004, INT J MANAG REV, V5-6, P1, DOI 10.1111/j.1460-8545.2004.00094.x; Guest D., 2002, HUMAN RESOURCE MANAG, V12, P22, DOI [10.1111/j.1748-8583.2002.tb00062.x, DOI 10.1111/J.1748-8583.2002.TB00062.X]; Ho VT, 2005, ORGAN SCI, V16, P275, DOI 10.1287/orsc.1050.0121; Jarrahi MH, 2018, BUS HORIZONS, V61, P577, DOI 10.1016/j.bushor.2018.03.007; Kellogg KC, 2020, ACAD MANAG ANN, V14, P366, DOI 10.5465/annals.2018.0174; Knapp JR, 2020, EUR J WORK ORGAN PSY, V29, P200, DOI 10.1080/1359432X.2019.1709538; KOTTER JP, 1973, CALIF MANAGE REV, V15, P91, DOI 10.2307/41164442; Kraak J. M., 2018, BI ANN PSYCH CONTR S; Kraak JM, 2020, EUR J WORK ORGAN PSY, V29, P243, DOI 10.1080/1359432X.2019.1681500; Lambert LS, 2020, EUR J WORK ORGAN PSY, V29, P294, DOI 10.1080/1359432X.2019.1697743; Lambert LS, 2003, PERS PSYCHOL, V56, P895, DOI 10.1111/j.1744-6570.2003.tb00244.x; Levinson H., 1962, MEN MANAGEMENT MENTA; Marks A, 2001, EMPL RELAT, V23, DOI [DOI 10.1108/EUM0000000005897, 10.1108/EUM0000000005897]; Montes SD, 2008, J APPL PSYCHOL, V93, P1367, DOI 10.1037/a0012851; Morrison EW, 1997, ACAD MANAGE REV, V22, P226, DOI 10.5465/AMR.1997.9707180265; Parzefall MR, 2010, J MANAGE PSYCHOL, V25, P4, DOI 10.1108/02683941011013849; Roe RA, 2008, EUR PSYCHOL, V13, P37, DOI 10.1027/1016-9040.13.1.37; Rousseau D., 1995, PSYCHOL CONTRACTS OR, DOI DOI 10.4135/9781452231594; Rousseau D., 1989, EMPLOYEE RESPONSIBIL, V2, P121, DOI DOI 10.1007/BF01384942; Rousseau DM, 2018, J ORGAN BEHAV, V39, P1081, DOI 10.1002/job.2284; Schalk R., 2008, SAGE LIB BUSINESS MA, P242; Schalk R, 2007, J THEOR SOC BEHAV, V37, P167, DOI 10.1111/j.1468-5914.2007.00330.x; Schein E., 1965, ORG PSYCHOL; Sherman UP, 2020, EUR J WORK ORGAN PSY, V29, P230, DOI 10.1080/1359432X.2019.1668844; Solinger O.N., 2019, HDB RES PSYCHOL CONT, P223; Solinger ON, 2016, J ORGAN BEHAV, V37, P494, DOI 10.1002/job.2047; Tekleab AG, 2020, EUR J WORK ORGAN PSY, V29, P279, DOI 10.1080/1359432X.2019.1608294; Tomprou M., 2018, PSYCHOL ORG CHANGE, P102; Tomprou M, 2015, J ORGAN BEHAV, V36, P561, DOI 10.1002/job.1997; Tomprou Maria., 2019, HDB RES PSYCHOL CONT, P206, DOI [10.4337/9781788115681, DOI 10.4337/9781788115681]; Van der Schaft A, 2020, EUR J WORK ORGAN PSY, V29, P164, DOI 10.1080/1359432X.2019.1656284; Woodrow C, 2017, J OCCUP ORGAN PSYCH, V90, P587, DOI 10.1111/joop.12178; Yang Y, 2020, EUR J WORK ORGAN PSY, V29, P183, DOI 10.1080/1359432X.2020.1725621; Yeung E, 2020, EUR J WORK ORGAN PSY, V29, P262, DOI 10.1080/1359432X.2019.1703804; Zhao H, 2007, PERS PSYCHOL, V60, P647, DOI 10.1111/j.1744-6570.2007.00087.x	54	5	5	2	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1359-432X	1464-0643		EUR J WORK ORGAN PSY	Eur. J. Work Organ. Psychol.	MAR 3	2020	29	2			SI		159	163		10.1080/1359432X.2020.1737219	http://dx.doi.org/10.1080/1359432X.2020.1737219			5	Psychology, Applied; Management	Social Science Citation Index (SSCI)	Psychology; Business & Economics	LK6PL		Bronze			2022-09-04	WOS:000530986100001
J	Fatima, MT; Islam, Z; Ahmad, E; Barreto, GE; Ashraf, GM				Fatima, Munazza Tamkeen; Islam, Zeyaul; Ahmad, Ejaj; Barreto, George E.; Ashraf, Ghulam Md			Ionic gradient liposomes: Recent advances in the stable entrapment and prolonged released of local anesthetics and anticancer drugs	BIOMEDICINE & PHARMACOTHERAPY			English	Review						Ionic gradient liposomes; Anthracyclines; Local anesthetics; pKa; Weak base; Entrapment; Controlled release; Drug delivery	LARGE UNILAMELLAR VESICLES; IN-VIVO EVALUATION; PH-GRADIENTS; DELIVERY SYSTEMS; TRANSMEMBRANE GRADIENT; TOPICAL ANESTHESIA; ANTITUMOR-ACTIVITY; AMMONIUM-SULFATE; ACRIDINE-ORANGE; AMPHOTERICIN-B	Liposomes have established themselves as great pharmaceutical carriers over the past three decades. These phospholipid vesicular systems have undergone great technical advances including remote drug loading, targeted delivery, and combinatorial drug therapy. Ionic gradient liposomes (IGL) necessitates active loading of the drug in preformed vesicles exhibiting a transmembrane pH or ion gradient, with a low intra liposome pH (similar to 4-5), and a high outside pH (similar to 7-8). It allows high drug encapsulation and prolonged release, particularly for amphipathic weak acids and weak bases. Most local anesthetics (Bupivacaine, Ropivacaine, Tetracaine, and others) have a pka in the range of 7-9, which makes them ideal candidates for their entrapment in IGL. The same is true for most anthracyclines which have great anti-tumor properties (Doxorubicin, Daunorubicin, Idarubicin, and others). Many FDA approved liposomal drugs utilise ion gradient for their encapsulation. Considering their immense utility, we summarize here in this review, the recent contributions made by various research groups utilizing IGL, to accentuate the development of these carriers in drug delivery. This would possibly be helpful in carrying new investigations and further contributions in the optimization and advancements of new drugs for better therapeutics.	[Fatima, Munazza Tamkeen] State Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, BR-13083862 Campinas, SP, Brazil; [Islam, Zeyaul] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083100 Campinas, SP, Brazil; [Ahmad, Ejaj] Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery MOE & PLA, Shanghai 201203, Peoples R China; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, POB 80216, Jeddah 21589, Saudi Arabia		Fatima, MT (corresponding author), State Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, BR-13083862 Campinas, SP, Brazil.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, POB 80216, Jeddah 21589, Saudi Arabia.	munazza.ibu@gmail.com; ashraf.gm@gmail.com	Ahmad, Ejaj/M-2716-2019; Ashraf, Ghulam Md/H-9485-2012; Barreto, George E./AAD-7420-2020; Islam, Zeyaul/AAZ-5625-2020	Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Islam, Zeyaul/0000-0002-5444-3910				Abraham SA, 2004, J CONTROL RELEASE, V96, P449, DOI 10.1016/j.jconrel.2004.02.017; [Anonymous], 2007, # WO/ 2007, Patent No. 049278; AUGER M, 1988, BIOCHEMISTRY-US, V27, P4660, DOI 10.1021/bi00413a012; Avnir Y, 2008, ARTHRITIS RHEUM-US, V58, P119, DOI 10.1002/art.23230; BALLY MB, 1988, CHEM PHYS LIPIDS, V47, P97, DOI 10.1016/0009-3084(88)90078-3; BANGHAM AD, 1980, LIPOSOMES BIOL SYSTE; Barbosa RM, 2013, J PHYS CONF SER, V429, DOI 10.1088/1742-6596/429/1/012035; Barenholz Y, 2003, J LIPOSOME RES, V13, P1, DOI 10.1081/LPR-120017482; Barenholz Y, 2001, CURR OPIN COLLOID IN, V6, P66, DOI 10.1016/S1359-0294(00)00090-X; Berezov T. T., 2004, Biomeditsinskaya Khimiya, V50, P412; Boccardo F, 1996, CANCER CHEMOTH PHARM, V38, P102, DOI 10.1007/s002800050454; BOULANGER Y, 1981, BIOCHEMISTRY-US, V20, P6824, DOI 10.1021/bi00527a013; CAFISO DS, 1978, BIOCHEMISTRY-US, V17, P3871, DOI 10.1021/bi00611a030; Cagdas M., 2014, APPL NANOTECHNOL DRU, V1, P1, DOI [10.5772/58459, DOI 10.5772/58459]; Cern A, 2012, J CONTROL RELEASE, V160, P147, DOI 10.1016/j.jconrel.2011.11.029; Chew T, 1996, ONCOL WILLIST PARK S, V10, P37; Chou TH, 2003, J BIOSCI BIOENG, V95, P405, DOI 10.1016/S1389-1723(03)80076-2; Clerc S, 1998, ANAL BIOCHEM, V259, P104, DOI 10.1006/abio.1998.2639; Clerc S, 1995, BBA-BIOMEMBRANES, V1240, P257, DOI 10.1016/0005-2736(95)00214-6; Cohen R, 2013, J MATER CHEM B, V1, P4619, DOI 10.1039/c3tb20609b; Cohen R, 2012, J CONTROL RELEASE, V160, P346, DOI 10.1016/j.jconrel.2011.12.030; COOLS AA, 1986, EXPERIENTIA, V42, P954, DOI 10.1007/BF01941777; Cruz M, 2016, REV PORT CARDIOL, V35, P359, DOI 10.1016/j.repc.2015.12.004; da Silva C. M. G., 2015, J LIPOSOME RES, P1; Daraee H, 2016, ARTIF CELL NANOMED B, V44, P381, DOI 10.3109/21691401.2014.953633; Davidson EM, 2010, ANESTH ANALG, V110, P1018, DOI 10.1213/ANE.0b013e3181d26d2a; DEAMER DW, 1990, BIOSYSTEMS, V24, P1, DOI 10.1016/0303-2647(90)90023-T; Dos Santos N, 2005, J CONTROL RELEASE, V105, P89, DOI 10.1016/j.jconrel.2005.03.007; Dos Santos N, 2002, BBA-BIOMEMBRANES, V1561, P188, DOI 10.1016/S0005-2736(02)00345-0; Dullebkopf A, 2003, ANAESTHESIST, V52, P329, DOI 10.1007/s00101-003-0463-5; Elbayoumi TA, 2007, EUR J PHARM SCI, V32, P159, DOI 10.1016/j.ejps.2007.05.113; FARHADIEH B, 1967, J PHARM SCI-US, V56, P18, DOI 10.1002/jps.2600560103; FERNANDEZ MS, 1980, BIOCHIM BIOPHYS ACTA, V597, P83, DOI 10.1016/0005-2736(80)90152-2; FERNANDEZ MS, 1981, BIOCHIM BIOPHYS ACTA, V646, P27, DOI 10.1016/0005-2736(81)90267-4; Franz-Montan M, 2007, ANESTH ANALG, V104, P1528, DOI 10.1213/01.ane.0000262040.19721.26; Franz-Montan M, 2015, J LIPOSOME RES, V25, P11, DOI 10.3109/08982104.2014.911315; Fritze A, 2006, BBA-BIOMEMBRANES, V1758, P1633, DOI 10.1016/j.bbamem.2006.05.028; GABIZON A, 1989, EUR J CANCER CLIN ON, V25, P1795, DOI 10.1016/0277-5379(89)90350-7; GESZTES A, 1988, ANESTH ANALG, V67, P1079, DOI 10.1213/00000539-198867110-00010; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Grant GJ, 2004, ANESTHESIOLOGY, V101, P133, DOI 10.1097/00000542-200407000-00021; Grant GJ, 2001, REGION ANESTH PAIN M, V26, P61, DOI 10.1053/rapm.2001.19166; Grant GJ, 2001, PHARM RES-DORDR, V18, P336, DOI 10.1023/A:1011059131348; GREGORIADIS G, 1993, DRUGS, V45, P15, DOI 10.2165/00003495-199345010-00003; Gubernator J, 2011, EXPERT OPIN DRUG DEL, V8, P565, DOI 10.1517/17425247.2011.566552; Gubernator J, 2010, J CONTROL RELEASE, V146, P68, DOI 10.1016/j.jconrel.2010.05.021; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Hrynyk R., 2014, PLOS ONE, V9; Hua S, 2015, NANOMED-NANOTECHNOL, V11, P1117, DOI 10.1016/j.nano.2015.02.018; Lagan G., 2004, CURR ANAESTH CRIT CA, V15, P247, DOI DOI 10.1016/J.CACC.2004.08.007; LASIC DD, 1995, BBA-BIOMEMBRANES, V1239, P145, DOI 10.1016/0005-2736(95)00159-Z; Li XG, 1998, BBA-BIOMEMBRANES, V1415, P23, DOI 10.1016/S0005-2736(98)00175-8; Lipka Dominik, 2013, Int J Nanomedicine, V8, P3573, DOI 10.2147/IJN.S47745; LOPEZBERESTEIN G, 1985, J INFECT DIS, V151, P704, DOI 10.1093/infdis/151.4.704; Lu T, 2015, J CONTROL RELEASE, V220, P425, DOI 10.1016/j.jconrel.2015.10.056; Matsui S, 2009, ARZNEIMITTELFORSCH, V59, P461, DOI 10.1055/s-0031-1296426; Maurer N, 1998, BBA-BIOMEMBRANES, V1374, P9, DOI 10.1016/S0005-2736(98)00125-4; Mayer LD, 2006, MOL CANCER THER, V5, P1854, DOI 10.1158/1535-7163.MCT-06-0118; MAYER LD, 1990, BIOCHIM BIOPHYS ACTA, V1025, P143, DOI 10.1016/0005-2736(90)90091-2; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V816, P294, DOI 10.1016/0005-2736(85)90497-3; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V857, P123, DOI 10.1016/0005-2736(86)90105-7; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mowat JJ, 1996, ANESTHESIOLOGY, V85, P635, DOI 10.1097/00000542-199609000-00024; NICHOLS JW, 1976, BIOCHIM BIOPHYS ACTA, V455, P269, DOI 10.1016/0005-2736(76)90169-3; RAHMAN A, 1986, CANCER RES, V46, P2295; Rasoulianboroujeni M, 2017, MAT SCI ENG C-MATER, V75, P191, DOI 10.1016/j.msec.2017.02.012; REDELMEIER TE, 1989, BIOPHYS J, V56, P385, DOI 10.1016/S0006-3495(89)82684-0; Cereda CMS, 2006, CAN J ANAESTH, V53, P1092; Cereda CMS, 2012, ANESTH ANALG, V115, P1234, DOI 10.1213/ANE.0b013e318266f3d9; Samad Abdus, 2007, Current Drug Delivery, V4, P297, DOI 10.2174/156720107782151269; Serpe L, 2014, BRIT J ORAL MAX SURG, V52, P452, DOI 10.1016/j.bjoms.2014.02.018; De Melo NFS, 2012, J PHARM SCI-US, V101, P1157, DOI 10.1002/jps.22829; Spena CR, 2018, J CONTROL RELEASE, V281, P1, DOI 10.1016/j.jconrel.2018.04.055; SUGARMAN SM, 1992, CRIT REV ONCOL HEMAT, V12, P231, DOI 10.1016/1040-8428(92)90056-V; Sur S, 2014, P NATL ACAD SCI USA, V111, P2283, DOI 10.1073/pnas.1324135111; VANROOIJEN N, 1980, IMMUNOL COMMUN, V9, P243, DOI 10.3109/08820138009065997; VEMURI S, 1994, J PHARM PHARMACOL, V46, P778, DOI 10.1111/j.2042-7158.1994.tb03729.x; Venditto VJ, 2010, MOL PHARMACEUT, V7, P307, DOI 10.1021/mp900243b; Warren R. C., 1987, PHYS ARCHITECTURE CE; Webb MS, 1998, ANTIMICROB AGENTS CH, V42, P45, DOI 10.1128/AAC.42.1.45; Wei HY, 2013, ASIAN J PHARM SCI, V8, P303, DOI 10.1016/j.ajps.2013.10.006; Weiniger CF, 2010, EXPERT OPIN DRUG DEL, V7, P737, DOI 10.1517/17425241003767383; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Yang JQ, 2013, CANCER RES, V73, P1662, DOI 10.1158/0008-5472.CAN-12-3453; Zhang JZ, 2007, BIOPHYS J, V92, P3988, DOI 10.1529/biophysj.106.102434; Zhigaltsev IV, 2006, J CONTROL RELEASE, V110, P378, DOI 10.1016/j.jconrel.2005.10.011; Zhigaltsev IV, 2005, J CONTROL RELEASE, V104, P103, DOI 10.1016/j.jconrel.2005.01.010; Zhigaltsev IV, 1999, BIOORG KHIM+, V25, P393; Zucker D, 2009, J CONTROL RELEASE, V139, P73, DOI 10.1016/j.jconrel.2009.05.036	89	15	15	2	45	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	NOV	2018	107						34	43		10.1016/j.biopha.2018.07.138	http://dx.doi.org/10.1016/j.biopha.2018.07.138			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GU1PC	30077836				2022-09-04	WOS:000445036200005
J	Vu, M; Li, R; Baskfield, A; Lu, B; Farkhondeh, A; Gorshkov, K; Motabar, O; Beers, J; Chen, GK; Zou, JH; Espejo-Mojica, AJ; Rodriguez-Lopez, A; Almeciga-Diaz, CJ; Barrera, LA; Jiang, XT; Ory, DS; Marugan, JJ; Zheng, W				Vu, Mylinh; Li, Rong; Baskfield, Amanda; Lu, Billy; Farkhondeh, Atena; Gorshkov, Kirill; Motabar, Omid; Beers, Jeanette; Chen, Guokai; Zou, Jizhong; Espejo-Mojica, Angela J.; Rodriguez-Lopez, Alexander; Almeciga-Diaz, Carlos J.; Barrera, Luis A.; Jiang, Xuntian; Ory, Daniel S.; Marugan, Juan J.; Zheng, Wei			Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease	ORPHANET JOURNAL OF RARE DISEASES			English	Article						Tay-Sachs disease; Induced pluripotent stem cells; Neural stem cells; Cyclodextrin; HP beta CD; delta-tocopherol; Enzyme replacement therapy; Hexosaminidase A; GM2 gangliosidosis; High throughput screening; Drug discovery	BETA-HEXOSAMINIDASE-A; ENZYME REPLACEMENT; CHOLESTEROL; DELIVERY; THERAPY; RED	Background: Tay-Sachs disease (TSD) is a rare neurodegenerative disorder caused by autosomal recessive mutations in the HEXA gene on chromosome 15 that encodes beta-hexosaminidase. Deficiency in HEXA results in accumulation of GM2 ganglioside, a glycosphingolipid, in lysosomes. Currently, there is no effective treatment for TSD. Results: We generated induced pluripotent stem cells (iPSCs) from two TSD patient dermal fibroblast lines and further differentiated them into neural stem cells (NSCs). The TSD neural stem cells exhibited a disease phenotype of lysosomal lipid accumulation. The Tay-Sachs disease NSCs were then used to evaluate the therapeutic effects of enzyme replacement therapy (ERT) with recombinant human Hex A protein and two small molecular compounds: hydroxypropyl-beta-cyclodextrin (HP beta CD) and 6-tocopherol. Using this disease model, we observed reduction of lipid accumulation by employing enzyme replacement therapy as well as by the use of HP beta CD and delta-tocopherol. Conclusion: Our results demonstrate that the Tay-Sachs disease NSCs possess the characteristic phenotype to serve as a cell-based disease model for study of the disease pathogenesis and evaluation of drug efficacy. The enzyme replacement therapy with recombinant Hex A protein and two small molecules (cyclodextrin and tocopherol) significantly ameliorated lipid accumulation in the Tay-Sachs disease cell model.	[Vu, Mylinh; Li, Rong; Baskfield, Amanda; Lu, Billy; Farkhondeh, Atena; Gorshkov, Kirill; Motabar, Omid; Marugan, Juan J.; Zheng, Wei] NIH, Natl Ctr Advancing Translat Sci, Bldg 10, Bethesda, MD 20892 USA; [Beers, Jeanette; Chen, Guokai; Zou, Jizhong] NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA; [Chen, Guokai] Univ Macau, Fac Hlth Sci, Macau, Peoples R China; [Espejo-Mojica, Angela J.; Rodriguez-Lopez, Alexander; Almeciga-Diaz, Carlos J.; Barrera, Luis A.] Pontificia Univ Javeriana, Fac Sci, Inst Study Inborn Errors Metab, Bogota, Colombia; [Rodriguez-Lopez, Alexander] Pontificia Univ Javeriana, Fac Sci, Chem Dept, Bogota, Colombia; [Jiang, Xuntian; Ory, Daniel S.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO USA		Zheng, W (corresponding author), NIH, Natl Ctr Advancing Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	wzheng@mail.nih.gov	Gorshkov, Kirill/W-2188-2019; Zheng, Wei/GOE-5990-2022; Alméciga-Díaz, Carlos J/A-2494-2017; Zheng, Wei/J-8889-2014; Espejo, Angela/AAF-9020-2019; Rodriguez-Lopez, Edwin Alexander/E-6650-2015	Gorshkov, Kirill/0000-0002-4652-8818; Alméciga-Díaz, Carlos J/0000-0001-6484-1173; Zheng, Wei/0000-0003-1034-0757; Rodriguez-Lopez, Edwin Alexander/0000-0001-5409-3466	Intramural Research Program of the Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health; Administrative Department of Science, Technology and Innovation COLCIENCIAS, Colombia; Pontificia Universidad Javeriana; Pontificia Universidad Javeriana [7204, 3637]; COLCIENCIAS [120356933205, 120356933427, 120352128575]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000018] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006145] Funding Source: NIH RePORTER	Intramural Research Program of the Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health; Administrative Department of Science, Technology and Innovation COLCIENCIAS, Colombia; Pontificia Universidad Javeriana; Pontificia Universidad Javeriana; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health. This work was also supported by the doctoral scholarship from the Administrative Department of Science, Technology and Innovation COLCIENCIAS, Colombia, and the Pontificia Universidad Javeriana (to AJEM and ARL), by the grants from the Pontificia Universidad Javeriana (Grant ID 7204 to CJAD, Grant ID 3637 to LAB) and COLCIENCIAS (Grant No. 120356933205 and 120356933427 to CJAD, Grant ID No. 120352128575 to LAB).	Aguisanda F, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0670-9; Akeboshi H, 2007, APPL ENVIRON MICROB, V73, P4805, DOI 10.1128/AEM.00463-07; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Baldo BA, 2015, BIODRUGS, V29, P31, DOI 10.1007/s40259-015-0116-7; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Bicker J, 2014, EUR J PHARM BIOPHARM, V87, P409, DOI 10.1016/j.ejpb.2014.03.012; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Clarke JTR, 2011, MOL GENET METAB, V102, P6, DOI 10.1016/j.ymgme.2010.09.004; Colaianni A, 2010, GENET MED, V12, pS5, DOI 10.1097/GIM.0b013e3181d5a669; Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6; Espejo-Mojica Angela J., 2016, Univ. Sci., V21, P195, DOI 10.11144/Javeriana.SC21-3.corh; Gray-Edwards HL, 2017, MOL THER-METH CLIN D, V6, P135, DOI 10.1016/j.omtm.2017.07.005; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; KRUTH HS, 1984, AM J PATHOL, V114, P201; Li R, 2017, ASSAY DRUG DEV TECHN, V15, P154, DOI 10.1089/adt.2017.774; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lin YS, 2017, STEM CELL TRANSL MED, V6, P527, DOI 10.5966/sctm.2015-0428; Long Y, 2016, STEM CELL TRANSL MED, V5, P1644, DOI 10.5966/sctm.2015-0373; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; MAHURAN DJ, 1991, BIOCHIM BIOPHYS ACTA, V1096, P87, DOI 10.1016/0925-4439(91)90044-A; Matsuoka K, 2011, MOL THER, V19, P1017, DOI 10.1038/mt.2011.27; Muro S, 2012, DRUG DELIV TRANSL RE, V2, P169, DOI 10.1007/s13346-012-0072-4; Ohsawa M, 2005, J HUM GENET, V50, P460, DOI 10.1007/s10038-005-0278-0; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Patterson MC, 2013, HAND CLINIC, V113, P1707, DOI 10.1016/B978-0-444-59565-2.00039-3; Rodriguez-Lopez A, 2016, SCI REP-UK, V6, DOI 10.1038/srep29329; Shapira E., 1989, BIOCH GENETICS LAB M; Sima N, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0798-2; VONSPECHT BU, 1979, NEUROLOGY, V29, P848, DOI 10.1212/WNL.29.6.848; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Xu M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.357707; Yu DZ, 2014, J BIOMOL SCREEN, V19, P1164, DOI 10.1177/1087057114537378	36	18	20	4	31	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1750-1172		ORPHANET J RARE DIS	Orphanet J. Rare Dis.	SEP 17	2018	13								152	10.1186/s13023-018-0886-3	http://dx.doi.org/10.1186/s13023-018-0886-3			15	Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Research & Experimental Medicine	GU0UK	30220252	Green Published, gold			2022-09-04	WOS:000444968000001
J	Fagua, G; Condamine, FL; Horak, M; Zwick, A; Sperling, FAH				Fagua, Giovanny; Condamine, Fabien L.; Horak, Marianne; Zwick, Andreas; Sperling, Felix A. H.			Diversification shifts in leafroller moths linked to continental colonization and the rise of angiosperms	CLADISTICS			English	Article							BAYESIAN-ANALYSIS; CLIMATE-CHANGE; PLANT; EVOLUTIONARY; BIOGEOGRAPHY; DISPERSAL; INFERENCE; PHYLOGENY; EXTINCTION; INSIGHTS	Tectonic dynamics and niche availability play intertwined roles in determining patterns of diversification. Such drivers explain the current distribution of many clades, whereas events such as the rise of angiosperms can have more specific impacts, such as on the diversification rates of herbivores. The Tortricidae, a diverse group of phytophagous moths, are ideal for testing the effects of these determinants on the diversification of herbivorous clades. To estimate ancestral areas and diversification patterns in Tortricidae, a complete tribal- level dated tree was inferred using molecular markers (one mitochondrial and five nuclear) and calibrated using fossil constraints. We found that Tortricidae diverged from their sister group c. 120 Myr ago (Ma) and diversified c. 97 Ma, a timeframe synchronous with the rise of angiosperms in the Early-mid Cretaceous. Ancestral areas analysis, based on updated Wallace's biogeographical regions, supports the hypothesis of a Gondwanan origin of Tortricidae in the South American plate. We also detected an increase in speciation rate that coincided with the peak of angiosperm diversification in the Cretaceous. This in turn probably was further heightened by continental colonization of the Palaeotropics when angiosperms became dominant by the end of the Late Cretaceous. (C) The Willi Hennig Society 2016.	[Fagua, Giovanny; Condamine, Fabien L.; Sperling, Felix A. H.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Fagua, Giovanny] Pontificia Univ Javeriana, Dept Biol, Carrera 7 40-62, Bogota, DC, Colombia; [Condamine, Fabien L.] Univ Montpellier, CNRS, UMR 5554, Inst Sci Evolut, Pl Eugene Bataillon, F-34095 Montpellier, France; [Horak, Marianne; Zwick, Andreas] CSIRO Natl Res Collect Australia, Australian Natl Insect Collect, Canberra, ACT 2601, Australia		Fagua, G (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.; Fagua, G (corresponding author), Pontificia Univ Javeriana, Dept Biol, Carrera 7 40-62, Bogota, DC, Colombia.	faguagon@ualberta.ca	Fagua, Giovanny/B-3135-2018; Zwick, Andreas/A-5735-2015; Sperling, Felix A.H./H-8376-2012	Fagua, Giovanny/0000-0003-1253-4416; Zwick, Andreas/0000-0002-7532-1752; Sperling, Felix A.H./0000-0001-5148-4226	Academic Vice rectory of the "Pontificia Universidad Javeriana-Bogota" [DJE-012-2011]; Administrative Department of Science, Technology and Innovation of Colombia (COLCIENCIAS) [APCC-80-134]; Marie Curie Action (EU 7th Framework Programme) (BIOMME project) [IOF-627684]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Academic Vice rectory of the "Pontificia Universidad Javeriana-Bogota"; Administrative Department of Science, Technology and Innovation of Colombia (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Marie Curie Action (EU 7th Framework Programme) (BIOMME project); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank Joaquin Baixeras and Niklas Wahlberg for their insights and constructive comments on the study as reviewers. Funding was provided by the Academic Vice rectory of the "Pontificia Universidad Javeriana-Bogota" (Agreement DJE-012-2011), the Administrative Department of Science, Technology and Innovation of Colombia (COLCIENCIAS, APCC-80-134) to G.F., a Marie Curie Action (EU 7th Framework Programme) (BIOMME project, IOF-627684) to F.L.C., and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to F.A.H.S. The authors declare no conflict of interest.	Almeida EAB, 2012, J BIOGEOGR, V39, P526, DOI 10.1111/j.1365-2699.2011.02624.x; Anderson JM, 1999, J AFR EARTH SCI, V28, P145, DOI 10.1016/S0899-5362(98)00083-9; Bouchenak-Khelladi Y, 2014, BOT J LINN SOC, V175, P4, DOI 10.1111/boj.12160; Boyce CK, 2009, P ROY SOC B-BIOL SCI, V276, P1771, DOI 10.1098/rspb.2008.1919; Brown JW, 2014, AFR ENTOMOL, V22, P343, DOI 10.4001/003.022.0225; Brown J. W., 2008, FOOD PLANT DATABASE; Brown John W., 2005, World Catalogue of Insects, V5, P1; Buchsbaum U., 2002, HETEROC SUMATR, V21, P155; Buerki S, 2011, J BIOGEOGR, V38, P531, DOI 10.1111/j.1365-2699.2010.02432.x; Carde RT, 2008, CURR BIOL, V18, pR472, DOI 10.1016/j.cub.2008.04.018; Cardinal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2686; Chaboureau AC, 2014, P NATL ACAD SCI USA, V111, P14066, DOI 10.1073/pnas.1324002111; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; CHUMAKOV NM, 1995, STRATIGR GEOL CORREL, V3, P241; Condamine FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19208; Condamine FL, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0347-8; Condamine FL, 2013, J BIOGEOGR, V40, P9, DOI 10.1111/j.1365-2699.2012.02787.x; Cooke Barry J., 2007, P487; Crane P.R., 1987, ORIGINS ANGIOSPERMS, P107; de Boer HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2217; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; DeConto R. M., 2000, WARM CLIMATES EARTH, P275, DOI DOI 10.1017/CBO9780511564512.010; Dombroskie JJ, 2013, ZOOTAXA, V3729, P1, DOI 10.11646/zootaxa.3729.1.1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Gilligan TM, 2014, TRTS ONLINE WORLD CA; Gilligan TM, 2014, SYST ENTOMOL, V39, P49, DOI 10.1111/syen.12036; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1, DOI 10.1016/B978-0-444-59425-9.00001-9; GREENBANK DO, 1980, MEM ENTOMOL SOC CAN, P1, DOI 10.4039/entm112110fv; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grimaldi David, 2005, pi; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Hochuli PA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00344; Horak M., 1991, World Crop Pests, V5, P23; HORAK M., 2006, MONOGRAPHS AUSTR LEP, V10; Horak Marianne, 1999, Handbuch der Zoologie (Berlin), V4, P199; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kergoat GJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0220-1; Kitching I. J., 2010, HOSTS A DATABASE WOR; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Kristensen Niels P., 1999, Handbuch der Zoologie (Berlin), V4, P7; Kuznetzov V.I., 1973, Trudy vses ent Obshch, V56, P18; LABANDEIRA CC, 1994, P NATL ACAD SCI USA, V91, P12278, DOI 10.1073/pnas.91.25.12278; Labandeira CC, 1998, ANNU REV EARTH PL SC, V26, P329, DOI 10.1146/annurev.earth.26.1.329; LABANDEIRA CC, 2014, PALEONTOL SOC PAP, V20, P163, DOI DOI 10.1017/S1089332600002850; Labandeira C, 2007, INSECT SCI, V14, P259, DOI 10.1111/j.1744-7917.2007.00152.x; Labandeira CC, 2013, ANNU REV EARTH PL SC, V41, P287, DOI 10.1146/annurev-earth-050212-124139; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Landis MJ, 2013, SYST BIOL, V62, P789, DOI 10.1093/sysbio/syt040; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lawyer L.A., 1992, ANTARCT RES SER, V56, P7, DOI DOI 10.1029/AR056P0007; LIDGARD S, 1988, NATURE, V331, P344, DOI 10.1038/331344a0; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; Lopez Rodrigo, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0312s48; Lupia R, 1999, PALEOBIOLOGY, V25, P305, DOI 10.1017/S009483730002131X; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Matzke N. J., 2014, FRONT BIOGEOGR, V5, P242; McCulloch GA, 2016, MOL PHYLOGENET EVOL, V96, P150, DOI 10.1016/j.ympev.2015.10.028; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Miller MA, 2015, EVOL BIOINFORM, V11, P43, DOI 10.4137/EBO.S21501; Moore BR, 2016, P NATL ACAD SCI USA, V113, P9569, DOI 10.1073/pnas.1518659113; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; Pena C, 2008, BIOL LETTERS, V4, P274, DOI 10.1098/rsbl.2008.0062; Peralta-Medina E, 2012, GEOLOGY, V40, P219, DOI 10.1130/G32733.1; Poinar G Jr, 1999, AMBER FOREST; POINAR GO, 1993, ENTOMOL SCAND, V24, P25; Powell J. A., 1964, U CALIFORNIA PUBLICA, V32; Powell JA, 1983, CHECK LIST LEPIDOPTE, P31; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; Rabosky DL, 2014, METHODS ECOL EVOL, V5, P701, DOI 10.1111/2041-210X.12199; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; Rambaut A., 2013, TRACER V1 6; RAZOWSKI J, 1976, Acta Zoologica Cracoviensia, V21, P73; Razowski J., 2008, POLISH J ENTOMOL, V77, P233; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058568, 10.1371/journal.pone.0072678]; Regier JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035574; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rota J, 2016, J BIOGEOGR, V43, P1254, DOI 10.1111/jbi.12721; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; Safonkin A. F., 2007, ENTOMOL REV, V87, P1238, DOI DOI 10.1134/S0013873807090138; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Schrank E, 2002, PALAEONTOLOGY, V45, P33, DOI 10.1111/1475-4983.00226; Scotese CR, 1999, J AFR EARTH SCI, V28, P99, DOI 10.1016/S0899-5362(98)00084-0; Silvestro D, 2015, NEW PHYTOL, V207, P425, DOI 10.1111/nph.13247; Skalski A. W., 1992, ANN UPPER SILESIAN M, V3, P137; SOHN JC, 2012, ZOOTAXA 0430, P1; Spriggs EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097722; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Sturtevant BR, 2013, AGR FOREST METEOROL, V168, P186, DOI 10.1016/j.agrformet.2012.09.008; Swofford D.L, 2003, PAUP PHYLOGENETIC AN; Vakhrameev V.A., 1991, JURASSIC CRETACEOUS; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	107	17	17	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0748-3007	1096-0031		CLADISTICS	Cladistics	OCT	2017	33	5					449	466		10.1111/cla.12185	http://dx.doi.org/10.1111/cla.12185			18	Evolutionary Biology; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Evolutionary Biology; Zoology	FH3ES	34724755				2022-09-04	WOS:000411028500001
J	Reynolds, CW; Aguiar, LG; Arbelaez, C; Restrepo, CG; Patino, A; Carranza, H; Pileika, L; Duarte, A				Reynolds, Christopher W.; Aguiar, Leonar G.; Arbelaez, Christian; Gomez Restrepo, Carlos; Patino, Andres; Carranza, Heidy; Pileika, Lindsey; Duarte, Andres			Healthcare access barriers for FARC ex-combatants in Colombia: qualitative perspectives from healthcare providers and FARC health promoters	BMC PUBLIC HEALTH			English	Article						Healthcare access barriers; FARC ex-combatant; Colombia; Global health; Armed conflict; Reintegration		Background Following the 2016 Peace Agreement with the Fuerzas Armadas Revolucionarias de Colombia (FARC), Colombia promised to reincorporate more than 13,000 guerrilla fighters into its healthcare system. Despite a subsidized healthcare insurance program and the establishment of 24 Espacios Territoriales de Capacitacion y Reincorporacion (ETCRs-Territorial Spaces for Training and Reintegration) to facilitate this transition, data has shown that FARC ex-combatants access care at disproportionately lower rates, and face barriers to healthcare services. Methods Semi-structured interviews were conducted with FARC health promoters and healthcare providers working in ETCRs to determine healthcare access barriers for FARC ex-combatants. Analysis was completed with a qualitative team-based coding method and barriers were categorized according to Julio Frenk's Domains of Healthcare Access framework. Results Among 32 participants, 25 were healthcare providers and 7 self-identified as FARC health promoters. The sample was majority female (71.9%) and worked with the FARC for an average of 12 months in hospital, health center, medical brigade, and ETCR settings. Our sample had experiences with FARC across 16 ETCRs in 13 Departments of Colombia. Participants identified a total of 141 healthcare access barriers affecting FARC ex-combatants, which affected healthcare needs, desires, seeking, initiation and continuation. Significant barriers were related to a lack of resources in rural areas, limited knowledge of the Colombian health system, the health insurance program, perceived stigma, and transition process from the FARC health system. Conclusions FARC ex-combatants face significant healthcare access barriers, some of which are unique from other low-resource populations in Colombia. Potential solutions to these barriers included health insurance provider partnerships with health centers close to ETCRs, and training and contracting FARC health promoters to be primary healthcare providers in ETCRs. Future studies are needed to quantify the healthcare barriers affecting FARC ex-combatants, in order to implement targeted interventions to improve healthcare access.	[Reynolds, Christopher W.] Univ Michigan, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Aguiar, Leonar G.; Arbelaez, Christian; Gomez Restrepo, Carlos; Carranza, Heidy; Duarte, Andres] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Cra 7 40-62, Bogota, Colombia; [Arbelaez, Christian] Brown Emergency Med, 125 Whipple St 3rd, Providence, RI 02908 USA; [Patino, Andres] Emory Univ, Sch Med, 550 Peachtree St NE, Atlanta, GA 30308 USA; [Pileika, Lindsey] Brown Univ, Warren Alpert Med Sch, 222 Richmond St, Providence, RI 02903 USA		Reynolds, CW (corresponding author), Univ Michigan, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	chriswreynolds18@gmail.com	; Aguiar Martinez, Leonar G/M-7447-2016	Gomez-Restrepo, Carlos/0000-0002-9013-5384; Reynolds, Christopher/0000-0001-6634-391X; Aguiar Martinez, Leonar G/0000-0002-5372-2459; Duarte Osorio, Andres/0000-0002-1982-6799; Patino, Andres/0000-0002-4599-4016	Fulbright U.S. Student Researcher Grant; Brown Emergency Medicine Innovation Grant	Fulbright U.S. Student Researcher Grant; Brown Emergency Medicine Innovation Grant	Fulbright U.S. Student Researcher Grant.; Brown Emergency Medicine Innovation Grant.	Agencia para la Reincorporacion y Normalizacion, 2019, PROGRAMAS DESARROLLO; [Anonymous], 2020, CIFRAS ASEGURAMIENTO; [Anonymous], 2018, NACION SEMANA; ARN en Cifras: Asi Avanza la Reincorporacion, 2020, AGENCIA REINCORPORAC; Avila C, 2018, ESPECTADOR; AyalaGarcia J, 2014, BANCO REPUBLICA; Baez S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00073; BarraganRamos J, 2019, RCN RADIO; Barrios Sabogal LC, 2019, FARIANAS REINTEGRATI, P38; Biel-Portero I, 2019, IBEROAM J DEV STUD, V8, P86, DOI 10.26754/ojs_ried/ijds.364; Bowd R, 2013, J INTERV STATEBUILD, V7, P453, DOI 10.1080/17502977.2012.727537; Carballo M., 2010, POSTCONFLICT TRANSIT; Castaneda Orjuela CA., 2017, 9 OBS NAC SAL I NAC; de la Espriella Ricardo, 2009, rev.colomb.psiquiatr., V38, P230; Defensoria del Pueblo de Colombia, 2017, INF ESP TERR CAP REI, P10; Escobar Arango A, 2017, DECRETO LEY N MERO 8; Fernandez-Nino Julian Alfredo, 2019, F1000Res, V8, P2140, DOI [10.12688/f1000research.21375.1, 10.12688/f1000research.21375.2]; Findley SE, 2012, AM J PUBLIC HEALTH, V102, P1981, DOI 10.2105/AJPH.2011.300566; Finn A, 2012, DRIVERS EXCOMBATANT; Frenk J, 1985, CONCEPTO MEDICION AC; Giedion U, 2009, HEALTH AFFAIR, V28, P853, DOI 10.1377/hlthaff.28.3.853; Hermenau K, 2013, J AGGRESS MALTREAT T, V22, P916, DOI 10.1080/10926771.2013.824057; Hume F, 1994, Med War, V10, P4, DOI 10.1080/07488009408409136; Idrobo F, 2018, LANCET PSYCHIAT, V5, P467, DOI 10.1016/S2215-0366(18)30134-2; International Organization for Migration, 2015, HLTH CARE PSYCHOSOCI; Johnson K, 2008, JAMA-J AM MED ASSOC, V300, P676, DOI 10.1001/jama.300.6.676; Johnson K, 2012, MIL MED, V177, P531, DOI 10.7205/MILMED-D-11-00185; LeGrand CC, 2017, CAN J LAT AM CARIBB, V42, P259, DOI 10.1080/08263663.2017.1378381; Lotscher W., 2016, **DROPPED REF**; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McLellan Eleanor, 1998, FIELD METHOD, V10, P31, DOI 10.1177/1525822X980100020301; Odenwald Michael, 2007, Confl Health, V1, P10, DOI 10.1186/1752-1505-1-10; Orjuela Benavides J., 2018, AS FUNCIONABA SISTEM; Ramirez MF, 2019, INSIGHT CRIME; Reardon S., 2018, NATURE; Reynolds C, 2021, J SEX RES, V58, P681, DOI 10.1080/00224499.2020.1786662; Rodriguez MC, 2016, ROLE COMMUNITY HLTH; Santos Calderon J. M., 2016, ACUERDO FINAL TERMIN; Sesquicentenario Universidad Nacional de Colombia, 2017, CARACTERIZACION COMU; Song SJ, 2013, COMMUNITY MENT HLT J, V49, P615, DOI 10.1007/s10597-013-9597-3; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trigos-Carrillo L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00047; Trujillo S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00510; United Nations Department of Peacekeeping Operations Office of Rule of Law and Security Institutions Disarmament Demobilization and Reintegration Section., 2010, 2 GENERATION DISARMA; United Nations Inter-Agency Working Group on Disarmament Demobilization and Reintegration, 2014, OPERATIONAL GUIDE IN; United Nations Peacekeeping, DISARMAMENT DEMOBILI; Valenzuela AS, 2018, EXCLUSIVO AS EST SAL; Vargas I, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-297; Worley W., 2018, PEACEBUILDING NEWS D	49	2	2	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	JAN 8	2021	21	1							102	10.1186/s12889-020-10062-3	http://dx.doi.org/10.1186/s12889-020-10062-3			18	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	PS8YC	33419406	Green Published, gold			2022-09-04	WOS:000608208400001
J	Remes-Troche, JM; Valdovinos-Diaz, MA; Viebig, R; Defilippi, C; Bustos-Fernandez, LM; Sole, L; Hani-Amador, AC				Remes-Troche, J. M.; Valdovinos-Diaz, M. A.; Viebig, R.; Defilippi, C.; Bustos-Fernandez, L. M.; Sole, L.; Hani-Amador, A. C.			Recommendations for the reopening and activity resumption of the neurogastroenterology units in the face of the COVID-19 pandemic. Position of the Sociedad Latinoamericana de Neurogastroenterologia	REVISTA DE GASTROENTEROLOGIA DE MEXICO			Spanish	Article						COVID-19; Neurogastroenterology; Motility; Manometry; pH study	BIOFEEDBACK	The COVID-19 pandemic has forced the establishment of preventive measures against contagion during the performance of diagnostic and therapeutic tests in gastroenterology. Digestive tract motility tests involve an intermediate and elevated risk for the transmission of COVID-19 infection. Given their elective or non-urgent indication in the majority of cases, we recommend postponing those tests until significant control of the infection rate in each Latin American country has been achieved during the pandemic. When the health authorities allow the return to normality, and in the absence of an effective treatment for or preventive vaccine against COVID-19 infection, we recommend a strict protocol for classifying patients according to their infectious-contagious status through the appropriate use of tests for the detection of the virus and the immune response to it, and the following of protective measures by the healthcare personnel to prevent contagion during the performance of a gastrointestinal motility test. (C) 2020 Asociacion Mexicana de Gastroenterologia. Published by Masson Doyma Mexico S.A.	[Remes-Troche, J. M.] Univ Veracruzana, Inst Invest Med Biol, Iturbide S-N, Veracruz 91400, Mexico; [Valdovinos-Diaz, M. A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Ciudad De Mexico, Mexico; [Viebig, R.] Inst Brasileiro Estudos & Pesquisas Gastroenterol, Sao Paulo, Brazil; [Defilippi, C.] Hosp Clin Univ Chile, Secc Gastroenterol, Santiago, Chile; [Bustos-Fernandez, L. M.] Ctr Med Dr Bustos Fernandez, Buenos Aires, DF, Argentina; [Sole, L.] Consultorios Motilidad Digest CMD, Buenos Aires, DF, Argentina; [Hani-Amador, A. C.] Pontificia Univ Javeriana, Unidad Gastroenterol Hosp San Ignacio, Bogota, Colombia		Remes-Troche, JM (corresponding author), Univ Veracruzana, Inst Invest Med Biol, Iturbide S-N, Veracruz 91400, Mexico.	jose.remes.troche@gmail.com						Asociacion Espanola de Gastroenterologia (AEG), 2020, REC GEN AS ESP GASTR; Asociacion Espanola de Neurogastroenterologia y Motilidad, REC ASENEM REAN ACT; Bharucha AE, 2005, GUT, V54, P546, DOI 10.1136/gut.2004.047696; Carrington EV, 2020, NEUROGASTROENT MOTIL, V32, DOI 10.1111/nmo.13679; Cheung KS, 2020, GASTROENTEROLOGY, V159, P81, DOI 10.1053/j.gastro.2020.03.065; Chiu PWY, 2020, GUT, V69, P991, DOI 10.1136/gutjnl-2020-321185; Dhawan I, 2018, DIGEST DIS SCI, V63, P3178, DOI 10.1007/s10620-018-5300-4; FELTBERSMA RJF, 1990, DIS COLON RECTUM, V33, P479, DOI 10.1007/BF02052142; Garcia-Zermeno KR, 2019, GASTROENTEROLOGY, V156, pS356; Hasak S, 2019, CLIN GASTROENTEROL H, V17, P1982, DOI 10.1016/j.cgh.2018.10.020; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Lee YY, 2020, CLIN GASTROENTEROL H, V18, P1906, DOI 10.1016/j.cgh.2020.04.075; Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1016/j.gastro.2003.09.039; Ozturk R, 2004, ALIMENT PHARM THER, V20, P667, DOI 10.1111/j.1365-2036.2004.02125.x; Pimentel M, 2020, AM J GASTROENTEROL, V115, P165, DOI 10.14309/ajg.0000000000000501; Rao SSC, 2015, NEUROGASTROENT MOTIL, V27, P594, DOI 10.1111/nmo.12520; Rezaie A, 2017, AM J GASTROENTEROL, V112, P775, DOI 10.1038/ajg.2017.46; Ridenhour B, 2015, REV PANAM SALUD PUBL, V38, P167; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101613; Sociedad Interamericana de Endoscopia Digestiva, 2020, REC UN END DUR PAND; Tian Y, 2020, ALIMENT PHARM THER, V51, P843, DOI 10.1111/apt.15731; van Engelenburg-van Lonkhuyzen ML, 2017, GASTROENTEROLOGY, V152, P82, DOI 10.1053/j.gastro.2016.09.015; Watts LS, 2020, NEUROGASTROENT MOTIL, V32, DOI 10.1111/nmo.13892; World Health Organization, COR DIS COVID 19 PAN	24	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0375-0906			REV GASTROENTEROL ME	Rev. Gastroenterol. Mex.	OCT-DEC	2020	85	4					428	436		10.1016/j.rgmx.2020.07.001	http://dx.doi.org/10.1016/j.rgmx.2020.07.001			9	Gastroenterology & Hepatology	Emerging Sources Citation Index (ESCI)	Gastroenterology & Hepatology	OV2DP	32773251	gold, Green Published			2022-09-04	WOS:000592027500010
J	Flores, RJ; Campo-Arias, A; Stimpson, JP; Chalela, CM; Reyes-Ortiz, CA				Flores, Renee J.; Campo-Arias, Adalberto; Stimpson, Jim P.; Chalela, Claudia M.; Reyes-Ortiz, Carlos A.			The Association Between Past Sexual Abuse and Depression in Older Adults From Colombia	JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY			English	Article						older adults; Colombia; sexual abuse; displacement; depression	SUBJECTIVE MEMORY; HEALTH; ASSAULT; DIAGNOSIS; PATHWAYS; VIOLENCE; SCALE	To explore the association between past sexual abuse and depression in elders living in Bogota, Colombia, we used data from the SABE (Salud, Bienestar y Envejecimiento [Health, Well-being, and Aging]) Bogota Study. Participants were 2000 community-dwelling adults aged 60 years and older in 2012. Sexual abuse was assessed by self-report. Depression was measured by the Geriatric Depression Scale. The weighted prevalence estimate was 2.6% for past sexual abuse and 23.4% for depression. Multivariate data analyses showed significantly higher odds of depression for past sexual abuse (odds ratio [OR] = 3.91, 95% confidence interval [CI]: 2.13-7.16). Other characteristics associated with depression were history of being displaced by violence (OR = 1.77, 95% CI: 1.30-2.40), low socioeconomic status, low education, poor self-rated health status, and poor self-rated memory. Thus, past sexual abuse and history of being displaced by violence were strongly associated with depression among Colombian elderly individuals.	[Flores, Renee J.; Reyes-Ortiz, Carlos A.] Univ Texas Hlth Sci Ctr Houston, Div Geriatr & Palliat Med, Dept Internal Med, Houston, TX 77030 USA; [Campo-Arias, Adalberto] Univ Magdalena, Fac Ciencias Salud, Programa Med, Santa Marta, Colombia; [Stimpson, Jim P.] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Chalela, Claudia M.] Pontificia Univ Javeriana, Programa Med, Bogota, Colombia		Reyes-Ortiz, CA (corresponding author), Univ Texas McGovern Med Sch Houston, Div Geriatr & Palliat Med, Dept Internal Med, 6431 Fannin St,MSB 5-111, Houston, TX 77030 USA.	careyesortiz@hotmail.com	Campo-Arias, Adalberto/AAZ-1605-2020	Campo-Arias, Adalberto/0000-0003-2201-7404; Stimpson, James/0000-0002-1266-9436; Chalela, Claudia/0000-0002-1863-6408	Administrative Department of Science, Technology and Innovation; Colciencias in Colombia [120354531692]	Administrative Department of Science, Technology and Innovation(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Colciencias in Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The SABE Bogota study was supported by a grant from the Administrative Department of Science, Technology and Innovation, Colciencias in Colombia, Code 120354531692. Dr Reyes-Ortiz was supported as US Fulbright Scholar 2017-2018.	Albala C, 2005, REV PANAM SALUD PUBL, V17, P307, DOI 10.1590/S1020-49892005000500003; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Amowitz LL, 2002, JAMA-J AM MED ASSOC, V287, P513, DOI 10.1001/jama.287.4.513; Badia X, 1999, MED CLIN-BARCELONA, V112, P79; Bryant-Davis T, 2010, AM J ORTHOPSYCHIAT, V80, P61, DOI 10.1111/j.1939-0025.2010.01007.x; Caceres Diana Carolina, 2002, Biomedica, V22 Suppl 2, P425; Campo-Arias Adalberto, 2014, rev.colomb.psiquiatr., V43, P212, DOI 10.1016/j.rcp.2014.09.004; Céspedes-Báez Lina-María, 2010, Estud. Socio-Juríd, V12, P273; Chen LP, 2010, MAYO CLIN PROC, V85, P618, DOI 10.4065/mcp.2009.0583; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forlani C, 2014, AM J GERIAT PSYCHIAT, V22, P370, DOI 10.1016/j.jagp.2012.08.015; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gomez-Angulo C, 2011, UNIV PSYCHOL, V10, P735; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hosmer DW., 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hulur G, 2015, GERONTOLOGY, V61, P232, DOI 10.1159/000369010; Kamiya Y, 2016, INT PSYCHOGERIATR, V28, P415, DOI 10.1017/S1041610215001672; Kaukinen C, 2005, J INTERPERS VIOLENCE, V20, P1244, DOI 10.1177/0886260505277732; Kirby P, 2013, EUR J INT RELAT, V19, P797, DOI 10.1177/1354066111427614; Krug E., 2002, WORLD REPORT VIOLENC, P125; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lindert J, 2013, INT J PUBLIC HEALTH, V58, P121, DOI 10.1007/s00038-012-0388-3; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; Morgan R.G., 2014, 2014 AS PAC INT S AE, P1; Mullers Evelyn-Sybille, 2008, Br J Nurs, V17, P1428; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Roepke-Buehler SK, 2015, J AGING HEALTH, V27, P1003, DOI 10.1177/0898264315571106; Rose R, 2008, ENCY AGING PUBLIC HL, P721; Shultz JM, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0475-7; Thoennes N., 1998, PREVALENCE INCIDENCE, P1, DOI DOI 10.1037/E330452004-001; Thomas R, 2011, PSYCHOL VIOLENCE, V1, P121, DOI 10.1037/a0022469; Trickett PK, 2001, DEV PSYCHOPATHOL, V13, P1001, DOI 10.1017/S0954579401004138; Ullman SE, 2015, J CHILD SEX ABUS, V24, P300, DOI 10.1080/10538712.2015.1006748; Williams J.L., 2017, ELDER ABUSE, P45, DOI [10.1007/978-3-319-47504-2_3, DOI 10.1007/978-3-319-47504-2_3]; Wirtz AL, 2016, CONFL HEALTH, V10, DOI 10.1186/s13031-016-0071-z; Wirtz Andrea L, 2014, Confl Health, V8, P10, DOI 10.1186/1752-1505-8-10; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	37	7	7	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0891-9887	1552-5708		J GERIATR PSYCH NEUR	J. Geriatr. Psychiatry Neurol.	JAN	2018	31	1					13	18		10.1177/0891988717743588	http://dx.doi.org/10.1177/0891988717743588			6	Geriatrics & Gerontology; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology; Psychiatry	FQ4BA	29172904				2022-09-04	WOS:000418301400002
J	Aschner, P; Munoz, OM; Giron, D; Garcia, OM; Fernandez, DG; Casas, LA; Bohorquez, LF; Arango, CM; Carvajal, L; Ramirez, DA; Sarmiento, JG; Colon, CA; Correa, NF; Alarcon, P; Bustamante, AA; Fino, V; Penagos, E				Aschner M, Pablo; Mauricio Munoz, Oscar, V; Giron C, Diana; Milena Garcia G, Olga; Gerardo Fernandez A, Daniel; Angela Casas, Luz; Fernanda Bohorquez, Luisa; Maria Arango T, Clara; Carvajal, Liliana; Amanda Ramirez, Doris; Guillermo Sarmiento, Juan; Alejandro Colon, Cristian; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro; Fino, Victor; Penagos, Ernesto			Clinical Practice Guideline for Treatment of type 2 Diabetes Mellitus: erapeutic Targets	UNIVERSITAS MEDICA			Spanish	Article						type 2 diabetes mellitus; goals; clinical practice guidelines	INTENSIVE GLUCOSE CONTROL; COMPLICATIONS; MANAGEMENT; OLDER; HYPERGLYCEMIA; OUTCOMES; DISEASE; RISK	Introduction: It is demonstrated that reach and maintain a glycated hemoglobin (HbA1c) of 7% reduce the incidence of macro and micro vascular complications in young adults with type 2 diabetes. It has been proposed that this therapeutic goal must be individualized in patients older than 65 years or in those with previous cardiovascular disease, however the evidence supporting this adjustment is controversial. Aim: To define the risk and benefits of intensified therapy to achieve HbA1 <7% in DMT2 patients older than 65 years, with or without significant comorbidities, and in patients with previous cardiovascular events. Methods: A clinical practice guide has been developed following the broad outline of the methodological guide from the Colombian Ministry of Health and Social Welfare, with the aim of systematically gathering scientific evidence and formulating recommendations using the GRADE methodology. Conclusions: In patients with DMT2 who are older than 65 years of age, and in those with antecedents of cardiovascular disease it is recommended not to intensify treatment to reach HbA1c values close to normal (<6,5% HbA1c). The therapeutic goals in patients older than 65 years should be individualized according with an integral evaluation considering hypoglycemia risk and life-threatening situation.	[Aschner M, Pablo; Mauricio Munoz, Oscar, V; Milena Garcia G, Olga; Gerardo Fernandez A, Daniel; Guillermo Sarmiento, Juan; Alejandro Colon, Cristian; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro] Hosp Univ San Ignacio, Bogota, Colombia; [Aschner M, Pablo; Mauricio Munoz, Oscar, V; Giron C, Diana; Milena Garcia G, Olga; Gerardo Fernandez A, Daniel; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro] Pontificia Univ Javeriana, Bogota, Colombia; [Angela Casas, Luz] Univ Valle, Cali, Colombia; [Fernanda Bohorquez, Luisa; Amanda Ramirez, Doris] Univ Nacl Colombia, Bogota, Colombia; [Maria Arango T, Clara] Univ Antioquia, Medellin, Colombia; [Carvajal, Liliana] Asociac Colombiana Diabet, Bogota, Colombia		Munoz, OM (corresponding author), Hosp Univ San Ignacio, Bogota, Colombia.; Munoz, OM (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.	o.munoz@javeriana.edu.co	Girón, Diana/ABC-1451-2021; Muñoz, Oscar/Q-2906-2019	Muñoz, Oscar/0000-0001-5401-0018				Anderson RT, 2011, DIABETES CARE, V34, P807, DOI 10.2337/dc10-1926; Aschner PJ, 2012, DIABETES TECHNOL THE, V14, pS68, DOI 10.1089/dia.2012.0012; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Buehler AM, 2013, CARDIOVASC THER, V31, P147, DOI 10.1111/j.1755-5922.2011.00308.x; Coca SG, 2012, ARCH INTERN MED, V172, P761, DOI 10.1001/archinternmed.2011.2230; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; European Diabetes Working Party for Older People working Group. European Diabetes Working Party for Older People, 2011, DIABETES METAB, V37, pS27; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gomez Huelgas R., 2012, MED CLIN, V134, pe1; Guideline Group, 2004, INT DIAB FED MAN OLD; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Hewitt J, 2011, DIABETIC MED, V28, P117, DOI 10.1111/j.1464-5491.2010.03142.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Miller ME, 2014, DIABETES CARE, V37, P634, DOI 10.2337/dc13-1545; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Riethof M, 2012, DIAGNOSIS MANAGEMENT; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zhang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054465, 10.1371/journal.pone.0059796, 10.1371/journal.pone.0059840, 10.1371/journal.pone.0066382]	28	0	0	0	1	PONTIFICIA UNIV JAVERIANA, FAC MEDICINA	BOGOTA	HOSPITAL SAN IGNACIO, CARRERA 7A, 40-62 PISO 5, BOGOTA, CUND 00000, COLOMBIA	0041-9095	2011-0839		UNIV MED	Univ. Med.		2017	58	4								10.11144/Javeriana.umed58-4.dmmm	http://dx.doi.org/10.11144/Javeriana.umed58-4.dmmm			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FV6HC		gold			2022-09-04	WOS:000424681100004
J	Parra, DC; Gomez, LF; Fleischer, NL; Pinzon, JD				Parra, Diana C.; Gomez, Luis F.; Fleischer, Nancy L.; David Pinzon, Jose			Built environment characteristics and perceived active park use among older adults: Results from a multilevel study in Bogota	HEALTH & PLACE			English	Article						Park use; Physical activity; Built environment; Older adults; GIS; Bogota	TIME PHYSICAL-ACTIVITY; PUBLIC-HEALTH; RECREATIONAL RESOURCES; WALKING; INTERVENTIONS; AMERICAN; LESSONS	Objective: Examine the associations between selected built environment (BE) attributes and perceived active park use among older adults in Bogota. Methods: A cross-sectional multilevel study was conducted. Participants included 1966 older adults in 50 neighborhoods. Socio-demographic covariates and BE attributes were measured. Multilevel logistic regression models were used for the analyses. Results: Residents from areas with higher park density and high land-use mix were more likely to report active park use while those from areas with high connectivity were less likely. Conclusions: This study suggests that objective attributes of the residential BE are associated with perceived active park use. However, our study also points to the importance of surrounding environment, with the result of an inverse relationship between connectivity and physical activity, which highlights the potentially necessary interventions in the realm of traffic and pedestrian safety. (C) 2010 Elsevier Ltd. All rights reserved.	[Parra, Diana C.] Washington Univ, George Warren Brown Sch Social Work, Prevent Res Ctr St Louis, St Louis, MO 63105 USA; [Gomez, Luis F.] Fdn FES Social, Hlth Div, Bogota, Colombia; [Gomez, Luis F.] Univ Javeriana, Dept Social Med, Sch Med, Bogota, Colombia; [Fleischer, Nancy L.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA; [David Pinzon, Jose] Corp Univ Ctr Bogota, Bogota, Colombia; [David Pinzon, Jose] Fdn Univ Bogota Jorge Tadeo Lozano, Urban Design Dept, Bogota, Colombia		Parra, DC (corresponding author), Washington Univ, George Warren Brown Sch Social Work, Prevent Res Ctr St Louis, 8150 Whitburn Dr 2W Clayton, St Louis, MO 63105 USA.	dianacpp79@yahoo.com	Parra, Diana C/D-7633-2013; Parra, Diana C/B-7761-2015	Parra, Diana C/0000-0002-9797-6231; Parra, Diana C/0000-0002-9797-6231; Gomez Gutierrez, Luis Fernando/0000-0003-1834-3012				*ALC MAY BOG, 2005, ESTR BOG DC EST REL; [Anonymous], 2005, STAT STAT SOFTW REL; Baker EA, 2008, J PHYS ACT HEALTH, V5, P252, DOI 10.1123/jpah.5.2.252; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; Boehmer T.K., 2006, J PHYS ACT HEALTH, V3, P22, DOI [DOI 10.1123/JPAH.3.1.22, 10.1123/jpah.3.1.22.]; Cervero R, 1997, TRANSPORT RES D-TR E, V2, P199, DOI 10.1016/S1361-9209(97)00009-6; Cervero R, 2009, INT J SUSTAIN TRANSP, V3, P203, DOI 10.1080/15568310802178314; Cohen DA, 2007, AM J PUBLIC HEALTH, V97, P509, DOI 10.2105/AJPH.2005.072447; *ESRI, 2006, ARC VIEW VERS 9 3; Forsyth BH, 1991, MEASUREMENT ERRORS S, P395; Frank LD., 2003, HLTH COMMUNITY DESIG, P11; *FUND FES SOC, 2009, IMP AMB URB PATR ACT; Gebre-Egziabher Axumite, 2004, Ann N Y Acad Sci, V1023, P62, DOI 10.1196/annals.1319.016; GOMEZ LF, 2007, AM J PREV MED, V38, P592; Hoehner CM, 2008, AM J PREV MED, V34, P224, DOI 10.1016/j.amepre.2007.11.016; Humpel N, 2004, ANN BEHAV MED, V27, P60, DOI 10.1207/s15324796abm2701_8; Huston SL, 2003, AM J HEALTH PROMOT, V18, P58, DOI 10.4278/0890-1171-18.1.58; *INSTITUTOCOLOMBIA, 2005, ENC NAC SIT NUTR COL; JOBE JB, 1990, PUBLIC HEALTH REP, V105, P518; Kaczynski AT, 2008, AM J PUBLIC HEALTH, V98, P1451, DOI 10.2105/AJPH.2007.129064; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Li FZ, 2005, J EPIDEMIOL COMMUN H, V59, P558, DOI 10.1136/jech.2004.028399; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Ogilvie D., 2008, INT J BEHAV NUTR PHY, V5; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Palloni A, 2006, J AGING HEALTH, V18, P149, DOI 10.1177/0898264306286766; Parra D, 2007, INDOOR BUILT ENVIRON, V16, P344, DOI 10.1177/1420326X07080462; Peel NM, 2007, ANN NY ACAD SCI, V1114, P162, DOI 10.1196/annals.1396.026; *QUALITYMETRICS, 2008, MAN US SF 8 HLTH SUR; RAU M, 2004, P 9 ANN INT CPTED C; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Schwartz FW, 1997, J MOL MED-JMM, V75, P699, DOI 10.1007/s001090050156; *SECRETARIADETRANS, 2006, ENC MOV BOG STT 2005; Simoes EJ, 2009, AM J PUBLIC HEALTH, V99, P68, DOI 10.2105/AJPH.2008.141978; Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913; Wendel-Vos GCW, 2008, J EPIDEMIOL COMMUN H, V62, P689, DOI 10.1136/jech.2007.062869; Wendel-Vos GCW, 2004, QUAL LIFE RES, V13, P667, DOI 10.1023/B:QURE.0000021313.51397.33; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; Wiggs I, 2008, HEALTH PROMOT PRACT, V9, P387, DOI 10.1177/1524839906289233; 2002, CALI COLOMBIA CITY D	44	50	53	1	36	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8292	1873-2054		HEALTH PLACE	Health Place	NOV	2010	16	6					1174	1181		10.1016/j.healthplace.2010.07.008	http://dx.doi.org/10.1016/j.healthplace.2010.07.008			8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	679CB	20708426				2022-09-04	WOS:000284135900013
J	Pai, KK; Omiunu, A; Vedula, S; Chemas-Velez, MM; Fang, CH; Baredes, S; Eloy, JA				Pai, Kavya K.; Omiunu, Ariel; Vedula, Sudeepti; Chemas-Velez, Maria Manuela; Fang, Christina H.; Baredes, Soly; Eloy, Jean Anderson			Impact of Prolonged Operative Time on Complications Following Endoscopic Sinonasal Surgery	LARYNGOSCOPE			English	Article; Early Access						Endoscopic sinonasal surgery; operative time; database; National Surgical Quality Improvement Program; otolaryngology; perioperative complications	QUALITY-OF-LIFE; SINUS SURGERY; CHRONIC RHINOSINUSITIS; EXPERIENCE; RESECTION; IMPROVES; OUTCOMES; CHILDREN; COST	Objective To determine how prolonged operative time (POT) impacts 30-day outcomes in patients undergoing endoscopic sinonasal surgery (ESNS). Study Design Retrospective study. Methods Data from patients who underwent ESNS (nonsinus, sinus, and extended sinus) between 2005 to 2018 were collected from the American College of Surgeons National Surgical Quality Improvement database. Univariate and multivariate analyses were performed to evaluate the effect of POT on postoperative outcomes. Results Among 1,994 ESNS cases, 495 nonsinus procedures, 1,191 sinus procedures, and 308 extended sinus procedures were identified. Median OT was 90 minutes (interquartile range [IQR], 51-165 minutes) for nonsinus procedures, 113 minutes (IQR, 66-189 minutes) for sinus procedures, and 187 minutes (IQR, 137-251 minutes) for extended sinus procedures. Other than older age (P = .008), POT was not significantly associated with baseline demographics and comorbidities for patients undergoing non-sinus procedures. Older age (P < .001), White and Black race (P < .001), ASA physical classifications III or IV (P < .001), and several preoperative comorbidities, including obesity (P = .045), and hypertension (P < .001) were associated with POT for sinus procedures. Older age (P = .030), male sex (P = .010), and lower body mass index (P = .004) were associated with POT for extended sinus procedures. After risk-adjustment, POT was independently associated with prolonged hospital stay (LOS) for all procedure categories, and associated with overall surgical complications and postoperative bleeding for sinus and extended sinus procedures specifically. Conclusion POT is independently associated with several adverse outcomes following ESNS, including prolonged LOS, overall surgical complications, and bleeding. Preoperative planning should include optimizing modifiable patient risk factors for POT and identifying surgeon-specific factors to enhance surgical efficiency. Level of Evidence 4 Laryngoscope, 2022	[Pai, Kavya K.] Univ Toledo, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Omiunu, Ariel; Vedula, Sudeepti; Baredes, Soly; Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, Newark, NJ 07103 USA; [Chemas-Velez, Maria Manuela] Pontificia Univ Javeriana, Dept Otolaryngol & Maxilofacial Surg, Bogota, Colombia; [Fang, Christina H.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bronx, NY 10467 USA; [Baredes, Soly; Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Ctr Skull Base & Pituitary Surg, Neurol Inst New Jersey, Newark, NJ 07103 USA; [Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA; [Eloy, Jean Anderson] Rutgers New Jersey Med Sch, Dept Ophthalmol & Visual Sci, Newark, NJ 07103 USA; [Eloy, Jean Anderson] St Barnabas Med Ctr RWJBarnabas Hlth, Dept Otolaryngol & Facial Plast Surg, Livingston, NJ 07039 USA		Eloy, JA (corresponding author), St Barnabas Med Ctr RWJBarnabas Hlth, Dept Otolaryngol & Facial Plast Surg, Livingston, NJ 07039 USA.; Eloy, JA (corresponding author), Rutgers New Jersey Med Sch, Rhinol & Sinus Surg, Neurol Inst New Jersey, 90 Bergen St,Suite 8100, Newark, NJ 07103 USA.; Eloy, JA (corresponding author), Rutgers New Jersey Med Sch, Otolaryngol Res, Neurol Inst New Jersey, 90 Bergen St,Suite 8100, Newark, NJ 07103 USA.; Eloy, JA (corresponding author), Rutgers New Jersey Med Sch, Endoscop Skull Base Surg Program, Dept Otolaryngol Head & Neck Surg, Neurol Inst New Jersey, 90 Bergen St,Suite 8100, Newark, NJ 07103 USA.; Eloy, JA (corresponding author), Rutgers New Jersey Med Sch, Neurol Surg, Neurol Inst New Jersey, 90 Bergen St,Suite 8100, Newark, NJ 07103 USA.; Eloy, JA (corresponding author), Rutgers New Jersey Med Sch, Ophthalmol & Visual Sci, Neurol Inst New Jersey, 90 Bergen St,Suite 8100, Newark, NJ 07103 USA.	jean.anderson.eloy@gmail.com		Chemas-Velez, Maria Manuela/0000-0002-7343-8260				Al-Swiahb JN, 2010, ANN SAUDI MED, V30, P149, DOI 10.4103/0256-4947.60522; Bhattacharyya N, 2010, LARYNGOSCOPE, V120, P635, DOI 10.1002/lary.20777; Cote DJ, 2017, J AM COLL SURGEONS, V224, P971, DOI 10.1016/j.jamcollsurg.2017.02.015; Crosby DL, 2019, INT FORUM ALLERGY RH, V9, P1456, DOI 10.1002/alr.22444; Daley BJ, 2015, J AM COLL SURGEONS, V220, P550, DOI 10.1016/j.jamcollsurg.2014.12.040; Dalgorf DM, 2013, OTOLARYNG HEAD NECK, V149, P17, DOI 10.1177/0194599813488519; Dlouhy BJ, 2012, J NEUROSURG, V116, P1311, DOI 10.3171/2012.2.JNS111837; Duchman KR, 2017, J ARTHROPLASTY, V32, P1285, DOI 10.1016/j.arth.2016.12.003; Ethun CG, 2017, CA-CANCER J CLIN, V67, P363, DOI 10.3322/caac.21406; Farber NI, 2019, INT FORUM ALLERGY RH, V9, P1492, DOI 10.1002/alr.22422; Fetta M, 2017, INT J PEDIATR OTORHI, V100, P145, DOI 10.1016/j.ijporl.2017.06.007; Fried Marvin P, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P163, DOI 10.1097/MOO.0b013e32814b0802; Gardner JR, 2021, EUR ARCH OTO-RHINO-L, V278, P1471, DOI 10.1007/s00405-020-06453-2; Goshtasbi K, 2021, INT FORUM ALLERGY RH, V11, P1596, DOI 10.1002/alr.22829; Hardy KL, 2014, AESTHET SURG J, V34, P614, DOI 10.1177/1090820X14528503; He N, 2017, THER CLIN RISK MANAG, V13, P593, DOI 10.2147/TCRM.S131185; Jackson TD, 2011, SURG ENDOSC, V25, P2288, DOI 10.1007/s00464-010-1550-8; Karakus MF, 2020, TURK ARCH OTORHINOL, V58, P5, DOI 10.5152/tao.2020.4828; Lee JT, 2019, AM J RHINOL ALLERGY, V33, P26, DOI 10.1177/1945892418804904; Lee YJ, 2018, AM J RHINOL ALLERGY, V32, P404, DOI 10.1177/1945892418787129; Lobo BC, 2017, LARYNGOSCOPE INVEST, V2, P215, DOI 10.1002/lio2.75; Maggino L, 2018, J AM COLL SURGEONS, V226, P844, DOI 10.1016/j.jamcollsurg.2018.01.004; Pant H, 2016, OTOLARYNG CLIN N AM, V49, P655, DOI 10.1016/j.otc.2016.03.011; Pecha PP, 2021, LARYNGOSCOPE, V131, pE1369, DOI 10.1002/lary.29047; Pollei TR, 2013, OTOLARYNG HEAD NECK, V148, P912, DOI 10.1177/0194599813482291; Povolotskiy R, 2020, LARYNGOSCOPE, V130, P1377, DOI 10.1002/lary.28228; Quinn NA, 2018, OTOLARYNG HEAD NECK, V159, P310, DOI 10.1177/0194599818765099; Rajendran B, 2020, J KOR ASSOC ORAL MAX, V46, P373, DOI 10.5125/jkaoms.2020.46.6.373; Sahlstrand-Johnson P, 2017, RHINOLOGY, V55, P251, DOI [10.4193/Rhino16126, 10.4193/Rhino16.126]; Scott JR, 2017, AM J RHINOL ALLERGY, V31, P135, DOI 10.2500/ajra.2017.31.4414; Soler ZM, 2012, AM J RHINOL ALLERGY, V26, P110, DOI 10.2500/ajra.2012.26.3741; Tajudeen Bobby A, 2017, World J Otorhinolaryngol Head Neck Surg, V3, P115, DOI 10.1016/j.wjorl.2016.12.001; Tassler A, 2016, OTOLARYNG CLIN N AM, V49, P517, DOI 10.1016/j.otc.2016.01.002; Viera-Artiles J, 2020, EUR ARCH OTO-RHINO-L, V277, P3341, DOI 10.1007/s00405-020-06196-0; Vlastarakos PV, 2013, CLIN PEDIATR, V52, P1091, DOI 10.1177/0009922813506489; VLEMING M, 1992, ARCH OTOLARYNGOL, V118, P617; Wais M, 2012, INT FORUM ALLERGY RH, V2, P20, DOI 10.1002/alr.20093; Wang EW, 2019, INT FORUM ALLERGY RH, V9, pS145, DOI 10.1002/alr.22326	38	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope												10.1002/lary.30057	http://dx.doi.org/10.1002/lary.30057		FEB 2022	8	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	ZA9PV	35174505				2022-09-04	WOS:000756488100001
J	de Vries, E; Rincon, CJ; Martinez, NT; Rodriguez, N; Tiemeier, H; Mackenbach, JP; Gomez-Restrepo, C; Guarnizo-Herreno, CC				de Vries, Esther; Javier Rincon, Carlos; Tamayo Martinez, Nathalie; Rodriguez, Nelcy; Tiemeier, Henning; Mackenbach, Johan P.; Gomez-Restrepo, Carlos; Guarnizo-Herreno, Carol C.			Housing index, urbanisation level and lifetime prevalence of depressive and anxiety disorders: a cross-sectional analysis of the Colombian national mental health survey	BMJ OPEN			English	Article							MIDDLE-INCOME COUNTRIES; SOCIOECONOMIC INEQUALITIES; ADDIS-ABABA; RURAL DIFFERENCES; POVERTY; POPULATION; ETHIOPIA; EPIDEMIOLOGY; COMORBIDITY; SEVERITY	Objectives To study socioeconomic inequalities in mental health in rural and urban Colombia, a country with a history of internal conflict and large socioeconomic inequalities. Recent survey data are available to study this understudied topic in a middle-income country. Methods Using data from 9656 respondents from the 2015 Colombian Mental Health survey, we investigated the association between lifetime prevalence of depressive and anxiety disorders and quality of dwellings and access to public services housing score (HS). We calculated the relative index of inequality (RII) and slope index of inequality (SII) for HS in urban and rural areas, adjusting for potential confounders and mediating factors. Outcomes The lifetime prevalence of anxiety and depression (combined) was 9.6% in urban versus 6.9% in rural areas (p<0.001). HS was not associated with prevalence of anxiety and depression in urban settings, whereas a higher HS (poorer housing quality) was associated with fewer mental disorders in rural areas in both univariate and multivariate models (multivariate RII(urban)0.96 (95% CI 0.51 to 1.81); RII(rural)0.11 (95% CI 0.04 to 0.32)). In rural areas, the prevalence of mental health problems was 12% points lower in persons living in the poorest quality dwellings than in those living in high-quality dwellings (SII -0.12 (95% CI -0.18 to -0.06)). Interestingly, within rural areas, persons living in 'populated centres' (small towns, villages) had a higher lifetime prevalence of any mental health disorder (9.8% (95% CI 6.9 to 13.6)) compared with those living in more isolated, dispersed areas (6.0% (95% CI 4.6 to 7.7)). Interpretation In rural Colombia, those living in the poorest houses and in dispersed areas had a lower prevalence of mental health problems. Further understanding of this phenomenon of a seemingly inverse association of prevalence of mental disorders with poverty and/or urbanisation in rural areas is needed. Particularly, considering the progressive urbanisation process in Colombia, it is important to monitor mental health in populations migrating to the cities.	[de Vries, Esther; Javier Rincon, Carlos; Tamayo Martinez, Nathalie; Rodriguez, Nelcy; Gomez-Restrepo, Carlos] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Tiemeier, Henning] Erasmus MC Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Mackenbach, Johan P.] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Gomez-Restrepo, Carlos] Hosp Univ San Ignacio, Dept Psychiat & Mental Hlh, Bogota, Colombia; [Guarnizo-Herreno, Carol C.] Univ Nacl Colombia, Fac Odontol, Dept Salud Colect, Bogota, Colombia; [Guarnizo-Herreno, Carol C.] UCL, Dept Epidemiol & Publ Hlth, London, England		de Vries, E (corresponding author), Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia.	estherdevries@javeriana.edu.co	de Vries, Esther/A-6603-2009; Tiemeier, Henning/H-6534-2019; Rincon, Carlos Javier/AAD-5847-2019	de Vries, Esther/0000-0002-5560-2258; Tiemeier, Henning/0000-0002-4395-1397; Rincon, Carlos Javier/0000-0002-0477-1908; Gomez-Restrepo, Carlos/0000-0002-9013-5384; Rodriguez, Nelcy/0000-0003-4320-695X	Administrative Department of Science, Technology and Innovation 'COLCIENCIAS'; Health and Social Welfare Ministry of Colombia [762-2013]	Administrative Department of Science, Technology and Innovation 'COLCIENCIAS'(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Health and Social Welfare Ministry of Colombia	The planning and execution of the Colombian Mental Health Survey was funded by The Administrative Department of Science, Technology and Innovation 'COLCIENCIAS' and The Health and Social Welfare Ministry of Colombia under the grant 762-2013.	Andersson LMC, 2018, HLTH SOC CARE COMMUN, V26; Andreeva E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2377-y; Ariza L, REV COLOMB PSIQUIATR, V35, P23; Cardona Arango Doris, 2016, rev.colomb.psiquiatr., V45, P170, DOI [10.1016/j.rcp.2015.10.002 0034-7450, 10.1016/j.rcp.2015.10.002]; Cifuentes M, 2008, SOC SCI MED, V67, P529, DOI 10.1016/j.socscimed.2008.04.003; Dai J, 2011, J AFFECT DISORDERS, V130, P438, DOI 10.1016/j.jad.2010.10.042; Das J, 2007, SOC SCI MED, V65, P467, DOI 10.1016/j.socscimed.2007.02.037; de Girolamo G, 2006, SOC PSYCH PSYCH EPID, V41, P853, DOI 10.1007/s00127-006-0097-4; de Vries E, 2016, BIOMEDICA, V36, P547, DOI 10.7705/biomedica.v36i4.3207; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Dzator J, 2013, J BEHAV HEALTH SER R, V40, P71, DOI 10.1007/s11414-012-9305-z; Evans GW, 2000, J CONSULT CLIN PSYCH, V68, P526, DOI 10.1037//0022-006X.68.3.526; Florez C, 2002, FUNCTION URBAN INFOR; Fonseca Z, 2011, ENCUESTA NACL SITUAC; Fontanella CA, 2015, JAMA PEDIATR, V169, P466, DOI 10.1001/jamapediatrics.2014.3561; Gomez-Restrepo C, 2015, ENCUESTA NACL SALUD, VI; Gómez-Restrepo Carlos, 2016, rev.colomb.psiquiatr., V45, P2, DOI 10.1016/j.rcp.2016.04.007; Gonzalez C, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-10; Guerrero R, 2011, SALUD PUBLICA MEXICO, V53, pS144; Handley TE, 2011, AUST J RURAL HEALTH, V19, P279, DOI 10.1111/j.1440-1584.2011.01235.x; Harpham T, 1997, T ROY SOC TROP MED H, V91, P497, DOI 10.1016/S0035-9203(97)90001-8; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Iemmi V, 2016, LANCET PSYCHIAT, V3, P774, DOI 10.1016/S2215-0366(16)30066-9; Jenkins R, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0693-5; Jenkins R, 2012, INT J ENV RES PUB HE, V9, P1810, DOI 10.3390/ijerph9051810; Kapusta ND, 2008, SOC PSYCH PSYCH EPID, V43, P311, DOI 10.1007/s00127-008-0317-1; Kebede D, 1999, ACTA PSYCHIAT SCAND, V100, P11, DOI 10.1111/j.1600-0447.1999.tb10688.x; Kebede D, 1999, ACTA PSYCHIAT SCAND, V100, P24, DOI 10.1111/j.1600-0447.1999.tb10690.x; Kebede D, 1999, ACTA PSYCHIAT SCAND, V100, P18, DOI 10.1111/j.1600-0447.1999.tb10689.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Maselko Joanna, 2017, Curr Epidemiol Rep, V4, P166, DOI 10.1007/s40471-017-0107-y; Meng XF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015156; Moreno-Betancur M, 2015, EPIDEMIOLOGY, V26, P518, DOI 10.1097/EDE.0000000000000311; Munhoz TN, 2016, J AFFECT DISORDERS, V192, P226, DOI 10.1016/j.jad.2015.12.038; Noorbala AA, 2017, ARCH IRAN MED, V20, P128, DOI 0172003/AIM.003; OJEDA GM, 2005, SALUD SEXUAL REPROD; Olesen SC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-144; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Risal A, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0810-0; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Sareen J, 2011, ARCH GEN PSYCHIAT, V68, P419, DOI 10.1001/archgenpsychiatry.2011.15; Trivedi Jitendra K, 2008, Indian J Psychiatry, V50, P161, DOI 10.4103/0019-5545.43623; Weich S, 2006, BRIT J PSYCHIAT, V188, P51, DOI 10.1192/bjp.bp.105.008714; Workshop of Australian National Tax Centre, 2002, SIZ MEAS INF EC 110; Xavier M, 2013, INT J MENT HEALTH SY, V7, DOI 10.1186/1752-4458-7-19	50	9	9	4	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2018	8	6							e019065	10.1136/bmjopen-2017-019065	http://dx.doi.org/10.1136/bmjopen-2017-019065			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GJ7LG	29880561	Green Published, gold			2022-09-04	WOS:000435567900015
J	Zhai, G; Rivadeneira, F; Houwing-Duistermat, JJ; Meulenbelt, I; Bijkerk, C; Hofman, A; van Meurs, JBJ; Uitterlinden, AG; Pols, HAP; Slagboom, PE; van Duijn, CM				Zhai, G; Rivadeneira, F; Houwing-Duistermat, JJ; Meulenbelt, I; Bijkerk, C; Hofman, A; van Meurs, JBJ; Uitterlinden, AG; Pols, HAP; Slagboom, PE; van Duijn, CM			Insulin-like growth factor I gene promoter polymorphism, collagen type II alpha 1 (COL2A1) gene, and the prevalence of radiographic osteoarthritis: the Rotterdam Study	ANNALS OF THE RHEUMATIC DISEASES			English	Article							TANDEM REPEAT; ASSOCIATION; POPULATION; CARTILAGE; LINKAGE; WOMEN; KNEE; LOCI; STRATIFICATION; EPIDEMIOLOGY	Objective: To examine the role of an IGF-I gene promoter polymorphism in the prevalence of radiographic osteoarthritis (ROA), and study its interaction with the COL2A1 gene. Methods: Individuals genotyped for IGF-I (n = 1546) and COL2A1 gene polymorphisms (n = 808) were selected from a random sample ( n = 1583) derived from the Rotterdam study. The presence of ROA was defined as a Kellgren score of 2 or more in at least one of four joints ( knee, hip, hand, and spine). Genotype specific odds ratios ( OR) were adjusted for age, sex, body mass index, and bone mineral density using logistic regression. Interaction with the COL2A1 genotype was tested. Results: Overall, no association was found between the IGF-I polymorphism and ROA. In subjects aged 65 years or younger ( n = 971), the prevalence of ROA increased with the absence of the 192 base pair ( bp) allele ( p for trend = 0.03). Compared with homozygotes for the 192 bp allele, the prevalence of ROA was 1.4 times higher in heterozygotes (95% confidence interval, 1.0 to 1.8) and 1.9 times higher in noncarriers (1.1 to 3.3). There was evidence of interaction between the IGF-I and COL2A1 genes. Individuals with the risk genotype of both genes had an increased prevalence of ROA ( OR 3.4 ( 1.1 to 10.7)). No effect was observed in subjects older than 65 years. Conclusions: Subjects with genetically determined low IGF-I expression (non-carriers of the 192 bp allele) may be at increased risk of ROA before the age of 65 years. Furthermore, an interaction between the IGF-I and COL2A1 genes is suggested.	Erasmus Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; Univ Med Ctr St Radboud, Dept Rheumatol, Nijmegen, Netherlands; Pontificia Univ Javeriana, Fac Med, Inst Genet Humana, Bogota, Colombia; Netherlands Inst Hlth Sci, Rotterdam, Netherlands		van Duijn, CM (corresponding author), Erasmus Med Ctr, Dept Epidemiol & Biostat, Postbus 1738, NL-3000 DR Rotterdam, Netherlands.	c.vanduijn@erasmusmc.nl	Meulenbelt, Ingrid/F-4756-2011; Rivadeneira, Fernando/O-5385-2015; Slagboom, P. Eline/R-4790-2016	Meulenbelt, Ingrid/0000-0001-7786-7081; Rivadeneira, Fernando/0000-0001-9435-9441; Slagboom, P. Eline/0000-0002-2875-4723; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137				BERG ES, 1993, GENOMICS, V16, P350, DOI 10.1006/geno.1993.1196; Bijkerk C, 1999, ARTHRITIS RHEUM, V42, P1729, DOI 10.1002/1529-0131(199908)42:8<1729::AID-ANR23>3.0.CO;2-H; BIJKERK C, 1999, ASS COL2A1 GENE RADI, P61; BURGER H, 1994, BONE MINER, V25, P1, DOI 10.1016/S0169-6009(08)80203-6; Chapman K, 1999, AM J HUM GENET, V65, P167, DOI 10.1086/302465; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; DENKO CW, 1990, J RHEUMATOL, V17, P1217; Felson DT, 1998, OSTEOARTHRITIS, P13; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1064, DOI 10.1002/1529-0131(199806)41:6<1064::AID-ART13>3.0.CO;2-K; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Hirsch R, 1998, ARTHRITIS RHEUM, V41, P1227, DOI 10.1002/1529-0131(199807)41:7<1227::AID-ART13>3.0.CO;2-N; HOCHBERG MC, 1994, ARTHRITIS RHEUM, V37, P1177, DOI 10.1002/art.1780370811; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hottenga J J, 2002, Ned Tijdschr Geneeskd, V146, P17; HOWELL DS, 1986, AM J MED, V80, P24, DOI 10.1016/0002-9343(86)90075-6; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; Kellgren JH, 1963, EPIDEMIOLOGY CHRONIC; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Leppavuori J, 1999, AM J HUM GENET, V65, P1060, DOI 10.1086/302569; Lloyd ME, 1996, ANN RHEUM DIS, V55, P870, DOI 10.1136/ard.55.12.870; Loeser RF, 2000, ARTHRITIS RHEUM, V43, P2110, DOI 10.1002/1529-0131(200009)43:9<2110::AID-ANR23>3.0.CO;2-U; Loughlin J, 1999, AM J HUM GENET, V65, P1795, DOI 10.1086/302685; LOUGHLIN J, 1994, BRIT J RHEUMATOL, V33, P1103; Loughlin J, 2001, CURR OPIN RHEUMATOL, V13, P111, DOI 10.1097/00002281-200103000-00004; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P2410, DOI 10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E; MCALINDON TE, 1993, ANN RHEUM DIS, V52, P229, DOI 10.1136/ard.52.3.229; Meulenbelt I, 1998, ANN RHEUM DIS, V57, P371, DOI 10.1136/ard.57.6.371; ODDING E, 1994, LOCOMOTOR DISABILITY; OSBORN KD, 1989, J ORTHOP RES, V7, P35, DOI 10.1002/jor.1100070106; Schneiderman R, 1995, ARCH BIOCHEM BIOPHYS, V324, P173, DOI 10.1006/abbi.1995.9913; Spector TD, 1996, BRIT MED J, V312, P940; Stecher RM, 1941, AM J MED SCI, V201, P801, DOI 10.1097/00000441-194106000-00004; TYLER JA, 1989, BIOCHEM J, V260, P543, DOI 10.1042/bj2600543; Uitterlinden AG, 1998, ELECTROPHORESIS, V19, P661, DOI 10.1002/elps.1150190509; Uitterlinden AG, 2000, ARTHRITIS RHEUM-US, V43, P1456, DOI 10.1002/1529-0131(200007)43:7<1456::AID-ANR7>3.0.CO;2-M; Vaessen N, 2001, DIABETES, V50, P637, DOI 10.2337/diabetes.50.3.637; van Meurs JBJ, 2000, ELECTROPHORESIS, V21, P3571, DOI 10.1002/1522-2683(200011)21:17<3571::AID-ELPS3571>3.0.CO;2-3; VANSAASE JLCM, 1989, ANN RHEUM DIS, V48, P271, DOI 10.1136/ard.48.4.271; VIKKULA M, 1993, ANN RHEUM DIS, V52, P762, DOI 10.1136/ard.52.10.762; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLIS DH, 1985, BIOCHIM BIOPHYS ACTA, V844, P72, DOI 10.1016/0167-4889(85)90236-8; Wright GD, 1996, ANN RHEUM DIS, V55, P317, DOI 10.1136/ard.55.5.317	43	27	29	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	MAY 1	2004	63	5					544	548		10.1136/ard.2003.010751	http://dx.doi.org/10.1136/ard.2003.010751			5	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Rheumatology	812AY	15082485	Green Submitted, Green Published, Bronze			2022-09-04	WOS:000220813600013
J	Faccini-Martinez, AA; Silva-Ramos, CR; Santodomingo, AM; Ramirez-Hernandez, A; Costa, FB; Labruna, MB; Munoz-Leal, S				Faccini-Martinez, Alvaro A.; Silva-Ramos, Carlos Ramiro; Santodomingo, Adriana M.; Ramirez-Hernandez, Alejandro; Costa, Francisco B.; Labruna, Marcelo B.; Munoz-Leal, Sebastian			Historical overview and update on relapsing fever group Borrelia in Latin America	PARASITES & VECTORS			English	Review						Soft ticks; Ornithodoros; Spirochetes; Tick-borne diseases; Relapsing fever; Borrelia; Clothing lice; Latin America	ACARI ARGASIDAE; PUERTORICENSIS FOX; TICK; SPIROCHETE; BURGDORFERI; THEILERI; IXODIDA; NEOTROPICALIS; TRANSMISSION; PREVALENCE	Relapsing fever group Borrelia (RFGB) are motile spirochetes transmitted to mammalian or avian hosts through the bite of hematophagous arthropods, such as soft ticks (Argasidae), hard ticks (Ixodidae) and the human clothing lice. RFGB can infect pets such as dogs and cats, as well as birds, cattle and humans. Borrelia recurrentis, B. anserina and B. theileri are considered to have worldwide distribution, affecting humans, domestic birds and ruminants, respectively. Borrelia spp. associated with soft ticks are transmitted mainly by Ornithodoros ticks and thrive in endemic foci in tropical and subtropical latitudes. Nowadays, human cases of soft tick-borne relapsing fever remain neglected diseases in several countries, and the impact these spirochetes have on the health of wild and domestic animals is largely understudied. Human infection with RFGB is difficult to diagnose, given the lack of distinguishing clinical features (undifferentiated febrile illness). Clinically, soft tick or louse-borne relapsing fever is often confused with other etiologies, such as malaria, typhoid or dengue. In Latin America, during the first half of the twentieth century historical documents elaborated by enlightened physicians were seminal, and resulted in the identification of RFGB and their associated vectors in countries such as Mexico, Panama, Colombia, Venezuela, Peru and Argentina. Almost 80 years later, research on relapsing fever spirochetes is emerging once again in Latin America, with molecular characterizations and isolations of novel RFGB members in Panama, Bolivia, Brazil and Chile. In this review we summarize historical aspects of RFGB in Latin America and provide an update on the current scenario regarding these pathogens in the region. To accomplish this, we conducted an exhaustive search of all the published literature for the region, including old medical theses deposited in libraries of medical academies. RFGB were once common pathogens in Latin America, and although unnoticed for many years, they are currently the focus of interest among the scientific community. A One Health perspective should be adopted to tackle the diseases caused by RFGB, since these spirochetes have never disappeared and the maladies they cause may be confused with etiologies with similar symptoms that prevail in the region.	[Faccini-Martinez, Alvaro A.] Fdn Univ Ciencias Salud FUCS, Res Inst, Bogota, Colombia; [Faccini-Martinez, Alvaro A.] Serv & Asesorias Infectol SAI, Bogota, Colombia; [Faccini-Martinez, Alvaro A.; Ramirez-Hernandez, Alejandro; Costa, Francisco B.; Labruna, Marcelo B.; Munoz-Leal, Sebastian] Gp Latinoamericano el Estudio Borreliosis Tran, Latin Amer Grp Study Ornithodorosborne Borrelios, Bogota, Colombia; [Santodomingo, Adriana M.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiologia, Grp Enfermedades Infecciosas, Bogota, Colombia; [Santodomingo, Adriana M.; Munoz-Leal, Sebastian] Univ Concepcion, Dept Anim Sci, Fac Vet Sci, Nuble, Chile; [Ramirez-Hernandez, Alejandro] Univ Nacl Colombia, Fac Med Vet Zootecnia, Dept Salud Anim, Grp Parasitol Vet, Bogota, Colombia; [Costa, Francisco B.] Univ Nacl Colombia, Fac Med VetZootecnia, Dept Salud Anim, Gro Parasitol Vet, Bogota, Colombia; [Munoz-Leal, Sebastian] Univ Sao Paulo, Dept Medicina Veterinaria Preventiva Saude Anim, Faculdade Medicina Veterinaria Zootecnia, Sao Paulo, Brazil		Munoz-Leal, S (corresponding author), Univ Concepcion, Dept Anim Sci, Fac Vet Sci, Nuble, Chile.	sebamunoz@udec.cl	Hernandez, Alejandro Ramirez/U-1567-2019	Hernandez, Alejandro Ramirez/0000-0001-8689-5930				Acosta Igor C L, 2016, Vet Parasitol Reg Stud Reports, V3-4, P66, DOI 10.1016/j.vprsr.2016.08.001; Ataliba AC, 2007, RES VET SCI, V83, P145, DOI 10.1016/j.rvsc.2006.11.014; Baneth G, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1530-5; Barbour AG, 2018, BERGEYS MANUAL SYSTE, P1, DOI [10.1016/S0580-9517(08)70161-2, DOI 10.1002/9781118960608.FBM00308]; Bates L. B., 1921, American Journal of Tropical Medicine, V1, P183; Bates LB, 1922, J AMER MED ASSOC, V79, P575, DOI 10.1001/jama.1922.02640070063029; Bello CJ., 1918, GAC MED CARACAS, V15, P215; Bello CJ., 1918, B MIN SAN AGR CR A, V220, P734; Bermudez SE, 2010, EXP APPL ACAROL, V52, P439, DOI 10.1007/s10493-010-9374-8; Bermúdez S, 2015, FAVE, Secc. Cienc. vet., V14, P1; Bermudez SE., 2013, PUENTE BIOL, V5, P81; Bermudez SE, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009642; Bermudez SE, 2017, TICKS TICK-BORNE DIS, V8, P466, DOI 10.1016/j.ttbdis.2017.02.004; Bernasconi VE., 1926, B I CLIN QUIRURG, V2, P74; Betancourt A, 1980, ACOVEZ CORDOBA, V002, P2; BRUMPT E., 1939, ANN PARASITOL HUMAINE ET COMP, V17, P275; Brumpt E., 1921, THESIS; CALERO C, 1946, AM J TROP MED, V26, P761; Callow L. L., 1961, Australian Veterinary Journal, V37, P381, DOI 10.1111/j.1751-0813.1961.tb03790.x; CALLOW LL, 1967, BRIT VET J, V123, P492, DOI 10.1016/S0007-1935(17)39704-X; Quintero JC, 2013, BIOMEDICA, V33, P38, DOI 10.7705/biomedica.v33i0.735; Cepeda MB, 2016, PESQUI VET BRASIL, V36, P687, DOI 10.1590/S0100-736X2016000800002; Chikeka I, 2015, CLIN MICROBIOL INFEC, V21, P404, DOI 10.1016/j.cmi.2015.04.022; CICERONI L, 1994, J TROP MED HYG, V97, P13; CLARK H. C., 1931, American Journal of Tropical Medicine, V11, P243; Connor RC., 1917, PROC MED ASS ISTHMIA, V10, P67; Cordeiro MD, 2018, REV BRAS PARASITOL V, V27, P555, DOI [10.1590/s1984-296120180083, 10.1590/S1984-296120180083]; Costa FB, 2020, VET PARASITOL REG ST, V21, DOI 10.1016/j.vprsr.2020.100413; Cruz NS, 2012, B MED HOSP INFANT M, V69, P121; Cutler S, 2019, EUROSURVEILLANCE, V24, P12, DOI 10.2807/1560-7917.ES.2019.24.18.1800170; Cutler SJ, 2017, VECTOR-BORNE ZOONOT, V17, P2, DOI 10.1089/vbz.2016.1962; Cutler SJ, 2015, CLIN LAB MED, V35, P847, DOI 10.1016/j.cll.2015.07.001; Dall'Agnol B, 2019, WILD ENVIRON MED, V30, P437, DOI 10.1016/j.wem.2019.06.012; Darling ST, 1922, J AMER MED ASSOC, V79, P810, DOI 10.1001/jama.1922.02640100030010; Darling ST, 1909, ARCH INTERN MED, V4, P150; DAVIS GE, 1952, J PARASITOL, V38, P473, DOI 10.2307/3273927; DAVIS GE, 1956, AM J HYG, V63, P13, DOI 10.1093/oxfordjournals.aje.a119787; DAVIS GE, 1955, INT B BACT NOMENCL T, V5, P107, DOI 10.1099/0096266X-5-3-107; De Alcantara EP, 2018, SYST APPL ACAROL-UK, V23, P1497, DOI 10.11158/saa.23.8.1; de Oliveira SV, 2018, TICKS TICK-BORNE DIS, V9, P1494, DOI 10.1016/j.ttbdis.2018.07.011; Del Prado E., 1920, AN FAC MED, V6, P26, DOI [10.15381/anales.v6i0.10630, DOI 10.15381/ANALES.V6I0.10630]; DUNN LAWRENCE H., 1933, AMER JOUR TROP MED, V13, P201; DUNN LAWRENCE H., 1927, JOUR PARASITOL, V13, P249, DOI 10.2307/3271661; DUNN LAWRENCE H., 1927, JOUR PARASITOL, V13, P177, DOI 10.2307/3271499; Dworkin MS, 2008, INFECT DIS CLIN N AM, V22, P449, DOI 10.1016/j.idc.2008.03.006; El TE., 1919, GAC MED CARACAS, V16, P73; El VP., 1941, REV HIGIENE, V22, P79; Elelu N, 2018, VET MED SCI, V4, P271, DOI 10.1002/vms3.108; Faccini-Martinez AA, 2021, REV SOC BRAS MED TRO, V54, DOI 10.1590/0037-8682-0443-2021; Faccini-Martinez Alvaro A, 2016, Vet Sci, V3, DOI 10.3390/vetsci3040033; Faccini-Martinez AA, 2018, REV MVZ CORDOBA, V23, P6399, DOI 10.21897/rmvz.1230; Fotso AF, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00254; FOX I, 1947, J PARASITOL, V33, P253, DOI 10.2307/3273558; Franco R., 1907, REV MED BOGOT, V28, P93; Franco R., 1911, ACAD NAC MED BOGOTA, V1, P169; Gallo P, 1946, ZOONOSIS VENEZUELA; Garcia PJ., 1911, SEMANA M DICA, V51, P57; Gettings JR, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00628-19; Goodman J., 2005, TICK BORNE DIS HUMAN; Guerin-Meneville M., 1849, REV MAG ZOOL PURE AP, V1, P342; Guglielmone A.A., 1987, Veterinaria Argentina, V4, P248; Guzman-Cornejo C, 2019, ZOOTAXA, V4623, P485, DOI 10.11646/zootaxa.4623.3.3; Hadani A., 1985, Revista de Medicina Veterinaria, Argentina, V66, P292; Heerdink G, 2006, Ned Tijdschr Geneeskd, V150, P2386; HERRER ARISTIDES, 1957, REV MED EXPTL [LIMA], V11, P34; Ibanez EA., 1959, HALLAZGO PAR SITOS G; Jorge FR, 2022, EXP APPL ACAROL, V86, P567, DOI 10.1007/s10493-022-00709-8; Kahlig P, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0008564; Kahlig P, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0008656; Kelly AL, 2014, TICKS TICK-BORNE DIS, V5, P95, DOI 10.1016/j.ttbdis.2013.08.005; Kingry LC, 2018, CLIN INFECT DIS, V66, P1864, DOI 10.1093/cid/cix1107; La ML., 1947, SALUBR ASISTENCIA, V7, P277; Labruna MB, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1796-7; Labruna MB, 2014, J MED ENTOMOL, V51, P283, DOI 10.1603/ME13062; Labruna MB, 1999, ARQ BRAS MED VET ZOO, V51, P551, DOI 10.1590/S0102-09351999000600008; Larsson C, 2006, J INFECT DIS, V194, P1367, DOI 10.1086/508425; Larsson Christer, 2008, Open Microbiol J, V2, P10, DOI 10.2174/1874285800802010010; Lassmann GW., 1946, REV MED XALAPE A, V11, P353; Lisboa RS, 2009, AVIAN DIS, V53, P166, DOI 10.1637/8377-061508-Reg.1; Lisboa RS, 2008, PESQUISA VET BRASIL, V28, P527, DOI 10.1590/S0100-736X2008001000014; Londono AF, 2017, TICKS TICK-BORNE DIS, V8, P887, DOI 10.1016/j.ttbdis.2017.07.007; Lopez Job E, 2016, Vet Sci, V3, DOI 10.3390/vetsci3030016; Lopez Y, 2021, FRONT VET SCI, V8, P4399, DOI 10.3389/fvets.2021.704399; Luz HR, 2019, PARASITOL RES, V118, P3185, DOI 10.1007/s00436-019-06442-3; Maia MO, 2018, EXP APPL ACAROL, V76, P523, DOI 10.1007/s10493-018-0323-2; Marchoux E., 1903, ANN I PASTEUR PARIS, V17, P569; Margos G, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8081251; Margos G, 2020, TICKS TICK-BORNE DIS, V11, DOI 10.1016/j.ttbdis.2019.101335; MARINKELLE CJ, 1968, NATURE, V218, P487, DOI 10.1038/218487a0; Martins JR, 2011, NEOTROP ENTOMOL, V40, P143, DOI 10.1590/S1519-566X2011000100022; Martins Joao Ricardo, 1996, Ciencia Rural, V26, P447, DOI 10.1590/S0103-84781996000300018; Martnez Rivas J., 1937, THESIS, P563; MATTON P, 1990, TROP ANIM HEALTH PRO, V22, P147, DOI 10.1007/BF02241005; MAZZOTTI L., 1949, REV INST SALUBRIDAD Y ENFERM TROP, V10, P277; Mazzotti L., 1947, REV INST SALUBRIDAD Y ENFERM TROP, V8, P69; Mazzotti L., 1943, REV INST SALUBRIDAD Y ENFERM TROP, V4, P371; Mazzotti L., 1942, REV INST SALUBRIDAD Y ENFERM TROP, V3, P47; MAZZOTTI LUIS, 1953, REV INST SALUBRIDAD Y ENFERM TROP, V13, P285; MELKERT PWJ, 1988, BRIT J OBSTET GYNAEC, V95, P1070, DOI 10.1111/j.1471-0528.1988.tb06516.x; Morel N, 2019, VET PARASITOL REG ST, V17, DOI 10.1016/j.vprsr.2019.100314; Munoz-Leal S, 2021, TICKS TICK-BORNE DIS, V12, DOI 10.1016/j.ttbdis.2021.101748; Munoz-Leal S, 2021, EMERG INFECT DIS, V27, P321, DOI 10.3201/eid2701.200349; Munoz-Leal S, 2021, ZOONOSES PUBLIC HLTH, V68, P12, DOI 10.1111/zph.12789; Munoz-Leal S, 2020, TICKS TICK-BORNE DIS, V11, DOI 10.1016/j.ttbdis.2020.101385; Munoz-Leal S, 2019, EXP APPL ACAROL, V78, P403, DOI 10.1007/s10493-019-00389-x; Munoz-Leal S, 2019, TICKS TICK-BORNE DIS, V10, P853, DOI 10.1016/j.ttbdis.2019.04.004; Munoz-Leal S, 2019, TRAVEL MED INFECT DI, V32, DOI 10.1016/j.tmaid.2019.03.005; Munoz-Leal S, 2019, ACTA TROP, V192, P91, DOI 10.1016/j.actatropica.2019.02.002; Munoz-Leal S, 2018, TICKS TICK-BORNE DIS, V9, P864, DOI 10.1016/j.ttbdis.2018.03.008; Munoz-Leal S, 2016, TICKS TICK-BORNE DIS, V7, P901, DOI 10.1016/j.ttbdis.2016.04.008; Munoz-Leal S, 2016, EXP APPL ACAROL, V69, P73, DOI 10.1007/s10493-016-0026-5; Najera LE., 1949, SOC ARG PATOL EPIDEM, V1, P5; Osorno-Mesa E., 1940, Revista de la Academia Colombiana, V4, P6; Ouchene N, 2020, COMP IMMUNOL MICROB, V68, DOI 10.1016/j.cimid.2019.101408; PAMPANA E. J., 1927, Transactions of the Royal Society of Tropical Medicine and Hygiene, V20, P357, DOI 10.1016/S0035-9203(27)80006-4; PAMPANA Emilio J., 1928, Transactions of the Royal Society of Tropical Medicine and Hygiene, V21, P315, DOI 10.1016/S0035-9203(28)90027-9; Pan American Health Organization, 1958, SCI PUBL, V38; Pan American Health Organization, 1963, SCI PUBL, V86; Pan American Health Organization, 1967, SCI PUBL, V149; Pan American Health Organization, 1971, SCI PUBL, V223; Pan American Health Organization, 1960, SCI PUBL, V48; Pan American Health Organization, 1965, SCI PUBL, V114; Pan American Health Organization, 1970, SCI PUBL, V199; Pan American Health Organization, 1966, SCI PUBL, V135; Pan American Health Organization, 1964, SCI PUBL, V102; Pan American Health Organization, 1969, SCI PUBL, V186; Pan American Health Organization, 1962, SCI PUBL, V58; Parola P, 2011, ANN TROP MED PARASIT, V105, P407, DOI 10.1179/1364859411Y.0000000021; PATERNINA LUIS E, 2009, Acta biol.Colomb., V14, P154; Piccione J, 2016, J VET INTERN MED, V30, P1222, DOI 10.1111/jvim.14363; PIFANO F., 1941, Revista de Sanidad y Asistencia Social, V6, P787; Pilz H, 1936, B I HIG MEXICO, V1, P295; Pino Pou R, 1918, REV OBSERV NOT SAN C, P13; Pino PR., 1918, DEMOCRACIA PARTICIPA, V30, P93; PINO-POU R., 1921, Gaceta Medica de Caracas, V28, P125; Raoult D, 1999, CLIN INFECT DIS, V29, P434, DOI 10.1086/520229; Reck J, 2018, TICKS TICK-BORNE DIS, V9, P1296, DOI 10.1016/j.ttbdis.2018.05.010; Reck J, 2013, TICKS TICK-BORNE DIS, V4, P101, DOI 10.1016/j.ttbdis.2012.09.004; Reck J, 2011, VET CLIN PATH, V40, P356, DOI 10.1111/j.1939-165X.2011.00338.x; KLEYNTJENS F, 1948, Scalpel (Brux), V101, P112; Replogle AJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81252-1; Robledo E., 1907, B MED, V1, P113; Roca-Garcia M., 1934, CONTRIBUCION ESTUDIO; Rodriguez-Morales Alfonso J, 2018, F1000Res, V7, P1988, DOI [10.12688/f1000research.17649.1, 10.12688/f1000research.17649.2]; Rogers AB, 1999, AM J VET RES, V60, P694; Romero Garcia AM., 1940, FIEBRE RECURRENTE; Ruiz SF., 1944, MEDICINA, V24, P199; Shirani D, 2016, TICKS TICK-BORNE DIS, V7, P424, DOI 10.1016/j.ttbdis.2015.12.020; SMITH RD, 1978, J INVERTEBR PATHOL, V32, P182, DOI 10.1016/0022-2011(78)90028-9; ST. JOHN J. H., 1922, American Journal of Tropical Medicine, V2, P251; Sv P., 1909, MEM I OSWALDO CRUZ, V1, P79, DOI [10.1590/S0074-02761909000200001, DOI 10.1590/S0074-02761909000200001]; Talagrand-Reboul E, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00098; Sanchez RST, 2020, REV BRAS PARASITOL V, V29, DOI [10.1590/S1984-29612020029, 10.1590/s1984-29612020029]; Thompson M., 2021, SYST APPL ACAROL-UK, V26, P11; UILENBERG G, 1988, VET QUART, V10, P63, DOI 10.1080/01652176.1988.9694148; Vazquez-Guerrero E, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007215; Wang GQ, 2002, J INFECT DIS, V186, P782, DOI 10.1086/343043; Warrell DA, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/s0950268819000116, 10.1017/S0950268819000116]; Whitney MS, 2007, VET CLIN PATH, V36, P212, DOI 10.1111/j.1939-165X.2007.tb00213.x; Yparraguirre LA, 2007, VECTOR-BORNE ZOONOT, V7, P717, DOI 10.1089/vbz.2007.0144	160	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUN 8	2022	15	1							196	10.1186/s13071-022-05289-5	http://dx.doi.org/10.1186/s13071-022-05289-5			20	Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Parasitology; Tropical Medicine	1Z0GJ	35676728	Green Published, gold			2022-09-04	WOS:000808512500001
J	Martinez-Cajas, J; Alvarado-Llano, B; Martinez-Buitrago, E; Torres-Isasiga, J; Arrivillaga, M; Camargo, P; Galindo-Orrego, X; Mueses-Marin, H				Martinez-Cajas, Jorge; Alvarado-Llano, Beatriz; Martinez-Buitrago, Ernesto; Torres-Isasiga, Julian; Arrivillaga, Marcela; Camargo, Pilar; Galindo-Orrego, Ximena; Mueses-Marin, Hector			AC-2020-12-1420.R1-HIV care providers' familiarity, concerns, and attitudes about HIV PrEP in Colombia: insights from the PrEP-Col-Study	AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV			English	Article; Early Access						Implementation science; HIV Pre-Exposure Prophylaxis (PrEP); HIV prevention	PREEXPOSURE PROPHYLAXIS; IMPLEMENTATION; PHYSICIANS; ADOPTION	In 2019, Colombia approved the combination of tenofovir disoproxil fumarate/emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP). Therefore, we conducted a situational analysis in HIV-care providers to identify barriers and facilitators for PrEP implementation. A survey was applied to a non-probabilistic sample of health care workers of HIV-specialized clinics. We examined PrEP awareness and familiarity, comfort with PrEP-related activities, perceived barriers for PrEP implementation, concerns, and attitudes. Poisson regressions assessed the relationship between these factors and the variable "having a plan to offer PrEP". The participation rate was 41% and included physicians (42.6%) and other health professionals (57.4%). Fifty-one percent of the participants reported more than five years of experience caring for people living with HIV. Forty-two percent of non-physician health care workers were nurses. Most reported high familiarity/comfort with PrEP-relevant activities. Concerns about PrEP were prevalent (> 50%) and included causing more harm than good, reducing condom use, medication non-adherence, drug resistance, and healthcare system barriers. Physicians had a plan to offer PrEP (72.2%) more often than other health professionals (52.6). Having a plan to offer PrEP was related to PrEP knowledge and comfort assessing sexual behavior and providing HIV counseling. Overall, about half of HIV-care providers seemed ready to offer PrEP and constitute an asset for PrEP implementation efforts in Colombia. PrEP awareness among non-physicians, PrEP concerns, and negative attitudes need to be addressed to enhance implementation.	[Martinez-Cajas, Jorge] Queens Univ, Dept Med, Kingston, ON, Canada; [Alvarado-Llano, Beatriz] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Martinez-Buitrago, Ernesto] Univ Valle, Hosp Univ Valle Evaristo Garcia, Unidad Epidemiol, Cali, Colombia; [Torres-Isasiga, Julian] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Torres-Isasiga, Julian] Montefiore Med Ctr, Div Infect Dis, 111 E 210th St, Bronx, NY 10467 USA; [Arrivillaga, Marcela] Pontificia Univ Javeriana, Cali, Colombia; [Camargo, Pilar] Queens Univ, Sch Nursing, Kingston, ON, Canada; [Galindo-Orrego, Ximena; Mueses-Marin, Hector] Corp Lucha SIDA, Cali, Colombia		Martinez-Cajas, J (corresponding author), Queens Univ, Dept Med, Kingston, ON, Canada.	jm209@queensu.ca	; Arrivillaga, Marcela/L-2786-2016	ALVARADO, BEATRIZ/0000-0002-1269-405X; Torres, Julian/0000-0001-6477-9867; Camargo-Plazas, Pilar/0000-0002-8349-7723; Galindo-Orrego, Ximena/0000-0003-0422-9200; Martinez-Cajas, Jorge Luis/0000-0003-2847-7823; Mueses-Marin, Hector Fabio/0000-0002-0608-6656; Arrivillaga, Marcela/0000-0001-5927-3386	Ministry of Science-Colombia [334780762872]	Ministry of Science-Colombia(Ministry of Health-Singapore)	This work was supported by grants from the Ministry of Science-Colombia (code: 334780762872).	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Blackstock OJ, 2017, J GEN INTERN MED, V32, P62, DOI 10.1007/s11606-016-3903-z; Cimen C, 2020, INT J STD AIDS, V31, P665, DOI 10.1177/0956462420921080; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; Desai M, 2016, HIV MED, V17, P133, DOI 10.1111/hiv.12285; Di Biagio A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181433; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Hayes R, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.41.1900598; Henderson JL, 2006, J CLIN CHILD ADOLESC, V35, P2, DOI 10.1207/s15374424jccp3501_1; Huijg JM, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-33; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Minsalud, 2019, ACT 01 2019 SES ORD, V28; Montana JF, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10196-y; OMS, 2017, HERR IMPL OMS PROF P; ONUSIDA, 2015, ESTR ONUSIDA 2016 20; OPS, 2019, OPS SECR SAL LANZ PL; Pleuhs B, 2020, AIDS PATIENT CARE ST, V34, P111, DOI 10.1089/apc.2019.0189; Plomer AS, 2020, AIDS CARE, V32, P994, DOI 10.1080/09540121.2020.1778626; Reyniers T, 2018, SEX HEALTH, V15, P606, DOI 10.1071/SH18072; Sánchez-Rubio Ferrández Javier, 2016, Farm Hosp., V40, P287, DOI 10.7399/fh.2016.40.4.10489; Sharma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105283; Sinno J, 2021, HIV AIDS-RES PALLIAT, V13, P157, DOI 10.2147/HIV.S287201; Tan DHS, 2017, CAN MED ASSOC J, V189, pE1448, DOI 10.1503/cmaj.170494; UNAIDS, 2018, COUNTR FACTSH COL 20; WHO, 2015, PREEX PROPH WHO EXP; World Health Organization, 2015, GUID START ANT THER	27	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0954-0121	1360-0451		AIDS CARE	Aids Care-Psychol. Socio-Med. Asp. Aids-Hiv												10.1080/09540121.2022.2029813	http://dx.doi.org/10.1080/09540121.2022.2029813		JAN 2022	7	Health Policy & Services; Public, Environmental & Occupational Health; Psychology, Multidisciplinary; Respiratory System; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychology; Respiratory System; Biomedical Social Sciences	YL4NE	35067114	hybrid			2022-09-04	WOS:000745868200001
J	Olaya-Galan, NN; Salas-Cardenas, SP; Rodriguez-Sarmiento, JL; Ibanez-Pinilla, M; Monroy, R; Corredor-Figueroa, AP; Rubiano, W; de la Pena, J; Shen, H; Buehring, GC; Patarroyo, MA; Gutierrez, MF				Olaya-Galan, Nury N.; Salas-Cardenas, Sandra P.; Rodriguez-Sarmiento, Jorge L.; Ibanez-Pinilla, Milciades; Monroy, Ricardo; Corredor-Figueroa, Adriana P.; Rubiano, Wilson; de la Pena, Jairo; Shen, HuaMin; Buehring, Gertrude C.; Patarroyo, Manuel A.; Gutierrez, Maria F.			Risk factor for breast cancer development under exposure to bovine leukemia virus in Colombian women: A case-control study	PLOS ONE			English	Article							DNA; SELECTION	Viruses have been implicated in cancer development in both humans and animals. The role of viruses in cancer is typically to initiate cellular transformation through cellular DNA damage, although specific mechanisms remain unknown. Silent and long-term viral infections need to be present, in order to initiate cancer disease. In efforts to establish a causative role of viruses, first is needed to demonstrate the strength and consistency of associations in different populations. The aim of this study was to determine the association of bovine leukemia virus (BLV), a causative agent of leukemia in cattle, with breast cancer and its biomarkers used as prognosis of the severity of the disease (Ki67, HER2, hormonal receptors) in Colombian women. An unmatched, observational case-control study was conducted among women undergoing breast surgery between 2016-2018. Malignant samples (n = 75) were considered as cases and benign samples (n = 83) as controls. Nested-liquid PCR, in-situ PCR and immunohistochemistry were used for viral detection in blood and breast tissues. For the risk assessment, only BLV positive samples from breast tissues were included in the analysis. BLV was higher in cases group (61.3%) compared with controls (48.2%), with a statistically significant association between the virus and breast cancer in the unconditional logistic regression (adjusted-OR = 2.450,95%CI:1.088-5.517, p = 0.031). In this study, BLV was found in both blood and breast tissues of participants and an association between breast cancer and the virus was confirmed in Colombia, as an intermediate risk factor.	[Olaya-Galan, Nury N.] Univ Rosario, PhD Program Biomed & Biol Sci, Bogota, Colombia; [Olaya-Galan, Nury N.; Salas-Cardenas, Sandra P.; Corredor-Figueroa, Adriana P.; Gutierrez, Maria F.] Pontificia Univ Javeriana, Dept Microbiol, Lab Virol, Grp Enfermedades Infecciosas, Bogota, Colombia; [Rodriguez-Sarmiento, Jorge L.] Pontificia Univ Javeriana, Dept Pathol, Hosp Univ San Ignacio, Bogota, Colombia; [Ibanez-Pinilla, Milciades; Monroy, Ricardo; Rubiano, Wilson; de la Pena, Jairo] Univ Rosario, Hosp Univ Mayor Mederi, Bogota, Colombia; [Shen, HuaMin; Buehring, Gertrude C.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Patarroyo, Manuel A.] Univ Nacl Colombia, Fac Med, Microbiol Dept, Bogota, Colombia; [Patarroyo, Manuel A.] Univ Santo Tomas, Hlth Sci Div, Main Campus, Bogota, Colombia		Olaya-Galan, NN (corresponding author), Univ Rosario, PhD Program Biomed & Biol Sci, Bogota, Colombia.; Olaya-Galan, NN (corresponding author), Pontificia Univ Javeriana, Dept Microbiol, Lab Virol, Grp Enfermedades Infecciosas, Bogota, Colombia.	nury.olaya@urosario.edu.co	Olaya-Galan, Nury-Nathalia/L-9782-2016	Olaya-Galan, Nury-Nathalia/0000-0002-4282-4951	DEPARTMENTO ADMINISTRATIVO DE CIENCIA, TECNOLOGIA E INNOVACION from Colombia [657/2014]; HOSPITAL UNIVERSITARIO MAYOR MEDERI - Universidad del Rosario, Bogota, Colombia by COLCIENCIAS; FULBRIGHT COLOMBIA	DEPARTMENTO ADMINISTRATIVO DE CIENCIA, TECNOLOGIA E INNOVACION from Colombia; HOSPITAL UNIVERSITARIO MAYOR MEDERI - Universidad del Rosario, Bogota, Colombia by COLCIENCIAS; FULBRIGHT COLOMBIA	This work was supported by the DEPARTMENTO ADMINISTRATIVO DE CIENCIA, TECNOLOGIA E INNOVACION (COLCIENCIAS -https://minciencias.gov.co/convocatorias), from Colombia, grant number 657/2014 in national calls for projects. Data analysis and statistical support was funded by HOSPITAL UNIVERSITARIO MAYOR MEDERI - Universidad del Rosario, Bogota, Colombia (https://www.mederi.com.co/hospital-universitario/investigacion.Grant for national doctorate programs was awarded to NOG by COLCIENCIAS (national call 647/2014) for the accomplishment of her PhD in Biological and Biomedical Sciences at Universidad del Rosario and grant by FULBRIGHT COLOMBIA (2017 - https://www.fulbright.edu.co/estudiante-doctoral-colombiano/) was also awarded to NOG as a visiting student researcher for partially fulfilling experiments (IN-PCR and IHC techniques) at UC Berkeley in the US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida Y, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00328; Al-Alem U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112916; Aluko R., 2012, MILK MILK PRODUCTS, P109; American Cancer Society, 2016, WHAT IS CANC, V1-62, DOI [10.1533/9780857097484.1.119, DOI 10.1002/9780470041000.CEDT005]; Armstrong CL, 2004, JOURNALISM MASS COMM, V81, P139, DOI 10.1177/107769900408100110; Bai LL, 2019, FASEB J, V33, P14516, DOI 10.1096/fj.201901528R; Barez PY, 2015, VIRUSES-BASEL, V7, P6080, DOI 10.3390/v7112929; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Buehring GC, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3891-9; Buehring GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179367; Buehring GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134304; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; Burrell CJ, 2017, FENNER WHITES MED VI, P121; Carioli G, 2018, BREAST, V37, P163, DOI 10.1016/j.breast.2017.12.004; Chang Y, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0264; Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406; Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145; De Paoli P, 2013, INT J CANCER, V133, P1517, DOI 10.1002/ijc.27995; Di Sibio A, 2016, CANCER EPIDEMIOL, V44, pS110, DOI 10.1016/j.canep.2016.08.010; Editorial-BoardWC of T, 2019, WHO CLASSIFICATION T; Egawa N, 2015, VIRUSES-BASEL, V7, P3863, DOI 10.3390/v7072802; Fitzgibbons PL, 2018, COLL AM PATHOLOGISTS, P1; Francies FZ, 2020, AM J CANCER RES, V10, P1568; Gaglia MM, 2018, CURR OPIN VIROL, V32, P48, DOI 10.1016/j.coviro.2018.09.003; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Gillet NA, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0308-3; Ginsburg O, 2018, CURR BREAST CANCER R, V10, P179, DOI 10.1007/s12609-018-0286-7; GIOVANNA M., 2013, OPEN J MED MICROBIOL, V3, P84, DOI [DOI 10.4236/OJMM.2013.31013, https://doi.org/10.4236/ojmm.2013.31013]; Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1; Hamada T, 2019, J PATHOL, V247, P615, DOI 10.1002/path.5236; Jimenez M, 2019, COMPLEXITY, DOI 10.1155/2019/9656938; Kamihira S, 2005, CLIN LAB HAEMATOL, V27, P235, DOI 10.1111/j.1365-2257.2005.00698.x; Khalilian M, 2019, MICROB PATHOGENESIS, V135, DOI 10.1016/j.micpath.2019.103566; Kundi M, 2006, ENVIRON HEALTH PERSP, V114, P969, DOI 10.1289/ehp.8297; Lawson JS, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00001; Lehrer S, 2019, DISCOV MED, V27, P163; Lendez P.A., 2018, MULTIDISCIP CANC INV, V2, P16, DOI 10.30699/acadpub.mci.4.16; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Murakami H, 2016, J GEN VIROL, V97, P2753, DOI 10.1099/jgv.0.000583; Niermann GL, 1997, VIROLOGY, V239, P249, DOI 10.1006/viro.1997.8868; NUOVO GJ, 1995, PCR METH APPL, V4, pS151; Olaya-Galan NN, 2017, EPIDEMIOL INFECT, V145, P3125, DOI [10.1017/S0950268817002229, 10.1017/s0950268817002229]; Ossa H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164414; Corredor AP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199397; Philpott SM, 1999, J NATL CANCER I, V91, P933, DOI 10.1093/jnci/91.11.933; Polat M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0876-4; Rakha EA, 2017, PATHOLOGY, V49, P111, DOI 10.1016/j.pathol.2016.10.012; Robinson LA, 2016, BRIT J CANCER, V115, P497, DOI 10.1038/bjc.2016.213; Salamat F, 2018, IRAN J MED SCI, V43, P355; Schwingel D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39834-7; Smith AJ, 2016, PROGR MOL BIOL TRANS, V1st; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; United Nations Food and Agriculture Organization (FAO), 2019, LIV PROD LAT AM CAR; Uribe A, 2006, ESTUDIO POTENCIAL ZO, P31; Vineis P, 2014, LANCET, V383, P549, DOI 10.1016/S0140-6736(13)62224-2; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Wu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05467-z; Zhang R, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0763-8; Zhao XR, 2007, VIROLOGY, V366, P150, DOI 10.1016/j.virol.2007.03.058; Zhong P, 2013, CURR OPIN VIROL, V3, P44, DOI 10.1016/j.coviro.2012.11.004	62	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257492	10.1371/journal.pone.0257492	http://dx.doi.org/10.1371/journal.pone.0257492			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547016	Green Published, gold			2022-09-04	WOS:000746527400013
J	Zhang, Y; Wang, Y; Kao, E; Florez-Valencia, L; Courbebaisse, G				Zhang, Yue; Wang, Yan; Kao, Evan; Florez-Valencia, Leonardo; Courbebaisse, Guy			Towards optimal flow diverter porosity for the treatment of intracranial aneurysm	JOURNAL OF BIOMECHANICS			English	Article						Intracranial aneurysm; Patient-specific geometry; Fully-resolved flow diverter stent; Lattice Boltzmann method; Blood flow simulation; Wall shear stress; Thrombosis	MECHANICAL-PROPERTIES; CURVED VESSELS; SEGMENTATION; THROMBUS; DEVICE; ARTERY; STENT; HEMODYNAMICS; SIMULATION; PREDICTION	Purpose: Low-porosity endovascular stents, known as flow diverters (FDs), have been proposed as an effective and minimally invasive treatment for sidewall intracranial aneurysms (IAs). Although it has been reported that the efficacy of a FD is substantially influenced by its porosity, clinical doctors would clearly prefer to do their interventions optimally based on refined quantitative data. This study focuses on the association between the porosity configurations and the FD efficacy, in order to provide practical data to help the clinical doctors optimize the interventions. Method: Numerical simulations in fluid dynamics were performed using four patient-specific IA geometries, pulsatile velocity profiles and braided fully resolved FDs. The variation of velocity and wall shear stress within the IAs, were investigated in this study. Lattice Boltzmann method (LBM) was used to solve the main challenge centered on the diversity of spatial scales since the typical diameter of struts of FDs is only 25 pm while the artery normally can be larger by a hundred times. Results: Numerical simulations revealed that the blood flow within IA sac was substantially reduced when the porosity is less than 86%. In particular, the flow condition within each IA sac is favorite to initialize thrombus formation when porosity is less than 70%. Conclusion: Our study suggests the existence of a porosity threshold below which the efficacy of a FD will be sufficient for the patients to initialize the thrombus formation. Therefore, by estimating the porosity of FD on patient-specific information, it may be potentially to predict whether or the blood flow condition will successfully become prothrombotic after the FD intervention. (C) 2018 Elsevier Ltd. All rights reserved.	[Zhang, Yue] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Wang, Yan; Kao, Evan] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Florez-Valencia, Leonardo] Pontificia Univ Javeriana, Bogot, Colombia; [Courbebaisse, Guy] Univ Claude Bernard Lyon 1, Univ Lyon, UJM St Etienne, INSA Lyon,CNRS,INSERM,CREATIS,UMR 5220,U1206, F-69621 Lyon, France		Wang, Y (corresponding author), Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA.	612ywnag@gmail.com	Flórez-Valencia, Leonardo/ABD-2236-2021; Flórez-Valencia, Leonardo/GPP-1063-2022; Courbebaisse, Guy/N-1732-2016; Courbebaisse, Guy/AGN-4327-2022	Flórez-Valencia, Leonardo/0000-0002-3146-2262; Courbebaisse, Guy/0000-0001-7753-1465; Courbebaisse, Guy/0000-0001-6181-2000; Zhang, Yue/0000-0003-3835-9409	European Commission via the Thrombus project [FP7-ICT-2009-6-269966]	European Commission via the Thrombus project	This paper has been partly funded by the European Commission via the Thrombus project FP7-ICT-2009-6-269966 (http://www.thrombus-vph.eu).	Arrese I, 2013, NEUROSURGERY, V73, P193, DOI 10.1227/01.neu.0000430297.17961.f1; Augsburger L, 2009, CLIN NEURORADIOL, V19, P204, DOI 10.1007/s00062-009-9005-0; Berg P, 2018, INT J ARTIF ORGANS; Berge J, 2012, AM J NEURORADIOL, V33, P1150, DOI 10.3174/ajnr.A2907; Chan TE, 2000, J VIS COMMUN IMAGE R, V11, P130, DOI 10.1006/jvci.1999.0442; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; Chen Y, 2014, MED IMAGE ANAL, V18, P1, DOI 10.1016/j.media.2013.08.003; Cito S, 2015, ANN BIOMED ENG, V43, P154, DOI 10.1007/s10439-014-1082-9; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eker OF, 2015, J CEREBR BLOOD F MET, V35, P2070, DOI 10.1038/jcbfm.2015.176; Florez-Valencia L, 2017, ELS MIC SOC BOOK SER, P131, DOI 10.1016/B978-0-12-811018-8.00006-0; Florez-Valencia L., 2012, MICCAI STENT 12 1 IN, P49; He X, 2009, COMPUT FLUIDS, V38, P789, DOI 10.1016/j.compfluid.2008.07.006; Hong B, 2012, NEURORADIOLOGY, V54, P849, DOI 10.1007/s00234-011-0984-6; Kallmes DF, 2007, STROKE, V38, P2346, DOI 10.1161/STROKEAHA.106.479576; Kim YH, 2010, ANN BIOMED ENG, V38, P2274, DOI 10.1007/s10439-010-9994-5; Larrabide I, 2014, J NEUROINTERVENT SUR, V2014; Li S, 2018, COMPUT FLUIDS; Lubicz B, 2010, STROKE, V41, P2247, DOI 10.1161/STROKEAHA.110.589911; Ma JY, 2014, ANN BIOMED ENG, V42, P960, DOI 10.1007/s10439-013-0967-3; Malaspinas O, 2016, J THEOR BIOL, V394, P68, DOI 10.1016/j.jtbi.2015.12.022; Malaspinas O, 2007, INT J MOD PHYS C, V18, P1939, DOI 10.1142/S0129183107011832; Meng H, 2006, AM J NEURORADIOL, V27, P1861; Murthy SB, 2014, J CLIN NEUROSCI, V21, P6, DOI 10.1016/j.jocn.2013.03.014; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Noel R, 2017, EUR SIGNAL PR CONF, P2654, DOI 10.23919/EUSIPCO.2017.8081692; Nourgaliev RR, 2003, INT J MULTIPHAS FLOW, V29, P117, DOI 10.1016/S0301-9322(02)00108-8; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rayz VL, 2008, ANN BIOMED ENG, V36, P1793, DOI 10.1007/s10439-008-9561-5; Sforza DM, 2009, ANNU REV FLUID MECH, V41, P91, DOI 10.1146/annurev.fluid.40.111406.102126; Shapiro M, 2014, AM J NEURORADIOL, V35, P727, DOI 10.3174/ajnr.A3742; Steiger H.-J, 1990, ACTA NEUROCHIR S; Succi S., 2001, LATTICE BOLTZMANN FL; Suzuki T, 2017, TECHNOL HEALTH CARE, V25, P611, DOI 10.3233/THC-160535; Wang Y, 2017, COMPUT SCI ENG, V19, P56, DOI 10.1109/MCSE.2017.3151252; Wang Y, 2017, MED IMAGE ANAL, V40, P1, DOI 10.1016/j.media.2017.05.005; Wang Y, 2016, MED PHYS, V43, P1777, DOI 10.1118/1.4943375; Wang Z, 2014, ANAL CAROTID WALL ME; Wang ZJ, 2015, INT J NUMER METH BIO, V31, DOI 10.1002/cnm.2709; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Zhang MZ, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0257-z; Zhang Y., 2015, THESIS	42	11	12	3	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JAN 3	2019	82						20	27		10.1016/j.jbiomech.2018.10.002	http://dx.doi.org/10.1016/j.jbiomech.2018.10.002			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	HI3MG	30381156				2022-09-04	WOS:000456353700002
J	Lujan, JV; Zacharias, N; Rakheja, D; Bhagat, TD; Lee, J; Dutta, P; Gonzalez, D; Andreeff, M; Bhattacharya, PK; Verma, A; Konopleva, M				Lujan, Juliana Velez; Zacharias, Niki; Rakheja, Dinesh; Bhagat, Tushar D.; Lee, Jaehyuk; Dutta, Prasanta; Gonzalez, Doriann; Andreeff, Michael; Bhattacharya, Pratip K.; Verma, Amit; Konopleva, Marina			Role of Glutamine in Metabolic and Epigenetic Reprogramming in AML	BLOOD			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Hematology	DEC 05-08, 2015	Orlando, FL	Amer Soc Hematol					[Lujan, Juliana Velez; Andreeff, Michael; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Lujan, Juliana Velez] Programa Integral Invest & Innovac Leucemia Aguda, Bogota, Colombia; [Lujan, Juliana Velez] Pontificia Univ Javeriana, Dept Biochem, Bogota, Colombia; [Zacharias, Niki; Lee, Jaehyuk; Dutta, Prasanta; Bhattacharya, Pratip K.] Univ Texas MD Anderson Canc Ctr, Div Diagnost Imaging, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Rakheja, Dinesh] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Rakheja, Dinesh] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Bhagat, Tushar D.; Verma, Amit] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Bhagat, Tushar D.; Verma, Amit] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Gonzalez, Doriann] Univ Puerto Rico, Sch Med, Puerto Rico, PR USA										0	1	1	0	1	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	DEC 3	2015	126	23												3	Hematology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Hematology	DA7XY					2022-09-04	WOS:000368020102071
J	Cabezas, R; Avila, M; Gonzalez, J; El-Bacha, RS; Baez, E; Garcia-Segura, LM; Coronel, JCJ; Capani, F; Cardona-Gomez, GP; Barreto, GE				Cabezas, Ricardo; Avila, Marcos; Gonzalez, Janneth; El-Bacha, Ramon Santos; Baez, Eliana; Miguel Garcia-Segura, Luis; Jurado Coronel, Juan Camilo; Capani, Francisco; Patricia Cardona-Gomez, Gloria; Barreto, George E.			Astrocytic modulation of blood brain barrier: perspectives on parkinson's disease	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Review						BBB; astrocytes; reactive astrogliosis; endothelial cells; Parkinson disease	SUPEROXIDE-DISMUTASE ACTIVITY; FIBROBLAST GROWTH-FACTORS; P-GLYCOPROTEIN FUNCTION; CELL-CELL JUNCTIONS; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; NEUROTROPHIC FACTORS; SUBSTANTIA-NIGRA; L-DOPA; PERICYTES	The blood-brain barrier (BBB) is a tightly regulated interface in the Central Nervous System (CNS) that regulates the exchange of molecules in and out from the brain thus maintaining the CNS homeostasis. It is mainly composed of endothelial cells (ECs), pericytes and astrocytes that create a neurovascular unit (NVU) with the adjacent neurons. Astrocytes are essential for the formation and maintenance of the BBB by providing secreted factors that lead to the adequate association between the cells of the BBB and the formation of strong tight junctions. Under neurological disorders, such as chronic cerebral ischemia, brain trauma, Epilepsy, Alzheimer and Parkinson's Diseases, a disruption of the BBB takes place, involving a lost in the permeability of the barrier and phenotypical changes in both the ECs and astrocytes. In this aspect, it has been established that the process of reactive gliosis is a common feature of astrocytes during BBB disruption, which has a detrimental effect on the barrier function and a subsequent damage in neuronal survival. In this review we discuss the implications of astrocyte functions in the protection of the BBB, and in the development of Parkinson's disease (PD) and related disorders. Additionally, we highlight the current and future strategies in astrocyte protection aimed at the development of the current and future stategies in astrocyte protection aimed at the development of restorative therapies for the BBB in pathological conditions.	[Cabezas, Ricardo; Avila, Marcos; Gonzalez, Janneth; Baez, Eliana; Jurado Coronel, Juan Camilo; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [El-Bacha, Ramon Santos] Univ Fed Bahia, Dept Biofuncao, Salvador, BA, Brazil; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Capani, Francisco] UBA CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Fac Med, Lab Citoarquitectura & Plasticidad Neuronal, Buenos Aires, DF, Argentina; [Patricia Cardona-Gomez, Gloria] Univ Antioquia UdeA, SIU, Fac Med, Cellular & Mol Neurobiol Area,Grp Neurosci Antioq, Medellin, Colombia		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Edf Carlos Ortiz,Oficina 107,Cra 7 40-62, Bogota, DC, Colombia.	gsampaio@javeriana.edu.co	El-Bachá, Ramon S/C-4889-2013; Barreto, George E./AAD-7420-2020; Barreto, George E./B-5747-2014; capani, Francisco/D-9781-2016; Garcia-Segura, Luis M/U-3711-2017; Cardona-Gomez, Gloria Patricia/D-8100-2016; GONZALEZ, JANNETH/AAB-9948-2020	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Garcia-Segura, Luis M/0000-0002-2450-2916; Cardona-Gomez, Gloria Patricia/0000-0002-3814-4494; GONZALEZ, JANNETH/0000-0003-4482-256X; Jurado, Juan/0000-0003-4167-8726; El-Bacha, Ramon/0000-0002-3321-0392	PUJ [4327, 4367]	PUJ	This work was supported in part by grants PUJ IDs 4327 and 4367 to George E. Barreto and Colciencias (convocatoria 528) to Ricardo Cabezas.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Agarwal R, 1999, NEUROCHEM RES, V24, P1507, DOI 10.1023/A:1021191729865; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Anderson CM, 2000, GLIA, V32, P1; Annese V, 2015, BRAIN STRUCT FUNCT, V220, P703, DOI 10.1007/s00429-014-0718-8; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bambrick L, 2004, NEUROCHEM RES, V29, P601, DOI 10.1023/B:NERE.0000014830.06376.e6; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bartels AL, 2008, J NEURAL TRANSM, V115, P1001, DOI 10.1007/s00702-008-0030-y; Bartels AL, 2011, CURR PHARM DESIGN, V17, P2771, DOI 10.2174/138161211797440122; Baxendale SA, 1998, NEUROPSY NEUROPSY BE, V11, P12; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Blackburn D, 2009, GLIA, V57, P1251, DOI 10.1002/glia.20848; Bonkowski D, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-8; Botella JA, 2008, NEUROBIOL DIS, V30, P65, DOI 10.1016/j.nbd.2007.11.013; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Bradaric BD, 2012, J NEURAL TRANSM, V119, P59, DOI 10.1007/s00702-011-0684-8; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Carvey PM, 2005, EUR J NEUROSCI, V22, P1158, DOI 10.1111/j.1460-9568.2005.04281.x; Castejon OJ, 2011, FOLIA NEUROPATHOL, V49, P162; Chen XS, 2008, J NEUROCHEM, V107, P1147, DOI 10.1111/j.1471-4159.2008.05697.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chinta SJ, 2008, BBA-GEN SUBJECTS, V1780, P1362, DOI 10.1016/j.bbagen.2008.02.005; Colangelo AM, 2014, NEUROSCI LETT, V565, P59, DOI 10.1016/j.neulet.2014.01.014; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; de Oliveira DM, 2011, HUM EXP TOXICOL, V30, P1382, DOI 10.1177/0960327110389837; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; del Zoppo GJ, 2006, ARTERIOSCL THROM VAS, V26, P1966, DOI 10.1161/01.ATV.0000232525.65682.a2; Dickson DW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009258; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935, DOI 10.1093/jnen/61.11.935; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Dore-Duffy P, 2011, METHODS MOL BIOL, V686, P49, DOI 10.1007/978-1-60761-938-3_2; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; ElAli A, 2014, INT J MOL SCI, V15, P6453, DOI 10.3390/ijms15046453; Enciu AM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/316495; Cespedes AE, 2013, BIOMEDICA, V33, P292, DOI 10.7705/biomedica.v33i2.830; Fernandez HH, 2012, CLEV CLIN J MED, V79, P28, DOI 10.3949/ccjm.78gr.11005; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fukui K, 2001, ANN NY ACAD SCI, V928, P168; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Giordano G, 2009, NEUROTOXICOLOGY, V30, P326, DOI 10.1016/j.neuro.2008.12.009; Grammas P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001918; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Hauser RA, 2011, INT J NEUROSCI, V121, P53, DOI 10.3109/00207454.2011.620195; Haussermann P, 2001, NEUROSCI LETT, V300, P182, DOI 10.1016/S0304-3940(01)01574-9; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hirano S, 2008, J NEUROSCI, V28, P4201, DOI 10.1523/JNEUROSCI.0582-08.2008; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Hurtado-Alvarado G, 2014, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00080; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jangula A, 2013, NEUROSCI LETT, V551, P23, DOI 10.1016/j.neulet.2013.06.058; Jankovic J, 2012, CURR OPIN NEUROL, V25, P433, DOI 10.1097/WCO.0b013e3283542fc2; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kim GW, 2003, J NEUROSCI, V23, P8733; Kim GW, 2001, NEUROSCIENCE, V105, P1007, DOI 10.1016/S0306-4522(01)00237-8; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kondo T, 1997, J NEUROSCI, V17, P4180; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; Lange S, 2013, DRUG DISCOV TODAY, V18, P456, DOI 10.1016/j.drudis.2012.12.007; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lee H, 2014, FRONT BIOSCI-LANDMRK, V19, P272, DOI 10.2741/4206; Lee SJ, 2009, ARCH GERONTOL GERIAT, V49, P255, DOI 10.1016/j.archger.2008.09.005; Lin JL, 2010, J CEREBR BLOOD F MET, V30, P1121, DOI 10.1038/jcbfm.2009.277; Lindenau J, 2000, GLIA, V29, P25, DOI 10.1002/(SICI)1098-1136(20000101)29:1<25::AID-GLIA3>3.0.CO;2-G; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Mokgokong R, 2014, PFLUG ARCH EUR J PHY, V466, P887, DOI 10.1007/s00424-013-1342-9; Mythri RB, 2011, NEUROCHEM RES, V36, P1452, DOI 10.1007/s11064-011-0471-9; Nag S, 2011, METHODS MOL BIOL, V686, P69, DOI 10.1007/978-1-60761-938-3_3; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-142; Niranjan R, 2010, FREE RADICAL RES, V44, P1304, DOI 10.3109/10715762.2010.501080; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Ogawa N, 2005, J NEUROL, V252, P23, DOI 10.1007/s00415-005-4006-7; Ohlin KE, 2011, BRAIN, V134, P2339, DOI 10.1093/brain/awr165; Ossig C, 2013, J NEURAL TRANSM, V120, P523, DOI 10.1007/s00702-013-1008-y; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Pang Y, 2010, PEDIATR RES, V67, P579, DOI 10.1203/PDR.0b013e3181dc240f; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Parpura V, 2011, BBA-MOL CELL RES, V1813, P984, DOI 10.1016/j.bbamcr.2010.11.006; Peterson AL, 2008, NEUROTHERAPEUTICS, V5, P270, DOI 10.1016/j.nurt.2008.02.003; Pilakka-Kanthikeel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062241; Popescu BO, 2009, J NEUROL SCI, V283, P99, DOI 10.1016/j.jns.2009.02.321; Price TO, 2012, ENDOCRINOLOGY, V153, P362, DOI 10.1210/en.2011-1638; Proschel C, 2014, EMBO MOL MED, V6, P504, DOI 10.1002/emmm.201302878; Radunovic A, 1997, NEUROSCI LETT, V239, P105, DOI 10.1016/S0304-3940(97)00905-1; Ramaswamy S, 2009, PARKINSONISM RELAT D, V15, pS176, DOI 10.1016/S1353-8020(09)70809-0; Rappold PM, 2010, NEUROTHERAPEUTICS, V7, P413, DOI 10.1016/j.nurt.2010.07.001; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Sa-Pereira I, 2012, MOL NEUROBIOL, V45, P327, DOI 10.1007/s12035-012-8244-2; Safi R, 2012, J MOL NEUROSCI, V46, P654, DOI 10.1007/s12031-011-9654-8; Samantaray S, 2007, NEUROSCIENCE, V146, P741, DOI 10.1016/j.neuroscience.2007.01.056; Sano Y, 2007, CELL STRUCT FUNCT, V32, P139, DOI 10.1247/csf.07015; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Schwartz M, 2012, ISR MED ASSOC J, V14, P175; SHUKLA A, 1993, FREE RADICAL BIO MED, V15, P97, DOI 10.1016/0891-5849(93)90128-H; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sims NR, 2004, J BIOENERG BIOMEMBR, V36, P329, DOI 10.1023/B:JOBB.0000041763.63958.e7; Singer Carlos, 2012, Cleve Clin J Med, V79 Suppl 2, pS3, DOI 10.3949/ccjm.79.s2a.01; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Smeyne M, 2013, FREE RADICAL BIO MED, V62, P13, DOI 10.1016/j.freeradbiomed.2013.05.001; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Sugaya K, 1998, MOL BRAIN RES, V58, P1, DOI 10.1016/S0169-328X(97)00365-3; Sullivan AM, 2011, CYTOKINE GROWTH F R, V22, P157, DOI 10.1016/j.cytogfr.2011.05.001; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Theis M, 2005, TRENDS NEUROSCI, V28, P188, DOI 10.1016/j.tins.2005.02.006; Timmer M, 2004, EXP NEUROL, V187, P118, DOI 10.1016/j.expneurol.2004.01.013; van Sorge NM, 2012, FUTURE MICROBIOL, V7, P383, DOI [10.2217/FMB.12.1, 10.2217/fmb.12.1]; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wada K, 2006, NEUROREPORT, V17, P705, DOI 10.1097/01.wnr.0000215769.71657.65; Wang HL, 2011, BBA-MOL BASIS DIS, V1812, P674, DOI 10.1016/j.bbadis.2011.03.007; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Yasuda T, 2010, EXPERT REV NEUROTHER, V10, P915, DOI [10.1586/ern.10.55, 10.1586/ERN.10.55]; Zechariah A, 2013, STROKE, V44, P1690, DOI 10.1161/STROKEAHA.111.000240; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	143	225	229	5	79	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	AUG 4	2014	8								211	10.3389/fncel.2014.00211	http://dx.doi.org/10.3389/fncel.2014.00211			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM5XS	25136294	Green Published, gold			2022-09-04	WOS:000339935000001
J	Cardona, AF; Balana, C; Torres, D; Becerra, H; Ortiz, LD; Fadul, CE				Felipe Cardona, Andres; Balana, Carmen; Torres, Diana; Becerra, Henry; Dario Ortiz, Leon; Fadul, Camilo E.			Stem Cells in Brain Tumorigenesis and their Impact on Therapy	CURRENT STEM CELL RESEARCH & THERAPY			English	Review						Brain tumor; glioma; stem cells; tumorigenesis; neurogenesis; development; genetics; molecular biology; central nervous system neoplasms; medulloblastoma	CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; GLIOMA-CELLS; PERIVASCULAR NICHE; TUMOR VASCULATURE; PROGENITOR CELLS; BETA-CATENIN; CANCER; GLIOBLASTOMA; NOTCH	The concept that the genesis of new cells in the adult mammalian brain is negligible has long influenced our perception and understanding of the origin and development of central nervous system (CNS) tumors. The discovery that neurons and glia are produced throughout life from neural stem cells provides new possibilities for candidate precursor cells of CNS neoplasms. The emerging hypothesis is that alterations in the cellular and genetic mechanisms that control adult neurogenesis might contribute to brain tumorigenesis. As such, opportunities become available to identify new therapeutic strategies.	[Felipe Cardona, Andres; Becerra, Henry] Fdn Santa Fe Bogota, Clin & Translat Oncol Grp, Inst Oncol, Bogota, Colombia; [Felipe Cardona, Andres; Becerra, Henry; Dario Ortiz, Leon; Fadul, Camilo E.] Hosp Badalona Germans Trias & Pujol, RedLANO ONCOLGrp, Barcelona, Spain; [Balana, Carmen] Hosp Badalona Germans Trias & Pujol, Dept Med Oncol, Neurooncol Serv, Catalan Inst Oncol, Barcelona, Spain; [Torres, Diana] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Mol Biol, Bogota, Colombia; [Dario Ortiz, Leon] Clin Amer, Inst Oncol, Neurooncol Grp, Medellin, Colombia; [Fadul, Camilo E.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Hematol Oncol Sect, Neurooncol Program, Lebanon, NH 03766 USA		Cardona, AF (corresponding author), Fdn Santa Fe Bogota, Clin & Translat Oncol Grp, Inst Oncol, Calle 119 7-75, Bogota, Colombia.	a_cardonaz@yahoo.com	Balana, Carmen/A-6828-2012	Torres-Lopez, Diana Maria/0000-0002-9879-9775; Cardona, Andres/0000-0003-3525-4126; Balana, Carmen/0000-0003-0771-0390				Abouantoun TJ, 2009, MOL CANCER THER, V5, P1; [Anonymous], CBTRUS 2000 2004 DAT; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Batchelor T, 2007, J CLIN ONCOL, V25; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Beier D, 2008, BRAIN PATHOL, V18, P370, DOI 10.1111/j.1750-3639.2008.00130.x; Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Bi Chang-Long, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P568; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Castellino RC, 2009, CURR PHARM DESIGN, V15, P380, DOI 10.2174/138161209787315873; Chearwae W, 2008, BRIT J CANCER, V99, P2044, DOI 10.1038/sj.bjc.6604786; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Clifford SC, 2006, CELL CYCLE, V5, P2666, DOI 10.4161/cc.5.22.3446; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dakubo GD, 2006, J NEURO-ONCOL, V79, P221, DOI 10.1007/s11060-006-9132-2; Dell'Albani P, 2008, NEUROCHEM RES, V33, P2407, DOI 10.1007/s11064-008-9723-8; Di Tomaso T, 2010, CLIN CANCER RES, V16, P800, DOI 10.1158/1078-0432.CCR-09-2730; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dresemann G, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.2048; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Ferrari-Toninelli G, 2010, NEURO-ONCOLOGY, V12, P1231, DOI 10.1093/neuonc/noq101; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Gilbert Mark R, 2007, Curr Oncol Rep, V9, P49, DOI 10.1007/BF02951425; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Gu HY, 2002, BRAIN RES, V943, P174, DOI 10.1016/S0006-8993(02)02615-X; Guerrero-Cazares H, 2009, METHODS MOL BIOL, V568, P73, DOI 10.1007/978-1-59745-280-9_6; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Jin F, 2010, BRAIN RES, V1336, P103, DOI 10.1016/j.brainres.2010.04.005; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; Kast RE, 2009, CURR STEM CELL RES T, V4, P314, DOI 10.2174/157488809789649241; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Knizetova P, 2008, J CELL MOL MED, V12, P111, DOI 10.1111/j.1582-4934.2007.00153.x; Koch A, 2007, INT J CANCER, V121, P284, DOI 10.1002/ijc.22675; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee Y, 2003, CANCER RES, V63, P5428; Leon SP, 1996, CANCER-AM CANCER SOC, V77, P362, DOI 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Loges S, 2007, BIOCHEM BIOPH RES CO, V357, P1016, DOI 10.1016/j.bbrc.2007.04.060; Lu JR, 2008, J NEURO-ONCOL, V87, P271, DOI 10.1007/s11060-008-9518-4; Massard C, 2006, ANN ONCOL, V17, P1620, DOI 10.1093/annonc/mdl074; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nam DH, 2004, ONCOL REP, V11, P863; Nicolis SK, 2007, NEUROBIOL DIS, V25, P217, DOI 10.1016/j.nbd.2006.08.022; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; RIES LAG, 2006, SEER CANC STAT REV 1; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sasai K, 2007, CANCER RES, V67, P3871, DOI 10.1158/0008-5472.CAN-07-0493; Sauvageot CME, 2009, NEURO-ONCOLOGY, V11, P109, DOI 10.1215/15228517-2008-060; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schimmer AD, 2004, CANCER RES, V64, P7183, DOI 10.1158/0008-5472.CAN-04-1918; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Shaifer CA, 2010, INT J CANCER, V127, P2063, DOI 10.1002/ijc.25249; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Spiller SE, 2008, J NEURO-ONCOL, V87, P133, DOI 10.1007/s11060-007-9505-1; Spira AI, 2003, CURR OPIN PHARMACOL, V3, P338, DOI 10.1016/S1471-4892(03)00081-X; Stupp R, 2008, ANN ONCOL, V19, P83, DOI 10.1093/annonc/mdn099; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2010, J CLIN ONCOL, V28, P2712, DOI 10.1200/JCO.2009.26.6650; Tabatabai G, 2010, TARGET ONCOL, V5, P175, DOI 10.1007/s11523-010-0156-3; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572; Xu QJ, 2009, STEM CELLS, V27, P1734, DOI 10.1002/stem.102; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Zhang MY, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-85; Zhang XP, 2008, MOL CELL BIOCHEM, V307, P101, DOI 10.1007/s11010-007-9589-0; ZHENJU J, 2006, EUR J CANCER, V42, P1197	108	2	2	0	7	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1574-888X	2212-3946		CURR STEM CELL RES T	Curr. Stem Cell Res. Ther.	DEC	2011	6	4					339	349						11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	910MB	21466481				2022-09-04	WOS:000301640300004
J	Bencardino, JT; Uriza-Carrasco, LF; Beltran, J; Jaramillo, D				Bencardino, Jenny T.; Uriza-Carrasco, Luis F.; Beltran, Javier; Jaramillo, Diego			International skeletal society outreach in Colombia	SKELETAL RADIOLOGY			English	Editorial Material									[Bencardino, Jenny T.] NYU, Hosp Joint Dis, Dept Radiol, New York, NY 10003 USA; [Uriza-Carrasco, Luis F.] Pontificia Univ Javeriana, Hosp San Ignacio, Dept Radiol, Bogota, Colombia; [Beltran, Javier] Maimonides Hosp, Dept Radiol, Brooklyn, NY 11219 USA; [Jaramillo, Diego] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA		Bencardino, JT (corresponding author), NYU, Hosp Joint Dis, Dept Radiol, 301 E 17th St, New York, NY 10003 USA.	jenny.bencardino@nyumc.org		Uriza Carrasco, Luis Felipe/0000-0002-1923-3934				ARENSON RL, 2010, INT MED GRADUATES AB; BOURGOIS JM, 2007, WORLD BOOK CAPITAL C; FUCHS WA, 1991, INVEST RADIOL, V26, P906, DOI 10.1097/00004424-199110000-00016; *RAD SOC N AM, 2010, LAT AM RAD HARN POW; RINCON C, 2003, REV HARVARD REV  SPR; Ruiz F, 2007, HEALTH ECON, V16, P3, DOI 10.1002/hec.1147; *WHO, 2010, COL NAT EXP HLTH; *WHO STAT INF SYST, 2001, COUNTR HLTH PROF	8	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2348			SKELETAL RADIOL	Skeletal Radiol.	OCT	2011	40	10					1245	1247		10.1007/s00256-011-1136-0	http://dx.doi.org/10.1007/s00256-011-1136-0			3	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	813DH	21384197	Bronze			2022-09-04	WOS:000294346500001
J	Colorado, JD; Calderon, F; Mendez, D; Petro, E; Rojas, JP; Correa, ES; Mondragon, IF; Rebolledo, MC; Jaramillo-Botero, A				Colorado, Julian D.; Calderon, Francisco; Mendez, Diego; Petro, Eliel; Rojas, Juan P.; Correa, Edgar S.; Mondragon, Ivan F.; Rebolledo, Maria Camila; Jaramillo-Botero, Andres			A novel NIR-image segmentation method for the precise estimation of above-ground biomass in rice crops	PLOS ONE			English	Article							VEGETATION INDEXES; GRAIN-YIELD; SYSTEM	Traditional methods to measure spatio-temporal variations in biomass rely on a labor-intensive destructive sampling of the crop. In this paper, we present a high-throughput phenotyping approach for the estimation of Above-Ground Biomass Dynamics (AGBD) using an unmanned aerial system. Multispectral imagery was acquired and processed by using the proposed segmentation method called GFKuts, that optimally labels the plot canopy based on a Gaussian mixture model, a Montecarlo based K-means, and a guided image filtering. Accurate plot segmentation results enabled the extraction of several canopy features associated with biomass yield. Machine learning algorithms were trained to estimate the AGBD according to the growth stages of the crop and the physiological response of two rice genotypes under lowland and upland production systems. Results report AGBD estimation correlations with an average ofr= 0.95 andR(2)= 0.91 according to the experimental data. We compared our segmentation method against a traditional technique based on clustering. A comprehensive improvement of 13% in the biomass correlation was obtained thanks to the segmentation method proposed herein.	[Colorado, Julian D.; Calderon, Francisco; Mendez, Diego; Rojas, Juan P.; Correa, Edgar S.; Mondragon, Ivan F.] Pontificia Univ Javeriana Bogota, Sch Engn, Bogota, Colombia; [Petro, Eliel; Rebolledo, Maria Camila] Int Ctr Trop Agr CIAT, Palmira, Colombia; [Rojas, Juan P.] Univ Montpellier, LIRMM ICAR, I2S, INRAE AFEF, Montpellier, France; [Rebolledo, Maria Camila] CIRAD, AGAP Pam, Montpellier, France; [Jaramillo-Botero, Andres] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Jaramillo-Botero, Andres] Pontificia Univ Javeriana Cali, Elect Engn & Comp Sci Dept, Bogota, Colombia		Colorado, JD (corresponding author), Pontificia Univ Javeriana Bogota, Sch Engn, Bogota, Colombia.	coloradoj@javeriana.edu.co	rebolledo, maria/AAQ-4981-2021	Colorado M., Julian/0000-0002-6925-0126; Correa Pinzon, Edgar Steven/0000-0002-1477-6825; Calderon Bocanegra, Francisco Carlos/0000-0001-8681-415X; Mendez, Diego/0000-0002-9866-4416; Jaramillo-Botero, Andres/0000-0003-2844-0756; Petro Paez, Eliel E./0000-0002-0577-6532	Optimizacion Multiescala In-silico de Cultivos Agri'colas Sostenibles (OMICAS) program (Infraestructura y validacion en Arroz y Cana de Azucar); Colombian Scientific Ecosystem by The World Bank; Colombian Ministry of Science, Technology and Innovation; Colombian Ministry of Education; Colombian Ministry of Industry and Turism; ICETEX [FP44842-217-2018]	Optimizacion Multiescala In-silico de Cultivos Agri'colas Sostenibles (OMICAS) program (Infraestructura y validacion en Arroz y Cana de Azucar); Colombian Scientific Ecosystem by The World Bank; Colombian Ministry of Science, Technology and Innovation; Colombian Ministry of Education; Colombian Ministry of Industry and Turism; ICETEX	This study was funded by the Optimizacion Multiescala In-silico de Cultivos Agri ' colas Sostenibles (OMICAS) program (Infraestructura y validacion en Arroz y Cana de Azucar), anchored at the Pontificia Universidad Javeriana in Cali and funded within the Colombian Scientific Ecosystem by The World Bank, the Colombian Ministry of Science, Technology and Innovation, the Colombian Ministry of Education and the Colombian Ministry of Industry and Turism, and ICETEX, in the form of a grant awarded to AJB and JC (FP44842-217-2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas F, 2020, AGRONOMY-BASEL, V10, P1046, DOI 10.3390/agronomy10071046; Arroyo JA, 2017, 2017 IEEE MEXICAN HUMANITARIAN TECHNOLOGY CONFERENCE (MHTC), P137, DOI 10.1109/MHTC.2017.8006410; [Anonymous], 2018, VOX             0919; Bendig J, 2013, PHOTOGRAMM FERNERKUN, P551, DOI 10.1127/1432-8364/2013/0200; Boykov YY, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P105, DOI 10.1109/ICCV.2001.937505; Caflisch R. E., 1998, Acta Numerica, V7, P1, DOI 10.1017/S0962492900002804; Caruso G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210804; Cen HY, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0418-8; Devia CA, 2019, J INTELL ROBOT SYST, V96, P573, DOI 10.1007/s10846-019-01001-5; Dyson J, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11161859; Feng LW, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12122028; Ganesan P., 2014, ADV EL ENG ICAEE 201, P1, DOI [DOI 10.1109/ICAEE.2014.6838440, 10.1109/ICAEE.2014.6838441]; Gnyp ML, 2014, FIELD CROP RES, V155, P42, DOI 10.1016/j.fcr.2013.09.023; Han L, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0394-z; He KM, 2010, LECT NOTES COMPUT SC, V6311, P1; Kandwal R., 2014, INT J ADV RES COMPUT, V4; Kanke Y, 2016, PRECIS AGRIC, V17, P507, DOI 10.1007/s11119-016-9433-1; Li H, 2015, REMOTE SENS ENVIRON, V169, P358, DOI 10.1016/j.rse.2015.08.021; Liu Gui-Fu, 2006, Acta Genetica Sinica, V33, P607, DOI 10.1016/S0379-4172(06)60090-5; Liu XJ, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040672; Ma X, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215676; Maimaitijiang M, 2019, ISPRS J PHOTOGRAMM, V151, P27, DOI 10.1016/j.isprsjprs.2019.03.003; Matsubara K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206054; Naito H, 2017, ISPRS J PHOTOGRAMM, V125, P50, DOI 10.1016/j.isprsjprs.2017.01.010; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Prabhakara K, 2015, INT J APPL EARTH OBS, V39, P88, DOI 10.1016/j.jag.2015.03.002; Rother C, 2004, ACM T GRAPHIC, V23, P309, DOI 10.1145/1015706.1015720; Sa I, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10091423; Schirrmann M, 2016, COMPUT ELECTRON AGR, V121, P374, DOI 10.1016/j.compag.2016.01.007; Shen X, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11070800; Siddiqui FU, 2011, IEEE T CONSUM ELECTR, V57, P833, DOI 10.1109/TCE.2011.5955230; Sun SP, 2020, ISPRS J PHOTOGRAMM, V160, P195, DOI 10.1016/j.isprsjprs.2019.12.011; TERZOPOULOS D, 1986, IEEE T PATTERN ANAL, V8, P413, DOI 10.1109/TPAMI.1986.4767807; Tilly N, 2015, REMOTE SENS-BASEL, V7, P11449, DOI 10.3390/rs70911449; Wan L, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10091484; Wang C, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9010011; Wang YM, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12081232; Yang G, 2017, UNMANNED AERIAL VEHI; Yang SX, 2018, REMOTE SENS ENVIRON, V204, P448, DOI 10.1016/j.rse.2017.10.011; Yang ZL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173627; Yue JB, 2019, ISPRS J PHOTOGRAMM, V150, P226, DOI 10.1016/j.isprsjprs.2019.02.022; Zhang K, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11040387; Zhou X, 2017, ISPRS J PHOTOGRAMM, V130, P246, DOI 10.1016/j.isprsjprs.2017.05.003	43	6	6	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2020	15	10							e0239591	10.1371/journal.pone.0239591	http://dx.doi.org/10.1371/journal.pone.0239591			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OB4VZ	33017406	Green Published, gold, Green Accepted			2022-09-04	WOS:000578470500028
J	Anderson, EP; Osborne, T; Maldonado-Ocampo, JA; Mills-Novoa, M; Castello, L; Montoya, M; Encalada, AC; Jenkins, CN				Anderson, Elizabeth P.; Osborne, Tracey; Maldonado-Ocampo, Javier A.; Mills-Novoa, Megan; Castello, Leandro; Montoya, Mariana; Encalada, Andrea C.; Jenkins, Clinton N.			Energy development reveals blind spots for ecosystem conservation in the Amazon Basin	FRONTIERS IN ECOLOGY AND THE ENVIRONMENT			English	Article							PROTECTED AREAS; OIL; BIODIVERSITY; FOREST; DEGAZETTEMENT; COMMUNITIES; POLITICS; ECUADOR; SOILS; PARKS	Energy development - as manifested by the proliferation of hydroelectric dams and increased oil and gas exploration - is a driver of change in Amazonian ecosystems. However, prevailing approaches to Amazonian ecosystem conservation that focus on terrestrial protected areas and Indigenous territories do not offer sufficient insurance against the risks associated with energy development. Here, we explore three related areas of concern: the exclusion of subsurface rights on Indigenous lands; the absence of frameworks for freshwater ecosystem conservation; and downgrading, downsizing, degazettement (loss of protection), and reclassification of protected areas. We consider these issues from the perspectives of multiple countries across the Amazon Basin, and link them directly to energy development. Finally, we offer suggestions for addressing the challenges of energy development for Amazon ecosystem conservation through existing policies, new approaches, and international collaboration.	[Anderson, Elizabeth P.] Florida Int Univ, Dept Earth & Environm, Miami, FL 33199 USA; [Anderson, Elizabeth P.] Florida Int Univ, Inst Water & Environm, Miami, FL 33199 USA; [Osborne, Tracey; Mills-Novoa, Megan] Univ Arizona, Sch Geog & Dev, Tucson, AZ USA; [Maldonado-Ocampo, Javier A.] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Ictiol,Unidad Ecol & Sistemat, Bogota, Colombia; [Castello, Leandro] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Montoya, Mariana] Wildlife Conservat Soc, Lima, Peru; [Encalada, Andrea C.] Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, Inst BIOSFERA, Quito, Ecuador; [Jenkins, Clinton N.] IPE, Nazare Paulista, Brazil		Anderson, EP (corresponding author), Florida Int Univ, Dept Earth & Environm, Miami, FL 33199 USA.; Anderson, EP (corresponding author), Florida Int Univ, Inst Water & Environm, Miami, FL 33199 USA.	epanders@fiu.edu	Jenkins, Clinton/D-6134-2011; Castello, Leandro/K-4389-2012	Jenkins, Clinton/0000-0003-2198-0637; Castello, Leandro/0000-0002-9968-1584; Montoya, Mariana/0000-0002-3824-0582; Encalada, Andrea C./0000-0003-2497-6086	Interdisciplinary Research in Earth Sciences program [NNX14AD29G]; MacArthur Foundation under the Living Andean Rivers initiative [16-1607-151053-CSD]	Interdisciplinary Research in Earth Sciences program; MacArthur Foundation under the Living Andean Rivers initiative	We are grateful to many colleagues for discussions that inspired this manuscript, especially those leading the Amazon Dams Network (S Athayde, D Kaplan, and B Loiselle), the Amazon Computational Sustainability project (A Flecker and C Gomes), and the Amazon Waters Initiative. LC acknowledges the Interdisciplinary Research in Earth Sciences program (grant #NNX14AD29G). EPA, ACE, and JAM-O acknowledge The MacArthur Foundation for financial support under the Living Andean Rivers initiative (#16-1607-151053-CSD). We thank B Kays for assistance with the references. This is #928 contribution from the Southeast Environmental Research Center in the Institute of Water and Environment at Florida International University. This manuscript is dedicated to the memory of our Colombian colleague J Maldonado-Ocampo.	Abell R, 2017, CONSERV LETT, V10, P384, DOI 10.1111/conl.12312; Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Anderson EP, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1642; Andrade G, 2011, GESTION AMBIENTE, V14, P65; Artaxo P, 2019, SCIENCE, V363, P323, DOI 10.1126/science.aaw6986; Atzeni G., 2016, CHALLENGE, V59, P205, DOI [DOI 10.1080/05775132.2016.1171665, 10.1080/05775132.2016.1171665]; Azevedo-Santos VM, 2016, BIODIVERS CONSERV, V25, P2831, DOI 10.1007/s10531-016-1192-9; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Blackman A, 2017, P NATL ACAD SCI USA, V114, P4123, DOI 10.1073/pnas.1603290114; Brechin SR, 2017, CLIMATIC CHANGE, V142, P311, DOI 10.1007/s10584-017-1938-8; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; Cella-Ribeiro A, 2017, ECOHYDROLOGY, V10, DOI 10.1002/eco.1889; Cisneros P., 2010, SUPERPOSICION TERRIT; Coomes OT, 2010, FISHERIES MANAG ECOL, V17, P513, DOI 10.1111/j.1365-2400.2010.00750.x; Coomes OT, 2016, J HYDROL, V539, P214, DOI 10.1016/j.jhydrol.2016.05.027; Cycon D. E., 1991, NEW ENGLAND L REV, V25, P761; Davis DC, 2013, ENERGY LAW J, V34, P667; Duponchelle F, 2016, J APPL ECOL, V53, P1511, DOI 10.1111/1365-2664.12665; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Finer M, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/024003; Finer M, 2010, BIOTROPICA, V42, P63, DOI 10.1111/j.1744-7429.2009.00587.x; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Fraser B, 2014, SCI AM; Fraser B, 2015, ECOAMERICAS      JAN, P6; Fraser B, 2017, SCIENCE, DOI [10.1126/science.aao7079, DOI 10.1126/SCIENCE.AAO7079]; Fraser B, 2018, NATURE, V562, P18, DOI 10.1038/d41586-018-06886-0; Fraser B, 2016, SCIENCE, V353, P641, DOI 10.1126/science.353.6300.641; Frederico RG, 2018, BIOL CONSERV, V219, P12, DOI 10.1016/j.biocon.2017.12.032; Garcia Olano E, 2017, GESTION EC       DEC, P14; Gullison RE, 2018, CONSERV BIOL, V32, P1020, DOI 10.1111/cobi.13122; Harfoot MBJ, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12448; Hermoso V, 2017, GLOBAL CHANGE BIOL, V23, P3433, DOI 10.1111/gcb.13655; Hindery D, 2013, ENRON EVO PIPELINE P; Hite K, 2004, GEO INT ENV L REV, V16, P763; Huertas Castillo B, 2012, MITOS SHAWI AGUA; Kimerling J., 2013, COLO J INT ENV LAW P, V24, P43; Kingston PF, 2002, SPILL SCI TECHNOL B, V7, P53, DOI 10.1016/S1353-2561(02)00051-8; Larrea C, 2009, ENERGY SUSTAIN DEV, V13, P219, DOI 10.1016/j.esd.2009.08.003; Latrubesse EM, 2017, NATURE, V546, P363, DOI 10.1038/nature22333; Lessmann J, 2016, ECOL EVOL, V6, P4997, DOI 10.1002/ece3.2099; Lovejoy TE, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat2340; Lu F., 2006, CONSERV SOC, V4, P499; Mega ER, 2016, SCI AM; MINAE (Ministro de Ambiente y Energia), 2015, 39199MINAE; Monterroso I, 2017, 224 CTR INT FOR RES; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Orta-Martinez M, 2018, ENVIRON RES, V160, P514, DOI 10.1016/j.envres.2017.10.009; Pack SM, 2016, BIOL CONSERV, V197, P32, DOI 10.1016/j.biocon.2016.02.004; Postigo J. C., 2013, SUBTERRANEAN STRUGGL; RAISG (Rede Amazonica de InformacAo Socioambiental Georreferenciada), 2016, CART HIST AR NAT PRO; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Riofrancos TN, 2016, PROLEPTIC PROTEST LO; Rosell-Mele A, 2018, SCI TOTAL ENVIRON, V610, P1010, DOI 10.1016/j.scitotenv.2017.07.208; San Sebastian M, 2004, REV PANAM SALUD PUBL, V15, P205; Sarkar S, 2011, BIOL CONSERV, V144, P979, DOI 10.1016/j.biocon.2010.03.008; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Sovacool BK, 2016, ENERG POLICY, V95, P158, DOI 10.1016/j.enpol.2016.04.045; Suarez E, 2013, ANIM CONSERV, V16, P265, DOI 10.1111/j.1469-1795.2012.00592.x; Walker R., 2019, CONVERSATION; Walker R, 2018, ENVIRONMENT, V60, P4, DOI 10.1080/00139157.2018.1418994; Walker R, 2009, P NATL ACAD SCI USA, V106, P10582, DOI 10.1073/pnas.0806059106; Walker W, 2015, CARBON MANAG, V5, P479; Wu X, 2018, P 32 ASS ADV ART INT	65	12	12	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1540-9295	1540-9309		FRONT ECOL ENVIRON	Front. Ecol. Environ.	NOV	2019	17	9					521	528		10.1002/fee.2114	http://dx.doi.org/10.1002/fee.2114		OCT 2019	8	Ecology; Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	JI6MN		hybrid, Green Published			2022-09-04	WOS:000491198700001
J	Herrera-Cuenca, M; Previdelli, AN; Kovalskys, I; Pareja, RP; Fisberg, M; Salas, GG; Rigotti, A; Cortes, LY; Garcia, MCY				Herrera-Cuenca, Marianella; Previdelli, Nogueira Agatha; Kovalskys, Irina; Pareja, Rossina Pareja; Fisberg, Maura; Gomez Salas, Georgina; Rigotti, Attilio; Cortes, Lilia Yadira; Yepez Garcia, Martha Ceclilia			LIFESTYLE PROFILE OF FERTILE AGE WOMEN IN LATIN AMERICA: RISKS AND CONSEQUENCES FOR THE NEXT GENERATION	ANNALS OF NUTRITION AND METABOLISM			English	Meeting Abstract						ELANS; Women; fertile age; lifestyle			[Herrera-Cuenca, Marianella] CENDES Fdn Bengoa, Ctr Estudios Desarrollo, Caracas, Venezuela; [Previdelli, Nogueira Agatha] Univ Sao Judas Tadeu Sao Paulo, Fac Ciencias Biol & Saude, Sao Paulo, Brazil; [Kovalskys, Irina] Int Life Sci Inst, Buenos Aires, DF, Argentina; [Pareja, Rossina Pareja] Inst Invest Nutr, Lima, Peru; [Fisberg, Maura] Hosp Infantil Sabara, Inst Pensi, Fundacao Jose Luiz Egydio Setubal, BR-01239040 Sao Paulo, Brazil; [Gomez Salas, Georgina] Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose 11501, Costa Rica; [Rigotti, Attilio] Pontificia Univ Catolica, Escuela Med, Dept Nutr Diabet & Metab, Ctr Nutr Mol & Enfermedades Cron, Santiago 8330024, Chile; [Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Yepez Garcia, Martha Ceclilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito 171200841, Ecuador				Cortes, Lilia Yadira/AAF-2960-2019		Coca Cola Company; Instituto Pensi / Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	Coca Cola Company; Instituto Pensi / Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	The ELANS is supported by a scientific grant from the Coca Cola Company and support from the Instituto Pensi / Hospital Infantil Sabara, International Life Science Institute of Argentina, Universidad de Costa Rica, Pontificia Universidad Catolica de Chile, Pontificia Universidad Javeriana, Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa, Universidad San Francisco de Quito, and Instituto de Investigacion Nutricional de Peru. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of this manuscript.		0	0	0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-6807	1421-9697		ANN NUTR METAB	Ann. Nutr. Metab.		2017	71			2			93	93						1	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	FM9QD					2022-09-04	WOS:000415605300154
J	Maksimov, ML; Svistunov, AA; Tarasov, VV; Chubarev, VN; Avila-Rodriguez, M; Barreto, GE; Dralova, OV; Aliev, G				Maksimov, Maksim L.; Svistunov, Andrey A.; Tarasov, Vadim V.; Chubarev, Vladimir N.; Avila-Rodriguez, Marco; Barreto, George E.; Dralova, Olga V.; Aliev, Gjumrakch			Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome	CURRENT PHARMACEUTICAL DESIGN			English	Article						Treatment of obesity and MS; pharmacotherapy of obesity; lorcaserin; tesofensine; sibutramine; orlistat; rimonabant; beloranib; Contrave (R); Empatic (TM); qsymia; adipokines; liraglutide	CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; GLUCAGON-LIKE PEPTIDE-1; TARGET ORGAN DAMAGE; WEIGHT-LOSS; EXTENDED-RELEASE; CONTROLLED-TRIAL; ADIPOSE-TISSUE; PRACTICE GUIDELINES; REUPTAKE INHIBITOR; AMERICAN-COLLEGE	Obesity and metabolic syndrome (MS) are risk factors for diabetes, cancer, some cardiovascular and musculoskeletal diseases. Pharmacotherapy should be used when the body mass index (BMI) exceeds 30 kg/m(2) or 27 kg/m(2) with comorbidity. Efficacy and safety of pharmacotherapy depend on the mechanism of action of drugs. In this context, drugs affecting the central and peripheral mediator systems such as cannabinoid receptor antagonists (Rimonabant), neuronal reuptake inhibitor of NE and 5-HT (Sibutramine), neuronal reuptake inhibitor of NE 5-HT DA (Tesofensine), agonist of 5-HT 2C receptors (Lorcaserin) have a high risk of side effects on the central nervous and cardiovascular systems when used for a long period. Apparently, the drugs design targeting obesity should screen safer drugs that affect fat absorption (Orlistat), activate energy metabolism (Adipokines), inhibit MetAP2 (Beloranib) and other peripheral metabolic processes. The use of synergies of anti-obesity drugs with different mechanisms of action is an effective approach for developing new combined pharmaceutical compositions (Contrave (R), Empatic (TM), Qsymia et al.). The purpose of this article is to review the currently available anti-obesity drugs and some new promising trends in the development of anti-obesity therapy.	[Maksimov, Maksim L.; Tarasov, Vadim V.; Chubarev, Vladimir N.] IM Sechenov First Moscow State Med Univ, Pharmaceut Fac, Dept Pharmacol, Nikitsky Blvd 13, Moscow 121019, Russia; [Svistunov, Andrey A.] IM Sechenov First Moscow State Med Univ, Res Inst Pharm, Moscow 121019, Russia; [Avila-Rodriguez, Marco; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Dralova, Olga V.] Sechenov First Moscow State Med Univ, Dept Clin Pharmacol & Propaedeut Internal Med, Moscow, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 330 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, E Johns Crossing 175, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia		Maksimov, ML (corresponding author), IM Sechenov First Moscow State Med Univ, Pharmaceut Fac, Dept Pharmacol, Nikitsky Blvd 13, Moscow 121019, Russia.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 330 USA.	maksim-maksimov@mail.ru; aliev03@gmail.com	Barreto, George E./B-5747-2014; Chubarev, Vladimir N/J-4321-2017; Aliev, Gjumrakch/K-7302-2017; Barreto, George E./AAD-7420-2020; Maksimov, Maksim/AAU-3086-2021; Aliev, Gjumrakch/AAE-7734-2020	Barreto, George E./0000-0002-6644-1971; Chubarev, Vladimir N/0000-0002-7047-1436; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Avila-Rodriguez, Marco/0000-0003-4612-3236; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994	GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA; Pontificia Universidad Javeriana	GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA; Pontificia Universidad Javeriana	This work partially supported by GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA. George E. Barreto's work is supported by the Pontificia Universidad Javeriana. Part of the experimental work was performed using the equipment of Center for collective use of IPAC RAS (Agreement No 14.621.21.0008, ID RFMEFI62114X0008). We are also very thankful to Ms. Galina Alieva for her editorial work throughout preparation of this manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Al-Barazanji K, 2015, J PHARMACOL EXP THER, V353, P496, DOI 10.1124/jpet.115.222828; Alfaris N, 2015, EXPERT OPIN PHARMACO, V16, P1263, DOI 10.1517/14656566.2015.1041505; Allison DB, 2012, OBESITY, V20, P330, DOI 10.1038/oby.2011.330; Amylin Pharmaceuticals ITPCL, 2011, AM TAK DISC DEV PRAM; [Anonymous], 2014, Prescrire Int, V23, P117; [Anonymous], 2010, MED LETT DRUGS THER, V52, P88; Astrup A, 2008, LANCET, V372, P1906, DOI 10.1016/S0140-6736(08)61525-1; Astrup A, 2008, OBESITY, V16, P1363, DOI 10.1038/oby.2008.56; Atkinson RL, 1995, OBES RES, V3, pS497, DOI 10.1002/j.1550-8528.1995.tb00218.x; Ayyad C, 2000, Obes Rev, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x; Bauche IB, 2007, ENDOCRINOLOGY, V148, P1539, DOI 10.1210/en.2006-0838; Biedermann F, 2014, INT CLIN PSYCHOPHARM, V29, P181, DOI 10.1097/YIC.0000000000000022; Billes SK, 2014, PHARMACOL RES, V84, P1, DOI 10.1016/j.phrs.2014.04.004; [Blood Institute and North American Association for the Study of Obesity National Heart L], 2000, PRACT GUID ID EV TRE; Bluher M, 2014, MOL METAB, V3, P230, DOI 10.1016/j.molmet.2014.01.005; Bluher M, 2012, DIABETES METAB J, V36, P317, DOI 10.4093/dmj.2012.36.5.317; Bray GA, 2003, OBES RES, V11, P722, DOI 10.1038/oby.2003.102; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Bray GA, 2012, CIRCULATION, V125, P1695, DOI 10.1161/CIRCULATIONAHA.111.026567; Caixas A, 2014, DRUG DES DEV THER, V8, P1419, DOI 10.2147/DDDT.S55587; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chou K, 2013, DRUGS, V73, P989, DOI 10.1007/s40265-013-0074-7; Clinical NIfHa, 2006, OB GUID PREV ID ASS; Cuspidi C, 2005, J HYPERTENS, V23, P1589, DOI 10.1097/01.hjh.0000174608.26404.84; Cuspidi C, 2005, J HYPERTENS, V23, P875, DOI 10.1097/01.hjh.0000163158.14493.23; da Silva AI, 2015, J BIOENERG BIOMEMBR, V47, P309, DOI 10.1007/s10863-015-9617-9; Dalton S., 1997, OVERWEIGHT WEIGHT MA; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Doggrell SA, 2009, EXPERT OPIN INV DRUG, V18, P1043, DOI 10.1517/13543780902967632; Fang Q, 2011, PHARMACOL BIOCHEM BE, V99, P738, DOI 10.1016/j.pbb.2011.06.019; Finan B, 2015, MOL CELL ENDOCRINOL, V418, P42, DOI 10.1016/j.mce.2015.07.003; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Franco RR, 2014, ARQ BRAS ENDOCRINOL, V58, P243, DOI 10.1590/0004-2730000002825; Fujioka K, 2015, DIABETES OBES METAB, V17, P1021, DOI 10.1111/dom.12502; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Gamaleddin IH, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00041; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; Garvey WT, 2012, AM J CLIN NUTR, V95, P297, DOI 10.3945/ajcn.111.024927; Greenway FL, 2009, OBESITY, V17, P30, DOI 10.1038/oby.2008.461; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guideline NPH, 2010, GUIDELINE NPH PREVEN; Hainer V, 2008, DIABETES CARE, V31, pS269, DOI 10.2337/dc08-s265; Halford JCG, 2010, NAT REV ENDOCRINOL, V6, P255, DOI 10.1038/nrendo.2010.19; Iepsen EW, 2015, INT J OBESITY, V39, P834, DOI 10.1038/ijo.2014.177; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Kawamoto R, 2005, INTERNAL MED, V44, P1232, DOI 10.2169/internalmedicine.44.1232; Kim DD, 2015, DIABETES OBES METAB, V17, P566, DOI 10.1111/dom.12457; Kim TS, 2006, PSYCHIAT CLIN NEUROS, V60, P347, DOI 10.1111/j.1440-1819.2006.01512.x; Kiortsis DN, 2013, HORM-INT J ENDOCRINO, V12, P507, DOI 10.14310/horm.2002.1438; Klein S, 2009, P 69 ANN SCI SESS AM, P1730; Kloting N, 2011, DIABETOLOGIA, V54, P1819, DOI 10.1007/s00125-011-2137-1; Kusminski CM, 2009, CLIN PHARMACOL THER, V86, P592, DOI 10.1038/clpt.2009.155; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409; Li YW, 2014, EUR J PHARMACOL, V737, P47, DOI 10.1016/j.ejphar.2014.03.024; Liang CS, 2014, PHARMACOPSYCHIATRY, V47, P162, DOI 10.1055/s-0034-1381984; Lotfy Mohamed, 2011, Open Med Chem J, V5, P82, DOI 10.2174/1874104501105010082; Maldonado R, 2002, PHARMACOL THERAPEUT, V95, P153, DOI 10.1016/S0163-7258(02)00254-1; Mancia G, 2007, HYPERTENSION, V49, P40, DOI 10.1161/01.HYP.0000251933.22091.24; Marks DM, 2008, CURR NEUROPHARMACOL, V6, P338, DOI 10.2174/157015908787386078; Marmura MJ, 2014, EXPERT OPIN DRUG SAF, V13, P1241, DOI 10.1517/14740338.2014.934669; McDuffie JR, 2002, PHARMACOTHERAPY, V22, P814, DOI 10.1592/phco.22.11.814.33627; McFarlane SI, 2001, J CLIN ENDOCR METAB, V86, P713, DOI 10.1210/jc.86.2.713; Mea Sheikh, 1999, DIABETES OBES METAB, V23, P82; Miller KJ, 2005, MOL INTERV, V5, P282, DOI 10.1124/mi.5.5.8; Muller TD, 2012, J PEPT SCI, V18, P383, DOI 10.1002/psc.2408; Mule G, 2005, J INTERN MED, V257, P503, DOI 10.1111/j.1365-2796.2005.01493.x; NICE clinical guidance 43, 2020, OB GUID PREV ID ASS; Nordisk N., 2014, MED GUID SAX 2014; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Patel KN, 2014, CAN J PHYSIOL PHARM, V92, P975, DOI 10.1139/cjpp-2014-0310; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Pipelinereview.com, 2008, AR PHARM LORC OB PAS; Plodkowski RA, 2009, EXPERT OPIN PHARMACO, V10, P1069, DOI [10.1517/14656560902775750, 10.1517/14656560902775750 ]; Potts JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126769; Pucci E, 2000, INT J OBESITY, V24, pS109, DOI 10.1038/sj.ijo.0801292; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Rascol O, 2008, ARCH NEUROL-CHICAGO, V65, P577, DOI 10.1001/archneur.65.5.577; Rescrire, 2012, MED PROD US WEIGHT C; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Savage DB, 2002, J CLIN INVEST, V109, P1285, DOI 10.1172/JCI200215326; Scheen AJ, 2014, LANCET DIABETES ENDO, V2, P911, DOI 10.1016/S2213-8587(14)70004-X; Schillaci G, 2005, HYPERTENSION, V45, P1078, DOI 10.1161/01.HYP.0000165313.84007.7d; Schoedel KA, 2010, CLIN PHARMACOL THER, V88, P69, DOI 10.1038/clpt.2010.67; Seoane LM, 2003, ENDOCRINOLOGY, V144, P544, DOI 10.1210/en.2002-220795; Singh Jagjit, 2015, Int J Appl Basic Med Res, V5, P157, DOI 10.4103/2229-516X.157177; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Toplak H, 2005, DIABETES OBES METAB, V7, P699, DOI 10.1111/j.1463-1326.2005.00483.x; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tsigos C, 2008, OBESITY FACTS, V1, P106, DOI 10.1159/000126822; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; van Bloemendaal L, 2014, J ENDOCRINOL, V221, pT1, DOI 10.1530/JOE-13-0414; WHO, 2011, GLOB HLTH RISKS MORT; Williams G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c824; Wilson JD, 1998, WILLIAMS TXB ENDOCRI, V9th, P250; Wirth A, 2005, DIABETES OBES METAB, V7, P21, DOI 10.1111/j.1463-1326.2004.00428.x; World Health Organization, 2014, 10 FACTS OB; Yanovski SZ, 2015, JAMA-J AM MED ASSOC, V313, P1213, DOI 10.1001/jama.2015.1617; ZHI JG, 1995, J CLIN PHARMACOL, V35, P1103, DOI 10.1002/j.1552-4604.1995.tb04034.x	110	12	14	0	21	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2016	22	7					895	903		10.2174/1381612822666151209153047	http://dx.doi.org/10.2174/1381612822666151209153047			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DG4VQ	26648466				2022-09-04	WOS:000372071600012
J	Arnold, M; Singh, D; Laversanne, M; Vignat, J; Vaccarella, S; Meheus, F; Cust, AE; de Vries, E; Whiteman, DC; Bray, F				Arnold, Melina; Singh, Deependra; Laversanne, Mathieu; Vignat, Jerome; Vaccarella, Salvatore; Meheus, Filip; Cust, Anne E.; de Vries, Esther; Whiteman, David C.; Bray, Freddie			Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040	JAMA DERMATOLOGY			English	Article							MALIGNANT-MELANOMA; CANCER INCIDENCE; THIN MELANOMAS; TRENDS; SKIN; MORTALITY; POPULATIONS; PREVENTION; CAMPAIGNS; SURVIVAL	IMPORTANCE Despite many cases being preventable, cutaneous melanoma remains the most serious skin cancer worldwide. Understanding the scale and profile of the disease is vital to concentrate and reinforce global prevention efforts. Objective To examine global patterns of cutaneous melanoma in 2020 and to provide projected estimates of cases and deaths by 2040. Design, Setting, and Participants This population-based study used the GLOBOCAN 2020 database for global epidemiological assessment of new cases and deaths due to invasive melanoma. Main Outcomes and Measures Age-standardized incidence and mortality rates were calculated per 100 000 person-years by country, world region, and 4-tier level of human development. Estimated numbers of cases and deaths were calculated for the year 2040. Results A worldwide total of 325 000 new melanoma cases (174 000 males, 151 000 females) and 57 000 deaths (32 000 males, 25 000 females) was estimated for 2020. Large geographic variations existed across countries and world regions, with the highest incidence rates among males (42 per 100 000 person-years) and females (31 per 100 000 person-years) observed in Australia/New Zealand, followed by Western Europe (19 per 100 000 person-years for males and females), North America (18 per 100 000 person-years for males, 14 per 100 000 person-years for females), and Northern Europe (17 per 100 000 person-years for males, 18 per 100 000 person-years for females). Melanoma continued to be rare in most African and Asian countries, with incidence rates commonly less than 1 per 100 000 person-years. Mortality rates peaked at 5 per 100 000 person-years in New Zealand, and geographic variations were less pronounced than for incidence. Melanoma was more frequent among males than females in most world regions. If 2020 rates continue, the burden from melanoma is estimated to increase to 510 000 new cases (a roughly 50% increase) and to 96 000 deaths (a 68% increase) by 2040. Conclusions and Relevance This epidemiological assessment suggests that melanoma remains an important challenge to cancer control and public health globally, especially in fair-skinned populations of European descent.	[Arnold, Melina; Singh, Deependra; Laversanne, Mathieu; Vignat, Jerome; Vaccarella, Salvatore; Meheus, Filip; Bray, Freddie] Int Agcy Res Canc, Canc Surveillance Branch, Lyon, France; [Cust, Anne E.] Univ Sydney, Canc Council New South Wales, Daffodil Ctr, Sydney, NSW, Australia; [Cust, Anne E.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [de Vries, Esther] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Whiteman, David C.] QIMR Berghofer Med Res Inst, Canc Control Grp, Herston, Qld, Australia		Arnold, M (corresponding author), Int Agcy Res Canc IARC WHO, Canc Surveillance Branch, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	arnoldm@iarc.fr	de Vries, Esther/A-6603-2009	de Vries, Esther/0000-0002-5560-2258	Australian NHMRC [1147843]	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Dr Cust is supported by a Career Development Fellowship (1147843) from the Australian NHMRC.	Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; ARMSTRONG BK, 1993, MELANOMA RES, V3, P395, DOI 10.1097/00008390-199311000-00002; Arnold M, 2014, J EUR ACAD DERMATOL, V28, P1170, DOI 10.1111/jdv.12236; Arnold M, 2018, INT J CANCER, V143, P1305, DOI 10.1002/ijc.31527; Baade P, 2012, INT J CANCER, V130, P170, DOI 10.1002/ijc.25996; Baade PD, 2020, INT J CANCER, V147, P1391, DOI 10.1002/ijc.32930; Bellenghi M, 2020, CANCERS, V12, DOI 10.3390/cancers12071819; Berk-Krauss J, 2020, AM J PUBLIC HEALTH, V110, P731, DOI 10.2105/AJPH.2020.305567; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; Bray F, 2002, CANCER CAUSE CONTROL, V13, P175, DOI 10.1023/A:1014344519276; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brunssen A, 2017, J AM ACAD DERMATOL, V76, P129, DOI 10.1016/j.jaad.2016.07.045; Day N E, 1992, IARC Sci Publ, P862; de Vries E, 2004, EUR J CANCER, V40, P2355, DOI 10.1016/j.ejca.2004.06.003; de Vriesa E, 2016, CANCER EPIDEMIOL, V44, pS100, DOI 10.1016/j.canep.2016.02.005; Doll R., 1966, CANC INCIDENCE 5 CON, DOI [10.1007/978-3-642-85849-9, DOI 10.1007/978-3-642-85849-9]; Dulskas A, 2021, INT J ENV RES PUB HE, V18, P4165, DOI 10.3390/ijerph18084165; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Ferlay J, 2021, INT J CANCER, V149, P778, DOI 10.1002/ijc.33588; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidler MM, 2017, LANCET ONCOL, V18, P1579, DOI 10.1016/S1470-2045(17)30677-0; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Garbe C, 2021, EUR J CANCER, V152, P18, DOI 10.1016/j.ejca.2021.04.029; Glazer AM, 2017, JAMA DERMATOL, V153, P225, DOI 10.1001/jamadermatol.2016.4512; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Herbert A, 2020, MELANOMA RES, V30, P279, DOI 10.1097/CMR.0000000000000489; Iannacone MR, 2014, MELANOMA MANAG, V1, P75, DOI [10.2217/mmt.14.6, 10.2217/MMT.14.6]; International Agency for Research on Cancer, 2012, RAD VOLUME 100 REV H, V100; International Agency for Research on Cancer: Global Cancer Observatory, 2021, CANC TODAY; Khair DO, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00453; Landi MT, 2020, NAT GENET, V52, P494, DOI 10.1038/s41588-020-0611-8; Lindholm C, 2004, CANCER-AM CANCER SOC, V101, P2067, DOI 10.1002/cncr.20602; MacKie RM, 2007, BRIT J CANCER, V96, P1772, DOI 10.1038/sj.bjc.6603801; Mason R, 2019, EXPERT OPIN PHARMACO, V20, P1135, DOI 10.1080/14656566.2019.1601700; Olsen CM, 2020, JAMA DERMATOL, V156, P553, DOI 10.1001/jamadermatol.2020.0470; Olsen CM, 2015, AUST NZ J PUBL HEAL, V39, P471, DOI 10.1111/1753-6405.12470; Paulson KG, 2020, JAMA DERMATOL, V156, P57, DOI 10.1001/jamadermatol.2019.3353; Purdue MP, 2005, CANCER EPIDEM BIOMAR, V14, P2015, DOI 10.1158/1055-9965.EPI-05-0097; Sacchetto L, 2018, EUR J CANCER, V92, P108, DOI 10.1016/j.ejca.2017.12.024; Sankaranarayanan R, 2011, CANC SURV AFR AS CAR; Segi M., 1960, CANC MORTALITY SELEC; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21332, 10.3322/caac.21708, 10.3322/caac.21551]; Sung H, 2019, LANCET PUBLIC HEALTH, V4, pE137, DOI 10.1016/S2468-2667(18)30267-6; United Nations Development Programme, 2020, HUMAN DEV REPORT 202; United Nations Statistics Division, 2021, STANDARD COUNTRY ARE; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; van der Leest RJT, 2015, EUR J CANCER, V51, P2833, DOI 10.1016/j.ejca.2015.09.008; Waldmann A, 2012, BRIT J CANCER, V106, P970, DOI 10.1038/bjc.2012.22; Watson M, 2016, PREV MED, V91, P294, DOI 10.1016/j.ypmed.2016.08.032; Welch HG, 2021, NEW ENGL J MED, V384, P72, DOI 10.1056/NEJMsb2019760; Whiteman DC, 2016, J INVEST DERMATOL, V136, P1161, DOI 10.1016/j.jid.2016.01.035; Whiteman DC, 2015, J INVEST DERMATOL, V135, P1190, DOI 10.1038/jid.2014.452; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	56	5	5	6	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6068	2168-6084		JAMA DERMATOL	JAMA Dermatol.	MAY	2022	158	5					495	503		10.1001/jamadermatol.2022.0160	http://dx.doi.org/10.1001/jamadermatol.2022.0160		MAR 2022	9	Dermatology	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology	1J6EG	35353115				2022-09-04	WOS:000776738100002
J	Rueda, EA; Suarez, E; Gempeler, FE; Torregrosa, L; Caballero, A; Bernal, D; Badoui, N				Rueda, Eduardo A.; Suarez, Edilma; Gempeler, Fritz E.; Torregrosa, Lilian; Caballero, Andrea; Bernal, Diana; Badoui, Nora			Ethical guidelines on cardiopulmonary resuscitation in the context of the COVID-19 pandemic in Colombia	BIOMEDICA			Spanish	Review						Coronavirus infections; cardiopulmonary resuscitation; codes of ethics; practice guideline	HOSPITAL CARDIAC-ARREST	The pandemic caused by COVID19 is associated with an increase in the number of cases of cardiorespiratory arrest, which has resulted in ethical concerns regarding the enforceability of cardiopulmonary resuscitation, as well as the conditions to carry it out. The risk of aerosol transmission and the clinical uncertainties about the efficacy, the potential sequelae, and the circumstances that could justify limiting this procedure during the pandemic have multiplied the ethical doubts on how to proceed in these cases. Based on ethical and legal grounds, this paper offers a practical guide on how to proceed in the clinical setting in cases of cardiopulmonary arrest during the pandemic. The criteria of justice, benefit, no harm, respect for autonomy, precaution, integrity, and transparency are asserted in an organized and practical framework for decision-making regarding cardiopulmonary resuscitation.	[Rueda, Eduardo A.] Int Bioeth Comm UNESCO, Red Latinoamer & Caribe Educ Bioet, Bogota, DC, Colombia; [Rueda, Eduardo A.] Univ Nacl Colombia, Fac Derecho & Ciencias Polit, Bogota, DC, Colombia; [Suarez, Edilma] Pontificia Univ Javeriana, Fac Enfermeria, Bogota, DC, Colombia; [Gempeler, Fritz E.; Torregrosa, Lilian; Badoui, Nora] Pontificia Univ Javeriana, Fac Med, Bogota, DC, Colombia; [Gempeler, Fritz E.; Torregrosa, Lilian] Hosp Univ San Ignacio, Serv Etica, Bogota, DC, Colombia; [Torregrosa, Lilian] Assoc Colombiana Cirugia, Bogota, DC, Colombia; [Torregrosa, Lilian] Hosp Univ San Ignacio, Dept Cirugia, Bogota, DC, Colombia; [Caballero, Andrea] EPS Sanitas, Clin Campo Abierto, Bogota, DC, Colombia; [Bernal, Diana] Univ Rosario, Fac Jurisprudencia, Bogota, DC, Colombia; [Bernal, Diana] Consejo Nacl Bioet Colombia, Bogota, DC, Colombia; [Badoui, Nora] Univ Nacl Colombia, Fac Med, Bogota, DC, Colombia		Rueda, EA (corresponding author), Univ Nacl Colombia, Carrera 45 26-85,Edificio Uriel Gutierrez, Bogota, DC, Colombia.	eruedab@gmail.com		Gempeler Rueda, Fritz Eduardo/0000-0002-6036-9155; Torregrosa Almonacid, Lilian/0000-0002-5392-7083; BADOUI, NORA/0000-0002-9066-0867				American Heart Association, 2013, STAT UPD; Cabrera Luis Felipe, 2020, rev. colomb. cir., V35, P190, DOI 10.30944/20117582.625; Craig S, 2020, MED J AUST; Curtis JR, 2020, JAMA-J AM MED ASSOC, V323, P1771, DOI 10.1001/jama.2020.4894; DeFilippis EM, 2020, CIRCULATION, V141, P1833, DOI 10.1161/CIRCULATIONAHA.120.047260; Edelson DP, 2020, CIRCULATION, V141, pE933, DOI 10.1161/CIRCULATIONAHA.120.047463; Eunjung Cha A, 2020, WASH POST; Fritz Z, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1387; Gempeler F. E., 2015, REV COLOMB ANESTESIO, V43, P142; Gempeler-Rueda Fritz Eduardo, 2016, Rev. colomb. anestesiol., V44, P146; Gomez-Marin Jorge E., 2020, Infect., V24, P1, DOI 10.22354/in.v24i3.896; Kramer DB, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2010758; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1282; Mallikethi-Reddy S, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003194; Morgenstern J., 2020, FIRST10EM BLOG, P1; Rueda Eduardo A., 2020, rev. colomb. cir., V35, P281, DOI 10.30944/20117582.653; Schluep M, 2018, RESUSCITATION, V132, P90, DOI 10.1016/j.resuscitation.2018.09.001; Shao F, 2020, RESUSCITATION, V151, P18, DOI 10.1016/j.resuscitation.2020.04.005; Torregrosa L, 2020, REV COLOMB CIR, V35, P264; Van de Voorde P., 2020, ETHICAL PRINCIPLES G	20	2	3	0	0	INST NACIONAL SALUD	BOGOTA D C	AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C, 00000, COLOMBIA	0120-4157	2590-7379		BIOMEDICA	Biomedica	OCT	2020	40			2			180	187		10.7705/biomedica.5762	http://dx.doi.org/10.7705/biomedica.5762			8	Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Tropical Medicine	OJ1XU	33152202	Green Published, gold			2022-09-04	WOS:000583761500021
J	Gomez, AEM; Sacanell, J; Huck-Iriart, C; Ramos, CP; Soldati, AL; Figueroa, SJA; Tabacniks, MH; Fantini, MCA; Craievich, AE; Lamas, DG				Mejia Gomez, Augusto E.; Sacanell, Joaquin; Huck-Iriart, Cristian; Ramos, Cinthia P.; Soldati, Analia L.; Figueroa, Santiago J. A.; Tabacniks, Manfredo H.; Fantini, Marcia C. A.; Craievich, Aldo E.; Lamas, Diego G.			Crystal structure, cobalt and iron speciation and oxygen non-stoichiometry of La(0.6)Sr(0.4)Co(1-)yFe(y)O(3-delta) nanorods for IT-SOFC cathodes	JOURNAL OF ALLOYS AND COMPOUNDS			English	Article						Electrode materials; Nanostructured materials; X-ray diffraction; NEXAFS; Mossbauer spectroscopy	ELECTROCHEMICAL PERFORMANCE; K-EDGE; LA0.6SR0.4COO3-DELTA; PEROVSKITES; FABRICATION; NANOTUBES; FE	Single-phased La(0.6)Sr(0.4)Co(1-)yFe(y)O(3-delta) (y = 0.2, 0.5, 0.8) nanorods exhibiting the rhombohedral perovskite-type phase were synthesized by a pore-wetting technique. We studied their chemical composition, crystal and electronic structures, morphology and hyperfine properties as a function of the Co/Fe content of the samples. Our results demonstrate that Co cations exhibit a slightly lower oxidation state than Fe ones, resulting in a higher oxygen non-stoichiometry delta for Co-rich samples. In addition, the values of delta determined in this work for nanostructured samples are much higher than those reported in the literature for bulk materials. This can be attributed to the high number of defects in nanomaterials and is probably one important factor in the high electrochemical performance for the oxygen reduction reaction of nanostructured La(0.6)Sr(0.4)Co(1-)yFe(y)O(3-delta) IT-SOFC cathodes, which have been reported in a previous work. (C) 2019 Elsevier B.V. All rights reserved.	[Mejia Gomez, Augusto E.] Pontificia Univ Javeriana, Dept Fis, Grp Peliculas Delgadas & Nanofoton, Bogota, Colombia; [Sacanell, Joaquin; Ramos, Cinthia P.] Comis Nacl Energia Atom, Dept Fis Mat Condensada, Ctr Atom Constituyentes, San Martin, Pcia De Buenos, Argentina; [Sacanell, Joaquin; Ramos, Cinthia P.; Soldati, Analia L.] CNEA CONICET, Inst Nanociencia & Nanotecnol, Buenos Aires, DF, Argentina; [Huck-Iriart, Cristian; Lamas, Diego G.] Univ Nacl Gral San Martin, Lab Cristalog Aplicada, CONICET, Escuela Ciencia & Tecnol, San Martin, Pcia De Buenos, Argentina; [Figueroa, Santiago J. A.] CNPEM, LNLS, BR-13083970 Campinas, SP, Brazil; [Tabacniks, Manfredo H.; Fantini, Marcia C. A.; Craievich, Aldo E.] Univ Sao Paulo, Inst Fis, Sao Paulo, SP, Brazil		Lamas, DG (corresponding author), Univ Nacl Gen San Martin, Escuela Ciencia & Tecnol, Martin de Irigoyen 3100,Edificio Tornavia, RA-1650 San Martin, Pcia De Buenos, Argentina.	dlamas@unsam.edu.ar	Figueroa, Santiago J. A./A-5104-2010; Craievich, Aldo F/A-2852-2013; Fantini, Marcia/AAH-7808-2020; Huck-Iriart, Cristián/J-1573-2019; Tabacniks, Manfredo/M-6620-2014	Figueroa, Santiago J. A./0000-0003-2694-3050; Craievich, Aldo F/0000-0002-5103-0248; Fantini, Marcia/0000-0001-6862-8716; Huck-Iriart, Cristián/0000-0001-5734-2499; Lamas, Diego German/0000-0002-9099-586X; Tabacniks, Manfredo/0000-0002-1303-2314	Brazilian Synchrotron Light Laboratory (LNLS, Brazil) [XPD 10152, XAFS1 9886]; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [3411]; CONICET (Argentina) [PIP 00362]; CAPES-MinCyT bilateral cooperation	Brazilian Synchrotron Light Laboratory (LNLS, Brazil); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CAPES-MinCyT bilateral cooperation	The present work was partially supported by the Brazilian Synchrotron Light Laboratory (LNLS, Brazil, proposals XPD 10152 and XAFS1 9886), Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina, PICT 2015 No. 3411), CONICET (Argentina, PIP 00362) and CAPES-MinCyT bilateral cooperation.	Acosta M, 2019, ADV MATER INTERFACES, V6, DOI 10.1002/admi.201900462; Acuna LM, 2011, J POWER SOURCES, V196, P9276, DOI 10.1016/j.jpowsour.2011.07.067; Ali SAM, 2018, J SOLID STATE ELECTR, V22, P263, DOI 10.1007/s10008-017-3754-5; Bai LG, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/43/435401; Bellino MG, 2007, J AM CHEM SOC, V129, P3066, DOI 10.1021/ja068115b; Berry FJ, 2005, J SOLID STATE CHEM, V178, P961, DOI 10.1016/j.jssc.2004.10.003; Bouwmeester HJM, 2004, J SOLID STATE ELECTR, V8, P599, DOI 10.1007/s10008-003-0488-3; Brand R.A., 2010, WINNORMOS IGOR V; CAPEHART TW, 1995, PHYS REV B, V52, P7907, DOI 10.1103/PhysRevB.52.7907; Closset N.M.L.N.P., 2013, POWDER DIFFR, V11, P31, DOI [10.1017/S0885715600008873, DOI 10.1017/S0885715600008873]; DANN SE, 1994, J SOLID STATE CHEM, V109, P134, DOI 10.1006/jssc.1994.1083; de Groot F, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/10/104207; Figueroa SJA, 2016, J PHYS CONF SER, V712, DOI 10.1088/1742-6596/712/1/012022; GIBB TC, 1985, J CHEM SOC DALTON, P1455, DOI 10.1039/dt9850001455; Goodenough J.B., 1963, MAGNETISM CHEMICAL B, P154; Haas O, 2009, MATER RES BULL, V44, P1397, DOI 10.1016/j.materresbull.2008.11.026; Huck-Iriart C, 2018, ACS CATAL, V8, P9625, DOI 10.1021/acscatal.8b02666; Katsuki M, 2003, SOLID STATE IONICS, V156, P453, DOI 10.1016/S0167-2738(02)00733-6; Krylova G, 2012, J AM CHEM SOC, V134, P4384, DOI 10.1021/ja211459p; Levy P, 2003, APPL PHYS LETT, V83, P5247, DOI 10.1063/1.1635663; Leyva AG, 2004, J SOLID STATE CHEM, V177, P3949, DOI 10.1016/j.jssc.2004.08.015; Mantzavinos D, 2000, SOLID STATE IONICS, V134, P103, DOI 10.1016/S0167-2738(00)00718-9; Mayer M, 1999, AIP CONF PROC, V475, P541; Gomez AM, 2016, CERAM INT, V42, P3145, DOI 10.1016/j.ceramint.2015.10.104; Gomez AEM, 2019, CERAM INT, V45, P14182, DOI 10.1016/j.ceramint.2019.04.122; Orikasa Y, 2011, J PHYS CHEM C, V115, P16433, DOI 10.1021/jp2029642; Rehman SU, 2019, J POWER SOURCES, V429, P97, DOI 10.1016/j.jpowsour.2019.05.007; RODRIGUEZCARVAJAL J, 1993, PHYSICA B, V192, P55, DOI 10.1016/0921-4526(93)90108-I; Sacanell J, 2007, PHYSICA B, V398, P341, DOI 10.1016/j.physb.2007.04.039; Sacanell J, 2010, J POWER SOURCES, V195, P1786, DOI 10.1016/j.jpowsour.2009.10.049; Shen QW, 2019, ENERGIES, V12, DOI 10.3390/en12030410; Shuvaeva VA, 2017, MATER CHEM PHYS, V193, P260, DOI 10.1016/j.matchemphys.2017.02.026; Stevenson JW, 1996, J ELECTROCHEM SOC, V143, P2722, DOI 10.1149/1.1837098; TAI LW, 1995, SOLID STATE IONICS, V76, P273, DOI 10.1016/0167-2738(94)00245-N; Van Espen P., 1986, AXIL X RAY ANAL SOFT; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Yamamoto T, 2008, X-RAY SPECTROM, V37, P572, DOI 10.1002/xrs.1103	37	2	2	4	59	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-8388	1873-4669		J ALLOY COMPD	J. Alloy. Compd.	MAR 15	2020	817								153250	10.1016/j.jallcom.2019.153250	http://dx.doi.org/10.1016/j.jallcom.2019.153250			8	Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Materials Science; Metallurgy & Metallurgical Engineering	KB0CI		Green Submitted, Green Published			2022-09-04	WOS:000506166400028
J	Hay, YO; Abril-Sierra, MA; Sequeda-Castaneda, LG; Bonnafous, C; Raynaud, C				Hay, Yann-Olivier; Abril-Sierra, Miguel A.; Sequeda-Castaneda, Luis G.; Bonnafous, Catherine; Raynaud, Christine			Evaluation of combinations of essential oils and essential oils with hydrosols on antimicrobial and antioxidant activities	JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH			English	Article						essential oil; fractional inhibitory indices; hydrosol; Lippia alba; Rosmarinus officinalis; Thymus vulgaris	THYME THYMUS-VULGARIS; CHEMICAL-COMPOSITION; FOODBORNE PATHOGENS; MENTHA-SPICATA; EFFICACY; GROWTH; PHASE	Context: Essential oils (EO) are commonly extracted from plants by steam distillation in which an aqueous phase called hydrosol (HD) is obtained. Unlike EO, hydrosol studies have been limited despite the interest of the food, cosmetic and phytotherapeutic industries to find natural preservative alternatives to synthetic ones. Aims: To evaluate the in vitro antimicrobial and antioxidant efficacies of combinations of essential oils (EOs) and essential oils and hydrosols (HDs) of Lippia alba, Rosmarinus officinalis, and Thymus vulgaris. Methods: The EOs and HDs were characterized by gas chromatography with flame ionization detector and gas chromatography coupled with mass spectrometry. Then, they were screened against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans and Aspergillus niger using the microdilution method for the four first strains and the agar diffusion method for Aspergillus niger. Antioxidant capacity was evaluated using ABTS method. Results: Interactions between essential oils, and essential oils and hydrosols were found to be as microbicide, and for the first time, antioxidant using the fractional inhibitory concentration. When compared with individual EOs, EO-EO combinations diminished the microbicide minimum concentration. Conclusions: The Thymus vulgaris EO-HD combination, in comparison with individual extracts, diminishes by four times the MBC against Escherichia coli and decrease by half their antioxidant capacity.	[Hay, Yann-Olivier; Sequeda-Castaneda, Luis G.] Pontificia Univ Javeriana, Sci Fac, Chem Dept, Bogota, Colombia; [Hay, Yann-Olivier; Abril-Sierra, Miguel A.] Farmaverde CTA, Bogota, Colombia; [Hay, Yann-Olivier; Raynaud, Christine] Univ Toulouse, LCA Lab Chim Agroind, INP, ENSIACET, F-31030 Toulouse, France; [Hay, Yann-Olivier; Raynaud, Christine] INRA, UMR1010, CAI, F-31030 Toulouse, France; [Bonnafous, Catherine] Act Bio, F-46170 Pern, France		Hay, YO (corresponding author), Pontificia Univ Javeriana, Sci Fac, Chem Dept, Bogota, Colombia.; Hay, YO (corresponding author), Farmaverde CTA, Bogota, Colombia.; Hay, YO (corresponding author), Univ Toulouse, LCA Lab Chim Agroind, INP, ENSIACET, F-31030 Toulouse, France.; Hay, YO (corresponding author), INRA, UMR1010, CAI, F-31030 Toulouse, France.	yann.olivier.hay@gmail.com; lsequeda@javeriana.edu.co	CASTAÑEDA, LUIS GONZALO SEQUEDA/CAA-9958-2022; CASTAÑEDA, LUIS GONZALO SEQUEDA/J-2354-2014; Raynaud, Christine/Q-7648-2019	CASTAÑEDA, LUIS GONZALO SEQUEDA/0000-0002-1639-1988; CASTAÑEDA, LUIS GONZALO SEQUEDA/0000-0002-1639-1988; Raynaud, Christine/0000-0001-7913-6653	COLCIENCIAS [120350227391]; Pontificia Universidad Javeriana [3743]	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Pontificia Universidad Javeriana	This study was supported by COLCIENCIAS (Project 120350227391) and the Academic Vice-Rectory and Vice-Rectory for Research of the Pontificia Universidad Javeriana (Project 3743).	Aazza S, 2011, J MED PLANTS RES, V5, P6688, DOI 10.5897/JMPR11.1176; Adams RP., 2007, IDENTIFICATION ESSEN, V456; Aggarwal KK, 2002, FLAVOUR FRAG J, V17, P59, DOI 10.1002/ffj.1040; ALTENBURGER R, 1990, ECOTOX ENVIRON SAFE, V20, P98, DOI 10.1016/0147-6513(90)90049-B; [Anonymous], 2001, AROMATHERAPIE EXACTE; Arnao MB, 2000, TRENDS FOOD SCI TECH, V11, P419, DOI 10.1016/S0924-2244(01)00027-9; Babushok VI, 2009, CHROMATOGRAPHIA, V69, P257, DOI 10.1365/s10337-008-0872-3; Bassole IHN, 2012, MOLECULES, V17, P3989, DOI 10.3390/molecules17043989; Blanco MA, 2013, J ETHNOPHARMACOL, V149, P803, DOI 10.1016/j.jep.2013.08.007; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Di Pasqua R, 2005, ANN MICROBIOL, V55, P139; Djabou N, 2014, J ESSENT OIL RES, V26, P393, DOI 10.1080/10412905.2014.964427; Ekstrom C.T., 2014, INTRO STAT DATA ANAL; El-Newary SA, 2017, ASIAN PAC J TROP MED, V10, P341, DOI 10.1016/j.apjtm.2017.03.023; EUCAST, 2000, CLIN MICROBIOL INFEC, V6, P570; FARAG RS, 1989, J FOOD PROTECT, V52, P665, DOI 10.4315/0362-028X-52.9.665; Fitsiou E, 2016, MOLECULES, V21, DOI 10.3390/molecules21081069; Gemeda N., 2015, PHARMACOLOGYONLINE, V2, P85; Gholoum F, 2013, INT J ENG SCI, V3, P20; Gonzalez M., 2017, Journal of Applied Pharmaceutical Science, V7, P024; Gutierrez J, 2008, INT J FOOD MICROBIOL, V124, P91, DOI 10.1016/j.ijfoodmicro.2008.02.028; Gutierrez J, 2009, FOOD MICROBIOL, V26, P142, DOI 10.1016/j.fm.2008.10.008; Gutierrez J, 2008, J FOOD PROTECT, V71, P1846, DOI 10.4315/0362-028X-71.9.1846; Hajlaoui H, 2010, ITAL J FOOD SCI, V22, P320; Hamedi A, 2017, J EVID-BASED INTEGR, V22, P824, DOI 10.1177/2156587217717413; Hammer KA, 1999, J APPL MICROBIOL, V86, P985, DOI 10.1046/j.1365-2672.1999.00780.x; Hay Yann-Olivier, 2015, INT J PHYTOCOSMETICS, V2, P1; Imelouane B, 2009, INT J AGRIC BIOL, V11, P205; Kumar A, 2008, INNOV FOOD SCI EMERG, V9, P575, DOI 10.1016/j.ifset.2007.12.005; Medina A, 2012, FUNGAL BIOL-UK, V116, P161, DOI 10.1016/j.funbio.2011.11.001; Miladi H., 2013, Natural Science, V5, P729, DOI 10.4236/ns.2013.56090; Moghtader M., 2012, J YEAST FUNGAL RES, V3, P83; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naigre R, 1996, PLANTA MED, V62, P275, DOI 10.1055/s-2006-957877; Nedorostova L, 2009, FOOD CONTROL, V20, P157, DOI 10.1016/j.foodcont.2008.03.007; Nowak A, 2012, FOOD MICROBIOL, V32, P212, DOI 10.1016/j.fm.2012.05.001; Oussalah M, 2007, FOOD CONTROL, V18, P414, DOI 10.1016/j.foodcont.2005.11.009; Pandey AK, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02161; Paparella A, 2008, FOOD CONTROL, V19, P1174, DOI 10.1016/j.foodcont.2008.01.002; Peng CT, 2010, J CHROMATOGR A, V1217, P3683, DOI 10.1016/j.chroma.2010.02.005; Price L., 2004, UNDERSTANDING HYDROL; Raskovic A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-225; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rota MC, 2008, FOOD CONTROL, V19, P681, DOI 10.1016/j.foodcont.2007.07.007; Sacchetti G, 2005, FOOD CHEM, V91, P621, DOI 10.1016/j.foodchem.2004.06.031; Sanchez-Moreno C, 1998, J SCI FOOD AGR, V76, P270, DOI 10.1002/(SICI)1097-0010(199802)76:2<270::AID-JSFA945>3.3.CO;2-0; Schwalbe R., 2007, ANTIMICROBIAL SUSCEP, P139; Stashenko E.E, 2010, SCI CHROMATOGR, V2, P29; Stashenko EE, 2004, J CHROMATOGR A, V1025, P93, DOI 10.1016/j.chroma.2003.10.058; Stashenko EE, 2007, J BIOCHEM BIOPH METH, V70, P235, DOI 10.1016/j.jbbm.2006.08.011; Tornuk F, 2011, INT J FOOD MICROBIOL, V148, P30, DOI 10.1016/j.ijfoodmicro.2011.04.022; Vale TG, 1999, J ETHNOPHARMACOL, V67, P127, DOI 10.1016/S0378-8741(98)00215-3; Zaouali Y, 2010, FOOD CHEM TOXICOL, V48, P3144, DOI 10.1016/j.fct.2010.08.010	53	13	13	1	8	JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRES	ANTOFAGASTA	ANGAMOS 0610, ANTOFAGASTA, 00000, CHILE	0719-4250			J PHARM PHARMACOGN R	J. Pharm. Pharmacogn. Res.	MAY-JUN	2018	6	3					216	230						15	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	GF3BV					2022-09-04	WOS:000431819900003
J	Balaguera-Lopez, HE; Espinal-Ruiz, M; Zacarias, L; Herrera, AO				Balaguera-Lopez, Helber E.; Espinal-Ruiz, Mauricio; Zacarias, Lorenzo; Herrera, Anibal O.			Effect of ethylene and 1-methylcyclopropene on the postharvest behavior of cape gooseberry fruits (Physalis peruviana L.)	FOOD SCIENCE AND TECHNOLOGY INTERNATIONAL			English	Article						1-MCP; ethylene; gooseberry; maturity; respiration; storage; volatile esters	VOLATILE BIOSYNTHESIS; ENZYME-ACTIVITY; TOMATO; 1-MCP; AROMA; ANTIOXIDANT; RESPONSES; BANANA; ACCUMULATION; SUPPRESSION	Cape gooseberry (Physalis peruviana L.) fruits are highly perishable berries that exhibit a climacteric respiratory behavior. The objective of this study was to evaluate the effect of ethylene and the ethylene action inhibitor 1-methylcyclopropene on the postharvest behavior of cape gooseberry fruits (ecotype Colombia). Fruits were treated with ethylene, in an ethephon application (1000 mu L L-1), and pretreated with 1-methylcyclopropene (1 mu L L-1), 1-methylcyclopropene+ethylene, and results compared with a control without application. Subsequently, the fruits were maintained at room temperature (20?, 75% RH) for up to 11 days. The pretreatment of the cape gooseberry fruits with 1-methylcyclopropene delayed most of the ripening-associated parameters, with a reduction in the respiration rate and ethylene production, skin color development, total soluble solids, total carotenoid content, loss of firmness, loss of total titratable acidity and emission of volatile compounds such as ethyl octanoate, ethyl butanoate, ethyl decanoate, and hexyl decanoate. Conversely, application of ethephon accelerated most of these physiological changes and also overcame most of the effects prevented by the ethylene action inhibitor. Altogether, the results supported the idea of a climacteric-like behavior for cape gooseberry fruits and pointing out that the pretreatment with 1-methylcyclopropene may be a promising and efficient postharvest treatment to delay maturity and extend the postharvest period.	[Balaguera-Lopez, Helber E.] Univ Pedagogica & Tecnol Colombia, Tunja, Colombia; [Balaguera-Lopez, Helber E.] Univ Bosque, Dept Biol, Bogota, Colombia; [Balaguera-Lopez, Helber E.; Herrera, Anibal O.] Univ Nacl Colombia, Dept Agronomia, Bogota, Colombia; [Espinal-Ruiz, Mauricio] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Zacarias, Lorenzo] CSIC, Dept Ciencia Alimentos, IATA, Valencia, Spain		Herrera, AO (corresponding author), Edificio Fac Ciencias Agrarias, Carrera 30 45-03,Off 405, Bogota, Colombia.	aoherreraa@unal.edu.co	ZACARIAS, LORENZO/W-2510-2018; Ruiz, Mauricio Espinal/AAC-3141-2020	ZACARIAS, LORENZO/0000-0003-3982-8860; Balaguera Lopez, Helber Enrique/0000-0003-3133-0355; Espinal-Ruiz, Mauricio/0000-0003-1207-1538; Herrera, Anibal/0000-0002-8057-5212				Bai JH, 2005, HORTSCIENCE, V40, P1534, DOI 10.21273/HORTSCI.40.5.1534; Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Beekwilder J, 2004, PLANT PHYSIOL, V135, P1865, DOI 10.1104/pp.104.042580; Blankenship SM, 2003, POSTHARVEST BIOL TEC, V28, P1, DOI 10.1016/S0925-5214(02)00246-6; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Cerqueira TS, 2009, REV BRAS FRUTIC, V31, P687, DOI 10.1590/S0100-29452009000300010; Choi ST, 2008, POSTHARVEST BIOL TEC, V49, P147, DOI 10.1016/j.postharvbio.2008.01.003; Choi ST, 2008, POSTHARVEST BIOL TEC, V48, P206, DOI 10.1016/j.postharvbio.2007.10.008; Defilippi BG, 2005, PLANT SCI, V168, P1199, DOI 10.1016/j.plantsci.2004.12.018; Defilippi BG, 2004, J AGR FOOD CHEM, V52, P5694, DOI 10.1021/jf049504x; Feng XQ, 2000, POSTHARVEST BIOL TEC, V20, P143, DOI 10.1016/S0925-5214(00)00126-5; Fischer G., 1999, Agronomia Colombiana, V16, P35; Fischer G., 2000, Acta Horticulturae, P263; Fischer G, 2011, WOODHEAD PUBL FOOD S, P374; Flores F, 2002, J EXP BOT, V53, P201, DOI 10.1093/jexbot/53.367.201; Fuggate P, 2010, SCI HORTIC-AMSTERDAM, V126, P120, DOI 10.1016/j.scienta.2010.06.019; Galvis J.A., 2005, AVANCES CULTIVO POSC, P165; Gutierrez MS, 2008, POSTHARVEST BIOL TEC, V48, P199, DOI 10.1016/j.postharvbio.2007.10.003; Kays SJ, 2004, POSTHARVEST BIOL, V568; Khan AS, 2007, POSTHARVEST BIOL TEC, V43, P298, DOI 10.1016/j.postharvbio.2006.10.005; Kondo S, 2005, POSTHARVEST BIOL TEC, V36, P61, DOI 10.1016/j.postharvbio.2004.11.005; Lohani S, 2004, POSTHARVEST BIOL TEC, V31, P119, DOI 10.1016/j.postharvbio.2003.08.001; Majumder K, 2002, SCI HORTIC-AMSTERDAM, V96, P91, DOI 10.1016/S0304-4238(02)00079-1; Marin AB, 2009, POSTHARVEST BIOL TEC, V51, P73, DOI 10.1016/j.postharvbio.2008.06.008; Martinez-Javega JM, 2008, P INT SOC CITRICULTU, V11, P1342; Nishiyama K, 2007, J EXP BOT, V58, P1281, DOI 10.1093/jxb/erl283; Novoa R. H., 2006, AGRON COLOMB, V24, P68; Pech JC, 2008, PLANT SCI, V175, P114, DOI 10.1016/j.plantsci.2008.01.003; Rodrigo MJ, 2007, POSTHARVEST BIOL TEC, V43, P14, DOI 10.1016/j.postharvbio.2006.07.008; Serek M, 2006, BIOTECHNOL ADV, V24, P368, DOI 10.1016/j.biotechadv.2006.01.007; Sitrit Y, 1998, PLANT PHYSIOL, V116, P1145, DOI 10.1104/pp.116.3.1145; Sun B, 2012, FOOD CHEM, V131, P519, DOI 10.1016/j.foodchem.2011.09.016; Trinchero GD, 1999, POSTHARVEST BIOL TEC, V16, P139, DOI 10.1016/S0925-5214(99)00011-3; Trivedi PK, 2004, PLANT SCI, V167, P1351, DOI 10.1016/j.plantsci.2004.07.005; Valdenegro M, 2012, POSTHARVEST BIOL TEC, V67, P110, DOI 10.1016/j.postharvbio.2011.12.021; Villalobos-Acuna M, 2008, POSTHARVEST BIOL TEC, V49, P187, DOI 10.1016/j.postharvbio.2008.03.003; Watkins CB, 2006, BIOTECHNOL ADV, V24, P389, DOI 10.1016/j.biotechadv.2006.01.005; Wu SJ, 2006, J ETHNOPHARMACOL, V108, P407, DOI 10.1016/j.jep.2006.05.027; Wu SJ, 2005, BIOL PHARM BULL, V28, P963, DOI 10.1248/bpb.28.963; Yahyaoui FEL, 2002, EUR J BIOCHEM, V269, P2359, DOI 10.1046/j.1432-1033.2002.02892.x; Yang XT, 2011, POSTHARVEST BIOL TEC, V62, P246, DOI 10.1016/j.postharvbio.2011.06.011; Zhang ZK, 2009, POSTHARVEST BIOL TEC, V54, P1, DOI 10.1016/j.postharvbio.2009.06.003	42	10	15	1	30	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1082-0132	1532-1738		FOOD SCI TECHNOL INT	Food Sci. Technol. Int.	JAN	2017	23	1					86	96		10.1177/1082013216658581	http://dx.doi.org/10.1177/1082013216658581			11	Chemistry, Applied; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Food Science & Technology	EG2CK	27440155				2022-09-04	WOS:000390850000008
J	Toro, M; Desainte-Catherine, M; Rueda, C				Toro, Mauricio; Desainte-Catherine, Myriam; Rueda, Camilo			Formal semantics for interactive music scores: a framework to design, specify properties and execute interactive scenarios	JOURNAL OF MATHEMATICS AND MUSIC			English	Article						temporal constraint programming; event structures; concurrency; interaction; ccp; ntcc; synchronization; interactive music scores; concurrent constraint programming		Most interactive scenarios are based on informal specifications, so that it is not possible to formally verify properties of such systems. We advocate the need for a general and formal model aiming at ensuring safe executions of interactive multimedia scenarios. Interactive scores (is) is a formalism based on temporal constraints to describe interactive scenarios. We propose new semantics for is based on timed event structures (TES). With such a semantics, we can specify more properties of the system, in particular, properties about execution traces, which are difficult to specify as constraints. We also present an operational semantics of is based on the non-deterministic timed concurrent constraint calculus and we relate such a semantics to the TES semantics. With the operational semantics, we can describe the behaviour of scores whose timed object durations can be arbitrary integer intervals.	[Toro, Mauricio; Desainte-Catherine, Myriam] Univ Bordeaux, ENSEIRB Matmeca, LaBRI, SCRIME,IPB,UMR 5600, Talence, France; [Rueda, Camilo] Pontificia Univ Javeriana Cali, Cali, Colombia		Toro, M (corresponding author), Univ Bordeaux, ENSEIRB Matmeca, LaBRI, SCRIME,IPB,UMR 5600, Talence, France.	mtoro@cs.ucy.ac.cy	Toro, Mauricio/AAR-1195-2020	Toro, Mauricio/0000-0002-7280-8231; Rueda, camilo/0000-0001-8387-9644				ALLEN JF, 1983, COMMUN ACM, V26, P832, DOI 10.1145/182.358434; Allombert A., 2008, DIMEA ACM INT C P SE, V349, P360; Allombert Antoine, 2009, ASPECTS TEMPORELS SY; Allombert Antoine, 2010, P ICMC 2010; Allombert Antoine, 2006, P SMC 06; Assayag Allombert Antoine, 2008, P JIM 2008; Bresson Jean, 2005, 10 BRAZ S COMP MUS R; Cormen Thomas H., 2001, INTRO ALGORITHMS; DECHTER R, 1991, ARTIF INTELL, V49, P61, DOI 10.1016/0004-3702(91)90006-6; Desainte-Catherine M., 2003, P CIM 19; Gennari R., 1998, CWI QUARTERLY, V11, P3; Langerak R., 1992, P IFIP TC6 WG6 1 5 I, P331; LatellaBaier Christel, 1998, P ICALP 98; Martello Silvano, 1990, KNAPSACK PROBLEMS AL; Muscettola, 1998, P 6 INT C PRINC KNOW, P444; Nielsen M., 2002, Nordic Journal of Computing, V9, P145; Olarte Carlos, 2009, P MATH COMPUTATION M, V38; Planken L., 2010, P 20 INT C AUT PLANN, P129; Puckette Miller, 1998, P ICMC 98; Rueda C, 2004, SOFT COMPUT, V8, P641, DOI 10.1007/S00500-004-0390-7; Saraswat V. A., 1992, CONCURRENT CONSTRAIN; Toro Mauricio, 2009, P ICMC 29; Toro Mauricio, 2010, P SMC 10; Valencia Frank D., 2002, TEMPORAL CONCURRENT; Valencia Frank D., 2005, THEORETICAL COMPUTER, V330, P557; Vickery Lindsay, 2004, P ACMC; Xu L, 2003, TIME-ICTL 2003: 10TH INTERNATIONAL SYMPOSIUM ON TEMPORAL REPRESENTATION AND REASONING AND FOURTH INTERNATIONAL CONFERENCE ON TEMPORAL LOGIC, PROCEEDINGS, P212	27	4	4	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-9737	1745-9745		J MATH MUSIC	J. Math. Music	JAN 2	2014	8	1					93	112		10.1080/17459737.2013.870610	http://dx.doi.org/10.1080/17459737.2013.870610			20	Mathematics, Interdisciplinary Applications; Music	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Mathematics; Music	AE4LB					2022-09-04	WOS:000333952800006
J	Lombo, B; Ibrahim, H; Lievano, M; Diez, J; Fish, D				Lombo, Bernardo; Ibrahim, Homan; Lievano, Marta; Diez, Jose; Fish, David			Prolonged bivalirudin infusion post percutaneous coronary intervention and risk of bleeding	CIRCULATION			English	Meeting Abstract	World Congress of Cardiology Scientific Sessions	APR 18-21, 2012	Dubai, U ARAB EMIRATES						[Lombo, Bernardo] Yale Univ, Hosp St Raphael, New Haven, CT USA; [Ibrahim, Homan] Methodist Hosp, Houston, TX 77030 USA; [Lievano, Marta] Univ Javeriana, Bogota, Colombia; [Diez, Jose] Baylor Coll Med, Houston, TX 77030 USA; [Fish, David] Texas Heart Inst, Houston, TX 77025 USA										0	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	MAY 15	2012	125	19				P581	E868	E868						1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cardiovascular System & Cardiology	981YQ					2022-09-04	WOS:000307009201334
J	Ruiz-Garcia, M; Caceres, AM; Luengas-Villamil, K; Aliaga-Rossel, E; Zeballos, H; Singh, MD; Shostell, JM				Ruiz-Garcia, Manuel; Maria Caceres, Ana; Luengas-Villamil, Kelly; Aliaga-Rossel, Enzo; Zeballos, Horacio; Singh, Michele D.; Mark Shostell, Joseph			Mitogenomic phylogenetics and population genetics of several taxa of agouties (Dasyprocta sp., Dasyproctidae, Rodentia): molecular nonexistence of some claimed endemic taxa	MAMMAL RESEARCH			English	Article						Agouties; Dasyprocta; Mitogenomes; Neotropics; Phylogenetics; Population changes; Spatial genetic structure; Systematics	MITOCHONDRIAL GENOMES; GEOGRAPHIC PATTERNS; STATISTICAL TESTS; MISMATCH ANALYSIS; NEW-WORLD; MAMMALS; SELECTION; SOFTWARE; MODELS; PHYLOGEOGRAPHY	Some neotropical rodents are of special interest because they are an important source of animal protein for human indigenous populations throughout Latin America. This is the case of the genus Dasyprocta (agouties). However, we still do not know how many species, taxa, or lineages are within Dasyprocta. To address this issue, we analyzed the complete mitogenomes of 93 specimens in addition to three mitochondrial genes of 128 specimens of Dasyprocta belonging to six supposed species (D. fuliginosa, D. punctata, D. leporina, D. kalinowski, D. ruatanica, and D. azarae). The phylogenetic results indicated five different lineages within D. fuliginosa, with two being polyphyletic (one more related to D. leporina and another more related to D. punctata). D. kalinowski, a species endemic to Peru, was un-differentiable from one of these D. fuliginosa lineages. D. azarae was related with some of the lineages of D. fuliginosa. Within D. leporina, two significant lineages were found (in central Atlantic Brazil and on the Caribbean islands of Trinidad and Tobago). Within D. punctata, three lineages were detected, one in Central America (central and northern), including D. ruatanica, a supposed endemic species on Roatan Island, Honduras, another in central and southern Panama, and another in trans-Andean and Pacific Colombia and Ecuador. Some of the lineages of D. fuliginosa from the western Amazon yielded the most ancestral haplotypes (around 7 million years ago, MYA, Late Miocene). In contrast, haplotypes of a lineage of D. punctata and those of a lineage of D. leporina (Trinidad and Tobago) were the most derived (around 0.2-0.3 MYA, Pleistocene). Other population genetic results showed that all groups or lineages presented elevated levels of genetic diversity, with the exception D. leporina in Trinidad and Tobago. Their lower genetic diversity is probably related to founder effect during the colonization of the Caribbean island, due to a bottleneck. Some of these Dasyprocta taxa showed some population expansions during the Pleistocene, but all of the lineages experienced some population decrease during the last 10,000-20,000 years. Note that some lineages showed a small population increase in the last few centuries. The spatial genetic structure was highly developed throughout the Neotropics for Dasyprocta. According to this study, (1) coat color (routinely used in the systematics of this rodent) is not valuable from a phylogenetic and systematics perspective and (2) two supposedly endemic species (D. kalinowski and D. ruatanica) were not full species. These results are of vital importance for the biological conservation of the different taxa and lineages of this rodent.	[Ruiz-Garcia, Manuel; Maria Caceres, Ana; Luengas-Villamil, Kelly] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut, Cra 7A,43-82, Bogota, DC, Colombia; [Aliaga-Rossel, Enzo] Univ Mayor San Andres, Inst Ecol, Calle 27 Cota Cota,Campus Univ, La Paz, Bolivia; [Zeballos, Horacio] Univ Catolica Santa Maria, Urb San Jose S-N, Arequipa, Peru; [Singh, Michele D.] Univ West Indies, Fac Food & Agr, St Augustine Campus, St Augustine, Trinidad Tobago; [Mark Shostell, Joseph] Univ Minnesota Crookston, Math Sci & Technol Dept, 2900 Univ Ave, Crookston, MN 56716 USA		Ruiz-Garcia, M (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut, Cra 7A,43-82, Bogota, DC, Colombia.	mruizgar@yahoo.es		Ruiz-Garcia, Manuel/0000-0003-2820-2950				Acosta G, 2018, B SOC GEOL MEX, V70, P1, DOI [10.18268/bsgm2018v70n1a1, 10.18268/BSGM2018v70n1a1]; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen JA, 1915, B AM MUS NAT HIST, V34, P147; Allen JA, 1915, B AM MUS NAT HIST, V34, P625; Alston E. R., 1876, P ZOOL SOC LOND, V1876, P347; Arbogast BS., 1998, SCIENCE, V282; Ascunce MS, 2003, ZOOL SCR, V32, P397, DOI 10.1046/j.1463-6409.2003.00123.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.ecolsys.18.1.489; Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bangs O., 1898, P BIOL SOC WASH, V12, P161; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Brouns G, 2003, J SURV ENG-ASCE, V129, P79, DOI 10.1061/(ASCE)0733-9453(2003)129:2(79); Cabrera A., 1917, TRAB MUS CIEN NAT MA, V31, P1, DOI DOI 10.5962/BHL.TITLE.5769; Cabrera A., 1961, REV MUSEO ARGENTINO, V4, P309, DOI DOI 10.22179/REVMACN.13.214; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clapperton CM, 1993, QUATERNARY GEOLOGY G; Clark PU, 2002, SCIENCE, V298, DOI 10.1126/science.298.5591.7; Da Silva MNF, 1998, MOL ECOL, V7, P475, DOI 10.1046/j.1365-294x.1998.00276.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feijo A, 2013, REV NORDESTINA BIOL, V22, P1, DOI DOI 10.11606/D.41.2006.TDE-16082007-065514; Ferreguetti AC, 2018, STUD NEOTROP FAUNA E, V53, P143, DOI 10.1080/01650521.2018.1434743; Figueira L, 2014, BRAZ J BIOL, V74, P585, DOI 10.1590/bjb.2014.0087; Fredga K., 1966, MAMMAL CHROM NEWSL, V20, P45; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gallina S, 2018, REV MEX BIODIVERS, V89, P1245, DOI 10.22201/ib.20078706e.2018.4.2476; George W, 1974, S ZOOL SOC LOND, V34, P79; Grant WS, 2015, J HERED, V106, P333, DOI 10.1093/jhered/esv020; Gray JE, 1842, ANN MAGAZINE NATURAL, V10, P255, DOI [10.1080/03745484209445232, DOI 10.1080/03745484209445232]; Guschanski K, 2013, SYST BIOL, V62, P539, DOI 10.1093/sysbio/syt018; Hall E.R., 1981, MAMMALS N AM; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hobbs RJ, 1998, CONSERV BIOL, V12, P271, DOI 10.1046/j.1523-1739.1998.96233.x; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Hsu, 1968, ATLAS MAMMALIAN CHRO; Huchon D, 2001, MOL PHYLOGENET EVOL, V20, P238, DOI 10.1006/mpev.2001.0961; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hungerford DA., 1964, AM NAT, V98, P899; Husson A.M., 1978, ZOOLOGISCHE MONOGRAP, V2; Joly C., 2008, BIOTA NEOTROP, V8, P1, DOI 10.1590/s1519-69842008000500019; Jones KR, 2019, SCIENTIFICA, V2019, DOI 10.1155/2019/3759783; Kartavtsev YP, 2011, MITOCHONDR DNA, V22, P55, DOI 10.3109/19401736.2011.588215; Kenup CF, 2018, ORYX, V52, P571, DOI [10.1017/S0030605316001149, 10.1017/s0030605316001149]; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Liais E., 1872, CLIMATS GEOLOGIE FAU, P640; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima, 1998, IHERINGIA SER ZOOL, V85, P141; Linnaeus C, 1758, SYSTEMA NATURAE REGN, VI, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; MacNeish R.S., 1979, PRELLANO CULTURES AM, P1; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; Maslin MA, 2000, SCIENCE, V290, P2285; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; Mayr E., 1942, P1; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mendieta-Aguilar G, 2015, ACTA AMAZON, V45, P45, DOI 10.1590/1809-4392201400283; Menendez-Fernandez, 2013, PREHISTORIA RECIENTE; Meritt D.A. Jr, 1983, Zoo Biology, V2, P127, DOI 10.1002/zoo.1430020205; Miller MA., 2010, GAT COMP ENV WORKSH, P1; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Mittelman P, 2020, BIOTROPICA, V52, P766, DOI 10.1111/btp.12788; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nei M., 1987, MOL EVOLUTIONARY GEN; Nowak R.M., 1999, WALKERS MAMMALS WORL; OJASTI J, 1972, Memoria de la Sociedad de Ciencias Naturales La Salle, V32, P159; Opazo JC, 2005, MOL PHYLOGENET EVOL, V37, P932, DOI 10.1016/j.ympev.2005.05.002; Patton J.L., 2015, MAMMALS S AM, V2, DOI DOI 10.7208/CHICA-G0/9780226169606.001.0001; Patton James L., 2015, P733; Pennington RT, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P373; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Rambaut A., 2012, FIGTREE V1 4 3; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Ramírez-Chaves Héctor E, 2018, Mastozool. neotrop., V25, P139; Ramos RSL, 2003, AN ACAD BRAS CIENC, V75, P55, DOI 10.1590/S0001-37652003000100007; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rodbell DT, 2000, QUATERNARY RES, V54, P328, DOI 10.1006/qres.2000.2177; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers AR, 1996, MOL BIOL EVOL, V13, P895, DOI 10.1093/molbev/13.7.895; Rostworowski M, 1981, COLECCION HIST ANDIN; Rothlisberger, 1987, 10 000 JAHRE GLETSCH; Rowe DL, 2010, J BIOGEOGR, V37, P305, DOI 10.1111/j.1365-2699.2009.02190.x; Ruiz-Garc?a M., 2016, ADV GENETICS RES, P151; Ruiz-Garcia M, 2021, ZOOL RES; Ruiz-Garcia M., 2020, MAMMALIAN CONSERVATI, P165; Ruiz-Garcia M, 2021, ZOOL RES, V42, P525, DOI 10.24272/j.issn.2095-8137.2020.365; Ruiz-Garcia M, 2020, J MAMMAL, V101, P1072, DOI 10.1093/jmammal/gyaa082; Ruiz-Garcia M, 2020, MAMM BIOL, V100, P521, DOI 10.1007/s42991-020-00050-w; Ruiz-Garcia M, 2014, MOL PHYLOGENET EVOL, V79, P179, DOI 10.1016/j.ympev.2014.05.034; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schrider DR, 2016, GENETICS, V204, P1207, DOI 10.1534/genetics.116.190223; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SERVANT M, 1981, CR ACAD SCI II, V292, P1295; Sheehan S, 2013, GENETICS, V194, P647, DOI 10.1534/genetics.112.149096; Silvius KM, 2003, BIOTROPICA, V35, P74, DOI 10.1111/j.1744-7429.2003.tb00264.x; Singh MD, 2018, BRAZ J BIOL, V78, P540, DOI 10.1590/1519-6984.172814; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Souza Ana L. G., 2007, Mastozool. neotrop., V14, P227; Spradling TA, 2001, J MAMMAL, V82, P65, DOI 10.1644/1545-1542(2001)082<0065:DIROCB>2.0.CO;2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SULLIVAN J, 1995, MOL BIOL EVOL, V12, P988; TAJIMA F, 1989, GENETICS, V123, P585; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; Thomas, 1917, ANN MAGAZ NAT HIST S, V8, P310; Thomas O., 1898, Annals of Natural History, Vii, P265; Thomas O, 1920, ANN MAGAZINE NATURAL, V5, P188; Thomas O., 1897, ANN MAGAZINE NATUR 6, V20, P218; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Upham N.S., 2015, BIOL CAVIOMORPH RODE, P63; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Van der Hammen T, 2001, DIVERSIDADE BIOL CUL, P19; Van der Hammen T., 1992, ERDKUNDE, V46, P252; Van Vuuren BJ, 2004, BIOL J LINN SOC, V81, P203, DOI 10.1111/j.1095-8312.2003.00278.x; VANDERHAMMEN T, 1992, HIST ECOLOGIA VEGETA; VANEGAS L, 2016, BIOTA COLOMB, V17, P26, DOI DOI 10.21068/C2016v17r01a03; Von Tschudi, 1845, ST GALLEN, V1, P1; Von Tschudi J. J., 1845, UNTERSUCHUNGEN FAUNA, P77, DOI DOI 10.5962/BHL.TITLE.60791; Voss Robert S., 2001, Bulletin of the American Museum of Natural History, V263, P1; Wagler J, 1832, ISIS OKEN, V25, P1218; Watson D.F., 1992, CONTOURING GUIDE ANA; West RG, 1967, QUATERNARY, V2, P1; Wilson D.E., 1993, MAMMAL SPECIES WORLD; Woods CA, 2005, MAMMAL SPECIES WORLD, V1, P1538; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615	148	0	1	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2199-2401	2199-241X		MAMMAL RES	Mammal Res.	JUL	2022	67	3					367	397		10.1007/s13364-022-00626-6	http://dx.doi.org/10.1007/s13364-022-00626-6		MAR 2022	31	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	1X5UG					2022-09-04	WOS:000765697900001
J	Fernandez, N; Chavarriaga, J; Ayala, P; Pedraza, A; Bolivar, J; Prada, JG; Catano, JG; Garcia-Perdomo, HA; Villanueva, J; Varela, D; Zarante, I				Fernandez, Nicolas; Chavarriaga, Julian; Ayala, Paola; Pedraza, Adriana; Bolivar, John; Guillermo Prada, Juan; Guillermo Catano, Juan; Andres Garcia-Perdomo, Herney; Villanueva, Juliana; Varela, Daniela; Zarante, Ignacio			MicroRNAs as Potential Liquid Biopsy Biomarker for Patients with Castration-Resistant Prostate Cancer	RESEARCH AND REPORTS IN UROLOGY			English	Article						prostatic neoplasm; prostatic neoplasms; castration-resistant; microRNAs; biomarkers; genital neoplasms; male	DOWN-REGULATION; EXPRESSION; PROTEIN; MIRNAS	Purpose: To identify micro-RNAs (miRNAs) expression profiles in peripheral blood plasma that could play a role as potential biomarkers in patients who progressed to castration-resistant prostate cancer (CRPC). Liquid biopsy analysis of miRNAs is a fast-developing field with a considerable likelihood to predict tumor progression and metastasis by targeting genes involved in oncogenesis. Patients and Methods: Differential expression analysis of miRNAs profile in CRPC patients was performed by creating small RNA libraries of circulating miRNAs using HiSeq2500 Illumina platform. A secondary analysis of aligned reads with miRNA identification and quantification was performed using miARmaSeq. Using the Bowtie algorithm, the selected variants were compared to reference nucleotide sequence GRCh38 and miRbase. Novel miRNA sequences were structurally analyzed using mirDeep2 (R). Results: A total of 16 patients with CRPC were included for analysis. Identified circulating miRNAs were hsa-miR-885-3p, hsa-miR -4467, hsa-miR-4686, hsa-miR-146a-3p, hsa-miR-6514-5p. Genes identified as regulated by these miRNAs were GPR56, BDNF, CTNND1, C17orf62, and DTNA. Conclusion: We explored the miRNA expression profile in patients with CRPC, identifying five miRNAs implicated in the regulation of genes involved in prostate cancer (PCa) oncogenesis and progression. We also found miRNA 855-3p in peripheral blood for the first time, which has a critical role in tumor growth mechanisms and higher expression profile than in healthy individuals.	[Fernandez, Nicolas] Univ Washington, Div Urol, Seattle Childrens Hosp, 5801 Sand Point Way NE, Seattle, WA 98105 USA; [Chavarriaga, Julian] Clin Imbanaco Quiron Salud, Div Urol, Cali, Colombia; [Ayala, Paola; Zarante, Ignacio] Pontificia Univ Javeriana, Human Genet Inst, Bogota, Colombia; [Pedraza, Adriana] Clin Desa, Div Urol, Cali, Colombia; [Bolivar, John] Hosp Univ San Ignacio, Dept Surg, Div Urol, Bogota, Colombia; [Guillermo Prada, Juan; Guillermo Catano, Juan; Villanueva, Juliana; Varela, Daniela] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Urol, Bogota, Colombia; [Andres Garcia-Perdomo, Herney] Univ Valle, Dept Surg, Div Urol, Cali, Colombia		Fernandez, N (corresponding author), Univ Washington, Div Urol, Seattle Childrens Hosp, 5801 Sand Point Way NE, Seattle, WA 98105 USA.	nicolas.fernandez@seattlechildrens.org		Pedraza Bermeo, Adriana Marcela/0000-0003-3275-7019; Villanueva Congote, Juliana/0000-0002-0700-5686; Varela, Daniela/0000-0002-3772-6177; Ayala Ramirez, Paola/0000-0002-0141-1149				Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Benoist GE, 2020, CLIN CHEM, V66, P842, DOI 10.1093/clinchem/hvaa095; Bhagirath D, 2018, CANCER RES, V78, P1833, DOI 10.1158/0008-5472.CAN-17-2069; Boerrigter Emmy, 2021, Molecular Oncology, V15, DOI 10.1002/1878-0261.12933; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Bryzgunova OE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215003; Cornford P, 2017, EUR UROL, V71, P630, DOI 10.1016/j.eururo.2016.08.002; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Endzelins E, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3737-z; Erdmann K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-82; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Foj L, 2017, PROSTATE, V77, P573, DOI 10.1002/pros.23295; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Huang XY, 2015, EUR UROL, V67, P33, DOI 10.1016/j.eururo.2014.07.035; Huang XY, 2013, INT J MOL SCI, V14, P14785, DOI 10.3390/ijms140714785; Konoshenko MY, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10010038; Lekchnov EA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124088; Li J, 2016, INT J ONCOL, V49, P838, DOI 10.3892/ijo.2016.3560; Li Z, 2015, ONCOTARGETS THER, V9, P139, DOI 10.2147/OTT.S95565; Lin HM, 2014, BRIT J CANCER, V110, P2462, DOI 10.1038/bjc.2014.181; Lin PC, 2013, CANCER RES, V73, P1232, DOI 10.1158/0008-5472.CAN-12-2968; Na R, 2016, ASIAN J ANDROL, V18, P575, DOI 10.4103/1008-682X.175096; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Pasqualini L, 2015, MOL ENDOCRINOL, V29, P1037, DOI 10.1210/me.2014-1358; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Schaefer A, 2010, NAT REV UROL, V7, P286, DOI 10.1038/nrurol.2010.45; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Selth LA, 2017, ONCOGENE, V36, P24, DOI 10.1038/onc.2016.185; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573; Thieu W, 2014, UROL ONCOL-SEMIN ORI, V32, P517, DOI 10.1016/j.urolonc.2013.11.004; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Wang SY., 2014, PLOS ONE, V9, P6; Watahiki A, 2013, INT J MOL SCI, V14, P7757, DOI 10.3390/ijms14047757; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; White RWD, 2009, UROL ONCOL-SEMIN ORI, V27, P307, DOI 10.1016/j.urolonc.2009.01.004	36	0	0	1	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	2253-2447			RES REP UROL	RES. REP. UROL.		2022	14						63	70		10.2147/RRU.S332578	http://dx.doi.org/10.2147/RRU.S332578			8	Urology & Nephrology	Emerging Sources Citation Index (ESCI)	Urology & Nephrology	ZO4QL	35257006	gold, Green Published			2022-09-04	WOS:000765710600001
J	Hoyos, LR; Davoodi-Bilesavar, R; Patil, UD; Yepes-Heredia, JE; Perez-Ruiz, DD; Cruz, JA				Hoyos, Laureano R.; Davoodi-Bilesavar, Roya; Patil, Ujwalkumar D.; Yepes-Heredia, Jairo E.; Perez-Ruiz, Diego D.; Cruz, Jose A.			Behavior of unsaturated cohesive-frictional soils over a whole range of suction/thermo-controlled stress paths and modes of deformation	SOILS AND ROCKS			English	Article						Suction-controlled testing; Triaxial testing; True triaxial testing; Plane strain testing; Ring shear testing; Resonant column testing	RING SHEAR APPARATUS; CRITICAL-STATE; MECHANICAL-BEHAVIOR; ELASTOPLASTIC MODEL; CONSTITUTIVE MODEL; SILT; FRAMEWORK; CALIBRATION; VOLUME	The present work documents some of the most recent experimental evidence of the thermohydro-mechanical behavior of compacted soils over a whole range of suction- and/or thermo-controlled stress paths and modes of deformation, including data from a series of triaxial, true triaxial, plane strain, ring shear, and resonant column tests conducted on different types of cohesive-frictional soils in the low-to-medium matric suction range under either room temperature or thermally controlled conditions. The work has been accomplished at the Advanced Geomechanics Laboratory of the University of Texas at Arlington, focusing primarily on the following essential features of unsaturated soil behavior: (1) Loading-collapse and apparent tensile strength loci assessed from suction-controlled triaxial and true triaxial testing on clayey sand, (2) Critical state lines from suction-controlled plane strain testing on silty soil, (3) Peak and residual failure envelopes from suction-controlled ring shear testing on clayey soil, (4) Frequency response curves and cyclic stress-strain hysteretic loops from thermo-controlled, constant-water content resonant column testing on clayey soil, and (5) Residual failure envelopes from suction/thermo-controlled ring shear testing on clayey soil. The work is intended to serve as a succinct yet reasonably thorough state-of-the-art paper contribution to PanAm-UNSAT 2021: Third Pan-American Conference on Unsaturated Soils, Rio de Janeiro, Brazil, July 21-25, 2021.	[Hoyos, Laureano R.; Davoodi-Bilesavar, Roya] Univ Texas Arlington, Dept Civil Engn, Arlington, TX 76019 USA; [Patil, Ujwalkumar D.] Univ Guam, Sch Engn, Mangilao, GU USA; [Yepes-Heredia, Jairo E.] Texas A&M Univ, Dept Civil & Environm Engn, College Stn, TX 77843 USA; [Perez-Ruiz, Diego D.] Pontificia Univ Javeriana, Dept Ciencias Ingn, Cali, Colombia; [Cruz, Jose A.] Univ Mil Nueva Granada, Fac Ingn, Bogota, Colombia		Hoyos, LR (corresponding author), Univ Texas Arlington, Dept Civil Engn, Arlington, TX 76019 USA.	hoyos@uta.edu		Yepes-Heredia, Jairo E./0000-0001-7981-2690; Cruz, Jose A/0000-0002-8049-9459	U.S. National Science Foundation (NSF) [MRI-1039956, MRI-0216545, CMS-0626090]	U.S. National Science Foundation (NSF)(National Science Foundation (NSF))	The core systems of the upgraded TX, TTX and RS devices were developed under the auspices of the U.S. National Science Foundation (NSF) : Awards MRI-1039956, MRI-0216545 and CMS-0626090, respectively. This support is gratefully acknowledged. Any findings, conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF. The authors would also like to acknowledge the invaluable suggestions made by Drs. Anand J. Puppala, Aritra Banerjee and Arcesio Lizcano throughout this effort, as well as the technical advice from Mr. Peter Goguen of Geotechnical Consulting and Testing Systems (GCTS) . Last but not least, the authors appreciate the opportunity offered by Drs. Tacio M.P. de Campos, Fernando A.M. Marinho, and Gilson Gitirana Jr. to submit a state-of-the-art paper contribution to PanAm-UNSAT 2021.	Adams BA, 1997, EUR J SOIL SCI, V48, P739, DOI 10.1046/j.1365-2389.1997.00112.x; ALONSO EE, 1990, GEOTECHNIQUE, V40, P405, DOI 10.1680/geot.1990.40.3.405; Alsherif NA, 2016, GEOTECH GEOL ENG, V34, P501, DOI 10.1007/s10706-015-9961-x; Alshibli K, 2004, GEOTECH TEST J, V27, P337; Bolzon G, 1996, GEOTECHNIQUE, V46, P279, DOI 10.1680/geot.1996.46.2.279; Cekerevac C, 2004, INT J NUMER ANAL MET, V28, P209, DOI 10.1002/nag.332; Cheng Q, 2017, SPRINGER SER GEOMECH, P191, DOI 10.1007/978-3-319-52773-4_21; Chiu CF, 2003, GEOTECHNIQUE, V53, P809, DOI 10.1680/geot.53.9.809.37426; Cruz J.A., 2011, UNSATURATED SOILS RE, V1, P233, DOI [10.1201/B17034-14, DOI 10.1201/B17034-14]; Cui YJ, 1996, GEOTECHNIQUE, V46, P291, DOI 10.1680/geot.1996.46.2.291; Davoodi-Bilesavar R, 2020, DYNAMIC PROPERTIES C; Drescher A., 1990, GEOTECH TEST J, V13, P226, DOI [10.1520/GTJ10161J, DOI 10.1520/GTJ10161J]; Estabragh AR, 2015, INT J GEOMECH, V15, DOI 10.1061/(ASCE)GM.1943-5622.0000422; Estabragh AR, 2004, CAN GEOTECH J, V41, P540, DOI 10.1139/T04-007; HARDIN B O, 1972, J SOIL MECH FDN DIVI, V98, P603; Hoyos LR, 2012, INT J GEOMECH, V12, P292, DOI 10.1061/(ASCE)GM.1943-5622.0000159; Hoyos LR, 2001, GEOTECH TEST J, V24, P5; Sedano JAI, 2007, GEOTECH TEST J, V30, P39; Janoo V.C, 1986, DRAINED UNDRAINED BE; Kramer S., 1996, GEOTECHNICAL EARTHQU, P633; Liu CY, 2012, INT J GEOMECH, V12, P248, DOI 10.1061/(ASCE)GM.1943-5622.0000147; Lu N., 2004, UNSATURATED SOIL MEC; Maatouk A, 1995, GEOTECHNIQUE, V45, P465, DOI 10.1680/geot.1995.45.3.465; Matsuoka H, 2002, CAN GEOTECH J, V39, P608, DOI 10.1139/T02-031; Merchan V, 2011, GEOTECH TEST J, V34, P433; Ng CWW, 2014, GEOTECHNIQUE, V64, P709, DOI 10.1680/geot.14.P.015; Patil U.D, 2014, RESPONSE UNSATURATED; Perez-Ruiz D.D, 2009, REFINED TRUE TRIAXIA; Prakash S., 1981, SOIL DYNAMICS; Rampino C, 2000, CAN GEOTECH J, V37, P748, DOI 10.1139/cgj-37-4-748; Reis RM, 2011, GEOTECH TEST J, V34, P177; Sheng D, 2008, CAN GEOTECH J, V45, P511, DOI 10.1139/T07-112; Sivakumar V, 2000, GEOTECHNIQUE, V50, P359, DOI 10.1680/geot.2000.50.4.359; SIVAKUMAR V, 1993, CRITICAL STATE FRAME; Sture S., 1979, GEOTECH TEST J, V2, P20; Tang GX, 2002, CAN GEOTECH J, V39, P894, DOI 10.1139/T02-024; Thu TM, 2007, SOILS FOUND, V47, P749, DOI 10.3208/sandf.47.749; TOLL DG, 1990, GEOTECHNIQUE, V40, P31, DOI 10.1680/geot.1990.40.1.31; Uchaipichat A, 2009, GEOTECHNIQUE, V59, P339, DOI 10.1680/geot.2009.59.4.339; Usmani A, 2012, INT J GEOMECH, V12, P323, DOI 10.1061/(ASCE)GM.1943-5622.0000144; Vanapalli SK, 1996, CAN GEOTECH J, V33, P379, DOI 10.1139/t96-060; VARDOULAKIS I, 1985, GEOTECHNIQUE, V35, P299, DOI 10.1680/geot.1985.35.3.299; Velosa C.L, 2011, UNSATURATED SOIL BEH; Wang Q, 2002, CAN GEOTECH J, V39, P213, DOI 10.1139/T01-086; Wheeler SJ, 1996, CAN GEOTECH J, V33, P42, DOI 10.1139/t96-023; Wheeler SJ, 1995, GEOTECHNIQUE, V45, P35, DOI 10.1680/geot.1995.45.1.35; Wood C.C., 1958, SHEAR STRENGTH VOLUM; Yepes J.E, 2015, THERMO HYDRO MECH BE; Zhang X, 2011, INT J GEOMECH, V11, P174, DOI 10.1061/(ASCE)GM.1943-5622.0000076	49	0	0	5	6	BRAZILIAN SOC SOIL MECHANICS & GEOTECHNICAL ENGINEERING	SAO PAULO	AV PROF ALMEIDA PRADO, 532, IPT, PREDIO 54, SAO PAULO, 05508-901, BRAZIL	1980-9743			SOILS ROCKS	Soils Rocks	JUL-SEP	2021	44	3			SI				e2021066621	10.28927/SR.2021.066621	http://dx.doi.org/10.28927/SR.2021.066621			12	Engineering, Geological	Emerging Sources Citation Index (ESCI)	Engineering	YB5BY		gold			2022-09-04	WOS:000739028900005
J	Caviedes-Bucheli, J; Lopez-Moncayo, LF; Munoz-Alvear, HD; Gomez-Sosa, JF; Diaz-Barrera, LE; Curtidor, H; Munoz, HR				Caviedes-Bucheli, Javier; Fernando Lopez-Moncayo, Luis; Dario Munoz-Alvear, Hernan; Francisco Gomez-Sosa, Jose; Eduardo Diaz-Barrera, Luis; Curtidor, Hernando; Roberto Munoz, Hugo			Expression of substance P, calcitonin gene-related peptide and vascular endothelial growth factor in human dental pulp under different clinical stimuli	BMC ORAL HEALTH			English	Article						SP; CGRP; VEGF; Occlusal trauma; Orthodontics force; Neurogenic inflammation		BackgroundThe aim of this study was to measure the dental pulp inflammatory response through neuropeptides (SP and CGRP) as a response to occlusal trauma, orthodontic movements and a combination of both, as well as the angiogenic defense mechanism through VEGF expression, which could be the initial step to mineralized tissue formation.MethodsForty human dental pulp samples were collected from healthy first premolars with extraction indicated due to orthodontic reasons from a sample of 20 patients. Patients were divided into four groups with 10 premolars each (1 mandibular and 1 maxillary premolar from each patient): healthy pulp control group, occlusal trauma group, moderate orthodontic forces group; and occlusal trauma plus moderate orthodontic forces group. Stimuli were applied for 24 h before tooth extraction in all experimental groups. All samples were processed, and SP, CGRP, and VEGF were measured by radioimmunoassay. The Kruskal-Wallis test was performed to assess significant differences among groups and Mann-Whitney's U post hoc pairwise comparisons were also performed.ResultsThe highest increase in SP, CGRP, and VEGF expressions was found in the occlusal trauma plus orthodontic forces group, followed by the moderate orthodontic forces, the occlusal trauma and the control groups, with statistically significant differences between all groups for each of the 3 peptides analyzed (Kruskal-Wallis p<0.001). All possible pairwise post-hoc comparisons were also significant for each peptide analyzed (Mann-Whitney's U p<0.001).ConclusionSP, CGRP, and VEGF expressions significantly increase in human dental pulps when stimulated by occlusal trauma combined with moderate orthodontic forces, as compared with these two stimuli applied independently.Name of the registry: Importance of Neurogenic Inflammation in the Angiogenic Response of the Dental Pulp as a Defensive Response.Trial registration number: NCT03804034.Date of registration: 01/15/2019 Retrospectively registered.URL of trial registry record: https://clinicaltrials.gov/ct2/show/NCT03804034?term=NCT03804034&draw=2&rank=1.	[Caviedes-Bucheli, Javier] Pontificia Univ Javeriana, Ctr Invest Odontol, Bogota, Colombia; [Caviedes-Bucheli, Javier; Fernando Lopez-Moncayo, Luis; Dario Munoz-Alvear, Hernan] Univ Cooperat Colombia, Endodont Dept, Pasto, Colombia; [Francisco Gomez-Sosa, Jose] Univ Cent Venezuela, Postgrad Endodont Dept, Caracas, Venezuela; [Eduardo Diaz-Barrera, Luis] Univ La Sabana, Engineer Sch, Chia, Colombia; [Curtidor, Hernando] Univ Rosario, Bogota, Colombia; [Roberto Munoz, Hugo] Univ San Carlos, Endodont Dept, Guatemala City, Guatemala		Caviedes-Bucheli, J (corresponding author), Pontificia Univ Javeriana, Ctr Invest Odontol, Bogota, Colombia.; Caviedes-Bucheli, J (corresponding author), Univ Cooperat Colombia, Endodont Dept, Pasto, Colombia.	javiercaviedes@gmail.com	Barrera, Luis Eduardo Díaz/U-2706-2019	Barrera, Luis Eduardo Díaz/0000-0002-9588-9935; Gomez-Sosa, Jose Francisco/0000-0002-2307-6214; Caviedes-Bucheli, Javier/0000-0003-0407-9847; Munoz, Hugo RobertO/0000-0001-6456-0566; MUNOZ ALVEAR, HERNAN DARIO/0000-0002-4327-4242				Arana-Chavez VE, 2004, INT J BIOCHEM CELL B, V36, P1367, DOI 10.1016/j.biocel.2004.01.006; Aranha AMF, 2010, J ENDODONT, V36, P1633, DOI 10.1016/j.joen.2010.05.013; Artese L, 2002, J ENDODONT, V28, P20, DOI 10.1097/00004770-200201000-00005; Caviedes-Bucheli J, 2006, INT ENDOD J, V39, P394, DOI 10.1111/j.1365-2591.2006.01093.x; Caviedes-Bucheli J, 2017, INT ENDOD J, V50, P339, DOI 10.1111/iej.12627; Caviedes-Bucheli J, 2008, J ENDODONT, V34, P773, DOI 10.1016/j.joen.2008.03.010; Caviedes-Bucheli J, 2011, J ENDODONT, V37, P934, DOI 10.1016/j.joen.2011.03.035; Caviedes-Bucheli J, 2011, J ENDODONT, V37, P627, DOI 10.1016/j.joen.2011.02.013; Derringer KA, 2003, ARCH ORAL BIOL, V48, P285, DOI 10.1016/S0003-9969(03)00008-6; El Karim IA, 2009, J ENDODONT, V35, P829, DOI 10.1016/j.joen.2009.03.005; Ikeda T, 1998, J ORAL REHABIL, V25, P589; Killough SA, 2009, J ENDODONT, V35, P73, DOI 10.1016/j.joen.2008.10.010; Lee YH, 2013, J ENDODONT, V39, P340, DOI 10.1016/j.joen.2012.10.031; Lundy FT, 2004, CRIT REV ORAL BIOL M, V15, P82, DOI 10.1177/154411130401500203; Mattuella LG, 2007, J ENDODONT, V33, P524, DOI 10.1016/j.jeon.2007.01.003; Mishima T, 2011, AM J PHYSIOL-HEART C, V300, pH431, DOI 10.1152/ajpheart.00466.2010; Olsson M, 2002, EUR J ORTHODONT, V24, P677, DOI 10.1093/ejo/24.6.677; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rechenberg DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167289; Ren YJ, 2003, ANGLE ORTHOD, V73, P86; Roberts-Clark DJ, 2000, ARCH ORAL BIOL, V45, P1013, DOI 10.1016/S0003-9969(00)00075-3; Romer P, 2014, CELL TISSUE RES, V355, P173, DOI 10.1007/s00441-013-1739-y; Rombouts C, 2017, J DENT RES, V96, P137, DOI 10.1177/0022034516671688; Saghiri MA, 2015, J ENDODONT, V41, P797, DOI 10.1016/j.joen.2014.12.019; Sakdee JB, 2009, J ENDODONT, V35, P818, DOI 10.1016/j.joen.2009.03.001; Tran-Hung L, 2006, J DENT RES, V85, P819, DOI 10.1177/154405910608500908; Tuo YH, 2013, J RECEPT SIG TRANSD, V33, P114, DOI 10.3109/10799893.2013.770528; Uddman R, 1999, ARCH ORAL BIOL, V44, P1, DOI 10.1016/S0003-9969(98)00102-2; von Bohl M, 2012, J ENDODONT, V38, P1463, DOI 10.1016/j.joen.2012.07.001; Wei F, 2015, MEDIATORS INFLAMM, P1; Zheng SA, 2010, AM J PHYSIOL-CELL PH, V299, pC1485, DOI 10.1152/ajpcell.00173.2010	31	2	2	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6831			BMC ORAL HEALTH	BMC Oral Health	MAR 23	2021	21	1							152	10.1186/s12903-021-01519-x	http://dx.doi.org/10.1186/s12903-021-01519-x			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	RF3WW	33757513	Green Published, Green Submitted, gold			2022-09-04	WOS:000634772800005
J	Ostos, AB; Moreno, S; Romero, AG; Toro, CE; Mora, C; Avila, DGF; Gualtero, JMB; LaTorre, MC; Barrios, MC; Patarroyo, PM; Molano, WB				Beltran Ostos, Adriana; Moreno, Sergio; Gonzalez Romero, Andres; Enrique Toro, Carlos; Mora, Claudia; Fernandez Avila, Daniel G.; Bello Gualtero, Juan Manuel; Constanza LaTorre, Maria; Charry Barrios, Marlio; Mendez Patarroyo, Paul; Bautista Molano, Wilson			CHARACTERIZATION OF THE EMPLOYMENT CONDITIONS OF RHEUMATOLOGISTS IN COLOMBIA	JCR-JOURNAL OF CLINICAL RHEUMATOLOGY			English	Meeting Abstract									[Beltran Ostos, Adriana; Moreno, Sergio] Cent Mil Hosp, Teaching & Res Dept, Bogota, Colombia; [Gonzalez Romero, Andres] Fracture Risk CAYRE, Res Subdirectorate, Bogota, Colombia; [Enrique Toro, Carlos] Refernce Ctr Osteoporosis & Rheumatol, Cali, Colombia; [Mora, Claudia] Univ Sabana, Dept Internal Med, Bogota, Colombia; [Fernandez Avila, Daniel G.] Pontificia Univ Javeriana, San Ignacio Univ Hosp, Bogota, Colombia; [Bello Gualtero, Juan Manuel] Univ Mil Nueva Granada, Cent Mil Hosp, Dept Rheumatol & Immunol, Sch Med,Clin Immunol Grp, Bogota, Colombia; [Constanza LaTorre, Maria] Colombian Rheumatol Assoc, Country Med Ctr, Bogota, Colombia; [Charry Barrios, Marlio] Colombian Rheumatol Assoc, Bogota, Colombia; [Mendez Patarroyo, Paul; Bautista Molano, Wilson] Univ Hosp Fdn Santa Fe Bogota, Dept Rheumatol, Bogota, Colombia					Fernandez-Avila, Daniel/0000-0003-1490-1822					0	0	0	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-1608	1536-7355		JCR-J CLIN RHEUMATOL	JCR-J. Clin. Rheumatol.	APR	2020	26			3		344	109	109						1	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Rheumatology	LK2AZ					2022-09-04	WOS:000530661500297
J	Florez, D; Schitz, D; Piquet, H; Diez, R				Florez, David; Schitz, Dmitry; Piquet, Hubert; Diez, Rafael			Efficiency of an Exciplex DBD Lamp Excited Under Different Methods	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Dielectric-barrier discharge (DBD); exciplex lamp; pulsed voltage; resonant converter; ultraviolet	DIELECTRIC BARRIER DISCHARGE; WINDING LOSSES; EXCIMER LAMPS; EXCILAMPS; POWER; MODE; TRANSFORMERS; HARMONICS; FREQUENCY; DESIGN	Three different electrical generators have been designed and used to supply an exciplex dielectric barrier discharge lamp in order to elucidate the influence of each one of these supplying strategies over the system performance; the first method consists on supplying the lamp with short bipolar voltage pulses; the second and third methods are based on semiresonant converters were current pulses, of controlled duration and magnitude, are injected into the lamp. For each one of the generators, measurements of the lamp and supply efficiency, are performed and analyzed, at different levels of power (up to 130 W) and operating frequencies (60-90 kHz). From the experimental results, the pulsed voltage-mode approach has allowed obtaining the highest lamp efficiency (7%), yet the maximum supply efficiency is offered by the resonant mode supplies. On the basis of the lamp and the supply efficiencies, the whole system performance is analyzed.	[Florez, David] Univ Sergio Arboleda, Escuela Ciencias Exactas & Ingn, Bogota 110221, Colombia; [Schitz, Dmitry] Immanuel Kant Baltic Fed Univ, Lab Opt Radiat, Kaliningrad 236001, Russia; [Piquet, Hubert] Univ Toulouse, CNRS, Lab Plasma & Convers Energie, INPT, F-31071 Toulouse, France; [Diez, Rafael] Pontificia Univ Javeriana, Dept Elect Engn, Bogota 110231, Colombia		Florez, D (corresponding author), Univ Sergio Arboleda, Escuela Ciencias Exactas & Ingn, Bogota 110221, Colombia.	david.florez@usa.edu.co; DSchitz@kantiana.ru; hubert.piquet@laplace.univ-tlse.fr; rdiez@javeriana.edu.co	Piquet, Hubert/D-4396-2013; Schitz, Dmitry/U-1709-2017	Piquet, Hubert/0000-0002-3736-2676; Schitz, Dmitry/0000-0002-0477-8456; Florez, David/0000-0002-1666-1247; Diez, Rafael/0000-0002-8107-2844	ECOS Nord Program [C16P01]; Pontificia Universidad Javeriana [7349]; Universidad Sergio Arboleda [IN.BG.086.17.001/4]; Ministry of Education and Science of the Russian Federation [2014/60/2809]	ECOS Nord Program; Pontificia Universidad Javeriana; Universidad Sergio Arboleda; Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported in part by the ECOS Nord Program under Project C16P01, in part by Pontificia Universidad Javeriana under Project 7349, in part by the Universidad Sergio Arboleda under Project IN.BG.086.17.001/4, and in part by the Ministry of Education and Science of the Russian Federation under Project 2014/60/2809. The review of this paper was arranged by Senior Editor W. Jiang.	Viejo CB, 2011, IEEE T IND APPL, V47, P1983, DOI 10.1109/TIA.2011.2155014; Bonnin X., 2013, P 15 EUR C POW EL AP, P1; Bonnin X, 2013, EUR PHYS J-APPL PHYS, V64, DOI 10.1051/epjap/2013130080; Carman RJ, 2004, J PHYS D APPL PHYS, V37, P2399, DOI 10.1088/0022-3727/37/17/010; Cousineau M, 2012, IEEE T IND ELECTRON, V59, P1920, DOI 10.1109/TIE.2011.2116761; Diez R, 2007, EUR PHYS J-APPL PHYS, V37, P307, DOI 10.1051/epjap:2007017; Diez Rafael, 2008, 2008 IEEE International Symposium on Industrial Electronics (ISIE 2008), P62, DOI 10.1109/ISIE.2008.4677220; Diez R, 2015, IEEE T PLASMA SCI, V43, P452, DOI 10.1109/TPS.2014.2370796; Florez D, 2016, IEEE T PLASMA SCI, V44, P1160, DOI 10.1109/TPS.2016.2568461; Florez D, 2014, IEEE T IND APPL, V50, P86, DOI 10.1109/TIA.2013.2271216; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; Heuer K, 2015, NITRIC OXIDE-BIOL CH, V44, P52, DOI 10.1016/j.niox.2014.11.015; Kuroki T, 2013, IEEE T IND APPL, V49, P293, DOI 10.1109/TIA.2012.2228612; Makarov M, 1996, J PHYS D APPL PHYS, V29, P350, DOI 10.1088/0022-3727/29/2/011; Matafonova G, 2012, CHEMOSPHERE, V89, P637, DOI 10.1016/j.chemosphere.2012.06.012; Meisser M, 2011, APPL POWER ELECT CO, P1180, DOI 10.1109/APEC.2011.5744743; Monge-Dauge C, 2012, IEEE T PLASMA SCI, V40, P2254, DOI 10.1109/TPS.2012.2207407; Murthy-Bellur D, 2010, IET POWER ELECTRON, V3, P804, DOI 10.1049/iet-pel.2009.0289; Oda A, 1999, J PHYS D APPL PHYS, V32, P2726, DOI 10.1088/0022-3727/32/21/304; Piquet H, 2010, IEEE T PLASMA SCI, V38, P2531, DOI 10.1109/TPS.2010.2060735; Robert E, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/13/135202; SIEMENS W, 1857, ANN PHYS, V178, P66, DOI DOI 10.1002/ANDP.18571780905; Smajic J, 2012, IEEE T MAGN, V48, P827, DOI 10.1109/TMAG.2011.2171926; Sosnin EA, 2015, INSTRUM EXP TECH+, V58, P309, DOI 10.1134/S0020441215030124; Taleghani AS, 2012, IEEE T PLASMA SCI, V40, P1434, DOI 10.1109/TPS.2012.2187683; Tarasenko V., 2011, J LIGHT VISUAL ENV, V35, P227; Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080; Vezzu G, 2009, IEEE T PLASMA SCI, V37, P890, DOI 10.1109/TPS.2009.2015452; Voronov A., 2008, 2008 17 INT C GAS DI, P501	29	6	6	0	7	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	JAN	2018	46	1					140	147		10.1109/TPS.2017.2777835	http://dx.doi.org/10.1109/TPS.2017.2777835			8	Physics, Fluids & Plasmas	Science Citation Index Expanded (SCI-EXPANDED)	Physics	FT0ES		Green Submitted			2022-09-04	WOS:000422795000018
J	Cortes, LY; Kovalskys, I; Salas, GG; Fisberg, M; Garcia, MCY; Pareja, RP; Herrera-Cuenca, M; Rigotti, A; Nogueira, P				Cortes, Lilia Yadira; Kovalskys, Irina; Gomez Salas, Georgina; Fisberg, Mauro; Yepez Garcia, Martha Cecilia; Pareja, Rossina Pareja; Herrera-Cuenca, Marianella; Rigotti, Attilio; Nogueira, Previdelli			MAJOR FOOD SOURCES FOR ENERGY AMONG COUNTRIES OF ELANS: ARE WE ALIKE?	ANNALS OF NUTRITION AND METABOLISM			English	Meeting Abstract						Energy intake; Main source of energy; Energy distribution			[Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Biochem, Bogota, Colombia; [Kovalskys, Irina] Int Life Sci Inst, Buenos Aires, DF, Argentina; [Gomez Salas, Georgina] Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose, Costa Rica; [Fisberg, Mauro] Hosp Infantil Sabara, Inst Pensi, Sao Paulo, Brazil; [Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador; [Pareja, Rossina Pareja] Inst Invest Nutr, Lima, Peru; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Fdn Bengoa, Ctr Estudios Desarrollo, Caracas, Venezuela; [Rigotti, Attilio] Pontificia Univ Catolica, Escuela Med, Dept Nutr Diabet & Metab, Ctr Nutr Mol & Enfermedades Cron, Santiago, Chile; [Nogueira, Previdelli] Univ Sao Judas Tadeu Sao Paulo, Fac Ciencias Biol & Saude, Sao Paulo, Brazil				Cortes, Lilia Yadira/AAF-2960-2019; Fisberg, Mauro/E-7149-2010	Fisberg, Mauro/0000-0003-2992-3215	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	The ELANS is supported by a scientific grant from the Coca Cola Company and support from the Instituto Pensi/Hospital Infantil Sabara, International Life Science Institute of Argentina, Universidad de Costa Rica, Pontificia Universidad Catolica de Chile, Pontificia Universidad Javeriana, Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa, Universidad San Francisco de Quito, and Instituto de Investigacion Nutricional de Peru. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of this symposium.		0	0	0	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-6807	1421-9697		ANN NUTR METAB	Ann. Nutr. Metab.		2017	71			2			91	92						2	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	FM9QD					2022-09-04	WOS:000415605300152
J	Rivera, D; Caracuel, A; Landa, LO; Perrin, P; Quijano, M; Diaz, D; Espinosa, I; Arango-Lasprilla, J				Rivera, Diego; Caracuel, Alfonso; Olabarrieta Landa, Laiene; Perrin, Paul; Quijano, Maria; Diaz, Dulce; Espinosa, Irma; Arango-Lasprilla, Juan			Factor structure and reliability of the Spanish family needs questionnaire (FNQ) in a Colombian, Mexican and Spanish sample	BRAIN INJURY			English	Meeting Abstract									[Rivera, Diego; Olabarrieta Landa, Laiene] Univ Deusto, Bilbao, Bizkaia, Spain; [Caracuel, Alfonso] Univ Granada, Granada, Andalucia, Spain; [Perrin, Paul] Virginia Commonwealth Univ, Richmond, VA USA; [Quijano, Maria] Javeriana Univ, Santiago De Cali, Colombia; [Diaz, Dulce] Univ Londres, Mexico City, DF, Mexico; [Espinosa, Irma] Inst Nacl Rehabil Mexico, Mexico City, DF, Mexico; [Arango-Lasprilla, Juan] Basque Fdn Sci, IKERBASQUE, Bilbao, Bizkaia, Spain				Caracuel, Alfonso/V-3695-2019; Rivera, Diego/U-8872-2017	Rivera, Diego/0000-0001-7477-1893					0	0	0	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2014	28	5-6				0139	564	564						1	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF9EA					2022-09-04	WOS:000335017000122
J	Rivillas-Ospina, G; Maza-Chamorro, MA; Restrepo, S; Lithgow, D; Silva, R; Sisa, A; Vargas, A; Sarmiento, JP; Caes, J; Bolivar, M; Del Rio, R; Campo, E; Casas, D; Rudas, D				Rivillas-Ospina, German; Antonio Maza-Chamorro, Mauro; Restrepo, Sebastian; Lithgow, Debora; Silva, Rodolfo; Sisa, Augusto; Vargas, Andres; Pablo Sarmiento, Juan; Caes, Juan; Bolivar, Marianella; Del Rio, Roberto; Campo, Erick; Casas, Diego; Rudas, Dennis			Alternatives for Recovering the Ecosystem Services and Resilience of the Salamanca Island Natural Park, Colombia	WATER			English	Article						erosion; green infrastructure; ecosystem-based management; morphological changes; basins; sediments; river flows	COASTAL LAGOON SYSTEM; CIENAGA-GRANDE; SANTA-MARTA; CARIBBEAN COAST; REHABILITATION; SALINITY; REGIME	From a comprehensive diagnosis of the associated basins, islands, and wetlands of the coastal lagoon system of Cienaga Grande de Santa Marta, Colombia, this work describes feasible options for the recovery of its ecosystem's health and ecological resilience. Firstly, the state of the coastal lagoon was assessed, finding that hydrology, wave climate, and the morphological changes of the coastline explain recent changes in the coastal wetlands. Key variables were used to describe the level of conservation or degradation of the coastal lagoon system and to identify measures to improve its ecological functions. Finally, to mimic some of these functions and improve connectivity of the ecosystems, green infrastructure alternatives were proposed for the short and medium term to recover the services of these ecosystems and restore their resilience.	[Rivillas-Ospina, German] Univ Norte, Coastal Ecosyst Management Network CEMAN, World Assoc Waterborne Transport Infrastruct PIAN, Red Invest Ecohidrol & Ecohidraul REDECOHH,Dept I, Barranquilla 081007, Colombia; [Antonio Maza-Chamorro, Mauro; Del Rio, Roberto; Campo, Erick] Univ Tecnol Bolivar, Grp Invest Sistemas Ambientales & Hidraulicos GIS, Coastal Ecosyst Management Network CEMAN, Red Invest Ecohidrol & Ecohidraul REDECOHH,Fac In, Cartagena De Indias 130001, Colombia; [Restrepo, Sebastian] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Desarrollo Rural & Reg, Bogota 110211, DC, Colombia; [Lithgow, Debora] AC INECOL, Inst Ecol, Red Ambiente & Sustentabilidad, Xalapa 91073, Veracruz, Mexico; [Silva, Rodolfo] Univ Nacl Autonoma Mexico, Inst Ingn, Mexico City 04510, DF, Mexico; [Sisa, Augusto; Caes, Juan; Casas, Diego; Rudas, Dennis] Univ Norte, Dept Ingn Civil & Ambiental, Barranquilla 081007, Colombia; [Vargas, Andres] Univ Norte, Dept Econ, Barranquilla 081007, Colombia; [Pablo Sarmiento, Juan] Univ Norte, Dept Derecho, Barranquilla 081007, Colombia; [Bolivar, Marianella] Univ Costa, Fac Ingn, Dept Ingn Civil & Ambiental, Barranquilla 080002, Colombia		Rivillas-Ospina, G (corresponding author), Univ Norte, Coastal Ecosyst Management Network CEMAN, World Assoc Waterborne Transport Infrastruct PIAN, Red Invest Ecohidrol & Ecohidraul REDECOHH,Dept I, Barranquilla 081007, Colombia.	grivillas@uninorte.edu.co; mmaza@utb.edu.co; sebastian-restrepo@javeriana.edu.co; debora.lithgow@inecol.mx; RSilvaC@iingen.unam.mx; asisa@uninorte.edu.co; andresmv@uninorte.edu.co; jpsarmiento@uninorte.edu.co; jccaez@uninorte.edu.co; mbolivar18@cuc.edu.co; rrios@utb.edu.co; ecampos@utb.edu.co; dacasas@uninorte.edu.co; dsarta@uninorte.edu.co	Sarmiento Erazo, Juan Pablo/GNH-3925-2022; Silva, Rodolfo/A-1854-2008; Maza-Chamorro, Mauro/AAP-2083-2020; Rivillas, German/L-3676-2016	Sarmiento Erazo, Juan Pablo/0000-0002-7303-3300; Maza-Chamorro, Mauro/0000-0002-0051-1439; BOLIVAR CARBONELL, MARIANELLA/0000-0003-3274-308X; Sisa-Camargo, Augusto/0000-0002-9187-7988; Vargas, Andres/0000-0002-8642-6154; Lithgow, Debora/0000-0001-5740-9980; Rivillas, German/0000-0002-6267-2027; Del Rio Colon, Roberto/0000-0003-1765-963X; Casas, Diego/0000-0002-3904-2422	Universidad del Norte; Universidad Tecnologica de Bolivar; National University of Mexico (UNAM); Exceed-Swindon Network; Red de Investigaciones en Ecohidrologia y Ecohidraulica (REDECOHH Network); World Association for Waterborne Transport Infrastructure (PIANC) colombian chapter; Universidad del Norte [DIDI-201730]	Universidad del Norte; Universidad Tecnologica de Bolivar; National University of Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Exceed-Swindon Network; Red de Investigaciones en Ecohidrologia y Ecohidraulica (REDECOHH Network); World Association for Waterborne Transport Infrastructure (PIANC) colombian chapter; Universidad del Norte	The authors would like to acknowledge all the support given by Universidad del Norte, and Universidad Tecnologica de Bolivar through the scholarship program for Master degree and the management of the Research and Innovation office in both universities, National University of Mexico (UNAM), Exceed-Swindon Network, Red de Investigaciones en Ecohidrologia y Ecohidraulica (REDECOHH Network), and World Association for Waterborne Transport Infrastructure (PIANC) colombian chapter. Centro de Investigaciones Oceanograficas e Hidrograficas (CIOH) have our appreciation for the opportunity of exchanging ideas and knowledge with their scientific staff working in wave modelling. Direccion General Maritima (DIMAR) provided the wave buoy information used in this work. Last, but not least, thanks to the families of all the research personnel involved for their patience and stubborn belief in Coastal Ecosystem Management Network (CEMAN Network). Andres Vargas would like to thank the financial support from Universidad del Norte through grant DIDI-201730.	Angarita H., 2016, BIODIVERSIDAD ECOSIS; Barbier EB, 2013, RESOURCES-BASEL, V2, P213, DOI 10.3390/resources2030213; Bernal G., 1996, B INVEST MAR COST, V25, P46, DOI [10.25268/bimc.invemar.1996.25.0.370, DOI 10.25268/BIMC.INVEMAR.1996.25.0.370]; Biggs R, 2018, ECOL SOC, V23, DOI [10.5751/ES-10264-230309, 10.5751/ES-]; Blanco JA, 2006, ESTUAR COAST SHELF S, V66, P157, DOI 10.1016/j.ecss.2005.08.001; Bolivar M, 2019, J COASTAL RES, P112, DOI 10.2112/SI92-013.1; Botero L, 1999, OCEAN COAST MANAGE, V42, P243, DOI 10.1016/S0964-5691(98)00056-8; Botero L, 1996, REV ACAD COLOMB CIEN, V20, P466; Brunn P., 1994, ELSEVIER OCEANOGR SE, V60, P507, DOI [10.1016/0148-9062(94)90100-7, DOI 10.1016/0148-9062(94)90100-7]; Deeb-Sossa S.C., 1993, ANALISIS SEDIMENTACI; del Rio Colon R., 2020, J MAR SCI ENG; ELDEBERKY Y, 1997, OCEANOGRAPHIC LIT RE, V4, P297; Friedman J.B, 2009, ADAPTACION IMPACTOS, VI; GEBCO, 2003, GEN BATH CHART OC; Hasselmann K., 1973, ERGNZUNGSHEFT DTSC A, V8, P12; HASSELMANN S, 1985, J PHYS OCEANOGR, V15, P1378, DOI 10.1175/1520-0485(1985)015<1378:CAPOTN>2.0.CO;2; Hoyos N, 2017, APPL GEOGR, V84, P42, DOI 10.1016/j.apgeog.2017.05.001; IDEAM, 2013, ZON COD UN HIDR HIDR; INVEMAR, 2016, MON COND AMB CAMB ES, V14; Jaramillo F, 2018, WETLANDS, V38, P755, DOI 10.1007/s13157-018-1024-7; Kininmonth S, 2015, AMBIO, V44, pS138, DOI 10.1007/s13280-014-0605-9; Kjerfve B., 1986, COMP OCEANOGRAPHY CO; Kobayashi S, 2015, J METEOROL SOC JPN, V93, P5, DOI 10.2151/jmsj.2015-001; KOMEN GJ, 1984, J PHYS OCEANOGR, V14, P1271, DOI 10.1175/1520-0485(1984)014<1271:OTEOAF>2.0.CO;2; Mancera P. Jose Ernesto, 1994, Anales del Instituto de Investigaciones Marinas de Punta de Betin, V23, P103; Mesa O.J., 1997, U NAC COLOMB, V1, P390; Oderiz I, 2020, COAST ENG, V158, DOI 10.1016/j.coastaleng.2020.103675; Osorio AF, 2016, APPL OCEAN RES, V56, P119, DOI 10.1016/j.apor.2016.01.004; Otero LJ, 2016, NAT HAZARD EARTH SYS, V16, P391, DOI 10.5194/nhess-16-391-2016; Polania T, 2001, ECOL STU AN, V144, P33; Ramirez CS, 1999, REV BIOL TROP, V47, P1067; Ris RC, 1999, J GEOPHYS RES-OCEANS, V104, P7667, DOI 10.1029/1998JC900123; Rivillas-Ospina G., 2014, P 34 C COAST ENG SOU; Rivillas-Ospina G.D., 2017, P COASTS PORTS C CAI, V1, P5; Rocha J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0273; Rocha JC, 2018, SCIENCE, V362, P1379, DOI 10.1126/science.aat7850; Rodriguez-Rodriguez J.A., 2018, WETLAND BOOK 2 DISTR, P757; Roderstein M, 2014, AQUAT BOT, V113, P19, DOI 10.1016/j.aquabot.2013.10.008; Ruiz-Ochoa M.A, 2009, AVANCES RECURSOS HID, V20; Santos-Martinez A, 1998, EVALUACION PRINCIPAL; Silva R, 2019, ESTUAR COAST, V42, P1695, DOI 10.1007/s12237-019-00559-5; Silva R, 2017, P I CIVIL ENG-MAR EN, V170, P39, DOI 10.1680/jmaen.2016.13; Silva R, 2014, J COASTAL RES, P1, DOI 10.2112/SI71-001.1; Tuchkovenko Yuri S, 2003, Bol. Invest. Mar. Cost., V32, P145; Vilardy SP, 2011, HYDROLOG SCI J, V56, P1423, DOI 10.1080/02626667.2011.631497; Viloria E., 2006, ECOTROPICOS, V19, P72; Viloria Maestre Efraín, 2012, Bol. Invest. Mar. Cost., V41, P399; Zamora A.P., 2013, B INVEST MAR COST, V41, P91	48	4	6	1	11	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4441		WATER-SUI	Water	MAY	2020	12	5							1513	10.3390/w12051513	http://dx.doi.org/10.3390/w12051513			22	Environmental Sciences; Water Resources	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Water Resources	MU8KA		Green Published, gold			2022-09-04	WOS:000555915200292
J	Bini, D; Geralico, A; Gionti, G; Plastino, W; Velandia, N				Bini, Donato; Geralico, Andrea; Gionti, Gabriele; Plastino, Wolfango; Velandia, Nelson			Scattering of uncharged particles in the field of two extremely charged black holes	GENERAL RELATIVITY AND GRAVITATION			English	Article						Particle scattering; Majumdar-Papapetrou spacetime; Gyroscope precession	PERIODIC-ORBITS; 2-CENTER PROBLEM; CHAOS; RELATIVITY; EQUATIONS	We investigate the motion of uncharged particles scattered by a binary system consisting of extremely charged black holes in equilibrium as described by the Majumdar-Papapetrou solution. We focus on unbound orbits confined to the plane containing both black holes. We consider the two complementary situations of particles approaching the system along a direction parallel to the axis where the black holes are displaced and orthogonal to it. We numerically compute the scattering angle as a function of the particle's conserved energy parameter, which provides a gauge-invariant information of the scattering process. We also study the precession of a test gyroscope along such orbits and evaluate the accumulated precession angle after a full scattering, which is another gauge-invariant quantity.	[Bini, Donato; Geralico, Andrea] CNR, Ist Applicaz Calcolo M Picone, I-00161 Rome, Italy; [Bini, Donato; Plastino, Wolfango] INFN, Sez Roma Tre, I-00146 Rome, Italy; [Gionti, Gabriele] Specola Vaticana, I-00120 Vatican City, Vatican City St, Vatican; [Gionti, Gabriele] Univ Arizona, Steward Observ, Vatican Observ Res Grp, 933 North Cherry Ave, Tucson, AZ 85721 USA; [Gionti, Gabriele] INFN, Lab Nazl Frascati, Via E Fermi 40, I-00044 Frascati, Italy; [Plastino, Wolfango] Roma Tre Univ, Dept Math & Phys, I-00146 Rome, Italy; [Velandia, Nelson] Univ Javeriana, Fac Ciencias Pontificia, Dept Fis, Bogota 110231, Colombia		Geralico, A (corresponding author), CNR, Ist Applicaz Calcolo M Picone, I-00161 Rome, Italy.	andrea.geralico@gmail.com	Plastino, Wolfango/AAS-7305-2021; Velandia, Nelson/AAF-9012-2019	Plastino, Wolfango/0000-0002-5737-6346; Geralico, Andrea/0000-0001-9608-3784				Alonso D, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.104024; Antonelli A, 2019, PHYS REV D, V99, DOI 10.1103/PhysRevD.99.104004; Assumpcao T, 2018, PHYS REV D, V98, DOI 10.1103/PhysRevD.98.064036; Baker J, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.127501; BEL L, 1981, GEN RELAT GRAVIT, V13, P963, DOI 10.1007/BF00756073; Bern Z, 2019, J HIGH ENERGY PHYS, DOI 10.1007/JHEP10(2019)206; Bern Z, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.201603; Bern Z, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.181602; Bernard L, 2019, PHYS REV D, V100, DOI 10.1103/PhysRevD.100.044002; Bini D, 2004, CLASSICAL QUANT GRAV, V21, P1987, DOI 10.1088/0264-9381/21/8/005; Bini D, 2018, PHYS REV D, V98, DOI 10.1103/PhysRevD.98.044036; Bini D, 2018, PHYS REV D, V98, DOI 10.1103/PhysRevD.98.024049; Bini D, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.104038; Bini D, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.084044; Bini D, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.064021; Bini D, 2017, GEN RELAT GRAVIT, V49, DOI 10.1007/s10714-017-2247-2; Bini D, 2016, GEN RELAT GRAVIT, V48, DOI 10.1007/s10714-016-2094-6; Bini D, 2016, CLASSICAL QUANT GRAV, V33, DOI 10.1088/0264-9381/33/12/125024; Buonanno A, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.064015; Buonanno A, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.084006; CHANDRASEKHAR S, 1989, P ROY SOC LOND A MAT, V421, P227, DOI 10.1098/rspa.1989.0010; CONTOPOULOS G, 1991, P ROY SOC LOND A MAT, V435, P551, DOI 10.1098/rspa.1991.0160; CONTOPOULOS G, 1990, P ROY SOC LOND A MAT, V431, P183, DOI 10.1098/rspa.1990.0126; Contopoulos G, 1999, CELEST MECH DYN ASTR, V73, P1, DOI 10.1023/A:1008376523356; Contopoulos G, 1993, CELEST MECH DYN ASTR, V55, P47, DOI 10.1007/BF00694394; Damour T, 2018, PHYS REV D, V97, DOI 10.1103/PhysRevD.97.044038; Damour T, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.104015; Damour T, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.084014; DETTMANN CP, 1995, FRACTALS, V3, P161; DETTMANN CP, 1994, PHYS REV D, V50, pR618, DOI 10.1103/PhysRevD.50.R618; Detweiler S, 2005, CLASSICAL QUANT GRAV, V22, pS681, DOI 10.1088/0264-9381/22/15/006; Foffa S, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/4/043001; HARTLE JB, 1972, COMMUN MATH PHYS, V26, P87, DOI 10.1007/BF01645696; IYER BR, 1993, PHYS REV D, V48, P5706, DOI 10.1103/PhysRevD.48.5706; JANTZEN RT, 1992, ANN PHYS-NEW YORK, V215, P1, DOI 10.1016/0003-4916(92)90297-Y; Ryzner J, 2015, CLASSICAL QUANT GRAV, V32, DOI 10.1088/0264-9381/32/20/205010; Semerak O, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.044006; Shipley JO, 2016, CLASSICAL QUANT GRAV, V33, DOI 10.1088/0264-9381/33/17/175001; WESTPFAHL K, 1985, FORTSCHR PHYS, V33, P417, DOI 10.1002/prop.2190330802; Wunsch A, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.024007; YURTSEVER U, 1995, PHYS REV D, V52, P3176, DOI 10.1103/PhysRevD.52.3176	41	3	3	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-7701	1572-9532		GEN RELAT GRAVIT	Gen. Relativ. Gravit.	NOV	2019	51	11							153	10.1007/s10714-019-2642-y	http://dx.doi.org/10.1007/s10714-019-2642-y			15	Astronomy & Astrophysics; Physics, Multidisciplinary; Physics, Particles & Fields	Science Citation Index Expanded (SCI-EXPANDED)	Astronomy & Astrophysics; Physics	JP5SP		Green Submitted			2022-09-04	WOS:000498324500001
J	Vesga, RAA; Calvo, E				Ariza Vesga, Rafael Alberto; Calvo, Eloy			Should Colombia Rethink the Legal Treatment of Reticence and Inaccuracy in the Insurance Risk Statement? Comparative View of this Problem, an Overview of the Spanish, French, and Swiss Legislations on this Topic	REVISTA E-MERCATORIA			Spanish	Article						Reticence; Inaccuracy; Nullity; Questionnaire; Good faith		In the most recent Colombian decisions, the Court's interpretation of Reticence includes elements which are NOT contained in the respective legislation. These pronouncements should lead us to reflect on the matter. Does Colombian commercial law require a change to take this new reality into account? We intend to address the problem by conducting a comparative analysis through the examination of other legislations that are seen as a reference on this subject, and by providing useful analysis to resolve the problem.	[Ariza Vesga, Rafael Alberto] Univ Nacl Colombia, Bogota, Colombia; [Ariza Vesga, Rafael Alberto] Univ Javeriana, Derecho Seguros, Bogota, Colombia; [Ariza Vesga, Rafael Alberto] Univ Externado, Derecho Seguros Posgrad, Bogota, Colombia; [Ariza Vesga, Rafael Alberto] Univ Nacl Colombia, Derecho Seguros Posgrad, Bogota, Colombia; [Ariza Vesga, Rafael Alberto] Univ Libre, Derecho Seguros Posgrad, Bogota, Colombia; [Ariza Vesga, Rafael Alberto] Univ Norte, Derecho Seguros Posgrad, Barranquilla, Colombia; [Ariza Vesga, Rafael Alberto] Univ La Sabana, Derecho Seguros Posgrad, Chia, Colombia; [Calvo, Eloy] Univ Ginebra, Geneva, Switzerland		Vesga, RAA (corresponding author), Univ Nacl Colombia, Bogota, Colombia.; Vesga, RAA (corresponding author), Univ Javeriana, Derecho Seguros, Bogota, Colombia.; Vesga, RAA (corresponding author), Univ Externado, Derecho Seguros Posgrad, Bogota, Colombia.; Vesga, RAA (corresponding author), Univ Nacl Colombia, Derecho Seguros Posgrad, Bogota, Colombia.; Vesga, RAA (corresponding author), Univ Libre, Derecho Seguros Posgrad, Bogota, Colombia.; Vesga, RAA (corresponding author), Univ Norte, Derecho Seguros Posgrad, Barranquilla, Colombia.; Vesga, RAA (corresponding author), Univ La Sabana, Derecho Seguros Posgrad, Chia, Colombia.	rafaelariza@arizaygomez.com						Bernard Viret, 1975, REV SUISSE ASSURANCE; Blanco Lopez, 2014, COMENTARIOS CONTRATO; Gomez Ossa, 1991, EL CONTRATO; Jaramillo Patricia, 2016, SEGUROS TEMAS ESENCI; Veiga Copo A. B., 2010, CARACTERES ELEMENTOS; Yvonne Lambert-Faivre, 2005, LEVENEUR LAURENT DRO	6	0	0	0	0	UNIV EXTERNADO COLOMBIA	BOGOTA	CALLE 12 NO 1-17 ESTE, BOGOTA, 00000, COLOMBIA	1692-3960			REV E-MERCATORIA	Rev. e-Mercatoria	JAN-JUN	2017	16	1					37	58		10.18601/16923960.v16n1.02	http://dx.doi.org/10.18601/16923960.v16n1.02			22	Law	Emerging Sources Citation Index (ESCI)	Government & Law	VH8QX		Green Submitted, gold			2022-09-04	WOS:000456505900002
J	Barreto, GE; Yarkov, A; Avila-Rodriguez, M; Aliev, G; Echeverria, V				Barreto, George E.; Yarkov, Alexander; Avila-Rodriguez, Marcos; Aliev, Gjumrakch; Echeverria, Valentina			Nicotine-Derived Compounds as Therapeutic Tools Against Post-Traumatic Stress Disorder	CURRENT PHARMACEUTICAL DESIGN			English	Article						Anxiety; depressive-like behavior; fear extinction; tobacco; trauma	ENDOTHELIAL GROWTH-FACTOR; GLYCOGEN-SYNTHASE KINASE-3; HIPPOCAMPAL INACTIVATION DISRUPTS; SENSORIMOTOR GATING DEFICITS; MEDIAL PREFRONTAL CORTEX; DEPRESSIVE-LIKE BEHAVIOR; WORKING-MEMORY DEFICITS; FEAR EXTINCTION; CONTEXTUAL FEAR; PHYSIOLOGICAL-RESPONSES	Post-traumatic stress disorder (PTSD) is an anxiety disorder that develops after experiencing trauma. Actual therapies do not help majority of patients with PTSD. Moreover, extinguished fear memories usually reappear in the individuals when exposed to trauma cues. New drugs to reduce the impact of conditioned cues in eliciting abnormal fear responses are urgently required. Cotinine, the main metabolite of nicotine, decreased anxiety and depressive-like behavior, and enhanced fear extinction in mouse models of PTSD. Cotinine, considered a positive modulator of the alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR), enhances fear extinction in rodents in a manner dependent on the activity of the nAChRs. Cotinine stimulates signaling pathways downstream of alpha 7nAChR including the protein kinase B (Akt)/glycogen synthase kinase 3 beta (GSK3) pathway and the extracellular signal-regulated kinases (ERKs). The stimulation of these factors promotes synaptic plasticity and the extinction of fear. In this review, we discuss the hypothesis that cotinine relieves PTSD symptoms and facilitates fear memory extinction by promoting brain plasticity through the positive modulation of presynaptic nAChRs and its effectors in the brain.	[Barreto, George E.; Avila-Rodriguez, Marcos] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Ctr Biomed Res, Santiago, Chile; [Yarkov, Alexander; Echeverria, Valentina] Univ San Sebastian, Concepcion 4030000, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Echeverria, Valentina] Bay Pines VA Hlth Care Syst, Res & Dev, Bay Pines, FL USA; [Echeverria, Valentina] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33647 USA		Echeverria, V (corresponding author), 10,000 Bay Pines Blvd,Bldg 23,Rm123, Bay Pines, FL 33744 USA.	gsampaio@javeriana.edu.co; echeverria.valentina@gmail.com	Barreto, George E./B-5747-2014; Aliev, Gjumrakch/AAE-7734-2020; Aliev, Gjumrakch/K-7302-2017; Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./AAD-7420-2020	Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Avila-Rodriguez, Marco/0000-0003-4612-3236	Universidad Autonoma de Chile; Pontificia Universidad Javeriana	Universidad Autonoma de Chile; Pontificia Universidad Javeriana	This material is the result of work supported with resources and the use of facilities at the Bay Pines VA Healthcare System. The contents do not necessarily represent the views of the Department of Veterans Affairs or the United States Government. This work was also supported by the Universidad Autonoma de Chile. We also thank Mr. Camilo Emiliano Rosas and Kelly Curtis for their Editorial help. GEB work is supported by Pontificia Universidad Javeriana.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alexander WH, 2010, NEUROIMAGE, V49, P3210, DOI 10.1016/j.neuroimage.2009.11.065; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Antequera D, 2012, J ALZHEIMERS DIS, V29, P187, DOI 10.3233/JAD-2011-111646; Bahi A, 2009, BIOL PSYCHIAT, V66, P1139, DOI 10.1016/j.biopsych.2009.07.004; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Beaulieu JM, 2012, J PSYCHIATR NEUROSCI, V37, P7, DOI 10.1503/jpn.110011; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; BORZELLECA JF, 1962, J PHARMACOL EXP THER, V137, P313; Bossini L, 2007, J CLIN PSYCHOPHARM, V27, P233, DOI 10.1097/01.jcp.0000264979.09862.a8; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Bremner J D, 1999, Semin Clin Neuropsychiatry, V4, P249; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Buccafusco JJ, 2009, BIOCHEM PHARMACOL, V78, P852, DOI 10.1016/j.bcp.2009.06.102; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; Cain CK, 2012, EXPERT OPIN INV DRUG, V21, P1323, DOI 10.1517/13543784.2012.704020; Calvo CF, 2011, GENE DEV, V25, P831, DOI 10.1101/gad.615311; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Castro AA, 2012, BEHAV BRAIN RES, V229, P208, DOI 10.1016/j.bbr.2012.01.016; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Contestabile A, 2013, J CLIN INVEST, V123, P348, DOI 10.1172/JCI64650; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Czermak C, 2008, INT J NEUROPSYCHOPH, V11, P419, DOI 10.1017/S1461145707008152; Davis JA, 2006, NEUROSCI LETT, V394, P202, DOI 10.1016/j.neulet.2005.10.026; Davis JA, 2005, J NEUROSCI, V25, P8708, DOI 10.1523/JNEUROSCI.2853-05.2005; de Aguiar RB, 2013, NEUROPHARMACOLOGY, V71, P292, DOI 10.1016/j.neuropharm.2013.03.032; de Bitencourt RM, 2013, NEUROPHARMACOLOGY, V64, P389, DOI 10.1016/j.neuropharm.2012.05.039; Debiec J, 2011, DEPRESS ANXIETY, V28, P186, DOI 10.1002/da.20803; Dhonnchadha BAN, 2011, PHARMACOL BIOCHEM BE, V99, P229, DOI 10.1016/j.pbb.2011.01.018; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Dillon GM, 2008, NEUROBIOL LEARN MEM, V90, P426, DOI 10.1016/j.nlm.2008.05.008; Domino EF, 2004, PROG NEURO-PSYCHOPH, V28, P319, DOI 10.1016/j.pnpbp.2003.10.011; Dunlop BW, 2012, CURR PHARM DESIGN, V18, P5645; Dwoskin LP, 1999, J PHARMACOL EXP THER, V288, P905; Echeverria V, 2011, J ALZHEIMERS DIS, V24, P817, DOI 10.3233/JAD-2011-102136; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Fournier NM, 2012, BEHAV BRAIN RES, V227, P440, DOI 10.1016/j.bbr.2011.04.022; Friedlander AH, 2004, ORAL SURG ORAL MED O, V97, P5, DOI 10.1016/j.tripleo.2003.09.004; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Froeliger B, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/265724; Fujita Yosuke, 2012, Nihon Shinkei Seishin Yakurigaku Zasshi, V32, P195; FUXE K, 1979, PHARMACOL BIOCHEM BE, V10, P671, DOI 10.1016/0091-3057(79)90319-8; Gallinat J, 2007, J CLIN PSYCHOPHARM, V27, P80, DOI 10.1097/JCP.0b013e31802dffde; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; Garcia R, 2008, NEUROBIOL LEARN MEM, V89, P560, DOI 10.1016/j.nlm.2007.10.005; Garrick T, 2001, PSYCHIATRY, V64, P346, DOI 10.1521/psyc.64.4.346.18600; Ghosheh OA, 2001, DRUG METAB DISPOS, V29, P645; Gilbert DG, 2008, EXP CLIN PSYCHOPHARM, V16, P33, DOI 10.1037/1064-1297.16.1.33; Gould TJ, 2014, NEUROBIOL LEARN MEM, V107, P108, DOI 10.1016/j.nlm.2013.08.004; Greene J, 2009, NEUROPSYCHOPHARMACOL, V34, P2459, DOI 10.1038/npp.2009.68; Grizzell JA, 2014, BEHAV NEUROSCI, V128, P713, DOI 10.1037/bne0000021; Grizzell JA, 2014, BEHAV BRAIN RES, V268, P55, DOI 10.1016/j.bbr.2014.03.047; Grizzell JA, 2014, NEUROCHEM RES; Hatsukami DK, 1997, PHARMACOL BIOCHEM BE, V57, P643, DOI 10.1016/S0091-3057(97)80001-9; Hauger RL, 2012, NEUROPHARMACOLOGY, V62, P705, DOI 10.1016/j.neuropharm.2011.11.007; Hawkins KA, 2013, EXP CLIN PSYCHOPHARM, V21, P434, DOI 10.1037/a0033966; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hofmann SG, 2003, J ANXIETY DISORD, V17, P573, DOI 10.1016/S0887-6185(02)00227-X; Hofmann SG, 2013, RESTORATIVE NEUROL N; Hofmann SG, 2012, CURR PHARM DESIGN, V18, P5659; Hruska B, 2014, ADDICT BEHAV, V39, P273, DOI 10.1016/j.addbeh.2013.10.002; Izquierdo I, 2004, NEUROTOX RES, V6, P175, DOI 10.1007/BF03033220; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jantas D, 2009, APOPTOSIS, V14, P900, DOI 10.1007/s10495-009-0370-6; Jope RS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00016; Joseph AM, 2012, J TRAUMA STRESS, V25, P10, DOI 10.1002/jts.21670; Kahl KG, 2009, PSYCHONEUROENDOCRINO, V34, P353, DOI 10.1016/j.psyneuen.2008.09.016; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Koenen KC, 2006, J CONSULT CLIN PSYCH, V74, P186, DOI 10.1037/0022-006X.74.1.186; Kutlu MG, 2014, BEHAV BRAIN RES, V263, P133, DOI 10.1016/j.bbr.2014.01.031; Lambrechts D, 2004, TRENDS MOL MED, V10, P275, DOI 10.1016/j.molmed.2004.04.004; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Leonard S, 2001, PHARMACOL BIOCHEM BE, V70, P561, DOI 10.1016/S0091-3057(01)00677-3; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Liu M, 2012, HEPATOLOGY, V55, P1754, DOI 10.1002/hep.25584; Lockman PR, 2005, J PHARMACOL EXP THER, V314, P636, DOI 10.1124/jpet.105.085381; Lunn JS, 2009, DEV NEUROBIOL, V69, P871, DOI 10.1002/dneu.20747; Malte CA, 2015, ADDICT BEHAV, V41, P238, DOI 10.1016/j.addbeh.2014.10.034; Matsumoto K, 2007, STRESS, V10, P3, DOI 10.1080/10253890701200997; Metzger LJ, 1999, J ABNORM PSYCHOL, V108, P347, DOI 10.1037/0021-843X.108.2.347; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Moran VE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00173; Morgan MA, 2003, BEHAV BRAIN RES, V146, P121, DOI 10.1016/j.bbr.2003.09.021; Myers KM, 2011, NEUROPSYCHOPHARMACOL, V36, P274, DOI 10.1038/npp.2010.88; Nandi A, 2005, PSYCHIATRY, V68, P299, DOI 10.1521/psyc.2005.68.4.299; Norrholm SD, 2011, BIOL PSYCHIAT, V69, P556, DOI 10.1016/j.biopsych.2010.09.013; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Orr SP, 1997, PSYCHIAT RES, V73, P103, DOI 10.1016/S0165-1781(97)00110-8; Orr SP, 2002, PSYCHIAT CLIN N AM, V25, P271, DOI 10.1016/S0193-953X(01)00007-7; Orr SP, 2003, ARCH GEN PSYCHIAT, V60, P283, DOI 10.1001/archpsyc.60.3.283; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Ortuzar N, 2013, BEHAV BRAIN RES, V246, P36, DOI 10.1016/j.bbr.2013.02.036; Pan JQ, 2011, NEUROPSYCHOPHARMACOL, V36, P1397, DOI 10.1038/npp.2011.24; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pidoplichko VI, 2013, J NEUROPHYSIOL, V110, P2358, DOI 10.1152/jn.01030.2012; Polanska Kinga, 2006, Ginekol Pol, V77, P726; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Rasmusson AM, 2006, J PSYCHOPHARMACOL, V20, P693, DOI 10.1177/0269881106060193; Reeves RR, 2007, J AM OSTEOPATH ASSOC, V107, P181; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; Roh MS, 2007, EXP MOL MED, V39, P353, DOI 10.1038/emm.2007.39; Rose JE, 2003, AM J PSYCHIAT, V160, P323, DOI 10.1176/appi.ajp.160.2.323; Schimanski LA, 2002, J NEUROSCI, V22, P8277; Schmajuk NA, 2007, BEHAV BRAIN RES, V177, P242, DOI 10.1016/j.bbr.2006.11.026; Sgobio C, 2008, GENES BRAIN BEHAV, V7, P427, DOI 10.1111/j.1601-183X.2007.00367.x; Smith LN, 2006, PHARMACOL BIOCHEM BE, V85, P91, DOI 10.1016/j.pbb.2006.07.014; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Steckler T, 2012, NEUROPHARMACOLOGY, V62, P617, DOI 10.1016/j.neuropharm.2011.06.012; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Su HC, 2012, INT IMMUNOPHARMACOL, V14, P150, DOI 10.1016/j.intimp.2012.06.015; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Sutton LP, 2011, NEUROSCIENCE, V199, P116, DOI 10.1016/j.neuroscience.2011.09.056; Terry AV, 2012, BIOCHEM PHARMACOL, V83, P941, DOI 10.1016/j.bcp.2011.12.043; Terry AV, 2005, CNS DRUG REV, V11, P229; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thorndike FP, 2006, ADDICT BEHAV, V31, P223, DOI 10.1016/j.addbeh.2005.04.023; Tian S, 2008, NEUROSCIENCE, V153, P935, DOI 10.1016/j.neuroscience.2008.03.005; Tillo M, 2012, CELL ADHES MIGR, V6, P541, DOI 10.4161/cam.22408; Vetter S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-92; Vianna MR, 2003, NEUROBIOL LEARN MEM, V79, P199, DOI 10.1016/S1074-7427(03)00003-0; Vieweg WVR, 2006, AM J MED, V119, P383, DOI 10.1016/j.amjmed.2005.09.027; Vrana SR, 2013, PSYCHOPHARMACOLOGY, V230, P477, DOI 10.1007/s00213-013-3181-y; Wakizono T, 2007, PHYSIOL BEHAV, V90, P687, DOI 10.1016/j.physbeh.2006.12.008; Walsh K, 2014, COMPR PSYCHIAT, V55, P621, DOI 10.1016/j.comppsych.2013.11.016; Wang YQ, 2009, NEUROCHEM INT, V55, P629, DOI 10.1016/j.neuint.2009.06.007; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Weaver TL, 2003, ADDICT BEHAV, V28, P1665, DOI 10.1016/j.addbeh.2003.08.041; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wildeboer-Andrud KM, 2014, PHARMACOL BIOCHEM BE, V117, P144, DOI 10.1016/j.pbb.2013.12.005; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Yamamoto S, 2008, NEUROPSYCHOPHARMACOL, V33, P2108, DOI 10.1038/sj.npp.1301605; Yamamoto S, 2009, DEPRESS ANXIETY, V26, P1110, DOI 10.1002/da.20629; Zeitlin R, 2012, CNS NEUROSCI THERAPE; Zeitlin R, 2012, BEHAV BRAIN RES, V228, P284, DOI 10.1016/j.bbr.2011.11.023; Zhu PJ, 2005, J NEUROPHYSIOL, V94, P3081, DOI 10.1152/jn.00974.2004; Zhu WL, 2011, J NEUROCHEM, V117, P1075, DOI 10.1111/j.1471-4159.2011.07285.x	145	16	16	0	8	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2015	21	25					3589	3595		10.2174/1381612821666150710145250	http://dx.doi.org/10.2174/1381612821666150710145250			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CP8ZB	26166610				2022-09-04	WOS:000360182400005
J	Mahmoud, AM; Nunez, MX; Blanco, C; Koch, DD; Wang, L; Weikert, MP; Frueh, BE; Tappeiner, C; Twa, MD; Roberts, CJ				Mahmoud, Ashraf M.; Nunez, Maria X.; Blanco, Claudia; Koch, Douglas D.; Wang, Li; Weikert, Mitchell P.; Frueh, Beatrice E.; Tappeiner, Christoph; Twa, Michael D.; Roberts, Cynthia J.			Expanding the Cone Location and Magnitude Index to Include Corneal Thickness and Posterior Surface Information for the Detection of Keratoconus	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article								PURPOSE: To extend the capabilities of the Cone Location and Magnitude Index algorithm to include a combination of topographic information from the anterior and posterior corneal surfaces and corneal thickness measurements to further improve our ability to correctly identify keratoconus using this new index: ConeLocationMagnitudeIndex_X. DESIGN: Retrospective case-control study. METHODS: Three independent data sets were analyzed: 1 development and 2 validation. The Anterior Corneal-Power index was calculated to stratify the keratoconus data from mild to severe. The ConeLocationMagnitudeIndex algorithm was applied to all tomography data collected using a dual Scheimpflug-Placido-based tomographer. The ConeLocationMagnitudeIndex_X formula, resulting from analysis of the Development set, was used to determine the logistic regression model that best separates keratoconus from normal and was applied to all data sets to calculate PercentProbabilityKeratoconus_X. The sensitivity/specificity of PercentProbabilityKeratoconus_X was compared with the original PercentProbabilityKeratoconus, which only uses anterior axial data. " RESULTS: The AnteriorCornealPower severity distribution for the combined data sets are 136 mild, 12 moderate, and 7 severe. The logistic regression model generated for ConeLocationMagnitudeIndex_X produces complete separation for the Development set. Validation Set 1 has 1 false-negative and Validation Set 2 has 1 false-positive. The overall sensitivity/specificity results for the logistic model produced using the ConeLocationMagnitudeIndex_X algorithm are 99.4% and 99.6%, respectively. The overall sensitivity/specificity results for using the original ConeLocationMagnitudeIndex algorithm are 89.2% and 98.8%, respectively. CONCLUSIONS: ConeLocationMagnitudeIndex X provides a robust index that can detect the presence or absence of a keratoconic pattern in corneal tomography maps with improved sensitivity/specificity from the original anterior surface only ConeLocationMagnitudeIndex algorithm. ((C) 2013 by Elsevier Inc. All rights reserved.)	[Mahmoud, Ashraf M.; Roberts, Cynthia J.] Ohio State Univ, Dept Ophthalmol, Columbus, OH 43210 USA; [Mahmoud, Ashraf M.; Roberts, Cynthia J.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Nunez, Maria X.; Blanco, Claudia] Pontificia Univ Javeriana, Clin Oftalmol Cali, Cali, Colombia; [Koch, Douglas D.; Wang, Li; Weikert, Mitchell P.] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Houston, TX 77030 USA; [Frueh, Beatrice E.; Tappeiner, Christoph] Univ Hosp Bern, Dept Ophthalmol, Inpelspital, CH-3010 Bern, Switzerland; [Twa, Michael D.] Univ Houston, Coll Optometry, Houston, TX USA		Roberts, CJ (corresponding author), Ohio State Univ, Dept Ophthalmol, Ctr Biomed Engn, 456 W 10th Ave, Columbus, OH 43210 USA.	Roberts.8@osu.edu	Twa, Michael/I-3131-2019; Pepose, Jay/M-5140-2019	Twa, Michael/0000-0003-4544-5153; Weikert, Mitchell/0000-0002-3135-0332				Ambrosio R, 2003, J REFRACT SURG, V19, P24; Ambrosio R, 2006, J CATARACT REFR SURG, V32, P1851, DOI 10.1016/j.jcrs.2006.06.025; Argawal V, 2013, IJKECD, V2, P16; Ashraf MM, 2008, CORNEA, V27, P480, DOI 10.1097/ICO.0b013e31816485d3; Mahmoud AM, 2006, OPTOMETRY VISION SCI, V83, P682, DOI 10.1097/01.opx.0000232944.91587.02; MANDELL RB, 1969, ARCH OPHTHALMOL-CHIC, V82, P182; McMahon TT, 2006, CORNEA, V25, P794, DOI 10.1097/01.ico.0000226359.26678.d1; Oliveira CM, 2011, CLIN EXP OPTOM, V94, P33, DOI 10.1111/j.1444-0938.2010.00509.x; Qazi MA, 2005, J CATARACT REFR SURG, V31, P48, DOI 10.1016/j.jcrs.2004.10.043; Qazi MA, 2009, CORNEA, V28, P616, DOI 10.1097/ICO.0b013e31819ba450; Saad A, 2010, INVEST OPHTH VIS SCI, V51, P2912, DOI 10.1167/iovs.09-4304; Zadnik K, 1998, INVEST OPHTH VIS SCI, V39, P2537	12	42	43	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	DEC	2013	156	6					1102	1111		10.1016/j.ajo.2013.07.018	http://dx.doi.org/10.1016/j.ajo.2013.07.018			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	261OQ	24075426				2022-09-04	WOS:000327674900006
J	Suarez-Ayala, D; Forero-Ronderos, C; Coll, M; Duran, P; Cespedes, C				Suarez-Ayala, Dv; Forero-Ronderos, C.; Coll, M.; Duran, P.; Cespedes, C.			Continuous Glucose Monitoring. Which is the evidence in Children?	ANDES PEDIATRICA			Spanish	Review						Biomedical Technology; Type 1 Diabetes Mellitus; Self-Monitoring of Blood Glucose; Continuous Glucose Monitoring	HYPOGLYCEMIA; MULTICENTER	Diabetes Technology refers to the software or hardware that is designed to facilitate and improve the quality of life of the patient with diabetes Mellitus. A non-systematic literature search was carried out which included articles in English and Spanish about the use of continuous glucose monitoring (CGM) in pediatric patients with Type 1 diabetes Mellitus. This review summarizes the performance of the CGM, its accuracy, and classification. A chronological synthesis of the general evidence up to June 2020 was done including both adult and pediatric studies. Aspects of metabolic control were specified on the use of real-time and intermittent / flash CGM, such as reduction of HbA1c levels, reduction in frequency and severity of hypoglycemia, decrease in episodes of ketoacidosis and wellbeing, and variables such as the Frequency of CGM use, which have been related to the improvement of the objectives of diabetes control. This review presents a chronological summary of the evidence for flash glucose monitoring in studies where only pediatric population is included and provides an account of diabetes technology recommendations that apply to pediatric population from the American Diabetes Association 2020 guideline, the International Society for Pediatric and Adolescent Diabetes 2018 recommendations.	[Suarez-Ayala, Dv] Univ Antioquia, Medellin Hosp Infantil Los Angeles, Pasto, Colombia; [Forero-Ronderos, C.] Hosp Univ San Ignacio, Hosp Univ Fdn Santafe, Endociencia Pontif Univ Javeriana, Bogota, Colombia; [Coll, M.] Univ Nacl Colombia, Endociencia, Bogota, Colombia; [Duran, P.] Univ Rosario, Fdn Cardio Infantil, Inst Cardiol, Bogota, Colombia; [Duran, P.] Univ Sabana Bogota, Endociencia, Bogota, Colombia; [Cespedes, C.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Endociencia, Bogota, Colombia		Suarez-Ayala, D (corresponding author), Univ Antioquia, Medellin Hosp Infantil Los Angeles, Pasto, Colombia.	dvanessa.suarez@udea.edu.co		Suarez Ayala, Diana Vanessa/0000-0003-2557-3262; Duran, Paola/0000-0002-4796-6270				Al Hayek Ayman A, 2020, Diabetes Ther, V11, P1551, DOI 10.1007/s13300-020-00849-3; Al Hayek AA, 2020, DIABETES THER, V11, P927, DOI 10.1007/s13300-020-00793-2; [Anonymous], 2019, DIABETES CARE, V42, pS1, DOI [10.2337/dc19-Sint01, 10.2337/dc19-SINT01]; [Anonymous], Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM; Basu Ananda, 2015, J Diabetes Sci Technol, V9, P63, DOI 10.1177/1932296814554797; Battelino T, 2015, DIABETIC MED, V32, P1568, DOI 10.1111/dme.12825; Beck RW, 2017, JAMA-J AM MED ASSOC, V317, P371, DOI 10.1001/jama.2016.19975; Blum Alyson, 2018, Clin Diabetes, V36, P203, DOI 10.2337/cd17-0130; Bolinder J, 2016, LANCET, V388, P2254, DOI 10.1016/S0140-6736(16)31535-5; Calliari LEP, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-019-0513-z; Chan CTL, 2020, DIABETES CARE, V43, pE35, DOI 10.2337/dc19-1690; Christiansen MP, 2017, DIABETES TECHNOL THE, V19, P446, DOI 10.1089/dia.2017.0087; Comunidad de Castilla y Leon, 2014, QUE LECT SENS GLUC S; Danne T, 2017, DIABETES CARE, V40, P1631, DOI 10.2337/dc17-1600; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; DeSalvo DJ, 2018, PEDIATR DIABETES, V19, P1271, DOI 10.1111/pedi.12711; DiMeglio LA, 2018, PEDIATR DIABETES, V19, P105, DOI 10.1111/pedi.12737; Edge J, 2017, ARCH DIS CHILD, V102, P543, DOI 10.1136/archdischild-2016-311530; FDA, EV AUT CLASS 3 DES F; Foster NC, 2016, DIABETES CARE, V39, pE81, DOI 10.2337/dc16-0207; Gimenez M, 2018, ENDOCRINOL DIAB NUTR, V65, P24, DOI 10.1016/j.endinu.2017.03.011; Hoss U, 2017, DIABETES TECHNOL THE, V19, pS44, DOI 10.1089/dia.2017.0025; Jafri RZ, 2019, 3 WAY ACCURACY COMP, P1; Kamann Stefanie, 2018, J Diabetes Sci Technol, V12, P630, DOI 10.1177/1932296818762946; Kramer G, 2019, ASS FLASH GLUCOSE MO; Landau Z, 2018, ACTA DIABETOL, V55, P1303, DOI 10.1007/s00592-018-1218-8; Langendam MW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008101.pub2; Lind M, 2017, JAMA-J AM MED ASSOC, V317, P379, DOI 10.1001/jama.2016.19976; Martin CT, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1177-7; Nana M, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107893; Oliver N, 2020, DIABETES CARE, V43, P53, DOI 10.2337/dc19-0977; Pickup JC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3805; Pintus D, 2019, DIABETES METAB SYND, V13, P2923, DOI 10.1016/j.dsx.2019.07.054; Schiavon M, 2015, DIABETES TECHNOL THE, V17, P825, DOI 10.1089/dia.2015.0119; Sherr JL, 2018, PEDIATR DIABETES, V19, P302, DOI 10.1111/pedi.12731; Soupal J, 2020, DIABETES CARE, V43, P37, DOI 10.2337/dc19-0888; Szadkowska A, 2018, DIABETES TECHNOL THE, V20, P17, DOI 10.1089/dia.2017.0287; Tauschmann M, 2020, DIABETES CARE, V43, pE40, DOI 10.2337/dc19-1358; Tsalikian E, 2012, PEDIATR DIABETES, V13, P294, DOI 10.1111/j.1399-5448.2011.00837.x; U.S. Food and Drug Administration, 2017, SUMM SAF EFF DAT SSE, P1; Vergier J, 2019, PRIM CARE DIABETES, V13, P63, DOI 10.1016/j.pcd.2018.08.004; Wong JC, 2014, DIABETES CARE, V37, P2702, DOI 10.2337/dc14-0303; Ziegler R, 2011, PEDIATR DIABETES, V12, P11, DOI 10.1111/j.1399-5448.2010.00650.x	43	0	0	0	0	SOC CHILENA PEDIATRIA	SANTIAGO	ALCALDE EDUARDO CASTILLO VELASCO 1838, NUNOA, CASILLA 593-11, SANTIAGO, 00000, CHILE		2452-6053		ANDES PEDIATRICA	Andes. Pediat.	JUL-AUG	2021	92	4					617	625		10.32641/andespediatr.v92i4.2973	http://dx.doi.org/10.32641/andespediatr.v92i4.2973			9	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	1Z4VN	34652382	Green Submitted, Bronze			2022-09-04	WOS:000808824400018
J	Blair, KJ; Martinez-Vernaza, S; Ordonez-Blanco, IT; Hernandez, W; Quiroga, C; Lowenstein, E; Valderrama-Beltran, SL; Clark, J; Lake, JE; Juillard, C; Amaya, LJL				Blair, Keuin J.; Martinez-Vernaza, Samuel; Ordonez-Blanco, Iuonne Tatiana; Hernandez, William; Quiroga, Camilo; Lowenstein, Ellen; Valderrama-Beltran, Sandra Liliana; Clark, Jesse; Lake, Jordan E.; Juillard, Catherine; Amaya, Luis Jorge Lombana			Screening With Anal Cytology in Colombia: Initial Experience and Need for High-Resolution Anoscopy	JOURNAL OF SURGICAL RESEARCH			English	Article						Anus neoplasms; Cytological techniques; Colposcopy; Men who have sex with men; HIV; Cancer screening	SQUAMOUS INTRAEPITHELIAL LESIONS; CANCER PRECURSOR LESIONS; HIV-INFECTED PATIENTS; COST-EFFECTIVENESS; HUMAN-PAPILLOMAVIRUS; GENITAL WARTS; PAP-SMEAR; DYSPLASIA; MORTALITY; NEOPLASIA	Background: Men who have sex with men (MSM) living with human immunodeficiency virus (HIV) are at increased risk of anal cancer. Anal cytology can be used to screen for dysplasia, with high-resolution anoscopy (HRA) required for diagnostic confirmation. We describe the impact lack of HRA had on management of abnormal screening results in Bogota, Colombia. Material and Methods: This retrospective cohort study includes MSM with HIV who underwent anal cytology screening between January 2019February 2020, with colorectal surgery (CRS) follow-up through July 2020. Cytology results included atypical squamous cells of undetermined significance (ASC-US), low-grade squamous intraepithelial lesion (LSIL), and high-grade squamous intraepithelial lesion (HSIL). Categorical and continuous variables were compared via Fisher's exact test and Wilcoxon rank-sum, respectively. Results: Of 211 MSM screened, 68 had abnormal cytology: ASC-US ( n = 23), LSIL ( n = 41), HSIL ( n = 4). Sixty (88.2%) were referred to CRS, and 51 (75.0%) attended > 1 appointment. At initial assessment, 17 were referred for anal exam under anesthesia (EUA) for tissue resection, and 21 for rectosigmoidoscopy. Having perianal condyloma was associated with recommendation for EUA ( P < 0.001), while cytology grade of dysplasia was not ( P = 0.308). Eleven (16.2%) underwent EUA for condyloma resection. Conclusions: Few studies have described anal cancer screening in settings without HRA. We found lack of HRA limited management of abnormal cytology in Colombia. Those with condyloma underwent resection, but HRA remains necessary to localize and treat microscopic disease. Next steps include implementation of HRA in order to further develop the anal cancer screening program for MSM with HIV in Bogota. (c) 2021 Elsevier Inc. All rights reserved.	[Blair, Keuin J.; Clark, Jesse; Lake, Jordan E.] Univ Calif Los Angeles UCLA, South Amer Program HIV Prevent Res SAPHIR, 10833 Conte Ave,72-227 CHS, Los Angeles, CA 90024 USA; [Blair, Keuin J.; Juillard, Catherine] UCLA, Program Adv Surg Equity PASE, Dept Surg, Los Angeles, CA USA; [Martinez-Vernaza, Samuel; Ordonez-Blanco, Iuonne Tatiana; Quiroga, Camilo; Lowenstein, Ellen; Valderrama-Beltran, Sandra Liliana] Hosp Univ San Ignacio HUSI, Dept Med Interna, Unidad Infectol, Bogota, Colombia; [Ordonez-Blanco, Iuonne Tatiana; Quiroga, Camilo; Valderrama-Beltran, Sandra Liliana] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia; [Hernandez, William] UCLA, Sch Nursing, Los Angeles, CA USA; [Hernandez, William] DAP Hlth, Palm Springs, CA USA; [Clark, Jesse] UCLA, Div Infect Dis, Dept Med, Los Angeles, CA USA; [Lake, Jordan E.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Houston, TX USA; [Amaya, Luis Jorge Lombana] Pontificia Univ Javeriana, Dept Cirugia Gen, Unidad Coloproctol, HUSI, Bogota, Colombia		Blair, KJ (corresponding author), Univ Calif Los Angeles UCLA, South Amer Program HIV Prevent Res SAPHIR, 10833 Conte Ave,72-227 CHS, Los Angeles, CA 90024 USA.	kevin.james.blair@gmail.com		Clark, Jesse/0000-0001-5862-6530; Valderrama-Beltran, Sandra Liliana/0000-0003-1833-1599; Lombana Amaya, Luis Jorge/0000-0002-7165-2124	University of California, Los Angeles' South American Program in HIV Prevention Research (SAPHIR) NIMH [R25MH087222]; UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH [P30MH58107]	University of California, Los Angeles' South American Program in HIV Prevention Research (SAPHIR) NIMH; UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH	This project was funded by the University of California, Los Angeles' South American Program in HIV Prevention Research (SAPHIR) NIMH grant R25MH087222. This work was also supported by the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant P30MH58107. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Abramowitz L, 2007, AIDS, V21, P1457, DOI 10.1097/QAD.0b013e3281c61201; Albuquerque A, 2021, LANCET GASTROENTEROL, V6, P327, DOI 10.1016/S2468-1253(20)30304-6; Albuquerque A, 2019, CANCERS, V11, DOI 10.3390/cancers11121942; [Anonymous], 2020, TOPICAL ABLATIVE TRE; [Anonymous], 2020, COL CONF ITS 1 CAS C; Augestad KM, 2017, SURG ENDOSC, V31, P3836, DOI 10.1007/s00464-017-5690-y; Barnell GM, 2019, JAIDS-J ACQ IMM DEF, V81, P292, DOI 10.1097/QAI.0000000000002040; Berry JM, 2014, INT J CANCER, V134, P1147, DOI 10.1002/ijc.28431; Berry JM, 2009, DIS COLON RECTUM, V52, P1860, DOI 10.1097/01.dcr.0000361970.30352.e0; Berry-Lawhorn JM, 2014, SEX TRANSM DIS, V41, P254, DOI 10.1097/OLQ.0000000000000119; Brady JT, 2017, SEMIN COLON RECTAL S, V28, P102, DOI 10.1053/j.scrs.2017.04.009; Cardinal LH, 2014, DIAGN CYTOPATHOL, V42, P396, DOI 10.1002/dc.23050; Castillo Canon, 2020, SITUACION VIH SIDA C; Charua-Guindic L, 2009, Rev Gastroenterol Mex, V74, P195; Chiao EY, 2006, CLIN INFECT DIS, V43, P223, DOI 10.1086/505219; Yepez MC, 2018, COLOMB MEDICA, V49, P42, DOI 10.25100/cm.v49i1.3616; Clifford GM, 2021, INT J CANCER, V148, P38, DOI 10.1002/ijc.33185; Darragh TM, 2011, CANCER CYTOPATHOL, V119, P5, DOI 10.1002/cncy.20126; EACS, 2018, EUROPEAN AIDS CLIN S; Factor SH, 2014, SEX TRANSM DIS, V41, P246, DOI 10.1097/OLQ.0000000000000105; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Geltzeiler CB, 2019, J SURG RES, V244, P117, DOI 10.1016/j.jss.2019.06.029; Gimenez Felicidad, 2011, Arq. Gastroenterol., V48, P136, DOI 10.1590/S0004-28032011000200010; Goldie SJ, 1999, JAMA-J AM MED ASSOC, V281, P1822, DOI 10.1001/jama.281.19.1822; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hillman RJ, 2016, J LOW GENIT TRACT DI, V20, P283, DOI 10.1097/LGT.0000000000000256; Howard K, 2012, SEX HEALTH, V9, P610, DOI 10.1071/SH12017; Huang EY, 2019, AM J SURG, V218, P760, DOI 10.1016/j.amjsurg.2019.07.018; Leeds IL, 2016, WORLD J GASTRO SURG, V8, P41, DOI 10.4240/wjgs.v8.i1.41; Machalek DA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-946; Maia LB, 2014, DIAGN CYTOPATHOL, V42, P840, DOI 10.1002/dc.23130; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; Mathews WC, 2004, JAIDS-J ACQ IMM DEF, V37, P1610, DOI 10.1097/00126334-200412150-00014; McCloskey JC, 2007, INT J STD AIDS, V18, P538, DOI 10.1258/095646207781439694; Ministerio de Salud y Proteccion Social, 2014, GUIA PRACT CLIN BAS; Nahas CSR, 2009, DIS COLON RECTUM, V52, P1854, DOI 10.1007/DCR.0b013e3181b98f36; Nowak RG, 2020, PAPILLOMAVIRUS RES, V10, DOI 10.1016/j.pvr.2020.100200; Nowak RG, 2019, J GLOB ONCOL, V5, DOI 10.1200/JGO.19.00102; Ong JJ, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20514; Palefsky JM, 2012, SEX HEALTH, V9, P580, DOI 10.1071/SH12045; Park IU, 2015, CLIN INFECT DIS, V61, pS849, DOI 10.1093/cid/civ813; Revollo B, 2020, CLIN INFECT DIS, V71, P390, DOI 10.1093/cid/ciz831; Schlecht HP, 2010, CLIN INFECT DIS, V51, P107, DOI 10.1086/653426; Sigel Keith, 2011, Curr HIV/AIDS Rep, V8, P142, DOI 10.1007/s11904-011-0085-5; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; StataCorp, 2019, STATA STAT SOFTWARE; Stewart DB, 2018, DIS COLON RECTUM, V61, P755, DOI 10.1097/DCR.0000000000001114; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Boldrini NAT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199058; Moranth RV, 2018, COLOMB MEDICA, V49, P55, DOI 10.25100/cm.v49i1.3627; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281	52	1	1	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2021	267						374	383		10.1016/j.jss.2021.05.037	http://dx.doi.org/10.1016/j.jss.2021.05.037		JUN 2021	10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UZ0GT	34216798				2022-09-04	WOS:000701892000007
J	Ostos, AB; Moreno, S; Romero, AG; Toro, CE; Mora, C; Avila, DGF; Gualtero, JMB; Latorre, MC; Barrios, MC; Patarroyo, PM; Molano, WB				Beltran Ostos, Adriana; Moreno, Sergio; Gonzalez Romero, Andres; Enrique Toro, Carlos; Mora, Claudia; Fernandez Avila, Daniel G.; Bello Gualtero, Juan Manuel; Constanza Latorre, Maria; Charry Barrios, Marlio; Mendez Patarroyo, Paul; Bautista Molano, Wilson			BARRIERS IN THE HEALTHCARE SERVICES FOR PATIENTS WITH MUSCULOSKELETAL DISEASES IN RHEUMATOLOGY SERVICES IN COLOMBIA. A RHEUMATOLOGIST PERSPECTIVE	JCR-JOURNAL OF CLINICAL RHEUMATOLOGY			English	Meeting Abstract									[Beltran Ostos, Adriana; Moreno, Sergio] Cent Mil Hosp, Teaching & Res Dept, Bogota, Colombia; [Gonzalez Romero, Andres] Fracture Risk CAYRE, Res Subdirectorate, Bogota, Colombia; [Enrique Toro, Carlos] Reference Ctr Osteoporosis & Rheumatol, Bogota, Colombia; [Mora, Claudia] Univ Sabana, Dept Internal Med, Bogota, Colombia; [Fernandez Avila, Daniel G.] Pontificia Univ Javeriana, San Ignacio Univ Hosp, Bogota, Colombia; [Bello Gualtero, Juan Manuel] Univ Mil Nueva Granada, Sch Med, Cent Mil Hosp, Rheumatol & Immunol Dept, Bogota, Colombia; [Constanza Latorre, Maria] Colombian Rheumatol Assoc, Country Med Ctr, Bogota, Colombia; [Charry Barrios, Marlio] Colombian Rheumatol Assoc, Bogota, Colombia; [Mendez Patarroyo, Paul; Bautista Molano, Wilson] Univ Hosp Fdn Santa Fe Bogota, Dept Rheumatol, Bogota, Colombia					Fernandez-Avila, Daniel/0000-0003-1490-1822					0	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-1608	1536-7355		JCR-J CLIN RHEUMATOL	JCR-J. Clin. Rheumatol.	APR	2020	26			3		365	110	110						1	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Rheumatology	LK2AZ					2022-09-04	WOS:000530661500299
J	Gomez, AM; Alfonso-Cristancho, R; Orozco, JJ; Lynch, PM; Prieto, D; Saunders, R; Roze, S; Valencia, JE				Maria Gomez, Ana; Alfonso-Cristancho, Rafael; Jairo Orozco, John; Lynch, Peter Matthew; Prieto, Diana; Saunders, Rhodri; Roze, Stephane; Valencia, Juan Esteban			Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia	ENDOCRINOLOGIA Y NUTRICION			Spanish	Article						Type 1 diabetes; Insulin infusion systems; Continuous glucose monitoring; Cost-effectiveness analysis; Decision modeling	QUALITY-OF-LIFE; COST-EFFECTIVENESS; GLYCEMIC CONTROL; HEALTH; HYPOGLYCEMIA; MELLITUS; MODEL; COMPLICATIONS; VALIDATION; AMERICA	Objective: To assess the long-term clinical and economic impact of integrated pump/CGM technology therapy as compared to multiple daily injections (MDI), for the treatment of type 1 diabetes (T1D) in Colombia. Methods: The CORE Diabetes Model was used to simulate a hypothetical cohort of patients with T1D. Mean baseline characteristics were taken from a clinical study conducted in Colombia and a healthcare payer perspective was adopted, with a 5% annual discount rate applied to both costs and outcomes. Results: The integrated pump/CGM improved mean life expectancy by 3.51 years compared with MDI. A similar increase occurred in mean quality-adjusted life expectancy with an additional 3.81 quality-adjusted life years (QALYs). Onset of diabetes-related complications was also delayed as compared to MDI, and mean survival time free of complication increased by 1.74 years with integrated pump/CGM. Although this increased treatment costs of diabetes as compared to MDI, savings were achieved thanks to reduced expenditure on diabetes-related complications. The estimated incremental cost-effectiveness ratio (ICER) for SAP was Colombian Pesos (COP) 44,893,950 (approximately USD$23,200) per QALY gained. Conclusions: Improved blood glucose control associated to integrated pump/CGM results in a decreased incidence of diabetes-related complications and improves life expectancy as compared to MDI. Using recommended thresholds from the World Health Organization and previous coverage decisions about health technologies in Colombia, it is a cost-effective alternative to MDI for the treatment of type 1 diabetes in Colombia. (C) 2016 SEEN. Published by Elsevier Espana, S.L.U. All rights reserved.	[Maria Gomez, Ana] Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Alfonso-Cristancho, Rafael; Prieto, Diana] Univ Washington, Seattle, WA 98195 USA; [Alfonso-Cristancho, Rafael] RANDOM Fdn, Bogota, Colombia; [Jairo Orozco, John] Medtron PLC Andean Reg, Bogota, Colombia; [Lynch, Peter Matthew] Medtron Diabet Inc, Northridge, CA USA; [Saunders, Rhodri] Ossian Hlth Econ & Commun, Basel, Switzerland; [Roze, Stephane] HEVA HEOR, Lyon, France; [Valencia, Juan Esteban] Medtron Latinamer Inc, Miami, FL USA		Gomez, AM (corresponding author), Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia.	amgomezm5@gmail.com		Gomez-Medina, Ana Maria/0000-0002-8907-3470				[Anonymous], 2005, WHO CHOOS INT AR COS; Aschner P, 2010, AV DIABETOL, V26, P95, DOI 10.1016/S1134-3230(10)62005-4; Aschner P, 2014, DIABETES RES CLIN PR, V103, P238, DOI 10.1016/j.diabres.2013.11.010; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; CD NH, 2010, 4 CD NH IMS HLTH; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Currie CJ, 2006, CURR MED RES OPIN, V22, P1523, DOI 10.1185/030079906X115757; Deis D, 2006, DIABETES CARE, V29, P2730, DOI 10.2337/dc06-1134; Delamater AM, 2006, CLIN DIABETES, V24, P71, DOI DOI 10.2337/DIACLIN.24.2.71; Guillermo Ariza Juan, 2012, Value Health Reg Issues, V1, P165, DOI 10.1016/j.vhri.2012.09.003; Huang ES, 2010, DIABETES CARE, V33, P1269, DOI 10.2337/dc09-2042; Kamble S, 2012, VALUE HEALTH, V15, P632, DOI 10.1016/j.jval.2012.02.011; Ly TT, 2013, JAMA-J AM MED ASSOC, V310, P1240, DOI 10.1001/jama.2013.277818; Lynch P, 2012, EASD; Gomez AM, 2013, AV DIABETOL, V29, P74, DOI 10.1016/j.avdiab.2013.04.001; McEwan P, 2014, VALUE HEALTH, V17, P714, DOI 10.1016/j.jval.2014.07.007; McQueen R Brett, 2011, Cost Eff Resour Alloc, V9, P13, DOI 10.1186/1478-7547-9-13; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Palmer AJ, 2004, CURR MED RES OPIN, V20, pS5, DOI 10.1185/030079904X1980; Palmer AJ, 2004, CURR MED RES OPIN, V20, pS27, DOI 10.1185/030079904X2006; Pickup JC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3805; Pratoomsoot C, 2009, DIABETIC MED, V26, P803, DOI 10.1111/j.1464-5491.2009.02775.x; Roze S, 2005, DIABETIC MED, V22, P1239, DOI 10.1111/j.1464-5491.2005.01576.x; Roze S, 2015, DIABETIC MED, V32, P618, DOI 10.1111/dme.12661; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; St Charles M, 2009, VALUE HEALTH, V12, P674; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	33	7	9	0	12	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	1575-0922	1579-2021		ENDOCRINOL NUTR	Endocrinol. Nutr.	NOV	2016	63	9					466	474		10.1016/j.endonu.2016.05.011	http://dx.doi.org/10.1016/j.endonu.2016.05.011			9	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	EA3WC	27595241				2022-09-04	WOS:000386539000005
J	Castilla-Puentes, R; Sala, R; Ng, B; Galvez, J; Camacho, A				Castilla-Puentes, Ruby; Sala, Regina; Ng, Bernardo; Galvez, Juan; Camacho, Alvaro			Anxiety Disorders and Rapid Cycling Data From a Cohort of 8129 Youths With Bipolar Disorder	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Anxiety disorders; bipolar disorder; children and adolescents; comorbidity; rapid cycling	BIPOLAR SPECTRUM DISORDERS; MANAGED CARE DATABASE; COMORBID ANXIETY; I DISORDER; CHILDREN; ADOLESCENTS; PREVALENCE; COHORT; HOSPITALIZATION; PHENOMENOLOGY	Anxiety disorders (ADs) are common in youths with bipolar disorder (BD). We examine psychiatric comorbidity, hospitalization, and treatment in youths with versus without AD and rapid cycling (four or more cycles per year). Data from the Integrated Healthcare Information Services cohort were used and included 8129 youths (ages e18 years). Prevalence of AD, demographic, type of AD, hospitalization, and use of psychotropics were compared between rapid and nonrapid cycling. Overall, 51% of the youths met criteria for at least one comorbid AD; they were predominantly female and were between 12 and 17 years of age. The most common comorbid ADs were generalized ADs and separation ADs. In the patients with rapid cycling, 65.5% met criteria for comorbid AD. The BD youths with AD were more likely to have major depressive disorders and other comorbid ADs, to be given more psychotropics, and to be hospitalized for depression and medical conditions more often than were those without AD.	[Castilla-Puentes, Ruby] Temple Univ, Ft Washington, MD USA; [Sala, Regina] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Ng, Bernardo; Camacho, Alvaro] Sun Valley Behav & Res Ctr, Imperial, CA USA; [Galvez, Juan] Pontificia Univ Javeriana, Bogota, Colombia; [Camacho, Alvaro] Univ Calif San Diego, San Diego, CA 92103 USA		Castilla-Puentes, R (corresponding author), 530 South 2nd St,Suite 743, Philadelphia, PA 19146 USA.	rcastil4@its.jnj.com	Castilla-Puentes, Ruby/M-8042-2019	Castilla-Puentes, Ruby/0000-0002-0597-6155	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079891] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL079891] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Psychiatric Association, 2012, PROP DSM 5 ORG STRUC; [Anonymous], 2009, VNITR LEK, V55, P650; [Anonymous], 2003, DIS STAGING CODED CR; Axelson D, 2006, ARCH GEN PSYCHIAT, V63, P1139, DOI 10.1001/archpsyc.63.10.1139; Ball S, 2002, J Postgrad Med, V48, P317; BELLDOLAN D, 1993, CHILD ADOLESCENT PSY, V2, P563; Blumentals WA, 2004, INT J IMPOT RES, V16, P350, DOI 10.1038/sj.ijir.3901174; Calabrese JR, 2000, RAPID CYCLING BIPOLA; Carballo JJ, 2011, PRIM CARE COMPANION, V13, P135; Castilla-Puentes R, 2008, INT J PSYCHIAT MED, V38, P61, DOI 10.2190/PM.38.1.f; Coryell W, 2003, ARCH GEN PSYCHIAT, V60, P914, DOI 10.1001/archpsyc.60.9.914; Cosoff SJ, 1998, AUST NZ J PSYCHIAT, V32, P67, DOI 10.3109/00048679809062708; DelBello MP, 2007, AM J PSYCHIAT, V164, P582, DOI 10.1176/appi.ajp.164.4.582; Dickstein DP, 2005, J CHILD ADOL PSYCHOP, V15, P534, DOI 10.1089/cap.2005.15.534; Dilsaver SC, 2008, B MENNINGER CLIN, V72, P130, DOI 10.1521/bumc.2008.72.2.130; Dilsaver SC, 2006, J AFFECT DISORDERS, V96, P249, DOI 10.1016/j.jad.2006.07.008; Dilsaver SC, 2009, J AFFECT DISORDERS, V116, P12, DOI 10.1016/j.jad.2008.10.016; Findling RL, 2001, BIPOLAR DISORD, V3, P202, DOI 10.1034/j.1399-5618.2001.030405.x; First M, 2002, RES AGENDA DSM 5 SUM; Frank E, 2002, ARCH GEN PSYCHIAT, V59, P905, DOI 10.1001/archpsyc.59.10.905; Geller B, 2004, ARCH GEN PSYCHIAT, V61, P459, DOI 10.1001/archpsyc.61.5.459; Geller B, 1998, J AFFECT DISORDERS, V51, P81, DOI 10.1016/S0165-0327(98)00175-X; Goldstein BI, 2012, ISR J PSYCHIATR REL, V49, P3; Goldstein BI, 2009, J AFFECT DISORDERS, V117, P151, DOI 10.1016/j.jad.2009.01.011; Gomez-Caminero A, 2005, PSYCHOSOM MED, V67, P688, DOI 10.1097/01.psy.0000174169.14227.1f; Lee S, 2010, BRIT J PSYCHIAT, V196, P217, DOI 10.1192/bjp.bp.109.067843; Levin A, 2005, PSYCHIAT NEWS, V40, P42; Marchand William R, 2006, J Psychiatr Pract, V12, P128, DOI 10.1097/00131746-200603000-00011; Motheral BR, 1997, CLIN THER, V19, P346, DOI 10.1016/S0149-2918(97)80122-1; Pistorio E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-192; Regenold WT, 2002, J AFFECT DISORDERS, V70, P19, DOI 10.1016/S0165-0327(01)00456-6; Romansky JB, 2003, PSYCHIAT SERV, V54, P356, DOI 10.1176/appi.ps.54.3.356; Sala R, 2012, J CLIN PSYCHIAT, V73, P87, DOI 10.4088/JCP.10m06720; Sala R, 2009, CHILD ADOL PSYCH CL, V18, P273, DOI 10.1016/j.chc.2008.11.002; Sareen J, 2005, DEPRESS ANXIETY, V21, P193, DOI 10.1002/da.20072; Slomski A, 2012, JAMA-J AM MED ASSOC, V308, P223, DOI 10.1001/jama.2012.6951; Staton D, 2008, J AFFECT DISORDERS, V105, P205, DOI 10.1016/j.jad.2007.05.015	37	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	DEC	2013	201	12					1060	1065		10.1097/NMD.0000000000000052	http://dx.doi.org/10.1097/NMD.0000000000000052			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	299EP	24284641	Green Accepted			2022-09-04	WOS:000330378700008
J	Gonzalez, AM; Jaimes, MC; Cajiao, I; Rojas, OL; Cohen, J; Pothier, P; Kohli, E; Butcher, EC; Greenberg, HB; Angel, J; Franco, MA				Gonzalez, AM; Jaimes, MC; Cajiao, I; Rojas, OL; Cohen, J; Pothier, P; Kohli, E; Butcher, EC; Greenberg, HB; Angel, J; Franco, MA			Rotavirus-specific B cells induced by recent infection in adults and children predominantly express the intestinal homing receptor alpha 4 beta 7	VIROLOGY			English	Article						rotavirus; mucosal immunology; B cells; homing; flow cytometry; ELISPOT	ANTIBODY-SECRETING CELLS; YOUNG-CHILDREN; FORMING-CELLS; IMMUNITY; MUCOSAL; SERUM; VACCINE; MEMORY; RESPONSES; VIRUS	In vivo replication of rotaviruses is generally limited to enterocytes. Because of this restriction, most blood circulating rotavirus-specific B cells are hypothesized to originate in Peyer's patches and should express the intestinal homing receptor alpha4beta7. To test this hypothesis in humans, we used a flow cytometry assay that identifies antigen-activated (IgD-) B cells (CD19(+)) that express surface rotavirus-specific immunoglobulin. With this assay we could detect rotavirus-specific B cells in both children and adults with an acute rotavirus (RV) infection. Staining with an anti-alpha4beta7 monoclonal antibody, we could determine that B cells that express rotavirus-specific surface immunoglobulin predominantly express alpha4beta7. The response of rotavirus-specific antibody-secreting cells in the peripheral blood of children and adults with acute rotavirus infection was also studied by ELISPOT. The antibody-secreting cells of children were mainly of the IgM isotype, while the antibody-secreting cells of adults were predominantly of the IgA and IgG isotype. alpha4beta7+ and alpha4beta7- subsets of peripheral blood mononuclear cells were purified using paramagnetic beads and then tested in the ELISPOT assay. Rotavirus-specific antibody-secreting cells were predominantly present in the alpha4beta7+ subpopulation. The flow cytometry assay we have described will permit future studies to characterize the phenotype of virus-specific B cells and could be useful in the study of the immunogenicity and protective efficacy of RV vaccines and the identification of markers of protective immunity. (C) 2002 Elsevier Science (USA).	Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; INRA, Lab Virol Mol & Cellulaire, F-78352 Jouy En Josas, France; Fac Med & Pharm Dijon, F-21034 Dijon, France; Ctr Hosp Univ, F-21034 Dijon, France; Stanford Univ, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Immunol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA		Franco, MA (corresponding author), Pontificia Univ Javeriana, Inst Genet Humana, Carrera 7 40-62, Bogota, Colombia.		Kohli, Evelyne/A-7612-2011; CORTES, Manuel Antonio FRANCO/M-7517-2014; Angel, Juana/O-2908-2014	Kohli, Evelyne/0000-0002-9383-6573; CORTES, Manuel Antonio FRANCO/0000-0002-0265-0563; Angel, Juana/0000-0001-6623-5337; greenberg, harry/0000-0002-2128-9080	FIC NIH HHS [TWO 5647-02] Funding Source: Medline; NIAID NIH HHS [R37AI21632, AI47822] Funding Source: Medline; NIDDK NIH HHS [1 P30 DK56339] Funding Source: Medline; NIGMS NIH HHS [GM37734] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW005647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047822, R37AI047822, R13AI021632, R21AI047822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037734, R37GM037734] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe T, 2000, BRAIN DEV-JPN, V22, P301, DOI 10.1016/S0387-7604(00)00111-X; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; Brown KA, 2000, J INFECT DIS, V182, P1039, DOI 10.1086/315808; BROWN TA, 1985, J CLIN MICROBIOL, V22, P259, DOI 10.1128/JCM.22.2.259-264.1985; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; COULSON BS, 1992, J CLIN MICROBIOL, V30, P1678, DOI 10.1128/JCM.30.7.1678-1684.1992; COULSON BS, 1989, J VIROL METHODS, V26, P53, DOI 10.1016/0166-0934(89)90074-8; ERLE DJ, 1994, J IMMUNOL, V153, P517; Franco MA, 2001, VIROLOGY, V281, P153, DOI 10.1006/viro.2001.0830; Franco MA, 1999, J INFECT DIS, V179, pS466, DOI 10.1086/314805; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; GILCHRIST MJR, 1987, DIAGN MICR INFEC DIS, V8, P221, DOI 10.1016/0732-8893(87)90053-8; Greenberg H B, 1994, Curr Top Microbiol Immunol, V185, P255; GRIMWOOD K, 1988, J CLIN MICROBIOL, V26, P732, DOI 10.1128/JCM.26.4.732-738.1988; Herremans TMPT, 1999, J IMMUNOL, V162, P5011; ISOLAURI E, 1995, VACCINE, V13, P310, DOI 10.1016/0264-410X(95)93319-5; JOHANSEN K, 1994, ARCH VIROL, V138, P247, DOI 10.1007/BF01379129; KAILA M, 1992, GUT, V33, P639, DOI 10.1136/gut.33.5.639; Kantele A, 1997, J IMMUNOL, V158, P574; KANTELE A, 1990, VACCINE, V8, P321, DOI 10.1016/0264-410X(90)90088-4; Kuklin NA, 2000, J CLIN INVEST, V106, P1541, DOI 10.1172/JCI10927; Kuklin NA, 2001, J IMMUNOL, V166, P1894, DOI 10.4049/jimmunol.166.3.1894; Lakew M, 1997, J IMMUNOL METHODS, V203, P193, DOI 10.1016/S0022-1759(97)00030-6; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; PONZI AN, 1985, J CLIN MICROBIOL, V22, P505, DOI 10.1128/JCM.22.4.505-509.1985; QuidingJarbrink M, 1997, J CLIN INVEST, V99, P1281, DOI 10.1172/JCI119286; Rose JR, 1998, J VIROL, V72, P726; Rott LS, 1997, J CLIN INVEST, V100, P1204, DOI 10.1172/JCI119633; Rott LS, 2000, J LEUKOCYTE BIOL, V68, P807; Willams S, 1998, HAEMOPHILIA, V4, P8, DOI 10.1046/j.1365-2516.1998.0040s1008.x; Youngman KR, 2002, J IMMUNOL, V168, P2173, DOI 10.4049/jimmunol.168.5.2173; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996	35	43	45	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	JAN 5	2003	305	1					93	105		10.1006/viro.2002.1708	http://dx.doi.org/10.1006/viro.2002.1708			13	Virology	Science Citation Index Expanded (SCI-EXPANDED)	Virology	632FX	12504544	Bronze			2022-09-04	WOS:000180214200010
J	Mariosa, DF; Morais, LP; Alvarez, JF; Politti, F; Conde, MAA; Valencia, AMS				Mariosa, Duarcides Ferreira; Morais, Leandro Pereira; Alvarez, Juan Fernando; Politti, Fabiano; Conde, Miguel Angel Alarcon; Valencia, Ana Milena Silva			Does the social and solidarity economy contribute to the reach and accomplishment of the sustainable development goals? A systematic literature review	INTERNATIONAL JOURNAL OF INNOVATION AND SUSTAINABLE DEVELOPMENT			English	Review						SDGs; sustainable development goals; SSE; social and solidarity economy; systematic literature review; methodological procedures; social and solidarity economy contributions agenda 2030; checklist to assess the quality of the study; social and solidarity economy impacts	METAANALYSES	Although the themes social and solidarity economy (SSE) and sustainable development goals (SDG) have been intensively researched, the works presenting results that demonstrate the intersection between the two subjects are still undergoing experimentation. Through a systematic review of the literature, this paper aims to find out how SSE organisations contribute to the implementation of the SDGs. The authors elaborated a checklist to assess the methodological procedures of the results from studies published. After applying the eligibility criteria, the selected papers show us that the 'metrics' for assessing SSE contributions to the implementation of the SDGs are not measured by fully quantified methodologies. We conclude that, according to the results of this systematic review, although the existence of a positive relationship between the SSE and the implementation of the SDGs is considered, the studies available in this period, do not present robust and consistent methodologies to demonstrate this relationship.	[Mariosa, Duarcides Ferreira] Univ Estadual Campinas, Ctr Econ & Adm Pontifical Catholic, Postgrad Program Sustainabil, R Prof Dr Euryclides Jesus Zerbini 1516, BR-13087571 Campinas, SP, Brazil; [Morais, Leandro Pereira] UNESP, Dept Econ, Araraquara, SP, Brazil; [Alvarez, Juan Fernando] Pontificia Univ Javeriana, Carrera 7 40-62, Bogota, Colombia; [Politti, Fabiano] Univ Nove Julho UNINOVE, Postgrad Program Rehabil Sci, Phys Therapy Dept, BR-425 Sao Paulo, Brazil; [Conde, Miguel Angel Alarcon] Univ Castilla La Mancha, Fac Econ & Business Adm, Campus Univ Albacete S-N, Albacete 02071, Spain; [Valencia, Ana Milena Silva] Univ ICESI, Calle 18 122-135, Cali, Colombia		Mariosa, DF (corresponding author), Univ Estadual Campinas, Ctr Econ & Adm Pontifical Catholic, Postgrad Program Sustainabil, R Prof Dr Euryclides Jesus Zerbini 1516, BR-13087571 Campinas, SP, Brazil.	duarcides@gmail.com; leandro.morais@unesp.br; alvarez_juan@javeriana.edu.co; fabianopolitti@gmail.com; miguelangel.alarcon@uclm.es; silvaysolucionescorporacion@gmail.com						Conde MAA, 2020, CIRIEC, V99, P57, DOI 10.7203/CIRIEC-E.99.14322; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Landin SA, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114529; Bastida M., 2020, REVESCO, V134, P1; Bastida M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12020500; Blagoycheva H, 2019, TRAKIA J SCI, V17, P488, DOI DOI 10.15547/tjs.2019.s.01.079; Blesh J, 2019, WORLD DEV, V118, P1, DOI 10.1016/j.worlddev.2019.02.004; Boaz A, 2002, 2 ESRC UK CTR EV BAS; Bonil J, 2010, REV EUREKA ENSEN DIV, V7, P198, DOI 10.25267/Rev_Eureka_ensen_divulg_cienc.2010.v7.iextra.05; Bretos I, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083262; Calderon-Milan MJ, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12031079; Nunez RBC, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125192; Chaves-Avila R, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12104059; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; Critical Appraisal Skills Programme (CASP), 2013, CASP ASS EC CHECKL; Fuertes-Fuertes I, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010048; Gil-Lacruz A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072665; Gomersall JS, 2015, INT J EVID-BASED HEA, V13, P170, DOI 10.1097/XEB.0000000000000063; Hernandez-Perlines F, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125045; Higgins J. P. T., 2011, COCHRANE HDB SYSTEMA; Inter-agency Task Force on Social and Solidarity Econ.omy, 2018, KNOWLEDGE HUB RESOUR, V1; Kerras H, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083347; Lee S, 2020, INT J SUST DEV WORLD, V27, P65, DOI 10.1080/13504509.2019.1670274; Ciruela-Lorenzo AM, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041325; Martinez-Leon IM, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125107; Mendell M., 2019, SUSTAINABLE DEV IMPA; Miedes-Ugarte B, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12124837; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Monzon Campos J. L., 2000, ECONOMISTAS, P113; Mook L, 2019, CAN J NONPROFIT SOC, V10, P81, DOI 10.29173/anserj.2019v10n2a343; Moreno A.S, 1996, ANALISIS EC SECTOR L; Mozas-Moral A, 2020, SUSTAINABILITY-BASEL, V12, P4747, DOI 10.3390/su12114747; NEWELL R, 2006, VITAL NOTES NURSES R; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; Quiroz-Nino C, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9122164; Rihter L, 2018, REV SOC POLIT, V25, P285, DOI 10.3935/rsp.v25i3.1492; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Soares-Weiser K, 2020, COCHRANE DB SYST REV, DOI 10.1002114651858.ED000149; Tremblay C, 2009, CANADIAN SOCIAL EC R, V1; United Nations, 2015, FUT NOW SCI SUST DEV; UNRISD, 2018, SOCIAL SOLIDARITY EC; Utting P, 2018, ACHIEVING SUSTAINABL	43	0	0	5	5	INDERSCIENCE ENTERPRISES LTD	GENEVA	WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 856, CH-1215 GENEVA, SWITZERLAND	1740-8822	1740-8830		INT J INNOV SUSTAIN	Int. J. Innov. Sustain. Dev.		2022	16	3-4					538	555		10.1504/IJISD.2022.123884	http://dx.doi.org/10.1504/IJISD.2022.123884			18	Green & Sustainable Science & Technology	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	2Q9ZT					2022-09-04	WOS:000820774800011
J	Espinosa, F; Castro, MP				Espinosa, Felipe; Pinedo Castro, Myreya			On the use of herbarium specimens for morphological and anatomical research	BOTANY LETTERS			English	Article						Dyes; Herbarium specimen; Plant Anatomy; Plant morphology; Restoration	COLLECTIONS; CHARACTERS; EVOLUTION; HYMENOPHYLLACEAE; OVARY	Herbarium material is crucial to answer questions in plant systematics and evolution. However, the exploitation of pressed and dried biological material from herbarium specimen can be challenging. Although some protocols have been designed to analyze fresh and dried material indistinctly, dried material may require additional treatments before being further exploited. In this technical note, we present general or more particular methods of restoration and exploitation of herbarium material used for morphological and anatomical studies in order to solve alpha systematic problems and address theoretical plant morphology and anatomy.	[Espinosa, Felipe] Sorbonne Univ, Inst Systemat Evolut Biodiversite ISYEB, Museum Natl Hist Nat, Ctr Natl Rech Sci,Ecole Prat Hautes Etud, Paris, France; [Espinosa, Felipe] Univ Paris Saclay, Agro Paris Tech, CNRS, Ecol Systemat Evolut,Univ Paris Sud, Orsay, France; [Pinedo Castro, Myreya] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, cLab Genet Poblac Mol Biol Evolut, Bogota, Colombia		Espinosa, F (corresponding author), Sorbonne Univ, Inst Systemat Evolut Biodiversite ISYEB, Museum Natl Hist Nat, Ctr Natl Rech Sci,Ecole Prat Hautes Etud, Paris, France.; Espinosa, F (corresponding author), Univ Paris Saclay, Agro Paris Tech, CNRS, Ecol Systemat Evolut,Univ Paris Sud, Orsay, France.	felipeespinosam@gmail.com	Castro, Myreya Pinedo/AAF-8450-2019		Colombian government agency Colciencias	Colombian government agency Colciencias	We thank Thierry Deroin for helping us prepare this article, and Sophie Nadot, Guillaume Besnard and two anonymous reviewers for their comments on a previous version of the manuscript. Financial support for Felipe Espinosa's PhD was provided by the Colombian government agency Colciencias.	ALBERCH P, 1993, TRENDS ECOL EVOL, V8, P372, DOI 10.1016/0169-5347(93)90222-B; Beaman RS, 2012, ZOOKEYS, P7, DOI 10.3897/zookeys.209.3313; Biye EH, 2014, PLANT SYST EVOL, V300, P263, DOI 10.1007/s00606-013-0879-6; Buzatto CR, 2012, ANN BOT-LONDON, V109, P135, DOI 10.1093/aob/mcr241; CARLQUIST S, 1982, STAIN TECHNOL, V57, P311, DOI 10.3109/10520298209066729; Chen JH, 2015, PLANT SYST EVOL, V301, P841, DOI 10.1007/s00606-014-1114-9; Chen  Y, BOT LETT; Chortier M, 2016, TAXON, V65, P1313, DOI 10.12705/656.6; Corney DPA, 2012, TAXON, V61, P231, DOI 10.1002/tax.611016; DEROIN T, 1993, CR ACAD SCI III-VIE, V316, P725; Deroin T., 1992, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V14, P235; Deroin T., 1995, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V17, P183; Deroin  T, 1997, B SOC BOT CTR QUEST, V28, P115; Deroin T, 2007, ADANSONIA, V29, P7; Dop  P, 1928, MANUEL TECHNIQUE BOT; Dubuisson JY, 2013, ACTA BOT GALLICA, V160, P173, DOI 10.1080/12538078.2013.819294; Espinosa F, 2017, INT J PLANT SCI, V178, P546, DOI 10.1086/692764; Fernandes VF, 2016, BOT J LINN SOC, V181, P682, DOI 10.1111/boj.12432; Fernandez M, 2016, SYST BOT, V41, P807, DOI 10.1600/036364416X692370; Forman L., 1989, HERBARIUM HDB; Forzza R. C., 2016, UNISANTA BIOSCIENCE, V9, P135; Fosberg FR, 1946, SCI MON, V63, P429; Gerlach D., 1984, BOT MIKROTECHNIK; Grew Nehemiah, 1682, ANATOMY PLANTS; Johansen D.A., 1940, PLANT MICROTECHNIQUE, V1, P182; Keating R, 2014, PREPARING PLANT TISS; Langeron M, 1942, PRECIS MICROSCOPIE; Malpighi M, 1675, ANATOMIA PLANTARUM; Mouly A, 2016, PLANT ECOL EVOL, V149, P112, DOI 10.5091/plecevo.2016.1038; Pacheco-Trejo J, 2009, PLANT SYST EVOL, V281, P137, DOI 10.1007/s00606-009-0195-3; Page LM, 2015, BIOSCIENCE, V65, P841, DOI 10.1093/biosci/biv104; Saunders RMK, 2010, BIOL REV, V85, P571, DOI 10.1111/j.1469-185X.2009.00116.x; SCHMID R, 1977, TAXON, V26, P551, DOI 10.2307/1219648; Schneider H, 2000, BOT J LINN SOC, V132, P29, DOI 10.1006/bojl.1999.0277; Smith FH, 1942, AM J BOT, V29, P464, DOI 10.2307/2437312; Sosnovsky Y, 2017, FLORA, V230, P26, DOI 10.1016/j.flora.2017.03.003; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Tripp EA, 2012, AM J BOT, V99, P967, DOI 10.3732/ajb.1100354; Vasco A, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400038; White RA, 2017, AM FERN J, V107, P30, DOI 10.1640/0002-8444-107.1.30	40	5	5	3	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2381-8107	2381-8115		BOT LETT	Botany Lett.		2018	165	3-4			SI		361	367		10.1080/23818107.2018.1451775	http://dx.doi.org/10.1080/23818107.2018.1451775			7	Plant Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences	HJ3IS					2022-09-04	WOS:000457064300005
J	Amerio, A; Galvez, JF; Odone, A; Dalley, SA; Ghaemi, SN				Amerio, Andrea; Galvez, Juan Francisco; Odone, Anna; Dalley, Shannon A.; Ghaemi, S. Nassir			Carcinogenicity of psychotropic drugs: A systematic review of US Food and Drug Administration-required preclinical in vivo studies	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY			English	Review						Psychotropic drugs; carcinogenicity; Food and Drug Administration; preclinical studies	NATIONAL PATTERNS; BREAST-CANCER; PRIMARY-CARE; ANTIDEPRESSANT; RISK; PHARMACEUTICALS; TRANSLATION; MEDICATIONS; UPDATE; GROWTH	Objective: The US Food and Drug Administration approval process for psychotropic drugs requires safety studies of carcinogenicity in animals. These studies are consistently conducted and provide a database for assessment of potential biological risk of carcinogenicity in humans. This report is a systematic review of that database for psychotropic drugs. Method: US Food and Drug Administration-approved registration data ('package inserts') were examined, where available, for all psychotropic drugs in the following classes: antidepressants, antipsychotics, benzodiazepines/sedative-hypnotics, amphetamines and anticonvulsants. Results: Overall, new generation (atypical) antipsychotics (90%, 9/10 agents) and anticonvulsants (85.7%, 6/7 agents) showed the highest evidence of carcinogenicity among psychotropic drugs classes assessed. Antidepressants (63.6%, 7/11) and benzodiazepines/sedative-hypnotics (70%, 7/10) were next, and stimulants (with the exception of methylphenidate) were last (25%, 1/4 agents). Overall, 71.4% of all drugs examined (30/42) showed evidence of carcinogenicity in 43.2% (38/88) of specific experimental studies. Conclusions: US Food and Drug Administration-based analyses demonstrate that almost all atypical antipsychotics and anticonvulsants are carcinogenic in animals, as are the majority of antidepressants and benzodiazepines and methylphenidate. These animal-based results are not sufficient to draw definitive conclusions in humans, but they provide data that could be acknowledged in the informed consent process of clinical treatment.	[Amerio, Andrea] Univ Parma, Sect Psychiat, Dept Neurosci, I-43126 Parma, Italy; [Amerio, Andrea; Galvez, Juan Francisco; Ghaemi, S. Nassir] Tufts Med Ctr, Mood Disorders Program, Boston, MA USA; [Galvez, Juan Francisco] Javeriana Univ, Sch Med, Bogota, Colombia; [Odone, Anna] Univ Parma, Sch Med, Publ Hlth Unit, I-43126 Parma, Italy; [Odone, Anna] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Dalley, Shannon A.] Roosevelt Univ, Dept Clin Psychol, Chicago, IL 60605 USA; [Ghaemi, S. Nassir] Tufts Univ, Sch Med, Boston, MA 02111 USA		Amerio, A (corresponding author), Univ Parma, Sect Psychiat, Dept Neurosci, Osped Maggiore, Pad 21 Braga,Viale Gramsci 14, I-43126 Parma, Italy.	andrea.amerio@studenti.unipr.it	Amerio, Andrea/AAB-8564-2019; Odone, Anna/AAC-4715-2022	Odone, Anna/0000-0002-5657-9774; Amerio, Andrea/0000-0002-3439-340X	Takeda Pharmaceuticals	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	Dr Amerio, Dr Galvez, Dr Odone and Mrs Dalley have no potential conflicts of interest to declare. Dr Ghaemi has provided research consulting to Sunovion and Pfizer and has obtained a research grant from Takeda Pharmaceuticals.	Brambilla G, 2009, MUTAT RES-REV MUTAT, V681, P209, DOI 10.1016/j.mrrev.2008.09.002; BRANDES LJ, 1992, CANCER RES, V52, P3796; Bucher JR, 1998, ENVIRON HEALTH PERSP, V106, P619, DOI 10.1289/ehp.98106619; BUCHER JR, 1994, FUND APPL TOXICOL, V23, P280, DOI 10.1006/faat.1994.1106; Casarett L.J., 2008, CASARETT DOULLS TOXI, V7th; Chou CT, 2007, TOXICOL APPL PHARM, V218, P265, DOI 10.1016/j.taap.2006.11.012; Coogan PF, 2005, AM J EPIDEMIOL, V162, P835, DOI 10.1093/aje/kwi301; Cosgrove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018210; Cotterchio M, 2000, AM J EPIDEMIOL, V151, P951, DOI 10.1093/oxfordjournals.aje.a010138; Dalton SO, 2000, EPIDEMIOLOGY, V11, P171, DOI 10.1097/00001648-200003000-00015; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Frick LR, 2008, BIOCHEM PHARMACOL, V75, P1817, DOI 10.1016/j.bcp.2008.01.015; Greenblatt DJ, 2011, J CLIN PSYCHOPHARM, V31, P1, DOI 10.1097/JCP.0b013e318209cf05; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Haukka J, 2010, INT J CANCER, V126, P285, DOI 10.1002/ijc.24537; Hayes AW, 2011, REGUL TOXICOL PHARM, V60, pS1, DOI 10.1016/j.yrtph.2010.10.002; IISHI H, 1993, CARCINOGENESIS, V14, P1837, DOI 10.1093/carcin/14.9.1837; International Agency for Research on Cancer (IARC) and World Health Organization, 2000, IARC IARC MON EV CAR; Jacobs AC, 2013, VET PATHOL, V50, P324, DOI 10.1177/0300985812450727; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; LAVE LB, 1988, NATURE, V336, P631, DOI 10.1038/336631a0; Linden M, 1999, J CLIN PSYCHOPHARM, V19, P132, DOI 10.1097/00004714-199904000-00007; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Mojtabai R, 2008, J CLIN PSYCHIAT, V69, P1064, DOI 10.4088/JCP.v69n0704; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; Pottegard A, 2013, BRIT J CLIN PHARMACO, V75, P1356, DOI 10.1111/bcp.12001; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; WATKINS JR, 1992, TOXICOLOGY, V71, P35, DOI 10.1016/0300-483X(92)90052-G	30	20	20	0	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0004-8674	1440-1614		AUST NZ J PSYCHIAT	Aust. N. Z. J. Psych.	AUG	2015	49	8					686	696		10.1177/0004867415582231	http://dx.doi.org/10.1177/0004867415582231			11	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CN9AN	25916799				2022-09-04	WOS:000358738100005
J	Sawamoto, K; Alvarez, JV; Herreno, AM; Otero-Espinar, FJ; Couce, ML; Almeciga-Diaz, CJ; Tomatsu, S				Sawamoto, Kazuki; Alvarez, J. Victor; Herreno, Angelica Maria; Otero-Espinar, Francisco J.; Couce, Maria L.; Almeciga-Diaz, Carlos J.; Tomatsu, Shunji			Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders	CURRENT OSTEOPOROSIS REPORTS			English	Review						Bone-targeting; Osteoporosis; Metabolic rare skeletal disorders; Acidic amino acid oligopeptide; Nanoparticles	ENZYME-REPLACEMENT THERAPY; ALKALINE-PHOSPHATASE; MINERAL DENSITY; HYPOPHOSPHATASIA; MORQUIO; SYSTEM; BISPHOSPHONATES; NANOPARTICLES; TRANSPLANTATION; OLIGOPEPTIDE	Purpose of Review The skeletal system provides an important role to support body structure and protect organs. The complexity of its architecture and components makes it challenging to deliver the right amount of the drug into bone regions, particularly avascular cartilage lesions. In this review, we describe the recent advance of bone-targeting methods using bisphosphonates, polymeric oligopeptides, and nanoparticles on osteoporosis and rare skeletal diseases. Recent Findings Hydroxyapatite (HA), a calcium phosphate with the formula Ca-10(PO4)(6)(OH)(2), is a primary matrix of bone mineral that includes a high concentration of positively charged calcium ion and is found only in the bone. This unique feature makes HA a general targeting moiety to the entire skeletal system. We have applied bone-targeting strategy using acidic amino acid oligopeptides into lysosomal enzymes, demonstrating the effects of bone-targeting enzyme replacement therapy and gene therapy on bone and cartilage lesions in inherited skeletal disorders. Virus or no-virus gene therapy using techniques of engineered capsid or nanomedicine has been studied preclinically for skeletal diseases. Efficient drug delivery into bone lesions remains an unmet challenge in clinical practice. Bone-targeting therapies based on gene transfer can be potential as new candidates for skeletal diseases.	[Sawamoto, Kazuki; Alvarez, J. Victor; Herreno, Angelica Maria; Tomatsu, Shunji] Nemours Alfred I duPont Hosp Children, Wilmington, DE 19803 USA; [Otero-Espinar, Francisco J.] Univ Santiago de Compostela, Sch Pharm, Dept Pharmacol Pharm & Pharmaceut Technol, Santiago De Compostela, Spain; [Couce, Maria L.] Univ Clin Hosp Santiago de Compostela, Dept CC Foren An Pat Gin & Obst & Paed, Neonatol Serv, Metab Unit, Santiago De Compostela, Spain; [Almeciga-Diaz, Carlos J.] Pontificia Univ Javeriana, Fac Sci, Inst Study Inborn Errors Metab, Bogota, DC, Colombia; [Tomatsu, Shunji] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan; [Tomatsu, Shunji] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA; [Tomatsu, Shunji] Nemours Alfred I duPont Hosp Children, Dept Biomed Res, 1600 Rockland Rd, Wilmington, DE 19899 USA		Tomatsu, S (corresponding author), Nemours Alfred I duPont Hosp Children, Wilmington, DE 19803 USA.; Tomatsu, S (corresponding author), Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan.; Tomatsu, S (corresponding author), Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA.; Tomatsu, S (corresponding author), Nemours Alfred I duPont Hosp Children, Dept Biomed Res, 1600 Rockland Rd, Wilmington, DE 19899 USA.	stomatsu@nemours.org	Alméciga-Díaz, Carlos J/A-2494-2017; Otero-Espinar, F. J./K-1337-2014; Tomatsu, Shunji/AAA-4360-2022	Alméciga-Díaz, Carlos J/0000-0001-6484-1173; Otero-Espinar, F. J./0000-0001-9030-2253; Tomatsu, Shunji/0000-0002-0673-2160; Alvarez Gonzalez, Jose Victor/0000-0003-3735-1341	National MPS Society; Austrian MPS Society; Carol Ann Foundation; Deborah McClellan and Brant Cali Foundation; Angelo R. Cali & Mary V. Cali Family Foundation, Inc.; Vain and Harry Fish Foundation, Inc.; Bennett Foundation; Jacob Randall Foundation; Help Morquio Foundation; Lubert Family Foundation; Nemours Funds; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of NIH [P20GM103464, P30GM114736]; Ministry of Science, Technology and Innovation [120380763212-PPTA, 8352]	National MPS Society; Austrian MPS Society; Carol Ann Foundation; Deborah McClellan and Brant Cali Foundation; Angelo R. Cali & Mary V. Cali Family Foundation, Inc.; Vain and Harry Fish Foundation, Inc.; Bennett Foundation; Jacob Randall Foundation; Help Morquio Foundation; Lubert Family Foundation; Nemours Funds; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of NIH; Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported by grants from National MPS Society Research Grant; Austrian MPS Society; The Carol Ann Foundation; Deborah McClellan and Brant Cali Foundation; The Radiant Hope donation; Angelo R. Cali & Mary V. Cali Family Foundation, Inc.; The Vain and Harry Fish Foundation, Inc.; The Bennett Foundation; Jacob Randall Foundation; Help Morquio Foundation; Vice Family; Lubert Family Foundation; Straughan Family; Paidipalli Family; and Nemours Funds. S.T. was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of NIH under grant numbers P20GM103464 and P30GM114736. CJAD was supported by the Ministry of Science, Technology and Innovation (Contract 120380763212-PPTA #8352).	Alencastre IS, 2016, EUR CELLS MATER, V31, P355, DOI 10.22203/eCM.v031a23; Almeciga-Diaz CJ, 2020, GENE THER, V27, P104, DOI 10.1038/s41434-019-0086-3; Almeciga-Diaz CJ, 2018, PEDIATR RES, V84, P545, DOI 10.1038/s41390-018-0095-8; Aoki K, 2012, ADV DRUG DELIVER REV, V64, P1220, DOI 10.1016/j.addr.2012.05.017; Bhandari KH, 2015, CURR DRUG DELIV, V12, P98, DOI 10.2174/156720181201150310154026; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Carbone EJ, 2017, NANOMED-NANOTECHNOL, V13, P37, DOI 10.1016/j.nano.2016.08.015; Castells L, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013269; Chaudhari KR, 2012, J CONTROL RELEASE, V158, P470, DOI 10.1016/j.jconrel.2011.11.020; Chinen Y, 2014, MOLEC GENET METAB RE, V1, P31, DOI 10.1016/j.ymgmr.2013.11.002; Choi SW, 2007, J CONTROL RELEASE, V122, P24, DOI 10.1016/j.jconrel.2007.06.003; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Doherty C, 2019, J HUM GENET, V64, P625, DOI 10.1038/s10038-019-0604-6; Doschak MR, 2009, MOL PHARMACEUT, V6, P634, DOI 10.1021/mp8002368; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Farrell Kristen B, 2018, Bone Rep, V9, P47, DOI 10.1016/j.bonr.2018.06.007; Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1; Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5; Gil L, 1999, BIOORGAN MED CHEM, V7, P901, DOI 10.1016/S0968-0896(99)00045-0; Ikeue R, 2018, MOL THER-METH CLIN D, V10, P361, DOI 10.1016/j.omtm.2018.08.004; Ishizaki J, 2009, J BONE MINER METAB, V27, P1, DOI 10.1007/s00774-008-0004-z; Jiang B, 2012, DRUG DELIV, V19, P317, DOI 10.3109/10717544.2012.714809; Katsumi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135966; Kecskemethy HH, 2016, MOL GENET METAB, V117, P144, DOI 10.1016/j.ymgme.2015.11.013; Khan I, 2019, ARAB J CHEM, V12, P908, DOI 10.1016/j.arabjc.2017.05.011; Kruger CA, 2018, MOLECULES, V23, DOI 10.3390/molecules23102628; Li CJ, 2016, ORTHOP SURG, V8, P105, DOI 10.1111/os.12238; Lin KL, 2014, ACTA BIOMATER, V10, P4071, DOI 10.1016/j.actbio.2014.06.017; Low SA, 2012, ADV DRUG DELIVER REV, V64, P1189, DOI 10.1016/j.addr.2012.01.012; Luhmann T, 2012, J CONTROL RELEASE, V161, P198, DOI 10.1016/j.jconrel.2011.10.001; Ma XW, 2016, BIOMATERIALS, V97, P10, DOI 10.1016/j.biomaterials.2016.04.026; Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081; Matsumoto T, 2011, HUM GENE THER, V22, P1355, DOI 10.1089/hum.2010.210; Melbouci M, 2018, MOL GENET METAB, V124, P1, DOI 10.1016/j.ymgme.2018.03.004; Melville AJ, 2008, J MATER SCI-MATER M, V19, P1187, DOI 10.1007/s10856-007-3185-4; Millan JL, 2016, CALCIFIED TISSUE INT, V98, P398, DOI 10.1007/s00223-015-0079-1; Mornet E, 2018, METABOLISM, V82, P142, DOI 10.1016/j.metabol.2017.08.013; Mornet E, 2013, CLIN REV BONE MINER, V11, P71, DOI 10.1007/s12018-013-9140-7; Morton SW, 2014, ADV HEALTHC MATER, V3, P867, DOI 10.1002/adhm.201300465; Nakamura-Takahashi A, 2020, CALCIFIED TISSUE INT, V106, P665, DOI 10.1007/s00223-020-00676-5; Nakamura-Takahashi A, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2015.59; Nakano C, 2019, MOL GENET METAB, V127, P158, DOI 10.1016/j.ymgme.2019.05.014; Nancollas GH, 2006, BONE, V38, P617, DOI 10.1016/j.bone.2005.05.003; Nishioka T, 2006, MOL GENET METAB, V88, P244, DOI 10.1016/j.ymgme.2006.02.012; Ojea-Jimenez I, 2013, CURR DRUG METAB, V14, P518, DOI 10.2174/13892002113149990008; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; Parent M, 2017, J CONTROL RELEASE, V252, P1, DOI 10.1016/j.jconrel.2017.02.012; Pignatello R, 2012, J FUNCT BIOMATER, V3, P79, DOI 10.3390/jfb3010079; RANNEVIK G, 1995, MATURITAS, V21, P103, DOI 10.1016/0378-5122(94)00869-9; Ray Katrina, 2012, Nat Rev Rheumatol, V8, P122, DOI 10.1038/nrrheum.2012.17; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Salerno M, 2010, CURR CANCER DRUG TAR, V10, P649, DOI 10.2174/156800910793605767; Sawamoto K, 2020, INT J MOL SCI; Sekido T, 2001, J DRUG TARGET, V9, P111, DOI 10.3109/10611860108997922; Sipila S, 2020, J CACHEXIA SARCOPENI, V11, P698, DOI 10.1002/jcsm.12547; Sowers MR, 2006, J CLIN ENDOCR METAB, V91, P1261, DOI 10.1210/jc.2005-1836; Stapleton M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071345; Sun X, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/6782653; Swami A, 2014, P NATL ACAD SCI USA, V111, P10287, DOI 10.1073/pnas.1401337111; Nguyen TBL, 2015, TISSUE ENG PT A, V21, P1376, DOI [10.1089/ten.tea.2014.0313, 10.1089/ten.TEA.2014.0313]; Tomatsu S, 2011, IMPAIRMENT BODY GROW; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Tomatsu S, 2015, MOL GENET METAB, V114, P94, DOI 10.1016/j.ymgme.2014.12.001; Tomatsu S, 2010, MOL THER, V18, P1094, DOI 10.1038/mt.2010.32; Tsushima N, 2000, J PHARM PHARMACOL, V52, P27, DOI 10.1211/0022357001773652; Uskokovic V, 2013, ACS APPL MATER INTER, V5, P2422, DOI 10.1021/am4000694; Victor alvarez J, 2019, INT J MOL SCI, P20; Vinay R, 2016, DRUG DELIV, V23, P21, DOI 10.3109/10717544.2014.913325; Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011; Whyte MP, 2017, BONE, V102, P15, DOI 10.1016/j.bone.2017.02.011; Whyte MP, 2017, J BONE MINER RES, V32, P667, DOI 10.1002/jbmr.3075; WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814; WHYTE MP, 1986, J PEDIATR-US, V108, P82, DOI 10.1016/S0022-3476(86)80773-9; Whyte MP, 1992, J BONE MINER RES, P7; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Yabe H, 2016, MOL GENET METAB, V117, P84, DOI 10.1016/j.ymgme.2015.09.011; Yamamoto S, 2011, J BONE MINER RES, V26, P135, DOI 10.1002/jbmr.201; Yang Y, 2017, DRUG DELIV TRANSL RE, V7, P482, DOI 10.1007/s13346-017-0407-2; Yang YS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10809-6; Yasuda E, 2016, MOL GENET METAB, V118, P111, DOI 10.1016/j.ymgme.2016.04.005; Yokogawa K, 2001, ENDOCRINOLOGY, V142, P1228, DOI 10.1210/en.142.3.1228; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zheng YL, 2012, J PHARM SCI-US, V101, P552, DOI 10.1002/jps.22773	86	4	4	3	16	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1544-1873	1544-2241		CURR OSTEOPOROS REP	Curr. Osteoporos. Rep.	OCT	2020	18	5					515	525		10.1007/s11914-020-00620-4	http://dx.doi.org/10.1007/s11914-020-00620-4		AUG 2020	11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	NW1CO	32845464	Green Accepted			2022-09-04	WOS:000562936800001
J	Romppel, M; Hinz, A; Finck, C; Young, J; Brahler, E; Glaesmer, H				Romppel, Matthias; Hinz, Andreas; Finck, Carolyn; Young, Jeremy; Braehler, Elmar; Glaesmer, Heide			Cross-cultural measurement invariance of the General Health Questionnaire-12 in a German and a Colombian population sample	INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH			English	Article						configural; German; GHQ-12; measurement equivalence; metric; scalar; Spanish	CONFIRMATORY FACTOR-ANALYSIS; PSYCHOMETRIC PROPERTIES; PRIMARY-CARE; SPANISH VERSION; GHQ-12; VALIDITY; RELIABILITY; VARIABLES; IMPACT; SCALE	While the General Health Questionnaire, 12-item version (GHQ-12) has been widely used in cross-cultural comparisons, rigorous tests of the measurement equivalence of different language versions are still lacking. Thus, our study aims at investigating configural, metric and scalar invariance across the German and the Spanish version of the GHQ-12 in two population samples. The GHQ-12 was applied in two large-scale population-based samples in Germany (N=1,977) and Colombia (N=1,500). To investigate measurement equivalence, confirmatory factor analyses were conducted in both samples. In the German sample mean GHQ-12 total scores were higher than in the Colombian sample. A one-factor model including response bias on the negatively worded items showed superior fit in the German and the Colombian sample; thus both versions of the GHQ-12 showed configural invariance. Factor loadings and intercepts were not equal across both samples; thus GHQ-12 showed no metric and scalar invariance. As both versions of the GHQ-12 did not show measurement equivalence, it is not recommendable to compare both measures and to conclude that mental distress is higher in the German sample, although we do not know if the differences are attributable to measurement problems or represent a real difference in mental distress. The study underlines the importance of measurement equivalence in cross-cultural comparisons.	[Romppel, Matthias] Bremen Univ, Inst Publ Hlth & Nursing Res, Dept Prevent & Hlth Promot, Bremen, Germany; [Hinz, Andreas; Braehler, Elmar; Glaesmer, Heide] Univ Leipzig, Dept Med Psychol & Med Sociol, Philipp Rosenthal Str 55, D-04103 Leipzig, Germany; [Finck, Carolyn; Young, Jeremy] Univ Los Andes, Dept Psychol, Bogota, Colombia; [Braehler, Elmar] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Clin Psychosomat Med & Psychotherapy, Mainz, Germany; [Young, Jeremy] Pontificia Univ Javeriana, Fac Ciencias Econ & Adm, Bogota, Colombia		Glaesmer, H (corresponding author), Univ Leipzig, Dept Med Psychol & Med Sociol, Philipp Rosenthal Str 55, D-04103 Leipzig, Germany.	heide.glaesmer@medizin.uni-leipzig.de	Romppel, Matthias/B-8977-2017; Braehler, Elmar/C-6535-2009	Romppel, Matthias/0000-0003-0420-7941; Braehler, Elmar/0000-0002-2648-2728; Young, Jeremy/0000-0002-6858-9144				Aguado J, 2012, ASSESSMENT, V19, P517, DOI 10.1177/1073191110388146; ARAYA R, 1992, SOC PSYCH PSYCH EPID, V27, P168, DOI 10.1007/BF00789001; Campbell A, 2007, EUR J PSYCHOL ASSESS, V23, P2, DOI 10.1027/1015-5759.23.1.2; Chen FF, 2008, J PERS SOC PSYCHOL, V95, P1005, DOI 10.1037/a0013193; Departamento Administrativo Nacional de Estadistica (DANE), 2012, CENS 2005; Dere J, 2015, PSYCHOL ASSESSMENT, V27, P68, DOI 10.1037/pas0000026; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Furukawa TA, 1999, LANCET, V353, P561, DOI 10.1016/S0140-6736(98)05470-1; Furukawa TA, 2001, PSYCHOL MED, V31, P519, DOI 10.1017/S0033291701003713; Molina JG, 2014, PSYCHOL ASSESSMENT, V26, P1031, DOI 10.1037/a0036472; Garcia Viniegras C., 1999, REV CUBA MED GEN, V15, P88; Gelaye B, 2015, J AFFECT DISORDERS, V187, P197, DOI 10.1016/j.jad.2015.08.045; Glaesmer H, 2012, PSYCHOTHERAPEUT, V57, P22, DOI 10.1007/s00278-011-0877-5; Goldberg D. P., 1988, USERS GUIDE GEN HLTH; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GUREJE O, 1991, ACTA PSYCHIAT SCAND, V84, P125, DOI 10.1111/j.1600-0447.1991.tb03115.x; Hankins Matthew, 2008, Clin Pract Epidemiol Ment Health, V4, P10, DOI 10.1186/1745-0179-4-10; Hankins M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-355; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kalliath TJ, 2004, STRESS HEALTH, V20, P11, DOI 10.1002/smi.993; Little TD, 1999, PSYCHOL METHODS, V4, P192, DOI 10.1037/1082-989X.4.2.192; Lopez-Castedo A, 2005, PERCEPT MOTOR SKILL, V100, P676, DOI 10.2466/PMS.100.3.676-680; MUNOZ PE, 1979, ARCH NEUROBIOL, V42, P139; Padron A, 2012, QUAL LIFE RES, V21, P1291, DOI 10.1007/s11136-011-0038-x; Picardi A, 2001, J EUR ACAD DERMATOL, V15, P410, DOI 10.1046/j.1468-3083.2001.00336.x; POLITI PL, 1994, ACTA PSYCHIAT SCAND, V90, P432, DOI 10.1111/j.1600-0447.1994.tb01620.x; Rey JJ, 2014, PSYCHOL ASSESSMENT, V26, P1021, DOI 10.1037/a0036468; Romppel M, 2013, COMPR PSYCHIAT, V54, P406, DOI 10.1016/j.comppsych.2012.10.010; Sanchez-Lopez MP, 2008, PSICOTHEMA, V20, P839; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Schmitz N, 2001, COMPR PSYCHIAT, V42, P166, DOI 10.1053/comp.2001.19751; Schmitz N, 1999, ACTA PSYCHIAT SCAND, V100, P462; Serrano-Aguilar P, 2009, EPIDEMIOL PSICHIAT S, V18, P229, DOI 10.1017/S1121189X00000518; Salazar MS, 2015, PSICOTHEMA, V27, P192, DOI 10.7334/psicothema2014.266; Stark S, 2006, J APPL PSYCHOL, V91, P1292, DOI 10.1037/0021-9010.91.6.1292; Toyabe S. I., 2007, BMC PUBLIC HEALTH, V7, P715; van Sonderen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068967; Vanheule S, 2005, STRESS HEALTH, V21, P217, DOI 10.1002/smi.1058; Villa IC, 2013, AV PSICOL LATINOAM, V31, P532; Wang L, 2011, PERS INDIV DIFFER, V50, P1056, DOI 10.1016/j.paid.2011.01.024; Werneke U, 2000, PSYCHOL MED, V30, P823, DOI 10.1017/S0033291799002287; Ye SQ, 2009, PERS INDIV DIFFER, V46, P197, DOI 10.1016/j.paid.2008.09.027	44	11	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1049-8931	1557-0657		INT J METH PSYCH RES	Int. J. Methods Psychiatr. Res.	DEC	2017	26	4							e1532	10.1002/mpr.1532	http://dx.doi.org/10.1002/mpr.1532			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FO8XX	28147466	Green Published, Bronze			2022-09-04	WOS:000417172900004
J	Cruz-Rodriguez, N; Combita, AL; Enciso, LJ; Raney, LF; Pinzon, PL; Lozano, OC; Campos, AM; Penaloza, N; Solano, J; Herrera, MV; Zabaleta, J; Quijano, S				Cruz-Rodriguez, Nataly; Combita, Alba L.; Enciso, Leonardo J.; Raney, Lauren F.; Pinzon, Paula L.; Lozano, Olga C.; Campos, Alba M.; Penaloza, Niyireth; Solano, Julio; Herrera, Maria V.; Zabaleta, Jovanny; Quijano, Sandra			Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH			English	Article						B-ALL; Risk-stratification; Survival; Gene-expression; Immunophenotype	ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL SELF-RENEWAL; HIGH-GRADE GLIOMA; CD20 EXPRESSION; CD10 EXPRESSION; BREAST-CANCER; UP-REGULATION; ID-1; PROTEINS; ID1	Background: Survival of adults with B-Acute Lymphoblastic Leukemia requires accurate risk stratification of patients in order to provide the appropriate therapy. Contemporary techniques, using clinical and cytogenetic variables are incomplete for prognosis prediction. Methods: To improve the classification of adult patients diagnosed with B-ALL into prognosis groups, two strategies were examined and combined: the expression of the ID1/ID3/IGJ gene signature by RT-PCR and the immunophenotypic profile of 19 markers proposed in the EuroFlow protocol by Flow Cytometry in bone marrow samples. Results: Both techniques were correlated to stratify patients into prognostic groups. An inverse relationship between survival and expression of the three-genes signature was observed and an immunophenotypic profile associated with clinical outcome was identified. Markers CD10 and CD20 were correlated with simultaneous overexpression of ID1, ID3 and IGJ. Patients with simultaneous expression of the poor prognosis gene signature and overexpression of CD10 or CD20, had worse Event Free Survival and Overall Survival than patients who had either the poor prognosis gene expression signature or only CD20 or CD10 overexpressed. Conclusion: By utilizing the combined evaluation of these two immunophenotypic markers along with the poor prognosis gene expression signature, the risk stratification can be significantly strengthened. Further studies including a large number of patients are needed to confirm these findings.	[Cruz-Rodriguez, Nataly; Combita, Alba L.; Enciso, Leonardo J.] Inst Nacl Cancerol, Programa Invest & Innovac Leucemias Agud & Cron P, Bogota, Colombia; [Cruz-Rodriguez, Nataly; Combita, Alba L.; Pinzon, Paula L.; Lozano, Olga C.] Inst Nacl Cancerol, Grp Invest Biol Canc, Bogota, Colombia; [Cruz-Rodriguez, Nataly] Pontificia Univ Javeriana, Programa Doctorado Ciencias Biol, Bogota, Colombia; [Combita, Alba L.] Univ Nacl Colombia, Fac Med, Bogota, Colombia; [Enciso, Leonardo J.] Inst Nacl Cancerol, Grp Hematooncol, Bogota, Colombia; [Raney, Lauren F.] Louisiana State Univ, Dept Pediat, Pediat Hematol Oncol, Hlth Sci Ctr, New Orleans, LA USA; [Raney, Lauren F.] Childrens Hosp New Orleans, New Orleans, LA USA; [Campos, Alba M.; Penaloza, Niyireth; Solano, Julio; Herrera, Maria V.; Quijano, Sandra] Hosp Univ San Ignacio, Bogota, Colombia; [Zabaleta, Jovanny] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA USA; [Zabaleta, Jovanny] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA USA; [Quijano, Sandra] Pontificia Univ Javeriana, Grp Inmunobiol & Biol Celular, Dept Microbiol, Fac Ciencias, Bogota, Colombia		Combita, AL (corresponding author), Inst Nacl Cancerol, Programa Invest & Innovac Leucemias Agud & Cron P, Bogota, Colombia.; Quijano, S (corresponding author), Hosp Univ San Ignacio, Bogota, Colombia.	acombita@cancer.gov.co; squijano@javeriana.edu.co	Quijano, Sandra/AAF-2945-2019; ENCISO, LEONARDO/ABG-2119-2021	Quijano, Sandra/0000-0003-4452-9291; Solano Vega, Julio Cesar/0000-0002-5150-3041; PENALOZA CASTANEDA, NIYIRETH/0000-0003-4999-8193; Campos, Alba/0000-0002-8405-9311	"Programa de Investigacion e Innovacion en Leucemias Agudas y Cronicas (PILAC), Instituto Nacional de Cancerologia, Bogota, Colombia" - Departamento administrativo de ciencia, tecnologia e innovacion, Colciencias, Bogota, Colombia; National Institute of General Medical Sciences [NIGMS P20GM103501, P30GM114732, U54GM104940-01]; National Institute on Minority Health and Health Disparities [NIMHD P20MD004817, U54MD008176-01]	"Programa de Investigacion e Innovacion en Leucemias Agudas y Cronicas (PILAC), Instituto Nacional de Cancerologia, Bogota, Colombia" - Departamento administrativo de ciencia, tecnologia e innovacion, Colciencias, Bogota, Colombia; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funded by "Programa de Investigacion e Innovacion en Leucemias Agudas y Cronicas (PILAC), Instituto Nacional de Cancerologia, Bogota, Colombia" funded by the Departamento administrativo de ciencia, tecnologia e innovacion, Colciencias, Bogota, Colombia. JZ has been partially supported by grants from the National Institute of General Medical Sciences (NIGMS P20GM103501, P30GM114732, U54GM104940-01), and the National Institute on Minority Health and Health Disparities (NIMHD P20MD004817, U54MD008176-01).	Advani AS, 2002, LEUKEMIA RES, V26, P713, DOI 10.1016/S0145-2126(01)00197-7; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bacher U, 2009, BRIT J HAEMATOL, V145, P555, DOI 10.1111/j.1365-2141.2009.07656.x; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Bassan R, 2011, J CLIN ONCOL, V29, P532, DOI 10.1200/JCO.2010.30.1382; Chang H, 2010, HAEMATOL-HEMATOL J, V95, P1040, DOI 10.3324/haematol.2009.021089; Choi CH, 2016, J PATHOL TRANSL MED, V50, P96, DOI 10.4132/jptm.2016.01.12; Coma S, 2010, CANCER RES, V70, P3823, DOI 10.1158/0008-5472.CAN-09-3048; Cruz-Rodriguez N, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0333-z; Cubillo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059948; Deschamps L, 2006, HUM PATHOL, V37, P802, DOI 10.1016/j.humpath.2006.02.024; Di KJ, 2007, EXP CELL RES, V313, P3983, DOI 10.1016/j.yexcr.2007.08.023; Ding R, 2010, CANCER BIOL THER, V10, P299; Ding Y, 2006, INT J ONCOL, V28, P847; Freeman CL, 2016, LEUKEMIA, V30, P1763, DOI 10.1038/leu.2016.41; Fujita S, 2010, INT J COLORECTAL DIS, V25, P681, DOI 10.1007/s00384-010-0913-x; Gokbuget N, 2000, HEMATOL ONCOL CLIN N, V14, P1307, DOI 10.1016/S0889-8588(05)70188-X; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; He RJ, 2014, ACTA PHARMACOL SIN, V35, P1227, DOI 10.1038/aps.2014.80; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Kalina T, 2012, LEUKEMIA, V26, P1986, DOI 10.1038/leu.2012.122; Koh H, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-36; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Lee KT, 2004, BRIT J CANCER, V90, P1198, DOI 10.1038/sj.bjc.6601684; Li X, 2007, HISTOPATHOLOGY, V50, P484, DOI 10.1111/j.1365-2559.2007.02637.x; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; Mannelli F, 2012, HAEMATOL-HEMATOL J, V97, P568, DOI 10.3324/haematol.2011.054064; Quijano SM, 2013, BIOMEDICA, V33, P468, DOI 10.7705/biomedica.v33i3.1441; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Oba J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149285; Okamoto R, 2010, HAEMATOL-HEMATOL J, V95, P1481, DOI 10.3324/haematol.2009.011114; Olsson L, 2015, BRIT J HAEMATOL, V169, P479, DOI 10.1111/bjh.13342; Piattelli A, 2006, ORAL DIS, V12, P301, DOI 10.1111/j.1601-0825.2005.01196.x; Poret N, 2015, CANCER RES, V75, P3902, DOI 10.1158/0008-5472.CAN-15-0893; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Qin Y, 2016, Zhonghua Yi Xue Za Zhi, V96, P2224, DOI 10.3760/cma.j.issn.0376-2491.2016.28.005; RADFORD JE, 1989, J CLIN ONCOL, V7, P58, DOI 10.1200/JCO.1989.7.1.58; Romero-Lanman EE, 2012, STEM CELLS DEV, V21, P384, DOI 10.1089/scd.2011.0428; Rosales-Avina JA, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-112; Rowe JM, 2010, BRIT J HAEMATOL, V150, P389, DOI 10.1111/j.1365-2141.2010.08246.x; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Safdari Y, 2016, INVEST NEW DRUG, V34, P497, DOI 10.1007/s10637-016-0349-4; Sagatys EM, 2012, CANCER CONTROL, V19, P18, DOI 10.1177/107327481201900103; Sayehmiri K, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-74; Schindl M, 2003, CLIN CANCER RES, V9, P779; Seegmiller AC, 2009, AM J CLIN PATHOL, V132, P940, DOI 10.1309/AJCP8G5RMTWUEMUU; Sharma P, 2012, CANCER MED-US, V1, P187, DOI 10.1002/cam4.19; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; Stighall M, 2005, INT J CANCER, V115, P403, DOI 10.1002/ijc.20875; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; van Dongen JJM, 2012, LEUKEMIA, V26, P1899, DOI 10.1038/leu.2012.121; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Vega GG, 2015, INT J ONCOL, V47, P1735, DOI 10.3892/ijo.2015.3170; Wilson JW, 2001, CANCER RES, V61, P8803; Yang HY, 2011, J SURG RES, V167, P258, DOI 10.1016/j.jss.2009.08.006; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	67	4	6	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-9966			J EXP CLIN CANC RES	J. Exp. Clin. Cancer Res.	FEB 28	2017	36								37	10.1186/s13046-017-0506-4	http://dx.doi.org/10.1186/s13046-017-0506-4			12	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	FI0JX	28245840	Green Published, gold			2022-09-04	WOS:000411612000001
J	Penaranda, A; Garcia, E; Barragan, AM; Rondon, MA; Perez, A; Rojas, MX; Caraballo, L; Dennis, RJ				Penaranda, Augusto; Garcia, Elizabeth; Barragan, Ana M.; Rondon, Martin A.; Perez, Adriana; Rojas, Maria X.; Caraballo, Luis; Dennis, Rodolfo J.			Factors associated with Allergic Rhinitis in Colombian subpopulations aged 1 to 17 and 18 to 59	RHINOLOGY			English	Article						rhinitis; chronic diseases; odds ratio; Colombia; case-control studies	PARACETAMOL USE; RISK-FACTORS; PARENTAL ALLERGY; NATURAL-HISTORY; CHILDHOOD ISAAC; FOOD ALLERGY; EARLY-LIFE; ASTHMA; PREVALENCE; CHILDREN	Background:Several studies have shown variations in the prevalence of allergic rhinitis (AR) around the world, and different potential predisposing factors. More studies are needed on risk factors, specifically in developing countries. This study explored the association of several factors and AR among urban residents in six cities of Colombia. Methodology:A cross-sectional study and a nested case-control study were carried out between 2009 and 2010 involving two Colombian subpopulations: children/adolescents and adults. Cases were affirmative respondents to "In the past 12 months, have you (or your child) had a problem with sneezing or a running or blocked nose, when you (or your child) did not have a cold or the flur""Controls"were subjects who never had been diagnosed with asthma, AR or atopic eczema by a physician, and whom did not report any symptoms in the past twelve months. Weighted logistic regression was used to assess the association of different factors with case/control status. Results:Factors associated with AR in children/adolescents were family history of AR, acetaminophen consumption and high socioeconomic status. Among adults, family history of asthma, AR and atopic eczema, and cetaminophen consumption were associated with AR. Consumption of cereals among children/adolescents and eating eggs among adults showed protective associations. Conclusions:Our findings suggest the presence of previously unknown cultural, environmental and family factors associated with the presence of AR in Colombia.	[Penaranda, Augusto] Fdn Santa Fe Bogota, Div Otorhinolaryngol, Bogota, Colombia; [Garcia, Elizabeth] Fdn Santa Fe Bogota, Div Paediat Allergies, Bogota, Colombia; [Barragan, Ana M.; Dennis, Rodolfo J.] Fdn Cardioinfantil, Inst Cardiol, Res Dept, Bogota, Colombia; [Barragan, Ana M.] Univ Rosario, Escuela Med & Ciencias Salud, Bogota, Colombia; [Rondon, Martin A.; Rojas, Maria X.; Dennis, Rodolfo J.] Pontificia Univ Javeriana, Sch Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Perez, Adriana] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, Austin, TX USA; [Perez, Adriana] Univ Texas Hlth Sci Ctr Houston, Michael & Susan Dell Ctr Hlth Living, Austin, TX USA; [Caraballo, Luis] Univ Cartagena, Immunol Res Inst, Cartagena, Colombia		Penaranda, A (corresponding author), Fdn Santa Fe Bogota, Dept Otorrinolaringol, Carrera 9 116-20,Off 205, Bogota, Colombia.	augpenar@gmail.com	Peñaranda, Augusto/GOE-5385-2022; Barragan, Ana M./AAC-2380-2022; RONDON, MARTIN/AAD-5855-2019; Rojas-Reyes, Maria Ximena/AAD-6800-2019	Barragan, Ana M./0000-0002-4646-4324; RONDON, MARTIN/0000-0002-3885-5448; Rojas-Reyes, Maria Ximena/0000-0001-5752-7653; Dennis, Rodolfo J/0000-0003-3215-9721; Penaranda, Augusto/0000-0003-1598-8472; Perez, Adriana/0000-0002-6859-9916	Colciencias grant [540-2008]; MSD; Astra-Zeneca; GSK; Sanofi-Aventis; NCI [3R37CA057030-20S1]; NATIONAL CANCER INSTITUTE [R37CA057030] Funding Source: NIH RePORTER	Colciencias grant(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); MSD; Astra-Zeneca(AstraZeneca); GSK(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to thank all subjects that participated in the study, as well as research assistants and all personnel involved in field work, specially Alberto Jurado and his team, Angelica Prieto, and Cristina Venegas. This work was made possible by funding from Colciencias grant 540-2008, and by unrestricted research grants from MSD, Astra-Zeneca, GSK, and Sanofi-Aventis. Dr Perez was supported by a research supplement (Grant 3R37CA057030-20S1) from NCI during the conduction of this study.	Alm JS, 1999, LANCET, V353, P1485, DOI 10.1016/S0140-6736(98)09344-1; Almqvist C, 2012, CLIN EXP ALLERGY, V42, P1369, DOI 10.1111/j.1365-2222.2012.04021.x; Amberbir A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022551; Arshad SH, 2012, J ALLERGY CLIN IMMUN, V130, P427, DOI 10.1016/j.jaci.2012.03.042; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Bjorksten B, 2008, PEDIAT ALLERG IMM-UK, V19, P110, DOI 10.1111/j.1399-3038.2007.00601.x; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Braback L, 2005, EUR RESPIR J, V26, P1064, DOI 10.1183/09031936.05.00022105; Neto HJC, 2012, ALLERGY ASTHMA IMMUN, V4, P62, DOI 10.4168/aair.2012.4.2.62; Cingi C, 2010, ACTA OTO-LARYNGOL, V130, P600, DOI 10.3109/00016480903311880; Dennis R, 2004, ANN ALLERG ASTHMA IM, V93, P568, DOI 10.1016/S1081-1206(10)61265-3; Dennis RJ, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-17; Departamento Administrativo Nacional de Estadistica (DANE), 2009, PROY POBL DEP MUN AR; DOLD S, 1992, ARCH DIS CHILD, V67, P1018, DOI 10.1136/adc.67.8.1018; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Ellwood P, 2013, THORAX, V68, P351, DOI 10.1136/thoraxjnl-2012-202285; Galindo P A, 1998, Allergol Immunopathol (Madr), V26, P199; Govaere E, 2007, PEDIAT ALLERG IMM-UK, V18, P671, DOI 10.1111/j.1399-3038.2007.00570.x; Holgate ST, 2011, AM J RESP CRIT CARE, V183, P147, DOI 10.1164/rccm.201007-1135ED; Keil T, 2010, PEDIAT ALLERG IMM-UK, V21, P962, DOI 10.1111/j.1399-3038.2010.01046.x; Kelly FJ, 1999, FOOD CHEM TOXICOL, V37, P963, DOI 10.1016/S0278-6915(99)00087-3; Kleinbaum D, 2010, LOGISTIC REGRESSION, P207; Kurukulaaratchy RJ, 2011, CLIN EXP ALLERGY, V41, P851, DOI 10.1111/j.1365-2222.2011.03765.x; Lagos Jaime A, 2007, Ther Clin Risk Manag, V3, P327, DOI 10.2147/tcrm.2007.3.2.327; Lowe AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4616; Matheson MC, 2011, J ALLERGY CLIN IMMUN, V128, P816, DOI 10.1016/j.jaci.2011.05.039; Meltzer EO, 2007, CLIN THER, V29, P1428, DOI 10.1016/j.clinthera.2007.07.013; Meltzer EO, 2009, J ALLERGY CLIN IMMUN, V124, pS43, DOI 10.1016/j.jaci.2009.05.013; Ministerio de Hacienda y Credit Publico, 2015, 3386 MIN HAC CRED PU, P1; Neffen H, 2010, ALLERGY ASTHMA PROC, V31, pS9, DOI 10.2500/aap.2010.31.3347; Newson RB, 2000, EUR RESPIR J, V16, P817, DOI 10.1183/09031936.00.16581700; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Nuttall SL, 2003, J CLIN PHARM THER, V28, P289, DOI 10.1046/j.1365-2710.2003.00493.x; Penaranda A, 2012, RHINOLOGY, V50, P122, DOI [10.4193/Rhin11.175, 10.4193/Rhino11.175]; Penard-Morand C, 2005, ALLERGY, V60, P1165, DOI 10.1111/j.1398-9995.2005.00860.x; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Rizo A., 2009, EAN, V67, P59; Rodriguez J., 2009, RESULTADOS NACL; Pac-Sa MR, 2008, REV PANAM SALUD PUBL, V23, P333, DOI 10.1590/S1020-49892008000500005; SETTIPANE RJ, 1994, ALLERGY PROC, V15, P21, DOI 10.2500/108854194778816634; Shaheen S, 2008, EUR RESPIR J, V32, P1231, DOI 10.1183/09031936.00039208; Stewart AW, 2001, INT J EPIDEMIOL, V30, P173, DOI 10.1093/ije/30.1.173; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tan RA, 2011, IMMUNOL ALLERGY CLIN, V31, P481, DOI 10.1016/j.iac.2011.05.010; Torres-Borrego J, 2008, ALLERGOL IMMUNOPATH, V36, P90, DOI 10.1157/13120394; Varner AE, 1998, ANN ALLERG ASTHMA IM, V81, P347, DOI 10.1016/S1081-1206(10)63127-4; Vidal C, 1997, PARACETAMOL ACETAMIN; Westman M, 2013, ALLERGY, V68, P1571, DOI 10.1111/all.12267; WOODRUFF RS, 1971, J AM STAT ASSOC, V66, P411, DOI 10.2307/2283947; Yepes-Nunez JJ, 2012, ALLERGOL IMMUNOPATH, V40, P379, DOI 10.1016/j.aller.2011.11.008	51	4	4	0	4	INT RHINOLOGIC SOC	UTRECHT	UNIV MEDICAL CENTER UTRECHT, RM G05 127, DEPT OTORHINOL, HEIDELBERGLAAN 100, 3584 CX UTRECHT, NETHERLANDS	0300-0729			RHINOLOGY	Rhinology	MAR	2016	54	1					56	67		10.4193/Rhin14.234	http://dx.doi.org/10.4193/Rhin14.234			12	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	DH3LI	26567471	Bronze			2022-09-04	WOS:000372688100010
J	Lizarralde, G; Bornstein, L; Herazo, B; Burdiles, R; Araneda, C; Martinez, HP; Diaz, JH; Fauveaud, G; Olivera, A; Gonzalez, G; Lopez, O; Lopez, A; Dhar, T				Lizarralde, Gonzalo; Bornstein, Lisa; Herazo, Benjamin; Burdiles, Roberto; Araneda, Claudio; Paez Martinez, Holmes; Helena Diaz, Julia; Fauveaud, Gabriel; Olivera, Andres; Gonzalez, Gonzalo; Lopez, Oswaldo; Lopez, Adriana; Dhar, Tapan			The problem of doing more: success and paradoxes in scaling up informal initiatives for disaster risk reduction and climate action	CANADIAN JOURNAL OF DEVELOPMENT STUDIES-REVUE CANADIENNE D ETUDES DU DEVELOPPEMENT			English	Article						Climate change; risk reduction; scaling up; transferability; climate action; informality	CHANGE ADAPTATION; URBAN AGRICULTURE; CHALLENGES; CITY	Development studies highlight the importance of scaling good practices and their replicability and transferability to face global warming. But what happens when practices originate in informal urban contexts? Should they be replicated, amplified and formalized? We explore the opportunities and contradictions that emerge in scaling disaster risk reduction in informal settings. For four years, we documented 24 local initiatives and the work of leaders in Latin America. Results show that impact depends on intermediaries, trust, dialogue and a delicate balance between conflicting objectives and different levels of involvement by externals. To succeed, initiatives must address "the problem of doing more."	[Lizarralde, Gonzalo; Herazo, Benjamin] Univ Montreal, Fac Built Environm, Montreal, PQ, Canada; [Bornstein, Lisa; Dhar, Tapan] McGill Univ, Sch Urban Planning, Montreal, PQ, Canada; [Burdiles, Roberto] Univ Bio Bio, Fac Architecture, Concepcion, Chile; [Araneda, Claudio] Univ Bio Bio, Dept Design & Theory Architecture, Concepcion, Chile; [Paez Martinez, Holmes; Helena Diaz, Julia] Pontificia Univ Javeriana, Dept Civil Engn, Bogota, Colombia; [Fauveaud, Gabriel] Univ Montreal, Dept Geog, Montreal, PQ, Canada; [Olivera, Andres; Gonzalez, Gonzalo] Univ Cent Marta Abreu, Santa Clara, Cuba; [Lopez, Oswaldo; Lopez, Adriana] Univ Valle, Sch Architecture, Cali, Colombia		Lizarralde, G (corresponding author), Univ Montreal, Fac Built Environm, Montreal, PQ, Canada.	gonzalo.lizarralde@umontreal.ca		Lizarralde, Gonzalo/0000-0001-6645-9269; lopez bernal, oswaldo/0000-0003-3781-2582; Herazo, Benjamin/0000-0001-8605-8147; Paez Martinez, Holmes Julian/0000-0002-6964-9073	Canada's IDRC [108501]; Social Sciences and Humanities Research Council of Canada (SSHRC); Fonds de recherche du Quebec (FRQSC)	Canada's IDRC; Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); Fonds de recherche du Quebec (FRQSC)	This project was funded by Canada's IDRC and reports on initiatives that were partially funded by this institution, Grant #108501. Project: Climate change adaptation in informal settings: Understanding and reinforcing bottom-up initiatives in Latin America and the Caribbean. It also received support from the Social Sciences and Humanities Research Council of Canada (SSHRC) and the Fonds de recherche du Quebec (FRQSC).	Alexander D., 2004, INT C POSTD REC PLAN; Alvarez J., 2004, ISSUE FOOD SECURITY; Amri A, 2017, NAT HAZARD EARTH SYS, V17, P595, DOI 10.5194/nhess-17-595-2017; Anguelovski I, 2019, INT J URBAN REGIONAL, V43, P133, DOI 10.1111/1468-2427.12725; Anguelovski I, 2018, URBAN GEOGR, V39, P458, DOI 10.1080/02723638.2017.1349987; Anguelovski I, 2016, J PLAN EDUC RES, V36, P333, DOI 10.1177/0739456X16645166; Aragon-Duran E, 2020, INT J DISAST RISK RE, V50, DOI 10.1016/j.ijdrr.2020.101712; Atkinson P., 1994, HDB QUALITATIVE RES, P248; Ayers J, 2014, CLIM DEV, V6, P293, DOI 10.1080/17565529.2014.977761; Bachelard G., 2014, POETICS SPACE; Budds J, 2004, SINGAPORE J TROP GEO, V25, P322, DOI 10.1111/j.0129-7619.2004.00189.x; Bunn C, 2019, CLIM SERV, V16, DOI 10.1016/j.cliser.2019.100123; Caprotti F, 2017, URBAN RES PRACT, V10, P367, DOI 10.1080/17535069.2016.1275618; Chmutina K, 2021, DISASTER PREV MANAG, V30, P149, DOI 10.1108/DPM-07-2020-0232; Ciplet D, 2013, GLOBAL ENVIRON POLIT, V13, P49, DOI 10.1162/GLEP_a_00153; Corporaci?n Antioquia Presente, 2019, FOR INT CAMB CLIM DE; Calle JJC, 2008, ICONOFACTO, V4, P43; Darghouth S., 2008, WATERSHED MANAGEMENT; Dixon T, 2013, BUILD RES INF, V41, P499, DOI 10.1080/09613218.2013.812432; Doherty G., 2011, BUILT ENV, V37, P30; Durand-Lasserve A, 2009, URBAN LAND MARKETS: IMPROVING LAND MANAGEMENT FOR SUCCESSFUL URBANIZATION, P101, DOI 10.1007/978-1-4020-8862-9_5; Gaillard JC, 2019, DISASTERS, V43, pS7, DOI 10.1111/disa.12323; Garc?a L.F., 2015, NUEVAS MASCULINIDADE; Gargani J., 2017, STANFORD SOCIAL INNO, P34, DOI [10.48558/CX49-R467, DOI 10.48558/CX49-R467]; Hammersley M., 2015, BLACKWELL ENCY SOCIO, V11, P1479, DOI DOI 10.1002/9781405165518.WBEOSE070.PUB2; Hansen K.T., 2001, INT ENCY SOCIAL BEHA, P7450; Hart C.A., 2013, CLIMATE CHANGE PRIVA; Hayley P.-K. L., 2020, SCALING PLAYBOOK PRA; Hern?ndez-Garc?a J., 2013, RES CONT CITY IDENTI, P141; Hussmanns R., 2004, MEASURING INFORM EC, P1; Informacion comercial, 2016, PAIS; Instituto de estudios urbanos, 2020, EL 88 MUN COL TIEN P; Kelman I., 2017, ROUTLEDGE HDB DISAST; Kousky C, 2014, ENERG ECON, V46, P576, DOI 10.1016/j.eneco.2013.09.029; Leal Acosta A., 2019, LA REPUBLICA; Leitgeb F, 2016, AGR HUM VALUES, V33, P415, DOI 10.1007/s10460-015-9616-9; Lizarralde G., 2008, 4 INT I REC C 2008 B; Lizarralde G., 2014, CONSTR INNOV-ENGL, V25, P47; Lizarralde G, 2021, INT J DISAST RISK RE, V58, DOI 10.1016/j.ijdrr.2021.102173; Lizarralde G, 2020, DISASTER PREV MANAG, V29, P909, DOI 10.1108/DPM-01-2020-0011; Lizarralde G, 2008, CONSTR MANAG ECON, V26, P103, DOI 10.1080/01446190701808965; Llanes L.M., VIOLENCIA LIDERES SO; Magnan AK, 2016, WIRES CLIM CHANGE, V7, P646, DOI 10.1002/wcc.409; McLean R., 2019, SCALING IMPACT INNOV; McLean R., 2020, LONDON SCH EC I 0907; Menter H. S., 2004, SCALING OUT ACHIEVIN, P9; Ministerio de Ciencia Tecnolog?a y Medio Ambiente-CITMA, 2016, ESTR AMB NAC 2016 20; Ministerio de Ciencia Tecnologia y Medio Ambiente-CITMA, 2020, TAR VID PLAN EST ENF; Posada DVM, 2019, REV VIRTUAL UNIV CAT, V56, P89; Moloney S., 2017, LOCAL ACTION CLIMATE; Moore K.D., 2019, CULTURE MEANING ARCH; Moreno Lorenzo X.A., 2015, NOVED POBLAC, V11, P98; Mu?oz L., 2019, TRIALOG, V134, P14; Musset A., 2010, VULNERABILIDAD SOCIA; Navas O.D.A., 2010, CONSTITUCION ECOLOGI; Norberg-Schulz C., 1997, GENIUS LOCI PAYSAGE; Norberg-Schulz C., 2019, HIST CITIES ISSUES U, V8, P31; OCDE, 2021, CLIM CHANG CONS IN O; OliverSmith A, 1996, ANNU REV ANTHROPOL, V25, P303, DOI 10.1146/annurev.anthro.25.1.303; Otagri B.B., 2008, MUJERES INDIGENAS CA, V181; Ouma GO, 2018, CLIM DEV, V10, P590, DOI 10.1080/17565529.2017.1372261; P?ez H., 2019, TRIALOG, V134, P9; Petter AM, 2020, CITIES, V104, DOI 10.1016/j.cities.2020.102805; Rapoport A., 2005, CULTURE ARCHITECTURE; Rapoport A., 1982, MEANING BUILT ENV NO; Rauken T, 2015, LOCAL ENVIRON, V20, P408, DOI 10.1080/13549839.2014.880412; Redaccion Vivir, 2020, EL ESPECTADOR; Reid H, 2014, COMMUNITY-BASED ADAPTATION TO CLIMATE CHANGE: SCALING IT UP, P3; Rozo Lopez D.P., 2021, LIDERES AMBIENTALES; Saito N, 2013, MITIG ADAPT STRAT GL, V18, P825, DOI 10.1007/s11027-012-9392-4; Sanchez Bustos S., 2019, COOPERATIVA OPI 1212; Schipper L, 2006, DISASTERS, V30, P19, DOI 10.1111/j.1467-9523.2006.00304.x; Scott James C. Scott, 1998, SEEING STATE CERTAIN; Scoville-Simonds M, 2020, WORLD DEV, V125, DOI 10.1016/j.worlddev.2019.104683; Shaw D, 2018, BRIT J MANAGE, V29, P266, DOI 10.1111/1467-8551.12274; Stone R., 2018, SCIENCE, V359; Tall A. J., 2014, SCALING CLIMATE SERV; UN-Habitat, 2006, M DEV GOALS SMALL UR; UNDRR, 2019, GLOB ASS REP DIS RIS; Valladares A, 2013, HABITAT INT, V38, P18, DOI 10.1016/j.habitatint.2012.09.004; Werna E, 2001, HABITAT INT, V25, P209, DOI 10.1016/S0197-3975(00)00018-7; Westermann, 2015, REACHING MORE FARMER; Westermann O, 2018, AGR SYST, V165, P283, DOI 10.1016/j.agsy.2018.07.007; Westoby R, 2021, LOCAL ENVIRON, V26, P313, DOI 10.1080/13549839.2021.1884669; Westoby R, 2020, ONE EARTH, V3, P388, DOI 10.1016/j.oneear.2020.09.002; World Bank, 2015, BUILD REG RES MAN RI	86	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0225-5189	2158-9100		CAN J DEV STUD	Can. J. Dev. Stud.	JUL 3	2022	43	3					339	369		10.1080/02255189.2021.2019574	http://dx.doi.org/10.1080/02255189.2021.2019574		FEB 2022	31	Development Studies	Social Science Citation Index (SSCI)	Development Studies	4A2OY		hybrid			2022-09-04	WOS:000758640500001
J	Alvarado, BE; Martinez-Cajas, JL; Mueses, HF; Sanchez, DC; Adam, BD; Hart, TA				Alvarado, Beatriz E.; Martinez-Cajas, Jorge Luis; Mueses, Hector F.; Correa Sanchez, Diego; Adam, Barry D.; Hart, Trevor A.			Adaptation and Pilot Evaluation of an Intervention Addressing the Sexual Health Needs of Gay Men Living with HIV Infection in Colombia	AMERICAN JOURNAL OF MENS HEALTH			English	Article						HIV prevention; people living with HIV; MSM; motivational interviewing; community-based intervention		Interventions addressing the sexual health need of HIV-positive men who have sex with men (MSM) in Latin America are scarce. We adapted and evaluated GPS, a group-based intervention led by peers, developed using the Information-Motivation-Behavioral (IMB) model and motivational interviewing (MI). We used McKleroy et al framework to culturally adapt GPS to MSM living with HIV infection in Colombia. Then, a one-armed pilot trial examined changes in depressive symptoms, loneliness, self-efficacy for engaging in sexual risk reduction behaviors, sexual sensation seeking and sexual compulsivity at pre-intervention, post-intervention, and 3-month follow-up. These results were complemented with semistructured interviews with participants 3 months after the intervention. GPS was identified to be culturally acceptable with few changes in materials and exercises. Facilitators showed high levels of adherence and fidelity to MI principles. Seven of 11 eligible participants finished the intervention; GPS positively influenced self-efficacy for condom negotiation, depressive symptoms, and condomless anal sex with partners of unknown HIV status. Exit interviews revealed that GPS was well-designed, relevant, facilitated discussion of sex in a nonjudgmental manner, and helped make positive changes in participants' sexual lives. These results provided preliminary evidence of an intervention to address sexual and mental health of MSM living with HIV in Latin America.	[Alvarado, Beatriz E.] Queens Univ, Dept Publ Hlth Sci, 34 Traymoor St, Kingston, ON K7L 4K8, Canada; [Martinez-Cajas, Jorge Luis] Queens Univ, Dept Med, Div Infect Dis, Kingston, ON, Canada; [Mueses, Hector F.] Corp Lucha Sida, Cali, Colombia; [Correa Sanchez, Diego] Pontificia Univ Javeriana Cali, Dept Ciencias Sociales, Cali, Colombia; [Correa Sanchez, Diego] Pontificia Univ Javeriana Cali, Dept Salud Publ & Epidemiol, Cali, Colombia; [Adam, Barry D.] Univ Windsor, Sociol Sociol Anthropol & Criminol, Windsor, ON, Canada; [Hart, Trevor A.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Alvarado, Beatriz E.; Martinez-Cajas, Jorge Luis; Hart, Trevor A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hart, Trevor A.] CIHR Canadian HIV Trials Network, Vancouver, BC, Canada		Alvarado, BE (corresponding author), Queens Univ, Dept Publ Hlth Sci, 34 Traymoor St, Kingston, ON K7L 4K8, Canada.	alvaradb@queensu.ca		Adam, Barry/0000-0002-8836-4153; Mueses-Marin, Hector Fabio/0000-0002-0608-6656; ALVARADO, BEATRIZ/0000-0002-1269-405X	 [CIHR-CTN-PT018]		The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project has received funds from CIHR-CTN-PT018.	Adamian MS, 2004, AIDS PATIENT CARE ST, V18, P229, DOI 10.1089/108729104323038900; Chariyeva Z, 2012, PATIENT EDUC COUNS, V87, P101, DOI 10.1016/j.pec.2011.07.021; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Crepaz N, 2015, AIDS, V29, P2371, DOI 10.1097/QAD.0000000000000879; Cruess DG, 2018, ANN BEHAV MED, V52, P116, DOI 10.1093/abm/kax031; DiIorio C, 2008, AIDS CARE, V20, P273, DOI 10.1080/09540120701593489; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Fereday J., 2006, INT J QUAL METH; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Golin CE, 2010, AIDS PATIENT CARE ST, V24, P237, DOI 10.1089/apc.2009.0252; Hart T.A., BEHAV THERAPY; Hart TA, 2016, COGN BEHAV PRACT, V23, P517, DOI 10.1016/j.cbpra.2015.11.002; Hart TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152762; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; Kalichman SC, 2008, J HEALTH PSYCHOL, V13, P680, DOI 10.1177/1359105307082456; Maiorana A, 2016, GLOB PUBLIC HEALTH, V11, P1076, DOI 10.1080/17441692.2016.1161814; McKleroy VS, 2006, AIDS EDUC PREV, V18, P59, DOI 10.1521/aeap.2006.18.supp.59; Miller WR, 2009, BEHAV COGN PSYCHOTH, V37, P129, DOI 10.1017/S1352465809005128; Mora-Rojas R.B., 2017, REV GERENC POLIT SAL; Moyers T. B., 2010, REVISED GLOBAL SCALE; Mueses-Marin H, 2019, BIOMEDICA, V39, DOI 10.7705/biomedica.v39i1.3843; Naar-King S, 2012, CURR HIV-AIDS REP, V9, P335, DOI 10.1007/s11904-012-0132-x; Newcomb M.E., 2013, HEALTH PSYCHOL; Nvivo, 2019, NVIVO PLUS Q, V12; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; STATA, 2013, STATA STAT DAT AN; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, 2017, COLOMBIA TREATMENT C; van der Heijden I, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010806.pub2; Vu L, 2015, AIDS BEHAV, V19, P1203, DOI 10.1007/s10461-014-0910-0; Wingood GM, 2008, JAIDS-J ACQ IMM DEF, V47, pS40, DOI 10.1097/QAI.0b013e3181605df1; Yin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107652; Zea MC, 2015, AM J PUBLIC HEALTH, V105, P1588, DOI 10.2105/AJPH.2014.302307	33	3	3	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1557-9883	1557-9891		AM J MENS HEALTH	Am. J. Mens Health	JAN	2021	15	1							1557988321989916	10.1177/1557988321989916	http://dx.doi.org/10.1177/1557988321989916			12	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	QG2QT	33511900	gold, Green Published			2022-09-04	WOS:000617435300001
J	Parraga-Alava, J; Moncayo-Nacaza, JD; Revelo-Fuelagan, J; Rosero-Montalvo, PD; Anaya-Isaza, A; Peluffo-Ordonez, DH				Parraga-Alava, Jorge; Dario Moncayo-Nacaza, Jorge; Revelo-Fuelagan, Javier; Rosero-Montalvo, Paul D.; Anaya-Isaza, Andres; Hernan Peluffo-Ordonez, Diego			A data set for electric power consumption forecasting based on socio-demographic features: Data from an area of southern Colombia	DATA IN BRIEF			English	Article; Data Paper						Electric power consumption; Forecasting; Machine learning; Socio-demographic data; Smart grid		In this article, we introduce a data set concerning electric-power consumption-related features registered in seven main municipalities of Narino, Colombia, from December 2010 to May 2016. The data set consists of 4427 socio-demographic characteristics, and 7 power-consumption-referred measured values. Data were fully collected by the company Centrales Electricas de Narino (CEDENAR) according to the client consumption records. Power consumption data collection was carried following a manual procedure wherein company workers are in charge of manually registering the readings (measured in kWh) reported by the electric energy meters installed at each housing/building. Released data set is aimed at providing researchers a suitable input for designing and assessing the performance of forecasting, modelling, simulation and optimization approaches applied to electric power consumption prediction and characterization problems. The data set, so-named in shorthand PCSTCOL, is freely and publicly available at https://doi.org/10.17632/xbt7scz5ny.3. (C) 2020 The Authors. Published by Elsevier Inc.	[Parraga-Alava, Jorge] Univ Tecn Manabi, Fac Ciencias Informat, Portoviejo, Ecuador; [Dario Moncayo-Nacaza, Jorge] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Revelo-Fuelagan, Javier] Univ Narino, Pasto, Colombia; [Rosero-Montalvo, Paul D.] Univ Tecn Norte, Ibarra, Ecuador; [Rosero-Montalvo, Paul D.] Inst Tecnol Super 17 Julio, Ibarra, Ecuador; [Anaya-Isaza, Andres; Hernan Peluffo-Ordonez, Diego] INDIGO Res, Bogota, Colombia; [Anaya-Isaza, Andres] Pontificia Univ Javeriana, Bogota, Colombia; [Hernan Peluffo-Ordonez, Diego] Corp Univ Autonoma Narino, Pasto, Colombia; [Hernan Peluffo-Ordonez, Diego] Univ Yachay Tech, Urcuqui, Ecuador		Parraga-Alava, J (corresponding author), Univ Tecn Manabi, Fac Ciencias Informat, Portoviejo, Ecuador.	jorge.parraga@usach.cl	Peluffo-Ordóñez, Diego Hernán/ABF-7707-2021; Rosero-Montalvo, Paul D./AFY-1573-2022; Parraga-Alava, Jorge/O-6976-2019; Rosero-Montalvo, Paul D./H-7223-2018	Peluffo-Ordóñez, Diego Hernán/0000-0002-9045-6997; Rosero-Montalvo, Paul D./0000-0003-1995-400X; Parraga-Alava, Jorge/0000-0001-8558-9122; Rosero-Montalvo, Paul D./0000-0003-1995-400X	research division from INDIGO Technologies	research division from INDIGO Technologies	This work is supported by the research division from INDIGO Technologies (http://www.indigo.ms/).Also, authors acknowledge the valuable support given by SDAS Research Group (https://sdas-group.com/).		0	3	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-3409			DATA BRIEF	Data Brief	APR	2020	29								105246	10.1016/j.dib.2020.105246	http://dx.doi.org/10.1016/j.dib.2020.105246			9	Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	LI3HF	32083158	Green Published, gold			2022-09-04	WOS:000529374500024
J	Ramirez-Velez, R; Correa-Bautista, JE; Garcia-Hermoso, A; Cano, CA; Izquierdo, M				Ramirez-Velez, Robinson; Enrique Correa-Bautista, Jorge; Garcia-Hermoso, Antonio; Alberto Cano, Carlos; Izquierdo, Mikel			Reference values for handgrip strength and their association with intrinsic capacity domains among older adults	JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE			English	Article						Skeletal muscle; Handgrip; Older adults; Locomotion; Vitality; Cognition; Mental health	GRIP STRENGTH; COGNITIVE DECLINE; PHYSICAL FUNCTION; ANOREXIA-NERVOSA; CUT POINTS; LMS METHOD; SARCOPENIA; DEPRESSION; COMMUNITY; HEALTH	Objective The purposes of this study were three-fold: (i) to describe handgrip strength in older individuals aged >= 60 years in Colombia; (ii) to identify sex-specific and age-specific muscle weakness cut-off points in older adults; and (iii) to determine the odds of adverse events for each of the intrinsic capacity domains for individuals with handgrip strength greater than the muscle weakness cut-off points, as compared with their weaker counterparts. Methods A cross-sectional study was conducted in Colombia, among 5237 older adults aged >= 60 years old (58.5% women, 70.5 +/- 7.8 years), according to 'SABE Survey 2015'. Handgrip strength data were obtained with a Takei dynamometer. Sociodemographic variables, five domains of intrinsic capacity (i.e. locomotion, vitality, cognition, psychological, and sensory), and medical conditions were assessed and analyzed. Adjustments variables were age, ethnicity, socio-economic status, urbanicity, body mass index, smoking status, alcohol intake, drug use, physical activity, and co-morbid chronic diseases. Sex-stratified analyses were conducted with logistic regression models. Results Handgrip strength was greater among men than among women (26.7 +/- 8.5 vs. 16.7 +/- 5.7 kg, respectively, P < 0.001) at all ages. Weak handgrip strength cut-off points ranged from 17.4 to 8.6 and from 10.1 to 4.9 in men and women, respectively. Overall, participants with optimal handgrip strength had better intrinsic capacity [in men, odds ratio (OR) = 0.62, 95% confidence interval (CI) 0.53 to 0.71; P < 0.001; and in women, OR = 0.79, 95% CI 0.68 to 0.92; P = 0.002] than their weaker counterparts. Also, men with optimal handgrip strength had a lower risk of hospitalization (OR = 0.47, 95% CI 0.29 to 0.78; P = 0.004) than their weaker counterparts. Conclusions This study is the first to describe handgrip strength values and cut-off points for muscle weakness among a nationally representative sample of Colombian older adults by age and sex. After categorizing older adults as weak or not weak based on the handgrip cut-off points, non-weakness was associated with a decreased odds of intrinsic capacity impairments. These cut-off points may be good candidates for clinical assessment of risks to physical and mental health in older Colombian adults.	[Ramirez-Velez, Robinson; Enrique Correa-Bautista, Jorge; Izquierdo, Mikel] Univ Rosario, Ctr Estudios Medic Actividad Fis CEMA, Escuela Med & Ciencias Salud, Cra 24 63C-69, Bogota, DC, Colombia; [Garcia-Hermoso, Antonio] Univ Santiago Chile, Lab Ciencias Actividad Fis Deporte & Salud, USACH, Santiago, Chile; [Alberto Cano, Carlos] Pontificia Univ Javeriana, Inst Envejecimiento Semillero Neurociencias & Env, Inst Envejecimiento, Fac Med,Hosp Univ San Ignacio, Bogota, Colombia; [Izquierdo, Mikel] Univ Publ Navarra, Dept Hlth Sci, CIBER Frailty & Hlth Aging CIBERFES, Navarrabiomed,Inst Salud Carlos III, Navarra, Spain		Ramirez-Velez, R (corresponding author), Univ Rosario, Ctr Estudios Medic Actividad Fis CEMA, Escuela Med & Ciencias Salud, Cra 24 63C-69, Bogota, DC, Colombia.	robin640@hotmail.com	Izquierdo, Mikel/A-4894-2010; García-Hermoso, Antonio/P-1857-2017; Ramírez-Vélez, Robinson/D-5311-2016; García-Hermoso, Antonio/ADU-2591-2022; Izquierdo, Mikel/O-8049-2019; Garcia-Hermoso, Antonio/AGK-7815-2022; Correa-Bautista, Jorge Enrique/N-2741-2015	Izquierdo, Mikel/0000-0002-1506-4272; García-Hermoso, Antonio/0000-0002-1397-7182; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Izquierdo, Mikel/0000-0002-1506-4272; Garcia-Hermoso, Antonio/0000-0002-1397-7182; Correa-Bautista, Jorge Enrique/0000-0002-0646-2316; Cano-Gutierrez, Carlos/0000-0001-5680-7880	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia [764]; ISCIII; Fondos FEDER [PI17/01814]	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia; ISCIII(Instituto de Salud Carlos III); Fondos FEDER(European Commission)	The SABE study is supported by a fund (2013, no. 764) from the Colciencias y Ministerio de Salud y la Proteccion Social de Colombia. Mikel Izquierdo is funded by ISCIII and Fondos FEDER (PI17/01814). The authors certify that they comply with the ethical guidelines for authorship and publishing of the Journal of Cachexia, Sarcopenia and Muscle. 53	Amaral TF, 2016, JMIR RESEARCH PROTOC, V5, pe184; APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1207; Batzan JJ, 1993, REV ESP GERIATR GERO, V28, P32; Beard JR, 2016, LANCET, V387, P2145, DOI 10.1016/S0140-6736(15)00516-4; Borda Miguel Germán, 2016, Acta Neurol Colomb., V32, P27; Bowen RS, 2011, SPORTS MED, V41, P73, DOI 10.2165/11536860-000000000-00000; Celis-Morales CA, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1651; Cesari M, 2018, J GERONTOL A-BIOL; Chang KV, 2017, AGE AGEING, V46, P738, DOI 10.1093/ageing/afx094; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de Lima TR, 2017, J BODYW MOV THER, V21, P401, DOI 10.1016/j.jbmt.2016.08.017; Dong R, 2014, J BIOSCI MED, V2, P14, DOI DOI 10.4236/jbm.2014.29003; Duchowny KA, 2017, AM J PREV MED, V53, P63, DOI 10.1016/j.amepre.2016.12.022; Gomez JF, 2013, COLOMB MEDICA, V44, P165; Fritz NE, 2017, AGEING RES REV, V35, P112, DOI 10.1016/j.arr.2017.01.004; Garcia-Hermoso A, 2018, ARCH PHYS MED REHAB, V99, P2100, DOI 10.1016/j.apmr.2018.01.008; Gomez F., 2016, CURRENT GERONTOLOGY, V2016, P7910205, DOI [10.1155/2016/7910205, DOI 10.1155/2016/7910205]; Helzner EP, 2011, J AM GERIATR SOC, V59, P972, DOI 10.1111/j.1532-5415.2011.03444.x; Ishizaki T, 2000, J AM GERIATR SOC, V48, P1424, DOI 10.1111/j.1532-5415.2000.tb02632.x; Kenny RA, 2013, J AM GERIATR SOC, V61, pS279, DOI [10.1111/jgs.12195, 10.1111/jgs.12200]; Leong DP, 2016, J CACHEXIA SARCOPENI, V7, P535, DOI 10.1002/jcsm.12112; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; McGrath RP, 2017, ETHN HLTH, P1; McLean RR, 2016, J GERONTOL A-BIOL, V71, P356, DOI 10.1093/gerona/glv184; Mendes J, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0590-5; Murphy SL, 2003, J GERONTOL A-BIOL, V58, P943; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; Nikolaus T, 1996, AGING CLIN EXP RES, V8, P271, DOI 10.1007/BF03339578; Ong HL, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0565-6; Pedrero-Chamizo R, 2012, ARCH GERONTOL GERIAT, V55, P406, DOI 10.1016/j.archger.2012.02.004; Petersen NT, 2003, J NEUROSCI, V23, P7974; Ribom EL, 2011, ARCH GERONTOL GERIAT, V53, pE114, DOI 10.1016/j.archger.2010.07.005; Rijk JM, 2016, GERIATR GERONTOL INT, V16, P5, DOI 10.1111/ggi.12508; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Royston P, 2000, STAT MED, V19, P2943, DOI 10.1002/1097-0258(20001115)19:21<2943::AID-SIM559>3.0.CO;2-5; Sallinen J, 2010, J AM GERIATR SOC, V58, P1721, DOI 10.1111/j.1532-5415.2010.03035.x; Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956; Simmonds SJ, 2015, AGE AGEING, V44, P954, DOI 10.1093/ageing/afv146; Solmi M, 2016, EUR EAT DISORD REV, V24, P101, DOI 10.1002/erv.2420; Solmi M, 2015, PSYCHONEUROENDOCRINO, V51, P237, DOI 10.1016/j.psyneuen.2014.09.031; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Thomas DR, 2000, J GERONTOL A-BIOL, V55, pM725, DOI 10.1093/gerona/55.12.M725; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33; Veronese N, 2017, PHYS THER, V97, P659, DOI 10.1093/ptj/pzx017; von Haehling S, 2017, J CACHEXIA SARCOPENI, V8, P1081, DOI 10.1002/jcsm.12261; Wang YC, 2019, J HAND THER, V32, P489, DOI 10.1016/j.jht.2018.03.002; Wattamwar K, 2018, JAMA OTOLARYNGOL, V144, P623, DOI 10.1001/jamaoto.2018.0643; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Wilson BS, 2017, LANCET, V390, P2503, DOI 10.1016/S0140-6736(17)31073-5; World Health Organization, 2015, DECADE HLTH AGEING B; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976	53	57	58	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2190-5991	2190-6009		J CACHEXIA SARCOPENI	J. Caxhexia Sarcopenia Muscle	APR	2019	10	2					278	286		10.1002/jcsm.12373	http://dx.doi.org/10.1002/jcsm.12373			9	Geriatrics & Gerontology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; General & Internal Medicine	HU2HN	30843369	Green Published, gold			2022-09-04	WOS:000465092100003
J	Gadducci, F; Santini, F; Pino, LF; Valencia, FD				Gadducci, Fabio; Santini, Francesco; Pino, Luis F.; Valencia, Frank D.			Observational and behavioural equivalences for soft concurrent constraint programming	JOURNAL OF LOGICAL AND ALGEBRAIC METHODS IN PROGRAMMING			English	Article							SEMANTICS; PI	We present a labelled semantics for Soft Concurrent Constraint Programming (SCCP), a meta-language where concurrent agents may synchronise on a shared store by either posting or checking the satisfaction of (soft) constraints. SCCP generalises the classical formalism by parametrising the constraint system over an order-enriched monoid, thus abstractly representing the store with an element of the monoid, and the standard unlabelled semantics just observes store updates. The novel operational rules are shown to offer a sound and complete co-inductive technique to prove the original equivalence over the unlabelled semantics. Based on this characterisation, we provide an axiomatisation for finite agents. (C) 2017 Elsevier Inc. All rights reserved.	[Gadducci, Fabio] Univ Pisa, Dipartimento Informat, Pisa, Italy; [Santini, Francesco] Univ Perugia, Dipartimento Matemat & Informat, Perugia, Italy; [Pino, Luis F.] Univ Cagliari, Dipartimento Matemat & Informat, Cagliari, Italy; [Valencia, Frank D.] Ecole Polytech Paris, CNRS, Paris, France; [Valencia, Frank D.] Ecole Polytech Paris, LIX, Paris, France; [Valencia, Frank D.] Pontificia Univ Javeriana Cali, Cali, Colombia		Gadducci, F (corresponding author), Univ Pisa, Dipartimento Informat, Pisa, Italy.; Santini, F (corresponding author), Univ Perugia, Dipartimento Matemat & Informat, Perugia, Italy.	fabio.gadducci@unipi.it; francesco.santini@dmi.unipg.it; luis.pino@unica.it; frank.valencia@lix.polytechnique.fr	Santini, Francesco/AAE-5575-2021	Santini, Francesco/0000-0002-3935-4696; GADDUCCI, FABIO/0000-0003-0690-3051	MIUR PRIN; PRIN; ANR [121502001 PACE]	MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); ANR(French National Research Agency (ANR))	The research has been partially supported by the MIUR PRIN 2010LHT4KM CINA and PRIN 2010XSEMLC "Security Horizons", by the ANR 121502001 PACE, and by the Aut. Reg. of Sardinia P.I.A. 2010 "Social Glue".	Aristizabal A, 2011, LECT NOTES COMPUT SC, V6604, P138, DOI 10.1007/978-3-642-19805-2_10; Baccelli F., 1992, SYNCHRONIZATION LINE; Bistarelli S, 1997, J ACM, V44, P201, DOI 10.1145/256303.256306; Bistarelli S, 2008, LECT NOTES COMPUT SC, V5052, P50, DOI 10.1007/978-3-540-68265-3_4; Bistarelli S, 2006, FRONT ARTIF INTEL AP, V141, P63; Bistarelli S, 2006, ACM T COMPUT LOG, V7, P563, DOI 10.1145/1149114.1149118; Bistarelli S, 2015, THEOR PRACT LOG PROG, V15, P743, DOI 10.1017/S1471068414000106; Bistarelli S, 2014, FUND INFORM, V134, P261, DOI 10.3233/FI-2014-1102; Bonchi F., 2014, ACM T COMPUT LOG, V15; Bonchi F, 2006, IEEE S LOG, P69, DOI 10.1109/LICS.2006.46; Bonchi F, 2009, LECT NOTES COMPUT SC, V5504, P272; Buscemi MG, 2008, LECT NOTES COMPUT SC, V4960, P254; Buscemi MG, 2007, LECT NOTES COMPUT SC, V4421, P18; CARRIERO N, 1989, COMMUN ACM, V32, P444, DOI 10.1145/63334.63337; DeNicola R, 1995, WORK COMP, P129; Fargier H., 1993, Symbolic and Quantitative Approaches to Reasoning and Uncertainty. European Conference ECSQARU '93 Proceedings, P97; Gadducci F, 2015, LECT NOTES COMPUT SC, V9037, P133, DOI 10.1007/978-3-319-19282-6_9; Galatos Nikolaos, 2007, RESIDUATED LATTICES; Golan J. S., 2003, SEMIRINGS AFFINE EQU; KARNER G, 1992, SEMIGROUP FORUM, V45, P148, DOI 10.1007/BF03025757; Kwiatkowska M.Z., 1992, LECT NOTES COMPUTER, V666, P348; Leifer J. J., 2000, CONCUR 2000 - Concurrency Theory. 11th International Conference. Proceedings (Lecture Notes in Computer Science Vol.1877), P243; Mendler N. P., 1995, Nordic Journal of Computing, V2, P181; MILNER R, 1992, LECT NOTES COMPUT SC, V623, P685; Monk J.D., 2000, LOG J IGPL, V8, P451, DOI DOI 10.1093/jigpal/8.4.451; Montanari U., 1992, Fundamenta Informaticae, V16, P171; Nystrom SO, 1998, INFORM COMPUT, V146, P138, DOI 10.1006/inco.1998.2738; SARASWAT VA, 1991, POPL, P333, DOI DOI 10.1145/99583.99627	28	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	2352-2208	2352-2216		J LOG ALGEBR METHODS	J. Log. Algebr. Methods Program	NOV	2017	92						45	63		10.1016/j.jlamp.2017.06.001	http://dx.doi.org/10.1016/j.jlamp.2017.06.001			19	Computer Science, Theory & Methods; Logic	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Science & Technology - Other Topics	FI5QI		Bronze			2022-09-04	WOS:000412038500003
J	Siles, JA; Cajthaml, T; Hernandez, P; Perez-Mendoza, D; Garcia-Romera, I; Sampedro, I				Siles, Jose A.; Cajthaml, Tomas; Hernandez, Paola; Perez-Mendoza, Daniel; Garcia-Romera, Inmaculada; Sampedro, Inmaculada			Shifts in Soil Chemical Properties and Bacterial Communities Responding to Biotransformed Dry Olive Residue Used as Organic Amendment	MICROBIAL ECOLOGY			English	Article						"Alpeorujo"; Bioremediation; Biotransformation; Mediterranean soil; Olive wastes; Soil microbial community	MILL WASTE-WATER; GRADIENT GEL-ELECTROPHORESIS; WHITE-ROT FUNGI; MICROBIAL COMMUNITIES; FUNCTIONAL DIVERSITY; GROVE PRODUCTION; COMPOST; MATTER; IMPACT; CARBON	Dry olive residue (DOR) is a waste product derived from olive oil extraction and has been proposed as an organic amendment. However, it has been demonstrated that a pre-treatment, such as its transformation by saprophytic fungi, is required before DOR soil application. A greenhouse experiment was designed where 0 and 50 g kg(-1) of raw DOR (DOR), Coriolopsis floccosa-transformed DOR (CORDOR) and Fusarium oxysporum-transformed DOR (FUSDOR) were added to soil. Analyses of the soil chemical properties as well as the structure and relative abundance of bacterial and actinobacterial communities were conducted after 0, 30 and 60 days following amendment. The different amendments produced a slight decrease in soil pH and significant increases in carbon fractions, C/N ratios, phenols and K, with these increases being more significant after DOR application. Quantitative PCR assays of the 16S rRNA gene and PLFA analyses showed that all amendments favoured bacterial growth at 30 and 60 days, although actinobacterial proliferation was more evident after CORDOR and FUSDOR application at 60 days. Bacterial and actinobacterial DGGE multivariate analyses showed that the amendments produced structural changes in both communities, especially after 60 days of amendment. PLFA data analysis identified changes in soil microbial communities according to the amendment considered, with FUSDOR and CORDOR being less disruptive than DOR. Finally, integrated analysis of all data monitored in the present study enabled us to conclude that the greatest impact on soil properties was caused by DOR at 30 days and that soil showed some degree of resilience after this time.	[Siles, Jose A.; Hernandez, Paola; Perez-Mendoza, Daniel; Garcia-Romera, Inmaculada; Sampedro, Inmaculada] CSIC, Dept Soil Microbiol & Symbiot Syst, Estn Expt Zaidin, E-18008 Granada, Spain; [Cajthaml, Tomas] Acad Sci Czech Republ, Inst Microbiol, Vvi, CZ-14220 Prague 4, Czech Republic; [Cajthaml, Tomas] Charles Univ Prague, Inst Environm Studies, Fac Sci, CZ-12801 Prague 2, Czech Republic; [Hernandez, Paola] Pontificia Univ Javeriana, Dept Microbiol, Unidad Invest Agr UNIDIA, Bogota, Colombia; [Sampedro, Inmaculada] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA		Siles, JA (corresponding author), CSIC, Dept Soil Microbiol & Symbiot Syst, Estn Expt Zaidin, C Prof Albareda 1, E-18008 Granada, Spain.	josesimartos@gmail.com	Siles, José A./A-7043-2019; MENDOZA, DANIEL PEREZ/L-9353-2014; Romera, Inmaculada García/L-1204-2014; Cajthaml, Tomas/I-1971-2014	Siles, José A./0000-0002-5850-0281; MENDOZA, DANIEL PEREZ/0000-0001-9918-5671; Romera, Inmaculada García/0000-0001-6351-1885; Cajthaml, Tomas/0000-0002-3393-1333; Sampedro, Inmaculada/0000-0003-0528-3954	Spanish Ministry of Science and Innovation [AGL2008-572]; Competence Center of the Czech Technology Agency [TE01020218]; Consejo Superior de Investigaciones Cientificas (CSIC); European Social Fund	Spanish Ministry of Science and Innovation(Spanish Government); Competence Center of the Czech Technology Agency; Consejo Superior de Investigaciones Cientificas (CSIC); European Social Fund(European Social Fund (ESF))	This study has been funded by the Spanish Ministry of Science and Innovation (Project AGL2008-572) and by a grant from the Competence Center TE01020218 of the Czech Technology Agency. J.A. Siles, D. Perez-Mendoza and I. Sampedro gratefully acknowledge assistance from the JAE program, which is co-financed by the Consejo Superior de Investigaciones Cientificas (CSIC) and the European Social Fund.	Alburquerque JA, 2004, BIORESOURCE TECHNOL, V91, P195, DOI 10.1016/S0960-8524(03)00177-9; Alburquerque JA, 2009, BIODEGRADATION, V20, P257, DOI 10.1007/s10532-008-9218-y; Aranda E, 2006, INT BIODETER BIODEGR, V58, P176, DOI 10.1016/j.ibiod.2006.06.006; Barbera AC, 2013, AGR WATER MANAGE, V119, P43, DOI 10.1016/j.agwat.2012.12.009; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bontemps C, 2013, FEMS MICROBIOL LETT, V342, P157, DOI 10.1111/1574-6968.12126; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Cardoso EJBN, 2013, SCI AGR, V70, P274, DOI 10.1590/S0103-90162013000400009; Brons JK, 2008, APPL ENVIRON MICROB, V74, P2717, DOI 10.1128/AEM.02195-07; Brozzoli V, 2009, BIORESOURCE TECHNOL, V100, P3395, DOI 10.1016/j.biortech.2009.02.022; Cayuela ML, 2008, SCI TOTAL ENVIRON, V399, P11, DOI 10.1016/j.scitotenv.2008.03.031; Chaudhry V, 2012, MICROB ECOL, V64, P450, DOI 10.1007/s00248-012-0025-y; Di Bene C, 2013, SOIL BIOL BIOCHEM, V56, P21, DOI 10.1016/j.soilbio.2012.02.019; Di Serio MG, 2008, INT BIODETER BIODEGR, V62, P403, DOI 10.1016/j.ibiod.2008.03.006; Drenovsky RE, 2008, AM MIDL NAT, V160, P140, DOI 10.1674/0003-0031(2008)160[140:NACMTF]2.0.CO;2; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; HULZEBOS EM, 1991, SCI TOTAL ENVIRON, V109, P493, DOI 10.1016/0048-9697(91)90203-Q; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jarboui R, 2010, J HAZARD MATER, V176, P992, DOI 10.1016/j.jhazmat.2009.11.140; Justino CIL, 2012, ECOTOXICOLOGY, V21, P615, DOI 10.1007/s10646-011-0806-y; Karpouzas DG, 2010, APPL SOIL ECOL, V45, P101, DOI 10.1016/j.apsoil.2010.03.002; Karpouzas DG, 2009, FEMS MICROBIOL ECOL, V70, P388, DOI 10.1111/j.1574-6941.2009.00779.x; Kibblewhite MG, 2008, PHILOS T R SOC B, V363, P685, DOI 10.1098/rstb.2007.2178; Kotsou M, 2004, APPL SOIL ECOL, V26, P113, DOI 10.1016/j.apsoil.2003.12.001; Lal R, 2006, LAND DEGRAD DEV, V17, P197, DOI 10.1002/ldr.696; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/CJSS2010-064, 10.4141/cjss2010-064]; Lopez-Pineiro A, 2008, BIORESOURCE TECHNOL, V99, P7982, DOI 10.1016/j.biortech.2008.03.051; Lopez-Pineiro A, 2011, SOIL TILL RES, V114, P175, DOI 10.1016/j.still.2011.05.002; Lopez-Pineiro A, 2011, SOIL SCI SOC AM J, V75, P1061, DOI 10.2136/sssaj2010.0230; Lozano-Garcia B, 2013, AGR ECOSYST ENVIRON, V165, P68, DOI 10.1016/j.agee.2012.12.007; Lv XC, 2012, FOOD CONTROL, V28, P426, DOI 10.1016/j.foodcont.2012.05.025; Magdich S, 2012, SCI TOTAL ENVIRON, V430, P209, DOI 10.1016/j.scitotenv.2012.05.004; Magurran AE, 1988, ECOLOGICAL DIVERSITY; Mechri B, 2007, APPL SOIL ECOL, V36, P216, DOI 10.1016/j.apsoil.2007.03.005; Mekki A, 2006, MICROBIOL RES, V161, P93, DOI 10.1016/j.micres.2005.06.001; Mekki A, 2009, PROG NAT SCI-MATER, V19, P1515, DOI 10.1016/j.pnsc.2009.04.014; Mingorance MD, 2007, CHEMOSPHERE, V68, P409, DOI 10.1016/j.chemosphere.2007.01.021; Montecchia MS, 2011, APPL SOIL ECOL, V47, P176, DOI 10.1016/j.apsoil.2010.12.008; Montemurro F, 2004, AGRONOMIE, V24, P481, DOI 10.1051/agro:2004044; Moore-Kucera J, 2008, MICROB ECOL, V55, P500, DOI 10.1007/s00248-007-9295-1; Morillo JA, 2009, APPL MICROBIOL BIOT, V82, P25, DOI 10.1007/s00253-008-1801-y; Nautiyal CS, 2010, SOIL TILL RES, V109, P55, DOI 10.1016/j.still.2010.04.008; Ntougias S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/784591; Paredes C, 2000, BIOL FERT SOILS, V32, P222, DOI 10.1007/s003740000239; Piotrowska A, 2006, SOIL BIOL BIOCHEM, V38, P600, DOI 10.1016/j.soilbio.2005.06.012; Piotrowska A, 2011, GEODERMA, V161, P8, DOI 10.1016/j.geoderma.2010.11.011; Reina R, 2013, CHEMOSPHERE, V93, P1406, DOI 10.1016/j.chemosphere.2013.07.006; Roig A, 2006, WASTE MANAGE, V26, P960, DOI 10.1016/j.wasman.2005.07.024; Rousidou C, 2010, EUR J SOIL BIOL, V46, P34, DOI 10.1016/j.ejsobi.2009.10.004; Sampedro I, 2004, APPL SOIL ECOL, V26, P149, DOI 10.1016/j.apsoil.2003.10.011; Sampedro I, 2009, PROCESS BIOCHEM, V44, P216, DOI 10.1016/j.procbio.2008.10.016; Sampedro I, 2007, BIORESOURCE TECHNOL, V98, P3547, DOI 10.1016/j.biortech.2006.11.015; Sampedro I, 2007, INT BIODETER BIODEGR, V60, P116, DOI 10.1016/j.ibiod.2007.02.001; Sampedro I, 2009, BIORESOURCE TECHNOL, V100, P6098, DOI 10.1016/j.biortech.2009.06.026; Saparrat MCN, 2014, J IND MICROBIOL BIOT, V41, P607, DOI 10.1007/s10295-014-1408-5; Sayadi S, 2000, PROCESS BIOCHEM, V35, P725, DOI 10.1016/S0032-9592(99)00134-X; Sierra J, 2007, SCI TOTAL ENVIRON, V378, P90, DOI 10.1016/j.scitotenv.2007.01.009; Siles JA, 2014, SYST APPL MICROBIOL, V37, P113, DOI 10.1016/j.syapm.2013.08.005; Snajdr J, 2008, ENZYME MICROB TECH, V43, P186, DOI 10.1016/j.enzmictec.2007.11.008; Tella M, 2013, WASTE MANAGE, V33, P184, DOI 10.1016/j.wasman.2012.07.021; Tornberg K, 2003, BIOL FERT SOILS, V37, P190, DOI 10.1007/s00374-002-0574-1; Tortosa G, 2012, J CLEAN PROD, V26, P48, DOI 10.1016/j.jclepro.2011.12.008; Toscano P, 2013, J AGR SCI TECH-IRAN, V15, P627; USDA-NRCS, 1996, SOIL SURVEY INVESTIG; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016; Xiao Y, 2011, BIORESOURCE TECHNOL, V102, P1383, DOI 10.1016/j.biortech.2010.09.034; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020	70	9	9	0	43	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0095-3628	1432-184X		MICROB ECOL	Microb. Ecol.	JUL	2015	70	1					231	243		10.1007/s00248-014-0552-9	http://dx.doi.org/10.1007/s00248-014-0552-9			13	Ecology; Marine & Freshwater Biology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Marine & Freshwater Biology; Microbiology	CJ7RC	25501891				2022-09-04	WOS:000355694900022
J	Dennis, R; Caraballo, L; Garcia, E; Rojas, M; Aristizabal, G; Rondon, M; Perez, A; Penaranda, A; Barragan, A; Ahumada, V; Jimenez, S				Dennis, R.; Caraballo, L.; Garcia, E.; Rojas, M.; Aristizabal, G.; Rondon, M.; Perez, A.; Penaranda, A.; Barragan, A.; Ahumada, V; Jimenez, S.			Prevalence of asthma, allergic rhinitis and other allergic conditions in Colombia, 2009	ALLERGY			English	Meeting Abstract	30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)	JUN 11-15, 2011	Istanbul, TURKEY	European Acad Allergy & Clin Immunol (EAACI)					[Dennis, R.; Barragan, A.] Fdn Cardioinfantil Inst Cardiol, Dept Internal Med, Bogota, Colombia; [Dennis, R.; Barragan, A.] Fdn Cardioinfantil Inst Cardiol, Invest Dept, Bogota, Colombia; [Caraballo, L.; Ahumada, V; Jimenez, S.] Univ Cartagena, Immunol Res Inst, Cartagena, Colombia; [Garcia, E.] Fdn Santa Fe Bogota, Pediat Allergy Dept, Bogota, Colombia; [Rojas, M.; Rondon, M.] Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Aristizabal, G.] Univ El Bosque, Dept Pediat, Bogota, Colombia; [Perez, A.] Univ Texas Hlth Sci Ctr Houston, Div Biostat, Sch Publ Hlth, Austin, TX USA; [Penaranda, A.] Fdn Santa Fe Bogota, Dept Otorhinolaryngol, Bogota, Colombia					RONDON, MARTIN/0000-0002-3885-5448					0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	JUN	2011	66			94	SI	1519	573	573						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	286IS					2022-09-04	WOS:000329462203257
J	Caviedes-Bucheli, J; Munoz-Alvear, HD; Lopez-Moncayo, LF; Narvaez-Hidalgo, A; Zambrano-Guerrero, L; Gavino-Orduna, JF; Portigliatti, R; Gomez-Sosa, JF; Munoz, HR				Caviedes-Bucheli, Javier; Munoz-Alvear, Hernan D.; Lopez-Moncayo, Luis F.; Narvaez-Hidalgo, Angela; Zambrano-Guerrero, Lorena; Gavino-Orduna, Jose F.; Portigliatti, Ricardo; Gomez-Sosa, Jose F.; Munoz, Hugo R.			Use of scaffolds and regenerative materials for the treatment of immature necrotic permanent teeth with periapical lesion: Umbrella review	INTERNATIONAL ENDODONTIC JOURNAL			English	Review; Early Access						immature necrotic teeth; periapical lesion; regenerative materials; scaffolds	MINERAL TRIOXIDE AGGREGATE; ENDODONTOLOGY POSITION STATEMENT; BEAM COMPUTED-TOMOGRAPHY; PULP REVASCULARIZATION; CALCIUM HYDROXIDE; APICAL PERIODONTITIS; SYSTEMATIC REVIEWS; EUROPEAN-SOCIETY; ROOT DEVELOPMENT; MATURE TEETH	Background Current treatment of immature necrotic permanent teeth with a periapical lesion is regenerative endodontics, which is based on tissue engineering under the triade of stem cells, scaffolds and bioactive molecules. Objectives This Umbrella Review was aimed to evaluate the success of scaffold and regenerative materials used for the treatment of these teeth, in terms of apical closure, tooth length increase, widening of root canal walls, tissue vitality and periapical lesion repair. Methods An extensive literature research was carried out in the Medline, ISI Web of Science, and Scopus databases for relevant systematic reviews matching the keyword search strategy. Based on inclusion and exclusion criteria, reviewers independently rated the quality of each study to determine their level of evidence. Methodological quality assessment of each article was obtained using A Measurement Tool to Assess Systematic Reviews (AMSTAR)-2 tool, and risk of bias was assessed with the Risk of Bias in Systematic Reviews (ROBIS) tool. Results After removing duplicates, 155 articles were found; from which 133 were excluded for being non-relevant and 15 other due to exclusion criteria. One more was discarded after methodological quality evaluation, for a total of six articles remaining. The most common scaffold used was the blood clot, others used were poly lactic-co-glycolic acid and platelet-rich fibrin matrix. The most common regeneration material used was Mineral Trioxide Aggregate (MTA), followed by Biodentine. An increase in tooth length and widening of root canal walls were reported in all selected studies with different proportions, as well as periapical lesion repair. ROBIS analysis showed that only one article had low bias, two were classified as unclear bias, while the remaining three had high risk of bias. Discussion An exhaustive literature search was carried out applying language filters, high-quality indexed journals, year of publication, which ensures the best quality articles were included. Blood clot was the most used scaffold as is the most easy to place inside the canal and does not require to extract blood from the patient. The use of MTA and Biodentine as sealing materials has been associated with thickening of canal walls, apical closure and reduced signs and symptoms of apical periodontitis. However, most of the included reviews assessed were case reports and only in a few of them were clinical trials included. There is also a lack of risk of bias analysis in most reviews. Conclusion The blood clot is the most common scaffold used for inducing regeneration during the treatment of immature necrotic teeth. Tooth length increase and widening of root canal walls are the most common criteria used in the studies as success indicators. MTA and Biodentine did not show differences in the results analysed. Quality assessment and bias risk evaluation showed that it is necessary to design better studies with rigorous methodology to recommend a trustable and predictable protocol for the treatment of immature necrotic permanent teeth with periapical lesions. Registration International Prospective Register of Systematic Reviews (PROSPERO) CRD42021248404.	[Caviedes-Bucheli, Javier] Pontificia Univ Javeriana, Ctr Invest Odontol, Bogota, Colombia; [Munoz-Alvear, Hernan D.; Lopez-Moncayo, Luis F.; Narvaez-Hidalgo, Angela; Zambrano-Guerrero, Lorena] Univ Cooperat Colombia, Endodont Dept, Pasto, Colombia; [Gavino-Orduna, Jose F.] Univ Barcelona, Sch Dent, Odontostomatol Dept, Barcelona, Spain; [Portigliatti, Ricardo] Univ Buenos Aires, Sch Dent, Buenos Aires, DF, Argentina; [Gomez-Sosa, Jose F.] Univ Cent Venezuela, Endodont Dept, Caracas, Venezuela; [Munoz, Hugo R.] Univ San Carlos, Endodont Dept, Guatemala City, Guatemala		Caviedes-Bucheli, J (corresponding author), Pontificia Univ Javeriana, Sch Dent, Ctr Invest Odontol, Carrera 7 40-62, Bogota, Colombia.	javiercaviedes@gmail.com		Munoz, Hugo RobertO/0000-0001-6456-0566; Gomez-Sosa, Jose Francisco/0000-0002-2307-6214				Adnan S, 2018, J ENDODONT, V44, P1650, DOI 10.1016/j.joen.2018.07.015; Alghamdi Faisal T, 2020, ScientificWorldJournal, V2020, P7954357, DOI 10.1155/2020/7954357; Ali MRW, 2019, EUR J ORAL SCI, V127, P261, DOI 10.1111/eos.12613; Andreasen JO, 2002, DENT TRAUMATOL, V18, P134, DOI 10.1034/j.1600-9657.2002.00097.x; Anna D, 2020, AUST ENDOD J, V46, P140, DOI 10.1111/aej.12371; Antunes LS, 2016, ACTA ODONTOL SCAND, V74, P161, DOI 10.3109/00016357.2015.1069394; Aromataris E, 2015, INT J EVID-BASED HEA, V13, P132, DOI 10.1097/XEB.0000000000000055; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Banchs F, 2004, J ENDODONT, V30, P196, DOI 10.1097/00004770-200404000-00003; Bezgin T, 2015, J ENDODONT, V41, P36, DOI 10.1016/j.joen.2014.10.004; Brozek JL, 2009, ALLERGY, V64, P669, DOI 10.1111/j.1398-9995.2009.01973.x; Bucchi C, 2017, INT J CLIN EXP MED, V10, P2006; Chala S, 2011, ORAL SURG ORAL MED O, V112, pE36, DOI 10.1016/j.tripleo.2011.03.047; Chisini LA, 2018, G ITAL ENDO, V32, P9, DOI 10.1016/j.gien.2018.03.006; CVEK M, 1992, ENDOD DENT TRAUMATOL, V8, P45; Diogenes Anibal, 2017, Dent Clin North Am, V61, P111, DOI 10.1016/j.cden.2016.08.004; do Couto AM, 2019, PEDIATR DENT, V41, P341; dos Reis S, 2020, J ENDODONT, V46, P682, DOI 10.1016/j.joen.2020.01.014; ElSheshtawy AS, 2020, INT ENDOD J, V53, P905, DOI 10.1111/iej.13303; Eramo S, 2018, INT ENDOD J, V51, P405, DOI 10.1111/iej.12868; Fahmy SH, 2017, AUST ENDOD J, V43, P73, DOI 10.1111/aej.12210; Galler KM, 2016, INT ENDOD J, V49, P717, DOI 10.1111/iej.12629; Gates A, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0746-1; Glynis A, 2021, J ENDODONT, V47, P873, DOI 10.1016/j.joen.2021.03.015; Gomes JE, 2012, J ENDODONT, V38, P91, DOI 10.1016/j.joen.2011.09.020; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hargreaves KM, 2008, J ENDODONT, V34, pS51, DOI 10.1016/j.joen.2008.02.032; Hargreaves KM, 2013, J ENDODONT, V39, pS30, DOI 10.1016/j.joen.2012.11.025; He L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14412-x; Jacobs JC, 2017, J ENDODONT, V43, P575, DOI 10.1016/j.joen.2016.12.014; Jakovljevic A, 2020, INT ENDOD J, V53, P1374, DOI 10.1111/iej.13364; Jitaru Stefan, 2016, Clujul Med, V89, P470; Kahler B, 2017, MATERIALS, V10, DOI 10.3390/ma10121389; Kahler B, 2017, J ENDODONT, V43, P1052, DOI 10.1016/j.joen.2017.03.003; Kim SG, 2018, INT ENDOD J, V51, P1367, DOI 10.1111/iej.12954; Koc S, 2020, J EVID-BASED DENT PR, V20, DOI 10.1016/j.jebdp.2020.101400; Kontakiotis EG, 2015, J ENDODONT, V41, P146, DOI 10.1016/j.joen.2014.08.003; Lin JC, 2016, J FORMOS MED ASSOC, V115, P523, DOI 10.1016/j.jfma.2016.01.010; Lolato A, 2016, PLATELETS, V27, P383, DOI 10.3109/09537104.2015.1131255; Lopes LB, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020754; Sanz JL, 2020, MATERIALS, V13, DOI 10.3390/ma13040974; Metlerska J, 2019, J ENDODONT, V45, P20, DOI 10.1016/j.joen.2018.09.003; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Murray PE, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00139; Nagendrababu V, 2020, INT ENDOD J, V53, P455, DOI 10.1111/iej.13253; Nicoloso GF, 2019, J CLIN PEDIATR DENT, V43, P305, DOI 10.17796/1053-4625-43.5.1; Nicoloso GF, 2017, INT J PAEDIATR DENT, V27, P217, DOI 10.1111/ipd.12261; Nosrat A, 2019, J ENDODONT, V45, P136, DOI 10.1016/j.joen.2018.10.012; Ong TK, 2020, J ENDODONT, V46, P1856, DOI 10.1016/j.joen.2020.08.016; Pace R, 2014, J ENDODONT, V40, P1250, DOI 10.1016/j.joen.2013.12.007; Panda S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102241; Patel S, 2015, INT ENDOD J, V48, P3, DOI 10.1111/iej.12270; Patel S, 2014, INT ENDOD J, V47, P502, DOI 10.1111/iej.12267; Peng CF, 2017, J ENDODONT, V43, P905, DOI 10.1016/j.joen.2017.01.031; Reynolds K, 2009, INT ENDOD J, V42, P84, DOI 10.1111/j.1365-2591.2008.01467.x; Rossi-Fedele Giampiero, 2019, Braz. Dent. J., V30, P527, DOI 10.1590/0103-6440201902670; Sabour S, 2013, MED ORAL PATOL ORAL, V18, pE822, DOI 10.4317/medoral.18642; Shaik I, 2021, J PHARM BIOALLIED SC, V13, P36, DOI 10.4103/jpbs.JPBS_807_20; Shamszadeh S, 2019, J ENDODONT, V45, P272, DOI 10.1016/j.joen.2018.11.010; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Taweewattanapaisan P, 2019, J ENDODONT, V45, P281, DOI 10.1016/j.joen.2018.10.010; Thomson K, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0235-3; Torabinejad M, 2018, INT ENDOD J, V51, P284, DOI 10.1111/iej.12843; Torabinejad M, 2017, J ENDODONT, V43, P1806, DOI 10.1016/j.joen.2017.06.029; Vandenbroucke JP, 2001, ANN INTERN MED, V134, P330, DOI 10.7326/0003-4819-134-4-200102200-00017; Zdrilic IV, 2017, J PERIODONTAL RES, V52, P1058, DOI 10.1111/jre.12478; Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI 10.1016/j.jclinepi.2015.06.005; Wigler R, 2013, J ENDODONT, V39, P319, DOI 10.1016/j.joen.2012.11.014; Xie Y, 2021, EUR J PAEDIATR DENT, V22, P207, DOI 10.23804/ejpd.2021.22.03.6	69	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.												10.1111/iej.13799	http://dx.doi.org/10.1111/iej.13799		JUL 2022	22	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	3D6BW	35821587	Bronze			2022-09-04	WOS:000829386000001
J	Velez, N; Vega-Vela, N; Munoz, M; Gomez, P; Escandon, P; Ramirez, JD; Zaragoza, O; Diaz, LM; Parra-Giraldo, CM				Velez, Norida; Vega-Vela, Nelson; Munoz, Marina; Gomez, Paola; Escandon, Patricia; David Ramirez, Juan; Zaragoza, Oscar; Monteoliva Diaz, Lucia; Parra-Giraldo, Claudia-Marcela			Deciphering the Association among Pathogenicity, Production and Polymorphisms of Capsule/Melanin in Clinical Isolates of Cryptococcus neoformans var. grubii VNI	JOURNAL OF FUNGI			English	Article						Cryptococcus neoformans; MLST; polymorphism; capsule; melanin	CELL-WALL; MOLECULAR EPIDEMIOLOGY; CAPSULE; VIRULENCE; PROTEIN; MELANIN; YEAST; MELANIZATION; GENE; PHAGOCYTOSIS	Background: Cryptococcus neoformans is an opportunistic fungal pathogen that can cause meningitis in immunocompromised individuals. The objective of this work was to study the relationship between the phenotypes and genotypes of isolates of clinical origin from different cities in Colombia. Methods: Genome classification of 29 clinical isolates of C. neoformans var. grubii was performed using multilocus sequence typing (MLST), and genomic sequencing was used to genotype protein-coding genes. Pathogenicity was assessed in a larval model, and melanin production and capsule size were evaluated in vitro and in vivo. Results: Eleven MLST sequence types (STs) were found, the most frequent being ST69 (n = 9), ST2, ST93, and ST377 (each with n = 4). In the 29 isolates, different levels of pigmentation, capsule size and pathogenicity were observed. Isolates classified as highly pathogenic showed a tendency to exhibit larger increases in capsule size. In the analysis of polymorphisms, 48 non-synonymous variants located in the predicted functional domains of 39 genes were found to be associated with capsule size change, melanin, or pathogenicity. Conclusions: No clear patterns were found in the analysis of the phenotype and genotype of Cryptococcus. However, the data suggest that the increase in capsule size is a key variable for the differentiation of pathogenic isolates, regardless of the method used for its induction.	[Velez, Norida; Vega-Vela, Nelson; Gomez, Paola; Parra-Giraldo, Claudia-Marcela] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Unidad Proteom & Micosis Humanas,Grp Enfermedades, Bogota 110231, Colombia; [Munoz, Marina; David Ramirez, Juan] Univ Rosario, Fac Ciencias Nat, Ctr Invest Microbiol & Biotecnol UR CIMBIUR, Bogota 111221, Colombia; [Escandon, Patricia] Inst Nacl Salud, Grp Microbiol, Bogota 111321, Colombia; [David Ramirez, Juan] Icahn Sch Med Mt Sinai, Dept Pathol Mol Microbiol Lab, Mol & Cell Based Med, New York, NY 10029 USA; [Zaragoza, Oscar] Inst Salud Carlos III, Mycol Reference Lab Natl Ctr Microbiol, Madrid 28222, Spain; [Monteoliva Diaz, Lucia] Univ Complutense Madrid, Fac Farm, Dept Microbiol & Parasitol, Madrid 28040, Spain		Parra-Giraldo, CM (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Unidad Proteom & Micosis Humanas,Grp Enfermedades, Bogota 110231, Colombia.	velez.norida@javeriana.edu.co; vega.nelson@javeriana.edu.co; claudia.munoz@urosario.edu.co; biopagoru@gmail.com; pescandon@ins.gov.co; juand.ramirez@urosario.edu.co; ozaragoza@isciii.es; luciamon@ucm.es; claudia.parra@javeriana.edu.co	Monteoliva, Lucia/G-8720-2015	Monteoliva, Lucia/0000-0003-4949-0664; Munoz, Marina/0000-0002-4216-6928	Pontificia Universidad Javeriana in Bogota, Colombia [7170]; MINCIENCIAS [715-2018]; Direccion de Investigacion e Innovacion from Universidad del Rosario; Spanish Ministry of Science, Innovation and Universities [RTI2018-094004-B-I00]	Pontificia Universidad Javeriana in Bogota, Colombia; MINCIENCIAS; Direccion de Investigacion e Innovacion from Universidad del Rosario; Spanish Ministry of Science, Innovation and Universities(Spanish Government)	We thank Oliver Clay and Andres Ceballos for critically revising the manuscript, and for their help in performing the required analyses. We acknowledge the Pontificia Universidad Javeriana. This work was financed by Grant ID 7170 of the Research Vice Presidency of the Pontificia Universidad Javeriana in Bogota, Colombia; MINCIENCIAS call 715-2018 contract RC No. 715-2018; Direccion de Investigacion e Innovacion from Universidad del Rosario; and RTI2018-094004-B-I00 from the Spanish Ministry of Science, Innovation and Universities to the Universidad Complutense de Madrid.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade-Silva LE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193237; Andrews S., 2018, FASTQC QUALITY CONTR; Armitage P., 2002, STAT METHODS MED RES, V4th; Arras SDM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18106-2; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; Barnett JA, 2010, YEAST, V27, P875, DOI 10.1002/yea.1786; Beale MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003847; Bose I, 2003, EUKARYOT CELL, V2, P655, DOI 10.1128/EC.2.4.655-663.2003; Brivio MF, 2010, DEV COMP IMMUNOL, V34, P991, DOI 10.1016/j.dci.2010.05.002; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Casadevall A, 2003, CURR OPIN MICROBIOL, V6, P332, DOI 10.1016/S1369-5274(03)00082-1; Casadevall A., 1998, CRYPTOCOCCUS NEOFORM, V107, P407; Chang YC, 1998, INFECT IMMUN, V66, P2230, DOI 10.1128/IAI.66.5.2230-2236.1998; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Claret S, 2005, EUKARYOT CELL, V4, P1375, DOI 10.1128/EC.4.8.1375-1386.2005; Cogliati M, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/675213; Cogliati M, 2013, MED MYCOL, V51, P499, DOI 10.3109/13693786.2012.751642; Cordero RJB, 2018, CURR BIOL, V28, P2657, DOI 10.1016/j.cub.2018.06.034; Day JN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005628; Dou HT, 2015, EUR J CLIN MICROBIOL, V34, P753, DOI 10.1007/s10096-014-2289-2; Duitama J, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1381; Escandon P, 2018, J FUNGI, V4, DOI 10.3390/jof4010032; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fan X, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.07.008; Firacative C, 2021, J FUNGI, V7, DOI 10.3390/jof7040282; Firacative C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105076; Fuchs BB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000368; Fuchs BB, 2007, ANTIMICROB AGENTS CH, V51, P2929, DOI 10.1128/AAC.00121-07; Gerstein AC, 2019, MBIO, V10, DOI 10.1128/mBio.01440-19; Hagen F, 2015, FUNGAL GENET BIOL, V78, P16, DOI 10.1016/j.fgb.2015.02.009; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Helsel ME, 2017, METALLOMICS, V9, P69, DOI [10.1039/c6mt00172f, 10.1039/C6MT00172F]; Hu GG, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030042; Huang C, 2002, INFECT IMMUN, V70, P5485, DOI 10.1128/IAI.70.10.5485-5493.2002; HUFFNAGLE GB, 1995, J IMMUNOL, V155, P3507; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Khayhan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072222; Kroslak T, 2001, J BIOL CHEM, V276, P39772, DOI 10.1074/jbc.M106991200; Kumar P, 2014, EUKARYOT CELL, V13, P560, DOI 10.1128/EC.00290-13; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; KWONCHUNG KJ, 1982, J BACTERIOL, V150, P1414, DOI 10.1128/JB.150.3.1414-1421.1982; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee D, 2019, MBIO, V10, DOI 10.1128/mBio.02267-19; Li C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23927; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Liu OW, 2007, EUKARYOT CELL, V6, P630, DOI 10.1128/EC.00398-06; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; McFadden DC, 2001, MED MYCOL, V39, P19, DOI 10.1080/714031007; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Mukaremera L, 2019, INFECT IMMUN, V87, DOI [10.1128/IAI.00046-19, 10.1128/iai.00046-19]; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Naicker SD, 2021, J FUNGI, V7, P338, DOI 10.3390/jof7050338; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Noverr MC, 2004, INFECT IMMUN, V72, P1693, DOI 10.1128/IAI.72.3.1693-1699.2004; O'Meara TR, 2012, CLIN MICROBIOL REV, V25, P387, DOI 10.1128/CMR.00001-12; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Perfect JR, 2006, FEMS YEAST RES, V6, P463, DOI 10.1111/j.1567-1364.2006.00051.x; Perfect JR, 2002, INFECT DIS CLIN N AM, V16, P837, DOI 10.1016/S0891-5520(02)00064-8; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Renney H., 2020, FASTER CRYPTOCOCCUS, DOI [10.1101/2020.07.29.222794, DOI 10.1101/2020.07.29.222794]; Rhodes J, 2017, GENETICS, V207, P327, DOI 10.1534/genetics.117.203836; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rosas AL, 2000, INFECT IMMUN, V68, P2845, DOI 10.1128/IAI.68.5.2845-2853.2000; Sabiiti W, 2014, J CLIN INVEST, V124, P2000, DOI 10.1172/JCI72950; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Sanchini A, 2014, MED MICROBIOL IMMUN, V203, P333, DOI 10.1007/s00430-014-0341-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Rocha DFS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197841; Simwami SP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001343; Tello D, 2019, BIOINFORMATICS, V35, P4716, DOI 10.1093/bioinformatics/btz275; Toolkit P., GITHUB REPOSITORY 20; van Duin D, 2002, ANTIMICROB AGENTS CH, V46, P3394, DOI 10.1128/AAC.46.11.3394-3400.2002; Vazquez O., 2005, ACTA PEDIATR MEX, V26, P18; Velez N, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0422-2019; Velez N, 2018, J FUNGI, V4, DOI 10.3390/jof4030082; Viviani MA, 2006, FEMS YEAST RES, V6, P614, DOI 10.1111/j.1567-1364.2006.00081.x; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Wiesner DL, 2012, MBIO, V3, DOI 10.1128/mBio.00196-12; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321; Xu YQ, 2001, J BIOL CHEM, V276, P18407, DOI 10.1074/jbc.M101204200; Zaragoza O, 2008, CELL MICROBIOL, V10, P2043, DOI 10.1111/j.1462-5822.2008.01186.x; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	92	0	0	3	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2309-608X		J FUNGI	J. Fungi	MAR	2022	8	3							245	10.3390/jof8030245	http://dx.doi.org/10.3390/jof8030245			23	Microbiology; Mycology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology; Mycology	0B7UB	35330247	gold, Green Published			2022-09-04	WOS:000774834300001
J	Borda, MG; Castellanos-Perilla, N; Tovar-Rios, DA; Oesterhus, R; Soennesyn, H; Aarsland, D				German Borda, Miguel; Castellanos-Perilla, Nicolas; Tovar-Rios, Diego Alejandro; Oesterhus, Ragnhild; Soennesyn, Hogne; Aarsland, Dag			Polypharmacy is associated with functional decline in Alzheimer's disease and Lewy body dementia	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Dementia; Functional disability; Alzheimer's disease; Medications; Polypharmacy; Lewy body dementia	COMPREHENSIVE GERIATRIC ASSESSMENT; CLINICAL-DIAGNOSIS; ELDERLY-PATIENTS; MEDICATION USE; PEOPLE; BODIES; MANAGEMENT; CRITERIA; ADULTS	Background: In dementia, a number of factors may influence functional decline in addition to cognition. In this study, we aimed to study the potential association of the number of prescribed medications with functional decline trajectories over a five-year follow-up in people diagnosed with mild Alzheimer's disease (AD) or Lewy Body dementia (LBD). Methods: This is a longitudinal analysis of a Norwegian cohort study entitled "The Dementia Study of Western Norway". We included 196 patients newly diagnosed with AD (n=111) and LBD (n=85), followed annually for 5 years. We conducted linear mixed-effects models to analyse the association of the number of medications with functional decline measured by the Rapid Disability Rating Scale - 2. Results: The mean prescribed medications at baseline was 4.18 +/- 2.60, for AD 3.92 +/- 2.51 and LBD 4.52 +/- 2.70. The number of medications increased during the follow-up; at year five the mean for AD was 7.28 +/- 4.42 and for LBD 8.11 +/- 5.16. Using more medications was associated with faster functional decline in AD (Est 0.04, SE 0.01, p-value 0.003) and LBD (Est 0.08, SE 0.03, p-value 0.008) after adjusting for age, sex, comorbidity, neuropsychiatric symptoms, and cognition. For each medication added during the follow-up, functional trajectories worsened by 1% for AD and 2% for LBD. The number of medications was not associated with cognitive decline. Conclusion: We found that higher number of medications was related to a faster functional decline, both in AD and LBD. With disease progression, there was an increase in the number of medications. Prescription in dementia should be carefully assessed, possibly improving the functional prognosis.	[German Borda, Miguel; Castellanos-Perilla, Nicolas; Tovar-Rios, Diego Alejandro; Oesterhus, Ragnhild; Soennesyn, Hogne; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [German Borda, Miguel; Castellanos-Perilla, Nicolas] Pontificia Univ Javeriana, Med Sch, Ageing Inst, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [German Borda, Miguel] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Tovar-Rios, Diego Alejandro] Univ Valle, Fac Engn, Grp Invest Estadist Aplicada INFERIR, Santiago De Cali, Valle Del Cauca, Colombia; [Tovar-Rios, Diego Alejandro] Univ Valle, Fac Hlth, Prevenc & Control Enfermedad Cron PRECEC, Santiago De Cali, Valle Del Cauca, Colombia; [Oesterhus, Ragnhild] Hosp Pharm Enterprise Western Norway, Bergen, Norway; [Aarsland, Dag] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England		Borda, MG (corresponding author), Stavanger Univ Hosp, PB 8100, N-4068 Stavanger, Norway.	migbor@sus.no	Castellanos, Nicolas/F-2868-2019; Borda, Miguel German/AHB-5593-2022	Castellanos, Nicolas/0000-0002-8229-2611; Borda, Miguel German/0000-0001-5832-0603; Tovar Rios, Diego Alejandro/0000-0003-3490-9899; Aarsland, Dag/0000-0001-6314-216X	Norwegian government, through hospital owner Helse Vest (Western Norway Regional Health Authority); National Institute for Health Research (NIHR) Biomedical Research center at South London and Maudsley NHS Foundation Trust and King's College London	Norwegian government, through hospital owner Helse Vest (Western Norway Regional Health Authority); National Institute for Health Research (NIHR) Biomedical Research center at South London and Maudsley NHS Foundation Trust and King's College London	This paper represents independent research supported by the Norwegian government, through hospital owner Helse Vest (Western Norway Regional Health Authority). Also, funded by the National Institute for Health Research (NIHR) Biomedical Research center at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.	Aarsland D, 2008, DEMENT GERIATR COGN, V26, P445, DOI 10.1159/000165917; Bayliss E. A., 2020, OPTIMIZE PATIENT FAM, V21, P542; Bierman AS, 2001, J GEN INTERN MED, V16, P785, DOI 10.1111/j.1525-1497.2001.10918.x; Borda MG, 2021, INT J GERIATR PSYCH, V36, P917, DOI 10.1002/gps.5494; Borda Miguel German, 2020, Neurodegener Dis Manag, V10, P357, DOI 10.2217/nmt-2020-0039; Bunn F, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0909-2; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Delgado J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-029172; Denholm R, 2019, EUR J CLIN PHARMACOL, V75, P1583, DOI 10.1007/s00228-019-02721-1; Dent E, 2019, LANCET, V394, P1376, DOI 10.1016/S0140-6736(19)31785-4; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher PF, 2008, AGE AGEING, V37, P96, DOI 10.1093/ageing/afm116; Borda MG, 2021, J ALZHEIMERS DIS, V79, P1713, DOI 10.3233/JAD-200961; Borda MG, 2020, J AM GERIATR SOC, V68, P2257, DOI 10.1111/jgs.16709; Gnjidic D, 2018, J GERONTOL A-BIOL, V73, P1410, DOI 10.1093/gerona/gly078; Gutierrez-Valencia M, 2018, BRIT J CLIN PHARMACO, V84, P1432, DOI 10.1111/bcp.13590; Jyrkka J, 2011, PHARMACOEPIDEM DR S, V20, P514, DOI 10.1002/pds.2116; Katsimpris A, 2019, J GEN INTERN MED, V34, P1865, DOI 10.1007/s11606-019-05106-3; Khezrian M, 2020, THER ADV DRUG SAF, V11, DOI 10.1177/2042098620933741; Kristensen RU, 2021, J ALZHEIMERS DIS, V79, P1459, DOI 10.3233/JAD-200627; Kristensen RU, 2018, J ALZHEIMERS DIS, V63, P383, DOI 10.3233/JAD-170905; Lee JL, 2018, J PATIENT EXPERIENCE, V5, P83, DOI 10.1177/2374373517727532; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; LINN MW, 1988, PSYCHOPHARMACOL BULL, V24, P799; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Maresova P, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7762-5; Masnoon N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0621-2; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Motter FR, 2018, EUR J CLIN PHARMACOL, V74, P679, DOI 10.1007/s00228-018-2446-0; Mueller C, 2018, EXP GERONTOL, V106, P240, DOI 10.1016/j.exger.2018.02.011; Namioka N, 2015, GERIATR GERONTOL INT, V15, P27, DOI 10.1111/ggi.12217; O'Mahony Denis, 2020, Expert Rev Clin Pharmacol, V13, P15, DOI 10.1080/17512433.2020.1697676; O'Mahony MS, 2020, BRIT J HOSP MED, V81, DOI 10.12968/hmed.2019.0213; Oesterhus R, 2017, INT J GERIATR PSYCH, V32, P183, DOI 10.1002/gps.4456; Page Amy, 2018, Journal of Pharmacy Practice and Research, V48, P356, DOI 10.1002/jppr.1403; Palmer K, 2019, EUR GERIATR MED, V10, P9, DOI 10.1007/s41999-018-0124-5; Parsons C, 2017, THER ADV DRUG SAF, V8, P31, DOI 10.1177/2042098616670798; Patterson SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008165.pub4, 10.1002/14651858.CD008165.pub3]; Qato DM, 2008, JAMA-J AM MED ASSOC, V300, P2867, DOI 10.1001/jama.2008.892; Ramjaun A, 2013, J GERIATR ONCOL, V4, P271, DOI 10.1016/j.jgo.2013.04.002; Rawle MJ, 2018, J AM GERIATR SOC, V66, P916, DOI 10.1111/jgs.15317; Roen I, 2015, DEMENT GERIATR COGN, V40, P233, DOI 10.1159/000437093; Rongve A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010357; Saraf AA, 2016, J HOSP MED, V11, P694, DOI 10.1002/jhm.2614; Scarmeas N, 2005, ARCH NEUROL-CHICAGO, V62, P1601, DOI 10.1001/archneur.62.10.1601; Skogseth R, 2017, J ALZHEIMERS DIS, V59, P1139, DOI 10.3233/JAD-170274; Stevens T, 2002, BRIT J PSYCHIAT, V180, P270, DOI 10.1192/bjp.180.3.270; Tjia J, 2014, JAMA INTERN MED, V174, P1763, DOI 10.1001/jamainternmed.2014.4103; Vik-Mo AO, 2018, INT J GERIATR PSYCH, V33, P1361, DOI 10.1002/gps.4933; Welsh TJ, 2014, INT J CLIN PRACT, V68, P290, DOI 10.1111/ijcp.12313; Welsh TJ, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-19; World Health Organization, 2014, COLL CTR DRUG STAT M	54	4	4	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	SEP-OCT	2021	96								104459	10.1016/j.archger.2021.104459	http://dx.doi.org/10.1016/j.archger.2021.104459		JUL 2021	6	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	UU2OO	34225098				2022-09-04	WOS:000698640900019
J	Sepulveda-Martinez, A; Rodriguez-Lopez, M; Mino, FPY; Casu, G; Crovetto, F; Gratacos, E; Crispi, F				Sepulveda-Martinez, A.; Rodriguez-Lopez, M.; Paz y Mino, F.; Casu, G.; Crovetto, F.; Gratacos, E.; Crispi, F.			Transgenerational transmission of small-for-gestational age	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Article						placental disease; pre-eclampsia; small-for-gestational age; transgenerational; transmission	BIRTH-WEIGHT; PRENATAL EXPOSURE; PRETERM BIRTH; MANAGEMENT; DIAGNOSIS; GROWTH; FETAL; CLASSIFICATION; GENERATIONS; ILLINOIS	Objective To evaluate the transgenerational transmission of small-for-gestational age (SGA). Methods This was a cohort study of a random sample of 2043 offspring delivered between 1975 and 1993 at Hospital Sant Joan de D ' eu in Barcelona. Exclusion criteria were multiple pregnancy, aneuploidy or genetic syndrome, major birth defects, severe mental disease and macrosomia. Eligible individuals were contacted and those with at least one offspring were included in the study. Participants were classified according to the presence of SGA (defined as birth weight <10th percentile) at birth. Multiple regression analysis was used to determine the presence of SGA or placenta-mediated disease (defined as the presence of SGA, pre-eclampsia, gestational hypertension and/or placental abruption) in the following generation. Results Of 623 individuals who agreed to participate, 152 (72 born SGA and 80 born appropriatefor-gestational age (AGA)) were reported to have at least one child. Descendants of SGA individuals presented with a lower birth-weight percentile (median, 26 (interquartile range (IQR), 7-52) vs 43 (IQR, 19-75); P < 0.001) and a higher prevalence of SGA (40.3% vs 16.3%; P = 0.001) and placenta-mediated disease (43.1% vs 17.5%; P = 0.001) than did the offspring of AGA individuals. After adjustment for confounding variables, parental SGA background was associated with an almost three-fold increased risk of subsequent SGA or any placenta-mediated disease in the following generation. This association was stronger in SGA mothers than in SGA fathers. Conclusions Our data provide evidence suggesting a transgenerational transmission of SGA, highlighting the importance of public health strategies for preventing intrauterine growth impairment. Copyright (c) 2018 ISUOG. Published by John Wiley & Sons Ltd.	[Sepulveda-Martinez, A.; Rodriguez-Lopez, M.; Paz y Mino, F.; Casu, G.; Crovetto, F.; Gratacos, E.; Crispi, F.] Univ Barcelona, Hosp Clin, Fetal Med Res Ctr,CIBER ER, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain; [Sepulveda-Martinez, A.; Rodriguez-Lopez, M.; Paz y Mino, F.; Casu, G.; Crovetto, F.; Gratacos, E.; Crispi, F.] Univ Barcelona, Inst Clin Ginecol Obstet & Neonatol, Hosp St Joan de Deu, CIBER ER,IDIBAPS, Barcelona, Spain; [Sepulveda-Martinez, A.] Hosp Clin Univ Chile, Dept Obstet & Gynecol, Fetal Med Unit, Santiago, Chile; [Rodriguez-Lopez, M.] Pontificia Univ Javeriana, Secc Cali, Cali, Colombia		Gratacos, E (corresponding author), Hosp Clin Barcelona, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Sabino de Arana 1, Barcelona 08028, Spain.; Gratacos, E (corresponding author), Hosp St Joan de Deu, Sabino de Arana 1, Barcelona 08028, Spain.	gratacos@clinic.cat	Rodriguez-Lopez, Merida/N-9273-2017; Sepulveda-Martinez, Alvaro/H-6546-2014; Gratacos, Eduard/AAR-4939-2020	Rodriguez-Lopez, Merida/0000-0001-8245-0811; Sepulveda-Martinez, Alvaro/0000-0002-8364-2732; Gratacos, Eduard/0000-0002-7405-7224; Crovetto, Francesca/0000-0003-0140-7411	Instituto de Salud Carlos III [PI15/00130, PI14/00226, PI17/00675, INT16/00168, CM16/00142]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) 'Otra manera de hacer Europa' (Spain); Erasmus+ Programme of the European Union [2013-0040]; 'la Caixa' Foundation (Spain); AGAUR 2014 SGR [928]; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) 'Otra manera de hacer Europa' (Spain); Erasmus+ Programme of the European Union; 'la Caixa' Foundation (Spain)(La Caixa Foundation); AGAUR 2014 SGR; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK)	We thank the staff members of the Medical Archives of Hospital Sant Joan de Deu for their support in obtaining old books of delivery information and medical charts, which were crucial for the conduct of this study. This project was funded with the support of the Instituto de Salud Carlos III (PI15/00130, PI14/00226, PI17/00675, INT16/00168 and CM16/00142) integrated in a national plan of I+D+I and co-financed by: ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) 'Otra manera de hacer Europa' (Spain); Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040); 'la Caixa' Foundation (Spain); AGAUR 2014 SGR grant no 928 and Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK). This publication reflects the views only of the authors, and the Commission cannot be held responsible for any use that may be made of the information contained herein.	Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; BARKER DJP, 1989, LANCET, V2, P577; Castrillio SM, 2014, MATERN CHILD HLTH J, V18, P2456, DOI 10.1007/s10995-014-1484-1; Coutinho R, 1997, AM J EPIDEMIOL, V146, P804; Crispi F, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.011; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Cruz-Lemini M, 2016, ULTRASOUND OBST GYN, V48, P349, DOI 10.1002/uog.15767; Drake AJ, 2010, TRENDS ENDOCRIN MET, V21, P206, DOI 10.1016/j.tem.2009.11.006; Figueras F, 2008, EUR J OBSTET GYN R B, V136, P20, DOI 10.1016/j.ejogrb.2006.12.015; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Jimenez R, 1982, ARCH PEDIATR, V33, P191; Kingdom JC, 2018, AM J OBSTET GYNECOL, V218, pS803, DOI 10.1016/j.ajog.2017.11.575; Nardozza LMM, 2017, ARCH GYNECOL OBSTET, V295, P1061, DOI 10.1007/s00404-017-4341-9; Margetts BM, 2002, J EPIDEMIOL COMMUN H, V56, P684, DOI 10.1136/jech.56.9.684; Master JS, 2015, J NUTR, V145, P876, DOI 10.3945/jn.114.205724; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Sarvari SI, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005270; Selling KE, 2006, BJOG-INT J OBSTET GY, V113, P430, DOI 10.1111/j.1471-0528.2006.00872.x; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.017, 10.1016/j.preghy.2014.04.007]; Veenendaal MVE, 2013, BJOG-INT J OBSTET GY, V120, P548, DOI 10.1111/1471-0528.12136; Wikstrom AK, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.009	28	4	6	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	MAY	2019	53	5					623	629		10.1002/uog.20119	http://dx.doi.org/10.1002/uog.20119			7	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	HX4RF	30207012	Green Accepted			2022-09-04	WOS:000467387000009
J	Zuluaga, A; Arango-Bustamante, K; Caceres, DH; Sanchez-Quitian, ZA; Velasquez, V; Gomez, BL; Parra-Giraldo, CM; Maldonado, N; Cano, LE; de Bedout, C; Rivera, RE				Zuluaga, Alejandra; Arango-Bustamante, Karen; Caceres, Diego H.; Sanchez-Quitian, Zilpa A.; Velasquez, Veronica; Gomez, Beatriz L.; Parra-Giraldo, Claudia M.; Maldonado, Natalia; Cano, Luz E.; de Bedout, Catalina; Rivera, Raul E.			Concordance analysis between different methodologies used for identification of oral isolates of Candida species	COLOMBIA MEDICA			English	Article						Candida; mouth mucosa; diagnosis; Polymerase Chain Reaction; Spectrometry; Mass; Matrix-Assisted Laser Desorption-Ionization; Colombia	DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; MALDI-TOF MS; VITEK 2; MICROBIOLOGY LABORATORIES; SUSCEPTIBILITY PROFILE; RAPID IDENTIFICATION; CULTURE COLLECTION; PATHOGENIC YEASTS; UNITED-KINGDOM	Background: The yeasts species determination is fundamental not only for an accurate diagnosis but also for establishing a suitable patient treatment. We performed a concordance study of five methodologies for the species identification of oral isolates of Candida in Colombia. Methods: Sixty-seven Candida isolates were tested by; API (R) 20C-AUX, Vitek (R) 2 Compact, Vitek (R) MS, Microflex (R) and a molecular test (panfungal PCR and sequencing). The commercial cost and processing time of the samples was done by graphical analysis. Results: Panfungal PCR differentiated 12 species of Candida, Vitek (R) MS and Microflex (R) methods identified 9 species, and API (R) 20C-AUX and Vitek (R) 2 Compact methods identified 8 species each. Weighted Kappa (wK) showed a high agreement between Panfungal PCR, Vitek (R) MS, Microflex (R) and API (R) 20C-AUX (wK 0.62-0.93). The wK that involved the Vitek (R) 2 Compact method presented moderate or good concordances compared with the other methods (wK 0.56-0.73). Methodologies based on MALDI TOF MS required 4 minutes to generate results and the Microflex (R) method had the lowest selling price. Conclusion: The methods evaluated showed high concordance in their results, being higher for the molecular methods and the methodologies based on MALDI TOF. The latter are faster and cheaper, presenting as promising alternatives for the routine identification of yeast species of the genus Candida.	[Zuluaga, Alejandra; Arango-Bustamante, Karen; Velasquez, Veronica; Gomez, Beatriz L.; Cano, Luz E.; de Bedout, Catalina] CIB, Unidad Micol Med & Expt, Medellin, Colombia; [Caceres, Diego H.] CDC, Mycot Dis Branch, Atlanta, GA 30333 USA; [Sanchez-Quitian, Zilpa A.; Parra-Giraldo, Claudia M.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Grp Enfermedades Infecciosas,Unidad Invest Proteo, Bogota, Colombia; [Gomez, Beatriz L.] Univ Rosario, Escuela Med & Ciencias Salud, Bogota, Colombia; [Maldonado, Natalia] Lab Med Referencia SAS, Grp GERMEN, Medellin, Colombia; [Cano, Luz E.] Univ Antioquia, Escuela Microbiol, Medellin, Colombia; [Rivera, Raul E.] Univ Antonio Narino, Programa Odontol, Armenia Quindio, Colombia		Caceres, DH (corresponding author), CDC, Mycot Dis Branch, Atlanta, GA 30333 USA.	xju7@cdc.gov	Sánchez Quitian, Zilpa Adriana/ABA-8835-2021; Rivera, Raul E/O-1869-2018; Gomez, Beatriz L./D-2612-2018	Sánchez Quitian, Zilpa Adriana/0000-0003-3520-6976; Caceres, Diego H/0000-0001-8749-9809; arango bustamante, karen/0000-0003-1431-0037; Gomez, Beatriz L./0000-0002-6641-1924; Cano, Luz E/0000-0001-5581-3015; Rivera Quiroga, Raul Eduardo/0000-0002-0234-4523; Zuluaga Rodriguez, Alejandra/0000-0001-6199-8570	Universidad Antonio Narino, Quindio, Colombia; Corporacion para Investigaciones Biologicas (CIB), Medellin, Colombia	Universidad Antonio Narino, Quindio, Colombia; Corporacion para Investigaciones Biologicas (CIB), Medellin, Colombia	Universidad Antonio Narino, Quindio, Colombia and Corporacion para Investigaciones Biologicas (CIB), Medellin, Colombia	Albataineh MT, 2016, INFECT DIS CLIN N AM, V30, P13, DOI 10.1016/j.idc.2015.10.014; Amaya-Delgado L, 2013, WORLD J MICROB BIOT, V29, P875, DOI 10.1007/s11274-012-1242-8; Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P76, DOI 10.1111/1469-0691.12360; Arvanitis M, 2014, CLIN MICROBIOL REV, V27, P490, DOI 10.1128/CMR.00091-13; Balleste R, 2005, REV MED URUG, V21, P186; Becton Dickinson and Company, TEST CAN ALB SAB DEX; Becton Dickinson and Company, 2014, BBL CHROMAGAR CAND M; bioMerieux, VITEK 2 COMP YEAST I; bioMerieux, VITEK MS; bioMerieux, API 20 C AUX YEAST I; Borman AM, 2012, J CLIN MICROBIOL, V50, P2639, DOI 10.1128/JCM.00913-12; Brandt ME, 2012, CURR FUNGAL INFECT R, V6, P170, DOI 10.1007/s12281-012-0094-x; Bruker, MALDI TOF MICR; Cendejas-Bueno E, 2012, J CLIN MICROBIOL, V50, P3641, DOI 10.1128/JCM.02248-12; Clinical and Laboratory Standards Institute, 2008, INT CRIT ID BACT FUN; Criseo G, 2015, J MICROBIOL METH, V111, P50, DOI 10.1016/j.mimet.2015.02.004; Crolla A, 2004, J BIOTECHNOL, V110, P73, DOI 10.1016/j.jbiotec.2004.01.007; Estrada-Barraza D, 2011, REV IBEROAM MICOL, V28, P36, DOI 10.1016/j.riam.2010.11.003; Howell SA, 2015, CANDIDA CRYPTOCOCCUS, P1984; Iriart X, 2012, J CLIN MICROBIOL, V50, P2107, DOI 10.1128/JCM.06713-11; Jordana-Lluch E, 2012, ENFERM INFEC MICR CL, V30, P635, DOI 10.1016/j.eimc.2012.01.012; Kathuria S, 2015, J CLIN MICROBIOL, V53, P1823, DOI 10.1128/JCM.00367-15; Lima-Neto R, 2014, BRAZ J MICROBIOL, V45, P515, DOI 10.1590/S1517-83822014000200020; Linton CJ, 2007, J CLIN MICROBIOL, V45, P1152, DOI 10.1128/JCM.02061-06; Liu WC, 2013, J MICROBIOL IMMUNOL, V46, P393, DOI 10.1016/j.jmii.2013.04.007; Lockhart SR, 2009, J CLIN MICROBIOL, V47, P242, DOI 10.1128/JCM.01889-08; Lohmann C, 2013, J CLIN MICROBIOL, V51, P1231, DOI 10.1128/JCM.03268-12; Mancini N, 2013, J CLIN MICROBIOL, V51, P2453, DOI 10.1128/JCM.00841-13; McCarty TP, 2016, INFECT DIS CLIN N AM, V30, P103, DOI 10.1016/j.idc.2015.10.013; Meletiadis J, 2011, J CLIN MICROBIOL, V49, P2722, DOI 10.1128/JCM.01253-10; Ochiuzzi ME, 2014, REV ARGENT MICROBIOL, V46, P107, DOI 10.1016/S0325-7541(14)70057-4; Panda A, 2015, J MICROBIOL METH, V109, P93, DOI 10.1016/j.mimet.2014.12.014; Pinto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025712; Romi W, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-52; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; Stefaniuk E, 2016, POL J MICROBIOL, V65, P111, DOI 10.5604/17331331.1197283; Tan KE, 2012, J CLIN MICROBIOL, V50, P3301, DOI 10.1128/JCM.01405-12; Tay ST, 2014, MYCOPATHOLOGIA, V178, P307, DOI 10.1007/s11046-014-9778-9; Vijayakumar Ramraj, 2012, J Lab Physicians, V4, P1, DOI 10.4103/0974-2727.98661; Voigt K, 1999, J CLIN MICROBIOL, V37, P3957, DOI 10.1128/JCM.37.12.3957-3964.1999; White T.J., 1990, PCR PROTOC GUIDE MET, P315	41	1	2	0	1	CORPORACION EDITORA MEDICA VALLE	CALI	UNIV VALLE, BLDG 118 FACULTY HEALTH, CALLE 4B 36-00, CALI, 00000, COLOMBIA	1657-9534			COLOMB MEDICA	Colomb. Medica	JUL-SEP	2018	49	3					193	200		10.25100/cm.v49i3.3774	http://dx.doi.org/10.25100/cm.v49i3.3774			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY7UQ	30410193	Green Published, Green Submitted, hybrid			2022-09-04	WOS:000448821800002
J	Botero-Trujillo, R; Gonzalez-Gomez, JC; Valenzuela-Rojas, JC; Garcia, LF				Botero-Trujillo, Ricardo; Gonzalez-Gomez, Julio; Valenzuela-Rojas, Juan; Garcia, Luis			A new species in the troglomorphic scorpion genus Troglotayosicus from Colombia, representing the northernmost known record for the genus (Scorpiones, Troglotayosicidae)	ZOOTAXA			English	Article						Forest leaf litter; troglomorphism; taxonomy; Rivera; Huila	CLASSIFICATION; PHYLOGENY	We describe a new scorpion species in the troglomorphic genus Troglotayosicus Lourenco, 1981 from Colombia. Troglotayosicus meijdeni sp. nov. inhabits the forest leaf litter at Rivera municipality, on the western slope of the Eastern Andes. The male of the new species remains unknown; however, this species can be distinguished from other species in the genus by the female (and juvenile) morphology. The type locality of T. meijdeni sp. nov. represents the northernmost known record for a population of Troglotayosicus, further extending the known limits of distribution of this genus, and shedding more light on the distributional range of this group of scorpions in northwestern South America. With this description, the number of known species of Troglotayosicus is raised to four; three of them are endogean species living in forested areas in the Andean region of Colombia, whereas one is a hypogean species from a cave in Ecuadorian Amazonia.	[Botero-Trujillo, Ricardo] Museo Argentino Ciencias Nat Bernardino Rivadavia, CONICET, Div Aracnol, Ave Angel Gallardo 470,CP 1405DJR, Buenos Aires, DF, Argentina; [Gonzalez-Gomez, Julio; Valenzuela-Rojas, Juan; Garcia, Luis] Corp Huiltur, Grp Invest BEA, Carrera 5 8-67, Neiva, Huila, Colombia; [Valenzuela-Rojas, Juan] Univ Tolima, Grp Invest Zool, Ibague, Tolima, Colombia; [Garcia, Luis] Univ Republ, Ctr Univ Reg Este, Simon del Pino 1132, Treinta Tres, Uruguay; [Botero-Trujillo, Ricardo] Pontificia Univ Javeriana, Dept Biol, Unidad Ecol & Sistemat UNESIS, Entomol Lab, Bogota, Colombia; [Garcia, Luis] Inst Invest Biol Clemente Estable, Lab Ecol Comportamiento, Ave Italia 3318, Montevideo, Uruguay		Botero-Trujillo, R (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, CONICET, Div Aracnol, Ave Angel Gallardo 470,CP 1405DJR, Buenos Aires, DF, Argentina.; Botero-Trujillo, R (corresponding author), Pontificia Univ Javeriana, Dept Biol, Unidad Ecol & Sistemat UNESIS, Entomol Lab, Bogota, Colombia.	rbt@macn.gov.ar	Gómez, Julio César González/ABE-2874-2020; Garcia, Luis F/H-9134-2017	Gómez, Julio César González/0000-0002-7672-6858; Valenzuela-Rojas, Juan Carlos/0000-0002-7425-0753; Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318; Garcia, Luis/0000-0001-8882-6226	3-year Doctoral Fellowship from the "Fondo para la Investigacion Cientifica y TecnologicaFONCyT", Argentina [PICT 2011-01007]; 2-year Doctoral Fellowship from the "Consejo Nacional de Investigaciones Cientificas y Tecnicas-CONICET", Argentina; "Agencia Nacional de Investigacion e Innovacion-ANII", Uruguay [8880]; Huiltur (Vigias del Patrimonio Cultural-Grupo Huiltur); Hotel Americano (Neiva, Colombia); Entomopixel (owner David Guzman);  [PICT 2011-1007];  [PIP 20120943]	3-year Doctoral Fellowship from the "Fondo para la Investigacion Cientifica y TecnologicaFONCyT", Argentina; 2-year Doctoral Fellowship from the "Consejo Nacional de Investigaciones Cientificas y Tecnicas-CONICET", Argentina; "Agencia Nacional de Investigacion e Innovacion-ANII", Uruguay; Huiltur (Vigias del Patrimonio Cultural-Grupo Huiltur); Hotel Americano (Neiva, Colombia); Entomopixel (owner David Guzman); ; 	We thank Dimitri Forero (MPUJ) for allowing access to specimens of Troglotayosicus under his care. We are grateful to Camilo I. Mattoni and two anonymous referees for providing constructive feedback. JCGG and JCVR are especially thankful to Angel Aparicio Palud for allowing entry into his property, and along with James Lopez Velez, Rodrigo Gonzalez and Lorena A. Cardozo, for their hospitality and assistance at their needs in the field. Juan P. Ramirez assisted with the generation of the map. RBT was initially supported by a 3-year Doctoral Fellowship associated to PICT 2011-01007 from the "Fondo para la Investigacion Cientifica y TecnologicaFONCyT", Argentina, and currently by a 2-year Doctoral Fellowship from the "Consejo Nacional de Investigaciones Cientificas y Tecnicas-CONICET", Argentina. LFG was supported by grant 8880 from the "Agencia Nacional de Investigacion e Innovacion-ANII", Uruguay. Field work was conducted with partial support from Huiltur (Vigias del Patrimonio Cultural-Grupo Huiltur), Hotel Americano (Neiva, Colombia), and Entomopixel (owner David Guzman). Financial support was also received from PICT 2011-1007 and PIP 20120943 to Martin J. Ramirez (MACN).	Botero-Trujillo R, 2009, TEXAS MEMORIAL MUSEU, V7, P1; Botero-Trujillo R, 2012, ZOOTAXA, P63; Cloudsley-Thompson J.L, 1968, SPIDERS SCORPIONS CE; Loria SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112913; LOURENCO W R, 1981, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V3, P635; Lourenco Wilson R., 1998, Biogeographica (Paris), V74, P133; McCormick S., 1990, Biology of scorpion, P145; Ochoa JA, 2010, AM MUS NOVIT, P1, DOI 10.1206/707.1; POLIS GA, 1980, BEHAV ECOL SOCIOBIOL, V7, P25, DOI 10.1007/BF00302515; Prendini L, 2005, CLADISTICS, V21, P446, DOI 10.1111/j.1096-0031.2005.00073.x; Prendini L, 2004, J ARACHNOL, V32, P109, DOI 10.1636/H03-17; Prendini L, 2000, CLADISTICS, V16, P1, DOI 10.1111/j.1096-0031.2000.tb00348.x; Prendini L., 2009, CLADISTICS, V25, P1; Sissom W.D., 1990, P445; STAHNKE H L, 1970, Entomological News, V81, P297; STAHNKE HL, 1972, BIOSCIENCE, V22, P604, DOI 10.2307/1296207; Vachon M., 1974, B MUSEUM NATL DHISTO, V3, P857; Vachon M., 1952, ETUDE SCORPIONS; VACHON MAX, 1963, BULL MUS NAT HIST NATUR, V35, P161; Vignoli Valerio, 2009, Bulletin of the American Museum of Natural History, V326, P1	20	2	3	0	1	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	MAR 22	2017	4244	4					568	582		10.11646/zootaxa.4244.4.7	http://dx.doi.org/10.11646/zootaxa.4244.4.7			15	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	EQ4DC	28610102				2022-09-04	WOS:000398023000007
J	Lasso, P; Cardenas, C; Guzman, F; Rosas, F; Thomas, MC; Lopez, MC; Gonzalez, JM; Cuellar, A; Campanera, JM; Luque, FJ; Puerta, CJ				Lasso, Paola; Cardenas, Constanza; Guzman, Fanny; Rosas, Fernando; Carmen Thomas, Maria; Carlos Lopez, Manuel; Mario Gonzalez, John; Cuellar, Adriana; Maria Campanera, Josep; Javier Luque, F.; Judith Puerta, Concepcion			Effect of secondary anchor amino acid substitutions on the immunogenic properties of an HLA-A*0201-restricted T cell epitope derived from the Trypanosoma cruzi KMP-11 protein	PEPTIDES			English	Article						CD8(+) T cells; Chagas disease; Peptides; MHC class I	MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I; PEPTIDE; ANTIGEN; BINDING; HLA-A2; IMMUNODOMINANCE; SPECIFICITY; GENERATION; DATABASE	The TcTLE peptide (TLEEFSAKL) is a CD8(+) T cell HLA-A*0201-restricted epitope derived from the Trypanosoma cruzi KMP-11 protein that is efficiently processed, presented and recognized by CD8(+) T cells from chagasic patients. Since the immunogenic properties of wild-type epitopes may be enhanced by suitable substitutions in secondary anchor residues, we have studied the effect of introducing specific mutations at position 3, 6 and 7 of the TcTLE peptide. Mutations (E3L, S6V and A7F) were chosen on the basis of in silico predictions and in vitro assays were performed to determine the TcTLE-modified peptide binding capacity to the HLA-A*0201 molecule. In addition, the functional activity of peptide-specific CD8(+) T cells in HLA-A2(+) chagasic patients was also interrogated. In contrast to bioinformatics predictions, the TcTLE-modified peptide was found to have lower binding affinity and stability than the original peptide. Nevertheless, CD8(+) T cells from chronic chagasic patients recognized the TcTLE-modified peptide producing TNF-alpha and INF-gamma and expressing CD107a/b, though in less extension than the response triggered by the original peptide. Overall, although the amino acids at positions 3, 6 and 7 of TcTLE are critical for the peptide affinity, they have a limited effect on the immunogenic properties of the TcTLE epitope. (C) 2016 Elsevier Inc. All rights reserved.	[Lasso, Paola; Judith Puerta, Concepcion] Pontificia Univ Javeriana, Lab Parasitol Mol, Carrera 7 43-82, Bogota, Colombia; [Lasso, Paola; Cuellar, Adriana] Pontificia Univ Javeriana, Grp Inmunobiol & Biol Celular, Carrera 7 43-82, Bogota, Colombia; [Lasso, Paola; Carmen Thomas, Maria; Carlos Lopez, Manuel] IPBLN CSIC, Parque Tecnol Ciencias Salud,Ave Conocimiento S-N, Granada 18016, Spain; [Cardenas, Constanza; Guzman, Fanny] Pontificia Univ Catolica Valparaiso, Nucleo Biotecnol Curauma, Ave Univ 330, Valparaiso, Chile; [Rosas, Fernando] Fdn Clin Abood Shaio, Inst Arritmias Joseph Brugada, Diagonal 115A 70C-75, Bogota, Colombia; [Mario Gonzalez, John] Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Carrera 1 18A-10, Bogota, Colombia; [Maria Campanera, Josep; Javier Luque, F.] Univ Barcelona, Fac Farm, Dept Fisicoquim, E-08028 Barcelona, Spain; [Maria Campanera, Josep; Javier Luque, F.] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain		Puerta, CJ (corresponding author), Carrera 7a 43-82,Ed 50,Lab 113, Bogota 110211, Colombia.	cpuerta@javeriana.edu.co	Puerta, Concepcion J/AAG-4912-2019; Cuellar, Adriana/AAF-2958-2019; Lopez, Manuel/Z-5641-2019; Zaky, Mohammad/I-3187-2017; Thomas, María Carmen PhD/D-9065-2016; Cárdenas, Constanza/ABA-6477-2021; Luque, F. Javier/L-9652-2014; Guzman, Fanny fg/K-5592-2013	Zaky, Mohammad/0000-0003-3547-2588; Luque, F. Javier/0000-0002-8049-3567; Guzman, Fanny fg/0000-0003-1537-0904; Thomas, M Carmen/0000-0003-3586-9657; Lopez, Manuel Carlos/0000-0003-0002-3678; Cuellar, Adriana/0000-0003-0834-8442; Mursalin, Adi/0000-0002-1867-0868; Puerta Bula, Concepcion Judith/0000-0002-3449-3961	Programa Estatal I+D+i (MINECO) [SAF2012-35777, SAF2013-48527-R, RTC-2014-2130]; Network of Tropical Diseases Research RICET; FEDER	Programa Estatal I+D+i (MINECO); Network of Tropical Diseases Research RICET; FEDER(European Commission)	We thank the patients who participated in this study. This work belongs to the project "Analisis de la respuesta inmune celular frente a epitopos analogos del peptido K1 de Trypanosome cruzi" supported by Pontificia Universidad Javeriana through "Apoyo a los programas de doctorado 2011" [PUJ ID PROP. 5249; ID PROY. 5132]. MCT and MCL were supported by grants SAF2012-35777, SAF2013-48527-R and RTC-2014-2130 from Programa Estatal I+D+i (MINECO); Network of Tropical Diseases Research RICET, grants RD12/0018/0021 and FEDER.	Andersen MH, 2000, TISSUE ANTIGENS, V55, P519, DOI 10.1034/j.1399-0039.2000.550603.x; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P519; Blanchard N, 2010, ANN NY ACAD SCI, V1183, P237, DOI 10.1111/j.1749-6632.2009.05135.x; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Cardenas C, 2010, J COMPUT AID MOL DES, V24, P1035, DOI 10.1007/s10822-010-9387-8; CASE D, 2012, AMBER 12, V1, P3; Chen WS, 2006, ADV CANCER RES, V95, P203, DOI 10.1016/S0065-230X(06)95006-4; Cifuentes G, 2005, VACCINE, V23, P1579, DOI 10.1016/j.vaccine.2004.08.052; Cubillos M, 2003, PROTEINS, V50, P400, DOI 10.1002/prot.10314; DOIG AJ, 1995, PROTEIN SCI, V4, P2247, DOI 10.1002/pro.5560041101; Doytchinova I, 2003, ORG BIOMOL CHEM, V1, P2648, DOI 10.1039/b300707c; Egui A, 2012, MOL IMMUNOL, V52, P289, DOI 10.1016/j.molimm.2012.05.021; Espejo F, 2001, ANGEW CHEM INT EDIT, V40, P4654, DOI 10.1002/1521-3773(20011217)40:24<4654::AID-ANIE4654>3.0.CO;2-F; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Feliu V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003449; Froloff N, 1997, PROTEIN SCI, V6, P1293, DOI 10.1002/pro.5560060617; Garg N, 1997, J IMMUNOL, V158, P3293; Goldszmid RS, 2010, CURR OPIN IMMUNOL, V22, P118, DOI 10.1016/j.coi.2010.01.017; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064365; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Insaidoo FK, 2011, J BIOL CHEM, V286, P40163, DOI 10.1074/jbc.M111.283564; Jofre C, 2011, PEPTIDES, V32, P852, DOI 10.1016/j.peptides.2011.01.026; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph MA, 2007, MOL IMMUNOL, V44, P322, DOI 10.1016/j.molimm.2006.02.027; Knapp B, 2008, PROTEIN SCI, V17, P977, DOI 10.1110/ps.073402508; Knapp B, 2009, J COMPUT AID MOL DES, V23, P301, DOI 10.1007/s10822-009-9259-2; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; Lasso P, 2010, PARASITE IMMUNOL, V32, P494, DOI 10.1111/j.1365-3024.2010.01206.x; Lasso P, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-198; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Mahnke YD, 2007, CLIN LAB MED, V27, P469, DOI 10.1016/j.cII.2007.05.002; Maranon C, 2001, MOL IMMUNOL, V38, P279, DOI 10.1016/S0161-5890(01)00059-1; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; PARKER KC, 1994, J IMMUNOL, V152, P163; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Saunders PM, 2011, TISSUE ANTIGENS, V78, P161, DOI 10.1111/j.1399-0039.2011.01735.x; Schrodinger, PYMOL MOL GRAPH SYST; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; SUDO T, 1995, J IMMUNOL, V155, P4749; Tangri S, 2001, J EXP MED, V194, P833, DOI 10.1084/jem.194.6.833; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	53	6	6	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0196-9781	1873-5169		PEPTIDES	Peptides	APR	2016	78						68	76		10.1016/j.peptides.2016.02.002	http://dx.doi.org/10.1016/j.peptides.2016.02.002			9	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	DH3WY	26854383				2022-09-04	WOS:000372718700009
J	Ledien, J; Cucunuba, ZM; Parra-Henao, G; Rodriguez-Mongui, E; Dobson, AP; Basanez, MG; Nouvellet, P				Ledien, Julia; Cucunuba, Zulma M.; Parra-Henao, Gabriel; Rodriguez-Mongui, Eliana; Dobson, Andrew P.; Basanez, Maria-Gloria; Nouvellet, Pierre			Spatiotemporal variations in exposure: Chagas disease in Colombia as a case study	BMC MEDICAL RESEARCH METHODOLOGY			English	Article						Force of infection; Model averaging; Chagas disease; Infectious disease; Modelling	EVOLUTION; PATTERNS; ECOLOGY; BURDEN	Age-stratified serosurvey data are often used to understand spatiotemporal trends in disease incidence and exposure through estimating the Force-of-Infection (FoI). Typically, median or mean FoI estimates are used as the response variable in predictive models, often overlooking the uncertainty in estimated FoI values when fitting models and evaluating their predictive ability. To assess how this uncertainty impact predictions, we compared three approaches with three levels of uncertainty integration. We propose a performance indicator to assess how predictions reflect initial uncertainty. In Colombia, 76 serosurveys (1980-2014) conducted at municipality level provided age-stratified Chagas disease prevalence data. The yearly FoI was estimated at the serosurvey level using a time-varying catalytic model. Environmental, demographic and entomological predictors were used to fit and predict the FoI at municipality level from 1980 to 2010 across Colombia. A stratified bootstrap method was used to fit the models without temporal autocorrelation at the serosurvey level. The predictive ability of each model was evaluated to select the best-fit models within urban, rural and (Amerindian) indigenous settings. Model averaging, with the 10 best-fit models identified, was used to generate predictions. Our analysis shows a risk of overconfidence in model predictions when median estimates of FoI alone are used to fit and evaluate models, failing to account for uncertainty in FoI estimates. Our proposed methodology fully propagates uncertainty in the estimated FoI onto the generated predictions, providing realistic assessments of both central tendency and current uncertainty surrounding exposure to Chagas disease.	[Ledien, Julia; Nouvellet, Pierre] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Cucunuba, Zulma M.; Basanez, Maria-Gloria] Imperial Coll London, London Ctr Neglected Trop Dis Res, London, England; [Cucunuba, Zulma M.; Basanez, Maria-Gloria] Imperial Coll London, MRC Ctr Global Infect Dis Anal, London, England; [Cucunuba, Zulma M.] Univ Javeriana, Fac Med, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia; [Parra-Henao, Gabriel] Univ Cooperat Colombia, Ctr Invest Salud El Trop, Santa Marta, Colombia; [Parra-Henao, Gabriel] Natl Inst Hlth, Bogota, Colombia; [Rodriguez-Mongui, Eliana] Pan Americana Hlth Org PAHO, Neglected Trop & Vector Borne Dis Program, Bogota, Colombia; [Dobson, Andrew P.] Princeton Univ, Ecol & Evolutionary Biol, Princeton, NJ USA		Ledien, J (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	j.ledien@sussex.ac.uk	Parra-Henao, Gabriel/Q-1535-2016; Cucunuba, Zulma M/X-5670-2019	Parra-Henao, Gabriel/0000-0003-4535-6521; Cucunuba, Zulma M/0000-0002-8165-3198; Basanez, Maria-Gloria/0000-0001-5031-3361; nouvellet, pierre/0000-0002-6094-5722; Ledien, Julia/0000-0002-6116-8371	UK Medical Research Council (MRC) [MR/R015600/1]; UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; European Union; School of Life Sciences, University of Sussex PhD Studentship	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); School of Life Sciences, University of Sussex PhD Studentship	M.G.B. acknowledges joint centre funding (grant No. MR/R015600/1) by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement which is also part of the European and Developing Countries Clinical Trials Partnership (EDCTP2) programme supported by the European Union. J.L. was funded by the School of Life Sciences, University of Sussex PhD Studentship to P.N.	Abubakar I., 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Alleman MM, 2016, VACCINE, V34, P6502, DOI 10.1016/j.vaccine.2016.10.059; Alvarez-Berrios NL, 2013, AMBIO, V42, P29, DOI 10.1007/s13280-012-0344-8; Beck HE, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.214; Behrend MR, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008033; Bivand RS, 2018, TEST-SPAIN, V27, P716, DOI 10.1007/s11749-018-0599-x; Cattarino L, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax4144; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Cucunuba Zulma M, 2017, BMJ Glob Health, V2, pe000345, DOI 10.1136/bmjgh-2017-000345; Cucunuba ZM, 2017, SOC SCI MED, V175, P187, DOI 10.1016/j.socscimed.2017.01.002; Feliciangeli MD, 2003, TRENDS PARASITOL, V19, P44, DOI 10.1016/S1471-4922(02)00013-2; Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Giorgi E, 2017, J STAT SOFTW, V78, P1, DOI 10.18637/jss.v078.i08; Hachiya M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194931; Levy MZ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1003; Massad E, 2008, EPIDEMIOL INFECT, V136, P1153, DOI 10.1017/S0950268807009879; Montgomery D.C., 2012, INTRO LINEAR REGRESS; Muench H., 2013, CATALYTIC MODELS EPI, DOI [10.4159/harvard.9780674428928, DOI 10.4159/HARVARD.9780674428928]; Nealon J, 2022, J INFECT DIS, V225, P75, DOI 10.1093/infdis/jiaa132; Nouvellet P, 2015, ADV PARASIT, V87, P135, DOI 10.1016/bs.apar.2014.12.004; O'Driscoll M, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008102; Oficina Sanitaria Panamericana Encuentro Continental de Educacion Medica, 1995, EDUCACION PRACTICA M; Parra-Henao G., 2015, COLOMBIAN CHAGAS NET; Parra-Henao Gabriel, 2016, J Trop Med, V2016, P1439090, DOI 10.1155/2016/1439090; Parra-Henao G, 2016, AM J TROP MED HYG, V94, P767, DOI 10.4269/ajtmh.15-0197; Parra-Henao GJ., 2013, RED CHAGAS COLOMBIA, V1era, P127; Dias JCP, 2015, GLOB HEART, V10, P193, DOI 10.1016/j.gheart.2015.06.003; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; SCHULTZ TP, 1971, REV ECON STAT, V53, P157, DOI 10.2307/1925711; Stanaway JD, 2015, GLOB HEART, V10, P139, DOI 10.1016/j.gheart.2015.06.001; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6	33	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	JAN 13	2022	22	1							13	10.1186/s12874-021-01477-6	http://dx.doi.org/10.1186/s12874-021-01477-6			12	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	YG3BO	35027002	Green Published, gold			2022-09-04	WOS:000742367600001
J	McKee, GB; Perrin, PB; Rodriguez-Agudelo, Y; Plaza, SLO; Quijano-Martinez, MC; Kuzu, D; Ohayagha, C; Pugh, M; Arango-Lasprilla, JC				McKee, Grace B.; Perrin, Paul B.; Rodriguez-Agudelo, Yaneth; Olivera Plaza, Silvia Leonor; Quijano-Martinez, Maria Cristina; Kuzu, Duygu; Ohayagha, Chimdindu; Pugh, Mickeal; Arango-Lasprilla, Juan Carlos			Suicidal Ideation After Acute Traumatic Brain Injury: A Longitudinal Actor-Partner Interdependence Model of Patients and Caregivers in Latin America	REHABILITATION PSYCHOLOGY			English	Article						TBI; suicidal ideation; family caregivers; Latin America	FAMILY CARERS; HEAD-INJURY; DEPRESSION; PEOPLE; BURDEN; RISK; DISORDERS; PREDICTORS; DEMENTIA; CONTEXT	Impact and Implications The current study highlights the importance of screening for suicidal ideation for both individuals with traumatic brain injury (TBI) and their caregivers, as findings suggest that thoughts of death and/or suicide are relatively common among both patients and caregivers up to a year post-injury. Moreover, patient suicidal ideation at hospitalization is predictive of reported caregiver suicidal ideation at later time points. Clinicians and rehabilitation specialists may wish to expanding practices of assessing suicide risk in patients to include caregivers, particularly caregivers of patients who endorsed suicidal ideation. Given that these findings demonstrate significant interdependence of suicidality between patients and caregivers, interventions for patients with TBI should include their respective caregivers or even incorporate family systems theories and approaches. Purpose/Objective: Traumatic brain injury (TBI) is associated with depression, anxiety, and even suicidality in individuals with TBI and in caregivers. Moreover, emotional functioning in individuals with TBI is linked with caregiver functioning. However, no known studies to date have examined linkages in suicidal ideation in individuals with TBI and family caregivers. This is especially important in Latin America, where TBI rates are high, and where cultural norms influence family caregiving. This study examined associations among self-reported suicidal ideation in individuals with TBI and their primary caregivers over time in Mexico and Colombia. Research Method/Design: A total of 109 individuals and their primary caregivers completed measures during hospitalization for TBI and at 2- and 4-months posthospitalization. The primary outcome was Item 9 from the Spanish version of the Patient Health Questionnaire-9, assessing for thoughts of death or suicide in the previous 2 weeks. Results: Patients and caregivers reported high levels of suicidal ideation (18.3%-22.4% and 12.4%-15.7%, respectively) at each time point, and suicidal ideation at one time point strongly predicted ideation at the next. When patients endorsed suicidal ideation in the hospital, their caregivers tended to endorse suicidal ideation 2 months later. Although unaccounted for variables could be driving these relationships, they may also provide possible evidence of causal preponderance between patient and caregiver suicidal ideation post-TBI. Conclusions/Implications: Clinicians and rehabilitation specialists can use these findings to inform suicide risk assessment by expanding these practices to caregivers of patients who endorsed suicidal ideation. Interventions after TBI should incorporate caregivers given this study showed significant interdependence of suicidality between patients and caregivers.	[McKee, Grace B.] Cent Virginia Vet Affairs Hlth Care Syst, Midatlantic Mental Illness Res Educ & Clin Ctr, Adv Fellowship Program Mental Illness Res & Treat, Richmond, VA USA; [McKee, Grace B.; Perrin, Paul B.; Kuzu, Duygu; Ohayagha, Chimdindu; Pugh, Mickeal] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Perrin, Paul B.] Cent Virginia Vet Affairs Hlth Care Syst, Polytrauma Rehabil Ctr, Richmond, VA USA; [Rodriguez-Agudelo, Yaneth] Natl Inst Neurol & Neurosurg, Dept Neuropsychol, Ciudad De Mexico, Mexico; [Olivera Plaza, Silvia Leonor] Univ Surcolombiana, Grp Invest Carlos Finlay, Neiva, Colombia; [Quijano-Martinez, Maria Cristina] Pontificia Univ Javeriana Cali, Dept Social Sci, Cali, Colombia; [Kuzu, Duygu] Istanbul Arel Univ, Dept Psychol, Istanbul, Turkey; [Arango-Lasprilla, Juan Carlos] BioCruces Bizkaia Hlth Res Inst, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain; [Arango-Lasprilla, Juan Carlos] Basque Fdn Sci, Ikerbasque, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), BioCruces Bizkaia Hlth Res Inst, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain.	jcalasprilla@gmail.com	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X; McKee, Grace/0000-0001-5823-203X; Kuzu, Duygu/0000-0002-1134-1551	Fogarty International Center of the National Institutes of Health [R21TW009746]; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; Medical Research and Mental Health Services of the Veterans Affairs Central Virginia Health Care System; Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC)	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment(US Department of Veterans Affairs); Medical Research and Mental Health Services of the Veterans Affairs Central Virginia Health Care System; Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC)(US Department of Veterans Affairs)	This study was funded by Grant R21TW009746 from Fogarty International Center of the National Institutes of Health and was supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Medical Research and Mental Health Services of the Veterans Affairs Central Virginia Health Care System, and the Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC).	Antonucci T. C., 2001, APPL DEV SCI, V5, P68, DOI [10.1207/S1532480XADS0502_2, DOI 10.1207/S1532480XADS0502_2, 10.1207/s1532480xads0502_2]; Bethune A, 2017, ARCH SUICIDE RES, V21, P392, DOI 10.1080/13811118.2016.1199990; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Buhse M, 2008, J NEUROSCI NURS, V40, P25, DOI 10.1097/01376517-200802000-00005; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Finkelstein E.., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Fortuna LR, 2007, J CLIN PSYCHIAT, V68, P572, DOI 10.4088/JCP.v68n0413; Garza MJ, 2010, SUICIDE LIFE-THREAT, V40, P561, DOI 10.1521/suli.2010.40.6.561; Gulin SL, 2014, FAM SYST HEALTH, V32, P53, DOI 10.1037/a0032623; Hostetter TA, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000489; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hui SKA, 2007, REHABIL PSYCHOL, V52, P113, DOI 10.1037/0090-5550.52.1.113; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kashy D. A., 2000, HDB RES METHODS SOCI, P451, DOI DOI 10.1017/CBO9780511996481; Kenny D.A, LONGITUDINAL MODELS; Kenny D.A, 2014, WILEY STATSREF STAT, DOI [10.1002/9781118445112.stat06464, DOI 10.1002/9781118445112.STAT06464]; Kenny DA, 1996, J SOC PERS RELAT, V13, P279, DOI 10.1177/0265407596132007; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Murray C.J.L., 1996, GLOBAL BURDEN DIS CO, V1; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; Nolle AP, 2012, AM J ORTHOPSYCHIAT, V82, P319, DOI 10.1111/j.1939-0025.2012.01166.x; O'Dwyer S, 2013, AGING MENT HEALTH, V17, P753, DOI 10.1080/13607863.2013.789001; O'Dwyer ST, 2016, AGING MENT HEALTH, V20, P222, DOI 10.1080/13607863.2015.1063109; O'Dwyer ST, 2013, INT J GERIATR PSYCH, V28, P1182, DOI 10.1002/gps.3941; Park B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060230; PAVOT W, 1993, SOC INDIC RES, V28, P1, DOI 10.1007/BF01086714; Pena JB, 2011, SUICIDE LIFE-THREAT, V41, P330, DOI 10.1111/j.1943-278X.2011.00032.x; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G.K., 2019, SUICIDE PREVENTION N, P107; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Stevens LF, 2012, NEUROREHABILITATION, V31, P443, DOI 10.3233/NRE-2012-00815; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Voracek M, 2007, WIEN KLIN WOCHENSCHR, V119, P463, DOI 10.1007/s00508-007-0823-2; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wheaton B., 1977, SOCIOLOGICAL METHODO, V8, P84, DOI [10.2307/270754, DOI 10.2307/270754]; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013	58	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					433	441		10.1037/rep0000395	http://dx.doi.org/10.1037/rep0000395			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	34871029				2022-09-04	WOS:000725826700015
J	Guevara-Morales, JM; Frohbergh, M; Castro-Abril, H; Vaca-Gonzalez, JJ; Barrera, LA; Garzon-Alvarado, DA; Schuchman, E; Simonaro, C				Guevara-Morales, Johana M.; Frohbergh, Michael; Castro-Abril, Hector; Vaca-Gonzalez, Juan J.; Barrera, Luis A.; Garzon-Alvarado, Diego A.; Schuchman, Edward; Simonaro, Calogera			Growth Plate Pathology in the Mucopolysaccharidosis Type VI Rat Model-An Experimental and Computational Approach	DIAGNOSTICS			English	Article						mucopolysaccharidosis type VI; growth plate histology; columnar arrangement; skeletal dysplasia; growth plate computational model	BIOMECHANICAL PROPERTIES; EXTRACELLULAR-MATRIX; JOINT DISEASE; ANIMAL-MODELS; LUMBAR SPINE; BONE; CARTILAGE; DECORIN; PROTEOGLYCANS; OSSIFICATION	Background: Mucopolysaccharidoses (MPS) are a group of inherited metabolic diseases caused by impaired function or absence of lysosomal enzymes involved in degradation of glycosaminoglycans. Clinically, MPS are skeletal dysplasias, characterized by cartilage abnormalities and disturbances in the process of endochondral ossification. Histologic abnormalities of growth cartilage have been reported at advanced stages of the disease, but information regarding growth plate pathology progression either in humans or in animal models, as well as its pathophysiology, is limited. Methods: Histological analyses of distal femur growth plates of wild type (WT) and mucopolysaccharidosis type VI (MPS VI) rats at different stages of development were performed, including quantitative data. Experimental findings were then analyzed in a theoretical scenario. Results: Histological evaluation showed a progressive loss of histological architecture within the growth plate. Furthermore, in silico simulation suggest the abnormal cell distribution in the tissue may lead to alterations in biochemical gradients, which may be one of the factors contributing to the growth plate abnormalities observed, highlighting aspects that must be the focus of future experimental works. Conclusion: The results presented shed some light on the progression of growth plate alterations observed in MPS VI and evidence the potentiality of combined theoretical and experimental approaches to better understand pathological scenarios, which is a necessary step to improve the search for novel therapeutic approaches.	[Guevara-Morales, Johana M.] Pontificia Univ, Inst Study Inborn Errors Metab, IEIM, Bogota 4665684, Colombia; [Frohbergh, Michael] Exponent Inc, Philadelphia, PA 19104 USA; [Castro-Abril, Hector; Garzon-Alvarado, Diego A.] Univ Nacl Colombia, Numer Methods & Modeling Res Grp GNUM, Biomimet Lab, Bogota 4665684, Colombia; [Vaca-Gonzalez, Juan J.] Fdn Univ Area Andina, Sch Hlth & Sports Sci, Nefertiti Wellness & New Technol Grp, Bogota 4665684, Colombia; [Barrera, Luis A.] Pontificia Univ, Inst Study Inborn Errors Metab, Hosp Univ San Ignacio, Javeriana Clin Inborn Errors Metab CEIM,IEM, Bogota 4665684, Colombia; [Schuchman, Edward; Simonaro, Calogera] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA		Guevara-Morales, JM (corresponding author), Pontificia Univ, Inst Study Inborn Errors Metab, IEIM, Bogota 4665684, Colombia.	Johana.guevara@javeriana.edu.co; mfrohbergh@exponent.com; hacastroa@unal.edu.co; jvaca8@areandina.edu.co; abarrera@javeriana.edu.co; dagarzona@unal.edu.co; edward.schuchman@mssm.edu; calogera.simonaro@mssm.edu		Garzon, Diego/0000-0003-0072-3738; Frohbergh, Michael/0000-0002-0167-116X	PONTIFICIA UNIVERSIDAD JAVERIA [5633]; COLCIENCIAS	PONTIFICIA UNIVERSIDAD JAVERIA; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This research was funded by PONTIFICIA UNIVERSIDAD JAVERIA, Project No. 5633, and J.G. received funding from COLCIENCIAS for completing a Ph.D program.	ABREU S, 1995, CALCIFIED TISSUE INT, V57, P185, DOI 10.1007/BF00310256; Al-Sannaa NA, 2018, J COMMUN GENET, V9, P65, DOI 10.1007/s12687-017-0329-1; Alini M, 2001, MATRIX BIOL, V19, P805, DOI 10.1016/S0945-053X(00)00129-3; Alliston T, 2010, J PEDIATR REHAB MED, V3, P129, DOI 10.3233/PRM-2010-0117; Amini S, 2013, BIOMECH MODEL MECHAN, V12, P67, DOI 10.1007/s10237-012-0382-y; ANDERSON CE, 1962, J BONE JOINT SURG AM, V44, P295, DOI 10.2106/00004623-196244020-00006; [Anonymous], **NON-TRADITIONAL**; Arita M, 2015, AM J PATHOL, V185, P214, DOI 10.1016/j.ajpath.2014.09.003; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Ballock RT, 2003, J BONE JOINT SURG AM, V85A, P715, DOI 10.2106/00004623-200304000-00021; Burdan F, 2009, FOLIA HISTOCHEM CYTO, V47, P5, DOI 10.2478/v10042-009-0007-1; BUTLER WF, 1971, BIOCHEM J, V122, P647, DOI 10.1042/bj1220647; Castro-Abril HA, 2017, J THEOR BIOL, V428, P87, DOI 10.1016/j.jtbi.2017.05.015; Chau M, 2011, J MOL ENDOCRINOL, V47, P99, DOI 10.1530/JME-10-0177; Cormark D.H, 1987, HAMS HISTOLOGY, V9th; Cowin S.C., 2007, CARTILAGE TISSUE MEC, P471; De Franceschi L, 2007, OSTEOARTHR CARTILAGE, V15, P1311, DOI 10.1016/j.joca.2007.04.008; de Oliveira PG, 2013, INT J EXP PATHOL, V94, P305, DOI 10.1111/iep.12033; Eliyahu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022447; Frohbergh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100882; Gentili C, 2009, CURR PHARM DESIGN, V15, P1334, DOI 10.2174/138161209787846739; Giugliani R, 2010, GENET MOL BIOL, V33, P589, DOI 10.1590/S1415-47572010005000093; Guevara JM, 2015, COMPUT METH PROG BIO, V118, P59, DOI 10.1016/j.cmpb.2014.10.007; Gustafsson E, 2003, ANN NY ACAD SCI, V995, P140, DOI 10.1111/j.1749-6632.2003.tb03217.x; Haskins M, 2002, ACTA PAEDIATR, V91, P88, DOI 10.1080/080352502762458003; Haskins ME, 2007, ACTA PAEDIATR, V96, P56, DOI 10.1111/j.1651-2227.2007.00211.x; Iwasaki S, 2008, ARCH HISTOL CYTOL, V71, P37, DOI 10.1679/aohc.71.37; Jiang ZR, 2018, MOL GENET METAB, V124, P135, DOI 10.1016/j.ymgme.2018.04.014; Kamisan N, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-62; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lai A, 2013, J ORTHOP RES, V31, P621, DOI 10.1002/jor.22281; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Guevara JM, 2016, J MECH MED BIOL, V16, DOI 10.1142/S0219519416500548; Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001; MCCLURE J, 1986, PATHOLOGY, V18, P217, DOI 10.3109/00313028609059462; Metcalf JA, 2009, MOL GENET METAB, V97, P202, DOI 10.1016/j.ymgme.2009.03.005; Morishita K, 2011, RHEUMATOLOGY, V50, pV19, DOI 10.1093/rheumatology/ker397; Myllyharju J, 2014, CURR OSTEOPOROS REP, V12, P439, DOI 10.1007/s11914-014-0232-1; Neufeld E.F., 2006, ONLINE METABOLIC MOL; Nikitovic D, 2012, J BIOL CHEM, V287, P33926, DOI 10.1074/jbc.R112.379602; Nuttall JD, 1999, CALCIFIED TISSUE INT, V65, P47, DOI 10.1007/s002239900656; Olsen BR, 1996, ANN NY ACAD SCI, V785, P124, DOI 10.1111/j.1749-6632.1996.tb56250.x; Oussoren E, 2011, BBA-MOL BASIS DIS, V1812, P1542, DOI 10.1016/j.bbadis.2011.07.013; Peck SH, 2015, MOL GENET METAB, V116, P195, DOI 10.1016/j.ymgme.2015.09.008; Piszczatowski S, 2012, ACTA BIOENG BIOMECH, V14, P93; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2001, LAB INVEST, V81, P1319, DOI 10.1038/labinvest.3780345; Smith LJ, 2010, J ORTHOP RES, V28, P616, DOI 10.1002/jor.21030; Stokes I. A. F., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P277; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tomatsu S, 2003, HUM MOL GENET, V12, P961, DOI 10.1093/hmg/ddg119; Tryfonidou MA, 2010, AM J PHYSIOL-ENDOC M, V299, pE1044, DOI 10.1152/ajpendo.00170.2010; Vaca-Gonzalez JJ, 2019, CARTILAGE, V10, P157, DOI 10.1177/1947603517730637; Valayannopoulos V, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-5; Valteau B, 2011, BONE, V49, P996, DOI 10.1016/j.bone.2011.07.008; Villemure I, 2009, J BIOMECH, V42, P1793, DOI 10.1016/j.jbiomech.2009.05.021; YOSHIDA M, 1993, J COMP PATHOL, V109, P141, DOI 10.1016/S0021-9975(08)80258-7; YOSHIDA M, 1993, J CLIN INVEST, V91, P1099, DOI 10.1172/JCI116268; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	64	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	JUN	2020	10	6							360	10.3390/diagnostics10060360	http://dx.doi.org/10.3390/diagnostics10060360			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS9GH	32486376	Green Published, gold			2022-09-04	WOS:000554579800001
J	Borda, MG; Reyes-Ortiz, C; Perez-Zepeda, MU; Patino-Hernandez, D; Gomez-Arteaga, C; Cano-Gutierrez, CA				German Borda, Miguel; Reyes-Ortiz, Carlos; Ulises Perez-Zepeda, Mario; Patino-Hernandez, Daniela; Gomez-Arteaga, Camilo; Alberto Cano-Gutierrez, Carlos			Educational level and its Association with the domains of the Montreal Cognitive Assessment Test	AGING & MENTAL HEALTH			English	Article						Dementia and cognitive disorders; age associated memory problems; education; screening and diagnosis	MENTAL-STATE-EXAMINATION; ASSESSMENT MOCA; SCREENING TOOL; VALIDATION; IMPAIRMENT; DEMENTIA; POPULATION; SPANISH; VERSION; BOGOTA	Objective: To explore the association between educational level and the scores obtained in each of the domains of the Montreal Cognitive Assessment test. Methods: This is a secondary analysis of the SABE/2012 Bogota survey; a cross-sectional study including 2000 subjects aged >= 60years. The MoCA test was the dependent variable and was stratified by cognitive domains, incorrect answers and scores were considered. Educational level was assessed through years of formal education. Age, sex and selected medical conditions were also included to adjust the multivariate models. Bivariate analyses, fitted logistic and linear regression models were employed for analyzing association between these variables. Results: The proportion of incorrect answers increased as schooling years decreased and as age increased. In the multivariate analysis, visuospatial and executive function were the most affected domains. Educational level displayed less influence than age on short memory-recall task (standardized beta 0.19 vs -0.24). Educational level showed a greater influence than age on no-memory tasks (the sum of all other domains; standardized beta 0.50 vs -0.29). Conclusions: It seems logical to consider that performance in most domains of the MoCA is influenced by years of education. Therefore, low scores on these tasks could lead to low total MoCA scores and thus to bias and over diagnosis of cognitive impairment in patients with lower educational levels. Memory-recall domain is not affected much by education and applying it separately could be useful in patients with low educational level in whom we suspect memory impairment.	[German Borda, Miguel; Ulises Perez-Zepeda, Mario; Patino-Hernandez, Daniela; Alberto Cano-Gutierrez, Carlos] Pontificia Univ Javeriana, Fac Med, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [German Borda, Miguel; Patino-Hernandez, Daniela; Gomez-Arteaga, Camilo; Alberto Cano-Gutierrez, Carlos] Pontificia Univ Javeriana, Inst Envejecimiento, Bogota, Colombia; [German Borda, Miguel; Gomez-Arteaga, Camilo; Alberto Cano-Gutierrez, Carlos] Hosp Univ San Ignacio, Unidad Geriatria, Bogota, Colombia; [German Borda, Miguel] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [Reyes-Ortiz, Carlos] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Ulises Perez-Zepeda, Mario] Inst Nacl Geriatria, Geriatr Epidemiol Res Dept, Mexico City, DF, Mexico; [Ulises Perez-Zepeda, Mario] Univ Anahuac Norte, Hlth Sci Fac, Sch Med, Mexico City, DF, Mexico		Borda, MG (corresponding author), Pontificia Univ Javeriana, Fac Med, Semillero Neurociencias & Envejecimiento, Bogota, Colombia.; Borda, MG (corresponding author), Pontificia Univ Javeriana, Inst Envejecimiento, Bogota, Colombia.; Borda, MG (corresponding author), Hosp Univ San Ignacio, Unidad Geriatria, Bogota, Colombia.; Borda, MG (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway.	mmborda@gmail.com	Borda, Miguel Germán/AAK-9029-2020; Perez-Zepeda, Mario/B-7265-2011; Borda, Miguel German/AHB-5593-2022	Borda, Miguel Germán/0000-0001-5832-0603; Perez-Zepeda, Mario/0000-0003-4374-976X; Borda, Miguel German/0000-0001-5832-0603; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Patino Hernandez, Daniela/0000-0003-4911-3869	Departamento Administrativo de Ciencia, Tecnologia e Innovacion, Colciencias [120354531692]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion, Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was funded by the Departamento Administrativo de Ciencia, Tecnologia e Innovacion, Colciencias, under the grant 120354531692.	Aguilar-Navarro S. G., 2017, REV COLOMBIANA PSIQU; Albala C, 2005, REV PANAM SALUD PUBL, V17, P307, DOI 10.1590/S1020-49892005000500003; Cano CA, 2014, BIOMEDICA, V34, P574, DOI [10.7705/biomedica.v34i4.2352, 10.1590/S0120-41572014000400010]; [Anonymous], 2017, COGN DECL PREV CORR; Cagney KA, 2002, J GERONTOL B-PSYCHOL, V57, pP163, DOI 10.1093/geronb/57.2.P163; Contador I, 2017, J CLIN EXP NEUROPSYC, V39, P112, DOI 10.1080/13803395.2016.1204992; Creavin S., COCHRANE, DOI [10. 1002/14651858. CD011145. pub2, DOI 10.1002/14651858.CD011145.PUB2]; Damian AM, 2011, DEMENT GERIATR COGN, V31, P126, DOI 10.1159/000323867; Duro D, 2010, J NEUROL, V257, P728, DOI 10.1007/s00415-009-5399-5; Freitas S, 2012, J INT NEUROPSYCH SOC, V18, P1031, DOI 10.1017/S135561771200077X; Freitas S, 2012, J GERIATR PSYCH NEUR, V25, P146, DOI 10.1177/0891988712455235; Gil L, 2015, INT J GERIATR PSYCH, V30, P655, DOI 10.1002/gps.4199; Gomez F, 2013, INT J GERIATR PSYCH, V28, P813, DOI 10.1002/gps.3885; Gomez F., 2016, CURR GERONTOL GERIAT, V2016, DOI [10.1155/2016/7910205, DOI 10.1155/2016/7910205]; Icaza M. G., 1999, OPS INVESTIGACIONES, V7; International Statistics at NationMaster. com, COUNTR COMP ED AV YE; Luis CA, 2009, INT J GERIATR PSYCH, V24, P197, DOI 10.1002/gps.2101; Marc LG, 2008, AM J GERIAT PSYCHIAT, V16, P914, DOI 10.1097/JGP.0b013e318186bd67; Matallana D, 2011, J GERIATR PSYCH NEUR, V24, P9, DOI 10.1177/0891988710373597; Ministerio de Educacion Colombia, SIST ED COL; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; Ozdilek B, 2014, CLIN NEUROPSYCHOL, V28, P333, DOI 10.1080/13854046.2014.881554; Paddick Stella-Maria, 2014, Dement. neuropsychol., V8, P117, DOI 10.1590/S1980-57642014DN82000006; Pedraza O. L., RELIABILITY CRITERIO; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Rios G., 2011, VALIDACION ESCALA MO; Samper-Ternent R, 2017, AGING CLIN EXP RES, V29, P265, DOI 10.1007/s40520-016-0561-2; Tsai CF, 2012, INT PSYCHOGERIATR, V24, P651, DOI 10.1017/S1041610211002298; Zhou Y, 2015, DEMENT GER COGN D EX, V5, P85, DOI 10.1159/000365506	31	10	13	0	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1360-7863	1364-6915		AGING MENT HEALTH	Aging Ment. Health	OCT 3	2019	23	10					1300	1306		10.1080/13607863.2018.1488940	http://dx.doi.org/10.1080/13607863.2018.1488940			7	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	IQ3FF	30449144				2022-09-04	WOS:000480636100004
J	Sepulveda-Martinez, A; Garcia-Otero, L; Soveral, I; Guirado, L; Valenzuela-Alcaraz, B; Torres, X; Rodriguez-Lopez, M; Gratacos, E; Gomez, O; Crispi, F				Sepulveda-Martinez, Alvaro; Garcia-Otero, Laura; Soveral, Iris; Guirado, Laura; Valenzuela-Alcaraz, Brenda; Torres, Ximena; Rodriguez-Lopez, Merida; Gratacos, Eduard; Gomez, Olga; Crispi, Fatima			Comparison of 2D versus M-mode echocardiography for assessing fetal myocardial wall thickness	JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE			English	Article						Reproducibility; fetal heart; echocardiography; ultrasound; comparison	CROSS-SECTIONAL ECHOCARDIOGRAPHY; NORMAL HUMAN-FETUS; SEPTAL THICKNESS; CARDIAC-FUNCTION; GROWTH; CARDIOMYOPATHY; DEFORMATION; DIMENSIONS	Objective: M-mode and 2D have been proposed for evaluating fetal myocardial thickness. However, studies comparing the performance of both modalities are lacking. We aimed to compare 2D versus M-mode reproducibility for assessing myocardial wall thicknesses. Methods: A prospective study including 45 healthy fetuses from low-risk pregnancies evaluated between 18 and 41 weeks of gestation. Left and right ventricular free-wall and septal myocardial thicknesses were measured at end-diastole (ED) and end-systole (ES) in transverse 4-chamber view using 2D and M-mode. Intra- and interobserver reproducibility was evaluated by the concordance correlation coefficient (CCC). Both techniques were compared by t-test of the CCC. Results: 2D and M-mode demonstrated excellent and similar intraobserver repeatability, with the best concordance in ES septal thickness (M-mode CCC 0.956 versus 2D-mode CCC 0.914). Interobserver reproducibility demonstrated also a high concordance, optimal in ES left ventricular free wall (M-mode 0.925 versus 2 D 0.855). Comparison of both techniques demonstrated a high concordance in all measurements, except for ED septal thickness with better reproducibility using M-mode (CCC 0.954 versus 0.847, p = .017). Conclusions: 2D and M-mode can be used in a reproducible manner for measuring fetal myocardial thickness, with a slightly better performance of M-mode for assessing ED septal wall thickness.	[Sepulveda-Martinez, Alvaro; Garcia-Otero, Laura; Soveral, Iris; Guirado, Laura; Valenzuela-Alcaraz, Brenda; Torres, Ximena; Rodriguez-Lopez, Merida; Gratacos, Eduard; Gomez, Olga; Crispi, Fatima] Univ Barcelona, Hosp Clin, Barcelona Ctr Maternal Fetal & Neonatal Med, Fetal I D Fetal Med Res Ctr,BCNatal,CIBER ER, Barcelona, Spain; [Sepulveda-Martinez, Alvaro; Garcia-Otero, Laura; Soveral, Iris; Guirado, Laura; Valenzuela-Alcaraz, Brenda; Torres, Ximena; Rodriguez-Lopez, Merida; Gratacos, Eduard; Gomez, Olga; Crispi, Fatima] Univ Barcelona, Hosp St Joan De Deu, Inst Clin Gynecol Obstet & Neonatol, IDIBAPS,CIBER ER, Barcelona, Spain; [Sepulveda-Martinez, Alvaro] Hosp Clin Univ Chile, Dept Obstet & Gynecol, Fetal Med Unit, Santiago, Chile; [Rodriguez-Lopez, Merida] Pontificia Univ Javeriana, Secc Cali, Cali, Colombia		Gomez, O (corresponding author), Hosp Clin Barcelona, BC Natal Barcelona Ctr Maternal Fetal & Neonatal, Barcelona, Spain.; Gomez, O (corresponding author), Hosp St Joan De Deu, Barcelona, Spain.	ogomez@clinic.cat	Rodriguez-Lopez, Merida/N-9273-2017; Gratacos, Eduard/AAR-4939-2020; Sepulveda-Martinez, Alvaro/H-6546-2014	Rodriguez-Lopez, Merida/0000-0001-8245-0811; Gratacos, Eduard/0000-0002-7405-7224; Sepulveda-Martinez, Alvaro/0000-0002-8364-2732; Gomez, O/0000-0003-4183-9876; Garcia-Otero, Laura/0000-0003-2766-5048; Soveral, Iris/0000-0002-3571-1780	Erasmus Mundus Joint Doctorate in Fetal and Perinatal Medicine Programme of the European Union [2013-0040]; "la Caixa" Foundation; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Instituto de Salud Carlos III as part of the Plan Nacional de I+D+I [PI14/00226, PI15/00263, PI15/00130, INT16/00168]; as part of the Plan Nacional de I+D+I; Secretaria d'Universitat i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya [928, 2016FI_B01184]; grant (Ajut Josep Font) from Hospital Clinic, Barcelona	Erasmus Mundus Joint Doctorate in Fetal and Perinatal Medicine Programme of the European Union; "la Caixa" Foundation(La Caixa Foundation); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Instituto de Salud Carlos III as part of the Plan Nacional de I+D+I(Instituto de Salud Carlos III); as part of the Plan Nacional de I+D+I; Secretaria d'Universitat i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); grant (Ajut Josep Font) from Hospital Clinic, Barcelona	This project has been cofunded with support of the Erasmus Mundus Joint Doctorate in Fetal and Perinatal Medicine Programme of the European Union (Framework Agreement number: 2013-0040). Additionally, the research leading to these results has received funding from "la Caixa" Foundation; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); the Instituto de Salud Carlos III (PI14/00226, PI15/00263, PI15/00130 and INT16/00168) as part of the Plan Nacional de I+D+I and cofunded by ISCIII-Subdireccion General de Evaluacion y el fondo europeo de desarrollo regional (FEDER) "Otra manera de hacer Europa" (Spain) and the support of the Secretaria d'Universitat i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya (Grant SGR no 928 and 2016FI_B01184). Iris Soveral was supported by a grant (Ajut Josep Font) from Hospital Clinic, Barcelona.	ALLAN LD, 1982, BRIT HEART J, V47, P573; Balli S, 2014, PEDIATR CARDIOL, V35, P30, DOI 10.1007/s00246-013-0734-0; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; Carvalho JS, 2013, ULTRASOUND OBST GYN, V41, P348, DOI 10.1002/uog.12403; Comas M, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.044; Crispi F, 2014, CIRC-CARDIOVASC IMAG, V7, P781, DOI 10.1161/CIRCIMAGING.113.001490; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Cruz-Lemini M, 2016, ULTRASOUND OBST GYN, V48, P349, DOI 10.1002/uog.15767; Cruz-Lemini M, 2013, ULTRASOUND OBST GYN, V42, P175, DOI 10.1002/uog.12374; Cruz-Lemini M, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.031; DeVore GR, 2005, SEMIN FETAL NEONAT M, V10, P515, DOI 10.1016/j.siny.2005.08.009; Figueras F, 2008, EUR J OBSTET GYN R B, V136, P20, DOI 10.1016/j.ejogrb.2006.12.015; Firpo C, 2001, AM J CARDIOL, V87, P594, DOI 10.1016/S0002-9149(00)01437-5; Garcia-Flores J, 2011, EUR J OBSTET GYN R B, V154, P24, DOI 10.1016/j.ejogrb.2010.08.002; Garcia-Otero L, 2016, AIDS, V30, P1393, DOI 10.1097/QAD.0000000000001066; Guirado L, 2018, ULTRASOUND OBST GYN, V51, P349, DOI 10.1002/uog.17456; Lang D., 1995, EUR J ULTRASOUND, V2, P93, DOI 10.1016/0929-8266(95)00086-0; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Luewan S, 2011, ULTRASOUND OBST GYN, V37, P416, DOI 10.1002/uog.8961; Macklon NS, 1998, BRIT J OBSTET GYNAEC, V105, P661, DOI 10.1111/j.1471-0528.1998.tb10182.x; Miranda JO, 2017, ULTRASOUND OBST GYN, V49, P623, DOI 10.1002/uog.15939; Mongiovi M, 2010, CURR PHARM DESIGN, V16, P2929, DOI 10.2174/138161210793176428; Ren YY, 2011, PRENATAL DIAG, V31, P459, DOI 10.1002/pd.2717; Rodriguez-Lopez M, 2017, ULTRASOUND OBST GYN, V50, P207, DOI 10.1002/uog.17365; Shapiro I, 1998, ULTRASOUND OBST GYN, V12, P404, DOI 10.1046/j.1469-0705.1998.12060404.x; SHARLAND GK, 1992, ULTRASOUND OBST GYN, V2, P175, DOI 10.1046/j.1469-0705.1992.02030175.x; Sivasankaran S, 2005, CARDIOL YOUNG, V15, P409, DOI 10.1017/S1047951105000855; SUTTON MGT, 1984, CIRCULATION, V69, P645, DOI 10.1161/01.CIR.69.4.645; TAN J, 1992, AM J CARDIOL, V70, P1459, DOI 10.1016/0002-9149(92)90300-N; Tedesco G, 2017, PEDIATR CARDIOL, V38, P271, DOI 10.1007/s00246-016-1509-1; Valenzuela-Alcaraz B, 2017, ULTRASOUND OBST GYN, V50, P63, DOI 10.1002/uog.16217; Valenzuela-Alcaraz B, 2013, CIRCULATION, V128, P1442, DOI 10.1161/CIRCULATIONAHA.113.002428; VEILLE JC, 1990, AM J PERINAT, V7, P54, DOI 10.1055/s-2007-999447; VEILLE JC, 1992, OBSTET GYNECOL, V79, P51; Votava-Smith JK, 2015, J AM SOC ECHOCARDIOG, V28, P533, DOI 10.1016/j.echo.2014.12.003; Wang HY, 2015, J MATERN-FETAL NEO M, V28, P2150, DOI 10.3109/14767058.2014.984290; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Wohlmuth C, 2018, ULTRASOUND OBST GYN, V51, P341, DOI 10.1002/uog.17480	39	5	5	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1476-7058	1476-4954		J MATERN-FETAL NEO M	J. Matern.-Fetal Neonatal Med.	JUL 18	2019	32	14					2319	2327		10.1080/14767058.2018.1432041	http://dx.doi.org/10.1080/14767058.2018.1432041			9	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	HS0CP	29431014	Green Accepted			2022-09-04	WOS:000463528600007
J	Bhatia, R; Sasser, JS; Ojeda, D; Hendrixson, A; Nadimpally, S; Foley, EE				Bhatia, Rajani; Sasser, Jade S.; Ojeda, Diana; Hendrixson, Anne; Nadimpally, Sarojini; Foley, Ellen E.			A feminist exploration of 'populationism': engaging contemporary forms of population control	GENDER PLACE AND CULTURE			English	Article						biopopulationism; demopopulationism; geopopulationism; population control; populationism	SUSTAINABLE DEVELOPMENT; POLITICS; GENDER; RACE	Following the International Conference on Population and Development in 1994 in Cairo, which prompted a discursive shift from population control to reproductive health and rights in international development, policy experts and scholars have relegated population control to the realm of history. This presents a unique challenge to feminist critics who seek to identify manifestations of population control in the present. In this article, we consider the potential of 'populationism' as terminology that may assist in clarifying varied new manifestations of population control. We explicate three interrelated populationist strategies that focus on optimizing numbers (demo), spaces (geo), and life itself (bio). Through our elaboration of these three populationisms and their interaction, we seek to inspire feminist, intersectional responses to the pernicious social, economic and environmental problems that technocratic populationist interventions obscure.	[Bhatia, Rajani] SUNY Albany, Dept Womens Gender & Sexual Studies, Humanities Bldg, Albany, NY 12222 USA; [Sasser, Jade S.] Univ Calif Riverside, Dept Gender & Sexual Studies, Riverside, CA 92521 USA; [Ojeda, Diana] Pontificia Univ Javeriana, Inst Pensar, Bogota, Colombia; [Hendrixson, Anne] Hampshire Coll, Populat & Dev Program, Amherst, MA 01002 USA; [Nadimpally, Sarojini] Sama Resource Grp Women & Hlth, New Delhi, India; [Foley, Ellen E.] Clark Univ, Int Dev Commun & Environm, Worcester, MA 01610 USA		Bhatia, R (corresponding author), SUNY Albany, Dept Womens Gender & Sexual Studies, Humanities Bldg, Albany, NY 12222 USA.	rbhatia2@albany.edu	Sasser, Jade/R-7605-2019	ojeda, diana/0000-0003-2009-8060; ojeda rengifo, diana stephanie/0000-0001-6174-751X				Albert Gwendolyn, 2011, DIFFERENT TAKES, V71; Angus I., 2011, TOO MANY PEOPLE POPU; [Anonymous], 2016, ECONOMIST; Arora-Jonsson S, 2011, GLOBAL ENVIRON CHANG, V21, P744, DOI 10.1016/j.gloenvcha.2011.01.005; Bandarage Asoka, 1997, WOMEN POPULATION GLO; Banerjee Sneha, 2017, THE WIRE        0520; Bhatia R., 2018, GENDER BIRTH SEX SEL; Bhattacharjee A, 2002, POLICING NATL BODY R; Birch K, 2013, SCI TECHNOL HUM VAL, V38, P299, DOI 10.1177/0162243912442398; Brockington D., 2008, NATURE UNBOUND CONSE; Camargo Alejandro, 2016, THESIS; Caster Michael, 2015, DIPLOMAT 0826; Center for Reproductive Rights, 2014, FORC STER CHIL; Clarke A., 2018, MAKING KIN NOT POPUL; Connelly M, 2003, COMP STUD SOC HIST, V45, P122; Connelly M., 2008, FATAL MISCONCEPTION; Cresswell T., 1996, INT ENCY HUMAN GEOGR; Das V., 2016, LIVING DYING CONT WO; Devine J, 2014, ENVIRON PLANN D, V32, P984, DOI 10.1068/d13043p; Eager, 2004, GLOBAL POPULATION PO; Ehrlich P.R., 1968, POPULATION BOMB; Federici Silvia, 2004, CALIBAN WITCH WOMEN; Fluri J, 2012, ANTIPODE, V44, P31, DOI 10.1111/j.1467-8330.2010.00835.x; Foster EA, 2014, GENDER PLACE CULT, V21, P1029, DOI 10.1080/0966369X.2013.810593; Gieseking J.J., 2014, PEOPLE PLACE SPACE R; Gilmore RW, 2002, PROF GEOGR, V54, P15, DOI 10.1111/0033-0124.00310; Global Witness, 2016, DEF EARTH GLOB KILL; GREENHALGH S, 2010, CULTIVATING GLOBAL C; Haberman Clyde, 2015, NEW YORK TIMES 0201; Haraway D, 2015, ENVIRON HUMANITIES, V6, P159, DOI 10.1215/22011919-3615934; Hartmann B., 2015, Economic and Political Weekly, V50, P10; Hartmann B, 2016, PATHWAY SUSTAIN, P56; Hartmann B, 2014, GEOPOLITICS, V19, P757, DOI 10.1080/14650045.2013.847433; Hartmann B, 2010, J INT DEV, V22, P233, DOI 10.1002/jid.1676; Hartmann Betsy, 1987, REPROD RIGHTS WRONGS; Hartmann Betsy, 2016, OLD NAPS NEW TERR RE; Hendrixson A, 2019, DEV CHANGE, V50, P786, DOI 10.1111/dech.12423; Huang Priscilla, 2009, DIFFERENTAKES, V59; Hyndman J, 1997, ANTIPODE, V29, P149, DOI 10.1111/1467-8330.00040; Hyndman J, 2012, GEOPOLITICS, V17, P243, DOI 10.1080/14650045.2011.569321; International Planned Parenthood Federation Population Sustainability Network and Population and Sustainable Development Alliance, 2016, CLIM CHANG TIM RETH; Katz C, 2008, GENDER PLACE CULT, V15, P15, DOI 10.1080/09663690701817485; Kaufman E, 2012, GENDER PLACE CULT, V19, P429, DOI 10.1080/0966369X.2011.625081; Law  Victoria, 2014, ITS 2014 WHY WE STIL; Lemke T., 2002, RETHINK MARXISM, V14, P49, DOI DOI 10.1080/089356902101242288; Li TM, 2011, J PEASANT STUD, V38, P281, DOI 10.1080/03066150.2011.559009; Lohmann Larry, 2016, OLD MAPS NEE TERR RE; Lunstrum E, 2014, ANN ASSOC AM GEOGR, V104, P816, DOI 10.1080/00045608.2014.912545; Lunstrum Elizabeth, 2016, OLD MAPS NEW TERR RE; MacGregor S., 2010, J INDIAN OCEAN REG, V6, P223, DOI DOI 10.1080/19480881.2010.536669; MacGregor Sherilyn, 2009, SPIRE J LAW POLITICS, V4, P4; Mamdani Mahmood, 1976, ECON POLIT WEEKLY, V11, P1141; Mass Bonnie, 1976, POPULATION TARGET PO; Massey D, 1999, GEOGR Z, V87, P1; McCann CaroleR., 2017, FIGURING POPULATION; McDowell Linda, 1999, GENDER IDENTITY PLAC; McGivering Jill, 2013, BBC WORLD SERVI 0206; Mckittrick K, 2006, DEMONIC GROUNDS BLAC; McMichael P, 2015, GLOBALIZATIONS, V12, P434, DOI 10.1080/14747731.2014.971615; Murphy M, 2017, ECONOMIZATION OF LIFE, P1; Nagel J., 2015, GENDER CLIMATE CHANG; Neumann R. P., 1998, IMPOSING WILDERNESS; Ojeda D, 2012, J PEASANT STUD, V39, P357, DOI 10.1080/03066150.2012.658777; Osborne TM, 2011, J PEASANT STUD, V38, P859, DOI 10.1080/03066150.2011.611281; Petzl Jennifer, 2016, THESIS; Phillips Tom, 2015, GUARDIAN; Rao Mohan, 2010, MARKETS MALTHUS POPU, P1; Resurreccion BP, 2013, WOMEN STUD INT FORUM, V40, P33, DOI 10.1016/j.wsif.2013.03.011; Rocheleau Dianne, 2015, SEM INT GEN CUID TEO; Rose N, 1996, INVENTING OUR SELVES; Sama Resource Group for Women and Health, 2014, CAMP WRONGS MOUR AFT; Sasser J, 2014, ANTIPODE, V46, P1240, DOI 10.1111/anti.12029; Sasser Jade, 2018, INFERTILE GROUND POP; Schultz S., 2010, MARKETS MALTHUS POPU, P173; Schultz Susanne., 2015, DISTINKTION SCANDINA, V16, P337; Seager J, 2000, ENVIRON PLANN A, V32, P1711, DOI 10.1068/a3210com; Seager Joni, 2014, REDUCING DISASTER EA; Silliman JM, 1999, DANGEROUS INTERSECTI; Simon-Kumar Rachel, 2010, MARKETS MALTHUS POPU, P127; Smith S, 2017, ENVIRON PLANN D, V35, P210, DOI 10.1177/0263775817699494; Torres, 2016, SYSTEMIC CRISES GLOB, P57; United Nations, 2014, FRAM ACT FOLL UP PRO; Wahlberg Ayo, 2017, SELECTIVE REPROD 21; Wilkinson S, 2008, J MED ETHICS, V34, P467, DOI 10.1136/jme.2007.021592; Wilson K, 2017, GLOBALIZATIONS, V14, P432, DOI 10.1080/14747731.2016.1275402; Wilton Katelin, 2013, DIFFERENTAKES, V80; Zeiderman Austin, 2016, ENDANGERED CITY POLI	87	14	15	1	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0966-369X	1360-0524		GENDER PLACE CULT	Gend. Place Cult.	MAR 3	2020	27	3					333	350		10.1080/0966369X.2018.1553859	http://dx.doi.org/10.1080/0966369X.2018.1553859		APR 2019	18	Geography; Women's Studies	Social Science Citation Index (SSCI)	Geography; Women's Studies	KQ7OK					2022-09-04	WOS:000463972300001
J	Castro, C; Cardona, AF; Reguart, N; Carrasco-Chaumel, E; Otero, JM; Carranza, H; Vargas, C; Reveiz, L; Torres, D; Blumenschein, G				Castro, C.; Cardona, A. F.; Reguart, N.; Carrasco-Chaumel, E.; Otero, J. M.; Carranza, H.; Vargas, C.; Reveiz, L.; Torres, D.; Blumenschein, G.			Wood-smoke exposure (WSE) as a predictor of response and survival in erlotinib-treated advanced lung adenocarcinoma (ALA) patients (pts) (ONCOLGroup study)	JOURNAL OF CLINICAL ONCOLOGY			English	Meeting Abstract	45th Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 29-JUN 02, 2009	Orlando, FL	Amer Soc Clin Oncol					Fdn Santa Fe Bogota, Bogota, Colombia; Hosp Badalona Germans Trias & Pujol, Barcelona, Spain; Hosp Clin Barcelona, Barcelona, Spain; Colombian Cochrane Grp, Bogota, Colombia; Pontificia Univ Javeriana, Bogota, Colombia; MD Anderson Canc Ctr, Houston, TX USA										0	0	0	0	0	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X			J CLIN ONCOL	J. Clin. Oncol.	MAY 20	2009	27	15		S		e19052								1	Oncology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Oncology	582OF					2022-09-04	WOS:000276606605358
J	Jaimes, MC; Rojas, OL; Gonzalez, AM; Cajiao, I; Charpilienne, A; Pothier, P; Kohli, E; Greenberg, HB; Franco, MA; Angel, J				Jaimes, MC; Rojas, OL; Gonzalez, AM; Cajiao, I; Charpilienne, A; Pothier, P; Kohli, E; Greenberg, HB; Franco, MA; Angel, J			Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults	JOURNAL OF VIROLOGY			English	Article							HERPES-SIMPLEX VIRUS; IMMUNE-RESPONSE; FLOW-CYTOMETRY; INTRACELLULAR DETECTION; CYTOKINE EXPRESSION; CELL FREQUENCIES; DENDRITIC CELLS; IFN-GAMMA; B-CELLS; MEMORY	Human rotavirus-specific CD4(+) and CD8(+) T-cell responses in peripheral blood lymphocytes were studied using a flow cytometric assay that detects the intracellular accumulation of cytokines after short-term in vitro antigen stimulation. The frequencies of virus-specific T cells that secrete gamma interferon and interleukin-13 (IL-13) were determined in adults and children during the acute or convalescent phase of rotavirus-induced diarrhea, in asymptomatically infected adults and laboratory workers who worked with human stool samples containing rotavirus, and in healthy adults. Significantly higher frequencies of rotavirus-specific interferon gamma-secreting CD8(+) and CD4(+) T cells, but not IL-13-secreting T cells, were detected in symptomatically infected adults and exposed laboratory workers than in healthy adults and children with acute rotavirus diarrhea. The levels of rotavirus-specific T cells returned to levels found in healthy adults by 32 days after the onset of rotavirus diarrhea in most adult subjects. Children with rotavirus diarrhea had undetectable or very low levels of CD4(+) and CD8(+) T cells that secrete gamma interferon. Adult cytomegalovirus-seropositive individuals had frequencies of cytomegalovirus-specific T cells that secrete gamma interferon that were approximately 20 times the level of rotavirus-specific T cells. This result suggests that rotavirus is a relatively poor inducer of circulating memory T cells that secrete gamma interferon. The frequencies of gamma interferon-secreting CD4(+) and CD8(+) T cells and the frequencies of IL-13-secreting CD4(+) T cells responding to the T-cell superantigen staphylococcal enterotoxin B (SEB) were lower in children than in adults. In both adults and children, the frequencies of CD4(+) cells secreting gamma interferon in response to SEB were higher than the frequencies of cells secreting IL-13.	Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; INRA, Lab Virol Mol & Cellulaire, F-78352 Jouy En Josas, France; CHU Dijon, F-21034 Dijon, France; Fac Med & Pharm Dijon, F-21034 Dijon, France; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA		Angel, J (corresponding author), Pontificia Univ Javeriana, Inst Genet Humana, Carrera 7 40-62, Bogota, Colombia.	jangel@javeriana.edu.co	Kohli, Evelyne/A-7612-2011; Angel, Juana/O-2908-2014; CORTES, Manuel Antonio FRANCO/M-7517-2014	Kohli, Evelyne/0000-0002-9383-6573; Angel, Juana/0000-0001-6623-5337; CORTES, Manuel Antonio FRANCO/0000-0002-0265-0563; greenberg, harry/0000-0002-2128-9080	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI021362, R56AI021362, R01AI021362, R37AI021362] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21362, R56 AI021362, R37 AI021362, R01 AI021362] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abramson JS, 1999, PEDIATRICS, V104, P575; Adkins B, 1999, IMMUNOL TODAY, V20, P330, DOI 10.1016/S0167-5699(99)01473-5; Adkins P, 2001, J IMMUNOL, V166, P918, DOI 10.4049/jimmunol.166.2.918; Asanuma H, 2000, J INFECT DIS, V181, P859, DOI 10.1086/315347; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; BURCHETT SK, 1992, J INFECT DIS, V165, P813, DOI 10.1093/infdis/165.5.813; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Callan MFC, 2000, J CLIN INVEST, V106, P1251, DOI 10.1172/JCI10590; Campbell DE, 1999, CLIN EXP IMMUNOL, V115, P377; CLERICI M, 1993, J CLIN INVEST, V91, P2829, DOI 10.1172/JCI116526; COULSON BS, 1992, J CLIN MICROBIOL, V30, P1678, DOI 10.1128/JCM.30.7.1678-1684.1992; COULSON BS, 1989, J VIROL METHODS, V26, P53, DOI 10.1016/0166-0934(89)90074-8; Franco MA, 1997, J VIROL, V71, P4165, DOI 10.1128/JVI.71.5.4165-4170.1997; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; FRANCO MA, 1995, J VIROL, V69, P7800, DOI 10.1128/JVI.69.12.7800-7806.1995; Fromantin C, 1998, VIROLOGY, V244, P252, DOI 10.1006/viro.1998.9149; Fukaura H, 1996, J CLIN INVEST, V98, P70, DOI 10.1172/JCI118779; Gans HA, 1999, J IMMUNOL, V162, P5569; GILCHRIST MJR, 1987, DIAGN MICR INFEC DIS, V8, P221, DOI 10.1016/0732-8893(87)90053-8; Greenberg H B, 1994, Curr Top Microbiol Immunol, V185, P255; HAYWARD A, 1994, PEDIATR RES, V35, P293, DOI 10.1203/00006450-199403000-00002; Hoshino Y, 1999, J IMMUNOL, V163, P5735; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kantele A, 1999, J IMMUNOL, V162, P5173; Kuklin NA, 2000, J CLIN INVEST, V106, P1541, DOI 10.1172/JCI10927; Kuzushima K, 1999, BLOOD, V94, P3094, DOI 10.1182/blood.V94.9.3094.421k14_3094_3100; LEWIS DB, 1991, J CLIN INVEST, V87, P194, DOI 10.1172/JCI114970; Maino VC, 1998, CYTOMETRY, V34, P207, DOI 10.1002/(SICI)1097-0320(19981015)34:5<207::AID-CYTO1>3.0.CO;2-J; Marchant A, 1999, J IMMUNOL, V163, P2249; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McNeal MM, 1995, VIROLOGY, V214, P387, DOI 10.1006/viro.1995.0048; Muthukkumar S, 2000, J IMMUNOL, V165, P4803, DOI 10.4049/jimmunol.165.9.4803; OFFIT PA, 1993, J INFECT DIS, V167, P1436, DOI 10.1093/infdis/167.6.1436; OFFIT PA, 1992, J INFECT DIS, V165, P1107, DOI 10.1093/infdis/165.6.1107; Rose JR, 1998, J VIROL, V72, P726; Rott LS, 1997, J CLIN INVEST, V100, P1204, DOI 10.1172/JCI119633; SAD S, 1994, J IMMUNOL, V153, P3514; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Stiehm E R, 1983, Birth Defects Orig Artic Ser, V19, P295; VanCott JL, 2000, J VIROL, V74, P5250, DOI 10.1128/JVI.74.11.5250-5256.2000; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Waldrop SL, 1998, J IMMUNOL, V161, P5284	42	63	68	0	6	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAY	2002	76	10					4741	4749		10.1128/JVI.76.10.4741-4749.2002	http://dx.doi.org/10.1128/JVI.76.10.4741-4749.2002			9	Virology	Science Citation Index Expanded (SCI-EXPANDED)	Virology	546DK	11967291	Green Published			2022-09-04	WOS:000175256500007
J	Rickard, M; Hannick, JH; Fernandez, N; Koyle, MA; MacMurdo, K; Lorenzo, AJ				Rickard, Mandy; Hannick, Jessica H.; Fernandez, Nicolas; Koyle, Martin A.; MacMurdo, Krista; Lorenzo, Armando J.			Publication trends in pediatric renal transplantation: Bibliometric analysis of literature from 1950 to 2017	PEDIATRIC TRANSPLANTATION			English	Article						bibliometrics; citation mapping; kidney transplantation; pediatrics	JOURNALS; CHILDREN; IMPACT	Introduction Pediatric renal transplantation has been heavily published since the 1950s. Herein, we describe the bibliometrics and impact of the 200 most-cited pediatric renal transplantation manuscripts. Methods We identified pediatric renal transplantation publications from 1900 onwards. Year, citations, h-index, geographic origin, impact factor, topic, and design of the 200 top-cited papers were extracted. Impact index was calculated, adjusting for citation volume and time since publication. Results Of the top 200 papers, mean citation count was 80 +/- 40, impact factor 3.9 +/- 3.7, h-index 35 +/- 20, and impact index 25 +/- 13. Studies were mostly retrospective (31%) or observational (32%). Most papers originated from the United States (58%), Germany (9%), and Italy (6%), which did not correlate with citation counts. Transplantation (18%), Pediatric Nephrology (16%), and American Journal of Transplantation (11%) had the highest publication volume, which did not correlate with citation count. The main topics were medical renal disease, drug monitoring, compliance, and viruses. Most of the top-cited papers (179; 90%) were published after 1991. The difference in the number of times cited between papers published before and after 1991 was insignificant (75 +/- 24 vs 80 +/- 42; P = 0.59). There was a difference in impact index for the same period (48 +/- 15 vs 22 +/- 10; P < 0.01). Conclusions The most-cited papers were concentrated in three journals, but the top three cited papers were published elsewhere. Recent publications were more cited with a higher impact than older papers. Despite the importance of surgery in transplantation, there is a paucity of high-impact papers on this topic.	[Rickard, Mandy; Hannick, Jessica H.; Fernandez, Nicolas; Koyle, Martin A.; Lorenzo, Armando J.] Univ Toronto, Hosp Sick Children, Div Urol, Toronto, ON, Canada; [Rickard, Mandy; Hannick, Jessica H.; Fernandez, Nicolas; Koyle, Martin A.; Lorenzo, Armando J.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Hannick, Jessica H.] McMaster Univ, Div Urol, Dept Surg, Hamilton, ON, Canada; [Fernandez, Nicolas] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Urol, Bogota, Colombia; [Fernandez, Nicolas] Univ Los Andes, Fdn Santa Fe Bogota, Dept Urol, Bogota, Colombia; [MacMurdo, Krista] Markham Stouffville Hosp, Div Emergency Med, Markham, ON, Canada		Lorenzo, AJ (corresponding author), Hosp Sick Children, Div Urol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	armando.lorenzo@sickkids.ca		Rickard, Mandy/0000-0003-0598-1824				Bartosh SM, 2003, TRANSPLANTATION, V76, P1195, DOI 10.1097/01.TP.0000092524.75807.84; Beall J, 2012, NATURE, V489, P179, DOI 10.1038/489179a; Curti M, 2001, HAEMATOLOGICA, V86, P1015; Desai N, 2018, J PEDIATR SURG, V53, P1098, DOI 10.1016/j.jpedsurg.2018.02.063; Di Lena M, 2018, CUAJ-CAN UROL ASSOC, V12, P239, DOI 10.5489/cuaj.4987; Eloy JA, 2013, LARYNGOSCOPE, V123, P1865, DOI 10.1002/lary.24039; Fernandez N, 2018, J PEDIATR UROL, V14, P446, DOI 10.1016/j.jpurol.2018.04.004; Fishman M, 2017, J PEDIATR-US, V191, P244, DOI 10.1016/j.jpeds.2017.08.044; Garfield E., 1975, CURR CONTENTS, V51, P396; Hook O, 1999, SCAND J REHABIL MED, V31, P3, DOI 10.1080/003655099444669; Klimo P, 2014, J NEUROSURG-PEDIATR, V14, P695, DOI 10.3171/2014.8.PEDS1488; Kokol P, 2018, PEDIATR RES, V83, P1093, DOI 10.1038/pr.2018.54; Li L, 2012, AM J TRANSPLANT, V12, P2710, DOI 10.1111/j.1600-6143.2012.04253.x; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; McDowell DT, 2017, PEDIATR TRANSPLANT, V21, DOI 10.1111/petr.12913; Memon AR, 2018, SCI ENG ETHICS, V24, P1617, DOI 10.1007/s11948-017-9955-6; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; POTTER DE, 1991, KIDNEY INT, V40, P752, DOI 10.1038/ki.1991.271; Qvist E, 2004, PEDIATR TRANSPLANT, V8, P120, DOI 10.1046/j.1399-3046.2003.00121.x; Royle P, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-74; Rymer BC, 2015, J PLAST RECONSTR AES, V68, P1304, DOI 10.1016/j.bjps.2015.05.024; Sarwal MM, 2012, AM J TRANSPLANT, V12, P2719, DOI 10.1111/j.1600-6143.2012.04145.x; Smith JM, 2007, PEDIATR TRANSPLANT, V11, P366, DOI 10.1111/j.1399-3046.2007.00704.x; Thompson DF, 2015, PHARMACOTHERAPY, V35, P551, DOI 10.1002/phar.1586; Warady BA, 1997, PEDIATR NEPHROL, V11, P49, DOI 10.1007/s004670050232; Watson AR, 2000, PEDIATR NEPHROL, V14, P469, DOI 10.1007/s004670050794; Welsh TS, 2017, QUAL QUANT METHODS L, V5, P1	27	3	3	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1397-3142	1399-3046		PEDIATR TRANSPLANT	Pediatr. Transplant.	AUG	2019	23	5							e13455	10.1111/petr.13455	http://dx.doi.org/10.1111/petr.13455			8	Pediatrics; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Transplantation	IM4QZ	31081212				2022-09-04	WOS:000477980900026
J	Malek, A; De la Hoz, A; Gomez-Villegas, SI; Nowbakht, C; Arias, CA				Malek, Alexandre; De la Hoz, Alejandro; Isabel Gomez-Villegas, Sara; Nowbakht, Cima; Arias, Cesar A.			Lactococcus garvieae, an unusual pathogen in infective endocarditis: case report and review of the literature	BMC INFECTIOUS DISEASES			English	Review						Lactococcus; Case report; Gram positive cocci; Infective endocarditis; Diagnosis; Treatment; Risk factors	1ST CASE-REPORT; ASSOCIATION; PATIENT; LACTIS	BackgroundLactococcus garvieae is an unusual cause of infective endocarditis (IE). No current diagnostic and therapeutic guidelines are available to treat IE caused by these organisms. Based on a case report, we provide a review of the literature of IE caused by L. garvieae and highlight diagnostic and treatment challenges of these infections and implications for management.Case presentationA 50-year-old Asian male with mitral prosthetic valve presented to the hospital with intracranial haemorrhage, which was successfully treated. Three weeks later, he complained of generalized malaise. Further work up revealed blood cultures positive for Gram-positive cocci identified as L. garvieae by MALDI-TOF. An echocardiogram confirmed the diagnosis of IE. Susceptibility testing showed resistance only to clindamycin. Vancomycin plus gentamicin were started as empirical therapy and, subsequently, the combination of ceftriaxone plus gentamicin was used after susceptibility studies were available. After two weeks of combination therapy, ceftriaxone was continued as monotherapy for six additional weeks with good outcome.ConclusionsTwenty-five cases of IE by Lactococcus garvieae have been reported in the literature. Compared to other Gram-positive cocci, L. garvieae affects more frequently patients with prosthetic valves. IE presents in a subacute manner and the case fatality rate can be as high as 16%, comparable to that of streptococcal IE (15.7%). Reliable methods for identification of L. garvieae include MALDI-TOF, 16S RNA PCR, API 32 strep kit and BD Automated Phoenix System. Recommended antimicrobials for L. garvieae IE are ampicillin, amoxicillin, ceftriaxone or vancomycin in monotherapy or in combination with gentamicin.	[Malek, Alexandre; Nowbakht, Cima; Arias, Cesar A.] UTHlth McGovern Med Sch, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA; [De la Hoz, Alejandro] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Grp Invest Enfermedades Infecciosas, Bogota, Colombia; [Isabel Gomez-Villegas, Sara] Univ Antioquia, Sch Med, Medellin, Colombia; [Arias, Cesar A.] UTHlth McGovern Med Sch, Ctr Antimicrobial Resistance & Microbial Genom CA, Houston, TX 77030 USA; [Arias, Cesar A.] UTHlth McGovern Med Sch, Ctr Infect Dis, Houston, TX USA; [Arias, Cesar A.] Univ El Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia; [Arias, Cesar A.] Univ El Bosque, Int Ctr Microbial Genom, Bogota, Colombia; [Arias, Cesar A.] Univ Texas Hlth Sci Ctr Houston UTHlth, 6431 Fannin St,MSB 2-112, Houston, TX 77030 USA		Arias, CA (corresponding author), UTHlth McGovern Med Sch, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA.; Arias, CA (corresponding author), UTHlth McGovern Med Sch, Ctr Antimicrobial Resistance & Microbial Genom CA, Houston, TX 77030 USA.	cesar.arias@uth.tmc.edu	Malek, Alexandre/AAF-9361-2020	Malek, Alexandre/0000-0002-7867-4502; De la Hoz Gomez, Alejandro/0000-0002-9073-1258	NIH-National Institute of Allergy and Infectious Diseases [K24-AI114818]	NIH-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work supported by NIH-National Institute of Allergy and Infectious Diseases grant number K24-AI114818 to CAA. This grant serves for undertaking research performed in CAA lab and for publication.	Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Bazemore TC, 2016, CASE REP INFECT DIS, V2016, DOI 10.1155/2016/5805326; Cavanagh D, 2015, FOOD MICROBIOL, V47, P45, DOI 10.1016/j.fm.2014.11.001; Chirouze C, 2013, CLIN MICROBIOL INFEC, V19, P1140, DOI 10.1111/1469-0691.12166; Clavero R, 2017, REV CHIL INFECTOL, V34, P397, DOI 10.4067/s0716-10182017000400397; COLLINS MD, 1983, J GEN MICROBIOL, V129, P3427; Fefer JJ, 1998, DIAGN MICR INFEC DIS, V32, P127, DOI 10.1016/S0732-8893(98)00065-0; Fihman Vincent, 2006, J Infect, V52, pe3, DOI 10.1016/j.jinf.2005.04.021; Fleming H, 2012, TRAVEL MED INFECT DI, V10, P101, DOI 10.1016/j.tmaid.2012.02.004; Gibello A, 2016, RES VET SCI, V109, P59, DOI 10.1016/j.rvsc.2016.09.010; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Heras Canas V., 2015, New Microbes and New Infections, V5, P13, DOI 10.1016/j.nmni.2015.02.001; Hirakawa TF, 2011, ARQ BRAS CARDIOL, V97, pE108, DOI 10.1590/S0066-782X2011001400016; Igneri L, 2015, CRIT CARE MED, V43; James PR, 2000, POSTGRAD MED J, V76, P301, DOI 10.1136/pmj.76.895.301; Landeloos E, 2017, CLIN MICROBIOL NEWSL, V39, P130, DOI [10.1016/j.clinmicnews.2017.08.002, DOI 10.1016/J.CLINMICNEWS.2017.08.002]; Li WK, 2008, INTERNAL MED, V47, P1143, DOI 10.2169/internalmedicine.47.0795; Lim FH, 2017, BMJ CASE REP, V22, P1; Munoz P, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001816; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Navas ME, 2013, J CLIN MICROBIOL, V51, P1990, DOI 10.1128/JCM.03400-12; Ortiz C, 2014, REV ESP CARDIOL, V67, P776, DOI 10.1016/j.rec.2014.04.008; Rasmussen M, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-13; Russo G, 2012, NEW MICROBIOL, V35, P495; SCHLEIFER KH, 1985, SYST APPL MICROBIOL, V6, P183, DOI 10.1016/S0723-2020(85)80052-7; Suh Y, 2016, INTERNAL MED, V55, P1011, DOI 10.2169/internalmedicine.55.5935; Tsur A, 2015, ZOONOSES PUBLIC HLTH, V62, P435, DOI 10.1111/zph.12162; Varsha KK, 2016, INT J SYST EVOL MICR, V66, P3805, DOI 10.1099/ijsem.0.001268; Vendrell D, 2006, COMP IMMUNOL MICROB, V29, P177, DOI 10.1016/j.cimid.2006.06.003; Vinh DC, 2006, DIAGN MICR INFEC DIS, V56, P91, DOI 10.1016/j.diagmicrobio.2006.02.010; Wang CYC, 2007, INT J CLIN PRACT, V61, P68, DOI 10.1111/j.1742-1241.2006.00855.x; Watanabe Yukiko, 2011, J Med Case Rep, V5, P356, DOI 10.1186/1752-1947-5-356; Wilbring M, 2011, CLIN RES CARDIOL, V100, P545, DOI 10.1007/s00392-011-0286-3; Yiu KH, 2007, INT J CARDIOL, V114, P286, DOI 10.1016/j.ijcard.2005.11.092; Zuily S, 2011, ARCH CARDIOVASC DIS, V104, P138, DOI 10.1016/j.acvd.2010.05.005	35	19	19	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2334		BMC INFECT DIS	BMC Infect. Dis.	APR 3	2019	19								301	10.1186/s12879-019-3912-8	http://dx.doi.org/10.1186/s12879-019-3912-8			10	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	HS2DQ	30943906	Green Published, gold			2022-09-04	WOS:000463671700001
J	Gonzalez-Giraldo, Y; Garcia-Segura, LM; Echeverria, V; Barreto, GE				Gonzalez-Giraldo, Yeimy; Miguel Garcia-Segura, Luis; Echeverria, Valentina; Barreto, George E.			Tibolone Preserves Mitochondrial Functionality and Cell Morphology in Astrocytic Cells Treated with Palmitic Acid	MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; Palmitic acid; Tibolone; Mitochondria; Morphology	ESTROGEN-RECEPTOR; PROTECTS MITOCHONDRIA; OXIDATIVE STRESS; CYTOCHROME-C; FATTY-ACIDS; DE-NOVO; EXPRESSION; GLUCOSE; BETA; APOPTOSIS	Obesity has been associated with increased chronic neuroinflammation and augmented risk of neurodegeneration. This is worsened during the normal aging process when the levels of endogenous gonadal hormones are reduced. In this study, we have assessed the protective actions of tibolone, a synthetic steroid with estrogenic actions, on T98G human astrocytic cells exposed to palmitic acid, a saturated fatty acid used to mimic obesity in vitro. Tibolone improved cell survival, and preserved mitochondrial membrane potential in palmitic acid-treated astrocytic cells. Although we did not find significant actions of tibolone on free radical production, it modulated astrocytic morphology after treatment with palmitic acid. These data suggest that tibolone protects astrocytic cells by preserving both mitochondrial functionality and morphological complexity.	[Gonzalez-Giraldo, Yeimy; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Madrid, Spain; [Miguel Garcia-Segura, Luis] Inst Salud Carlos III, CIBER Invest Biomed Red Fragilidad & Envejecimien, Madrid, Spain; [Echeverria, Valentina] Univ San Sebastian, Fac Cs Salud, Lientur 1457, Concepcion 4080871, Chile; [Echeverria, Valentina] Bay Pines VA Hlth Care Syst, 10,000 Bay Pines Blvd,Bldg 23,Rm 123, Bay Pines, FL 33744 USA; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gesbarreto@gmail.com	Barreto, George E./AAD-7420-2020; González-Giraldo, Yeimy/Q-5652-2018; Gonzalez, Yeimy/Y-1975-2019; Garcia-Segura, Luis M/U-3711-2017; Valentina Echeverria Moran, BCh/E-7765-2013	Barreto, George E./0000-0002-6644-1971; González-Giraldo, Yeimy/0000-0002-2527-218X; Gonzalez, Yeimy/0000-0002-2527-218X; Garcia-Segura, Luis M/0000-0002-2450-2916; Valentina Echeverria Moran, BCh/0000-0003-2393-5418	Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program); Ministerio de Economia y Competitividad (MINECO), Spain [BFU2014-51836-C2-1-R]; CIBERFES; Fondos FEDER	Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program); Ministerio de Economia y Competitividad (MINECO), Spain; CIBERFES; Fondos FEDER(European Commission)	YG-G is supported by a PhD fellowship from Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program). We acknowledge support from Ministerio de Economia y Competitividad (MINECO), Spain (grant no. BFU2014-51836-C2-1-R), CIBERFES, and Fondos FEDER.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Belenichev IF, 2012, NEUROCHEM J+, V6, P202, DOI 10.1134/S181971241203004X; Belot N, 2001, GLIA, V36, P375, DOI 10.1002/glia.1124; Beltran-Campos V, 2015, NEUROLOGIA, V30, P401, DOI 10.1016/j.nrl.2014.03.002; Blazquez C, 2001, FEBS LETT, V489, P149, DOI 10.1016/S0014-5793(01)02089-0; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Buckman LB, 2014, BRAIN BEHAV IMMUN, V35, P33, DOI 10.1016/j.bbi.2013.06.007; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Catts VS, 2014, AUST NZ J PSYCHIAT, V48, P722, DOI 10.1177/0004867414531078; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; de Aguiar RB, 2008, BIOGERONTOLOGY, V9, P285, DOI 10.1007/s10522-008-9137-7; de Gooyer ME, 2001, MOL CELL ENDOCRINOL, V183, P55, DOI 10.1016/S0303-7207(01)00606-2; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; Fauconnier J, 2007, DIABETES, V56, P1136, DOI 10.2337/db06-0739; Fernandez E, 2001, METHODS, V24, P309, DOI 10.1006/meth.2001.1201; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5; Gasque P, 1996, J IMMUNOL, V156, P2247; Geekiyanage H, 2011, J NEUROSCI, V31, P14820, DOI 10.1523/JNEUROSCI.3883-11.2011; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Gibbs RB, 2006, J NEUROENDOCRINOL, V18, P643, DOI 10.1111/j.1365-2826.2006.01463.x; Gonzalez-Barosso MMRE, 2009, CURR CHEM BIOL, V3, P180, DOI [10.1079/PNS2003336, DOI 10.2174/187231309788166451]; Gupta S, 2012, J NEUROCHEM, V120, P1060, DOI 10.1111/j.1471-4159.2012.07660.x; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hickson-Bick DLM, 2002, AM J PHYSIOL-HEART C, V282, pH656, DOI 10.1152/ajpheart.00726.2001; Jayaraman A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0162-y; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Karmi A, 2010, DIABETES, V59, P2171, DOI 10.2337/db09-0138; Karperien AL, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00051; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Kong JY, 2002, AM J PHYSIOL-HEART C, V282, pH717, DOI 10.1152/ajpheart.00257.2001; Kongsui R, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0182-7; Kwon B, 2014, BBA-MOL CELL RES, V1843, P1402, DOI 10.1016/j.bbamcr.2014.04.004; Landolfi C, 1998, EUR J PHARMACOL, V360, P55, DOI 10.1016/S0014-2999(98)00663-3; Lee CH, 2014, INT J MOL SCI, V15, P10334, DOI 10.3390/ijms150610334; Lee CY, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00082; Liu L, 2014, NEUROBIOL AGING, V35, P309, DOI 10.1016/j.neurobiolaging.2013.08.016; Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58; Mao XR, 2006, J BIOL CHEM, V281, P35863, DOI 10.1074/jbc.M604166200; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Martin-Jimenez CA, 2017, MOL NEUROBIOL, V54, P7096, DOI 10.1007/s12035-016-0193-8; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Nguyen JCD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00375; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Patil S, 2007, EUR J NEUROSCI, V26, P2131, DOI 10.1111/j.1460-9568.2007.05797.x; Perea G, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ncel.2014.00378, 10.3389/fncel.2014.00378]; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pinto-Almazan R, 2014, REV NEUROLOGIA, V58, P441, DOI 10.33588/rn.5810.2013357; Pirici D, 2009, ROM J MORPHOL EMBRYO, V50, P381; Qiu J, 2008, J NEUROENDOCRINOL, V20, P1310, DOI 10.1111/j.1365-2826.2008.01789.x; Saetre P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-46; Santiago JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34579; de Medeiros ARS, 2012, REGUL PEPTIDES, V179, P55, DOI 10.1016/j.regpep.2012.08.015; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Sun Y, 2008, ACTA PHARMACOL SIN, V29, P443, DOI 10.1111/j.1745-7254.2008.00717.x; Swagell CD, 2005, BIOCHEM BIOPH RES CO, V328, P432, DOI 10.1016/j.bbrc.2004.12.188; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; TORRESALEMAN I, 1992, GLIA, V6, P180, DOI 10.1002/glia.440060305; Wang Z, 2012, J PINEAL RES, V52, P253, DOI 10.1111/j.1600-079X.2011.00952.x; Wong KL, 2014, PHARMACOL REP, V66, P1106, DOI 10.1016/j.pharep.2014.07.009; Yue G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-608; Zeng XN, 2007, MOL CELL NEUROSCI, V34, P34, DOI 10.1016/j.mcn.2006.09.008	78	22	23	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAY	2018	55	5					4453	4462		10.1007/s12035-017-0667-3	http://dx.doi.org/10.1007/s12035-017-0667-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB7EY	28667487				2022-09-04	WOS:000429238900065
J	Gonzalez-Giraldo, Y; Barreto, GE; Fava, C; Forero, DA				Gonzalez-Giraldo, Yeimy; Barreto, George E.; Fava, Cristiano; Forero, Diego A.			Ischemic Stroke and Six Genetic Variants in CRP, EPHX2, FGA, and NOTCH3 Genes: A Meta-Analysis	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Candidate gene; genetic factors; ischemic stroke; meta-analysis; polymorphism; risk factor	C-REACTIVE PROTEIN; SOLUBLE EPOXIDE HYDROLASE; RISK; POLYMORPHISMS; ASSOCIATION; SUSCEPTIBILITY; FIBRINOGEN; INCREASES; DISEASE; ALPHA	Background: Ischemic stroke (IS) is a leading cause of death and disability worldwide. As genetic heritability for IS is estimated at about 35%-40%, the identification of genetic variants associated with IS risk is of great importance. The main objective of this study was to carry out a meta-analysis for polymorphisms in CRP, EPHX2, FGA, and NOTCH3 genes and the risk for IS. Methods: Literature search for 6 candidate polymorphisms and IS was conducted using HuGE Navigator, PubMed, and Google Scholar databases. Meta-Analyst program was used to calculate pooled odds ratios (ORs) with a random effects model. Results: Twenty-five published studies for 6 candidate polymorphisms were included: CRP-rs1800947 (5 studies), CRP-rs1205 (3 studies), EPHX2-rs751141 (5 studies), FGA-rs6050 (6 studies), NOTCH3-rs3815188 (3 studies), and NOTCH3-rs1043994 (3 studies), for a total number of 7,825 IS cases and 56,532 control subjects. We did not find significant pooled ORs (P values > .05) for any of the genetic variants evaluated in this work. Conclusions: Our meta-analysis results did not show significant associations between these 6 polymorphisms in 4 candidate genes and IS, despite the functional role of some of these single nucleotide polymorphisms (e.g., rs6050 in FGA gene). Future studies are needed to identify additional main genetic risk factors for IS in different populations.	[Gonzalez-Giraldo, Yeimy; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Cient Sur, Lima, Peru; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Fava, Cristiano] Univ Verona, Dept Med, Verona, Italy; [Fava, Cristiano] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Forero, Diego A.] Univ Antonio Narino, Sch Med, Biomed Sci Res Grp, Lab NeuroPsychiat Genet, Bogota, Colombia; [Forero, Diego A.] Univ Antonio Narino, Sch Med, Lab NeuroPsychiat Genet, Bogota, Colombia		Forero, DA (corresponding author), Univ Antonio Narino, Sch Med, Lab NeuroPsychiat Genet, Bogota, Colombia.	diego.forero@uan.edu.co	Forero, Diego A./O-9981-2019; Gonzalez, Yeimy/Y-1975-2019; González-Giraldo, Yeimy/Q-5652-2018; Barreto, George E./AAD-7420-2020; Barreto, George E./B-5747-2014; Fava, Cristiano/K-9590-2015	Forero, Diego A./0000-0001-9175-3363; Gonzalez, Yeimy/0000-0002-2527-218X; González-Giraldo, Yeimy/0000-0002-2527-218X; Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Fava, Cristiano/0000-0002-8910-7378	Universidad Antonio Narino (VCTI-UAN) [20131079]; Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program)	Universidad Antonio Narino (VCTI-UAN); Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program)	Grant support: This study was supported by a research grant from Universidad Antonio Narino (VCTI-UAN, project 20131079). Y.G.-G. was supported by a PhD fellowship from Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program).	Au J, 2015, PSYCHON B REV, V22, P366, DOI 10.3758/s13423-014-0699-x; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Bevan S, 2012, STROKE, V43, P3161, DOI 10.1161/STROKEAHA.112.665760; Chen B, 2014, CELL BIOCHEM BIOPHYS, V70, P1585, DOI 10.1007/s12013-014-0099-x; Chen ZY, 2015, NEUROL RES, V37, P979, DOI 10.1179/1743132815Y.0000000053; Chi LF, 2014, NEUROREPORT, V25, P452, DOI 10.1097/WNR.0000000000000114; Falcone GJ, 2014, LANCET NEUROL, V13, P405, DOI 10.1016/S1474-4422(14)70029-8; Fava C, 2010, PHARMACOGENET GENOM, V20, P94, DOI 10.1097/FPC.0b013e3283349ec9; Flex A, 2004, STROKE, V35, P2270, DOI 10.1161/01.STR.0000140740.19421.fe; Forero DA, 2015, DRUG ALCOHOL DEPEN, V149, P259, DOI 10.1016/j.drugalcdep.2015.01.017; Forero DA, 2014, WORLD J PSYCHIATR, V4, P69, DOI 10.5498/wjp.v4.i4.69; Forero DA, 2009, J PSYCHIATR NEUROSCI, V34, P361; Fornage M, 2005, HUM MOL GENET, V14, P2829, DOI 10.1093/hmg/ddi315; Gschwendtner A, 2008, STROKE, V39, P1593, DOI 10.1161/STROKEAHA.107.502179; Gu L, 2014, THROMB RES, V133, P993, DOI 10.1016/j.thromres.2014.01.001; Hamedani AG, 2010, STROKE, V41, P1599, DOI 10.1161/STROKEAHA.110.581256; Jood K, 2008, J THROMB HAEMOST, V6, P897, DOI 10.1111/j.1538-7836.2008.02950.x; Kavvoura FK, 2008, HUM GENET, V123, P1, DOI 10.1007/s00439-007-0445-9; Kopyta I, 2015, EUR J PAEDIATR NEURO, V19, P176, DOI 10.1016/j.ejpn.2014.11.011; Ladenvall C, 2006, STROKE, V37, P2018, DOI 10.1161/01.STR.0000231872.86071.68; Li PP, 2014, GENE, V535, P359, DOI 10.1016/j.gene.2013.09.066; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136, 10.1136/bmj.b2700]; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Markus HS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-113; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Mitropoulos K, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0033-3; Mizuno T, 2002, ANN NY ACAD SCI, V977, P252, DOI 10.1111/j.1749-6632.2002.tb04823.x; Morita A, 2006, AM J HYPERTENS, V19, P593, DOI 10.1016/j.amjhyper.2005.11.015; Neyeloff Jeruza L, 2012, BMC Res Notes, V5, P52, DOI 10.1186/1756-0500-5-52; Ojeda DA, 2014, J NEUROL SCI, V337, P176, DOI 10.1016/j.jns.2013.12.005; Ojeda DA, 2014, NEUROL SCI, V35, P41, DOI 10.1007/s10072-013-1466-x; Ross OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075035; Rubattu S, 2005, EUR J NEUROL, V12, P989, DOI 10.1111/j.1468-1331.2005.01136.x; Rubattu S, 2005, THROMB HAEMOSTASIS, V93, P1095, DOI 10.1160/TH04-07-0457; Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028; Sharma P, 2013, J NEUROL NEUROSUR PS, V84, P1302, DOI 10.1136/jnnp-2012-304834; Siegerink B, 2009, J THROMB HAEMOST, V7, P385, DOI 10.1111/j.1538-7836.2008.03266.x; Stankovic S, 2010, CRIT REV CL LAB SCI, V47, P72, DOI 10.3109/10408361003791520; Tan RYY, 2015, J NEUROL, V262, P2601, DOI 10.1007/s00415-015-7794-4; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Wang Q, 2009, ACTA PHARMACOL SIN, V30, P291, DOI 10.1038/aps.2009.14; Wang QY, 2013, J NEURAL TRANSM, V120, P1479, DOI 10.1007/s00702-013-1019-8; Wang T, 2000, J NEUROL NEUROSUR PS, V69, P652, DOI 10.1136/jnnp.69.5.652; Wang XY, 2009, STROKE, V40, P683, DOI 10.1161/STROKEAHA.108.524587; Wypasek E, 2009, THROMB HAEMOSTASIS, V102, P1280, DOI 10.1160/TH09-03-0144; Yi XY, 2015, GENE, V565, P85, DOI 10.1016/j.gene.2015.03.068; Yin GT, 2015, INT J CLIN EXP MED, V8, P1888; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618; Zhang JJ, 2013, GENET TEST MOL BIOMA, V17, P789, DOI 10.1089/gtmb.2013.0131; Zhang L, 2008, PHARMACOGENET GENOM, V18, P45, DOI 10.1097/FPC.0b013e3282f313e8; Zhang ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046495	51	10	13	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	SEP	2016	25	9					2284	2289		10.1016/j.jstrokecerebrovasdis.2016.05.020	http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2016.05.020			6	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	DX0AK	27266621				2022-09-04	WOS:000384023700038
J	Cabezas, R; Baez-Jurado, E; Hidalgo-Lanussa, O; Echeverria, V; Ashraf, GM; Sahebkar, A; Barreto, GE				Cabezas, Ricardo; Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Echeverria, Valentina; Ashraf, Ghulam Md; Sahebkar, Amirhossein; Barreto, George E.			Growth Factors and Neuroglobin in Astrocyte Protection Against Neurodegeneration and Oxidative Stress (vol 56, pg 2339, 2019)	MOLECULAR NEUROBIOLOGY			English	Correction									[Cabezas, Ricardo; Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Cabezas, Ricardo] Univ Santo Tomas, Dept Ciencias Basicas, Bucaramanga, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL 33744 USA; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gsampaio@javeriana.edu.co	Ashraf, Ghulam Md/H-9485-2012; Barreto, George E./AAD-7420-2020; Sahebkar, Amirhossein/B-5124-2018	Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X				Cabezas R, 2019, MOL NEUROBIOL, V56, P2339, DOI 10.1007/s12035-018-1203-9	1	6	6	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2019	56	4					2352	2352		10.1007/s12035-018-1257-8	http://dx.doi.org/10.1007/s12035-018-1257-8			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU7XZ	30027339	Bronze			2022-09-04	WOS:000465498200005
J	Cabrera, R; Miranda-Fernandez, MC; Huertas-Quinones, VM; Carreno, M; Pineda, I; Restrepo, CM; Silva, CT; Quero, R; Cano, JD; Manrique, DC; Camacho, C; Tabares, S; Garcia, A; Sandoval, N; Moreno Medina, KJ; Dennis Verano, RJ				Cabrera, Rodrigo; Catalina Miranda-Fernandez, Marta; Manuel Huertas-Quinones, Victor; Carreno, Marisol; Pineda, Ivonne; Restrepo, Carlos M.; Tamar Silva, Claudia; Quero, Rossi; David Cano, Juan; Carolina Manrique, Diana; Camacho, Camila; Tabares, Sebastian; Garcia, Alberto; Sandoval, Nestor; Moreno Medina, Karen Julieth; Dennis Verano, Rodolfo Jose			Identification of clinically relevant phenotypes in patients with Ebstein anomaly	CLINICAL CARDIOLOGY			English	Article						Congenital Heart Defect; Ebstein Anomaly; Epidemiology; Genetics; Phenotype	HEART-SURGERY; MUTATIONS; BLOCK	BackgroundEbstein anomaly (EA) is a heterogeneous congenital heart defect (CHD), frequently accompanied by diverse cardiac and extracardiac comorbidities, resulting in a wide range of clinical outcomes. HypothesisPhenotypic characterization of EA patients has the potential to identify variables that influence prognosis and subgroups with distinct contributing factors. MethodsA comprehensive cross-sectional phenotypic characterization of 147 EA patients from one of the main referral institutions for CHD in Colombia was carried out. The most prevalent comorbidities and distinct subgroups within the patient cohort were identified through cluster analysis. ResultsThe most prevalent cardiac comorbidities identified were atrial septal defect (61%), Wolff-Parkinson-White syndrome (WPW; 27%), and right ventricular outflow tract obstruction (25%). Cluster analysis showed that patients can be classified into 2 distinct subgroups with defined phenotypes that determine disease severity and survival. Patients in cluster 1 represented a particularly homogeneous subgroup with a milder spectrum of disease, including only patients with WPW and/or supraventricular tachycardia (SVT). Cluster 2 included patients with more diverse cardiovascular comorbidities. ConclusionsThis study represents one of the largest phenotypic characterizations of EA patients reported. The data show that EA is a heterogeneous disease, very frequently associated with cardiovascular and noncardiovascular comorbidities. Patients with WPW and SVT represent a homogeneous subgroup that presents with a less severe spectrum of disease and better survival when adequately managed. This should be considered when searching for genetic causes of EA and in the clinical setting.	[Cabrera, Rodrigo; Catalina Miranda-Fernandez, Marta] Fdn Cardioinfantil Inst Cardiol, Lab Biol Mol & Pruebas Diagnost Alta Complejidad, Calle 163A,13B-60, Bogota 110131595, Colombia; [Manuel Huertas-Quinones, Victor; Garcia, Alberto; Sandoval, Nestor] Fdn Cardioinfantil Inst Cardiol, Inst Cardiopatias Congenitas, Bogota, Colombia; [Manuel Huertas-Quinones, Victor] Univ Nacl Colombia, Fac Med, Bogota, Colombia; [Manuel Huertas-Quinones, Victor; Garcia, Alberto; Sandoval, Nestor] Univ Rosario, Fac Med, Bogota, Colombia; [Carreno, Marisol; Pineda, Ivonne] Fdn Cardioinfantil Inst Cardiol, Dept Cirugia Cardiovasc, Bogota, Colombia; [Restrepo, Carlos M.; Tamar Silva, Claudia; Quero, Rossi] Univ Rosario, Ctr Invest Genet & Genom CIGGUR, Grp GENIUROS, Escuela Med & Ciencias Salud, Bogota, Colombia; [David Cano, Juan; Carolina Manrique, Diana; Camacho, Camila; Tabares, Sebastian; Garcia, Alberto] Univ Mil Nueva Granada, Fac Med, Bogota, Colombia; [Garcia, Alberto] Univ El Bosque, Fac Med, Bogota, Colombia; [Moreno Medina, Karen Julieth; Dennis Verano, Rodolfo Jose] Fdn Cardioinfantil Inst Cardiol, Dept Invest, Bogota, Colombia; [Dennis Verano, Rodolfo Jose] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia		Cabrera, R (corresponding author), Fdn Cardioinfantil Inst Cardiol, Lab Biol Mol & Pruebas Diagnost Alta Complejidad, Calle 163A,13B-60, Bogota 110131595, Colombia.	rcabrerap@cardioinfantil.org	Cabrera, Rodrigo/GQH-9828-2022; Cano, Juan/I-6371-2019; Patnala, Alekhya/H-9142-2018; Alexander, Catherine/H-9073-2018; Kiron, Gaddam/G-9933-2018; Miranda-Fernandez, Marta-Catalina/B-8456-2018; Restrepo, Carlos M./K-2830-2016; Silva Aldana, Claudia T./K-2760-2016	Cano, Juan/0000-0001-7447-5269; Patnala, Alekhya/0000-0002-3661-7198; Alexander, Catherine/0000-0001-9348-4566; Kiron, Gaddam/0000-0002-8891-1874; Miranda-Fernandez, Marta-Catalina/0000-0002-6072-3863; Huertas Quinones, Victor Manuel/0000-0002-2552-9870; Restrepo, Carlos M./0000-0001-6410-0084; Moreno-Medina, Karen/0000-0003-3265-9240; Dennis, Rodolfo J/0000-0003-3215-9721; Silva Aldana, Claudia T./0000-0001-8172-5860; Sandoval, Nestor F/0000-0002-9020-0422; Cabrera, Rodrigo/0000-0002-5731-1788; Pineda Rodriguez, Ivonne Gisel/0000-0001-6619-7465	Fondo Nacional de Financiamiento para la ciencia, tecnologia y la innovacion, Francisco Jose de Caldas-Colciencias [662-2015]	Fondo Nacional de Financiamiento para la ciencia, tecnologia y la innovacion, Francisco Jose de Caldas-Colciencias	This study was possible thanks to the activities of Fundacion Cardioinfantil's social campaign program "Regale una vida", and to funding to support research centers of excellence by "Fondo Nacional de Financiamiento para la ciencia, tecnologia y la innovacion, Francisco Jose de Caldas-Colciencias", contract 662-2015.	Ammash NM, 1997, AM HEART J, V134, P508, DOI 10.1016/S0002-8703(97)70088-7; Andelfinger GU, 2016, CONGENITAL HEART DISEASES: THE BROKEN HEART, P613, DOI 10.1007/978-3-7091-1883-2_53; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Cai K, 2016, ARTIF ORGANS, V40, P459, DOI 10.1111/aor.12586; Capodanno D, 2011, HEART VESSELS, V26, P138, DOI 10.1007/s00380-010-0037-9; CELERMAJER DS, 1994, J AM COLL CARDIOL, V23, P170, DOI 10.1016/0735-1097(94)90516-9; Chang YM, 2009, EUR J PEDIATR, V168, P685, DOI 10.1007/s00431-008-0820-0; Cohen MS, 2013, CIRC-CARDIOVASC IMAG, V6, P508, DOI 10.1161/CIRCIMAGING.112.000189; Fundacion Cardioinfantil Instituto de Cardiologia, REG UNA VID; Garcia A, 2016, PEDIATR CARDIOL, V37, P1507, DOI 10.1007/s00246-016-1464-x; GENTLES TL, 1992, AM J CARDIOL, V69, P377, DOI 10.1016/0002-9149(92)90237-S; Giamberti A, 2014, TRICUSPID VALVE CONG; Jost CHA, 2007, CIRCULATION, V115, P277, DOI 10.1161/CIRCULATIONAHA.106.619338; Kouchoukos NT, 2013, CARDIAC SURG MORPHOL, P1576; Liberman L, 2008, PEDIATR CARDIOL, V29, P56, DOI 10.1007/s00246-007-9034-x; Liberman L, 2016, J THORAC CARDIOV SUR, V152, P197, DOI 10.1016/j.jtcvs.2016.03.081; Lupo PJ, 2011, AM J MED GENET A, V155A, P1007, DOI 10.1002/ajmg.a.33883; Merabet Y, 2012, INT J CARDIOVAS IMAG, V28, P1267, DOI 10.1007/s10554-011-9918-y; Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P237, DOI 10.1007/978-3-642-12541-6_9; Sistema Estadistico Nacional, 2017, PLAN EST NAC 2017 20; Traylor M, 2015, EUR J HUM GENET, V23, P863, DOI 10.1038/ejhg.2014.194; VERLOES A, 1995, AM J MED GENET, V55, P433, DOI 10.1002/ajmg.1320550410; Vermeer AMC, 2013, AM J MED GENET C, V163, P178, DOI 10.1002/ajmg.c.31365; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	24	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-9289	1932-8737		CLIN CARDIOL	Clin. Cardiol.	MAR	2018	41	3					343	348		10.1002/clc.22870	http://dx.doi.org/10.1002/clc.22870			6	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	GB1YA	29569399	Green Published			2022-09-04	WOS:000428846300012
J	Tellez, J; Lopez, C; Ospina, J; Martinez, S; Gonzalez, C; Molinello, H; Taborda, L; Parra, K; Rangel, O; Demyttenaere, K				Tellez, J.; Lopez, C.; Ospina, J.; Martinez, S.; Gonzalez, C.; Molinello, H.; Taborda, L.; Parra, K.; Rangel, O.; Demyttenaere, K.			Measuring change in depression using the LAPS - findings in the "Mosaic of Emotions" group experience with agomelatine	EUROPEAN NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	30th Congress of the European-College-of-Neuropsychopharmacology (ECNP)	SEP 02-05, 2017	Paris, FRANCE	European Coll Neuropsychopharmacol					[Tellez, J.; Martinez, S.] Univ El Bosque, Bogota, Colombia; [Lopez, C.; Ospina, J.] Univ Antioquia, Grp Invest Psiquiatria GIPSI, Medellin, Colombia; [Gonzalez, C.] Univ Valle, Cali, Colombia; [Molinello, H.] Univ Simon Bolivar, Barranquilla, Colombia; [Taborda, L.] Univ Javeriana, Bogota, Colombia; [Parra, K.] Clin Nuestra Senora La Paz, Outpatient Care, Bogota, Colombia; [Rangel, O.] Clin Nuestra Senora La Paz, Inpatient Care, Bogota, Colombia; [Demyttenaere, K.] Katholieke Univ Leuven, Leuven, Belgium				demyttenaere, koen/AAG-4716-2021		Servier	Servier(Servier)	This abstract is financially supported by Servier.	Gargoloff PD, 2016, HUM PSYCHOPHARM CLIN, V31, P412, DOI 10.1002/hup.2557; Joormann J, 2016, BEHAV RES THER, V86, P35, DOI 10.1016/j.brat.2016.07.007; Nelis S, 2015, COGNITIVE THER RES, V39, P480, DOI 10.1007/s10608-015-9671-y; Taylor D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1888	4	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0924-977X	1873-7862		EUR NEUROPSYCHOPHARM	Eur. Neuropsychopharmacol.	OCT	2017	27			4		P.2.b.031	S802	S802		10.1016/S0924-977X(17)31454-2	http://dx.doi.org/10.1016/S0924-977X(17)31454-2			1	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	FK9RE					2022-09-04	WOS:000413847702120
J	Galvis, RA; Ramirez, WA; Gomez, MA; Lamus, AS; Barbosa, GV				Abello Galvis, Ricardo; Arevalo Ramirez, Walter; Alejandra Gomez, Maria; Sarmiento Lamus, Andres; Vega Barbosa, Giovanny			Translation of the judgment of the International Court of Justice in the case of alleged violations of sovereign rights and maritime areas in the Caribbean Sea (Nicaragua c. Colombia). Preliminary exceptions	ANUARIO COLOMBIANO DE DERECHO INTERNACIONAL-ACDI			Spanish	Article									[Abello Galvis, Ricardo; Arevalo Ramirez, Walter] Univ Rosario, Fac Derecho, Derecho Int Publ, Bogota, Colombia; [Abello Galvis, Ricardo] Pontificia Univ Javeriana, Ciencias Jurid, Bogota, Colombia; [Abello Galvis, Ricardo] IHLADI, Madrid, Spain; [Arevalo Ramirez, Walter] Stetson Univ, Coll Law, Invest, Deland, FL USA; [Arevalo Ramirez, Walter] Univ Rosario, Fac Jurisprudencia, Grp Invest Derecho Int, Bogota, Colombia; [Arevalo Ramirez, Walter] Univ Rosario, Derecho, Bogota, Colombia; [Alejandra Gomez, Maria] Univ Colegio Mayor de Nuestra Senora Rosario, Jurisprudencia, Bogota, Colombia; [Sarmiento Lamus, Andres] Univ Sergio Arboleda Derecho Int Publ, Barranquilla, Atlantico, Colombia; [Sarmiento Lamus, Andres] Leiden Univ, NL-2300 RA Leiden, Netherlands; [Sarmiento Lamus, Andres] Leiden Univ, Derecho Int Publ, NL-2300 RA Leiden, Netherlands; [Sarmiento Lamus, Andres] Acad Colombiana Derecho Int, Bogota, Colombia; [Vega Barbosa, Giovanny] Univ Rosario, Bogota, Colombia; [Vega Barbosa, Giovanny] Univ Rosario, Fac Jurisprudencia, Catedra Derecho Int Publ, Bogota, Colombia		Galvis, RA (corresponding author), Univ Rosario, Fac Derecho, Derecho Int Publ, Bogota, Colombia.; Galvis, RA (corresponding author), Pontificia Univ Javeriana, Ciencias Jurid, Bogota, Colombia.; Galvis, RA (corresponding author), IHLADI, Madrid, Spain.	ricardo.abello@urosario.edu.co; walter.arevalo@urosario.edu.co; malegozu@gmail.com; andres.sarmiento@usa.edu.co; giovanny.vega@urosario.edu.co		Arevalo-Ramirez, Walter/0000-0002-8501-5513					0	0	0	0	2	UNIV ROSARIO, EDITORIAL	BOGOTA	CARRETERA 7, N 13-41, OFICINA 501, BOGOTA, 00000, COLOMBIA	2027-1131	2145-4493		ANU COLOMB DERECHO I	Anu. Colomb. Derecho Int.-ACDI		2017	10						545	608						64	Law	Emerging Sources Citation Index (ESCI)	Government & Law	EP2DY					2022-09-04	WOS:000397194400015
J	Perez, A; Dennis, RJ; Rondon, MA; Metcalfe, MA; Rowan, KM				Perez, A; Dennis, RJ; Rondon, MA; Metcalfe, MA; Rowan, KM			A Colombian survey found intensive care mortality ratios were better in private vs. public hospitals	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						evaluation; research; Colombia; APACHE; ranking; league tables; mortality	SOCIETY APACHE-II; STATISTICAL ISSUES; LEAGUE TABLES; CASE-MIX; UNITS; PERFORMANCE; OUTCOMES; IRELAND; BRITAIN; IMPACT	Background: Our main outcome was to identify organizational characteristics that help to evaluate the differences between the intensive care mortality ratios adjusted by APACHE II. We incorporated the variation associated with the ranking of institutions simulating its random effects under a binomial distribution. Methods: A nationwide survey on structure, technology, and staffing resources available in Colombian intensive care units during 1997-1998 was conducted. We collected data on admissions from 20 randomly selected adult medical and surgical intensive care units. Results: The mortality ratio from the 20 intensive care units ranged from 0.59 to 2.36; 80% of the intensive care units had a mortality ratio greater than 1. All four intensive care units with the lowest mortality ratio belonged to private institutions, while four of five institutions with the highest mortality belonged to the public sector. Intensive care units in private institutions also had fewer number of beds, lower median length of stay, lower occupancy rates, higher education training for specialists and nurses and fewer emergency nonelective surgical procedures. Conclusion: We successfully accounted for intensive care mortality baseline differences and random effects variations. There were substantial differences between intensive care units in institution type, bed availability, technology, staffing resources, and degree of training, which may have been associated with patient outcome. These results are of crucial importance to track, detect and assess future changes. (c) 2006 Elsevier Inc. All rights reserved.	Pontificia Univ Javeriana, Sch Med, Clin Epidemiol & Biostat Unit, Bogota, Colombia; Univ Texas, Houston Hlth Sci Ctr, Sch Publ Hlth, Div Biostat, Brownsville, TX 78520 USA; Fdn Cardioinfantil, Dept Med, Bogota, Colombia; Fdn Cardioinfantil, Dept Res, Bogota, Colombia; London Sch Hyg & Trop Med, Canc & Publ Hlth Unit, London WC1, England; Intens Care Natl Audit & Res Ctr, London, England		Perez, A (corresponding author), Pontificia Univ Javeriana, Sch Med, Clin Epidemiol & Biostat Unit, Bogota, Colombia.	adriana.perez@uth.tmc.edu	RONDON, MARTIN/AAD-5855-2019	RONDON, MARTIN/0000-0002-3885-5448; Perez, Adriana/0000-0002-6859-9916; Dennis, Rodolfo J/0000-0003-3215-9721				Baldock G, 2001, INTENS CARE MED, V27, P865, DOI 10.1007/s001340100938; Dennis R. J., 2000, ACTA MED COLOMB, V25, P211; Dennis RJ, 2002, ARCH BRONCONEUMOL, V38, P117, DOI 10.1016/S0300-2896(02)75168-5; Diderichsen F., 2001, SOCIAL BASIS DISPARI; Ferdinande P, 1997, INTENS CARE MED, V23, P226, DOI 10.1007/s001340050321; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; *ICNARC, 1997, ICMPDS ICNARC CASE M; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; KNAUS WA, 1985, CRITICAL CARE MED, V13, P10; LANGFORD IH, 1996, J ROY STAT SOC A STA, V159, P427; Leyland A, 2001, MULTILEVEL MODELLING; Marshall C, 2004, J R STAT SOC A STAT, V167, P541, DOI 10.1111/j.1467-985X.2004.apm10.x; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; METCALFE A, 1995, STUDY PROVISION INTE; Nouira S, 1998, INTENS CARE MED, V24, P1144, DOI 10.1007/s001340050737; Perez A, 2002, STAT MED, V21, P3885, DOI 10.1002/sim.1391; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; *REP COL MIN SAL, 1994, CARG ENF COL; ROWAN KM, 1993, BRIT MED J, V307, P977, DOI 10.1136/bmj.307.6910.977; ROWAN KM, 1993, BRIT MED J, V307, P972, DOI 10.1136/bmj.307.6910.972; ROWAN KM, 1993, BRIT MED J, V16, P307; Shortell S M, 1992, QRB Qual Rev Bull, V18, P150; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Snijders TAB, 2011, MULTILEVEL ANAL INTR; SPIEGELHALTER D, 1997, BAYESIAN INFERENCE U; *US C OFF TECHN AS, 1995, HLTH CAR TECHN ITS A; 1998, ORG MANAGEMENT INTEN, P29; 1982, DIARIO OFICIAL ANO, V129, P41148	28	7	10	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-4356			J CLIN EPIDEMIOL	J. Clin. Epidemiol.	JAN	2006	59	1					94	101		10.1016/j.jclinepi.2005.06.004	http://dx.doi.org/10.1016/j.jclinepi.2005.06.004			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	000HJ	16360567				2022-09-04	WOS:000234451600014
J	Gonzalez, AM; Jaimes, MC; Cajiao, I; Rojas, OL; Cohen, J; Pothier, P; Kohli, E; Butcher, EC; Greenberg, HB; Angel, J; Franco, MA				Gonzalez, AM; Jaimes, MC; Cajiao, I; Rojas, OL; Cohen, J; Pothier, P; Kohli, E; Butcher, EC; Greenberg, HB; Angel, J; Franco, MA			Rotavirus-specific B cells induced by recent infection in adults and children predominantly express the intestinal homing receptor alpha 4 beta 7 (vol 305, pg 93, 2003)	VIROLOGY			English	Correction									Pontificia Univ Javeriana, Inst Genet Humana, Bogota 94305, Colombia; INRA, Lab Virol Mol & Cellulaire, F-78352 Jouy En Josas, France; Ctr Hosp Univ, F-21034 Dijon, France; Fac Med & Pharm Dijon, F-21034 Dijon, France; Stanford Univ, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol & Microbiol, Stanford, CA 94305 USA		Franco, MA (corresponding author), Pontificia Univ Javeriana, Inst Genet Humana, Carrera 7 40-62, Bogota 94305, Colombia.	mafranco@javeriana.edu.co	CORTES, Manuel Antonio FRANCO/M-7517-2014; Kohli, Evelyne/A-7612-2011; Angel, Juana/O-2908-2014	CORTES, Manuel Antonio FRANCO/0000-0002-0265-0563; Kohli, Evelyne/0000-0002-9383-6573; Angel, Juana/0000-0001-6623-5337; greenberg, harry/0000-0002-2128-9080				Gonzalez AM, 2003, VIROLOGY, V305, P93, DOI 10.1006/viro.2002.1708	1	0	0	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	MAY 1	2004	322	2					382	382		10.1016/j.virol.2004.02.004	http://dx.doi.org/10.1016/j.virol.2004.02.004			1	Virology	Science Citation Index Expanded (SCI-EXPANDED)	Virology	817WH		Bronze			2022-09-04	WOS:000221207100017
J	Cabezas, R; Martin-Jimenez, C; Zuluaga, M; Pinzon, A; Barreto, GE; Gonzalez, J				Cabezas, Ricardo; Martin-Jimenez, Cynthia; Zuluaga, Martha; Pinzon, Andres; Barreto, George E.; Gonzalez, Janneth			Integrated Metabolomics and Lipidomics Reveal High Accumulation of Glycerophospholipids in Human Astrocytes under the Lipotoxic Effect of Palmitic Acid and Tibolone Protection	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						lipidomics; tibolone; palmitic acid; astrocytes	FATTY-ACIDS; VITAMIN-D; BRAIN; METABOLISM; CELLS; NEURODEGENERATION; EXPRESSION; MICROGLIA; COGNITION; DATABASE	Lipotoxicity is a metabolic condition resulting from the accumulation of free fatty acids in non-adipose tissues which involves a series of pathological responses triggered after chronic exposure to high levels of fatty acids, severely detrimental to cellular homeostasis and viability. In brain, lipotoxicity affects both neurons and other cell types, notably astrocytes, leading to neurodegenerative processes, such as Alzheimer (AD) and Parkinson diseases (PD). In this study, we performed for the first time, a whole lipidomic characterization of Normal Human Astrocytes cultures exposed to toxic concentrations of palmitic acid and the protective compound tibolone, to establish and identify the set of potential metabolites that are modulated under these experimental treatments. The study covered 3843 features involved in the exo- and endo-metabolome extracts obtained from astrocytes with the mentioned treatments. Through multivariate statistical analysis such as PCA (principal component analysis), partial least squares (PLS-DA), clustering analysis, and machine learning enrichment analysis, it was possible to determine the specific metabolites that were affected by palmitic acid insult, such as phosphoethanolamines, phosphoserines phosphocholines and glycerophosphocholines, with their respective metabolic pathways impact. Moreover, our results suggest the importance of tibolone in the generation of neuroprotective metabolites by astrocytes and may be relevant to the development of neurodegenerative processes.	[Cabezas, Ricardo] Univ Antonio Narino, Fac Med, Gp Invest Ciencias Biomed GRINCIBIO, Bogota 110231, Colombia; [Martin-Jimenez, Cynthia] Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, Atlanta, GA 30301 USA; [Zuluaga, Martha] Univ Nacl Abierta & Distancia, Escuela Ciencias Basicas Tecnol & Ingn, Bogota 111511, Colombia; [Zuluaga, Martha] Univ Caldas, Grp Invest Cromatog & Tecn Afines, Manizales 170002, Colombia; [Pinzon, Andres] Univ Nacl Colombia, Lab Bioinformat & Biol Sistemas, Bogota 111321, Colombia; [Barreto, George E.] Univ Limerick, Dept Biol Sci, Limerick V94 T9PX, Ireland; [Barreto, George E.] Univ Limerick, Hlth Res Inst, Limerick V94 T9PX, Ireland; [Gonzalez, Janneth] Pontificia Univ Javeriana Bogota, Fac Ciencias, Dept Nutr & Bioquim, Bogota 110231, Colombia		Cabezas, R (corresponding author), Univ Antonio Narino, Fac Med, Gp Invest Ciencias Biomed GRINCIBIO, Bogota 110231, Colombia.; Gonzalez, J (corresponding author), Pontificia Univ Javeriana Bogota, Fac Ciencias, Dept Nutr & Bioquim, Bogota 110231, Colombia.	rcabezas15@uan.edu.co; cmart51@emory.edu; viviana.zuluagarojas@gmail.com; ampinzonv@unal.edu.co; george.barreto@ul.ie; janneth.gonzalez@javeriana.edu.co		Zuluaga, Martha/0000-0003-1720-8476; Pinzon, Andres/0000-0002-4133-810X; Gonzalez, Janneth/0000-0003-2009-3374				Aizawa F, 2016, BIOL PHARM BULL, V39, P1100, DOI 10.1248/bpb.b15-01037; Alaamery M, 2021, J NEUROCHEM, V158, P25, DOI 10.1111/jnc.15044; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Almaguel FG, 2009, J NEUROSCI RES, V87, P1207, DOI 10.1002/jnr.21918; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Annweiler C, 2015, J INTERN MED, V277, P45, DOI 10.1111/joim.12279; Astarita G, 2018, METHODS MOL BIOL, V1750, P255, DOI 10.1007/978-1-4939-7704-8_17; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Azizi S.A., 2013, DERIVATION NEURONAL; Castellanos DB, 2021, FRONT NEUROENDOCRIN, V61, DOI 10.1016/j.yfrne.2021.100899; Banerjee P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080940; Bhaduri A, 2021, JACS AU, V1, P2261, DOI 10.1021/jacsau.1c00393; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkt1103, 10.1093/nar/gkm900]; Checa A, 2015, ANAL CHIM ACTA, V885, P1, DOI 10.1016/j.aca.2015.02.068; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Di Guida R, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1030-9; Di Somma C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112482; Durk MR, 2014, J NEUROSCI, V34, P7091, DOI 10.1523/JNEUROSCI.2711-13.2014; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Ford JH, 2010, AGE, V32, P231, DOI 10.1007/s11357-009-9128-x; Gupta S, 2012, J NEUROCHEM, V120, P1060, DOI 10.1111/j.1471-4159.2012.07660.x; Guttenplan KA, 2021, NATURE, V599, P102, DOI 10.1038/s41586-021-03960-y; Hidalgo-Lanussa O, 2020, J NEUROENDOCRINOL, V32, DOI 10.1111/jne.12776; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Ioannou MS, 2019, CELL, V177, P1522, DOI 10.1016/j.cell.2019.04.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kao YC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041505; Kim S, 2021, NUCLEIC ACIDS RES, V49, pD1388, DOI 10.1093/nar/gkaa971; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Landel V, 2018, J STEROID BIOCHEM, V177, P129, DOI 10.1016/j.jsbmb.2017.09.008; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Lee JAK, 2021, SEMIN CELL DEV BIOL, V112, P123, DOI 10.1016/j.semcdb.2020.07.017; Liu L, 2013, NEUROBIOL AGING, V34, P540, DOI 10.1016/j.neurobiolaging.2012.05.017; Maciejczyk M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6940515; Martin-Jimenez C, 2020, NEUROTOX RES, V38, P585, DOI 10.1007/s12640-020-00247-4; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Menze BH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-213; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Ortiz-Rodriguez A, 2019, MOL NEUROBIOL, V56, P1665, DOI 10.1007/s12035-018-1183-9; Pinto-Almazan R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8630764; Rieske P, 2009, EXP CELL RES, V315, P462, DOI 10.1016/j.yexcr.2008.11.004; Ruiz-Perez D, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-019-3310-7; de Medeiros ARS, 2012, REGUL PEPTIDES, V179, P55, DOI 10.1016/j.regpep.2012.08.015; Sarbu C, 2005, TALANTA, V65, P1215, DOI 10.1016/j.talanta.2004.08.047; Savary S, 2012, CURR DRUG METAB, V13, P1358, DOI 10.2174/138920012803762729; Snowden SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002266; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Turovsky EA, 2021, INT J MOL SCI, V22, P13216, DOI 10.3390/ijms222413216; Unger RH, 2000, INT J OBESITY, V24, pS28, DOI 10.1038/sj.ijo.0801498; Walter A, 2004, NEUROBIOL AGING, V25, P1299, DOI 10.1016/j.neurobiolaging.2004.02.016; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wong EHJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19697-0; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yadav RS, 2014, MOL NEUROBIOL, V50, P168, DOI 10.1007/s12035-014-8661-5; Zhuo CJ, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01080-1	62	0	0	8	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	MAR	2022	23	5							2474	10.3390/ijms23052474	http://dx.doi.org/10.3390/ijms23052474			19	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	ZS4XS	35269616	Green Published, gold			2022-09-04	WOS:000768471800001
J	Jimenez-Bolivar, AC; Prada-Lara, L; St Laurent, RA; Rougerie, R				Jimenez-Bolivar, Andrea C.; Prada-Lara, Liliana; St Laurent, Ryan A.; Rougerie, Rodolphe			The Wild Silkmoths (Lepidoptera: Bombycoidea: Saturniidae) of Colombia: a database of occurrence points and taxonomic checklist	ZOOTAXA			English	Article						Arsenurinae; Ceratocampinae; Cercophaninae; Distribution; Hemileucinae; Neotropical moths; Oxyteninae; Saturniinae	SUBGENUS-MEROLEUCOIDES MICHENER; GENUS ERYTHROMERIS LEMAIRE; TAXA; PACKARD; WALKER; HUBNER	Based on the review of literature and biological collections, information retrieved from public online databases, and from fieldwork conducted between 2015 and 2020, we provide more than 3500 occurrence records and an updated checklist of Colombian Saturniidae, annotated with distribution data for all species. In the first checklist of Colombian saturniids published two decades ago, a total of 184 species were cited; in the current update the number has risen to 653 species/ subspecies classified in 55 genera, representing all six recognized Neotropical subfamilies. The Andean and Pacific regions are the richest, accounting for about three quarters of all species listed herein. We call attention to the fact that for most speciose saturniid genera in the Neotropics, there remains a significant need for further taxonomic and systematic research with objective and integrative approaches. Likewise, it is necessary to continue the study of Saturniidae moths in Colombia, strategically increasing the sampling efforts in specific under-sampled natural regions to further document the diversity of this family in the country.	[Jimenez-Bolivar, Andrea C.] Univ Atlantico, Dept Biol, Grp Invest Biodiversidad Caribe Colombian, Barranquilla, Colombia; [Prada-Lara, Liliana] Pontificia Univ Javeriana, Dept Biol, Lab Entomol, Bogota, Colombia; [St Laurent, Ryan A.] Florida Museum Nat Hist, McGuire Ctr Lepidoptera & Biodivers, Gainesville, FL 32611 USA; [Rougerie, Rodolphe] Sorbonne Univ, Univ Antilles, Inst Systemat Evolut Biodiversite ISYEB, Museum Natl Hist Nat,CNRS,EPHE, Paris, France		Jimenez-Bolivar, AC (corresponding author), Univ Atlantico, Dept Biol, Grp Invest Biodiversidad Caribe Colombian, Barranquilla, Colombia.	andreajbolivar@gmail.com; lilianapradalara@gmail.com; ryanstlaurent93@gmail.com; rodolphe.rougerie@mnhn.fr		Jimenez Bolivar, Andrea Carolina/0000-0002-2745-5588; Prada Lara, Liliana/0000-0002-8108-9654; St Laurent, Ryan/0000-0001-6439-5249	ANR SPHINX [ANR-16-CE02-0011-01]; MNHN (ATM grants)	ANR SPHINX(French National Research Agency (ANR)); MNHN (ATM grants)	We are grateful to curators Giovanny Fagua (MPUJ) and Erika Vergara (CTNI) who kindly facilitated the revision of the material surveyed here. Fieldwork by RR in Colombia and subsequent DNA barcoding was made possible through funding from ANR SPHINX (ANR-16-CE02-0011-01) and by MNHN (ATM grants) and thanks to the invaluable support of Camila Gonzalez Rosas (UNIANDES) and Mailyn Gonzalez (IAvH) ; RR warmly thanks Jerome Barbut (MNHN) , Thibaud Decaens (University of Montpellier) , Juana Diaz (UNIANDES) and all colleagues and students who also participated to this fieldwork. This research also benefited from the support by the synthesis Centre CESAB of the French Foundation for Research on Biodiversity (FRB; www.fondationbiodiversite.fr) to the ACTIAS group, especially for databasing the collection of the late Claude Lemaire at MNHN, with help from Monica Arias. We also thank Eduardo Villarreal (Universidad del Atlantico) for producing the map, and Ian J. Kitching (NHMUK) for commenting on the manuscript. ACJB owes further special thanks to her family, Martha Bolivar Cotes and Ayen Jimenez Ortiz, for providing very valuable support and making this work possible. This paper is dedicated to the memory of professor Luis Carlos Gutierrez, esteemed researcher and mentor, who worked for over 20 years contributing to the development of science and academia at Universidad del Atlantico and the Colombian Caribbean.	Albertoni FF, 2018, AN ACAD BRAS CIENC, V90, P2827, DOI 10.1590/0001-3765201820170629; Alvarez-García Deivys Moisés, 2015, Acta Zool. Mex, V31, P327; Amarillo A., 2007, LIBRO ROJO INVERTEBR, P140; Amarillo A., 2009, SERIE GUIAS CAMPO I, V5, P203; Amarillo-S. Angela R., 2000, Biota Colombiana, V1, P177; Armenteras-Pascual D, 2011, AGR FOREST METEOROL, V151, P279, DOI 10.1016/j.agrformet.2010.11.002; Basset Y, 2017, ECOL EVOL, V7, P9991, DOI 10.1002/ece3.3515; Brechlin R., 2010, ENTOMO-SATSPHINGIA, V3, P13; Brechlin R, 2019, ENTOMOSATSPHINGIA, V12, P5; Brechlin R., 2018, ENTOMOSATSPHINGIA, V11, P5; Brechlin R., 2014, ENTOMO-SATSPHINGIA, V7, P32; Brechlin R, ENTOMOSATSPHINGIA, V9, P70; Brechlin R., 2013, ENTOMO-SATSPHINGIA, V6, P5; Brechlin R., 2012, ENTOMOSATSPHINGIA, V5, P44; Brechlin R., 2014, ENTOMOSATSPHINGIA, V7, P5; Brechlin R., ENTOMO-SATSPHINGIA, V9, P5; Brechlin R., 2013, ENTOMO-SATSPHINGIA, V6, P9; Brechlin R, 2017, ENTOMO-SATSPHINGIA, V10, P32; Brechlin R, 2017, ENTOMO-SATSPHINGIA, V10, P38; Brechlin R., 2016, ENTOMO-SATSPHINGIA, V1, P42; Brechlin R., 2011, ENTOMO-SATSPHINGIA, V4, P5; Brechlin R., 2011, ENTOMOSATSPHINGIA, V4, P30; Brechlin Ronald, 2021, Entomo-Satsphingia, V14, P10; Brechlin Ronald, 2021, Entomo-Satsphingia, V14, P32; Brechlin Ronald, 2021, Entomo-Satsphingia, V14, P28; Brechlin Ronald, 2021, Entomo-Satsphingia, V14, P36; Brechlin Ronald, 2020, Entomo-Satsphingia, V13, P4; Brechlin Ronald, 2018, Entomo-Satsphingia, V11, P84; Brechlin Ronald, 2018, Entomo-Satsphingia, V11, P27; Brechlin Ronald, 2016, Entomo-Satsphingia, V9, P59; Brechlin Ronald, 2016, Entomo-Satsphingia, V9, P64; Brechlin Ronald, 2017, Entomo-Satsphingia, V10, P60; Brechlin Ronald, 2018, Entomo-Satsphingia, V11, P49; Brechlin Ronald, 2013, Entomo-Satsphingia, V6, P26; Brechlin Ronald, 2013, Entomo-Satsphingia, V6, P72; Brechlin Ronald, 2011, Entomo-Satsphingia, V4, P5; Brechlin Ronald, 2012, Entomo-Satsphingia, V5, P8; Brechlin Ronald, 2011, Entomo-Satsphingia, V4, P72; Brechlin Ronald, 2011, Entomo-Satsphingia, V4, P48; Brechlin Ronald, 2010, Entomo-Satsphingia, V3, P75; Brechlin Ronald, 2010, Entomo-Satsphingia, V3, P10; Calero-Mejia H, 2014, REV BIOL TROP, V62, P317, DOI 10.15517/rbt.v62i0.16351; Camargo A.J.A., 2020, SATURNIIDAE CATALOGO; Clavijo A.M.G., 2019, THESIS U NACL COLOMB; Comoglio L., 2021, UPDATED CHECKLIST WI, DOI [10.3897/arphapreprints.e72657, DOI 10.3897/ARPHAPREPRINTS.E72657]; Comoglio Lorenzo, 2016, Journal of Insect Biodiversity, V4, P1, DOI 10.12976/jib/2016.4.22; Dash BC, 2009, J BIOTECHNOL, V144, P321, DOI 10.1016/j.jbiotec.2009.09.019; Decaens T., 2004, GALATHEA, V15, P47; Decaens T., 2004, GALATHEA, V15, P13; Decaens T., 2003, B CIENT MUS HIST NAT, V7, P57; Decaens Thibaud, 2021, Zookeys, V1031, P183, DOI 10.3897/zookeys.1031.56035; Decaens T, 2018, CONSERV BIOL, V32, P1380, DOI 10.1111/cobi.13206; Decaens Thibaud, 2005, Galathea Supplement, V16, P173; Decaens Thibaud, 2003, Nachrichten des Entomologischen Vereins Apollo, V24, P35; Decaens Thibaud, 2007, Nachrichten des Entomologischen Vereins Apollo, V28, P69; Decaens T, 2008, ZOOTAXA, P34, DOI 10.11646/zootaxa.1944.1.2; Fagerstrom C., 2021, LUND MUSEUM ZOOLOGY, DOI [10.15468/dahk2aaccessedviaGBIF.orgon2020-02-02, DOI 10.15468/DAHK2A, 10.15468/dahk2a]; Gall L, 2021, ENTOMOLOGY DIVISION, DOI [10.15468/95waq3, DOI 10.15468/95WAQ3]; Garcia H., 2014, BOSQUE SECO TROPICAL, P229; Garzon R.E.C., 2014, COLECCION MARIPOSAS, DOI [10.15472/YFJGEL, DOI 10.15472/YFJGEL]; Gómez C Juan P, 2014, Biosalud, V13, P59; Instituto de Investigacion de Recursos Biologicos Alexander von Humboldt, 2019, COL TEJ I INV REC BI, DOI [10.15472/9uddlh, DOI 10.15472/9UDDLH]; Janzen D.H., 1984, Oxford Surveys in Evolutionary Biology, V1, P85; Janzen DH, 2012, INVERTEBR SYST, V26, P478, DOI 10.1071/IS12038; Jaramillo N., 2017, COLECCION ENTOMOLOGI, DOI [10.15472/xblw2v, DOI 10.15472/XBLW2V]; Jordan K., 1924, Novitates Zoologicae, V31, P135; Kasiske Toni, 2019, Nachrichten des Entomologischen Vereins Apollo, V39, P149; Kitching IJ, 2018, BIODIVERS DATA J, V6, DOI 10.3897/BDJ.6.e22236; Lemaire C., 1978, ATTACIDAE AM ATTAC 1; Lemaire C., 1988, SATURNIIDAE AM SAT 3; Lemaire C., 1980, ATTACIDAE ATTACIDA 2; Lemaire C., 2002, ATTACIDAE AM ATTAC 4; Martinez J.C.A., 2021, COLECCION ENTOMOLOGI, DOI [10.15472/vp8v42, DOI 10.15472/VP8V42]; Martinez S., 2019, MONITOREO PARTICIPAT; Algarin CM, 2008, REV COLOMB ENTOMOL, V34, P116; MINET J, 1994, ENTOMOL SCAND, V25, P63, DOI 10.1163/187631294X00045; Miranda Aline V., 2015, Nachrichten des Entomologischen Vereins Apollo, V36, P136; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; Munoz A, 2010, REV COLOMB ENTOMOL, V36, P292; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nassig W.A., 2010, NACHRICHTEN ENTOMOLO, V31, P145; Natural History Museum, 2014, DAT COLL SPEC, DOI [10.5519/0002965, DOI 10.5519/0002965]; Neil TR, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2019.0692; Neves MO, 2020, NAT CONSERV-BULGARIA, P71, DOI 10.3897/natureconservation.41.54265; Ntelezos A, 2017, BIOL OPEN, V6, P109, DOI 10.1242/bio.021782; Nunez Bustos Ezequiel O., 2015, Tropical Lepidoptera Research, V25, P22; Pineda D., 2001, Biomedica, V21, P328; Prada Lara Liliana, 2019, Biota colombiana, V20, P134, DOI 10.21068/c2019.v20n02a11; Racheli L., 2006, SHILAP Revista de Lepidopterologia, V34, P197; Racheli L., 2005, SHILAP Revista de Lepidopterologia, V33, P203; Racheli L., 2005, SHILAP Revista de Lepidopterologia, V33, P225; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x; Ricardo-Molina J, 2019, SHILAP-REV LEPIDOPT, V47, P5; Rios-Gonzalez TA, 2019, REV MEX BIODIVERS, V90, DOI 10.22201/ib.20078706e.2019.90.2837; Rubin JJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar7428; Sano-Martins IS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006721; SiB Colombia, 2020, PORT DAT SIST INF BI; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Toro-Vargas D.M., 2018, THESIS U ANDES MEDEL; Tuskes P.M., 1996, WILD SILK MOTHS N AM, DOI [10.7591/9781501738005, DOI 10.7591/9781501738005]; Wolfe Kirby L., 2003, Nachrichten des Entomologischen Vereins Apollo, V24, P143; Wolfe Kirby L., 2005, Nachrichten des Entomologischen Vereins Apollo, V26, P121; Wolfe Kirby L., 2003, Journal of the Lepidopterists' Society, V57, P54	104	0	0	3	3	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	DEC 10	2021	5081	2					151	202		10.11646/zootaxa.5081.2.1	http://dx.doi.org/10.11646/zootaxa.5081.2.1			52	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	XQ1RO	35391014				2022-09-04	WOS:000731330300001
J	Aschner, P; Munoz, OM; Giron, D; Garcia, OM; Fernandez-Avila, D; Casas, LA; Bohorquez, LF; Arango, CM; Carvajal, L; Ramirez, DA; Sarmiento, JG; Colon, CA; Fabian, NF; Alarcon, P; Bustamante, AA				Aschner M, Pablo; Mauricio Munoz, Oscar, V; Giron, Diana; Milena Garcia, Olga; Fernandez-Avila, Daniel; Angela Casas, Luz; Fernanda Bohorquez, Luisa; Maria Arango T, Clara; Carvajal, Liliana; Amanda Ramirez, Doris; Guillermo Sarmiento, Juan; Alejandro Colon, Cristian; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro			Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults	COLOMBIA MEDICA			Spanish	Article						Type 2 diabetes mellitus; clinical practice guidelines	SILENT-MYOCARDIAL-ISCHEMIA; INTENSIVE GLUCOSE CONTROL; CARDIOVASCULAR-DISEASE; MULTIFACTORIAL INTERVENTION; NORMOTENSIVE PATIENTS; ECONOMIC-EVALUATION; RECEPTOR BLOCKERS; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; ADVERSE EVENTS	In Colombia, diabetes mellitus is a public health program for those responsible for creating and implementing strategies for prevention, diagnosis, treatment, and follow-up that are applicable at all care levels, with the objective of establishing early and sustained control of diabetes. A clinical practice guide has been developed following the broad outline of the methodological guide from the Ministry of Health and Social Welfare, with the aim of systematically gathering scientific evidence and formulating recommendations using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology. The current document presents in summary form the results of this process, including the recommendations and the considerations taken into account in formulating them. In general terms, what is proposed here is a screening process using the Finnish Diabetes Risk Score questionnaire adapted to the Colombian population, which enables early diagnosis of the illness, and an algorithm for determining initial treatment that can be generalized to most patients with diabetes mellitus type 2 and that is simple to apply in a primary care context. In addition, several recommendations have been made to scale up pharmacological treatment in those patients that do not achieve the objectives or fail to maintain them during initial treatment. These recommendations also take into account the evolution of weight and the individualization of glycemic control goals for special populations. Finally, recommendations have been made for opportune detection of micro- and macrovascular complications of diabetes.	[Aschner M, Pablo; Mauricio Munoz, Oscar, V; Milena Garcia, Olga; Fernandez-Avila, Daniel; Guillermo Sarmiento, Juan; Alejandro Colon, Cristian; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro] Hosp Univ San Ignacio, Bogota, Colombia; [Aschner M, Pablo; Mauricio Munoz, Oscar, V; Milena Garcia, Olga; Fernandez-Avila, Daniel; Guillermo Sarmiento, Juan; Alejandro Colon, Cristian; Fabian Correa G, Nestor; Alarcon R, Pilar; Andres Bustamante S, Alvaro] Pontificia Univ Javeriana, Cra 7 40-62, Bogota, Colombia; [Aschner M, Pablo; Carvajal, Liliana] Asociac Colombiana Diabet, Bogota, Colombia; [Giron, Diana] Pontificia Univ Javeriana, Dept Epidemiol & Bioestadist, Bogota, Colombia; [Angela Casas, Luz] Univ Valle, Asociac Colombiana Endocrinol, Cali, Colombia; [Fernanda Bohorquez, Luisa] Federac Diabetol Colombiana, Bogota, Colombia; [Fernanda Bohorquez, Luisa; Amanda Ramirez, Doris] Univ Nacl Colombia, Bogota, Colombia; [Maria Arango T, Clara] Univ Antioquia, Medellin, Colombia		Aschner, P (corresponding author), Pontificia Univ Javeriana, Cra 7 40-62, Bogota, Colombia.	pabloaschner@gmail.com	Girón, Diana/ABC-1451-2021; Muñoz, Oscar/Q-2906-2019	Muñoz, Oscar/0000-0001-5401-0018; garcia morales, olga milena/0000-0002-9921-883X; Ramirez, Doris/0000-0003-1125-0390; Fernandez-Avila, Daniel/0000-0003-1490-1822; Casas-Figueroa, Luz Angela/0000-0003-3643-0742				Agency for Healthcare Research and Quality, 2011, COMP EFFECTIVENESS R, V27; Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; Anderson RT, 2011, DIABETES CARE, V34, P807, DOI 10.2337/dc10-1926; [Anonymous], 2013, REV ALAD, P1; Aschner P, 2010, AV DIABETOL, V26, P95, DOI 10.1016/S1134-3230(10)62005-4; Aschner P, 2012, MINERVA ENDOCRINOL, V37, P114; Aschner P, 2011, DIABETES RES CLIN PR, V93, P243, DOI 10.1016/j.diabres.2011.05.002; Aschner PJ, 2012, DIABETES TECHNOL THE, V14, pS68, DOI 10.1089/dia.2012.0012; Atmaca A, 2006, ADV THER, V23, P615, DOI 10.1007/BF02850049; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Buehler AM, 2013, CARDIOVASC THER, V31, P147, DOI 10.1111/j.1755-5922.2011.00308.x; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Farmer AJ, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18140; Federacion Internacional de diabetes, 2014, ATLAS DIABETES FID; Ferwana M, 2013, DIABETIC MED, V30, P1026, DOI 10.1111/dme.12144; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Geng DF, 2014, J RENIN-ANGIO-ALDO S, V15, P44, DOI 10.1177/1470320312474054; Huelgas RG, 2013, MED CLIN-BARCELONA, V140, P134, DOI 10.1016/j.medcli.2012.10.003; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Gross JL, 2011, ANN INTERN MED, V154, P672, DOI 10.7326/0003-4819-154-10-201105170-00007; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Henry RR, 2012, INT J CLIN PRACT, V66, P446, DOI 10.1111/j.1742-1241.2012.02911.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation, 2014, MAN OLD PEOPL TYP 2; Kadowaki T, 2014, DIABETES OBES METAB, V16, P418, DOI [10.1111/dom.12235, 10.1111/dom.12233]; King P, 1999, BRIT J CLIN PHARMACO, V48, P643, DOI 10.1046/j.1365-2125.1999.00092.x; Lievre MM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-23; Lincoff A, 2014, JAMA-J AM MED ASSOC, V298, P1180; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Liu SC, 2012, DIABETES OBES METAB, V14, P810, DOI 10.1111/j.1463-1326.2012.01606.x; Loke YK, 2009, CAN MED ASSOC J, V180, P32, DOI 10.1503/cmaj.080486; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; McIntosh Brendan, 2012, Open Med, V6, pe62; McIntosh Brendan, 2011, Open Med, V5, pe35; Miller ME, 2014, DIABETES CARE, V37, P634, DOI 10.2337/dc13-1545; Monami M, 2014, DIABETES OBES METAB, V16, P833, DOI 10.1111/dom.12287; Monami M, 2014, DIABETES OBES METAB, V16, P38, DOI 10.1111/dom.12175; Muhlestein JB, 2014, JAMA-J AM MED ASSOC, V312, P2234, DOI 10.1001/jama.2014.15825; Perez A, 2009, CURR MED RES OPIN, V25, P2915, DOI 10.1185/03007990903350011; Phung OSJ., 2014, JAMA-J AM MED ASSOC, V303, P1410; Quitian H, 2015, VALUE HEALTH, V18, pA608, DOI 10.1016/j.jval.2015.09.2104; Quitian H, 2015, VALUE HEALTH, V18, pA356, DOI 10.1016/j.jval.2015.09.668; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Shyangdan DS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006423.pub2; Simmons RK, 2011, DIABETOLOGIA, V54, P312, DOI 10.1007/s00125-010-1949-8; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4; Slinin Y, 2012, AM J KIDNEY DIS, V60, P747, DOI 10.1053/j.ajkd.2012.07.017; Sluik D, 2012, ARCH INTERN MED, V172, P1285, DOI 10.1001/archinternmed.2012.3130; Soriguer F, 2012, MED CLIN-BARCELONA, V138, P371, DOI 10.1016/j.medcli.2011.05.025; Tankova T, 2011, DIABETES RES CLIN PR, V92, P46, DOI 10.1016/j.diabres.2010.12.020; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Wackers FJT, 2004, DIABETES CARE, V27, P1954, DOI 10.2337/diacare.27.8.1954; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wu D, 2014, DIABETES OBES METAB, V16, P30, DOI 10.1111/dom.12174; Xu N, 2014, DIABETES RES CLIN PR, V106, P11, DOI 10.1016/j.diabres.2014.04.010; Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X; Zhang CS, 2013, DISCRETE DYN NAT SOC, V2013, DOI 10.1155/2013/815193; Zhang F, 2013, ENDOCRINE, V44, P648, DOI 10.1007/s12020-013-9970-6; Zhang Q, 2014, DIABETES RES CLIN PR, V105, P313, DOI 10.1016/j.diabres.2014.06.006; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	71	23	25	0	12	CORPORACION EDITORA MEDICA VALLE	CALI	UNIV VALLE, BLDG 118 FACULTY HEALTH, CALLE 4B 36-00, CALI, 00000, COLOMBIA	1657-9534			COLOMB MEDICA	Colomb. Medica	APR-JUN	2016	47	2					109	131						23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY1DS	27546934				2022-09-04	WOS:000384835700009
J	Rusanov, AL; Luzgina, NG; Barreto, GE; Aliev, G				Rusanov, Alexander L.; Luzgina, Natalia G.; Barreto, George E.; Aliev, Gjumrakch			Role of Microfluidics in Blood-Brain Barrier Permeability Cell Culture Modeling: Relevance to CNS Disorders	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Blood-brain barrier; in vitro cell models; transport; permeability; drug development; shear stress; microfluidics; endothelial cells	IN-VITRO MODELS; MICROVASCULAR ENDOTHELIAL-CELLS; PLURIPOTENT STEM-CELLS; HUMAN INTESTINAL-CELLS; ACUTE SKIN IRRITATION; DRUG-DELIVERY; ELECTRICAL-RESISTANCE; NEUROVASCULAR UNIT; SHEAR-STRESS; DEPENDENT REGULATION	In vitro modeling of the human blood-brain barrier (BBB) is critical for pre-clinical evaluation and predicting the permeability of newly developed potentially neurotoxic and neurotrophic drugs. Here we summarize the specific structural and functional features of endothelial cells as a key component of the BBB and compare analysis of different cell culture models in reflecting these features. Particular attention is paid to cellular models of the BBB in microfluidic devices capable of circulating nutrient media to simulate the blood flow of the brain. In these conditions, it is possible to reproduce a number of factors affecting endothelial cells under physiological conditions, including shear stress. In comparison with static cell models, concentration gradients, which determine the velocity of transport of substances, reproduce more accurately conditions of nutrient medium flow, since they eliminate the accumulation of substances near the basal membrane of cells, not typical for the situation in vivo. Co-cultivation of different types of cells forming the BBB, in separate cell chambers connected by microchannels, allows to evaluate the mutual influences of cells under normal conditions and when exposed to the test substance. New experimental possibilities that can be achieved through modeling of BBB in microfluidic devices determine the feasibility of their use in the practice for pre-clinical studies of novel drugs against neurodegenerative diseases.	[Rusanov, Alexander L.; Luzgina, Natalia G.] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia; [Rusanov, Alexander L.; Luzgina, Natalia G.] Res & Mfg Assoc Perspectiva, Novosibirsk, Russia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiologically Act Cpds, Chernogolovka 142432, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA USA		Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.	aliev03@gmail.com	Barreto, George E./B-5747-2014; Rusanov, Alexander/AAT-2136-2021; Aliev, Gjumrakch/K-7302-2017; Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./AAD-7420-2020; Rusanov, Alexander/B-4115-2014; Rusanov, Alexander/AAT-3159-2021	Barreto, George E./0000-0002-6644-1971; Rusanov, Alexander/0000-0002-2342-5330; Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; 	Russian Science Foundation (Rossiysky Nauchny Fond) [14-23-00160]	Russian Science Foundation (Rossiysky Nauchny Fond)(Russian Science Foundation (RSF))	This work partly supported by the Russian Science Foundation (www.rscf.ru, Rossiysky Nauchny Fond), grant number 14-23-00160 for 2014-2016 years, title "Directed design, synthesis, and study of biological activity of multitarget compounds as innovative drugs for treatment of neurodegenerative diseases.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Ando J, 1996, JPN HEART J, V37, P19; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Arshad Farheen, 2010, Patholog Res Int, V2011, P920509, DOI 10.4061/2011/920509; Ashraf MW, 2011, INT J MOL SCI, V12, P3648, DOI 10.3390/ijms12063648; Atac B, 2013, LAB CHIP, V13, P3555, DOI 10.1039/c3lc50227a; Avdeef A, 2011, EUR J PHARM SCI, V43, P109, DOI 10.1016/j.ejps.2011.04.001; Azad TD, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2014.12.FOCUS14758; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bauer HC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00392; Bernas MJ, 2010, NAT PROTOC, V5, P1265, DOI 10.1038/nprot.2010.76; Bicker J, 2014, EUR J PHARM BIOPHARM, V87, P409, DOI 10.1016/j.ejpb.2014.03.012; Booth R, 2014, ANN BIOMED ENG, V42, P2379, DOI 10.1007/s10439-014-1086-5; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Cecchelli R, 1999, ADV DRUG DELIVER REV, V36, P165, DOI 10.1016/S0169-409X(98)00083-0; Cheng KC, 2008, EXPERT OPIN DRUG MET, V4, P581, DOI [10.1517/17425255.4.5.581, 10.1517/17425255.4.5.581 ]; Cucullo L, 2005, CURR OPIN DRUG DISC, V8, P89; Cucullo L, 2008, J CEREBR BLOOD F MET, V28, P312, DOI 10.1038/sj.jcbfm.9600525; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Dauchy S, 2008, J NEUROCHEM, V107, P1518, DOI 10.1111/j.1471-4159.2008.05720.x; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Enerson BE, 2006, J CEREBR BLOOD F MET, V26, P959, DOI 10.1038/sj.jcbfm.9600249; Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]; Ferruzza S, 2002, TOXICOL IN VITRO, V16, P399, DOI 10.1016/S0887-2333(02)00020-6; Filosa JA, 2015, NEUROSCIENCE; Fitsanakis VA, 2005, J NEUROSCI RES, V81, P235, DOI 10.1002/jnr.20560; Gao D, 2013, LAB CHIP, V13, P978, DOI 10.1039/c2lc41215b; Garberg P, 2005, TOXICOL IN VITRO, V19, P299, DOI 10.1016/j.tiv.2004.06.011; Ghosh S, 2012, ADV EXP MED BIOL, V740, P833, DOI 10.1007/978-94-007-2888-2_37; Giacomini KM, 2013, CLIN PHARMACOL THER, V94, P3, DOI 10.1038/clpt.2013.86; Gonzalez J, 2015, INT J NEUROSCI, V125, P315, DOI 10.3109/00207454.2014.940941; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Halpin ST, 2010, ANAL CHEM, V82, P7492, DOI 10.1021/ac101130s; Hampl R, 2015, HORM MOL BIOL CLIN I, V21, P159, DOI 10.1515/hmbci-2014-0042; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Howarth C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00103; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Lanevskij K, 2013, EXPERT OPIN DRUG MET, V9, P473, DOI 10.1517/17425255.2013.754423; Larsen JM, 2014, CURR TOP MED CHEM, V14, P1148, DOI 10.2174/1568026614666140329230311; Li MW, 2008, ANALYST, V133, P1358, DOI 10.1039/b807093h; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lippmann ES, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-2; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Malek AM, 1996, J CELL SCI, V109, P713; Maschmeyer I, 2015, EUR J PHARM BIOPHARM, V95, P77, DOI 10.1016/j.ejpb.2015.03.002; Materne EM, 2013, LAB CHIP, V13, P3481, DOI 10.1039/c3lc50240f; Mathieu F, 2005, EUR J DRUG METAB PH, V30, P85, DOI 10.1007/BF03226412; Muendoerfer M, 2010, INT J PHARMACEUT, V392, P134, DOI 10.1016/j.ijpharm.2010.03.046; Munoz MF, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00059; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nelson CM, 2012, ANNU REV BIOMED ENG, V14, P129, DOI [10.1146/annurev.bioeng-071811-150043, 10.1146/annurev-bioeng-071811-150043]; Neuhaus W, 2006, J BIOTECHNOL, V125, P127, DOI 10.1016/j.jbiotec.2006.02.019; Northrop NA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00069; Oblak TD, 2006, ANAL CHEM, V78, P3193, DOI 10.1021/ac052066o; Ohtsuki S, 2007, PHARM RES-DORDR, V24, P1745, DOI 10.1007/s11095-007-9374-5; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2006, CURR OPIN PHARMACOL, V6, P494, DOI 10.1016/j.coph.2006.06.001; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Parrish KE, 2015, CLIN PHARMACOL THER, V97, P336, DOI 10.1002/cpt.71; Pasternak AS, 1996, BIOTECHNOL BIOENG, V50, P568, DOI 10.1002/(SICI)1097-0290(19960605)50:5<568::AID-BIT12>3.3.CO;2-W; Peyton SR, 2011, BIOTECHNOL BIOENG, V108, P1181, DOI 10.1002/bit.23027; Portes P, 2002, TOXICOL IN VITRO, V16, P765, DOI 10.1016/S0887-2333(02)00090-5; Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j; Prasad Shikha, 2014, J Pharmacovigil, V2, P125; Reichel Andreas, 2003, Methods Mol Med, V89, P307; Roguet R., 2000, International Journal of Cosmetic Science, V22, P409, DOI 10.1046/j.1467-2494.2000.00016.x; Roguet R, 2002, SKIN PHARMACOL APPL, V15, P1, DOI 10.1159/000066681; Rusanov AL, 2015, TOXICOL IN VITRO, V29, P1006, DOI 10.1016/j.tiv.2015.03.018; Santaguida S, 2006, BRAIN RES, V1109, P1, DOI 10.1016/j.brainres.2006.06.027; Sato M, 2005, BIORHEOLOGY, V42, P421; Sergachev I, 2013, ANALYST, V138, P4066, DOI 10.1039/c3an00248a; Serlin Y, 2015, SEMIN CELL DEV BIOL, V38, P2, DOI 10.1016/j.semcdb.2015.01.002; Shao JB, 2010, BIOMED MICRODEVICES, V12, P81, DOI 10.1007/s10544-009-9362-0; Shkurupii V A, 2005, Morfologiia, V128, P73; Shkurupy VA, 2009, B EXP BIOL MED+, V148, P874, DOI 10.1007/s10517-010-0839-x; Shkurupy VA, 2008, B EXP BIOL MED+, V146, P627, DOI 10.1007/s10517-009-0363-z; Sloan CDK, 2012, ANNU REV ANAL CHEM, V5, P505, DOI 10.1146/annurev-anchem-062011-143002; Spielmann H, 2007, ATLA-ALTERN LAB ANIM, V35, P559, DOI 10.1177/026119290703500614; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Takata F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055166; Tian WM, 2011, AM J PATHOL, V179, P860, DOI 10.1016/j.ajpath.2011.05.002; Toyoda K, 2013, CELL MOL NEUROBIOL, V33, P489, DOI 10.1007/s10571-013-9913-z; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; TWISS IM, 1994, J PHARM SCI, V83, P699, DOI 10.1002/jps.2600830521; van der Meer AD, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3366720; Vandenhaute E, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-11; Vandenhaute E, 2012, DRUG DISCOV TODAY, V17, P285, DOI 10.1016/j.drudis.2011.10.006; Vastag M, 2009, CURR OPIN DRUG DISC, V12, P115; Vogel PA, 2011, ANAL CHEM, V83, P4296, DOI 10.1021/ac2004746; Vozzi F, 2009, TISSUE ENG PT A, V15, P1291, DOI 10.1089/ten.tea.2008.0066; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Wilhelm I, 2014, MOL PHARMACEUT, V11, P1949, DOI 10.1021/mp500046f; Wolff A, 2015, J PHARM SCI-US, V104, P2727, DOI 10.1002/jps.24329; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Xue Q, 2013, INT J BIOL SCI, V9, P174, DOI 10.7150/ijbs.5115; Zehendner CM, 2009, J CEREBR BLOOD F MET, V29, P1879, DOI 10.1038/jcbfm.2009.103; Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h	117	3	4	1	26	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2016	15	3					301	309		10.2174/1871527315666160202125304	http://dx.doi.org/10.2174/1871527315666160202125304			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DI9DH	26831260				2022-09-04	WOS:000373801100005
J	Flechas, ID; Cuellar, A; Cucunuba, ZM; Rosas, F; Velasco, V; Steindel, M; Thomas, MD; Lopez, MC; Gonzalez, JM; Puerta, CJ				Flechas, Ivonne D.; Cuellar, Adriana; Cucunuba, Zulma M.; Rosas, Fernando; Velasco, Victor; Steindel, Mario; del Carmen Thomas, Maria; Carlos Lopez, Manuel; Mario Gonzalez, John; Judith Puerta, Concepcion			Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients	BMC INFECTIOUS DISEASES			English	Article							KINETOPLASTID MEMBRANE PROTEIN-11; TRYPANOSOMA-CRUZI INFECTION; HEAT-SHOCK PROTEINS; IGG ISOTYPES; DISEASE; HSP70; EPITOPE; SERODIAGNOSIS; DETERMINANTS; ANTIBODIES	Background: Antigen specificity and IgG subclass could be significant in the natural history of Chagas' disease. The relationship between the different stages of human Chagas' disease and the profiles of total IgG and its subclasses were thus analysed here; they were directed against a crude T. cruzi extract and three recombinant antigens: the T. cruzi kinetoplastid membrane protein-11 (rKMP-11), an internal fragment of the T. cruzi HSP-70 protein(192-433), and the entire Trypanosoma rangeli HSP-70 protein. Methods: Seventeen Brazilian acute chagasic patients, 50 Colombian chronic chagasic patients (21 indeterminate and 29 cardiopathic patients) and 30 healthy individuals were included. Total IgG and its subtypes directed against the above-mentioned recombinant antigens were determined by ELISA tests. Results: The T. cruzi KMP-11 and T. rangeli HSP-70 recombinant proteins were able to distinguish both acute from chronic chagasic patients and infected people from healthy individuals. Specific antibodies to T. cruzi crude antigen in acute patients came from IgG3 and IgG4 subclasses whereas IgG1 and IgG3 were the prevalent isotypes in indeterminate and chronic chagasic patients. By contrast, the specific prominent antibodies in all disease stages against T. cruzi KMP-11 and T. rangeli HSP-70 recombinant antigens were the IgG1 subclass. Conclusion: T. cruzi KMP-11 and the T. rangeli HSP-70 recombinant proteins may be explored together in the immunodiagnosis of Chagas' disease. Polarising the IgG1 subclass of the IgG response to T. cruzi KMP-11 and T. rangeli HSP-70 recombinant proteins could have important biological effects, taking into account that this is a complement fixing antibody.	[Flechas, Ivonne D.; Judith Puerta, Concepcion] Pontificia Univ Javeriana, Mol Parasitol Lab, Bogota, Colombia; [Cuellar, Adriana] Pontificia Univ Javeriana, Grp Inmunobiol & Biol Celular, Bogota, Colombia; [Cucunuba, Zulma M.] Inst Nacl Salud, Grp Parasitol, Bogota, Colombia; [Rosas, Fernando; Velasco, Victor] Fdn Clin Abood Shaio, Bogota, Colombia; [Steindel, Mario] Univ Fed Santa Catarina, Dept Microbiol & Parasitol, BR-88040900 Florianopolis, SC, Brazil; [del Carmen Thomas, Maria; Carlos Lopez, Manuel] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Mario Gonzalez, John] Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Bogota, Colombia		Puerta, CJ (corresponding author), Pontificia Univ Javeriana, Mol Parasitol Lab, Cra 7A,43-82,Ed 50,Lab 113, Bogota, Colombia.	iflechas@gmail.com; acuellar@javeriana.edu.co; zulmacp@ins.gov.co; fernandorosas1994@gmail.com; electrofisiologia@shaio.org; cccb1mst@ccb.ufsc.br; mcthomas@ipb.csic.es; mclopez@ipb.csic.es; jmario_gonzalez@yahoo.com; cpuerta@javeriana.edu.co	Cucunuba, Zulma M/X-5670-2019; Steindel, Mario/H-2945-2015; Lopez, Manuel/Z-5641-2019; Steindel, Mario/N-2040-2018; Puerta, Concepcion J/AAG-4912-2019; Zaky, Mohammad/I-3187-2017; Thomas, María Carmen PhD/D-9065-2016; Cuellar, Adriana/AAF-2958-2019	Cucunuba, Zulma M/0000-0002-8165-3198; Steindel, Mario/0000-0002-2768-7469; Steindel, Mario/0000-0002-2768-7469; Zaky, Mohammad/0000-0003-3547-2588; Cuellar, Adriana/0000-0003-0834-8442; Mursalin, Adi/0000-0002-1867-0868; Gonzalez, John M./0000-0001-6925-0620; Lopez, Manuel Carlos/0000-0003-0002-3678; Thomas, M Carmen/0000-0003-3586-9657; Puerta Bula, Concepcion Judith/0000-0002-3449-3961	Colciencias Research project [1203-33318692]; Colciencias and the Universidad Javeriana's Young Researcher; PAI (Junta de Andalucia) [P06-CTS-02242, RICET-RD06/0021-0014]; Brazilian agency-CNPq	Colciencias Research project; Colciencias and the Universidad Javeriana's Young Researcher; PAI (Junta de Andalucia)(Junta de Andalucia); Brazilian agency-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Colciencias Research project No. 1203-33318692. IDF was supported by Colciencias and the Universidad Javeriana's Young Researcher 2008 Programme (Bogota, Colombia). MCT and MCL were supported by P06-CTS-02242 Grant from PAI (Junta de Andalucia) and RICET-RD06/0021-0014, Spain. MS received financial support from the Brazilian agency-CNPq.	Beltran M, 2001, MANUAL PROCEDIMIENTO, P32; Bhatia V, 2008, CLIN VACCINE IMMUNOL, V15, P1158, DOI 10.1128/CVI.00144-08; Campo VA, 2006, MICROBES INFECT, V8, P401, DOI 10.1016/j.micinf.2005.07.008; CERBAN FM, 1993, CLIN IMMUNOL IMMUNOP, V67, P25, DOI 10.1006/clin.1993.1041; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; Cuellar A, 2008, IMMUNOL CELL BIOL, V86, P255, DOI 10.1038/sj.icb.7100146; de Moraes MH, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-20; Diez H, 2007, PEPTIDES, V28, P1520, DOI 10.1016/j.peptides.2007.06.017; dos Santos DM, 2009, EXP PARASITOL, V121, P8, DOI 10.1016/j.exppara.2008.09.012; Dutra WO, 2005, TRENDS PARASITOL, V21, P581, DOI 10.1016/j.pt.2005.09.007; Franchin G, 1997, INFECT IMMUN, V65, P2548, DOI 10.1128/IAI.65.7.2548-2554.1997; Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08; Hernandez-Becerril Nidia, 2001, Archivos de Cardiologia de Mexico, V71, P199; Kierszenbaum F, 2005, TRENDS PARASITOL, V21, P513, DOI 10.1016/j.pt.2005.08.013; KRETTLI AU, 1976, J IMMUNOL, V116, P755; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; Mejia-Jaramillo AM, 2009, EXP PARASITOL, V121, P83, DOI 10.1016/j.exppara.2008.10.002; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Milei J, 2009, AM HEART J, V157, P22, DOI 10.1016/j.ahj.2008.08.024; Morgan J, 1996, AM J TROP MED HYG, V55, P355, DOI 10.4269/ajtmh.1996.55.355; OLSON CL, 1994, J BIOL CHEM, V269, P3868; Planelles L, 2002, IMMUNOL CELL BIOL, V80, P241, DOI 10.1046/j.1440-1711.2002.01081.x; REQUENA JM, 1993, MOL IMMUNOL, V30, P1115, DOI 10.1016/0161-5890(93)90158-8; REQUENA JM, 1988, NUCLEIC ACIDS RES, V16, P1393, DOI 10.1093/nar/16.4.1393; REQUENA JM, 1992, MOL BIOCHEM PARASIT, V53, P201, DOI 10.1016/0166-6851(92)90022-C; Rico AI, 2002, CELL STRESS CHAPERON, V7, P339, DOI 10.1379/1466-1268(2002)007<0339:THSPHA>2.0.CO;2; RODRIGUEZ AM, 1981, INFECT IMMUN, V31, P524, DOI 10.1128/IAI.31.2.524-529.1981; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd; SCOTT MT, 1981, PARASITE IMMUNOL, V3, P209, DOI 10.1111/j.1365-3024.1981.tb00400.x; SOLANA ME, 1995, J CLIN MICROBIOL, V33, P1456, DOI 10.1128/JCM.33.6.1456-1460.1995; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; STEBECK CE, 1995, MOL BIOCHEM PARASIT, V71, P1, DOI 10.1016/0166-6851(95)00022-S; Steindel M, 2008, DIAGN MICR INFEC DIS, V60, P25, DOI 10.1016/j.diagmicrobio.2007.07.016; TAKEHARA HA, 1989, IMMUNOL LETT, V23, P81, DOI 10.1016/0165-2478(89)90117-X; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Thomas MC, 2000, DNA CELL BIOL, V19, P47, DOI 10.1089/104454900314708; Thomas MC, 2001, CLIN EXP IMMUNOL, V123, P465, DOI 10.1046/j.1365-2249.2001.01478.x; Trujillo C, 1999, IMMUNOL LETT, V70, P203; Umekita LF, 1999, IMMUNOL LETT, V70, P73, DOI 10.1016/S0165-2478(99)00139-X; Umekita LF, 2000, BRAZ J MED BIOL RES, V33, P253, DOI 10.1590/S0100-879X2000000300001; Umezawa ES, 1996, J CLIN MICROBIOL, V34, P2143, DOI 10.1128/JCM.34.9.2143-2147.1996; Vercosa AFA, 2007, J CLIN LAB ANAL, V21, P271, DOI 10.1002/jcla.20186; World Health Organization (WHO), 2002, WHO TECH REP SER, V905, P1	43	27	28	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2334		BMC INFECT DIS	BMC Infect. Dis.	NOV 25	2009	9								186	10.1186/1471-2334-9-186	http://dx.doi.org/10.1186/1471-2334-9-186			11	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	527TC	19939275	Green Published, gold			2022-09-04	WOS:000272388400002
J	Bastus, NG; Gonzalez, EE; Puntes, V				Bastus, Neus G.; Gonzalez, Edgar E.; Puntes, Victor			Increasing complexity of nanocrystals	NANO TODAY			English	Editorial Material							GOLD NANOPARTICLES; SIZE CONTROL; GROWTH; SHAPE		[Bastus, Neus G.; Gonzalez, Edgar E.; Puntes, Victor] CSIC, Catalan Inst Nanosci & Nanotechnol ICN2, Campus UAB, Bellaterra 08193, Spain; [Bastus, Neus G.; Gonzalez, Edgar E.; Puntes, Victor] BIST, Campus UAB, Bellaterra 08193, Spain; [Puntes, Victor] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain; [Puntes, Victor] Vall dHebron Inst Recerca VHIR, Barcelona 08035, Catalonia, Spain; [Gonzalez, Edgar E.] Univ Javeriana, Fac Ingn, Grp Nanociencia & Nanotecnol, Bogota, Colombia		Puntes, V (corresponding author), CSIC, Catalan Inst Nanosci & Nanotechnol ICN2, Campus UAB, Bellaterra 08193, Spain.; Puntes, V (corresponding author), BIST, Campus UAB, Bellaterra 08193, Spain.	victor.puntes@icn2.cat	Bastús, Neus G./J-2407-2012; Puntes, Victor/AAL-6081-2021; Bastús, Neus G./AAK-8755-2020	Bastús, Neus G./0000-0002-3144-7986; Puntes, Victor/0000-0001-8996-9499; Bastús, Neus G./0000-0002-3144-7986; Gonzalez, Edgar E/0000-0003-3103-3959	Spanish Ministerio de Ciencia, Innovacion y Universidades (MCIU) (AEI/FEDER,UE) [RTI2018-099965-B-I00]; Catalan Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2017SGR-1431]; MINECO [RYC-2012-10991]; Severo Ochoa program from Spanish MINECO [SEV-2017-0706]; CERCA Programme/Generalitat de Catalunya	Spanish Ministerio de Ciencia, Innovacion y Universidades (MCIU) (AEI/FEDER,UE)(Spanish Government); Catalan Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); MINECO(Spanish Government); Severo Ochoa program from Spanish MINECO(Spanish Government); CERCA Programme/Generalitat de Catalunya	The authors acknowledge financial support from the Spanish Ministerio de Ciencia, Innovacion y Universidades (MCIU) (RTI2018-099965-B-I00, AEI/FEDER,UE) and from the Catalan Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) (2017SGR-1431). N.G.B. acknowledges financial support by MINECO through the Ramon y Cajal program (RYC-2012-10991). ICN2 is supported by the Severo Ochoa program from Spanish MINECO (Grant No. SEV-2017-0706) and is funded by the CERCA Programme/Generalitat de Catalunya.	Alivisatos AP, 1998, ADV MATER, V10, P1297; Allen PM, 2008, J AM CHEM SOC, V130, P9240, DOI 10.1021/ja8036349; Bastus NG, 2018, CURR MED CHEM, V25, P4587, DOI 10.2174/0929867324666170413124915; Bastus NG, 2011, LANGMUIR, V27, P11098, DOI 10.1021/la201938u; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Carrettin S, 2004, ANGEW CHEM INT EDIT, V43, P2538, DOI 10.1002/anie.200353570; Divins NJ, 2014, SCIENCE, V346, P620, DOI 10.1126/science.1258106; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Gonzalez E, 2011, SCIENCE, V334, P1377, DOI 10.1126/science.1212822; Jana NR, 2001, LANGMUIR, V17, P6782, DOI 10.1021/1a0104323; Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964; Lim SI, 2010, CHEM MATER, V22, P4495, DOI 10.1021/cm101436p; Lim SI, 2010, NANO LETT, V10, P964, DOI 10.1021/nl100032c; Merkoci F, 2020, MATER TODAY ADV, V5, DOI 10.1016/j.mtadv.2019.100037; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Patarroyo J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55105-x; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Piella J, 2019, CHEM MATER, V31, P7922, DOI 10.1021/acs.chemmater.9b02005; Puntes VF, 2001, SCIENCE, V291, P2115, DOI 10.1126/science.1057553; Shavel A, 2010, J AM CHEM SOC, V132, P4514, DOI 10.1021/ja909498c; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055	23	0	0	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-0132	1878-044X		NANO TODAY	Nano Today	JUN	2020	32								100859	10.1016/j.nantod.2020.100859	http://dx.doi.org/10.1016/j.nantod.2020.100859			3	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science	LU7PB					2022-09-04	WOS:000537941700005
J	Ramirez-Velez, R; Perez-Sousa, MA; Venegas-Sanabria, LC; Chavarro-Carvajal, DA; Cano-Gutierrez, CA; Correa-Bautista, JE; Gonzalez-Ruiz, K; Izquierdo, M				Ramirez-Velez, Robinson; Perez-Sousa, Miguel A.; Venegas-Sanabria, Luis C.; Chavarro-Carvajal, Diego A.; Cano-Gutierrez, Carlos A.; Correa-Bautista, Jorge E.; Gonzalez-Ruiz, Katherine; Izquierdo, Mikel			Gait speed moderates the adverse effect of obesity on dependency in older Colombian adult	EXPERIMENTAL GERONTOLOGY			English	Article						Gait speed; Obesity; Dependence; Latin-American; Elderly	INCIDENT DISABILITY; WALKING SPEED; MORTALITY; STRENGTH; DECLINE; PERFORMANCE; WEIGHT; PEOPLE; HEALTH; RISK	Introduction: Gait speed worsens with the presence of obesity, and is a powerful marker of functional dependence. Accordingly, gait speed could be a factor that improves or worsens the relationship between obesity and dependence in activities of daily living (ADL). However, to date this potential role has not been examined and the minimum gait speed threshold in the relationship between obesity and ADL is not known. The aim of this study was to determine whether speed moderates the association between obesity and dependence in ADL, and also define the gait speed threshold of this relationship. Methods: A total of 20,507 community-dwelling older adults from a cross-sectional analysis of national survey data - the Colombian Health, Well-being and Aging study (SABE, 2015) - were surveyed. The research data were collected using structured questionnaires, including basic information, ADL measured using the Barthel Index, body mass index, and gait speed (3 m). The Johnson-Neyman technique was applied to determine the gait speed threshold adjusted for age, sex and comorbidities. Results: Regression analysis showed a significant detrimental effect of obesity on dependence in ADL, which was moderated by gait speed (beta = 0.081; 95%CI: 0.045 to 0.117; p < 0.001). Adjusted for major covariates, the Johnson-Neyman technique defined two gait speed thresholds: < 0.77 m/s, indicating an aggravated adverse effect; and > 1.06 m/s, indicating a positive effect. Conclusions: The adverse effect of obesity on dependence in ADL is moderated by gait speed. Considering these thresholds, the distribution of older adults in each of the proposed areas of significance were: below 0.77 (m/s) = 14,324 (70.0%), above 1.06 (m/s) = 1553 older adults (7.5%) and between areas = 4630 older adults (22.5%).	[Ramirez-Velez, Robinson; Correa-Bautista, Jorge E.; Izquierdo, Mikel] Univ Publ Navarra UPNA, Navarrabiomed, CHN, Inst Invest Sanit Navarra IdiSNA, Navarra, Spain; [Perez-Sousa, Miguel A.] Univ Huelva, Fac Sport Sci, Ave Fuerzas Armadas S-N, Huelva 21007, Spain; [Venegas-Sanabria, Luis C.; Chavarro-Carvajal, Diego A.; Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Aging Inst, Hosp Univ San Ignacio, Bogota, Colombia; [Gonzalez-Ruiz, Katherine] Univ Manuela Beltran, Programa Fisioterapia, Fac Salud, Grp Ejercicio Fis & Deportes, Bogota 110231, Colombia; [Izquierdo, Mikel] Inst Salud Carlos III, GIBER Frailty & Hlth Aging CIBERFES, Madrid, Spain		Ramirez-Velez, R (corresponding author), Univ Publ Navarra UPNA, Navarrabiomed, CHN, Inst Invest Sanit Navarra IdiSNA, Navarra, Spain.; Ramirez-Velez, R (corresponding author), Univ Pabl Navarra UPNA, CHN, IDISNA, Navarrabiomed, Navarra, Spain.	robin640@hotmail.com; venegasl@javeriana.edu.co; ccano@javeriana.edu.co; katherine.gonzalez@docentes.umb.edu.co	Perez-Sousa, Miguel A./M-5931-2019; Ramírez-Vélez, Robinson/D-5311-2016; Izquierdo, Mikel/A-4894-2010; González-Ruíz, Katherine/AGI-4611-2022; Izquierdo, Mikel/O-8049-2019; Chavarro-Carvajal, Diego Andres/F-5659-2019	Perez-Sousa, Miguel A./0000-0003-4392-6850; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Izquierdo, Mikel/0000-0002-1506-4272; González-Ruíz, Katherine/0000-0001-7518-0761; Izquierdo, Mikel/0000-0002-1506-4272; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Venegas-Sanabria, Luis Carlos/0000-0001-8260-9108; Chavarro-Carvajal, Diego Andres/0000-0002-8584-3191	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia [764]; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER) [PI17/01814]	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER)	The SABE study is supported by a fund (2013, no. 764) from the Colciencias y Ministerio de Salud y la Proteccion Social de Colombia. Mikel Izquierdo is funded in part by a research grant PI17/01814 of the Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER).	Abdelaal M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.107; Akhmedov D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00371; Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; [Anonymous], 2018, ENDOTEXT; Barbat-Artigas S, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2013.12.008; Beavers KM, 2013, AM J CLIN NUTR, V97, P552, DOI 10.3945/ajcn.112.047860; Berraho M, 2010, J AGING HEALTH, V22, P68, DOI 10.1177/0898264309349422; Bollinger LM, 2017, GAIT POSTURE, V56, P100, DOI 10.1016/j.gaitpost.2017.05.003; Cesari M, 2018, J GERONTOL A-BIOL, V73, P1653, DOI 10.1093/gerona/gly011; Chen HL, 2002, J GERONTOL A-BIOL, V57, pM19, DOI 10.1093/gerona/57.1.M19; Clark DJ, 2013, EXP GERONTOL, V48, P358, DOI 10.1016/j.exger.2013.01.010; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Forhan M, 2013, BEST PRACT RES CL EN, V27, P129, DOI 10.1016/j.beem.2013.01.003; Garcia-Pinillos F, 2016, PSYCHOGERIATRICS, V16, P165, DOI 10.1111/psyg.12133; Gomez Fernando, 2016, Curr Gerontol Geriatr Res, V2016, P7910205; Hardy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056483; Hayes AF., 2018, INTRO MEDIATION MODE, V2nd ed.; Hayes J, 2016, QUEER ROOTS FOR THE DIASPORA: GHOSTS IN THE FAMILY TREE, P1; Hong S, 2016, J CLIN GERONTOL GERI, V7, P141, DOI 10.1016/j.jcgg.2016.05.002; Ko SU, 2010, J BIOMECH, V43, P1104, DOI 10.1016/j.jbiomech.2009.12.004; Kumar A, 2015, SALUD PUBLICA MEXICO, V57, pS31; Lai PPK, 2008, CLIN BIOMECH, V23, pS2, DOI 10.1016/j.clinbiomech.2008.02.004; Lang IA, 2008, J AM GERIATR SOC, V56, P1474, DOI 10.1111/j.1532-5415.2008.01813.x; LaRoche DP, 2015, MED SCI SPORT EXER, V47, P1017, DOI 10.1249/MSS.0000000000000501; LaRoche DP, 2011, J ELECTROMYOGR KINES, V21, P754, DOI 10.1016/j.jelekin.2011.07.006; Lopez-Teros T, 2014, J FRALITY AGING, V3, P109, DOI 10.14283/jfa.2014.10; Lv YB, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1915; Maffetone PB, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00190; Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010; Mendes J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22584-3; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Miller JW, 2013, MULTIVAR BEHAV RES, V48, P267, DOI 10.1080/00273171.2013.763567; Mlinac ME, 2016, ARCH CLIN NEUROPSYCH, V31, P506, DOI 10.1093/arclin/acw049; National Institute for Health and Clinical Excellence, 2014, OB ID ASS MAN; Pararasa C, 2015, BIOGERONTOLOGY, V16, P235, DOI 10.1007/s10522-014-9536-x; Perera S, 2016, J GERONTOL A-BIOL, V71, P63, DOI 10.1093/gerona/glv126; Portegijs E, 2016, J AM MED DIR ASSOC, V17, P410, DOI 10.1016/j.jamda.2015.12.010; Ramirez-Velez R, 2019, J CACHEXIA SARCOPENI, V10, P278, DOI 10.1002/jcsm.12373; Straight CR, 2015, AM J LIFESTYLE MED, V9, P130, DOI 10.1177/1559827613510681; Tallis J, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.190132; Tallis J, 2017, J APPL PHYSIOL, V122, P170, DOI 10.1152/japplphysiol.00836.2016; Tomlinson DJ, 2016, BIOGERONTOLOGY, V17, P467, DOI 10.1007/s10522-015-9626-4; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Verghese J, 2011, J GERONTOL A-BIOL, V66, P1083, DOI 10.1093/gerona/glr099; Veronese N, 2018, J AM MED DIR ASSOC, V19, P981, DOI 10.1016/j.jamda.2018.06.007; Wee CC, 2011, ANN INTERN MED, V154, P645, DOI 10.7326/0003-4819-154-10-201105170-00003	47	2	2	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	NOV	2019	127								110732	10.1016/j.exger.2019.110732	http://dx.doi.org/10.1016/j.exger.2019.110732			6	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	JH3ZM	31505226				2022-09-04	WOS:000492707500009
J	Godoy, DA; Nunez-Patino, RA; Zorrilla-Vaca, A; Ziai, WC; Hemphill, JC				Agustin Godoy, Daniel; Nunez-Patino, Rafael A.; Zorrilla-Vaca, Andres; Ziai, Wendy C.; Hemphill, J. Claude, III			Intracranial Hypertension After Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-analysis of Prevalence and Mortality Rate	NEUROCRITICAL CARE			English	Review						Intracerebral hemorrhage; Intracranial hypertension; Intracranial pressure; Meta-analysis; Prevalence; Mortality	NOT-RESUSCITATE ORDERS; COMATOSE PATIENTS; SURGICAL-MANAGEMENT; PRESSURE; GUIDELINES; HEMATOMAS; ICP	The objective of this study was to determine the prevalence of intracranial hypertension (IHT) and the associated mortality rate in patients who suffered from primary intracerebral hemorrhage (ICH). A secondary objective was to assess predisposing factors to IHT development. We conducted a systematic literature search of major electronic databases (MEDLINE, EMBASE, and Cochrane Library), for studies that assessed intracranial pressure (ICP) monitoring in patients with acute ICH. Study level and outcome measures were extracted. The meta-analysis was performed using a random-effects model. A total of six studies comprising 381 patients were pooled to estimate the overall prevalence of any episode of IHT (ICP>20mmHg) after ICH. The pooled prevalence rate for any episode of IHT after ICH was 67% (95% CI 51-84%). Four studies comprising 239 patients were pooled in order to estimate the overall mortality rate associated with IHT. Pooled mortality rate was 50% (95% CI 24-76%). For both outcomes, heterogeneity was statistically significant, and risk of bias was nonsignificant. Reported variables correlated significantly with increased ICP were lower Glasgow Coma Scale score at admission, midline shift, hemorrhage volume, and hydrocephalus. The prevalence and mortality rates associated with IHT after ICH are high and may be underestimated. Predicting factors for the development of IHT reflect the magnitude of the primary injury. However, the results of present meta-analysis should be interpreted with caution due to methodological limitations such as selection bias of patients who had ICP monitoring, and lack of standardized IHT definition.	[Agustin Godoy, Daniel] Hosp San Juan Bautista, Intens Care Unit, Sanatorio Pasteur, Neurointens Care Unit, Chacabuco 675, RA-4700 Catamarca, Argentina; [Nunez-Patino, Rafael A.] Pontificia Univ Javeriana, Sch Med, Fac Hlth Sci, Cali, Colombia; [Zorrilla-Vaca, Andres; Ziai, Wendy C.] Johns Hopkins Univ Hosp, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Zorrilla-Vaca, Andres] Univ Valle, Hosp Univ Valle, Fac Hlth, Cali, Colombia; [Ziai, Wendy C.] Johns Hopkins Univ, Sch Med, Dept Neurol, Div Neurosci Crit Care, Baltimore, MD 21205 USA; [Ziai, Wendy C.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol, Div Neurosci Crit Care, Baltimore, MD USA; [Ziai, Wendy C.] Johns Hopkins Univ, Sch Med, Dept Crit Care Med, Div Neurosci Crit Care, Baltimore, MD USA; [Hemphill, J. Claude, III] Univ Calif San Francisco, Neurocrit Care, San Francisco, CA 94143 USA; [Hemphill, J. Claude, III] Univ Calif San Francisco, Neurol & Neurol Surg, San Francisco, CA 94143 USA		Godoy, DA (corresponding author), Hosp San Juan Bautista, Intens Care Unit, Sanatorio Pasteur, Neurointens Care Unit, Chacabuco 675, RA-4700 Catamarca, Argentina.	dagodoytorres@yahoo.com.ar	Hemphill, Claude/AAY-5630-2021; Vaca, Andrés Zorrilla/I-9274-2014	Hemphill, Claude/0000-0003-4019-7525; Vaca, Andrés Zorrilla/0000-0001-8140-8486				Godoy DA, 2017, NEUROL CLIN, V35, P613, DOI 10.1016/j.ncl.2017.06.002; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Berlin T, 2015, SPRINGERPLUS, V4, DOI 10.1186/2193-1801-4-10; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P1935, DOI 10.1001/jama.274.24.1935; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Diedler J, 2014, CRIT CARE, V18, DOI 10.1186/cc13796; DUFF TA, 1981, NEUROSURGERY, V9, P387, DOI 10.1227/00006123-198110000-00007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fernandes HM, 2000, ACT NEUR S, V76, P463; Godoy Daniel Agustin, 2015, World J Crit Care Med, V4, P213, DOI 10.5492/wjccm.v4.i3.213; Hamani C, 2003, ARQ NEURO-PSIQUIAT, V61, P376, DOI 10.1590/S0004-282X2003000300010; Hara M, 1998, NEUROL RES, V20, P225, DOI 10.1080/01616412.1998.11740510; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; JANNY P, 1982, ACTA NEUROCHIR, V61, P181, DOI 10.1007/BF01740083; JANNY P, 1978, SURG NEUROL, V10, P371; Kamel H, 2012, NEUROCRIT CARE, V17, P172, DOI 10.1007/s12028-012-9744-7; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Ko SB, 2011, STROKE, V42, P3087, DOI 10.1161/STROKEAHA.111.623165; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136, 10.1136/bmj.b2700]; Manoel ALD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1432-0; Naidech AM, 2009, NEUROCRIT CARE, V11, P45, DOI 10.1007/s12028-009-9186-z; PAPO I, 1979, NEUROSURGERY, V4, P504, DOI 10.1227/00006123-197906000-00002; Rincon Fred, 2004, Curr Opin Crit Care, V10, P94, DOI 10.1097/00075198-200404000-00003; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P725, DOI 10.1001/archneur.1984.04050180047016; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Su WQ, 2017, WORLD NEUROSURG, V107, P389, DOI 10.1016/j.wneu.2017.07.179; Sykora M, 2014, J NEUROL SCI, V342, P141, DOI 10.1016/j.jns.2014.05.012; Tewari MK, 2015, TURK NEUROSURG, V25, P712, DOI 10.5137/1019-5149.JTN.11011-14.1; Thabet AM, 2017, HAND CLINIC, V140, P177, DOI 10.1016/B978-0-444-63600-3.00011-8; Tian Y, 2013, J NEUROL SCI, V330, P38, DOI 10.1016/j.jns.2013.04.001; Wells G., 2009, NEWCASTLE OTTAWA SCA; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72; Zahuranec DB, 2010, NEUROLOGY, V75, P626, DOI 10.1212/WNL.0b013e3181ed9cc9; Zeng JS, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-19; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170; Ziai WC, 2012, CRIT CARE MED, V40, P1601, DOI 10.1097/CCM.0b013e318241e380; Zurasky JA, 2005, NEUROLOGY, V64, P725, DOI 10.1212/01.WNL.0000152045.56837.58	39	15	20	1	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2019	31	1					176	187		10.1007/s12028-018-0658-x	http://dx.doi.org/10.1007/s12028-018-0658-x			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IH0YF	30565090				2022-09-04	WOS:000474217800022
J	Cabezas, R; Baez-Jurado, E; Hidalgo-Lanussa, O; Echeverria, V; Ashrad, GM; Sahebkar, A; Barreto, GE				Cabezas, Ricardo; Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Echeverria, Valentina; Ashrad, Ghulam Md; Sahebkar, Amirhossein; Barreto, George E.			Growth Factors and Neuroglobin in Astrocyte Protection Against Neurodegeneration and Oxidative Stress	MOLECULAR NEUROBIOLOGY			English	Review						PDGF-BB; Neuroglobin; Astrocyte; Oxidative stress; Neurodegeneration	ROTENONE INDUCES APOPTOSIS; UNFOLDED PROTEIN RESPONSE; RHO-ASSOCIATED KINASE; PARKINSONS-DISEASE; PDGF-BB; CELL-MIGRATION; FACTOR-I; TRANSCRIPTIONAL REGULATION; SIGNAL-TRANSDUCTION; REACTIVE ASTROCYTES	Neurodegenerative diseases, such as Parkinson and Alzheimer, are among the main public health issues in the world due to their effects on life quality and high mortality rates. Although neuronal death is the main cause of disruption in the central nervous system (CNS) elicited by these pathologies, other cells such as astrocytes are also affected. There is no treatment for preventing the cellular death during neurodegenerative processes, and current drug therapy is focused on decreasing the associated motor symptoms. For these reasons, it has been necessary to seek new therapeutical procedures, including the use of growth factors to reduce -synuclein toxicity and misfolding in order to recover neuronal cells and astrocytes. Additionally, it has been shown that some growth factors are able to reduce the overproduction of reactive oxygen species (ROS), which are associated with neuronal death through activation of antioxidative enzymes such as catalase, superoxide dismutase, glutathione peroxidase, and neuroglobin. In the present review, we discuss the use of growth factors such as PDGF-BB, VEGF, BDNF, and the antioxidative enzyme neuroglobin in the protection of astrocytes and neurons during the development of neurodegenerative diseases.	[Cabezas, Ricardo; Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Cabezas, Ricardo] Univ Santo Tomas, Dept Ciencias Basicas, Bucaramanga, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL 33744 USA; [Ashrad, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gsampaio@javeriana.edu.co	Barreto, George E./AAD-7420-2020; Sahebkar, Amirhossein/B-5124-2018	Barreto, George E./0000-0002-6644-1971; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X	PUJ	PUJ	This work was supported in part by PUJ grants to GEB.	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Ahmed Z, 2013, BRAIN PATHOL, V23, P263, DOI 10.1111/j.1750-3639.2012.00637.x; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Amri F, 2017, J NEUROCHEM, V140, P151, DOI 10.1111/jnc.13876; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Antao ST, 2010, ANTIOXID REDOX SIGN, V13, P769, DOI 10.1089/ars.2009.2977; Arrazola MS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00166; Ashino T, 2013, ARTERIOSCL THROM VAS, V33, P760, DOI 10.1161/ATVBAHA.112.300614; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Baez E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00146; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Ball SG, 2012, STEM CELLS, V30, P548, DOI 10.1002/stem.1015; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Berry C, 2010, CELL DEATH DIFFER, V17, P1115, DOI 10.1038/cdd.2009.217; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Board R, 2005, DRUG RESIST UPDATE, V8, P75, DOI 10.1016/j.drup.2005.03.004; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Brittain Thomas, 2012, Cells, V1, P1133, DOI 10.3390/cells1041133; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cabeza-Arvelaiz Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044700; Cabezas R, 2018, MOL NEUROBIOL, V55, P3085, DOI 10.1007/s12035-017-0567-6; Cabezas R, 2016, MED CHEM, V12, P204, DOI 10.2174/1573406411666151019120444; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Chen LW, 2005, CURR DRUG TARGETS, V6, P821, DOI 10.2174/138945005774574506; Chen XM, 2015, NEUROSCI LETT, V606, P194, DOI 10.1016/j.neulet.2015.09.002; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chen YY, 2008, BIOCHEM PHARMACOL, V76, P128, DOI 10.1016/j.bcp.2008.04.010; CHENG B, 1995, J NEUROSCI, V15, P7095; Chung YC, 2010, BMB REP, V43, P225, DOI 10.5483/BMBRep.2010.43.4.225; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; Correia AS, 2005, ANN MED, V37, P487, DOI 10.1080/07853890500327967; Avila-Gomez IC, 2010, BASIC CLIN PHARMACOL, V106, P53, DOI 10.1111/j.1742-7843.2009.00472.x; De Andrade DVG, 2008, BRAIN RES, V1198, P188, DOI 10.1016/j.brainres.2008.01.006; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; de Oliveira DM, 2011, HUM EXP TOXICOL, V30, P1382, DOI 10.1177/0960327110389837; de Oliveria DM, 2009, NEUROCHEM RES, V34, P215, DOI 10.1007/s11064-008-9749-y; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; dos Santos AB, 2015, NEUROCHEM RES, V40, P421, DOI 10.1007/s11064-014-1488-7; dos Santos AB, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00273; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Egawa-Tsuzuki T, 2004, EXP NEUROL, V186, P89, DOI 10.1016/j.expneurol.2003.11.001; Emara M, 2009, MOL ONCOL, V3, P45, DOI 10.1016/j.molonc.2008.11.002; 'Episcopo Francesca L, 2013, Curr Aging Sci, V6, P45; Fago A, 2008, IUBMB LIFE, V60, P398, DOI 10.1002/iub.35; Falk T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-49; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Fujimura M, 2012, TOXICOL SCI, V126, P506, DOI 10.1093/toxsci/kfr352; Funa K, 2014, J NEUROIMMUNE PHARM, V9, P168, DOI 10.1007/s11481-013-9479-z; Furlong M, 2015, ENVIRON INT, V75, P144, DOI 10.1016/j.envint.2014.11.002; Garofalo T, 2018, MOL CELL NEUROSCI, V88, P167, DOI 10.1016/j.mcn.2018.01.007; Gorbatyuk MS, 2012, MOL THER, V20, P1327, DOI 10.1038/mt.2012.28; Gosslau A, 2001, COMP BIOCHEM PHYS A, V128, P241, DOI 10.1016/S1095-6433(00)00303-2; Greenamyre JT, 2010, TRENDS PHARMACOL SCI, V31, P141, DOI 10.1016/j.tips.2009.12.006; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Haines B, 2012, NEUROSCI LETT, V514, P137, DOI 10.1016/j.neulet.2012.01.080; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hashida K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047950; Hauser RA, 2006, ARCH NEUROL-CHICAGO, V63, P1756, DOI 10.1001/archneur.63.12.1756; HEDBERG KM, 1993, CELL MOTIL CYTOSKEL, V24, P139, DOI 10.1002/cm.970240207; Heinz S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45465; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Henriques A, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00032; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Hsuan SL, 2006, J NEUROSCI, V26, P4481, DOI 10.1523/JNEUROSCI.4922-05.2006; Iihara K, 1997, J CEREBR BLOOD F MET, V17, P1097, DOI 10.1097/00004647-199710000-00012; Iqbal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030764; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Jankovic J, 2012, CURR OPIN NEUROL, V25, P433, DOI 10.1097/WCO.0b013e3283542fc2; Jarlestedt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010397; Jin KL, 2012, NEUROSCI LETT, V519, P47, DOI 10.1016/j.neulet.2012.05.018; Johnson ME, 2015, NEUROTOXICOLOGY, V46, P101, DOI 10.1016/j.neuro.2014.12.002; Kagiyama S, 2010, REGUL PEPTIDES, V160, P133, DOI 10.1016/j.regpep.2009.12.002; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Kang SW, 2007, CELL MOL LIFE SCI, V64, P533, DOI 10.1007/s00018-007-6437-z; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Klingelhoefer L, 2015, NAT REV NEUROL, V11, P625, DOI 10.1038/nrneurol.2015.197; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Krupinski J, 1997, STROKE, V28, P564, DOI 10.1161/01.STR.28.3.564; LEE S, BRAIN RES MOL BRAIN, V47, P183; Lehwald N, 2012, GASTROENTEROLOGY, V143, P754, DOI 10.1053/j.gastro.2012.05.048; Li L, 2010, CHINESE MED J-PEKING, V123, P2502, DOI 10.3760/cma.j.issn.0366-6999.2010.18.002; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu B, 2003, ENVIRON HEALTH PERSP, V111, P1065, DOI 10.1289/ehp.6361; Liu N, 2013, NEUROSCI LETT, V534, P333, DOI 10.1016/j.neulet.2012.11.025; Liu N, 2012, BIOCHEM J, V443, P153, DOI 10.1042/BJ20111856; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Mena MA, 2008, NEUROSCIENTIST, V14, P544, DOI 10.1177/1073858408322839; Menza M, 2010, PSYCHOSOMATICS, V51, P474, DOI 10.1176/appi.psy.51.6.474; More SV, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/952375; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Niranjan R, 2010, FREE RADICAL RES, V44, P1304, DOI 10.3109/10715762.2010.501080; NOBES CD, 1995, J CELL SCI, V108, P225; Noma K, 2007, J AM COLL CARDIOL, V49, P698, DOI 10.1016/j.jacc.2006.06.082; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Ogawa N, 2005, J NEUROL, V252, P23, DOI 10.1007/s00415-005-4006-7; Osborne A, 2018, STEM CELLS, V36, P65, DOI 10.1002/stem.2722; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Pang Y, 2010, PEDIATR RES, V67, P579, DOI 10.1203/PDR.0b013e3181dc240f; Parpura V, 2011, BBA-MOL CELL RES, V1813, P984, DOI 10.1016/j.bbamcr.2010.11.006; Paul G, 2015, J CLIN INVEST, V125, P1339, DOI 10.1172/JCI79635; Peng FW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047572; Perier C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009332; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Pinzani M, 2002, FRONT BIOSCI-LANDMRK, V7, pD1720, DOI 10.2741/pinzani; Post B, 2011, MOVEMENT DISORD, V26, P449, DOI 10.1002/mds.23467; POWIS G, 1990, J BIOL CHEM, V265, P10266; Proschel C, 2014, EMBO MOL MED, V6, P504, DOI 10.1002/emmm.201302878; Ramakers GJA, 1998, EXP CELL RES, V245, P252, DOI 10.1006/excr.1998.4224; Ramaswamy S, 2009, PARKINSONISM RELAT D, V15, pS176, DOI 10.1016/S1353-8020(09)70809-0; RIDEFELT P, 1995, GROWTH FACTORS, V12, P191, DOI 10.3109/08977199509036879; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Ruusala A, 1998, J CELL SCI, V111, P111; Safi R, 2012, J MOL NEUROSCI, V46, P654, DOI 10.1007/s12031-011-9654-8; Sakata M, 1998, BRAIN RES, V784, P250, DOI 10.1016/S0006-8993(97)01345-0; Samantaray S, 2007, NEUROSCIENCE, V146, P741, DOI 10.1016/j.neuroscience.2007.01.056; Sanchez M, 2008, TOXICOL SCI, V104, P352, DOI 10.1093/toxsci/kfn092; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; Shin Hye Won, 2009, Korean J Hepatol, V15, P486, DOI 10.3350/kjhep.2009.15.4.486; Simon AR, 2002, AM J PHYSIOL-LUNG C, V282, pL1296, DOI 10.1152/ajplung.00315.2001; Simpkins JW, 2010, BBA-GEN SUBJECTS, V1800, P1113, DOI 10.1016/j.bbagen.2009.11.013; Song YJC, 2009, J NEUROPATH EXP NEUR, V68, P1073, DOI 10.1097/NEN.0b013e3181b66f1b; Sonsalla Patricia K, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS116, DOI 10.1016/j.parkreldis.2008.04.008; SUGAYA K, BRAIN RES MOL BRAIN, V58, P1; Sugitani K, 2017, BIOCHEM BIOPH RES CO, V493, P1254, DOI 10.1016/j.bbrc.2017.09.127; Svitkina T, 2010, J NEUROSCI, V30, P14937, DOI 10.1523/JNEUROSCI.4276-10.2010; Swarnkar S, 2012, NEUROCHEM RES, V37, P2178, DOI 10.1007/s11064-012-0841-y; Tang ZS, 2010, J EXP MED, V207, P867, DOI 10.1084/jem.20091704; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tiwari M, 2011, J BIOL CHEM, V286, P8493, DOI 10.1074/jbc.M110.163824; Tong JC, 2015, NEUROBIOL DIS, V82, P243, DOI 10.1016/j.nbd.2015.06.010; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Torrente Daniel, 2015, Front Biosci (Elite Ed), V7, P434; Toshkezi G, 2018, J NEUROSURG, V129, P1286, DOI 10.3171/2017.7.JNS17878; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Trojanowska M, 2008, RHEUMATOLOGY, V47, pV2, DOI 10.1093/rheumatology/ken265; Tseng HC, 2005, NEUROBIOL DIS, V19, P77, DOI 10.1016/j.nbd.2004.11.007; Van Leuven W, 2013, BBA-PROTEINS PROTEOM, V1834, P1764, DOI 10.1016/j.bbapap.2013.04.015; Varma D, 2015, ACTA NEUROBIOL EXP, V75, P1; Venugopal C, 2018, NEUROTOXICOLOGY, V69, P189, DOI 10.1016/j.neuro.2017.11.010; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wachter B, 2010, CELL TISSUE RES, V342, P147, DOI 10.1007/s00441-010-1061-x; Wang HL, 2011, BBA-MOL BASIS DIS, V1812, P674, DOI 10.1016/j.bbadis.2011.03.007; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI 10.1089/ARS.2009.2485; Wang Z, 2010, BBA-REV CANCER, V1806, P122, DOI 10.1016/j.bbcan.2010.04.003; Watabe M, 2004, J PHARMACOL EXP THER, V311, P948, DOI 10.1124/jpet.104.071381; Weissmiller AM, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-14; Xie LK, 2016, MED GAS RES, V6, P154, DOI 10.4103/2045-9912.191361; Ye SQ, 2009, ACTA PHARMACOL SIN, V30, P913, DOI 10.1038/aps.2009.70; Yu JC, 2001, J PHARMACOL EXP THER, V298, P1172; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Yu Z, 2012, NEUROSCIENCE, V218, P235, DOI 10.1016/j.neuroscience.2012.05.054; Yu ZY, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/756989; Zachrisson O, 2011, J PARKINSON DIS, V1, P49, DOI 10.3233/JPD-2011-0003; Zhang S, 2011, CELL MOL NEUROBIOL, V31, P111, DOI 10.1007/s10571-010-9560-6; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302; Zhu XH, 2009, TOXICOL APPL PHARM, V240, P286, DOI 10.1016/j.taap.2009.06.020; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	175	25	28	1	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2019	56	4					2339	2351		10.1007/s12035-018-1203-9	http://dx.doi.org/10.1007/s12035-018-1203-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU7XZ	29982985				2022-09-04	WOS:000465498200004
J	Alvarez-Moreno, CA; Valderrama-Beltran, SL; Rosenthal, VD; Mojica-Carreno, BE; Valderrama-Marquez, IA; Matta-Cortes, L; Gualtero-Trujillo, SM; Rodriguez-Pena, J; Linares-Miranda, CJ; Gonzalez-Rubio, AP; Vega-Galvis, MC; Riano-Forero, I; Ariza-Ayala, BE; Garcia-Laverde, G; Susmann, O; Mancera-Paez, O; Olarte, N; Rendon-Campo, LF; Astudillo, Y; Trullo-Escobar, MD; Orellano, PW				Alvarez-Moreno, Carlos A.; Valderrama-Beltran, Sandra L.; Rosenthal, Victor D.; Mojica-Carreno, Beatriz E.; Valderrama-Marquez, Ismael A.; Matta-Cortes, Lorena; Gualtero-Trujillo, Sandra M.; Rodriguez-Pena, Jazmin; Linares-Miranda, Claudia J.; Gonzalez-Rubio, Angela P.; Vega-Galvis, Maria C.; Riano-Forero, Ivan; Ariza-Ayala, Beatriz E.; Garcia-Laverde, German; Susmann, Otto; Mancera-Paez, Oscar; Olarte, Narda; Rendon-Campo, Luis F.; Astudillo, Yamileth; del Socorro Trullo-Escobar, Maria; Orellano, Pablo W.			Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line-associated bloodstream infection rates	AMERICAN JOURNAL OF INFECTION CONTROL			English	Article						Hospital infection; health care-acquired infection; device-associated infection; developing countries; limited-resource countries; low-income countries; critical care; surveillance; incidence density; bundle	INTENSIVE-CARE UNITS; CENTRAL VENOUS CATHETER; ATTRIBUTABLE COST; 8 CITIES; DEVICE; SURVEILLANCE; MORTALITY; COUNTRIES; LENGTH; HOSPITALS	Background: The objective of this study was to analyze the impact of a multidimensional infection control approach and the use of the International Nosocomial Infection Control Consortium (INICC) Surveillance Online System on central line-associated bloodstream infection (CLABSI) rates from June 2003-April 2010. Methods: We conducted a prospective, before-after surveillance study of 2,564 patients hospitalized in 4 adult intensive care units (ICUs) and 424 patients in 2 pediatric ICUs of 4 hospitals in 2 cities of Colombia. During baseline, we performed outcome surveillance of CLABSI applying the Centers for Disease Control and Prevention's National Healthcare Safety Network definitions. During intervention, we implemented the INICC multidimensional approach and the ISOS, which included a bundle of infection prevention practice interventions, education, outcome surveillance, process surveillance, feedback on CLABSI rates and consequences, and performance feedback of process surveillance. Bivariate and multivariate regression analyses were performed using a logistic regression model to estimate the effect of the intervention on the CLABSI rate. Results: The baseline rate of 12.9 CLABSIs per 1,000 central line (CL) days, with 3,032 CL days and 39 CLABSIs, was reduced to 3.5 CLABSIs per 1,000 CL days, with 3,686 CL days and 13 CLABSIs, accounting for a 73% CLABSI rate reduction (relative risk, 0.27; 95% confidence interval, 0.14-0.52; P =. 002). Conclusions: Implementing the INICC multidimensional infection control approach for CLABSI prevention was associated with a significant reduction in the CLABSI rate of ICUs of Colombia. (C) 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.	[Alvarez-Moreno, Carlos A.] Univ Nacl Colombia, Fac Med, Bogota, Colombia; [Valderrama-Beltran, Sandra L.; Gualtero-Trujillo, Sandra M.; Rodriguez-Pena, Jazmin; Linares-Miranda, Claudia J.; Gonzalez-Rubio, Angela P.; Vega-Galvis, Maria C.; Riano-Forero, Ivan; Ariza-Ayala, Beatriz E.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Rosenthal, Victor D.; Orellano, Pablo W.] Int Nosocomial Infect Control Consortium, 11 Septiembre 4567,Floor 12th,Apt 1201, RA-1429 Buenos Aires, DF, Argentina; [Mojica-Carreno, Beatriz E.] Clin Nueva, Bogota, Colombia; [Valderrama-Marquez, Ismael A.; Mancera-Paez, Oscar; Olarte, Narda] Hosp El Tunal ESE, Bogota, Colombia; [Matta-Cortes, Lorena; Rendon-Campo, Luis F.; Astudillo, Yamileth; del Socorro Trullo-Escobar, Maria] Univ Libre, Corp Comfenalco Valle, Santiago De Cali, Colombia; [Orellano, Pablo W.] Univ Tecnol Nacl, Fac Reg San Nicolas, San Nicolas, Argentina; [Orellano, Pablo W.] Consejo Nacl Invest Cient & Tecn, San Nicolas, Argentina		Rosenthal, VD (corresponding author), Int Nosocomial Infect Control Consortium, 11 Septiembre 4567,Floor 12th,Apt 1201, RA-1429 Buenos Aires, DF, Argentina.	victor_rosenthal@inicc.org	Moreno, carlos Arturo alvarez/P-6678-2016; Matta Cortes, Lorena/I-9030-2016; Orellano, Pablo/H-2733-2015	Moreno, carlos Arturo alvarez/0000-0001-5419-4494; Matta Cortes, Lorena/0000-0002-5215-3215; Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318; ROSENTHAL, VICTOR DANIEL/0000-0001-9138-4801; Orellano, Pablo/0000-0001-8911-663X; , Ivan/0000-0002-9696-2866; Valderrama-Beltran, Sandra Liliana/0000-0003-1833-1599; ARIZA AYALA, BEATRIZ ELENA/0000-0001-8650-5285				Navoa-Ng JA, 2013, J INFECT PUBLIC HEAL, V6, P389, DOI 10.1016/j.jiph.2013.03.002; Rosenthal VD, 2016, AM J INFECT CONTROL, V44, pE81, DOI 10.1016/j.ajic.2016.01.005; Rosenthal VD, 2015, AM J INFECT CONTROL, V43, P1040, DOI 10.1016/j.ajic.2015.05.042; Rosenthal VD, 2013, INFECT CONT HOSP EP, V34, P229, DOI 10.1086/669511; Dudeck MA, 2015, AM J INFECT CONTROL, V43, P206, DOI 10.1016/j.ajic.2014.11.014; Geffers C, 2011, DTSCH ARZTEBL INT, V108, P87, DOI 10.3238/arztebl.2011.0087; Higuera F, 2007, INFECT CONT HOSP EP, V28, P31, DOI 10.1086/510812; Higuera F, 2005, CRIT CARE MED, V33, P2022, DOI 10.1097/01.CCM.0000178190.89663.E5; Jaggi N, 2013, INT J INFECT DIS, V17, pE1218, DOI 10.1016/j.ijid.2013.07.007; Leblebicioglu H, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-10; Maki DG, 2011, INFECT CONT HOSP EP, V32, P50, DOI 10.1086/657632; Olarte NM, 2010, BIOMEDICA, V30, P353, DOI 10.7705/biomedica.v30i3.269; Marschall J, 2008, INFECT CONT HOSP EP, V29, pS22, DOI 10.1086/591059; MCGEER A, 1991, AM J INFECT CONTROL, V19, P1, DOI 10.1016/0196-6553(91)90154-5; Moreno CA, 2006, INFECT CONT HOSP EP, V27, P349, DOI 10.1086/503341; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Osorio J, 2013, REV CHIL INFECTOL, V30, P465, DOI 10.4067/S0716-10182013000500001; Villalobos AP, 2014, BIOMEDICA, V34, P67, DOI [10.7705/biomedica.v34i0.1698, 10.1590/S0120-41572014000500009]; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Rosenthal VD, 2012, INFECTION, V40, P415, DOI 10.1007/s15010-012-0246-5; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P392, DOI 10.1016/j.ajic.2004.08.009; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P475, DOI 10.1016/j.ajic.2003.03.002; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P291, DOI 10.1067/mic.2003.1; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P405, DOI 10.1067/mic.2003.52; Rosenthal VD, 2016, AM J INFECT CONTROL; Rosenthal VD, 2008, AM J INFECT CONTROL, V36, P627, DOI [10.1016/j.ajic.2008.10.009, 10.1016/j.ajic.2008.06.003]; Rosenthal VD, 2006, ANN INTERN MED, V145, P582, DOI 10.7326/0003-4819-145-8-200610170-00007; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Rosenthal VD, 2011, LANCET, V377, P186, DOI 10.1016/S0140-6736(10)62005-3; Rosenthal VD, 2010, INFECT CONT HOSP EP, V31, P1264, DOI 10.1086/657140; Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004; Rosenthal VD, 2009, CLIN INFECT DIS, V49, P1899, DOI 10.1086/648439; Rosenthal VD, 2014, AM J INFECT CONTROL, V42, P942, DOI 10.1016/j.ajic.2014.05.029; Stevens V, 2014, CLIN MICROBIOL INFEC, V20, pO318, DOI 10.1111/1469-0691.12407; Stone PW, 2005, AM J INFECT CONTROL, V33, P501, DOI 10.1016/j.ajic.2005.04.246	35	18	20	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-6553	1527-3296		AM J INFECT CONTROL	Am. J. Infect. Control	NOV 1	2016	44	11					E235	E241		10.1016/j.ajic.2016.03.043	http://dx.doi.org/10.1016/j.ajic.2016.03.043			7	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	EE3QQ	27317408				2022-09-04	WOS:000389510700009
J	Priebe, S; Fung, C; Sajun, SZ; Alinaitwe, R; Giacco, D; Gomez-Restrepo, C; Kulenovic, AD; Nakasujja, N; Ramirez, SM; Slatina, S; Sewankambo, NK; Sikira, H; Uribe, M; Bird, VJ				Priebe, Stefan; Fung, Catherine; Sajun, Sana Z.; Alinaitwe, Racheal; Giacco, Domenico; Gomez-Restrepo, Carlos; Kulenovic, Alma Dzubur; Nakasujja, Noeline; Milena Ramirez, Sandra; Slatina, Sabina; Sewankambo, Nelson K.; Sikira, Hana; Uribe, Miguel; Bird, Victoria Jane			Resource-oriented interventions for patients with severe mental illnesses in low- and middle-income countries: trials in Bosnia-Herzegovina, Colombia and Uganda	BMC PSYCHIATRY			English	Article						Global mental health; Psychosocial interventions; Resource-oriented approach; LMICs; Solution-focused; Volunteer support; Family involvement; Severe mental illness	ATTITUDES; SCALE; SCHIZOPHRENIA; MEDICATION; PSYCHOSIS; OUTCOMES; LIFE	BackgroundSevere mental illness (SMI) presents a major burden to societies worldwide. Low- and middle-income countries (LMICs) often do not have sufficient financial resources and qualified staff to provide extensive specialised services for outpatients with SMI. Our research therefore aims to explore and test low-cost interventions that use existing resources in routine patient-clinician meetings, families and communities.MethodsIn Bosnia-Herzegovina, Colombia and Uganda, three psychosocial interventions will be tested, i.e. making patient-clinician meetings therapeutically effective through DIALOG+, family involvement in multi-family group meetings, and support for patients in befriending schemes with volunteers. All interventions will be provided to patients with SMI, delivered over a six-month period and evaluated with assessments at baseline and after six and 12months. We will conduct nine trials including non-controlled trials, non-randomised controlled trials and randomised controlled trials (RCTs). Core outcome criteria will be used across all studies. However, details of study delivery and additional outcome criteria vary to accommodate local contexts, interests and priorities. The studies will be analysed separately, but with the option to compare and combine findings.DiscussionThe approach provides the opportunity to learn from commonalities and differences in the results and experiences across the three resource-oriented approaches and the three countries. If successfully implemented the studies can lead to more extensive research and are expected to inform health policies and clinical practice of community care for patients with SMI in the three participating countries and other LMICs.Trial registrationAll RCTs were registered prospectively and non-randomised trials retrospectively within the ISRCTN Registry.DIALOG+ in Uganda: ISRCTN25146122 (Date of Registration: 20/11/2018, prospective); DIALOG+ in Colombia: ISRCTN83333181 (Date of Registration: 20/11/2018, prospective); DIALOG+ in Bosnia-Herzegovina: ISRCTN13347129 (Date of Registration: 20/11/2018, prospective); Volunteer Support in Uganda: ISRCTN86689958 (Date of Registration: 04/03/2019, retrospective); Volunteer Support in Colombia: ISRCTN72241383 (Date of Registration: 04/03/2019, retrospective);Volunteer Support in Bosnia-Herzegovina: ISRCTN51290984 (Date of Registration: 20/11/2018, prospective); Family Involvement in Uganda: ISRCTN78948497 (Date of Registration: 04/03/2019, retrospective); Family Involvement in Colombia: ISRCTN11440755 (Date of Registration: 04/03/2019, retrospective); Family Involvement in Bosnia-Herzegovina: ISRCTN13347355 (Date of Registration: 20/11/2018, prospective).	[Priebe, Stefan; Fung, Catherine; Sajun, Sana Z.; Giacco, Domenico; Bird, Victoria Jane] Queen Mary Univ London, WHO Collaborating Ctr Mental Hlth Serv Dev, Unit Social & Community Psychiat, Newham Ctr Mental Hlth, London E13 8SP, England; [Alinaitwe, Racheal; Nakasujja, Noeline] Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda; [Gomez-Restrepo, Carlos] Pontifica Univ Javeriana, Hosp Univ San Ignacio, Dept Clin Epidemiol & Biostat & Psychiat & Mental, Bogota, Colombia; [Kulenovic, Alma Dzubur; Slatina, Sabina; Sikira, Hana] Univ Sarajevo, Clin Ctr, Sarajevo, Bosnia & Herceg; [Milena Ramirez, Sandra] Pontificia Univ Javeriana, Dept Clin Med, Cali, Colombia; [Sewankambo, Nelson K.] Makerere Univ, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Uribe, Miguel] Pontificia Univ Javeriana, Dept Social & Prevent Med & Psychiat & Mental Hlt, Bogota, Colombia		Priebe, S (corresponding author), Queen Mary Univ London, WHO Collaborating Ctr Mental Hlth Serv Dev, Unit Social & Community Psychiat, Newham Ctr Mental Hlth, London E13 8SP, England.	s.priebe@qmul.ac.uk	; Bird, Victoria/N-1165-2013	Priebe, Stefan/0000-0001-9864-3394; Uribe Restrepo, Jose Miguel/0000-0003-4284-7886; Slatina Murga, Sabina/0000-0002-2506-3409; Giacco, Domenico/0000-0001-7809-8800; Ramirez, Sandra/0000-0002-1882-0870; Sikira, Hana/0000-0001-8135-6911; Bird, Victoria/0000-0002-2053-7679	National Institute for Health Research (NIHR) - [NIHR Global Health Group on Developing Psycho-Social Interventions], Official Development Assistance (ODA) [16/137/97]	National Institute for Health Research (NIHR) - [NIHR Global Health Group on Developing Psycho-Social Interventions], Official Development Assistance (ODA)	This research was peer-reviewed and commissioned by the National Institute for Health Research (NIHR) - [NIHR Global Health Group on Developing Psycho-Social Interventions] Grant number 16/137/97, using Official Development Assistance (ODA) funding. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Beecham J., 2001, MEASURING MENTAL HLT, V2, P200; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; BROWNE RH, 1995, STAT MED, V14, P1933, DOI 10.1002/sim.4780141709; Cam L., 1986, STAT SCI, V1, P78, DOI DOI 10.1214/ss/1177013818; Davidson J, 1994, CENTRAL LIMIT THEORE, P345; Grasel E., 2003, DEV VALIDATION BURDE; Hammer J.H., 2017, STIGMA HLTH, V2, P159, DOI [10.1037/sah0000049, DOI 10.1037/SAH0000049]; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Kaselionyte J, 2016, BJPSYCH OPEN, V2, P330, DOI 10.1192/bjpo.bp.116.003269; Lecomte T, 2006, PSYCHIAT RES, V143, P99, DOI 10.1016/j.psychres.2005.08.019; Lovibond S.H., 1995, MANUAL DEPRESSION AN, V2nd; MacGabhann L, 2018, MENT HEALTH REV J, V23, P94, DOI 10.1108/MHRJ-08-2017-0032; McGuire-Snieckus R, 2007, PSYCHOL MED, V37, P85, DOI 10.1017/S0033291706009299; Mohamed S, 2009, SCHIZOPHRENIA BULL, V35, P336, DOI 10.1093/schbul/sbn067; Nguyen T D, 1983, Eval Program Plann, V6, P299, DOI 10.1016/0149-7189(83)90010-1; Omer S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148415; Patel V, 2010, JAMA-J AM MED ASSOC, V303, P1397; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000160; Priebe S, 2008, ACTA PSYCHIAT SCAND, V118, P57, DOI 10.1111/j.1600-0447.2008.01217.x; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Priebe S, 2017, NIHR J LIB HLTH TECH, V5; Priebe S, 2015, PSYCHOTHER PSYCHOSOM, V84, P304, DOI 10.1159/000430991; Priebe S, 2014, BRIT J PSYCHIAT, V204, P256, DOI 10.1192/bjp.bp.113.135038; Priebe S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-173; Schomerus G, 2015, ACTA PSYCHIAT SCAND, V132, P357, DOI 10.1111/acps.12401; Siette J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014304; Szymczynska P, 2017, J PSYCHIATR RES, V90, P67, DOI 10.1016/j.jpsychires.2017.02.009; TAYLOR SM, 1981, SCHIZOPHRENIA BULL, V7, P225, DOI 10.1093/schbul/7.2.225; Thombal R. S., 2015, J CHEM APPL BIOCH, V2, P1, DOI DOI 10.2196/MENTAL.3926; Thompson K, 2000, SCHIZOPHR RES, V42, P241, DOI 10.1016/S0920-9964(99)00130-9; Toner S, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1643-9; Ventura J., 1993, BRIEF PSYCHIAT RATIN; World Health Organization, 1993, ICD 10 CLASSIFICATIO, V1	33	10	10	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-244X			BMC PSYCHIATRY	BMC Psychiatry	JUN 14	2019	19								181	10.1186/s12888-019-2148-x	http://dx.doi.org/10.1186/s12888-019-2148-x			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	ID5MH	31200671	Green Published, gold			2022-09-04	WOS:000471720000001
J	Ramos-Castaneda, JA; Ruano-Ravina, A; Barbosa-Lorenzo, R; Paillier-Gonzalez, JE; Saldana-Campos, JC; Salinas, DF; Lemos-Luengas, EV				Ramos-Castaneda, Jorge A.; Ruano-Ravina, Alberto; Barbosa-Lorenzo, Raquel; Paillier-Gonzalez, Jaime E.; Saldana-Campos, Javier C.; Salinas, Diego F.; Lemos-Luengas, Elkin V.			Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis Mortality due to KPC Klebsiella pneumoniae infections	JOURNAL OF INFECTION			English	Review						Klebsiella pneumoniae; Carbapenemase; KPC; Bacterial resistance; Mortality	BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; EXTENSIVELY DRUG-RESISTANT; GRAM-NEGATIVE BACTERIA; ACUTE KIDNEY INJURY; K.-PNEUMONIAE; RISK-FACTORS; MOLECULAR CHARACTERIZATION; NOSOCOMIAL OUTBREAK; POLYMYXIN-B	Introduction: KPC carbapenemase- producing Klebsiella pneumoniae (KPC- KP)has become a major public health challenge. Accordingly, this study sought to use a systematic review of the scientific literature to ascertain the mortality of KPC- KP infection, and analyze such mortality by country, year of publication, hospital ward, and type of interpretation used to define carbapenem resistance. Methodology: A search without language restrictions was made of the MEDLINE, CENTRAL, EBSCO, LILACS and EMBASE databases from 1996 through June 2017, to locate all studies which had determined the existence of KPC- KP infection. We then performed a meta- analysis of all studies that reported KPC- KP infection- related mortality, and analyzedmortality by subgroup in accordance with standardmethodology. Results: A total of 51 papers were included in the systematic review. From 2005 through 2017, data on KPC- KP infection were reported in 5124 patients, with an average of 465 patients per year. The most widely studied type of infection was bacteremia (28.0%). The meta- analysis showed that overall mortality for the 37 studies was 41.0% (95%CI 37.0-44.0), with the highest mortality rates being observed in oncology patients, 56.0% (95%CI 38.1-73.0), and Brazil, 51.3% (95%CI 43.0-60.0). Conclusion: KPC- KP infection- related mortality is high, is manifested differently in some countries, and is highest among oncology patients. (C) 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.	[Ramos-Castaneda, Jorge A.] Univ CES, Grad Sch, Medellin, Colombia; [Ruano-Ravina, Alberto] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain; [Ruano-Ravina, Alberto] CIBERESP, CIBER Epidemiol & Publ Hlth, Madrid, Spain; [Barbosa-Lorenzo, Raquel] Monforte de Lemos Local Hosp, Prevent Med & Publ Hlth Unit, Monforte De Lemos, Spain; [Paillier-Gonzalez, Jaime E.] Hosp Gen Medellin Luz Castro de Gutierrez, Intens Care Unit, Medellin, Colombia; [Saldana-Campos, Javier C.] Javeriana Univ, Cali, Colombia; [Salinas, Diego F.] Hosp Univ Hernando Moncaleano Perdomo, Infect Dis Unit, Neiva, Colombia; [Lemos-Luengas, Elkin V.] Univ CES, Publ Hlth Observ, Medellin, Colombia		Ramos-Castaneda, JA (corresponding author), Univ CES, Grad Sch, Medellin, Colombia.	jormos2806@gmail.com	Ramos-Castaneda, Jorge Andres/AAE-6277-2020; Lemos, Elkin V/I-6846-2012; Ruano-Ravina, Alberto/M-5705-2018	Ramos-Castaneda, Jorge Andres/0000-0003-3297-0012; Lemos, Elkin V/0000-0002-2506-2000; Ruano-Ravina, Alberto/0000-0001-9927-7453				Agodi A, 2011, J CLIN MICROBIOL, V49, P3986, DOI 10.1128/JCM.01242-11; Aguayo A, 2016, REV CHIL INFECTOL, V33, P166, DOI 10.4067/S0716-10182016000200006; Akajagbor DS, 2013, CLIN INFECT DIS, V57, P1300, DOI 10.1093/cid/cit453; Alevizakos M, 2017, TRANSPL INFECT DIS, V19; [Anonymous], 2014, BREAKP TABL INT MICS; [Anonymous], 2014, REV ANTIMICROBIAL RE; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Bartolleti F, 2016, EMERG INFECT DIS, V22, P1849, DOI 10.3201/eid2210.160695; Bathoorn E, 2016, J ANTIMICROB CHEMOTH, V71, P1207, DOI 10.1093/jac/dkv467; Bergamasco MD, 2012, TRANSPL INFECT DIS, V14, P198, DOI 10.1111/j.1399-3062.2011.00688.x; CDC, 2015, FAC GUID CONTR CARB, P1; CDC, 2017, CDC WORKS 24 7; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Cercenado E, 2014, ENFERM INFEC MICR CL, V32, P66, DOI 10.1016/j.eimc.2013.09.005; Chang LWK, 2015, INTERN MED J, V45, P1037, DOI 10.1111/imj.12863; Chang YY, 2015, J MICROBIOL IMMUNOL, V48, P219, DOI 10.1016/j.jmii.2014.05.010; Chitnis AS, 2012, INFECT CONT HOSP EP, V33, P984, DOI 10.1086/667738; Clancy CJ, 2013, AM J TRANSPLANT, V13, P2619, DOI 10.1111/ajt.12424; Clinical & Laboratory Standards Institute, CLSI GUID; CLSI, 2014, PERFORMANCE STANDARD; Corbellini S, 2014, NEW MICROBIOL, V37, P177; Cordova E, 2012, ENFERM INFEC MICR CL, V30, P376, DOI 10.1016/j.eimc.2011.12.003; Daikos GL, 2014, ANTIMICROB AGENTS CH, V58, P2322, DOI 10.1128/AAC.02166-13; Di Carlo P, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-13; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V64, P1102, DOI 10.1093/jac/dkp327; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Falcone M, 2016, CLIN MICROBIOL INFEC, V22, P444, DOI 10.1016/j.cmi.2016.01.016; Fierro J D, 2016, REV FAC SALUD RFS, V7, P29; Florescu DF, 2012, CLIN INFECT DIS, V54, P670, DOI 10.1093/cid/cir934; Freire MP, 2015, EUR J CLIN MICROBIOL, V34, P277, DOI 10.1007/s10096-014-2233-5; Freire MP, 2015, INFECTION, V43, P315, DOI 10.1007/s15010-015-0743-4; Giacobbe DR, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.08.001; Giani T, 2015, J CLIN MICROBIOL, V53, P3341, DOI 10.1128/JCM.01017-15; Girometti N, 2014, MEDICINE, V93, P298, DOI 10.1097/MD.0000000000000111; Goncalves IR, 2016, J HOSP INFECT, V94, P322, DOI 10.1016/j.jhin.2016.08.019; Grupo Germen, IN; Hawser SP, 2011, ANTIMICROB AGENTS CH, V55, P3917, DOI 10.1128/AAC.00070-11; Hayden MK, 2015, CLIN INFECT DIS, V60, P1153, DOI 10.1093/cid/ciu1173; Huang SR, 2014, J MICROBIOL IMMUNOL, V47, P187, DOI 10.1016/j.jmii.2012.08.029; IDWeek, 2017, ADV SCI IMPR CAR; Cuervo SI, 2014, BIOMEDICA, V34, P170, DOI [10.1590/S0120-41572014000500020, 10.7705/biomedica.v34i0.1680]; Ji SJ, 2015, INT J INFECT DIS, V38, P108, DOI 10.1016/j.ijid.2015.07.024; Kaiser RM, 2013, DIAGN MICR INFEC DIS, V76, P356, DOI 10.1016/j.diagmicrobio.2013.03.032; Kassim A, 2016, ANN CLIN MICROB ANTI, V11, P15; Katsiari M, 2015, J GLOB ANTIMICROB RE, V3, P123, DOI 10.1016/j.jgar.2015.01.006; Kazmierczak KM, 2015, DIAGN MICR INFEC DIS, V82, P209, DOI 10.1016/j.diagmicrobio.2015.03.025; Lee CM, 2012, ANTIMICROB AGENTS CH, V56, P5016, DOI 10.1128/AAC.00878-12; Lemos EV, 2014, CLIN MICROBIOL INFEC, V20, P174, DOI 10.1111/1469-0691.12251; Lim LM, 2010, PHARMACOTHERAPY, V30, P1279, DOI 10.1592/phco.30.12.1279; Leal AL, 2013, ENFERM INFEC MICR CL, V31, P298, DOI 10.1016/j.eimc.2012.04.007; Maltezou HC, 2009, J INFECTION, V58, P213, DOI 10.1016/j.jinf.2009.01.010; Maltezou HC, 2014, J GLOB ANTIMICROB RE, V2, P11, DOI 10.1016/j.jgar.2013.06.002; Mathur P, 2016, INDIAN J MED MICROBI, V34, P495, DOI 10.4103/0255-0857.195367; Mauldin PD, 2010, ANTIMICROB AGENTS CH, V54, P109, DOI 10.1128/AAC.01041-09; Sampaio JLM, 2016, BRAZ J MICROBIOL, V47, P31, DOI 10.1016/j.bjm.2016.10.002; Mezzatesta ML, 2014, INT J ANTIMICROB AG, V44, P112, DOI 10.1016/j.ijantimicag.2014.04.014; Morris D, 2012, J ANTIMICROB CHEMOTH, V67, P2367, DOI 10.1093/jac/dks239; Mouloudi E, 2010, INFECT CONT HOSP EP, V31, P1250, DOI 10.1086/657135; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Murri R, 2017, INFECTION, V45, P209, DOI 10.1007/s15010-016-0968-x; Nordmann P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719; Ocampo AM, 2016, ANTIMICROB AGENTS CH, V60, P332, DOI 10.1128/AAC.01775-15; OMS, ORG MUND SAL; Organization W. H., 2016, ANTIMICROBIAL RESIST; Orsi GB, 2013, INFECTION, V41, P61, DOI 10.1007/s15010-012-0354-2; Osorio J, 2017, REV CHIL INFECTOL, V34, P7, DOI 10.4067/S0716-10182017000100001; Papadimitriou-Olivgeris M, 2014, SCAND J INFECT DIS, V46, P642, DOI 10.3109/00365548.2014.923106; Villalobos AP, 2014, BIOMEDICA, V34, P67, DOI [10.7705/biomedica.v34i0.1698, 10.1590/S0120-41572014000500009]; Pontikis K, 2014, INT J ANTIMICROB AG, V43, P52, DOI 10.1016/j.ijantimicag.2013.09.010; Poulou A, 2012, J CLIN MICROBIOL, V50, P2618, DOI 10.1128/JCM.00459-12; Pournaras S, 2009, J ANTIMICROB CHEMOTH, V64, P348, DOI 10.1093/jac/dkp207; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Sanchez-Bautista A, 2018, ENFERM INFEC MICR CL, V36, P229, DOI 10.1016/j.eimc.2017.03.003; Sbrana F, 2013, CLIN INFECT DIS, V56, P697, DOI 10.1093/cid/cis969; Seibert G, 2014, EINSTEIN-SAO PAULO, V12, P282, DOI [10.1590/s1679-45082014ao3131, 10.1590/S1679-45082014AO3131]; Souli M, 2010, CLIN INFECT DIS, V50, P364, DOI 10.1086/649865; Spyropoulou A, 2016, J MED MICROBIOL, V65, P240, DOI 10.1099/jmm.0.000217; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suarez I, 2016, MED KLIN-INTENSIVMED, V111, P84, DOI 10.1007/s00063-015-0039-6; Team R.C., 2017, R LANG ENV STAT COMP; Tofas P, 2016, INT J ANTIMICROB AG, V47, P335, DOI 10.1016/j.ijantimicag.2016.01.011; Tumbarello M, 2015, J ANTIMICROB CHEMOTH, V70, P2133, DOI 10.1093/jac/dkv086; Tuon FF, 2012, BRAZ J INFECT DIS, V16, P416, DOI 10.1016/j.bjid.2012.08.006; WHO, 2014, EB MARB VIR DIS EP P; Xu L, 2017, ANN CLIN MICROB ANTI, P16; Yang J, 2013, CLIN MICROBIOL INFEC, V19, pE509, DOI 10.1111/1469-0691.12275; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x; Zhao F, 2015, J INFECT DEV COUNTR, V9, P1016, DOI 10.3855/jidc.6679	89	43	46	1	11	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0163-4453	1532-2742		J INFECTION	J. Infect.	MAY	2018	76	5					438	448		10.1016/j.jinf.2018.02.007	http://dx.doi.org/10.1016/j.jinf.2018.02.007			11	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	GD3ZK	29477802				2022-09-04	WOS:000430442100002
J	Duarte-Rey, C; Bogdanos, DP; Leung, PSC; Anaya, JM; Gershwin, ME				Duarte-Rey, Carolina; Bogdanos, Dimitrios P.; Leung, Patrick S. C.; Anaya, Juan-Manuel; Gershwin, M. Eric			IgM predominance in autoimmune disease: Genetics and gender	AUTOIMMUNITY REVIEWS			English	Review						Immunoglobulin M; Autoimmune disease; Autoimmune hemolytic anemia; Multiple sclerosis; Cryoglobulinemia; Primary biliary cirrhosis	X-LINKED IMMUNODEFICIENCY; ANHIDROTIC ECTODERMAL DYSPLASIA; INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN-M SYNDROME; MOLECULAR-WEIGHT IGM; B-CELL POPULATION; CD4(+) T-CELLS; HYPER-IGM; CD40 LIGAND; MULTIPLE-SCLEROSIS	The role of specific immunoglobulin isotypes in human autoimmune disease has long attracted attention. Indeed, the presence of a polyclonal gammopathy is well known in a variety of systemic autoimmune diseases and is likely the result of chronic inflammation. However, in specific clinical situations, patients manifest isolated and elevated IgM levels, but normal IgG and IgA. The pathophysiology of this elevation and the clinical significance have been elusive. However, the relationships between specific genes and hyper-IgM are now very well defined, as it has been documented in primary hyper IgM syndromes. In this review we present data on clinical diseases with characteristic IgM abnormalities, including primary and secondary hyper IgM syndromes, autoimmune hemolytic anemia, cryoglobulinemia, primary biliary cirrhosis and multiple sclerosis and place the data in the perspective of the normal maturation of the immune response, including somatic mutation and genetic rearrangement. (C) 2011 Elsevier B.V. All rights reserved.	[Duarte-Rey, Carolina; Leung, Patrick S. C.; Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Duarte-Rey, Carolina] Pontificia Univ Javeriana, Fac Med, Dept Med Interna, Bogota, Colombia; [Duarte-Rey, Carolina; Anaya, Juan-Manuel] Univ Rosario, Fac Med, Ctr Estudio Enfermedades Autoinmunes CREA, Bogota, Colombia; [Bogdanos, Dimitrios P.] Kings Coll Hosp London, Kings Coll London Sch Med, London, England		Leung, PSC (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, 451 Hlth Sci Dr,Suite 6510, Davis, CA 95616 USA.	psleung@ucdavis.edu	Bogdanos, Dimitrios/AAF-8620-2020; Anaya, Juan-Manuel/J-1960-2016; Duarte-Rey, Carolina/I-7129-2016	Bogdanos, Dimitrios/0000-0002-9697-7902; Anaya, Juan-Manuel/0000-0002-6444-1249; Duarte-Rey, Carolina/0000-0003-2195-7963; Universidad del Rosario, Biblioteca/0000-0003-3491-9392	NIDDK NIH HHS [R01 DK090019, R01 DK039588] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039588] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agematsu K, 1998, J CLIN INVEST, V102, P853, DOI 10.1172/JCI3409; Ameratunga R, 2009, J CLIN IMMUNOL, V29, P99, DOI 10.1007/s10875-008-9219-y; Azuma E, 1996, BONE MARROW TRANSPL, V18, P243; Balashov KE, 1997, P NATL ACAD SCI USA, V94, P599, DOI 10.1073/pnas.94.2.599; BANATVALA N, 1994, ARCH DIS CHILD, V71, P150, DOI 10.1136/adc.71.2.150; Ben Aissa-Fennira F, 2011, IMMUNOL LETT, V136, P130, DOI 10.1016/j.imlet.2010.11.006; Ben-Aissa-Fennira F, 1998, IMMUNOL LETT, V63, P59, DOI 10.1016/S0165-2478(98)00053-4; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Boes M, 1998, J IMMUNOL, V160, P4776; Bogdanos DP, 2010, DIS MARKERS, V29, P301, DOI [10.1155/2010/595078, 10.3233/DMA-2010-0745]; Bogdanos DP, 2011, CLIN CHIM ACTA, V412, P502, DOI 10.1016/j.cca.2010.12.019; Bogdanos DP, 2009, CLIN REV ALLERG IMMU, V36, P30, DOI 10.1007/s12016-008-8087-9; Brandlein S, 2003, CANCER RES, V63, P7995; BRETHERTON L, 1981, CLIN IMMUNOL IMMUNOP, V18, P425, DOI 10.1016/0090-1229(81)90135-5; BREWER JW, 1994, J BIOL CHEM, V269, P17338; BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3; Brunner B, 2007, PEDIATR TRANSPLANT, V11, P547, DOI 10.1111/j.1399-3046.2007.00711.x; Catellani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018925; Choi YS, 2012, EUR J IMMUNOL, V42, P120, DOI 10.1002/eji.201141890; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; CROUZIER R, 1995, J IMMUNOL, V154, P413; Davies EG, 2010, BRIT J HAEMATOL, V149, P167, DOI 10.1111/j.1365-2141.2010.08077.x; DeKruyff RH, 1997, J IMMUNOL, V158, P359; DELACONCHA EG, 1982, CLIN EXP IMMUNOL, V49, P670; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dourakis SP, 2006, AGE AGEING, V35, P196, DOI 10.1093/ageing/afj021; Durandy A, 2005, IMMUNOL REV, V203, P67, DOI 10.1111/j.0105-2896.2005.00222.x; Durandy Anne, 2007, Adv Immunol, V94, P275, DOI 10.1016/S0065-2776(06)94009-7; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Ehrenstein MR, 2000, J EXP MED, V191, P1253, DOI 10.1084/jem.191.7.1253; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; Ferri C, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-25; FINLAND M, 1945, J CLIN INVEST, V24, P458, DOI 10.1172/JCI101624; FUSSEY SPM, 1990, P NATL ACAD SCI USA, V87, P3987, DOI 10.1073/pnas.87.10.3987; Gertz Morie A, 2006, Hematology Am Soc Hematol Educ Program, P19; GRAY JD, 1995, J IMMUNOL, V154, P5656; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; GUIZARVAZQUEZ J, 1977, AM J HUM GENET, V29, P571; Gulino AV, 2003, CURR OPIN RHEUMATOL, V15, P422, DOI 10.1097/00002281-200307000-00009; Hartung HP, 2011, J PERIPHER NERV SYST, V16, P75, DOI 10.1111/j.1529-8027.2011.00334.x; Havouis S, 2002, EUR J IMMUNOL, V32, P1147, DOI 10.1002/1521-4141(200204)32:4<1147::AID-IMMU1147>3.0.CO;2-O; Hayashi T, 1999, INFECT IMMUN, V67, P3558, DOI 10.1128/IAI.67.7.3558-3565.1999; Hayward AR, 1997, J IMMUNOL, V158, P977; Herve M, 2007, J EXP MED, V204, P1583, DOI 10.1084/jem.20062287; Higuchi M, 1998, SCAND J CLIN LAB INV, V58, P429, DOI 10.1080/00365519850186418; HOBBS JR, 1967, BRIT MED J, V4, P583, DOI 10.1136/bmj.4.5579.583; Hughey CT, 1998, J IMMUNOL, V161, P4091; Imai K, 2003, J CLIN INVEST, V112, P136, DOI 10.1172/JCI200318161; INOUE T, 1986, J CLIN IMMUNOL, V6, P130, DOI 10.1007/BF00918745; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Jesus AA, 2008, J CLIN IMMUNOL, V28, pS62, DOI 10.1007/s10875-008-9171-x; Karaca NE, 2011, EUR J PEDIATR, V170, P1039, DOI 10.1007/s00431-011-1400-2; Karni A, 2002, J NEUROIMMUNOL, V125, P134, DOI 10.1016/S0165-5728(02)00018-8; Khan FY, 2009, BRAZ J INFECT DIS, V13, P77, DOI 10.1590/S1413-86702009000100018; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Kracker S, 2010, CLIN IMMUNOL, V135, P193, DOI 10.1016/j.clim.2010.01.012; Lacroix-Desmazes S, 1999, J IMMUNOL, V162, P5601; Leung Patrick S C, 2003, Clin Dev Immunol, V10, P227, DOI 10.1080/10446670310001642429; Leung PSC, 1997, SEMIN LIVER DIS, V17, P61, DOI 10.1055/s-2007-1007183; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Lleo A, 2012, HEPATOLOGY, V55, P153, DOI 10.1002/hep.24630; Lodi Gianluca, 2010, J Med Case Rep, V4, P252, DOI 10.1186/1752-1947-4-252; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mayo MJ, 2008, CLIN LIVER DIS, V12, P277, DOI 10.1016/j.cld.2008.02.012; Melegari A, 2007, ANN NY ACAD SCI, V1109, P106, DOI 10.1196/annals.1398.012; Miga A., 2000, Immunological Investigations, V29, P111, DOI 10.3109/08820130009062292; Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956; MIX E, 1990, CLIN EXP IMMUNOL, V79, P21; MONTAGNINO G, 1988, SPRINGER SEMIN IMMUN, V10, P1, DOI 10.1007/BF02054020; Morbach H, 2006, ANN RHEUM DIS, V65, P482, DOI 10.1136/ard.2005.040840; Mori T, 2005, BONE MARROW TRANSPL, V36, P263, DOI 10.1038/sj.bmt.1705029; Morra Enrica, 2005, Hematology Am Soc Hematol Educ Program, P368; Murphy K, 2007, JANNEWAYS IMMUNOBIOL; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; Notarangelo LD, 2000, CLIN EXP IMMUNOL, V120, P399, DOI 10.1046/j.1365-2249.2000.01142.x; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Oertelt S, 2005, ANN NY ACAD SCI, V1051, P205, DOI 10.1196/annals.1361.062; Orange JS, 2005, IMMUNOL REV, V203, P21, DOI 10.1111/j.0105-2896.2005.00221.x; PADAYACHEE M, 1992, GENOMICS, V14, P551, DOI 10.1016/S0888-7543(05)80270-8; Palacin PS, 2007, J PAEDIATR CHILD H, V43, P716, DOI 10.1111/j.1440-1754.2007.01144.x; Pets LD, 2004, IMMUNE HEMOLYTIC ANE, P61; Poupon R, 1999, J HEPATOL, V30, P408, DOI 10.1016/S0168-8278(99)80098-1; Quartier P, 2004, CLIN IMMUNOL, V110, P22, DOI 10.1016/j.clim.2003.10.007; Raju TNK, 1999, LANCET, V354, P434, DOI 10.1016/S0140-6736(05)75863-3; Ramos-Casals M, 2005, AUTOIMMUN REV, V4, P8, DOI 10.1016/j.autrev.2004.04.004; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; RAZIUDDIN S, 1989, EUR J IMMUNOL, V19, P469, DOI 10.1002/eji.1830190309; RHODES K, 1969, BRIT MED J, V3, P439, DOI 10.1136/bmj.3.5668.439; ROBERTSTHOMSON PJ, 1990, GUT, V31, P88, DOI 10.1136/gut.31.1.88; ROSEN FS, 1961, PEDIATRICS, V28, P182; SANTIAGOSCHWARZ F, 1992, J RHEUMATOL, V19, P223; SCHIMKE RN, 1969, AM J DIS CHILD, V118, P626, DOI 10.1001/archpedi.1969.02100040628018; Schwartz-Albiez R, 2009, CLIN EXP IMMUNOL, V158, P43, DOI [10.1111/j.1365-2249.2009.04026.X, 10.1111/j.1365-2249.2009.04026.x]; Selmi C, 2009, CURR MOL MED, V9, P45, DOI 10.2174/156652409787314525; Seyama K, 1998, J INFECT DIS, V178, P318, DOI 10.1086/515633; Shinoda K, 2010, INT J RHEUM DIS, V13, P94, DOI 10.1111/j.1756-185X.2009.01450.x; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; SRINIVAS SK, 1995, J VIROL, V69, P8155, DOI 10.1128/JVI.69.12.8155-8158.1995; Stauch C, 2011, MULT SCLER J, V17, P327, DOI 10.1177/1352458510388543; STOELINGA GB, 1969, ACTA PAEDIATR SCAND, V58, P352, DOI 10.1111/j.1651-2227.1969.tb04731.x; Subauste CS, 1999, J IMMUNOL, V162, P6690; Tanaka Y, 2006, INT J HEMATOL, V84, P220, DOI 10.1532/IJH97.06046; TZIOUFAS AG, 1986, ARTHRITIS RHEUM, V29, P1098, DOI 10.1002/art.1780290907; Villar LM, 2010, CLIN IMMUNOL, V137, P51, DOI 10.1016/j.clim.2010.06.007; Vollmers HP, 2006, ADV DRUG DELIVER REV, V58, P755, DOI 10.1016/j.addr.2005.08.007; Webster EA, 1999, ARTHRITIS RHEUM, V42, P1291, DOI 10.1002/1529-0131(199906)42:6<1291::AID-ANR29>3.0.CO;2-#; Winkelstein JA, 2003, MEDICINE, V82, P373, DOI 10.1097/01.md.0000100046.06009.b0; XU H, 1992, DIS MARKERS, V10, P115; YOCUM MW, 1976, AM J MED, V60, P486, DOI 10.1016/0002-9343(76)90714-2; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914; Zuckerman NS, 2010, J AUTOIMMUN, V35, P325, DOI 10.1016/j.jaut.2010.07.004	119	36	39	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1568-9972	1873-0183		AUTOIMMUN REV	Autoimmun. Rev.	MAY	2012	11	6-7			SI		A404	A412		10.1016/j.autrev.2011.12.001	http://dx.doi.org/10.1016/j.autrev.2011.12.001			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	928HE	22178509				2022-09-04	WOS:000302973000004
J	Vancova, O; Baciak, L; Kasparova, S; Kucharska, J; Palacios, HH; Horecky, J; Aliev, G				Vancova, Ol'ga; Baciak, Ladislav; Kasparova, Svatava; Kucharska, Jarmila; Palacios, Hector H.; Horecky, Jaromir; Aliev, Gjumrakch			In vivo and in vitro assessment of brain bioenergetics in aging rats	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						aging; brain; P-31 NMR; mitochondria; OXPHOS; antioxidants	P-31 MAGNETIZATION-TRANSFER; MITOCHONDRIA DNA DELETIONS; CREATINE-KINASE; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; KINETIC-PARAMETERS; PRIMARY TARGET; ANIMAL-MODELS; LIPOIC ACID	Brain energy disorders can be present in aged men and animals. To this respect, the mitochondrial and free radical theory of aging postulates that age-associated brain energy disorders are caused by an imbalance between pro- and anti-oxidants that can result in oxidative stress. Our study was designed to investigate brain energy metabolism and the activity of endogenous antioxidants during their lifespan in male Wistar rats. In vivo brain bioenergetics were measured using P-31 nuclear magnetic resonance (NMR) spectroscopy and in vitro by polarographic analysis of mitochondrial oxidative phosphorylation. When compared to the young controls, a significant decrease of age-dependent mitochondrial respiration and adenosine-3-phosphate (ATP) production measured in vitro correlated with significant reduction of forward creatine kinase reaction (kfor) and with an increase in phosphocreatine (PCr)/ATP, PCr/Pi and PME/ATP ratio measured in vivo. The levels of enzymatic antioxidants catalase, GPx and GST significantly decreased in the brain tissue as well as in the peripheral blood of aged rats. We suppose that mitochondrial dysfunction and oxidative inactivation of endogenous enzymes may participate in age-related disorders of brain energy metabolism.	[Palacios, Hector H.; Aliev, Gjumrakch] Univ Texas San Antonio, Coll Sci, Dept Biol, San Antonio, TX 78249 USA; [Vancova, Ol'ga; Kucharska, Jarmila] Comenius Univ, Sch Med, Pharmacobiochem Lab, Bratislava, Slovakia; [Baciak, Ladislav; Kasparova, Svatava] Slovak Tech Univ, Inst Analyt Chem, Bratislava, Slovakia; [Horecky, Jaromir] Slovak Med Univ, Surg Pathophysiol & Tissue Engn Ctr, Bratislava, Slovakia; [Aliev, Gjumrakch] Javeriana Univ, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia; [Aliev, Gjumrakch] Stress Relief & Memory Training Ctr, Brooklyn, NY USA		Aliev, G (corresponding author), Univ Texas San Antonio, Coll Sci, Dept Biol, 1 UTSA Circle, San Antonio, TX 78249 USA.	aliev03@gmail.com	Aliev, Gjumrakch/K-7302-2017; Aliev, Gjumrakch/AAE-7734-2020; Baciak, Ladislav/AGZ-4401-2022	Aliev, Gjumrakch/0000-0001-7373-3182; Baciak, Ladislav/0000-0002-5191-2750	Slovak Research and Development Agency [APVV-21-022004]	Slovak Research and Development Agency(Slovak Research and Development Agency)	This study was supported by the Slovak Research and Development Agency, project APVV-21-022004.	Acuna-Castroviejo D, 2001, J PINEAL RES, V30, P65, DOI 10.1034/j.1600-079X.2001.300201.x; AEBI H, 1984, METHOD ENZYMOL, V105, P121; AKAI F, 1990, NEUROSCI LETT, V115, P19, DOI 10.1016/0304-3940(90)90510-G; Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018; Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608; Aliev G, 2009, INT J BIOCHEM CELL B, V41, P1989, DOI 10.1016/j.biocel.2009.03.015; Aliev G, 2009, J CELL MOL MED, V13, P320, DOI 10.1111/j.1582-4934.2008.00324.x; Aliev G, 2008, MINI-REV MED CHEM, V8, P1395, DOI 10.2174/138955708786369582; Aliyev A, 2005, J NEUROL SCI, V229, P285, DOI 10.1016/j.jns.2004.11.040; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x; Beckman KB, 1999, MUTAT RES-FUND MOL M, V424, P51, DOI 10.1016/S0027-5107(99)00007-X; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CLARK JF, 1991, MAGNET RESON MED, V17, P274, DOI 10.1002/mrm.1910170130; CORBETT RJT, 1994, J CEREBR BLOOD F MET, V14, P1070, DOI 10.1038/jcbfm.1994.140; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; de la Torre J, 2000, NEUROBIOL AGING, V21, pIII, DOI 10.1016/S0197-4580(00)00135-4; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; DEGANI H, 1987, MAGNET RESON MED, V5, P1, DOI 10.1002/mrm.1910050102; DogruAbbasoglu S, 1997, MECH AGEING DEV, V98, P177, DOI 10.1016/S0047-6374(97)00082-1; Du F, 2007, MAGN RESON MED, V57, P103, DOI 10.1002/mrm.21107; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Kemp GJ, 2000, DEV NEUROSCI-BASEL, V22, P418, DOI 10.1159/000017471; Kunz WS, 1999, J NEUROCHEM, V72, P1580, DOI 10.1046/j.1471-4159.1999.721580.x; Kwong LK, 1998, ARCH BIOCHEM BIOPHYS, V350, P118, DOI 10.1006/abbi.1997.0489; Lei H, 2003, P NATL ACAD SCI USA, V100, P14409, DOI 10.1073/pnas.2332656100; Linseman DA, 2009, ANTIOXID REDOX SIGN, V11, P421, DOI 10.1089/ARS.2008.2236; Long JG, 2009, NEUROCHEM RES, V34, P755, DOI 10.1007/s11064-008-9850-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANGANARO F, 1995, FREE RADICAL BIO MED, V19, P823, DOI 10.1016/0891-5849(95)02008-X; Matthews RT, 1998, J NEUROSCI, V18, P156; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Mueller SG, 2006, NMR BIOMED, V19, P655, DOI 10.1002/nbm.1062; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rao AV, 2002, NUTR NEUROSCI, V5, P291, DOI 10.1080/1028415021000033767; Raz N, 2003, BEHAV NEUROSCI, V117, P1169, DOI 10.1037/0735-7044.117.6.1169; SARMA JSM, 1976, J MOL CELL CARDIOL, V8, P951, DOI 10.1016/0022-2828(76)90077-8; Sarti C, 2002, J NEUROL SCI, V203, P263, DOI 10.1016/S0022-510X(02)00302-7; SAUTER A, 1993, J BIOL CHEM, V268, P13166; SCHOSINSKY KH, 1974, CLIN CHEM, V20, P1556; Schulz JB, 1997, MOL CELL BIOCHEM, V174, P193, DOI 10.1023/A:1006852306789; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; UGURBIL K, 1985, CIRCULATION, V72, P94; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wendel A, 1981, Methods Enzymol, V77, P325	59	14	15	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	NOV	2010	14	11					2667	2674		10.1111/j.1582-4934.2009.00879.x	http://dx.doi.org/10.1111/j.1582-4934.2009.00879.x			8	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	687JA	19906014	Green Published, Bronze			2022-09-04	WOS:000284773600015
J	Fazelian, S; Moradi, F; Agah, S; Hoseini, A; Heydari, H; Morvaridzadeh, M; Omidi, A; Pizarro, AB; Ghafouri, A; Heshmati, J				Fazelian, Siavash; Moradi, Fatemeh; Agah, Shahram; Hoseini, Akramsadat; Heydari, Hafez; Morvaridzadeh, Mojgan; Omidi, Amirhosein; Pizarro, Ana Beatriz; Ghafouri, Atie; Heshmati, Javad			Effect of omega-3 fatty acids supplementation on cardio-metabolic and oxidative stress parameters in patients with chronic kidney disease: a systematic review and meta-analysis	BMC NEPHROLOGY			English	Review						Cardio-metabolic outcomes; CKD; Omega-3 FAs; Oxidative stress; Blood lipids	SERUM-LIPID PROFILE; CARDIOVASCULAR-DISEASE; OMEGA-3 SUPPLEMENT; RISK-FACTORS; HEMODIALYSIS; ATHEROSCLEROSIS; FISH; CKD	Background Omega-3 fatty acids (FAs) have been suggested as a beneficial supplement in chronic kidney disease (CKD) patients, but the results of randomized clinical trials (RCTs) are controversial. We conducted a systematic review and meta-analysis to evaluate all the RCTs about the impact of omega-3 FAs supplementation on cardiometabolic outcomes and oxidative stress parameters in patients with CKD. Methods We performed a systematic database search in PubMed/MEDLINE, EMBASE, Scopus, Web of Science, and Cochrane Central, up to May 2020. We included all placebo-controlled randomized trials that assessed the effect of omega-3 FAs supplementation on any cardiometabolic outcomes: blood pressure, total cholesterol (TC), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) or triglycerides (TG) and oxidative stress parameters. Data were pooled using DerSimonian-Laird's random-effects model. Results Finally, thirteen articles met the inclusion criteria for this review omega-3 FAs supplementation significantly decrease TC (SMD: -0.26; 95% CI: - 0.51, - 0.02; I-2 = 52.7%), TG (SMD: -0.22; 95% CI: - 0.43, - 0.02; I-2 = 36.0%) and Malondialdehyde (MDA) levels (SMD: -0.91; 95% CI: - 1.29, - 0.54; I-2 = 00.0%) and also significantly increase superoxide dismutase (SOD) (SMD: 0.58; 95% CI: 0.27, 0.90; I-2 = 00.0%) and Glutathione peroxidase (GPx) (SMD: 0.50; 95% CI: 0.14, 0.86; I-2 = 00.0%) activities. However our results show that omega-3 FAs supplementation have no significant effects on HDL, LDL and blood pressure. Conclusion This systematic review and meta-analysis supports current evidence for the clinical benefit of omega-3 FAs intake to improve cardiometabolic parameters in CKD patients. However, well-designed RCTs still needed to provide a conclusive picture in this field.	[Fazelian, Siavash] Shahrekord Univ Med Sci, Ayatollah Kashani Hosp, Clin Res Dev Unit, Shahrekord, Iran; [Moradi, Fatemeh] Isfahan Univ Med Sci, Sch Nutr & Food Sci, Dept Community Nutr, Esfahan, Iran; [Agah, Shahram] Iran Univ Med Sci, Colorectal Res Ctr, Tehran, Iran; [Hoseini, Akramsadat] Iran Univ Med Sci, Sch Hlth, Dept Educ & Hlth Promot, Tehran, Iran; [Heydari, Hafez] Sabzevar Univ Med Sci, Cellular & Mol Res Ctr, Sabzevar, Iran; [Morvaridzadeh, Mojgan; Omidi, Amirhosein; Heshmati, Javad] Kermanshah Univ Med Sci, Farabi Hosp, Fac Nutr Sci & Food Technol, Sch Nutr Sci & Food Technol,Dept Nutr Sci, Isar Sq, Kermanshah 6715847141, Iran; [Pizarro, Ana Beatriz] Pontificia Univ Javeriana, Bogota, Colombia; [Ghafouri, Atie] Iran Univ Med Sci, Sch Publ Hlth, Dept Nutr, Tehran, Iran		Heshmati, J (corresponding author), Kermanshah Univ Med Sci, Farabi Hosp, Fac Nutr Sci & Food Technol, Sch Nutr Sci & Food Technol,Dept Nutr Sci, Isar Sq, Kermanshah 6715847141, Iran.; Ghafouri, A (corresponding author), Iran Univ Med Sci, Sch Publ Hlth, Dept Nutr, Tehran, Iran.	atie.ghafouri@gmail.com; javad.heshmati@gmail.com	Pizarro, Ana Beatriz/AAC-8021-2022; Morvaridzadeh, Mojgan/GLU-6418-2022; heshmati, javad/H-6812-2019	Pizarro, Ana Beatriz/0000-0003-4089-454X; Morvaridzadeh, Mojgan/0000-0002-1771-4697; heshmati, javad/0000-0002-2676-0185				Abo N.F., 2015, EGYPTIAN J BASIC APP, V2, P65, DOI [10.1016/j.ejbas.2014.12.005, DOI 10.1016/J.EJBAS.2014.12.005]; Agah S, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.17652; Akbari A, 2020, EUR J CLIN PHARMACOL, V76, P1483, DOI 10.1007/s00228-020-02919-8; Al-Gubory KH, 2012, INT J BIOCHEM CELL B, V44, P1569, DOI 10.1016/j.biocel.2012.06.003; Alexopoulos E, 2004, RENAL FAILURE, V26, P453, DOI 10.1081/JDI-200026763; Algamas-Dimantov A, 2012, J LIPID RES, V53, P1056, DOI 10.1194/jlr.M021949; Ando M, 1999, J AM SOC NEPHROL, V10, P2177; Ateya AM, 2017, J RENAL NUTR, V27, P169, DOI 10.1053/j.jrn.2016.11.005; Back M, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0067; Bouzidi N, 2010, J RENAL NUTR, V20, P321, DOI 10.1053/j.jrn.2010.01.002; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Neto MPC, 2018, PHARMACOL RES, V130, P152, DOI 10.1016/j.phrs.2018.01.020; Chen LH, 2020, J MULTIDISCIP HEALTH, V13, P863, DOI 10.2147/JMDH.S270454; Cicero AFG, 2010, CLIN EXP HYPERTENS, V32, P137, DOI 10.3109/10641960903254448; Corral-Jara Karla Fabiola, 2020, Nutrients, V12, P3864, DOI 10.3390/nu12123864; Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024; Delgado-Lista J, 2012, BRIT J NUTR, V107, pS201, DOI 10.1017/S0007114512001596; Eslick GD, 2009, INT J CARDIOL, V136, P4, DOI 10.1016/j.ijcard.2008.03.092; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Foroughinia F, 2017, J RES PHARM PRACT, V6, P94, DOI 10.4103/jrpp.JRPP_17_24; Gelsomino G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-137; Gharekhani A, 2016, IRAN J KIDNEY DIS, V10, P310; Heshmati J, 2019, PHARMACOL RES, V149, DOI 10.1016/j.phrs.2019.104462; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Holm T, 2001, EUR HEART J, V22, P428, DOI 10.1053/euhj.2000.2369; Howell G, 2009, BBA-MOL CELL BIOL L, V1791, P1190, DOI 10.1016/j.bbalip.2009.08.008; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Jabbari M, 2016, ROM J INTERN MED, V54, P222, DOI 10.1515/rjim-2016-0031; Jamilian M, 2020, BRIT J NUTR, V123, P792, DOI 10.1017/S0007114519003416; Jiang D, 2020, THERANOSTICS, V10, P7260, DOI 10.7150/thno.46332; Jiang QH, 2017, MOL NEUROBIOL, V54, P594, DOI 10.1007/s12035-015-9670-8; Jiang QH, 2013, INT J DATA MIN BIOIN, V8, P282, DOI 10.1504/IJDMB.2013.056078; Kaur G, 2011, PROSTAG LEUKOTR ESS, V85, P155, DOI 10.1016/j.plefa.2011.06.002; Khajehdehi P, 2000, J Ren Nutr, V10, P191, DOI 10.1053/jren.2000.16326; Khandouzi N, 2015, IRAN J PHARM RES, V14, P149; Khosroshahi HT, 2013, IRAN J KIDNEY DIS, V7, P479; Leng S, 2018, J NUTR BIOCHEM, V57, P228, DOI 10.1016/j.jnutbio.2018.04.002; Lewis Amanda, 2004, J Am Acad Nurse Pract, V16, P384, DOI 10.1111/j.1745-7599.2004.tb00388.x; Ling X.C., 2018, RENAL REPLACE THER, V4, P1, DOI [DOI 10.1186/S41100-018-0195-2, 10.1186/s41100-018-0195-2]; Liu Jia, 2019, J Am Heart Assoc, V8, pe010870, DOI 10.1161/JAHA.118.010870; Mehrkash M, 2012, SE ASIAN J TROP MED, V43, P756; Miller PE, 2014, AM J HYPERTENS, V27, P885, DOI 10.1093/ajh/hpu024; Mittman N, 2001, AM J KIDNEY DIS, V38, P1358, DOI 10.1053/ajkd.2001.29256; Moeinzadeh F, 2016, IRAN J KIDNEY DIS, V10, P381; Mofrad MD, 2021, INT J VITAM NUTR RES, V91, P343, DOI 10.1024/0300-9831/a000584; Moher David, 2009, Ann Intern Med, V151, P264, DOI 10.1136/bmj.b2535; Mori TA, 2004, REDOX REP, V9, P193, DOI 10.1179/135100004225005200; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Naini AE, 2015, J RES PHARM PRACT, V4, P135, DOI 10.4103/2279-042X.162356; Natto ZS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54535-x; Omidian M, 2020, ENDOCR METAB IMMUNE, V20, P718, DOI 10.2174/1871530319666191116112950; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; PETTERSSON EE, 1994, CLIN NEPHROL, V41, P183; Pirillo A, 2013, ATHEROSCLEROSIS SUPP, V14, P237, DOI 10.1016/S1567-5688(13)70004-7; Potier L, 2020, DIABETES CARE, V43, pE43, DOI 10.2337/dc19-2209; Qu KY, 2019, CURR BIOINFORM, V14, P246, DOI 10.2174/1574893614666181212102030; Rao G., 2018, J CARDIOL CARDIOVASC, V12, P1, DOI [10.19080/JOCCT.2018.12.555834, DOI 10.19080/JOCCT.2018.12.555834, 10.19080/jocct.2018.12.555834]; Reiss AB, 2018, ATHEROSCLEROSIS, V278, P49, DOI 10.1016/j.atherosclerosis.2018.08.046; Reyna Gallegos S., 2018, ADDING PURPLE CORN E, DOI [10.1016/j.plefa.2018.03.005, DOI 10.1016/J.PLEFA.2018.03.005]; Rotllan N, 2012, CHOLESTEROL, DOI 10.1155/2012/847849; Saglimbene VM, 2020, CLIN NUTR, V39, P358, DOI 10.1016/j.clnu.2019.02.041; Schmitz PG, 2002, J AM SOC NEPHROL, V13, P184, DOI 10.1681/ASN.V131184; Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035; Sepidarkish M, 2020, CLIN NUTR, V39, P1019, DOI 10.1016/j.clnu.2019.05.004; Serini S, 2016, EXPERT OPIN THER TAR, V20, P843, DOI 10.1517/14728222.2016.1139085; Tanaka Y, 2021, HEMODIAL INT, V25, P104, DOI 10.1111/hdi.12892; Tayyebi-Khosroshahi H, 2010, IRAN J KIDNEY DIS, V4, P322; Vafa M, 2016, J MATERN-FETAL NEO M, V29, P461, DOI 10.3109/14767058.2015.1004052; Vallejo-Vaz AJ., 2017, LDL CHOLESTEROL LOWE; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wang MH, 2019, BIOSENS BIOELECTRON, V142, DOI 10.1016/j.bios.2019.111536; Weintraub H, 2013, ATHEROSCLEROSIS, V230, P381, DOI 10.1016/j.atherosclerosis.2013.07.041; Wilson AC, 2009, AM J KIDNEY DIS, V54, P345, DOI 10.1053/j.ajkd.2009.04.027; Wu PK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153645; Yin FL, 2021, SPE J, V26, P1614, DOI 10.2118/205013-PA; Zhang J, 2019, CURR BIOINFORM, V14, P190, DOI 10.2174/1574893614666181212102749; Zhu SY, 2020, J PHARMACEUT BIOMED, V185, DOI 10.1016/j.jpba.2020.113263; Zhu W, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-127; Zou Q, 2019, RNA, V25, P205, DOI 10.1261/rna.069112.118	79	5	5	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2369		BMC NEPHROL	BMC Nephrol.	MAY 1	2021	22	1							160	10.1186/s12882-021-02351-9	http://dx.doi.org/10.1186/s12882-021-02351-9			13	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	SD2NY	33933009	Green Published, gold			2022-09-04	WOS:000651206100001
J	Lara, M; Sisa, I; Yepez, MC; Fisberg, M; Kovalskys, I; Salas, GG; Rigotti, A; Sanabria, LYC; Garcia, MCY; Torres, RGP; Herrera-Cuenca, M; Koletzko, B; Moreno, LA; Pratt, M; Tucker, KL; Guajardo, V; Zimberg, IZ; Amigo, MP; Janezic, X; Cardini, F; Echeverria, G; Landaeta, L; Castillo, O; Sanabria, LYC; Vargas, LN; Tobar, LF; Castillo, YM; Gomez, G; Rojas, RM; Chinnock, A; Cecilia, M; Garcia, Y; Caceres, MV; Ocampo, MB; Torres, RP; Liria, MR; Meza, K; Abad, M; Penny, M; Landaeta, M; Mendez, B; Vasquez, M; Ramirez, G; Hernandez, P; Chiavegatto, ADP; Goncalves, PB; Alberico, C; Ferrari, GLD; Previdelli, AN; de Franca, NAG				Lara, Melissa; Sisa, Ivan; Cecilia Yepez, Martha; Fisberg, Mauro; Kovalskys, Irina; Salas, Georgina Gomez; Rigotti, Attilio; Sanabria, Lilia Yadira Cortes; Garcia, Martha Cecilia Yepez; Torres, Rossina Gabriella Pareja; Herrera-Cuenca, Marianella; Koletzko, Berthold; Moreno, Luis A.; Pratt, Michael; Tucker, Katherine L.; Guajardo, Viviana; Zalcman Zimberg, Iona; Paz Amigo, Maria; Janezic, Ximena; Cardini, Fernando; Echeverria, Guadalupe; Landaeta, Leslie; Castillo, Oscar; Cortes Sanabria, Lilia Yadira; Nayibe Vargas, Luz; Fernanda Tobar, Luisa; Milena Castillo, Yuri; Gomez, Georgina; Monge Rojas, Rafael; Chinnock, Anne; Cecilia, Martha; Garcia, Yepez; Villar Caceres, Monica; Belen Ocampo, Maria; Pareja Torres, Rossina; Reyna Liria, Maria; Meza, Krysty; Abad, Mellisa; Penny, Mary; Landaeta, Maritza; Mendez, Betty; Vasquez, Maura; Ramirez, Guillermo; Hernandez, Pablo; Chiavegatto Filho, Alexandre D. P.; Bezerra Goncalves, Priscila; Alberico, Claudia; Ferrari, Gerson Luis de Moraes; Previdelli, Agatha Nogueira; Aparecida Grande de Franca, Natasha		ELANS Study Grp	Breakfast skipping, nutritional status, and physical activity in a middle-aged Latin American population: a population-based study from Ecuador	NUTRICION HOSPITALARIA			English	Article						Breakfast skipping; Obesity; Physical activity; Nutrition; Ecuador	RANDOMIZED CONTROLLED-TRIAL; EXCESS BODY-WEIGHT; CAUSAL ROLE; ENERGY-BALANCE; HEALTH; OVERWEIGHT; PROTEIN; HABITS	Introduction: the failure to eat breakfast has been associated with weight gain, a lower level of physical activity, and poor diet quality. Objective: to examine the frequency of skipping breakfast in an Ecuadorian population and its association with nutritional status and level of physical activity. Methods: a cross-sectional study of individuals who reported breakfast omission in a national survey. Nutritional status and physical activity were evaluated through anthropometric measures and the International Physical Activity Questionnaire, respectively. Results: the mean age of the study sample was 34.2 +/- 14 years, 40% were aged 20 to 34 years, one half were women, 55% were living in the coastal region, and one half were classified as low socioeconomic status. Overall, 6.6% of participants did not mention breakfast in both recalls. Individuals who skipped breakfast were more likely to be aged 20 to 34 years (42.6% vs. 37.4%) and from the coastal region (61.1% vs. 51.8%) than those who ate breakfast. We did not find an association between skipping breakfast and being overweight or obese (35.2% vs. 36.1%), nor achieving a low level of physical activity (28.6% vs. 29.8%). In addition, breakfast consumers (vs. non-consumers) had higher intake of total energy, macronutrients (protein, carbohydrate, fat, and sugar), and micronutrients (fiber and calcium). Conclusions: in Ecuador, similar to 7% of the population skips breakfast. The nutritional status and level of physical activity did not differ between those who ate breakfast and those who did not. However, the long-term health consequences should be avoided by changing this eating habit.	[Lara, Melissa; Sisa, Ivan; Cecilia Yepez, Martha; ELANS Study Grp] Univ San Francisco Quito, Coll Hlth Sci, Sch Med, Quito, Ecuador; [Kovalskys, Irina; Guajardo, Viviana; Paz Amigo, Maria; Janezic, Ximena; Cardini, Fernando] ILSI, Buenos Aires, DF, Argentina; [Fisberg, Mauro; Zalcman Zimberg, Iona; Aparecida Grande de Franca, Natasha] Hosp Infantil Sabara, Inst Pensi, Sao Paulo, SP, Brazil; [Rigotti, Attilio; Echeverria, Guadalupe; Landaeta, Leslie; Castillo, Oscar] Pontificia Univ Catolica Chile, Santiago, Chile; [Sanabria, Lilia Yadira Cortes; Cortes Sanabria, Lilia Yadira; Nayibe Vargas, Luz; Fernanda Tobar, Luisa; Milena Castillo, Yuri] Pontificia Univ Javeriana, Bogota, Colombia; [Gomez, Georgina; Monge Rojas, Rafael; Chinnock, Anne] Univ Costa Rica, San Pedro, Costa Rica; [Garcia, Martha Cecilia Yepez; Cecilia, Martha; Garcia, Yepez; Villar Caceres, Monica; Belen Ocampo, Maria] Univ San Francisco Quito, Quito, Ecuador; [Torres, Rossina Gabriella Pareja; Pareja Torres, Rossina; Reyna Liria, Maria; Meza, Krysty; Abad, Mellisa; Penny, Mary] Inst Invest Nutr, Lima, Peru; [Herrera-Cuenca, Marianella; Landaeta, Maritza; Mendez, Betty; Vasquez, Maura; Ramirez, Guillermo; Hernandez, Pablo] Univ Cent Venezuela, Caracas, Venezuela		Sisa, I (corresponding author), Univ San Francisco Quito, Coll Hlth Sci, Sch Med, Hosp Valles, Edificio Especialidades Med,Av Interocean,Km 12, Quito, Ecuador.	isisa@usfq.edu.ec	Fisberg, Mauro/E-7149-2010; Hernandez rivas, Pablo Ignacio/AAA-3727-2021; Liria, Reyna/CAA-0410-2022; Filho, Alexandre D P Chiavegatto/A-2092-2013; Gomez, Georgina/AAR-7272-2020; Castillo, Oscar/AAA-2368-2022; Ferrari, Gerson/ABG-6635-2021	Fisberg, Mauro/0000-0003-2992-3215; Hernandez rivas, Pablo Ignacio/0000-0002-6691-7618; Liria, Reyna/0000-0002-5637-1519; Gomez, Georgina/0000-0003-3514-2984; Ferrari, Gerson/0000-0003-3177-6576	Coca-Cola Company (Atlanta, GA, USA); Universidad San Francisco de Quito	Coca-Cola Company (Atlanta, GA, USA); Universidad San Francisco de Quito	This work was supported by a scientific grant from the Coca-Cola Company (Atlanta, GA, USA) and Universidad San Francisco de Quito. The funders had no role in study design, data collection, analysis, the decision to publish or the preparation of this manuscript.	[Anonymous], 2014, LANCET DIABETES ENDO, V2, P263, DOI [10.1016/S2213-8587(14)70079-8, 10.1016/S2213-8587(13)70173-6]; [Anonymous], 2014, HLTH PEOPL WHAT; Bermudez Odilia I., 2003, Cad. Saúde Pública, V19, pS87, DOI 10.1590/S0102-311X2003000700010; Betts JA, 2014, AM J CLIN NUTR, V100, P539, DOI 10.3945/ajcn.114.083402; Chowdhury EA, 2016, AM J CLIN NUTR, V103, P747, DOI 10.3945/ajcn.115.122044; Dai YN, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0218-3; Farshchi HR, 2005, AM J CLIN NUTR, V81, P388; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fisberg M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2765-y; Fisberg M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040389; Freire W., 2014, ENCUESTA NACL SALUD, VI; Freire WB, 2014, AM J CLIN NUTR, V100, p1636S, DOI 10.3945/ajcn.114.083766; Horikawa C, 2011, PREV MED, V53, P260, DOI 10.1016/j.ypmed.2011.08.030; Leidy HJ, 2016, ADV NUTR, V7, p563S, DOI 10.3945/an.115.010223; Leidy HJ, 2013, AM J CLIN NUTR, V97, P677, DOI 10.3945/ajcn.112.053116; Lopez-Cevallos DF, 2012, REV PANAM SALUD PUBL, V31, P9, DOI 10.1590/S1020-49892012000100002; Lyerly JE, 2014, PUBLIC HEALTH NUTR, V17, P896, DOI 10.1017/S1368980013000700; Mesas AE, 2012, OBES REV, V13, P106, DOI 10.1111/j.1467-789X.2011.00936.x; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Mullan BA, 2010, NUTR FOOD SCI, V40, P81, DOI 10.1108/00346651011015953; National Center for Health Statistics (NCHS), 1996, AN REP GUID 3 NAT HL, P1; Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694; Rabinovitz HR, 2014, OBESITY, V22, pE46, DOI 10.1002/oby.20654; Reeves S, 2013, APPETITE, V60, P51, DOI 10.1016/j.appet.2012.09.024; St-Onge MP, 2017, CIRCULATION, V135, pE96, DOI 10.1161/CIR.0000000000000476; Thomas EA, 2015, OBESITY, V23, P750, DOI 10.1002/oby.21049; Uzhova I, 2017, J AM COLL CARDIOL, V70, P1833, DOI 10.1016/j.jacc.2017.08.027; Witbracht M, 2015, PHYSIOL BEHAV, V140, P215, DOI 10.1016/j.physbeh.2014.12.044; Yoshimura E, 2017, PHYSIOL BEHAV, V174, P89, DOI 10.1016/j.physbeh.2017.03.008	29	3	3	0	5	ARAN EDICIONES, S L	MADRID	C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN	0212-1611	1699-5198		NUTR HOSP	Nutr. Hosp.	SEP-OCT	2019	36	5					1123	1132		10.20960/nh.02393	http://dx.doi.org/10.20960/nh.02393			10	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	JN9BF	31545071	gold			2022-09-04	WOS:000497184300019
J	Florez, MM; de Oliveira, CI; Puerta, C; Guzman, F; Ayala, M; Montoya, G; Delgado, G				Melissa Florez, Magda; Indiani de Oliveira, Camila; Puerta, Concepcion; Guzman, Fanny; Ayala, Martha; Montoya, Gladis; Delgado, Gabriela			Synthetic Peptides Derived from Ribosomal Proteins of Leishmania spp. in Mucocutaneous Leishmaniasis: Diagnostic Usefulness	PROTEIN AND PEPTIDE LETTERS			English	Article						Mucocutaneous leishmaniasis; diagnosis; synthetic peptide; ribosomal protein; parasite; Leishmania braziliensis	LINKED-IMMUNOSORBENT-ASSAY; VISCERAL LEISHMANIASIS; TEGUMENTARY LEISHMANIASIS; SERODIAGNOSIS; ELISA; CANINE; IMMUNODIAGNOSIS; INFECTIONS; ANTIGENS	Background: The serological diagnostic methods currently available for mucocutaneous leishmaniasis (MCL) lack specificity when complete parasites are used; however, such specificity increases when protein fractions are used. Ribosomal proteins have been reported to induce antibodies in animal and humans infected with the parasite, making them a worth candidate to assess its diagnosis potential. Objective: This study was thus aimed at evaluating synthetic peptides derived from Leishmania braziliensis ribosomal proteins S25 and S5 as antigen candidates for diagnosing MCL by ELISA Methods: It was used 8 and 13 peptides derived from ribosomal proteins 25 and S5 respectively as antigens in order to detect IgG antibodies by ELISA in people with active MCL, Chagas disease (CH) and autoimmune disease (AID). Results: 4 of these 21 peptides (P4, P6, P19 and P21) had the greatest sensitivity (21.7%, 13.04%, 20% and 20%, respectively) as well as having 95%, 100%, 100% and 82.5% specificity, respectively. Conclusion: The study revealed the limited usefulness of the peptides being studied as a diagnostic tool in the conditions used here, because its low sensitivity, but it is worth highlighting that the use of peptides as antigen in the serodiagnosis of MCL may overcome the cross reaction presented with other antigens, thus avoiding false positives.	[Melissa Florez, Magda; Delgado, Gabriela] Univ Nacl Colombia, Fac Ciencias, Dept Farm, Grp Invest Inmunotoxicol, Carrera 30 45-01, Bogota, Colombia; [Indiani de Oliveira, Camila] Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Lab Inmunoparasitol, Salvador Bahia Rua Waldemar Falcao 121, Candeal Salvador, BA, Brazil; [Puerta, Concepcion] Pontificia Univ Javeriana, Fac Ciencias, Grp Invest Enfermedades Infecciosas, Carrera 7 40-62, Bogota, Colombia; [Guzman, Fanny] Pontificia Univ Catolica Valparaiso, Nucleo Biolotecnol Curauma, Ave Univ 330, Valparaiso, Chile; [Ayala, Martha] Inst Nacl Salud, Lab Parasitol, Ave Calle 26 51-20, Bogota, Colombia; [Montoya, Gladis] Univ Rosario, Ctr Estudio Enfermedades Autoinmunes, Carrera 26,63B-51, Bogota, Colombia		Delgado, G (corresponding author), Univ Nacl Colombia, Fac Ciencias, Dept Farm, Grp Invest Inmunotoxicol, Carrera 30 45-01, Bogota, Colombia.	lgdelgadom@unal.edu.co	de Oliveira, Camila I/B-4358-2009; Puerta, Concepcion J/AAG-4912-2019; Guzman, Fanny fg/K-5592-2013	de Oliveira, Camila I/0000-0002-7868-5164; Guzman, Fanny fg/0000-0003-1537-0904; Delgado, Gabriela/0000-0003-2947-7796; Florez, Magda Melissa/0000-0002-5751-9773; Puerta Bula, Concepcion Judith/0000-0002-3449-3961	Universidad Nacional de Colombia's Bogota Research Division (DIB) [16015]; Colombian Science, Technology and Innovation Department's (Colciencias) Young Researchers and Innovators programme "Virginia Gutierrez de Pineda"; Colombian Science, Technology and Innovation Department's (Colciencias) Grant [03092013, 57635945, 6]	Universidad Nacional de Colombia's Bogota Research Division (DIB); Colombian Science, Technology and Innovation Department's (Colciencias) Young Researchers and Innovators programme "Virginia Gutierrez de Pineda"; Colombian Science, Technology and Innovation Department's (Colciencias) Grant	This work was financed by the Universidad Nacional de Colombia's Bogota Research Division (DIB) project 16015, as well as a grant from the Colombian Science, Technology and Innovation Department's (Colciencias) Young Researchers and Innovators programme "Virginia Gutierrez de Pineda" (2012) and Colciencias Grant (contract number 03092013, code 57635945-project 6). We Thank to National University of Colombia and its Master program on Microbiology. Thanks to Juqueline Cristal and to FAMETRA group by all their support in the development of the present work.	Abass E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002322; [Anonymous], NEW TECHN REP SER CO; Barroso-Freitas APT, 2009, T ROY SOC TROP MED H, V103, P383, DOI 10.1016/j.trstmh.2008.12.019; Bhattacharyya T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002892; Bottino CG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-568; Celeste BJ, 2014, AM J TROP MED HYG, V90, P860, DOI 10.4269/ajtmh.13-0623; Celeste BI, 2004, BRAZ J MED BIOL RES, V37, P1591, DOI 10.1590/S0100-879X2004001100001; Costa MM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001622; de Carvalho CA, 2013, ACTA TROP, V125, P128, DOI 10.1016/j.actatropica.2012.10.010; Metz GE, 2014, J VIROL METHODS, V205, P3, DOI 10.1016/j.jviromet.2014.04.018; Faria AR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001310; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; GUIMARAES MCS, 1989, B WORLD HEALTH ORGAN, V67, P643; Intapan PM, 2013, KOREAN J PARASITOL, V51, P763, DOI 10.3347/kjp.2013.51.6.763; Kaur Jaspreet, 2013, J Parasit Dis, V37, P68, DOI 10.1007/s12639-012-0133-0; Lakhal S, 2012, CLIN VACCINE IMMUNOL, V19, P1487, DOI 10.1128/CVI.00257-12; MALCHIODI EL, 1994, CLIN EXP IMMUNOL, V97, P417, DOI 10.1111/j.1365-2249.1994.tb06104.x; Montoya Y, 1997, T ROY SOC TROP MED H, V91, P674, DOI 10.1016/S0035-9203(97)90520-4; Requena JM, 2000, PARASITOL TODAY, V16, P246, DOI 10.1016/S0169-4758(00)01651-3; Romero GAS, 2005, ACTA TROP, V93, P49, DOI 10.1016/j.actatropica.2004.09.005; Soto M, 1996, CLIN DIAGN LAB IMMUN, V3, P387, DOI 10.1128/CDLI.3.4.387-391.1996; Souza AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066110; Vargas-Duarte Jimmy J, 2009, Rev. salud pública, V11, P641	23	7	7	0	1	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8665	1875-5305		PROTEIN PEPTIDE LETT	Protein Pept. Lett.		2017	24	10					982	988		10.2174/0929866524666170728143924	http://dx.doi.org/10.2174/0929866524666170728143924			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6JK	28758598	Green Published			2022-09-04	WOS:000419903500013
J	Velez, J; Pan, RQ; Lee, JTC; Enciso, L; Suarez, M; Duque, JE; Jaramillo, D; Lopez, C; Morales, L; Bornmann, W; Konopleva, M; Krystal, G; Andreeff, M; Samudio, I				Velez, Juliana; Pan, Rongqing; Lee, Jason T. C.; Enciso, Leonardo; Suarez, Marta; Eduardo Duque, Jorge; Jaramillo, Daniel; Lopez, Catalina; Morales, Ludis; Bornmann, William; Konopleva, Marina; Krystal, Gerald; Andreeff, Michael; Samudio, Ismael			Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport	ONCOTARGET			English	Article						metformin; phenformin; leukemia; mitochondria; ABT 737	CANCER-CELL; PROTEIN-KINASE; METFORMIN; CHEMOTHERAPY; TRIAL; MTOR; ACTIVATION; MECHANISMS; RESISTANCE; EFFECTOR	Metformin displays antileukemic effects partly due to activation of AMPK and subsequent inhibition of mTOR signaling. Nevertheless, Metformin also inhibits mitochondrial electron transport at complex I in an AMPK-independent manner, Here we report that Metformin and rotenone inhibit mitochondrial electron transport and increase triglyceride levels in leukemia cell lines, suggesting impairment of fatty acid oxidation (FAO). We also report that, like other FAO inhibitors, both agents and the related biguanide, Phenformin, increase sensitivity to apoptosis induction by the bcl-2 inhibitor ABT-737 supporting the notion that electron transport antagonizes activation of the intrinsic apoptosis pathway in leukemia cells. Both biguanides and rotenone induce superoxide generation in leukemia cells, indicating that oxidative damage may sensitize toABT-737 induced apoptosis. In addition, we demonstrate that Metformin sensitizes leukemia cells to the oligomerization of Bak, suggesting that the observed synergy with ABT-737 is mediated, at least in part, by enhanced outer mitochondrial membrane permeabilization. Notably, Phenformin was at least 10-fold more potent than Metformin in abrogating electron transport and increasing sensitivity to ABT-737, suggesting that this agent may be better suited for targeting hematological malignancies. Taken together, our results suggest that inhibition of mitochondrial metabolism by Metformin or Phenformin is associated with increased leukemia cell susceptibility to induction of intrinsic apoptosis, and provide a rationale for clinical studies exploring the efficacy of combining biguanides with the orally bioavailable derivative of ABT-737, Venetoclax.	[Velez, Juliana; Jaramillo, Daniel; Morales, Ludis; Samudio, Ismael] Pontificia Univ Javeriana, Grp Terapia Celular & Mol, Bogota, Colombia; [Velez, Juliana; Enciso, Leonardo; Suarez, Marta; Samudio, Ismael] Programa Invest & Innovac Leucemia Aguda & Cron P, Bogota, Colombia; [Eduardo Duque, Jorge] Ctr Oncol Antioquia, Medellin, Colombia; [Lopez, Catalina] Univ Caldas, Grp Terapia Regenerat, Manizales, Colombia; [Bornmann, William] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Pan, Rongqing; Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Lee, Jason T. C.; Krystal, Gerald] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Samudio, Ismael] Ctr Drug Res & Dev, Vancouver, BC, Canada		Samudio, I (corresponding author), Pontificia Univ Javeriana, Grp Terapia Celular & Mol, Bogota, Colombia.; Samudio, I (corresponding author), Programa Invest & Innovac Leucemia Aguda & Cron P, Bogota, Colombia.; Samudio, I (corresponding author), Ctr Drug Res & Dev, Vancouver, BC, Canada.	isamudio@cdrd.ca	ENCISO, LEONARDO/ABG-2119-2021; Morales, Ludis/AAZ-7053-2020; Samudio, Ismael/D-3581-2013	LOPEZ, CATALINA/0000-0003-4954-1601; Samudio, Ismael/0000-0001-8676-1035; Lee, Jason TC/0000-0001-8681-8257; Krystal, Gerald/0000-0002-1961-6281; Morales-Alvarez, Ludis/0000-0002-8541-9729	Oficina para el Fomento de la Investigacion, Pontificia Universidad Javeriana [4049]; COLCIENCIAS [120351929072, 210157636410]; NIH [CA51164, CA16672, CA100632]; Paul and Mary Haas chair in Genetics; NATIONAL CANCER INSTITUTE [P50CA100632, P01CA049639, P30CA016672] Funding Source: NIH RePORTER	Oficina para el Fomento de la Investigacion, Pontificia Universidad Javeriana; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Mary Haas chair in Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Oficina para el Fomento de la Investigacion, Pontificia Universidad Javeriana (Project ID 4049) to I.S., grants from COLCIENCIAS (Project ID 120351929072; Project ID 210157636410) to I.S. NIH CA51164, CA16672 and CA100632 to M.A., and the Paul and Mary Haas chair in Genetics to M.A. Lotte & John Hecht Memorial Foundation with core support from the BC Cancer Foundation and the BC Cancer Agency to G.K.	Anderson MA, 2016, BLOOD; [Anonymous], 2016, CANC DISCOV; Bost F, 2012, CURR OPIN ONCOL, V24, P103, DOI 10.1097/CCO.0b013e32834d8155; Brower V, 2016, LANCET ONCOL, V17, pE11, DOI 10.1016/S1470-2045(15)00576-8; Cabrero A, 2003, J LIPID RES, V44, P388, DOI 10.1194/jlr.M200294-JLR200; Corominas-Faja B, 2012, AGING-US, V4, P480, DOI 10.18632/aging.100472; Dai HM, 2015, GENE DEV, V29, P2140, DOI 10.1101/gad.267997.115; Dowling RJO, 2012, J MOL ENDOCRINOL, V48, pR31, DOI 10.1530/JME-12-0007; Esteva FJ, 2013, CANCER CHEMOTH PHARM, V71, P63, DOI 10.1007/s00280-012-1977-9; Fernandez MIG, 2004, ANAL BIOCHEM, V328, P174, DOI 10.1016/j.ab.2004.01.020; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gonzalvez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009342; Holubarsch CJF, 2007, CLIN SCI, V113, P205, DOI 10.1042/CS20060307; Howard AN, 2009, CANCER CHEMOTH PHARM, V65, P41, DOI 10.1007/s00280-009-1001-1; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kohli R, 2007, J BIOL CHEM, V282, P21327, DOI 10.1074/jbc.M701759200; Konopleva M, 2007, CURR DRUG TARGETS, V8, P685, DOI 10.2174/138945007780830827; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Koppers AJ, 2010, FREE RADICAL BIO MED, V48, P112, DOI 10.1016/j.freeradbiomed.2009.10.033; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Martelli AM, 2012, EXPERT OPIN THER TAR, V16, P729, DOI 10.1517/14728222.2012.694869; Mitsuhashi A, 2014, CANCER-AM CANCER SOC, V120, P2986, DOI 10.1002/cncr.28853; Nair V, 2013, CARCINOGENESIS, V34, P2870, DOI 10.1093/carcin/bgt231; Narayanan S, 2012, CRIT REV ONCOL HEMAT, V81, P94, DOI 10.1016/j.critrevonc.2011.01.014; Ofran Y, 2012, CURR OPIN HEMATOL, V19, P89, DOI 10.1097/MOH.0b013e32834ff4e1; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pan JX, 2012, CELL CYCLE, V11, P2314, DOI 10.4161/cc.20770; Poh A, 2016, CANCER DISCOV, V6, P113, DOI 10.1158/2159-8290.CD-NB2015-180; Rothermundt C, 2014, EUR UROL, V66, P468, DOI 10.1016/j.eururo.2013.12.057; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Sani MA, 2009, BBA-BIOMEMBRANES, V1788, P623, DOI 10.1016/j.bbamem.2008.12.014; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Shimizu I, 2012, CELL METAB, V15, P51, DOI 10.1016/j.cmet.2011.12.006; Starr Phoebe, 2016, Am Health Drug Benefits, V9, P21; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Tabe Yoko, 2004, Rinsho Byori, V52, P642; Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499; Vogler M, 2008, CELL DEATH DIFFER, V15, P820, DOI 10.1038/cdd.2008.25; Welters HJ, 2004, FEBS LETT, V560, P103, DOI 10.1016/S0014-5793(04)00079-1; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490	45	23	22	0	6	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	AUG 9	2016	7	32					51435	51449		10.18632/oncotarget.9843	http://dx.doi.org/10.18632/oncotarget.9843			15	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	DY9CC	27283492	Green Published, Green Submitted, gold			2022-09-04	WOS:000385429100053
J	Tomatsu, S; Barrera, LA; Almeciga-Diaz, CJ; Montano, AM; Yabe, H; Kubaski, F; Orii, T				Tomatsu, Shunji; Barrera, Luis A.; Almeciga-Diaz, Carlos J.; Montano, Adriana M.; Yabe, Hiromasa; Kubaski, Francyne; Orii, Tadao			Therapies for the bone in mucopolysaccharidoses	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Tomatsu, Shunji; Kubaski, Francyne] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Barrera, Luis A.; Almeciga-Diaz, Carlos J.] Pontificia Univ Javeriana, Bogota, Colombia; [Montano, Adriana M.] St Louis Univ, St Louis, MO 63103 USA; [Yabe, Hiromasa] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Kubaski, Francyne] Univ Delaware, Newark, DE USA; [Orii, Tadao] Gifu Univ, Gifu, Japan				Montano, Adriana/AHE-8741-2022; Alméciga-Díaz, Carlos J/A-2494-2017; Kubaski, Francyne/M-2410-2017	Alméciga-Díaz, Carlos J/0000-0001-6484-1173; Kubaski, Francyne/0000-0002-9330-0154					0	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				264	S116	S116		10.1016/j.ymgme.2014.12.267	http://dx.doi.org/10.1016/j.ymgme.2014.12.267			1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK					2022-09-04	WOS:000348973100263
J	Salazar, BE; Perez-Cala, T; Gomez-Villegas, SI; Cardona-Zapata, L; Pazos-Bastidas, S; Cardona-Estepa, A; Velez-Gomez, DE; Justinico-Castro, JA; Bernal-Cobo, A; Davila-Giraldo, HA; Benitez-Guerra, JC; Valencia-Cardenas, JT; Ospina, ED; Castano-Llano, R; Bravo, MM; Catano-Correa, JC; Zabaleta, J; Trespalacios-Rangel, AA; Cock-Botero, AM; Roldan-Perez, MI; Martinez, A				Salazar, Beatriz E.; Perez-Cala, Tania; Isabel Gomez-Villegas, Sara; Cardona-Zapata, Laura; Pazos-Bastidas, Sebastian; Cardona-Estepa, Alejandra; Enrique Velez-Gomez, Diego; Armando Justinico-Castro, Jose; Bernal-Cobo, Andres; Adrian Davila-Giraldo, Harold; Carlos Benitez-Guerra, Juan; Tiberio Valencia-Cardenas, Joaquin; de Jesus Ospina, Edgar; Castano-Llano, Rodrigo; Mercedes Bravo, Maria; Carlos Catano-Correa, Juan; Zabaleta, Jovanny; Alicia Trespalacios-Rangel, Alba; Maria Cock-Botero, Ana; Ignacio Roldan-Perez, Miguel; Martinez, Alonso			The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study	VIRCHOWS ARCHIV			English	Article						OLGA; OLGIM; Histopathology; Gastroduodenal diseases	HELICOBACTER-PYLORI; INTESTINAL METAPLASIA; CANCER; RISK; CLASSIFICATION; DIAGNOSIS	Stomach cancer (SC) incidence and mortality are relevant public health issues worldwide. In Colombia, screening for preneoplastic lesions (PNL) and the presence of H. pylori is not routinely performed. Therefore, the aim of this study was to evaluate OLGA-OLGIM staging and the interobserver agreement in gastritis and preneoplastic lesions in patients with gastroduodenal symptoms from Colombia. A cross-sectional study was conducted in 272 patients with gastroduodenal symptoms. Gastric biopsies were taken following the Updated Sydney System with the OLGA-OLGIM classification, and the results were evaluated by two pathologists. Chronic gastritis and PNL were reported in 76% and 24% of the patients, respectively. Furthermore, 25% of the patients with PNL displayed gastric atrophy (GA) and 75% intestinal metaplasia (IM). Agreement in the histopathological reading for IM was good, whereas for OLGA was variable, and for the H. pylori quantity was poor. OLGA-OLGIM stages 0-II were the most frequent (96%), while stage III (4%) and SC (4%) were the least frequent. Age and coffee consumption were associated with a higher prevalence of PNL. This work determined that 4% of the population is at high risk of developing SC and would benefit from follow-up studies. Reinforcement of training programs to improve the agreement in histopathology readings is required.	[Salazar, Beatriz E.; Perez-Cala, Tania; Isabel Gomez-Villegas, Sara; Cardona-Zapata, Laura; Pazos-Bastidas, Sebastian; Cardona-Estepa, Alejandra; Enrique Velez-Gomez, Diego; Carlos Benitez-Guerra, Juan; Ignacio Roldan-Perez, Miguel; Martinez, Alonso] Univ Antioquia, Sch Med, Dept Microbiol, Bacteria & Canc Grp, Medellin, Colombia; [Armando Justinico-Castro, Jose; Bernal-Cobo, Andres; Adrian Davila-Giraldo, Harold; Ignacio Roldan-Perez, Miguel] Univ Antioquia, Sch Med, Dept Pathol, Medellin, Colombia; [Carlos Benitez-Guerra, Juan] Promedan IPS, Medellin, Colombia; [Tiberio Valencia-Cardenas, Joaquin] Univ Antioquia, IPS Univ, Medellin, Colombia; [de Jesus Ospina, Edgar] Somer Clin, Rionegro, Colombia; [Castano-Llano, Rodrigo] Amer Clin, Canc Inst, Medellin, Colombia; [Mercedes Bravo, Maria] Natl Canc Inst, Canc Biol Res Grp, Bogota, Colombia; [Carlos Catano-Correa, Juan] Univ Antioquia, Internal Med Infect Dis Sect, Medellin, Colombia; [Zabaleta, Jovanny] Louisiana State Univ, Dept Integrat Oncol, Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA USA; [Zabaleta, Jovanny] Louisiana State Univ, Dept Pediat, Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA USA; [Alicia Trespalacios-Rangel, Alba] Pontificia Univ Javeriana, Dept Microbiol, Infect Dis Grp, Bogota, Colombia; [Maria Cock-Botero, Ana] Las Vegas Clin, Cytol & Pathol Unit, Medellin, Colombia		Salazar, BE (corresponding author), Univ Antioquia, Sch Med, Dept Microbiol, Bacteria & Canc Grp, Medellin, Colombia.	beatriz.salazar@udea.edu.co		Velez, Diego/0000-0002-6095-3706; Cardona Estepa, Alejandra/0000-0001-5660-6405; Perez, Tania/0000-0001-5095-3289; Salazar Giraldo, Beatriz Eugenia/0000-0003-1108-015X	Comite Para el Desarrollo de la Investigacion (CODI) Universidad de Antioquia [20141062]; Ministerio de Ciencia, Tecnologia e Innovacion (Minciencias) [617-2013]	Comite Para el Desarrollo de la Investigacion (CODI) Universidad de Antioquia; Ministerio de Ciencia, Tecnologia e Innovacion (Minciencias)	This study was funded by Comite Para el Desarrollo de la Investigacion (CODI) Universidad de Antioquia, grant number 20141062 and National Doctoral Scholar by Ministerio de Ciencia, Tecnologia e Innovacion (Minciencias), grant number 617-2013.	ANDREW A, 1994, HISTOPATHOLOGY, V25, P317, DOI 10.1111/j.1365-2559.1994.tb01349.x; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Aydin O, 2003, WORLD J GASTROENTERO, V9, P2232; Bravo LE., 2003, COLOMB MEDICA, V34, P124; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Businello G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189950; Capelle LG, 2010, GASTROINTEST ENDOSC, V71, P1150, DOI 10.1016/j.gie.2009.12.029; Chen FM, 2019, ANN DIAGN PATHOL, V38, P106, DOI 10.1016/j.anndiagpath.2018.12.002; Cho SJ, 2013, ALIMENT PHARM THER, V38, P1292, DOI 10.1111/apt.12515; Conchillo JM, 2001, EUR J CANCER PREV, V10, P307, DOI 10.1097/00008469-200108000-00003; Correa P, 1976, GASTRIC CANC COLOMBI; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; Correa S., 2016, ASOC COLOMB GASTROEN, V31, P9, DOI [10.22516/25007440.67, DOI 10.22516/25007440.67]; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dorer MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000544; Bravo LE, 2008, COLOMB MEDICA, V39, P58; Emura Fabián, 2010, Rev Col Gastroenterol, V25, P19; Flores-Luna L, 2020, CANCER EPIDEMIOL, V64, DOI 10.1016/j.canep.2019.101630; Guarner J, 2001, HUM PATHOL, V32, P31, DOI 10.1053/hupa.2001.20889; IARC, 1994, IARC MONOGR EVAL CAR, V61, P121; International Agency for Research on Cancer W,,, 2020, COL GLOB 2020; Isajevs S, 2014, VIRCHOWS ARCH, V464, P403, DOI 10.1007/s00428-014-1544-3; Jansen M, 2018, F1000RESEARCH, V7, DOI 10.12688/f1000research.12087.1; Kasamatsu E, 2010, SALUD PUBLICA MEXICO, V52, P386, DOI 10.1590/s0036-36342010000500005; KHULUSI S, 1995, GUT, V37, P319, DOI 10.1136/gut.37.3.319; Kinn HJ, 2019, HELICOBACTER, V24, DOI 10.1111/hel.12605; Lee YC, 2016, GUT LIVER, V10, P12, DOI 10.5009/gnl15091; Lenti MV, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0187-8; Martínez Diana, 2016, Rev. colomb. Gastroenterol., V31, P360; Mera R., 2017, PHYSIOL BEHAV, V176, P139, DOI DOI 10.1016/J.PHYSBEH.2017.03.040; Miwata T, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0327-x; Nam JH, 2014, HELICOBACTER, V19, P81, DOI 10.1111/hel.12112; Neumann WL, 2013, NAT REV GASTRO HEPAT, V10, P529, DOI 10.1038/nrgastro.2013.101; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Park Yo Han, 2015, J Cancer Prev, V20, P25, DOI 10.15430/JCP.2015.20.1.25; PEEK RM, 1995, J CLIN MICROBIOL, V33, P28, DOI 10.1128/JCM.33.1.28-32.1995; Pimentel-Nunes P, 2019, ENDOSCOPY, V51, P365, DOI 10.1055/a-0859-1883; Ramirez-Mendoza P, REV MED I MEX SEGURO, V53, P584; Rugge M, 2008, DIGEST LIVER DIS, V40, P650, DOI 10.1016/j.dld.2008.02.030; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Rugge M, 2018, AM J GASTROENTEROL, V113, P1621, DOI 10.1038/s41395-018-0353-8; Rugge M, 2016, GUT, V65, P721, DOI 10.1136/gutjnl-2015-310846; Rugge M, 2014, BEST PRACT RES CL GA, V28, P1043, DOI 10.1016/j.bpg.2014.09.002; Satoh K, 2008, HELICOBACTER, V13, P225, DOI 10.1111/j.1523-5378.2008.00599.x; Shah Dharmesh K, 2015, Trop Gastroenterol, V36, P101; Sipponen P, 2011, J GASTROEN HEPATOL, V26, P31, DOI 10.1111/j.1440-1746.2010.06536.x; Sonnenberg A, 2015, CLIN GASTROENTEROL H, V13, P2276, DOI 10.1016/j.cgh.2015.02.020; Tepes B, 1999, HISTOPATHOLOGY, V34, P124; van Doorn LJ, 1998, J CLIN MICROBIOL, V36, P2597, DOI 10.1128/JCM.36.9.2597-2603.1998; Wang ZS, 2018, INT J EPIDEMIOL, V47, P966, DOI 10.1093/ije/dyy055; Yue H, 2018, GASTRIC CANCER, V21, P579, DOI 10.1007/s10120-018-0812-3	51	1	1	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	APR	2022	480	4					759	769		10.1007/s00428-022-03286-8	http://dx.doi.org/10.1007/s00428-022-03286-8		JAN 2022	11	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	0Q2PW	35089403				2022-09-04	WOS:000749111000002
J	Ruiz-Garcia, M; Pinilla-Beltran, D; Murillo-Garcia, OE; Pinto, CM; Brito, J; Shostell, JM				Ruiz-Garcia, Manuel; Pinilla-Beltran, Daniel; Murillo-Garcia, Oscar E.; Miguel Pinto, Christian; Brito, Jorge; Mark Shostell, Joseph			Comparative mitogenome phylogeography of two anteater genera (Tamandua and Myrmecophaga; Myrmecophagidae, Xenarthra): Evidence of discrepant evolutionary traits	ZOOLOGICAL RESEARCH			English	Article						Anteaters; Genetic diversity; Mitogenomes; Myrmecophaga; Neotropics; Phylogeography; Spatial structure; Tamandua	GENETIC DIVERSITY; TRIDACTYLA MYRMECOPHAGIDAE; POPULATION-STRUCTURE; CAT POPULATIONS; GIANT ANTEATER; PHYLOGENETIC ANALYSIS; STATISTICAL TESTS; MTDNA VARIATION; MITOCHONDRIAL; MAMMALS	The species within Xenarthra (sloths, anteaters, and armadillos) are quintessential South American mammals. Of the three groups, Vermilingua (anteaters) contains the fewest extant and paleontological species. Here, we sampled and sequenced the entire mitochondrial genomes (mitogenomes) of two Tamandua species (Tamandua tetradactyla and T. mexicana) (n=74) from Central and South America, as well as Myrmecophaga tridactyla (n=41) from South America. Within Tamandua, we detected three different haplogroups. The oldest (THI) contained many specimens with the T. tetradactyla morphotype (but also several with the T. mexicana morphotype) and originated in southeastern South America (currently Uruguay) before moving towards northern South America, where the THII haplogroup originated. THII primarily contained specimens with the T. mexicana morphotype (but also several with the T. tetradactyla morphotype) and was distributed in Central America, Colombia, and Ecuador. THI and THII yielded a genetic distance of 4%. THII originated in either northern South America or " in situ" in Central America with haplogroup THIII, which consisted of similar to 50% T. mexicana and 50% T. tetradactyla phenotypes. THIII was mostly located in the same areas as THII, i.e., Central America, Ecuador, and Colombia, though mainly in the latter. The three haplogroups overlapped in Colombia and Ecuador. Thus, T. tetradactyla and T. mexicana were not reciprocally monophyletic. For this reason, we considered that a unique species of Tamandua likely exists, i.e., T. tetradactyla. In contrast to Tamandua, M. tridactyla did not show different morphotypes throughout its geographical range in the Neotropics. However, two very divergent genetic haplogroups (MHI and MHII), with a genetic distance of similar to 10%, were detected. The basal haplogroup, MHI, originated in northwestern South America, whereas the more geographically derived haplogroup, MHII, overlapped with MHI, but also expanded into central and southern South America. Thus, Tamandua migrated from south to north whereas Myrmecophaga migrated from north to south. Our results also showed that temporal mitochondrial diversification for Tamandua began during the Late Pliocene and Upper Pleistocene, but for Myrmecophaga began during the Late Miocene. Furthermore, both taxa showed elevated levels of mitochondrial genetic diversity. Tamandua showed more evidence of female population expansion than Myrmecophaga. Tamandua experienced population expansion similar to 0.6-0.17 million years ago (Mya), whereas Myrmecophaga showed possible population expansion similar to 0.3-0.2 Mya. However, both taxa experienced a conspicuous female decline in the last 10 000-20 000 years. Our results also showed little spatial genetic structure for both taxa. However, several analyses revealed higher spatial structure in Tamandua than in Myrmecophaga. Therefore, Tamandua and Myrmecophaga were not subjected to the same biogeographical, geological, or climatological events in shaping their genetic structures.	[Ruiz-Garcia, Manuel; Pinilla-Beltran, Daniel] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut, Bogota 110231, DC, Colombia; [Murillo-Garcia, Oscar E.] Univ Valle, Fac Ciencias Nat & Exactas, Dept Biol, Grp Invest Ecol Anim, Cali 25360, Colombia; [Miguel Pinto, Christian] Escuela Politec Nacl, Inst Ciencias Biol, Quito 17012759, Ecuador; [Brito, Jorge] Inst Nacl Biodiversidad INABIO, Quito 170135, Ecuador; [Mark Shostell, Joseph] Univ Minnesota Crookston, Math Sci & Technol Dept, Crookston, MN 56716 USA		Ruiz-Garcia, M (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut, Bogota 110231, DC, Colombia.	mruiz@javeriana.edu.co		Ruiz-Garcia, Manuel/0000-0003-2820-2950; Murillo-Garcia, Oscar Enrique/0000-0001-5040-7894				Abba Agustin Manuel, 2010, Edentata, V11, P135; Aguiar J.M, 2004, EDENTATA, V6, P3, DOI 10.1896/1413-4411.6.1.3; Allen JA, 1904, B AM MUS NAT HIST, V20, P327; Allen JA, 1916, B AM MUS NAT HIST, V35, P83; AMEGHINO C, 1919, 1 REUN NAC SOC ARG C, P151; Ameghino F., 1904, ANALES SOC CIENTIFIC, V56, P193, DOI DOI 10.5962/BHL.TITLE.14834; Ameghino F., 1889, ACTAS ACAD NACL CIEN, V6, P1, DOI DOI 10.5962/BHL.TITLE.121288; [Anonymous], 1991, ICE AGE RETURN LIFE; Ascunce MS, 2003, ZOOL SCR, V32, P397, DOI 10.1046/j.1463-6409.2003.00123.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.ecolsys.18.1.489; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barros MC, 2008, GENET MOL BIOL, V31, P793, DOI 10.1590/S1415-47572008000400029; Barros MC, 2003, GENET MOL BIOL, V26, P5, DOI 10.1590/S1415-47572003000100002; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; BERTORELLE G, 1995, GENETICS, V140, P811; Bigarella J.J., 1975, AN ACAD BRAS CIENC, V47, P411; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Brouns G, 2003, J SURV ENG-ASCE, V129, P79, DOI 10.1061/(ASCE)0733-9453(2003)129:2(79); Cabrera A., 1958, Revista del Museo Argentino de Ciencias Naturales Bernardino Rivadavia (Zool), V4, P1; Carlini A. A., 1992, AMEGHINIANA, V29, P176; Carroll Robert, 1988, VERTEBRATE PALEONTOL; Casali DD, 2020, SYST BIODIVERS, V18, P216, DOI 10.1080/14772000.2020.1729894; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clapperton CM, 1993, QUATERNARY GEOLOGY G; Arteaga MC, 2012, J MAMMAL, V93, P547, DOI 10.1644/11-MAMM-A-211.1; Clozato CL, 2017, GENET MOL BIOL, V40, P50, DOI [10.1590/1678-4685-GMB-2016-0104, 10.1590/1678-4685-gmb-2016-0104]; Clozato CL, 2015, ECOL EVOL, V5, P4932, DOI 10.1002/ece3.1656; Clozato CL, 2014, THESIS U SAO PAULO S; Collevatti RG, 2007, GENET MOL BIOL, V30, P112, DOI 10.1590/S1415-47572007000100020; Condamine FL, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12062; COPE ED, 1889, AM NAT, V23, P128, DOI DOI 10.1086/274871; Cossios D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-68; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Cuaron AD, 2005, MAMIFEROS SILVESTRES, P121; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Jong W.W., 1985, P65; de Vivo Mario, 1997, Journal of Comparative Biology, V2, P65; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Delsuc F, 2003, MOL PHYLOGENET EVOL, V28, P261, DOI 10.1016/S1055-7903(03)00111-8; Delsuc F, 2002, MOL BIOL EVOL, V19, P1656, DOI 10.1093/oxfordjournals.molbev.a003989; Delsuc F, 2012, MOL PHYLOGENET EVOL, V62, P673, DOI 10.1016/j.ympev.2011.11.008; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Dollfus O., 1964, B SOC GEOGRAFICA LIM, VLXXXIII, P65; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eldredge N., 1972, P82; Engelmann G.F., 1985, P51; Espurt N, 2007, GEOLOGY, V35, P515, DOI 10.1130/G23237A.1; Espurt N, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P89; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Coimbra RTF, 2017, GENET MOL BIOL, V40, P40, DOI [10.1590/1678-4685-GMB-2016-0040, 10.1590/1678-4685-gmb-2016-0040]; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; GABRIEL KR, 1969, SYST ZOOL, V18, P259, DOI 10.2307/2412323; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Gardner A. L., 2008, MAMMALS S AM, V1, P127; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gaudin Timothy J., 2018, Mammalian Species, P1, DOI 10.1093/mspecies/sey001; Gaudin Timothy J., 1998, Journal of Mammalian Evolution, V5, P237, DOI 10.1023/A:1020512529767; Gaudin Timothy J., 1999, Fieldiana Geology, V41, P1; Genoways Hugh H., 2003, Mastozoologia Neotropical, V10, P231; Geoffroy E, 1803, CATALOGUE MAMMIFERES; Gibb GC, 2016, MOL BIOL EVOL, V33, P621, DOI 10.1093/molbev/msv250; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Gray JE, 1873, HAND LIST EDENTATE T; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; HIRSCHFELD SE, 1976, J PALEONTOL, V50, P419; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Hsu TC, 1965, MAMMALIAN CHROMOSOME, V15, P107; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Isaaks EH, 1989, INTRO APPL GEOSTATIS, P561; Jorge W., 1985, P121; Jorge Wilham, 2008, P196; Kartavtsev YP, 2011, MITOCHONDR DNA, V22, P55, DOI 10.3109/19401736.2011.588215; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kraglievich L, 1934, ANTIGUEDAD PLIOCENA; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lessa EP, 1997, PALAEOGEOGR PALAEOCL, V135, P157, DOI 10.1016/S0031-0182(97)00042-4; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LINNE C., 1758, SYSTEMA NATURAE REGN, V1; Lundberg John G., 1998, P13; Lyon MW, 1906, P US NATL MUSEUM, V31, P569; Lyons SK, 2004, EVOL ECOL RES, V6, P339; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; Marshall LG, 1991, EOCENE PLEISTOCENE V, V1, P631; Martin L.D., 1989, P536; Martins FM, 2007, J ZOOL SYST EVOL RES, V45, P372, DOI 10.1111/j.1439-0469.2007.00419.x; MATULA DW, 1980, GEOGR ANAL, V12, P205; Mayr E., 1942, P1; Mayr E., 1963, ANIMAL SPECIES EVOLU; McDonald H. Gregory, 2008, P64; McKenna M. C., 1997, CLASSIFICATION MAMMA; Miller MA., 2010, GAT COMP ENV WORKSH, P1; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Miranda FR, 2018, ZOOL J LINN SOC-LOND, V183, P687, DOI 10.1093/zoolinnean/zlx079; Moller-Krull M, 2007, MOL BIOL EVOL, V24, P2573, DOI 10.1093/molbev/msm201; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Moraes-Barros N, 2015, J MAMMAL, V96, P690, DOI 10.1093/jmammal/gyv077; Morgan CC, 2013, MOL BIOL EVOL, V30, P2145, DOI 10.1093/molbev/mst117; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nabholz B, 2013, MOL BIOL EVOL, V30, P272, DOI 10.1093/molbev/mss238; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; ODEN NL, 1984, GEOGR ANAL, V16, P1, DOI 10.1111/j.1538-4632.1984.tb00796.x; Osgood WH, 1912, MAMMALS W VENEZUELA, P1; PATTERSON B, 1968, Q REV BIOL, V43, P409, DOI 10.1086/405916; Patterson B, 1992, EAR REGION XENARTHRA, P1; Patton JL, 1998, ENDLESS FORMS, P202; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; Pennington RT, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P373; Pereira HRJ, 2004, GENET MOL BIOL, V27, P391, DOI 10.1590/S1415-47572004000300014; Prodohl Paulo A., 2008, P205; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RASANEN ME, 1995, SCIENCE, V269, P386, DOI 10.1126/science.269.5222.386; Reiss Karen Zich, 1997, Journal of Mammalian Evolution, V4, P87, DOI 10.1023/A:1027366129277; Rios-Alvear Gorki, 2019, Neotropical Biology and Conservation, V14, P339, DOI 10.3897/neotropical.14.e37714; Ripley, 1981, SPAT STAT-NETH; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers AR, 1996, MOL BIOL EVOL, V13, P895, DOI 10.1093/molbev/13.7.895; Rojano C, 2014, MANUAL REHABILITACIO; Romiguier J, 2013, MOL BIOL EVOL, V30, P2134, DOI 10.1093/molbev/mst116; ROSE KD, 1993, MAMMAL PHYLOGENY : PLACENTALS, P81; Rossi LF, 2014, ITAL J ZOOL, V81, P322, DOI 10.1080/11250003.2014.943308; Rovereto C., 1914, Anales del Museo Nacional Buenos Aires, V25; Ruiz-Garcia M, 1999, GENET MOL BIOL, V22, P493, DOI 10.1590/S1415-47571999000400006; Ruiz-Garcia M, 2016, J PHYLOGENETICS EVOL, V4; Ruiz-Garcia M, 2013, MOL POPULATION GENET, P97; Ruiz-Garcia M, 2019, FOLIA PRIMATOL, V90, P215, DOI 10.1159/000497251; Ruiz-Garcia M, 2020, J MAMM EVOL, V27, P461, DOI 10.1007/s10914-019-09465-w; Ruiz-Garcia M, 2018, MAMM BIOL, V93, P153, DOI 10.1016/j.mambio.2018.09.004; Ruiz-Garcia M, 2018, J MAMM EVOL, V25, P213, DOI 10.1007/s10914-016-9375-4; Ruiz-Garcia M, 2018, MITOCHONDRIAL DNA A, V29, P281, DOI 10.1080/24701394.2016.1275602; Ruiz-Garcia M, 2014, MOL PHYLOGENET EVOL, V79, P179, DOI 10.1016/j.ympev.2014.05.034; RUIZGARCIA M, 1993, J HERED, V84, P173, DOI 10.1093/oxfordjournals.jhered.a111312; RUIZGARCIA M, 1994, GENET SEL EVOL, V26, P39, DOI 10.1051/gse:19940104; RuizGarcia M, 1997, J GENET, V76, P1, DOI 10.1007/BF02931765; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Saussure H, 1860, REV MAGASIN ZOOLOG 2, V12, P3; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Schrider DR, 2016, GENETICS, V204, P1207, DOI 10.1534/genetics.116.190223; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAW CA, 1987, SCIENCE, V236, P186, DOI 10.1126/science.236.4798.186; Sheehan S, 2013, GENETICS, V194, P647, DOI 10.1534/genetics.112.149096; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Simpson G. G., 1980, SPLENDID ISOLATION C; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Siriano MRC, 1996, FILOGENIA TAMANDUA M; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Superina Mariella, 2010, Edentata, V11, P96; Svartman M, 2006, PLOS GENET, V2, P1006, DOI 10.1371/journal.pgen.0020109; TAJIMA F, 1989, GENETICS, V123, P585; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Taylor B.K., 1985, P163; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; Thomas O, 1911, P ZOOL SOC LOND, V1911, P687; THOMAS OLDFIELD, 1927, ANN & MAG NAT HIST, V19, P361; Upton G., 1985, SPATIAL DATA ANAL EX; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; van Dijk MAM, 1999, SYST BIOL, V48, P94, DOI 10.1080/106351599260463; VANDERHAMMEN T, 1992, HIST ECOLOGIA VEGETA; Voss RS, 2001, B AM MUS NAT HIST, P3; Watson D.F., 1992, CONTOURING GUIDE ANA; Wetzel R.M., 1985, P5; WETZEL R M, 1975, Proceedings of the Biological Society of Washington, V88, P95; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	187	4	5	2	12	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	2095-8137			ZOOL RES	Zool. Res.	SEP 18	2021	42	5					525	+		10.24272/j.issn.2095-8137.2020.365	http://dx.doi.org/10.24272/j.issn.2095-8137.2020.365			43	Zoology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Zoology	UZ5UY	34313411	Green Published, gold			2022-09-04	WOS:000702272000001
J	Linares-Vargas, CA; Bolivar-Garcia, W; Herrera-Martinez, A; Osorio-Dominguez, D; Ospina, OE; Thomas, R; Daza, JD				Linares-Vargas, Camilo A.; Bolivar-Garcia, Wilmar; Herrera-Martinez, Alexandra; Osorio-Dominguez, Daniel; Ospina, Oscar E.; Thomas, Richard; Daza, Juan D.			The status of the anomalepidid snake Liotyphlops albirostris and the revalidation of three taxa based on morphology and ecological niche models	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						blind snake; Colombia; morphology; osteology	SERPENTES ANOMALEPIDIDAE; HIGH-RESOLUTION; TYPHLOPIDAE; BLINDSNAKE; FOREST	Liotyphlops is a genus of blindsnakes distributed in Central and South America. We reviewed specimens of Liotyphlops albirostris along its current distribution range and, based on morphological data and ecological niche modeling analyses, we restrict the geographical range of L. albirostris and validate three previously described species. In this revision, we describe the morphological variation in the populations from Panama, Colombia, Ecuador, and Venezuela, and propose a new taxonomic arrangement. We revalidate three previous synonyms of L. albirostris to full species status, while dividing the populations from Colombia in two subspecies?one attributed to a previously recognized species from the Caribbean region, and a new one from the Andean region. The new species differs from L. albirostris from Panama in cephalic scale arrangements that effectively reduces the previously reported variability of these scales in L. albirostris. We also explore some osteological differences that are congruent with the variation observed. We hope that the recognition of these new species better represents the diversity within Liotyphlops, helping to bring these new species out of their cryptic status so that they will be considered in future conservation efforts.	[Linares-Vargas, Camilo A.; Bolivar-Garcia, Wilmar] Univ Valle, Dept Biol, Grp Invest Ecol Anim, Cali, Colombia; [Herrera-Martinez, Alexandra] Sam Houston State Univ, Diagnost Lab Human Hlth, Huntsville, TX 77340 USA; [Osorio-Dominguez, Daniel] Pontificia Univ Javeriana Cali, Dept Ciencias Nat & Matemat, Cali, Colombia; [Ospina, Oscar E.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [Thomas, Richard] Univ Puerto Rico, Biol Dept, Rio Piedras Campus, Rio Piedras, PR USA; [Daza, Juan D.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77341 USA		Daza, JD (corresponding author), Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77341 USA.	juand.daza@gmail.com	Ospina, Oscar/S-2918-2016	Ospina, Oscar/0000-0001-5986-4207; Herrera Martinez, Alexandra/0000-0001-5774-2863; Daza, Juan Diego/0000-0002-5651-0240; Bolivar Garcia, Wilmar/0000-0002-9395-721X; Linares Vargas, Camilo Andres/0000-0003-1433-7301; Osorio-Domingiez, Daniel/0000-0003-0005-0430	National Science Foundation [1657656]; Investigacion y desarrollo de accidentes ofidicos en el Valle del Cauca [BPIN 2017000100064]	National Science Foundation(National Science Foundation (NSF)); Investigacion y desarrollo de accidentes ofidicos en el Valle del Cauca	National Science Foundation, Grant/Award Number: 1657656; OCAD CTeI; Investigacion y desarrollo de accidentes ofidicos en el Valle del Cauca, Grant/Award Number: BPIN 2017000100064	Bell CJ, 2021, ANAT REC, V304, P2110, DOI 10.1002/ar.24729; Boulenger G.A., 1889, ANN MAGAZINE NATUR 6, V6, P360; Burbrink FT, 2020, SYST BIOL, V69, P502, DOI 10.1093/sysbio/syz062; Centeno FC, 2010, HERPETOLOGICA, V66, P86, DOI 10.1655/08-079.1; Core Team R., 2019, LANG ENV STAT COMP R; Cundall David, 2008, Contributions to Herpetology, V23, P349; Dixon J.R., 1984, Amphibia-Reptilia, V4, P241; Duan RY, 2016, PEERJ, V4, DOI 10.7717/peerj.2185; Dunn ER, 1944, J MORPHOL, V74, P287, DOI 10.1002/jmor.1050740203; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ellis RJ, 2016, HERPETOLOGICA, V72, P271, DOI 10.1655/Herpetologica-D-16-00007.1; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Figueroa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161070; GENTRY A H, 1986, Caldasia, V15, P71; Gignac PM, 2016, J ANAT, V228, P889, DOI 10.1111/joa.12449; Guallart J., 2015, AUSTR GOVT THREATENE; Haad Juan J. Silva, 2008, Biota Colombiana, V9, P295; HAAS G., 1964, ACTA ZOOL [ STOCKHOLM], V45, P1; HEDGES SB, 1991, HERPETOLOGICA, V47, P448; Joshi S., 2012, ADV MICROBIOL, V2, P465, DOI DOI 10.4236/AIM.2012.24060; List J. C., 1966, Illinois Biological Monographs, VNo. 36, P1; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Santos FJM, 2018, COPEIA, V106, P507, DOI 10.1643/CH-18-081; Santos FJM, 2019, COPEIA, V107, P239, DOI 10.1643/CH-19-181; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Mijares-Urrutia Abraham, 2000, Smithsonian Herpetological Information Service, V123, P1; Moreno A.G, 1991, SERPIENTES ECUADOR; Mumaw M.N., 2015, ATLAS SERPIENTES VEN; Naimi B, 2016, ECOGRAPHY, V39, P368, DOI 10.1111/ecog.01881; Perez-Escobar OA, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01328; Peters J. A, 1970, Bull. U.S. natn. Mus., VNo. 297, P1; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rieppel O, 2009, J MORPHOL, V270, P536, DOI 10.1002/jmor.10703; Roze J. A., 1952, Mem Soc Cienc nat, V32, P143; Roze J.A, 1966, TAXONOMIA ZOOGEOGRAP; Santos, 2018, THESIS PONTIFICIA U, P164; Savage JM., 2002, AMPHIBIANS REPTILES; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soriano P., 2004, REPTILES ANDES VENEZ; Strong CRC, 2021, ANAT REC, V304, P2303, DOI 10.1002/ar.24630; Thomas R, 2007, ZOOTAXA, P1; Vidal N, 2010, BIOL LETTERS, V6, P558, DOI 10.1098/rsbl.2010.0220; Wallach V., 2009, Hamadryad, V34, P34; Freire EMX, 2007, ZOOTAXA, P19, DOI 10.11646/zootaxa.1393.2	45	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	OCT	2021	304	10			SI		2264	2278		10.1002/ar.24730	http://dx.doi.org/10.1002/ar.24730		AUG 2021	15	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	UR2UF	34436828				2022-09-04	WOS:000688535100001
J	Sepulveda-Martinez, A; Steding-Ehrenborg, K; Rodriguez-Lopez, M; Ostenfeld, E; Valenzuela-Alcaraz, B; Heiberg, E; Gratacos, E; Prat-Gonzalez, S; Crispi, F; Hedstrom, E				Sepulveda-Martinez, Alvaro; Steding-Ehrenborg, Katarina; Rodriguez-Lopez, Merida; Ostenfeld, Ellen; Valenzuela-Alcaraz, Brenda; Heiberg, Einar; Gratacos, Eduard; Prat-Gonzalez, Susanna; Crispi, Fatima; Hedstrom, Erik			Atrioventricular plane displacement versus mitral and tricuspid annular plane systolic excursion: A comparison between cardiac magnetic resonance and M-mode echocardiography	CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING			English	Article						atrioventricular plane displacement; cardiac magnetic resonance; comparison; echocardiography; MAPSE; TAPSE		Introduction Both echocardiography and CMR imaging are used to quantify longitudinal function. Inter-method variability for mitral (MAPSE) and tricuspid (TAPSE) annular plane systolic excursion, and variability between directly measured MAPSE and TAPSE and as based on atrioventricular plane displacement (AVPD) analysis by CMR, are, however, not known. This study, therefore, assessed inter-method variability and variability between annular plane systolic excursion and AVPD-based values in a healthy adult population. Methods Echocardiography and CMR were performed in 111 adults (35 [32-38] years). Method comparisons were assessed with Deming regression, Bland-Altman analysis and coefficient of variation. Observer reproducibility was assessed by the concordance correlation coefficient. Results Echocardiography and semi-automatic CMR agreed on MAPSE (17 +/- 2 mm vs. 17 +/- 2 mm, p = 0.1) and TAPSE (25 +/- 3 mm vs. 25 +/- 3 mm, p = 0.5), correlated highly between methods (fitted-slope 1.22 [95% CI 1.07-1.38] and 1.12 [95% CI 0.95-1.29]) and showed low bias (0.42 [95% CI - 2.05 to 2.88] and - 0.18 [95% CI - 4.78 to 4.43]). Intra-/inter-observer reproducibility was high for both methods for both MAPSE (echocardiography 0.96/0.86; CMR 0.87/0.85) and TAPSE (echocardiography 0.96/0.95; CMR 0.97/0.96). MAPSE (16 +/- 2 mm vs. 17 +/- 2 mm; p < 0.001) and TAPSE (24 +/- 3 vs. 25 +/- 3 mm; p < 0.001) based on AVPD were similar but statistically different compared with semi-automatic CMR. Conclusions Echocardiography and semi-automatic CMR have low variability and provide similar values for MAPSE and TAPSE and are thus interchangeable for follow-up studies. Lateral values based on tracked data from AVPD analysis are not clinically significantly different and could be used as a representation of annular displacement.	[Sepulveda-Martinez, Alvaro; Rodriguez-Lopez, Merida; Valenzuela-Alcaraz, Brenda; Gratacos, Eduard; Crispi, Fatima] Univ Barcelona, Hosp Clin, Fetal Med Res Ctr, BCNatal, Barcelona, Spain; [Sepulveda-Martinez, Alvaro; Rodriguez-Lopez, Merida; Valenzuela-Alcaraz, Brenda; Gratacos, Eduard; Crispi, Fatima] Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain; [Sepulveda-Martinez, Alvaro] Hosp Clin Univ Chile, Dept Obstet & Gynecol, Fetal Med Unit, Santiago, Chile; [Sepulveda-Martinez, Alvaro; Steding-Ehrenborg, Katarina; Ostenfeld, Ellen; Heiberg, Einar; Hedstrom, Erik] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Clin Physiol, Lund, Sweden; [Steding-Ehrenborg, Katarina] Lund Univ, Dept Hlth Sci, Physiotherapy, Lund, Sweden; [Rodriguez-Lopez, Merida] Pontificia Univ Javeriana Cali, Cali, Colombia; [Rodriguez-Lopez, Merida] Lund Univ, Fac Engn, Dept Biomed Engn, Lund, Sweden; [Heiberg, Einar] Lund Univ, Wallenberg Ctr Mol Med, Lund, Sweden; [Prat-Gonzalez, Susanna] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Hosp Clin, Cardiovasc Inst, Barcelona, Spain; [Hedstrom, Erik] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Diagnost Radiol, Lund, Sweden		Hedstrom, E (corresponding author), Lund Univ, Dept Clin Sci Lund, Clin Physiol, Lund, Sweden.	erik.hedstrom@med.lu.se	Rodriguez-Lopez, Merida/N-9273-2017; Sepulveda-Martinez, Alvaro/H-6546-2014; Steding-Ehrenborg, Katarina/AAW-9919-2021; Ostenfeld, Ellen/F-2133-2014	Rodriguez-Lopez, Merida/0000-0001-8245-0811; Sepulveda-Martinez, Alvaro/0000-0002-8364-2732; Steding-Ehrenborg, Katarina/0000-0002-7250-6508; Gratacos, Eduard/0000-0002-7405-7224; Hedstrom, Erik/0000-0003-0041-9357; Ostenfeld, Ellen/0000-0002-2655-2423	Erasmus Mundus; Region of Skane; Skane University Hospital Lund; Medical Faculty at Lund University; Knut and Alice Wallenberg foundation; Instituto de Salud Carlos III [PI15/00130, PI14/00226, PI17/00675, INT16/00168]; por el ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) `Otra manera de hacer Europa' (Spain); Erasmus + Programme of the European Union [2013-0040]; 'la Caixa' Foundation (Spain) [LCF/PR/GN14/10270005]; AGAUR 2014 SGR grant [928]; Heart-Lung Foundation	Erasmus Mundus; Region of Skane; Skane University Hospital Lund; Medical Faculty at Lund University; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); por el ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) `Otra manera de hacer Europa' (Spain); Erasmus + Programme of the European Union; 'la Caixa' Foundation (Spain)(La Caixa Foundation); AGAUR 2014 SGR grant; Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This project has been funded with support of Erasmus Mundus, Heart-Lung Foundation, Region of Skane, Skane University Hospital Lund, Medical Faculty at Lund University, and the Knut and Alice Wallenberg foundation, the Instituto de Salud Carlos III (PI15/00130, PI14/00226, PI17/00675, INT16/00168) integrados en el Plan Nacional de I + D + I y cofinanciados por el ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) `Otra manera de hacer Europa' (Spain); Erasmus + Programme of the European Union (Framework Agreement number: 2013-0040) This publication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein; 'la Caixa' Foundation under agreement LCF/PR/GN14/10270005 (Spain); AGAUR 2014 SGR grant no 928 and Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK). This publication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carlsson M, 2007, AM J PHYSIOL-HEART C, V293, pH636, DOI 10.1152/ajpheart.01376.2006; Carlsson M, 2007, AM J PHYSIOL-HEART C, V292, pH1452, DOI 10.1152/ajpheart.01148.2006; CORNBLEET PJ, 1979, CLIN CHEM, V25, P432; Dutta T, 2017, CLIN CARDIOL, V40, P542, DOI 10.1002/clc.22694; FEIGENBAUM H, 1967, CIRCULATION, V35, P1092, DOI 10.1161/01.CIR.35.6.1092; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; KAUL S, 1984, AM HEART J, V107, P526, DOI 10.1016/0002-8703(84)90095-4; Lin L. I., 2005, NIWA CLIENT REP HAM2, V45, P307; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Medvedofsky D, 2015, J AM SOC ECHOCARDIOG, V28, P1222, DOI 10.1016/j.echo.2015.06.013; Ochs MM, 2017, INT J CARDIOVAS IMAG, V33, P721, DOI 10.1007/s10554-016-1058-y; Romano S, 2019, JACC-CARDIOVASC IMAG, V12, P1769, DOI 10.1016/j.jcmg.2018.10.003; Seemann F, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-017-0189-5; Steding-Ehrenborg K, 2015, J PHYSIOL-LONDON, V593, P5157, DOI 10.1113/JP271621	15	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1475-0961	1475-097X		CLIN PHYSIOL FUNCT I	Clin. Physiol. Funct. Imaging	MAY	2021	41	3					262	270		10.1111/cpf.12693	http://dx.doi.org/10.1111/cpf.12693		FEB 2021	9	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	RJ8NM	33550709	hybrid			2022-09-04	WOS:000622674800001
J	Hurtado-M, AB; Echeverry-Galvis, MA; Salgado-Negret, B; Munoz, JC; Posada, JM; Norden, N				Belen Hurtado-M, Ana; Angela Echeverry-Galvis, Maria; Salgado-Negret, Beatriz; Camilo Munoz, Juan; Manuel Posada, Juan; Norden, Natalia			Little trace of floristic homogenization in peri-urban Andean secondary forests despite high anthropogenic transformation	JOURNAL OF ECOLOGY			English	Article						Andean forests; dispersal limitation; environmental filtering; human&#8208; impacted landscape; peri&#8208; urban forests; seedlings; succession	TROPICAL FORESTS; BIOTIC HOMOGENIZATION; HABITAT ASSOCIATIONS; NUTRIENT LIMITATION; TREE COMMUNITIES; ATLANTIC FOREST; SOIL NUTRIENTS; SEED-DISPERSAL; DIVERSITY; ADULT	Pervasive human impact in heavily transformed landscapes may lead disturbance-adapted species to thrive, resulting in floristic homogenization across forest stands. However, environmental heterogeneity and dispersal limitation may be antagonistic forces to homogenization, maintaining inherent floristic differentiation across sites. We evaluated the extent to which peri-urban Andean forests are undergoing floristic homogenization in both late- and early-successional stands. We considered seedling assemblages as well, as they provide key insights into forests' future. We then quantified the relative importance of dispersal limitation and environmental filtering in determining the observed patterns of floristic similarity across the landscape. We used tree, seedling, soil and climatic data from six sites located in the high plain where Bogota lies (Colombia). Within each site, we established six 20 x 20 m plots, three in early-successional stands and three in late-successional stands, for a total of 36 plots. To evaluate the extent of floristic homogenization, we defined tree floristic similarity among late-successional stands as a baseline, reflecting our best-guess of the original species composition that would have once occurred previous to intense anthropogenic intervention. Tree floristic turnover across the landscape was alike in late- and in early-secondary stands, a finding that does not support the homogenization scenario. Seedling species composition, in contrast, was more homogeneous among early- than among late-secondary stands, an outcome suggestive of homogenization. The relative importance of spatial and environmental drivers shifted between life stages. Distance between plots was the best predictor of tree species dissimilarity (29% of variance explained), whereas seedling compositional variation was more sensitive to changes in environmental conditions (41% of the variance explained). Relative humidity and several variables related to soil fertility showed a significant effect on floristic dissimilarity across the landscape, although significant factors were often different between life stages. Synthesis. Despite high anthropogenic transformation, we found little trace of floristic homogenization in these peri-urban landscapes. Inherent floristic differentiation, promoted both by dispersal limitation and environmental heterogeneity, suggests that all patches are important to the conservation in these Andean forests, critical centres of endemism.	[Belen Hurtado-M, Ana; Angela Echeverry-Galvis, Maria] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rural, Dept Ecol & Terr, Bogota, Colombia; [Belen Hurtado-M, Ana; Norden, Natalia] Inst Invest Recursos Biol Alexander von Humboldt, Bogota, Colombia; [Belen Hurtado-M, Ana; Norden, Natalia] Fdn Cedrela, Bogota, Colombia; [Salgado-Negret, Beatriz] Univ Nacl Colombia, Fac Ciencias, Dept Biol, Bogota, Colombia; [Camilo Munoz, Juan] Fdn Humedales, Bogota, Colombia; [Camilo Munoz, Juan] Ciemco Ltda Bosques Canoas SCA, Bogota, Colombia; [Manuel Posada, Juan] Univ Rosario, Fac Ciencias Nat & Matemat, Dept Biol, Bogota, Colombia		Norden, N (corresponding author), Inst Invest Recursos Biol Alexander von Humboldt, Bogota, Colombia.; Norden, N (corresponding author), Fdn Cedrela, Bogota, Colombia.	nnorden@humboldt.org.co		Hurtado-M, Ana Belen/0000-0002-2765-4966; Salgado-Negret, Beatriz/0000-0002-3103-9878; Munoz, Juan Camilo/0000-0002-0003-9285; Echeverry-Galvis, Maria Angela/0000-0002-5273-8694	Pontificia Universidad Javeriana [Ppt 6568]; Programa Bosques Andinos; Jardin Botanico de Bogota; Instituto Humboldt	Pontificia Universidad Javeriana; Programa Bosques Andinos; Jardin Botanico de Bogota; Instituto Humboldt	Pontificia Universidad Javeriana, Grant/Award Number: Ppt 6568- Convocatoria VRI-05 de 2017; Programa Bosques Andinos; Jardin Botanico de Bogota; Instituto Humboldt	Arellano G, 2016, OIKOS, V125, P326, DOI 10.1111/oik.02426; Arroyo-Rodriguez V, 2017, BIOL REV, V92, P326, DOI 10.1111/brv.12231; Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Avella M A., 2017, BOSQUES ROBLES FAGAC, VXV, P1; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2013.0548, 10.1098/rspb.2012.2532]; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; Barlow J, 2016, NATURE, V535, P144, DOI 10.1038/nature18326; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernal R., 2019, CATALOGO PLANTAS LIQ; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Calbi M, 2020, FORESTS, V11, DOI 10.3390/f11080788; Chao AN, 2014, ANNU REV ECOL EVOL S, V45, P297, DOI 10.1146/annurev-ecolsys-120213-091540; Chazdon RL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501639; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 2013, P NATL ACAD SCI USA, V110, P5064, DOI 10.1073/pnas.1218042110; Cortes-Sanchez S. P., 2018, ESTADOS POLITICA, V5, P17, DOI [10.15446/cep.v5n2.68552, DOI 10.15446/CEP.V5N2.68552]; Solar RRD, 2015, ECOL LETT, V18, P1108, DOI 10.1111/ele.12494; Departamento Administrativo Nacional de Estadistica (DANE), 2019, CENS NAC POBL VIV 20; Duque A, 2015, P NATL ACAD SCI USA, V112, P10744, DOI 10.1073/pnas.1506570112; Emer C, 2018, ECOL LETT, V21, P484, DOI 10.1111/ele.12909; Engelbrecht BMJ, 2003, OECOLOGIA, V136, P383, DOI 10.1007/s00442-003-1290-8; Escobedo FJ, 2015, URBAN FOR URBAN GREE, V14, P1040, DOI 10.1016/j.ufug.2015.09.011; Etter A, 2000, MT RES DEV, V20, P236, DOI 10.1659/0276-4741(2000)020[0236:AFAFSI]2.0.CO;2; Fadrique B, 2018, NATURE, V564, P207, DOI 10.1038/s41586-018-0715-9; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Green PT, 2014, P NATL ACAD SCI USA, V111, P18649, DOI 10.1073/pnas.1321892112; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hethcoat MG, 2019, OECOLOGIA, V191, P475, DOI 10.1007/s00442-019-04497-8; Hoffman GE, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1323-z; Hubbell Stephen P., 2001, V32, pi; Hurtado-M A. B., 2020, DRYAD DATASET, DOI [10.5061/dryad.ngf1vhhsn, DOI 10.5061/DRYAD.NGF1VHHSN]; IDEAM-Instituto de Hidrologia Meteorologia y Estudios Ambientales, 2012, ACT NOT TECN HEL; Jakovac CC, 2015, J ECOL, V103, P67, DOI 10.1111/1365-2745.12298; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mendoza JE, 2002, LANDSCAPE URBAN PLAN, V59, P147, DOI 10.1016/S0169-2046(02)00012-9; Mora F, 2015, BIOTROPICA, V47, P38, DOI 10.1111/btp.12187; Muller-Landau H. C., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P35, DOI 10.1079/9780851995250.0035; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; Oksanen FJ, 2017, VEGAN COMMUNITY ECOL; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Osuri AM, 2017, J TROP ECOL, V33, P270, DOI 10.1017/S0266467417000219; Piper FI, 2006, PLANT ECOL, V185, P29, DOI 10.1007/s11258-005-9081-4; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; Prada CM, 2017, J VEG SCI, V28, P859, DOI 10.1111/jvs.12540; Rada F, 2019, PLANT ECOL DIVERS, V12, P539, DOI 10.1080/17550874.2019.1674396; Rehm EM, 2015, ECOLOGY, V96, P1856, DOI 10.1890/14-1992.1; Rubiano K, 2017, FORESTS, V8, DOI 10.3390/f8060216; Ruiz M., 2008, HIST AMBIENTAL BOGOT, P48; Santo-Silva EE, 2015, PLANT ECOL DIVERS, V8, P483, DOI 10.1080/17550874.2015.1048486; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Tanner EVJ, 1998, ECOLOGY, V79, P10, DOI 10.1890/0012-9658(1998)079[0010:EIONLO]2.0.CO;2; Team R.C., 2017, R LANG ENV STAT COMP; TIETEMA T, 1993, FOREST ECOL MANAG, V60, P257, DOI 10.1016/0378-1127(93)90083-Y; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Uriarte M, 2011, ECOLOGY, V92, P924, DOI 10.1890/10-0709.1; Urli M, 2013, TREE PHYSIOL, V33, P672, DOI 10.1093/treephys/tpt030; van Breugel M, 2019, J ECOL, V107, P566, DOI 10.1111/1365-2745.13126; Van der Hammen T, 1998, PLAN AMBIENTAL CUENC; vanderHammen T, 1960, LEIDSE GEOLOGISCHE M, V25, P261; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; Zalamea PC, 2016, NEW PHYTOL, V212, P400, DOI 10.1111/nph.14045	68	4	4	5	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-0477	1365-2745		J ECOL	J. Ecol.	MAR	2021	109	3					1468	1478		10.1111/1365-2745.13570	http://dx.doi.org/10.1111/1365-2745.13570		DEC 2020	11	Plant Sciences; Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Environmental Sciences & Ecology	QT3ZX					2022-09-04	WOS:000602192800001
J	Lopez-Valdes, FJ; Bohman, K; Jimenez-Octavio, J; Logan, D; Raphael, W; Quintana, L; del Fueyo, RS; Koppel, S				Lopez-Valdes, Francisco J.; Bohman, Katarina; Jimenez-Octavio, Jesus; Logan, David; Raphael, Wassim; Quintana, Leonardo; Fueyo, Rocio Suarez del; Koppel, Sjaan			Understanding users' characteristics in the selection of vehicle seating configurations and positions in fully automated vehicles	TRAFFIC INJURY PREVENTION			English	Article						Seating configurations; seating positions; fully automated vehicles; autonomous vehicle	FUTURE	Objective To understand which users' characteristics influence their preferences in the selection of vehicle seating configurations and positions across different traveling scenarios involving a fully automated vehicle (FAV). Methods Participants (n = 730) completed an online survey in which they were asked to imagine traveling in a FAV across three hypothetical scenarios. Participants were asked to select between five different seating configurations and four positions for each scenario and about their anthropometry and their driving/riding experience. Multinomial regression analyses were conducted to identify the factors that influenced users' preferences. Results FAV Configuration #3 (traditional light vehicle seating configuration) was the preferred seating configuration for 74% of the participants, followed by FAV #2 (in which the two seating rows face each other, 13%) in Scenario 1 (riding by oneself). Similar numbers were observed in Scenario 3 (riding with an unknown person). In Scenario 2 (riding with their partner), participants preferred FAV #2 (12.5%) and FAV #5 (in which the front seat passengers point toward a common point in the front, conventional rear seat configuration, 17.5%). Having close family was significant to choose the traditional vehicle configuration over other vehicle configurations, but only when the participants were driving by themselves. Having previously experienced motion sickness was significant to prefer a forward seating configuration when the trip was shared with partners. Belonging to a particular height or weight group was significantly associated with the preferred seat within the preferred FAV configuration (the driver's position in FAV #3; a rear-facing seat in FAV #2), although there was not a clear trend between increasing weight and/or height and preferring one seating position over the others. Conclusions Previous work had shown differences in participants' preferences for seating configurations and positions depending on age, sex and country. While increasing the sample size, the current study analyses other factors that were associated with choosing one vehicle configuration and seating position over others. As these factors are directly related to the likelihood of sustaining injuries in the event of a crash, the current study provides important insights regarding the potential risk factors for FAV occupants.	[Lopez-Valdes, Francisco J.; Jimenez-Octavio, Jesus] Univ Pontificia Comillas, Mech Engn, Madrid, Spain; [Lopez-Valdes, Francisco J.; Jimenez-Octavio, Jesus] Univ Pontificia Comillas, Inst Invest Tecnol, Madrid, Spain; [Bohman, Katarina] Volvo Cars, Gothenburg, Sweden; [Logan, David; Koppel, Sjaan] Monash Univ, Accid Res Ctr, Clayton, Vic, Australia; [Raphael, Wassim] St Joseph Univ Beirut, Beirut, Lebanon; [Quintana, Leonardo] Pontificia Univ Javeriana, Fac Engn, Bogota, Colombia; [Fueyo, Rocio Suarez del] Dr Ing HCF Porsche AG, Stuttgart, Germany		Lopez-Valdes, FJ (corresponding author), Univ Pontificia Comillas, ICAI Engn Sch, Inst Invest Tecnol IIT, Dept Tech Engn ICAI, C Alberto Aguilera 25, Madrid 28015, Spain.	fjlvaldes@comillas.edu	Lopez-Valdes, Francisco/AAG-5519-2019; Jimenez-Octavio, Jesus R./G-4290-2016; /I-3649-2012	Jimenez-Octavio, Jesus R./0000-0002-6869-8332; Quintana, Leonardo/0000-0001-5625-0111; koppel, sjaan/0000-0003-3973-299X; /0000-0003-3167-5732				Bose D, 2010, ACCIDENT ANAL PREV, V42, P1398, DOI 10.1016/j.aap.2010.03.004; Das S, 2015, J TRAFFIC TRANSP ENG, V2, P145, DOI 10.1016/j.jtte.2015.03.003; European Commission, 2017, AUT CARS BIG OPP EUR; Forman J, 2018, 20185234 JSAE; Gepner B., 2018, SAE GOVT IND M, P24; Haboucha CJ, 2017, TRANSPORT RES C-EMER, V78, P37, DOI 10.1016/j.trc.2017.01.010; Hensher DA, 2018, TRANSPORT POLICY, V66, pA1, DOI 10.1016/j.tranpol.2018.02.007; Jin X, 2018, OCCUPANT KINEMATICS; Jorlov S, 2017, SEATING POSITIONS AC; Katrakazas C, 2015, TRANSPORT RES C-EMER, V60, P416, DOI 10.1016/j.trc.2015.09.011; Kitagawa Y., 2017, STAPP CAR CRASH J, V61, P101; Koppel S, 2019, TRAFFIC INJ PREV, V20, pS103, DOI 10.1080/15389588.2019.1625336; MoveAmerica, 2020, FUT URB MOB WE MOV; Mueller AlexandraS., 2020, WHAT HUMANLIKE ERROR; Ntousakis IA, 2016, TRANSPORT RES C-EMER, V71, P464, DOI 10.1016/j.trc.2016.08.007; Segui-Gomez M, 2011, RISK ANAL, V31, P466, DOI 10.1111/j.1539-6924.2010.01509.x	16	2	2	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	OCT 12	2020	21			1	SI		S19	S24		10.1080/15389588.2020.1810245	http://dx.doi.org/10.1080/15389588.2020.1810245		SEP 2020	6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	SI3UO	32926638	Green Submitted			2022-09-04	WOS:000569179800001
J	Barreto, GE; Iarkov, A; Moran, VE				Barreto, George E.; Iarkov, Alexander; Echeverria Moran, Valentina			Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease	FRONTIERS IN AGING NEUROSCIENCE			English	Review						Akt(PKB); synucleinopathies; beta-amyloid; cotinine; nicotine; Parkinson disease	WHITE-MATTER HYPERINTENSITIES; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; ACETYLCHOLINE-RECEPTORS; DOPAMINERGIC-NEURONS; COGNITIVE IMPAIRMENT; CIGARETTE-SMOKING; MOLECULAR-MECHANISMS; INDUCED DYSKINESIAS; OXIDATIVE STRESS	Parkinsons disease (PD) is a progressive neurodegenerative disorder, which is characterized by neuroinflammation, dopaminergic neuronal cell death and motor dysfunction, and for which there are no proven effective treatments. The negative correlation between tobacco consumption and PD suggests that tobacco-derived compounds can be beneficial against PD. Nicotine, the more studied alkaloid derived from tobacco, is considered to be responsible for the beneficial behavioral and neurological effects of tobacco use in PD. However, several metabolites of nicotine, such as cotinine, also increase in the brain after nicotine administration. The effect of nicotine and some of its derivatives on dopaminergic neurons viability, neuroinflammation, and motor and memory functions, have been investigated using cellular and rodent models of PD. Current evidence shows that nicotine, and some of its derivatives diminish oxidative stress and neuroinflammation in the brain and improve synaptic plasticity and neuronal survival of dopaminergic neurons. In vivo these effects resulted in improvements in mood, motor skills and memory in subjects suffering from PD pathology. In this review, we discuss the potential benefits of nicotine and its derivatives for treating PD.	[Barreto, George E.] Pontificia Univ Javeriana, Dept Biochem & Nutr, Bogota, DC, Colombia; [Iarkov, Alexander; Echeverria Moran, Valentina] Univ Autonoma Chile, Biomed Sci Res Ctr, Santiago, Chile; [Iarkov, Alexander; Echeverria Moran, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL USA; [Echeverria Moran, Valentina] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA; [Echeverria Moran, Valentina] Univ South, Morsani Coll Med, Dept Mol Med, Tampa, FL USA		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Dept Biochem & Nutr, Carrera 7 40-62, Bogota, DC, Colombia.	gsampaio@javeriana.edu.co; echeverria.valentina@gmail.com	Barreto, George E./B-5747-2014; Barreto, George E./AAD-7420-2020; Valentina Echeverria Moran, BCh/E-7765-2013	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418	Universidad Autonoma de Chile	Universidad Autonoma de Chile	This material is the result of work supported with resources and the use of facilities at the Bay Pines VA Healthcare System. The contents do not necessarily represent the views of the Department of Veterans Affairs or the United States Government. This work was supported by financial support from the Universidad Autonoma de Chile.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Alcalay RN, 2009, ARCH NEUROL-CHICAGO, V66, P1517, DOI 10.1001/archneurol.2009.267; Aosaki T, 2010, GERIATR GERONTOL INT, V10, pS148, DOI 10.1111/j.1447-0594.2010.00588.x; Balakumar P, 2009, PHARMACOL RES, V60, P361, DOI 10.1016/j.phrs.2009.06.005; Bar-Shira A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.014; Baron JA, 1996, BRIT MED BULL, V52, P58, DOI 10.1093/oxfordjournals.bmb.a011533; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENVIRON MOL MUTAGEN, V50, P771, DOI 10.1002/em.20500; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00117; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Baykan A, 2008, ANADOLU KARDIYOL DER, V8, P243; Benowitz N L, 1997, NIDA Res Monogr, V173, P48; Benowitz NL, 2011, NICOTINE TOB RES, V13, P772, DOI 10.1093/ntr/ntr072; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; BENOWITZ NL, 1994, CLIN PHARMACOL THER, V56, P483, DOI 10.1038/clpt.1994.169; BENOWITZ NL, 1993, CLIN PHARMACOL THER, V53, P316, DOI 10.1038/clpt.1993.27; Benowitz NL, 1996, PHARMACOGENETICS, V6, P239, DOI 10.1097/00008571-199606000-00006; BENOWITZ NL, 1994, J PHARMACOL EXP THER, V268, P296; Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X; Benowitz NL, 2002, HYPERTENSION, V39, P1107, DOI 10.1161/01.HYP.0000018825.76673.EA; Bergen AW, 1999, JNCI-J NATL CANCER I, V91, P1365, DOI 10.1093/jnci/91.16.1365; Bordia T, 2015, EXP NEUROL, V263, P277, DOI 10.1016/j.expneurol.2014.09.015; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; BRIGGS CA, 1995, NEUROPHARMACOLOGY, V34, P583, DOI 10.1016/0028-3908(95)00028-5; Buccafusco JJ, 2009, BIOCHEM PHARMACOL, V78, P852, DOI 10.1016/j.bcp.2009.06.102; Buccafusco JJ, 2003, LIFE SCI, V72, P2931, DOI 10.1016/S0024-3205(03)00226-1; Budzianowski Jaromir, 2013, Przegl Lek, V70, P865; Bueler H, 2010, APOPTOSIS, V15, P1336, DOI 10.1007/s10495-010-0465-0; Burghaus L, 2003, PARKINSONISM RELAT D, V9, P243, DOI 10.1016/S1353-8020(03)00028-2; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Caldwell B, 2012, NICOTINE TOB RES, V14, P1127, DOI 10.1093/ntr/nts009; Camilleri A, 2014, CNS NEUROSCI THER, V20, P591, DOI 10.1111/cns.12264; Carnevale D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P388; CASHMAN JR, 1992, CHEM RES TOXICOL, V5, P639, DOI 10.1021/tx00029a008; Celardo I, 2014, BRIT J PHARMACOL, V171, P1943, DOI 10.1111/bph.12433; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Conte A, 2013, NAT REV NEUROL, V9, P687, DOI 10.1038/nrneurol.2013.224; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Costa G, 2001, BRAIN RES, V888, P336, DOI 10.1016/S0006-8993(00)03087-0; Cummings J L, 1988, J Geriatr Psychiatry Neurol, V1, P24, DOI 10.1177/089198878800100106; CUMMINGS JL, 1988, EUR NEUROL, V28, P15; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Davis SJ, 2012, RETINA-J RET VIT DIS, V32, P1171, DOI 10.1097/IAE.0b013e31823496b8; De Reuck J, 2005, J NEUROL SCI, V231, P35, DOI 10.1016/j.jns.2004.12.003; Dempsey D, 2000, CLIN PHARMACOL THER, V67, P458, DOI 10.1067/mcp.2000.106129; Dempsey DA, 2013, CLIN PHARMACOL THER, V94, P400, DOI 10.1038/clpt.2013.114; Derkinderen P, 2014, MOVEMENT DISORD, V29, P976, DOI 10.1002/mds.25882; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Diaz A, 2010, NEUROSCI LETT, V468, P151, DOI 10.1016/j.neulet.2009.10.087; dos Santos AB, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00273; Dwoskin LP, 1999, J PHARMACOL EXP THER, V288, P905; Echeverria V., 2012, J CLINC TOXICOL, V1, P2011, DOI [DOI 10.4172/2161-0495.S6-003, 10.4172/2161-0495.S6-003]; Echeverria V, 2012, CNS NEUROSCI THER, V18, P517, DOI 10.1111/j.1755-5949.2012.00317.x; Echeverria V, 2011, J ALZHEIMERS DIS, V24, P817, DOI 10.3233/JAD-2011-102136; Edison P, 2013, NEUROPSYCHOPHARMACOL, V38, P938, DOI 10.1038/npp.2012.255; El-Agnaf OMA, 2002, BIOCHEM SOC T, V30, P559; Faucheux BA, 2003, J NEUROCHEM, V86, P1142, DOI 10.1046/j.1471-4159.2003.01923.x; Fujii YX, 2007, J NEUROIMMUNOL, V189, P69, DOI 10.1016/j.jneuroim.2007.07.003; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Garrido-Gil P, 2013, EXP NEUROL, V250, P384, DOI 10.1016/j.expneurol.2013.10.013; Graham AJ, 2002, CNS NEUROL DISORD-DR, V1, P387, DOI 10.2174/1568007023339283; Grizzell JA, 2014, BEHAV BRAIN RES, V268, P55, DOI 10.1016/j.bbr.2014.03.047; Guan YZ, 2015, MOL NEUROBIOL, V51, P1480, DOI 10.1007/s12035-014-8825-3; Gupta Himanshu, 2013, Recent Pat Drug Deliv Formul, V7, P184; Murer MG, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00051; Havekes R, 2011, BEHAV BRAIN RES, V221, P412, DOI 10.1016/j.bbr.2010.11.047; Hecht SS, 2000, CARCINOGENESIS, V21, P850, DOI 10.1093/carcin/21.4.850; Heitzer T, 1999, J AM COLL CARDIOL, V33, P499, DOI 10.1016/S0735-1097(98)00584-1; Helen A, 1999, VET HUM TOXICOL, V41, P316; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Hirsch EC, 2003, ADV NEUROL, V91, P29; Hong DP, 2009, BBA-PROTEINS PROTEOM, V1794, P282, DOI 10.1016/j.bbapap.2008.09.026; Hu MTM, 2014, MOVEMENT DISORD, V29, P351, DOI 10.1002/mds.25748; Hughes TA, 2000, NEUROLOGY, V54, P1596, DOI 10.1212/WNL.54.8.1596; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jellinger KA, 2003, MOVEMENT DISORD, V18, P1207, DOI 10.1002/mds.10513; Kalaitzakis ME, 2008, J NEUROPATH EXP NEUR, V67, P155, DOI 10.1097/NEN.0b013e31816362aa; Kalra R, 2004, CLIN DIAGN LAB IMMUN, V11, P563, DOI 10.1128/CDLI.11.3.563-568.2004; Kalra R, 2002, J PHARMACOL EXP THER, V302, P935, DOI 10.1124/jpet.302.3.935; Kawamata J, 2011, J ALZHEIMERS DIS, V24, P95, DOI 10.3233/JAD-2011-110173; Kelton MC, 2000, BRAIN COGNITION, V43, P274; Kem WR, 1997, J PHARMACOL EXP THER, V283, P979; Kem WR, 2000, BEHAV BRAIN RES, V113, P169, DOI 10.1016/S0166-4328(00)00211-4; Klein Autumn M., 2007, V46, P205; Kurosinski P, 2002, TRENDS MOL MED, V8, P3, DOI 10.1016/S1471-4914(01)02246-8; Labandeira-Garcia JL, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00067; Liu JH, 2012, AGING MENT HEALTH, V16, P529, DOI 10.1080/13607863.2011.628979; Lorenz R, 2014, ACTA NEUROL SCAND, V130, P164, DOI 10.1111/ane.12259; LUETJE CW, 1990, FASEB J, V4, P2753, DOI 10.1096/fasebj.4.10.2197155; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Maggio R, 1997, J NEURAL TRANSM, V104, P1113, DOI 10.1007/BF01273324; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Mckay BE, 2007, BIOCHEM PHARMACOL, V74, P1120, DOI 10.1016/j.bcp.2007.07.001; MCKENNIS H, 1963, J BIOL CHEM, V238, P719; Mellick GD, 2006, NEUROLOGY, V67, P179, DOI 10.1212/01.wnl.0000223618.53129.56; Meredith Gloria E, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS112, DOI 10.1016/j.parkreldis.2008.04.012; Molander L, 2001, CLIN PHARMACOL THER, V69, P57, DOI 10.1067/mcp.2001.113181; Moran VE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00173; NEURATH GB, 1994, CLIN INVESTIGATOR, V72, P190; NORDBERG A, 1994, NEUROCHEM INT, V25, P93, DOI 10.1016/0197-0186(94)90059-0; Nunomura A., 2007, CNS & Neurological Disorders-Drug Targets, V6, P411, DOI 10.2174/187152707783399201; O'Leary K, 2008, J PHARMACOL EXP THER, V325, P646, DOI 10.1124/jpet.108.136838; O'Reilly EJ, 2009, AM J EPIDEMIOL, V169, P678, DOI 10.1093/aje/kwn388; Palazzolo Dominic L, 2013, Front Public Health, V1, P56, DOI 10.3389/fpubh.2013.00056; Parain K, 2003, BRAIN RES, V984, P224, DOI 10.1016/S0006-8993(03)03195-0; Perez VP, 2010, CURR NEUROVASC RES, V7, P15, DOI 10.2174/156720210790820172; Perez XA, 2013, J NEUROCHEM, V127, P762, DOI 10.1111/jnc.12442; Perez XA, 2012, J PHARMACOL EXP THER, V342, P335, DOI 10.1124/jpet.112.194084; Perfeito R, 2013, FREE RADICAL BIO MED, V62, P186, DOI 10.1016/j.freeradbiomed.2013.05.042; Perier C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009332; Pillai S, 2012, CURR DRUG TARGETS, V13, P671, DOI 10.2174/138945012800398847; Quik M, 2006, J NEUROSCI, V26, P4681, DOI 10.1523/JNEUROSCI.0215-06.2006; Quik M, 2006, J NEUROCHEM, V98, P1866, DOI 10.1111/j.1471-4159.2006.04078.x; Quik M, 2012, MOVEMENT DISORD, V27, P947, DOI 10.1002/mds.25028; Quik M, 2012, NEUROPHARMACOLOGY, V63, P450, DOI 10.1016/j.neuropharm.2012.04.029; Quik M, 2011, CNS NEUROL DISORD-DR, V10, P651, DOI 10.2174/187152711797247849; Quik M, 2011, PHARMACOL REV, V63, P938, DOI 10.1124/pr.110.003269; Quik M, 2011, BIOCHEM PHARMACOL, V82, P873, DOI 10.1016/j.bcp.2011.06.001; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; Riedel O, 2014, PARKINSONISM RELAT D, V20, P1365, DOI 10.1016/j.parkreldis.2014.09.025; Ritz B, 2014, NEUROLOGY, V83, P1396, DOI 10.1212/WNL.0000000000000879; Rodella LF, 2012, CELLS TISSUES ORGANS, V195, P252, DOI 10.1159/000324919; Roth JA, 2014, NEUROTOXICOLOGY, V44, P314, DOI 10.1016/j.neuro.2014.08.006; Rottschy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061786; Sanford Zachary, 2014, W V Med J, V110, P10; Sasaki M, 1992, Ann Nucl Med, V6, P241; Schmid AW, 2013, MOL CELL PROTEOMICS, V12, P3543, DOI 10.1074/mcp.R113.032730; Schneider NG, 2001, CLIN PHARMACOKINET, V40, P661, DOI 10.2165/00003088-200140090-00003; Shi CJ, 2013, J MOL MODEL, V19, P871, DOI 10.1007/s00894-012-1618-6; Shin J, 2012, J NEUROL NEUROSUR PS, V83, P315, DOI 10.1136/jnnp-2011-300872; Simuni T, 2008, ANN NEUROL, V64, pS65, DOI 10.1002/ana.21472; Slawek J, 2008, NEUROL NEUROCHIR POL, V42, P505; SRIVASTAVA ED, 1989, HUM TOXICOL, V8, P461, DOI 10.1177/096032718900800605; Stewart T, 2014, AM J PATHOL, V184, P966, DOI 10.1016/j.ajpath.2013.12.007; Suzuki S, 2013, J NEUROSCI RES, V91, P462, DOI 10.1002/jnr.23160; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489; Tavassoly O, 2014, EUR J MED CHEM, V88, P42, DOI 10.1016/j.ejmech.2014.07.090; Terry AV, 2012, BIOCHEM PHARMACOL, V83, P941, DOI 10.1016/j.bcp.2011.12.043; Thiriez Claire, 2011, Expert Rev Clin Pharmacol, V4, P429, DOI 10.1586/ecp.11.27; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; Tiwari MN, 2013, FREE RADICAL BIO MED, V65, P704, DOI 10.1016/j.freeradbiomed.2013.07.042; Torrente D, 2014, NEUROSCI LETT, V565, P2, DOI 10.1016/j.neulet.2013.12.058; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132; WHITEHOUSE PJ, 1988, NEUROLOGY, V38, P720, DOI 10.1212/WNL.38.5.720; Wirths O, 2003, PROG NEURO-PSYCHOPH, V27, P103, DOI 10.1016/S0278-5846(02)00339-1; Wright JW, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/860923; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yanagida T, 2008, NEUROSCI RES, V62, P254, DOI 10.1016/j.neures.2008.09.003; Yu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007040; Zeng H, 2001, BIOL PSYCHIAT, V49, P248, DOI 10.1016/S0006-3223(00)01111-2; Zhang DH, 2014, MOVEMENT DISORD, V29, P508, DOI 10.1002/mds.25817; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; Zokaei N, 2014, BRAIN, V137, P2303, DOI 10.1093/brain/awu143; Zuo L, 2013, GENE, V532, P18, DOI 10.1016/j.gene.2013.07.085	161	69	70	0	61	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	JAN 9	2015	6								340	10.3389/fnagi.2014.00340	http://dx.doi.org/10.3389/fnagi.2014.00340			13	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	AZ3GD	25620929	Green Published, gold			2022-09-04	WOS:000348114600001
J	McAlpine, CA; Ryan, JG; Seabrook, L; Thomas, S; Dargusch, PJ; Syktus, JI; Pielke, RA; Etter, AE; Fearnside, PM; Laurance, WF				McAlpine, C. A.; Ryan, J. G.; Seabrook, L.; Thomas, S.; Dargusch, P. J.; Syktus, J. I.; Pielke, R. A., Sr.; Etter, A. E.; Fearnside, P. M.; Laurance, W. F.			More than CO2: a broader paradigm for managing climate change and variability to avoid ecosystem collapse	CURRENT OPINION IN ENVIRONMENTAL SUSTAINABILITY			English	Review							LAND-COVER CHANGE; WATER-VAPOR FLOWS; TERRESTRIAL ECOSYSTEM; CARBON; CONSERVATION; FEEDBACKS; DEFORESTATION; IMPACTS; DRIVEN; AGRICULTURE	Climate change policies currently focus on reducing the concentration of industrial atmospheric greenhouse gases due to burning fossil fuels and deforestation, but pay limited attention to feedbacks between the land surface and the climate system. In tropical and subtropical regions, forests and woodlands play an important role in the climate system by buffering climate extremes, maintaining the hydrological cycle and sequestering carbon. Despite the obvious significance of these feedbacks to the functioning of the climate system, deforestation continues apace. It is critical, therefore, that a broader focus be developed that includes the restoration of feedbacks between vegetation and climate. In this paper, we present a synthesis of the best available, policy-relevant science on the feedbacks between the land surface and the climate system, with a focus on tropical and subtropical regions. On the basis of this science, we argue for a stronger integration of land-use and climate-change policies. These policies need to include a virtual halt to all deforestation and an acceleration of investment in strategic reforestation, supported by a comprehensive global forest monitoring program. Without these actions, the degradation of the Earth's ecosystems will become exacerbated as their resilience is eroded by accelerated changes in temperature, precipitation and extreme weather events.	[McAlpine, C. A.; Ryan, J. G.; Seabrook, L.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld 4072, Australia; [Thomas, S.; Dargusch, P. J.] Univ Queensland, Sch Integrat Syst, Brisbane, Qld 4072, Australia; [Syktus, J. I.] Queensland Climate Change Ctr Excellence, Queensland Dept Environm & Resource Management, Brisbane, Qld 4068, Australia; [Pielke, R. A., Sr.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Etter, A. E.] Univ Javeriana, Dept Ecol & Terr, Bogota, Colombia; [Fearnside, P. M.] Natl Inst Res Amazon INPA, BR-69011970 Manaus, Amazonas, Brazil; [Laurance, W. F.] James Cook Univ, Sch Marine & Trop Biol, Cairns 4870, Australia		McAlpine, CA (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld 4072, Australia.	c.mcalpine@uq.edu.au	Etter, Andrés/E-1860-2011; Fearnside, Philip M/D-6559-2011; Laurance, William F/B-2709-2012; Fearnside, Philip M/GQA-6023-2022; Seabrook, Leonie M K/D-2992-2009; McAlpine, Clive A/A-3907-2010; Servamb, Inct/K-3437-2013; Syktus, Jozef/E-7173-2011	Etter, Andrés/0000-0003-0665-9300; Fearnside, Philip M/0000-0003-3672-9082; Laurance, William F/0000-0003-4430-9408; Fearnside, Philip M/0000-0003-3672-9082; Seabrook, Leonie M K/0000-0001-5602-5168; Syktus, Jozef/0000-0003-1782-3073; Thomas, Sebastian/0000-0002-3345-9120; DARGUSCH, Paul/0000-0001-9255-2803; McAlpine, Clive/0000-0003-0457-8144				Ambrosi P., 2009, STATE TRENDS CARBON; Anderson RG, 2011, FRONT ECOL ENVIRON, V9, P174, DOI 10.1890/090179; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Asner GP, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034009; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Blom B, 2010, ENVIRON SCI POLICY, V13, P164, DOI 10.1016/j.envsci.2010.01.002; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Boyd E, 2009, ENVIRON SCI POLICY, V12, P820, DOI 10.1016/j.envsci.2009.06.007; Brennan G, 2009, AUST J AGR RESOUR EC, V53, P309, DOI 10.1111/j.1467-8489.2009.00457.x; Brockhaus M., 2009, REALISING REDD NATL; Chapin FS, 2008, FRONT ECOL ENVIRON, V6, P313, DOI 10.1890/080005; Corbera E, 2010, CLIMATIC CHANGE, V100, P355, DOI 10.1007/s10584-009-9773-1; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Deo RC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037666; Dias MAFS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000335; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Ellis J, 2007, ENERG POLICY, V35, P15, DOI 10.1016/j.enpol.2005.09.018; *FAO, 2006, FAO GLOB FOR RES ASS; Fearnside PM, 2004, ECOL APPL, V14, P982, DOI 10.1890/03-5225; FEARNSIDE PM, 2009, ACTA AMAZONICA, V39, P951; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Fischlin A., 2007, CLIMATE CHANGE 2007; Foley JA, 2003, FRONT ECOL ENVIRON, V1, P38, DOI 10.2307/3867963; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Ghazoul J, 2010, TRENDS ECOL EVOL, V25, P396, DOI 10.1016/j.tree.2010.03.005; Gobron N, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043870; GOLDEWIJK KK, 2010, GLOBAL IN PRESS 0910, DOI DOI 10.1111/J.1466-8238.2010.00587.X; Gordon L, 2003, PHILOS T R SOC B, V358, P1973, DOI 10.1098/rstb.2003.1381; Gordon LJ, 2005, P NATL ACAD SCI USA, V102, P7612, DOI 10.1073/pnas.0500208102; Hajkowicz S, 2007, ECOL ECON, V61, P208, DOI 10.1016/j.ecolecon.2006.10.011; HAMILTON K, 2010, ECOSYST MARKETPLACE; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hunt C, 2008, ECOL ECON, V66, P309, DOI 10.1016/j.ecolecon.2007.09.012; Irland L. C., 2008, Journal of Sustainable Forestry, V27, P189, DOI 10.1080/10549810802219963; *IUCN, 2009, POS PAP RED EM DEF F; Jones C, 2009, NAT GEOSCI, V2, P484, DOI 10.1038/ngeo555; Jung M, 2006, ENERG POLICY, V34, P2173, DOI 10.1016/j.enpol.2005.03.014; Junkermann W, 2009, ATMOS CHEM PHYS, V9, P6531, DOI 10.5194/acp-9-6531-2009; Kabat P, 2004, VEGETATION WATER HUM; Kravcik M, 2007, WATER RECOVERY CLIMA; Lambin EF, 2010, LAND USE POLICY, V27, P108, DOI 10.1016/j.landusepol.2009.09.003; Lawrence PJ, 2010, INT J CLIMATOL, V30, P2066, DOI 10.1002/joc.2061; Leemans R, 2004, GLOBAL ENVIRON CHANG, V14, P219, DOI 10.1016/j.gloenvcha.2004.04.009; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Liu Z, 2007, QUATERNARY SCI REV, V26, P1818, DOI 10.1016/j.quascirev.2007.03.002; Lowell K, 2007, ECOL ECON, V64, P61, DOI 10.1016/j.ecolecon.2007.06.016; MacKerron GJ, 2009, ENERG POLICY, V37, P1372, DOI 10.1016/j.enpol.2008.11.023; MAHFOUF JF, 1987, J CLIM APPL METEOROL, V26, P1483, DOI 10.1175/1520-0450(1987)026<1483:TIOSAV>2.0.CO;2; Marland G, 2003, CLIM POLICY, V3, P149, DOI 10.1016/S1469-3062(03)00028-7; Marshall CH, 2004, MON WEATHER REV, V132, P28, DOI 10.1175/1520-0493(2004)132<0028:TIOALC>2.0.CO;2; McAlpine CA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031524; Mcalpine CA, 2009, GLOBAL CHANGE BIOL, V15, P2206, DOI 10.1111/j.1365-2486.2009.01939.x; McAlpine CA, 2009, GLOBAL ENVIRON CHANG, V19, P21, DOI 10.1016/j.gloenvcha.2008.10.008; McKeon GM, 2009, RANGELAND J, V31, P1, DOI 10.1071/RJ08068; National Research Council, 2005, RAD FORC CLIM CHANG; Nicholson SE, 2007, Q J ROY METEOR SOC, V133, P2065, DOI 10.1002/qj.104; Nobre CA, 2009, CURR OPIN ENV SUST, V1, P28, DOI 10.1016/j.cosust.2009.07.003; Olander LP, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/025011; OLMSTEAD SM, 2010, 3 KEY ELEMENTS POST2; Olsen KH, 2007, CLIMATIC CHANGE, V84, P59, DOI 10.1007/s10584-007-9267-y; Parry M. L., 2007, CONTRIBUTION WORKING; Patt AG, 2010, GLOBAL ENVIRON CHANG, V20, P33, DOI 10.1016/j.gloenvcha.2009.09.006; Penman J., 2003, GOOD PRACTICE GUIDAN; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; PIEKLE RA, 2009, EOS, V90, P413; PIEKLE RA, 2004, CONCLUSIONS VEGETATI; Pielke Jr R., 2010, CLIMATE FIX WHAT SCI; Pielke RA, 2005, SCIENCE, V310, P1625, DOI 10.1126/science.1120529; Pielke RA, 2007, AGR FOREST METEOROL, V142, P234, DOI 10.1016/j.agrformet.2006.06.012; POTTINGER L, 2008, INT RIVERS; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Rial JA, 2004, CLIMATIC CHANGE, V65, P11, DOI 10.1023/B:CLIM.0000037493.89489.3f; Ribaudo M, 2010, ECOL ECON, V69, P2085, DOI 10.1016/j.ecolecon.2010.02.004; Ring I, 2010, CURR OPIN ENV SUST, V2, P50, DOI 10.1016/j.cosust.2010.02.004; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rudel TK, 2007, LAND USE POLICY, V24, P35, DOI 10.1016/j.landusepol.2005.11.004; Ryan JG, 2010, LANDSCAPE ECOL, V25, P1277, DOI 10.1007/s10980-010-9509-7; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Scholes RJ, 2009, TRENDS ECOL EVOL, V24, P427, DOI 10.1016/j.tree.2009.03.006; SCHWARZ W, 2004, RISE RISE FLUORINATE, P3; Skutsch MM, 2010, CLIMATIC CHANGE, V100, P395, DOI 10.1007/s10584-009-9768-y; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steininger MK, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034015; Stern N.H., 2006, STERN REV EC CLIMATE; Strassburg B, 2009, GLOBAL ENVIRON CHANG, V19, P265, DOI 10.1016/j.gloenvcha.2008.11.004; TANDON S, ABC NEWS ONLINE 0915; Thomas S, 2010, LAND USE POLICY, V27, P880, DOI 10.1016/j.landusepol.2009.12.002; UNEP, 2010, ASS ENV IMP CONS PRO; *UNEP, 2010, CDM JI PIP AN DAT; *UNFCCC, RED EM DEF DEV COUNT; UNFCCC, 2009, COP ACC; *USEPA, GLOB ANTHR NONCO2 GR; Venter O, 2009, SCIENCE, V326, P1368, DOI 10.1126/science.1180289; Wara M, 2007, NATURE, V445, P595, DOI 10.1038/445595a; Webb TJ, 2006, P ROY SOC B-BIOL SCI, V273, P757, DOI 10.1098/rspb.2005.3364; WERTZKANOUNNIKO.S, 2009, REDD NATL STRATEGY P; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; Woolley J, 2009, WATER INT, V34, P4, DOI 10.1080/02508060802666179; *WORLD BANK, 2009, FOR CARB PARTN FAC; World Bank Environment Department, 2009, CONV SOL INC TRUTH E; *WORLD RES I, 2009, GLOB FOR WATCH IND F	107	33	33	2	60	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1877-3435	1877-3443		CURR OPIN ENV SUST	Curr. Opin. Environ. Sustain.	DEC	2010	2	5-6					334	346		10.1016/j.cosust.2010.10.001	http://dx.doi.org/10.1016/j.cosust.2010.10.001			13	Green & Sustainable Science & Technology; Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics; Environmental Sciences & Ecology	704XK					2022-09-04	WOS:000286088700004
S	Cabezas, R; Sahebkar, A; Echeverria, V; Santos, JG; Ashraf, GM; Barreto, GE		Barreto, GE; Sahebkar, A		Cabezas, Ricardo; Sahebkar, Amirhossein; Echeverria, Valentina; Gonzalez Santos, Janneth; Ashraf, Ghulam Md; Barreto, George E.			In Silico Identification of Novel Interactions for FABP5 (Fatty Acid-Binding Protein 5) with Nutraceuticals: Possible Repurposing Approach	PHARMACOLOGICAL PROPERTIES OF PLANT-DERIVED NATURAL PRODUCTS AND IMPLICATIONS FOR HUMAN HEALTH	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						FABP5; Molecular docking; Nutraceuticals; ADME; Inflammation	MECHANISM	Fatty Acid Binding-Protein 5 (FABP5) is a cytoplasmic protein, which binds long-chain fatty acids and other hydrophobic ligands. This protein is implicated in several physiological processes including mitochondrial beta-oxidation and transport of fatty acids, membrane phospholipid synthesis, lipid metabolism, inflammation and pain. In the present study, we used molecular docking tools to determine the possible interaction of FABP5 with six selected compounds retrieved form Drugbank. Our results showed that FABP5 binding pocket included 31 polar and non-polar amino acids, and these residues may be related to phosphorylation, acetylation, ubiquitylation, and mono-methylation. Docking results showed that the most energetically favorable compounds are NADH (-9.12 kcal/mol), 5'-O-({[(Phosphonatooxy)phosphinato]oxy}phosphinato)adenosine (-8.62 kcal/mol), lutein (-8.25 kcal/mol), (2S)-2-[(4{[(2-Amino-4-oxo-1,4,5,6,7,8-hexahydro-6-pteridinyl)methyl]amino}benzoyl)amino]pentanedioate (-7.17 kcal/mol), Pteroyl-L-glutamate (-6.86 kcal/mol) and (1S,3R, 5E, 7Z)-9,10-Secocholesta- 5,7,10-triene-1,3,25-triol (-6.79 kcal/mol). Common interacting residues of FABP5 with nutraceuticals included SER16, LYS24, LYS34, LYS40 and LYS17. Further, we used the SwissADME server to determine the physicochemical and pharmacokinetic characteristics and to predict the ADME parameters of the selected nutraceuticals after molecular analysis by docking with the FABP5 protein. Amongst all compounds, pteroyl-L-glutamate is the only one meeting the Lipinski's rule of five criteria, demonstrating its potential pharmacological use. Finally, our results also suggest the importance of FABP5 in mediating the anti-inflammatory activity of the nutraceutical compounds.	[Cabezas, Ricardo] Univ Antonio Narino, Sch Med, Dept Physiol, Bogota, Colombia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Polish Mothers Mem Hosp Res Inst PMMHRI, Lodz, Poland; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Dept Res & Dev, Bay Pines, FL USA; [Gonzalez Santos, Janneth] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Barreto, George E.] Univ Limerick, Dept Biol Sci, Limerick, Ireland; [Barreto, George E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland		Barreto, GE (corresponding author), Univ Limerick, Dept Biol Sci, Limerick, Ireland.; Barreto, GE (corresponding author), Univ Limerick, Hlth Res Inst, Limerick, Ireland.	George.Barreto@ul.ie	Ashraf, Ghulam Md/H-9485-2012; GONZALEZ, JANNETH/AAB-9948-2020; Santos-Junior, Jair Guilherme/B-1880-2016	Ashraf, Ghulam Md/0000-0002-9820-2078; GONZALEZ, JANNETH/0000-0003-4482-256X; 				Adhikary T, 2013, ONCOGENE, V32, P5241, DOI 10.1038/onc.2012.549; Areiza-Mazo N, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00276; Armstrong EH, 2014, J BIOL CHEM, V289, P14941, DOI 10.1074/jbc.M113.514646; Berger WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050968; Bibak B, 2019, BIOFACTORS, V45, P867, DOI 10.1002/biof.1550; Chen JZ, 2020, PHYS CHEM CHEM PHYS, V22, P2262, DOI 10.1039/c9cp05704h; Chen W, 2018, EUR MED J, V3, P90; Cianciulli A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5240127; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Danenberg PV, 2016, CRIT REV ONCOL HEMAT, V106, P118, DOI 10.1016/j.critrevonc.2016.08.001; Deutsch DG, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.7016.00370; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Floresta G, 2017, EUR J MED CHEM, V138, P854, DOI 10.1016/j.ejmech.2017.07.022; Furuhashi M, 2014, CLIN MED INSIGHTS-CA, V8, P23, DOI 10.4137/CMC.S17067; Ghanaatian N, 2019, J CELL PHYSIOL, V234, P12237, DOI 10.1002/jcp.27965; Jurado-Coronel JC, 2016, CNS NEUROL DISORD-DR, V15, P292, DOI 10.2174/1871527315666160202125519; Kaczocha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094200; Keshavarzi Z, 2019, BIOFACTORS, V45, P517, DOI 10.1002/biof.1516; Lee JH, 2017, INT J OBESITY, V41, P645, DOI 10.1038/ijo.2017.3; Mazo NA, 2017, CURR PHARM DESIGN, V23, P4180, DOI 10.2174/1381612823666170316142803; Nasri H, 2014, INT J PREVENTIVE MED, V5, P1487; Ohata T, 2017, CANCER MED-US, V6, P1049, DOI 10.1002/cam4.1020; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Shinoda Y, 2020, J PHARMACOL SCI, V143, P264, DOI 10.1016/j.jphs.2020.05.005; Singh SK, 2017, CURR DRUG METAB, V18, P112, DOI 10.2174/1389200217666161201112206; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Souyoul SA, 2018, DERMATOLOGY THER, V8, P5, DOI 10.1007/s13555-018-0221-x; Uddin MS, 2019, MOL NEUROBIOL, V56, P4925, DOI 10.1007/s12035-018-1420-2; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Xu J, 2013, CURR MED CHEM, V20, P4109; Yan FF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092496; Yaribeygi H, 2019, J CELL PHYSIOL, V234, P8610, DOI 10.1002/jcp.27843; Zhang YR, 2020, FEBS OPEN BIO, V10, P861, DOI 10.1002/2211-5463.12840; Zhou YC, 2019, BIOCHEMISTRY-US, V58, P4304, DOI 10.1021/acs.biochem.9b00625	34	1	1	3	5	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-030-64872-5; 978-3-030-64871-8	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2021	1308						589	599		10.1007/978-3-030-64872-5_29	http://dx.doi.org/10.1007/978-3-030-64872-5_29	10.1007/978-3-030-64872-5		11	Chemistry, Medicinal; Medicine, Research & Experimental; Pharmacology & Pharmacy	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Research & Experimental Medicine	BR3MG	33861460				2022-09-04	WOS:000647701200029
J	Dousa, KM; De la Hoz, A; Church, E; Onger, T; Perez, F; Saade, E				Dousa, Khalid M.; De la Hoz, Alejandro; Church, Elizabeth; Onger, Tiffany; Perez, Federico; Saade, Elie			Progressive and disseminated histoplasma infection and hemophagocytic lymphohistiocytosis in an immunocompetent adult	CLINICAL CASE REPORTS			English	Article						hemophagocytic lymphohistiocytosis; Histoplasma spp; histoplasmosis; systemic lupus erythematosus		Key Clinical Message Hemophagocytic lymphohistiocytosis (HLH) in adults is a life-threatening underdiagnosed disorder that complicates different infectious syndromes and overlaps with sepsis. No guidelines are available for the management of HLH in adults. A high index of suspicion is required in patients with disseminated histoplasmosis.	[Dousa, Khalid M.; Church, Elizabeth; Saade, Elie] Univ Hosp Cleveland, Med Ctr, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Dousa, Khalid M.; Church, Elizabeth; Saade, Elie] Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [De la Hoz, Alejandro] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Grp Invest Enfermedades Infecciosas, Bogota, Colombia; [Onger, Tiffany] Univ Hosp Cleveland, Med Ctr, Dept Med, Cleveland, OH 44106 USA; [Perez, Federico] Case Western Reserve Univ, Sch Med, Louis Stokes Cleveland VA Med Ctr, Div Infect Dis & HIV Med, Cleveland, OH USA		De la Hoz, A (corresponding author), Hosp Univ San Ignacio, Dept Internal Med, Div Infect Dis, Bogota, Colombia.	adelahoz@husi.org.co	Church, Elizabeth Chandler/GQP-2008-2022	Church, Chandler/0000-0002-3614-5311; Saade, Elie/0000-0002-2514-3820; De la Hoz Gomez, Alejandro/0000-0002-9073-1258				Akenroye AT, 2017, EUR ANN ALLERGY CLIN, V49, P31; Contreras Kateir, 2017, Rev. colom. nefrol., V4, P93, DOI 10.22265/acnef.4.1.250; Souto JT, 2017, INT J HEMATOL, V106, P727, DOI 10.1007/s12185-017-2308-z; Ferguson-Paul K, 2016, EMERG INFECT DIS, V22, P1119, DOI 10.3201/eid2206.151682; George M, 2014, J BLOOD MED, P69; Ishii E, 2007, INT J HEMATOL, V86, P58, DOI 10.1532/IJH97.07012; Kashif M, 2015, CASE REP CRIT CARE, V2015; Loganantharaj N, 2018, INT J STD AIDS; Mehta RS, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0740-3; Ramos-Casals M, 2014, LANCET, V383, P1503, DOI 10.1016/S0140-6736(13)61048-X; Subedee Anup, 2015, J Int Assoc Provid AIDS Care, V14, P391, DOI 10.1177/2325957415570740; Townsend JL, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv055; Untanu RV, 2016, CASE REP INFECT DIS, V2016, DOI 10.1155/2016/1358742; Wheat LJ, 2007, CLIN INFECT DIS, V45, P807, DOI 10.1086/521259	14	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2050-0904			CLIN CASE REP	Clin. Case Rep.	MAY	2019	7	5					913	916		10.1002/ccr3.2079	http://dx.doi.org/10.1002/ccr3.2079			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HX7DK	31110713	Green Published, gold			2022-09-04	WOS:000467564200011
J	Silva-Ramos, CR; Jacinavicius, FD; Weitzel, T; Walker, DH; Faccini-Martinez, AA				Silva-Ramos, Carlos Ramiro; Jacinavicius, Fernando de Castro; Weitzel, Thomas; Walker, David H.; Faccini-Martinez, Alvaro A.			Scrub typhus: A new cause of acute undifferentiated febrile illness in Latin America?	TRAVEL MEDICINE AND INFECTIOUS DISEASE			English	Editorial Material						Scrub typhus; Orientia; Latin America; Fever; Travel	TROMBIDIFORMES TROMBICULIDAE; RECORDS		[Silva-Ramos, Carlos Ramiro] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Grp Enfermedades Infecciosas, Bogota, Colombia; [Jacinavicius, Fernando de Castro] Inst Butantan, Lab Colecoes Zool, Sao Paulo, Brazil; [Weitzel, Thomas] Univ Desarrollo, Fac Med Clin Alemana, Lab Clin, Clin Alemana Santiago, Santiago, Chile; [Weitzel, Thomas] Univ Desarrollo, Fac Med Clin Alemana, Inst Ciencias & Innovac Med ICIM, Santiago, Chile; [Walker, David H.; Faccini-Martinez, Alvaro A.] Univ Texas Med Branch, Dept Pathol, Univ Blvd, Galveston, TX 77555 USA; [Faccini-Martinez, Alvaro A.] Asociac Colombiana Infectol, Comm Trop Med Zoonoses & Travel Med, Bogota, Colombia		Faccini-Martinez, AA (corresponding author), Univ Texas Med Branch, Dept Pathol, Univ Blvd, Galveston, TX 77555 USA.; Weitzel, T (corresponding author), Clin Alemana, Av Vitacura, Santiago 5951, Chile.	tweitzel@alemana.cl; afaccini@gmail.com	de C Jacinavicius, Fernando/F-2856-2015	de C Jacinavicius, Fernando/0000-0002-5503-3120; Weitzel, Thomas/0000-0002-9804-2123	FAPESP [2019/19853-0]; Agencia Nacional de Investigacion y Desarrollo (FONDECYT) [1170810]; National Institutes of Health Fogarty International Center training grant; Fogarty fellowship [2D43TW010331]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Agencia Nacional de Investigacion y Desarrollo (FONDECYT); National Institutes of Health Fogarty International Center training grant; Fogarty fellowship	This work was supported by FAPESP under code 2019/19853-0 to FCJ, the Agencia Nacional de Investigacion y Desarrollo (FONDECYT Regular No 1170810) to TW, a National Institutes of Health Fogarty International Center training grant to DHW, and a Fogarty fellowship grant (No 2D43TW010331) to AAFM.	Abarca K, 2020, EMERG INFECT DIS, V26, P2148, DOI 10.3201/eid2609.200918; Abarca K, 2018, REV CHIL INFECTOL, V35, P696, DOI 10.4067/S0716-10182018000600696; Acosta-Jamett G, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007619; Balcells ME, 2011, EMERG INFECT DIS, V17, P1659, DOI 10.3201/eid1709.100960; Bassini-Silva Ricardo, 2018, Acarina, V26, P197, DOI 10.21684/0132-8077-2018-26-2-197-204; Bassini-Silva R, 2018, ACAROLOGIA, V58, P976, DOI 10.24349/acarologia/20184304; Beltrán María, 2009, Rev. perú. med. exp. salud publica, V26, P58; BRENNAN J M, 1975, Brigham Young University Science Bulletin Biological Series, V20, P45; Brennan J.M., 1966, ECTOPARASITES PANAMA, P221; [Бронштейн Александр Маркович Bronshteyn A.M.], 2016, [Эпидемиология и инфекционные болезни, Epidemiologiya i infektsionnye bolezni], V21, P43, DOI 10.18821/1560-9529-2016-21-1-43-50; Silva-de La Fuente MC, 2021, J MED ENTOMOL, V58, P646, DOI 10.1093/jme/tjaa258; Chaccour CJ, 2005, DERMATOLOGIA VENEZOL, V43, P18; Chao CC, 2022, MIL MED, V187, P802, DOI 10.1093/milmed/usab120; Eitrem Rickard, 2012, Lakartidningen, V109, P2358; Hoffmann A, 1990, ACARIDA TROMBICULIDA, V2; Faccini JLH, 2017, REV BRAS PARASITOL V, V26, P104, DOI [10.1590/S1984-29612016088, 10.1590/s1984-29612016088]; Izzard L, 2010, J CLIN MICROBIOL, V48, P4404, DOI 10.1128/JCM.01526-10; Jacinavicius FC, J MED ENTOMOL, V2021; Jacinavicius FD, 2018, ZOOKEYS, P1, DOI 10.3897/zookeys.743.22675; Kocher C, 2017, EMERG INFECT DIS, V23, P1389, DOI 10.3201/eid2308.170050; Martens H, 2012, NETH J MED, V70, P321; Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962; Richards AL, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5020049; Salje J, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009353; Taylor AJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003971; Tweeten KA, 2008, TROP DOCT, V38, P63, DOI 10.1258/td.2006.006291; Walker DH, 2016, NEW ENGL J MED, V375, P913, DOI 10.1056/NEJMp1608499; Weitzel T, 2021, CLIN MICROBIOL INFEC, V27, P793, DOI 10.1016/j.cmi.2020.11.023; Weitzel T, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008297; Weitzel T, 2019, EMERG INFECT DIS, V25, P1214, DOI 10.3201/eid2506.181860; Weitzel T, 2019, TRAVEL MED INFECT DI, V29, P78, DOI 10.1016/j.tmaid.2019.01.004; Weitzel T, 2016, NEW ENGL J MED, V375, P954, DOI 10.1056/NEJMoa1603657; Weller, 2011, TROPICAL INFECT DIS, P334; Wharton GW, 1952, MEMOIRS ENTOMOLOGY S, V4; Yen TY, 2019, VECTOR-BORNE ZOONOT, V19, P821, DOI 10.1089/vbz.2018.2426	35	3	3	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1477-8939	1873-0442		TRAVEL MED INFECT DI	Travel Med. Infect. Dis.	SEP-OCT	2021	43								102138	10.1016/j.tmaid.2021.102138	http://dx.doi.org/10.1016/j.tmaid.2021.102138		JUL 2021	3	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	UM5YR	34260988				2022-09-04	WOS:000693407400014
J	Lizarralde, G; Paez, H; Lopez, A; Lopez, O; Bornstein, L; Gould, K; Herazo, B; Munoz, L				Lizarralde, Gonzalo; Paez, Holmes; Lopez, Adriana; Lopez, Oswaldo; Bornstein, Lisa; Gould, Kevin; Herazo, Benjamin; Munoz, Lissette			We said, they said: the politics of conceptual frameworks in disasters and climate change in Colombia and Latin America	DISASTER PREVENTION AND MANAGEMENT			English	Article						Narrative; Adaptation; Resilience; Climate change; Informality	RESILIENCE POLICY; BUILT ENVIRONMENT; NEOLIBERALISM; COMMUNITY; PARTICIPATION; EARTHQUAKE; CHALLENGES; STATE	Purpose Few people living in informal settlements in the Global South spontaneously claim that they are "resilient" or "adapting" to disaster risk or climate change. Surely, they often overcome multiple challenges, including natural hazards exacerbated by climate change. Yet their actions are increasingly examined through the framework of resilience, a notion developed in the North, and increasingly adopted in the South. To what extent eliminate' do these initiatives correspond to the concepts that scholars and authorities place under the resilience framework? Design/methodology/approach Three longitudinal case studies in Yumbo, Salgar and San Andres (Colombia) serve to investigate narratives of disaster risks and responses to them. Methods include narrative analysis from policy and project documents, presentations, five workshops, six focus groups and 24 interviews. Findings The discourse adopted by most international scholars and local authorities differs greatly from that used by citizens to explain risk and masks the politics involved in disaster reduction and the search for social justice. Besides, narratives of social change, aspirations and social status are increasingly masked in disaster risk explanations. Tensions are also concealed, including those regarding the winners and losers of interventions and the responsibilities for disaster risk reduction. Originality/value Our findings confirm previous results that have shown that the resilience framework contributes to "depoliticize" the analysis of risk and serves to mask and dilute the responsibility of political and economic elites in disaster risk creation. But they also show that resilience fails to explain the type of socioeconomic change that is required to reduce vulnerabilities in Latin America.	[Lizarralde, Gonzalo; Herazo, Benjamin] Univ Montreal, Sch Architecture, Montreal, PQ, Canada; [Paez, Holmes] Pontificia Univ Javeriana, Bogota, Colombia; [Lopez, Adriana; Lopez, Oswaldo] Univ Valle, Cali, Colombia; [Bornstein, Lisa] McGill Univ, Montreal, PQ, Canada; [Gould, Kevin] Concordia Univ, Montreal, PQ, Canada; [Munoz, Lissette] Univ Los Andes, Bogota, Colombia		Lizarralde, G (corresponding author), Univ Montreal, Sch Architecture, Montreal, PQ, Canada.	gonzalo.lizarralde@umontreal.ca; paez.holmes@javeriana.edu.co; adriana.lopez@correounivalle.edu.co; oswaldo.lopez@correounivalle.edu.co; lisa.bornstein@mcgill.ca; kevin.gould@concordia.ca; bj.herazo.cueto@umontreal.ca; lissette_munoz@cun.edu.co		Paez Martinez, Holmes Julian/0000-0002-6964-9073; Herazo, Benjamin/0000-0001-8605-8147; lopez bernal, oswaldo/0000-0003-3781-2582; Lopez-Valencia, Adriana Patricia/0000-0003-1857-7580	Canada's International Development Research Centre (IDRC) [108501]; Social Sciences and Humanities Research Council of Canada (SSHRC); Fonds de recherche du Quebec (FRQSC)	Canada's International Development Research Centre (IDRC); Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); Fonds de recherche du Quebec (FRQSC)	This research was supported by Canada's International Development Research Centre (IDRC), Grant #108501. Project: Climate change adaptation in informal settings: Understanding and reinforcing bottom-up initiatives in Latin America and the Caribbean. It also received support from the Social Sciences and Humanities Research Council of Canada (SSHRC) and the Fonds de recherche du Quebec (FRQSC). We acknowledge the special contribution of our partners: the Universidad del Valle, the Pontificia Universidad Javeriana, and the Corporacion Antioquia Presente, Colombia. Special thanks to the communities of Yumbo, Salgar, and San Andr	Aguilar L., 2009, STATE WORLD 2009 WAR, P59; Alberti M, 2003, BIOSCIENCE, V53, P1169, DOI 10.1641/0006-3568(2003)053[1169:IHIEOA]2.0.CO;2; Alexander D., 2019, DISASTER STUDIES INS; Alexander D.E., 2013, NAT HAZARD EARTH SYS, V1, P1257, DOI DOI 10.5194/NHESSD-1-1257-2013; Anguelovski I, 2016, J PLAN EDUC RES, V36, P333, DOI 10.1177/0739456X16645166; [Anonymous], 2004, TERT EDUC MANAG, DOI [DOI 10.1080/13583883.2004.9967114, 10.1080/13583883.2004.9967114]; Baptiste B., 2017, REV SEMANA; Bertholet C., 2016, CITE INT LYON 6 ARRO; Bicknell J., 2009, ADAPTING CITIES CLIM; Blaikie PM, 1994, RISK NATURAL HAZARDS; Blanco-Wells G, 2019, REV COLOMB SOCIOL, V42, P19, DOI 10.15446/rcs.v42n1.73190; Bornstein L., 1992, BERKELEY PLANNING J, V7, P121; Bornstein L., 2018, INT J DISASTER RESIL, V4, P43; Bornstein Lisa, 2008, J PEACEBUILDING DEV, V4, P1; Cardona O.D., 2002, INT WORK C VULN DIS; Cardona O.D., 1996, CIUDADES RIESGO DEGR, P57; Cardona O.D., 1993, DESASTRES SON NATURA; Chen Martha Alter, 2005, 102005 UN U WORLD I; Chmutina K, 2016, CITIES, V58, P70, DOI 10.1016/j.cities.2016.05.017; Davoudi S, 2012, PLAN THEORY PRACT, V13, P299, DOI 10.1080/14649357.2012.677124; Doherty G., 2011, BUILT ENV, V37, P30; EISENHARDT KM, 1989, ACAD MANAGE J, V32, P543, DOI 10.2307/256434; El Pais, 2016, PAIS; Escobar A., 1995, ECOLOGIA POLTICA, P7; Evans Brad, 2014, RESILIENT LIFE ART L; FORTMANN L, 1995, WORLD DEV, V23, P1053, DOI 10.1016/0305-750X(95)00024-7; Franco E, 1996, ESTADO SOC GESTION D; Fernandez AG, 2020, ICONOS, V24, P7, DOI 10.17141/iconos.66.2020.4156; Gaillard JC, 2019, DISASTERS, V43, pS7, DOI 10.1111/disa.12323; Gledhill John, 2004, COMPANION ANTHR POLI; Gould KA, 2016, J POLIT ECOL, V23, P93, DOI 10.2458/v23i1.20181; Guarneros-Meza V, 2010, INT J URBAN REGIONAL, V34, P115, DOI 10.1111/j.1468-2427.2010.00952.x; Gudynas E., 2003, ECOLOGIA EC ETICA DE; Hansen K.T., 2001, INT ENCY SOCIAL BEHA, P7450; IDEAM  PNUD  MADS  DNP and Cancillleria, 2017, ACC ED FOR SENS PUBL; Jooste BS, 2018, JAMBA-J DISASTER RIS, V10, DOI 10.4102/jamba.v10i1.508; Joseph J, 2013, RESILIENCE, V1, P38, DOI 10.1080/21693293.2013.765741; Juhola S, 2016, ENVIRON SCI POLICY, V55, P135, DOI 10.1016/j.envsci.2015.09.014; KASARDA JD, 1991, ANNU REV SOCIOL, V17, P467, DOI 10.1146/annurev.so.17.080191.002343; Kelman I, 2016, NAT HAZARDS, V82, pS129, DOI 10.1007/s11069-016-2294-0; Kelman I., 2017, ROUTLEDGE HDB DISAST; Klein N., 2010, SHOCK DOCTRINE RISE; Klein R. J., 2003, ENV HAZARDS, V5, P35, DOI DOI 10.1016/J.HAZARDS.2004.02.001; Klepp S, 2018, ROUT ADV CLIMATE, P3; Lavell A., 2004, RED ESTUDIOS SOCIALE; Lebel J, 2018, NATURE, V559, P23, DOI 10.1038/d41586-018-05581-4; Levine S., 2014, ASSESSING RESILIENCE; Lizarralde G., 2006, 3 INT I REC C 2006 F; Lizarralde G., 2008, 4 INT I REC C 2008 B; Lizarralde G., 2014, INVISIBLE HOUSES RET; Lizarralde G., 2016, ONLINE DEBATE RESILI; Lizarralde G., 2019, COMMUNICATION; Lizarralde G, 2015, SUSTAIN CITIES SOC, V15, P96, DOI 10.1016/j.scs.2014.12.004; Lizarralde G, 2015, DISASTERS, V39, pS76, DOI 10.1111/disa.12109; Lopez-Bernal O., 2010, PLANEAMIENTO URBANO; Lopez-Valencia A.P., 2017, SOSTENIBILIDAD MEDIO; Lopez-Valencia A.P., 2015, DISENO URBANO ADAPTA; Love P.E.D., 2002, ENG CONSTR ARCHIT MA, V9, P294, DOI DOI 10.1108/EB021224; MacKinnon D, 2013, PROG HUM GEOG, V37, P253, DOI 10.1177/0309132512454775; Manyena SB, 2006, DISASTERS, V30, P433; Mayne Alan, 2017, SLUMS HIST GLOBAL IN; Mitchell T., 2002, RULE EXPERTS EGYPT T; Moezzi M, 2017, ENERGY RES SOC SCI, V31, P1, DOI 10.1016/j.erss.2017.06.034; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Obregon R., 2009, CUBRIMIENTO PERIODIS; OliverSmith A, 1996, ANNU REV ANTHROPOL, V25, P303, DOI 10.1146/annurev.anthro.25.1.303; Owusu-Daaku KN, 2018, LOCAL ENVIRON, V23, P934, DOI 10.1080/13549839.2018.1505836; Paschen JA, 2014, RES POLICY, V43, P1083, DOI 10.1016/j.respol.2013.12.006; Pelling M., 2003, EARTHSCAN, DOI 10.4324/9781849773379; Perreault T, 2005, ENVIRON PLANN A, V37, P191, DOI 10.1068/a37394; Pizzo B, 2015, CITIES, V43, P133, DOI 10.1016/j.cities.2014.11.015; Polo Blanco Jorge, 2019, Izquierdas (Santiago), P194; Pratt Mary Louise., 2007, IMPERIAL EYES TRAVEL, V2nd; Proverbs D., 2008, ADV RES METHODS BUIL, P183; RAKOWSKI CA, 1994, WORLD DEV, V22, P501, DOI 10.1016/0305-750X(94)90107-4; ROE EM, 1991, WORLD DEV, V19, P287, DOI 10.1016/0305-750X(91)90177-J; Roy A, 2005, J AM PLANN ASSOC, V71, P147, DOI 10.1080/01944360508976689; Roy A, 2011, INT J URBAN REGIONAL, V35, P223, DOI 10.1111/j.1468-2427.2011.01051.x; Satterthwaite D., 2007, ADAPTING CLIMATE CHA, V1; SELVARATNAM V, 1988, HIGH EDUC, V17, P41, DOI 10.1007/BF00130899; Stumpp EM, 2013, CITIES, V32, P164, DOI 10.1016/j.cities.2013.01.003; Szasz A., 2014, WORLDS RELIG ARE RES; Tobin G.A., 1999, ENVIRON HAZARDS-UK, V1, P13, DOI DOI 10.1016/S1464-2867(99)00002-9; Valladares A, 2013, HABITAT INT, V38, P18, DOI 10.1016/j.habitatint.2012.09.004; Visvanathan S, 1991, ALTERNATIVES, V16, P377, DOI DOI 10.1177/030437549101600306; Watts Michael J., 2015, ROUTLEDGE HDB POLITI, P19, DOI DOI 10.4324/9781315759289-11; Werna E, 2001, HABITAT INT, V25, P209, DOI 10.1016/S0197-3975(00)00018-7; White I, 2014, ENVIRON PLANN C, V32, P934, DOI 10.1068/c12117; Wilches-Chaux G., 1989, DESASTRES ECOLOGISMO; Wilches-Chaux G., 2005, NOMADAS, V22, P48; WILCHES-CHAUX G., 1993, DESASTRES SON NATURA, P9; Wisner B, 2001, DISASTERS, V25, P251, DOI 10.1111/1467-7717.00176; Wisner B., 2007, CLIMATE CHANGE HUMAN; Yarina L, 2018, PLACES J	94	5	5	1	13	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	0965-3562	1758-6100		DISASTER PREV MANAG	Disaster Prev. Manag.	OCT 22	2020	29	6			SI		909	928		10.1108/DPM-01-2020-0011	http://dx.doi.org/10.1108/DPM-01-2020-0011		JUL 2020	20	Environmental Studies; Public, Environmental & Occupational Health; Management	Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Business & Economics	PB6UL		hybrid			2022-09-04	WOS:000554705400001
J	Rossi, E; Granzow-de la Cerda, I; Oliver, CD; Kulakowski, D				Rossi, E.; Granzow-de la Cerda, I.; Oliver, C. D.; Kulakowski, D.			Wind effects and regeneration in broadleaf and pine stands after hurricane Felix (2007) in Northern Nicaragua	FOREST ECOLOGY AND MANAGEMENT			English	Article						Stand dynamics; Wind disturbances; Tropical forestry; Forest management; Region autonoma del Caribe Norte - RACN	TROPICAL RAIN-FOREST; LAND-USE HISTORY; LIFE-HISTORY; FIELD-MEASUREMENTS; DISTURBANCE; DAMAGE; GROWTH; DIVERSITY; DYNAMICS; SUCCESSION	Large-scale wind disturbances shape forest structure and composition and leave long lasting legacies. Adequate understanding of the role of disturbances in tropical stand dynamics is necessary to guide management efforts. In this study, we used field data to characterize the effects of a major hurricane in broad-leaf and pine stands in Northern Nicaragua. First, we described tree and stand attributes associated with observed structural effects: branch loss, snapping and uprooting. Secondly, to assess the potential influence of hurricane Felix on stand composition, we characterized two key life-history traits: regeneration through resprouting and shade tolerance. Findings indicated that tree attributes such as diameter at breast height (dbh) and height to diameter ratio (hdr), were strongly associated with the type and magnitude of wind effects. All trees >70 cm dbh exhibited visible effects and trees taller than 14 m were more likely to be uprooted (7.3% vs. 0.8% of total). Results confirmed that Felix caused significant structural effects in broadleaf stands and mild effects in pine stands. Abundant post-hurricane resprouting was observed in both shade-tolerant and shade-intolerant species but was absent in pines. Among canopy trees we found eleven shade-intolerant species that exhibited abundant resprouting. These species could become dominant in the next decade. Our findings illustrate the role of wind disturbances on tropical stand dynamics at different spatial and temporal scales. (C) 2017 Elsevier B.V. All rights reserved.	[Rossi, E.] Pontificia Univ Javeriana, Inst Bioet, Bogota, Colombia; [Rossi, E.; Kulakowski, D.] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Granzow-de la Cerda, I.] CREAF, Cerdanyola Del Valles 08193, Spain; [Granzow-de la Cerda, I.] Univ Autonoma Barcelona, Cerdanyola Del Valles 08193, Spain; [Oliver, C. D.] Yale Sch Forestry & Environm Studies, New Haven, CT USA; [Kulakowski, D.] SLF, WSL Inst Snow & Avalanche Res, Davos, Switzerland		Rossi, E (corresponding author), Pontificia Univ Javeriana, Inst Bioet, Bogota, Colombia.	esteban.rossi@javeriana.edu.co	rossi, esteban/AAG-8285-2020		Clark University; Finfor project at CATIE, Costa Rica	Clark University; Finfor project at CATIE, Costa Rica	This research was supported by a Prusser Fellowship from Clark University and by the Finfor project at CATIE, Costa Rica. The following people provided valuable support: Y. Ordofiez, W. Lau, and Canales J. Special thanks to D. Salazar, E. Cordon, W. Watler, F. Bascope and the late Rodolfo Cruz "Chaparro", from Moss. Two anonymous reviewers provided thoughtful suggestions.	Alvarado C., 2010, CASOS EJEMPLARES MAN; Baker PJ, 2005, ECOL MONOGR, V75, P317, DOI 10.1890/04-0488; Beven JL, 2008, MON WEATHER REV, V136, P1109, DOI 10.1175/2007MWR2074.1; Boose ER, 2004, ECOL MONOGR, V74, P335, DOI 10.1890/02-4057; BOUCHER DH, 1990, ECOLOGY, V71, P2022, DOI 10.2307/1937611; Boucher DH, 1997, FOREST ECOL MANAG, V91, P195, DOI 10.1016/S0378-1127(96)03890-X; Brennan MJ, 2009, MON WEATHER REV, V137, P4061, DOI 10.1175/2009MWR2995.1; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; Castilleja G., 1993, UNASYLVA, V43, P175; Chambers JQ, 2013, P NATL ACAD SCI USA, V110, P3949, DOI 10.1073/pnas.1202894110; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Colwell R.K., 2013, ESTIMATES STAT ESTIM; Comita LS, 2010, ECOL APPL, V20, P1270, DOI 10.1890/09-1350.1; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; Curtis J.T., 1962, PLANT ECOLOGY WORKBO; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; DENSLOW JS, 1995, ECOL APPL, V5, P962, DOI 10.2307/2269347; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Everham EM, 1996, BOT REV, V62, P113, DOI 10.1007/BF02857920; FOSTER DR, 1992, J ECOL, V80, P79, DOI 10.2307/2261065; Foster DR, 1998, ECOSYSTEMS, V1, P96, DOI 10.1007/s100219900008; Granzow-de la Cerda I, 1997, REV BIOL TROP, V45, P1409; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Gunter S, 2011, TROP FOREST, P527, DOI 10.1007/978-3-642-19986-8_34; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; Institute Nacional Forestal-INAFOR, 2007, EV DAN EC FOR OC HUR; Institute Nacional Forestal-INAFOR, 2009, RES INV NAC FOR 2007; Kar D., 2010, THESIS; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kulakowski D, 2003, J VEG SCI, V14, P653, DOI 10.1111/j.1654-1103.2003.tb02197.x; Lugo AE, 2008, AUSTRAL ECOL, V33, P368, DOI 10.1111/j.1442-9993.2008.01894.x; Lugo AE, 1996, BIOTROPICA, V28, P585, DOI 10.2307/2389099; Lugo AE, 2002, LANDSCAPE ECOL, V17, P601, DOI 10.1023/A:1021419815480; McSweeney K, 2004, ANN ASSOC AM GEOGR, V94, P638, DOI 10.1111/j.1467-8306.2004.00418.x; Mitchell SJ, 1998, FOREST CHRON, V74, P100, DOI 10.5558/tfc74100-1; MITCHELL SJ, 1995, FOREST CHRON, V71, P446, DOI 10.5558/tfc71446-4; Montagnini F., 2005, TROP FOR; Myers R., 2006, 20061B GFI NAT CONS; Negreros-Castillo P, 2003, FOREST ECOL MANAG, V183, P351, DOI 10.1016/S0378-1127(03)00143-9; Negron-Juarez RI, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043733; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; Nicaraguan Census Bureau-Institute Nacional de Informacion y Desarrollo INIDE, 2005, CAR SOC REG AUT ATL; NOAA, 2013, HIST HURR TRACKS; NOAA, 2016, HIST HURR TRACKS; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; O'Brien JJ, 2008, AMBIO, V37, P542, DOI 10.1579/0044-7447-37.7.542; Oliver C.D., 1996, FOREST STAND DYNAMIC; Oliver CD, 2005, FOREST ECOL MANAG, V210, P393, DOI 10.1016/j.foreco.2005.02.036; PACALA SW, 1993, CAN J FOREST RES, V23, P1980, DOI 10.1139/x93-249; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Parsons JJ, 1955, ANN ASSOC AM GEOGR, V45, P36, DOI 10.1111/j.1467-8306.1955.tb01482.x; Perez Flores M. A., 2001, Revista Forestal Centroamericana, P66; Perez-Flores MA, 2000, THESIS; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Rejmanek M, 2001, BIOTROPICA, V33, P214, DOI 10.1111/j.1744-7429.2001.tb00173.x; Rossi E, 2013, GISCI REMOTE SENS, V50, P385, DOI 10.1080/15481603.2013.820066; Salazar M. E., 2005, PROPUESTA DESARROLLO; Smith JH, 2003, ENVIRON MANAGE, V31, P252, DOI 10.1007/s00267-002-2774-8; Snook LK, 2003, ECOL STU AN, V159, P169; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; STEVENS WD, 2001, FLORA NICARAGUA, V1; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Van Bloem SJ, 2005, BIOTROPICA, V37, P571, DOI 10.1111/j.1744-7429.2005.00074.x; Van Bloem SJ, 2007, TREE PHYSIOL, V27, P475, DOI 10.1093/treephys/27.3.475; Vandermeer J, 2000, SCIENCE, V290, P788, DOI 10.1126/science.290.5492.788; Vandermeer JH, 2001, FOREST ECOL MANAG, V148, P221, DOI 10.1016/S0378-1127(00)00538-7; Veblen TT, 2001, CAN J FOREST RES, V31, P2089, DOI 10.1139/cjfr-31-12-2089; Veldman JW, 2015, FRONT ECOL ENVIRON, V13, P154, DOI 10.1890/140270; Vreugdenhil D., 2002, MAP ECOSYSTEMS CENTR; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; Wilson JS, 2000, CAN J FOREST RES, V30, P910, DOI 10.1139/cjfr-30-6-910; YIH K, 1991, BIOTROPICA, V23, P106, DOI 10.2307/2388295; Zar J.H, 1998, BIOSTAT ANAL, V4th; ZIMMERMAN JK, 1994, J ECOL, V82, P911, DOI 10.2307/2261454	79	3	3	1	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0378-1127	1872-7042		FOREST ECOL MANAG	For. Ecol. Manage.	SEP 15	2017	400						199	207		10.1016/j.foreco.2017.05.034	http://dx.doi.org/10.1016/j.foreco.2017.05.034			9	Forestry	Science Citation Index Expanded (SCI-EXPANDED)	Forestry	FC3IK					2022-09-04	WOS:000406732100021
J	Torres, D; Bermejo, JL; Rashid, MU; Briceno, I; Gil, F; Beltran, A; Ariza, V; Hamann, U				Torres, D.; Bermejo, J. Lorenzo; Rashid, M. U.; Briceno, I.; Gil, F.; Beltran, A.; Ariza, V.; Hamann, U.			Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients	SCIENTIFIC REPORTS			English	Article							OVARIAN-CANCER; BREAST/OVARIAN CANCER; RECURRENT BRCA1; HIGH PROPORTION; FAMILIES; RISKS; IDENTIFICATION; REARRANGEMENTS; SPECTRUM; CARRIERS	Pathogenic BRCA1/2 germline mutations confer high risks of breast and ovarian cancer to women of European ancestry. Characterization of BRCA1/2 mutations in other ethnic groups is also medically important. We comprehensively screened 68 Colombian breast/ovarian cancer families for small-range mutations, 221 families for large-genomic rearrangements, and 1,022 unselected breast cancer cases for Colombian founder mutations in BRCA1/2. The risk of cancer among relatives of mutation carriers and the mutation penetrance were estimated by survival analysis. Identified BRCA2 mutations included 6310delGA and the recurrent 1991del4 mutations. A novel large BRCA2 deletion was found in 0.9% of the screened families. Among unselected breast cancer cases, 3.3% tested positive for BRCA1/3450del4, 2.2% for BRCA1/A1708E, 1.1% for BRCA2/3034del4, and 0.4% for BRCA2/1991del4. Female relatives of carriers of BRCA1/2 founder mutations showed a 5.90 times higher risk of breast cancer, when the woman herself carried a BRCA1 mutation compared to a non-carrier (95% CI 2.01-17.3). The estimated cumulative risk of breast cancer by age 70 years for BRCA1 mutations carriers was 14% (95% CI 5-38) compared to 3% for the general Colombian population (relative risk of breast cancer 4.05). Together with known founder mutations, reported novel variants may ease a cost-effective BRCA1/2 screening in women with Colombian ancestry.	[Torres, D.; Rashid, M. U.; Hamann, U.] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Torres, D.; Briceno, I.] Pontificia Univ Javeriana, Inst Human Genet, Bogota, Colombia; [Bermejo, J. Lorenzo] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Rashid, M. U.] SKMCH RC, Dept Basic Sci Res, Lahore, Pakistan; [Briceno, I.] Univ Sabana, Bogota, Colombia; [Gil, F.] Pontificia Univ Javeriana, Unit Clin Epidemiol & Biostat, Bogota, Colombia; [Beltran, A.; Ariza, V.] Univ Nacl Colombia, Bogota, Colombia		Hamann, U (corresponding author), German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany.	u.hamann@dkfz-heidelberg.de	Gil, Fabian/A-3352-2011; Briceno Balcazar, Ignacio/N-3337-2017	Gil, Fabian/0000-0001-6444-7248; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Beltran, Angela/0000-0002-7420-9558; Briceno Balcazar, Ignacio/0000-0001-7300-6401; Rashid, Muhammad Usman/0000-0002-7684-3122	Deutsches Krebsforschungszentrum; Alexander von Humboldt Foundation (postdoctoral fellowship), Bonn; Pontificia Universidad Javeriana, Bogota	Deutsches Krebsforschungszentrum(Helmholtz Association); Alexander von Humboldt Foundation (postdoctoral fellowship), Bonn; Pontificia Universidad Javeriana, Bogota	We thank J. Leary, M. Thomassen, B. Fiebig, T. Caldes, J. N. Weitzel, I. Kostantopoulou, and D. Steinmann for providing BRCA1/2 mutation controls and M. Gilbert for expert technical assistance. We thank the Colombian Breast Cancer Study Group (COLBCS) for its contribution. COLBCS: researchers: D. Torres, I. Briceno (Pontificia Universidad Javeriana, Bogota); F. Gil (Unit of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogota); A. Beltran, V. Ariza, (Universidad Nacional, Bogota); clinicians: J. Caicedo, C. Ramirez, E. Quintero, S. Quintero, J. Robledo (Country Clinic, Bogota); M. Tawil, L. Torregrosa (Pontificia Universidad Javeriana, Bogota); J. German Olaya (Hospital Universitario Hernando Moncaleano Perdomo, Neiva); study coordinator: U. Hamann, DKFZ, Heidelberg. We thank all women who participated in this study. This work was supported by the Deutsches Krebsforschungszentrum, the Alexander von Humboldt Foundation (postdoctoral fellowship to D. Torres), Bonn, and the Pontificia Universidad Javeriana, Bogota.	Abugattas J, 2015, CLIN GENET, V88, P371, DOI 10.1111/cge.12505; Akbari MR, 2014, CLIN GENET, V85, P64, DOI 10.1111/cge.12132; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1365; Arnold N, 1999, HUM MUTAT, V14, P333, DOI 10.1002/(SICI)1098-1004(199910)14:4<333::AID-HUMU9>3.0.CO;2-C; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; de la Hoya M, 2006, CLIN CHEM, V52, P1480, DOI 10.1373/clinchem.2006.070110; Timoteo ARD, 2015, HERED CANCER CLIN PR, V13, DOI 10.1186/s13053-014-0022-x; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Dobricic J, 2013, J HUM GENET, V58, P501, DOI 10.1038/jhg.2013.30; Donenberg T, 2011, BREAST CANCER RES TR, V125, P591, DOI 10.1007/s10549-010-1156-9; Dutil J, 2015, BREAST CANCER RES TR, V154, P441, DOI 10.1007/s10549-015-3629-3; Dutil J, 2012, CANCER GENET-NY, V205, P242, DOI 10.1016/j.cancergen.2012.04.002; EASTON DF, 1995, AM J HUM GENET, V56, P265; Evans DG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-155; Fachal L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093306; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Gomes MCB, 2007, BREAST CANCER RES TR, V103, P349, DOI 10.1007/s10549-006-9378-6; Gross E, 1999, HUM GENET, V105, P72, DOI 10.1007/s004390051066; Hines LM, 2010, CANCER-AM CANCER SOC, V116, P3215, DOI 10.1002/cncr.25154; Judkins T, 2012, CANCER-AM CANCER SOC, V118, P5210, DOI 10.1002/cncr.27556; Kanaan Y, 2003, HUM GENET, V113, P452, DOI 10.1007/s00439-003-0999-0; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; LAITINEN J, 1994, BIOTECHNIQUES, V17, P316; Lange K, 2005, GENET EPIDEMIOL, V29, P36, DOI 10.1002/gepi.20073; Lange K, 2013, BIOINFORMATICS, V29, P1568, DOI 10.1093/bioinformatics/btt187; Hernandez JEL, 2014, HERED CANCER CLIN PR, V12, DOI 10.1186/1897-4287-12-11; Metcalfe KA, 2000, J MED GENET, V37, P866, DOI 10.1136/jmg.37.11.866; Piñeros Marion, 2007, Rev. salud pública, V9, P327, DOI 10.1590/S0124-00642007000300002; Porchia L. M., 2015, J CARCINOG MUTAGEN, V6. 3; Rodriguez AO, 2012, GYNECOL ONCOL, V124, P236, DOI 10.1016/j.ygyno.2011.10.027; Rodriguez RC, 2008, FAM CANCER, V7, P275, DOI 10.1007/s10689-008-9187-7; Sanchez A, 2011, BREAST CANCER RES TR, V128, P845, DOI 10.1007/s10549-011-1382-9; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; Torres D, 2009, BREAST CANCER RES TR, V117, P679, DOI 10.1007/s10549-009-0383-4; Torres-Mejia G, 2015, CANCER EPIDEM BIOMAR, V24, P498, DOI 10.1158/1055-9965.EPI-13-0980; Villarreal-Garza C, 2015, CANCER-AM CANCER SOC, V121, P372, DOI 10.1002/cncr.29058; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Weitzel JN, 2013, J CLIN ONCOL, V31, P210, DOI 10.1200/JCO.2011.41.0027	40	20	20	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 5	2017	7								4713	10.1038/s41598-017-05056-y	http://dx.doi.org/10.1038/s41598-017-05056-y			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6RW	28680148	Green Published, gold			2022-09-04	WOS:000404846300051
J	Holme, F; Kapambwe, S; Nessa, A; Basu, P; Murillo, R; Jeronimo, J				Holme, Francesca; Kapambwe, Sharon; Nessa, Ashrafun; Basu, Partha; Murillo, Raul; Jeronimo, Jose			Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low-and lower-middle-income countries	INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS			English	Article						Cervical cancer; HPV test; Low-and lower-middle income countries; Scale-up; Screening; Visual inspection with acetic acid	CLUSTER-RANDOMIZED-TRIAL; VISUAL INSPECTION; ACETIC-ACID; BANGLADESH; NEOPLASIA; WOMEN	The problem of cervical cancer in low-and lower-middle-income countries (LLMICs) is both urgent and important, and calls for governments to move beyond pilot testing to population-based screening approaches as quickly as possible. Experiences from Zambia, Bangladesh, Guatemala, Honduras, and Nicaragua, where scale-up of evidence-based screening strategies is taking place, may help other countries plan for large-scale implementation. These countries selected screening modalities recommended by the WHO that are within budgetary constraints, improve access for women, and reduce health system bottlenecks. In addition, some common elements such as political will and government investment have facilitated action in these diverse settings. There are several challenges for continued scale-up in these countries, including maintaining trained personnel, overcoming limited follow-up and treatment capacity, and implementing quality assurance measures. Countries considering scale-up should assess their readiness and conduct careful planning, taking into consideration potential obstacles. International organizations can catalyze action by helping governments overcome initial barriers to scale-up.	[Holme, Francesca; Jeronimo, Jose] PATH, Seattle, WA 98121 USA; [Kapambwe, Sharon] Minist Hlth Zambia, Lusaka, Zambia; [Kapambwe, Sharon] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Nessa, Ashrafun] Bangabandhu Sheikh Mujib Med Univ, Dhaka, Bangladesh; [Basu, Partha] Int Agcy Res Canc, Lyon, France; [Murillo, Raul] Hosp Univ San Ignacio, Ctr Javeriano Oncol, Bogota, Colombia; [Murillo, Raul] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia		Holme, F (corresponding author), PATH, Seattle, WA 98121 USA.	fholme@path.org	Murillo, Raúl/AAY-4416-2021		Bill & Melinda Gates Foundation [OPP1086544]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	On behalf of PATH and our collaborating partners in Central America, Francesca Holme and Jose Jeronimo are grateful to the Ministries of Health of Guatemala, Honduras, and Nicaragua. We would like to acknowledge the Bill & Melinda Gates Foundation and the Union for International Cancer Control for their support of scale-up of cervical cancer screening efforts in Central America. PATH's work in cervical cancer prevention is funded in part by the Bill & Melinda Gates Foundation (OPP1086544). The findings and conclusions contained within this publication are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. Ashrafun Nessa is grateful to the Ministry of Health and Family Welfare of Bangladesh for collaboration with Bangabandhu Sheikh Mujib Medical University in developing the Cervical and Breast Cancer Screening Program, and to the UNFPA and WHO in Bangladesh and the International Agency for Research on Cancer for their valuable technical support and active cooperation. Sharon Kapambwe is grateful to the Zambia Ministry of Health, the Centre for Infectious Disease Research in Zambia, and all cooperating partners working on the cervical cancer screening program for their valuable technical support and active cooperation.	[Anonymous], 2013, WHO GUID SCREEN TREA; Arrossi S, 2015, LANCET GLOB HEALTH, V3, pE85, DOI 10.1016/S2214-109X(14)70354-7; Basu P, 2010, J FAM PLAN REPROD H, V36, P131, DOI 10.1783/147118910791749218; Bateman AC, 2014, JAIDS-J ACQ IMM DEF, V67, P212, DOI 10.1097/QAI.0000000000000270; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Gok M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1040; Kitchener HC, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20680; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Nessa A, 2013, J OBSTET GYNAECOL RE, V39, P564, DOI 10.1111/j.1447-0756.2012.01998.x; Nessa A, 2010, INT J GYNECOL OBSTET, V111, P115, DOI 10.1016/j.ijgo.2010.06.004; Ogilvie GS, 2013, INT J GYNECOL OBSTET, V122, P118, DOI 10.1016/j.ijgo.2013.03.019; Parham GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122169; Phongsavan K, 2011, INT J GYNECOL OBSTET, V114, P268, DOI 10.1016/j.ijgo.2011.03.009; [No title captured]	14	31	31	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-7292	1879-3479		INT J GYNECOL OBSTET	Int. J. Gynecol. Obstet.	JUL	2017	138			1			63	68		10.1002/ijgo.12185	http://dx.doi.org/10.1002/ijgo.12185			6	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	EZ9ZZ	28691331	hybrid			2022-09-04	WOS:000405091100011
J	Gomez, RM; Ghotme, K; Botero, L; Bernal, JE; Perez, R; Barreto, GE; Bustos, RH				Gomez, Rosa M.; Ghotme, Kemel; Botero, Lucia; Bernal, Jaime E.; Perez, Rosalia; Barreto, George E.; Helena Bustos, Rosa			Ultrastructural analysis of olfactory ensheathing cells derived from olfactory bulb and nerve of neonatal and juvenile rats	NEUROSCIENCE RESEARCH			English	Article						Olfactory ensheathing cells; Electron microscopy; Regeneration; Neural repair; Cell therapy	INJURED SPINAL-CORD; IN-VITRO; NEURITE OUTGROWTH; LAMINA PROPRIA; NEURAL REPAIR; GLIAL-CELLS; REMYELINATION; REGENERATION; CULTURES; RECEPTOR	Olfactory nerve derived and olfactory bulb derived olfactory ensheathing cells (OECs) have the ability to promote axonal regeneration and remyelination, both of which are essential in a successful cell transplant. Thus, morphological identification of OECs is a key aspect to develop an applicable cell therapy for injuries to the nervous system. However, there is no clear definition regarding which developmental stage or anatomical origin of OECs is more adequate for neural repair. In the present study, an ultrastructural comparison was made between OECs recovered from primary cultures of olfactory nerve and bulb in two developmental stages. The most notorious difference between cells obtained from olfactory nerve and bulb was the presence of indented nuclei in bulb derived OECs, suggesting a greater ability for possible chemotaxis. In neonatal OECs abundant mitochondria, lipid vacuoles, and smooth endoplasmic reticulum were detected, suggesting an active lipid metabolism, probably involved in synthesis of myelin. Our results suggest that neonatal OECs obtained from olfactory bulb have microscopic properties that could make them more suitable for neural repair. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Gomez, Rosa M.; Ghotme, Kemel; Perez, Rosalia; Helena Bustos, Rosa] Univ La Sabana, Fac Med, Campus Univ Puente Comun,Km 7 Autopista Norte, Chia, Colombia; [Gomez, Rosa M.] Fdn Neuroregeneracion de Colombia, Bogota, Colombia; [Ghotme, Kemel] Fdn Santafe Bogota, Unidad Neurocirugia, Bogota, Colombia; [Botero, Lucia] Univ Nacl Colombia, Fac Med Vet & Zootecnia, Bogota, Colombia; [Bernal, Jaime E.] Univ Javeriana, Inst Genet, Carrera 7 45-02, Bogota, Colombia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Helena Bustos, Rosa] Univ La Sabana, Dept Farmacol, Grp Evidencia Terapaut, Chia, Colombia		Gomez, RM (corresponding author), Univ Sabana, Campus Univ Puente Comun,Km 7 Autopista Norte, Chia, Colombia.	rosa.gomez@unisabana.edu.co	Barreto, George E./AAD-7420-2020; Barreto, George E./B-5747-2014; Ghotme, Kemel Ahmed Ghotme/V-6138-2019; Bustos, Helena/R-5723-2019; Bustos, Rosa Helena/P-2742-2018; Ghotme, Kemel Ahmed Ghotme/AAR-6104-2020	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Ghotme, Kemel Ahmed Ghotme/0000-0001-6802-4373; Bustos, Helena/0000-0003-0243-2299; Bustos, Rosa Helena/0000-0003-0243-2299; Ghotme, Kemel Ahmed Ghotme/0000-0001-6802-4373; Bernal Villegas, Jaime Eduardo/0000-0002-9733-5143	Universidad de La Sabana [MED29]	Universidad de La Sabana	The authors appreciate the cooperation extended by the Biological Reagents Laboratory, Institute of Biotechnology, Universidad Nacional de Colombia, and the Special Endowment Fund of the Universidad de La Sabana (Grant MED29).	Au E, 2003, GLIA, V41, P224, DOI 10.1002/glia.10160; BARBER PC, 1982, NEUROSCIENCE, V7, P3077, DOI 10.1016/0306-4522(82)90231-7; Boyd JG, 2005, FASEB J, V19, P694, DOI 10.1096/fj.04-2833rev; Chou RH, 2014, CELL TRANSPLANT, V23, P567, DOI 10.3727/096368914X678508; Coutts DJC, 2013, CELL TRANSPLANT, V22, P1249, DOI 10.3727/096368912X656153; DEVON R, 1995, BRAIN RES, V688, P223, DOI 10.1016/0006-8993(95)00562-5; DOUCETTE JR, 1984, ANAT REC, V210, P385, DOI 10.1002/ar.1092100214; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; GOODMAN MN, 1993, BRAIN RES, V619, P199; He BR, 2014, MOL NEUROBIOL, V49, P1501, DOI 10.1007/s12035-013-8588-2; Higginson JR, 2011, EXP NEUROL, V229, P2, DOI 10.1016/j.expneurol.2010.08.020; Hoffmann K, 2007, CHROMOSOMA, V116, P227, DOI 10.1007/s00412-007-0094-8; Kocsis JD, 2009, NEUROSCI LETT, V456, P137, DOI 10.1016/j.neulet.2008.08.093; Kueh JLL, 2011, GLIA, V59, P1658, DOI 10.1002/glia.21213; Kumar R, 2005, GLIA, V50, P12, DOI 10.1002/glia.20154; Leaver SG, 2006, GLIA, V53, P467, DOI 10.1002/glia.20311; Nash HH, 2001, GLIA, V34, P81, DOI 10.1002/glia.1043; Ozdemir M, 2012, CURR STEM CELL RES T, V7, P364, DOI 10.2174/157488812802481481; Pellitteri R, 2007, NEUROSCI LETT, V417, P24, DOI 10.1016/j.neulet.2007.02.065; Pellitteri Rosalia, 2010, Front Biosci (Schol Ed), V2, P289; PIXLEY SK, 1992, GLIA, V5, P269, DOI 10.1002/glia.440050405; Plant GW, 2011, EXP NEUROL, V229, P99, DOI 10.1016/j.expneurol.2010.09.010; Radtke C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/608496; RAMONCUETO A, 1993, EUR J NEUROSCI, V5, P1172, DOI 10.1111/j.1460-9568.1993.tb00971.x; RAMONCUETO A, 1992, NEUROSCIENCE, V47, P213, DOI 10.1016/0306-4522(92)90134-N; Richter Miranda, 2008, V438, P95, DOI 10.1007/978-1-59745-133-8_9; Roet KCD, 2014, EXP NEUROL, V261, P594, DOI 10.1016/j.expneurol.2014.05.007; Sasaki M, 2007, PROG BRAIN RES, V161, P419, DOI 10.1016/S0079-6123(06)61030-3; Sasaki M, 2011, EXP NEUROL, V229, P88, DOI 10.1016/j.expneurol.2011.01.010; VALVERDE F, 1992, NEUROSCIENCE, V49, P255, DOI 10.1016/0306-4522(92)90094-I; Van den Pol AN, 2003, J COMP NEUROL, V458, P175, DOI 10.1002/cne.10577; Watanabe K, 2006, BRAIN RES, V1116, P82, DOI 10.1016/j.brainres.2006.07.124; Wewetzer K, 2005, GLIA, V49, P577, DOI 10.1002/glia.20149; Zhu YL, 2010, GLIA, V58, P716, DOI 10.1002/glia.20957	34	6	8	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	FEB	2016	103						10	17		10.1016/j.neures.2015.07.012	http://dx.doi.org/10.1016/j.neures.2015.07.012			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DG3AV	26254553	Green Published			2022-09-04	WOS:000371942800002
J	Paz, CG; Lares, M; Sandoval, J; Hernandez, MS				Gutierrez Paz, Carina; Lares, Mary; Sandoval, Jorge; Hernandez, Maria S.			PROTEIN ISOLATE EXTRACTION FROM QUINOA (Chenopodium quinua: Blanca Junin variety) FOR USE IN HIGH PROTEIN SUPPLEMENTS	INTERCIENCIA			Spanish	Article								Quinoa is a pseudocereal that is recognized by the FAO as a powerful tool in the fight against hunger, poverty, and malnutrition, problems that affect two-thirds of the planet's inhabitants. Its high protein content, containing all essential amino acids, especially histidine and lysine (limited amino acids in cereals), provides an alternative to animal protein in cases of juvenile malnutrition. The present study aimed to obtain a protein iso-late from quinoa, Chenopodium quinoa: Blanca Junin variety, grown in Boyaca, Colombia (with four different methods), for use as an alternative in protein supplement products. The extraction process was carried out by applying: 1) enzymatic method in pre-cooked quinoa flour degreased with petroleum ether, 2) isoelectric precipitation in pre-cooked quinoa flour degreased with petroleum ether, 3) isoelectric precipitation and ultrasound applications to destarched quinoa flour, and 4) isoelectric precipitation in pre-cooked, destarched quinoa flour. The third method obtained the highest protein concentration, 72.4%, and is recommended for use in food because solvents can leave residues that are harmful to consumer health. Supplements made with this protein isolate can be employed not only in patients with malnutrition but also by athletes, among other uses.	[Gutierrez Paz, Carina] Univ Nacl Colombia, Ciencia & Tecnol Alimentos, Bogota, Colombia; [Gutierrez Paz, Carina] Pontificia Univ Javeriana, Calidad, Bogota, Colombia; [Gutierrez Paz, Carina] Calle 146F 73 A-20 Int 12-604, Bogota 111156, Colombia; [Lares, Mary] Univ Cent Venezuela, Ciencia & Tecnol Alimentos, Caracas, Venezuela; [Lares, Mary] Univ Cent Venezuela, Caracas, Venezuela; [Lares, Mary] Hosp Mil Univ Dr Carlos Arvelo, Serv Endocrinol & Enfermedades Metab, Caracas, Venezuela; [Sandoval, Jorge] Univ INCCA, Alimentos, Bogota, Colombia; [Sandoval, Jorge] Univ Pedag & Tecnol Colombia, Seguridad & Calidad Alimentaria, Bogota, Colombia; [Sandoval, Jorge] Univ Nacl Colombia, Bogota, Colombia; [Hernandez, Maria S.] Univ Los Andes, Bogota, Colombia; [Hernandez, Maria S.] Univ Nacl Colombia, Ciencias Agr, Bogota, Colombia; [Hernandez, Maria S.] Univ Nacl Colombia, Inst Ciencia & Tecnol Alimentos, Bogota, Colombia		Paz, CG (corresponding author), Univ Nacl Colombia, Ciencia & Tecnol Alimentos, Bogota, Colombia.; Paz, CG (corresponding author), Pontificia Univ Javeriana, Calidad, Bogota, Colombia.; Paz, CG (corresponding author), Calle 146F 73 A-20 Int 12-604, Bogota 111156, Colombia.	cgutierrezp@unal.edu.co; marylares@hotmail.com; jlsandovals@unal.edu.co; mshernandez@unal.edu.co						Ali A, 2019, WHEY PROTEINS: FROM MILK TO MEDICINE, P579, DOI 10.1016/B978-0-12-812124-5.00017-5; Alvarez Gavilanez JJ, 2019, REV UNIANDES CIENC S, V2, P72; Bergesse AE, 2015, APROVECHAMIENTO INTE; Brena Diaz DA, 2018, THESIS U NACL AGRARI; Elsohaimy S. A., 2015, Annals of Agricultural Science (Cairo), V60, P297, DOI 10.1016/j.aoas.2015.10.007; FAO, 2013, 2013 INT YEAR QUIN S; FAO-ALADI, 2013, MEM SEM INT QUIN AL; Romani-Moron MJ, 2019, SCI AGROPEC, V10, P293, DOI 10.17268/sci.agropecu.2019.02.15; Padron Pereira CA, 2014, REV VENEZ CIENC TECN, V5, P166; Pezua Cespedes R, 2017, THESIS U NACL JOSE M; Rivera Figueroa MM, 2006, THESIS U CHILE; Rosas-Mendoza ME, 2017, MEMORIAS CONGRESOS S, P52; Tapia MS, 2012, J CELL PLAST, V48, P526, DOI 10.1177/0021955X12445291; Vasquez J. M. M., 2016, Ciencia y Tecnologia de Alimentos, V26, P60; Vilcacundo R, 2017, PLANT FOOD HUM NUTR, V72, P294, DOI 10.1007/s11130-017-0626-1; Waglay A, 2019, LWTFOOD SCI TECHNOL, V113, P1	16	0	0	0	0	INTERCIENCIA	CARACAS	APARTADO 51842, CARACAS 1050A, VENEZUELA	0378-1844			INTERCIENCIA	Interciencia	JUL	2022	47	7					279	283						5	Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	3Q1LO					2022-09-04	WOS:000837995800005
J	Calvache, JA; Moreno, S; Prue, G; Reid, J; Ahmedzai, SH; Arango-Gutierrez, A; Ardila, L; Arroyo, LI; de Vries, E				Calvache, Jose A.; Moreno, Socorro; Prue, Gillian; Reid, Joanne; Ahmedzai, Sam H.; Arango-Gutierrez, Angelica; Ardila, Liliana; Arroyo, Lucia, I; de Vries, Esther			Knowledge of end-of-life wishes by physicians and family caregivers in cancer patients	BMC PALLIATIVE CARE			English	Article						End of life; Cancer; Communication; Advance Directives; Decision Making	PALLIATIVE CARE; HEALTH; COMMUNICATION; ASSOCIATIONS; DEATH	Objectives To describe communication regarding cancer patient's end-of-life (EoL) wishes by physicians and family caregivers. Methods An online questionnaire and telephone-based surveys were performed with physicians and family caregivers respectively in three teaching hospitals in Colombia which had been involved in the EoL care of cancer patients. Results For 138 deceased patients we obtained responses from physicians and family caregivers. In 32 % physicians reported they spoke to the caregiver and in 17 % with the patient regarding EoL decisions. In most cases lacking a conversation, physicians indicated the treatment option was "clearly the best for the patient" or that it was "not necessary to discuss treatment with the patient". Twenty-six percent of the caregivers indicated that someone from the medical team spoke with the patient about treatment, and in 67% who had a conversation, caregivers felt that the provided information was unclear or incomplete. Physicians and family caregivers were aware if the patient had any advance care directive in 6% and 26% of cases, respectively, with low absolute agreement (34%). Conclusions There is a lack of open conversation regarding EoL in patients with advanced cancer with their physicians and family caregivers in Colombia. Communication strategies are urgently needed.	[Calvache, Jose A.] Univ Cauca, Dept Anesthesiol, Popayan, Colombia; [Calvache, Jose A.] Erasmus MC, Dept Anesthesiol, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Moreno, Socorro; de Vries, Esther] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Prue, Gillian] Queens Univ Belfast, Sch Nursing & Midwifery, Reader Chron Illness, Belfast, Antrim, North Ireland; [Reid, Joanne] Queens Univ Belfast, Sch Nursing & Midwifery, Canc & Palliat Care, Belfast, Antrim, North Ireland; [Ahmedzai, Sam H.] Univ Sheffield, Royal Hallamshire Hosp, Sch Med & Biomed Sci, Acad Unit Support Care,Sect Oncol, Sheffield, S Yorkshire, England; [Arango-Gutierrez, Angelica] Pontificia Univ Javeriana, Clin Epidemiol, Bogota, Colombia; [Ardila, Liliana] Natl Canc Inst, Bogota, Colombia; [Arroyo, Lucia, I] Univ Cauca, Dept Fonoaudiol, Popayan, Colombia; [Arroyo, Lucia, I] Pontificia Univ Javeriana Cali, MPH Programme Publ Hlth, Cali, Colombia		Reid, J (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, Canc & Palliat Care, Belfast, Antrim, North Ireland.	j.reid@qub.ac.uk	Calvache, Jose Andres/V-7932-2019; Arroyo Castillo, Lucía Inés/ABC-5886-2021; de Vries, Esther/A-6603-2009	Calvache, Jose Andres/0000-0001-9421-3717; Arroyo Castillo, Lucía Inés/0000-0002-1261-6297; de Vries, Esther/0000-0002-5560-2258; /0000-0002-4119-4409; Prue, Gillian/0000-0003-2198-3731; Ahmedzai, Sam/0000-0002-2028-8510; Arango Gutierrez, Angelica Maria/0000-0002-2980-6847; Reid, Joanne/0000-0001-5820-862X	Minciencias [CT-826-2018]	Minciencias	This work was supported by Minciencias, in the framework of the "777-2017 Convocatoria para proyectos de ciencia, tecnologia e innovacion en Salud 2017", project CT-826-2018 -Decisiones medicas al final de la vida en pacientes oncologicos en Colombia". Minciencias (Colombian government research funding body) had no role in the design of the study and collection, analysis, and interpretation of data of in writing the manuscript.	Agarwal R, 2018, SEMIN ONCOL NURS, V34, P316, DOI 10.1016/j.soncn.2018.06.012; Almansour I, 2019, INTENS CRIT CARE NUR, V53, P8, DOI 10.1016/j.iccn.2019.04.003; Anderson RJ, 2019, PALLIATIVE MED, V33, P926, DOI 10.1177/0269216319852007; Bar-Sela G, 2020, SUPPORT CARE CANCER, V28, P4183, DOI 10.1007/s00520-019-05253-7; Brighton LJ, 2016, POSTGRAD MED J, V92, P466, DOI 10.1136/postgradmedj-2015-133368; Brinkman-Stoppelenburg A, 2014, PALLIATIVE MED, V28, P1000, DOI 10.1177/0269216314526272; Calvache José A., 2020, Rev. colomb. anestesiol., V48, pe201, DOI 10.1097/cj9.0000000000000159; CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Cheung JTK, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-00587-0; Comer AR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5179; Cuevas Rivero V., 2016, HUMANIZACION CUIDADO; Dalal S, 2017, ONCOLOGIST, V22, P361, DOI 10.1634/theoncologist.2016-0277; de Vogel-Voogt E, 2007, PALLIATIVE MED, V21, P243, DOI 10.1177/0269216307077352; De Vries E, 2021, RES SQUARE, DOI [10.21203/rs.3.rs-288762/v1, DOI 10.21203/RS.3.RS-288762/V1]; de Vries E, 2018, J Cancer Policy, V15, P104, DOI 10.1016/j.jcpo.2018.01.003; DescLAB, LAB DER EC SOC CULT; Donnelly S, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0365-6; Frank Rosanna Kay, 2009, Br J Nurs, V18, P612; Gazarian PK, 2019, GERIATR NURS, V40, P174, DOI 10.1016/j.gerinurse.2018.09.011; Gempeler Rueda Fritz Eduardo, 2021, Univ. Med., V62, P13, DOI 10.11144/javeriana.umed62-1.imnp; Glass DP, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.3053; Higgins PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066066; Hu WY, 2010, SOC SCI MED, V70, P1701, DOI 10.1016/j.socscimed.2010.02.011; Jimenez G, 2018, J PAIN SYMPTOM MANAG, V56, P436, DOI 10.1016/j.jpainsymman.2018.05.016; Love A, 2014, PALLIATIVE MED, V28, P1026, DOI 10.1177/0269216314531313; Luna-Meza A, 2021, BMC PALLIAT CARE, V20, P76, DOI 10.1186/s12904-021-00768-5; Mc Veigh C, 2017, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-017-0220-1; Medina Rico MA, 2021, DESEOS FINAL VIDA PA; Nagelschmidt K, 2021, BMJ SUPPORT PALLIAT, V11, P253, DOI 10.1136/bmjspcare-2020-002219; Pena AJ, 2020, MORIR DIGNAMENTE VIS, V1; Rao JK, 2014, AM J PREV MED, V46, P65, DOI 10.1016/j.amepre.2013.09.008; Rauch J, 2013, ATLANTIC; Reid J, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9070789; Salmon P, 2005, PSYCHO-ONCOLOGY, V14, P885, DOI 10.1002/pon.970; Sandman L, 2010, HEALTH CARE ANAL, V18, P60, DOI 10.1007/s10728-008-0108-6; Sarmiento-Medina María I, 2012, Rev. salud pública, V14, P116; Shen MJ, 2019, PALLIAT SUPPORT CARE, V17, P374, DOI 10.1017/S1478951518000834; Sleeman KE, 2019, LANCET GLOB HEALTH, V7, pE883, DOI 10.1016/S2214-109X(19)30172-X; Sterfgevallenonderzoek, 2010, EUTH AND MED BESL RO; TOWERS B, 1978, J MED ETHICS, V4, P96, DOI 10.1136/jme.4.2.96; Uebersax J., RAW AGREEMENT INDICE; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	44	2	3	2	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-684X			BMC PALLIAT CARE	BMC Palliat. Care	SEP 10	2021	20	1							140	10.1186/s12904-021-00823-1	http://dx.doi.org/10.1186/s12904-021-00823-1			7	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	UO7JD	34507567	Green Accepted, gold, Green Published, Green Submitted			2022-09-04	WOS:000694868500001
J	Mendez, H; Heimel, G; Winkler, S; Frisch, J; Opitz, A; Sauer, K; Wegner, B; Oehzelt, M; Rothel, C; Duhm, S; Tobbens, D; Koch, N; Salzmann, I				Mendez, Henry; Heimel, Georg; Winkler, Stefanie; Frisch, Johannes; Opitz, Andreas; Sauer, Katrein; Wegner, Berthold; Oehzelt, Martin; Roethel, Christian; Duhm, Steffen; Toebbens, Daniel; Koch, Norbert; Salzmann, Ingo			Charge-transfer crystallites as molecular electrical dopants	NATURE COMMUNICATIONS			English	Article							ORGANIC SEMICONDUCTORS; CONDUCTING POLYMERS; CONJUGATED POLYMERS; SOLAR-CELLS; THIN-FILMS; TRANSPORT; MODEL; SOLITONS; TETRAFLUOROTETRACYANOQUINODIMETHANE; POLY(3-HEXYLTHIOPHENE)	Ground-state integer charge transfer is commonly regarded as the basic mechanism of molecular electrical doping in both, conjugated polymers and oligomers. Here, we demonstrate that fundamentally different processes can occur in the two types of organic semiconductors instead. Using complementary experimental techniques supported by theory, we contrast a polythiophene, where molecular p-doping leads to integer charge transfer reportedly localized to one quaterthiophene backbone segment, to the quaterthiophene oligomer itself. Despite a comparable relative increase in conductivity, we observe only partial charge transfer for the latter. In contrast to the parent polymer, pronounced intermolecular frontier-orbital hybridization of oligomer and dopant in 1:1 mixed-stack co-crystallites leads to the emergence of empty electronic states within the energy gap of the surrounding quaterthiophene matrix. It is their Fermi-Dirac occupation that yields mobile charge carriers and, therefore, the co-crystallites-rather than individual acceptor molecules-should be regarded as the dopants in such systems.	[Mendez, Henry; Heimel, Georg; Winkler, Stefanie; Frisch, Johannes; Opitz, Andreas; Sauer, Katrein; Wegner, Berthold; Oehzelt, Martin; Koch, Norbert; Salzmann, Ingo] Humboldt Univ, Inst Phys & IRIS Adlershof, AG Supramol Syst, D-12489 Berlin, Germany; [Mendez, Henry] Pontificia Univ Javeriana, Dept Fis, Bogota, Colombia; [Winkler, Stefanie; Frisch, Johannes; Oehzelt, Martin; Koch, Norbert] Helmholtz Zentrum Berlin Mat & Energie GmbH, Bereich Solarenergieforsch, D-12489 Berlin, Germany; [Roethel, Christian] Graz Univ Technol, Inst Festkorperphys, A-8010 Graz, Austria; [Duhm, Steffen; Koch, Norbert] Soochow Univ, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou 215123, Peoples R China; [Duhm, Steffen; Koch, Norbert] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Suzhou 215123, Peoples R China; [Duhm, Steffen] Soochow Univ, Soochow Univ Western Univ Joint Ctr Synchrotron R, Suzhou 215123, Peoples R China; [Duhm, Steffen] Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou 215123, Peoples R China; [Toebbens, Daniel] Helmholtz Zentrum Berlin Mat & Energie GmbH BESSY, D-12489 Berlin, Germany		Salzmann, I (corresponding author), Humboldt Univ, Inst Phys & IRIS Adlershof, AG Supramol Syst, Brook Taylor Str 6, D-12489 Berlin, Germany.	ingo.salzmann@physik.hu-berlin.de	Mendez, Henry/J-6819-2014; Koch, Norbert/J-4057-2012; Duhm, Steffen/AAT-5306-2020; Duhm, Steffen/E-6310-2019; Wegner, Berthold/D-2042-2017; Salzmann, Ingo/AAP-3378-2020; Salzmann, Ingo/F-9702-2011; Opitz, Andreas/L-7700-2015	Koch, Norbert/0000-0002-6042-6447; Duhm, Steffen/0000-0002-5099-5929; Duhm, Steffen/0000-0002-5099-5929; Wegner, Berthold/0000-0002-2021-6031; Salzmann, Ingo/0000-0001-9977-3422; Salzmann, Ingo/0000-0001-9977-3422; Opitz, Andreas/0000-0002-3214-8398	Major State Basic Research Development Program of China (973 Program) [2013CB933500, 2014CB932600]; DFG [SFB 951]; Helmholtz-Energy Alliance 'Hybrid Photovoltaics'; Academic Vice-Rectorate of Pontificia Universidad Javeriana (Colombia); Katholischer Akademischer Auslander Dienst (KAAD), Germany	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); DFG(German Research Foundation (DFG)European Commission); Helmholtz-Energy Alliance 'Hybrid Photovoltaics'; Academic Vice-Rectorate of Pontificia Universidad Javeriana (Colombia); Katholischer Akademischer Auslander Dienst (KAAD), Germany	We thank the HZB for support during beamtime at beamline KMC-2. We further acknowledge the European Synchrotron Radiation Facility (ESRF) for provision of beamtime and we thank Oleg Konovalov and Giovanni Li Destri (both ESRF) for assistance in using beamline ID10, Stefan Krause (HUB) for supporting UPS/IPES data on pure F6TCNNQ, Paul Zybarth (HUB) for experimental support, Dieter Neher (University Potsdam) for fruitful discussions on the molecular doping of P3HT, Armin Moser (TU-Graz) for providing the software PyGID for GIXRD analysis, as well as Roland Resel (TU-Graz) for fruitful discussions on GIXRD. Financial support from the Major State Basic Research Development Program of China (973 Program, Nos 2013CB933500 and 2014CB932600), from the DFG (SFB 951), and from the Helmholtz-Energy Alliance 'Hybrid Photovoltaics' is gratefully acknowledged. H.M. wants to acknowledge support by the Academic Vice-Rectorate of Pontificia Universidad Javeriana (Colombia) and the Katholischer Akademischer Auslander Dienst (KAAD), Germany.	Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522; Aziz EE, 2007, ADV MATER, V19, P3257, DOI 10.1002/adma.200700926; BASSLER H, 1993, PHYS STATUS SOLIDI B, V175, P15, DOI 10.1002/pssb.2221750102; Blakesley JC, 2009, J APPL PHYS, V106, DOI 10.1063/1.3187787; Braun KF, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2961014; BREDAS JL, 1985, ACCOUNTS CHEM RES, V18, P309, DOI 10.1021/ar00118a005; Brinkmann M, 2011, J POLYM SCI POL PHYS, V49, P1218, DOI 10.1002/polb.22310; Brown PJ, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125204; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; CHAPPELL JS, 1981, J AM CHEM SOC, V103, P2442, DOI 10.1021/ja00399a066; Cochran JE, 2014, MACROMOLECULES, V47, P6836, DOI 10.1021/ma501547h; Djurovich PI, 2009, ORG ELECTRON, V10, P515, DOI 10.1016/j.orgel.2008.12.011; Duong DT, 2014, ADV MATER, V26, P6069, DOI 10.1002/adma.201402015; Duong DT, 2013, ORG ELECTRON, V14, P1330, DOI 10.1016/j.orgel.2013.02.028; EMGE TJ, 1981, MOL CRYST LIQ CRYST, V65, P161, DOI 10.1080/00268948108082132; FICHOU D, 1990, SYNTHETIC MET, V39, P125, DOI 10.1016/0379-6779(90)90207-2; FICHOU D, 1990, SYNTHETIC MET, V39, P243, DOI 10.1016/0379-6779(90)90189-R; Frisch J, 2011, ORG ELECTRON, V12, P916, DOI 10.1016/j.orgel.2011.03.005; Gao J, 2013, J PHYS CHEM LETT, V4, P2953, DOI 10.1021/jz401555x; Gao WY, 2003, J APPL PHYS, V94, P359, DOI 10.1063/1.1577400; Gao WY, 2001, APPL PHYS LETT, V79, P4040, DOI 10.1063/1.1424067; Harada K, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3456394; Heeger AJ, 2001, ANGEW CHEM INT EDIT, V40, P2591, DOI 10.1002/1521-3773(20010716)40:14<2591::AID-ANIE2591>3.0.CO;2-0; HEEGER AJ, 1988, REV MOD PHYS, V60, P781, DOI 10.1103/RevModPhys.60.781; Heimel G, 2012, AIP CONF PROC, V1456, P148, DOI 10.1063/1.4730654; Hill IG, 2000, CHEM PHYS LETT, V327, P181, DOI 10.1016/S0009-2614(00)00882-4; Hinderhofer A, 2012, CHEMPHYSCHEM, V13, P628, DOI 10.1002/cphc.201100737; Igor F., 2009, HDB THIOPHENE BASED; Kampar E., 1986, RUSS CHEM REV+, V55, P334; Kanai K, 2009, APPL PHYS A-MATER, V95, P309, DOI 10.1007/s00339-008-5021-1; Kayunkid N, 2010, MACROMOLECULES, V43, P4961, DOI 10.1021/ma100551m; Kleemann H, 2012, ORG ELECTRON, V13, P58, DOI 10.1016/j.orgel.2011.09.027; LOGDLUND M, 1989, PHYS REV LETT, V63, P1841, DOI 10.1103/PhysRevLett.63.1841; Lussem B, 2013, PHYS STATUS SOLIDI A, V210, P9, DOI 10.1002/pssa.201228310; Lussem B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3775; Ma L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2883927; Maennig B, 2004, APPL PHYS A-MATER, V79, P1, DOI 10.1007/s00339-003-2494-9; Mayer T, 2012, ORG ELECTRON, V13, P1356, DOI 10.1016/j.orgel.2012.03.028; Mendez H, 2013, ANGEW CHEM INT EDIT, V52, P7751, DOI 10.1002/anie.201302396; MENEGHETTI M, 1986, J CHEM PHYS, V84, P4149, DOI 10.1063/1.450086; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Oehzelt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5174; Olthof S, 2009, J APPL PHYS, V106, DOI 10.1063/1.3259436; Olthof S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176601; Osterbacka R, 2000, SCIENCE, V287, P839, DOI 10.1126/science.287.5454.839; Parthasarathy G, 2001, J APPL PHYS, V89, P4986, DOI 10.1063/1.1359161; Pfeiffer M, 2000, SOL ENERG MAT SOL C, V63, P83, DOI 10.1016/S0927-0248(00)00022-2; Pfeiffer M., 1999, ADV SOLID STATE PHYS, V39, P77; Pingel P, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115209; Pingel P, 2010, J PHYS CHEM LETT, V1, P2037, DOI 10.1021/jz100492c; PROSA TJ, 1992, MACROMOLECULES, V25, P4364, DOI 10.1021/ma00043a019; Reineke S, 2009, NATURE, V459, P234, DOI 10.1038/nature08003; Salzmann I., 2015, J ELECT SPECTROSC RE, DOI [10.1016/j.elspec.2015.1005.1001, DOI 10.1016/J.ELSPEC.2015.1005.1001]; Salzmann I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.035502; Scalmani G, 2009, GAUSSIAN 09; Service RF, 2011, SCIENCE, V332, P293, DOI 10.1126/science.332.6027.293; Siegrist T, 1998, ADV MATER, V10, P379, DOI 10.1002/(SICI)1521-4095(199803)10:5<379::AID-ADMA379>3.0.CO;2-A; Sirringhaus H, 1998, SCIENCE, V280, P1741, DOI 10.1126/science.280.5370.1741; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; Sze S. M., 2021, PHYS SEMICONDUCTOR D; Tietze ML, 2015, ADV FUNCT MATER, V25, P2701, DOI 10.1002/adfm.201404549; Tietze ML, 2013, ORG ELECTRON, V14, P2348, DOI 10.1016/j.orgel.2013.05.036; Vogel JO, 2010, J MATER CHEM, V20, P4055, DOI 10.1039/b927594k; Walzer K, 2007, CHEM REV, V107, P1233, DOI 10.1021/cr050156n; Wang CC, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.085205; Yang JP, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300128; Yim KH, 2008, ADV MATER, V20, P3319, DOI 10.1002/adma.200800735; Yong C., 1986, CHINESE J STRUC CHEM, V5, P163; ZANON I, 1983, J PHYS CHEM-US, V87, P3657, DOI 10.1021/j100242a018; Zhu LY, 2011, CHEM MATER, V23, P5149, DOI 10.1021/cm201798x	70	246	246	20	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	OCT	2015	6								8560	10.1038/ncomms9560	http://dx.doi.org/10.1038/ncomms9560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4AD	26440403	gold, Green Published			2022-09-04	WOS:000364932600007
J	Couairon, A; Brambilla, E; Corti, T; Majus, D; Ramirez-Gongora, OD; Kolesik, M				Couairon, A.; Brambilla, E.; Corti, T.; Majus, D.; Ramirez-Gongora, O. de J.; Kolesik, M.			Practitioner's guide to laser pulse propagation models and simulation	EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS			English	Review							DISPERSIVE MEDIA; FEMTOSECOND FILAMENTATION; TRANSPARENT MEDIA; FAR-FIELD; GENERATION; DYNAMICS; AIR; IONIZATION; COLLAPSE; PHYSICS	The purpose of this article is to provide practical introduction into numerical modeling of ultrashort optical pulses in extreme nonlinear regimes. The theoretic background section covers derivation of modern pulse propagation models starting from Maxwell's equations, and includes both envelope-based models and carrier-resolving propagation equations. We then continue with a detailed description of implementation in software of Nonlinear Envelope Equations as an example of a mixed approach which combines finite-difference and spectral techniques. Fully spectral numerical solution methods for the Unidirectional Pulse Propagation Equation are discussed next. The modeling part of this guide concludes with a brief introduction into efficient implementations of nonlinear medium responses. Finally, we include several worked-out simulation examples. These are mini-projects designed to highlight numerical and modeling issues, and to teach numerical-experiment practices. They are also meant to illustrate, first and foremost for a non-specialist, how tools discussed in this guide can be applied in practical numerical modeling.	[Couairon, A.] Ecole Polytech, CNRS, Ctr Phys Theor, F-91128 Palaiseau, France; [Brambilla, E.; Corti, T.] Univ Insubria, Dept Math & Phys, I-22100 Como, Italy; [Majus, D.] Vilnius Univ, Dept Quantum Elect, LT-10222 Vilnius, Lithuania; [Ramirez-Gongora, O. de J.] Pontificia Univ Javeriana Cali, Dept Ciencias Nat & Matemat, Cali, Colombia; [Kolesik, M.] Coll Opt Sci, Tucson, AZ 85721 USA; [Kolesik, M.] Constantine Philosopher Univ, Dept Phys, Nitra, Slovakia		Couairon, A (corresponding author), Ecole Polytech, CNRS, Ctr Phys Theor, F-91128 Palaiseau, France.	couairon@cpht.polytechnique.fr; kolesik@optics.arizona.edu	Brambilla, Enrico/C-3831-2009; Corti, Tommaso/J-8204-2012	Brambilla, Enrico/0000-0003-2515-528X; 	CARIPLO; UNIVERCOMO; Banca del Monte di Lombardia Foundations; U.S.A. Air Force Office for Scientific Research [FA9550-10-1-0064]; Multi University Research Initiative [FA9550-10-1-0561]	CARIPLO(Fondazione Cariplo); UNIVERCOMO; Banca del Monte di Lombardia Foundations; U.S.A. Air Force Office for Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Multi University Research Initiative(MURI)	The numerical experiments have been performed in the context of STELLA, the School for Training in Experiments with Lasers and Laser Applications, held at the Insubria University in Como from June 20 to July 8 2011 (see www-stella-school.eu). The Authors wish to acknowledge CARIPLO, UNIVERCOMO and Banca del Monte di Lombardia Foundations for having financed the project. M. K. is grateful for the support from the U.S.A. Air Force Office for Scientific Research through the grant no. FA9550-10-1-0064 and Multi University Research Initiative FA9550-10-1-0561. The Authors like also to acknowledge Dr. Yi Liu for his careful reading of the manuscript, and the STELLA-school students for their support in developing the numerical laboratory used during STELLA.	Akozbek N, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.143901; Ames W.F, 1977, NUMERICAL METHODS PA, Vsecond, P1; Brabec T, 1997, PHYS REV LETT, V78, P3282, DOI 10.1103/PhysRevLett.78.3282; BRAUN A, 1995, OPT LETT, V20, P73, DOI 10.1364/OL.20.000073; Brodeur A, 1997, OPT LETT, V22, P304, DOI 10.1364/OL.22.000304; Chakraborty HS, 2006, OPT LETT, V31, P3662, DOI 10.1364/OL.31.003662; COLLINO F, 1997, J COMPUT PHYS, V113; Couairon A, 2007, PHYS REP, V441, P47, DOI 10.1016/j.physrep.2006.12.005; Couairon A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016608; Couairon A, 2003, EUR PHYS J D, V27, P159, DOI 10.1140/epjd/e2003-00255-9; Couairon A, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.015801; Couairon A, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.053814; Cox SM, 2002, J COMPUT PHYS, V176, P430, DOI 10.1006/jcph.2002.6995; CRANK J, 1947, P CAMB PHILOS SOC, V43, P50, DOI 10.1017/S0305004100023197; Dmitriev V.G., 1999, HDB NONLINEAR OPTICA, V64; Esarey E, 2009, REV MOD PHYS, V81, P1229, DOI 10.1103/RevModPhys.81.1229; Faccio D, 2007, OPT EXPRESS, V15, P13077, DOI 10.1364/OE.15.013077; Faccio D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.037601; Faccio D, 2005, J OPT SOC AM B, V22, P862, DOI 10.1364/JOSAB.22.000862; Faccio D, 2007, CONICAL WAVES FILAME; Faccio D, 2007, OPT LETT, V32, P184, DOI 10.1364/OL.32.000184; Faccio D, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.033826; FEIT MD, 1988, J OPT SOC AM B, V5, P633, DOI 10.1364/JOSAB.5.000633; Fibich G, 2001, PHYSICA D, V157, P112, DOI 10.1016/S0167-2789(01)00293-7; Gaarde MB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.043901; Gaarde MB, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/13/132001; Geissler M, 1999, PHYS REV LETT, V83, P2930, DOI 10.1103/PhysRevLett.83.2930; Husakou AV, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.203901; Jackson J. D, 1998, CLASSICAL ELECTRODYN, Vthird; Kassam AK, 2005, SIAM J SCI COMPUT, V26, P1214, DOI 10.1137/S1064827502410633; Kinsler P, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.023813; Kolesik M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.036604; Kolesik M, 2005, OPT EXPRESS, V13, P10729, DOI 10.1364/OPEX.13.010729; Kolesik M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.253901; Kolesik M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.043905; Kolesik M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.283902; Kolesik M, 2003, APPL PHYS B-LASERS O, V77, P185, DOI 10.1007/s00340-003-1178-7; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Liu Y, 2011, OPT COMMUN, V284, P4706, DOI 10.1016/j.optcom.2011.05.050; Lotti A, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.053804; LOY MMT, 1969, PHYS REV LETT, V22, P994, DOI 10.1103/PhysRevLett.22.994; Lugovoi V.N., 1974, SOV PHYS USP, V16, P658; LUGOVOI VN, 1968, JETP LETT-USSR, V7, P117; LUTHER GG, 1994, OPT LETT, V19, P862, DOI 10.1364/OL.19.000862; MAINE P, 1988, IEEE J QUANTUM ELECT, V24, P398, DOI 10.1109/3.137; Marburger J. H., 1975, Progress in Quantum Electronics, P35, DOI 10.1016/0079-6727(75)90003-8; Minardi S, 2008, OPT LETT, V33, P86, DOI 10.1364/OL.33.000086; Minardi S, 2009, OPT LETT, V34, P3020, DOI 10.1364/OL.34.003020; Moloney J., 2004, NONLINEAR OPTICS; Polynkin P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.153902; Porras MA, 1999, PHYS REV A, V60, P5069, DOI 10.1103/PhysRevA.60.5069; Press W. H., 1992, NUMERICAL RECIPES; RAE SC, 1992, PHYS REV A, V46, P2077, DOI 10.1103/PhysRevA.46.2077; Schulz E, 2011, OPT EXPRESS, V19, P19495, DOI 10.1364/OE.19.019495; Shen Y. R., 1984, PRINCIPLE NONLINEAR; SILBERBERG Y, 1990, OPT LETT, V15, P1282, DOI 10.1364/OL.15.001282; Steingrube DS, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043022; Strikwerda JC., 2004, FINITE DIFFERENCE SC; Whalen P, 2011, OPT LETT, V36, P2542, DOI 10.1364/OL.36.002542; YABLONOVITCH E, 1972, PHYS REV LETT, V29, P907, DOI 10.1103/PhysRevLett.29.907	60	243	247	10	74	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1951-6355			EUR PHYS J-SPEC TOP	Eur. Phys. J.-Spec. Top.	NOV	2011	199	1					5	76		10.1140/epjst/e2011-01503-3	http://dx.doi.org/10.1140/epjst/e2011-01503-3			72	Physics, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Physics	858PT					2022-09-04	WOS:000297814600002
J	Cuervo, AM; Cadena, CD; Krabbe, N; Renjifo, LM				Cuervo, AM; Cadena, CD; Krabbe, N; Renjifo, LM			Scytalopus stilesi, a new species of tapaculo (Rhinocryptidae) from the Cordillera Central of Colombia	AUK			English	Article						Andes; cytochrome b; new species; Scytalopus; suboscines; systematics	HISTORY; ISLAND; BIRDS	We describe Scytalopus stilesi, an overlooked species of tapaculo endemic to Colombia, on the basis of a series of eight specimens taken in 2002 and comparative analyses of its vocalizations, mitochondrial DNA sequences, and distribution. The new species ranges in the northern half of the Cordillera Central of the Colombian Andes in the Departments of Antioquia, Caldas, and Risaralda, in cloud forests between 1,420 and 2,130 m above sea level. The song, calls, and female song of the new species differ distinctly from those of all other known Scytalopus taxa. Phylogenetic analyses based on sequences of the cytochrome-b gene strongly suggest affinities with S. robbinsi of southwestern Ecuador and with two as-yet-undescribed tapaculos from the Colombian Andes. Scytalopus stilesi coexists locally with, though it is ecologically segregated from, S. atratus, S. latrans, and S. spillmanni. The mid-elevation premontane wet forests to which the new species is restricted have been subject to severe deforestation and fragmentation. The species is, however, relatively common in continuous mature-forest remnants, large primary-forest fragments, riparian forests, and tall secondary-forest patches. We employed a geographic information system (GIS) approach to model the potential distribution of the new species and assess its conservation status under the International Union for the Conservation of Nature (IUCN) criteria. Scytalopus stilesi does not qualify as threatened according to those criteria, but it should be regarded as near threatened. The new species coexists with numerous threatened bird species that are in need of more effective conservation.	Univ Antioquia, Inst Biol, Medellin AA 1226, Colombia; Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Univ Missouri, Int Ctr Trop Ecol, St Louis, MO 63121 USA; Univ Copenhagen, Museum Zool, DK-2100 Copenhagen, Denmark; Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Ecol & Terr, Bogota, Colombia		Cuervo, AM (corresponding author), Univ Puerto Rico, Dept Biol, POB 23360, San Juan, PR 00931 USA.	wa022129@cnnet.upr.edu	Cadena, Carlos Daniel/G-1313-2010; Cuervo, Andres/B-6259-2012	Renjifo, Luis Miguel/0000-0003-1907-2760				ARCTANDER P, 1994, EXS, V68, P205; ARCTANDER P, 1995, P ROY SOC B-BIOL SCI, V262, P13, DOI 10.1098/rspb.1995.0170; Bennett S.E., 2002, LIBRO ROJO AVES COLO, P146; Coopmans Paul, 2001, Bulletin of the British Ornithologists' Club, V121, P208; Cracraft J., 1989, P28; Cracraft J., 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI [10.2307/40168278, DOI 10.2307/40168278]; Cresswell W, 1999, BIRD CONSERV INT, V9, P129, DOI 10.1017/S0959270900002252; CUADROS T, 1988, Hornero, V13, P8; CUATRECASAS J., 1958, Rev. Acad. colomb. Cienc. exact. fis. -nat., V10, P221; Cuervo AM, 2001, IBIS, V143, P353, DOI 10.1111/j.1474-919X.2001.tb04937.x; CUERVO AM, 2003, B BRIT ORNITHOLOGIST, V120, P7; de Queiroz K, 1998, ENDLESS FORMS, P57; EDWARDS SV, 1991, P ROY SOC B-BIOL SCI, V243, P99, DOI 10.1098/rspb.1991.0017; Etter A, 2000, AMBIO, V29, P432, DOI 10.1639/0044-7447(2000)029[0432:POLTIC]2.0.CO;2; Etter A., 1998, INFORME NACL ESTADO, V3; FJELDSA J, 1990, BIRDS  HIGH ANDES ZO; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; GarciuY-Moreno J., 2000, BONN ZOOL MONOGR, P25; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Hernandez J, 1992, DIVERSIDAD BIOL LBER, P105; Holdridge L.R., 1967, LIFE ZONE ECOLOGY; *IAVH, 2004, MAP EC AND COL 2000; Irestedt M, 2002, MOL PHYLOGENET EVOL, V23, P499, DOI 10.1016/S1055-7903(02)00034-9; IUCN, 2012, IUCN RED LIST CATEGO, V2nd; Johansson US, 2002, AUK, V119, P984, DOI 10.1642/0004-8038(2002)119[0984:BPOTTB]2.0.CO;2; Johnson N. K., 1999, P INT ORNITHOLOGICAL, P1470; Krabbe Niels, 1997, Ornithological Monographs, V48, P47; Krabbe NK., 2003, BROADBILLS TAPACULOS; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Lynch John D., 1999, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V23, P143; Renjifo LM, 2001, ECOL APPL, V11, P14, DOI 10.1890/1051-0761(2001)011[0014:EONAAL]2.0.CO;2; RENJIFO LM, 1999, THESIS U MISSOURI ST; Ridgely RS, 1994, BIRDS S AM, V2; RIDGWAY R, 1911, B US NATL MUSEUM, V50; Robinson WD, 2000, ECOL MONOGR, V70, P209, DOI 10.1890/0012-9615(2000)070[0209:FBCSIC]2.0.CO;2; Santa E., 1993, COLONIZACION ANTIOQU; Smithe F.B., 1975, NATURALISTS COLOR GU; Vielliard J., 1990, ARARAJUBA, V1, P5; Voss RS, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)373<0001:ANGFAF>2.0.CO;2; Warren BH, 2003, MOL PHYLOGENET EVOL, V29, P67, DOI 10.1016/S1055-7903(03)00063-0; WHITNEY BM, 1994, WILSON BULL, V106, P585; WILLIS EO, 1974, ECOL MONOGR, V44, P153, DOI 10.2307/1942309; Witte H., 1990, STUDIES TROPICAL AND, V4, P279; ZIMMER JOHN T., 1939, AMER MUS NOVITATES, V1044, P1	44	41	47	0	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0004-8038	1938-4254		AUK	AUK	APR	2005	122	2					445	463		10.1642/0004-8038(2005)122[0445:SSANSO]2.0.CO;2	http://dx.doi.org/10.1642/0004-8038(2005)122[0445:SSANSO]2.0.CO;2			19	Ornithology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	924UI					2022-09-04	WOS:000229005600005
J	de Vries, E; Arenas, FAL; van der Heide, A; Rueda, FEG; Murillo, R; Morales, O; Diaz-Amado, E; Rodriguez, N; Gonzalez, BJ; Delgado, DSC; Calvache, JA				de Vries, Esther; Leal Arenas, Fabian Alexander; van der Heide, Agnes; Gempeler Rueda, Fritz E.; Murillo, Raul; Morales, Olga; Diaz-Amado, Eduardo; Rodriguez, Nelcy; Juliana Gonzalez, Beatriz; Castilblanco Delgado, Danny Steven; Calvache, Jose A.			Medical decisions concerning the end of life for cancer patients in three Colombian hospitals - a survey study	BMC PALLIATIVE CARE			English	Article						End of life; Palliative care; Decision making; Medical decision; Colombia; Cancer; Euthanasia; Palliative sedation	PHYSICIAN-ASSISTED SUICIDE; PALLIATIVE CARE; EUTHANASIA; NETHERLANDS	Background Cancer patients' end-of-life care may involve complex decision-making processes. Colombia has legislation regarding provision of and access to palliative care and is the only Latin American country with regulation regarding euthanasia. We describe medical end-of-life decision-making practices among cancer patients in three Colombian hospitals. Methods Cancer patients who were at the end-of-life and attended in participating hospitals were identified. When these patients deceased, their attending physician was invited to participate. Attending physicians of 261 cancer patients (out of 348 identified) accepted the invitation and answered a questionnaire regarding end-of-life decisions: a.) decisions regarding the withdrawal or withholding of potentially life-prolonging medical treatments, b.) intensifying measures to alleviate pain or other symptoms with hastening of death as a potential side effect, and c.) the administration, supply or prescription of drugs with an explicit intention to hasten death. For each question addressing the first two decision types, we asked if the decision was fully or partially made with the intention or consideration that it may hasten the patient's death. Results Decisions to withdraw potentially life-prolonging treatment were made for 112 (43%) patients, 16 of them (14%) with an intention to hasten death. For 198 patients (76%) there had been some decision to not initiate potentially life-prolonging treatment. Twenty-three percent of patients received palliative sedation, 97% of all patients received opioids. Six patients (2%) explicitly requested to actively hasten their death, for two of them their wish was fulfilled. In another six patients, medications were used with the explicit intention to hasten death without their explicit request. In 44% (n = 114) of all cases, physicians did not know if their patient had any advance care directives, 26% (n = 38) of physicians had spoken to the patient regarding the possibility of certain treatment decisions to hasten death where this applied. Conclusions Decisions concerning the end of life were common for patients with cancer in three Colombian hospitals, including euthanasia and palliative sedation. Physicians and patients often fail to communicate about advance care directives and potentially life-shortening effects of treatment decisions. Specific end-of-life procedures, patients' wishes, and availability of palliative care should be further investigated.	[de Vries, Esther; Rodriguez, Nelcy] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Cra 7 40-62 Edificio Hosp San Ignacio,Piso 2, Bogota, Colombia; [Leal Arenas, Fabian Alexander; Castilblanco Delgado, Danny Steven] Inst Nacl Cancerol, Cl 1 9-85, Bogota, Colombia; [Leal Arenas, Fabian Alexander; Murillo, Raul; Morales, Olga; Juliana Gonzalez, Beatriz] Hosp Univ San Ignacio, Ctr Javeriano Oncol, Carrera 7a 40-62 Edificio Santacoloma 30, Bogota, Colombia; [van der Heide, Agnes] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Gempeler Rueda, Fritz E.] Pontificia Univ Javeriana, Anesthesiol Dept, Cra 7 40-62 Edificio Hosp San Ignacio, Bogota, Colombia; [Gempeler Rueda, Fritz E.] Hosp Univ San Ignacio, Clin Eth Serv, Cra 7 40-62, Bogota, Colombia; [Murillo, Raul] Pontificia Univ Javeriana, Dept Internal Med, Cra 7 40-62 Edificio Hosp San Ignacio, Bogota, Colombia; [Diaz-Amado, Eduardo] Pontificia Univ Javeriana, Inst Bioet, Tv 4 42, Bogota, Colombia; [Castilblanco Delgado, Danny Steven] Univ Mil Nueva Granada, Carrera 11 101-80, Bogota, Colombia; [Calvache, Jose A.] Univ Cauca, Dept Anesthesiol, Cl 5 4-70, Popayan, Cauca, Colombia; [Calvache, Jose A.] Erasmus MC Univ Med Ctr Rotterdam, Dept Anesthesiol, POB 2040, NL-3000 CA Rotterdam, Netherlands		de Vries, E (corresponding author), Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Cra 7 40-62 Edificio Hosp San Ignacio,Piso 2, Bogota, Colombia.	estherdevries@javeriana.edu.co	de Vries, Esther/A-6603-2009; Calvache, Jose Andres/V-7932-2019	de Vries, Esther/0000-0002-5560-2258; Calvache, Jose Andres/0000-0001-9421-3717; Gempeler Rueda, Fritz Eduardo/0000-0002-6036-9155	 [7772017]		This study was financed by Minciencias, in the framework of the "7772017 Convocatoria para proyectos de ciencia, tecnologia e innovacion en Salud 2017", project CT-826-2018 -Decisiones medicas al final de la vida en pacientes oncologicos en Colombia". Minciencias (Colombian government research funding body) had no role in the design of the study, the collection, analysis, and interpretation of data nor in writing the manuscript.	Anquinet L, 2012, J PAIN SYMPTOM MANAG, V44, P33, DOI 10.1016/j.jpainsymman.2011.07.007; Armstrong MH, 2014, MAYO CLIN PROC, V89, P1599, DOI 10.1016/j.mayocp.2014.08.017; Beernaert K, 2018, PATIENT EDUC COUNS, V101, P132, DOI 10.1016/j.pec.2017.06.034; Bergenholtz H, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0448-z; Bodas M, 2020, ISR J HEALTH POLICY, V9, DOI 10.1186/s13584-020-00419-9; Bolívar Góez Piedad Lucía, 2016, rev.latinoam.bioet., V16, P128, DOI 10.18359/rlbi.1444; Calvache JA, 2021, BMC PALLIAT CARE, V20, P140, DOI 10.1186/s12904-021-00823-1; Calvache José A., 2020, Rev. colomb. anestesiol., V48, pe201, DOI 10.1097/cj9.0000000000000159; CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Correa L., 2021, 2 SOC CULT DESCKAB B; Cuadrado DM., 2010, TRATAMIENTOS NO PROP; de Arruda LM, 2020, EINSTEIN-SAO PAULO, V18, DOI [10.31744/einstein_journal/2020RW4852, 10.31744/einstein_journal/2020rw4852]; de Vries E, 2018, J Cancer Policy, V15, P104, DOI 10.1016/j.jcpo.2018.01.003; Emanuel E, 2017, MED J AUSTRALIA, V206, DOI 10.5694/mja16.00132; Emanuel EJ, 2016, JAMA-J AM MED ASSOC, V316, P79, DOI 10.1001/jama.2016.8499; Gaviria Uribe A, 2015, PROTOCOLO APLICACION; Gempeler Rueda Fritz Eduardo, 2021, Univ. Med., V62, P13, DOI 10.11144/javeriana.umed62-1.imnp; Rueda FEG, 2018, UNIV MED, V59, DOI 10.11144/Javeriana.umed59-2.rean; He YJ, 2021, INT J ENV RES PUB HE, V18, P417, DOI 10.3390/ijerph18020417; Lopez Benavides L. L., 2018, FORENSIC RES CRIMINO, V6, P426, DOI DOI 10.15406/FRCIJ.2018.06.00239; Luna Meza A., 2020, TOMA DECISIONES PR C; Luna-Meza A, 2021, BMC PALLIAT CARE, V20, P76, DOI 10.1186/s12904-021-00768-5; Marinho FM, 2013, LANCET, V381, P89; Medina Rico MA., 2021, DESEOS FINAL VIDA PA; Nappa U, 2011, ANN ONCOL, V22, P2375, DOI 10.1093/annonc/mdq778; Pastrana T, 2013, CURR OPIN SUPPORT PA, V7, P411, DOI 10.1097/SPC.0000000000000008; Pereira I., 2018, 5 BOG CTR STUD LAW J; R Core Team, 2021, R LANG ENV STAT COMP; Radbruch L, 2016, PALLIATIVE MED, V30, P104, DOI 10.1177/0269216315616524; Rich E R, 1997, J N Y State Nurses Assoc, V28, P8; Rietjens JAC, 2012, SOC SCI MED, V74, P1282, DOI 10.1016/j.socscimed.2011.12.046; Sarmiento-Medina María I, 2012, Rev. salud pública, V14, P116; Sharma RK, 2019, J PAIN SYMPTOM MANAG, V58, P216, DOI 10.1016/j.jpainsymman.2019.05.002; Soto-Perez-de-Celis E, 2017, J GLOB ONCOL, V3, P261, DOI 10.1200/JGO.2016.005579; Valdivieso J., 2020, ANAL FACTORS ASS DEA; Van der Heide A., 2010, EUTHANASIE ANDERE ME; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143; Portilla MV, 2021, UNIV MED, V62, DOI 10.11144/Javeriana.umed62-1.euta	39	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-684X			BMC PALLIAT CARE	BMC Palliat. Care	OCT 18	2021	20	1							161	10.1186/s12904-021-00853-9	http://dx.doi.org/10.1186/s12904-021-00853-9			12	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	WH7EU	34657613	Green Published, Green Submitted, gold			2022-09-04	WOS:000707836800002
J	van Loggerenberg, F; McGrath, M; Akena, D; Birabwa-Oketcho, H; Mendez, CAC; Gomez-Restrepo, C; Kulenovic, AD; Muhic, M; Sewankambo, NK; Sikira, H; Priebe, S				van Loggerenberg, Francois; McGrath, Michael; Akena, Dickens; Birabwa-Oketcho, Harriet; Mendez, Camilo Andres Cabarique; Gomez-Restrepo, Carlos; Kulenovic, Alma Dzubur; Muhic, Maja; Sewankambo, Nelson K.; Sikira, Hana; Priebe, Stefan			Feasibility, experiences and outcomes of using DIALOG plus in primary care to improve quality of life and mental distress of patients with chronic conditions: an exploratory non-controlled trial in Bosnia and Herzegovina, Colombia and Uganda	PILOT AND FEASIBILITY STUDIES			English	Article						Global mental health; Primary care; Psychosocial interventions; Resource-oriented approach; LMICs; Solution-focused; Quality of life; DIALOG	SOUTH-AFRICA; HEALTH-CARE; DEPRESSION; ANXIETY; MULTIMORBIDITY; SYMPTOMS; ILLNESS; SF-36	Background: DIALOG+ is a resource-oriented and evidence-based intervention to improve quality of life and reduce mental distress. While it has been extensively studied in mental health care, there is little evidence for how to use it in primary care settings for patients with chronic physical conditions. Considering that DIALOG+ is used in existing routine patient-clinician meetings and is very low cost, it may have the potential to help large numbers of patients with chronic physical conditions, mental distress and poor quality of life who are treated in primary care. This is particularly relevant in low- and middle-income countries (LMICs) where resources for specialised services for such patients are scarce or non-existent. Methods: An exploratory non-controlled trial will be conducted to primarily assess the feasibility and acceptability and, secondarily, outcomes of delivering DIALOG+ to patients with chronic physical conditions and poor quality of life in primary care settings in Bosnia and Herzegovina, Colombia and Uganda. Thirty patients in each country will receive DIALOG+ up to three times in monthly meetings over a 3-month period. Feasibility will be assessed by determining the extent to which the intervention is implemented as planned. Experiences will be captured in interviews and focus groups with care providers and participants to understand acceptability. Quality of life, symptoms of anxiety and depression, objective social situation and health status will be assessed at baseline and again after the three-session intervention. Discussion: This study will inform our understanding of the extent to which DIALOG+ may be used in the routine care of patients with chronic physical conditions in different primary care settings. The findings of this exploratory trial can inform the design of future full randomised controlled trials of DIALOG+ in primary care settings in LMICs.	[van Loggerenberg, Francois; McGrath, Michael] Queen Mary Univ London, Unit Social & Community Psychiat, London, England; [Akena, Dickens; Priebe, Stefan] Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda; [Birabwa-Oketcho, Harriet] Butabika Natl Referral Mental Hosp, Kampala, Uganda; [Mendez, Camilo Andres Cabarique; Gomez-Restrepo, Carlos] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Gomez-Restrepo, Carlos] Pontificia Univ Javeriana, Dept Psychiat & Mental Hlth, Bogota, Colombia; [Gomez-Restrepo, Carlos] Hosp Univ San Ignacio, Bogota, Colombia; [Kulenovic, Alma Dzubur; Muhic, Maja; Sikira, Hana] Univ Sarajevo, Clin Ctr, Sarajevo, Bosnia & Herceg; [Sewankambo, Nelson K.] Makerere Univ, Dept Internal Med, Coll Hlth Sci, Kampala, Uganda		van Loggerenberg, F (corresponding author), Queen Mary Univ London, Unit Social & Community Psychiat, London, England.	f.vanloggerenberg@qmul.ac.uk	McGrath, Michael/ABD-1704-2021	McGrath, Michael/0000-0003-0465-176X; Dzubur Kulenovic, Alma/0000-0002-1883-7111; Gomez-Restrepo, Carlos/0000-0002-9013-5384; Birabwa-Oketcho, Harriet/0000-0003-1145-8669; van Loggerenberg, Francois/0000-0001-5317-7983	National Institute for Health Research (NIHR); UK Government [16/137/97]	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Government	This research is funded by the National Institute for Health Research (NIHR), The NIHR Global Health Group on developing psychosocial interventions (ref. 16/137/97) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care. The NIHR had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results.	Andersen L, 2015, AIDS CARE, V27, P59, DOI 10.1080/09540121.2014.951306; [Anonymous], 2012, LONG TERM CONDITIONS; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss Elizabeth A, 2005, Health Qual Life Outcomes, V3, P51; Cam L., 1986, STAT SCI, V1, P78, DOI DOI 10.1214/ss/1177013818; CASSILETH BR, 1984, NEW ENGL J MED, V311, P506, DOI 10.1056/NEJM198408233110805; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Daar AS, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24589; Dobson C., 2008, CONDUCTING RES PEOPL; Docrat S, 2019, HEALTH POLICY PLANN, V34, P706, DOI 10.1093/heapol/czz085; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Jack H, 2014, GLOBAL HEALTH ACTION, V7, P137, DOI 10.3402/gha.v7.23431; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; Kagee A, 2010, AIDS CARE, V22, P159, DOI 10.1080/09540120903111445; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lund C, 2012, AFR J PSYCHIATRY, V15, P402, DOI [10.4314/ajpsy.v15i6.48, http://dx.doi.org/10.4314/ajpsy.v15i6.48]; Ministry of Health Health Systems 20/20 and Makerere University School of Public Health, 2012, UG HLTH SYST ASS 201; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Ngo VK, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001443; Noel PH, 2004, ANN FAM MED, V2, P555, DOI 10.1370/afm.143; Omer S, 2016, EXPLORING MECH PATIE; Patel V, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4516; Patel V, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001448; Patel V, 2009, INT J PUBLIC HEALTH, V54, P1, DOI 10.1007/s00038-009-0016-z; Petersen I, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2081-z; Petersen I, 2017, HEALTH POLICY PLANN, V32, P699, DOI 10.1093/heapol/czx014; Petersen I, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-8; POLITICA DE ATENCION INTEGRAL EN SALUD Ministerio de Salud y Proteccion Social, 2016, REPCI DIG MINS RID; Priebe S, 2008, ACTA PSYCHIAT SCAND, V118, P57, DOI 10.1111/j.1600-0447.2008.01217.x; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Priebe S, 2007, BRIT J PSYCHIAT, V191, P420, DOI 10.1192/bjp.bp.107.036939; Priebe S, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2148-x; Priebe S, 2015, PSYCHOTHER PSYCHOSOM, V84, P304, DOI 10.1159/000430991; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Ramírez-Vélez Robinson, 2010, Rev. salud pública, V12, P807; Ramírez-Vélez Róbinson, 2008, Rev. salud pública, V10, P529; Shin C, 2019, PSYCHIAT INVEST, V16, P300, DOI 10.30773/pi.2019.02.01; Strine TW, 2004, PSYCHIAT SERV, V55, P1408, DOI 10.1176/appi.ps.55.12.1408; Thabane L, 2019, PILOT FEASIBILITY ST, V5, DOI 10.1186/s40814-019-0423-8; Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, APPR MENT HLTH CAR R	45	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2055-5784		PILOT FEASIBILITY ST	Pilot Feasibility Stud.	SEP 30	2021	7	1							180	10.1186/s40814-021-00914-z	http://dx.doi.org/10.1186/s40814-021-00914-z			10	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	UZ7LQ	34593055	Green Published, gold, Green Submitted			2022-09-04	WOS:000702383700001
J	Rojas, MR; Ceballos, EC; Bermudez-Jaimes, ME; Blanco, OAC; Sanchez, JE; Jimenez, JC; Moreno, MR				Rojas, Monica Reyes; Ceballos, Elda Cerchiaro; Bermudez-Jaimes, Milton E.; Blanco, Olga Alicia Carbonell; Sanchez, Jose Eduardo; Jimenez, Jackeline Cantor; Moreno, Monica Roncancio			Resilience factors and familiar well-being in Colombian families	INTERDISCIPLINARIA			Spanish	Article						family resilience; family well-being; family functioning; family relationships; family stress; social support	PARENTAL STRESS; HEALTH; CHILD; SUPPORT	Currently, modern families are coping with different stressful situations. The family studies are focused on the conceptual perspective, political perspective and methodological topic and they leave aside the familiar dynamics and functioning. This paper was interested in describing and comparing indicators of family resilience and family welfare of 442 Colombian families. This study had three hypotheses: The first one is focused on differences in well-being family dimension per location; the second hypothesis was focused on significant differences in family resilience per location, and the third one was interested in significant relations in family resilience and family well-being. The theoretical support to this research is the McCubbin and Patterson's resilience model called Double ABCX and Family Adaptation and Adjust Response Model by Patterson. The family well-being is considered a result of internal family functioning and is measured by the family member perception about the concern about health problems, fears, anger and sadness. Family resilience is understood as the capacity to recover from adversity. This capacity strengthens families and improves their resources. In this theoretic resilience approach the resilience is a dynamic result to the adaptation phase and the family well-being is the final adjustment. The design was cross-sectional analytical with a convenience sample. The families were interviewed in their homes, from each family both parents and a child between 9 and 17 years old participated. They are located geographically in Bogota (n = 196), Santa Marta (n = 81) and Cali-Palmira (n = 145). Families completed the Family Member Wellbeing Index (FMWB) and the Family Regeneration and Adaptation Index (FIRA-G) to assess resilience. Families residing in Bogota showed significant differences with those of Cali-Palmira in the dimension of family wellbeing, family stress and support from friends and family. While families located in Santa Marta showed differences with respect to the families located in Cali-Palmira in family stress and in community and social support. The father correlations between the family resilience index and the well-being family index is strong and inverse with the family stress and the family well-being summarized. The mother well-being family perception is significant associated with family resilience, and these correlations was strongest with family well-being summarized. The family stress index, strains and distress exposed moderate and inverse relations with the posi-tive resilience family summarized. The discussion deals with family resilience as a product of the dynamic interaction in the hole family system and is oriented to the fact that the presence of support from family and friends reduces the burden of family stress, promotes support in the face of crisis and, in general, improves the well-being and family adaptation. In general, the differences reflect varied resilience trajectories that depend on the challenges posed by the close context of the city where they live. An approach to this result leads us to think as a hypothesis not yet widely explored, in the mobility factor of cities, which limits contact with close family networks. In big cities like Bogota, its internal mobility compromises the times and spaces of daily life, and thus allows or prevents fami-lies from organizing their relationships in the different areas of their social life. Resil-ience occurs through positive adaptive family resources that included social support and family coherence and allow families to reduce stress and meet the demands of the environ-ment. On the other hand, the presence of the two parents in families without clinical indi-cators shows that the burden of shared stress helps family resilience, which is also fed by the presence of external aids to the family nucleus, such as the support of the commu-and friends.	[Rojas, Monica Reyes] Univ Magdalena, Fac Ciencias Salud, Psicol Clin & Terapia Familiar, Santa Marta, Colombia; [Ceballos, Elda Cerchiaro] Univ Magdalena, Fac Ciencias Salud, Psicol, Santa Marta, Colombia; [Bermudez-Jaimes, Milton E.] Pontificia Univ Javeriana, Psicol, Bogota, Colombia; [Blanco, Olga Alicia Carbonell] Pontif Univ Javeriana, Univ Purdue EE UU, Desarrollo Infantil & Etudios, Bogota, Colombia; [Sanchez, Jose Eduardo] Univ Valle, Psicol, Cali, Colombia; [Sanchez, Jose Eduardo] Univ ICESI, ICESI, Psicol, Cali, Colombia; [Jimenez, Jackeline Cantor] Univ ICESI, Psicol, Cali, Colombia; [Moreno, Monica Roncancio] Univ Pontificia Bolivariana, Procesos Desarrollo Humano & Salud, Palmira, Colombia; Univ Javeriana, Bogota, Colombia; Univ ICESI, Cali, Colombia; Univ Pontificia Bolivariana, Palmira, Colombia; Univ Magdalena, Santa Marta, Colombia		Rojas, MR (corresponding author), Univ Magdalena, Fac Ciencias Salud, Psicol Clin & Terapia Familiar, Santa Marta, Colombia.	mreyesr@unimagdalena.edu.co; ecerchiaro@unimagdalena.edu.co; milton.bermudez@javeriana.edu.co; carbonel@javeriana.edu.co; jesanchez@icesi.edu.co; jcantor@icesi.edu.co; monica.roncancio@upb.edu.co						Amar J. A., 2014, DESPLAZAMIENTO CLIMA; Arribillaga A., 2016, QUE RESILIENCIA QUE; Baron J. D., 2010, DOCUMENTOS TRABAJO E, V128; Becvar D. S., 2013, HDB FAMILY RESILIENC, DOI [10.1007/978-1-4614-3917-2, DOI 10.1007/978-1-4614-3917-2]; Belzak W.C.M., 2017, HAPPY MIND COGNITIVE, P117, DOI [10.1007/978-3-319-58763-9_7, DOI 10.1007/978-3-319-58763-9_7, DOI 10.1007/978-3-319-58763]; Bermudez JM., 2013, HDB FAMILY RESILIENC, P215, DOI [10.1007/978-1-4614-3917-2_13, DOI 10.1007/978-1-4614-3917-2_13]; Bermudez-Jaimes M., PSYCHOL MENTAL HLTH; Bermudez-Jaimes M. E., 2018, CONSTRUCCION MODELO; Bermudez-Jaimes M. E., 2014, THESIS U LOS ANDES B; Bernal E. C., 2009, THESIS U NEBRASKA NE; BIBOUNIKOU I, 2004, CLIN CHILD PSYCHOL P, V9, P309; Black K, 2008, J FAM NURS, V14, P33, DOI 10.1177/1074840707312237; Brito Pacheco K., 2019, THESIS U COOPERATIVA; Campos B, 2016, J SOC PERS RELAT, V33, P81, DOI 10.1177/0265407514562564; Cardoso JB, 2010, FAM SOC, V91, P257, DOI 10.1606/1044-3894.4003; Rusinque AAC, 2017, INTERDISCIPLINARIA, V34, P235; Corona K, 2017, HISPANIC J BEHAV SCI, V39, P46, DOI 10.1177/0739986316671297; Covarrubias Ortiz E., 2014, REV RUMBOS TS ESPACI, P46; Cruz A., 2017, THESIS U JAVERIANA B; Cummings E.M., 2010, ROLE FATHER CHILD DE, V5th ed., P154, DOI DOI 10.1007/978-1-4613-9820-2_7; de Andrade Seidl Marisol Lurdes, 2011, Divers.: Perspect. Psicol., V7, P43; Dominguez L., 2016, THESIS I HUELVA ESPA; Durtschi JA, 2017, J MARITAL FAM THER, V43, P308, DOI 10.1111/jmft.12194; Araoz EGE, 2020, APUNT UNIV, V10, P56, DOI 10.17162/au.v10i4.491; Fernandez J., 2012, REV ATLANTIDA, V4, P91; Martinez CF, 2015, REV ESTUD SOC, P52, DOI 10.7440/res54.2015.04; Frishman N, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0612-1; Golombok S., 2016, FAMILIAS MODERNAS PA; Hantrais L, 2020, CONTEMP SOC SCI, V15, P275, DOI 10.1080/21582041.2018.1519195; Harrist A. W., 2019, APA HDB PSYCHOL R AP, P223, DOI DOI 10.1037/0000099-013; Hernandez-Sampieri R., 2018, METODOLOGIA INVESTIG, V4; Herscovici Raush C., 2011, CULTURA EDUCACION SO, V2, P105, DOI [10.1159/000353263, DOI 10.1159/000353263]; Jiménez Arrieta Myriam, 2012, Salud, Barranquilla, V28, P99; Jimenez-Picon N, 2019, AN SIST SANIT NAVAR, V42, P121, DOI [10.23938/ASSN.0589, 10.23938/assn.0589]; Kotliarenco M. A., 2010, REV PSICOLOGIA, V19, P103, DOI DOI 10.5354/RDP.V19I2.17112; Lee CYS, 2018, J ADULT DEV, V25, P25, DOI 10.1007/s10804-017-9271-z; Lin WH, 2019, YOUTH SOC, V51, P680, DOI 10.1177/0044118X17704865; MADARIAGA J. M., 2014, NUEVAS MIRADAS RESIL; Madariaga J. M., 2014, NUEVAS MIRADAS RESIL, P5; Martinez S., 2018, THESIS U ARGENTINA E; Masten AS, 2018, J FAM THEOR REV, V10, P12, DOI 10.1111/jftr.12255; Masten Ann S., 2016, DEV PSYCHOPATHOLOGY, P271, DOI [10.1002/9781119125556.devpsy406, DOI 10.1002/9781119125556.DEVPSY406]; Mayordomo Teresa, 2016, Pensam. psicol., V14, P101, DOI 10.11144/Javerianacali.PPSI14-2.bpfe; McCubbin H., 1983, MARRIAGE FAM REV, V6, P7, DOI [10.1300/J002v06n01_02, DOI 10.1300/J002V06N01_02]; MCCUBBIN H, 1991, FWBI FAMILY MEMBER W, P337; McCubbin H. I., 1991, FAMILY ASSESSMENT IN, P295; McCubbin LD, 2013, HDB FAMILY RESILIENC, P175, DOI [10.1007/978-1-4614-3917-2_11, DOI 10.1007/978-1-4614-3917-2_11]; McCubbin M, 2002, FAM RELAT, V51, P103, DOI 10.1111/j.1741-3729.2002.00103.x; Mendez-Luck CA, 2016, J MARRIAGE FAM, V78, P813, DOI 10.1111/jomf.12300; Moreno Carmona Norman Darío, 2013, Psicol. caribe, V30, P177; Nichols W., 2013, HARVARD BUS REV, P1; Observatorio de Politicas de las Familias-OPF, 2016, 20161 OPF; Olson DH, 2000, J FAM THER, V22, P144, DOI 10.1111/1467-6427.00144; Omar A, 2007, PSICODEBATE-PSICOL C, V7, P141, DOI 10.18682/pd.v7i0.432; Ospina-Gomez Y, 2019, INTERDISCIPLINARIA, V36, P171; Patterson JM, 2002, J MARRIAGE FAM, V64, P349, DOI 10.1111/j.1741-3737.2002.00349.x; Pereira R, 2010, SISTEMAS FAMILIARES, V26, P93; Puyana Villamizar Yolanda, 2005, Rev.latinoam.cienc.soc.niñez juv, V3, P111; Reyes-Rojas M, 2021, REV COLOMB CIENC SOC, V12, P50, DOI 10.21501/22161201.3335; Reyes-Rojas M, 2019, DUAZARY, V16, P149; Rodríguez-Fernández Arantzazu, 2016, Suma Psicol., V23, P60, DOI 10.1016/j.sumpsi.2016.02.002; Ryff CD, 2014, PSYCHOTHER PSYCHOSOM, V83, P10, DOI 10.1159/000353263; Saloviita T, 2003, J INTELL DISABIL RES, V47, P300, DOI 10.1046/j.1365-2788.2003.00492.x; Silva I., 2020, ESTUDOS PSICOLOGIA C, V38, DOI [10.1590/1982-0275202138-190116, DOI 10.1590/1982-0275202138-190116]; Theiss JA, 2018, J APPL COMMUN RES, V46, P10, DOI 10.1080/00909882.2018.1426706; Umberson D, 2010, ANNU REV SOCIOL, V36, P139, DOI 10.1146/annurev-soc-070308-120011; Ungar M, 2016, J MARITAL FAM THER, V42, P19, DOI 10.1111/jmft.12124; Venegas Luque R., 2020, VICTIMAS CONFLICTO A; Villarreal R, 2005, HISPANIC J BEHAV SCI, V27, P409, DOI 10.1177/0739986305281125; Villavicencio-Colon M., 2020, THESIS U PUERTO RICO; Waldfogel J, 2010, FUTURE CHILD, V20, P87; Walsh F., STRENGTHENING FAMILY, V3rd; Walsh F., 2005, SISTEMAS FAMILIARES, V21, P76; Walsh F, 2016, EUR J DEV PSYCHOL, V13, P313, DOI 10.1080/17405629.2016.1154035; Wang M, 2019, ASIA PAC J SOC WORK, V29, P249, DOI 10.1080/02185385.2019.1616213; Zapata Arias A., 2018, THESIS U SANTIAGO CA	76	0	0	9	11	CENTRO INTERAMERICANO INVESTIGACIONES PSICOLOGICAS Y CIENCIAS AFINES-CIIPCA	BUENOS AIRES	TTE GRAL J D PERON 2158, BUENOS AIRES, 00000, ARGENTINA	1668-7027			INTERDISCIPLINARIA	Interdisciplinaria	SEP-DEC	2021	38	3					117	138		10.16888/interd.2021.38.3.7	http://dx.doi.org/10.16888/interd.2021.38.3.7			22	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	UR8WE		gold			2022-09-04	WOS:000697021500006
J	Vinck, EE; Angel, EP; Barrios, RV; Martinez, SI; Arias, CA; Garzon, JC; Ebels, T; Alzate, SA; Fernandez, A				Vinck, Eric E.; angel, Eduardo Posada; V. Barrios, Rodolfo; Martinez, Stella I.; Arias, Carlos A.; Garzon, Juan C.; Ebels, Tjark; Alzate, Sergio A.; Fernandez, Alexander			Video-Assisted Thoracoscopy For Penetrating Cardiac Box Injury in Stable Patients	BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY			English	Review						Wounds; Gunshot; Trauma Centers; Thoracic Injuries; Wounds; Penetraing; Pericardial Window Techniques; Data Management	PERICARDIAL-EFFUSION; DIAGNOSIS; SURGERY; TRAUMA; MANAGEMENT; TAMPONADE; ECHOCARDIOGRAPHY; ASSOCIATION	Introduction: In high-volume trauma centers, especially in developing countries, penetrating cardiac box injuries are frequent. Although many aspects of penetrating chest injuries have been well established, video-assisted thoracoscopy is still finding its place in cardiac box trauma and algorithmic approaches are still lacking. The purpose of this manuscript is to provide a streamlined recommendation for penetrating cardiac box injury in stable patients. Methods: Literature review was carried out using PubMed/ MEDLINE and Google Scholar databases to identify articles describing the characteristics and concepts of penetrating cardiac box trauma, including the characteristics of tamponade, cardiac ultrasound, indications and techniques of pericardial windows and, especially, the role of video-assisted thoracoscopy in stable patients. Results: Penetrating cardiac box injuries, whether by stab or gunshot wounds, require rapid surgical consultation. Unstable patients require immediate open surgery, however, determining which stable patients should be taken to thoracoscopic surgery is still controversial. Here, the classification of penetrating cardiac box injury used in Colombia is detailed, as well as the algorithmic approach to these types of trauma. Conclusion: Although open surgery is mandatory in unstable patients with penetrating cardiac box injuries, a more conservative and minimally invasive approach may be undertaken in stable patients. As rapid decision-making is critical in the trauma bay, surgeons working in high-volume trauma centers should expose themselves to thoracoscopy and always consider this possibility in the setting of penetrating cardiac box injuries in stable patients, always in the context of an experienced trauma team.	[Vinck, Eric E.] Pontifical Bolivarian Univ, Cardio VID Clin, Dept Cardiovasc Surg, Medellin, Colombia; [angel, Eduardo Posada] Pontificia Univ Javeriana, Dept Surg, Bogota, Colombia; [V. Barrios, Rodolfo; Martinez, Stella I.; Fernandez, Alexander] El Bosque Univ, Dept Thorac Surg, Bogota, Colombia; [Arias, Carlos A.] Cent Mil Hosp, Dept Cardiovasc Surg, Bogota, Colombia; [Garzon, Juan C.] Fdn Cardioinfantil, Dept Thorac Surg, Bogota, Colombia; [Ebels, Tjark] Univ Med Ctr Groningen, Dept Cardiothorac Surg, Groningen, Netherlands; [Alzate, Sergio A.] Fdn Clin Shaio, Dept Cardiovasc Surg, Bogota, Colombia		Vinck, EE (corresponding author), Cl 78b 75-21, Medellin, Colombia.	evinck518@gmail.com						Adler Y, 2015, EUR HEART J, V36, P2921, DOI 10.1093/eurheartj/ehv318; Agrawal A, 2018, ANN AM THORAC SOC, V15, P637, DOI 10.1513/AnnalsATS.201709-739CC; Altman E, 2015, ANN ROY COLL SURG, V97, P375, DOI 10.1308/003588415X14181254789925; Ancion A, 2018, Rev Med Liege, V73, P277; Anderson JE, 2016, J TRAUMA ACUTE CARE, V81, P1035, DOI 10.1097/TA.0000000000001173; Andrade-Alegre R, 2015, ANN THORAC SURG, V99, pE115, DOI 10.1016/j.athoracsur.2015.02.004; Argula RG, 2015, CLIN CARDIOL, V38, P139, DOI 10.1002/clc.22370; Ariyarajah V, 2007, TEX HEART I J, V34, P347; Barrios RV, 2013, J TRAUMA TREAT, V2, P161, DOI [10.4172/2167-1222.1000161, DOI 10.4172/2167-1222.1000161]; Beck CS, 1935, J AMER MED ASSOC, V104, P714, DOI 10.1001/jama.1935.02760090018005; Bruch C, 2001, J AM COLL CARDIOL, V38, P219, DOI 10.1016/S0735-1097(01)01313-4; Correa Marin Jessica, 2016, J Vis Surg, V2, P110, DOI 10.21037/jovs.2016.06.06; Franco A, 2005, C COL CIR TOR AS COL; Garcia, 2019, REV COLOMB CIRUGIA, V34, P16; Goodman Adam, 2012, J Emerg Trauma Shock, V5, P72, DOI 10.4103/0974-2700.93118; Goodman Michael, 2013, J Emerg Trauma Shock, V6, P106, DOI 10.4103/0974-2700.110757; He Jianxing, 2011, J Thorac Dis, V3, P115, DOI 10.3978/j.issn.2072-1439.2010.03.01; Honasoge AP, 2018, EMERG MED CLIN N AM, V36, P557, DOI 10.1016/j.emc.2018.04.004; Isaza-Restrepo A, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0138-1; IVATURY RR, 1987, ANN SURG, V205, P61, DOI 10.1097/00000658-198701000-00011; Kang N, 2009, INJURY, V40, P919, DOI 10.1016/j.injury.2008.12.008; Karmy-Jones R, 2014, J TRAUMA ACUTE CARE, V77, P994, DOI 10.1097/TA.0000000000000426; Katlic MR, 2018, J AM COLL SURGEONS, V226, P58, DOI 10.1016/j.jamcollsurg.2017.09.017; Langdon SE, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0466-3; Larrey D. J., 1829, CLIN CHIR, V36, P303; Liberman M, 2005, ARCH SURG-CHICAGO, V140, P191, DOI 10.1001/archsurg.140.2.191; Mandavia DP, 2001, ANN EMERG MED, V38, P377, DOI 10.1067/mem.2001.118224; Martinez SI, 2008, PREVENCION MANEJO CO, V2a; Navsaria PH, 2006, S AFR J SURG, V44, P18; SAADIA R, 1994, BRIT J SURG, V81, P1572, DOI 10.1002/bjs.1800811106; SAUER PE, 1967, ARCH SURG-CHICAGO, V95, P7; Scott MF, 2015, CURR TRAUMA REP, V1, P203, DOI 10.1007/s40719-015-0025-8; Vinck EE, 2018, AM J EMERG MED, V36, DOI 10.1016/j.ajem.2018.04.041; Vinck EE, 2020, J THORAC CARDIOV SUR, V159, P2347, DOI 10.1016/j.jtcvs.2019.09.079; Vinck EE, 2019, J THORAC CARDIOV SUR, V157, P2542, DOI 10.1016/j.jtcvs.2018.10.036; Weil MH, 2005, UPD INT CAR, V42, P9; Wu N, 2015, WORLD J SURG, V39, P940, DOI 10.1007/s00268-014-2900-9; Zhao Ze-Rui, 2017, J Vis Surg, V3, P108, DOI 10.21037/jovs.2017.07.05	38	2	2	0	0	SOC BRASIL CIRURGIA CARDIOVASC	SAO PAULO SP	RUA AFONSO CELSO, 1178, SAO PAULO SP, 04119-061, BRAZIL	0102-7638	1678-9741		BRAZ J CARDIOV SURG	Braz. J. Cardiovasc. Surg.		2021	36	4					550	556		10.21470/1678-9741-2020-0361	http://dx.doi.org/10.21470/1678-9741-2020-0361			7	Cardiac & Cardiovascular Systems; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Surgery	XC0HV	34236793	gold, Green Published, Green Submitted			2022-09-04	WOS:000721701200015
J	Echeverria, V; Aliev, G; Foitzick, M; Avila-Rodriguez, M; Barreto, GE				Echeverria, Valentina; Aliev, Gjumrakch; Foitzick, Madeline; Avila-Rodriguez, Marco; Barreto, George E.			Advances in Medicinal Plants with Effects on Anxiety Behavior Associated to Mental and Health Conditions	CURRENT MEDICINAL CHEMISTRY			English	Review						Herbs; anxiety; dementia; cotinine; depression; neurodegeneration	ST-JOHNS-WORT; RANDOMIZED CONTROLLED-TRIAL; LABORATORY-INDUCED STRESS; PLACEBO-CONTROLLED TRIAL; DEPRESSIVE-LIKE BEHAVIOR; OFFICINALIS LEMON BALM; GALPHIMIA-GLAUCA; GENERALIZED ANXIETY; DOUBLE-BLIND; MELISSA-OFFICINALIS	Background: Many mental health conditions including psychiatric disorders and neurodegenerative conditions are poorly responsive for actual medications or have low patient adherence to treatment due to the side effects or costs associated with these treatments. Objective: The main goal of this review is to provide clinical providers and patients with actualized information about the efficacy of selected herbal medicines for anxiety disorders derived from mental and/or health conditions, and their associated side effects. Methods: In this review, actual scientific advances about the use of medicinal plants for anxiety disorders are presented. Results: In recent years, the herbal therapies have reemerged as a source of efficacious natural treatments, at a lower cost and most of the time reduced side effects than currently prescribed pharmaceutical drugs. The herbs described mainly correspond to plants of traditional medicine from the American continent and near islands and Asia. Conclusion: Current evidence confirms the therapeutic effects of traditional medicine. Further clinical investigation is required to confirm these findings. The current understanding of the molecular mechanisms involved in psychiatric disorders, as well as the new advances in brain imaging permit a rapid and serious evaluation of anxiolytic compounds.	[Echeverria, Valentina; Foitzick, Madeline] Univ San Sebastian, Lientur 1457, Concepcion 4030000, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr 330, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Active Cpds, Chernogolovka 142432, Moscow Region, Russia; [Avila-Rodriguez, Marco; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Ctr Biomed Res, Carlos Antunez 1920, Santiago, Chile		Echeverria, V (corresponding author), Univ San Sebastian, Lientur 1457, Concepcion 4030000, Chile.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr 330, San Antonio, TX 78229 USA.	echeverria.valentina@gmail.com; aliev03@gmail.com	Aliev, Gjumrakch/K-7302-2017; Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./B-5747-2014; Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./AAD-7420-2020	Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Avila-Rodriguez, Marco/0000-0003-4612-3236	Fondecyt [1150194]; "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA; Pontificia Universidad Javeriana, Colombia; Russian Scientific Foundation [14-23-00160]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA; Pontificia Universidad Javeriana, Colombia; Russian Scientific Foundation(Russian Science Foundation (RSF))	This work was performed with resources from the University San Sebastian, Chile and the Grant Fondecyt regular 1150194 (to VE). G. Aliev work is supported by the "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA. GEB work is supported by Pontificia Universidad Javeriana, Colombia. This work partly was partly supported by the Russian Scientific Foundation (www.rscf.ru, Grant No. 14-23-00160 for 2014-2016: Directed design, synthesis, and study of biological activity of multi-target compounds as innovative drugs for treatment of neurodegenerative diseases).	Aguilar-Santamaria L, 2007, J ETHNOPHARMACOL, V109, P35, DOI 10.1016/j.jep.2006.06.013; Akhondzadeh S, 2001, J CLIN PHARM THER, V26, P369, DOI 10.1046/j.1365-2710.2001.00366.x; Akhondzadeh S, 2001, J CLIN PHARM THER, V26, P363, DOI 10.1046/j.1365-2710.2001.00367.x; Amsterdam JD, 2012, ALTERN THER HEALTH M, V18, P44; Amsterdam JD, 2009, J CLIN PSYCHOPHARM, V29, P378, DOI 10.1097/JCP.0b013e3181ac935c; Andreatini R, 2002, PHYTOTHER RES, V16, P650, DOI 10.1002/ptr.1027; Appel K, 2011, PHYTOTHER RES, V25, P838, DOI 10.1002/ptr.3352; Arushanyan E. B., 2004, Eksperimental'naya i Klinicheskaya Farmakologiya, V67, P23; Awad R, 2007, CAN J PHYSIOL PHARM, V85, P933, DOI 10.1139/Y07-083; Awad R, 2003, PHYTOMEDICINE, V10, P640, DOI 10.1078/0944-7113-00374; Baker JD, 2011, SOC STUD SCI, V41, P361, DOI 10.1177/0306312710395341; BALDERER G, 1985, PSYCHOPHARMACOLOGY, V87, P406, DOI 10.1007/BF00432503; Bencan Z, 2008, PHYSIOL BEHAV, V95, P408, DOI 10.1016/j.physbeh.2008.07.009; BENOWITZ NL, 1983, CLIN PHARMACOL THER, V34, P604, DOI 10.1038/clpt.1983.222; Boerner Reinhard J, 2004, Wien Med Wochenschr, V154, P508, DOI 10.1007/s10354-004-0115-7; BOUNTHANH C, 1981, PLANTA MED, V41, P21, DOI 10.1055/s-2007-971668; Butterweck V, 2003, CNS DRUGS, V17, P539, DOI 10.2165/00023210-200317080-00001; Cagnacci A, 2003, MATURITAS, V44, P103, DOI 10.1016/S0378-5122(02)00317-1; Cranwell-Bruce Lisa, 2008, Medsurg Nurs, V17, P52; de Aguiar RB, 2013, NEUROPHARMACOLOGY, V71, P292, DOI 10.1016/j.neuropharm.2013.03.032; Defrancesco M, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv055; Dempsey DA, 2013, CLIN PHARMACOL THER, V94, P400, DOI 10.1038/clpt.2013.114; Dimpfel W, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-126; Fu PP, 2008, J ENVIRON SCI HEAL C, V26, P89, DOI 10.1080/10590500801907407; FUXE K, 1979, PHARMACOL BIOCHEM BE, V10, P671, DOI 10.1016/0091-3057(79)90319-8; Gastpar A, 2003, PHYTOMEDICINE, V10, P631; Gonzalez-Cortazar M, 2014, PLANTA MED, V80, P90, DOI 10.1055/s-0033-1360150; Goodwin AK, 2015, NEUROTOXICOL TERATOL, V47, P25, DOI 10.1016/j.ntt.2014.10.005; Grizzell JA, 2015, NEUROCHEM RES, V40, P2032, DOI 10.1007/s11064-014-1359-2; Grizzell JA, 2014, BEHAV NEUROSCI, V128, P713, DOI 10.1037/bne0000021; Grizzell JA, 2014, BEHAV BRAIN RES, V268, P55, DOI 10.1016/j.bbr.2014.03.047; Gurley BJ, 2008, MOL NUTR FOOD RES, V52, P755, DOI 10.1002/mnfr.200600300; Gutierrez S, 2004, PHARMACOL BIOCHEM BE, V78, P57, DOI 10.1016/j.pbb.2004.02.011; Gyllenhaal C, 2000, SLEEP MED REV, V4, P229, DOI 10.1053/smrv.1999.0093; Hatsukami D, 1998, PSYCHOPHARMACOLOGY, V138, P184, DOI 10.1007/s002130050661; Hatsukami D, 1998, PSYCHOPHARMACOLOGY, V135, P141, DOI 10.1007/s002130050495; Hatsukami DK, 1997, PHARMACOL BIOCHEM BE, V57, P643, DOI 10.1016/S0091-3057(97)80001-9; Health Canada, 2002, CAN ADV REACT NEWSL; Herrera-Arellano A, 2007, PLANTA MED, V73, P713, DOI 10.1055/s-2007-981539; Herrera-Ruiz M, 2006, PHYTOMEDICINE, V13, P23, DOI 10.1016/j.phymed.2005.03.003; Herrera-Ruiz M, 2006, J NAT PROD, V69, P59, DOI 10.1021/np050305x; Herzig KE, 1998, PSYCHOPHARMACOLOGY, V135, P127, DOI 10.1007/s002130050493; Izzo AA, 2001, DRUGS, V61, P2163, DOI 10.2165/00003495-200161150-00002; Izzo AA, 2012, MED PRIN PRACT, V21, P404, DOI 10.1159/000334488; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Jacobs BP, 2005, MEDICINE, V84, P197, DOI 10.1097/01.md.0000172299.72364.95; Jimenez-Ferrer E, 2011, J ETHNOPHARMACOL, V137, P724, DOI 10.1016/j.jep.2011.06.029; Kakehashi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113610; Kennedy DO, 2002, PHARMACOL BIOCHEM BE, V72, P953, DOI 10.1016/S0091-3057(02)00777-3; Kennedy DO, 2004, PSYCHOSOM MED, V66, P607, DOI 10.1097/01.psy.0000132877.72833.71; Kennedy DO, 2006, PHYTOTHER RES, V20, P96, DOI 10.1002/ptr.1787; Kepa Ma, 2006, AWA VIEWS ETHNOBOTAN, P16; Kessler RC, 2001, AM J PSYCHIAT, V158, P289, DOI 10.1176/appi.ajp.158.2.289; Knuppel L, 2004, J CLIN PSYCHIAT, V65, P1470; KOHNEN R, 1988, PHARMACOPSYCHIATRY, V21, P447, DOI 10.1055/s-2007-1017047; Lin S, 2015, J ASIAN NAT PROD RES, V17, P455, DOI 10.1080/10286020.2015.1041933; Lin S, 2015, PLANTA MED, V81, P56, DOI 10.1055/s-0034-1383369; Linde K, 2005, BRIT J PSYCHIAT, V186, P99, DOI 10.1192/bjp.186.2.99; Maroo N, 2013, INDIAN J PHARMACOL, V45, P34, DOI 10.4103/0253-7613.106432; Mills E, 2004, J GEN INTERN MED, V19, P269, DOI 10.1111/j.1525-1497.2004.21108.x; Miroddi M, 2013, J ETHNOPHARMACOL, V150, P791, DOI 10.1016/j.jep.2013.09.047; Modabbernia A, 2013, PSYCHIAT CLIN N AM, V36, P85, DOI 10.1016/j.psc.2012.12.007; Nakajima M, 2002, DRUG METAB REV, V34, P865, DOI 10.1081/DMR-120015696; Nascimento SD, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/149468; Ngan A, 2011, PHYTOTHER RES, V25, P1153, DOI 10.1002/ptr.3400; Nierenberg AA, 1999, BIOL PSYCHIAT, V46, P1707, DOI 10.1016/S0006-3223(99)00233-4; Pakseresht S., 2011, J COMPLEMENT INTEGR, V8; Paladini AC, 1999, J PHARM PHARMACOL, V51, P519, DOI 10.1211/0022357991772790; Paladini CA, 1999, SYNAPSE, V32, P165, DOI 10.1002/(SICI)1098-2396(19990601)32:3<165::AID-SYN3>3.0.CO;2-N; Pass SE, 2004, AM J HEALTH-SYST PH, V61, P899, DOI 10.1093/ajhp/61.9.899; Pass SE, 2004, AM J HEALTH-SYST PH, V61, P913; Pittler M. H., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003383; Pittler MH, 2000, J CLIN PSYCHOPHARM, V20, P84, DOI 10.1097/00004714-200002000-00014; Pittler MH, 2001, COCHRANE DB SYST REV; PITTLER MH, 2002, COCHRANE DB SYST REV; Prieto-Gomez B, 2003, PLANTA MED, V69, P38, DOI 10.1055/s-2003-37043; Rahimi R, 2009, PROG NEURO-PSYCHOPH, V33, P118, DOI 10.1016/j.pnpbp.2008.10.018; Reckziegel P, 2011, ECOTOX ENVIRON SAFE, V74, P1770, DOI 10.1016/j.ecoenv.2011.04.022; Rotblatt M., 2002, EVIDENCE BASED HERBA; ROWELL PP, 1987, J NEUROCHEM, V49, P1449, DOI 10.1111/j.1471-4159.1987.tb01013.x; Salin-Pascual RJ, 2003, REV INVEST CLIN, V55, P677; Sarris J, 2013, PHYTOTHER RES, V27, P1723, DOI 10.1002/ptr.4916; Sarris J, 2013, CNS DRUGS, V27, P301, DOI 10.1007/s40263-013-0059-9; Sarris J, 2011, EUR NEUROPSYCHOPHARM, V21, P841, DOI 10.1016/j.euroneuro.2011.04.002; Sarris J, 2011, PLANTA MED, V77, P107, DOI 10.1055/s-0030-1250290; Sarris J, 2009, J ALTERN COMPLEM MED, V15, P827, DOI 10.1089/acm.2009.0066; Schneck C, 1998, J CLIN PSYCHIAT, V59, P689, DOI 10.4088/JCP.v59n1208d; Schulz V, 2006, PHYTOMEDICINE, V13, P199, DOI 10.1016/j.phymed.2005.07.005; Shimoda LMN, 2012, PHYTOTHER RES, V26, P1934, DOI 10.1002/ptr.4652; Shinomiya K, 2005, BIOL PHARM BULL, V28, P808, DOI 10.1248/bpb.28.808; Sood A, 2008, AM J MED, V121, P207, DOI 10.1016/j.amjmed.2007.11.014; Spielberger C, 2005, ACTAS ESP PSIQUIATRI, V33, P374; SPIELBERGER CD, 1984, J PERS ASSESS, V48, P95; Spinella M, 2002, BRAIN INJURY, V16, P359, DOI 10.1080/02699050110103319; Tedeschi E, 2003, J PHARMACOL EXP THER, V307, P254, DOI 10.1124/jpet.103.054460; Terry AV, 2015, J PHARMACOL EXP THER, V352, P405, DOI 10.1124/jpet.114.219881; Teschke R, 2013, PHYTOTHER RES, V27, P472, DOI 10.1002/ptr.4729; Teschke R, 2012, BRIT J CLIN PHARMACO, V73, P170, DOI 10.1111/j.1365-2125.2011.04070.x; Teschke R, 2011, BRIT J CLIN PHARMACO, V71, P445, DOI 10.1111/j.1365-2125.2010.03775.x; Teschke R, 2011, PHYTOMEDICINE, V18, P96, DOI 10.1016/j.phymed.2010.10.002; TORTORIELLO J, 1993, PLANTA MED, V59, P398, DOI 10.1055/s-2006-959717; Tucci S, 2003, BEHAV PHARMACOL, V14, P323, DOI 10.1097/01.fbp.0000081782.35927.c6; Tyndale RF, 2002, THER DRUG MONIT, V24, P163, DOI 10.1097/00007691-200202000-00026; Van Vleet TR, 2001, TOXICOL SCI, V64, P185, DOI 10.1093/toxsci/64.2.185; Vera-Villarroel P, 2010, PSYCHOL REP, V106, P65, DOI 10.2466/PR0.106.1.65-77; Vonderheid-Guth B, 2000, Eur J Med Res, V5, P139; Whitaker P, 2008, FOOD CHEM TOXICOL, V46, P168, DOI 10.1016/j.fct.2007.07.013; Wolfson P, 2003, ALTERN THER HEALTH M, V9, P74; Wooltorton E, 2002, CAN MED ASSOC J, V166, P777; Xu C, 2002, ADV DRUG DELIVER REV, V54, P1245, DOI 10.1016/S0169-409X(02)00065-0; Yoshimura R, 2002, NEUROPSYCHOBIOLOGY, V45, P32, DOI 10.1159/000048670; Zarrindast MR, 2012, J PSYCHOPHARMACOL, V26, P555, DOI 10.1177/0269881111412094; Zeitlin R, 2012, BEHAV BRAIN RES, V228, P284, DOI 10.1016/j.bbr.2011.11.023; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	114	11	11	0	38	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8673	1875-533X		CURR MED CHEM	Curr. Med. Chem.		2017	24	4					411	423		10.2174/0929867323666161101140908	http://dx.doi.org/10.2174/0929867323666161101140908			13	Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	EN5BK	27804869				2022-09-04	WOS:000396020400008
J	Springer, AE; McQueen, A; Quintanilla, G; Arrivillaga, M; Ross, MW				Springer, Andrew E.; McQueen, Amy; Quintanilla, Guillermo; Arrivillaga, Marcela; Ross, Michael W.			Reliability and validity of the Student Perceptions of School Cohesion Scale in a sample of Salvadoran secondary school students	BMC INTERNATIONAL HEALTH AND HUMAN RIGHTS			English	Article							HEALTH-RISK BEHAVIOR; INVOLVEMENT; ADOLESCENTS; PEER	Background: Despite a growing body of research from the United States and other industrialized countries on the inverse association between supportive social relationships in the school and youth risk behavior engagement, research on the measurement of supportive school social relationships in Central America is limited. We examined the psychometric properties of the Student Perceptions of School Cohesion (SPSC) scale, a 10-item scale that asks students to rate with a 5-point Likert-type response scale their perceptions of the school social environment, in a sample of public secondary school students (mean age = 15 years) living in central El Salvador. Methods: Students (n = 982) completed a self-administered questionnaire that included the SPSC scale along with measures of youth health risk behaviors based on the Center for Disease Control and Prevention's Youth Risk Behavior Survey. Exploratory factor analysis was used to assess the factor structure of the scale, and two internal consistency estimates of reliability were computed. Construct validity was assessed by examining whether students who reported low school cohesion were significantly more likely to report physical fighting and illicit drug use. Results: Results indicated that the SPSC scale has three latent factors, which explained 61.6% of the variance: supportive school relationships, student-school connectedness, and student-teacher connectedness. The full scale and three subscales had good internal consistency (r(s) =.87 and alpha =.84 for the full scale; r(s) and alpha between.71 and.75 for the three subscales). Significant associations were found between the full scale and all three subscales with physical fighting (p <=.001) and illicit drug use (p <.05). Conclusion: Findings provide evidence of reliability and validity of the SPSC for the measurement of supportive school relationships in Latino adolescents living in El Salvador. These findings provide a foundation for further research on school cohesion and health risk behavior in Latino adolescents living in the U. S. and other Latin American countries.	[Springer, Andrew E.] Univ Texas Austin, Sch Publ Hlth, Michael & Susan Dell Ctr Adv Healthy Living, Austin, TX 78712 USA; [McQueen, Amy] Washington Univ, Sch Med, Div Hlth Behav Res, St Louis, MO USA; [Quintanilla, Guillermo] Univ El Salvador, Dept Educ Salud, San Salvador, El Salvador; [Arrivillaga, Marcela] Pontificia Univ Javeriana Cali, Dept Ciencias Sociales, Cali, Colombia; [Ross, Michael W.] Univ Texas Houston, Sch Publ Hlth, Ctr Hlth Promot & Prevent Res, Houston, TX USA		Springer, AE (corresponding author), Univ Texas Austin, Sch Publ Hlth, Michael & Susan Dell Ctr Adv Healthy Living, Austin Reg Campus, Austin, TX 78712 USA.	andrew.e.springer@uth.tmc.edu; AMCQUEEN@dom.wustl.edu; joguiller@hotmail.com; marceq@javerianacali.edu.co; Michael.w.ross@uth.tmc.edu	Arrivillaga, Marcela/Q-4970-2019; Arrivillaga, Marcela/L-2786-2016	Arrivillaga, Marcela/0000-0001-5927-3386; Arrivillaga, Marcela/0000-0001-5927-3386; Ross, Michael/0000-0002-5718-9989				Battistich V, 1997, AM J PUBLIC HEALTH, V87, P1997, DOI 10.2105/AJPH.87.12.1997; BERNARD B, 1991, FOSTERING RESILIENCY; Bond L., 2007, J ADOLESCENT HEALTH, V40, P357, DOI [10.1016/j.jadohealth.2006.10.013, DOI 10.1016/J.JADOHEALTH.2006.10.013, https://doi.org/10.1016/j.jadohealth.2006.10.013]; Coker JK, 2001, J COUNS DEV, V79, P200, DOI 10.1002/j.1556-6676.2001.tb01961.x; DeVellis R.F., 2017, SCALE DEV THEORY APP; Dormitzer CM, 2004, REV PANAM SALUD PUBL, V15, P400, DOI 10.1590/S1020-49892004000600006; Gabriel RM, 1996, AM J PREV MED, V12, P48, DOI 10.1016/S0749-3797(18)30236-8; GORE S, 1992, J HEALTH SOC BEHAV, V33, P97, DOI 10.2307/2137249; Green S., 2005, USING SPSS WINDOWS M; Hawkins J D, 1985, J Prim Prev, V6, P73, DOI 10.1007/BF01325432; Hirschi T., 1969, CAUSES DELINQUENCY; Israel BA, 1990, HLTH BEHAV HLTH ED T, P187; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Kann L, 1998, MMWR CDC Surveill Summ, V47, P1; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Konu A, 2002, HEALTH EDUC RES, V17, P732, DOI 10.1093/her/17.6.732; KROHN MD, 1983, J HEALTH SOC BEHAV, V24, P337, DOI 10.2307/2136400; Lightfoot C., 1997, CULTURE ADOLESCENT R; MCBRIDE CM, 1995, J SCHOOL HEALTH, V65, P63, DOI 10.1111/j.1746-1561.1995.tb03347.x; McNeely C, 2004, J SCHOOL HEALTH, V74, P284, DOI 10.1111/j.1746-1561.2004.tb08285.x; Mertler C.A., 2002, ADV MULTIVARIATE STA; Nunnally J, 1978, PSYCHOMETRIC THEORY; Oetting ER, 1998, SUBST USE MISUSE, V33, P995, DOI 10.3109/10826089809056252; Opdenakker MC, 2000, SCH EFF SCH IMPROV, V11, P165, DOI 10.1076/0924-3453(200006)11:2;1-Q;FT165; Patton GC, 2006, AM J PUBLIC HEALTH, V96, P1582, DOI 10.2105/AJPH.2004.047399; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; SAMDAL O, 1998, SCH ENV RISK RESOURC; Simons-Morton B, 2004, ADDICT BEHAV, V29, P299, DOI 10.1016/j.addbeh.2003.08.005; Simons-Morton BG, 2004, HEALTH EDUC BEHAV, V31, P22, DOI 10.1177/1090198103258850; Simons-Morton BG, 2003, J SCHOOL HEALTH, V73, P121, DOI 10.1111/j.1746-1561.2003.tb03586.x; Simons-Morton BG, 1999, HEALTH EDUC RES, V14, P99, DOI 10.1093/her/14.1.99; Springer A, 2007, ETHNIC HEALTH, V12, P69, DOI 10.1080/13557850601002155; Springer AE, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-8; Springer Andrew E, 2006, BMC Int Health Hum Rights, V6, P3, DOI 10.1186/1472-698X-6-3	34	6	6	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-698X		BMC INT HEALTH HUM R	BMC Int. Health Hum. Rights.		2009	9								30	10.1186/1472-698X-9-30	http://dx.doi.org/10.1186/1472-698X-9-30			9	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	V17AZ	19939259	Green Published, gold			2022-09-04	WOS:000207911400030
J	Perez-Zepeda, MU; Almeda-Valdes, P; Fernandez-Villa, JM; Gomez-Arteaga, RC; Borda, MG; Cesari, M				Perez-Zepeda, Mario U.; Almeda-Valdes, Paloma; Manuel Fernandez-Villa, Julio; Gomez-Arteaga, Ronald C.; Borda, Miguel G.; Cesari, Matteo			Thyroid stimulating hormone levels and geriatric syndromes: secondary nested case-control study of the Mexican Health and Aging Study	EUROPEAN GERIATRIC MEDICINE			English	Article						Thyroid stimulating hormone; Aging; Geriatric syndromes; Chronic disease; Subclinical hypothyroidism	SUBCLINICAL HYPOTHYROIDISM; ANTITHYROID ANTIBODIES; COGNITIVE FUNCTION; THYROTROPIN; DISEASE; AGE; POPULATION; PREVALENCE; THYROXINE; COMMUNITY	Purpose To determine the incidence of geriatric syndromes (GS) in community dwelling older adults with subclinical hypothyroidism. Methods This is an analysis from the Mexican Health and Aging Study, of a subsample of 2089 subjects with TSH determination. From this last subsample, we included 1628 individuals with TSH levels in the subclinical range (4.5-10 mu U/ml). Results The multivariate analysis showed that when comparing data obtained from the 2012 wave with the 2015 wave results, there was a significant incidence of some GS such as falls (OR 1.79, CI 1.16-2.77, p = 0.0116), fatigue (OR 2.17, CI 1.40-3.38, p = 0.0348) and depression (OR 1.70, CI 1.06-2.71, p = 0.0246) among the subclinical hypothyroidism group. Conclusion This study showed a greater incidence of GS in subjects 50 years and older with sub-clinical hypothyroidism, when compared to those with normal thyroid function. Key summary pointsAim Does geriatric syndrome have an association with subclinical hypothyroidism. Findings This study showed a greater incidence of GS in subjects 50 years and older with sub-clinical hypothyroidism, when compared to those with normal thyroid function. Message Endocrine assessment should be taken in account in frail individuals as part of an integral evaluation for patients.	[Perez-Zepeda, Mario U.] INGER Inst Nacl Geriatria, Res Dept, Mexico City, DF, Mexico; [Perez-Zepeda, Mario U.] Hlth Sci Res Ctr CICSA, FCS, Univ Anahuac Mexico Campus Norte, Mexico City, Edo De Mexico, Mexico; [Almeda-Valdes, Paloma] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Res Ctr Metab Dis, Mexico City, DF, Mexico; [Manuel Fernandez-Villa, Julio] CONACyT, Red Temat Envejecimiento Salud & Desarrollo Socia, Mexico City, DF, Mexico; [Gomez-Arteaga, Ronald C.] Clin Country Hosp Univ San Ignacio, Bogota, Colombia; [Borda, Miguel G.] Pontificia Univ Javeriana, Fac Med, Inst Envejecimiento, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Borda, Miguel G.] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [Cesari, Matteo] IRCCS Ist Clin Sci Maugeri, Geriatr Unit, Milan, Italy		Fernandez-Villa, JM (corresponding author), CONACyT, Red Temat Envejecimiento Salud & Desarrollo Socia, Mexico City, DF, Mexico.	fervilnut@icloud.com	Borda, Miguel German/AHB-5593-2022	Borda, Miguel German/0000-0001-5832-0603; Fernandez-Villa, Julio/0000-0002-5802-2494; Gomez arteaga, Ronald Camilo/0000-0002-1652-5042				Aggarwal N, 2013, J THROID RES, V2013, DOI 10.1155/2013/481287; Aguilar-Navarro SG, 2007, SALUD PUBLICA MEXICO, V49, P256, DOI 10.1590/S0036-36342007000400005; Anzaldi LJ, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0645-7; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Diez JJ, 2022, EUR GERIATR MED, V13, P127, DOI 10.1007/s41999-021-00544-x; Gan EH, 2012, J CLIN ENDOCR METAB, V97, P3438, DOI 10.1210/jc.2012-2284; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Instituto Nacional de Salud Publica, 2012, MAN PROC ANTHR BIOL; Lee PG, 2009, J AM GERIATR SOC, V57, P511, DOI 10.1111/j.1532-5415.2008.02150.x; Robles-Osorio ML, 2014, REV INVEST CLIN, V66, P113; MARIOTTI S, 1993, J CLIN ENDOCR METAB, V77, P1130, DOI 10.1210/jc.77.5.1130; Mattiuzzi C, 2020, EUR GERIATR MED, V11, P147, DOI 10.1007/s41999-019-00265-2; Mejia-Arango S, 2015, SALUD PUBLICA MEXICO, V57, pS90; Ogunsakin A, 2017, NEW ENGL J MED, V377, DOI 10.1056/NEJMc1709989; Silva SOE, 2014, ENDOCRINE, V47, P255, DOI 10.1007/s12020-013-0077-x; Parle J, 2010, J CLIN ENDOCR METAB, V95, P3623, DOI 10.1210/jc.2009-2571; Razvi S, 2008, J CLIN ENDOCR METAB, V93, P2998, DOI 10.1210/jc.2008-0167; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Retornaz F, 2013, REV MED INTERNE, V34, P694, DOI 10.1016/j.revmed.2012.11.012; Retornaz F, 2013, REV MED INTERNE, V34, P623, DOI 10.1016/j.revmed.2012.11.011; Rikkert MGMO, 2003, NETH J MED, V61, P83; SPENCER CA, 1990, J CLIN ENDOCR METAB, V70, P453, DOI 10.1210/jcem-70-2-453; Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; van Boxtel MPJ, 2004, PSYCHONEUROENDOCRINO, V29, P891, DOI 10.1016/j.psyneuen.2003.08.002; van den Beld AW, 2005, J CLIN ENDOCR METAB, V90, P6403, DOI 10.1210/jc.2005-0872; WHO, 2004, WHO GLOBAL DATABASE; Wong R, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyu263; Wong R, 2015, SALUD PUBLICA MEXICO, V57, pS79; Wopereis DM, 2018, J CLIN ENDOCR METAB, V103, P3658, DOI 10.1210/jc.2018-00481	30	1	1	1	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1878-7649	1878-7657		EUR GERIATR MED	Eur. Geriatr. Med.	FEB	2022	13	1					139	145		10.1007/s41999-021-00564-7	http://dx.doi.org/10.1007/s41999-021-00564-7		OCT 2021	7	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	ZE3YL	34601711	Green Accepted			2022-09-04	WOS:000702796500001
J	Hurtado-Parrado, C; Sierra-Puentes, M; El Hazzouri, M; Morales, A; Gutierrez-Villamarin, D; Velasquez, L; Correa-Chica, A; Rincon, JC; Henao, K; Castaneda, JG; Lopez-Lopez, W				Hurtado-Parrado, Camilo; Sierra-Puentes, Myriam; El Hazzouri, Mohammed; Morales, Alexandra; Gutierrez-Villamarin, Diana; Velasquez, Laura; Correa-Chica, Andrea; Carlos Rincon, Juan; Henao, Karen; Gabriel Castaneda, Juan; Lopez-Lopez, Wilson			Emotion Regulation and Attitudes Toward Conflict in Colombia: Effects of Reappraisal Training on Negative Emotions and Support for Conciliatory and Aggressive Statements	FRONTIERS IN PSYCHOLOGY			English	Article						emotion regulation; cognitive reappraisal; conciliation; aggression; peace; intractable conflict; Colombia; FARC-EP	INDIVIDUAL-DIFFERENCES; INTRACTABLE CONFLICT; METAANALYSIS; VIOLENCE; RECONCILIATION; STRATEGIES; TRAUMA	Control of negative emotions (e. g., anger and fear) by political cues perpetuate intractable conflict by mobilizing public support for aggressive actions. Halperin et al. (2013) found that reappraisal-an adaptive form of emotion regulation - decreased negative emotions triggered by anger-inducing information related to the Israeli-Palestinian conflict, and increased support for conciliatory statements. We tested these effects in the context of the conflict between the Colombian government and the Fuerzas Armadas Revolucionarias de Colombia-Ejercito del Pueblo (FARC-EP). Reappraisal training reduced negative emotions produced by a presentation that illustrated FARC's violent actions, and increased support for conciliatory statements (with overall moderate effect magnitudes). We also found that negative emotions mediated the effects of reappraisal on the support for aggressive and conciliatory statements. These findings indicate a high degree of generality of the phenomena, especially considering the differences between the Israeli-Palestinian conflict and the Colombian conflict. Our findings also show promise for replicating these effects on other types of intergroup conflicts and guiding effective public policy.	[Hurtado-Parrado, Camilo] Troy Univ, Dept Psychol, Troy, AL 36082 USA; [Hurtado-Parrado, Camilo; Sierra-Puentes, Myriam; Morales, Alexandra; Gutierrez-Villamarin, Diana; Carlos Rincon, Juan; Henao, Karen] Fdn Univ Konrad Lorenz, Fac Psychol, Bogota, Colombia; [El Hazzouri, Mohammed] Mt Royal Univ, Bissett Sch Business, Calgary, AB, Canada; [Velasquez, Laura; Lopez-Lopez, Wilson] Pontificia Univ Javeriana, Dept Psychol, Bogota, Colombia; [Correa-Chica, Andrea] Univ Santiago Compostela, Fac Psicol, Dept Psicol Social Bas & Metodol, Santiago De Compostela, Spain; [Gabriel Castaneda, Juan] Corporac Univ Minuto Dios, Direct Invest, Bogota, Colombia		Hurtado-Parrado, C (corresponding author), Troy Univ, Dept Psychol, Troy, AL 36082 USA.; Hurtado-Parrado, C (corresponding author), Fdn Univ Konrad Lorenz, Fac Psychol, Bogota, Colombia.	hhurtadoparrado@troy.edu	López López, Wilson/AAV-8032-2021; Henao, Karen/AAN-7414-2021; Hurtado-Parrado, Camilo/W-9832-2019; Correa-Chica, Andrea/G-8383-2019; Puentes, Myriam Carmenza Sierra/AAG-4604-2020	López López, Wilson/0000-0002-2964-0402; Henao, Karen/0000-0003-2462-1795; Hurtado-Parrado, Camilo/0000-0001-5923-8054; Correa-Chica, Andrea/0000-0003-2936-5137; Puentes, Myriam Carmenza Sierra/0000-0002-9829-2827; Rincon Vasquez, Juan Carlos/0000-0001-8625-579X; castaneda polanco, juan gabriel/0000-0001-7632-7526	Fundacion Universitaria Konrad Lorenz [9IN10181]	Fundacion Universitaria Konrad Lorenz	Financial support for this research was provided by Fundacion Universitaria Konrad Lorenz - grant number 9IN10181.	Abello-Llanos R, 2009, UNIV PSYCHOL, V8, P455; Alzate M, 2009, UNIV PSYCHOL, V8, P703; American Psychological Association (June 1 2010), 2017, AM PSYCHOL; Amnesty International, 2017, AMN INT REP 2016 201; [Anonymous], 2016, EL ESPECTADOR; Bar-Tal D, 1998, INT J CONFL MANAGE, V9, P22, DOI 10.1108/eb022803; Bar-Tal D, 2000, POLIT PSYCHOL, V21, P351, DOI 10.1111/0162-895X.00192; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Caracol Radio, 2016, SI PLEB LOGR 54 SEG; Cehajic-Clancy S, 2016, PSYCHOL INQ, V27, P73, DOI 10.1080/1047840X.2016.1153945; Centro Nacional de Memoria Historica, 2013, GUERR POBL CIV TRAYE; CHARROW RP, 1979, COLUMBIA LAW REV, V79, P1306, DOI 10.2307/1121842; Colombian Government, 2016, AC FIN TERM CONFL CO; Correa JC, 2018, REV LAT AM PSICOL, V50, P61, DOI 10.14349/rlp.2018.v50.n1.6; Cortes A, 2016, PSYCHOSOC INTERV, V25, P19, DOI 10.1016/j.psi.2015.09.004; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; delHuila Diario, 2016, COMMUNICATION; Dufey M., 2012, REV IBEROAM DIAGN EV, V2, P157; El Pais, 2016, PAIS; Ferrando PJ, 2000, PSICOTHEMA, V12, P383; Frijda NH, 2009, COGNITION EMOTION, V23, P1444, DOI 10.1080/02699930903093276; Gignac GE, 2016, PERS INDIV DIFFER, V102, P74, DOI 10.1016/j.paid.2016.06.069; Grajales J, 2011, J PEASANT STUD, V38, P771, DOI 10.1080/03066150.2011.607701; Gross JJ, 2013, CURR DIR PSYCHOL SCI, V22, P423, DOI 10.1177/0963721413495871; Gross JJ, 2013, EMOTION, V13, P359, DOI 10.1037/a0032135; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ., 2014, HDB EMOTION REGULATI; Gutentag T, 2017, COGNITION EMOTION, V31, P1225, DOI 10.1080/02699931.2016.1213704; Halperin E, 2015, POLIT PSYCHOL, V36, P119, DOI 10.1111/pops.12236; Halperin E, 2014, EMOT REV, V6, P68, DOI 10.1177/1754073913491844; Halperin E, 2013, PSYCHOL SCI, V24, P106, DOI 10.1177/0956797612452572; Halperin E, 2011, COGNITION EMOTION, V25, P1228, DOI 10.1080/02699931.2010.536081; Hayes AF., 2018, INTRO MEDIATION MODE, V2nd ed.; Hayes Andrew F, 2017, Behav Res Ther, V98, P39, DOI 10.1016/j.brat.2016.11.001; Historical Memory Group, 2016, BAST YA COL MEM WAR; Hu TQ, 2014, PSYCHOL REP, V114, P341, DOI 10.2466/03.20.PR0.114k22w4; Human Rights Watch, 2015, WORLD REP 2015 COL; Jones N., 2012, J TECH WRIT COMMUN, V42, P331, DOI [10.2190/TW.42.4.b, DOI 10.2190/TW.42.4.B]; Kriesberg L., 1993, PEACE REV, V5, P417, DOI [DOI 10.1080/10402659308425753, 10.1080/10402659308425753]; Lara-Cantu M. A., 1990, SALUD MENT, V13, P35; Lopez WL, 2018, PEACE CONFL, V24, P201, DOI 10.1037/pac0000295; Lopez-Lopez W, 2013, SOC INDIC RES, V114, P287, DOI 10.1007/s11205-012-0146-1; Mandic CG, 2012, J SPEC EDUC, V45, P195, DOI 10.1177/0022466910362774; Paez D, 2013, J POSIT PSYCHOL, V8, P249, DOI 10.1080/17439760.2013.786751; Pico-Perez M, 2017, PROG NEURO-PSYCHOPH, V79, P96, DOI 10.1016/j.pnpbp.2017.06.001; Registraduria Nacional del Estado Civil, 2016, B NAT REG NAC EST CI, V53; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Rosler N, 2017, J CONFLICT RESOLUT, V61, P114, DOI 10.1177/0022002715569772; Thomson F, 2011, J AGRAR CHANGE, V11, P321, DOI 10.1111/j.1471-0366.2011.00314.x; Unidad para las Victimas, 2017, REG UN VICT COL; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600	53	10	10	1	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	APR 24	2019	10								908	10.3389/fpsyg.2019.00908	http://dx.doi.org/10.3389/fpsyg.2019.00908			9	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	HU7UB	31068877	Green Published, gold			2022-09-04	WOS:000465487300001
J	Reveiz, L; Cortes-Jofre, M; Lobos, CA; Nicita, G; Ciapponi, A; Garcia-Dieguez, M; Tellez, D; Delgado, M; Sola, I; Ospina, E				Reveiz, L.; Cortes-Jofre, M.; Asenjo Lobos, C.; Nicita, G.; Ciapponi, A.; Garcia-Dieguez, M.; Tellez, D.; Delgado, M.; Sola, I.; Ospina, E.		Iberoamerican Cochrane Network	Influence of trial registration on reporting quality of randomized trials: Study from highest ranked journals	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Randomized controlled trials; Clinical trials; Editorial policies; Quality control; Bias; Methods	METHODOLOGICAL QUALITY; CONSORT STATEMENT; INTERNATIONAL-COMMITTEE; CONSOLIDATED STANDARDS; CLINICAL-TRIALS; ASSOCIATION; ADHERENCE; CHECKLIST; BIAS	Objective: To evaluate the reporting quality of key methodological items of randomized control trials (RCTs) in 55 of the highest ranked journals. Study Design and Setting: A list of the highest top ranked journals was identified, and a search for detecting RCTs in those journals was made. Two hundred sixty four journals were screened and 55 of them were identified having at least one RCT. Three RCTs were randomly selected a priori from each journal; 148 RCTs were finally included. RCTs were assessed by two reviewers using the Consolidated Standards of Reporting Trials (CONSORT) statement. Results: Only 11 (8%) RCTs had all items adequately reported. In addition, 36% of RCTs reported that the study was registered in any trial registry. We found a significant difference in the quality of reporting for baseline characteristics, recruitment, participant's flow, and randomization implementation between those studies having reported the registration of their RCT in a trial registry and those that have not. Adherence to key methodological items of the CONSORT statement was as follows: sample size determination (60%), sequence generation (49%), allocation concealment (40%), and blinding (25%). Conclusions: Reporting of varied CONSORT items remains suboptimal. Registration in a trial registry was associated with improved reporting. Further efforts to enhance RCT registration could contribute to this improvement. (C) 2010 Elsevier Inc. All rights reserved.	[Reveiz, L.] Sanitas Univ Fdn, Sanitas Res Inst, Colombian Cochrane Branch, Bogota, Colombia; [Cortes-Jofre, M.] Univ Catolica Santisima Concepcion, Chilean Cochrane Branch, Concepcion, Chile; [Asenjo Lobos, C.] Univ Concepcion, CRAI, Ctr Iberoamer Cochrane Ctr, Chilean Cochrane Branch, Concepcion, Chile; [Nicita, G.] Univ Carabobo, Venezuela Cochrane Branch, Valencia, Venezuela; [Ciapponi, A.] IECS, Argentine Cochrane Branch, Buenos Aires, DF, Argentina; [Garcia-Dieguez, M.] Acad Nacl Med Buenos Aires, Argentine Cochrane Branch, Buenos Aires, DF, Argentina; [Delgado, M.] Pontificia Univ Javeriana, Colombian Cochrane Branch, Bogota, Colombia; [Sola, I.] Hosp Santa Creu & St Pau Barcelona, Iberoamer Cochrane Ctr, Barcelona, Spain		Reveiz, L (corresponding author), Sanitas Univ Fdn, Sanitas Res Inst, Colombian Cochrane Branch, Bogota, Colombia.	lreveiz@yahoo.com	Asenjo-Lobos, Claudia/AAO-6815-2020; Dieguez, Marcelo Garcia/AAW-5810-2020	Ciapponi, Agustin/0000-0001-5142-6122; Delgado-Ramirez, Martha B./0000-0003-0364-4955; Asenjo-Lobos, Claudia/0000-0002-8264-0524	Iberoamerica Cochrane Center	Iberoamerica Cochrane Center	The authors wish to acknowledge the Iberoamerica Cochrane Center for his support. Ludovic Reveiz is a PhD candidate at the Universitat Autonoma de Barcelona.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Barbui C, 2006, J CLIN PSYCHIAT, V67, P37, DOI 10.4088/JCP.v67n0106; Berghmans T, 2003, ANN ONCOL, V14, P715, DOI 10.1093/annonc/mdg203; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Devereaux PJ, 2002, CONTROL CLIN TRIALS, V23, P380, DOI 10.1016/S0197-2456(02)00214-3; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Fung AE, 2009, OPHTHALMOLOGY, V116, P286, DOI 10.1016/j.ophtha.2008.09.014; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Hahn S, 2000, STAT MED, V19, P3325, DOI 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D; Halpern SH, 2004, INT J OBSTET ANESTH, V13, P207, DOI 10.1016/j.ijoa.2004.03.009; Higgins J., 2011, JOHN WILEY SONS; HOLM S, 1979, SCAND J STAT, V6, P65; Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Mills E, 2005, J CLIN EPIDEMIOL, V58, P662, DOI 10.1016/j.jclinepi.2005.01.004; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Smith BA, 2008, NURS OUTLOOK, V56, P31, DOI 10.1016/j.outlook.2007.09.002; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Thomson Reuters, INTR IMP FACT; Thomson Reuters, THOMS REUT IMP FACT; TUKEY JW, 1977, SCIENCE, V198, P679, DOI 10.1126/science.333584; Uetani K, 2009, INTERNAL MED, V48, P307, DOI 10.2169/internalmedicine.48.1358; *WHO, 2005, WHO INT CLIN TRIALS; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; Ziogas DC, 2009, ANN EPIDEMIOL, V19, P494, DOI 10.1016/j.annepidem.2009.03.018	33	48	49	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	NOV	2010	63	11					1216	1222		10.1016/j.jclinepi.2010.01.013	http://dx.doi.org/10.1016/j.jclinepi.2010.01.013			7	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	663CW	20430576				2022-09-04	WOS:000282861600007
J	Rodriguez-Grande, EI; Buitrago-Lopez, A; Torres-Narvaez, MR; Serrano-Villar, Y; Verdugo-Paiva, F; Avila, C				Rodriguez-Grande, Eliana-Isabel; Buitrago-Lopez, Adriana; Torres-Narvaez, Martha-Rocio; Serrano-Villar, Yannely; Verdugo-Paiva, Francisca; Avila, Camila			Therapeutic exercise to improve motor function among children with Down Syndrome aged 0 to 3 years: a systematic literature review and meta-analysis	SCIENTIFIC REPORTS			English	Article							BODY-WEIGHT SUPPORT; TREADMILL INTERVENTIONS; PHYSICAL-ACTIVITY; INFANTS; PERFORMANCE; DELAY	The effects and the prescription parameters of therapeutic exercise are not clear. For this reason, is needed to determine the effect of therapeutic exercises on the motor function of children with Down Syndrome (DS) aged 0 to 3 years. The present study is systematic review and meta-analysis of effectiveness outcomes in this population: gait, balance, motor development, fine motor skills, and executive functions. The databases of PubMed, PEDro, EMBASE, SCIELO, Lilacs, Cochrane library were searched from January to December 2019. We recruited Randomized Controlled Trials (RCTs) which met the inclusion criteria in our study. Six studies and 151 participants were included. Two types of therapeutic exercises, aerobic and neuromuscular, were identified. Both types of exercise were effective in improving outcomes. There were no differences between the modes of application of the exercise. No differences were identified between the treadmill and the physiotherapy plan for the reduction of the time to reach independent walking, Mean Difference (MD) 46.79, 95% Confidence Interval (IC) (- 32.60, 126.19), nor for the increase in walking speed MD 0.10 IC (- 0.02, 0.21) m/s. This study suggests that aerobic exercise therapy has a potentially effective role to promote the gait and motor development of children with DS aged 0 to 3 years when it is applied using a treadmill with a frequency of 5 days, a duration of 6-8 min, and an intensity of between 0.2 and 0.5 m/s. Studies with less heterogeneity and larger sample sizes are required.	[Rodriguez-Grande, Eliana-Isabel] Pontificia Univ Javeriana, Masters & PhD Programs Clin Epidemiol, Bogota, Colombia; [Rodriguez-Grande, Eliana-Isabel] Univ Rosario, Sch Med & Hlth Sci, GI Rehabil Sci, Carrera 24 N 63D-69,PBX 2970200 Ext 3420, Bogota, Cundinamarca, Colombia; [Buitrago-Lopez, Adriana] Erasmus Univ, Rotterdam, Netherlands; [Buitrago-Lopez, Adriana] Univ Catolica Parana, Curitiba, Parana, Brazil; [Buitrago-Lopez, Adriana] Pontificia Univ Javeriana, Sch Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Torres-Narvaez, Martha-Rocio] Univ Rosario, Sch Med & Hlth Sci, GI Rehabil Sci, Physiotherapy Program, Bogota, Colombia; [Serrano-Villar, Yannely] Univ CES, Medellin, Colombia; [Verdugo-Paiva, Francisca] Pontificia Univ Catolica, Sch Med, Ctr Evidencia UC, Santiago, Chile; [Verdugo-Paiva, Francisca; Avila, Camila] Fdn Epistemonikos, Santiago, Chile		Rodriguez-Grande, EI (corresponding author), Pontificia Univ Javeriana, Masters & PhD Programs Clin Epidemiol, Bogota, Colombia.; Rodriguez-Grande, EI (corresponding author), Univ Rosario, Sch Med & Hlth Sci, GI Rehabil Sci, Carrera 24 N 63D-69,PBX 2970200 Ext 3420, Bogota, Cundinamarca, Colombia.	eliana.rodriguez@urosario.edu.co			Colombia Consortium	Colombia Consortium	Open Access funding provided by Colombia Consortium.	Alesi M., MED US, V97; American College of Sports Medicine, 2020, CURATORI ACSMS GUIDE, V11; Andriolo RB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005176.pub4; Angulo-Barroso R, 2008, INFANT BEHAV DEV, V31, P255, DOI 10.1016/j.infbeh.2007.10.003; Angulo-Barroso RM, 2008, GAIT POSTURE, V27, P231, DOI 10.1016/j.gaitpost.2007.03.014; [Anonymous], FUNDAMENTOS TECNICAS; [Anonymous], REVMAN 5 DOWNLOAD CO; [Anonymous], BAYLEY 3 CLIN USE IN; [Anonymous], 2007, INTRO ERRORES MEDICO; [Anonymous], GRADE HDB; [Anonymous], ED390210 PDF; [Anonymous], COCHRANE HDB SYSTEMA; Banerjee Amitav, 2009, Ind Psychiatry J, V18, P127, DOI 10.4103/0972-6748.62274; Bauer SM, 2014, INFANT YOUNG CHILD, V27, P162, DOI 10.1097/IYC.0000000000000004; BOSWELL B, 1991, PERCEPT MOTOR SKILL, V73, P759, DOI 10.2466/PMS.73.7.759-764; Cano-de-la-Cuerda R, 2015, NEUROLOGIA, V30, P32, DOI 10.1016/j.nrl.2011.12.010; Chen CC, 2016, J INTELL DISABIL RES, V60, P606, DOI 10.1111/jir.12258; Chen CC, 2014, RES DEV DISABIL, V35, P288, DOI 10.1016/j.ridd.2013.10.032; Chien CW, 2009, AM J PHYS MED REHAB, V88, P376, DOI 10.1097/PHM.0b013e318198a7c9; Dodd K., 2007, DATABASE ABSTR REV E; Dolva AS, 2004, AM J OCCUP THER, V58, P621, DOI 10.5014/ajot.58.6.621; Epistemonikos, DAT BEST EV BAS HLTH; Esbensen AJ, 2017, AJIDD-AM J INTELLECT, V122, P247, DOI 10.1352/1944-7558-122.3.247; Ferreifta-Vasques AT, 2015, J APPL ORAL SCI, V23, P424, DOI 10.1590/1678-775720150102; Flore P, 2008, EUR J CARDIOV PREV R, V15, P35, DOI 10.1097/HJR.0b013e3282f2bff3; HARRIS SR, 1981, DEV MED CHILD NEUROL, V23, P477; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Johnson CC, 2009, AM J HEALTH PROMOT, V23, P157, DOI 10.4278/ajhp.070930103; Sanabria AJ, 2015, ATEN PRIM, V47, P48, DOI 10.1016/j.aprim.2013.12.013; Kavlak E., DEV MED CHILD NEUROL, V60, P43; Larun L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003200.pub4; Latash M. L., 1998, PROGR MOTOR CONTROL, V280; Lin HC, 2012, RES DEV DISABIL, V33, P2236, DOI 10.1016/j.ridd.2012.06.017; Lloyd M, 2010, ADAPT PHYS ACT Q, V27, P1; Looper J, 2011, PEDIATR PHYS THER, V23, P70, DOI 10.1097/PEP.0b013e318208cdea; Looper J, 2010, PHYS THER, V90, P382, DOI 10.2522/ptj.20090021; Lowe L, 2015, PEDIATR PHYS THER, V27, P386, DOI 10.1097/PEP.0000000000000172; Malak Roksana, 2015, Med Sci Monit, V21, P1904, DOI 10.12659/MSM.893377; Marinho-Buzelli AR, 2015, CLIN REHABIL, V29, P741, DOI 10.1177/0269215514556297; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Orlewska E, 2009, PHARMACOECONOMICS, V27, P807, DOI 10.2165/11313770-000000000-00000; Paul Y, 2019, AFR J DISABIL, V8, DOI 10.4102/ajod.v8i0.576; Roostaei M, 2017, PHYS OCCUP THER PEDI, V37, P496, DOI 10.1080/01942638.2016.1247938; Ruiz-Gonzalez L, 2019, J INTELL DISABIL RES, V63, P1041, DOI 10.1111/jir.12606; Sugimoto D, 2016, RES DEV DISABIL, V55, P197, DOI 10.1016/j.ridd.2016.04.003; Ulrich DA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e84; Ulrich DA, 2008, PHYS THER, V88, P114, DOI 10.2522/ptj.20070139; Valentin-Gudiol M, 2013, EUR J PHYS REHAB MED, V49, P67; Valentin-Gudiol M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009242.pub2; Winders P, 2019, J INTELL DISABIL RES, V63, P346, DOI 10.1111/jir.12580; Wu J, 2007, DEV MED CHILD NEUROL, V49, P839, DOI 10.1111/j.1469-8749.2007.00839.x; Wu JH, 2010, PHYS THER, V90, P1265, DOI 10.2522/ptj.20090281	52	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 29	2022	12	1							13051	10.1038/s41598-022-16332-x	http://dx.doi.org/10.1038/s41598-022-16332-x			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3J3ZD	35906275	gold, Green Published			2022-09-04	WOS:000833335700076
J	Eliason, CM; Riede, T; Laverde-R, O; Goller, F; Clarke, JA				Eliason, C. M.; Riede, T.; Laverde-R, O.; Goller, F.; Clarke, J. A.			Shared acoustic allometry in the largest and smallest known birds	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Integrative-and-Comparative-Biology (SICB)	JAN 31-FEB 28, 2021	ELECTR NETWORK	Soc Integrat & Comparat Biol					Field Museum Nat Hist, Chicago, IL 60605 USA; Midwestern Univ, Downers Grove, IL 60515 USA; Pontificia Univ Javeriana, Bogota, Colombia; Univ Utah, Salt Lake City, UT 84112 USA; Univ Texas Austin, Austin, TX 78712 USA			celiason@fieldmuseum.org							0	0	0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	MAR	2021	61			1		110-9	E229	E229						1	Zoology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Zoology	SE1DI					2022-09-04	WOS:000651814700291
J	Garcia-Alzate, CA; Lima, F; Taphorn, DC; Mojica, JI; Urbano-Bonilla, A; Teixeira, TF				Arturo Garcia-Alzate, Carlos; Lima, Flavio; Taphorn, Donald Charles; Ivan Mojica, Jose; Urbano-Bonilla, Alexander; Teixeira, Tulio Franco			A new species of Hyphessobrycon Durbin (Characiformes: Characidae) from the western Amazon basin in Colombia and Peru	JOURNAL OF FISH BIOLOGY			English	Article						Hyphessobrycon agulha; neotropical diversity; Rio Caqueta drainage; Rio Ucayali drainage; Serrania de Chiribiquete	RIO MADEIRA BASIN; OSTARIOPHYSI CHARACIFORMES; TELEOSTEI CHARACIFORMES; CENTRAL BRAZIL; JURUENA BASIN; PHYLOGENY; FISHES	Hyphessobrycon chiribiquete n. sp. is described from the Rio Caqueta drainage in Colombia and the Rio Ucayali drainage in Peru, western Amazon. The new species is diagnosed from its congeners by having the following combination of characters: a conspicuous narrow midlateral stripe, starting on the sides of the body behind the opercle near the lateral line; lateral stripe overlapped anteriorly with a vertically elongated humeral blotch; inner premaxillary teeth pentacuspid; margin of anal fin falcate in mature males.	[Arturo Garcia-Alzate, Carlos] Univ Atlantico, Programa Biol, Barranquilla, Colombia; [Arturo Garcia-Alzate, Carlos] Corp Univ Autonoma Cauca, Fac Ciencias Ambientales & Desarrollo Sostenible, Popayan, Colombia; [Lima, Flavio] Univ Estadual Campinas Adao Jose Cardoso, Museu Zool, Campinas, Brazil; [Taphorn, Donald Charles] Royal Ontario Museum, Ichthyol, Belleville, IL USA; [Ivan Mojica, Jose] Univ Nacl Colombia, Fac Ciencias, Inst Ciencias Nat, Bogota, Colombia; [Urbano-Bonilla, Alexander] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Ictiol, Bogota, Colombia; [Teixeira, Tulio Franco] Pontificia Univ Catolica Minas Gerais, Programa Posgrad Biol Vertebrados, Belo Horizonte, MG, Brazil; [Teixeira, Tulio Franco] Museu Ciencias Nat PUC Minas, Av Dom Jose Gaspar 290, BR-30535901 Belo Horizonte, MG, Brazil		Garcia-Alzate, CA (corresponding author), Univ Atlantico, Barranquilla 081001, Colombia.	carlosgarciaa@mail.uniatlantico.edu.co	Lima, Flávio C.T./B-6218-2013	Lima, Flávio C.T./0000-0002-7636-5431; Garcia-Alzate, Carlos/0000-0002-8527-0661	Andes Amazon Fund; FAPESP; Universidad del Atlantico	Andes Amazon Fund; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Universidad del Atlantico	Andes Amazon Fund; FAPESP; Universidad del Atlantico	Camelier P, 2018, J FISH BIOL, V92, P1149, DOI 10.1111/jfb.13579; Dagosta FCP, 2016, COPEIA, V104, P250, DOI 10.1643/CI-15-243; de Souza L. S., 2019, RAPID BIOL SOCIAL IN, V30, P105; Eigenmann CH, 1917, MEMOIRS MUSEUM COMP, V53, P1; Eigenmann CH, 1908, B MUS COMP ZOOL HARV, V52, P93; Faria TC, 2020, P ACAD NAT SCI PHILA, V166, DOI 10.1635/053.166.0103; Fink W.L., 1974, Smithsonian Contributions to Zoology, VNo. 172, P1; Garcia-Alzate Carlos A., 2008, Vertebrate Zoology, V58, P139; Gery J, 1877, CHARACOIDS WORLD, P672; Hoffmann P., 2012, AQUARIEN TERRARIEN Z, V65, P34; Ingenito LFS, 2013, NEOTROP ICHTHYOL, V11, P33, DOI 10.1590/S1679-62252013000100004; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; Lima F.C.T., 2013, PEIXES RIO MADEIRA, VI, P213; Lima FCT, 2014, ZOOTAXA, V3872, P167, DOI 10.11646/zootaxa.3872.2.3; Mirande JM, 2019, CLADISTICS, V35, P282, DOI 10.1111/cla.12345; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; MENEZES NA, 1990, P BIOL SOC WASH, V103, P380; Menni Roberto Carlos, 2004, Monografias del Museo Argentino de Ciencias Naturales, V5, P1; Miller R.R., 2006, FRESHWATER FISHES ME, P490; Mojica J. I., 2017, REV COLOMBIA AMAZONI, V10, P161; Moreira CR, 2017, ZOOTAXA, V4318, P123, DOI 10.11646/zootaxa.4318.1.5; Ohara WM, 2019, ZOOTAXA, V4712, P561, DOI 10.11646/zootaxa.4712.4.5; Ohara WM, 2017, ZOOTAXA, V4221, P242, DOI 10.11646/zootaxa.4221.2.8; Ohara WM, 2015, ZOOTAXA, V3972, P562, DOI 10.11646/zootaxa.3972.4.7; Ohara WM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170648; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Pastana MNL, 2016, ZOOTAXA, V4161, P386, DOI 10.11646/zootaxa.4161.3.6; Sabaj, 2019, STANDARD SYMBOLIC CO; TAYLOR W R, 1985, Cybium, V9, P107; Teixeira TF, 2020, J FISH BIOL, V96, P140, DOI 10.1111/jfb.14198; Urbano-Bonilla A., 2019, EXPEDICIONES CIENTIF, P135; WEITZMAN SH, 1997, ICHTHYOL EXPLOR FRES, V7, P202; World Wildlife Foundation, 2018, WWF SERR CHIR NAT PA	33	1	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1112	1095-8649		J FISH BIOL	J. Fish Biol.	JUN	2020	96	6					1444	1453		10.1111/jfb.14319	http://dx.doi.org/10.1111/jfb.14319		APR 2020	10	Fisheries; Marine & Freshwater Biology	Science Citation Index Expanded (SCI-EXPANDED)	Fisheries; Marine & Freshwater Biology	MA3MX	32166742				2022-09-04	WOS:000522506000001
J	Rigotti, A; Fisberg, M; Kovalskys, I; Salas, GG; Cortes, LY; Garcia, MCY; Pareja, RP; Herrera-Cuenca, M				Rigotti, Attilio; Fisberg, mauro; Kovalskys, Irina; Gomez Salas, Georgina; Cortes, Lilia Yadira; Yepez Garcia, Martha Cecilia; Pareja, Rossina Pareja; Herrera-Cuenca, Marianella			INTRODUCTION TO ELANS: NUTRITION AND HEALTH SURVEY IN URBAN POPULATION FROM EIGHT LATIN AMERICAN COUNTRIES	ANNALS OF NUTRITION AND METABOLISM			English	Meeting Abstract						Food intake; physical activity; nutritional status; cross-sectional study; Latin America			[Rigotti, Attilio] Pontificia Univ Catolica, Dept Nutr & Diabet, Ctr Nutr Mol & Enfermedades Cron, Santiago, Chile; [Fisberg, mauro] Univ Fed Sao Paulo, Inst Pensi, Hosp Infantil Sabara, Fundacao Jose Luiz Egydio Setubal, Sao Paulo, Brazil; [Kovalskys, Irina] Int Life Sci Inst, Buenos Aires, DF, Argentina; [Gomez Salas, Georgina] Univ Costa Rica, Dept Bioquim, Escuela Med, San Jose, Costa Rica; [Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador; [Pareja, Rossina Pareja] Inst Invest Nutr, Lima, Peru; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Ctr Estudios Desarrollo, Fdn Bengoa, Caracas, Venezuela				Fisberg, Mauro/E-7149-2010; Cortes, Lilia Yadira/AAF-2960-2019	Fisberg, Mauro/0000-0003-2992-3215; 	Coca-Cola Company	Coca-Cola Company	This study was funded by an unrestricted research grant from The Coca-Cola Company		0	0	0	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-6807	1421-9697		ANN NUTR METAB	Ann. Nutr. Metab.		2017	71			2			39	40						2	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	FM9QD					2022-09-04	WOS:000415605300063
J	Bruder-Nascimento, T; Chinnasamy, P; Riascos-Bernal, DF; Cau, SB; Callera, GE; Touyz, RM; Tostes, RC; Sibinga, NES				Bruder-Nascimento, T.; Chinnasamy, P.; Riascos-Bernal, D. F.; Cau, S. B.; Callera, G. E.; Touyz, R. M.; Tostes, R. C.; Sibinga, N. E. S.			Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Angiotensin II; Fat1; Nox1; ROS; Migration; Vascular smooth muscle cell	NADPH OXIDASES; RECEPTOR; DISEASE; KINASE; GROWTH; NOX1	Fat1 is an atypical cadherin that controls vascular smooth muscle cell (VSMC) proliferation and migration. Nicotinamide adenine dinudeotide phosphate (NADPH) oxidase 1 (Nox1) is an important source of reactive oxygen species (ROS) in VSMCs. Angiotensin II (Mg II) induces the expression and/or activation of both Fat1 and Nox1 proteins. This study tested the hypothesis that Ang II-induced Fat1 activation and VSMC migration are mediated by Nox1-dependent ROS generation and redox signaling. Studies were performed in cultured VSMCs from Sprague-Dawley rats. Cells were treated with Ang II (1 prnol/L) for short (5 to 30 min) or long term stimulations (3 to 12 h) in the absence or presence of the antioxidant apocynin (10 mu mol/L), extracellular-signal-regulated kinases 1/2 ( Erk1/2) inhibitor P098059(1 mu mol/L), or Ang II type 1 receptor (AT1R) valsartan (1 mu mol/L). siRNA was used to knockdown Nox1 or Fat1. Cell migration was determined by Boyden chamber assay. Ang II increased Fat1 mRNA and protein levels and promoted Fat1 translocation to the cell membrane, responses that were inhibited by AT1R antagonist and antioxidant treatment. Downregulation of Nox1 inhibited the effects of Ang II on Fat1 protein expression. Nox1 protein induction, ROS generation, and p44/p42 MAPK phosphoiylation in response to Ang II were prevented by valsartan and apocynin, and Nox1 siRNA inhibited Ang II-induced ROS generation. Knockdown of Fat1 did not affect Ang II-mediated increases in Nox1 expression or ROS. Inhibition of p44/p42 MAPK phosphorylation by PD98059 abrogated the Ang II-induced increase in Fat1 expression and membrane translocation. Knockdown of Fat1 inhibited Ang Il-induced VSMC migration, which was also prevented by valsartan, apocynin, PD98059, and Nox1 siRNA. Our findings indicate that Ang II regulates Fat1 expression and activity and induces Fat1 -dependent VSMC migration via activation of AT1R, ERK1/2, and Nox1 -derived ROS, suggesting a role for Fat1 downstream of Ang II signaling that leads to vascular remodeling. (C) 2013 Elsevier Ltd. All rights reserved.	[Bruder-Nascimento, T.; Cau, S. B.; Tostes, R. C.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pharmacol, BR-05508 Sao Paulo, Brazil; [Bruder-Nascimento, T.; Chinnasamy, P.; Riascos-Bernal, D. F.; Sibinga, N. E. S.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Med, Div Cardiovasc, Bronx, NY 10461 USA; [Bruder-Nascimento, T.; Chinnasamy, P.; Riascos-Bernal, D. F.; Sibinga, N. E. S.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10461 USA; [Riascos-Bernal, D. F.] Pontificia Univ Javeriana, Fac Med, Dept Physiol Sci, Bogota, Colombia; [Bruder-Nascimento, T.; Callera, G. E.; Touyz, R. M.] Univ Ottawa, Kidney Res Ctr, Ottawa, ON K1N 6N5, Canada; [Touyz, R. M.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland		Sibinga, NES (corresponding author), Albert Einstein Coll Med, Forchheimer G46,1300 Morris Pk Ave, Bronx, NY 10461 USA.	nicholas.sibinga@einstein.yu.edu	Sibinga, Nicholas/GOJ-8544-2022; Tostes, Rita C/C-1025-2012; Cau, Stefany/AAL-3224-2021; Touyz, Rhian/AAM-3564-2020; Bruder-Nascimento, Thiago/M-7051-2013	Tostes, Rita C/0000-0002-9446-0707; Cau, Stefany/0000-0002-0442-739X; Touyz, Rhian/0000-0003-0670-0887; Sibinga, Nicholas/0000-0003-4838-910X; Riascos Bernal, Dario/0000-0002-8790-4699	FAPESP (Foundation for Research Support of the State of Sao Paulo) [2011/01785-6, 2011/22035-5]; National Institutes of Health [HL088104, HL104518]; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104518, R01HL088104] Funding Source: NIH RePORTER	FAPESP (Foundation for Research Support of the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by FAPESP (Foundation for Research Support of the State of Sao Paulo 2011/01785-6; 2011/22035-5) to RT and by the National Institutes of Health Grants HL088104 and HL104518 to NS.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Angst BD, 2001, J CELL SCI, V114, P629; Braun GS, 2007, J BIOL CHEM, V282, P22823, DOI 10.1074/jbc.M701758200; Briones AM, 2011, J AM SOC HYPERTENS, V5, P137, DOI 10.1016/j.jash.2011.02.001; Callera GE, 2005, HYPERTENSION, V45, P773, DOI 10.1161/01.HYP.0000154365.30593.d3; Cat AND, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI 10.1089/ars.2012.4641; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Diet F, 1996, CIRCULATION, V94, P2756, DOI 10.1161/01.CIR.94.11.2756; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; Hartney T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027531; Hitomi H, 2006, J HYPERTENS, V24, P1089, DOI 10.1097/01.hjh.0000226199.51805.88; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Hou R, 2009, J BIOL CHEM, V284, P6955, DOI 10.1074/jbc.M809333200; Jagadeesha DK, 2012, CARDIOVASC RES, V93, P406, DOI 10.1093/cvr/cvr308; Knock GA, 2011, ANTIOXID REDOX SIGN, V15, P1531, DOI 10.1089/ars.2010.3614; Lemarie CA, 2010, J RENIN-ANGIO-ALDO S, V11, P19, DOI 10.1177/1470320309347785; Luo XQ, 2012, CARDIOVASC RES, V95, P241, DOI 10.1093/cvr/cvs130; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6; Montezano AC, 2012, BASIC CLIN PHARMACOL, V110, P87, DOI 10.1111/j.1742-7843.2011.00785.x; Nosadini R, 2002, J AM SOC NEPHROL, V13, pS216, DOI 10.1097/01.ASN.0000034687.62568.9B; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pendergrass KD, 2009, BIOCHEM BIOPH RES CO, V384, P149, DOI 10.1016/j.bbrc.2009.04.126; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; Shang Y, 2010, MOL FUNCTIONAL DIVER, P253; Sibinga NES, 1997, CIRC RES, V80, P532, DOI 10.1161/01.RES.80.4.532; Skultetyova Dana, 2007, Recent Pat Cardiovasc Drug Discov, V2, P23, DOI 10.2174/157489007779606130; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Touyz RM, 1999, CIRC RES, V84, P505, DOI 10.1161/01.RES.84.5.505; Touyz RM, 2000, PHARMACOL REV, V52, P639; Wedlich D, 2002, CURR OPIN CELL BIOL, V14, P563, DOI 10.1016/S0955-0674(02)00374-5; Wiedon A, 2012, BIOCHEM BIOPH RES CO, V417, P1035, DOI 10.1016/j.bbrc.2011.12.088; Wingler M, 2001, FREE RADICAL BIO MED, V31, P1456, DOI 10.1016/S0891-5849(01)00727-4; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje; Yogi A, 2012, TOXICOL APPL PHARM, V264, P470, DOI 10.1016/j.taap.2012.08.029	38	47	52	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	JAN	2014	66						18	26		10.1016/j.yjmcc.2013.10.013	http://dx.doi.org/10.1016/j.yjmcc.2013.10.013			9	Cardiac & Cardiovascular Systems; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Cell Biology	294XH	24445059	Green Accepted			2022-09-04	WOS:000330080700003
J	Lasso, P; Mesa, D; Bolanos, N; Cuellar, A; Guzman, F; Cucunuba, Z; Rosas, F; Velasco, V; Thomas, MC; Lopez, MC; Gonzalez, JM; Puerta, CJ				Lasso, Paola; Mesa, Diana; Bolanos, Natalia; Cuellar, Adriana; Guzman, Fanny; Cucunuba, Zulma; Rosas, Fernando; Velasco, Victor; Thomas, Maria C.; Carlos Lopez, Manuel; Mario Gonzalez, John; Judith Puerta, Concepcion			Chagasic patients are able to respond against a viral antigen from influenza virus	BMC INFECTIOUS DISEASES			English	Article						CD8(+) T cells; Chagas disease; Non-T. cruzi microbial antigen; Nonspecific immune-suppression	CD8(+) T-CELLS; TRYPANOSOMA-CRUZI INFECTION; DISEASE PATIENTS; KMP-11 PROTEIN; EPITOPES; PEPTIDE; MEMORY; IDENTIFICATION; DIFFERENTIATION; SPECIFICITY	Background: Trypanosoma cruzi, the etiological agent of Chagas' disease, is an obligate intracellular parasite which induces a CD8(+) T cell immune response with secretion of cytokines and release of cytotoxic granules. Although an immune-suppressive effect of T. cruzi on the acute phase of the disease has been described, little is known about the capacity of CD8(+) T cell from chronic chagasic patients to respond to a non-T. cruzi microbial antigen. Methods: In the present paper, the frequency, phenotype and the functional activity of the CD8(+) T cells specific from Flu-MP*, an influenza virus epitope, were determined in 13 chagasic patients and 5 healthy donors. Results: The results show that Flu-MP* peptide specific CD8(+) T cells were found with similar frequencies in both groups. In addition, Flu-MP* specific CD8(+) T cells were distributed in the early or intermediate/late differentiation stages without showing enrichment of a specific sub-population. The mentioned Flu-MP* specific CD8(+) T cells from chagasic patients were predominately TEM (CCR7-CD62L-), producing IL-2, IFN gamma, CD107a/b and perforin, and did not present significant differences when compared with those from healthy donors. Conclusions: Our results support the hypothesis that there is no CD8(+) T cell nonspecific immune-suppression during chronic Chagas disease infection. Nonetheless, other viral antigens must be studied in order to confirm our findings.	[Judith Puerta, Concepcion] Pontificia Univ Javeriana, Lab Parasitol Mol, Dept Microbiol, Fac Ciencias, Bogota, Colombia; [Bolanos, Natalia; Mario Gonzalez, John] Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Bogota, Colombia; [Cuellar, Adriana] Pontificia Univ Javeriana, Grp Inmunobiol & Biol Celular, Bogota, Colombia; [Guzman, Fanny] Pontificia Univ Catolica Valparaiso, Nucleo Biotecnol Curauma, Valparaiso, Chile; [Cucunuba, Zulma] Inst Nacl Salud, Grp Parasitol, Bogota, Colombia; [Rosas, Fernando; Velasco, Victor] Fdn Clin Abood Shaio, Bogota, Colombia; [Thomas, Maria C.; Carlos Lopez, Manuel] CSIC, IPBLN, Granada 18100, Spain		Puerta, CJ (corresponding author), Pontificia Univ Javeriana, Lab Parasitol Mol, Dept Microbiol, Fac Ciencias, Carrera 7 43-82, Bogota, Colombia.	cpuerta@javeriana.edu.co	Cucunuba, Zulma M./L-4076-2016; Thomas, María Carmen PhD/D-9065-2016; Puerta, Concepcion J/AAG-4912-2019; Lopez, Manuel/Z-5641-2019; Cucunuba, Zulma M/X-5670-2019; Zaky, Mohammad/I-3187-2017; Cuellar, Adriana/AAF-2958-2019; Guzman, Fanny fg/K-5592-2013	Cucunuba, Zulma M./0000-0002-8165-3198; Cucunuba, Zulma M/0000-0002-8165-3198; Zaky, Mohammad/0000-0003-3547-2588; Guzman, Fanny fg/0000-0003-1537-0904; Lopez, Manuel Carlos/0000-0003-0002-3678; Mursalin, Adi/0000-0002-1867-0868; Gonzalez, John M./0000-0001-6925-0620; Thomas, M Carmen/0000-0003-3586-9657; Cuellar, Adriana/0000-0003-0834-8442; Puerta Bula, Concepcion Judith/0000-0002-3449-3961	Colciencias Research project [1203-333-18692]; COLCIENCIAS; CONICYT COLCIENCIAS; CONICYT [2008-151]; Vicerrectoria Academica, Universidad de los Andes, Colombia; PAI (Junta de Andalucia) [P08-CVI-04037]; Plan Nacional I + D + i (MICINN) [BFU2010-1670]; ISCIII-RETIC (MICINN Spain) [RD06/0021/0014]; ISCIII-RETIC (FEDER) [RD06/0021/0014]	Colciencias Research project; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); CONICYT COLCIENCIAS; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Vicerrectoria Academica, Universidad de los Andes, Colombia; PAI (Junta de Andalucia)(Junta de Andalucia); Plan Nacional I + D + i (MICINN)(Spanish Government); ISCIII-RETIC (MICINN Spain)(Instituto de Salud Carlos IIISpanish Government); ISCIII-RETIC (FEDER)	The HLA-A2/Flu-MP* tetramers were generated and kindly provided by the NIH Tetramer Facility. This work was supported by Colciencias Research project No. 1203-333-18692, and COLCIENCIAS and CONICYT COLCIENCIAS and CONICYT 2008-151, Research Exchange Program. JMG was supported by an associate professor grant form Vicerrectoria Academica, Universidad de los Andes, Colombia. MC Lopez and MC Thomas were supported by Grants P08-CVI-04037 from PAI (Junta de Andalucia), BFU2010-1670 from Plan Nacional I + D + i (MICINN) and RD06/0021/0014 from ISCIII-RETIC (MICINN Spain and FEDER).	Albareda MC, 2006, INT IMMUNOL, V18, P465, DOI 10.1093/intimm/dxh387; Alvarez MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000288; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; BEDNAREK MA, 1991, J IMMUNOL, V147, P4047; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Borges M, 2003, IMMUNOLOGY, V109, P147, DOI 10.1046/j.1365-2567.2003.01637.x; Britten CM, 2009, CANCER IMMUNOL IMMUN, V58, P1701, DOI 10.1007/s00262-009-0681-z; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Chaves F, 2001, J PEPT RES, V58, P307, DOI 10.1034/j.1399-3011.2001.00921.x; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dauby N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000571; Diez H, 2006, PARASITE IMMUNOL, V28, P101, DOI 10.1111/j.1365-3024.2005.00815.x; Field V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-330; Fonseca SG, 2005, MICROBES INFECT, V7, P688, DOI 10.1016/j.micinf.2005.01.001; Garcia F, 2003, MICROBES INFECT, V5, P351, DOI 10.1016/S1286-4579(03)00044-3; Higuchi MD, 2003, CARDIOVASC RES, V60, P96, DOI 10.1016/S0008-6363(03)00361-4; Hoji A, 2005, IMMUNOLOGY, V115, P239, DOI 10.1111/j.1365-2567.2005.02135.x; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; KRAUSA P, 1995, TISSUE ANTIGENS, V45, P223, DOI 10.1111/j.1399-0039.1995.tb02444.x; Lasso P, 2010, PARASITE IMMUNOL, V32, P494, DOI 10.1111/j.1365-3024.2010.01206.x; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Leavey JK, 2003, J IMMUNOL, V170, P2264, DOI 10.4049/jimmunol.170.5.2264; Maranon C, 2011, MICROBES INFECT, V13, P1025, DOI 10.1016/j.micinf.2011.05.010; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; Michelin MA, 2005, EXP PARASITOL, V111, P71, DOI 10.1016/j.exppara.2005.05.001; MINOPRIO P, 1989, IMMUNOL REV, V112, P183, DOI 10.1111/j.1600-065X.1989.tb00558.x; Muller U, 2003, EUR J IMMUNOL, V33, P70, DOI 10.1002/immu.200390009; Padilla AM, 2009, J IMMUNOL, V183, P1245, DOI 10.4049/jimmunol.0901178; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Poncini CV, 2008, INFECT IMMUN, V76, P2633, DOI 10.1128/IAI.01298-07; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; TARLETON RL, 1994, INFECT IMMUN, V62, P1820, DOI 10.1128/IAI.62.5.1820-1829.1994; Teixeira ARL, 2011, CLIN MICROBIOL REV, V24, P592, DOI 10.1128/CMR.00063-10; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P334	43	6	7	0	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2334			BMC INFECT DIS	BMC Infect. Dis.	AUG 24	2012	12								198	10.1186/1471-2334-12-198	http://dx.doi.org/10.1186/1471-2334-12-198			8	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	045TQ	22920436	Green Published, gold			2022-09-04	WOS:000311720100002
J	Mbanya, JC; Aschner, P; Chan, JCN; Gagliardino, JJ; Saji, J				Mbanya, Jean Claude; Aschner, Pablo; Chan, Juliana C. N.; Gagliardino, Juan Jose; Saji, Jude			Self-monitoring of blood glucose (SMBG) and glycaemic control in Cameroon: Results of the International Diabetes Management Practices Study (IDMPS)	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Africa South of the Sahara; Type 1 diabetes; Type 2 diabetes; HbA1c; Blood glucose self-monitoring	TYPE-2; METAANALYSIS; INSULIN	This study examined the relationship between self-monitoring of blood glucose (SMBG) and glycaemic control among patients from Cameroon. A minority of patients with diabetes owned a blood glucose meter; of these patients, most performed SMBG inconsistently. The lack of SMBG may be a contributing factor to the poor glycaemic control in the country. (C) 2017 Elsevier B. V. All rights reserved.	[Mbanya, Jean Claude; Saji, Jude] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Mbanya, Jean Claude; Saji, Jude] Univ Yaounde I, Lab Mol Med & Metab, Biotechnol Ctr, Yaounde, Cameroon; [Mbanya, Jean Claude] Hlth Populat Transit Med Res Grp, POB 8046, Yaounde, Cameroon; [Aschner, Pablo] Javeriana Univ, Endocrinol Unit, Bogota, Colombia; [Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Peoples R China; [Gagliardino, Juan Jose] Natl Univ La Plata, Ctr Expt & Appl Endocrinol, Natl Sci & Tech Res Council,Sch Med, Pan Amer Hlth Org,World Hlth Org Collaborating Ct, La Plata, Buenos Aires, Argentina		Mbanya, JC (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.; Mbanya, JC (corresponding author), Univ Yaounde I, Lab Mol Med & Metab, Biotechnol Ctr, Yaounde, Cameroon.	jcmbanya@yahoo.co.uk; paschner@cable.net.co; jchan@cuhk.edu.hk; cenexaar@yahoo.com.ar; judesaji@yahoo.com	Saji, Jude/R-6395-2019; Chan, Juliana/B-7918-2016; Mbanya, Jean Claude N/T-5147-2018	Saji, Jude/0000-0002-5278-3647; Chan, Juliana/0000-0003-1325-1194; Mbanya, Jean Claude N/0000-0001-9651-8653	Sanofi [DIRED_R_05941]	Sanofi(Sanofi-Aventis)	The International Diabetes Management Practices Study (IDMPS) was funded by Sanofi, Sanofi study number DIRED_R_05941.	American Diabetes Association, 2007, DIABETES CARE, V30, pS3; Brown JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106716; Camara A, 2015, DIABETES RES CLIN PR, V108, P187, DOI 10.1016/j.diabres.2014.08.025; Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435; Clar C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14120; Elgart JF, 2016, ACTA DIABETOL, V53, P57, DOI 10.1007/s00592-015-0745-9; Farmer AJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e486; Houle J, 2015, DIABETIC MED, V32, P1247, DOI 10.1111/dme.12686; Jingi AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111812; Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2; Kengne AP, 2013, PROG CARDIOVASC DIS, V56, P302, DOI 10.1016/j.pcad.2013.10.011; Polonsky WH, 2011, DIABETES CARE, V34, P262, DOI 10.2337/dc10-1732; Poolsup N, 2009, DIABETES TECHNOL THE, V11, P775, DOI 10.1089/dia.2009.0091; Strowig SM, 1998, DIABETES CARE, V21, P1694, DOI 10.2337/diacare.21.10.1694; Towfigh A, 2008, AM J MANAG CARE, V14, P468	15	7	9	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	APR	2017	126						198	201		10.1016/j.diabres.2016.11.029	http://dx.doi.org/10.1016/j.diabres.2016.11.029			4	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	EW4JM	28259009				2022-09-04	WOS:000402467800025
J	Srygley, RB; Dudley, R; Oliveira, EG; Riveros, AJ				Srygley, Robert B.; Dudley, Robert; Oliveira, Evandro G.; Riveros, Andre J.			El Nino, Host Plant Growth, and Migratory Butterfly Abundance in a Changing Climate	BIOTROPICA			English	Article						climate change; drought; ENSO; phenology; plant-insect interaction; tropical rain forest	WIND DRIFT COMPENSATION; TROPICAL DEFORESTATION; RAINFALL; ENSO; VARIABILITY; PHENOLOGY; AMPLITUDE; DYNAMICS; PATTERNS; INSECTS	In the wet forests of Panama, El Nino typically brings a more prolonged and severe dry season. Interestingly, many trees and lianas that comprise the wet forests increase their productivity as a response to El Nino. Here, we quantify the abundance of migrating Marpesia chiron butterflies over 17yr and the production of new leaves of their hostplants over 9yr to test the generality of the El Nino migration syndrome, i.e., whether increased abundance of migrating insects and productivity of their food plants are associated with El Nino and La Nina events. We find that the quantity of M. chiron migrating across the Panama Canal was directly proportional to the sea surface temperature (SST) anomaly of the Pacific Ocean, which characterizes El Nino and La Nina events. We also find that production of new leaves by its larval host trees, namely Brosimum alicastrum, Artocarpus altilis, and Ficus citrifolia, was directly proportional to the SST anomaly, with greater leaf flushing occurring during the period of the annual butterfly migration that followed an El Nino event. Combining these and our previously published results for the migratory butterfly Aphrissa statira and its host lianas, we conclude that dry season rainfall and photosynthetically active radiation can serve as primary drivers of larval food production and insect population outbreaks in Neotropical wet forests, with drier years resulting in enhanced plant productivity and herbivore abundance. Insect populations should closely track changes in both frequency and amplitude of the El Nino Southern Oscillation with climate change.	[Srygley, Robert B.] ARS, USDA, Northern Plains Agr Res Lab, Sidney, MT 59270 USA; [Srygley, Robert B.; Dudley, Robert; Riveros, Andre J.] Smithsonian Trop Res Inst, Balboa 2072, Panama; [Dudley, Robert] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Oliveira, Evandro G.] Ctr Univ Una, Inst Ciencias Biol & Saude, BR-30180100 Belo Horizonte, MG, Brazil; [Riveros, Andre J.] Pontificia Univ Javeriana, Fac Med, Dept Ciencias Fisiol, Bogota, Colombia		Srygley, RB (corresponding author), ARS, USDA, Northern Plains Agr Res Lab, 1500 N Cent Ave, Sidney, MT 59270 USA.	robert.srygley@ars.usda.gov		Riveros, Andre J./0000-0001-7928-1885	National Geographic Society Committeee for Research and Exploration; Smithsonian Tropical Research Institute (STRI); Smithsonian Institution	National Geographic Society Committeee for Research and Exploration(National Geographic Society); Smithsonian Tropical Research Institute (STRI)(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Institution(Smithsonian Institution)	We thank Rafael Aizprua, Javier Hernandez, Felix Matias, and Nicole Z. Pelaez for assisting with the plant and butterfly censuses. We also thank J. Wright and an anonymous reviewer for suggestions to improve the paper. Grants from the National Geographic Society Committeee for Research and Exploration, the Smithsonian Tropical Research Institute (STRI), and the Smithsonian Institution supported the research. The Autoridad Nacional del Ambiente (ANAM) granted permission to conduct the research in Panama. The Terrestrial Environmental Science Program at STRI provided the hydrological and radiation data. The Meteorological and Hydrological Branch of the Panama Canal Authority (ACP) provided beginning and end dates for the dry seasons. This research could not have been accomplished without the long-term weather data collected by ACP and STRI, and we thank these institutions for their continuing efforts.	Beccaloni George W., 2008, m3m Monografias Tercer Milenio, V8, P1; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Coelho CAS, 2009, J CLIMATE, V22, P6456, DOI 10.1175/2009JCLI3185.1; Coley PD, 1998, CLIMATIC CHANGE, V39, P455, DOI 10.1023/A:1005307620024; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; DeVries P.J., 1986, Journal of Research on the Lepidoptera, V24, P290; DeVries P.J., 1987, BUTTERFLIES COSTA RI; Foley JA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001872; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Kleinbaum D.G., 1988, APPL REGRESSION ANAL; Leigh Jr E. G, 1999, TROPICAL FOREST ECOL; Li JB, 2011, NAT CLIM CHANGE, V1, P114, DOI [10.1038/NCLIMATE1086, 10.1038/nclimate1086]; Lyon B, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020901; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Meserve PL, 2003, BIOSCIENCE, V53, P633, DOI 10.1641/0006-3568(2003)053[0633:TYOSTA]2.0.CO;2; Morrison SA, 2002, OECOLOGIA, V133, P315, DOI 10.1007/s00442-002-1040-3; Mujica N, 2011, ENVIRON ENTOMOL, V40, P217, DOI 10.1603/EN10170; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Polis GA, 1997, ECOLOGY, V78, P1884; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; SRYGLEY RB, 1990, AM NAT, V135, P766, DOI 10.1086/285073; Srygley RB, 2001, J NAVIGATION, V54, P405, DOI 10.1017/S0373463301001448; Srygley RB, 1996, P ROY SOC B-BIOL SCI, V263, P1351, DOI 10.1098/rspb.1996.0198; Srygley RB, 2008, INTEGR COMP BIOL, V48, P119, DOI 10.1093/icb/icn011; Srygley RB, 2010, GLOBAL CHANGE BIOL, V16, P936, DOI 10.1111/j.1365-2486.2009.01986.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stevenson S, 2012, J CLIMATE, V25, P2129, DOI 10.1175/JCLI-D-11-00252.1; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Todd MC, 2002, J APPL ECOL, V39, P31, DOI 10.1046/j.1365-2664.2002.00691.x; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; Vandenbosch R, 2003, GLOBAL CHANGE BIOL, V9, P785, DOI 10.1046/j.1365-2486.2003.00621.x; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552; Xian Xiaoqing, 2007, Acta Ecologica Sinica, V27, P3144, DOI 10.1016/S1872-2032(07)60069-9; Yeh SW, 2007, J CLIMATE, V20, P203, DOI 10.1175/JCLI4001.1; Yu JY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052483; Zhang H, 1996, J CLIMATE, V9, P2498, DOI 10.1175/1520-0442(1996)009<2498:IOTDPI>2.0.CO;2; Zhang H, 1996, J CLIMATE, V9, P1497, DOI 10.1175/1520-0442(1996)009<1497:IOTDPI>2.0.CO;2	46	19	21	0	72	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3606	1744-7429		BIOTROPICA	Biotropica	JAN	2014	46	1					90	97		10.1111/btp.12081	http://dx.doi.org/10.1111/btp.12081			8	Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	284BB					2022-09-04	WOS:000329289900012
J	Reid, J; de Vries, E; Ahmedzai, SH; Arias-Rojas, M; Calvache, JA; Gomez-Sarmiento, SC; Gomez-Serrano, ML; Parra-Cubides, SL; Prue, G; Luna, SM				Reid, Joanne; de Vries, Esther; Ahmedzai, Sam H.; Arias-Rojas, Mauricio; Calvache, Jose Andres; Gomez-Sarmiento, Susana Carolina; Gomez-Serrano, Monica Lucia; Parra-Cubides, Sandra Liliana; Prue, Gillian; Moreno Luna, Socorro			Palliative Care and Oncology in Colombia: The Potential of Integrated Care Delivery	HEALTHCARE			English	Editorial Material							ADVANCED CANCER; OUTCOMES		[Reid, Joanne; Prue, Gillian] Queens Univ Belfast, Sch Nursing & Midwifery, Med Biol Ctr, Belfast BT9 7BL, Antrim, North Ireland; [de Vries, Esther; Moreno Luna, Socorro] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota 110231, Colombia; [Ahmedzai, Sam H.] Univ Sheffield, Med Sch, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England; [Arias-Rojas, Mauricio] Univ Antioquia, Fac Nursing, Medellin 050010, Colombia; [Calvache, Jose Andres] Univ Cauca, Dept Anesthesiol, Popayan 760032, Colombia; [Gomez-Sarmiento, Susana Carolina] Liga Colombiana El Canc, Pain & Palliat Care Phys, Bogota 110231, Colombia; [Gomez-Serrano, Monica Lucia] Liga Colombiana El Canc, Colombian Canc League, Holist Volunteering Support VIDA, Bogota 110231, Colombia; [Parra-Cubides, Sandra Liliana] Clin Rosario, Palliat Care & Pain Med Serv, Medellin 050010, Colombia		Reid, J (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, Med Biol Ctr, Belfast BT9 7BL, Antrim, North Ireland.	j.reid@qub.ac.uk; estherdevries@javeriana.edu.co; s.ahmedzai@sheffield.ac.uk; emauricio.arias@udea.edu.co; jacalvache@unicauca.edu.co; cuidadospaliativos@ligacancercolombia.org; matana44@yahoo.es; dolor@clinicaelrosario.com; g.prue@qub.ac.uk; Isabel.moreno@javeriana.edu.co	Calvache, Jose Andres/V-7932-2019; de Vries, Esther/A-6603-2009	Calvache, Jose Andres/0000-0001-9421-3717; de Vries, Esther/0000-0002-5560-2258; Ahmedzai, Sam/0000-0002-2028-8510; Reid, Joanne/0000-0001-5820-862X; Prue, Gillian/0000-0003-2198-3731				Ahmed N, 2021, AGE AGEING, V50, P366, DOI 10.1093/ageing/afaa266; Ahmedzai SH, 2004, EUR J CANCER, V40, P2192, DOI 10.1016/j.ejca.2004.06.009; Ahmedzai SH, 2000, SEMIN ONCOL, V27, P1; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Bakitas MA, 2015, J CLIN ONCOL, V33, P1438, DOI 10.1200/JCO.2014.58.6362; Brinkman DJ, 2011, BASIC CLIN PHARMACOL, V109, P122; Calvache José A., 2020, Rev. colomb. anestesiol., V48, pe201, DOI 10.1097/cj9.0000000000000159; Carney P A, 1999, Acad Med, V74, pS59, DOI 10.1097/00001888-199901000-00033; Congreso de la Republica de Colombia, 2014, LEY CONS DEV CAAV ME LEY CONS DEV CAAV ME, P5; Cox-Seignoret K, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-0516-4; Crocker H, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05374-4; de Vries E, 2018, J Cancer Policy, V15, P104, DOI 10.1016/j.jcpo.2018.01.003; Dionne-Odom JN, 2015, J CLIN ONCOL, V33, P1446, DOI 10.1200/JCO.2014.58.7824; Donkor A, 2018, INT J PUBLIC HEALTH, V63, P1047, DOI 10.1007/s00038-018-1142-2; Ferrell BR, 2017, J CLIN ONCOL, V35, P96, DOI 10.1200/JCO.2016.70.1474; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Hassankhani H, 2020, J CANCER EDUC, V35, P3, DOI 10.1007/s13187-019-01532-3; Hasselaar J., 2016, INTEGRATED PALLIATIV; Haun MW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011129.pub2; Hjermstad MJ, 2020, TRIALS, V21, DOI 10.1186/s13063-020-4224-4; Jackson K, 2015, PALLIATIVE CARE GLOB; Kaasa S, 2018, LANCET ONCOL, V19, pE588, DOI 10.1016/S1470-2045(18)30415-7; Knaul FM, 2018, LANCET ONCOL, V19, pE566, DOI 10.1016/S1470-2045(18)30600-4; Knaul FM, 2018, LANCET, V391, P1391, DOI 10.1016/S0140-6736(17)32513-8; Luna-Meza A, 2021, BMC PALLIAT CARE, V20, P76, DOI 10.1186/s12904-021-00768-5; National Institute for Clinical Excellence, 2004, GUID CANC SERV IMPR; Osman Hibah, 2018, J Glob Oncol, V4, P1, DOI 10.1200/JGO.18.00026; Pastrana T., 2021, ATLAS CUIDADOS PALIA, V2; Sanchez-Cardenas MA, 2021, J PAIN SYMPTOM MANAG, V62, P293, DOI 10.1016/j.jpainsymman.2020.12.010; Schenker Y, 2014, J PALLIAT MED, V17, P667, DOI 10.1089/jpm.2013.0537; Strasser-Weippl K, 2015, LANCET ONCOL, V16, P1405, DOI 10.1016/S1470-2045(15)00218-1; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; United Nations, 2019, WORLD POPULATION AGE; Uribe C, 2019, CIENC SAUDE COLETIVA, V24, P1596, DOI 10.1590/1413-81232018245.04432019; World Health Organisation, 2018, NONC DIS COUNTR PROF; World Health Organization, FRAM INT PEOPL CENTR; World Health Organization, PALL CAR; Worldwide Hospice Palliative Care Alliance (WHPCA) : WHO, 2020, GLOBAL ATLAS PALLIAT, V2nd; Zimmermann Camilla, 2019, BMJ Support Palliat Care, DOI 10.1136/bmjspcare-2019-001903; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	41	2	2	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9032		HEALTHCARE-BASEL	Healthcare	JUL	2021	9	7							789	10.3390/healthcare9070789	http://dx.doi.org/10.3390/healthcare9070789			5	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	TO1XX	34201639	Green Published			2022-09-04	WOS:000676714800001
J	Caicedo-Martinez, M; Li, B; Gonzalez-Motta, A; Gamboa, O; Bobadilla, I; Wiesner, C; Murillo, R				Caicedo-Martinez, Maria; Li, Benjamin; Gonzalez-Motta, Alejandro; Gamboa, Oscar; Bobadilla, Ivan; Wiesner, Carolina; Murillo, Raul			Radiation Oncology in Colombia: An Opportunity for Improvement in the Postconflict Era	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Editorial Material									[Caicedo-Martinez, Maria; Murillo, Raul] Hosp Univ San Ignacio, Ctr Javeriano Oncol, Bogota, Colombia; [Li, Benjamin] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Li, Benjamin] Rayos Canc, Nashville, TN USA; [Gonzalez-Motta, Alejandro] Hosp Univ San Ignacio, Div Radiat Oncol, Ctr Javeriano Oncol, Bogota, Colombia; [Gonzalez-Motta, Alejandro; Bobadilla, Ivan] Asociac Colombiana Radioterapia Oncol, Bogota, Colombia; [Gamboa, Oscar; Wiesner, Carolina] Inst Nacl Cancerol, Bogota, Colombia; [Bobadilla, Ivan] Clin Country, Div Radiat Oncol, Ctr Control Canc, Bogota, Colombia; [Murillo, Raul] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia		Caicedo-Martinez, M (corresponding author), Hosp Univ San Ignacio, Ctr Javeriano Oncol, Bogota, Colombia.	caicedom.maria@gmail.com	Murillo, Raúl/AAY-4416-2021	Caicedo-Martinez, Maria/0000-0001-5799-2096				Buitrago-Garci D, BUDGET IMPACT ANAL R; Colombian Association of Radiation Oncology, REPRESENTATIVENESS R; Colombian Fund for High Cost Diseases High Cost Account [CAC], 2019, CANC SITUATION ADULT; de Vries E, 2018, J Cancer Policy, V15, P104, DOI 10.1016/j.jcpo.2018.01.003; García-Ubaque Juan Carlos, 2008, Rev. salud pública, V10, P583; International Agency for Research on Cancer, 2018, GLOBAL CANC OBSERVAT; International Atomic Energy Agency, DATABASE; Jurado FDM, 2011, U SALUD, V13, P19; Ministry of Health and Social Protection, 2019, HLTH SITUATION ANAL; Ministry of Health and Social Protection, 2019, HLTH ASSURANCE FIGUR; Ministry of Health and Social Protection, INTEGRATED SOCIAL PR; Ministry of Health. Government of Colombia, 2018, UPDATING TARIFF REGI; Murillo R, 2017, MODEL CANC CARE COLO, V5; Murillo R, 2020, JCO GLOB ONCOL, V6, P190, DOI 10.1200/JGO.19.00195; National Administrative Department of Statistics, NATL POPULATION HOUS; National Health Service, 2010, MODEL CARE CANC SERV; National Institute of Cancerology ESE, 2017, ANAL CANC SITUATION, V1st; National Institute of Health. National Health Observatory, 2017, 9 TECHNICAL REPORT; National Planning Department-Special Projects Group, 2016, INDEX INCIDENCE ARME; Ospino R, 2019, REV COLOMB CANCEROL, V23, P45, DOI 10.35509/01239015.59; Pan American Health Organization, 2009, PROFILE HLTH SYSTEM; Sánchez-Vanegas Guillermo, 2013, Rev. salud pública, V15, P671; Teckie S, 2014, J CLIN ONCOL, V32, P2864, DOI 10.1200/JCO.2014.55.1150; The UN Refugee Agency (UNHCR), AMERICAS; The World Bank, COLOMBIA	25	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	APR 1	2021	109	5					1142	1150		10.1016/j.ijrobp.2020.12.006	http://dx.doi.org/10.1016/j.ijrobp.2020.12.006		MAR 2021	9	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Radiology, Nuclear Medicine & Medical Imaging	RB3FA	33714525				2022-09-04	WOS:000631998800006
J	Yaribeygi, H; Atkin, SL; Simental-Mendia, LE; Barreto, GE; Sahebkar, A				Yaribeygi, Habib; Atkin, Stephen L.; Simental-Mendia, Luis E.; Barreto, George E.; Sahebkar, Amirhossein			Anti-inflammatory effects of resolvins in diabetic nephropathy: Mechanistic pathways	JOURNAL OF CELLULAR PHYSIOLOGY			English	Review						diabetic nephropathy; inflammation; NF-B; oxidative stress; resolvin D1; resolvin E1	POLYUNSATURATED FATTY-ACIDS; DIETARY FISH-OIL; CAPILLARY ENDOTHELIAL FENESTRATION; OXIDE SYNTHASE ACTIVITY; OXIDATIVE STRESS; KIDNEY-DISEASE; INFLAMMATION-RESOLUTION; PODOCYTE DETACHMENT; GLYCEMIC CONTROL; POSSIBLE LINK	The incidence of diabetes mellitus is growing rapidly. The exact pathophysiology of diabetes is unclear, but there is increasing evidence of the role of the inflammatory response in both developing diabetes as well as its complications. Resolvins are naturally occurring polyunsaturated fatty acids that are found in fish oil and sea food that have been shown to possess anti-inflammatory actions in several tissues including the kidneys. The pathways by which resolvins exert this anti-inflammatory effect are unclear. In this review we discuss the evidence showing that resolvins can suppress inflammatory responses via at least five molecular mechanisms through inhibition of the nucleotide-binding oligomerization domain protein 3 inflammasome, inhibition of nuclear factor B molecular pathways, improvement of oxidative stress, modulation of nitric oxide synthesis/release and prevention of local and systemic leukocytosis. Complete understanding of these molecular pathways is important as this may lead to the development of new effective therapeutic strategies for diabetes and diabetic nephropathy.	[Yaribeygi, Habib] Shahid Beheshti Univ Med Sci, Chron Kidney Dis Res Ctr, Tehran 1985717443, Iran; [Atkin, Stephen L.] Weill Cornell Med Qatar, Doha, Qatar; [Simental-Mendia, Luis E.] Mexican Social Secur Inst, Biomed Res Unit, Durango, Mexico; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Yaribeygi, H (corresponding author), Shahid Beheshti Univ Med Sci, Chron Kidney Dis Res Ctr, Tehran 1985717443, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Razavi Khorasan, Iran.	habib.yari@yahoo.com; sahebkara@mums.ac.ir	Yaribeygi, Habib/R-8998-2019; Atkin, stephen/ABE-7047-2020; Barreto, George E./AAD-7420-2020; Sahebkar, Amirhossein/B-5124-2018; Atkin, Stephen/D-7400-2014	Yaribeygi, Habib/0000-0002-1706-6212; Barreto, George E./0000-0002-6644-1971; Atkin, Stephen/0000-0002-5887-7257				Agrawal NK, 2014, WORLD J DIABETES, V5, P697, DOI 10.4239/wjd.v5.i5.697; Ali S. R, 2016, INFLAMMASOME, V2, P7; An WS, 2009, AM J PHYSIOL-RENAL, V297, pF895, DOI 10.1152/ajprenal.00217.2009; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Balta MG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01682; Barden A, 2018, PROSTAG LEUKOTR ESS, V133, P29, DOI 10.1016/j.plefa.2018.04.004; Benabdoune H, 2016, INFLAMM RES, V65, P635, DOI 10.1007/s00011-016-0946-x; Borgeson E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00318; Brown SA, 1998, J LAB CLIN MED, V131, P447, DOI 10.1016/S0022-2143(98)90146-9; Bruno G, 2003, DIABETES CARE, V26, P2150, DOI 10.2337/diacare.26.7.2150; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Cardenas C, 2004, Diabetes Care, V27, P1454, DOI 10.2337/diacare.27.6.1454; CHAET MS, 1994, J SURG RES, V57, P65, DOI 10.1006/jsre.1994.1111; Chen Y, 2018, INT IMMUNOPHARMACOL, V59, P252, DOI 10.1016/j.intimp.2018.03.023; CollieDuguid ESR, 1996, BIOCHEM BIOPH RES CO, V220, P969, DOI 10.1006/bbrc.1996.0516; Cox R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136755; Dangi B, 2010, BIOCHEM PHARMACOL, V79, P251, DOI 10.1016/j.bcp.2009.08.001; Das UN, 2013, NUTRITION, V29, P1, DOI 10.1016/j.nut.2012.02.003; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; De Boer AA, 2016, J NUTR BIOCHEM, V34, P61, DOI 10.1016/j.jnutbio.2016.04.004; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Dellamea BS, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-17; Dmitrieva N, 2014, FERTIL STERIL, V102, P1191, DOI 10.1016/j.fertnstert.2014.06.046; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; Donadio JV, 2004, SEMIN NEPHROL, V24, P225, DOI 10.1016/j.semnephrol.2004.01.004; Duvall MG, 2016, EUR J PHARMACOL, V785, P144, DOI 10.1016/j.ejphar.2015.11.001; DYERBERG J, 1979, LANCET, V2, P433, DOI 10.1016/S0140-6736(79)91490-9; Eickmeier O, 2013, MUCOSAL IMMUNOL, V6, P256, DOI 10.1038/mi.2012.66; El-Mesery ME, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-6; Engstrom K, 2009, UPSALA J MED SCI, V114, P206, DOI 10.3109/03009730903268958; ERITSLAND J, 1995, BLOOD COAGUL FIBRIN, V6, P17, DOI 10.1097/00001721-199502000-00003; Gao Y, 2017, J IMMUNOL, V199, P2043, DOI 10.4049/jimmunol.1700315; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gonzalez-Reyes RE, 2016, CURR PHARM DESIGN, V22, P812, DOI 10.2174/1381612822666151209152013; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Haffner S, 2005, DIABETES, V54, pA1; Halade GV, 2010, J IMMUNOL, V184, P5280, DOI 10.4049/jimmunol.0903282; Herishanu Y, 2006, EUR J HAEMATOL, V76, P516, DOI 10.1111/j.1600-0609.2006.00658.x; Herrera BS, 2015, INFECT IMMUN, V83, P792, DOI 10.1128/IAI.02444-14; Hilpert KF, 2007, AM J CLIN NUTR, V85, P369, DOI 10.1093/ajcn/85.2.369; Kamei N., 2017, ADV MOD MED, P188, DOI [10.2174/9781681080239115010022, DOI 10.2174/9781681080239115010022]; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Karstoft K, 2016, IMMUNOL CELL BIOL, V94, P146, DOI 10.1038/icb.2015.101; KATARY M, 2017, FASEB J S1, V31, P1028; Kohli P, 2009, BRIT J PHARMACOL, V158, P960, DOI 10.1111/j.1476-5381.2009.00290.x; Lakshmi D, 2012, NEUROCHEM RES, V37, P1859, DOI 10.1007/s11064-012-0794-1; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee H.-N., 2013, J CELL SCI; Li G, 2017, IOP C SER EARTH ENV, V59, DOI 10.1088/1755-1315/59/1/012002; Liao ZL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-110; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martins MA, 2014, FOOD FUNCT, V5, P3208, DOI [10.1039/c4fo00055b, 10.1039/C4FO00055B]; MCVEIGH GE, 1993, DIABETOLOGIA, V36, P33, DOI 10.1007/BF00399090; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Monk JM, 2015, J NUTR, V145, P829, DOI 10.3945/jn.114.205443; Moon Y, 2003, J NUTR BIOCHEM, V14, P717, DOI 10.1016/j.jnutbio.2003.08.009; Moro K, 2016, WORLD J CLIN CASES, V4, P155, DOI 10.12998/wjcc.v4.i7.155; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakamura N, 2011, NEPHRON EXTRA, V1, P139, DOI 10.1159/000333479; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; Obrosov Alexander, 2017, J Neurol Neurophysiol, V8, DOI 10.4172/2155-9562.1000453; Ogilvie GK, 2000, CANCER, V88, P1916, DOI 10.1002/(SICI)1097-0142(20000415)88:8&lt;1916::AID-CNCR22&gt;3.0.CO;2-F; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Parinyasiri Uraiwan, 2004, Journal of the Medical Association of Thailand, V87, P143; Peake JM, 2011, MOL NUTR FOOD RES, V55, P400, DOI 10.1002/mnfr.201000195; Pfutzner A, 2005, J AM COLL CARDIOL, V45, P1925, DOI 10.1016/j.jacc.2005.03.041; PRICKETT JD, 1981, J CLIN INVEST, V68, P556, DOI 10.1172/JCI110288; Qu Q, 2015, CELL BIOL INT, V39, P3, DOI 10.1002/cbin.10345; Rabkin Ralph, 2003, Clin Cornerstone, V5, P1, DOI 10.1016/S1098-3597(03)90014-7; Ramos-Zavala MG, 2011, DIABETES CARE, V34, P1591, DOI 10.2337/dc11-0357; Sakai C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187934; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan C. N., 2018, J CLIN INVEST, V128, P6; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shapiro H, 2011, NAT REV NEPHROL, V7, P110, DOI 10.1038/nrneph.2010.156; Shevalye H, 2015, J NEUROPHYSIOL, V114, P199, DOI 10.1152/jn.00224.2015; SHIMIZU H, 1995, DIABETES RES CLIN PR, V28, P35, DOI 10.1016/0168-8227(95)01056-J; Spite M, 2009, BRIT J PHARMACOL, V158, P1062, DOI 10.1111/j.1476-5381.2009.00234.x; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Takahashi T., 2014, J DIABETES RES, V2014, P2014; Tapp RJ, 2004, AM J KIDNEY DIS, V44, P792, DOI 10.1053/j.ajkd.2004.07.006; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Wachira JK, 2014, BRIT J NUTR, V111, P1652, DOI 10.1017/S000711451300425X; Wachtler P, 1997, J TRAUMA, V42, P191, DOI 10.1097/00005373-199702000-00004; Wang J, 2012, NUTRITION, V28, P623, DOI 10.1016/j.nut.2011.08.004; Wang L, 2014, CHINESE MED J-PEKING, V127, P803, DOI 10.3760/cma.j.issn.0366-6999.20131044; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yaribeygi H., 2018, DRUG DISCOV TODAY; Yaribeygi H., 2018, J CELLULAR PHYSL; Yaribeygi H, 2018, METABOLISM, V87, P48, DOI 10.1016/j.metabol.2018.07.001; Yaribeygi H, 2018, J CELL BIOCHEM, V119, P7458, DOI 10.1002/jcb.27055; Yaribeygi H, 2018, J CELL BIOCHEM, V119, P6080, DOI 10.1002/jcb.26806; Yaribeygi H, 2018, J CELL BIOCHEM, V119, P2990, DOI 10.1002/jcb.26450; Yin YZ, 2017, MOL VIS, V23, P242; Zghebi SS, 2017, DIABETES OBES METAB, V19, P1537, DOI 10.1111/dom.12964	102	17	17	1	40	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	SEP	2019	234	9					14873	14882		10.1002/jcp.28315	http://dx.doi.org/10.1002/jcp.28315			10	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	IB3NM	30746696				2022-09-04	WOS:000470174200041
J	James, EK; Saxena, A; Restrepo, CF; Llorente, B; Vecino-Ortiz, AI; Uribe, MV; Iunes, RF; Verguet, S				James, Erin Kinsella; Saxena, Akshar; Franco Restrepo, Camila; Llorente, Blanca; Vecino-Ortiz, Andres I.; Uribe, Manuela Villar; Iunes, Roberto F.; Verguet, Stephane			Distributional health and financial benefits of increased tobacco taxes in Colombia: results from a modelling study	TOBACCO CONTROL			English	Article							EXCISE TAX; SMOKING; SMOKERS; CONSEQUENCES; IMPACT; PRICE	Background In Colombia, smoking is the second leading modifiable risk factor for premature mortality. In December 2016, Colombia passed a major tax increase on tobacco products in an effort to decrease smoking and improve population health. While tobacco taxes are known to be highly effective in reducing the prevalence of smoking, they are often criticised as being regressive in consumption. This analysis attempts to assess the distributional impact (across socioeconomic groups) of the new tax on selected health and financial outcomes. Methods This study builds on extended cost-effectiveness analysis methods to study the new tobacco tax in Colombia, and estimates, over a time period of 20 years and across income quintiles of the current urban population (80% of the country population), the years of life gained with smoking cessation and the increased tax revenues, all associated with a 70% relative price increase of the pack of cigarettes. Where possible, we use parameters that vary by income quintile, including price elasticity of demand for cigarettes (average of -0.44 estimated from household survey data). Findings Over 20 years, the tax increase would lead to an estimated 191000 years of life gained among Colombia's current urban population, with the largest gains among the bottom two income quintiles. The additional annual tax revenues raised would amount to about 2%-4% of Colombia's annual government health expenditure, with the poorest quintiles bearing the smallest tax burden increase. Conclusions The tobacco tax increase passed by Colombia has substantial implications for the country's population health and financial well-being, with large benefits likely to accrue to the two poorest quintiles of the population.	[James, Erin Kinsella; Saxena, Akshar; Verguet, Stephane] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Franco Restrepo, Camila] Minist Hlth & Social Protect, Bogota, Colombia; [Llorente, Blanca] Fundac Anaas, Bogota, Colombia; [Vecino-Ortiz, Andres I.] Univ Javeriana, Inst Publ Hlth, Bogota, Colombia; [Vecino-Ortiz, Andres I.] Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Uribe, Manuela Villar; Iunes, Roberto F.] World Bank, 1818 H St NW, Washington, DC 20433 USA		Verguet, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	verguet@hsph.harvard.edu	Vecino-Ortiz, Andres I./R-4022-2019	Vecino-Ortiz, Andres I./0000-0002-8089-2488; Saxena, Akshar/0000-0001-8518-0466; Llorente, Blanca/0000-0003-3350-1648; James, Erin/0000-0003-0172-5292	World Bank; World Bank's Global Tobacco Program; Bill & Melinda Gates Foundation; Bloomberg Foundation	World Bank(The World Bank India); World Bank's Global Tobacco Program; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Bloomberg Foundation	Funding for this study was provided by the World Bank and the World Bank's Global Tobacco Program, co-financed by the Bill & Melinda Gates Foundation and the Bloomberg Foundation. An earlier version of this paper was published as a World Bank working paper (James, Saxena, Franco Restrepo, et al. World Bank, Washington, DC 2017: https://openknowledge.worldbank.org/handle/10986/28598. License: CC BY 3.0 IGO) and was presented during seminars at the Ministry of Health and Social Protection and the Ministry of Finance and Public Credit, Colombia, and at the Harvard T H Chan School of Public Health, where we received valuable comments from seminar participants as well as from Andres Escobar, Alan Fuchs, Alejandro Gaviria, Patricio Marquez, Margaret McConnell, Francisco Meneses, Ece Ozcelik, Michael Reich and Juanita Carolina Bodmer Rico. The findings, interpretations, and conclusions in this article are entirely those of the authors. Responsibility for the views and opinions expressed rests solely with the authors; they are not endorsed by any member institution of the World Bank Group, its Executive Directors, or the countries they represent.	[Anonymous], 2011, IARC HDB CANC PREV T, V14; [Anonymous], B EPIDEMIOL HEBD; Chaloupka FL, 2012, TOB CONTROL, V21, P329, DOI 10.1136/tobaccocontrol-2011-050417corr1; Chaloupka FJ, 1997, J HEALTH ECON, V16, P359, DOI 10.1016/S0167-6296(96)00530-9; Choi SE, 2016, TOB CONTROL, V25, P141, DOI 10.1136/tobaccocontrol-2014-051680; DANE,, 2005, EST PROYECC POBL NAC; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Fuchs A, 2018, TOBACCO PRICE ELASTI; Fuchs A, 2017, 7988 WORLD BANK; Iglesias RM, 2016, REV PANAM SALUD PUBL, V40, P243; Jha Prabhat, 2014, NEW ENGL J MED, V370, P60, DOI DOI 10.1056/NEJMra1308383; Joossens L, 2008, TOB CONTROL, V17, P399, DOI 10.1136/tc.2008.026567; Linegar DJ, 2018, TOB CONTROL, V27, P65, DOI 10.1136/tobaccocontrol-2016-053340; Maldonado N, 2016, REV PANAM SALUD PUBL, V40, P229; Ministerio de Salud y Proteccion Social, 2013, PLAN DEC SAL PUBL PD; OECD, 2015, OECD REV HLTH SYST C; Pichon-Riviere A, 2013, CARGA ENFERMEDAD ATR; Pichon-Riviere A, 2016, REV PANAM SALUD PUBL, V40, P213; Postolovska I, 2018, HEALTH SYST REFORM, V4, P30, DOI 10.1080/23288604.2017.1413494; Salti N, 2016, SOC SCI MED, V170, P161, DOI 10.1016/j.socscimed.2016.10.020; Verguet S, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020701; Verguet S, 2016, PHARMACOECONOMICS, V34, P913, DOI 10.1007/s40273-016-0414-z; Verguet S, 2015, LANCET GLOB HEALTH, V3, pE206, DOI 10.1016/S2214-109X(15)70095-1; Verguet S, 2015, HEALTH ECON, V24, P318, DOI 10.1002/hec.3019; WHO, 2010, WHO TECHNICAL MANUAL ON TOBACCO TAX ADMINISTRARTION, P1; World Health Organization, 2017, WHO REPORT GLOBAL TO; World Health Organization, 2017, NONC DIS PROGR MON; [No title captured]; [No title captured]	29	12	12	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0964-4563	1468-3318		TOB CONTROL	Tob. Control	JUL	2019	28	4					374	380		10.1136/tobaccocontrol-2018-054378	http://dx.doi.org/10.1136/tobaccocontrol-2018-054378			7	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	IJ1HO	30093415				2022-09-04	WOS:000475649600004
J	Yaribeygi, H; Zare, V; Butler, AE; Barreto, GE; Sahebkar, A				Yaribeygi, Habib; Zare, Vahid; Butler, Alexandra E.; Barreto, George E.; Sahebkar, Amirhossein			Antidiabetic potential of saffron and its active constituents	JOURNAL OF CELLULAR PHYSIOLOGY			English	Review						crocin; Crocus sativus; diabetes mellitus; inflammation; insulin signal transduction; oxidative stress; saffron; safranal	NECROSIS-FACTOR-ALPHA; CROCUS-SATIVUS L.; OXIDATIVE STRESS; DIABETES-MELLITUS; INSULIN SENSITIVITY; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISMS; METABOLIC SYNDROME; MEDICINAL-PLANTS; IN-VITRO	The prevalence of diabetes mellitus is growing rapidly worldwide. This metabolic disorder affects many physiological pathways and is a key underlying cause of a multitude of debilitating complications. There is, therefore, a critical need for effective diabetes management. Although many synthetic therapeutic glucose-lowering agents have been developed to control glucose homeostasis, they may have unfavorable side effects or limited efficacy. Herbal-based hypoglycemic agents present an adjunct treatment option to mitigate insulin resistance, improve glycemic control and reduce the required dose of standard antidiabetic medications. Saffron (Crocus sativus L.), whilst widely used as a food additive, is a natural product with insulin-sensitizing and hypoglycemic effects. Saffron contains several bioactive beta carotenes, which exert their pharmacological effects in various tissues without any obvious side effects. In this study, we discuss how saffron and its major components exert their hypoglycemic effects by induction of insulin sensitivity, improving insulin signaling and preventing beta-cell failure, all mechanisms combining to achieve better glycemic control.	[Yaribeygi, Habib] Shahid Beheshti Univ Med Sci, Chron Kidney Dis Res Ctr, Tehran 1666677951, Iran; [Zare, Vahid] Baqiyatallah Univ Med Sci, Appl Microbiol Res Ctr, Tehran, Iran; [Butler, Alexandra E.] Qatar Biomed Res Inst, Diabet Res Ctr, Doha, Qatar; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran		Yaribeygi, H (corresponding author), Shahid Beheshti Univ Med Sci, Chron Kidney Dis Res Ctr, Tehran 1666677951, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Iran.	habib.yari@yahoo.com; sahebkara@mums.ac.ir	Yaribeygi, Habib/R-8998-2019; Sahebkar, Amirhossein/B-5124-2018; Zare, Vahid/AAG-1772-2019; Barreto, George E./AAD-7420-2020	Yaribeygi, Habib/0000-0002-1706-6212; Zare, Vahid/0000-0003-4863-5024; Barreto, George E./0000-0002-6644-1971				Abe K, 2000, PHYTOTHER RES, V14, P149, DOI 10.1002/(SICI)1099-1573(200005)14:3&lt;149::AID-PTR665&gt;3.0.CO;2-5; Alexiou A., 2018, MOL NEUROBIOLOGY MOL; [Anonymous], 2017, BERNE LEVY PHYSL E B; [Anonymous], [No title captured]; Arasteh A, 2010, J MED PLANTS RES, V4, P397; Ashrafi M, 2015, DNA CELL BIOL, V34, P684, DOI 10.1089/dna.2015.2951; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Brownlee M, 2003, J CLIN INVEST, V112, P1788, DOI 10.1172/JCI200320501; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Chaudhury A, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00006; Chen Yu, 2015, Methods Mol Biol, V1298, P173, DOI 10.1007/978-1-4939-2569-8_14; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Dehghan F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25139; Domingueti CP, 2016, J DIABETES COMPLICAT, V30, P738, DOI 10.1016/j.jdiacomp.2015.12.018; Du JF, 2018, J CELL BIOCHEM, V119, P1746, DOI 10.1002/jcb.26335; Eddouks M, 2014, J PHARM PHARMACOL, V66, P1197, DOI 10.1111/jphp.12243; Elgazar AF., 2013, EUR J BIOL SCI, V5, P14; Elsherbiny NM, 2016, CHEM-BIOL INTERACT, V247, P39, DOI 10.1016/j.cbi.2016.01.014; Faerch K., 2016, DIABETES, V65; Fernandez-Millan E, 2015, MOL NUTR FOOD RES, V59, P820, DOI [10.1002/mnfr.201400746, 10.1002/mnfr]; Garg RC, 2016, NUTRACEUTICALS, P145; Ghadrdoost B, 2011, EUR J PHARMACOL, V667, P222, DOI 10.1016/j.ejphar.2011.05.012; Ghorbani M., 2008, World Applied Sciences Journal, V4, P523; Ghorbanzadeh V, 2017, PHARM SCI-IRAN, V23, P182, DOI [10.15171/PS.2017.27, 10.15171/ps.2017.27]; Gonzalez-Reyes RE, 2016, CURR PHARM DESIGN, V22, P812, DOI 10.2174/1381612822666151209152013; Hall J. E, 2021, GUYTON HALL TXB MED; Hatziagapiou K, 2018, CURR CARDIOL REV, V14, P272, DOI 10.2174/1573403X14666180628095918; Hazman O, 2016, TURK J MED SCI, V46, P1593, DOI 10.3906/sag-1506-108; Ho CK, 2016, MOL GENET METAB, V119, P288, DOI 10.1016/j.ymgme.2016.09.007; Hoshyar R, 2017, J PHARM PHARMACOL, V69, P1419, DOI 10.1111/jphp.12776; Hosseinzadeh H, 2013, PHYTOTHER RES, V27, P475, DOI 10.1002/ptr.4784; Hu F, 2018, FEBS LETT, V592, P644, DOI 10.1002/1873-3468.12982; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jam IN, 2017, ADV CLIN EXP MED, V26, P925, DOI 10.17219/acem/62891; Javadi B, 2017, CURR PHARM DESIGN, V23, P1623, DOI 10.2174/1381612822666161021143332; Javadi B, 2013, IRAN J BASIC MED SCI, V16, P1; Kang C, 2012, FOOD CHEM, V135, P2350, DOI 10.1016/j.foodchem.2012.06.092; Keane K. N., 2015, OXIDATIVE MED CELLUL, V2015; Kermani T, 2017, J RES PHARM PRACT, V6, P228, DOI 10.4103/jrpp.JRPP_17_26; Kianbakht S., 2011, Journal of Medicinal Plants, V10, P82; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Liadis N, 2005, MOL CELL BIOL, V25, P3620, DOI 10.1128/MCB.25.9.3620-3629.2005; Liou JC, 2018, J FUNCT FOODS, V49, P314, DOI 10.1016/j.jff.2018.08.031; Lopresti AL, 2014, HUM PSYCHOPHARM CLIN, V29, P517, DOI 10.1002/hup.2434; Lv BC, 2016, INT J MOL MED, V37, P225, DOI 10.3892/ijmm.2015.2418; Maeda A, 2014, MOL NUTR FOOD RES, V58, P1177, DOI 10.1002/mnfr.201300675; Maksimov ML, 2016, CURR PHARM DESIGN, V22, P895, DOI 10.2174/1381612822666151209153047; Malviya N, 2016, ANDROLOGIA, V48, P880, DOI 10.1111/and.12677; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Mayer-Davis EJ, 2017, NEW ENGL J MED, V376, P1419, DOI 10.1056/NEJMoa1610187; Milajerdi A, 2016, J MED PLANTS, V4, P142; Milajerdi A, 2018, J RES MED SCI, V23, DOI 10.4103/jrms.JRMS_286_17; Moradzadeh M, 2018, J CELL PHYSIOL, V233, P2170, DOI 10.1002/jcp.25953; Moraes-Vieira PM, 2016, DIABETES, V65, P1808, DOI 10.2337/db16-0221; Nam KN, 2010, EUR J PHARMACOL, V648, P110, DOI 10.1016/j.ejphar.2010.09.003; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nentwich MM, 2015, WORLD J DIABETES, V6, P489, DOI 10.4239/wjd.v6.i3.489; Nikbakht-Jam I, 2016, EUR J INTEGR MED, V8, P307, DOI 10.1016/j.eujim.2015.12.008; Poma Anna, 2012, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V11, P37; Putta S., 2017, CURRENT MED CHEM, V25; Putta S, 2017, CURR PHARM DESIGN, V23, P4475, DOI 10.2174/1381612823666170823103830; Rahiman N, 2018, MICROVASC RES, V118, P82, DOI 10.1016/j.mvr.2018.03.003; Rahmani A. H., 2017, Pharmacognosy Journal, V9, P873, DOI 10.5530/pj.2017.6.137; Rajaei Z, 2013, J MED FOOD, V16, P206, DOI 10.1089/jmf.2012.2407; Rameshrad M, 2018, EXPERT OPIN THER PAT, V28, P147, DOI 10.1080/13543776.2017.1355909; Riazi A, 2017, ITAL J MED, V11, P196, DOI 10.4081/itjm.2016.758; Riya MP, 2014, J SCI FOOD AGR, V94, P943, DOI 10.1002/jsfa.6340; Sadoughi S., 2017, J ARDABIL U MED SCI, V17, P198; Saleem F, 2017, IND CROP PROD, V107, P518, DOI 10.1016/j.indcrop.2017.06.023; Samarghandian S, 2016, CYTOKINE, V88, P20, DOI 10.1016/j.cyto.2016.08.002; Sarfarazi M, 2015, FOOD ANAL METHOD, V8, P2273, DOI 10.1007/s12161-014-9995-3; Schaper NC, 2016, DIABETES-METAB RES, V32, P7, DOI 10.1002/dmrr.2695; Sepahi S, 2018, AM J OPHTHALMOL, V190, P89, DOI 10.1016/j.ajo.2018.03.007; Shafiee M, 2018, J AFFECT DISORDERS, V227, P330, DOI 10.1016/j.jad.2017.11.020; Shirali S, 2013, PHYTOTHER RES, V27, P1042, DOI 10.1002/ptr.4836; Sobhani Z, 2017, CURR PHARM DESIGN, V23, P2428, DOI 10.2174/1381612823666170215104101; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xi L, 2007, BRIT J PHARMACOL, V151, P610, DOI 10.1038/sj.bjp.0707276; Xi L, 2005, PLANTA MED, V71, P917, DOI 10.1055/s-2005-871248; Xi L, 2007, J NUTR BIOCHEM, V18, P64, DOI 10.1016/j.jnutbio.2006.03.010; Yang XG, 2017, J MOL NEUROSCI, V61, P581, DOI 10.1007/s12031-017-0899-8; YARIBEYGI H, 2018, COMP CLIN PATHOL, V27, P691, DOI DOI 10.1007/s00580-018-2652-2; Yaribeygi H., 2014, TEHRAN U MED J, V72, P570; YARIBEYGI H, 2014, AM J BIOL LIFE SCI, V2, P41; Yaribeygi H., 2018, J CELLULAR PHYSL, V234, P1300; Yaribeygi H, 2018, METABOLISM, V87, P48, DOI 10.1016/j.metabol.2018.07.001; Yaribeygi H, 2019, J CELL PHYSIOL, V234, P2436, DOI 10.1002/jcp.27278; Yaribeygi H, 2018, J CELL BIOCHEM, V119, P6080, DOI 10.1002/jcb.26806; Yaribeygi H, 2018, BIOMED PHARMACOTHER, V98, P333, DOI 10.1016/j.biopha.2017.12.077; Zhang QZ, 2015, J BONE MINER RES, V30, P2300, DOI 10.1002/jbmr.2577	94	26	27	0	59	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	JUN	2019	234	6					8610	8617		10.1002/jcp.27843	http://dx.doi.org/10.1002/jcp.27843			8	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	HM2QU	30515777				2022-09-04	WOS:000459314500080
J	de Leon, FROD; Chavarro, LAN				Ostau de Lafont de Leon, Francisco Rafael; Nino Chavarro, Leidy Angela			THE INTERNATIONAL LABOUR ORGANIZATION AGREEMENTS AND THE NON-UNIONIZED WORKERS COLLECTIVE BARGAINING: THE COLOMBIAN CASE	PROLEGOMENOS-DERECHOS Y VALORES			Spanish	Article						Collective bargaining; collective agreement; freedom of association; labor governance		This research article has a goal to analyze the coexistence between the collective bargaining agreement between the union and the employer - and the collective agreement - agreement between non-unionized workers and the employer - within a company as a reality that does not recognize the 87, 98 nor the 154 International Labour Organization and Committee on Freedom of Association agreements. By using legal sociology both the labor law and its application are approached from a documentary analysis methodology from Colombian labor reality as an academic input with regard to the protection and warranty of the freedom of association. The purpose is to conclude that this coexistence is a jurisprudence's outcome contrario sensu to international agreements of freedom of association.	[Ostau de Lafont de Leon, Francisco Rafael] Univ La Gran Colombia, Derecho & Ciencias Polit, Bogota, Colombia; [Ostau de Lafont de Leon, Francisco Rafael] Univ Nacl Colombia, Derecho Lab & Acc Social, Bogota, Colombia; [Ostau de Lafont de Leon, Francisco Rafael] Pontificia Univ Javeriana, Derecho, Bogota, Colombia; [Ostau de Lafont de Leon, Francisco Rafael] Univ Rosario, Bogota, Colombia; [Ostau de Lafont de Leon, Francisco Rafael] Univ Externado Colombia, Bogota, Colombia; Univ Externado Colombia, Sociol Jurid, Bogota, Colombia; Univ Externado Colombia, Inst Polit, Bogota, Colombia; [Ostau de Lafont de Leon, Francisco Rafael; Nino Chavarro, Leidy Angela] Univ Libre Colombia, Bogota, Colombia; [Ostau de Lafont de Leon, Francisco Rafael] Univ Catolica Colombia, Bogota, Colombia; [Nino Chavarro, Leidy Angela] Univ Rosario, Derecho Laboral & Seguridad Social, Bogota, Colombia; [Nino Chavarro, Leidy Angela] Univ Externado Colombia, Derecho Conenfasis Derecho Trabajo, Bogota, Colombia; [Nino Chavarro, Leidy Angela] Univ Libre Colombia, Ctr Invest Sociojurid, Bogota, Colombia		de Leon, FROD (corresponding author), Univ La Gran Colombia, Derecho & Ciencias Polit, Bogota, Colombia.; de Leon, FROD (corresponding author), Univ Nacl Colombia, Derecho Lab & Acc Social, Bogota, Colombia.; de Leon, FROD (corresponding author), Pontificia Univ Javeriana, Derecho, Bogota, Colombia.; de Leon, FROD (corresponding author), Univ Rosario, Bogota, Colombia.; de Leon, FROD (corresponding author), Univ Externado Colombia, Bogota, Colombia.; de Leon, FROD (corresponding author), Univ Libre Colombia, Bogota, Colombia.; de Leon, FROD (corresponding author), Univ Catolica Colombia, Bogota, Colombia.	laninoc@ucatolica.edu.co; angie_nomore@yahoo.es						Anzola Aydee, 1980, SENTENCIA 2 OCTUBRE; Barreto H., 2007, 19 ENC JUEC TRAB RIO; Central Unitaria de Trabajadores, 2015, SIND GAN QUER PRES B; Correa Maria Victoria Calle, 2012, C571 CORT CONST; Escuela Nacional Sindical, 2016, SIST INF LAB SIND; Escuela Nacional Sindical, 2014, SEIS CAS QUE MUESTR; Ministerio del Trabajo, 2015, ID48381 MIN TRAB; Mucha R. E., 2010, REV DERECHO CAMBIO S, V7, P23; Odero A., 1995, LAW FREEDOM ASS STAN; Organizacion Internacional del Trabajo, 2006, LIB SIND REC DEC PRI; Organizacion Internacional del Trabajo, 2006, INF COM EXP APL CONV; Organizacion Internacional del Trabajo, 1951, CONV DER SIND NEG CO; Organizacion Internacional del Trabajo, 1951, CONV REL IG REM NER; Ostau de Lafont F. R., 2010, REV PROLEGOMENOS DER, VXIII, P89; Ostau de Lafont F. R., 2006, DISCURSO PATERNALIST; Ostau de Lafont F. R., 2012, DIALOGO SABERES, V37, P49; Palma E., 2014, PACTOS COLECTIVOS MA; Pasco M., 2012, REV CHILENA DERECHO, V3, P8; Pla A., 1965, CONVENIOS INT TRABAJ; Renteria Jaime Araujo, 2006, T205 CORT CONST; Tangarife C. L., 2016, LIBERTADES SINDICALE; Tribunal Constitucional de Chile, SINT STC 3016 16 302; Villa H., TENDENCIAS PERSPECTI; Von Potobsky G., 1998, INT LABOUR REV SPECI, V137, P32; Zegarra G., 2005, REV DERECHO THEMIS, V51, P65	25	0	0	1	2	UNIV MILITAR NUEVA GRANADA	BOGOTA	FAC DERECHO, SEDE BOGOTA CRA 11 N 101-80, BOGOTA, 00000, COLOMBIA	0121-182X			PROLEGOMENOS	Prolegomenos	JAN-JUN	2018	21	41					115	129		10.18359/prole.3333	http://dx.doi.org/10.18359/prole.3333			15	Law	Emerging Sources Citation Index (ESCI)	Government & Law	GN4WA		gold, Green Submitted			2022-09-04	WOS:000439039000007
J	Galvis, RA; Ramirez, WA; Gomez, MA; Lamus, AS; Barbosa, GV				Abello Galvis, Ricardo; Arevalo Ramirez, Walter; Alejandra Gomez, Maria; Sarmiento Lamus, Andres; Vega Barbosa, Giovanny			Translation of the judgment of the International Court of Justice in the case of the delimitation of the continental shelf between Nicaragua and Colombia beyond 200 nautical miles from the Nicaraguan coast (Nicaragua v. Colombia). Preliminary exceptions	ANUARIO COLOMBIANO DE DERECHO INTERNACIONAL-ACDI			Spanish	Article									[Abello Galvis, Ricardo; Arevalo Ramirez, Walter] Univ Rosario, Fac Derecho, Derecho Int Publ, Bogota, Colombia; [Abello Galvis, Ricardo] Pontificia Univ Javeriana, Doctorado Ciencias Jurid, Bogota, Colombia; [Abello Galvis, Ricardo] IHLADI, Madrid, Spain; [Arevalo Ramirez, Walter] Stetson Univ, Invest, Coll Law, Deland, FL USA; [Arevalo Ramirez, Walter] Univ Rosario, Fac Jurisprudencia, Grp Invest Derecho Int, Bogota, Colombia; [Arevalo Ramirez, Walter] Univ Rosario, Derecho, Bogota, Colombia; [Alejandra Gomez, Maria] Univ Colegio Mayor de Nuestra Senora Rosario, Jurisprudencia, Bogota, Colombia; [Sarmiento Lamus, Andres] Univ Sergio Arboleda Derecho Int Publ, Barranquilla, Atlantico, Colombia; [Sarmiento Lamus, Andres] Leiden Univ, NL-2300 RA Leiden, Netherlands; [Sarmiento Lamus, Andres] Leiden Univ, Derecho Int Publ, NL-2300 RA Leiden, Netherlands; [Sarmiento Lamus, Andres] Acad Colombiana Derecho Int, Bogota, Colombia; [Vega Barbosa, Giovanny] Univ Rosario, Bogota, Colombia; [Vega Barbosa, Giovanny] Univ Rosario, Fac Jurisprudencia, Catedra Derecho Int Publ, Bogota, Colombia		Galvis, RA (corresponding author), Univ Rosario, Fac Derecho, Derecho Int Publ, Bogota, Colombia.; Galvis, RA (corresponding author), Pontificia Univ Javeriana, Doctorado Ciencias Jurid, Bogota, Colombia.; Galvis, RA (corresponding author), IHLADI, Madrid, Spain.	ricardo.abello@urosario.edu.co; walter.arevalo@urosario.edu.co; malegozu@gmail.com; andres.sarmiento@usa.edu.co; giovanny.vega@urosario.edu.co							0	0	0	0	2	UNIV ROSARIO, EDITORIAL	BOGOTA	CARRETERA 7, N 13-41, OFICINA 501, BOGOTA, 00000, COLOMBIA	2027-1131	2145-4493		ANU COLOMB DERECHO I	Anu. Colomb. Derecho Int.-ACDI		2017	10						609	674						66	Law	Emerging Sources Citation Index (ESCI)	Government & Law	EP2DY					2022-09-04	WOS:000397194400016
J	Ramirez-Velez, R; De Asteasu, MLS; Morley, JE; Cano-Gutierrez, CA; Izquierdo, M				Ramirez-Velez, R.; Lopez Saez De Asteasu, M.; Morley, J. E.; Cano-Gutierrez, C. A.; Izquierdo, M.			Performance of the Short Physical Performance Battery in Identifying the Frailty Phenotype and Predicting Geriatric Syndromes in Community-Dwelling Elderly	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						Physical performance; frailty; geriatric syndromes; elderly; Latinos	LOWER-EXTREMITY FUNCTION; OLDER-ADULTS; PEOPLE; ASSOCIATION; DISABILITY; SARCOPENIA; MORTALITY; FALLS; SCALE; STATE	The early identification of seniors at high risk of geriatric syndromes is fundamental for targeting interventions to those who most need them. To date, the predictive value of the Short Physical Performance Battery (SPPB) for multifactorial clinical conditions has not been clearly established. Thus, the aim of the present study was to determine whether the SPPB could identify frailty and predict geriatric syndromes in community-dwelling older adults. Participants comprised men and women aged 60 years and older who participated in the Health and Well-being and Aging Survey in Colombia 2015 (n=4125, 57.6% women). A structured interview was administered to obtain socio-demographic data which included age, sex, ethnicity, socioeconomic status, and urbanicity. The study included the measurement of body mass, grip strength, SPPB, Lawton's instrumental ADL scale, specific subjective memory complaints (SSMC), frailty phenotype (Fried and FRAIL Scale), and self-reported falls, geriatric syndromes and/or medical conditions. ROC analysis was used to examine the ability of the SPPB test to predict frailty and geriatric syndromes. The cutoff that maximized both sensitivity and specificity for the frailty phenotype was 8 points or below for men and 7 points or below for women. These cutoff values significantly predicted four geriatric syndromes in descending order: mild dementia (female ORajus 3.34, and male ORajus 2.79), low grip strength (female ORajus 1.98, and male ORajus 2.45), falls (female ORajus 1.39, and male ORajus 1.49), and SSMC (female ORajus 1.39). In summary, the main finding of the present study was that SPPB score (i.e., <= 8 female and <= 7 female) seems to be a useful measure for identifying the physical frailty phenotype and predicting geriatric syndromes in community-dwelling older adults.	[Ramirez-Velez, R.; Lopez Saez De Asteasu, M.; Izquierdo, M.] Navarrabiomed Univ Publ Navarra UPNA, Complejo Hosp Navarra CHN, Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Navarra, Spain; [Ramirez-Velez, R.; Lopez Saez De Asteasu, M.; Izquierdo, M.] Inst Salud Carlos III, Ctr Invest Biomed Red Fragilidad & Envejecimiento, Madrid, Spain; [Morley, J. E.] St Louis Univ, Sch Med, Div Geriatr Med, St Louis, MO 63104 USA; [Cano-Gutierrez, C. A.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Inst Aging, Bogota, Colombia		Ramirez-Velez, R (corresponding author), Publ Navarra UPNA, Complejo Hosp Navarra CHN, Inst Invest Sanitaria Navarra IdiSNA, Calle Cataluna S-N, Pamplona 31006, Navarra, Spain.	robin640@hotmail.com	Izquierdo, Mikel/O-8049-2019; Izquierdo, Mikel/A-4894-2010; Ramirez-Velez, Robinson/D-5311-2016	Izquierdo, Mikel/0000-0002-1506-4272; Izquierdo, Mikel/0000-0002-1506-4272; Saez de Asteasu, Mikel Lopez/0000-0002-4111-5045; Ramirez-Velez, Robinson/0000-0003-3075-6960	Robinson Ramirez-Velez training grant [ID420]; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER) [PI17/01814]	Robinson Ramirez-Velez training grant; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER)(Spanish Government)	This project was not directly supported by any funding. Robinson Ramirez-Velez training grant (ID420) as a post-doctoral research fellow with the Universidad Publica de Navarra (UPNA). Mikel Izquierdo was supported by a research grant PI17/01814 of the Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER).	da Camara SMA, 2013, GERIATR GERONTOL INT, V13, P421, DOI 10.1111/j.1447-0594.2012.00920.x; Amariglio RE, 2011, J AM GERIATR SOC, V59, P1612, DOI 10.1111/j.1532-5415.2011.03543.x; Aprahamian I, 2017, J AM MED DIR ASSOC, V18, P592, DOI 10.1016/j.jamda.2017.01.009; Barberger-Gateau P, 1999, J GERONTOL B-PSYCHOL, V54, pP293, DOI 10.1093/geronb/54B.5.P293; BARBERGERGATEAU P, 1992, J AM GERIATR SOC, V40, P1129, DOI 10.1111/j.1532-5415.1992.tb01802.x; Belloni G, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00133; Cesar M, 2017, CLIN GERIATR MED, V33, P293, DOI 10.1016/j.cger.2017.02.002; Cesari M, 2017, AGING CLIN EXP RES, V29, P81, DOI 10.1007/s40520-016-0716-1; Cesari M, 2016, EUR J INTERN MED, V35, P1, DOI 10.1016/j.ejim.2016.07.021; Cesari M, 2016, J AM MED DIR ASSOC, V17, P188, DOI 10.1016/j.jamda.2015.12.016; Cuevas-Lara C, 2021, J AM MED DIR ASSOC, V22, P364, DOI 10.1016/j.jamda.2020.07.027; Alexandre TD, 2014, J NUTR HEALTH AGING, V18, P751, DOI [10.1007/s12603-014-0450-3, 10.1007/s12603-014-0540-2]; Dent E, 2016, EUR J INTERN MED, V31, P3, DOI 10.1016/j.ejim.2016.03.007; Gomez JF, 2013, COLOMB MEDICA, V44, P165; Fisher S, 2009, AGING CLIN EXP RES, V21, P445, DOI 10.1007/BF03327444; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freiberger E, 2012, AGE AGEING, V41, P712, DOI 10.1093/ageing/afs099; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Garcia-Hermoso A, 2020, SPORTS MED, V50, P1095, DOI 10.1007/s40279-020-01259-y; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Izquierdo M, 2019, NUTR HOSP, V36, P50, DOI 10.20960/nh.02680; Landi F, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008281; Lim YJ, 2020, J NUTR HEALTH AGING, V24, P582, DOI 10.1007/s12603-020-1396-2; Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; Oh-Park M, 2011, J AM GERIATR SOC, V59, P1225, DOI 10.1111/j.1532-5415.2011.03475.x; Pavasini R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0763-7; Ramirez-Velez R, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00052; Ramirez-Velez R, 2019, EXP GERONTOL, V127, DOI 10.1016/j.exger.2019.110732; REUBEN DB, 1990, J AM GERIATR SOC, V38, P855, DOI 10.1111/j.1532-5415.1990.tb05699.x; Rockwood K, 2000, DRUG AGING, V17, P295, DOI 10.2165/00002512-200017040-00005; Sanchez-Garcia S, 2014, GERIATR GERONTOL INT, V14, P395, DOI 10.1111/ggi.12114; Siriwardhana DD, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018195; Sleeper Rebecca B, 2009, Consult Pharm, V24, P447, DOI 10.4140/TCP.n.2009.051; Sousa-Santos Ana Rita, 2020, BMJ Open, V10, pe033661, DOI 10.1136/bmjopen-2019-033661; St John PD, 2014, CAN FAM PHYSICIAN, V60, pE272; Strandberg TE, 2013, ANN MED, V45, P265, DOI 10.3109/07853890.2012.727022; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Sverdrup K, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0724-4; Thaweewannakij T, 2013, PHYS THER, V93, P1312, DOI 10.2522/ptj.20120411; Turner G, 2014, AGE AGEING, V43, P744, DOI 10.1093/ageing/afu138; Vasunilashorn S, 2009, J GERONTOL A-BIOL, V64, P223, DOI 10.1093/gerona/gln022; Verghese J, 2010, AGE AGEING, V39, P382, DOI 10.1093/ageing/afp226; Vermeiren S, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.09.010; Veronese N, 2014, REJUV RES, V17, P276, DOI 10.1089/rej.2013.1491	51	10	10	0	3	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	FEB	2021	25	2					209	217		10.1007/s12603-020-1484-3	http://dx.doi.org/10.1007/s12603-020-1484-3		OCT 2020	9	Geriatrics & Gerontology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Nutrition & Dietetics	QA8WM	33491036				2022-09-04	WOS:000577041700005
J	Milanowski, L; Sitek, EJ; Dulski, J; Cerquera-Cleves, C; Gomez, JD; Brockhuis, B; Schinwelski, M; Kluj-Kozlowska, K; Ross, OA; Slawek, J; Wszolek, ZK				Milanowski, Lukasz; Sitek, Emilia J.; Dulski, Jaroslaw; Cerquera-Cleves, Catalina; Gomez, Juan D.; Brockhuis, Bogna; Schinwelski, Michal; Kluj-Kozlowska, Klaudia; Ross, Owen A.; Slawek, Jaroslaw; Wszolek, Zbigniew K.			Cognitive and behavioral profile of Perry syndrome in two families	PARKINSONISM & RELATED DISORDERS			English	Article						DCTN1 gene; Depression; Dynactin; Frontotemporal dementia; Mild cognitive impairment; Neuropsychological examination; Perry syndrome	CENTRAL HYPOVENTILATION; DCTN1 MUTATION; WEIGHT-LOSS; PARKINSONISM; DEPRESSION	Objective: Perry syndrome (PS) is a rare neurodegenerative disorder with autosomal dominant inheritance caused by point mutations in DCTN1 and characterized by parkinsonism, hypoventilation, weight loss, and psychiatric symptoms. Even though behavioral manifestation is a main feature of PS, detailed neuropsychological assessment was not performed in this cohort. In this study, the neuropsychological profile of individuals from one Polish and one Colombian family are presented. Methods: Detailed clinical and neuropsychological data were obtained from Polish and Colombian families. Clinical and neuropsychological examinations on the proband from the Polish family were performed 6 times over 11 years. Each of 3 individuals from the Colombian family received a clinical and neuropsychological assessment. Results: The neurologic examination showed severe parkinsonism, levodopa-induced motor fluctuations, and dyskinesias in all cases. Respiratory insufficiency was observed in 2 patients and weight loss in 1 individual. Neuropsychological assessment revealed predominant deterioration of working memory and learning capacity in the Polish patient. He also demonstrated compulsive behaviors, such as excessive shopping and eating, but only in the "on" phase. In the Colombian family, attentional deficits were present in 2 out of 3 cases. Out of 4 reported cases apathy and depressed mood were present in 2 individuals. Two cases demonstrated impulsivity and one had episodes of hypomania. Conclusions: Both of these families revealed relatively similar neurologic and neuropsychological profiles. The Polish patient's behavioral and neuropsychological profile was mostly compatible with a behavioral variant of frontotemporal dementia. Of note, not only depression and apathy, but also impulsivity can occur in PS.	[Milanowski, Lukasz; Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Milanowski, Lukasz] Med Univ Warsaw, Fac Hlth Sci, Dept Neurol, Warsaw, Poland; [Sitek, Emilia J.; Dulski, Jaroslaw; Schinwelski, Michal; Kluj-Kozlowska, Klaudia; Slawek, Jaroslaw] Copernicus PL Ltd, St Adalbert Hosp, Dept Neurol, Gdansk, Poland; [Sitek, Emilia J.; Dulski, Jaroslaw; Slawek, Jaroslaw] Med Univ Gdansk, Dept Neurol & Psychiat Nursing, Gdansk, Poland; [Cerquera-Cleves, Catalina] Pontificia Univ Javeriana, San Ignacio Hosp, Neurol Unit, Bogota, Colombia; [Cerquera-Cleves, Catalina] Clin Univ Colombia, Movement Disorders Clin, Bogota, Colombia; [Gomez, Juan D.] Pontificia Univ Javeriana, San Ignacio Hosp, Neuropsychol Clin, Bogota, Colombia; [Brockhuis, Bogna] Med Univ Gdansk, Dept Nucl Med, Gdansk, Poland; [Kluj-Kozlowska, Klaudia] Univ Gdansk, Fac Languages, Gdansk, Poland; [Ross, Owen A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA		Wszolek, ZK (corresponding author), Mayo Clin, Dept Neurol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	Wszolek.Zbigniew@mayo.edu	Sitek, Emilia/I-6913-2013; Sitek, Emilia/AAJ-2666-2021	Sitek, Emilia/0000-0003-4141-072X; Sitek, Emilia/0000-0003-4141-072X; Milanowski, Lukasz/0000-0003-4197-8518; Dulski, Jaroslaw/0000-0002-5517-9875; Cerquera, Catalina/0000-0002-3874-0261	Mayo Clinic Center for Regenerative Medicine; Haworth Family Professorship in Neurodegenerative Diseases fund; Albertson Parkinson's Research Foundation	Mayo Clinic Center for Regenerative Medicine; Haworth Family Professorship in Neurodegenerative Diseases fund; Albertson Parkinson's Research Foundation	This study was partially funded by the Mayo Clinic Center for Regenerative Medicine and gifts from The Sol Goldman Charitable Trust, the Haworth Family Professorship in Neurodegenerative Diseases fund (to Z.K.W.), and the Albertson Parkinson's Research Foundation. Z.K.W. serves as PI of the Mayo Clinic American Parkinson Disease Association (APDA) Information and Referral Center, and as Co-PI of the Mayo Clinic APDA Center for Advanced Research.	Aji BM, 2013, J NEUROL SCI, V330, P117, DOI 10.1016/j.jns.2013.04.008; Araki E, 2014, MOVEMENT DISORD, V29, P1201, DOI 10.1002/mds.25833; BHATIA KP, 1993, ANN NEUROL, V34, P842, DOI 10.1002/ana.410340614; Caroppo P, 2014, JAMA NEUROL, V71, P208, DOI 10.1001/jamaneurol.2013.5100; Chung EJ, 2014, PARKINSONISM RELAT D, V20, P388, DOI 10.1016/j.parkreldis.2014.01.010; Dulski J, 2018, NEUROL NEUROCHIR POL, V52, P514, DOI 10.1016/j.pjnns.2018.05.006; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Felicio AC, 2014, MOVEMENT DISORD, V29, P1197, DOI 10.1002/mds.25893; Gustavsson EK, 2016, PARKINSONISM RELAT D, V28, P56, DOI 10.1016/j.parkreldis.2016.04.025; Hamed M, 2019, PARKINSONISM RELAT D, V61, P236, DOI 10.1016/j.parkreldis.2018.10.024; Honda H, 2018, PARKINSONISM RELAT D, V51, P105, DOI 10.1016/j.parkreldis.2018.02.038; Ishikawa K, 2019, NEUROSCI LETT, V690, P181, DOI 10.1016/j.neulet.2018.10.036; Kobylecki C, 2015, J NEUROL, V262, P916, DOI 10.1007/s00415-015-7657-z; Konno T, 2018, MAYO CLIN PROC, V93, P263, DOI 10.1016/j.mayocp.2017.11.014; Konno T, 2017, PARKINSONISM RELAT D, V41, P14, DOI 10.1016/j.parkreldis.2017.06.004; LECHEVALIER B, 1992, REV NEUROL, V148, P39; Mishima T, 2018, J NEUROL NEUROSUR PS, V89, P482, DOI 10.1136/jnnp-2017-316864; Mishima T, 2017, J NEUROPATH EXP NEUR, V76, P676, DOI 10.1093/jnen/nlx049; Mishima T, 2015, PARKINSONISM RELAT D, V21, P1381, DOI 10.1016/j.parkreldis.2015.09.037; Newsway V, 2010, MOVEMENT DISORD, V25, P767, DOI 10.1002/mds.22950; Nojszewska M, 2019, NEUROL NEUROCHIR POL, V53, P26, DOI 10.5603/PJNNS.a2019.0005; Ohshima S, 2010, PARKINSONISM RELAT D, V16, P612, DOI 10.1016/j.parkreldis.2010.07.001; PERRY TL, 1990, NEUROLOGY, V40, P1882, DOI 10.1212/WNL.40.12.1882; Poreh A, 2016, APPL NEUROPSYCH-ADUL, V23, P155, DOI 10.1080/23279095.2015.1027343; Pretelt F, 2014, J NEUROL, V261, P620, DOI 10.1007/s00415-014-7262-6; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Saka E, 2010, PARKINSONISM RELAT D, V16, P68, DOI 10.1016/j.parkreldis.2009.05.010; Sanchez-Contreras M, 2017, PARKINSONISM RELAT D, V44, P151, DOI 10.1016/j.parkreldis.2017.08.027; Sitek EJ, 2014, NEUROCASE, V20, P69, DOI 10.1080/13554794.2012.732087; Stockmann M, 2013, J NEURAL TRANSM, V120, P785, DOI 10.1007/s00702-012-0910-z; Tacik P, 2014, PARKINSONISM RELAT D, V20, P884, DOI 10.1016/j.parkreldis.2014.05.004; Tsuboi Y, 2002, NEUROLOGY, V58, P1025, DOI 10.1212/WNL.58.7.1025; Wider C, 2008, PARKINSONISM RELAT D, V14, P1, DOI 10.1016/j.parkreldis.2007.07.014; Wider C, 2009, PARKINSONISM RELAT D, V15, P281, DOI 10.1016/j.parkreldis.2008.07.005	34	2	2	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	AUG	2020	77						114	120		10.1016/j.parkreldis.2020.05.019	http://dx.doi.org/10.1016/j.parkreldis.2020.05.019			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OA8FF	32717578				2022-09-04	WOS:000578015000026
J	Ramirez-Velez, R; Perez-Sousa, MA; Cano-Gutierrez, CA; Izquierdo, M; Garcia-Hermoso, A; Correa-Rodriguez, M				Ramirez-Velez, Robinson; Angel Perez-Sousa, Miguel; Cano-Gutierrez, Carlos A.; Izquierdo, Mikel; Garcia-Hermoso, Antonio; Correa-Rodriguez, Maria			Association Between Ideal Cardiovascular Health Score and Relative Handgrip Strength of Community-Dwelling Older Adults in Colombia	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Letter									[Ramirez-Velez, Robinson; Izquierdo, Mikel; Garcia-Hermoso, Antonio] Navarrabiomed Univ Publ Navarra UPNA, Dept Hlth Sci, Publ Univ Navarra, CHN,Inst Invest Sanitaria Navarra IdiSNA Pamplona, Navarra, Spain; [Angel Perez-Sousa, Miguel] Univ Huelva, Fac Sport Sci, Huelva, Spain; [Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Aging Inst, Bogota, Colombia; [Izquierdo, Mikel] Inst Salud Carlos III, Ctr Invest Biomed Red Fragilidad & Envejecimiento, Madrid, Spain; [Correa-Rodriguez, Maria] Univ Granada, Dept Nursing, Granada, Spain		Ramirez-Velez, R (corresponding author), Navarrabiomed Univ Publ Navarra UPNA, Dept Hlth Sci, Publ Univ Navarra, CHN,Inst Invest Sanitaria Navarra IdiSNA Pamplona, Navarra, Spain.		Correa-Rodriguez, Maria/G-1793-2018; Izquierdo, Mikel/A-4894-2010; García-Hermoso, Antonio/P-1857-2017; Perez-Sousa, Miguel A./M-5931-2019; Izquierdo, Mikel/O-8049-2019; García-Hermoso, Antonio/ADU-2591-2022; Garcia-Hermoso, Antonio/AGK-7815-2022; Ramirez-Velez, Robinson/D-5311-2016	Correa-Rodriguez, Maria/0000-0001-9165-4349; Izquierdo, Mikel/0000-0002-1506-4272; García-Hermoso, Antonio/0000-0002-1397-7182; Perez-Sousa, Miguel A./0000-0003-4392-6850; Izquierdo, Mikel/0000-0002-1506-4272; Garcia-Hermoso, Antonio/0000-0002-1397-7182; Ramirez-Velez, Robinson/0000-0003-3075-6960; Cano-Gutierrez, Carlos/0000-0001-5680-7880	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia [764]; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER), Spain [PI17/01814]; Universidad Publica de Navarra, Spain [420/2019]	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER), Spain; Universidad Publica de Navarra, Spain	The SABE study is supported by a fund (2013, no. 764) from the Colciencias y Ministerio de Salud y la Proteccion Social de Colombia.M.I. is funded in part by a research grant PI17/01814 of the Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER), Spain. R.R.-V. is funded in part by a Postdoctotal fellowship grant ID 420/2019 of the Universidad Publica de Navarra, Spain.	Agostinis-Sobrinho C, 2018, NUTR METAB CARDIOVAS, V28, P892, DOI 10.1016/j.numecd.2018.05.012; Garcia-Hermoso A, 2019, J STRENGTH COND RES, V33, P747, DOI 10.1519/JSC.0000000000003052; Garcia-Hermoso A, 2018, ARCH PHYS MED REHAB, V99, P2100, DOI 10.1016/j.apmr.2018.01.008; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; McLeod M, 2016, BIOGERONTOLOGY, V17, P497, DOI 10.1007/s10522-015-9631-7; Ramirez-Velez R, 2019, J CACHEXIA SARCOPENI, V10, P278, DOI 10.1002/jcsm.12373; Ramirez-Velez R, 2018, MAYO CLIN PROC, V93, P1589, DOI 10.1016/j.mayocp.2018.05.035; Ramirez-Velez R, 2016, J PEDIATR-US, V179, P82, DOI 10.1016/j.jpeds.2016.08.099	9	4	4	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	MAR	2020	21	3					434	+		10.1016/j.jamda.2019.12.010	http://dx.doi.org/10.1016/j.jamda.2019.12.010			5	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	KR7XU	31956013				2022-09-04	WOS:000517831000028
J	Rugeles, SJ; Gautier, JBO; Dickerson, RN; Coss-Bu, JA; Wernerman, J; Paddon-Jones, D				Rugeles, Saul J.; Gautier, Juan B. Ochoa; Dickerson, Roland N.; Coss-Bu, Jorge A.; Wernerman, Jan; Paddon-Jones, Douglas			How Many Nonprotein Calories Does a Critically Ill Patient Require? A Case for Hypocaloric Nutrition in the Critically Ill Patient	NUTRITION IN CLINICAL PRACTICE			English	Review						enteral nutrition; protein; hypocaloric nutrition; critical illness; intensive care unit; nutritional support	ENTERAL NUTRITION; INTENSIVE-CARE; SOFA SCORE; ORGAN DYSFUNCTION/FAILURE; SUPPORT; GUIDELINES	Calculation of energy and protein doses for critically ill patients is still a matter of controversy. For more than 40 years of nutrition support, the total amount of nutrients to be delivered to these patients has been calculated based on expert recommendations, and this calculation is based on the administration of nonprotein calories in one attempt to ameliorate catabolic response and avoid the weight loss. New evidence suggests protein delivery is the most important intervention to improve clinical and metabolic outcomes. This article describes the metabolic rationale and the new evidence supporting a change in the approach of metabolic support of the critically ill, proposing a physiological-based intervention supported by the recognition of ancillary characteristics of the metabolic response to trauma and injury. A moderate dose of calories around 15 kcal/kg/d with a delivery of protein of 1.5 g/kg/d appears to be the new recommendation for many hypercatabolic patients in the first week following injury.	[Rugeles, Saul J.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Sch Med, Calle 106 21 95 Apto 301, Bogota 110111, Colombia; [Gautier, Juan B. Ochoa] Nestle Hlth Sci Inst, Lausanne, Switzerland; [Dickerson, Roland N.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Coss-Bu, Jorge A.] Texas Childrens Hosp, Baylor Coll Med, Sect Crit Care Med, Dept Pediat,Intens Care Serv,Res, Houston, TX 77030 USA; [Wernerman, Jan] Karolinska Univ Sjukhuset, Dept Clin Sci Intervent Technol, Stockholm, Sweden; [Paddon-Jones, Douglas] Univ Texas Med Branch, Dept Nutr & Metab, Galveston, TX 77555 USA		Rugeles, SJ (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Sch Med, Calle 106 21 95 Apto 301, Bogota 110111, Colombia.	saul.rugeles@gmail.com	Rugeles, Saúl/AAV-9510-2020	Rugeles, Saúl/0000-0003-0401-0743; Dickerson, Roland/0000-0002-2086-6317; Paddon-Jones, Douglas/0000-0002-3762-5130	Lafrancol (a pharmaceutical company in Colombia); Nestle HealthCare Nutrition, Inc.	Lafrancol (a pharmaceutical company in Colombia); Nestle HealthCare Nutrition, Inc.(Nestle SA)	Two unrestrictive research grants from Lafrancol (a pharmaceutical company in Colombia). Financial support for the publication of the supplement in which this article appears was provided by Nestle HealthCare Nutrition, Inc.	APELGREN KN, 1983, SURG CLIN N AM, V63, P497; Arabi YM, 2015, NEW ENGL J MED, V372, P2398, DOI 10.1056/NEJMoa1502826; Arabi YM, 2011, AM J CLIN NUTR, V93, P569, DOI 10.3945/ajcn.110.005074; BRENNER WI, 1973, ANN SURG, V178, P651, DOI 10.1097/00000658-197311000-00017; Charles EJ, 2014, AM J CLIN NUTR, V100, P1337, DOI 10.3945/ajcn.114.088609; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Japur CC, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.12.007; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1177/0148607115621863, 10.1097/CCM.0000000000001525]; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Patino JF, 1999, WORLD J SURG, V23, P553, DOI 10.1007/PL00012346; Petros S, 2016, JPEN-PARENTER ENTER, V40, P242, DOI 10.1177/0148607114528980; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rice TW, 2011, CRIT CARE MED, V39, P967, DOI 10.1097/CCM.0b013e31820a905a; Rugeles S, 2016, J CRIT CARE, V35, P110, DOI 10.1016/j.jcrc.2016.05.004; Rugeles SJ, 2013, INDIAN J CRIT CARE M, V17, P343, DOI 10.4103/0972-5229.123438; RUTTEN P, 1975, J SURG RES, V18, P477, DOI 10.1016/0022-4804(75)90121-3; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; VARY TC, 1986, JPEN-PARENTER ENTER, V10, P351, DOI 10.1177/0148607186010004351; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; WILLIFORD WO, 1991, NEW ENGL J MED, V325, P525; Wilmore DW, 2000, WORLD J SURG, V24, P705, DOI 10.1007/s002689910113	23	10	11	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-5336	1941-2452		NUTR CLIN PRACT	Nutr. Clin. Pract.	APR	2017	32			1			72S	76S		10.1177/0884533617693608	http://dx.doi.org/10.1177/0884533617693608			5	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	ET3QZ	28388377	Bronze			2022-09-04	WOS:000400195900008
J	Mattoni, CI; Garcia-Hernandez, S; Botero-Trujillo, R; Ochoa, JA; Ojanguren-Affilastro, AA; Pinto-Da-Rocha, R; Prendini, L				Mattoni, Camilo I.; Garcia-Hernandez, Solimary; Botero-Trujillo, Ricardo; Ochoa, Jose A.; Ojanguren-Affilastro, Andres A.; Pinto-da-Rocha, Ricardo; Prendini, Lorenzo			Scorpion Sheds 'Tail' to Escape: Consequences and Implications of Autotomy in Scorpions (Buthidae: Ananteris)	PLOS ONE			English	Article							LIGHT; MICROANANTERIS; LOURENCO; URODACUS; THORELL; BRAZIL	Autotomy, the voluntary shedding or detachment of a body part at a determined cleavage plane, is a common anti-predation defense mechanism in several animal taxa, including arthropods. Among arachnids, autotomy has been observed in harvestmen, mites, and spiders, always involving the loss of legs. Autotomy of the opisthosoma (abdomen) was recently reported in a single species of the Neotropical buthid scorpion genus Ananteris Thorell, 1891, but few details were revealed. Based on observations in the field and laboratory, examination of material in museum collections, and scanning electron microscopy, we document autotomy of the metasoma (the hind part of the opisthosoma, or 'tail') in fourteen species of Ananteris. Autotomy is more common in males than females, and has not been observed in juveniles. When the scorpion is held by the metasoma, it is voluntarily severed at the joints between metasomal segments I and II, II and III, or III and IV, allowing the scorpion to escape. After detachment, the severed metasoma moves (twitches) automatically, much like the severed tail of a lizard or the severed leg of a spider, and reacts to contact, even attempting to sting. The severed surface heals rapidly, scar tissue forming in five days. The lost metasomal segments and telson cannot be regenerated. Autotomy of the metasoma and telson results in permanent loss of the posterior part of the scorpion's digestive system (the anus is situated posteriorly on metasomal segment V) and the ability to inject venom by stinging. After autotomy, scorpions do not defecate and can only capture small prey items. However, males can survive and mate successfully for up to eight months in the laboratory. In spite of diminished predation ability after autotomy, survival allows males to reproduce. Autotomy in Ananteris therefore appears to be an effective, adaptive, anti-predation escape mechanism.	[Mattoni, Camilo I.] Univ Nacl Cordoba, RA-5000 Cordoba, Argentina; [Garcia-Hernandez, Solimary] Univ Ind Santander, Bucaramanga, Colombia; [Botero-Trujillo, Ricardo; Ojanguren-Affilastro, Andres A.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Ojanguren-Affilastro, Andres A.] Frankfurt Zool Soc, Cuzco, Peru; [Botero-Trujillo, Ricardo] Pontificia Univ Javeriana, Bogota, Colombia; [Ochoa, Jose A.; Pinto-da-Rocha, Ricardo] Univ Sao Paulo, Sao Paulo, Brazil; [Prendini, Lorenzo] Amer Museum Nat Hist, New York, NY USA		Mattoni, CI (corresponding author), Univ Nacl Cordoba, RA-5000 Cordoba, Argentina.	cmattoni@efn.uncor.edu	Prendini, Lorenzo/AAY-6611-2021; GARCIA-HERNANDEZ, SOLIMARY/ABA-5826-2020; Pinto-da-Rocha, Ricardo/J-6774-2012	GARCIA-HERNANDEZ, SOLIMARY/0000-0002-4458-8948; Pinto-da-Rocha, Ricardo/0000-0002-3959-2205; Prendini, Lorenzo/0000-0001-8727-7106; Jose Antonio, Ochoa/0000-0001-6580-7268; Mattoni, Camilo/0000-0001-8570-8814	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/06604-7, 2012/02969-6]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-1764, PICT 2006-750, 2010-0906]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	Financial support was provided by: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://www.fapesp.br), grant numbers 2008/06604-7 and 2012/02969-6 to RPR; and Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar), grant numbers PICT 2010-1764 to AAOA, PICT 2006-750 and 2010-0906 to CIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, BIOL SCORPIONS; [Anonymous], 1981, BIOL CENTIPEDES; ARNOLD EN, 1984, J NAT HIST, V18, P127, DOI 10.1080/00222938400770131; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Blass GRC, 2008, ANIM BEHAV, V76, P365, DOI 10.1016/j.anbehav.2007.12.022; Botero-Trujillo R, 2011, ZOOTAXA, P1; Botero-Trujillo R, 2011, ZOOTAXA, P37; Bradstock C. A., 1950, Zoology Publications from Victoria University College, V7, P1; Chapman RF, 1998, INSECTS STRUCTURE FU; Chen XL, 2013, MAR FRESHW BEHAV PHY, V46, P321, DOI 10.1080/10236244.2013.833365; Fleming PA, 2007, BIOL REV, V82, P481, DOI 10.1111/j.1469-185X.2007.00020.x; Fredericq L, 1883, ARCH ZOOL EXP GEN 2, V1, P413; Garcia Hernandez S, 2011, 3 C LAT AR MEM RES, P135; Gnaspini Pedro, 2007, P374; Hadley N.F., 1990, P321; Higham TE, 2010, BIOL LETTERS, V6, P70, DOI 10.1098/rsbl.2009.0577; Hjelle J.T., 1990, P9; LAWRENCE JM, 1986, J EXP MAR BIOL ECOL, V102, P47, DOI 10.1016/0022-0981(86)90125-5; Lira AFA, 2014, J INSECT BEHAV, V27, P279, DOI 10.1007/s10905-013-9431-3; Lourenco W. R., 2012, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V16, P41; Lourenco WR, 2013, AN ACAD BRAS CIENC, V85, P709, DOI 10.1590/S0001-37652013000200016; Lourenco Wilson R., 2012, Boletin de la SEA, V50, P73; Lourenco WR, 2012, CR BIOL, V335, P555, DOI 10.1016/j.crvi.2012.06.005; Lourenco Wilson R., 2011, Boletin de la SEA, V48, P105; Mattoni CI, 2001, 3 C LAT AR MEM RES, P83; Nelson Ximena J., 2011, P99; Ojanguren-Affilastro A.A., 2001, PHYSIS C, V58, P15; Polis G.A., 1990, P161; R Core Team, 2021, R LANG ENV STAT COMP; RAO G, 1973, J EXP BIOL, V58, P189; STAHNKE HL, 1972, BIOSCIENCE, V22, P604, DOI 10.2307/1296207; Weygoldt P., 2000, WHIP SPIDERS CHELICE; Wilkie IC, 2001, MICROSC RES TECHNIQ, V55, P369, DOI 10.1002/jemt.1185; Wood FD, 1926, J MORPHOL PHYSIOL, V42, P143, DOI 10.1002/jmor.1050420106; ZWICKY KT, 1968, LIFE SCI PT 1 PHYSI, V7, P257, DOI 10.1016/0024-3205(68)90020-9; ZWICKY KT, 1970, EXPERIENTIA, V26, P317, DOI 10.1007/BF01900120	36	16	17	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116639	10.1371/journal.pone.0116639	http://dx.doi.org/10.1371/journal.pone.0116639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629529	Green Submitted, Green Published, gold			2022-09-04	WOS:000348732100044
J	Dantes, H; Castro, MV; Franco-Marina, F; Bedregal, P; Garcia, JR; Espinoza, A; Huarcaya, WV; Lozano, R				Gomez Dantes, Hector; Victoria Castro, Ma; Franco-Marina, Francisco; Bedregal, Paula; Rodriguez Garcia, Jesus; Espinoza, Azalea; Valdez Huarcaya, William; Lozano, Rafael		Iniciat Amer Latina Caribe	Burden of disease in Latin America	SALUD PUBLICA DE MEXICO			Spanish	Article						burden of disease; Latin America	DISABILITY	Objective. To describe the burden of disease studies made in the region, identify the main priorities in health from the indicator Disability Adjusted Life Years (DALYs). Material and Methods. By the use of DALYs identify the burden of disease in the countries in the network. Results. DALYs emphasize the emergency of mental disorders, diabetes mellitus in women and the disorders associated with alcohol consumption and injuries in men. Conclusions. Latin America is the region with more national studies of burden of disease, using a standardized methodology, that allows identifying new health priorities which are pressing to the health services; for that reason these results constitute an element to take into account in the establishment of public policies in each country.	[Gomez Dantes, Hector] Inst Nacl Salud Publ, Cuernavaca 62100, Morelos, Mexico; [Gomez Dantes, Hector; Victoria Castro, Ma] Fdn Mexicana Salud, Observ Salud, Mexico City, DF, Mexico; [Franco-Marina, Francisco] Secretaria Salud Mexico, Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Bedregal, Paula] Pontificia Univ Catolica Chile, Santiago, Chile; [Rodriguez Garcia, Jesus] Pontificia Univ Javeriana Colombia, Bogota, Colombia; [Espinoza, Azalea] Minist Salud Costa Rica, Direcc Vigilancia Salud, San Jose, Costa Rica; [Valdez Huarcaya, William] Minist Salud Peru, Direcc Gen Epidemiol, Lima, Peru; [Lozano, Rafael] Univ Washington, Inst Metr & Evaluac Salud, Seattle, WA 98195 USA		Dantes, H (corresponding author), Inst Nacl Salud Publ, Av Univ 655, Cuernavaca 62100, Morelos, Mexico.	hgdantes@hotmail.com	Lozano, Rafael/T-5352-2018	Lozano, Rafael/0000-0002-7356-8823				BARRIENTOS MC, 1996, ESTUDIO CARGA ENFERM; BOBADILLA JL, 1997, OBSERVATORIO SALUD N, P255; COALE AJ, REGIONAL MODEL LIFE, V193, P3; de Salud Ministerio, 2008, EST CARG ENF CARG AT; Departamento de Epidemiologia MINSAL, 2007, EST CARG ENF CARG AT; Escobar M, 1994, CARGA ENFERMEDAD COL; GADELHA AMJ, 1998, ESTUDIO CARGA GLOBAL; Lozano R, 2009, CARGA ENFERMEDAD MUN; LOZANO R, 1997, OBSERVATORIO SALUD N, P23; *MIN SAL DGE, 2006, EST CARG ENF PER 200; Ministerio de Salud de Costa Rica, 2008, PROGR DES SECT SAL; MORROW RH, 1984, SOC SCI MED, V19, P1039, DOI 10.1016/0277-9536(84)90306-X; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P447; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P481; Rodriguez J, 2008, CARGA ENFERMEDAD COL; Rodriguez J, 2000, CARGA GLOBAL ENFERME; Sassi F., 2006, CALCULATING QALYS CO, P402; VALDIVIA AV, 2006, ANALISIS ESTUDIO CAR, P64; WHO, HLTH STAT HLTH INF S; WHO, 2009, GLOB BURD DIS	22	15	16	0	8	INST NACIONAL SALUD PUBLICA	CUERNAVACA	AV UNIVERSIDAD 655, COL SANTA MARIA AHUACATITLAN, CUERNAVACA 62508, MORELOS, MEXICO	0036-3634			SALUD PUBLICA MEXICO	Salud Publica Mexico		2011	53			2			S72	S77						6	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	807WM	21877095				2022-09-04	WOS:000293933700003
J	Blair, KJ; Martinez-Vernaza, S; Segura, E; Barrientos, JLG; Garber, K; Gualtero-Trujillo, SM; Juillard, C; Castro, R				Blair, Kevin J.; Martinez-Vernaza, Samuel; Segura, Eddy; Gallardo Barrientos, Jose Luis; Garber, Kent; Gualtero-Trujillo, Sandra M.; Juillard, Catherine; Castro, Rodolfo			Protecting healthcare workers in the COVID-19 pandemic: respirator shortages and health policy responses in South America	CADERNOS DE SAUDE PUBLICA			English	Article									[Blair, Kevin J.; Garber, Kent; Juillard, Catherine] Univ Calif Los Angeles, Dept Surg, 10833 Le Conte Ave,72-227 CHS, Los Angeles, CA 90034 USA; [Martinez-Vernaza, Samuel; Gualtero-Trujillo, Sandra M.] Hosp Univ San Ignacio, Unidad Infectol, Bogota, Colombia; [Segura, Eddy] Univ Cient Sur, Fac Ciencias Salud, Lima, Peru; [Gallardo Barrientos, Jose Luis] La Caja Nacl Salud, Dept Cirugia, Potosi, Bolivia; [Gualtero-Trujillo, Sandra M.] Pontificia Univ Javeriana, Bogota, Colombia; [Castro, Rodolfo] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil; [Castro, Rodolfo] Univ Fed Estado Rio de Janeiro, Inst Saude Colet, Rio De Janeiro, Brazil		Blair, KJ (corresponding author), Univ Calif Los Angeles, Dept Surg, 10833 Le Conte Ave,72-227 CHS, Los Angeles, CA 90034 USA.	kevin.james.blair@gmail.com	Castro, Rodolfo/D-4231-2013	Castro, Rodolfo/0000-0002-0701-2528; Segura, Eddy R/0000-0003-3580-7712; Martinez Vernaza, Samuel/0000-0001-5363-5729				Agencia Nacional de Vigilancia Sanitaria, 2020, OR GER RAC US RESP D; Agencia Nacional de Vigilancia Sanitaria, 2020, 042020 GVIMSGGTESANV; Amnesty International, 2020, COST CUR HLTH WORK R; [Anonymous], 2020, DINERO          0406; Asociacion Colombiana de Especialistas em Medicina de Urgencias y Emergencias, 2020, EL PROT PERS EPP SEC; Centers for Disease Control and Prevention, NPPTL RESP ASS SUPP; Comision Economica para America Latina y el Caribe, RESTR EXP MED PROD H; Corcho C, 2020, ENCUESTA BIOSEGURIDA; Cruz Roja Colombiana, CRUZ ROJ COL ACT PLA; Delgado D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082798; Direccion Regional de Medicamentos Insumos y Drogas, 2020, CONS ADQ RESP PROT R; Feinmann J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1910; Instituto de Evaluacion de Tecnologias en Salud e Investigacion, 2020, US REUS RESP N95 EST; Instituto Nacional de Vigilancia de Medicamentos y Alimentos, COR COVID 19; Kobayashi LM, 2020, INFECT CONT HOSP EP, V41, P1364, DOI 10.1017/ice.2020.173; Mera-Mamin A, 2020, REV FAC CIENC SALUD, V22, P1623, DOI [10.47373/rfcs.2020.v22.1581, DOI 10.47373/RFCS.2020.V22.1581]; Ministerio de Salud, 2020, REC US APR MASC RESP; Ministerio de Salud, 2020, NORM TECN PROC BIOS; N95Decon, N95 DEC REUS METH CO; Pan American Health Organization, 2020, ASP TECN REG US PROL; Pan American Health Organization, 2020, RESP COVID 19 AM; Pan American Health Organization, COVID 19 HAS INF SOM; Pan American Health Organization, 2020, REG MED DEV CONT COV; RIBEIRO MI, 2020, REV COL BRAS CIR, V47; Roser M, INCOME INEQUALITY; Rubin R, 2020, JAMA-J AM MED ASSOC, V324, P217, DOI 10.1001/jama.2020.11182; Saaavedra-Trujillo CH, 2020, INFECTIO, V24, P1, DOI [10.22354/in.v24i3.851, DOI 10.22354/IN.V24I3.851]; WHO) WHO, 2020, RAT US PERS PROT EQ	28	0	0	0	0	CADERNOS SAUDE PUBLICA	RIO DE JANIERO	RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL	0102-311X	1678-4464		CAD SAUDE PUBLICA	Cad. Saude Publica		2020	36	12							e00227520	10.1590/0102-311X00227520	http://dx.doi.org/10.1590/0102-311X00227520			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	PH3RG	33331543	gold			2022-09-04	WOS:000600333700001
J	Aschner, P; Horton, E; Leiter, LA; Munro, N; Skyler, JS				Aschner, P.; Horton, E.; Leiter, L. A.; Munro, N.; Skyler, J. S.		Global Partnership Effective Diabe	Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article							SUBCUTANEOUS INSULIN INFUSION; ENABLE DIETARY FREEDOM; POOR GLYCEMIC CONTROL; BETA-CELL FUNCTION; CARDIOVASCULAR-DISEASE; BLOOD-GLUCOSE; MICROVASCULAR COMPLICATIONS; SEVERE HYPOGLYCEMIA; METABOLIC SYNDROME; AFRICAN-AMERICANS	P>The Diabetes Control and Complications Trial (DCCT) led to considerable improvements in the management of type 1 diabetes, with the wider adoption of intensive insulin therapy to reduce the risk of complications. However, a large gap between evidence and practice remains, as recently shown by the Pittsburgh Epidemiology of Diabetes Complications (EDC) study, in which 30-year rates of microvascular complications in the 'real world' EDC patients were twice that of DCCT patients who received intensive insulin therapy. This gap may be attributed to the many challenges that patients and practitioners face in the day-to-day management of the disease. These barriers include reaching glycaemic goals, overcoming the reality and fear of hypoglycaemia, and appropriate insulin therapy and dose adjustment. As practitioners, the question remains: how do we help patients with type 1 diabetes manage glycaemia while overcoming barriers? In this article, the Global Partnership for Effective Diabetes Management provides practical recommendations to help improve the care of patients with type 1 diabetes.	[Skyler, J. S.] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33101 USA; [Aschner, P.] Javeriana Univ, Sch Med, Bogota, Colombia; [Horton, E.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Leiter, L. A.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Leiter, L. A.] Univ Toronto, Toronto, ON, Canada; [Munro, N.] Chelsea & Westminster Hosp, Beta Cell Diabet Ctr, London, England		Skyler, JS (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, 1450 NW 10th Ave,Suite 3054,POB 016960 D-110, Miami, FL 33101 USA.	jskyler@miami.edu	Leiter, Lawrence/AAG-4059-2020; Skyler, Jay S/F-4211-2016; Del Prato, Stefano/K-3405-2016	Del Prato, Stefano/0000-0002-5388-0270; Skyler, Jay/0000-0003-1136-8110				Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beck RW, 2009, DIABETES CARE, V32, P2047, DOI 10.2337/dc09-0846; Beck RW, 2009, DIABETES CARE, V32, P1378, DOI 10.2337/dc09-0108; Beijers HJBH, 2009, DIABETES CARE, V32, P1698, DOI 10.2337/dc08-1544; BORCHJOHNSEN K, 1987, BMJ-BRIT MED J, V294, P1651, DOI 10.1136/bmj.294.6588.1651; Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720; Bruno G, 2005, DIABETES CARE, V28, P312, DOI 10.2337/diacare.28.2.312; Calvert M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1870; Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2008, CAN J DIABETES S1, V32, pS168, DOI [10.1016/S1499-2671(08)24300-5, DOI 10.1503/CMAJ.080554]; Chapman TM, 2004, DRUGS, V64, P2577, DOI 10.2165/00003495-200464220-00008; CHENG AYY, 2005, JOSLINS DIABETES MEL, P559; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; Colton PA, 2007, DIABETES CARE, V30, P2861, DOI 10.2337/dc07-1057; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; DAGOGOJACK S, 1994, DIABETES, V43, P1426, DOI 10.2337/diabetes.43.12.1426; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Deis D, 2006, DIABETES CARE, V29, P2730, DOI 10.2337/dc06-1134; Del Prato S, 2007, INT J CLIN PRACT, V61, P9, DOI 10.1111/j.1742-1241.2007.01609.x; Del Prato S, 2005, INT J CLIN PRACT, V59, P1345, DOI 10.1111/j.1742-1241.2005.00674.x; DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dunn CJ, 2003, DRUGS, V63, P1743, DOI 10.2165/00003495-200363160-00007; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; FANELLI C, 1994, DIABETOLOGIA, V37, P1265, DOI 10.1007/BF00399801; Frier BM, 2008, DIABETES-METAB RES, V24, P87, DOI 10.1002/dmrr.796; Garg S, 2006, DIABETES CARE, V29, P44, DOI 10.2337/diacare.29.01.06.dc05-1686; Geddes J, 2008, DIABETIC MED, V25, P501, DOI 10.1111/j.1464-5491.2008.02413.x; Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Goldman-Levine JD, 2005, ANN PHARMACOTHER, V39, P502, DOI 10.1345/aph.1E334; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Hirsch IB, 2008, DIABETES TECHNOL THE, V10, P419, DOI 10.1089/dia.2008.0104; *IDF, 1998, DESKT GUID TYP 1 INS; *INT DIS FED, 2007, DIAB ATL; Jeitler K, 2008, DIABETOLOGIA, V51, P941, DOI 10.1007/s00125-008-0974-3; JENSEN T, 1987, DIABETOLOGIA, V30, P144, DOI 10.1007/BF00274218; Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2; Karter AJ, 2000, DIABETES CARE, V23, P477, DOI 10.2337/diacare.23.4.477; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; McGill M, 2008, J DIABETES COMPLICAT, V22, P18, DOI 10.1016/j.jdiacomp.2006.10.005; Meneghini L, 2008, INT J CLIN PRACT, V62, P1255, DOI 10.1111/j.1742-1241.2008.01816.x; MUHLHAUSER I, 1983, DIABETOLOGIA, V25, P470; MUHLHAUSER I, 1987, DIABETOLOGIA, V30, P681, DOI 10.1007/BF00296989; Mullins P, 2007, CLIN THER, V29, P1607, DOI 10.1016/j.clinthera.2007.08.020; *NAT I CLIN EXC, 2004, CLIN GUID, V15; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; Nathan DM, 2003, NEW ENGL J MED, V348, P761; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nyomba BLG, 2002, DIABETES CARE, V25, P1244, DOI 10.2337/diacare.25.7.1244-a; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Petersen M, 2008, DIABETES CARE, V31, P596, DOI 10.2337/dc08-9017; Pickup JC, 2008, DIABETIC MED, V25, P765, DOI 10.1111/j.1464-5491.2008.02486.x; Plank J, 2005, ARCH INTERN MED, V165, P1337, DOI 10.1001/archinte.165.12.1337; Plotnikoff RC, 2006, MED SCI SPORT EXER, V38, P1526, DOI 10.1249/01.mss.0000228937.86539.95; Retnakaran R, 2004, DIABETES CARE, V27, P2590, DOI 10.2337/diacare.27.11.2590; Rodin G, 2002, J PSYCHOSOM RES, V53, P943, DOI 10.1016/S0022-3999(02)00305-7; Roy MS, 2007, DIABETIC MED, V24, P1361, DOI 10.1111/j.1464-5491.2007.02293.x; Roy MS, 2007, PSYCHOSOM MED, V69, P537, DOI 10.1097/PSY.0b013e3180df84e2; Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601; Samann A, 2005, DIABETOLOGIA, V48, P1965, DOI 10.1007/s00125-005-1905-1; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shearer A, 2004, DIABETIC MED, V21, P460, DOI 10.1111/j.1464-5491.2004.01183.x; Sheppard P, 2005, PRACT DIAB INT, V22, P15; Siebenhofer A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003287.pub4; Snell-Bergeon JK, 2009, DIABETOLOGIA, V52, P801, DOI 10.1007/s00125-009-1280-4; Soedamah-Muthu SS, 2006, DIABETES CARE, V29, P798, DOI 10.2337/diacare.29.04.06.dc05-1433; Spitzer C, 2008, DIABETIC MED, V25, P349, DOI 10.1111/j.1464-5491.2007.02369.x; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Thorn LM, 2009, DIABETES CARE, V32, P950, DOI 10.2337/dc08-2022; Tuomilehto J, 1998, DIABETOLOGIA, V41, P784, DOI 10.1007/s001250050988; Van Tilburg MAL, 2001, PSYCHOSOM MED, V63, P551, DOI 10.1097/00006842-200107000-00005; Wallace TM, 2004, QJM-INT J MED, V97, P773, DOI 10.1093/qjmed/hch132; Wang F, 2003, CLIN THER, V25, P1541, DOI 10.1016/S0149-2918(03)80156-X; Warren E, 2004, HEALTH TECHNOL ASSES, V8, P1; Weinzimer SA, 2008, DIABETES CARE, V31, P934, DOI 10.2337/dc07-1967; Zgibor JC, 2005, DIABETES CARE, V28, P521, DOI 10.2337/diacare.28.3.521; Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089	87	40	41	0	2	WILEY-HINDAWI	LONDON	ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND	1368-5031	1742-1241		INT J CLIN PRACT	Int. J. Clin. Pract.	FEB	2010	64	3					305	315		10.1111/j.1742-1241.2009.02296.x	http://dx.doi.org/10.1111/j.1742-1241.2009.02296.x			11	Medicine, General & Internal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pharmacology & Pharmacy	543DC	20456170	Green Published, gold			2022-09-04	WOS:000273549300008
J	Nieto-Ruiz, A; Garcia-Santos, JA; Verdejo-Roman, J; Dieguez, E; Sepulveda-Valbuena, N; Herrmann, F; Cerdo, T; De-Castellar, R; Jimenez, J; Bermudez, MG; Perez-Garcia, M; Miranda, MT; Lopez-Sabater, MC; Catena, A; Campoy, C				Nieto-Ruiz, Ana; Garcia-Santos, Jose A.; Verdejo-Roman, Juan; Dieguez, Estefania; Sepulveda-Valbuena, Natalia; Herrmann, Florian; Cerdo, Tomas; De-Castellar, Roser; Jimenez, Jesus; Bermudez, Mercedes G.; Perez-Garcia, Miguel; Teresa Miranda, M.; Carmen Lopez-Sabater, M.; Catena, Andres; Campoy, Cristina			Infant Formula Supplemented With Milk Fat Globule Membrane, Long-Chain Polyunsaturated Fatty Acids, and Synbiotics Is Associated With Neurocognitive Function and Brain Structure of Healthy Children Aged 6 Years: The COGNIS Study	FRONTIERS IN NUTRITION			English	Article						neuroimaging; early nutrition; infant formula; breastfeeding; MFGM; LC-PUFAs; synbiotics; cognition	CHEEK CELL PHOSPHOLIPIDS; SURFACE-BASED ANALYSIS; BREAST-MILK; OCCIPITOTEMPORAL CORTEX; LCPUFA SUPPLEMENTATION; DOCOSAHEXAENOIC ACID; PUFA SUPPLEMENTATION; IRON-DEFICIENCY; NUTRITION; RECOMMENDATIONS	Background: Adequate nutrient intake during the first few months of life plays a critical role on brain structure and function development. Objectives: To analyze the long-term effects of an experimental infant formula (EF) on neurocognitive function and brain structure in healthy children aged 6 years compared to those fed with a standard infant formula or breastfed. Methods: The current study involved 108 healthy children aged 6 years and participating in the COGNIS Study. At 0-2 months, infants were randomized to receive up to 18 months of life a standard infant formula (SF) or EF enriched with milk fat globule membrane (MFGM), long-chain polyunsaturated fatty acids (LC-PUFAs) and synbiotics. Furthermore, a reference group of breastfed (BF) infants were also recruited. Children were assessed using neurocognitive tests and structural Magnetic Resonance Imaging (MRI) at 6 years old. Results: Experimental infant formula (EF) children showed greater volumes in the left orbital cortex, higher vocabulary scores and IQ, and better performance in an attention task than BF children. EF children also presented greater volumes in parietal regions than SF kids. Additionally, greater cortical thickness in the insular, parietal, and temporal areas were found in children from the EF group than those fed with SF or BF groups. Further correlation analyses suggest that higher volumes and cortical thickness of different parietal and frontal regions are associated with better cognitive development in terms of language (verbal comprehension) and executive function (working memory). Finally, arachidonic acid (ARA), adrenic acid (AdA), docosahexaenoic acid (DHA) levels in cheek cell glycerophospholipids, ARA/DHA ratio, and protein, fatty acid, and mineral intake during the first 18 months of life seem to be associated with changes in the brain structures at 6 years old. Conclusions: Supplemented infant formula with MFGM components, LC-PUFAs, and synbiotics seems to be associated to long-term effects on neurocognitive development and brain structure in children at 6 years old.	[Nieto-Ruiz, Ana; Garcia-Santos, Jose A.; Dieguez, Estefania; Herrmann, Florian; Bermudez, Mercedes G.; Campoy, Cristina] Univ Granada, Sch Med, Dept Paediat, Granada, Spain; [Nieto-Ruiz, Ana; Garcia-Santos, Jose A.; Dieguez, Estefania; Bermudez, Mercedes G.; Campoy, Cristina] Inst Invest Biosanitaria Ibs GRANADA, Hlth Sci Technol Pk, Granada, Spain; [Nieto-Ruiz, Ana; Garcia-Santos, Jose A.; Dieguez, Estefania; Herrmann, Florian; Cerdo, Tomas; Bermudez, Mercedes G.; Campoy, Cristina] Univ Granada, EURISTIKOS Excellence Ctr Paediat Res, Biomed Res Ctr, Granada, Spain; [Verdejo-Roman, Juan; Perez-Garcia, Miguel] Univ Granada, Sch Psychol, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Sepulveda-Valbuena, Natalia] Pontificia Univ Javeriana, Fac Sci, Nutr & Biochem Dept, Bogota, Colombia; [Cerdo, Tomas] Carlos III Hlth Inst, Madrid, Spain; [De-Castellar, Roser; Jimenez, Jesus] Labs Ordesa, St Boi De Ljobregat, Spain; [Perez-Garcia, Miguel; Catena, Andres] Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain; [Teresa Miranda, M.] Univ Granada, Sch Med, Dept Biostat, Granada, Spain; [Carmen Lopez-Sabater, M.] Univ Barcelona, Fac Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Barcelona, Spain; [Carmen Lopez-Sabater, M.] Inst Recerca Nutr & Seguretat Alimentaria UB INSA, Barcelona, Spain; [Carmen Lopez-Sabater, M.] Inst Hlth Carlos III Barcelonas Node, Natl Network Res Physiopathol Obes & Nutr CIBERob, Madrid, Spain; [Catena, Andres] Univ Granada, Sch Psychol, Dept Expt Psychol, Granada, Spain; [Campoy, Cristina] Inst Hlth Carlos III Granadas Node, Natl Network Res Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Cerdo, Tomas] Maimonides Inst Res Biomed Cordoba IMIBIC, Cordoba, Spain		Campoy, C (corresponding author), Univ Granada, Sch Med, Dept Paediat, Granada, Spain.; Campoy, C (corresponding author), Inst Invest Biosanitaria Ibs GRANADA, Hlth Sci Technol Pk, Granada, Spain.; Campoy, C (corresponding author), Univ Granada, EURISTIKOS Excellence Ctr Paediat Res, Biomed Res Ctr, Granada, Spain.; Campoy, C (corresponding author), Inst Hlth Carlos III Granadas Node, Natl Network Res Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	ccampoy@ugr.es	Román, Juan Verdejo/B-5188-2017; Catena, Andres/I-2159-2015; G. Bermudez, Mercedes/E-7708-2013	Román, Juan Verdejo/0000-0001-5112-8918; Catena, Andres/0000-0002-0775-5751; Nieto Ruiz, Ana/0000-0002-4303-6228; G. Bermudez, Mercedes/0000-0002-2643-5956; Cerdo, Tomas/0000-0002-5653-4314; Sepulveda-Valbuena, Natalia/0000-0002-1900-6475	Laboratorios Ordesa; Contract University of Granada General Foundation [3349]; SMARTFOODS (CIEN) Contract University of Granada General Foundation [4003]; Spanish Ministry of Economy, Industry and Competitiveness. Furthermore; EU DynaHEALTH Project [633595]	Laboratorios Ordesa; Contract University of Granada General Foundation; SMARTFOODS (CIEN) Contract University of Granada General Foundation; Spanish Ministry of Economy, Industry and Competitiveness. Furthermore; EU DynaHEALTH Project	This project has been funded by Laboratorios Ordesa, S.L. Contract University of Granada General Foundation, No. 3349 and SMARTFOODS (CIEN) Contract University of Granada General Foundation, No. 4003, Spanish Ministry of Economy, Industry and Competitiveness. Furthermore, the project has been partially funded by HORIZON 2020 EU DynaHEALTH Project (GA No. 633595).	Agostoni C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3760; Aguinaga G., 2005, PLON R PRUEBA LENGUA, V2nd ed; Agyei SB, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00100; Alce Ingenieria, ROGR DIAL CLCUL NUTR; Anjos T, 2013, EUR J NUTR, V52, P1825, DOI 10.1007/s00394-013-0560-4; Baker RD, 2010, PEDIATRICS, V126, P1040, DOI 10.1542/peds.2010-2576; Bardanzellu F, 2020, CURR NUTR REP, V9, P1, DOI 10.1007/s13668-020-00303-7; Bass JL, 2020, J PEDIATR-US, V218, P16, DOI 10.1016/j.jpeds.2019.08.059; Bauer CE, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10010019; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Belfort MB, 2016, J PEDIATR-US, V177, P133, DOI 10.1016/j.jpeds.2016.06.045; Bhatnagar S, 2001, BRIT J NUTR, V85, pS139, DOI 10.1079/BJN2000306; Birch EE, 2010, AM J CLIN NUTR, V91, P848, DOI 10.3945/ajcn.2009.28557; Black MM, 2003, J NUTR, V133, p1473S, DOI 10.1093/jn/133.5.1473S; Carlson AL, 2018, BIOL PSYCHIAT, V83, P148, DOI 10.1016/j.biopsych.2017.06.021; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Cattell RB., 1994, G FACTOR TEST SCALE; Chen YC, 2016, NEUROPSYCHOPHARMACOL, V41, P197, DOI 10.1038/npp.2015.181; Colombo J, 2013, AM J CLIN NUTR, V98, P403, DOI 10.3945/ajcn.112.040766; Connor SL, 2000, AM J CLIN NUTR, V71, P21; Cowan Caitlin S M, 2021, Mod Trends Psychiatry, V32, P12, DOI 10.1159/000510414; Cowan CSM, 2020, J CHILD PSYCHOL PSYC, V61, P353, DOI 10.1111/jcpp.13156; Cruz-Quintana F., 2013, BENCI BATER A EVALUA; Cusick SE, 2016, J PEDIATR-US, V175, P16, DOI 10.1016/j.jpeds.2016.05.013; Dai XT, 2019, HUM BRAIN MAPP, V40, P4130, DOI 10.1002/hbm.24690; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Puentes AD, 2015, INT J FOOD SCI NUTR, V66, P936, DOI 10.3109/09637486.2015.1102872; Dean DC, 2016, NEUROIMAGE, V132, P225, DOI 10.1016/j.neuroimage.2016.02.040; Deoni S, 2018, NEUROIMAGE, V178, P649, DOI 10.1016/j.neuroimage.2017.12.056; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dror DK, 2018, ADV NUTR, V9, p278S, DOI 10.1093/advances/nmy022; Drover JR, 2011, EARLY HUM DEV, V87, P223, DOI 10.1016/j.earlhumdev.2010.12.047; Duncan AF, 2018, CLIN PERINATOL, V45, P377, DOI 10.1016/j.clp.2018.05.001; Escribano J, 2019, Br J Nutr, V122, pS22, DOI 10.1017/S0007114515000768; Fasfous AF, 2015, CHILD NEUROPSYCHOL, V21, P210, DOI 10.1080/09297049.2014.896330; Fedorenko E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00335; Fernandes MF, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030298; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gaillard R, 2016, BJOG-INT J OBSTET GY, V123, P207, DOI 10.1111/1471-0528.13700; Garcia-Esteve L, 2003, J AFFECT DISORDERS, V75, P71, DOI 10.1016/S0165-0327(02)00020-4; Gasquoine PG, 2014, NEUROPSYCHOL REV, V24, P77, DOI 10.1007/s11065-014-9246-9; Georgieff MK, 2007, AM J CLIN NUTR, V85, p614S; Georgieff MK, 2018, ACTA PAEDIATR, V107, P1310, DOI 10.1111/apa.14287; Girard LC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1848; Hartikainen KM, 2012, J CLIN EXP NEUROPSYC, V34, P588, DOI 10.1080/13803395.2012.666231; Hernell O, 2019, NESTLE NUTR WORKS SE, V90, P35, DOI 10.1159/000490291; Hernell O, 2016, J PEDIATR-US, V173, pS60, DOI 10.1016/j.jpeds.2016.02.077; Hernell O, 2015, J PEDIATR-US, V167, pS40, DOI 10.1016/j.jpeds.2015.07.020; Hesslinger B, 2002, NEUROSCI LETT, V328, P319, DOI 10.1016/S0304-3940(02)00554-2; Hoffman DR, 1999, LIPIDS, V34, P337, DOI 10.1007/s11745-999-0371-y; Holme A, 2010, CHILD CARE HLTH DEV, V36, P583, DOI 10.1111/j.1365-2214.2009.01068.x; Horta BL, 2018, CURR OPIN CLIN NUTR, V21, P174, DOI 10.1097/MCO.0000000000000453; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Jednorog K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042486; Jharap VV, 2017, EARLY HUM DEV, V108, P23, DOI 10.1016/j.earlhumdev.2017.03.006; Jirout J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081953; Johnson SB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3075; Kaneko KJ, 2020, J PEDIATR-US, V216, P250, DOI 10.1016/j.jpeds.2019.08.035; Kar P, 2021, NEUROIMAGE, V236, DOI 10.1016/j.neuroimage.2021.118084; Kaufman AS., 2000, KAUMAN BRIEF INTELLI; Kaufman AS, 2004, KAUFMAN BRIEF INTELL; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Koletzko B, 2005, J PEDIATR GASTR NUTR, V41, P584, DOI 10.1097/01.mpg.0000187817.38836.42; Koletzko B, 2020, AM J CLIN NUTR, V111, P10, DOI 10.1093/ajcn/nqz252; Koletzko B, 2014, ANN NUTR METAB, V65, P49, DOI 10.1159/000365767; Kuusinen V, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00437; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lepping RJ, 2019, DEV PSYCHOBIOL, V61, P5, DOI 10.1002/dev.21780; Lien EL, 2018, PROSTAG LEUKOTR ESS, V128, P26, DOI 10.1016/j.plefa.2017.09.005; Lin WL, 2019, NESTLE NUTR WORKS SE, V90, P121, DOI 10.1159/000490300; Lonnerdal B, 2017, AM J CLIN NUTR, V106, p1681S, DOI 10.3945/ajcn.117.156042; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Mano QR, 2013, CEREB CORTEX, V23, P988, DOI 10.1093/cercor/bhs093; Mattei D, 2019, CURR NUTR REP, V8, P99, DOI 10.1007/s13668-019-0268-z; McCann JC, 2005, AM J CLIN NUTR, V82, P281, DOI 10.1093/ajcn/82.2.281; McDermott CL, 2019, J NEUROSCI, V39, P1365, DOI 10.1523/JNEUROSCI.1808-18.2018; Michaelsen KF, 2009, ADV EXP MED BIOL, V639, P199, DOI 10.1007/978-1-4020-8749-3_15; Miklavcic JJ, 2017, J PEDIATR GASTR NUTR, V64, P446, DOI 10.1097/MPG.0000000000001283; Miliku K, 2019, AM J CLIN NUTR, V110, P1370, DOI 10.1093/ajcn/nqz229; Morita T, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00464; Nieto-Ruiz Ana, 2020, Nutrients, V12, P3825, DOI 10.3390/nu12123825; Nieto-Ruiz A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020535; Nieto-Ruiz A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102456; Ottolini KM, 2020, PEDIATR RES, V87, P194, DOI 10.1038/s41390-019-0508-3; Ou X, 2016, AM J NEURORADIOL, V37, P713, DOI 10.3174/ajnr.A4593; Perez-Garcia Miguel, 2019, Br J Nutr, V122, pS59, DOI 10.1017/S0007114517000824; Pietschnig J, 2015, NEUROSCI BIOBEHAV R, V57, P411, DOI 10.1016/j.neubiorev.2015.09.017; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Qawasmi A, 2013, PEDIATRICS, V131, pE262, DOI 10.1542/peds.2012-0517; Radlowski EC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00585; Rochat TJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002044; Rosales FJ, 2009, NUTR NEUROSCI, V12, P190, DOI 10.1179/147683009X423454; Rosenfeld E, 2009, ACTA PAEDIATR, V98, P91, DOI 10.1111/j.1651-2227.2008.00988.x; Ryan AS, 2010, PROSTAG LEUKOTR ESS, V82, P305, DOI 10.1016/j.plefa.2010.02.007; Lorenzo IS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030602; Schipper L, 2020, OCL OILS FAT CROP LI, V27, DOI 10.1051/ocl/2020001; Sebastian R, 2014, COGN NEUROPSYCHOL, V31, P511, DOI 10.1080/02643294.2014.884060; Sepulveda-Valbuena N, 2021, BRIT J NUTR, V126, P1809, DOI 10.1017/S000711452100057X; Smirnov D, 2014, NEUROPSYCHOLOGIA, V63, P293, DOI 10.1016/j.neuropsychologia.2014.09.007; Soldan MMP, 2012, SEMIN NEUROL, V32, P9, DOI 10.1055/s-0032-1306381; Timby N, 2017, ADV NUTR, V8, P351, DOI 10.3945/an.116.014142; Timby N, 2014, AM J CLIN NUTR, V99, P860, DOI 10.3945/ajcn.113.064295; Tognini P, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00025; Toth AB, 2016, CELL CALCIUM, V59, P124, DOI 10.1016/j.ceca.2016.02.011; Uddin LQ, 2017, J CLIN NEUROPHYSIOL, V34, P300, DOI 10.1097/WNP.0000000000000377; United States Department of Agriculture, FOODDATA CENTR; Verdejo-Roman J, 2019, INT J OBESITY, V43, P1995, DOI 10.1038/s41366-018-0268-x; Verduci E, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020486; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO, 2017, EXCLUSIVE BREASTFEED; Willatts P, 2013, AM J CLIN NUTR, V98, p536S, DOI 10.3945/ajcn.112.038612; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Worls Health Organization, 1998, PREP US FOOD BAS DIE; Yang S, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002554; Zlatkina V, 2016, EUR J NEUROSCI, V43, P1268, DOI 10.1111/ejn.13049	118	0	0	7	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-861X			FRONT NUTR	Front. Nutr.	MAR 9	2022	9								820224	10.3389/fnut.2022.820224	http://dx.doi.org/10.3389/fnut.2022.820224			19	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nutrition & Dietetics	1K6UB	35356726	gold, Green Published			2022-09-04	WOS:000798732100001
J	Yadav, BS; Chaturvedi, N; Yadav, PK; Marina, N; Ganash, M; Barreto, GE; Ashraf, GM; Ahmad, K; Baig, MH				Yadav, Brijesh S.; Chaturvedi, Navaneet; Yadav, Pavan K.; Marina, Ninoslav; Ganash, Magdah; Barreto, George E.; Ashraf, Ghulam Md; Ahmad, Khurshid; Baig, Mohammad H.			Protein modeling, molecular network and molecular dynamics study of newly sequenced interleukin-18 (IL-18) gene in Mus musculus	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						cloning and sequencing; functional enrichment; interleukin-18; molecular dynamics; network analysis	IFN-GAMMA; BIOLOGICAL-ACTIVITY; BINDING-SITES; MM-PBSA; IDENTIFICATION; COMPLEXES; IMMUNITY; GROMACS; ACID; TOOL	Interleukin-18 (IL-18) belongs to the superfamily of IL-1 protein and exerts a pleiotropic pro-inflammatory effect on the body. Generally, this protein is significantly involved in immune defense during infection in cells, but sometimes its anomalous activities produce some inflammatory diseases like rheumatoid arthritis and Crohn's disease. In the present study, the IL-18 gene was isolated from mice and was subsequently cloned and sequenced. Further, the network analysis was carried out to explore the functional role of IL-18 protein in animals. The 3D protein structure of the IL-18 protein was generated and docked with appropriate 3-([3-cholamidopropyl]dimethylammonio)-1-propanesulfonate (CPS) ligand. Later the complex structure of the protein was subjected to molecular dynamics simulation (MDS) for 50ns to determine the effect of ligand on protein. The network analysis explored the correlation of IL-18 protein with others proteins and their involvement in the different significant pathway to defend the cell from various diseases. As confirmed by MDS, the CPS:IL-18 complex was found to be highly stable. Our results further indicated that CPS ligand has the potential to act as a drug molecule, in future, for counteracting IL-18 activity. To date, no structural details were available for animal IL-18. Hence, the finding of this study will be useful in broadening the horizon towards a better understanding of the functional and structural aspects of IL-18 in animals.	[Yadav, Brijesh S.; Marina, Ninoslav] Univ Informat Sci & Technol, Dept Bioengn, Ohrid, Macedonia; [Chaturvedi, Navaneet] Banaras Hindu Univ, Indian Inst Technol, Sch Biochem Engn, Varanasi, Uttar Pradesh, India; [Yadav, Pavan K.] Banaras Hindu Univ, Fac Vet & Anim Sci, Dept Vet Physiol & Biochem, Varanasi, Uttar Pradesh, India; [Ganash, Magdah] King Abdulaziz Univ, Fac Sci, Dept Biol, Jeddah, Saudi Arabia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Ahmad, Khurshid; Baig, Mohammad H.] Yeungnam Univ, Dept Med Biotechnol, Gyongsan 38541, South Korea		Yadav, BS (corresponding author), Univ Informat Sci & Technol, Dept Bioengn, Ohrid, Macedonia.; Ahmad, K; Baig, MH (corresponding author), Yeungnam Univ, Dept Med Biotechnol, Gyongsan 38541, South Korea.	brijeshbioinfo@gmail.com; ahmadkhursheed2008@gmail.com; mohdhassanbaig@gmail.com	Ashraf, Ghulam Md/H-9485-2012; Barreto, George E./AAD-7420-2020; Chaturvedi, Navaneet/AAK-2364-2020; Ganash, Magdah/AAY-6666-2020; Ahmad, Khurshid/M-4676-2014	Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Chaturvedi, Navaneet/0000-0002-4265-9255; Ganash, Magdah/0000-0003-3709-0487; Ahmad, Khurshid/0000-0002-1095-8445; Baig, Mohd Hassan/0000-0001-8227-4838; Yadav, Brijesh/0000-0002-3095-3369; Marina, Ninoslav/0000-0003-4862-0199				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amber-Vitos O, 2016, BBA-MOL CELL BIOL L, V1861, P1852, DOI 10.1016/j.bbalip.2016.09.003; [Anonymous], 2002, PROTEINS STRUCTURE F, V30, pS97; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brieland JK, 2000, INFECT IMMUN, V68, P6567, DOI 10.1128/IAI.68.12.6567-6573.2000; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Chaturvedi N, 2017, J MOL GRAPH MODEL, V74, P315, DOI 10.1016/j.jmgm.2017.04.014; Coker E. A., 2018, AACR NCI EORTC INT C, DOI [10.1158/1535-7163.TARG-17-B096, DOI 10.1158/1535-7163.TARG-17-B096]; Cuadrado A, 2018, PHARMACOL REV, V70, P348, DOI 10.1124/pr.117.014753; Du GY, 2012, J CANCER RES CLIN, V138, P1727, DOI 10.1007/s00432-012-1248-5; Avila MF, 2014, J THEOR BIOL, V345, P43, DOI 10.1016/j.jtbi.2013.12.010; Fu T, 2013, CURR PHARM DESIGN, V19, P2293, DOI 10.2174/1381612811319120016; Gonzalez J., 2013, J AMINO ACIDS, V2013; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanai T, 2013, CURR DRUG TARGETS, V14, P1392, DOI 10.2174/13894501113149990006; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kazakov AS, 2017, J BIOMOL STRUCT DYN, V35, P78, DOI 10.1080/07391102.2015.1132392; Kim SH, 2002, J BIOL CHEM, V277, P10998, DOI 10.1074/jbc.M108311200; Kim SHM, 2001, P NATL ACAD SCI USA, V98, P3304, DOI 10.1073/pnas.051634098; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Marshall DJ, 2006, VACCINE, V24, P244, DOI 10.1016/j.vaccine.2005.07.087; Martin-Jimenez CA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00023; Mentes A, 2016, J CHEM THEORY COMPUT, V12, P2459, DOI 10.1021/acs.jctc.6b00134; Micallef MJ, 1997, CANCER IMMUNOL IMMUN, V43, P361, DOI 10.1007/s002620050345; Nagai H, 2002, J INVEST DERMATOL, V119, P541, DOI 10.1046/j.1523-1747.2002.01866.x; Nakamura S, 2000, J IMMUNOL, V164, P3330, DOI 10.4049/jimmunol.164.6.3330; Nolan KF, 1998, GENOMICS, V51, P161, DOI 10.1006/geno.1998.5336; OKAMURA H, 1995, INFECT IMMUN, V63, P3966, DOI 10.1128/IAI.63.10.3966-3972.1995; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Osaki T, 1998, J IMMUNOL, V160, P1742; Pillai H, 2017, COMB CHEM HIGH T SCR, V20, P186, DOI 10.2174/1386207319666161220124532; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Reddy MR, 2014, CURR PHARM DESIGN, V20, P3323, DOI 10.2174/13816128113199990604; Ryu JY, 2018, P NATL ACAD SCI USA, V115, pE4304, DOI 10.1073/pnas.1803294115; Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shakour N, 2019, J CELL BIOCHEM, V120, P4710, DOI 10.1002/jcb.27761; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Bello OS, 2012, J THEOR BIOL, V315, P53, DOI 10.1016/j.jtbi.2012.09.004; Tofoleanu F, 2017, J COMPUT AID MOL DES, V31, P107, DOI 10.1007/s10822-016-9965-5; TOUKAN K, 1985, PHYS REV B, V31, P2643, DOI 10.1103/PhysRevB.31.2643; Tse BWC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024241; Tsutsumi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6340; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang YL, 2017, NUCLEIC ACIDS RES, V45, pD955, DOI 10.1093/nar/gkw1118; Yadav BS, 2012, EXP MOL PATHOL, V92, P7, DOI 10.1016/j.yexmp.2011.09.018; Yadav BS, 2018, CURR TOP MED CHEM, V18, P1737, DOI 10.2174/1568026618666181025112344; Yadav PK, 2017, COMB CHEM HIGH T SCR, V20, P539, DOI 10.2174/1386207320666170217150741	57	4	5	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	AUG	2019	234	8					14285	14295		10.1002/jcp.28127	http://dx.doi.org/10.1002/jcp.28127			11	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	HX2SA	30624775				2022-09-04	WOS:000467240800190
J	Orioli, IM; Mastroiacovo, P; Lopez-Camelo, JS; Saldarriaga, W; Isaza, C; Aiello, H; Zarante, I; Castilla, EE				Orioli, Ieda M.; Mastroiacovo, Pierpaolo; Lopez-Camelo, Jorge S.; Saldarriaga, Wilmar; Isaza, Carolina; Aiello, Horacio; Zarante, Ignacio; Castilla, Eduardo E.			Clusters of Sirenomelia in South America	BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY			English	Article						cluster analysis; congenital abnormalities; epidemics; landfill leachate; monsters; South America	CONGENITAL-MALFORMATIONS; DEFECTS; MERMAID; EXPOSURE; RISK	BACKGROUND: One hospital in the city of Cali, Colombia, of the ECLAMC (Latin-American Collaborative Study of Congenital Malformations) network, reported the unusual occurrence of four cases of sirenomelia within a 55-day period. METHODS: An ECLAMC routine for cluster evaluation (RUMOR) was followed that included: calculations of observed /expected ratios, site visits, comparison with comprehensively collected local, South American, and worldwide data, cluster analysis, and search for risk factors. RESULTS: All four Cali sirenomelia cases were born to mothers living in a 2 km(2) area, in neighboring communes, within the municipality of Cali. Considering the total births of the city of Cali as the denominator, and based on ECLAMC baseline birth prevalence rates (per 100,000) for sirenomelia (2.25, 95% CI: 2.66, 3.80), the cluster for this congenital abnormality was unlikely to have occurred by chance (observed/ expected ratio = 5.77; 95% CI: 1.57-14.78; p =.002). No consistent common factor was identified, but vicinity to an open landfill as the cause could not be rejected. Another ECLAMC hospital in San Justo, Buenos Aires, Argentina, reported three further cases but these did not seem to constitute a nonrandom cluster. CONCLUSIONS: The methodology used to evaluate the two possible clusters of sirenomelia determined that the Cali sirenomelia cluster was unlikely to have occurred by chance whereas the sirenomelia cluster from San Justo seemed to be random. Birth Defects Research (Part A) 85:112-118, 2009. (C) 2008 Wiley-Liss, Inc.	[Orioli, Ieda M.] Univ Fed Rio de Janeiro, Dept Genet, ECLAMC Latin Amer Collaborat Study Congenital Mal, BR-21941 Rio De Janeiro, Brazil; [Mastroiacovo, Pierpaolo] Int Clearinghouse Birth Defects Surveillance & Re, Int Ctr Birth Defects, Rome, Italy; [Lopez-Camelo, Jorge S.] IMBICE, ECLAMC, La Plata, Buenos Aires, Argentina; [Lopez-Camelo, Jorge S.; Castilla, Eduardo E.] CEMIC, ECLAMC, La Plata, Buenos Aires, Argentina; [Saldarriaga, Wilmar; Isaza, Carolina] Univ Valle, ECLAMC, Cali, Colombia; [Zarante, Ignacio] Univ Javeriana, Inst Med Genet, ECLAMC, Bogota, Colombia; [Castilla, Eduardo E.] Inst Oswaldo Cruz, FIOCRUZ, ECLAMC, BR-20001 Rio De Janeiro, Brazil		Castilla, EE (corresponding author), Fiocruz MS, GENETICA, ECLAMC, Av Brasil 4365,Pav 26,Sala 617, BR-21045900 Rio De Janeiro, Brazil.	castilla@centroin.com.br	Zarante, Ignacio/AAL-6215-2021; Zarante, Ignacio/L-6467-2017	Zarante, Ignacio/0000-0002-0729-6866; Zarante, Ignacio/0000-0002-0729-6866; Lopez-Camelo, Jorge S./0000-0002-3146-5447; Saldarriaga, Wilmar/0000-0001-7815-4390	PHS HHS [U50/CCU 207141] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSSON K, 2005, THESIS ROYAL I TECHN, V5, P11; Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776; CHEN R, 1978, J AM STAT ASSOC, V73, P323, DOI 10.2307/2286660; CZEIZEL AE, 1993, LANCET, V341, P539, DOI 10.1016/0140-6736(93)90293-P; DUHAMEL B, 1961, ARCH DIS CHILD, V36, P152, DOI 10.1136/adc.36.186.152; Elliott P, 2001, BRIT MED J, V323, P363, DOI 10.1136/bmj.323.7309.363; Foerster A., 1861, MISSBILDUNGEN MENSCH, P1861; GISCHLER C, 2005, THESIS ROYAL I TECHN, V5, P13; GRETHER JK, 1988, INVESTIGATING CLUSTE; HILBELINK DR, 1986, TERATOGEN CARCIN MUT, V6, P431, DOI 10.1002/tcm.1770060509; Holmes LB, 2002, AM J MED GENET, V112, P297, DOI 10.1002/ajmg.10781; *INT CLEAR BIRTH D, 1991, CONG MALF WORLDW; KALLEN B, 1992, J MED GENET, V29, P30, DOI 10.1136/jmg.29.1.30; KELSEY FO, 1988, TERATOLOGY, V38, P221, DOI 10.1002/tera.1420380305; Last J., 1995, DICT EPIDEMIOLOGY; Lynch SA, 1997, CLIN DYSMORPHOL, V6, P75; McNamee R, 2001, BRIT MED J, V323, P351, DOI 10.1136/bmj.323.7309.351; *MIN HLTH, 1997, INV CLUST NONC DIS G; Opitz JM, 2002, AM J MED GENET, V115, P269, DOI 10.1002/ajmg.10983; Padmanabhan R, 2003, BIRTH DEFECTS RES B, V68, P428, DOI 10.1002/bdrb.10042; Pareyra F. X., 2003, B ENG GEOL ENVIRON, V62, P341, DOI [10.1007/s10064-003-0199-0, DOI 10.1007/S10064-003-0199-0]; Patel S, 2004, ULTRASOUND OBST GYN, V24, P684, DOI 10.1002/uog.1758; ROBERT JM, 1981, J GENET HUM, V29, P379; SARPONG S, 1992, SOUTHERN MED J, V85, P545, DOI 10.1097/00007611-199205000-00017; Schiesser M, 2003, PRENATAL DIAG, V23, P493, DOI 10.1002/pd.624; Stocker J T, 1987, Perspect Pediatr Pathol, V10, P7; Vrijheid M, 2000, ARCH DIS CHILD, V82, P349, DOI 10.1136/adc.82.5.349; Williams LJ, 2002, TERATOLOGY, V66, pS50, DOI 10.1002/tera.90011; Yoon PW, 2001, PUBLIC HEALTH REP, V116, P32, DOI 10.1093/phr/116.S1.32; 1990, MMWR, V39, P1	30	8	11	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1542-0752	1542-0760		BIRTH DEFECTS RES A	Birth Defects Res. Part A-Clin. Mol. Teratol.	FEB	2009	85	2					112	118		10.1002/bdra.20492	http://dx.doi.org/10.1002/bdra.20492			7	Developmental Biology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Toxicology	414WK	18712806				2022-09-04	WOS:000263895700002
J	Lozada-Martinez, ID; Carvajal-Bautista, J; Picon-Jaimes, YA; Dominguez-Alvarado, G; Cabrera-Vargas, LF; Torregrosa-Almonacid, L; Guevara-Cruz, O; Narvaez-Rojas, AR				Lozada-Martinez, Ivan David; Carvajal-Bautista, Jeremias; Picon-Jaimes, Yelson Alejandro; Dominguez-Alvarado, Gonzalo; Cabrera-Vargas, Luis Felipe; Torregrosa-Almonacid, Lilian; Guevara-Cruz, Oscar; Narvaez-Rojas, Alexis Rafael			Surgical research in Colombia part 1: Scientific and academic productivity of the Colombian research groups in surgery	ANNALS OF MEDICINE AND SURGERY			English	Article						Research; Research group; General surgery; Publishing; Colombia	GLOBAL SURGERY; DEPARTMENTS	Introduction: Global surgery has become the undisputed starting point for addressing a myriad of problems in surgery today. Therefore, it is necessary to constantly evaluate the scientific productivity in surgery, its behavior, validity and impact. In Latin America, specifically in Colombia, there are no studies that have analyzed this production.Methods: A retrospective cross-sectional bibliometric study was carried out, in which the Colombian Ministry of Science database was consulted with the validated results up to July 2021. In the search section for research groups, the key word "Surgery" was used, and all associated GrupLAC (platform where the information of the research groups can be found) and their registered products were reviewed. Results: 40 groups were included. Only 5 (12.5%) were registered in surgery as main line of research. The great majority of the groups were in the medium-low category, 50% in category C and 22.5% in category B. The vast majority of surgical groups are located in Bogot acute accent a (19; 47.5%). The first surgery group in the country was created in 1994 and the last one in 2017. In 27 years of surgical research, a total of 4121 registered scientific articles were found, 83 books, 713 book chapters, 2891 products associated with participation in scientific events, 1221 theses directed, and 1670 projects in colombian surgical research groups. There was evidence of a high rate of underreporting of data, due to duplication of products and incomplete registration of data.Conclusions: There is a high rate of underreporting of products and data in the GrupLAC of Colombian surgical research groups. Most of the production is located in the Andes region (Antioquia, Valle del Cauca and Bogot acute accent a), and is predominantly composed of scientific articles and products associated with participation in scientific events.	[Lozada-Martinez, Ivan David; Picon-Jaimes, Yelson Alejandro] Colombian Surg Assoc, Med & Surg Res Ctr, Future Surg Chapter, Cartagena, Colombia; [Lozada-Martinez, Ivan David] Univ Cartagena, Sch Med, Grp Prometheus & Biomed Aplicada Ciencias Clin, Cartagena, Colombia; [Carvajal-Bautista, Jeremias] Univ Pamplona, Sch Med, Pamplona, Colombia; [Dominguez-Alvarado, Gonzalo] Grp Innovac Invest Cirugia, Semillero Innovac Invest Quirurg, Bucaramanga, Colombia; [Cabrera-Vargas, Luis Felipe] Univ Mil Nueva Granada, Dept Surg, Bogota, Colombia; [Torregrosa-Almonacid, Lilian] Pontificia Univ Javeriana, Dept Surg, Bogota, Colombia; [Guevara-Cruz, Oscar] Univ Nacl Colombia, Dept Surg, Bogota, Colombia; [Narvaez-Rojas, Alexis Rafael] Univ Nacl Autonoma Nicaragua, Hosp Carlos Roberto Huembes, Dept Surg, Managua, Nicaragua		Narvaez-Rojas, AR (corresponding author), Univ Nacl Autonoma Nicaragua, Hosp Carlos Roberto Huembes, Dept Surg, Managua, Nicaragua.	ilozadam@unicartagena.edu.co; jerecarvajal2@gmail.com; ypicon@unab.edu.co; gdominguez@unab.edu.co; luis.felipe.cabrera@hotmail.com; lilian.torregrosa@gmail.com; oaguevarac@unal.edu.co; axnarvaez@gmail.com	Jaimes, Yelson Alejandro Picón/AAJ-7860-2020; Guardo Carmona, Daniela/GOV-6152-2022	Jaimes, Yelson Alejandro Picón/0000-0002-7498-5346; Carvajal Bautista, Jeremias/0000-0002-3054-6368; Lozada Martinez, Ivan David/0000-0002-1960-7334; Narvaez-Rojas, Alexis Rafael/0000-0001-6987-5030				Ahmed K, 2011, J SURG RES, V167, P298, DOI 10.1016/j.jss.2010.11.916; Baroutjian A, 2021, AM SURGEON, V87, P30, DOI 10.1177/0003134820949508; Bell TM, 2017, ANN SURG, V265, P111, DOI 10.1097/SLA.0000000000001657; Bigelow BF, 2021, J SURG RES, V263, P251, DOI 10.1016/j.jss.2021.01.015; Cash-Gibson L, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0048-1; Chen H., 2017, SUCCESS ACAD SURG, Vsecond; Colombian Ministry of Sciences, FUNCTIONS; Colombian Ministry of Sciences, REC RES GROUPS RES; Colombian Ministry of Sciences, RES FIND; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dominguez-Alvarado G.A., 2021, INT J SURG, V90; Dominguez-Alvarado G, 2021, ANN MED SURG, V69, DOI 10.1016/j.amsu.2021.102688; Dominguez-Alvarado GA, 2021, INT J SURG, V91, DOI 10.1016/j.ijsu.2021.106009; Franzen SRP, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012332; Ortega-Sierra MG, 2021, J SURG RES, V267, P209, DOI 10.1016/j.jss.2021.04.045; Hedt-Gauthier BL, 2019, BRIT J SURG, V106, pE151, DOI 10.1002/bjs.11066; Khan N., 2013, WORLD NEUROSURG, V80, pe3; Khan Nickalus, 2013, World Neurosurg, V80, P759, DOI 10.1016/j.wneu.2013.07.010; Lozada-Martinez I.D., 2022, INT J SURG, V99; Maragh-Bass AC, 2016, SURGERY, V160, P1447, DOI 10.1016/j.surg.2016.06.026; Mariette C, 2013, LANGENBECK ARCH SURG, V398, P587, DOI 10.1007/s00423-012-0991-z; Mathew G, 2021, INT J SURG, V96, DOI 10.1016/j.ijsu.2021.106165; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Nundy S., 2022, PRACTICE ACAD MED PU, Vfirst; Nunez-Gomez JA, 2021, ANN MED SURG, V71, DOI 10.1016/j.amsu.2021.103002; OECD, 2018, INEQUALITY DEV CHALL; Pugh C.M., 2019, SUCCESS ACAD SURG DE, Vsecond; Roa L, 2019, BRIT J SURG, V106, pE44, DOI 10.1002/bjs.11044; Sánchez-Jaramillo José Manuel, 2021, rev. colomb. cir., V36, P205, DOI 10.30944/20117582.702; Sgro A, 2019, WORLD J SURG, V43, P2689, DOI 10.1007/s00268-019-05112-w; Szomszor Martin, 2020, Front Res Metr Anal, V5, P628703, DOI 10.3389/frma.2020.628703; Thompson DF, 2015, PHARMACOTHERAPY, V35, P551, DOI 10.1002/phar.1586; Valsangkar NP, 2016, SURGERY, V160, P1440, DOI 10.1016/j.surg.2016.07.009; Valsangkar NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131678; Wang H, 2021, ANN THORAC SURG, V112, P1664, DOI 10.1016/j.athoracsur.2020.10.013; Zarzaur BL, 2016, J TRAUMA ACUTE CARE, V81, P137, DOI 10.1097/TA.0000000000001066	36	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	MAY	2022	77								103667	10.1016/j.amsu.2022.103667	http://dx.doi.org/10.1016/j.amsu.2022.103667			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	1V6BG	35638019	gold, Green Published			2022-09-04	WOS:000806172000011
J	Carvajal, SK; Alvarado, M; Rodriguez, YM; Parra-Giraldo, CM; Varon, C; Morales-Lopez, SE; Rodriguez, JY; Gomez, BL; Escandon, P				Carvajal, Silvia Katherine; Alvarado, Maira; Rodriguez, Yuli M.; Parra-Giraldo, Claudia M.; Varon, Carmen; Morales-Lopez, Soraya E.; Rodriguez, Jose Y.; Gomez, Beatriz L.; Escandon, Patricia			Pathogenicity Assessment of Colombian Strains of Candida auris in the Galleria mellonella Invertebrate Model	JOURNAL OF FUNGI			English	Article						Candida auris; pathogenicity; Galleria mellonella; virulence; enzymatic activity; survival study	HEMOLYTIC ACTIVITIES; CLONAL STRAIN; PHOSPHOLIPASE; ALBICANS; HOST; MICE	Candida auris, first described in 2009, is an opportunistic pathogenic yeast that causes nosocomial outbreaks around the world, with high mortality rates associated with therapeutic failure. In this study, we evaluated the pathogenicity of 107 isolates from two cities in Colombia, associated with fungemia or colonization processes; to achieve this, we used the Galleria mellonella invertebrate model to compare pathogenicity. Our results showed that less than half of the total isolates of C. auris presented a high pathogenicity compared to the reference strain SC5314, and most of those highly pathogenic strains were from colonization processes. We observed that there was formation of large aggregates of cells that cannot be disrupted easily, without statistically significant differences between the pathogenicity of the aggregated and non-aggregated strains. In addition, protease activity was observed in 100% of the C. auris strains; phospholipase and hemolysin activity were observed in 67.3 and 68.2% of the studied strains, respectively. In conclusion, these results highlight the utility of determining survival using G. mellonella, which allowed us to provide new information on the pathogenicity, enzymatic activity, and the relationship of the aggregated and non-aggregated phenotypes of C. auris in this model.	[Carvajal, Silvia Katherine; Alvarado, Maira; Escandon, Patricia] Inst Nacl Salud, Grp Microbiol, Bogota 111321, Colombia; [Carvajal, Silvia Katherine; Parra-Giraldo, Claudia M.] Pontificia Univ Javeriana, Fac Ciencias, Unidad Prote & Micosis Humanas, Grp Enfermedades Infecciosas,Dept Microbiol, Bogota 110231, Colombia; [Rodriguez, Yuli M.] Univ Colegio Mayor Cundinamarca, Bacteriol & Lab Clin, Bogota 111311, Colombia; [Varon, Carmen] Hosp Infantil Napoleon Franco Pareja, Cartagena 130010, Colombia; [Morales-Lopez, Soraya E.] Univ Popular Cesar, Dept Microbiol, Grp CINBIOS, Valledupar 200004, Colombia; [Rodriguez, Jose Y.] Ctr Invest Microbiol Cesar, Valledupar 200002, Colombia; [Rodriguez, Jose Y.] Clin Alta Complejidad, Valledupar 200002, Colombia; [Rodriguez, Jose Y.] Clin Laura Daniela, Valledupar 200002, Colombia; [Rodriguez, Jose Y.] Inst Cardiovasc Cesar, Valledupar 200002, Colombia; [Gomez, Beatriz L.] Univ Rosario, Sch Med & Hlth Sci, Translat Microbiol & Emerging Dis MICROS, Bogota 111221, Colombia		Escandon, P (corresponding author), Inst Nacl Salud, Grp Microbiol, Bogota 111321, Colombia.	silvia.carvajal@javeriana.edu.co; maira8822@gmail.com; ymelissarodriguez@unicolmayor.edu.co; daudia.parra@javeriana.edu.co; cajuvame@yahoo.com.mx; sorayaeugeniam@hotmail.com; jyrodriguezq@gmail.com; beatriz.gomez@urosario.edu.co; pescandon@ins.gov.co		Carvajal, Silvia Katherine/0000-0002-8772-9261	Ministerio de Ciencia, Tecnologia e Innovacion [20173600106463]; Instituto Nacional de Salud	Ministerio de Ciencia, Tecnologia e Innovacion; Instituto Nacional de Salud	This research was funded by Ministerio de Ciencia, Tecnologia e Innovacion, MinCiencias, grant number 20173600106463. Research was also funded by the Instituto Nacional de Salud.	Borman AM, 2018, VIRULENCE, V9, P9, DOI 10.1080/21505594.2017.1382799; Borman AM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00189-16; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Champion OL, 2016, VIRULENCE, V7, P840, DOI 10.1080/21505594.2016.1203486; Chowdhary A, 2014, EUR J CLIN MICROBIOL, V33, P919, DOI 10.1007/s10096-013-2027-1; Chowdhary A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006290; Chowdhary A, 2013, EMERG INFECT DIS, V19, P1670, DOI 10.3201/eid1910.130393; Corsi-Vasquez G, 2019, CURR OPIN INFECT DIS, V32, P559, DOI 10.1097/QCO.0000000000000603; Cortés Jorge Alberto, 2020, Biomed., V40, P195, DOI 10.7705/biomedica.4400; Du H, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008921; Escandon P, 2018, MMWR-MORBID MORTAL W, V67, P459, DOI 10.15585/mmwr.mm6715a6; Eyre DW, 2018, NEW ENGL J MED, V379, P1322, DOI 10.1056/NEJMoa1714373; Fasciana T, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9110778; Firacative C, 2020, J FUNGI, V6, DOI 10.3390/jof6030130; Ayala-Gaytan JJ, 2021, INFECTION, V49, P523, DOI 10.1007/s15010-020-01525-1; Jeffery-Smith A, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00029-17; Junqueira JC, 2012, REV INST MED TROP SP, V54, P17, DOI 10.1590/S0036-46652012000100004; Kean R, 2020, J FUNGI, V6, DOI 10.3390/jof6010030; Larkin E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02396-16, 10.1128/aac.02396-16]; Lee WG, 2011, J CLIN MICROBIOL, V49, P3139, DOI 10.1128/JCM.00319-11; Leone R, 1999, J MYCOL MED, V9, P42; MANNS JM, 1994, INFECT IMMUN, V62, P5154, DOI 10.1128/IAI.62.11.5154-5156.1994; Morales-Lopez SE, 2017, EMERG INFECT DIS, V23, P162, DOI 10.3201/eid2301.161497; Munoz JE, 2020, J FUNGI, V6, P104, DOI 10.3390/jof6030104; Sardi JDO, 2018, MICROB PATHOGENESIS, V125, P116, DOI 10.1016/j.micpath.2018.09.014; Pakshir K, 2013, J MYCOL MED, V23, P113, DOI 10.1016/j.mycmed.2013.04.007; Pappas PC, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.26; Parra-Giraldo CM, 2018, INT J INFECT DIS, V69, P63, DOI 10.1016/j.ijid.2018.01.034; Pereira TC, 2018, J FUNGI, V4, DOI 10.3390/jof4040128; Plachouras D, 2020, EUROSURVEILLANCE, V25, P21, DOI 10.2807/1560-7917.ES.2020.25.12.2000240; Polke M, 2015, ADV APPL MICROBIOL, V91, P139, DOI 10.1016/bs.aambs.2014.12.002; PRICE MF, 1982, SABOURAUDIA, V20, P7; Romera D, 2020, PATHOG DIS, V78, DOI 10.1093/femspd/ftaa067; Rossato L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03081; Rossoni Rodnei Dennis, 2013, Braz. J. Oral Sci., V12, P199, DOI 10.1590/S1677-32252013000300009; Satoh K, 2009, MICROBIOL IMMUNOL, V53, P41, DOI 10.1111/j.1348-0421.2008.00083.x; Sherry L, 2017, EMERG INFECT DIS, V23, P328, DOI 10.3201/eid2302.161320; Tsang CSP, 2007, J MED MICROBIOL, V56, P1393, DOI 10.1099/jmm.0.47303-0; Zuluaga-Rodríguez Alejandra, 2020, Biomed., V40, P5	40	5	5	0	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2309-608X		J FUNGI	J. Fungi	JUN	2021	7	6							401	10.3390/jof7060401	http://dx.doi.org/10.3390/jof7060401			10	Microbiology; Mycology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology; Mycology	TA1DO	34063862	Green Published, gold			2022-09-04	WOS:000666994600001
J	Gutierrez, S; Iwanaga, J; Pekala, P; Yilmaz, E; Clifton, WE; Dumont, AS; Tubbs, RS				Gutierrez, Santiago; Iwanaga, Joe; Pekala, Przemyslaw; Yilmaz, Emre; Clifton, William E.; Dumont, Aaron S.; Tubbs, R. Shane			The pharyngeal plexus: an anatomical review for better understanding postoperative dysphagia	NEUROSURGICAL REVIEW			English	Review						Pharyngeal plexus; Glossopharyngeal nerve; Vagus nerve; Superior sympathetic ganglion; Anterior cervical discectomy fusion	RECURRENT LARYNGEAL NERVE; GLOSSOPHARYNGEAL; INNERVATION; MUSCLE; VAGUS	The pharyngeal plexus is an essential anatomical structure, but the contributions from the glossopharyngeal and vagus nerves and the superior cervical ganglion that give rise to the pharyngeal plexus are not fully understood. The pharyngeal plexus is likely to be encountered during various anterior cervical surgical procedures of the neck such as anterior cervical discectomy and fusion. Therefore, a detailed understanding of its anatomy is essential for the surgeon who operates in and around this region. Although the pharyngeal plexus is an anatomical structure that is widely mentioned in literature and anatomy books, detailed descriptions of its structural nuances are scarce; therefore, we provide a comprehensive review that encompasses all the available data from this critical structure. We conducted a narrative review of the current literature using databases like PubMed, Embase, Ovid, and Cochrane. Information was gathered regarding the pharyngeal plexus to improve our understanding of its anatomy to elucidate its involvement in postoperative spine surgery complications such as dysphagia. The neural contributions of the cranial nerves IX, X, and superior sympathetic ganglion intertwine to form the pharyngeal plexus that can be injured during ACDF procedures. Factors like surgical retraction time, postoperative hematoma, surgical hardware materials, and profiles and smoking are related to postoperative dysphagia onset. Thorough anatomical knowledge and lateral approaches to ACDF are the best preventing measures.	[Gutierrez, Santiago] Pontificia Univ Javeriana, Bogota, Colombia; [Iwanaga, Joe; Dumont, Aaron S.; Tubbs, R. Shane] Tulane Univ, Sch Med, Tulane Ctr Clin Neurosci, Dept Neurosurg, 131 S Robertson St,Suite 1300, New Orleans, LA 70112 USA; [Pekala, Przemyslaw] Jagiellonian Univ, Dept Anat, Krakow, Poland; [Yilmaz, Emre] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Trauma Surg, Bochum, Germany; [Clifton, William E.] Mayo Clin, Dept Neurosurg, Jacksonville, FL 32224 USA; [Tubbs, R. Shane] St Georges Univ, Dept Anat Sci, St Georges, West Indies, Grenada; [Tubbs, R. Shane] Ochsner Neurosci Inst, Ochsner Hlth Syst, Dept Neurosurg, New Orleans, LA USA; [Tubbs, R. Shane] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA		Iwanaga, J (corresponding author), Tulane Univ, Sch Med, Tulane Ctr Clin Neurosci, Dept Neurosurg, 131 S Robertson St,Suite 1300, New Orleans, LA 70112 USA.	iwanagajoeca@gmail.com	Gutiérrez, Santiago/H-6456-2015; Iwanaga, Joe/ABC-7040-2021	Gutiérrez, Santiago/0000-0001-6659-1390; Iwanaga, Joe/0000-0002-8502-7952; Gutierrez-Gomez, Santiago/0000-0003-1326-8308				Binder DK, 2011, CRANIAL NERVES ANATO, P146; Binder DK, 2011, CRANIAL NERVES ANATO, P158; Broussard Delma L., 2000, American Journal of Medicine, V108, p79S; Brown H, 2002, EXP BIOL MED, V227, P570, DOI 10.1177/153537020222700804; Carucci LR, 2015, AM J ROENTGENOL, V204, P768, DOI 10.2214/AJR.14.13148; Chen XY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013667; Dobran Mauro, 2018, BMJ Case Rep, V11, DOI 10.1136/bcr-2018-226022; Fisahn C, 2019, GLOB SPINE J, V9, P383, DOI 10.1177/2192568218810198; Goyal RK, 2001, AM J MED, V111, P95, DOI 10.1016/S0002-9343(01)00863-4; Hammond CS, 1997, J APPL PHYSIOL, V83, P89, DOI 10.1152/jappl.1997.83.1.89; Hermida Perez JA, 2012, DESCRIPCION CASO CLI, V38, P111, DOI [10.1016/j.semerg.2011.06.013, DOI 10.1016/J.SEMERG.2011.06.013]; Joaquim AF, 2019, INT ORTHOP, V43, P767, DOI 10.1007/s00264-018-04281-y; Kim JH, 2019, WORLD NEUROSURG, V125, P87, DOI 10.1016/j.wneu.2019.01.156; Lima AF, 2018, TURK ARCH OTORHINOL, V56, P237, DOI 10.5152/tao.2018.3690; Matsuzaki H, 2014, LARYNGOSCOPE, V124, P516, DOI 10.1002/lary.24345; McHanwell S, 2016, GRAYS ANATOMY ANATOM, P571; MERMER RW, 1990, J ORAL MAXIL SURG, V48, P1102, DOI 10.1016/0278-2391(90)90297-F; Mu LC, 2000, ANAT REC, V258, P406, DOI 10.1002/(SICI)1097-0185(20000401)258:4<406::AID-AR9>3.0.CO;2-5; Mu L, 2007, ANN OTO RHINOL LARYN, V116, P604, DOI 10.1177/000348940711600809; Netter F.H., 2019, ATLAS HUMAN ANATOMY; Olsson EC, 2015, ORTHOPEDICS, V38, pE319, DOI 10.3928/01477447-20150402-61; Peng Y, 2000, Zhonghua Er Bi Yan Hou Ke Za Zhi, V35, P298; Rajabian A, 2017, SPINE J, V17, pS33, DOI 10.1016/j.spinee.2017.01.011; Reed MD, 2019, LUNG, V197, P235, DOI 10.1007/s00408-018-00192-2; Rong YL, 2018, CLIN INTERV AGING, V13, P2543, DOI 10.2147/CIA.S182969; Sakamoto Y, 2013, SURG RADIOL ANAT, V35, P721, DOI 10.1007/s00276-013-1102-8; Sakamoto Y, 2009, SURG RADIOL ANAT, V31, P755, DOI 10.1007/s00276-009-0516-9; She HC, 2009, QUALITY RESEARCH IN LITERACY AND SCIENCE EDUCATION: INTERNATIONAL PERSPECTIVES AND GOLD STANDARDS, P467, DOI 10.1007/978-1-4020-8427-0_23; Shoja MM, 2019, CUREUS, V11, DOI 10.7759/cureus.3898; Shoja MM, 2014, CLIN ANAT, V27, P131, DOI 10.1002/ca.22342; SINCLAIR WJ, 1971, AM J PHYSIOL, V221, P1260, DOI 10.1152/ajplegacy.1971.221.5.1260; Staloff RT, 2016, HEAD NECK SURG; Steventon B, 2014, DEV BIOL, V389, P28, DOI 10.1016/j.ydbio.2014.01.021; Tubbs RS, 2011, J NEUROSURG, V115, P179, DOI 10.3171/2011.2.JNS101757; Uludag M, 2017, LANGENBECK ARCH SURG, V402, P683, DOI 10.1007/s00423-016-1376-5; Wang CY, 2016, LARYNGOSCOPE, V126, P2010, DOI 10.1002/lary.25706; Warshafsky D, 2012, OTOLARYNG CLIN N AM, V45, P1203, DOI 10.1016/j.otc.2012.08.001; Watkinson JC, 2016, GRAYS ANATOMY ANATOM; Yerneni K, 2020, NEUROSURGERY, V86, P30, DOI 10.1093/neuros/nyy636; Yerneni K, 2019, WORLD NEUROSURG, V122, P380, DOI 10.1016/j.wneu.2018.11.066; Yntema CL, 1944, J COMP NEUROL, V81, P147, DOI 10.1002/cne.900810204; Zhu D, 2019, MED SCI MONITOR, V25, P547, DOI 10.12659/MSM.911234	42	3	3	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	APR	2021	44	2					763	772		10.1007/s10143-020-01303-5	http://dx.doi.org/10.1007/s10143-020-01303-5		APR 2020	10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RL0HI	32318923				2022-09-04	WOS:000528160400001
J	Shevtsova, EF; Vinogradova, DV; Neganova, ME; Avila-Rodriguez, M; Ashraf, GM; Barreto, GE; Bachurin, SO; Aliev, G				Shevtsova, Elena F.; Vinogradova, Daria V.; Neganova, Margarita E.; Avila-Rodriguez, Marco; Ashraf, Ghulam Md; Barreto, George E.; Bachurin, Sergey O.; Aliev, Gjumrakch			Mitochondrial Permeability Transition Pore as a Suitable Target for Neuroprotective Agents Against Alzheimer's Disease	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Review						Alzheimer's disease; Mitochondria; Mitochondrial dysfunction; Multitarget benefits; Neurodegenerative diseases; Neuroprotective	ATP SYNTHASE; AMINOPROPYL CARBAZOLES; EXPERIMENTAL-MODELS; MOUSE MODEL; DIMEBON; MELATONIN; EFFICACY; CYCLOSPORINE; BRAIN; BETA	Background: A considerable amount of data suggests the age-related impairments of mitochondrial functions in the development of sporadic forms of neurodegenerative pathologies. Mitochondria and the phenomenon of mitochondrial permeability transition (MPT), which marks the point of no return in cell death cascades, have special value in this regard. It is important that the vulnerability to MPT-inducing factors is increased with aging. Simultaneously, a decrease in the calcium retention capacity of mitochondria is developed, which leads to the disturbance of the functional activity of neurons. Method: The systematic investigations and web content related to the importance of MPT as the target for the search of neuroprotective and cognitive enhancing drugs, especially with multitargeted action, are reviewed. Results: Here, we have highlighted some experimental data that determines the importance of mitochondria for the search of neuroprotective drugs, and drugs with multitargeted action. We have also discussed a number of new compounds with similar properties. Being MPT inhibitors/modulators, virtually all the compounds described in this review have the ability to exhibit a neuroprotective effect, interact with some other targets, providing coupled beneficial therapeutic effects such as cognitive stimulation, anti-seizure, and antidepressant actions. Conclusion: Inhibitors of MPT, which increases calcium retention capacity of mitochondria, are considered as promising neuroprotective drugs able not only to halt the neurodegenerative cascade, but also to increase the functional activity of neurons.	[Shevtsova, Elena F.; Vinogradova, Daria V.; Neganova, Margarita E.; Bachurin, Sergey O.; Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka, Russia; [Avila-Rodriguez, Marco; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Avila-Rodriguez, Marco] Univ Tolima, Fac Ciencias Salud, Ibague, Colombia; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA		Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA.	aliev03@gmail.com	Barreto, George E./AAD-7420-2020; Shevtsova, Elena/G-6288-2017; Ashraf, Ghulam Md/H-9485-2012; Neganova, Margarita E/L-8499-2017; Sergey, Bachurin/I-1708-2018; Aliev, Gjumrakch/AAE-7734-2020	Barreto, George E./0000-0002-6644-1971; Ashraf, Ghulam Md/0000-0002-9820-2078; Aliev, Gjumrakch/0000-0001-7373-3182; Avila-Rodriguez, Marco/0000-0003-4612-3236; Elena, Shevtsova/0000-0003-2887-1185	Russian Science Foundation, Moscow, Russia [14-23-00160]; "GALLY" International Biomedical Research Consulting LLC., San Antonio, TX, USA; scientific program of IPAC RAS; Russian Science Foundation [17-23-00013] Funding Source: Russian Science Foundation	Russian Science Foundation, Moscow, Russia(Russian Science Foundation (RSF)); "GALLY" International Biomedical Research Consulting LLC., San Antonio, TX, USA; scientific program of IPAC RAS; Russian Science Foundation(Russian Science Foundation (RSF))	The financial supports from Russian Science Foundation (Grant No. 14-23-00160), Moscow, Russia and "GALLY" International Biomedical Research Consulting LLC., San Antonio, TX, USA, are gratefully acknowledged. Authors' also very grateful for the financial support according to scientific program of IPAC RAS and the facilities of the "Center of Collective Use" of IPAC RAS, Russia.	Abramov AY, P NATL ACAD SCI, V104, P18091; Aleshkina IA, 1956, PHARMAKOL TOXICOL, V19, P11; Andrabi SA, 2004, FASEB J, V18, P869, DOI 10.1096/fj.03-1031fje; ATKINSON K, 1984, J CLIN PATHOL, V37, P1167, DOI 10.1136/jcp.37.10.1167; Averina EB, 2016, BIOORGAN MED CHEM, V24, P712, DOI 10.1016/j.bmc.2015.12.040; Bachurin S, 2007, EXP GERONTOL, V42, P142, DOI 10.1016/j.exger.2006.06.017; Bachurin S, 2000, ANN NY ACAD SCI, V890, P156; Bachurin SO, 2012, NEUROTOX RES, V22, P33, DOI 10.1007/s12640-011-9299-y; Bachurin SO, 2003, ANN NY ACAD SCI, V993, P334, DOI 10.1111/j.1749-6632.2003.tb07541.x; Bachurin SO, 2015, J NANOMEDINE BIOTHER, V5, P137; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Barsukova A, 2011, EUR J NEUROSCI, V33, P831, DOI 10.1111/j.1460-9568.2010.07576.x; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; BEUTLER JA, 1985, BRAIN RES, V330, P135, DOI 10.1016/0006-8993(85)90014-9; Bharadwaj PR, 2012, J ALZHEIMERS DIS, V32, P949, DOI 10.3233/JAD-2012-120178; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Copperman R, 1973, Pa Med, V76, P36; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; De Jesus-Cortest H, 2015, NPJ PARKINSON DIS, V1, DOI 10.1038/npjparkd.2015.10; Eckert A, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt74; Eckert SH, 2012, J ALZHEIMERS DIS, V31, P21, DOI 10.3233/JAD-2012-120310; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Gingrich JR, 2004, P NATL ACAD SCI USA, V101, P6237, DOI 10.1073/pnas.0401413101; Harman D, 1996, ANN NY ACAD SCI, V786, P152, DOI 10.1111/j.1749-6632.1996.tb39059.x; He HW, 2010, CURR NEUROPHARMACOL, V8, P211, DOI 10.2174/157015910792246137; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Hokari M, 2010, J PHARM PHARMACOL, V62, P485, DOI 10.1211/jpp.62.04.0011; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076721; Jiang B, 2016, NEUROCHEM RES, V41, P1010, DOI 10.1007/s11064-015-1783-y; Khritankova IV, 2012, DOKL BIOCHEM BIOPHYS, V446, P251, DOI 10.1134/S1607672912050079; Kim DY, 2015, ANN NEUROL, V78, P77, DOI 10.1002/ana.24424; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Korde AS, 2012, J BIOL CHEM, V287, P35192, DOI 10.1074/jbc.M111.322032; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kudin AP, 2004, EPILEPSIA, V45, P1478, DOI 10.1111/j.0013-9580.2004.13504.x; Kuharskiy MS, 2014, SCI WORLD, V2, P137; Kumar A, 2009, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.002.2009; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; MATVEEVA IA, 1983, FARMAKOL TOKSIKOL, V46, P27; Merlini L, 2011, OXIDATIVE MED CELLUL, V2011, P1; Millan-Plano S, 2010, INT J MOL SCI, V11, P312, DOI 10.3390/ijms11010312; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Neganova ME, 2014, EUR NEUROPSYCHOPHARM, V24, pS261, DOI 10.1016/S0924-977X(14)70409-2; Neganova ME, 2011, NEUROCHEM J+, V5, P208, DOI 10.1134/S1819712411030056; Neganova ME, 2016, CNS NEUROL DISORD-DR, V15, P102, DOI 10.2174/1871527314666150821111812; Neganova ME, 2016, CNS NEUROL DISORD DR; Neganova ME, 2011, NAT TECH SCI, V5, P86; Nighoghossian N, 2015, NEUROLOGY, V84, P2216, DOI 10.1212/WNL.0000000000001639; Nowikovsky K, 2009, BBA-BIOENERGETICS, V1787, P345, DOI 10.1016/j.bbabio.2008.10.006; Oh MM, 2013, J NEUROSCI, V33, P7905, DOI 10.1523/JNEUROSCI.5457-12.2013; Pandi-Perumal SR, 2013, NEUROTOX RES, V23, P267, DOI 10.1007/s12640-012-9337-4; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pavlov E, 2005, BIOPHYS J, V88, P2614, DOI 10.1529/biophysj.104.057281; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Peters OM, 2013, J ALZHEIMERS DIS, V36, P589, DOI 10.3233/JAD-130071; Peters OM, 2013, J ALZHEIMERS DIS, V33, P1041, DOI 10.3233/JAD-2012-121732; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Raj D, 2008, FITOTERAPIA, V79, P419, DOI 10.1016/j.fitote.2008.02.011; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Rocha M, 2010, CURR PHARM DESIGN, V16, P3124, DOI 10.2174/138161210793292519; Roestenberg P, 2012, MITOCHONDRION, V12, P57, DOI 10.1016/j.mito.2011.06.011; Roy S, 2015, CHEMMEDCHEM, V10, P1655, DOI 10.1002/cmdc.201500284; Shevtsova EP, 2006, EUR NEUROPSYCHOPHARM, V16, pS243, DOI 10.1016/S0924-977X(06)70205-X; Shevtsova EF, 2014, CURR ALZHEIMER RES, V11, P422, DOI 10.2174/1567205011666140505094808; Shevtzova EF, 2001, B EXP BIOL MED+, V132, P1173, DOI 10.1023/A:1014559331402; Shin JY, 2015, BIOMOL THER, V23, P313, DOI 10.4062/biomolther.2015.016; Skulachev VP, 2012, J ALZHEIMERS DIS, V28, P283, DOI 10.3233/JAD-2011-111391; Smith RAJ, 2008, ANN NY ACAD SCI, V1147, P105, DOI 10.1196/annals.1427.003; Soskic V, 2008, J PROTEOME RES, V7, P2262, DOI 10.1021/pr700686x; Srinivasan Venkatramanujam, 2011, Int J Alzheimers Dis, V2011, P326320, DOI 10.4061/2011/326320; Steele JW, 2013, AUTOPHAGY, V9, P617, DOI 10.4161/auto.23487; Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Ustyugov AA, 2012, B EXP BIOL MED+, V152, P731, DOI 10.1007/s10517-012-1618-7; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Velikanov GA, 2013, CELL TISS BIOL, V7, P504; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang SN, 2016, CNS NEUROSCI THER, V22, P782, DOI 10.1111/cns.12576; Wang X, 2009, CNS NEUROSCI THER, V15, P345, DOI 10.1111/j.1755-5949.2009.00105.x; Wang X, 2009, STROKE, V40, P1877, DOI 10.1161/STROKEAHA.108.540765; Warne J, 2016, J BIOL CHEM, V291, P4356, DOI 10.1074/jbc.M115.700385; Weeber EJ, 2002, J BIOL CHEM, V277, P18891, DOI 10.1074/jbc.M201649200; Wissing ER, 2010, NEUROMUSCULAR DISORD, V20, P753, DOI 10.1016/j.nmd.2010.06.016; Xu L, 2004, NEUROL RES, V26, P792, DOI 10.1179/016164104225014148; Yamashita M, 2009, FEBS LETT, V583, P2419, DOI 10.1016/j.febslet.2009.06.042; Yonally SK, 2006, MITOCHONDRION, V6, P305, DOI 10.1016/j.mito.2006.10.001; Zhang ST, 2010, J ALZHEIMERS DIS, V21, P389, DOI 10.3233/JAD-2010-100174; Zhou H, 2014, J NEUROSCI, V34, P2967, DOI 10.1523/JNEUROSCI.1948-13.2014	99	18	19	0	10	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2017	16	6					677	685		10.2174/1871527316666170424114444	http://dx.doi.org/10.2174/1871527316666170424114444			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	FE8JR	28440192				2022-09-04	WOS:000408451900006
J	Krishnasamy, M; So, WKW; Yates, P; de Calvo, LEA; Annab, R; Wisniewski, T; Aranda, S				Krishnasamy, Meinir; So, Winnie Kwok-Wei; Yates, Patsy; Esperanza Ayala de Calvo, Luz; Annab, Rachid; Wisniewski, Tami; Aranda, Sanchia			The Nurse's Role in Managing Chemotherapy-Induced Nausea and Vomiting An International Survey	CANCER NURSING			English	Article						Cancer; Chemotherapy-induced nausea and vomiting; Education; Nurses		Background: Nurses play a substantial role in the prevention and management of chemotherapy-induced nausea and vomiting (CINV). Objectives: This study set out to describe nurses' roles in the prevention and management of CINV and to identify any gaps that exist across countries. Methods: A self-reported survey was completed by 458 registered nurses who administered chemotherapy to cancer patients in Australia, China, Hong Kong, and 9 Latin American countries. Results: More than one-third of participants regarded their own knowledge of CINV as fair to poor. Most participants (965%) agreed that chemotherapy-induced nausea and chemotherapy-induced vomiting should be considered separately (79%), but only 35% were confident in their ability to manage chemotherapy-induced nausea (53%) or chemotherapy-induced vomiting (59%). Only one-fifth reported frequent use of a standardized CINV assessment tool and only a quarter used international clinical guidelines to manage CINV. Conclusions: Participants perceived their own knowledge of CINV management to be insufficient. They recognized the need to develop and use a standardized CINV assessment tool and the importance of adopting international guidelines to inform the management of CINV. Implications for Practice: Findings indicate that international guidelines should be made available to nurses in clinically relevant and easily accessible formats, that a review of chemotherapy assessment tools should be undertaken to identify reliable and valid measures amenable to use in a clinical settings, and that a CINV risk screening tool should be developed as a prompt for nurses to enable timely identification of and intervention for patients at high risk of CINV.	[Krishnasamy, Meinir; Annab, Rachid; Aranda, Sanchia] Peter MacCallum Canc Ctr, East Melbourne, Vic 8006, Australia; [Krishnasamy, Meinir; Annab, Rachid; Aranda, Sanchia] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia; [So, Winnie Kwok-Wei] Chinese Univ Hong Kong, Nethersole Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Yates, Patsy] Queensland Univ Technol, Sch Nursing & Midwifery, Brisbane, Qld 4001, Australia; [Esperanza Ayala de Calvo, Luz] Pontificia Univ Javeriana, Sch Nursing, Bogota, Colombia; [Wisniewski, Tami] Merck & Co Inc, Whitehouse Stn, NJ USA; [Aranda, Sanchia] Canc Inst New South Wales, Sydney, NSW, Australia		Krishnasamy, M (corresponding author), Peter MacCallum Canc Ctr, St Andrews Pl, East Melbourne, Vic 8006, Australia.	meinir.krishnasamy@petermac.org	Aranda, Sanchia/ABC-3840-2021; So, Winnie/A-3994-2015	So, Winnie/0000-0001-9243-2924; Yates, Patsy/0000-0001-8946-8504; Aranda, Sanchia/0000-0003-4170-9799	International Society of Nurses in Cancer Care; Merck, Inc	International Society of Nurses in Cancer Care; Merck, Inc(Merck & Company)	This study was supported through a collaboration between the International Society of Nurses in Cancer Care and Merck, Inc, through an unrestricted educational grant.	Aranda S, 2012, ANN ONCOL, V23, P222, DOI 10.1093/annonc/mdr042; Benner P, 1984, NOVICE EXPERT EXCELL; Braud AC, 2003, CANCER NURS, V26, P468; Elcigil A, 2011, J PEDIAT HEMATOL ONC, V33, pS33, DOI 10.1097/MPH.0b013e3182121bef; Farrell C, SUPPORT CARE CANC; Fernandez-Ortega P, 2012, SUPPORT CARE CANC; Molassiotis A, J PAIN SYMPTOM MANAG; Multinational Association of Supportive Care in Cancer, MASCC ESMO ANT GUID; National Cancer Institute, 2011, NAUS VOM; National Comprehensive Cancer Network, NCCN PRACT GUID ONC; Schofield P, 2008, SUPPORT CARE CANCER, V16, P37, DOI 10.1007/s00520-007-0273-4; SPSSV6, 2011, SPSS V6 SPSS DAT COL; Turner S, 1999, Int J Nurs Pract, V5, P14, DOI 10.1046/j.1440-172x.1999.00147.x	13	13	13	0	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0162-220X	1538-9804		CANCER NURS	Cancer Nurs.	JUL-AUG	2014	37	4					E27	E35		10.1097/NCC.0b013e3182a3534a	http://dx.doi.org/10.1097/NCC.0b013e3182a3534a			9	Oncology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Nursing	AK9CI	24145248				2022-09-04	WOS:000338724700002
J	Kokilashvili, V; Meskhi, A; Rafeiro, H				Kokilashvili, Vakhtang; Meskhi, Alexander; Rafeiro, Humberto			Boundedness of commutators of singular and potential operators in generalized grand Morrey spaces and some applications	STUDIA MATHEMATICA			English	Article						commutators; singular operators; potential operators; Morrey spaces; elliptic equations	ELLIPTIC-EQUATIONS; MAXIMAL FUNCTIONS; INTEGRALS	In the setting of spaces of homogeneous type, it is shown that the cornmutator of Calderon-Zygmund type operators as well as the commutator of a potential operator with a BMO function are bounded in a generalized grand Morrey space. Interior estimates for solutions of elliptic equations are also given in the framework of generalized grand Morrey spaces.	[Kokilashvili, Vakhtang; Meskhi, Alexander] I Javakhishvili Tbilisi State Univ, A Razmadze Math Inst, Dept Math Anal, GE-0186 Tbilisi, Georgia; [Kokilashvili, Vakhtang] Int Black Sea Univ, GE-0131 Tbilisi, Georgia; [Meskhi, Alexander] Georgian Tech Univ, Fac Informat & Control Syst, Dept Math, Tbilisi, Georgia; [Meskhi, Alexander] Govt Coll Univ, Abdus Salam Sch Math Sci, Lahore, Pakistan; [Rafeiro, Humberto] Pontificia Univ Javeriana, Dept Matemat, Bogota, Colombia; [Rafeiro, Humberto] Inst Super Tecn, Dept Matemat, Ctr CEAF, P-1049001 Lisbon, Portugal		Kokilashvili, V (corresponding author), I Javakhishvili Tbilisi State Univ, A Razmadze Math Inst, Dept Math Anal, 2 Univ St, GE-0186 Tbilisi, Georgia.	kokil@rmi.ge; meskhi@rmi.ge; hrafeiro@math.ist.utl.pt	Rafeiro, Humberto/AAK-4908-2020; Meskhi, Alexander/ACT-3186-2022	Rafeiro, Humberto/0000-0002-5304-8572; 	Shota Rustaveli National Science Foundation Grant [D/13-23, 31/47]; Pontificia Universidad Javeriana under the research project "Commutators in generalized grand Morrey spaces and some applications" [PRY:005447]	Shota Rustaveli National Science Foundation Grant; Pontificia Universidad Javeriana under the research project "Commutators in generalized grand Morrey spaces and some applications"	The first and second named authors were partially supported by the Shota Rustaveli National Science Foundation Grant (Project Nos. D/13-23 and 31/47). The third named author was partially supported by Pontificia Universidad Javeriana under the research project "Commutators in generalized grand Morrey spaces and some applications" (ID PRY:005447).	Capone C., 2005, J FUNCT SPACES APPL, V3, P73, DOI [10.1155/2005/192538, DOI 10.1155/2005/192538]; CHIARENZA F, 1993, T AM MATH SOC, V336, P841, DOI 10.2307/2154379; Chiarenza F., 1991, RICERCHE MAT, V40, P149; Coifman R. R., 1971, ETUDE CERTAINES INTE, V242; COIFMAN RR, 1980, P AM MATH SOC, V79, P249, DOI 10.2307/2043245; Di Fratta G, 2009, NONLINEAR ANAL-THEOR, V70, P2582, DOI 10.1016/j.na.2008.03.044; DIFAZIO G, 1991, B UNIONE MAT ITAL, V5A, P323; DIFAZIO G, 1993, J FUNCT ANAL, V112, P241, DOI 10.1006/jfan.1993.1032; Fiorenza A, 2004, Z ANAL ANWEND, V23, P657; Fiorenza A., 2001, C R ACAD SCI PARIS S, V333, P1; Fiorenza A., 2000, COLLECT MATH, V51, P131; Fiorenza A, 2008, STUD MATH, V188, P123, DOI 10.4064/sm188-2-2; Giaquinta M., 1983, MULTIPLE INTEGRALS C; Gilbarg G, 1983, ELLIPTIC PARTIAL DIF; Greco L, 1997, MANUSCRIPTA MATH, V92, P249, DOI 10.1007/BF02678192; IWANIEC T, 1992, ARCH RATION MECH AN, V119, P129, DOI 10.1007/BF00375119; Kokilashvili V., 2010, LECT COURS SUMM SCH; Kokilashvili V, 2013, GEORGIAN MATH J, V20, P43, DOI 10.1515/gmj-2013-0009; Kokilashvili V, 2012, STUD MATH, V210, P159, DOI 10.4064/sm210-2-4; Kokilashvili V, 2008, ARMEN J MATH, V1, P18; Kokilashvili V, 2010, COMPLEX VAR ELLIPTIC, V55, P923, DOI 10.1080/17476930903276068; Kufner A., 1977, FUNCTION SPACES; Liflyand E, 2010, TURK J MATH, V34, P207, DOI 10.3906/mat-0812-8; Liu LZ, 2005, ACTA MATH SCI, V25, P89, DOI 10.1016/S0252-9602(17)30264-3; Meskhi A., 2009, P A RAZMADZE MATH I, V151, P139; Meskhi A, 2011, COMPLEX VAR ELLIPTIC, V56, P1003, DOI 10.1080/17476933.2010.534793; Morrey CB, 1938, T AM MATH SOC, V43, P126, DOI 10.2307/1989904; Pradolini G, 2007, CZECH MATH J, V57, P75, DOI 10.1007/s10587-007-0045-9; Rafeiro H, 2012, OPER THEORY ADV APPL, V228, P293; RAFEIRO H., 2011, J MATH SCI N Y, V172, P143; Rafeiro H., 2013, OPER THEORY ADV APPL, V229, P343; Ragusa MA, 2012, APPL MATH COMPUT, V218, P11952, DOI 10.1016/j.amc.2012.06.005; Ragusa MA, 2008, Z ANAL ANWEND, V27, P469; Rubio de Francia J. L., 1985, MATH STUD, V116; Samko SG, 2011, AZERBAIJAN J MATH, V1, P67; SARASON D, 1975, T AM MATH SOC, V207, P391; Stromberg J.-O., 1989, LECT NOTES MATH, P1381; Torchinsky A., 1986, REAL VARIABLE METHOD, P29; WHEEDEN RL, 1993, STUD MATH, V107, P257; [叶晓峰 Ye Xiaofeng], 2011, [数学学报, Acta Mathematica Sinica], V54, P343	40	15	15	0	1	POLISH ACAD SCIENCES INST MATHEMATICS-IMPAN	WARSZAWA	8 SNIADECKICH ST, PL 00 656 WARSZAWA, POLAND	0039-3223	1730-6337		STUD MATH	Studia Math.		2013	217	2					159	178		10.4064/sm217-2-4	http://dx.doi.org/10.4064/sm217-2-4			20	Mathematics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	287QC		Green Submitted			2022-09-04	WOS:000329556300004
J	Arango-Lasprilla, JC; Quijano, MC; Nicholls, E; Aponte, M; Lequerica, AH; Cuervo, MT; Rogers, H				Arango-Lasprilla, Juan Carlos; Cristina Quijano, Maria; Nicholls, Elizabeth; Aponte, Monica; Lequerica, Anthony H.; Teresa Cuervo, Maria; Rogers, Heather			The usefulness of self-generation to improve learning and memory in Spanish-speaking individuals with traumatic brain injury from Colombia	BRAIN INJURY			English	Article						Cognitive rehabilitation; traumatic brain injury; learning; memory	MULTIPLE-SCLEROSIS; ALZHEIMER-TYPE; SEMANTIC-MEMORY; DEMENTIA; AGE; ACQUISITION; WORDS; PEOPLE	Objective: To examine the effect of self-generation on learning and memory in Spanish-speaking individuals with traumatic brain injury (TBI). Method: Thirty Spanish-speaking individuals with moderate-to-severe TBI and 31 healthy controls were recruited to read 32 individual sentences and required to remember the last word in each sentence. Target words were presented both in a self-generated and provided condition for each participant. Recall and recognition of the words were examined immediately, after 30 minutes and after 1 week. Results: Findings indicated that both healthy controls and individuals with TBI showed significantly better recall and recognition for words in the generated condition than words that had been provided to them at immediate, 30-minute and 1-week time intervals. Conclusion: The self-generation technique effectively improves learning and memory in Spanish-speaking individuals with TBI. Results should encourage researchers and clinicians to use the principles of cognitive psychology to adapt (as opposed to simply translate) cognitive rehabilitation protocols for use in Spanish-speaking populations with neurological conditions.	[Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Richmond, VA 23219 USA; [Cristina Quijano, Maria; Aponte, Monica; Teresa Cuervo, Maria] Pontificia Univ Javeriana Cali, Dept Social Sci, Cali, Colombia; [Lequerica, Anthony H.] Drexel Univ, Philadelphia, PA 19104 USA; [Lequerica, Anthony H.] UMDNJ New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Rogers, Heather] Kessler Fdn, W Orange, NJ USA; [Nicholls, Elizabeth] Univ Antioquia, Grp Rehabil Salud, Medellin, Colombia		Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, 4th Floor,Room 4230A,POB 843038,Theater Row Bldg,, Richmond, VA 23219 USA.	jcarangolasp@vcu.edu	Rogers, Heather L./AAB-8486-2022	Rogers, Heather L./0000-0002-7562-4542; Cuervo Cuesta, Maria teresa/0000-0002-4907-4604; Quijano Martinez, Maria Cristina/0000-0003-3548-1628	Pontificia Universidad Javeriana [RII -218-020100150]	Pontificia Universidad Javeriana	This research was supported by grant RII -218-020100150 from the Pontificia Universidad Javeriana.	Arango-Lasprilla J., 2009, J MINORITY DISABILIT, V1, P47; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P63, DOI 10.1080/13803390601186957; Basso MR, 2006, J INT NEUROPSYCH SOC, V12, P640, DOI 10.1017/S1355617706060759; BEGG I, 1989, J EXP PSYCHOL LEARN, V15, P977, DOI 10.1037/0278-7393.15.5.977; Bertsch S, 2007, MEM COGNITION, V35, P201, DOI 10.3758/BF03193441; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; DICK MB, 1989, BRAIN COGNITION, V9, P88, DOI 10.1016/0278-2626(89)90046-8; Ellis AW, 1998, J EXP PSYCHOL LEARN, V24, P515, DOI 10.1037/0278-7393.24.2.515; GILHOOLY KJ, 1979, MEM COGNITION, V7, P214, DOI 10.3758/BF03197541; GROSSE DA, 1990, PSYCHOL AGING, V5, P304; Holtbrugge D, 2010, ACAD MANAG LEARN EDU, V9, P622, DOI 10.5465/AMLE.2010.56659880; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; Lutz J, 2003, J GEN PSYCHOL, V130, P171, DOI 10.1080/00221300309601283; MCELROY LA, 1982, J VERB LEARN VERB BE, V21, P249, DOI 10.1016/S0022-5371(82)90593-X; MCFARLAND CE, 1983, J EXP CHILD PSYCHOL, V36, P413, DOI 10.1016/0022-0965(83)90043-7; McFarland CE, 1985, J GERONTOL, V41, P79; MITCHELL DB, 1986, J GERONTOL, V41, P79, DOI 10.1093/geronj/41.1.79; Multhaup KS, 1997, NEUROPSYCHOLOGY, V11, P382, DOI 10.1037/0894-4105.11.3.382; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Ostrosky-Solis F, 1999, J INT NEUROPSYCH SOC, V5, P413, DOI 10.1017/S1355617799555045; ROODENRYS S, 1994, MEM COGNITION, V22, P695, DOI 10.3758/BF03209254; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; SLAMECKA NJ, 1983, J VERB LEARN VERB BE, V22, P153, DOI 10.1016/S0022-5371(83)90112-3; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Souliez L, 1996, CORTEX, V32, P347, DOI 10.1016/S0010-9452(96)80056-6	25	1	1	0	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2012	26	6					875	881		10.3109/02699052.2012.655361	http://dx.doi.org/10.3109/02699052.2012.655361			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	943EO	22583178				2022-09-04	WOS:000304103500009
J	Gliske, SV; Qin, ZH; Lau, K; Alvarado-Rojas, C; Salami, P; Zelmann, R; Stacey, WC				Gliske, Stephen, V; Qin, Zihan; Lau, Katy; Alvarado-Rojas, Catalina; Salami, Pariya; Zelmann, Rina; Stacey, William C.			Distinguishing false and true positive detections of high frequency oscillations	JOURNAL OF NEURAL ENGINEERING			English	Article						ripple; fast ripple; HFO	LONG-TERM OUTCOMES; EPILEPSY SURGERY; FAST RIPPLES; RESECTION; ZONE	Objective.High frequency oscillations (HFOs) are a promising biomarker of tissue that instigates seizures. However, ambiguous data and random background fluctuations can cause any HFO detector (human or automated) to falsely label non-HFO data as an HFO (a false positive detection). The objective of this paper was to identify quantitative features of HFOs that distinguish between true and false positive detections.Approach.Feature selection was performed using background data in multi-day, interictal intracranial recordings from ten patients. We selected the feature most similar between randomly selected segments of background data and HFOs detected in surrogate background data (false positive detections by construction). We then compared these results with fuzzy clustering of detected HFOs in clinical data to verify the feature's applicability. We validated the feature is sensitive to false versus true positive HFO detections by using an independent data set (six subjects) scored for HFOs by three human reviewers. Lastly, we compared the effect of redacting putative false positive HFO detections on the distribution of HFOs across channels and their association with seizure onset zone (SOZ) and resected volume (RV).Main results.Of the 15 analyzed features, the analysis selected only skewness of the curvature (skewCurve). The feature was validated in human scored data to be associated with distinguishing true and false positive HFO detections. Automated HFO detections with higher skewCurve were more focal based on entropy measures and had increased localization to both the SOZ and RV.Significance.We identified a quantitative feature of HFOs which helps distinguish between true and false positive detections. Redacting putative false positive HFO detections improves the specificity of HFOs as a biomarker of epileptic tissue.	[Gliske, Stephen, V] Univ Nebraska Med Ctr, Dept Neurosurg, Omaha, NE 68198 USA; [Gliske, Stephen, V; Stacey, William C.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Gliske, Stephen, V; Qin, Zihan; Stacey, William C.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Lau, Katy] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Alvarado-Rojas, Catalina] Pontificia Univ Javeriana, Dept Elect Engn, Bogota, Colombia; [Salami, Pariya; Zelmann, Rina] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Salami, Pariya; Zelmann, Rina] Harvard Med Sch, Boston, MA 02115 USA		Gliske, SV (corresponding author), Univ Nebraska Med Ctr, Dept Neurosurg, Omaha, NE 68198 USA.; Gliske, SV (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.; Gliske, SV (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	steve.gliske@unmc.edu	Alvarado-Rojas, Catalina/AAR-8761-2021; Salami, Pariya/AAQ-7972-2021; Stacey, William/D-1123-2009	Stacey, William/0000-0002-8359-8057; Gliske, Stephen/0000-0002-2259-2612; Alvarado-Rojas, Catalina/0000-0002-2315-5692; Zelmann, Rina/0000-0002-2142-7324	National Institutes of Health [K01-ES026839, R01-NS094399]; Doris Duke Foundation [2015096]; University of Michigan Coulter Translational Research Partnership Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); University of Michigan Coulter Translational Research Partnership Program	This work was supported by the National Institutes of Health [Grant Nos. K01-ES026839, R01-NS094399], the Doris Duke Foundation [Grant No. 2015096], and the University of Michigan Coulter Translational Research Partnership Program. The Coulter program support specifically included paying consulting fees to C.A-R., P.S., and R.S. for the manual scoring of HFOs. This research was also supported in part through computational resources and services provided by Advanced Research Computing at the University of Michigan, Ann Arbor.	Adamczyk L, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.092010; Akiyama T, 2012, CLIN NEUROPHYSIOL, V123, P93, DOI 10.1016/j.clinph.2011.05.026; Akiyama T, 2011, EPILEPSIA, V52, P1802, DOI 10.1111/j.1528-1167.2011.03199.x; Alkawadri R, 2014, EPILEPSIA, V55, P1986, DOI 10.1111/epi.12851; Benar CG, 2010, CLIN NEUROPHYSIOL, V121, P301, DOI 10.1016/j.clinph.2009.10.019; Berisha V, 2016, IEEE T SIGNAL PROCES, V64, P580, DOI 10.1109/TSP.2015.2477805; Blanco JA, 2011, BRAIN, V134, P2948, DOI 10.1093/brain/awr212; Bragin A, 2002, ANN NEUROL, V52, P407, DOI 10.1002/ana.10291; Brown CD, 2006, CHEMOMETR INTELL LAB, V80, P24, DOI 10.1016/j.chemolab.2005.05.004; Burg J. P., 1968, NATO ADV STUD I SIGN; Burnos S, 2016, CLIN NEUROPHYSIOL, V127, P2140, DOI 10.1016/j.clinph.2016.01.002; Cimbalnik J, 2018, ANN CLIN TRANSL NEUR, V5, P1062, DOI 10.1002/acn3.618; Edelvik A, 2013, NEUROLOGY, V81, P1244, DOI 10.1212/WNL.0b013e3182a6ca7b; Engel J, 2009, EPILEPSIA, V50, P598, DOI 10.1111/j.1528-1167.2008.01917.x; Gardner AB, 2007, CLIN NEUROPHYSIOL, V118, P1134, DOI 10.1016/j.clinph.2006.12.019; Geertsema EE, 2015, INT J NEURAL SYST, V25, DOI 10.1142/S012906571550015X; Gliske SV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04549-2; Gliske SV, 2016, INT CONF ACOUST SPEE, P6290, DOI 10.1109/ICASSP.2016.7472887; Gliske SV, 2016, CLIN NEUROPHYSIOL, V127, P1057, DOI 10.1016/j.clinph.2015.07.016; Haegelen C, 2013, EPILEPSIA, V54, P848, DOI 10.1111/epi.12075; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jacobs J, 2010, ANN NEUROL, V67, P209, DOI 10.1002/ana.21847; Jehi L, 2018, EPILEPSY CURR, V18, P12, DOI 10.5698/1535-7597.18.1.12; Kallner A, 2018, BIOCHEM MEDICA, V28, DOI 10.11613/BM.2018.010101; Khadjevand F, 2017, CURR OPIN BIOMED ENG, V4, P87, DOI 10.1016/j.cobme.2017.09.006; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Liu S, 2018, BRAIN, V141, P713, DOI 10.1093/brain/awx374; Liu S, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026026; Matsumoto A, 2013, J NEUROPHYSIOL, V110, P1958, DOI 10.1152/jn.00341.2013; Mooij AH, 2020, CLIN NEUROPHYSIOL, V131, P183, DOI 10.1016/j.clinph.2019.10.025; Moon AKR, 2015, 2015 IEEE SIGNAL PROCESSING AND SIGNAL PROCESSING EDUCATION WORKSHOP (SP/SPE), P13, DOI 10.1109/DSP-SPE.2015.7369520; Noe K, 2013, JAMA NEUROL, V70, P1003, DOI 10.1001/jamaneurol.2013.209; Oliver TA, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4866813; Ren SJ, 2019, CLIN NEUROPHYSIOL, V130, P976, DOI 10.1016/j.clinph.2019.03.028; Roehri N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174702; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Wang S, 2013, EPILEPSIA, V54, P370, DOI 10.1111/j.1528-1167.2012.03721.x; Wu JY, 2010, NEUROLOGY, V75, P1686, DOI 10.1212/WNL.0b013e3181fc27d0; Xiang J, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa036; Yu SK, 2014, EPILEPSY RES, V108, P555, DOI 10.1016/j.eplepsyres.2013.12.004; Zelmann R, 2010, IEEE ENG MED BIO, P2329, DOI 10.1109/IEMBS.2010.5627464; Zelmann R, 2009, CLIN NEUROPHYSIOL, V120, P1457, DOI 10.1016/j.clinph.2009.05.029; Zijlmans M, 2011, CLIN NEUROPHYSIOL, V122, P664, DOI 10.1016/j.clinph.2010.09.021	43	5	5	0	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	OCT	2020	17	5							056005	10.1088/1741-2552/abb89b	http://dx.doi.org/10.1088/1741-2552/abb89b			15	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	OB3GC	32932244	hybrid, Green Accepted			2022-09-04	WOS:000578359800001
J	Baron, RM; Lopez-Guzman, S; Riascos, DF; Macias, AA; Layne, MD; Cheng, GY; Harris, C; Chung, SW; Reeves, R; von Andrian, UH; Perrella, MA				Baron, Rebecca M.; Lopez-Guzman, Silvia; Riascos, Dario F.; Macias, Alvaro A.; Layne, Matthew D.; Cheng, Guiying; Harris, Cailin; Chung, Su Wol; Reeves, Raymond; von Andrian, Ulrich H.; Perrella, Mark A.			Distamycin A Inhibits HMGA1-Binding to the P-Selectin Promoter and Attenuates Lung and Liver Inflammation during Murine Endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; MOBILITY GROUP-I(Y) PROTEIN; MINOR-GROOVE BINDERS; TRANSCRIPTIONAL REGULATION; INDUCED EXPRESSION; ADHESION MOLECULE; ENDOTHELIAL-CELLS; IMPROVES SURVIVAL; VIRUS INDUCTION; DOWN-REGULATION	Background: The architectural transcription factor High Mobility Group-A1 (HMGA1) binds to the minor groove of AT-rich DNA and forms transcription factor complexes ("enhanceosomes'') that upregulate expression of select genes within the inflammatory cascade during critical illness syndromes such as acute lung injury (ALI). AT-rich regions of DNA surround transcription factor binding sites in genes critical for the inflammatory response. Minor groove binding drugs (MGBs), such as Distamycin A (Dist A), interfere with AT-rich region DNA binding in a sequence and conformation-specific manner, and HMGA1 is one of the few transcription factors whose binding is inhibited by MGBs. Objectives: To determine whether MGBs exert beneficial effects during endotoxemia through attenuating tissue inflammation via interfering with HMGA1-DNA binding and modulating expression of adhesion molecules. Methodology/Principal Findings: Administration of Dist A significantly decreased lung and liver inflammation during murine endotoxemia. In intravital microscopy studies, Dist A attenuated neutrophil-endothelial interactions in vivo following an inflammatory stimulus. Endotoxin induction of P-selectin expression in lung and liver tissue and promoter activity in endothelial cells was significantly reduced by Dist A, while E-selectin induction was not significantly affected. Moreover, Dist A disrupted formation of an inducible complex containing NF-kappa B that binds an AT-rich region of the P-selectin promoter. Transfection studies demonstrated a critical role for HMGA1 in facilitating cytokine and NF-kappa B induction of P-selectin promoter activity, and Dist A inhibited binding of HMGA1 to this AT-rich region of the P-selectin promoter in vivo. Conclusions/Significance: We describe a novel targeted approach in modulating lung and liver inflammation in vivo during murine endotoxemia through decreasing binding of HMGA1 to a distinct AT-rich region of the P-selectin promoter. These studies highlight the ability of MGBs to function as molecular tools for dissecting transcriptional mechanisms in vivo and suggest alternative treatment approaches for critical illness.	[Baron, Rebecca M.; Lopez-Guzman, Silvia; Riascos, Dario F.; Macias, Alvaro A.; Harris, Cailin; Chung, Su Wol; Perrella, Mark A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Baron, Rebecca M.; Perrella, Mark A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Perrella, Mark A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Newborn Med, Boston, MA 02115 USA; [Riascos, Dario F.] Pontificia Univ Javeriana, Dept Physiol Sci, Bogota, Colombia; [Layne, Matthew D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Cheng, Guiying; von Andrian, Ulrich H.] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; [Cheng, Guiying; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chung, Su Wol] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Reeves, Raymond] Washington State Univ, Dept Biochem & Biophys, Pullman, WA 99164 USA		Baron, RM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	rbaron@partners.org	von Andrian, Ulrich H/A-5775-2008; Lopez-Guzman, Silvia/G-7595-2012	Riascos Bernal, Dario/0000-0002-8790-4699; Lopez-Guzman, Silvia/0000-0003-0271-3576; Layne, Matthew/0000-0003-0007-4870	National Institutes of Health [AI054465, HL091957, AI061246, GM53249, HL60788]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091957, R01HL060788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072252, U01AI061246, K08AI054465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants AI054465 (to R. M. B.), HL091957 (to R. M. B.), AI061246 (to M. A. P.), GM53249 (to M. A. P.), and HL60788 (to M. A. P.), all from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; ASADUZZAMAN M, 2009, BRIT J PHARMACOL, DOI DOI 10.1111/J.1476-5381.2008.00021; Baraldi PG, 2004, MED RES REV, V24, P475, DOI 10.1002/med.20000; Baraldi PG, 2007, BIOORGAN MED CHEM, V15, P17, DOI 10.1016/j.bmc.2006.07.004; Baron RM, 2004, FASEB J, V18, P1276, DOI 10.1096/fj.04-1518fje; Baron RM, 2004, J IMMUNOL, V173, P4147, DOI 10.4049/jimmunol.173.6.4147; Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Bell A, 1997, J MOL RECOGNIT, V10, P245, DOI 10.1002/(SICI)1099-1352(199711/12)10:6<245::AID-JMR367>3.0.CO;2-3; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Carvajal IM, 2002, CRIT CARE MED, V30, pS36, DOI 10.1097/00003246-200201001-00005; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; COUGHLAN AF, 1994, J EXP MED, V179, P329, DOI 10.1084/jem.179.1.329; Cozzi P, 2000, FARMACO, V55, P168, DOI 10.1016/S0014-827X(00)00013-6; Dolenc J, 2005, NUCLEIC ACIDS RES, V33, P725, DOI 10.1093/nar/gki195; Dolenc J, 2006, BIOPHYS J, V91, P1460, DOI 10.1529/biophysj.105.074617; Doss RM, 2006, J AM CHEM SOC, V128, P9074, DOI 10.1021/ja0621795; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; Ejima K, 2003, FASEB J, V17, P1325, DOI 10.1096/fj.02-1078fje; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Geng JG, 2004, CURR MED CHEM, V11, P2153, DOI 10.2174/0929867043364720; Ghersa P, 1997, NUCLEIC ACIDS RES, V25, P339, DOI 10.1093/nar/25.2.339; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Grant MA, 2009, BIOCHEM J, V418, P103, DOI 10.1042/BJ20081427; Henikoff S, 2000, CELL, V103, P695, DOI 10.1016/S0092-8674(00)00172-0; Hickey MJ, 2001, ACTA PHYSIOL SCAND, V173, P119, DOI 10.1046/j.1365-201X.2001.00892.x; Himes SR, 2000, J IMMUNOL, V164, P3157, DOI 10.4049/jimmunol.164.6.3157; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Janssen S, 2000, MOL CELL, V6, P1013, DOI 10.1016/S1097-2765(00)00100-3; Janssen S, 2000, MOL CELL, V6, P999, DOI 10.1016/S1097-2765(00)00099-X; Kamochi M, 1999, AM J PHYSIOL-LUNG C, V277, pL310, DOI 10.1152/ajplung.1999.277.2.L310; Klintman D, 2004, CLIN DIAGN LAB IMMUN, V11, P56, DOI 10.1128/CDLI.11.1.56-62.2004; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; Lewis JF, 2003, CRIT CARE MED, V31, pS324, DOI 10.1097/01.CCM.0000057911.19145.9F; MacCallum NS, 2005, CURR OPIN CRIT CARE, V11, P43, DOI 10.1097/00075198-200502000-00007; Marshall JC, 1999, SEPSIS, V3, P5; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Pan JL, 1998, J BIOL CHEM, V273, P10068, DOI 10.1074/jbc.273.16.10068; Pan JL, 1998, J BIOL CHEM, V273, P10058, DOI 10.1074/jbc.273.16.10058; Pellacani A, 2001, J BIOL CHEM, V276, P1653, DOI 10.1074/jbc.M008170200; Pellacani A, 1999, J BIOL CHEM, V274, P1525, DOI 10.1074/jbc.274.3.1525; Perrella MA, 1999, J BIOL CHEM, V274, P9045, DOI 10.1074/jbc.274.13.9045; RADIC MZ, 1992, CHROMOSOMA, V101, P602, DOI 10.1007/BF00360537; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Reeves R, 1999, METHOD ENZYMOL, V304, P155; REEVES R, 1990, J BIOL CHEM, V265, P8573; SANDERS WE, 1992, BLOOD, V80, P795; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Steeber DA, 1998, P NATL ACAD SCI USA, V95, P7562, DOI 10.1073/pnas.95.13.7562; Steeber DA, 1999, J IMMUNOL, V163, P2176; Susbielle Guillaume, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P409, DOI 10.2174/1568011054222355; Takamiya R, 2008, FEBS LETT, V582, P810, DOI 10.1016/j.febslet.2008.02.008; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; THOMAS R, 2004, NUCLEIC ACIDS RES, V32, P1; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang X, 2004, J BIOL CHEM, V279, P5237, DOI 10.1074/jbc.M309271200; Wang Y, 2006, J IMMUNOL, V176, P275, DOI 10.4049/jimmunol.176.1.275; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEGNER M, 1990, BIOCHEM BIOPH RES CO, V166, P1110, DOI 10.1016/0006-291X(90)90981-R; WELLER A, 1992, J BIOL CHEM, V267, P15176; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; YOSHIZUMI M, 1995, MOL CELL BIOL, V15, P3266; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	75	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2010	5	5							e10656	10.1371/journal.pone.0010656	http://dx.doi.org/10.1371/journal.pone.0010656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597PU	20498830	Green Published, Green Submitted, gold			2022-09-04	WOS:000277771600018
J	Castro, SM; Cubillos, L; Uribe-Restrepo, JM; Suarez-Obando, F; Meier, A; Naslund, JA; Bartels, SM; Williams, MJ; Cepeda, M; Torrey, WC; Marsch, LA; Gomez-Restrepo, C				Castro, Sergio M.; Cubillos, Leonardo; Miguel Uribe-Restrepo, Jose; Suarez-Obando, Fernando; Meier, Andrea; Naslund, John A.; Bartels, Sophia M.; Williams, Makeda J.; Cepeda, Magda; Torrey, William C.; Marsch, Lisa A.; Gomez-Restrepo, Carlos			Assessing the Integration of Behavioral Health Services in Primary Care in Colombia	ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH			English	Article						Primary health care; Behavioral health; Integrated care; International collaboration; Substance use disorders treatment	DUAL DIAGNOSIS CAPABILITY; MENTAL-HEALTH; SUBSTANCE-ABUSE; MEDICAL-CARE; DEPRESSION; ADDICTION; BURDEN; SYSTEM	Integration of behavioral health care into primary care can improve health and economic outcomes. This study adapted the Behavioral Health Integration in Medical Care (BHIMC) index to the Colombian context and assessed the baseline level of behavioral health integration in a sample of primary care organizations. The BHIMC was able to detect the capacity to provide integrated behavioral care in Colombian settings. Results indicate a minimal to partial integration level across all sites, and that it is possible to measure the degree of integrated care capacity and identify improvement areas for better behavioral health care provision.	[Castro, Sergio M.; Cepeda, Magda; Gomez-Restrepo, Carlos] Pontificia Univ Javeriana, Fac Med, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia; [Cubillos, Leonardo; Meier, Andrea; Bartels, Sophia M.; Marsch, Lisa A.] Dartmouth Coll, Geisel Sch Med, Ctr Technol & Behav Hlth, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Cubillos, Leonardo] Dartmouth Hitchcock Med Ctr, Dept Psychiat, Lebanon, NH 03766 USA; [Miguel Uribe-Restrepo, Jose; Gomez-Restrepo, Carlos] Pontificia Univ Javeriana, Fac Med, Dept Psiquiatria & Salud Mental, Bogota, Colombia; [Suarez-Obando, Fernando] Pontificia Univ Javeriana, Fac Med, Inst Genet Humana, Bogota, Colombia; [Naslund, John A.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Williams, Makeda J.] NIMH, Ctr Global Mental Hlth Res, NIH, Bethesda, MD 20892 USA; [Torrey, William C.] Dartmouth Coll, Geisel Sch Med, Dept Psychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Gomez-Restrepo, Carlos] Hosp Univ San Ignacio, Bogota, Colombia		Castro, SM (corresponding author), Pontificia Univ Javeriana, Fac Med, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia.	sergio.castro@javeriana.edu.co	Suarez-Obando, Fernando/AAY-3327-2021; Suárez-Obando, Fernando/AAA-9602-2020	Suárez-Obando, Fernando/0000-0001-6336-5347; Castro Diaz, Sergio/0000-0001-6820-8711; Cepeda-Gil, Magda/0000-0003-4579-6033; Uribe Restrepo, Jose Miguel/0000-0003-4284-7886; Marsch, Lisa/0000-0001-6429-0965	NIDA NIH HHS [P30 DA029926] Funding Source: Medline; NIMH NIH HHS [U19 MH109988] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaya J., 2013, GPES1682C13; Andrade LH, 2014, PSYCHOL MED, V44, P1303, DOI 10.1017/S0033291713001943; [Anonymous], 2008, INT MENT HLTH PRIM C; Bautista MAC, 2016, MILBANK Q, V94, P862, DOI 10.1111/1468-0009.12233; Bernal O, 2015, SALUD PUBLICA MEXICO, V57, P433; Butler M, 2008, AHRQ PUBLICATION, V09-E003; Chaple M, 2013, J DUAL DIAGN, V9, P171, DOI 10.1080/15504263.2013.779128; Chaskel Roberto, 2015, BJPsych Int, V12, P95; Crowley RA, 2015, ANN INTERN MED, V163, P298, DOI 10.7326/M15-0510; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Fajardo-Gonzalez J, 2016, J ECON INEQUAL, V14, P395, DOI 10.1007/s10888-016-9338-2; Friedmann PD, 2003, J GEN INTERN MED, V18, P1, DOI 10.1046/j.1525-1497.2003.10601.x; Gagnon MP, 2016, J AM MED INFORM ASSN, V23, P212, DOI 10.1093/jamia/ocv052; Giedion U, 2009, HEALTH AFFAIR, V28, P853, DOI 10.1377/hlthaff.28.3.853; Goldberg D, 2010, WORLD PSYCHIATRY, V9, P16; Gomez-Restrepo C., 2015, ENCUESTA NACL SALUD; González Lina María, 2016, rev.colomb.psiquiatr., V45, P89, DOI 10.1016/j.rcp.2016.10.004; Hill JM, 2015, INT J PSYCHIAT MED, V50, P36, DOI 10.1177/0091217415592357; Hoffman L, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00094; Katon W, 2006, DIABETES CARE, V29, P265, DOI 10.2337/diacare.29.02.06.dc05-1572; Kwan BM., 2013, INTEGRATED BEHAV HLT, P65, DOI [10.1007/978-1-4614-6889-9_5, DOI 10.1007/978-1-4614-6889-9_5]; Lehmann U, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-19; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Mbemba GIC, 2016, J PUBLIC HEALTH AFR, V7, P61, DOI 10.4081/jphia.2016.565; McGough PM, 2016, POPUL HEALTH MANAG, V19, P81, DOI 10.1089/pop.2015.0039; McGovern MP, 2012, J SUBST ABUSE TREAT, V43, P402, DOI 10.1016/j.jsat.2012.08.013; McGovern MP, 2010, J DUAL DIAGN, V6, P237, DOI 10.1080/15504263.2010.537221; Miller BF, 2014, AM PSYCHOL, V69, P443, DOI 10.1037/a0036093; Miller BF, 2014, J AM BOARD FAM MED, V27, P367, DOI 10.3122/jabfm.2014.03.130260; OECD, 2015, OECD REV HLTH SYST C; Rivera Felipe, 2017, Lect. Econ., P125, DOI 10.17533/udea.le.n87a05; Roselli Cock D. A, 2000, MED ESPECIALIZADA CO; Gomez FR, 2013, REV PANAM SALUD PUBL, V33, P107, DOI 10.1590/S1020-49892013000200005; Sacks S, 2013, J SUBST ABUSE TREAT, V44, P488, DOI 10.1016/j.jsat.2012.11.001; Valev N., 2015, A6510 WHO WORLD HLTH; van Ginneken N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009149.pub2; Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; WHO, 2002, GLOBAL REPORT	39	1	1	2	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0894-587X	1573-3289		ADM POLICY MENT HLTH	Adm. Policy. Ment. Health	MAY	2020	47	3					435	442		10.1007/s10488-019-01002-4	http://dx.doi.org/10.1007/s10488-019-01002-4			8	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	LC6QE	31832852	Green Accepted			2022-09-04	WOS:000525457900009
J	Gomez-Restrepo, C; Maldonado, P; Rodriguez, N; Ruiz-Gaviria, R; Escalante, MA; Gomez, RA; de Araujo, MR; de Oliveira, ACS; Rivera, JSC; Garcia, JAG; Ferrand, MP; Blitchtein-Winicki, D				Gomez-Restrepo, Carlos; Maldonado, Patricia; Rodriguez, Nelcy; Ruiz-Gaviria, Rafael; Angel Escalante, Miguel; Angel Gomez, Raul; Ribeiro de Araujo, Marcelo; Schmidt de Oliveira, Ana Carolina; Chavez Rivera, Joel Salvador; Godinez Garcia, Jorge Alberto; Piazza Ferrand, Marina; Blitchtein-Winicki, Dora			Quality measurers of therapeutic communities for substance dependence: an international collaborative study survey in Latin America	SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY			English	Article						Therapeutic communities (TCs); Substance-related disorders; Patient satisfaction; Patient compliance	FOLLOW-UP; MODEL	Background: In Latin America, substance related disorders are highly prevalent and one of the treatment strategies is the Therapeutic Communities (TCs), however, in Latin America there is scarce data about this treatment strategies, their quality, drop-out rates and patient satisfaction. Methods: Based on a previous study in 5 Latin American countries, the TCs who had a score equal or higher than 9 according to the De Leon criteria which are some fundamental items that the TCs should meet, were selected to carry out a descriptive and retrospective study of qualitative and quantitative characteristics of the TCs. Results: Data from 58 TCs in 5 countries were included, with a sample of 1414 patients interviewed, of which most were single men, with no hospitalization history in a therapeutic community. Marijuana was the most commonly substance used in the 30 days prior to hospitalization, with 78% of interviewees referring alcohol consumption in the last 6 months and an average onset of psychoactive substances at 16 years of age. A 79% of the patients interviewed perceived some improvement during their stay in the TCs. The less fulfilled Quality Indicators by the TCs were "Requesting a professional qualification to former addicts that belonged to the program" and " Work as part of the therapeutic program". Among the reasons for discharge found in the database, 44% were due to therapeutic discharge with fulfillment of the treatment plan and 44% withdraws. Conclusion: The user satisfaction with TCs, in terms of infrastructure and quality are quite high, as the fulfillment of essential quality items, however, the follow up information to evaluate effectiveness of the treatment is poor or in some cases unknown.	[Gomez-Restrepo, Carlos; Rodriguez, Nelcy; Ruiz-Gaviria, Rafael] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Maldonado, Patricia] Pontificia Univ Javeriana, Sch Med, Bogota, Colombia; [Angel Escalante, Miguel; Angel Gomez, Raul] Natl Univ Cordoba, Psychol Fac, Unity Epidemiol Studies Mental Hlth, Cordoba, Argentina; [Ribeiro de Araujo, Marcelo; Schmidt de Oliveira, Ana Carolina] Fed Univ Sao Paulo UNIFESP, Dept Psychiat, Sao Paulo, Brazil; [Chavez Rivera, Joel Salvador] Consejero Terapeut State Council Addict, Guadalajara, Jalisco, Mexico; [Godinez Garcia, Jorge Alberto] Polymetrix, Cabo San Lucas, Jalisco, Mexico; [Piazza Ferrand, Marina] Univ Peruana Cayetano Heredia, Lima, Peru; [Blitchtein-Winicki, Dora] Natl Inst Publ Hlth, Lima, Peru		Gomez-Restrepo, C (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Clin Epidemiol & Biostat, Bogota, Colombia.	cgomez_restrepo@yahoo.com	Blitchtein, Dora/AFS-2751-2022	Blitchtein, Dora/0000-0002-9986-7442; Gomez-Restrepo, Carlos/0000-0002-9013-5384; Rodriguez, Nelcy/0000-0003-4320-695X	Corporative Foundations, A.C, USA	Corporative Foundations, A.C, USA	This study was financially supported by:. Corporative Foundations, A.C, USA embassy in Peru, Bancolombia group S.A.	[Anonymous], 2000, Bull World Health Organ, V78, P413; Caulkins J. P., 2014, INT PUBLIC HLTH J, V6, P269; Darke S, 2012, DRUG ALCOHOL REV, V31, P64, DOI 10.1111/j.1465-3362.2011.00298.x; De Leon G., 1997, COMMUNITY METHOD THE; DELEON G, 1995, INT J ADDICT, V30, P1603; DeLeon George, 2000, THERAPEUTIC COMMUNIT; Fernandez-Montalvo J, 2008, SUBST USE MISUSE, V43, P1362, DOI 10.1080/10826080801922231; Ferrando SJ, 2008, CRIT CARE CLIN, V24, P889, DOI 10.1016/j.ccc.2008.05.007; Fiestas Fabián, 2012, Rev. perú. med. exp. salud publica, V29, P12, DOI 10.1590/s1726-46342012000100003; Goethals I, 2011, SUBST USE MISUSE, V46, P1023, DOI 10.3109/10826084.2010.544358; Hubbard RL, 2003, J SUBST ABUSE TREAT, V25, P125, DOI 10.1016/S0740-5472(03)00130-2; Instituto Nacional sobre el Abuso de Drogas Departamento de Salud y Servicios Humanos de los EE.UU, 2010, PRINC TRAT DROG GUIA; Johnson K, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-26; Johnson KW, 2012, SUBST USE MISUSE, V47, P889, DOI 10.3109/10826084.2012.663279; Lopez-Goni J. J., 2008, TRASTORNOS ADICTIVOS, V10, P104; Melnick G, 1999, J SUBST ABUSE TREAT, V16, P307, DOI 10.1016/S0740-5472(98)00036-1; Ministerio de Justicia y del Derecho-Observatorio de Drogas de Colombia y el Ministerio de Salud y Proteccion Social, 2014, EST NAC CONS SUST PS; NIDA, 2010, DRUGS BRAINS BEH SCI; Observatorio argentino de drogas, 2007, OBSERVATORIO ARGENTI; Sadir N, 2013, INT J HEALTH POLICY, V1, P131, DOI 10.15171/ijhpm.2013.24; Schulden JD, 2012, PSYCHIAT CLIN N AM, V35, P411, DOI 10.1016/j.psc.2012.03.007; Smith LA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005338.pub2; United Nations Office on Drugs and Crime, 2014, WORLD DRUG REP 2014; Vanderplasschen W, 2013, SCI WORLD J, DOI 10.1155/2013/427817; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; World Federation of Therapeutic Communities (WFTC), WHAT IS THER COMM	26	0	0	2	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1747-597X			SUBST ABUSE TREAT PR	Subst/ Abus. Treatment Prev. Pol.	DEC 20	2017	12								53	10.1186/s13011-017-0129-y	http://dx.doi.org/10.1186/s13011-017-0129-y			9	Substance Abuse	Social Science Citation Index (SSCI)	Substance Abuse	FR1FK	29262838	Green Published, gold			2022-09-04	WOS:000418811200001
J	Garzon, D; Cabezas, R; Vega, N; Avila-Rodriguez, M; Gonzalez, J; Gomez, RM; Echeverria, V; Aliev, G; Barreto, GE				Garzon, Daniel; Cabezas, Ricardo; Vega, Nelson; Avila-Rodriguez, Marcos; Gonzalez, Janneth; Margarita Gomez, Rosa; Echeverria, Valentina; Aliev, Gjumrakch; Barreto, George E.			Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Astrocytes; Neurosteroids; Growth factors; Mesenchymal stemfactors; Nicotine; Computational biology	MESENCHYMAL STEM-CELLS; NICOTINIC ACETYLCHOLINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; GROWTH-FACTORS; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; OXIDATIVE STRESS; SYSTEMS BIOLOGY; BREAST-CANCER; RAT MODEL	Astrocytes are important for normal brain functioning. Astrocytes are metabolic regulators of the brain that exert many functions such as the preservation of blood-brain barrier (BBB) function, clearance of toxic substances, and generation of antioxidant molecules and growth factors. These functions are fundamental to sustain the function and survival of neurons and other brain cells. For these reasons, the protection of astrocytes has become relevant for the prevention of neuronal death during brain pathologies such as Parkinson's disease, Alzheimer's disease, stroke, and other neurodegenerative conditions. Currently, different strategies are being used to protect the main astrocytic functions during neurological diseases, including the use of growth factors, steroid derivatives, mesenchymal stem cell paracrine factors, nicotine derivatives, and computational biology tools. Moreover, the combined use of experimental approaches with bioinformatics tools such as the ones obtained through system biology has allowed a broader knowledge in astrocytic protection both in normal and pathological conditions. In the present review, we highlight some of these recent paradigms in assessing astrocyte protection using experimental and computational approaches and discuss how they could be used for the study of restorative therapies for the brain in pathological conditions.	[Garzon, Daniel; Cabezas, Ricardo; Vega, Nelson; Avila-Rodriguez, Marcos; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Margarita Gomez, Rosa] Univ La Sabana, Grp Neurociencias, Chia, Cundinamarca, Colombia; [Echeverria, Valentina] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33647 USA; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Concepcion 1457, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci, E Johns Crossing 175, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Univ Atlanta, Healthcare Adm, E Johns Crossing 175, Johns Creek, GA USA; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gesbarreto@gmail.com	Aliev, Gjumrakch/K-7302-2017; Aliev, Gjumrakch/AAE-7734-2020; GONZALEZ, JANNETH/AAB-9948-2020; Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./B-5747-2014; Barreto, George E./AAD-7420-2020	Aliev, Gjumrakch/0000-0001-7373-3182; GONZALEZ, JANNETH/0000-0003-4482-256X; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Avila-Rodriguez, Marco/0000-0003-4612-3236; Vega, Nelson/0000-0003-2404-6858	grants PUJ [4509, 5024, 5608]; Colciencias project [528, 511]; GALLY International Biomedical Research Consulting LLC, San Antonio, TX, USA	grants PUJ; Colciencias project(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); GALLY International Biomedical Research Consulting LLC, San Antonio, TX, USA	This work was supported in part by grants PUJ IDs 4509, 5024, and 5608 to GEB, Colciencias project (convocatoria 528) to RC and Colciencias project (convocatoria 511). G. Aliev work was supported by the GALLY International Biomedical Research Consulting LLC, San Antonio, TX, USA.	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Andriamaharavo NR, 2005, J NAT PROD, V68, P1743, DOI 10.1021/np058089f; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Barragan-Osorio L., 2015, CENT NERV SYST AGENT; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2015, CURR PHARM DESIGN, V21, P3589, DOI 10.2174/1381612821666150710145250; Barreto GE, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00340; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Burkhalter J, 2003, J NEUROSCI, V23, P8212; Cabezas R., 2015, MED CHEM IN PRESS; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Caiazzo M, 2015, STEM CELL REP, V4, P25, DOI 10.1016/j.stemcr.2014.12.002; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Castellani G, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00253; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; CHENG B, 1995, J NEUROSCI, V15, P7095; Ciurea A.V., 2011, ROMANIAN NEUROSURGER, V18, P11; COLDITZ GA, 1993, AM J OBSTET GYNECOL, V168, P1473, DOI 10.1016/S0002-9378(11)90784-4; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Coulter DA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022434; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; De Schutter E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000078; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fujita KA, 2014, MOL NEUROBIOL, V49, P88, DOI 10.1007/s12035-013-8489-4; Funa K, 2014, J NEUROIMMUNE PHARM, V9, P168, DOI 10.1007/s11481-013-9479-z; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Gibson W., 2008, MATH MODELING BIOL S, P193; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gompel A, 1999, CONTRACEPT FERTIL S, V27, P368; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Han D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-95, 10.1186/1471-2164-15-477]; He T, 2012, MICROVASC RES, V83, P366, DOI 10.1016/j.mvr.2012.01.001; Henriques A, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00032; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Krupinski J, 1997, STROKE, V28, P564, DOI 10.1161/01.STR.28.3.564; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lanussa O.H., 2015, CNS NEUROLO IN PRESS; Likic Vladimir A., 2010, Advances in Bioinformatics, V2010, P268925, DOI 10.1155/2010/268925; Lin CH, 2006, EXP NEUROL, V201, P225, DOI 10.1016/j.expneurol.2006.04.014; Liu Y, 2015, NEUROPHARMACOLOGY, V91, P87, DOI 10.1016/j.neuropharm.2014.11.028; Liu Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-98; Lunn JS, 2011, ANN NEUROL, V70, P353, DOI 10.1002/ana.22487; Malik N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096139; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; McMurray R, 2003, BRAIN RES, V980, P140, DOI 10.1016/S0006-8993(03)02984-6; Miller RH, 2010, DISCOV MED, V9, P236; MORENS DM, 1995, NEUROLOGY, V45, P1041, DOI 10.1212/WNL.45.6.1041; Nimmerjahn A, 2015, CURR OPIN NEUROBIOL, V32, P95, DOI 10.1016/j.conb.2015.01.015; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliveira SLB, 2013, CYTOM PART A, V83A, P76, DOI 10.1002/cyto.a.22161; Parpura V, 2011, BBA-MOL CELL RES, V1813, P984, DOI 10.1016/j.bbamcr.2010.11.006; Paul G, 2015, J CLIN INVEST, V125, P1339, DOI 10.1172/JCI79635; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez-Alvarez A, 2013, CURR DRUG TARGETS, V14, P1220; Pogocki D, 2007, EUR J PHARMACOL, V563, P18, DOI 10.1016/j.ejphar.2007.02.038; Proschel C, 2014, EMBO MOL MED, V6, P504, DOI 10.1002/emmm.201302878; Ramaswamy S, 2009, PARKINSONISM RELAT D, V15, pS176, DOI 10.1016/S1353-8020(09)70809-0; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Rossignol J, 2014, STEM CELLS, V32, P500, DOI 10.1002/stem.1508; Safi R, 2012, J MOL NEUROSCI, V46, P654, DOI 10.1007/s12031-011-9654-8; Salazar DA, 2016, MOL GENET METAB, V117, P129, DOI 10.1016/j.ymgme.2015.08.001; Sejnowski TJ, 2015, INT ENCY SOCIAL BEHA, P480; Sertbas M, 2014, FEBS OPEN BIO, V4, P542, DOI 10.1016/j.fob.2014.05.006; Tegner JN, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-56; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; [田文艳 TIAN Wen-yan], 2009, [第二军医大学学报, Academic Journal of Second Military Medical University], V30, P790; Tonder JE, 2001, CURR MED CHEM, V8, P651, DOI 10.2174/0929867013373165; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Torrente Daniel, 2015, Front Biosci (Elite Ed), V7, P434; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Vos RME, 2002, DRUG METAB DISPOS, V30, P106, DOI 10.1124/dmd.30.2.106; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Yasuda T, 2010, EXPERT REV NEUROTHER, V10, P915, DOI [10.1586/ern.10.55, 10.1586/ERN.10.55]; Yildiz D, 2004, TOXICON, V43, P619, DOI 10.1016/j.toxicon.2004.01.017; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302	97	13	13	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	APR	2016	58	4					483	492		10.1007/s12031-016-0719-6	http://dx.doi.org/10.1007/s12031-016-0719-6			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DJ5YI	26803310				2022-09-04	WOS:000374286300011
J	Kokilashvili, V; Meskhi, A; Rafeiro, H				Kokilashvili, Vakhtang; Meskhi, Alexander; Rafeiro, Humberto			Estimates for nondivergence elliptic equations with VMO coefficients in generalized grand Morrey spaces	COMPLEX VARIABLES AND ELLIPTIC EQUATIONS			English	Article						elliptic equation; Morrey spaces; VMO; singular integrals; commutators; 35J25; 42B20	LEBESGUE SPACES	In this paper, we establish the regularity, in generalized grand Morrey spaces, of the solution to elliptic equations in non-divergence form with VMO coefficients by means of the theory of singular integrals and linear commutators.	[Kokilashvili, Vakhtang; Meskhi, Alexander] I Javakhishvili Tbilisi State Univ, A Razmadze Math Inst, Dept Math Anal, Tbilisi 0186, Georgia; [Kokilashvili, Vakhtang] Int Black Sea Univ, GE-0131 Tbilisi, Georgia; [Meskhi, Alexander] Georgian Tech Univ, Fac Informat & Control Syst, Dept Math, Tbilisi, Georgia; [Meskhi, Alexander] Govt Coll Univ, Abdus Salam Sch Math Sci, Lahore, Pakistan; [Rafeiro, Humberto] Pontificia Univ Javeriana, Dept Matemat, Bogota, Colombia; [Rafeiro, Humberto] Inst Super Tecn, Dept Matemat, Ctr CEAF, P-1049001 Lisbon, Portugal		Rafeiro, H (corresponding author), Pontificia Univ Javeriana, Dept Matemat, Cra 7a 43-82 Ed Carlos Ortiz 604, Bogota, Colombia.	hrafeiro@math.ist.utl.pt	Meskhi, Alexander/ACT-3186-2022; Rafeiro, Humberto/AAK-4908-2020	Rafeiro, Humberto/0000-0002-5304-8572	Shota Rustaveli National Science Foundation [D/13-23, 31/47]; Pontificia Universidad Javeriana, Research Project Elliptic Equations in Grand Morrey spaces [PRY: 005779]	Shota Rustaveli National Science Foundation; Pontificia Universidad Javeriana, Research Project Elliptic Equations in Grand Morrey spaces	The first and second named authors were partially supported by the Shota Rustaveli National Science Foundation with Grant (Project numbers D/13-23 and 31/47). The third named author was partially supported by Pontificia Universidad Javeriana, Research Project Elliptic Equations in Grand Morrey spaces ID PRY: 005779. We would like to thank the anonymous referee for helpful comments.	Capone C., 2005, J FUNCT SPACES APPL, V3, P73, DOI [10.1155/2005/192538, DOI 10.1155/2005/192538]; Capone C, 2013, NONLINEAR ANAL-THEOR, V85, P125, DOI 10.1016/j.na.2013.02.021; CHIARENZA F, 1993, T AM MATH SOC, V336, P841, DOI 10.2307/2154379; Di Fratta G, 2009, NONLINEAR ANAL-THEOR, V70, P2582, DOI 10.1016/j.na.2008.03.044; DIFAZIO G, 1993, J FUNCT ANAL, V112, P241, DOI 10.1006/jfan.1993.1032; Fan D., 1998, GEORGIAN MATH J, V5, P425, DOI DOI 10.1023/B:GEOR.0000008114.52420.AF; Fefferman C, 1972, ACTA MATH-DJURSHOLM, V129, P137, DOI 10.1007/BF02392215; Fiorenza A, 1998, STUD MATH, V127, P223; Fiorenza A, 2004, Z ANAL ANWEND, V23, P657; Fiorenza A., 2001, C R ACAD SCI PARIS S, V333, P1; Fiorenza A., 2000, COLLECT MATH, V51, P131; Fiorenza A, 2008, STUD MATH, V188, P123, DOI 10.4064/sm188-2-2; Giaquinta M., 1983, MULTIPLE INTEGRALS C; Gilbarg D., 1993, ELLIPTIC PARTIAL DIF, V2; Greco L, 1997, MANUSCRIPTA MATH, V92, P249, DOI 10.1007/BF02678192; IWANIEC T, 1992, ARCH RATION MECH AN, V119, P129, DOI 10.1007/BF00375119; Kufner A., 1977, FUNCTION SPACES; Liflyand E, 2010, TURK J MATH, V34, P207, DOI 10.3906/mat-0812-8; Meskhi A., 2009, P A RAZMADZE MATH I, V151, P139; Meskhi A, 2011, COMPLEX VAR ELLIPTIC, V56, P1003, DOI 10.1080/17476933.2010.534793; Morrey CB, 1938, T AM MATH SOC, V43, P126, DOI 10.2307/1989904; Samko SG, 2011, AZERBAIJAN J MATH, V1, P67; [叶晓峰 Ye Xiaofeng], 2011, [数学学报, Acta Mathematica Sinica], V54, P343	23	15	15	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1747-6933	1747-6941		COMPLEX VAR ELLIPTIC	Complex Var. Elliptic Equ.	AUG 3	2014	59	8					1169	1184		10.1080/17476933.2013.831844	http://dx.doi.org/10.1080/17476933.2013.831844			16	Mathematics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	AF6OQ					2022-09-04	WOS:000334834800009
J	Li, JZ; Claude, N; Tassi, P; Cordier, F; Vargas-Luna, A; Crosato, A; Rodrigues, S				Li, Jiaze; Claude, Nicolas; Tassi, Pablo; Cordier, Florian; Vargas-Luna, Andres; Crosato, Alessandra; Rodrigues, Stephane			Effects of Vegetation Patch Patterns on Channel Morphology: A Numerical Study	JOURNAL OF GEOPHYSICAL RESEARCH-EARTH SURFACE			English	Article							RIPARIAN VEGETATION; SEDIMENT TRANSPORT; FLOW; MODEL; BAR; RECRUITMENT; MECHANISMS; DIRECTION; SURVIVAL; SCOUR	This study investigates the effects of vegetation patch patterns on the morphological evolution of alluvial river channels at the reach-scale. For this, a new two-dimensional numerical biomorphodynamic model has been developed using the Telemac-Mascaret system. Considering the newest development in the topic, the effects of vegetation on bedload transport are included by extending Einstein's parameters for the sediment transport formula. The model was subsequently validated by published laboratory experiments reproducing alternate bar dynamics with different vegetation establishment scenarios. The validated model was then used to study the influence of vegetation patch patterns on the channel morphological evolution considering the two most observed ones: (a) the filled pattern with plants well distributed within the patch, and (b) the stripe pattern with plants established only along the patch edges. 14 scenarios were simulated in total, including sensitivity analyses on the coefficients of vegetation characteristics. The results indicate that the morphological responses of an alternate bar system to the stripe pattern consist of channel widening, steeper slope and reduced water depth, with increased sediment transport rates. The effects of the filled pattern are similar but weaker. The results also show that with the stripe pattern, the alternate bars tend to migrate toward the centerline forming center bars. Besides, the scroll bars forming downstream are shorter, corresponding to less visible chute channels, compared to the filled pattern. Despite much less vegetation coverage, the stripe pattern decreases the bar elongation rates in a way similar to the filled pattern.	[Li, Jiaze; Tassi, Pablo; Cordier, Florian] EDF R&D, Natl Lab Hydraul & Environm LNHE, Chatou, France; [Li, Jiaze; Tassi, Pablo] St Venant Lab Hydraul, Chatou, France; [Li, Jiaze; Rodrigues, Stephane] Univ Tours, CNRS, CITERES, UMR, Tours, France; [Claude, Nicolas] Ctr Ingenierie Hydraul, EDF, La Motte Servolex, France; [Vargas-Luna, Andres] Pontificia Univ Javeriana, Dept Civil Engn, Bogota, Colombia; [Crosato, Alessandra] Delft Univ Technol, Fac Civil Engn & Geosci, Delft, Netherlands; [Crosato, Alessandra] IHE Delft Inst Water Educ, Dept Water Resources & Ecosyst, Delft, Netherlands; [Rodrigues, Stephane] Univ Tours, Grad Sch Engn, Polytech Tours, Tours, France		Li, JZ (corresponding author), EDF R&D, Natl Lab Hydraul & Environm LNHE, Chatou, France.; Li, JZ (corresponding author), St Venant Lab Hydraul, Chatou, France.; Li, JZ (corresponding author), Univ Tours, CNRS, CITERES, UMR, Tours, France.	jiaze.li@edf.fr	; Crosato, Alessandra/C-6734-2009	, Jiaze/0000-0003-1643-6792; Crosato, Alessandra/0000-0001-9531-005X; Tassi, Pablo/0000-0003-4625-4295				Abderrezzak KE, 2016, ADV WATER RESOUR, V93, P75, DOI 10.1016/j.advwatres.2015.11.004; Armanini A, 2019, ADV WATER RESOUR, V129, P250, DOI 10.1016/j.advwatres.2019.05.021; BAPTIST MJ, 2005, THESIS DELFT U TECHN; Bau' V, 2021, GEOPHYS RES LETT, V48, DOI 10.1029/2021GL092388; Bennett SJ, 2008, EARTH SURF PROC LAND, V33, P890, DOI 10.1002/esp.1581; Bennett SJ, 2002, GEOMORPHOLOGY, V44, P115, DOI 10.1016/S0169-555X(01)00148-9; Bertoldi W, 2015, GEOMORPHOLOGY, V246, P178, DOI 10.1016/j.geomorph.2015.05.038; Bertoldi W, 2014, GEOPHYS RES LETT, V41, P7167, DOI 10.1002/2014GL061666; Bonilla-Porras J.A., 2020, RIVER FLOW 2020, P1582, DOI [10.1201/b22619-220/sediment-transport-submerged-vegetation-bonilla-porras-armanini-crosato, DOI 10.1201/B22619-220/SEDIMENT-TRANSPORT-SUBMERGED-VEGETATION-BONILLA-PORRAS-ARMANINI-CROSATO]; Bonilla-Porras JA, 2021, ADV WATER RESOUR, V152, DOI 10.1016/j.advwatres.2021.103928; Bouma TJ, 2007, CONT SHELF RES, V27, P1020, DOI 10.1016/j.csr.2005.12.019; Bywater-Reyes S, 2018, EARTH SURF DYNAM, V6, P487, DOI 10.5194/esurf-6-487-2018; Bywater-Reyes S, 2015, WATER RESOUR RES, V51, P9190, DOI 10.1002/2014WR016641; Camporeale C, 2013, REV GEOPHYS, V51, P379, DOI 10.1002/rog.20014; Caponi F, 2018, GEOPHYS RES LETT, V45, P9013, DOI 10.1029/2018GL078696; Caponi F, 2019, FRONT ENV SCI-SWITZ, V7, DOI 10.3389/fenvs.2019.00124; Corenblit D, 2020, EARTH SURF PROC LAND, V45, P2020, DOI 10.1002/esp.4863; Corenblit D, 2016, EARTH SURF PROC LAND, V41, P1276, DOI 10.1002/esp.3954; de Saint V., 1871, CR HEBD ACAD SCI, V73, P147; Dzubakova K, 2015, HYDROL EARTH SYST SC, V19, P195, DOI 10.5194/hess-19-195-2015; Edmaier K, 2011, HYDROL EARTH SYST SC, V15, P1615, DOI 10.5194/hess-15-1615-2011; ENGELUND F, 1974, J HYDR ENG DIV-ASCE, V100, P1631; Euler T, 2014, HYDROL PROCESS, V28, P1358, DOI 10.1002/hyp.9655; Exner F.M., 1920, HOLDER; Follett EM, 2012, GEOMORPHOLOGY, V179, P141, DOI 10.1016/j.geomorph.2012.08.006; Guan MF, 2017, ENVIRON MODELL SOFTW, V88, P10, DOI 10.1016/j.envsoft.2016.11.008; Gurnell A, 2014, EARTH SURF PROC LAND, V39, P4, DOI 10.1002/esp.3397; Gurnell AM, 2020, RIVER RES APPL, V36, P1730, DOI 10.1002/rra.3691; Hervouet J., 2011, P 34 WORLD C INT ASS, P4103; Hervouet J.-M., 2007, HYDRODYNAMICS FREE S, V360; HICKIN EJ, 1984, CAN GEOGR-GEOGR CAN, V28, P111, DOI 10.1111/j.1541-0064.1984.tb00779.x; Jang CL, 2007, J HYDRAUL RES, V45, P763, DOI 10.1080/00221686.2007.9521814; Johnson WC, 2000, HYDROL PROCESS, V14, P3051, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;3051::AID-; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Jourdain C, 2020, EARTH SURF PROC LAND, V45, P1100, DOI 10.1002/esp.4776; Khosronejad A, 2012, ADV WATER RESOUR, V37, P73, DOI 10.1016/j.advwatres.2011.09.013; Kim HS, 2019, WATER-SUI, V11, DOI 10.3390/w11112255; Kim HS, 2015, EARTH SURF PROC LAND, V40, P375, DOI 10.1002/esp.3639; Koch F.G., 1980, WATERLOOPKUNDIG LABO; Kondziolka JM., 2014, LIMNOL OCEANOGR FLUI, V4, P106, DOI [DOI 10.1215/21573689-2846314, 10.1215/21573689-2846314]; Kui L, 2016, FOREST ECOL MANAG, V366, P32, DOI 10.1016/j.foreco.2016.02.001; Le Bouteiller C, 2014, GEOPHYS RES LETT, V41, P3876, DOI 10.1002/2014GL060155; Leu JM, 2008, ADV WATER RESOUR, V31, P1299, DOI 10.1016/j.advwatres.2008.06.001; Li J., 2020, ONLINE P PAPERS SUBM, P2; Li WQ, 2019, J HYDRODYN, V31, P1052, DOI 10.1007/s42241-018-0086-6; Mahoney JM, 1998, WETLANDS, V18, P634, DOI 10.1007/BF03161678; Marsooli R, 2014, ADV WATER RESOUR, V74, P245, DOI 10.1016/j.advwatres.2014.09.012; Meron E, 2019, PHYS TODAY, V72, P30, DOI 10.1063/PT.3.4340; Murphy E, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005229; Nagata N, 2005, J HYDRAUL ENG, V131, P1074, DOI 10.1061/(ASCE)0733-9429(2005)131:12(1074); Nagata N, 2000, J HYDRAUL ENG-ASCE, V126, P243, DOI 10.1061/(ASCE)0733-9429(2000)126:4(243); Nepf HM, 1999, WATER RESOUR RES, V35, P479, DOI 10.1029/1998WR900069; Nepf HM, 2000, J GEOPHYS RES-OCEANS, V105, P28547, DOI 10.1029/2000JC900145; Nikuradse J, 1937, NACATM1292; Rominger JT, 2010, J HYDRAUL ENG, V136, P994, DOI 10.1061/(ASCE)HY.1943-7900.0000215; Schwarz C, 2018, NAT GEOSCI, V11, P672, DOI 10.1038/s41561-018-0180-y; Shimizu Y, 2020, EARTH SURF PROC LAND, V45, P11, DOI 10.1002/esp.4653; Stone BM, 2002, J HYDRAUL ENG-ASCE, V128, P500, DOI 10.1061/(ASCE)0733-9429(2002)128:5(500); Swartenbroekx C, 2010, J HYDRAUL RES, V48, P302, DOI 10.1080/00221686.2010.481856; Tal M, 2010, EARTH SURF PROC LAND, V35, P1014, DOI 10.1002/esp.1908; TALMON AM, 1995, J HYDRAUL RES, V33, P495, DOI 10.1080/00221689509498657; Tsujimoto T, 1999, J HYDRAUL RES, V37, P789, DOI 10.1080/00221689909498512; van Dijk WM, 2013, WATER RESOUR RES, V49, P7558, DOI 10.1002/2013WR013574; VANBENDEGOM L, 1947, INGENIEUR, V59, pB1; VANRIJN LC, 1984, J HYDRAUL ENG-ASCE, V110, P1733, DOI 10.1061/(ASCE)0733-9429(1984)110:12(1733); Vargas-Luna A, 2019, J GEOPHYS RES-EARTH, V124, P1981, DOI 10.1029/2018JF004878; Vargas-Luna A, 2019, J HYDRAUL RES, V57, P51, DOI 10.1080/00221686.2018.1434836; Wintenberger CL, 2019, WETLANDS, V39, P275, DOI 10.1007/s13157-018-1121-7; Wu WM, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003730; Xu ZX, 2020, ENVIRON FLUID MECH, V20, P707, DOI 10.1007/s10652-019-09718-5; Zhang ML, 2013, APPL MATH MODEL, V37, P540, DOI 10.1016/j.apm.2012.02.049; Zhou Y., 2018, J WATER RESOURCE PRO, V10, P441, DOI [10.4236/jwarp.2018.104024, DOI 10.4236/JWARP.2018.104024]; Zong LJ, 2012, J FLUID MECH, V691, P368, DOI 10.1017/jfm.2011.479; Zong LJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009516	74	0	0	3	3	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9003	2169-9011		J GEOPHYS RES-EARTH	J. Geophys. Res.-Earth Surf.	MAY	2022	127	5							e2021JF006529	10.1029/2021JF006529	http://dx.doi.org/10.1029/2021JF006529			20	Geosciences, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Geology	1J9YJ					2022-09-04	WOS:000798266800001
J	Fernandez, N; Florez-Valencia, L; Prada, JG; Chua, M; Villanueva, C				Fernandez, Nicolas; Florez-Valencia, Leonardo; Prada, Juan Guillermo; Chua, Michael; Villanueva, Carlos			Standardization of penile angle estimation with a semi-automated algorithm	JOURNAL OF PEDIATRIC UROLOGY			English	Article						Hypospadias; Geometry; Penile curvature; Chordee	HYPOSPADIAS REPAIR; CURVATURE; QUANTIFICATION; SEGMENTATION	Introduction Penile curvature (PC) refers to an abnormal bending of the main longitudinal axis of the penis. It is frequently associated to hypospadias. To date, accurate and objective evaluation of PC is not easily reproducible amongst surgeons and there are no stablished protocols on how to measure PC in a standard way and in real-time to guide intraoperative decision making. For this reason, we want to present the results of creating a semi automated algorithm to establish a reproducible and objective assessment of PC and propose it as a standard protocol for clinical applicability using inanimate 3-D penile models. Methods This project consisted in two different phases. 1. Creation of an automated algorithm to estimate penile angle based on digital images. 2 Use of the algorithm to estimate penile angle on 3-D models and estimate interrater agreement using the algorithm. The algorithm was created to initially identify the geometrical centerline of the penile model to establish an automated output for angle estimation. 3-D printed penile models with known curvature angles ranging from 10 to 90 degrees were used to test the algorithm (total of 9 penile models. These models were curved at one hinge as opposed to an arc type model. For each inanimate model, a set of 5 pictures were obtained from a lateral view at different camera angles (00, 150, 300, 450 and 600) at a standard distance of 75 cm. Angle estimation using our designed PC algorithm was performed by a total of 10 different evaluators. Inter-rater reliability analysis in using the semiautomated algorithm was performed using the inter-class correlation coefficient (ICC) with two-way mixed effect model. Results If the camera angle was greater than 30 degrees, the absolute angle mean difference was greater than 10 degrees. Camera angle with the smallest mean difference was at 00 with a mean difference of 7.83 degrees. Agreement between raters showed greater variability towards the higher camera angles. Nonetheless, a high degree of between evaluator reliability was found between the measurements at different camera angles. Single measures ICC ranges from .873 to .946, p-values were all <.0001. Conclusion Our results help standardize PC assessment using digital images and reduce subjectivity using an algorithm for PC estimation. Optimal camera position between 00 to 300 vertical from the penis gives the least variable and most accurate angle estimation. Future studies using algorithms will help define predictive PC cutoff values and evaluate postoperative outcomes. [GRAPHICS] .	[Fernandez, Nicolas] Univ Washington, Seattle Childrens Hosp, Div Urol, Seattle, WA 98195 USA; [Florez-Valencia, Leonardo] Pontificia Univ Javeriana, Fac Ingn, Dept Ingn Sistemas, Bogota, Colombia; [Prada, Juan Guillermo] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Urol, Bogota, Colombia; [Chua, Michael] Univ Toronto, Hosp Sick Children, Div Urol, Toronto, ON, Canada; [Villanueva, Carlos] Phoenix Childrens Hosp, Phoenix, AZ USA		Fernandez, N (corresponding author), Seattle Childrens Hosp, 4800 Sand Point Way NE, Seattle, WA 98105 USA.; Fernandez, N (corresponding author), Univ Washington, 4800 Sand Point Way NE, Seattle, WA 98105 USA.	nicolas.fernandez@seat-tlechildrens.org	Flórez-Valencia, Leonardo/GPP-1063-2022; Flórez-Valencia, Leonardo/ABD-2236-2021	Flórez-Valencia, Leonardo/0000-0002-3146-2262				Andersson M, 2020, J PEDIATR UROL, V16, DOI 10.1016/j.jpurol.2020.07.005; Blecher GA, 2019, INT J IMPOT RES, V31, P444, DOI 10.1038/s41443-019-0135-x; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [10.1007/BF01386390, DOI 10.1007/BF01386390]; Fernandez N, 2019, FRONT SURG, V6, DOI 10.3389/fsurg.2019.00009; Florez-Valencia L, 2006, IEEE IMAGE PROC, P2441, DOI 10.1109/ICIP.2006.312770; Frenet F., 1847, J MATH PURE APPL, V17, P1; Gittes R F, 1974, Urology, V4, P473, DOI 10.1016/0090-4295(74)90025-9; KAPLAN GW, 1975, J UROLOGY, V114, P769, DOI 10.1016/S0022-5347(17)67140-4; Kirisli HA, 2013, MED IMAGE ANAL, V17, P859, DOI 10.1016/j.media.2013.05.007; Koo TK, 2017, J CHIROPR MED, V16, P346, DOI 10.1016/j.jcm.2017.10.001; Makovey I, 2012, CURR UROL REP, V13, P290, DOI 10.1007/s11934-012-0257-x; Montag S, 2011, THESCIENTIFICWORLDJO, V11, P1470, DOI 10.1100/tsw.2011.136; Nascimento B, 2018, J SEX MED, V15, P1638, DOI 10.1016/j.jsxm.2018.08.017; Pfistermuller KLM, 2015, J PEDIATR UROL, V11, P54, DOI 10.1016/j.jpurol.2014.12.006; Salle JLP, 2016, J PEDIATR UROL, V12, DOI 10.1016/j.jpurol.2015.06.011; Schlomer B, 2014, J PEDIATR UROL, V10, P672, DOI 10.1016/j.jpurol.2014.01.024; Schlomer BJ, 2017, CURR UROL REP, V18, DOI 10.1007/s11934-017-0659-x; Snodgrass W, 2017, J UROLOGY, V198, P680, DOI 10.1016/j.juro.2017.04.019; Snodgrass WT, 2008, CURR OPIN UROL, V18, P431, DOI 10.1097/MOU.0b013e32830056d0; Sozubir S, 2003, J PEDIATR SURG, V38, P1157, DOI 10.1016/S0022-3468(03)00261-6; Spinoit AF, 2013, J UROLOGY, V189, P2276, DOI 10.1016/j.juro.2012.12.100; Villanueva CA, 2020, J PEDIATR UROL, V16, DOI 10.1016/j.jpurol.2020.04.027; Villanueva CA, 2019, J PEDIATR UROL, V15, P628, DOI 10.1016/j.jpurol.2019.09.020; Weber DM, 2008, J UROLOGY, V180, P1080, DOI 10.1016/j.juro.2008.05.060	25	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1477-5131	1873-4898		J PEDIATR UROL	J. Pediatr. Urol	APR	2021	17	2								10.1016/j.jpurol.2021.01.006	http://dx.doi.org/10.1016/j.jpurol.2021.01.006		APR 2021	6	Pediatrics; Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Urology & Nephrology	RQ7OS	33551367				2022-09-04	WOS:000642604700038
J	De la Hoz-Restrepo, F; Alvis-Zakzuk, NJ; De la Hoz-Gomez, JF; De la Hoz, A; Del Corral, LG; Alvis-Guzman, N				De la Hoz-Restrepo, Fernando; Alvis-Zakzuk, Nelson J.; Fernando De la Hoz-Gomez, Juan; De la Hoz, Alejandro; Gomez Del Corral, Luz; Alvis-Guzman, Nelson			Is Colombia an example of successful containment of the 2020 COVID-19 pandemic? A critical analysis of the epidemiological data, March to July 2020	INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES			English	Article						SARS-Cov-2; COVID-19; Epidemiology; Colombia; Pandemic; Lockdown		Background: Colombia detected its first coronavirus disease 2019 (COVID-19) case on March 2, 2020. From March 22 to April 25, it implemented a national lockdown that, apparently, allowed the country to keep a low incidence and mortality rate up to mid-May. Forced by the economic losses, the government then opened many commercial activities, which was followed by an increase in cases and deaths. This paper presents a critical analysis of the Colombian surveillance data in order to identify strengths and pitfalls of the control measures. Methods: A descriptive analysis of PCR-confirmed cases between March and July 25 was performed. Data were described according to the level of measurement. Incidence and mortality rates of COVID-19 were estimated by age, sex, and geographical area. Sampling rates for suspected cases were estimated by geographical area, and the potential for case underestimation was assessed using sampling differences. Results: By July 25, Colombia (population 50 372 424) had reported 240 745 cases and 8269 deaths (case fatality rate of 3.4%). A total of 1 370 271 samples had been analyzed (27 405 samples per million people), with a positivity rate of 17%. Sampling rates per million varied by region from 2664 to 158 681 per million, and consequently the incidence and mortality rates also varied. Due to geographical variations in surveillance capacity, Colombia may have overlooked up to 82% of the actual cases. Conclusion: Colombia has a lower case and mortality incidence compared to other South American countries. This may be an effect of the lockdown, but may also be attributed, to some extent, to geographical differences in surveillance capacity. Indigenous populations with little health infrastructure have been hit the hardest. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.	[De la Hoz-Restrepo, Fernando] Univ Nacl Colombia, Dept Publ Hlth, Carrera 10 93-51 Apto 505, Bogota, DC, Colombia; [Alvis-Zakzuk, Nelson J.] Univ Costa CUC, Dept Econ Sci, Calle 58 55-66, Barranquilla, Colombia; [Alvis-Zakzuk, Nelson J.; Alvis-Guzman, Nelson] ALZAK Fdn, Dept Hlth Technol Assessment, Crespo Calle 67 5-44 Edificio Costa Marfil 101, Cartagena, Colombia; [Fernando De la Hoz-Gomez, Juan] Univ Calif Los Angeles, Bioinformat Interdept Program, 621 Charles E Young Dr S, Los Angeles, CA 90024 USA; [De la Hoz, Alejandro] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Grp Invest Enfermedades Infecciosas, Carrera 7 40-62, Bogota, DC, Colombia; [Alvis-Guzman, Nelson] Univ Cartagena, Dept Econ Sci, Ave Consulado,Calle 30 39 B-192, Cartagena, Colombia		Alvis-Zakzuk, NJ (corresponding author), Univ Costa CUC, Calle 58 55-66, Barranquilla, Colombia.	nalvis1@cuc.edu.co	Alvis-Guzman, Nelson/D-4913-2013; Zakzuk, Nelson J. Alvis/AAV-3171-2021	Alvis-Guzman, Nelson/0000-0001-9458-864X; 				Amariles P, 2020, RES SOC ADM PHARM; Asociacion Colombiana de Hospitales y Clinicas, 2019, SIG AUM DEUD HOSP CL; Cagnacci A, 2020, AM J OBSTET GYNECOL, V223, P453, DOI 10.1016/j.ajog.2020.05.039; Castellanos J, 2020, INFECTIO, V24; Chen T, 2019, BMJ, V2020, P368; Cotes K, 2012, REV SALUD PUBLICA, V14; Departamento Administrativo Nacional de Estadistica, 2018, CENS NAC POBL VIV; Dintrans PV, 2021, J GERONTOL B-PSYCHOL, V76, pE275, DOI 10.1093/geronb/gbaa092; Gomez-Marin Jorge E., 2020, Infect., V24, P1, DOI 10.22354/in.v24i3.896; Hasell J, CORONAVIRUS COVID 19, P19; IHME, COVID 19 PROJ; Immovilli P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02957-9; Instituto Nacional de Salud, 2020, MOD TRANSM COR COVID; Instituto Nacional de Salud, 2020, COR COL; Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1; Kennedy DM, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104440; Ministerio de Salud y Proteccion Social, 2018, COMP AS; Pan American Health Organization, CUM SUSP CONF COVID; Perez-Brumer A, 2020, AIDS BEHAV, V24, P2477, DOI 10.1007/s10461-020-02889-z; Ramirez AP, 2009, REV PANAM SALUD PUBL, V26, P435, DOI 10.1590/S1020-49892009001100008; Pung R, 2020, LANCET, V395, P1039, DOI 10.1016/S0140-6736(20)30528-6; Tiempo El, 2020, ELTIEMPO; World Health Organization, ROLL UPD COR DIS COV; World Health Organization, WHO COR DIS COVID 19; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	25	18	21	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1201-9712	1878-3511		INT J INFECT DIS	Int. J. Infect. Dis.	OCT	2020	99						522	529		10.1016/j.ijid.2020.08.017	http://dx.doi.org/10.1016/j.ijid.2020.08.017			8	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	OH1IP	32791206	Green Published, gold			2022-09-04	WOS:000582325600099
J	Lopes, RI; Fernandez, N; Koyle, MA; dos Santos, J; Perez, J; Romao, R; Lorenzo, AJ				Lopes, Roberto Iglesias; Fernandez, Nicolas; Koyle, Martin A.; dos Santos, Joana; Perez, Jaime; Romao, Rodrigo; Lorenzo, Armando J.			Clinical Outcomes of the Upper Urinary Tract after Ureteral Clipping for Treatment of Low Functioning or Nonfunctioning Renal Moieties	JOURNAL OF UROLOGY			English	Article						hydronephrosis; ureterocele; ureter; laparoscopy; minimally invasive surgical procedures	LAPAROSCOPIC HEMINEPHRECTOMY; DUPLEX KIDNEY; NATIVE URETER; TRANSPLANTATION; LIGATION; CHILDREN; URETEROURETEROSTOMY; INCONTINENCE; NEPHRECTOMY; EXPERIENCE	Purpose: A growing body of evidence suggests that it is safe to ligate the ureter of poorly functioning renal moieties during renal transplantation. We present clinical outcomes and data on hydronephrosis progression in pediatric cases associated with ectopic ureters and obstructive ureteroceles. Materials and Methods: We prospectively collected data for 35 consecutive patients (23 females and 12 males) who underwent ureteral clipping between February 2011 and August 2016. Patients were divided into 4 groups consisting of 1) duplex system with ectopic ureter (45.7%), 2) duplex system with a large ureterocele (11.4%), 3) other duplex system (8.6%) and 4) single system kidneys (34.3%). Patients were followed for clinical outcomes and hydronephrosis trends. Comparisons included preoperative and postoperative anteroposterior diameter, maximal ureteral diameter and ureterocele size. Results: Median age at surgery was 59 months (IQR 11 to 120, range 5 to 216). Median +/- SD operative time was 108.9 +/- 31.1 minutes (range 20 to 180) and median length of stay was 7.5 hours (IQR 6 to 19, range 5 to 336). Immediate resolution of urinary incontinence was observed in all 16 ectopic ureter cases. After a median +/- SD followup of 20.8 +/- 13.8 months (IQR 8.5 to 30, range 6 to 50) 97.2% of the patients remained asymptomatic. No significant differences were observed between initial and last anteroposterior diameter measurements except in group 1 (p = 0.001). All ureteroceles demonstrated a significant decrease in median +/- SD size after clipping (from 2.7 +/- 0.41 to 0.53 +/- 0.92 cm, p = 0.003). Pyonephrosis developed in 1 patient, who underwent laparoscopic nephrectomy. Conclusions: Ureteral clipping appears to be a reasonable, safe and effective option for pediatric patients in the reported settings, with the potential to be simpler and quicker than extirpative or reconstructive procedures.	[Lopes, Roberto Iglesias; Fernandez, Nicolas; Koyle, Martin A.; dos Santos, Joana; Lorenzo, Armando J.] Univ Toronto, Hosp Sick Children, Div Urol, Toronto, ON, Canada; [Lopes, Roberto Iglesias; Fernandez, Nicolas; Koyle, Martin A.; dos Santos, Joana; Lorenzo, Armando J.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Romao, Rodrigo] IWK Hlth Ctr, Div Urol, Halifax, NS, Canada; [Romao, Rodrigo] Dalhousie Univ, Halifax, NS, Canada; [Lopes, Roberto Iglesias] Univ Sao Paulo, Med Sch, Hosp Clin, Div Urol, Sao Paulo, Brazil; [Fernandez, Nicolas; Perez, Jaime] Pontificia Univ Javeriana, Div Urol, Bogota, Colombia; [Fernandez, Nicolas; Perez, Jaime] Hosp Univ San Ignacio, Bogota, Colombia		Lorenzo, AJ (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	armando.lorenzo@sickkids.ca		Perez Nino, Jaime/0000-0002-2231-4321				Byun E, 2006, J UROLOGY, V176, P1871, DOI 10.1016/S0022-5347(06)00601-X; Cabezali D, 2013, J ENDOUROL, V27, P133, DOI 10.1089/end.2012.0379; Chacko JK, 2007, J UROLOGY, V178, P1689, DOI 10.1016/j.juro.2007.05.098; Gallentine ML, 2002, J UROLOGY, V167, P29, DOI 10.1016/S0022-5347(05)65375-X; Guzman JA, 2012, TRANSPL P, V44, P2940, DOI 10.1016/j.transproceed.2012.03.062; Jayram G, 2011, J PEDIATR UROL, V7, P272, DOI 10.1016/j.jpurol.2011.02.029; Malik RD, 2015, J ENDOUROL, V29, P1346, DOI 10.1089/end.2014.0818; McLeod DJ, 2014, J PEDIATR UROL, V10, P616, DOI 10.1016/j.jpurol.2014.05.003; Michaud JE, 2017, CURR UROL REP, V18, DOI 10.1007/s11934-017-0664-0; Palmer BW, 2011, J UROLOGY, V186, P1700, DOI 10.1016/j.juro.2011.04.007; Romao RLP, 2014, J PEDIATR UROL, V10, P1089, DOI 10.1016/j.jpurol.2014.04.008; Sander JC, 2015, J UROLOGY, V193, P662, DOI 10.1016/j.juro.2014.08.095; Sharifi SHH, 2017, J PEDIATR UROL, V13, P217, DOI 10.1016/j.jpurol.2016.12.006; Timsit MO, 2010, J UROLOGY, V184, P2043, DOI 10.1016/j.juro.2010.06.144; Wallis MC, 2006, J UROLOGY, V175, P2277, DOI 10.1016/S0022-5347(06)00338-7	15	6	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	FEB	2018	199	2					558	564		10.1016/j.juro.2017.09.080	http://dx.doi.org/10.1016/j.juro.2017.09.080			7	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	FS2BA	28943272				2022-09-04	WOS:000419581800100
J	Baez, S; Santamaria-Garcia, H; Orozco, J; Fittipaldi, S; Garcia, AM; Pino, M; Ibanez, A				Baez, Sandra; Santamaria-Garcia, Hernando; Orozco, Janni; Fittipaldi, Sol; Garcia, Adolfo M.; Pino, Mariana; Ibanez, Agustin			Your misery is no longer my pleasure: Reduced schadenfreude in Huntington's disease families	CORTEX			English	Article						Huntington's disease; First-degree asymptomatic relatives; Schadenfreude; Envy; Social emotions	VOXEL-BASED MORPHOMETRY; FRONTOTEMPORAL DEMENTIA; BASAL GANGLIA; SOCIAL COGNITION; EMOTION RECOGNITION; BEHAVIORAL VARIANT; ENVY; ADULTS; BRAIN; RISK	Schadenfreude - pleasure at others' misfortunes - has been systematically related to ventral striatum activity. This brain region is affected early in individuals with manifest and pre-manifest Huntington's disease (HD). However, the experience of schadenfreude has not yet been investigated in HD. In this study, 21 manifest HD patients, 19 first-degree asymptomatic relatives, and 23 healthy controls performed an experimental task designed to trigger schadenfreude, envy (another social emotion acting as an affective control condition), and control situations.. Both HD patients and first-degree relatives experienced lower schadenfreude in response to others' misfortunes, with no group differences in ratings of envy and control conditions. These results offer unprecedented evidence of a highly specific impairment in reward processing, extending previous reports in manifest and pre-manifest HD individuals. Moreover, these findings suggest that early striatal impairments may be related to reduced feelings of schadenfreude. In sum, our work contributes to the understanding of emotional impairments in early stages of HD, while shedding light on their neural correlates. (C) 2016 Elsevier Ltd. All rights reserved.	[Baez, Sandra; Santamaria-Garcia, Hernando; Fittipaldi, Sol; Garcia, Adolfo M.; Ibanez, Agustin] Favaloro Univ, Lab Expt Psychol & Neurosci LPEN, INECO Fdn, Inst Cognit & Translat Neurosci INCyT, Buenos Aires, DF, Argentina; [Baez, Sandra; Santamaria-Garcia, Hernando] Grp Invest Cerebro & Cogn Social, Bogota, Colombia; [Santamaria-Garcia, Hernando] Pontificia Univ Javeriana, Bogota, Colombia; [Garcia, Adolfo M.] Natl Univ Cuyo UNCuyo, Fac Elementary & Special Educ FEEyE, Mendoza, Argentina; [Orozco, Janni; Pino, Mariana; Ibanez, Agustin] Univ Autonoma Caribe, Barranquilla, Colombia; [Ibanez, Agustin] Univ Adolfo Ibanez, Sch Psychol, Ctr Social & Cognit Neurosci, Santiago, Chile; [Ibanez, Agustin] Australian Res Council Ctr Excellence Cognit & It, Sydney, NSW, Australia		Ibanez, A (corresponding author), Inst Cognit & Translat Neurosci INCyT, Pacheco de Melo 1860, RA-1126 Buenos Aires, DF, Argentina.; Ibanez, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Pacheco de Melo 1860, RA-1126 Buenos Aires, DF, Argentina.	aibanez@ineco.org.ar	García, Adolfo/E-7150-2017; Ibanez, Agustin/H-7976-2015	García, Adolfo/0000-0002-6936-0114; Ibanez, Agustin/0000-0001-6758-5101; Santamaria Garcia, Hernando/0000-0001-9422-3579; Baez, Sandra/0000-0003-0875-1709	CONICET; CONICYT/FONDECYT Regular [1130920]; INECO Foundation; FONCyT-PICT [2012-0412, 2012-1309]; FONDAP [15150012]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICYT/FONDECYT Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); INECO Foundation; FONCyT-PICT(ANPCyTFONCyT); FONDAP	This work was partially supported by grants from CONICET, CONICYT/FONDECYT Regular (1130920), FONCyT-PICT 2012-0412, FONCyT-PICT 2012-1309, FONDAP 15150012 and the INECO Foundation.	Aviezer H, 2009, BRAIN, V132, P1633, DOI 10.1093/brain/awp067; AYLWARD EH, 1994, NEUROLOGY, V44, P823, DOI 10.1212/WNL.44.5.823; Baez S, 2016, NEURODEGENER DIS, V16, P206, DOI 10.1159/000441918; Baez S, 2016, CORTEX, V75, P20, DOI 10.1016/j.cortex.2015.11.007; Baez S, 2015, NEUROPSYCHOLOGIA, V68, P158, DOI 10.1016/j.neuropsychologia.2015.01.012; Baez S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00262; Baez S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00270; Baez S, 2014, PSYCHIAT RES, V216, P269, DOI 10.1016/j.psychres.2014.01.020; Baez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057664; Baez S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00302; Bault N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003477; Cikara M, 2013, ANN NY ACAD SCI, V1299, P52, DOI 10.1111/nyas.12179; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; Coricelli G, 2010, PHILOS T R SOC B, V365, P241, DOI 10.1098/rstb.2009.0159; Della Nave R, 2010, AM J NEURORADIOL, V31, P1675, DOI 10.3174/ajnr.A2128; Dorsey ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029522; Dvash J, 2010, HUM BRAIN MAPP, V31, P1741, DOI 10.1002/hbm.20972; Enzi B, 2012, EXP NEUROL, V235, P256, DOI 10.1016/j.expneurol.2012.02.003; Garcia A. M., 2016, CURRENT TOPICS BEHAV; GIORDANI B, 1995, ARCH NEUROL-CHICAGO, V52, P59, DOI 10.1001/archneur.1995.00540250063014; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/10628-000; Hennenlotter A, 2004, BRAIN, V127, P1446, DOI 10.1093/brain/awh165; Ibanez A, 2014, WORLD PSYCHIATRY, V13, P148, DOI 10.1002/wps.20125; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ille R, 2011, J PSYCHIATR NEUROSCI, V36, P383, DOI 10.1503/jpn.100143; Joel D, 2001, MOVEMENT DISORD, V16, P407, DOI 10.1002/mds.1096; Kargieman L, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00122; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; Kipps CM, 2007, J COGNITIVE NEUROSCI, V19, P1206, DOI 10.1162/jocn.2007.19.7.1206; Lawrence AD, 1996, BRAIN, V119, P1633, DOI 10.1093/brain/119.5.1633; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; Longworth CE, 2005, BRAIN, V128, P584, DOI 10.1093/brain/awh387; Markianos M, 2008, MOL GENET METAB, V93, P341, DOI 10.1016/j.ymgme.2007.10.002; MAZZIOTTA JC, 1987, NEW ENGL J MED, V316, P357, DOI 10.1056/NEJM198702123160701; Muhlau M, 2007, J NEURAL TRANSM, V114, P367, DOI 10.1007/s00702-006-0571-x; MYERS RH, 1988, NEUROLOGY, V38, P341, DOI 10.1212/WNL.38.3.341; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nopoulos PC, 2010, NEUROBIOL DIS, V40, P544, DOI 10.1016/j.nbd.2010.07.014; Panegyres PK, 2011, J NEUROL SCI, V301, P14, DOI 10.1016/j.jns.2010.11.015; Paulsen JS, 2006, ARCH NEUROL-CHICAGO, V63, P883, DOI 10.1001/archneur.63.6.883; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Renoir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022133; Sedeno L, 2016, J INT NEUROPSYCH SOC, V22, P250, DOI 10.1017/S1355617715000703; Siesling S, 1998, MOVEMENT DISORD, V13, P915, DOI 10.1002/mds.870130609; Solca F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126773; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; THOMPSON PD, 1988, BRAIN, V111, P223, DOI 10.1093/brain/111.2.223; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; Uekermann J, 2010, NEUROSCI BIOBEHAV R, V34, P734, DOI 10.1016/j.neubiorev.2009.10.009; Unschuld PG, 2012, NEUROSCI LETT, V514, P204, DOI 10.1016/j.neulet.2012.02.095; van de Ven N, 2015, COGNITION EMOTION, V29, P954, DOI 10.1080/02699931.2014.957657; van Dijk WW, 2006, EMOTION, V6, P156, DOI 10.1037/1528-3542.6.1.156; Verny C, 2007, EUR J NEUROL, V14, P1344, DOI 10.1111/j.1468-1331.2007.01975.x; Wahlin TBR, 2000, ACTA NEUROL SCAND, V102, P150, DOI 10.1034/j.1600-0404.2000.102003150.x; Weeks RA, 1996, ANN NEUROL, V40, P49, DOI 10.1002/ana.410400110; Weir DW, 2011, LANCET NEUROL, V10, P573, DOI 10.1016/S1474-4422(11)70070-9; Wolf RC, 2008, EUR J NEUROL, V15, P1180, DOI 10.1111/j.1468-1331.2008.02253.x	58	21	23	0	13	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	OCT	2016	83						78	85		10.1016/j.cortex.2016.07.009	http://dx.doi.org/10.1016/j.cortex.2016.07.009			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	DZ1LG	27498039	Green Published			2022-09-04	WOS:000385599300007
J	Serrano-Gomez, SJ; Sanabria, MC; Hernandez-Suarez, GA; Garcia, O; Silva, C; Romero, A; Mejia, JC; Fejerman, L; Antonia, T; Miele, L; Zabaleta, J				Serrano-Gomez, S. J.; Sanabria, M. C.; Hernandez-Suarez, G. A.; Garcia, O.; Silva, C.; Romero, A.; Mejia, J. C.; Fejerman, L.; Antonia, T.; Miele, L.; Zabaleta, J.			Increased prevalence of luminal B subtype in Colombian women with breast cancer	CANCER RESEARCH			English	Meeting Abstract	38th Annual CTRC-AACR San Antonio Breast Cancer Symposium	DEC 08-12, 2015	San Antonio, TX	Canc Therapy Res Ctr, Amer Assoc Canc Res					Inst Nacl Cancerol, Bogota, Cundinamarca, Colombia; Pontificia Univ Javeriana, Bogota, Cundinamarca, Colombia; Stanley S Scott Canc Ctr, New Orleans, LA USA; UCSF, San Francisco, CA USA; Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; Dept Genet, New Orleans, LA USA; Dept Pediat, New Orleans, LA USA										0	0	0	0	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	FEB 15	2016	76			4		P1-08-09				10.1158/1538-7445.SABCS15-P1-08-09	http://dx.doi.org/10.1158/1538-7445.SABCS15-P1-08-09			2	Oncology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Oncology	DL4QN					2022-09-04	WOS:000375622402294
J	Kokilashvili, V; Meskhi, A; Rafeiro, H				Kokilashvili, Vakhtang; Meskhi, Alexander; Rafeiro, Humberto			Riesz type potential operators in generalized grand Morrey spaces	GEORGIAN MATHEMATICAL JOURNAL			English	Article						Morrey spaces; Hardy-Littlewood maximal operator; Calderon-Zygmund operator; potentials	SMALL LEBESGUE SPACES; MAXIMAL FUNCTIONS	We introduce generalized grand Money spaces in the framework of quasimetric measure spaces, in the spirit of the so-called grand Lebesgue spaces. We prove a kind of reduction lemma which is applicable to a variety of operators to reduce their boundedness in generalized grand Money spaces to the corresponding boundedness in Money spaces. As a result of this application, we obtain the boundedness of the Hardy-Littlewood maximal operator as well as the boundedness of Calderon-Zygmund operators. The boundedness of Riesz type potential operators is also obtained in the framework of homogeneous and also in the nonhomogeneous cases in generalized grand Money spaces.	[Kokilashvili, Vakhtang; Meskhi, Alexander] I Javakhishvili Tbilisi State Univ, Dept Math Anal, GE-0186 Tbilisi, Georgia; [Meskhi, Alexander] Int Black Sea Univ, GE-0131 Tbilisi, Georgia; [Meskhi, Alexander] Georgian Tech Univ, Dept Math, GE-0175 Tbilisi, Georgia; [Meskhi, Alexander] Govt Coll Univ, Abdus Salam Sch Math Sci, Lahore, Pakistan; [Rafeiro, Humberto] Pontificia Univ Javeriana, Dept Matemat, Bogota, Colombia; [Rafeiro, Humberto] Inst Super Tecn, Dept Matemat, Centro CEAF, P-1049001 Lisbon, Portugal		Kokilashvili, V (corresponding author), I Javakhishvili Tbilisi State Univ, Dept Math Anal, 2 Univ St, GE-0186 Tbilisi, Georgia.	kokil@rmi.ge; meskhi@rmi.ge; silva-h@javeriana.edu.co	Meskhi, Alexander/ACT-3186-2022; Rafeiro, Humberto/AAK-4908-2020	Rafeiro, Humberto/0000-0002-5304-8572	Shota Rustaveli National Science Foundation [D/13-23]; FCT Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/63085/2009]; Pontificia Universidad Javeriana [5453]	Shota Rustaveli National Science Foundation; FCT Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Pontificia Universidad Javeriana	The first and second author were partially supported by the Shota Rustaveli National Science Foundation Grant (Contract No. D/13-23). The third author was partially supported by FCT Fundacao para a Ciencia e a Tecnologia (Grant SFRH/BPD/63085/2009), Portugal and by Pontificia Universidad Javeriana under the research project ID 5453.	Capone C., 2005, J FUNCT SPACES APPL, V3, P73, DOI [10.1155/2005/192538, DOI 10.1155/2005/192538]; Coifman R. R., 1971, ETUDE CERTAINES INTE, V242; Di Fratta G, 2009, NONLINEAR ANAL-THEOR, V70, P2582, DOI 10.1016/j.na.2008.03.044; Duoandikoetxea Zuazo J., 2001, AM MATH SOC, V29; Edmunds D. E., 2002, MATH APPL, V543; Fiorenza A, 2004, Z ANAL ANWEND, V23, P657; Fiorenza A, 2002, CR MATH, V334, P23, DOI 10.1016/S1631-073X(02)02199-4; Fiorenza A., 2000, COLLECT MATH, V51, P131; Fiorenza A, 2008, STUD MATH, V188, P123, DOI 10.4064/sm188-2-2; GIAQUINTA M, 1983, ANN MATH STUD, V105; Greco L, 1997, MANUSCRIPTA MATH, V92, P249, DOI 10.1007/BF02678192; IWANIEC T, 1992, ARCH RATION MECH AN, V119, P129, DOI 10.1007/BF00375119; John O., 1977, FUNCTION SPACES; KOKILASHVILI V, 1990, TEUB TEXT M, V119, P86; Kokilashvili V., 2010, LECT COURS SUMM SCH; Kokilashvili V., 2008, B GEORGIAN NATL ACAD, V2, P18; Kokilashvili V, 2010, COMPLEX VAR ELLIPTIC, V55, P923, DOI 10.1080/17476930903276068; Liflyand E, 2010, TURK J MATH, V34, P207, DOI 10.3906/mat-0812-8; Meskhi A., 2009, P A RAZMADZE MATH I, V151, P139; Meskhi A, 2011, COMPLEX VAR ELLIPTIC, V56, P1003, DOI 10.1080/17476933.2010.534793; Morrey CB, 1938, T AM MATH SOC, V43, P126, DOI 10.2307/1989904; Rafeiro H., 2013, OPERATOR THEORY ADV, V228, P293; Rafeiro H., 2013, OPER THEORY ADV APPL, V229, P343; Samko SG, 2011, AZERBAIJAN J MATH, V1, P67; Sawano Y, 2005, ACTA MATH SIN, V21, P1535, DOI 10.1007/s10114-005-0660-z; [叶晓峰 Ye Xiaofeng], 2011, [数学学报, Acta Mathematica Sinica], V54, P343	26	21	22	0	5	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1072-947X	1572-9176		GEORGIAN MATH J	Georgian Math. J.		2013	20	1					43	64		10.1515/gmj-2013-0009	http://dx.doi.org/10.1515/gmj-2013-0009			22	Mathematics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	130SO		Green Submitted			2022-09-04	WOS:000317940500003
J	Soria-Auza, RW; Kessler, M; Bach, K; Barajas-Barbosa, PM; Lehnert, M; Herzog, SK; Bohner, J				Soria-Auza, Rodrigo W.; Kessler, Michael; Bach, Kerstin; Barajas-Barbosa, Paola M.; Lehnert, Marcus; Herzog, Sebastian K.; Boehner, Juergen			Impact of the quality of climate models for modelling species occurrences in countries with poor climatic documentation: a case study from Bolivia	ECOLOGICAL MODELLING			English	Article						Birds; Bolivia; Ecological niche modelling; Ferns; Maxent; Saga; Species modelling; Worldclim	ANDEAN FORESTS; RANGE SIZE; DISTRIBUTIONS; PREDICTION; COMMUNITIES; DIVERSITY; RICHNESS; PATTERNS	The quality of climate models has largely been overlooked as a possible source of uncertainty that may affect the outcomes of species distribution models, especially in the tropics, where comparatively few climatic stations are available. We compared the geographical discrepancies and potential conservation implications of using two different climate models (Saga and Worldclim) in combination with the species modelling approach Maxent in Bolivia. We estimated ranges of selected bird and fern species biogeographically restricted to either humid montane forest of the northern Bolivian Andes or seasonal dry tropical forests (in the Andes and southern lowlands). Saga and Worldclim predicted roughly similar climate patterns of temperature that were significantly correlated. Precipitation layers of both climate models were also roughly similar, but showed important differences. Species ranges estimated with Worldclim and Saga likewise produced different results. Ranges of species endemic to humid montane forests estimated with Saga had higher AUC (Area under the curve) values than those estimated with Worldclim, which for example predicted the occurrence of humid montane forest bird species near Lake Titicaca, an area that is clearly unsuitable for these species. Likewise, Worldclim overpredicted the occurrence of fern and bird species in the lowlands of the Chapare region and well south of the Andean Elbow, where more seasonal biomes occur. By contrast, Saga predictions were coherent with the known distribution of humid montane forests in the northern Bolivian Andes. Estimated ranges of species endemic to seasonal dry tropical forests predicted with Saga and Worldclim were not statistically different in most cases. However, detailed comparisons revealed that Saga was able to distinguish fragments of seasonal dry tropical forests in rain-shadow valleys of the northern Bolivian Andes, whereas Worldclim was not. These differences highlight the neglected influence of climate layers on modelling results and the importance of using the most accurate climate data available when modelling species distributions. (C) 2010 Elsevier B.V. All rights reserved.	[Soria-Auza, Rodrigo W.; Barajas-Barbosa, Paola M.] Univ Gottingen, Fac Forest Sci & Forest Ecol, Biodivers Macroecol & Conservat Biogeog Grp, D-37077 Gottingen, Germany; [Soria-Auza, Rodrigo W.; Herzog, Sebastian K.] Asociac Armonia BirdLife Int, Santa Cruz, Bolivia; [Kessler, Michael] Univ Zurich, Inst Systemat Bot, CH-8008 Zurich, Switzerland; [Bach, Kerstin] Univ Marburg, Fac Geog, D-35032 Marburg, Germany; [Barajas-Barbosa, Paola M.] Pontificia Univ Javeriana, Bogota, Colombia; [Lehnert, Marcus] Staatl Museum Nat Kunde Stuttgart, D-70191 Stuttgart, Germany; [Boehner, Juergen] Univ Hamburg, Inst Geog, D-20146 Hamburg, Germany		Soria-Auza, RW (corresponding author), Univ Gottingen, Fac Forest Sci & Forest Ecol, Biodivers Macroecol & Conservat Biogeog Grp, Busgenweg 2, D-37077 Gottingen, Germany.	wilbersa@daad-alumni.de	Kessler, Michael/A-3605-2009; Lehnert, Marcus/X-5509-2019; Lehnert, Marcus/F-3288-2011; Boehner, Juergen/I-9844-2014	Lehnert, Marcus/0000-0002-7202-7734; Lehnert, Marcus/0000-0002-7202-7734; Boehner, Juergen/0000-0002-0842-0152	German Academic Exchange Service (Deutscher Akademischer Austauschdienst; DAAD); WWFs Russell E. Train Education for Nature program; German Research Foundation (Deutsche Forschungsgemeinschaft; DFG); Nature Conservancy (Bolivia programme); NatureServe; World Wide Fund for Nature (Bolivia office)	German Academic Exchange Service (Deutscher Akademischer Austauschdienst; DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); WWFs Russell E. Train Education for Nature program; German Research Foundation (Deutsche Forschungsgemeinschaft; DFG)(German Research Foundation (DFG)); Nature Conservancy (Bolivia programme); NatureServe; World Wide Fund for Nature (Bolivia office)	We thank all colleagues who have made their raw distributional data available. RWSA and MK thank the German Academic Exchange Service (Deutscher Akademischer Austauschdienst; DAAD), WWFs Russell E. Train Education for Nature program and the German Research Foundation (Deutsche Forschungsgemeinschaft; DFG) for financial support. SKH thanks The Nature Conservancy (Bolivia programme), NatureServe and the World Wide Fund for Nature (Bolivia office) for financial support of Asociacion Armonias distributional bird data base. We are grateful to V. Mass for comments on earlier versions of this manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bahn V, 2007, GLOBAL ECOL BIOGEOGR, V16, P733, DOI 10.1111/j.1466-8238.2007.00331.x; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bohner J, 2005, ARBEITSBERICHTE GEOG, V109, P49; Cumming GS, 2000, J BIOGEOGR, V27, P425, DOI 10.1046/j.1365-2699.2000.00419.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FJELDSA J, 1996, 1 DIVA; Garcia-Moreno J, 1999, MOL PHYLOGENET EVOL, V12, P273, DOI 10.1006/mpev.1999.0617; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Hastenrath S, 1997, J GEOPHYS RES-ATMOS, V102, P4267, DOI 10.1029/96JD03122; HENNESSEY AB, 2003, LISTA ANOTADA SAVES; Hernandez PA, 2008, BIODIVERS CONSERV, V17, P1353, DOI 10.1007/s10531-007-9314-z; Herzog Sebastian K., 2005, Ecología en Bolivia, V40, P27; Herzog SK, 2006, GLOBAL ECOL BIOGEOGR, V15, P163, DOI 10.1111/j.1466-822X.2006.00199.x; Herzog SK, 2002, J ORNITHOL, V143, P171, DOI 10.1046/j.1439-0361.2002.02004.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; HUTCHINSON MF, 1995, INT J GEOGR INF SYST, V9, P385, DOI 10.1080/02693799508902045; Ibisch P.L., 2003, BIODIVERSIDAD RIQUEZ, P47; IBISCH PL, 2003, BIODIVERSIDAD RIQUEZ; Kessler M, 2002, BOT REV, V68, P100, DOI 10.1663/0006-8101(2002)068[0100:EPAECO]2.0.CO;2; Kessler M, 2002, GLOBAL ECOL BIOGEOGR, V11, P89, DOI 10.1046/j.1466-822X.2002.00176.x; Kessler M, 2007, ECOL MODEL, V207, P223, DOI 10.1016/j.ecolmodel.2007.05.001; Killeen TJ, 2007, J BIOGEOGR, V34, P1357, DOI 10.1111/j.1365-2699.2006.01682.x; Linares-Palomino R, 2009, J BIOGEOGR, V36, P280, DOI 10.1111/j.1365-2699.2008.02028.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Maijer S, 1997, IBIS, V139, P607; Navarro G., 2002, GEOGRAFIA ECOLOGICA; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Poyry J, 2008, GLOBAL ECOL BIOGEOGR, V17, P403, DOI 10.1111/j.1466-8238.2007.00373.x; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Ridgely R.S., 1994, BIRDS S AM; Soria-Auza R. W., 2007, Ecologia en Bolivia, V42, P136; Soria-Auza RW, 2008, DIVERS DISTRIB, V14, P123, DOI 10.1111/j.1472-4642.2007.00433.x; Wood JRI, 2006, SYST ASSOC SPEC VOL, P235	49	79	80	1	37	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0304-3800	1872-7026		ECOL MODEL	Ecol. Model.	APR 24	2010	221	8					1221	1229		10.1016/j.ecolmodel.2010.01.004	http://dx.doi.org/10.1016/j.ecolmodel.2010.01.004			9	Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	582DD					2022-09-04	WOS:000276574900014
J	Gomez, C; Arbelaez, P; Navarrete, M; Alvarado-Rojas, C; Le Van Quyen, M; Valderrama, M				Gomez, Catalina; Arbelaez, Pablo; Navarrete, Miguel; Alvarado-Rojas, Catalina; Le Van Quyen, Michel; Valderrama, Mario			Automatic seizure detection based on imaged-EEG signals through fully convolutional networks	SCIENTIFIC REPORTS			English	Article							PREDICTION	Seizure detection is a routine process in epilepsy units requiring manual intervention of well-trained specialists. This process could be extensive, inefficient and time-consuming, especially for long term recordings. We proposed an automatic method to detect epileptic seizures using an imaged-EEG representation of brain signals. To accomplish this, we analyzed EEG signals from two different datasets: the CHB-MIT Scalp EEG database and the EPILEPSIAE project that includes scalp and intracranial recordings. We used fully convolutional neural networks to automatically detect seizures. For our best model, we reached average accuracy and specificity values of 99.3% and 99.6%, respectively, for the CHB-MIT dataset, and corresponding values of 98.0% and 98.3% for the EPILEPSIAE patients. For these patients, the inclusion of intracranial electrodes together with scalp ones increased the average accuracy and specificity values to 99.6% and 58.3%, respectively. Regarding the other metrics, our best model reached average precision of 62.7%, recall of 58.3%, F-measure of 59.0% and AP of 54.5% on the CHB-MIT recordings, and comparatively lowers performances for the EPILEPSIAE dataset. For both databases, the number of false alarms per hour reached values less than 0.5/h for 92% of the CHB-MIT patients and less than 1.0/h for 80% of the EPILEPSIAE patients. Compared to recent studies, our lightweight approach does not need any estimation of pre-selected features and demonstrates high performances with promising possibilities for the introduction of such automatic methods in the clinical practice.	[Gomez, Catalina; Arbelaez, Pablo; Navarrete, Miguel; Valderrama, Mario] Univ Los Andes, Dept Biomed Engn, Bogota, Colombia; [Gomez, Catalina; Arbelaez, Pablo] Univ Los Andes, Ctr Res & Format Artificial Intelligence CINFONIA, Bogota, Colombia; [Navarrete, Miguel] Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff, Wales; [Alvarado-Rojas, Catalina] Pontificia Univ Javeriana, Dept Elect Engn, Bogota, Colombia; [Le Van Quyen, Michel] Sorbonne Univ, LIB, Inserm U1146, UMCR2,UMR7371,CNRS, 15 Rue Ecole Med, F-75006 Paris, France		Valderrama, M (corresponding author), Univ Los Andes, Dept Biomed Engn, Bogota, Colombia.	mvalderr@uniandes.edu.co	Navarrete, Miguel/E-3130-2019; Alvarado-Rojas, Catalina/AAR-8761-2021	Navarrete, Miguel/0000-0002-4903-2156; Valderrama, Mario/0000-0001-8791-6078; Alvarado-Rojas, Catalina/0000-0002-2315-5692; Arbelaez, Pablo/0000-0001-5244-2407				Acharya UR, 2018, COMPUT BIOL MED, V100, P270, DOI 10.1016/j.compbiomed.2017.09.017; Andrzejak RG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061907; Beniczky S, 2018, EPILEPSIA, V59, P9, DOI 10.1111/epi.14049; Birjandtalab J, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI), P552, DOI 10.1109/ICHI.2017.55; Buzsaki G., 2006, RHYTHMS BRAIN, DOI 10.1093/acprof:oso/9780195301069.001.0001; Cecotti H, 2011, IEEE T PATTERN ANAL, V33, P433, DOI 10.1109/TPAMI.2010.125; Cho KO, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56958-y; Gao YY, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00375; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hussein R., 2018, ARXIV PREPRINT ARXIV; Hussein R, 2019, CLIN NEUROPHYSIOL, V130, P25, DOI 10.1016/j.clinph.2018.10.010; Khan H, 2018, IEEE T BIO-MED ENG, V65, P2109, DOI 10.1109/TBME.2017.2785401; Klatt J, 2012, EPILEPSIA, V53, P1669, DOI 10.1111/j.1528-1167.2012.03564.x; Klimes P., 2016, FUNCTIONAL ORG HUMAN; Kwak NS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172578; Liang J, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI), P184, DOI 10.1109/ICHI.2016.27; Long J., 2014, ARXIV14114038; Mestre T, 2009, EXPERT OPIN INV DRUG, V18, P221, DOI [10.1517/13543780802635107, 10.1517/13543780802635107 ]; Michielli N, 2019, COMPUT BIOL MED, V106, P71, DOI 10.1016/j.compbiomed.2019.01.013; Mirowski PW, 2008, MACHINE LEARN SIGN P, P244, DOI 10.1109/MLSP.2008.4685487; Mousavi S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216456; Nagel S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221909; O'Shea A, 2020, NEURAL NETWORKS, V123, P12, DOI 10.1016/j.neunet.2019.11.023; Paul Yash, 2018, Brain Inform, V5, P6, DOI 10.1186/s40708-018-0084-z; Rizhevsky A, 2012, ADV NEURAL INFORM PR, V25, P1097; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Shoeb A, 2010, P 27 INT C MACH LEAR, P975, DOI DOI 10.0RG/PAPERS/; Siddiqui Mohammad Khubeb, 2020, Brain Inform, V7, P5, DOI 10.1186/s40708-020-00105-1; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Supratak A., 2017, IEEE T NEUR SYS REH, V25, P1998, DOI [DOI 10.1109/TNSRE.2017.2721116, 10.1109/TNSRE.2017.2721116]; Thodoroff P, 2016, ARXIV160800220; Thomas J, 2017, IEEE SYS MAN CYBERN, P234, DOI 10.1109/SMC.2017.8122608; Tsiouris KM, 2018, COMPUT BIOL MED, V99, P24, DOI 10.1016/j.compbiomed.2018.05.019; Tzallas A. T, 2012, EPILEPSYHISTOLOGICAL; Ullah I, 2018, EXPERT SYST APPL, V107, P61, DOI 10.1016/j.eswa.2018.04.021; Wei XY, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0693-8; Wei ZC, 2019, BIOMED SIGNAL PROCES, V53, DOI 10.1016/j.bspc.2019.04.028; Wilson SB, 2004, CLIN NEUROPHYSIOL, V115, P2280, DOI 10.1016/j.clinph.2004.05.018; Yildirim O, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040599; Yosinski J, 2014, ADV NEUR IN, V27; Zhou MN, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00095	43	20	20	1	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	DEC 11	2020	10	1							21833	10.1038/s41598-020-78784-3	http://dx.doi.org/10.1038/s41598-020-78784-3			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG7YR	33311533	Green Published, Green Accepted, gold			2022-09-04	WOS:000599947000011
J	Rojas, A; Sepulveda, H; Henriquez, B; Aguilar, R; Opazo, T; Nardocci, G; Bustos, F; Lian, JB; Stein, JL; Stein, GS; van Zundert, B; van Wijnen, AJ; Allende, ML; Montecino, M				Rojas, Adriana; Sepulveda, Hugo; Henriquez, Berta; Aguilar, Rodrigo; Opazo, Tatiana; Nardocci, Gino; Bustos, Fernando; Lian, Jane B.; Stein, Janet L.; Stein, Gary S.; van Zundert, Brigitte; van Wijnen, Andre J.; Allende, Miguel L.; Montecino, Martin			Mll-COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2/p57 in osteoblasts	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						epigenetic control of osteoblast gene transcription; osteoblast differentiation; Runx2	WD-40 REPEAT PROTEIN; LINEAGE COMMITMENT; DIFFERENTIATION; PROMOTERS; FAMILY; WDR5	Expression of Runx2/p57 is a hallmark of the osteoblast-lineage identity. Although several regulators that control the expression of Runx2/p57 during osteoblast-lineage commitment have been identified, the epigenetic mechanisms that sustain this expression in differentiated osteoblasts remain to be completely determined. Here, we assess epigenetic mechanisms associated with Runx2/p57 gene transcription in differentiating MC3T3 mouse osteoblasts. Our results show that an enrichment of activating histone marks at the Runx2/p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5 and Utx proteins, both are components of COMPASS complexes. Knockdown of Wdr5 and Utx expression confirms the activating role of both proteins at the Runx2-P1 promoter. Other chromatin modifiers that were previously described to regulate Runx2/p57 transcription in mesenchymal precursor cells (Ezh2, Prmt5, and Jarid1b proteins) were not found to contribute to Runx2/p57 transcription in full-committed osteoblasts. We also determined the presence of additional components of COMPASS complexes at the Runx2/p57 promoter, evidencing that the Mll2/COMPASS- and Mll3/COMPASS-like complexes bind to the P1 promoter in osteoblastic cells expressing Runx2/p57 to modulate the H3K4me1 to H3K4me3 transition.	[Rojas, Adriana] Pontificia Univ Javeriana, Inst Human Genet, Fac Med, Bogota 110231, Colombia; [Rojas, Adriana; Sepulveda, Hugo; Henriquez, Berta; Aguilar, Rodrigo; Opazo, Tatiana; Nardocci, Gino; Bustos, Fernando; van Zundert, Brigitte; Montecino, Martin] Univ Andres Bello, Inst Biomed Sci, Fac Med, Ave Republ 239, Santiago 8370146, Chile; [Rojas, Adriana; Sepulveda, Hugo; Henriquez, Berta; Aguilar, Rodrigo; Opazo, Tatiana; Nardocci, Gino; Bustos, Fernando; van Zundert, Brigitte; Montecino, Martin] Univ Andres Bello, Fac Life Sci, Inst Biomed Sci, Santiago, Chile; [Rojas, Adriana; Sepulveda, Hugo; Aguilar, Rodrigo; Opazo, Tatiana; Nardocci, Gino; Bustos, Fernando; Allende, Miguel L.; Montecino, Martin] FONDAP Ctr Genome Regulat, Santiago, Chile; [Henriquez, Berta] Univ San Sebastian, Fac Med & Sci, Santiago, Chile; [Lian, Jane B.; Stein, Janet L.; Stein, Gary S.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [van Wijnen, Andre J.] Mayo Clin, Rochester, MN USA; [Allende, Miguel L.] Univ Chile, Dept Biol, Fac Sci, Santiago, Chile		Rojas, A (corresponding author), Pontificia Univ Javeriana, Inst Human Genet, Fac Med, Bogota 110231, Colombia.; Montecino, M (corresponding author), Univ Andres Bello, Inst Biomed Sci, Fac Med, Ave Republ 239, Santiago 8370146, Chile.	rojas-adriana@javeriana.edu.co; mmontecino@unab.cl	Nardocci, Gino/GLQ-7690-2022; Nardocci, Gino/AAE-7793-2019; van Wijnen, Andre J./AAG-3578-2019; Allende, Miguel L/C-5167-2008; Aguilar, Rodrigo/AAG-6178-2019	Nardocci, Gino/0000-0002-2342-6480; van Wijnen, Andre J./0000-0002-4458-0946; Allende, Miguel L/0000-0002-2783-2152; Rojas, Adriana/0000-0001-8528-4433; Aguilar, Rodrigo/0000-0003-0410-5478; van Zundert, Brigitte/0000-0002-4129-9972; Bustos, Fernando/0000-0002-0487-7032	Conicyt-redes [150109]; P. Universidad Javeriana [6276]; FONDAP [15090007]; Fondecyt [11130584, 1170878]	Conicyt-redes; P. Universidad Javeriana; FONDAP; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Conicyt-redes, Grant/Award Number: 150109; P. Universidad Javeriana, Grant/Award Number: 6276; FONDAP, Grant/Award Number: 15090007; Fondecyt, Grant/Award Numbers: 11130584, 1170878	Aguilar R, 2016, BBA-GENE REGUL MECH, V1859, P1043, DOI 10.1016/j.bbagrm.2016.05.009; Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Busto F, 2017, STEM CELLS, V35, P2430, DOI 10.1002/stem.2704; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Cruzat F, 2009, BIOCHEMISTRY-US, V48, P7287, DOI 10.1021/bi9004792; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Gori F, 2004, ENDOCRINOLOGY, V145, P1050, DOI 10.1210/en.2003-1314; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Gori F, 2006, DEV BIOL, V295, P498, DOI 10.1016/j.ydbio.2006.02.031; Hou H, 2008, BIOCHEM BIOPH RES CO, V369, P641, DOI 10.1016/j.bbrc.2008.02.094; Hovhannisyan H, 2013, J CELL PHYSIOL, V228, P313, DOI 10.1002/jcp.22109; Hu DQ, 2013, NAT STRUCT MOL BIOL, V20, P1093, DOI 10.1038/nsmb.2653; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Komori T, 2018, HISTOCHEM CELL BIOL, V149, P313, DOI 10.1007/s00418-018-1640-6; Ma Q, 2015, ACTA PHARMACOL SIN, V36, P966, DOI 10.1038/aps.2015.48; MAJESKA RJ, 1980, ENDOCRINOLOGY, V107, P1494, DOI 10.1210/endo-107-5-1494; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Nayak A, 2014, MOL CELL, V55, P47, DOI 10.1016/j.molcel.2014.05.011; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Rojas A, 2015, J BIOL CHEM, V290, P28329, DOI 10.1074/jbc.M115.657825; Sepulveda H, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00177-17; Sepulveda H, 2017, J CELL PHYSIOL, V232, P2519, DOI 10.1002/jcp.25627; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sontag JM, 2010, J NEUROCHEM, V115, P1455, DOI 10.1111/j.1471-4159.2010.07049.x; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Tai PWL, 2014, GENE, V550, P1, DOI 10.1016/j.gene.2014.05.044; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Yang D, 2013, J BIOL CHEM, V288, P33530, DOI 10.1074/jbc.M113.497040; Yang JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08868-0; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang F, 2015, SCI REP-UK, V5, DOI 10.1038/srep13418; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	39	6	8	1	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	MAY	2019	234	5					6244	6253		10.1002/jcp.27355	http://dx.doi.org/10.1002/jcp.27355			10	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	HK7AQ	30256410	Green Accepted			2022-09-04	WOS:000458138600078
J	Gonzalez-Reyes, RE; Aliev, G; Avila-Rodrigues, M; Barreto, GE				Gonzalez-Reyes, Rodrigo E.; Aliev, Gjumrakch; Avila-Rodrigues, Marco; Barreto, George E.			Alterations in Glucose Metabolism on Cognition: A Possible Link Between Diabetes and Dementia	CURRENT PHARMACEUTICAL DESIGN			English	Article						Diabetes; Alzheimer Disease; dementia; insulin resistance; antidiabetic drugs	INSULIN IMPROVES COGNITION; SYNTHASE KINASE-3 ACTIVITY; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; PPAR-GAMMA; AMYLOID-BETA; TAU HYPERPHOSPHORYLATION; POSTPRANDIAL GLYCEMIA; RECEPTOR STIMULATION; SYNAPTIC PLASTICITY	The use of the carbohydrate glucose as an energetic source is essential for an adequate function of the human body. The complex regulation of this molecule involves the coordinated action of various organs such as pancreas, liver and brain. Any disruption of this physiological balance may result in a dangerous compromise of general metabolic activities increasing the possibility of developing T1DM, T2DM and possibly AD. Astrocytes convert glucose into lactate and transfer it to neurons. This lactate is essential for neuronal metabolism and for various processes including the formation of synapses, dendrites and the expression of genes involved in memory. The brain is highly susceptible to variations in glucose blood levels, and both hypoglycemia and hyperglycemia can be dangerous. Pathological hyperglycemia induces changes in plasmatic osmotic pressure, mitochondrial production of free radicals, oxidative stress and activation of neuronal apoptosis, among others. Both AD and diabetes are chronic diseases having age as an important risk factor. As the brain ages, it seems to become much more susceptible to cellular damage induced by excess of circulating glucose and this could explain the appearance of cognitive changes observed in some patients with diabetes. Excessive circulation of pro-inflammatory agents has been observed in insulin resistance and is likely that some of these mediators may cross the blood-brain barrier and induce abnormal neuroinflammation. GSK-3 is overexpressed in diabetes and also has been reported to regulate tau phosphorylation and production of A beta peptides in the brain. Currently, diabetes (hyperglycemia) is considered as a risk factor for the development of AD. A novel therapeutic approach, using intranasal insulin and anti-diabetic medications in patients suffering from AD is being explored and is discussed in this review.	[Gonzalez-Reyes, Rodrigo E.] Univ Antonio Narino, Sch Med, Biomed Sci Res Grp GRINCIBIO, Bogota, Colombia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, E Johns Crossing 175, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia; [Avila-Rodrigues, Marco] Univ Tolima, Fac Ciencias Salud, Ibague, Tolima, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Gonzalez-Reyes, RE (corresponding author), Univ Antonio Narino, Sch Med, Bogota, Colombia.	rodrigonzalez@uan.edu.co; gsampaio@javeriana.edu.co	Aliev, Gjumrakch/K-7302-2017; Barreto, George E./AAD-7420-2020; Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./B-5747-2014; Gonzalez-Reyes, Rodrigo E./K-4571-2017	Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Gonzalez-Reyes, Rodrigo E./0000-0002-7865-0527; Avila-Rodriguez, Marco/0000-0003-4612-3236	PUJ grant [5024]	PUJ grant	This work was funded in part by PUJ grant #5024 to GEB.	Ahmed RR, 2010, J NEUROCHEM, V112, P1045, DOI 10.1111/j.1471-4159.2009.06528.x; Alagiakrishnan K, 2013, DISCOV MED, V16, P277; Albers JW, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0473-5; Alcarraz-Vizan G, 2015, FASEB J, V29, P95, DOI 10.1096/fj.14-255489; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Baltan S, 2015, METAB BRAIN DIS, V30, P25, DOI 10.1007/s11011-014-9595-3; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; Benarroch EE, 2014, NEUROLOGY, V82, P1374, DOI 10.1212/WNL.0000000000000328; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bezzi P, 2011, CELL, V144, P644, DOI 10.1016/j.cell.2011.02.027; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Bloemer J, 2014, PROG MOL BIOL TRANSL, V121, P413, DOI 10.1016/B978-0-12-800101-1.00013-2; BONDY CA, 1992, MOL CELL NEUROSCI, V3, P305, DOI 10.1016/1044-7431(92)90027-Y; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cai ZY, 2014, INT J NEUROSCI, V124, P307, DOI 10.3109/00207454.2013.833510; Carey M, 2013, J BIOL CHEM, V288, P34981, DOI 10.1074/jbc.R113.506782; Carvalho C, 2012, DIABETES, V61, P1234, DOI 10.2337/db11-1186; Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004; Chen YX, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00100; Chen YX, 2014, NEUROSCI BULL, V30, P282, DOI 10.1007/s12264-013-1408-x; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Choi J, 2014, MITOCHONDRION, V18, P41, DOI 10.1016/j.mito.2014.09.005; Choi J, 2013, BIOCHEM BIOPH RES CO, V435, P671, DOI 10.1016/j.bbrc.2013.05.041; Colberg SR, 2014, J AM MED DIR ASSOC, V15, P261, DOI 10.1016/j.jamda.2013.11.026; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; de la Lastra CA, 2004, CURR PHARM DESIGN, V10, P3505; Dhamoon MS, 2009, NEUROLOGY, V72, P292, DOI 10.1212/01.wnl.0000344246.91081.2c; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; DiNuzzo M, 2012, NEUROCHEM RES, V37, P2432, DOI 10.1007/s11064-012-0802-5; DiTacchio KA, 2015, J ALZHEIMERS DIS, V44, P43, DOI 10.3233/JAD-141332; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Duarte AI, 2013, BBA-MOL BASIS DIS, V1832, P527, DOI 10.1016/j.bbadis.2013.01.008; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gandhi GK, 2010, ASN NEURO, V2, DOI 10.1042/AN20090048; Gengler S, 2012, NEUROBIOL AGING, V33, P265, DOI 10.1016/j.neurobiolaging.2010.02.014; Gibbs ME, 2008, NEUROSCI BIOBEHAV R, V32, P927, DOI 10.1016/j.neubiorev.2008.02.001; Gibbs ME, 2012, NEUROCHEM RES, V37, P2456, DOI 10.1007/s11064-012-0805-2; Guglielmotto M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.026; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Handelsman Y, 2011, ENDOCR PRACT, V17, P287, DOI 10.4158/EP.17.2.287; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Herczenik E, 2007, ARTERIOSCL THROM VAS, V27, P1657, DOI 10.1161/ATVBAHA.107.143479; Hess K, 2015, HAMOSTASEOLOGIE, V35, P25, DOI 10.5482/HAMO-14-09-0039; Holscher C, 2014, ALZHEIMERS DEMENT, V10, pS47, DOI 10.1016/j.jalz.2013.12.009; Holscher C, 2014, ALZHEIMERS DEMENT, V10, pS33, DOI 10.1016/j.jalz.2013.12.006; Holscher C, 2014, J ENDOCRINOL, V221, pT31, DOI 10.1530/JOE-13-0221; HOYER S, 1994, ANN NY ACAD SCI, V719, P248, DOI 10.1111/j.1749-6632.1994.tb56833.x; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Imfeld P, 2012, J AM GERIATR SOC, V60, P916, DOI 10.1111/j.1532-5415.2012.03916.x; JAGUST WJ, 1991, J CEREBR BLOOD F MET, V11, P323, DOI 10.1038/jcbfm.1991.65; Jahrling JB, 2014, J NEUROSCI, V34, P4054, DOI 10.1523/JNEUROSCI.4024-13.2014; Jing L, 2013, INT J BIOL SCI, V9, P190, DOI 10.7150/ijbs.5844; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x; KALIMO H, 1980, ACTA NEUROL SCAND, V62, P345; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Landreth G, 2007, CURR ALZHEIMER RES, V4, P159, DOI 10.2174/156720507780362092; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li L, 2012, EUR J PHARMACOL, V674, P280, DOI 10.1016/j.ejphar.2011.11.005; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Lian XY, 2004, EUR J NEUROSCI, V19, P2446, DOI 10.1111/j.0953-816X.2004.03289.x; Liani R, 2012, FREE RADICAL BIO MED, V52, P1318, DOI 10.1016/j.freeradbiomed.2012.02.012; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Lozano L, 2014, EXP GERONTOL, V58, P198, DOI 10.1016/j.exger.2014.08.008; Lynch AM, 2010, AGING DIS, V1, P262; Ma T, 2012, J NEUROSCI, V32, P13701, DOI 10.1523/JNEUROSCI.2107-12.2012; Magistretti PJ, 2011, EXP PHYSIOL, V96, P407, DOI 10.1113/expphysiol.2010.053157; Mahmoudi Z, 2014, DIABETES TECHNOL THE, V16, P667, DOI 10.1089/dia.2014.0043; Mamczur P, 2015, GLIA, V63, P328, DOI 10.1002/glia.22753; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; McCall AL, 1996, J CEREBR BLOOD F MET, V16, P69, DOI 10.1097/00004647-199601000-00008; McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023; Medina JM, 2005, J NEUROSCI RES, V79, P2, DOI 10.1002/jnr.20336; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Milone M, 2012, DIABETES, V61, P991, DOI 10.2337/db12-0209; Mirza Z, 2014, CNS NEUROL DISORD-DR, V13, P501, DOI 10.2174/18715273113126660154; Moore EM, 2013, DIABETES CARE, V36, P2981, DOI 10.2337/dc13-0229; Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143; Muller MS, 2014, GLIA, V62, P526, DOI 10.1002/glia.22623; Nenov MN, 2014, J NEUROSCI, V34, P1028, DOI 10.1523/JNEUROSCI.3413-13.2014; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; Oberlin DJ, 2014, MED SCI SPORT EXER, V46, P232, DOI 10.1249/MSS.0b013e3182a54d85; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Percy M, 2014, J ALZHEIMERS DIS, V38, P907, DOI 10.3233/JAD-131409; Piert M, 1996, J NUCL MED, V37, P201; Qu ZS, 2014, SCI WORLD J, DOI 10.1155/2014/878123; Rafiki A, 2003, NEUROSCIENCE, V122, P677, DOI 10.1016/j.neuroscience.2003.08.040; Randriamboavonjy V, 2014, CURR ALZHEIMER RES, V11, P862, DOI 10.2174/156720501109141013115258; Rdzak GM, 2014, PHARMACOTHERAPY, V34, P1317, DOI 10.1002/phar.1494; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Rozance PJ, 2010, EARLY HUM DEV, V86, P275, DOI 10.1016/j.earlhumdev.2010.05.002; Saab AS, 2013, CURR OPIN NEUROBIOL, V23, P1065, DOI 10.1016/j.conb.2013.09.008; Seidel JL, 2011, NEUROSCIENCE, V192, P295, DOI 10.1016/j.neuroscience.2011.05.006; SMALL GW, 1992, J AM GERIATR SOC, V40, P1075, DOI 10.1111/j.1532-5415.1992.tb04492.x; Spielman LJ, 2014, J NEUROIMMUNOL, V273, P8, DOI 10.1016/j.jneuroim.2014.06.004; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Takeda S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00171; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Vardarajan BN, 2014, ANN NEUROL; Vinik AI, 2013, ENDOCRIN METAB CLIN, V42, P747, DOI 10.1016/j.ecl.2013.06.001; Wang J, 2012, NEUROSCIENCE, V202, P58, DOI 10.1016/j.neuroscience.2011.11.062; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Wang XH, 2010, NEUROSCIENCE, V170, P1239, DOI 10.1016/j.neuroscience.2010.08.028; Wang X, 2014, INT J NEUROSCI, V124, P601, DOI 10.3109/00207454.2013.866110; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012; Yan Liang-Jun, 2013, Aging Neurodegener, V1, P7; Yang Y, 2013, J ALZHEIMERS DIS, V33, P329, DOI 10.3233/JAD-2012-121294; Yu S, 2008, BRAIN RES, V1211, P22, DOI 10.1016/j.brainres.2005.04.029	129	50	53	0	31	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2016	22	7					812	818		10.2174/1381612822666151209152013	http://dx.doi.org/10.2174/1381612822666151209152013			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DG4VQ	26648470				2022-09-04	WOS:000372071600006
J	Moretti, K; Aluisio, AR; Marin, BG; Chen, CJJ; Marques, CG; Beaudoin, FL; Clark, M; Patino, A; Carranza, H; Duarte, A; Moreno, A; Aguiar, LG; Arbelaez, C				Moretti, Katelyn; Aluisio, Adam R.; Marin, Benjamin Gallo; Chen, Chuan-Jay Jeffrey; Marques, Catalina GonzaLez; Beaudoin, Francesca L.; Clark, Melissa; Patino, Andres; Carranza, Heidy; Duarte, Andres; Moreno, Atilio; Aguiar, Leonar G.; Arbelaez, Christian			Confidence and knowledge in emergency management among medical students across Colombia: A role for the WHO basic emergency care course	PLOS ONE			English	Article								Introduction Globally, medical students have demonstrated knowledge gaps in emergency care and acute stabilization. In Colombia, new graduates provide care for vulnerable populations. The World Health Organization (WHO) Basic Emergency Care (BEC) course trains frontline providers with limited resources in the management of acute illness and injury. While this course may serve medical students as adjunct to current curriculum, its utility in this learner group has not been investigated. This study performs a baseline assessment of knowledge and confidence in emergency management taught in the BEC amongst medical students in Colombia. Methods A validated, cross-sectional survey assessing knowledge and confidence of emergency care congruent with BEC content was electronically administered to graduating medical students across Colombia. Knowledge was evaluated via 15 multiple choice questions and confidence via 13 questions using 100 mm visual analog scales. Mean knowledge and confidence scores were compared across demographics, geography and prior training using Chi-Squared or one-way ANOVA analyses. Results Data were gathered from 468 graduating medical students at 36 institutions. The mean knowledge score was 59.9% +/- 23% (95% CI 57.8-62.0%); the mean confidence score was 59.6 mm +/- 16.7 mm (95% CI 58.1-61.2). Increasing knowledge and confidence scores were associated with prior completion of emergency management training courses (p<0.0001). Conclusion Knowledge and confidence levels of emergency care management for graduating medical students across Colombia demonstrated room for additional, specialized training. Higher scores were seen in groups that had completed emergency care courses. Implementation of the BEC as an adjunct to current curriculum may serve a valuable addition.	[Moretti, Katelyn; Aluisio, Adam R.; Marin, Benjamin Gallo; Marques, Catalina GonzaLez; Beaudoin, Francesca L.; Arbelaez, Christian] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Moretti, Katelyn; Aluisio, Adam R.; Marques, Catalina GonzaLez; Beaudoin, Francesca L.; Arbelaez, Christian] Brown Emergency Med, Providence, RI 02903 USA; [Chen, Chuan-Jay Jeffrey] Massachusetts Gen Hosp, Boston, MA USA; [Clark, Melissa] Brown Sch Publ Hlth, Providence, RI USA; [Patino, Andres] Emory Univ, Dept Emergency Med, Sch Med, Atlanta, GA USA; [Carranza, Heidy; Duarte, Andres; Moreno, Atilio; Aguiar, Leonar G.; Arbelaez, Christian] Pontificia Univ Javeriana, Bogota, Colombia; [Carranza, Heidy; Duarte, Andres; Moreno, Atilio; Aguiar, Leonar G.; Arbelaez, Christian] Hosp Univ San Ignacio, Bogota, Colombia		Moretti, K (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	katelyn_moretti@brown.edu	Gallo Marin, Benjamin/AAZ-8696-2021; Aguiar Martinez, Leonar G/M-7447-2016	Gallo Marin, Benjamin/0000-0003-4877-354X; Chen, Chuanjay/0000-0001-7411-4746; Gonzalez Marques, Catalina/0000-0002-6562-1591; Aguiar Martinez, Leonar G/0000-0002-5372-2459	Brown Emergency Medicine Innovation's grant through Brown Emergency Physicians, Inc.	Brown Emergency Medicine Innovation's grant through Brown Emergency Physicians, Inc.	This research was funded, in part, through the Brown Emergency Medicine Innovation's grant through Brown Emergency Physicians, Inc. (KM). The funders did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://brownphysicians.org/brownemergency-medicine/.	[Anonymous], IMPR PREH TRAUM CAR; Avabratha K. S., 2012, Al Ameen Journal of Medical Sciences, V5, P152; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black RS, 2003, BJOG-INT J OBSTET GY, V110, P837, DOI 10.1111/j.1471-0528.2003.02488.x; Blanch DC, 2008, PATIENT EDUC COUNS, V72, P374, DOI 10.1016/j.pec.2008.05.021; Broccoli MC, 2021, AFR J EMERG MED, V11, P140, DOI 10.1016/j.afjem.2020.09.011; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jayaraman S, 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004173.PUB4/FULL.PMID:25146524; Kivlehan SM, 2021, EMERG MED J, V38, P636, DOI 10.1136/emermed-2020-209718; Macfarlane SBJ, 1997, TROP DOCT, V27, P14, DOI 10.1177/004947559702700108; Olufadeji A, 2021, AFR J EMERG MED, V11, P231, DOI 10.1016/j.afjem.2021.02.004; Patino A, 2017, WEST J EMERG MED, V18, P1120, DOI 10.5811/westjem.2017.7.34668; Penafiel MJM, SERVICIO SOCIAL OBLI, P7; Promes SB, 2009, ACAD EMERG MED, V16, pS58, DOI 10.1111/j.1553-2712.2009.00600.x; Qureshi F, 2009, J PAK MED ASSOC, V59, P5; SKINNER DV, 1985, BRIT MED J, V290, P1549, DOI 10.1136/bmj.290.6481.1549; Straube S, 2020, AFR J EMERG MED, V10, P30, DOI 10.1016/j.afjem.2019.11.003; Tenner AG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224257; Turner NM, 2008, MED EDUC, V42, P503, DOI 10.1111/j.1365-2923.2007.02950.x; WHO, WHO PIL WHO BAS EM C	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2022	17	1							e0262282	10.1371/journal.pone.0262282	http://dx.doi.org/10.1371/journal.pone.0262282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z4TQ	35061787	gold, Green Published			2022-09-04	WOS:000791072800122
J	Ocampo-Chaparro, JM; Reyes-Ortiz, CA; Castro-Florez, X; Gomez, F				Ocampo-Chaparro, Jose M.; Reyes-Ortiz, Carlos A.; Castro-Florez, Ximena; Gomez, Fernando			Frailty in older adults and their association with social determinants of Health. The SABE Colombia Study	COLOMBIA MEDICA			English	Article						Frailty; SABE Colombia study; elderly; aging; aged; social determinants of health; socioeconomic factors; health surveys; Colombia	SOCIOECONOMIC-STATUS; MEXICAN-AMERICANS; LIFE-COURSE; PREVALENCE	Objective: To estimate the prevalence of frailty and evaluate the relationship with the social determinants of health in elderly residents in urban and rural areas of Colombia. Methods: The SABE (Health, Wellbeing, and Aging) Colombia project is a cross-sectional study, carried out in 2014-2015, involving 24,553 men and women aged 60 years and older who live in the community in Colombia. For this analysis, we used data from 4,474 participants included as a subsample with grip strength measurements. The frailty syndrome was diagnosed according to the Fried criteria (weakness, low speed, low physical activity, exhaustion, and weight loss). The independent variables were grouped as (a) biological and genetic flow, (b) lifestyle (adverse conditions in childhood) (c) social networks and community, and (d) socio-economic, cultural and environmental conditions. Multiple logistic and linear regression analyses were used to assess the prognostic value of frailty for the outcomes of interest. Results: The prevalence of frailty was 17.9%. The factors significantly associated with frailty were older age, being women, living in rural areas, having low education, a greater number of medical conditions, insufficient current income, childhood health problems and a poor economic situation in childhood. Conclusions: Our results support the need to include frailty prevention programs, to improve the socioeconomic health conditions of infants to avoid future development of frailty.	[Ocampo-Chaparro, Jose M.] Univ Valle, Fac Salud, Dept Med Familiar, Cali, Colombia; [Ocampo-Chaparro, Jose M.] Univ Libre, Fac Ciencias Salud, Dept Med Interna, GIMI 1, Cali, Colombia; [Reyes-Ortiz, Carlos A.] Univ Texas Houston, Dept Internal Med, McGovern Med Sch, Div Geriatr & Palliat Med, Houston, TX USA; [Reyes-Ortiz, Carlos A.] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Inst Publ Hlth, 1515 So MLK Blvd,Suite 209D, Tallahassee, FL 32307 USA; [Castro-Florez, Ximena] Univ Valle, Fac Salud, Dept Med Familiar, Escuela Med, Cali, Colombia; [Castro-Florez, Ximena] Pontificia Univ Javeriana, Dept Clin Med, Cali, Colombia; [Gomez, Fernando] Univ Caldas, Grp Epidemiol & Poblac, Grp Invest Gerontol & Geriatria, Manizales, Colombia		Reyes-Ortiz, CA (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Inst Publ Hlth, 1515 So MLK Blvd,Suite 209D, Tallahassee, FL 32307 USA.	creyesortiz@hotmail.com		CASTRO FLOREZ, XIMENA/0000-0002-2686-0346				Ade C. Mello, 2014, CAD SAUDE PUBLICA, V30, P1143; Alvarado BE, 2008, J GERONTOL A-BIOL, V63, P1399, DOI 10.1093/gerona/63.12.1399; Aranda MP, 2011, J AGING HEALTH, V23, P1189, DOI 10.1177/0898264311421961; Birnie K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015564; Buchner D M, 1992, Clin Geriatr Med, V8, P1; Carmona-Meza Zenén, 2015, Salud, Barranquilla, V31, P608, DOI 10.14482/sun.31.3.7685; CEPAL, 2011, EST EC AM LAT CAR 20; Cesar M, 2017, CLIN GERIATR MED, V33, P293, DOI 10.1016/j.cger.2017.02.002; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Colbert SJ, 2009, HEALTH EDUC BEHAV, V36, P259, DOI 10.1177/1090198107303310; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Curcio CL, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-2; Dalhlgren G, 1991, WORKING PAPER NO 200; Tavares DMD, 2017, COLOMB MEDICA, V48, P125, DOI 10.25100/cm.v48i3.1978; Dury S, 2017, AGING MENT HEALTH, V21, P1031, DOI 10.1080/13607863.2016.1193120; Espinoza S.E., 2007, CONSULTANT 360, V15, P37; Feng ZY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178383; Da Mata FAF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160019; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P344, DOI 10.1016/j.jamda.2009.11.003; Gomes CD, 2018, ARCH GERONTOL GERIAT, V76, P26, DOI 10.1016/j.archger.2018.02.002; Gomez F, 2012, REV MED SANITAS, V15, P8; Gomez F., 2016, CURR GERONTOL GERIAT, V2016, DOI [10.1155/2016/7910205, DOI 10.1155/2016/7910205]; Gomez F, 2018, INT J EPIDEMIOL, V47, P1393, DOI 10.1093/ije/dyy074; Guralnik JM, 2006, J GERONTOL A-BIOL, V61, P694, DOI 10.1093/gerona/61.7.694; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hirsch C, 2006, ANN EPIDEMIOL, V16, P545, DOI 10.1016/j.annepidem.2005.10.003; Hoogendijk EO, 2014, ANN EPIDEMIOL, V24, P538, DOI 10.1016/j.annepidem.2014.05.002; Karunananthan S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-68; Keating DP, 1999, DEV HLTH WEALTH NATI, P30; Levers MJ, 2006, J ADV NURS, V56, P282, DOI 10.1111/j.1365-2648.2006.04021.x; Macklai NS, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-3; McHugh J. E., 2016, Irish Journal of Psychological Medicine, V33, P111, DOI 10.1017/ipm.2015.67; Ministerio de Salud y Proteccion Social-Departamento Administrativo de Ciencia Tecnologia e Innovacion Caldas CU del V y U de, 2016, ENC SABE COL SIT SAL; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Myers V, 2014, INT J CARDIOL, V170, P338, DOI 10.1016/j.ijcard.2013.11.009; Ocampo-Chaparro JM, 2013, COLOMB MEDICA, V44, P224; Ottenbacher KJ, 2009, AM J PUBLIC HEALTH, V99, P673, DOI 10.2105/AJPH.2008.143958; Sousa ACPD, 2012, ARCH GERONTOL GERIAT, V54, pE95, DOI 10.1016/j.archger.2011.08.010; Poli S, 2017, AGING CLIN EXP RES, V29, P721, DOI 10.1007/s40520-016-0623-5; REUBEN DB, 1990, J AM GERIATR SOC, V38, P855, DOI 10.1111/j.1532-5415.1990.tb05699.x; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Szanton SL, 2010, J EPIDEMIOL COMMUN H, V64, P63, DOI 10.1136/jech.2008.078428; Woo J, 2005, GERONTOLOGY, V51, P402, DOI 10.1159/000088705; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x	48	11	12	2	13	CORPORACION EDITORA MEDICA VALLE	CALI	UNIV VALLE, BLDG 118 FACULTY HEALTH, CALLE 4B 36-00, CALI, 00000, COLOMBIA	1657-9534			COLOMB MEDICA	Colomb. Medica	APR-JUN	2019	50	2					89	101		10.25100/cm.v50i2.4121	http://dx.doi.org/10.25100/cm.v50i2.4121			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IZ7IU	31607766	Green Published, gold			2022-09-04	WOS:000487266200005
J	Blonde, L; Aschner, P; Bailey, C; Ji, LN; Leiter, LA; Matthaei, S				Blonde, Lawrence; Aschner, Pablo; Bailey, Clifford; Ji, Linong; Leiter, Lawrence A.; Matthaei, Stephan		Global Partnership Effective	Gaps and barriers in the control of blood glucose in people with type 2 diabetes	DIABETES & VASCULAR DISEASE RESEARCH			English	Review						Diabetes mellitus; type 2; glycaemic control; review; surveys; clinical inertia	POOR GLYCEMIC CONTROL; CLINICAL INERTIA; FOLLOW-UP; TREATMENT INTENSIFICATION; GENERAL-PRACTITIONERS; INSULIN INITIATION; PRIMARY-CARE; ADULT CARE; MANAGEMENT; HEALTH	Background: Glycaemic control is suboptimal in a large proportion of people with type 2 diabetes who are consequently at an increased and avoidable risk of potentially severe complications. We sought to explore attitudes and practices among healthcare professionals that may contribute to suboptimal glycaemic control through a review of recent relevant publications in the scientific literature. Methods: An electronic search of the PubMed database was performed to identify relevant publications from January 2011 to July 2015. The electronic search was complemented by a manual search of abstracts from key diabetes conferences in 2014/2015 available online. Results: Recently published data indicate that glycaemic control is suboptimal in a substantial proportion (typically 40%-60%) of people with diabetes. This is the case across geographic regions and in both low- and higher-income countries. Therapeutic inertia appears to be an important contributor to poor glycaemic control in up to half of people with type 2 diabetes. In particular, prescribers are often willing to tolerate extended periods of mild' hyperglycaemia as well as having low expectations for their patients. There are often delays of 3years or longer in initiating or intensifying glucose-lowering therapy when needed. Conclusion: Many people with type 2 diabetes are failed by current management, with approximately half not achieving or maintaining appropriate target blood glucose levels, leaving these patients at increased and avoidable risk of serious complications. Review criteria: The methodology of this review article is detailed in the Methods' section.	[Blonde, Lawrence] Ochsner Med Ctr, Dept Endocrinol, 1514 Jefferson Highway, New Orleans, LA 70121 USA; [Aschner, Pablo] Javeriana Univ, Endocrinol Unit, Sch Med, Bogota, Colombia; [Bailey, Clifford] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Ji, Linong] Peking Univ, Peoples Hosp, Beijing, Peoples R China; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Leiter, Lawrence A.] Univ Toronto, Div Endocrinol & Metab, Toronto, ON, Canada; [Matthaei, Stephan] Quakenbruck Hosp, Diabet Metab & Endocrinol Ctr, Quakenbruck, Germany		Blonde, L (corresponding author), Ochsner Med Ctr, Dept Endocrinol, 1514 Jefferson Highway, New Orleans, LA 70121 USA.	lblonde@ochsner.org	Linong, Ji/AAB-6543-2020; Leiter, Lawrence/AAG-4059-2020	Bailey, Clifford J/0000-0002-6998-6811	AstraZeneca [69680]	AstraZeneca(AstraZeneca)	The literature search was supported by an unrestricted educational grant from AstraZeneca (grant ID #69680).	Alhyas Layla, 2013, JRSM Short Rep, V4, P14, DOI 10.1177/2042533313476419; Aronson R, 2015, J DIABETES, DOI [10.1111/1753-0407, DOI 10.1111/1753-0407]; Aschner PJ, 2012, DIABETES TECHNOL THE, V14, pS68, DOI 10.1089/dia.2012.0012; Aujoulat I, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0221-1; Balkau B, 2012, DIABETES METAB, V38, pS29, DOI 10.1016/S1262-3636(12)71532-X; Braga MFB, 2012, INT J CLIN PRACT, V66, P457, DOI 10.1111/j.1742-1241.2012.02894.x; Davis J, 2014, ANN PHARMACOTHER, V48, P41, DOI 10.1177/1060028013517870; de Pablos-Velasco P, 2014, CLIN ENDOCRINOL, V80, P47, DOI 10.1111/cen.12119; Del Prato S, 2010, INT J CLIN PRACT, V64, P295, DOI 10.1111/j.1742-1241.2009.02227.x; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Duckworth WC, 2011, J DIABETES COMPLICAT, V25, P355, DOI 10.1016/j.jdiacomp.2011.10.003; Elliott DJ, 2011, AM J MED QUAL, V26, P284, DOI 10.1177/1062860610383332; Engel S, 2003, NEW ENGL J MED, V348, P2294; European Coalition for Diabetes, 2014, DIAB EUR POL PUZZL S, V4th ed.; Garvey KC, 2013, ENDOCR PRACT, V19, P946, DOI 10.4158/EP13109.OR; George JT, 2011, QJM-INT J MED, V104, P761, DOI 10.1093/qjmed/hcr046; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Halimi S, 2012, DIABETES METAB, V38, pS36, DOI 10.1016/S1262-3636(12)71533-1; Harrison LB, 2014, J INVEST MED, V62, P676, DOI 10.2310/JIM.0000000000000068; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Helgeson VS, 2013, DIABETIC MED, V30, P610, DOI 10.1111/dme.12067; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holt RIG, 2013, DIABETIC MED, V30, P789, DOI 10.1111/dme.12242; Huang LY, 2015, J CLIN PHARMACOL, V55, P17, DOI 10.1002/jcph.367; International Diabetes Federation, 2012, GLOB G UID TYP 2 DIA; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Ji LN, 2015, DIABETES TECHNOL THE, V17, P735, DOI 10.1089/dia.2015.0054; Ji LN, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.035; Kahlon AS, 2011, J PHARM BIOALLIED SC, V3, P324, DOI 10.4103/0975-7406.84431; Khan H, 2011, PRIM CARE DIABETES, V5, P251, DOI 10.1016/j.pcd.2011.07.001; Khunti K, 2013, DIABETES CARE, V36, P3411, DOI 10.2337/dc13-0331; Laiteerapong N, 2015, MED CARE, V53, P25, DOI 10.1097/MLR.0000000000000255; Lamoureux EL, 2012, CLIN EXP OPHTHALMOL, V40, P73, DOI 10.1111/j.1442-9071.2011.02697.x; Lang VB, 2015, MED SCI MONITOR, V21, P403, DOI 10.12659/MSM.892248; LeBlanc ES, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000062; Leiter LA, 2013, CAN J DIABETES, V37, P82, DOI 10.1016/j.jcjd.2013.02.055; Letshwiti J B, 2015, Ir Med J, V108, P118; Lotstein DS, 2013, PEDIATRICS, V131, pE1062, DOI 10.1542/peds.2012-1450; Lu JM, 2014, PATIENT PREFER ADHER, V8, P1161, DOI 10.2147/PPA.S66915; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Marrett Elizabeth, 2012, Diabetes Ther, V3, P5, DOI 10.1007/s13300-012-0005-8; Mata-Cases M, 2013, CURR MED RES OPIN, V29, P1495, DOI 10.1185/03007995.2013.833089; Mc Hugh S, 2013, BMJ OPEN, V3; Narasimhan S, 2014, MAYO CLIN PROC, V89, P806, DOI 10.1016/j.mayocp.2014.01.009; O'Connor R, 2013, Ir Med J, V106, P77; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Raaijmakers LGM, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-114; Rajpathak SN, 2014, J DIABETES COMPLICAT, V28, P831, DOI 10.1016/j.jdiacomp.2014.06.004; Ratanawongsa N, 2012, DIABETES EDUCATOR, V38, P94, DOI 10.1177/0145721711432649; Reach G, 2013, PATIENT PREFER ADHER, V7, P1007, DOI 10.2147/PPA.S51299; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Rodriguez-Vigil E, 2014, P R HEALTH SCI J, V33, P157; Romanelli RJ, 2015, DIABETES RES CLIN PR, V108, P170, DOI 10.1016/j.diabres.2014.12.019; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; The Health and Social Care Information Centre (HSCIC), 2014, NAT DIAB AUD 2012 20; Thepwongsa I, 2014, RURAL REMOTE HEALTH, V14; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Dieren S, 2014, DIABETES OBES METAB, V16, P426, DOI 10.1111/dom.12238; Whitford DL, 2014, PRIM CARE DIABETES, V8, P133, DOI 10.1016/j.pcd.2013.10.007; Williamson C, 2014, POSTGRAD MED, V126, P145, DOI 10.3810/pgm.2014.05.2764; Zafar A, 2015, DIABETIC MED, V32, P407, DOI 10.1111/dme.12592; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	65	59	62	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1479-1641	1752-8984		DIABETES VASC DIS RE	Diabetes Vasc. Dis. Res.	MAY	2017	14	3					172	183		10.1177/1479164116679775	http://dx.doi.org/10.1177/1479164116679775			12	Endocrinology & Metabolism; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Cardiovascular System & Cardiology	EU0GE	28467203	hybrid, Green Accepted, Green Published			2022-09-04	WOS:000400686700002
J	Romero, J; Muniz, J; Tornatore, TL; Holubiec, M; Gonzalez, J; Barreto, GE; Guelman, L; Lillig, CH; Blanco, E; Capani, F				Romero, J.; Muniz, J.; Logica Tornatore, T.; Holubiec, M.; Gonzalez, J.; Barreto, G. E.; Guelman, L.; Lillig, C. H.; Blanco, E.; Capani, F.			Dual role of astrocytes in perinatal asphyxia injury and neuroprotection	NEUROSCIENCE LETTERS			English	Review						Perinatal asphyxia; Astrocytes; Neuroprotection; Redox signaling; Cell death	CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; HYPOXIA-ISCHEMIA; REACTIVE ASTROCYTES; CEREBROSPINAL-FLUID; QUINOLINIC ACID; BIRTH ASPHYXIA; THIOREDOXIN; BRAIN; EXPRESSION	Perinatal asphyxia represents an important cause of severe neurological deficits including delayed mental and motor development, epilepsy, major cognitive deficits and blindness. However, at the moment, most of the therapeutic strategies were not well targeted toward the processes that induced the brain injury during perinatal asphyxia. Traditionally, experimental research focused on neurons, whereas astrocytes have been more related with the damage mechanisms of perinatal asphyxia. In this work, we propose to review possible protective as well as deleterious roles of astrocytes in the asphyctic brain with the aim to stimulate further research in this area of perinatal asphyxia still not well studied. (C) 2013 Elsevier Ireland Ltd. All rights	[Romero, J.; Muniz, J.; Logica Tornatore, T.; Holubiec, M.; Gonzalez, J.; Capani, F.] UBA CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Lab Citoarquitectura & Plasticidad Neuronal, Buenos Aires, DF, Argentina; [Capani, F.] Univ Argentina John F Kennedy, Dept Biol, Buenos Aires, DF, Argentina; [Gonzalez, J.; Barreto, G. E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Blanco, E.] Univ Malaga, Fac Psicol, Dept Psicobiol & Metodol Ciencias Comportamiento, E-29071 Malaga, Spain; [Guelman, L.] Fac Med UBA, Catedra Farmacol, Buenos Aires, DF, Argentina; [Guelman, L.] CEFYBO UBA CONICET, Buenos Aires, DF, Argentina; [Lillig, C. H.] Ernst Moritz Arndt Univ Greifswald, Univ Med Greifswald, Inst Med Biochem & Mol Biol, Greifswald, Germany; [Blanco, E.] Univ Lleida, Fac Ciencies Educ, Dept Pedagogia & Psicol, Lleida 25001, Spain		Capani, F (corresponding author), UBA CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Marcelo T de Alvear 2270,C1122AAJ, Buenos Aires, DF, Argentina.	fcapani@fmed.uba.ar	Barreto, George E./AAD-7420-2020; Barreto, George E./B-5747-2014; capani, Francisco/D-9781-2016; Lillig, Christopher Horst/AAD-7098-2019; Calvo, Eduardo Blanco/H-5805-2013; GONZALEZ, JANNETH/AAB-9948-2020	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Lillig, Christopher Horst/0000-0003-2509-5117; Calvo, Eduardo Blanco/0000-0003-0357-1151; GONZALEZ, JANNETH/0000-0003-4482-256X; Capani, Francisco/0000-0003-0342-0628; Holubiec, Mariana/0000-0002-7532-8890; Romero, Juan Ignacio/0000-0003-2323-0864; Guelman, Laura Ruth/0000-0002-5251-3006				Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; AMIELTISON C, 1986, DEV MED CHILD NEUROL, V28, P671; Arnold T, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-4; Barone E, 2012, ANTIOXID REDOX SIGN, V16, P1407, DOI 10.1089/ars.2011.4124; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Berggren M, 1996, ANTICANCER RES, V16, P3459; Bona E, 1999, PEDIATR RES, V45, P500, DOI 10.1203/00006450-199904010-00008; Burkovetskaya ME, 2007, NEUROSCI LETT, V416, P236, DOI 10.1016/j.neulet.2006.12.059; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Capani F, 2009, EXP NEUROL, V219, P404, DOI 10.1016/j.expneurol.2009.06.007; Cebral E, 2006, INT J NEUROSCI, V116, P697, DOI 10.1080/00207450600674970; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Galeano P, 2011, INT J DEV NEUROSCI, V29, P609, DOI 10.1016/j.ijdevneu.2011.05.002; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; Hanschmann M.E., 2013, ANTIOXID REDOX SIGNA; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; HILL A, 1981, ANN NEUROL, V10, P109, DOI 10.1002/ana.410100202; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Im JY, 2012, HUM MOL GENET, V21, P3013, DOI 10.1093/hmg/dds131; Kim Young Sun, 2011, Korean Journal of Internal Medicine, V26, P304, DOI 10.3904/kjim.2011.26.3.304; Aon-Bertolino ML, 2011, BBA-GEN SUBJECTS, V1810, P93, DOI 10.1016/j.bbagen.2010.06.011; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Martin LJ, 1997, ANN NEUROL, V42, P335, DOI 10.1002/ana.410420310; MUGNAINI E, 1964, Ergeb Anat Entwicklungsgesch, V37, P194; O'Connor JJ, 2013, IRISH J MED SCI, V182, P157, DOI 10.1007/s11845-013-0911-4; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Sankarapandi S, 1998, ARCH BIOCHEM BIOPHYS, V353, P312, DOI 10.1006/abbi.1998.0658; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Saraceno GE, 2012, SYNAPSE, V66, P9, DOI 10.1002/syn.20978; Savman K, 1998, PEDIATR RES, V43, P746; Savman K, 2013, TRANSL STROKE RES, V4, P228, DOI 10.1007/s12975-012-0216-3; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shankaran S, 2009, J NEUROTRAUM, V26, P437, DOI 10.1089/neu.2008.0678; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2000, MOL PSYCHIATR, V5, P230, DOI 10.1038/sj.mp.4000753; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Kruse MS, 2009, BRAIN RES, V1303, P1, DOI 10.1016/j.brainres.2009.09.078; Stroev SA, 2004, NEUROSCI LETT, V370, P224, DOI 10.1016/j.neulet.2004.08.022; Tahraoui SL, 2001, BRAIN PATHOL, V11, P56; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Takatsuru Y., 2013, NEUROSCI RES; Taniguchi Y, 1996, NUCLEIC ACIDS RES, V24, P2746, DOI 10.1093/nar/24.14.2746; Thomas R, 2004, J NEUROPATH EXP NEUR, V63, P856, DOI 10.1093/jnen/63.8.856; van Bel F, 2008, NEONATOLOGY, V94, P203, DOI 10.1159/000143723; Vannucci RC, 1997, PEDIATRICS, V100, P1004, DOI 10.1542/peds.100.6.1004; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Villapol S, 2008, NEUROSCIENTIST, V14, P339, DOI 10.1177/1073858408316003; Wells W W, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P149; Zhou J, 2003, AM J PHYSIOL-CELL PH, V284, pC439, DOI 10.1152/ajpcell.00294.2002	59	23	23	0	21	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 17	2014	565				SI		42	46		10.1016/j.neulet.2013.10.046	http://dx.doi.org/10.1016/j.neulet.2013.10.046			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG0OI	24172702				2022-09-04	WOS:000335114400008
J	Castelblanco-Martinez, DN; Moreno-Arias, RA; Velasco, JA; Moreno-Bernal, JW; Restrepo, S; Noguera-Urbano, EA; Baptiste, MP; Garcia-Loaiza, LM; Jimenez, G				Castelblanco-Martinez, D. N.; Moreno-Arias, R. A.; Velasco, J. A.; Moreno-Bernal, J. W.; Restrepo, S.; Noguera-Urbano, E. A.; Baptiste, M. P.; Garcia-Loaiza, L. M.; Jimenez, G.			A hippo in the room: Predicting the persistence and dispersion of an invasive mega-vertebrate in Colombia, South America	BIOLOGICAL CONSERVATION			English	Article						Hippopotamus amphibius; Magdalena River basin; Invasive alien species; Population viability analysis; Niche modeling	HIPPOPOTAMUS HIPPOPOTAMUS-AMPHIBIUS; POPULATION VIABILITY ANALYSIS; MAGDALENA RIVER; NATIONAL-PARK; PLEISTOCENE; MODELS; REGION	Biological invasions are a big concern due to their potential to impact ecosystems, as well as local people. The hippo Hippopotamus amphibius, native to Africa, has invaded extensive areas of the Magdalena River basin (Colombia) over the past decades, and has been considered the largest invasive animal in the world. Here, we propose the use of two approaches of predictive modeling, in order to guide recommendations for the management of this biological invasion. First, we developed a population viability analysis (PVA) to simulate a hypothetical population growth under different management scenarios. Next, we explored the potential invasion area under future climate change scenarios throughout ecological niche modeling analyses. PVA models predicted that in the absence of an intense culling/hunting pressure, the population size will continue to steadily increase, which is consistent with the population growth observed during the last 20 years. Furthermore, our static and dynamic habitat suitability projections suggested that without dispersal limiting factors, potential colonization habitat for hippos may become very extensive across the landscape and can be favored by climate change in the future. Therefore, our findings show the urgent need of taking critical management decisions by the Colombian authorities, which should be focused on limiting the hippos' population growth and expansion. Ignoring cost-benefit considerations for the control of this invasive species may have unexpected and long-term social and ecological implications. However, the proposal of a course of action can become controversial when the species has a charismatic value for the society, regardless of its ecological or social impact.	[Castelblanco-Martinez, D. N.] Consejo Nacl Ciencia & Technol, Av Insurgentes Sur 1582, Mexico City 03940, DF, Mexico; [Castelblanco-Martinez, D. N.] Univ Quintana Roo, Div Ciencias & Ingn, Blvd Bahia S-N Esq Ignacio Comonfort, Chetmal 77019, Quintana Roo, Mexico; [Castelblanco-Martinez, D. N.] Fdn Int Nat & Sustentabilidad FINS, Chetmal 77014, Quintana Roo, Mexico; [Moreno-Arias, R. A.] Univ Nacl Colombia, Ciudad Univ, Inst Ciencias Nat, Grp Morfol & Ecol Evolut, Bogota, Colombia; [Moreno-Arias, R. A.] Pontificia Univ Javeriana, Fac Estudios Ambient & Rurales, Dept Ecol & Terr, Cra 7,40-62, Bogota, Colombia; [Velasco, J. A.] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Invest Cientif S-N, Mexico City 04510, DF, Mexico; [Moreno-Bernal, J. W.] Univ Norte, Grp Invest Geociencias GEO4, Km 5 Via Puerto Colombia, Barranquilla, Atlantico, Colombia; [Restrepo, S.] Pontificia Univ Javeriana, Fac Estudios Ambient & Rurales, Dept Desarrollo Rural & Reg, Cra 7,40-62, Bogota, Colombia; [Noguera-Urbano, E. A.; Baptiste, M. P.; Garcia-Loaiza, L. M.] Inst Invest Recursos Biol, Cl 28a,15 09, Bogota, Colombia; [Jimenez, G.] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Unidad Ecol & Sistemat UNESIS, Cra 7,40-62, Bogota, Colombia		Castelblanco-Martinez, DN (corresponding author), Consejo Nacl Ciencia & Technol, Av Insurgentes Sur 1582, Mexico City 03940, DF, Mexico.; Castelblanco-Martinez, DN (corresponding author), Univ Quintana Roo, Div Ciencias & Ingn, Blvd Bahia S-N Esq Ignacio Comonfort, Chetmal 77019, Quintana Roo, Mexico.; Castelblanco-Martinez, DN (corresponding author), Fdn Int Nat & Sustentabilidad FINS, Chetmal 77014, Quintana Roo, Mexico.	dncastelblancoma@conacyt.mx	Castelblanco-Martínez, Nataly/T-5997-2018; Jimenez, German/AAE-5898-2021; Castelblanco-Martínez, Delma Nataly/AAQ-3666-2021	Castelblanco-Martínez, Nataly/0000-0003-3229-8406; Castelblanco-Martínez, Delma Nataly/0000-0003-3229-8406; Jimenez, German/0000-0003-1525-0822	Colombian Minciencias Postdoctoral Fellowship [811-2018]; Canadian Queen Elizabeth II Diamond Jubilee Scholarship (QES) for Advanced scholars; IDRC; SSHRC	Colombian Minciencias Postdoctoral Fellowship; Canadian Queen Elizabeth II Diamond Jubilee Scholarship (QES) for Advanced scholars; IDRC; SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. David Echeverry and Yina Paola Serna (CorporaciOn AutOnoma Regional de los rfos Negro y Nare Cornare) provided relevant data to feed PVA models. We thank Oscar Calderon Bustamante for his help during the preparation of climate datasets from CMIP5. RAM-A was recipient of the Colombian Minciencias Postdoctoral Fellowship program No. 811-2018. JWM-B was benefited with a Canadian Queen Elizabeth II Diamond Jubilee Scholarship (QES) for Advanced scholars. The QES is managed through a unique partnership of Universities Canada, the Rideau Hall Foundation (RHF), Community Foundations of Canada (CFC), and Canadian universities. The QES-AS is made possible with financial support from IDRC and SSHRC. The manuscript was greatly improved by the comments of one anonymous reviewer.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alvarez- Correa M., 2020, TIEMPO; Andersen MC, 2005, HUM ECOL RISK ASSESS, V11, P1083, DOI 10.1080/10807030500278610; [Anonymous], 2014, COOP AGR 184; [Anonymous], 2011, COOP AGR 050; [Anonymous], 2013, COOP AGR 043; Bengis R., 2016, S AFRICA J S AFR VET, V87, P1; Benton CH, 2018, J ANIM ECOL, V87, P1500, DOI 10.1111/1365-2656.12878; Berg S.S., 2012, B ECOL SOC AM, V93, P160; Buruso F.H., 2018, ENV SYSTEMS RES, V6; Chansa W, 2011, AFR J ECOL, V49, P221, DOI 10.1111/j.1365-2028.2010.01252.x; Chen SH, 2008, MATH COMPUT SIMULAT, V78, P379, DOI 10.1016/j.matcom.2008.01.028; CHOMBA C, 2013, INT J BIODIVERS CONS, V5, P109, DOI DOI 10.5897/IJBC12.023; Conover M., 2001, RESOLVING HUMAN WILD; De Porta J., 1965, B GEOLOGIA, P111; Dembitzer J, 2017, ISR J ECOL EVOL, V63, P5, DOI 10.1163/22244662-06303002; Di Cola V, 2017, ECOGRAPHY, V40, P774, DOI 10.1111/ecog.02671; Dittrich L., 1976, International Zoo Yearbook, V16, P171, DOI 10.1111/j.1748-1090.1976.tb00168.x; Domning Daryl P., 1997, P383; Dudley JP, 2016, MAMMAL REV, V46, P191, DOI 10.1111/mam.12056; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Eltringham SK, 1999, HIPPOS NATURAL HIST; Engler R, 2012, ECOGRAPHY, V35, P872, DOI 10.1111/j.1600-0587.2012.07608.x; ERTIBAN SM, 2016, AM J SCI IND RES, V7, P32; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Galvis G, 2007, AQUAT ECOSYST HEALTH, V10, P127, DOI 10.1080/14634980701357640; Gonzalez LM, 2017, ORYX, V51, P222, DOI 10.1017/S003060531500109X; Graham LH, 2002, GEN COMP ENDOCR, V128, P74, DOI 10.1016/S0016-6480(02)00066-7; Guerin C, 2013, GEODIVERSITAS, V35, P155, DOI 10.5252/g2013n1a7; Hayward MW, 2016, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00148; Hernandez CA, 2015, J ZOO WILDLIFE MED, V46, P374, DOI 10.1638/2014-0129R1.1; Hoogesteijn Rafael, 1996, Bulletin of the Florida Museum of Natural History, V39, P195; INDERENA, 1994, INF TECN MARZ 1994 I; Inman VL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219652; IUCN, 2013, GUIDELINES REINTRODU; Johnson B., 2016, AZA ANIMAL PROGRAM, P27; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Kanga EM, 2011, ORYX, V45, P20, DOI 10.1017/S0030605310000931; Kendall CI, 2011, ORYX, V45, P28, DOI 10.1017/S0030605310000359; Kingdon J., 2015, KINGDON FIELD GUIDE, V2nd edition.; LAWS R. M., 1966, SYMP ZOOL SOC LONDON, V15, P117; le Roex N, 2018, J ZOOL, V306, P95, DOI 10.1111/jzo.12572; Lewison R, 2017, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2017-2.RLTS.T10103A18567364.en, DOI 10.2305/IUCN.UK.2017-2.RLTS.T10103A18567364.EN]; Lewison R, 2007, AFR J ECOL, V45, P407, DOI 10.1111/j.1365-2028.2006.00747.x; Lewison RL, 2004, ECOL MODEL, V171, P127, DOI 10.1016/S0304-3800(03)00305-3; LINDENMAYER DB, 1993, ENVIRON MANAGE, V17, P745, DOI 10.1007/BF02393895; Lockwood JL, 2013, INVASION ECOLOGY; Lundgren EJ, 2020, P NATL ACAD SCI USA, V117, P7871, DOI 10.1073/pnas.1915769117; MacDonald, 2012, CAPYBARA BIOL USE CO; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Masese FO, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.3000; MAVDT, 2009, JUST CONTR TRES HIP; Miller KA, 2009, MOL ECOL, V18, P3792, DOI 10.1111/j.1365-294X.2009.04315.x; Monsalve Buritica S., 2018, Revista CES Medicina Veterinaria y Zootecnia, V13, P338; Naimi B, 2014, ECOGRAPHY, V37, P191, DOI 10.1111/j.1600-0587.2013.00205.x; Jimenez PN, 2018, BIOLAW J, P205; Nyhus PJ, 2016, ANNU REV ENV RESOUR, V41, P143, DOI 10.1146/annurev-environ-110615-085634; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Perez ME, 2017, J MAMM EVOL, V24, P111, DOI 10.1007/s10914-016-9356-7; Peterson AT, 2011, ECOLOGICAL NICHES GE; Pluhacek J, 2015, ETHOLOGY, V121, P462, DOI 10.1111/eth.12357; Pollack JP., 2020, VORTEX STOCHASTIC SI; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Qiao H., 2017, SCI REP, V7, P1, DOI DOI 10.1038/s41598-016-0028-x; Restrepo Betancur Giovanni, 2016, Acta Zoologica Mexicana Nueva Serie, V32, P158; Restrepo JD, 2000, J HYDROL, V235, P137, DOI 10.1016/S0022-1694(00)00269-9; Reynolds JE, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P682, DOI 10.1016/B978-0-12-373553-9.00159-0; Rial M.I., 2016, ESTADO PLANICIES INU; Roth HH, 2004, AFR ZOOL, V39, P211; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Seeber PA, 2019, MOL ECOL RESOUR, V19, P1486, DOI 10.1111/1755-0998.13069; Shackleton RT, 2019, J ENVIRON MANAGE, V229, P145, DOI 10.1016/j.jenvman.2018.05.007; Shockey B.J., 2001, ACTA PALAEONTOLOGICA, V46; Shurin JB, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2991; SKINNER JD, 1975, GEN COMP ENDOCR, V26, P92, DOI 10.1016/0016-6480(75)90218-X; SMUTS G L, 1981, Koedoe, P169; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sogbohossou E., 2011, LIONS W AFRICA ECOLO, P107; Spinage C.A., 2012, AFRICAN ECOLOGY BENC, P615; Stears K, 2018, P NATL ACAD SCI USA, V115, pE5028, DOI 10.1073/pnas.1800407115; Stommel C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157145; Subalusky A.L., 2019, ORYX, P1; Thuiller W., 2019, NAT COMMUN, V10, P1; Dantas MAT, 2017, QUATERNARY SCI REV, V170, P152, DOI 10.1016/j.quascirev.2017.06.030; Tsi E. A., 2011, Journal of Agriculture and Biological Sciences, V2, P31; Utete B, 2020, AFR ZOOL, V55, P187, DOI 10.1080/15627020.2020.1779613; van Poorten BT, 2019, BIOL INVASIONS, V21, P1197, DOI 10.1007/s10530-018-1890-1; Villa D, 2017, CALDASIA, V39, P292, DOI 10.15446/caldasia.v39n2.63661; Villarroel A.C., 1996, GEOL COLOMB, V21, P81, DOI [10.15446/gc, DOI 10.15446/GC]; Villarroel A. Carlos, 2001, Geologia Colombiana, V26, P79; Wittenberg R., 2001, INVASIVE ALIEN SPECI; Zisadza P, 2010, S AFR J WILDL RES, V40, P149, DOI 10.3957/056.040.0206	93	5	5	10	28	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0006-3207	1873-2917		BIOL CONSERV	Biol. Conserv.	JAN	2021	253								108923	10.1016/j.biocon.2020.108923	http://dx.doi.org/10.1016/j.biocon.2020.108923			12	Biodiversity Conservation; Ecology; Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation; Environmental Sciences & Ecology	PU7LR					2022-09-04	WOS:000609483300007
J	Buitrago-Lopez, A; van den Hooven, EH; Rueda-Clausen, CF; Serrano, N; Ruiz, AJ; Pereira, MA; Mueller, NT				Buitrago-Lopez, Adriana; van den Hooven, Edith H.; Rueda-Clausen, Christian F.; Serrano, Norma; Ruiz, Alvaro J.; Pereira, Mark A.; Mueller, Noel T.			Socioeconomic status is positively associated with measures of adiposity and insulin resistance, but inversely associated with dyslipidaemia in Colombian children	JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH			English	Article							SCHOOL-CHILDREN; METABOLIC SYNDROME; DIETARY PATTERN; DOUBLE BURDEN; RISK-FACTORS; OBESITY; AMERICAN; HEALTH; DETERMINANTS; ADOLESCENTS	Background Low socioeconomic status (SES) has been associated with higher risk of cardiometabolic diseases in developed societies, but investigation of SES and cardiometabolic risk in children in less economically developed populations is sparse. We aimed to examine associations among SES and cardiometabolic risk factors in Colombian children. Methods We used data from a population-based study of 1282 children aged 6-10 years from Bucaramanga, Colombia. SES was classified according to household wealth, living conditions and access to public utilities. Anthropometric and biochemical parameters were measured at a clinic visit. Cardiometabolic risk factors were analysed continuously using linear regression and as binary outcomes-according to established paediatric cut points-using logistic regression to calculate OR and 95% CIs. Results Mean age of the children was 8.4 (SD 1.4) and 51.1% of the sample were boys. Odds of overweight/obesity, abdominal obesity and insulin resistance were greater among higher SES. Compared with the lowest SES stratum, children in the highest SES had higher odds of overweight/obesity (OR=3.25, 95% CI 1.89 to 5.57), abdominal obesity (OR=2.74, 95% CI 1.41 to 5.31) and insulin resistance (OR=2.60, 95% CI 1.81 to 3.71). In contrast, children in the highest SES had lower odds of hypertriglyceridaemia (triglycerides >= 90th centile; OR=0.28, 95% CI 0.14 to 0.54) and low (<= 10th centile) high-density lipoprotein (HDL) cholesterol (OR=0.35, 95% CI 0.15 to 0.78). Conclusions In Colombian children, SES is directly associated with obesity and insulin resistance, but inversely associated with dyslipidaemia (hypertriglyceridaemia and low HDL cholesterol). Our findings highlight the need to analyse cardiometabolic risk factors separately in children and to carefully consider a population's level of economic development when studying their social determinants of cardiometabolic disease.	[Buitrago-Lopez, Adriana; van den Hooven, Edith H.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Rueda-Clausen, Christian F.] Univ Alberta, Dept Med, Li Ka Shing Ctr Heath Res Innovat, Edmonton, AB, Canada; [Serrano, Norma] Fdn Cardiovasc Colombia, Div Res, Santander, Spain; [Ruiz, Alvaro J.] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, DC, Colombia; [Pereira, Mark A.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Mueller, Noel T.] Columbia Univ, Med Ctr, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10002 USA; [Mueller, Noel T.] Columbia Univ, Med Ctr, Inst Human Nutr, Coll Physicians & Surg, New York, NY 10002 USA; [Mueller, Noel T.] Columbia Univ, Med Ctr, Dept Med, Coll Physicians & Surg, New York, NY 10002 USA		Mueller, NT (corresponding author), Columbia Univ, Med Ctr, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10002 USA.	nm2768@columbia.edu	Buitrago-Lopez, Adriana/AAD-6697-2019; Rueda-Clausen, Christian/S-2428-2019; Ruiz, Alvaro/AAD-5422-2019	Buitrago-Lopez, Adriana/0000-0002-2840-0781; Rueda-Clausen, Christian/0000-0002-4077-6159; Ruiz, Alvaro/0000-0001-6528-4268; Mueller, Noel/0000-0002-7412-8352; Serrano Diaz, Norma Cecilia/0000-0003-3532-2002	Department of Science, Technology, and Innovation in Colombia [COLCIENCIAS 65660418215]; National Institutes of Health [T32 DK091227]; Nestle Nutrition (Nestec Ltd); Metagenics Inc; AXA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091227] Funding Source: NIH RePORTER	Department of Science, Technology, and Innovation in Colombia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nestle Nutrition (Nestec Ltd); Metagenics Inc; AXA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Department of Science, Technology, and Innovation (COLCIENCIAS 65660418215) in Colombia. NTM is funded by the National Institutes of Health (T32 DK091227). AB-L and EHvdH work in ErasmusAGE, a centre for aging research across the life course funded by Nestle Nutrition (Nestec Ltd), Metagenics Inc, and AXA. None of the funding agencies had any role in the conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Arroyave I, 2014, PREV MED, V64, P41, DOI 10.1016/j.ypmed.2014.03.018; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; CHRISTIANSEN N, 1975, BRIT J PREV SOC MED, V29, P121; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cook Stephen, 2009, J Pediatr, V155, DOI 10.1016/j.jpeds.2009.04.051; Daniels SR, 2011, AM J CLIN NUTR, V94, P699, DOI 10.3945/ajcn.111.022483; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Departamento de Administracion Nacional de Estadistica, 2005, ESTR SOC SERV PUBL D; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Ferri CP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001179; Galiano LP, 2012, ARCH LATINOAM NUTR, V62, P119; Gilbert-Diamond D, 2009, J WOMENS HEALTH, V18, P1145, DOI 10.1089/jwh.2008.1179; International Diabetes Federation, 2005, IDF CONS DEF MET SYN; International Physical Activity Questionnaire-IPAQ, 2002, CUEST INT ACT FIS; KOOPMAN JS, 1981, AM J PUBLIC HEALTH, V71, P31, DOI 10.2105/AJPH.71.1.31; Lawlor DA, 2005, BRIT MED J, V331, P183, DOI 10.1136/bmj.331.7510.183; Lawlor DA, 2004, AM J PUBLIC HEALTH, V94, P1386, DOI 10.2105/AJPH.94.8.1386; Leinsalu M, 2003, INT J EPIDEMIOL, V32, P1081, DOI 10.1093/ije/dyg192; Magnussen CG, 2008, CIRCULATION, V117, P32, DOI 10.1161/CIRCULATIONAHA.107.718981; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Masuccio FG, 2009, J PEDIATR ENDOCR MET, V22, P695; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; McDonald CM, 2009, J NUTR, V139, P370, DOI 10.3945/jn.108.098111; MENDOZA S, 1980, ATHEROSCLEROSIS, V37, P219, DOI 10.1016/0021-9150(80)90007-6; MENDOZA S, 1980, PEDIATR RES, V14, P272, DOI 10.1203/00006450-198004000-00002; Monteiro CA, 2001, J NUTR, V131, p881S, DOI 10.1093/jn/131.3.881S; Mueller NT, 2013, PUBLIC HEALTH NUTR, V16, P248, DOI 10.1017/S136898001200393X; Mueller NT, 2012, CFW PLEXUS, P38; National Sleep Foundation, 2004, SUMM FIND 2004 SLEEP; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P93, DOI 10.1079/PHN200180; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; SICHIERI R, 1994, AM J PUBLIC HEALTH, V84, P793, DOI 10.2105/AJPH.84.5.793; Slopen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064418; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stiglitz JE, 2012, J HUM DEV CAPABIL, V13, P31, DOI 10.1080/19452829.2011.643098; Velasquez E, 2006, ARCH LATINOAM NUTR, V56, P22; Vidmar S, 2004, STATA J, V4, P50, DOI 10.1177/1536867X0100400104; Villa-Roel C, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-28; Villamor E, 2008, J NUTR, V138, P1391, DOI 10.1093/jn/138.7.1391; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	45	14	16	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0143-005X	1470-2738		J EPIDEMIOL COMMUN H	J. Epidemiol. Community Health	JUN	2015	69	6					580	587		10.1136/jech-2014-204992	http://dx.doi.org/10.1136/jech-2014-204992			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CH7OF	25691273	Green Accepted			2022-09-04	WOS:000354225800013
J	Dembinski, JL; Wilson, SM; Spaeth, EL; Studeny, M; Zompetta, C; Samudio, I; Roby, K; Andreeff, M; Marini, FC				Dembinski, Jennifer L.; Wilson, Shanna M.; Spaeth, Erika L.; Studeny, Matus; Zompetta, Claudia; Samudio, Ismael; Roby, Katherine; Andreeff, Michael; Marini, Frank C.			Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer	CYTOTHERAPY			English	Article						gene therapy; ID8; interferon-beta; mesenchymal stem cell; MSC; noninvasive imaging; ovarian carcinoma	INTERFERON-BETA; IFN-BETA; DELIVERY VEHICLES; INDUCED APOPTOSIS; RECOMBINANT HUMAN; LINES; INDUCTION; PHARMACOKINETICS; PHARMACODYNAMICS; INTRAPERITONEAL	Background aims. Many ovarian cancers originate from ovarian surface epithelium, where they develop from cysts intermixed with stroma. The stromal layer is critical to the progression and survival of the neoplasm and consequently is recruited into the tumor microenvironment. Methods. Using both syngeneic mouse tumors (ID8-R) and human xenograft (OVCAR3, SKOV3) tumor models, we first confirmed that intraperitoneally injected circulating mesenchymal stem cells (MSCs) could target, preferentially engraft and differentiate into alpha-smooth muscle actin-positive myofibroblasts, suggesting their role as "reactive stoma" in ovarian carcinoma development and confirming their potential as a targeted delivery vehicle for the intratumoral production of interferon-beta (IFN-beta). Mice with ovarian carcinomas then received weekly intraperitoneal injections of IFN-beta expressing MSCs. Results. Intraperitoneal injections of IFN-beta expressing MSCs resulted in complete eradication of tumors in 70% of treated OVCAR3 mice (P = 0.004) and an increased survival of treated SKOV3 mice compared with controls (P = 0.01). Similar tumor growth control was observed using murine IFN-beta delivered by murine MSCs in ID8-R ovarian carcinoma. As a potential mechanism of tumor killing, MSCs produced IFN-beta-induced caspase-dependent tumor cell apoptosis. Conclusions. Our results demonstrate that ovarian carcinoma engrafts MSCs to participate in myofibrovascular networks and that IFN-beta produced by MSCs intratumorally modulates tumor kinetics, resulting in prolonged survival.	[Dembinski, Jennifer L.; Wilson, Shanna M.; Spaeth, Erika L.; Studeny, Matus; Zompetta, Claudia; Samudio, Ismael; Andreeff, Michael; Marini, Frank C.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Zompetta, Claudia] Univ Roma La Sapienza, Rome, Italy; [Roby, Katherine] Univ Kansas, Med Ctr, Ctr Reprod Sci, Kansas City, KS 66103 USA; [Roby, Katherine] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Samudio, Ismael] Pontificia Univ Javeriana, Cellular & Mol Therapy Grp, Bogota, Colombia; [Marini, Frank C.] Wake Forest Univ, Wake Forest Sch Med, Inst Regenerat Med, Comprehens Canc Ctr,Wake Forest Baptist Med Ctr, Winston Salem, NC 27157 USA		Marini, FC (corresponding author), Wake Forest Univ, Wake Forest Sch Med, Inst Regenerat Med, Comprehens Canc Ctr,Wake Forest Baptist Med Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA.	fmarini@wakehealth.edu	Marini, Frank C/L-8018-2016; Samudio, Ismael/D-3581-2013	Dembinski, Jennifer/0000-0001-9259-9572; Samudio, Ismael/0000-0001-8676-1035; Spaeth, Erika/0000-0002-5397-3493	National Cancer Institute [CA-1094551, Ca-116199 RC1C A146381, P50CA083639, R01CA109451, R01NS06994, CA-55164, CA-16672, CA-49639]; Stringer Professorship for Cancer Treatment and Research; Susan G. Komen Breast Cancer Foundation; Ladies Leukemia League; W.M. Keck Foundation; U.S. Army Department of Defense [BC083397]; NATIONAL CANCER INSTITUTE [RC1CA146381, P50CA083639, R01CA109451, P50CA116199, P30CA012197, P01CA055164, P30CA016672, P01CA049639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069964] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stringer Professorship for Cancer Treatment and Research; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Ladies Leukemia League; W.M. Keck Foundation(W.M. Keck Foundation); U.S. Army Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by grants from the National Cancer Institute (CA-1094551, Ca-116199 RC1C A146381, P50CA083639, R01CA109451 and R01NS06994 for FCM, CA-55164, CA-16672 and CA-49639 for MA), by the Stringer Professorship for Cancer Treatment and Research (MA), by grants from the Susan G. Komen Breast Cancer Foundation, the Ladies Leukemia League and the W.M. Keck Foundation (JLD, FCM) and by U.S. Army Department of Defense (BC083397 for ELS).	American Cancer Society, 2009, CANC FACTS FIG 2009; Buchwalder PA, 2000, J INTERF CYTOK RES, V20, P857, DOI 10.1089/10799900050163226; CAPPELLI R, 1992, Recenti Progressi in Medicina, V83, P82; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; DeFeudis P, 1997, BRIT J CANCER, V76, P474, DOI 10.1038/bjc.1997.412; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Einhorn S, 1996, J INTERF CYTOK RES, V16, P275, DOI 10.1089/jir.1996.16.275; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Fulda S, 2006, ONCOGENE, V25, P5125, DOI 10.1038/sj.onc.1209518; Ghahremani M, 1999, MED HYPOTHESES, V52, P23, DOI 10.1054/mehy.1997.0620; Gomez-Benito M, 2005, FEBS LETT, V579, P6217, DOI 10.1016/j.febslet.2005.10.007; Hata N, 2010, NEUROSURGERY, V66, P144, DOI 10.1227/01.NEU.0000363149.58885.2E; Hu WH, 2011, BIOTECHNOL APPL BIOC, V58, P397, DOI 10.1002/bab.63; JOHNS TG, 1990, CANCER RES, V50, P4718; JOHNS TG, 1992, J NATL CANCER I, V84, P1185, DOI 10.1093/jnci/84.15.1185; KARDAMAKIS D, 1991, In Vivo (Attiki), V5, P589; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Matuskova M, 2010, CANCER LETT, V290, P58, DOI 10.1016/j.canlet.2009.08.028; Morrison BH, 2005, BIOCHEM J, V385, P595, DOI 10.1042/BJ20040971; Odaka M, 2001, CANCER RES, V61, P6201; Pan JP, 2005, J CANCER RES CLIN, V131, P468, DOI 10.1007/s00432-004-0651-y; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; RAMBALDI A, 1985, CANCER, V56, P294, DOI 10.1002/1097-0142(19850715)56:2<294::AID-CNCR2820560216>3.0.CO;2-K; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Saidi RF, 2006, AM J SURG, V191, P358, DOI 10.1016/j.amjsurg.2005.10.037; Salmon P, 1996, J INTERF CYTOK RES, V16, P759, DOI 10.1089/jir.1996.16.759; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Sonabend AM, 2008, STEM CELLS, V26, P831, DOI 10.1634/stemcells.2007-0758; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Streck CJ, 2005, CLIN CANCER RES, V11, P6020, DOI 10.1158/1078-0432.CCR-05-0502; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Studeny M, 2002, CANCER RES, V62, P3603; Studeny M, 2001, BLOOD 1, V98; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; WONG VLY, 1989, INT J CANCER, V43, P526, DOI 10.1002/ijc.2910430331; Xu F, 2010, ONCOL REP, V23, P1561, DOI 10.3892/or_00000796; Yotnda P, 2004, HUM GENE THER, V15, P1229, DOI 10.1089/hum.2004.15.1229; Zhang HF, 1999, EXP CELL RES, V247, P133, DOI 10.1006/excr.1998.4329	44	52	57	0	21	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1465-3249			CYTOTHERAPY	Cytotherapy	JAN	2013	15	1					20	32		10.1016/j.jcyt.2012.10.003	http://dx.doi.org/10.1016/j.jcyt.2012.10.003			13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	068RF	23260083	Green Accepted, Bronze			2022-09-04	WOS:000313383200004
J	Charpak, N; Tessier, R; Ruiz, JG; Uriza, F; Hernandez, JT; Cortes, D; Montealegre-Pomar, A				Charpak, Nathalie; Tessier, Rejean; Ruiz, Juan Gabriel; Uriza, Felipe; Tiberio Hernandez, Jose; Cortes, Darwin; Montealegre-Pomar, Adriana			Kangaroo mother care had a protective effect on the volume of brain structures in young adults born preterm	ACTA PAEDIATRICA			English	Article						grey matter; Kangaroo mother care; magnetic resonance imaging; premature infants; white matter	CEREBRAL-CORTEX; PREMATURE; INFANTS; LIFE	Aim The protective effects of Kangaroo mother care (KMC) on the neurodevelopment of preterm infants are well established, but we do not know whether the benefits persist beyond infancy. Our aim was to determine whether providing KMC in infancy affected brain volumes in young adulthood. Method Standardised cognitive, memory and motor skills tests were used to determine the brain volumes of 20-year-old adults who had formed part of a randomised controlled trial of KMC versus incubator care. Multivariate analysis of brain volumes was conducted according to KMC exposure. Results The study comprised 178 adults born preterm: 97 had received KMC and 81 were incubator care controls. Bivariate analysis showed larger volumes of total grey matter, basal nuclei and cerebellum in those who had received KMC, and the white matter was better organised. This means that the volumes of the main brain structures associated with intelligence, attention, memory and coordination were larger in the KMC group. Multivariate lineal regression analysis demonstrated the direct relationship between brain volumes and duration of KMC, after controlling for potential confounders. Conclusion Our findings suggest that the neuroprotective effects of KMC for preterm infants persisted beyond childhood and improved their lifetime functionality and quality of life.	[Charpak, Nathalie; Montealegre-Pomar, Adriana] Kangaroo Fdn, Carrera 7 46-20, Bogota, Colombia; [Tessier, Rejean] Univ Laval, Sch Psychol, Quebec City, PQ, Canada; [Ruiz, Juan Gabriel] Florida Int Univ, Dept Med & Populat Hlth Sci Res, Herber Wertheim, Miami, FL USA; [Uriza, Felipe; Montealegre-Pomar, Adriana] Univ Javeriana, Hosp San Ignacio, Bogota, Colombia; [Tiberio Hernandez, Jose] Univ los Andes, IMAGINE Team, Syst & Comp Engn, Bogota, Colombia; [Cortes, Darwin] Univ Rosario, Econ Dept, Bogota, Colombia		Charpak, N (corresponding author), Kangaroo Fdn, Carrera 7 46-20, Bogota, Colombia.	ncharpak@gmail.com	Cortes, Darwin/F-5161-2016	Cortes, Darwin/0000-0003-2280-9452; charpak, nathalie/0000-0001-6697-5837; Montealegre, Adriana/0000-0001-5464-2701	Grand Challenge Canada	Grand Challenge Canada	Grand Challenge Canada.	Angulo DA, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00036; Arya S, 2021, NEW ENGL J MED, V384, P2028, DOI [10.1056/NEJMoa2026486, 10.1056/NEJMoa2026486Copyright<(c)>2021MassachusettsMedical]; Borsani E, 2019, BRAIN DEV-JPN, V41, P225, DOI 10.1016/j.braindev.2018.10.009; Boundy EO, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2238; Charpak N, 1997, PEDIATRICS, V100, P682, DOI 10.1542/peds.100.4.682; CHARPAK N, 1994, PEDIATRICS, V94, P804; Charpak N, 2001, PEDIATRICS, V108, P1072, DOI 10.1542/peds.108.5.1072; Charpak N, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2063; Conde-Agudelo A., 2017, COCHRANE DB SYST REV, V2017, P1; Cook P., 2006, INT SOC MAGN RESON M, V14, P2759; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Donders J, 2008, ASSESSMENT, V15, P123, DOI 10.1177/1073191107310926; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Head LM, 2014, J PERINAT NEONAT NUR, V28, P290, DOI 10.1097/JPN.0000000000000062; Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213; Irby SM, 2013, CAN J SCH PSYCHOL, V28, P295, DOI 10.1177/0829573513493982; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Linner A, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038938; McCormick MC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1694; Ortinau C, 2015, CLIN ANAT, V28, P168, DOI 10.1002/ca.22430; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Rizopoulos D, 2006, J STAT SOFTW, V17; Saigal S, 2016, SEMIN PERINATOL, V40, P578, DOI 10.1053/j.semperi.2016.09.010; Tadel F., VOLUME SOURCE ESTIMA; Tessier R, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.2.e17; Tessier R, 2009, ACTA PAEDIATR, V98, P1444, DOI 10.1111/j.1651-2227.2009.01370.x; Wang YC, 2011, J HAND THER, V24, P313, DOI 10.1016/j.jht.2011.05.001; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zellkowitz P., 2006, ENCY OLD EARLY CHILD, P11	30	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	MAY	2022	111	5					1004	1014		10.1111/apa.16265	http://dx.doi.org/10.1111/apa.16265		FEB 2022	11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	0K8LG	35067976	Green Published			2022-09-04	WOS:000749641500001
J	Anderies, JM; Janssen, MA; Bousquet, F; Cardenas, JC; Castillo, D; Lopez, MC; Tobias, R; Vollan, B; Wutich, A				Anderies, John M.; Janssen, Marco A.; Bousquet, Francois; Cardenas, Juan-Camilo; Castillo, Daniel; Lopez, Maria-Claudio; Tobias, Robert; Vollan, Bjoern; Wutich, Amber			The challenge of understanding decisions in experimental studies of common pool resource governance	ECOLOGICAL ECONOMICS			English	Article						Common pool resources; Collective action; Experimental economics; Methodology; Context	GENDER-DIFFERENCES; FIELD EXPERIMENTS; SOCIAL DILEMMAS; COOPERATION; TRUST; COMMUNICATION; PUNISHMENT; BEHAVIOR; GAME; CONSERVATION	Common pool resource experiments in the laboratory and the field have provided insights that have contrasted to those derived from conventional non-cooperative game theory. Contrary to predictions from non-cooperative game theory, participants are sometimes willing to restrain voluntarily from over extracting resources and use costly punishment to sanction other participants. Something as simple as face-to-face communication has been shown to increase average earnings significantly. In the next generation of experiments, both in the laboratory and in the field, we need to extract more information that provides insight concerning why people make the decisions they make. More information is needed concerning attributes of individuals as well as the social and social-ecological context in which they interact that may give rise to such deviations from theoretical predictions. In the process of extracting more information from participants and the contexts in which they interact, we face several methodological and ethical challenges which we address in this paper. (C) 2011 Elsevier B.V. All rights reserved.	[Anderies, John M.; Janssen, Marco A.; Wutich, Amber] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Anderies, John M.; Janssen, Marco A.; Wutich, Amber] Arizona State Univ, Ctr Study Inst Divers, Tempe, AZ USA; [Anderies, John M.] Arizona State Univ, Sch Sustainabil, Tempe, AZ USA; [Bousquet, Francois] CIRAD GREEN, Montpellier, France; [Cardenas, Juan-Camilo] Univ Los Andes, Fac Econ, Bogota, Colombia; [Castillo, Daniel; Lopez, Maria-Claudio] Univ Javeriana, Fac Estudios Ambietales & Rurales, Bogota, Colombia; [Tobias, Robert] Swiss Fed Inst Aquat Sci & Technol Dept, Dubendorf, Switzerland; [Vollan, Bjoern] Univ Mannheim, Dept Econ, Mannheim, Germany		Anderies, JM (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	m.anderies@asu.edu	Castillo Brieva, Daniel/C-4104-2015; Bousquet, Francois/G-3605-2010; cardenas, juan-camilo/B-4658-2009; Vollan, Björn/AAN-9265-2020; Tobias, Robert/AAQ-3002-2021; Bousquet, Francois/Y-7904-2019	Castillo Brieva, Daniel/0000-0001-9251-6124; cardenas, juan-camilo/0000-0003-0005-7595; Vollan, Björn/0000-0002-5592-4185; Tobias, Robert/0000-0001-7972-122X; Bousquet, Francois/0000-0002-4552-3724	Arizona State University; National Science Foundation [BCS-0432894, BCS-0527744]	Arizona State University; National Science Foundation(National Science Foundation (NSF))	The authors acknowledge support from Arizona State University and the National Science Foundation through grants BCS-0432894 and BCS-0527744.	Alvard M. S., 2004, FDN HUMAN SOCIALITY, P413, DOI 10.1093/0199262055.003.0014; ATTANASIO O, 2009, RISK POOLING RISK PR; ATTANASIO O, 2008, EWP0803 I FISC STUD; Bahry D, 2005, AM POLIT SCI REV, V99, P521, DOI 10.1017/S0003055405051853; Balliet D, 2010, J CONFLICT RESOLUT, V54, P39, DOI 10.1177/0022002709352443; BARR A, 2001, WPS200111 OXF U CTR; BARR A, 2004, FDN HUMAN SOCIALITY, P305; Barreteau O, 2003, JASSS-J ARTIF SOC S, V6; BECU N, 2006, THESIS U MONTPELLIER; Bouma J, 2008, J ENVIRON ECON MANAG, V56, P155, DOI 10.1016/j.jeem.2008.03.004; Bousquet F, 2002, COMPLEXITY AND ECOSYSTEM MANAGEMENT, P248; Bousquet F., 1999, ADV ENV ECOLOGICAL M, V113, P122; BREHMER B, 1992, ACTA PSYCHOL, V81, P211, DOI 10.1016/0001-6918(92)90019-A; Cardenas JC, 2009, ECONOMIA, V9, P45, DOI 10.1353/eco.0.0027; Cardenas JC, 2009, ANNU REV RESOUR ECON, V1, P157, DOI 10.1146/annurev.resource.050708.144056; Cardenas J.C., 2000, THESIS U MASSACHUSET; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Cardenas JC, 2003, J DEV ECON, V70, P263, DOI 10.1016/S0304-3878(02)00098-6; Cardenas JC, 2008, J DEV STUD, V44, P311, DOI 10.1080/00220380701848327; Cardenas Juan Camilo, 2000, ENVIRON DEV SUSTAIN, V2, P305, DOI [10.1023/A:1011422313042, DOI 10.1023/A:1011422313042]; Castillo D, 2005, ECOL ECON, V55, P420, DOI 10.1016/j.ecolecon.2004.12.014; CHAMBERS R, 1994, WORLD DEV, V22, P1253, DOI 10.1016/0305-750X(94)90003-5; Clark C. W., 2006, WORLDWIDE CRISIS FIS; Clark C.W., 1990, MATH BIOECONOMICS OP; CLARK CW, 1979, ECONOMETRICA, V47, P25, DOI 10.2307/1912344; CLARK CW, 1973, SCIENCE, V181, P630, DOI 10.1126/science.181.4100.630; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; COLEMAN EA, 2009, RECONSTRUCTING COOPE; Coleman EA, 2009, J POLICY ANAL MANAG, V28, P122, DOI 10.1002/pam.20405; Cronk L, 2007, EVOL HUM BEHAV, V28, P352, DOI 10.1016/j.evolhumbehav.2007.05.006; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Danielson AJ, 2007, J ECON BEHAV ORGAN, V62, P255, DOI 10.1016/j.jebo.2004.10.011; DAWES RM, 1977, J PERS SOC PSYCHOL, V35, P1, DOI 10.1037/0022-3514.35.1.1; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; DEXELLE B, 2008, INEQUALITY NETWORKS; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Durlauf SN, 2002, ECON J, V112, pF459, DOI 10.1111/1468-0297.00079; Ensminger J, 2004, FDN HUMAN SOCIALITY, P356, DOI DOI 10.1093/0199262055.003.0012; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fong CM, 2009, AM ECON J-APPL ECON, V1, P64, DOI 10.1257/app.1.2.64; Gibson CC, 2005, WORLD DEV, V33, P273, DOI 10.1016/j.worlddev.2004.07.013; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; Gneezy U, 2009, ECONOMETRICA, V77, P1637, DOI 10.3982/ECTA6690; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Gurung TR, 2006, ECOL SOC, V11; Gurven M, 2004, EXP ECON, V7, P5, DOI 10.1023/A:1026256404208; Gurven M, 2008, J ECON BEHAV ORGAN, V67, P587, DOI 10.1016/j.jebo.2007.09.005; Gurven M, 2008, AM ANTHROPOL, V110, P179, DOI 10.1111/j.1548-1433.2008.00024.x; HACKETT S, 1994, J ENVIRON ECON MANAG, V27, P99, DOI 10.1006/jeem.1994.1029; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; Hayes TM, 2006, WORLD DEV, V34, P2064, DOI 10.1016/j.worlddev.2006.03.002; Henrich J., 2004, FDN HUMAN SOCIALITY, P194, DOI DOI 10.1093/0199262055.003.0007; Henrich J.P., 2004, FDN HUMAN SOCIALITY, DOI DOI 10.1093/0199262055.001.0001; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Higgins E. T., 1996, SOCIAL PSYCHOL HDB B, P133; Hill K., 2004, FDN HUMAN SOCIALITY, DOI DOI 10.1093/0199262055.001.0001; Hofstede G., 1991, CULTURES ORG SOFTWAR; HUTCHINSON SR, 2004, RES METHODS SOCIAL S, P283; Inglehart R, 2000, CULTURE MATTERS VALU; Janssen MA, 2010, ECOL SOC, V15; Janssen MA, 2010, SCIENCE, V328, P613, DOI 10.1126/science.1183532; Janssen Marco A., HDB EXPT EC IN PRESS; Karlan DS, 2005, AM ECON REV, V95, P1688, DOI 10.1257/000282805775014407; Krosnick JA, 1999, ANNU REV PSYCHOL, V50, P537, DOI 10.1146/annurev.psych.50.1.537; Ledyard O., 1995, HDB EXPT EC, V1, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Lesorogol CK, 2007, CURR ANTHROPOL, V48, P920, DOI 10.1086/523017; Lopez Maria Claudia, HDB EXPT EC IN PRESS; LOPEZ MC, 2010, COMBINING EXPT PARTI; Macfarlan SJ, 2008, HUM NATURE-INT BIOS, V19, P294, DOI 10.1007/s12110-008-9045-1; MALTHUS RT, 1798, ESSAY PRINCIPLE; Marlowe FW, 2008, P R SOC B, V275, P587, DOI 10.1098/rspb.2007.1517; McElreath Richard, 2004, FDN HUMAN SOCIALITY, P335; NRC (National Research Council), 1986, P C COMM PROP RES MA; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E., 1994, RULES GAMES COMMON P; Ostrom E., 2002, DRAMA COMMONS; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ostrom E, 2006, P NATL ACAD SCI USA, V103, P19224, DOI 10.1073/pnas.0607962103; Ostrom Elinor, 1991, LAB RES POLITICAL EC, P287; PAK MV, 2009, DESIGNING IMPLEMENTI; PATTON JQ, 2004, FDN HUMAN SOCIALITY, P96; Pavitt C, 2005, COMMUN MONOGR, V72, P345, DOI 10.1080/03637750500206482; Pigou A. C., 1920, EC WELFARE; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; Presser S., 2004, METHODS TESTING EVAL; Rodriguez-Sickert C, 2008, J ECON BEHAV ORGAN, V67, P215, DOI 10.1016/j.jebo.2007.06.004; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; SALLY D, 1995, RATION SOC, V7, P58, DOI 10.1177/1043463195007001004; Saris W. E., 2007, DESIGN EVALUATION AN; Smith VL, 2010, J ECON BEHAV ORGAN, V73, P3, DOI 10.1016/j.jebo.2009.02.008; SMITH VL, 1969, J POLIT ECON, V77, P181, DOI 10.1086/259507; Sterman JD, 2007, CLIMATIC CHANGE, V80, P213, DOI 10.1007/s10584-006-9107-5; STERN PC, 1976, J PERS SOC PSYCHOL, V34, P1285, DOI 10.1037/0022-3514.34.6.1285; Sudman S, 2004, ASKING QUESTIONS DEF; Takahashi C, 2008, INT J INTERCULT REL, V32, P215, DOI 10.1016/j.ijintrel.2007.11.003; Tracer D, 2004, FDN HUMAN SOCIALITY, P232, DOI DOI 10.1093/0199262055.003.0008; Velez MA, 2010, ECON INQ, V48, P254, DOI 10.1111/j.1465-7295.2008.00125.x; Vollan B, 2008, ECOL ECON, V67, P560, DOI 10.1016/j.ecolecon.2008.01.015; Whitt S, 2007, AM J POLIT SCI, V51, P655, DOI 10.1111/j.1540-5907.2007.00273.x; Wiessner P, 2009, CURR ANTHROPOL, V50, P133, DOI 10.1086/595622; Wilson DS, 2009, EVOL HUM BEHAV, V30, P190, DOI 10.1016/j.evolhumbehav.2008.12.002; [No title captured]	106	67	68	0	62	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0921-8009	1873-6106		ECOL ECON	Ecol. Econ.	JUL 15	2011	70	9			SI		1571	1579		10.1016/j.ecolecon.2011.01.011	http://dx.doi.org/10.1016/j.ecolecon.2011.01.011			9	Ecology; Economics; Environmental Sciences; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Business & Economics	793EN					2022-09-04	WOS:000292803300004
J	Castro-Huertas, V; Grazia, J; Forero, D; Fernandez, F; Schwertner, CF				Castro-Huertas, Valentina; Grazia, Jocelia; Forero, Dimitri; Fernandez, Fernando; Schwertner, Cristiano F.			Stink bugs (Hemiptera: Heteroptera: Pentatomidae) of Colombia: An annotated checklist of species	ZOOTAXA			English	Article						species list; stink bugs; Neotropical region; Heteroptera; Northwestern South America	SOUTH-AMERICA HEMIPTERA; TIBRACA-LIMBATIVENTRIS HEMIPTERA; GENUS MORMIDEA HEMIPTERA; WESTERN HEMISPHERE; STAL HEMIPTERA; OCHLERINI HEMIPTERA; DISTRIBUTIONAL RECORDS; NOMENCLATURAL CHANGES; BIOTIC INTERCHANGE; CLADISTIC-ANALYSIS	A checklist of 5 subfamilies, 108 genera, and 246 species of stinks bugs (Hemiptera, Pentatomidae) from Colombia is provided. Three genera [Andrallus Bergroth, Placocoris Mayr, and Pseudobebaeus Distant], and eight species [Arocera spectabilis (Drury), Andrallus spinidens (Fabricius), Banasa excavata Thomas, Banasa saileri Thomas, Banasa varians Stal, Chinavia scutellata (Distant), Pelidnocoris haglundi Ruckes, and Pseudobebaeus truncatus (Fallou)] are recorded for the first time from Colombia. Images of dorsal external habitus for all genera that occur in Colombia are offered. This is the first time a comprehensive list of the stink bugs from Colombia is presented, providing a baseline to develop further studies in this of true bugs.	[Castro-Huertas, Valentina] UNLP, Muse La Plata, Div Entomol, La Plata, Buenos Aires, Argentina; [Castro-Huertas, Valentina] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Grazia, Jocelia] Univ Fed Rio Grande do Sul, Inst Biociencias, Lab Entomol Sistemcit, Porto Alegre, RS, Brazil; [Forero, Dimitri] Pontificia Univ Javeriana, Dept Biol, Lab Entomol, UNESIS, Bogota, Colombia; [Forero, Dimitri; Fernandez, Fernando] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Colombia; [Schwertner, Cristiano F.] Univ Fed Sao Paulo, Dept Ecol & Biol Evolut, Diadema, Brazil		Castro-Huertas, V (corresponding author), UNLP, Muse La Plata, Div Entomol, La Plata, Buenos Aires, Argentina.; Castro-Huertas, V (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina.	valeoptepri@gmail.com; jocelia@ufrgs.br; forego-i@javeriana.edu.co; ffernandezca@unal.edu.co; schwertner@unifesp.br	Castro-Huertas, Valentina/AAF-6007-2019; Forero, Dimitri/P-4860-2016	Castro-Huertas, Valentina/0000-0002-9173-7387; Schwertner, Cristiano/0000-0001-5104-4925; Forero, Dimitri/0000-0002-6358-757X	IAVH; FAPESP [2014/00729-3, 2018/09469-5]	IAVH; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We would like to thank Claudia Medina, Diana Espitia, and Miguel Torres (IAvH), Maria Alejandra Rodriguez (MPUJ), Carolina Londono (MUSENUV), and Erika Vergara and Francisco Serna (UNAB) for the hospitality during the visits to the collections. To all colleagues that share images with us: Lurdiana Barros (UFRGS), Filipe M. Bianchi (UFRGS), Luiz Alexandre Campos (UFRGS), Renan Carrenho (MZ-USP), Lucas Fonzaghi (UNIFESP), Andre Correia (UFRGS), Thereza Garbelotto (UNISUL), Jhon Cesar Neita (IAVH), Talita Roell (MZ-USP), and Ruth Salas (AMNH). Phereclus pluto NHRS-GULI000038141, holotype photographed by Gunvi Lindberg ((c) 2020 Naturhistoriska Riksmuseet), made available by the Swedish Museum of Natural History under Creative Commons Attribution 4.0 International Public License, CC-BY 4.0. To Ricardo Brugnera for the Andrallus identification. To Filipe Bianchi for the help with the terminology and interpretation of some characters. To Sara Natalia Castro for the locality information digitalization of the ICN material. To David Rider (NDSU); Gimena Dellape (MALP), and Kim Barao (UFAL) for the critical reading of the last version of the manuscript. To Claudia Medina and the IAVH for helping secure funding to visit the MUSENUV as part of the project "Colombia Bio: Gira de especialistas". Partial funding to CFS was provided by FAPESP (Procs. n. 2014/00729-3 and 2018/09469-5). The authors dedicate this paper to all victims during the Colombian protests in 2021, which offered their lives by the fair demands of the Colombian people.	Agudelo J.G., 2008, CORPOICA CIENCIA TEC, V9, P56, DOI [10.21930/rcta.vol9_num1_art:104, DOI 10.21930/RCTA.VOL9_NUM1_ART:104]; Andrade-C. M. Gonzalo, 2011, Rev. acad. colomb. cienc. exact. fis. nat., V35, P491; Antonelli A, 2018, P NATL ACAD SCI USA, V115, P6034, DOI 10.1073/pnas.1713819115; Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Arbelaez-Cortes E, 2013, BIODIVERS CONSERV, V22, P2875, DOI 10.1007/s10531-013-0560-y; ARBELÁEZ CORTÉS¹ ENRIQUE, 2013, Acta biol.Colomb., V18, P165; Arismendi N., 2003, INSECTA MUNDI, V17, P1; Barao KR, 2020, AUSTRAL ENTOMOL, V59, P770, DOI 10.1111/aen.12489; Barber H. G., 1946, BULL BROOKLYN ENT SOC, V41, P52; Barcellos A, 2008, ZOOTAXA, P25, DOI 10.11646/zootaxa.1821.1.3; Barcellos Aline, 2003, Iheringia, Sér. Zool., V93, P413, DOI 10.1590/S0073-47212003000400008; Barros LD, 2021, ZOOTAXA, V4981, P1, DOI [10.11646/zootaxa.4981.1.1, 10.11646/ZOOTAXA.4981.1.1]; Barter H. G., 1932, Journal of the Department of Agriculture Puerto Rico, V16, P231; BECKER M, 1989, MEM I OSWALDO CRUZ, V84, P57, DOI 10.1590/S0074-02761989000800015; BECKER M, 1986, Revista Brasileira de Biologia, V46, P453; BECKER M, 1985, Revista Brasileira de Zoologia, V3, P65; BECKER M, 1977, Revista Brasileira de Biologia, V37, P367; BECKER M, 1971, Revista Brasileira de Biologia, V31, P389; BECKER M, 1970, Revista Brasileira de Biologia, V30, P217; Becker M., 1971, IHERINGIA SER ZOOL, V40, P3; Becker Miriam, 1992, Revista Brasileira de Entomologia, V36, P831; Bianchi FM, 2017, SYST ENTOMOL, V42, P399, DOI 10.1111/syen.12224; Brailovsky H., 1989, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V59, P219; Brailovsky H, 1981, ANALES I BIOL U NACL, V1, P239; Brailovsky H, 1987, ANALES I BIOL U NACL, V58, P154; Brugnera R, 2020, ZOOTAXA, V4766, P128, DOI 10.11646/zootaxa.4766.1.6; Brugnera R, 2020, ZOOTAXA, V4751, P546, DOI 10.11646/zootaxa.4751.3.7; Brugnera R, 2019, ZOOTAXA, V4656, P445, DOI 10.11646/zootaxa.4656.3.3; Cambra Roberto A., 2018, Revista Nicaraguense de Entomologia, V149, P3; Campos Luiz A., 2006, Iheringia, Sér. Zool., V96, P147, DOI 10.1590/S0073-47212006000200004; Campos LA, 2018, ZOOTAXA, V4434, P184, DOI 10.11646/zootaxa.4434.1.12; Campos Luiz Alexandre, 1995, Iheringia Serie Zoologia, V79, P163; Campos LA, 2017, ZOOTAXA, V4286, P134, DOI 10.11646/zootaxa.4286.1.11; Castro-Huertas V, 2015, ZOOTAXA, V3973, P553, DOI 10.11646/zootaxa.3973.3.9; Peredo LC, 2013, DEUT ENTOMOL Z, V60, P25, DOI 10.1002/mmnd.201300002; Cervantes-Peredo L, 2014, NEOTROP ENTOMOL, V43, P236, DOI 10.1007/s13744-014-0203-3; Cioato A, 2015, ZOOTAXA, V4048, P565, DOI 10.11646/zootaxa.4048.4.7; Cody S, 2010, ECOGRAPHY, V33, P326, DOI 10.1111/j.1600-0587.2010.06327.x; Correia AO, 2016, ZOOTAXA, V4107, P541, DOI 10.11646/zootaxa.4107.4.4; Coscaron MDC, 2017, ZOOTAXA, V4295, P1, DOI 10.11646/zootaxa.4295.1.1; Da Silva VJ, 2018, ZOOTAXA, V4425, P401, DOI 10.11646/zootaxa.4425.3.1; Da Silva VJ, 2017, ZOOTAXA, V4347, P255, DOI 10.11646/zootaxa.4347.2.3; Da Silva VJ, 2013, ZOOTAXA, V3716, P395, DOI 10.11646/zootaxa.3716.3.4; Dallas W.S., 1851, J BRIT ASTRON ASS; Cadena Carlos Daniel, 2016, Rev. acad. colomb. cienc. exact. fis. nat., V40, P275; Daza E., 1991, THESIS U NACL COLOMB; De Barros LD, 2020, ZOOTAXA, V4747, P585, DOI 10.11646/zootaxa.4747.3.11; De Clercq P., 2008, ENCY ENTOMOLOGY, P3042; de Fortes NDF, 2005, REV BRAS ENTOMOL, V49, P294, DOI 10.1590/S0085-56262005000300002; De los Santos G., 2016, NOVIT CARIBAEA, V10, P89, DOI [10.33800/nc.v0i10.32, DOI 10.33800/NC.V0I10.32]; Dellape G, ENTOMOLOGICAL COMMUN, V3, DOI [10.37486/2675-1305.ec03004, DOI 10.37486/2675-1305.EC03004]; Dellape G, 2021, REV SOC ENTOMOL ARGE, V80, P23, DOI 10.25085/rsea.800103; Dellape G, 2015, REV BRAS ENTOMOL, V59, P169, DOI 10.1016/j.rbe.2015.06.001; Dellape P.M., 2003, ZOOTAXA, V318, P1, DOI 10.11646/zootaxa.318.1.1; Dellape P.M., 2020, HETEROPTERA HEMIPTER; EGER JE, 1978, J NEW YORK ENTOMOL S, V86, P224; Faundez Eduardo I., 2014, Boletin de la SEA, P159; Faundez EI, 2011, ZOOTAXA, P53, DOI 10.11646/zootaxa.2835.1.4; Fernandes J. A. M., 2000, Zoologische Mededelingen (Leiden), V74, P151; Fernandes J. A. M., 2000, Zoologische Mededelingen (Leiden), V74, P143; Fernandes J.A.M., 1998, IHERINGIA SER ZOOL, V84, P153; Fernandes J.A.M., 1996, REV BRAS ENTOMOL, V40, P341; Fernandes Jose Antonio Marin, 1998, Revista Brasileira de Zoologia, V15, P1049, DOI 10.1590/S0101-81751998000400022; Ferrari A, 2010, IHERINGIA SER ZOOL, V100, P449, DOI 10.1590/S0073-47212010000400018; Froeschner R.C., 1981, HETEROPTERA TRUE BUG; Froeschner R. C., 1999, MEMOIRS AM ENTOMOLOG, V61, pi; Garbelotto TD, 2016, ZOOTAXA, V4137, P545, DOI 10.11646/zootaxa.4137.4.6; Garbelotto TD, 2014, ZOOTAXA, V3869, P281, DOI 10.11646/zootaxa.3869.3.4; GRAZIA J, 1987, Revista Brasileira de Entomologia, V31, P83; GRAZIA J, 1983, Revista Brasileira de Entomologia, V27, P177; GRAZIA J, 1982, Revista Brasileira de Entomologia, V26, P173; GRAZIA J, 1981, Anais da Sociedade Entomologica do Brasil, V10, P9; GRAZIA J, 1978, Iheringia Serie Zoologia, P3; GRAZIA J, 1967, Iheringia Serie Zoologia, P45; Grazia J., 2008, BIODIVERSIDAD ARTROP, V2, P223; Grazia J., 2020, PENTATOMIDAE CATALOG; Grazia J., 2017, STINK BUGS, P1; Grazia J, 2008, CLADISTICS, V24, P932, DOI 10.1111/j.1096-0031.2008.00224.x; Grazia Jocélia, 2005, Iheringia, Sér. Zool., V95, P173, DOI 10.1590/S0073-47212005000200007; Grazia Jocelia, 1994, Iheringia Serie Zoologia, V76, P55; Grazia J, 2016, ZOOTAXA, V4092, P561, DOI 10.11646/zootaxa.4092.4.6; Grazia J, 2015, ENTOMOL FOCUS, V2, P681, DOI 10.1007/978-94-017-9861-7_22; Grazia Jocelia, 1999, Acta Societatis Zoologicae Bohemicae, V63, P71; Grazia Jocelia, 1995, Revista Brasileira de Entomologia, V39, P409; GRAZIA-VIEIRA J, 1972, Revista Peruana de Entomologia, V15, P117; HALLMAN GJ, 1992, FLA ENTOMOL, V75, P190, DOI 10.2307/3495621; Da Silva LMH, 2021, ZOOTAXA, V4958, P605, DOI [10.11646/ZOOTAXA.4958.1.36, 10.11646/zootaxa.4958.1.36]; Hazzi NA, 2018, P NATL ACAD SCI USA, V115, P7985, DOI 10.1073/pnas.1803908115; Henry TJ, 2017, INSECT BIODIVERSITY: SCIENCE AND SOCIETY, VOL I, 2ND EDITION, P279; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Jaramillo C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602321; JENSEN-HAARUP A. C., 1926, ENT MEDDEL [COPENHAGEN], V16, P41; Kattan GH, 2004, J BIOGEOGR, V31, P1829, DOI 10.1111/j.1365-2699.2004.01109.x; Kirkaldy GW., 1909, CATALOGUE HEMIPTERA; Kment P, 2018, ZOOKEYS, P347, DOI 10.3897/zookeys.796.22517; Kormilev N.A, 1956, ACTA SCI I INVESTIGA, V3, P1; KORMILEV NICOLAS A., 1951, REV SOC ENT ARGENTINA, V15, P83; Krein V, 2020, ZOOTAXA, V4779, P391, DOI 10.11646/zootaxa.4779.3.7; Lopez M, 2010, P ENTOMOL SOC WASH, V112, P81, DOI 10.4289/0013-8797-112.1.81; Maes Jean-Michel, 1994, Revista Nicaraguense de Entomologia, V28, P1; Fernandes JAM, 2006, REV BRAS ENTOMOL, V50, P165, DOI 10.1590/S0085-56262006000200004; Fernandes JAM, 2021, ZOOTAXA, V4958, P628, DOI [10.11646/zootaxa.4958.1.37, 10.11646/ZOOTAXA.4958.1.37]; Fernandes JAM, 2018, ZOOTAXA, V4461, P205, DOI 10.11646/zootaxa.4461.2.3; Fernandes JAM, 2011, ZOOTAXA, P63, DOI 10.11646/zootaxa.3019.1.4; Fernandes JAM, 2010, ZOOTAXA, P53, DOI 10.11646/zootaxa.2662.1.3; MARSHALL LG, 1982, SCIENCE, V215, P1351, DOI 10.1126/science.215.4538.1351; McCafferty WP, 1998, J N AM BENTHOL SOC, V17, P1, DOI 10.2307/1468048; MCDONALD FJD, 1986, J NEW YORK ENTOMOL S, V94, P1; Melo Maria C., 2017, Check List, V13, P479; Montes C, 2015, SCIENCE, V348, P226, DOI 10.1126/science.aaa2815; Morrone J. J., 2017, NEOTROPICAL BIOGEOGR; Nunes BM, 2020, ZOOTAXA, V4742, P401, DOI 10.11646/zootaxa.4742.3.1; Nunes BM, 2019, ARTHROPOD SYST PHYLO, V77, P215, DOI 10.26049/ASP77-2-2019-02; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; Ocampo-Perez J., 2007, BIOTA COLOMB, V8; Rangel-Ch. J. Orlando, 2015, Rev. acad. colomb. cienc. exact. fis. nat., V39, P176, DOI 10.18257/raccefyn.136; Ortega-Leon G, 2010, REV MEX BIODIVERS, V81, P61; Osorio R., 1988, REV ICA, V4; Packauskas RJ, 1998, ANN ENTOMOL SOC AM, V91, P363, DOI 10.1093/aesa/91.4.363; Panizzi AR, 2015, ENTOMOL FOCUS, V2, P3, DOI 10.1007/978-94-017-9861-7_1; PANTOJA A, 1995, J ENTOMOL SCI, V30, P463, DOI 10.18474/0749-8004-30.4.463; Pantoja A, 2007, J AGR U PUERTO RICO, V91, P11; Pantoja A, 2005, J AGR U PUERTO RICO, V89, P221; Perez-Gelabert Daniel E., 2005, Boletin de la S.E.A., P319; Piran A. A., 1948, Acta Zoologica Lilloana, V5, P5; Piran A. A., 1956, Revista de la Sociedad Uruguaya de Entomologia, V1, P29; Pires EM, 2015, BIOSCI J, V31, P1530, DOI 10.14393/BJ-v31n5a2015-27335; Posada-Ochoa L, 1989, BOL TEC, V43, P662; Rider DA, 2008, P ENTOMOL SOC WASH, V110, P1050, DOI 10.4289/0013-8797-110.4.1050; Rider D.A., 2018, INVASIVE STINK BUGS, P25, DOI DOI 10.1201/9781315371221-2; Rider D.A, 2009, PENTATOMOIDEA HOME P, P1; RIDER DA, 1992, J NEW YORK ENTOMOL S, V100, P99; RIDER DA, 1995, P ENTOMOL SOC WASH, V97, P845; RIDER DA, 1991, J NEW YORK ENTOMOL S, V99, P1; Rider DA, 1998, ENTOMOL NEWS, V109, P274; RIDER DA, 1987, J NEW YORK ENTOMOL S, V95, P428; RIDER DA, 1994, J NEW YORK ENTOMOL S, V102, P193; RIDER DA, 1991, J NEW YORK ENTOMOL S, V99, P583; Roca-Cusachs M, 2022, SYST ENTOMOL, V47, P36, DOI 10.1111/syen.12514; Roell T, 2021, ZOOTAXA, V4958, P570, DOI [10.11646/zootaxa.4958.1.33, 10.11646/ZOOTAXA.4958.1.33]; Roell T, 2018, ZOOTAXA, V4508, P47, DOI 10.11646/zootaxa.4508.1.3; ROLSTON L H, 1974, Entomologica Americana, V48, P1; ROLSTON LH, 1988, J NEW YORK ENTOMOL S, V96, P284; ROLSTON LH, 1986, J NEW YORK ENTOMOL S, V94, P424; ROLSTON LH, 1980, J NEW YORK ENTOMOL S, V88, P257; ROLSTON LH, 1983, J NEW YORK ENTOMOL S, V91, P97; ROLSTON LH, 1980, J NEW YORK ENTOMOL S, V88, P120; ROLSTON LH, 1992, J NEW YORK ENTOMOL S, V100, P1; ROLSTON LH, 1984, J NEW YORK ENTOMOL S, V92, P69; ROLSTON LH, 1978, J NEW YORK ENTOMOL S, V86, P161; ROLSTON LH, 1988, J NEW YORK ENTOMOL S, V96, P299; ROLSTON LH, 1987, J NEW YORK ENTOMOL S, V95, P62; ROLSTON LH, 1975, J NEW YORK ENTOMOL S, V83, P218; ROLSTON LH, 1978, J NEW YORK ENTOMOL S, V86, P102; ROLSTON LH, 1984, J NEW YORK ENTOMOL S, V92, P342; ROLSTON LH, 1978, J NEW YORK ENTOMOL S, V86, P20; ROLSTON LH, 1983, J NEW YORK ENTOMOL S, V91, P183; ROLSTON LH, 1983, J NEW YORK ENTOMOL S, V91, P1; ROLSTON LH, 1984, J NEW YORK ENTOMOL S, V92, P352; Romero-Ortiz C, 2019, ZOOTAXA, V4711, P107, DOI 10.11646/zootaxa.4711.1.4; Ruckes H, 1970, Am. Mus. Novit., VNo. 2409, P1; Ruckes H, 1959, NEW GENERA SPECIES P, V1939, P1; Ruckes H, 1966, AM MUS NOVIT, V2256, P1; RUCKES HERBERT, 1965, J N Y ENTOMOL SOC, V73, P114; RUCKES HERBERT, 1966, AMER MUS NOVITATES, V2254, P1; RUCKES HERBERT, 1966, AMER MUS NOVITATES, V2257, P1; RUCKES HERBERT, 1958, AMER MUS NOVITATES, V1868, P1; RUCKES HERBERT, 1966, AMER MUS NOVITATES, V2255, P1; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; SAILER R. I., 1957, PROC ENT SOC WASHINGTON, V59, P41; Sailer Reece I., 1944, PROC ENT SOC WASHINGTON, V46, P105; Saulich A.K., 2018, INVASIVE STINK BUGS, P565, DOI [10.1201/9781315371221-12, DOI 10.1201/9781315371221-12]; Schuh R. T., 2020, TRUE BUGS WORLD HEMI, V2nd; Schwertner Cristiano F., 2006, Iheringia, Sér. Zool., V96, P237, DOI 10.1590/S0073-47212006000200015; Schwertner CF, 2007, REV BRAS ENTOMOL, V51, P416, DOI 10.1590/S0085-56262007000400005; Segarra-Carmona Alejandro E., 2016, Journal of Agriculture of the University of Puerto Rico, V100, P1; Servino L.M., 2020, ELECT IDENTIFICATION; SIB Colombia, 2020, SIST INF BIOD COL; Silva Eduardo J. Ely e, 2006, Iheringia, Sér. Zool., V96, P345, DOI 10.1590/S0073-47212006000300012; Simoes FL, 2012, ZOOTAXA, P39; Simoes FL, 2014, ZOOTAXA, V3774, P496, DOI 10.11646/zootaxa.3774.5.8; Stephens Cardenas-Bautista Johann, 2020, Check List, V16, P821, DOI 10.15560/16.4.821; Thomas D.B., 2000, BIODIVERSIDAD TAXONO, VII, P335; THOMAS DB, 1990, P ENTOMOL SOC WASH, V92, P304; THOMAS DB, 1988, ANN ENTOMOL SOC AM, V81, P28, DOI 10.1093/aesa/81.1.28; THOMAS DB, 1990, ANN ENTOMOL SOC AM, V83, P657, DOI 10.1093/aesa/83.4.657; THOMAS DB, 1985, ANN ENTOMOL SOC AM, V78, P674, DOI 10.1093/aesa/78.5.674; Thomas DB., 1992, LANHAM ENTOMOL SOC A, V16, P1; Thomas DB, 2021, ZOOTAXA, V4958, P595, DOI 10.11646/zootaxa.4958.1.35; Torres C., 2004, INSECTOCOLOMBIA, P61; Torres Diego A., 2021, Neotropical Biology and Conservation, V16, P145, DOI 10.3897/neotropical.16.e57109; Vidal J., 1981, ACTA AGRON, V31, P113; Waldbauer G.P., 1977, ANAIS SOC ENTOMOLOGI, V6, P223, DOI [10.37486/0301-8059.v6i2.116, DOI 10.37486/0301-8059.V6I2.116]; Walker F., 1867, CATALOGUE SPECIMEN 2, V1, DOI [10.5962/bhl.title.118688, DOI 10.5962/BHL.TITLE.118688]; Wilson JS, 2014, ECOGRAPHY, V37, P791, DOI 10.1111/ecog.00663; Zwetsch Adriana, 2001, Iheringia Serie Zoologia, V91, P5	196	0	0	0	0	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	FEB 9	2022	5097	1					1	88		10.11646/zootaxa.5097.1.1	http://dx.doi.org/10.11646/zootaxa.5097.1.1			88	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	ZD8MC	35391430				2022-09-04	WOS:000758448400001
J	Liu, Y; Samsami, M; Meshreki, H; Pereira, F; Schott, T				Liu, Ye; Samsami, Mahsa; Meshreki, Hakim; Pereira, Fernando; Schott, Thomas			Sustainable Development Goals in Strategy and Practice: Businesses in Colombia and Egypt	SUSTAINABILITY			English	Article						sustainable development goals; business; strategy; practice; Colombia; Egypt	ENTREPRENEURSHIP; ORGANIZATIONS; COMPANIES	Businesses may adopt strategies and practices that support sustainable development goals. Such strategies include considering social and environmental impacts as well as prioritizing socio-environmental benefits at a higher level than profits. Supportive practices comprise enhancing social benefits and limiting environmental harm. What SDG-related strategies and practices are businesses pursuing? Are businesses implementing practices and strategies? Do the practices and strategies differ across societies? A survey of representative samples of 399 businesses in Colombia and 413 businesses in Egypt was conducted in 2021, by the Global Entrepreneurship Monitor. The owner-managers reported that they frequently had strategies that considered social and environmental impacts of business operations, and they prioritized socio-environmental considerations over financial goals. In Columbia, there were more frequent practices that enhanced social benefits and limited environmental harm than in Egypt. In addition, strategies were implemented in practices supporting the SDGs more in Colombia than in Egypt. Our findings contribute to understanding business strategies that consider SDGs and their implementation in practices that are embedded in society.	[Liu, Ye] Zhejiang Sci Tech Univ, Sch Polit & Law, Dept Publ Adm, Hangzhou 310018, Peoples R China; [Samsami, Mahsa] Univ Santiago de Compostela, Fac Econ & Business, Int PhD Sch, Santiago De Compostela 15705, Spain; [Meshreki, Hakim; Schott, Thomas] Amer Univ Cairo, Sch Business, Dept Management, New Cairo 11835, Egypt; [Pereira, Fernando] Pontificia Univ Javeriana Cali, Sch Management, Dept Management, Cali 760031, Colombia; [Schott, Thomas] Univ Agder, Sch Business & Law, Dept Strategy & Management, N-4630 Kristiansand, Norway; [Schott, Thomas] Univ Southern Denmark, Dept Entrepreneurship & Relationship Management, DK-6000 Kolding, Denmark		Liu, Y (corresponding author), Zhejiang Sci Tech Univ, Sch Polit & Law, Dept Publ Adm, Hangzhou 310018, Peoples R China.	LiuYe8205@sina.cn; samsami.mahsa@rai.usc.es; hmeshreki@aucegypt.edu; fpereira@javerianacali.edu.co; tsc@sam.sdu.dk		Samsami, Mahsa/0000-0001-7906-5795	Research and Development Office, Javeriana University Cali, Colombia	Research and Development Office, Javeriana University Cali, Colombia	The survey in Colombia was funded by Research and Development Office, Javeriana University Cali, Colombia, and GEM Colombia team members.	Agarwal N., 2017, RAISING BAR RETHINKI; Ahmad N.H., 2010, INT J BUSINESS SOC, V11, P77; Alvarez-Risco A, 2021, SUSTAINABILITY-BASEL, V13, P3306, DOI 10.3390/su13063306; Bansal S, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11041091; Bosma N, 2013, FOUND TRENDS ENTREP, V9, P143, DOI 10.1561/0300000033; Brinks D., 2019, UNDERSTANDING I WEAK; Calvin CG, 2020, J INT FIN MANAG ACC, V31, P323, DOI 10.1111/jifm.12123; Czerwinska T, 2015, ECON NOTES, V44, P211, DOI 10.1111/ecno.12031; Diez-Busto E., 2021, FUTURE ADVANCEMENTS, P198; Figge F, 2012, INT J PROD ECON, V140, P92, DOI 10.1016/j.ijpe.2012.02.001; Garcia-Sanchez IM, 2014, MANAGE DECIS, V52, P1014, DOI 10.1108/MD-09-2013-0446; Global Reporting Initiative (GRI) & United Nations Global Compact (UN Global Compact), 2017, BUS REP SDG AN GOALS; Hechavarria DM, 2017, SMALL BUS ECON, V48, P225, DOI 10.1007/s11187-016-9747-4; Hockerts K, 2015, BUS STRATEG ENVIRON, V24, P102, DOI 10.1002/bse.1813; Horisch J, 2014, ORGAN ENVIRON, V27, P328, DOI 10.1177/1086026614535786; Hoogendoorn B, 2019, J BUS ETHICS, V157, P1133, DOI 10.1007/s10551-017-3646-8; Inglehart Ronald., 2005, MODERNIZATION CULTUR; Jizi M, 2017, BUS STRATEG ENVIRON, V26, P640, DOI 10.1002/bse.1943; Kraus S, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101828; Luomi M., 2019, ARAB REGION SDG INDE; Mattingly J.E., 2006, BUSINESS SOC, V45, P20, DOI [10.1177/0007650305281939, DOI 10.1177/0007650305281939]; MEYER JW, 1977, AM J SOCIOL, V83, P340, DOI 10.1086/226550; Moses O., 2020, SOCIAL ENV ACCOUNTAB, V40, P24; ORTON JD, 1990, ACAD MANAGE REV, V15, P203, DOI 10.2307/258154; Owusu-Ansah S., 1998, INT J ACCOUNT, V33, P605, DOI [10.1016/S0020-7063(98)90015-2, DOI 10.1016/S0020-7063(98)90015-2]; Perez Andrea., 2021, FUTURE ADVANCEMENTS, DOI [10.4018/978-1-7998-8065-3, DOI 10.4018/978-1-7998-8065-3]; Pineda-Escobar MA, 2019, CORP GOV-INT J BUS S, V19, P176, DOI 10.1108/CG-11-2017-0268; Rendtorff J.D., 2021, FUTURE ADVANCEMENTS, P50; Rosati F, 2019, CORP SOC RESP ENV MA, V26, P588, DOI 10.1002/csr.1705; Rosati F, 2019, J CLEAN PROD, V215, P1312, DOI 10.1016/j.jclepro.2018.12.107; Sachs J., 2021, SUSTAINABLE DEV REPO; Sarango-Lalangui P, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10062005; Schonherr N., 2017, TRANSNATIONAL CORPOR, V24, P33, DOI DOI 10.18356/CFB5B8B6-EN; Schott T, 2008, ESTUD ECONOMIA, V35, P195, DOI 10.4067/S0718-52862008000200005; Schramade W, 2017, J APPL CORP FINANC, V29, P87, DOI 10.1111/jacf.12234; Shehata N.F, 2015, AUC BUS REV, V5, P46; Shehata N.F., 2020, INT ACCOUNTING REPOR, P13; Srinidhi B, 2011, CONTEMP ACCOUNT RES, V28, P1610, DOI 10.1111/j.1911-3846.2011.01071.x; Tayan, 2016, CORP GOV-OXFORD; Tiba S, 2019, CORP SOC RESP ENV MA, V26, P265, DOI 10.1002/csr.1682; UN Secretary-General World Commission on Environment and Development (WCED), 1987, REPORT WORLD COMMISS; UNCTAD, 2019, GUID COR IND ENT REP; United Nations, 2018, SUSTAINABLE DEV GOAL; Wang DJ, 2022, INT ENTREP MANAG J, V18, P327, DOI 10.1007/s11365-020-00681-y; WEICK KE, 1976, ADMIN SCI QUART, V21, P1, DOI 10.2307/2391875; York JG, 2016, J MANAGE STUD, V53, P695, DOI 10.1111/joms.12198	46	2	2	5	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2071-1050		SUSTAINABILITY-BASEL	Sustainability	NOV	2021	13	22							12453	10.3390/su132212453	http://dx.doi.org/10.3390/su132212453			15	Green & Sustainable Science & Technology; Environmental Sciences; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics; Environmental Sciences & Ecology	XH2AK		Green Published, gold			2022-09-04	WOS:000725242700001
J	Weirauch, C; Zhang, G; Forero, D; Berenger, JM				Weirauch, C.; Zhang, G.; Forero, D.; Berenger, J-M			Living on a sticky trap: natural history and morphology of Bactrodes assassin bugs (Insecta: Hemiptera: Reduviidae: Bactrodinae)	JOURNAL OF NATURAL HISTORY			English	Article						Heteroptera; sticky plant specialist; maternal care; egg parasitoid	MATERNAL-CARE; PARENTAL CARE; BURROWER BUG; PHYLLOMORPHA-LACINIATA; ADOMERUS TRIGUTTULUS; HETEROPTERA; PLANT; REDUVIOIDEA; PHYLOGENY; EVOLUTION	Plants with glandular trichomes have been shown to attract specialist, mutualistic predatory insects. Despite recent advances in understanding the plant component in this association, few sticky plant specialist insects are well documented and their adaptations to the sticky plant environment are understudied. We here describe and illustrate, for the first time, aspects of the natural history and morphology of a small clade of predatory hemipteran insects, the Bactrodinae (Reduviidae). Our study suggests that these insects are exclusively associated with plant species with glandular trichomes. The relationship is not specific as one species of Bactrodes Stal may be associated with multiple species, genera or even families of plants. We document a unique clamp-like structure formed by one of the pretarsal claws and opposing tarsal spine-like setae that enables Bactrodinae to grasp trichomes and walk on leaves densely covered with trichomes. We further present observations of Bactrodes species scavenging on insects entrapped on leaves. Bactrodinae also oviposit on their host plants, and females engage in behaviours that we interpret as maternal egg guarding, a life history strategy that is rare in predatory true bugs. We speculate that instead of or in addition to decreasing egg predation or egg parasitism, female egg guarding may be a response to the limited availability of sticky plants and a strategy against cannibalism.	[Weirauch, C.; Zhang, G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Forero, D.] Pontificia Univ Javeriana, Dept Biol, Lab Entomol, Bogota, Colombia; [Berenger, J-M] Aix Marseille Univ, AP HM, Lab Entomol, IRD,VITROME, Marseille, France; [Berenger, J-M] Museum Natl Hist Nat, Lab Biol & Evolut Insectes, Paris, France; [Zhang, G.] Deoxy LLC, 2630 E Ridge Rd, Beloit, WI 53511 USA		Weirauch, C (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	christiane.weirauch@ucr.edu	Forero, Dimitri/P-4860-2016	Forero, Dimitri/0000-0002-6358-757X	National Science Foundation [093333853,1655769]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation [093333853,1655769].	Andersen NM, 1997, BIOL J LINN SOC, V61, P345, DOI 10.1111/j.1095-8312.1997.tb01796.x; Anderson B, 2007, OECOLOGIA, V152, P115, DOI 10.1007/s00442-006-0640-8; Audino PG, 2007, J VECTOR ECOL, V32, P75, DOI 10.3376/1081-1710(2007)32[75:VCSBBO]2.0.CO;2; Beal CA, 2006, J ETHOL, V24, P305, DOI 10.1007/s10164-005-0190-2; Bequaert J., 1935, Bulletin of the Brooklyn Entomological Society, V30, P177; Berenger JM, 1997, CR ACAD SCI III-VIE, V320, P1007, DOI 10.1016/S0764-4469(97)82474-2; Cassis G, 2012, ANNU REV ENTOMOL, V57, P377, DOI 10.1146/annurev-ento-121510-133533; Choe DH, 2007, ANN ENTOMOL SOC AM, V100, P320, DOI 10.1603/0013-8746(2007)100[320:UOPRBA]2.0.CO;2; Coscaron MC., 2003, ZOOTAXA, V304, P1, DOI [10.11646/zootaxa.304.1.1, DOI 10.11646/ZOOTAXA.304.1.1]; DAVIS NORMAN T., 1957, ANN ENT SOC AMER, V50, P432; DAVIS NT, 1966, ANN ENTOMOL SOC AM, V59, P911, DOI 10.1093/aesa/59.5.911; DAVIS NT, 1969, ANN ENTOMOL SOC AM, V62, P74, DOI 10.1093/aesa/62.1.74; DOLLING WR, 1991, SYST ENTOMOL, V16, P319, DOI 10.1111/j.1365-3113.1991.tb00692.x; Filippi L, 2000, ANIM BEHAV, V60, P757, DOI 10.1006/anbe.2000.1526; Forero D, 2006, ZOOTAXA, P1; Forero D, 2013, MOL PHYLOGENET EVOL, V66, P283, DOI 10.1016/j.ympev.2012.10.002; Forero D, 2017, ZOOL J LINN SOC-LOND, V179, P62, DOI 10.1111/zoj.12454; Giffney RA, 2016, AUSTRAL ENTOMOL, V55, P170, DOI 10.1111/aen.12164; Giffney RA, 2014, ETHOLOGY, V120, P607, DOI 10.1111/eth.12233; Gilbert JDJ, 2015, EVOLUTION, V69, P1255, DOI 10.1111/evo.12656; Gilbert JDJ, 2010, ECOL ENTOMOL, V35, P639, DOI 10.1111/j.1365-2311.2010.01221.x; Gogala M, 1998, EUR J ENTOMOL, V95, P311; Gogala Matija, 1994, Proteus, V56, P266; Gomendio M, 2008, ANIM BEHAV, V75, P763, DOI 10.1016/j.anbehav.2006.12.029; Guidoti M, 2015, REV BRAS ENTOMOL, V59, P104, DOI 10.1016/j.rbe.2015.03.004; Guilbert E, 2003, EUR J ENTOMOL, V100, P61, DOI 10.14411/eje.2003.013; Hanelova Jana, 2013, Acta Musei Moraviae Scientiae Biologicae, V98, P433; Henry Thomas J., 1997, Memoirs of the Entomological Society of Washington, V19, P1; Inadomi K, 2014, CAN ENTOMOL, V146, P211, DOI 10.4039/tce.2013.69; Jahnke Simone M., 2003, Neotrop. entomol., V32, P123, DOI 10.1590/S1519-566X2003000100018; Kaitala A, 1997, OIKOS, V80, P3, DOI 10.2307/3546509; Kaiwa N, 2014, CURR BIOL, V24, P2465, DOI 10.1016/j.cub.2014.08.065; Kaiwa N, 2010, APPL ENVIRON MICROB, V76, P3486, DOI 10.1128/AEM.00421-10; KALIN M, 1975, ANN ENTOMOL SOC AM, V68, P126, DOI 10.1093/aesa/68.1.126; Kolliker M, 2005, ANIM BEHAV, V69, P959, DOI 10.1016/j.anbehav.2004.06.031; Krimmel BA, 2013, ECOL LETT, V16, P219, DOI 10.1111/ele.12032; Krimmel BA, 2014, ARTHROPOD-PLANT INTE, V8, P403, DOI 10.1007/s11829-014-9318-z; KUDO S, 1989, J ETHOL, V7, P75, DOI 10.1007/BF02350027; Kudo S, 1996, ETHOLOGY, V102, P227; Law YH, 2010, ANN ENTOMOL SOC AM, V103, P771, DOI 10.1603/AN09143; LoPresti EF, 2015, ECOLOGY, V96, P2862, DOI 10.1890/15-0342.1; Maldonado Capriles J., 1990, CARIBB J SCI; Miller NC, 1971, BIOL HETEROPTERA; Monteith G. B., 2006, Denisia, P1135; Nakahira T, 2008, J INSECT BEHAV, V21, P306, DOI 10.1007/s10905-008-9129-0; Nakahira T, 2013, ENTOMOL SCI, V16, P151, DOI 10.1111/j.1479-8298.2012.00553.x; Odhiambo TR., 2009, P R ENT SOC LOND A, V34, P175, DOI [10.1111/j.1365-3032.1959.tb00234.x, DOI 10.1111/J.1365-3032.1959.TB00234.X]; PARKER A. H., 1965, ENTOMOL EXP APPL, V8, P13, DOI 10.1007/BF00304533; Parr A, 2002, J INSECT BEHAV, V15, P495, DOI 10.1023/A:1016329216655; Peredo LC, 2002, FLA ENTOMOL, V85, P464, DOI 10.1653/0015-4040(2002)085[0464:DBAMCO]2.0.CO;2; Reguera P, 1999, BEHAV ECOL, V10, P541, DOI 10.1093/beheco/10.5.541; Santos Adao V., 2001, Neotropical Entomology, V30, P105, DOI 10.1590/S1519-566X2001000100016; Santos Jean C., 2005, Lundiana, V6, P107; Schuh R.T., 2002, ON LINE SYSTEMATIC C; Schuh R. T., 2020, TRUE BUGS WORLD HEMI, V2nd; SMITH RL, 1993, J INSECT BEHAV, V6, P93, DOI 10.1007/BF01049150; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Sugiura S, 2006, BIOL J LINN SOC, V88, P593, DOI 10.1111/j.1095-8312.2006.00645.x; TALLAMY DW, 1981, ANIM BEHAV, V29, P771, DOI 10.1016/S0003-3472(81)80010-3; Tallamy DW, 2004, J INSECT BEHAV, V17, P431, DOI 10.1023/B:JOIR.0000042532.50112.0c; TAYLOR SJ, 1988, GREAT LAKES ENTOMOL, V21, P159; Voigt D, 2008, J EXP BIOL, V211, P2647, DOI 10.1242/jeb.019273; Voigt D, 2007, ARTHROPOD-PLANT INTE, V1, P221, DOI 10.1007/s11829-007-9021-4; Voigt D, 2010, PLANTA, V232, P1511, DOI 10.1007/s00425-010-1270-2; Voigt D, 2010, ARTHROPOD-PLANT INTE, V4, P69, DOI 10.1007/s11829-010-9088-1; Weirauch C, 2006, EUR J ENTOMOL, V103, P97, DOI 10.14411/eje.2006.015; Weirauch C, 2005, ACTA ZOOL-STOCKHOLM, V86, P91, DOI 10.1111/j.1463-6395.2005.00190.x; Weirauch C., 2014, Canadian Journal of Arthropod Identification, V26, P1; Weirauch C., 2006, Denisia, P1169; Weirauch C., 1998, RAUBWANZEN REDUVIIDA; Weirauch C, 2008, SYST ENTOMOL, V33, P229, DOI 10.1111/j.1365-3113.2007.00417.x; Weirauch C, 2019, CLADISTICS, V35, P67, DOI 10.1111/cla.12233; WHEELER AG, 1982, ANN ENTOMOL SOC AM, V75, P498, DOI 10.1093/aesa/75.5.498; Wheeler AG, 2015, ANNU REV ENTOMOL, V60, P393, DOI 10.1146/annurev-ento-010814-020932; Wheeler Jr A.G., 2001, BIOL PLANT BUGS PEST, P507; Wignall AE, 2009, ACTA ETHOL, V12, P23, DOI 10.1007/s10211-008-0049-y; Zhang JX, 2016, CLADISTICS, V32, P538, DOI 10.1111/cla.12140	77	1	2	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0022-2933	1464-5262		J NAT HIST	J. Nat. Hist.	FEB 1	2021	55	5-6					341	363		10.1080/00222933.2021.1903110	http://dx.doi.org/10.1080/00222933.2021.1903110			23	Biodiversity Conservation; Ecology; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation; Environmental Sciences & Ecology; Zoology	SR3LL					2022-09-04	WOS:000660944200001
J	Rodriguez-Lopez, M; Merlo, J; Perez-Vicente, R; Austin, P; Leckie, G				Rodriguez-Lopez, Merida; Merlo, Juan; Perez-Vicente, Raquel; Austin, Peter; Leckie, George			Cross-classified Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA) to evaluate hospital performance: the case of hospital differences in patient survival after acute myocardial infarction	BMJ OPEN			English	Article						Multilevel analysis; Health Evaluation; Decision Making; ROC curve; Variance analysis	BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; LOGISTIC-REGRESSION; LEAGUE TABLES; RISK; CARE; LIMITATIONS; POPULATION; MORTALITY; SWEDEN	Objective To describe a novel strategy, Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA) to evaluate hospital performance, by analysing differences in 30-day mortality after a first-ever acute myocardial infarction (AMI) in Sweden. Design Cross-classified study. Setting 68 Swedish hospitals. Participants 43 247 patients admitted between 2007 and 2009, with a first-ever AMI. Primary and secondary outcome measures We evaluate hospital performance by analysing differences in 30-day mortality after a first-ever AMI using a cross-classified multilevel analysis. We classified the patients into 10 categories according to a risk score (RS) for 30-day mortality and created 680 strata defined by combining hospital and RS categories. Results In the cross-classified multilevel analysis the overall RS adjusted hospital 30-day mortality in Sweden was 4.78% and the between-hospital variation was very small (variance partition coefficient (VPC)=0.70%, area under the curve (AUC)=0.54). The benchmark value was therefore achieved by all hospitals. However, as expected, there were large differences between the RS categories (VPC=34.13%, AUC=0.77) Conclusions MAIHDA is a useful tool to evaluate hospital performance. The benefit of this novel approach to adjusting for patient RS is that it allowed one to estimate separate VPCs and AUC statistics to simultaneously evaluate the influence of RS categories and hospital differences on mortality. At the time of our analysis, all hospitals in Sweden were performing homogeneously well. That is, the benchmark target for 30-day mortality was fully achieved and there were not relevant hospital differences. Therefore, possible quality interventions should be universal and oriented to maintain the high hospital quality of care.	[Rodriguez-Lopez, Merida; Merlo, Juan; Perez-Vicente, Raquel] Lund Univ, Unit Social Epidemiol, Fac Med, Malmo, Sweden; [Rodriguez-Lopez, Merida] Pontificia Univ Javeriana Cali, Dept Publ Hlth & Epidemiol, Cali, Colombia; [Merlo, Juan] Ctr Primary Hlth Care Res, Malmo, Sweden; [Austin, Peter] Univ Toronto, Inst Hlth Management Policy & Evaluat, Toronto, ON, Canada; [Austin, Peter] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Austin, Peter] Sunnybrook Res Inst, Schulich Heart Res Program, Toronto, ON, Canada; [Leckie, George] Univ Bristol, Ctr Multilevel Modelling, Bristol, Avon, England		Rodriguez-Lopez, M (corresponding author), Lund Univ, Unit Social Epidemiol, Fac Med, Malmo, Sweden.; Rodriguez-Lopez, M (corresponding author), Pontificia Univ Javeriana Cali, Dept Publ Hlth & Epidemiol, Cali, Colombia.	merida.rdguez@gmail.com	Rodriguez-Lopez, Merida/N-9273-2017; Merlo, Juan/E-2136-2011	Rodriguez-Lopez, Merida/0000-0001-8245-0811; Merlo, Juan/0000-0001-8379-9708	Swedish Research Council (Vetenskapsradet) [2017-01321]; Heart and Stroke Foundation	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	The Swedish Research Council (Vetenskapsradet) supported this work through the project 'Multilevel Analyses of Individual Heterogeneity: innovative concepts and methodological approaches in Public Health and Social Epidemiology': (#2017-01321, PI: Juan Merlo). Dr Austin received a personal Mid-Career Investigator award from the Heart and Stroke Foundation.	Alexandrescu R, 2011, J AM COLL SURGEONS, V213, P392, DOI 10.1016/j.jamcollsurg.2011.06.423; Anderson JL, 2017, NEW ENGL J MED, V376, P2053, DOI 10.1056/NEJMra1606915; [Anonymous], 2009, PUBLIC ACCESS INFORM; Ash AS, 2011, STAT ISSUES ASSESSIN; Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Austin PC, 2017, STAT MED, V36, P928, DOI 10.1002/sim.7188; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung SC, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3913; Cohen ME, 2009, J AM COLL SURGEONS, V209, P687, DOI 10.1016/j.jamcollsurg.2009.08.020; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Evans CR, 2020, SOC SCI MED, V245, DOI 10.1016/j.socscimed.2019.112499; Ghith N, 2019, BMJ OPEN QUAL, V8, DOI 10.1136/bmjoq-2018-000449; Ghith N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148187; Glance LG, 2006, MED CARE, V44, P311, DOI 10.1097/01.mlr.0000204106.64619.2a; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; Hjerpe P, 2011, EUR J CLIN PHARMACOL, V67, P415, DOI 10.1007/s00228-010-0973-4; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; KHOURY MJ, 1985, AM J PUBLIC HEALTH, V75, P1204, DOI 10.2105/AJPH.75.10.1204; Krell RW, 2014, JAMA SURG, V149, P467, DOI 10.1001/jamasurg.2013.4249; Leckie G., 2013, CROSS CLASSIFIED MUL, V12, P1; Leckie G, 2013, J STAT SOFTW, V52, P1; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Merlo J, 2005, MED CARE, V43, P1092, DOI 10.1097/01.mlr.0000182484.14608.b9; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Merlo J, 2001, J EPIDEMIOL COMMUN H, V55, P323, DOI 10.1136/jech.55.5.323; Merlo J, 2013, EUR J EPIDEMIOL, V28, P135; Merlo J, 2019, HEALTH PLACE, V58, DOI 10.1016/j.healthplace.2019.102145; Merlo J, 2018, SSM-POPUL HLTH, V5, P33, DOI 10.1016/j.ssmph.2018.05.006; Merlo J, 2018, SOC SCI MED, V203, P74, DOI 10.1016/j.socscimed.2017.12.026; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Merlo J, 2014, AM J EPIDEMIOL, V180, P208, DOI 10.1093/aje/kwu108; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; Merlo Juan, 2005, Lakartidningen, V102, P20; Normand SLT, 2016, ANNU REV STAT APPL, V3, P21, DOI 10.1146/annurev-statistics-022513-115617; OECD, 2017, HLTH GLANC, DOI [10.1787/health_glance-2017-en, DOI 10.1787/HEALTH_GLANCE-2017-EN]; Ohlsson H, 2005, EUR J CLIN PHARMACOL, V61, P657, DOI 10.1007/s00228-005-0975-9; Ohlsson H, 2011, MED CARE, V49, P327, DOI 10.1097/MLR.0b013e31820325c5; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Snijders TAB, 2011, MULTILEVEL ANAL INTR; van Dishoeck AM, 2011, BMJ QUAL SAF, V20, P869, DOI 10.1136/bmjqs.2010.048058; Van Leeuwen W, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001260; Wagner P, 2014, 20 IEA WORLD C EP; Zhang ZZ, 2016, J STAT SOFTW, V72, P1, DOI 10.18637/jss.v072.i10	50	2	2	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	10							e036130	10.1136/bmjopen-2019-036130	http://dx.doi.org/10.1136/bmjopen-2019-036130			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OP4MV	33099490	Green Published, gold			2022-09-04	WOS:000588056700002
J	Ariz, M; Abad, RC; Castellanos, G; Martinez, M; Munoz-Barrutia, A; Fernandez-Seara, MA; Pastor, P; Pastor, MA; Ortiz-de-Solorzano, C				Ariz, Mikel; Abad, Ricardo C.; Castellanos, Gabriel; Martinez, Martin; Munoz-Barrutia, Arrate; Fernandez-Seara, Maria A.; Pastor, Pau; Pastor, Maria A.; Ortiz-de-Solorzano, Carlos			Dynamic Atlas-Based Segmentation and Quantification of Neuromelanin-Rich Brainstem Structures in Parkinson Disease	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Parkinson disease; neuromelanin; magnetic resonance imaging; multi-image atlas based segmentation; neural network based classifier	SUBSTANTIA-NIGRA NEUROMELANIN; LOCUS-COERULEUS; MRI; CONTRAST; DIAGNOSIS; BIOMARKER; SYSTEM; IMAGES	We present a dynamic atlas composed of neuromelanin-enhancedmagnetic resonance brain images of 40 healthy subjects. The performance of this atlas is evaluated on the fully automated segmentation of two paired neuromelanin-rich brainstem healthy structures: the substantia nigra pars compacta and the locus coeruleus. We show that our dynamic atlas requires in average 60% less images and, therefore, 60% less computation time than a static multi-image atlas while achieving a similar segmentation performance. Then, we show that by applying our dynamic atlas, composed of healthy subjects, to the segmentation and neuromelanin quantification of a set of brain images of 39 Parkinson disease patients, we are able to find significant quantitative differences in the level of neuromelanin between healthy subjects and Parkinson disease patients, thus opening the door to the use of these structures as image biomarkers in future computer aided diagnosis systems for the diagnosis of Parkinson disease.	[Ariz, Mikel; Abad, Ricardo C.; Munoz-Barrutia, Arrate; Ortiz-de-Solorzano, Carlos] Univ Navarra, IDISNA, Ctr Appl Med Res, Ciberonc & Solid Tumours & Biomarkers Program, Pamplona 31008, Spain; [Abad, Ricardo C.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Castellanos, Gabriel; Martinez, Martin; Pastor, Maria A.] Univ Navarra, Ctr Appl Med Res, Div Neurosci, Neuroimaging Lab, Pamplona 31008, Spain; [Castellanos, Gabriel] Pontificia Univ Javeriana, Fac Med, Bogota 110231, Colombia; [Munoz-Barrutia, Arrate] Univ Carlos III Madrid, Bioengn & Aerosp Engn Dept, Leganes 28911, Spain; [Munoz-Barrutia, Arrate] Inst Invest Sanitaria Gregorio Maranon, Madrid 28007, Spain; [Fernandez-Seara, Maria A.] Clin Univ Navarra, Dept Radiol, Pamplona 31008, Spain; [Pastor, Pau] Univ Hosp Mutua Terrassa, Dept Neurol, Memory Unit, Barcelona 08221, Spain; [Pastor, Pau] Univ Hosp Mutua Terrassa, Dept Neurol, Movement Disorder Unit, Barcelona 08221, Spain; [Ortiz-de-Solorzano, Carlos] Univ Navarra, Sch Engn TECNUN, Dept Biomed Engn & Appl Sci, San Sebastian 20018, Spain		Ortiz-de-Solorzano, C (corresponding author), Univ Navarra, IDISNA, Ctr Appl Med Res, Ciberonc & Solid Tumours & Biomarkers Program, Pamplona 31008, Spain.	mikelariz@unav.es; ricardo_abad@berkeley.edu; g_castellanos@javeriana.edu.co; mmvillar@unav.es; mamunozb@ing.uc3m.es; mfseara@unav.es; pastorpau@gmail.com; mapastor@unav.es; codesolorzano@unav.es	Fernandez-Seara, Maria A./K-1246-2014; Martinez, Martin/A-1126-2016; Ariz, Mikel/T-5502-2017; Ortiz-de-Solorzano, Carlos/G-3278-2010; castellanos, gabriel/G-3358-2016; Pastor, Pau/C-9834-2009; Pastor, Maria A./C-7851-2009; Munoz-Barrutia, Arrate/G-1776-2016	Fernandez-Seara, Maria A./0000-0001-8536-6295; Martinez, Martin/0000-0002-3053-7920; Ariz, Mikel/0000-0002-7328-1582; Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205; castellanos, gabriel/0000-0001-8121-1552; Pastor, Pau/0000-0002-7493-8777; Pastor, Maria A./0000-0003-2404-9346; Munoz-Barrutia, Arrate/0000-0002-1573-1661	Science and Innovation Ministry of the Government of Spain [TEC2013-48552-C2-1-R, TEC2015-73064-EXP, TEC2016-78052-R, DPI2015-64221-C2-2]	Science and Innovation Ministry of the Government of Spain	This work was supported in part by the Science and Innovation Ministry of the Government of Spain (A.M.B) underProject TEC2013-48552-C2-1-R, Project TEC2015-73064-EXP, and Project TEC2016-78052-R and in part by the Science and Innovation Ministry of the Government of Spain (C.O.S) under Grant DPI2015-64221-C2-2 (MINECO/FEDER, UE).	Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Babalola KO, 2008, LECT NOTES COMPUT SC, V5241, P409, DOI 10.1007/978-3-540-85988-8_49; Baglieri A, 2013, FUNCT NEUROL, V28, P73, DOI 10.11138/FNeur/2013.28.2.073; Cabezas M, 2011, COMPUT METH PROG BIO, V104, pE158, DOI 10.1016/j.cmpb.2011.07.015; Castellanos G, 2015, MOVEMENT DISORD, V30, P945, DOI 10.1002/mds.26201; Dordevic M, 2017, J ALZHEIMERS DIS REP, V1, P159, DOI 10.3233/ADR-170021; Enochs WS, 1997, RADIOLOGY, V204, P417, DOI 10.1148/radiology.204.2.9240529; Iglesias JE, 2015, MED IMAGE ANAL, V24, P205, DOI 10.1016/j.media.2015.06.012; Fabbri M, 2017, J PARKINSON DIS, V7, P491, DOI 10.3233/JPD-171135; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kashihara K, 2011, J CLIN NEUROSCI, V18, P1093, DOI 10.1016/j.jocn.2010.08.043; Keren NI, 2015, NEUROIMAGE, V113, P235, DOI 10.1016/j.neuroimage.2015.03.020; Kitao S, 2013, NEURORADIOLOGY, V55, P947, DOI 10.1007/s00234-013-1199-9; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Langerak TR, 2013, MED PHYS, V40, DOI 10.1118/1.4816654; Lehericy S, 2014, MOVEMENT DISORD, V29, P1574, DOI 10.1002/mds.26043; Matsuura K, 2016, NEUROSCI LETT, V633, P112, DOI 10.1016/j.neulet.2016.09.011; Nakane Toshiki, 2008, Magn Reson Med Sci, V7, P205; Ogisu K, 2013, NEURORADIOLOGY, V55, P719, DOI 10.1007/s00234-013-1171-8; Ohtsuka C, 2013, NEUROSCI LETT, V541, P93, DOI 10.1016/j.neulet.2013.02.012; Priovoulos N, 2018, NEUROIMAGE, V168, P427, DOI 10.1016/j.neuroimage.2017.07.045; Puigvert M, 2015, PROC SPIE, V9414, DOI 10.1117/12.2080779; Reimao S, 2015, EUR J NEUROL, V22, P540, DOI 10.1111/ene.12613; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sasaki M, 2006, NEUROREPORT, V17, P1215, DOI 10.1097/01.wnr.0000227984.84927.a7; Sasaki M, 2008, CLIN NEURORADIOL, V18, P147, DOI 10.1007/s00062-008-8018-4; Schwarz ST, 2017, RADIOLOGY, V283, P788, DOI 10.1148/radiol.2016160662; Schwarz ST, 2011, MOVEMENT DISORD, V26, P1633, DOI 10.1002/mds.23722; Shibata Eri, 2006, Magn Reson Med Sci, V5, P197, DOI 10.2463/mrms.5.197; Sommerauer M, 2018, BRAIN, V141, P496, DOI 10.1093/brain/awx348; Trujillo P, 2017, MAGN RESON MED, V78, P1790, DOI 10.1002/mrm.26584; Xiao YM, 2015, INT J COMPUT ASS RAD, V10, P1029, DOI 10.1007/s11548-014-1119-4; Xiao YM, 2014, HUM BRAIN MAPP, V35, P4330, DOI 10.1002/hbm.22478; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	37	18	18	1	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	MAR	2019	38	3					813	823		10.1109/TMI.2018.2872852	http://dx.doi.org/10.1109/TMI.2018.2872852			11	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	HO1JV	30281440				2022-09-04	WOS:000460662400015
J	Parra-Padilla, D; Zakzuk, J; Carrasquilla, M; Alvis-Guzman, N; Dennis, R; Rojas, MX; Rondon, M; Perez, A; Penaranda, A; Barragan, AM; Caraballo, L; Garcia, E				Parra-Padilla, Devian; Zakzuk, Josefina; Carrasquilla, Maria; Alvis-Guzman, Nelson; Dennis, Rodolfo; Rojas, Maria X.; Rondon, Martin; Perez, Adriana; Penaranda, Augusto; Barragan, Ana M.; Caraballo, Luis; Garcia, Elizabeth			Cost-effectiveness of the subcutaneous house dust mite allergen immunotherapy plus pharmacotherapy for allergic asthma: A mathematical model	ALLERGY			English	Letter									[Parra-Padilla, Devian; Zakzuk, Josefina; Carrasquilla, Maria; Alvis-Guzman, Nelson] Univ Cartagena, Hlth Econ Res Grp, Cartagena, Colombia; [Parra-Padilla, Devian; Zakzuk, Josefina; Carrasquilla, Maria; Alvis-Guzman, Nelson] ALZAK Fdn, Cartagena, Colombia; [Zakzuk, Josefina; Caraballo, Luis] Univ Cartagena, Inst Immunol Res, Cartagena, Colombia; [Dennis, Rodolfo; Rojas, Maria X.] Fdn Cardioinfantil, Dept Res, Bogota, Colombia; Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Rondon, Martin] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Perez, Adriana] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Dept Biostat & Data Sci, Austin, TX USA; [Penaranda, Augusto] Fdn Santa Fe Bogota, Dept Otolaryngol, Bogota, Colombia; [Penaranda, Augusto; Garcia, Elizabeth] Univ Los Andes, Sch Med, Bogota, Colombia; [Barragan, Ana M.] Univ Rosario, Sch Med, Publ Hlth Res Grp, Bogota, Colombia; [Garcia, Elizabeth] Fdn Santa Fe Bogota, Dept Pediat Allergol, Av 9 116-20,Off 213, Bogota, Colombia		Garcia, E (corresponding author), Fdn Santa Fe Bogota, Dept Pediat Allergol, Av 9 116-20,Off 213, Bogota, Colombia.	devianparrapadilla@gmail.com	Peñaranda, Augusto/GOE-5385-2022; Alvis-Guzman, Nelson/D-4913-2013	Alvis-Guzman, Nelson/0000-0001-9458-864X; Zakzuk, Josefina/0000-0002-6007-5376; Parra Padilla, Devian/0000-0002-0781-8441; Dennis, Rodolfo J/0000-0003-3215-9721; Rojas-Reyes, Maria Ximena/0000-0001-5752-7653; RONDON, MARTIN/0000-0002-3885-5448; Penaranda, Augusto/0000-0003-1598-8472	Departamento Administrativo de Ciencia, Tecnologia e Innovacion [540-2008]; Colombian Academy of Allergy, Asthma, and Immunology (ACAAI)	Departamento Administrativo de Ciencia, Tecnologia e Innovacion; Colombian Academy of Allergy, Asthma, and Immunology (ACAAI)	Departamento Administrativo de Ciencia, Tecnologia e Innovacion, Grant/Award Number: 540-2008; Colombian Academy of Allergy, Asthma, and Immunology (ACAAI)	Asaria M, 2018, ALLERGY, V73, P269, DOI 10.1111/all.13254; Buendia E, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0058-z; Dennis RJ, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-17; Duenas-Meza E, 2018, PEDIATR PULM, V53, P1356, DOI 10.1002/ppul.24079; Ehteshami-Afshar S, 2019, VALUE HEALTH, V22, P1070, DOI 10.1016/j.jval.2019.03.016; Jutel M, 2020, ALLERGY, V75, P2050, DOI 10.1111/all.14240; Schmitt J, 2020, ALLERGY, V75, P596, DOI 10.1111/all.14020; Simoens S, 2012, ALLERGY, V67, P1087, DOI 10.1111/j.1398-9995.2012.02861.x; Stelmach I, 2012, ANN ALLERG ASTHMA IM, V109, P274, DOI 10.1016/j.anai.2012.07.015; Tabar AI, 2011, J ALLERGY CLIN IMMUN, V127, P57, DOI 10.1016/j.jaci.2010.10.025; Zielen S, 2010, J ALLERGY CLIN IMMUN, V126, P942, DOI 10.1016/j.jaci.2010.06.002	11	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	JUL	2021	76	7					2229	2233		10.1111/all.14723	http://dx.doi.org/10.1111/all.14723		JAN 2021	5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TB9WH	33377199				2022-09-04	WOS:000608494000001
J	Glukhova, XA; Prusakova, OV; Trizna, JA; Zaripov, MM; Afanas'eva, GV; Glukhov, AS; Poltavtseva, RA; Ivanov, AA; Avila-Rodriguez, M; Barreto, GE; Aliev, G; Beletsky, IP				Glukhova, Xenia A.; Prusakova, Olga V.; Trizna, Julia A.; Zaripov, Michael M.; Afanas'eva, Gaida V.; Glukhov, Anatoly S.; Poltavtseva, Rimma A.; Ivanov, Alexei A.; Avila-Rodriguez, Marco; Barreto, George E.; Aliev, Gjumrakch; Beletsky, Igor P.			Updates on the Production of Therapeutic Antibodies Using Human Hybridoma Technique	CURRENT PHARMACEUTICAL DESIGN			English	Article						Therapeutic antibodies; hybridoma; fusion partner; B cells; EBV transformation; miR transformation	HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; HEPATITIS-C VIRUS; STEM-CELLS; IN-VITRO; C3D RECEPTOR; PLASMA-CELLS; LYMPH-NODE; GENERATION; LYMPHOCYTES	Therapeutic antibodies are implicated into the very promising and fast growing area of pharmaceutics. Human hybridoma technology, allowing generation of natural human antibodies in a native form, seems to be the most direct way that require no additional modifications for production of therapeutic antibodies. However, technical difficulties in human hybridoma creation discovered in the 80s of the last century have switched the mainstream therapeutic antibody development into new directions like display and transgenic mice techniques. These approaches have provided remarkable achievements in antibody engineering within last 15 years, but also revealed other limitations. Thus, it is time to turn back to forgotten human hybridoma technology. In this review, we describe new advances in all components of human hybridoma technology and discuss challenges in generating novel therapeutic mABs based on hybridoma technologies.	[Glukhova, Xenia A.; Prusakova, Olga V.; Trizna, Julia A.; Zaripov, Michael M.; Afanas'eva, Gaida V.; Glukhov, Anatoly S.; Poltavtseva, Rimma A.; Beletsky, Igor P.] Russian Acad Sci, Inst Theoret & Expt Biophys, Inst Skaya St 3, Pushchino 142290, Russia; [Ivanov, Alexei A.] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow 119991, Russia; [Avila-Rodriguez, Marco; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia; [Beletsky, Igor P.] Innograd Pushchino Ltd, Pushchino, Russia		Beletsky, IP (corresponding author), Russian Acad Sci, Inst Theoret & Expt Biophys, Inst Skaya St 3, Pushchino 142290, Russia.	ipbeletsky@gmail.com	Poltavtseva, Rimma Alekseevna/Q-6824-2016; glukhova, ksenia A/A-7683-2014; Glukhova, Xenia/AAA-6114-2020; Zaripov, Mikhail/E-1682-2014; Barreto, George E./AAD-7420-2020; Aliev, Gjumrakch/AAE-7734-2020; Aliev, Gjumrakch/K-7302-2017; Barreto, George E./B-5747-2014	Poltavtseva, Rimma Alekseevna/0000-0001-8625-9205; Glukhova, Xenia/0000-0002-5900-5872; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Avila-Rodriguez, Marco/0000-0003-4612-3236	Ministry of Education and Science of the Russian Federation [14.604.21.0025/RFMEFI60414X0025]; Pontificia Universidad Javeriana; GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA; Russian Science Foundation (RSCF) [14-23-00160]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Pontificia Universidad Javeriana; GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA; Russian Science Foundation (RSCF)(Russian Science Foundation (RSF))	This work was supported by the grant from Ministry of Education and Science of the Russian Federation (No 14.604.21.0025/RFMEFI60414X0025). Part of the experimental work was performed using the equipment of Center for collective use of IPAC RAS (Agreement No 14.621.21.0008, ID RFMEFI62114X0008) for G. Aliev: GEB was supported by Pontificia Universidad Javeriana. Gjumrakch Aliev was supported by the GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA and Russian Science Foundation (RSCF: No. 14-23-00160). We especially would like to thank Dr. Yi Li and Ms. Kuvshinkina T. B. for English editing.	Alaribe FN, 2013, LEUKEMIA RES, V37, P681, DOI 10.1016/j.leukres.2013.02.003; ARAKELOV S, 1993, J INFECT DIS, V168, P580, DOI 10.1093/infdis/168.3.580; Arienti KL, 2005, J MED CHEM, V48, P1873, DOI 10.1021/jm0495935; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Basalp A, 2003, HYBRIDOMA HYBRIDOM, V22, P329, DOI 10.1089/153685903322538863; Becker PD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013137; Beerli RR, 2010, MABS-AUSTIN, V2, P365, DOI 10.4161/mabs.12187; Benson JM, 2011, NAT BIOTECHNOL, V29, P615, DOI 10.1038/nbt.1903; Berardi AC, 1997, BLOOD, V89, P3554, DOI 10.1182/blood.V89.10.3554.3554_3554_3564; Boss IW, 2011, J VIROL, V85, P9877, DOI 10.1128/JVI.05558-11; CALLARD RE, 1988, IMMUNOLOGY, V65, P379; Cao TH, 2001, J VIROL, V75, P6359, DOI 10.1128/JVI.75.14.6359-6366.2001; Carpenter L, 2011, BLOOD, V117, P4008, DOI 10.1182/blood-2010-08-299941; Chan CEZ, 2014, INT IMMUNOL, V26, P649, DOI 10.1093/intimm/dxu082; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiarella P, 2011, RECENT PAT ANTI-CANC, V6, P258, DOI 10.2174/157489211795328549; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; COTE RJ, 1983, P NATL ACAD SCI-BIOL, V80, P2026, DOI 10.1073/pnas.80.7.2026; Crotty S, 2012, FUNDAMENTAL IMMUNOLO; Crowe Jr J, 2015, MICROBIOL SPECTR, V3, P1, DOI DOI 10.1128/MICR0BI0LSPEC.AID; Dahlke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049435; de Souza GT, 2015, WORLD J STEM CELLS, V7, P106, DOI 10.4252/wjsc.v7.i1.106; Depraetere S, 2001, J IMMUNOL, V166, P2929, DOI 10.4049/jimmunol.166.5.2929; Doerner A, 2014, FEBS LETT, V588, P278, DOI 10.1016/j.febslet.2013.11.025; Ducancel F, 2012, MABS-AUSTIN, V4, P445, DOI 10.4161/mabs.20776; Duvall M, 2011, MABS-AUSTIN, V3, P203, DOI 10.4161/mabs.3.2.14774; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; Fluckiger AC, 1998, BLOOD, V92, P4509; Forte E, 2012, J VIROL, V86, P6889, DOI 10.1128/JVI.07056-11; FRADE R, 1985, P NATL ACAD SCI USA, V82, P1490, DOI 10.1073/pnas.82.5.1490; French A, 2015, STEM CELLS DEV, V24, P1082, DOI 10.1089/scd.2014.0318; Gao J, 2011, CANCER RES, V71, P1029, DOI 10.1158/0008-5472.CAN-10-2274; Giles-Komar J, 2008, United States patent, Patent No. [WO2008046033 A2, 2008046033A2]; Golestani R, 2007, HYBRIDOMA, V26, P296, DOI 10.1089/hyb.2007.0510; Golestani R, 2009, HYBRIDOMA, V28, P139, DOI 10.1089/hyb.2008.0076; Gottesman A, 2010, BIOTECHNIQUES, V49, P747, DOI 10.2144/000113515; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Green Larry L, 2014, Curr Drug Discov Technol, V11, P74; Gu L, 2013, ACTA HAEMATOL-BASEL, V130, P87, DOI 10.1159/000346441; Harman Benjamin C, 2014, Curr Drug Discov Technol, V11, P65; Hayashi H, 2012, FASEB J, V26, P2306, DOI 10.1096/fj.11-196063; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hernando H, 2014, NUCLEIC ACIDS RES, V42, P249, DOI 10.1093/nar/gkt886; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HOLLYOAKE M, 1995, CANCER RES, V55, P4784; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Huggins J, 2007, BLOOD, V109, P1611, DOI 10.1182/blood-2006-03-008441; Hur EM, 2012, BLOOD, V120, P4571, DOI 10.1182/blood-2012-04-422303; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; Iskra S, 2010, J VIROL, V84, P3612, DOI 10.1128/JVI.01400-09; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Johnson SE, 2005, J IMMUNOL, V175, P7325, DOI 10.4049/jimmunol.175.11.7325; Jourdan M, 2009, BLOOD, V114, P5173, DOI 10.1182/blood-2009-07-235960; Kalantarov Gary F., 2002, Human Antibodies, V11, P85; Kametani Y, 2006, EXP HEMATOL, V34, P1240, DOI 10.1016/j.exphem.2006.05.006; Kanduser M, 2014, EXPERT OPIN DRUG DEL, V11, P1885, DOI 10.1517/17425247.2014.938632; Kaneko MK, 2013, BIOCHEM BIOPH RES CO, V432, P40, DOI 10.1016/j.bbrc.2013.01.088; KANKI T, 1994, HYBRIDOMA, V13, P327, DOI 10.1089/hyb.1994.13.327; Karpas A, 2001, P NATL ACAD SCI USA, V98, P1799, DOI 10.1073/pnas.98.4.1799; Kaseko G, 2011, BMC P, V5, P130; Kataoka H, 1997, DIFFERENTIATION, V62, P203; King David J, 2014, Curr Drug Discov Technol, V11, P56; Kirman I, 2002, HYBRIDOMA HYBRIDOM, V21, P405, DOI 10.1089/153685902321043936; KJELDSEN TB, 1988, CANCER RES, V48, P3208; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kondo Y, 2013, WORLD J GASTROENTERO, V19, P7889, DOI 10.3748/wjg.v19.i44.7889; KOZBOR D, 1979, SCAND J IMMUNOL, V10, P187, DOI 10.1111/j.1365-3083.1979.tb01339.x; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lee RJ, 2010, J IMMUNOL METHODS, V361, P89, DOI 10.1016/j.jim.2010.08.001; Lee TY, 2013, J INTERF CYTOK RES, V33, P34, DOI 10.1089/jir.2012.0062; Li JH, 2014, ONCOL LETT, V8, P198, DOI 10.3892/ol.2014.2067; Liebig Tanja M, 2009, J Vis Exp, DOI 10.3791/1373; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Liu JKH, 2014, ANN MED SURG, V3, P113, DOI 10.1016/j.amsu.2014.09.001; Luo X, 2012, United States patent, Patent No. [US8133727 B2, 8133727B2]; Luo XM, 2009, BLOOD, V113, P1422, DOI 10.1182/blood-2008-09-177139; Luppi M, 1996, HAEMATOLOGICA, V81, P265; Macdonald LE, 2014, P NATL ACAD SCI USA, V111, P5147, DOI 10.1073/pnas.1323896111; Malik D, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-175; Mead EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047422; Miele L, 1997, J IMMUNOTHER, V20, P214; Munro TP, 2011, MABS-AUSTIN, V3, P440, DOI 10.4161/mabs.3.5.16968; Murphy AJ, 2014, P NATL ACAD SCI USA, V111, P5153, DOI 10.1073/pnas.1324022111; NAGATA S, 1991, HYBRIDOMA, V10, P369, DOI 10.1089/hyb.1991.10.369; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Neron S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051946; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; NILSSON K, 1971, INT J CANCER, V8, P443, DOI 10.1002/ijc.2910080312; Ohkawara JI, 1998, LEUKEMIA, V12, P764, DOI 10.1038/sj.leu.2401004; Ohkohchi N, 2000, LASER SURG MED, V27, P262, DOI 10.1002/1096-9101(2000)27:3<262::AID-LSM8>3.0.CO;2-Q; Okamoto T, 2002, BIOSCI BIOTECH BIOCH, V66, P1241, DOI 10.1271/bbb.66.1241; Okubo M, CANC GENET CYTOGENET, V129, P30; OLSSON L, 1980, P NATL ACAD SCI-BIOL, V77, P5429, DOI 10.1073/pnas.77.9.5429; Palacios F, 2015, LEUKEMIA, V29, P115, DOI 10.1038/leu.2014.158; PALACIOS R, 1995, P NATL ACAD SCI USA, V92, P7530, DOI 10.1073/pnas.92.16.7530; POSNER MR, 1987, HYBRIDOMA, V6, P611, DOI 10.1089/hyb.1987.6.611; Prieto Y, 2011, CYTOTECHNOLOGY, V63, P351, DOI 10.1007/s10616-011-9348-7; Reichert JM, 2015, MABS-AUSTIN, V7, P1, DOI 10.4161/19420862.2015.988944; Rubinchik S, 2014, United States Patent, Patent No. [US20140275492 A1, 20140275492A1]; Sandhu SK, 2013, P NATL ACAD SCI USA, V110, P18208, DOI 10.1073/pnas.1315365110; Santanam U, 2010, P NATL ACAD SCI USA, V107, P12210, DOI 10.1073/pnas.1007186107; Scholzen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102885; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shealy D, 2010, MABS-AUSTIN, V2, P428, DOI 10.4161/mabs.12304; Shim SM, 2013, BIOCHEM BIOPH RES CO, V441, P438, DOI 10.1016/j.bbrc.2013.10.081; Siripen T, 1997, CYTOTECHNOLOGY, V25, P155, DOI 10.1023/A:1007932420835; Smith N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064868; STEUBING RW, 1991, CYTOMETRY, V12, P505, DOI 10.1002/cyto.990120607; Su R, 2015, ONCOGENE, V34, P3226, DOI 10.1038/onc.2014.274; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TENG NNH, 1983, P NATL ACAD SCI-BIOL, V80, P7308, DOI 10.1073/pnas.80.23.7308; Tomita M, 2011, IMMUNOTHERAPY-UK, V3, P371, DOI 10.2217/IMT.11.4; Tournoy KG, 2000, CLIN EXP IMMUNOL, V119, P231, DOI 10.1046/j.1365-2249.2000.01099.x; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trakht I, 2007, United States patent, Patent No. [US20070141064 A1, 20070141064A1]; Ueda T, 2008, United States Patent, Patent No. [US20080102524 A1, 20080102524A1]; Uherkova L, 2013, LEUKEMIA RES, V37, P320, DOI 10.1016/j.leukres.2012.12.004; van Keimpema M, 2014, BLOOD, V124, P3431, DOI 10.1182/blood-2014-01-553412; Villaudy J, 2014, J IMMUNOL METHODS, V410, P18, DOI 10.1016/j.jim.2014.06.010; Wiesner M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001464; Xu SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7764; Yagami H, 2013, PHARM PAT ANAL, V2, P249, DOI [10.4155/ppa.13.2, 10.4155/PPA.13.2]; Yang J, 2006, METH MOL B, V325, P59; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008; Zhu Y, 2013, CURR OPIN VIROL, V3, P266, DOI 10.1016/j.coviro.2013.05.013; Zimmermann U, 1985, Adv Biotechnol Processes, V4, P79	131	6	8	0	40	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2016	22	7					870	878		10.2174/1381612822666151223102845	http://dx.doi.org/10.2174/1381612822666151223102845			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DG4VQ	26696411				2022-09-04	WOS:000372071600010
J	Tacik, P; Fiesel, FC; Fujioka, S; Ross, OA; Pretelt, F; Cardona, CC; Kidd, A; Hlavac, M; Raizis, A; Okun, MS; Traynor, S; Strongosky, AJ; Springer, W; Wszolek, ZK				Tacik, Pawel; Fiesel, Fabienne C.; Fujioka, Shinsuke; Ross, Owen A.; Pretelt, Felipe; Castaneda Cardona, Camilo; Kidd, Alexa; Hlavac, Michael; Raizis, Anthony; Okun, Michael S.; Traynor, Sharleen; Strongosky, Audrey J.; Springer, Wolfdieter; Wszolek, Zbigniew K.			Three families with Perry syndrome from distinct parts of the world	PARKINSONISM & RELATED DISORDERS			English	Article						Perry syndrome; DCTN1; Gene mutation; Respiratory insufficiency; Familial; Parkinsonism	PARKINSONISM; DEPRESSION; INITIATION; TRANSPORT	Objectives: Perry syndrome consists of autosomal dominant Parkinsonism, depression, weight loss, and central hypoventilation. Eight mutations in 16 families have been reported: p.F52L, p.G67D, p.G71R, p.G71E, p.G71A, p.T72P, p.Q74P, and p.Y78C located in exon 2 of the dynactin 1 (DCTN1) gene on chromosome 2p13.1. Methods: Genealogical, clinical, genetic, and functional studies were performed in three kindreds from New Zealand, the United States, and Colombia. A diaphragmatic pacemaker was implanted in the proband from the Colombian family to treat her respiratory insufficiency. Dopaminergic therapy was initiated in probands from two families. Results: Besides the probands, 17 symptomatic relatives from all families were identified. The cardinal signs of Perry syndrome were present in all three probands with symptomatic disease onset in their fifth or sixth decade of life. Parkinsonism was moderate with a partial response to dopaminergic treatment. All affected persons but two died of respiratory insufficiency. The proband from the Colombian family is alive most likely due to early diagnosis and implantation of a diaphragmatic pacemaker. Two-and-a-half-year follow-up examination has revealed that the diaphragmatic pacemaker is optimally functioning without any major complications. In the Colombian and US families, the DCTN1 p.G71R and in the New Zealand family the DCTN1 p.Y78C mutations were identified. In functional assays, both mutations altered microtubule binding consistent with a pathogenic role. Conclusions: Perry syndrome is a rare condition, but new cases are expected to be diagnosed worldwide. Early diagnosis prevents life-threatening acute respiratory failure. Diaphragmatic pacemakers should be considered as an effective symptomatic treatment option. (C) 2014 Elsevier Ltd. All rights reserved.	[Tacik, Pawel; Fujioka, Shinsuke; Traynor, Sharleen; Strongosky, Audrey J.; Wszolek, Zbigniew K.] Mayo Clin Florida, Dept Neurol, Jacksonville, FL 32224 USA; [Fiesel, Fabienne C.; Ross, Owen A.; Springer, Wolfdieter] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA; [Ross, Owen A.; Springer, Wolfdieter] Mayo Clin Florida, Mayo Grad Sch, Jacksonville, FL 32224 USA; [Pretelt, Felipe; Castaneda Cardona, Camilo] Pontificia Univ Javeriana, Dept Neurol, Hosp Univ San Ignacio, Bogota, Colombia; [Kidd, Alexa] Canterbury Hlth Labs, Christchurch, New Zealand; [Hlavac, Michael] Christchurch Hosp, Resp Serv, Canterbury Dist Hlth Board, Christchurch, New Zealand; [Raizis, Anthony] Canterbuly Hlth Labs, Mol Pathol Lab, Christchurch, New Zealand; [Okun, Michael S.] Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, McKnight Brain Inst, Gainesville, FL USA; [Okun, Michael S.] Univ Florida, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, McKnight Brain Inst, Gainesville, FL USA		Wszolek, ZK (corresponding author), Mayo Clin Florida, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA.	Wszolek.Zbigniew@mayo.edu	Wszolek, Zbigniew K./AAB-1431-2019	Fiesel, Fabienne/0000-0002-1919-9676; Ross, Owen/0000-0003-4813-756X; Okun, Michael/0000-0002-6247-9358; Springer, Wolfdieter/0000-0002-1178-3149	Max Kade Foundation; NIH/NINDS [R01 NS078086, P50 NS072187]; NIH; NPF; Michael J. Fox Foundation; Parkinson Alliance; Smallwood Foundation; Bachmann-Strauss Foundation; Tourette Syndrome Association; UF Foundation; PeerView; Prime; Vanderbilt University; Medtronic; ANS/St. Jude; Mayo Clinic Center for Individualized Medicine; Marriott Family Foundation; Gerstner Family Career Development Award; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187, R01NS078086] Funding Source: NIH RePORTER	Max Kade Foundation; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NPF; Michael J. Fox Foundation; Parkinson Alliance; Smallwood Foundation; Bachmann-Strauss Foundation; Tourette Syndrome Association; UF Foundation; PeerView; Prime; Vanderbilt University; Medtronic(Medtronic); ANS/St. Jude; Mayo Clinic Center for Individualized Medicine; Marriott Family Foundation; Gerstner Family Career Development Award; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Pawel Tacik is supported by the Max Kade Foundation.; Owen A. Ross is partially supported by NIH/NINDS R01 NS078086 and supported by the NIH/NINDS P50 NS072187.; Michael S. Okun serves as a consultant for the National Parkinson Foundation, and has received research grants from NIH, NPF, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. Dr. Okun has previously received honoraria, but in the past >36 months has received no support from industry. Dr. Okun has received royalties for publications with Demos, Manson, Amazon, and Cambridge (movement disorders books). Dr. Okun is an associate editor for New England Journal of Medicine, Journal Watch Neurology. Dr. Okun has participated in CME activities on movement disorders in the last 36 months sponsored by PeerView, Prime, and by Vanderbilt University. The institution and not Dr. Okun receives grants from Medtronic and ANS/St. Jude, and the PI has no financial interest in these grants. Dr. Okun has participated as a site PI and/or co-I for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria.; Wolfdieter Springer is partially supported by the Mayo Clinic Center for Individualized Medicine, the Marriott Family Foundation and the Gerstner Family Career Development Award.; Zbigniew K. Wszolek is partially supported by the NIH/NINDS P50 NS072187, the Michael J. Fox Foundation for Parkinson's Research, and the gift from Carl Edward Bolch, Jr., and Susan Bass Bolch.	Aji BM, 2013, J NEUROL SCI, V330, P117, DOI 10.1016/j.jns.2013.04.008; Araki E, 2014, MOV DISORD; Caroppo P, 2014, JAMA NEUROL, V71, P208, DOI 10.1001/jamaneurol.2013.5100; Chung EJ, 2014, PARKINSONISM RELAT D, V20, P388, DOI 10.1016/j.parkreldis.2014.01.010; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Newsway V, 2010, MOVEMENT DISORD, V25, P767, DOI 10.1002/mds.22950; PERRY TL, 1975, ARCH NEUROL-CHICAGO, V32, P108, DOI 10.1001/archneur.1975.00490440058009; Pretelt F, 2014, J NEUROL, V261, P620, DOI 10.1007/s00415-014-7262-6; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Wider C, 2008, PARKINSONISM RELAT D, V14, P1, DOI 10.1016/j.parkreldis.2007.07.014; Wider C, 2010, J NEUROL SCI, V289, P149, DOI 10.1016/j.jns.2009.08.044	13	20	21	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	AUG	2014	20	8					884	888		10.1016/j.parkreldis.2014.05.004	http://dx.doi.org/10.1016/j.parkreldis.2014.05.004			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO0DF	24881494	Green Accepted			2022-09-04	WOS:000340978600017
J	Tomatsu, S; Montano, AM; Oguma, T; Dung, VC; Oikawa, H; de Carvalho, TG; Gutierrez, ML; Yamaguchi, S; Suzuki, Y; Fukushi, M; Kida, K; Kubota, M; Barrera, L; Orii, T				Tomatsu, Shunji; Montano, Adriana M.; Oguma, Toshihiro; Vu Chi Dung; Oikawa, Hirotaka; de Carvalho, Talita Giacomet; Gutierrez, Maria L.; Yamaguchi, Seiji; Suzuki, Yasuyuki; Fukushi, Masaru; Kida, Kazuhiro; Kubota, Mitsuru; Barrera, Luis; Orii, Tadao			Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry	JOURNAL OF INHERITED METABOLIC DISEASE			English	Article								Mucopolysaccharidosis type IVA (MPS IVA, Morquio A disease), a progressive lysosomal storage disease, causes skeletal chondrodysplasia through excessive storage of keratan sulfate (KS). KS is synthesized mainly in cartilage and released to the circulation. The excess storage of KS disrupts cartilage, consequently releasing more KS into circulation, which is a critical biomarker for MPS IVA. Thus, assessment of KS level provides a potential screening strategy and determines clinical course and efficacy of therapies. We have recently developed a tandem mass spectrometry liquid chromatography [LC/MS/MS] method to assay KS levels in blood. Forty-nine blood specimens from patients with MPS IVA [severe (n=33), attenuated (n=11) and undefined (n=5)] were analyzed for comparison of blood KS concentration with that of healthy subjects and for correlation with clinical severity. Plasma samples were digested by keratanase II to obtain disaccharides of KS. Digested samples were assayed by LC/MS/MS. We found that blood KS levels (0.4-26 mu g/ml) in MPS IVA patients were significantly higher than those in age-matched controls (0.67-4.6 mu g/ml; P<0.0001). It was found that blood KS level varied with age and clinical severity in the patients. Blood KS levels in MPS IVA peaked between 2 years and 5 years of age (mean 11.4 mu g/ml). Blood KS levels in severe MPS IVA (mean 7.3 mu g/ml) were higher than in the attenuated form (mean 2.1 mu g/ml) (P=0.012). We also found elevated blood KS levels in other types of MPS. These findings indicate that the new KS assay for blood is suitable for early diagnosis and longitudinal assessment of disease severity in MPS IVA.	[Tomatsu, Shunji; Montano, Adriana M.; Vu Chi Dung; Oikawa, Hirotaka; de Carvalho, Talita Giacomet; Gutierrez, Maria L.] St Louis Univ, Doisy Res Ctr, Dept Pediat, St Louis, MO 63104 USA; [Oguma, Toshihiro] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Yamaguchi, Seiji] Shimane Univ, Dept Pediat, Matsue, Shimane, Japan; [Suzuki, Yasuyuki; Orii, Tadao] Gifu Univ, Dept Pediat, Gifu, Japan; [Fukushi, Masaru] Sapporo City Hyg Inst, Sapporo, Hokkaido, Japan; [Kida, Kazuhiro; Kubota, Mitsuru] Hokkaido Univ, Dept Pediat, Sapporo, Hokkaido, Japan; [Barrera, Luis] Pontificia Univ Javeriana, Inst Errores Innatos Metab, Bogota, Colombia		Tomatsu, S (corresponding author), St Louis Univ, Doisy Res Ctr, Dept Pediat, 1100 South Grand Blvd, St Louis, MO 63104 USA.	tomatsus@slu.edu	Montano, Adriana/AHE-8741-2022; Oikawa, Hirotaka/D-6657-2018	Oikawa, Hirotaka/0000-0002-2050-4957; Gutierrez, Maria Lucia/0000-0002-2430-5015	Austrian MPS Society; Bennett Foundation; Jacob Randall Foundation; International Morquio Organization	Austrian MPS Society; Bennett Foundation; Jacob Randall Foundation; International Morquio Organization	This work was supported by grants from the Austrian MPS Society, the Bennett Foundation, the Jacob Randall Foundation, and the International Morquio Organization.	BECK M, 1986, CLIN GENET, V29, P325; CATERSON B, 1983, J BIOL CHEM, V258, P8848; Dorfman A, 1976, Adv Exp Med Biol, V68, P261; FangKircher SG, 1997, LIFE SCI, V61, P771, DOI 10.1016/S0024-3205(97)00558-4; FUJIMOTO A, 1983, AM J MED GENET, V15, P265, DOI 10.1002/ajmg.1320150210; GLOSSL J, 1982, BIOCHEM J, V203, P335, DOI 10.1042/bj2030335; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; MEHMET H, 1986, EUR J BIOCHEM, V157, P385, DOI 10.1111/j.1432-1033.1986.tb09680.x; Montano AM, 2007, J INHERIT METAB DIS, V30, P165, DOI 10.1007/s10545-007-0529-7; Montano AM, 2008, AM J MED GENET A, V146A, P1286, DOI 10.1002/ajmg.a.32281; Neufeld E. F., 2001, METABOLIC MOL BASES, P3421, DOI DOI 10.1036/OMMBID.165; Northover H, 1996, J INHERIT METAB DIS, V19, P357, DOI 10.1007/BF01799267; Oguma T, 2007, BIOMED CHROMATOGR, V21, P356, DOI 10.1002/bmc.760; Ohashi A, 2009, ACTA PAEDIATR, V98, P768, DOI 10.1111/j.1651-2227.2009.01134.x; THONAR EJMA, 1988, J CLIN CHEM CLIN BIO, V26, P57; THONAR EJMA, 1985, ARTHRITIS RHEUM, V28, P1367, DOI 10.1002/art.1780281209; Tomatsu S, 2005, J INHERIT METAB DIS, V28, P187, DOI 10.1007/s10545-005-5673-3; Tomatsu S, 2004, PEDIATR RES, V55, P592, DOI 10.1203/01.PDR.0000113767.60140.E9; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Toyoda H, 1998, CHEM PHARM BULL, V46, P97; WHITLEY CB, 1989, CLIN CHEM, V35, P374; Yamada H, 2000, J RHEUMATOL, V27, P1721	22	42	42	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-8955	1573-2665		J INHERIT METAB DIS	J. Inherit. Metab. Dis.	DEC	2010	33			3			S35	S42		10.1007/s10545-009-9013-x	http://dx.doi.org/10.1007/s10545-009-9013-x			8	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	V33ME	20107903				2022-09-04	WOS:000209022100006
J	Tomatsu, S; Montano, AM; Oguma, T; Dung, VC; Oikawa, H; Gutierrez, ML; Yamaguchi, S; Suzuki, Y; Fukushi, M; Barrera, LA; Kida, K; Kubota, M; Orii, T				Tomatsu, Shunji; Montano, Adriana M.; Oguma, Toshihiro; Dung, Vu Chi; Oikawa, Hirotaka; Gutierrez, Maria L.; Yamaguchi, Seiji; Suzuki, Yasuyuki; Fukushi, Masaru; Barrera, Luis A.; Kida, Kazuhiro; Kubota, Mitsuru; Orii, Tadao			Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry	MOLECULAR GENETICS AND METABOLISM			English	Article						glycosaminoglycans; dermatan sulfate; heparan sulfate; mucopolysaccharicloses; mucolipicloses; liquid chromatography tandem mass spectrometry	ENZYME-REPLACEMENT THERAPY; PERFORMANCE LIQUID-CHROMATOGRAPHY; KERATAN SULFATE; CHONDROITIN/DERMATAN SULFATE; HUMAN SERUM; OLIGOSACCHARIDES; VI; GLYCOSAMINOGLYCANS; HUNTER; CELL	Glycosaminoglycans (GAGs) are accumulated in various organs in both mucopolysaccharidoses (MPS) and mucolipicloses II and III (ML II and III). MPS and ML II and III patients can not properly degrade dermatan sulfate (DS) and/or heparan sulfate (HS). HS storage occurs in the brain leading to neurological signs while DS storage involves mainly visceral and skeletal manifestations. Excessive DS and HS released into circulation and thus blood levels of both are elevated, therefore, DS and HS in blood could be critical biomarkers for MPS and ML. Such measurement can provide a potential early screening, assessment of the clinical course and efficacy of therapies. We here assay DS and HS levels in MPS and ML patients using liquid chromatography tandem mass spectrometry (LC/MS/MS). Plasma samples were digested by heparitinase and chondroitinase B to obtain disaccharides of DS and HS, followed by LC/MS/MS analysis. One hundred-twenty samples from patients and 112 control samples were analyzed. We found that all MPS I, II, III and VI patients had a significant elevation of all DS + HS compositions analyzed in plasma, compared with the controls (P < 0.0001). Specificity and sensitivity was 100% if the cut off value is 800 ng/ml between control and these types of MPS group. All MPS I, II and III patients also had a significant elevation of plasma HS, compared with the controls (P < 0.0001). All MPS VI patients had a significant elevation of plasma DS, compared with the controls (P < 0.0001). These findings suggest measurement of DS and/or HS levels by LC/MS/MS is applicable to the screening for MPS I, II, III and VI patients.	[Tomatsu, Shunji; Montano, Adriana M.; Dung, Vu Chi; Oikawa, Hirotaka; Gutierrez, Maria L.] St Louis Univ, Dept Pediat, Doisy Res Ctr, 1100 S Grand Blvd,Room 307, St Louis, MO 63104 USA; [Oguma, Toshihiro] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Yamaguchi, Seiji] Shimane Univ, Dept Pediat, Izumo, Shimane, Japan; [Suzuki, Yasuyuki] Gifu Univ, Med Educ Dev Ctr, Gifu, Japan; [Fukushi, Masaru] Sapporo City Inst Publ Hlth, Sapporo, Hokkaido 0038505, Japan; [Barrera, Luis A.] Pontificia Univ Javeriana, Inst Errores Innatos Metab, Bogota, Colombia; [Kida, Kazuhiro; Kubota, Mitsuru] Hokkaido Univ, Dept Pediat, Sapporo, Hokkaido, Japan; [Orii, Tadao] Gifu Univ, Dept Pediat, Gifu, Japan		Tomatsu, S (corresponding author), St Louis Univ, Dept Pediat, Doisy Res Ctr, 1100 S Grand Blvd,Room 307, St Louis, MO 63104 USA.	tomatsus@slu.edu	Oikawa, Hirotaka/D-6657-2018; Montano, Adriana/AHE-8741-2022	Oikawa, Hirotaka/0000-0002-2050-4957; Gutierrez, Maria Lucia/0000-0002-2430-5015				Chai WG, 1998, ANAL CHEM, V70, P2060, DOI 10.1021/ac9712761; Chan YM, 2000, J HOSP INFECT, V46, P67, DOI 10.1053/jhin.2000.0797; COL RD, 1993, J CHROMATOGR, V647, P289; Crawley AC, 1997, J CLIN INVEST, V99, P651, DOI 10.1172/JCI119208; CROW J, 1983, J CLIN PATHOL, V36, P415, DOI 10.1136/jcp.36.4.415; Ellinwood NM, 2004, J GENE MED, V6, P481, DOI 10.1002/jgm.581; Harmatz P, 2005, PEDIATRICS, V115, pE681, DOI 10.1542/peds.2004-1023; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Harmatz P, 2008, MOL GENET METAB, V94, P469, DOI 10.1016/j.ymgme.2008.04.001; Harmatz P, 2006, J PEDIATR-US, V148, P533, DOI 10.1016/j.jpeds.2005.12.014; Hodges BL, 2006, CURR GENE THER, V6, P227, DOI 10.2174/156652306776359522; Hua CT, 1998, CLIN CHEM, V44, P2094; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Karlsson M, 2000, ANAL BIOCHEM, V286, P51, DOI 10.1006/abio.2000.4767; Karlsson NG, 2005, J CHROMATOGR B, V824, P139, DOI 10.1016/j.jchromb.2005.07.014; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kornfeld S., 2001, METABOLIC MOL BASES, P3469; LIGHTBODY J, 1971, LANCET, V1, P451; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Meikle PJ, 1997, CLIN CHEM, V43, P1325; Montano AM, 2008, MOL GENET METAB, V94, P178, DOI 10.1016/j.ymgme.2008.01.007; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Neufeld E. F., 2001, METABOLIC MOL BASES, P3421, DOI DOI 10.1036/OMMBID.165; Oguma T, 2001, ANAL BIOCHEM, V290, P68, DOI 10.1006/abio.2000.4940; Oguma T, 2001, BIOMED CHROMATOGR, V15, P356, DOI 10.1002/bmc.74.abs; Oguma T, 2001, J CHROMATOGR B, V754, P153, DOI 10.1016/S0378-4347(00)00601-0; Oguma T, 2007, ANAL BIOCHEM, V368, P79, DOI 10.1016/j.ab.2007.05.016; Oguma T, 2007, BIOMED CHROMATOGR, V21, P356, DOI 10.1002/bmc.760; Ohashi A, 2009, ACTA PAEDIATR, V98, P768, DOI 10.1111/j.1651-2227.2009.01134.x; Pope RM, 2001, GLYCOBIOLOGY, V11, P505, DOI 10.1093/glycob/11.6.505; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Saad OM, 2003, ANAL CHEM, V75, P2985, DOI 10.1021/ac0340455; SILVESTRO L, 1992, J CHROMATOGR, V591, P225, DOI 10.1016/0021-9673(92)80241-L; Skidmore MA, 2006, J CHROMATOGR A, V1135, P52, DOI 10.1016/j.chroma.2006.09.064; Thanawiroon C, 2004, J BIOL CHEM, V279, P2608, DOI 10.1074/jbc.M304772200; Tomatsu S, 2005, J INHERIT METAB DIS, V28, P743, DOI 10.1007/s10545-005-0069-y; TONDEUR M, 1971, J PEDIATR-US, V79, P366, DOI 10.1016/S0022-3476(71)80143-9; Toyoda H, 1998, CHEM PHARM BULL, V46, P97; VOGLER C, 1990, AM J PATHOL, V136, P207; Whitley CB, 2002, MOL GENET METAB, V75, P56, DOI 10.1006/mgme.2001.3271; WIESMANN UN, 1980, PEDIATR RES, V14, P749, DOI 10.1203/00006450-198005000-00008; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Yamada H, 2000, J RHEUMATOL, V27, P1721; Zaia J, 2001, ANAL CHEM, V73, P233, DOI 10.1021/ac000777a; Zamfir A, 2002, RAPID COMMUN MASS SP, V16, P2015, DOI 10.1002/rcm.820; Zhang Y, 2005, ANAL CHEM, V77, P902, DOI 10.1021/ac040074j; Zhang YT, 2005, INVEST OPHTH VIS SCI, V46, P1604, DOI 10.1167/iovs.04-1453	48	55	55	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2010	99	2					124	131		10.1016/j.ymgme.2009.10.001	http://dx.doi.org/10.1016/j.ymgme.2009.10.001			8	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	548XV	19932038				2022-09-04	WOS:000274004300004
J	Simpson, JL; Gray, R; Perez, A; Mena, P; Queenan, J; Barbato, M; Pardo, F; Kambic, R; Jennings, V				Simpson, JL; Gray, R; Perez, A; Mena, P; Queenan, J; Barbato, M; Pardo, F; Kambic, R; Jennings, V			Fertilisation involving ageing gametes, major birth defects, and Down's syndrome	LANCET			English	Article							RISK	For many years, ageing of gametes as a result of prolonged retention In the female reproductive tract before fertilisation has been circumstantially associated with major birth defects. To assess this association, we studied pregnant women who had recorded the timing, with regard to presumed ovulation, of the coital event leading to conception. We found major anomalies In 11 l of 400 Infants born to women with optimally timed conceptions (on the day of or 1 day before ovulation), compared with 14 (2.5%) of 538 Infants of women with non-optimally timed conceptions (odds ratio 0.94, 95% CI 0.43-2.06). The numbers of Infants with Down's syndrome were two l of 400, and four (0.7%) of 538, respectively (1.48, 0.27-8.06). There is no association between ageing gametes and major birth defects, Including Down's syndrome.	Baylor Coll Med, Houston, TX 77030 USA; Johns Hopkins Univ, Baltimore, MD USA; Pontificia Univ Catolica Chile, Santiago, Chile; Univ Los Andes, Santiago, Chile; Georgetown Univ, Inst Reprod Hlth, Washington, DC USA; Ctr Ambrosiano Metodi Nat, Milan, Italy; Univ Javeriana, Bogota, Colombia		Simpson, JL (corresponding author), Baylor Coll Med, 6650 Fannin, Houston, TX 77030 USA.							CASTILLA EE, 1995, AM J MED GENET, V59, P525, DOI 10.1002/ajmg.1320590424; GRAY RH, 1995, AM J OBSTET GYNECOL, V172, P1567, DOI 10.1016/0002-9378(95)90498-0; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; SIMPSON J L, 1988, Advances in Contraception, V4, P247, DOI 10.1007/BF01849266; Yoon PW, 1996, AM J HUM GENET, V58, P628	5	1	1	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1670	1671		10.1016/S0140-6736(02)08559-8	http://dx.doi.org/10.1016/S0140-6736(02)08559-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020531				2022-09-04	WOS:000175593300014
J	Tulloch-Reid, M; Saravia, NG; Dennis, RJ; Jaramillo, A; Cuervo, LG; Walker, SP; Salicrup, LA				Tulloch-Reid, Marshall K.; Saravia, Nancy Gore; Dennis, Rodolfo J.; Jaramillo, Andres; Cuervo, Luis Gabriel; Walker, Susan P.; Salicrup, Luis Alejandro			Strengthening institutional capacity for equitable health research: lessons from Latin America and the Caribbean	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tulloch-Reid, Marshall K.; Walker, Susan P.] Univ West Indies, Caribbean Inst Hlth Res, Kingston, Jamaica; [Jaramillo, Andres] Ctr Int Entrenamiento & Invest Med, Res & Training Portfolio, Cali, Colombia; [Jaramillo, Andres] Univ Icesi, Res & Training Portfolio, Cali, Colombia; [Dennis, Rodolfo J.] Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia; [Cuervo, Luis Gabriel] WHO, Pan Amer Hlth Org, Dept Hlth Syst & Serv, Hlth Serv & Access Unit,Hlth Syst Res, Washington, DC USA; [Salicrup, Luis Alejandro] NCI, Ctr Global Hlth, US NIH, Global Hlth Res, Bethesda, MD 20892 USA; [Saravia, Nancy Gore] Ctr Int Entrenamiento & Invest Med, Cali, Colombia; [Saravia, Nancy Gore] Univ Icesi, Cali, Colombia; [Salicrup, Luis Alejandro] WHO, Pan Amer Hlth Org, Dept Hlth Syst & Serv, Hlth Serv & Access Unit,Global Hlth Res, Washington, DC USA		Tulloch-Reid, M (corresponding author), Univ West Indies, Caribbean Inst Hlth Res, Kingston, Jamaica.	marshall.tullochreid@uwimona.edu.jm	CUERVO, Luis Gabriel/A-9464-2009	CUERVO, Luis Gabriel/0000-0003-2732-5019; Dennis, Rodolfo J/0000-0003-3215-9721; Gore Saravia, Nancy/0000-0002-2440-9658	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Alger J, 2010, REV MED HONDUR, V78, P97; Board on Science and Technology for International Development Institute of Medicine National Academy of Sciences, 1987, US CAP ADD TROP INF; Commission on Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Council on Health Research and Development, 2018, FAIR RES CONTR; Franzen SRP, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012332; Restrepo CG, 2017, J CLIN EPIDEMIOL, V86, P71, DOI 10.1016/j.jclinepi.2016.10.002; HALSTEAD SB, 1991, J CLIN EPIDEMIOL, V44, P579, DOI 10.1016/0895-4356(91)90222-U; Lucas S., 2017, FUND THINK TANKS EFF; Mckee M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001209; Morrow R H Jr, 1991, Infect Dis Clin North Am, V5, P235; Ogundahunsi OAT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003380; Pan American Health Organization, 2017, REP STRENGTH RES CAP; Pan American Health Organization/ World Health Organization, 2009, CD4910 WHO PAN AM HL; Saravia NG, 2004, B WORLD HEALTH ORGAN, V82, P608; Tulloch-Reid MK, 2015, J CLIN EPIDEMIOL, V68, P1099, DOI 10.1016/j.jclinepi.2015.04.012; United States National Institutes of Health, 2017, NIH GRANTS POL STAT; Wellcome Trust, 2018, SCHEM FIND; World Health Organization, 2015, INTR TDR NETW	18	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2018	362								k2456	10.1136/bmj.k2456	http://dx.doi.org/10.1136/bmj.k2456			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP7UM	30012634	Green Published, hybrid			2022-09-04	WOS:000441115600002
J	Abdolmaleki, F; Farahani, N; Hayat, SMG; Pirro, M; Bianconi, V; Barreto, GE; Sahebkar, A				Abdolmaleki, Fereshte; Farahani, Najmeh; Hayat, Seyed Mohammad Gheibi; Pirro, Matteo; Bianconi, Vanessa; Barreto, George E.; Sahebkar, Amirhossein			The Role of Efferocytosis in Autoimmune Diseases	FRONTIERS IN IMMUNOLOGY			English	Review						apoptosis; efferocytosis; autoimmune disease; phagocytosis; systemic lupus erythematous	SYSTEMIC-LUPUS-ERYTHEMATOSUS; APOPTOTIC CELL CLEARANCE; INFLAMMATORY-BOWEL-DISEASE; FIND-ME SIGNALS; MONOCYTE-DERIVED MACROPHAGES; GENOME-WIDE ASSOCIATION; INNATE IMMUNE-RESPONSE; TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; LYMPHOPROLIFERATIVE SYNDROME	Apoptosis happens continuously for millions of cells along with the active removal of apoptotic debris in order to maintain tissue homeostasis. In this respect, efferocytosis, i.e., the process of dead cell clearance, is orchestrated through cell exposure of a set of "find me," "eat me," and "tolerate me" signals facilitating the engulfment of dying cells through phagocytosis by macrophages and dendritic cells. The clearance of dead cells via phagocytes is of utmost importance to maintain the immune system tolerance to self-antigens. Accordingly, this biological activity prevents the release of autoantigens by dead cells, thus potentially suppressing the undesirable autoreactivity of immune cells and the appearance of inflammatory autoimmune disorders as systemic lupus erythematous and rheumatoid arthritis. In the present study, the apoptosis pathways and their immune regulation were reviewed. Moreover, efferocytosis process and its impairment in association with some autoimmune diseases were discussed.	[Abdolmaleki, Fereshte] Qazvin Univ Med Sci, Sch Paramed Sci, Cellular & Mol Res Ctr, Qazvin, Iran; [Farahani, Najmeh] Isfahan Univ Med Sci, Dept Genet & Mol Biol, Esfahan, Iran; [Hayat, Seyed Mohammad Gheibi] Shahid Sadoughi Univ Med Sci, Sch Med, Dept Genet, Yazd, Iran; [Pirro, Matteo; Bianconi, Vanessa] Univ Perugia, Dept Med, Unit Internal Med Angiol & Arteriosclerosis Dis, Perugia, Italy; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran.	sahebkara@mums.ac.ir	Sahebkar, Amirhossein/B-5124-2018; Pirro, Matteo/AAC-2318-2022; Barreto, George E./AAD-7420-2020; Gheibihayat, Seyed Mohammad ./T-7187-2017; Bianconi, Vanessa/AAC-2058-2019	Barreto, George E./0000-0002-6644-1971; Gheibihayat, Seyed Mohammad ./0000-0002-1378-118X; Bianconi, Vanessa/0000-0001-6987-9349; Abdolmaleki, fereshte/0000-0003-1242-4006				Apoptosome Shi Y., 2002, STRUCTURE, V10, P285, DOI [10.1016/S0969-2126(02)00732-3, DOI 10.1016/S0969-2126(02)00732-3]; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Baird AC, 2016, WORLD J GASTROENTERO, V22, P9104, DOI 10.3748/wjg.v22.i41.9104; Biermann M, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065007; Bleesing JJH, 2001, CLIN IMMUNOL, V100, P314, DOI 10.1006/clim.2001.5069; Bournazou I, 2010, IMMUNOL CELL BIOL, V88, P220, DOI 10.1038/icb.2009.86; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Cancro MP, 2009, J CLIN INVEST, V119, P1066, DOI 10.1172/JCI38010; Castellano F, 2000, J CELL SCI, V113, P2955; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Choi Y, 1999, CLIN IMMUNOL, V93, P34, DOI 10.1006/clim.1999.4767; Clarke AJ, 2015, ANN RHEUM DIS, V74, P912, DOI 10.1136/annrheumdis-2013-204343; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 1998, J IMMUNOL, V161, P6250; Fehr EM, 2009, AUTOIMMUNITY, V42, P322, DOI 10.1080/08916930902832173; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gonzalez D, 2010, CURR SIGNAL TRANSD T, V5, P181, DOI 10.2174/157436210791112172; Green DR, 2016, CELL DEATH DIFFER, V23, P915, DOI 10.1038/cdd.2015.172; Gregory C, 1998, ROLES ICAM 3 CD 14 R; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Gude DR, 2008, FASEB J, V22, P2629, DOI 10.1096/fj.08-107169; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hart SP, 2008, METHODS, V44, P280, DOI 10.1016/j.ymeth.2007.11.009; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Henckaerts L, 2011, INFLAMM BOWEL DIS, V17, P1392, DOI 10.1002/ibd.21486; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hilbi H, 1997, INFECT IMMUN, V65, P5165, DOI 10.1128/IAI.65.12.5165-5170.1997; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoshino K, 1999, J IMMUNOL, V162, P3749; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hu CY, 2009, LUPUS, V18, P676, DOI 10.1177/0961203309103027; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ikehara S, 2002, DRUGS TODAY, V38, P103, DOI 10.1358/dot.2002.38.2.820106; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kenyon KD, 2011, J IMMUNOL, V187, P2101, DOI 10.4049/jimmunol.1003468; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Krysko DV, 2010, APOPTOSIS, V15, P995, DOI 10.1007/s10495-010-0524-6; Kuenkele Susanne, 2003, Curr Rheumatol Rep, V5, P175, DOI 10.1007/s11926-003-0061-1; Kurosaka K, 2003, J IMMUNOL, V171, P4672, DOI 10.4049/jimmunol.171.9.4672; Lassmann H, 2005, BRAIN PATHOL, V15, P217; Lazzerini PE, 2016, LUPUS SCI MED, V3, DOI 10.1136/lupus-2016-000189; Lazzerini PE, 2013, EUR J INTERN MED, V24, P368, DOI 10.1016/j.ejim.2013.02.009; Lee CS, 2016, IMMUNITY, V44, P807, DOI 10.1016/j.immuni.2016.02.005; Leverrier Y, 2001, J IMMUNOL, V166, P4831, DOI 10.4049/jimmunol.166.8.4831; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Lopatin U, 2001, BLOOD, V97, P3161, DOI 10.1182/blood.V97.10.3161; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Luban S, 2010, INT J RHEUM DIS, V13, P284, DOI 10.1111/j.1756-185X.2010.01553.x; Magerus-Chatinet A, 2013, J ALLERGY CLIN IMMUN, V131, P486, DOI 10.1016/j.jaci.2012.06.011; Magerus-Chatinet A, 2009, BLOOD, V113, P3027, DOI 10.1182/blood-2008-09-179630; Marques-da-Silva C, 2011, IMMUNOBIOLOGY, V216, P1, DOI 10.1016/j.imbio.2010.03.010; Martin SJ, 1996, J BIOL CHEM, V271, P28753, DOI 10.1074/jbc.271.46.28753; Martinez J, 2017, CURR TOP MICROBIOL, V403, P1, DOI 10.1007/82_2015_467; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Martinez J, 2013, CELL METAB, V17, P895, DOI 10.1016/j.cmet.2013.05.012; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Mazaheri F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5046; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Migita K, 2001, CLIN EXP IMMUNOL, V126, P334, DOI 10.1046/j.1365-2249.2001.01677.x; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Peter C, 2012, AUTOIMMUNITY, V45, P568, DOI 10.3109/08916934.2012.719947; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Potter PK, 2003, J IMMUNOL, V170, P3223, DOI 10.4049/jimmunol.170.6.3223; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rai Nirendra K, 2005, Int J Low Extrem Wounds, V4, P138, DOI 10.1177/1534734605280018; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rovere P, 2000, ARTHRITIS RHEUM-US, V43, P1663, DOI 10.1002/1529-0131(200008)43:8<1663::AID-ANR1>3.0.CO;2-1; Rubio-Moscardo F, 2005, BLOOD, V106, P3214, DOI 10.1182/blood-2005-05-2013; RUMORE PM, 1990, J CLIN INVEST, V86, P69, DOI 10.1172/JCI114716; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Santiago C, 2007, IMMUNITY, V27, P941, DOI 10.1016/j.immuni.2007.11.008; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schillaci G, 2006, ARCH INTERN MED, V166, P909, DOI 10.1001/archinte.166.8.909; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Suzuki J, 2016, P NATL ACAD SCI USA, V113, P9509, DOI 10.1073/pnas.1610403113; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Suzuki M, 2007, J NEUROSCI, V27, P1879, DOI 10.1523/JNEUROSCI.5282-06.2007; Taberner M, 2005, INFLAMM RES, V54, P10, DOI 10.1007/s00011-004-1315-8; Tanaka M, 2017, CURR TOP MICROBIOL, V403, P171, DOI 10.1007/82_2015_472; Targan SR, 2005, IMMUNOL REV, V206, P296, DOI 10.1111/j.0105-2896.2005.00286.x; Temple SEL, 2003, GENES IMMUN, V4, P283, DOI 10.1038/sj.gene.6363963; Toda S, 2012, MOL CELL BIOL, V32, P118, DOI 10.1128/MCB.05993-11; Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Vallejo-Illarramendi A, 2006, NEUROBIOL DIS, V21, P154, DOI 10.1016/j.nbd.2005.06.017; vanBruggen MCJ, 1997, NEPHROL DIAL TRANSPL, V12, P57, DOI 10.1093/ndt/12.1.57; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; WEISS J, 1984, J IMMUNOL, V132, P3109; Weiss J., 2003, BACTERICIDAL PERMEAB; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yoon KW, 2017, BMB REP, V50, P496, DOI 10.5483/BMBRep.2017.50.10.147; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang T, 2011, INT J CARDIOL, V147, P239, DOI 10.1016/j.ijcard.2009.08.047; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	162	59	61	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	JUL 20	2018	9								1645	10.3389/fimmu.2018.01645	http://dx.doi.org/10.3389/fimmu.2018.01645			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN8FM	30083153	Green Published, Green Accepted, gold			2022-09-04	WOS:000439394600001
J	Gomez, RM; Sanchez, MY; Portela-Lomba, M; Ghotme, K; Barreto, GE; Sierra, J; Moreno-Flores, MT				Gomez, Rosa M.; Sanchez, Magdy Y.; Portela-Lomba, Maria; Ghotme, Kemel; Barreto, George E.; Sierra, Javier; Teresa Moreno-Flores, M.			Cell therapy for spinal cord injury with olfactory ensheathing glia cells (OECs)	GLIA			English	Review						cell therapies; cell transplantation; neuroregeneration; olfactory ensheathing glia cells; spinal cord injuries; transplantation	CHONDROITIN-SULFATE PROTEOGLYCAN; MYELIN-ASSOCIATED GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; PROMOTES FUNCTIONAL RECOVERY; NEURITE OUTGROWTH INHIBITOR; HORIZONTAL BASAL-CELLS; RECEPTOR FAMILY-MEMBER; DORSAL-ROOT AXONS	The prospects of achieving regeneration in the central nervous system (CNS) have changed, as most recent findings indicate that several species, including humans, can produce neurons in adulthood. Studies targeting this property may be considered as potential therapeutic strategies to respond to injury or the effects of demyelinating diseases in the CNS. While CNS trauma may interrupt the axonal tracts that connect neurons with their targets, some neurons remain alive, as seen in optic nerve and spinal cord (SC) injuries (SCIs). The devastating consequences of SCIs are due to the immediate and significant disruption of the ascending and descending spinal pathways, which result in varying degrees of motor and sensory impairment. Recent therapeutic studies for SCI have focused on cell transplantation in animal models, using cells capable of inducing axon regeneration like Schwann cells (SchCs), astrocytes, genetically modified fibroblasts and olfactory ensheathing glia cells (OECs). Nevertheless, and despite the improvements in such cell-based therapeutic strategies, there is still little information regarding the mechanisms underlying the success of transplantation and regarding any secondary effects. Therefore, further studies are needed to clarify these issues. In this review, we highlight the properties of OECs that make them suitable to achieve neuroplasticity/neuroregeneration in SCI. OECs can interact with the glial scar, stimulate angiogenesis, axon outgrowth and remyelination, improving functional outcomes following lesion. Furthermore, we present evidence of the utility of cell therapy with OECs to treat SCI, both from animal models and clinical studies performed on SCI patients, providing promising results for future treatments.	[Gomez, Rosa M.; Sanchez, Magdy Y.] Fdn Neuroregenerac Colombia, Grp Invest NeuroRec, Bogota, Colombia; [Sanchez, Magdy Y.] Univ Nacl Colombia, Neurociencias, Bogota, Colombia; [Portela-Lomba, Maria; Sierra, Javier] Univ Francisco de Vitoria, Fac CC Expt, Madrid, Spain; [Ghotme, Kemel] Univ Sabana, Fac Med, Chia, Colombia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Teresa Moreno-Flores, M.] Univ Autonoma Madrid, Fac Med, C Arzobispo Morcillo 2, E-28029 Madrid, Spain		Gomez, RM (corresponding author), Fdn Neuroregenerac Colombia, Grp Invest NeuroRec, Bogota, Colombia.; Moreno-Flores, MT (corresponding author), Univ Autonoma Madrid, Fac Med, C Arzobispo Morcillo 2, E-28029 Madrid, Spain.	rosa.gomez.b1@gmail.com; mteresa.moreno@uam.es	Ghotme, Kemel Ahmed Ghotme/V-6138-2019; Sierra, Javier/ABH-1165-2020; Moreno-Flores, M. Teresa/E-8949-2018; Moreno-Flores, M. Teresa/ABH-9655-2020; Ghotme, Kemel Ahmed Ghotme/AAR-6104-2020; Barreto, George E./AAD-7420-2020	Ghotme, Kemel Ahmed Ghotme/0000-0001-6802-4373; Moreno-Flores, M. Teresa/0000-0002-8494-8143; Moreno-Flores, M. Teresa/0000-0002-8494-8143; Ghotme, Kemel Ahmed Ghotme/0000-0001-6802-4373; Barreto, George E./0000-0002-6644-1971; PORTELA LOMBA, MARIA/0000-0001-8725-0712	Fundacion de Neuroregeneracion de Colombia; Grupo NeuroRec; Fundacion Universidad Francisco de Vitoria	Fundacion de Neuroregeneracion de Colombia; Grupo NeuroRec; Fundacion Universidad Francisco de Vitoria	Fundacion de Neuroregeneracion de Colombia; Grupo NeuroRec; Fundacion Universidad Francisco de Vitoria	Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Ahuja Christopher S, 2016, F1000Res, V5, DOI 10.12688/f1000research.7586.1; Akiyama Y, 2004, NEURON GLIA BIOL, V1, P47, DOI 10.1017/s1740925x04000079; Alexander CL, 2002, GLIA, V37, P349, DOI 10.1002/glia.10044; Amemori T, 2010, CYTOTHERAPY, V12, P212, DOI 10.3109/14653240903440103; Andrews MR, 2007, J NEUROTRAUM, V24, P1773, DOI 10.1089/neu.2007.0353; Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Asher RA, 2000, J NEUROSCI, V20, P2427; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Au E, 2003, GLIA, V41, P224, DOI 10.1002/glia.10160; Au Edmund, 2002, Methods Mol Biol, V198, P49; Au WW, 2002, J COMP NEUROL, V446, P68, DOI 10.1002/cne.10182; BALENTINE JD, 1988, J NEUROPATH EXP NEUR, V47, P77, DOI 10.1097/00005072-198803000-00001; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BARGER SW, 1992, BIOCHIM BIOPHYS ACTA, V1160, P105, DOI 10.1016/0167-4838(92)90043-D; Barnett SC, 2000, BRAIN, V123, P1581, DOI 10.1093/brain/123.8.1581; Barnett SC, 2004, TRENDS NEUROSCI, V27, P54, DOI 10.1016/j.tins.2003.10.011; BARNETT SC, 1993, DEV BIOL, V155, P337, DOI 10.1006/dbio.1993.1033; Barnett SC, 2007, NAT CLIN PRACT NEURO, V3, P152, DOI 10.1038/ncpneuro0447; Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1983, NEUROSCIENCE, V10, P1471, DOI 10.1016/0306-4522(83)90128-8; Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Boruch AV, 2001, GLIA, V33, P225, DOI 10.1002/1098-1136(200103)33:3<225::AID-GLIA1021>3.3.CO;2-P; Botero L., 2015, THESIS; Botero L, 2013, REV NEUROLOGIA, V56, P521, DOI 10.33588/rn.5610.2013109; Bovolenta P, 1997, EUR J NEUROSCI, V9, P977, DOI 10.1111/j.1460-9568.1997.tb01448.x; BOVOLENTA P, 1993, EUR J NEUROSCI, V5, P454, DOI 10.1111/j.1460-9568.1993.tb00512.x; BOVOLENTA P, 1993, NEUROREPORT, V5, P345, DOI 10.1097/00001756-199312000-00042; Boyd JG, 2006, GLIA, V53, P434, DOI 10.1002/glia.20299; Boyd JG, 2004, P NATL ACAD SCI USA, V101, P2162, DOI 10.1073/pnas.0303842101; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; BRAY GM, 1987, J EXP BIOL, V132, P5; Bregman BS, 2002, PROG BRAIN RES, V137, P257; Bretzner F, 2010, J NEUROSCI RES, V88, P2833, DOI 10.1002/jnr.22440; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Cajal SR, 1928, DEGENERATION REGENER; Cao L, 2007, GLIA, V55, P897, DOI 10.1002/glia.20511; Cao L, 2006, GLIA, V54, P536, DOI 10.1002/glia.20403; CARR VM, 1991, NEUROSCIENCE, V45, P433, DOI 10.1016/0306-4522(91)90239-K; CARRI NG, 1988, J NEUROSCI RES, V19, P428, DOI 10.1002/jnr.490190407; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Chen L, 2014, CELL TRANSPLANT, V23, pS35, DOI 10.3727/096368914X685014; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; Chhabra HS, 2009, SPINAL CORD, V47, P887, DOI 10.1038/sc.2009.54; CHUAH MI, 1991, J NEUROSCI RES, V29, P172, DOI 10.1002/jnr.490290206; Chuah MI, 2004, EXP NEUROL, V185, P15, DOI 10.1016/j.expneurol.2003.09.008; Chuah MI, 2002, MICROSC RES TECHNIQ, V58, P216, DOI 10.1002/jemt.10151; Chung RS, 2004, CELL MOL LIFE SCI, V61, P1238, DOI 10.1007/s00018-004-4026-y; Collazos-Castro JE, 2005, J NEUROSURG-SPINE, V3, P308, DOI 10.3171/spi.2005.3.4.0308; COSTANZO RM, 1985, BRAIN RES, V361, P258, DOI 10.1016/0006-8993(85)91297-1; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Crespo D, 2007, EXP NEUROL, V206, P159, DOI 10.1016/j.expneurol.2007.05.001; Czepiel M, 2015, GLIA, V63, P513, DOI 10.1002/glia.22769; Czyz M, 2015, BRIT J NEUROSURG, V29, P362, DOI 10.3109/02688697.2015.1006170; David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; DeLucia Tracey A, 2003, Anat Rec B New Anat, V271, P61, DOI 10.1002/ar.b.10014; Deng C, 2006, J NEUROSCI RES, V83, P1201, DOI 10.1002/jnr.20817; Deng YB, 2008, CYTOTHERAPY, V10, P551, DOI 10.1080/14653240802165673; Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; DEVON R, 1995, BRAIN RES, V688, P223, DOI 10.1016/0006-8993(95)00562-5; DEVON R, 1992, BRAIN RES, V589, P175; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Dobkin BH, 2006, NEUROREHAB NEURAL RE, V20, P5, DOI 10.1177/1545968305284675; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; DOU CL, 1994, J NEUROSCI, V14, P7616; DOUCETTE JR, 1984, ANAT REC, V210, P385, DOI 10.1002/ar.1092100214; DOUCETTE JR, 1983, J ANAT, V137, P1; Doucette R, 1996, INT J DEV NEUROSCI, V14, P945, DOI 10.1016/S0736-5748(96)00042-1; DOUCETTE R, 1995, HISTOL HISTOPATHOL, V10, P503; DOUCETTE R, 1991, J COMP NEUROL, V312, P451, DOI 10.1002/cne.903120311; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; DOUCETTE R, 1993, MICROSC RES TECHNIQ, V24, P113, DOI 10.1002/jemt.1070240204; Duan D, 2011, ACTA NEUROCHIR, V153, P2085, DOI 10.1007/s00701-011-0955-z; Eggers R, 2008, MOL CELL NEUROSCI, V39, P105, DOI 10.1016/j.mcn.2008.05.018; Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489; FARBMAN AI, 1994, ENDEAVOUR, V18, P2, DOI 10.1016/0160-9327(94)90114-7; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Felts PA, 1997, J NEUROSCI, V17, P7267; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Feron F, 2013, METHODS MOL BIOL, V1059, P107, DOI 10.1007/978-1-62703-574-3_10; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Forni PE, 2011, J NEUROSCI, V31, P6915, DOI 10.1523/JNEUROSCI.6087-10.2011; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Fouad K, 2009, SPINAL CORD, V47, P727, DOI 10.1038/sc.2009.10; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Franceschini IA, 1996, DEV BIOL, V173, P327, DOI 10.1006/dbio.1996.0027; Franklin RJM, 1996, GLIA, V17, P217, DOI 10.1002/(SICI)1098-1136(199607)17:3<217::AID-GLIA4>3.0.CO;2-Y; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Franssen EHP, 2009, J NEUROSCI RES, V87, P1556, DOI 10.1002/jnr.21979; Franzen R, 1999, NEUROREPORT, V10, P1551, DOI 10.1097/00001756-199905140-00029; FRISCH D, 1967, AM J ANAT, V121, P87, DOI 10.1002/aja.1001210107; Garcia-Alias G, 2004, J NEUROSCI RES, V75, P632, DOI 10.1002/jnr.20029; Garcia-Escudero V, 2012, NEUROSCI LETT, V509, P27, DOI 10.1016/j.neulet.2011.12.037; Garcia-Escudero V, 2010, MOL THER, V18, P394, DOI 10.1038/mt.2009.268; Ge LT, 2016, REV NEUROSCIENCE, V27, P259, DOI 10.1515/revneuro-2015-0030; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Girard SD, 2011, JOVE-J VIS EXP, DOI 10.3791/2762; Gomez R. M., 2015, CENTRAL NERVOUS SYST; Gomez R. M., 2009, THESIS; Gomez RM, 2016, NEUROSCI RES, V103, P10, DOI 10.1016/j.neures.2015.07.012; Gorrie CA, 2010, BRAIN RES, V1337, P8, DOI 10.1016/j.brainres.2010.04.019; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GRIFFITHS IR, 1978, ACTA NEUROPATHOL, V41, P33, DOI 10.1007/BF00689554; Grill R, 1997, J NEUROSCI, V17, P5560; Grill RJ, 1997, EXP NEUROL, V148, P444, DOI 10.1006/exnr.1997.6704; Guest J, 2006, SPINAL CORD, V44, P135, DOI 10.1038/sj.sc.3101820; Guest J, 2015, J NEUROTRAUM, V32, P1176, DOI 10.1089/neu.2014.3790; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; HARDING J, 1977, BRAIN RES, V132, P11, DOI 10.1016/0006-8993(77)90703-X; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Higginson JR, 2012, J NEUROSCI, V32, P15902, DOI 10.1523/JNEUROSCI.6340-11.2012; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Honore A, 2012, GLIA, V60, P404, DOI 10.1002/glia.22274; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang Hongyun, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P14; Huang ZH, 2008, CELL RES, V18, P479, DOI 10.1038/cr.2008.38; Huang ZH, 2011, J CELL SCI, V124, P186, DOI 10.1242/jcs.071357; Ibanez C, 2007, GLIA, V55, P144, DOI 10.1002/glia.20443; Ibrahim A, 2014, CELL TRANSPLANT, V23, P1465, DOI 10.3727/096368913X676213; Ibrahim AG, 2009, BRAIN, V132, P1268, DOI 10.1093/brain/awp030; Imaizumi T, 2000, BRAIN RES, V854, P70, DOI 10.1016/S0006-8993(99)02285-4; Imaizumi T, 1998, J NEUROSCI, V18, P6176; Imaizumi T, 2000, NAT BIOTECHNOL, V18, P949, DOI 10.1038/79432; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Iwatsuki K, 2008, NEUROREPORT, V19, P1249, DOI 10.1097/WNR.0b013e328305b70b; Jahed A, 2007, J COMP NEUROL, V503, P209, DOI 10.1002/cne.21385; Jani HR, 2004, GLIA, V47, P130, DOI 10.1002/glia.20038; Jiang SC, 2008, PURINERG SIGNAL, V4, P61, DOI 10.1007/s11302-007-9093-8; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Jurevics H, 1998, NEUROCHEM RES, V23, P401, DOI 10.1023/A:1022469803426; Kafitz KW, 1997, J NEUROBIOL, V32, P298, DOI 10.1002/(SICI)1097-4695(199703)32:3<298::AID-NEU4>3.3.CO;2-G; Kafitz KW, 1998, J NEUROBIOL, V34, P271, DOI 10.1002/(SICI)1097-4695(19980215)34:3<271::AID-NEU6>3.0.CO;2-#; Kafitz KW, 1999, GLIA, V25, P99, DOI 10.1002/(SICI)1098-1136(19990115)25:2<99::AID-GLIA1>3.0.CO;2-V; Kanno H, 2015, REV NEUROSCIENCE, V26, P121, DOI 10.1515/revneuro-2014-0068; Katoh H, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-34; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Kubo Takekazu, 2007, Recent Pat CNS Drug Discov, V2, P173, DOI 10.2174/157488907782411738; Kubo Takekazu, 2008, Ther Clin Risk Manag, V4, P605; Kwon BK, 2007, SPINE, V32, P1164, DOI 10.1097/BRS.0b013e318053ec35; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X; Lankford KL, 2008, GLIA, V56, P1664, DOI 10.1002/glia.20718; Lankford KL, 2014, GLIA, V62, P52, DOI 10.1002/glia.22583; Laroni A, 2013, J NEUROIMMUNE PHARM, V8, P1062, DOI 10.1007/s11481-013-9456-6; Lauren J, 2003, MOL CELL NEUROSCI, V24, P581, DOI 10.1016/S1044-7431(03)00199-4; Lauren J, 2007, J BIOL CHEM, V282, P5715, DOI 10.1074/jbc.M609797200; Lee IH, 2004, EXP NEUROL, V187, P509, DOI 10.1016/j.expneurol.2004.02.007; Leng ZK, 2013, NEURAL REGEN RES, V8, P1286, DOI 10.3969/j.issn.1673-5374.2013.14.005; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Li BC, 2011, J NEUROL SCI, V303, P67, DOI 10.1016/j.jns.2011.01.013; Li FQ, 2010, J PHARMACOL EXP THER, V334, P106, DOI 10.1124/jpet.110.167882; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 2004, EXP NEUROL, V188, P300, DOI 10.1016/j.expneurol.2004.04.021; Li Y, 2003, J NEUROSCI, V23, P727; Li Y, 1998, J NEUROSCI, V18, P10514; Li Y, 2005, J NEUROCYTOL, V34, P343, DOI 10.1007/s11068-005-8361-1; Lim F, 2010, GLIA, V58, P546, DOI 10.1002/glia.20944; Lima C, 2006, J SPINAL CORD MED, V29, P205; Lima C, 2010, NEUROREHAB NEURAL RE, V24, P10, DOI 10.1177/1545968309347685; Lindsay SL, 2017, NEUROCHEM INT, V106, P101, DOI 10.1016/j.neuint.2016.08.001; Lindsay SL, 2017, GLIA, V65, P639, DOI 10.1002/glia.23117; Lindsay SL, 2013, GLIA, V61, P368, DOI 10.1002/glia.22440; Lindsay SL, 2010, GLIA, V58, P125, DOI 10.1002/glia.20917; Lindsay SL, 2016, STEM CELL REP, V6, P729, DOI 10.1016/j.stemcr.2016.03.009; Lipson AC, 2003, EXP NEUROL, V180, P167, DOI 10.1016/S0014-4886(02)00058-4; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Liu Y, 1999, J NEUROSCI, V19, P4370; Lopez-Vales R, 2006, NEUROBIOL DIS, V21, P57, DOI 10.1016/j.nbd.2005.06.011; Lopez-Vales R, 2004, J NEUROTRAUM, V21, P1031, DOI 10.1089/0897715041651105; Lopez-Vales R, 2007, GLIA, V55, P303, DOI 10.1002/glia.20457; Losey P, 2014, NEURAL REGEN RES, V9, P1783, DOI 10.4103/1673-5374.143422; Losey P, 2014, BRAIN RES, V1569, P9, DOI 10.1016/j.brainres.2014.04.033; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu J, 2001, BRAIN RES, V889, P344, DOI 10.1016/S0006-8993(00)03235-2; Lu P, 2006, J NEUROSCI, V26, P11120, DOI 10.1523/JNEUROSCI.3264-06.2006; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Lukovic D, 2014, STEM CELLS, V32, P594, DOI 10.1002/stem.1562; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; MARSHAK DR, 1990, PROG BRAIN RES, V86, P169; Masgutova GA, 2010, B EXP BIOL MED+, V149, P135, DOI 10.1007/s10517-010-0892-5; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mayeur A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062860; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; McKerracher L, 2006, J NEUROTRAUM, V23, P309, DOI 10.1089/neu.2006.23.309; Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Miller AM, 2010, J COMP NEUROL, V518, P4825, DOI 10.1002/cne.22497; Mills CD, 2007, MOL CELL NEUROSCI, V36, P185, DOI 10.1016/j.mcn.2007.06.011; Mimura F, 2006, J BIOL CHEM, V281, P15970, DOI 10.1074/jbc.M510934200; Miyata S, 2005, NEUROSCIENCE, V136, P95, DOI 10.1016/j.neuroscience.2005.07.031; Modi PK, 2010, CELL MOL NEUROBIOL, V30, P709, DOI 10.1007/s10571-009-9495-y; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Moreno-Flores M.T., 2002, J BIOMED BIOTECHNOL, V2, P37, DOI DOI 10.1155/S1110724302000372; Moreno-Flores MT, 2010, FRONT CNS DRUG DISC, V1, P497, DOI 10.2174/978160805159511001010497; Moreno-Flores Maria Teresa, 2006, Recent Pat CNS Drug Discov, V1, P55, DOI 10.2174/157488906775245264; Moreno-Flores MT, 2006, MOL THER, V13, P598, DOI 10.1016/j.ymthe.2005.11.014; Moreno-Flores MT, 2003, J NEUROCHEM, V85, P861, DOI 10.1046/j.1471-4159.2003.01729.x; Moreno-Flores MT, 2003, J NEUROSCI RES, V71, P871, DOI 10.1002/jnr.10527; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; MUIR D, 1989, J CELL BIOL, V109, P2353, DOI 10.1083/jcb.109.5.2353; Murrell W, 2008, STEM CELLS, V26, P2183, DOI 10.1634/stemcells.2008-0074; Nan B, 2001, J COMP NEUROL, V435, P60, DOI 10.1002/cne.1193; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Niederost B, 2002, J NEUROSCI, V22, P10368; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Nishihara T, 2015, J BIOL CHEM, V290, P3693, DOI 10.1074/jbc.M114.603431; Nivet E, 2011, J CLIN INVEST, V121, P2808, DOI 10.1172/JCI44489; Nocentini S, 2012, CELL MOL LIFE SCI, V69, P1689, DOI 10.1007/s00018-011-0893-1; Novikova LN, 2011, CYTOTHERAPY, V13, P873, DOI 10.3109/14653249.2011.574116; O'Neill P, 2017, GLIA, V65, P19, DOI 10.1002/glia.23047; O'Toole DA, 2007, CELL MOL LIFE SCI, V64, P1303, DOI 10.1007/s00018-007-7106-y; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Pastrana E, 2007, NEUROCHEM INT, V50, P491, DOI 10.1016/j.neuint.2006.10.004; Pastrana E, 2006, J NEUROSCI, V26, P5347, DOI 10.1523/JNEUROSCI.1111-06.2006; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Pellitteri R, 2007, NEUROSCI LETT, V417, P24, DOI 10.1016/j.neulet.2007.02.065; Pellitteri R, 2009, INT J DEV NEUROSCI, V27, P453, DOI 10.1016/j.ijdevneu.2009.05.001; PIXLEY SK, 1992, GLIA, V5, P269, DOI 10.1002/glia.440050405; Plant GW, 2003, J NEUROTRAUM, V20, P1, DOI 10.1089/08977150360517146; Plant GW, 2001, MOL CELL NEUROSCI, V17, P471, DOI 10.1006/mcne.2000.0948; Plemel JR, 2014, PROG NEUROBIOL, V117, P54, DOI 10.1016/j.pneurobio.2014.02.006; Pollock GS, 1999, EUR J NEUROSCI, V11, P769, DOI 10.1046/j.1460-9568.1999.00484.x; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Radtke C, 2003, FASEB J, V17, P335, DOI 10.1096/fj.03-0214fje; Radtke C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/608496; RAISMAN G, 1985, NEUROSCIENCE, V14, P237, DOI 10.1016/0306-4522(85)90176-9; Raisman G, 2004, NAT REV NEUROSCI, V5, P157, DOI 10.1038/nrn1328; Raisman G, 2001, NAT REV NEUROSCI, V2, P369, DOI 10.1038/35072576; Raisman G, 2007, NAT REV NEUROSCI, V8, P312, DOI 10.1038/nrn2099; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Ramer MS, 2001, J NEUROSCI, V21, P2651, DOI 10.1523/JNEUROSCI.21-08-02651.2001; Ramer MS, 2002, MOL CELL NEUROSCI, V19, P239, DOI 10.1006/mcne.2001.1067; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; RAMONCUETO A, 1995, GLIA, V14, P163, DOI 10.1002/glia.440140302; RAMONCUETO A, 1992, NEUROSCIENCE, V47, P213, DOI 10.1016/0306-4522(92)90134-N; RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099; Reginensi D, 2015, CELL MOL LIFE SCI, V72, P2719, DOI 10.1007/s00018-015-1869-3; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Richter MW, 2008, EXP NEUROL, V209, P353, DOI 10.1016/j.expneurol.2007.06.011; Richter MW, 2005, J NEUROSCI, V25, P10700, DOI 10.1523/JNEUROSCI.3632-05.2005; Rieger A, 2007, GLIA, V55, P352, DOI 10.1002/glia.20460; Rizek PN, 2006, NEUROREPORT, V17, P459, DOI 10.1097/01.wnr.0000209000.32857.1b; Roet KCD, 2014, EXP NEUROL, V261, P594, DOI 10.1016/j.expneurol.2014.05.007; Roet KCD, 2013, J NEUROSCI, V33, P11116, DOI 10.1523/JNEUROSCI.1002-13.2013; Rogers WK, 2016, BEST PRACT RES-CLIN, V30, P27, DOI 10.1016/j.bpa.2015.11.003; Romero MI, 2001, J NEUROSCI, V21, P8408, DOI 10.1523/JNEUROSCI.21-21-08408.2001; Ruitenberg MJ, 2008, RESTOR NEUROL NEUROS, V26, P183; Ruitenberg MJ, 2008, J NEUROIMMUNOL, V205, P80, DOI 10.1016/j.jneuroim.2008.09.010; Ruitenberg MJ, 2005, BRAIN, V128, P839, DOI 10.1093/brain/awh424; Ruitenberg MJ, 2003, J NEUROSCI, V23, P7045, DOI 10.1523/JNEUROSCI.23-18-07045.2003; Runyan SA, 2009, EXP NEUROL, V216, P95, DOI 10.1016/j.expneurol.2008.11.015; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Santos-Silva A, 2007, J NEUROSCI, V27, P7154, DOI 10.1523/JNEUROSCI.1184-07.2007; Sasaki M, 2006, GLIA, V53, P352, DOI 10.1002/glia.20285; Sasaki M, 2006, J NEUROSCI, V26, P1803, DOI 10.1523/JNEUROSCI.3611-05.2006; Sasaki M, 2004, J NEUROSCI, V24, P8485, DOI 10.1523/JNEUROSCI.1998-04.2004; Sasaki M, 2007, PROG BRAIN RES, V161, P419, DOI 10.1016/S0079-6123(06)61030-3; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Schwob JE, 2017, J COMP NEUROL, V525, P1034, DOI 10.1002/cne.24105; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sharma HS, 2007, CURR PHARM DESIGN, V13, P1841; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon D, 2011, GLIA, V59, P1458, DOI 10.1002/glia.21189; SMITHTHOMAS LC, 1994, J CELL SCI, V107, P1687; Sonigra RJ, 1999, GLIA, V25, P256, DOI 10.1002/(SICI)1098-1136(19990201)25:3<256::AID-GLIA6>3.0.CO;2-Y; Spitzbarth I, 2011, J NEUROPATH EXP NEUR, V70, P703, DOI 10.1097/NEN.0b013e3182270f8e; Stamegna JC, 2014, STEM CELL RES, V12, P673, DOI 10.1016/j.scr.2014.02.010; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Su ZD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008141; Tabakow P, 2014, CELL TRANSPLANT, V23, P1631, DOI 10.3727/096368914X685131; Tabakow P, 2013, CELL TRANSPLANT, V22, P1591, DOI 10.3727/096368912X663532; Takami T, 2002, J NEUROSCI, V22, P6670; Tan AM, 2006, J NEUROSCI, V26, P4729, DOI 10.1523/JNEUROSCI.3900-05.2006; Tang XQ, 2007, J NEUROSCI, V27, P6068, DOI 10.1523/JNEUROSCI.1442-07.2007; Tang XQ, 2004, EUR J NEUROSCI, V20, P1211, DOI 10.1111/j.1460-9568.2004.03595.x; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Tator C. H., 1998, NEUROSURGERY, V42, P708; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Toft A, 2007, BRAIN, V130, P970, DOI 10.1093/brain/awm040; Tome M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-74; Tome M, 2009, STEM CELLS, V27, P2196, DOI 10.1002/stem.130; Tuszynski MH, 1998, CELL TRANSPLANT, V7, P187, DOI 10.1016/S0963-6897(97)00166-8; Tuszynski MH, 1997, CELL TRANSPLANT, V6, P361, DOI 10.1016/S0963-6897(97)00021-3; UBINK R, 1994, NEUROSCIENCE, V60, P709, DOI 10.1016/0306-4522(94)90499-5; Ughrin YM, 2003, J NEUROSCI, V23, P175; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; Vadivelu S, 2015, STEM CELL TRANSL MED, V4, P401, DOI 10.5966/sctm.2014-0107; VALVERDE F, 1992, NEUROSCIENCE, V49, P255, DOI 10.1016/0306-4522(92)90094-I; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Vavrek R, 2007, J NEUROTRAUM, V24, P1667, DOI 10.1089/neu.2007.0290; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; Vincent AJ, 2005, J NEUROCYTOL, V34, P65, DOI 10.1007/s11068-005-5048-6; Vukovic J, 2009, MATRIX BIOL, V28, P406, DOI 10.1016/j.matbio.2009.06.001; Vukovic J, 2009, GLIA, V57, P424, DOI 10.1002/glia.20771; Wang G, 2010, CELL TRANSPLANT, V19, P1325, DOI 10.3727/096368910X505855; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang Y, 2012, EXP CELL RES, V318, P1889, DOI 10.1016/j.yexcr.2012.05.024; Watts J, 2005, LANCET, V365, P109, DOI 10.1016/S0140-6736(05)17721-6; Williams SK, 2004, J COMP NEUROL, V470, P50, DOI 10.1002/cne.11045; Windus LCE, 2007, GLIA, V55, P1708, DOI 10.1002/glia.20586; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Woodhall E, 2003, CELL MOL LIFE SCI, V60, P2241, DOI 10.1007/s00018-003-3265-7; Woodhall E, 2001, MOL BRAIN RES, V88, P203, DOI 10.1016/S0169-328X(01)00044-4; Wu SF, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/516215; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; Yamamoto M, 2009, BRAIN RES, V1303, P26, DOI 10.1016/j.brainres.2009.09.073; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3; Zeng Y, 2013, NEUROCHEM RES, V38, P2483, DOI 10.1007/s11064-013-1186-x; Zhang LQ, 2009, GLIA, V57, P1178, DOI 10.1002/glia.20840; Zhang SX, 2011, BRAIN RES, V1399, P1, DOI 10.1016/j.brainres.2011.05.005; Zhang Y, 1998, J NEUROSCI RES, V54, P554; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951; Zurita M, 2008, TRANSPLANTATION, V86, P845, DOI 10.1097/TP.0b013e318186198f; Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069	354	52	57	1	51	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JUL	2018	66	7					1267	1301		10.1002/glia.23282	http://dx.doi.org/10.1002/glia.23282			35	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH6SB	29330870	Green Submitted, Green Accepted			2022-09-04	WOS:000433573200001
J	Canas, A; Alvarez-Moreno, C; Le Pape, P; Ariza, B; Robinson, E; Alvarado, J; Caballero, A; Montanez, A				Canas, A.; Alvarez-Moreno, C.; Le Pape, P.; Ariza, B.; Robinson, E.; Alvarado, J.; Caballero, A.; Montanez, A.			Aspergillus spp. in Patients with Chronic Lung Disease in Colombia: Prevalence of Increased Serum IgE, Aspergillus Sensitization and Colonization Chronic Obstructive Lung Disease COPD	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Meeting Abstract	International Conference of the American-Thoracic-Society	MAY 18-23, 2018	San Diego, CA	Amer Thoracic Soc					[Canas, A.] Pontificia Univ Javeriana, Dept Med Interna, Unidad Neumol, Hosp Univ San Ignacio, Bogota, Colombia; [Alvarez-Moreno, C.] Univ Nacl Colombia, Dept Med Interna, Fac Med, Bogota, Colombia; [Le Pape, P.] CHU Nantes, Lab Parasitol Mycol, Inst Biol, Nantes, France; [Ariza, B.] Hosp Univ San Ignacio, Lab Clin, Bogota, Colombia; [Robinson, E.; Caballero, A.] Clin Colsanitas, Clin Reina Sofia, Bogota, Colombia; [Alvarado, J.] Programas Atenc Integral SAS IPS, Clin Clin, Bogota, Colombia; [Montanez, A.] Asociac Colombiana Infectol, Bogota, Colombia			alejandra.canas@javeriana.edu.co	Le Pape, Patrice/AAY-3632-2021; Le Pape, Patrice/W-1472-2019	Le Pape, Patrice/0000-0001-5059-6402; Canas, Alejandra/0000-0003-3975-2835	research office of the University Hospital San Ignacio [EA1155-IICiMed]; ClAnicas Colsanitas and DA(C)partement de Parasitologie et MycologieMA(C)dicale; UniversitA(C) de Nantes; Nantes Atlantique universitA(C)s [EA1155-IICiMed]; FacultA(C)de Pharmacie, Nantes, France	research office of the University Hospital San Ignacio; ClAnicas Colsanitas and DA(C)partement de Parasitologie et MycologieMA(C)dicale; UniversitA(C) de Nantes; Nantes Atlantique universitA(C)s; FacultA(C)de Pharmacie, Nantes, France	This abstract is funded by: This work was funded by the research office of the University Hospital San Ignacio, ClAnicas Colsanitas and DA(C)partement de Parasitologie et MycologieMA(C)dicale,UniversitA(C) de Nantes, Nantes Atlantique universitA(C)s, EA1155-IICiMed, FacultA(C)de Pharmacie, Nantes, France		0	0	0	0	0	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.		2018	197					A5515								2	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Respiratory System	HA1NM					2022-09-04	WOS:000449980301545
J	Graca, MAS; Ferreira, V; Canhoto, C; Encalada, AC; Guerrero-Bolano, F; Wantzen, KM; Boyero, L				Graca, Manuel A. S.; Ferreira, Veronica; Canhoto, Cristina; Encalada, Andrea C.; Guerrero-Bolano, Francisco; Wantzen, Karl M.; Boyero, Luz			A conceptual model of litter breakdown in low order streams	INTERNATIONAL REVIEW OF HYDROBIOLOGY			English	Article						Decomposition; Organic matter; Processing; Streams; Shredders; Aquatic hyphomycetes	TROPICAL RAIN-FOREST; LEAF-LITTER; SECONDARY PRODUCTION; DISSOLVED NUTRIENTS; FUNGAL COMMUNITIES; SPECIES RICHNESS; LAND-USE; INVERTEBRATE SHREDDERS; TERRESTRIAL ECOSYSTEMS; LATITUDINAL GRADIENTS	The detrital-based food web of many streams and rivers plays a fundamental role in the cycling and retention of carbon and nutrients. However, we still need to understand which global mechanisms underlie the biogeochemical pathways that control energy transfer from the detrital pool through local food webs into nutrient and energy cycles and storage. Previous attempts to understand the variability in litter breakdown rates have included the search for latitudinal variation patterns and analysis of the influence of different factors. Here we complement those studies by developing a conceptual model to predict litter breakdown dynamics in low order streams. According to the model, litter breakdown rates and the relative role of microbial decomposers and shredder detritivores on this process are hierarchically governed by interactions between climate/hydrology and geology acting upon plant traits, nutrient and leaf availability to decomposers, and metabolism of microbial decomposers and shredders. The model explains variations in leaf litter breakdown rates and shredder abundance across large geographic areas, allowing the formulation of predictions of how anthropogenic pressures may affect litter breakdown rates.	[Graca, Manuel A. S.; Canhoto, Cristina] Univ Coimbra, Dept Life Sci, P-3001401 Coimbra, Portugal; [Graca, Manuel A. S.; Ferreira, Veronica; Canhoto, Cristina; Encalada, Andrea C.] Univ Coimbra, MARE Marine & Environm Sci Ctr, IMAR Marine Res Ctr, P-3001401 Coimbra, Portugal; [Encalada, Andrea C.] Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, Lab Ecol Acuat, Quito, Ecuador; [Guerrero-Bolano, Francisco] Pontificia Univ Javeriana, Inst Geofis, Bogota, Colombia; [Wantzen, Karl M.] Univ Tours, Interdisciplinary Res Ctr Cities & Terr, Tours, France; [Boyero, Luz] Univ Basque Country UPV EHU, Fac Sci & Technol, Leioa, Spain; [Boyero, Luz] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Boyero, Luz] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia		Graca, MAS (corresponding author), Univ Coimbra, Dept Life Sci, Apartado 3046, P-3001401 Coimbra, Portugal.	mgraca@ci.uc.pt	Boyero, Luz/N-1719-2019; Graca, Manuel A.S./A-5785-2013; Canhoto, Cristina/M-4211-2014; Ferreira, Verónica/I-6457-2013; Wantzen, Karl M./A-5954-2015	Boyero, Luz/0000-0001-7366-9299; Graca, Manuel A.S./0000-0002-7303-9382; Canhoto, Cristina/0000-0003-3343-8757; Ferreira, Verónica/0000-0001-7688-2626; Wantzen, Karl M./0000-0002-2192-1883; Encalada, Andrea C./0000-0003-2497-6086; Graca, Manuel/0000-0002-6470-8919	FCT Portugal [POCI/BIA-BDE/58297/2004, SFRH/BPD/76482/2011]; POPH/FSE; Ponticifia Universidad Javeriana-Project [12010RD0401200]; MINECO [CGL2010-16285]; Deutsche Forschungsgemeinschaft, WW-DECOEX-Project, DFG grant [WA 1612-2]	FCT Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH/FSE(European Social Fund (ESF)); Ponticifia Universidad Javeriana-Project; MINECO(Spanish Government); Deutsche Forschungsgemeinschaft, WW-DECOEX-Project, DFG grant(German Research Foundation (DFG))	We thank Mark Gessner and Marcelo Moretti for comments on an earlier version of the manuscript. The authors acknowledge the financial support of several projects while discussing the ideas here presented: FCT Portugal - POCI/BIA-BDE/58297/2004 grant to MASG and ACE; fellowship SFRH/BPD/76482/2011, program POPH/FSE to VF; Ponticifia Universidad Javeriana-Project-12010RD0401200 to FGB; Project #CGL2010-16285 from the Spanish Ministry for Science and Innovation (currently MINECO) to LB; Deutsche Forschungsgemeinschaft, WW-DECOEX-Project, DFG grant WA 1612-2 to KMW.	Abelho M, 2005, BIOTROPICA, V37, P397, DOI 10.1111/j.1744-7429.2005.00052.x; Abelho M, 2001, ScientificWorldJournal, V1, P656; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Alvarez-Clare S, 2011, BIOTROPICA, V43, P433, DOI 10.1111/j.1744-7429.2010.00732.x; Ardon M, 2008, OECOLOGIA, V155, P311, DOI 10.1007/s00442-007-0913-x; Azevedo-Pereira HVS, 2006, HYDROBIOLOGIA, V559, P183, DOI 10.1007/s10750-005-1267-1; Barlocher F, 2010, FUND APPL LIMNOL, V177, P209, DOI 10.1127/1863-9135/2010/0177-0209; Bakker MA, 2011, FUNCT ECOL, V25, P473, DOI 10.1111/j.1365-2435.2010.01802.x; Barlocher F, 2003, OIKOS, V101, P247, DOI 10.1034/j.1600-0706.2003.12372.x; BARLOCHER F, 1995, ARCH HYDROBIOL, V133, P457; Bastian M, 2008, AUSTRAL ECOL, V33, P301, DOI 10.1111/j.1442-9993.2007.01817.x; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benstead JP, 2009, ECOLOGY, V90, P2556, DOI 10.1890/08-0862.1; Benstead JP, 1996, BIOTROPICA, V28, P367, DOI 10.2307/2389200; Berggren M, 2010, MICROB ECOL, V60, P894, DOI 10.1007/s00248-010-9751-1; Boulton AJ, 2008, AQUAT ECOL-SAN DIEGO, P257, DOI 10.1016/B978-012088449-0.50011-X; Boyero L, 2008, ECOL RES, V23, P649, DOI 10.1007/s11284-007-0424-6; Boyero L, 2012, GLOBAL ECOL BIOGEOGR, V21, P134, DOI 10.1111/j.1466-8238.2011.00673.x; Boyero L, 2011, ECOLOGY, V92, P1839, DOI 10.1890/10-2244.1; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Brito EF, 2006, AUSTRAL ECOL, V31, P623, DOI 10.1111/j.1442-9993.2006.01610.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Camacho R, 2009, BIOTROPICA, V41, P625, DOI 10.1111/j.1744-7429.2009.00519.x; Canhoto C, 1999, MICROBIAL ECOL, V37, P163, DOI 10.1007/s002489900140; Capps KA, 2011, J TROP ECOL, V27, P205, DOI 10.1017/S0266467410000635; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; CHANDRASHEKAR KR, 1991, HYDROBIOLOGIA, V218, P151, DOI 10.1007/BF00006787; Chara J, 2007, INT REV HYDROBIOL, V92, P183, DOI 10.1002/iroh.200510954; Chara-Serna AM, 2012, ANN LIMNOL-INT J LIM, V48, P139, DOI 10.1051/limn/2012013; Cheshire K, 2005, FRESHWATER BIOL, V50, P748, DOI 10.1111/j.1365-2427.2005.01355.x; Chung N, 2009, FRESHWATER BIOL, V54, P2212, DOI 10.1111/j.1365-2427.2009.02260.x; Clivot H, 2013, MICROB ECOL, V65, P1, DOI 10.1007/s00248-012-0107-x; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; COLEY PD, 1987, REV BIOL TROP, V35, P151; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Coq S, 2010, ECOLOGY, V91, P2080, DOI 10.1890/09-1076.1; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Coughlan JF, 2010, MAR FRESHWATER RES, V61, P541, DOI 10.1071/MF09132; Cross WF, 2008, FRESHWATER BIOL, V53, P2504, DOI 10.1111/j.1365-2427.2008.02078.x; Crowl TA, 2001, ECOLOGY, V82, P775, DOI 10.1890/0012-9658(2001)082[0775:FSEODP]2.0.CO;2; Dang CK, 2009, ECOLOGY, V90, P122, DOI 10.1890/07-1974.1; Dang CK, 2005, ECOL LETT, V8, P1129, DOI 10.1111/j.1461-0248.2005.00815.x; Dangles O, 2001, INT REV HYDROBIOL, V86, P395, DOI 10.1002/1522-2632(200107)86:4/5<395::AID-IROH395>3.0.CO;2-1; Duarte S, 2006, OECOLOGIA, V147, P658, DOI 10.1007/s00442-005-0300-4; Dudgeon D, 2008, AQUAT ECOL SER, P1; Dudgeon D, 2010, MAR FRESHWATER RES, V61, P1218, DOI 10.1071/MF10109; Dudgeon D, 2010, J N AM BENTHOL SOC, V29, P395, DOI 10.1899/09-058.1; Elosegi A., 2005, LEAF RETENTION METHO, P13; Encalada AC, 2010, FRESHWATER BIOL, V55, P1719, DOI 10.1111/j.1365-2427.2010.02406.x; Fabre E, 1998, ARCH HYDROBIOL, V141, P167; Fernandes I, 2009, INT REV HYDROBIOL, V94, P410, DOI 10.1002/iroh.200811163; Ferreira V, 2006, OECOLOGIA, V149, P718, DOI 10.1007/s00442-006-0478-0; Ferreira V, 2006, ARCH HYDROBIOL, V166, P467, DOI 10.1127/0003-9136/2006/0166-0467; Ferreira V, 2012, FRESHW SCI, V31, P945, DOI 10.1899/11-062.1; Ferreira V, 2011, OECOLOGIA, V167, P279, DOI 10.1007/s00442-011-1976-2; Ferreira V, 2011, GLOBAL CHANGE BIOL, V17, P551, DOI 10.1111/j.1365-2486.2010.02185.x; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gessner MO, 1997, LIMNOL OCEANOGR, V42, P496, DOI 10.4319/lo.1997.42.3.0496; Gessner MO, 1999, OIKOS, V85, P377, DOI 10.2307/3546505; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Goncalves JFJ, 2007, FRESHWATER BIOL, V52, P1440, DOI 10.1111/j.1365-2427.2007.01769.x; Goncalves JF, 2006, J N AM BENTHOL SOC, V25, P344, DOI 10.1899/0887-3593(2006)25[344:LBISIT]2.0.CO;2; Gonzalez JM, 2003, FRESHWATER BIOL, V48, P1578, DOI 10.1046/j.1365-2427.2003.01110.x; Graca MAS, 2010, INT REV HYDROBIOL, V95, P27, DOI 10.1002/iroh.200911173; Graca MAS, 2001, J N AM BENTHOL SOC, V20, P408, DOI 10.2307/1468038; Gulis V, 2006, FRESHWATER BIOL, V51, P1655, DOI 10.1111/j.1365-2427.2006.01615.x; Gulis V, 2003, MICROBIAL ECOL, V45, P11, DOI 10.1007/s00248-002-1032-1; Hieber M, 2002, ECOLOGY, V83, P1026, DOI 10.1890/0012-9658(2002)083[1026:COSDFA]2.0.CO;2; IRONS JG, 1994, FRESHWATER BIOL, V32, P401, DOI 10.1111/j.1365-2427.1994.tb01135.x; Del Arco AI, 2012, LIMNETICA, V31, P141; Jabiol J, 2013, FUNGAL ECOL, V6, P439, DOI 10.1016/j.funeco.2013.04.002; Jonsson M, 2006, ACTA OECOL, V29, P72, DOI 10.1016/j.actao.2005.08.002; Jonsson M, 2000, OIKOS, V89, P519, DOI 10.1034/j.1600-0706.2000.890311.x; Jonsson M, 2002, P ROY SOC B-BIOL SCI, V269, P1047, DOI 10.1098/rspb.2002.1979; Kaspari M, 2004, ECOLOGY, V85, P1800, DOI 10.1890/03-0682; Laitung B, 2005, ARCH HYDROBIOL, V164, P217, DOI 10.1127/0003-9136/2005/0164-0217; Larned ST, 2003, ARCH HYDROBIOL, V156, P241, DOI 10.1127/0003-9136/2003/0156-0241; Lau DCP, 2008, FRESHWATER BIOL, V53, P139, DOI 10.1111/j.1365-2427.2007.01873.x; Lau DCP, 2009, J N AM BENTHOL SOC, V28, P426, DOI 10.1899/07-079.1; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; Leberfinger K, 2010, J N AM BENTHOL SOC, V29, P934, DOI 10.1899/09-179.1; Lecerf A, 2005, OECOLOGIA, V146, P432, DOI 10.1007/s00442-005-0212-3; Li AOY, 2009, AQUAT SCI, V71, P80, DOI 10.1007/s00027-008-8117-y; Li Hiram W., 1996, P391; LINKLATER W, 1995, HYDROBIOLOGIA, V306, P241, DOI 10.1007/BF00017694; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Marquis RJ, 2012, OECOLOGIA, V169, P811, DOI 10.1007/s00442-012-2249-4; Martinez A, 2014, FEMS MICROBIOL ECOL, V87, P257, DOI 10.1111/1574-6941.12221; Mathuriau C, 2002, J N AM BENTHOL SOC, V21, P384, DOI 10.2307/1468477; MCINTIRE CD, 1978, ECOL MONOGR, V48, P167, DOI 10.2307/2937298; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; da Silva DM, 2011, PLANT ECOL, V212, P181, DOI 10.1007/s11258-010-9813-y; Niyogi DK, 2003, FRESHWATER BIOL, V48, P1698, DOI 10.1046/j.1365-2427.2003.01104.x; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Pascoal C, 2004, APPL ENVIRON MICROB, V70, P5266, DOI 10.1128/AEM.70.9.5266-5273.2004; Pearson RG, 2009, J N AM BENTHOL SOC, V28, P504, DOI 10.1899/08-118.1; Pennings SC, 2009, ECOLOGY, V90, P183, DOI 10.1890/08-0222.1; Perez J, 2012, MICROB ECOL, V64, P279, DOI 10.1007/s00248-012-0022-1; Perez J, 2011, INT REV HYDROBIOL, V96, P105, DOI 10.1002/iroh.201011254; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; PRINGLE CM, 1988, J N AM BENTHOL SOC, V7, P503, DOI 10.2307/1467303; Rajashekhar M, 2003, HYDROBIOLOGIA, V501, P167, DOI 10.1023/A:1026239917232; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Riipinen MP, 2009, FRESHWATER BIOL, V54, P2127, DOI 10.1111/j.1365-2427.2008.01964.x; Rincon J, 2009, J N AM BENTHOL SOC, V28, P416, DOI 10.1899/07-084.1; Rosemond AD, 1998, FRESHWATER BIOL, V39, P515, DOI 10.1046/j.1365-2427.1998.00301.x; Rosemond AD, 2002, LIMNOL OCEANOGR, V47, P278, DOI 10.4319/lo.2002.47.1.0278; Royer TV, 2003, J N AM BENTHOL SOC, V22, P352, DOI 10.2307/1468266; Rueda-Delgado G, 2006, J N AM BENTHOL SOC, V25, P233, DOI 10.1899/0887-3593(2006)25[233:LDIAAF]2.0.CO;2; Salgado CS, 2005, ECOLOGY, V86, P1571, DOI 10.1890/04-1257; Salinas N, 2011, NEW PHYTOL, V189, P967, DOI 10.1111/j.1469-8137.2010.03521.x; Santos A., 2011, THESIS IMPA MANAUS; Santos-Flores C. J., 1998, CARIBB J SCI, V2, P1; Shaftel RS, 2012, BIOGEOCHEMISTRY, V107, P135, DOI 10.1007/s10533-010-9541-3; SMITS Gunta, 2007, Acta Bot. Venez., V30, P345; Sridhar KR, 2000, APPL ENVIRON MICROB, V66, P1114, DOI 10.1128/AEM.66.3.1114-1119.2000; Stelzer RS, 2003, FRESHWATER BIOL, V48, P1925, DOI 10.1046/j.1365-2427.2003.01141.x; STOUT RJ, 1989, CAN J FISH AQUAT SCI, V46, P1097, DOI 10.1139/f89-142; Suberkropp K, 1998, MYCOL RES, V102, P998, DOI 10.1017/S0953756297005807; Swan CM, 2006, OECOLOGIA, V147, P469, DOI 10.1007/s00442-005-0297-8; Swan CM, 2004, J N AM BENTHOL SOC, V23, P15, DOI 10.1899/0887-3593(2004)023&lt;0015:LDALBI&gt;2.0.CO;2; Tank JL, 2010, J N AM BENTHOL SOC, V29, P118, DOI 10.1899/08-170.1; VANNOTE RL, 1980, AM NAT, V115, P667, DOI 10.1086/283591; Walpola H, 2011, INT REV HYDROBIOL, V96, P90, DOI 10.1002/iroh.201011248; Wantzen K. M., 2011, PANTANAL ECOLOGY BIO; Wantzen KM, 2006, J N AM BENTHOL SOC, V25, P216, DOI 10.1899/0887-3593(2006)25[216:DPBISA]2.0.CO;2; Wantzen KM, 2002, INT VER THEOR ANGEW, V28, P815; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WINTERBOURN MJ, 1981, NEW ZEAL J MAR FRESH, V15, P321, DOI 10.1080/00288330.1981.9515927; WOODEGGENSCHWILER S, 1983, T BRIT MYCOL SOC, V81, P371, DOI 10.1016/S0007-1536(83)80089-8; Woodward G, 2012, SCIENCE, V336, P1438, DOI 10.1126/science.1219534; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Yule CM, 2009, J N AM BENTHOL SOC, V28, P404, DOI 10.1899/07-161.1; Yule CM, 1996, J TROP ECOL, V12, P517, DOI 10.1017/S0266467400009755	138	114	126	4	108	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1434-2944	1522-2632		INT REV HYDROBIOL	Int. Rev. Hydrobiol.	FEB	2015	100	1					1	12		10.1002/iroh.201401757	http://dx.doi.org/10.1002/iroh.201401757			12	Marine & Freshwater Biology	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology	AY8AU		Green Published			2022-09-04	WOS:000347777600001
J	Uddin, MS; Al Mamun, A; Kabir, MT; Jakaria, M; Mathew, B; Barreto, GE; Ashraf, GM				Uddin, Md. Sahab; Al Mamun, Abdullah; Kabir, Md. Tanvir; Jakaria, Md.; Mathew, Bijo; Barreto, George E.; Ashraf, Ghulam Md			Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology	MOLECULAR NEUROBIOLOGY			English	Article						Medicinal plants; Nootropics; Cognitive enhancers; Alzheimer's disease; Senile plaques; Neurofibrillary tangles	CROCUS-SATIVUS L.; WITHANIA-SOMNIFERA L.; ANTIOXIDANT ACTIVITY; CLITORIA-TERNATEA; ROOT EXTRACT; CENTELLA-ASIATICA; OXIDATIVE STRESS; PROTECTIVE ROLE; SPATIAL MEMORY; ACTIVE CONSTITUENT	Medicinal plants are the backbone of modern medicine. In recent times, there is a great urge to discover nootropic medicinal plants to reverse cognitive dysfunction owing to their less adverse effects. Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by the inevitable loss of cognitive function, memory and language impairment, and behavioral disturbances, which turn into gradually more severe. Alzheimer's has no current cure, but symptomatic treatments are available and research continues. The number of patients suffering from AD continues to rise and today, there is a worldwide effort under study to find better ways to alleviate Alzheimer's pathogenesis. In this review, the nootropic and anti-Alzheimer's potentials of 6 medicinal plants (i.e., Centella asiatica, Clitoria ternatea, Crocus sativus, Terminalia chebula, Withania somnifera, and Asparagus racemosus) were explored through literature review. This appraisal focused on available information about neuroprotective and anti-Alzheimer's use of these plants and their respective bioactive compounds/metabolites and associated effects in animal models and consequences of its use in human as well as proposed molecular mechanisms. This review progresses our existing knowledge to reveal the promising linkage of traditional medicine to halt AD pathogenesis. This analysis also avowed a new insight to search the promising anti-Alzheimer's drugs.	[Uddin, Md. Sahab; Al Mamun, Abdullah] Southeast Univ, Dept Pharm, Dhaka, Bangladesh; [Kabir, Md. Tanvir] BRAC Univ, Dept Pharm, Dhaka, Bangladesh; [Jakaria, Md.] Konkuk Univ, Dept Appl Life Sci, Chungju, South Korea; [Mathew, Bijo] Ahalia Sch Pharm, Div Drug Design, Palakkad, India; [Mathew, Bijo] Ahalia Sch Pharm, Med Chem Res Lab, Dept Pharmaceut Chem, Palakkad, India; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia		Uddin, MS (corresponding author), Southeast Univ, Dept Pharm, Dhaka, Bangladesh.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	msu-neuropharma@hotmail.com; ashraf.gm@gmail.com	, fvcx/AAE-2909-2021; Barreto, George E./AAD-7420-2020; Jakaria, Md/J-3922-2015; Ashraf, Ghulam Md/H-9485-2012; Uddin, Md. Sahab/Q-2315-2015	Barreto, George E./0000-0002-6644-1971; Jakaria, Md/0000-0001-8216-1171; Ashraf, Ghulam Md/0000-0002-9820-2078; Uddin, Md. Sahab/0000-0002-0805-7840; Kabir, Md. Tanvir/0000-0002-6078-8587				Moneim AEA, 2015, CURR ALZHEIMER RES, V12, P335, DOI 10.2174/1567205012666150325182702; Afshari AR, 2016, ADV PHARMACOL SCI, V2016, DOI 10.1155/2016/8964849; Ahmad MP, 2015, PAK J PHARM SCI, V28, P509; Akhondzadeh S, 2010, PSYCHOPHARMACOLOGY, V207, P637, DOI 10.1007/s00213-009-1706-1; Al-Snafi A. E., 2016, IOSR J PHARM, V6, P68; Ali SK, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-121; Aliev G, 2008, MINI-REV MED CHEM, V8, P1395, DOI 10.2174/138955708786369582; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Almutairi MM, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1976-9; Aloqbi A., 2016, Natural Science, V8, P235, DOI 10.4236/ns.2016.86028; Armstrong R A, 2011, Int J Alzheimers Dis, V2011, P630865, DOI 10.4061/2011/630865; Ayaz M, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00697; Balez R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31450; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Barbosa Filho José M., 2006, Rev. bras. farmacogn., V16, P258, DOI 10.1590/S0102-695X2006000200021; Batarseh YS, 2017, ACS CHEM NEUROSCI, V8, P1756, DOI 10.1021/acschemneuro.7b00101; Batumalaie K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27236; Berte TE, 2018, STEROIDS, V132, P5, DOI 10.1016/j.steroids.2018.01.002; Bhattacharya A, 2001, J ETHNOPHARMACOL, V74, P1, DOI 10.1016/S0378-8741(00)00309-3; Bone K., 1996, CLIN APPL AYURVEDIC; Boominathan R., 2003, Natural Product Sciences, V9, P260; Bredie SJH, 2012, J CARDIOVASC PHARM, V59, P215, DOI 10.1097/FJC.0b013e31823c0bed; Brinkhaus B, 2000, PHYTOMEDICINE, V7, P427, DOI 10.1016/S0944-7113(00)80065-3; Buchman AS, 2011, EXPERT REV NEUROTHER, V11, P665, DOI [10.1586/ern.11.57, 10.1586/ERN.11.57]; BURNS A, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B158; Carlson LE, 1999, NEUROBIOL AGING, V20, P315, DOI 10.1016/S0197-4580(99)00052-4; Cherdyntseva NV, 2013, J CANCER RES THER, V9, P364, DOI 10.4103/0973-1482.119303; Choudhary Dnyanraj, 2017, Journal of Dietary Supplements, V14, P599, DOI 10.1080/19390211.2017.1284970; Chusak C, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-017-2075-7; Defina Philip A, 2013, J Aging Res, V2013, P207178, DOI 10.1155/2013/207178; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; Dhivya P. S., 2014, International Journal of PharmTech Research, V6, P1450; Dhuley JN, 2001, PHYTOTHER RES, V15, P524, DOI 10.1002/ptr.874; Dolu N, 2015, J EXP NEUROSCI, V9, P81, DOI 10.4137/JEN.S29843; Escribano J, 1996, CANCER LETT, V100, P23, DOI 10.1016/0304-3835(95)04067-6; Estevez L, 2008, J PHYS CHEM A, V112, P10614, DOI 10.1021/jp8043237; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Farkhondeh Tahereh, 2018, Am J Neurodegener Dis, V7, P1; Farokhnia M, 2014, HUM PSYCHOPHARM CLIN, V29, P351, DOI 10.1002/hup.2412; Garcia-Ayllon Maria-Salud, 2011, Front Mol Neurosci, V4, P22, DOI 10.3389/fnmol.2011.00022; Geromichalos GD, 2012, J AGR FOOD CHEM, V60, P6131, DOI 10.1021/jf300589c; Ghadrdoost B, 2011, EUR J PHARMACOL, V667, P222, DOI 10.1016/j.ejphar.2011.05.012; Gupta R, 2017, MOL NEUROBIOL, V54, P4560, DOI 10.1007/s12035-016-9950-y; Guven M, 2015, IRAN J BASIC MED SCI, V18, P356; Heidari S, 2017, IRAN J BASIC MED SCI, V20, P1250, DOI 10.22038/IJBMS.2017.9541; Hong JT, 2009, TOXICOL APPL PHARM, V237, P59, DOI 10.1016/j.taap.2009.02.014; Hosseinzadeh H, 2012, PHYTOTHER RES, V26, P381, DOI 10.1002/ptr.3566; Hu Y, 2005, BRAIN RES, V1060, P26, DOI 10.1016/j.brainres.2005.08.019; Huang YN, 2012, TOXICOL APPL PHARM, V265, P241, DOI 10.1016/j.taap.2012.08.036; Hussein RH, 2014, SAUDI J BIOL SCI, V21, P589, DOI 10.1016/j.sjbs.2014.03.004; Ibrahim AE, 2015, J FORENSIC TOXICOL P, V04, DOI [10.4172/2325-9841.1000135, DOI 10.4172/2325-9841.1000135]; Inhee MJ, 1999, J NEUROSCI RES, V58, P417; Jain NN, 2003, PHARMACOL BIOCHEM BE, V75, P529, DOI 10.1016/S0091-3057(03)00130-8; Jang S, 2008, P NATL ACAD SCI USA, V105, P7534, DOI 10.1073/pnas.0802865105; Jayaprakasam B, 2010, PHYTOTHER RES, V24, P859, DOI 10.1002/ptr.3033; Jayashree G, 2003, FITOTERAPIA, V74, P431, DOI 10.1016/S0367-326X(03)00121-7; Kahkonen M, 2012, J AGR FOOD CHEM, V60, P1167, DOI 10.1021/jf203431g; Kahkonen MP, 2003, J AGR FOOD CHEM, V51, P628, DOI 10.1021/jf025551i; Khajehnejad M, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080109; Khalili M., 2010, Iranian Journal of Pathology, V5, P27; Khalili Mohsen, 2010, Iran Biomed J, V14, P59; Kilic I, 2014, SPECTROCHIM ACTA A, V130, P447, DOI 10.1016/j.saa.2014.04.052; Kilic I, 2013, SPECTROCHIM ACTA A, V115, P719, DOI 10.1016/j.saa.2013.06.110; Kim HJ, 2014, BIOMOL THER, V22, P275, DOI 10.4062/biomolther.2014.068; Klika KD, 2004, ARKIVOC, P83, DOI 10.3998/ark.5550190.0005.708; Kuboyama T, 2006, EUR J NEUROSCI, V23, P1417, DOI 10.1111/j.1460-9568.2006.04664.x; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kujawski R., 2016, J MED SCI, V85, P313, DOI [10.20883/jms.2016.172, DOI 10.20883/JMS.2016.172]; KULKARNI C, 1988, INDIAN J EXP BIOL, V26, P957; Kulsoom Zahara, 2014, Pure and Applied Biology, V3, P152; Kumar Anil, 2009, Int J Alzheimers Dis, V2009, DOI 10.4061/2009/972178; Kumar MHV, 2003, CLIN EXP PHARMACOL P, V30, P336, DOI 10.1046/j.1440-1681.2003.03842.x; Kumar Vikas, 2015, [CELLMED, 셀메드], V5, P1, DOI 10.5667/tang.2014.0030; Kurapati KRV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077624; Labak M, 2010, ACTA NEUROCHIR SUPPL, V106, P177, DOI 10.1007/978-3-211-98811-4_32; Lalert L, 2018, J ETHNOPHARMACOL, V225, P336, DOI 10.1016/j.jep.2018.07.014; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Lee CW, 2011, BIOMOL THER, V19, P181, DOI 10.4062/biomolther.2011.19.2.181; Lee HS, 2007, ARCH TOXICOL, V81, P211, DOI 10.1007/s00204-006-0139-4; Lee MK, 2000, RES COMMUN MOL PATH, V108, P75; Lee Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep25094; Lei XM, 2015, MOL MED REP, V12, P3688, DOI 10.3892/mmr.2015.3857; Li T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00176; Li YJ, 2008, ENVIRON TOXICOL PHAR, V26, P13, DOI 10.1016/j.etap.2007.12.008; Lin TY, 2016, NEUROTOXICOLOGY, V55, P48, DOI 10.1016/j.neuro.2016.05.008; Linardaki ZI, 2013, FOOD CHEM TOXICOL, V52, P163, DOI 10.1016/j.fct.2012.11.016; Ling YT, 2017, ONCOTARGET, V8, P51066, DOI 10.18632/oncotarget.17654; Maheep Bhatnagar, 2013, Journal of Medicinal Plants Research, V7, P2259; Malik J, 2011, PHARM BIOL, V49, P1234, DOI 10.3109/13880209.2011.584539; Mathew M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086804; Mendiola-Precoma J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2589276; Mo EK, 2012, FOOD SCI BIOTECHNOL, V21, P485, DOI 10.1007/s10068-012-0061-x; Mohamadpour AH, 2013, IRAN J BASIC MED SCI, V16, P39; Mukherjee PK, 2007, PHYTOTHER RES, V21, P1142, DOI 10.1002/ptr.2224; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Murugan S M A R D, 2015, IOSR J DENT MED SCI, V14, P23; Nag G., 2011, INT J PHARM PHARM SC, V3, P121; Nageswara Rao S., 2013, ASIAN J BIOMED PHARM, V3, P59; Naidu PS, 2006, PHYTOTHER RES, V20, P140, DOI 10.1002/ptr.1823; Nair V, 2015, J AGR FOOD CHEM, V63, P6355, DOI 10.1021/acs.jafc.5b00928; Narinderpal K, 2013, RES REV J BOT SCI, V2, P6; Nasir MN, 2012, PHYTOMEDICINE, V19, P311, DOI 10.1016/j.phymed.2011.10.004; Nasir MN, 2011, J ETHNOPHARMACOL, V134, P203, DOI 10.1016/j.jep.2010.12.010; Ng T. B., 2004, Neuroembryology and Aging, V3, P136, DOI 10.1159/000094576; Nidhi Rao, 2013, Advances in Bio Research, V4, P136; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Ohnishi T, 2001, AM J NEURORADIOL, V22, P1680; Ostrovskaya RU, 2007, J PSYCHOPHARMACOL, V21, P611, DOI 10.1177/0269881106071335; Papandreou MA, 2006, J AGR FOOD CHEM, V54, P8762, DOI 10.1021/jf061932a; Papandreou MA, 2011, BEHAV BRAIN RES, V219, P197, DOI 10.1016/j.bbr.2011.01.007; Parihar MS, 2004, J NEURAL TRANSM, V111, P1, DOI 10.1007/s00702-003-0069-8; Parle M, 2007, MEMORY ENHANCING ACT; Parra MA, 2009, BRAIN, V132, P1057, DOI 10.1093/brain/awp036; Murray AP, 2013, CURR NEUROPHARMACOL, V11, P388, DOI 10.2174/1570159X11311040004; Pitsikas N, 2006, BEHAV BRAIN RES, V173, P112, DOI 10.1016/j.bbr.2006.06.005; Pojer E, 2013, COMPR REV FOOD SCI F, V12, P483, DOI 10.1111/1541-4337.12024; Power R, 2018, J ALZHEIMERS DIS, V61, P947, DOI 10.3233/JAD-170713; Prakash A, 2013, INT J NEUROSCI, V123, P636, DOI 10.3109/00207454.2013.785542; Qi FY, 2014, NEURAL REGEN RES, V9, P1275, DOI 10.4103/1673-5374.137574; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Rai Kiranmai S., 2001, Indian Journal of Physiology and Pharmacology, V45, P305; Rai KS, 2005, PHYTOTHER RES, V19, P592, DOI 10.1002/ptr.1657; Rai KS, 2002, FITOTERAPIA, V73, P685, DOI 10.1016/S0367-326X(02)00249-6; Rajashree R., 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P107, DOI [10.1515/jbcpp-2016-0024, 10.1515/jbcpp-2016-002423]; Ravishankar K., 2012, Journal of Pharmacy Research, V5, P2763; Romanova D, 2001, NEOPLASMA, V48, P104; Sachan AK, 2012, INT J PHARM CHEM SCI, V1, P588; Sahu, 2014, ASIAN J PHARM CLIN R, V7, P152; Sancheti S, 2010, S AFR J BOT, V76, P285, DOI 10.1016/j.sajb.2009.11.006; Sarbishegi M, 2016, AVICENNA J PHYTOMEDI, V6, P399; Sarkaki Alireza, 2008, Pak J Biol Sci, V11, P1114, DOI 10.3923/pjbs.2008.1114.1119; Sarkar S, 2016, CURR ALZHEIMER RES, V13, P1363, DOI 10.2174/1567205013666160625082839; Saxena G, 2007, ANN NEUROSCI, V14, P57, DOI 10.5214/ans.0972.7531.2007.140302; Saxena R B, 2010, Ayu, V31, P374, DOI 10.4103/0974-8520.77153; Schliebs R, 1997, NEUROCHEM INT, V30, P181, DOI 10.1016/S0197-0186(96)00025-3; Shanmuganathan S, 2018, VASC PHARMACOL, V108, P23, DOI 10.1016/j.vph.2018.04.005; Sharma K, 2010, INDIAN J EXP BIOL, V48, P479; Sharma S, 2013, EXPERT OPIN INV DRUG, V22, P1063, DOI 10.1517/13543784.2013.805744; Singh S, 2012, EUR REV MED PHARMACO, V16, P1651; Smith AD, 2002, P NATL ACAD SCI USA, V99, P4135, DOI 10.1073/pnas.082107399; Soumyanath Amala, 2012, Int J Alzheimers Dis, V2012, P381974, DOI 10.1155/2012/381974; Sowndhararajan K, 2017, SCI PHARM, V85, DOI 10.3390/scipharm85020021; Sulaiman CT, 2012, J TROPICAL MED PLANT; Sunanda BPV, 2014, INDIAN J PHARM EDUC, V48, P31, DOI 10.5530/ijper.48.4.5; Surveswaran S, 2007, FOOD CHEM, V102, P938, DOI 10.1016/j.foodchem.2006.06.033; Surveswaran S, 2010, NAT PROD RES, V24, P206, DOI 10.1080/14786410802228827; Talpate KA, 2014, J PHARM BIOALLIED SC, V6, P48, DOI 10.4103/0975-7406.124317; Taranalli AD, 2000, PHARM BIOL, V38, P51, DOI 10.1076/1388-0209(200001)3811-BFT051; TARAWNEH R, 2012, COLD SPRING HARB PER, V2, DOI DOI 10.1101/CSHPERSPECT.A006148; Tiwari S., 2008, DIGST J NANOMATER BI, V3, P215; Tohda C, 2009, BRIT J PHARMACOL, V157, P1427, DOI 10.1111/j.1476-5381.2009.00313.x; Tzeng CW, 2011, J AGR FOOD CHEM, V59, P5073, DOI 10.1021/jf200354y; Uddin M.S., 2016, AM J PSYCHIAT NEUROS, V4, P26, DOI DOI 10.11648/J.AJPN.20160402.12; Uddin Md Sahab, 2019, Mol Neurobiol, V56, P2450, DOI 10.1007/s12035-018-1237-z; Uddin MS, 2019, J CELL PHYSIOL, V234, P8094, DOI 10.1002/jcp.27588; Uddin Md Sahab, 2019, Psychogeriatrics, V19, P87, DOI 10.1111/psyg.12368; Uddin MS, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00004; Uddin MS, 2016, ANN NEUROSCI, V23, P218, DOI 10.1159/000449482; Uddin MS., 2016, J NEUROLOGY NEUROSCI, V7, P1, DOI DOI 10.21767/2171-6625.1000126; Uddin MS, 2016, J NEUROL NEUROPHYSIO, V7, P1, DOI DOI 10.4172/2155-9562.1000397; Uddin MS, 2018, HDB RES CRITICAL EXA; Upadhyay A, 2014, INT J PHARMACOL, V10, P289, DOI 10.3923/ijp.2014.289.298; Upadhyay A, 2011, CHEMOSPHERE, V85, P1095, DOI 10.1016/j.chemosphere.2011.07.041; Upendra Bhadoriya, 2012, Asian Pacific Journal of Tropical Disease, pS833; Vinutha B, 2007, J ETHNOPHARMACOL, V109, P359, DOI 10.1016/j.jep.2006.06.014; Wang DM, 2014, NEUROCHEM RES, V39, P1533, DOI 10.1007/s11064-014-1343-x; Wang ZQ, 2016, NEUROSCI LETT, V627, P185, DOI 10.1016/j.neulet.2016.05.014; Wattanathorn J, 2008, J ETHNOPHARMACOL, V116, P325, DOI 10.1016/j.jep.2007.11.038; Xu CL, 2013, FITOTERAPIA, V90, P112, DOI 10.1016/j.fitote.2013.07.009; Xu CL, 2012, PHARMACOL BIOCHEM BE, V100, P413, DOI 10.1016/j.pbb.2011.09.014; Xu YN, 2008, J ALZHEIMERS DIS, V13, P341; Xue CY, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/523027; Yao XY, 2017, BANGL J PHARMACOL, V12, P133, DOI 10.3329/bjp.v12i2.30985; Yoshino Y., 2014, Pharmacology and Pharmacy, V5, P37, DOI 10.4236/pp.2014.51007; Zandi PP, 2004, ARCH NEUROL-CHICAGO, V61, P82, DOI 10.1001/archneur.61.1.82; Zhang XN, 2012, EUR J PHARMACOL, V679, P51, DOI 10.1016/j.ejphar.2012.01.006; ZHANG YX, 1994, BIOL PHARM BULL, V17, P217, DOI 10.1248/bpb.17.217; Zhao J, 2002, CHEM PHARM BULL, V50, P760, DOI 10.1248/cpb.50.760; Zhao L, 2013, BRAIN RES, V1492, P33, DOI 10.1016/j.brainres.2012.11.019; Zhao XY, 2005, BBA-GEN SUBJECTS, V1725, P103, DOI 10.1016/j.bbagen.2005.04.015; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523	181	61	61	2	42	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2019	56	7					4925	4944		10.1007/s12035-018-1420-2	http://dx.doi.org/10.1007/s12035-018-1420-2			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IT8VJ	30414087				2022-09-04	WOS:000483159700025
J	Bastus, NG; Gonzalez, E; Esteve, J; Piella, J; Patarroyo, J; Merkoci, F; Puntes, V				Bastus, Neus G.; Gonzalez, Edgar; Esteve, Joan; Piella, Jordi; Patarroyo, Javier; Merkoci, Florind; Puntes, Victor			Exploring New Synthetic Strategies for the Production of Advanced Complex Inorganic Nanocrystals	ZEITSCHRIFT FUR PHYSIKALISCHE CHEMIE-INTERNATIONAL JOURNAL OF RESEARCH IN PHYSICAL CHEMISTRY & CHEMICAL PHYSICS			English	Article						Nanocrystals; Synthesis; Kinetic Control; Chemical Transformations; Applicability	ONE-POT SYNTHESIS; CATION-EXCHANGE; GOLD NANOPARTICLES; NANOROD HETEROSTRUCTURES; METAL NANOSTRUCTURES; SELECTIVE GROWTH; SHAPE CONTROL; CDSE; SILVER; TIPS	The design of new protocols for the colloidal synthesis of complex nanocrystals (NCs) with advanced functionalities, comprising both hybrid and hollow structures, and the study of their fundamental properties is of paramount importance for the development of a new generation of nanostructured materials. The possibility of tailoring the dimensional regime of NCs, along with its composition and structure, represents a landmark achievement in the control of their unique physico-chemical properties. These properties, alongside with the ability to cheaply produce high quality NCs in fairly large amounts by wet-chemistry techniques, leads to their potential applicability from materials science to nanomedicine. Within this context, this review is focused on describing a successful framework for designing synthetic strategies for the production of advanced complex NCs, integrating the development of new synthetic methods with its structural characterization, monitoring of their properties, and study of its reactivity. As a result, it is expected to provide new routes to produce robust and easy-to-process NCs in a wide range of sizes, shapes and configurations that can be explored to achieve the combination of all degrees of control, aiming to produce a complete and diverse library of material combinations that will expand its applicability in a wide diversity of fields.	[Bastus, Neus G.; Piella, Jordi; Patarroyo, Javier; Merkoci, Florind; Puntes, Victor] Inst Catala Nanociencia &Nanotecnol ICN2, Barcelona 08193, Spain; [Gonzalez, Edgar] Pontificia Univ Javeriana, Inst Geofis, Bogota 001120, Colombia; [Esteve, Joan] Univ Barcelona, Dept Fis Aplicada & Opt, E-08028 Barcelona, Spain; [Puntes, Victor] Vall dHebron Inst Recerca VHIR, Barcelona 08035, Spain; [Puntes, Victor] Inst Catala Recerca & Estudis Avancats, Barcelona 08010, Spain		Bastus, NG (corresponding author), Inst Catala Nanociencia &Nanotecnol ICN2, Campus UAB, Barcelona 08193, Spain.	neus.bastus@icn.cat	Bastús, Neus G./AAK-8755-2020; Puntes, Víctor F./F-8407-2013; Bastús, Neus G./J-2407-2012; Puntes, Victor/AAL-6081-2021; Esteve, Joan/L-5056-2014; Patarroyo, Javier/AAG-1126-2020	Bastús, Neus G./0000-0002-3144-7986; Puntes, Víctor F./0000-0001-8996-9499; Bastús, Neus G./0000-0002-3144-7986; Puntes, Victor/0000-0001-8996-9499; Esteve, Joan/0000-0003-1469-9847; Patarroyo, Javier/0000-0002-3703-666X; Gonzalez, Edgar E/0000-0003-3103-3959; Piella, Jordi/0000-0002-5788-3145	Generalitat de Catalunya [2014-SGR-612]; Spanish MICINN [MAT2012-33330, CONSOLIDER2010-CSD 2008-0023-FUNCOAT]; European Community (EU-FP7) through the FutureNanoNeeds project; Spanish MICINN through the Juan de la Cierva program; European Commission	Generalitat de Catalunya(Generalitat de Catalunya); Spanish MICINN(Spanish Government); European Community (EU-FP7) through the FutureNanoNeeds project; Spanish MICINN through the Juan de la Cierva program; European Commission(European CommissionEuropean Commission Joint Research Centre)	We acknowledge financial support from the Generalitat de Catalunya (2014-SGR-612), Spanish MICINN (MAT2012-33330 and CONSOLIDER2010-CSD 2008-0023-FUNCOAT) and European Community (EU-FP7) through the FutureNanoNeeds project. N. G. B. thanks the Spanish MICINN for the financial support through the Juan de la Cierva program and European Commission for the Career Integration Grant (CIG)-Marie Curie Action.	Alivisatos AP, 2001, SCI AM, V285, P66, DOI 10.1038/scientificamerican0901-66; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; Banholzer MJ, 2008, CHEM SOC REV, V37, P885, DOI 10.1039/b710915f; Banin U, 2014, CHEM MATER, V26, P97, DOI 10.1021/cm402131n; Bastus NG, 2014, CHEM MATER, V26, P2836, DOI 10.1021/cm500316k; Bastus NG, 2012, DELIVERY OF NANOPARTICLES, P377; Bastus NG, 2011, LANGMUIR, V27, P11098, DOI 10.1021/la201938u; Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Buck MR, 2013, ANGEW CHEM INT EDIT, V52, P6154, DOI 10.1002/anie.201207240; Buonsanti R, 2010, J AM CHEM SOC, V132, P2437, DOI 10.1021/ja910322a; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Cabot A, 2007, J AM CHEM SOC, V129, P10358, DOI 10.1021/ja072574a; Casals E, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/44/443001; Chen CL, 2008, J AM CHEM SOC, V130, P13555, DOI 10.1021/ja805683r; Chen CL, 2010, J AM CHEM SOC, V132, P6902, DOI 10.1021/ja102000g; Conca E, 2014, NANOSCALE, V6, P2238, DOI 10.1039/c3nr05567a; Costi R, 2008, NANO LETT, V8, P637, DOI 10.1021/nl0730514; Costi R, 2010, ANGEW CHEM INT EDIT, V49, P4878, DOI 10.1002/anie.200906010; Cozzoli PD, 2006, CHEM SOC REV, V35, P1195, DOI 10.1039/b517790c; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; De Trizio L, 2013, ACS NANO, V7, P3997, DOI 10.1021/nn3060219; De Trizio L, 2012, CHEM MATER, V24, P2400, DOI 10.1021/cm301211e; De Trizio L, 2012, ACS NANO, V6, P32, DOI 10.1021/nn203702r; Deka S, 2009, J AM CHEM SOC, V131, P12817, DOI 10.1021/ja904493c; Elmalem E, 2008, ADV MATER, V20, P4312, DOI 10.1002/adma.200800044; Feldheim, 1999, ADV MATER, V11, P447, DOI 10.1002/(SICI)1521- 4095(199904)11:63.0.CO;2-I; Figuerola A, 2008, J AM CHEM SOC, V130, P1477, DOI 10.1021/ja078034v; Figuerola A, 2009, ADV MATER, V21, P550, DOI 10.1002/adma.200801928; Franchini IR, 2010, J MATER CHEM, V20, P1357, DOI 10.1039/b915687a; Fu AH, 2004, J AM CHEM SOC, V126, P10832, DOI 10.1021/ja046747x; George C, 2011, J AM CHEM SOC, V133, P2205, DOI 10.1021/ja108781w; Ghosh SK, 2007, CHEM REV, V107, P4797, DOI 10.1021/cr0680282; GOLDSTEIN AN, 1992, SCIENCE, V256, P1425, DOI 10.1126/science.256.5062.1425; Gonzalez E, 2011, SCIENCE, V334, P1377, DOI 10.1126/science.1212822; Goris B, 2012, SMALL, V8, P937, DOI 10.1002/smll.201101897; Grebinski JW, 2004, CHEM MATER, V16, P5260, DOI 10.1021/cm048498h; Grzelczak M, 2010, ACS NANO, V4, P3591, DOI 10.1021/nn100869j; Gu HW, 2004, J AM CHEM SOC, V126, P5664, DOI 10.1021/ja0496423; Guisbiers G, 2011, J PHYS CHEM C, V115, P2616, DOI 10.1021/jp108041q; Hyeon T, 2003, CHEM COMMUN, P927, DOI 10.1039/b207789b; Jain PK, 2010, J AM CHEM SOC, V132, P9997, DOI 10.1021/ja104126u; Jain PK, 2008, ACCOUNTS CHEM RES, V41, P1578, DOI 10.1021/ar7002804; Kalsin AM, 2006, NANO LETT, V6, P1896, DOI 10.1021/nl060967m; Kowalczyk B, 2012, NAT MATER, V11, P227, DOI [10.1038/NMAT3202, 10.1038/nmat3202]; Kudera S, 2005, NANO LETT, V5, P445, DOI 10.1021/nl048060g; Kumar S, 2006, SMALL, V2, P316, DOI 10.1002/smll.200500357; Lagzi I, 2010, ANGEW CHEM INT EDIT, V49, P8616, DOI 10.1002/anie.201004231; Lee JS, 2010, J AM CHEM SOC, V132, P6382, DOI 10.1021/ja100029s; Lesnyak V, 2014, ACS NANO, V8, P8407, DOI 10.1021/nn502906z; Li F, 2011, ANGEW CHEM INT EDIT, V50, P4202, DOI 10.1002/anie.201007433; Li HB, 2013, ACCOUNTS CHEM RES, V46, P1387, DOI 10.1021/ar3002409; Li HB, 2011, NANO LETT, V11, P4964, DOI 10.1021/nl202927a; Liakakos N, 2012, J AM CHEM SOC, V134, P17922, DOI 10.1021/ja304487b; Lim SI, 2011, J MATER CHEM, V21, P11518, DOI 10.1039/c1jm10313j; Lim SI, 2010, CHEM MATER, V22, P4495, DOI 10.1021/cm101436p; Lim SI, 2010, NANO LETT, V10, P964, DOI 10.1021/nl100032c; Linic S, 2011, NAT MATER, V10, P911, DOI [10.1038/NMAT3151, 10.1038/nmat3151]; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Ma XD, 2011, J PHYS CHEM LETT, V2, P2466, DOI 10.1021/jz201131u; Maneeprakorn W, 2010, J AM CHEM SOC, V132, P1780, DOI 10.1021/ja910022q; Maynadie J, 2009, ANGEW CHEM INT EDIT, V48, P1814, DOI 10.1002/anie.200804798; Meyns M, 2010, J MATER CHEM, V20, P10602, DOI 10.1039/c0jm03004j; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Miszta K, 2011, ACS NANO, V5, P7176, DOI 10.1021/nn201988w; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; Nie ZH, 2007, NAT MATER, V6, P609, DOI 10.1038/nmat1954; Novak JP, 2000, J AM CHEM SOC, V122, P3979, DOI 10.1021/ja000477a; Oh MH, 2013, SCIENCE, V340, P964, DOI 10.1126/science.1234751; Ojea-Jimenez I, 2011, J PHYS CHEM C, V115, P15752, DOI 10.1021/jp2017242; Parak WJ, 2011, SCIENCE, V334, P1359, DOI 10.1126/science.1215080; Pellegrino T, 2006, J AM CHEM SOC, V128, P6690, DOI 10.1021/ja0607741; Peng XG, 1997, ANGEW CHEM INT EDIT, V36, P145, DOI 10.1002/anie.199701451; Perez-Juste J, 2005, COORDIN CHEM REV, V249, P1870, DOI 10.1016/j.ccr.2005.01.030; Puntes VF, 2002, J AM CHEM SOC, V124, P12874, DOI 10.1021/ja027262g; REISS H, 1951, J CHEM PHYS, V19, P482, DOI 10.1063/1.1748251; Sadtler B, 2009, J AM CHEM SOC, V131, P5285, DOI 10.1021/ja809854q; Sailor MJ, 2012, ADV MATER, V24, P3779, DOI 10.1002/adma.201200653; Salant A, 2006, J AM CHEM SOC, V128, P10006, DOI 10.1021/ja063192s; Sanchez C, 2014, CHEM MATER, V26, P221, DOI 10.1021/cm402528b; Scarabelli L, 2013, CHEM MATER, V25, P4232, DOI 10.1021/cm402177b; Schmidtke C, 2013, NANOSCALE, V5, P11783, DOI 10.1039/c3nr04155g; Schneider G, 2006, NANO LETT, V6, P530, DOI 10.1021/nl052441s; Shevchenko EV, 2008, ADV MATER, V20, P4323, DOI 10.1002/adma.200702994; Shi WL, 2006, NANO LETT, V6, P875, DOI 10.1021/nl0600833; Skrabalak SE, 2007, ADV MATER, V19, P3177, DOI 10.1002/adma.200701972; SMIGELSKAS AD, 1947, T AM I MIN MET ENG, V171, P130; Son DH, 2004, SCIENCE, V306, P1009, DOI 10.1126/science.1103755; Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a; Sun YG, 2003, ADV MATER, V15, P641, DOI 10.1002/adma.200301639; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Talapin DV, 2001, NANO LETT, V1, P207, DOI 10.1021/nl0155126; Talapin DV, 2004, J PHYS CHEM B, V108, P18826, DOI 10.1021/jp046481g; Tao AR, 2008, SMALL, V4, P310, DOI 10.1002/smll.200701295; Tao F, 2008, SCIENCE, V322, P932, DOI 10.1126/science.1164170; van Huis MA, 2011, NANO LETT, V11, P4555, DOI 10.1021/nl2030823; Vaneski A, 2011, ADV FUNCT MATER, V21, P1547, DOI 10.1002/adfm.201002444; Walker DA, 2011, NANOSCALE, V3, P1316, DOI 10.1039/c0nr00698j; Wang DW, 2011, ACS NANO, V5, P530, DOI 10.1021/nn1025252; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Xiao F, 2007, J AM CHEM SOC, V129, P10068, DOI 10.1021/ja073032w; Xie RG, 2009, J AM CHEM SOC, V131, P5691, DOI 10.1021/ja9005767; Xu ZC, 2007, J AM CHEM SOC, V129, P8698, DOI 10.1021/ja073057v; Yang J, 2009, NAT MATER, V8, P683, DOI [10.1038/NMAT2490, 10.1038/nmat2490]; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; Yu H, 2005, NANO LETT, V5, P379, DOI 10.1021/nl047955q; Zeng J, 2010, ADV MATER, V22, P1936, DOI 10.1002/adma.200903982; Zhang JT, 2010, SCIENCE, V327, P1634, DOI 10.1126/science.1184769; Zhao N, 2009, NANO LETT, V9, P3077, DOI 10.1021/nl901567a	111	7	7	1	35	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0942-9352			Z PHYS CHEM	Z. Phys. Chemie-Int. J. Res. Phys. Chem. Chem. Phys.		2015	229	1-2			SI		65	83		10.1515/zpch-2014-0611	http://dx.doi.org/10.1515/zpch-2014-0611			19	Chemistry, Physical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	CB7MW		Green Published			2022-09-04	WOS:000349812500003
J	Tomatsu, S; Dieter, T; Schwartz, IV; Sarmient, P; Giugliani, R; Barrera, LA; Guelbert, N; Kremer, R; Repetto, GM; Gutierrez, MA; Nishioka, T; Serrato, OP; Montano, AM; Yamaguchi, S; Noguchi, A				Tomatsu, S; Dieter, T; Schwartz, IV; Sarmient, P; Giugliani, R; Barrera, LA; Guelbert, N; Kremer, R; Repetto, GM; Gutierrez, MA; Nishioka, T; Serrato, OP; Montano, AM; Yamaguchi, S; Noguchi, A			Identification of a common mutation in mucopolysaccharidosis IVA: correlation among genotype, phenotype, and keratan sulfate	JOURNAL OF HUMAN GENETICS			English	Article						N-acetylgalactosamine-6-sulfate sulfatase; mucopolysaccharidosis IVA; common mutation; genomic PCR amplification; Latin America	N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE; GENE; MORQUIO; HETEROGENEITY; DEFICIENCY; GALNS	Mucopolysaccharidosis IVA (MPS IVA) is a lysosomal storage disorder caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS). Mutation screening of the GALNS was performed by genomic PCR and direct sequence analyses in 20 NIPS IVA patients from Latin America. In this study, 12 different gene mutations including nine unreported ones were identified in 16 severe and four attenuated patients and accounted for 90.0% of the unrelated mutant alleles. The gene alterations were missense mutations except one insertion. Six recurrent mutations, p.A75G, p.G116S, p.G139S., p.N164T, p.R380S, and p.R386C, accounted for 5.0, 10.0, 5.0, 7.5, 5.0, and 32.5% of the unrelated mutant alleles, respectively. The p.R386C mutation was identified in all Latin American populations studied. Eleven mutations correlated with a severe form, while one mutation, p.R380S, was associated with an attenuated form. MPS IVA patients had an elevation of urine and plasma keratan sulfate (KS) concentrations compared with those of the age-matched control. KS concentrations in severe patients were higher than those in attenuated patients. These data provide evidence for extensive allelic heterogeneity and presence of a common mutation in Latin American patients. Accumulation of mutations with clinical description and KS concentration will lead us to predict clinical severity of the patient more precisely.	St Louis Univ, Dept Pediat, Pediat Res Inst, St Louis, MO 63110 USA; Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil; Hosp Ninos Cordoba, CEMECO, Ctr Estudio Metab Congenitas, Bogota, Colombia; Univ Desarrollo, Fac Ciencias Salud, Clin Alemana, Santiago, Chile; Grad Univ Adv Studies, Dept Biosyst Sci, Kanagawa, Japan; Shimane Univ, Dept Pediat, Izumo, Shimane, Japan; Javeriana Univ, Inst Inborn Errrors Metab, Bogota, Colombia		Tomatsu, S (corresponding author), St Louis Univ, Dept Pediat, Pediat Res Inst, 3662 Park Ave, St Louis, MO 63110 USA.	tomatsus@slu.edu	Schwartz, Ida/M-1422-2015; Schwartz, Ida V/H-5923-2016; Giugliani, Roberto/G-4790-2015; Repetto, Gabriela/C-7833-2012; Montano, Adriana/AHE-8741-2022	Schwartz, Ida/0000-0002-7933-6687; Giugliani, Roberto/0000-0001-9655-3686; Repetto, Gabriela/0000-0003-0120-5684; 				Bunge S, 1997, HUM MUTAT, V10, P223; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; FUKUDA S, 1992, J CLIN INVEST, V90, P1049, DOI 10.1172/JCI115919; IWATA H, 1995, HUM GENET, V95, P257; Montano AM, 2003, HUM GENET, V113, P162, DOI 10.1007/s00439-003-0959-8; NAKASHIMA Y, 1994, GENOMICS, V20, P99, DOI 10.1006/geno.1994.1132; OGAWA T, 1995, HUM MOL GENET, V4, P341, DOI 10.1093/hmg/4.3.341; Sukegawa K, 2000, HUM MOL GENET, V9, P1283, DOI 10.1093/hmg/9.9.1283; TOMATSU S, 1995, AM J HUM GENET, V57, P556; Tomatsu S, 2004, PEDIATR RES, V55, P592, DOI 10.1203/01.PDR.0000113767.60140.E9; TOMATSU S, 1991, BIOCHEM BIOPH RES CO, V181, P677, DOI 10.1016/0006-291X(91)91244-7; Tomatsu S, 1997, HUM MUTAT, V10, P368, DOI 10.1002/(SICI)1098-1004(1997)10:5<368::AID-HUMU6>3.3.CO;2-8; Tomatsu SJ, 1998, HUM MUTAT, pS42; Yamada N, 1998, HUM MUTAT, V11, P202, DOI 10.1002/(SICI)1098-1004(1998)11:3<202::AID-HUMU4>3.3.CO;2-0	15	36	37	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.		2004	49	9					490	494		10.1007/s10038-004-0178-8	http://dx.doi.org/10.1007/s10038-004-0178-8			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	856OR	15309681	Bronze			2022-09-04	WOS:000224055000005
J	Cabrera, LF; Ferrada, P; Mayol, J; Mendoza, AC; Herrera, G; Pedraza, M; Sanchez, S				Felipe Cabrera, Luis; Ferrada, Paula; Mayol, Julio; Camilo Mendoza, Andres; Herrera, Gabriel; Pedraza, Mauricio; Sanchez, Sebastian			Impact of social media on the continuous education of the general surgeon, a new experience, @Cirbosque: A Latin American example	SURGERY			English	Article								Social media has gained widespread recognition for its importance in the medical field. Such platforms play an important role for learning and teaching, because knowledge can be transmitted instantly and massively, and specialists in different world-wide locations can discuss experiences instantaneously. The present article presents our experience of using social media to facilitate surgical learning while encouraging leadership and global mentoring. This retrospective descriptive study was initiated at the time of the creation of our social media handle on Twitter, February 22, 2019. Since that time, we have posted 10,587 academic tweets; the monthly growth rate has been 9% (393 new followers per month). Currently, we have 4,213 followers, 11,241,000 impressions, 121,105 visits, and 121,105 mentions. We have reviewed 59 topics of interest in general surgery and 132 clinical cases in trauma, as well as in hepatobiliary, gastrointestinal, thoracic, and acute-care surgery. We have made 13 image challenges using illustrations of diagnostic and intraoperative images. Although the evidence is uncertain to promote education performed entirely through social media, we show that @Cirbosque has been effective, and the impact of this initiative on Twitter is appreciated by many surgeons worldwide, including renowned teachers in each of the topics addressed. Furthermore, the number of participants in the discussions increased each day, as did all impact indicators according to Twitter Analytics. Thus, we conclude that the educational message of @Cirbosque is having a positive effect and reaching thousands of people worldwide, suggesting that others can develop similar outreach programs in education and communication. (C) 2020 Elsevier Inc. All rights reserved.	[Felipe Cabrera, Luis; Herrera, Gabriel] Hosp Univ Fundacion Santa Fe Bogota, Dept Gen Surg, Bogota, Colombia; [Ferrada, Paula] Virginia Commonwealth Univ, Dept Acute Care, Surg Serv, Richmond, VA USA; [Mayol, Julio] Univ Complutense Madrid, Inst Invest Sanitaria San Carlos, Hosp Clin San Carlos Madrid, Dept Surg, Madrid, Spain; [Camilo Mendoza, Andres; Pedraza, Mauricio] Univ El Bosque, Dept Surg, Bogota, Colombia; [Felipe Cabrera, Luis; Herrera, Gabriel] Univ Los Andes, Sch Med, Bogota, Colombia; [Sanchez, Sebastian] Pontificia Univ Javeriana, Dept Surg, Bogota, Colombia		Pedraza, M (corresponding author), El Bosque Univ, Resident Gen Surg, Bogota 111166, DC, Colombia.	mpedraza93@gmail.com	Mayol, Julio/M-2265-2019	Mayol, Julio/0000-0003-2411-6668; Pedraza Ciro, Mauricio/0000-0001-8726-5578				Chapman SJ, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3973; Cheston CC, 2013, ACAD MED, V88, P893, DOI 10.1097/ACM.0b013e31828ffc23; Ferrada Paula, 2016, Bull Am Coll Surg, V101, P19; Rivas AM, 2019, CIR ESPAN, V97, P11, DOI 10.1016/j.ciresp.2018.07.001; Ovaere S, 2018, J SURG EDUC, V75, P1423, DOI 10.1016/j.jsurg.2018.04.004; Petrucci AM, 2017, CLIN COLON RECT SURG, V30, P244, DOI 10.1055/s-0037-1604252; Steele SR, 2015, SURGERY, V158, P857, DOI 10.1016/j.surg.2015.06.002; Wexner SD, 2017, COLORECTAL DIS, V19, P105, DOI 10.1111/codi.13572; Zerrweck C, 2020, SURG ENDOSC, V34, P1634, DOI 10.1007/s00464-019-06933-5	9	3	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JUN	2020	167	6					890	894		10.1016/j.surg.2020.03.008	http://dx.doi.org/10.1016/j.surg.2020.03.008			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	LS2GR	32359773	Green Published, Bronze			2022-09-04	WOS:000536208400002
J	Leszek, J; Barreto, GE; Gasiorowski, K; Koutsouraki, E; Avila-Rodrigues, M; Aliev, G				Leszek, Jerzy; Barreto, George E.; Gasiorowski, Kazimierz; Koutsouraki, Euphrosyni; Avila-Rodrigues, Marco; Aliev, Gjumrakch			Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Microglia; neurodegenerative disorders; neuroinflammation; oxidative stress; toll-like receptors	TOLL-LIKE RECEPTORS; ALZHEIMERS-DISEASE; AMYLOID-BETA; MICROGLIAL ACTIVATION; A-BETA; GENE-EXPRESSION; PIVOTAL ROLE; MITOCHONDRIAL; NEUROINFLAMMATION; NEURONS	Chronic inflammation is characterized by longstanding microglial activation followed by sustained release of inflammatory mediators, which aid in enhanced nitrosative and oxidative stress. The sustained release of inflammatory mediators propels the inflammatory cycle by increased microglial activation, promoting their proliferation and thus stimulating enhanced release of inflammatory factors. Elevated levels of several cytokines and chronic neuroinflammation have been associated with many neurodegenerative disorders of central nervous system like age-related macular degeneration, Alzheimer disease, multiple sclerosis, Parkinson's disease, Huntington' disease, and tauopathies. This review highlights the basic mechanisms of neuroinflammation, the characteristics of neurodegenerative diseases, and the main immunologic responses in CNS neurodegenerative disorders. A comprehensive outline for the crucial role of microglia in neuroinflammation and neurodegeneration and the role of Toll-like receptor signalling in coexistence of inflammatory mechanisms and oxidative stress as major factors responsible for progression of neurodegeneration have also been presented.	[Leszek, Jerzy] Wroclaw Med Univ, Dept Psychiat, Wroclaw, Poland; [Barreto, George E.; Avila-Rodrigues, Marco] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Gasiorowski, Kazimierz] Wroclaw Med Univ, Dept Basic Med Sci, Wroclaw, Poland; [Koutsouraki, Euphrosyni] Aristotle Univ Thessaloniki, Dept Neurol, Lab Neuroimmunol, GR-54006 Thessaloniki, Greece; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiologically Act Cpds, Chernogolovka 142432, Russia		Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.	aliev03@gmail.com	Aliev, Gjumrakch/AAE-7734-2020; Aliev, Gjumrakch/K-7302-2017; Barreto, George E./B-5747-2014; Barreto, George E./AAD-7420-2020	Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Koutsouraki, Euphrosyni/0000-0001-6057-3749; Leszek, Jerzy/0000-0002-2316-2470	GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA; Russian Science Foundation (RSCF) [14-23-00160]; Pontificia Universidad Javeriana; Universidad Autonoma de Chile	GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA; Russian Science Foundation (RSCF)(Russian Science Foundation (RSF)); Pontificia Universidad Javeriana; Universidad Autonoma de Chile	This study was supported by the GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA, and Russian Science Foundation (RSCF: No 14-23-00160). GEB work is supported by Pontificia Universidad Javeriana and Universidad Autonoma de Chile.	Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Ahmad A., 2013, MED PLANTS INT J PHY, V5; Ahmad A, 2012, PHYTOMEDICINE, V19, P639, DOI 10.1016/j.phymed.2012.02.012; Ahmad A, 2012, CAN J NEUROL SCI, V39, P311, DOI 10.1017/S0317167100013433; Aliev G, 2014, CURR MED CHEM, V21, P2208, DOI 10.2174/0929867321666131227161303; Aliev G, 2009, SYSTEMS BIOL FREE RA, P2023; Aliev G., 2011, SYSTEMS BIOL FREE RA, P2325; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; [Anonymous], 2009, J MOL NEUROSCI, V39, P1; Meraz-Rios MA, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/375968; Arroyo DS, 2011, INT IMMUNOPHARMACOL, V11, P1415, DOI 10.1016/j.intimp.2011.05.006; Ashraf GM, 2014, CNS NEUROL DISORD-DR, V13, P1280, DOI 10.2174/1871527313666140917095514; Babot M, 2014, BBA-BIOENERGETICS, V1837, P1083, DOI 10.1016/j.bbabio.2014.02.018; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benakis C, 2010, BRAIN BEHAV IMMUN, V24, P800, DOI 10.1016/j.bbi.2009.11.001; Beutner C, 2013, GLIA, V61, P1429, DOI 10.1002/glia.22524; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Booy E, 2013, CURRENT MED CHEM ANT, V4, P349; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Cabezas R, 2014, NEUROTOX RES; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Castellani RJ, 2006, ACTA NEUROPATHOL, V111, P503, DOI 10.1007/s00401-006-0071-y; Castellani Rudy J, 2006, Am J Alzheimers Dis Other Demen, V21, P126, DOI 10.1177/153331750602100213; Chao Y, 2014, BIOMED RES INT, V2014; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050771; Chio CC, 2014, CURR MED CHEM; Christensen LB, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-70; Crutcher KA, 2006, J NEUROIMMUNE PHARM, V1, P195, DOI 10.1007/s11481-006-9021-7; Dai XJ, 2014, CELL STRESS CHAPERON; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; DELBO R, 1995, NEUROSCI LETT, V188, P70, DOI 10.1016/0304-3940(95)11384-9; Drose S, 2014, BBA-PROTEINS PROTEOM, V1844, P1344, DOI 10.1016/j.bbapap.2014.02.006; Avila MF, 2014, J THEOR BIOL, V345, P43, DOI 10.1016/j.jtbi.2013.12.010; Forman MS, 2007, NEUROLOGY, V68, P757, DOI 10.1212/01.wnl.0000256373.39415.b1; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Harris Robert A, 2014, Front Immunol, V5, P612, DOI 10.3389/fimmu.2014.00612; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kurpius D, 2006, GLIA, V54, P58, DOI 10.1002/glia.20355; Bitzer-Quintero OK, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/348642; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lau Francis C, 2007, Subcell Biochem, V42, P299; Lee EJ, 2014, J IMMUNOL, V193, P2384, DOI 10.4049/jimmunol.1303240; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Letiembre M, 2007, NEUROSCIENCE, V146, P248, DOI 10.1016/j.neuroscience.2007.01.004; Liazoghli D, 2012, ACS CHEM NEUROSCI, V3, P90, DOI 10.1021/cn2000734; Liu P, 2014, STROKE; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Luque-Contreras D, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/497802; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; McGeer EG, 2007, CNS DRUGS, V21, P789, DOI 10.2165/00023210-200721100-00001; Miklossy J, 2006, EXP NEUROL, V197, P275, DOI 10.1016/j.expneurol.2005.10.034; Minoretti P, 2006, NEUROSCI LETT, V391, P147, DOI 10.1016/j.neulet.2005.08.047; Mirza Z, 2014, CNS NEUROL DISORD-DR, V13, P213, DOI 10.2174/18715273113126660144; Misonou H, 2000, BIOCHEMISTRY-US, V39, P6951, DOI 10.1021/bi000169p; Moreira PI, 2006, MECH AGEING DEV, V127, P501, DOI 10.1016/j.mad.2006.01.024; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Okamoto Takashi, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P359; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Peila R, 2006, ACTA NEUROL SCAND, V114, P102, DOI 10.1111/j.1600-0404.2006.00693.x; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Pratico D, 2002, BIOCHEM PHARMACOL, V63, P563, DOI 10.1016/S0006-2952(01)00919-4; Qian F, 2014, AGING-US, V6, P131, DOI 10.18632/aging.100642; Ramesh G, 2013, MEDIATORS INFLAMMATI, V2013; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Scheibye-Knudsen M, 2014, TRENDS CELL BIOL; Schmid CD, 2009, J NEUROCHEM, V109, P117, DOI 10.1111/j.1471-4159.2009.05984.x; Schwartz M, 2008, TRENDS IMMUNOL, V29, P211, DOI 10.1016/j.it.2008.01.003; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Smith MA, 2002, FREE RADICAL BIO MED, V33, P1194, DOI 10.1016/S0891-5849(02)01021-3; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tansey Malu G., 2008, P59; Trotta T, 2014, J NEUROIMMUNOL, V268, P1, DOI 10.1016/j.jneuroim.2014.01.014; Vontell R, 2013, DEV NEUROSCI-BASEL, V35, P130, DOI 10.1159/000346158; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wang Y, 2013, CNS NEUROSCI THER, V19, P358, DOI 10.1111/cns.12090; Xie A, 2014, BIOMED RES INT, V2014; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	102	107	112	2	50	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2016	15	3					329	336		10.2174/1871527315666160202125914	http://dx.doi.org/10.2174/1871527315666160202125914			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DI9DH	26831258				2022-09-04	WOS:000373801100008
J	Carvajal-Castro, JD; Ospina, AM; Toro-Lopez, Y; Pulido, A; Cabrera-Casas, LX; Guerrero-Pelaez, S; Garcia-Merchan, VH; Vargas-Salinas, F				Carvajal-Castro, Juan D.; Ospina-L, Ana Maria; Toro-Lopez, Yemay; Pulido-G, Anny; Cabrera-Casas, Laura Ximena; Guerrero-Pelaez, Sebastian; Garcia-Merchan, Victor Hugo; Vargas-Salinas, Fernando			Urbanization is associated to a loss of phylogenetic diversity of birds in a medium size city on the Andes of Colombia, South America	STUDIES ON NEOTROPICAL FAUNA AND ENVIRONMENT			English	Article; Early Access						Urbanization; phylogenetic diversity; bird; biodiversity	NULL MODEL ANALYSIS; FUNCTIONAL DIVERSITY; SPECIES RICHNESS; URBAN AREAS; COMMUNITIES; CONSERVATION; SIMILARITY; ABUNDANCE; AVIFAUNA; ECOLOGY	Accelerated rates of urbanization negatively impact natural habitats and biodiversity. Studies of the effects of urbanization on fauna have emphasized taxonomic diversity, but this does not necessarily reflect effects on the evolutionary history of assemblages. Here, we study how urbanization influences phylogenetic diversity (PD) of bird assemblages in a small-medium city in the Central Andes of Colombia. Between 2016 and 2017, we performed bird surveys in 76 urban cells and 23 rural cells around the city. Then, we measured habitat characteristics (e.g. anthropogenic noise level, impervious and forested area) in sampled cells. PD of birds was between 1.37-1.42 MY higher in the rural than in the urban habitat. Within the urban habitat, the PD of birds reduces as impervious area and noise levels increase, while in the urban cells with most forested areas reach the highest PD values. Most of these differences and relationships disappear when we performed similar analysis controlling for differences in species richness. A low turnover of PD between assemblages of birds recorded inside Armenia and its less urbanized surroundings suggest green areas in the study area could mitigate the effects of urbanization in native fauna, and ameliorate connectivity between urban cells.	[Carvajal-Castro, Juan D.] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA; [Carvajal-Castro, Juan D.; Ospina-L, Ana Maria; Garcia-Merchan, Victor Hugo; Vargas-Salinas, Fernando] Univ Quindio, Grp Invest Evoluc Ecol & Conservac EECO, Armenia, Colombia; [Ospina-L, Ana Maria] Purdue Univ, Dept Biol Sci, Behav & Sensory Ecol Lab, W Lafayette, IN 47907 USA; [Toro-Lopez, Yemay] Lab Aves Urbanas, Armenia, Colombia; [Pulido-G, Anny] Univ CES, Area Proyectos, Medellin, Colombia; [Cabrera-Casas, Laura Ximena] Univ Nacl Sede Maniz, Maestria Ensenanza Ias Ciencias Exactas, Manizales, Colombia; [Guerrero-Pelaez, Sebastian] Pontificia Univ Javeriana, Maestria Conservac & Uso Biodiversidad, Bogota, DC, Colombia		Carvajal-Castro, JD (corresponding author), St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA.; Carvajal-Castro, JD (corresponding author), Univ Quindio, Grp Invest Evoluc Ecol & Conservac EECO, Armenia, Colombia.	carvajaljcastro@gmail.com		Ospina Larrea, Ana Maria/0000-0003-1398-7521; Guerrero Pelaez, Sebastian/0000-0003-3008-0139				Medina PA, 2010, BITACORA URBANO TERR, V17, P73; [Anonymous], 2017, AVIAN ECOLOGY LATIN; Aronson MFJ, 2016, ECOLOGY, V97, P2952, DOI 10.1002/ecy.1535; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; BEISSINGER SR, 1982, CONDOR, V84, P75, DOI 10.2307/1367825; Bhakti T, 2020, FLORESTA AMBIENTE, V27, DOI 10.1590/2179-8087.011119; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Ceplova N, 2015, PRESLIA, V87, P1; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chao AN, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1343; Chao A, 2016, TOP BIODIV CON, V14, P141, DOI 10.1007/978-3-319-22461-9_8; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chiu CH, 2014, ECOL MONOGR, V84, P21, DOI 10.1890/12-0960.1; Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035; Croci S, 2008, CONDOR, V110, P223, DOI 10.1525/cond.2008.8409; CRQ-SIG, 2016, COL GOB QUIN; Cadena CD, 2012, P ROY SOC B-BIOL SCI, V279, P194, DOI 10.1098/rspb.2011.0720; Darwin CR, 1859, ORIGIN SPECIES MEANS; Carvajal-Castro JD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218775; del Hoyo J., 2019, HDB BIRDS WORLD ALIV; Delgado CA, 2012, LANDSCAPE URBAN PLAN, V105, P5, DOI 10.1016/j.landurbplan.2011.12.019; Ibanez-Alamo JD, 2017, GLOBAL CHANGE BIOL, V23, P2990, DOI 10.1111/gcb.13567; Edwards DP, 2015, CURR BIOL, V25, P2384, DOI 10.1016/j.cub.2015.07.063; Escobar-Ibanez Juan F., 2017, P11; Quintero-Gallego ME, 2018, SCI TOTAL ENVIRON, V634, P1288, DOI 10.1016/j.scitotenv.2018.03.359; Faggi Ana, 2017, P79; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fontana CS, 2011, URBAN ECOSYST, V14, P341, DOI 10.1007/s11252-011-0156-9; Forman RTT, 2014, URBAN ECOLOGY: SCIENCE OF CITIES, P1; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Freitas JR, 2018, BRAZ J BIOL, V78, P517, DOI 10.1590/1519-6984.09416; Frishkoff LO, 2014, SCIENCE, V345, P1343, DOI 10.1126/science.1254610; Garden J, 2006, AUSTRAL ECOL, V31, P126, DOI 10.1111/j.1442-9993.2006.01578.x; Gill Frank B., 1995, ORNITHOLOGY; Gomez-Baggethun Erik, 2013, P175; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.2307/177478; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; Grandcolas P., 2016, BIODIVERS CONSERV, V1st Edn, DOI [10.1007/978-3-319-22461-9, DOI 10.1007/978-3-319-22461-9]; Gregory RD, 2004, TECH ECOL CONSERVAT, P17; Halfwerk W, 2018, SPRINGER HANDB AUDIT, V66, P209, DOI 10.1007/978-1-4939-8574-6_8; Harris L. D., 1984, FRAGMENTED FOREST IS; Hilty SL, 1986, GUIDE BIRDS COLOMBIA; Hsieh TC, 2017, SYST BIOL, V66, P100, DOI 10.1093/sysbio/syw073; Hutter CR, 2017, AM NAT, V190, P828, DOI 10.1086/694319; IBM Corp N, 2013, IBM SPSS STAT WINDOW; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Molina-Rico LJ, 2019, REV COLOMB CIENC SOC, V10, P93, DOI 10.21501/22161201.3061; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jokimaki J, 2003, J BIOGEOGR, V30, P1183, DOI 10.1046/j.1365-2699.2003.00896.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kattan GH, 2004, J BIOGEOGR, V31, P1829, DOI 10.1111/j.1365-2699.2004.01109.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kight CR, 2011, ECOL LETT, V14, P1052, DOI 10.1111/j.1461-0248.2011.01664.x; Kluge J, 2011, J BIOGEOGR, V38, P394, DOI 10.1111/j.1365-2699.2010.02433.x; Krasnov BR, 2005, J BIOGEOGR, V32, P633, DOI 10.1111/j.1365-2699.2004.01206.x; La Sorte FA, 2018, DIVERS DISTRIB, V24, P928, DOI 10.1111/ddi.12738; La Sorte FA, 2014, GLOBAL ECOL BIOGEOGR, V23, P1225, DOI 10.1111/geb.12199; LANCASTER RK, 1979, CAN J ZOOL, V57, P2358, DOI 10.1139/z79-307; Lankau R, 2011, EVOL APPL, V4, P315, DOI 10.1111/j.1752-4571.2010.00171.x; Lean C, 2016, TOP BIODIV CON, V14, P19, DOI 10.1007/978-3-319-22461-9_2; Lees AC, 2017, URBAN ECOSYST, V20, P1019, DOI 10.1007/s11252-017-0661-6; Lepczyk C. A., 2017, ECOLOGY CONSERVATION, DOI DOI 10.1007/978-3-319-43314-1_2; Leveau Lucas M., 2017, P57; Li D., 2018, J OPEN SOURCE SOFTWA, V3, P1041, DOI DOI 10.21105/JOSS.01041; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Luck GW, 2011, J BIOGEOGR, V38, P894, DOI 10.1111/j.1365-2699.2010.02449.x; Luck Gary W., 2010, P88; MAC ARTHUR ROBERT H., 1967; MacGregor-Fors I, 2016, FORESTS, V7, DOI 10.3390/f7070146; Magura T, 2010, GLOBAL ECOL BIOGEOGR, V19, P16, DOI 10.1111/j.1466-8238.2009.00499.x; Marin-Gomez O.H., 2005, B SAO, V15, P42; Marin-Gomez OH, 2020, LANDSCAPE URBAN PLAN, V194, DOI 10.1016/j.landurbplan.2019.103665; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McMullan M, 2011, GUIA CAMPO AVES COLO; Moiron M, 2015, BEHAV ECOL, V26, P843, DOI 10.1093/beheco/arv026; Morelli F, 2016, GLOBAL ECOL BIOGEOGR, V25, P1284, DOI 10.1111/geb.12486; Munoz Marcia C., 2007, Ornitologia Colombiana, V5, P5; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Orlando L, 2020, ECOL INDIC, V111, DOI 10.1016/j.ecolind.2019.106036; Ortega-Alvarez R, 2011, AUK, V128, P415, DOI 10.1525/auk.2011.10082; Palacio FX, 2018, CAN J ZOOL, V96, P1114, DOI 10.1139/cjz-2018-0008; Palacio RD., 2018, BIOTA COLOMB, V18, P228; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Partecke J, 2006, ECOLOGY, V87, P1945, DOI 10.1890/0012-9658(2006)87[1945:SATCUA]2.0.CO;2; Pauchard Anibal, 2013, P589; Peterson MN, 2014, URBAN WILDLIFE CONSE; Proppe DS, 2013, GLOBAL CHANGE BIOL, V19, P1075, DOI 10.1111/gcb.12098; Quinones FA., 2009, REV NOVEDADES COLOMB, V9, P1; R Core Team, 2021, R LANG ENV STAT COMP; Rabosky DL, 2015, EVOLUTION, V69, P3207, DOI 10.1111/evo.12817; RESNATUR, 2004, MAN MON AV MIGR; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rosselli L, 2017, ACTA BIOL COLOMB, V22, P181, DOI 10.15446/abc.v22n2.60688; Sanchez-Gonzalez K, 2021, ETHOL ECOL EVOL, V33, P377, DOI 10.1080/03949370.2020.1837963; Santiago-Alarcon Diego, 2017, P125; Scherton R., 2018, PHYLOGENETIC DIVERSI; Seddon PJ., 2017, ECOLOGY CONSERVATION, P185, DOI DOI 10.1007/978-3-319-43314-1_10; Sekercioglu C.H., 2016, WHY BIRDS MATTER AVI; Shanahan DF, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P3; Silva V, 2018, URBAN ECOSYST, V21, P625, DOI 10.1007/s11252-018-0745-y; Sims V, 2008, DIVERS DISTRIB, V14, P387, DOI 10.1111/j.1472-4642.2007.00444.x; Sol D, 2017, ECOLOGY CONSERVATION, P75, DOI [DOI 10.1007/978-3-319-43314-1_5, 10.1007/978-3-319-43314-1%5F5]; Sol D, 2017, ECOL LETT, V20, P721, DOI 10.1111/ele.12769; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; Swenson NG, 2014, USE R, P1, DOI 10.1007/978-1-4614-9542-0; Threlfall CG, 2017, J APPL ECOL, V54, P1874, DOI 10.1111/1365-2664.12876; Tucker CM, 2018, ECOLOGY, V99, P1473, DOI 10.1002/ecy.2349; van Heezik Y, 2012, NEW ZEAL J ECOL, V36, P391; Vanegas-Guerrero Jhonattan, 2016, Herpetological Review, V47, P180; Vanschoenwinkel B, 2007, OIKOS, V116, P1255, DOI 10.1111/j.2007.0030-1299.15860.x; Vellend Mark, 2011, P194; Veron S, 2019, Q REV BIOL, V94, P123, DOI 10.1086/703580; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Wittig TW, 2017, AVIAN CONSERV ECOL, V12, DOI [10.5751/ACE-01014-120117, 10.5751/ace-01014-120117]; Zuckerberg B, 2016, DIVERS DISTRIB, V22, P717, DOI 10.1111/ddi.12428; Zuniga-Palacios J, 2020, URBAN FOR URBAN GREE, V47, DOI 10.1016/j.ufug.2019.126551	120	0	0	3	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0165-0521	1744-5140		STUD NEOTROP FAUNA E	Stud. Neotrop. Fauna Environ.												10.1080/01650521.2021.1974709	http://dx.doi.org/10.1080/01650521.2021.1974709		OCT 2021	13	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	WQ0OV					2022-09-04	WOS:000713523300001
J	Barrero, LH; Cifuentes, M; Rodriguez, AC; Rey-Becerra, E; Johnson, PW; Marin, LS; Piedrahita, H; Dennerlein, JT				Barrero, Lope H.; Cifuentes, Manuel; Rodriguez, Andres C.; Rey-Becerra, Estefany; Johnson, Peter W.; Marin, Luz S.; Piedrahita, Hugo; Dennerlein, Jack T.			Whole-body vibration and back pain-related work absence among heavy equipment vehicle mining operators	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article						dorsalgia; back pain; epidemiology; vibration metrics; cox-regression	HAUL TRUCK DRIVERS; EXPOSURE; RISK; DETERMINANTS; DISABILITY	Objective To determine the association between several whole-body vibration (WBV) exposure estimates and back pain-related work absence. Methods Exposures (based on the weighted daily root mean square acceleration, A(8); the daily vibration dose value, VDV(8); and the daily equivalent static compression dose, S-ed(8)) of 2302 workers during 4 years were estimated using each worker's monthly vehicle operation records and WBV measurements from 11 different types of heavy equipment vehicles in a large coal mine. Company payroll data provided work absence during the concurrent 4 years of exposure. Cox regression models estimated the associations between the different WBV metrics and time to first work absence related to back pain. An adjusted R-2 statistic provided a measure of model fit. Results All estimated metrics of WBV exposures were positively and significantly associated with back pain-related absence. HRs varied from 2.03 to 12.39 for every 0.21 m/s(2) increase in the A(8)-based exposures; from 1.03 to 1.18 for every 1.72 m/s(1.75) increase in VDV(8)-based exposures; and from 1.04 to 1.07 for every 0.06 MPa increase in S-ed(8)-based exposures. Models using the estimated VDV(8) metric for the z axis fit the data best as measured by the R-2 statistic. Conclusion Higher WBV exposures were associated with back pain-related absences in this population, which appears after a few years of follow-up. Introducing controls to lower exposure levels may help reduce back pain-related work absences.	[Barrero, Lope H.; Rodriguez, Andres C.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia; [Cifuentes, Manuel] Regis Coll, Sch Hlth Sci, Program Publ Hlth, Weston, MA USA; [Rey-Becerra, Estefany] Pontificia Univ Javeriana, Dept Civil & Ind Engn, Cali, Colombia; [Johnson, Peter W.] Univ Washington, Dept Ind Engn, Seattle, WA 98195 USA; [Marin, Luz S.] Indiana Univ Penn, Dept Safety Sci, Indiana, PA USA; [Piedrahita, Hugo] Hlth & Welf Dept, Cerrejon, La Guajira, Colombia; [Dennerlein, Jack T.] Northeastern Univ, Bouve Coll Hlth Sci, Dept Phys Therapy Movement & Rehabil Sci, Boston, MA 02115 USA		Barrero, LH (corresponding author), Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia.	lopehugo@javeriana.edu.co	; Johnson, Peter/C-3046-2011	Dennerlein, Jack/0000-0001-7703-643X; Barrero, Lope/0000-0003-1503-0264; Johnson, Peter/0000-0001-5583-5919; Marin, Luz S./0000-0002-1383-8166	ALPHA Foundation [120113E01011O5]	ALPHA Foundation	The ALPHA Foundation funded this study with grant number 120113E01011O5.	Allison P. D., 2010, SURVIVAL ANAL USING, V2; [Anonymous], 1997, 26311 ISO; Armstrong TJ, 2018, SCAND J WORK ENV HEA, V44, P323, DOI 10.5271/sjweh.3718; Bernard BP, 1997, PUBLICATION US DEP H, P97; Blood RP, 2010, ERGONOMICS, V53, P1385, DOI 10.1080/00140139.2010.519053; Bovenzi M, 2010, IND HEALTH, V48, P584, DOI 10.2486/indhealth.MSWBVI-02; Bovenzi M, 2009, INT ARCH OCC ENV HEA, V82, P893, DOI 10.1007/s00420-008-0376-3; Burstrom L, 2015, INT ARCH OCC ENV HEA, V88, P403, DOI 10.1007/s00420-014-0971-4; Chaudhary DK, 2015, PROCED EARTH PLAN SC, V11, P524, DOI 10.1016/j.proeps.2015.06.054; Crook J, 2002, J OCCUP REHABIL, V12, P277, DOI 10.1023/A:1020278708861; Eger T., 2006, Occupational Ergonomics, V6, P121; Hansson T, 2004, SCAND J PUBLIC HEALT, V32, P109, DOI 10.1080/14034950410021862; Howard B, 2009, WORK, V34, P297, DOI 10.3233/WOR-2009-0927; International Organization for Standardization, 2004, MECH VIBRATION SHOCK; Keeney BJ, 2013, SPINE, V38, P178, DOI 10.1097/BRS.0b013e318266187d; Kuijer W, 2006, J OCCUP REHABIL, V16, P439, DOI 10.1007/s10926-006-9021-8; Lings S, 2000, INT ARCH OCC ENV HEA, V73, P290, DOI 10.1007/s004200000118; Marin LS, 2017, ANN WORK EXPOS HEAL, V61, P669, DOI 10.1093/annweh/wxx043; Mayton AG, 2014, INT J HEAVY VEH SYST, V21, P241, DOI 10.1504/IJHVS.2014.066080; Palmer KT, 2015, BEST PRACT RES CL RH, V29, P424, DOI 10.1016/j.berh.2015.05.001; Stanton TR, 2008, SPINE, V33, P2923, DOI 10.1097/BRS.0b013e31818a3167; Sterud T, 2013, SCAND J WORK ENV HEA, V39, P468, DOI 10.5271/sjweh.3359; Waters T, 2008, ERGONOMICS, V51, P602, DOI 10.1080/00140130701779197; Werner EL, 2009, EUR J GEN PRACT, V15, P74, DOI 10.1080/13814780903051866; Wolfgang R, 2014, APPL ERGON, V45, P1700, DOI 10.1016/j.apergo.2014.05.020	25	8	8	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	AUG	2019	76	8					554	559		10.1136/oemed-2019-105914	http://dx.doi.org/10.1136/oemed-2019-105914			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	IS9BX	31300561				2022-09-04	WOS:000482444500007
J	Herrera, AS; Esparza, MDA; Arias, PES; Avila-Rodriguez, M; Barreto, GE; Li, Y; Bachurin, SO; Aliev, G				Solis Herrera, Arturo; Arias Esparza, Maria del Carmen; Sols Arias, Paola Eugenia; Avila-Rodriguez, Marco; Emilio Barreto, George; Li, Yi; Bachurin, Sergey Olegovich; Aliev, Gjumrakch			Unsuspected Intrinsic Property of Melanin to Dissociate Water Can Be Used for the Treatment of CNS Diseases	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Retina; oncotic pressure; photoreceptors; pharmacological effects; melanin; QIAPI-1-(Medical enhancer of human photosynthesis or Chemical energy modulator)	IN-VIVO; CULTURE	Retinal adhesion mechanisms in mammals are quite complex and multifactorial in nature. To date, these mechanisms are incompletely understood due to a variety of chemical, physical, and physiological forces impinging upon retinal tissue: retinal pigment epithelium, nearby tissues as sclera and vitreous, the subretinal space, and the highly complex interphotoreceptor matrix that fills subretinal space. The adhesion of the retina to the choroid, rather than anatomical, is a dynamic process, as the retina detaches a few minutes after life ceases. The adhesion mechanisms described in the literature, such as intraocular pressure and the oncotic pressure of the choroid that seems to push the retina towards the choroid, the delicate anatomical relationships between the rod and cone photoreceptors, the retinal pigment epithelium, the existence of a complex material called interphotoreceptor matrix, as well as other metabolic and structural factors, still cannot explain the remarkable features observed in the adhesion mechanisms between the photoreceptor layer and retinal pigment epithelium cells. The unexpected intrinsic property of melanin to absorb light energy and transform it into chemically based free energy can explain normal adhesion of the sensory retina to the pigment epithelium. In this article, we explore and highlight this explanation, which states that it is definitely able to provide a new treatment avenue against devastating neurodegenerative properties.	[Solis Herrera, Arturo; Arias Esparza, Maria del Carmen; Sols Arias, Paola Eugenia] Human Photosynth Study Ctr, R&D&I Dept, Lopez Velarde 108, Aguascalientes 20000, Aguascalientes, Mexico; [Avila-Rodriguez, Marco; Emilio Barreto, George] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Emilio Barreto, George] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Li, Yi] Texas A&M Univ, Dept Human Sci, Kingsville, TX 78363 USA; [Bachurin, Sergey Olegovich; Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Severniy Proezd 1, Chernogolovka 142432, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA		Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.	aliev03@gmail.com	Barreto, George E./B-5747-2014; Barreto, George E./AAD-7420-2020; Aliev, Gjumrakch/AAE-7734-2020; Sergey, Bachurin/I-1708-2018; Aliev, Gjumrakch/K-7302-2017	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Avila-Rodriguez, Marco/0000-0003-4612-3236; Li, Yi/0000-0002-5048-6075	Human Photosynthesis Study Center, Aguascalientes, Mexico; GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA; Russian Science Foundation (Rossiysky Nauchny Fond) [14-23-00160]; Pontificia Universidad Javeriana	Human Photosynthesis Study Center, Aguascalientes, Mexico; GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA; Russian Science Foundation (Rossiysky Nauchny Fond)(Russian Science Foundation (RSF)); Pontificia Universidad Javeriana	This work was partially supported by Human Photosynthesis Study Center, Aguascalientes, Mexico, GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA, and by the Russian Science Foundation (www.rscf.ru, Rossiysky Nauchny Fond), grant number 14-23-00160 for 2014-2016 years, title "Directed design, synthesis, and study of biological activity of multi-target compounds as innovative drugs for treatment of neurodegenerative diseases. George E. Barreto's work is supported by the Pontificia Universidad Javeriana.	Aliev G, 2013, OPEN J PSYCHIAT, V3, P408, DOI [10.4236/ojpsych.2013.34045, DOI 10.4236/OJPSYCH.2013.34045]; Boulton ME, 2014, EXP EYE RES, V126, P61, DOI 10.1016/j.exer.2014.01.016; Burian HM, 1974, BINOCULAR VISION OCU; FOOS RY, 1972, INVEST OPHTH VISUAL, V11, P801; FRANCOIS J, 1970, AM J OPHTHALMOL, V69, P763, DOI 10.1016/0002-9394(70)93418-5; Herrera Arturo S., 2015, Central Nervous System Agents in Medicinal Chemistry, V15, P32; Hu DN, 2008, PHOTOCHEM PHOTOBIOL, V84, P639, DOI 10.1111/j.1751-1097.2008.00316.x; Hu DN, 2008, OPHTHALMOLOGY, V115, P757, DOI 10.1016/j.ophtha.2007.11.011; Hu DN, 2002, INT J TOXICOL, V21, P465, DOI 10.1080/10915810290169891; KITA M, 1992, INVEST OPHTH VIS SCI, V33, P1883; Liu Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P135, DOI 10.1562/2004-08-03-RA-259.1; Peters S, 2006, Z NATURFORSCH C, V61, P427; Piccirelli M, 2012, NMR BIOMED, V25, P59, DOI 10.1002/nbm.1713; SCHRAERMEYER U, 1993, PIGM CELL RES, V6, P193, DOI 10.1111/j.1600-0749.1993.tb00602.x; SEBAG J, 1992, EYE, V6, P541, DOI 10.1038/eye.1992.119; Solis-Herrera Arturo, 2015, Central Nervous System Agents in Medicinal Chemistry, V15, P99; TSUBOI S, 1987, INVEST OPHTH VIS SCI, V28, P1776; Zareba M, 2006, FREE RADICAL BIO MED, V40, P87, DOI 10.1016/j.freeradbiomed.2005.08.015; ZAUBERMAN H, 1969, EXP EYE RES, V8, P276, DOI 10.1016/S0014-4835(69)80039-4; ZAUBERMAN H, 1972, ARCH OPHTHALMOL-CHIC, V87, P549	20	2	3	0	6	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2016	15	2					135	140		10.2174/1871527315666160202122943	http://dx.doi.org/10.2174/1871527315666160202122943			6	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DG5HI	26831264				2022-09-04	WOS:000372107500003
J	Delgado-Serrano, MD; Oteros-Rozas, E; Vanwildemeersch, P; Ortiz-Guerrero, C; London, S; Escalante, R				del Mar Delgado-Serrano, Maria; Oteros-Rozas, Elisa; Vanwildemeersch, Pieter; Ortiz-Guerrero, Cesar; London, Silvia; Escalante, Roberto			Local perceptions on social-ecological dynamics in Latin America in three community-based natural resource management systems	ECOLOGY AND SOCIETY			English	Article						Argentina; Colombia; common-pool resources; environmental challenges; governance; Mexico; network analysis; Ostrom; prospective structural analysis; social-ecological resilience	ADAPTIVE CAPACITY; NETWORK ANALYSIS; LANDSCAPE CONNECTIVITY; MULTILEVEL GOVERNANCE; FRAMEWORK; RESILIENCE; SUSTAINABILITY; SCALE; COMANAGEMENT; INSTITUTIONS	Several examples of community-based natural resource management in Latin American social-ecological systems exist in which communities control the management of common-pool resources. Understanding community perceptions of the performance of these systems is essential to involve communities in sustainable management strategies. In this analysis of three areas in Colombia, Mexico, and Argentina, we analyzed the local perceptions of the social and environmental challenges faced by these social-ecological systems and how these challenges and drivers affect their resilience. To do this, we combined prospective structural analysis to unravel stakeholders' perceptions of each system's functioning along with network analysis to assess resilience. We identified external variables as the most influential variables in the Colombian and Argentine cases. In the Mexican case, larger influence is exerted by internal variables, particularly those linked to the governance system. The case study analysis revealed that the community-based natural resource management approach needs external support and recognition to work effectively. In the Argentine and Colombian cases, megaprojects were perceived as controllers with medium or strong influence but low dependence. The use of ancestral knowledge (Colombia), the history of land use (Mexico), and the history of the artisanal fishery (Argentina) were all perceived as common challenges to community-based natural resource management. In terms of social-ecological resilience, framed within the three-dimensional model of the adaptive cycle, all three social-ecological systems were considered to be highly connected and resilient but with different degrees of capacity or cumulative potential.	[del Mar Delgado-Serrano, Maria; Oteros-Rozas, Elisa; Vanwildemeersch, Pieter] Univ Cordoba, Dept Agr Econ Sociol & Policy, E-14071 Cordoba, Spain; [Oteros-Rozas, Elisa] Univ Pablo de Olavide, Social & Participatory Act Res Grp, Seville, Spain; [Oteros-Rozas, Elisa] Univ Copenhagen, Dept Geosci & Nat Resource Management, DK-1168 Copenhagen, Denmark; [Ortiz-Guerrero, Cesar] Pontificia Univ Javeriana, Dept Rural & Reg Dev, Bogota, Colombia; [London, Silvia] Univ Nacl Sur, CONICET, Inst Invest Econ & Sociales Sur, Dept Econ, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Escalante, Roberto] Univ Nacl Autonoma Mexico, Fac Econ, Mexico City 04510, DF, Mexico		Delgado-Serrano, MD (corresponding author), Univ Cordoba, Dept Agr Econ Sociol & Policy, E-14071 Cordoba, Spain.		del mar delgado-serrano, maria/B-7581-2011; Oteros-Rozas, Elisa/L-8633-2014	del mar delgado-serrano, maria/0000-0003-0171-6097; Oteros-Rozas, Elisa/0000-0003-4313-3041; London, Silvia/0000-0002-4597-0233	Seventh Framework Programme of the European Commission in the frame of the project "Community-based management of environmental challenges in Latin America" [FP7-ENV2011-282845 COMET-LA]	Seventh Framework Programme of the European Commission in the frame of the project "Community-based management of environmental challenges in Latin America"	The first two authors (MD and EO) contributed equally to this work. This research was funded by the Seventh Framework Programme of the European Commission in the frame of the project "Community-based management of environmental challenges in Latin America" (FP7-ENV2011-282845 COMET-LA). We acknowledge the collaboration of the people in the Community Council of Black Communities of Bajo Calima (Colombia), Santiago Comaltepec (Mexico), and Bahia Blanca Estuary and adjacent coasts (Argentina) in the research. We also thank Irene Iniesta-Arandia for assistance with network analysis and insightful comments. Finally, we are grateful to two anonymous reviewers for their insightful comments.	Abrahamson E, 1997, ORGAN SCI, V8, P289, DOI 10.1287/orsc.8.3.289; Velez MA, 2013, ECOL SOC, V18, DOI 10.5751/ES-05721-180310; Allison HE, 2004, ECOL SOC, V9; Anderies JM, 2004, ECOL SOC, V9; [Anonymous], 2010, INT J COMMONS, DOI DOI 10.18352/IJC.224; Arbelaez-Cortes E, 2013, BIODIVERS CONSERV, V22, P2875, DOI 10.1007/s10531-013-0560-y; Armitage D, 2005, ENVIRON MANAGE, V35, P703, DOI 10.1007/s00267-004-0076-z; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Becker E., 2012, HUMAN NATURE INTERAC, P37, DOI DOI 10.4324/9780203123195; Benassouli P., 2005, PLANIFICATION SCENAR; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Berkes F., 1998, LINKING SOCIAL ECOLO; Berkes F, 2007, NAT HAZARDS, V41, P283, DOI 10.1007/s11069-006-9036-7; Bettencourt LMA, 2011, P NATL ACAD SCI USA, V108, P19540, DOI 10.1073/pnas.1102712108; Binder CR, 2013, ECOL SOC, V18, DOI 10.5751/ES-05551-180426; Blaikie P, 2006, WORLD DEV, V34, P1942, DOI 10.1016/j.worlddev.2005.11.023; Bodin O, 2012, GLOBAL ENVIRON CHANG, V22, P430, DOI 10.1016/j.gloenvcha.2012.01.005; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; Borgatti S.P., 2002, HARV MA ANAL TECHNOL; Borgatti S. P., 2002, NETDRAW GRAPH VISUAL; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Borrini-Feyerabend G., 1996, COLLABORATIVE MANAGE; Bunn AG, 2000, J ENVIRON MANAGE, V59, P265, DOI 10.1006/jema.2000.0373; Carmona-Torres C, 2011, LANDSCAPE URBAN PLAN, V103, P24, DOI 10.1016/j.landurbplan.2011.05.009; Carpenter SR, 2001, BIOSCIENCE, V51, P451, DOI 10.1641/0006-3568(2001)051[0451:CWCEAS]2.0.CO;2; Carpenter SR, 2008, ECOL SOC, V13; Chan KMA, 2012, BIOSCIENCE, V62, P744, DOI 10.1525/bio.2012.62.8.7; Chapela F., 2007, BOSQUES COMUNITARIOS, P123; Chapuy P, 2010, TECHNOL FORECAST SOC, V77, P1540, DOI 10.1016/j.techfore.2010.06.025; Cicalese G., 1997, COMUNICACIONES, V4, P4; Cox M, 2014, HUM ECOL, V42, P311, DOI 10.1007/s10745-014-9651-y; Crona BI, 2006, ECOL SOC, V11; Crutzen PJ, 2000, GLOBAL CHANGE NEWSLE, V41, P12; Cumming GS, 2013, LANDSCAPE ECOL, V28, P1139, DOI 10.1007/s10980-012-9725-4; Cumming GS, 2010, DIVERS DISTRIB, V16, P414, DOI 10.1111/j.1472-4642.2010.00651.x; Dadon J., 2011, SOSTENIBILIDAD ZONA; Delgado-Serrano MD, 2015, INT J COMMONS, V9, P808, DOI 10.18352/ijc.567; Delgado-Serrano M. M., 2014, D1 2 LOCALLY ADAPTED; Delgado-Serrano M. M., 2013, D1 1 LOCALLY ADAPTED; Departamento del Valle del Cauca, 2013, INF ESP POB MUN BUEN; Diaz S, 2011, P NATL ACAD SCI USA, V108, P895, DOI 10.1073/pnas.1017993108; Dressler W, 2010, ENVIRON CONSERV, V37, P5, DOI 10.1017/S0376892910000044; Du Plessis C., 2008, EXPLORING SUSTAINABI, P59; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; European Commission, 2014, EUR FOR PLATF; Farah M. A., 2012, STAKEHOLDER VISION S; Ferse SCA, 2010, ENVIRON CONSERV, V37, P23, DOI 10.1017/S0376892910000172; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Garcia-Lopez GA, 2013, INT J COMMONS, V7, P406; Gavigan J. P., 2001, 59 IPTS; Gertler MS, 2004, FUTURES, V36, P45, DOI 10.1016/S0016-3287(03)00139-3; Gobel B., 2014, EXTRACTIVISMO MINERO; GODET M, 1986, FUTURES, V18, P134, DOI 10.1016/0016-3287(86)90094-7; Godet M, 1994, ANTICIPATION ACTION, P83; Godet M, 2004, SCENARIOS STRATEGIES; Gonzales R, 2012, GEOGR COMPASS, V6, P76, DOI 10.1111/j.1749-8198.2011.00470.x; Gunderson L. H., 2002, Panarchy: understanding transformations in human and natural systems; Gunderson LH, 2002, SCOPE SER, V60, P249; Hicks CC, 2013, GLOBAL ENVIRON CHANG, V23, P1444, DOI 10.1016/j.gloenvcha.2013.07.028; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling C. S., 2002, PANARCHY UNDERSTANDI, P3, DOI DOI 10.1016/J.ECOLECON.2004.01.010; Holling C. S., 2002, PANARCHY UNDERSTANDI, P63; IDEAM, 2010, SEGUNDA COMUNICACION; INEC, 2010, CENS POBL VIV 2010; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Janssen MA, 2007, INT J COMMONS, V1, P43, DOI DOI 10.18352/IJC.12; Janssen MA, 2006, ECOL SOC, V11; Kates RW, 2001, SCIENCE, V292, P641, DOI 10.1126/science.1059386; Kelly R., 2004, Foresight, V6, P80, DOI 10.1108/14636680410537547; Lafourcade B, 2000, TECHNOL FORECAST SOC, V65, P67, DOI 10.1016/S0040-1625(99)00128-6; Leach M, 1999, WORLD DEV, V27, P225, DOI 10.1016/S0305-750X(98)00141-7; Lechner C, 2010, ACAD MANAGE J, V53, P865, DOI 10.5465/AMJ.2010.52814620; Leslie HM, 2015, P NATL ACAD SCI USA, V112, P5979, DOI 10.1073/pnas.1414640112; Marin A, 2012, CUHSO-CULT-HOMBRE-SO, V22, P131, DOI 10.7770/CUHSO-V22N1-ART366; McCulloh I. A., 2008, SOCIAL NETWORK CHANG; Meadowcroft J, 2002, LANDSCAPE URBAN PLAN, V61, P169, DOI 10.1016/S0169-2046(02)00111-1; Ortiz-Guerrero C., 2014, REV REDESMA, V14, P2; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pomeroy RS, 1995, OCEAN COAST MANAGE, V27, P143, DOI 10.1016/0964-5691(95)00042-9; Pomeroy RS, 2001, MAR POLICY, V25, P197, DOI 10.1016/S0308-597X(01)00010-0; Pretty J, 2001, WORLD DEV, V29, P209, DOI 10.1016/S0305-750X(00)00098-X; Redman CL, 2003, CONSERV ECOL, V7; Shackleton CM, 2010, ENVIRON CONSERV, V37, P1, DOI 10.1017/S0376892910000366; SIAR SV, 1992, FISH RES, V14, P295, DOI 10.1016/0165-7836(92)90038-U; Sistema de Las Naciones Unidas en Colombia y Ministerio de Ambiente y Desarrollo Sostenible (SNUCMADS), 2014, CONS AMB CONSTR PAZ; Smith M., 2010, NODEXL NETWORK OVERV; Steffen W., 2004, GLOBAL CHANGE EARTH; Sterman JD, 2001, CALIF MANAGE REV, V43, P8, DOI 10.2307/41166098; Stratigea A., 2013, J MANAGEMENT STRATEG, V4, P1, DOI DOI 10.5430/JMS.V4N2P1; Tang Zhenghong, 2011, Journal of Environmental Assessment Policy and Management, V13, P405, DOI 10.1142/S1464333211003948; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Vezzetti Hugo, 2002, PASADO PRESENTE GUER; Walker B, 2002, CONSERV ECOL, V6; WESTERN D, 1994, NATURAL CONNECTIONS, P1; Wolf J, 2011, WIRES CLIM CHANGE, V2, P547, DOI 10.1002/wcc.120; Zetterberg A, 2010, LANDSCAPE URBAN PLAN, V95, P181, DOI 10.1016/j.landurbplan.2010.01.002	98	23	23	5	52	RESILIENCE ALLIANCE	WOLFVILLE	ACADIA UNIV, BIOLOGY DEPT, WOLFVILLE, NS B0P 1X0, CANADA	1708-3087			ECOL SOC	Ecol. Soc.		2015	20	4							24	10.5751/ES-07965-200424	http://dx.doi.org/10.5751/ES-07965-200424			34	Ecology; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology	DA2MM		Green Published, gold			2022-09-04	WOS:000367628900024
J	Garcia-Giraldo, G; Posada, LF; Perez-Jaramillo, JE; Carrion, VJ; Raaijmakers, JM; Villegas-Escobar, V				Garcia-Giraldo, Gisell; Posada, Luisa F.; Perez-Jaramillo, Juan E.; Carrion, Victor J.; Raaijmakers, Jos M.; Villegas-Escobar, Valeska			Bacillus subtilis EA-CB0575 inoculation of micropropagated banana plants suppresses black Sigatoka and induces changes in the root microbiome	PLANT AND SOIL			English	Article; Early Access						Micropropagated banana plants; Biopriming; PGPR; Black Sigatoka disease; Microbiota assembly; Rhizosphere	GROWTH PROMOTION; ENDOPHYTIC BACTERIA; SYSTEMIC RESISTANCE; STRESS RESISTANCE; RHIZOSPHERE; SOIL; COLONIZATION; ENHANCEMENT; COMMUNITIES; PROTECTION	Purpose Root inoculation of plants with beneficial microorganisms promotes plant growth and improves tolerance to biotic and abiotic stresses. In banana plants, microbial inoculation has shown promising effects on plant growth, but the effect on foliar diseases and on the resident native microbial community is yet unknown. We examined the effects of Bacillus subtilis EA-CB0575 introduced on roots of micropropagated banana plants on black Sigatoka disease and on the root microbiome. Methods In vitro banana seedlings were root-inoculated with strain EA-CB0575, and then treated with the foliar pathogen Pseudocercospora fijiensis. Root bacterial communities were characterized using 16S rRNA gene sequencing, before and after pathogen inoculation; and the severity of the disease was determined. Results Inoculation of strain EA-CB0575 on in vitro banana roots provided a reduction in the severity of black Sigatoka disease in greenhouse. This inoculation induced changes in the composition of the bacterial root microbiome, changes that arose from amplicon sequence variants (ASVs) of low abundances. Differential abundance analysis of ASV indicated that prior pathogen inoculation significantly more enriched sequences were identified in roots treated with EA-CB0575 (191-ASVs) compared to control plants (73-ASVs), but after pathogen inoculation more sequences were found in control (277-ASVs) than bacterial inoculated plants (60-ASVs). Furthermore, in vitro banana roots host a bacterial community that differ from that of greenhouse plants. Conclusion Results suggest that banana plants inoculated with B. subtilis EA-CB0575, reshape the composition of the bacterial community in a P. fijiensis dependent manner and induce systemic resistance protecting plants against black Sigatoka.	[Garcia-Giraldo, Gisell; Posada, Luisa F.; Villegas-Escobar, Valeska] Univ EAFIT, Dept Biol Sci, CIBIOP Grp, Carrera 49 7 Sur 50, Medellin, Colombia; [Garcia-Giraldo, Gisell] Banana Res Ctr, Conjunto Residencial Almendros Km 4, Carepa, Colombia; [Posada, Luisa F.] Pontificia Univ Javeriana, Dept Ingn Ind, Grp Invest Zentech, Carrera 7 40-62, Bogota, Colombia; [Perez-Jaramillo, Juan E.; Carrion, Victor J.; Raaijmakers, Jos M.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Droevendaalsesteeg 10, NL-6708 PB Wageningen, Netherlands; [Perez-Jaramillo, Juan E.] Univ Antioquia, PECET, Calle 67 53 108, Medellin, Colombia; [Carrion, Victor J.; Raaijmakers, Jos M.] Leiden Univ, Inst Biol, Sylviusweg 72, NL-2333 BE Leiden, Netherlands		Villegas-Escobar, V (corresponding author), Univ EAFIT, Dept Biol Sci, CIBIOP Grp, Carrera 49 7 Sur 50, Medellin, Colombia.	vvilleg2@eafit.edu.co	Raaijmakers, Jos M/D-1574-2014; Carrion, Victor/GPG-1248-2022	Raaijmakers, Jos M/0000-0003-1608-6614; Villegas Escobar, Valeska/0000-0002-9636-3644	Universidad EAFIT (Colombia); Association of Banana Producers of Colombia (AUGURA); Department of Science, Technology and Innovation (COLCIENCIAS) [249-2016]	Universidad EAFIT (Colombia); Association of Banana Producers of Colombia (AUGURA); Department of Science, Technology and Innovation (COLCIENCIAS)	This work was supported by Universidad EAFIT (Colombia), the Association of Banana Producers of Colombia (AUGURA), and the Department of Science, Technology and Innovation (COLCIENCIAS) (contract number 249-2016).	Backer R, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01473; Bakker PAHM, 2018, CELL, V172, P1178, DOI 10.1016/j.cell.2018.02.024; Barka EA, 2000, FEMS MICROBIOL LETT, V186, P91, DOI 10.1111/j.1574-6968.2000.tb09087.x; Berg G, 2016, J EXP BOT, V67, P995, DOI 10.1093/jxb/erv466; Berg G, 2010, CELL ORIG LIFE EXTRE, V17, P447, DOI 10.1007/978-90-481-9449-0_22; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Chandra S, 2010, BIOTECHNOL LETT, V32, P1199, DOI 10.1007/s10529-010-0290-0; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Dias ACF, 2009, WORLD J MICROB BIOT, V25, P189, DOI 10.1007/s11274-008-9878-0; Dupont, 1982, BLACK YELL SIG IMPR; Elsayed TR, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02835; Foo JL, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600099; Franco-Sierra ND, 2020, FUNCT INTEGR GENOMIC, V20, P575, DOI 10.1007/s10142-020-00736-x; Gadhave KR, 2018, MICROB ECOL, V76, P741, DOI 10.1007/s00248-018-1160-x; Gamez R, 2019, MICROBIOL RES, V220, P12, DOI 10.1016/j.micres.2018.11.006; Harish S, 2008, APPL SOIL ECOL, V39, P187, DOI 10.1016/j.apsoil.2007.12.006; Hassani MA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0445-0; Hol WHG, 2015, ECOLOGY, V96, P2042, DOI 10.1890/14-2359.1; Jaizme-Vega MDC, 2004, FRUITS, V59, P83, DOI [10.1051/fruits:2004008, DOI 10.1051/FRUITS:2004008]; Jebakumar RM, 2018, BIOCONTROL SCI TECHN, V28, P1074, DOI 10.1080/09583157.2018.1514583; Jousset A, 2017, ISME J, V11, P853, DOI 10.1038/ismej.2016.174; Kanani P, 2020, WOODHEAD PUBL FOOD S, P357, DOI 10.1016/B978-0-12-818734-0.00015-2; Kavino M, 2018, EUR J PLANT PATHOL, V151, P371, DOI 10.1007/s10658-017-1379-2; Koberl M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45318; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kumar AS, 2012, PLANT J, V72, P694, DOI 10.1111/j.1365-313X.2012.05116.x; Liaqat F, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0442-6; Liu HW, 2020, TRENDS PLANT SCI, V25, P733, DOI 10.1016/j.tplants.2020.03.014; Liu X., 2016, YALE J BIOL MED, V89, P275; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; LYNCH JM, 1990, PLANT SOIL, V129, P1, DOI 10.1007/BF00011685; Miliute I, 2015, ZEMDIRBYSTE, V102, P465, DOI 10.13080/z-a.2015.102.060; Muganu M, 2015, VITIS, V54, P73; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nowak J, 1998, IN VITRO CELL DEV-PL, V34, P122, DOI 10.1007/BF02822776; Nowak J, 2003, IN VITRO CELL DEV-PL, V39, P107, DOI 10.1079/IVP2002403; Oliveira ALM, 2002, PLANT SOIL, V242, P205, DOI 10.1023/A:1016249704336; Orlikowska T, 2017, PLANT CELL TISS ORG, V128, P487, DOI 10.1007/s11240-016-1144-9; Panke-Buisse K, 2015, ISME J, V9, P980, DOI 10.1038/ismej.2014.196; Parray JA, 2015, PLANT CELL TISS ORG, V121, P325, DOI 10.1007/s11240-014-0703-1; Paulson J, 2016, METAGENOMESEQ STAT A; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Perez-Jaramillo JE, 2017, ISME J, V11, P2244, DOI 10.1038/ismej.2017.85; Pester M, 2010, ISME J, V4, P1591, DOI 10.1038/ismej.2010.75; Pethybridge SJ, 2015, PLANT DIS, V99, P1310, DOI 10.1094/PDIS-03-15-0319-RE; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Posada LF, 2018, MICROBIOL RES, V217, P69, DOI 10.1016/j.micres.2018.08.017; Posada LF, 2016, SCI HORTIC-AMSTERDAM, V212, P81, DOI 10.1016/j.scienta.2016.09.040; R Core Team, 2017, R LANG ENV STAT COMP; Rajamanickam S, 2018, SCI HORTIC-AMSTERDAM, V231, P179, DOI 10.1016/j.scienta.2017.12.037; Ramirez KS, 2018, NAT MICROBIOL, V3, P189, DOI 10.1038/s41564-017-0062-x; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schneider C, 2017, ACTA HORTIC, V1155, P483, DOI 10.17660/ActaHortic.2017.1155.71; Stringlis IA, 2018, P NATL ACAD SCI USA, V115, pE5213, DOI 10.1073/pnas.1722335115; Torres JM, 2012, EUR J PLANT PATHOL, V133, P887, DOI 10.1007/s10658-012-0012-7; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Vannier N, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0459-7; Vestberg A, 2004, APPL SOIL ECOL, V27, P243, DOI 10.1016/j.apsoil.2004.05.006; Salomon MV, 2014, PHYSIOL PLANTARUM, V151, P359, DOI 10.1111/ppl.12117; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Wani SP, 2019, PLANT GROWTH PROMOTI, P19, DOI [10.1007/978-981-13-6790-8_2, DOI 10.1007/978-981-13-6790-8_2]; Wei Z, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw0759; Zakharchenko NS, 2011, APPL BIOCHEM MICRO+, V47, P661, DOI 10.1134/S0003683811070118	68	0	0	7	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil												10.1007/s11104-022-05540-z	http://dx.doi.org/10.1007/s11104-022-05540-z		JUN 2022	15	Agronomy; Plant Sciences; Soil Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Plant Sciences	1Y9FT					2022-09-04	WOS:000808443200002
J	Fisberg, M; Kovalskys, I; Salas, GG; Rigotti, A; Sanabria, LYC; Garcia, MCY; Torres, RGP; Herrera-Cuenca, M; Zimberg, IZ; Guajardo, V				Fisberg, Mauro; Kovalskys, Irina; Salas, Georgina Gomez; Rigotti, Attilio; Cortes Sanabria, Lilia Yadira; Yepez Garcia, Martha Cecilia; Pareja Torres, Rossina Gabriela; Herrera-Cuenca, Marianella; Zimberg, Iona Zalcman; Guajardo, Viviana			Developing a cooperative multicenter study in Latin America: issues and difficulties (ELANS Project)	ANNALS OF NUTRITION AND METABOLISM			English	Meeting Abstract						multicenter study; Latin America; design; difficulties			[Fisberg, Mauro] Sabara Childrens Hosp, Pensi Inst, Feeding Difficulties Ctr, Sao Paulo, Brazil; [Kovalskys, Irina; Guajardo, Viviana] ILSI, Buenos Aires, DF, Argentina; [Salas, Georgina Gomez] Univ Costa Rica, Escuela Med San Jose, Dept Bioquim, San Jose, Costa Rica; [Rigotti, Attilio] Pontificia Univ Catolica Chile, Ctr Nutr Mol & Enfermedades Cron, Dept Nutr Diabet & Metab, Santiago, Chile; [Cortes Sanabria, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Quito, Ecuador; [Pareja Torres, Rossina Gabriela] Inst Invest Nutr, Lima, Peru; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Ctr Estudos Desenvolvimento, FundacionBengoa, Caracas, Venezuela; [Zimberg, Iona Zalcman] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil				Cortes, Lilia Yadira/AAF-2960-2019; PAREJA TORRES, ROSSINA GABRIELLA/D-9892-2018; Fisberg, Mauro/E-7149-2010	PAREJA TORRES, ROSSINA GABRIELLA/0000-0001-7523-3181; Fisberg, Mauro/0000-0003-2992-3215					0	0	0	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-6807	1421-9697		ANN NUTR METAB	Ann. Nutr. Metab.		2015	67			1		149/886	245	246						2	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	DK5VM					2022-09-04	WOS:000374988801106
J	Leon-Sarmiento, FE; Mendoza, E; Torres-Hillera, M; Pinto, N; Prada, J; Silva, CA; Vera, SJ; Castillo, E; Valderrama, V; Prada, DG; Bayona-Prieto, J; Garcia, I				Leon-Sarmiento, FE; Mendoza, E; Torres-Hillera, M; Pinto, N; Prada, J; Silva, CA; Vera, SJ; Castillo, E; Valderrama, V; Prada, DG; Bayona-Prieto, J; Garcia, I			Trypanosoma cruzi-associated cerebrovascular disease: a case-control study in Eastern Colombia	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						cerebrovascular disease; Tryanosoma cruzi; Colombia; case-control studies; neurotrypanosomiasis; neuroepidemiology	CHAGAS-DISEASE; NITRIC-OXIDE; STROKE	Trypanosoma cruzi infection is a common cause of cardiopathy in South America leading it eventually to an established stroke; however, the association between T. cruzi infection itself and cerebrovascular disease is still unknown. We did a case-control study at Eastern Colombia and found that T. cruzi infection was more frequent and statistically significant in stroke cases (24.4%) than controls (1.9%), (Chi square: 21.72; OR: 16.13; 95% confidence interval (CI): 3.64-71.4; p < 0.00001). After removing the seropositive patients with cardiological abnormalities, the significance still remained by multivariate analysis (p < 0.05). This is the first case-control study that demonstrated a significant link between this infection and symptomatic cerebrovascular disease, mainly ischemic, regardless of cardiac abnormalities. Therefore, we recommend that patients with stroke must be screened for T. cruzi infection if they currently live or have lived in places where this parasite is considered endemic. (C) 2003 Elsevier B.V. All rights reserved.	Santander Univ, Sch Med, Bucaramanga, Colombia; Univ Pamplona, Pamplona, Colombia; Neuro Net Inst Colombiano Neurociencias Aplicades, Bucaramanga, Colombia; Univ Francisco Paula Santander, Cucuta, Colombia; Pontificia Univ Javeriana, Bogota, Colombia; Inst Nacl Salud, Bogota, Colombia		Leon-Sarmiento, FE (corresponding author), NINDS, Med Neurol Branch, NIH, Bldg 10-5N 234,10 Ctr Dr, Bethesda, MD 20892 USA.	leonf@ninds.nih.gov	Prada-Arismendy, Jeanette/GLR-4134-2022; Prada-Arismendy, Jeanette/N-5696-2016	Prada-Arismendy, Jeanette/0000-0002-4779-1941				Becher H, 2000, J Epidemiol Biostat, V5, P277; Bestetti R, 2000, ACTA CARDIOL, V55, P33, DOI 10.2143/AC.55.1.2005715; Carod-Artal FJ, 2003, J NEUROL NEUROSUR PS, V74, P516, DOI 10.1136/jnnp.74.4.516; De Castro S C, 1986, Arq Neuropsiquiatr, V44, P139; Del Brutto OH, 2001, LANCET, V358, P74, DOI 10.1016/S0140-6736(00)05288-0; FERNANDES M, 1992, REV I MED TROP, V34, P9, DOI 10.1590/S0036-46651992000100002; GAMARRA G, 1998, ACTA MED COLOMB, V12, P50; Genovese O, 1996, ARQ NEURO-PSIQUIAT, V54, P190, DOI 10.1590/S0004-282X1996000200002; LEON SFE, 1999, SALUD UIS, V31, P14; LEONS FE, 1998, ACTA MED COL S, V23, P256; LEONSARMIENTO FE, 2001, ACTA NEUROL COLOMB, V17, P171; LEONSARMIENTO FE, 2003, IN PRESS BIOMEDICA B; Lopes E R, 1991, Rev Soc Bras Med Trop, V24, P101; Lopez M. C., 1999, Biomedica, V19, P159; Oliveira E, 2002, INT J CARDIOL, V82, P49, DOI 10.1016/S0167-5273(01)00599-X; Parmentier S, 1999, BRIT J PHARMACOL, V127, P546, DOI 10.1038/sj.bjp.0702549; Pinto NX, 2002, MED HYPOTHESES, V58, P374, DOI 10.1054/mehy.2001.1401; REY RC, 1991, ARCH NEUROL-CHICAGO, V48, P359, DOI 10.1001/archneur.1991.00530160019006; SARMIENTO FEL, 2003, REV NEUROL, V36, P412; Umezawa ES, 2001, LANCET, V357, P797, DOI 10.1016/S0140-6736(00)04174-X; WHISNANT JP, 1990, STROKE, V21, P707, DOI 10.1161/01.STR.21.5.707	21	31	33	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JAN 15	2004	217	1					61	64		10.1016/j.jns.2003.08.015	http://dx.doi.org/10.1016/j.jns.2003.08.015			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	764KN	14675611				2022-09-04	WOS:000188206200011
J	Gomez-Restrepo, C; Naranjo-Lujan, S; Rondon, M; Acosta, A; Maldonado, P; Villegas, CA; Hurtado, J; Hernandez, JC; Angarita, MD; Pena, M; Saavedra, MA; Quitian, H				Gomez-Restrepo, Carlos; Naranjo-Lujan, Salome; Rondon, Martin; Acosta, Andres; Maldonado, Patricia; Arango Villegas, Carlos; Hurtado, Jaime; Carlos Hernandez, Juan; del Pilar Angarita, Maria; Pena, Marcela; Angel Saavedra, Miguel; Quitian, Hoover			Latin American Clinical Epidemiology Network Series - Paper 6: The influence of alcohol in traffic accidents and health care costs of it in Bogota-Colombia	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Cost of accidents; Productivity; Health costs; Alcohol consumption; Traffic accident; Health care	INJURY; DISABILITY; CRASHES	Objectives: In Colombia, some studies have estimated medical costs associated to traffic accidents. It is required to assess results by city or region and determine the influence of variables such as alcohol consumption. The main objective of this study was to identify health care costs associated to traffic accidents in Bogota and determine whether alcohol consumption can increase them. Study Design and Setting: Cross-sectional costs study conducted in patients over 18 years treated in the emergency rooms of six different hospitals in Bogota, Colombia. Results: The average total cost of medical care per patient was 628 USD, in Bogota-Colombia. The average cost per accident was estimated at 1,349 USD. On average, the total cost for health care for patients with positive blood alcohol level was 1.8 times higher than those who did not consume alcohol. The indirect costs were on average 115.3 USD per injured person. Numbers are expressed in 2011 U.S. dollars. Conclusion: Alcohol consumption increases the risk of traffic accidents and direct medical health costs. (C) 2016 Elsevier Inc. All rights reserved.	[Gomez-Restrepo, Carlos] Dept Psychiat & Mental Hlth, Kra 7 40-62 Piso 2, Bogota, Cundinamarca, Colombia; [Gomez-Restrepo, Carlos; Rondon, Martin; Acosta, Andres; Maldonado, Patricia; Quitian, Hoover] Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol & Biostat, Kra 7 40-62 Piso 2, Bogota, Cundinamarca, Colombia; [Naranjo-Lujan, Salome] Univ Los Andes, Econ, Rd Prevent Fund Corp, Kra 1 18a12, Bogota, Cundinamarca, Colombia; [Arango Villegas, Carlos] Hosp Univ San Ignacio, Kra 7 40-62, Bogota, Cundinamarca, Colombia; [Hurtado, Jaime] Ctr Politecn Olaya, Intens Care Unit, Kra 21 22-68, Bogota, Cundinamarca, Colombia; [Carlos Hernandez, Juan] Clin Occidente, Emergency Room,Kra 71c, Bogota, Cundinamarca, Colombia; [del Pilar Angarita, Maria] Hosp Engativa, Emergency Room,Tv 100a 80A-50, Bogota, Cundinamarca, Colombia; [Pena, Marcela] Hosp El Tunal, Emergency Room,Kra 22 42 Sur47, Bogota, Cundinamarca, Colombia; [Angel Saavedra, Miguel] Hosp San Jose, Emergency Room,Kra 1811, Bogota, Cundinamarca, Colombia		Gomez-Restrepo, C (corresponding author), Kra 7 40-62 Piso 2, Bogota, Cundinamarca, Colombia.	mauricioamrva@hotmail.com		Quitian-Reyes, Hoover/0000-0001-8286-4977; RONDON, MARTIN/0000-0002-3885-5448; Gomez-Restrepo, Carlos/0000-0002-9013-5384	Corporacion Fondo de Prevencion Vial; Instituto Nacional de Medicina Legal y Ciencias Forenses, La Direccion de Transito y Transporte de la Policia Nacional	Corporacion Fondo de Prevencion Vial; Instituto Nacional de Medicina Legal y Ciencias Forenses, La Direccion de Transito y Transporte de la Policia Nacional	This project was made possible by the funding of the Corporacion Fondo de Prevencion Vial, and the collaboration from Instituto Nacional de Medicina Legal y Ciencias Forenses, La Direccion de Transito y Transporte de la Policia Nacional, and the six hospitals that participated.	Antic B, 2011, TRANSPORT-VILNIUS, V26, P433, DOI 10.3846/16484142.2011.635425; Berecki-Gisolf J, 2013, ACCIDENT ANAL PREV, V51, P129, DOI 10.1016/j.aap.2012.11.010; Blincoe L, NHTSA EC IMPACT MOTO; Bocarejo J, 2010, DESARROLLO METODOLOG; Departamento Administrativo Nacional de Estadistica DANE, EST VIT; Garcia-Altes A, 2007, INJURY PREV, V13, P65, DOI 10.1136/ip.2006.012732; Garcia-Altes A, 2011, J TRAUMA, V70, P744, DOI 10.1097/TA.0b013e3181eaaa5b; Gómez-Restrepo Carlos, 2011, rev.colomb.psiquiatr., V40, P229; Gotsens M, 2013, ACCIDENT ANAL PREV, V51, P120, DOI 10.1016/j.aap.2012.10.020; Hijar M, 2004, ACCIDENT ANAL PREV, V36, P37, DOI 10.1016/S0001-4575(02)00112-4; Lugo LH, 2013, COLOMB MEDICA, V44, P100; Parkinson F, 2014, INJURY, V45, P342, DOI 10.1016/j.injury.2013.04.007; Popova S, 2011, CONTEMP DRUG PROBL, V38, P467; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Secretaria de Movilidad, 2013, MOV CIFR 2012; Sheridan A, 2011, Ir Med J, V104, P199; Sommers BD, 2011, TRAFFIC INJ PREV, V12, P149, DOI 10.1080/15389588.2010.536599; Takanishi DM, 2008, ASIA-PAC J PUBLIC HE, V20, P327, DOI 10.1177/1010539508322539; Torres D Martinez, 2013, CARACTERIZACION ACCI; Treno AJ, 2007, ACCIDENT ANAL PREV, V39, P894, DOI 10.1016/j.aap.2006.12.011; United Nations, 2008, GEN ASS AD RES EAS G; World Health Organization, 2013, PEDESTRIAN SAFETY RO	22	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	JUN	2017	86						106	110		10.1016/j.jclinepi.2016.10.003	http://dx.doi.org/10.1016/j.jclinepi.2016.10.003			5	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	FB6MC	27771356				2022-09-04	WOS:000406256100013
J	Kokilashvili, V; Meskhi, A; Rafeiro, H				Kokilashvili, Vakhtang; Meskhi, Alexander; Rafeiro, Humberto			Grand Bochner-Lebesgue space and its associate space	JOURNAL OF FUNCTIONAL ANALYSIS			English	Article						Bochner spaces; Grand Bochner-Lebesgue space; Associate space		Our aim is to introduce the grand Bochner-Lebesgue space in the spirit of Iwaniec-Sbordone spaces, also known as grand Lebesgue spaces, and prove some of its properties. We will also deal with the associate space for grand Bochner-Lebesgue spaces. (C) 2013 Elsevier Inc. All rights reserved.	[Kokilashvili, Vakhtang; Meskhi, Alexander] I Javakhishvili Tbilisi State Univ, A Razmadze Math Inst, Dept Math Anal, GE-0177 Tbilisi, Georgia; [Kokilashvili, Vakhtang] Int Black Sea Univ, GE-0131 Tbilisi, Georgia; [Meskhi, Alexander] Georgian Tech Univ, Fac Informat & Control Syst, Dept Math, Tbilisi, Georgia; [Meskhi, Alexander] Govt Coll Univ, Abdus Salam Sch Math Sci, Lahore, Pakistan; [Rafeiro, Humberto] Pontificia Univ Javeriana, Dept Matemat, Fac Ciencias, Bogota, Colombia; [Rafeiro, Humberto] Inst Super Tecn, Grp CEAF, P-1049001 Lisbon, Portugal		Rafeiro, H (corresponding author), Pontificia Univ Javeriana, Dept Matemat, Fac Ciencias, Bogota, Colombia.	kokil@rmi.ge; meskhi@rmi.ge; hrafeiro@math.ist.utl.pt	Meskhi, Alexander/ACT-3186-2022; Rafeiro, Humberto/AAK-4908-2020	Rafeiro, Humberto/0000-0002-5304-8572	Shota Rustaveli National Science Foundation [D/13-23, 31/47]; Pontificia Universidad Javeriana, under the research project Study of Grand Bochner spaces	Shota Rustaveli National Science Foundation; Pontificia Universidad Javeriana, under the research project Study of Grand Bochner spaces	V.K. and A.M. were partially supported by the Shota Rustaveli National Science Foundation Grant (Contract Numbers: D/13-23 and 31/47). H.R. was partially supported by Pontificia Universidad Javeriana, under the research project Study of Grand Bochner spaces. The authors wish to express their gratitude to the referee for his/her valuable comments and suggestions.	Bennett C., 1988, INTERPOLATION OPERAT; Bochner S., 1933, FUND MATH, V20, P262, DOI [10.4064/fm-20-1-262-176, DOI 10.4064/FM-20-1-262-176]; Capone C., 2005, J FUNCT SPACES APPL, V3, P73, DOI [10.1155/2005/192538, DOI 10.1155/2005/192538]; Capone C, 2013, NONLINEAR ANAL-THEOR, V85, P125, DOI 10.1016/j.na.2013.02.021; Carozza M., 1997, DIFFERENTIAL INTEGRA, V10, P599; Di Fratta G, 2009, NONLINEAR ANAL-THEOR, V70, P2582, DOI 10.1016/j.na.2008.03.044; Diestel J., 1977, AM MATH SOC; Dunford N, 1935, T AM MATH SOC, V37, P441, DOI 10.2307/1989719; Fiorenza A, 1998, STUD MATH, V127, P223; Fiorenza A, 2004, Z ANAL ANWEND, V23, P657; FIORENZA A, 2001, C R MATH ACAD SCI PA, V333, P23; Fiorenza A., 2000, COLLECT MATH, V51, P131; Fiorenza A, 2008, STUD MATH, V188, P123, DOI 10.4064/sm188-2-2; Greco L, 1997, MANUSCRIPTA MATH, V92, P249, DOI 10.1007/BF02678192; Greco L., 1993, DIFFERENTIAL INTEGRA, V6, P1089; HILDEBRANDT TH, 1953, B AM MATH SOC, V59, P111, DOI 10.1090/S0002-9904-1953-09694-X; IWANIEC T, 1992, ARCH RATION MECH AN, V119, P129, DOI 10.1007/BF00375119; Kokilashvili V., 2010, LECT COURS SUMM SCH; Kokilashvili V, 2014, COMPLEX VAR ELLIPTIC, V59, P1169, DOI 10.1080/17476933.2013.831844; Kokilashvili V, 2013, STUD MATH, V217, P159, DOI 10.4064/sm217-2-4; Kokilashvili V, 2013, GEORGIAN MATH J, V20, P43, DOI 10.1515/gmj-2013-0009; Liflyand E, 2010, TURK J MATH, V34, P207, DOI 10.3906/mat-0812-8; Meskhi A, 2011, COMPLEX VAR ELLIPTIC, V56, P1003, DOI 10.1080/17476933.2010.534793; Rafeiro H., 2013, OPER THEORY ADV APPL, V229, P343; Samko SG, 2011, AZERBAIJAN J MATH, V1, P67	25	16	16	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-1236	1096-0783		J FUNCT ANAL	J. Funct. Anal.	FEB 15	2014	266	4					2125	2136		10.1016/j.jfa.2013.10.027	http://dx.doi.org/10.1016/j.jfa.2013.10.027			12	Mathematics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	295ZL		Bronze			2022-09-04	WOS:000330154800009
J	Dennis, RJ; Caraballo, L; Garcia, E; Rojas, MX; Rondon, MA; Perez, A; Aristizabal, G; Penaranda, A; Barragan, AM; Ahumada, V; Jimenez, S				Dennis, Rodolfo J.; Caraballo, Luis; Garcia, Elizabeth; Rojas, Maria X.; Rondon, Martin A.; Perez, Adriana; Aristizabal, Gustavo; Penaranda, Augusto; Barragan, Ana M.; Ahumada, Velky; Jimenez, Silvia			Prevalence of asthma and other allergic conditions in Colombia 2009-2010: a cross-sectional study	BMC PULMONARY MEDICINE			English	Article							CHILDHOOD ISAAC; SYMPTOM PREVALENCE; SCHOOL-CHILDREN; LATIN-AMERICA; ADULTS; SEVERITY; RHINOCONJUNCTIVITIS; TROPOMYOSIN; INSIGHTS; ASCARIS	Background: While it is suggested that the prevalence of asthma in developed countries may have stabilized, this is not clear in currently developing countries. Current available information for both adults and children simultaneously on the burden and impact of allergic conditions in Colombia and in many Latin American countries is limited. The objectives of this study were to estimate the prevalence for asthma, allergic rhinitis (AR), atopic eczema (AE), and atopy in six colombian cities; to quantify costs to the patient and her/his family; and to determine levels of Immunoglobulin E (IgE) in asthmatic and healthy subjects. Methods: We conducted a cross-sectional, population-based study in six cities during the academic year 2009-2010. We used a school-based design for subjects between 5-17 years old. We carried out a community-based strategy for subjects between 1-4 years old and adults between 18-59 years old. Serum samples for total and antigen-specific (IgE) levels were collected using a population-based, nested, case-control design. Results: We obtained information on 5978 subjects. The largest sample of subjects was collected in Bogota (2392). The current prevalence of asthma symptoms was 12% (95% CI, 10.5-13.7), with 43% (95% CI, 36.3-49.2) reporting having required an emergency department visit or hospitalization in the past 12 months. Physician diagnosed asthma was 7% (95% CI, 6.1-8.0). The current prevalence of AR symptoms was 32% (95% CI, 29.5-33.9), and of AE symptoms was 14% (95% CI, 12.5-15.3). We collected blood samples from 855 subjects; 60.2% of asthmatics and 40.6% of controls could be classified as atopic. Conclusions: In Colombia, symptom prevalence for asthma, AR and AE, as well as levels of atopy, are substantial. Specifically for asthma, symptom severity and absence from work or study due to symptoms are important. These primary care sensitive conditions remain an unmet public health burden in developing countries such as Colombia.	[Dennis, Rodolfo J.; Barragan, Ana M.] Fdn Cardioinfantil, Inst Cardiol, Res Dept, Bogota, Colombia; [Caraballo, Luis; Ahumada, Velky; Jimenez, Silvia] Univ Cartagena, Inst Immunol Res, Cartagena, Colombia; [Garcia, Elizabeth; Penaranda, Augusto] Fdn Santa Fe Bogota, Bogota, Colombia; [Rojas, Maria X.; Rondon, Martin A.] Pontificia Univ Javeriana, Sch Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Perez, Adriana] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, Austin, TX 78701 USA; [Perez, Adriana] Michael & Susan Dell Ctr Hlth Living, Austin, TX 78701 USA; [Aristizabal, Gustavo] Univ El Bosque, Dept Pediat, Bogota, Colombia		Dennis, RJ (corresponding author), Fdn Cardioinfantil, Inst Cardiol, Res Dept, Carrera 13 B 163-85,Torre A,Tercer Piso, Bogota, Colombia.	rjdennis@cardioinfantil.org	Peñaranda, Augusto/GOE-5385-2022; Barragan, Ana M./AAC-2380-2022	Barragan, Ana M./0000-0002-4646-4324; Perez, Adriana/0000-0002-6859-9916; RONDON, MARTIN/0000-0002-3885-5448; Dennis, Rodolfo J/0000-0003-3215-9721; Penaranda, Augusto/0000-0003-1598-8472; Rojas-Reyes, Maria Ximena/0000-0001-5752-7653; Ahumada, Velky/0000-0003-0905-7276	Colciencias [540-2008]; MSD; Astra-Zeneca; GlaxoSmithKline; Sanofi-Aventis; NCI [3R37CA057030-20S1]; Michael & Susan Dell Foundation [8075]; NATIONAL CANCER INSTITUTE [R37CA057030] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); MSD; Astra-Zeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Michael & Susan Dell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was made possible by funding from Colciencias grant 540-2008, and by unrestricted research grants from MSD, Astra-Zeneca, GlaxoSmithKline, and Sanofi-Aventis. Dr Perez was supported by a research supplement [Grant 3R37CA057030-20S1] from NCI during the conduction of this study and by the Michael & Susan Dell Foundation [Grant 8075] during the writing of this manuscript. Neither Colciencias nor any of the other sponsors had any role in the conception, design, analysis, interpretation of data, drafting the article or approving the final manuscript version to be published.	Acevedo N, 2011, INT ARCH ALLERGY IMM, V154, P195, DOI 10.1159/000321106; Acevedo N, 2009, ALLERGY, V64, P1635, DOI 10.1111/j.1398-9995.2009.02084.x; Ait-Khaled N, 2009, ALLERGY, V64, P123, DOI 10.1111/j.1398-9995.2008.01884.x; [Anonymous], INV ED FORM; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Caminal J, 2004, EUR J PUBLIC HEALTH, V14, P246, DOI 10.1093/eurpub/14.3.246; Caraballo Luis, 2011, Front Biosci (Elite Ed), V3, P51, DOI 10.2741/e219; Caudri D, 2009, J ALLERGY CLIN IMMUN, V124, P903, DOI 10.1016/j.jaci.2009.06.045; Cooper PJ, 2009, ALLERGY, V64, P5, DOI 10.1111/j.1398-9995.2008.01902.x; Cooper PJ, 2004, CLIN EXP ALLERGY, V34, P845, DOI 10.1111/j.1365-2222.2004.01958.x; Dennis R, 2004, ANN ALLERG ASTHMA IM, V93, P568, DOI 10.1016/S1081-1206(10)61265-3; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ellwood P, 2001, EUR RESPIR J, V17, P436, DOI 10.1183/09031936.01.17304360; Ford ES, 2005, J ALLERGY CLIN IMMUN, V115, P897, DOI 10.1016/j.jaci.2004.11.050; Fuhlbrigge AL, 2002, AM J RESP CRIT CARE, V166, P1044, DOI 10.1164/rccm.2107057; Garcia E, 2008, PEDIAT ALLERG IMM-UK, V19, P307, DOI 10.1111/j.1399-3038.2007.00650.x; Garcia-Marcos L, 2004, ALLERGY, V59, P1301, DOI 10.1111/j.1398-9995.2004.00562.x; Gergen PJ, 2009, J ALLERGY CLIN IMMUN, V124, P447, DOI 10.1016/j.jaci.2009.06.011; Godard P, 2002, EUR RESPIR J, V19, P61, DOI 10.1183/09031936.02.00232001; Lawson JA, 2005, CURR OPIN PULM MED, V11, P79, DOI 10.1097/01.mcp.0000147861.60768.24; Mallol J, 2010, J ASTHMA, V47, P644, DOI 10.3109/02770901003686480; Martinez CR, 2008, J ASTHMA, V45, P141, DOI 10.1080/02770900701840253; Martinez FD, 2009, ALLERGOL IMMUNOPATH, V37, P249, DOI 10.1016/j.aller.2009.06.008; McCarthy M, 2003, LANCET, V361, P1797, DOI 10.1016/S0140-6736(03)13452-6; Neffen H, 2005, REV PANAM SALUD PUBL, V17, P191, DOI 10.1590/S1020-49892005000300007; Newson RB, 2000, EUR RESPIR J, V16, P817, DOI 10.1183/09031936.00.16581700; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Penaranda A, 2012, INT J PEDIAT OTORHIN; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Sarndal C. E., 1992, MODEL ASSISTED SURVE, P172; Sole Dirceu, 2006, J Pediatr (Rio J), V82, P341, DOI [10.1590/S0021-75572006000600006, 10.2223/JPED.1521]; Sole D, 2010, PEDIAT ALLERG IMM-UK, V21, pE127, DOI 10.1111/j.1399-3038.2009.00947.x; Stewart AW, 2001, INT J EPIDEMIOL, V30, P173, DOI 10.1093/ije/30.1.173; Subbarao P, 2009, CMAJ, V9, P181; Thomson CC, 2003, CHEST, V124, P795, DOI 10.1378/chest.124.3.795; van Schayck CP, 2005, EUR RESPIR J, V26, P647, DOI 10.1183/09031936.05.00019805; von Hertzen L, 2005, ALLERGY, V60, P283, DOI 10.1111/j.1398-9995.2005.00769.x; Weiland SK, 2004, THORAX, V59, P637, DOI 10.1136/thx.2004.026302; Weinmayr G, 2007, AM J RESP CRIT CARE, V176, P565, DOI 10.1164/rccm.200607-994OC; WHO/PAHO, HLTH IND AND REG; Wickens K, 1999, CLIN EXP ALLERGY, V29, P766; WOODRUFF RS, 1971, J AM STAT ASSOC, V66, P411, DOI 10.2307/2283947	44	79	96	0	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2466			BMC PULM MED	BMC Pulm. Med.	MAY 2	2012	12								17	10.1186/1471-2466-12-17	http://dx.doi.org/10.1186/1471-2466-12-17			9	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Respiratory System	066XO	22551171	Green Published, gold			2022-09-04	WOS:000313255700001
J	Felknor, SA; Delclos, GL; Gimeno, D; Wesseling, I; Monge, P; Chavez, J; Quintana, L; Schulze, LJH				Felknor, Sarah A.; Delclos, George L.; Gimeno, David; Wesseling, Ineke; Monge, Patricia; Chavez, Jorge; Quintana, Leonardo; Schulze, Lawrence J. H.			Funding of pilot projects in Latin America: A tool for capacity building in Occupational Health Research	INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH			English	Article						research training; funding; collaboration; Fogarty International Center; Latin America	DEVELOPING-COUNTRIES; COLLABORATION	There is a global need for trained researchers who can address the increasing burden of illness and injury and prepare future generations of researchers. Developing countries have a special need for practical, action-oriented interventions to address workplace problems, based on identification of needs and priorities, development of locally available solutions, and consideration of the sociopolitical context of work and how best to translate research findings into policies. Effective translation and application of research products from industrialized nations to developing countries is essential, but differences in the contexts and local realities of other nations limit extrapolating such research. Funding pilot research projects in developing countries is an effective, practical, and useful tool for training new investigators in research techniques and developing collaborative relationships among countries.	Univ Texas, Sch Publ Hlth, Hlth Sci Ctr, SW Ctr Occupat & Environm Hlth, Houston, TX 77225 USA; Univ Nacl Heredia, Heredia, Costa Rica; Inst Tecnol Costa Rica, Cartago, Costa Rica; Pontificia Univ Javeriana, Bogota, Colombia; Univ Houston, Dept Ind Engn, Cullen Coll Engn, Houston, TX 77204 USA		Felknor, SA (corresponding author), Univ Texas, Sch Publ Hlth, Hlth Sci Ctr, SW Ctr Occupat & Environm Hlth, POB 20186, Houston, TX 77225 USA.	Sarah.A.Felknor@uth.tmc.edu	Schulze, Lawrence J H/C-3727-2019	Schulze, Lawrence J H/0000-0002-5918-3855; Gimeno, David/0000-0003-2502-0465; Quintana, Leonardo/0000-0001-5625-0111	FIC NIH HHS [D43 TW00644] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000644] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		BREMEN J, 2001, EMERG INFECT DIS S, V7, P524; BROOTEN D, 1997, J NURS SCHOLARSHIP, V29, P369; Delclos G L, 1999, Int J Occup Environ Health, V5, P203; Delclos GL, 2005, INT J OCCUP ENV HEAL, V11, P185, DOI 10.1179/oeh.2005.11.2.185; Froines J R, 1999, Int J Occup Environ Health, V5, P208; GIUFFRIDA A, 2001, PUBLICATION; GUTIERREZ E, 2000, PERSPECTIVES HLTH, P5; Hryhorczuk D O, 1999, Int J Occup Environ Health, V5, P213; JEYARATNAM J, 1985, SCAND J WORK ENV HEA, V11, P229, DOI 10.5271/sjweh.2230; Kogi K, 1998, Int J Occup Environ Health, V4, P189; Kupfer L, 2004, B WORLD HEALTH ORGAN, V82, P616; Markowitz S, 1999, Int J Occup Environ Health, V5, P237; *NAT I ENV HLTH SC, 1999, ENV HLTH PERSPECT, V107, pA350; Norman JN, 1998, MED EDUC, V32, P82, DOI 10.1046/j.1365-2923.1998.00692.x; Nuwayhid IA, 2004, AM J PUBLIC HEALTH, V94, P1916, DOI 10.2105/AJPH.94.11.1916; Partanen TJ, 1999, SCAND J WORK ENV HEA, V25, P296, DOI 10.5271/sjweh.438; Perry SE, 2001, J NURS SCHOLARSHIP, V33, P107; Petropoulos E A, 1999, Int J Occup Environ Health, V5, P223; van Teijlingen Edwin, 2002, Nurs Stand, V16, P33; van Teijlingen ER, 2001, J ADV NURS, V34, P289, DOI 10.1046/j.1365-2648.2001.01757.x	20	7	7	0	5	ABEL PUBLICATION SERVICES	BURLINGTON	1611 AQUINAS COURT, BURLINGTON, NC 27215 USA	1077-3525			INT J OCCUP ENV HEAL	Int. J. Occup. Environ. Health	OCT-DEC	2006	12	4					408	414		10.1179/oeh.2006.12.4.408	http://dx.doi.org/10.1179/oeh.2006.12.4.408			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	113ZD	17168230				2022-09-04	WOS:000242635600016
J	Boelens, R; Forigua-Sandoval, J; Duarte-Abadia, B; Gutierrez-Camargo, JC				Boelens, Rutgerd; Forigua-Sandoval, Juliana; Duarte-Abadia, Bibiana; Gutierrez-Camargo, Juan Carlos			River lives, River movements. Fisher communities mobilizing local and official rules in defense of the Magdalena River	JOURNAL OF LEGAL PLURALISM AND UNOFFICIAL LAW			English	Editorial Material						Fisher communities; environmental justice; legal complexity; Magdalena River; Colombia		The Magdalena River, Colombia's main river backbone, features multiple tensions and socio-environmental conflicts. They manifest themselves in the river's ecological degradation and negatively impact the riparian communities and artisanal fishermen, whose productive activities and rights of access to water are restricted. For these communities, the river is a means of passing down and exchanging knowledge between generations. However, their knowledge and practices are not recognized in the dominant governance processes over the Magdalena River. In an interview with Juan Carlos Gutierrez-Camargo, environmental activist, researcher and companion of artisanal fishermen, we illustrate the universe of epistemologies and worldviews of these communities. We discuss, from a legal-pluralism perspective, the contradictions between state norms and authorities, parastatal powers, and the customary rights of fishing communities. We analyze how the simultaneous presence of various authorities and the complex, unequal arena of legal, extra-legal and illegal forces, hinders enforcement of fishermen's customary socio-legal repertoires and also of the Colombian Constitution to protect riverside communities' human rights. The interview reflects on the great complexity of exercising community leadership, environmental protection and defense of artisanal fishing in the midst of a socio-normative political arena permeated by state abandonment and paramilitary violence. For this reason, the interview stresses the importance of recognizing artisanal fisher collectives as political subjects in river co-governance. It also highlights the ambivalent implications of granting rights to nature and rivers: their meaning, functions and impact depend on their political trajectory and mobilization by grassrooted collectives. Finally, Gutierrez proposes strengthening knowledge networks to bolster river co-governance where the political-cultural and socio-normative frameworks of riverside communities play a preponderant role.	[Boelens, Rutgerd; Forigua-Sandoval, Juliana; Duarte-Abadia, Bibiana] Wageningen Univ, Dept Environm Sci, Wageningen, Netherlands; [Boelens, Rutgerd; Duarte-Abadia, Bibiana] Univ Amsterdam, Fac Humanities, Amsterdam, Netherlands; [Boelens, Rutgerd; Duarte-Abadia, Bibiana] Univ Amsterdam, CEDLA, Amsterdam, Netherlands; [Boelens, Rutgerd] Catholic Univ Peru, Dept Social Sci, Lima, Peru; [Boelens, Rutgerd] Univ Cent Ecuador, Dept Agr Sci, Quito, Ecuador; [Forigua-Sandoval, Juliana] Univ Andes, EInterdisciplinary Ctr Dev Studies, Bogota, Colombia; [Duarte-Abadia, Bibiana] Pontificia Univ Javeriana, Inst & Rural Dev Res Grp, Fac Environm & Rural Studies, Bogota, Colombia; [Gutierrez-Camargo, Juan Carlos] Alma Fdn, Bogota, Colombia		Boelens, R (corresponding author), Wageningen Univ, Dept Environm Sci, Wageningen, Netherlands.	rutgerd.boelens@wur.nl		Duarte Abadia, Bibiana/0000-0003-4203-050X				Andrade Pérez Martín, 2016, rev.estud.soc., P73, DOI 10.7440/res55.2016.05; Bavinck M, 2018, MAR POLICY, V94, P46, DOI 10.1016/j.marpol.2018.04.026; Boelens R, 2015, SOC NATUR RESOUR, V28, P1059, DOI 10.1080/08941920.2015.1024370; Castro C., 2016, AGUA BENDITA ESPECIA; Centro Nacional de Memoria Historica (CNMH), 2014, LUCH AR DEF PESC ART; Duarte-Abadia B, 2015, HUM ORGAN, V74, P243, DOI 10.17730/0018-7259-74.3.243; Fals Borda O., 1979, HIST DOBLE COSTA; Gutierrez J.C., 2016, B OPCA, V11, P15; Molano-Bravo A., 2009, MEDIO MAGDALENA MEDI; Restrepo J.D, 2005, SEDIMENTOS RIO MAGDA; Roa-Avendano T., 2012, AGUAS REPRESADAS CAS; Rodriguez-Becerra M., 2015, CONECTAR DESENVENENA, P172; Roth D, 2015, J LEG PLUR UNOFF LAW, V47, P456, DOI 10.1080/07329113.2015.1111502; Scholtens J, 2018, ECOL SOC, V23, DOI 10.5751/ES-10216-230331; Shah E, 2021, J PEASANT STUD, V48, P1008, DOI 10.1080/03066150.2019.1669566	15	0	0	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0732-9113	2305-9931		J LEG PLUR UNOFF LAW	J. Leg. Plur. Unoff. Law	SEP 2	2021	53	3					458	476		10.1080/07329113.2021.2012376	http://dx.doi.org/10.1080/07329113.2021.2012376			19	Law	Emerging Sources Citation Index (ESCI)	Government & Law	YD6BE		Green Published, hybrid			2022-09-04	WOS:000740524600015
J	Borda, MG; Aarsland, D; Cano-Gutierrez, CA; Perez-Zepeda, MU				Borda, Miguel German; Aarsland, Dag; Cano-Gutierrez, Carlos Alberto; Perez-Zepeda, Mario Ulises			Actions to be taken for improving functional prognosis in dementia	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Letter						Dementia; Alzheimer; Lewy bodies; Disability; Aging; Functional capacity			[Borda, Miguel German; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, N-4068 Stavanger, Norway; [Borda, Miguel German; Cano-Gutierrez, Carlos Alberto; Perez-Zepeda, Mario Ulises] Pontificia Univ Javeriana, Inst Envejecimiento, Fac Med, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Borda, Miguel German] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Aarsland, Dag] Kings Coll London, Dept Old Age Psychiat, London, England; [Cano-Gutierrez, Carlos Alberto] Hosp Univ San Ignacio, Bogota, Colombia; [Perez-Zepeda, Mario Ulises] Univ Anahuac Mexico Campus Norte, Mexico Hlth Sci Res Ctr CICSA, FCS, Mexico City, DF, Mexico; [Perez-Zepeda, Mario Ulises] INGER, Res Dept, Inst Nacl Geriatria, Mexico City, DF, Mexico		Borda, MG (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, N-4068 Stavanger, Norway.	migbor@sus.no		Aarsland, Dag/0000-0001-6314-216X; Cano-Gutierrez, Carlos/0000-0001-5680-7880				Borda M.G., INT J GERIATRIC PSYC, V36; Connolly D., 2016, IRISH LONGITUDINAL S, V39, P809, DOI [10.3109/09638288.2016.1161848, DOI 10.3109/09638288.2016.1161848]; Dent E, 2019, J NUTR HEALTH AGING, V23, P771, DOI 10.1007/s12603-019-1273-z; Borda MG, 2021, ARCH GERONTOL GERIAT, V96, DOI 10.1016/j.archger.2021.104459; Borda MG, 2021, J ALZHEIMERS DIS, V79, P1713, DOI 10.3233/JAD-200961; Borda MG, 2020, J AM GERIATR SOC, V68, P2257, DOI 10.1111/jgs.16709; High KP, 2019, J AM GERIATR SOC, V67, P1782, DOI 10.1111/jgs.15975; Laan W, 2013, MATURITAS, V75, P276, DOI 10.1016/j.maturitas.2013.04.005; Spinnler H, 2020, NEUROPSYCHOLOGY, P689, DOI [10.4324/9781315791272-39, DOI 10.4324/9781315791272-39]; Volkert D, 2015, CLIN NUTR, V34, P1052, DOI 10.1016/j.clnu.2015.09.004	10	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAR 15	2022	434								120156	10.1016/j.jns.2022.120156	http://dx.doi.org/10.1016/j.jns.2022.120156			2	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	0Z7SQ	35085958				2022-09-04	WOS:000791273900026
J	Egui, A; Thomas, MC; Morell, M; Maranon, C; Carrilero, B; Segovia, M; Puerta, CJ; Pinazo, MJ; Rosas, F; Gascon, J; Lopez, MC				Egui, Adriana; Carmen Thomas, M.; Morell, Maria; Maranon, Concepcion; Carrilero, Bartolome; Segovia, Manuel; Puerta, Concepcion J.; Jesus Pinazo, Maria; Rosas, Fernando; Gascon, Joaquim; Carlos Lopez, Manuel			Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients	MOLECULAR IMMUNOLOGY			English	Article						Trypanosoma cruzi; Chagas disease; CD8(+) T epitope; Paraflagellar rod proteins (PFRs); Cytotoxic T lymphocytes	TRANSGENIC MICE; KMP-11 PROTEIN; IDENTIFICATION; ANTIGEN; IMMUNIZATION; LYMPHOCYTES; PEPTIDE; COMPONENTS; FREQUENCY; IMMUNITY	The protozoan parasite Trypanosoma cruzi is the etiological agent of Chagas disease. To date, no vaccine is available for protection against T. cruzi infection. The CD8(+) T cells immune response against specific antigens has shown to efficiently control the spread of the parasite in murine experimental infection. However, data concerning CD8(+) response in Chagas patients are still restricted to a few epitopes. We have studied the existence of immunodominant CD8(+) T cell epitopes in the paraflagellar rod proteins 2 and 3 (PFR2 and PFR3) from T. cruzi in a mouse model, and analyzed their recognition by cytotoxic T lymphocytes from Chagas disease patients. Immunization of C57BL/6-A2/K-b transgenic mice with plasmids coding for the fusion proteins PFR2-HSP70 and PFR3-HSP70 induced a specific CTL response against two PFRs epitopes (PFR2(449-457) and PFR3(481-489)), and showed specific lysis percentages of 24 and 12, respectively. Moreover, the PFR2(19-28), PFR2(156-163), PFR2(449-457), PFR3(428-436), PFR3(475-482) and PFR3(481-489) peptides were observed to have a high binding affinity to the HLA-A*02 :01 molecule. Remarkably, these HLA-A 02:01-binding peptides are successfully processed and presented during natural infection by T. cruzi in the context of MHC class I as evidenced by using peptide-pulsed K562-A2 cells as antigen presenting cells. The T cells from Chagas disease chronic patients specific for PFR2/PFR3 selected CD8(+) epitopes showed a pro-inflammatory cytokine secretion profile (IFN-gamma, TNF-alpha and IL-6). A positive Granzime B secretion was observed in three out of 16 patients in response to PFR2(156-463) and PFR2(449-457) peptides, two out of 11 patients in response to PFR219-28 peptide and one out of 14 and 11 patients in response to PFR3428-436 and PFR3481-489 peptides, respectively. The PFRs-specific cytotoxic activity in purified PBMC was only detected in patients in the indeterminate phase of the disease. (C) 2012 Elsevier Ltd. All rights reserved.	[Egui, Adriana; Carmen Thomas, M.; Morell, Maria; Maranon, Concepcion; Carlos Lopez, Manuel] Consejo Super Invest Cient IPBLN CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Carrilero, Bartolome; Segovia, Manuel] Hosp Virgen Arrixaca, Unidad Reg Med Trop, Murcia 30120, Spain; [Puerta, Concepcion J.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Mol Parasitol Lab, Bogota, Colombia; [Jesus Pinazo, Maria; Gascon, Joaquim] Hosp Clin Barcelona, Ctr Int Hlth Res CRESIB, E-08036 Barcelona, Spain; [Rosas, Fernando] Fdn Clin Abood Shaio, Bogota, Colombia		Lopez, MC (corresponding author), Consejo Super Invest Cient IPBLN CSIC, Inst Parasitol & Biomed Lopez Neyra, Parque Tecnol Ciencias Salud,Avda Conocimiento S-, Granada 18100, Spain.	mclopez@ipb.csic.es	Zaky, Mohammad/I-3187-2017; Morell, Maria/ABF-8213-2020; Delgado, Maria Jesús Pinazo/X-6093-2018; Egui, Adriana/AAA-5983-2019; C, maranon/E-1484-2013; Morell, Maria/C-4606-2017; Gascon, Joaquim/M-3598-2015; Thomas, María Carmen PhD/D-9065-2016; Puerta, Concepcion J/AAG-4912-2019; Lopez, Manuel/Z-5641-2019	Zaky, Mohammad/0000-0003-3547-2588; Morell, Maria/0000-0001-9613-9741; Delgado, Maria Jesús Pinazo/0000-0002-4237-1075; C, maranon/0000-0002-7827-6301; Morell, Maria/0000-0002-3692-1333; Gascon, Joaquim/0000-0002-5045-1585; Carrilero Fernandez, Bartolome/0000-0002-0110-603X; Egui, Adriana/0000-0002-3038-0468; Lopez, Manuel Carlos/0000-0003-0002-3678; Mursalin, Adi/0000-0002-1867-0868; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Thomas, M Carmen/0000-0003-3586-9657	Junta de Andalucia [P08-CVI-04037PAI]; Plan Nacional I+D+i (MICINN) [BFU2010-1670]; ISCIII-RETIC (MICINN, Spain) [RD06/0021 /0014, RD06/0021 /1007]; FEDER; ISCIII (MICINN, Spain) [20095GR385]	Junta de Andalucia(Junta de Andalucia); Plan Nacional I+D+i (MICINN)(Spanish Government); ISCIII-RETIC (MICINN, Spain)(Instituto de Salud Carlos IIISpanish Government); FEDER(European Commission); ISCIII (MICINN, Spain)	We are grateful to Prof. M.E. Patarroyo for his help in the peptide synthesis. We thank A. Lopez-Brajas (IPBLN-CSIC) for her technical assistance in the purification of the recombinant proteins and purification of PFRs specific antibodies; A.I. Fernandez and L Montosa (IPBLN-CSIC) for their technical assistance in the purification of peripheral mononuclear cells from blood samples; B. Rojas (IPBLN-CSIC) for her technical assistance in the indirect immunofluorescence assays. Dr. M.A. Lopez-Nevot and A. Moreno, Hospital Universitario Virgen de las Nieves, for HLA-A typing and Dr. C. Britten (Johanes Gutenberg-University) for the K562-A2 cell line. We also thank to Dr. L. Murcia and A. lborra from Hospital Virgen de la Arrixaca (Murcia, Spain) for collecting human biological samples. This work was supported by grants P08-CVI-04037PAI (Junta de Andalucia), BFU2010-1670 from Plan Nacional I+D+i (MICINN), RD06/0021 /0014 and RD06/0021 /1007 - ISCIII-RETIC (MICINN, Spain) and FEDER. MS and BC were supported by grant FIS, 20095GR385 from ISCIII (MICINN, Spain).	Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; Cazorla SI, 2009, EXPERT REV VACCINES, V8, P921, DOI [10.1586/erv.09.45, 10.1586/ERV.09.45]; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; Diez H, 2006, PARASITE IMMUNOL, V28, P101, DOI 10.1111/j.1365-3024.2005.00815.x; Dutra WO, 2005, TRENDS PARASITOL, V21, P581, DOI 10.1016/j.pt.2005.09.007; Fonseca CT, 2004, MEM I OSWALDO CRUZ, V99, P63, DOI 10.1590/S0074-02762004000900011; Fonseca SG, 2005, MICROBES INFECT, V7, P688, DOI 10.1016/j.micinf.2005.01.001; Fouts DL, 1998, J BIOL CHEM, V273, P21846, DOI 10.1074/jbc.273.34.21846; Garg N, 1997, J IMMUNOL, V158, P3293; Gowthaman U, 2010, AMINO ACIDS, V39, P1333, DOI 10.1007/s00726-010-0579-2; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; KRAUSA P, 1995, TISSUE ANTIGENS, V45, P223, DOI 10.1111/j.1399-0039.1995.tb02444.x; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Lasso P, 2010, PARASITE IMMUNOL, V32, P494, DOI 10.1111/j.1365-3024.2010.01206.x; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Luhrs KA, 2003, VACCINE, V21, P3058, DOI 10.1016/S0264-410X(03)00108-7; Maga JA, 1999, TRENDS CELL BIOL, V9, P409, DOI 10.1016/S0962-8924(99)01635-9; Maranon C, 2000, INT IMMUNOL, V12, P1685, DOI 10.1093/intimm/12.12.1685; Maranon C, 2001, MOL IMMUNOL, V38, P279, DOI 10.1016/S0161-5890(01)00059-1; Maranon C, 2011, MICROBES INFECT, V13, P1025, DOI 10.1016/j.micinf.2011.05.010; Marin-Neto JA, 2009, MEM I OSWALDO CRUZ, V104, P319, DOI 10.1590/S0074-02762009000900042; Matsuda NM, 2009, CLINICS, V64, P1219, DOI 10.1590/S1807-59322009001200013; Miyahira Y, 2008, PARASITOL INT, V57, P38, DOI 10.1016/j.parint.2007.07.005; Morell M, 2006, VACCINE, V24, P7046, DOI 10.1016/j.vaccine.2006.07.006; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Punukollu G, 2007, INT J CARDIOL, V115, P279, DOI 10.1016/j.ijcard.2006.03.004; Rassi A, 2010, INT J CARDIOL, V145, P64, DOI 10.1016/j.ijcard.2009.04.034; SETTE A, 1994, MOL IMMUNOL, V31, P813, DOI 10.1016/0161-5890(94)90019-1; Tanowitz HB, 2009, PROG CARDIOVASC DIS, V51, P524, DOI 10.1016/j.pcad.2009.02.001; Thomas MC, 2000, DNA CELL BIOL, V19, P47, DOI 10.1089/104454900314708; Thomas MC, 2001, CLIN EXP IMMUNOL, V123, P465, DOI 10.1046/j.1365-2249.2001.01478.x; van der Aar AMG, 2011, J IMMUNOL, V187, P3488, DOI 10.4049/jimmunol.1101105; Vazquez-Chagoyan JC, 2011, ADV PARASIT, V75, P121, DOI 10.1016/B978-0-12-385863-4.00006-X; VITIELLO A, 1991, J EXP MED, V173, P1007, DOI 10.1084/jem.173.4.1007; Wizel B, 1997, J IMMUNOL, V159, P6120; Wrightsman RA, 2002, PARASITE IMMUNOL, V24, P401, DOI 10.1046/j.1365-3024.2002.00479.x; WRIGHTSMAN RA, 1995, INFECT IMMUN, V63, P122, DOI 10.1128/IAI.63.1.122-125.1995	40	27	27	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0161-5890			MOL IMMUNOL	Mol. Immunol.	OCT-DEC	2012	52	3-4					289	298		10.1016/j.molimm.2012.05.021	http://dx.doi.org/10.1016/j.molimm.2012.05.021			10	Biochemistry & Molecular Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Immunology	988KM	22750229				2022-09-04	WOS:000307489800025
J	Guisande, C; Aranguren, N; Andrade-Sossa, C; Prat, N; Granado-Lorencio, C; Barrios, ML; Bolivar, A; Nunez-Avellaneda, M; Duque, SR				Guisande, C; Aranguren, N; Andrade-Sossa, C; Prat, N; Granado-Lorencio, C; Barrios, ML; Bolivar, A; Nunez-Avellaneda, M; Duque, SR			Relative balance of the cost and benefit associated with carnivory in the tropical Utricularia foliosa	AQUATIC BOTANY			English	Article						bladderwort; carnivorous plant; predation; zooplankton; nutrients	VULGARIS L; SIZE; DAPHNIA; BIOMASS; LENTIBULARIACEAE; ZOOPLANKTON; BLADDERWORT; INVESTMENT; MACRORHIZA; PURPUREA	Investment by bladderwort (Utricularia foliosa) in carnivory, in terms of total C and N of bladders per leaf, was estimated in places with different nutrient concentrations from the Yahuarcaca Creek in the Colombian Amazon. The aims were to determine whether nutrient limiting conditions stimulate the investment in carnivory, and the relative balance between C and N invested in carnivory versus C and N obtained from prey. There were no significant differences either for phosphate (PO43-) concentration or for ammonia (NH4+) concentration among five sampling areas, along approximately 5 km long stretch of the creek, with a pooled mean +/- S.D. of 0.19 +/- 0.06 and 8.6 +/- 3.0 muM, respectively. However, there were significant differences in the nitrate (NO3-) concentration ranging from 0.6 to 2.5 muM. Total C and N of bladders per leaf increased with decreasing NO3-. This corroborates the hypotheses that the carnivorous plant U. foliosa optimises its investment in carnivory according to nutrient availability in the water, and that N is a limiting factor that stimulates the investment in carnivory. The numbers of prey per bladder were also higher under NO3- limitation, thus enhancing the input of nutrients toward the plant through the bladders. The ratio of total C of prey captured/total C invested in bladders was always lower than 1. However, the efficiency of N was higher since when NO3- concentration was lower than 1 muM, the ratio of total N of prey captured/total N invested in bladders ranged between 0.97 and 1.67. (C) 2004 Published by Elsevier B.V.	Univ Vigo, Fac Ciencias, Dep Ecol & Biol Anim, Vigo 36200, Spain; Univ Pedagog & Tecnol Colombia, Unidad Ecol Sistemas Acuat, Bogota 72487, Colombia; Pontif Univ Javeriana, UNESIS, Dept Ciencias Biol, Bogota 72487, Colombia; Univ Barcelona, Fac Biol, Dept Ecol, E-08028 Barcelona, Spain; Univ Sevilla, Fac Biol, Seville, Spain; Univ Nacl Colombia, Inst Amazon Invest IMANI, Leticia 215, Colombia; Inst Amazon Invest Cientif SINCHI, Leticia, Colombia		Guisande, C (corresponding author), Univ Vigo, Fac Ciencias, Dep Ecol & Biol Anim, Campus Lagoas Marcosende, Vigo 36200, Spain.	castor@uvigo.es	Prat, Narcis/D-4405-2014; Sossa, Camilo Ernesto Andrade/AAD-1954-2019	Prat, Narcis/0000-0002-1550-1305; Sossa, Camilo Ernesto Andrade/0000-0003-4047-2443; Aranguren-Riano, Nelson J./0000-0003-0117-1015; Granado Lorencio, Carlos Antonio/0000-0002-3322-4276				ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; *APHA AWWA WEF, 1992, MET NORM AN AG POT R; BAUDOUIN MF, 1972, LIMNOL OCEANOGR, V17, P645; Carrillo P, 2001, J PLANKTON RES, V23, P537, DOI 10.1093/plankt/23.5.537; Cobo F., 2000, NACC Bioloxia, V10, P77; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Ellison AM, 2002, P NATL ACAD SCI USA, V99, P4409, DOI 10.1073/pnas.022057199; Ellison AM, 2001, TRENDS ECOL EVOL, V16, P623, DOI 10.1016/S0169-5347(01)02269-8; FRIDAY LE, 1991, FUNCT ECOL, V5, P602, DOI 10.2307/2389478; FRIDAY LE, 1992, NEW PHYTOL, V121, P439, DOI 10.1111/j.1469-8137.1992.tb02944.x; Furch K, 1997, CENTRAL AMAZON FLOOD, V1, P69; GLIWICZ ZM, 1990, ARCH HYDROBIOL, V120, P51; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; GUISANDE C, 1992, J PLANKTON RES, V14, P997, DOI 10.1093/plankt/14.7.997; Guisande C., 2000, Aquatic Ecology, V34, P137, DOI 10.1023/A:1009966231287; Jobson RW, 2001, AUSTRAL ECOL, V26, P680, DOI 10.1046/j.1442-9993.2001.01149.x; KNIGHT SE, 1991, ECOLOGY, V72, P728, DOI 10.2307/2937212; KNIGHT SE, 1992, OECOLOGIA, V89, P348, DOI 10.1007/BF00317412; LOLLAR AQ, 1971, ARCH HYDROBIOL, V60, P400; MONROY D, 2002, THESIS U PEDAGOGICA; NOLTE U, 1990, FRESHWATER BIOL, V24, P443, DOI 10.1111/j.1365-2427.1990.tb00723.x; Richards JH, 2001, AM J BOT, V88, P170, DOI 10.2307/2657137; STEMBERGER RS, 1987, ECOLOGY, V68, P181, DOI 10.2307/1938818; TESSIER AJ, 1991, ECOLOGY, V72, P468, DOI 10.2307/2937188; Villar-Argaiz M, 2002, ECOLOGY, V83, P1899, DOI 10.1890/0012-9658(2002)083[1899:LLHSAO]2.0.CO;2	25	25	27	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3770	1879-1522		AQUAT BOT	Aquat. Bot.	DEC	2004	80	4					271	282		10.1016/j.aquabot.2004.08.007	http://dx.doi.org/10.1016/j.aquabot.2004.08.007			12	Plant Sciences; Marine & Freshwater Biology	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Marine & Freshwater Biology	889DW					2022-09-04	WOS:000226424700004
J	Gallegos, M; Perez-Acosta, AM; Klappenbach, H; Lopez, WL; Bregman, C				Gallegos, Miguel; Perez-Acosta, Andres M.; Klappenbach, Hugo; Lopez Lopez, Wilson; Bregman, Claudia			The bibliometric studies in the field of Ibero-American psychology: A metabibliometric review	INTERDISCIPLINARIA			Spanish	Review						scientometrics; bibliometric analysis; metabibliometric analysis; history of psychology; Ibero-America	CLINICAL-PSYCHOLOGY; JOURNALS; SPANISH; ARGENTINA; HISTORY; REVISTA; COLLABORATION; INTERVENTIONS; PUBLICATION; VISIBILITY	Bibliometry consists on the mathematical and statistical treatment of published scientific information. This methodology, or technique (following some authors), includes the quantification of bibliographic information that can be analyzed. Bibliometric and qualitative data reviews can be combined in order to offer high-quality conclusions. For more than three decades, bibliometric studies have proliferated with different uses, orientations, and applications in Ibero-American psychology. All the classic areas of psychology (basic psychological processes, clinical and health psychology, organizational and work psychology, educational psychology), as well as new areas, such as sports psychology, traffic psychology, consumer psychology, and others have been subject of bibliometric works. Several productions can be recognized where bibliometry is used for historical analysis, review of specialized literature, scientific journals analysis, and the recognition of different areas of research. The goal of this work is to provide a metabibliometric analysis, that is, a bibliometry of bibliometric studies. It is a descriptive study in which different documentary sources are retrieved, classified, and analyzed based on the proper procedure of bibliometric studies. This study examined the scientific and scholarly productions in the field of Ibero-American psychology, using three specific databases: Dialnet (Spain), Redalyc (Mexico), and SciELO (Brazil). The choice of such databases was because they provide the indexation of a large number of psychology journals and also allow free access to their contents, which gives some coverage to the psychological production of the Ibero-American region. The search was guided by the following general descriptors: "Bibliometric" and "Psychology", present in any of the search fields of these databases. These two words are functionally equivalent to detect items in Spanish and Portuguese (because all articles have abstracts in English). Interdisciplinary studies were ruled out, and those clearly outside of psychological science or the profession of psychology. The final refined sample of 81 articles were classified according to the following indicators: a) lines of research; b) more frequent authors; c) countries of the authors; d) range of years of publications; e) language of the publications; f) gender in the writing of the works; g) the journals that published the most bibliometric studies; and h) the most analyzed journals from the bibliometric perspective. The vast majority of articles are from the present century (70), which highlights the recent explosion of work in the field. For reference only, eight articles were published in the 1990s, 34 articles were published in the 2000s, and 36 articles were published in the current half-decade. The language of the articles is distributed as follows: 71 in Spanish (88 %), 5 in English (6 %), and 5 in Portuguese (6 %). The proportion by gender of correspondence authors reflects that 40 % are women (33 articles), and 60 % are men (48 articles), always considering the first signatory in cases of multiple authorship. The countries according to the correspondence author, taking the first author in the cases of multiple authors- hips, are: Spain (45), Colombia (15), Argentina (6), Brazil (5), Mexico (4), Chile (3), Peru (2) and Costa Rica (1). Results confirm that the bibliometric research design is a consistent methodological approach to evaluate the field of psychology as a discipline and a professional practice in Ibero-America. These results do not reflect the entire set of bibliometric research in Ibero-American psychology. However, they can also be considered as a representative map of bibliometric studies in the region. The most significant criticism that can be indicated for these bibliometric studies is the abusive descriptive perspective that appears in them. It would be desirable for this kind of research to incorporate other analytical perspectives to go beyond the purely descriptive, which could obtain greater interpretative and explanatory potential regarding what was investigated.	[Gallegos, Miguel; Bregman, Claudia] Univ Nacl Rosario, Rosario, Argentina; [Gallegos, Miguel] Univ Catolica Maule, Curico, Chile; [Gallegos, Miguel; Perez-Acosta, Andres M.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Perez-Acosta, Andres M.] Univ Rosario, Escuela Med & Ciencias Salud, Programa Psicol, Bogota, Colombia; [Klappenbach, Hugo] Univ Nacl San Luis, Fac Psicol, San Luis, Argentina; [Lopez Lopez, Wilson] Pontificia Univ Javeriana, Bogota, Colombia; [Bregman, Claudia] Fdn Aigle, Buenos Aires, DF, Argentina; [Bregman, Claudia] Univ Rosario, Bogota, Colombia		Gallegos, M (corresponding author), Univ Nacl Rosario, Rosario, Argentina.; Gallegos, M (corresponding author), Univ Catolica Maule, Curico, Chile.; Gallegos, M (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina.	maypsi@yahoo.com.ar; andres.perez@urosario.edu.co; lopezw@javeriana.edu.co	López López, Wilson/AAV-8032-2021; Gallegos, Miguel/AAX-6132-2020	López López, Wilson/0000-0002-2964-0402; Gallegos, Miguel/0000-0001-6891-7833; Bregman, Claudia/0000-0003-4128-5666; Perez Acosta, Andres Manuel/0000-0002-1133-8926				Agudelo D, 2003, PSICOTHEMA, V15, P507; Aguilar B. María Constanza, 2007, Divers.: Perspect. Psicol., V3, P317; Alcain M. D., 1993, Revista Espanola de Documentacion Cientifica, V16, P30; Alcain M.D., 2001, PAPELES PSICOLOGO, V78, P11; Almendro Marin M.T., 2007, INFORM PSICOLOGICA, V89, P10; Alonso F., 2002, IBERPSICOLOGIA, V7; Annicchiarico I, 2013, AV PSICOL LATINOAM, V31, P3; [Anonymous], 1996, INTRO BIBLIOMETRIA; Ibarzabal FA, 2010, REV PSICOL DEPORTE, V19, P231; ARCH M, 2010, REV IBEROAMERICANA P, V1, P155; Ardila R, 2005, REV LAT AM PSICOL, V37, P595; Arias W., 2011, NUEVOS PARADIGMAS, V5, P59; Arias W., 2015, REV PERUANA PSICOLOG, V4, P57; Arias W., 2016, IND DATA, V19, P17, DOI [10.15381/idata.v19i1.12533, DOI 10.15381/IDATA.V19I1.12533]; Ariza T, 2012, TER PSICOL, V30, P89, DOI 10.4067/S0718-48082012000300009; Ávila-Toscano José Hernando, 2016, Psicol. caribe, V33, P66, DOI 10.14482/psdc.33.1.8063; Benito E., 2010, 2 C INT INV PRACT PR, P34; Bilyk E, 2015, PSIENCIA-REV LATINOA, V7, P383, DOI 10.5872/psiencia/7.2.121; Blumen S, 2013, REV PSICOL-LIMA, V31, P173; Bregman C, 2015, TER PSICOL, V33, P205, DOI 10.4067/S0718-48082015000300005; BROADUS RN, 1987, SCIENTOMETRICS, V12, P373, DOI 10.1007/BF02016680; Brozek J, 1998, REV LAT AM PSICOL, V30, P103; Brozek J., 1991, REV HIST PSICOLOGIA, V12, P15; Buela-Casal G., 2005, REV LATINOAMERICANA, V37, P211; Cairo Valcarcel E., 1998, REV CUBANA PSICOLOGI, V15, P168; Cajal B., 2001, METODOLOGIA CIENCIAS, V3, P53; Carpintero H., 1981, PSICOLOGIA CONT TEOR; Carpintero H., 1983, REV HIST PSICOLOGIA, V4, P21; Carpintero H., 1977, ANUARIO PSICOLOGIA, V16, P23; Angulo EC, 2012, REV COSTARRIC PSICOL, V31, P1; Ceacero J., 1991, REV HIST PSICOLOGIA, V12, P115; Cervigni M, 2015, CUAD NEUROPSICOL, V9, P109, DOI 10.7714/cnps/9.1.205; Chilito Pinto M.A., 2010, REV ELECT MOTIVACION, V35-36, P1; Colotla V.A., 1983, REV HIST PSICOLOGIA, V4, P59; COSTA VÍVIAN FLORES, 2015, RAM, Rev. Adm. Mackenzie, V16, P45, DOI 10.1590/1678-69712015/administracao.v16n2p45-71; Crego Diaz A., 2004, REV PSICOLOGIA TRABA, V20, P291; Cudina JN., 2017, REV INTERAM PSICOL, V51, P282; Diaz-Escoto A.S., 2010, BIBLIOTECA U, V13, P16; Diez Florez G.M., 2014, REV IBEROAMERICANA P, V9, P421; Diez Zamorano M.A., 2003, INT J CLIN HLTH PSYC, V3, P645; Fierro C., 2016, ENSENANZA HISTORIA P; Fierro C., 2019, TRENDS PSYCHOL TEMAS, V27, P819; Fierro C, 2019, REV ARGENT CLIN PSIC, V28, P32, DOI 10.24205/03276716.2018.1075; Fierro C, 2017, CUAD NEUROPSICOL, V11, P30; Gallardo C., 1996, PAPELES PSICOLOGO, V64, P61; Gallegos M., 2019, HISTORIAS PSICOLOGIA, P167; Gallegos M., 2012, THESIS; Gallegos M., 2016, ENSENANZA INVESTIGAC, V21, P319; Gallegos M., 2012, REV INTERAMERICANA P, V46, P21; GALLEGOS MIGUEL, 2010, Univ. Psychol., V9, P911; GARCIA J, 2005, REV PSICOLOGIA DEPOR, V0014, P00125; Martinez ATG, 2008, PSICOTHEMA, V20, P465; Garcia-Silberman S, 2004, SALUD MENT, V27, P8; Garfield E, 1978, METRIC SCI ADVENT SC; Gil PJM, 2000, PSICOTHEMA, V12, P346; GÓMEZ MORALES YURI JACK, 2012, Rev. colomb. psicol., V21, P97; GÓMEZ-MORALES YURI JACK, 2015, Rev. colomb. antropol., V51, P291; Gonzalez E. N., 2015, UNIV PSYCHOL, V14, P15; Gonzalez-Alcaide G, 2010, PSICOTHEMA, V22, P41; Gonzalez-Forteza C, 2012, SALUD MENT, V35, P13; Guerra Viadero M.L., 2003, INT J CLIN HLTH PSYC, V3, P371; Gutierrez G, 2009, REV LAT AM PSICOL, V41, P413; Avila-Toscano JH, 2014, AV PSICOL LATINOAM, V32, P167, DOI 10.12804/apl32.1.2014.12; Jaraba-Barrios B, 2011, AV PSICOL LATINOAM, V29, P354; Klappenbach H., 1999, ACTA PSIQUIATRICA PS, V45, P303; Klappenbach H., 2011, REV ARGENTINA PSICOL, V50, P44; Klappenbach H., 2017, REV GUILLERMO OCKHAM, V15, P5; Klappenbach H., 2008, REV PSICOLOGIA LA PL, V10, P13; Lascurain Sanchez M., 1997, REV GEN INFORM DOCUM, V7, P95; LEON R, 1981, REV LAT AM PSICOL, V13, P345; LEON R, 1982, REV LAT AM PSICOL, V14, P171; Leon R., 1989, REV PSICOLOGIA, V7, P105; Liberatore G., 2008, REV INTERAM PSICOL, V42, P507; Liberatore G., 2014, PERSPECTIVAS PSICOLO, V11, P6; Lopes C. A., 1999, ANAL PSICOL, V17, P457; Lopez Lopez P., 1999, REV PSICOLOGIA UNIVE, V21, P127; Lopez Lopez P., 1994, REV GEN INFORM DOCUM, V4, P41; Lopez WL, 2006, AV PSICOL LATINOAM, V24, P59; LÓPEZ LÓPEZ WILSON, 2010, Act.Colom.Psicol., V13, P35; Lopez-Lopez W, 2015, PSICOL-REFLEX CRIT, V28, P72, DOI 10.1590/1678-7153.20152840011; López-López Wilson, 2010, Univ. Psychol., V9, P607; Lopez-Pinero J.M., 1973, HACIA CIENCIA CIENCI, P5; Magaz A., 2004, REV PSICOPATOLOGIA P, V9, P231; Marin E, 2013, SPORT TK, V2, P77; Marinelarena-Dondena L, 2012, REV ARGENT CIENC COM, V4, P21; Marinelarena-Dondena L, 2010, PSICODEBATE-PSICOL C, V10, P9, DOI 10.18682/pd.v10i0.386; Marti-Vilar M, 2014, REV COLOMB CIENC SOC, V5, P367; Martinez-Taboas A., 2006, REV PUERTORRIQUENA P, V17, P571; Mateus J., 2014, REV VANGUARDIA PSICO, V4, P122; Rivera-Garzon DM, 2008, UNIV PSYCHOL, V7, P917; Maya Jariego I., 1997, REV PSICOLOGIA SOCIA, V1, P69; Miguel Sandra, 2013, Inf. cult. soc., P117; Moncada L, 2014, REV ARGENT CLIN PSIC, V23, P71; Merida JAM, 2007, REV IBEROAM PSICOL E, V2, P13; Navarlaz V.E., 2008, REV ANUARIO INVESTIG, V15, P151; Navarrete-Cortes J, 2010, UNIV PSYCHOL, V9, P553, DOI 10.11144/Javeriana.upsy9-2.gpba; Gonzalez EN, 2008, REV ARGENT CLIN PSIC, V17, P277; Osca J, 2005, AN DOC, V8, P165; Osca-Lluch J, 2009, PSICOTHEMA, V21, P300; Pachon-Basallo M, 2013, TER PSICOL, V31, P325, DOI 10.4067/S0718-48082013000300007; Pastor Carballo R., 1981, REV HIST PSICOLOGIA, V2, P361; Perdomo Escobar S.J., 2003, ACTA COLOMB PSICOL, V9, P105; Pérez Fernández Francisco, 2010, Clínica y Salud, V21, P141; Perez Nieto M.A., 2014, REV PSICOLOGIA EDUCA, V13, P75; Pinto AL, 2014, TRANSINFORMACAO, V26, P253, DOI 10.1590/0103-3786201400030003; Polanco F., 2017, REV GUILLERMO OCKHAM, V15, P13; Polanco F., 2017, REV INTERAM PSICOL, V51, P297, DOI [10.30849/rip/ijp.v51i3.910, DOI 10.30849/RIP/IJP.V51I3.910]; Polanco-Carrasco R, 2017, TER PSICOL, V35, P81; Polo L, 2014, UNIV PSYCHOL, V13, P2047, DOI 10.11144/Javeriana.upsy13-5.ftea; Portillo-Salido EF, 2010, SPAN J PSYCHOL, V13, P503, DOI 10.1017/S1138741600004054; PRITCHARD A, 1969, J DOC, V25, P348; PUCHE-NAVARRO REBECA, 2012, Rev. colomb. psicol., V21, P79; Quevedo-Blasco Raúl, 2010, Psicol. Reflex. Crit., V23, P384, DOI 10.1590/S0102-79722010000200021; Quevedo-Blasco R, 2010, SALUD MENT, V33, P133; Vidal EQ, 2008, HIST CIENC SAUDE-MAN, V15, P543; Quintana A., 2006, REV INVESTIGACION PS, V9, P81; Ravelo E. L, 2016, ACTA COLOMB PSICOL, V19, P281, DOI DOI 10.14718/ACP.2016.19.2.12; Botero JCR, 2015, SOPHIA-EDUC, V11, P21; REY A CÉSAR A, 2005, Act.Colom.Psicol., V8, P97; Rey Anacona César Armando, 2009, Ter Psicol, V27, P61; Ribas Jr R.C., 2009, REV INTERAMERICANA P, V43, P532, DOI [10.1590/S1413-294X2013000100010, DOI 10.1590/S1413-294X2013000100010]; Robles JR, 2010, AV PSICOL LATINOAM, V28, P12; Croce JR, 2014, LIBERABIT-LIMA, V20, P369; Saiz M., 1994, ANUARIO PSICOLOGIA, V63, P25; Salas Gonzalo, 2017, Psykhe, V26, P1, DOI 10.7764/psykhe.26.1.1205; Sampaio Maria Imaculada Cardoso, 2010, Psicol. cienc. prof., V30, P220; Sanchez Hernandez A.M., 1995, ANALES PSICOLOGIA, V11, P1; Sanz J., 2002, PAPELES PSICOLOGO, P54; Sesé Albert, 2012, Clínica y Salud, V23, P97; Peralta YFS, 2010, PASOS, V8, P13; Souza-Silva J.R., 2010, ANALISE PRODUCAO CIE, V12, P164; Stasiejko H., 1994, REV ARGENT CLIN PSIC, V3, P349; Steil Andrea Valéria, 2014, Estud. psicol. (Natal), V19, P31, DOI 10.1590/S1413-294X2014000100005; Garcia-Martinez AT, 2009, UNIV PSYCHOL, V8, P13; Vazquez Ferrero S., 2009, REV LATINOAMERICANA, V1, P48, DOI DOI 10.5872/PSIENCIA.V1I2.23; Ferrero SV, 2010, PSIENCIA-REV LATINOA, V2, P55; Velasco J, 2014, REV IBEROAM PSICOL S, V5, P105; Vera-Villarroel P.E., 2003, TER PSICOL, V21, P61; Vera-Villarroel P, 2006, REV LAT AM PSICOL, V38, P551; Mestre MV, 2005, REV HIST PSICOL, V26, P45; Villalobos-Galvis F, 2007, REV LAT AM PSICOL, V39, P593; Visca J., 2018, REV ARGENT CLIN PSIC, V27, P1, DOI [10.21205/03276716.2018.1061, DOI 10.21205/03276716.2018.1061]; Yamamoto O. H., 2002, Ciencia da Informacao, V31, P163, DOI 10.1590/S0100-19652002000200017; YAMAMOTO OH, 1999, PSICOL-REFLEX CRIT, V12, P549; Ynoub R.C., 2004, INVESTIGACIONES PSIC, V1, P129	145	4	4	4	13	CENTRO INTERAMERICANO INVESTIGACIONES PSICOLOGICAS Y CIENCIAS AFINES-CIIPCA	BUENOS AIRES	TTE GRAL J D PERON 2158, BUENOS AIRES, 00000, ARGENTINA	1668-7027			INTERDISCIPLINARIA	Interdisciplinaria	JUL-DEC	2020	37	2					95	115		10.16888/interd.2020.37.2.6	http://dx.doi.org/10.16888/interd.2020.37.2.6			21	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	PM0RH		gold			2022-09-04	WOS:000603517000006
J	Mandrik, O; Zielonke, N; Meheus, F; Severens, JL; Guha, N; Acosta, RH; Murillo, R				Mandrik, Olena; Zielonke, Nadine; Meheus, Filip; Severens, J. L. (Hans); Guha, Neela; Acosta, Rolando Herrero; Murillo, Raul			Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening	INTERNATIONAL JOURNAL OF CANCER			English	Article						breast cancer screening; systematic review; benefits; harms; mortality; accuracy; overdiagnosis; false-positive	PREVENTIVE HEALTH-CARE; DIGITAL MAMMOGRAPHY; COST-EFFECTIVENESS; 2001 UPDATE; MORTALITY; EUROPE; WOMEN; METAANALYSIS; TRIALS; IMPACT	This systematic review, stimulated by inconsistency in secondary evidence, reports the benefits and harms of breast cancer (BC) screening and their determinants according to systematic reviews. A systematic search, which identified 9,976 abstracts, led to the inclusion of 58 reviews. BC mortality reduction with screening mammography was 15-25% in trials and 28-56% in observational studies in all age groups, and the risk of stage III+ cancers was reduced for women older than 49 years. Overdiagnosis due to mammography was 1-60% in trials and 1-12% in studies with a low risk of bias, and cumulative false-positive rates were lower with biennial than annual screening (3-17% vs 0.01-41%). There is no consistency in the reviews' conclusions about the magnitude of BC mortality reduction among women younger than 50 years or older than 69 years, or determinants of benefits and harms of mammography, including the type of mammography (digital vs screen-film), the number of views and the screening interval. Similarly, there was no solid evidence on determinants of benefits and harms or BC mortality reduction with screening by ultrasonography or clinical breast examination (sensitivity ranges, 54-84% and 47-69%, respectively), and strong evidence of unfavourable benefit-to-harm ratio with breast self-examination. The reviews' conclusions were not dependent on the quality of the reviews or publication date. Systematic reviews on mammography screening, mainly from high-income countries, systematically disagree on the interpretation of the benefit-to-harm ratio. Future reviews are unlikely to clarify the discrepancies unless new original studies are published.	[Mandrik, Olena; Meheus, Filip; Acosta, Rolando Herrero; Murillo, Raul] Int Agcy Res Canc, Sect Early Detect & Prevent, Lyon, France; [Mandrik, Olena; Severens, J. L. (Hans)] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Mandrik, Olena] Univ Sheffield, Sch Hlth & Related Res ScHARR, HEDS, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England; [Zielonke, Nadine] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Severens, J. L. (Hans)] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands; [Guha, Neela] Int Agcy Res Canc, Sect Evidence Synth & Classificat, Lyon, France; [Murillo, Raul] Hosp Univ San Ignacio, Ctr Javeriano Oncol, Bogota, Colombia; [Murillo, Raul] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia		Mandrik, O (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, HEDS, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.	olena.dem@gmail.com	Murillo, Raúl/AAY-4416-2021; Guha, Neela/AAG-3989-2021	Guha, Neela/0000-0003-3991-4662; Mandrik, Olena/0000-0003-3755-3031	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	European Commission (OM); Grant number: FP7 Marie Curie Actions -People -Co-funding	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Baxter N, 2001, CAN MED ASSOC J, V164, P1837; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Broeders M, 2012, J MED SCREEN, V19, P14, DOI 10.1258/jms.2012.012078; Carter JL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7773; Chen Tony Hsiu-Hsi, 2017, Medicine (Baltimore), V96, pe5684, DOI [10.1097/MD.0000000000005684, 10.1097/md.0000000000005684]; Dinnes J, 2001, BREAST, V10, P455, DOI 10.1054/brst.2001.0350; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Erpeldinger S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-368; Fitzpatrick-Lewis D., 2011, BRE CANC SCREENING; Galit W, 2007, MATURITAS, V57, P109, DOI 10.1016/j.maturitas.2007.01.010; Gartlehner G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009632.pub2; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Gotzsche Peter C, 2011, Dan Med Bull, V58, pA4246; Hamashima C, 2016, JPN J CLIN ONCOL, V46, P482, DOI 10.1093/jjco/hyw008; Havrilesky L, 2014, DUKE EVIDENCE SYNTHE, V179; Ho C, 2002, 30 CAN COORD OFF HLT, P68; Hofvind S, 2012, J MED SCREEN, V19, P57, DOI 10.1258/jms.2012.012083; Huang Yuan, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1296; Humphrey L, 2002, SCREEN BREAST CANC; IARC Working Group, 2014, BRE CANC SCREENING; Iared W, 2011, SAO PAULO MED J, V129, P250, DOI 10.1590/S1516-31802011000400009; Irvin VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098105; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Koleva-Kolarova RG, 2015, BREAST, V24, P354, DOI 10.1016/j.breast.2015.03.013; Kosters J P, 2003, Cochrane Database Syst Rev, pCD003373, DOI 10.1002/14651858.CD003373; Lee EH, 2015, J KOREAN MED ASSOC, V58, P408, DOI 10.5124/jkma.2015.58.5.408; Mandrik O, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0510-y; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Medical Advisory Secretariat, 2010, Ont Health Technol Assess Ser, V10, P1; Moss SM, 2012, J MED SCREEN, V19, P26, DOI 10.1258/jms.2012.012079; Murad M Hassan, 2016, Evid Based Med, V21, P125, DOI 10.1136/ebmed-2016-110401; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; Nagtegaal ID, 2013, BREAST CANCER RES TR, V137, P653, DOI 10.1007/s10549-012-2384-y; Nelson HD, 2016, SCREENING BREAST CAN; Nelson HD, 2009, SCREENING BREAST CAN; Nickson C, 2012, CANCER EPIDEM BIOMAR, V21, P1479, DOI 10.1158/1055-9965.EPI-12-0468; Njor S, 2012, J MED SCREEN, V19, P33, DOI 10.1258/jms.2012.012080; Olsen O, 2001, COCHRANE DB SYST REV, V58; Petticrew MP, 2000, HEALTH TECHNOL ASSES, V4, P1; Posso M, 2017, EUR J RADIOL, V96, P40, DOI 10.1016/j.ejrad.2017.09.013; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Ringash J, 2001, CAN MED ASSOC J, V164, P469; Rothenberg Barbara M, 2006, J Am Coll Radiol, V3, P586, DOI 10.1016/j.jacr.2006.02.030; Saadatmand S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4901; Schiller-Fruthwirth IC, 2017, APPL HEALTH ECON HEA, V15, P333, DOI 10.1007/s40258-017-0312-3; Schmidt AF, 2013, J CLIN EPIDEMIOL, V66, P599, DOI 10.1016/j.jclinepi.2012.08.008; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Tabar L, 2015, BREAST J, V21, P13, DOI 10.1111/tbj.12354; van den Ende C, 2017, INT J CANCER, V141, P1295, DOI 10.1002/ijc.30794; World Bank, 2015, BALI FINTECH AGENDA	54	24	24	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-7136	1097-0215		INT J CANCER	Int. J. Cancer	AUG 15	2019	145	4					994	1006		10.1002/ijc.32211	http://dx.doi.org/10.1002/ijc.32211			13	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	IE7RJ	30762235	Green Published, hybrid, Green Accepted			2022-09-04	WOS:000472571300013
J	Cariello, AN; Perrin, PB; Agudelo, YR; Plaza, SLO; Quijano-Martinez, MC; Trujillo, MA; Arango-Lasprilla, JC				Cariello, Anna N.; Perrin, Paul B.; Rodriguez Agudelo, Yaneth; Olivera Plaza, Silvia Leonor; Cristina Quijano-Martinez, Maria; Trujillo, Michael A.; Carlos Arango-Lasprilla, Juan			Predictors of longitudinal depression trajectories after traumatic brain injury in Latin America: A multi-site study	NEUROREHABILITATION			English	Article						Traumatic brain injury; caregivers; depression; Latin America; rehabilitation	QUALITY-OF-LIFE; QUESTIONNAIRE EBIQ; BEHAVIOR; HEALTH; MODEL; REHABILITATION; INDIVIDUALS; MILD; IMPAIRMENT; CAREGIVERS	BACKGROUND: Latin America has exceptionally high rates of traumatic brain injury (TBI), but very little research has been conducted on longitudinal TBI outcomes in this global region. OBJECTIVE: This study examined whether cognitive dysfunction and social disadaptation in individuals with TBI in Latin America at hospital discharge predict longitudinal trajectories of depression at baseline, 2 months, and 4 months. METHODS: A sample of 109 people with a new TBI was recruited from three hospitals: Mexico City, Mexico, Cali, Colombia and Neiva, Colombia. Participants completed measures of cognitive dysfunction and social disadaptation before hospital discharge and measures of depression at baseline, 2 months, and 4 months. RESULTS: Results suggested that depression scores were found to decrease over time in a quadratic (or U-shaped) fashion, and more significant cognitive dysfunction at hospital discharge was associated with higher longitudinal depression trajectories. Social disadaptation did not exert a unique effect on depression trajectories after controlling for cognitive dysfunction. Depression trajectories changed differentially over time as a function of baseline cognitive dysfunction, such that for those with high cognitive impairment, depression scores started high and then dropped to a moderated range and plateaued, but for individuals with low cognitive dysfunction, depression scores started lower and decreased linearly but moderately. CONCLUSIONS: The results suggest a strong need for neuropsychological assessments and evidence-based cognitive rehabilitation strategies to be implemented immediately after TBI in Latin America, which could exert salubrious effects on depression trajectories over time.	[Cariello, Anna N.; Perrin, Paul B.] Virginia Commonwealth Univ, Richmond, VA USA; [Rodriguez Agudelo, Yaneth] Natl Inst Neurol & Neurosur, Dept Neuropsychol, Mexico City, DF, Mexico; [Olivera Plaza, Silvia Leonor] Univ Sur Colombiana, Neiva, Huila, Colombia; [Cristina Quijano-Martinez, Maria] Pontificia Univ Javeriana Cali, Dept Social Sci, Valle Del Cauca, Colombia; [Trujillo, Michael A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp Barakaldo, BioCruces Bizkaia Hlth Res Inst, Baracaldo, Spain; [Carlos Arango-Lasprilla, Juan] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Carlos Arango-Lasprilla, Juan] Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Leioa, Spain		Arango-Lasprilla, JC (corresponding author), Ikerbasque, Basque Fdn Sci, BioCruces Bizkaia Hlth Res Inst, Grp Psicol & Salud, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain.	jcalasprilla@gmail.com			Fogarty International Center of the National Institutes of Health [R21TW009746]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by grant #R21TW009746 from Fogarty International Center of the National Institutes of Health.	Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arrieta J, 2017, J CLIN PSYCHOL, V73, P1076, DOI 10.1002/jclp.22390; Bateman A, 2009, NEUROPSYCHOL REHABIL, V19, P941, DOI 10.1080/09602010903021170; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Calzada EJ, 2012, CULT DIVERS ETHN MIN, V18, P285, DOI 10.1037/a0028694; Caracuel A, 2011, J HEAD TRAUMA REHAB, V26, P478, DOI 10.1097/HTR.0b013e3181fc042c; Christensen, 2000, INT HDB NEUROPSYCHOL, P81; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gururaj G., 1995, NEUROL INDIA, V43, P95; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hsieh MY, 2012, DISABIL REHABIL, V34, P408, DOI 10.3109/09638288.2011.607219; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Julio Csar C.M.C., 2008, VIGILANCIA EPIDEMIOL, V26, P1; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Munoz-Navarro R, 2017, ANSIEDAD ESTRES, V23, P124, DOI 10.1016/j.anyes.2017.10.002; Ottowitz WE, 2002, HARVARD REV PSYCHIAT, V10, P86, DOI 10.1080/10673220216210; Perrin PB, 2013, NEUROREHABILITATION, V32, P679, DOI 10.3233/NRE-130891; Pradilla A Gustavo, 2003, Rev Panam Salud Publica, V14, P104, DOI 10.1590/S1020-49892003000700005; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Silver JM., 2018, TXB TRAUMATIC BRAIN, V3rd, P664; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Ting-Toomey S, 2000, INT J INTERCULT REL, V24, P47, DOI 10.1016/S0147-1767(99)00023-1; Yody BB, 2000, J HEAD TRAUMA REHAB, V15, P1041, DOI 10.1097/00001199-200008000-00006	44	1	1	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	2					205	212		10.3233/NRE-192972	http://dx.doi.org/10.3233/NRE-192972			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LE6CR	32083603				2022-09-04	WOS:000526811100007
J	Singh, SK; Barreto, GE; Aliev, G; Echeverria, V				Singh, Sandeep Kumar; Barreto, George E.; Aliev, Gjumrakch; Echeverria, Valentina			Ginkgo biloba as an Alternative Medicine in the Treatment of Anxiety in Dementia and other Psychiatric Disorders	CURRENT DRUG METABOLISM			English	Review						Anxiety; medicinal plants; oxidative stress; neurodegeneration; neuroinflammation; Alzheimer	EXTRACT EGB 761(R); ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PLACEBO-CONTROLLED TRIAL; LONG-TERM TREATMENT; OXIDATIVE STRESS; DOUBLE-BLIND; NEUROPSYCHIATRIC SYMPTOMS; OLDER-ADULTS; COGNITIVE DYSFUNCTION; ALZHEIMERS-DISEASE	Background: Mental disorders are the most common health problems in the worldwide population. Current medicines against these conditions have undesired side effects or limited effectiveness. These disadvantageous pharmacological and therapeutic characteristics provoke a low adherence to treatment in an important percentage of patients with mental disorders. Since ancient times, ethnically different groups have been using plants extracts as medicines for the treatment of mental conditions including dementia, depression and anxiety disorders. Among them are extracts of Ginkgo biloba, a tree in the division Gingophyta, that has been used by millions of people worldwide. Objective: This review aims to discuss current scientific evidence of efficacy, neuroprotective and antioxidant effects as mechanism of action, side effects and potential interaction with other commonly prescribed anxiolytic drugs. Methods: A PubMed search of preclinical studies as well as individual clinical trials and meta-analysis were scrutinized. Results: Various preclinical and clinical studies have shown a positive effect of Ginkgo biloba to improve cognitive abilities in impaired individuals and reducing anxiety under pathological conditions. Conclusion: A more advanced clinical research is needed to confirm the efficacy of Gingko biloba for the treatment of anxiety in different health conditions.	[Singh, Sandeep Kumar] Banaras Hindu Univ, Fac Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Ctr Biomed Res, Carlos Antunez 1920, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, E Johns Crossing 175, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiologically Act Cpds, Severniy Proezd 1, Chernogolovka 142432, Russia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA		Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX USA.; Echeverria, V (corresponding author), Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile.	aliev03@gmail.com; valentina.echeverria@uss.cl	Singh, Sandeep Kumar/D-6544-2013; Barreto, George E./AAD-7420-2020; Aliev, Gjumrakch/K-7302-2017; Valentina Echeverria Moran, BCh/E-7765-2013; Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./B-5747-2014	Singh, Sandeep Kumar/0000-0002-0022-6240; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971	Grant Fondecyt regular [1150194]; Pontificia Universidad Javeriana; Universidad Autonoma de Chile; Russian Science Foundation [14-23-00160]	Grant Fondecyt regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Pontificia Universidad Javeriana; Universidad Autonoma de Chile; Russian Science Foundation(Russian Science Foundation (RSF))	This work was performed with resources from the University San Sebastian, Chile and the Grant Fondecyt regular 1150194 (to VE). GEB work is supported by the Pontificia Universidad Javeriana and the Universidad Autonoma de Chile. G. Aliev work was supported by the Russian Science Foundation (www.rscf.ru, Grant No. 14-23-00160 for 2014-2016: Directed design, synthesis, and study of biological activity of multi-target compounds as innovative drugs for treatment of neurodegenerative diseases).	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Ahmad AS, 2006, J NEUROTRAUM, V23, P1895, DOI 10.1089/neu.2006.23.1895; Aliev G, 2002, BRAIN PATHOL, V12, P21; Allgulander C, 2003, CNS SPECTR, V8, P53, DOI 10.1017/S1092852900006945; Amieva H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052755; Andreazza AC, 2013, J NEUROCHEM, V127, P552, DOI 10.1111/jnc.12316; Andreazza AC, 2015, AM J GERIAT PSYCHIAT, V23, P314, DOI 10.1016/j.jagp.2014.05.008; Attia A, 2012, J NEURO-ONCOL, V109, P357, DOI 10.1007/s11060-012-0901-9; Bachinskaya N, 2011, NEUROPSYCH DIS TREAT, V7, P209, DOI 10.2147/NDT.S18741; Baldwin DS, 2010, CURR TOP BEHAV NEURO, V2, P453, DOI 10.1007/7854_2009_2; Barton DL, 2013, SUPPORT CARE CANCER, V21, P1185, DOI 10.1007/s00520-012-1647-9; Belviranli M, 2015, BEHAV BRAIN RES, V278, P453, DOI 10.1016/j.bbr.2014.10.032; Benet LZ, 2009, MOL PHARMACEUT, V6, P1631, DOI 10.1021/mp900253n; Bernatoniene J, 2011, PHYTOTHER RES, V25, P1054, DOI 10.1002/ptr.3399; Birks J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003120.pub2; BIRKS J, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003120; BIRKS J, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003120.PUB3; Brondino N, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/915691; Chiappedi M, 2010, CNS DRUG DISCOV, V5, P164, DOI DOI 10.2174/157488910791213158; Davidson JR, 2010, J PSYCHOPHARMACOL, V24, P3, DOI 10.1177/0269881108096505; de Oliveria DM, 2009, NEUROCHEM RES, V34, P215, DOI 10.1007/s11064-008-9749-y; Diamond BJ, 2013, PSYCHIAT CLIN N AM, V36, P73, DOI 10.1016/j.psc.2012.12.006; Echeverria V, 2005, EUR J NEUROSCI, V22, P2199, DOI 10.1111/j.1460-9568.2005.04427.x; Ernst E, 2002, ANN INTERN MED, V136, P42, DOI 10.7326/0003-4819-136-1-200201010-00010; Evans J. L., 2000, ENDOTEXT; Evans JR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001775.pub2; Fan L, 2009, ANN PHARMACOTHER, V43, P944, DOI 10.1345/aph.1L656; Faustino TT, 2010, REV BRAS PSIQUIATR, V32, P429, DOI 10.1590/S1516-44462010005000026; Franke AG, 2014, AGE, V36, P435, DOI 10.1007/s11357-013-9550-y; Fuchikami H, 2006, DRUG METAB DISPOS, V34, P577, DOI 10.1124/dmd.105.007872; Fugh-Berman A, 1999, PSYCHOSOM MED, V61, P712, DOI 10.1097/00006842-199909000-00012; Gavrilova SI, 2014, INT J GERIATR PSYCH, V29, P1087, DOI 10.1002/gps.4103; Grenier S, 2012, J AFFECT DISORDERS, V136, P724, DOI 10.1016/j.jad.2011.09.052; HALBERSTEIN R A, 1978, Culture Medicine and Psychiatry, V2, P177, DOI 10.1007/BF00054583; Halberstein RA, 2005, ANN EPIDEMIOL, V15, P686, DOI 10.1016/j.annepidem.2005.02.004; Han ZY, 2014, J NEUROCHEM, V131, P498, DOI 10.1111/jnc.12817; Hasanzadeh E, 2012, CHILD PSYCHIAT HUM D, V43, P674, DOI 10.1007/s10578-012-0292-3; Hasenohrl RU, 1998, PHARMACOL BIOCHEM BE, V59, P527, DOI 10.1016/S0091-3057(97)00406-1; He Gai-ying, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1064; He Gaiying, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2130; Herrschaft H, 2012, J PSYCHIATR RES, V46, P716, DOI 10.1016/j.jpsychires.2012.03.003; Huang SH, 2004, EUR J PHARMACOL, V494, P131, DOI 10.1016/j.ejphar.2004.04.051; HUGUET F, 1992, J PHARM PHARMACOL, V44, P24, DOI 10.1111/j.2042-7158.1992.tb14357.x; HUGUET F, 1994, J PHARM PHARMACOL, V46, P316, DOI 10.1111/j.2042-7158.1994.tb03802.x; Ihl R, 2012, PHARMACOPSYCHIATRY, V45, P41, DOI 10.1055/s-0031-1291217; Ihl R, 2010, J NEUROL SCI, V299, P184, DOI 10.1016/j.jns.2010.08.033; Ihl R, 2013, INT J PSYCHIAT CLIN, V17, P8, DOI 10.3109/13651501.2013.814796; Ihl R, 2011, INT J GERIATR PSYCH, V26, P1186, DOI 10.1002/gps.2662; Jahanshahi M, 2012, ANAT CELL BIOL, V45, P92, DOI 10.5115/acb.2012.45.2.92; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jang CH, 2012, INT J PEDIATR OTORHI, V76, P1823, DOI 10.1016/j.ijporl.2012.09.009; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Kasper S, 2015, WIEN MED WOCHENSCHR, V165, P217, DOI 10.1007/s10354-015-0360-y; Kaur S, 2013, PHYTOMEDICINE, V20, P178, DOI 10.1016/j.phymed.2012.10.003; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kuribara H, 2003, J NAT PROD, V66, P1333, DOI 10.1021/np030122f; Laws KR, 2012, HUM PSYCHOPHARM CLIN, V27, P527, DOI 10.1002/hup.2259; Li CY, 2004, J AGR FOOD CHEM, V52, P3721, DOI 10.1021/jf049920h; Lin LZ, 2008, J AGR FOOD CHEM, V56, P6671, DOI 10.1021/jf800488x; Liu JP, 2006, EXPLORE-NY, V2, P262, DOI 10.1016/j.explore.2006.03.012; Liu X, 2015, BRAIN BEHAV IMMUN, V46, P121, DOI 10.1016/j.bbi.2015.01.011; Lovera JF, 2012, NEUROLOGY, V79, P1278, DOI 10.1212/WNL.0b013e31826aac60; Lu SP, 2011, MOLECULES, V16, P9194, DOI 10.3390/molecules16119194; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Mandy HM, 2011, NEUROCHEM INT, V59, P770, DOI 10.1016/j.neuint.2011.07.012; Menezo YJR, 2015, JAMA PEDIATR, V169, P1066, DOI 10.1001/jamapediatrics.2015.2125; Mhatre M, 2004, J ALZHEIMERS DIS, V6, P147; Michel TM, 2007, PSYCHIAT RES, V151, P145, DOI 10.1016/j.psychres.2006.04.013; Mix JA, 2002, HUM PSYCHOPHARM CLIN, V17, P267, DOI 10.1002/hup.412; Montes P, 2015, CNS NEUROL DISORD-DR, V14, P132, DOI 10.2174/1871527314666150202151440; Montgomery SA, 2002, J AFFECT DISORDERS, V69, P119, DOI 10.1016/S0165-0327(01)00313-5; Muller WE, 2012, INT PSYCHOGERIATR, V24, pS21, DOI 10.1017/S1041610212000592; Nash KM, 2015, INTEGR MED INSIGHTS, V10, P1, DOI 10.4137/IMI.S25054; Ong WY, 2015, ACS CHEM NEUROSCI, V6, P814, DOI 10.1021/acschemneuro.5b00073; Oskouei DS, 2013, J STROKE CEREBROVASC, V22, pE557, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.010; Pedroso JL, 2011, NEUROLOGIST, V17, P89, DOI 10.1097/NRL.0b013e3181f097b4; Pilija V, 2010, MOLECULES, V15, P2079, DOI 10.3390/molecules15042079; Qin XF, 2014, NEUROREPORT, V25, P267, DOI 10.1097/WNR.0000000000000096; Ribonnet L, 2011, TOXICOL LETT, V202, P193, DOI 10.1016/j.toxlet.2011.02.006; Roland Pal-Didrik Hoff, 2012, Tidsskr Nor Laegeforen, V132, P956, DOI 10.4045/tidsskr.11.0780; Rossignol Daniel A, 2007, BMC Pediatr, V7, P36, DOI 10.1186/1471-2431-7-36; Salehi B, 2010, PROG NEURO-PSYCHOPH, V34, P76, DOI 10.1016/j.pnpbp.2009.09.026; Sarris J, 2013, CNS DRUGS, V27, P301, DOI 10.1007/s40263-013-0059-9; Sarris J, 2011, EUR NEUROPSYCHOPHARM, V21, P841, DOI 10.1016/j.euroneuro.2011.04.002; Shakibaei F, 2015, COMPLEMENT THER CLIN, V21, P61, DOI 10.1016/j.ctcp.2015.04.001; Shen YF, 2011, PSYCHOPHARMACOLOGY, V215, P403, DOI 10.1007/s00213-011-2244-1; Shi J, 2012, ANN NEUROL, V72, P788, DOI 10.1002/ana.23677; Shirasaka Y, 2011, DRUG METAB PHARMACOK, V26, P171, DOI 10.2133/dmpk.DMPK-10-RG-073; Snitz BE, 2009, JAMA-J AM MED ASSOC, V302, P2663, DOI 10.1001/jama.2009.1913; Solomon PR, 2002, JAMA-J AM MED ASSOC, V288, P835, DOI 10.1001/jama.288.7.835; Soto-Otero R, 2002, BIOCHEM PHARMACOL, V64, P125, DOI 10.1016/S0006-2952(02)01070-5; Sun BN, 2003, P NATL ACAD SCI USA, V100, P7141, DOI 10.1073/pnas.1232419100; Tsaluchidu S, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-S1-S5; Unger M, 2013, DRUG METAB REV, V45, P353, DOI 10.3109/03602532.2013.815200; van Dongen MCJM, 2000, J AM GERIATR SOC, V48, P1183, DOI 10.1111/j.1532-5415.2000.tb02589.x; Wettstein A, 1999, Fortschr Med, V117, P48; White HL, 1996, LIFE SCI, V58, P1315, DOI 10.1016/0024-3205(96)00097-5; Wiegman DJ, 2009, AIDS, V23, P1184, DOI 10.1097/QAD.0b013e32832c412b; Woelk H, 2007, J PSYCHIATR RES, V41, P472, DOI 10.1016/j.jpsychires.2006.05.004; Wong AHC, 1998, ARCH GEN PSYCHIAT, V55, P1033, DOI 10.1001/archpsyc.55.11.1033; Yeh GY, 2006, AM J CARDIOL, V98, P673, DOI 10.1016/j.amjcard.2006.03.051; Zadoyan G, 2012, EUR J CLIN PHARMACOL, V68, P553, DOI 10.1007/s00228-011-1174-5; Zhang AL, 2008, PHARMACOEPIDEM DR S, V17, P1006, DOI 10.1002/pds.1610; Zhang WF, 2011, J CLIN PSYCHIAT, V72, P615, DOI 10.4088/JCP.09m05125yel; Zhang XY, 2013, PROG NEURO-PSYCHOPH, V46, P197, DOI 10.1016/j.pnpbp.2013.03.003; Zhao, 2013, IEEE T AUTOM SCI ENG, V5, P1, DOI DOI 10.1145/2470654.2470656; Zhao M, 2014, GENET MOL RES, V13, P220, DOI 10.4238/2014.January.14.1; Zhao Z, 2011, J NEUROCHEM, V116, P1057, DOI 10.1111/j.1471-4159.2010.07160.x	109	33	34	1	62	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1389-2002	1875-5453		CURR DRUG METAB	Curr. Drug Metab.		2017	18	2					112	119		10.2174/1389200217666161201112206	http://dx.doi.org/10.2174/1389200217666161201112206			8	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	EP2ZZ	27908257				2022-09-04	WOS:000397253600004
J	Johnson, ED; Oak, S; Griswold, DP; Olaya, S; Puyana, JC; Rubiano, AM				Johnson, Erica D.; Oak, Sangki; Griswold, Dylan P.; Olaya, Sandra; Puyana, Juan C.; Rubiano, Andres M.			Neurotrauma Registry Implementation in Colombia: A Qualitative Assessment	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						traumatic brain injury; LMICS; trauma registry; neurotrauma	THEORETICAL DOMAINS FRAMEWORK; TRAUMATIC BRAIN-INJURY; BEHAVIOR-CHANGE; GLOBAL BURDEN; MORTALITY; CARE; CHALLENGES	Objectives Latin America is among several regions of the world that lacks robust data on injuries due to neurotrauma. This research project sought to investigate a multi-institution brain injury registry in Colombia, South America, by conducting a qualitative study to identify factors affecting the creation and implementation of a multi-institution TBI registry in Colombia before the establishment of the current registry. Methods Key informant interviews and participant observation identified barriers and facilitators to the creation of a TBI registry at three health care institutions in this upper-middle-income country in South America. Results The study identified barriers to implementation involving incomplete clinical data, limited resources, lack of information and technology (IT) support, time constraints, and difficulties with ethical approval. These barriers mirrored similar results from other studies of registry implementation in low- and middle-income countries (LMICs). Ease of use and integration of data collection into the clinical workflow, local support for the registry, personal motivation, and the potential future uses of the registry to improve care and guide research were identified as facilitators to implementation. Stakeholders identified local champions and support from the administration at each institution as essential to the success of the project. Conclusion Barriers for implementation of a neurotrauma registry in Colombia include incomplete clinical data, limited resources and lack of IT support. Some factors for improving the implementation process include local support, personal motivation and potential uses of the registry data to improve care locally. Information from this study may help to guide future efforts to establish neurotrauma registries in Latin America and in LMICs.	[Johnson, Erica D.] Univ Pittsburgh, Med Ctr, Sch Med, Pittsburgh, PA USA; [Oak, Sangki] Brigham & Womens Hosp, Dept Gen Surg, 75 Francis St, Boston, MA 02115 USA; [Griswold, Dylan P.] Stanford Sch Med, Stanford, CA 94305 USA; [Olaya, Sandra] Javeriana Univ, Meditech Fdn, Emergency Med Program, Cali, Colombia; [Puyana, Juan C.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Rubiano, Andres M.] INUB MEDITECH Res Grp, Neurosci Inst, Bogota, Colombia; [Rubiano, Andres M.] Univ El Bosque, Bogota, Colombia; [Rubiano, Andres M.] Meditech Fdn, Valle Salud Clin, Cali, Colombia		Rubiano, AM (corresponding author), INUB MEDITECH Res Grp, Neurosci Inst, Bogota, Colombia.; Rubiano, AM (corresponding author), Univ El Bosque, Bogota, Colombia.; Rubiano, AM (corresponding author), Meditech Fdn, Valle Salud Clin, Cali, Colombia.	andresrubiano@aol.com	Griswold, Dylan/ABC-7890-2021	Griswold, Dylan/0000-0003-0291-8360				Assan A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024845; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Bommakanti K, 2018, J SURG RES, V223, P72, DOI 10.1016/j.jss.2017.09.039; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Dasari M, 2016, WORLD J SURG, V40, P2840, DOI 10.1007/s00268-016-3654-3; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Fetterman DM., 2009, ETHNOGRAPHY STEP BY, V17; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Leavy MB, MULTINATIONAL REGIST; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mirbaha F, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0302-5; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Patton M.Q, 2014, QUALITATIVE RES EVAL, V3rd ed., DOI DOI 10.1080/1750984X.2017.1317357; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; St-Louis E, 2018, INJURY, V49, P2100, DOI 10.1016/j.injury.2018.10.007; Takian A, 2013, FAM PRACT, V30, P551, DOI 10.1093/fampra/cmt025	20	3	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JUL	2021	12	03					518	523		10.1055/s-0041-1727577	http://dx.doi.org/10.1055/s-0041-1727577		JUN 2021	6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TK9DX	34295106	gold, Green Published			2022-09-04	WOS:000662018900005
J	Jaramillo-Jimenez, A; Ying, YB; Ren, P; Xiao, Z; Zhang, Q; Wang, J; Rong, H; Borda, MG; Bonanni, L; Aarsland, D; Wu, DH				Jaramillo-Jimenez, Alberto; Ying, Yinbing; Ren, Ping; Xiao, Zhan; Zhang, Qian; Wang, Jian; Rong, Han; Borda, Miguel German; Bonanni, Laura; Aarsland, Dag; Wu, Donghui			Prodromal Dementia With Lewy Bodies and Recurrent Panic Attacks as the First Symptom: A Case Report	FRONTIERS IN NEUROLOGY			English	Article						dementia with Lewy bodies; panic attacks; case report; prodromal dementia with Lewy bodies; neuropsychiatric symptoms	DIAGNOSIS; MANAGEMENT; CRITERIA	Psychiatric-onset dementia with Lewy bodies (DLB) might include symptoms of depression, hallucinations, anxiety, and apathy. Here, we report a patient with DLB with recurrent panic attacks as her first symptom 5 years before a biological-based diagnosis of probable DLB. We provide an extended description of the clinical presentation and course from psychiatric-onset DLB to dementia in an 83-year-old woman. This case illustrates the common misdiagnosis of DLB and the delay of having a detailed clinical and biomarker assessment for structured diagnosis. With a detailed description of the clinical presentation of this case, the empirical treatment strategies, and the patient perspectives, we aim to make clinicians aware of panic attacks within the psychiatric-onset DLB.	[Jaramillo-Jimenez, Alberto; Borda, Miguel German; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [Jaramillo-Jimenez, Alberto; Borda, Miguel German] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Jaramillo-Jimenez, Alberto] Univ Antioquia, Sch Med Medellin, Grp Neurociencias Antioquia, Medellin, Colombia; [Jaramillo-Jimenez, Alberto] Univ Antioquia, Sch Med Medellin, Grp Neuropsicol & Conducta, Medellin, Colombia; [Ying, Yinbing; Ren, Ping; Xiao, Zhan; Zhang, Qian; Wang, Jian; Rong, Han; Wu, Donghui] Shenzhen Kangning Hosp, Shenzhen Mental Hlth Ctr, Shenzhen, Peoples R China; [Borda, Miguel German] Pontificia Univ Javeriana, Med Sch, Ageing Inst, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Bonanni, Laura] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Aarsland, Dag] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England		Jaramillo-Jimenez, A; Aarsland, D (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway.; Jaramillo-Jimenez, A (corresponding author), Univ Stavanger, Fac Hlth Sci, Stavanger, Norway.; Jaramillo-Jimenez, A (corresponding author), Univ Antioquia, Sch Med Medellin, Grp Neurociencias Antioquia, Medellin, Colombia.; Jaramillo-Jimenez, A (corresponding author), Univ Antioquia, Sch Med Medellin, Grp Neuropsicol & Conducta, Medellin, Colombia.; Wu, DH (corresponding author), Shenzhen Kangning Hosp, Shenzhen Mental Hlth Ctr, Shenzhen, Peoples R China.; Aarsland, D (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England.	alberto.jaramilioj@udea.edu.co; daarsland@gmail.com; xyfwdh@qq.com		Jaramillo-Jimenez, Alberto/0000-0001-5374-6410; Aarsland, Dag/0000-0001-6314-216X	Sanming Project of Medicine in Shenzhen [SZSM201812052]; Guangdong Natural Science Foundation for Major Cultivation Project [2018B030336001]; Norwegian government-Helse Vest; National Institute for Health Research (NIHR) Biomedical Research Centre at South London, Maudsley NHS Foundation Trust; King's College London-U.K	Sanming Project of Medicine in Shenzhen; Guangdong Natural Science Foundation for Major Cultivation Project; Norwegian government-Helse Vest; National Institute for Health Research (NIHR) Biomedical Research Centre at South London, Maudsley NHS Foundation Trust; King's College London-U.K	This work was supported by the Sanming Project of Medicine in Shenzhen (SZSM201812052) and Guangdong Natural Science Foundation for Major Cultivation Project (2018B030336001). This article also represents independent research partly funded by the Norwegian government-Helse Vest, the National Institute for Health Research (NIHR) Biomedical Research Centre at South London, Maudsley NHS Foundation Trust, and King's College London-U.K.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Auning E, 2011, DEMENT GERIATR COGN, V32, P202, DOI 10.1159/000333072; Bonanni L, 2015, NEUROBIOL AGING, V36, P434, DOI 10.1016/j.neurobiolaging.2014.07.009; Chiba Y, 2012, DEMENT GERIATR COGN, V33, P273, DOI 10.1159/000339363; Degner D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1575; Dickson DW, 2018, NEUROLOGY, V91, pE1182, DOI 10.1212/WNL.0000000000006212; Dogu O, 2003, ANN PHARMACOTHER, V37, P1224, DOI 10.1345/aph.1C516; Donaghy PC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt274; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Flint AJ, 2003, DRUG AGING, V20, P881, DOI 10.2165/00002512-200320120-00002; Freitas ME, 2017, SEMIN NEUROL, V37, P147, DOI 10.1055/s-0037-1602423; Gagnier JJ, 2013, DTSCH ARZTEBL INT, V110, P603, DOI [10.3238/arztebl.2013.0603, 10.1136/bcr-2013-201554, 10.1186/1752-1947-7-223, 10.7453/gahmj.2013.008]; Goukasian N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031947; Hanseeuw BJ, 2020, MOL PSYCHIATR, V25, P2599, DOI 10.1038/s41380-018-0214-2; Jaunarajs KLE, 2011, NEUROSCI BIOBEHAV R, V35, P556, DOI 10.1016/j.neubiorev.2010.06.007; Lemstra AW, 2017, J NEUROL NEUROSUR PS, V88, P113, DOI 10.1136/jnnp-2016-313775; Mahamud Z, 2020, SEIZURE-EUR J EPILEP, V82, P118, DOI 10.1016/j.seizure.2020.09.001; Marawar R, 2020, EPILEPSY BEHAV, V111, DOI 10.1016/j.yebeh.2020.107311; McKeith IG, 2020, NEUROLOGY, V94, P743, DOI 10.1212/WNL.0000000000009323; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; SCHELTENS P, 1995, J NEUROL, V242, P557, DOI 10.1007/BF00868807; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Segers K, 2020, PSYCHOGERIATRICS, V20, P242, DOI 10.1111/psyg.12490; Thompson SA, 2000, BMJ-BRIT MED J, V321, P1002, DOI 10.1136/bmj.321.7267.1002; van der Velden RMJ, 2018, MOVEMENT DISORD, V33, P1521, DOI 10.1002/mds.27465	26	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 13	2022	13								839539	10.3389/fneur.2022.839539	http://dx.doi.org/10.3389/fneur.2022.839539			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	1C0ON	35493812	Green Published, gold			2022-09-04	WOS:000792828400001
J	Reynolds, CW; Aguiar, LG; Moretti, K; Duarte, A; Romero, FAR; Patino, A; Fricke, A; Zarama, V; Moreno, A; Carranza, H; Arbelaez, C				Reynolds, Christopher W.; Aguiar, Leonar G.; Moretti, Katelyn; Duarte, Andres; Rosas Romero, Fabian Andres; Patino, Andres; Fricke, Adrienne; Zarama, Virginia; Moreno, Atilio; Carranza, Heidy; Arbelaez, Christian			Evaluating emergency physicians' knowledge, attitudes, and experiences of FARC ex-combatants: A pilot study of Colombia's emergency medicine teaching hospitals	JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN			English	Article						FARC ex-combatant; armed conflict; attitudes and practices; bias; global health; health knowledge; public health	MENTAL-HEALTH	ObjectivesIn the 2016 Peace Accord with the Fuerzas Armadas Revolucionarias de Colombia (FARC), Colombia promised to reincorporate 14,000 ex-combatants into the healthcare system. However, FARC ex-combatants have faced significant challenges in receiving healthcare, and little is known about physicians' abilities to address this population's healthcare needs. MethodsAn electronic questionnaire sent to the Colombian Emergency Medicine professional society and teaching hospitals assessed physicians' knowledge, attitudes, and experiences with the FARC ex-combatant reincorporation process. ResultsAmong 53 participants, most were male (60.4%), and similar to 25% were affected by the FARC conflict (22.6%). Overall knowledge of FARC reincorporation was low, with nearly two-thirds of participants (61.6%) scoring in the lowest category. Attitudes around ex-combatants showed low bias. Few physicians received training about reincorporation (7.5%), but 83% indicated they would like such training. Twenty-two participants (41.5%) had identified a patient as an ex-combatant in the healthcare setting. Higher knowledge scores were significantly correlated with training about reincorporation (r = 0.354, n = 53, P = 0.015), and experience identifying patients as ex-combatants (r = 0.356, n = 47, P = 0.014). ConclusionFindings suggested high interest in training and low knowledge of the reincorporation process. Most physicians had low bias, frequent experiences with ex-combatants, and cared for these patients when they self-identify. The emergency department (ED) serves as an entrance into healthcare for this population and a potential setting for interventions to improve care delivery, especially those related to mental healthcare. Future studies could evaluate effects of care delivery following training on ex-combatant healthcare reintegration.	[Reynolds, Christopher W.] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA; [Aguiar, Leonar G.; Duarte, Andres; Moreno, Atilio; Carranza, Heidy; Arbelaez, Christian] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Moretti, Katelyn; Arbelaez, Christian] Brown Emergency Med, Providence, RI USA; [Rosas Romero, Fabian Andres] Fdn Santa Fe Bogota, Bogota, Colombia; [Patino, Andres] Emory Univ, Sch Med, Atlanta, GA USA; [Fricke, Adrienne] Harvard Humanitarian Initiat, Cambridge, MA USA; [Zarama, Virginia] Fdn Valle Lili, Cali, Valle Del Cauca, Colombia		Reynolds, CW (corresponding author), Univ Michigan, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	chriswreynolds18@gmail.com	; Aguiar Martinez, Leonar G/M-7447-2016	Moreno-Carrillo, Atilio/0000-0001-9148-6111; Zarama, Virginia/0000-0001-7609-1162; Duarte Osorio, Andres/0000-0002-1982-6799; Reynolds, Christopher/0000-0001-6634-391X; Aguiar Martinez, Leonar G/0000-0002-5372-2459	Fulbright U.S. Student Researcher Scholarship; Pontificia Universidad Javeriana, Bogota as the Fulbright Host Country Supporting University; Brown Emergency Medicine Innovation Grant	Fulbright U.S. Student Researcher Scholarship; Pontificia Universidad Javeriana, Bogota as the Fulbright Host Country Supporting University; Brown Emergency Medicine Innovation Grant	This project was funded through a Fulbright U.S. Student Researcher Scholarship, with Pontificia Universidad Javeriana, Bogota as the Fulbright Host Country Supporting University, and Brown Emergency Medicine Innovation Grant.	Broadbent M, 2004, J EVAL CLIN PRACT, V10, P57, DOI 10.1111/j.1365-2753.2003.00459.x; Calderon JMP, 2016, CAMPESINOS, ESPECTADORES, VICTIMAS Y VERDUGOS: RELATOS DEL PERIODO DE LA VIOLENCIA EN ZONAS RURALES DEL VALLE DEL CAUCA, P1; Carmona-Meza Zenén, 2015, Salud, Barranquilla, V31, P608, DOI 10.14482/sun.31.3.7685; Chapman EN, 2013, J GEN INTERN MED, V28, P1504, DOI 10.1007/s11606-013-2441-1; Idrobo F, 2018, LANCET PSYCHIAT, V5, P467, DOI 10.1016/S2215-0366(18)30134-2; International Labour Office, 2010, PROGR CRIS RESP REC; International Organization for Migration, 2015, HLTH DIV HLTH CAR PS; Johnson K, 2012, MIL MED, V177, P531, DOI 10.7205/MILMED-D-11-00185; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Ministerio de Salud (MINSA), 2016, GUIA PRACT CLIN DIAG, P1; Odenwald Michael, 2007, Confl Health, V1, P10, DOI 10.1186/1752-1505-1-10; SCHULHOFERWOHL J, 2010, DISARMAMENT DEMOBILI; Sopko J., 2019, REINTEGRATION EXCOMB; Trigos-Carrillo L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00047; Trujillo S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00510; United Nations Department of Peacekeeping Operations, 2010, 2 GEN DIS DEM REINTR; Valenzuela AS, 2018, EXCLUSIVO ASI ESTA S; Worley W., 2018, FARC FIGHTERS LACK H	18	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2688-1152		JACEP OPEN	J. Am. Coll. Emerg. Phys. Open	OCT	2020	1	5					757	765		10.1002/emp2.12066	http://dx.doi.org/10.1002/emp2.12066			9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	RZ6GP	33145516	Green Published, gold			2022-09-04	WOS:000648695300010
J	Tabue-Teguo, M; Peres, K; Simo, N; Le Goff, M; Zepeda, MUP; Feart, C; Dartigues, JF; Amieva, H; Cesari, M				Tabue-Teguo, Maturin; Peres, Karine; Simo, Nadine; Le Goff, Melanie; Perez Zepeda, Mario Ulises; Feart, Catherine; Dartigues, Jean-Francois; Amieva, Helene; Cesari, Matteo			Gait speed and body mass index: Results from the AMI study	PLOS ONE			English	Article							PSYCHOMOTOR SPEED; OLDER PEOPLE; FAT MASS; ASSOCIATION; OBESITY; WALKING; DISABILITY; FRAILTY; HEALTH; MOBILITY	Background While physical frailty and malnutrition/obesity (parameters easily measured by a nurse) are not the same, older persons who are malnourished/obese are more likely to be frail and there is a potential overlap between these conditions. The objective was to examine the relationship between gait speed (GS) and body mass index (BMI) in men and women aged 75 years and older. Design Cross-sectional analysis. Setting, participants Data from the Aging Multidisciplinary Investigation (AMI), a French prospective cohort study with participants randomly selected from the farmer Health Insurance rolls. Measurements Usual GS was measured over a 4 meters-track. BMI was categorized using clinical cutpoints for European populations: (e.g, <20.0 kg/m(2); 20.0-24.9 kg/m(2); 25.0-29.9 kg/m(2); 30.0-34.9 kg/m(2);.35.0 kg/m(2)). Results The current analyses were performed in 449 participants. Mean age was 81 years. Being malnourished/obese was significantly associated with slow GS. Unadjusted and age-adjusted models showed that underweight, overweight and obesity statuses were significantly associated with slow GS for both women (0.83m/s [0.61; 1.04], 0.87m/s [0.72; 1.02], 0.70 m/s [0.41; 0.98], respectively) and men (0.83m/s [0.61; 1.04], 1.11m/s [1.03; 1.20], 0.97m/s [0.75; 1.19], respectively). Conclusion Malnourished/obese are associated with slow GS in older persons. These variables could be contributed at comprehensively and complementarily assessing the older person.	[Tabue-Teguo, Maturin; Simo, Nadine] CHU Guadeloupe, Les Abymes, Guadeloupe, France; [Tabue-Teguo, Maturin; Peres, Karine; Le Goff, Melanie; Feart, Catherine; Dartigues, Jean-Francois; Amieva, Helene] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM 1219, Bordeaux, France; [Tabue-Teguo, Maturin] Univ Antilles, Equipe LAMIA, Pointe A Pitre, Guadeloupe, France; [Perez Zepeda, Mario Ulises] Inst Nacl Geriatria, Dept Invest Epidemiol & Geriatria, Mexico City, DF, Mexico; [Perez Zepeda, Mario Ulises] Pontificia Univ Javeriana, Inst Envejecimiento, Bogota, Colombia; [Cesari, Matteo] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Geriatr Unit, Milan, Italy; [Cesari, Matteo] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy		Tabue-Teguo, M (corresponding author), CHU Guadeloupe, Les Abymes, Guadeloupe, France.; Tabue-Teguo, M (corresponding author), Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM 1219, Bordeaux, France.; Tabue-Teguo, M (corresponding author), Univ Antilles, Equipe LAMIA, Pointe A Pitre, Guadeloupe, France.; Cesari, M (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Geriatr Unit, Milan, Italy.; Cesari, M (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.	maturin.tabue-teguo@u-bordeaux.fr; macesari@gmail.com	Amieva, Helene/T-4170-2019; Cesari, Matteo/A-4649-2008; FEART, Catherine/A-3339-2016	Amieva, Helene/0000-0002-0119-7242; Cesari, Matteo/0000-0002-0348-3664; FEART, Catherine/0000-0002-7959-1610; LE GOFF, Melanie/0000-0003-2848-6287	AGRICA (CAMARCA); AGRICA (CRCCA); AGRICA (CCPMA PREVOYANCE); AGRICA (CPCEA); AGRICA (AGRI PREVOYANCE); Mutualite Sociale Agricole(MSA) de Gironde; Caisse Centrale de la Mutualite Sociale Agricole (CCMSA); Mutualite Sociale Agricole (MSA)	AGRICA (CAMARCA); AGRICA (CRCCA); AGRICA (CCPMA PREVOYANCE); AGRICA (CPCEA); AGRICA (AGRI PREVOYANCE); Mutualite Sociale Agricole(MSA) de Gironde; Caisse Centrale de la Mutualite Sociale Agricole (CCMSA); Mutualite Sociale Agricole (MSA)	The AMI project was funded by AGRICA (CAMARCA, CRCCA, CCPMA PREVOYANCE, CPCEA, AGRI PREVOYANCE), la Mutualite Sociale Agricole(MSA) de Gironde, la Caisse Centrale de la Mutualite Sociale Agricole (CCMSA). The AGRICA Group is a specialist for companies and employees of the agricultural world seeking supplemental pension, savings and healthcare insurance. AGRICA is one of the major French insurance providers offering protection for people employed in the agricultural sector. The other fundings come from the Mutualite Sociale Agricole (MSA), which is the unique Farmer Health Insurance System in France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Andersen JL, 2010, SCAND J MED SCI SPOR, V20, P32, DOI 10.1111/j.1600-0838.2010.01196.x; Blaum CS, 2005, J AM GERIATR SOC, V53, P927, DOI 10.1111/j.1532-5415.2005.53300.x; Cesari M, 2006, GERONTOLOGY, V52, P24, DOI 10.1159/000089822; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Cesari M, 2011, JAMA-J AM MED ASSOC, V305, P93, DOI 10.1001/jama.2010.1970; Dufour AB, 2013, J GERONTOL A-BIOL, V68, P168, DOI 10.1093/gerona/gls109; Feart C, 2007, BRIT J NUTR, V98, P1046, DOI 10.1017/S0007114507756520; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forhan M, 2013, BEST PRACT RES CL EN, V27, P129, DOI 10.1016/j.beem.2013.01.003; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill SV, 2017, OSTEOARTHR CARTILAGE, V25, P60, DOI 10.1016/j.joca.2016.07.011; Gill SV, 2012, ARCH PHYS MED REHAB, V93, P728, DOI 10.1016/j.apmr.2011.09.012; Guigoz Y, 1996, NUTR REV, V54, pS59; Guralnik JM, 1996, ANNU REV PUBL HEALTH, V17, P25, DOI 10.1146/annurev.pu.17.050196.000325; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kentaro Kamiya, 2017, JCSM CLIN REPORTS, V2; Kuate-Tegueu C, 2017, J ALZHEIMERS DIS, V60, P585, DOI 10.3233/JAD-170267; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Mendes J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22584-3; Peres K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-558; Perez-Sousa MA, 2019, J CACHEXIA SARCOPENI, V10, P1009, DOI 10.1002/jcsm.12444; Rietman ML, 2018, J NUTR HEALTH AGING, V22, P8, DOI 10.1007/s12603-016-0854-3; SEIDELL JC, 1995, INT J OBESITY, V19, pS13; SEIDELL JC, 1995, INT J OBESITY, V19, pS1; Semba RD, 2007, AM J MED, V120, P1084, DOI 10.1016/j.amjmed.2007.07.028; Shaffer NC, 2020, J GERONTOL A-BIOL, V75, P784, DOI 10.1093/gerona/glz103; Stenholm S, 2007, J GERONTOL A-BIOL, V62, P859, DOI 10.1093/gerona/62.8.859; Stenholm S, 2015, J GERONTOL A-BIOL, V70, P591, DOI 10.1093/gerona/glv004; Tabue-Teguo M, 2015, J NUTR HEALTH AGING, V19, P468, DOI 10.1007/s12603-014-0560-y; Visser M, 1998, AM J CLIN NUTR, V68, P584, DOI 10.1093/ajcn/68.3.584; Woo J, 2018, J AM MED DIR ASSOC, V19, P679, DOI 10.1016/j.jamda.2018.03.003; Zoico E, 2007, AGING CLIN EXP RES, V19, P154, DOI 10.1007/BF03324682	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2020	15	3							e0229979	10.1371/journal.pone.0229979	http://dx.doi.org/10.1371/journal.pone.0229979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8WI	32155194	Green Published, gold			2022-09-04	WOS:000535278500048
J	Gomez, AM; Henao, D; Imitola, A; Corrales, BG; Conget, I; Gimenez, M; Vinals, C; Martin, R; Jaramillo, MG; Leon-Vargas, F				Gomez, A. M.; Henao, D.; Imitola, A.; Grassi Corrales, B.; Conget, I.; Gimenez, M.; Vinals, C.; Martin, R.; Garcia Jaramillo, M.; Leon-Vargas, F.			FACTORS ASSOCIATED WITH CLINICALLY SIGNIFICANT HYPOGLYCEMIA IN PATIENTS WITH TYPE 1 DIABETES USING SUSPEND-BEFORE-LOW SENSOR AUGMENTED PUMP TECHNOLOGY	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Gomez, A. M.; Imitola, A.; Martin, R.] Pontificia Univ Javeriana, Endocrinol, Bogota, Colombia; [Henao, D.] Hosp Univ San Ignacio, Endocrinol, Bogota, Colombia; [Grassi Corrales, B.] Univ Catolica Chile, Endocrinol, Santiago, Chile; [Conget, I.] Hosp Clin Barcelona, Endocrinol, Barcelona, Spain; [Gimenez, M.] Hosp Clin Barcelona, Diabet Unit, Endocrinol & Nutr, Barcelona, Spain; [Vinals, C.] Hosp Clin Barcelona, Endocrinol & Nutr, Barcelona, Spain; [Garcia Jaramillo, M.] Univ Ean, Bogota, Colombia; [Leon-Vargas, F.] Univ Antonio Narino, Bogota, Colombia				Garcia Jaramillo, Maira/AAE-8251-2022	Garcia Jaramillo, Maira/0000-0001-6008-9068					0	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2020	22			1		465	A171	A172						2	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	KM3MO					2022-09-04	WOS:000514025300435
J	Diaz-Granados, N; McDermott, S; Wang, F; Posada-Villa, J; Saavedra, J; Rondon, MB; DesMeules, M; Dorado, L; Torres, Y; Stewart, DE				Diaz-Granados, Natalia; McDermott, Sarah; Wang, Feng; Posada-Villa, Jose; Saavedra, Javier; Rondon, Marta B.; DesMeules, Marie; Dorado, Linda; Torres, Yolanda; Stewart, Donna E.			Monitoring Gender Equity in Mental Health in a Low-, Middle-, and High-Income Country in the Americas	PSYCHIATRIC SERVICES			English	Article							12-MONTH PREVALENCE; GENERAL-POPULATION; UNITED-STATES; DISORDERS; EPIDEMIOLOGY; DEPRESSION; COLOMBIA; ORGANIZATION; ADOLESCENTS; INDICATORS	Objective: Gender disparities in mental health highlight the need to include gender equity measures when planning, implementing, and evaluating mental health programs at national, state or provincial, and municipal levels. This study aimed to identify, select, and assess the feasibility of comparing gender-sensitive mental health indicators in a low- (Peru), middle- (Colombia), and high- (Canada) income country. Methods: The indicators were selected by a multidisciplinary group of experts who used criteria and a framework proposed by the World Health Organization. Data from national, population-based databases from each country were used to measure the indicators. Results: Seven indicators (12-month prevalence of the following: depression, psychological distress, generalized anxiety disorder, suicide attempts, alcohol dependence, mental health service use, and psychological impairment) were feasible for measurement in at least two countries. Only five indicators were comparable between two countries, and only one was comparable among all countries (suicide attempts). The indicators that showed the greatest inequities between men and women were depression, anxiety, suicide attempts, use of mental health services, and alcohol dependence. Female-to-male ratios for prevalence of mental illness ranged from .1 to 2.3, and ratios for service use ranged from 1.3 to 1.9. Significant trends were found when the indicators were considered by age, education, marital status, and income. Conclusions: Some of these indicators can be used to identify populations most vulnerable to gender inequities in mental health. The results from this study may provide useful information to program planners who aim to implement, improve, and monitor national mental health strategies that reduce gender inequities under different national conditions. (Psychiatric Services 62: 516-524, 2011)	[Diaz-Granados, Natalia; Dorado, Linda; Stewart, Donna E.] Univ Hlth Network, Womens Hlth Program, Toronto, ON M5G 2C4, Canada; [Stewart, Donna E.] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Stewart, Donna E.] Toronto Gen Res Inst, Toronto, ON, Canada; [DesMeules, Marie] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Posada-Villa, Jose] Univ Javeriana, Dept Psychiat, Bogota, Colombia; [Saavedra, Javier] Inst Nacl Salud Mental, Lima, Peru; [Saavedra, Javier] Univ Peruana Cayetano Heredia, Dept Psychiat, Lima, Peru; [Rondon, Marta B.; Torres, Yolanda] Univ CES, Fac Med, Medellin, Colombia		Diaz-Granados, N (corresponding author), Univ Hlth Network, Womens Hlth Program, 200 Elizabeth St, EN 7-234, Toronto, ON M5G 2C4, Canada.	natalia.diaz.granados@utoronto.ca	Stewart, Donna Eileen E/J-2844-2016; Posada-Villa, José/AAA-2355-2019	Stewart, Donna Eileen E/0000-0002-8157-7746; Posada-Villa, José/0000-0001-5840-3118; Rondon, Marta/0000-0001-8459-6785; Saavedra, Javier Esteban/0000-0001-8403-5363	Institute of Gender and Health of the Canadian Institute of Health Research [NIG-79774A]	Institute of Gender and Health of the Canadian Institute of Health Research	This study was supported by grant NIG-79774A from the Institute of Gender and Health of the Canadian Institute of Health Research.	Afifi TO, 2006, SOC PSYCH PSYCH EPID, V41, P122, DOI 10.1007/s00127-005-0005-3; Ahmad OB, 2000, GPE DISCUSSION PAPER, V31; Akhtar-Danesh Noori, 2007, Int J Ment Health Syst, V1, P4, DOI 10.1186/1752-4458-1-4; [Anonymous], 2000, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890423349; *AUSTR GOV DEP HLT, 2005, 6 AUSTR GOV DEP HLTH; Bijl RV, 2002, SOC PSYCH PSYCH EPID, V37, P372, DOI 10.1007/s00127-002-0566-3; Boardman JD, 2008, TWIN RES HUM GENET, V11, P12, DOI 10.1375/twin.11.1.12; BRADY KT, 1993, AM J PSYCHIAT, V150, P1707; Bulloch AG, 2009, DEPRESS ANXIETY, V26, P1172, DOI 10.1002/da.20618; Cairney J, 2006, CAN J PSYCHIAT, V51, P671, DOI 10.1177/070674370605101007; Chotai J, 2004, NORD J PSYCHIAT, V58, P429, DOI 10.1080/08039480410006052; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008; Garfield R, 2004, REV PANAM SALUD PUBL, V16, P266, DOI 10.1590/S1020-49892004001000006; Gomez-Restrepo C, 2004, REV PANAM SALUD PUBL, V16, P378, DOI 10.1590/S1020-49892004001200003; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Gravel R, 2005, CAN J PSYCHIAT, V50, P573, DOI 10.1177/070674370505001002; Harpham T, 2004, SOC SCI MED, V58, P2267, DOI 10.1016/j.socscimed.2003.08.013; Judd F, 2007, AUSTRALAS PSYCHIATRY, V15, P185, DOI 10.1080/10398560601123724; KELLY A, 1995, CAN J PSYCHIAT, V40, P527, DOI 10.1177/070674379504000905; Kessler R. C, 2008, WORLD MENTAL HLTH SU; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Korkeila J, 2003, SCAND J PUBLIC HEALT, V31, P451, DOI 10.1080/14034940210165208; Lee TMC, 1998, PERCEPT MOTOR SKILL, V87, P1120, DOI 10.2466/pms.1998.87.3.1120; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; Lin V, 2007, INT J PUBLIC HEALTH, V52, pS19, DOI 10.1007/s00038-006-6050-1; Medina-Mora ME, 2005, PSYCHOL MED, V35, P1773, DOI 10.1017/S0033291705005672; Moscicki Eve K., 1994, Annals of Epidemiology, V4, P152; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Pigott TA, 1999, J CLIN PSYCHIAT, V60, P4; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rieker P. P., 2005, Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, V60, pS40; Riolo SA, 2005, AM J PUBLIC HEALTH, V95, P998, DOI 10.2105/AJPH.2004.047225; Robergeau K, 2006, J ADOLESCENT HEALTH, V39, P806, DOI 10.1016/j.jadohealth.2006.08.003; SALMON A, 2006, INTEGRATING SEX GEND; Saxena S, 2007, PSYCHIAT SERV, V58, P816, DOI 10.1176/appi.ps.58.6.816; Stewart Donna E, 2004, BMC Womens Health, V4 Suppl 1, pS19, DOI 10.1186/1472-6874-4-S1-S19; Vicente B, 2006, AM J PSYCHIAT, V163, P1362, DOI 10.1176/appi.ajp.163.8.1362; WAHLBECK K, 2006, MINDFUL MENTAL HLTH; Walters Vivienne, 2004, BMC Womens Health, V4 Suppl 1, pS2, DOI 10.1186/1472-6874-4-S1-S2; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P305; WHO, 2020, GLOB REP EP BURD SEP; *WHO, 2004, P 4 INT M WOM HLTH G; *WORLD BANK GROUP, 2009, CHALL OPP GEND EQ LA; World Health Organization, 2003, COMP EV IND GEND EQ	48	13	15	1	22	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	MAY	2011	62	5					516	524		10.1176/appi.ps.62.5.516	http://dx.doi.org/10.1176/appi.ps.62.5.516			9	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	756QE	21532078				2022-09-04	WOS:000290028700012
J	Borda, MG; Jaramillo-Jimenez, A; Giil, LM; Tovar-Rios, DA; Soennesyn, H; Aarsland, D				Borda, Miguel G.; Jaramillo-Jimenez, Alberto; Giil, Lasse M.; Tovar-Rios, Diego A.; Soennesyn, Hogne; Aarsland, Dag			Body mass index trajectories and associations with cognitive decline in people with Lewy body dementia and Alzheimer's disease	HEALTH SCIENCE REPORTS			English	Article						Alzheimer's disease; body mass index; dementia; Lewy body dementia; malnutrition	WEIGHT-LOSS; MORTALITY; BODIES; RISK	Background and Aims In older adults with dementia, low body mass index (BMI) is associated with higher mortality and other adverse health outcomes. BMI or nutritional status trajectories from diagnosis have not yet been well described in dementia, especially in people with Lewy body dementia (LBD); a group that has a poorer prognosis. With this study, we aimed to evaluate the BMI trajectory in people diagnosed with mild LBD and Alzheimer's disease (AD). Methods The Dementia Study of Western Norway is a cohort study with annual assessments. Five-year measurements of BMI from 196 patients (LBD = 85 and AD = 111) diagnosed with mild dementia were analyzed using adjusted linear mixed-effects models. Results There were no differences between LBD and AD in baseline BMI, age, or mini-mental status examination (MMSE). During the follow-up, we observed a significant decrease in BMI in the LBD group across the study period (estimation [Est.]: -0.63, SE: 0.14; p < 0.001). By contrast, there was no significant change in BMI trajectory associated with AD diagnosis (Est.: 0.05, SE: 0.15; p = 0.730). Further, the introduction of an interaction term between diagnosis and time in the study showed that this difference (BMI trajectories) was significant (Est.: -0.63, SE: 0.14; p < 0.001). In addition, there was a significant interaction between MMSE total score and the follow-up time; the lower the MMSE, the lower the BMI (Est.: 0.01, SE: 0.01; p = 0.044). Conclusion In LBD, BMI significantly decreased with disease progression. In addition, low cognitive performance was associated with a reduction in BMI. These results highlight the importance of BMI evaluation in people with dementia, particularly patients diagnosed with LBD, and suggest that patients with LBD could be targeted for dietary intervention to maintain body weight.	[Borda, Miguel G.; Jaramillo-Jimenez, Alberto; Tovar-Rios, Diego A.; Soennesyn, Hogne; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, N-4068 Stavanger, Norway; [Borda, Miguel G.] Pontificia Univ Javeriana, Med Sch, Ageing Inst, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Borda, Miguel G.; Jaramillo-Jimenez, Alberto; Tovar-Rios, Diego A.] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Jaramillo-Jimenez, Alberto] Univ Antioquia, Sch Med, Grp Neurociencias Antioquia, Medellin, Colombia; [Jaramillo-Jimenez, Alberto] Univ Antioquia, Sch Med, Grp Neuropsicol & Conducta, Medellin, Colombia; [Giil, Lasse M.] Haraldsplass Deaconess Hosp, Dept Internal Med, Bergen, Norway; [Tovar-Rios, Diego A.] Univ Valle, Fac Engn, Valle Del Cauca, Colombia; [Aarsland, Dag] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England		Borda, MG (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, N-4068 Stavanger, Norway.	mmborda@gmail.com		Aarsland, Dag/0000-0001-6314-216X; Jaramillo-Jimenez, Alberto/0000-0001-5374-6410; Borda, Miguel German/0000-0001-5832-0603	Norwegian government, through Helse Vest (Western Norway Regional Health Authority) [911973]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London	Norwegian government, through Helse Vest (Western Norway Regional Health Authority); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London(General Electric)	The authors want to thank the participants, researchers, and technical staff that made the DemVest study possible, as well as staff and facilities provided by SESAM Centre for age-related medicine at Stavanger University Hospital, Norway. This paper represents independent research supported by the Norwegian government, through hospital owner Helse Vest (Western Norway Regional Health Authority) num. 911973. Also, funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London.	Aarsland D, 2008, DEMENT GERIATR COGN, V26, P445, DOI 10.1159/000165917; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Bergland AK, 2017, J ALZHEIMERS DIS, V56, P575, DOI 10.3233/JAD-160847; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/s2213-8587(18)30288-2, 10.1016/S2213-8587(18)30288-2]; Bredal IS, 2010, PSYCHO-ONCOLOGY, V19, P216, DOI 10.1002/pon.1564; Cumming K, 2017, NEUROLOGY, V89, P2254, DOI [10.1212/WNL.0000000000004691, 10.1212/wnl.0000000000004691]; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dent E, 2019, LANCET, V394, P1376, DOI 10.1016/S0140-6736(19)31785-4; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Feart C, 2019, PROG NEURO-PSYCHOPH, V95, DOI 10.1016/j.pnpbp.2019.109703; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Borda MG, 2021, ARCH GERONTOL GERIAT, V96, DOI 10.1016/j.archger.2021.104459; Borda MG, 2021, J ALZHEIMERS DIS, V79, P1713, DOI 10.3233/JAD-200961; Borda MG, 2020, J AM GERIATR SOC, V68, P2257, DOI 10.1111/jgs.16709; Borda MG, 2019, DEMENT GER COGN D EX, V9, P176, DOI 10.1159/000496537; Inskip M, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2019-231336; Javed AA, 2020, OBES REV, V21, DOI 10.1111/obr.13035; Jellinger KA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1016-8; Kashihara K, 2006, J NEUROL, V253, P38, DOI 10.1007/s00415-006-7009-0; Kivimaki M, 2018, ALZHEIMERS DEMENT, V14, P601, DOI 10.1016/j.jalz.2017.09.016; Koyama A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157053; Lavie CJ, 2009, AM J MED, V122, P1106, DOI 10.1016/j.amjmed.2009.06.006; Londos E, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-140; Luchsinger JA, 2008, J NUTR HEALTH AGING, V12, P127, DOI 10.1007/BF02982565; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Mueller C, 2017, LANCET NEUROL, V16, P390, DOI 10.1016/S1474-4422(17)30074-1; Napolitani M., 2019, EUR J PUBLIC HEALTH, V29, P29; Nuttall FQ., 2015, NUTR TODAY, V50, P117, DOI [DOI 10.1097/NT.0000000000000092, 10.1097/NT.0000000000000092]; Skogseth R, 2017, J ALZHEIMERS DIS, V59, P1139, DOI 10.3233/JAD-170274; Soininen H, 2021, ALZHEIMERS DEMENT, V17, P29, DOI 10.1002/alz.12172; Soysal P, 2020, J AM MED DIR ASSOC, V21, P1430, DOI 10.1016/j.jamda.2020.06.051; Tomic S, 2017, J NEUROL SCI, V375, P235, DOI 10.1016/j.jns.2017.01.070; Volkert D, 2015, CLIN NUTR, V34, P1052, DOI 10.1016/j.clnu.2015.09.004; Zadak Z, 2013, CURR OPIN CLIN NUTR, V16, P50, DOI 10.1097/MCO.0b013e32835b612e	34	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2398-8835		HEALTH SCI REP-US	Health Sci. Rep.	MAY	2022	5	3							e590	10.1002/hsr2.590	http://dx.doi.org/10.1002/hsr2.590			7	Public, Environmental & Occupational Health; Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health; General & Internal Medicine	0X3DO	35509416	Green Published			2022-09-04	WOS:000789591300001
J	Colorado, JD; Cera-Bornacelli, N; Caldas, JS; Petro, E; Rebolledo, MC; Cuellar, D; Calderon, F; Mondragon, IF; Jaramillo-Botero, A				Colorado, Julian D.; Cera-Bornacelli, Natalia; Caldas, Juan S.; Petro, Eliel; Rebolledo, Maria C.; Cuellar, David; Calderon, Francisco; Mondragon, Ivan F.; Jaramillo-Botero, Andres			Estimation of Nitrogen in Rice Crops from UAV-Captured Images	REMOTE SENSING			English	Article						UAV; machine learning; plant nitrogen estimation; multispectral imagery; vegetation index; image segmentation	VEGETATION INDEXES; GRAIN-YIELD; BIOMASS; ALGORITHM; TRAITS; SYSTEM	Leaf nitrogen (N) directly correlates to chlorophyll production, affecting crop growth and yield. Farmers use soil plant analysis development (SPAD) devices to calculate the amount of chlorophyll present in plants. However, monitoring large-scale crops using SPAD is prohibitively time-consuming and demanding. This paper presents an unmanned aerial vehicle (UAV) solution for estimating leaf N content in rice crops, from multispectral imagery. Our contribution is twofold: (i) a novel trajectory control strategy to reduce the angular wind-induced perturbations that affect image sampling accuracy during UAV flight, and (ii) machine learning models to estimate the canopy N via vegetation indices (VIs) obtained from the aerial imagery. This approach integrates an image processing algorithm using the GrabCut segmentation method with a guided filtering refinement process, to calculate the VIs according to the plots of interest. Three machine learning methods based on multivariable linear regressions (MLR), support vector machines (SVM), and neural networks (NN), were applied and compared through the entire phonological cycle of the crop: vegetative (V), reproductive (R), and ripening (Ri). Correlations were obtained by comparing our methods against an assembled ground-truth of SPAD measurements. The higher N correlations were achieved with NN: 0.98 (V), 0.94 (R), and 0.89 (Ri). We claim that the proposed UAV stabilization control algorithm significantly improves on the N-to-SPAD correlations by minimizing wind perturbations in real-time and reducing the need for offline image corrections.	[Colorado, Julian D.; Cera-Bornacelli, Natalia; Caldas, Juan S.; Cuellar, David; Calderon, Francisco; Mondragon, Ivan F.] Pontificia Univ Javeriana Bogota, Sch Engn, Carrera 7 40-62, Bogota 110231, Colombia; [Petro, Eliel; Rebolledo, Maria C.] Int Ctr Trop Agr CIAT, Km 17 Recta Cali Palmira, Cali 110231, Colombia; [Rebolledo, Maria C.] CIRAD, UMR AGAP, F-34398 Montpellier, France; [Rebolledo, Maria C.] Univ Montpellier, Montpellier SupAgro, INRA, CIRAD, F-34000 Montpellier, France; [Jaramillo-Botero, Andres] CALTECH, Chem & Chem Engn Div, Pasadena, CA 91125 USA; [Jaramillo-Botero, Andres] Pontificia Univ Javeriana Cali, Elect & Comp Sci, Calle 18 118-250, Cali 760031, Colombia		Colorado, JD (corresponding author), Pontificia Univ Javeriana Bogota, Sch Engn, Carrera 7 40-62, Bogota 110231, Colombia.	coloradoj@javeriana.edu.co; ceran@javeriana.edu.co; jcaldas@javeriana.edu.co; e.e.petro@cgiar.org; m.c.rebolledo@cgiar.org; david.cuellar@javeriana.edu.co; calderonf@javeriana.edu.co; imondragon@javeriana.edu.co; ajaramil@caltech.edu	rebolledo, maria/AAQ-4981-2021	Colorado M., Julian/0000-0002-6925-0126; Calderon Bocanegra, Francisco Carlos/0000-0001-8681-415X; Jaramillo-Botero, Andres/0000-0003-2844-0756; Petro Paez, Eliel E./0000-0002-0577-6532	OMICAS program: Optimizacion Multiescala In-silico de Cultivos Agricolas Sostenibles (Infraestructura y validacion en Arroz y Cana de Azucar); World Bank; Colombian Ministry of Science, Technology and Innovation; Colombian Ministry of Education; Colombian Ministry of Industry and Turism; ICETEX [FP44842-217-2018]	OMICAS program: Optimizacion Multiescala In-silico de Cultivos Agricolas Sostenibles (Infraestructura y validacion en Arroz y Cana de Azucar); World Bank(The World Bank India); Colombian Ministry of Science, Technology and Innovation; Colombian Ministry of Education; Colombian Ministry of Industry and Turism; ICETEX	This work was funded by the OMICAS program: Optimizacion Multiescala In-silico de Cultivos Agricolas Sostenibles (Infraestructura y validacion en Arroz y Cana de Azucar), anchored at the Pontificia Universidad Javeriana in Cali and funded within the Colombian Scientific Ecosystem by The World Bank, the Colombian Ministry of Science, Technology and Innovation, the Colombian Ministry of Education and the Colombian Ministry of Industry and Turism, and ICETEX under GRANT ID: FP44842-217-2018.	[Anonymous], FOILSIM 3 NASA AER S; Arai K., 2014, INT J ADV RES ARTIF, P3, DOI [10.14569/IJARAI.2014.030303, DOI 10.14569/IJARAI.2014.030303]; Assmann JJ, 2019, J UNMANNED VEH SYST, V7, P54, DOI 10.1139/juvs-2018-0018; Bendig J, 2013, PHOTOGRAMM FERNERKUN, P551, DOI 10.1127/1432-8364/2013/0200; Bergstrasser S, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0043-0; Cammarano D, 2014, REMOTE SENS-BASEL, V6, P2827, DOI 10.3390/rs6042827; Caruso G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210804; Comba L, 2018, COMPUT ELECTRON AGR, V155, P84, DOI 10.1016/j.compag.2018.10.005; Devia CA, 2019, J INTELL ROBOT SYST, V96, P573, DOI 10.1007/s10846-019-01001-5; Dong ZZ, 2015, COMMUN SOIL SCI PLAN, V46, P1579, DOI 10.1080/00103624.2015.1045595; Ganesan P., 2014, ADV EL ENG ICAEE 201, P1, DOI [DOI 10.1109/ICAEE.2014.6838440, 10.1109/ICAEE.2014.6838441]; Ghosal S, 2018, P NATL ACAD SCI USA, V115, P4613, DOI 10.1073/pnas.1716999115; Gnyp ML, 2014, FIELD CROP RES, V155, P42, DOI 10.1016/j.fcr.2013.09.023; Guan SL, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11020112; Han YL, 2020, PHOTOGRAMM REC, V35, P58, DOI 10.1111/phor.12310; He K. M., 2010, LECT NOTES COMPUTER, V6311; Kandwal Rohan, 2014, INT J ADV RES COMPUT, V4, P2277; Kanke Y, 2016, PRECIS AGRIC, V17, P507, DOI 10.1007/s11119-016-9433-1; Li J, 2015, IET IMAGE PROCESS, V9, P977, DOI 10.1049/iet-ipr.2014.0803; Li SY, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01834; Liu Y, 2016, INT GEOSCI REMOTE SE, P7362, DOI 10.1109/IGARSS.2016.7730920; Lu JS, 2020, PRECIS AGRIC, V21, P324, DOI 10.1007/s11119-019-09670-w; Mahajan GR, 2017, PRECIS AGRIC, V18, P736, DOI 10.1007/s11119-016-9485-2; Maimaitijiang M, 2019, ISPRS J PHOTOGRAMM, V151, P27, DOI 10.1016/j.isprsjprs.2019.03.003; Mishra P, 2017, BIOSYST ENG, V164, P49, DOI 10.1016/j.biosystemseng.2017.09.009; Naito H, 2017, ISPRS J PHOTOGRAMM, V125, P50, DOI 10.1016/j.isprsjprs.2017.01.010; Tran NK, 2015, INT CONF UNMAN AIRCR, P320, DOI 10.1109/ICUAS.2015.7152306; Nigon TJ, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12081234; PANDEY P, 2017, FRONT PLANT SCI, V8; Prabhakara K, 2015, INT J APPL EARTH OBS, V39, P88, DOI 10.1016/j.jag.2015.03.002; Rojas BJP, 2018, INT CONF UNMAN AIRCR, P846, DOI 10.1109/ICUAS.2018.8453283; Rother C, 2004, ACM T GRAPHIC, V23, P309, DOI 10.1145/1015706.1015720; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Schirrmann M, 2016, COMPUT ELECTRON AGR, V121, P374, DOI 10.1016/j.compag.2016.01.007; Siddiqui FU, 2011, IEEE T CONSUM ELECTR, V57, P833, DOI 10.1109/TCE.2011.5955230; Singh AK, 2018, TRENDS PLANT SCI, V23, P883, DOI 10.1016/j.tplants.2018.07.004; Sun DW, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0432-x; Sun J, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9090951; Sun SP, 2020, ISPRS J PHOTOGRAMM, V160, P195, DOI 10.1016/j.isprsjprs.2019.12.011; Thaiparnit S, 2017, ENG J-THAIL, V21, P269, DOI 10.4186/ej.2017.21.3.269; Tilly N, 2015, REMOTE SENS-BASEL, V7, P11449, DOI 10.3390/rs70911449; Tran N.K., 2015, THESIS; Ubbens JR, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01190; Wan L, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10091484; Wang C, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9010011; Wang W, 2012, J INTEGR AGR, V11, P2001, DOI 10.1016/S2095-3119(12)60457-2; Wang YM, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12081232; Xiong X, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0254-7; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yang H, 2014, PLANT PROD SCI, V17, P81, DOI 10.1626/pps.17.81; Yang ZL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173627; Zhang DY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0187470; Zhang K, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9020106; Zhou X, 2017, ISPRS J PHOTOGRAMM, V130, P246, DOI 10.1016/j.isprsjprs.2017.05.003	54	7	7	11	23	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-4292		REMOTE SENS-BASEL	Remote Sens.	OCT	2020	12	20							3396	10.3390/rs12203396	http://dx.doi.org/10.3390/rs12203396			31	Environmental Sciences; Geosciences, Multidisciplinary; Remote Sensing; Imaging Science & Photographic Technology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Geology; Remote Sensing; Imaging Science & Photographic Technology	OL7VY		Green Accepted, gold, Green Submitted			2022-09-04	WOS:000585543700001
J	Mendoza, C; Barreto, GE; Iarkov, A; Tarasov, VV; Aliev, G; Echeverria, V				Mendoza, Cristhian; Barreto, George E.; Iarkov, Alexandre; Tarasov, Vadim V.; Aliev, Gjumrakch; Echeverria, Valentina			Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder	MOLECULAR NEUROBIOLOGY			English	Review						Post-traumatic stress disorder; Cotinine; Fear; Inflammation; Nicotinic receptor; Extinction	NICOTINIC ACETYLCHOLINE-RECEPTORS; VENTROMEDIAL PREFRONTAL CORTEX; GLYCOGEN-SYNTHASE KINASE-3; DEPRESSIVE-LIKE BEHAVIOR; DEEP BRAIN-STIMULATION; CONTEXTUAL FEAR MEMORY; COMBAT-RELATED PTSD; PHYSICAL-ACTIVITY; ALZHEIMERS-DISEASE; MENTAL-HEALTH	Post-traumatic stress disorder (PTSD) is a mental disorder that may develop after exposure to exceptionally threatening or unescapable horrifying events. Actual therapies fail to alleviate the emotional suffering and cognitive impairment associated with this disorder, mostly because they are ineffective in treating the failure to extinguish trauma memories in a great percentage of those affected. In this review, current behavioral, cellular, and molecular evidence supporting the use of cotinine for treating PTSD are reviewed. The role of the positive modulation by cotinine of the nicotinic acetylcholine receptors (nAChRs) and their downstream effectors, the protection of astroglia, and the inhibition of microglia in the PTSD brain are also discussed.	[Mendoza, Cristhian; Iarkov, Alexandre; Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Barreto, George E.] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Tarasov, Vadim V.] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, Moscow 119991, Russia; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 1142432, Moscow Region, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Echeverria, Valentina] Bay Pines VA Healthcare Syst Res & Dev, Bay Pines, FL 33744 USA		Echeverria, V (corresponding author), Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile.; Aliev, G (corresponding author), Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 1142432, Moscow Region, Russia.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.; Aliev, G (corresponding author), Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA.; Echeverria, V (corresponding author), Bay Pines VA Healthcare Syst Res & Dev, Bay Pines, FL 33744 USA.	aliev03@gmail.com; echeverria.valentina@gmail.com	Aliev, Gjumrakch/K-7302-2017; Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./AAD-7420-2020; Valentina Echeverria Moran, BCh/E-7765-2013	Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Mendoza, Cristhian/0000-0002-5038-0991	Fondo de Ciencia y Tecnologia (FONDECYT) de Chile [1150149]	Fondo de Ciencia y Tecnologia (FONDECYT) de Chile	This work was supported by the Fondo de Ciencia y Tecnologia (FONDECYT) de Chile, Grant #1150149.	Abbruscato TJ, 2002, J PHARM SCI-US, V91, P2525, DOI 10.1002/jps.10256; Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Armony JL, 2005, AM J PSYCHIAT, V162, P1961, DOI 10.1176/appi.ajp.162.10.1961; Armour C, 2017, J ANXIETY DISORD, V45, P49, DOI 10.1016/j.janxdis.2016.11.008; Armour C, 2016, CLIN PSYCHOL REV, V44, P60, DOI 10.1016/j.cpr.2015.12.003; Bangasser DA, 2016, BRAIN RES, V1641, P177, DOI 10.1016/j.brainres.2015.11.021; Bangasser DA, 2015, HORM BEHAV, V76, P125, DOI 10.1016/j.yhbeh.2015.04.003; Bangasser DA, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-2; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2016, PROG NEUROBIOL, V144, P1, DOI 10.1016/j.pneurobio.2016.09.001; Barreto GE, 2015, CURR PHARM DESIGN, V21, P3589, DOI 10.2174/1381612821666150710145250; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Beaulieu JM, 2012, J PSYCHIATR NEUROSCI, V37, P7, DOI 10.1503/jpn.110011; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Blach-Olszewska Z, 2015, CURR PHARM DESIGN, V21, P3582, DOI 10.2174/1381612821666150710144829; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Brancu M, 2016, PSYCHOL TRAUMA-US, V8, P222, DOI 10.1037/tra0000078; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Buccafusco JJ, 2009, BIOCHEM PHARMACOL, V78, P852, DOI 10.1016/j.bcp.2009.06.102; Burgess S ZR, 2012, J CLIN TOXICOL; Burri Andrea, 2014, BMC Res Notes, V7, P407, DOI 10.1186/1756-0500-7-407; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Jurado-Coronel JC, 2016, CURR PHARM DESIGN, V22, P1305, DOI 10.2174/138161282210160304112133; Chapman JM, 2012, SOC NEUR NEW ORL LA; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Clark-Raymond A, 2013, J PSYCHIATR RES, V47, P1080, DOI 10.1016/j.jpsychires.2013.04.008; COLLINS AC, 1990, CIBA F SYMP, V152, P68; Conard PL, 2014, NURS FORUM, V49, P1, DOI 10.1111/nuf.12049; Conklin BS, 2002, AM J PATHOL, V160, P413, DOI 10.1016/S0002-9440(10)64859-6; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dai WJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0891-9; Davis M, 2002, BIOL PSYCHIAT, V52, P998, DOI 10.1016/S0006-3223(02)01507-X; de Aguiar RB, 2013, NEUROPHARMACOLOGY, V71, P292, DOI 10.1016/j.neuropharm.2013.03.032; Deering CG, 1996, COMPR PSYCHIAT, V37, P336, DOI 10.1016/S0010-440X(96)90015-2; Dwoskin LP, 1999, J PHARMACOL EXP THER, V288, P905; Echeverria V, 2017, CURR ALZHEIMER RES, V14, P1155, DOI 10.2174/1567205014666170329113007; Echeverria V, 2016, PROG NEUROBIOL, V144, P142, DOI 10.1016/j.pneurobio.2016.01.002; Echeverria V, 2016, CURR PHARM DESIGN, V22, P1324, DOI 10.2174/138161282210160304112511; Echeverria V, 2012, CNS NEUROSCI THER, V18, P517, DOI 10.1111/j.1755-5949.2012.00317.x; Echeverria V, 2011, J ALZHEIMERS DIS, V24, P817, DOI 10.3233/JAD-2011-102136; Edmondson D, 2013, AM HEART J, V166, P806, DOI 10.1016/j.ahj.2013.07.031; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P737, DOI 10.1002/da.20845; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Frueh BC, 1998, CLIN PSYCHOL REV, V18, P287, DOI 10.1016/S0272-7358(97)00087-1; FUXE K, 1979, PHARMACOL BIOCHEM BE, V10, P671, DOI 10.1016/0091-3057(79)90319-8; Gao J, 2014, BIOORG MED CHEM LETT, V24, P1472, DOI 10.1016/j.bmcl.2014.02.008; Garzon D, 2016, J MOL NEUROSCI, V58, P483, DOI 10.1007/s12031-016-0719-6; Goldmann E, 2012, ANN EPIDEMIOL, V22, P71, DOI 10.1016/j.annepidem.2011.11.003; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Gould E, 1997, J NEUROSCI, V17, P2492; Grizzell JA, 2017, PROG NEURO-PSYCHOPH, V78, P75, DOI 10.1016/j.pnpbp.2017.05.010; Grizzell JA, 2015, NEUROCHEM RES, V40, P2032, DOI 10.1007/s11064-014-1359-2; Grizzell JA, 2014, BEHAV NEUROSCI, V128, P713, DOI 10.1037/bne0000021; Harte CB, 2015, EVAL HEALTH PROF, V38, P42, DOI 10.1177/0163278713494774; Hatsukami D, 1998, PSYCHOPHARMACOLOGY, V138, P184, DOI 10.1007/s002130050661; Hatsukami D, 1998, PSYCHOPHARMACOLOGY, V135, P141, DOI 10.1007/s002130050495; Hatsukami DK, 1997, PHARMACOL BIOCHEM BE, V57, P643, DOI 10.1016/S0091-3057(97)80001-9; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Herringa RJ, 2013, P NATL ACAD SCI USA, V110, P19119, DOI 10.1073/pnas.1310766110; Hetrick SE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007316.pub2; Himmelfarb N, 2006, J TRAUMA STRESS, V19, P837, DOI 10.1002/jts.20163; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoffman JR, 2017, AMINO ACIDS, V49, P871, DOI 10.1007/s00726-017-2383-8; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Iarkov A, 2016, CANCER CHEMOTH PHARM, V78, P1033, DOI 10.1007/s00280-016-3161-0; Iglesias J, 2017, MOL NEUROBIOL, V54, P2518, DOI 10.1007/s12035-016-9833-2; Izquierdo I, 2004, NEUROTOX RES, V6, P175, DOI 10.1007/BF03033220; Jatzko A, 2006, J AFFECT DISORDERS, V94, P121, DOI 10.1016/j.jad.2006.03.010; Jatzko A, 2006, EUR ARCH PSY CLIN N, V256, P112, DOI 10.1007/s00406-005-0617-3; Jayakody K, 2014, BRIT J SPORT MED, V48, P187, DOI 10.1136/bjsports-2012-091287; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Kaladchibachi Sevag A, 2007, J Circadian Rhythms, V5, P3, DOI 10.1186/1740-3391-5-3; Kiguchi N, 2012, NEUROCHEM INT, V61, P1212, DOI 10.1016/j.neuint.2012.09.001; Knox D, 2016, NEUROBIOL LEARN MEM, V133, P39, DOI 10.1016/j.nlm.2016.06.001; Knox D, 2016, HIPPOCAMPUS, V26, P718, DOI 10.1002/hipo.22553; Koenen KC, 2011, DEPRESS ANXIETY, V28, P639, DOI 10.1002/da.20825; Koh S, 2018, J CHILD NEUROL, V33, P64, DOI 10.1177/0883073817739528; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lall D, 2017, J CLIN INVEST, V127, P3250, DOI 10.1172/JCI90607; Lancaster CL, 2016, J CLIN MED, V5, DOI 10.3390/jcm5110105; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lawrence S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007171.pub2; Leiva-Bianchi MC, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21239; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Levin ED, 2012, CURR DRUG TARGETS, V13, P602, DOI 10.2174/138945012800398937; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lopes S, 2017, CEREB CORTEX, V27, P2580, DOI 10.1093/cercor/bhw057; Lopez-Valdes HE, 2016, REV INVEST CLIN, V68, P40; Martin-Jimenez CA, 2017, PROG NEUROBIOL, V158, P45, DOI 10.1016/j.pneurobio.2017.08.001; Mendoza C, 2016, MOL CELL ENDOCRINOL, V434, P266, DOI 10.1016/j.mce.2016.05.016; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Miyazaki I, 2016, CURR MED CHEM, V23, P686, DOI 10.2174/0929867323666160122115057; Moser JS, 2010, J NERV MENT DIS, V198, P72, DOI 10.1097/NMD.0b013e3181c81fac; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; Myers KM, 2011, NEUROPSYCHOPHARMACOL, V36, P274, DOI 10.1038/npp.2010.88; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nacasch N, 2007, CNS SPECTRUMS, V12, P690, DOI 10.1017/S1092852900021520; Najavits Lisa M, 2015, F1000Prime Rep, V7, P43, DOI 10.12703/P7-43; Neigh GN, 2016, NEUROBIOL DIS, V92, P116, DOI 10.1016/j.nbd.2015.11.012; Ning K, 2010, HUM MOL GENET, V19, P3159, DOI 10.1093/hmg/ddq226; Norrholm SD, 2011, BIOL PSYCHIAT, V69, P556, DOI 10.1016/j.biopsych.2010.09.013; Papagni SA, 2011, STRESS, V14, P227, DOI 10.3109/10253890.2010.522279; Pardo M, 2017, EUR J NEUROSCI, V45, P490, DOI 10.1111/ejn.13446; Parker G, 2016, INT PSYCHOGERIATR, V28, P11, DOI 10.1017/S1041610215001210; Patel S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00162; Picciotto MR, 2001, PHARMACOL THERAPEUT, V92, P89, DOI 10.1016/S0163-7258(01)00161-9; Pilar-Cuellar F, 2014, CURR PHARM DESIGN, V20, P3776, DOI 10.2174/13816128113196660736; Puetz VB, 2016, J CHILD PSYCHOL PSYC, V57, P1165, DOI 10.1111/jcpp.12595; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Reznikov R, 2017, NEUROMODULATION, V20, P7, DOI 10.1111/ner.12551; Reznikov R, 2016, NEUROPSYCHOPHARMACOL, V41, P2810, DOI 10.1038/npp.2016.34; Rosenbaum S, 2016, EARLY INTERV PSYCHIA, V10, P435, DOI 10.1111/eip.12238; Rosenbaum S, 2015, PSYCHIAT RES, V230, P130, DOI 10.1016/j.psychres.2015.10.017; Rosenbaum Simon, 2014, BMC Res Notes, V7, P576, DOI 10.1186/1756-0500-7-576; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Santini E, 2008, J NEUROSCI, V28, P4028, DOI 10.1523/JNEUROSCI.2623-07.2008; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saur L, 2016, NEUROCHEM RES, V41, P892, DOI 10.1007/s11064-015-1770-3; Schreurs BG, 2011, J PSYCHIATR RES, V45, P638, DOI 10.1016/j.jpsychires.2010.10.010; Schuch F, 2017, J AFFECT DISORDERS, V210, P139, DOI 10.1016/j.jad.2016.10.050; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Shaw JLV, 2010, AM J PATHOL, V177, P2509, DOI 10.2353/ajpath.2010.100243; Shi S, 2016, J ALZHEIMERS DIS, V50, P859, DOI 10.3233/JAD-150963; Shin LM, 2009, J TRAUMA STRESS, V22, P409, DOI 10.1002/jts.20442; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Smith NB, 2017, NEUROSCI LETT, V649, P170, DOI 10.1016/j.neulet.2017.01.006; SRIWARSINI, 2014, ISSUES MENT HEALTH N, V35, P420, DOI DOI 10.3109/01612840.2013.875085; Steckler T, 2012, NEUROPHARMACOLOGY, V62, P617, DOI 10.1016/j.neuropharm.2011.06.012; Stevelink SAM, 2015, OCCUP ENVIRON MED, V72, P243, DOI 10.1136/oemed-2014-102207; STEWART AL, 1994, J CLIN EPIDEMIOL, V47, P719, DOI 10.1016/0895-4356(94)90169-4; Stubbs B, 2016, ACTA PSYCHIAT SCAND, V134, P546, DOI 10.1111/acps.12654; Stubbs B, 2017, SCHIZOPHRENIA BULL, V43, P536, DOI 10.1093/schbul/sbw111; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Teicher MH, 2016, NAT REV NEUROSCI, V17, P652, DOI 10.1038/nrn.2016.111; Teicher MH, 2002, PSYCHIAT CLIN N AM, V25, P397, DOI 10.1016/S0193-953X(01)00003-X; Terry AV, 2015, J PHARMACOL EXP THER, V352, P405, DOI 10.1124/jpet.114.219881; Terry AV, 2012, BIOCHEM PHARMACOL, V83, P941, DOI 10.1016/j.bcp.2011.12.043; Terry AV, 2005, CNS DRUG REV, V11, P229; Thomason ME, 2015, SOC COGN AFFECT NEUR, V10, P1460, DOI 10.1093/scan/nsv030; Thomsen MS, 2012, J NEUROCHEM, V123, P73, DOI 10.1111/j.1471-4159.2012.07876.x; Uddin M, 2010, P NATL ACAD SCI USA, V107, P9470, DOI 10.1073/pnas.0910794107; Vainio P J, 2001, Nicotine Tob Res, V3, P177; Vainio PJ, 2000, TOXICOL APPL PHARM, V163, P183, DOI 10.1006/taap.1999.8863; Vancampfort D, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0463-5; Vancampfort D, 2016, J PHYS ACT HEALTH, V13, P910, DOI 10.1123/jpah.2015-0436; Vancampfort D, 2016, J AFFECT DISORDERS, V195, P82, DOI 10.1016/j.jad.2016.01.046; Vancampfort D, 2016, SCHIZOPHR RES, V170, P336, DOI 10.1016/j.schres.2016.01.001; Vancampfort D, 2015, AUST NZ J PSYCHIAT, V49, P681, DOI 10.1177/0004867415590831; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; Vitriol V, 2013, REV MED CHILE, V141, P338, DOI 10.4067/S0034-98872013000300009; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2003, BRAIN RES, V965, P290, DOI 10.1016/S0006-8993(02)04162-8; Vyas A, 2002, J NEUROSCI, V22, P6810; Waller R, 2016, J NEUROIMMUNOL, V299, P139, DOI 10.1016/j.jneuroim.2016.09.010; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wicking M, 2016, NEUROBIOL LEARN MEM, V136, P116, DOI 10.1016/j.nlm.2016.09.016; Wildeboer-Andrud KM, 2014, PHARMACOL BIOCHEM BE, V117, P144, DOI 10.1016/j.pbb.2013.12.005; Wilson MA, 2017, J NEUROSCI RES, V95, P836, DOI 10.1002/jnr.23840; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Yamamoto S, 2008, NEUROPSYCHOPHARMACOL, V33, P2108, DOI 10.1038/sj.npp.1301605; Zeitlin R, 2012, BEHAV BRAIN RES, V228, P284, DOI 10.1016/j.bbr.2011.11.023; Zevin S, 2000, DRUG ALCOHOL DEPEN, V60, P13, DOI 10.1016/S0376-8716(99)00135-0; Zhang J, 2016, CELL, V166, P716, DOI 10.1016/j.cell.2016.06.026; Zhang XY, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.10.003; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zlotnick C, 2006, PSYCHOL MED, V36, P1523, DOI 10.1017/S0033291706008282; Zschucke Elisabeth, 2013, J Prev Med Public Health, V46 Suppl 1, pS12, DOI 10.3961/jpmph.2013.46.S.S12	179	10	11	1	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2018	55	8					6700	6711		10.1007/s12035-018-0869-3	http://dx.doi.org/10.1007/s12035-018-0869-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GO1YO	29335846				2022-09-04	WOS:000439758300031
J	Jurado-Coronel, JC; Cabezas, R; Rodriguez, MFA; Echeverria, V; Garcia-Segura, LM; Barreto, GE				Camilo Jurado-Coronel, Juan; Cabezas, Ricardo; Avila Rodriguez, Marco Fidel; Echeverria, Valentina; Miguel Garcia-Segura, Luis; Barreto, George E.			Sex differences in Parkinson's disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics	FRONTIERS IN NEUROENDOCRINOLOGY			English	Review						Parkinson's disease; Sex; Nigrostriatal degeneration; Motor symptoms; Non-motor symptoms; MPTP; 6-OHDA; Estradiol	QUALITY-OF-LIFE; NIGROSTRIATAL DOPAMINERGIC SYSTEM; DEEP BRAIN-STIMULATION; ESTROGEN-RECEPTOR-BETA; NITRIC-OXIDE SYNTHASE; GENDER-DIFFERENCES; NONMOTOR SYMPTOMS; ALPHA-SYNUCLEIN; SUBTHALAMIC STIMULATION; MITOCHONDRIAL DYSFUNCTION	Parkinson's disease (PD) is the second most frequent age-related neurodegenerative disorder. Sex is an important factor in the development of PD, as reflected by the fact that it is more common in men than in women by an approximate ratio of 2:1. Our hypothesis is that differences in PD among men and women are highly determined by sex-dependent differences in the nigrostriatal dopaminergic system, which arise from environmental, hormonal and genetic influences. Sex hormones, specifically estrogens, influence PD pathogenesis and might play an important role in PD differences between men and women. The objective of this review was to discuss the PD physiopathology and point out sex differences in nigrostriatal degeneration, symptoms, genetics, responsiveness to treatments and biochemical and molecular mechanisms among patients suffering from this disease. Finally, we discuss the role estrogens may have on PD sex differences.	[Camilo Jurado-Coronel, Juan; Cabezas, Ricardo; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Avila Rodriguez, Marco Fidel] Univ Tolima, Fac Ciencias Salud, Ibague, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Cs Salud, Lientur 1457, Concepcion 4080871, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Madrid, Spain; [Miguel Garcia-Segura, Luis] Inst Salud Carlos III, CIBER Invest Biomed Red Fragilidad & Envejecimien, Madrid, Spain; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.	gsampaio@javeriana.edu.co	Barreto, George E./AAD-7420-2020; Valentina Echeverria Moran, BCh/E-7765-2013; Garcia-Segura, Luis M/U-3711-2017	Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Garcia-Segura, Luis M/0000-0002-2450-2916; Avila-Rodriguez, Marco/0000-0003-4612-3236	PUJ [5623]	PUJ	This work received support from PUJ grant ID #5623.	Acaz-Fonseca E, 2017, SCI REP-UK, V7, DOI 10.1038/srep43878; Accolla E, 2007, MOVEMENT DISORD, V22, P1150, DOI 10.1002/mds.21520; Al Sweidi S, 2012, J NEUROENDOCRINOL, V24, P48, DOI 10.1111/j.1365-2826.2011.02193.x; Althaus A, 2008, PARKINSONISM RELAT D, V14, P626, DOI 10.1016/j.parkreldis.2008.01.016; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Antzoulatos E, 2010, PHARMACOL BIOCHEM BE, V95, P466, DOI 10.1016/j.pbb.2010.03.009; Baldereschi M, 2000, NEUROLOGY, V55, P1358, DOI 10.1212/WNL.55.9.1358; Baraka AM, 2011, LIFE SCI, V88, P879, DOI 10.1016/j.lfs.2011.03.010; Betancourt E, 2017, NEUROSCIENCE, V345, P297, DOI 10.1016/j.neuroscience.2016.05.041; Bhatt SD, 2005, BRAIN RES, V1035, P188, DOI 10.1016/j.brainres.2004.12.013; Bjornara KA, 2013, PARKINSONISM RELAT D, V19, P120, DOI 10.1016/j.parkreldis.2012.05.027; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Bourque M, 2012, FRONT NEUROENDOCRIN, V33, P169, DOI 10.1016/j.yfrne.2012.02.003; Bugalho P, 2011, J NEUROL, V258, P50, DOI 10.1007/s00415-010-5679-0; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Caranci G, 2013, J NEURAL TRANSM, V120, P1209, DOI 10.1007/s00702-013-0972-6; Casas S, 2011, PHARM BIOCH BEHAV, V4, P614; Caslake R, 2013, PARKINSONISM RELAT D, V19, P515, DOI 10.1016/j.parkreldis.2013.01.014; Cereda E, 2016, PARKINSONISM RELAT D, V26, P67, DOI 10.1016/j.parkreldis.2016.02.024; Chandran S, 2014, ANN INDIAN ACAD NEUR, V17, P66, DOI 10.4103/0972-2327.128557; Chiara P, 2013, BASAL GANGLIA, V3, P131, DOI 10.1016/j.baga.2012.10.004; Cilia R, 2014, PARKINSONISM RELAT D, V20, P911, DOI 10.1016/j.parkreldis.2014.04.016; Colombo Delia, 2015, ScientificWorldJournal, V2015, P787451, DOI 10.1155/2015/787451; Cubo E, 2000, CLIN NEUROPHARMACOL, V23, P331, DOI 10.1097/00002826-200011000-00006; Czech DP, 2012, J NEUROCHEM, V122, P260, DOI 10.1111/j.1471-4159.2012.07782.x; Dahodwala N, 2016, JOGNN-J OBST GYN NEO, V45, P749, DOI 10.1016/j.jogn.2016.05.002; Das SK, 2010, NEUROLOGY, V75, P1362, DOI 10.1212/WNL.0b013e3181f735a7; de Michele F, 2003, NEUROL SCI, V24, P172, DOI 10.1007/s10072-003-0115-1; Disshon KA, 2000, BRAIN RES, V868, P95, DOI 10.1016/S0006-8993(00)02329-5; Dluzen DE, 2005, PHARMACOL BIOCHEM BE, V80, P27, DOI 10.1016/j.pbb.2004.10.007; Dluzen DE, 1996, NEUROTOXICOL TERATOL, V18, P603, DOI 10.1016/0892-0362(96)00086-4; dos Santos AB, 2015, NEUROCHEM RES, V40, P421, DOI 10.1007/s11064-014-1488-7; dos Santos AB, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00273; Dowding CH, 2006, DRUG AGING, V23, P693, DOI 10.2165/00002512-200623090-00001; Fukae J, 2007, MITOCHONDRION, V7, P58, DOI 10.1016/j.mito.2006.12.002; Gao L, 2015, J CLIN NEUROSCI, V22, P488, DOI 10.1016/j.jocn.2014.08.032; Gao X, 2001, NEUROSCIENCE, V103, P385, DOI 10.1016/S0306-4522(01)00014-8; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Gillies GE, 2014, FRONT NEUROENDOCRIN, V35, P370, DOI 10.1016/j.yfrne.2014.02.002; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Gillies GE, 2010, HORM BEHAV, V57, P23, DOI 10.1016/j.yhbeh.2009.06.002; Goldwurm S, 2011, MOVEMENT DISORD, V26, P2144, DOI 10.1002/mds.23807; Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085; Guo XY, 2013, PARKINSONISM RELAT D, V19, P961, DOI 10.1016/j.parkreldis.2013.06.009; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; Hakansson A, 2005, AM J MED GENET B, V133B, P88, DOI 10.1002/ajmg.b.30136; Hariz GM, 2013, ACTA NEUROL SCAND, V128, P281, DOI 10.1111/ane.12127; Hariz GM, 2000, PARKINSONISM RELAT D, V6, P155, DOI 10.1016/S1353-8020(00)00009-2; Hariz GM, 2011, PARKINSONISM RELAT D, V17, P146, DOI 10.1016/j.parkreldis.2010.12.002; Heller J, 2014, AGING DIS, V5, P63, DOI 10.14366/AD.2014.050063; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Heneka MT, 2001, J NEUROIMMUNOL, V114, P8, DOI 10.1016/S0165-5728(01)00246-6; Hirsch L, 2016, NEUROEPIDEMIOLOGY, V46, P292, DOI 10.1159/000445751; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Janowsky JS, 2006, NEUROSCIENCE, V138, P1015, DOI 10.1016/j.neuroscience.2005.09.007; Ji J, 2009, BIOCHEM PHARMACOL, V78, P1401, DOI 10.1016/j.bcp.2009.07.004; Joniec I, 2009, BRAIN RES, V1261, P7, DOI 10.1016/j.brainres.2008.12.081; Kaasinen V, 2015, NEUROBIOL AGING, V36, P1757, DOI 10.1016/j.neurobiolaging.2015.01.016; Kelada SN, 2002, NEUROTOXICOLOGY, V23, P515, DOI 10.1016/S0161-813X(02)00061-X; Kishore A, 2010, MOVEMENT DISORD, V25, P2438, DOI 10.1002/mds.23269; Kuikka JT, 1997, EUR J NUCL MED, V24, P1085, DOI 10.1007/BF01254238; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lavalaye J, 2000, EUR J NUCL MED, V27, P867, DOI 10.1007/s002590000279; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Lewis C, 2008, NEUROSCI LETT, V448, P130, DOI 10.1016/j.neulet.2008.10.011; Litim N, 2016, NEUROSCI BIOBEHAV R, V67, P79, DOI 10.1016/j.neubiorev.2015.09.024; Liu B, 2007, CLIN EXP PHARMACOL P, V34, P555, DOI 10.1111/j.1440-1681.2007.04616.x; Loke H, 2015, INT J BIOCHEM CELL B, V65, P139, DOI 10.1016/j.biocel.2015.05.024; Lubomski M, 2014, J CLIN NEUROSCI, V21, P1503, DOI 10.1016/j.jocn.2013.12.016; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; McFarland K, 2013, ACS CHEM NEUROSCI, V4, P1249, DOI 10.1021/cn400132u; Melcangi RC, 2016, NEUROSCI BIOBEHAV R, V67, P25, DOI 10.1016/j.neubiorev.2015.09.023; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; Milanov I, 2001, NEUROEPIDEMIOLOGY, V20, P212, DOI 10.1159/000054790; Miller DB, 1998, ANN NY ACAD SCI, V844, P153, DOI 10.1111/j.1749-6632.1998.tb08230.x; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; Misiak M, 2010, BBA-BIOENERGETICS, V1797, P1178, DOI 10.1016/j.bbabio.2010.04.009; Mitra S, 2015, NEUROSCIENCE, V292, P46, DOI 10.1016/j.neuroscience.2014.12.052; MOGHAL S, 1994, NEUROEPIDEMIOLOGY, V13, P175, DOI 10.1159/000110376; Mosley RL, 2006, CLIN NEUROSCI RES, V6, P261, DOI 10.1016/j.cnr.2006.09.006; Ookubo M, 2009, MOL CELL ENDOCRINOL, V311, P62, DOI 10.1016/j.mce.2009.07.011; Picillo M, 2016, PARKINSONISM RELAT D, V27, P89, DOI 10.1016/j.parkreldis.2016.04.001; Picillo M, 2014, PARKINSONISM RELAT D, V20, P850, DOI 10.1016/j.parkreldis.2014.04.023; Postuma RB, 2009, NEUROLOGY, V72, P1296, DOI 10.1212/01.wnl.0000340980.19702.6e; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; RIVEST R, 1995, BRAIN RES, V692, P269, DOI 10.1016/0006-8993(95)00611-S; Rodriguez-Navarro JA, 2008, J NEUROCHEM, V106, P2143, DOI 10.1111/j.1471-4159.2008.05569.x; Rodriguez-Pallares J, 2007, J NEUROCHEM, V103, P145, DOI 10.1111/j.1471-4159.2007.04699.x; Rodriguez-Perez AI, 2013, NEUROBIOL DIS, V58, P209, DOI 10.1016/j.nbd.2013.06.004; Romito LM, 2010, J NEUROL, V257, P603, DOI 10.1007/s00415-009-5381-2; San Luciano M, 2012, NEUROSCI LETT, V506, P312, DOI 10.1016/j.neulet.2011.11.032; Schrag A, 2000, BRIT MED J, V321, P21, DOI 10.1136/bmj.321.7252.21; Shephard F, 2016, MITOCHONDRION, V29, P45, DOI 10.1016/j.mito.2016.05.001; Shephard F, 2014, MITOCHONDRION, V14, P64, DOI 10.1016/j.mito.2013.12.001; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Simunovic F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008856; Smith KM, 2014, EXP NEUROL, V259, P44, DOI 10.1016/j.expneurol.2014.03.010; Solla P, 2012, J NEUROL SCI, V323, P33, DOI 10.1016/j.jns.2012.07.026; Song Y, 2014, NEUROL SCI, V35, P1991, DOI 10.1007/s10072-014-1879-1; Stacy MA, 2010, PROG NEURO-PSYCHOPH, V34, P57, DOI 10.1016/j.pnpbp.2009.09.023; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Szewczyk-Krolikowski K, 2014, PARKINSONISM RELAT D, V20, P99, DOI 10.1016/j.parkreldis.2013.09.025; Teixeira-Arroyo Claudia, 2014, Motriz: rev. educ. fis., V20, P461, DOI 10.1590/S1980-65742014000400014; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tripanichkul W, 2006, BRAIN RES, V1084, P28, DOI 10.1016/j.brainres.2006.02.029; van der Hoek TC, 2011, J NEUROL SCI, V310, P220, DOI 10.1016/j.jns.2011.07.007; Vegeto E, 2001, J NEUROSCI, V21, P1809, DOI 10.1523/JNEUROSCI.21-06-01809.2001; Weiduschat N, 2014, PARKINSONISM RELAT D, V20, P545, DOI 10.1016/j.parkreldis.2014.02.003; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Wong KK, 2012, J CLIN NEUROSCI, V19, P183, DOI 10.1016/j.jocn.2011.05.013; Xu K, 2006, J NEUROSCI, V26, P535, DOI 10.1523/JNEUROSCI.3008-05.2006; Yang WW, 2016, ONCOTARGET, V7, P7441, DOI 10.18632/oncotarget.7046	119	64	67	1	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0091-3022	1095-6808		FRONT NEUROENDOCRIN	Front. Neuroendocrinol.	JUL	2018	50				SI		18	30		10.1016/j.yfrne.2017.09.002	http://dx.doi.org/10.1016/j.yfrne.2017.09.002			13	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	GU6RP	28974386				2022-09-04	WOS:000445443600003
J	Echeverria, V; Barreto, GE; Avila-Rodriguez, M; Tarasov, VV; Aliev, G				Echeverria, Valentina; Barreto, George E.; Avila-Rodriguez, Marco; Tarasov, Vadim V.; Aliev, Gjumrakch			Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease?	CURRENT ALZHEIMER RESEARCH			English	Review						VEGF; Alzheimer disease; amyotrophic lateral sclerosis; cotinine; nicotinic receptors; depression; tobacco; angiogenesis; dementia; neurodegeneration	ENDOTHELIAL-GROWTH-FACTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ADULT HIPPOCAMPAL NEUROGENESIS; DEPRESSIVE-LIKE BEHAVIOR; TRANSGENIC MOUSE MODEL; FACTOR RECEPTOR 2; IN-VIVO; PARKINSONS-DISEASE; FACTOR EXPRESSION	Background: The vascular endothelial growth factor (VEGF) is a neuroprotective cytokine that promotes neurogenesis and angiogenesis in the brain. In animal models, it has been shown that environmental enrichment and exercise, two non-pharmacological interventions that are beneficial decreasing the progression of Alzheimer disease (AD) and depressive-like behavior, enhance hippocampal VEGF expression and neurogenesis. Furthermore, the stimulation of VEGF expression promotes neurotransmission and synaptic plasticity processes such as neurogenesis. It is thought that these VEGF actions in the brain, may underly its beneficial therapeutic effects against psychiatric and other neurological conditions. Conclusion: In this review, evidence linking VEGF deficit with the development of AD as well as the potential role of VEGF signaling as a therapeutic target for cotinine and other interventions in neurodegenerative conditions are discussed.	[Echeverria, Valentina] Univ San Sebastian, Fac Cs Salud, Lientur 1457, Concepcion 4030000, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA; [Barreto, George E.; Avila-Rodriguez, Marco] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Ctr Biomed Res, Carlos Antunez 1920, Santiago, Chile; [Tarasov, Vadim V.] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, 2-4 Bolshaya Pirogovskaya St, Moscow 119991, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia		Echeverria, V (corresponding author), 10,000 Bay Pines Blvd,Bldg 23,Rm123, Bay Pines, FL 33744 USA.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, Cardiovasc Neuropathol Gerontol & Hlth Sci & Heal, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA.	echeverria.valentina@gmail.com; aliev03@gmail.com	Barreto, George E./AAD-7420-2020; Valentina Echeverria Moran, BCh/E-7765-2013; Aliev, Gjumrakch/AAE-7734-2020	Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Aliev, Gjumrakch/0000-0001-7373-3182; Avila-Rodriguez, Marco/0000-0003-4612-3236; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994	Russian Scientific Foundation [14-23-00160]; "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA; Pontificia Universidad Javeriana; Grant Fondecyt regular [1150194]	Russian Scientific Foundation(Russian Science Foundation (RSF)); "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA; Pontificia Universidad Javeriana; Grant Fondecyt regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was performed with resources from the University San Sebastian, Chile and the Grant Fondecyt regular 1150194 (to VE). G. Aliev work is supported by the Russian Scientific Foundation (www.rscf.ru, Grant No 14-23-00160 for 2014-2016: Directed design, synthesis, and study of biological activity of multi-target compounds as innovative drugs for treatment of neurodegenerative diseases) and "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA. GEB work is supported by Pontificia Universidad Javeriana.	Allaman I, 2011, PSYCHOPHARMACOLOGY, V216, P75, DOI 10.1007/s00213-011-2190-y; Arnold SE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.63; Barreto GE, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00340; Blasko I, 2006, DEMENT GERIATR COGN, V21, P9, DOI 10.1159/000089137; Boscolo E, 2007, INT J MOL MED, V19, P581; Burger S, 2010, INT J DEV NEUROSCI, V28, P597, DOI 10.1016/j.ijdevneu.2010.07.231; Calvo CF, 2011, GENE DEV, V25, P831, DOI 10.1101/gad.615311; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Chapuis J, 2006, NEUROBIOL AGING, V27, P1212, DOI 10.1016/j.neurobiolaging.2005.07.013; Chen HJ, 2012, NEUROSCI LETT, V507, P118, DOI 10.1016/j.neulet.2011.11.058; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Cui W, 2011, NEUROCHEM INT, V59, P945, DOI 10.1016/j.neuint.2011.07.005; Del Bo R, 2005, ANN NEUROL, V57, P373, DOI 10.1002/ana.20390; Del Bo R, 2008, NEUROBIOL AGING, V29, P1917, DOI 10.1016/j.neurobiolaging.2007.05.003; Del Bo R, 2009, J NEUROL SCI, V283, P66, DOI 10.1016/j.jns.2009.02.318; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Falk T, 2011, NEUROSCI LETT, V496, P43, DOI 10.1016/j.neulet.2011.03.088; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Fournier NM, 2012, BEHAV BRAIN RES, V227, P440, DOI 10.1016/j.bbr.2011.04.022; Galecki P, 2013, J AFFECT DISORDERS, V147, P144, DOI 10.1016/j.jad.2012.10.025; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; Gordon PH, 2013, AGING DIS, V4, P295, DOI 10.14336/AD.2013.0400295; Grizzell JA, 2015, NEUROCHEM RES, V40, P2032, DOI 10.1007/s11064-014-1359-2; Grizzell JA, 2014, BEHAV NEUROSCI, V128, P713, DOI 10.1037/bne0000021; Grizzell JA, 2014, BEHAV BRAIN RES, V268, P55, DOI 10.1016/j.bbr.2014.03.047; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1997, J NEUROL, V244, pS15, DOI 10.1007/BF03160575; Gurney ME, 2000, BIOESSAYS, V22, P297, DOI 10.1002/(SICI)1521-1878(200003)22:3<297::AID-BIES12>3.0.CO;2-I; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Halmai Z, 2013, J AFFECT DISORDERS, V144, P269, DOI 10.1016/j.jad.2012.09.006; Hermann MM, 2014, OPHTHALMOLOGY, V121, P905, DOI 10.1016/j.ophtha.2013.10.047; Herran E, 2014, INT J NANOMED, V9, P2677, DOI 10.2147/IJN.S61940; Herran E, 2013, EUR J PHARM BIOPHARM, V85, P1183, DOI 10.1016/j.ejpb.2013.03.034; Herran E, 2013, J CONTROL RELEASE, V170, P111, DOI 10.1016/j.jconrel.2013.04.028; Hohman TJ, 2015, JAMA NEUROL, V72, P520, DOI 10.1001/jamaneurol.2014.4761; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Isung J, 2012, WORLD J BIOL PSYCHIA, V13, P468, DOI 10.3109/15622975.2011.624549; Kalaria RN, 1998, MOL BRAIN RES, V62, P101, DOI 10.1016/S0169-328X(98)00190-9; Kim BW, 2008, CELL SIGNAL, V20, P714, DOI 10.1016/j.cellsig.2007.12.009; Kirby ED, 2015, P NATL ACAD SCI USA, V112, P4128, DOI 10.1073/pnas.1422448112; Kiuchi T, 2012, NEUROSCIENCE, V207, P208, DOI 10.1016/j.neuroscience.2012.01.023; Krakora D, 2013, MOL THER, V21, P1602, DOI 10.1038/mt.2013.108; Landgren S, 2010, NEUROMOL MED, V12, P224, DOI 10.1007/s12017-009-8096-8; Laske C, 2009, J ALZHEIMERS DIS, V17, P115, DOI 10.3233/JAD-2009-1017; Lazarovici P, 2006, CURR PHARM DESIGN, V12, P2609, DOI 10.2174/138161206777698738; Lee JS, 2009, J NEUROSCI, V29, P8493, DOI 10.1523/JNEUROSCI.1321-09.2009; Licht T, 2013, CELL MOL LIFE SCI, V70, P1727, DOI 10.1007/s00018-013-1280-x; Luppi C, 2009, ARCH GERONTOL GERIAT, V49, P173, DOI 10.1016/j.archger.2009.09.027; Ma YH, 2012, J NEUROSCI RES, V90, P1873, DOI 10.1002/jnr.23088; Makanya AN, 2015, METHODS MOL BIOL, V1214, P185, DOI 10.1007/978-1-4939-1462-3_11; Mateo I, 2007, ACTA NEUROL SCAND, V116, P56, DOI 10.1111/j.1600-0404.2006.00775.x; Mateo I, 2006, NEUROSCI LETT, V401, P171, DOI 10.1016/j.neulet.2006.03.020; McCloskey DP, 2005, J NEUROSCI, V25, P8889, DOI 10.1523/JNEUROSCI.2577-05.2005; Millauer B, 1996, CANCER RES, V56, P1615; Minelli A, 2011, PROG NEURO-PSYCHOPH, V35, P1322, DOI 10.1016/j.pnpbp.2011.04.013; Moran VE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00173; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Nowacka MM, 2012, NEUROPEPTIDES, V46, P1, DOI 10.1016/j.npep.2011.05.005; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Patel NS, 2010, J NEUROCHEM, V112, P66, DOI 10.1111/j.1471-4159.2009.06426.x; Patel S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00162; Pati S, 2009, BRAIN RES, V1256, P85, DOI 10.1016/j.brainres.2008.11.086; Patt S, 1998, NEUROSCI LETT, V252, P199, DOI 10.1016/S0304-3940(98)00582-5; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Provias J, 2014, CURR NEUROVASC RES, V11, P202, DOI 10.2174/1567202611666140520122316; Pucci S, 2008, PROG BRAIN RES, V173, P555, DOI 10.1016/S0079-6123(08)01138-2; Religa P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02053; Rigau V, 2007, BRAIN, V130, P1942, DOI 10.1093/brain/awm118; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schultheiss Caroline, 2006, Angiogenesis, V9, P59, DOI 10.1007/s10456-006-9030-4; Siddique T, 2011, Acta Myol, V30, P117; Spuch C, 2010, BIOMATERIALS, V31, P5608, DOI 10.1016/j.biomaterials.2010.03.042; Strong M, 2003, AMYOTROPH LATERAL SC, V4, P136, DOI 10.1080/14660820310011250; Subramony SH, 2011, MUSCLE NERVE, V44, P499, DOI 10.1002/mus.22117; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Tillo M, 2012, CELL ADHES MIGR, V6, P541, DOI 10.4161/cam.22408; Tsai SJ, 2009, PSYCHIAT RES, V169, P113, DOI 10.1016/j.psychres.2008.06.028; Udo H, 2008, J NEUROSCI, V28, P14522, DOI 10.1523/JNEUROSCI.3673-08.2008; Ventriglia M, 2009, PROG NEURO-PSYCHOPH, V33, P146, DOI 10.1016/j.pnpbp.2008.11.009; Viboolvorakul S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/230791; Viikki M, 2010, NEUROSCI LETT, V477, P105, DOI 10.1016/j.neulet.2010.04.039; Villar-Cheda B, 2009, J CEREBR BLOOD F MET, V29, P230, DOI 10.1038/jcbfm.2008.127; Wang P, 2011, BIOCHEM BIOPH RES CO, V411, P620, DOI 10.1016/j.bbrc.2011.07.003; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xue Yuan, 2009, J Angiogenes Res, V1, P9, DOI 10.1186/2040-2384-1-9; Yang SP, 2004, NEUROBIOL AGING, V25, P283, DOI 10.1016/S0197-4580(03)00111-8; Yue X, 2014, NEUROSCIENCE, V258, P385, DOI 10.1016/j.neuroscience.2013.11.038	90	20	21	0	13	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2050	1875-5828		CURR ALZHEIMER RES	Curr. Alzheimer Res.		2017	14	11					1155	1163		10.2174/1567205014666170329113007	http://dx.doi.org/10.2174/1567205014666170329113007			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FJ5DT	28356047				2022-09-04	WOS:000412767100004
J	Bautista-Molano, W; Saldarriaga-Rivera, LM; Junca-Ramirez, A; Fernandez-Aldana, AR; Fernandez-Avila, DG; Jaimes, DA; Jauregui, EA; Segura-Charry, JS; Romero-Sanchez, C; Felipe-Diaz, OJ				Bautista-Molano, Wilson; Saldarriaga-Rivera, Lina M.; Junca-Ramirez, Alejandro; Fernandez-Aldana, Andres R.; Fernandez-Avila, Daniel G.; Jaimes, Diego A.; Jauregui, Edwin A.; Segura-Charry, Juan S.; Romero-Sanchez, Consuelo; Felipe-Diaz, Oscar J.			2021 clinical practice guideline for the early detection, diagnosis, treatment, and monitoring of patients with axial spondyloarthritis. Colombian Association of Rheumatology	REUMATOLOGIA CLINICA			English	Article						Spondylarthritis; Practice guideline; Early diagnosis; Treatment; Monitoring	INFLAMMATORY BACK-PAIN; ACTIVE ANKYLOSING-SPONDYLITIS; SACROILIAC JOINTS; DISEASE-ACTIVITY; TREATMENT RECOMMENDATIONS; CLASSIFICATION CRITERIA; EFFICACY; SOCIETY; PERFORMANCE; PREVALENCE	Background: Axial Spondyloarthritis is a rheumatic condition affecting young patients with social and occupational consequences. Diagnosis delay is associated with functional impairment and impact on quality of life, requiring a multidisciplinary approach. Objective: To develop a set of recommendations based on the best available evidence for early detection, diagnosis, treatment and monitoring adult patients with axial spondyloarthritis. Methods: A working group was established, questions were developed, outcomes were graded, and a systematic search for evidence was conducted. A multidisciplinary panel of members was established (including patient representatives), minimizing bias in relation to conflicts of interest. The GRADE approach "Grading of Recommendations Assessment, Development and Evaluation" was used to assess the quality of the evidence as well as the direction and strength of recommendations. In total, 11 recommendations with regard to diagnosis (n = 2), pharmacological treatment (n = 6), non-pharmacological treatment (n = 2) and monitoring (n = 1) are presented. Results: Sacroiliac joint radiography as the first diagnostic method, and the use of disease activity scales for patient monitoring (ASDAS or BASDAI), are recommended. Nonsteroidal anti-inflammatory drugs are the first treatment option; in case of intolerance or residual pain, acetaminophen or opioids are recommended. In patients with axial involvement, it is recommended not to use conventional disease-modifying antirheumatic drugs or systemic or local glucocorticoids. In patients with failure to non-steroidal anti-inflammatory drugs, anti-TNF or anti-IL17A is recommended. In those patients presenting with anti-TNF failure, starting an anti-IL17A is recommended. Exercise, physical and occupational therapy are recommended as part of treatment. It is recommended not to use unconventional therapies as the only treatment option. Conclusions: This set of recommendations provides an updated guide on the diagnosis, treatment and monitoring of patients with axial spondyloarthritis.(c) 2021 Elsevier Espan tilde a, S.L.U. and Sociedad Espan tilde ola de Reumatologi acute accent a y Colegio Mexicano de Reumatologi acute accent a. All rights reserved.	[Bautista-Molano, Wilson] Univ Bosque, Hosp Univ Fdn St Fe Bogota, Secc Reumatol, Bogota, Colombia; [Saldarriaga-Rivera, Lina M.] Univ Tecnol Pereira, Hosp Univ San Jorge, Inst Univ Vis Amer, Fac Med,Serv Reumatol,Clin Los Rosales, Pereira, Colombia; [Junca-Ramirez, Alejandro] Colombia Bienestar IPS, Colsanitas, IPS Especializada, Serv Reumatol, Bogota, Colombia; [Fernandez-Aldana, Andres R.] Inmunar SAS I, Serv Reumatol I, Ibague, Colombia; [Fernandez-Avila, Daniel G.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Fac Med, Serv Reumatol, Bogota, Colombia; [Jaimes, Diego A.] Univ Sabana, Clin IPS, Bogota, Colombia; [Jauregui, Edwin A.] Cayre IPS, Riesgo Fractura SA, Serv Reumatol, Bogota, Colombia; [Segura-Charry, Juan S.] Clin IPS, Clin Medilaser Ne, Serv Reumatol, Bogota, Colombia; [Romero-Sanchez, Consuelo] Univ Bosque, Hosp Mil Cent, Serv Reumatol & Inmunol, Grp Inmunol Celular & Mol, Bogota, Colombia; [Felipe-Diaz, Oscar J.] Medicarte SA, Clin Las Vegas, Serv Reumatol, Medellin, Colombia		Bautista-Molano, W (corresponding author), Univ Bosque, Hosp Univ Fdn St Fe Bogota, Secc Reumatol, Bogota, Colombia.	wilson.bautista@gmail.com		Bautista-Molano, Wilson/0000-0003-0684-9542	Abbvie; Amgen; Janssen; Novartis; Pfizer	Abbvie(AbbVie); Amgen(Amgen); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Pfizer(Pfizer)	The development of this CPG was possible thanks to the unre-stricted support of the following entities that jointly financed its realization: Abbvie, Amgen, Janssen, Novartis, and Pfizer. The tech-nical work of the process for the development of this CPG was carried out independently by the GDG.	Akyuz G, 2018, RHEUMATOL INT, V38, P321, DOI 10.1007/s00296-017-3867-2; Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2089; Altan L, 2012, RHEUMATOL INT, V32, P2093, DOI 10.1007/s00296-011-1932-9; Arnbak B, 2016, SCAND J RHEUMATOL, V45, P321, DOI 10.3109/03009742.2015.1105289; Arnbak B, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3768; Au YLE, 2014, CLIN RHEUMATOL, V33, P1127, DOI 10.1007/s10067-014-2729-5; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bautista-Molano W, 2017, CLIN EXP RHEUMATOL, V35, P122; Bautista-Molano W, 2018, J RHEUMATOL, V45, P206, DOI 10.3899/jrheum.170520; Bautista-Molano W, 2016, CLIN RHEUMATOL, V35, P1759, DOI 10.1007/s10067-016-3184-2; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Byrnes K, 2018, J BODYW MOV THER, V22, P192, DOI 10.1016/j.jbmt.2017.04.008; Caete Crespillo J., 2015, SOC ESPONOLA REUMATO; CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613, DOI 10.1001/jama.237.24.2613; Chang JK, 2013, CLIN RHEUMATOL, V32, P341, DOI 10.1007/s10067-012-2125-y; Chen FC, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011265; Chen JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004800.pub3; Chen JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004524.pub4; Coates LC, 2016, ARTHRITIS RHEUMATOL, V68, P1060, DOI 10.1002/art.39573; Cruz Josiane Cristiane, 2016, Fisioter. mov., V29, P609, DOI 10.1590/1980-5918.029.003.AO19; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Deodhar A, 2020, LANCET, V395, P53, DOI 10.1016/S0140-6736(19)32971-X; Dougados M, 2017, ANN RHEUM DIS, V76, P1823, DOI 10.1136/annrheumdis-2017-211596; Duarte C, 2017, ACTA REUMATOL PORT, V42, P112; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hamilton L, 2017, RHEUMATOLOGY, V56, P313, DOI 10.1093/rheumatology/kew223; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Kilic E, 2015, RHEUMATOL INT, V35, P981, DOI 10.1007/s00296-014-3168-y; Kwan YH, 2019, INT J RHEUM DIS, V22, P2206, DOI 10.1111/1756-185X.13735; Lautenschlager J, 1997, Z RHEUMATOL, V56, P8, DOI 10.1007/s003930050016; Londoño John, 2018, Rev.Colomb.Reumatol., V25, P245, DOI 10.1016/j.rcreu.2018.08.003; Londoo J, 2005, REV COLOMB REUMATOL, V12, P195; Lv Z, 2015, COMPLEMENT MED RES, V22, P395, DOI [DOI 10.1159/000442733, 10.1159/000442733]; Marzo-Ortega H, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000592; Mrquez J, 2010, REV COLOMB REUMATOL, V17, P80; National Institute for Health and Care Excellence (UK), 2017, NATL I HLTH CARE EXC; Aquino MBN, 2019, MED CLIN-BARCELONA, V153, P250, DOI 10.1016/j.medcli.2019.04.020; Pavelka K, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1490-y; Pecourneau V, 2018, ARCH PHYS MED REHAB, V99, P383, DOI 10.1016/j.apmr.2017.07.015; Poddubnyy D, 2018, RMD OPEN, V4, DOI 10.1136/rmdopen-2018-000825; Poddubnyy D, 2013, J RHEUMATOL, V40, P1557, DOI 10.3899/jrheum.130141; Reyes-Cordero G, 2021, REUMATOL CLIN, V17, P37, DOI 10.1016/j.reuma.2019.03.010; Rohekar S, 2015, J RHEUMATOL, V42, P665, DOI 10.3899/jrheum.141001; Romero-Sanchez C, 2021, JCR-J CLIN RHEUMATOL, V27, pS148, DOI 10.1097/RHU.0000000000001671; Romero-Sanchez C, 2018, CURR RHEUMATOL REV, V14, P246, DOI 10.2174/1573397113666170329121552; Rosu MO, 2014, RHEUMATOL INT, V34, P367, DOI 10.1007/s00296-013-2869-y; Rudwaleit M, 2006, ARTHRITIS RHEUM, V54, P569, DOI 10.1002/art.21619; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Schunemann HJ, 2017, J CLIN EPIDEMIOL, V81, P101, DOI 10.1016/j.jclinepi.2016.09.009; Schunemann HJ, 2016, J CLIN EPIDEMIOL, V76, P89, DOI 10.1016/j.jclinepi.2016.01.032; Fernandez ASI, 2017, RHEUMATOL INT, V37, P1817, DOI 10.1007/s00296-017-3814-2; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Sieper J, 2009, ANN RHEUM DIS, V68, P784, DOI 10.1136/ard.2008.101501; Sieper J, 2017, ANN RHEUM DIS, V76, P571, DOI 10.1136/annrheumdis-2016-210023; Simon ST, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub3; Smolen JS, 2018, ANN RHEUM DIS, V77, P472, DOI 10.1136/annrheumdis-2017-211734corr1; Solmaz D, 2014, CLIN RHEUMATOL, V33, P1475, DOI 10.1007/s10067-014-2622-2; Rodriguez-Lopez ES, 2019, J ALTERN COMPLEM MED, V25, P1054, DOI 10.1089/acm.2018.0405; Spadaro A, 2008, JOINT BONE SPINE, V75, P29, DOI 10.1016/j.jbspin.2007.07.006; Stolwijk C, 2016, ARTHRIT CARE RES, V68, P1320, DOI 10.1002/acr.22831; Tam LS, 2019, INT J RHEUM DIS, V22, P340, DOI 10.1111/1756-185X.13510; Ungprasert P, 2017, CLIN RHEUMATOL, V36, P1569, DOI 10.1007/s10067-017-3693-7; Van De Sande M, 2019, ARTHRITIS RHEUMATOL, V71, P5270, DOI [10.1002/central/CN-02195391/full, DOI 10.1002/CENTRAL/CN-02195391/FULL]; van der Heijde D, 2018, LANCET, V392, P2378, DOI 10.1016/S0140-6736(18)32463-2; van der Heijde D, 2017, ANN RHEUM DIS, V76, P1340, DOI 10.1136/annrheumdis-2016-210322; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; Ward MM, 2019, ARTHRITIS RHEUMATOL, V71, P1599, DOI 10.1002/art.41042; Ward MM, 2016, ARTHRIT CARE RES, V68, P151, DOI 10.1002/acr.22708; Weber U, 2015, ANN RHEUM DIS, V74, P985, DOI 10.1136/annrheumdis-2013-203887; Wendling D, 2014, JOINT BONE SPINE, V81, P6, DOI 10.1016/j.jbspin.2013.12.002; Wijnen BFM, 2016, EXPERT REV PHARM OUT, V16, P723, DOI 10.1080/14737167.2016.1246961; Zao A, 2017, RHEUMATOL INT, V37, P1979, DOI 10.1007/s00296-017-3829-8; Zhang Y, 2019, J CLIN EPIDEMIOL, V111, P83, DOI 10.1016/j.jclinepi.2018.05.011	75	0	0	1	1	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1699-258X	1885-1398		REUMATOL CLIN	Reumatol. Clin.	APR	2022	18	4					191	199		10.1016/j. reumae.2021.09.003	http://dx.doi.org/10.1016/j. reumae.2021.09.003			9	Rheumatology	Emerging Sources Citation Index (ESCI)	Rheumatology	1L3JJ	35305953				2022-09-04	WOS:000799187300001
J	Fisberg, RM; Fontanelli, MM; Kowalskys, I; Gomez, G; Rigotti, A; Cortes, LY; Garcia, MY; Pareja, RG; Herrera-Cuenca, M; Fisberg, M				Fisberg, Regina Mara; Fontanelli, Mariane Mello; Kowalskys, Irina; Gomez, Georgina; Rigotti, Attilio; Yadira Cortes, Lilia; Yepez Garcia, Martha; Pareja, Rossina G.; Herrera-Cuenca, Marianella; Fisberg, Mauro		ELANS Study Grp	Total and whole grain intake in Latin America: findings from the multicenter cross-sectional Latin American Study of Health and Nutrition (ELANS)	EUROPEAN JOURNAL OF NUTRITION			English	Article						Latin America; Multicenter study; Epidemiology; Whole grain; Socioeconomic factors; Dietary intake	DIET QUALITY; RECOMMENDATIONS; TRENDS; DATABASE	Purpose Understanding whole-grain intake and its associated factors is essential to tackle the double burden of malnutrition faced by Latin American countries. This study aimed to characterize total and whole grain intake in Latin American countries and to investigate foods contributing to these intake in the region. Methods Data were obtained from the multicenter cross-sectional survey Latin American Study of Nutrition and Health (ELANS), including 9128 participants residing in urban areas of eight Latin American countries. Data collection was performed via two household visits using a standardized questionnaire and two 24 h dietary recalls. Usual dietary intake of total grain foods and foods containing whole grains was estimated. The association between the intake of grain food groups and sociodemographic variables was investigated using multiple linear regression models with random intercepts. Results Mean intake of total grain foods and foods containing whole grains was 318.6 g/d and 14.7 g/d, respectively. Total grain foods were less consumed by participants at older ages (-9.8 g/d), and females (-9.9 g/d), and more consumed by those in the lowest socioeconomic category (24.8 g/d). Foods containing whole grains were more consumed by participants at older ages (3.3 g/d), and females (4.0 g/d), while those in the lowest socioeconomic category consumed 2.9 g/d less. Major contributors to energy provided from foods containing whole grains were oatmeal, masa harina, whole-wheat bread, corn chips, and wheat crackers. Conclusion The intake of grain foods represented a substantial part of the Latin American population's diet, but the intake of foods containing whole grains was extremely low in all assessed countries.	[Fisberg, Regina Mara; Fontanelli, Mariane Mello] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, Brazil; [Kowalskys, Irina] Pontificia Univ Catolica Argentina, Fac Ciencias Med, Carrera Nutr, C1107 AAZ, Buenos Aires, DF, Argentina; [Gomez, Georgina] Univ Costa Rica, Dept Bioquim, Escuela Med, San Jose 115012060, Costa Rica; [Rigotti, Attilio] Pontificia Univ Catolica, Ctr Nutr Mol & Enfermedades Cron, Dept Nutr Diabet & Metab, Escuela Med, Santiago 8330024, Chile; [Yadira Cortes, Lilia] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota 110231, Colombia; [Yepez Garcia, Martha] Univ San Francisco Quito, Colegio Ciencias Salud, Quito 171200841, Ecuador; [Pareja, Rossina G.] Inst Invest Nutr, Lima 15026, Peru; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Ctr Estudios Desarrollo, Fdn Bengoa, Caracas 1053, Venezuela; [Fisberg, Mauro] Hosp Infantil Sabara, Inst Pensi, Fundacao Jose Luiz Egydio Setubal, BR-01227200 Sao Paulo, Brazil		Kowalskys, I (corresponding author), Pontificia Univ Catolica Argentina, Fac Ciencias Med, Carrera Nutr, C1107 AAZ, Buenos Aires, DF, Argentina.	rfisberg@usp.br; marianefontanelli@gmail.com; ikovalskys@gmail.com; georgina.gomez@uer.ac.er; arigotti@med.puc.cl; ycortes@javeriana.edu.co; myepez@usfq.edu.ec; rpareja@iin.sld.pe; manyma@gmail.com; mauro.fisberg@gmail.com	Fisberg, Mauro/E-7149-2010; Pareja, Rossina/D-9892-2018	Fisberg, Mauro/0000-0003-2992-3215; Pareja, Rossina/0000-0001-7523-3181; Herrera-Cuenca, Marianella/0000-0003-0162-3480; Gomez, Georgina/0000-0003-3514-2984; Yepez, Martha Cecilia/0000-0003-4119-238X; Cortes, Lilia Yadira/0000-0003-2789-3219; Fontanelli, Mariane/0000-0002-3480-6948; Kovalskys, Irina/0000-0001-8481-5415	Coca Cola Company; International Life Science Institute of Argentina; Cereal Partner Worldwide (CPW); Instituto Pensi/Hospital Infantil Sabara; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	Coca Cola Company; International Life Science Institute of Argentina; Cereal Partner Worldwide (CPW); Instituto Pensi/Hospital Infantil Sabara; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	The International Breakfast Researcher Initiative and this data analysis were funded by Cereal Partner Worldwide (CPW). Fieldwork and data analysis compromised in ELANS protocol was supported by a scientific grant from the Coca Cola Company, and by grant and/or support from Instituto Pensi/Hospital Infantil Sabara, International Life Science Institute of Argentina, Universidad de Costa Rica, Pontificia Universidad Catolica de Chile, Pontificia Universidad Javeriana, Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa, Universidad San Francisco de Quito, and Instituto de Investigacion Nutricional de Peru.	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Anast?cio LR, 2020, RES SOC DEV, DOI [10.33448/rsd-v9i10.7350, DOI 10.33448/RSD-V9I10.7350]; Bellisle F, 2014, BRIT J NUTR, V112, P1674, DOI 10.1017/S0007114514002670; Bonvecchio Arenas A., 2015, GUIAS ALIMENTARIAS A; Brazil. Proposal for Public Consultation, 2020, PROC N 25351 715085, P124; Buyken AE, 2018, EUR J CLIN NUTR, V72, P1625, DOI 10.1038/s41430-017-0035-4; Christoph MJ, 2019, AM J CLIN NUTR, V109, P656, DOI 10.1093/ajcn/nqy333; Oliveira MSD, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00177418, 10.1590/0102-311X00177418]; de Mello AV, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0784-2; Department of Agriculture Philippine Rice Research Institute, BE RIC; Direccion General de Promocion de la Salud Ministerio de Salud, 2013, BAS TECN GUIAS AL PO; FAO-Food and Agriculture Organization, 2017, AM LAT CAR PAN SEG A; FAO-Food and Agriculture Organization, 2018, EST ID AN EXP NAC RE; Fisberg M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2765-y; Galea LM, 2016, J FOOD COMPOS ANAL, V50, P23, DOI 10.1016/j.jfca.2016.05.005; Harriman C, 2012, WHOL GRAIN SUMM AACC; Herforth A, 2019, ADV NUTR, V10, P590, DOI 10.1093/advances/nmy130; Hu Y, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2206; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Kissock KR, 2020, PUBLIC HEALTH NUTR, V23, P1307, DOI 10.1017/S1368980019004452; Kovalskys I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225101; Kovalskys I, 2018, PUBLIC HEALTH NUTR, V21, P2535, DOI 10.1017/S1368980018001222; Kovalskys I, 2015, NUTRIENTS, V7, P7914, DOI 10.3390/nu7095373; Kyro C, 2012, SCAND J PUBLIC HEALT, V40, P76, DOI 10.1177/1403494811421057; Lanuza Fabian, 2020, Nutrients, V12, P2815, DOI 10.3390/nu12092815; Lieffere JRL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196333; Liu JX, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231572; Liu JX, 2020, JAMA-J AM MED ASSOC, V323, P1161, DOI 10.1001/jama.2020.0878; Mann KD, 2015, BRIT J NUTR, V113, P1643, DOI 10.1017/S0007114515000422; Martorell R, 2017, FOOD NUTR BULL, V38, P384, DOI 10.1177/0379572117707890; Mathews R, 2020, NUTR REV, V78, P98, DOI 10.1093/nutrit/nuz055; Miller KB, 2020, NUTR REV, V78, P29, DOI 10.1093/nutrit/nuz052; Ministerio de Salud, 2014, GUIAS AL SAN; Ministerio de Salud Publica; Organizacion Panamericana de la Salud, 2016, GUIA AL POBL UR AL S; Ministerio de Salud Publica y Bienestar Social, 2015, OLL NUTR PAR GUIAS A; Mora-Garcia G, 2020, INT J PUBLIC HEALTH, V65, P547, DOI 10.1007/s00038-020-01396-1; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Oldways Whole Grain Council, CORN OCT GRAIN MONTH; Ordunez P, 2015, GLOB HEART, V10, P234, DOI 10.1016/j.gheart.2015.04.005; Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; Ross AB, 2017, ADV NUTR, V8, P525, DOI [10.3945/an116.014001, 10.3945/an.116.014001]; Ross AB, 2015, AM J CLIN NUTR, V101, P903, DOI 10.3945/ajcn.114.098046; Seal CJ, 2016, BRIT J NUTR, V115, P2031, DOI 10.1017/S0007114516001161; Shan ZL, 2019, JAMA-J AM MED ASSOC, V322, P1178, DOI 10.1001/jama.2019.13771; Sisa I, 2021, PUBLIC HEALTH NUTR, V24, P2577, DOI 10.1017/S1368980020000646; Suthers R, 2018, J NUTR EDUC BEHAV, V50, P813, DOI 10.1016/j.jneb.2018.05.013; Tan DI, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092771; Tester JM, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160540; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Toups KE, 2020, NUTR REV, V78, P54, DOI 10.1093/nutrit/nuz067; U.S. Department of Agriculture Agricultural Research Service, 2013, USDA NAT NUTR DAT ST; USDA-United States Department of Agriculture Food and Nutrition Service, 2013, SP 02 2013 CORN MAS; Willett W., 2013, NUTR EPIDEMIOLOGY	54	2	2	3	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1436-6207	1436-6215		EUR J NUTR	Eur. J. Nutr.	FEB	2022	61	1					489	501		10.1007/s00394-021-02635-8	http://dx.doi.org/10.1007/s00394-021-02635-8		JUL 2021	13	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	YL0UA	34232375	hybrid, Green Published			2022-09-04	WOS:000672226700001
J	Subalusky, AL; Anderson, EP; Jimenez, G; Post, DM; Lopez, DE; Garcia, S; Leon, LJN; Parrish, JFR; Rojas, A; Solari, S; Jimenez-Segura, LF				Subalusky, Amanda L.; Anderson, Elizabeth P.; Jimenez, German; Post, David M.; Lopez, David Echeverri; Garcia-R., Sebastian; Nova Leon, Laura J.; Reatiga Parrish, Juan F.; Rojas, Ana; Solari, Sergio; Jimenez-Segura, Luz F.			Potential ecological and socio-economic effects of a novel megaherbivore introduction: the hippopotamus in Colombia	ORYX			English	Review						Colombia; ecosystem engineer; Hippopotamus amphibius; introduced species; novel ecosystem; population growth; rewilding; socio-ecological system	MAGDALENA RIVER-BASIN; ECOSYSTEM ENGINEERS; OKAVANGO DELTA; CAPE-HORN; CONSERVATION; AMPHIBIUS; VECTORS; IMPACTS; DEPRESSION; INVASION	Introduced species can have strong ecological, social and economic effects on their non-native environment. Introductions of megafaunal species are rare and may contribute to rewilding efforts, but they may also have pronounced socio-ecological effects because of their scale of influence. A recent introduction of the hippopotamus Hippopotamus amphibius into Colombia is a novel introduction of a megaherbivore onto a new continent, and raises questions about the future dynamics of the socio-ecological system into which it has been introduced. Here we synthesize current knowledge about the Colombian hippopotamus population, review the literature on the species to predict potential ecological and socio-economic effects of this introduction, and make recommendations for future study. Hippopotamuses can have high population growth rates (7-11%) and, on the current trajectory, we predict there could be 400-800 individuals in Colombia by 2050. The hippopotamus is an ecosystem engineer that can have profound effects on terrestrial and aquatic environments and could therefore affect the native biodiversity of the Magdalena River basin. Hippopotamuses are also aggressive and may pose a threat to the many inhabitants of the region who rely upon the Magdalena River for their livelihoods, although the species could provide economic benefits through tourism. Further research is needed to quantify the current and future size and distribution of this hippopotamus population and to predict the likely ecological, social and economic effects. This knowledge must be balanced with consideration of social and cultural concerns to develop appropriate management strategies for this novel introduction.	[Subalusky, Amanda L.; Post, David M.] Yale Univ, Dept Ecol & Evolutionary Biol, 165 Prospect St, New Haven, CT 06511 USA; [Anderson, Elizabeth P.; Rojas, Ana] Florida Int Univ, Dept Earth & Environm, Inst Water & Environm, Miami, FL 33199 USA; [Jimenez, German; Nova Leon, Laura J.; Reatiga Parrish, Juan F.] Pontificia Univ Javeriana, Dept Biol, Bogota, Colombia; [Lopez, David Echeverri] Corp Autonoma Reg Cuencas Rios Negro & Nare, Antioquia, Colombia; [Garcia-R., Sebastian] Univ Antioquia, Grp Mastozool, Medellin, Colombia; [Solari, Sergio; Jimenez-Segura, Luz F.] Univ Antioquia, Inst Biol, Medellin, Colombia; [Subalusky, Amanda L.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Garcia-R., Sebastian] Univ Andes, Dept Ciencias Biol, Bogota, Colombia		Subalusky, AL (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 165 Prospect St, New Haven, CT 06511 USA.	asubalusky@ufl.edu	Post, David M/A-6987-2009; Jimenez, German/AAE-5898-2021	Post, David M/0000-0003-1434-7729; Jimenez, German/0000-0003-1525-0822	National Geographic Society [W447-16]; US National Science Foundation [DEB 1354053, 1753727]	National Geographic Society(National Geographic Society); US National Science Foundation(National Science Foundation (NSF))	Funding was provided by a grant from the National Geographic Society to EPA (W447-16) and by grants from the US National Science Foundation to DMP (DEB 1354053, 1753727). This is contribution no. 929 from the Southeast Environmental Research Center in the Institute of Water & Environment at Florida International University. We thank colleagues in Colombia for sharing valuable information about introduced hippopotamuses, especially historical accounts, and A. Farah and G. Herrera for creating the map.	Aldana Ana Maria, 2008, Neotropical Primates, V15, P46, DOI 10.1896/044.015.0203; Anderson CB, 2006, BIOL CONSERV, V128, P467, DOI 10.1016/j.biocon.2005.10.011; Anderson CB, 2007, OECOLOGIA, V154, P141, DOI 10.1007/s00442-007-0757-4; Angarita H, 2018, HYDROL EARTH SYST SC, V22, P2839, DOI 10.5194/hess-22-2839-2018; Bakker ES, 2016, ECOGRAPHY, V39, P162, DOI 10.1111/ecog.01651; Balcazar-Vargas MP, 2000, CALDASIA, V22, P191; CHOMBA C, 2013, INT J BIODIVERS CONS, V5, P109, DOI DOI 10.5897/IJBC12.023; Cormagdalena, 2007, ATL CUENC RIO GRAND; Cormagdalena, 2013, CAR FIS DEM SOC EC M; Courchamp F, 2017, TRENDS ECOL EVOL, V32, P13, DOI 10.1016/j.tree.2016.11.001; Crowley SL, 2017, FRONT ECOL ENVIRON, V15, P133, DOI 10.1002/fee.1471; Dawson J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37359; Dembitzer J, 2017, ISR J ECOL EVOL, V63, P5, DOI 10.1163/22244662-06303002; Deutsch C.J., 2008, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2008.RLTS.T22103A9356917.en, DOI 10.2305/IUCN.UK.2008.RLTS.T22103A9356917.EN]; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dutton CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04391-6; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Eltringham SK, 1999, HIPPOS NATURAL HIST; Fernanda Jimenez-Segura Luz, 2014, Biota Colombiana, V15, P3; Gallardo B, 2016, GLOBAL CHANGE BIOL, V22, P151, DOI 10.1111/gcb.13004; Galvis G, 2007, AQUAT ECOSYST HEALTH, V10, P127, DOI 10.1080/14634980701357640; Garcia-Llorente M, 2008, BIOL CONSERV, V141, P2969, DOI 10.1016/j.biocon.2008.09.003; Grey J, 2002, ISOT ENVIRON HEALT S, V38, P245, DOI 10.1080/10256010208033269; Guhl E., 2016, COLOMBIA BOSQUEJO GE, V2; Huisman J, 2016, P NATL ACAD SCI USA, V113, P3585, DOI 10.1073/pnas.1518046113; Jacobs SM, 2007, ECOSYSTEMS, V10, P1231, DOI 10.1007/s10021-007-9092-1; Jeschke JM, 2014, CONSERV BIOL, V28, P1188, DOI 10.1111/cobi.12299; Jimenez-Segura LF, 2016, J FISH BIOL, V89, P65, DOI 10.1111/jfb.13018; Jimenez-Segura LF, 2010, ECOL FRESHW FISH, V19, P178, DOI 10.1111/j.1600-0633.2009.00402.x; Kanga EM, 2012, J LAND USE SCI, V7, P395, DOI 10.1080/1747423X.2011.590235; Kanga EM, 2013, LANDSC ECOL ENG, V9, P47, DOI 10.1007/s11355-011-0175-y; Kanga EM, 2011, ORYX, V45, P20, DOI 10.1017/S0030605310000931; Kodric-Brown A, 2007, FRONT ECOL ENVIRON, V5, P549, DOI 10.1890/1540-9295(2007)5[549:NFEMAT]2.0.CO;2; Laverde O, 2005, CALDASIA, V27, P247; Laws R.M., 1966, COMP BIOL REPRODUCTI, P117; Lewison R., 2008, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2008.RLTS.T10103A3163790.en, DOI 10.2305/IUCN.UK.2008.RLTS.T10103A3163790.E]; Link Andres, 2015, P74; Link A, 2015, INT J PRIMATOL, V36, P530, DOI 10.1007/s10764-015-9840-6; LOCK JM, 1972, J ECOL, V60, P445, DOI 10.2307/2258356; Lundgren EJ, 2018, ECOGRAPHY, V41, P857, DOI 10.1111/ecog.03430; Martin, 2005, TRANSBOUNDARY SPECIE; Mascaro J, 2012, ECOL MONOGR, V82, P221, DOI 10.1890/11-1014.1; Masese FO, 2015, ECOSYSTEMS, V18, P686, DOI 10.1007/s10021-015-9859-8; McCarthy TS, 1998, AFR J ECOL, V36, P44, DOI 10.1046/j.1365-2028.1998.89-89089.x; Mojica-Figueroa Beatriz H., 2014, Biota Colombiana, V15, P174; Moore JW, 2006, BIOSCIENCE, V56, P237, DOI 10.1641/0006-3568(2006)056[0237:AEEIS]2.0.CO;2; Mosepele K, 2009, BIOSCIENCE, V59, P53, DOI 10.1525/bio.2009.59.1.9; Naiman RJ, 1997, BIOSCIENCE, V47, P521, DOI 10.2307/1313120; Pienaar U. de V., 1966, Koedoe, VNo. 9, P1; Pinch Geraldine, 2004, EGYPTIAN MYTHOLOGY G; Pluh?ek R, 2017, HIPPOPOTAMUS AMPHIBI; Post A.W.C.H.M., 2000, HIPPOPOTAMUS NOTHING; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Ramírez-Chaves Héctor E, 2011, Bol. Cient. Mus. Hist. Nat. Univ. Caldas, V15, P139; Restrepo Betancur Giovanni, 2016, Acta Zoologica Mexicana Nueva Serie, V32, P158; Restrepo JD, 2006, J HYDROL, V316, P213, DOI 10.1016/j.jhydrol.2005.05.002; Restrepo JD, 2018, GEOMORPHOLOGY, V302, P76, DOI 10.1016/j.geomorph.2016.12.013; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; Sandoval J, 2017, AUK, V134, P168, DOI 10.1642/AUK-16-91.1; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; SMUTS G.L., 1981, KOEDOE, V24, P169, DOI DOI 10.4102/koedoe.v24i1.626; Stears K, 2018, P NATL ACAD SCI USA, V115, pE5028, DOI 10.1073/pnas.1800407115; Stiles F. Gary, 2000, Caldasia, V22, P61; Subalusky AL, 2018, ECOLOGY, V99, P2558, DOI 10.1002/ecy.2509; Subalusky AL, 2015, FRESHWATER BIOL, V60, P512, DOI 10.1111/fwb.12474; Svenning JC, 2017, PERSPECT ECOL CONSER, V15, P282, DOI 10.1016/j.pecon.2017.09.006; Svenning JC, 2016, P NATL ACAD SCI USA, V113, P898, DOI 10.1073/pnas.1502556112; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Werner PA, 2006, AUST J BOT, V54, P283, DOI 10.1071/BT04135; Wolanski E, 1999, AFR J ECOL, V37, P419, DOI 10.1046/j.1365-2028.1999.00198.x	70	7	7	6	18	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0030-6053	1365-3008		ORYX	Oryx	JAN	2021	55	1					105	113	PII S0030605318001588	10.1017/S0030605318001588	http://dx.doi.org/10.1017/S0030605318001588			9	Biodiversity Conservation; Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation; Environmental Sciences & Ecology	PR4SC		Green Published, hybrid			2022-09-04	WOS:000607226800013
J	Mandrik, O; Tolma, E; Zielonke, N; Meheus, F; Ordonez-Reyes, C; Severens, JL; Murillo, R				Mandrik, O.; Tolma, E.; Zielonke, N.; Meheus, F.; Ordonez-Reyes, C.; Severens, J. L.; Murillo, R.			Systematic reviews as a "lens of evidence": Determinants of participation in breast cancer screening	JOURNAL OF MEDICAL SCREENING			English	Review						Attitude to health; breast neoplasms; cancer; early detection of cancer; mass screening; oncology; patient acceptance of healthcare; patient participation; systematic review	CLINICAL PREVENTIVE CARE; MAMMOGRAPHY; INTERVENTIONS; PROGRAMS; DISPARITIES; MODEL; MORTALITY; LEVEL	Objective To assess the determinants of the participation rate in breast cancer screening programs by conducting a systematic review of reviews. Methods We conducted a systematic search in PubMed via Medline, Scopus, Embase, and Cochrane identifying the literature up to April 2019. Out of 2258 revealed unique abstracts, we included 31 reviews, from which 25 were considered as systematic. We applied the Walsh & McPhee Systems Model of Clinical Preventive Care to systematize the determinants of screening participation. Results The reviews, mainly in high-income settings, reported a wide range for breast cancer screening participation rate: 16-90%. The determinants of breast cancer screening participation were simple low-cost interventions such as invitation letters, basic information on screening, multiple reminders, fixed appointments, prompts from healthcare professionals, and healthcare organizational factors (e.g. close proximity to screening facility). More complex interventions (such as face-to-face counselling or home visits), mass media or improved access to transport should not be encouraged by policy makers unless other information appears. The repeated participation in mammography screening was consistently high, above 62%. Previous positive experience with screening influenced the repeated participation in screening programs. The reviews were inconsistent in the use of terminology related to breast cancer screening participation, which may have contributed to the heterogeneity in the reported outcomes. Conclusions This study shows that consistent findings of systematic reviews bring more certainty into the conclusions on the effects of simple invitation techniques, fixed appointments and prompts, as well as healthcare organizational factors on promoting participation rate in screening mammography.	[Mandrik, O.; Severens, J. L.] Univ Sheffield, Sch Hlth & Related Res, HEDS, Regent Court 30,Regent St, Sheffield S1 4DA, S Yorkshire, England; [Mandrik, O.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Mandrik, O.; Meheus, F.; Murillo, R.] Int Agcy Res Canc, Sect Early Detect & Prevent, Lyon, France; [Tolma, E.] Kuwait Univ, Fac Publ Hlth, Jabriya, Kuwait; [Zielonke, N.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Ordonez-Reyes, C.; Severens, J. L.; Murillo, R.] Hosp Univ San Ignacio, Ctr Javeriano Oncol, Bogota, Colombia; Erasmus Univ, iMTA, Rotterdam, Netherlands; [Murillo, R.] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia		Mandrik, O (corresponding author), Univ Sheffield, Sch Hlth & Related Res, HEDS, Regent Court 30,Regent St, Sheffield S1 4DA, S Yorkshire, England.	o.mandrik@sheffield.ac.uk	Murillo, Raúl/AAY-4416-2021	Ordonez-Reyes, Camila/0000-0002-8941-9064; Mandrik, Olena/0000-0003-3755-3031	European Commission; International Agency for Research on Cancer	European Commission(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Some part of the work reported in this paper was undertaken during the tenure of a postdoctoral fellowship of Dr. Olena Mandrik from the International Agency for Research on Cancer partially supported by the European Commission FP7 Marie Curie Actions, People, Co-funding of regional, national, and international programmes (COFUND).	Abdel-Aleem H, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009677.pub2; Bellhouse S, 2018, PSYCHO-ONCOLOGY, V27, P1089, DOI 10.1002/pon.4575; Bhargava S, 2018, ACTA RADIOL, V59, P1285, DOI 10.1177/0284185118758132; Bonfill X, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002943; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Brouwers MC, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-112; Bulliard JL, 2005, SCHWEIZ RUNDSCH MED, V94, P1381, DOI 10.1024/0369-8394.94.36.1381; Camilloni L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-464; Chen THH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005684; Curbow B, 2004, PREV MED, V38, P676, DOI 10.1016/j.ypmed.2004.01.015; Daly J, 2014, J CANCER EDUC, V29, P401, DOI 10.1007/s13187-014-0637-7; Damiani G, 2015, PREV MED, V81, P281, DOI 10.1016/j.ypmed.2015.09.011; de Cuevas RMA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020892; Denhaerynck K, 2003, AM J PREV MED, V25, P195, DOI 10.1016/S0749-3797(03)00201-0; Donnelly TT, 2013, ASIAN PAC J CANCER P, V14, P4519, DOI 10.7314/APJCP.2013.14.8.4519; Drossaert CHC, 2002, J MED SCREEN, V9, P168, DOI 10.1136/jms.9.4.168; Edwards AGK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub3; Ferroni E, 2012, PREV MED, V55, P587, DOI 10.1016/j.ypmed.2012.10.007; Gianino MM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6155-5; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Greenwald ZR, 2017, CANCER EPIDEM BIOMAR, V26, P1679, DOI 10.1158/1055-9965.EPI-17-0454; Hamashima C, 2016, JPN J CLIN ONCOL, V46, P482, DOI 10.1093/jjco/hyw008; Hebert JR, 2009, CANCER-AM CANCER SOC, V115, P2539, DOI 10.1002/cncr.24270; Jepson R., 2000, HEALTH TECHNOL ASSES, V4, P14, DOI DOI 10.3310/hta4140; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kelly DM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016941; Koc H, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091961; Lane DS, 2000, PREV MED, V31, P481, DOI 10.1006/pmed.2000.0747; Mandrik O, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0510-y; Mandrik O, 2019, CANCER MED-US, V8, P7846, DOI 10.1002/cam4.2498; Mandrik O, 2019, INT J CANCER, V145, P994, DOI 10.1002/ijc.32211; Mathioudakis AG, 2019, PSYCHO-ONCOLOGY, V28, P939, DOI 10.1002/pon.5041; McDaniel JT, 2019, GLOB HEALTH PROMOT, V26, P41, DOI 10.1177/1757975916686913; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Nguyen BH, 2015, AM J PUBLIC HEALTH, V105, P2083, DOI 10.2105/AJPH.2015.302713; O'Malley AS, 2003, AM J PREV MED, V25, P264, DOI 10.1016/S0749-3797(03)00190-9; Pasick RJ, 2008, ANNU REV PUBL HEALTH, V29, P351, DOI 10.1146/annurev.publhealth.29.020907.143420; Perry N., 2006, EUROPEAN GUIDELINES, V4th; Relecom A, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0811-3; Rivera-Franco MM, 2018, BREAST CANCER-BASIC, V12, DOI 10.1177/1178223417752677; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sin JP, 1999, J MED SCREEN, V6, P170, DOI 10.1136/jms.6.4.170; Smith D, 2019, CANCER EPIDEMIOL, V60, P77, DOI 10.1016/j.canep.2019.03.008; Sohl SJ, 2007, PREV MED, V45, P252, DOI 10.1016/j.ypmed.2007.06.009; Soler-Michel P, 2005, REV EPIDEMIOL SANTE, V53, P549, DOI 10.1016/S0398-7620(05)84731-5; Vernon SW, 2010, JNCI-J NATL CANCER I, V102, P1023, DOI 10.1093/jnci/djq223; WALSH JME, 1992, HEALTH EDUC QUART, V19, P157, DOI 10.1177/109019819201900202; Whelehan P, 2013, BREAST, V22, P389, DOI 10.1016/j.breast.2013.03.003	48	5	5	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0969-1413	1475-5793		J MED SCREEN	J. Med. Screen.	JUN	2021	28	2					70	79	0969141320930743	10.1177/0969141320930743	http://dx.doi.org/10.1177/0969141320930743		JUN 2020	10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	SK5AW	32517538	Green Accepted, hybrid, Green Published			2022-09-04	WOS:000539860500001
J	Ashraf, JM; Ansari, MA; Fatma, S; Abdulla, SMS; Iqbal, J; Madkhali, A; Hamali, A; Ahmad, S; Jerah, A; Echeverria, V; Barreto, GE; Ashraf, GM				Ashraf, Jalaluddin M.; Ansari, Mohammad Azam; Fatma, Sana; Abdulla, Saleh M. S.; Iqbal, Johar; Madkhali, Aymen; Hamali, Al Hassan; Ahmad, Saheem; Jerah, Ahmed; Echeverria, Valentina; Barreto, George E.; Ashraf, Ghulam Md			Inhibiting Effect of Zinc Oxide Nanoparticles on Advanced Glycation Products and Oxidative Modifications: a Potential Tool to Counteract Oxidative Stress in Neurodegenerative Diseases	MOLECULAR NEUROBIOLOGY			English	Article						Advanced glycation end products; Anti-glycating agent; Neurodegenerative diseases; Nanoparticles	BOVINE SERUM-ALBUMIN; MAILLARD REACTION; IN-VITRO; ALZHEIMERS-DISEASE; SILVER NANOPARTICLES; GOLD NANOPARTICLES; AMINO-ACIDS; ACUTE TOXICITY; ZNO NANOPARTICLES; CARBONYL GROUPS	Advanced glycation end products (AGEs) are implicated in several central nervous system (CNS) pathologies including Alzheimer and Parkinson's diseases. In the face-off of AGE menace, we have attempted to investigate the zinc oxide nanoparticle (ZnONP) role in inhibition of AGE formation. Synthesized ZnONPs were used to investigate the inhibitory effects on AGE formation. The inhibitory effects of ZnONPs on AGE formation were determined by biophysical immunological and biochemical techniques. The results showed that ZnONP is a potential anti-glycating agent inhibiting AGE formation as well as protecting the protein structure from change. Therefore, our findings suggest ZnONPs may be used as a therapeutic in resolving the AGE role in CNS-related complications.	[Ashraf, Jalaluddin M.; Abdulla, Saleh M. S.; Madkhali, Aymen; Hamali, Al Hassan; Jerah, Ahmed] Jazan Univ, Fac Appl Med Sci, Jazan, Saudi Arabia; [Ansari, Mohammad Azam] Imam Abdulrahman Bin Faisal Univ, Dept Epidem Dis Res, IRMC, Dammam 31441, Saudi Arabia; [Fatma, Sana] Bananas Hindu Univ, Inst Sci, Varanasi, Uttar Pradesh, India; [Iqbal, Johar] Jazan Univ, Fac Med, Jazan, Saudi Arabia; [Ahmad, Saheem] Integral Univ, Dept Biosci, Lucknow, Uttar Pradesh, India; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia		Ashraf, JM (corresponding author), Jazan Univ, Fac Appl Med Sci, Jazan, Saudi Arabia.; Ansari, MA (corresponding author), Imam Abdulrahman Bin Faisal Univ, Dept Epidem Dis Res, IRMC, Dammam 31441, Saudi Arabia.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	ashrafgm@gmail.com; azammicro@gmail.com; jmashraf@gmail.com	Ansari, Mohammad Azam/AFO-5715-2022; Ahmad, Saheem/R-7016-2017; ANSARI, MOHAMMAD AZAM/R-3143-2017; Ashraf, Ghulam Md/H-9485-2012; Ahmad, Saheem/T-2609-2019; Madkhali, Aymen/AAC-5660-2021; ANSARI, MOHAMMAD AZAM/AAO-6807-2020; Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./AAD-7420-2020; Ashraf, Jalauddin M/P-5391-2014	Ansari, Mohammad Azam/0000-0002-6122-5479; Ahmad, Saheem/0000-0003-1215-0279; ANSARI, MOHAMMAD AZAM/0000-0002-6122-5479; Ashraf, Ghulam Md/0000-0002-9820-2078; Ahmad, Saheem/0000-0003-1215-0279; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Ashraf, Jalauddin M/0000-0001-7885-2551; Hamali, Hassan A./0000-0003-3791-460X; Iqbal, Johar/0000-0002-1853-0988				Abate G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7039816; Ahmad S, 2012, LIFE SCI, V90, P980, DOI 10.1016/j.lfs.2012.05.002; AHMED MU, 1986, J BIOL CHEM, V261, P4889; Ajandouz EH, 1999, J AGR FOOD CHEM, V47, P1786, DOI 10.1021/jf980928z; Ali K, 2016, J COLLOID INTERF SCI, V472, P145, DOI 10.1016/j.jcis.2016.03.021; Aliev G, 2014, CURR MED CHEM, V21, P2208, DOI 10.2174/0929867321666131227161303; Aliev G, 2015, CNS NEUROL DISORD-DR, V14, P1235, DOI 10.2174/1871527314666150821102631; Angeloni C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238485; Ansari MA, 2012, APPL MICROBIOL BIOT, V94, P467, DOI 10.1007/s00253-011-3733-1; Antony SM, 2000, J AGR FOOD CHEM, V48, P3985, DOI 10.1021/jf000305x; Arfat MY, 2014, INT J BIOL MACROMOL, V69, P408, DOI 10.1016/j.ijbiomac.2014.05.069; Ashe S, 2016, ACS APPL MATER INTER, V8, P30005, DOI 10.1021/acsami.6b10639; ASHOOR SH, 1984, J FOOD SCI, V49, P1206, DOI 10.1111/j.1365-2621.1984.tb10432.x; Ashraf GM, 2011, PROTEIN J, V30, P39, DOI 10.1007/s10930-010-9300-2; Ashraf GM, 2010, AMINO ACIDS, V39, P1321, DOI 10.1007/s00726-010-0574-7; Ashraf JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20414; Ashraf JM, 2014, APPL BIOCHEM BIOTECH, V174, P398, DOI 10.1007/s12010-014-1065-1; Ashraf JM, 2012, INT J BIOL MACROMOL, V51, P604, DOI 10.1016/j.ijbiomac.2012.06.013; Ashraf JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130630; Bardhan M, 2009, J APPL PHYS, V106, DOI 10.1063/1.3190483; Bhattacharya J, 2007, NANOMED-NANOTECHNOL, V3, P14, DOI 10.1016/j.nano.2006.10.159; Bhogale A, 2013, COLLOID SURFACE B, V102, P257, DOI 10.1016/j.colsurfb.2012.08.023; BURTON DR, 1986, MONOGR ALLERGY, V19, P7; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Chetyrkin SV, 2008, FREE RADICAL BIO MED, V44, P1276, DOI 10.1016/j.freeradbiomed.2007.09.016; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; Dey A, 2017, BIOTECHNOL ADV, V35, P178, DOI 10.1016/j.biotechadv.2016.12.005; Doak SH, 2012, MUTAT RES-GEN TOX EN, V745, P104, DOI 10.1016/j.mrgentox.2011.09.013; DOLHOFER R, 1985, BIOL CHEM H-S, V366, P361, DOI 10.1515/bchm3.1985.366.1.361; DOLHOFERBLIESENER R, 1990, BIOL CHEM H-S, V371, P693, DOI 10.1515/bchm3.1990.371.2.693; Echavarria AP, 2013, SCI AGROPEC, V4, P45; El-Ghorab AH, 2010, J ARAB SOC MED RES, V5, P131; Gao LF, 2013, J APPL TOXICOL, V33, P1079, DOI 10.1002/jat.2842; Gasiorowski K, 2018, MOL NEUROBIOL, V55, P1463, DOI 10.1007/s12035-017-0419-4; Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108; Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007; Hackenberg S, 2011, TOXICOL IN VITRO, V25, P657, DOI 10.1016/j.tiv.2011.01.003; Hawe A, 2009, EUR J PHARM SCI, V38, P79, DOI 10.1016/j.ejps.2009.06.001; Hu XG, 2005, NANOTECHNOLOGY, V16, P2164, DOI 10.1088/0957-4484/16/10/032; Huang B, 2003, FREE RADICAL BIO MED, V35, P805, DOI 10.1016/S0891-5849(03)00428-3; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Kaminsky YG, 2013, AGING DIS, V4, P244, DOI 10.14336/AD.2013.0400244; Kessel L, 2002, PHOTOCHEM PHOTOBIOL, V76, P549, DOI 10.1562/0031-8655(2002)076<0549:TRASSF>2.0.CO;2; Khan TA, 2016, CNS NEUROL DISORD-DR, V15, P310, DOI 10.2174/1871527315666160202124518; KIHARA M, 1991, P NATL ACAD SCI USA, V88, P6107, DOI 10.1073/pnas.88.14.6107; Kim JH, 2012, BIOL PHARM BULL, V35, P260, DOI 10.1248/bpb.35.260; Kim S, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7110354; Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187; Leszek J, 2017, CURR ALZHEIMER RES, V14, P1182, DOI 10.2174/1567205014666170203125008; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Li JQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43126; Li XH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.180; Liggins J, 1997, BBA-MOL BASIS DIS, V1361, P123, DOI 10.1016/S0925-4439(97)00023-9; Liu SF, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-433; LO TWC, 1994, J BIOL CHEM, V269, P32299; Loeffler DA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0198-z; Long TC, 2006, ENVIRON SCI TECHNOL, V40, P4346, DOI 10.1021/es060589n; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Mazo NA, 2017, CURR PHARM DESIGN, V23, P4180, DOI 10.2174/1381612823666170316142803; Munch G, 1997, BRAIN RES REV, V23, P134, DOI 10.1016/S0165-0173(96)00016-1; Natarajan S, 2013, PHARM BIOL, V51, P492, DOI 10.3109/13880209.2012.738423; Obayashi H, 1996, BIOCHEM BIOPH RES CO, V226, P37, DOI 10.1006/bbrc.1996.1308; Pan Y, 2009, SMALL, V5, P2067, DOI 10.1002/smll.200900466; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Reddy VP, 2006, DRUG DISCOV TODAY, V11, P646, DOI 10.1016/j.drudis.2006.05.016; Roufail E, 1998, DIABETOLOGIA, V41, P1419, DOI 10.1007/s001250051087; Schmitt A, 2005, ANAL BIOCHEM, V346, P101, DOI 10.1016/j.ab.2005.07.035; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Seneviratne C, 2011, J INORG BIOCHEM, V105, P1548, DOI 10.1016/j.jinorgbio.2011.09.001; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; Simsikova M, 2013, COLLOID SURFACE B, V103, P630, DOI 10.1016/j.colsurfb.2012.10.058; Singh SK, 2017, CURR DRUG METAB, V18, P112, DOI 10.2174/1389200217666161201112206; Singha S, 2009, NANOMED-NANOTECHNOL, V5, P21, DOI 10.1016/j.nano.2008.06.005; SMITH RE, 1978, ANAL BIOCHEM, V90, P246, DOI 10.1016/0003-2697(78)90029-5; Sruthi S, 2017, INT J BIOL MACROMOL, V103, P808, DOI 10.1016/j.ijbiomac.2017.05.088; Tajes M, 2014, NEUROSCI LETT, V580, P78, DOI 10.1016/j.neulet.2014.07.047; Tajes M, 2014, J ALZHEIMERS DIS, V41, P273, DOI 10.3233/JAD-131685; Thornalley PJ, 2002, INT REV NEUROBIOL, V50, P37; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Tian L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16117; Turci F, 2010, LANGMUIR, V26, P8336, DOI 10.1021/la904758j; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Wang B, 2006, TOXICOL LETT, V161, P115, DOI 10.1016/j.toxlet.2005.08.007; Wang LJ, 2010, J NANOSCI NANOTECHNO, V10, P8617, DOI 10.1166/jnn.2010.2483; Wang YG, 2011, SCI TOTAL ENVIRON, V409, P4753, DOI 10.1016/j.scitotenv.2011.07.039; Wangoo N, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2902302; Webster J, 2005, NEUROTOX RES, V7, P95, DOI 10.1007/BF03033780; Wei LM, 2017, INT J NANOMED, V12, P1891, DOI 10.2147/IJN.S129375; WellsKnecht KJ, 1996, NEPHROL DIAL TRANSPL, V11, P41; Wong KH, 2008, INT J FOOD SCI TECH, V43, P1512, DOI 10.1111/j.1365-2621.2006.01445.x; Yu SX, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/14/145703	101	19	19	2	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	SEP	2018	55	9					7438	7452		10.1007/s12035-018-0935-x	http://dx.doi.org/10.1007/s12035-018-0935-x			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO9UK	29423819				2022-09-04	WOS:000440453100026
J	Rengel, DT; Grajales, JLT; Oriola, J; Ferrer, J; Webb, SM				Tundidor Rengel, Diana; Torres Grajales, Jose L.; Oriola, Josep; Ferrer, Jorge; Webb, Susan M.			Cinacalcet for the management of hypercalcemia secondary to calcium-sensing receptor mutation	ENDOCRINOLOGIA Y NUTRICION			English	Letter									[Tundidor Rengel, Diana; Webb, Susan M.] Hosp Santa Creu & Sant Pau, Serv Endocrinol & Nutr, Barcelona, Spain; [Torres Grajales, Jose L.] Pontificia Univ Javeriana, Hosp San Ignacio, Unidad Endocrinol, Bogota, Colombia; [Oriola, Josep] Hosp Clin Barcelona, Ctr Diagnost Biomed Bioquim & Genet Mol, Barcelona, Spain; [Ferrer, Jorge] Hosp Clin Barcelona, Serv Endocrinol & Nutr, Barcelona, Spain; [Webb, Susan M.] ISCIII, Ctr Invest Biomed Red Enfermedades Raras, CIBERER, Unidad 747, Barcelona, Spain; [Webb, Susan M.] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain		Rengel, DT (corresponding author), Hosp Santa Creu & Sant Pau, Serv Endocrinol & Nutr, Barcelona, Spain.	dtundidor@santpau.cat						Alon US, 2010, PEDIATR NEPHROL, V25, P1747, DOI 10.1007/s00467-010-1547-5; Drueke TB, 2004, NEPHROL DIAL TRANSPL, V19, P20, DOI 10.1093/ndt/gfh1052; Egbuna OI, 2008, BEST PRACT RES CL RH, V22, P129, DOI 10.1016/j.berh.2007.11.006; Festen-Spanjer B, 2008, CLIN ENDOCRINOL, V68, P324, DOI 10.1111/j.1365-2265.2007.03027.x; Guarnieri V, 2010, J CLIN ENDOCR METAB, V95, P1819, DOI 10.1210/jc.2008-2430; Peacock M, 2005, J CLIN ENDOCR METAB, V90, P135, DOI 10.1210/jc.2004-0842; Timmers HJLM, 2006, J INTERN MED, V260, P177, DOI 10.1111/j.1365-2796.2006.01684.x	7	1	1	0	2	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	1575-0922	1579-2021		ENDOCRINOL NUTR	Endocrinol. Nutr.	JAN	2013	60	1					40	41						2	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	V43XN					2022-09-04	WOS:000209714200008
J	Duarte-Rey, C; Bogdanos, D; Yang, CY; Roberts, K; Leung, PSC; Anaya, JM; Worman, HJ; Gershwin, ME				Duarte-Rey, Carolina; Bogdanos, Dimitrios; Yang, Chen-Yen; Roberts, Krista; Leung, Patrick S. C.; Anaya, Juan-Manuel; Worman, Howard J.; Gershwin, M. Eric			Primary biliary cirrhosis and the nuclear pore complex	AUTOIMMUNITY REVIEWS			English	Review						Autoantibody; Autoantigen; Autoimmunity; Nuclear envelope; Nuclear pore complex; Nucleoporin; Primary biliary cirrhosis	ORTHOTOPIC LIVER-TRANSPLANTATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTINUCLEAR ANTIBODIES; CLINICAL-SIGNIFICANCE; P62 COMPLEX; MEMBRANE GLYCOPROTEIN; GP210 AUTOANTIBODIES; MAJOR GLYCOPROTEIN; PROGNOSTIC MARKER; CYTOPLASMIC TAIL	Experimental models of autoimmune diseases have led to the conclusion that an immune response to nuclear antigens is a sentinel marker for loss of tolerance and potential tissue damage. Various proteins are targets of antinuclear antibodies in a variety of autoimmune diseases, ranging from systemic rheumatologic disorders to diseases affecting specific organs such as the liver. Autoantibodies against specific nuclear constituents have also been used as probes to understand the structure and the function of the targeted components and their relevance to disease pathogenesis. Approximately a quarter of patients with primary biliary cirrhosis (PBC) have antibodies targeting proteins of the nuclear pore complex (NPC), a multi-protein structure that mediates molecular transport across the nuclear envelope. Autoantibodies against the integral membrane glycoprotein gp210 and nucleoporin p62 appear to be highly specific for PBC, an autoimmune disease characterized by progressive destruction of intrahepatic biliary epithelial cells. This review discusses the diagnostic and clinical relevance of anti-NPC antibodies in PBC and the possibility that this autoimmune response may arise as a result of molecular mimicry. (C) 2012 Elsevier B.V. All rights reserved.	[Duarte-Rey, Carolina; Yang, Chen-Yen; Roberts, Krista; Leung, Patrick S. C.; Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Duarte-Rey, Carolina] Pontificia Univ Javeriana, Fac Med, Dept Med Interna, Bogota, Colombia; [Bogdanos, Dimitrios] Kings Coll London, Sch Med, Kings Coll Hosp, Inst Liver Studies Transplantat Immunol & Mucosal, London WC2R 2LS, England; [Anaya, Juan-Manuel] Univ Rosario, Fac Med, Ctr Estudio Enfermedades Autoinmunes, Bogota, Colombia; [Worman, Howard J.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA; [Worman, Howard J.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY USA		Gershwin, ME (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, 451 Hlth Sci Dr,Suite 6510, Davis, CA 95616 USA.	megershwin@ucdavis.edu	Anaya, Juan-Manuel/J-1960-2016; Bogdanos, Dimitrios/AAF-8620-2020; Duarte-Rey, Carolina/I-7129-2016	Anaya, Juan-Manuel/0000-0002-6444-1249; Bogdanos, Dimitrios/0000-0002-9697-7902; Duarte-Rey, Carolina/0000-0003-2195-7963; Universidad del Rosario, Biblioteca/0000-0003-3491-9392	National Institutes of Health [DK39588]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039588, R01DK039588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support for this study was provided by the National Institutes of Health grant DK39588.	Agmon-Levin N, 2010, J AUTOIMMUN, V34, P55, DOI 10.1016/j.jaut.2009.08.009; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Aringer M, 2012, AUTOIMMUN REV, V11, P321, DOI 10.1016/j.autrev.2011.05.001; Bandin O, 1996, HEPATOLOGY, V23, P1020; Belizna C, 2010, AUTOIMMUN REV, V9, P691, DOI 10.1016/j.autrev.2010.05.020; Bogdanos DP, 2008, WORLD J GASTROENTERO, V14, P3374, DOI 10.3748/wjg.14.3374; Bogdanos DP, 2007, HEPATOLOGY, V45, P1583, DOI 10.1002/hep.21678; Bogdanos DP, 2011, CLIN CHIM ACTA, V412, P502, DOI 10.1016/j.cca.2010.12.019; Bonaguri C, 2011, AUTOIMMUN REV, V11, P1, DOI 10.1016/j.autrev.2011.06.006; CALLAN HG, 1950, PROC R SOC SER B-BIO, V137, P367, DOI 10.1098/rspb.1950.0047; Capelson M, 2010, COLD SH Q B, V75, P585, DOI 10.1101/sqb.2010.75.059; Courvalin JC, 1997, SEMIN LIVER DIS, V17, P79, DOI 10.1055/s-2007-1007185; COURVALIN JC, 1990, J CLIN INVEST, V86, P279, DOI 10.1172/JCI114696; COURVALIN JC, 1990, J EXP MED, V172, P961, DOI 10.1084/jem.172.3.961; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Defendenti C, 2011, AUTOIMMUN REV, V10, P150, DOI 10.1016/j.autrev.2010.09.005; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Dubel L, 1998, J HEPATOL, V28, P169, DOI 10.1016/S0168-8278(98)80220-1; Favreau C, 2001, EUR J BIOCHEM, V268, P3883, DOI 10.1046/j.1432-1327.2001.02290.x; Forger F, 2004, LUPUS, V13, P36, DOI 10.1191/0961203304lu485oa; GREBER UF, 1990, EMBO J, V9, P1495, DOI 10.1002/j.1460-2075.1990.tb08267.x; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Invernizzi P, 2001, J HEPATOL, V34, P366, DOI 10.1016/S0168-8278(00)00040-4; Itoh S, 1998, J GASTROEN HEPATOL, V13, P257, DOI 10.1111/j.1440-1746.1998.01553.x; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kraemer DM, 2003, CLIN DIAGN LAB IMMUN, V10, P329, DOI 10.1128/CDLI.10.2.329-331.2003; Kraemer Doris M, 2010, Open Rheumatol J, V4, P24, DOI 10.2174/1874312901004010024; LASSOUED K, 1988, ANN INTERN MED, V108, P829, DOI 10.7326/0003-4819-108-6-829; LASSOUED K, 1990, GASTROENTEROLOGY, V99, P181, DOI 10.1016/0016-5085(90)91246-3; Lee TP, 2010, J AUTOIMMUN, V35, P358, DOI 10.1016/j.jaut.2010.07.007; Liu HY, 2010, J AUTOIMMUN, V35, P436, DOI 10.1016/j.jaut.2010.09.005; LOZANO F, 1988, HEPATOLOGY, V8, P930, DOI 10.1002/hep.1840080438; Luettig B, 1998, J HEPATOL, V28, P824, DOI 10.1016/S0168-8278(98)80233-X; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mattalia A, 1997, J AUTOIMMUN, V10, P491, DOI 10.1006/jaut.1997.0156; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Meda F, 2009, J HEPATOL, V50, pS248, DOI 10.1016/S0168-8278(09)60678-4; Meroni PL, 2008, AUTOIMMUN REV, V7, P585, DOI 10.1016/j.autrev.2008.08.001; Miyachi K, 2003, J AUTOIMMUN, V20, P247, DOI 10.1016/S0896-8411(03)00033-7; Miyachi K, 1996, MOL BIOL REP, V23, P227, DOI 10.1007/BF00351173; Muratori P, 2003, AM J GASTROENTEROL, V98, P431, DOI 10.1016/S0002-9270(02)05925-7; Nakamura M, 2006, J AUTOIMMUN, V26, P138, DOI 10.1016/j.jaut.2005.10.007; Nakamura M, 2005, J HEPATOL, V42, P386, DOI 10.1016/j.jhep.2004.11.016; Nakamura M, 2007, HEPATOLOGY, V45, P118, DOI 10.1002/hep.21472; Neuberger J, 2003, AUTOIMMUN REV, V2, P1, DOI 10.1016/S1568-9972(02)00103-9; Neuberger J, 2003, J HEPATOL, V39, P142, DOI 10.1016/S0168-8278(03)00283-6; Neuberger J, 1997, LANCET, V350, P875, DOI 10.1016/S0140-6736(97)05419-6; NICKOWITZ RE, 1993, J EXP MED, V178, P2237, DOI 10.1084/jem.178.6.2237; NICKOWITZ RE, 1994, GASTROENTEROLOGY, V106, P193, DOI 10.1016/S0016-5085(94)95333-3; Ou Y, 2004, CLIN EXP IMMUNOL, V136, P379, DOI 10.1111/j.1365-2249.2004.02432.x; Perl A, 2010, AUTOIMMUNITY, V43, P1, DOI 10.3109/08916930903374741; ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771; RUFFATTI A, 1985, J CLIN IMMUNOL, V5, P357, DOI 10.1007/BF00918255; Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030; Sfakianaki O, 2010, WORLD J GASTROENTERO, V16, P4938, DOI 10.3748/wjg.v16.i39.4938; Shimoda S, 2003, GASTROENTEROLOGY, V124, P1915, DOI 10.1016/S0016-5085(03)00387-1; Shoenfeld Y, 2005, ARTHRITIS RHEUM, V52, P2599, DOI 10.1002/art.21252; Szalat R, 2010, AUTOIMMUN REV, V9, P652, DOI 10.1016/j.autrev.2010.05.001; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; TARTAKOVSKY F, 1995, HEPATOLOGY, V21, P495, DOI 10.1002/hep.1840210234; Ullal AJ, 2011, J AUTOIMMUN, V36, P173, DOI 10.1016/j.jaut.2011.02.001; Wang YH, 2011, J AUTOIMMUN, V37, P18, DOI 10.1016/j.jaut.2011.03.002; WATSON ML, 1959, J BIOPHYS BIOCHEM CY, V6, P147, DOI 10.1083/jcb.6.2.147; Wesierska-Gadek J, 2006, HEPATOLOGY, V43, P1135, DOI 10.1002/hep.21172; Wesierska-Gadek J, 2008, J CELL BIOCHEM, V104, P27, DOI 10.1002/jcb.21595; Wesierska-Gadek J, 2007, ANN NY ACAD SCI, V1109, P519, DOI 10.1196/annals.1398.058; WESIERSKAGADEK J, 1995, J EXP MED, V182, P1159, DOI 10.1084/jem.182.4.1159; WesierskaGadek J, 1996, GASTROENTEROLOGY, V110, P840, DOI 10.1053/gast.1996.v110.pm8608894; Worman HJ, 2003, AUTOIMMUN REV, V2, P211, DOI 10.1016/S1568-9972(03)00013-2; Worman HJ, 2007, HEPATOL RES, V37, pS406, DOI 10.1111/j.1872-034X.2007.00227.x; WOZNIAK RW, 1989, J CELL BIOL, V108, P2083, DOI 10.1083/jcb.108.6.2083	75	25	28	1	24	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-9972			AUTOIMMUN REV	Autoimmun. Rev.	OCT	2012	11	12					898	902		10.1016/j.autrev.2012.03.005	http://dx.doi.org/10.1016/j.autrev.2012.03.005			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	026DZ	22487189	Green Accepted, Green Published			2022-09-04	WOS:000310255800009
J	Grismaldo, A; Sobrevia, L; Morales, L				Grismaldo, Adriana; Sobrevia, Luis; Morales, Ludis			Role of platelet-derived growth factor c on endothelial dysfunction in cardiovascular diseases	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Platelet-derived growth factor C; Cardiovascular diseases; Diabetes mellitus; High glucose; Angiogenesis	DIABETES-MELLITUS; PDGF-C; OXIDATIVE STRESS; NITRIC-OXIDE; CELLS; VEGF; ANGIOGENESIS; HYPERGLYCEMIA; ALPHA; COMPLICATIONS	Loss of endothelial function is a common feature to all cardiovascular diseases (CVDs). One of the risk factors associated with the development of CVDs is the hyperglycaemia that occurs in patients with metabolic disorders such as Type 1 and Type 2 diabetes mellitus. Hyperglycaemia causes endothelial dysfunction through increased production of reactive oxygen species (ROS) from different cellular sources leading to oxidative stress. Vascular endothelial growth factor (VEGF) is essential in the stimulation and maintenance of endothelial functional aspects and, although it can mitigate the impact of ROS, VEGF-mediated signalling is partially inhibited in diabetes mellitus. The search for therapeutic strategies that preserve, protect and improve the functions of the endothelium is of great relevance in the investigation of CVDs associated with hyperglycaemia. Platelet-derived growth factor C (PDGF-C) is a peptide with angiogenic properties, independent of VEGF, that stimulates angiogenesis and revascularization of ischemic tissue. In a diabetic mouse model, PDGF-C stimulates mature endothelial cell migration, angiogenesis, endothelial progenitor cell mobilization, and increased neovascularization, and protects blood vessels in a retinal degeneration model activating anti-apoptosis and proliferation signalling pathways in endothelial cells. This review summarizes the information on the damage that high D-glucose causes on endothelial function and the beneficial effects that PDGF-CC could exert in this condition.	[Grismaldo, Adriana; Morales, Ludis] Pontificia Univ Javeriana, Fac Sci, Nutr & Biochem Dept, Expt & Computat Biochem Grp, Bogota, DC, Colombia; [Grismaldo, Adriana; Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, Dept Obstet,Cellular & Mol Physiol Lab,Div Obstet, Santiago 8330024, Chile; [Sobrevia, Luis] Univ Seville, Fac Pharm, Dept Physiol, E-41012 Seville, Spain; [Sobrevia, Luis] Sao Paulo State Univ UNESP, Fac Med, Med Sch, Sao Paulo, Brazil; [Sobrevia, Luis] Univ Queensland, Univ Queensland Ctr Clin Res UQCCR, Fac Med & Biomed Sci, Herston, Qld 4029, Australia; [Sobrevia, Luis] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands; [Sobrevia, Luis] Tecnol Monterrey, Inst Obes Res IOR, Sch Med & Hlth Sci, Eutra, Monterrey, Mexico; [Grismaldo, Adriana; Morales, Ludis] Pontificia Univ Javeriana, Fac Sci, Nutr & Biochem Dept, Bogota, Colombia; [Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, Dept Obstet,Cellular & Mol Physiol Lab,Div Obstet, POB 114-D, Santiago 8330024, Chile		Grismaldo, A; Morales, L (corresponding author), Pontificia Univ Javeriana, Fac Sci, Nutr & Biochem Dept, Bogota, Colombia.; Sobrevia, L (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Sch Med, Dept Obstet,Cellular & Mol Physiol Lab,Div Obstet, POB 114-D, Santiago 8330024, Chile.	mgrismaldo@javeriana.edu.co; lsobrevia@uc.cl; ludis.morales@javeriana.edu.co			Colciencias [8306]; Pontificia Universidad Javeriana, Colombia [00007142, 00007731]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile [1190316]; Vicerectorate of Academic Affairs, Academic Development Office of the Pontificia Universidad Catolica de Chile, Chile; Diamater Study Group, Sao Paulo Research Foundation-FAPESP, Sao Paulo [FAPESP 2016 / 01743-5]; Centro de Estudios Interdisciplinarios Basicos y Aplicados (CeiBA) at the Pontificia Universidad Javeriana - Bogota; CeiBA (Colombia)	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Pontificia Universidad Javeriana, Colombia; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Vicerectorate of Academic Affairs, Academic Development Office of the Pontificia Universidad Catolica de Chile, Chile; Diamater Study Group, Sao Paulo Research Foundation-FAPESP, Sao Paulo; Centro de Estudios Interdisciplinarios Basicos y Aplicados (CeiBA) at the Pontificia Universidad Javeriana - Bogota; CeiBA (Colombia)	This work was supported by Colciencias [grant number 8306] and Pontificia Universidad Javeriana [grant numbers 00007142, 00007731], Colombia, the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [grant number 1190316], Chile, the International Sabbaticals (LS) (University Medical Centre Groningen, University of Groningen, The Netherlands) from the Vicerectorate of Academic Affairs, Academic Development Office of the Pontificia Universidad Catolica de Chile, Chile. LS is also supported by The Diamater Study Group, Sao Paulo Research Foundation-FAPESP, Sao Paulo [grant number FAPESP 2016 / 01743-5], Brazil. AG was the recipient of a PhD fellowship from Centro de Estudios Interdisciplinarios Basicos y Aplicados (CeiBA) at the Pontificia Universidad Javeriana - Bogota and benefited with a travel grant from CeiBA (Colombia) to CMPL, Faculty of Medicine, Pontificia Universidad Catolica de Chile.	Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Bach LA, 2015, J MOL ENDOCRINOL, V54, pR1, DOI 10.1530/JME-14-0215; Bassi R, 2012, EXP DIABETES RES, DOI 10.1155/2012/916560; Boor P, 2010, AM J PATHOL, V177, P58, DOI 10.2353/ajpath.2010.091008; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Cannata A, 2020, CIRC RES, V126, P1394, DOI 10.1161/CIRCRESAHA.120.315855; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Cao YH, 2013, TRENDS MOL MED, V19, P460, DOI 10.1016/j.molmed.2013.05.002; Cheng R, 2015, REV ENDOCR METAB DIS, V16, P67, DOI 10.1007/s11154-015-9310-7; Chistiakov DA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00365; Chocry M, 2020, ANTIOXID REDOX SIGN, V33, P332, DOI 10.1089/ars.2019.7915; Cole JB, 2020, NAT REV NEPHROL, V16, P377, DOI 10.1038/s41581-020-0278-5; Costantino S, 2015, CARDIOVASC DIAGN THE, V5, P403, DOI 10.3978/j.issn.2223-3652.2015.05.02; Dal Canto E, 2019, EUR J PREV CARDIOL, V26, P25, DOI 10.1177/2047487319878371; Darenskaya MA, 2021, B EXP BIOL MED+, V171, P179, DOI 10.1007/s10517-021-05191-7; di Tomaso E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005123; Dijkmans J, 2002, INT J BIOCHEM CELL B, V34, P414, DOI 10.1016/S1357-2725(01)00124-8; Dimmeler S, 2005, NEW ENGL J MED, V352, P1815, DOI 10.1056/NEJMcibr050670; Domingueti CP, 2016, J DIABETES COMPLICAT, V30, P738, DOI 10.1016/j.jdiacomp.2015.12.018; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Faselis C, 2020, CURR VASC PHARMACOL, V18, P117, DOI 10.2174/1570161117666190502103733; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fetterman JL, 2016, ATHEROSCLEROSIS, V247, P207, DOI 10.1016/j.atherosclerosis.2016.01.043; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Folestad E, 2018, MOL ASPECTS MED, V62, P1, DOI 10.1016/j.mam.2018.01.005; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Fredriksson L, 2012, AM J PATHOL, V180, P1136, DOI 10.1016/j.ajpath.2011.12.006; Galicia-Garcia U, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176275; Gambardella J, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8080277; Giacca M, 2012, GENE THER, V19, P622, DOI 10.1038/gt.2012.17; Gilbertson DG, 2001, J BIOL CHEM, V276, P27406, DOI 10.1074/jbc.M101056200; Glovaci D, 2019, CURR CARDIOL REP, V21, DOI 10.1007/s11886-019-1107-y; Godo S, 2017, ARTERIOSCL THROM VAS, V37, pE108, DOI 10.1161/ATVBAHA.117.309813; Guo JE, 2015, ATHEROSCLEROSIS, V241, P111, DOI 10.1016/j.atherosclerosis.2015.04.799; He C, 2014, P NATL ACAD SCI USA, V111, P14806, DOI 10.1073/pnas.1404140111; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hu WN, 2015, CLIN EXP PHARMACOL P, V42, P1221, DOI 10.1111/1440-1681.12478; Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005; Jeong IK, 2011, DIABETES METAB J, V35, P8, DOI 10.4093/dmj.2011.35.1.8; Kang SW, 2007, CELL MOL LIFE SCI, V64, P533, DOI 10.1007/s00018-007-6437-z; Kazlauskas A, 2017, GENE, V614, P1, DOI 10.1016/j.gene.2017.03.003; Kolluru GK, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/918267; Kota Sunil K, 2012, Indian J Endocrinol Metab, V16, P918, DOI 10.4103/2230-8210.102992; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Lee C, 2018, MOL ASPECTS MED, V62, P12, DOI 10.1016/j.mam.2017.09.005; Lee C, 2013, TRENDS MOL MED, V19, P474, DOI 10.1016/j.molmed.2013.04.006; Li XR, 2005, J CLIN INVEST, V115, P118, DOI 10.1172/JCI200519189; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Li XR, 2010, ONCOTARGET, V1, P309, DOI 10.18632/oncotarget.141; Moriya J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0180-9; Moriya J, 2014, J VASC SURG, V59, P1402, DOI 10.1016/j.jvs.2013.04.053; Moriya J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004996; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Negri S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061341; Nomi Masashi, 2006, Curr Stem Cell Res Ther, V1, P333; Patel H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-142; Peplow PV, 2014, GROWTH FACTORS, V32, P83, DOI 10.3109/08977194.2014.904300; Rajagopalan S, 2003, AM HEART J, V145, P1114, DOI 10.1016/S0002-8703(03)00102-9; Rapoport RM, 2014, HYPERTENSION, V64, P908, DOI 10.1161/HYPERTENSIONAHA.114.03837; Remes A, 2020, BIOCHEM PHARMACOL, V182, DOI 10.1016/j.bcp.2020.114265; Rojas S, 2003, EXP PHYSIOL, V88, P209, DOI 10.1113/eph8802515; Schroder K, 2019, EXP PHYSIOL, V104, P447, DOI 10.1113/EP087125; Shen SH, 2020, DIABETES VASC DIS RE, V17, DOI 10.1177/1479164120942119; Shi Y, 2017, J DIABETES, V9, P434, DOI 10.1111/1753-0407.12521; Sobrevia L, 2022, BIOCHEM PHARMACOL, V201, DOI 10.1016/j.bcp.2022.115092; Sun L, 2009, AGEING RES REV, V8, P306, DOI 10.1016/j.arr.2009.04.003; Tang XQ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00175; Tchaikovski V, 2009, CIRCULATION, V120, P150, DOI 10.1161/CIRCULATIONAHA.108.817528; Thiriet M, 2018, BIOMATH BIOMECH MODE, V8, P1, DOI 10.1007/978-3-319-89315-0_1; Triggle CR, 2020, CAN J PHYSIOL PHARM, V98, P415, DOI 10.1139/cjpp-2019-0677; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Viigimaa M, 2020, CURR VASC PHARMACOL, V18, P110, DOI 10.2174/1570161117666190405165151; Villalobos-Labra R, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/5947859; Virani SS, 2021, CIRCULATION, V143, pe254, DOI 10.1161/CIR.0000000000000950; Waltenberger J, 2009, BIOCHEM SOC T, V37, P1167, DOI 10.1042/BST0371167; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030503; Wang J., 2020, CLIN SURG, V5, P2819; Wang YJ, 2014, LAB INVEST, V94, P674, DOI 10.1038/labinvest.2014.60; Warren CM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004235; World Health Organization, 2021, CARDIOVASC DIS; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Zhang Q, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010415; Zhao TQ, 2013, AM J PHYSIOL-HEART C, V304, pH1719, DOI 10.1152/ajpheart.00130.2013; Zhao WY, 2011, J MOL CELL CARDIOL, V51, P830, DOI 10.1016/j.yjmcc.2011.06.023; Zubair M, 2019, REV ENDOCR METAB DIS, V20, P207, DOI 10.1007/s11154-019-09492-1	89	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	OCT	2022	1866	10							130188	10.1016/j.bbagen.2022.130188	http://dx.doi.org/10.1016/j.bbagen.2022.130188			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	2H9UB	35691459	hybrid			2022-09-04	WOS:000814630800002
J	Dulski, J; Cerquera-Cleves, C; Milanowski, L; Kidd, A; Sitek, EJ; Strongosky, A; Monroy, AMV; Dickson, DW; Ross, OA; Pentela-Nowicka, J; Wszolek, ZK; Stawek, J				Dulski, Jaroslaw; Cerquera-Cleves, Catalina; Milanowski, Lukasz; Kidd, Alexa; Sitek, Emilia J.; Strongosky, Audrey; Vanegas Monroy, Ana Maria; Dickson, Dennis W.; Ross, Owen A.; Pentela-Nowicka, Jolanta; Wszolek, Zbigniew K.; Stawek, Jarostaw			Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review	EUROPEAN JOURNAL OF NEUROLOGY			English	Review						DCTN1 gene; dynactin; neurodegenerative disorder; parkinsonism; TDP-43	FAMILIAL PARKINSONISM; ATYPICAL PARKINSONISM; DCTN1 MUTATION; DEPRESSION; SCLEROSIS	Background and purpose Perry disease (or Perry syndrome) is an autosomal dominant neurodegenerative disorder characterized by parkinsonism, neuropsychiatric symptoms, central hypoventilation, weight loss and distinct TDP-43 pathology. It is caused by mutations of the DCTN1 gene encoding an essential component of axonal transport. The objectives were to provide the current state of knowledge on clinical, pathological and genetic aspects of Perry disease, as well as practical suggestions for the management of the disease. Methods Data on new patients from New Zealand, Poland and Colombia were collected, including autopsy report. Also all of the published papers since the original work by Perry in 1975 were gathered and analyzed. Results Parkinsonism was symmetrical, progressed rapidly and was poorly responsive to L-Dopa; nonetheless, a trial with high doses of L-Dopa is warranted. Depression was severe, associated with suicidal ideations, and benefited from antidepressants and L-Dopa. Respiratory symptoms were the leading cause of death, and artificial ventilation or a diaphragm pacemaker prolonged survival. Weight loss occurred in most patients and was of multifactorial etiology. Autonomic dysfunction was frequent but underdiagnosed. There was a clinical overlap with other neurodegenerative disorders. An autopsy showed distinctive pallidonigral degeneration with TDP-43 pathology. Genetic testing provided evidence of a common founder for two families. There was striking phenotypic variability in DCTN1-related disorders. It is hypothesized that oligogenic or polygenic inheritance is at play. Conclusions Perry disease and other DCTN1-related diseases are increasingly diagnosed worldwide. Relatively effective symptomatic treatments are available. Further studies are needed to pave the way toward curative/gene therapy.	[Dulski, Jaroslaw; Sitek, Emilia J.; Stawek, Jarostaw] Med Univ Gdansk, Div Neurol & Psychiat Nursing, Fac Hlth Sci, Gdansk, Poland; [Dulski, Jaroslaw; Sitek, Emilia J.; Stawek, Jarostaw] St Adalbert Hosp, Neurol Dept, Copernicus PL, Gdansk, Poland; [Cerquera-Cleves, Catalina] Pontificia Univ Javeriana, San Ignacio Hosp, Neurol Unit, Bogota, Colombia; [Cerquera-Cleves, Catalina] Clin Univ Colombia, Movement Disorders Clin, Bogota, Colombia; [Milanowski, Lukasz; Strongosky, Audrey; Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Milanowski, Lukasz; Dickson, Dennis W.; Ross, Owen A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Milanowski, Lukasz] Med Univ Warsaw, Fac Hlth Sci, Dept Neurol, Warsaw, Poland; [Kidd, Alexa] Clin Genet NZ Ltd, Christchurch, New Zealand; [Vanegas Monroy, Ana Maria] Clin Univ Colombia, Lab Clin Sanitas, Bogota, Colombia; [Pentela-Nowicka, Jolanta] Med Univ Lodz, Dept Neurol, Lodz, Poland		Wszolek, ZK (corresponding author), Mayo Clin, Dept Neurol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	Wszolek.Zbigniew@mayo.edu	Sitek, Emilia/AAJ-2666-2021; Sitek, Emilia/I-6913-2013	Sitek, Emilia/0000-0003-4141-072X; Sitek, Emilia/0000-0003-4141-072X; Milanowski, Lukasz/0000-0003-4197-8518; Dulski, Jaroslaw/0000-0002-5517-9875				Aoki N, 2015, ACTA NEUROPATHOL, V129, P53, DOI 10.1007/s00401-014-1358-z; Balicza P, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000515; Bercier V, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0327-3; BHATIA KP, 1993, ANN NEUROL, V34, P842, DOI 10.1002/ana.410340614; Caroppo P, 2014, JAMA NEUROL, V71, P208, DOI 10.1001/jamaneurol.2013.5100; Cheong RY, 2019, J HUNTINGTONS DIS, V8, P375, DOI 10.3233/JHD-190372; Chung EJ, 2014, PARKINSONISM RELAT D, V20, P388, DOI 10.1016/j.parkreldis.2014.01.010; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Felicio AC, 2014, MOVEMENT DISORD, V29, P1197, DOI 10.1002/mds.25893; Fiandaca MS, 2020, NEUROL NEUROCHIR POL, V54, P220, DOI 10.5603/PJNNS.a2020.0046; Fischer NM, 2021, AM J GERIAT PSYCHIAT, V29, P958, DOI 10.1016/j.jagp.2020.12.009; Frisina PG, 2009, PARKINSONISM RELAT D, V15, P144, DOI 10.1016/j.parkreldis.2008.04.038; Goeleven A, 2006, AMYOTROPH LATERAL SC, V7, P235, DOI 10.1080/17482960600664870; Gustavsson EK, 2016, PARKINSONISM RELAT D, V28, P56, DOI 10.1016/j.parkreldis.2016.04.025; Hamed M, 2019, PARKINSONISM RELAT D, V61, P236, DOI 10.1016/j.parkreldis.2018.10.024; Huang CH, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00219-w; Konno T, 2018, MAYO CLIN PROC, V93, P263, DOI 10.1016/j.mayocp.2017.11.014; Konno T, 2017, PARKINSONISM RELAT D, V41, P14, DOI 10.1016/j.parkreldis.2017.06.004; Kurian SM, 2011, MOL PSYCHIATR, V16, P37, DOI 10.1038/mp.2009.117; Lansdall CJ, 2017, BRAIN, V140, P1792, DOI 10.1093/brain/awx101; Mann DMA, 2017, BRAIN PATHOL, V27, P723, DOI 10.1111/bpa.12486; McManus EJ, 2020, NEW ZEAL MED J, V133, P116; Milanowski L, 2020, PARKINSONISM RELAT D, V77, P114, DOI 10.1016/j.parkreldis.2020.05.019; Mishima T, 2021, PARKINSONISM RELAT D, V83, P49, DOI 10.1016/j.parkreldis.2020.12.017; Mishima T, 2018, J NEUROL NEUROSUR PS, V89, P482, DOI 10.1136/jnnp-2017-316864; Mishima T, 2017, PARKINSONISM RELAT D, V42, P85, DOI 10.1016/j.parkreldis.2017.06.003; Mishima T, 2017, J NEUROPATH EXP NEUR, V76, P676, DOI 10.1093/jnen/nlx049; Newsway V, 2010, MOVEMENT DISORD, V25, P767, DOI 10.1002/mds.22950; Oetjens MT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12869-0; Ohshima S, 2010, PARKINSONISM RELAT D, V16, P612, DOI 10.1016/j.parkreldis.2010.07.001; PERRY TL, 1975, ARCH NEUROL-CHICAGO, V32, P108, DOI 10.1001/archneur.1975.00490440058009; Pretelt F, 2014, J NEUROL, V261, P620, DOI 10.1007/s00415-014-7262-6; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Saka E, 2010, PARKINSONISM RELAT D, V16, P68, DOI 10.1016/j.parkreldis.2009.05.010; Selim B, 2021, NEUROTHERAPEUTICS, V18, P81, DOI 10.1007/s13311-020-00955-x; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Tacik P, 2020, NEW ZEAL MED J, V133, P84; Tacik P, 2014, PARKINSONISM RELAT D, V20, P884, DOI 10.1016/j.parkreldis.2014.05.004; Tsuboi Y, 2008, ACTA NEUROPATHOL, V115, P263, DOI 10.1007/s00401-007-0246-1; Tsuboi Y, 2021, J MOV DISORD, V14, P1, DOI 10.14802/jmd.20060; Umemoto G, 2017, CASE REP NEUROL, V9, P161, DOI 10.1159/000457900; Wang CM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00220; Wider C, 2008, PARKINSONISM RELAT D, V14, P1, DOI 10.1016/j.parkreldis.2007.07.014; Wider C, 2009, PARKINSONISM RELAT D, V15, P281, DOI 10.1016/j.parkreldis.2008.07.005; Wilson RS, 2013, JAMA PSYCHIAT, V70, P1320, DOI 10.1001/jamapsychiatry.2013.2224; Zhang JF, 2021, NEUROL SCI, V42, P3695, DOI 10.1007/s10072-020-04962-w	47	3	3	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	DEC	2021	28	12					4010	4021		10.1111/ene.15048	http://dx.doi.org/10.1111/ene.15048		AUG 2021	12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW4YZ	34342072				2022-09-04	WOS:000690545200001
J	Barranco-Ruiz, Y; Villa-Gonzalez, E; Venegas-Sanabria, LC; Chavarro-Carvajal, DA; Cano-Gutierrez, CA; Izquierdo, M; Correa-Bautista, JE; Gonzalez-Ruiz, K; Ramirez-Velez, R				Barranco-Ruiz, Yaira; Villa-Gonzalez, Emilio; Venegas-Sanabria, Luis C.; Chavarro-Carvajal, Diego A.; Cano-Gutierrez, Carlos A.; Izquierdo, Mikel; Correa-Bautista, Jorge E.; Gonzalez-Ruiz, Katherine; Ramirez-Velez, Robinson			Metabolic Syndrome and Its Associated Factors in Older Adults: A Secondary Analysis of SABE Colombia in 2015	METABOLIC SYNDROME AND RELATED DISORDERS			English	Article						aged; metabolic syndrome; cardiovascular diseases; prevalence	RISK-FACTORS; CARDIOVASCULAR-DISEASE; GENDER-DIFFERENCE; HEALTH; PREVALENCE; POPULATION; SARCOPENIA; WOMEN; MENOPAUSE; SYMPTOMS	Background:Understanding the metabolic syndrome (MetS) prevalence at the national level is important to develop effective programs and strategies to prevent and control MetS. This study aimed to analyze the prevalence of MetS according to gender and aging stage, and its association with potential factors in older individuals >= 60 years of age in Colombia. Methods:The data for this study came from a secondary cross-sectional, nationally representative SABE study Survey on Health, Well-Being, and Aging in Colombia, 2015. A total of 1637 participants (60.7% women, 70.5 +/- 7.9 years) from 86 Colombian municipalities participated. A structured questionnaire was used to collect data on socio-demography, lifestyle, and self-report medical conditions. Measurements included anthropometric (weight, waist circumference, body mass index), sarcopenia "proxy" status (calf circumference) handgrip strength levels, high-density lipoprotein cholesterol, triglycerides, fasting glucose, and blood pressure. Univariate and multiple regression models were established as part of the main analysis. Results:Using the harmonized Joint Scientific Statement criteria, MetS was present in 54.9% of the study population, with a higher prevalence among females than males (59.8% vs. 47.3%). Individuals who were cigarette smokers (odds ratio [OR] = 1.5; 95% confidence interval [CI] = 1.0-2.4;P = 0.034), female gender (OR = 1.3; 95% CI = 1.0-1.8;P = 0.020), and sarcopenia "proxy" (OR = 1.6; 95% CI = 1.0-2.5;P = 0.026) were more likely to have a higher prevalence estimate of MetS, after controlling for relevant covariates. Conclusions:Overall prevalence of MetS among older adults in Colombia is high. Smoking, female gender, and sarcopenia "proxy" status are associated with MetS. These results suggested that MetS is still a serious public burden in Colombia, and screening for promotion of healthy lifestyle and nutrition counseling should be offered routinely in old age.	[Barranco-Ruiz, Yaira; Villa-Gonzalez, Emilio] Univ Granada, Fac Educ & Sport Sci, Melilla, Spain; [Venegas-Sanabria, Luis C.; Chavarro-Carvajal, Diego A.; Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Hosp Univ San Ignacio Aging Inst, Bogota, Colombia; [Izquierdo, Mikel; Correa-Bautista, Jorge E.; Ramirez-Velez, Robinson] Navarrabiomed Univ Publ Navarra UPNA, Complejo Hosp Navarra CHN, Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain; [Izquierdo, Mikel; Ramirez-Velez, Robinson] Inst Salud Carlos III, CIBER Frailty & Hlth Aging CIBERFES, Madrid, Spain; [Gonzalez-Ruiz, Katherine] Univ Manuela Beltran, Grp Ejercicio Fis & Deportes, Vicerrectoria Invest, Bogota, Colombia		Ramirez-Velez, R (corresponding author), Univ Publ Navarra, Dept Hlth Sci, Navarrabiomed, Pamplona 31008, Spain.	robin640@hotmail.com	González-Ruíz, Katherine/AGI-4611-2022; Barranco-Ruiz, Yaira/G-3007-2017; Izquierdo, Mikel/A-4894-2010; Izquierdo, Mikel/O-8049-2019; Chavarro-Carvajal, Diego Andres/F-5659-2019	González-Ruíz, Katherine/0000-0001-7518-0761; Barranco-Ruiz, Yaira/0000-0002-7435-7702; Izquierdo, Mikel/0000-0002-1506-4272; Izquierdo, Mikel/0000-0002-1506-4272; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Chavarro-Carvajal, Diego Andres/0000-0002-8584-3191; Venegas-Sanabria, Luis Carlos/0000-0001-8260-9108	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia [764]; Ministerio de Economia, Industria, y Competitividad (ISCIII, FEDER) [PI17/01814]; Universidad Publica de Navarra, Spain [420/2019]	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia; Ministerio de Economia, Industria, y Competitividad (ISCIII, FEDER); Universidad Publica de Navarra, Spain	This study is part of a larger project that has been funded by a Colciencias y Ministerio de Salud y la Proteccion Social de Colombia (The SABE Study ID 2013, no. 764). The funder had no role in the study design, data collection, data analysis and interpretation, the preparation of the article, or the decision to publish. Mikel Izquierdo is funded in part by a research grant PI17/01814 from the Ministerio de Economia, Industria, y Competitividad (ISCIII, FEDER). Robinson Ramirez-Velez is funded in part by a Postdoctotal fellowship grant ID 420/2019 of the Universidad Publica de Navarra, Spain.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2012, WASTE MANAGEMENT RES, DOI DOI 10.1553/POPULATIONYEARBOOK2010S77; Ansarimoghaddam A, 2018, DIABETES METAB SYND, V12, P195, DOI 10.1016/j.dsx.2017.11.004; Arbel Y, 2015, AM J CARDIOL, V115, P283, DOI 10.1016/j.amjcard.2014.10.037; Arvandi M, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0381-4; Beigh SH, 2012, BIOINFORMATION, V8, P613, DOI 10.6026/97320630008613; Bermudez Valmore, 2018, F1000Res, V7, P565, DOI 10.12688/f1000research.14571.2; Blumel JE, 2000, MATURITAS, V34, P17, DOI 10.1016/S0378-5122(99)00081-X; Blumel JE, 2006, MENOPAUSE, V13, P706, DOI 10.1097/01.gme.0000227338.73738.2d; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Cena H, 2011, NUTR REV, V69, P745, DOI 10.1111/j.1753-4887.2011.00446.x; Chedraui P., 2007, Archives of Gynecology and Obstetrics, V275, P161, DOI 10.1007/s00404-006-0239-7; Chen YC, 2010, J CLIN NURS, V19, P3031, DOI 10.1111/j.1365-2702.2010.03280.x; Chimbo-Yunga Jenny M., 2017, Rev. salud pública, V19, P754, DOI [10.15446/rsap.V19n6.60503, 10.15446/rsap.v19n6.60503]; Dallongeville J, 2004, ANN NUTR METAB, V48, P43, DOI 10.1159/000075304; Davila EP, 2013, PREV MED, V56, P30, DOI 10.1016/j.ypmed.2012.10.027; Eapen D, 2009, VASC HEALTH RISK MAN, V5, P731; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Franca SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167320; Gomez F, 2016, CURR GERONTOL GERIAT, V2016, P7910205, DOI 10.1155/2016/7910205; Gurgenyan SV, 2014, TERAPEVT ARKH, V86, P106; He Y, 2009, J AM COLL CARDIOL, V53, P363, DOI 10.1016/j.jacc.2008.08.073; Hoskins I, 2005, REV PANAM SALUD PUBL, V17, P444, DOI 10.1590/S1020-49892005000500017; Huang YJ, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-22; Hwang HJ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0106-4; Iso H, 2007, STROKE, V38, P1744, DOI 10.1161/STROKEAHA.106.469072; Kang Y, 2016, EUR J NUTR, V55, P2321, DOI 10.1007/s00394-015-1127-3; Kapourchali FR, 2016, CRIT REV FOOD SCI, V56, P2408, DOI 10.1080/10408398.2013.842887; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Landi F, 2014, CLIN NUTR, V33, P539, DOI 10.1016/j.clnu.2013.07.013; Li XL, 2017, J CLIN NEUROSCI, V40, P34, DOI 10.1016/j.jocn.2017.01.018; Marquez-Sandoval F, 2011, PUBLIC HEALTH NUTR, V14, P1702, DOI 10.1017/S1368980010003320; Martinez-Torres J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030233; Martone AM, 2019, J GERONTOL GERIATR, V67, P39; McCarthy M, 2004, LANCET, V363, P458, DOI 10.1016/S0140-6736(04)15525-6; Ortega-Lenis D, 2019, COLOMB MEDICA, V50, P128, DOI 10.25100/cm.v50i2.4557; PAHO/WHO, 2017, HLTH AM HLTH OLD PER; Patino-Hernandez D, 2017, GERONTOL GERIATR MED, V3, DOI 10.1177/2333721417703734; Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694; Pucci G, 2017, PHARMACOL RES, V120, P34, DOI 10.1016/j.phrs.2017.03.008; Ramirez-Velez R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081701; Regitz-Zagrosek V, 2016, EUR HEART J, V37, P24, DOI 10.1093/eurheartj/ehv598; Rochlani Y, 2015, CARDIOVASC DRUG THER, V29, P329, DOI 10.1007/s10557-015-6593-6; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Rubinstein AL, 2015, INT J CARDIOL, V183, P82, DOI 10.1016/j.ijcard.2015.01.062; Sempertegui F, 2011, PUBLIC HEALTH NUTR, V14, P758, DOI 10.1017/S1368980010002636; Sierra B, 2005, MATURITAS, V51, P236, DOI 10.1016/j.maturitas.2004.08.003; St-Onge MP, 2004, DIABETES CARE, V27, P2222, DOI 10.2337/diacare.27.9.2222; Stambler I, 2018, AGING DIS, V9, P331, DOI 10.14336/AD.2017.1120; United Nations, 2015, STESASERA390 UN; Vishram JKK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107294; Waist Circumference, 2019, NIH CLASS OV OB BMI; Wang WS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-111; Wilson PWF, 1999, ARCH INTERN MED, V159, P1104, DOI 10.1001/archinte.159.10.1104; Xanthakis V, 2015, DIABETES CARE, V38, P1082, DOI 10.2337/dc14-2460; Xi B, 2013, PREV MED, V57, P867, DOI 10.1016/j.ypmed.2013.09.023; Zhang HQ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030364	57	5	5	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-4196	1557-8518		METAB SYNDR RELAT D	Metab. Syndr. Relat. Disord.	OCT 1	2020	18	8					389	398		10.1089/met.2019.0066	http://dx.doi.org/10.1089/met.2019.0066		JUN 2020	10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	NV1XR	32609058				2022-09-04	WOS:000546951600001
J	Escandon, P; Chow, NA; Caceres, DH; Gade, L; Berkow, EL; Armstrong, P; Rivera, S; Misas, E; Duarte, C; Moulton-Meissner, H; Welsh, RM; Parra, C; Pescador, LA; Villalobos, N; Salcedo, S; Berrio, I; Varon, C; Espinosa-Bode, A; Lockhart, SR; Jackson, BR; Litvintseva, AP; Beltran, M; Chiller, TM				Escandon, Patricia; Chow, Nancy A.; Caceres, Diego H.; Gade, Lalitha; Berkow, Elizabeth L.; Armstrong, Paige; Rivera, Sandra; Misas, Elizabeth; Duarte, Carolina; Moulton-Meissner, Heather; Welsh, Rory M.; Parra, Claudia; Pescador, Luz Angela; Villalobos, Nohora; Salcedo, Soraya; Berrio, Indira; Varon, Carmen; Espinosa-Bode, Andres; Lockhart, Shawn R.; Jackson, Brendan R.; Litvintseva, Anastasia P.; Beltran, Mauricio; Chiller, Tom M.			Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance	CLINICAL INFECTIOUS DISEASES			English	Article						Candida auris; candidemia; environmental contamination; transmission; amphotericin B resistance	YEAST	Background. Candida auris is a multidrug-resistant yeast associated with hospital outbreaks worldwide. During 2015-2016, multiple outbreaks were reported in Colombia. We aimed to understand the extent of contamination in healthcare settings and to characterize the molecular epidemiology of C. auris in Colombia. Methods. We sampled patients, patient contacts, healthcare workers, and the environment in 4 hospitals with recent C. auris outbreaks. Using standardized protocols, people were swabbed at different body sites. Patient and procedure rooms were sectioned into 4 zones and surfaces were swabbed. We performed whole-genome sequencing (WGS) and antifungal susceptibility testing (AFST) on all isolates. Results. Seven of the 17 (41%) people swabbed were found to be colonized. Candida auris was isolated from 37 of 322 (11%) environmental samples. These were collected from a variety of items in all 4 zones. WGS and AFST revealed that although isolates were similar throughout the country, isolates from the northern region were genetically distinct and more resistant to amphotericin B (AmB) than the isolates from central Colombia. Four novel nonsynonymous mutations were found to be significantly associated with AmB resistance. Conclusions. Our results show that extensive C. auris contamination can occur and highlight the importance of adherence to appropriate infection control practices and disinfection strategies. Observed genetic diversity supports healthcare transmission and a recent expansion of C. auris within Colombia with divergent AmB susceptibility.	[Escandon, Patricia; Rivera, Sandra; Duarte, Carolina; Beltran, Mauricio] Inst Nacl Salud, Bogota, Colombia; [Chow, Nancy A.; Caceres, Diego H.; Gade, Lalitha; Berkow, Elizabeth L.; Armstrong, Paige; Welsh, Rory M.; Lockhart, Shawn R.; Jackson, Brendan R.; Litvintseva, Anastasia P.; Chiller, Tom M.] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA 30329 USA; [Misas, Elizabeth] Univ Antioquia, Unidad Biol Celular & Mol Corp Invest Biol, Medellin, Colombia; [Misas, Elizabeth] Univ Antioquia, Inst Biol, Medellin, Colombia; [Moulton-Meissner, Heather] Ctr Dis Control & Prevent, Div Healthcare Qual & Promot, Atlanta, GA 30329 USA; [Parra, Claudia] Pontificia Univ Javeriana, Fac Ciencias, Unidad Invest Prote & Micosis Humanas, Bogota, Colombia; [Pescador, Luz Angela] Hosp Mil Cent, Bogota, Colombia; [Villalobos, Nohora] Clin Los Nogales, Bogota, Colombia; [Salcedo, Soraya] Clin Gen Norte, Barranquilla, Colombia; [Berrio, Indira] Corp Invest Biol, Grp Micol Med & Expt, Medellin, Colombia; [Berrio, Indira] Hosp Gen Medellin, Luz Castro Gutierrez ESE, Medellin, Colombia; [Varon, Carmen] Fdn Unidad Cuidados Intens Dona Pilar, Cartagena, Colombia; [Espinosa-Bode, Andres] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA 30329 USA		Chow, NA (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Bldg 17,MS G-11, Atlanta, GA 30329 USA.	yln3@cdc.gov	Giraldo, Claudia Marcela Parra/AAG-3047-2019	Giraldo, Claudia Marcela Parra/0000-0003-1302-5429; Berrio Medina, Indira/0000-0001-8234-607X; Caceres, Diego H/0000-0001-8749-9809; Moulton-Meissner, Heather/0000-0002-0728-2552	US CDC; Instituto Nacional de Salud, Colombia	US CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Instituto Nacional de Salud, Colombia	This work was supported by the US CDC and Instituto Nacional de Salud, Colombia.	Chowdhary A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006290; CLSI, 2008, M27A3 CLSI, VThird; Girard V, 2016, MYCOSES, V59, P535, DOI 10.1111/myc.12519; Hull CM, 2012, ANTIMICROB AGENTS CH, V56, P6417, DOI 10.1128/AAC.01145-12; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Laprade DJ, 2016, MICROB CELL, V3, P285, DOI 10.15698/mic2016.07.512; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lockhart SR, 2017, CLIN INFECT DIS, V64, P134, DOI 10.1093/cid/ciw691; Piedrahita CT, 2017, INFECT CONT HOSP EP, V38, P1107, DOI 10.1017/ice.2017.127; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rose LJ, 2011, APPL ENVIRON MICROB, V77, P8355, DOI 10.1128/AEM.05377-11; Sahl JW, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000074; Schelenz S, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0132-5; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sherry L, 2017, EMERG INFECT DIS, V23, P328, DOI 10.3201/eid2302.161320; Vallabhaneni S, 2017, AM J TRANSPLANT, V17, P296, DOI 10.1111/ajt.14121; Vandeputte P, 2008, ANTIMICROB AGENTS CH, V52, P3701, DOI 10.1128/AAC.00423-08; Welsh RM, 2017, J CLIN MICROBIOL, V55, P2996, DOI [10.1128/JCM.00921-17, 10.1128/jcm.00921-17]	19	97	108	1	13	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1058-4838	1537-6591		CLIN INFECT DIS	Clin. Infect. Dis.	JAN 1	2019	68	1					15	21		10.1093/cid/ciy411	http://dx.doi.org/10.1093/cid/ciy411			7	Immunology; Infectious Diseases; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases; Microbiology	HM7CX	29788045	hybrid			2022-09-04	WOS:000459636000005
J	Previdelli, A; Gomez, G; Kovalskys, I; Fisberg, M; Cortes, Y; Herrera-Cuenca, M; Yepez, M; Pareja, R; Rigotti, A; Guajardo, V; Zimberg, I				Previdelli, Agatha; Gomez, Georgina; Kovalskys, Irina; Fisberg, Mauro; Cortes, Yadira; Herrera-Cuenca, Marianella; Yepez, Martha; Pareja, Rossina; Rigotti, Attilio; Guajardo, Viviana; Zimberg, Iona			Misreporting of energy intake in multicenter study in Latin America population: results from the Latin American Study of Nutrition and Health (ELANS)	FASEB JOURNAL			English	Meeting Abstract	Experimental Biology (EB) Annual Meeting	APR 22-26, 2017	Chicago, IL	Amer Soc Pharmacol & Expt Therapeut, Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr					[Previdelli, Agatha] UJST, Sao Paulo, Brazil; [Gomez, Georgina] Univ Costa Rica, San Jose, Costa Rica; [Kovalskys, Irina; Guajardo, Viviana] ILSI Argentina, Buenos Aires, DF, Argentina; [Fisberg, Mauro] Sabara Childrens Hosp, Pensi Inst, Sao Paulo, Brazil; [Fisberg, Mauro; Zimberg, Iona] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Cortes, Yadira] Pontificia Univ Javeriana, Bogota, Colombia; [Herrera-Cuenca, Marianella] CENDES UCV Fdn Bengoa, Caracas, Venezuela; [Yepez, Martha] Univ San Francisco Quito, Quito, Ecuador; [Pareja, Rossina] Inst Invest Nutr, Lima, Peru; [Rigotti, Attilio] Pontificia Univ Catolica, Santiago, Chile				Gomez, Georgina/AAR-7272-2020; Fisberg, Mauro/E-7149-2010	Gomez, Georgina/0000-0003-3514-2984; Fisberg, Mauro/0000-0003-2992-3215	Coca-Cola Company	Coca-Cola Company	The Coca-Cola Company		0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31			1		296.5								2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FA5CY					2022-09-04	WOS:000405461405313
J	Castellanos-Perilla, N; Borda, MG; Catano, S; Giraldo, S; Vik-Mo, AO; Aarsland, D; Rao, RT				Castellanos-Perilla, Nicolas; Borda, Miguel German; Catano, Sara; Giraldo, Salomon; Vik-Mo, Audun Osland; Aarsland, Dag; Rao, Rahul Tony			Specific depressive symptoms are related with different patterns of alcohol use in community-dwelling older adults	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Aged; Depression; Depressive disorder; Alcohol drinking; Mental health	GERIATRIC DEPRESSION; CONSUMPTION; DRINKING; DEPENDENCE; RISK; ANXIETY; ABUSE	Objectives: To explore how individual depressive symptoms might contribute to different patterns of alcohol consumption in Colombian older adults living in the community.Methods: A Secondary analysis from a nationally representative cross-sectional study of more than 23,000 older adults, with data from 19,004 participants. Drinking frequency, and level (moderate or heavy drinking) were used to assess alcohol use and depressive symptoms explored with the 15 items-GDS., using bivariate and multivariate adjusted regression models.Results: Lower weekly drinking frequency and a higher number of drinks per serving were associated with total GDS score. For individual symptoms, higher drinking frequency was associated with dropping activities and a preference to stay at home. Lower drinking frequency was associated with low mood, unhappiness, feelings of emptiness, worthlessness, hopelessness, and a lack of vigour. Lower number of drinks per serving was associated with withdrawal/apathy related symptoms; these also related to higher frequency of weekly alcohol consumption. Higher number of drinks per serving was associated with feelings of emptiness, worthlessness, boredom, help-lessness, worthlessness. not wanting to be alive, thinking that other people are better off in their mood, being afraid that something bad will happen and subjective memory problems. Moderate drinkers had a higher like-lihood of reporting lack of vigour.Conclusion: There were diverse patterns of alcohol use according to individual depressive symptoms. This has implications for interventions to reduce alcohol related harm in older people across a range of depressive symptoms with different patterns of alcohol use.	[Castellanos-Perilla, Nicolas; Borda, Miguel German; Vik-Mo, Audun Osland; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, N-4068 Stavanger, Norway; [Castellanos-Perilla, Nicolas; Borda, Miguel German; Catano, Sara; Giraldo, Salomon] Pontificia Univ Javeriana, Med Sch, Ageing Inst, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Borda, Miguel German] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Vik-Mo, Audun Osland] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Aarsland, Dag] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England; [Rao, Rahul Tony] South London & Maudsley NHS Fdn Trust, London, England; [Rao, Rahul Tony] Inst Psychiat Psychol & Neurosci, London, England		Castellanos-Perilla, N; Borda, MG (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, N-4068 Stavanger, Norway.	nicolascastellanos@javeriana.edu.co; mmborda@gmail.com		Rao, Rahul/0000-0002-0262-5122; Aarsland, Dag/0000-0001-6314-216X; Vik-Mo, Audun Osland/0000-0002-5162-3035	Colciencias [764]; Ministry of Health and Social Protection of Colombia	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Ministry of Health and Social Protection of Colombia	SABE-Colombia study is supported by a fund (2013, no. 764) from Colciencias and the Ministry of Health and Social Protection of Colombia.	Adams KB, 2001, GERONTOLOGIST, V41, P768, DOI 10.1093/geront/41.6.768; Axley PD, 2019, CLIN LIVER DIS, V23, P39, DOI 10.1016/j.cld.2018.09.011; Bacca A. M., 2005, PENSAM PSICOLOGICO, V1, P4; Bell S, 2015, DRUG ALCOHOL DEPEN, V155, P111, DOI 10.1016/j.drugalcdep.2015.08.008; Bellos S, 2016, PSYCHIAT RES, V243, P30, DOI 10.1016/j.psychres.2016.05.049; Blow F. C., 2004, ALCOHOL CLIN EXP RES, V28, DOI [10.1111/j.1530-0277.2004.tb03603.x, DOI 10.1111/J.1530-0277.2004.TB03603.X]; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Cagney KA, 2002, J GERONTOL B-PSYCHOL, V57, pP163, DOI 10.1093/geronb/57.2.P163; Cheruvu VK, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1203-2; Choi NG, 2011, INT J GERIATR PSYCH, V26, P860, DOI 10.1002/gps.2616; DANE, 2021, AD MAYOR COL; El-Gilany AH, 2018, ARCH GERONTOL GERIAT, V77, P103, DOI 10.1016/j.archger.2018.04.011; Enoch MA, 2002, AM FAM PHYSICIAN, V65, P441; Fergusson DM, 2009, ARCH GEN PSYCHIAT, V66, P260, DOI 10.1001/archgenpsychiatry.2008.543; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Garcia-Esquinas E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29985-4; Gea A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-954; Gomez Fernando, 2016, Curr Gerontol Geriatr Res, V2016, P7910205; Johansson S., 2021, CLIN FEASIBLE SHORT, DOI [10.1080/13607863.2021.1881759, DOI 10.1080/13607863.2021.1881759]; Keyes KM, 2019, INT REV NEUROBIOL, V148, P1, DOI 10.1016/bs.irn.2019.09.001; Kirchner JE, 2007, J GEN INTERN MED, V22, P92, DOI 10.1007/s11606-006-0017-z; Kok RM, 2017, JAMA-J AM MED ASSOC, V317, P2114, DOI 10.1001/jama.2017.5706; Krishnamoorthy Y, 2020, ARCH GERONTOL GERIAT, V87, DOI 10.1016/j.archger.2019.104002; Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564; Mirand AL, 1996, AM J PUBLIC HEALTH, V86, P978, DOI 10.2105/AJPH.86.7.978; NIH & NIAAA., DRINK LEV DEF; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; O'Connell H, 2003, BMJ-BRIT MED J, V327, P664, DOI 10.1136/bmj.327.7416.664; Onen SH, 2005, ARCH GERONTOL GERIAT, V41, P191, DOI 10.1016/j.archger.2005.02.002; Ortola R, 2017, OSTEOPOROSIS INT, V28, P3143, DOI 10.1007/s00198-017-4157-2; Probst C, 2018, ADDICTION, V113, P1231, DOI 10.1111/add.14173; RODDA J, 2011, BMJ-BRIT MED J, V343, DOI DOI 10.1136/BMJ.D5219; Satre DD, 2011, AM J GERIAT PSYCHIAT, V19, P695, DOI 10.1097/JGP.0b013e3181f17f0a; Schmitz A, 2019, ARCH GERONTOL GERIAT, V82, P207, DOI 10.1016/j.archger.2019.02.015; Skogen JC, 2009, ADDICTION, V104, P1519, DOI 10.1111/j.1360-0443.2009.02659.x; Smith JW, 1995, INT J ADDICT, V30, P1749, DOI 10.3109/10826089509071055; Steffens DC, 2009, CURR OPIN PSYCHIATR, V22, P522, DOI 10.1097/YCO.0b013e32832fcd93; WHO & GHO., 2020, GHO CAT REC ALC PER; Wolle CC, 2011, REV BRAS PSIQUIATR, V33, P367, DOI 10.1590/S1516-44462011000400010; Wongpakaran N, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02300; World Health Organization, 2018, ALCOHOL CONSUMPTION	42	0	0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	JUL-AUG	2022	101								104696	10.1016/j.archger.2022.104696	http://dx.doi.org/10.1016/j.archger.2022.104696			7	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	1D3ZR	35364452	hybrid, Green Published			2022-09-04	WOS:000793742700012
J	Galipo, E; Dixon, MA; Fronterre, C; Cucunuba, ZM; Basanez, MG; Stevens, K; Sanchez, ACF; Walker, M				Galipo, Erika; Dixon, Matthew A.; Fronterre, Claudio; Cucunuba, Zulma M.; Basanez, Maria-Gloria; Stevens, Kim; Sanchez, Astrid Carolina Florez; Walker, Martin			Spatial distribution and risk factors for human cysticercosis in Colombia	PARASITES & VECTORS			English	Article						Taenia solium; Cysticercosis; Risk factors; Spatial analysis; Geostatistics; Colombia	TAENIA-SOLIUM TAENIASIS; PREVALENCE; INFECTION; COMMUNITY; EPIDEMIOLOGY; POPULATION; STRATEGIES; VILLAGE; EGGS	Background: Cysticercosis is a zoonotic neglected tropical disease (NTD) that affects humans and pigs following the ingestion of Taenia solium eggs. Human cysticercosis poses a substantial public health burden in endemic countries. The World Health Organization (WHO) aims to target high-endemicity settings with enhanced interventions in 17 countries by 2030. Between 2008 and 2010, Colombia undertook a national baseline serosurvey of unprecedented scale, which led to an estimated seroprevalence of T. solium cysticercus antibodies among the general population of 8.6%. Here, we use contemporary geostatistical approaches to analyse this unique dataset with the aim of understanding the spatial distribution and risk factors associated with human cysticercosis in Colombia to inform how best to target intervention strategies. Methods: We used a geostatistical model to estimate individual and household risk factors associated with seropositivity to T. solium cysticercus antibodies from 29,253 people from 133 municipalities in Colombia. We used both independent and spatially structured random effects at neighbourhood/village and municipality levels to account for potential clustering of exposure to T. solium. We present estimates of the distribution and residual correlation of seropositivity at the municipality level. Results: High seroprevalence was identified in municipalities located in the north and south of Colombia, with spatial correlation in seropositivity estimated up to approximately 140 km. Statistically significant risk factors associated with seropositivity to T. solium cysticercus were related to age, sex, educational level, socioeconomic status, use of rainwater, consumption of partially cooked/raw pork meat and possession of dogs. Conclusions: In Colombia, the distribution of human cysticercosis is influenced by socioeconomic considerations, education and environmental factors related to the spread of T. solium eggs. This information can be used to tailor national intervention strategies, such as targeting spatial hotspots and more highly exposed groups, including displaced people and women. Large-scale seroprevalence surveys accompanied by geospatial mapping are an essential step towards reaching the WHO's 2021-2030 NTD roadmap targets.	[Galipo, Erika] Anim & Plant Hlth Agcy, Dept Epidemiol Sci, Addlestone, Surrey, England; [Galipo, Erika; Stevens, Kim; Walker, Martin] Royal Vet Coll, Dept Pathobiol & Populat Sci, Hatfield, Herts, England; [Galipo, Erika; Stevens, Kim; Walker, Martin] Royal Vet Coll, London Ctr Neglected Trop Dis Res, Hatfield, Herts, England; [Dixon, Matthew A.; Cucunuba, Zulma M.; Basanez, Maria-Gloria; Walker, Martin] Imperial Coll London, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England; [Dixon, Matthew A.; Cucunuba, Zulma M.; Basanez, Maria-Gloria; Walker, Martin] Imperial Coll London, London Ctr Neglected Trop Dis Res, Sch Publ Hlth, London, England; [Dixon, Matthew A.; Cucunuba, Zulma M.; Basanez, Maria-Gloria] Imperial Coll London, Med Res Ctr Global Infect Dis Anal, Sch Publ Hlth, London, England; [Dixon, Matthew A.] Schistosomiasis Control Initiat SCI Fdn, Edinburgh House,170 Kennington Lane, London SE11 5DP, England; [Fronterre, Claudio] Univ Lancaster, Ctr Hlth Informat Comp & Stat, Lancaster, England; [Sanchez, Astrid Carolina Florez] Inst Nacl Salud, Grp Parasitol, Bogota, Colombia; [Cucunuba, Zulma M.] Pontificia Univ Javeriana, Dept Epidemiol Clin, Bogota, Colombia		Dixon, MA (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England.; Dixon, MA (corresponding author), Imperial Coll London, London Ctr Neglected Trop Dis Res, Sch Publ Hlth, London, England.; Dixon, MA (corresponding author), Imperial Coll London, Med Res Ctr Global Infect Dis Anal, Sch Publ Hlth, London, England.; Dixon, MA (corresponding author), Schistosomiasis Control Initiat SCI Fdn, Edinburgh House,170 Kennington Lane, London SE11 5DP, England.	m.dixon15@imperial.ac.uk	Fronterre, Claudio/AGW-2090-2022; Dixon, Matthew A/ABE-9187-2021; Cucunuba, Zulma M/X-5670-2019	Fronterre, Claudio/0000-0001-6723-9727; Dixon, Matthew A/0000-0002-1710-6237; Cucunuba, Zulma M/0000-0002-8165-3198; Basanez, Maria-Gloria/0000-0001-5031-3361	Medical Research Council (MRC) Centre for Global Infectious Disease Analysis - UK MRC under the MRC/FCDO Concordat agreement [MR/R015600/1]; Medical Research Council (MRC) Centre for Global Infectious Disease Analysis - UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement; European Union; Medical Research Council Doctoral Training Partnership (MRC DTP) research studentship	Medical Research Council (MRC) Centre for Global Infectious Disease Analysis - UK MRC under the MRC/FCDO Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (MRC) Centre for Global Infectious Disease Analysis - UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council Doctoral Training Partnership (MRC DTP) research studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MAD, ZMC and MGB acknowledge funding from the Medical Research Council (MRC) Centre for Global Infectious Disease Analysis (reference MR/R015600/1), jointly funded by the UK MRC and the UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement and is also part of the European and Developing Countries Clinical Trials Partnership (EDCTP2) programme supported by the European Union. MAD has also been funded by a Medical Research Council Doctoral Training Partnership (MRC DTP) research studentship to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Flórez Piedad, 2009, Rev. salud pública, V11, P191; Alidadi S., 2015, AIR WATER BORNE DIS, V4, pE135; Allan JC, 1996, ANN TROP MED PARASIT, V90, P157, DOI 10.1080/00034983.1996.11813039; Bruno E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002480; Carabin H, 2018, LANCET GLOB HEALTH, V6, pE411, DOI 10.1016/S2214-109X(18)30027-5; Carabin H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004248; Coral-Almeida M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003919; Corrales LF, 2006, TROP MED INT HEALTH, V11, P1821, DOI 10.1111/j.1365-3156.2006.01737.x; Corredor A., 1996, Biomedica, V16, P131; CystiTeam Group for Epidemiology and Modelling of Taenia solium Taeniasis/Cysticercosis, 2019, GATES OOPEN RES, V3, P1546; de Coster T, 2018, Food Waterborne Parasitol, V13, pe00030, DOI 10.1016/j.fawpar.2018.e00030; Dermauw V, 2018, AM J TROP MED HYG, V99, P1018, DOI 10.4269/ajtmh.18-0294; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Dixon MA, 2020, SCI REP-UK, V10, P17637, DOI 10.1038/s41598-020-74007-x; Dixon MA, 2020, B WORLD HEALTH ORGAN, V98, P198, DOI 10.2471/BLT.19.238485; Enander RT, 2010, INT J ENVIRON HEAL R, V20, P329, DOI 10.1080/09603123.2010.482152; Flórez Sánchez Astrid Carolina, 2013, Acta Neurol Colomb., V29, P73; Fuglstad GA, 2019, J AM STAT ASSOC, V114, P445, DOI 10.1080/01621459.2017.1415907; Gabriel S, 2020, NEW ENGL J MED, V383, P396, DOI 10.1056/NEJMc1909955; Garcia HH, 2014, PARASITE IMMUNOL, V36, P388, DOI 10.1111/pim.12126; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Garcia HH, 1998, AM J TROP MED HYG, V59, P902, DOI 10.4269/ajtmh.1998.59.902; Garcia HH, 2000, INFECT DIS CLIN N AM, V14, P97, DOI 10.1016/S0891-5520(05)70220-8; GarciaNoval J, 1996, AM J TROP MED HYG, V55, P282, DOI 10.4269/ajtmh.1996.55.282; Giorgi E, 2021, J R SOC INTERFACE, V18, DOI 10.1098/rsif.2021.0104; Gomez-Puerta LA, 2018, ACTA TROP, V183, P92, DOI 10.1016/j.actatropica.2018.04.003; Gupta DS, 2012, J ORAL MAXIL SURG, V70, P2605, DOI 10.1016/j.joms.2011.12.013; Humphries DL, 1997, T ROY SOC TROP MED H, V91, P518, DOI 10.1016/S0035-9203(97)90007-9; Ito A, 2004, VECTOR-BORNE ZOONOT, V4, P95, DOI 10.1089/1530366041210756; Ito A, 2002, J HELMINTHOL, V76, P311, DOI 10.1079/JOH2002128; Jansen F, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-04589-6; Johansen MV, 2014, TRENDS PARASITOL, V30, P372, DOI 10.1016/j.pt.2014.06.003; Kanobana K, 2011, INT J PARASITOL, V41, P1015, DOI 10.1016/j.ijpara.2011.06.004; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Moro PL, 2003, ANN TROP MED PARASIT, V97, P373, DOI 10.1179/000349803235002371; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; National Administrative Department of Statistics (DANE), 2020, INF TECN CENS NAC PO; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Nithiuthai S, 2004, VET PARASITOL, V126, P167, DOI 10.1016/j.vetpar.2004.09.018; Nkwengulila G., 2014, Health, V6, P2959, DOI 10.4236/health.2014.621334; O'Neal SE, 2021, EMERG INFECT DIS, V27, P2389, DOI 10.3201/eid2709.203349; Organizacion Panamericana de la Salud/Organizacion Mundial de la Salud Oficina Regional para las Americas, 2015, 1 REUN REG CONTR TAE; Praet N, 2010, INT J PARASITOL, V40, P85, DOI 10.1016/j.ijpara.2009.07.007; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Rodriguez-Morales AJ, 2018, TRAVEL MED INFECT DI, V22, P51, DOI 10.1016/j.tmaid.2017.12.006; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sanchez AL, 1998, ACTA TROP, V69, P141, DOI 10.1016/S0001-706X(97)00132-0; Scandrett WB, 2004, CAN VET J, V45, P758; Skrip LA, 2021, PLOS NEGLECT TROP D, V15, P9234, DOI 10.1371/journal.pntd.0009234; Socioeconomic Data and Applications Center (SEDAC), MAPS POP DENS GRID V; Trevisan C, 2016, VET PARASITOL, V220, P67, DOI 10.1016/j.vetpar.2016.02.025; U.S. Centers for Disease Control and Prevention, PAR CYST BIOL; Vargas-Calla A, 2018, AM J TROP MED HYG, V99, P1198, DOI 10.4269/ajtmh.18-0355; Wandra T, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0755-z; Wardrop NA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004223; World Health Organisation, 2016, 2016 STAK M GEN 17 1; World Health Organization, END NEGL ATT SUST DE, P2021	57	1	1	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 27	2021	14	1							590	10.1186/s13071-021-05092-8	http://dx.doi.org/10.1186/s13071-021-05092-8			15	Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Parasitology; Tropical Medicine	XD9DT	34838117	gold, Green Published			2022-09-04	WOS:000723001200005
J	Trojsi, F; Christidi, F; Migliaccio, R; Santamaria-Garcia, H; Santangelo, G				Trojsi, Francesca; Christidi, Foteini; Migliaccio, Raffaella; Santamaria-Garcia, Hernando; Santangelo, Gabriella			Behavioural and Cognitive Changes in Neurodegenerative Diseases and Brain Injury	BEHAVIOURAL NEUROLOGY			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; SPECTRUM; OVERLAP		[Trojsi, Francesca] Univ Campania Luigi Vanvitelli, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy; [Christidi, Foteini] Univ Athens, Med Sch, Aeginition Hosp, Dept Neurol 1, Athens, Greece; [Migliaccio, Raffaella] Sorbonne Univ, CNRS UMR 7225, INSERM U1127, F-75013 Paris, France; [Migliaccio, Raffaella] Univ Pierre & Marie Curie Paris 6, UMRS 1127, Inst Cerveau & Moelle Epiniere ICM, F-75013 Paris, France; [Santamaria-Garcia, Hernando] Pontificia Univ Javeriana Bogota, Hosp Univ San Ignacio, Ctr Memoria & Cogn Intellectus, Bogota, Colombia; [Santangelo, Gabriella] Univ Campania Luigi Vanvitelli, Dept Psychol, Caserta, Italy		Trojsi, F (corresponding author), Univ Campania Luigi Vanvitelli, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy.	francesca.trojsi@unicampania.it	Trojsi, Francesca/AHD-9665-2022	Trojsi, Francesca/0000-0002-3790-8018; Migliaccio, Raffaella/0000-0002-6960-8474; Santamaria Garcia, Hernando/0000-0001-9422-3579				Ahmed RM, 2016, J NEUROL NEUROSUR PS, V87, P1234, DOI 10.1136/jnnp-2014-308350; Deutschlander AB, 2018, EUR J NEUROL, V25, P41, DOI 10.1111/ene.13412; Douven E, 2018, J NEUROL NEUROSUR PS, V89, P859, DOI 10.1136/jnnp-2017-317548; Giannini LAA, 2017, NEUROLOGY, V88, P2276, DOI 10.1212/WNL.0000000000004034; Hallikainen I, 2018, J ALZHEIMERS DIS, V61, P1367, DOI 10.3233/JAD-170697; Heyburn L, 2017, MOL CELL NEUROSCI, V83, P46, DOI 10.1016/j.mcn.2017.07.001; Hodges JR, 2018, J ALZHEIMERS DIS, V62, P1467, DOI 10.3233/JAD-171087; Kobylecki C, 2015, J NEUROL, V262, P916, DOI 10.1007/s00415-015-7657-z; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Peng C, 2018, NEUROBIOL DIS, V109, P209, DOI 10.1016/j.nbd.2017.07.018; Strong MJ, 2017, AMYOTROPH LAT SCL FR, V18, P153, DOI 10.1080/21678421.2016.1267768; Warren JD, 2012, NAT REV NEUROL, V8, P451, DOI 10.1038/nrneurol.2012.135	13	9	9	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2018	2018								4935915	10.1155/2018/4935915	http://dx.doi.org/10.1155/2018/4935915			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GP5TQ	30147810	Green Published, Green Submitted, gold			2022-09-04	WOS:000440937200001
J	Lanussa, OH; Avila-Rodriguez, M; Garcia-Segura, LM; Gonzalez, J; Echeverria, V; Aliev, G; Barreto, GE				Hidalgo Lanussa, Oscar; Avila-Rodriguez, Marco; Miguel Garcia-Segura, Luis; Gonzalez, Janneth; Echeverria, Valentina; Aliev, Gjumrakch; Emilio Barreto, George			Microglial Dependent Protective Effects of Neuroactive Steroids	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Neurosteroids; microglia; neuroinflammation; brain damage; neuroprotection; neurodegeneration	TRAUMATIC BRAIN-INJURY; ESTROGEN-RECEPTOR MODULATORS; ACUTE REGULATORY PROTEIN; CENTRAL-NERVOUS-SYSTEM; NEUROPROTECTIVE ACTIONS; NEURODEGENERATIVE DISEASES; MEDIATED NEUROPROTECTION; INFLAMMATORY RESPONSE; CLINICAL-IMPLICATIONS; PARKINSONS-DISEASE	Microglial cells are extremely important for homeostasis of the CNS. Upon brain damage, microglia become reactive in response to inflammatory stimuli and lead to the secretion of inflammatory cytokines. Because microglia have the ability of adjusting their steady state to an active phenotype that modulates the CNS environment, chronic activation of microglia has an important role in mediating neuroinflammatory brain diseases. Depending upon the nature and degree of the injury stimulus, microglial activity may alternate, either to acute and mild responses - sometimes beneficial- or chronic and severe that may result in neurodegeneration. In this context, proper and controlled activation of microglia should be considered as a potential neuroprotective strategy against neurodegeneration. More recently, the use of estrogenic compounds to regulate microgliosis has shown promising results, and is currently being investigated due to their potential pharmacologic ability in the regulation of inflammation. In this review, we highlight the role of microglia-mediated damage and discuss the effect of neurosteroids in reducing the adverse impact of inflammation in the brain.	[Hidalgo Lanussa, Oscar; Avila-Rodriguez, Marco; Gonzalez, Janneth; Emilio Barreto, George] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Concepcion, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Severniy Proezd 1, Chernogolovka 142432, Russia; [Emilio Barreto, George] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.	aliev03@gmail.com; gsampaio@javeriana.edu.co	Barreto, George E./AAD-7420-2020; Garcia-Segura, Luis M/U-3711-2017; Aliev, Gjumrakch/AAE-7734-2020; Valentina Echeverria Moran, BCh/E-7765-2013; GONZALEZ, JANNETH/AAB-9948-2020; Barreto, George E./B-5747-2014; Aliev, Gjumrakch/K-7302-2017	Barreto, George E./0000-0002-6644-1971; Garcia-Segura, Luis M/0000-0002-2450-2916; Aliev, Gjumrakch/0000-0001-7373-3182; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; GONZALEZ, JANNETH/0000-0003-4482-256X; Barreto, George E./0000-0002-6644-1971; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X; Avila-Rodriguez, Marco/0000-0003-4612-3236	Colciencias [4509, 5024, 5608, 511, 226 de 2014]; GALLY International Biomedical Research Inc., San Antonio, TX, USA	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); GALLY International Biomedical Research Inc., San Antonio, TX, USA	This work was supported in part by grants PUJ IDs 4509, 5024 and 5608 to GEB, and PhD fellowship (Colciencias, convocatoria 511) to MA and Young Investigator fellowship (Colciencias, cooperacion No. 226 de 2014) to OHL. G. Aliev work supported by the GALLY International Biomedical Research Inc., San Antonio, TX, USA. Part of the experimental work described in this paper was performed using the equipment of Center for collective use of IPAC RAS (Agreement. 14.621.21.0008, ID RFMEFI62114 X0008).	Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Akwa Yvette, 1999, Journal de la Societe de Biologie, V193, P293; Almado CEL, 2012, J NEUROSCI, V32, P16736, DOI 10.1523/JNEUROSCI.2654-12.2012; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Amantea D, 2014, CURR MED CHEM, V21, P2098, DOI 10.2174/0929867321666131227162634; Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Avila MF, 2013, CELL BIOL INT, V37, P521, DOI 10.1002/cbin.10058; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Azcoitia I, 2005, J NEURAL TRANSM, V112, P171, DOI 10.1007/s00702-004-0179-y; Azcoitia I, 2001, Prog Brain Res, V132, P469; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; Azcoitia I, 2011, TRENDS ENDOCRIN MET, V22, P467, DOI 10.1016/j.tem.2011.08.002; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Barreto GE, 2011, HUM EXP TOXICOL, V30, P1737, DOI 10.1177/0960327111398676; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bechade C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00032; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Casbas-Hernandez P, 2015, CANCER EPIDEM BIOMAR, V24, P406, DOI 10.1158/1055-9965.EPI-14-0934; Ceylan U, 2012, NEUROENDOCRINOL LETT, V33, P505; Chen SH, 2015, GLIA, V63, P118, DOI 10.1002/glia.22738; Cox DJ, 2015, GLIA, V63, P812, DOI 10.1002/glia.22786; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dimayuga FO, 2005, J NEUROIMMUNOL, V161, P123, DOI 10.1016/j.jneuroim.2004.12.016; DonCarlos LL, 2003, ENDOCRINOLOGY, V144, P3632, DOI 10.1210/en.2002-0105; Drew PD, 2003, ANN NY ACAD SCI, V1007, P329, DOI 10.1196/annals.1286.031; Duncan KA, 2014, ESTROGEN EFFECTS TRA, P73; Espinet C, 2015, CURR DRUG TARGETS, V16, P20, DOI 10.2174/1389450116666150107153233; Espinosa-Raya J, 2012, HORM BEHAV, V61, P76, DOI 10.1016/j.yhbeh.2011.10.005; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; Avila MF, 2014, J THEOR BIOL, V345, P43, DOI 10.1016/j.jtbi.2013.12.010; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; Gonzalez H, 2014, J NEUROIMMUNOL, V274, P1, DOI 10.1016/j.jneuroim.2014.07.012; Goujon E, 1997, PSYCHONEUROENDOCRINO, V22, pS75, DOI 10.1016/S0306-4530(97)00009-7; Habib P, 2014, J MOL NEUROSCI, V52, P277, DOI 10.1007/s12031-013-0137-y; Hammond J, 2001, J NEUROCHEM, V77, P1319, DOI 10.1046/j.1471-4159.2001.00345.x; Heese K, 1997, NEUROSCI LETT, V231, P83, DOI 10.1016/S0304-3940(97)00545-4; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; Jalloh I, 2014, METAB BRAIN DIS, P1; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; King SR, 2002, J NEUROSCI, V22, P10613; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar G Phani, 2012, Pharmacogn Rev, V6, P81, DOI 10.4103/0973-7847.99898; Lambrinoudaki I, 2014, MATURITAS, V77, P311, DOI 10.1016/j.maturitas.2014.01.001; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luconi M, 2002, J STEROID BIOCHEM, V80, P369, DOI 10.1016/S0960-0760(02)00041-9; Mahesh VB, 2006, MOL CELL ENDOCRINOL, V246, P1, DOI 10.1016/j.mce.2005.11.017; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Manthey D, 2006, NEUROSCIENCE, V138, P845, DOI 10.1016/j.neuroscience.2005.10.058; McCluskey LP, 2000, J NEUROPATH EXP NEUR, V59, P177, DOI 10.1093/jnen/59.3.177; McDowell ML, 2011, NEUROCHEM INT, V59, P175, DOI 10.1016/j.neuint.2011.04.011; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Menghini L, 2014, J BIOL REG HOMEOS AG, V28, P775; Morali G, 2011, RESTOR NEUROL NEUROS, V29, P1, DOI 10.3233/RNN-2011-0571; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Ng TF, 2009, INVEST OPHTH VIS SCI, V50, P5472, DOI 10.1167/iovs.08-2877; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Park J, 2015, NEUROSCI LETT, V584, P191, DOI 10.1016/j.neulet.2014.10.016; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Petrone AB, 2014, AGING DIS, V5, P340, DOI 10.14336/AD.2014.0500340; Pinto-Almazan R, 2014, REV NEUROLOGIA, V58, P441, DOI 10.33588/rn.5810.2013357; Pinto-Almazan R, 2012, J NEUROSCI RES, V90, P878, DOI 10.1002/jnr.22808; Raffo D, 2015, ONCOL REP, V33, P439, DOI 10.3892/or.2014.3558; de Medeiros ARS, 2012, REGUL PEPTIDES, V179, P55, DOI 10.1016/j.regpep.2012.08.015; Schumacher M, 2003, PROG NEUROBIOL, V71, P3, DOI 10.1016/j.pneurobio.2003.09.004; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shen MQ, 2014, HORM MOL BIOL CLIN I, V17, P99, DOI 10.1515/hmbci-2014-0007; Shinozaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04329; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Simpkins JW, 2012, NEUROENDOCRINOLOGY, V96, P119, DOI 10.1159/000338409; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Smith JA, 2011, NEUROCHEM RES, V36, P1587, DOI 10.1007/s11064-010-0336-7; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Streit WJ, 2002, MICROGLIA REGENERATI, P188; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sugino N, 2002, MOL HUM REPROD, V8, P68, DOI 10.1093/molehr/8.1.68; Suuronen T, 2005, INFLAMM RES, V54, P194, DOI 10.1007/s00011-005-1343-z; Suzuki S, 2006, ENDOCRINE, V29, P209, DOI 10.1385/ENDO:29:2:209; Takeuchi K, 2015, BRAIN RES, V1621, P222, DOI 10.1016/j.brainres.2014.11.016; Tang H, 2014, MOL CELL ENDOCRINOL, V389, P92, DOI 10.1016/j.mce.2014.05.005; Tapia-Gonzalez S, 2008, J ENDOCRINOL, V198, P219, DOI 10.1677/JOE-07-0294; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; van Noort JM, 2009, PROG BRAIN RES, V175, P139, DOI 10.1016/S0079-6123(09)17509-X; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Wang XJ, 2007, J NEUROIMMUNE PHARM, V2, P259, DOI 10.1007/s11481-007-9075-1; Weiss EP, 2011, AGING-US, V3, P533, DOI 10.18632/aging.100327; West LA, 2001, ENDOCRINOLOGY, V142, P502, DOI 10.1210/en.142.1.502; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Zhang S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-154; Zhuang Z, 2013, J NEUROSCI RES, V91, P1599, DOI [10.1002/jnr.23281, 10.1002/jnr.23186]	116	10	10	0	7	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2016	15	2					242	249		10.2174/1871527315666160202122032	http://dx.doi.org/10.2174/1871527315666160202122032			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DG5HI	26831265				2022-09-04	WOS:000372107500005
J	Rosenbaum, SE; Glenton, C; Wiysonge, CS; Abalos, E; Mignini, L; Young, T; Althabe, F; Ciapponi, A; Marti, SG; Meng, QY; Wang, JA; Bradford, AMD; Kiwanuka, SN; Rutebemberwa, E; Pariyo, GW; Flottorp, S; Oxman, AD				Rosenbaum, Sarah E.; Glenton, Claire; Wiysonge, Charles Shey; Abalos, Edgardo; Mignini, Luciano; Young, Taryn; Althabe, Fernando; Ciapponi, Agustin; Garcia Marti, Sebastian; Meng, Qingyue; Wang, Jian; De la Hoz Bradford, Ana Maria; Kiwanuka, Suzanne N.; Rutebemberwa, Elizeus; Pariyo, George W.; Flottorp, Signe; Oxman, Andrew D.			Evidence summaries tailored to health policy-makers in low- and middle-income countries	BULLETIN OF THE WORLD HEALTH ORGANIZATION			English	Article							SYSTEMATIC REVIEWS; INFORMATION; NUMERACY	Objective To describe how the SUPPORT collaboration developed a short summary format for presenting the results of systematic reviews to policy-makers in low- and middle-income countries (LMICs). Methods We carried out 21 user tests in six countries to explore users' experiences with the summary format. We modified the summaries based on the results and checked our conclusions through 13 follow-up interviews. To solve the problems uncovered by the user testing, we also obtained advisory group feedback and conducted working group workshops. Findings Policy-makers liked a graded entry format (i.e. short summary with key messages up front). They particularly valued the section on the relevance of the summaries for LMICs, which compensated for the lack of locally-relevant detail in the original review. Some struggled to understand the text and numbers. Three issues made redesigning the summaries particularly challenging: (i) participants had a poor understanding of what a systematic review was; (ii) they expected information not found in the systematic reviews and (iii) they wanted shorter, clearer summaries. Solutions included adding information to help understand the nature of a systematic review, adding more references and making the content clearer and the document quicker to scan. Conclusion Presenting evidence from systematic reviews to policy-makers in LMICs in the form of short summaries can render the information easier to assimilate and more useful, but summaries must be clear and easy to read or scan quickly. They should also explain the nature of the information provided by systematic reviews and its relevance for policy decisions.	[Rosenbaum, Sarah E.; Flottorp, Signe; Oxman, Andrew D.] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway; [Glenton, Claire] SINTEF, N-7034 Trondheim, Norway; [Wiysonge, Charles Shey] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Abalos, Edgardo; Mignini, Luciano] Ctr Rosarino Estudios Perinatales, Santa Fe, Argentina; [Young, Taryn] S African Cochrane Ctr, Cape Town, South Africa; [Althabe, Fernando; Ciapponi, Agustin; Garcia Marti, Sebastian] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Meng, Qingyue; Wang, Jian] Shandong Univ, Ctr Hlth Management & Policy, Jinan 250100, Peoples R China; [De la Hoz Bradford, Ana Maria] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Kiwanuka, Suzanne N.; Rutebemberwa, Elizeus; Pariyo, George W.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda		Rosenbaum, SE (corresponding author), Norwegian Knowledge Ctr Hlth Serv, Boks 7004, N-0130 Oslo, Norway.	sarah@rosenbaum.no	Wang, Jian/AAI-6424-2021; Wiysonge, Charles/AAF-2845-2019; Pariyo, George W/K-2335-2017; Oxman, Andrew/Y-3004-2019	Wang, Jian/0000-0001-8769-7928; Wiysonge, Charles/0000-0002-1273-4779; Pariyo, George W/0000-0002-4411-2309; Oxman, Andrew/0000-0002-5608-5061; Glenton, Claire/0000-0002-7558-7737; Ciapponi, Agustin/0000-0001-5142-6122; Rutebemberwa, Elizeus/0000-0001-8363-7928; Flottorp, Signe/0000-0003-2961-7461; Young, Taryn/0000-0003-2406-081X	European Commission [FP6-2004-INCO-DEV-3]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The SUPPORT collaboration was funded by the European Commission's 6th Framework Programme Priority FP6-2004-INCO-DEV-3. SUPPORT summaries are freely available, at http://www.support-collaboration.org	Ancker JS, 2007, J AM MED INFORM ASSN, V14, P713, DOI 10.1197/jamia.M2464; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Beney J., 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000336; BRIGGS CJ, 2006, COCHRANE DB SYST REV, V19; *CAN AG DRUGS TECH, RX CHANG; *CAN HLTH SERV RES, EVIDENCEBOOST; *CAN HLTH SERV RES, 2001, READ FRIENDL WRIT 1; *COCHR COLL, EV AID SUMM; *COCHR IMS, GRADEPRO GRADEPROFIL; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dobbins M, 2004, INT J TECHNOL ASSESS, V20, P399, DOI 10.1017/S0266462304001278; Dobbins M, 2001, INT J TECHNOL ASSESS, V17, P203, DOI 10.1017/S0266462300105069; Dobbins M, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-20; Dobbins M, 2007, WORLDV EVID-BASED NU, V4, P156, DOI 10.1111/j.1741-6787.2007.00089.x; Edejer TTT, 2000, BRIT MED J, V321, P797, DOI 10.1136/bmj.321.7264.797; Elliott H, 2000, J EPIDEMIOL COMMUN H, V54, P461, DOI 10.1136/jech.54.6.461; Glenton C, 2010, MED DECIS MAKING, V30, P566, DOI 10.1177/0272989X10375853; Gosden T, 2001, J Health Serv Res Policy, V6, P44, DOI 10.1258/1355819011927198; Greenhalgh T, 1997, BRIT MED J, V315, P672, DOI 10.1136/bmj.315.7109.672; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Isaakidis P, 2002, BRIT MED J, V324, P702, DOI 10.1136/bmj.324.7339.702; Jewell CJ, 2008, MILBANK Q, V86, P177, DOI 10.1111/j.1468-0009.2008.00519.x; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549; Lavis JN, 2010, INT J TECHNOL ASSESS, V26, P405, DOI 10.1017/S026646231000108X; Lavis JN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000141; LEVIS JN, 2006, HEALTHCARE POLICY, V1, P21; Lewin S A, 2005, Cochrane Database Syst Rev, pCD004015; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Lomas J, 1997, IMPROVING RES DISSEM; Lomas Jonathan, 2005, Healthc Policy, V1, P55; Morkes J., 1997, CONCISE SCANNABLE OB; Morville P., 2004, USER EXPERIENCE DESI; Nutley S., 2007, USING EVIDENCE RES C; Nutley S., 2000, WHAT WORKS EVIDENCE; Petticrew M, 2004, J EPIDEMIOL COMMUN H, V58, P811, DOI 10.1136/jech.2003.015289; *POL LIALS IN, LINK HLTH POL LAT EV; REINAR LM, 2005, WORKING PARTNERSHIP; Robeson P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-95; Rosenbaum SE, 2010, J CLIN EPIDEMIOL, V63, P620, DOI 10.1016/j.jclinepi.2009.12.014; SHELDON TA, 2005, J HLTH SERV RES P S1, V10, P1, DOI DOI 10.1258/1355819054308521; Smith R, 2003, BRIT MED J, V326, P238, DOI 10.1136/bmj.326.7383.238; *SUPPORT COLL, SUPPORT SUMM PREP; *SUPPORT COLL, SUPP POL REL REV TRI; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; TURNER T, DISASTER ME IN PRESS; UN, 2008, MILL DEV GOALS REP 2; Waters H, 2003, HEALTH POLICY PLANN, V18, P127, DOI 10.1093/heapol/czg017; WEISS CH, 1979, PUBLIC ADMIN REV, V39, P426, DOI 10.2307/3109916	50	71	71	1	15	WORLD HEALTH ORGANIZATION	GENEVA 27	MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND	0042-9686	1564-0604		B WORLD HEALTH ORGAN	Bull. World Health Organ.	JAN	2011	89	1					54	61		10.2471/BLT.10.075481	http://dx.doi.org/10.2471/BLT.10.075481			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	712WO	21346891	Green Published, Bronze			2022-09-04	WOS:000286697200011
J	Pinzon, AM; Hoyos, MH; Richard, JC; Florez-Valencia, L; Orkisz, M				Morales Pinzon, Alfredo; ernandez Hoyos, Marcela; Richard, Jean-Christophe; Florez-Valencia, Leonardo; Orkisz, Maciej			A tree-matching algorithm: Application to airways in CT images of subjects with the acute respiratory distress syndrome	MEDICAL IMAGE ANALYSIS			English	Article						Tree matching; Airway tree; Acute respiratory distress syndrome; Computed tomography	REGISTRATION	To match anatomical trees such as airways, we propose a graph-based strategy combined with an appropriate distance function. The strategy was devised to cope with topological and geometrical differences that may arise between trees corresponding to the same subject, but extracted from images acquired in different conditions. The proposed distance function, called father/family distance, combines topological and geometrical information in a single measure, by calculating a sum of path-to-path distances between sub-trees of limited extent. To use it successfully, the branches of these sub-trees need to be brought closer, which is obtained by successively translating the roots of these sub-trees prior to their actual matching. The work herein presented contributes to a study of the acute respiratory distress syndrome, where a series of pulmonary CT images from the same subject is acquired at varying settings (pressure and volume) of the mechanical ventilation. The method was evaluated on 45 combinations of synthetic trees, as well as on 15 pairs of real airway trees: nine corresponding to end-expiration and end inspiration with the same pressure, and six corresponding to end-inspiration with significantly different pressures. It achieved a high rate of successful matches with respect to a hand-made reference containing a total of 2391 matches in real data: sensitivity of 94,3% and precision of 92.8%, when using the basic parameter settings of the algorithm. (C) 2016 Elsevier B.V. All rights reserved.	[Morales Pinzon, Alfredo; ernandez Hoyos, Marcela] Univ Los Andes, Sch Engn, Syst & Comp Engn Dept, Bogota, Colombia; [Morales Pinzon, Alfredo; Richard, Jean-Christophe; Orkisz, Maciej] Univ Lyon 1, CREATIS, INSA Lyon, CNRS UMR5220,Inserm U1206, F-69621 Lyon, France; [Richard, Jean-Christophe] Hosp Civils Lyon, Hop Croix Rousse, Serv Reanimat Med, Lyon, France; [Florez-Valencia, Leonardo] Pontificia Univ Javeriana, Dept Ingn Sistemas, Bogota, Colombia		Orkisz, M (corresponding author), INSA Lyon, Campus LyonTech Doua,Batiment Blaise Pascal 7, F-69621 Villeurbanne, France.	alf-mora@uniandes.edu.co; marc-her@uniandes.edu.co; j-christophe.richard@chu-lyon.fr; florez-l@javeriana.edu.co; maciej.orkisz@creatis.insa-lyon.fr	Flórez-Valencia, Leonardo/GPP-1063-2022; Morales Pinzon, Alfredo/ABF-8316-2021; Flórez-Valencia, Leonardo/ABD-2236-2021; Orkisz, Maciej/H-3761-2013; RICHARD, Jean-Christophe/A-4097-2009	Morales Pinzon, Alfredo/0000-0001-7598-5260; Flórez-Valencia, Leonardo/0000-0002-3146-2262; Orkisz, Maciej/0000-0003-1709-5766; RICHARD, Jean-Christophe/0000-0003-1503-3035	French-Colombian ECOS-Nord Committee grant [C15M04]; French-Polish Programme Hubert Curien Polonium grant [34852WG]; Colombian doctoral grant from Colciencias [convocatoria 528/2011]; Ecole Doctorale Electronique Electrotechnique Automatique de Lyon, France [ED160]	French-Colombian ECOS-Nord Committee grant; French-Polish Programme Hubert Curien Polonium grant; Colombian doctoral grant from Colciencias; Ecole Doctorale Electronique Electrotechnique Automatique de Lyon, France	The authors thank Claude Guerin for the design of the study on the animal model and his work on data acquisition. The study was supported by the French-Colombian ECOS-Nord Committee grant C15M04 and by the French-Polish Programme Hubert Curien Polonium grant 34852WG. It also was partly founded by General Electrics who provided the ventilator, disposables, and technical assistance. A. Morales Pinzon was supported by a Colombian doctoral grant from Colciencias (convocatoria 528/2011) and by the Ecole Doctorale Electronique Electrotechnique Automatique de Lyon ED160, France.	Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Bulow T., 2006, P SPIE MED IM PHYSL, DOI [10.1117/12.650024, DOI 10.1117/12.650024.]; CARRAGHAN R, 1990, OPER RES LETT, V9, P375, DOI 10.1016/0167-6377(90)90057-C; Fan E, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-85; Feragen A, 2015, IEEE T MED IMAGING, V34, P1212, DOI 10.1109/TMI.2014.2380991; Geveci B., 2005, VISUALIZATION HDB, P717, DOI 10.1016/B978-012387582-2/50038-1; Graham MW, 2006, PROC SPIE, V6144, DOI 10.1117/12.651719; Graham MW, 2006, I S BIOMED IMAGING, P109; Homann H., 2007, INSIGHT J; Kaftan JN, 2006, PROC SPIE, V6143, DOI 10.1117/12.652440; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Malbouisson LM, 2001, AM J RESP CRIT CARE, V163, P1444, DOI 10.1164/ajrccm.163.6.2005001; Martynowicz MA, 1999, AM J RESP CRIT CARE, V160, P250, DOI 10.1164/ajrccm.160.1.9808101; Metzen JH, 2007, LECT NOTES COMPUT SC, V4538, P13; Metzen JH, 2009, IMAGE VISION COMPUT, V27, P923, DOI 10.1016/j.imavis.2008.04.002; Morales Pinzon A., 2016, LUNG SEGMENTATION AI; Mori K., 1996, P 13 INT C PATT REC, VVolume 3, P528; Pelillo M, 1999, IEEE T PATTERN ANAL, V21, P1105, DOI 10.1109/34.809105; Petersen J, 2013, LECT NOTES COMPUT SC, V8150, P287, DOI 10.1007/978-3-642-40763-5_36; Pierrakos Charalampos, 2012, J Clin Med Res, V4, P7, DOI 10.4021/jocmr761w; Pisupati C, 1996, PROCEEDINGS OF THE IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, P160, DOI 10.1109/MMBIA.1996.534068; Pisupati C., 1996, P 12 ANN S COMP GEOM, P419, DOI DOI 10.1145/237218.237421.; Polzin T., 2013, P 5 INT WORKSH PULM, P85; Pu JT, 2012, MED PHYS, V39, P2603, DOI 10.1118/1.4703901; Richard JC, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/2197-425X-2-10; Smeets D., 2010, WORKSH PULM IM AN, P61; Tang WH, 2006, LECT NOTES COMPUT SC, V4091, P116; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1540, DOI 10.1109/TMI.2005.857653; Vieira SRR, 1998, AM J RESP CRIT CARE, V158, P1571, DOI 10.1164/ajrccm.158.5.9802101; Xue H, 2006, I S BIOMED IMAGING, P125; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134	35	5	5	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1361-8415	1361-8423		MED IMAGE ANAL	Med. Image Anal.	JAN	2017	35						101	115		10.1016/j.media.2016.06.020	http://dx.doi.org/10.1016/j.media.2016.06.020			15	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Radiology, Nuclear Medicine & Medical Imaging	EC6LT	27352141				2022-09-04	WOS:000388248300008
J	Guayasamin, JM; Castroviejo-Fisher, S; Trueb, L; Ayarzaguena, J; Rada, M; Vila, C				Guayasamin, Juan M.; Castroviejo-Fisher, Santiago; Trueb, Linda; Ayarzaguena, Jose; Rada, Marco; Vila, Carles			Phylogenetic systematics of Glassfrogs (Amphibia: Centrolenidae) and their sister taxon Allophryne ruthveni	ZOOTAXA			English	Review						Allophrynidae; Amazon; Andes; Anura; Centrolenid frogs; Classification; Cordillera de la Costa; Central America; Diversity; Guiana Shield; Hyloidea; Neobatrachia; Neotropics; Phylogeny; South America; Systematics	FROG CENTROLENIDAE; HYALINOBATRACHIUM ANURA; NORTHWESTERN ECUADOR; MITOCHONDRIAL-DNA; COCHRANELLA; LOWLANDS; COLOMBIA; FAMILY; GENUS; CHARACTERS	Based on a molecular phylogeny, a new phylogenetic taxonomy that is compatible with both the International Code of Zoological Nomenclature (ICZN) and the PhyloCode is proposed for Glassfrogs and their sister taxon, Allophryne ruthveni. The arrangement presented herein emphasizes the recognition of clades having (i) significant statistical support and congruence among phylogenetic estimation methods (i.e., parsimony, maximum likelihood, and Bayesian inference criteria), (ii) congruence among genetic markers, and (iii) morphological and/or behavioral distinctiveness. Also, when previously recognized groups are recovered as monophyletic or nearly monophyletic, we propose taxa that minimize the number of name changes required to make these groups monophyletic, preserving the names and contents of previous classifications (i.e., nomenclatural stability). The evolutionary proximity of Centrolenidae and Allophrynidae is recognized by combining these families into an unraked taxon, Allocentroleniae-a proposal that maintains the traditional names and species contents of Centrolenidae and Allophrynidae. We arrange centrolenid diversity in two subfamilies: Centroleninae and Hyalinobatrachinae. Within Centroleninae, the diagnosis and species content of the genera Centrolene, Cochranella, and Nymphargus are modified; Teratohyla is resurrected and modified, and Chimerella, Espadarana, Rulyrana, Sachatamia, and Vitreorana are proposed as new genera. The other subfamily, Hyalinobatrachinae, contains the new genus Celsiella and a modified Hyalinobatrachium that fully corresponds to the former fleischmanni Group. Additionally, the genus Ikakogi is described. Ikakogi could not be assigned with confidence to either subfamily and it is placed as incertae sedis in Centrolenidae. The data at hand suggest that Ikakogi tayrona is a lineage as old as the subfamilies Hyalinobatrachinae and Centroleninae. The revised taxonomy differs markedly from previous arrangements, which were based on phenetics and few morphological characters. Most of the genera defined herein are confined to distinct biogeographic regions, highlighting the importance of geography in the speciation of Glassfrogs. The principal limitation of this proposal is that it is based on an incomplete sampling of taxa (54% of the recognized Glassfrogs). Although diagnoses are based on phenotypic traits, there are several cases (16% of all species) in which the allocation of species is ambiguous because of morphological homoplasy and the lack of molecular data. Finally, in an attempt to facilitate species identification, comparison, and generic placement, we provide photographs for most (similar to 96%) of the recognized centrolenid species.	[Guayasamin, Juan M.] Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Museo Zool, Quito, Ecuador; [Guayasamin, Juan M.; Trueb, Linda] Univ Kansas, Dept Ecol & Evolutionary Biol, Nat Hist Museum & Biodivers Res Ctr, Lawrence, KS 66045 USA; [Castroviejo-Fisher, Santiago; Vila, Carles] Uppsala Univ, Dept Evolut Genom & Systemat, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; [Ayarzaguena, Jose] Asociac Amigos Donana, Seville 41012, Spain; [Ayarzaguena, Jose] Fdn La Salle Ciencias Nat, Museo Hist Nat, Caracas 1010A, Venezuela; [Rada, Marco] Pontificia Univ Javeriana, Lab Herpetol, Bogota, Colombia; [Rada, Marco] Conservac Int Colombia, Anfibios & Reptiles, Bogota, Colombia; [Vila, Carles] CSIC, Estac Biol Donana, Seville 41013, Spain		Guayasamin, JM (corresponding author), Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Museo Zool, Apartado 17-01-2184, Quito, Ecuador.	jmguayasamin@gmail.com	Castroviejo-Fisher, Santiago/G-9007-2013; Vila, Carles/H-4893-2013; Rada, Marco/F-9306-2015	Castroviejo-Fisher, Santiago/0000-0002-1048-2168; Vila, Carles/0000-0002-4206-5246; Guayasamin, Juan/0000-0003-0098-978X	National Science Foundation [DEB-0608011: LT, JMG, EF-0334928: LT]; Secretaria Nacional de Ciencia y Tecnololg a del Ecuador [SENACYT PIC-08470]; JRS Biodiversity Foundation; American Philosophical Society; Lewis and Clark Fund for Exploration and Field Research; Panorama Society Grant; Harris Scholarship Award of the University of Kansas Natural History Museum; Stiftelsen Sven och Lilly Lawskis; Helge Axelsson Johnsons Stiftelse Foundation; Synthesis Project [ES-TAF-2827, NL-TAF-4090]; Sederholms' stipend; Royal Swedish Academy of Science; Lars Hiertas Minne Foundation; Swedish Research Council; Programa de Captacion del Conocimiento para Andalucia; Becas	National Science Foundation(National Science Foundation (NSF)); Secretaria Nacional de Ciencia y Tecnololg a del Ecuador; JRS Biodiversity Foundation; American Philosophical Society; Lewis and Clark Fund for Exploration and Field Research; Panorama Society Grant; Harris Scholarship Award of the University of Kansas Natural History Museum; Stiftelsen Sven och Lilly Lawskis; Helge Axelsson Johnsons Stiftelse Foundation; Synthesis Project; Sederholms' stipend; Royal Swedish Academy of Science; Lars Hiertas Minne Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Programa de Captacion del Conocimiento para Andalucia; Becas	This article was greatly improved by discussions and comments from many colleagues, including Elisa Bonaccorso, Rafe Brown, Kevin de Queiroz, Miguel Vences, William E. Duellman, Taran Grant, Charles Linkem, Andrew T. Peterson, Omar Torres-Carvajal, Jeet Sukumaran, Ignacio De la Riva, Jose Manuel Padial, and Edward O. Wiley. We are grateful to the many individuals ( and institutions) who provided the specimens, permits, and tissues necessary for this study: Luis A. Coloma, Martin R. Bustamante, Italo Tapia, Nestor Acosta, Diego Almeida-Reinoso (QCAZ), Josefa Senaris, Gilson Rivas, Carlos Lasso ( MHNLS), William E. Duellman, John E. Simmons ( KU), John D. Lynch ( ICN), Roy W. McDiarmid, James A. Poindexter, Ron Heyer, Addison Wynn ( USNM), Julian Faivovich, Taran Grant, Linda S. Ford ( AMNH), Maureen A. Donnelly ( Florida International University, USA), S. Blair Hedges ( Penn State University, USA), James Hanken, Jose Rosado ( MCZ), Brice P. Noonan ( Brigham Young University, Provo), Roberto Ibanez ( Universidad de Panama, Panama), Margarita Medina, Cesar Aguilar ( MHNSM), Karl-Heinz Jungfer ( Geobotanisches Institut, Switzerland), Gerardo Chavez, Federico Bola os ( UCR), Kirsten E. Nicholson ( Washington University in St. Louis), Diego F. Cisneros-Heredia (USFQ), Edgar Lehr (MTD), Jonathan A. Campbell, Paul C. Ustach ( UTA), Alan Resetar ( FMNH), Jorge Gualdron, Pedro. A. Galvis, Alvaro Andres Velasquez Alvarez ( Conservation International-Colombia), Paul Gutierrez, Vivian Paez, Mauricio Rivera, Juan Camilo Arredondo ( MHUA), Mauricio Vejarano, Gladys Reinoso (CZUT-A), Ignacio De la Riva, Jose Manuel Padial ( MNCN), Juan Carlos Chaparro (MHNCP), Cesar Barrio-Amoros ( Fundacion And gena, Venezuela), Raffael Ernst, Ardiel Quintana ( SMNS), Gunther Koehler ( SMF), Michel Blanc, Rodrigo Aguayo ( CBG), Andrew J. Crawford ( Smithsonian Research Tropical Institute, Panama), Enrique La Marca ( ULABG), Robert den Tex ( Uppsala University, Sweden), Koos van Egmond ( RMNH), and Barry Clarke ( BM). For assistance during fieldwork, we thank Elisa Bonaccorso, Martin R. Bustamante, Cesar Barrio-Amoros, Lizi Ernst, Handel Guayasamin, Justo Gonzalez, Emira Sanchez, Antonio Bonaccorso, Juan F. Freile, Jose Ruiz, Jose Maria Castroviejo, Jorge Gualdron, Felipe Barrera, Alvaro Andres Velasquez Alvarez, Julia Gunther, Rafael Antelo, Daniel Gonzalez, Enrique Avila, Ignacio De la Riva, Jose Manuel Padial, Jaime Bosh, Juan Carlos Chaparro, Marcos Natera and Gilson Rivas. El Frio Biological Station and its director Javier Castroviejo supported SCF, JA and CV fieldwork in Venezuela. The work of SCF in Venezuela would have not been possible without the continuous help of Rafael Antelo. The work of MR in Colombia has had the continuous support of Jose Vicente Rodriguez-Mahecha and Jose Vicente Rueda-Almonacid ( Conservation International-Colombia). Special thanks to Julian Faivovich for providing sequences of Vitreorana eurygnatha. Several friends and collegues contributed photographs for this article; their names are listed in the figure captions. Research permits in Ecuador were issued by the Ministerio del Ambiente (#033IC-FAU- DNBAPVS/MA) and in Peru by INRENA-IFFS-DCB (# 008-2005). This study is included in the "Contrato Marco de Acceso a Recursos Geneticos N degrees 0001, 11 Enero 2007" subscribed between Fundacion La Salle de Ciencias Naturales and the Ministerio del Ambiente, Venezuela. John J. Wiens provided primers and PCR protocols prior to their publication. JMG thanks John D.; Lynch, and Angela Surez for their hospitality during specimen examination in Coombia. Luis F. Garcia provided workspace and supplies during JMG's molecular work in Colombia. Michael Alfaro, Hugo Alamillo, and Barbara Banbury facilitad access to the computer cluster at Washington State University for some of the final analyses. This work was supported by grants from the National Science Foundation ( Doctoral Dissertation Improvement Grant DEB-0608011: LT, JMG, EF-0334928:LT), Secretaria Nacional de Ciencia y Tecnololg a del Ecuador ( SENACYT PIC-08470), JRS Biodiversity Foundation, the American Philosophical Society through the Lewis and Clark Fund for Exploration and Field Research, Panorama Society Grant and Harris Scholarship Award of the University of Kansas Natural History Museum ( JMG), Stiftelsen Sven och Lilly Lawskis ( SCF), Helge Axelsson Johnsons Stiftelse Foundation ( SCF), Synthesis Project ( European Union) ES-TAF-2827 and NL-TAF-4090 ( SCF), Sederholms' stipend ( SCF), the Royal Swedish Academy of Science ( SCF), Lars Hiertas Minne Foundation ( SCF), the Swedish Research Council ( CV and SCF), Programa de Captacion del Conocimiento para Andalucia ( CV) and the Becas ( IEA) Jorge Hernandez-Camacho ( MR). Special thanks go to Elisa Bonaccorso for her help in this and other projects of her negrito ( JMG).	Aguayo R, 2006, HERPETOLOGICA, V62, P323, DOI 10.1655/0018-0831(2006)62[323:ANGOTC]2.0.CO;2; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; *AMPHIBIAWEB, 2009, INF AMPH BIOL CONS; [Anonymous], 1991, LOZANIA; Austin JD, 2002, ZOOL J LINN SOC-LOND, V134, P335, DOI 10.1046/j.1096-3642.2002.00011.x; Avise JC, 1999, P NATL ACAD SCI USA, V96, P7358, DOI 10.1073/pnas.96.13.7358; AYARZAGUENA J, 1996, PUBLICACIONES ASOCIA, V8, P8; AYARZAGUENA J, 1992, PUBLICACIONES ASOCIA, V1, P1; BARRAQUAND J, 1989, REV INTELLIGENCE ART, V3, P77; Barrera-Rodriguez M., 2000, REV ACAD COLOMBIAN S, V23, P245; BARRIAMOROS CL, 1942, ZOOTAXA, P3; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Boettger O., 1893, Bericht ueber die Senckenbergische Gesellschaft, P252; Boettger O, 1892, KATALOG BATRACHIER S; Bolivar-G. Wilmar, 1999, Alytes (Paris), V16, P77; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; BOULENGER GA, 1918, ANN MAGAZINE NATURAL, V9, P427; BOULENGER GA, 1895, P ZOOL SOC LOND, P640; Boulenger GA, 1882, CATALOGUE BATRACHIA; Burton TC, 2004, J MORPHOL, V260, P209, DOI 10.1002/jmor.10204; Burton Thomas C., 1998, American Museum Novitates, V3229, P1; CADLE JE, 1990, P BIOL SOC WASH, V103, P746; Caldwell Janalee P., 1998, Catalogue of American Amphibians and Reptiles, V666, P1; CANNATELLA D C, 1980, Proceedings of the Biological Society of Washington, V93, P714; CANNATELLA DC, 1982, HERPETOLOGICA, V38, P380; CANTINO PD, 2007, PHYLOCODE INT CODE P; Castroviejo-Fisher S, 2007, NATURE, V449, P972, DOI 10.1038/449972b; Castroviejo-Fisher S, 2007, ZOOTAXA, P51; Castroviejo-Fisher S, 2009, ZOOTAXA, P16, DOI 10.11646/zootaxa.1980.1.2; Castroviejo-Fisher S, 2008, HERPETOLOGICA, V64, P472, DOI 10.1655/07-049R2.1; Cisneros-Heredia Diego F., 2007, Herpetozoa, V20, P27; Cisneros-Heredia DF, 2007, ZOOTAXA, P3; Cisneros-Heredia Diego F., 2006, Check List, V2, P93; Cisneros-Heredia DF, 2007, ZOOTAXA, P33, DOI 10.11646/zootaxa.1485.1.3; Cisneros-Heredia DF, 2006, ZOOTAXA, P1; Cisneros-Heredia DF, 2006, ZOOTAXA, P21, DOI 10.11646/zootaxa.1361.1.2; Cisneros-Heredia Diego F., 2008, HERPETOZOA, V21, P49; CISNEROSHEREDIA DF, 2007, HERPETOZOA, V2, P1; COCHRAN DM, 1970, FROGS COLOMBIA, P655; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; Darwin CR., 1859, J MURRAY, DOI 10.5962/bhl.title.82303; DASILVA HR, 1998, THESIS U KANSAS LAWR; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; DELAESPADA MJ, 1872, ANALES SOC ESPANOLA, V1, P85; DEPINNA MCC, 1991, CLADISTICS, V7, P367; Dubois Alain, 2006, Alytes (Paris), V24, P1; DUELLMAN W E, 1980, Transactions of the Kansas Academy of Science, V83, P26, DOI 10.2307/3627268; Duellman W.E., 1976, Occasional Papers Mus Nat Hist Univ Kans, VNo. 52, P1; DUELLMAN W E, 1976, Herpetologica, V32, P401; Duellman W.E., 1993, U KANSAS MUSEUM NATU, V155, P1; Duellman W.E., 1994, BIOL AMPHIBIANS; DUELLMAN WE, 1979, HERPETOLOGICA, V35, P60; Duellman WE, 2003, HERPETOLOGICA, V59, P247, DOI 10.1655/0018-0831(2003)059[0247:ANSOGF]2.0.CO;2; Duellman WE, 2001, HYLID FROGS MIDDLE A; DUELLMAN WE, 1981, OCCASIONAL PAPERS MU, V88, P1; Duellman WE., 1989, OCCAS PAP NAT HIST M, V132, P1; DUNN EMMETT R., 1931, OCC PAPERS BOSTON SOC NAT HIST, V5, P385; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Fabrezi M, 1996, HERPETOLOGICA, V52, P188; FABREZI M, 1992, Alytes (Paris), V10, P1; Fabrezi Marissa, 2000, Cuadernos de Herpetologia, V14, P47; Fabrezi Marissa, 1993, Alytes (Paris), V11, P47; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; FLORES G, 1985, J HERPETOL, V19, P313, DOI 10.2307/1564260; FLORES G, 1989, HERPETOLOGICA, V45, P401; FLORES G, 1987, J HERPETOL, V21, P185, DOI 10.2307/1564481; Ford Linda S., 1993, Herpetological Monographs, V7, P94, DOI 10.2307/1466954; Frost DR, 2008, CLADISTICS, V24, P385, DOI 10.1111/j.1096-0031.2007.00181.x; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; FROST DR, 2009, AMPHIBIAN SPECIES WO; GAIGE HELEN T., 1926, UNIV MICHIGAN OCCAS PAPERS, V176, P1; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; Goin C. J., 1968, Quarterly Journal of the Florida Academy of Sciences, V30, P115; Goin C. J., 1961, Zoologischer Anzeiger, V166, P95; GOIN C. J., 1962, INTRO HERPETOLOGY, pi; GOIN CJ, 1966, GUYANAS, V8, P77; GOIN COLEMAN J., 1963, ACTA BIOL VENEZUELICA, V3, P283; GOIN COLEMAN J., 1964, HERPETOLOGICA, V20, P1; Grant T, 1998, J HERPETOL, V32, P452, DOI 10.2307/1565465; Grant T, 2006, B AM MUS NAT HIST, P6; Guayasamin JM, 2004, HERPETOLOGICA, V60, P485, DOI 10.1655/03-74; Guayasamin JM, 2008, MOL PHYLOGENET EVOL, V48, P574, DOI 10.1016/j.ympev.2008.04.012; Guayasamin JM, 2008, ZOOTAXA, P25, DOI 10.11646/zootaxa.1815.1.2; Guayasamin JM, 2007, ZOOTAXA, P27; Guayasamin Juan M., 2005, Salamandra, V41, P153; Guayasamin JM, 2006, ZOOL J LINN SOC-LOND, V147, P489, DOI 10.1111/j.1096-3642.2006.00223.x; Guayasamin JM, 2006, HERPETOLOGICA, V62, P163, DOI 10.1655/05-21.1; Haas A, 2003, CLADISTICS, V19, P23, DOI 10.1111/j.1096-0031.2003.tb00405.x; Harvey MB, 1996, HERPETOLOGICA, V52, P427; Harvey MB, 2005, P BIOL SOC WASH, V118, P428, DOI 10.2988/0006-324X(2005)118[428:BGFACW]2.0.CO;2; HAYES M P, 1980, Bulletin Southern California Academy of Sciences, V79, P89; Hedges SB, 2008, ZOOTAXA, P1; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; Hennig W., 1966, PHYLOGENETIC SYSTEMA; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hillis DM, 2005, MOL PHYLOGENET EVOL, V34, P299, DOI 10.1016/j.ympev.2004.10.007; Hooghiemstra H, 2006, ANN MO BOT GARD, V93, P297, DOI 10.3417/0026-6493(2006)93[297:TPROCI]2.0.CO;2; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; ICZN, 1999, INT COD ZOOL NOM; Kok PJR, 2008, ZOOTAXA, P25; Kubicki B., 2007, GLASS FROGS COSTA RI, P299; Langone Jose A., 1997, Cuadernos de Herpetologia, V11, P87; LESCURE J, 1975, B SOC ZOOL FR, V100, P385; LESCURE J, 2001, ATLAS AMPHIBIENS GUY, V45; Linnaeus C., 1758, SYSTEMA NATURAE SIVE, P1; Lutz A, 1925, CR SOC BIOL, V93, P137; Lutz B., 1952, Memorias do Instituto Oswaldo Cruz, V50, P625; LUTZ B, 1947, COPEIA, P242; Lynch J.D., 1973, Occasional Papers Mus Nat Hist Univ Kans, VNo. 16, P1; Lynch J.D., 1973, EVOLUTIONARY BIOL AN, P133; Lynch JD, 1996, HERPETOLOGICA, V52, P525; LYNCH JD, 1990, P BIOL SOC WASH, V103, P35; LYNCH JD, 1981, J HERPETOL, V15, P283, DOI 10.2307/1563431; LYNCH JD, 1983, STUD NEOTROP FAUNA E, V18, P239, DOI 10.1080/01650528309360638; Lynch John D., 1993, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V18, P567; LYNCH JOHND., 1966, UNTV KANS PUBLICATIONS MUS NATUR HIST, V17, P493; Manzano AS, 2007, ANAT REC, V290, P1551, DOI 10.1002/ar.20608; Mayr E., 2004, WHAT MAKES BIOL UNIQ; McCranie J.R., 2002, AMPHIBIANS HONDURAS; McDiarmid R.W., 1978, P127; MCDIARMID RW, 1984, J HERPETOL, V18, P213, DOI 10.2307/1563758; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Muller L., 1924, Zoologischer Anzeiger Leipzig, V59, P233; Myers Charles W., 1997, American Museum Novitates, V3213, P1; Myers CW, 2001, B AM MUS NAT HIST, P1; Noble G. K., 1924, Proceedings of the Biological Society of Washington, V37, P65; Noble G. K, 1931, BIOL AMPHIBIA; Noble GK, 1920, B AM MUS NAT HIST, V42, P441; Noble GK, 1921, B AM MUS NAT HIST, V44, P1; Noonan BP, 2003, J HERPETOL, V37, P91, DOI 10.1670/0022-1511(2003)037[0091:ANSOHA]2.0.CO;2; Padial JM, 2007, ZOOTAXA, P1; Peters W., 1873, Monatsberichte Akademie Berlin, P603; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; RAFINESQUE CS, 1815, ANAL NATURE TABLE UN; RIVERO J A, 1968, Memoria de la Sociedad de Ciencias Naturales La Salle, V28, P301; RIVERO JA, 1985, BRENESIA, V23, P335; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rueda-Almonacid Jose Vicente, 1994, Trianea, V5, P133; Ruiz-Carranza P., 1989, TRIANEA, V3, P67; RUIZ-CARRANZA P M, 1986, Caldasia, V15, P431; Ruiz-Carranza P. M., 1991, LOZANIA, V60, P1; Ruiz-Carranza Pedro M., 1996, Lozania, V68, P1; Ruiz-Carranza Pedro M., 1995, Lozania, V65, P1; Ruiz-Carranza Pedro M., 1995, Lozania, V62, P1; Ruiz-Carranza Pedro M., 1995, Lozania, V63, P1; Ruiz-Carranza Pedro M., 1997, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V21, P541; Ruiz-Carranza Pedro M., 1998, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V22, P571; Ruiz-Carranza PM, 1991, LOZANIA, V59, P1; Ruiz-Carranza PM, 1991, LOZANIA, V58, P1; San Mauro D, 2004, MOL PHYLOGENET EVOL, V33, P413, DOI 10.1016/j.ympev.2004.05.014; Sanchiz B., 1993, Graellsia, V49, P115; SAVAGE J. M., 2002, AMPHIBIANS REPTILES; Savage J.M., 1973, EVOLUTIONARY BIOL AN, P351; SAVAGE JM, 1967, COPEIA, P325, DOI 10.2307/1442121; SAVAGE JM, 1967, COPEIA, P604, DOI 10.2307/1442239; SCHWALM PA, 1980, J MORPHOL, V163, P37, DOI 10.1002/jmor.1051630106; Senaris JC, 2001, REV BIOL TROP, V49, P1083; SENARIS JC, 2001, VENEZUELA MEMORIA FU, V59, P133; Senaris JC, 2005, PUBLICACIONES COMITE; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STARRETT P H, 1973, Bulletin Southern California Academy of Sciences, V72, P57; STARRETT PRISCILLA, 1960, MISC PUBL MUS ZOOL UNIV MICHIGAN, V110, P1; TAYLOR EDWARD A., 1958, UNIV KANSAS SCI BULL, V39, P41; TAYLOR EDWARD H., 1952, UNIV KANSAS SCI BULL, V35, P577; TAYLOR EDWARD H., 1951, PROC BIOL SOC WASHINGTON, V64, P33; TAYLOR EDWARD H., 1949, UNIV KANSAS SCI BULL, V33, P257; TORRES G, 2008, J NATL MUSEUM PRAGUE, V176, P1; Trueb L., 1973, P65; TSCHANZ CM, 1974, GEOL SOC AM BULL, V85, P273, DOI 10.1130/0016-7606(1974)85<273:GEOTSN>2.0.CO;2; Velasco M, 2007, REV LATINOAM HIPERTE, V2, P191; Werner F., 1894, ZOOL ANZ, V1'7, P155; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; WIENS JJ, 2007, Q REV BIOL, V82, P55; Wiens JJ, 2008, BIOSCIENCE, V58, P297, DOI 10.1641/B580405; WILD ER, 1994, J HERPETOL, V28, P299, DOI 10.2307/1564528; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P6520, DOI 10.1073/pnas.0501936102; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	181	125	144	0	35	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	MAY 11	2009		2100					1	97						97	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	448AC					2022-09-04	WOS:000266232500001
J	Mosquera, CEM; Lozano, MNR				Mosquera Mosquera, Carlos Enrique; Rodriguez Lozano, Maria Nelsy			To thematize the memory of armed conflict from literature, music and narrative to form political subjectivity, compassion and responsive ethics	HALLAZGOS-REVISTA DE INVESITIGACIONES			Spanish	Article						corporeity; self-care; responsive ethics; narratives; sense and meaning; memory; educational subject; subjectivity and forgiveness		This article presents part of the results of the doctoral thesis entitled "the institutional educational project and the formation of political subjectivity for a post-conflict scenario: collective memory of the armed conflict and school identity". The methodology that was used was oral history, and the approach was hermeneutic. The objective pursued for this purpose was to reveal the sense and meaning that the collective memory of the Colombian armed conflict had for the institution under study, through the memory that is conveyed in literature, music and narrative as pedagogical devices. The findings can be summarized in that: 1) through literature, music and narratives as pedagogical devices, pedagogy of memory can be made, given that educational subjects acquire new sense and meanings about the impacts of the Colombian armed conflict; 2) by unveiling the sense and meaning of the armed conflict from literature, music and narratives, the educational subjects become political, ethical, civilized and compassionate; 3) the ethics that arise from memory, and that is conveyed in literature, music and narratives, is different from the ethics taught by the school as competences; 4) students can acquire a transient identity when they listen imaginatively to the other that is narrated when activated in them ethical devices (feelings of longings, desires, complicities, sympathies and compathies(2)) as opposed to what they hear and as opposed to the condition of the victim; 5) self-care and care for others is given when the students faced with the alter-victim acquire a semantic of cordiality; 6) before the alter-victim the students understand that forgiveness is a gift of the victim; and 7) the students become democratic and move away from the logic of evil from the memory that music entails, when they respect diversity, they do not get involved in the word and direct their actions toward peace.	[Mosquera Mosquera, Carlos Enrique] Univ Cooperat Colombia, Inst Univ Marco Fidel Suarez, Bogota, Colombia; [Mosquera Mosquera, Carlos Enrique] UCO, Filosofia, Rionegro, Colombia; [Mosquera Mosquera, Carlos Enrique] Univ Santo Tomas, Educ, Bogota, Colombia; [Mosquera Mosquera, Carlos Enrique] Corp Univ Amer, Barranquilla, Colombia; [Mosquera Mosquera, Carlos Enrique] UNR, Educ, Rosario, Santa Fe, Argentina; [Rodriguez Lozano, Maria Nelsy] Univ Nacl Educ UNAE, Invest & Posgrad, Quito, Ecuador; [Rodriguez Lozano, Maria Nelsy] Univ Santiago Cali, Literatura & Idiomas, Cali, Colombia; [Rodriguez Lozano, Maria Nelsy] Pontificia Univ Javeriana, Educ, Bogota, Colombia; [Rodriguez Lozano, Maria Nelsy] Univ Leipzig, Educ, Leipzig, Germany		Mosquera, CEM (corresponding author), Univ Cooperat Colombia, Inst Univ Marco Fidel Suarez, Bogota, Colombia.; Mosquera, CEM (corresponding author), UCO, Filosofia, Rionegro, Colombia.; Mosquera, CEM (corresponding author), Univ Santo Tomas, Educ, Bogota, Colombia.; Mosquera, CEM (corresponding author), Corp Univ Amer, Barranquilla, Colombia.; Mosquera, CEM (corresponding author), UNR, Educ, Rosario, Santa Fe, Argentina.	carlosfilosofo@hotmail.com; maria.rodriguez@unae.edu.ec	MOSQUERA, CARLOS ENRIQUE MOSQUERA/AAS-1286-2021; MOSQUERA MOSQUERA, CARLOS ENRIQUE/AAK-5976-2021	MOSQUERA MOSQUERA, CARLOS ENRIQUE/0000-0002-4806-3145				Alguacil M., 2010, M RGENES MORAL, P305; Barcena F., 2016, REV EDUCACION CULTUR, P30; BARCENA F., 2003, ETICA ANTE VICTIMAS; Barcena F., 2000, REV COMPLUTENSE ED, V2, P59; Barcena F., 2016, REV EDUCACION CULT 3, P8; Colom A., 1997, DESPUES MODERNIDAD; Mosquera-Mosquera CE, 2016, PRAX-COLOMB, V12, P21, DOI 10.21676/23897856.1844; Melich J. C., 2014, LOGICA MALDAD; Melich J. C., 1998, ARS BREVIS, P171; MELICH J. C., 2000, ENRAHONAR, V31, P81; Melich J. C., 1997, EXTRANO COMPLICE EDU; Melich J. C., 2010, OTRO SI MISMO PERSPE; Melich J-C., 2010, ETICA COMPASION; Melich J-C., 2004, LECCION AUSCHWITZ; Mosquera C. E., 2016, EDUCARE, V19, P154; Mosquera C. E., 2016, ENCUENTRO EDUCACIONA, V22, P447; Mounier E., 2000, EL PERSONALISMO; Ricoeur P., 2000, HORIZONTES RELATO LE; Ricoeur Paul, 2013, MEMORIA HIST OLVIDO; Sucasas A., 2003, ETICA ANTE VICTIMAS; Todorov Tzvetan, 2008, MIEDO BARBAROS	21	1	1	1	5	UNIV SANTO TOMAS	BOGOTA	CRA 9 NRO 51 11, BOGOTA, 00000, COLOMBIA	1794-3841			HALLAZGOS	Hallazgos	JAN-JUN	2018	15	29					45	70		10.15332/s1794-3841.2018.0029.02	http://dx.doi.org/10.15332/s1794-3841.2018.0029.02			26	Area Studies	Emerging Sources Citation Index (ESCI)	Area Studies	GT7PM					2022-09-04	WOS:000444720600003
J	Quezada, JC; Etter, A; Ghazoul, J; Buttler, A; Guillaume, T				Quezada, Juan Carlos; Etter, Andres; Ghazoul, Jaboury; Buttler, Alexandre; Guillaume, Thomas			Carbon neutral expansion of oil palm plantations in the Neotropics	SCIENCE ADVANCES			English	Article							LAND-USE CHANGE; ORGANIC-CARBON; TROPICAL FORESTS; STOCKS; CONVERSION; IMPACTS; SEQUESTRATION; BIODIVERSITY; VARIABILITY; COLOMBIA	Alternatives to ecologically devastating deforestation land use change trajectories are needed to reduce the carbon footprint of oil palm (OP) plantations in the tropics. Although various land use change options have been proposed, so far, there are no empirical data on their long-term ecosystem carbon pools effects. Our results demonstrate that pasture-to-OP conversion in savanna regions does not change ecosystemcarbon storage, after 56 years in Colombia. Compared to rainforest conversion, this alternative land use change reduces net ecosystem carbon losses by 99.7 +/- 9.6%. Soil organic carbon (SOC) decreased until 36 years after conversion, due to a fast decomposition of pasture-derived carbon, counterbalancing the carbon gains in OP biomass. The recovery of topsoil carbon content, suggests that SOCstocks might partly recover during a third plantation cycle. Hence, greater OP sustainability can be achieved if its expansion is oriented toward pasture land.	[Quezada, Juan Carlos; Buttler, Alexandre; Guillaume, Thomas] Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn ENAC, Lab Ecol Syst ECOS, CH-1015 Lausanne, Switzerland; [Quezada, Juan Carlos; Buttler, Alexandre; Guillaume, Thomas] Swiss Fed Inst Forest Snow & Landscape Res WSL, Site Lausanne, CH-1015 Lausanne, Switzerland; [Etter, Andres] Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota, Colombia; [Ghazoul, Jaboury] ETHZ, Dept Environm Syst Sci, Inst Terr Ecosyst, Chair Ecosyst Management, CH-8092 Zurich, Switzerland; [Ghazoul, Jaboury] Univ Utrecht, Int Nat Conservat Ecol & Biodivers, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Ghazoul, Jaboury] Univ Edinburgh, Ctr Sustainable Forests & Landscapes, Kings Bldg,Alexander Crum Brown Rd, Edinburgh EH9 3FF, Midlothian, Scotland; [Buttler, Alexandre] Univ Franche Comte, UFR Sci & Tech, Lab Chronoenvironm, UMR CNRS 6249, 16 Route Gray, F-25030 Besancon, France		Quezada, JC (corresponding author), Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn ENAC, Lab Ecol Syst ECOS, CH-1015 Lausanne, Switzerland.; Quezada, JC (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Site Lausanne, CH-1015 Lausanne, Switzerland.	quezadarivera@gmail.com	Guillaume, Thomas/B-1651-2018; Etter, Andrés/E-1860-2011	Guillaume, Thomas/0000-0002-6926-9337; Etter, Andrés/0000-0003-0665-9300; Quezada Rivera, Juan Carlos/0000-0001-8856-4756	Swiss National Science Foundation (r4d-Ecosystems) "Oil Palm Adaptive Landscape" [152019]	Swiss National Science Foundation (r4d-Ecosystems) "Oil Palm Adaptive Landscape"	This work was financed by the Swiss National Science Foundation (r4d-Ecosystems) "Oil Palm Adaptive Landscape" no. 152019.	Allen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133325; Balesdent J., 1996, Mass spectrometry of soils., P83; BALESDENT J, 1987, SOIL BIOL BIOCHEM, V19, P25, DOI 10.1016/0038-0717(87)90120-9; Balesdent J, 2018, NATURE, V559, P599, DOI 10.1038/s41586-018-0328-3; Barcena TG, 2014, GLOBAL CHANGE BIOL, V20, P2393, DOI 10.1111/gcb.12576; Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Boucher D., 2011, TROPICAL FOREST CLIM, P1; Braz SP, 2013, SOIL SCI SOC AM J, V77, P914, DOI 10.2136/sssaj2012.0269; Castiblanco C, 2013, ENVIRON SCI POLICY, V27, P172, DOI 10.1016/j.envsci.2013.01.003; Cerri CEP, 2007, AGR ECOSYST ENVIRON, V122, P58, DOI 10.1016/j.agee.2007.01.008; Chiti T, 2014, PLANT SOIL, V375, P47, DOI 10.1007/s11104-013-1928-1; COVINGTON WW, 1981, ECOLOGY, V62, P41, DOI 10.2307/1936666; de Blecourt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069357; Dislich C, 2017, BIOL REV, V92, P1539, DOI 10.1111/brv.12295; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Etter A., 2010, ECOSYSTEM FUNCTION S, P383; Fedepalma, 2015, B EC; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; Fisher MJ, 2007, TROP GRASSLANDS, V41, P65; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Frazao LA, 2013, GCB BIOENERGY, V5, P384, DOI 10.1111/j.1757-1707.2012.01196.x; Garcia-Ulloa J, 2012, CONSERV LETT, V5, P366, DOI 10.1111/j.1755-263X.2012.00254.x; Gaveau DLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32017; Gee GW., 1986, METHODS SOIL ANAL 1, V(9):; Gharibreza M, 2013, SOIL TILL RES, V131, P1, DOI 10.1016/j.still.2013.02.010; Gilroy JJ, 2015, GLOBAL CHANGE BIOL, V21, P1531, DOI 10.1111/gcb.12696; Goodrick I, 2015, GCB BIOENERGY, V7, P263, DOI 10.1111/gcbb.12138; Gottingen C. V, 2005, ECOLOGY DEV SERIES, V28, P115; Guillaume T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04755-y; Guillaume T, 2016, ECOL INDIC, V67, P49, DOI 10.1016/j.ecolind.2016.02.039; Guillaume T, 2015, GLOBAL CHANGE BIOL, V21, P3548, DOI 10.1111/gcb.12907; Guimaraes E. P, 2004, AGROPASTORAL SYSTEMS; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Henders S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125012; Jimenez JJ, 2006, CRIT REV PLANT SCI, V25, P337, DOI 10.1080/0735268060094240; Jourdan C, 1997, PLANT SOIL, V190, P217, DOI 10.1023/A:1004218030608; Khasanah N, 2015, COGENT ENVIRON SCI, V1, DOI 10.1080/23311843.2015.1119964; Khasanah N, 2015, AGR ECOSYST ENVIRON, V211, P195, DOI 10.1016/j.agee.2015.06.009; Koh LP, 2011, P NATL ACAD SCI USA, V108, P5127, DOI 10.1073/pnas.1018776108; Koh LP, 2010, P NATL ACAD SCI USA, V107, P11140, DOI 10.1073/pnas.1000530107; Kotowska MM, 2015, GLOBAL CHANGE BIOL, V21, P3620, DOI 10.1111/gcb.12979; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lavelle P, 2014, AGR ECOSYST ENVIRON, V185, P106, DOI 10.1016/j.agee.2013.12.020; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Lobe I, 2001, EUR J SOIL SCI, V52, P93, DOI 10.1046/j.1365-2389.2001.t01-1-00362.x; Lucey J., 2014, CHANGE CARBON STOCKS; Major J, 2012, J ENVIRON QUAL, V41, P1076, DOI 10.2134/jeq2011.0128; MEDINA E, 1982, ECOL STUD, V42, P308; Mosquera O, 2012, GEODERMA, V189, P81, DOI 10.1016/j.geoderma.2012.04.022; Nelson PN, 2015, PLANT SOIL, V394, P421, DOI 10.1007/s11104-015-2490-9; Ocampo-Penuela N, 2018, BIOL CONSERV, V224, P117, DOI 10.1016/j.biocon.2018.05.024; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Penman J., 2003, INTERGOVERNMENTAL PA, V177; Prescott GW, 2016, BIOL CONSERV, V197, P139, DOI 10.1016/j.biocon.2016.02.013; Furumo PR, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5892; Romero-Ruiz M, 2010, GLOBAL CHANGE BIOL, V16, P2013, DOI 10.1111/j.1365-2486.2009.02081.x; Rueda-Zarate A., 2015, POLITICAS MERCADOS M; Smith DR, 2012, GCB BIOENERGY, V4, P588, DOI 10.1111/j.1757-1707.2012.01168.x; Tao HH, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0439-5; Tao HH, 2016, AGR ECOSYST ENVIRON, V218, P133, DOI 10.1016/j.agee.2015.11.012; Taylor P., 1984, COMMUN SOIL SCI PLAN, P37; van Lent J, 2015, BIOGEOSCIENCES, V12, P7299, DOI 10.5194/bg-12-7299-2015; van Straaten O, 2015, P NATL ACAD SCI USA, V112, P9956, DOI 10.1073/pnas.1504628112; Vijay V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159668; ZAK DR, 1990, BIOGEOCHEMISTRY, V11, P111, DOI 10.1007/BF00002062; Ziegler AD, 2012, GLOBAL CHANGE BIOL, V18, P3087, DOI 10.1111/j.1365-2486.2012.02747.x	67	24	24	4	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	NOV	2019	5	11							eaaw4418	10.1126/sciadv.aaw4418	http://dx.doi.org/10.1126/sciadv.aaw4418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR6MC	31799387	Green Published, gold			2022-09-04	WOS:000499736100015
J	Casals, E; Barrena, R; Garcia, A; Gonzalez, E; Delgado, L; Busquets-Fite, M; Font, X; Arbiol, J; Glatzel, P; Kvashnina, K; Sanchez, A; Puntes, V				Casals, Eudald; Barrena, Raquel; Garcia, Ana; Gonzalez, Edgar; Delgado, Lucia; Busquets-Fite, Marti; Font, Xavier; Arbiol, Jordi; Glatzel, Pieter; Kvashnina, Kristina; Sanchez, Antoni; Puntes, Victor			Programmed Iron Oxide Nanoparticles Disintegration in Anaerobic Digesters Boosts Biogas Production	SMALL			English	Article							ENERGY DEMAND; SEWAGE-SLUDGE; ACETIC-ACID; WASTE; OPTIMIZATION; MANAGEMENT; CONVERSION; IMPACTS; SIZE		[Casals, Eudald; Puntes, Victor] ICN2, Bellaterra 08193, Spain; [Barrena, Raquel; Puntes, Victor] ICREA, Barcelona 08010, Spain; [Barrena, Raquel; Garcia, Ana; Delgado, Lucia; Font, Xavier; Sanchez, Antoni] Univ Autonoma Barcelona, Dept Chem Engn, Escola Engn, Bellaterra 08193, Spain; [Gonzalez, Edgar] Pontificia Univ Javeriana, Fac Ingn, Inst Geofis, Bogota 110231, Colombia; [Busquets-Fite, Marti] Appl Nanoparticles SL, Barcelona 08025, Spain; [Glatzel, Pieter; Kvashnina, Kristina] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Arbiol, Jordi] ICMAB CSIC, Inst Ciencia Mat Barcelona, Bellaterra 08193, Spain		Puntes, V (corresponding author), ICN2, Campus UAB, Bellaterra 08193, Spain.	victor.puntes@icn.cat	Kvashnina, Kristina O./O-2374-2016; Barrena, Raquel/M-4051-2014; Puntes, Victor/AAL-6081-2021; Font, Xavier/A-1459-2009; Puntes, Víctor F./F-8407-2013; Glatzel, Pieter/E-9958-2010; Casals, Eudald/P-2382-2016; Arbiol, Jordi/B-6048-2008; Sanchez, Antoni/A-1507-2009	Kvashnina, Kristina O./0000-0003-4447-4542; Barrena, Raquel/0000-0002-6077-7765; Puntes, Victor/0000-0001-8996-9499; Font, Xavier/0000-0003-4981-7436; Puntes, Víctor F./0000-0001-8996-9499; Glatzel, Pieter/0000-0001-6532-8144; Casals, Eudald/0000-0002-2900-7295; Arbiol, Jordi/0000-0002-0695-1726; Busquets-Fite, Marti/0000-0002-7939-5265; Gonzalez, Edgar E/0000-0003-3103-3959; Sanchez, Antoni/0000-0003-4254-8528	Spanish Ministerio de Medio Ambiente y Medio Rural y Marino [007/RN08/03.1]; Bill and Melinda Gates Foundation [OPP1044410]; ICREA Funding Source: Custom	Spanish Ministerio de Medio Ambiente y Medio Rural y Marino(Spanish Government); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ICREA(ICREA)	Financial support was provided by the Spanish Ministerio de Medio Ambiente y Medio Rural y Marino (Project Exp. 007/RN08/03.1). The continuation of this research is being supported by the Bill and Melinda Gates Foundation (Grand Challenges Exploration, Proposal OPP1044410).	Abelleira J, 2012, ENVIRON SCI TECHNOL, V46, P6158, DOI 10.1021/es204203y; Banfield JF, 2001, REV MINERAL GEOCHEM, V44, P1, DOI 10.2138/rmg.2001.44.01; Barrena R, 2009, CHEMOSPHERE, V75, P850, DOI 10.1016/j.chemosphere.2009.01.078; Bianchini M, 2012, J SYNCHROTRON RADIAT, V19, P911, DOI 10.1107/S0909049512038551; Borm P, 2006, TOXICOL SCI, V90, P23, DOI 10.1093/toxsci/kfj084; Bougrier C, 2007, BIOCHEM ENG J, V34, P20, DOI 10.1016/j.bej.2006.11.013; Bowker M, 2002, NAT MATER, V1, P205, DOI 10.1038/nmat774; Campbell CT, 2002, SCIENCE, V298, P811, DOI 10.1126/science.1075094; Casals E, 2011, SMALL, V7, P3479, DOI 10.1002/smll.201101511; Corrias A, 2009, J PHYS CHEM C, V113, P18667, DOI 10.1021/jp9047677; Distaso Alba, 2012, International Journal of Sustainable Development, V15, P220, DOI 10.1504/IJSD.2012.047757; Donoso-Bravo A, 2012, J CHEM TECHNOL BIOT, V87, P1375, DOI 10.1002/jctb.3890; Gauthier C, 1999, J SYNCHROTRON RADIAT, V6, P164, DOI 10.1107/S0909049598016835; GOLDSTEIN AN, 1992, SCIENCE, V256, P1425, DOI 10.1126/science.256.5062.1425; HOBAN DJ, 1979, J APPL BACTERIOL, V47, P153, DOI 10.1111/j.1365-2672.1979.tb01179.x; Hou DY, 2012, ENVIRON SCI TECHNOL, V46, P2494, DOI 10.1021/es3004552; Jess A, 2010, ENERG POLICY, V38, P4663, DOI 10.1016/j.enpol.2010.04.026; JOLIVET JP, 1983, NOUV J CHIM, V7, P325; Karve AD, 2003, SCIENCE, V302, P987, DOI 10.1126/science.302.5647.987; Lu J, 2006, NANOTECHNOLOGY, V17, P5812, DOI 10.1088/0957-4484/17/23/017; MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188; Morita M, 2012, APPL MICROBIOL BIOT, V94, P575, DOI 10.1007/s00253-012-3953-z; Nasir IM, 2012, APPL MICROBIOL BIOT, V95, P321, DOI 10.1007/s00253-012-4152-7; Nielsen HB, 2008, WATER SCI TECHNOL, V58, P1521, DOI 10.2166/wst.2008.507; Nyiro-Kosa I, 2009, EUR J MINERAL, V21, P293, DOI 10.1127/0935-1221/2009/0021-1920; Ostwald, 1897, Z PHYS CHEM, V22, P289, DOI DOI 10.1515/ZPCH-1897-2233; Ostwald W., 1896, LEHRBUCH ALLGEMEINEN, V2; Ponsa S, 2008, WATER RES, V42, P3972, DOI 10.1016/j.watres.2008.07.002; Ram MS, 2000, WATER AIR SOIL POLL, V117, P305, DOI 10.1023/A:1005100924609; RAO PP, 1994, WORLD J MICROB BIOT, V10, P211, DOI 10.1007/BF00360890; Schievano A, 2008, BIORESOURCE TECHNOL, V99, P8112, DOI 10.1016/j.biortech.2008.03.030; Sherrill M S, 1936, Science, V84, P217, DOI 10.1126/science.84.2175.217; Talapin DV, 2001, J PHYS CHEM B, V105, P12278, DOI 10.1021/jp012229m; VANDENBERG L, 1980, J APPL BACTERIOL, V48, P437, DOI 10.1111/j.1365-2672.1980.tb01033.x; Wolfram C, 2012, J ECON PERSPECT, V26, P119, DOI 10.1257/jep.26.1.119; Yadvika, 2004, BIORESOURCE TECHNOL, V95, P1, DOI 10.1016/j.biortech.2004.02.010; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165	37	100	100	5	93	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1613-6810	1613-6829		SMALL	Small	JUL 23	2014	10	14					2801	2808		10.1002/smll.201303703	http://dx.doi.org/10.1002/smll.201303703			8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AN5VX	24692328				2022-09-04	WOS:000340660900008
J	Sawamoto, K; Stapleton, M; Almeciga-Diaz, CJ; Espejo-Mojica, AJ; Losada, JC; Suarez, DA; Tomatsu, S				Sawamoto, Kazuki; Stapleton, Molly; Almeciga-Diaz, Carlos J.; Espejo-Mojica, Angela J.; Camilo Losada, Juan; Suarez, Diego A.; Tomatsu, Shunji			Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments	DRUGS			English	Review							ENZYME-REPLACEMENT THERAPY; HEMATOPOIETIC STEM-CELL; BLOOD-BRAIN-BARRIER; ALPHA-L-IDURONIDASE; 6-MINUTE WALK TEST; CENTRAL-NERVOUS-SYSTEM; PHARMACOLOGICAL CHAPERONE THERAPY; BONE-MARROW-TRANSPLANTATION; 2-SULFATE SULFATASE-LIKE; MAROTEAUX-LAMY-SYNDROME	Mucopolysaccharidoses (MPS) are inborn errors of metabolism produced by a deficiency of one of the enzymes involved in the degradation of glycosaminoglycans (GAGs). Although taken separately, each type is rare. As a group, MPS are relatively frequent, with an overall estimated incidence of around 1 in 20,000-25,000 births. Development of therapeutic options for MPS, including hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT), has modified the natural history of many MPS types. In spite of the improvement in some tissues and organs, significant challenges remain unsolved, including blood-brain barrier (BBB) penetration and treatment of lesions in avascular cartilage, heart valves, and corneas. Newer approaches, such as intrathecal ERT, ERT with fusion proteins to cross the BBB, gene therapy, substrate reduction therapy (SRT), chaperone therapy, and some combination of these strategies may provide better outcomes for MPS patients in the near future. As early diagnosis and early treatment are imperative to improve therapeutic efficacy, the inclusion of MPS in newborn screening programs should enhance the potential impact of treatment in reducing the morbidity associated with MPS diseases. In this review, we evaluate available treatments, including ERT and HSCT, and future treatments, such as gene therapy, SRT, and chaperone therapy, and describe the advantages and disadvantages. We also assess the current clinical endpoints and biomarkers used in clinical trials.	[Sawamoto, Kazuki; Stapleton, Molly; Tomatsu, Shunji] Nemours Alfred I duPont Hosp Children, Nemours Biomed Res, 1600 Rockland Rd, Wilmington, DE 19899 USA; [Stapleton, Molly] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Almeciga-Diaz, Carlos J.; Espejo-Mojica, Angela J.; Camilo Losada, Juan; Suarez, Diego A.] Pontificia Univ Javeriana, Fac Sci, Inst Study Inborn Errors Metab, Bogota, DC, Colombia; [Suarez, Diego A.] Univ Nacl Colombia, Fac Med, Bogota, DC, Colombia; [Tomatsu, Shunji] Shimane Univ, Dept Pediat, Matsue, Shimane, Japan; [Tomatsu, Shunji] Gifu Univ, Dept Pediat, Gifu, Japan; [Tomatsu, Shunji] Thomas Jefferson Univ, Philadelphia, PA 19107 USA		Tomatsu, S (corresponding author), Nemours Alfred I duPont Hosp Children, Nemours Biomed Res, 1600 Rockland Rd, Wilmington, DE 19899 USA.; Tomatsu, S (corresponding author), Shimane Univ, Dept Pediat, Matsue, Shimane, Japan.; Tomatsu, S (corresponding author), Gifu Univ, Dept Pediat, Gifu, Japan.; Tomatsu, S (corresponding author), Thomas Jefferson Univ, Philadelphia, PA 19107 USA.	stomatsu@nemours.org	Espejo, Angela/AAF-9020-2019; Garcia, Diego Alejandro Suarez/AAF-9363-2019; Alméciga-Díaz, Carlos J/A-2494-2017	Alméciga-Díaz, Carlos J/0000-0001-6484-1173; Suarez Garcia, Diego Alejandro/0000-0001-9519-4706	The Carol Ann Foundation; Angelo R. Cali and Mary V. Cali Family Foundation, Inc.; The Vain and Harry Fish Foundation, Inc.; The Bennett Foundation; Jacob Randall Foundation; Austrian MPS Society; Japanese MPS Society; Nemours Funds; Baby and Infant in Research of Health and Development to Adolescent and Young Adult from the Japan Agency for Medical Research and Development (AMED) [JP18gk0110017]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) [P30GM114736]; Pontificia Universidad Javeriana (PPTA) [8275]; COLCIENCIAS [120380763212-PPTA, 8352]	The Carol Ann Foundation; Angelo R. Cali and Mary V. Cali Family Foundation, Inc.; The Vain and Harry Fish Foundation, Inc.; The Bennett Foundation; Jacob Randall Foundation; Austrian MPS Society; Japanese MPS Society; Nemours Funds; Baby and Infant in Research of Health and Development to Adolescent and Young Adult from the Japan Agency for Medical Research and Development (AMED); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (NIH); Pontificia Universidad Javeriana (PPTA); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The following funding was used to assist with the preparation of this review article: The Carol Ann Foundation, Angelo R. Cali and Mary V. Cali Family Foundation, Inc., The Vain and Harry Fish Foundation, Inc., The Bennett Foundation, Jacob Randall Foundation, Austrian and Japanese MPS Societies, Nemours Funds, Baby and Infant in Research of Health and Development to Adolescent and Young Adult from the Japan Agency for Medical Research and Development (AMED), under Grant number JP18gk0110017, an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) under Grant number P30GM114736, Pontificia Universidad Javeriana (PPTA #8275), and COLCIENCIAS (Grant ID 120380763212-PPTA #8352).	Ahluwalia MS, 2018, ONCOLOGIST, V23, P1199, DOI 10.1634/theoncologist.2017-0572; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aldenhoven M, 2015, BIOL BLOOD MARROW TR, V21, P1106, DOI 10.1016/j.bbmt.2015.02.011; Almeciga-Diaz C, 2018, THERAPIES MUCOPOLYSA; [Anonymous], GEN TRANSF CLIN TRIA; [Anonymous], PEDIAT RES; Aoki J, 2016, AM J HEMATOL, V91, P302, DOI 10.1002/ajh.24270; Aoyagi-Scharber M, 2017, MOL THER-METH CLIN D, V6, P43, DOI 10.1016/j.omtm.2017.05.009; Ashby WR, 1937, BRAIN, V60, P149, DOI 10.1093/brain/60.2.149; Australian Government Department of Health, 2013, GUID TREATM MUC TYP; Bartels B, 2013, PHYS THER, V93, P529, DOI 10.2522/ptj.20120210; Barth A, 2018, J INBORN ERRORS META, V6, P1; Barth AL, 2017, MOL GENET METAB REP, V12, P62, DOI 10.1016/j.ymgmr.2017.05.010; Bennell K, 2011, ARTHRIT CARE RES, V63, pS350, DOI 10.1002/acr.20538; Berliner ML, 1939, ARCH OPHTHALMOL-CHIC, V22, P97, DOI 10.1001/archopht.1939.00860070113008; Biswas SN, 2017, BMJ CASE REP, V2017, P1; Bitencourt Fernanda Hendges de, 2015, Value Health Reg Issues, V8, P99, DOI 10.1016/j.vhri.2015.08.002; Boado RJ, 2008, BIOTECHNOL BIOENG, V99, P475, DOI 10.1002/bit.21602; Boado RJ, 2017, MOL PHARMACEUT, V14, P1271, DOI 10.1021/acs.molpharmaceut.6b01166; Boado RJ, 2016, MOL PHARMACEUT, V13, P1385, DOI 10.1021/acs.molpharmaceut.6b00037; Boado RJ, 2014, MOL PHARMACEUT, V11, P2928, DOI 10.1021/mp500258p; Boelens JJ, 2008, HSCT INBORN ERRORS M; Bosch A, 2000, MOL THER, V1, P63, DOI 10.1006/mthe.1999.0005; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Boyd RE, 2013, J MED CHEM, V56, P2705, DOI 10.1021/jm301557k; Braun SE, 1996, HUM GENE THER, V7, P283, DOI 10.1089/hum.1996.7.3-283; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Burton BK, 2015, AM J MED GENET A, V167, P2272, DOI 10.1002/ajmg.a.37172; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Chan MJ, 2018, J PEDIAT, V276, P176; Chen Y, 2018, BONE MARROW TRANSPL, V53, P770, DOI 10.1038/s41409-018-0175-8; Chicoine LG, 2014, MOL THER, V22, P338, DOI 10.1038/mt.2013.244; Chinen Y, 2014, MOLEC GENET METAB RE, V1, P31, DOI 10.1016/j.ymgmr.2013.11.002; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; Chuang CK, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0816-4; Ciron C, 2006, ANN NEUROL, V60, P204, DOI 10.1002/ana.20870; Clarke LA, 2017, J PEDIATR-US, V182, P363, DOI 10.1016/j.jpeds.2016.11.036; Clarke LA, 2012, MOL GENET METAB, V106, P395, DOI 10.1016/j.ymgme.2012.05.003; Clarke LA, 2009, PEDIATRICS, V123, P229, DOI 10.1542/peds.2007-3847; CLEARY MA, 1993, ARCH DIS CHILD, V69, P403, DOI 10.1136/adc.69.3.403; ClinicalTrials. gov, GEN THER MOD AUT HEM; ClinicalTrials. gov, ASC DOS STUD GEN ED; ClinicalTrials. gov, LONG TERM FOLL UP SA; ClinicalTrials. gov, INTR GEN THER SANF T; ClinicalTrials. gov, GEN THER PAT MUC DIS; ClinicalTrials. gov, PHAS 1 2 GEN TRANSF; Cordoba-Ruiz HA, 2009, AFR J BIOTECHNOL, V8, P1786; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Dai M, 2014, P NATL ACAD SCI USA, V111, P2680, DOI 10.1073/pnas.1323155111; Morales-Alvarez ED, 2013, J MICROBIOL, V51, P213, DOI 10.1007/s12275-013-2416-2; de Ru MH, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-55; Delgadillo V, 2011, J INHERIT METAB DIS, V34, P1039, DOI 10.1007/s10545-011-9342-4; Dempsey TM, 2018, MAYO CLIN PROC, V93, P763, DOI 10.1016/j.mayocp.2018.04.009; Desmaris N, 2004, ANN NEUROL, V56, P68, DOI 10.1002/ana.20150; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; Dickson PI, 2015, MOL GENET METAB, V116, P69, DOI 10.1016/j.ymgme.2015.07.005; Do Cao J, 2016, MOL GENET METAB REP, V9, P42, DOI 10.1016/j.ymgmr.2016.10.001; Doherty C, 2019, J HUM GENET; Donida B, 2015, BBA-MOL BASIS DIS, V1852, P1012, DOI 10.1016/j.bbadis.2015.02.004; Downing WL, 2006, PLANT BIOTECHNOL J, V4, P169, DOI 10.1111/j.1467-7652.2005.00166.x; Dziedzic D, 2010, EUR J HUM GENET, V18, P200, DOI 10.1038/ejhg.2009.144; Ellinwood NM, 2011, MOL THER, V19, P251, DOI 10.1038/mt.2010.265; Espejo-Mojica AJ, 2015, MOL GENET METAB, V116, P13, DOI 10.1016/j.ymgme.2015.06.001; Fahnehjelm KT, 2018, ACTA PAEDIATR, V107, P1995, DOI 10.1111/apa.14368; Ferla R, 2013, HUM GENE THER, V24, P163, DOI 10.1089/hum.2012.179; Food and Drug Administration, 2018, LUXTURNA; Fox JE, 2015, MOL GENET METAB, V114, P203, DOI 10.1016/j.ymgme.2014.10.017; Fraldi A, 2007, HUM MOL GENET, V16, P2693, DOI 10.1093/hmg/ddm223; Fraldi A, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0565-y; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Friedman MA, 2009, ARCH CLIN NEUROPSYCH, V24, P689, DOI 10.1093/arclin/acp060; Frisella WA, 2001, MOL THER, V3, P351, DOI 10.1006/mthe.2001.0274; Fu H, 2002, MOL THER, V5, P42, DOI 10.1006/mthe.2001.0514; Fu HY, 2016, CURR OPIN VIROL, V21, P87, DOI 10.1016/j.coviro.2016.08.006; Fu HY, 2011, MOL THER, V19, P1025, DOI 10.1038/mt.2011.34; Gaffke L, 2018, METAB BRAIN DIS, V33, P1, DOI 10.1007/s11011-017-0111-4; Horovitz DDG, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0437-8; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Ghazikhanian SE, 2017, BONE MARROW TRANSPL, V52, P279, DOI 10.1038/bmt.2016.248; Ghosh A, 2016, MOL GENET METAB, V117, P373, DOI 10.1016/j.ymgme.2016.01.011; Giugliani R, 2017, MOL GENET METAB REP, V12, P2, DOI 10.1016/j.ymgmr.2017.01.014; Giugliani R, 2018, EXPERT OPIN ORPHAN D, V6, P403, DOI 10.1080/21678707.2018.1487838; Giugliani R, 2017, MOL GENET METAB REP, V10, P61, DOI 10.1016/j.ymgmr.2017.01.004; Golchin A, 2019, STEM CELL REV REP, V15, P166, DOI 10.1007/s12015-018-9866-1; Gray SJ, 2013, GENE THER, V20, P450, DOI 10.1038/gt.2012.101; Grewal SS, 2005, GENET MED, V7, P143, DOI 10.1097/01.GIM.0000154299.22120.6A; GUISE KS, 1985, GENE, V34, P105, DOI 10.1016/0378-1119(85)90300-2; Guo Ningning, 2019, JIMD Rep, V43, P37, DOI 10.1007/8904_2018_96; Gurda BL, 2016, MOL THER, V24, P206, DOI 10.1038/mt.2015.189; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; Harmatz P, 2005, PEDIATRICS, V115, pE681, DOI 10.1542/peds.2004-1023; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Harmatz P, 2008, MOL GENET METAB, V94, P469, DOI 10.1016/j.ymgme.2008.04.001; Harmatz P, 2006, J PEDIATR-US, V148, P533, DOI 10.1016/j.jpeds.2005.12.014; Haurigot V, 2013, J CLIN INVEST, V123, P3254, DOI 10.1172/JCI66778; Hendriksz C, 2013, MOL GENET METAB, V108, pS48, DOI 10.1016/j.ymgme.2012.11.110; Hendriksz CJ, 2015, MOLEC GENET METAB RE, V5, P103, DOI 10.1016/j.ymgmr.2015.11.001; Hendriksz CJ, 2016, MOL GENET METAB, V119, P131, DOI 10.1016/j.ymgme.2016.05.018; Hendriksz CJ, 2015, MOL GENET METAB, V114, P178, DOI 10.1016/j.ymgme.2014.08.012; Hendriksz CJ, 2014, J INHERIT METAB DIS, V37, P979, DOI 10.1007/s10545-014-9715-6; Hennermann JB, 2016, J INHERIT METAB DIS, V39, P831, DOI 10.1007/s10545-016-9974-5; Hinderer C, 2014, MOL THER, V22, P2018, DOI 10.1038/mt.2014.135; HOBBS JR, 1981, LANCET, V2, P709; Holley RJ, 2018, BRAIN, V141, P99, DOI 10.1093/brain/awx311; Hoshina H, 2018, MOL GENET METAB, V123, P118, DOI [10.1016/j.yragme.2017.12.428, 10.1016/j.ymgme.2017.12.428]; Hsu YH, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0649-6; Hughes DA, 2017, J MED GENET, V54, P288, DOI 10.1136/jmedgenet-2016-104178; Jakobkiewicz-Banecka J, 2011, CURR PHARM BIOTECHNO, V12, P1860, DOI 10.2174/138920111798376932; Jakobkiewicz-Banecka J, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-26; Jameson E, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009354.pub4; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Jones SA, 2016, MOL GENET METAB, V118, P198, DOI 10.1016/j.ymgme.2016.05.006; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kan S, 2014, P NATL ACAD SCI USA, V111, P14870, DOI 10.1073/pnas.1416660111; Kan SH, 2014, BIOCHEM J, V458, P281, DOI 10.1042/BJ20130845; Kemper AR, 2015, NEWBORN SCREENING MU, P1; Khan SA, 2018, MOL GENET METAB, V125, P44, DOI 10.1016/j.ymgme.2018.04.011; Kiely BT, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0583-7; Kim C, 2017, J HUM GENET, V62, P167, DOI 10.1038/jhg.2016.133; Kim S, 2017, MOL GENET METAB, V122, P92, DOI 10.1016/j.ymgme.2017.06.001; King B, 2017, J INHERIT METAB DIS, V40, P443, DOI 10.1007/s10545-016-9994-1; King B, 2016, EXP NEUROL, V278, P11, DOI 10.1016/j.expneurol.2015.11.013; Kobayashi H, 2019, J HUM GENET, V64, P127, DOI 10.1038/s10038-018-0534-8; Kor D, 2016, J INVEST ALLERG CLIN, V26, P130, DOI 10.18176/jiaci.0030; Krivit W, 1999, Curr Opin Neurol, V12, P167, DOI 10.1097/00019052-199904000-00007; KRIVIT W, 1984, NEW ENGL J MED, V311, P1606, DOI 10.1056/NEJM198412203112504; Kubaski F, 2017, BIOL BLOOD MARROW TR, V23, P1795, DOI 10.1016/j.bbmt.2017.06.020; Lampe C, 2014, J INHERIT METAB DIS, V37, P823, DOI 10.1007/s10545-014-9686-7; Landazuri P, 2009, AFR J BIOTECHNOL, V8, P2871; Langford-Smith A, 2012, MOL THER, V20, P1610, DOI 10.1038/mt.2012.82; Laoharawee K, 2018, MOL THER, V26, P1127, DOI 10.1016/j.ymthe.2018.03.002; Li MD, 2018, PEDIATR ANN, V47, pE191, DOI 10.3928/19382359-20180424-01; Lin HY, 2018, MOL GENET GENOM MED, V6, P982, DOI 10.1002/mgg3.471; Lin SP, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-147; Long B, 2017, CLIN THER, V39, P118, DOI 10.1016/j.clinthera.2016.11.017; Lum SH, 2017, BONE MARROW TRANSPL, V52, P846, DOI 10.1038/bmt.2017.5; Lum SH, 2016, EXPERT OPIN ORPHAN D, V4, P379, DOI 10.1517/21678707.2016.1147948; Lum SH, 2017, J INHERIT METAB DIS, V40, P455, DOI 10.1007/s10545-017-0034-6; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; Martins AM, 2009, J PEDIATR-US, V155, pS32, DOI 10.1016/j.jpeds.2009.07.005; Mentzer WC, 1990, BLOOD, V76, p69a; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Montano AM, 2008, MOL GENET METAB, V94, P178, DOI 10.1016/j.ymgme.2008.01.007; Montano AM, 2016, J MED GENET, V53, P403, DOI 10.1136/jmedgenet-2015-103322; Monteilhet V, 2011, MOL THER, V19, P2084, DOI 10.1038/mt.2011.108; Moore D, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-24; Mosquera A, 2012, PROCESS BIOCHEM, V47, P2097, DOI 10.1016/j.procbio.2012.07.028; Muenzer J, 2007, MOL GENET METAB, V90, P329, DOI 10.1016/j.ymgme.2006.09.001; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Muenzer J, 2016, GENET MED, V18, P73, DOI 10.1038/gim.2015.36; Muenzer J, 2011, GENET MED, V13, P95, DOI 10.1097/GIM.0b013e3181fea459; Mumal I, SANFILIPPO NEWS; Mylius CF, 2016, EXPERT REV RESP MED, V10, P1335, DOI 10.1080/17476348.2016.1258305; Naimy H, 2016, BIOANALYSIS, V8, P285, DOI 10.4155/bio.15.243; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nestrasil I, 2017, AM J MED GENET A, V173, P780, DOI 10.1002/ajmg.a.38073; Neufeld E. F., 2001, METABOLIC MOL BASES, P3421, DOI DOI 10.1036/OMMBID.165; Nijmeijer SCM, 2018, EXPERT OPIN ORPHAN D, V6, P9, DOI 10.1080/21678707.2018.1411797; Nishioka T, 2006, MOL GENET METAB, V88, P244, DOI 10.1016/j.ymgme.2006.02.012; Noh H, 2014, J CLIN PHARM THER, V39, P215, DOI 10.1111/jcpt.12136; Okuyama T, 2019, MOL THER, V27, P456, DOI 10.1016/j.ymthe.2018.12.005; Olarte S, 2014, MOL GENET METAB, V111, pS82, DOI 10.1016/j.ymgme.2013.12.193; Olarte-Avellaneda S, 2014, MOL BIOL REP, V41, P7073, DOI 10.1007/s11033-014-3383-3; Orii K, 2016, MOL GENET METAB, V117, pS88, DOI 10.1016/j.ymgme.2015.12.384; Ou L, 2019, MOL THER, V27, P178, DOI 10.1016/j.ymthe.2018.10.018; Pan P, 2018, BIOANALYSIS, V10, P825, DOI 10.4155/bio-2018-0025; Pardridge WM, 2018, BIODRUGS, V32, P169, DOI 10.1007/s40259-018-0264-7; Parenti G, 2015, MOL THER, V23, P1138, DOI 10.1038/mt.2015.62; Parenti G, 2014, FUTURE MED CHEM, V6, P1031, DOI [10.4155/fmc.14.40, 10.4155/FMC.14.40]; Parini R, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0662-9; Parini R, 2015, MOLEC GENET METAB RE, V3, P65, DOI 10.1016/j.ymgmr.2015.03.011; Patel P, 2014, MOLEC GENET METAB RE, V1, P184, DOI 10.1016/j.ymgmr.2014.04.001; Cacau LDP, 2016, BRAZ J CARDIOVA SURG, V31, P381, DOI 10.5935/1678-9741.20160081; Pereira DM, 2018, CHEM SCI, V9, P1740, DOI 10.1039/c7sc04712f; Peters C, 1998, J PEDIATR-US, V133, P7, DOI 10.1016/S0022-3476(98)70170-2; Pierce OM, 2017, PLANT MOL BIOL, V95, P593, DOI 10.1007/s11103-017-0673-x; Pierce Rob, 2005, Aust Fam Physician, V34, P535; Pimentel N, 2018, BIOTECHNOL APPL BIOC, V65, P655, DOI 10.1002/bab.1660; Piotrowska E, 2009, ACTA PAEDIATR, V98, P743, DOI 10.1111/j.1651-2227.2008.01153.x; Platt Frances M., 2007, P153, DOI 10.1007/978-0-387-70909-3_11; Polgreen LE, 2016, MOL GENET METAB, V117, P427, DOI 10.1016/j.ymgme.2016.01.012; Ponder KP, 2008, J CLIN INVEST, V118, P2686, DOI 10.1172/JCI36521; Poutou-Pinales RA, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue3-fulltext-8; Qi YL, 2019, CLIN PHARMACOKINET, V58, P673, DOI 10.1007/s40262-018-0721-y; Raymond GV, 2016, SCI REP-UK, V6, DOI 10.1038/srep38305; Reyes LH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06367-w; Ribera A, 2015, HUM MOL GENET, V24, P2078, DOI 10.1093/hmg/ddu727; Ries M, 2017, J INHERIT METAB DIS, V40, P343, DOI 10.1007/s10545-017-0032-8; Roberts ALK, 2007, MOL GENET METAB, V92, P115, DOI 10.1016/j.ymgme.2007.06.016; Roberts ALK, 2006, PEDIATR RES, V60, P309, DOI 10.1203/01.pdr.0000233037.00707.da; Rodgers NJ, 2017, J INHERIT METAB DIS, V40, P271, DOI 10.1007/s10545-016-0006-2; Rodriguez A, 2010, J IND MICROBIOL BIOT, V37, P1193, DOI 10.1007/s10295-010-0766-x; Rodriguez-Lopez A, 2016, SCI REP-UK, V6, DOI 10.1038/srep29329; Rodriguez-Nunez I, 2018, REV CHIL PEDIATR-CHI, V89, P128, DOI 10.4067/S0370-41062018000100128; Ruzo A, 2012, HUM GENE THER, V23, P1237, DOI 10.1089/hum.2012.029; Saif MA, 2012, HAEMATOL-HEMATOL J, V97, P1320, DOI 10.3324/haematol.2011.058644; Samaranch L, 2013, HUM GENE THER, V24, P526, DOI 10.1089/hum.2013.005; Sanford M, 2014, DRUGS, V74, P713, DOI 10.1007/s40265-014-0210-z; Schmidt M, 2018, MOL GENET METAB, V123, pS126, DOI 10.1016/j.ymgme.2017.12.343; Schmidt M, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0470-7; Schneller JL, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0798-4; Schrover R, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0633-1; Schuh RS, 2018, J CONTROL RELEASE, V288, P23, DOI 10.1016/j.jconrel.2018.08.031; Schuh RS, 2018, EUR J PHARM BIOPHARM, V122, P158, DOI 10.1016/j.ejpb.2017.10.017; Schweighardt B, 2015, CLIN THER, V37, P1012, DOI 10.1016/j.clinthera.2014.11.005; Seoul National University Hospital, 2014, TARG BUS FLUD ET CON; Sergijenko A, 2013, MOL THER, V21, P1938, DOI 10.1038/mt.2013.141; Sferra TJ, 2000, HUM GENE THER, V11, P507, DOI 10.1089/10430340050015707; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Sheridan C, 2018, NAT BIOTECHNOL, V36, P907, DOI 10.1038/nbt1018-907; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; Sisinni L, 2018, PEDIATR TRANSPLANT, V22, DOI 10.1111/petr.13278; Skorupa AF, 1999, EXP NEUROL, V160, P17, DOI 10.1006/exnr.1999.7176; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; Sohn YB, 2018, J INHERIT METAB DIS, V41, P1235, DOI 10.1007/s10545-018-0221-0; Sohn YB, 2015, MOL GENET METAB, V114, P156, DOI 10.1016/j.ymgme.2014.08.009; Sohn YB, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-42; Sonoda H, 2018, MOL THER, V26, P1366, DOI 10.1016/j.ymthe.2018.02.032; Sorrentino NC, 2016, MOL THER, V24, P276, DOI 10.1038/mt.2015.212; Spina V, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0556-z; Sun XJ, 2015, ANAL CHEM, V87, P6220, DOI 10.1021/acs.analchem.5b00913; Tanaka A, 2012, MOL GENET METAB, V107, P513, DOI 10.1016/j.ymgme.2012.09.004; Tanaka N, 2018, MOL GENET METAB, V125, P53, DOI 10.1016/j.ymgme.2018.07.013; Tardieu M, 2017, LANCET NEUROL, V16, P712, DOI 10.1016/S1474-4422(17)30169-2; Tardieu M, 2014, HUM GENE THER, V25, P506, DOI 10.1089/hum.2013.238; Taylor M, 2019, BIOL BLOOD MARROW TR; Tomatsu S, 2005, HUM MUTAT, V26, P500, DOI 10.1002/humu.20257; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Tomatsu S, 2015, EXPERT OPIN ORPHAN D, V3, P1279, DOI 10.1517/21678707.2015.1086640; Tomatsu S, 2015, DRUG DES DEV THER, V9, P1937, DOI 10.2147/DDDT.S68562; Tomatsu S, 2015, MOL GENET METAB, V114, P94, DOI 10.1016/j.ymgme.2014.12.001; Tomatsu S, 2014, METABOLITES, V4, P655, DOI 10.3390/metabo4030655; Tomatsu S, 2010, MOL THER, V18, P1094, DOI 10.1038/mt.2010.32; Tumani H, 2018, HAND CLINIC, V146, P21, DOI 10.1016/B978-0-12-804279-3.00002-2; Turbeville S, 2011, MOL GENET METAB, V102, P111, DOI 10.1016/j.ymgme.2010.09.010; Ulrich S, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-49; Valayannopoulos V, 2011, RHEUMATOLOGY, V50, pV49, DOI 10.1093/rheumatology/ker396; Valenzano KJ, 2011, ASSAY DRUG DEV TECHN, V9, P213, DOI 10.1089/adt.2011.0370; Valstar MJ, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-43; Visigalli I, 2010, BLOOD, V116, P5130, DOI 10.1182/blood-2010-04-278234; Wakabayashi T, 2015, HUM GENE THER, V26, P357, DOI 10.1089/hum.2014.158; Walker RWM, 2018, J CHILD SCI, V8, pe116; Wang DR, 2009, P NATL ACAD SCI USA, V106, P19958, DOI 10.1073/pnas.0908528106; Wang JM, 2016, BIOL BLOOD MARROW TR, V22, P2104, DOI 10.1016/j.bbmt.2016.08.015; Warkentin P I, 1986, Birth Defects Orig Artic Ser, V22, P31; Welling L, 2015, JIMD REP, V18, P63, DOI 10.1007/8904_2014_350; White K, 2018, ORTHOPEDIC SURG INTE, P597; White KK, 2011, RHEUMATOLOGY, V50, pV26, DOI 10.1093/rheumatology/ker393; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; Winner LK, 2016, HUM GENE THER, V27, P363, DOI 10.1089/hum.2015.170; WOLFE JH, 1992, NATURE, V360, P749, DOI 10.1038/360749a0; Wraith JE, 2014, PEDIATR ENDOCR REV P, V12, P102; Wraith JE, 2007, PEDIATRICS, V120, pE37, DOI 10.1542/peds.2006-2156; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046; Xue Y, 2016, MOL GENET METAB, V117, P419, DOI 10.1016/j.ymgme.2016.02.006; Yabe H, 2016, MOL GENET METAB, V117, P84, DOI 10.1016/j.ymgme.2015.09.011; Yamada Y, 1998, BONE MARROW TRANSPL, V21, P629, DOI 10.1038/sj.bmt.1701141; Yasuda E, 2015, MOLEC GENET METAB RE, V2, P65, DOI 10.1016/j.ymgmr.2014.12.006; Zhang HY, 2011, CLIN CHEM, V57, P1005, DOI 10.1373/clinchem.2010.161141; Zhang HW, 2011, MOL THER, V19, P1440, DOI 10.1038/mt.2011.98; Zhou QH, 2012, DRUG METAB DISPOS, V40, P329, DOI 10.1124/dmd.111.042903; Zou H, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0461-z	265	42	43	1	6	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0012-6667	1179-1950		DRUGS	Drugs	JUL	2019	79	10					1103	1134		10.1007/s40265-019-01147-4	http://dx.doi.org/10.1007/s40265-019-01147-4			32	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	IF6TW	31209777				2022-09-04	WOS:000473214000006
J	Guajardo, VB; Kovalskys, I; Fisberg, M; Salas, GG; Rigotti, A; Cortes, LY; Garcia, MCY; Pareja, RP; Cuenca, MH; Previdelli, AN; Zimberg, IZ				Guajardo, Viviana Beatriz; Kovalskys, Irina; Fisberg, Mauro; Gomez Salas, Georgina; Rigotti, Attilio; Cortes, Lilia Yadira; Yepez Garcia, Martha Cecilia; Pareja, Rossina Pareja; Herrera Cuenca, Marianella; Nogueira Previdelli, Agatha; Zalcman Zimberg, Iona			LEARNING FOR RESEARCHERS: A MULTICENTER STUDY SHARING METHODS OF EVALUATION OF PHYSICAL ACTIVITIES AND INTAKE IN EIGHT COUNTRIES	ANNALS OF NUTRITION AND METABOLISM			English	Meeting Abstract						Multicenter study; feasibility; learnings; Latin America			[Guajardo, Viviana Beatriz; Kovalskys, Irina] Int Life Sci Inst ILSI, Nutr & Hlth Area, Buenos Aires, DF, Argentina; [Fisberg, Mauro] Hosp Infantil Sabara, Fundacao Jose Luiz Egydio Setubal, Inst Pensi, Sao Paulo, Brazil; [Fisberg, Mauro] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Gomez Salas, Georgina] Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose, Costa Rica; [Rigotti, Attilio] Pontificia Univ Catolica, Dept Nutr Diabet & Metab, Escuela Medicina, Ctr Nutr Mol & Enfermedades Cron, Santiago, Chile; [Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador; [Pareja, Rossina Pareja] Inst Invest Nutr, Lima, Peru; [Herrera Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Ctr Estudios Desarrollo, Fdn Bengoa, Caracas, Venezuela; [Nogueira Previdelli, Agatha; Zalcman Zimberg, Iona] Univ Sao Judas Tadeu Sao Paulo, Fac Ciencias Biol & Saude, Sao Paulo, Brazil				Cortes, Lilia Yadira/AAF-2960-2019; Fisberg, Mauro/E-7149-2010	Fisberg, Mauro/0000-0003-2992-3215	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	The ELANS is supported by a scientific grant from the Coca Cola Company and support from the Instituto Pensi/Hospital Infantil Sabara, International Life Science Institute of Argentina, Universidad de Costa Rica, Pontificia Universidad Catolica de Chile, Pontificia Universidad Javeriana, Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa, Universidad San Francisco de Quito, and Instituto de Investigacion Nutricional de Peru. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of this symposium.		0	0	0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-6807	1421-9697		ANN NUTR METAB	Ann. Nutr. Metab.		2017	71			2			43	43						1	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	FM9QD					2022-09-04	WOS:000415605300067
J	Charpak, N; Ruiz, JG; Zupan, J; Cattaneo, A; Figueroa, Z; Tessier, R; Cristo, M; Anderson, G; Ludington, S; Mendoza, S; Mokhachane, M; Worku, B				Charpak, N; Ruiz, JG; Zupan, J; Cattaneo, A; Figueroa, Z; Tessier, R; Cristo, M; Anderson, G; Ludington, S; Mendoza, S; Mokhachane, M; Worku, B			Kangaroo mother care: 25 years after	ACTA PAEDIATRICA			English	Review						neonatology; preterm infants; Kangaroo Mother Care; breastfeeding; infant development	SKIN-TO-SKIN; LOW-BIRTH-WEIGHT; RANDOMIZED CONTROLLED-TRIAL; PRETERM INFANTS; PREMATURE-INFANTS; OXYGEN-CONSUMPTION; TRADITIONAL CARE; CONTACT; TEMPERATURE	The components of the Kangaroo Mother Care (KMC) intervention, their rational bases, and their current uses in low-, middle-, and high-income countries are described. KMC was started in 1978 in Bogota (Colombia) in response to overcrowding and insufficient resources in neonatal intensive care units associated with high morbidity and mortality among low-birth-weight infants. The intervention consists of continuous skin-to-skin contact between the mother and the infant, exclusive breastfeeding, and early home discharge in the kangaroo position. In studies of the physiological effects of KMC, the results for most variables were within clinically acceptable ranges or the same as those for premature infants under other forms of care. Body temperature and weight gain are significantly increased, and a meta-analysis showed that the kangaroo position increases the uptake and duration of breastfeeding. Investigations of the behavioral effects of KMC show rapid quiescence. The psychosocial effects of KMC include reduced stress, enhancement of mother-infant bonding, and positive effects on the family environment and the infant's cognitive development. Conclusion: Past and current research has clarified some of the rational bases of KMC and has provided evidence for its effectiveness and safety, although more research is needed to clearly define the effectiveness of the various components of the intervention in different settings and for different therapeutic goals.	Kangaroo Fdn, Bogota, Colombia; Javeriana Univ, Clin Epidemiol Unit, Bogota, Colombia; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; IRCCS Burlo Garofolo, Unit Hlth Serv Res & Int Hlth, Trieste, Italy; Univ Laval, Sch Psychol, Laval, PQ, Canada; Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA; Jose Fabella Mem Hosp, Dept Neonatol, Manila, Philippines; Chris Hani Baragwana Hosp, Dept Neonatol, Johannesburg, South Africa; Univ Addis Ababa, Fac Med, Dept Pediat & Child Hlth, Addis Ababa, Ethiopia		Charpak, N (corresponding author), Kangaroo Fdn, Carrera 7A 46-20,Apto 2001, Bogota, Colombia.	herchar5@colomsat.net.co	Cattaneo, Adriano/G-6685-2011; Mokhachane, Mantoa/AAO-8740-2021; Ruiz, Juan Gabriel/AAZ-5882-2021	Mokhachane, Mantoa/0000-0001-5596-3654; Ruiz, Juan Gabriel/0000-0003-3088-5834; charpak, nathalie/0000-0001-6697-5837				Affonso D, 1993, Neonatal Netw, V12, P25; Anderson G C, 1991, J Perinatol, V11, P216; Anderson GC, 2003, JOGNN, V32, P604, DOI 10.1177/0884217503256616; Anderson GC, 1999, NURTURING THE PREMATURE INFANT, P131; ANDERSON GC, 1989, AM J NURS, V89, P662, DOI 10.2307/3470761; Anderson GC, 1995, TOUCH EARLY DEV, P35; ANDERSON GC, 2004, SKIN SKIN BREASTFEED; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Bauer J, 1996, J PEDIATR-US, V129, P608, DOI 10.1016/S0022-3476(96)70129-4; Bauer K, 1997, J PEDIATR-US, V130, P240, DOI 10.1016/S0022-3476(97)70349-4; Bauer K, 1998, PEDIATR RES, V44, P247, DOI 10.1203/00006450-199808000-00018; Bergman NJ, 2004, ACTA PAEDIATR, V93, P779, DOI 10.1111/j.1651-2227.2004.tb03018.x; BERGMAN NJ, 1994, TROP DOCT, V24, P57, DOI 10.1177/004947559402400205; BUEHLER DM, 1995, PEDIATRICS, V96, P923; Cattaneo A, 1998, ACTA PAEDIATR, V87, P976, DOI 10.1080/080352598750031653; Charpak N, 1997, PEDIATRICS, V100, P682, DOI 10.1542/peds.100.4.682; CHARPAK N, 1994, PEDIATRICS, V94, P804; Charpak N, 2001, PEDIATRICS, V108, P1072, DOI 10.1542/peds.108.5.1072; Charpak Nathalie, 1996, Current Opinion in Pediatrics, V8, P108, DOI 10.1097/00008480-199604000-00004; CHRISTENSSON K, 1992, ACTA PAEDIATR, V81, P488, DOI 10.1111/j.1651-2227.1992.tb12280.x; Chwo Miao-Ju, 2002, J Nurs Res, V10, P129; CONDEAGUDELO A, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002771; CRISTO M, 2001, THESIS LAVAL U SCH P; Feldman R, 2002, DEV PSYCHOL, V38, P194, DOI 10.1037//0012-1649.38.2.194; Feldman R, 2002, PEDIATRICS, V110, P16, DOI 10.1542/peds.110.1.16; FIELD TM, 1996, J PEDIATR, V109, P183; Fischer CB, 1998, EARLY HUM DEV, V52, P145, DOI 10.1016/S0378-3782(98)00022-X; Gale G, 1993, Neonatal Netw, V12, P49; Kambarami R. A., 1999, Central African Journal of Medicine, V45, P56; Kambarami RA, 2003, ANN TROP PAEDIATR, V23, P55, DOI 10.1179/000349803125002931; LEFEBVRE F, 1982, ARCH DIS CHILD, V57, P511, DOI 10.1136/adc.57.7.511; Lincetto O, 2000, J TROP PEDIATRICS, V46, P293, DOI 10.1093/tropej/46.5.293; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; LUDINGTON SM, 1990, HEART LUNG, V19, P445; Ludington-Hoe S., 1993, KANGAROO CARE BEST Y, V1st ed.; Ludington-Hoe S M, 1996, J Obstet Gynecol Neonatal Nurs, V25, P691, DOI 10.1111/j.1552-6909.1996.tb01483.x; Ludington-Hoe S M, 1999, J Obstet Gynecol Neonatal Nurs, V28, P94, DOI 10.1111/j.1552-6909.1999.tb01970.x; Ludington-Hoe S M, 1993, J Hum Lact, V9, P241, DOI 10.1177/089033449300900424; Ludington-Hoe SM, 2003, JOGNN-J OBST GYN NEO, V32, P579, DOI 10.1177/0884217503257618; Ludington-Hoe Susan M, 2002, Neonatal Netw, V21, P29; LUDINGTONHOE SM, 1992, J DEV PHYSIOL, V18, P223; LUDINGTONHOE SM, 1999, J INVEST MED, V47, P173; LUDINGTONHOE SM, 1992, INFANT BEHAV DEV, V15, P537; Malhotra N, 1999, EARLY HUM DEV, V54, P29, DOI 10.1016/S0378-3782(98)00082-6; Merritt T A, 1998, J Perinatol, V18, pS27; Messmer P R, 1997, Pediatr Nurs, V23, P408; Moore ER, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub2; Neu M, 1999, J Obstet Gynecol Neonatal Nurs, V28, P157, DOI 10.1111/j.1552-6909.1999.tb01980.x; Neu M, 2000, NURS RES, V49, P215, DOI 10.1097/00006199-200007000-00005; Ruiz JG, 2002, ACTA PAEDIATR, V91, P1130, DOI 10.1080/080352502760311665; SLOAN NL, 1994, LANCET, V344, P782, DOI 10.1016/S0140-6736(94)92341-8; SMITH SL, 2001, ADV NEONATAL CARE, V1, P28; Swinth Joan Y, 2003, Neonatal Netw, V22, P33; SYMINGTON A, 2001, COCHRANE DB SYST REV, V4, P1814; Tessier R, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.2.e17; Tessier R, 2003, INFANT BEHAV DEV, V26, P384, DOI 10.1016/S0163-6383(03)00037-7; Wahlberg V, 1992, EUR J PUBLIC HEALTH, V2, P34, DOI DOI 10.1093/EURPUB/2.1.34; Weller A, 2002, HORM RES, V57, P22, DOI 10.1159/000057942; WHITELAW A, 1988, ARCH DIS CHILD, V63, P1377, DOI 10.1136/adc.63.11.1377; *WHO, 2003, DEP REPR HLTH RES WH	60	161	171	3	46	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	MAY	2005	94	5					514	522		10.1080/08035250510027381	http://dx.doi.org/10.1080/08035250510027381			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	926IR	16188735				2022-09-04	WOS:000229117400001
J	Barreto, GE; Gonzalez, J; Reiner, Z; Jamialahmadi, T; Echeverria, V; Ashraf, GM; Sahebkar, A				Barreto, George E.; Gonzalez, Janneth; Reiner, Zeljko; Jamialahmadi, Tannaz; Echeverria, Valentina; Ashraf, Ghulam Md; Sahebkar, Amirhossein			In silico interactions of statins with cell death-inducing DNA fragmentation factor-like effector A (CIDEA)	CHEMICO-BIOLOGICAL INTERACTIONS			English	Article						CIDEA; Statins; Lipid metabolism; Molecular docking; Cardiovascular disease; Cerebrovascular disease; Apoptosis	LIPID DROPLETS; ATORVASTATIN; LYMPHOCYTES; SECRETION; PROTEINS; STORAGE; SILICO	Statins are the low-density lipoproteins (LDL)-cholesterol-lowering drugs of first choice and are used to prevent the increased risk of cardiovascular and cerebrovascular diseases. Although some of their effects are well known, little is known about their ability to regulate other lipid-related proteins which control apoptotic mechanisms. The aim of this study was to explore whether statins can bind to cell death-inducing DNA fragmentation factorlike effector A (CIDEA), which might be a possible pleiotropic mechanism of action of these drugs on the modulation of apoptosis and lipid metabolism. The structures of statins were subjected to molecular docking and dynamics with the human CIDEA protein to investigate the interaction pattern and identify which residues are important. The docking results indicated that atorvastatin and rosuvastatin showed the best interaction energy (-8.51 and -8.04 kcal/mol, respectively) followed by fluvastatin (-7.39), pitavastatin (-6.5), lovastatin (-6.23), pravastatin (-6.04) and simvastatin (-5.29). Atorvastatin and rosuvastatin were further subjected to molecular dynamics at 50 ns with CIDEA and the results suggested that rosuvastatin-CIDEA complex had lower root-mean square deviation and root-mean square fluctuation when compared with atorvastatin-CIDEA. Since two arginine residues -ARG19 and ARG22-were identified to be common for the interaction with CIDEA, a singlepoint mutation was induced in these residues to determine whether they are important for binding interaction. Mutation of these two residues seemed to affect mostly the interaction of atorvastatin with CIDEA, suggesting that they are important for the binding and therefore indicate another possible metabolic mechanism of the pleiotropic effects of this statin.	[Barreto, George E.] Univ Limerick, Dept Biol Sci, Limerick, Ireland; [Barreto, George E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland; [Gonzalez, Janneth] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Reiner, Zeljko] Univ Hosp Ctr Zagreb, Dept Internal Med, Zagreb, Croatia; [Jamialahmadi, Tannaz] Islamic Azad Univ, Dept Food Sci & Technol, Quchan Branch, Quchan, Iran; [Jamialahmadi, Tannaz] Mashhad Univ Med Sci, Fac Med, Dept Nutr, Mashhad, Razavi Khorasan, Iran; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lab Neurobiol, Concepcion, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Barreto, GE (corresponding author), Univ Limerick, Dept Biol Sci, Limerick, Ireland.	George.Barreto@ul.ie	GONZALEZ, JANNETH/AAB-9948-2020; Ashraf, Ghulam Md/H-9485-2012	GONZALEZ, JANNETH/0000-0003-4482-256X; Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Jami, Tannaz/0000-0001-9521-3153				Afshari A.R., 2020, SEMIN CANCER BIOL; Alidadi M., 2021, BIOMED RES INT, P2021; Aqeel MT, 2018, DRUG DES DEV THER, V12, P2443, DOI 10.2147/DDDT.S158554; Araujo-Lima CF, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7820890; Bagheri H, 2020, BIOFACTORS, V46, P309, DOI 10.1002/biof.1597; Cabezas R, 2021, ADV EXP MED BIOL, V1308, P589, DOI 10.1007/978-3-030-64872-5_29; Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272; Chakraborty S, 2019, J NUTR SCI, V8, DOI 10.1017/jns.2019.28; Chatterjee A, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.38; Chu LW, 2015, ACS CHEM NEUROSCI, V6, P889, DOI 10.1021/acschemneuro.5b00032; CIARAVINO V, 1995, MUTAT RES-GENET TOX, V343, P95, DOI 10.1016/0165-1218(95)90076-4; Clarke RM, 2008, J BIOL CHEM, V283, P1808, DOI 10.1074/jbc.M707442200; Dulka K, 2021, INT J MOL SCI, V22, P3412, DOI 10.3390/ijms22073412; Feldo Marcin, 2013, Pol Przegl Chir, V85, P644, DOI 10.2478/pjs-2013-0097; Forouzanfar F, 2018, PHARMACOL RES, V134, P134, DOI 10.1016/j.phrs.2018.06.020; Gajski G, 2008, TOXICOL APPL PHARM, V231, P85, DOI 10.1016/j.taap.2008.03.013; Gajski G, 2008, J ENVIRON SCI HEAL A, V43, P78, DOI 10.1080/10934520701750066; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Islam B, 2015, DRUG DES DEV THER, V9, P4943, DOI 10.2147/DDDT.S86705; Kata D, 2016, NEUROSCIENCE, V314, P47, DOI 10.1016/j.neuroscience.2015.11.053; Kumar SK, 2020, INT J BIOL MACROMOL, V146, P1087, DOI 10.1016/j.ijbiomac.2019.09.235; Lee N, 2020, J CELL MOL MED, V24, P7055, DOI 10.1111/jcmm.15389; Li JZ, 2010, BBA-MOL CELL BIOL L, V1801, P577, DOI 10.1016/j.bbalip.2010.01.012; Lindberg C, 2005, J NEUROSCI RES, V82, P10, DOI 10.1002/jnr.20615; Liu AM, 2019, PHARMACOL THERAPEUT, V195, P54, DOI 10.1016/j.pharmthera.2018.10.004; Lugovskoy AA, 1999, CELL, V99, P747, DOI 10.1016/S0092-8674(00)81672-4; Lyons A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-27; Mollazadeh H, 2021, J CACHEXIA SARCOPENI, V12, P237, DOI 10.1002/jcsm.12654; Paez PA, 2020, J PHARMACOL EXP THER, V374, P104, DOI 10.1124/jpet.119.264234; Parizadeh SMR, 2011, LIPIDS, V46, P333, DOI 10.1007/s11745-010-3517-x; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Reiner Z, 2020, ARCH MED SCI, V16, P490, DOI 10.5114/aoms.2020.94655; Reiner Z, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0420-6; Reiner Z, 2013, NAT REV CARDIOL, V10, DOI 10.1038/nrcardio.2013.80-c2; Sahebkar A, 2016, THROMB HAEMOSTASIS, V115, P520, DOI 10.1160/TH15-08-0620; Schneider MR, 2016, EXP CELL RES, V340, P205, DOI 10.1016/j.yexcr.2015.11.008; Shakour N, 2019, J CELL BIOCHEM, V120, P4710, DOI 10.1002/jcb.27761; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Wang S, 2018, J MOL NEUROSCI, V64, P363, DOI 10.1007/s12031-018-1032-3; Wang WS, 2012, NAT MED, V18, P235, DOI 10.1038/nm.2614; Wei G., J BIOCHEM MOL TOXIC, V35; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Zhang SS, 2014, MOL CELL BIOL, V34, P1827, DOI 10.1128/MCB.01723-13; Zi L, 2021, INT J NANOMED, V16, P2933, DOI 10.2147/IJN.S294916	44	2	2	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0009-2797	1872-7786		CHEM-BIOL INTERACT	Chem.-Biol. Interact.	AUG 25	2021	345								109528	10.1016/j.cbi.2021.109528	http://dx.doi.org/10.1016/j.cbi.2021.109528		JUN 2021	6	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	TU6GC	34022192	Green Published, hybrid			2022-09-04	WOS:000681131700010
J	Zarante, I; Hurtado-Villa, P; Walani, SR; Kancherla, V; Camelo, JL; Giugliani, R; Groisman, B; Howson, CP; Duran, P				Zarante, Ignacio; Hurtado-Villa, Paula; Walani, Salimah R.; Kancherla, Vijaya; Lopez Camelo, Jorge; Giugliani, Roberto; Groisman, Boris; Howson, Christopher P.; Duran, Pablo		8th Int Conference Birth Defects	A consensus statement on birth defects surveillance, prevention, and care in Latin America and the Caribbean	REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article						Congenital abnormalities; epidemiology; medical care; neonatal screening; prenatal diagnosis; primary prevention; surveillance; Latin America; West Indies		Birth defects contribute up to 21% of the mortality in those under 5 years of age in Latin America and the Caribbean (LAC), and that burden has been compounded by the Zika virus epidemic. In 2001, the March of Dimes launched a series of biennial assemblies called the International Conference on Birth Defects and Disabilities in the Developing World (ICBD). The latest ICBD, in 2017, convened in Bogota, Colombia, and was attended by over 300 professionals, policymakers, and donors. The conference attendees, a majority of whom were from LAC, supported a call to action in the form of a consensus statement. The consensus statement lists key actions for maximizing birth defects surveillance, prevention, and care in LAC: 1) improving surveillance; 2) reducing risks for birth defects; 3) fortifying staple foods; 4) preventing and treating infections associated with birth defects; 5) implementing newborn screening; 6) providing care and services for people with birth defects and disabilities; 7) involving governments, civil society, and international agencies; and 8) advancing research for birth defects. Implementation and scale-up of evidence-based interventions using multisectoral and multidisciplinary collaborative approaches were endorsed. LAC countries can leverage technology and social media to advance and advocate for approaches identified in the consensus statement. The consensus statement can be used as a guide by both governments and nongovernmental agencies to take immediate steps for improving the quality of life of those living with birth defects and associated disabilities in the LAC countries.	[Zarante, Ignacio] Pontificia Univ Javeriana, Sch Med, Inst Human Genet, Bogota, Colombia; [Hurtado-Villa, Paula] Pontificia Univ Javeriana, Fac Hlth Sci, Basic Hlth Sci Dept, Cali, Colombia; [Walani, Salimah R.] March Dimes, Arlington, VA 22202 USA; [Kancherla, Vijaya] Emory Univ, Ctr Spina Bifida Prevent, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Lopez Camelo, Jorge] Ctr Med Educ & Clin Res CEMIC CONICET, Latin Amer Collaborat Study Congenital Malformat, Buenos Aires, DF, Argentina; [Giugliani, Roberto] Univ Fed Rio Grande do Sul, Med Genet Serv, Hosp Clin Porto Alegre, Dept Genet, Porto Alegre, RS, Brazil; [Groisman, Boris] Natl Network Congenital Anomalies Argentina, Natl Ctr Med Genet, Natl Adm Labs & Hlth Inst, Buenos Aires, DF, Argentina; [Howson, Christopher P.] Howson & Partners Global Hlth, Santa Fe, NM USA; [Duran, Pablo] World Hlth Org, Pan Amer Hlth Org, Latin Amer Ctr Perinatol Womens & Reprod Hlth, Montevideo, Uruguay		Walani, SR (corresponding author), March Dimes, Arlington, VA 22202 USA.	swalani@marchofdimes.org	Zarante, Ignacio/L-6467-2017; Zarante, Ignacio/AAL-6215-2021; Villa, Paula Margarita Hurtado/O-2543-2014	Zarante, Ignacio/0000-0002-0729-6866; Zarante, Ignacio/0000-0002-0729-6866; Villa, Paula Margarita Hurtado/0000-0003-3822-7780; Lopez-Camelo, Jorge S./0000-0002-3146-5447	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743; [Anonymous], 2017, 8 INT C BIRTH DEF DI; Gili JA, 2016, BIRTH DEFECTS RES A, V106, P257, DOI 10.1002/bdra.23481; Bautista LE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5566-7; Botto LD, 2018, ANN NY ACAD SCI, V1414, P126, DOI 10.1111/nyas.13600; Campana H, 2010, J ULTRAS MED, V29, P203, DOI 10.7863/jum.2010.29.2.203; Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776; Darmstadt GL, 2016, JAMA PEDIATR, V170, P790, DOI 10.1001/jamapediatrics.2016.0388; Every Woman Every Child, GLOB STRAT WOM CHILD; Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194; Howson CP, 2018, MOL GENET METAB, V124, P177, DOI 10.1016/j.ymgme.2018.04.009; International Telecommunication Union, ICT FACTS FIGURES 20; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Martorell R, 2017, FOOD NUTR BULL, V38, P384, DOI 10.1177/0379572117707890; Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402; Nading A, 2018, MED ANTHROPOL, P1; O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8; Rittler M, 2004, BIRTH DEFECTS RES A, V70, P939, DOI 10.1002/bdra.20089; Rosenthal J, 2014, PUBLIC HEALTH NUTR, V17, P537, DOI 10.1017/S1368980013000256; The United Nations Development Programme, SOC IMP ASS ZIK VIR; Trindade IEK, 2006, CLEFT PALATE-CRAN J, V43, P722, DOI 10.1597/05-124; United Nations, SUST DEV GOAL 3 ENS; Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485; Woodhouse C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091292	24	6	8	0	0	PAN AMER HEALTH ORGANIZATION	WASHINGTON	525 23RD ST NW, WASHINGTON, DC 20037 USA	1020-4989			REV PANAM SALUD PUBL	Rev. Panam. Salud Publica		2019	43								e2	10.26633/RPSP.2019.2	http://dx.doi.org/10.26633/RPSP.2019.2			6	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	IU2MW	31093226	Green Published, gold, Green Submitted			2022-09-04	WOS:000483415500001
J	Bachurin, SO; Shevtsova, EF; Makhaeva, GF; Grigoriev, VV; Boltneva, NP; Kovaleva, NV; Lushchekina, SV; Shevtsov, PN; Neganova, ME; Redkozubova, OM; Bovina, EV; Gabrelyan, AV; Fisenko, VP; Sokolov, VB; Aksinenko, AY; Echeverria, V; Barreto, GE; Aliev, G				Bachurin, Sergey O.; Shevtsova, Elena F.; Makhaeva, Galina F.; Grigoriev, Vladimir V.; Boltneva, Natalia P.; Kovaleva, Nadezhda V.; Lushchekina, Sofya V.; Shevtsov, Pavel N.; Neganova, Margarita E.; Redkozubova, Olga M.; Bovina, Elena V.; Gabrelyan, Alexey V.; Fisenko, Vladimir P.; Sokolov, Vladimir B.; Aksinenko, Alexey Yu; Echeverria, Valentina; Barreto, George E.; Aliev, Gjumrakch			Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment	SCIENTIFIC REPORTS			English	Article							METHYL-D-ASPARTATE; BETA-AMYLOID PEPTIDE; NMDA RECEPTOR ANTAGONISM; TARGET-DIRECTED LIGANDS; SLOW-BINDING INHIBITION; ALZHEIMERS-DISEASE; BUTYRYLCHOLINESTERASE INHIBITION; THERAPEUTIC TARGET; ESTERASE PROFILES; IFENPRODIL	A new group of compounds, promising for the design of original multitarget therapeutic agents for treating neurodegenerative diseases, based on conjugates of aminoadamantane and carbazole derivatives was synthesized and investigated. Compounds of these series were found to interact with a group of targets that play an important role in the development of this type of diseases. First of all, these compounds selectively inhibit butyrylcholinest erase, block NMDA receptors containing NR2B subunits while maintaining the properties of MK-801 binding site blockers, exert microtubules stabilizing properties, and possess the ability to protect nerve cells from death at the calcium overload conditions. The leading compound C-2h has been shown the most promising effects on all analyzed parameters. Thus, these compounds can be regarded as promising candidates for the design of multitarget disease-modifying drugs for treatment of AD and/or similar neuropathologies.	[Bachurin, Sergey O.; Shevtsova, Elena F.; Makhaeva, Galina F.; Grigoriev, Vladimir V.; Boltneva, Natalia P.; Kovaleva, Nadezhda V.; Lushchekina, Sofya V.; Shevtsov, Pavel N.; Neganova, Margarita E.; Redkozubova, Olga M.; Bovina, Elena V.; Gabrelyan, Alexey V.; Sokolov, Vladimir B.; Aksinenko, Alexey Yu; Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia; [Lushchekina, Sofya V.] Russian Acad Sci, Emanuel Inst Biochem Phys, Moscow 119334, Russia; [Fisenko, Vladimir P.] IM Setchenov Moscow Med Acad, Therapeut Fac, Dept Pharmacol, Ul Bolshaya Pirogovskaya 2-6, Moscow 119881, Russia; [Echeverria, Valentina] Univ San Sebastian, Gen Cruz 1577, Concepcion, Chile; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA		Aliev, G (corresponding author), Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.; Aliev, G (corresponding author), Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA.	aliev03@gmail.com	Lushchekina, Sofya/F-8469-2010; Barreto, George E./AAD-7420-2020; Makhaeva, Galina/A-9412-2014; Bovina, Elena/R-1233-2017; Aksinenko, Alexey/AAB-4616-2021; Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./B-5747-2014; Aliev, Gjumrakch/K-7302-2017; Neganova, Margarita E/L-8499-2017; Sergey, Bachurin/I-1708-2018; Valentina Echeverria Moran, BCh/E-7765-2013; Shevtsova, Elena/G-6288-2017; Grigoriev, Vladimir/ABA-7052-2020	Lushchekina, Sofya/0000-0002-6922-020X; Barreto, George E./0000-0002-6644-1971; Bovina, Elena/0000-0002-0251-3614; Aksinenko, Alexey/0000-0002-7281-9467; Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Elena, Shevtsova/0000-0003-2887-1185; Boltneva, Natalia/0000-0002-7171-8832; Kovaleva, Nadezhda/0000-0002-4990-5068	Russian Science Foundation [14-23-00160]; Russian Science Foundation [17-23-00013] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by the grant of the Russian Science Foundation (project number 14-23-00160). Authors are grateful to the Lomonosov State University Research Super Computer Center for providing computational facilities92.	Agis-Torres A, 2014, CURR NEUROPHARMACOL, V12, P2, DOI 10.2174/1570159X113116660047; Al-Aboudi A, 2015, ACTA PHARMACOL SIN, V36, P879, DOI 10.1038/aps.2014.173; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Averina EB, 2016, BIOORGAN MED CHEM, V24, P712, DOI 10.1016/j.bmc.2015.12.040; Bachurin S. O, 2015, Russian Fedeartion patent Appl, Patent No. 2015146080; Bachurin S. O., 2015, Russian Federation patent Appl., Patent No. 2015146079; Bachurin SO, 2017, MED RES REV, V37, P1186, DOI 10.1002/med.21434; Ballatore C, 2012, J MED CHEM, V55, P8979, DOI 10.1021/jm301079z; Blasco H, 2014, CURR MED CHEM, V21, P3551, DOI 10.2174/0929867321666140916120118; Bolognesi ML, 2016, CHEMMEDCHEM, V11, P1190, DOI 10.1002/cmdc.201600161; Borza I, 2006, CURR TOP MED CHEM, V6, P687, DOI 10.2174/156802606776894456; Brunden KR, 2014, BIOORGAN MED CHEM, V22, P5040, DOI 10.1016/j.bmc.2013.12.046; Cacabelos R, 1999, INT J GERIATR PSYCH, V14, P3, DOI 10.1002/(SICI)1099-1166(199901)14:1<3::AID-GPS897>3.0.CO;2-7; Canas PM, 2014, NEUROPHARMACOLOGY, V76, P51, DOI 10.1016/j.neuropharm.2013.08.026; Carreiras MC, 2013, CURR TOP MED CHEM, V13, P1745, DOI 10.2174/15680266113139990135; Cavalli A, 2008, J MED CHEM, V51, P347, DOI 10.1021/jm7009364; Chazot PL, 2004, CURR MED CHEM, V11, P389, DOI 10.2174/0929867043456061; CHENARD BL, 1991, J MED CHEM, V34, P3085, DOI 10.1021/jm00114a018; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Coughenour LL, 2001, J PHARMACOL EXP THER, V296, P150; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; DANA C, 1991, NEUROSCI LETT, V125, P45, DOI 10.1016/0304-3940(91)90127-F; Darvesh S, 2016, CHEM-BIOL INTERACT, V259, P307, DOI 10.1016/j.cbi.2016.04.022; Darvesh S, 2016, CURR ALZHEIMER RES, V13, P1173, DOI 10.2174/1567205013666160404120542; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Furukawa-Hibi Y, 2011, BEHAV BRAIN RES, V225, P222, DOI 10.1016/j.bbr.2011.07.035; Gandy S, 2013, ANNU REV MED, V64, P367, DOI 10.1146/annurev-med-092611-084441; Gauthier S, 2013, ALZHEIMERS DEMENT, V9, P326, DOI 10.1016/j.jalz.2011.11.005; Gluszynska A, 2015, EUR J MED CHEM, V94, P405, DOI 10.1016/j.ejmech.2015.02.059; Gornstein E, 2014, NEUROPHARMACOLOGY, V76, P175, DOI 10.1016/j.neuropharm.2013.08.016; Greig NH, 2005, P NATL ACAD SCI USA, V102, P17213, DOI 10.1073/pnas.0508575102; Grimwood S, 2000, J NEUROCHEM, V75, P2455, DOI 10.1046/j.1471-4159.2000.0752455.x; Hofner G, 2000, EUR J PHARMACOL, V394, P211, DOI 10.1016/S0014-2999(00)00084-4; Hu NW, 2009, P NATL ACAD SCI USA, V106, P20504, DOI 10.1073/pnas.0908083106; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hur EM, 2014, INT NEUROUROL J, V18, P171, DOI 10.5213/inj.2014.18.4.171; Ihalainen J, 2011, NEUROPHARMACOLOGY, V61, P891, DOI 10.1016/j.neuropharm.2011.06.008; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Kamal MA, 2008, NEUROCHEM RES, V33, P745, DOI 10.1007/s11064-007-9490-y; KARBON EW, 1990, EUR J PHARMACOL, V176, P247, DOI 10.1016/0014-2999(90)90538-H; Kharlamova AD, 2016, BIOCHEM J, V473, P1225, DOI 10.1042/BCJ20160084; Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280; LEE JC, 1977, BIOCHEMISTRY-US, V16, P1754, DOI 10.1021/bi00627a037; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Lushchekina SV, 2013, RUSS CHEM B+, V62, P2527, DOI 10.1007/s11172-013-0366-9; MacMillan KS, 2011, J AM CHEM SOC, V133, P1428, DOI 10.1021/ja108211m; Makhaeva GF, 2016, CHEM-BIOL INTERACT, V259, P332, DOI 10.1016/j.cbi.2016.05.002; Makhaeva GF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13164; Makhaeva GF, 2013, CHEM-BIOL INTERACT, V203, P231, DOI 10.1016/j.cbi.2012.10.012; Maksay G, 2005, EUR J PHARMACOL, V514, P17, DOI 10.1016/j.ejphar.2005.03.019; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Masson P, 2016, ARCH BIOCHEM BIOPHYS, V593, P60, DOI 10.1016/j.abb.2016.02.010; Masson P, 2013, BIOCHEM J, V454, P387, DOI 10.1042/BJ20130389; MCCOOL BA, 1995, NEUROPHARMACOLOGY, V34, P621, DOI 10.1016/0028-3908(95)00030-A; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; NIKS M, 1990, J IMMUNOL METHODS, V130, P149, DOI 10.1016/0022-1759(90)90309-J; Nordberg Agneta, 2013, Prim Care Companion CNS Disord, V15, DOI 10.4088/PCC.12r01412; NOWAK G, 1993, J PHARMACOL EXP THER, V265, P1380; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Parsons CG, 2013, NEUROTOX RES, V24, P358, DOI 10.1007/s12640-013-9398-z; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Pieper AA, 2014, CHEM SOC REV, V43, P6716, DOI 10.1039/c3cs60448a; Ramanan VK, 2014, MOL PSYCHIATR, V19, P351, DOI 10.1038/mp.2013.19; Reid GA, 2015, NEUROSCIENCE, V298, P424, DOI 10.1016/j.neuroscience.2015.04.039; Rosini M, 2014, NEUROCHEM RES, V39, P1914, DOI 10.1007/s11064-014-1250-1; Rosini M, 2014, FUTURE MED CHEM, V6, P485, DOI 10.4155/fmc.14.25; Saturnino C, 2014, MOLECULES, V19, P9307, DOI 10.3390/molecules19079307; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sekutor M, 2012, BIOORG CHEM, V41-42, P28, DOI 10.1016/j.bioorg.2012.01.004; Sengottuvel Vetrivel, 2011, Commun Integr Biol, V4, P391, DOI 10.4161/cib.4.4.15552; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Shevtsov PN, 2008, B EXP BIOL MED+, V145, P218, DOI 10.1007/s10517-008-0054-1; Shevtsov PN, 2006, B EXP BIOL MED+, V141, P265, DOI 10.1007/s10517-006-0145-9; Shevtsov PN, 2014, B EXP BIOL MED+, V156, P768, DOI 10.1007/s10517-014-2445-9; Shevtzova EF, 2001, B EXP BIOL MED+, V132, P1173, DOI 10.1023/A:1014559331402; Simoni E, 2012, J MED CHEM, V55, P9708, DOI 10.1021/jm3009458; Sokolov VB, 2016, RUSS CHEM B+, V65, P1354, DOI 10.1007/s11172-016-1461-5; STERRI SH, 1985, BIOCHEM PHARMACOL, V34, P2779, DOI 10.1016/0006-2952(85)90579-9; Takahashi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14781; Dias KST, 2014, CURR NEUROPHARMACOL, V12, P239, DOI 10.2174/1570159X1203140511153200; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsurkan LG, 2013, CHEM-BIOL INTERACT, V203, P226, DOI 10.1016/j.cbi.2012.10.018; Voevodin V. V., 2012, OPEN SYSTEMS J, V7; Wang L, 2014, EUR J MED CHEM, V80, P543, DOI 10.1016/j.ejmech.2014.04.078; Williams K, 2001, CURR DRUG TARGETS, V2, P285, DOI 10.2174/1389450013348489; Wu LJ, 2009, NEUROTHERAPEUTICS, V6, P693, DOI 10.1016/j.nurt.2009.07.008; Zhou LM, 1997, J PHARMACOL EXP THER, V280, P422	92	43	44	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 30	2017	7								45627	10.1038/srep45627	http://dx.doi.org/10.1038/srep45627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6XM	28358144	Green Published, Green Submitted, gold			2022-09-04	WOS:000398953200001
J	Arroyave, I; Hessel, P; Burdorf, A; Rodriguez-Garcia, J; Cardona, D; Avendano, M				Arroyave, Ivan; Hessel, Philipp; Burdorf, Alex; Rodriguez-Garcia, Jesus; Cardona, Doris; Avendano, Mauricio			The public health impact of economic fluctuations in a Latin American country: mortality and the business cycle in Colombia in the period 1980-2010	INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH			English	Article						Mortality; Economic recession; Colombia; Developing countries; Health insurance	RECESSIONS GOOD; CYCLICALITY; INSURANCE; TIMES	Introduction: Studies in high-income countries suggest that mortality is related to economic cycles, but few studies have examined how fluctuations in the economy influence mortality in low-and middle-income countries. We exploit regional variations in gross domestic product per capita (GDPpc) over the period 1980-2010 in Colombia to examine how changes in economic output relate to adult mortality. Methods: Data on the number of annual deaths at ages 20 years and older (n = 3,506,600) from mortality registries, disaggregated by age groups, sex and region, were linked to population counts for the period 1980-2010. We used region fixed effect models to examine whether changes in regional GDPpc were associated with changes in mortality. We carried out separate analyses for the periods 1980-1995 and 2000-2010 as well as by sex, distinguishing three age groups: 20-44 (predominantly young working adults), 45-64 (middle aged working adults), and 65+ (senior, predominantly retired individuals). Results: The association between regional economic conditions and mortality varied by period and age groups. From 1980 to 1995, increases in GDPpc were unrelated to mortality at ages 20 to 64, but they were associated with reductions in mortality for senior men. In contrast, from 2000 to 2010, changes in GDPpc were not associated with old age mortality, while an increase in GDPpc was associated with a decline in mortality at ages 20-44 years. Analyses restricted to regions with high registration coverage yielded similar albeit less precise estimates for most sub-groups. Conclusions: The relationship between business cycles and mortality varied by period and age in Colombia. Most notably, mortality shifted from being acyclical to being countercyclical for males aged 20-44, while it shifted from being countercyclical to being acyclical for males aged 65+.	[Arroyave, Ivan; Burdorf, Alex; Avendano, Mauricio] Erasmus Univ, Med Ctr, Dept Publ Hlth, NL-3015 GE Rotterdam, Netherlands; [Arroyave, Ivan] Univ Antioquia, Natl Sch Publ Hlth, Medellin, Colombia; [Hessel, Philipp; Avendano, Mauricio] Univ London London Sch Econ & Polit Sci, LSE Hlth & Social Care, London WC2A 2AE, England; [Hessel, Philipp; Avendano, Mauricio] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Rodriguez-Garcia, Jesus] Pontificia Univ Javeriana, Bogota 11001000, DC, Colombia; [Cardona, Doris] Univ CES, Fac Med, Medellin, Colombia		Arroyave, I (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	ivan.arroyave@udea.edu.co	Hessel, Philipp/AAU-6761-2020; Burdorf, Alex/A-2226-2008; Avendano, Mauricio/C-9658-2018	Hessel, Philipp/0000-0002-8754-5710; Burdorf, Alex/0000-0003-3129-2862; Avendano, Mauricio/0000-0002-7295-2911	European Union Erasmus Mundus Partnerships Program Erasmus-Columbus (Eracol); Rotterdam Global Health Initiative (RGHI); Direction of Research of the Universidad CES, Medellin-Colombia [2012DI09]; European Research Council (ERC) [263684]; National Institute on Aging [R01AG040248, R01AG037398]; Erasmus University; McArthur Foundation Research Network on Ageing; NATIONAL INSTITUTE ON AGING [R01AG037398, R01AG040248] Funding Source: NIH RePORTER	European Union Erasmus Mundus Partnerships Program Erasmus-Columbus (Eracol); Rotterdam Global Health Initiative (RGHI); Direction of Research of the Universidad CES, Medellin-Colombia; European Research Council (ERC)(European Research Council (ERC)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Erasmus University; McArthur Foundation Research Network on Ageing; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Ivan Arroyave was supported by the European Union Erasmus Mundus Partnerships Program Erasmus-Columbus (Eracol), and researcher grants from the Rotterdam Global Health Initiative (RGHI), and the Direction of Research of the Universidad CES, Medellin-Colombia (grant No 2012DI09). Mauricio Avendano and Philipp Hessel were supported by a Starting Researcher grant from the European Research Council (ERC grant No 263684). Mauricio Avendano was additionally supported by the National Institute on Aging (grants R01AG040248 and R01AG037398), a fellowship from the Erasmus University, and the McArthur Foundation Research Network on Ageing. The sponsors of the authors had no role in study design, data collection, data analysis, interpretation of the results, or writing of the report. There was no financial support for this work that could have influenced its outcome. The authors are pleased to declare that they have no competing interests.	Calderon CAA, 2011, CIENC SAUDE COLETIVA, V16, P2817, DOI 10.1590/S1413-81232011000600020; [Anonymous], 2001, GPE DISCUSSION PAPER; Ariizumi H, 2012, SOC SCI MED, V74, P1224, DOI 10.1016/j.socscimed.2011.12.038; Arriaga EE, 2003, RURAL URBAN PROJECTI, VII; Avendano M., 2014, SOCIAL EPIDEMIOLOGY, V2, P182, DOI [10.1093/med/9780195377903.001.0001, DOI 10.1093/MED/9780195377903.001.0001]; Bhalotra S, 2010, J DEV ECON, V93, P7, DOI 10.1016/j.jdeveco.2009.03.006; Bossert TJ, 2003, B WORLD HEALTH ORGAN, V81, P95; Buchmueller T., 2007, WORKING PAPER SERIES, V2007-04; Camacho A, 2013, ECON DEV CULT CHANGE, V61, P633, DOI 10.1086/669263; Céspedes-Londoño Juan Eduardo, 2002, Cad. Saúde Pública, V18, P1003, DOI 10.1590/S0102-311X2002000400008; DANE, 2011, MET CUENT DEP BAS 20; DANE, 2011, CUENT NAC DEP; Dehejia R, 2004, Q J ECON, V119, P1091, DOI 10.1162/0033553041502216; Departamento Administrativo Nacional de Estadistica, 2007, COL TABL ABR MORT NA; Departamento Nacional de Planeacion, 2013, PROGR DES SOC SUBD S; Departamento Nacional de Planeacion, 2013, AS HIST PART TERR 19; Economic Commission for Latin America and the Caribbean, 2011, SOC PAN LAT AM 2010, P252; Ferreira FHG, 2009, WORLD BANK RES OBSER, V24, P147, DOI 10.1093/wbro/lkp006; Fiess NM, 2010, J DEV ECON, V91, P211, DOI 10.1016/j.jdeveco.2009.09.009; Florez C.E., 1995, NIVEL SUBREGISTRO DE, P69; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Gonzalez F, 2011, EMPIR ECON, V40, P305, DOI 10.1007/s00181-010-0360-0; Gonzalez F, 2010, SOC SCI MED, V71, P2066, DOI 10.1016/j.socscimed.2010.09.047; Granados J, 2005, EUR J POPUL, V21, P393, DOI 10.1007/s10680-005-4767-9; Helmsdorff L, 2007, AMPLIACION COBERTURA; Johansson Edvard, 2004, Eur J Health Econ, V5, P335, DOI 10.1007/s10198-004-0244-3; Lin SJ, 2009, APPL ECON, V41, P519, DOI 10.1080/00036840701720754; Miller DL, 2009, AM ECON REV, V99, P122, DOI 10.1257/aer.99.2.122; Miller G, 2013, AM ECON J-APPL ECON, V5, P61, DOI 10.1257/app.5.4.61; Miller G, 2010, J POLIT ECON, V118, P113, DOI 10.1086/651673; Ministerio de Educacion Nacional, 2013, SIST NAC INF ED SUP; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Naciones Unidas, 1986, MAN 10 LECN IND EST; Neumayer E, 2004, SOC SCI MED, V58, P1037, DOI 10.1016/S0277-9536(03)00276-4; Pan American Health Organization, 2006, HLTH STAT AM 2006 ED; Pena X, 2013, 146 INT LAB ORG; Garcia JR, 2007, REV PANAM SALUD PUBL, V21, P111; Ruhm CJ, 2007, DEMOGRAPHY, V44, P829, DOI 10.1007/BF03208384; Ruhm CJ, 2015, J HEALTH ECON, V42, P17, DOI 10.1016/j.jhealeco.2015.03.004; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Ruhm CJ, 2005, J HEALTH ECON, V24, P341, DOI 10.1016/j.jhealeco.2004.09.007; Salamanca-Lugo A, 2009, CICLO EC COLOMBIANO; Sanchez-Torres F, 2011, DOCUMENTOS CEDE; Stevens AH, 2011, NBER WORKING PAPER S; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Suhrcke M, 2012, SOC SCI MED, V74, P647, DOI 10.1016/j.socscimed.2011.12.011; Torrenegra-Cabrera EC, 2011, SHARING INNOVATIVE E, P29; U.S. Census Bureau, 2011, POP AN SPREADSH; World Health Organization, 2012, DIS INJ REG EST CAUS	49	9	9	0	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-9276			INT J EQUITY HEALTH	Int. J. Equity Health	MAY 27	2015	14								48	10.1186/s12939-015-0176-9	http://dx.doi.org/10.1186/s12939-015-0176-9			14	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CL0RH	26014135	Green Published, Green Accepted, gold			2022-09-04	WOS:000356650300001
J	Chan, JCN; Aschner, P; Owens, DR; Picard, S; Vincent, M; Dain, MP; Pilorget, V; Loizeau, V; Echtay, A; Fonseca, V				Chan, Juliana C. N.; Aschner, Pablo; Owens, David R.; Picard, Sylvie; Vincent, Maya; Dain, Marie-Paule; Pilorget, Valerie; Loizeau, Virginie; Echtay, Akram; Fonseca, Vivian			Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: The EASIE post-hoc analysis and extension trial	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						EASIE; A1c; Insulin glargine; Metformin; Sitagliptin; Type 2 diabetes	GLYCEMIC CONTROL; MANAGEMENT; MULTICENTER; THERAPY; HBA(1C)	Aim: We examined the effects of adding glargine to metformin-sitagliptin (MS + G) or sitagliptin to metforminglargine (MG + 5) therapy in type 2 diabetic persons uncontrolled after 24-week MS or MG dual therapy. Methods: Subjects with A1c >= 7% on MS or MG treatment were respectively given glargine (0.2 U/kg starting dose) or sitagliptin (100 mg daily) for 12 weeks. The primary endpoint was number of subjects attaining A1 c goal defined as <7%. Results: After receiving 24-week MS or MG dual therapy in the original EASIE Study, 42% (104/248) on MS and 68% (152/224) on MG attained A1 c < 7% (p < 0.0001). The reduction in A1 c was negatively associated with baseline fasting blood glucose (FBG) only in the MG group. Reduction in A1 c was not related to baseline postprandial blood glucose (PPBG) in either the MG or MS group. Amongst 194 eligible patients, 57.7% (n = 111) entered the 12-week extension trial [MS + G:74/131, 57.3%; MG + S:37/63, 58.7%) with 55 (51.9%) subjects attaining goal [MS + G:59.2%; MG + S:37.1%] at week 12. The final insulin dosage was similar in both groups [MS + G: 0.46 U/kg; MG + S:0.45 U/kg] with a higher rate of hypoglycemia in the MG + S (6.5 events/patient-year) than the MS + G group (3.2 events/patient-year), although neither group had severe hypoglycemia. Conclusion: In metformin-treated type 2 diabetes patients, high fasting BG predicted greater Al c reductions with the addition of glargine, but not with sitagliptin. In subjects uncontrolled with 6-month dual therapy of MS or MG, 50% attained Al c < 7% with triple therapy of MS + G or MG + Sin 12 weeks. The increased rate of hypoglycemia with MG + S (but not with MS + G) underlines the need to take measures to avoid the hypoglycemia. (C) 2015 The Authors. Published by Elsevier Inc.	[Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Inst Diabet & Obes, Dept Med & Therapeut,Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Aschner, Pablo] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Owens, David R.] Swansea Univ, Inst Life Sci, Diabet Res Grp, Swansea, W Glam, Wales; [Picard, Sylvie] Point Med Rond Point Nation, Dijon, France; [Vincent, Maya; Dain, Marie-Paule; Pilorget, Valerie] Sanofi, Paris, France; [Echtay, Akram] Rafic Hariri Univ Hosp, Beirut, Lebanon; [Fonseca, Vivian] Tulane Univ, Med Ctr, New Orleans, IA USA		Chan, JCN (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Room 114025,9th Floor,Clin Sci Bldg, Shatin, Hong Kong, Peoples R China.	jchan@cuhk.edu.hk	PICARD, Sylvie/AAI-6569-2020; Chan, Juliana/B-7918-2016	PICARD, Sylvie/0000-0003-0463-8063; Chan, Juliana/0000-0003-1325-1194	Sanofi	Sanofi	The study was funded by Sanofi.	Aschner P, 2012, LANCET, V379, P2262, DOI 10.1016/S0140-6736(12)60439-5; Barnett AH, 2013, LANCET, V382, P1413, DOI 10.1016/S0140-6736(13)61500-7; DeFronzo RA, 2010, DIABETIC MED, V27, P309, DOI 10.1111/j.1464-5491.2010.02941.x; Del Prato S, 2009, DIABETOLOGIA, V52, P1219, DOI 10.1007/s00125-009-1352-5; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Gregg EW, 2010, MED CARE, V48, P31, DOI 10.1097/MLR.0b013e3181bd4783; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Krobot KJ, 2012, CURR MED RES OPIN, V28, P1281, DOI 10.1185/03007995.2012.703134; McIntosh Brendan, 2011, Open Med, V5, pe35; Pozzilli P, 2010, DIABETES-METAB RES, V26, P239, DOI 10.1002/dmrr.1092; Raz I, 2013, DIABETES CARE, V36, P1779, DOI 10.2337/dc13-0512; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Tong PCY, 2008, DIABETES RES CLIN PR, V82, P346, DOI 10.1016/j.diabres.2008.09.006; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Yeung R. O, 2014, LANCET DIABETES ENDO	18	3	4	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	JAN-FEB	2015	29	1					134	141		10.1016/j.jdiacomp.2014.08.007	http://dx.doi.org/10.1016/j.jdiacomp.2014.08.007			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	AZ5EY	25283485	hybrid			2022-09-04	WOS:000348244400026
J	Ayala-Ramirez, P; Gonzalez, M; Escudero, C; Quintero-Arciniegas, L; Giachini, FR; De Freitas, RA; Damiano, AE; Garcia-Robles, R				Ayala-Ramirez, Paola; Gonzalez, Marcelo; Escudero, Carlos; Quintero-Arciniegas, Laura; Giachini, Fernanda R.; Alves de Freitas, Raiany; Damiano, Alicia E.; Garcia-Robles, Reggie			Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy. A Non-systematic Review of Clinical Presentation, Potential Effects of Physiological Adaptations in Pregnancy, and Placental Vascular Alterations	FRONTIERS IN PHYSIOLOGY			English	Review						COVID-19; pregnancy; renin-angiotensin-aldosterone system; coronavirus in pregnancy; placenta	ANGIOTENSIN-II; VERTICAL TRANSMISSION; COVID-19; ACE2; SARS-COV-2; EXPRESSION; WOMEN; RECEPTOR; OUTCOMES; LOCALIZATION	In December 2019, the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) rapidly spread to become a pandemic. To date, increasing evidence has described the potential negative impact of SARS-CoV-2 infection on pregnant women. Although the pathophysiology of coronavirus disease 2019 (COVID-19) is not entirely understood, there is emerging evidence that it causes a severe systemic inflammatory response associated with vascular alterations that could be of special interest considering some physiological changes in pregnancy. Additionally, these alterations may affect the physiology of the placenta and are associated with pregnancy complications and abnormal histologic findings. On the other hand, data about the vaccine against SARS-CoV-2 are limited, but the risks of administering COVID-19 vaccines during pregnancy appear to be minimal. This review summarizes the current literature on SARSCoV2 virus infection, the development of COVID-19 and its relationship with physiological changes, and angiotensin-converting enzyme 2 (ACE2) function during pregnancy. We have particularly emphasized evidence coming from Latin American countries.	[Ayala-Ramirez, Paola] Pontificia Univ Javeriana, Inst Human Genet, Sch Med, Bogota, Colombia; [Gonzalez, Marcelo; Escudero, Carlos] Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Chillan, Chile; [Gonzalez, Marcelo] Univ Concepcion, Facultad Medicina, Dept Obstetricia Ginecologia, Laboratorio Investigac Materno Fetal LIMaF, Concepcion, Chile; [Escudero, Carlos] Univ Bio Bio, Dept Basic Sci, Lab Vasc Physiol, Fac Sci, Chillan, Chile; [Quintero-Arciniegas, Laura] Pontificia Univ Javeriana, Sch Med, Perinatal Med Seedbed, Bogota, Colombia; [Quintero-Arciniegas, Laura; Garcia-Robles, Reggie] Pontificia Univ Javeriana, Sch Med, Dept Physiol Sci, Bogota, Colombia; [Giachini, Fernanda R.] Univ Fed Mato Grosso, Inst Biol Sci & Hlth, Barra Do Garcas, Brazil; [Giachini, Fernanda R.; Alves de Freitas, Raiany] Univ Fed Goias, Inst Biol Sci, Goiania, Go, Brazil; [Damiano, Alicia E.] Univ Buenos Aires, Inst Fisiologia Biofis Bernardo Houssay IFIBIO CO, Laboratorio Biol Reproducc, Buenos Aires, DF, Argentina; [Damiano, Alicia E.] Univ Buenos Aires, Facultad Farm Bioquim, Dept Ciencias Biolog, Catedra Biol Celular Mol, Buenos Aires, DF, Argentina		Ayala-Ramirez, P (corresponding author), Pontificia Univ Javeriana, Inst Human Genet, Sch Med, Bogota, Colombia.; Gonzalez, M (corresponding author), Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Chillan, Chile.; Gonzalez, M (corresponding author), Univ Concepcion, Facultad Medicina, Dept Obstetricia Ginecologia, Laboratorio Investigac Materno Fetal LIMaF, Concepcion, Chile.	payala@javeriana.edu.co; mgonzalezo@udec.cl	Giachini, Fernanda R/J-7958-2012	Giachini, Fernanda R/0000-0003-2688-7204				AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; Ahlberg M, 2020, JAMA-J AM MED ASSOC, V324, P1782, DOI 10.1001/jama.2020.19124; Algarroba GN, 2020, AM J OBSTET GYNECOL, V223, P953, DOI 10.1016/j.ajog.2020.08.106; Algarroba GN, 2020, AM J OBSTET GYNECOL, V223, P275, DOI 10.1016/j.ajog.2020.05.023; AlGhatrif M, 2020, JAMA CARDIOL, V5, P747, DOI 10.1001/jamacardio.2020.1329; [Anonymous], 2020, LANCET, V396, P1463, DOI 10.1016/S0140-6736(20)32328-X; Anton L, 2008, HYPERTENSION, V51, P1066, DOI 10.1161/HYPERTENSIONAHA.107.103861; Baergen RN, 2020, PEDIATR DEVEL PATHOL, V23, P177, DOI 10.1177/1093526620925569; Baud D, 2020, JAMA-J AM MED ASSOC, V323, P2198, DOI 10.1001/jama.2020.7233; Bavishi C, 2020, JAMA CARDIOL, V5, P745, DOI 10.1001/jamacardio.2020.1282; Beigi RH, 2021, VACCINE, V39, P868, DOI 10.1016/j.vaccine.2020.12.074; Rocha AB, 2020, LAB INVEST, V100, P1485, DOI 10.1038/s41374-020-0464-x; Bharadwaj MS, 2011, HYPERTENSION, V58, P852, DOI 10.1161/HYPERTENSIONAHA.111.179358; Bortoletto Pietro, 2021, F S Rep, V2, P209, DOI 10.1016/j.xfre.2021.04.005; Brandt JS, 2021, AM J OBSTET GYNECOL, V224, DOI 10.1016/j.ajog.2020.09.043; Cai H., 2020, CORRES SEX DIFFERENC, V2600, P19, DOI [10.1111/all.14238.Yang, DOI 10.1111/ALL.14238.YANG]; Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z; Chavan M, 2021, J OBSTET GYNAECOL CA, V43, P814, DOI 10.1016/j.jogc.2021.03.010; Chen W, 2020, ENGINEERING-PRC, V6, P1162, DOI 10.1016/j.eng.2020.07.013; Chlamydas S, 2021, EPIGENETICS-US, V16, P263, DOI 10.1080/15592294.2020.1796896; Corthorn J, 2006, ENDOCRINE, V29, P491, DOI 10.1385/ENDO:29:3:491; Cosma S, 2021, AM J OBSTET GYNECOL, V224, DOI [10.1016/j.ajog.2020.10.005, 10.1016/j.ajog.2020.10.OO5]; Cruz NAN, 2021, CLIN SCI, V135, P1805, DOI 10.1042/CS20210284; Della Gatta AN, 2020, AM J OBSTET GYNECOL, V223, P36, DOI 10.1016/j.ajog.2020.04.013; Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107; Diaz-Corvillon P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239887; Edlow AG, 2020, JAMA NETW OPEN, V3, P30455, DOI 10.1001/jamanetworkopen.2020.30455; Elias C, 2021, INT J INFECT DIS, V104, P708, DOI 10.1016/j.ijid.2021.01.069; Ellington S, 2020, MMWR-MORBID MORTAL W, V69, P769, DOI [10.15585/mmwr.mm6925a1, 10.15585/mmwr.mm6925a1externalicon]; Evans PC, 2020, CARDIOVASC RES, V116, P2177, DOI 10.1093/cvr/cvaa230; Fan SR, 2021, MATERN-FETAL MED, V3, P53, DOI 10.1097/FM9.0000000000000071; Fenizia C, 2020, NAT COMMUN, V11, P5128, DOI 10.1038/s41467-020-18933-4; Ferraiolo Antonella, 2020, Medicina (Kaunas), V56, DOI 10.3390/medicina56060306; Flores-Pliego Arturo, 2021, Cells, V10, P364, DOI 10.3390/cells10020364; Fraga-Silva RA, 2013, HYPERTENSION, V61, P1233, DOI 10.1161/HYPERTENSIONAHA.111.00627; GANT NF, 1973, J CLIN INVEST, V52, P2682, DOI 10.1172/JCI107462; GANT NF, 1980, KIDNEY INT, V18, P253, DOI 10.1038/ki.1980.133; Gilbert JS, 2008, AM J PHYSIOL-REG I, V294, pR915, DOI 10.1152/ajpregu.00018.2008; Goldshtein I, 2022, JAMA PEDIATR, V176, P470, DOI 10.1001/jamapediatrics.2022.0001; Goshua G, 2020, LANCET HAEMATOL, V7, pE575, DOI 10.1016/S2352-3026(20)30216-7; Halici-Ozturk F, 2021, PLACENTA, V106, P25, DOI 10.1016/j.placenta.2021.02.006; Han Y, 2020, J PERINAT MED, V48, P912, DOI 10.1515/jpm-2020-0431; Hecht JL, 2020, MODERN PATHOL, V33, P2092, DOI 10.1038/s41379-020-0639-4; Hosier H, 2020, J CLIN INVEST, V130, P4947, DOI 10.1172/JCI139569; Hsu AL, 2021, J MED VIROL, V93, P1038, DOI 10.1002/jmv.26386; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang FM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4595; Jackson CB, 2022, NAT REV MOL CELL BIO, V23, P3, DOI 10.1038/s41580-021-00418-x; Jaiswal N, 2021, EUR J OBSTET GYN R B, V259, P7, DOI 10.1016/j.ejogrb.2021.01.049; Jardine J, 2021, BJOG-INT J OBSTET GY, V128, P880, DOI 10.1111/1471-0528.16547; Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, P152, DOI 10.3389/fpubh.2020.00152; Jordan RE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1198; Kalafat E, 2020, ULTRASOUND OBST GYN, V55, P835, DOI 10.1002/uog.22034; Khalil A, 2020, JAMA-J AM MED ASSOC, V324, P705, DOI 10.1001/jama.2020.12746; Khodarahmi R, 2021, J IRAN CHEM SOC, V18, P495, DOI 10.1007/s13738-020-02049-z; Kirtsman M, 2020, CAN MED ASSOC J, V192, pE647, DOI 10.1503/cmaj.200821; Knock GA, 1996, AM J OBSTET GYNECOL, V175, P1668, DOI 10.1016/S0002-9378(96)70123-0; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kulkarni R, 2021, INFECTION, V49, P339, DOI 10.1007/s15010-020-01493-6; Lambelet V, 2020, PRENATAL DIAG, V40, P1641, DOI 10.1002/pd.5759; Levitan D, 2021, ARCH PATHOL LAB MED, V145, P648, DOI 10.5858/arpa.2020-0793-SA; Levy A, 2008, AM J PHYSIOL-REG I, V295, pR1953, DOI 10.1152/ajpregu.90592.2008; Li H, 2020, LANCET, V395, P1517, DOI 10.1016/S0140-6736(20)30920-X; Li MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230295; Li N, 2020, CLIN INFECT DIS, V71, P2035, DOI 10.1093/cid/ciaa352; Liu DH, 2020, AM J ROENTGENOL, V215, P127, DOI 10.2214/AJR.20.23072; Liu H, 2020, J REPROD IMMUNOL, V139, DOI 10.1016/j.jri.2020.103122; Lovren F, 2008, AM J PHYSIOL-HEART C, V295, pH1377, DOI 10.1152/ajpheart.00331.2008; Lu-Culligan Alice, 2021, medRxiv, DOI 10.1101/2021.01.25.21250452; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270; Marinho PS, 2021, FRONT MED-LAUSANNE, V8, P77001, DOI 10.3389/fmed.2021.677001; Marques FZ, 2011, PLACENTA, V32, P214, DOI 10.1016/j.placenta.2010.12.006; Mendoza M, 2020, BJOG-INT J OBSTET GY, V127, P1374, DOI 10.1111/1471-0528.16339; Merrill DC, 2002, ENDOCRINE, V18, P239, DOI 10.1385/ENDO:18:3:239; Meyer JA, 2021, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2021.1977791; Meyer R, 2021, AM J OBSTET GYNECOL, V224, P234, DOI 10.1016/j.ajog.2020.10.017; Monteil Vanessa, 2021, EMBO Molecular Medicine, V13, pe13426, DOI 10.15252/emmm.202013426; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014; Mulvey JJ, 2020, ANN DIAGN PATHOL, V46, DOI 10.1016/j.anndiagpath.2020.151530; National Center for Immunization and Respiratory Diseases, 2021, NAT CTR IMM RESP DIS; Ng WF, 2006, PATHOLOGY, V38, P210, DOI 10.1080/00313020600696280; Ona S., 2021, AM J OBSTET GYNECOL, V224, DOI [10.1016/J.AJOG.2020.12.976, DOI 10.1016/J.AJOG.2020.12.976]; PAHO, 2022, COVID 19 VACC DOS AD; PAHO, 2021, PAHO NEWS; Papageorghiou AT, 2021, AM J OBSTET GYNECOL, V225, DOI 10.1016/j.ajog.2021.05.014; Patane L, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100145; Patberg ET, 2021, AM J OBSTET GYNECOL, V224, DOI 10.1016/j.ajog.2020.10.020; Peiro C, 2020, CIRCULATION, V141, P1665, DOI 10.1161/CIRCULATIONAHA.120.047297; Penfield CA, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100133; Peng ZJ, 2020, J INFECT PUBLIC HEAL, V13, P818, DOI 10.1016/j.jiph.2020.04.004; Pique-Regi R, 2020, ELIFE, V9, DOI 10.7554/eLife.58716; Poisson Tiffany M, 2021, Case Rep Womens Health, V30, pe00289, DOI 10.1016/j.crwh.2021.e00289; Pringle KG, 2011, PLACENTA, V32, P956, DOI 10.1016/j.placenta.2011.09.020; Rabi FA, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030231; Richtmann R, 2020, CASE REP WOMENS HLTH, V27, DOI 10.1016/j.crwh.2020.e00243; Riley L., 2021, COVID 19 VACC CONS O; Rizzo G, 2021, ACTA OBSTET GYN SCAN, V100, P1034, DOI 10.1111/aogs.14130; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Rotshenker-Olshinka K, 2021, ARCH GYNECOL OBSTET, V303, P839, DOI 10.1007/s00404-020-05848-0; Sanchez-Duque JA, 2020, ATEN PRIM, V52, P369, DOI 10.1016/j.aprim.2020.04.001; Sanchis-Gomar F, 2020, MAYO CLIN PROC, V95, P1222, DOI 10.1016/j.mayocp.2020.03.026; Santos RA, 2014, HYPERTENSION, V63, P1138, DOI 10.1161/HYPERTENSIONAHA.113.01274; Scaife PJ, 2017, PLACENTA, V56, P53, DOI 10.1016/j.placenta.2017.01.100; Shanes ED, 2020, AM J CLIN PATHOL, V154, P23, DOI 10.1093/ajcp/aqaa089; Shimabukuro TT, 2021, OBSTET GYNECOL SURV, V76, P729, DOI [10.1097/01.ogx.0000802676.57373.17, 10.1056/NEJMx210016, 10.1056/NEJMoa2104983]; Siriwattananon K, 2021, FRONT PLANT SCI, V11, P4663, DOI 10.3389/fpls.2020.604663; Sisman J, 2020, PEDIATR INFECT DIS J, V39, pE265, DOI 10.1097/INF.0000000000002815; Smithgall MC, 2020, HISTOPATHOLOGY, V77, P994, DOI 10.1111/his.14215; Sola A, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.47; Sommerstein R, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016509; Stelzig KE, 2020, AM J PHYSIOL-LUNG C, V318, pL1280, DOI 10.1152/ajplung.00153.2020; Stettner Dominika, 2013, Folia Med Cracov, V53, P31; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Taglauer E, 2020, PLACENTA, V100, P69, DOI 10.1016/j.placenta.2020.08.015; Takemoto MLS, 2022, J MATERN-FETAL NEO M, V35, P2355, DOI 10.1080/14767058.2020.1786056; Tamanna Sonia, 2020, Frontiers in Physiology, V11, P590787, DOI 10.3389/fphys.2020.590787; Tang T, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104792; Trad A.T.A., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3576828, DOI 10.2139/SSRN.3576828]; Tukiainen T, 2017, NATURE, V550, P244, DOI 10.1038/nature24265; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; Valdes G, 2006, PLACENTA, V27, P200, DOI 10.1016/j.placenta.2005.02.015; Valdespino-Vazquez MY, 2021, J MED VIROL, V93, P4480, DOI 10.1002/jmv.26965; Villar J, 2021, JAMA PEDIATR, V175, P817, DOI 10.1001/jamapediatrics.2021.1050; Viruez-Soto J.A., 2021, RESPIRAR, V13, P65; Vivanti AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17436-6; Wang CL, 2021, INT J MED SCI, V18, P763, DOI 10.7150/ijms.49923; Wang JY, 2020, FASEB J, V34, P10505, DOI 10.1096/fj.202001020R; Wastnedge EAN, 2021, PHYSIOL REV, V101, P303, DOI 10.1152/physrev.00024.2020; Watanabe T, 2005, HYPERTENSION, V45, P163, DOI 10.1161/01.HYP.0000153321.13792.b9; Wei SQ, 2021, CAN MED ASSOC J, V193, pE540, DOI 10.1503/cmaj.202604; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; World Health Organization, 2021, UPD WHO INT REC COVI; Yang H, 2020, ULTRASOUND OBST GYN, V55, P435, DOI 10.1002/uog.22006; Zhang ML, 2018, AM J PHYSIOL-LUNG C, V315, pL1015, DOI 10.1152/ajplung.00163.2018; Zhang PL, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100197; Zhang ZY, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00302-0; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V588, pE6, DOI 10.1038/s41586-020-2951-z; Ziai SA, 2021, J CELL PHYSIOL, V236, P2430, DOI 10.1002/jcp.30041; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0	144	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1664-042X		FRONT PHYSIOL	Front. Physiol.	MAR 30	2022	13								785274	10.3389/fphys.2022.785274	http://dx.doi.org/10.3389/fphys.2022.785274			14	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	0P6OC	35431989	gold, Green Published			2022-09-04	WOS:000784348300001
J	Ossa, H; Posada, Y; Trujillo, N; Martinez, B; Loiola, S; Simao, F; Ossa, RH; Castillo, A; Ibarra, A; Marrugo, J; de Carvalho, EF; Vargas, CI; Pereira, R; Gusmao, L				Ossa, Humberto; Posada, Yeny; Trujillo, Nathalia; Martinez, Beatriz; Loiola, Silvia; Simao, Filipa; Ossa, Rafael H.; Castillo, Adriana; Ibarra, Adriana; Marrugo, Javier; de Carvalho, Elizeu Fagundes; Ines Vargas, Clara; Pereira, Rui; Gusmao, Leonor			Patterns of genetic diversity in Colombia for 38 indels used in human identification	FORENSIC SCIENCE INTERNATIONAL-GENETICS			English	Article						Insertion/deletion; Forensic genetics; Native Americans; Admixed populations; South America; Population substructure	ADMIXTURE; ANCESTRY; REVEALS	The current population of Colombia has a genetic heterogeneity resulting from different migrations from other continents and within the country. In addition, there are small groups in their territory that have remained isolated and therefore have a different genetic pool in relation to that of the neighbouring urban populations. This population stratification must be considered in forensic analysis, being more complex for markers with marked intercontinental differentiation. In this study, population differentiation in Colombian admixed, native, and Afro-descendant populations was evaluated for a group of 38 indels described for forensic use. Allelic frequencies and parameters of forensic relevance were determined in each of the groups defined based on population differentiation analyses. In addition to the differences found between population groups, the results show that the set of 38 indels analysed could be useful in studies of individual identification in Colombia. The exclusion power presented by this set of markers suggests the need for joint use with other markers, being able to complement the STRs in paternity cases. High levels of both power of discrimination and exclusion were found when complementing the 38 HID-indels with a second multiplex, for a total of 83 indels.	[Ossa, Humberto; Ossa, Rafael H.] Pontificia Univ Javeriana, Fac Ciencias, Bogota, Colombia; [Ossa, Humberto; Ossa, Rafael H.] Lab Genet & Biol Mol, Bogota, Colombia; [Posada, Yeny; Ibarra, Adriana] Univ Antioquia, Sch Nat & Exact Sci FCEN, Inst Biol, IdentiGEN Genet Identificat Lab, Medellin, Antioquia, Colombia; [Posada, Yeny; Ibarra, Adriana] Univ Antioquia, Sch Nat & Exact Sci FCEN, Inst Biol, Res Grp Genet Identificat, Medellin, Antioquia, Colombia; [Trujillo, Nathalia; Castillo, Adriana; Ines Vargas, Clara] Univ Ind Santander UIS, Lab Genet, Bucaramanga, Santander, Colombia; [Martinez, Beatriz; Marrugo, Javier] Univ Cartagena, Inst Immunol Res, Mol Genet Lab, Cartagena, Colombia; [Loiola, Silvia; Simao, Filipa; de Carvalho, Elizeu Fagundes; Gusmao, Leonor] State Univ Rio de Janeiro UERJ, DNA Diagnost Lab LDD, Rio De Janeiro, Brazil; [Pereira, Rui] Univ Porto, Inst Invest & Inovacho Saude I3S, Porto, Portugal; [Pereira, Rui] Univ Porto, IPATIMUP Inst Patol & Imunol Mol, Porto, Portugal		Ossa, H (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Bogota, Colombia.	hossa@genetica.com.co	Pereira, Rui/B-1656-2013; Gusmão, Leonor/L-8931-2019; Simao, Filipa/D-7105-2019	Pereira, Rui/0000-0002-3889-798X; Gusmão, Leonor/0000-0003-0432-6481; Ossa Trujillo, Rafael Humberto/0000-0003-3112-8712; Simao, Filipa/0000-0002-2003-2320	Laboratorio de Genetica y Biologia Molecular, Bogota - Colombia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [306342/2019-7]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [CNE-2018]; Vicerrectoria de Investigacion y extension de la Universidad Industrial de Santander (VIE-UIS) [5694]	Laboratorio de Genetica y Biologia Molecular, Bogota - Colombia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Vicerrectoria de Investigacion y extension de la Universidad Industrial de Santander (VIE-UIS)	HO was supported by Laboratorio de Genetica y Biologia Molecular, Bogota - Colombia. LG was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (ref. 306342/2019-7), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (CNE-2018). NT, AC and CIV were supported by Vicerrectoria de Investigacion y extension de la Universidad Industrial de Santander (VIE-UIS), Project code 5694.	Avena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034695; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Heinz T, 2013, FORENSIC SCI INT-GEN, V7, P537, DOI 10.1016/j.fsigen.2013.05.012; Kling D, 2014, FORENSIC SCI INT-GEN, V13, P121, DOI 10.1016/j.fsigen.2014.07.004; Parolin ML, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214830; Martinez B., 2018, FORENSIC SCI INT G S, V4, P74; Martinez-Cortes G, 2015, FORENSIC SCI INT-GEN, V17, P149, DOI 10.1016/j.fsigen.2015.04.011; Nachman MW, 2000, GENETICS, V156, P297; Ossa H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164414; Pena SDJ, 2020, AM J MED GENET C, V184, P928, DOI 10.1002/ajmg.c.31853; Pereira R, 2018, FORENSIC SCI INT-GEN, V32, P18, DOI 10.1016/j.fsigen.2017.09.012; Pereira R, 2009, ELECTROPHORESIS, V30, P3682, DOI 10.1002/elps.200900274; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Salzano FM, 2014, GENET MOL BIOL, V37, P151, DOI 10.1590/S1415-47572014000200003; Sandoval JR, 2013, J HUM GENET, V58, P627, DOI 10.1038/jhg.2013.73	15	2	2	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1872-4973	1878-0326		FORENSIC SCI INT-GEN	Forensic Sci. Int.-Genet.	JUL	2021	53								102495	10.1016/j.fsigen.2021.102495	http://dx.doi.org/10.1016/j.fsigen.2021.102495		MAR 2021	5	Genetics & Heredity; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Legal Medicine	TK9YS	33743518				2022-09-04	WOS:000674512400004
J	Gonzalez-Giraldo, Y; Forero, DA; Echeverria, V; Garcia-Segura, LM; Barreto, GE				Gonzalez-Giraldo, Yeimy; Forero, Diego A.; Echeverria, Valentina; Garcia-Segura, Luis Miguel; Barreto, George E.			Tibolone attenuates inflammatory response by palmitic acid and preserves mitochondrial membrane potential in astrocytic cells through estrogen receptor beta	MOLECULAR AND CELLULAR ENDOCRINOLOGY			English	Article						Tibolone; Astrocytes; Palmitic acid; Gene expression; Estrogen receptors	NF-KAPPA-B; TELOMERASE REVERSE-TRANSCRIPTASE; RANDOMIZED-CONTROLLED-TRIAL; MESSENGER-RNA; NEUROPROTECTIVE ROLE; THERAPEUTIC TARGET; COGNITIVE FUNCTION; UP-REGULATION; ALPHA; EXPRESSION	Palmitic acid (PA) induces several metabolic and molecular changes in astrocytes, and, it is involved in pathological conditions related to neurodegenerative diseases. Previously, we demonstrated that tibolone, a synthetic steroid with estrogenic, progestogenic and androgenic actions, protects cells from mitochondrial damage and morphological changes induced by PA. Here, we have evaluated which estrogen receptor is involved in protective actions of tibolone and analyzed whether tibolone reverses gene expression changes induced by PA. Tibolone actions on astrocytic cells were mimicked by agonists of estrogen receptor a (ER alpha) and beta (ER beta), but the blockade of both ERs suggested a predominance of ER beta on mitochondria membrane potential. Expression analysis showed a significant effect of tibolone on genes associated with inflammation such as IL6, IL1B and miR155-3p. It is noteworthy that tibolone attenuated the increased expression of TERT, TERC and DNMT3B genes induced by palmitic acid. Our results suggest that tibolone has anti-inflammatory effects and can modulate pathways associated with DNA methylation and telomeric complex. However, future studies are needed to elucidate the role of epigenetic mechanisms and telomere-associated proteins on tibolone actions.	[Gonzalez-Giraldo, Yeimy; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Forero, Diego A.] Univ Antonio Narino, Sch Med, Lab Neuropsychiat Genet, Biomed Sci Res Grp, Bogota, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4080871, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA; [Garcia-Segura, Luis Miguel] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Garcia-Segura, Luis Miguel] Inst Salud Carlos III, CIBERFES, Madrid 28029, Spain		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.	gsampaio@javeriana.edu.co	Forero, Diego A./O-9981-2019; Barreto, George E./AAD-7420-2020; Garcia-Segura, Luis M/U-3711-2017; Valentina Echeverria Moran, BCh/E-7765-2013; González-Giraldo, Yeimy/Q-5652-2018; Gonzalez, Yeimy/Y-1975-2019	Forero, Diego A./0000-0001-9175-3363; Barreto, George E./0000-0002-6644-1971; Garcia-Segura, Luis M/0000-0002-2450-2916; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; González-Giraldo, Yeimy/0000-0002-2527-218X; Gonzalez, Yeimy/0000-0002-2527-218X	Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program); Fondecyt [1150194]; COLCIENCIAS [824-2017]	Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	YG-G is supported by a PhD fellowship from Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program). VE was supported by the Fondecyt 1150194. This study was supported by a research grant from COLCIENCIAS (Grant No. 824-2017).	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Alsabeeh N, 2018, BBA-MOL CELL BIOL L, V1863, P143, DOI 10.1016/j.bbalip.2017.11.006; Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Baez E, 2017, NEUROTOX RES, V32, P163, DOI 10.1007/s12640-017-9733-x; Blutstein T, 2006, J NEUROENDOCRINOL, V18, P692, DOI 10.1111/j.1365-2826.2006.01466.x; Oliveira ADB, 2018, NEUROCHEM INT, V120, P140, DOI 10.1016/j.neuint.2018.08.010; Camandola S, 2007, EXPERT OPIN THER TAR, V11, P123, DOI 10.1517/14728222.11.2.123; Carta G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00902; Cha Y, 2008, MOL CELLS, V26, P454; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Christensen A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00130; Contreras A, 2017, NEUROREPORT, V28, P354, DOI 10.1097/WNR.0000000000000774; Crespo-Castrillo A, 2018, MOL NEUROBIOL, V55, P8651, DOI 10.1007/s12035-018-1008-x; Crowley Lisa C, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087163; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dodel RC, 1999, J NEUROCHEM, V73, P1453, DOI 10.1046/j.1471-4159.1999.0731453.x; Dumas JA, 2016, METABOLISM, V65, P1582, DOI 10.1016/j.metabol.2016.08.003; Falany JL, 1997, ONCOL RES, V9, P589; Falany JL, 2004, J STEROID BIOCHEM, V88, P383, DOI 10.1016/j.jsbmb.2004.01.005; Fluck E, 2002, J CLIN PSYCHOPHARM, V22, P62, DOI 10.1097/00004714-200202000-00010; Fluteau A, 2015, NEUROSCI LETT, V609, P11, DOI 10.1016/j.neulet.2015.10.001; Forero DA, 2018, AM J MED GENET B, V177, P126, DOI 10.1002/ajmg.b.32516; Frago LM, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00330; Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5; Geekiyanage H, 2011, J NEUROSCI, V31, P14820, DOI 10.1523/JNEUROSCI.3883-11.2011; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Giatti S, 2019, PROG NEUROBIOL, V176, P1, DOI 10.1016/j.pneurobio.2018.06.007; Gizard F, 2011, ARTERIOSCL THROM VAS, V31, P245, DOI 10.1161/ATVBAHA.110.219808; Gonzalez-Giraldo Y, 2018, MOL NEUROBIOL, V55, P4453, DOI 10.1007/s12035-017-0667-3; Gonzalez-Giraldo Y, 2016, AGEING RES REV, V28, P37, DOI 10.1016/j.arr.2016.04.004; Gupta S, 2012, J NEUROCHEM, V120, P1060, DOI 10.1111/j.1471-4159.2012.07660.x; Gurney EP, 2014, J STEROID BIOCHEM, V142, P4, DOI 10.1016/j.jsbmb.2013.10.009; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Huang HT, 2017, INT J BIOCHEM CELL B, V86, P42, DOI 10.1016/j.biocel.2017.03.008; Hussain G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00144; Hutchison ER, 2013, GLIA, V61, P1018, DOI 10.1002/glia.22483; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Karagkouni D, 2018, NUCLEIC ACIDS RES, V46, pD239, DOI 10.1093/nar/gkx1141; Kipp M, 2007, J NEUROENDOCRINOL, V19, P819, DOI 10.1111/j.1365-2826.2007.01588.x; Kloosterboer HJ, 2011, CLIMACTERIC, V14, P609, DOI 10.3109/13697137.2011.580639; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kulkarni J, 2015, MOL PSYCHIATR, V20, P695, DOI 10.1038/mp.2014.33; Kulkarni J, 2018, J AFFECT DISORDERS, V236, P88, DOI 10.1016/j.jad.2018.04.103; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Liu L, 2014, NEUROBIOL AGING, V35, P309, DOI 10.1016/j.neurobiolaging.2013.08.016; Liu MM, 2002, J BIOL CHEM, V277, P24353, DOI 10.1074/jbc.M201829200; Lu YP, 2003, EXP NEUROL, V183, P482, DOI 10.1016/S0014-4886(03)00205-X; Luine VN, 2014, HORM BEHAV, V66, P602, DOI 10.1016/j.yhbeh.2014.08.011; Maran A, 2006, BONE, V39, P523, DOI 10.1016/j.bone.2006.03.006; Martin-Jimenez C, 2019, NEUROENDOCRINOLOGY, V108, P142, DOI 10.1159/000495078; Martin-Jimenez CA, 2017, PROG NEUROBIOL, V158, P45, DOI 10.1016/j.pneurobio.2017.08.001; Martin-Jimenez CA, 2017, MOL NEUROBIOL, V54, P7096, DOI 10.1007/s12035-016-0193-8; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Morselli E, 2014, CELL REP, V9, P633, DOI 10.1016/j.celrep.2014.09.025; Nagy C, 2015, MOL PSYCHIATR, V20, P320, DOI 10.1038/mp.2014.21; Neal M, 2018, BBA-MOL BASIS DIS, V1864, P432, DOI 10.1016/j.bbadis.2017.11.004; Nicolia V, 2017, J NEUROPATH EXP NEUR, V76, P27, DOI 10.1093/jnen/nlw099; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Omran A, 2013, SCI WORLD J, DOI 10.1155/2013/208309; Ortiz-Rodriguez A, 2019, MOL NEUROBIOL, V56, P1665, DOI 10.1007/s12035-018-1183-9; Patil S, 2007, EUR J NEUROSCI, V26, P2131, DOI 10.1111/j.1460-9568.2007.05797.x; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pike CJ, 2017, J NEUROSCI RES, V95, P671, DOI 10.1002/jnr.23827; Pinto-Almazan R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8630764; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Ramoz N, 2013, VITAM HORM, V92, P141, DOI 10.1016/B978-0-12-410473-0.00006-4; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Reed MJ, 2004, MATURITAS, V48, pS4, DOI 10.1016/j.maturitas.2004.02.013; Rocha DM, 2016, ATHEROSCLEROSIS, V244, P211, DOI 10.1016/j.atherosclerosis.2015.11.015; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Salahudeen MS, 2017, SAUDI PHARM J, V25, P165, DOI 10.1016/j.jsps.2016.07.002; Schmidt PJ, 2015, JAMA PSYCHIAT, V72, P714, DOI 10.1001/jamapsychiatry.2015.0111; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simpkins JW, 2005, CNS NEUROL DISORD-DR, V4, P69, DOI 10.2174/1568007053005073; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Stone DJ, 1997, EXP NEUROL, V143, P313, DOI 10.1006/exnr.1996.6360; Su XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134087; Wang JM, 2006, P NATL ACAD SCI USA, V103, P16983, DOI 10.1073/pnas.0608128103; Wang Z, 2012, J PINEAL RES, V52, P253, DOI 10.1111/j.1600-079X.2011.00952.x; Wang Z, 2012, BRIT J NUTR, V107, P229, DOI 10.1017/S0007114511002868; Wohleb ES, 2016, NAT REV NEUROSCI, V17, P497, DOI 10.1038/nrn.2016.69; Wong KL, 2014, PHARMACOL REP, V66, P1106, DOI 10.1016/j.pharep.2014.07.009; Xu T, 2013, NEUROCHEM RES, V38, P1914, DOI 10.1007/s11064-013-1097-x; Yang QL, 2016, MOL NEUROBIOL, V53, P436, DOI 10.1007/s12035-014-9027-8; Zumkehr J, 2018, J ALZHEIMERS DIS, V63, P965, DOI 10.3233/JAD-170828; Zuo QP, 2011, EUR J PHARMACOL, V672, P113, DOI 10.1016/j.ejphar.2011.09.187	97	16	17	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0303-7207			MOL CELL ENDOCRINOL	Mol. Cell. Endocrinol.	APR 15	2019	486						65	78		10.1016/j.mce.2019.02.017	http://dx.doi.org/10.1016/j.mce.2019.02.017			14	Cell Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Endocrinology & Metabolism	HP0MQ	30822454				2022-09-04	WOS:000461360500008
J	Pottoo, FH; Tabassum, N; Javed, MN; Nigar, S; Rasheed, R; Khan, A; Barkat, MA; Alam, MS; Maqbool, A; Ansari, MA; Barreto, GE; Ashraf, GM				Pottoo, Faheem Hyder; Tabassum, Nahida; Javed, Md Noushad; Nigar, Shah; Rasheed, Rouqia; Khan, Ayash; Barkat, Md Abul; Alam, Md Sabir; Maqbool, Amir; Ansari, Mohammad Azam; Barreto, George E.; Ashraf, Ghulam Md			The Synergistic Effect of Raloxifene, Fluoxetine, and Bromocriptine Protects Against Pilocarpine-Induced Status Epilepticus and Temporal Lobe Epilepsy	MOLECULAR NEUROBIOLOGY			English	Article						Epilepsy; Serotonin; Dopamine; Neurodegeneration; Neuropeptide Y; Status epilepticus	ESTROGEN-RECEPTOR MODULATORS; NEUROPEPTIDE-Y; ANTIEPILEPTIC DRUGS; OXIDATIVE STRESS; MOUSE MODEL; BRAIN; ANTICONVULSANT; SEIZURES; RAT; CARBAMAZEPINE	The present antiepileptic drugs pose several problems in the management of seizures owing to their meager neuroprotective potential, adverse effects on bone, detrimental effects on cognitive function, chronic toxicity, drug interactions, side effects including aggression, agitation, and irritability and sometimes exacerbation of seizures. We followed up progressive preclinical investigation in mice against pilocarpine (PILO)-induced status epilepticus (SE) and temporal lobe epilepsy (TLE). To determine the response of raloxifene (RF) (4 and 8mg/kg), fluoxetine (FT) (14 and 22mg/kg), bromocriptine (BC) (6 and 10mg/kg), and their low-dose combinations, oral treatment was scheduled for 28days followed by PILO (300mg/kg, i.p). The response was stalked for intensive behavioral monitoring of convulsions, hippocampal neuropeptide Y (NPY), and oxidative stress discernment along with histomorphological studies. The resultant data confirmed the therapeutic potential of triple drug combination of raloxifene (4mg/kg) with fluoxetine (14mg/kg) and bromocriptine (6mg/kg) compared to monotherapy with raloxifene (4mg/kg), and bromocriptine (6mg/kg) as otherwise monotherapy with fluoxetine (14mg/kg) was ineffective to suppress convulsions; an effect better than sodium valproate (300mg/kg), a standard AED, was validated. Most profoundly, PILO-induced compensatory increases in hippocampal NPY levels (20.01%), which was escalated (100%) with the triple drug combination. The same pattern of results was superseded for oxidative stress indices and neuronal damage. The results for the first time demonstrate the propitious role of triple drug combination in the management of SE and TLE. Therapeutically, this enhancing profile of drugs fosters a safer and more effective drug-combination regimen.	[Pottoo, Faheem Hyder; Tabassum, Nahida; Nigar, Shah; Rasheed, Rouqia; Khan, Ayash] Univ Kashmir, Fac Appl Sci & Tech, Dept Pharmaceut Sci, Srinagar, Jammu & Kashmir, India; [Javed, Md Noushad] Jamia Hamdard, Dept Pharmaceut, Sch Pharmaceut Sci & Res, New Delhi, India; [Barkat, Md Abul; Alam, Md Sabir] KR Mangalam Univ, Sch Med & Allied Sci, Dept Pharm, Gurugram, India; [Maqbool, Amir] Govt Coll Women, Dept Zool, MA Rd, Srinagar, Jammu & Kashmir, India; [Ansari, Mohammad Azam] Imam Abdulrahman Bin Faisal Univ, Dept Epidem Dis Res, IRMC, Dammam 31441, Saudi Arabia; [Barreto, George E.] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia		Pottoo, FH; Tabassum, N (corresponding author), Univ Kashmir, Fac Appl Sci & Tech, Dept Pharmaceut Sci, Srinagar, Jammu & Kashmir, India.	fahihyder@gmail.com; n.tabassum.uk@gmail.com	Maqbool, Amir/AAP-6349-2021; ANSARI, MOHAMMAD AZAM/R-3143-2017; Pottoo, Faheem Hyder/AAE-7427-2019; ANSARI, MOHAMMAD AZAM/AAO-6807-2020; Ashraf, Ghulam Md/H-9485-2012; Alam, Dr. Md Sabir/AAU-2826-2021; Maqbool, Amir/ABH-2058-2021; JAVED, MD NOUSHAD/R-8746-2017; Barreto, George E./AAD-7420-2020; Barkat, Abul/S-9210-2018; Ansari, Mohammad Azam/AFO-5715-2022	ANSARI, MOHAMMAD AZAM/0000-0002-6122-5479; Pottoo, Faheem Hyder/0000-0003-2577-7505; Ashraf, Ghulam Md/0000-0002-9820-2078; Alam, Dr. Md Sabir/0000-0002-2845-0156; Maqbool, Amir/0000-0003-4659-4775; JAVED, MD NOUSHAD/0000-0002-5775-8256; Barreto, George E./0000-0002-6644-1971; Barkat, Abul/0000-0001-6009-5222; Ansari, Mohammad Azam/0000-0002-6122-5479; Tabassum, Nahida/0000-0002-0530-0323				Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Shiha AA, 2015, BRAIN RES BULL, V111, P36, DOI 10.1016/j.brainresbull.2014.12.009; [Anonymous], 2016, J NEUROLOGY RES, DOI [10.14740/jnr.v5i6.356, DOI 10.14740/JNR.V5I6.356]; Bernardi F, 2003, ANN NY ACAD SCI, V997, P378, DOI 10.1196/annals.1290.041; Beydoun A, 1997, EPILEPSIA, V38, pS21, DOI 10.1111/j.1528-1157.1997.tb05201.x; Borowicz KK, 2012, ANN AGR ENV MED, V19, P487; Bozzi Y, 2000, J NEUROSCI, V20, P8643, DOI 10.1523/JNEUROSCI.20-22-08643.2000; Brodie MJ, 2016, PHARMACOL REV, V68, P563, DOI 10.1124/pr.115.012021; Brodie MJ, 2011, SEIZURE-EUR J EPILEP, V20, P369, DOI 10.1016/j.seizure.2011.01.004; BRODIE MJ, 1995, LANCET, V345, P476, DOI 10.1016/S0140-6736(95)90581-2; Brothers SP, 2010, EMBO MOL MED, V2, P429, DOI 10.1002/emmm.201000100; Browning RA, 1997, EUR J PHARMACOL, V336, P1, DOI 10.1016/S0014-2999(97)01215-6; Carrasco-Pozo C, 2015, J NEUROCHEM, V135, P932, DOI 10.1111/jnc.13361; Chepurnov S. A., 2012, Uspekhi Fiziologicheskikh Nauk, V43, P55; Cho Inja, 2014, J Epilepsy Res, V4, P7; Ciriza I, 2004, J NEUROBIOL, V61, P209, DOI 10.1002/neu.20043; CLEMENS B, 1988, EPILEPSY RES, V2, P340, DOI 10.1016/0920-1211(88)90044-7; Costa DA, 2012, CELL MOL NEUROBIOL, V32, P633, DOI 10.1007/s10571-012-9812-8; DAILEY JW, 1992, J PHARMACOL EXP THER, V260, P533; DAM AM, 1980, EPILEPSIA, V21, P617, DOI 10.1111/j.1528-1157.1980.tb04315.x; Deepak D, 2007, CLIN ENDOCRINOL, V66, P503, DOI 10.1111/j.1365-2265.2007.02759.x; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; do Nascimento AL, 2012, BRAIN RES, V1470, P98, DOI 10.1016/j.brainres.2012.06.008; Elms J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073505; Etemad L, 2012, J RES MED SCI, V17, P876; FARJO IB, 1979, BRIT J PHARMACOL, V67, P353, DOI 10.1111/j.1476-5381.1979.tb08687.x; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; Franco V, 2016, PHARMACOL RES, V103, P95, DOI 10.1016/j.phrs.2015.11.007; Frantseva MV, 2000, EUR J NEUROSCI, V12, P1431, DOI 10.1046/j.1460-9568.2000.00016.x; Gao F, 2014, NEUROPSYCH DIS TREAT, V10, P2139, DOI 10.2147/NDT.S73210; Gatti G, 2000, CURR PHARM DESIGN, V6, P839, DOI 10.2174/1381612003400245; Genazzani AR, 2003, GYNECOL ENDOCRINOL, V17, P159, DOI 10.1080/713603211; Guo H, 2002, J NEUROPHYSIOL, V87, P558, DOI 10.1152/jn.00532.2001; Halasz M, 2004, ADV EXP MED BIOL, V541, P91; Hussein Abdelaziz M, 2016, J Epilepsy Res, V6, P8, DOI 10.14581/jer.16002; Ibrahim NK, 1999, SURG ONCOL, V8, P103, DOI 10.1016/S0960-7404(99)00047-X; Javed M. N., 2016, J ADV MED PHARM SCI, P1, DOI [10.9734/JAMPS/2016/24441, DOI 10.9734/JAMPS/2016/24441]; Kiasalari Z, 2013, BASIC CLIN NEUROSCI, V4, P299; Kim YB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-42; Kimiskidis V, 2008, ANN GEN PSYCHIATR, V7, pS74, DOI [10.1186/1744-859X-7-S1-S74, DOI 10.1186/1744-859X-7-S1-S74]; Klitgaard H, 2002, EPILEPSY RES, V51, P93, DOI 10.1016/S0920-1211(02)00099-2; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; LANGE SC, 1978, ELECTROEN CLIN NEURO, V44, P94, DOI 10.1016/0013-4694(78)90108-6; LEANDER JD, 1992, EPILEPSIA, V33, P573, DOI 10.1111/j.1528-1157.1992.tb01712.x; LEMOS T, 1995, EXP BRAIN RES, V102, P423; LIU Z, 1994, EPILEPSY RES, V17, P237; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDBERG JM, 1990, FUNDAM CLIN PHARM, V4, P373, DOI 10.1111/j.1472-8206.1990.tb00692.x; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Mani Jayanti, 2013, J Assoc Physicians India, V61, P40; Mao XY, 2015, PROG NEURO-PSYCHOPH, V60, P11, DOI 10.1016/j.pnpbp.2015.01.015; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; May RM, 2014, BRAIN STRUCT FUNCT, V219, P1947, DOI 10.1007/s00429-013-0614-7; Mazzuferi M, 2012, EXP NEUROL, V238, P156, DOI 10.1016/j.expneurol.2012.08.022; Micale V, 2006, EUR NEUROPSYCHOPHARM, V16, P195, DOI 10.1016/j.euroneuro.2005.08.003; Mohanasundari M, 2006, J NEUROL SCI, V249, P140, DOI 10.1016/j.jns.2006.06.018; MORRIS BJ, 1989, J COMP NEUROL, V290, P358, DOI 10.1002/cne.902900305; O'Neill MJ, 1998, EUR J PHARMACOL, V352, P37, DOI 10.1016/S0014-2999(98)00333-1; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oliveira AA, 2007, CELL MOL NEUROBIOL, V27, P395, DOI 10.1007/s10571-006-9132-y; Pazdernik TL, 2001, J APPL TOXICOL, V21, pS87, DOI 10.1002/jat.818; Pericic D, 2005, BRAIN RES, V1033, P90, DOI 10.1016/j.brainres.2004.11.025; Pottoo FH, 2014, EUR J PHARM SCI, V65, P167, DOI 10.1016/j.ejps.2014.09.002; PRENDIVILLE S, 1993, EPILEPSIA, V34, P381, DOI 10.1111/j.1528-1157.1993.tb02425.x; Puttachary S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/745613; Qian J, 1997, J NEUROSCI, V17, P8169; REYNOLDS EH, 1981, EPILEPSIA, V22, P1, DOI 10.1111/j.1528-1157.1981.tb04327.x; RICHENS A, 1994, J NEUROL NEUROSUR PS, V57, P682, DOI 10.1136/jnnp.57.6.682; Rocca WA, 2011, BRAIN RES, V1379, P188, DOI 10.1016/j.brainres.2010.10.031; Rodrigues AD, 2013, NUTR RES, V33, P120, DOI 10.1016/j.nutres.2012.12.002; Saad K, 2014, INT J NEUROSCI, V124, P181, DOI 10.3109/00207454.2013.831851; Sankaraneni R, 2015, PEDIATR ANN, V44, pE36, DOI 10.3928/00904481-20150203-10; Scharfman HE, 2009, ENDOCRINOLOGY, V150, P4437, DOI 10.1210/en.2009-0135; Starr MS, 1996, SYNAPSE, V22, P159, DOI 10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C; Stroud LM, 2005, BRAIN RES, V1033, P151, DOI 10.1016/j.brainres.2004.11.022; Suda S, 2015, BRAIN RES, V1606, P1, DOI 10.1016/j.brainres.2015.02.013; Trojnar MK, 2002, POL J PHARMACOL, V54, P557; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Veliskova J, 2007, J NEUROSCI, V27, P6054, DOI 10.1523/JNEUROSCI.0366-07.2007; Vezzani A, 2002, NEUROSCIENCE, V110, P237, DOI 10.1016/S0306-4522(01)00581-4; Waldbaum S, 2010, J BIOENERG BIOMEMBR, V42, P449, DOI 10.1007/s10863-010-9320-9; Weinshenker D, 2001, J NEUROSCI, V21, P7764, DOI 10.1523/JNEUROSCI.21-19-07764.2001; White HS, 2007, INT REV NEUROBIOL, V81, P85, DOI 10.1016//S0074-7742(06)81006-8; Wieser HG, 2004, EPILEPSIA, V45, P32; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	88	35	37	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	FEB	2019	56	2					1233	1247		10.1007/s12035-018-1121-x	http://dx.doi.org/10.1007/s12035-018-1121-x			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN8TY	29881945				2022-09-04	WOS:000460470300033
J	Fisberg, M; Kovalskys, I; Salas, GG; Previdelli, AN; Rigotti, A; Cortes, LY; Garcia, MCY; Pareja, RP; Herrera-Cuenca, M				Fisberg, Mauro; Kovalskys, Irina; Gomez Salas, Georgina; Previdelli, Agatha Nogueira; Rigotti, Attilio; Cortes, Lilia Yadira; Yepez Garcia, Martha Cecilia; Pareja, Rossina Pareja; Herrera-Cuenca, Marianella			LATIN AMERICAN POPULATION: MAINLY ACTIVE OR SEDENTARY? IS THERE AN ASSOCIATION BETWEEN LIFESTYLE AND DIET NUTRITIONAL COMPOSITION?	ANNALS OF NUTRITION AND METABOLISM			English	Meeting Abstract						Physical activity; sedentarism; obesity; accelerometry; IPAQ			[Fisberg, Mauro] Fundacao Jose Luiz Setubal, Nutr & Feeding Difficulties Ctr, Pensi Inst, Sao Paulo, Brazil; [Fisberg, Mauro] Univ Fed Sao Paulo, Pediat, Escola Paulista Med, Sao Paulo, Brazil; [Kovalskys, Irina] Int Life Sci Inst ILSI, Buenos Aires, DF, Argentina; [Gomez Salas, Georgina] Univ Costa Rica, Dept Bioquim, Escuela Med, San Jose, Costa Rica; [Previdelli, Agatha Nogueira] Univ Sao Judas Tadeu Sao Paulo, Fac Ciencias Biol & Saude, Sao Paulo, Brazil; [Rigotti, Attilio] Pontificia Univ Catolica, Ctr Nutr Mol & Enfermedades Cron, Dept Nutr Diabet & Metab, Escuela Med, Santiago, Chile; [Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador; [Pareja, Rossina Pareja] Inst Invest Nutr, Lima, Peru; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Fdn Bengoa, Ctr Estudios Desarrollo, Caracas, Venezuela				Cortes, Lilia Yadira/AAF-2960-2019; Fisberg, Mauro/E-7149-2010	Fisberg, Mauro/0000-0003-2992-3215	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	The ELANS is supported by a scientific grant from the Coca Cola Company and support from the Instituto Pensi/Hospital Infantil Sabara, International Life Science Institute of Argentina, Universidad de Costa Rica, Pontificia Universidad Catolica de Chile, Pontificia Universidad Javeriana, Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa, Universidad San Francisco de Quito, and Instituto de Investigacion Nutricional de Peru. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of this symposium.		0	2	2	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-6807	1421-9697		ANN NUTR METAB	Ann. Nutr. Metab.		2017	71			2			41	41						1	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	FM9QD					2022-09-04	WOS:000415605300065
J	Luquetti, DV; Heike, CL; Zarante, I; Timms, AE; Gustafson, J; Pachajoa, H; Porras-Hurtado, GL; Ayala-Ramirez, P; Duenas-Roque, MM; Jimenez, N; Ibanez, LM; Hurtado-Villa, P				Luquetti, Daniela, V; Heike, Carrie L.; Zarante, Ignacio; Timms, Andrew E.; Gustafson, Jonas; Pachajoa, Harry; Porras-Hurtado, Gloria L.; Ayala-Ramirez, Paola; Duenas-Roque, Milagros M.; Jimenez, Natalia; Ibanez, Lina M.; Hurtado-Villa, Paula			MYT1 role in the microtia-craniofacial microsomia spectrum	MOLECULAR GENETICS & GENOMIC MEDICINE			English	Article						craniofacial microsomia; genetics; hemifacial microsomia; microtia; oculo-auriculo-vertebral spectrum		Background Craniofacial microsomia (CFM), also known as the oculo-auriculo-vertebral spectrum, comprises a variable phenotype with the most common features including microtia and mandibular hypoplasia on one or both sides, in addition to lateral oral clefts, epibulbar dermoids, cardiac, vertebral, and renal abnormalities. The etiology of CFM is largely unknown. TheMYT1gene has been reported as a candidate based in mutations found in three unrelated individuals. Additional patients with mutations in this gene are required to establish its causality. We present two individuals with CFM that have rare variants inMYT1contributing to better understand the genotype and phenotype associated with mutations in this gene. Methods/Results We conducted genetic analysis using whole-exome and -genome sequencing in 128 trios with CFM. Two novelMYT1mutations were identified in two participants. Sanger sequencing was used to confirm these mutations. Conclusion We identified two additional individuals with CFM who carry rare variants inMYT1, further supporting the presumptive role of this gene in the CFM spectrum.	[Luquetti, Daniela, V; Heike, Carrie L.] Univ Washington, Sch Med, Seattle, WA USA; [Luquetti, Daniela, V; Heike, Carrie L.; Timms, Andrew E.; Gustafson, Jonas] Seattle Childrens Res Inst, Seattle, WA USA; [Zarante, Ignacio; Ayala-Ramirez, Paola] Pontificia Univ Javeriana, Human Genom Inst, Bogota, Colombia; [Zarante, Ignacio] Hosp Univ San Ignacio, Bogota, Colombia; [Pachajoa, Harry] Univ Icesi, Cali, Colombia; [Porras-Hurtado, Gloria L.] Clin Comfamiliar Risaralda, Pereira, Colombia; [Duenas-Roque, Milagros M.] Hosp Edgardo Rebagliati Martins, Lima, Peru; [Jimenez, Natalia; Ibanez, Lina M.; Hurtado-Villa, Paula] Pontificia Univ Javeriana, Cali, Colombia		Luquetti, DV (corresponding author), 1900 9th Ave C9S-5, Seattle, WA 98145 USA.	Daniela.luquetti@seattlechildrens.org	Luquetti, Daniela Varela/AAB-4902-2021; Zarante, Ignacio/AAL-6215-2021; Heike, Carrie/ABA-4852-2021; Villa, Paula Margarita Hurtado/O-2543-2014	Luquetti, Daniela Varela/0000-0001-6059-7708; Zarante, Ignacio/0000-0002-0729-6866; Heike, Carrie/0000-0003-2178-7730; Villa, Paula Margarita Hurtado/0000-0003-3822-7780; Ibanez Correa, Lina Maria/0000-0003-2367-2320; Ayala Ramirez, Paola/0000-0002-0141-1149	NIH: NIDCD [R00DC011282]; NIH: NIDCR [RC1 DE 020270, R01 DE022438]; NIH: NICHD [X01 HL140518-01]	NIH: NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH: NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH: NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH: NIDCD (R00DC011282), NIDCR (RC1 DE 020270, R01 DE022438), NICHD (X01 HL140518-01).	Beleza-Meireles A, 2014, J MED GENET, V51, P635, DOI 10.1136/jmedgenet-2014-102476; Berenguer M, 2017, EUR J HUM GENET, V25, P1083, DOI 10.1038/ejhg.2017.101; Dixon J, 2004, DEV DYNAM, V229, P907, DOI 10.1002/dvdy.20004; Donaldson IJ, 2012, NUCLEIC ACIDS RES, V40, P3990, DOI 10.1093/nar/gkr1240; Gorlin R.J., 2001, SYNDROMES HEAD NECK; Hudson LD, 2011, TRANSGENIC RES, V20, P951, DOI 10.1007/s11248-010-9470-x; Keogh IJ, 2007, ARCH OTOLARYNGOL, V133, P997, DOI 10.1001/archotol.133.10.997; Lopez E, 2016, J MED GENET, V53, P752, DOI 10.1136/jmedgenet-2016-103774; Pagon RA, 2009, GENEREVIEWS; ROLLNICK BR, 1983, AM J MED GENET, V15, P233, DOI 10.1002/ajmg.1320150207; Smits SM, 2005, NEUROSCIENCE, V136, P171, DOI 10.1016/j.neuroscience.2005.07.053; Vasconcelos FF, 2016, CELL REP, V17, P469, DOI 10.1016/j.celrep.2016.09.024; Vendramini-Pittoli S, 2009, CLIN DYSMORPHOL, V18, P67, DOI 10.1097/MCD.0b013e328323a7dd; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Zamariolli M, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.959	15	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2324-9269			MOL GENET GENOM MED	Mol. Genet. Genom. Med.	OCT	2020	8	10							e1401	10.1002/mgg3.1401	http://dx.doi.org/10.1002/mgg3.1401		SEP 2020	5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	OH2FB	32871052	gold, Green Published			2022-09-04	WOS:000564459500001
J	Ospina-Serrano, AV; Bruges, R; Ramos, P; Bernal, L; Aruachan, S; Quiroga, A; Rivas, G; Munevar, I; Mantilla, W; Sanchez-Vanegas, G				Vanessa Ospina-Serrano, Aylen; Bruges, Ricardo; Ramos, Pedro; Bernal, Laura; Aruachan, Sandra; Quiroga, Alicia; Rivas, Giovanna; Munevar, Isabel; Mantilla, William; Sanchez-Vanegas, Guillermo			Impact of health insurance type on access to vaccination and mortality due to COVID-19 on patients with cancer in Colombia: a cohort study	LANCET ONCOLOGY			English	Meeting Abstract									[Vanessa Ospina-Serrano, Aylen] ICCAL Hosp Univ Fdn Santa Fe Bogota, Bogota, Colombia; [Vanessa Ospina-Serrano, Aylen] Asociac Colombiana Hematol & Oncol ACHO, Bogota, Colombia; [Bruges, Ricardo] Pontificia Univ Javeriana, Inst Nacl Cancerol, Bogota, Colombia; [Ramos, Pedro] Clin Univ Colombia Sanitas, Bogota, Colombia; [Bernal, Laura] Clin Univ Colombia, Bogota, Colombia; [Aruachan, Sandra] IMAT Oncomed, Monteria, Colombia; [Quiroga, Alicia] Hosp PabloTobon Uribe, Medellin, Colombia; [Rivas, Giovanna] Clin Occidente, Cali, Colombia; [Munevar, Isabel] Hosp Militar Cent, Fdn Cardioinfantil, Hemato Oncol Asociados, Bogota, Colombia; [Mantilla, William] Fdn Cardioinfantil Univ Rosario, Grp ICAROS, Bogota, Colombia; [Sanchez-Vanegas, Guillermo] Fdn Univ Ciencias Salud FUCS, Bogota, Colombia			avospina@hotmail.com		Quiroga, Alicia/0000-0001-9041-0238					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	JUL	2022	23			1			S39	S39						1	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	3C4CN	35837936	Bronze, Green Accepted			2022-09-04	WOS:000828572700040
J	Kovalskys, I; Fisberg, M; Salas, GG; Rigotti, A; Cortes, LY; Garcia, MCY; Pareja, RP; Cuenca, MH; Previdelli, AN				Kovalskys, Irina; Fisberg, Mauro; Gomez Salas, Georgina; Rigotti, Attilio; Cortes, Lilia Yadira; Yepez Garcia, Martha Cecilia; Pareja, Rossina Pareja; Herrera Cuenca, Marianella; Nogueira Previdelli, Agatha			HABITS & CULTURE: RELATIONSHIP BETWEEN FOOD HABITS AND NUTRITIONAL PROFILE BASED ON MICRONUTRIENTS	ANNALS OF NUTRITION AND METABOLISM			English	Meeting Abstract						Epidemiology; Macronutrients; Nutrition Food patterns; ELANS			[Kovalskys, Irina] Int Life Sci Inst ILSI, Nutr & Hlth Area, Buenos Aires, DF, Argentina; [Fisberg, Mauro] Hosp Infantil Sabara, Inst Pensi, Fundacao Jose Luiz Egydio Setubal, Sao Paulo, Brazil; [Fisberg, Mauro] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Gomez Salas, Georgina] Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose, Costa Rica; [Rigotti, Attilio] Pontificia Univ Catolica, Dept Nutr Diabet & Metab, Escuela Med, Ctr Nutr Mol & Enfermedades Cron, Santiago, Chile; [Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador; [Pareja, Rossina Pareja] Inst Invest Nutr, Lima, Peru; [Herrera Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Fdn Bengoa, Ctr Estudios Desarrollo, Caracas, Venezuela; [Nogueira Previdelli, Agatha] Univ Sao Judas Tadeu Sao Paulo, Fac Ciencias Biol & Saude, Sao Paulo, Brazil				Fisberg, Mauro/E-7149-2010; Cortes, Lilia Yadira/AAF-2960-2019	Fisberg, Mauro/0000-0003-2992-3215; 	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	The ELANS is supported by a scientific grant from the Coca Cola Company and support from the Instituto Pensi/Hospital Infantil Sabara, International Life Science Institute of Argentina, Universidad de Costa Rica, Pontificia Universidad Catolica de Chile, Pontificia Universidad Javeriana, Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa, Universidad San Francisco de Quito, and Instituto de Investigacion Nutricional de Peru. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of this symposium.		0	0	0	1	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-6807	1421-9697		ANN NUTR METAB	Ann. Nutr. Metab.		2017	71			2			42	42						1	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	FM9QD					2022-09-04	WOS:000415605300066
J	Ossa, H; Aquino, J; Pereira, R; Ibarra, A; Ossa, RH; Perez, LA; Granda, JD; Lattig, MC; Groot, H; de Carvalho, EF; Gusmao, L				Ossa, Humberto; Aquino, Juliana; Pereira, Rui; Ibarra, Adriana; Ossa, Rafael H.; Adriana Perez, Luz; David Granda, Juan; Claudia Lattig, Maria; Groot, Helena; de Carvalho, Elizeu Fagundes; Gusmao, Leonor			Outlining the Ancestry Landscape of Colombian Admixed Populations	PLOS ONE			English	Article							DNA MTDNA HAPLOGROUPS; MITOCHONDRIAL-DNA; Y-CHROMOSOME; UNRELATED INDIVIDUALS; AMERICAN POPULATIONS; GENETIC ANCESTRY; ADMIXTURE; SUBSTRUCTURE; ASSOCIATION; COMMUNITIES	The ancestry of the Colombian population comprises a large number of well differentiated Native communities belonging to diverse linguistic groups. In the late fifteenth century, a process of admixture was initiated with the arrival of the Europeans, and several years later, Africans also became part of the Colombian population. Therefore, the genepool of the current Colombian population results from the admixture of Native Americans, Europeans and Africans. This admixture occurred differently in each region of the country, producing a clearly stratified population. Considering the importance of population substructure in both clinical and forensic genetics, we sought to investigate and compare patterns of genetic ancestry in Colombia by studying samples from Native and non-Native populations living in its 5 continental regions: the Andes, Caribe, Amazonia, Orinoquia, and Pacific regions. For this purpose, 46 AIM-Indels were genotyped in 761 non-related individuals from current populations. Previously published genotype data from 214 Colombian Natives from five communities were used for population comparisons. Significant differences were observed between Native and non-Native populations, among non-Native populations from different regions and among Native populations from different ethnic groups. The Pacific was the region with the highest African ancestry, Amazonia harboured the highest Native ancestry and the Andean and Orinoquian regions showed the highest proportion of European ancestry. The Andean region was further sub-divided into 6 sub-regions: North East, Central West, Central East, West, South West and South East. Among these regions, the South West region showed a significantly lower European admixture than the other regions. Hardy-Weinberg equilibrium and variance values of ancestry among individuals within populations showed a potential stratification of the Pacific population.	[Ossa, Humberto] Pontificia Univ Javeriana, Fac Ciencias, Bogota, Colombia; [Ossa, Humberto; Ossa, Rafael H.] Lab Genet & Biol Mol, Bogota, Colombia; [Aquino, Juliana; de Carvalho, Elizeu Fagundes; Gusmao, Leonor] State Univ Rio de Janeiro UERJ, DNA Diagnost Lab, Rio De Janeiro, Brazil; [Pereira, Rui] Univ Porto, i3S, Oporto, Portugal; [Pereira, Rui; Gusmao, Leonor] Univ Porto, IPATIMUP Inst Patol Imunol Mol, Oporto, Portugal; [Ibarra, Adriana; David Granda, Juan] Univ Antioquia, Sch Nat & Exact Sci FCEN, Inst Biol, IdentiGEN Genet Identificat Lab, Medellin, Antioquia, Colombia; [Ibarra, Adriana; David Granda, Juan] Univ Antioquia, Sch Nat & Exact Sci FCEN, Inst Biol, Res Grp Genet Identificat, Medellin, Antioquia, Colombia; [Ossa, Rafael H.] Univ Bosque, Fac Med, Bogota, Colombia; [Adriana Perez, Luz; Claudia Lattig, Maria; Groot, Helena] Univ Los Andes, Lab Genet Humana, Bogota, Colombia		Gusmao, L (corresponding author), State Univ Rio de Janeiro UERJ, DNA Diagnost Lab, Rio De Janeiro, Brazil.; Gusmao, L (corresponding author), Univ Porto, IPATIMUP Inst Patol Imunol Mol, Oporto, Portugal.	Igusmao@ipatimup.pt	DE CARVALHO, ELIZEU F/B-8525-2013; Pereira, Rui/B-1656-2013; Gusmão, Leonor/L-8931-2019; Gusmao, Leonor/B-3122-2013	DE CARVALHO, ELIZEU F/0000-0003-4620-7253; Pereira, Rui/0000-0002-3889-798X; Gusmão, Leonor/0000-0003-0432-6481; Gusmao, Leonor/0000-0003-0432-6481; Ossa Trujillo, Rafael Humberto/0000-0003-3112-8712; Groot, Helena/0000-0002-9152-2175; lattig, claudia/0000-0003-2113-9266	DNA Program State University and Justice Court of Rio de Janeiro (UERJ/TJRJ/MPRJ), Brazil; FCT, Portugal [SFRH/BPD/81986/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil; Portuguese Foundation for Science and Technology	DNA Program State University and Justice Court of Rio de Janeiro (UERJ/TJRJ/MPRJ), Brazil; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	Financial support was granted by DNA Program State University and Justice Court of Rio de Janeiro (UERJ/TJRJ/MPRJ), Brazil. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, and is partially supported by FCT, the Portuguese Foundation for Science and Technology. JA was supported through a Doctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil. RP is supported by a postdoctoral fellowship from FCT (SFRH/BPD/81986/2011), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alonso LA, 2013, HOMO, V64, P71, DOI 10.1016/j.jchb.2012.11.006; Aquino JG, 2015, FORENS SCI INT-GEN S, V5, pE34, DOI 10.1016/j.fsigss.2015.09.014; Arango Ochoa Raul., 2004, PUEBLOS INDIGENAS CO; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Briceno I, 1996, EUR J IMMUNOGENET, V23, P235, DOI 10.1111/j.1744-313X.1996.tb00118.x; Builes JJ, 2006, INT C SERIES, V1288, P174; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; Casas-Vargas A, 2011, AM J PHYS ANTHROPOL, V146, P637, DOI 10.1002/ajpa.21626; Noguera MC, 2014, ANN HUM BIOL, V41, P453, DOI 10.3109/03014460.2013.852244; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gonzales De Perez MS, 2000, LENGUAS INDIGENAS CO; Homburger JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005602; Ibarra A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087202; Ibarra A, 2014, INT J LEGAL MED, V128, P19, DOI 10.1007/s00414-013-0858-z; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Manta FSN, 2013, ANN HUM BIOL, V40, P94, DOI 10.3109/03014460.2012.742138; Oliveros D. E., 1996, GEOGRAFIA HUMANA COL, V2, P153; Ossa H, 2015, FORENS SCI INT-GEN S, V5, pE332, DOI 10.1016/j.fsigss.2015.09.132; Pereira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029684; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rodas C, 2003, HUM BIOL, V75, P13, DOI 10.1353/hub.2003.0026; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salzano FM, 2014, GENET MOL BIOL, V37, P151, DOI 10.1590/S1415-47572014000200003; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Usme-Romero S, 2013, GENET MOL BIOL, V36, P149, DOI 10.1590/S1415-47572013005000011; Vullo C, 2015, INT J LEGAL MED, V129, P673, DOI 10.1007/s00414-014-1025-x; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Xavier C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120155; Yunis JJ, 2005, FORENSIC SCI INT, V151, P307, DOI 10.1016/j.forsciint.2005.02.005; Yunis JJ, 2013, GENET MOL BIOL, V36, P329, DOI 10.1590/S1415-47572013000300005; Zhivotovsky LA, 2001, FORENSIC SCI INT, V119, P269, DOI 10.1016/S0379-0738(00)00442-4	37	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164414	10.1371/journal.pone.0164414	http://dx.doi.org/10.1371/journal.pone.0164414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736937	gold, Green Published, Green Submitted			2022-09-04	WOS:000385505800064
J	Pareja, PR; Kovalskys, I; Fisberg, M; Salas, GG; Rigotti, A; Cortes, LY; Garcia, MCY; Herrera-Cuenca, M; Previdelli, AN				Pareja, Rossina Pareja; Kovalskys, Irina; Fisberg, Mauro; Gomez Salas, Georgina; Rigotti, Attilio; Cortes, Lilia Yadira; Yepez Garcia, Martha Cecilia; Herrera-Cuenca, Marianella; Nogueira Previdelli, Agatha			MAJOR FOOD SOURCES OF SUGAR AND ITS ASSOCIATION WITH OBESITY AMONG COUNTRIES OF ELANS	ANNALS OF NUTRITION AND METABOLISM			English	Meeting Abstract						Added sugar; beverage; energy; obesity; Latin America			[Pareja, Rossina Pareja] Inst Invest Nutr, Buenos Aires, DF, Argentina; [Kovalskys, Irina] ILSI, Nutr & Hlth Area, Buenos Aires, DF, Argentina; [Fisberg, Mauro] Hosp Infantil Sabara, Fundacao Jose Luiz Egydio Setubal, Inst Pensi, Sao Paulo, Brazil; [Fisberg, Mauro] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Gomez Salas, Georgina] Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose, Costa Rica; [Rigotti, Attilio] Pontificia Univ Catolica, Escuela Med, Dept Nutr Diabet & Metab, Ctr Nutr Mol & Enfermedades Cron, Santiago, Chile; [Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Fdn Bengoa, Ctr Estudios Desarrollo, Caracas, Venezuela; [Nogueira Previdelli, Agatha] Univ Sao Judas Tadeu Sao Paulo, Fac Ciencias Biol & Saude, Sao Paulo, Brazil				Fisberg, Mauro/E-7149-2010; Cortes, Lilia Yadira/AAF-2960-2019	Fisberg, Mauro/0000-0003-2992-3215; 	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	The ELANS is supported by a scientific grant from the Coca Cola Company and support from the Instituto Pensi/Hospital Infantil Sabara, International Life Science Institute of Argentina, Universidad de Costa Rica, Pontificia Universidad Catolica de Chile, Pontificia Universidad Javeriana, Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa, Universidad San Francisco de Quito, and Instituto de Investigacion Nutricional de Peru. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of this symposium.		0	0	0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-6807	1421-9697		ANN NUTR METAB	Ann. Nutr. Metab.		2017	71			2			90	91						2	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	FM9QD					2022-09-04	WOS:000415605300151
J	Ortiz, G; Duenas, C; Rodriguez, F; Barrera, L; de La Rosa, G; Dennis, R; Granados, M; Londono, D; Molina, F; Jaimes, F				Ortiz, Guillermo; Duenas, Carmelo; Rodriguez, Ferney; Barrera, Lena; de La Rosa, Gisela; Dennis, Rodolfo; Granados, Marcela; Londono, Dario; Molina, Francisco; Jaimes, Fabian			Epidemiology of sepsis in Colombian intensive care units	BIOMEDICA			English	Article						Sepsis/epidemiology; septic shock; intensive care	SEPTIC SHOCK; HOSPITAL MORTALITY; SURVIVING SEPSIS; ACUTE PHYSIOLOGY; MULTICENTER; MANAGEMENT; OUTCOMES; POPULATION; GUIDELINES; INFECTION	Introduction: Currently, there is not enough data available concerning sepsis in developing countries, especially in Latin America. Objective: We developed a study aimed at determining the frequency, clinical and epidemiological characteristics, and the consequences of sepsis in patients requiring admission to intensive care units in Colombia. Materials and methods: This was a secondary analysis of a prospective cohort study carried out over a six-month period, from September 1, 2007, to February 28, 2008, in ten medical/surgical intensive care units in four Colombian cities. Patients were considered eligible if they had a probable or confirmed diagnosis of infection according to medical records. We recorded demographic characteristics, first admission diagnosis and co-morbidities, clinical status, and sepsis, severe sepsis or septic shock. Results: During the study period, 826 patients were admitted to the intensive care units. From these patients, 421 (51%) developed sepsis in the community, 361 (44%) in the ICU, and 44 (5%) during hospitalization in the general ward. Two hundred and fifty three patients (30.6%) had involvement of one organ system: 20% had respiratory involvement, followed by kidney and central nervous system involvement with 3.4% and 2.7%, respectively. Conclusions: In our cohort of septic patients, the prevalence of sepsis treated in ICU is similar to that reported in other studies, as well as the overall mortality.	[Ortiz, Guillermo] Hosp Santa Clara, Dept Cuidado Intensivo, Bogota, DC, Colombia; [Duenas, Carmelo] Hosp Bocagrande, Dept Cuidado Intensivo, Cartagena, Colombia; [Rodriguez, Ferney] Univ Antioquia, Dept Med Interna, Medellin, Colombia; [Barrera, Lena] Univ Valle, Dept Epidemiol, Cali, Colombia; [de La Rosa, Gisela] Hosp Pablo Tobon Uribe, Dept Cuidado Intensivo, Medellin, Colombia; [Dennis, Rodolfo] Fdn Cardio Infantil, Dept Med Interna, Bogota, DC, Colombia; [Granados, Marcela] Fdn Valle de Lili, Dept Cuidado Intensivo, Cali, Colombia; [Londono, Dario] Pontificia Univ Javeriana, Dept Cuidado Intensivo, Bogota, DC, Colombia; [Molina, Francisco] Univ Pontificia Bolivariana, Dept Cuidado Intensivo, Medellin, Colombia; [Jaimes, Fabian] Univ Antioquia, Dept Cuidado Intensivo, Medellin, Colombia		Ortiz, G (corresponding author), Calle 105 23-30,Apartamento 402, Bogota, DC, Colombia.	ortiz_guillermo@hotmail.com	Jaimes, Fabian/AAE-4109-2020; Jaimes, Fabian/R-4258-2016	Jaimes, Fabian/0000-0002-7315-5367; Jaimes, Fabian/0000-0002-7315-5367; Ortiz, Guillermo/0000-0002-3374-5709; Dennis, Rodolfo J/0000-0003-3215-9721; Barrera, Lena/0000-0001-9179-7796; De La Rosa Echavez, Gisela Del Carmen/0000-0002-7690-0959	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia (Colciencias) [1115-3431-9154]; Universidad de Antioquia	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Antioquia	Supported by the Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia (Colciencias) through grant 1115-3431-9154, and by Universidad de Antioquia.	Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Bochud Pierre-Yves, 2004, Crit Care Med, V32, pS495, DOI 10.1097/01.CCM.0000143118.41100.14; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Cavazzoni SLZ, 2006, CRIT CARE, V10, DOI 10.1186/cc4829; Cheng AC, 2007, CLIN INFECT DIS, V45, P308, DOI 10.1086/519261; Danai PA, 2006, CHEST, V129, P1432, DOI 10.1378/chest.129.6.1432; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2003, CRIT CARE MED, V31, P946, DOI 10.1097/01.CCM.0000057403.73299.A6; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; *DIV HLTH QUAL PRO, 2007, THE NATIONAL HEALTHC; Dombrovskiy VY, 2005, CRIT CARE MED, V33, P2555, DOI 10.1097/01.CCM.0000186748.64438.7B; Esper A, 2007, CRIT CARE MED, V35, P1414, DOI 10.1097/01.CCM.0000262946.68003.21; Esper AM, 2006, CRIT CARE MED, V34, P2576, DOI 10.1097/01.CCM.0000239114.50519.0E; Esteban A, 2007, CRIT CARE MED, V35, P1284, DOI 10.1097/01.CCM.0000260960.94300.DE; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Girard TD, 2005, CLIN INFECT DIS, V40, P719, DOI 10.1086/427876; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-00017; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Howell MD, 2007, CRIT CARE MED, V35, P1422, DOI 10.1097/01.CCM.0000262933.08673.0C; Jaimes F, 2005, REV PANAM SALUD PUBL, V18, P163, DOI 10.1590/S1020-49892005000800003; Jones AE, 2008, CRIT CARE MED, V36, P2734, DOI 10.1097/CCM.0b013e318186f839; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lundberg JS, 1998, CRIT CARE MED, V26, P1020, DOI 10.1097/00003246-199806000-00019; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McBean M, 2001, J INFECT DIS, V183, P596, DOI 10.1086/318526; Minneci PC, 2004, ANN INTERN MED, V141, P47, DOI 10.7326/0003-4819-141-1-200407060-00014; Mrus JM, 2005, CRIT CARE, V9, pR623, DOI 10.1186/cc3811; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2008, CRIT CARE CLIN, V24, pS1, DOI 10.1016/j.ccc.2008.04.002; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; Siddiqui Shahla, 2007, J Indian Med Assoc, V105, P221; Sprung CL, 1999, CRIT CARE MED, V27, P1073, DOI 10.1097/00003246-199906000-00021; Stoll BJ, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.2.e18; Tanriover MD, 2006, EPIDEMIOL INFECT, V134, P315, DOI 10.1017/S0950268805004978; Trzeciak S, 2007, INTENS CARE MED, V33, P970, DOI 10.1007/s00134-007-0563-9; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wilhelms SB, 2010, CRIT CARE MED, V38, P1442, DOI 10.1097/CCM.0b013e3181de4406; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893; Young MP, 2003, J GEN INTERN MED, V18, P77, DOI 10.1046/j.1525-1497.2003.20441.x; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0; Zimmerman JE, 1998, CRIT CARE MED, V26, P1317, DOI 10.1097/00003246-199808000-00012	51	17	27	0	5	INST NACIONAL SALUD	BOGOTA D C	AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C, 00000, COLOMBIA	0120-4157	2590-7379		BIOMEDICA	Biomedica	JAN-MAR	2014	34	1					40	47		10.7705/biomedica.v34i1.1439	http://dx.doi.org/10.7705/biomedica.v34i1.1439			8	Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Tropical Medicine	AP9NU	24967858	Green Published, gold			2022-09-04	WOS:000342407300007
J	Dans, AM; Dans, L; Oxman, AD; Robinson, V; Acuin, J; Tugwell, P; Dennis, R; Kang, DY				Dans, Antonio Miguel; Dans, Leonila; Oxman, Andrew David; Robinson, Vivian; Acuin, Joselito; Tugwell, Peter; Dennis, Rodolfo; Kang, Deying			Assessing equity in clinical practice guidelines	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						equity; clinical practice guideline; inequity; developing countries; effectiveness; knowledgment management	MEASLES-VACCINE; HYPERTENSION; POLICY	Recognition of the need for systematically developed clinical practice guidelines (CPGs) has increased dramatically over the past 20 years. CPGs have focused primarily on the effectiveness of interventions, explicitly or implicitly addressing the following question: Will adherence to a recommendation do more good than harm? At times they have also focused on the cost-effectiveness of interventions: Are the net benefits worth the costs? They rarely have focused on equity: Are the recommendations fair? The Knowledge Plus Project of the International Clinical Epidemiology Network attempts to improve the process of CPG development by formulating strategies to consider not just technical issues (effectiveness, and efficiency) but sociopolitical dimensions as well (equity and local appropriateness). This article discusses a proposed lens for users to evaluate how well CPGs address issues of equity. (c) 2007 Elsevier Inc. All rights reserved.	Philippine Gen Hosp, Dept Med, Sect Adult Med, Manila, Philippines; Univ Philippines, Dept Clin Epidemiol, Manila, Philippines; Philipping Gen Hosp, Dept Pediat, Manila, Philippines; Norwegian Hlth Serv Res Ctr, Oslo, Norway; Univ Ottawa, Ctr Global Hlth, Ottawa, ON, Canada; Dela Salle Univ, Med Ctr, Cavite, Philippines; Univ Javeriana, Dept Med, Fdn Cardioinfantil, Clin Epidemiol Unit, Bogota, Colombia; Sichuan Univ, Dept Clin Epidemiol, Chengdu 610064, Peoples R China; Sichuan Univ, W China Hosp, EMB, Chengdu 610064, Peoples R China		Dans, AM (corresponding author), Philippine Gen Hosp, Dept Med, Sect Adult Med, Mexxanine Floor,Taft Ave, Manila, Philippines.	tdans@zpdee.net	Tugwell, Peter/AFD-8076-2022; Oxman, Andrew/Y-3004-2019	Tugwell, Peter/0000-0001-5062-0556; Oxman, Andrew/0000-0002-5608-5061; Dennis, Rodolfo J/0000-0003-3215-9721; Welch, Vivian/0000-0002-5238-7097				Aaserud M, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-68; ADU FD, 1992, B WORLD HEALTH ORGAN, V70, P457; Aldrich R, 2003, BMJ-BRIT MED J, V327, P1283, DOI 10.1136/bmj.327.7426.1283; Anderson G, 2005, ARCHAEOLOGY, V58, P8; [Anonymous], 1999, 10 90 REP HLTH RES 1; Bautista-Lopez NL, 2001, B WORLD HEALTH ORGAN, V79, P1038; Brandt ER, 2000, NAT MED, V6, P455, DOI 10.1038/74719; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; Burgers JS, 2003, INT J QUAL HEALTH C, V15, P31, DOI 10.1093/intqhc/15.1.31; CASTRO T, 1995, INT FAM PLAN PERSPEC, V21, P52; *CDCP, 2004, BURD CHRON DIS THEIR; Chowdhury AMR, 2003, J HEALTH POPUL NUTR, V21, P193; Cooper LA, 2003, MED CARE, V41, P479, DOI 10.1097/00005650-200304000-00004; Corbie-Smith G, 2003, J CLIN EPIDEMIOL, V56, P416, DOI 10.1016/S0895-4356(03)00031-3; Dans A, 2002, USERS GUIDE MED LIT, V369-84; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Davis DA, 1997, CAN MED ASSOC J, V157, P408; DELMAR CB, 2004, COCHRANE DATABASE SY; DEVEREAUX PJ, 2001, BRIT MED J, V323, P1; DOULL M, 2004, SEXUAL HLTH CRITERIA; DULEY L, 2003, COCHRANE DATABASE SY; ELLRODT AG, 1995, ANN INTERN MED, V122, P277, DOI 10.7326/0003-4819-122-4-199502150-00007; EVANS T, 2001, CHALLENGING INEQUITI, P3; Flottorp S, 2000, Tidsskr Nor Laegeforen, V120, P1754; *FOO NUTR RES I, 2004, NAT NUTR HLTH SURV; FORBES C, 2003, COCHRANE LIB; Fretheim A, 2002, J FAM PRACTICE, V51, P963; *GEGA, 2003, EQ GAUG CONC PRINC G; Gepkens A., 1996, European Journal of Public Health, V6, P218, DOI 10.1093/eurpub/6.3.218; *GLOB FOR HLTH RES, 2004, MON FIN FLOWS HLTH R, P60; Goldstein ST, 2001, J SCHOOL HEALTH, V71, P184, DOI 10.1111/j.1746-1561.2001.tb07313.x; Grimshaw J, 1995, Qual Health Care, V4, P55, DOI 10.1136/qshc.4.1.55; GUYATT G, 2002, USERS GUIDES MED LIT, P188; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; *IMS PHIL, 2003, INT MED STAT IMS DRU; KAHN KL, 1993, RAND DOCUMENT, V18, P139; KRISTJANSSON E, 2003, B 11 COCHR C BARC OC; Lopes AA, 2002, J HUM HYPERTENS, V16, pS11, DOI 10.1038/sj.jhh.1001333; Macintyre S, 2001, BRIT MED J, V322, P222, DOI 10.1136/bmj.322.7280.222; MARCUS AC, 1992, MED CARE, V30, P216, DOI 10.1097/00005650-199203000-00004; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Royal College of Paediatricians and Child Health, 2000, MAN AC REC SOR THROA; SCHENEIDER P, 2004, IMPACT PHILHEALTH IN; Singh-Manoux A, 2005, SOC SCI MED, V60, P2129, DOI 10.1016/j.socscimed.2004.08.070; Strzelczyk Jadwiga Jodi, 2002, Ethnicity and Disease, V12, P77; TSUKATA S, 11 COCHR C EV HLTH C; van Alken WG, 2004, WHO TECH REP SER, V926, P1; VEASY LG, 1994, J PEDIATR-US, V124, P9, DOI 10.1016/S0022-3476(94)70247-0; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease, 2001, WHO TECHN REP SER; Wilkinson RG., 1998, SOLID FACTS SOCIAL D; Yount KM, 2003, SOC SCI MED, V56, P753, DOI 10.1016/S0277-9536(02)00072-2	53	37	44	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	JUN	2007	60	6					540	546		10.1016/j.jclinepi.2006.10.008	http://dx.doi.org/10.1016/j.jclinepi.2006.10.008			7	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	172DP	17493507	Green Accepted			2022-09-04	WOS:000246784600003
J	Fisberg, RM; Fontanelli, MM; Kowalskys, I; Gomez, G; Rigotti, A; Cortes, LY; Garcia, MY; Pareja, RG; Herrera-Cuenca, M; Fisberg, M				Fisberg, Regina Mara; Fontanelli, Mariane Mello; Kowalskys, Irina; Gomez, Georgina; Rigotti, Attilio; Cortes, Lilia Yadira; Garcia, Martha Yepez; Pareja, Rossina G.; Herrera-Cuenca, Marianella; Fisberg, Mauro		ELANS Study Grp	Total and whole grain intake in Latin America: fndings from the multicenter cross-sectional Latin American Study of Health and Nutrition (ELANS) (Jul, 10.1007/s00394-021-02635-8, 2021)	EUROPEAN JOURNAL OF NUTRITION			English	Correction									[Fisberg, Regina Mara; Fontanelli, Mariane Mello] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, Brazil; [Kowalskys, Irina] Pontificia Univ Catolica Argentina, Fac Ciencias Med, Carrera Nutr, C1107 AAZ, Buenos Aires, DF, Argentina; [Gomez, Georgina] Univ Costa Rica, Dept Bioquim, Escuela Med, San Jose 115012060, Costa Rica; [Rigotti, Attilio] Pontificia Univ Catolica, Ctr Nutr Mol & Enfermedades Cron, Dept Nutr Diabet & Metab, Escuela Med, Santiago 8330024, Chile; [Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota 110231, Colombia; [Garcia, Martha Yepez] Univ San Francisco Quito, Colegio Ciencias Salud, Quito 171200841, Ecuador; [Pareja, Rossina G.] Inst Invest Nutr, Lima 15026, Peru; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Fdn Bengoa, Ctr Estudios Desarrollo, Caracas 1053, Venezuela; [Fisberg, Mauro] Hosp Infantil Sabara, Fundacao Jose Luiz Egydio Setubal, Inst Pensi, BR-01227200 Sao Paulo, Brazil		Kowalskys, I (corresponding author), Pontificia Univ Catolica Argentina, Fac Ciencias Med, Carrera Nutr, C1107 AAZ, Buenos Aires, DF, Argentina.	rfisberg@usp.br; marianefontanelli@gmail.com; ikovalskys@gmail.com; georgina.gomez@ucr.ac.cr; arigotti@med.puc.cl; ycortes@javeriana.edu.co; myepez@usfq.edu.ec; rpareja@iin.sld.pe; manyma@gmail.com; mauro.fisberg@gmail.com	; Fisberg, Mauro/E-7149-2010	Cortes, Lilia Yadira/0000-0003-2789-3219; Kovalskys, Irina/0000-0001-8481-5415; Fontanelli, Mariane/0000-0002-3480-6948; Herrera-Cuenca, Marianella/0000-0003-0162-3480; Gomez, Georgina/0000-0003-3514-2984; Fisberg, Mauro/0000-0003-2992-3215; Yepez, Martha Cecilia/0000-0003-4119-238X				Fisberg RM, 2022, EUR J NUTR, V61, P489, DOI 10.1007/s00394-021-02635-8	1	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1436-6207	1436-6215		EUR J NUTR	Eur. J. Nutr.	FEB	2022	61	1					503	504		10.1007/s00394-021-02723-9	http://dx.doi.org/10.1007/s00394-021-02723-9		NOV 2021	2	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	YL0UA	34748061	hybrid, Green Published			2022-09-04	WOS:000715679700003
J	Ayala, JC; Grismaldo, A; Aristizabal-Pachon, AF; Mikhaylenko, EV; Nikolenko, VN; Mikhaleva, LM; Somasundaram, SG; Kirkland, CE; Aliev, G; Morales, L				Carlos Ayala, Juan; Grismaldo, Adriana; Felipe Aristizabal-Pachon, Andres; Mikhaylenko, Elizaveta, V; Nikolenko, Vladimir N.; Mikhaleva, Liudmila M.; Somasundaram, Siva G.; Kirkland, Cecil E.; Aliev, Gjumrakch; Morales, Ludis			Mitochondrial Dysfunction In Intensive Care Unit Patients	CURRENT PHARMACEUTICAL DESIGN			English	Article						Mitochondrial dysfunction; oxidative stress; sepsis; ICU; SIRS; CRP	C-REACTIVE PROTEIN; COMPLEX-III; SEPSIS; MECHANISMS; IMMUNOPARALYSIS; FAILURE; HYPOXIA; MARKERS; SCORE	Background: In patients admitted to the Intensive Care Unit (ICU), mortality is high due to multiple organ damage. Mitochondrial dysfunction and impaired oxygen consumption, as causative mechanisms, play a significant role in reducing the activity of immune cells in sepsis, resulting in the progression of the multiple organ dysfunction syndromes (MODS). The evaluation of mitochondrial function in critical care patients in the immune cells, especially in lymphocytes, could reveal the target point that determines mitochondrial failure. Objective: To find the relationship between mitochondrial reactive oxygen species production (mROS), mitochondrial membrane potential (Delta Psi m), and mitochondrial oxygen consumption (mVO2) in peripheral plasma lymphocytes collected from ICU patients. We also compared these three characteristic mitochondrial functions with C-reactive protein (CRP), serum lactate, and central venous saturation (SvO2) that would enable the prediction of the ultimate outcome. Methods: Isolated lymphocytes from 54 critical care patients with SIRS by sepsis and non-sepsis etiologies were analyzed with flow cytometry by staining with dihydroethidium and JC-1, measuring mROS, Delta Psi m, and mVO2. Clinical variables, such as serum lactate (mmol/L) and C-reactive protein (mg/L) from peripheral blood, were measured in the first 24 hours of admission. A confounding analysis was performed using logistic regression, and a p-value of <0.05 was considered statistically significant. Results: It has been confirmed that there is a drastic increase in reactive oxygen species (ROS) and mVO2 in critically ill patients immediately after exposure to the insult pathogen-associated molecular pattern /damageassociated molecular pattern (PAMPS/DAMPS) and continued for the first 24 hours thereafter. The results showed no significant alterations in the mitochondrial membrane potential (Delta Psi m) compared with the lymphocytes in controls. A significant correlation between CRP and SvO2 and a strong positive relationship between CRP, values above 3 mg/l, and white blood cells were observed. Conclusion: Lymphocytes from patients with SIRS displayed higher mitochondrial respiratory capacities and reactive oxygen species production compared with controls. Clinical markers of inflammation indirectly evaluate the mitochondrial function, most of which have been validated in a clinical setting.	[Carlos Ayala, Juan; Grismaldo, Adriana] Pontificia Univ Javeriana, Fac Ciencias, Carrera 7 40, Bogota, Colombia; [Felipe Aristizabal-Pachon, Andres; Morales, Ludis] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Carrera 7,40, Bogota, Colombia; [Mikhaylenko, Elizaveta, V; Nikolenko, Vladimir N.; Aliev, Gjumrakch] Sechenov Univ, Sechenov First Moscow State Med Univ Minist Hlth, 8-2 Trubetskaya Str, Moscow 119991, Russia; [Nikolenko, Vladimir N.] Moscow MV Lomonosov State Univ, Dept Normal & Topog Anat, Leninskie Gory 1, Moscow 119991, Russia; [Mikhaleva, Liudmila M.; Aliev, Gjumrakch] Res Inst Human Morphol, 3 Tsyurupy Str, Moscow 117418, Russia; [Somasundaram, Siva G.; Kirkland, Cecil E.] Salem Univ, Dept Biol Sci, Salem, WV 26426 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiologically Act Cpds, Chernogolovka, Russia; [Aliev, Gjumrakch] GALLY Int Res Inst, 7733 Louis Pasteur Dr, San Antonio, TX 78229 USA		Morales, L (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Carrera 7,40, Bogota, Colombia.; Aliev, G (corresponding author), GALLY Int Res Inst, 7733 Louis Pasteur Dr, San Antonio, TX 78229 USA.	aliev03@gmail.com; ludis.morales@javeriana.edu.co	Николенко, Владимир Николаевич/AAD-4696-2022; Aristizabal-Pachon, Andres Felipe/AAM-3695-2021; Mikhaleva, Liudmila/AAG-8330-2019; Aristizabal-Pachon, Andres Felipe felipe/J-3046-2015	Aristizabal-Pachon, Andres Felipe/0000-0003-3004-4867; Mikhaleva, Liudmila/0000-0003-2052-914X; Aristizabal-Pachon, Andres Felipe felipe/0000-0003-3004-4867; Mikhaylenko, Elizaveta/0000-0002-6175-8179; Grismaldo, Adriana/0000-0002-9225-3413; Morales-Alvarez, Ludis/0000-0002-8541-9729; AYALA ACOSTA, JUAN CARLOS/0000-0002-7337-8026	Pontificia Universidad Javeriana, Bogota-Colombia; Russian Academic Excellence project "5-100" for the Sechenov University, Moscow, Russia	Pontificia Universidad Javeriana, Bogota-Colombia; Russian Academic Excellence project "5-100" for the Sechenov University, Moscow, Russia	This work was supported by Pontificia Universidad Javeriana, Bogota-Colombia, and the Russian Academic Excellence project "5-100" for the Sechenov University, Moscow, Russia.	Ansar W., 2016, BIOL C REACT PROTEIN, P67; Arulkumaran N, 2016, SHOCK, V45, P271, DOI 10.1097/SHK.0000000000000463; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bilevicius E, 2001, Braz J Infect Dis, V5, P103; Chakraborty R.K., 2022, STATPEARLS INTERNET; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; Dada LA, 2011, J CLIN INVEST, V121, P1683, DOI 10.1172/JCI57748; de Pablo R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/671087; Escobar DA, 2015, J SURG RES, V194, P262, DOI 10.1016/j.jss.2014.10.009; Exline MC, 2008, FRONT BIOSCI-LANDMRK, V13, P5030; Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764; Grundler K, 2014, CRIT CARE, V18, DOI 10.1186/cc13724; Hamers L, 2015, MINERVA ANESTESIOL, V81, P426; HOTCHKISS RS, 1992, JAMA-J AM MED ASSOC, V267, P1503, DOI 10.1001/jama.267.11.1503; Jensen IJ, 2018, J IMMUNOL, V200, P1543, DOI 10.4049/jimmunol.1701618; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koozi H, 2020, J CRIT CARE, V56, P73, DOI 10.1016/j.jcrc.2019.12.009; Luan YY, 2014, J INTERF CYTOK RES, V34, P2, DOI 10.1089/jir.2013.0042; Maestraggi Q, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7897325; Miglietta Fabio, 2015, Infez Med, V23, P230; Morgan TJ., 2018, OHS INTENSIVE CARE M, V8, P160; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P532, DOI 10.1016/j.bbagen.2012.01.003; Povoa P, 2005, CLIN MICROBIOL INFEC, V11, P101, DOI 10.1111/j.1469-0691.2004.01044.x; Safari S, 2016, TURK J EMERG MED, V16, P146, DOI 10.1016/j.tjem.2016.09.005; Sakr Y, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy313; SCCM, SURV SEPS CAMP GUID; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907; Singh S, 2006, INTENS CARE MED, V32, P349, DOI 10.1007/s00134-005-0038-9; Sjovall F, 2013, CRIT CARE, V17, DOI 10.1186/cc12831; Skrupky LP, 2011, ANESTHESIOLOGY, V115, P1349, DOI 10.1097/ALN.0b013e31823422e8; Textoris J, 2011, CRIT CARE, V15, DOI 10.1186/cc10325; Timmermans K, 2016, SHOCK, V45, P607, DOI 10.1097/SHK.0000000000000549; TUCHSCHMIDT J, 1991, CRIT CARE MED, V19, P664, DOI 10.1097/00003246-199105000-00013; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wei YP, 2019, PHARMACOL RES, V141, P114, DOI 10.1016/j.phrs.2018.12.017; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	42	2	2	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2021	27	27					3074	3081		10.2174/1381612826666201207112931	http://dx.doi.org/10.2174/1381612826666201207112931			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	UM5ZY	33292115				2022-09-04	WOS:000693410800008
J	Posada, G; Trumbell, J; Noblega, M; Plata, S; Pena, P; Carbonell, OA; Lu, T				Posada, German; Trumbell, Jill; Noblega, Magaly; Plata, Sandra; Pena, Paola; Carbonell, Olga A.; Lu, Ting			Maternal Sensitivity and Child Secure Base Use in Early Childhood: Studies in Different Cultural Contexts	CHILD DEVELOPMENT			English	Article							ATTACHMENT SECURITY; INFANT ATTACHMENT; Q-SORT; BEHAVIOR; CLASSIFICATIONS; ASSOCIATIONS; ANTECEDENTS; AMERICAN; CARE	This study tested whether maternal sensitivity and child security are related during early childhood and whether such an association is found in different cultural and social contexts. Mother-child dyads (N=237) from four different countries (Colombia, Mexico, Peru, and the United States) were observed in naturalistic settings when children were between 36 and 72months of age. Maternal and child behavior during interactions at home and in the playground were described using Q methodology. Findings reveal that across cultures, concurrent maternal sensitivity and more specific behavioral domains of maternal care (e.g., contributions to harmonious interactions and secure base support) are important for children's attachment security during early childhood. Implications for the study of attachment relationships beyond infancy and in diverse contexts are highlighted.	[Posada, German] Purdue Univ, W Lafayette, IN 47907 USA; [Trumbell, Jill] Univ New Hampshire, Durham, NH 03824 USA; [Noblega, Magaly] Pontificia Univ Catolica Peru, Lima, Peru; [Plata, Sandra; Pena, Paola; Carbonell, Olga A.] Pontificia Univ Javeriana, Bogota, Colombia; [Lu, Ting] Auburn Univ, Auburn, AL 36849 USA		Posada, G (corresponding author), Purdue Univ, Dept Human Dev & Family Studies, W Lafayette, IN 47907 USA.	gposada@purdue.edu		Noblega, Magaly/0000-0001-6572-813X	National Science Foundation [BCS-0645530]; Kinley Trust; Purdue Research Foundation	National Science Foundation(National Science Foundation (NSF)); Kinley Trust; Purdue Research Foundation	Some of the ideas and data presented were supported by grants from the National Science Foundation (BCS-0645530), the Kinley Trust, and the Purdue Research Foundation to the first author.	Ainsworth M. D. S., 2006, ATTACHMENT LIFE CYCL, P33, DOI DOI 10.13189/UJER.2016.040517; Ainsworth M.D.S., 1971, ORIGINS HUMAN SOCIAL; Ainsworth M.D.S., 1978, PATTERNS ATTACHMENT; Ainsworth M. D. S, 1977, CULTURE INFANCY VARI, P49; Ainsworth MDS., 1974, INTEGRATION CHILD SO, P99; [Anonymous], DEV CROSS CULTURAL C; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Barnett D, 1998, CHILD DEV, V69, P1657, DOI 10.2307/1132138; Block J., 1978, THE Q SORT METHOD; BOWLBY J, 1958, INT J PSYCHOANAL, V39, P350; Bowlby J, 1969, ATTACHMENT LOSS, V1; Bowlby J., 1988, SECURE BASE PARENT C; Bretherton I, 2008, HDB ATTACHMENT THEOR, V2nd; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; George C., 2008, HDB ATTACHMENT THEOR, p383 ; KERMOIAN R, 1986, INT J BEHAV DEV, V9, P455, DOI 10.1177/016502548600900404; LEADBEATER BJ, 1994, CHILD DEV, V65, P638, DOI 10.1111/j.1467-8624.1994.tb00773.x; LeVine Robert A., 2001, PSYCHOL CULTURAL EXP, P83; LEYENDECKER B, 1995, SOC DEV, V4, P194, DOI 10.1111/j.1467-9507.1995.tb00060.x; LEYENDECKER B, 1999, PARENTING CHILD DEV, P247; Martin C. A., 1997, PARENTING LIFE SPAN; MARVIN RS, 1999, HDB ATTACHMENT THEOR, P44; Mesman J, 2012, CHILD DEV PERSPECT, V6, P239, DOI 10.1111/j.1750-8606.2011.00223.x; NAKAGAWA M, 1992, J CROSS CULT PSYCHOL, V23, P300, DOI 10.1177/0022022192233002; Okagaki L., 1993, PARENTING ECOLOGICAL, P35; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Pederson DR, 1996, CHILD DEV, V67, P915, DOI 10.2307/1131870; PIANTA RC, 1989, CHILD DEV, V60, P481, DOI 10.1111/j.1467-8624.1989.tb02729.x; Posada G, 1995, MONOGR SOC RES CHILD, V60, P27, DOI 10.2307/1166169; Posada G, 2004, DEV PSYCHOL, V40, P508, DOI 10.1037/0012-1649.40.4.508; Posada G, 2002, DEV PSYCHOL, V38, P67, DOI 10.1037//0012-1649.38.1.67; Posada G, 1999, DEV PSYCHOL, V35, P1379, DOI 10.1037/0012-1649.35.6.1379; Posada G, 2007, ATTACH HUM DEV, V9, P393, DOI 10.1080/14616730701712316; Posada G, 2013, CHILD DEV, V84, P1896, DOI 10.1111/cdev.12084; Posada German, 2011, HDB LIFE SPAN DEV, P87; Richmond M., 2001, M SOC RES CHILD DEV; Rivera Fernando I, 2008, Hisp J Behav Sci, V30, P357; Rothbaum F, 2001, AM PSYCHOL, V56, P827, DOI 10.1037/0003-066X.56.10.827; Rothbaum F, 2005, CULTURE AND HUMAN DEVELOPMENT: THE IMPORTANCE OF CROSS-CULTURAL RESEARCH FOR THE SOCIAL SCIENCES, P92; Rudy D, 2006, J FAM PSYCHOL, V20, P68, DOI 10.1037/0893-3200.20.1.68; Sroufe LA, 2002, MON PARENT, P187; Sroufe LA., 1988, CLIN IMPLICATIONS AT, V3, P18; STEVENSONHINDE J, 1995, CHILD DEV, V66, P583, DOI 10.2307/1131936; Valenzuela M, 1997, DEV PSYCHOL, V33, P845, DOI 10.1037/0012-1649.33.5.845; Van IJzendoorn M. H., 2008, HDB ATTACHMENT THEOR, P713; van Ijzendoorn MH, 2004, CHILD DEV, V75, P1188, DOI 10.1111/j.1467-8624.2004.00733.x; VAUGHN BE, 1990, CHILD DEV, V61, P1965, DOI 10.2307/1130850; Vereijken CMJL, 1997, INT J BEHAV DEV, V21, P35, DOI 10.1080/016502597384974; Waters E, 2000, CHILD DEV, V71, P164, DOI 10.1111/1467-8624.00130; Waters E, 1995, MONOGR SOC RES CHILD, V60, P234, DOI 10.2307/1166181; WATERS E, 1994, PSYCHIATRY, V57, P32; WATERS E, 1991, MINN SYM CHILD PSYCH, V23, P217; Zevalkink J, 2001, INT J BEHAV DEV, V25, P167, DOI 10.1080/01650250042000113	53	37	40	4	42	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-3920	1467-8624		CHILD DEV	Child Dev.	JAN-FEB	2016	87	1					297	311		10.1111/cdev.12454	http://dx.doi.org/10.1111/cdev.12454			15	Psychology, Educational; Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	DD3UK	26525825				2022-09-04	WOS:000369848300024
J	Baez-Jurado, E; Hidalgo-Lanussa, O; Guio-Vega, G; Ashraf, GM; Echeverria, V; Aliev, G; Barreto, GE				Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Guio-Vega, Gina; Ashraf, Ghulam Md; Echeverria, Valentina; Aliev, Gjumrakch; Barreto, George E.			Conditioned Medium of Human Adipose Mesenchymal Stem Cells Increases Wound Closure and Protects Human Astrocytes Following Scratch Assay In Vitro	MOLECULAR NEUROBIOLOGY			English	Article						Human astrocytes; Brain injury; Conditioned medium; Mesenchymal stem cells; Migration; Scratch	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD-INJURY; HUMAN BONE-MARROW; REACTIVE ASTROCYTES; GLUCOSE DEPRIVATION; MORPHOLOGICAL-CHANGES; NEURITE OUTGROWTH; PARACRINE FACTORS	Astrocytes perform essential functions in the preservation of neural tissue. For this reason, these cells can respond with changes in gene expression, hypertrophy, and proliferation upon a traumatic brain injury event (TBI). Different therapeutic strategies may be focused on preserving astrocyte functions and favor a non-generalized and non-sustained protective response over time post-injury. A recent strategy has been the use of the conditioned medium of human adipose mesenchymal stem cells (CM-hMSCA) as a therapeutic strategy for the treatment of various neuropathologies. However, although there is a lot of information about its effect on neuronal protection, studies on astrocytes are scarce and its specific action in glial cells is not well explored. In the present study, the effects of CM-hMSCA on human astrocytes subjected to scratch assay were assessed. Our findings indicated that CM-hMSCA improved cell viability, reduced nuclear fragmentation, and preserved mitochondrial membrane potential. These effects were accompanied by morphological changes and an increased polarity index thus reflecting the ability of astrocytes to migrate to the wound stimulated by CM-hMSCA. In conclusion, CM-hMSCA may be considered as a promising therapeutic strategy for the protection of astrocyte function in brain pathologies.	[Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Guio-Vega, Gina; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA; [Echeverria, Valentina] Univ San Sebastian, Fac Cs Salud, Lientur 1457, Concepcion 4080871, Chile; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Moscow Region, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Univ Atlanta, Healthcare Adm, Johns Creek, GA 30097 USA; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gsampaio@javeriana.edu.co	Ashraf, Ghulam Md/H-9485-2012; Barreto, George E./AAD-7420-2020; Aliev, Gjumrakch/AAE-7734-2020; Valentina Echeverria Moran, BCh/E-7765-2013	Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X	PUJ [6260]; Vicerrectoria Academica of PUJ	PUJ; Vicerrectoria Academica of PUJ	The authors thank Dr. Camilo Prieto and the staff of the cosmetic surgery in Bogota, Colombia, for the adipose tissue samples. This work was supported by PUJ ID 6260 to GEB and scholarship for doctoral studies awarded by the Vicerrectoria Academica of PUJ to Baez-Jurado E.	Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Aye T, 2011, DIABETES CARE, V34, P1458, DOI 10.2337/dc10-2164; Baez E, 2017, NEUROTOX RES, V32, P163, DOI 10.1007/s12640-017-9733-x; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Beller JA, 2014, NEURAL REGEN RES, V9, P343, DOI 10.4103/1673-5374.128235; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bovolenta P, 2000, PROG NEUROBIOL, V61, P113, DOI 10.1016/S0301-0082(99)00044-1; Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012; Brown JIM, 1998, NEUROSURGERY, V42, P1057, DOI 10.1097/00006123-199805000-00060; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Calviello LA, 2017, MINERVA ANESTESIOL, V83, P844, DOI 10.23736/S0375-9393.17.12043-2; Cano V, 2014, NEUROREPORT, V25, P819, DOI 10.1097/WNR.0000000000000180; Chen J, 2015, CELL PHYSIOL BIOCHEM, V37, P1830, DOI 10.1159/000438545; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Dennis EL, 2017, NEUROIMAGE-CLIN, V15, P125, DOI 10.1016/j.nicl.2017.03.014; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Ding S, 2014, NEURAL REGEN RES, V9, P2048, DOI 10.4103/1673-5374.147929; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Duncan T, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0567-5; Egashira Y, 2012, BRAIN RES, V1461, P87, DOI 10.1016/j.brainres.2012.04.033; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; FaberElman A, 1995, FASEB J, V9, P1605, DOI 10.1096/fasebj.9.15.8529840; Farhan H, 2016, TRENDS CELL BIOL, V26, P241, DOI 10.1016/j.tcb.2015.11.003; FEDOROFF S, 1984, J NEUROSCI RES, V12, P15, DOI 10.1002/jnr.490120103; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; FOKSEANG J, 1995, BRAIN RES, V689, P207, DOI 10.1016/0006-8993(95)00575-B; Frese L, 2016, TRANSFUS MED HEMOTH, V43, P268, DOI 10.1159/000448180; Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13; Gzielo K, 2017, CELL MOL NEUROBIOL, V37, P783, DOI 10.1007/s10571-016-0417-5; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hershey T, 2005, DIABETES CARE, V28, P2372, DOI 10.2337/diacare.28.10.2372; Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Huang WY, 2015, J CELL PHYSIOL, V230, P2461, DOI 10.1002/jcp.24981; Huang XQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-145; Ishii T, 2017, J BIOL CHEM, V292, P1240, DOI 10.1074/jbc.M116.748871; Jacobsen CT, 2003, DEV NEUROSCI-BASEL, V25, P207, DOI 10.1159/000072269; Jain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016135; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Johnson KM, 2015, NEUROSCI LETT, V600, P104, DOI 10.1016/j.neulet.2015.06.013; Kane CJM, 2014, ALCOHOL CLIN EXP RES, V38, P384, DOI 10.1111/acer.12244; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim WS, 2008, J DERMATOL SCI, V49, P133, DOI 10.1016/j.jdermsci.2007.08.004; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee DE, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0303-6; Li Z, 2010, INDIAN J BIOCHEM BIO, V47, P359; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meadows EA, 2017, J INT NEUROPSYCH SOC, V23, P451, DOI 10.1017/S1355617717000352; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Mytych J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304575; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI [10.1016/j.mito.2010.10.007, 10.1016/j.mito.2011.09.001]; Paco S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2623-4; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Paquet M, 2006, J COMP NEUROL, V494, P752, DOI 10.1002/cne.20854; Pawitan JA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965849; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pirici D, 2009, ROM J MORPHOL EMBRYO, V50, P381; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rutkowska A, 2015, GLIA, V63, P341, DOI 10.1002/glia.22757; Salgado AJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00249; Saur L, 2014, BRAIN STRUCT FUNCT, V219, P293, DOI 10.1007/s00429-012-0500-8; Seaquist ER, 2015, PSYCHOSOM MED, V77, P616, DOI 10.1097/PSY.0000000000000207; Shen CY, 2015, MOL MED REP, V12, P20, DOI 10.3892/mmr.2015.3409; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Song M, 2015, J NEUROSCI RES, V93, P973, DOI 10.1002/jnr.23569; Steele ML, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.018; Stiles MC, 2010, MINERVA MED, V101, P105; Su J, 2012, TRANSL PEDIATR, V1, P108, DOI 10.3978/j.issn.2224-4336.2012.04.06; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun H., 2013, PLOS ONE, V8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teixeira FG, 2013, CELL MOL LIFE SCI, V70, P3871, DOI 10.1007/s00018-013-1290-8; Tiryaki VM, 2015, NANOMEDICINE-UK, V10, P529, DOI 10.2217/nnm.14.33; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Vardjan N, 2014, GLIA, V62, P566, DOI 10.1002/glia.22626; Walter MNM, 2015, J STEM CELLS REGEN, V11, pP18; Wei X, 2009, NEUROSCI LETT, V462, P76, DOI 10.1016/j.neulet.2009.06.054; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Xiong J., 2006, NEW METHOD STUDYING; Xu C, 2017, INT J NEUROSCI, V127, P1124, DOI 10.1080/00207454.2017.1325884; Yalvac ME, 2013, BRAIN BEHAV IMMUN, V32, P122, DOI 10.1016/j.bbi.2013.03.007; Yamazaki H, 2015, NEUROSCI LETT, V609, P53, DOI 10.1016/j.neulet.2015.10.023; Yasen AL, 2017, MED SCI SPORT EXER, V49, P1066, DOI 10.1249/MSS.0000000000001217; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeng Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119912; Zhang L, 2015, CELL STEM CELL, V17, P735, DOI 10.1016/j.stem.2015.09.012; Zhang L, 2015, TOXICOL LETT, V236, P43, DOI 10.1016/j.toxlet.2015.04.015; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015	116	18	18	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2018	55	6					5377	5392		10.1007/s12035-017-0771-4	http://dx.doi.org/10.1007/s12035-017-0771-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF5FI	28936798				2022-09-04	WOS:000431991500067
J	Delgado-Serrano, MD; Oteros-Rozas, E; Ruiz-Mallen, I; Calvo-Boyero, D; Ortiz-Guerrero, CE; Escalante-Semerena, RI; Corbera, E				del Mar Delgado-Serrano, Maria; Oteros-Rozas, Elisa; Ruiz-Mallen, Isabel; Calvo-Boyero, Diana; Enrique Ortiz-Guerrero, Cesar; Ivan Escalante-Semerena, Roberto; Corbera, Esteve			Influence of community-based natural resource management strategies in the resilience of social-ecological systems (vol 18, pg 581, 2017)	REGIONAL ENVIRONMENTAL CHANGE			English	Correction								The published online version contains mistake. Author name was incorrectly captured. Instead of Maria del Mar Delgado-Serrano was incorrectly captured as Ma del Mar Delgado-Serrano. Correct author group section is shown above.	[del Mar Delgado-Serrano, Maria] Univ Cordoba, Dept Agr Econ, Campus Rabanales,C5,Planta 3, E-14071 Cordoba, Spain; [Oteros-Rozas, Elisa] Univ Pablo Olavide, Social & Participatory Act Res Grp, Seville, Spain; [Oteros-Rozas, Elisa] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Ruiz-Mallen, Isabel] Univ Oberta Catalunya, Internet Interdisciplinary Inst IN3, Barcelona, Spain; [Ruiz-Mallen, Isabel; Calvo-Boyero, Diana; Corbera, Esteve] Univ Autonoma Barcelona, Inst Environm Sci & Technol, Barcelona, Spain; [Enrique Ortiz-Guerrero, Cesar] Pontificia Univ Javeriana, Bogota, Colombia; [Ivan Escalante-Semerena, Roberto] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico		Delgado-Serrano, MD (corresponding author), Univ Cordoba, Dept Agr Econ, Campus Rabanales,C5,Planta 3, E-14071 Cordoba, Spain.	mmdelgado@uco.es	Oteros-Rozas, Elisa/L-8633-2014; Corbera, Esteve/C-5368-2015; del mar delgado-serrano, maria/B-7581-2011	Oteros-Rozas, Elisa/0000-0003-4313-3041; Corbera, Esteve/0000-0001-7970-4411; del mar delgado-serrano, maria/0000-0003-0171-6097				Delgado-Serrano MD, 2018, REG ENVIRON CHANGE, V18, P581, DOI 10.1007/s10113-017-1223-4	1	0	0	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1436-3798	1436-378X		REG ENVIRON CHANGE	Reg. Envir. Chang.	FEB	2018	18	2			SI		593	593		10.1007/s10113-017-1237-y	http://dx.doi.org/10.1007/s10113-017-1237-y			1	Environmental Sciences; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology	FV5SS		Bronze			2022-09-04	WOS:000424643300025
J	Panesso-Gomez, S; Pavia, P; Rodriguez-Mantilla, IE; Lasso, P; Orozco, LA; Cuellar, A; Puerta, CJ; de Molano, BM; Gonzalez, JM				Panesso-Gomez, Santiago; Pavia, Paula; Enrique Rodriguez-Mantilla, Ivan; Lasso, Paola; Orozco, Luis A.; Cuellar, Adriana; Puerta, Concepcion J.; de Molano, Belen Mendoza; Gonzalez, John M.			Trypanosoma cruzi Detection in Colombian Patients with a Diagnosis of Esophageal Achalasia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; POLYMERASE-CHAIN-REACTION; CHAGAS-DISEASE; RECOMBINANT ANTIGENS; SYNTHETIC PEPTIDE; BLOOD; ANTIBODIES; PROTEIN; MEGAESOPHAGUS; SERODIAGNOSIS	Achalasia is a motility disorder of the esophagus that might be secondary to a chronic Trypanosoma cruzi infection. Several studies have investigated esophageal achalasia in patients with Chagas disease (CD) in Latin America, but no related studies have been performed in Colombia. The goals of the present study were to determine the presence of anti-T. cruzi antibodies in patients with esophageal achalasia who visited a referral hospital in Bogota, Colombia, and to detect the presence of the parasite and its discrete typing units (DTUs). This cross-sectional study was conducted in adult patients (18-65 years old) who were previously diagnosed with esophageal achalasia and from whom blood was drawn to assess antibodies against T. cruzi using four different serological tests. Trypanosoma cruzi DNA was detected by conventional polymerase chain reaction (cPCR) and quantitative polymerase chain reaction (qPCR). In total, 38 patients, with an average age of 46.6 years (standard deviation of +/- 16.2) and comprising 16 men and 22 women, were enrolled. Five (13.15%) patients were found to be positive for anti-T. cruzi antibodies by indirect immunofluorescence assay (IFA), and two patients who were negative according to IFA were reactive by both enzyme-linked immunosorbent assay and immunoblot (5.3%). Parasite DNA was detected in two of these seven patients by cPCR and in one of these by qPCR. The parasite DTU obtained was TcI. In summary, this study identified T. cruzi in Colombian patients with esophageal achalasia, indicating that digestive compromise could also be present in patients with chronic CD.	[Panesso-Gomez, Santiago; Enrique Rodriguez-Mantilla, Ivan; Gonzalez, John M.] Univ Los Andes, Sch Med, Grp Ciencias Basicas Med, Bogota, Colombia; [Pavia, Paula] Hosp Mil Cent, Sci Res Unit, Bogota, Colombia; [Lasso, Paola; Puerta, Concepcion J.] Pontificia Univ Javeriana, Sch Sci, Lab Parasitol Mol, Bogota, Colombia; [Orozco, Luis A.] Invest & Desarrollo Sistemas Clin, Gastroctr, Bogota, Colombia; [Cuellar, Adriana] Pontificia Univ Javeriana, Sch Sci, Grp Inmunobiol & Biol Celular, Bogota, Colombia; [de Molano, Belen Mendoza] Hosp Univ Fdn Santa Fe Bogpta, Gastroenterol Sect, Bogota, Colombia; [Panesso-Gomez, Santiago] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH USA; [Pavia, Paula] Hosp Militar Cent, Sci Res Unit, Bogota, Colombia; [Enrique Rodriguez-Mantilla, Ivan] Del Rosario Univ, CREA Grp, Bogota, Colombia; [Lasso, Paola] Pontificia Univ Javeriana, Lab Inmunobiol & Biol Celular, Bogota, Colombia; [Orozco, Luis A.] Gastrocenter, Bogota, Colombia; [Cuellar, Adriana; Puerta, Concepcion J.] Pontificia Univ Javeriana, Sch Sci, Bogota, Colombia; [de Molano, Belen Mendoza] Fdn Santa Fe Bogota, Gastroenterol Sect, Bogota, Colombia; [Gonzalez, John M.] Univ Los Andes, Sch Med, Bogota, DC, Colombia		Gonzalez, JM (corresponding author), Univ Los Andes, Sch Med, Grp Ciencias Basicas Med, Carrera 1 18A-12, Bogota 111711, Colombia.	s.panesso2262@uniandes.edu.co; paulapavia@yahoo.com.ar; ie.rodriguez438@uniandes.edu.co; plasso@javeriana.edu.co; aorozco@gastrocenter.co; acuellar@javeriana.edu.co; cpuerta@javeriana.edu.co; bmolano@gmail.com; johgonza@uniandes.edu.co	Cuellar, Adriana/AAF-2958-2019; Puerta, Concepcion J/AAG-4912-2019	Mendoza de Molano, Belen/0000-0003-1572-9526; Pavia, Paula/0000-0002-0422-5173; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Panesso-Gomez, Santiago/0000-0003-2563-6403	Research Conjoint Program from Universidad de los Andes; Hospital Universitario Fundacion Santa Fe de Bogota	Research Conjoint Program from Universidad de los Andes; Hospital Universitario Fundacion Santa Fe de Bogota	This work was supported by a grant from the Research Conjoint Program from Universidad de los Andes and Hospital Universitario Fundacion Santa Fe de Bogota.	Albuja Sebastian, 2010, FORCED MIGRATION REV, V34, P10; Andrade CD, 2015, REV SOC BRAS MED TRO, V48, P706, DOI 10.1590/0037-8682-0235-2015; Andrade Sonia G., 1997, Revista da Sociedade Brasileira de Medicina Tropical, V30, P27, DOI 10.1590/S0037-86821997000100006; Batista AM, 2010, INT J INFECT DIS, V14, pE974, DOI 10.1016/j.ijid.2010.05.017; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Breniere SF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004792; BRITTO C, 1995, PARASITOLOGY, V110, P241, DOI 10.1017/S0031182000080823; BURNS JM, 1992, P NATL ACAD SCI USA, V89, P1239, DOI 10.1073/pnas.89.4.1239; Vargas-Zambrano JC, 2013, MEM I OSWALDO CRUZ, V108, P212, DOI 10.1590/0074-0276108022013014; Castillo-Riquelme M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000336; Chang CD, 2006, TRANSFUSION, V46, P1737, DOI 10.1111/j.1537-2995.2006.00965.x; Cheng KY, 2007, CLIN VACCINE IMMUNOL, V14, P355, DOI 10.1128/CVI.00401-06; Cucunuba ZM, 2017, SOC SCI MED, V175, P187, DOI 10.1016/j.socscimed.2017.01.002; da Nobrega AA, 2014, AM J TROP MED HYG, V91, P528, DOI 10.4269/ajtmh.13-0574; da Silveira ABM, 2005, PARASITOLOGY, V131, P627, DOI 10.1017/S0031182005008061; da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9; Dantas Roberto Oliveira, 2003, Arq. Gastroenterol., V40, P126, DOI 10.1590/S0004-28032003000200012; de Lima MA, 2008, ANN DIAGN PATHOL, V12, P271, DOI 10.1016/j.anndiagpath.2007.12.002; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; Ferreira AW, 2001, J CLIN MICROBIOL, V39, P4390, DOI 10.1128/JCM.39.12.4390-4395.2001; Gobbi F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003361; Gomes ML, 1998, EXP PARASITOL, V88, P28, DOI 10.1006/expr.1998.4191; Guhl F, 2005, TRENDS PARASITOL, V21, P259, DOI 10.1016/j.pt.2005.04.011; Guhl F, 2013, INFECT GENET EVOL, V20, P148, DOI 10.1016/j.meegid.2013.08.028; Guzman-Gomez D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1072-2; Herbella FAM, 2004, DIGEST DIS SCI, V49, P353, DOI 10.1023/B:DDAS.0000020486.71719.62; Hernandez C, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004997, 10.1371/journal.pntd.0005112]; HOFT DF, 1989, INFECT IMMUN, V57, P1959, DOI 10.1128/IAI.57.7.1959-1967.1989; Houghton RL, 1999, J INFECT DIS, V179, P1226, DOI 10.1086/314723; Houghton RL, 2000, J INFECT DIS, V181, P325, DOI 10.1086/315165; IBANEZ CF, 1988, MOL BIOCHEM PARASIT, V30, P27, DOI 10.1016/0166-6851(88)90129-6; Barrera YK, 2008, BIOMEDICA, V28, P616; Lages-Silva E, 2001, AM J TROP MED HYG, V65, P435, DOI 10.4269/ajtmh.2001.65.435; Lasso P, 2015, J IMMUNOL, V195, P3748, DOI 10.4049/jimmunol.1500459; Llano M, 2014, BIOMEDICA, V34, P228, DOI [10.1590/S0120-41572014000200009, 10.7705/biomedica.v34i2.1580]; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; Manoel-Caetano FD, 2008, T ROY SOC TROP MED H, V102, P1102, DOI 10.1016/j.trstmh.2008.05.027; Mantilla JC, 2010, HUM PATHOL, V41, P610, DOI 10.1016/j.humpath.2009.11.005; Mateus J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003432; Moure Z, 2016, CLIN MICROBIOL INFEC, V22, P788, DOI 10.1016/j.cmi.2016.06.001; Nascimento RD, 2010, HUM PATHOL, V41, P528, DOI 10.1016/j.humpath.2009.05.018; PERALTA JM, 1994, J CLIN MICROBIOL, V32, P971, DOI 10.1128/JCM.32.4.971-974.1994; Perez-Ayala A, 2011, ANN TROP MED PARASIT, V105, P25, DOI 10.1179/136485910X12851868780423; Pinazo MJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003105; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; PRIMAVERA KSC, 1990, REV I MED TROP, V32, P172, DOI 10.1590/S0036-46651990000300005; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Reis DD, 2001, T ROY SOC TROP MED H, V95, P177, DOI 10.1016/S0035-9203(01)90153-1; Sales-Campos H, 2015, ACTA PARASITOL, V60, P435, DOI 10.1515/ap-2015-0060; de Souza DHS, 2013, REV SOC BRAS MED TRO, V46, P316, DOI 10.1590/0037-8682-0065-2013; SIMMONS AB, 1972, INT MIGR REV, V6, P166, DOI 10.2307/3002135; Torres-Aguilera M, 2011, Rev Gastroenterol Mex, V76, P199; Umezawa ES, 1999, J CLIN MICROBIOL, V37, P1554, DOI 10.1128/JCM.37.5.1554-1560.1999; VERGARA U, 1992, AM J TROP MED HYG, V46, P39, DOI 10.4269/ajtmh.1992.46.39; VERGARA U, 1991, J CLIN MICROBIOL, V29, P2034, DOI 10.1128/JCM.29.9.2034-2037.1991; World Health Organization, 2010, 1 WHO; Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	58	3	3	0	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2018	98	3					717	723		10.4269/ajtmh.17-0417	http://dx.doi.org/10.4269/ajtmh.17-0417			7	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	GE1BW	29405099	Green Published, Green Submitted			2022-09-04	WOS:000430952800015
J	Weber, N; Trujillo-Trujillo, J; Krucken, J; Michl, C; Hidalgo, ME; Appraez-Ippolito, G; Castillo, F; Feldmeier, H; Sunderkotter, C				Weber, Niklas; Trujillo-Trujillo, Julian; Kruecken, Juergen; Michl, Christiane; Hidalgo, Maryln E.; Appraez-Ippolito, Giovanni; Castillo, Felipe; Feldmeier, Hermann; Sunderkoetter, Cord			Tickbite-associated chronic pruritic lesions in an Afro-descendant population in the Cauca Department, Colombia. I. Clinical features and impact on health	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Article							SPOTTED-FEVER; TICKS; CLASSIFICATION; PREVALENCE; IXODIDAE; BITES	Background During a health survey in a remote area in southwest Colombia, it became apparent that a high percentage of the population suffered from chronic pruritus in association with high numbers of ticks and tickbites. Objective To determine the clinical features and severity of tickbite-associated pruritus. Method At twotime points - 8 weeks apart to account for seasonal effects - a cross-sectional study was conducted encompassing physical examination of the population, histological analysis of skin biopsies, and determining serum for antibodies against spotted fever (SFG) rickettsiae and typhus group (TG) rickettsiae. Ticks were identified using morphological criteria, and infection by rickettsiae was determined by PCR. Results About 94.5% of the population (95% CI 92-97%) showed clinical signs of a pruritic arthropod reaction and of chronic pruritus with lichenoid papules and hyper- and hypopigmented nodules on otherwise noninflamed skin. Pruritus markedly impaired the quality of life in terms of sleeping disturbances. No signs for other diseases were observed. Chronic pruritus appeared to be because of repeated tickbites and scratching, but not because of other dermatological or medical conditions. Antibodies against SFG and TG-rickettsiae were detected at 79.0% (95% CI 73-86) and 3.6% (95% CI 0.7-6), respectively. Ticks were identified asAmblyomma cajennense. Conclusion Remarkably high exposure to tick bites caused an unusually high rate of acute and chronic pruritus and markedly impaired quality of life of the investigated rural community. This underlines the necessity of public health measures and surveillance of rickettsial disease.	[Weber, Niklas; Michl, Christiane; Sunderkoetter, Cord] Univ Hosp Halle, Dept Dermatol & Venereol, Halle, Germany; [Trujillo-Trujillo, Julian] Minist Hlth & Social Protect Colombia, Bogota, Colombia; [Kruecken, Juergen] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Hidalgo, Maryln E.] Pontificia Univ Javeriana, Dept Microbiol, Grp Enfermedades Infecciosas, Bogota, Colombia; [Appraez-Ippolito, Giovanni; Castillo, Felipe] Secretaria Salud Cauca, Popayan, Colombia; [Feldmeier, Hermann] Charite Univ Med Berlin, Inst Microbiol & Hyg, Berlin, Germany; [Sunderkoetter, Cord] Univ Munster, Dept Translat Dermatoinfectiol, Munster, Germany		Weber, N (corresponding author), Martin Luther Univ Halle Wittenberg, Univ Hosp Halle, Dept Dermatol & Venereol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.	niklasweber@posteo.de	Krücken, Jürgen/CAF-6903-2022; Krücken, Jürgen/AAE-3133-2021	Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; TRUJILLO-TRUJILLO, JULIAN/0000-0003-0739-5781	Roland Ernst Stiftung, Germany; Projekt DEAL	Roland Ernst Stiftung, Germany; Projekt DEAL	We are obliged to the community healthcare workers, especially to Agobardo Caicedo and the personnel of the hospital El Tambo, for their support toward this study. The skillful assistance of Heydi Martines and Paula Betancourt is greatly acknowledged. We thank KSK-Pharma, Germany, for providing antihistamines (cetirizine/loratadine) free of charge. N.W. received a scholarship from the Roland Ernst Stiftung, Germany. Open access funding enabled and organized by Projekt DEAL.	BarrosBattesti DAMG, 2006, ICCTD3; Costa LFD, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-222; Faccini-Martinez AA, 2015, EMERG INFECT DIS, V21, P537, DOI 10.3201/eid2013.140721; Fisher EJ, 2006, ARCH DERMATOL, V142, P491, DOI 10.1001/archderm.142.4.491; Garcia GR, 2014, PARASITE VECTOR, V7, P1; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Haddad V, 2018, AN BRAS DERMATOL, V93, P251, DOI 10.1590/abd1806-4841.20186378; Heukelbach J, 2005, BRIT J DERMATOL, V153, P150, DOI 10.1111/j.1365-2133.2005.06591.x; Hidalgo M, 2007, EMERG INFECT DIS, V13, P1058, DOI 10.3201/eid1307.060537; Isohisa T, 2011, J DERMATOL, V38, P1110, DOI 10.1111/j.1346-8138.2010.01180.x; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; KRINSKY WL, 1983, INT J DERMATOL, V22, P75, DOI 10.1111/j.1365-4362.1983.tb03319.x; Labruna MB, 2001, VET PARASITOL, V97, P1, DOI 10.1016/S0304-4017(01)00387-9; Londono AF, 2017, TICKS TICK-BORNE DIS, V8, P477, DOI 10.1016/j.ttbdis.2017.02.006; Moore TC, 2018, PLOS NEGLECT TROP D, V12, P1; Nakamura-Uchiyama F, 2000, J Dermatol, V27, P774; Nava S, 2014, TICKS TICK-BORNE DIS, V5, P252, DOI 10.1016/j.ttbdis.2013.11.004; Padmanabha H, 2009, VECTOR-BORNE ZOONOT, V9, P483, DOI 10.1089/vbz.2008.0092; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Patiño Camargo Luis, 2006, Biomed., V26, P178; Patrick Y ., 1973, DERMATOLOGICA, V147, P214; Pereira MP, 2018, J EUR ACAD DERMATOL, V32, P1059, DOI 10.1111/jdv.14570; Portillo A, 2017, VECTOR-BORNE ZOONOT, V17, P23, DOI 10.1089/vbz.2016.1966; Velez JCQ, 2016, INT J INFECT DIS, V53, P62, DOI 10.1016/j.ijid.2016.11.158; Velez JCQ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006911; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Renvoise A, 2009, INT HEALTH, V1, P17, DOI 10.1016/j.inhe.2009.03.003; Schreiber C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0535-1; Stander S, 2007, ACTA DERM-VENEREOL, V87, P291, DOI 10.2340/00015555-0305; VARMA MGR, 1973, T ROY SOC TROP MED H, V67, P92, DOI 10.1016/0035-9203(73)90325-8; Wiese S, 2018, PLOS NEGLECT TROP D, V12, P1; Wikel SK, 1996, SYSTEM ECTOPARASITIC, P311; Wilhelmsson P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-362; Zanetti AS, 2008, J MED ENTOMOL, V45, P267, DOI 10.1603/0022-2585(2008)45[267:CORIIA]2.0.CO;2; Zavala-Velazquez JE, 1999, AM J TROP MED HYG, V61, P405, DOI 10.4269/ajtmh.1999.61.405; Zeidler C, 2018, DERMATOL CLIN, V36, P189, DOI 10.1016/j.det.2018.02.003	36	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	DEC	2020	59	12					1491	1501		10.1111/ijd.15184	http://dx.doi.org/10.1111/ijd.15184		SEP 2020	11	Dermatology	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology	OR5JG	32975315	hybrid			2022-09-04	WOS:000572428700001
J	Reynolds, CW; Duarte, A; Fricke, A; Restrepo, CG; Patino, A; Arbelaez, C; Moretti, K; Aguiar, LG				Reynolds, Christopher W.; Duarte, Andres; Fricke, Adrienne; Restrepo, Carlos Gomez; Patino, Andres; Arbelaez, Christian; Moretti, Katelyn; Aguiar, Leonar G.			Supporting healthcare workers caring for ex-combatants: incentives among Colombian providers with FARC ex-combatants	GLOBAL PUBLIC HEALTH			English	Article; Early Access						Rural healthcare; medical education; global health; FARC ex-combatants; post-conflict healthcare		With the Peace Agreement between Fuerzas Armadas Revolucionarias de Colombia (FARC), Colombia promised healthcare to 13,000 'reincorporating' FARC ex-combatants. Shortages of healthcare workers in reincorporation camps means this promise is in danger of going unfulfilled. More information is needed to determine incentives, disincentives, and recruitment of healthcare providers to address this shortage. Semi-structured interviews were conducted with healthcare providers across FARC reincorporation camps, and a multidisciplinary team conducted analysis in NVivo12 using a team-based coding method. Twenty-four healthcare professionals from 15 camps participated, of which 75% were female. Incentives to work with FARC included improved clinical skills, professional advancement, increased comfort with FARC, and contributing to the peace process. Disincentives included poor living conditions, lack of support, biases, familial commitments, and sacrificing career opportunities. Three-fourths of the sample recommended working with FARC, and 92% reported a shortage of healthcare workers. Recruitment strategies included improved resources and specialised career development for healthcare workers, facilitating interactions between FARC and healthcare professionals outside clinical scenarios, and integrating medicine for vulnerable populations into health education. This study shows the impact that working with FARC ex-combatants can have on healthcare providers and tangible suggestions for increasing provider participation to address the healthcare worker shortage.	[Reynolds, Christopher W.] Univ Michigan, Med Sch, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Duarte, Andres; Restrepo, Carlos Gomez; Aguiar, Leonar G.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Fricke, Adrienne] Harvard Humanitarian Initiat, Cambridge, MA USA; [Patino, Andres] Emory Univ, Sch Med, Atlanta, GA USA; [Arbelaez, Christian] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA; [Moretti, Katelyn] Brown Emergency Med, Providence, RI USA		Reynolds, CW (corresponding author), Univ Michigan, Med Sch, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	chriswreynolds18@gmail.com	Aguiar Martinez, Leonar G/M-7447-2016	Aguiar Martinez, Leonar G/0000-0002-5372-2459	Fulbright U.S. Student Researcher Grant; Brown Emergency Medicine Innovation Grant	Fulbright U.S. Student Researcher Grant; Brown Emergency Medicine Innovation Grant	Fulbright U.S. Student Researcher Grant and Brown Emergency Medicine Innovation Grant. These funding sources had no role in the design, execution, analyses, data interpretation, or decision to submit results.	Arango A.E., 2017, DECRETO LEY 890 DE 2; Baez S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00073; Basinga P, 2010, POLICY RES WORKING P; Baxter D., 2011, MOVING CATCH MIGRATI; Budhathoki SS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013501; Buseh A., 2008, EMPOWERING RESILIENC; Byrne M M, 2001, AORN J, V73, P830, DOI 10.1016/S0001-2092(06)61812-7; Carod-Artal F., 2013, BURNOUT EXPERTS PREV, P15, DOI DOI 10.1007/978-1-4614-4391-9_2; Cordoba L, 2011, COLOMB MEDICA, V42, P286; Defensoria del Pueblo de Colombia, 2017, INF ESP TERR CAP REI, P10; Deshpande SP, 2010, J AM BOARD FAM MED, V23, P762, DOI 10.3122/jabfm.2010.06.100075; Dzinesa G.A., 2018, DISARMAMENT DEMOBILI; International Office for Migration, 2015, MIGR HLTH DIV INF SH; Laveta V., 2017, NEW TACTICS HUMAN RI; Leff J, 2008, AFR J CONFL RESOLUT, V8, P9, DOI 10.4314/ajcr.v8i1.39419; McLellan Eleanor, 1998, FIELD METHOD, V10, P31, DOI 10.1177/1525822X980100020301; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Ospina C, 2016, J COMPLEX OPERATIONS; Otake Yuko, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6040094; Reynolds CW, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10062-3; Reynolds CW, 2020, JACEP OPEN, V1, P757, DOI 10.1002/emp2.12066; Rivillas JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188654; Rodriguez Moreno J.H., 2017, PRIMARY HLTH CARE SY; Salazar-Xirinachs J.M., 2009, SOCIOECONOMIC REINTE; Santos Calderon J. M., 2016, ACUERDO FINAL TERMIN; Toonen J, 2009, PERFORMANCE BASED FI; Trigos-Carrillo L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00047; U.S. Department of State, 2021, FOR TERR ORG; United Nations, MAND LEG BAS PEAC; Universidad Nacional de Colombia, 2017, CAR COM FARC EP RES; Uribe A.G., 2017, DECRETO 294 DE 2017; Valencia R, 2019, WORLD POLITICS REV; Varpilah ST, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-11; Witter S, 2012, HLTH WORKERS INCENTI	34	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1744-1692	1744-1706		GLOB PUBLIC HEALTH	Glob. Public Health												10.1080/17441692.2022.2037150	http://dx.doi.org/10.1080/17441692.2022.2037150		FEB 2022	17	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	YV8UR	35132944				2022-09-04	WOS:000753000300001
J	Estela, FA; Sanchez-Sarria, CE; Arbelaez-Cortes, E; Ocampo, D; Garcia-Arroyo, M; Perlaza-Gamboa, A; Wagner-Wagner, CM; MacGregor-Fors, I				Estela, F. A.; Sanchez-Sarria, C. E.; Arbelaez-Cortes, E.; Ocampo, D.; Garcia-Arroyo, M.; Perlaza-Gamboa, A.; Wagner-Wagner, C. M.; MacGregor-Fors, I			Changes in the nocturnal activity of birds during the COVID-19 pandemic lockdown in a neotropical city	ANIMAL BIODIVERSITY AND CONSERVATION			English	Article						Anthropause; Artificial light at night; COVID-19 lockdown; Tropical cities; Urbanization; Urban ecology		Changes in the nocturnal activity of birds during the COVID-19 pandemic lockdown in a neotropical city. The COVID-19 lockdown provided the opportunity to measure species biodiversity in urban environments under conditions divergent from regular urban rhythms. For 90 days, including weeks of strict lockdown and the subsequent relaxation of restrictions, we measured the presence and abundance of birds that were active at night at two sites in the city of Cali, Colombia. Our results show that species richness of nocturnal birds decreased 40% to 58% during the weeks with more human activity, adding further evidence to the biodiversity responses of the 'anthropause' on urban environments.	[Estela, F. A.; Sanchez-Sarria, C. E.] Pontificia Univ Javeriana, Dept Ciencias Nat & Matemat, Cali, Colombia; [Sanchez-Sarria, C. E.; Garcia-Arroyo, M.; MacGregor-Fors, I] AC INECOL, Inst Ecol, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico; [Arbelaez-Cortes, E.] Univ Ind Santander, Escuela Biol, Bucaramanga, Colombia; [Ocampo, D.] Inst Invest Recursos Biol Alexander von Humboldt, Villa De Leyva, Colombia; [Perlaza-Gamboa, A.] Univ Valle, Dept Biol, Grp Invest Ecol Anim, Cali, Colombia; [Wagner-Wagner, C. M.] Colombia BirdFair, Cali, Colombia; [Garcia-Arroyo, M.; MacGregor-Fors, I] Univ Helsinki, Fac Biol & Environm Sci, Ecosyst & Environm Res Programme, Niemenkatu 73, Lahti 15140, Finland		MacGregor-Fors, I (corresponding author), AC INECOL, Inst Ecol, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico.; MacGregor-Fors, I (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Ecosyst & Environm Res Programme, Niemenkatu 73, Lahti 15140, Finland.	ian.macgregor@helsinki.fi	MacGregor-Fors, Ian/P-1455-2014	MacGregor-Fors, Ian/0000-0003-3198-7322; Garcia-Arroyo, Michelle/0000-0002-9167-4777; Sanchez Sarria, Camilo Enrique/0000-0001-7990-7366; Ocampo, David/0000-0003-1597-4038				Bates AE, 2020, BIOL CONSERV, V248, DOI 10.1016/j.biocon.2020.108665; Carral-Murrieta CO, 2020, AVIAN RES, V11, P32, DOI 10.1186/s40657-020-00218-5; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Frohlich A, 2019, ENVIRON SCI POLLUT R, V26, P17284, DOI 10.1007/s11356-019-05063-8; Gaston KJ, 2018, SCIENCE, V362, P744, DOI 10.1126/science.aau8226; Google, 2020, 8000 COMMUNITY COLL; Gordo O, 2021, P ROY SOC B-BIOL SCI, V288, DOI 10.1098/rspb.2020.2513; Kettel EF, 2018, J ORNITHOL, V159, P1, DOI 10.1007/s10336-017-1497-9; La VT, 2012, CONDOR, V114, P245, DOI 10.1525/cond.2012.100193; MacGregor-Fors I, 2010, ECOL RES, V25, P883, DOI 10.1007/s11284-010-0717-z; Marin-Gomez OH, 2020, AVIAN RES, V11, P9, DOI 10.1186/s40657-020-00197-7; Mukhin A, 2009, J BIOL RHYTHM, V24, P225, DOI 10.1177/0748730409335349; Nix JH, 2018, BEHAV PROCESS, V146, P16, DOI 10.1016/j.beproc.2017.11.002; R Core Team, 2021, R LANG ENV STAT COMP; Rutz C, 2020, NAT ECOL EVOL, V4, P1156, DOI 10.1038/s41559-020-1237-z	15	1	1	5	9	MUSEU DE CIENCIES NATURALS-ZOOLOGIA	BARCELONA	PASSEIG PICASSO S-N, PARC CIUTADELLA, BARCELONA, E-08003, SPAIN	1578-665X	2014-928X		ANIM BIODIV CONSERV	Anim. Biodivers. Conserv.		2021	44	2					213	217		10.32800/abc.2021.44.0213	http://dx.doi.org/10.32800/abc.2021.44.0213			5	Biodiversity Conservation	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation	WV1GW		gold, Green Published			2022-09-04	WOS:000716986200001
J	Simonaro, CM; Tomatsu, S; Sikora, T; Kubaski, F; Frohbergh, M; Guevara, JM; Wang, RY; Vera, M; Kang, JL; Smith, LJ; Schuchman, EH; Haskins, ME				Simonaro, Calogera M.; Tomatsu, Shunji; Sikora, Tracy; Kubaski, Francyne; Frohbergh, Michael; Guevara, Johana M.; Wang, Raymond Y.; Vera, Moin; Kang, Jennifer L.; Smith, Lachlan J.; Schuchman, Edward H.; Haskins, Mark E.			Pentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I Dogs	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; CREUTZFELDT-JAKOB-DISEASE; CELL TRANSPLANTATION; HURLER-SYNDROME; MPS-I; STORAGE; OSTEOARTHRITIS; INVOLVEMENT; PROGRESSION; INFUSION	Background We previously demonstrated the therapeutic benefits of pentosan polysulfate (PPS) in a rat model of mucopolysaccharidosis (MPS) type VI. Reduction of inflammation, reduction of glycosaminoglycan (GAG) storage, and improvement in the skeletal phenotype were shown. Herein, we evaluate the long-term safety and therapeutic effects of PPS in a large animal model of a different MPS type, MPS I dogs. We focused on the arterial phenotype since this is one of the most consistent and clinically significant features of the model. Methodology/Principal Findings MPS I dogs were treated with daily oral or biweekly subcutaneous (subQ) PPS at a human equivalent dose of 1.6 mg/kg for 17 and 12 months, respectively. Safety parameters were assessed at 6 months and at the end of the study. Following treatment, cytokine and GAG levels were determined in fluids and tissues. Assessments of the aorta and carotid arteries also were performed. No drug-related increases in liver enzymes, coagulation factors, or other adverse effects were observed. Significantly reduced IL-8 and TNF-alpha were found in urine and cerebrospinal fluid (CSF). GAG reduction was observed in urine and tissues. Increases in the luminal openings and reduction of the intimal media thickening occurred in the carotids and aortas of PPS-treated animals, along with a reduction of storage vacuoles. These results were correlated with a reduction of GAG storage, reduction of clusterin 1 staining, and improved elastin integrity. No significant changes in the spines of the treated animals were observed. Conclusions PPS treatment led to reductions of pro-inflammatory cytokines and GAG storage in urine and tissues of MPS I dogs, which were most evident after subQ administration. SubQ administration also led to significant cytokine reductions in the CSF. Both treatment groups exhibited markedly reduced carotid and aortic inflammation, increased vessel integrity, and improved histopathology. We conclude that PPS may be a safe and useful therapy for MPS I, either as an adjunct or as a stand-alone treatment that reduces inflammation and GAG storage.	[Simonaro, Calogera M.; Frohbergh, Michael; Guevara, Johana M.; Schuchman, Edward H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Tomatsu, Shunji; Kubaski, Francyne] Nemours Alfred I duPont Hosp Children, Skeletal Dysplasia Lab, Wilmington, DE USA; [Sikora, Tracy; Haskins, Mark E.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Guevara, Johana M.] Pontificia Univ Javeriana, Bogota, Colombia; [Wang, Raymond Y.; Vera, Moin] Childrens Hosp Orange Cty, Div Metab Disorders, Orange, CA 92668 USA; [Wang, Raymond Y.] Harbor UCLA Med Ctr, Dept Pediat, Div Med Genet, Torrance, CA 90509 USA; [Kang, Jennifer L.; Smith, Lachlan J.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Simonaro, CM (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	calogera.simonaro@mssm.edu	Wang, Raymond Yu Jeang/CAJ-3535-2022; Wang, Raymond Yu Jeang/H-8870-2019; Kubaski, Francyne/M-2410-2017; GUEVARA-MORALES, JOHANA M./AAF-9014-2019	Wang, Raymond Yu Jeang/0000-0001-6494-7613; Kubaski, Francyne/0000-0002-9330-0154; Sikora, Tracey/0000-0002-5102-0859; Smith, Lachlan/0000-0001-5823-6073; Guevara Morales, Johana Maria/0000-0002-9467-4430; Kang, Jennifer/0000-0003-3597-9290	Ryan Foundation; MPS1 Research Foundation; National Center for Research Resources [1S10OD018523-01]; National Institute of Diabetes and Digestive and Kidney Diseases [5R21DK096182, 1R01DK087185, P40OD010939]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR057397]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR065142, P30AR069619, R01AR057397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054481, R21DK096182, R01DK087185] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	Ryan Foundation; MPS1 Research Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by The Ryan Foundation, recipient: Calogera Maria Simonaro; MPS1 Research Foundation, recipient: Calogera Maria Simonaro; National Center for Research Resources, award number: 1S10OD018523-01; National Institute of Diabetes and Digestive and Kidney Diseases, award number: 5R21DK096182, recipient: Calogera Maria Simonaro; National Institute of Diabetes and Digestive and Kidney Diseases, award number: 1R01DK087185, recipient: Calogera Maria Simonaro; National Institute of Diabetes and Digestive and Kidney Diseases, award number: P40OD010939, recipient: Mark E. Haskins; National Institute of Arthritis and Musculoskeletal and Skin Diseases, award number: 1R01AR057397, recipient: Mark E. Haskins.	Al-Sannaa NA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0344-4; Aldenhoven M, 2015, BLOOD, V125, P2164, DOI 10.1182/blood-2014-11-608075; Anger JT, 2011, INT UROGYNECOL J, V22, P395, DOI 10.1007/s00192-010-1252-8; Budsberg SC, 2007, VET SURG, V36, P234, DOI 10.1111/j.1532-950X.2007.00256.x; Chiaro JA, 2014, J BONE MINER RES, V29, P2610, DOI 10.1002/jbmr.2290; Chiaro JA, 2013, BONE, V55, P78, DOI 10.1016/j.bone.2013.03.014; Clarke LA, 2015, BEST PRACT RES CL EN, V29, P219, DOI 10.1016/j.beem.2014.08.010; Clarke LA, 2011, RHEUMATOLOGY, V50, pV13, DOI 10.1093/rheumatology/ker395; Dickson PI, 2010, MOL GENET METAB, V101, P115, DOI 10.1016/j.ymgme.2010.06.020; DIEMER V, 1992, J BIOL CHEM, V267, P5257; Eliyahu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022447; FRANCIS DJ, 1993, RHEUMATOL INT, V13, P61, DOI 10.1007/BF00307735; Frohbergh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100882; Ghosh P, 2001, BEST PRACT RES CL RH, V15, P693, DOI 10.1053/berh.2001.0188; Herrero LJ, 2015, J VIROL, V89, P8063, DOI 10.1128/JVI.00224-15; Honda H, 2012, NEUROPATHOLOGY, V32, P124, DOI 10.1111/j.1440-1789.2011.01245.x; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; Khalid O, 2016, PLOS ONE IN PRESS; Kilgore KS, 1998, J PHARMACOL EXP THER, V285, P987; Kramer CM, 2014, AUST VET J, V92, P482, DOI 10.1111/avj.12266; Lampe C, 2013, RHEUM DIS CLIN N AM, V39, P431, DOI 10.1016/j.rdc.2013.03.004; Langereis EJ, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-155; Losonczy Hajna, 1993, Orvosi Hetilap, V134, P291; Lyons JA, 2011, LAB INVEST, V91, P665, DOI 10.1038/labinvest.2011.7; MENON KP, 1992, GENOMICS, V14, P763, DOI 10.1016/S0888-7543(05)80182-X; Muenzer J, 2014, MOL GENET METAB, V111, P63, DOI 10.1016/j.ymgme.2013.11.015; Neufeld E. F., 2001, METABOLIC MOL BASES, P3421, DOI DOI 10.1036/OMMBID.165; Nickel JC, 2015, J UROLOGY, V193, P857, DOI 10.1016/j.juro.2014.09.036; Oguma T, 2007, ANAL BIOCHEM, V368, P79, DOI 10.1016/j.ab.2007.05.016; Parry A, 2007, J NEUROL NEUROSUR PS, V78, P733, DOI 10.1136/jnnp.2006.104505; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; SHULL RM, 1982, AM J PATHOL, V109, P244; SHULL RM, 1984, AM J PATHOL, V114, P487; SHULL RM, 1994, P NATL ACAD SCI USA, V91, P12937, DOI 10.1073/pnas.91.26.12937; Sifuentes M, 2007, MOL GENET METAB, V90, P171, DOI 10.1016/j.ymgme.2006.08.007; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2001, LAB INVEST, V81, P1319, DOI 10.1038/labinvest.3780345; Todd NV, 2005, J INFECTION, V50, P394, DOI 10.1016/j.jinf.2004.07.015; Tomatsu S, 2015, DRUG DES DEV THER, V9, P1937, DOI 10.2147/DDDT.S68562; Walter BA, 2015, SPINE, V40, P955, DOI 10.1097/BRS.0000000000000932; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Yano S, 2014, J INHERIT METAB DIS, V37, P255, DOI 10.1007/s10545-013-9642-y	44	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153136	10.1371/journal.pone.0153136	http://dx.doi.org/10.1371/journal.pone.0153136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064989	Green Submitted, Green Published, gold			2022-09-04	WOS:000373891000033
J	Londono, AF; Acevedo-Gutierrez, LY; Marin, D; Contreras, V; Diaz, FJ; Valbuena, G; Labruna, MB; Hidalgo, M; Arboleda, M; Mattar, S; Solari, S; Rodas, JD				Londono, Andres F.; Acevedo-Gutierrez, Leidy Y.; Marin, Diana; Contreras, Veronica; Diaz, Francisco J.; Valbuena, Gustavo; Labruna, Marcelo B.; Hidalgo, Marylin; Arboleda, Margarita; Mattar, Salim; Solari, Sergio; Rodas, Juan D.			Wild and domestic animals likely involved in rickettsial endemic zones of Northwestern Colombia	TICKS AND TICK-BORNE DISEASES			English	Article						Rickettsia; Colombia; Rodents; Canines; Equines	BRAZILIAN SPOTTED-FEVER; SP STRAIN COLOMBIANENSI; MOLECULAR-DETECTION; ACARI IXODIDAE; SAO-PAULO; TICKS; AREA; INFECTION; STATE; ANTIBODIES	Between 2006 and 2008, three outbreaks of human rickettsiosis occurred in Northwestern Colombia (municipalities of Necocli, Los Cordobas and Turbo), with case fatality rates between 27% and 54%. The aim of this study was to determine previous exposure of wild and domestic animals to spotted fever group (SFG) rickettsiae through serological tests, to detect rickettsial evidence in their ectoparasites, and to analyze their possible role in the epidemiology of rickettsial diseases in this zone of the country. A cross-sectional association study was performed from 2010 to 2011. Blood and ectoparasite samples were collected from domestic animals and small mammals. A statistically significant association (p < 0.05) between seropositive animals and the study zones was observed. A total of 2937 ticks, 672 fleas and 74 lice were collected and tested in pools by PCR. The minimum infection rate (MIR) of the positive pools was 5% in ticks, 4% in fleas, and 0% in lice. Phylogenetic analyses showed circulation of three 4.Rickettsia species: R. felis in fleas, and R. bellii and Rickettsia sp. strain Atlantic rainforest, both in Amblyomma ovale ticks. In conclusion, this study demonstrated the occurrence of SFG rickettsiae in domestic, synanthropic and wild animals, and suggests the use of equines and canines as good sentinels of infection, in the study zone. We speculate that a transmission cycle exist involving rodents in the areas where these outbreaks have occurred. Tomes' spiny rats (Proechimys semispinosus) and common opossums (Didelphis marsupialis) could be good candidates as amplifier hosts for SFG rickettsiae in enzootic/endemic zones.	[Londono, Andres F.; Acevedo-Gutierrez, Leidy Y.; Rodas, Juan D.] Univ Antioquia, Grp Invest Ciencias Vet, Centauro, Calle 70 52-21, Medellin, Colombia; [Marin, Diana] Univ Pontificia Bolivariana, Medellin, Colombia; [Contreras, Veronica; Mattar, Salim] Univ Cordoba, Inst Invest Biol Trop, Monteria, Colombia; [Diaz, Francisco J.] Univ Antioquia, Grp Inmunovirol, Medellin, Colombia; [Valbuena, Gustavo] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Labruna, Marcelo B.] Univ Sao Paulo, Dept Med Vet Prevent & Saude Anim, Fac Med Vet & Zootecnia, Sao Paulo, Brazil; [Hidalgo, Marylin] Pontificia Univ Javeriana, Dept Microbiol, Bogota, Colombia; [Arboleda, Margarita] CES, ICMT, Medellin, Colombia; [Solari, Sergio] CTUA, Grp Mastozool, Inst Biol, Medellin, Colombia		Rodas, JD (corresponding author), Univ Antioquia, Grp Invest Ciencias Vet, Centauro, Calle 67 53-108, Medellin, Colombia.	jdavid.rodas@udea.edu.co	Rodas, Juan David/AAM-6382-2020; Labruna, Marcelo B/B-6241-2013; Hidalgo, Marylin/AAF-5736-2019; GONZALEZ, JUAN DAVID RODAS/AAU-7011-2020	Labruna, Marcelo B/0000-0002-9675-3132; GONZALEZ, JUAN DAVID RODAS/0000-0002-7054-9918; Solari, Sergio/0000-0002-7002-2200; Hidalgo, Marylin/0000-0001-8960-0616; Contreras Cogollo, Veronica/0000-0001-5380-2347; Marin Pineda, Diana/0000-0002-4715-8388; Arboleda, Margarita/0000-0002-4939-1212	[Ecological study of Rickettsia endemicity in Colombia] "Estudio ecologico de endemicidad por Rickettsia en Colombia" [111549326228]; University of Antioquia	[Ecological study of Rickettsia endemicity in Colombia] "Estudio ecologico de endemicidad por Rickettsia en Colombia"; University of Antioquia	We thank Colciencias for their financial support through project No. 111549326228 [Ecological study of Rickettsia endemicity in Colombia] "Estudio ecologico de endemicidad por Rickettsia en Colombia". We are also grateful with the 2013/2014 University of Antioquia sustainability program for their financial support.	Acosta J., 2006, Informe Quincenal - Epidemiologico Nacional, V11, P177; Barros-Battesti D.M.B., 2006, CARRAPATOS IMPORTANC; Correa F.K., 2009, GEOGRAFIA GENERALIDA, P23; Emmons LH., 1997, NEOTROPICAL RAINFORE; Faccini-Martinez A.A., 2013, BIOMEDICA, V3333, P9; FOURNIER PE, 2007, RICKETTSIAL DIS, P1, DOI DOI 10.3109/9781420019971.001; Furman DP., 1982, MANUAL MEDICAL ENTOM; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Giraldo M, 2008, INF QUINC EPIDEMIOL, V13, P145; Guedes E, 2005, MEM I OSWALDO CRUZ, V100, P841, DOI 10.1590/S0074-02762005000800004; Hidalgo M., 2007, I NAC SALUD, V12, P371; Hidalgo M, 2009, AM J TROP MED HYG, V80, P1029, DOI 10.4269/ajtmh.2009.80.1029; Horta MC, 2009, VECTOR-BORNE ZOONOT, V9, P109, DOI 10.1089/vbz.2008.0114; Labruna MB, 2014, EMERG INFECT DIS, V20, P1768, DOI 10.3201/eid2010.131797; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Linardi PM., 2000, SIFONAPTEROS BRASIL; Londono AF, 2014, TICKS TICK-BORNE DIS, V5, P672, DOI 10.1016/j.ttbdis.2014.04.018; Mangold AJ, 1998, PARASITOL RES, V84, P478, DOI 10.1007/s004360050433; Martins TF, 2010, TICKS TICK-BORNE DIS, V1, P75, DOI 10.1016/j.ttbdis.2010.03.002; Mendez E, 1993, ROEDORES PANAMA; Mills J, 1998, METODOS TRAMPEO MUES; Miranda J, 2014, TICKS TICK-BORNE DIS, V5, P208, DOI 10.1016/j.ttbdis.2013.10.008; Miranda J, 2012, J MED ENTOMOL, V49, P960, DOI 10.1603/ME11195; Ogrzewalska M, 2015, TICKS TICK-BORNE DIS, V6, P478, DOI 10.1016/j.ttbdis.2015.03.016; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; PATINO L., 1937, American Journal of Tropical Medicine, V17, P639; PATINO-CAMARGO Luis, 1941, Boletin de la Oficina Sanitaria Panamericana, V20, P1112; Pena DCH, 2009, CLIN MICROBIOL INFEC, V15, P243, DOI 10.1111/j.1469-0691.2008.02165.x; Pinter A, 2008, CAD SAUDE PUBLICA, V24, P247, DOI 10.1590/S0102-311X2008000200003; Portillo A, 2017, VECTOR-BORNE ZOONOT, V17, P23, DOI 10.1089/vbz.2016.1966; Quintero J., 2013, BIOMEDICA, V33, P2, DOI DOI 10.7705/BI0MEDICA.V33I0.735; Ramirez-Hernandez A, 2013, AM J TROP MED HYG, V89, P453, DOI 10.4269/ajtmh.12-0698; Sangioni LA, 2005, EMERG INFECT DIS, V11, P265, DOI 10.3201/eid1102.040656; Silva N, 2011, EMERG INFECT DIS, V17, P275, DOI 10.3201/eid1702.100859; Spolidorio MG, 2010, EMERG INFECT DIS, V16, P521, DOI 10.3201/eid1603.091338; Wenzel R., 1966, FIELD MUSEUM NATURAL	36	17	17	2	13	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	1877-959X	1877-9603		TICKS TICK-BORNE DIS	Ticks Tick-Borne Dis.		2017	8	6					887	894		10.1016/j.ttbdis.2017.07.007	http://dx.doi.org/10.1016/j.ttbdis.2017.07.007			8	Infectious Diseases; Microbiology; Parasitology	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Microbiology; Parasitology	FJ0DL	28774495				2022-09-04	WOS:000412378600012
J	Barragan-Barrera, DC; Luna-Acosta, A; May-Collado, LJ; Polo-Silva, CJ; Riet-Sapriza, FG; Bustamante, P; Hernandez-Avila, MP; Velez, N; Farias-Curtidor, N; Caballero, S				Barragan-Barrera, Dalia C.; Luna-Acosta, Andrea; May-Collado, Laura J.; Polo-Silva, Carlos J.; Riet-Sapriza, Federico G.; Bustamante, Paco; Paula Hernandez-Avila, Maria; Velez, Natalia; Farias-Curtidor, Nohelia; Caballero, Susana			Foraging habits and levels of mercury in a resident population of bottlenose dolphins (Tursiops truncatus) in Bocas del Toro Archipelago, Caribbean Sea, Panama	MARINE POLLUTION BULLETIN			English	Article						Tursiops truncatus; Inshore form; Bocas del Toro; Bioaccumulation; Stable isotopes	DISSOLVED ORGANIC-CARBON; NITROGEN STABLE-ISOTOPE; STRIPED DOLPHINS; CORAL-REEFS; FOOD-WEB; POLYCHLORINATED-BIPHENYLS; GENETIC DIVERSITY; SPATIAL VARIATION; FEEDING ECOLOGY; SMALL CETACEANS	A small and genetically isolated bottlenose dolphin (Tursiops truncatus) population resides year-round in the Bocas del Toro Archipelago-Panama (BDT). Photo-identification and genetic data showed that this dolphin population is highly phylopatric and is formed exclusively by individuals of the "inshore form". This study aimed to investigate the trophic ecology and mercury concentrations of bottlenose dolphins in BDT to assess their coastal habits. We collected muscle samples (n = 175) of 11 potential fish prey species, and skin samples from free-ranging dolphins in BDT (n = 37) and La Guajira-Colombia (n = 7) to compare isotopic niche width. Results showed that BDT dolphins have a coastal feeding habit, belong to the "inshore form" (delta C-13 = -13.05 +/- 1.89 parts per thousand), and have low mercury concentrations (mean = 1637 +/- 1387 ng g(-1)dw). However, this element is biomagnified in the BDT food chain, showing a marginal dolphins health risk (RQ = 1.00). We call for a monitoring pollutant program and conservation strategies aimed to protect the dolphin population at BDT.	[Barragan-Barrera, Dalia C.; Riet-Sapriza, Federico G.; Paula Hernandez-Avila, Maria; Caballero, Susana] Univ Los Andes, Dept Ciencias Biol, LEMVA, Carrera 1 18A-10, Bogota, Colombia; [Barragan-Barrera, Dalia C.; Farias-Curtidor, Nohelia] Fdn Macuaticos Colombia, Calle 27 79-167, Medellin, Colombia; [Barragan-Barrera, Dalia C.] Corp Ctr Excellence Marine Sci CEMarin, Carrera 21 35-53, Bogota, Colombia; [Luna-Acosta, Andrea; Velez, Natalia] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Ecol & Territorio, Transversal 4 42-00, Bogota, Colombia; [May-Collado, Laura J.] Univ Vermont, Dept Biol, 109 Carrigan Dr, Burlington, VT 05405 USA; [May-Collado, Laura J.] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol, San Jose, Costa Rica; [Polo-Silva, Carlos J.] Univ Bogota Jorge Tadeo Lozano, Fac Ciencias Nat & Ingn, Santa Marta, Colombia; [Bustamante, Paco] Univ La Rochelle, UMR CNRS 7266, Littoral Environm & Soc LIENSs, 2 Rue Olympe de Gouges, F-17000 La Rochelle, France; [Velez, Natalia] Fdn Malpelo & Otros Ecosistemas Marinos, Carrera 11 87-51,Local 4 Piso 2, Bogota, Colombia		Barragan-Barrera, DC (corresponding author), Univ Los Andes, Dept Ciencias Biol, LEMVA, Carrera 1 18A-10, Bogota, Colombia.	dc.barragan140@uniandes.edu.co	Bustamante, Paco/G-5833-2011; Barragán-Barrera, Dalia C./ABA-2913-2020; Polo, Carlos/AAG-5163-2021	Bustamante, Paco/0000-0003-3877-9390; Barragán-Barrera, Dalia C./0000-0003-4023-9908; Polo, Carlos/0000-0001-5541-8226; Riet, Federico/0000-0002-6568-2802; Luna-Acosta, Andrea/0000-0002-4712-2721	Society for Marine Mammalogy; Sciences Faculty of Universidad de los Andes; Administrative Department of Science, Technology and Innovation - Colciencias; Corporation Center of Excellence in Marine Sciences - CEMarin; Universidad de los Andes (Biological Sciences Department); Colciencias; IUF (Institut Universitaire de France); Rufford Foundation	Society for Marine Mammalogy; Sciences Faculty of Universidad de los Andes; Administrative Department of Science, Technology and Innovation - Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Corporation Center of Excellence in Marine Sciences - CEMarin; Universidad de los Andes (Biological Sciences Department); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); IUF (Institut Universitaire de France); Rufford Foundation	We thank C. Churlaud and M. Brault-Favrou from the Plateforme Analyses Elementaires of the LIENSs laboratory for facilitating Hg analyses, and G. Guillou from the Plateforme Analyses Isotopiques of the LIENS5 laboratory for its support in the stable isotope analyses. We thank the STRI Marine Biological Station and Panacetacea for their logistical support. We want to thank to Gabriel Jacome, Rachel Collin, Plinio Gondola, Marlon Smith, Arcadio Castillo, Urania Gonzalez, Gilberto Murray, Deyvis Gonzalez, Tanyusha Grenald, Cynthia Pena, Celia Mercado, Zurenayka Alain, and Orelis Arosemana at the STRI Bocas del Toro Research Station. Special thanks to boat captains Demetrio Georget, Arnulfo Record, Christian Harris, Roger Ayala, Tomas Ayala, and fishermen for their support on the small-scale surveys out of Bocas del Toro and La Guajira. We also thank to several people that assisted in the field: Shakira Quinones-Lebron, Monica Gamboa-Poveda, Monica Acosta, Ayshah Kassamali-Fox, Betzi Perez, Jose Julio Casas, Lissette Trejos, Joel Sanchez, Whitney Kwiers, Evelin Mosquera, Roberto Santamaria, Julie Tomczyk, Giselle Veve, Cole Tanner, Ashley Sitar, Paula Chavez, and Roosevelt Mesa. Special thanks to Angelica Batista -Morales for her support identifying fish species. Samples in Bocas del Toro (Panama) were collected with permission from the Autoridad Nacional del Ambiente (ANAM; permits SC/A-11-12, SC/A43-12, SC/A-17-14; SE/A-101-16, SE/AO-6-16). Samples in La Guajira (Colombia) were collected under Resolution 1177 of Marco Permit for Specimen Collection of Wildlife Biodiversity Non Commercial Purposes of Scientific Research. This permit was provided by the National Authority for Environmental Licenses (ANLA) to Universidad de los Andes. This study was supported by the Small Grant in Aid of Research from the Society for Marine Mammalogy (DCBB, 2011; 2014; MPHA, 2015). The Sciences Faculty of Universidad de los Andes provided following four Research Grants to DCBB: "Proyecto Semilla - 2013-2 Call for Funding of Research Category: Master and Doctoral students, project 'Genetic structure and diversity of bottlenose dolphins Tursiops truncatus (Montagu, 1821) (Cetacea: Delphinidae) in La Guajira, Colombian Caribbean'" from Universidad de los Andes (DCBB, 2014); the "Proyecto Semilla - 2015-1 Call for Funding of Research Category: Master and Doctoral students, project 'Occurrence, distribution and preliminary genetic status of delphinids in La Guajira, Colombian Caribbean'" (DCBB, 2015); "Proyecto Semilla - 2017-1 Call for Funding of Research Category: Candidates PhD students, project "Mercury concentrations in bottlenose dolphins Tursiops truncatus (Montagu, 1821) (Cetacea: Delphinidae) in Bocas del Toro, Caribbean Coast of Panama" (DCBB, 2016); "Proyecto Semilla -2018-1 Call for Funding of Research Category: Candidates PhD students, project "Isotopic analyses of bottlenose dolphins' diet in Bocas del Toro: a conservation perspective" (DCBB, 2017). The Rufford Foundation provided five grants for this research: the Rufford Small Grant (DCBB, 2012), the Second Rufford Small Grant (DCBB, 2014), the Booster Grant (DCBB, 2015), the Second Booster Grant (DCBB, 2017), and another Rufford Small Grant (NFC, 2016). The Administrative Department of Science, Technology and Innovation - Colciencias, and the Corporation Center of Excellence in Marine Sciences - CEMarin also supported this study (DCBB, 2016; 2018, respectively). Funds for PhD studies to DCBB were generously provided by Universidad de los Andes (Biological Sciences Department) and Colciencias.; The IUF (Institut Universitaire de France) is acknowledged for its support to PB as a Senior Member. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Pachon TA, 2019, MAR BIOL RES, V15, P97, DOI 10.1080/17451000.2019.1578377; Allen G., 1985, FAO FISH, V6, P208; Allen MC, 2001, MAR ECOL PROG SER, V222, P253, DOI 10.3354/meps222253; Allen SJ, 2011, MAR MAMMAL SCI, V27, P449, DOI 10.1111/j.1748-7692.2010.00409.x; Alonso-Fernandez A, 2012, J EXP MAR BIOL ECOL, V416, P8, DOI 10.1016/j.jembe.2012.02.001; AMOS B, 1991, P99; Andrade CA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001549; Andrade CA, 2005, CONT SHELF RES, V25, P1003, DOI 10.1016/j.csr.2004.12.012; Angel -Romero P.A., 2018, SC67BE09 INT WHAL CO; Arnot JA, 2006, ENVIRON REV, V14, P257, DOI [10.1139/A06-005, 10.1139/a06-005]; Aubail A, 2013, MAR POLLUT BULL, V76, P158, DOI 10.1016/j.marpolbul.2013.09.008; Barkay T, 1997, APPL ENVIRON MICROB, V63, P4267, DOI 10.1128/AEM.63.11.4267-4271.1997; Barker D., 2002, GUIDE ACCEPTABLE PRO; Barragan-Barrera DC, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00010; Barragan-Barrera DC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189370; Barros NB, 2010, MAR MAMMAL SCI, V26, P324, DOI 10.1111/j.1748-7692.2009.00315.x; Barwick M, 2003, MAR ENVIRON RES, V56, P471, DOI 10.1016/S0141-1136(03)00028-X; Bearzi G., 2012, IUCN RED LIST THREAT, V2012; BELAND P, 1993, J GREAT LAKES RES, V19, P766, DOI 10.1016/S0380-1330(93)71264-2; Bergamaschi BA, 2012, ENVIRON SCI TECHNOL, V46, P1371, DOI 10.1021/es2029137; Berry KLE, 2013, ENVIRON MONIT ASSESS, V185, P9089, DOI 10.1007/s10661-013-3238-8; Bisi TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082205; Blanco C, 2001, J MAR BIOL ASSOC UK, V81, P1053, DOI 10.1017/S0025315401005057; Blessing JJ, 2010, J FISH BIOL, V76, P2571, DOI 10.1111/j.1095-8649.2010.02633.x; Blum JD, 2013, NAT GEOSCI, V6, P879, DOI [10.1038/ngeo1918, 10.1038/NGEO1918]; Borrell A, 2014, CHEMOSPHERE, V107, P319, DOI 10.1016/j.chemosphere.2013.12.076; Bossart GD, 2011, VET PATHOL, V48, P676, DOI 10.1177/0300985810388525; Botta S, 2018, DEEP-SEA RES PT II, V149, P240, DOI 10.1016/j.dsr2.2017.11.005; BOUSH GM, 1983, B ENVIRON CONTAM TOX, V30, P291, DOI 10.1007/BF01610135; Bowen WD, 1997, MAR ECOL PROG SER, V158, P267, DOI 10.3354/meps158267; Browning NE, 2014, J EXP MAR BIOL ECOL, V457, P15, DOI 10.1016/j.jembe.2014.03.016; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Bussing WA., 1995, GUIA FAO IDENTIFICAT, V2, P1114; Bustamante P, 2006, SCI TOTAL ENVIRON, V368, P585, DOI 10.1016/j.scitotenv.2006.01.038; Caceres-Saez I, 2015, CHEMOSPHERE, V138, P735, DOI 10.1016/j.chemosphere.2015.07.026; Cai Y, 2007, CAN J FISH AQUAT SCI, V64, P458, DOI 10.1139/F07-017; Cairns, 2003, HDB ECOTOXICOLOGY; Catry T, 2008, MAR BIOL, V155, P637, DOI 10.1007/s00227-008-1060-6; Chouvelon T, 2017, SCI TOTAL ENVIRON, V596, P481, DOI 10.1016/j.scitotenv.2017.04.048; Choy CA, 2009, P NATL ACAD SCI USA, V106, P13865, DOI 10.1073/pnas.0900711106; Colaco A, 2006, CHEMOSPHERE, V65, P2260, DOI 10.1016/j.chemosphere.2006.05.034; Correa L, 2014, MAR POLLUT BULL, V82, P175, DOI 10.1016/j.marpolbul.2014.02.022; D'Croz L, 2005, CARIBB J SCI, V41, P414; Damseaux F, 2017, ENVIRON POLLUT, V220, P577, DOI 10.1016/j.envpol.2016.10.005; Das K, 2003, MAR ECOL PROG SER, V263, P287, DOI 10.3354/meps263287; Bayas-Rea RD, 2018, PEERJ, V6, DOI 10.7717/peerj.4589; De Pierrepont JF, 2005, J MAR BIOL ASSOC UK, V85, P1539, DOI 10.1017/S0025315405012762; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Desforges JPW, 2016, ENVIRON INT, V86, P126, DOI 10.1016/j.envint.2015.10.007; Diaz-Gamboa R. E., 2003, THESIS; Duarte-Fajardo M. A., 2018, 5 COL C ZOOL BOG COL; Duffy-Echevarria EE, 2008, MAR MAMMAL SCI, V24, P202, DOI 10.1111/j.1748-7692.2007.00151.x; Evans D. W., 2001, FLOR BAY SCI C KEY L, P181; Evans DW, 2005, B MAR SCI, V77, P321; Farias-Curtidor N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171000; Fernandez R, 2011, MAR BIOL, V158, P1043, DOI 10.1007/s00227-011-1629-3; Fey P, 2019, SCI TOTAL ENVIRON, V667, P208, DOI 10.1016/j.scitotenv.2019.02.311; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Fossi MC, 2012, MAR ENVIRON RES, V77, P156, DOI 10.1016/j.marenvres.2012.03.003; Friedlander AM, 1997, FISH RES, V31, P61, DOI 10.1016/S0165-7836(97)00015-5; Frodello JP, 2002, MAR POLLUT BULL, V44, P551, DOI 10.1016/S0025-326X(02)00067-X; Fruet Pedro F., 2016, Latin American Journal of Aquatic Mammals, V11, P121; Fruet PF, 2014, CONSERV GENET, V15, P879, DOI 10.1007/s10592-014-0586-z; Gannon DP, 2004, MAR MAMMAL SCI, V20, P527, DOI 10.1111/j.1748-7692.2004.tb01177.x; Gilson A, 1998, CALIF FISH GAME, V84, P159; GORDON AL, 1967, J GEOPHYS RES, V72, P6207, DOI 10.1029/JZ072i024p06207; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Guzman HM, 1998, REV BIOL TROP, V46, P601; Guzman HM, 2005, CARIBB J SCI, V41, P430; Guzman HM, 2002, MAR POLLUT BULL, V44, P1415, DOI 10.1016/S0025-326X(02)00318-1; GUZMAN HM, 1992, MAR POLLUT BULL, V24, P554, DOI 10.1016/0025-326X(92)90708-E; Hernandez-Milian G, 2015, AQUAT MAMM, V41, P226, DOI 10.1578/AM.41.2.2015.226; HISLOP JRG, 1991, J ZOOL, V224, P501, DOI 10.1111/j.1469-7998.1991.tb06039.x; Hobson KA, 2002, DEEP-SEA RES PT II, V49, P5131, DOI 10.1016/S0967-0645(02)00182-0; Hooker SK, 2001, CAN J ZOOL, V79, P1442, DOI 10.1139/cjz-79-8-1442; Hung CLH, 2004, CHEMOSPHERE, V56, P643, DOI 10.1016/j.chemosphere.2004.04.016; Hung CLH, 2007, CHEMOSPHERE, V66, P1175, DOI 10.1016/j.chemosphere.2006.08.005; Ingram SN, 2002, MAR ECOL PROG SER, V244, P247, DOI 10.3354/meps244247; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jarek S, 2015, PACKAGE MVNORMTEST N, P1; Jefferson T., 2002, MARINE MAMMALS WORLD; Jimenez Pedro J., 2015, Latin American Journal of Aquatic Mammals, V10, P33; Kannan K, 2000, HUM ECOL RISK ASSESS, V6, P181, DOI 10.1080/10807030091124491; Kassamali-Fox A., 2015, SC66AWW11 INT WHAL C; Kastelein RA, 2002, MAR ENVIRON RES, V53, P199, DOI 10.1016/S0141-1136(01)00123-4; Kehrig HA, 2017, REV BIOL MAR OCEANOG, V52, P233, DOI 10.4067/S0718-19572017000200004; Kehrig HA, 2013, MAR POLLUT BULL, V75, P283, DOI 10.1016/j.marpolbul.2013.06.046; Krey A, 2015, SCI TOTAL ENVIRON, V509, P237, DOI 10.1016/j.scitotenv.2014.05.134; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Lailson-Brito Jose Jr, 2002, Latin American Journal of Aquatic Mammals, V1, P107; Lavoie RA, 2013, ENVIRON SCI TECHNOL, V47, P13385, DOI 10.1021/es403103t; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LEONZIO C, 1992, SCI TOTAL ENVIRON, V119, P77, DOI 10.1016/0048-9697(92)90257-S; Lonin SA, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005100; Loor-Andrade P, 2015, RAPID COMMUN MASS SP, V29, P821, DOI 10.1002/rcm.7169; Marrugo-Negrete JL, 2018, ARCH ENVIRON CON TOX, V74, P121, DOI 10.1007/s00244-017-0459-9; Luna S. M, 2018, SPARISOMA CHIYSOPTER; MARTINEAU D, 1994, SCI TOTAL ENVIRON, V154, P201, DOI 10.1016/0048-9697(94)90088-4; May-Collado LJ, 2008, J MAMMAL, V89, P1229, DOI 10.1644/07-MAMM-A-310.1; May-Collado LJ, 2014, J ACOUST SOC AM, V135, pEL193, DOI 10.1121/1.4869255; May-Collado LJ, 2015, SC66AWW10 INT WHAL C; May-Collado LJ, 2012, SC64WW2 INT WHAL COM; Mead J.G., 1990, P165; Mead J. G, 1995, IBI REP, V5, P1; Mendes S, 2007, OECOLOGIA, V151, P605, DOI 10.1007/s00442-006-0612-z; Mendez-Fernandez P, 2012, J EXP MAR BIOL ECOL, V413, P150, DOI 10.1016/j.jembe.2011.12.007; Milmann L, 2016, BRAZ J OCEANOGR, V64, P415, DOI 10.1590/S1679-87592016116406404; MISKIMMIN BM, 1992, CAN J FISH AQUAT SCI, V49, P17, DOI 10.1139/f92-002; Monteiro LR, 1996, MAR ECOL PROG SER, V141, P21, DOI 10.3354/meps141021; Moura Jailson F., 2016, Latin American Journal of Aquatic Mammals, V11, P191; MULLERKARGER FE, 1989, PROG OCEANOGR, V23, P23, DOI 10.1016/0079-6611(89)90024-4; Murray J, 1969, COMPOSITION FISH TOR, P14; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Nfon E, 2009, SCI TOTAL ENVIRON, V407, P6267, DOI 10.1016/j.scitotenv.2009.08.032; Paramo J, 2011, REV BIOL MAR OCEANOG, V46, P421, DOI 10.4067/S0718-19572011000300011; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Parsons KM, 2006, MAR MAMMAL SCI, V22, P276, DOI 10.1111/j.1748-7692.2006.00019.x; Payne SA, 1999, FISH OCEANOGR, V8, P159, DOI 10.1046/j.1365-2419.1999.00097.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Polo-Silva C, 2013, MAR BIOL RES, V9, DOI 10.1080/17451000.2013.793802; Polo-Silva CJ, 2012, RAPID COMMUN MASS SP, V26, P1631, DOI 10.1002/rcm.6275; Power M, 2002, J APPL ECOL, V39, P819, DOI 10.1046/j.1365-2664.2002.00758.x; Quintana-Rizzo Ester, 2011, Latin American Journal of Aquatic Mammals, V9, P179; RADAKOV D V, 1974, Journal of Ichthyology, V14, P283; Reeves R., 2008, GUIDE MARINE MAMMALS; Reif John S, 2015, Vet Sci, V2, P407, DOI 10.3390/vetsci2040407; Riccialdelli L, 2010, MAR ECOL PROG SER, V418, P235, DOI 10.3354/meps08826; RIVERS JB, 1972, B ENVIRON CONTAM TOX, V8, P257, DOI 10.1007/BF01684554; Roditi-Elasar M, 2003, MAR POLLUT BULL, V46, P503, DOI 10.1016/S0025-326X(03)00003-1; Romero MB, 2016, MAR POLLUT BULL, V109, P650, DOI 10.1016/j.marpolbul.2016.05.012; Rossman S, 2015, OECOLOGIA, V178, P415, DOI 10.1007/s00442-015-3241-6; Samarra FIP, 2017, MAR ECOL PROG SER, V564, P199, DOI 10.3354/meps11998; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P231, DOI 10.1017/S0025315407055233; Schell DM, 1998, MAR ECOL PROG SER, V162, P11, DOI 10.3354/meps162011; Schwacke LH, 2002, ENVIRON TOXICOL CHEM, V21, P2752, DOI 10.1897/1551-5028(2002)021<2752:PRAORE>2.0.CO;2; Seemann J, 2014, ENVIRON MONIT ASSESS, V186, P1747, DOI 10.1007/s10661-013-3490-y; Segura I, 2006, BIOL CONSERV, V133, P336, DOI 10.1016/j.biocon.2006.06.017; Sellas AB, 2005, CONSERV GENET, V6, P715, DOI 10.1007/s10592-005-9031-7; Shoham-Frider E, 2016, MAR POLLUT BULL, V109, P624, DOI 10.1016/j.marpolbul.2016.05.021; Silva LFF, 2003, WATER AIR SOIL POLL, V145, P67, DOI 10.1023/A:1023610623280; Sitar A, 2016, MAR POLICY, V68, P221, DOI 10.1016/j.marpol.2016.03.011; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; Spitz J, 2006, ESTUAR COAST SHELF S, V70, P259, DOI 10.1016/j.ecss.2006.04.020; Stavros HCW, 2007, SCI TOTAL ENVIRON, V388, P300, DOI 10.1016/j.scitotenv.2007.07.030; Stock B.C., 2016, MIXSIAR GUI USER MAN; Strandberg B, 1998, SCI TOTAL ENVIRON, V217, P143, DOI 10.1016/S0048-9697(98)00173-9; Strom DG, 2001, ESTUARIES, V24, P597, DOI 10.2307/1353260; Tezanos-Pinto G, 2011, NEW ZEAL J MAR FRESH, V1, P1; Tezanos-Pinto G, 2009, J HERED, V100, P11, DOI 10.1093/jhered/esn039; van Waerebeek K., 1990, P143; Van Waerebeek Koen, 2006, Latin American Journal of Aquatic Mammals, V5, P39; Vermeulen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119182; Walker JL, 1999, MAR MAMMAL SCI, V15, P335, DOI 10.1111/j.1748-7692.1999.tb00805.x; Wang WX, 2002, MAR ECOL PROG SER, V243, P295, DOI 10.3354/meps243295; Weller David W., 1997, Aquatic Mammals, V23, P49; Wells R., 2004, ECOHEALTH, DOI 10.1007/s10393-004-0094-6; Woshner V, 2008, ECOHEALTH, V5, P360, DOI 10.1007/s10393-008-0164-2	159	2	2	1	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0025-326X	1879-3363		MAR POLLUT BULL	Mar. Pollut. Bull.	AUG	2019	145						343	356		10.1016/j.marpolbul.2019.04.076	http://dx.doi.org/10.1016/j.marpolbul.2019.04.076			14	Environmental Sciences; Marine & Freshwater Biology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Marine & Freshwater Biology	IS9UI	31590796	Green Submitted			2022-09-04	WOS:000482493000041
J	Borda, MG; Soennesyn, H; Steves, CJ; Vik-Mo, AO; Perez-Zepeda, MU; Aarsland, D				German Borda, Miguel; Soennesyn, Hogne; Steves, Claire J.; Osland Vik-Mo, Audun; Ulises Perez-Zepeda, Mario; Aarsland, Dag			Frailty in Older Adults with Mild Dementia: Dementia with Lewy Bodies and Alzheimer's Disease	DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA			English	Article						Frailty; Dementia; Alzheimer's disease; Dementia with Lewy bodies	MINI-MENTAL-STATE; CLINICAL-DIAGNOSIS; POPULATION; PREVALENCE; MANAGEMENT; DISABILITY; ACCURACY	Introduction: The aim of the study is to describe the frequency of frailty in people with a new diagnosis of mild dementia due to Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). Methods: This is a secondary analysis of the Dementia Study of Western Norway (Demvest). For this study, we analysed a sample of 186 patients, 116 with AD and 70 with DLB. Subjects were included at a time in which mild dementia was diagnosed according to consensus criteria after comprehensive standardized assessment. Frailty was evaluated retrospectively using a frailty index generated from existing data. The cut-off value used to classify an older adult as frail was 0.25. Results: The prevalence of frailty was 25.81% (n = 48). In the DLB group, 37.14% (n = 26) were classified as frail, compared to 18.97% (n = 22) of those with AD (p < 0.001). The adjusted multivariate analysis revealed an OR of 2.45 (1.15-5.23) for being frail in those with DLB when using AD as the reference group. Conclusion: Frailty was higher than expected in both types of dementia. The prevalence of frailty was higher in those with DLB compared to AD. This new finding underscores the need for a multi-systems approach in both dementias, with a particular focus on DLB. (C) 2019 The Author(s) Published by S. Karger AG, Basel	[German Borda, Miguel; Soennesyn, Hogne; Osland Vik-Mo, Audun; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, NO-4068 Stavanger, Norway; [German Borda, Miguel; Ulises Perez-Zepeda, Mario] Pontificia Univ Javeriana, Med Sch, Ageing Inst, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [German Borda, Miguel] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Steves, Claire J.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Osland Vik-Mo, Audun] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Ulises Perez-Zepeda, Mario] Inst Nacl Geriatria, Geriatr Epidemiol Res Dept, Mexico City, DF, Mexico; [Ulises Perez-Zepeda, Mario] Dalhousie Univ, Dept Med, Geriatr Med Res Unit, Halifax, NS, Canada; [Aarsland, Dag] Kings Coll London, Dept Old Age Psychiat, Inst Psychiat Psychol & Neurosci, London, England		Borda, MG (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, NO-4068 Stavanger, Norway.	mmborda@gmail.com	Borda, Miguel Germán/AAK-9029-2020; Perez-Zepeda, Mario/B-7265-2011; Borda, Miguel German/AHB-5593-2022	Borda, Miguel Germán/0000-0001-5832-0603; Perez-Zepeda, Mario/0000-0003-4374-976X; Borda, Miguel German/0000-0001-5832-0603; Vik-Mo, Audun Osland/0000-0002-5162-3035; Steves, Claire/0000-0002-4910-0489; Aarsland, Dag/0000-0001-6314-216X	Norwegian government; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London	Norwegian government; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London	This paper represents independent research supported by the Norwegian government, through hospital owner Helse Vest (Western Norway Regional Health Authority). Also, funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Aarsland D, 2008, DEMENT GERIATR COGN, V26, P445, DOI 10.1159/000165917; Amin J, 2017, ALZHEIMERS DEMENT, V13, pP594; Avila-Funes JA, 2014, J FRALITY AGING, V3, P206, DOI 10.14283/jfa.2014.25; Borda MG, 2017, MOJ GERONTOL GER, V2, P222; Bunn Frances, 2015, Nurs Stand, V30, P45, DOI 10.7748/ns.30.1.45.e9816; Enciu AM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/316495; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIED LP, 1994, J CLIN EPIDEMIOL, V47, P747, DOI 10.1016/0895-4356(94)90172-4; Kojima G, 2017, CURR ALZHEIMER RES, V14, P1256, DOI 10.2174/1567205014666170417104236; Kulmala J, 2014, GERONTOLOGY, V60, P16, DOI 10.1159/000353859; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Mueller C, 2017, LANCET NEUROL, V16, P390, DOI 10.1016/S1474-4422(17)30074-1; Muller T, 2007, CLIN ORAL IMPLAN RES, V18, P2, DOI 10.1111/j.1600-0501.2007.01459.x; Neale R, 2001, INT J EPIDEMIOL, V30, P1383, DOI 10.1093/ije/30.6.1383; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Rockwood K, 2011, CLIN GERIATR MED, V27, P17, DOI 10.1016/j.cger.2010.08.008; Samper-Ternet R, 2015, EUROPEAN GERIATRIC M, V6, pS84; Sampson EL, 2012, AGING MENT HEALTH, V16, P269, DOI 10.1080/13607863.2012.657158; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Shimada H, 2016, J NUTR HEALTH AGING, V20, P729, DOI 10.1007/s12603-016-0685-2; Siriwardhana DD, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018195; Skogseth R, 2017, J ALZHEIMERS DIS, V59, P1139, DOI 10.3233/JAD-170274; Solfrizzi V, 2012, AGE, V34, P507, DOI 10.1007/s11357-011-9247-z; Vik-Mo AO, 2018, INT J GERIATR PSYCH, V33, P1361, DOI 10.1002/gps.4933; World Health Organisation, 2012, DEM PUBL HLTH PRIOR; Zweig YR, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt251	30	14	14	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND		1664-5464		DEMENT GER COGN D EX	Dement. Geriatr. Cogn. Disord. Extra		2019	9	1					176	183		10.1159/000496537	http://dx.doi.org/10.1159/000496537			8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HU3XS		Green Published, gold			2022-09-04	WOS:000465209000016
J	Dupuis, JR; Brunet, BMT; Bird, HM; Lumley, LM; Fagua, G; Boyle, B; Levesque, R; Cusson, M; Powell, JA; Sperling, FAH				Dupuis, J. R.; Brunet, B. M. T.; Bird, H. M.; Lumley, L. M.; Fagua, G.; Boyle, B.; Levesque, R.; Cusson, M.; Powell, J. A.; Sperling, F. A. H.			Genome-wide SNPs resolve phylogenetic relationships in the North American spruce budworm (Choristoneura fumiferana) species complex	MOLECULAR PHYLOGENETICS AND EVOLUTION			English	Article						Phylogenomics; Systematics; Genotyping-by-sequencing; RAD-seq; Population genetics; Species relationships	MITOCHONDRIAL-DNA; GENE TREES; EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; DE-NOVO; LEPIDOPTERA; INFERENCE; TORTRICIDAE; MARKER; LOCI	High throughput sequencing technologies have revolutionized the potential to reconcile incongruence between gene and species trees, and numerous approaches have been developed to take advantage of these advances. Genotyping-by-sequencing is becoming a regular tool for gathering phylogenetic data, yet comprehensive evaluations of phylogenetic methods using these data are sparse. Here we use multiple phylogenetic and population genetic methods for genotyping-by-sequencing data to assess species relationships in a group of forest insect pests, the spruce budworm (Choristoneura fumiferana) species complex. With few exceptions, all methods agree on the same relationships, most notably placing C. pinus as basal to the remainder of the group, rather than C fumiferana as previously suggested. We found strong support for the monophyly of C pinus, C fumiferana, and C retiniana, but more ambiguous relationships and signatures of introgression in a Glade of western lineages, including C carnana, C lambertiana, C occidentalis occidentalis, C. occidentalis biennis, and C orae. This represents the most taxonomically comprehensive genomic treatment of the spruce budworm species group, which is further supported by the broad agreement among multiple methodologies. (C) 2017 Elsevier Inc. All rights reserved.	[Dupuis, J. R.; Brunet, B. M. T.; Bird, H. M.; Lumley, L. M.; Fagua, G.; Sperling, F. A. H.] Univ Alberta, Dept Biol Sci, CW 405 Biosci Ctr, Edmonton, AB T6G 2E9, Canada; [Lumley, L. M.; Cusson, M.] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, 1055 PEPS,POB 10380, Quebec City, PQ, Canada; [Fagua, G.] Pontificia Univ Javeriana, Dept Biol, Carrera 7 40-62, Bogota, DC, Colombia; [Boyle, B.; Levesque, R.] Univ Laval, IBIS, Quebec City, PQ, Canada; [Powell, J. A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, 130 Mulford Hall 3114, Berkeley, CA 94720 USA		Dupuis, JR (corresponding author), USDA ARS, DKI PBARC, 64 Nowelo St, Hilo, HI 96720 USA.	jrdupuis@hawaii.edu	Levesque, Roger C./ABD-8407-2021; Sperling, Felix A.H./H-8376-2012; Fagua, Giovanny/B-3135-2018; Cusson, Michel/AAG-9036-2019	Sperling, Felix A.H./0000-0001-5148-4226; Fagua, Giovanny/0000-0003-1253-4416; Levesque, Roger/0000-0001-8315-5937; Brunet, Bryan/0000-0001-5083-9662; Dupuis, Julian/0000-0002-6989-9179; Lumley, Lisa/0000-0002-8925-8803	Alberta Innovates Bio Solutions grant [VCS-11-034]; National Science and Engineering Research Council [217174]; Genomics Research and Development Initiative (GRDI) grant; Genome Quebec grant (GreenSNPs project); Academic Vice rectory of the "Pontificia Universidad Javeriana-Bogota"-Administrative Department of Science, Technology and Innovation of Colombia (COLCIENCIAS) [DJE-012-2011, APCC-80-134]; WestGrid; Compute Canada Calcul Canada	Alberta Innovates Bio Solutions grant; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genomics Research and Development Initiative (GRDI) grant; Genome Quebec grant (GreenSNPs project); Academic Vice rectory of the "Pontificia Universidad Javeriana-Bogota"-Administrative Department of Science, Technology and Innovation of Colombia (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); WestGrid; Compute Canada Calcul Canada	We thank Alberta Environment and Sustainable Resource Development, G. Anweiler, S. Brunet, Canadian Forest Service, J. De Benedictis, J. Dombroskie, J. Doucette, A. Hundsdoerfer, J.F. Landry, L. Nolan, B. Proshek, A. Roe, D. Rubinoff, Saskatchewan Environment, and C. Whitehouse for assistance in specimen collection and two anonymous reviewers for comments. Funding was provided by an Alberta Innovates Bio Solutions grant (# VCS-11-034) and National Science and Engineering Research Council Discovery grant (# 217174) to FAHS, a Genomics Research and Development Initiative (GRDI) grant to M. Cusson, a Genome Quebec grant (GreenSNPs project) to R. Levesque, and a scholarship from the Academic Vice rectory of the "Pontificia Universidad Javeriana-Bogota" (Agreement DJE-012-2011)-Administrative Department of Science, Technology and Innovation of Colombia (COLCIENCIAS, APCC-80-134) to G. Fagua. This research was enabled in part by support provided by WestGrid (www.westgrid.ca) and Compute Canada Calcul Canada (www.computecanada.ca).	AVISE JC, 1983, MOL BIOL EVOL, V1, P38; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bapteste E, 2012, P NATL ACAD SCI USA, V109, P18266, DOI 10.1073/pnas.1206541109; Bird H.M., 2013, THESIS; Blackburn G.S., DISTINCT SOURC UNPUB; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bouckaert RR, 2014, BIORXIV; Brunet B.M.T., 2016, SYST ENT; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Cariou M, 2013, ECOL EVOL, V3, P846, DOI 10.1002/ece3.512; Castrovillo P.J., 1982, THESIS; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chan KMA, 2005, EVOLUTION, V59, P720; Cruaud A, 2014, MOL BIOL EVOL, V31, P1272, DOI 10.1093/molbev/msu063; DaCosta JM, 2016, MOL PHYLOGENET EVOL, V94, P122, DOI 10.1016/j.ympev.2015.07.026; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DANG PT, 1992, CAN ENTOMOL, V124, P7, DOI 10.4039/Ent1247-1; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Diaz-Arce N, 2016, MOL PHYLOGENET EVOL, V102, P202, DOI 10.1016/j.ympev.2016.06.002; Dombroskie JJ, 2013, ZOOTAXA, V3729, P1, DOI 10.11646/zootaxa.3729.1.1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; FREEMAN TN, 1967, CAN ENTOMOL, V99, P445; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gatesy J, 2014, MOL PHYLOGENET EVOL, V80, P231, DOI 10.1016/j.ympev.2014.08.013; Giarla TC, 2015, SYST BIOL, V64, P727, DOI 10.1093/sysbio/syv029; Gohli J, 2015, MOL ECOL, V24, P180, DOI 10.1111/mec.13008; Gray DR, 2006, FOREST CHRON, V82, P550, DOI 10.5558/tfc82550-4; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harvey G.T., 1985, P16; Harvey GT, 1997, CAN ENTOMOL, V129, P519, DOI 10.4039/Ent129519-3; HARVEY GT, 1967, CAN ENTOMOL, V99, P486, DOI 10.4039/Ent99486-5; Harvey GT, 1996, CAN ENTOMOL, V128, P245, DOI 10.4039/Ent128245-2; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hipp AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093975; Huang HT, 2016, SYST BIOL, V65, P357, DOI 10.1093/sysbio/syu046; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94, DOI 10.1111/brv.12083]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones JC, 2013, MOL ECOL, V22, P2986, DOI 10.1111/mec.12269; Knowles L.L., 2010, ESTIMATING SPECIES T; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leache AD, 2015, SYST BIOL, V64, P1032, DOI 10.1093/sysbio/syv053; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIEBHOLD AM, 1984, CAN ENTOMOL, V116, P991, DOI 10.4039/Ent116991-7; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Liu L, 2011, SYST BIOL, V60, P661, DOI 10.1093/sysbio/syr027; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Lumley LM, 2011, ECOL EVOL, V1, P119, DOI 10.1002/ece3.11; Lumley LM, 2011, MOL PHYLOGENET EVOL, V58, P232, DOI 10.1016/j.ympev.2010.11.023; Lumley LM, 2010, SYST ENTOMOL, V35, P416, DOI 10.1111/j.1365-3113.2009.00514.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; McVay JD, 2013, J PHYLOGENET EVOL BI, V1, P114; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Mirarab S, 2014, BIOINFORMATICS, V30, pI541, DOI 10.1093/bioinformatics/btu462; Mirarab S, 2015, BIOINFORMATICS, V31, P44, DOI 10.1093/bioinformatics/btv234; Mirarab S, 2016, SYST BIOL, V65, P366, DOI 10.1093/sysbio/syu063; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Powell J. A., 1995, BIOSYSTEMATIC STUDIE; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; R Core Team, 2021, R LANG ENV STAT COMP; Rambaut A, 2015, TRACER V1 6 2014; Razkin O, 2016, MOL PHYLOGENET EVOL, V101, P267, DOI 10.1016/j.ympev.2016.05.002; Rivers D.M., 2016, CLADISTICS; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; SANDERS CJ, 1977, CAN ENTOMOL, V109, P1203, DOI 10.4039/Ent1091203-9; Shaw TI, 2013, NUCLEIC ACIDS RES, V41, pW238, DOI 10.1093/nar/gkt377; Silk P.J., 2012, PHEROMONE COMMUNICAT; Simmons MP, 2015, MOL PHYLOGENET EVOL, V91, P98, DOI 10.1016/j.ympev.2015.05.011; SMITH S. G., 1953, CANADIAN ENT, V85, P141; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Sperling F.A.H., 2003, BUTTERFLIES ECOLOGY; SPERLING FAH, 1995, CAN ENTOMOL, V127, P277, DOI 10.4039/Ent127277-3; SPERLING FAH, 1994, MOL BIOL EVOL, V11, P656; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; STEHR GW, 1967, CAN ENTOMOL, V99, P456, DOI 10.4039/Ent99456-5; Stervander M, 2016, MOL PHYLOGENET EVOL, V102, P233, DOI 10.1016/j.ympev.2016.05.032; Stervander M, 2015, MOL ECOL, V24, P2477, DOI 10.1111/mec.13145; STOCK MW, 1981, CAN ENTOMOL, V113, P857, DOI 10.4039/Ent113857-9; Swofford D., 2002, MAC VERS, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; Swofford D.L., 1990, BUTTERFLIES ECOLOGY; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Volney WJA, 2007, GLOBAL CHANGE BIOL, V13, P1630, DOI 10.1111/j.1365-2486.2007.01402.x; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Weisrock DW, 2012, MOL BIOL EVOL, V29, P1615, DOI 10.1093/molbev/mss008; Wielstra B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111011; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zimmermann T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S6-S11	109	23	24	3	80	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1055-7903	1095-9513		MOL PHYLOGENET EVOL	Mol. Phylogenet. Evol.	JUN	2017	111						158	168		10.1016/j.ympev.2017.04.001	http://dx.doi.org/10.1016/j.ympev.2017.04.001			11	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	EU0QA	28390910				2022-09-04	WOS:000400715100013
J	Hidalgo-Lanussa, O; Avila-Rodriguez, M; Baez-Jurado, E; Zamudio, J; Echeverria, V; Garcia-Segura, LM; Barreto, GE				Hidalgo-Lanussa, Oscar; Avila-Rodriguez, Marco; Baez-Jurado, Eliana; Zamudio, Jairo; Echeverria, Valentina; Miguel Garcia-Segura, Luis; Barreto, George E.			Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta	MOLECULAR NEUROBIOLOGY			English	Article						Palmitic acid; Obesity; Neurodegenerative diseases; Microglia; Neuroglobin; Estrogen receptors; Tibolone; Neuroinflammation	PI3K/AKT SIGNALING PATHWAY; SATURATED FATTY-ACIDS; NF-KAPPA-B; NEUROGLOBIN EXPRESSION; GLUCOSE DEPRIVATION; DIABETES-MELLITUS; ASTROCYTIC CELLS; BV-2 MICROGLIA; UP-REGULATION; 17-BETA-ESTRADIOL	High concentrations of palmitic acid in plasma increase both the inflammation associated with obesity and the susceptibility to develop a neurodegenerative event. In the brain, the inflammatory response is mediated by activated microglial cells, which undergo morphological and biochemical changes and can directly affect cell viability. Recent evidence shows that the use of estrogenic compounds can control microglia-induced inflammation with promising results. In this study, we explored the actions of the synthetic steroid tibolone on BV-2 microglia cells stimulated with palmitic acid. Our results demonstrated that tibolone increased cell viability and reduced nuclear fragmentation and the production of reactive oxygen species, as well as preserved mitochondrial membrane potential. These effects were accompanied by reduced nuclear translocation of NF-kappa B p65, upregulation of neuroglobin, and improved antioxidant defense. Furthermore, estrogen receptor beta (ER beta) inhibition partially dampened tibolone's protective actions in BV-2 cells stimulated with palmitic acid. In conclusion, tibolone protects BV-2 cells by a mechanism involving ER beta and upregulation of neuroglobin.	[Hidalgo-Lanussa, Oscar; Baez-Jurado, Eliana; Zamudio, Jairo; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Avila-Rodriguez, Marco] Univ Tolima, Fac Ciencias Salud, Dept Ciencias Clin, Ibague, Colombia; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA; [Echeverria, Valentina] Univ San Sebastian, Fac Cs Salud, Lientur 1457, Concepcion 4080871, Chile; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Ave Doctor Arce 37, E-28002 Madrid, Spain; [Miguel Garcia-Segura, Luis] Inst Salud Carlos III, CIBERFES, Madrid, Spain		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.; Garcia-Segura, LM (corresponding author), CSIC, Inst Cajal, Ave Doctor Arce 37, E-28002 Madrid, Spain.; Garcia-Segura, LM (corresponding author), Inst Salud Carlos III, CIBERFES, Madrid, Spain.	lmgs@cajal.csic.es; gsampaio@javeriana.edu.co	Barreto, George E./AAD-7420-2020; Garcia-Segura, Luis M/U-3711-2017; Valentina Echeverria Moran, BCh/E-7765-2013; Rodriguez, Jairo Alberto Zamudio/AAQ-7186-2021	Barreto, George E./0000-0002-6644-1971; Garcia-Segura, Luis M/0000-0002-2450-2916; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Rodriguez, Jairo Alberto Zamudio/0000-0003-3412-8320; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X; Avila-Rodriguez, Marco/0000-0003-4612-3236	Ministerio de Economia y Competitividad (MINECO) [BFU2014-51836-C2-1-R]; CIBERFES; Fondos FEDER	Ministerio de Economia y Competitividad (MINECO); CIBERFES; Fondos FEDER(European Commission)	We acknowledge support from Ministerio de Economia y Competitividad (MINECO; grant number BFU2014-51836-C2-1-R), from CIBERFES, and Fondos FEDER.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Acton QA, 2012, BRAIN ISCHEMIA NEW I; Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Amri F, 2017, J NEUROCHEM, V140, P151, DOI 10.1111/jnc.13876; Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Baez E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00146; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Biswas Debajit K, 2005, Sci STKE, V2005, ppe27, DOI 10.1126/stke.2882005pe27; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cordeau P, 2016, NEUROBIOL AGING, V40, P50, DOI 10.1016/j.neurobiolaging.2016.01.002; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; De Marinis E, 2010, NEUROSIGNALS, V18, P223, DOI 10.1159/000323906; de Zwaan M, 2002, OBES RES, V10, P1143, DOI 10.1038/oby.2002.155; Deshpande R, 1997, AM J REPROD IMMUNOL, V38, P46; El Akoum S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-34; Fan R, 2016, BRAIN RES, V1648, P345, DOI 10.1016/j.brainres.2016.08.002; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; Feng L, 2017, FISH SHELLFISH IMMUN, V60, P185, DOI 10.1016/j.fsi.2016.11.048; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Galea E, 2002, NEUROREPORT, V13, P1469, DOI 10.1097/00001756-200208070-00024; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; Giatti S, 2015, STEROIDS, V103, P23, DOI 10.1016/j.steroids.2015.03.014; Gompel A, 2002, FERTIL STERIL, V78, P351, DOI 10.1016/S0015-0282(02)03203-X; GRIES FA, 1970, DEUT MED WOCHENSCHR, V95, P727, DOI 10.1055/s-0028-1108532; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Heese K, 1997, NEUROSCI LETT, V231, P83, DOI 10.1016/S0304-3940(97)00545-4; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Kappe C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-276; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; KINGSBURY KJ, 1962, BIOCHEM J, V84, P124, DOI 10.1042/bj0840124; Kloosterboer HJ, 2004, MATURITAS, V49, pS5, DOI 10.1016/j.maturitas.2004.06.022; Lambertucci RH, 2008, J CELL PHYSIOL, V216, P796, DOI 10.1002/jcp.21463; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Little JP, 2012, J ALZHEIMERS DIS, V30, pS179, DOI 10.3233/JAD-2011-111262; Madan K, 2006, J CLIN GASTROENTEROL, V40, P930, DOI 10.1097/01.mcg.0000212608.59090.08; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Mattson MP, 2002, PHYSIOL REV, V82, P637, DOI 10.1152/physrev.00004.2002; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001; Mizoguchi S, 2017, PROSTATE, V77, P803, DOI 10.1002/pros.23320; Nilsen J, 2004, CNS NEUROL DISORD-DR, V3, P297, DOI 10.2174/1568007043337193; Pedraza-Alva G, 2015, IMMUNOL REV, V265, P231, DOI 10.1111/imr.12294; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pozzi S, 2006, ANN NY ACAD SCI, V1089, P302, DOI 10.1196/annals.1386.035; Priyanka HP, 2014, CELL IMMUNOL, V292, P1, DOI 10.1016/j.cellimm.2014.08.001; RANDLE PJ, 1963, LANCET, V1, P785; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Reed MJ, 2004, MATURITAS, V48, pS4, DOI 10.1016/j.maturitas.2004.02.013; Richardson TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034600; Said MM, 2017, N-S ARCH PHARMACOL, V390, P197, DOI 10.1007/s00210-016-1325-4; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Sandhir R, 2014, NEUROSCI LETT, V577, P123, DOI 10.1016/j.neulet.2014.06.005; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Simpkins JW, 2008, MOL CELL ENDOCRINOL, V290, P51, DOI 10.1016/j.mce.2008.04.013; Simpkins JW, 2005, CNS NEUROL DISORD-DR, V4, P69, DOI 10.2174/1568007053005073; Simpkins JW, 2010, BBA-GEN SUBJECTS, V1800, P1113, DOI 10.1016/j.bbagen.2009.11.013; Skiljic D, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0392-0; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Sribnick EA, 2006, NEUROSCIENCE, V137, P197, DOI 10.1016/j.neuroscience.2005.08.074; Strle K, 2007, J NEUROIMMUNOL, V188, P48, DOI 10.1016/j.jneuroim.2007.05.003; Sukocheva OA, 2009, STEROIDS, V74, P410, DOI 10.1016/j.steroids.2008.12.010; Sun HZ, 2010, J ENDOCRINOL, V204, P311, DOI 10.1677/JOE-09-0270; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; Tracy LM, 2013, J MOL NEUROSCI, V51, P805, DOI 10.1007/s12031-013-0068-7; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wang Z, 2012, BRIT J NUTR, V107, P229, DOI 10.1017/S0007114511002868; Wood H, 2011, NAT REV NEUROL, V7, P415, DOI [10.1038/nrneurol.2011.115, 10.1038/nrneurol.2011.87, 10.1038/nrneurol.2011.127, 10.1038/nrneurol.2011.162, 10.1038/nrneurol.2012.145]; Wu S., 2016, SCI REP, V6, P1, DOI DOI 10.1038/SREP22864; Wu WF, 2013, P NATL ACAD SCI USA, V110, P3543, DOI 10.1073/pnas.1300313110; Yang LY, 2017, INT J GYNECOL CANCER, V27, P196, DOI 10.1097/IGC.0000000000000875; Yuan L, 2014, MOL CELL BIOCHEM, V386, P153, DOI 10.1007/s11010-013-1854-9; Zhou ZQ, 2012, BIOCHEM BIOPH RES CO, V427, P305, DOI 10.1016/j.bbrc.2012.09.047	85	35	36	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2018	55	7					5462	5477		10.1007/s12035-017-0777-y	http://dx.doi.org/10.1007/s12035-017-0777-y			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GI8VY	28948468				2022-09-04	WOS:000434805100005
J	Kattan, GH; Roncancio, N; Banguera, Y; Kessler-Rios, M; Londono, GA; Marin, OH; Munoz, MC				Kattan, Gustavo H.; Roncancio, Nestor; Banguera, Yurany; Kessler-Rios, Margarita; Londono, Gustavo A.; Humberto Marin, Oscar; Munoz, Marcia C.			Spatial variation in population density of an endemic and endangered bird, the Cauca Guan (Penelope perspicax)	TROPICAL CONSERVATION SCIENCE			English	Article						Cracidae; Colombia; endangered species; endemicity; population density	CENTRAL ANDES; CLOUD-FOREST; NATURAL-HISTORY; HABITAT USE; ABUNDANCE; RARITY	Endemic species tend to be habitat specialists with low population densities, but densities may vary among sites and may be temporally dynamic. In addition, species may exhibit plasticity in habitat use, with the result that densities vary in different habitats. The Cauca Guan (Penelope perspicax) is an endangered species endemic to the mid-Cauca Valley in Colombia. To assess spatial variation in population densities, we surveyed different habitat types (mature and secondary forest, early regeneration, and vegetation strips along streams) in three sites and compared them to densities reported in previous studies to explore possible changes over a period of several years. At the three sites, densities varied between 10 and 40 birds/km(2) in different habitats. Variation in population density may be related to forest area and habitat productivity, but guans are known to move among locales and regions in response to temporal fluctuations in resource availability. Cauca Guan densities are comparable to those of other montane Penelopine guans with broader geographic distributions. Although the Cauca Guan is not a habitat specialist and may reach high densities under some conditions, globally this guan remains rare and efforts for its conservation should be sustained.	[Kattan, Gustavo H.] Pontificia Univ Javeriana Cali, Dept Ciencias Nat & Matemat, Cali, Colombia; [Roncancio, Nestor] Wildlife Conservat Soc Programa Colombia, Cali, Colombia; [Roncancio, Nestor] Inst Amazon Invest Cient, Leticia, Colombia; [Banguera, Yurany] Univ Quindio, Dept Biol, Armenia, Colombia; [Londono, Gustavo A.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Londono, Gustavo A.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Humberto Marin, Oscar] Univ Nacl Colombia, Inst Ciencias Nat, Grp Ornitol GOUN, Bogota, Colombia; [Munoz, Marcia C.] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany		Kattan, GH (corresponding author), Pontificia Univ Javeriana Cali, Dept Ciencias Nat & Matemat, Ave Canasgordas 118-250, Cali, Colombia.	gustavokattan@gmail.com; nabel8@yahoo.com; yuranyb@gmail.com; gmargaritarios@gmail.com; galondo@ufl.edu; oschumar@gmail.com; marcarmu@gmail.com	Marín, Oscar/J-7625-2015; Gómez, Oscar H. Marín/I-9667-2019	Marín, Oscar/0000-0002-0743-8350; Gómez, Oscar H. Marín/0000-0002-0743-8350; Munoz, Marcia Carolina/0000-0001-6391-0587	Wildlife Conservation Society; Fundacion EcoAndina; John D. and Catherine T. MacArthur Foundation; Corporacion Autonoma Regional del Valle del Cauca; Corporacion Autonoma Regional de Risaralda	Wildlife Conservation Society; Fundacion EcoAndina; John D. and Catherine T. MacArthur Foundation; Corporacion Autonoma Regional del Valle del Cauca; Corporacion Autonoma Regional de Risaralda	We thank the National Parks Unit and the staff at the Santuario de Fauna y Flora Otun Quimbaya for logistical support. Work at Otun Quimbaya was funded by the Wildlife Conservation Society, Fundacion EcoAndina and the John D. and Catherine T. MacArthur Foundation. Work at Yotoco was possible through permits and financial support from the Corporacion Autonoma Regional del Valle del Cauca, the John D. and Catherine T. MacArthur Foundation, the Wildlife Conservation Society and Fundacion EcoAndina. Work at Barbas-Bremen was funded by Corporacion Autonoma Regional de Risaralda.	[Anonymous], 2000, PATTERN PROCESS MACR; Begazo AJ, 1998, ORYX, V32, P301, DOI 10.1046/j.1365-3008.1998.d01-60.x; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Brooks DM, 2006, CONSERVING CRACIDS M, P9; Buckland S.T., 2001, pi; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Chaves-Campos Johel, 2003, Ornitologia Neotropical, V14, P195; Cresswell W, 1999, BIRD CONSERV INT, V9, P129, DOI 10.1017/S0959270900002252; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Del Hoyo J., 1994, HDB BIRDS WORLD, V2, P310; Jacobs MD, 1999, BIRD CONSERV INT, V9, P73, DOI 10.1017/S0959270900003361; Jankowski JE, 2007, BIOL CONSERV, V138, P453, DOI 10.1016/j.biocon.2007.05.015; KATTAN GH, 1992, CONSERV BIOL, V6, P64, DOI 10.1046/j.1523-1739.1992.610064.x; Kattan GH, 1999, BIRD CONSERV INT, V9, P271, DOI 10.1017/S0959270900003452; Kattan GH, 2006, BIRD CONSERV INT, V16, P299, DOI 10.1017/S0959270906000475; Kikuchi DW, 2009, J TROP ECOL, V25, P523, DOI 10.1017/S0266467409990101; Londono GA, 2007, WILSON J ORNITHOL, V119, P228, DOI 10.1676/06-041.1; Munoz MC, 2007, CONDOR, V109, P841, DOI 10.1650/0010-5422(2007)109[841:DOTCGE]2.0.CO;2; Munoz MC, 2007, ORNITOL NEOTROP, V18, P21; Nadachowski E., 1994, UCUMARI CASO TIPICO, P329; RENJIFO LM, 2002, LIBRO ROJO AVES COLO, P124; Rios MM, 2008, ORNITOL NEOTROP, V19, P295; Rios MM, 2005, ORNITOL NEOTROP, V16, P205; Thomas L., 2009, DISTANCE 6 0 RELEASE	24	4	8	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1940-0829			TROP CONSERV SCI	Trop. Conserv. Sci.		2014	7	1					161	170		10.1177/194008291400700106	http://dx.doi.org/10.1177/194008291400700106			10	Biodiversity Conservation	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation	AD4TB		gold			2022-09-04	WOS:000333242400013
J	Suarez-Ortegon, MF; Echeverri, I; Prats-Puig, A; Bassols, J; Carreras-Badosa, G; Lopez-Bermejo, A; Fernandez-Real, JM				Fabian Suarez-Ortegon, Milton; Echeverri, Isabella; Prats-Puig, Anna; Bassols, Judit; Carreras-Badosa, Gemma; Lopez-Bermejo, Abel; Manuel Fernandez-Real, Jose			Iron Status and Metabolically Unhealthy Obesity in Prepubertal Children	OBESITY			English	Article							SERUM FERRITIN LEVELS; INSULIN-RESISTANCE; PUBERTAL CHANGES; HEALTHY; ASSOCIATION; ADIPONECTIN; ADOLESCENTS; HOMEOSTASIS; WEIGHT; INDIVIDUALS	Objective This study aimed to evaluate the association of metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) with iron status markers in prepubertal children. Methods Three hundred twelve prepubertal children with overweight and obesity from a pediatric general Spanish population were evaluated. MHO and MUO were defined as obesity with the absence or presence of metabolic syndrome components. Phenotypes of metabolically healthy overweight including obesity (MHOV) and metabolically unhealthy overweight including obesity (MUOV) were also studied and defined using the same criteria. Serum ferritin, transferrin, and blood hemoglobin levels were evaluated. Results Prevalence rates of MHOV and MHO were 35% (n = 111/312) and 27.1% (n = 42/155), respectively. Ferritin and hemoglobin levels were higher in children with MUOV versus MHOV (P < 0.05). MUO was positively associated with ferritin (beta [95% CI] = 0.43 [0.05 to 0.81]) and hemoglobin levels (0.43 [0.05 to 0.81]). These associations remained significant independently of age, sex, C-reactive protein, physical activity, and BMI/waist z scores in bivariate linear regression models. In multivariable models, transaminase levels attenuated the association of MUO with ferritin and hemoglobin levels (P > 0.05). Conclusions MUOV and MUO are associated with higher ferritin and hemoglobin levels in prepubertal children affected by overweight and obesity. Increased circulating ferritin in MUO might be influenced by liver injury.	[Fabian Suarez-Ortegon, Milton] Pontificia Univ Javeriana, Basic & Clin Sci Grp, Dept Basic Sci Hlth, Cali, Colombia; [Fabian Suarez-Ortegon, Milton] Univ Valle, Nutr Grp, Cali, Colombia; [Echeverri, Isabella] Icesi Univ, Fac Hlth Sci, Cali, Colombia; [Prats-Puig, Anna; Bassols, Judit; Carreras-Badosa, Gemma; Lopez-Bermejo, Abel] Girona Inst Biomed Res, Pediat Res Grp, Girona, Spain; [Prats-Puig, Anna; Bassols, Judit; Carreras-Badosa, Gemma; Lopez-Bermejo, Abel] Dr Josep Trueta Hosp, Dept Pediat, Girona, Spain; [Prats-Puig, Anna] Univ Girona, Univ Sch Hlth & Sports, Dept Phys Therapy, Girona, Spain; [Lopez-Bermejo, Abel] Univ Girona, Dept Med Sci, TransLab Res Grp, Fac Med, Girona, Spain; [Manuel Fernandez-Real, Jose] Spanish Biomed Res Ctr Physiopathol Obes & Nutr, Girona Inst Biomed Res, Dept Med Sci, Dept Diabet Endocrinol & Nutr,Fac Med, Girona, Spain; [Manuel Fernandez-Real, Jose] Natl Inst Hlth Carlos III, Girona, Spain		Lopez-Bermejo, A (corresponding author), Univ Girona, Dept Med Sci, TransLab Res Grp, Fac Med, Girona, Spain.; Fernandez-Real, JM (corresponding author), Spanish Biomed Res Ctr Physiopathol Obes & Nutr, Girona Inst Biomed Res, Dept Med Sci, Dept Diabet Endocrinol & Nutr,Fac Med, Girona, Spain.; Fernandez-Real, JM (corresponding author), Natl Inst Hlth Carlos III, Girona, Spain.	alopezbermejo@idibgi.org; jmfreal@idibgi.org	Echeverri, Isabella IE/D-4350-2017; Prats-Puig, Anna/ABE-6969-2020; Fernández-Real, Jose Manuel/AGH-3599-2022; Prats, Anna/V-4223-2019	Echeverri, Isabella IE/0000-0001-7916-3897; Prats-Puig, Anna/0000-0002-5253-3808; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Bassols, Judit/0000-0001-8821-6655; Carreras-Badosa, Gemma/0000-0003-2100-0221; Lopez-Bermejo, Abel/0000-0002-5828-8911	National Institute of Health Carlos III (Health Research Fund, Spain) [10/00553, 15/01934]; European Regional Development Fund	National Institute of Health Carlos III (Health Research Fund, Spain); European Regional Development Fund(European Commission)	This work was supported by grant numbers 10/00553 (to AL-B) and 15/01934 (to JMF-R) from the National Institute of Health Carlos III (Health Research Fund, Spain), a project funded in part by the European Regional Development Fund.	Abril-Ulloa V, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-483; Adams PC, 2011, J HEPATOL, V55, P453, DOI 10.1016/j.jhep.2011.02.010; Aeberli I, 2009, INT J OBESITY, V33, P1111, DOI 10.1038/ijo.2009.146; ARGUELLES B, 1994, NEFROLOGIA, V14, P175; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Carrascosa Lezcano A, 2008, An Pediatr (Barc), V68, P552; Civera M, 2010, DIABETES-METAB RES, V26, P187, DOI 10.1002/dmrr.1070; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Facchini FS, 1998, METABOLISM, V47, P831, DOI 10.1016/S0026-0495(98)90121-4; Festi D, 2004, Obes Rev, V5, P27, DOI 10.1111/j.1467-789X.2004.00126.x; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Garcia-Valls Marisol, 2010, 2010 10th Annual International Conference on New Technologies of Distributed Systems (NOTERE), P267, DOI 10.1109/NOTERE.2010.5536645; Goncalves CG, 2016, NUTRITION, V32, P14, DOI 10.1016/j.nut.2015.07.010; Han LL, 2014, MOL NUTR FOOD RES, V58, P2189, DOI 10.1002/mnfr.201400088; Hutchinson C, 2016, EUR J NUTR, V55, P2179, DOI 10.1007/s00394-016-1155-7; Jeon Yeon Jin, 2013, Ann Pediatr Endocrinol Metab, V18, P141, DOI 10.6065/apem.2013.18.3.141; Khan A, 2016, J OBES, V2016, DOI 10.1155/2016/1937320; Lohmann TAG, 1988, ANTHROPOMETRIC STAND, P177; Fernandez-Real JM, 2015, DIABETES CARE, V38, P2169, DOI 10.2337/dc14-3082; Fernandez-Real JM, 2014, LANCET DIABETES ENDO, V2, P513, DOI 10.1016/S2213-8587(13)70174-8; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Martinez-Gomez D, 2009, GAC SANIT, V23, P512, DOI 10.1016/j.gaceta.2009.02.013; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McMorrow AM, 2015, P NUTR SOC, V74, P67, DOI 10.1017/S002966511400158X; Menzie CM, 2008, J AM DIET ASSOC, V108, P145, DOI 10.1016/j.jada.2007.10.034; Messier V, 2010, OBESITY, V18, P911, DOI 10.1038/oby.2009.364; National Heart Lung and Blood Institute, 2015, BLOOD PRESS TABL CHI; Okuda M, 2011, J PEDIATR GASTR NUTR, V52, P333, DOI 10.1097/MPG.0b013e318201aecc; Park SK, 2014, ENDOCR J, V61, P215, DOI 10.1507/endocrj.EJ13-0173; Podmore C, 2016, DIABETES CARE, V39, P572, DOI 10.2337/dc15-0257; Prince RL, 2014, DIABETES CARE, V37, P1462, DOI 10.2337/dc13-1697; Serra-Majem L, 2004, PUBLIC HEALTH NUTR, V7, P931, DOI 10.1079/PHN2004556; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Tanoglu A, 2015, EUR J GASTROEN HEPAT, V27, P1126, DOI 10.1097/MEG.0000000000000434; Tussing-Humphreys LM, 2010, OBESITY, V18, P1449, DOI 10.1038/oby.2009.319; Wlazlo N, 2013, DIABETES CARE, V36, P309, DOI 10.2337/dc12-0505; Zhao L, 2015, OBES REV, V16, P1081, DOI 10.1111/obr.12323; Zhu N, 2010, J CLIN ENDOCR METAB, V95, P5097, DOI 10.1210/jc.2010-0716; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	42	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	APR	2019	27	4					636	644		10.1002/oby.22425	http://dx.doi.org/10.1002/oby.22425			9	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	HQ1IR	30821086				2022-09-04	WOS:000462152000016
J	Delgado-Serrano, MD; Oteros-Rozas, E; Ruiz-Mallen, I; Calvo-Boyero, D; Ortiz-Guerrero, CE; Escalante-Semerena, RI; Corbera, E				del Mar Delgado-Serrano, Maria; Oteros-Rozas, Elisa; Ruiz-Mallen, Isabel; Calvo-Boyero, Diana; Enrique Ortiz-Guerrero, Cesar; Ivan Escalante-Semerena, Roberto; Corbera, Esteve			Influence of community-based natural resource management strategies in the resilience of social-ecological systems	REGIONAL ENVIRONMENTAL CHANGE			English	Article						Adaptation; Environmental challenges; Global change; Rural communities; Social-ecological systems	POLITICAL-ECONOMY; GOVERNANCE; OPPORTUNITIES; CONSERVATION; PARTICIPATION; ADAPTATION; CHALLENGES; KNOWLEDGE; COMMONS; TRENDS	Different social-ecological systems around the world are managed under community-based natural resource management (CBNRM) strategies. This paper analyses how CBNRM strategies influence the resilience of social-ecological systems to the disturbances they face, drawing upon the experience of three Latin American cases (two in Mexico and one in Colombia). The cases differ in their CBNRM approach and in the time these governance systems have been in place. By using a mixed-method approach, we review the socio-ecological history and describe each CBNRM characteristics. We then assess their resilience to socioeconomic and environmental disturbances through a set of indicators. We found that CBNRM strategies influence positively and negatively resilience and that internal decisions might address important threats. On the positive side, the social-ecological systems with longer tradition of CBNRM and more local buy-in of commonly agreed objectives appear to be more resilient to environmental challenges. But, internal governance factors such as power imbalances, poor income distribution, and gender inequities linked to CBNRM undermine resilience and foster out migration. Finally, communities appear to have limited capacities to cope with external disturbances such as global drivers of change or national policies that negatively affect their social-ecological resilience.	[del Mar Delgado-Serrano, Maria] Univ Cordoba, Dept Agr Econ, Campus Rabanales,C5,Planta 3, E-14071 Cordoba, Spain; [Oteros-Rozas, Elisa] Univ Pablo Olavide, Social & Participatory Act Res Grp, Seville, Spain; [Oteros-Rozas, Elisa] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Ruiz-Mallen, Isabel] Univ Oberta Catalunya, Internet Interdisciplinary Inst IN3, Barcelona, Spain; [Ruiz-Mallen, Isabel; Calvo-Boyero, Diana; Corbera, Esteve] Univ Autonoma Barcelona, Inst Environm Sci & Technol, Barcelona, Spain; [Enrique Ortiz-Guerrero, Cesar] Pontificia Univ Javeriana, Bogota, Colombia; [Ivan Escalante-Semerena, Roberto] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico		Delgado-Serrano, MD (corresponding author), Univ Cordoba, Dept Agr Econ, Campus Rabanales,C5,Planta 3, E-14071 Cordoba, Spain.	mmdelgado@uco.es	Oteros-Rozas, Elisa/L-8633-2014; Corbera, Esteve/C-5368-2015; del mar delgado-serrano, maria/B-7581-2011; Ruiz-Mallen, Isabel/E-9614-2018	Oteros-Rozas, Elisa/0000-0003-4313-3041; Corbera, Esteve/0000-0001-7970-4411; del mar delgado-serrano, maria/0000-0003-0171-6097; Ruiz-Mallen, Isabel/0000-0002-9679-3329	European Commission [FP7-ENV2011-282845 COMET-LA, FP7-ENV-2011-282899 COMBIOSERVE]; UAB-Banco de Santander Talent Retention Programme; Spanish government's Research Agency through a "Ramon y Cajal" research fellowship [RYC-2015-17676]	European Commission(European CommissionEuropean Commission Joint Research Centre); UAB-Banco de Santander Talent Retention Programme; Spanish government's Research Agency through a "Ramon y Cajal" research fellowship	This research was funded by the Seventh Framework Programme of the European Commission in the frame of the projects "Community-based management of environmental challenges in Latin America- FP7-ENV2011-282845 COMET-LA" and "Assessing the effectiveness of community-based management strategies for biocultural diversity conservation- FP7-ENV-2011-282899 COMBIOSERVE". EC acknowledges the financial support of the UAB-Banco de Santander Talent Retention Programme and EOR acknowledges the Andalusia Talent Hub postdoctoral program. We also acknowledge the collaboration of the people in the Community Council Alto y Medio Dagua (Colombia), Santiago Comaltepec (Mexico), and Once de Mayo (Mexico) in the research. IRM acknowledges the financial support of the Spanish government's Research Agency through a "Ramon y Cajal" research fellowship (RYC-2015-17676).	Adger WN, 2000, PROG HUM GEOG, V24, P347, DOI 10.1191/030913200701540465; Agarwal B, 2009, ECOL ECON, V68, P2785, DOI 10.1016/j.ecolecon.2009.04.025; Agrawal A, 2006, WORLD DEV, V34, P149, DOI 10.1016/j.worlddev.2005.07.013; Almeida-Lenero L, 2017, ENVIRON CONSERV, V44, P201, DOI 10.1017/S0376892916000564; AMDA-CVC (Consejo Comunitario de la Comunidad Negra de la Parte Alta y Media de la Cuenca del Rio Dagua and Corporacion Autonoma Regional del Valle), 2007, FORM PLAN ADM MAN RE; Anderies JM, 2006, ECOL SOC, V11; Armitage D, 2005, ENVIRON MANAGE, V35, P703, DOI 10.1007/s00267-004-0076-z; Baggio JA, 2015, ECOL SOC, V20, DOI 10.5751/ES-07484-200202; Basurto X, 2013, GLOBAL ENVIRON CHANG, V23, P1366, DOI 10.1016/j.gloenvcha.2013.08.001; Bergamini N., 2013, INDICATORS RESILIENC; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Berkes F., 2000, LINKING SOCIAL ECOLO; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Berkes F, 2010, ENVIRON CONSERV, V37, P489, DOI 10.1017/S037689291000072X; Biggs R., 2015, PRINCIPLES BUILDING, DOI 10.1017/CBO9781316014240; Blaikie P, 2006, WORLD DEV, V34, P1942, DOI 10.1016/j.worlddev.2005.11.023; Broderstad EG, 2014, ECOL SOC, V19, DOI 10.5751/ES-06533-190301; Brondizio ES, 2016, SCIENCE, V352, P1272, DOI 10.1126/science.aaf5122; Campbell LM, 2003, HUM ECOL, V31, P417, DOI 10.1023/A:1025071822388; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2009, ECOL SOC, V14; CHAPELA FJ, 1993, IMPACTO POLITICA FOR; Colding J, 2003, NAVIGATING SOCIAL EC, P163; Corbera E, 2007, DEV CHANGE, V38, P587, DOI 10.1111/j.1467-7660.2007.00425.x; Cosens B, 2014, SUSTAINABILITY-BASEL, V6, P2338, DOI 10.3390/su6042338; Cotula L, 2012, J PEASANT STUD, V39, P649, DOI 10.1080/03066150.2012.674940; Cox M, 2010, ECOL SOC, V15; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006253; Dauvergne P, 2010, J PEASANT STUD, V37, P631, DOI 10.1080/03066150.2010.512451; Delgado-Serrano MD, 2017, ECOL SOC, V22, DOI 10.5751/ES-08924-220104; Delgado-Serrano MD, 2015, AGER, P91, DOI 10.4422/ager.2015.07; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Duit A, 2010, GLOBAL ENVIRON CHANG, V20, P363, DOI 10.1016/j.gloenvcha.2010.04.006; Escalante R, 2015, COMMUNITY BASED SUST; Fabricius C., 2004, RIGHTS RESOURCES RUR, P3; Fischer J, 2006, FRONT ECOL ENVIRON, V4, P80, DOI 10.1890/1540-9295(2006)004[0080:BEFART]2.0.CO;2; Fleischman FD, 2010, ECOL SOC, V15; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Folke C., 2003, NAVIGATING SOCIAL EC, V9, P352, DOI DOI 10.1017/CBO9780511541957.020; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Folke C, 2016, ECOL SOC, V21, DOI 10.5751/ES-09088-210444; Garmestani AS, 2013, ECOL SOC, V18, DOI 10.5751/ES-05180-180109; Gomez-Baggethun E, 2009, P 8 INT C EUR SOC EC; Gomez-Baggethun E, 2012, GLOBAL ENVIRON CHANG, V22, P640, DOI 10.1016/j.gloenvcha.2012.02.005; Gunderson L. H, 2001, PANARCHY UNDERSTANDI; Haenn N, 2006, LAND USE POLICY, V23, P136, DOI 10.1016/j.landusepol.2004.07.002; Hayes TM, 2007, HUM ECOL, V35, P733, DOI 10.1007/s10745-007-9117-6; Holling C. S., 2003, NAVIGATING SOCIAL EC, pxv; INE, 1999, PROGR MAN RES BIOS C; INEC, 2010, CENS POBL VIV 2010; Josserand H., 2001, COMMUNITY BASED NATU; Kellert SR, 2000, SOC NATUR RESOUR, V13, P705, DOI 10.1080/089419200750035575; Kinzig AP, 2013, BIOSCIENCE, V63, P164, DOI 10.1525/bio.2013.63.3.5; Leach M, 1999, WORLD DEV, V27, P225, DOI 10.1016/S0305-750X(98)00141-7; McLellan Eleanor, 1998, FIELD METHOD, V10, P31, DOI 10.1177/1525822X980100020301; Nellemann C., 2011, WOMEN FRONTLINE CLIM, P32; Nelson DR, 2007, ANNU REV ENV RESOUR, V32, P395, DOI 10.1146/annurev.energy.32.051807.090348; Olsson P, 2004, ECOL SOC, V9; Olsson P, 2006, ECOL SOC, V11, DOI 10.5751/ES-01595-110118; Ortiz-Guerrero C, 2015, COMMUNITY BASED SUST; Ostrom, 1999, 20 CIFOR OSTR; Ostrom, 1990, GOVERNING COMMONS EV; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Ratajczyk E, 2016, INT J COMMONS, V10, P440, DOI 10.18352/ijc.652; Ruiz-Mallen I, 2015, ECOL SOC, V20, DOI 10.5751/ES-07733-200333; Ruiz-Mallen I, 2015, GLOBAL ENVIRON CHANG, V33, P97, DOI 10.1016/j.gloenvcha.2015.05.002; Ruiz-Mallen I, 2013, ECOL SOC, V18, DOI 10.5751/ES-05867-180412; Schmook B, 2013, HUM ECOL, V41, P93, DOI 10.1007/s10745-012-9557-5; Shackleton CM, 2010, ENVIRON CONSERV, V37, P1, DOI 10.1017/S0376892910000366; Stoll-Kleemann S., 2006, PERSPECT BIODIVERS G, V1, P40; Tengo M., 2003, NAVIGATING SOCIAL EC, P132; Voss JP, 2006, REFLEXIVE GOVERNANCE FOR SUSTAINABLE DEVELOPMENT, P1; Western D., 1994, NATURAL CONNECTIONS; Zanetell BA, 2004, WORLD DEV, V32, P793, DOI 10.1016/j.worlddev.2004.01.002	74	10	11	2	70	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1436-3798	1436-378X		REG ENVIRON CHANGE	Reg. Envir. Chang.	FEB	2018	18	2			SI		581	592		10.1007/s10113-017-1223-4	http://dx.doi.org/10.1007/s10113-017-1223-4			12	Environmental Sciences; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology	FV5SS					2022-09-04	WOS:000424643300024
J	de Luna, AG; Link, A; Montes, A; Alfonso, F; Mendieta, L; Di Fiore, A				Gabriela de Luna, Ana; Link, Andres; Montes, Andres; Alfonso, Felipe; Mendieta, Leonardo; Di Fiore, Anthony			Increased folivory in brown spider monkeys Ateles hybridus living in a fragmented forest in Colombia	ENDANGERED SPECIES RESEARCH			English	Article						Behavioral flexibility; Ficus; Habitat fragmentation; Leaf consumption	FISSION-FUSION DYNAMICS; RAIN-FOREST; ASSOCIATION PATTERNS; FEEDING ECOLOGY; SEED DISPERSAL; DIET; GEOPHAGY; ALOUATTA; DENSITY; DEFORESTATION	Brown spider monkeys Ateles hybridus are one of the most threatened primates in the Neotropics. Most of the remaining populations of this species already live either in forest fragments or in areas that face imminent anthropogenic disturbance. Understanding how these animals cope with the challenge of living in small fragments, while at the same time being a large, frugivorous mammal is crucial to design effective conservation and management strategies. We studied the diet of wild A. hybridus and measured forest productivity in a small (similar to 65 ha) fragment in the Magdalena Region of northern Colombia over a period of 26 mo. Spider monkeys at this site spent far less time feeding on fruits than reported in previous studies of Ateles spp. living in less fragmented sites. Moreover, we registered a high consumption of leaves in every month (on average 37% of their feeding time) as well as the consistent inclusion of decayed wood in the diet. Ficus trees can be considered staple feeding items, as they were present in high proportions in the monkeys' diet throughout the study. Although wild populations of spider monkeys can have flexible diets that include large proportions of leaves over long periods of time, they may also be exposed to a suboptimal diet which may have negative implications for their reproduction and well-being in the long run, further compromising the viability of wild populations living in disturbed habitats.	[Gabriela de Luna, Ana] Univ Complutense Madrid, Dept Biol & Antropol Fis, Calle Jose Antonio Novais 2,Ciudad Univ, E-28040 Madrid, Spain; [Gabriela de Luna, Ana; Link, Andres; Montes, Andres; Alfonso, Felipe; Mendieta, Leonardo; Di Fiore, Anthony] Fdn Proyecto Primates, Cra 11A 91-55, Bogota, Colombia; [Link, Andres] Univ Los Andes, Dept Ciencias Biol, Cra 1 18A-12, Bogota, Colombia; [Link, Andres] Univ Los Andes, Fac Adm, Cra 1 18A-12, Bogota, Colombia; [Montes, Andres] Univ Tolima, Dept Biol, Barrio Santa Helena Parte Alta 730006299 Ibague, Tolima, Colombia; [Alfonso, Felipe] Pontificia Univ Javeriana, Dept Biol, Carrera 7 40-62, Bogota, Colombia; [Mendieta, Leonardo] Univ Caldas, Dept Biol, Calle 65 26-10, Manizales, Colombia; [Di Fiore, Anthony] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA		Link, A (corresponding author), Fdn Proyecto Primates, Cra 11A 91-55, Bogota, Colombia.; Link, A (corresponding author), Univ Los Andes, Dept Ciencias Biol, Cra 1 18A-12, Bogota, Colombia.; Link, A (corresponding author), Univ Los Andes, Fac Adm, Cra 1 18A-12, Bogota, Colombia.	a.link74@uniandes.edu.co		de Luna, Ana Gabriela/0000-0002-3006-7041	WCS-Research Fellowship Programme; Rufford Small Grants Foundation; Primate Conservation Inc.; Primate Action Fund; National Geographic Society-CRE; National Science Foundation [BCS1025675]	WCS-Research Fellowship Programme; Rufford Small Grants Foundation; Primate Conservation Inc.; Primate Action Fund; National Geographic Society-CRE(National Geographic Society); National Science Foundation(National Science Foundation (NSF))	We thank all students and collaborators of Fundacion Proyecto Primates who contributed to the long-term study and conservation of brown spider monkeys at San Juan de Carare. We are grateful to the Lalinde and De Greiff families for allowing us to conduct research at San Juan de Carare since 2007. We also thank the editor and 3 anonymous reviewers who significantly contributed to the final version of the manuscript. This project was funded by WCS-Research Fellowship Programme, Rufford Small Grants Foundation, Primate Conservation Inc., Primate Action Fund, National Geographic Society-CRE and the National Science Foundation BCS1025675.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 1980, ACTA AMAZON, DOI DOI 10.1590/1809-43921985155238; [Anonymous], 2016, ALOPIAS SUPERCILIOSU, DOI 10.2305/IUCN.UK.2021-1.RLTS.T59103A177612384.en; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Arroyo-Rodriguez V, 2013, LANDSCAPE ECOL, V28, P1717, DOI 10.1007/s10980-013-9929-2; Asensio N, 2008, BEHAVIOUR, V145, P983, DOI 10.1163/156853908784089234; Asensio N, 2009, BEHAV ECOL SOCIOBIOL, V63, P649, DOI 10.1007/s00265-008-0699-9; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Campbell C., 2000, THESIS; Cant JGH, 1977, THESIS; Castellanos HG, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P451; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; CHAPMAN CA, 1990, BEHAV ECOL SOCIOBIOL, V26, P409; CHAPMAN CA, 1990, B TORREY BOT CLUB, V117, P226, DOI 10.2307/2996691; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; Chapman CA, 2013, DEV PRIMATOL-PROG PR, P89, DOI 10.1007/978-1-4614-8839-2_7; Chaves OM, 2012, BIOTROPICA, V44, P105, DOI 10.1111/j.1744-7429.2011.00766.x; Chaves OM, 2011, INT J PRIMATOL, V32, P960, DOI 10.1007/s10764-011-9515-x; Di Fiore A, 2008, CAM S BIO EVOL ANTHR, V55, P81; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Felton AM, 2008, INT J PRIMATOL, V29, P379, DOI 10.1007/s10764-008-9241-1; Ferrari SF, 2008, FOLIA PRIMATOL, V79, P402, DOI 10.1159/000141901; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Ganzhorn SM, 2015, ENDANGER SPECIES RES, V26, P189, DOI 10.3354/esr00645; Hill JL, 2003, J BIOGEOGR, V30, P1391, DOI 10.1046/j.1365-2699.2003.00930.x; Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796; IZAWA K, 1993, INT J PRIMATOL, V14, P229, DOI 10.1007/BF02192633; Klein L. L, 1977, P153; Krebs C., 2014, ECOLOGICAL METHODOLO; Krishnamani R, 2000, ANIM BEHAV, V59, P899, DOI 10.1006/anbe.1999.1376; Lehmann J, 2004, BEHAV ECOL SOCIOBIOL, V56, P207, DOI 10.1007/s00265-004-0781-x; Link A., 2013, PRIMATES COLOMBIANOS, P88; Link A, 2006, J TROP ECOL, V22, P235, DOI 10.1017/S0266467405003081; Link Andres, 2003, Neotropical Primates, V11, P104; Link A, 2012, AM J PRIMATOL, V74, P1097, DOI 10.1002/ajp.22066; Link A, 2011, FOLIA PRIMATOL, V82, P25, DOI 10.1159/000326056; Link Andres, 2010, Endangered Species Research, V13, P41, DOI 10.3354/esr00312; Link A, 2011, AM J PRIMATOL, V73, P386, DOI 10.1002/ajp.20910; Marsh LK, 2013, DEV PRIMATOL-PROG PR, P503, DOI 10.1007/978-1-4614-8839-2_34; Mbora DNM, 2015, CONSERV GENET, V16, P559, DOI 10.1007/s10592-014-0680-2; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Mittermeier Russell A., 2009, Primate Conservation, V24, P1; Nunes A, 1998, FOLIA PRIMATOL, V69, P61, DOI 10.1159/000021573; Rimbach R, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0110; ROSENBERGER AL, 1989, J HUM EVOL, V18, P717, DOI 10.1016/0047-2484(89)90102-4; Russo SE, 2005, INT J PRIMATOL, V26, P1017, DOI 10.1007/s10764-005-6456-2; Shimooka Y, 2003, PRIMATES, V44, P83, DOI 10.1007/s10329-002-0028-2; Steenbeek R, 1999, BEHAVIOUR, V136, P627, DOI 10.1163/156853999501496; Stevenson P.R., 2002, THESIS, P344; Stevenson PR, 2000, BIOTROPICA, V32, P533, DOI 10.1111/j.1744-7429.2000.tb00499.x; Stevenson PR, 2011, HIPOTESIS, V12, P29; Suarez SA, 2006, INT J PRIMATOL, V27, P411, DOI 10.1007/s10764-006-9023-6; Symington M. M., 1987, THESIS; SYMINGTON MM, 1990, INT J PRIMATOL, V11, P47, DOI 10.1007/BF02193695; TEMPLETON AR, 1990, ANN MO BOT GARD, V77, P13, DOI 10.2307/2399621; Villanueva B, 2008, THESIS; Wallace RB, 2005, INT J PRIMATOL, V26, P1053, DOI 10.1007/s10764-005-6458-4	61	5	6	0	31	INTER-RESEARCH	OLDENDORF LUHE	NORDBUNTE 23, D-21385 OLDENDORF LUHE, GERMANY	1863-5407	1613-4796		ENDANGER SPECIES RES	Endanger. Species Res.		2017	32						123	134		10.3354/esr00787	http://dx.doi.org/10.3354/esr00787			12	Biodiversity Conservation	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation	EN0ED		gold, Green Submitted			2022-09-04	WOS:000395682200011
J	Gonzalez, E; Merkoci, F; Arenal, R; Arbiol, J; Esteve, J; Bastus, NG; Puntes, V				Gonzalez, Edgar; Merkoci, Florind; Arenal, Raul; Arbiol, Jordi; Esteve, Joan; Bastus, Neus G.; Puntes, Victor			Enhanced reactivity of high-index surface platinum hollow nanocrystals	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							SHAPE-CONTROLLED SYNTHESIS; GALVANIC REPLACEMENT; BIMETALLIC NANOPARTICLES; SILVER NANOPARTICLES; CATALYTIC-ACTIVITY; OXYGEN; NANOSTRUCTURES; AG; NANOCAGES; GOLD	The precise morphological control of the surface of inorganic nanocrystals (NCs) is critical for the understanding of the unique properties of the materials at the nanoscale and useful in a wide range of applications, such as catalysis, where the development of highly active and low-cost materials represents a landmark for the development of industrial technologies. Here we show how combining solid state chemistry and colloidal synthesis allows us to prepare exotic materials, in particular, PtAg@Pt single-crystal hollow NCs with high-index planes synthesized at room temperature by controlled corrosion of silver templates, which minimize Pt consumption and maximize surface reactivity.	[Gonzalez, Edgar; Merkoci, Florind; Bastus, Neus G.; Puntes, Victor] ICN, Bellaterra 08193, Spain; [Gonzalez, Edgar] Ctr Ciencia & Tecnol Nanoescalar, Bogota 111311, Colombia; [Gonzalez, Edgar] Pontificia Univ Javeriana, Inst Geofis, Fac Ingn, Bogota 110231, Colombia; [Arenal, Raul] Univ Zaragoza, Inst Nanociencia Aragon, Zaragoza 50018, Spain; [Arenal, Raul] ARAID Fdn, Zaragoza 50004, Spain; [Arbiol, Jordi] Inst Ciencia Mat Barcelona ICMAB CSIC, Bellaterra 08193, Spain; [Arbiol, Jordi; Puntes, Victor] ICREA, Barcelona 08010, Spain; [Esteve, Joan] Univ Barcelona, Dept Fis Aplicada & Opt, E-08028 Barcelona, Spain		Puntes, V (corresponding author), ICN, Campus UAB, Bellaterra 08193, Spain.	victor.puntes@icn.cat	Arbiol, Jordi/B-6048-2008; Puntes, Victor/AAL-6081-2021; Bastús, Neus G./AAK-8755-2020; Arenal, Raul/GPW-8689-2022; Bastús, Neus G./J-2407-2012; Puntes, Víctor F./F-8407-2013; Arenal, Raul/AAO-1882-2021; Esteve, Joan/L-5056-2014	Arbiol, Jordi/0000-0002-0695-1726; Puntes, Victor/0000-0001-8996-9499; Bastús, Neus G./0000-0002-3144-7986; Arenal, Raul/0000-0002-2071-9093; Bastús, Neus G./0000-0002-3144-7986; Puntes, Víctor F./0000-0001-8996-9499; Arenal, Raul/0000-0002-2071-9093; Gonzalez, Edgar E/0000-0003-3103-3959; Esteve, Joan/0000-0003-1469-9847	grant XaRMAE; NanoAraCat; Juan de la Cierva program [JCI-2011-09678]; European Commission for the Career Integration Grant Marie Curie Action [322153-MINE];  [2009 SGR 770];  [2009 SGR 776];  [2014 SGR 612];  [2014 SGR 1638];  [CSD2009-00013];  [MAT2006-13572-C02-02];  [MAT2009-14734-C02-01];  [MAT2010-15138];  [MAT2012-33330];  [MAT2014-51480-ERC];  [VALTEC09-2-0085];  [VALTEC09-2-0089]; ICREA Funding Source: Custom	grant XaRMAE; NanoAraCat; Juan de la Cierva program; European Commission for the Career Integration Grant Marie Curie Action; ; ; ; ; ; ; ; ; ; ; ; ; ICREA(ICREA)	The authors acknowledge funding from grants 2009 SGR 770, 2009 SGR 776, 2014 SGR 612, 2014 SGR 1638, XaRMAE, CSD2009-00013, MAT2006-13572-C02-02, MAT2009-14734-C02-01, MAT2010-15138, MAT2012-33330, MAT2014-51480-ERC, VALTEC09-2-0085 and VALTEC09-2-0089. J. A. acknowledges NanoAraCat funding for the use of advanced (S)TEM facilities at Instituto de Nanociencia de Aragon-Laboratorio de Microscopia Avanzada. N. G. B. acknowledges financial support through the Juan de la Cierva program (JCI-2011-09678) and European Commission for the Career Integration Grant (322153-MINE) Marie Curie Action. A patent application related to this work was filed on 14 March 2011 (European Union application number EP11158024.7).	Bastus NG, 2014, CHEM MATER, V26, P2836, DOI 10.1021/cm500316k; Catalan G, 2011, NAT MATER, V10, P963, DOI [10.1038/nmat3141, 10.1038/NMAT3141]; Chang LY, 2010, NANO LETT, V10, P3073, DOI 10.1021/nl101642f; Chen HM, 2008, J PHYS CHEM C, V112, P7522, DOI 10.1021/jp8017698; Chen JY, 2009, NANO TODAY, V4, P81, DOI 10.1016/j.nantod.2008.09.002; Chen JY, 2005, ADV MATER, V17, P2255, DOI 10.1002/adma.200500833; Chen JY, 2005, NANO LETT, V5, P2058, DOI 10.1021/nl051652u; Chen ZW, 2007, ANGEW CHEM INT EDIT, V46, P4060, DOI 10.1002/anie.200700894; de Bruijn FA, 2008, FUEL CELLS, V8, P3, DOI 10.1002/fuce.200700053; Ferreira PJ, 2005, J ELECTROCHEM SOC, V152, pA2256, DOI 10.1149/1.2050347; Gao JN, 2007, SCRIPTA MATER, V57, P687, DOI 10.1016/j.scriptamat.2007.06.049; Gonzalez E, 2011, SCIENCE, V334, P1377, DOI 10.1126/science.1212822; Gu J, 2012, CHEM SOC REV, V41, P8050, DOI 10.1039/c2cs35184f; Guisbiers G, 2011, J PHYS CHEM C, V115, P2616, DOI 10.1021/jp108041q; Liang H.-P., 2004, ANGEW CHEM, V116, P1566, DOI DOI 10.1002/ange.200352956; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Lim SI, 2010, NANO LETT, V10, P964, DOI 10.1021/nl100032c; LIZ-MARZAN LM, 1995, J PHYS CHEM-US, V99, P15120, DOI 10.1021/j100041a031; Lou XW, 2008, ADV MATER, V20, P3987, DOI 10.1002/adma.200800854; Peng ZM, 2008, J SOLID STATE CHEM, V181, P1546, DOI 10.1016/j.jssc.2008.03.013; Peng ZM, 2010, ADV FUNCT MATER, V20, P3734, DOI 10.1002/adfm.201001194; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Porter NS, 2013, ACCOUNTS CHEM RES, V46, P1867, DOI 10.1021/ar3002238; Qin GWW, 2010, J PHYS CHEM C, V114, P6909, DOI 10.1021/jp910864w; Shen YY, 2014, J MATER CHEM A, V2, P2977, DOI 10.1039/c3ta14502f; SOMORJAI GA, 1975, NATURE, V258, P580, DOI 10.1038/258580a0; Somorjai GA, 2006, P NATL ACAD SCI USA, V103, P10577, DOI 10.1073/pnas.0507691103; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Wang L, 2013, J AM CHEM SOC, V135, P16762, DOI 10.1021/ja407773x; Wanjala BN, 2010, CHEM MATER, V22, P4282, DOI 10.1021/cm101109e; Wiley B, 2004, NANO LETT, V4, P1733, DOI 10.1021/nl048912c; Wu JB, 2013, ACCOUNTS CHEM RES, V46, P1848, DOI 10.1021/ar300359w; Xia BY, 2013, ANGEW CHEM INT EDIT, V52, P12337, DOI 10.1002/anie.201307518; Xia XH, 2013, ADV MATER, V25, P6313, DOI 10.1002/adma.201302820; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165; Yin YD, 2006, ADV FUNCT MATER, V16, P1389, DOI 10.1002/adfm.200600256; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; Yu T, 2011, ANGEW CHEM INT EDIT, V50, P2773, DOI 10.1002/anie.201007859; Yu TY, 2010, ADV MATER, V22, P5188, DOI 10.1002/adma.201002763; Yu XL, 2014, J AM CHEM SOC, V136, P9236, DOI 10.1021/ja502076b; Yu Y, 2014, ACCOUNTS CHEM RES, V47, P3530, DOI 10.1021/ar5002704; Zeng J, 2010, NANO LETT, V10, P30, DOI 10.1021/nl903062e; Zhang H, 2012, CHEM SOC REV, V41, P8035, DOI 10.1039/c2cs35173k; Zhang L, 2015, SCIENCE, V349, P412, DOI 10.1126/science.aab0801; Zhang QB, 2008, SMALL, V4, P1067, DOI 10.1002/smll.200701196; Zhang WQ, 2012, ACS NANO, V6, P7397, DOI 10.1021/nn302590k	47	29	30	0	90	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2016	4	1					200	208		10.1039/c5ta07504a	http://dx.doi.org/10.1039/c5ta07504a			9	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Energy & Fuels; Materials Science	CZ0VX					2022-09-04	WOS:000366825300020
J	Vinueza, R; Boissonnet, CP; Acevedo, M; Uriza, F; Benitez, FJ; Silva, H; Schargrodsky, H; Champagne, B; Wilson, E				Vinueza, Raul; Pablo Boissonnet, Carlos; Acevedo, Monica; Uriza, Felipe; Jose Benitez, Francisco; Silva, Honorio; Schargrodsky, Herman; Champagne, Beatriz; Wilson, Elinor		CARMELA Study Investigators	Dyslipidemia in seven Latin American cities: CARMELA study	PREVENTIVE MEDICINE			English	Article						Dyslipidemia; Urban population; Cross-sectional studies; Latin America	DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; RISK-FACTORS; CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; FOLLOW-UP; PREVALENCE; PREVENTION; INTERVENTIONS	Objective. The objective of this study was to describe the prevalence of dyslipidemia in the CARMELA study population. Methods. CARMELA was a cross-sectional study of cardiovascular risk conducted between September 2003 and August 2005 in adults (aged 25 to 64 years) living in Barquisimeto (n = 1,824), Bogot (n = 1,511), Buenos Aires (n = 1,412), Lima (n = 1,628), Mexico City (n = 1,677), Quito (n = 1,620), and Santiago (n = 1,605). Dyslipidemia was defined as the presence of one or more of the following conditions: triglycerides >= 200 mg/dL, or total cholesterol (TC) >= 240 mg/dL, or HDL cholesterol < 40 mg/dL, or LDL cholesterol = not optimal, or currently taking antilipemic agents. Results. Prevalence rates of dyslipidemia in men and women were: 75.5% (CI: 71.9-79.1) and 48.7% (CI: 45.4-51.9) in Barquisimeto: 70% (CI: 66.2-73.8) and 47.7% (CI: 43.9-51.5) in Bogota; 50.4% (CI: 46.8-54.0) and 24.1% (CI: 21.0-27.2) in Buenos Aires: 73.1% (CI: 69.3-76.8) and 62.8% (CI: 59.2-66.5) in Lima; 62.5% (CI: 58.5-66.5) and 37.5% (CI: 33.5-41.6) in Mexico City; 52.2% (CI: 47.9-56.5) and 38.1% (CI: 34.5-41.7) in Quito: and, 50.8% (CI: 47.1-54.4) and 32.8% (CI: 29.3-36.3) in Santiago. Conclusions. Dyslipidemia was disturbingly prevalent and varied across cities. The most frequent dyslipidemia was low HDL-C followed by high triglycerides. The high TC/HDL-C ratios and non-HDL-C levels suggest a high risk of cardiovascular disease. (C) 2009 Elsevier Inc. All rights reserved.	[Vinueza, Raul; Silva, Honorio] InterAmer Fdn Clin Res, New York, NY 10017 USA; [Pablo Boissonnet, Carlos] Ctr Educ Med & Invest Clin Norberto Quirno, Coronary Care Unit, Buenos Aires, DF, Argentina; [Acevedo, Monica] Pontificia Univ Catolica Chile, Dept Cardiovasc Dis, Santiago, Chile; [Uriza, Felipe] Pontificia Univ Javeriana, Bogota, Colombia; [Jose Benitez, Francisco] Hosp Metropolitano Quito, Serv Cardiol, Quito, Ecuador; [Schargrodsky, Herman] Hosp Italiano Buenos Aires, Dept Cardiol, Buenos Aires, DF, Argentina; [Champagne, Beatriz] InterAmer Heart Fdn, Dallas, TX USA; [Wilson, Elinor] Univ Rochester, Sch Med & Dent, Dept Community & Prevent Hlth, Rochester, NY USA		Vinueza, R (corresponding author), InterAmer Fdn Clin Res, 708 3rd Ave,6th Floor, New York, NY 10017 USA.	raulvinueza@yahoo.com		Acevedo, Monica/0000-0002-7989-6633; Uriza Carrasco, Luis Felipe/0000-0002-1923-3934	Pfizer Inc.	Pfizer Inc.(Pfizer)	The CARMELA study was funded by Pfizer Inc.	AlNuaim AR, 1997, INT J CARDIOL, V58, P141, DOI 10.1016/S0167-5273(96)02850-1; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Assmann G, 1998, EUR HEART J, V19, pA2; BAUTISTA L, 2006, EUROPEAN J CARDIOVAS, V13; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Bittner V, 2002, CIRCULATION, V106, P2537, DOI 10.1161/01.CIR.0000038496.57570.06; Bonita R., 2001, SURVEILLANCE RISK FA; CAMPOS H, 1992, CIRCULATION, V85, P648, DOI 10.1161/01.CIR.85.2.648; Castelli WP, 1996, ATHEROSCLEROSIS, V124, pS1, DOI 10.1016/0021-9150(96)05851-0; Ciruzzi M, 2003, MEDICINA-BUENOS AIRE, V63, P697; Criqui MH, 1998, AM J MED, V105, p48S, DOI DOI 10.1016/S0002-9343(98)00212-5; Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413; Souza Luiz José de, 2003, Arq. Bras. Cardiol., V81, P257, DOI 10.1590/S0066-782X2003001100005; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Ezzati M, 2004, LANCET, V364, P912, DOI 10.1016/S0140-6736(04)17035-9; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GROVER SA, 1994, ARCH INTERN MED, V154, P679, DOI 10.1001/archinte.154.6.679; Grundy, 2004, CIRCULATION, V110, P763, DOI 10.1161/01.CIR.0000140446.06098.6B; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; *INT MON FUND, 2007, WORLD EC OUTL DAT; KINOSIAN B, 1994, ANN INTERN MED, V121, P641, DOI 10.7326/0003-4819-121-9-199411010-00002; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; MENOTTI A, 1993, EUR J EPIDEMIOL, V9, P527, DOI 10.1007/BF00209531; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; TOUBOUL PJ, 2006, INT J CARDIOVASC IMA; *WHO, 2007, CARD DIS STRAT PRIOR; *WHO, 2007, GLOB INFOBASE ONL; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	37	38	48	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0091-7435	1096-0260		PREV MED	Prev. Med.	MAR	2010	50	3					106	111		10.1016/j.ypmed.2009.12.011	http://dx.doi.org/10.1016/j.ypmed.2009.12.011			6	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	560PB	20034514				2022-09-04	WOS:000274913500002
J	Borda, MG; Reyes-Ortiz, CA; Heredia, RA; Castellanos-Perilla, N; Copete, AMA; Soennesyn, H; Cano-Gutierrez, CA; Perez-Zepeda, MU				German Borda, Miguel; Reyes-Ortiz, Carlos A.; Alberto Heredia, Rodrigo; Castellanos-Perilla, Nicolas; Ayala Copete, Ana Maria; Soennesyn, Hogne; Alberto Cano-Gutierrez, Carlos; Ulises Perez-Zepeda, Mario			Association between self-reported hearing impairment, use of a hearing aid and performance of instrumental activities of daily living	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Aged; Hearing loss; Hearing aid; Functionality; Older adult care; Disability	QUALITY-OF-LIFE; OLDER-ADULTS; HEALTH; SABE	Background and purpose: Age-related hearing loss is a prevalent condition among the growing elderly population, which has been associated with both cognitive decline and decreased daily functioning. Decreased functioning is linked to lower performance, predominantly regarding instrumental activities of daily living (IADLs). The present study aims to explore the association between hearing loss and impairment in IADLs. Methods: This is a secondary analysis of The Health, Well-Being, and Aging Colombia study, performed in 2015. Participants were classified into three groups: 1) without hearing loss, 2) hearing loss corrected through the use of a hearing aid, and 3) hearing loss without a hearing aid. Bivariate and adjusted multivariate analyses were performed. The measured outcome was IADLs. Results and discussion: Information from a total of 23,694 community-dwelling Colombian older adults (age >= 60 years) was used. The prevalence of hearing impairment was 23.4%, 1.8% out of those reported the use of hearing aids. Independent associations were found for having impaired IADLs when comparing participants with hearing loss without a hearing aid and those with normal hearing. However, there was no statistical significance with respect to IADLs when comparing hearing loss corrected by hearing aids versus participants with normal hearing. Participants using hearing aids have better functioning evaluated by IADLs when compared with participants with hearing impairment and no hearing aids. Conclusion: This study evidences a positive association between hearing impairment and performance in the IADLs. This association is not significant in older adults using hearing aids	[German Borda, Miguel; Soennesyn, Hogne] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [German Borda, Miguel] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [German Borda, Miguel; Alberto Heredia, Rodrigo; Castellanos-Perilla, Nicolas; Ayala Copete, Ana Maria; Alberto Cano-Gutierrez, Carlos; Ulises Perez-Zepeda, Mario] Pontificia Univ Javeriana, Med Sch, Ageing Inst, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Alberto Heredia, Rodrigo; Alberto Cano-Gutierrez, Carlos] Hosp Univ San Ignacio, Geriatr Unit, Bogota, Colombia; [Reyes-Ortiz, Carlos A.] Univ Texas Hlth Sci Ctr Houston, Div Geriatr & Palliat Med, Dept Internal Med, Houston, TX 77030 USA; [Ulises Perez-Zepeda, Mario] Inst Nacl Geriatria, Geriatr Epidemiol Res Dept, Bulevar Adolfo Lopez Mateo 2767, Mexico City 10200, DF, Mexico; [Ulises Perez-Zepeda, Mario] Dalhousie Univ, Dept Med, Geriatr Med Res Unit, Halifax, NS, Canada		Perez-Zepeda, MU (corresponding author), Inst Nacl Geriatria, Geriatr Epidemiol Res Dept, Bulevar Adolfo Lopez Mateo 2767, Mexico City 10200, DF, Mexico.	Carlos.A.ReyesOrtiz@uth.tmc.edu; herediar@javeriana.edu.co; nicolascastellanos@javeriana.edu.co; anaayala@javeriana.edu.com; hogne.sonnesyn@sus.no; ccano@javeriana.edu.co; mperez@inger.gob.mx	Borda, Miguel German/AHB-5593-2022; Castellanos, Nicolas/F-2868-2019; Perez-Zepeda, Mario/B-7265-2011; Borda, Miguel Germán/AAK-9029-2020	Borda, Miguel German/0000-0001-5832-0603; Castellanos, Nicolas/0000-0002-8229-2611; Perez-Zepeda, Mario/0000-0003-4374-976X; Borda, Miguel Germán/0000-0001-5832-0603; Cano-Gutierrez, Carlos/0000-0001-5680-7880	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia [764]	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia	The Health, Well-Being, and Aging (SABE) Colombia study was supported by a fund (2013, no. 764) from Colciencias y Ministerio de Salud y la Proteccion Social de Colombia.	Albala C, 2005, REV PANAM SALUD PUBL, V17, P307, DOI 10.1590/S1020-49892005000500003; Albala C., 1999, OPAS, P1; Cano CA, 2014, BIOMEDICA, V34, P574, DOI [10.7705/biomedica.v34i4.2352, 10.1590/S0120-41572014000400010]; Cardemil F, 2014, ACTA OTORRINOLAR ESP, V65, P249, DOI 10.1016/j.otorri.2013.10.005; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Davis A, 2016, GERONTOLOGIST, V56, pS256, DOI 10.1093/geront/gnw033; Diaz C, 2016, REV MEDICA CLINICA C, V27, P731, DOI [10.1016/j.rmdc.2016.11.003, DOI 10.1016/J.RMCLC.2016.11.003, 10.1016/j.rmclc.2016.11.003]; Gobbens R., 2019, PEERJ, V2018, pe5425; Gomez F., 2016, CURRENT GERONTOLOGY, V2016; Gopinath B, 2012, AGE AGEING, V41, P195, DOI 10.1093/ageing/afr155; Guerra-Zuniga M, 2014, ACTA OTORRINOLAR ESP, V65, P8, DOI 10.1016/j.otorri.2013.09.004; Heine C, 2002, DISABIL REHABIL, V24, P763, DOI 10.1080/09638280210129162; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371; Skrzypek Aleksandra, 2014, Otolaryngol Pol, V68, P25, DOI 10.1016/j.otpol.2013.07.001; Viljanen A, 2009, J GERONTOL A-BIOL, V64, P312, DOI 10.1093/gerona/gln015; Who.int, 2018, HEAR LOSS PERS 65 YE	19	1	1	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	JUL-AUG	2019	83						101	105		10.1016/j.archger.2019.04.001	http://dx.doi.org/10.1016/j.archger.2019.04.001			5	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	IA1IS	30999124				2022-09-04	WOS:000469313500018
J	Mendoza, C; Barreto, GE; Iarkov, A; Tarasov, VV; Aliev, G; Echeverria, V				Mendoza, Cristhian; Barreto, George E.; Iarkov, Alexandre; Tarasov, Vadim V.; Aliev, Gjumrakch; Echeverria, Valentina			Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder (vol 55, pg 6700, 2018)	MOLECULAR NEUROBIOLOGY			English	Correction									[Mendoza, Cristhian; Iarkov, Alexandre; Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Barreto, George E.] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Tarasov, Vadim V.] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, Moscow 119991, Russia; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 1142432, Moscow Region, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Echeverria, Valentina] Bay Pines VA Healthcare Syst Res & Dev, Bay Pines, FL 33744 USA		Echeverria, V (corresponding author), Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile.; Aliev, G (corresponding author), Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 1142432, Moscow Region, Russia.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.; Aliev, G (corresponding author), Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA.; Echeverria, V (corresponding author), Bay Pines VA Healthcare Syst Res & Dev, Bay Pines, FL 33744 USA.	aliev03@gmail.com; echeverria.valentina@gmail.com	Aliev, Gjumrakch/AAE-7734-2020; Aliev, Gjumrakch/K-7302-2017; Barreto, George E./AAD-7420-2020	Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994; Mendoza, Cristhian/0000-0002-5038-0991	Fondo de Ciencia y Tecnologia (FONDECYT) de Chile [1150194]	Fondo de Ciencia y Tecnologia (FONDECYT) de Chile	This work was supported by the Fondo de Ciencia y Tecnologia (FONDECYT) de Chile, Grant #1150194.	Mendoza C, 2018, MOL NEUROBIOL, V55, P6700, DOI 10.1007/s12035-018-0869-3	1	0	0	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2018	55	8					6712	6712		10.1007/s12035-018-1094-9	http://dx.doi.org/10.1007/s12035-018-1094-9			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO1YO	29700774	Bronze			2022-09-04	WOS:000439758300032
J	Salas, GG; Previdelli, AN; Fisberg, M; Kovalskys, I; Cortes, LY; Herrera-Cuenca, M; Garcia, MCY; Pareja, RP; Guajardo, VB; Rigotti, A				Gomez Salas, Georgina; Nogueira Previdelli, Agatha; Fisberg, Mauro; Kovalskys, Irina; Cortes, Lilia Yadira; Herrera-Cuenca, Marianella; Yepez Garcia, Martha Cecilia; Pareja, Rossina Pareja; Guajardo, Viviana Beatriz; Rigotti, Attilio			RELATIONSHIP BETWEEN DIET QUALITY AND OBESITY RISK: IS IT POSSIBLE TO DEVELOP A LA DIET QUALITY INDEX?	ANNALS OF NUTRITION AND METABOLISM			English	Meeting Abstract						Dietary Patters; Diet Quality; Latin American			[Gomez Salas, Georgina] Univ Costa Rica, Dept Bioquim, Escuela Med, San Jose, Costa Rica; [Nogueira Previdelli, Agatha] Univ Sao Judas Tadeu Sao Paulo, Fac Ciencias Biol & Saude, Sao Paulo, Brazil; [Fisberg, Mauro] Hosp Infantil Sabara, Inst Pensi, Fundacao Jose Luiz Egydio Setubal, Sao Paulo, Brazil; [Fisberg, Mauro] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Kovalskys, Irina; Guajardo, Viviana Beatriz] Int Life Sci Inst ILSI, Nutr & Hlth Area, Buenos Aires, DF, Argentina; [Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Ctr Estudios Desarrollo, Fdn Bengoa, Caracas, Venezuela; [Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador; [Pareja, Rossina Pareja] Inst Invest Nutr, Lima, Peru; [Rigotti, Attilio] Pontificia Univ Catolica, Dept Nutr Diabet & Metab, Escuela Med, Ctr Nutr Mol & Enfermedades Cron, Santiago, Chile				Fisberg, Mauro/E-7149-2010; Cortes, Lilia Yadira/AAF-2960-2019	Fisberg, Mauro/0000-0003-2992-3215; 	Coca Cola Company; Instituto Pensi / Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	Coca Cola Company; Instituto Pensi / Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	The ELANS is supported by a scientific grant from the Coca Cola Company and support from the Instituto Pensi / Hospital Infantil Sabara, International Life Science Institute of Argentina, Universidad de Costa Rica, Pontificia Universidad Catolica de Chile, Pontificia Universidad Javeriana, Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa, Universidad San Francisco de Quito, and Instituto de Investigacion Nutricional de Peru. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of this manuscript.		0	0	0	1	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-6807	1421-9697		ANN NUTR METAB	Ann. Nutr. Metab.		2017	71			2			40	40						1	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	FM9QD					2022-09-04	WOS:000415605300064
J	Riveros-Rivera, A; Penzel, T; Gunga, HC; Opatz, O; Paul, F; Klug, L; Boschmann, M; Maehler, A				Riveros-Rivera, Alain; Penzel, Thomas; Gunga, Hanns-Christian; Opatz, Oliver; Paul, Friedemann; Klug, Lars; Boschmann, Michael; Maehler, Anja			Hypoxia Differentially Affects Healthy Men and Women During a Daytime Nap With a Dose-Response Relationship: a Randomized, Cross-Over Pilot Study	FRONTIERS IN PHYSIOLOGY			English	Article						napping; sleep; hypoxia; high altitude (low air pressure); autonomic nervous system; physiological stress	HEART-RATE-VARIABILITY; HIGH-ALTITUDE; NORMOBARIC HYPOXIA; SLEEP RESTRICTION; COGNITIVE PERFORMANCE; HYPOBARIC HYPOXIA; CIRCADIAN-RHYTHM; RAPID ASCENT; IMPACT; SEX	Context: The use of daytime napping as a countermeasure in sleep disturbances has been recommended but its physiological evaluation at high altitude is limited. Objective: To evaluate the neuroendocrine response to hypoxic stress during a daytime nap and its cognitive impact. Design, Subject, and Setting: Randomized, single-blind, three period cross-over pilot study conducted with 15 healthy lowlander subjects (8 women) with a mean (SD) age of 29(6) years (Clinicaltrials identifier: NCT04146857, ). Interventions: Volunteers underwent a polysomnography, hematological and cognitive evaluation around a 90 min midday nap, being allocated to a randomized sequence of three conditions: normobaric normoxia (NN), normobaric hypoxia at FiO(2) 14.7% (NH15) and 12.5% (NH13), with a washout period of 1 week between conditions. Results: Primary outcome was the interbeat period measured by the RR interval with electrocardiogram. Compared to normobaric normoxia, RR during napping was shortened by 57 and 206 ms under NH15 and NH13 conditions, respectively (p < 0.001). Sympathetic predominance was evident by heart rate variability analysis and increased epinephrine levels. Concomitantly, there were significant changes in endocrine parameters such as erythropoietin (~6 UI/L) and cortisol (~100 nmol/L) (NH13 vs. NN, p < 0.001). Cognitive evaluation revealed changes in the color-word Stroop test. Additionally, although sleep efficiency was preserved, polysomnography showed lesser deep sleep and REM sleep, and periodic breathing, predominantly in men. Conclusion: Although napping in simulated altitude does not appear to significantly affect cognitive performance, sex-dependent changes in cardiac autonomic modulation and respiratory pattern should be considered before napping is prescribed as a countermeasure.	[Riveros-Rivera, Alain; Gunga, Hanns-Christian; Opatz, Oliver] Charite Univ Med Berlin, Inst Physiol, Ctr Space Med & Extreme Environm Berlin, Berlin, Germany; [Riveros-Rivera, Alain; Penzel, Thomas; Gunga, Hanns-Christian; Opatz, Oliver; Paul, Friedemann; Klug, Lars; Boschmann, Michael; Maehler, Anja] Free Univ Berlin, Berlin, Germany; [Riveros-Rivera, Alain; Penzel, Thomas; Gunga, Hanns-Christian; Opatz, Oliver] Humboldt Univ, Berlin, Germany; [Riveros-Rivera, Alain] Pontificia Univ Javeriana, Fac Med, Dept Physiol Sci, Bogota, Colombia; [Penzel, Thomas] Charite Univ Med Berlin, Interdisciplinary Ctr Sleep Med, Berlin, Germany; [Paul, Friedemann; Klug, Lars; Boschmann, Michael; Maehler, Anja] Cooperat Max Delbruck Ctr Mol Med Helmholtz Assoc, Expt & Clin Res Ctr, Berlin, Germany; [Paul, Friedemann; Klug, Lars; Boschmann, Michael; Maehler, Anja] Charite Univ Med Berlin, Berlin, Germany; [Paul, Friedemann; Klug, Lars; Boschmann, Michael; Maehler, Anja] Humboldt Univ, Expt & Clin Res Ctr, Berlin, Germany; [Paul, Friedemann; Klug, Lars; Boschmann, Michael; Maehler, Anja] Max Delbruck Ctr Mol Med Helmholtz Assoc MDC, Berlin, Germany; [Maehler, Anja] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany		Riveros-Rivera, A (corresponding author), Charite Univ Med Berlin, Inst Physiol, Ctr Space Med & Extreme Environm Berlin, Berlin, Germany.; Riveros-Rivera, A (corresponding author), Free Univ Berlin, Berlin, Germany.; Riveros-Rivera, A (corresponding author), Humboldt Univ, Berlin, Germany.; Riveros-Rivera, A (corresponding author), Pontificia Univ Javeriana, Fac Med, Dept Physiol Sci, Bogota, Colombia.	riveros-a@javeriana.edu.co		Mahler, Anja/0000-0002-3904-5789	Experimental and Clinical Research Center; Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association; Charite Universitaetsmedizin Berlin, Germany; Deutsche Akademische Austauschdienst-COLFUTURO [2016-57310880]; Pontificia Universidad Javeriana	Experimental and Clinical Research Center; Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association(Helmholtz Association); Charite Universitaetsmedizin Berlin, Germany; Deutsche Akademische Austauschdienst-COLFUTURO; Pontificia Universidad Javeriana	This study was funded by internal funds of the Experimental and Clinical Research Center, a cooperation between the Max-Delbrueck Center for Molecular Medicine in the Helmholtz Association and Charite Universitaetsmedizin Berlin, Germany. AR-R was supported by the Deutsche Akademische Austauschdienst-COLFUTURO (2016-57310880) and Pontificia Universidad Javeriana.	Berry CC, 2006, J SLEEP RES, V15, P348, DOI 10.1111/j.1365-2869.2006.00546.x; Bird JD, 2021, J APPL PHYSIOL, V131, P1432, DOI 10.1152/japplphysiol.00363.2021; Bloch KE, 2015, J APPL PHYSIOL, V119, P1466, DOI 10.1152/japplphysiol.00448.2015; Boos CJ, 2017, MED SCI SPORT EXER, V49, P2562, DOI 10.1249/MSS.0000000000001384; Boudreau P, 2012, CHRONOBIOL INT, V29, P757, DOI 10.3109/07420528.2012.674592; Boukhris O, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134650; Camargo G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242266; Camm AJ, 1996, CIRCULATION, V93, P1043; Camm AJ, 1996, EUR HEART J, V17, P354; Caravita S, 2015, CHEST, V147, P120, DOI 10.1378/chest.14-0317; Cellini N, 2018, J SLEEP RES, V27, P159, DOI 10.1111/jsr.12539; Chapleau MW, 2011, HEART FAIL REV, V16, P109, DOI 10.1007/s10741-010-9174-6; Coste O, 2005, STEROIDS, V70, P803, DOI 10.1016/j.steroids.2005.05.003; Cousins JN, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84625-8; Cousins JN, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy207; Cristancho E, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12901; Dimai H P, 2000, Wien Med Wochenschr, V150, P178; Dutheil F, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph181910212; Elmenhorst EM, 2022, NAT SCI SLEEP, V14, P193, DOI 10.2147/NSS.S339196; Faraut B, 2017, SLEEP MED REV, V35, P85, DOI 10.1016/j.smrv.2016.09.002; Fekedulegn D, 2020, ANN WORK EXPOS HEAL, V64, P350, DOI 10.1093/annweh/wxaa007; Ferrini RL, 1998, AM J EPIDEMIOL, V147, P750; Fultz NE, 2019, SCIENCE, V366, P628, DOI 10.1126/science.aax5440; Gaiduk M, 2022, IEEE J BIOMED HEALTH, V26, P505, DOI 10.1109/JBHI.2021.3099295; Gargaglioni LH, 2019, COMP BIOCHEM PHYS A, V238, DOI 10.1016/j.cbpa.2019.110543; Gerber M, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0876-8; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hauer ME, 2020, NAT REV EARTH ENV, V1, P28, DOI 10.1038/s43017-019-0002-9; Herzig D, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01100; Hill CM, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy181; Horiuchi M, 2017, HIGH ALT MED BIOL, V18, P171, DOI 10.1089/ham.2016.0162; Hoshikawa M, 2007, J APPL PHYSIOL, V103, P2005, DOI 10.1152/japplphysiol.00315.2007; Hughes BH, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx120; Humphreys S, 2005, ANAESTHESIA, V60, P458, DOI 10.1111/j.1365-2044.2005.04124.x; IATA, 2020, ANN REV 76 ANN GEN M; Insalaco G, 2016, SLEEP BREATH, V20, P197, DOI 10.1007/s11325-015-1205-z; Jiang F, 2018, IEEJ T ELECTR ELECTR, V13, P1357, DOI 10.1002/tee.22702; Ju JD, 2021, HIGH ALT MED BIOL, V22, P14, DOI 10.1089/ham.2020.0009; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Keenan DM, 2020, AM J PHYSIOL-ENDOC M, V318, pE297, DOI 10.1152/ajpendo.00243.2019; Klug L, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13949; Lastella M, 2021, NAT SCI SLEEP, V13, P841, DOI 10.2147/NSS.S315556; Latshang TD, 2013, SLEEP, V36, P1969, DOI 10.5665/sleep.3242; Lee YJ, 2022, J CLIN SLEEP MED, V18, P193, DOI 10.5664/jcsm.9538; Lemos VD, 2012, PSYCHOPHYSIOLOGY, V49, P1298, DOI 10.1111/j.1469-8986.2012.01411.x; Lerchbaum E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108263; LEUENBERGER U, 1991, American Journal of Physiology, V261, pH1659; Littlejohn EL, 2020, AM J PHYSIOL-REG I, V319, pR60, DOI 10.1152/ajpregu.00357.2019; Loh S, 2004, BEHAV RES METH INS C, V36, P339, DOI 10.3758/BF03195580; Lombardi C, 2013, J SLEEP RES, V22, P322, DOI 10.1111/jsr.12012; MacDonald EA, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00170; Mackenzie RWA, 2008, HIGH ALT MED BIOL, V9, P28, DOI 10.1089/ham.2008.1043; Mahler A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02819; Manzar MD, 2012, BIOL RHYTHM RES, V43, P439, DOI 10.1080/09291016.2011.597621; McDevitt EA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33209-0; McMorris T, 2017, NEUROSCI BIOBEHAV R, V74, P225, DOI 10.1016/j.neubiorev.2017.01.019; Millet GP, 2012, J APPL PHYSIOL, V112, P1783, DOI 10.1152/japplphysiol.00067.2012; Milner CE, 2009, J SLEEP RES, V18, P272, DOI 10.1111/j.1365-2869.2008.00718.x; Azmi NASM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020676; Mounier R, 2012, J APPL PHYSIOL, V112, P1784, DOI 10.1152/japplphysiol.00067.2012a; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Mugele H, 2021, EXP PHYSIOL, V106, P350, DOI 10.1113/EP088512; Muhm JM, 2009, AVIAT SPACE ENVIR MD, V80, P691, DOI 10.3357/ASEM.2327.2009; Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x; Okamoto-Mizuno K, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-14; Panjwani Usha, 2006, Indian J Physiol Pharmacol, V50, P250; Phillips JB, 2015, AEROSP MED HUM PERF, V86, P357, DOI 10.3357/AMHP.3925.2015; Pramsohler S, 2019, SLEEP BREATH, V23, P703, DOI 10.1007/s11325-019-01829-z; Qian L, 2021, J SLEEP RES, V30, P13242, DOI 10.1111/jsr.13242; ROWELL LB, 1989, J APPL PHYSIOL, V66, P1736, DOI 10.1152/jappl.1989.66.4.1736; Schaedler T, 2018, SLEEP SCI, V11, P152, DOI 10.5935/1984-0063.20180029; Schulz A, 2020, PHYSIOL BEHAV, V215, DOI 10.1016/j.physbeh.2019.112792; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Simka M, 2018, HIGH ALT MED BIOL, V19, P394, DOI 10.1089/ham.2018.0066; Souissi W, 2020, PHYSIOL BEHAV, V227, DOI 10.1016/j.physbeh.2020.113165; Steier J, 2017, HIGH ALT MED BIOL, V18, P242, DOI 10.1089/ham.2016.0097; Suzuki M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215345; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Tobaldini E, 2014, ARCH ITAL BIOL, V152, P103, DOI 10.12871/000298292014235; Tseng CH, 2015, SLEEP BREATH, V19, P819, DOI 10.1007/s11325-014-1093-7; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Voderholzer U, 2012, NEUROSCI LETT, V507, P161, DOI 10.1016/j.neulet.2011.12.014; Weibel J, 2020, PROG NEURO-PSYCHOPH, V99, DOI 10.1016/j.pnpbp.2019.109851; Wu H, 2010, PHYSIOL RES, V59, P821, DOI 10.33549/physiolres.931895; Wurtman RJ, 2002, METABOLISM, V51, P11, DOI 10.1053/meta.2002.33185; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yih ML, 2017, EUR J APPL PHYSIOL, V117, P757, DOI 10.1007/s00421-017-3555-7; Zera T, 2019, PHYSIOLOGY, V34, P264, DOI 10.1152/physiol.00057.2018	88	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1664-042X		FRONT PHYSIOL	Front. Physiol.	MAY 24	2022	13								899636	10.3389/fphys.2022.899636	http://dx.doi.org/10.3389/fphys.2022.899636			14	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	1X9PG	35685284	Green Accepted, Green Published, gold			2022-09-04	WOS:000807780000001
J	Parra, DC; Gomez, LF; Sarmiento, OL; Buchner, D; Brownson, R; Schimd, T; Gomez, V; Lobelo, F				Parra, Diana C.; Gomez, Luis F.; Sarmiento, Olga L.; Buchner, David; Brownson, Ross; Schimd, Thomas; Gomez, Viviola; Lobelo, Felipe			Perceived and objective neighborhood environment attributes and health related quality of life among the elderly in Bogota, Colombia	SOCIAL SCIENCE & MEDICINE			English	Article						Health related quality of life; Neighborhood environment; Walking; Older adults; Colombia; Perceived environmental indicators	SELF-RATED HEALTH; BUILT ENVIRONMENT; OLDER-ADULTS; PHYSICAL-ACTIVITY; WALKING ACTIVITY; POPULATION; POLICY; LEVEL	This study examines associations between neighborhood environment attributes and health related quality of life (HRQOL) and self-rated health (SRH) among older adults (60 years and over) in Bogota, Colombia. Perceived and objective neighborhood environmental characteristics were assessed in a cross sectional multilevel design with 1966 older adults within 50 neighborhoods. Outcome variables included HRQOL (physical and mental dimensions) and SRH measured with the Spanish version of the Short Form 8 (SF-8). Independent variables included perceived and objective neighborhood characteristics as well as self-reported levels of walking. Hierarchical linear and logistic regression models were used for the analysis. Among perceived neighborhood characteristics, safety from traffic was positively associated with both HRQOL dimensions and SRH. Having safe parks was positively associated with the mental dimension of HRQOL and with SRH. Street noise was negatively associated with both HRQOL dimensions. Regarding objective neighborhood characteristics, residing in areas with more than eight percent of land covered by public parks was positively associated with SRH. Objective and perceived neighborhood characteristics could provide insight into potential interventions among older adults from rapidly urbanizing settings in Latin America. (C) 2010 Elsevier Ltd. All rights reserved.	[Parra, Diana C.; Brownson, Ross] Washington Univ, George Warren Brown Sch Social Work, Prevent Res Ctr St Louis, St Louis, MO 63130 USA; [Parra, Diana C.; Gomez, Luis F.] Fdn FES Social, Hlth Div, Bogota, Colombia; [Gomez, Luis F.] Univ Javeriana, Sch Med, Bogota, Colombia; [Sarmiento, Olga L.] Univ Los Andes, Sch Med, Bogota, Colombia; [Buchner, David] Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL USA; [Brownson, Ross] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Brownson, Ross] Alvin J Siteman Canc Ctr, St Louis, MO USA; [Schimd, Thomas; Lobelo, Felipe] Ctr Dis Control & Prevent, Div Nutr & Phys Act, Atlanta, GA USA; [Gomez, Viviola] Univ Los Andes, Fac Social Sci, Dept Psychol, Bogota, Colombia		Parra, DC (corresponding author), Washington Univ, George Warren Brown Sch Social Work, Prevent Res Ctr St Louis, St Louis, MO 63130 USA.	dianacpp79@yahoo.com	Parra, Diana C/B-7761-2015; Sarmiento, Olga L/AAS-4165-2020; lobelo, felipe/B-9148-2013; Parra, Diana C/D-7633-2013; Lobelo, R.L Felipe/AAB-2264-2021	Parra, Diana C/0000-0002-9797-6231; Sarmiento, Olga L/0000-0002-9190-3568; Parra, Diana C/0000-0002-9797-6231; Lobelo, R.L Felipe/0000-0003-4185-7193; Gomez Gutierrez, Luis Fernando/0000-0003-1834-3012; Gomez, Viviola/0000-0002-1066-9483				Andresen EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-35; Balfour JL, 2002, AM J EPIDEMIOL, V155, P507, DOI 10.1093/aje/155.6.507; BAZARGAN M, 1994, INT J AGING HUM DEV, V38, P99, DOI 10.2190/FHQY-5T3L-GADM-PUD0; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; CAMARGO A, 2005, PERFIL INFORMALIDAD; CERRUTTI M, 2003, C AFR MIGR COMP PERS; Cervero R, 2009, INT J SUSTAIN TRANSP, V3, P203, DOI 10.1080/15568310802178314; CETINA S, 2008, HIST ESPACIO PUBLICO; Clarke P, 2005, AM J PUBLIC HEALTH, V95, P1933, DOI 10.2105/AJPH.2004.054494; Clarke P, 2008, AM J EPIDEMIOL, V168, P506, DOI 10.1093/aje/kwn185; *DANE, 2005, ESTR BOG EST REL 198; Dawson J, 2007, J AGING PHYS ACTIV, V15, P318, DOI 10.1123/japa.15.3.318; Fagg J, 2008, J ENVIRON PSYCHOL, V28, P128, DOI 10.1016/j.jenvp.2007.10.004; Fleischer NL, 2008, J EPIDEMIOL COMMUN H, V62, P842, DOI 10.1136/jech.2007.067371; Forsyth BH, 1991, MEASUREMENT ERRORS S, P395; FRIED L, 2005, HDB URBAN HLTH, P185; Gavazzi G, 2004, CLIN INFECT DIS, V39, P83, DOI 10.1086/421559; Gebel K, 2009, ANN BEHAV MED, V37, P228, DOI 10.1007/s12160-009-9098-3; Gebre-Egziabher Axumite, 2004, Ann N Y Acad Sci, V1023, P62, DOI 10.1196/annals.1319.016; Gomez L.F., 2005, COLOMBIA J PHYS ACT, V2, P445, DOI [10.1123/jpah.2.4.445, DOI 10.1123/JPAH.2.4.445]; *INT PHYS ACT QUES, 2002, INT PHYS ACT ENV NET; JOBE JB, 1990, PUBLIC HEALTH REP, V105, P518; JOBE JB, 1989, AM J PUBLIC HEALTH, V79, P1053, DOI 10.2105/AJPH.79.8.1053; Kaczynski AT, 2008, AM J PUBLIC HEALTH, V98, P1451, DOI 10.2105/AJPH.2007.129064; Kepka D, 2007, AM J HEALTH BEHAV, V31, P535, DOI 10.5993/AJHB.31.5.9; Kinsella KG, 1995, OLDER WORKERS RETIRE; Lash TL, 2003, AM J EPIDEMIOL, V157, P472, DOI 10.1093/aje/kwf191; Li FZ, 2005, J EPIDEMIOL COMMUN H, V59, P558, DOI 10.1136/jech.2004.028399; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lunenfeld B, 2008, GYNECOL ENDOCRINOL, V24, P1, DOI 10.1080/09513590701718364; Michael YL, 2009, AM J EPIDEMIOL, V169, P409, DOI 10.1093/aje/kwn394; Miller TR, 2007, J GERONTOL B-PSYCHOL, V62, pS22, DOI 10.1093/geronb/62.1.S22; MOREY MC, 2008, J AM GERIATRIC SOC; Nagel CL, 2008, AM J EPIDEMIOL, V168, P461, DOI 10.1093/aje/kwn158; O'Campo P, 2006, METHODS SOCIAL EPIDE, P196; Parra D, 2007, INDOOR BUILT ENVIRON, V16, P344, DOI 10.1177/1420326X07080462; *QUALITYMETRICS, 2008, MAN US SF 8; Raudenbush S.W., 2002, HIERARCHICAL LINEAR; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sarmiento O, 2007, 19 IUHPE WORLD C HLT; SARMIENTO OL, 2008, NOTA UNIANDINA AGOST, P52; *SECR TRANS, 2009, MAY 60 PRINC VICT AC; Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913; Torres A, 2009, 56 ANN M AM COLL SPO; Wen M, 2006, SOC SCI MED, V63, P2575, DOI 10.1016/j.socscimed.2006.06.025; 2004, CONSEJO DISTRITAL PO	46	136	143	4	79	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	APR	2010	70	7					1070	1076		10.1016/j.socscimed.2009.12.024	http://dx.doi.org/10.1016/j.socscimed.2009.12.024			7	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	581AU	20138418				2022-09-04	WOS:000276493400016
J	Yezioro-Rubinsky, S; Eslava-Schmalbach, JH; Otero, L; Rodriguez-Aguirre, SA; Duque, AM; Campos, FM; Gomez, JP; Gomez-Arango, S; Posso-Moreno, SL; Rojas, NE; Garzon-Orjuela, N				Yezioro-Rubinsky, Salomon; Eslava-Schmalbach, Javier H.; Otero, Liliana; Rodriguez-Aguirre, Sara A.; Duque, Angela M.; Campos, Flora M.; Gomez, Juan P.; Gomez-Arango, Sara; Posso-Moreno, Sandra L.; Rojas, Nancy E.; Garzon-Orjuela, Nathaly			Dental Anomalies in Permanent Teeth Associated With Nonsyndromic Cleft Lip and Palate in a Group of Colombian Children	CLEFT PALATE-CRANIOFACIAL JOURNAL			English	Article						Cleft lip; cleft palate; dental anomaly; supernumerary teeth	TOOTH AGENESIS; AND/OR PALATE; PREVALENCE; ABNORMALITIES; INDIVIDUALS; DENTITION; POPULATION; POSITION; INCISORS; NUMBER	Objectives: To assess the risk of dental anomaly presentation in permanent teeth in a group of Colombian children with nonsyndromic cleft lip and palate (NSCLP) and to determine the frequency of the anomalies according to the cleft type. Methods: An analytical matched case-control study was conducted with 210 controls and 210 patients with NSCLP. The patients were classified into 3 groups: complete right unilateral cleft lip and palate (RCLP), complete left unilateral cleft lip and palate (LCLP), and complete bilateral cleft lip and palate (BCLP). Univariate and multivariate Poisson regression models were used to analyze paired samples (Bonferroni adjustment, P <= .002). Results: A high risk of finding agenesis of the maxillary lateral incisors, supernumerary teeth, microdontia of the maxillary lateral incisors, and rotation of the maxillary central incisors adjacent to the cleft (P < .0001) was observed in the patients with NSCLP. One or more dental anomalies were found in 98% of patients with BCLP, in 96% of those with LCLP, and in 87% of those with RCLP. Most of the anomalies were located on the cleft area. The incidence relative risk (IRR) of anomalies was highest in patients with BCLP (IRR: 10.5; 95% confidence interval [CI]: 6.76-16.3), followed by in those with LCLP (IRR: 8.51; 95% CI: 5.64-12.8). Conclusions: Most dental anomalies were found in the cleft area; this was expected because the cleft area was the most affected in the patients included in this study.	[Yezioro-Rubinsky, Salomon] Univ Nacl Colombia, Fac Dent, Bogota, Colombia; [Eslava-Schmalbach, Javier H.; Garzon-Orjuela, Nathaly] Univ Nacl Colombia, Hosp Univ Nacl Colombia, Sch Med, Bogota, Colombia; [Otero, Liliana] Pontificia Univ Javeriana, Fac Dent, Bogota, Colombia; [Rodriguez-Aguirre, Sara A.] Univ Antioquia, Fac Dent, Medellin, Colombia; [Duque, Angela M.] Univ Valle, Fac Dent, Cali, Colombia; [Campos, Flora M.] Univ Cooperat Colombia, Fac Dent, Bogota, Colombia; [Campos, Flora M.] Univ Antonio Narino, Bogota, Colombia; [Gomez, Juan P.] Univ Autonoma Manizales, Fac Dent, Manizales, Colombia; [Gomez-Arango, Sara; Posso-Moreno, Sandra L.] Pontificia Univ Javeriana, Bogota, Colombia		Garzon-Orjuela, N (corresponding author), Univ Nacl Colombia, Hosp Univ Nacl Colombia, Sch Med, Bogota, Colombia.	ngarzono@unal.edu.co		Garzon-Orjuela, Nathaly/0000-0001-6181-8154; Otero, Liliana/0000-0003-1803-9141	Fundacion Hospital Pediatrico de la Misericordia, Bogota; Hospital San Ignacio, Bogota; Clinica Noel, Medellin; Hospital Universitario del Valle, Cali; Fundacion Sonrisa, Pereira	Fundacion Hospital Pediatrico de la Misericordia, Bogota; Hospital San Ignacio, Bogota; Clinica Noel, Medellin; Hospital Universitario del Valle, Cali; Fundacion Sonrisa, Pereira	The authors would like to thank Fundacion Hospital Pediatrico de la Misericordia, Bogota; Hospital San Ignacio, Bogota; Clinica Noel, Medellin; Hospital Universitario del Valle, Cali, and Fundacion Sonrisa, Pereira, for supporting this research. Also, the authors would like to thank Vanessa Elias for reviewing the final version of this article before being submitted to this journal.	Abd Rahman Normastura, 2004, Malays J Med Sci, V11, P41; Akcam MO, 2010, EUR J ORTHODONT, V32, P207, DOI 10.1093/ejo/cjp156; Al Jamal GA, 2010, CLEFT PALATE-CRAN J, V47, P413, DOI 10.1597/08-275.1; Al-Kharboush GH, 2015, SAUDI DENT J, V27, P75, DOI 10.1016/j.sdentj.2014.11.007; Bartzela TN, 2013, ARCH ORAL BIOL, V58, P596, DOI 10.1016/j.archoralbio.2012.12.007; Bergstrom K, 1977, Swed Dent J, V1, P145; Cash AC, 2012, FRONT ORAL BIOL, V16, P111, DOI 10.1159/000337665; Damante JH, 1972, ANOMALIAS DENT NUMER; Dentino KM, 2012, ANGLE ORTHOD, V82, P959, DOI 10.2319/012012-49.1; Dewinter G, 2003, CLEFT PALATE-CRAN J, V40, P343, DOI 10.1597/1545-1569(2003)040<0343:DABGQA>2.0.CO;2; Ely NJ, 2006, EUR J ORTHODONT, V28, P145, DOI 10.1093/ejo/cji092; Eslami N, 2013, J CRANIOFAC SURG, V24, P1695, DOI 10.1097/SCS.0b013e3182801bc8; Tereza GPG, 2010, CLEFT PALATE-CRAN J, V47, P247, DOI 10.1597/08-268.1; Gundlach KKH, 2006, J CRANIO MAXILL SURG, V34, P1; Hamasha AA, 2002, INT ENDOD J, V35, P910, DOI 10.1046/j.1365-2591.2002.00593.x; Heinze G, 2010, STAT MED, V29, P770, DOI 10.1002/sim.3794; Hodgkinson PD., 2005, FETAL MAT MED REV, V16, P1, DOI DOI 10.1017/S0965539505001452; Howe BJ, 2015, J DENT RES, V94, P905, DOI 10.1177/0022034515588281; Kim NY, 2006, AM J ORTHOD DENTOFAC, V130, P752, DOI 10.1016/j.ajodo.2005.02.029; Lekkas C, 2000, CLEFT PALATE-CRAN J, V37, P17, DOI 10.1597/1545-1569(2000)037<0017:TAUCPA>2.3.CO;2; Letra A, 2007, J DENT RES, V86, P986, DOI 10.1177/154405910708601013; Menezes R, 2008, CLEFT PALATE-CRAN J, V45, P414, DOI 10.1597/07-064.1; Pindborg J. J., 1970, PATHOLOGY DENT HARD, P15; PURCELL P D, 1985, Journal of Pedodontics, V9, P302; QUEZADA MGC, 1988, J BIOL BUCCALE, V16, P185; Qureshi WA, 2012, J DENT CHILD, V79, P69; da Silva APRB, 2008, CLEFT PALATE-CRAN J, V45, P473, DOI 10.1597/06-099.1; Rawashdeh MA, 2009, J CRANIOFAC SURG, V20, P465, DOI 10.1097/SCS.0b013e31819b97bf; Reina HAR, 2016, REV ODONTOLOGICA MEX, V20, P175; Paranaiba LMR, 2013, CLEFT PALATE-CRAN J, V50, P400, DOI 10.1597/11-029; Sa J, 2016, CLEFT PALATE-CRAN J, V53, P714, DOI 10.1597/14-303; Sa J, 2016, MED ORAL PATOL ORAL, V21, pE48, DOI 10.4317/medoral.20757; SEDGWICK P, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G6284; Seo YJ, 2013, ANGLE ORTHOD, V83, P1036, DOI 10.2319/020513-104.1; SEOW W K, 1989, Pediatric Dentistry, V11, P214; Slayton RL, 2003, CLEFT PALATE-CRAN J, V40, P274, DOI 10.1597/1545-1569(2003)040<0274:GASOCL>2.0.CO;2; Tannure PN, 2012, CLEFT PALATE-CRAN J, V49, P194, DOI 10.1597/10-043; Tortora C, 2008, CLEFT PALATE-CRAN J, V45, P154, DOI 10.1597/06-218.1; Vichi M, 1995, J DENT CHILD, V62, P412; Wu Ting-Ting, 2011, Chang Gung Med J, V34, P306	40	8	8	0	4	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1055-6656	1545-1569		CLEFT PALATE-CRAN J	Cleft Palate-Craniofac. J.	JAN	2020	57	1					73	79		10.1177/1055665619861498	http://dx.doi.org/10.1177/1055665619861498			7	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	JW0RE	31284730				2022-09-04	WOS:000502766200009
J	Garcia, MCY; Kovalskys, I; Fisberg, M; Salas, GG; Attilio, R; Cortes, LY; Pareja, RP; Cuenca, MH; Previdelli, AN				Yepez Garcia, Martha Cecilia; Kovalskys, Irina; Fisberg, Mauro; Gomez Salas, Georgina; Attilio, Rigotti; Cortes, Lilia Yadira; Pareja, Rassina Pareja; Herrera Cuenca, Marianella; Previdelli, Nogueira Agatha			HYDRATION PROFILE OF POPULATION OF COUNTRIES OF ELANS	ANNALS OF NUTRITION AND METABOLISM			English	Meeting Abstract						Hydration; consumption habits; water; population			[Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador; [Kovalskys, Irina] ILSI, Nutr & Hlth Area, Buenos Aires, DF, Argentina; [Fisberg, Mauro] Hosp Infantil Sabara, Fundacao Jose Luiz Egydio Setubal, Inst Pensi, Sao Paulo, Brazil; [Fisberg, Mauro] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Gomez Salas, Georgina] Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose, Costa Rica; [Attilio, Rigotti] Pontificia Univ Catolica, Escuela Med, Dept Nutr Diabet & Metab, Ctr Nutr Mol & Enfermedades Cron, Santiago, Chile; [Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Pareja, Rassina Pareja] Inst Invest Nutr, Lima, Peru; [Herrera Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Fdn Bengoa, Ctr Estudios Desarrollo, Caracas, Venezuela; [Previdelli, Nogueira Agatha] Univ Sao Judas Tadeu Sao Paulo, Fac Ciencias Biol & Saude, Sao Paulo, Brazil				Fisberg, Mauro/E-7149-2010; Cortes, Lilia Yadira/AAF-2960-2019	Fisberg, Mauro/0000-0003-2992-3215; 	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	The ELANS is supported by a scientific grant from the Coca Cola Company and support from the Instituto Pensi/Hospital Infantil Sabara, International Life Science Institute of Argentina, Universidad de Costa Rica, Pontificia Universidad Catolica de Chile, Pontificia Universidad Javeriana, Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa, Universidad San Francisco de Quito, and Instituto de Investigacion Nutricional de Peru. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of this symposium.		0	0	0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-6807	1421-9697		ANN NUTR METAB	Ann. Nutr. Metab.		2017	71			2			92	92						1	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	FM9QD					2022-09-04	WOS:000415605300153
J	Rowland, JA; Bland, LM; Keith, DA; Juffe-Bignoli, D; Burgman, MA; Etter, A; Ferrer-Paris, JR; Miller, RM; Skowno, AL; Nicholson, E				Rowland, Jessica A.; Bland, Lucie M.; Keith, David A.; Juffe-Bignoli, Diego; Burgman, Mark A.; Etter, Andres; Ferrer-Paris, Jose Rafael; Miller, Rebecca M.; Skowno, Andrew L.; Nicholson, Emily			Ecosystem indices to support global biodiversity conservation	CONSERVATION LETTERS			English	Letter						biodiversity indicators; conservation actions; conservation management; ecosystem collapse; ecosystem risk assessment; global biodiversity conventions; IUCN Red List of Ecosystems; United Nations Sustainable Development Goals	INDICATORS; EXTENT	Governments have committed to global targets to slow biodiversity loss and sustain ecosystem services. Biodiversity state indicators that measure progress toward these targets mostly focus on species, while indicators synthesizing ecosystem change are largely lacking. We fill this gap with three indices quantifying past and projected changes in ecosystems using data from the International Union for Conservation of Nature (IUCN) Red List of Ecosystems. Our indices quantify changes in risk of ecosystem collapse, ecosystem area and ecological processes, and capture variation in underlying patterns among ecosystems. We apply the indices to three case studies of regional and national assessments (American/Caribbean forests, terrestrial ecosystems of Colombia, and terrestrial ecosystems of South Africa) to illustrate the indices' complementarity and versatility in revealing patterns of interest for users across sectors. Our indices have the potential to fill the recognized need for ecosystem indicators to inform conservation targets, guide policy, and prioritize management actions.	[Rowland, Jessica A.; Bland, Lucie M.; Nicholson, Emily] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic, Australia; [Keith, David A.; Ferrer-Paris, Jose Rafael] Univ NSW, Ctr Ecosyst Sci, Sydney, NSW, Australia; [Keith, David A.] New South Wales Dept Planning Ind & Environm, Canberra, ACT, Australia; [Juffe-Bignoli, Diego] WCMC, UNEP, Cambridge, England; [Burgman, Mark A.] Imperial Coll London, Ctr Environm Policy, London, England; [Etter, Andres] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Ecol & Terr, Bogota, DC, Colombia; [Keith, David A.; Miller, Rebecca M.] IUCN Commiss Ecosyst Management, Gland, Switzerland; [Skowno, Andrew L.] Kirstebosch Res Ctr, SANBI, Cape Town, South Africa; [Skowno, Andrew L.] Univ Cape Town, Dept Biol Sci, Cape Town, South Africa		Rowland, JA (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic, Australia.	jrowlan@deakin.edu.au	Etter, Andrés/E-1860-2011; Rowland, Jessica A/Q-9851-2019; Bland, Lucie Morgane/AAU-8712-2020; Ferrer-Paris, José R./M-3785-2015; Nicholson, Emily/H-9001-2013	Etter, Andrés/0000-0003-0665-9300; Rowland, Jessica A/0000-0001-9831-681X; Ferrer-Paris, José R./0000-0002-9554-3395; Burgman, Mark/0000-0003-0435-4829; Keith, David/0000-0002-7627-4150; Nicholson, Emily/0000-0003-2199-3446; Skowno, Andrew/0000-0002-2726-7886; Juffe Bignoli, Diego/0000-0002-1498-4317	ARC Linkage Project [LP170101143]; ARC Discovery Project [DP170100609]; Veski Inspiring Women Fellowship; Endeavour Research Fellowship; Australian Research Training Program scholarship	ARC Linkage Project(Australian Research Council); ARC Discovery Project(Australian Research Council); Veski Inspiring Women Fellowship; Endeavour Research Fellowship; Australian Research Training Program scholarship	ARC Linkage Project, Grant/Award Number: LP170101143; ARC Discovery Project, Grant/Award Number: DP170100609; Veski Inspiring Women Fellowship; Endeavour Research Fellowship; Australian Research Training Program scholarship	Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Bland L.M., 2017, GUIDELINES APPL IUCN; Bland LM, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12666; Bland LM, 2018, BIOL CONSERV, V227, P19, DOI 10.1016/j.biocon.2018.08.019; Bland LM, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0660; Brooks TM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.7; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; CBD, 2010, UNEPCBDCOPDECX2; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Cowling R. M., 2004, VEGETATION S AFRICA; Darrah SE, 2019, ECOL INDIC, V99, P294, DOI 10.1016/j.ecolind.2018.12.032; Driver A., 2012, NATL BIODIVERSITY AS; Etter A., 2017, RISK ASSESSMENT COLO; Etter A, 2008, ANN ASSOC AM GEOGR, V98, P2, DOI 10.1080/00045600701733911; Faber-Langendoen D, 2014, ECOL MONOGR, V84, P533, DOI 10.1890/13-2334.1; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, P110; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hansen MC, 2013, SCIENCE, V342, P850, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hill SLL, 2016, CONSERV LETT, V9, P405, DOI 10.1111/conl.12291; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; ICSU ISSC., 2015, REV TARGETS SUSTAINA; Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services and Intergovernmental Panel on Climate Change, 2021, SPOTL INT SCI BIOD C; [IUCN] International Union for Conservation of Nature, 2012, IUCN HAB CLASS SCHEM; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Keith DA, 2015, CONSERV LETT, V8, P214, DOI 10.1111/conl.12167; Keith DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062111; Lee CKF, 2019, ECOGRAPHY, V42, P1050, DOI 10.1111/ecog.04143; Likens GE, 1992, ECOSYSTEM APPROACH I; Mace GM, 2018, NAT SUSTAIN, V1, P448, DOI 10.1038/s41893-018-0130-0; Mace GM, 2005, NATURE, V434, P32, DOI 10.1038/434032a; Maron M, 2018, NAT ECOL EVOL, V2, P1194, DOI 10.1038/s41559-018-0595-2; Mucina L., 2018, VEGETATION MAP S AFR; Murray NJ, 2019, NATURE, V565, P222, DOI 10.1038/s41586-018-0805-8; Murray NJ, 2018, METHODS ECOL EVOL, V9, P2019, DOI 10.1111/2041-210X.13043; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newbold T, 2016, SCIENCE, V353, P288, DOI 10.1126/science.aaf2201; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Pressey RL, 1996, FOREST ECOL MANAG, V85, P311, DOI 10.1016/S0378-1127(96)03766-8; Quinn Gerard, 2002, EXPT DESIGN DATA ANA; Ferrer-Paris JR, 2019, CONSERV LETT, V12, P12623, DOI 10.1111/conl.12623; Reyers B, 2007, DIVERS DISTRIB, V13, P608, DOI 10.1111/j.1472-4642.2007.00379.x; Rowland JA, 2018, CONSERV BIOL, V32, P1233, DOI 10.1111/cobi.13107; Shi JM, 2010, BIODIVERS CONSERV, V19, P1279, DOI 10.1007/s10531-009-9757-5; Tansley AG, 1935, ECOLOGY, V16, P284, DOI 10.2307/1930070; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Zhang GG, 2011, GLOBAL CHANGE BIOL, V17, P377, DOI 10.1111/j.1365-2486.2010.02237.x	48	18	18	4	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-263X			CONSERV LETT	Conserv. Lett.	JAN	2020	13	1							e12680	10.1111/conl.12680	http://dx.doi.org/10.1111/conl.12680		NOV 2019	11	Biodiversity Conservation	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation	KU5BN		Green Published, gold			2022-09-04	WOS:000497205400001
J	Santos, G; Giraldez-Alvarez, LD; Avila-Rodriguez, M; Capani, F; Galembeck, E; Neto, AG; Barreto, GE; Andrade, B				Santos, Gesivaldo; Giraldez-Alvarez, Lisandro Diego; Avila-Rodriguez, Marco; Capani, Francisco; Galembeck, Eduardo; Neto, Aristoteles Goes; Barreto, George E.; Andrade, Bruno			SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson	FRONTIERS IN AGING NEUROSCIENCE			English	Article						Valeriana officinalis; Parkinson disease; neuroprotection; SUR1; GABAA	SENSITIVE POTASSIUM CHANNELS; VALERENIC ACID-DERIVATIVES; OXIDATIVE STRESS; CUDRANIA-TRICUSPIDATA; MOLECULAR-MECHANISMS; NEUROPROTECTIVE ROLE; DOPAMINE METABOLISM; IN-VITRO; DISEASE; ROTENONE	Parkinson's disease (PD) is one of the most common neurodegenerative disorders. A theoretical approach of our previous experiments reporting the cytoprotective effects of the Valeriana officinalis compounds extract for PD is suggested. In addiction to considering the PD as a result of mitochondrial metabolic imbalance and oxidative stress, such as in our previous in vitro model of rotenone, in the present manuscript we added a genomic approach to evaluate the possible underlying mechanisms of the effect of the plant extract. Microarray of substantia nigra (SN) genome obtained from Allen Brain Institute was analyzed using gene set enrichment analysis to build a network of hub genes implicated in PD. Proteins transcribed from hub genes and their ligands selected by search ensemble approach algorithm were subjected to molecular docking studies, as well as 20 ns Molecular Dynamics (MD) using a Molecular Mechanic Poison/Boltzman Surface Area (MMPBSA) protocol. Our results bring a new approach to Valeriana officinalis extract, and suggest that hesperidin, and probably linarin are able to relieve effects of oxidative stress during ATP depletion due to its ability to binding SUR1. In addition, the key role of valerenic acid and apigenin is possibly related to prevent cortical hyperexcitation by inducing neuronal cells from SN to release GABA on brain stem. Thus, under hyperexcitability, oxidative stress, asphyxia and/or ATP depletion, Valeriana officinalis may trigger different mechanisms to provide neuronal cell protection.	[Santos, Gesivaldo; Andrade, Bruno] Univ Estadual Sudoeste Bahia, Dept Ciencias Biol, Jequie, Brazil; [Giraldez-Alvarez, Lisandro Diego] Univ Estadual Sudoeste Bahia, Dept Quim & Exatas, PNPD CAPES, Jequie, Brazil; [Avila-Rodriguez, Marco; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Capani, Francisco] UBA CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Buenos Aires, DF, Argentina; [Galembeck, Eduardo] Univ Estadual Paulista, Inst Biol, Dept Bioquim, Campinas, SP, Brazil; [Neto, Aristoteles Goes] Univ Fed Estadual Feira Santana, Dept Ciencias Biol, Feira De Santana, Brazil; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Barreto, George E.] Univ Cient Sur, Lima, Peru		Santos, G (corresponding author), Univ Estadual Sudoeste Bahia, Dept Ciencias Biol, Jequie, Brazil.; Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.; Barreto, GE (corresponding author), Univ Cient Sur, Lima, Peru.	colisor@gmail.com; gsampaio@javeriana.edu.co	Barreto, George E./AAD-7420-2020; Goes-Neto, Aristoteles/A-6955-2013; Andrade, Bruno S/C-8170-2013; Galembeck, Eduardo/F-7465-2012; Andrade, Bruno/AAP-8926-2020; santos, gesivaldo/AAO-4565-2021; Barreto, George E./B-5747-2014; capani, Francisco/D-9781-2016	Barreto, George E./0000-0002-6644-1971; Goes-Neto, Aristoteles/0000-0002-7692-6243; Galembeck, Eduardo/0000-0003-4238-5546; Andrade, Bruno/0000-0002-8031-9454; Barreto, George E./0000-0002-6644-1971; Avila-Rodriguez, Marco/0000-0003-4612-3236	Universidade Estadual do Sudoeste da Bahia; Pontificia Universidad Javeriana [5575, 5024]; Jovenes Investigadores (Colciencias) [6027]	Universidade Estadual do Sudoeste da Bahia; Pontificia Universidad Javeriana; Jovenes Investigadores (Colciencias)	GS work is supported by Universidade Estadual do Sudoeste da Bahia. This work was also supported in part by Pontificia Universidad Javeriana grants IDs 5575 and 5024 and Jovenes Investigadores (Colciencias, 2014, ID 6027).	Abdin AA, 2008, NEUROPHARMACOLOGY, V55, P1340, DOI 10.1016/j.neuropharm.2008.08.033; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; AMOROSO S, 1990, SCIENCE, V247, P852, DOI 10.1126/science.2305257; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avallone R, 2000, BIOCHEM PHARMACOL, V59, P1387, DOI 10.1016/S0006-2952(00)00264-1; Bae N, 2015, J ETHNOPHARMACOL, V159, P93, DOI 10.1016/j.jep.2014.11.007; Bajusz D, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0069-3; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Beitz Janice M, 2014, Front Biosci (Schol Ed), V6, P65; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Cabeza-Arvelaiz Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044700; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Carlini EA, 2003, PHARMACOL BIOCHEM BE, V75, P501, DOI 10.1016/S0091-3057(03)00112-6; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen EY, 2012, BIOINFORMATICS, V28, P105, DOI 10.1093/bioinformatics/btr625; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Cummings JL, 2006, NAT REV DRUG DISCOV, V5, P64, DOI 10.1038/nrd1928; Dannenfelser R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-156; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; de Oliveria DM, 2009, NEUROCHEM RES, V34, P215, DOI 10.1007/s11064-008-9749-y; Deutch AY, 2006, NAT MED, V12, P17, DOI 10.1038/nm0106-17; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; dos Santos AB, 2015, NEUROCHEM RES, V40, P421, DOI 10.1007/s11064-014-1488-7; dos Santos AB, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00273; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Fernandez S, 2004, PHARMACOL BIOCHEM BE, V77, P399, DOI 10.1016/j.pbb.2003.12.003; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Giordano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044610; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Houghton PJ, 1999, J PHARM PHARMACOL, V51, P505, DOI 10.1211/0022357991772772; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Johnson ME, 2015, NEUROTOXICOLOGY, V46, P101, DOI 10.1016/j.neuro.2014.12.002; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kennedy DO, 2011, ADV NUTR, V2, P32, DOI 10.3945/an.110.000117; Khom S, 2007, NEUROPHARMACOLOGY, V53, P178, DOI 10.1016/j.neuropharm.2007.04.018; Khom S, 2010, BRIT J PHARMACOL, V161, P65, DOI 10.1111/j.1476-5381.2010.00865.x; Kim SW, 2011, BIOCHEM BIOPH RES CO, V415, P602, DOI 10.1016/j.bbrc.2011.10.115; Kwon J, 2014, J NAT PROD, V77, P1893, DOI 10.1021/np500364x; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; National Toxicology Program, 2009, CHEM INF REV DOC; Hiep NT, 2015, PHYTOCHEMISTRY, V111, P141, DOI 10.1016/j.phytochem.2014.10.021; Oinonen PP, 2006, FITOTERAPIA, V77, P429, DOI 10.1016/j.fitote.2006.05.002; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Perier C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009332; Pilerood SA, 2014, J FOOD SCI TECH MYS, V51, P845, DOI 10.1007/s13197-011-0573-z; Qi Z, 2014, TOXICOLOGY, V315, P92, DOI 10.1016/j.tox.2013.11.003; Rieckmann A, 2015, NEUROIMAGE-CLIN, V8, P554, DOI 10.1016/j.nicl.2015.06.001; RIEDEL E, 1982, PLANTA MED, V46, P219, DOI 10.1055/s-2007-971218; Sai Y, 2008, TOXICOL IN VITRO, V22, P1461, DOI 10.1016/j.tiv.2008.04.019; Sun HS, 2013, ACTA PHARMACOL SIN, V34, P24, DOI 10.1038/aps.2012.138; Tirkey Naveen, 2005, BMC Pharmacology, V5, P15, DOI 10.1186/1471-2210-5-15; Trauner G, 2008, PLANTA MED, V74, P19, DOI 10.1055/s-2007-993761; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Uversky VN, 2014, CHEM REV, V114, P6844, DOI 10.1021/cr400713r; Wang JS, 2011, CRIT REV EUKAR GENE, V21, P303, DOI 10.1615/CritRevEukarGeneExpr.v21.i4.10; Willard AM, 2015, NEUROSCIENCE, V301, P254, DOI 10.1016/j.neuroscience.2015.05.068; Yao Z, 2009, ANTIOXID REDOX SIGN, V11, P2135, DOI [10.1089/ars.2009.2624, 10.1089/ARS.2009.2624]; Yuan CS, 2004, ANESTH ANALG, V98, P353, DOI 10.1213/01.ANE.0000096189.70405.A5	64	23	24	0	27	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	MAY 2	2016	8								97	10.3389/fnagi.2016.00097	http://dx.doi.org/10.3389/fnagi.2016.00097			12	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	DL5AA	27199743	Green Published, gold			2022-09-04	WOS:000375647800001
J	Solano, ML; Benavidez, RL; Pineros, M; Prieto, J; Morales, M; Mancilla, S; Ospina, S; Espinosa, E; Acosta, A; Mino, M; Lengua, M; Nulnez, L; Giovannetti, D				Solano, M. L.; Benavidez, R. L.; Pineros, M.; Prieto, J.; Morales, M.; Mancilla, S.; Ospina, S.; Espinosa, E.; Acosta, A.; Mino, M.; Lengua, M.; Nulnez, L.; Giovannetti, D.			CLINICAL CARATERIZATION AND FOLLOW UP OF 26 COLOMBIAN PATIENTS WITH MPS VI	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th International Conference of Inborn Errors of Metabolism	AUG 29-SEP 02, 2009	San Diego, CA						[Solano, M. L.] Fdn Cardio Infantil, Bogota, Cundinamarea, Colombia; [Benavidez, R. L.] Hosp Angeles Pasto, Pasto, Narino, Colombia; [Pineros, M.] Clin Federman, Bogota, Cundinamarea, Colombia; [Prieto, J.] Univ Javeriana, Bogota, Cundinamarea, Colombia; [Morales, M.] Clin Nueva Eps, Bogota, Cundinamarea, Colombia; [Mancilla, S.] Hosp Fedeico Yeras, Ibague, Tolima, Colombia; [Ospina, S.] Saludeoop, Ibague, Tolima, Colombia; [Espinosa, E.] Hosp Mil, Cundinamarea, Colombia; [Acosta, A.; Mino, M.] Hosp San Jose, Popayan, Cauca, Colombia; [Lengua, M.] Hosp Naval, Cartagena, Colombia; [Nulnez, L.] Cardiovasc Clin, Bucaramanga, Santander, Colombia; [Giovannetti, D.] Biomarin, Sao Paulo, Brazil				Piñeros, Marion/K-3255-2019	Piñeros, Marion/0000-0002-4249-7276					0	0	0	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192			MOL GENET METAB	Mol. Genet. Metab.	SEP-OCT	2009	98	1-2				464	85	85						1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	483DQ					2022-09-04	WOS:000268942600363
J	Montilla, SO; Mopan-Chilito, AM; Murcia, LNS; Triana, JDM; Ruiz, OMC; Montoya-Cepeda, J; Gutierrez-Barreto, DA; Holguin-Vivas, JA; Agamez, CJ; Perez-Grisales, LJ; Cruz-Moncada, M; Corredor-Durango, NJ; Diaz, EAC; Cardona-Cardona, AH; Franco-Perez, E; Rivera-Ospina, AM; Link, A				Montilla, Sebastian O.; Mauricio Mopan-Chilito, Alex; Sierra Murcia, Laura Natalia; Mahecha Triana, Jonathan David; Caro Ruiz, Otto Mauricio; Montoya-Cepeda, Juanita; Alejandra Gutierrez-Barreto, Daniela; Alejandra Holguin-Vivas, Julie; Agamez, Carlos J.; Javier Perez-Grisales, Luis; Cruz-Moncada, Mariana; Juliana Corredor-Durango, Nicole; Chaves Diaz, Erika Alejandra; Humberto Cardona-Cardona, Andres; Franco-Perez, Estefania; Maria Rivera-Ospina, Ana; Link, Andres			Activity Patterns, Diet and Home Range of Night Monkeys (Aotus griseimembra and Aotus lemurinus) in Tropical Lowland and Mountain Forests of Central Colombia	INTERNATIONAL JOURNAL OF PRIMATOLOGY			English	Article						Altitudinal gradient; Behavior; Feeding; Nocturnality; Tropical forests; Use of space		Most primates live in lowland ecosystems; however, some species have been particularly successful at colonizing higher altitudes, such as night monkeys (genus Aotus). Studies of the ecology of night monkeys in tropical forests are numerous, but behavioral data are limited due to the challenges associated with their nocturnal habits. Although Andean night monkeys (A. lemurinus) live in mountain forests >1000 m.a.s.l. and Caribbean night monkeys (A. griseimembra) live in rainforests <1000 m.a.s.l., they are found at similar tropical latitudes. Between 2018 and 2019, we followed three groups of A. lemurinus and one group of A. griseimembra at three sites in Colombia and recorded data on their ecology and behavior. Although they live at different altitudes, the two species had similar activity patterns and diet, investing approximately half of the night in resting (48%), and feeding primarily on fruits. We found differences among groups in the time invested in feeding on flowers, their home range, and distance traveled per night. These differences may be related to the unique characteristics of each study site and differences in resource availability and floristic composition of forests at different altitudes. Although the most important families in their diet were Moraceae and Urticaceae, highland groups also fed frequently on a large number of Melastomataceae and Rubiaceae trees. This research suggests these two nocturnal primates, living in contrasting environments, use similar strategies to cope with the challenges of being active at night in tropical forests.	[Montilla, Sebastian O.; Sierra Murcia, Laura Natalia; Link, Andres] Univ Andes, Lab Ecol Bosques Trop & Primatol LEBTYP, Dept Ciencias Biol, Bogota, Colombia; [Montilla, Sebastian O.; Sierra Murcia, Laura Natalia; Link, Andres] Fdn Proyecto Primates, Bogota, Colombia; [Mauricio Mopan-Chilito, Alex; Humberto Cardona-Cardona, Andres] Univ Quindio, Ctr Estudios Alta Montana CEAM, Programa Biol, Armenia, Colombia; [Mahecha Triana, Jonathan David; Caro Ruiz, Otto Mauricio; Alejandra Holguin-Vivas, Julie] Univ El Bosque, Programa Biol, Bogota, Colombia; [Montoya-Cepeda, Juanita; Chaves Diaz, Erika Alejandra] Pontificia Univ Javeriana, Programa Biol, Bogota, Colombia; [Alejandra Gutierrez-Barreto, Daniela; Chaves Diaz, Erika Alejandra] Pontificia Univ Javeriana, Programa Ecol, Bogota, Colombia; [Agamez, Carlos J.] Univ Cordoba, Grp Invest Biodiversidad, Programa Biol, Monteria, Colombia; [Javier Perez-Grisales, Luis; Cruz-Moncada, Mariana] Univ EAFIT, Dept Ciencias Biol, Escuela Ciencias, Grp Invest Biodiversidad Evolut & Conservat BEC, Medellin, Colombia; [Juliana Corredor-Durango, Nicole; Maria Rivera-Ospina, Ana] Univ INCCA Colombia, Programa Biol, Bogota, Colombia; [Franco-Perez, Estefania] Univ Caldas, Semillero Invest Primatol & Conservac Sus Ecosist, Programa Biol, Manizales, Colombia		Montilla, SO (corresponding author), Univ Andes, Lab Ecol Bosques Trop & Primatol LEBTYP, Dept Ciencias Biol, Bogota, Colombia.; Montilla, SO (corresponding author), Fdn Proyecto Primates, Bogota, Colombia.	juansomontilla94@gmail.com		O. Montilla, Sebastian/0000-0001-6133-8142	National Geographic Society [EC-323R-18]; Global Wildlife Conservation Primates Action Fund; Margot Marsh Biodiversity Foundation [5236.005-0255]; Fundacion Proyecto Primates	National Geographic Society(National Geographic Society); Global Wildlife Conservation Primates Action Fund; Margot Marsh Biodiversity Foundation; Fundacion Proyecto Primates	The authors thank the National Geographic Society (Grant EC-323R-18), the Global Wildlife Conservation Primates Action Fund, and the Margot Marsh Biodiversity Foundation (Grant No. 5236.005-0255) for funding the field phase and facilitating the long-term establishment of the night monkey project in Colombia. Fundacion Proyecto Primates also provided valuable logistical and financial support for the study. We thank the Lalinde and De Greiff families, who have allowed primate research at San Juan de Carare over the past 13 years; the Montilla family and Ruben Orozco for allowing us to carry out this research on their property and facilitating our accommodation in Pijao; and Shella Ovalle and Raul Ladino for accommodating us in their home in the Cuchilla de Pena Blanca reserve and for all the logistical support provided during the project. We sincerely thank Sandra Gomez (Fundacion Ingenial Colombia) and biologist Danilo Santos for the support and logistical facilities given with the Tequendama group.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AQUINO R, 1986, AM J PRIMATOL, V11, P319, DOI 10.1002/ajp.1350110403; Arditi SI., 1992, B PRIMATOLOGICO LATI, V3, P11; Bare MC, 2016, NEW FOREST, V47, P333, DOI 10.1007/s11056-015-9519-z; Bicca-Marques JC, 2004, AM J PRIMATOL, V62, P171, DOI 10.1002/ajp.20014; Blanco MB, 2010, NATURWISSENSCHAFTEN, V97, P945, DOI 10.1007/s00114-010-0707-6; Buitron-Jurado G, 2014, FLORA, V209, P299, DOI 10.1016/j.flora.2014.03.009; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Campos FA, 2014, ANIM BEHAV, V91, P93, DOI 10.1016/j.anbehav.2014.03.007; Caselli CB, 2011, PRIMATES, V52, P351, DOI 10.1007/s10329-011-0266-2; Casta?o JH., 2010, PRIMATOLOGIA COLOMBI, P69; Castano John Harold, 2005, Boletin Cientifico Museo de Historia Natural Universidad de Caldas, V9, P111; Defler T. R., 2010, HIST NATURAL PRIMATE; Defler Thomas R., 2007, Primate Conservation, V22, P55, DOI 10.1896/052.022.0104; DIXSON AF, 1981, J ZOOL, V194, P25, DOI 10.1111/j.1469-7998.1981.tb04576.x; ERKERT HG, 1991, PRIMATOLOGY TODAY, P435; ERKERT HG, 1986, FOLIA PRIMATOL, V47, P171, DOI 10.1159/000156276; ERKERT HG, 1976, FOLIA PRIMATOL, V25, P186, DOI 10.1159/000155712; ESRI, 2018, ARCGIS DESKTOP V10 6; Fernandez-Duque E., 2013, P414; Fernandez-Duque E, 2003, INT J PRIMATOL, V24, P1113, DOI 10.1023/A:1026284430453; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; Fernandez-Duque E, 2008, INT J PRIMATOL, V29, P421, DOI 10.1007/s10764-008-9244-y; Fernandez-Duque E, 2013, INT J PRIMATOL, V34, P752, DOI 10.1007/s10764-013-9689-5; Fernandez-Duque E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012572; de Luna AG, 2017, ENDANGER SPECIES RES, V32, P123, DOI 10.3354/esr00787; GANZHORN JU, 1994, FOLIA PRIMATOL, V63, P203, DOI 10.1159/000156820; GARCIA JE, 1987, PRIMATES, V28, P337, DOI 10.1007/BF02381016; Garcia-R Sebastian, 2018, Neotropical Primates, V24, P56; GENTRY AH, 1982, EVOL BIOL, V15, P1; Grow NB., 2014, HIGH ALTITUDE PRIMAT, P43; Gursky S, 2000, INT J PRIMATOL, V21, P477, DOI 10.1023/A:1005444020059; Guzman A, 2016, AGR ECOSYST ENVIRON, V215, P57, DOI 10.1016/j.agee.2015.09.002; Hanya G, 2003, PRIMATES, V44, P51, DOI 10.1007/s10329-002-0007-7; Helenbrook WD, 2020, ACTA AMAZON, V50, P37, DOI 10.1590/1809-4392201900172; Hemson G, 2005, J ANIM ECOL, V74, P455, DOI 10.1111/j.1365-2656.2005.00944.x; Khimji SN, 2014, PRIMATES, V55, P19, DOI 10.1007/s10329-013-0395-x; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; Kleiber M., 1961, J CHEM EDUC; KORNER C, 1989, OECOLOGIA, V81, P379, DOI 10.1007/BF00377088; Krzton, 2014, DEV PRIMATOLOGY PROG; Lehman SM., 2014, HIGH ALTITUDE PRIMAT, P3, DOI [10.1007/978-1-4614-8175-1_1, DOI 10.1007/978-1-4614-8175-1_1]; LEMAHO Y, 1981, AM J PHYSIOL, V240, pR156, DOI 10.1152/ajpregu.1981.240.3.R156; Link, 2019, AOTUS GRISEIMEMBRA I, DOI [10.2305/IUCN.UK.2019-2.RLTS.T1807A17922228.en, DOI 10.2305/IUCN.UK.2019-2.RLTS.T1807A17922228.EN]; Menard N, 2002, EVOL ANTHROPOL, V11, P95, DOI 10.1002/evan.10067; Montilla SO., 2018, MAMMALOGY NOTES, V4, P6, DOI [10.47603/manovol4n2.6-10, DOI 10.47603/MANOVOL4N2.6-10]; Morales-Jim?nez, 2008, AOTUS LEMURINUS IUCN, DOI [10.2305/IUCN.UK.2008.RLTS.T1808A7651803.en, DOI 10.2305/IUCN.UK.2008.RLTS.T1808A7651803.EN]; Parr Nigel A., 2011, International Journal of Zoology, V2011, P1, DOI 10.1155/2011/967274; Pearce F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2122; PERES CA, 1994, BIOTROPICA, V26, P98, DOI 10.2307/2389114; Puertas P., 1992, FOLIA AMAZ NICA, V4, P151, DOI [10.24841/fa.v4i2.213, DOI 10.24841/FA.V4I2.213]; R Core Team, 2017, R LANGUAGE ENV STAT; Rojas-Rojas AV., 2012, GU A CAMPO PLANTAS C; Rotundo M, 2005, INT J PRIMATOL, V26, P1459, DOI 10.1007/s10764-005-5329-z; Rylands A. B., 2012, International Zoo Yearbook, V46, P11, DOI 10.1111/j.1748-1090.2011.00152.x; Schmitt CB, 2010, APPL VEG SCI, V13, P291, DOI 10.1111/j.1654-109X.2009.01067.x; Serio-Silva JC, 2002, J TROP ECOL, V18, P913, DOI 10.1017/S0266467402002596; Shanee Sam, 2015, Journal of Threatened Taxa, V7, P6947; Shanee S, 2013, TROP CONSERV SCI, V6, P138, DOI 10.1177/194008291300600104; Solano C., 1995, THESIS PONTIFICIA U; Southwick C. H., 1996, P95; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Stevenson PR, 2006, PRIMATES, V47, P239, DOI 10.1007/s10329-005-0172-6; Stevenson PR, 2010, TROP CONSERV SCI, V3, P45, DOI 10.1177/194008291000300105; Stevenson PR., 2012, HIP TESIS, V12, P29; Terborgh J., 1983, 5 NEW WORLD PRIMATES; Vargas WG., 2002, GU A ILUSTRADA PLANT; Wartmann FM, 2014, INT J PRIMATOL, V35, P919, DOI 10.1007/s10764-014-9771-7; Wenyuan Qu, 1993, International Journal of Primatology, V14, P607, DOI 10.1007/BF02215450; WHITEN A, 1987, INT J PRIMATOL, V8, P367, DOI 10.1007/BF02737389; WRIGHT PC, 1978, FOLIA PRIMATOL, V29, P43, DOI 10.1159/000155825; Xiang ZF, 2007, AM J PRIMATOL, V69, P1141, DOI 10.1002/ajp.20412; Xiang ZF, 2012, AM J PRIMATOL, V74, P551, DOI 10.1002/ajp.22008; Zhuang L, 2012, J MT SCI-ENGL, V9, P115, DOI 10.1007/s11629-012-2009-2; Zuidema PA, 1996, ENVIRON CONSERV, V23, P290, DOI 10.1017/S037689290003914X	76	3	4	2	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0164-0291	1573-8604		INT J PRIMATOL	Int. J. Primatol.	FEB	2021	42	1					130	153		10.1007/s10764-020-00192-1	http://dx.doi.org/10.1007/s10764-020-00192-1		FEB 2021	24	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	QN2YO					2022-09-04	WOS:000616892400001
J	Zubizarreta-Macho, A; Alvarez, JM; Martinez, AA; Segura-Egea, JJ; Brucheli, JC; Agustin-Panadero, R; Piriz, RL; Alonso-Ezpeleta, O				Zubizarreta-Macho, Alvaro; Mena Alvarez, Jesus; Albaladejo Martinez, Alberto; Jose Segura-Egea, Juan; Caviedes Brucheli, Javier; Agustin-Panadero, Ruben; Lopez Piriz, Roberto; Alonso-Ezpeleta, Oscar			Influence of the Pecking Motion Frequency on the Cyclic Fatigue Resistance of Endodontic Rotary Files	JOURNAL OF CLINICAL MEDICINE			English	Article						endodontics; cyclic fatigue; pecking motion; endodontic rotary files; NiTi rotary files	PROTAPER UNIVERSAL INSTRUMENTS; NICKEL-TITANIUM FILES; ROTATIONAL SPEED; SEPARATION; RECIPROC; OPERATOR; DEFECTS; SYSTEMS; CANALS; LIFE	Purpose: To analyze the influence of the pecking motion frequency on the cyclic fatigue resistance of endodontic rotary files. Material and Methods: Sixty PlexV 25.06 endodontic rotary files were selected and distributed into three groups: 30 movements/min (n = 20), 60 movements/min (n = 20), and 120 movements/min (n = 20). A dynamic cyclic fatigue device was designed using Computer Aided Design/ Computer Aided Engineering (CAD/CAE) technology and manufactured by 3D impressions to simulate the pecking motion performed by an operator. Failures of the endodontic rotary files were detected by a Light-Emitting Diode (LED)/Light-Dependent Resistor (LDR) system controlled by an Arduino-Driver complex and management software. Endodontic rotary files were tested on an artificial root canal manufactured by wire electrical discharge machining (EDM), with similar dimensions to those of the instrument under examination. Endodontic rotary files were used following the manufacturer's recommendations. The results were analyzed by ANOVA and Weibull statistics. Results: All pairwise comparisons revealed statistically significant differences in all three variables, except for the difference in the number of cycles between the groups with 60 and 120 movements/min (p = 0.298). The scale distribution parameter of Weibull statistics showed statistically significant differences in all three variables, except for the differences in the number of cycles between groups with 30 and 60 movements/min (p = 0.0722). No statistically significant differences in the three variables were observed for the shape distribution parameter. Conclusion: A low frequency of pecking motion is recommended to reduce the risk of failure of endodontic rotary files associated with cyclic fatigue.	[Zubizarreta-Macho, Alvaro; Mena Alvarez, Jesus] Alfonso X El Sabio Univ, Fac Hlth Sci, Dept Endodont, Madrid 28691, Spain; [Albaladejo Martinez, Alberto] Univ Salamanca, Sch Med, Dept Dent, E-37008 Salamanca, Spain; [Jose Segura-Egea, Juan] Univ Seville, Fac Dent, C Avicena S-N, E-41009 Seville, Spain; [Caviedes Brucheli, Javier] Pontificia Univ Javeriana, CIO, Bogota 1101, Colombia; [Agustin-Panadero, Ruben] Univ Valencia, Fac Med & Dent, Dept Stomatol, Valencia 46010, Spain; [Lopez Piriz, Roberto] Inst Mat Sci Madrid, Super Council Sci Invest, Madrid 28222, Spain; [Alonso-Ezpeleta, Oscar] Univ Zaragoza, Sch Hlth Sci, Dept Endodont, Aragorn 22006, Spain		Zubizarreta-Macho, A (corresponding author), Alfonso X El Sabio Univ, Fac Hlth Sci, Dept Endodont, Madrid 28691, Spain.	amacho@uax.es; jmenaalvarez@gmail.com; albertoalbaladejo@hotmail.com; segurajj@us.es; javiercaviedes@gmail.com; rubenagustinpanadero@gmail.com; lopezpiriz@gmail.com; lalonezp@unizar.es	Sánchez-Margalet, Victor/AAB-9986-2021; Agustín-Panadero, Rubén/R-9296-2018; ALVAREZ, JESUS MENA/R-7942-2019; Segura-Egea, Juan J./A-6312-2009	Sánchez-Margalet, Victor/0000-0001-8638-8680; Agustín-Panadero, Rubén/0000-0003-2757-6619; ALVAREZ, JESUS MENA/0000-0003-0533-9065; Segura-Egea, Juan J./0000-0002-0427-9059; Zubizarreta, Alvaro/0000-0001-9362-9702; Alonso Ezpeleta, Luis Oscar/0000-0003-3868-6784; Caviedes-Bucheli, Javier/0000-0003-0407-9847; Lopez-Piriz, Roberto/0000-0003-2431-6950				[Anonymous], 2008, ISO36303631 1; *ANSI ADA, 2002, 282002 ANSIADA; Bhagabati N, 2012, J ENDODONT, V38, P515, DOI 10.1016/j.joen.2011.12.034; De-Deus G, 2014, J ENDODONT, V40, P575, DOI 10.1016/j.joen.2013.10.013; DEDERICH DN, 1986, ORAL SURG ORAL MED O, V61, P192, DOI 10.1016/0030-4220(86)90186-6; Ferreira F, 2017, INT ENDOD J, V50, P143, DOI 10.1111/iej.12613; Gambarini Gianluca, 2019, J Clin Exp Dent, V11, pe609, DOI 10.4317/jced.55839; Gambarra-Soares T, 2013, ENDO-ENDOD PRACT TOD, V7, P101; Gutmann JL, 2012, INT ENDOD J, V45, P113, DOI 10.1111/j.1365-2591.2011.01957.x; Hilfer PB, 2011, J ENDODONT, V37, P72, DOI 10.1016/j.joen.2010.09.011; Hlsmann M, 2019, INT ENDOD J, V52, P1427, DOI 10.1111/iej.13182; Inan U, 2009, J ENDODONT, V35, P1396, DOI 10.1016/j.joen.2009.06.014; Li UM, 2002, J ENDODONT, V28, P448, DOI 10.1097/00004770-200206000-00007; Lopes HP, 2013, J ENDODONT, V39, P693, DOI 10.1016/j.joen.2012.11.048; Lopes HP, 2013, J ENDODONT, V39, P516, DOI 10.1016/j.joen.2012.12.006; Lopes HP, 2010, ORAL SURG ORAL MED O, V110, P401, DOI 10.1016/j.tripleo.2010.05.013; Mandel E, 1999, INT ENDOD J, V32, P436, DOI 10.1046/j.1365-2591.1999.00239.x; Martin B, 2003, INT ENDOD J, V36, P262, DOI 10.1046/j.1365-2591.2003.00630.x; Parashos P, 2004, J ENDODONT, V30, P722, DOI 10.1097/01.DON.0000129963.42882.C9; Patino PV, 2005, J ENDODONT, V31, P114, DOI 10.1097/01.don.0000136209.28647.13; Pedulla E, 2016, J ENDODONT, V42, P156, DOI 10.1016/j.joen.2015.10.004; Peters OA, 2004, J ENDODONT, V30, P559, DOI 10.1097/01.DON.0000129039.59003.9D; Pirani C, 2011, J ENDODONT, V37, P1013, DOI 10.1016/j.joen.2011.04.009; Plotino G, 2014, ODONTOLOGY, V102, P31, DOI 10.1007/s10266-012-0088-8; Plotino G, 2010, ORAL SURG ORAL MED O, V109, pE60, DOI 10.1016/j.tripleo.2009.08.009; Plotino G, 2009, J ENDODONT, V35, P1469, DOI 10.1016/j.joen.2009.06.015; Ray JJ, 2007, J ENDODONT, V33, P1469, DOI 10.1016/j.joen.2007.07.041; Rodrigues RCV, 2011, J ENDODONT, V37, P1553, DOI 10.1016/j.joen.2011.08.011; Roland DD, 2002, J ENDODONT, V28, P543, DOI 10.1097/00004770-200207000-00015; Santos LD, 2013, J ENDODONT, V39, P1444, DOI 10.1016/j.joen.2013.07.030; Sattapan B, 2000, J ENDODONT, V26, P161, DOI 10.1097/00004770-200003000-00008; SCHNEIDER SW, 1971, ORAL SURG ORAL MED O, V32, P271, DOI 10.1016/0030-4220(71)90230-1; Topcuoglu HS, 2016, J ENDODONT, V42, P969, DOI 10.1016/j.joen.2016.03.010; WALIA H, 1988, J ENDODONT, V14, P346, DOI 10.1016/S0099-2399(88)80196-1; Yared GM, 2002, INT ENDOD J, V35, P7, DOI 10.1046/j.1365-2591.2002.00443.x; Zelada G, 2002, J ENDODONT, V28, P540, DOI 10.1097/00004770-200207000-00014	36	12	12	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JAN	2020	9	1							45	10.3390/jcm9010045	http://dx.doi.org/10.3390/jcm9010045			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KO2OF	31878217	gold, Green Published			2022-09-04	WOS:000515388400045
J	Burwick, RM; Velasquez, JA; Valencia, CM; Silva, JL; Echeverry-Coral, SJ; Gutierrez-Marin, JH; Edna-Estrada, F; Trujillo-Otalvaro, JM; Rincon, M; Tolosa, JE				Burwick, Richard M.; Velasquez, Jesus A.; Valencia, Catalina M.; Silva, Jaime L.; Echeverry-Coral, Sandra J.; Gutierrez-Marin, Jorge H.; Edna-Estrada, Francisco; Trujillo-Otalvaro, Juliana M.; Rincon, Monica; Tolosa, Jorge E.			Increased complement activation in preeclampsia, a strong association with severe disease	AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY			English	Meeting Abstract	38th Annual Meeting and Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine	JAN 29-FEB 03, 2018	Dallas, TX	Soc Maternal Fetal Med					[Burwick, Richard M.; Rincon, Monica; Tolosa, Jorge E.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Portland, OR 97201 USA; [Burwick, Richard M.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Burwick, Richard M.; Velasquez, Jesus A.; Valencia, Catalina M.; Silva, Jaime L.; Gutierrez-Marin, Jorge H.; Edna-Estrada, Francisco; Rincon, Monica; Tolosa, Jorge E.] FUNDARED MATERNA, Bogota, Colombia; [Velasquez, Jesus A.] Univ Antioquia, Hosp Univ San Vicente Fdn, Medellin, Colombia; [Velasquez, Jesus A.; Tolosa, Jorge E.] Univ Antioquia, Dept Obstet & Ginecol, Medellin, Colombia; [Velasquez, Jesus A.; Tolosa, Jorge E.] Univ Antioquia, NACER Salud Sexual & Reprod, Medellin, Colombia; [Valencia, Catalina M.] Clin Colsanitas SA, Bogota, Colombia; [Silva, Jaime L.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Echeverry-Coral, Sandra J.] Clin Colsanitas SA, Lab Clin Sanitas, Grp Invest INPAC, Bogota, Colombia; [Gutierrez-Marin, Jorge H.] Univ Pontificia Bolivariana, Clin Univ Bolivariana, Medellin, Colombia; [Edna-Estrada, Francisco] ESE Clin Maternidad Rafael Calvo, Grp Invest Maternidad Segura, Cartagena, Colombia; [Trujillo-Otalvaro, Juliana M.] Hosp Gen Medellin, Luz Castro Gutierrez ESE, Medellin, Colombia				Burwick, Richard/AAA-3365-2020	Burwick, Richard/0000-0002-2340-3772					0	0	0	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9378	1097-6868		AM J OBSTET GYNECOL	Am. J. Obstet. Gynecol.	JAN	2018	218	1		S		305	S193	S193						1	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Obstetrics & Gynecology	FT2CT					2022-09-04	WOS:000422946900306
J	Dong, SL; Baranwal, S; Garcia, A; Serrano-Gomez, SJ; Eastlack, S; Iwakuma, T; Mercante, D; Mauvais-Jarvis, F; Alahari, SK				Dong, Shengli; Baranwal, Somesh; Garcia, Anapatricia; Serrano-Gomez, Silvia J.; Eastlack, Steven; Iwakuma, Tomoo; Mercante, Donald; Mauvais-Jarvis, Franck; Alahari, Suresh K.			Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); calorimetry; cell metabolism; cell migration; glucose; obesity	RICH REPEAT PROTEINS; GLUCOSE-METABOLISM; BINDING PROTEIN; CELL-MIGRATION; BREAST-CANCER; TRANSCRIPTIONAL ACTIVITY; INSULIN-RESISTANCE; HEPATIC STEATOSIS; FATTY-ACID; IQGAP1	Nischarin (Nisch) is a key protein functioning as a molecular scaffold and thereby hosting interactions with several protein partners. To explore the physiological importance of Nisch, here we generated Nisch loss-of-function mutant mice and analyzed their metabolic phenotype. Nisch-mutant embryos exhibited delayed development, characterized by small size and attenuated weight gain. We uncovered the reason for this phenotype by showing that Nisch binds to and inhibits the activity of AMP-activated protein kinase (AMPK), which regulates energy homeostasis by suppressing anabolic and activating catabolic processes. The Nisch mutations enhanced AMPK activation and inhibited mechanistic target of rapamycin signaling in mouse embryonic fibroblasts as well as in muscle and liver tissues of mutant mice. Nisch-mutant mice also exhibited increased rates of glucose oxidation with increased energy expenditure, despite reduced overall food intake. Moreover, the Nisch-mutant mice had reduced expression of liver markers of gluconeogenesis associated with increased glucose tolerance. As a result, these mice displayed decreased growth and body weight. Taken together, our results indicate that Nisch is an important AMPK inhibitor and a critical regulator of energy homeostasis, including lipid and glucose metabolism.	[Dong, Shengli; Baranwal, Somesh; Serrano-Gomez, Silvia J.; Eastlack, Steven; Alahari, Suresh K.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Mercante, Donald] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Biostat, New Orleans, LA 70112 USA; [Baranwal, Somesh] Cent Univ Punjab, Ctr Biochem & Microbial Sci, City Campus Mansa Rd, Bathinda 151001, India; [Garcia, Anapatricia] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Serrano-Gomez, Silvia J.] Pontificia Univ Javeriana, Bogota 11001000, Colombia; [Iwakuma, Tomoo] Univ Kansas, Dept Canc Biol, Med Ctr, Kansas City, KS 66160 USA; [Mauvais-Jarvis, Franck] Tulane Univ, Sch Med, Div Endocrinol, New Orleans, LA 70112 USA		Alahari, SK (corresponding author), Louisiana Sch Med, Biochem, CSRB 406, New Orleans, LA 70112 USA.	salaha@lsuhsc.edu			Louisiana State University School of Medicine; Fred G. Brazda Foundation; National Institutes of Health [R01 DK074970, DK107444]; NATIONAL CANCER INSTITUTE [R01CA174735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074970, R01DK107444] Funding Source: NIH RePORTER	Louisiana State University School of Medicine; Fred G. Brazda Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Louisiana State University School of Medicine and the Fred G. Brazda Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants R01 DK074970 and DK107444.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Baranwal S, 2011, J NATL CANCER I, V103, P1513, DOI 10.1093/jnci/djr350; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Chawla B, 2017, J BIOL CHEM, V292, P3273, DOI 10.1074/jbc.M116.752642; Crescenti A, 2015, J NUTR BIOCHEM, V26, P912, DOI 10.1016/j.jnutbio.2015.03.003; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jain P, 2013, J BIOL CHEM, V288, P15495, DOI 10.1074/jbc.M112.418103; Jha S, 2009, J IMMUNOL, V183, P7623, DOI 10.4049/jimmunol.0902425; Kimura T, 2013, MOL CELL BIOL, V33, P4834, DOI 10.1128/MCB.00895-13; Kohan AB, 2009, BIOCHEM BIOPH RES CO, V388, P117, DOI 10.1016/j.bbrc.2009.07.130; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liangpunsakul S, 2013, J INVEST MED, V61, P270, DOI 10.2310/JIM.0b013e31827c2795; Liao YL, 2005, CARDIOVASC RES, V67, P705, DOI 10.1016/j.cardiores.2005.04.018; Liu XN, 2014, MOL CANCER THER, V13, P596, DOI 10.1158/1535-7163.MCT-13-0579; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Marini C, 2013, CELL CYCLE, V12, P3490, DOI 10.4161/cc.26461; Maziveyi M, 2015, CANCER RES, V75, P4252, DOI 10.1158/0008-5472.CAN-15-1395; Meng XY, 2016, J BIOL CHEM, V291, P10625, DOI 10.1074/jbc.M116.713768; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Ota S, 2009, BIOCHEM BIOPH RES CO, V388, P311, DOI 10.1016/j.bbrc.2009.07.164; PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7; Piletz JE, 2000, DNA CELL BIOL, V19, P319, DOI 10.1089/10445490050043290; Rittmeyer EN, 2008, J CELL SCI, V121, P391, DOI 10.1242/jcs.016881; Sayedyahossein S, 2016, J BIOL CHEM, V291, P19261, DOI 10.1074/jbc.M116.732529; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shan TZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36561; Smith AC, 2005, J PHYSIOL-LONDON, V565, P537, DOI 10.1113/jphysiol.2004.081679; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Tran L, 2015, ANN PHARMACOTHER, V49, P540, DOI 10.1177/1060028014558289; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; WIESE TJ, 1991, COMP BIOCHEM PHYS B, V100, P297, DOI 10.1016/0305-0491(91)90378-Q; Zhang L, 2013, CNS NEUROSCI THER, V19, P978, DOI 10.1111/cns.12192; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	54	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16833	16846		10.1074/jbc.M117.784256	http://dx.doi.org/10.1074/jbc.M117.784256			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842496	Green Published, hybrid			2022-09-04	WOS:000413140600006
J	Plaza, V; Bellido-Casado, J; Rodrigo, GJ; Solarte, J; Rodriguez-Trigo, G; Sepulveda, R; Neffen, H; Perpina, M				Plaza, Vicente; Bellido-Casado, Jesus; Rodrigo, Gustavo J.; Solarte, Javier; Rodriguez-Trigo, Gema; Sepulveda, Ricardo; Neffen, Hugo; Perpina, Miguel			Impact of Preventive Treatment With Long-Acting beta(2)-Adrenergic Agonists and Inhaled Corticosteroids on the Morbidity and Mortality of Severe Asthma Exacerbations in 1543 Patients	ARCHIVOS DE BRONCONEUMOLOGIA			Spanish	Article						Asthma; Morbidity; Mortality; Severe asthma exacerbation; Preventive treatment of asthma; Inhaled corticosteroids; Inhaled long-acting #b(2)-agonists	BETA-AGONISTS; PRESCRIBED FENOTEROL; SAFETY; SALMETEROL; DEATH; SALBUTAMOL; FORMOTEROL; ZEALAND; RISK	Background and Objectives: Recent systematic reviews and meta-analyses examining long-acting #b(2)-adrenergic agonists (LABA) as maintenance treatment for asthma have shown surprisingly conflicting results. The aim of the present study was to determine the impact, in terms of efficacy and safety, of previous maintenance treatment on severe asthma exacerbations. Patients and Methods: We retrospectively evaluated the clinical characteristics of exacerbations experienced by 1543 patients with moderate persistent and severe persistent asthma. Drug therapy was as follows: a combination of inhaled LABAs and corticosteroids (493 patients), an inhaled corticosteroid only (456 patients), and no maintenance treatment (594 patients). Results: Asthmatic patients taking LABAs did not show higher mortality, longer stay in the intensive care unit, longer hospital stay, lower pH, or worse airflow obstruction than the other 2 groups. On the contrary, they had a higher mean (SD) forced expiratory volume in 1 second at discharge (54% [16%]) than patients taking inhaled corticosteroids (48% [19%]) and patients taking no maintenance treatment (48% [20%]) (P=.009). Patients taking no maintenance treatment also had lower mean (SD) pH values (7.37 [0.11]) than patients taking LABAs (7.39 [0.09]) and patients taking inhaled corticosteroids (7.39 [0.08]) (P=.002), and more admissions to the intensive care unit (11.1% vs 6.5% and 7.7%: P=.002 and P=.018, respectively). Conclusions: This study did not reveal higher morbidity or mortality in severe asthma exacerbations in patients with moderate persistent or severe persistent asthma who had received inhaled LABAs combined with inhaled corticosteroids. On, the contrary, asthma patients who did not use maintenance treatment experienced more severe asthma exacerbations. (C) 2009 SEPAR. Published by Elsevier Espana, S.L. All rights reserved.	[Plaza, Vicente; Bellido-Casado, Jesus] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Serv Neumol, E-08193 Barcelona, Spain; [Rodrigo, Gustavo J.] Fac Med Claeh, Punta Del Este, Maldonado, Uruguay; [Rodrigo, Gustavo J.] Hosp Cent Fuerzas Armadas, Dept Emergencia, Montevideo, Uruguay; [Solarte, Javier] Univ Javeriana, Hosp San Ignacio, Unidad Med Resp, Bogota, Colombia; [Rodriguez-Trigo, Gema] Complejo Hosp Univ, Serv Neumol, La Coruna, Spain; [Rodriguez-Trigo, Gema] Hosp Clin San Carlos, Serv Neumol, Madrid, Spain; [Sepulveda, Ricardo] Inst Torax, Santiago, Chile; [Neffen, Hugo] Hosp Ninos O Allassia, Unidad Med Resp, Santa Fe, Argentina; [Perpina, Miguel] Hosp Univ La Fe, Serv Neumol, Valencia, Spain		Plaza, V (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Serv Neumol, E-08193 Barcelona, Spain.	vplaza@santpau.cat		Plaza, Vicente/0000-0003-2567-5496				Beasley R, 2009, EUR RESPIR J, V33, P3, DOI 10.1183/09031936.00163408; Casado JB, 2006, ARCH BRONCONEUMOL, V42, P522, DOI 10.1016/S1579-2129(06)60579-X; *BRIT THOR SOC SCO, 2007, BRIT GUID MAN ASTHM; Carroll CL, 2006, PEDIATR PULM, V41, P1213, DOI 10.1002/ppul.20521; CRANE J, 1989, LANCET, V1, P917; Ribas CD, 2007, ARCH BRONCONEUMOL, V43, P355; Ernst P, 2006, ANN INTERN MED, V145, P692, DOI 10.7326/0003-4819-145-9-200611070-00012; *GLOB IN ASTH, 2006, GLOB STRAT ASTHM MAN; Haahtela T, 2001, THORAX, V56, P806, DOI 10.1136/thorax.56.10.806; Lee DKC, 2004, THORAX, V59, P662, DOI 10.1136/thx.2003.019059; Lopez-Campos JL, 2008, J ASTHMA, V45, P611, DOI 10.1080/02770900802127006; Matz J, 2001, J ALLERGY CLIN IMMUN, V107, P783, DOI 10.1067/mai.2001.114709; Morell F, 2008, ARCH BRONCONEUMOL, V44, P303, DOI 10.1016/S0300-2896(08)70437-X; *NAC ASTHM ED PREV, 2007, 3 NAC ASTH ED PREV P, P1007; Nelson HS, 2006, J ALLERGY CLIN IMMUN, V117, P3, DOI 10.1016/j.jaci.2005.10.013; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Orriols R, 2007, MED CLIN-BARCELONA, V128, P352, DOI 10.1157/13099804; PEARCE N, 1990, THORAX, V45, P170, DOI 10.1136/thx.45.3.170; Rodrigo GJ, 2009, PULM PHARMACOL THER, V22, P9, DOI 10.1016/j.pupt.2008.10.008; Rodrigo Gustavo Javier, 2008, J. bras. pneumol., V34, P546, DOI 10.1590/S1806-37132008000800002; Rodriguez-Trigo G, 2008, ARCH BRONCONEUMOL, V44, P192, DOI 10.1016/S1579-2129(09)60015-X; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sanchez-Bahillo M, 2009, ARCH BRONCONEUMOL, V45, P123, DOI 10.1016/j.arbres.2008.05.004; Sears MR, 2009, EUR RESPIR J, V33, P21, DOI 10.1183/09031936.00145006; SPEIZER FE, 1968, BRIT MED J, V1, P339, DOI 10.1136/bmj.1.5588.339; van der Woude HJ, 2001, THORAX, V56, P529, DOI 10.1136/thorax.56.7.529	26	6	7	0	5	EDICIONES DOYMA S A	BARCELONA	TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN	0300-2896	1579-2129		ARCH BRONCONEUMOL	Arch. Bronconeumol.	NOV	2009	45	11					545	549		10.1016/j.arbres.2009.05.009	http://dx.doi.org/10.1016/j.arbres.2009.05.009			5	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Respiratory System	513DV	19651467				2022-09-04	WOS:000271303500004
J	Velasquez, JA; Burwick, RM; Silva, JL; Lenis, V; Bernal, Y; Vargas, J; Valencia, CMM; Gutierrez, J; Edna, F; Trujillo, J; Rincon, M; Hersh, AR; Tolosa, JE				Velasquez, Jesus A.; Burwick, Richard M.; Silva, Jaime L.; Lenis, Viviana; Bernal, Yamile; Vargas, Johanna; Valencia, Catalina Maria M.; Gutierrez, Jorge; Edna, Francisco; Trujillo, Juliana; Rincon, Monica; Hersh, Alyssa R.; Tolosa, Jorge E.			CD59 and regulation of terminal complement in hypertensive disorders of pregnancy: The COPA II Study	AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY			English	Meeting Abstract	40th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine (SMFM)	FEB 03-08, 2020	Grapevine, TX	Soc Maternal Fetal Med					[Velasquez, Jesus A.; Lenis, Viviana] Univ Antioquia, Medellin, Colombia; [Burwick, Richard M.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Silva, Jaime L.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Bernal, Yamile; Vargas, Johanna] Lab Clin Colsanitas, Bogota, Colombia; [Valencia, Catalina Maria M.] Med Fetal SAS, Medellin, Colombia; [Gutierrez, Jorge] Clin Univ Bolivariana, Medellin, Colombia; [Edna, Francisco] ESE Clin Maternidad Rafael Calvo, Cartagena, Colombia; [Trujillo, Juliana] Hosp Gen Medellin, Luz Castro de Gutierrez ESE, Medellin, Colombia; [Rincon, Monica; Hersh, Alyssa R.; Tolosa, Jorge E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA										0	0	0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9378	1097-6868		AM J OBSTET GYNECOL	Am. J. Obstet. Gynecol.	JAN	2020	222	1		S		87	S72	S72						1	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Obstetrics & Gynecology	JZ3JD					2022-09-04	WOS:000504997300087
J	Mandrik, O; Ekwunife, MI; Meheus, F; Severens, JL; Lhachimi, S; Uyl-de Groot, CA; Murillo, R				Mandrik, Olena; Ekwunife, Minna Ikechukwu; Meheus, Filip; Severens, Johan L. (Hans); Lhachimi, Stefan; Uyl-de Groot, Carin A.; Murillo, Raul			Systematic reviews as a "lens of evidence": Determinants of cost-effectiveness of breast cancer screening	CANCER MEDICINE			English	Review						breast cancer screening; cost-effectiveness; costs; review	FOLLOW-UP STRATEGIES; NONCOMMUNICABLE DISEASES; GLOBAL IMPACT; HEALTH-CARE; ECONOMIC EVALUATIONS; MAMMOGRAPHY; SURVIVORS; WOMEN; PRODUCTIVITY; QUALITY	Systematic reviews with economic components are important decision tools for stakeholders seeking to evaluate technologies, such as breast cancer screening (BCS) programs. This overview of systematic reviews explores the determinants of the cost-effectiveness of BCS and assesses the quality of secondary evidence. The search identified 30 systematic reviews that reported on the determinants of the cost-effectiveness of BCS, including the costs of breast cancer and BCS. While the quality of the reviews varied widely, only four out of 30 papers were considered to be of a high quality. We did not identify publication bias in the original evidence on the cost-effectiveness of mammography screening; however, we highlight a need for improved clarity in both reporting and data verification. The reviews consisted mainly of studies from high-income countries. Breast cancer costs varied widely among the studies. Factors leading to higher costs included: time (diagnosis and last months before death), later stage or metastases, recurrence of the disease, age below 64 years and type of follow-up (more intensive or more specialized). Overall, screening with mammography was considered cost-effective in the age range 50-69 years in Western European and Northern American countries but not for older or younger women. Its cost-effectiveness was questionable for low-income settings and Asia. Mammography screening was more cost-effective with biennial screening compared to annual screening and single reading using computer-aided detection vs double reading. No information on the cost-effectiveness of ultrasonography was found, and there is much uncertainty on the cost-effectiveness of CBE because of methodological limitations.	[Mandrik, Olena; Severens, Johan L. (Hans); Uyl-de Groot, Carin A.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Burgemeester Oudlaan 50, NL-3062 PA Rotterdam, Netherlands; [Mandrik, Olena] Univ Sheffield, Hlth Econ & Decis Sci, Sch Hlth & Related Res ScHARR, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England; [Mandrik, Olena; Meheus, Filip; Murillo, Raul] Int Agcy Res Canc, Sect Early Detect & Prevent, Lyon, France; [Ekwunife, Minna Ikechukwu] Univ Bremen, Leibniz Inst Prevent Res & Epidemiol, Dept Prevent & Evaluat, Collaborat Res Grp Evidence Based Publ Hlth,BIPS, Bremen, Germany; [Ekwunife, Minna Ikechukwu; Lhachimi, Stefan] Nnamdi Azikiwe Univ, Dept Clin Pharm & Pharm Management, Awka, Nigeria; [Severens, Johan L. (Hans); Uyl-de Groot, Carin A.] Erasmus Univ, Inst Med Technol Assessment iMTA, Rotterdam, Netherlands; [Lhachimi, Stefan] Univ Bremen, Inst Publ Hlth & Nursing Res IPP, Hlth Sci Bremen, Bremen, Germany; [Murillo, Raul] Hosp Univ San Ignacio, Ctr Javeriano Oncol, Bogota, Colombia; [Murillo, Raul] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia		Mandrik, O (corresponding author), Erasmus Univ, Erasmus Sch Hlth Policy & Management, Burgemeester Oudlaan 50, NL-3062 PA Rotterdam, Netherlands.; Mandrik, O (corresponding author), Univ Sheffield, Hlth Econ & Decis Sci, Sch Hlth & Related Res ScHARR, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.	o.mandrik@sheffield.ac.uk	Lhachimi, Stefan K/D-9227-2014; Murillo, Raúl/AAY-4416-2021	Lhachimi, Stefan K/0000-0001-8597-0935; Mandrik, Olena/0000-0003-3755-3031; Ekwunife, Obinna/0000-0003-0879-3861; Uyl-de Groot, Carin/0000-0001-5808-302X	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	European Commission FP7 Marie Curie Actions, People, Co-funding of regional, national, and international programmes (COFUND)	Abdel-Aleem H, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009677.pub2; Anderson BO, 2003, BREAST J, V9, P51, DOI DOI 10.1046/j.1524-4741.9.s2.4.x; [Anonymous], 2013, NAT GUID CANC MAN KE; [Anonymous], 2013, GUID EARL DET PER IN; [Anonymous], 2016, IEEE ASME T MECHATRO, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2011, GUID EARL DET BREAST; [Anonymous], 2015, 396 MIN HLTH UKR; [Anonymous], 2015, PLAN FIGHT CANC TUN; [Anonymous], 2014, EARL DET MAN BREAST; Arnold M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2766-2; Barbieri M, 2018, BRIT MED BULL, V126, P85, DOI 10.1093/bmb/ldy011; Baron RC, 2008, AM J PREV MED, V35, pS34, DOI 10.1016/j.amepre.2008.04.002; Baron RC, 2010, AM J PREV MED, V38, P110, DOI 10.1016/j.amepre.2009.09.031; Baxter N, 2001, CAN MED ASSOC J, V164, P1837; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Bertram MY, 2016, B WORLD HEALTH ORGAN, V94, P925, DOI 10.2471/BLT.15.164418; Bray F, 2018, CA CANC J CLIN; Browall M, 2017, J CLIN NURS, V26, P1770, DOI 10.1111/jocn.13496; Campbell JD, 2009, PHARMACOECONOMICS, V27, P199, DOI 10.2165/00019053-200927030-00003; Chaker L, 2015, EUR J EPIDEMIOL, V30, P357, DOI 10.1007/s10654-015-0026-5; Collins RF, 2004, CANCER TREAT REV, V30, P19, DOI 10.1016/S0305-7372(03)00141-5; de Boer AGEM, 2009, JAMA-J AM MED ASSOC, V301, P753, DOI 10.1001/jama.2009.187; Dinnes J, 2001, BREAST, V10, P455, DOI 10.1054/brst.2001.0350; Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x; EU, 2016, FAZ, P1, DOI DOI 10.5194/ACP16-150752016; Evans DB, 2001, BRIT MED J, V323, P307, DOI 10.1136/bmj.323.7308.307; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Foster TS, 2011, CANCER TREAT REV, V37, P405, DOI 10.1016/j.ctrv.2010.12.008; Ho C., 2002, 30 CAN COORD OFF HLT; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Jaspers L, 2015, EUR J EPIDEMIOL, V30, P163, DOI 10.1007/s10654-014-9983-3; Kamal KM, 2017, J MANAG CARE SPEC PH, V23, P136, DOI 10.18553/jmcp.2017.23.2.136; Koleva-Kolarova RG, 2015, BREAST, V24, P354, DOI 10.1016/j.breast.2015.03.013; Lewis R, 2009, J ADV NURS, V65, P706, DOI 10.1111/j.1365-2648.2008.04927.x; Li JJ, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1394-8; Mandelblatt J, 2003, ANN INTERN MED, V139, P835, DOI 10.7326/0003-4819-139-10-200311180-00011; Mandrik O, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0510-y; Mandrik O, 2019, INT J CANCER, V145, P994, DOI 10.1002/ijc.32211; Martinez AO, REVITALIZATION PRECL; Meregaglia M, 2015, EXPERT REV PHARM OUT, V15, P913, DOI 10.1586/14737167.2015.1087316; Ministry of Health and Family Welfare, 2008, NAT CANC CONTR STRAT; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; Murad M Hassan, 2016, Evid Based Med, V21, P125, DOI 10.1136/ebmed-2016-110401; Nelson HD., 2016, PREVENTIVE SERVICES; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Posso M, 2017, EUR J RADIOL, V96, P40, DOI 10.1016/j.ejrad.2017.09.013; Rashidian A, 2013, IRAN J PUBLIC HEALTH, V42, P347; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sun YL, 2017, SUPPORT CARE CANCER, V25, P709, DOI 10.1007/s00520-016-3446-1; van Hezewijk M, 2012, BREAST, V21, P693, DOI 10.1016/j.breast.2012.09.009; Wagner TH, 1998, AM J PREV MED, V14, P64, DOI 10.1016/S0749-3797(97)00003-2; WHO, 2014, GUID APPR GUID REV C; World Bank, GDP PER CAP CURR US; Yoo KB, 2013, ASIAN PAC J CANCER P, V14, P4141, DOI 10.7314/APJCP.2013.14.7.4141; Zelle SG, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-20	56	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	DEC	2019	8	18					7846	7858		10.1002/cam4.2498	http://dx.doi.org/10.1002/cam4.2498		SEP 2019	13	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	KN5BP	31568702	gold, Green Published, Green Accepted			2022-09-04	WOS:000488201000001
J	Rathmann, K; Pfortner, TK; Hurrelmann, K; Osorio, AM; Bosakova, L; Elgar, FJ; Richter, M				Rathmann, Katharina; Pfoertner, Timo-Kolja; Hurrelmann, Klaus; Osorio, Ana M.; Bosakova, Lucia; Elgar, Frank J.; Richter, Matthias			The great recession, youth unemployment and inequalities in psychological health complaints in adolescents: a multilevel study in 31 countries	INTERNATIONAL JOURNAL OF PUBLIC HEALTH			English	Article						Subjective health; Health inequalities; Recession; Youth unemployment; Adolescence; Multilevel analysis	SCHOOL-AGED CHILDREN; FAMILY AFFLUENCE; ECONOMIC RECESSION; FINANCIAL CRISIS; MENTAL-HEALTH; BEHAVIOR	Little is known about the impact of recessions on young people's socioeconomic inequalities in health. This study investigates the impact of the economic recession in terms of youth unemployment on socioeconomic inequalities in psychological health complaints among adolescents across Europe and North America. Data from the WHO collaborative 'Health Behaviour in School-aged Children' (HBSC) study were collected in 2005/06 (N = 160,830) and 2009/10 (N = 166,590) in 31 European and North American countries. Logistic multilevel models were used to assess the contribution of youth unemployment in 2009/10 (enduring recession) and the change in youth unemployment (2005-2010) to adolescent psychological health complaints and socioeconomic inequalities in complaints in 2009/10. Youth unemployment during the recession is positively related to psychological health complaints, but not to inequalities in complaints. Changes in youth unemployment (2005-2010) were not associated with adolescents' psychological health complaints, whereas greater inequalities in complaints were found in countries with greater increases in youth unemployment. This study highlights the need to tackle the impact of increasing unemployment on adolescent health and health inequalities during economic recessions.	[Rathmann, Katharina; Pfoertner, Timo-Kolja; Richter, Matthias] Univ Halle Wittenberg, Inst Med Sociol, Fac Med, Halle, Saale, Germany; [Pfoertner, Timo-Kolja] Univ Cologne, Inst Med Sociol Hlth Serv Res & Rehabil Sci, Fac Human Sci, Cologne, Germany; [Pfoertner, Timo-Kolja] Univ Cologne, Fac Med, Cologne, Germany; [Hurrelmann, Klaus] Hertie Sch Governance Berlin, Berlin, Germany; [Osorio, Ana M.] Pontificia Univ Javeriana Cali, Dept Econ, Cali, Colombia; [Bosakova, Lucia] PJ Safarik Univ Kosice, Hlth Psychol Unit, Inst Publ Hlth, Fac Med, Kosice, Slovakia; [Bosakova, Lucia] Univ Econ Bratislava, Dept Quantitat Methods, Fac Business Econ Kosice, Kosice, Slovakia; [Bosakova, Lucia] Palacky Univ, OUSHI, Olomouc, Czech Republic; [Elgar, Frank J.] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Elgar, Frank J.] McGill Univ, Douglas Inst, Montreal, PQ, Canada		Rathmann, K (corresponding author), Univ Halle Wittenberg, Inst Med Sociol, Fac Med, Halle, Saale, Germany.	katharina.rathmann@medizin.uni-halle.de	Elgar, Frank/ABE-7450-2020; Bosakova, Lucia/AAE-2085-2022; Hurrelmann, Klaus/AAB-7404-2019; Pförtner, Timo-Kolja/AAE-1765-2021; Osorio Mejia, Ana Maria/K-7377-2016	Bosakova, Lucia/0000-0001-8381-7064; Pfortner, Timo-Kolja/0000-0002-8188-894X; Rathmann, Katharina/0000-0002-2892-1624; Osorio Mejia, Ana Maria/0000-0002-8318-6343; Richter, Matthias/0000-0003-3898-3332				Andersen A, 2008, J EPIDEMIOL COMMUN H, V62, P1092, DOI 10.1136/jech.2007.065169; [Anonymous], 2012, MULTILEVEL LONGITUDI; Bell DNF, 2011, OXFORD REV ECON POL, V27, P241, DOI 10.1093/oxrep/grr011; Boyce W, 2006, SOC INDIC RES, V78, P473, DOI 10.1007/s11205-005-1607-6; Catalano R, 2011, ANNU REV PUBL HEALTH, V32, P431, DOI 10.1146/annurev-publhealth-031210-101146; Choudhry M., 2010, QUADERNI DIPARTIMENT, V79; Chzhen Y, 2014, 201406 INN; Coutts A.P., 2014, WELLBEING COMPLETE R, P1; Cui WJ, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.1203346, 10.5888/pcd10.120334]; Currie C., 2012, HLTH BEHAV SCH AGED; Currie C., 2008, INEQUALITIES YOUNG P; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Currie C, 2009, INT J PUBLIC HEALTH, V54, P131, DOI 10.1007/s00038-009-5404-x; Evans GW, 2007, PSYCHOL SCI, V18, P953, DOI 10.1111/j.1467-9280.2007.02008.x; Gavrilovic M, 2010, IMPACTS EC CRISIS YO; Harper C, 2011, DEV POLICY REV, V29, P621, DOI 10.1111/j.1467-7679.2011.00550.x; Hempel K, 2012, ADOLESCENCE PROTECTI; Holmqvist G, 2014, 201414 INN; Holstein BE, 2009, INT J PUBLIC HEALTH, V54, P260, DOI 10.1007/s00038-009-5418-4; Institute of Health Equity for the London Health Inequalities Network, 2012, IMP EC DOWNT POL CHA; International Labour Office, 2013, GLOB EMPL TRENDS YOU; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Kondo N, 2008, J EPIDEMIOL COMMUN H, V62, P869, DOI 10.1136/jech.2007.070334; Lundberg M., 2012, CHILDREN YOUTH CRISI; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; McLoyd V. C., 2009, HDB ADOLESCENT PSYCH, P444, DOI DOI 10.1002/9780470479193.ADLPSY002014; Novo M, 2001, SOC SCI MED, V53, P293, DOI 10.1016/S0277-9536(00)00340-3; OECD, 2012, SOC SPEND CRIS; Pfoertner TK, 2014, EUR J PUBLIC HEALTH, V24, P961, DOI 10.1093/eurpub/cku056; Rajmil L, 2014, INT J ENV RES PUB HE, V11, P6528, DOI 10.3390/ijerph110606528; Rajmil L, 2014, INT J PUBLIC HEALTH, V59, P95, DOI 10.1007/s00038-013-0479-9; Rajmil L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003286; Ravens-Sieberer U, 2008, EUR J PUBLIC HEALTH, V18, P294, DOI 10.1093/eurpub/ckn001; Reine I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-159; Richardson D, 2010, CHILD SOC, V24, P495, DOI 10.1111/j.1099-0860.2010.00334.x; Schnohr CW, 2015, EUR J PUBLIC HEALTH, V25, P7, DOI 10.1093/eurpub/ckv010; Starfield B, 2002, J EPIDEMIOL COMMUN H, V56, P354, DOI 10.1136/jech.56.5.354; Strandh M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2496-5; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; UNICEF, 2014, CHILDR REC IMP EC CR; Urbanos-Garrido RM, 2015, EUR J HEALTH ECON, V16, P175, DOI 10.1007/s10198-014-0563-y; Verick S., 2009, IZA DISCUSSION PAPER	42	12	12	2	38	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1661-8556	1661-8564		INT J PUBLIC HEALTH	Int. J. Public Health	SEP	2016	61	7					809	819		10.1007/s00038-016-0866-0	http://dx.doi.org/10.1007/s00038-016-0866-0			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DU5VL	27502510				2022-09-04	WOS:000382281200009
J	Blach-Olszewska, Z; Zaczynska, E; Gustaw-Rothenberg, K; Avila-Rodrigues, M; Barreto, GE; Leszek, J; Aliev, G				Blach-Olszewska, Zofia; Zaczynska, Ewa; Gustaw-Rothenberg, Kasia; Avila-Rodrigues, Marco; Barreto, George E.; Leszek, Jerzy; Aliev, Gjumrakch			The Innate Immunity in Alzheimer Disease-Relevance to Pathogenesis and Therapy	CURRENT PHARMACEUTICAL DESIGN			English	Article						Alzheimer disease; human peripheral blood leukocytes; innate immunity; therapy	VESICULAR STOMATITIS-VIRUS; HERPES-SIMPLEX-VIRUS; TOLL-LIKE RECEPTORS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HISTAMINE H-3 RECEPTOR; HUMAN-LEUKOCYTES; ANTIVIRAL IMMUNITY; AMYLOID-BETA; MOUSE MODEL; BRAIN-INJURY	The genetic, cellular, and molecular changes associated with Alzheimer disease provide evidence of immune and inflammatory processes involvement in its pathogenesis. These are supported by epidemiological studies, which show some benefit of long-term use of NSAID. The hypothesis that AD is in fact an immunologically mediated and even inflammatory pathological process may be in fact scientifically intriguing. There are several obstacles that suggest the need for more complex view, in the process of targeting inflammation and immunity in AD. In our previous studies we proposed a reliable methodology to assess innate immunity in Alzheimer patients and controls. The methodology is based on the phenomenon of human leukocytes being resistant to viral infection. The unspecific character of the resistance, dependent on interferons and tumor necrosis factor, and occurrence in cells ex vivo indicate that an in vivo mechanism of innate immunity may be involved. The above mentioned resistance could be estimated in a test based on peripheral blood leukocytes infection by vesicular stomachs virus.	[Blach-Olszewska, Zofia; Zaczynska, Ewa] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; [Gustaw-Rothenberg, Kasia] Case Western Reserve Med Ctr, Univ Hosp, Dept Psychiat, Cleveland, OH USA; [Avila-Rodrigues, Marco; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Leszek, Jerzy] Med Univ, Dept Psychiat, Wroclaw, Poland; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA		Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.	jerzy.leszek@umed.wroc.pl; aliev03@gmail.com	Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./B-5747-2014; Aliev, Gjumrakch/K-7302-2017; Barreto, George E./AAD-7420-2020	Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Leszek, Jerzy/0000-0002-2316-2470; Zaczynska, Ewa/0000-0003-0174-3677	Ministry of Science and Higher Education, Poland [N407 081439]; GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA	This work supported by grant no. N407 081439 from the Ministry of Science and Higher Education, Poland. Gjumrakch Aliev work was supported by the GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA. We are also extremely grateful to Prof. Maria Janusz for helpful advice during the preparation of this manuscript.	Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Anekonda TS, 2005, BRAIN RES REV, V50, P361, DOI 10.1016/j.brainresrev.2005.09.001; Arroyo DS, 2011, INT IMMUNOPHARMACOL, V11, P1415, DOI 10.1016/j.intimp.2011.05.006; Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; Bali S, 2008, INDIAN J PUBLIC HLTH, V52; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Blach-Olszewska Z, 2005, ARCH IMMUNOL THER EX, V53, P245; Blach-Olszewska Z, 2005, POL J ENV STUDIES S2, V14, P36; Blach-Olszewska Z, 2008, J INTERF CYTOK RES, V28, P571, DOI 10.1089/jir.2008.0125; Blach-Olszewska Zofia, 2007, Neuropsychiatr Dis Treat, V3, P365; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bloor S, 2010, P NATL ACAD SCI USA, V107, P6970, DOI 10.1073/pnas.0908536107; BONINA L, 1983, INFECT IMMUN, V39, P575, DOI 10.1128/IAI.39.2.575-579.1983; Breitner JCS, 2009, NEUROLOGY, V72, P1899, DOI 10.1212/WNL.0b013e3181a18691; Butt AM, 2014, GLIA, V62, P1762, DOI 10.1002/glia.22674; Cabezas R, 2014, NEUROTOX RES; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Carnevale D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P388; Coil DA, 2004, J VIROL, V78, P10920, DOI 10.1128/JVI.78.20.10920-10926.2004; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Dai XJ, 2015, CELL STRESS CHAPERON, V20, P321, DOI 10.1007/s12192-014-0552-1; Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48; Ferreira R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-90; Frank S, 2009, NEUROSCI LETT, V453, P41, DOI 10.1016/j.neulet.2009.01.075; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Gasiorowski K, 2011, CNS NEUROL DISORD-DR, V10, P184, DOI 10.2174/187152711794480384; Godoy DA, 2008, NEUROCRIT CARE, V9, P217, DOI 10.1007/s12028-008-9063-1; Haddad JJ, 2002, J NEUROIMMUNOL, V133, P1, DOI 10.1016/S0165-5728(02)00357-0; Holmes C, 2003, J NEUROL NEUROSUR PS, V74, P788, DOI 10.1136/jnnp.74.6.788; Hosli E, 2000, NEUROCHEM INT, V36, P301, DOI 10.1016/S0197-0186(99)00138-2; HOSLI L, 1993, NEUROREPORT, V4, P679; Hwang J, 2010, NEUROPHARMACOLOGY, V58, P1122, DOI 10.1016/j.neuropharm.2010.02.003; Jatczak B, 2012, EXP GERONTOL, V47, P8, DOI 10.1016/j.exger.2011.09.010; Jiang Y, 2013, NEUROPHARMACOLOGY, V73, P415, DOI 10.1016/j.neuropharm.2013.06.023; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jung S, 2000, J PHYSIOL-LONDON, V527, P549, DOI 10.1111/j.1469-7793.2000.00549.x; Katoh Y, 2001, NEUROSCI LETT, V305, P181, DOI 10.1016/S0304-3940(01)01835-3; Katsel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007642; Kim HG, 2014, NEUROTOXICOLOGY, V40, P23, DOI 10.1016/j.neuro.2013.10.004; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; Leszek J, 2004, NEUROBIOL AGING, V3, P281; Leszek J, 2002, MED SCI MONITOR, V8, pP193; Leszek Jerzy, 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P377; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Luo W, 2013, BIOORGAN MED CHEM, V21, P7275, DOI 10.1016/j.bmc.2013.09.061; Lv C, 2015, NEUROPHARMACOLOGY, V89, P175, DOI 10.1016/j.neuropharm.2014.09.019; Lyketsos CG, 2007, EVID-BASED MENT HEAL, V10, DOI 10.1136/ebmh.10.4.115; MacDowell K, 2014, INT J NEUROPSYCHOPH, V18, P3; Martin BK, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010033; McGeer PL, 2000, ARCH NEUROL-CHICAGO, V57, P789, DOI 10.1001/archneur.57.6.789; Mele T, 2013, EUR J PHARMACOL, V720, P198, DOI 10.1016/j.ejphar.2013.10.028; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; MOGENSEN SC, 1977, INFECT IMMUN, V17, P268, DOI 10.1128/IAI.17.2.268-273.1977; Morales I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00112; Newman DJ, 2004, CURR MED CHEM, V11, P1693, DOI 10.2174/0929867043364982; Nguyen TV, 2004, AUTON NEUROSCI-BASIC, V115, P1, DOI 10.1016/j.autneu.2004.06.006; NIJHUIS E, 1994, CLIN IMMUNOL IMMUNOP, V73, P45, DOI 10.1006/clin.1994.1168; Orzechowska B, 2003, ARCH IMMUNOL THER EX, V51, P51; Orzechowska B, 2007, ARCH IMMUNOL THER EX, V55, P111, DOI 10.1007/s00005-007-0013-y; Orzechowska Beata, 1996, Archivum Immunologiae et Therapiae Experimentalis, V44, P325; Palin K, 2009, NEUROBIOL AGING, V30, P1677, DOI 10.1016/j.neurobiolaging.2007.12.006; Paradowska E, 1996, J INTERF CYTOK RES, V16, P941, DOI 10.1089/jir.1996.16.941; Paradowska E, 1997, PLACENTA, V18, P441, DOI 10.1016/S0143-4004(97)80045-8; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Piasecki E, 2010, VIRAL IMMUNOL, V23, P567, DOI 10.1089/vim.2010.0054; Poea-Guyon S, 2005, J IMMUNOL, V174, P5941, DOI 10.4049/jimmunol.174.10.5941; Reale M, 2005, EXP GERONTOL, V40, P165, DOI 10.1016/j.exger.2004.12.003; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Rodriguez GA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-111; ROSENTHAL KL, 1986, J VIROL, V60, P539, DOI 10.1128/JVI.60.2.539-547.1986; Rybka K, 2003, MED SCI MONITOR, V9, P413; Salminen A, 2008, BIOCHEM BIOPH RES CO, V371, P587, DOI 10.1016/j.bbrc.2008.04.148; Saltykova TS, 2008, TERAPEVT ARKH, V80, P40; Saneto H, 2008, J GASTROENTEROL, V43, P975, DOI 10.1007/s00535-008-2268-4; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Saxena G, 2008, EUR J PHARMACOL, V581, P283, DOI 10.1016/j.ejphar.2007.12.009; Scieux C, 1997, PATHOL BIOL, V45, P159; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Silva T, 2014, AGEING RES REV, V15, P116, DOI 10.1016/j.arr.2014.03.008; Sochocka M, 2008, J NEUROL SCI, V273, P75, DOI 10.1016/j.jns.2008.06.021; Sochocka M, 2010, INT IMMUNOPHARMACOL, V10, P1505, DOI 10.1016/j.intimp.2010.08.024; Szekely CA, 2010, CNS NEUROL DISORD-DR, V9, P132, DOI 10.2174/187152710791012026; Szekely CA, 2004, NEUROEPIDEMIOLOGY, V23, P159, DOI 10.1159/000078501; Tabet N, 2006, AGE AGEING, V35, P336, DOI 10.1093/ageing/afl027; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Teuscher C, 2007, P NATL ACAD SCI USA, V104, P10146, DOI 10.1073/pnas.0702291104; Thal DR, 2005, NEUROPATH APPL NEURO, V31, P270, DOI 10.1111/j.1365-2990.2005.00635.x; Trotta T, 2014, J NEUROIMMUNOL, V268, P1, DOI 10.1016/j.jneuroim.2014.01.014; Trudler D, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/497987; Tyagi E, 2007, LIFE SCI, V80, P1977, DOI 10.1016/j.lfs.2007.02.039; Tyagi E, 2010, INNATE IMMUN-LONDON, V16, P3, DOI 10.1177/1753425909104680; Van Nostrand WE, 2012, NEURODEGENER DIS, V10, P108, DOI 10.1159/000334763; Yip Agustin G, 2005, BMC Geriatr, V5, P2, DOI 10.1186/1471-2318-5-2; Yoshiyama Y, 2010, J ALZHEIMERS DIS, V22, P295, DOI 10.3233/JAD-2010-100681; ZACZYNSKA E, 1995, J INTERF CYTOK RES, V15, P811, DOI 10.1089/jir.1995.15.811; Zaczynska E, 2001, ARCH IMMUNOL THER EX, V49, pS53; Zaczynska E, 2008, FOLIA HISTOCHEM CYTO, V46, P39, DOI 10.2478/v10042-008-0004-9; Zaczynska Ewa, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P243	102	21	24	1	14	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2015	21	25					3582	3588		10.2174/1381612821666150710144829	http://dx.doi.org/10.2174/1381612821666150710144829			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CP8ZB	26166611				2022-09-04	WOS:000360182400004
J	Tordrup, D; Bishop, C; Green, N; Petzold, M; Vallejo, FR; Vogel, JP; Pallitto, C				Tordrup, David; Bishop, Chrissy; Green, Nathan; Petzold, Max; Vallejo, Fernando Ruiz; Vogel, Joshua P.; Pallitto, Christina			Economic burden of female genital mutilation in 27 high-prevalence countries	BMJ GLOBAL HEALTH			English	Article						child health; health economics; maternal health; obstetrics; public health	QUALITY-OF-LIFE; SEXUAL FUNCTION; HEALTH CONSEQUENCES; IMMIGRANT WOMEN; CIRCUMCISION; COMPLICATIONS; OUTCOMES; IMPACT; ASSOCIATION; INFERTILITY	Background Female genital mutilation (FGM) is a traditional harmful practice affecting 200 million women and girls globally. Health complications of FGM occur immediately and over time, and are associated with healthcare costs that are poorly understood. Quantifying the global FGM-related burden is essential for supporting programmes and policies for prevention and mitigation. Methods Health complications of FGM are derived from a meta-analysis and stratified by acute, uro-gynaecological, obstetric and psychological/sexual. Treatment costs are calculated from national cohort models of 27 high-burden countries over 30 years. Savings associated with full/partial abandonment are compared with a current incidence reference scenario, assuming no changes in FGM practices. Results Our model projects an increasing burden of FGM due to population growth. As a reference scenario assuming no change in practices, prevalent cases in 27 countries will rise from 119.4 million (2018) to 205.8 million (2047). Full abandonment could reduce this to 80.0 million (2047), while partial abandonment is insufficient to reduce cases. Current incidence economic burden is US$1.4 billion/year, rising to US$2.1 billion/year in 2047. Full abandonment would reduce the future burden to US$0.8 billion/year by 2047. Conclusion FGM is a human rights violation, a public health issue and a substantial economic burden that can be avoided through effective prevention strategies. While decreasing trends are observed in some countries, these trends are variable and not consistently observed across settings. Additional resources are needed to prevent FGM to avoid human suffering and growing costs. The findings of this study warrant increased political commitment and investment in the abandonment of FGM.	[Tordrup, David] WHO Collaborating Ctr Pharmaceut Policy & Regulat, Utrecht, Netherlands; [Tordrup, David] Triangulate Hlth Ltd, Doncaster, England; [Green, Nathan] UCL, London, England; [Petzold, Max] Univ Gothenburg, Inst Med, Sch Publ Hlth & Community Med, Gothenburg, Sweden; [Vallejo, Fernando Ruiz] Pontificia Univ Javeriana, Inst Publ Hlth, Bogota, Colombia; [Vogel, Joshua P.] Burnet Inst, Maternal Child & Adolescent Hlth Program, Melbourne, Vic, Australia; [Pallitto, Christina] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dev & ResearchTraining Human Reprod HRP, Dept Sexual & Reprod Hlth & Res, Geneva, Switzerland		Pallitto, C (corresponding author), WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dev & ResearchTraining Human Reprod HRP, Dept Sexual & Reprod Hlth & Res, Geneva, Switzerland.	pallittoc@who.int	Vogel, Joshua/K-7649-2019	Vogel, Joshua/0000-0002-3214-7096; Tordrup, David/0000-0002-7779-9303	Government of Norway; Government of the United Kingdom; UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP)	Government of Norway; Government of the United Kingdom; UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP)	This study was conducted with the financial support of the Government of Norway, the Government of the United Kingdom and the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a co-sponsored programme executed by the World Health Organization (WHO).	Abdel-Aleem MA, 2016, INT J GYNECOL OBSTET, V132, P305, DOI 10.1016/j.ijgo.2015.07.030; Abdulcadir J, 2016, J SEX MED, V13, P226, DOI 10.1016/j.jsxm.2015.12.023; Adam T, 2010, B WORLD HEALTH ORGAN, V88, P281, DOI 10.2471/BLT.09.064808; Adinma J I, 1997, West Afr J Med, V16, P227; Afifi M, 2009, ARCH IRAN MED, V12, P154; Ahmed MR, 2017, EUR J CONTRACEP REPR, V22, P280, DOI 10.1080/13625187.2017.1355454; Ahmed UT., SUDAN J MED SCI; Akinsulure-Smith AM, 2014, J IMMIGR MINOR HEALT, V16, P559, DOI 10.1007/s10903-012-9763-7; Ali HAA, 2018, J PEDIATR ADOL GYNEC, V31, P571, DOI 10.1016/j.jpag.2018.07.010; Almroth L, 2005, LANCET, V366, P385, DOI 10.1016/S0140-6736(05)67023-7; Almroth Lars, 2005, Afr J Reprod Health, V9, P118; Alsibiani SA, 2010, FERTIL STERIL, V93, P722, DOI 10.1016/j.fertnstert.2008.10.035; Ameyaw EK, 2020, BMC INT HEALTH HUM R, V20, DOI 10.1186/s12914-020-00240-0; Amin MM, 2013, INT J GYNECOL OBSTET, V123, P21, DOI 10.1016/j.ijgo.2013.06.010; Andersson SHA, 2012, BJOG-INT J OBSTET GY, V119, P1606, DOI 10.1111/1471-0528.12004; Andro A, 2014, SOC SCI MED, V106, P177, DOI 10.1016/j.socscimed.2014.02.003; Anikwe Chidebe C, 2019, Eur J Obstet Gynecol Reprod Biol X, V1, P100005, DOI 10.1016/j.eurox.2019.100005; Anis TH, 2012, J SEX MED, V9, P2682, DOI 10.1111/j.1743-6109.2012.02866.x; Applebaum Julia, 2008, Prim Care Companion J Clin Psychiatry, V10, P453; Arafa AE, 2018, MIDDLE EAST FERTIL S, V23, P184, DOI 10.1016/j.mefs.2017.11.005; Asekun-Olarinmoye EO, 2008, EUR J CONTRACEP REPR, V13, P289, DOI 10.1080/13625180802075174; Avenir, 2016, ONEHLTH INT INP MAN; Baillot H, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-017-0713-9; Balachandran AA, 2018, INT UROGYNECOL J, V29, P339, DOI 10.1007/s00192-017-3466-5; Banks E, 2006, LANCET, V367, P1835, DOI 10.1016/S0140-6736(06)68805-3; Barsoum G., 2011, 22 NY POP COUNC; Behrendt A, 2005, AM J PSYCHIAT, V162, P1000, DOI 10.1176/appi.ajp.162.5.1000; BERARDI J C, 1985, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V14, P743; Berg RC, 2013, PAEDIATR INT CHILD H, V33, P322, DOI 10.1179/2046905513Y.0000000086; Bewley S, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2728; Biglu MH, 2016, SEX REPROD HEALTHC, V10, P3, DOI 10.1016/j.srhc.2016.07.002; Birge O, 2017, CLIN EXP OBSTET GYN, V44, P691, DOI 10.12891/ceog3464.2017; Boghossian AS, 2020, AUST NZ J OBSTET GYN, V60, P76, DOI 10.1111/ajo.13001; BOHOUSSOU K M, 1986, Afrique Medicale, V25, P160; Brewer DD, 2007, ANN EPIDEMIOL, V17, P217, DOI 10.1016/j.annepidem.2006.10.010; Burger M., 2018, RUNIT R UNIT TEST FR; Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS) D. N. de la Statistique et de l'Informatique du Ministere de l'Economie de l'Industrie et du C. 2007. (DNSI/MEIC) et Macro International Inc, 2006, ENQ DEM SANT MAL 200; Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS) Direction Nationale de la Statistique et de l'Informatique (DNSI) et ORC Macro, 2002, ENQ DEM SANT MAL; Chibber R, 2011, J MATERN-FETAL NEO M, V24, P833, DOI 10.3109/14767058.2010.531318; Chu T, 2016, J AGGRESS MALTREAT T, V25, P63, DOI 10.1080/10926771.2015.1081663; CSO and MI, 1998, YEM DEM MAT CHILD SU; Daneshkhah F, 2017, IRAN J PUBLIC HEALTH, V46, P1265; Davis G, 2019, AUST NZ J OBSTET GYN, V59, P312, DOI 10.1111/ajo.12954; DESILVA S, 1989, EUR J OBSTET GYN R B, V32, P233, DOI 10.1016/0028-2243(89)90041-5; Diop NJ, 2009, STUD FAMILY PLANN, V40, P307, DOI 10.1111/j.1728-4465.2009.00213.x; *DIR NAT STAT MACR, 2000, ENQ DEM SANT GUIN 19; Direction Nationale de la Statistique (DNS) (Guinee) et ORC Macro, 2006, ENQ DEM SANT GUIN 20; Ekwueme O C, 2010, East Afr J Public Health, V7, P64; El-Defrawi MH, 2001, J SEX MARITAL THER, V27, P465, DOI 10.1080/713846810; Elnashar A, 2007, INT J GYNECOL OBSTET, V97, P238, DOI 10.1016/j.ijgo.2007.03.008; Elnashar AM, 2007, BJOG-INT J OBSTET GY, V114, P201, DOI 10.1111/j.1471-0528.2006.01106.x; Esho T, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0433-z; Essen B, 2005, EUR J OBSTET GYN R B, V121, P182, DOI 10.1016/j.ejogrb.2004.12.010; Evans WD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213380; Feldman-Jacobs C., 2013, ENDING FEMALE GENITA; Filipovic-Pierucci A, 2017, ARXIV170203252V1; Frega A, 2013, ARCH GYNECOL OBSTET, V288, P513, DOI 10.1007/s00404-013-2779-y; Gebremicheal K, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1937-4; Gudu Wondimu, 2017, Ethiop Med J, V55, P11; Hakim L Y, 2001, East Afr Med J, V78, P255; Hex N, 2016, ESTIMATING COSTS FEM; Holmgren B, 2003, AIDS, V17, P241, DOI 10.1097/00002030-200301240-00015; Hussein SA., 2019, NO CIRCUMCISIONROAD; Ibrahim ZM, 2013, ARCH GYNECOL OBSTET, V287, P1173, DOI 10.1007/s00404-012-2677-8; Institut National de la Statistique et de l'Analyse Economique (INSAE) [Benin] et Macro International Inc, 2007, ENQ DEM SANT BEN 200; Institut National de la Statistique et de l'Analyse Economique (INSAE) et ORC Macro, 2002, ENQ DEM SANT BEN 2; Ismail SA, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0371-9; Johansen REB, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/348248; KANKI P, 1992, AM J EPIDEMIOL, V136, P895, DOI 10.1093/aje/136.7.895; Kaplan A, 2013, INT J WOMENS HEALTH, V5, P323, DOI 10.2147/IJWH.S42064; Kasim K., 2012, J COMMUNITY MED HLTH, V2, P1; Katz I, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244946; Khodabakhshi Koolaee Anahita, 2012, Int J High Risk Behav Addict, V1, P115, DOI 10.5812/ijhrba.5365; Kimani S, 2020, BMC INT HEALTH HUM R, V20, DOI 10.1186/s12914-020-0222-6; Kizilhan JI, 2011, EUR J PSYCHIAT, V25, P92; Kobach A, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1757-0; Larsen U, 2002, J BIOSOC SCI, V34, P363, DOI 10.1017/S0021932002003632; Larsen U, 2002, INT J GYNECOL OBSTET, V77, P255, DOI 10.1016/S0020-7292(02)00028-0; Larsen U, 2000, DEMOGRAPHY, V37, P313, DOI 10.2307/2648044; Maheu-Giroux M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0871-6; Mahgoub E, 2019, E MEDITERR HEALTH J, V25, P406, DOI 10.26719/emhj.18.053; Mahmoud MIH, 2016, ALEX J MED, V52, P55, DOI 10.1016/j.ajme.2015.03.003; Mahmoudi O., 2017, Journal of Kermanshah University of Medical Sciences, V20, P135; Marouani Y.`, 2019, PUBLICATIONS MINISTE; Maslovskaya O, 2009, J BIOSOC SCI, V41, P815, DOI 10.1017/S0021932009990150; Millogo-Traore F, 2007, J Gynecol Obstet Biol Reprod (Paris), V36, P393; Minsart AF, 2015, J MATERN-FETAL NEO M, V28, P1741, DOI 10.3109/14767058.2014.967676; Mohammed GF, 2014, J SEX MED, V11, P2756, DOI 10.1111/jsm.12655; Morison L, 2001, TROP MED INT HEALTH, V6, P643, DOI 10.1046/j.1365-3156.2001.00749.x; Msuya SE, 2002, TROP MED INT HEALTH, V7, P159, DOI 10.1046/j.1365-3156.2002.00838.x; Ndiaye P, 2010, SANTE PUBLIQUE, V22, P563, DOI 10.3917/spub.105.0563; Ndiaye S, 2006, ENQUETE DEMOGRAPHIQU; O'Neill S, 2021, QUAL HEALTH RES, V31, P1738, DOI 10.1177/10497323211001862; Odoi A, 1997, INT J GYNECOL OBSTET, V56, P179, DOI 10.1016/S0020-7292(96)02800-7; Oduro Ar, 2006, Ghana Med J, V40, P87; Office National de la Statistique (ONS) [Mauritanie] et ORC Macro, 2000, ENQ DEM SANT MAUR 20; Okonofua FE, 2002, BJOG-INT J OBSTET GY, V109, P1089, DOI 10.1016/S1470-0328(02)01950-X; Ouagadjio B., 2005, ENQUETE DEMOGRAPHIQU; Oyefara J. L., 2015, African Population Studies, V29, P1526; Pepin J, 2006, AIDS, V20, P1303, DOI 10.1097/01.aids.0000232239.05545.33; R Development Core Team, 2008, R LANG ENV STAT COMP; Raheem T.A.A, 2018, INT J COMMUNITY MED, V5, P905, DOI [https://doi.org/10.18203/2394-6040.ijcmph20180745, DOI 10.18203/2394-6040.IJCMPH20180745, 10.18203/2394-6040.ijcmph20180745]; Ramu Rawat, 2017, African Journal of Midwifery and Women's Health, V11, P137, DOI 10.12968/ajmw.2017.11.3.137; Robbers G., 2020, HLTH CONSEQUENCES FE; Rodriguez MI, 2017, INT J GYNECOL OBSTET, V139, P21, DOI 10.1002/ijgo.12234; Saleh WF, 2018, J PERINAT MED, V46, P419, DOI 10.1515/jpm-2016-0429; Shandall A A, 1967, Sudan Med J, V5, P178; Shiferaw MT, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.246.2230; Slanger TE, 2002, STUD FAMILY PLANN, V33, P173, DOI 10.1111/j.1728-4465.2002.00173.x; Suzuki C., 2008, Global Public Health, V3, P383, DOI 10.1080/17441690701437187; The World Bank, INFL GDP DEFL LINK S; Thera T, 2015, J GYNECOL OBST BIO R, V44, P276, DOI 10.1016/j.jgyn.2013.12.004; UNFPA, 2018, BEND CURV FGM TRENDS; UNICEF, 2013, STAT PROF FEM GEN MU; UNICEF, FEMALE GENITAL MUTIL; UNICEF, 2010, DYN SOC CHANG AB FEM; UNICEF, 2008, LONG TERM EV TOST PR; United Nations, 2017, WORLD POPULATION PRO; Varol N, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1123-5; Waigwa S, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0503-x; WHO, 2021, HLTH RISKS FEM GEN M; WHO-CHOICE, WHO HLTH SERV DEL CO; World Health Organization, SEX RAT; World Health Organization, 2020, FEMALE GENITAL MUTIL; Wuest S, 2009, BJOG-INT J OBSTET GY, V116, P1204, DOI 10.1111/j.1471-0528.2009.02215.x; Yassin K, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-017-0442-y; Yount KM, 2007, STUD FAMILY PLANN, V38, P73, DOI 10.1111/j.1728-4465.2007.00119.x; Zayed AA, 2012, J FORENSIC LEG MED, V19, P196, DOI 10.1016/j.jflm.2011.12.013	128	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2059-7908			BMJ GLOB HEALTH	BMJ Glob. Health	FEB	2022	7	2							e004512	10.1136/bmjgh-2020-004512	http://dx.doi.org/10.1136/bmjgh-2020-004512			13	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	YS8RV	35105556	gold, Green Published			2022-09-04	WOS:000750940800001
J	Moghaddam, NSA; Oskouie, MN; Butler, AE; Petit, PX; Barreto, GE; Sahebkar, A				Moghaddam, Nazanin Sadat Aghili; Oskouie, Mohammad Nosrati; Butler, Alexandra E.; Petit, Patrice X.; Barreto, George E.; Sahebkar, Amirhossein			Hormetic effects of curcumin: What is the evidence?	JOURNAL OF CELLULAR PHYSIOLOGY			English	Review						biphasic effect; curcumin; hormesis; hormetic response	FATTY LIVER-DISEASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CHRONIC PULMONARY COMPLICATIONS; RANDOMIZED CONTROLLED-TRIAL; SYSTEMIC OXIDATIVE STRESS; HUMAN SKIN FIBROBLASTS; FACTOR-KAPPA-B; PIPERINE COMBINATION; SULFUR MUSTARD; PHYTOSOMAL CURCUMIN	Curcumin (diferuloylmethane), a component of the yellow powder prepared from the roots of Curcuma longa or Zingiberaceae (known as turmeric) is not only widely used to color and flavor food but also used as a pharmaceutical agent. Curcumin demonstrates anti-inflammatory, anticarcinogenic, antiaging, and antioxidant activity, as well as efficacy in wound healing. Notably, curcumin is a hormetic agent (hormetin), as it is stimulatory at low doses and inhibitory at high doses. Hormesis by curcumin could be also a particular function at low doses (i.e., antioxidant behavior) and another function at high dose (i.e., induction of autophagy and cell death). Recent findings suggest that curcumin exhibits biphasic dose-responses on cells, with low doses having stronger effects than high doses; examples being activation of the mitogen-activated protein kinase signaling pathway or antioxidant activity. This indicates that many effects induced by curcumin are dependent on dose and some effects might be greater at lower doses, indicative of a hormetic response. Despite the consistent occurrence of hormetic responses of curcumin in a wide range of biomedical models, epidemiological and clinical trials are needed to assess the nature of curcumin's dose-response in humans. Fortunately, more than one hundred clinical trials with curcumin and curcumin derivatives are ongoing. In this review, we provide the first comprehensive analysis supportive of the hormetic behavior of curcumin and curcumin derivatives.	[Moghaddam, Nazanin Sadat Aghili] Mashhad Univ Med Sci, Fac Med, Dept Nutr, Mashhad, Razavi Khorasan, Iran; [Oskouie, Mohammad Nosrati] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran; [Butler, Alexandra E.] Qatar Biomed Res Inst, Diabet Res Ctr, Doha, Qatar; [Petit, Patrice X.] Univ Paris 05, CNRS, FR3636, Inst Neurosci Mitochondria Apoptosis & Autophagy, Paris, France; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad 9177948564, Razavi Khorasan, Iran.	sahebkara@mums.ac.ir	Petit, patrice/AAF-6774-2020; Petit, Patrice X./A-3692-2009; Barreto, George E./AAD-7420-2020; Sahebkar, Amirhossein/B-5124-2018	Petit, Patrice X./0000-0002-5038-9101; Barreto, George E./0000-0002-6644-1971; Nosrati-Oskouie, Mohammad/0000-0002-5722-553X				Abdollahi E, 2018, J CELL PHYSIOL, V233, P830, DOI 10.1002/jcp.25778; Ahn J, 2010, AM J PHYSIOL-CELL PH, V298, pC1510, DOI 10.1152/ajpcell.00369.2009; Ali RE, 2006, ANN NY ACAD SCI, V1067, P394, DOI 10.1196/annals.1354.056; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Arumugam TV, 2006, AGEING RES REV, V5, P165, DOI 10.1016/j.arr.2006.03.003; Asai A, 2001, J NUTR, V131, P2932, DOI 10.1093/jn/131.11.2932; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bayet-Robert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057971; Beevers CS, 2009, CANCER RES, V69, P1000, DOI 10.1158/0008-5472.CAN-08-2367; Berge U, 2008, EXP GERONTOL, V43, P658, DOI 10.1016/j.exger.2007.12.009; Berge U, 2007, ANN NY ACAD SCI, V1100, P524, DOI 10.1196/annals.1395.058; BJORKMAN D, 1998, AM J MED, V105, P17; Calabrese EJ, 2001, ANNU REV PUBL HEALTH, V22, P15, DOI 10.1146/annurev.publhealth.22.1.15; Cappell MS, 2000, GASTROENTEROL CLIN N, V29, P97, DOI 10.1016/S0889-8553(05)70109-6; Cicero AFG, 2017, ARCH MED SCI, V13, P965, DOI [10.5114/aoms.2017.69326, 10.1093/nutrit/nux047]; Cuttler JM, 2009, DOSE-RESPONSE, V7, P52, DOI 10.2203/dose-response.08-024.Cuttler; Cuttler Jerry M., 2007, Dose-Response, V5, P80, DOI 10.2203/dose-response.06-106.Cuttler; Demirovic D, 2011, BIOGERONTOLOGY, V12, P437, DOI 10.1007/s10522-011-9326-7; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Etminan M, 2003, BMJ-BRIT MED J, V327, P128, DOI 10.1136/bmj.327.7407.128; Ganjali S, 2017, PHARMACOL RES, V119, P208, DOI 10.1016/j.phrs.2017.02.008; Ghandadi M, 2017, CURR PHARM DESIGN, V23, P921, DOI 10.2174/1381612822666161006151605; Ghazimoradi M, 2017, PHYTOTHER RES, V31, P1715, DOI 10.1002/ptr.5899; Grabowska W, 2015, AGE, V37, DOI 10.1007/s11357-014-9744-y; Hamzehzadeh L, 2018, J CELL PHYSIOL, V233, P6530, DOI 10.1002/jcp.26620; Hendrayani SF, 2013, NEOPLASIA, V15, P631, DOI 10.1593/neo.13478; Hoffmann GR, 2009, DOSE-RESPONSE, V7, P1, DOI 10.2203/dose-response.08-023.Hoffmann; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Karimian MS, 2017, CYTOKINE GROWTH F R, V33, P55, DOI 10.1016/j.cytogfr.2016.10.001; Kato K, 1998, CELL STRESS CHAPERON, V3, P152, DOI 10.1379/1466-1268(1998)003<0152:SOTSIE>2.3.CO;2; Keihanian F, 2018, J CELL PHYSIOL, V233, P4497, DOI 10.1002/jcp.26249; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kunnumakkara AB, 2008, CLIN CANCER RES, V14, P2128, DOI 10.1158/1078-0432.CCR-07-4722; Landi F, 2003, AM J GERIAT PSYCHIAT, V11, P179, DOI 10.1176/appi.ajgp.11.2.179; Lee YK, 2009, ANN NY ACAD SCI, V1171, P489, DOI 10.1111/j.1749-6632.2009.04699.x; Lelli D, 2017, PHARMACOL RES, V115, P133, DOI 10.1016/j.phrs.2016.11.017; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lima CF, 2011, MOL NUTR FOOD RES, V55, P430, DOI 10.1002/mnfr.201000221; Lin JA, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq018; Manson MM, 2005, EUR J CANCER, V41, P1842, DOI 10.1016/j.ejca.2005.05.008; Masoodi M, 2018, J CELL BIOCHEM, V119, P9552, DOI 10.1002/jcb.27273; McGettigan P, 2000, CURR PHARM DESIGN, V6, P1693, DOI 10.2174/1381612003398690; Mirzaei H, 2017, BIOMED PHARMACOTHER, V85, P102, DOI 10.1016/j.biopha.2016.11.098; Mirzaei H, 2016, INT J CANCER, V139, P1683, DOI 10.1002/ijc.30224; Momtazi AA, 2016, REV PHYSIOL BIOCH P, V171, P1, DOI 10.1007/112_2016_3; Momtazi AA, 2016, CURR PHARM DESIGN, V22, P4386, DOI 10.2174/1381612822666160527113501; Momtazi AA, 2016, MOL DIAGN THER, V20, P335, DOI 10.1007/s40291-016-0202-7; Momtazi-Borojeni AA, 2018, AUTOIMMUN REV, V17, P125, DOI 10.1016/j.autrev.2017.11.016; Moos PJ, 2004, CARCINOGENESIS, V25, P1611, DOI 10.1093/carcin/bgh163; Moustapha A, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.17; Panahi Y, 2015, DRUG RES, V65, P567, DOI 10.1055/s-0034-1389986; Panahi Y, 2018, DRUG RES, V68, P403, DOI 10.1055/s-0044-101752; Panahi Y, 2017, DRUG RES, V67, P244, DOI 10.1055/s-0043-100019; Panahi Y, 2016, J CARDIOVASC PHARM, V68, P223, DOI 10.1097/FJC.0000000000000406; Panahi Y, 2015, CLIN NUTR, V34, P1101, DOI 10.1016/j.clnu.2014.12.019; Panahi Yunes, 2016, Journal of Dietary Supplements, V13, P209, DOI 10.3109/19390211.2015.1008611; Panahi Yunes, 2016, Journal of Dietary Supplements, V13, P93, DOI 10.3109/19390211.2014.952865; Panahi Y, 2015, PHYTOTHER RES, V29, P17, DOI 10.1002/ptr.5211; Panahi Y, 2014, COMPLEMENT THER MED, V22, P851, DOI 10.1016/j.ctim.2014.07.006; Panahi Y, 2014, PHYTOTHER RES, V28, P1625, DOI 10.1002/ptr.5174; Panahi Y, 2012, ANN CLIN BIOCHEM, V49, P580, DOI 10.1258/acb.2012.012040; Pietrocola F, 2012, CELL CYCLE, V11, P3851, DOI 10.4161/cc.22027; Rahmani S, 2016, PHYTOTHER RES, V30, P1540, DOI 10.1002/ptr.5659; Rainey N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.343; Rashmi R, 2003, FEBS LETT, V538, P19, DOI 10.1016/S0014-5793(03)00099-1; Rattan SIS, 2007, ANN NY ACAD SCI, V1100, P424, DOI 10.1196/annals.1395.047; Rattan SIS, 2009, DOSE-RESPONSE, V7, P90, DOI 10.2203/dose-response.08-014.Rattan; Saberi-Karimian M., 2018, Comparative Clinical Pathology, V27, P555, DOI 10.1007/s00580-017-2624-y; Sahebkar A, 2016, PAIN MED, V17, P1192, DOI 10.1093/pm/pnv024; Sahebkar A, 2016, PHARMACOL RES, V107, P234, DOI 10.1016/j.phrs.2016.03.026; Sahebkar A, 2015, J FUNCT FOODS, V18, P898, DOI 10.1016/j.jff.2015.01.005; Sahebkar A, 2014, NAT REV CARDIOL, V11, P123, DOI 10.1038/nrcardio.2013.140-c1; Salahshooh M. M., 2017, Comparative Clinical Pathology, V26, P17, DOI 10.1007/s00580-016-2339-5; Santel T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003508; Scapagnini G, 2006, ANTIOXID REDOX SIGN, V8, P395, DOI 10.1089/ars.2006.8.395; Scott BR, 2008, DOSE-RESPONSE, V6, P333, DOI 10.2203/dose-response.07-005.Scott; Soflaei SS, 2018, CURR PHARM DESIGN, V24, P123, DOI 10.2174/1381612823666171114165051; Soleimani V, 2018, PHYTOTHER RES, V32, P985, DOI 10.1002/ptr.6054; Son S, 2014, J KOREAN NEUROSURG S, V56, P1, DOI 10.3340/jkns.2014.56.1.1; Southam CM, 1943, PHYTOPATHOLOGY, V33, P517; Sung JJY, 2000, J GASTROEN HEPATOL, V15, pG58, DOI 10.1046/j.1440-1746.2000.02267.x; Tabeshpour J, 2018, J CELL BIOCHEM, V119, P8713, DOI 10.1002/jcb.27192; Teymouri M, 2017, BIOFACTORS, V43, P331, DOI 10.1002/biof.1344; Tomoda T, 1998, ACTA PAEDIATR JAPON, V40, P593; Vashisht M, 2018, J CELL BIOCHEM, V119, P1488, DOI 10.1002/jcb.26309; Veld BAI, 1998, NEUROBIOL AGING, V19, P607, DOI 10.1016/S0197-4580(98)00096-7; Weisberg SP, 2008, ENDOCRINOLOGY, V149, P3549, DOI 10.1210/en.2008-0262; Xu Y, 2007, BRAIN RES, V1162, P9, DOI 10.1016/j.brainres.2007.05.071; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zabihi NA, 2017, CURR PHARM DESIGN, V23, P969, DOI 10.2174/1381612822666161010115235; Zandi PP, 2002, NEUROLOGY, V59, P880, DOI 10.1212/WNL.59.6.880; Zhao R., 2013, OXIDATIVE MED CELLUL, V2013, DOI DOI 10.1155/2013/412576; Zingg JM, 2012, J CELL BIOCHEM, V113, P833, DOI 10.1002/jcb.23411	95	42	43	1	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	JUL	2019	234	7					10060	10071		10.1002/jcp.27880	http://dx.doi.org/10.1002/jcp.27880			12	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	HQ8AL	30515809				2022-09-04	WOS:000462645700015
J	Mandrik, O; Ekwunife, OI; Zielonke, N; Meheus, F; Severens, JL; Lhachimi, SK; Murillo, R				Mandrik, O.; Ekwunife, O. I.; Zielonke, N.; Meheus, F.; Severens, J. L.; Lhachimi, S. K.; Murillo, R.			What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviews	SYSTEMATIC REVIEWS			English	Review						Breast cancer screening; Systematic review; Costs; Efficacy; Effectiveness; Cost-effectiveness	GUIDELINE	Background: Multiple reviews demonstrated high variability in effectiveness and cost-effectiveness outcomes among studies on breast cancer screening (BCS) programmes. No study to our knowledge has summarized the current evidence on determinants of effectiveness and cost-effectiveness of the most used BCS approaches or tried to explain differences in conclusions of systematic reviews on this topic. Based on published reviews, this systematic review aims to assess the degree of variability of determinants for (a) effectiveness and (b) cost-effectiveness of BCS programmes using mammography, clinical breast examination, breast self-examination, ultrasonography, or their combinations among the general population. Methods: We will perform a comprehensive systematic literature search in Cochrane, Scopus, Embase, and Medline (via Pubmed). The search will be supplemented with hand searching of references of the included reviews, with hand searching in the specialized journals, and by contacting prominent experts in the field. Additional search for grey literature will be conducted on the websites of international cancer associations and networks. Two trained research assistants will screen titles and abstracts of publications independently, with at least random 10% of all abstracts being also screened by the principal researcher. The full texts of the systematic reviews will then be screened independently by two authors, and disagreements will be solved by consensus. The included reviews will be grouped by publication year, outcomes, designs of original studies, and quality. Additionally, for reviews published since 2011, transparency in reporting will be assessed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist for the review on determinants of effectiveness and a modified PRISMA checklist for the review on determinants for cost-effectiveness. The study will apply the Assessing the Methodological Quality of Systematic Reviews checklist to assess the methodological quality of systematic reviews. We will report the data extracted from the systematic reviews in a systematic format. Meta-meta-analysis of extracted data will be conducted when feasible. Discussion: This systematic review of reviews will examine the degree of variability in the effectiveness and cost-effectiveness of BCS programmes. Systematic review registration: PROSPERO CRD42016050764 and CRD42016050765	[Mandrik, O.; Meheus, F.; Murillo, R.] Int Agcy Res Canc, Early Detect & Prevent Sect, 150 Cours Albert Thomas, F-69372 Lyon, France; [Mandrik, O.; Severens, J. L.] Erasmus Univ, Inst Hlth Policy & Management, Burgemeester Oudlaan 50, NL-3062 PA Rotterdam, Netherlands; [Ekwunife, O. I.; Lhachimi, S. K.] Univ Bremen, Collaborat Res Grp Evidence Based Publ Hlth, Dept Prevent & Evaluat, Leibniz Inst Prevent Res & Epidemiol,BIPS, Achterstr 30, D-28359 Bremen, Germany; [Ekwunife, O. I.] Nnamdi Azikiwe Univ, Dept Clin Pharm & Pharm Management, PMB 5025, Awka, Nigeria; [Zielonke, N.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands; [Severens, J. L.] Erasmus Univ, Inst Med Technol Assessment, iMTA, Burgemeester Oudlaan 50, NL-3062 PA Rotterdam, Netherlands; [Lhachimi, S. K.] Univ Bremen, Hlth Sci Bremen, Inst Publ Hlth & Nursing Res IPP, Grazer Str 2, D-28359 Bremen, Germany; [Murillo, R.] Hosp Univ San Ignacio, Ctr Javeriano Oncol, Carrera 7 40-62, Bogota, Colombia; [Murillo, R.] Pontificia Univ Javeriana, Fac Med, Carrera 7 40-62, Bogota, Colombia		Mandrik, O (corresponding author), Int Agcy Res Canc, Early Detect & Prevent Sect, 150 Cours Albert Thomas, F-69372 Lyon, France.; Mandrik, O (corresponding author), Erasmus Univ, Inst Hlth Policy & Management, Burgemeester Oudlaan 50, NL-3062 PA Rotterdam, Netherlands.	mandriko@fellows.iarc.fr	Lhachimi, Stefan K/D-9227-2014; Ekwunife, Obinna Ikechukwu/AAZ-5595-2020; Murillo, Raúl/AAY-4416-2021	Lhachimi, Stefan K/0000-0001-8597-0935; Mandrik, Olena/0000-0003-3755-3031; Ekwunife, Obinna/0000-0003-0879-3861	International Agency for Research on Cancer - European Commission FP7 Marie Curie Actions, People, Co-funding of regional, national, and international programmes (COFUND)	International Agency for Research on Cancer - European Commission FP7 Marie Curie Actions, People, Co-funding of regional, national, and international programmes (COFUND)	The work reported in this paper was undertaken during the tenure of a postdoctoral fellowship of Dr. Olena Mandrik from the International Agency for Research on Cancer, partially supported by the European Commission FP7 Marie Curie Actions, People, Co-funding of regional, national, and international programmes (COFUND).	Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Hamashima C, 2015, CANCER SCI, V106, P812, DOI 10.1111/cas.12693; Higgins J., 2011, JOHN WILEY SONS; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Lee EH, 2015, J KOREAN MED ASSOC, V58, P408, DOI 10.5124/jkma.2015.58.5.408; Moher D, 2015, SYST REV, V4, P1, DOI DOI 10.1186/2046-4053-4-1; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nelson H.D., 2016, EUROPE PMC; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10	12	4	4	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2046-4053		SYST REV-LONDON	Syst. Rev.		2017	6								122	10.1186/s13643-017-0510-y	http://dx.doi.org/10.1186/s13643-017-0510-y			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HE2QH	28659183	Green Published, gold			2022-09-04	WOS:000453154500122
J	Benavides-Cordoba, V; Barros-Poblete, M; Vieira, RP; Mazzucco, G; Fregonezi, G; Torres-Castro, R				Benavides-Cordoba, Vicente; Barros-Poblete, Marisol; Vieira, Rodolfo P.; Mazzucco, Guillermo; Fregonezi, Guilherme; Torres-Castro, Rodrigo			Provision of pulmonary rehabilitation in Latin America 18 months after the COVID-19 pandemic: A survey of the Latin American Thoracic Association	CHRONIC RESPIRATORY DISEASE			English	Article						Pulmonary rehabilitation; Latin America; post-COVID-19; survey	HEALTH	Introduction The Coronavirus disease (COVID-19) pandemic has significantly altered the provision of rehabilitation services, especially pulmonary rehabilitation (PR). Our objective was to assess the provision of PR services in Latin America 18 months after the COVID-19 pandemic was declared. Methods A cross-sectional study that included professionals dedicated to PR in centres in Latin America was applied. Responses to an online questionnaire were collected from May to September 2021. The following data were included for the analysis: demographic data, evaluation strategies, program structure, PR intervention in post-COVID-19 patients, and perception of strategies therapies for the care of post-COVID-19 patients. The questionnaire was distributed in Spanish and Portuguese languages. Results Responses were received from 196 PR centres. Exercise tolerance was predominantly measured with the six-minute walk test. Less than 50% of the institutions evaluate quality of life, physical qualities, symptoms, and lung function. Most of the programmes have physiotherapists (90.8%), as well as pulmonologists (60%), and psychologists (35%), among other professionals. Conclusion PR services in Latin America have adapted in their way to the requirements of the pandemic, and most continued to provide face-to-face services. It was identified that the application of the programs is heterogeneous both in evaluations and interventions.	[Benavides-Cordoba, Vicente] Univ Valle, Fac Ciencias Salud, Pontificia Univ Javeriana Cali, Cali, Colombia; [Barros-Poblete, Marisol] Univ Austral Chile, Escuela Grad Fac Med, Programa Doctorado Ciencias Med, Valdivia, Chile; [Vieira, Rodolfo P.] Fed Univ Sao Paulo UNIFESP, Postgrad Program Rehabil Sci & Human Movement & P, Santos, SP, Brazil; [Vieira, Rodolfo P.] Univ Brasil, Postgrad Program Bioengn, Sao Paulo, SP, Brazil; [Mazzucco, Guillermo] Univ Gran Rosario, Ctr Univ Asistencia Docencia & Invest, Inst Cardiovasc Rosario ICR, Rosario, Argentina; [Fregonezi, Guilherme] Univ Fed Rio Grande do Norte, Hosp Univ Onofre Lopes, Empresa Brasileira Serv Hosp EBSERH, PneumoCardioVasc Lab HUOL, Natal, RN, Brazil; [Fregonezi, Guilherme] Univ Fed Rio Grande do Norte, Hosp Univ Onofre Lopes, Empresa Brasileira Serv Hosp EBSERH, Lab Inovacao Tecnol Reabilitacao, Natal, RN, Brazil; [Fregonezi, Guilherme] Univ Fed Rio Grande do Norte, Dept Fisioterapia, Natal, RN, Brazil; [Fregonezi, Guilherme; Torres-Castro, Rodrigo] Int Physiotherapy Res Network PhysioEvidence, Barcelona, Spain; [Torres-Castro, Rodrigo] Univ Chile, Fac Med, Dept Phys Therapy, Santiago, Chile		Torres-Castro, R (corresponding author), Univ Chile, Fac Med, Dept Phys Therapy, Independencia 1027, Santiago 1025000, Chile.	klgorodrigotorres@gmail.com	Torres-Castro, Rodrigo/E-3630-2014	Torres-Castro, Rodrigo/0000-0001-7974-4333; Benavides, Vicente/0000-0002-9129-0183				Agostini F, 2021, J REHABIL MED, V53, DOI 10.2340/16501977-2776; [Anonymous], 2011, LANCET, V377, P1977, DOI 10.1016/S0140-6736(11)60844-1; [Anonymous], EC DIMENSIONS NONCOM, V3; Arbillaga-Etxarri A., 2022, OPEN RESPIR ARCH, V4, P100139, DOI [10.1016/j.opresp.2021.100139, DOI 10.1016/J.OPRESP.2021.100139]; Ashktorab Hassan, 2021, Res Sq, DOI 10.21203/rs.3.rs-141245/v1; Barker-Davies RM, 2020, BRIT J SPORT MED, V54, P949, DOI 10.1136/bjsports-2020-102596; Barreto GZ, 2021, COPD, V18, P401, DOI 10.1080/15412555.2021.1934822; Bickton FM, 2021, AM J PHYS MED REHAB, V100, P209, DOI 10.1097/PHM.0000000000001666; Cheng YY, 2021, J FORMOS MED ASSOC, V120, P83, DOI 10.1016/j.jfma.2020.08.015; Colberg SR, 2003, DIABETES CARE, V26, P986, DOI 10.2337/diacare.26.4.986; Curci C, 2020, EUR J PHYS REHAB MED, V56, P633, DOI 10.23736/S1973-9087.20.06339-X; Dani M, 2021, CLIN MED, V21, pE63, DOI 10.7861/clinmed.2020-0896; de Albornoz SC, 2021, J PSYCHOSOM RES, V142, DOI 10.1016/j.jpsychores.2021.110356; Deng JW, 2021, ANN NY ACAD SCI, V1486, P90, DOI 10.1111/nyas.14506; Ezequiel GE, 2021, INT J QUAL HEALTH C, V33, DOI 10.1093/intqhc/mzaa062; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; George PM, 2020, THORAX, V75, P1009, DOI 10.1136/thoraxjnl-2020-215314; Goertz YMJ, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00542-2020; Guo L, 2020, NEUROPSYCH DIS TREAT, V16, P2661, DOI 10.2147/NDT.S278245; Ilyas A, 2021, CUREUS, V13, DOI 10.7759/cureus.18303; Jacobs LG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243882; Kanjrawi AA, 2021, BMC PULM MED, V21, DOI 10.1186/s12890-021-01418-5; Kirby T, 2020, LANCET RESP MED, V8, P551, DOI 10.1016/S2213-2600(20)30218-6; Kruk ME, 2018, LANCET, V392, P2203, DOI 10.1016/s0140-6736(18)31668-4; Mazza MG, 2020, BRAIN BEHAV IMMUN, V89, P594, DOI 10.1016/j.bbi.2020.07.037; McCarthy B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub3; Mechanick JI, 2021, JPEN-PARENTER ENTER, V45, P13, DOI 10.1002/jpen.2036; Meys R, 2020, HEALTH QUAL LIFE OUT, V18, P300, DOI 10.1186/s12955-020-01505-x; Mills JA, 2021, ARCH PHYS MED REHAB, V102, P1113, DOI 10.1016/j.apmr.2020.10.129; Natalucci V, 2020, FRONT PUBLIC HEALTH, V8, P2020, DOI 10.3389/fpubh.2020.602020; Nunez-Cortes R, 2021, CHRON RESP DIS, V18, DOI 10.1177/1479973121999205; Osadnik CR, 2019, RESPIROLOGY, V24, P871, DOI 10.1111/resp.13569; Paneroni M, 2021, AM J PHYS MED REHAB, V100, P105, DOI 10.1097/PHM.0000000000001641; Parker AM, 2021, LANCET RESP MED, V9, P1328, DOI 10.1016/S2213-2600(21)00385-4; Pizarro-Pennarolli C, 2021, PEERJ, V9, DOI 10.7717/peerj.11026; Poudel AN, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259164; Rivera-Lillo G, 2020, ARCH PHYS MED REHAB, V101, P1470, DOI 10.1016/j.apmr.2020.04.013; Sanchez-Ramirez DC, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9080900; Sarzynska K, 2021, EUR REV MED PHARMACO, V25, P4983, DOI 10.26355/eurrev_202108_26455; Seron P., 2021, PHYS THER REHABIL J, V101, ppzab053, DOI [10.1093/ptj/pzab053, DOI 10.1093/PTJ/PZAB053]; Shariat A, 2018, WORK, V60, P549, DOI 10.3233/WOR-182762; Sibila O., 2020, OPEN RESPIR ARCH, V2, P278, DOI [10.1016/j.opresp.2020.09.002, DOI 10.1016/J.OPRESP.2020.09.002]; Singh MK, 2021, COMPUT BIOL MED, V130, P4219, DOI 10.1016/j.compbiomed.2021.104219; Soriano JB, 2021, ARCH BRONCONEUMOL, V57, P735, DOI 10.1016/j.arbres.2021.04.001; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Wong AW, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.03276-2020	46	1	1	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1479-9723	1479-9731		CHRON RESP DIS	Chronic Respir. Dis.	MAY	2022	19								14799731221104102	10.1177/14799731221104102	http://dx.doi.org/10.1177/14799731221104102			9	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Respiratory System	1U2XB	35616253	gold, Green Published			2022-09-04	WOS:000805280200001
J	Momtazi-Borojeni, AA; Sabouri-Rad, S; Gotto, AM; Pirro, M; Banach, M; Awan, Z; Barreto, GE; Sahebkar, A				Momtazi-Borojeni, Amir Abbas; Sabouri-Rad, Sarvenaz; Gotto, Antonio M., Jr.; Pirro, Matteo; Banach, Maciej; Awan, Zuhier; Barreto, George E.; Sahebkar, Amirhossein			PCSK9 and inflammation: a review of experimental and clinical evidence	EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY			English	Review						Atherosclerosis; Inflammation; LDLR; LDL-C; PCSK9	C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B; KEXIN TYPE 9; CARDIOVASCULAR-DISEASE; MONOCLONAL-ANTIBODIES; CROSS-TALK; ATHEROSCLEROSIS; CHOLESTEROL	Proprotein convertase subtilisin/kexin Type 9 (PCSK9) is now identified as an important and major player in hypercholesterolaemia and atherosclerosis pathophysiology. PCSK9, through promoting lysosomal degradation of hepatic low-density lipoprotein (LDL) receptor, can decrease the clearance of plasma LDLs, leading to hypercholesterolaemia and consequent atherosclerotic plaque formation. Hypercholesterolaemia has been found to promote systemic and vascular inflammation, which can cause atherosclerotic lesion formation and progression and subsequent incidence of cardiovascular disease. Recent studies have shown the involvement of PCSK9 in the inflammatory pathway of atherosclerosis. Although trials with PCSK9 inhibitors have not shown any alteration in plasma C-reactive protein levels, there is accumulating evidence showing lessened inflammatory response in the arterial wall that could attenuate atherosclerotic plaque development beyond the established LDL-lowering effect of PCSK9 inhibition. In this review, we represent mounting evidence indicating that PCSK9 can locally increase vascular inflammation and contribute to atherosclerotic plaque progression in patients with hypercholesterolaemia.	[Momtazi-Borojeni, Amir Abbas] Mashhad Univ Med Sci, Bu Ali Res Inst, Nanotechnol Res Ctr, POB 91779-48564, Mashhad, Razavi Khorasan, Iran; [Momtazi-Borojeni, Amir Abbas] Mashhad Univ Med Sci, Fac Med, Student Res Comm, Dept Med Biotechnol, Mashhad, Razavi Khorasan, Iran; [Sabouri-Rad, Sarvenaz] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Gotto, Antonio M., Jr.] Weill Cornell Med Coll, New York, NY USA; [Pirro, Matteo] Univ Perugia, Dept Med, Unit Internal Med Angiol & Arteriosclerosis Dis, Perugia, Italy; [Banach, Maciej] Med Univ Lodz, WAM Univ Hosp Lodz, Dept Hypertens, Zeromskiego 113, Lodz, Poland; [Banach, Maciej] PMMHRI, Lodz, Poland; [Awan, Zuhier] King Abdulaziz Univ, Dept Clin Biochem, Jeddah, Saudi Arabia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran.; Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran.	sahebkara@mums.ac.ir	Sahebkar, Amirhossein/B-5124-2018; Pirro, Matteo/AAC-2318-2022; Barreto, George E./AAD-7420-2020; Sabourirad, Sarvenaz/AAQ-3692-2021; Banach, Maciej/A-1271-2009; Momtazi-Borojeni, Amir Abaas/AAC-6972-2019	Barreto, George E./0000-0002-6644-1971; Sabourirad, Sarvenaz/0000-0002-9104-6092; Banach, Maciej/0000-0001-6690-6874; Momtazi-Borojeni, Amir Abaas/0000-0002-4376-1083; Awan, Zuhier/0000-0002-4176-335X	National Institute for Medical Research Development (NIMAD), Tehran, Iran [963401]	National Institute for Medical Research Development (NIMAD), Tehran, Iran	We are thankful for the financial support from the National Institute for Medical Research Development (NIMAD), Tehran, Iran [grant no: 963401].	Abela GS, 2010, J CLIN LIPIDOL, V4, P156, DOI 10.1016/j.jacl.2010.03.003; Ason B, 2014, J LIPID RES, V55, P2370, DOI 10.1194/jlr.M053207; Awan Z, 2016, ANGIOLOGY, V67, P157, DOI 10.1177/0003319715583205; Baruch A, 2017, AM J CARDIOL, V119, P1576, DOI 10.1016/j.amjcard.2017.02.020; Bonaca MP, 2018, CIRCULATION, V137, P338, DOI 10.1161/CIRCULATIONAHA.117.032235; Boren J, 1998, J CLIN INVEST, V101, P2658, DOI 10.1172/JCI2265; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Chen F, 1999, CLIN CHEM, V45, P7; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; Ding ZF, 2016, ANTIOXID REDOX SIGN, V25, P997, DOI 10.1089/ars.2016.6631; Ding ZF, 2015, CARDIOVASC RES, V107, P556, DOI 10.1093/cvr/cvv178; Ding ZF, 2015, ANTIOXID REDOX SIGN, V22, P760, DOI 10.1089/ars.2014.6054; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Dwivedi DJ, 2016, SHOCK, V46, P672, DOI 10.1097/SHK.0000000000000682; Feingold KR, 2008, BIOCHEM BIOPH RES CO, V374, P341, DOI 10.1016/j.bbrc.2008.07.023; Ferri N, 2016, ATHEROSCLEROSIS, V253, P214, DOI 10.1016/j.atherosclerosis.2016.07.910; Ferri N, 2012, ATHEROSCLEROSIS, V220, P381, DOI 10.1016/j.atherosclerosis.2011.11.026; Gencer B, 2016, EUR HEART J, V37, P546, DOI 10.1093/eurheartj/ehv637; Giunzioni I, 2016, J PATHOL, V238, P52, DOI 10.1002/path.4630; Grune J, 2017, BIOCHEM BIOPH RES CO, V485, P312, DOI 10.1016/j.bbrc.2017.02.085; Guo J, 2009, CARDIOVASC RES, V81, P278, DOI 10.1093/cvr/cvn311; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jialal I, 2004, HYPERTENSION, V44, P6, DOI 10.1161/01.HYP.0000130484.20501.df; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Koenig W, 2003, THROMB HAEMOSTASIS, V89, P601; Kuhnast S, 2014, J LIPID RES, V55, P2103, DOI 10.1194/jlr.M051326; Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; Landlinger C, 2017, EUR HEART J, V38, P2499, DOI 10.1093/eurheartj/ehx260; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Li S, 2015, ANN MED, V47, P386, DOI 10.3109/07853890.2015.1042908; Li S, 2014, ATHEROSCLEROSIS, V234, P441, DOI 10.1016/j.atherosclerosis.2014.04.001; Libby P, 2006, AM J CARDIOL, V98, p26P, DOI 10.1016/j.amjcard.2006.09.017; Madjid M, 2013, TEX HEART I J, V40, P17; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Moens SJB, 2017, EUR HEART J, V38, P1584, DOI 10.1093/eurheartj/ehx002; Momtazi-Borojeni AA, 2019, ARCH MED SCI, V15, P570, DOI 10.5114/aoms.2019.84734; Momtazi-Borojeni AA, 2019, ARCH MED SCI, V15, P559, DOI 10.5114/aoms.2019.84732; Momtazi-Borojeni AA, 2019, ATHEROSCLEROSIS, V283, P69, DOI 10.1016/j.atherosclerosis.2019.02.001; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Pearson TA, 2004, CIRCULATION, V110, pE543, DOI 10.1161/01.CIR.0000148979.11121.6B; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Pirillo A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152786; Pradhan AD, 2018, CIRCULATION, V138, P141, DOI [10.1161/CIRCULATIONAHA.118.035432, 10.1161/CIRCULATIONAHA.118.034645]; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Ruparelia N, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.185; Sahebkar A, 2016, BRIT J CLIN PHARMACO, V81, P1175, DOI 10.1111/bcp.12905; Schulz R, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0463-z; Shah PK, 2009, CARDIOVASC DRUG THER, V23, P31, DOI 10.1007/s10557-008-6147-2; Shapiro MD, 2017, J ATHEROSCLER THROMB, V24, P462, DOI 10.5551/jat.RV17003; Signorelli SS, 2012, CURR PHARM DESIGN, V18, P4350; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tang YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123685; Tang ZH, 2017, ATHEROSCLEROSIS, V262, P113, DOI 10.1016/j.atherosclerosis.2017.04.023; Tang ZH, 2012, INT J MOL MED, V30, P931, DOI 10.3892/ijmm.2012.1072; Walley KR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008782; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Zhang Y, 2014, J CLIN LIPIDOL, V8, P494, DOI 10.1016/j.jacl.2014.07.001; Zhang YX, 1999, ATHEROSCLEROSIS, V145, P375, DOI 10.1016/S0021-9150(99)00105-7	67	64	65	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2055-6837	2055-6845		EUR HEART J-CARD PHA	EUR. HEART J.-CARDIOVASC. PHARMACOTHER.	OCT	2019	5	4					237	245		10.1093/ehjcvp/pvz022	http://dx.doi.org/10.1093/ehjcvp/pvz022			9	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	JF2WW	31236571	Bronze			2022-09-04	WOS:000491247800011
J	Varon, A; Santos, L; Tapias, M; Caez, C; Marin, JI; Santos, O; Garzon, M; Beltran, O; Gomez-Aldana, A; Yepes, IJ; Rondon, M; Rosselli, D				Varon, Adriana; Santos, Luisa; Tapias, Monica; Caez, Clara; Ignacio Marin, Juan; Santos, Oscar; Garzon, Martin; Beltran, Oscar; Gomez-Aldana, Andres; Yepes, Ismael J.; Rondon, Martin; Rosselli, Diego			COLOMBIAN EXPERIENCE IN THE TREATMENT OF HEPATITIS C WITH DIRECT-ACTING ANTIVIRAL AGENTS	MEDICINA-BUENOS AIRES			English	Article						antiviral agents; drug therapy; hepatitis C; chronic hepatitis; liver transplantation; treatment outcome	SUSTAINED VIROLOGICAL RESPONSE; VIRUS-INFECTION; PERSISTENT THROMBOCYTOPENIA; HCV INFECTION; BLOOD-DONORS; SOFOSBUVIR; PREVALENCE; DACLATASVIR; RIBAVIRIN; EFFICACY	There are few published real-world studies on hepatitis C in Latin America. This paper describes a cohort of Colombian subjects treated with direct-acting antiviral agents. A total of 195 patients from 5 hepatology centers in 4 Colombian cities were retrospectively studied. For each patient, serum biomarkers were obtained, and Child-Pugh, MELD, cirrhosis and fibrosis stage were calculated. Additionally, viral load was quantified at initiation, end of treatment and at 12 weeks of completion. Adverse effects were recorded. Patients with liver transplant were compared with non-transplanted patients in terms of serum biomarkers. The patients had received 9 different regimes. The most prevalent viral genotype was 1b 981.5%). Overall, 186 patients 995.4%) attained sustained virologic response. When comparing transplanted vs. non-transplanted patients, those in the non-transplanted group were more likely to have cirrhosis 952.6% vs. 12.5%, p = 0.0004). Pre-treatment viral load was higher in the transplant group 91 743 575 IQR = 1 038 062-4 252 719 vs. 345 769 IQR = 125 806-842 239; p < 0.0001) as well as ALT and AST levels 982.5 IQR 43.5-115.5 vs. 37.0 IQR = 24.7-73.3; p = 0.0009 and 70 IQR = 41-140 vs. 37 IQR = 24-68; p = 0.004 respectively). Adverse events were reported by 28.7% of the patients; asthenia 95.6%) was the most prevalent. Our results are comparable with those from other countries in terms of therapy and biomarkers. However, our cohort reported less adverse events. Further research is needed in the region.	[Varon, Adriana; Santos, Luisa; Garzon, Martin; Beltran, Oscar] Fdn Cardioinfantil, Serv Hepatol & Trasplante Hepat, Bogota, Colombia; [Varon, Adriana; Garzon, Martin; Beltran, Oscar] Univ Rosario, Bogota, Colombia; [Tapias, Monica; Gomez-Aldana, Andres] Hosp Univ Fdn Santa Fe Bogota, Bogota, Colombia; [Tapias, Monica] Org Sanitas Int, Bogota, Colombia; [Caez, Clara] Serv Hepatol, Barranquilla, Colombia; [Ignacio Marin, Juan; Santos, Oscar] Hosp Pablo Tobon Uribe, Grp Hepatol & Trasplante Hepat, Medellin, Colombia; [Ignacio Marin, Juan] Univ Pontificia Bolivariana, Medellin, Colombia; [Gomez-Aldana, Andres] Gut Med, Bogota, Colombia; [Yepes, Ismael J.] Univ Cartagena, Pharos Grp Invest Ciencia Tecnol & Salud, Cartagena, Colombia; [Rondon, Martin; Rosselli, Diego] Pontificia Univ Javeriana, Fac Med, Dept Epidemiol & Bioestat Clin, Carrera 7 40-62, Bogota, Colombia		Rosselli, D (corresponding author), Pontificia Univ Javeriana, Fac Med, Dept Epidemiol & Bioestat Clin, Carrera 7 40-62, Bogota, Colombia.	diego.rosselli@gmail.com		Marin, Juan Ignacio/0000-0001-6954-8910; Gomez-Aldana, Andres Jose/0000-0002-7954-4910; Rosselli, Diego/0000-0003-0960-9480	Abbvie Colombia	Abbvie Colombia(AbbVie)	This study was supported by Abbvie Colombia	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Mora MVA, 2010, J MED VIROL, V82, P1889, DOI 10.1002/jmv.21908; Alvarado-Mora MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018888; Ampuero J, 2016, PHARMACOGENOMICS, V17, P1587, DOI 10.2217/pgs.16.28; Gomez LA, 2014, CLIN LAB, V60, P869, DOI 10.7754/Clin.Lab.2013.130703; Bautista Amorocho Henry, 2011, Rev Col Gastroenterol, V26, P15; Beltran M, 2005, J CLIN VIROL S2, V34, P33; Berbesi-Fernandez D, 2015, ADICCIONES, V27, P246; Bhamidimarri Kalyan Ram, 2017, Gastroenterol Hepatol (N Y), V13, P214; Botero R, 1994, ACTA MED COLOMB, V19, P62; Cho BW, 2017, CLIN MOL HEPATOL, V23, P51, DOI 10.3350/cmh.2016.0053; Dieterich DT, 2009, J VIRAL HEPATITIS, V16, P833, DOI 10.1111/j.1365-2893.2009.01218.x; Echevarría José M., 2003, Cad. Saúde Pública, V19, P1583, DOI 10.1590/S0102-311X2003000600003; Farfán Yezid Alfonso, 2007, Rev. colomb. Gastroenterol., V22, P308; Gane EJ, 2016, GASTROENTEROLOGY, V151, P902, DOI 10.1053/j.gastro.2016.07.038; Hernandez-Vasquez Akram, 2017, F1000Res, V6, P1536, DOI 10.12688/f1000research.12314.1; Jacobson I, LANCET, V384, P403; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Maheshwari A, 2004, LIVER TRANSPLANT, V10, P165, DOI 10.1002/lt.20031; Medeiros T, 2017, INT J CLIN PHARM-NET, V39, P1304, DOI 10.1007/s11096-017-0552-1; Mendez-Sanchez Nahum, 2014, Ann Hepatol, V13 Suppl 2, ps4; Morio K, 2017, J GASTROEN HEPATOL, V32, P645, DOI 10.1111/jgh.13511; Olariu M, 2010, J GASTROINTEST LIVER, V19, P381; Pol S, 2016, HEPATIC MED-EVID RES, V8, P21, DOI 10.2147/HMER.S62014; Quesada P, 2015, J CLIN VIROL, V68, P89, DOI 10.1016/j.jcv.2015.05.005; Ramírez Roberto, 2010, Rev. colomb. Gastroenterol., V25, P14; Robinson JW, 1996, J MED VIROL, V50, P188, DOI 10.1002/(SICI)1096-9071(199610)50:2&lt;188::AID-JMV13&gt;3.0.CO;2-I; Santos O, 2017, BIOMEDICA, V37, P22, DOI 10.7705/biomedica.v37i1.3173; Schmunis GA, 1998, EMERG INFECT DIS, V4, P5, DOI 10.3201/eid0401.980102; Sclair Seth N, 2016, Gastroenterol Hepatol (N Y), V12, P490; Sepulveda-Arias JC, 2014, J INFECT DEV COUNTR, V8, P1228, DOI 10.3855/jidc.4525; Smith-Palmer J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0748-8; Sreekumar R, 2000, HEPATOLOGY, V32, P1125, DOI 10.1053/jhep.2000.19340; Stanca CM, 2010, TRANSPL P, V42, P1769, DOI 10.1016/j.transproceed.2010.02.075; Sutedja DS, 2004, TRANSPL P, V36, P2331, DOI 10.1016/j.transproceed.2004.07.001; Tanaka Y, 1998, AM J TROP MED HYG, V59, P462, DOI 10.4269/ajtmh.1998.59.462; Tsoulfas G, 2009, HIPPOKRATIA, V13, P211; Weil C, 2018, J VIRAL HEPATITIS, V25, P144, DOI 10.1111/jvh.12800; Welzel TM, 2016, GUT, V65, P1861, DOI 10.1136/gutjnl-2016-312444; Werner CR, 2016, WORLD J GASTROENTERO, V22, P8050, DOI 10.3748/wjg.v22.i35.8050; Wiesner RH, 2003, LIVER TRANSPLANT, V9, pS1, DOI 10.1053/jlts.2003.50268; WRIGHT TL, 1992, GASTROENTEROLOGY, V103, P317, DOI 10.1016/0016-5085(92)91129-R; Yepes A, 2002, Gastroenterol Hepatol, V25, P334; Yepes IDJ, 2016, BIOMEDICA, V36, P564, DOI 10.7705/biomedica.v36i4.3105	45	3	3	0	0	MEDICINA (BUENOS AIRES)	BUENOS AIRES	DONATO ALVAREZ 3150, 1427 BUENOS AIRES, ARGENTINA	0025-7680	1669-9106		MEDICINA-BUENOS AIRE	Med.-Buenos Aires		2019	79	1					29	36						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ6DX	30694186				2022-09-04	WOS:000468943400005
J	Tomatsu, S; Montano, AM; Oguma, T; Dung, VC; Oikawa, H; de Carvalho, TG; Gutierrez, ML; Yamaguchi, S; Suzuki, Y; Fukushi, M; Sakura, N; Barrera, L; Kida, K; Kubota, M; Orii, T				Tomatsu, Shunji; Montano, Adriana M.; Oguma, Toshihiro; Dung, Vu Chi; Oikawa, Hirotaka; de Carvalho, Talita Giacomet; Gutierrez, Maria L.; Yamaguchi, Seiji; Suzuki, Yasuyuki; Fukushi, Masaru; Sakura, Nobuo; Barrera, Luis; Kida, Kazuhiro; Kubota, Mitsuru; Orii, Tadao			Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I	JOURNAL OF INHERITED METABOLIC DISEASE			English	Article							ENZYME-REPLACEMENT THERAPY; TANDEM MASS-SPECTROMETRY; DRIED BLOOD-SPOTS; URINARY GLYCOSAMINOGLYCAN EXCRETION; LYSOSOMAL STORAGE DISORDERS; DIMETHYLMETHYLENE BLUE; THROMBIN COMPLEX; KERATAN SULFATE; DIAGNOSTIC-TEST; HUNTER-SYNDROME	Mucopolysaccharidosis I (MPS I) is an autosomal recessive disorder caused by deficiency of alpha-L-iduronidase leading to accumulation of its catabolic substrates, dermatan sulfate (DS) and heparan sulfate (HS), in lysosomes. This results in progressive multiorgan dysfunction and death in early childhood. The recent success of enzyme replacement therapy (ERT) for MPS I highlights the need for biomarkers that reflect response to such therapy. To determine which biochemical markers are better, we determined serum and urine DS and HS levels by liquid chromatography tandem mass spectrometry in ERT-treated MPS I patients. The group included one Hurler, 11 Hurler/Scheie, and two Scheie patients. Seven patients were treated from week 1, whereas the other seven were treated from week 26. Serum and urine DS (Delta Di-4S/6S) and HS (Delta DiHS-0S, Delta DiHS-NS) were measured at baseline, week 26, and week 72. Serum Delta Di-4S/6S, Delta DiHS-0S, and Delta DiHS-NS levels decreased by 72%, 56%, and 56%, respectively, from baseline at week 72. Urinary glycosaminoglycan level decreased by 61.2%, whereas urine Delta Di-4S/6S, Delta DiHS-0S, and Delta DiHS-NS decreased by 66.8%, 71.8%, and 71%, respectively. Regardless of age and clinical severity, all patients showed marked decrease of DS and HS in blood and urine samples. We also evaluated serum DS and HS from dried blood-spot samples of three MPS I newborn patients, showing marked elevation of DS and HS levels compared with those in control newborns. In conclusion, blood and urine levels of DS and HS provide an intrinsic monitoring and screening tool for MPS I patients.	[Tomatsu, Shunji; Montano, Adriana M.; Dung, Vu Chi; Oikawa, Hirotaka; de Carvalho, Talita Giacomet; Gutierrez, Maria L.] St Louis Univ, Dept Pediat, Doisy Res Ctr, 1100 S Grand Blvd,Room 307, St Louis, MO 63104 USA; [Oguma, Toshihiro] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Yamaguchi, Seiji] Shimane Univ, Dept Pediat, Matsue, Shimane, Japan; [Suzuki, Yasuyuki; Orii, Tadao] Gifu Univ, Dept Pediat, Gifu, Japan; [Fukushi, Masaru] Sapporo City Inst Publ Hlth, Sapporo, Hokkaido 0038505, Japan; [Sakura, Nobuo] Suzugamine Hosp, Hiroshima, Japan; [Barrera, Luis] Pontificia Univ Javeriana, Inst Errores Innatos Metab, Bogota, Colombia; [Kida, Kazuhiro; Kubota, Mitsuru] Hokkaido Univ, Dept Pediat, Sapporo, Hokkaido, Japan; [Tomatsu, Shunji] St Louis Univ Doisy Res Ctr, Dept Pediat, St Louis, MO USA		Tomatsu, S (corresponding author), St Louis Univ, Dept Pediat, Doisy Res Ctr, 1100 S Grand Blvd,Room 307, St Louis, MO 63104 USA.	tomatsus@slu.edu	Oikawa, Hirotaka/D-6657-2018; Montano, Adriana/AHE-8741-2022	Oikawa, Hirotaka/0000-0002-2050-4957; Gutierrez, Maria Lucia/0000-0002-2430-5015	Austrian MPS; Bennett Foundation; Jacob Randall Foundation; International Morquio Organization; Muconet Twinkle Days; Japanese Health, Labor and Welfare Ministry	Austrian MPS; Bennett Foundation; Jacob Randall Foundation; International Morquio Organization; Muconet Twinkle Days; Japanese Health, Labor and Welfare Ministry	This work was supported by grants from Austrian MPS, Bennett Foundation, Jacob Randall Foundation, International Morquio Organization, Muconet Twinkle Days, and Japanese Health, Labor and Welfare Ministry. We thank BioMarin and Genzyme Co. for funding the study and Dr. A. Noguchi for critical comments.	An Y, 2005, MOL GENET METAB, V85, P247, DOI 10.1016/j.ymgme.2005.03.010; Beesley CE, 2009, MOL GENET METAB, V96, P218, DOI 10.1016/j.ymgme.2008.12.002; BJORNSSON S, 1993, ANAL BIOCHEM, V210, P282, DOI 10.1006/abio.1993.1197; Blanchard S, 2008, CLIN CHEM, V54, P2067, DOI 10.1373/clinchem.2008.115410; Byers S, 1998, MOL GENET METAB, V65, P282, DOI 10.1006/mgme.1998.2761; Church H, 2007, BONE MARROW TRANSPL, V39, P207, DOI 10.1038/sj.bmt.1705569; Civallero G, 2006, CLIN CHIM ACTA, V372, P98, DOI 10.1016/j.cca.2006.03.029; Crawley A, 2004, PEDIATR RES, V55, P585, DOI 10.1203/01.PDR.0000113789.30640.5C; Di Natale P, 2008, BIOTECHNOL APPL BIOC, V49, P219, DOI 10.1042/BA20070093; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Froissart R, 2002, ACTA PAEDIATR, V91, P82, DOI 10.1080/080352502762457996; Fuller M, 2005, MOL GENET METAB, V84, P18, DOI 10.1016/j.ymgme.2004.09.004; Fuller M, 2004, PEDIATR RES, V56, P733, DOI 10.1203/01.PDR.0000141987.69757.DD; Gallegos-Arreola MP, 2000, ARCH MED RES, V31, P505, DOI 10.1016/S0188-4409(00)00104-1; Gelb MH, 2006, J INHERIT METAB DIS, V29, P397, DOI 10.1007/s10545-006-0265-4; GOLD EW, 1981, BIOCHIM BIOPHYS ACTA, V673, P408, DOI 10.1016/0304-4165(81)90472-4; Harmatz P, 2005, PEDIATRICS, V115, pE681, DOI 10.1542/peds.2004-1023; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Harmatz P, 2006, J PEDIATR-US, V148, P533, DOI 10.1016/j.jpeds.2005.12.014; Hein LK, 2005, CLIN CHIM ACTA, V353, P67, DOI 10.1016/j.cccn.2004.10.009; Karlsson M, 2000, ANAL BIOCHEM, V286, P51, DOI 10.1006/abio.2000.4767; King B, 2006, MOL GENET METAB, V87, P107, DOI 10.1016/j.ymgme.2005.09.026; LANGFORDSMITH K, 2009, MOL GENET METAB; Litjens T, 1996, AM J HUM GENET, V58, P1127; Mabe P, 2004, CLIN CHIM ACTA, V345, P135, DOI 10.1016/j.cccn.2004.03.015; Meikle PJ, 2006, MOL GENET METAB, V88, P307, DOI 10.1016/j.ymgme.2006.02.013; Montano AM, 2008, MOL GENET METAB, V94, P178, DOI 10.1016/j.ymgme.2008.01.007; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Oguma T, 2007, ANAL BIOCHEM, V368, P79, DOI 10.1016/j.ab.2007.05.016; Oguma T, 2007, BIOMED CHROMATOGR, V21, P356, DOI 10.1002/bmc.760; Ramsay SL, 2004, MOL GENET METAB, V83, P231, DOI 10.1016/j.ymgme.2004.07.015; Ramsay SL, 2003, MOL GENET METAB, V78, P193, DOI 10.1016/S1096-7192(03)00018-0; Randall DR, 2008, MOL GENET METAB, V94, P456, DOI 10.1016/j.ymgme.2008.05.001; Randall DR, 2006, MOL GENET METAB, V88, P235, DOI 10.1016/j.ymgme.2006.01.005; Roddy TP, 2005, CLIN CHEM, V51, P237; SHULL RM, 1994, P NATL ACAD SCI USA, V91, P12937, DOI 10.1073/pnas.91.26.12937; Terlato NJ, 2003, GENET MED, V5, P286, DOI 10.1097/01.GIM.0000078027.83236.49; Tomatsu S, 2005, J INHERIT METAB DIS, V28, P743, DOI 10.1007/s10545-005-0069-y; Tomatsu S, 2005, J INHERIT METAB DIS, V28, P187, DOI 10.1007/s10545-005-5673-3; Tomatsu S, 2004, PEDIATR RES, V55, P592, DOI 10.1203/01.PDR.0000113767.60140.E9; TOMATSU S, INHERIT MET IN PRESS; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Wang D, 2005, CLIN CHEM, V51, P898, DOI 10.1373/clinchem.2004.047167; Wang D, 2007, CLIN CHEM, V53, P137, DOI 10.1373/clinchem.2006.077263; WHITLEY CB, 1989, CLIN CHEM, V35, P374; Whitley CB, 2002, MOL GENET METAB, V75, P56, DOI 10.1006/mgme.2001.3271; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046	48	48	48	0	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-8955	1573-2665		J INHERIT METAB DIS	J. Inherit. Metab. Dis.	APR	2010	33	2					141	150		10.1007/s10545-009-9036-3	http://dx.doi.org/10.1007/s10545-009-9036-3			10	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	589UC	20162367				2022-09-04	WOS:000277178700006
J	Rojas, MA; Lozano, JM; Rojas, MX; Rondon, MA; Charry, L; Laughon, M; Bose, C; Bastidas, J; Ovalle, O; Perez, LA; Rojas, C; Garcia, J; Celis, A; Jaramillo, ML				Rojas, M. A.; Lozano, J. M.; Rojas, M. X.; Rondon, M. A.; Charry, L.; Laughon, M.; Bose, C.; Bastidas, J.; Ovalle, O.; Perez, L. A.; Rojas, C.; Garcia, J.; Celis, A.; Jaramillo, M. L.			Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure. A randomized controlled trial	ACTA PAEDIATRICA			English	Meeting Abstract									[Rojas, M. A.] Vanderbilt Univ, Nashville, TN USA; [Lozano, J. M.; Rojas, M. X.; Rondon, M. A.; Charry, L.] Javeriana Univ, Bogota, Colombia; [Laughon, M.; Bose, C.] Univ N Carolina, Chapel Hill, NC USA; [Bastidas, J.] Clin Farallones & Remedios, Cali, Colombia; [Ovalle, O.] Clin SaludCoop, Bogota, Colombia; [Perez, L. A.] Univ Ind Santander, Bucaramanga, Colombia; [Rojas, C.] Policlin Del Olaya, Bogota, Colombia; [Garcia, J.] Clin San Luis, Bucaramanga, Colombia; [Celis, A.] Hos Reg Simon Bolivar, Bogota, Colombia; [Jaramillo, M. L.] Fdn Valle De Lili, Cali, Colombia										0	0	0	0	4	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0803-5253			ACTA PAEDIATR	Acta Paediatr.	OCT	2007	96			456			235	235						1	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	245AR					2022-09-04	WOS:000251907200604
J	Kaniusas, E; Szeles, JC; Kampusch, S; Alfageme-Lopez, N; Yucuma-Conde, D; Li, X; Mayol, J; Neumayer, C; Papa, M; Panetsos, F				Kaniusas, Eugenijus; Szeles, Jozsef C.; Kampusch, Stefan; Alfageme-Lopez, Nuria; Yucuma-Conde, Daniela; Li, Xie; Mayol, Julio; Neumayer, Christoph; Papa, Michele; Panetsos, Fivos			Non-invasive Auricular Vagus Nerve Stimulation as a Potential Treatment for Covid19-Originated Acute Respiratory Distress Syndrome	FRONTIERS IN PHYSIOLOGY			English	Article						parasympathetic system; cholinergic anti-inflammatory pathway; hypothalamic pituitary adrenal axis; sympatho-vagal balance; lung inflammation	RENIN-ANGIOTENSIN SYSTEM; VAGAL-STIMULATION; LUNG INJURY; INFLAMMATORY RESPONSE; RHEUMATOID-ARTHRITIS; BLOOD-PRESSURE; HEART-FAILURE; MODULATES GUT; DYSFUNCTION; ELECTROACUPUNCTURE	Background:Covid-19 is an infectious disease caused by an invasion of the alveolar epithelial cells by coronavirus 19. The most severe outcome of the disease is the Acute Respiratory Distress Syndrome (ARDS) combined with hypoxemia and cardiovascular damage. ARDS and co-morbidities are associated with inflammatory cytokine storms, sympathetic hyperactivity, and respiratory dysfunction. Hypothesis:In the present paper, we present and justify a novel potential treatment for Covid19-originated ARDS and associated co-morbidities, based on the non-invasive stimulation of the auricular branch of the vagus nerve. Methods:Auricular vagus nerve stimulation activates the parasympathetic system including anti-inflammatory pathways (the cholinergic anti-inflammatory pathway and the hypothalamic pituitary adrenal axis) while regulating the abnormal sympatho-vagal balance and improving respiratory control. Results:Along the paper (1) we expose the role of the parasympathetic system and the vagus nerve in the control of inflammatory processes (2) we formulate our physiological and methodological hypotheses (3) we provide a large body of clinical and preclinical data that support the favorable effects of auricular vagus nerve stimulation in inflammation, sympatho-vagal balance as well as in respiratory and cardiac ailments, and (4) we list the (few) possible collateral effects of the treatment. Finally, we discuss auricular vagus nerve stimulation protective potential, especially in the elderly and co-morbid population with already reduced parasympathetic response. Conclusions:Auricular vagus nerve stimulation is a safe clinical procedure and it could be either an effective treatment for ARDS originated by Covid-19 and similar viruses or a supplementary treatment to actual ARDS therapeutic approaches.	[Kaniusas, Eugenijus] Vienna Univ Technol, Fac Elect Engn & Informat Technol, Inst Electrodynam Microwave & Circuit Engn, Vienna, Austria; [Kaniusas, Eugenijus; Kampusch, Stefan] SzeleSTIM GmbH, Vienna, Austria; [Szeles, Jozsef C.; Neumayer, Christoph] Gen Hosp City Vienna, Vienna, Austria; [Szeles, Jozsef C.; Neumayer, Christoph] Med Univ Vienna, Div Vasc Surg, Dept Surg, Vienna, Austria; [Alfageme-Lopez, Nuria; Panetsos, Fivos] Univ Complutense Madrid, Fac Biol, Madrid, Spain; [Alfageme-Lopez, Nuria; Panetsos, Fivos] Univ Complutense Madrid, Fac Opt, Madrid, Spain; [Yucuma-Conde, Daniela] Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Li, Xie] Women & Childrens Hosp Hunan, Pediat Dept, Changsha, Peoples R China; [Mayol, Julio] San Carlos Clin Hosp, Madrid, Spain; [Mayol, Julio; Panetsos, Fivos] San Carlos Clin Hosp IdISSC, Inst Hlth Res, Madrid, Spain; [Mayol, Julio] Univ Complutense Madrid, Fac Med, Madrid, Spain; [Papa, Michele] Univ Campania Luigi Vanvitelli, Dept Mental & Phys Hlth & Prevent Med, Naples, Italy		Panetsos, F (corresponding author), Univ Complutense Madrid, Fac Biol, Madrid, Spain.; Panetsos, F (corresponding author), Univ Complutense Madrid, Fac Opt, Madrid, Spain.; Panetsos, F (corresponding author), San Carlos Clin Hosp IdISSC, Inst Hlth Res, Madrid, Spain.	fivos@ucm.es	Kaniušas, Eugenijus/GLV-0557-2022; Papa, Michele/AAB-1759-2021; Mayol, Julio/M-2265-2019	Kaniušas, Eugenijus/0000-0002-1228-3859; Papa, Michele/0000-0002-6609-7453; Mayol, Julio/0000-0003-2411-6668; Yucuma, Daniela/0000-0002-3815-7244	European Union [880603]	European Union(European Commission)	EK, JS, and SK have received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement no. 880603.	Afanasiev SA, 2016, ANN NONINVAS ELECTRO, V21, P548, DOI 10.1111/anec.12349; Akella A, 2015, TOXICON, V108, P189, DOI 10.1016/j.toxicon.2015.10.013; Annoni EM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12476; Antonino D, 2017, BRAIN STIMUL, V10, P875, DOI 10.1016/j.brs.2017.05.006; Babygirija R, 2017, NEUROSCIENCE, V356, P11, DOI 10.1016/j.neuroscience.2017.05.012; Badran BW, 2018, BRAIN STIMUL, V11, P699, DOI 10.1016/j.brs.2018.04.004; Barone L, 2008, NEUROIMMUNOMODULAT, V14, P331, DOI 10.1159/000127360; Bauer S, 2016, BRAIN STIMUL, V9, P356, DOI 10.1016/j.brs.2015.11.003; Beekwilder JP, 2010, J CLIN NEUROPHYSIOL, V27, P130, DOI 10.1097/WNP.0b013e3181d64d8a; Bernateck M, 2008, FORSCH KOMPLEMENTMED, V15, P187, DOI 10.1159/000141929; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Bonaz B, 2017, J INTERN MED, V282, P46, DOI 10.1111/joim.12611; Bonaz B, 2013, NEUROGASTROENT MOTIL, V25, P208, DOI 10.1111/nmo.12076; Bonaz B, 2016, J PHYSIOL-LONDON, V594, P5781, DOI 10.1113/JP271539; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brack KE, 2009, J PHYSIOL-LONDON, V587, P3045, DOI 10.1113/jphysiol.2009.169417; Brier TJ, 2015, FUTUR CARDIOL, V11, P503, DOI 10.2217/fca.15.34; Buchholz B, 2015, PFLUG ARCH EUR J PHY, V467, P1509, DOI 10.1007/s00424-014-1591-2; Busl KM, 2015, CRIT CARE MED, V43, P1710, DOI 10.1097/CCM.0000000000001101; Busse LW, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02862-1; Cabyoglu MT, 2006, INT J NEUROSCI, V116, P165, DOI 10.1080/00207450500341522; Camm AJ, 1996, CIRCULATION, V93, P1043; Capone F, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7876507; Carr MJ, 2003, RESPIROLOGY, V8, P291, DOI 10.1046/j.1440-1843.2003.00473.x; Chakravarthy K, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0528-6; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Chapleau MW, 2016, AM J PHYSIOL-HEART C, V311, pH276, DOI 10.1152/ajpheart.00043.2016; Chen IC, 2016, J CHIN MED ASSOC, V79, P17, DOI 10.1016/j.jcma.2015.10.001; Cody RJ, 1997, AM J CARDIOL, V79, P9, DOI 10.1016/S0002-9149(97)00123-9; Deuchars SA, 2018, EXP PHYSIOL, V103, P326, DOI 10.1113/EP086433; Diaz JH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa041; dos Santos CC, 2011, AM J RESP CRIT CARE, V183, P471, DOI 10.1164/rccm.201002-0314OC; DUPREZ D, 1995, EUR HEART J, V16, P1050, DOI 10.1093/oxfordjournals.eurheartj.a061046; Ellrich J, 2011, EUR NEUROL REV, V6, P254, DOI DOI 10.17925/ENR.2011.06.04.254; Fallgatter AJ, 2003, J NEURAL TRANSM, V110, P1437, DOI 10.1007/s00702-003-0087-6; Fang JL, 2016, BIOL PSYCHIAT, V79, P266, DOI 10.1016/j.biopsych.2015.03.025; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Fisher JP, 2012, J HUM HYPERTENS, V26, P463, DOI 10.1038/jhh.2011.66; French JA, 2017, EPILEPSIA, V58, P69, DOI 10.1111/epi.13779; Fudim M, 2020, J CARDIOVASC TRANSL, V13, P894, DOI 10.1007/s12265-020-10031-6; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Hackl G, 2017, VASA, V46, P462, DOI 10.1024/0301-1526/a000660; Hein E, 2013, J NEURAL TRANSM, V120, P821, DOI 10.1007/s00702-012-0908-6; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hong GS, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13501; Hoover DB, 2017, PHARMACOL THERAPEUT, V179, P1, DOI 10.1016/j.pharmthera.2017.05.002; Huang F, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1190-1; Huang JA, 2010, J NEURAL TRANSM, V117, P729, DOI 10.1007/s00702-010-0407-6; Huang Y, 2019, QJM-INT J MED, V112, P483, DOI 10.1093/qjmed/hcy154; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Inoue T, 2016, J CLIN INVEST, V126, P1939, DOI 10.1172/JCI83658; Jacobs HIL, 2015, NEUROBIOL AGING, V36, P1860, DOI 10.1016/j.neurobiolaging.2015.02.023; Johnson RL, 2018, J INFLAMM RES, V11, P203, DOI 10.2147/JIR.S163248; Johnson RL, 2016, RESP PHYSIOL NEUROBI, V229, P1, DOI 10.1016/j.resp.2016.03.014; Jones Veena G, 2020, Hosp Pediatr, V10, P537, DOI 10.1542/hpeds.2020-0123; Ju YL, 2014, COMPLEMENT THER MED, V22, P858, DOI 10.1016/j.ctim.2014.09.002; Kampusch Stefan, 2016, Current Directions in Biomedical Engineering, V2, P593, DOI 10.1515/cdbme-2016-0131; Kampusch S, 2015, ARTIF ORGANS, V39, pE202, DOI 10.1111/aor.12621; Kampusch S, 2013, I IEEE EMBS C NEUR E, P263, DOI 10.1109/NER.2013.6695922; Kaniusas E., 2015, SAS 2015 2015 IEEE S; Kaniusas E, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00854; Kaniusas E, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00772; Karas M, 2005, J HYPERTENS, V23, P1251, DOI 10.1097/01.hjh.0000170389.69202.53; Kessler W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/467620; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Kovacic K, 2017, LANCET GASTROENTEROL, V2, P727, DOI 10.1016/S2468-1253(17)30253-4; Kox M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0667-5; Kox M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034431; Kraus T, 2007, J NEURAL TRANSM, V114, P1485, DOI 10.1007/s00702-007-0755-z; Krzyzaniak MJ, 2011, SURGERY, V150, P379, DOI 10.1016/j.surg.2011.06.008; Kwan Harwood, 2016, Bioelectron Med, V3, P1; Lehtimaki J, 2013, ACTA OTO-LARYNGOL, V133, P378, DOI 10.3109/00016489.2012.750736; Levy G, 2012, J TRAUMA ACUTE CARE, V73, P338, DOI 10.1097/TA.0b013e31825debd3; Li H, 2015, NUTRITION, V31, P1416, DOI 10.1016/j.nut.2015.05.007; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Liu JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17108; Liu Y, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0436-0; LOCKARD JS, 1990, EPILEPSIA, V31, pS20, DOI 10.1111/j.1528-1157.1990.tb05844.x; Lowry DM, 2014, J SURG RES, V192, P12, DOI 10.1016/j.jss.2014.06.012; Mahadi KM, 2019, BRAIN STIMUL, V12, P1151, DOI 10.1016/j.brs.2019.05.002; Marshall R, 2015, CLIN MED INSIGHTS-GA, V8, P55, DOI 10.4137/CGast.S31779; Mercante B, 2018, MED ACUPUNCT, V30, P141, DOI 10.1089/acu.2017.1254; Mertens A, 2018, EXPERT REV MED DEVIC, V15, P527, DOI 10.1080/17434440.2018.1507732; Nanchal Rahul S, 2018, F1000Res, V7, DOI 10.12688/f1000research.15493.1; Napadow V, 2012, PAIN MED, V13, P777, DOI 10.1111/j.1526-4637.2012.01385.x; Nonis R, 2017, CEPHALALGIA, V37, P1285, DOI 10.1177/0333102417717470; Oleson T, 2002, NEUROREHABILITATION, V17, P49; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; OSTERZIEL KJ, 1994, J CARDIOVASC PHARM, V24, pS70; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Payrits T, 2011, ZBL CHIR, V136, P431, DOI 10.1055/s-0031-1283739; Peterson CY, 2012, ARCH SURG-CHICAGO, V147, P76, DOI 10.1001/archsurg.2011.237; Polak T, 2009, J NEURAL TRANSM, V116, P1237, DOI 10.1007/s00702-009-0282-1; Poulat P, 1998, EUR J PHARMACOL, V344, P251, DOI 10.1016/S0014-2999(97)01569-0; Powell Keren, 2019, Bioelectron Med, V5, P17, DOI 10.1186/s42234-019-0033-z; Reys LG, 2013, LIFE SCI, V92, P783, DOI 10.1016/j.lfs.2013.02.009; Richards D, 1998, AUST FAM PHYSICIAN, V27, P73; Roberts A, 2016, MED DEVICES-EVID RES, V9, P389, DOI 10.2147/MDER.S107426; Rong PJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-255; Rong PJ, 2016, J AFFECT DISORDERS, V195, P172, DOI 10.1016/j.jad.2016.02.031; Salama M., 2017, INTERACT CARDIOVASC, V25, DOI [10.1093/ICVTS/IVX280.005, DOI 10.1093/ICVTS/IVX280.005]; Sator-Katzenschlager SM, 2004, ANESTH ANALG, V98, P1359, DOI 10.1213/01.ANE.0000107941.16173.F7; Sator-Katzenschlager SM, 2003, ANESTH ANALG, V97, P1469, DOI 10.1213/01.ANE.0000082246.67897.0B; Schukro RP, 2014, COMPLEMENT THER MED, V22, P21, DOI 10.1016/j.ctim.2013.10.002; Shinlapawittayatorn K, 2014, HEART RHYTHM, V11, P2278, DOI 10.1016/j.hrthm.2014.08.001; Stavrakis S, 2016, TRENDS CARDIOVAS MED, V26, P12, DOI 10.1016/j.tcm.2015.04.007; Stavrakis S, 2015, J AM COLL CARDIOL, V65, P867, DOI 10.1016/j.jacc.2014.12.026; Stevens Jennifer P, 2018, JAMA, V319, P732, DOI 10.1001/jama.2018.0483; Stojanovich L, 2007, LUPUS, V16, P181, DOI 10.1177/0961203306076223; Straube A, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0543-3; Szeles J. C., 2013, P 17 INT C BIOM ENG, P73; Szeles JC, 2004, NEUROL RES, V26, P797, DOI 10.1179/016164104225016100; Tarras SL, 2013, SURGERY, V154, P841, DOI 10.1016/j.surg.2013.07.018; Tekdemir I, 1998, SURG RADIOL ANAT, V20, P253, DOI 10.1007/s00276-998-0253-5; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Umbrello M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010064; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; VANOLI E, 1991, CIRC RES, V68, P1471, DOI 10.1161/01.RES.68.5.1471; Vellingiri B, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138277; Wang DW, 2016, INT REV IMMUNOL, V35, P415, DOI 10.3109/08830185.2015.1127369; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Z, 2015, J CARDIOVASC PHARM, V65, P342, DOI 10.1097/FJC.0000000000000201; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Ylikoski J, 2017, ACTA OTO-LARYNGOL, V137, P426, DOI 10.1080/00016489.2016.1269197; Zamotrinsky A, 1997, CORONARY ARTERY DIS, V8, P551; Zamotrinsky AV, 2001, AUTON NEUROSCI-BASIC, V88, P109, DOI 10.1016/S1566-0702(01)00227-2; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zucker IH, 2014, CLIN SCI, V126, P695, DOI 10.1042/CS20130294	131	18	18	4	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1664-042X		FRONT PHYSIOL	Front. Physiol.	JUL 28	2020	11								890	10.3389/fphys.2020.00890	http://dx.doi.org/10.3389/fphys.2020.00890			11	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	NC6QJ	32848845	Green Published, gold			2022-09-04	WOS:000561341700001
J	Burwick, RM; Velasquez, JA; Lenis, V; Silva, JL; Sanin, JE; Quintero-Posada, A; Alvarez-Mendieta, MI; Valencia, CMM; Edna, F; Vargas, J; Bernal, Y; Rincon, M; Tolosa, JE				Burwick, Richard M.; Velasquez, Jesus A.; Lenis, Viviana; Silva, Jaime L.; Sanin, Jose E.; Quintero-Posada, Alvaro; Alvarez-Mendieta, Maria I.; Valencia, Catalina Maria M.; Edna, Francisco; Vargas, Johanna; Bernal, Yamile; Rincon, Monica; Tolosa, Jorge E.			Terminal complement complex C5b-9 and its endogenous inhibitor CD59 in preeclampsia: The COPA II study	AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY			English	Meeting Abstract	40th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine (SMFM)	FEB 03-08, 2020	Grapevine, TX	Soc Maternal Fetal Med					[Burwick, Richard M.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Velasquez, Jesus A.; Lenis, Viviana] Univ Antioquia, Medellin, Colombia; [Silva, Jaime L.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Sanin, Jose E.] Univ Pontificia Bolivariana, Medellin, Colombia; [Quintero-Posada, Alvaro] Hosp Gen Medellin Luz Castro de Gutierrez, Medellin, Colombia; [Alvarez-Mendieta, Maria I.] Univ Antioquia, Dept Obstet & Ginecol, Medellin, Colombia; [Valencia, Catalina Maria M.] Med Fetal SAS, Medellin, Colombia; [Edna, Francisco] ESE Clin Maternidad Rafael Calvo, Cartagena, Colombia; [Vargas, Johanna; Bernal, Yamile] Lab Clin COLSANITAS, Bogota, Colombia; [Rincon, Monica; Tolosa, Jorge E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA										0	0	0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9378	1097-6868		AM J OBSTET GYNECOL	Am. J. Obstet. Gynecol.	JAN	2020	222	1		S		184	S129	S130		10.1016/j.ajog.2019.11.200	http://dx.doi.org/10.1016/j.ajog.2019.11.200			2	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Obstetrics & Gynecology	JZ3JD		Bronze			2022-09-04	WOS:000504997300184
J	Uddin, MS; Kabir, MT; Jakaria, M; Al Mamun, A; Niaz, K; Amran, MS; Barreto, GE; Ashraf, GM				Uddin, Md. Sahab; Kabir, Md. Tanvir; Jakaria, Md.; Al Mamun, Abdullah; Niaz, Kamal; Amran, Md. Shah; Barreto, George E.; Ashraf, Ghulam Md			Endothelial PPAR gamma Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK (vol 36, pg 1, 2019)	NEUROTOXICITY RESEARCH			English	Correction									[Uddin, Md. Sahab; Al Mamun, Abdullah] Southeast Univ, Dept Pharm, Dhaka, Bangladesh; [Kabir, Md. Tanvir] BRAC Univ, Dept Pharm, Dhaka, Bangladesh; [Jakaria, Md.] Konkuk Univ, Grad Sch, Dept Appl Life Sci, Chungju, South Korea; [Niaz, Kamal] Cholistan Univ Vet & Anim Sci, Fac Biosci, Dept Pharmacol & Toxicol, Bahawalpur, Pakistan; [Amran, Md. Shah] Univ Dhaka, Dept Pharmaceut Chem, Dhaka, Bangladesh; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Ashraf, Ghulam Md] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia		Uddin, MS (corresponding author), Southeast Univ, Dept Pharm, Dhaka, Bangladesh.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.; Ashraf, GM (corresponding author), King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia.	msu-neuropharma@hotmail.com; ashraf.gm@gmail.com	Barreto, George E./AAD-7420-2020; Jakaria, Md/J-3922-2015; , fvcx/AAE-2909-2021; Ashraf, Ghulam Md/H-9485-2012; Uddin, Md. Sahab/Q-2315-2015; Niaz, Kamal/U-4917-2017	Barreto, George E./0000-0002-6644-1971; Jakaria, Md/0000-0001-8216-1171; Ashraf, Ghulam Md/0000-0002-9820-2078; Uddin, Md. Sahab/0000-0002-0805-7840; Kabir, Md. Tanvir/0000-0002-6078-8587; Niaz, Kamal/0000-0001-8670-4356				Uddin MS, 2019, NEUROTOX RES, V36, P583, DOI 10.1007/s12640-019-00047-5	1	1	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	AUG	2019	36	2			SI		437	438		10.1007/s12640-019-00065-3	http://dx.doi.org/10.1007/s12640-019-00065-3			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IJ1SP	31134581	Bronze			2022-09-04	WOS:000475678900017
J	Colom-Cadena, M; Grau-Rivera, O; Planellas, L; Cerquera, C; Morenas, E; Helgueta, S; Munoz, L; Kulisevsky, J; Marti, MJ; Tolosa, E; Clarimon, J; Lleo, A; Gelpi, E				Colom-Cadena, Marti; Grau-Rivera, Oriol; Planellas, Lluis; Cerquera, Catalina; Morenas, Estrella; Helgueta, Sergio; Munoz, Laia; Kulisevsky, Jaime; Jose Marti, Maria; Tolosa, Eduard; Clarimon, Jordi; Lleo, Alberto; Gelpi, Ellen			Regional Overlap of Pathologies in Lewy Body Disorders	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						proportional to-Synuclein; beta-Amyloid; Copathology; Dementia with Lewy bodies; Parkinson disease; Parkinson disease dementia; Tau	PARKINSONS-DISEASE DEMENTIA; MAPT H1 HAPLOTYPE; A-BETA-DEPOSITION; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; NEUROPATHOLOGIC ASSESSMENT; COGNITIVE IMPAIRMENT; ARGYROPHILIC GRAINS; AMYLOID DEPOSITION; CLINICAL-FEATURES	Lewy body disorders (LBD) are common neurodegenerative diseases characterized by the presence of aggregated proportional to-synuclein in Lewy bodies and Lewy neurites in the central and peripheral nervous systems. The brains of patients with LBD often display other comor-bid pathologies, i. e. insoluble tau, beta-amyloid aggregates, TAR DNA-binding protein 43 (TDP-43) deposits, and argyrophilic grain disease (AGD). The incidence and physiological relevance of these concurrent pathological findings remain controversial. We per-formed a semiquantitative detailed mapping of proportional to-synuclein, tau, beta-amyloid (A beta), TDP-43, and AGD pathologies in 17 areas in 63 LBD cases (44 with Parkinson disease [PD], 28 with dementia, and 19 with dementia with Lewy bodies). APOE and MAPT genetic variants were also investigated. A majority of LBD cases had 2 or 3 concomitant findings, particularly Alzheimer disease-related pathology. Pathological stages of tau, beta-amyloid and proportional to-synuclein pathologies were increased in cases with dementia. A beta score was the best correlate of the time to dementia in PD. In addition, beta-amyloid deposition correlated with beta-synuclein load in all groups. MAPT H1 haplotype did not influence any assessed pathology in PD. These results highlight the common concurrence of pathologies in patients with LBD that may have an impact on the clinical expression of the diseases.	[Colom-Cadena, Marti; Morenas, Estrella; Helgueta, Sergio; Munoz, Laia; Clarimon, Jordi; Lleo, Alberto] Univ Autonoma Barcelona, Hosp St Pau, Inst Invest Biomed St Pau, Dept Neurol, Barcelona, Spain; [Colom-Cadena, Marti; Morenas, Estrella; Helgueta, Sergio; Munoz, Laia; Kulisevsky, Jaime; Jose Marti, Maria; Tolosa, Eduard; Clarimon, Jordi; Lleo, Alberto] CIBERNED, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Grau-Rivera, Oriol; Tolosa, Eduard; Gelpi, Ellen] Biobanc Hosp Clin IDIBAPS, Neurol Tissue Bank, C Casanova 143,Planta 0, Barcelona 08036, Spain; [Planellas, Lluis; Cerquera, Catalina; Jose Marti, Maria] Univ Barcelona, Hosp Clin, Parkinsons Dis & Movement Disorders Unit, Barcelona, Spain; [Cerquera, Catalina] Pontificia Univ Javeriana, Sch Med, Hosp Univ San Ignacio, Neurol Unit, Bogota, Colombia; [Cerquera, Catalina] Autonomous Univ Barcelona, Univ Oberta Catalunya, Movement Disorders Unit, Neurol Dept,Hosp St Pau, Barcelona, Spain		Gelpi, E (corresponding author), Biobanc Hosp Clin IDIBAPS, Neurol Tissue Bank, C Casanova 143,Planta 0, Barcelona 08036, Spain.; Lleo, A (corresponding author), Hosp Santa Creu & Sant Pau, Dept Neurol, C St Antoni M Claret 167, Barcelona 08025, Spain.	alleo@santpau.cat; ellen.gelpi@idibaps.org	Lleó, Alberto/K-5783-2019	Grau-Rivera, Oriol/0000-0002-4730-5341; Cerquera, Catalina/0000-0002-3874-0261; Munoz, Laia/0000-0003-0578-3094	CIBERNED; Fundacio Marato de TV3 [20141610]; Fondo de Investigacion Sanitario [PI14/1561]; FIS (Instituto de Salud Carlos III) [PI 15/00962, PI12/03005]; Fundacio La marato de TV3 [20142410, 2910]; AGAUR [SGR1203]	CIBERNED(Instituto de Salud Carlos III); Fundacio Marato de TV3; Fondo de Investigacion Sanitario; FIS (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); Fundacio La marato de TV3; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was funded in part by "CIBERNED". Part of this study was funded by a grant of the Fundacio Marato de TV3 to EG (grant no. 20141610) and the Fondo de Investigacion Sanitario to AL (PI14/1561). Dr Kulisevsky has received research support from CIBERNED and FIS PI 15/00962 and PI12/03005 (Instituto de Salud Carlos III), Fundacio La marato de TV3 20142410 and 2910, and AGAUR SGR1203.	Aarsland D, 2005, ANN NEUROL, V58, P773, DOI 10.1002/ana.20635; Alafuzoff I, 2006, J NEUROPATH EXP NEUR, V65, P740, DOI 10.1097/01.jnen.0000229986.17548.27; Apaydin H, 2002, ARCH NEUROL-CHICAGO, V59, P102, DOI 10.1001/archneur.59.1.102; Attems J, 2012, NEUROPATH APPL NEURO, V38, P582, DOI 10.1111/j.1365-2990.2011.01244.x; Bachhuber T, 2015, NAT MED, V21, P802, DOI 10.1038/nm.3885; Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Balasa M, 2011, NEUROLOGY, V76, P1720, DOI 10.1212/WNL.0b013e31821a44dd; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Cervera-Carles L, 2016, AM J MED GENET B, V171, P175, DOI 10.1002/ajmg.b.32390; Pham CT, 2011, NEUROBIOL AGING, V32, P1296, DOI 10.1016/j.neurobiolaging.2009.07.009; Ciaccioli G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055848; Clarimon J, 2009, J NEUROPATH EXP NEUR, V68, P73, DOI 10.1097/NEN.0b013e3181927577; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Colom-Cadena M, 2013, J NEUROPATH EXP NEUR, V72, P1203, DOI 10.1097/NEN.0000000000000018; Colom-Cadena M, 2013, NEUROBIOL AGING, V34, P936, DOI 10.1016/j.neurobiolaging.2012.06.015; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Cykowski MD, 2016, J NEUROPATH EXP NEUR, V75, P397, DOI 10.1093/jnen/nlw014; Deramecourt V, 2006, J NEUROPATH EXP NEUR, V65, P278, DOI 10.1097/01.jnen.0000205145.54457.ea; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Duyckaerts C, 2015, ACTA NEUROPATHOL, V129, P749, DOI 10.1007/s00401-015-1390-7; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goris A, 2007, ANN NEUROL, V62, P145, DOI 10.1002/ana.21192; Gratwicke J, 2015, BRAIN, V138, P1454, DOI 10.1093/brain/awv104; Grau-Rivera O, 2013, J NEUROL, V260, P3002, DOI 10.1007/s00415-013-7101-1; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hall H, 2014, BRAIN, V137, P2493, DOI 10.1093/brain/awu193; Halliday GM, 2014, MOVEMENT DISORD, V29, P634, DOI 10.1002/mds.25857; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Halliday G, 2011, J NEURAL TRANSM, V118, P713, DOI 10.1007/s00702-011-0641-6; Hepp DH, 2016, J NEUROPATH EXP NEUR, V75, P936, DOI 10.1093/jnen/nlw070; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Horvath J, 2013, PARKINSONISM RELAT D, V19, P864, DOI 10.1016/j.parkreldis.2013.05.010; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; James BD, 2012, JAMA-J AM MED ASSOC, V307, P1798, DOI 10.1001/jama.2012.3556; Jellinger KA, 2008, ACTA NEUROPATHOL, V115, P427, DOI 10.1007/s00401-008-0347-5; Josephs KA, 2016, ACTA NEUROPATHOL, V131, P571, DOI 10.1007/s00401-016-1537-1; Kalaitzakis ME, 2011, NEUROBIOL DIS, V41, P377, DOI 10.1016/j.nbd.2010.10.005; Kalaitzakis ME, 2008, J NEUROPATH EXP NEUR, V67, P155, DOI 10.1097/NEN.0b013e31816362aa; Kempster PA, 2010, BRAIN, V133, P1755, DOI 10.1093/brain/awq059; Kobayashi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018569; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Kovacs GG, 2011, ACTA NEUROPATHOL, V122, P205, DOI 10.1007/s00401-011-0819-x; Lashley T, 2008, ACTA NEUROPATHOL, V115, P417, DOI 10.1007/s00401-007-0336-0; Lin CL, 2016, EXP NEUROL, V275, P84, DOI 10.1016/j.expneurol.2015.10.009; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Marsh SE, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt109; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; McAleese KE, 2016, BRAIN PATHOL, P1; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Overk CR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-18; Pletnikova O, 2005, NEUROBIOL AGING, V26, P1183, DOI 10.1016/j.neurobiolaging.2004.10.006; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; Robakis D, 2016, J NEURAL TRANSM, V123, P583, DOI 10.1007/s00702-016-1552-3; Roy B, 2014, HUM MOL GENET, V23, P3008, DOI 10.1093/hmg/ddu011; Ruffmann C, 2016, NEUROPATH APPL NEURO, V42, P436, DOI 10.1111/nan.12294; Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P229, DOI 10.1097/WAD.0b013e318199d833; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Tsuboi Y, 2007, PARKINSONISM RELAT D, V13, pS221, DOI 10.1016/S1353-8020(08)70005-1; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Wakabayashi K, 1998, ACTA NEUROPATHOL, V95, P450, DOI 10.1007/s004010050824; Walker Z, 2015, LANCET, V386, P1683, DOI 10.1016/S0140-6736(15)00462-6; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Winslow AR, 2014, BRAIN, V137, P1958, DOI 10.1093/brain/awu119; Yokota O, 2010, ACTA NEUROPATHOL, V120, P789, DOI 10.1007/s00401-010-0731-9; Zabetian CP, 2007, ANN NEUROL, V62, P137, DOI 10.1002/ana.21157	81	48	48	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	MAR	2017	76	3					216	224		10.1093/jnen/nlx002	http://dx.doi.org/10.1093/jnen/nlx002			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	EP1NM	28395086	Bronze, Green Published			2022-09-04	WOS:000397151600006
J	Vaughn, BE; Coppola, G; Verissimo, M; Monteiro, L; Santos, AJ; Posada, G; Carbonell, OA; Plata, SJ; Waters, HS; Bost, KK; McBride, B; Shin, N; Korth, B				Vaughn, Brian E.; Coppola, Gabrielle; Verissimo, Manuela; Monteiro, Ligia; Santos, Antonio Jose; Posada, German; Carbonell, Olga A.; Plata, Sandra J.; Waters, Harriet S.; Bost, Kelly K.; McBride, Brent; Shin, Nana; Korth, Bryan			The quality of maternal secure-base scripts predicts children's secure-base behavior at home in three sociocultural groups	INTERNATIONAL JOURNAL OF BEHAVIORAL DEVELOPMENT			English	Article						attachment script representation task; secure bare relationships	ATTACHMENT REPRESENTATIONS; Q-SORT; SENSITIVITY; MOTHER; ASSOCIATIONS; METAANALYSIS; CHILDHOOD; CARE	The secure-base phenomenon is central to the Bowlby/Ainsworth theory of attachment and is also central to the assessment of attachment across the lifespan. The present study tested whether mothers' knowledge about the secure-base phenomenon, as assessed using a recently designed word-list prompt measure for eliciting attachment-relevant stories, would predict their children's secure-base behavior, as assessed by observers in the home and summarized with the Attachment Q-set (AQS). In each of three sociocultural groups (from Colombia, Portugal, and the US), scores characterizing the quality of maternal secure-base narratives elicited using the word-list prompt procedure were internally consistent, as indicated by tests of cross-story reliability, and they were positively and significantly associated with the child's security score from the AQS for each subsample. The correlation in the combined sample was r(129) = .33, p < .001. Subsequent analyses with the combined sample evaluated the AQS item-correlates of the secure-base script score. These analyses showed that mothers whose stories indicate that they have access to and use a positive secure-base script in their story production have children who treat them as a "secure base" at home. These results suggest that a core feature of adult attachment models, in each of the three sociocultural groups studied, is access to a secure-base script. Additional results from the study indicate that cross-language translations of the maternal narratives can receive valid, reliable scores even when evaluated by non-native speakers.	Auburn Univ, Auburn, AL 36849 USA; Purdue Univ, W Lafayette, IN 47907 USA; Univ Javeriana, Bogota, Colombia; SUNY Stony Brook, Stony Brook, NY 11794 USA; Univ Illinois, Champaign, IL 61820 USA		Vaughn, BE (corresponding author), Auburn Univ, 203 Spidle Hall, Auburn, AL 36849 USA.	vaughbe@auburn.edu	Santos, António/H-7922-2013; Veríssimo, Manuela/H-7775-2013	Santos, António/0000-0003-2451-9352; Veríssimo, Manuela/0000-0003-4356-5696; Coppola, Gabrielle/0000-0003-0147-6142; Monteiro, Ligia/0000-0002-2933-8836				Ainsworth M.D.S., 1978, PATTERNS ATTACHMENT; Ainsworth M. D. S., 1967, INFANCY UGANDA INFAN; AINSWORTH MDS, 1991, AM PSYCHOL, V46, P333, DOI 10.1037/0003-066X.46.4.333; Ainsworth MDS., 1974, INTEGRATION CHILD SO, P99; ANBIJZENDOORN MH, 1999, HDB ATTACHMENT THEOR, P713; Atkinson L, 2005, DEV PSYCHOL, V41, P42, DOI 10.1037/0012-1649.41.1.42; Bowlby J., 1973, ATTACHMENT LOSS SEPA; Bowlby J., 1988, SECURE BASE CLIN APP; Bowlby J, 1969, ATTACHMENT LOSS, V1; Bretherton I., 1990, ATTACHMENT PRESCHOOL, P272; Bretherton I., 1999, HDB ATTACHMENT THEOR, P89, DOI DOI 10.2307/1166187; BUSS DM, 1980, CHILD DEV, V51, P401, DOI 10.2307/1129273; Carlson EA, 2004, CHILD DEV, V75, P66, DOI 10.1111/j.1467-8624.2004.00654.x; Crowell JA, 2002, DEV PSYCHOL, V38, P679, DOI 10.1037//0012-1649.38.5.679; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; Elliott M. E., 2003, BIENN M SOC RES CHIL; FIVUSH R, 1990, KNOWING REMEMBERING; George C, 2001, Attach Hum Dev, V3, P30; Gunnar M., 1991, MINN SYM CHILD PSYCH, P1; HARWOOD RL, 1991, MERRILL PALMER QUART, V37, P583; HARWOOD RL, 1995, CULTURE HUMAN DEV; Hesse E., 1999, HDB ATTACHMENT HIST, P395, DOI DOI 10.1016S0191-8869(02)00333-1; Karavasilis L, 2003, INT J BEHAV DEV, V27, P153, DOI 10.1080/0165025024400015; MAIN M, 1984, UNPUB ADULT ATTACHME; Nelson K., 1986, EVENT KNOWLEDGE; NELSON K, 1988, MEMORY DEV UNIVERSAL, P87; OPPENHEIM D, 1995, MONOGRAPHS SOC RES C, V60; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; PARK KA, 1989, CHILD DEV, V60, P1076, DOI 10.1111/j.1467-8624.1989.tb03538.x; Pederson DR, 1998, DEV PSYCHOL, V34, P925, DOI 10.1037/0012-1649.34.5.925; Posada G, 2004, DEV PSYCHOL, V40, P508, DOI 10.1037/0012-1649.40.4.508; Posada G, 2002, DEV PSYCHOL, V38, P67, DOI 10.1037//0012-1649.38.1.67; Posada G, 1999, DEV PSYCHOL, V35, P1379, DOI 10.1037/0012-1649.35.6.1379; POSADA G, 1995, MONOGRAPHS SOC RES C, V60; Rodrigues-Doolabh L., 2003, SCRIPT LIKE REPRESEN; Rothbaum F, 2000, CHILD DEV, V71, P1159, DOI 10.1111/1467-8624.00220; Sroufe LA., 2005, DEV PERSON MINNESOTA; Tarabulsy GM, 2005, DEV PSYCHOL, V41, P212, DOI 10.1037/0012-1649.41.1.212; Tini M., 2003, SCRIPT LIKE REPRESEN; VAN IJZENDOORN MH, 1988, CHILD DEV, V59, P147, DOI 10.2307/1130396; van Ijzendoorn MH, 2004, CHILD DEV, V75, P1188, DOI 10.1111/j.1467-8624.2004.00733.x; VAUGHN BE, 1990, CHILD DEV, V61, P1965, DOI 10.2307/1130850; VAUGHN BE, 1988, CHILD DEV, V59, P1020, DOI 10.2307/1130268; VAUGHN BE, 1988, DEV PSYCHOL, V24, P589, DOI 10.1037/0012-1649.24.4.589; WARD MJ, 1995, CHILD DEV, V66, P69, DOI 10.1111/j.1467-8624.1995.tb00856.x; Waters E, 2000, CHILD DEV, V71, P164, DOI 10.1111/1467-8624.00130; WATERS E, 1995, MONOGRAPHS SOC RES C, V60; WATERS E, 1985, MONOGRAPHS SOC RES C, V50; WATERS H, 2004, UNPUB MANUAL DECODIN; Waters HS, 1998, J EXP CHILD PSYCHOL, V71, P211, DOI 10.1006/jecp.1998.2473; WATERS HS, 2001, NARRATIVE MEASURES A; Zimmermann P, 2004, J EXP CHILD PSYCHOL, V88, P83, DOI 10.1016/j.jecp.2004.02.002	52	54	59	0	22	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0165-0254	1464-0651		INT J BEHAV DEV	Int. J. Behav. Dev.	JAN	2007	31	1					65	76		10.1177/0165025407073574	http://dx.doi.org/10.1177/0165025407073574			12	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	131FH		Green Published			2022-09-04	WOS:000243853300008
J	Perez-Sousa, MA; del Pozo-Cruz, J; Cano-Gutierrez, CA; Izquierdo, M; Ramirez-Velez, R				Perez-Sousa, Miguel Angel; del Pozo-Cruz; Cano-Gutierrez, Carlos A.; Izquierdo, Mikel; Ramirez-Velez, Robinson			High Prevalence of Probable Sarcopenia in a Representative Sample From Colombia: Implications for Geriatrics in Latin America	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Sarcopenia; associated factors; older adults; Colombia	PHYSICAL-ACTIVITY; OLDER-ADULTS; STRENGTH; MUSCLE; BONE	Objectives: The European Working Group on Sarcopenia in Older People 2 (EWGSOP2) recently defined the new concept of probable sarcopenia to help improve screening and prevent future sarcopenia. We investigated the prevalence of probable sarcopenia, defined as weak grip strength, in community dwelling older Colombian adults, and examined the long-term associated conditions. Design: Cross-sectional study. Setting: Urban and rural Colombian older adults from the "Estudio Nacional de Salud, Bienestar y Envejecimiento (SABE) study". Participants: 5237 Colombian older adults aged >60 years. Measurements: Probable sarcopenia was assessed following the cut-off points for weak grip strength recommended by EWGSOP2 guidelines. Odds ratios (ORs) of the relationship between long-term conditions and probable sarcopenia were determined using logistic regression. Results: The prevalence of probable sarcopenia defined as weak grip strength was 46.5% [95% confidence interval (CI), 45.1-47.8]. Physical inactivity "proxy" (OR 1.35, 95% CI 1.14-1.59); diabetes (OR 1.32, 95% CI 1.11-1.56); and arthritis, osteoarthritis, and rheumatism (OR 1.44, 95% CI 1.25-1.67) were independently associated with probable sarcopenia. Conclusions and Implications: We found that almost half of all the Colombian older adults in our sample had probable sarcopenia. Individuals with physical inactivity, diabetes, arthritis, or osteoarthritis and rheumatism had a higher prevalence of probable sarcopenia. Probable sarcopenia is clinically highly relevant, and several of the factors associated with this condition are potentially preventable, treatable, and reversible. (c) 2020 AMDA The Society for Post-Acute and Long-Term Care Medicine.	[Perez-Sousa, Miguel Angel] Univ Extremadura, Fac Sport Sci, Caceres, Spain; [Perez-Sousa, Miguel Angel; del Pozo-Cruz; Cano-Gutierrez, Carlos A.] Univ Seville, Epidemiol Phys Act & Fitness Lifespan Res Grp, Seville, Spain; [del Pozo-Cruz] Univ Seville, Dept Phys Educ & Sport, Seville, Spain; [Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Inst Aging, Hosp Univ San Ignacio, Bogota, Colombia; [Izquierdo, Mikel; Ramirez-Velez, Robinson] Navarrabiomed Univ Publ Navarra UPNA, Inst Invest Sanitaria de Navarra IdiSNA, Complejo Hosp Navarra CHN, Navarra, Spain; [Izquierdo, Mikel; Ramirez-Velez, Robinson] Inst Salud Carlos III, CIBER Frailty & Hlth Aging CIBERFES, Navarra, Spain		Izquierdo, M (corresponding author), Univ Publ Navarra, Dept Hlth Sci, Av De Baranain S-N, Navarra 31008, Spain.	mikel.izquierdo@gmail.com	Izquierdo, Mikel/O-8049-2019; Perez-Sousa, Miguel A./M-5931-2019	Izquierdo, Mikel/0000-0002-1506-4272; Perez-Sousa, Miguel A./0000-0003-4392-6850; Cano-Gutierrez, Carlos/0000-0001-5680-7880	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia [764]; Universidad Publica de Navarra (UPNA), Spain [ID420]; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER), Spain [PI17/01814]	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia; Universidad Publica de Navarra (UPNA), Spain; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER), Spain	This study is part of a larger project that has been funded by a Colciencias y Ministerio de Salud y la Proteccion Social de Colombia (The SABE Study ID 2013, no. 764). Robinson Ramirez-Velez received a training grant (ID420) as a postdoctoral research fellow with the Universidad Publica de Navarra (UPNA), Spain. Mikel Izquierdo was supported by a research grant (PI17/01814) of the Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER), Spain.	Arevalo-Rodriguez I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010783.pub2; Banks J, 2018, ENGLISH LONGITUDINAL, P1998; Bohannon RW, 2019, CLIN INTERV AGING, V14, P1681, DOI 10.2147/CIA.S194543; Rezende IFB, 2020, J PEDIAT-BRAZIL, V96, P439, DOI 10.1016/j.jped.2019.02.005; Borges VS, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00107319, 10.1590/0102-311x00107319]; Bravo-Jose P, 2018, CLIN NUTR ESPEN, V27, P113, DOI 10.1016/j.clnesp.2018.05.008; Cesari M, 2018, J GERONTOL A-BIOL, V73, P1653, DOI 10.1093/gerona/gly011; Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Cvecka J, 2015, EUR J TRANSL MYOL, V25, P249, DOI 10.4081/ejtm.2015.5280; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dodds RM, 2020, EUR GERIATR MED, V11, P433, DOI 10.1007/s41999-020-00310-5; Dodds RM, 2020, J CACHEXIA SARCOPENI, V11, P62, DOI 10.1002/jcsm.12503; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gomez F., 2016, CURRENT GERONTOLOGY, V2016, P7910205, DOI [10.1155/2016/7910205, DOI 10.1155/2016/7910205]; Ida S, 2018, GERIATR GERONTOL INT, V18, P1393, DOI 10.1111/ggi.13498; Ida S, 2018, GERIATR GERONTOL INT, V18, P1318, DOI 10.1111/ggi.13461; Kawao N, 2015, J CELL BIOCHEM, V116, P687, DOI 10.1002/jcb.25040; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Kirk B, 2020, CURR OSTEOPOROS REP, V18, P388, DOI 10.1007/s11914-020-00599-y; Lurz E, 2018, J PEDIATR GASTR NUTR, V66, P222, DOI 10.1097/MPG.0000000000001792; Mesinovic J, 2019, DIABET METAB SYND OB, V12, P1057, DOI 10.2147/DMSO.S186600; Murai J, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0755-3; National Clinical Guideline Centre (UK), 2014, OB ID ASS MAN OV OB; Pal R, 2020, EUR GERIATR MED, V11, P725, DOI 10.1007/s41999-020-00332-z; Ramirez-Velez R, 2019, J CACHEXIA SARCOPENI, V10, P278, DOI 10.1002/jcsm.12373; Sousa-Santos AR, 2019, NUTR DIET, V76, P604, DOI 10.1111/1747-0080.12542; Straight CR, 2015, AM J LIFESTYLE MED, V9, P130, DOI 10.1177/1559827613510681; Su Y, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030291; Sui S.X., 2020, JCSM CLIN REP, V5, P89; Tagliaferri C, 2015, AGEING RES REV, V21, P55, DOI 10.1016/j.arr.2015.03.002; Taylor AH, 2004, J SPORT SCI, V22, P703, DOI 10.1080/02640410410001712421; Volaklis KA, 2016, EUR J INTERN MED, V31, P35, DOI 10.1016/j.ejim.2016.04.001; Wang DXM, 2020, J CACHEXIA SARCOPENI, V11, P3, DOI 10.1002/jcsm.12502; Yang L, 2019, J EPIDEMIOL COMMUN H, V73, P86, DOI 10.1136/jech-2018-211258; Yasuda T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17814-z; Yeung SSY, 2019, J CACHEXIA SARCOPENI, V10, P485, DOI 10.1002/jcsm.12411	39	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	APR	2021	22	4					859	+		10.1016/j.jamda.2020.10.021	http://dx.doi.org/10.1016/j.jamda.2020.10.021		APR 2021	7	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	RJ0TZ	33197411				2022-09-04	WOS:000637317600023
J	Fernandez, N; Lorenzo, AJ; Rickard, M; Chua, M; Pippi-Salle, JL; Perez, J; Braga, LH; Matava, C				Fernandez, Nicolas; Lorenzo, Armando J.; Rickard, Mandy; Chua, Michael; Pippi-Salle, Joao L.; Perez, Jaime; Braga, Luis H.; Matava, Clyde			Digital Pattern Recognition for the Identification and Classification of Hypospadias Using Artificial Intelligence vs Experienced Pediatric Urologist	UROLOGY			English	Article							PROXIMAL HYPOSPADIAS; LONG; REPAIR	OBJECTIVE To improve hypospadias classification system, we hereby, show the use of machine learning/image recognition to increase objectivity of hypospadias recognition and classification. Hypospadias anatomical variables such as meatal location, quality of urethral plate, glans size, and ventral curvature have been identified as predictors for postoperative outcomes but there is still significant subjectivity between evaluators. MATERIALS AND METHODS A hypospadias image database with 1169 anonymized images (837 distal and 332 proximal) was used. Images were standardized (ventral aspect of the penis including the glans, shaft, and scrotum) and classified into distal or proximal and uploaded for training with TensorFlow. Data from the training were outputted to TensorBoard, to assess for the loss function. The model was then run on a set of 29 "Test" images randomly selected. Same set of images were distributed among expert clinicians in pediatric urology. Inter- and intrarater analyses were performed using Fleiss Kappa statistical analysis using the same 29 images shown to the algorithm. RESULTS After training with 627 images, detection accuracy was 60%. With 1169 images, accuracy increased to 90%. Inter-rater analysis among expert pediatric urologists was k= 0.86 and intrarater 0.74. Image recognition model emulates the almost perfect inter-rater agreement between experts. CONCLUSION Our model emulates expert human classification of patients with distal/proximal hypospadias. Future applicability will be on standardizing the use of these technologies and their clinical applicability. The ability of using variables different than only anatomical will feed deep learning algorithms and possibly better assessments and predictions for surgical outcomes. (C) 2020 Elsevier Inc.	Univ Washington, Seattle Childrens Hosp, Div Urol, Seattle, WA 98195 USA; Univ Toronto, Hosp Sick Children, Dept Surg, Div Urol, Toronto, ON, Canada; Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Urol, Bogota, Colombia; Fdn Santa Fe Bogota, Dept Urol, Bogota, Colombia; McMaster Univ, McMaster Childrens Hosp, Div Urol, Hamilton, ON, Canada; Sidra Med & Res Ctr, Div Pediat Urol, Doha, Qatar; Univ Toronto, Hosp Sick Children, Dept Anesthesia, Toronto, ON, Canada		Matava, C (corresponding author), Univ Toronto, Hosp SickKids, Dept Anesthesia, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	clyde.matava@sickkids.ca		Perez Nino, Jaime/0000-0002-2231-4321				Al-Juraibah F, 2019, SEX DEV, V13, P67, DOI 10.1159/000497260; Aslam R, 2013, J PLAST RECONSTR AES, V66, P1591, DOI 10.1016/j.bjps.2013.06.041; BROWNE D, 1949, P ROY SOC MED, V42, P466, DOI 10.1177/003591574904200703; Bujang M, 2017, EPIDEMIOL BIOSTAT PU, V14; Bush NC, 2015, J PEDIATR UROL, V11, DOI 10.1016/j.jpurol.2015.05.029; Chua ME, 2017, J PEDIATR UROL, V13, P470, DOI 10.1016/j.jpurol.2017.06.019; DAVID S, 2017, J PEDIAT UROL, V13, DOI DOI 10.1371/JOURNAL.PGEN.1006855; El-Hout Y, 2010, J PEDIATR UROL, V6, P294, DOI 10.1016/j.jpurol.2009.09.003; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fernandez N, 2015, UROL COLOMB, V24, P155; Fernandez N, 2012, J PEDIATR UROL, V8, P121, DOI 10.1016/j.jpurol.2011.07.005; George M, 2000, PEDIAT SURG INT, V31, P519; Gong EM, 2017, J PEDIATR UROL, V13, P457, DOI 10.1016/j.jpurol.2017.03.024; Gorduza DB, 2011, J PEDIATR UROL, V7, P158, DOI 10.1016/j.jpurol.2010.05.003; Holland AJA, 2001, BJU INT, V88, P255, DOI 10.1046/j.1464-410x.2001.02280.x; Huang G, 2015, GENET MOL RES, V14, P1580, DOI 10.4238/2015.March.6.5; Johnson EK, 2020, J UROLOGY, V204, P345, DOI 10.1097/JU.0000000000000810; Kojima Y, 2010, J PEDIATR UROL, V6, P346, DOI 10.1016/j.jpurol.2009.11.007; Lorenzo AJ, 2019, UROLOGY, V123, P204, DOI 10.1016/j.urology.2018.05.041; Luo CC, 2003, PEDIATR SURG INT, V19, P82, DOI 10.1007/s00383-002-0717-3; Merriman LS, 2013, J PEDIATR UROL, V9, P707, DOI 10.1016/j.jpurol.2013.04.006; Orkiszewski M, 2012, J PEDIATR UROL, V8, P410, DOI 10.1016/j.jpurol.2011.08.011; Pfistermuller KLM, 2015, J PEDIATR UROL, V11, P54, DOI 10.1016/j.jpurol.2014.12.006; Poletta FA, 2014, PUBLIC HEALTH GENOM, V17, P61, DOI 10.1159/000356568; Salle JLP, 2016, J PEDIATR UROL, V12, DOI 10.1016/j.jpurol.2015.06.011; Snodgrass WT, 2010, J PEDIATR UROL, V6, P408, DOI 10.1016/j.jpurol.2009.09.010; Spinoit AF, 2015, J PEDIATR UROL, V11, DOI 10.1016/j.jpurol.2014.11.014; Spinoit AF, 2013, J UROLOGY, V189, P2276, DOI 10.1016/j.juro.2012.12.100; van der Zanden LFM, 2012, HUM REPROD UPDATE, V18, P260, DOI 10.1093/humupd/dms002; Villanueva CA, 2019, J PEDIATR UROL, V15, P628, DOI 10.1016/j.jpurol.2019.09.020	30	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-4295	1527-9995		UROLOGY	Urology	JAN	2021	147						264	269		10.1016/j.urology.2020.09.019	http://dx.doi.org/10.1016/j.urology.2020.09.019			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	PX1SQ	32991907				2022-09-04	WOS:000611143200059
J	Uddin, MS; Kabir, MT; Jakaria, M; Al Mamun, A; Niaz, K; Amran, MS; Barreto, GE; Ashraf, GM				Uddin, Md. Sahab; Kabir, Md. Tanvir; Jakaria, Md.; Al Mamun, Abdullah; Niaz, Kamal; Amran, Md. Shah; Barreto, George E.; Ashraf, Ghulam Md			Endothelial PPAR gamma Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK	NEUROTOXICITY RESEARCH			English	Review						PPAR gamma; Inflammation; Aging; Vascular dysfunction; Oxidative stress; ROCK	PROLIFERATOR-ACTIVATED-RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; KINASE-MEDIATED PHOSPHORYLATION; TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTORS; NITRIC-OXIDE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); INTERLEUKIN-12 PRODUCTION; AGONIST ROSIGLITAZONE	Aging plays a significant role in the progression of vascular diseases and vascular dysfunction. Activation of the ADP-ribosylation factor 6 and small GTPases by inflammatory signals may cause vascular permeability and endothelial leakage. Pro-inflammatory molecules have a significant effect on smooth muscle cells (SMC). The migration and proliferation of SMC can be promoted by tumor necrosis factor alpha (TNF-alpha). TNF-alpha can also increase oxidative stress in SMCs, which has been identified to persuade DNA damage resulting in apoptosis and cellular senescence. Peroxisome proliferator-activated receptor (PPAR) acts as a ligand-dependent transcription factor and a member of the nuclear receptor superfamily. They play key roles in a wide range of biological processes, including cell differentiation and proliferation, bone formation, cell metabolism, tissue remodeling, insulin sensitivity, and eicosanoid signaling. The PPAR gamma activation regulates inflammatory responses, which can exert protective effects in the vasculature. In addition, loss of function of PPAR gamma enhances cardiovascular events and atherosclerosis in the vascular endothelium. This appraisal, therefore, discusses the critical linkage of PPAR gamma in the inflammatory process and highlights a crucial defensive role for endothelial PPAR gamma in vascular dysfunction and disease, as well as therapy for vascular aging.	[Uddin, Md. Sahab; Al Mamun, Abdullah] Southeast Univ, Dept Pharm, Dhaka, Bangladesh; [Kabir, Md. Tanvir] BRAC Univ, Dept Pharm, Dhaka, Bangladesh; [Jakaria, Md.] Konkuk Univ, Grad Sch, Dept Appl Life Sci, Chungju, South Korea; [Niaz, Kamal] Cholistan Univ Vet & Anim Sci, Fac Biosci, Dept Pharmacol & Toxicol, Bahawalpur, Pakistan; [Amran, Md. Shah] Univ Dhaka, Dept Pharmaceut Chem, Dhaka, Bangladesh; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Ashraf, Ghulam Md] King Abdulaziz Univ, Dept Med Lab Technol, Fac Appl Med Sci, Jeddah, Saudi Arabia		Uddin, MS (corresponding author), Southeast Univ, Dept Pharm, Dhaka, Bangladesh.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.; Ashraf, GM (corresponding author), King Abdulaziz Univ, Dept Med Lab Technol, Fac Appl Med Sci, Jeddah, Saudi Arabia.	msu-neuropharma@hotmail.com; ashraf.gm@gmail.com	Ashraf, Ghulam Md/H-9485-2012; Jakaria, Md/J-3922-2015; , fvcx/AAE-2909-2021; Barreto, George E./AAD-7420-2020; Niaz, Kamal/U-4917-2017; Uddin, Md. Sahab/Q-2315-2015	Ashraf, Ghulam Md/0000-0002-9820-2078; Jakaria, Md/0000-0001-8216-1171; Barreto, George E./0000-0002-6644-1971; Niaz, Kamal/0000-0001-8670-4356; Uddin, Md. Sahab/0000-0002-0805-7840; Kabir, Md. Tanvir/0000-0002-6078-8587				Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Akahori T, 2007, J HEPATOL, V47, P784, DOI 10.1016/j.jhep.2007.07.030; Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Allred CD, 2008, J NUTR, V138, P250, DOI 10.1093/jn/138.2.250; Angulo J, 2012, EXP GERONTOL, V47, P734, DOI 10.1016/j.exger.2012.06.014; Annese V, 2012, PPAR RES, V2012, P1; Aprahamian T, 2009, J IMMUNOL, V182, P340, DOI 10.4049/jimmunol.182.1.340; Argmann C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000752; Asada K, 2004, AM J RESP CRIT CARE, V169, P195, DOI 10.1164/rccm.200207-740OC; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; BELMIN J, 1995, AM J PHYSIOL-HEART C, V268, pH2288, DOI 10.1152/ajpheart.1995.268.6.H2288; Beyer AM, 2008, CIRC RES, V103, P654, DOI 10.1161/CIRCRESAHA.108.176339; Bloomfield SF, 2006, CLIN EXP ALLERGY, V36, P402, DOI 10.1111/j.1365-2222.2006.02463.x; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Bright JJ, 2003, J IMMUNOL, V171, P5743, DOI 10.4049/jimmunol.171.11.5743; Brown KA, 2007, ARTERIOSCL THROM VAS, V27, P1941, DOI 10.1161/ATVBAHA.107.146852; Brunmeir R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061738; Calnek DS, 2003, ARTERIOSCL THROM VAS, V23, P52, DOI 10.1161/01.ATV.0000044461.01844.C9; Camp HS, 1997, J BIOL CHEM, V272, P10811; Carter AB, 2009, PPAR RES, V2009, DOI 10.1155/2009/498352; CAU S, 2012, FRONT PHYSIOL, V3, P1; CAYGILL CPJ, 1995, EUR J CANCER PREV, V4, P329, DOI 10.1097/00008469-199508000-00008; Celinski K, 2011, J PHYSIOL PHARMACOL, V62, P347; Chantler PD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00090; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2003, INT J OBESITY, V27, pS41, DOI 10.1038/sj.ijo.0802499; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Chung SW, 2000, J BIOL CHEM, V275, P32681, DOI 10.1074/jbc.M002577200; Collino M, 2010, BRIT J PHARMACOL, V160, P1892, DOI 10.1111/j.1476-5381.2010.00671.x; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Corona JC, 2016, FREE RADICAL BIO MED, V100, P153, DOI 10.1016/j.freeradbiomed.2016.06.023; Coste A, 2008, J IMMUNOL, V180, P4939, DOI 10.4049/jimmunol.180.7.4939; Croasdell A, 2015, PPAR RES, V2015, DOI 10.1155/2015/549691; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; Cuzzocrea S, 2003, BRIT J PHARMACOL, V140, P366, DOI 10.1038/sj.bjp.0705419; D'Elia RV, 2013, CLIN VACCINE IMMUNOL, V20, P319, DOI 10.1128/CVI.00636-12; De Silva TM, 2018, HYPERTENSION, V72, P227, DOI 10.1161/HYPERTENSIONAHA.117.10799; De Silva TM, 2016, HYPERTENSION, V68, P809, DOI 10.1161/HYPERTENSIONAHA.116.07430; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Didion SP, 2006, HYPERTENSION, V48, P1072, DOI 10.1161/01.HYP.0000247302.20559.3a; Donato AJ, 2008, AGING CELL, V7, P805, DOI 10.1111/j.1474-9726.2008.00438.x; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Eisenach JH, 2014, BRIT J CLIN PHARMACO, V78, P815, DOI 10.1111/bcp.12397; El Assar M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00132; Emdin CA, 2018, CIRCULATION, V137, P222, DOI 10.1161/CIRCULATIONAHA.117.028021; Faraci FM, 2011, AM J PHYSIOL-HEART C, V300, pH1566, DOI 10.1152/ajpheart.01310.2010; Faveeuw C, 2000, FEBS LETT, V486, P261, DOI 10.1016/S0014-5793(00)02319-X; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Fleenor BS, 2012, AGING CELL, V11, P269, DOI 10.1111/j.1474-9726.2011.00783.x; Gao M, 2015, J SURG RES, V195, P550, DOI 10.1016/j.jss.2015.02.007; Genovese T, 2008, SHOCK, V30, P142, DOI 10.1097/SHK.0b013e31815dd381; Glass CK, 2000, GENE DEV, V14, P121; Goh KL, 2009, J DIGEST DIS, V10, P1, DOI 10.1111/j.1751-2980.2008.00355.x; Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hodis HN, 2006, DIABETES CARE, V29, P1545, DOI 10.2337/dc05-2462; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Hossain Md. Sarwar, 2017, Journal of Coastal Life Medicine, V5, P22, DOI 10.12980/jclm.5.2017J6-229; Hu CY, 2016, PHYSIOL GENOMICS, V48, P124, DOI 10.1152/physiolgenomics.00087.2015; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Huang FR, 2008, LIVEST SCI, V119, P194, DOI 10.1016/j.livsci.2008.04.003; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jacobsen BA, 2006, EUR J GASTROEN HEPAT, V18, P601, DOI 10.1097/00042737-200606000-00005; Jaudszus A, 2013, J LIPID RES, V54, P923, DOI 10.1194/jlr.P031260; Blanco FJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00054; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jin H, 2015, ARTERIOSCL THROM VAS, V35, P838, DOI 10.1161/ATVBAHA.115.305378; Kajikawa M, 2014, HYPERTENSION, V63, P856, DOI 10.1161/HYPERTENSIONAHA.113.02296; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Ketsawatsomkron P, 2010, J BIOL CHEM, V285, P9311, DOI 10.1074/jbc.R109.025031; Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5; Kim T, 2013, WORLD J CARDIOL, V5, P164, DOI 10.4330/wjc.v5.i6.164; Klotz L, 2009, NEUROSCI LETT, V449, P81, DOI 10.1016/j.neulet.2008.10.066; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Konkel L, 2016, ENVIRON HEALTH PERSP, V124, pA49, DOI 10.1289/ehp.124-A49; Kulkarni AA, 2012, PPAR RES, V2012, DOI 10.1155/2012/705352; Lesniewski LA, 2011, AM J PHYSIOL-HEART C, V301, pH1025, DOI 10.1152/ajpheart.01276.2010; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Liang HL, 2008, WORLD J GASTROENTERO, V14, P114, DOI 10.3748/wjg.14.114; Marathe C, 2009, J LIPID RES, V50, P214, DOI 10.1194/jlr.M800189-JLR200; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; Marion-Letellier R, 2008, AM J CLIN NUTR, V87, P939, DOI 10.1093/ajcn/87.4.939; Martens CR, 2016, J PHYSIOL-LONDON, V594, P7177, DOI 10.1113/JP272348; Martin H, 2010, MUTAT RES-FUND MOL M, V690, P57, DOI 10.1016/j.mrfmmm.2009.09.009; Marx N, 1999, ARTERIOSCL THROM VAS, V19, P546, DOI 10.1161/01.ATV.19.3.546; Mayhan WG, 2008, MICROCIRCULATION, V15, P225, DOI 10.1080/10739680701641421; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Mistriotis P, 2017, AGEING RES REV, V37, P94, DOI 10.1016/j.arr.2017.05.006; Modrick ML, 2012, AM J PHYSIOL-REG I, V302, pR1184, DOI 10.1152/ajpregu.00557.2011; Modrick ML, 2009, AM J PHYSIOL-HEART C, V296, pH1914, DOI 10.1152/ajpheart.00300.2009; Mukohda Masashi, 2016, Am J Physiol Heart Circ Physiol, V310, pH39, DOI 10.1152/ajpheart.00490.2015; Natarajan C, 2002, GENES IMMUN, V3, P59, DOI 10.1038/sj.gene.6363832; Neri T, 2012, CARDIOVASC RES, V94, P537, DOI 10.1093/cvr/cvs125; Ng Siew C, 2016, Gastroenterol Hepatol (N Y), V12, P193; Niino M, 2001, J NEUROIMMUNOL, V116, P40, DOI 10.1016/S0165-5728(01)00285-5; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Oh SH, 2009, RESP MED, V103, P1020, DOI 10.1016/j.rmed.2009.01.015; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Padilla J, 2002, CLIN IMMUNOL, V103, P22, DOI 10.1006/clim.2001.5181; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Parnell GP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00425; Pascual G, 2007, NOVART FDN SYMP, V286, P196; Pelham CJ, 2013, AM J PHYSIOL-REG I, V304, pR690, DOI 10.1152/ajpregu.00607.2012; Pendse AA, 2012, ARTERIOSCL THROM VAS, V32, P1436, DOI 10.1161/ATVBAHA.112.248682; Penyige A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-152; Pisanu A, 2014, NEUROBIOL DIS, V71, P280, DOI 10.1016/j.nbd.2014.08.011; Rao JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39727; Reddy AT, 2013, J IMMUNOL, V191, P2053, DOI 10.4049/jimmunol.1300730; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Regieli JJ, 2009, DIABETES CARE, V32, P839, DOI 10.2337/dc08-1819; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rispens E, 2012, PATHOPHYSIOL CELL IN, V3, P99; Roach REJ, 2013, BLOOD, V121, P4948, DOI 10.1182/blood-2013-01-479238; Rodriguez-Manas L, 2009, AGING CELL, V8, P226, DOI 10.1111/j.1474-9726.2009.00466.x; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Sanchez-Hidalgo M, 2005, BIOCHEM PHARMACOL, V69, P1733, DOI 10.1016/j.bcp.2005.03.024; Sasaki Makoto, 2005, BMC Physiol, V5, P3, DOI 10.1186/1472-6793-5-3; Sawada N, 2014, ANTIOXID REDOX SIGN, V20, P1251, DOI 10.1089/ars.2013.5524; Seals DR, 2014, PHYSIOLOGY, V29, P250, DOI 10.1152/physiol.00059.2013; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG657, DOI 10.1152/ajpgi.00381.2006; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Sharma R, 2009, PULM PHARMACOL THER, V22, P183, DOI 10.1016/j.pupt.2008.11.011; Shrestha UK, 2010, INFLAMM BOWEL DIS, V16, P312, DOI 10.1002/ibd.21059; Sigmund CD, 2010, HYPERTENSION, V55, P437, DOI 10.1161/HYPERTENSIONAHA.109.144170; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Sung B, 2004, J GERONTOL A-BIOL, V59, P997; Syrovets T, 2002, THROMB HAEMOSTASIS, V88, P274; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Pereira PAT, 2015, EUR J PHARM SCI, V78, P132, DOI 10.1016/j.ejps.2015.07.001; Toth P, 2014, AM J PHYSIOL-HEART C, V306, pH299, DOI 10.1152/ajpheart.00744.2013; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Tsai YS, 2004, J CLIN INVEST, V114, P240, DOI 10.1172/JCI200420964; Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Villegas I, 2004, EUR J PHARMACOL, V505, P195, DOI 10.1016/j.ejphar.2004.10.020; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Wan YH, 2007, GENE DEV, V21, P1895, DOI 10.1101/gad.1567207; Wang LY, 2014, ENVIRON INT, V73, P1, DOI 10.1016/j.envint.2014.07.004; Wang MY, 2014, TRENDS ENDOCRIN MET, V25, P72, DOI 10.1016/j.tem.2013.10.002; Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Williams Chadwick, 2011, Therap Adv Gastroenterol, V4, P237, DOI 10.1177/1756283X11405250; Williamson K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00030; Wojciechowska W, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00209; Xu XL, 2017, AGING DIS, V8, P486, DOI 10.14336/AD.2017.0507; Yamamoto K, 2005, CARDIOVASC RES, V66, P276, DOI 10.1016/j.cardiores.2004.11.013; Yazdani SK, 2010, J VASC SURG, V51, P174, DOI 10.1016/j.jvs.2009.08.074; Yin Y, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-28; Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065; Yu JH, 2008, INT J BIOCHEM CELL B, V40, P677, DOI 10.1016/j.biocel.2007.10.007; Zachary I, 2000, ARTERIOSCL THROM VAS, V20, P1512, DOI 10.1161/01.ATV.20.6.1512; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771; Zhang Q, 2010, NEUROL RES, V32, P852, DOI 10.1179/016164110X12556180206112; Zingarelli B, 2003, J IMMUNOL, V171, P6827, DOI 10.4049/jimmunol.171.12.6827	172	22	23	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	OCT	2019	36	3					583	601		10.1007/s12640-019-00047-5	http://dx.doi.org/10.1007/s12640-019-00047-5			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX8LQ	31055770				2022-09-04	WOS:000485939200012
J	Baez-Jurado, E; Vega, GG; Aliev, G; Tarasov, VV; Esquinas, P; Echeverria, V; Barreto, GE				Baez-Jurado, Eliana; Guio Vega, Gina; Aliev, Gjumrakch; Tarasov, Vadim V.; Esquinas, Paula; Echeverria, Valentina; Barreto, George E.			Blockade of Neuroglobin Reduces Protection of Conditioned Medium from Human Mesenchymal Stem Cells in Human Astrocyte Model (T98G) Under a Scratch Assay	MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; Scratch assay; Mesenchymal stem cells; Conditioned medium; Adipose tissue; Neuroglobin	TRAUMATIC BRAIN-INJURY; HUMAN BONE-MARROW; IMPROVES SENSORIMOTOR OUTCOMES; OXYGEN-GLUCOSE DEPRIVATION; FIBRILLARY ACIDIC PROTEIN; ESTROGEN-RECEPTOR BETA; MOUSE MODEL; IN-VITRO; ADIPOSE-TISSUE; STROMAL CELLS	Previous studies have indicated that paracrine factors (conditioned medium) increase wound closure and reduce reactive oxygen species in a traumatic brain injury in vitro model. Although the beneficial effects of conditioned medium from human adipose tissue-derived mesenchymal stem cells (hMSCA-CM) have been previously suggested for various neurological diseases, their actions on astrocytic cells are not well understood. In this study, we have explored the effect of hMSCA-CM on human astrocyte model (T98G cells) subjected to scratch assay. Our results indicated that hMSCA-CM improved cell viability, reduced nuclear fragmentation, attenuated the production of reactive oxygen species, and preserved mitochondrial membrane potential and ultrastructural parameters. In addition, hMSCA-CM upregulated neuroglobin in T98G cells and the genetic silencing of this protein prevented the protective action of hMSCA-CM on damaged cells, suggesting that neuroglobin is mediating, at least in part, the protective effect of hMSCA-CM. Overall, this evidence suggests that the use of hMSCA-CM is a promising therapeutic strategy for the protection of astrocytic cells in central nervous system (CNS) pathologies.	[Baez-Jurado, Eliana; Guio Vega, Gina; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Tarasov, Vadim V.] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, 2-4 Bolshaya Pirogovskaya St, Moscow 119991, Russia; [Esquinas, Paula] Univ Nacl Colombia, Fac Med Vet & Zootecnia, Bogota, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gsampaio@javeriana.edu.co	Valentina Echeverria Moran, BCh/E-7765-2013; Aliev, Gjumrakch/K-7302-2017; Barreto, George E./AAD-7420-2020; Aliev, Gjumrakch/AAE-7734-2020	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994	Vicerrectoria Academica of PUJ; PUJ [6260]	Vicerrectoria Academica of PUJ; PUJ	The authors thank Dr. Jorge Andres Afanador and the staff of the cosmetic surgery Clinic DHARA in Bogota - Colombia, for the adipose tissue samples. This work was supported by PUJ grant # 6260 to GEB and scholarship for doctoral studies awarded by the Vicerrectoria Academica of PUJ to Baez-Jurado E.	Acaz-Fonseca E., 2015, GLIA; Aizman I, 2013, STEM CELL TRANSL MED, V2, P223, DOI 10.5966/sctm.2012-0119; Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Amri F, 2017, J NEUROCHEM, V140, P151, DOI 10.1111/jnc.13876; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Baez E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00146; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bankhead P., 2013, ANAL FLUORESCENCE MI; Bertheuil N, 2015, ANN CHIR PLAST ESTH, V60, P94, DOI 10.1016/j.anplas.2014.09.014; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cantinieaux D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069515; Chen D, 2016, J NEUROSCI RES; Chen XM, 2015, NEUROSCI LETT, V606, P194, DOI 10.1016/j.neulet.2015.09.002; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Cirillo G, 2011, NEUROBIOL DIS, V41, P630, DOI 10.1016/j.nbd.2010.11.012; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/BSE0470115, 10.1042/bse0470115]; Egashira Y, 2012, BRAIN RES, V1461, P87, DOI 10.1016/j.brainres.2012.04.033; Eirin A, 2014, GENE, V551, P55, DOI 10.1016/j.gene.2014.08.041; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; Fiocchetti M, 2015, J STEROID BIOCHEM, V149, P128, DOI 10.1016/j.jsbmb.2015.02.005; George E, 2011, ROLE ASTROCYTES NEUR; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2016, METHODS MOL BIOL, V1416, P123, DOI 10.1007/978-1-4939-3584-0_7; Gonzalez A, 2007, BRAIN RES, V1178, P28, DOI 10.1016/j.brainres.2007.08.040; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; GRIFFITHS CEM, 1990, J INVEST DERMATOL, V95, pS53, DOI 10.1111/1523-1747.ep12505786; Guerit D, 2014, STEM CELLS DEV, V23, P1195, DOI 10.1089/scd.2013.0463; Guo ZY, 2015, NEURAL REGEN RES, V10, P651, DOI 10.4103/1673-5374.155442; Habersetzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075429; Hao P, 2014, METAB BRAIN DIS, V29, P193, DOI 10.1007/s11011-014-9490-y; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32993; Huang B, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0792-1; Huang WY, 2015, J CELL PHYSIOL, V230, P2461, DOI 10.1002/jcp.24981; HUE L, 1976, BIOCHEM SOC T, V4, P994, DOI 10.1042/bst0040994; Hwang B, 2016, J THORAC CARDIOV SUR, V151, P841, DOI 10.1016/j.jtcvs.2015.11.043; Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159; Jeong SH, 2014, MAR DRUGS, V12, P4602, DOI 10.3390/md12084602; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Kaewsuya P, 2007, ANAL BIOANAL CHEM, V387, P2775, DOI 10.1007/s00216-007-1135-0; Kallakuri S, 2015, J CLIN IMAG SCI, V5, DOI 10.4103/2156-7514.166354; Kemp K, 2010, J NEUROCHEM, V114, P1569, DOI 10.1111/j.1471-4159.2009.06553.x; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim WS, 2008, J DERMATOL SCI, V49, P133, DOI 10.1016/j.jdermsci.2007.08.004; Lattanzi W, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/468705; Lechauve C, 2013, BBA-PROTEINS PROTEOM, V1834, P1772, DOI 10.1016/j.bbapap.2013.04.014; Lee Hyun-Ho, 2015, Korean J Neurotrauma, V11, P44, DOI 10.13004/kjnt.2015.11.2.44; Lee JC, 2016, J PATHOL TRANSL MED, V50, P325, DOI 10.4132/jptm.2015.09.11.r; Li L, 2014, MOL NEUROBIOL, V49, P149, DOI 10.1007/s12035-013-8506-7; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li Y, 2016, J MOL NEUROSCI, V58, P28, DOI 10.1007/s12031-015-0645-z; Liang CM, 2014, CYTOTHERAPY, V16, P1371, DOI 10.1016/j.jcyt.2014.05.015; Lin WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063444; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Liu YC, 2015, BRAIN INJURY, V29, P651, DOI 10.3109/02699052.2014.1002004; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078514; Mimura J, 2011, J BIOCHEM, V150, P209, DOI 10.1093/jb/mvr065; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Mita T, 2015, BEHAV BRAIN RES, V293, P189, DOI 10.1016/j.bbr.2015.07.043; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Oliva CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024665; Oliveira K, 2015, METAB BRAIN DIS, V30, P1401, DOI 10.1007/s11011-015-9718-5; Ong WK, 2013, INT J BIOCHEM CELL B, V45, P1083, DOI 10.1016/j.biocel.2013.02.013; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI [10.1016/j.mito.2010.10.007, 10.1016/j.mito.2011.09.001]; Park CM, 2016, IN VITRO CELL DEV-AN, V52, P68, DOI 10.1007/s11626-015-9948-1; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Pires AO, 2016, STEM CELLS DEV, V25, P1073, DOI 10.1089/scd.2016.0048; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Platas J, 2016, AGING-US, V8, P1703, DOI 10.18632/aging.101007; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qi X, 2016, INT J BIOL SCI, V12, P836, DOI 10.7150/ijbs.14809; Rampelt H, 2016, BIOCH BIOPHYS ACTA; Ren CH, 2015, RESTOR NEUROL NEUROS, V33, P369, DOI 10.3233/RNN-140413; Salgado AJ, 2010, STEM CELLS DEV, V19, P1067, DOI 10.1089/scd.2009.0279; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Sandhir R, 2014, NEUROSCI LETT, V577, P123, DOI 10.1016/j.neulet.2014.06.005; Sasaki S, 2015, J BIOL CHEM, V290, P2303, DOI 10.1074/jbc.M114.581892; Scheibe F, 2012, CELL MOL NEUROBIOL, V32, P567, DOI 10.1007/s10571-012-9798-2; SHAFITZAGARDO B, 1988, GLIA, V1, P346, DOI 10.1002/glia.440010507; Skalnikova HK, 2013, BIOCHIMIE, V95, P2196, DOI 10.1016/j.biochi.2013.07.015; Song M, 2015, J NEUROSCI RES, V93, P973, DOI 10.1002/jnr.23569; Stetler RA, 2013, J CEREBR BLOOD F MET, V33, P22, DOI 10.1038/jcbfm.2012.158; Sun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072926; Taniguchi H, 2016, J VIS EXP; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; van Koppen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038746; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Witte I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.91; Xie BC, 2016, AM J TRANSL RES, V8, P3241; Yalvac ME, 2013, BRAIN BEHAV IMMUN, V32, P122, DOI 10.1016/j.bbi.2013.03.007; Yamazaki H, 2015, NEUROSCI LETT, V609, P53, DOI 10.1016/j.neulet.2015.10.023; Yousefi F, 2016, IMMUNOL LETT, V172, P94, DOI 10.1016/j.imlet.2016.02.016; Yu Z, 2012, NEUROSCIENCE, V218, P235, DOI 10.1016/j.neuroscience.2012.05.054; Yu ZL, 2014, NEUROSCIENCE, V270, P158, DOI 10.1016/j.neuroscience.2014.04.013; Yu ZY, 2016, MOL NEUROBIOL, V53, P3249, DOI 10.1007/s12035-015-9273-4; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Yuan H, 2016, CELL BIOL INT; Yuan YJ, 2016, CLIN SCI, V130, P2181, DOI 10.1042/CS20160235; Zhang JY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0417-0; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	125	27	27	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2018	55	3					2285	2300		10.1007/s12035-017-0481-y	http://dx.doi.org/10.1007/s12035-017-0481-y			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY5TG	28332151				2022-09-04	WOS:000426897800038
J	Laajaj, R; Webb, D; Aristizabal, D; Behrentz, E; Bernal, R; Buitrago, G; Cucunuba, Z; de la Hoz, F; Gaviria, A; Hernandez, LJ; De Los Rios, C; Varela, AR; Restrepo, S; Schady, N; Vives, M				Laajaj, Rachid; Webb, Duncan; Aristizabal, Danilo; Behrentz, Eduardo; Bernal, Raquel; Buitrago, Giancarlo; Cucunuba, Zulma; de la Hoz, Fernando; Gaviria, Alejandro; Jorge Hernandez, Luis; De Los Rios, Camilo; Ramirez Varela, Andrea; Restrepo, Silvia; Schady, Norbert; Vives, Martha			Understanding how socioeconomic inequalities drive inequalities in COVID-19 infections	SCIENTIFIC REPORTS			English	Article								Across the world, the COVID-19 pandemic has disproportionately affected economically disadvantaged groups. This differential impact has numerous possible explanations, each with significantly different policy implications. We examine, for the first time in a low- or middle-income country, which mechanisms best explain the disproportionate impact of the virus on the poor. Combining an epidemiological model with rich data from Bogota, Colombia, we show that total infections and inequalities in infections are largely driven by inequalities in the ability to work remotely and in within-home secondary attack rates. Inequalities in isolation behavior are less important but non-negligible, while access to testing and contract-tracing plays practically no role because it is too slow to contain the virus. Interventions that mitigate transmission are often more effective when targeted on socioeconomically disadvantaged groups.	[Laajaj, Rachid; Aristizabal, Danilo; Behrentz, Eduardo; Bernal, Raquel; Gaviria, Alejandro; Jorge Hernandez, Luis; Ramirez Varela, Andrea; Restrepo, Silvia; Vives, Martha] Univ Andes, Bogota, Colombia; [Webb, Duncan] Paris Sch Econ, Paris, France; [Buitrago, Giancarlo; de la Hoz, Fernando] Univ Nacl Colombia, Bogota, Colombia; [Buitrago, Giancarlo] Hosp Univ Nacl Colombia, Bogota, Colombia; [Cucunuba, Zulma] Imperial Coll London, London, England; [Cucunuba, Zulma] Pontificia Univ Javeriana, Bogota, Colombia; [De Los Rios, Camilo] Interamer Dev Bank, Washington, DC USA; [Schady, Norbert] World Bank, 1818 H St NW, Washington, DC 20433 USA		Laajaj, R (corresponding author), Univ Andes, Bogota, Colombia.	r.laajaj@uniandes.edu.co		Ramirez Varela, Andrea/0000-0003-2685-9617	Interamerican Development Bank; Development Bank of Latin America (CAF); University of Los Andes; Universidad Nacional de Colombia; University Paris 1 [ED 465]; EUR project [ANR-17-EURE-0001]	Interamerican Development Bank; Development Bank of Latin America (CAF); University of Los Andes; Universidad Nacional de Colombia; University Paris 1; EUR project	The authors acknowledge generous support from the Interamerican Development Bank, the Development Bank of Latin America (CAF), the University of Los Andes and the Universidad Nacional de Colombia. Duncan Webb gratefully acknowledges support from the ED 465 at University Paris 1, and the EUR project ANR-17-EURE-0001. The authors declare no conflicts of interest. We thank members of the CoVIDA working group, Yessica Daniela Campaz Landazabal, Marylin Hidalgo, Juliana Quintero, Paola Betancourt, Leonardo Leon, Pablo Rodriguez, Diana Sofia Rios Oliveros, Andres Felipe Patino, Jose David Pinzon Ortiz, Maribel Rincon, Alejandro Segura, Leonardo Salas Zapata, Philip Keefer, Diane Moyano, Elkin Osorio, Rodrigo Rodriguez.	Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2; Aleta A, 2020, NAT HUM BEHAV, V4, P964, DOI 10.1038/s41562-020-0931-9; Almagro M., 2020, OPPORTUNITY INCLUSIV, DOI DOI 10.2139/SSRN.3695249; Becerra O., 2020, DOCUMENTOS CEDE; Brandily P, 2021, EUR ECON REV, V140, DOI 10.1016/j.euroecorev.2021.103923; Byrne AW, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039856; Cifuentes MP, 2021, J EPIDEMIOL COMMUN H, V75, P610, DOI 10.1136/jech-2020-216275; Dingel JI, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104235; Figueroa JF, 2020, HEALTH AFFAIR, V39, P1984, DOI 10.1377/hlthaff.2020.01040; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Grassly NC, 2020, LANCET INFECT DIS, V20, P1381, DOI 10.1016/S1473-3099(20)30630-7; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Jing QL, 2020, LANCET INFECT DIS, V20, P1141, DOI 10.1016/S1473-3099(20)30471-0; Kim SJ, 2020, HEALTH EDUC BEHAV, V47, P509, DOI 10.1177/1090198120929677; Klinkenberg D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000012; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Laajaj R., 2021, COLOMBIA NAT COMMUN, V12, P1, DOI [10.1038/s41467-020-20314-w, DOI 10.1038/S41467-020-20314-W]; Lee EC, 2020, SCIENCE, V370, P406, DOI 10.1126/science.abd8755; McAloon C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039652; Mena G, 2021, SCIENCE, V372, P934, DOI 10.1126/science.abg5298; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Rocha R, 2021, LANCET GLOB HEALTH, V9, pE782, DOI 10.1016/S2214-109X(21)00081-4; Schmitt-Groh S, 2020, COVID 19 TESTING INE; Smith LE, 2020, PUBLIC HEALTH, V187, P41, DOI 10.1016/j.puhe.2020.07.024; Stiglitz J., 2021, CONQUERING GREAT DIV; The Associated Press, BID ADV MARC NUN SMI; Williams SN, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039334	28	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAY 18	2022	12	1							8269	10.1038/s41598-022-11706-7	http://dx.doi.org/10.1038/s41598-022-11706-7			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J0SO	35585211	Green Published, gold, Green Submitted			2022-09-04	WOS:000797636300081
J	Justo, N; Espinoza, MA; Ratto, B; Nicholson, M; Rosselli, D; Ovcinnikova, O; Marti, SG; Ferraz, MB; Langsam, M; Drummond, MF				Justo, Nahila; Espinoza, Manuel A.; Ratto, Barbara; Nicholson, Martha; Rosselli, Diego; Ovcinnikova, Olga; Marti, Sebastian Garcia; Ferraz, Marcos B.; Langsam, Martin; Drummond, Michael F.			Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America	VALUE IN HEALTH			English	Review						big data; epidemiology; health policy; health technology assessment; Latin America; real-world evidence	TUBERCULOSIS; PREVALENCE; COUNTRIES; COLOMBIA; QUALITY; ACCESS; IMPACT; BRAZIL	Background: Real-world evidence (RWE) is increasingly used to inform health technology assessments for resource allocation, which are valuable tools for emerging economies such as in America. Nevertheless, the characteristics and uses in South America are unknown. Objectives: To identify sources, characteristics, and uses of RWE in Argentina, Brazil, Colombia, and Chile, and evaluate the context-specific challenges. The implications for future regulation and responsible management of RWE in the region are also considered. Methods: A systematic literature review, database mapping, and targeted gray literature search were conducted to identify the sources and characteristics of RWE. Findings were validated by key opinion leaders attending workshops in 4 South American countries. Results: A database mapping exercise revealed 407 unique databases. Geographic scope, database type, population, and outcomes captured were reported. Characteristics of national health information systems show efforts to collect interoperable data from service providers, insurers, and government agencies, but that initiatives are hampered by fragmentation, lack of stewardship, and resources. In South America, RWE is mainly used for pharmacovigilance and as pure academic research, but less so for health technology assessment decision making or pricing negotiations and not at all to inform early access schemes. Conclusions: The quality of real-world data in the case study countries vary and RWE is not consistently used in healthcare decision making. Authors recommend that future studies monitor the impact of digitalization and the potential effects of access to RWE on the quality of patient care.	[Justo, Nahila] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Justo, Nahila; Nicholson, Martha] ICON Plc, Real World Evidence Strategy & Analyt, Stockholm, Sweden; [Espinoza, Manuel A.; Ratto, Barbara] Pontificia Univ Catolica Chile, Dept Publ Hlth, Santiago, Chile; [Ratto, Barbara] Novartis Pharmaceut, E Hanover, NJ USA; [Rosselli, Diego] Pontificia Univ Javeriana, Clin Epidemiol & Biostat Dept, Bogata, Colombia; [Ovcinnikova, Olga] ICON Plc, HTA Strategy & Analyt, London, England; [Marti, Sebastian Garcia] Inst Clin Effectiveness & Publ Hlth, Buenos Aires, DF, Argentina; [Ferraz, Marcos B.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Langsam, Martin] Univ Isalud, Buenos Aires, DF, Argentina; [Drummond, Michael F.] Univ York, Ctr Hlth Econ, York, N Yorkshire, England		Justo, N (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, BioClinicum J9 20, Div Neurogeriatr, Visionsgatan 4, SE-17164 Solna, Sweden.	nahila.justo@ki.se	Justo, Nahila/AAN-7837-2020; Espinoza, Manuel A/AAU-5178-2020	Justo, Nahila/0000-0001-7981-7299; Nicholson, Martha/0000-0002-1948-0935; Berrio Parra, Felipe Leopoldo/0000-0001-9297-6016; Langsam, Martin Gustavo/0000-0002-3907-2429; Rosselli, Diego/0000-0003-0960-9480	Novartis Pharmaceutical Corporation	Novartis Pharmaceutical Corporation	This study was funded with an unrestricted research grant from Novartis Pharmaceutical Corporation.	Abalos E, 2014, BJOG-INT J OBSTET GY, V121, P14, DOI 10.1111/1471-0528.12629; ANAMED, FARM; ANMAT, TECHN PROGR; [Anonymous], 2016, FINAL REPORT ADAPTIV; Baird LG, 2014, CLIN PHARMACOL THER, V96, P559, DOI 10.1038/clpt.2014.145; Barengo NC, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/946419; Belizan JM, 2012, AM J PERINAT, V29, P649, DOI 10.1055/s-0032-1314885; Belo EN, 2013, REV PANAM SALUD PUBL, V34, P321; Beltran CMO, 2016, ORINOQUIA REGION, V21, P47; Berger ML, 2017, PHARMACOEPIDEM DR S, V26, P1033, DOI 10.1002/pds.4297; Bocanegra Horta DP, 2016, AMAZON REGION, V21, P2; Borzutzky A, 2012, RHEUMATOL INT, V32, P2491, DOI 10.1007/s00296-011-2050-4; Bose CL, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S1; Cabieses B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1013; Cano-Gutierrez C, 2015, J AGING HEALTH, V27, P1046, DOI 10.1177/0898264315573518; Cendales R, 2012, BIOMEDICA, V32, P536, DOI [10.7705/biomedica.v32i4.756, 10.1590/S0120-41572012000400009]; Center for Global Development, 2016, MILLIONS SAVED NEW C, pWashington DC; Dhaded SM, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S6; European Medicines Agency, 2013, POST SAF STUD PASS; European Medicines Agency. Guideline on Good Pharmacovigilance Practices (GVP), 2016, MOD 7 POST SAF STUD; Food and Drug Administration, 2016, US REAL WORLD EV SUP; Garcia Marti S, 2015, THESIS; Marti SG, 2015, VACCINE, V33, P5684, DOI 10.1016/j.vaccine.2015.08.026; Gregory V, 2014, VALUE HEALTH, V17, pA188, DOI 10.1016/j.jval.2014.03.1099; Hibberd PL, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0177-1; International Society for Pharmacoeconomics and Outcomes Research Task Force, 2013, US REAL WORLD DAT CO; Jiménez-Pérez Cheryl E, 2015, Acta Neurol Colomb., V31, P385; Nogueira PCK, 2011, REV ASSOC MED BRAS, V57, P443, DOI 10.1590/S0104-42302011000400020; Laranjeira FO, 2013, BIS B I SAUDE, V14, P165; Ministerio de Salud de la Nacion, CAR SISA; Ministerio de Salud y Proteccion Social, SISPRO APLICATIVOS M; Minowa E, 2015, ISPOR 20 ANN INT M 2; Moher David, 2009, Ann Intern Med, V151, P264, DOI 10.1136/bmj.b2535; Nita ME, 2016, VALUE HEALTH, V19, pA286, DOI 10.1016/j.jval.2016.03.759; O'Ryan M, 2007, PEDIATR INFECT DIS J, V26, P41, DOI 10.1097/01.inf.0000247104.01291.71; Osorio-Arango K, 2017, BIOMEDICA, V37, P175, DOI 10.7705/biomedica.v37i2.3246; Patel A, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S10; Ramirez Alexandra Porras, 2014, Malar J, V13, P202, DOI 10.1186/1475-2875-13-202; Ramos Vergara Paulina, 2013, Rev. chil. derecho, V40, P1055; Reyes CC, 2011, IMPROVING QUALITY CA; Rodriguez DA, 2016, REV PANAM SALUD PUBL, V39, P12; Rojas Donoso MG, 2015, GUIA TECNOVIGILANCIA; Rosselli D, 2016, SALUD PUBLICA MEXICO, V58, P595, DOI 10.21149/spm.v58i6.7880; Santos JV, 2017, WORLD J SURG, V41, P2006, DOI 10.1007/s00268-017-3988-5; Santos RIF, CADASTRAMENTO POPULA; Schneeweiss S, 2016, CLIN PHARMACOL THER, V100, P633, DOI 10.1002/cpt.512; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Sposato LA, 2008, STROKE, V39, P3036, DOI 10.1161/STROKEAHA.108.521062; Taylor EA, 2016, DEV STRATEGIC PROGRA, P10; The Economist Intelligence Unit, 2017, EV VAL BAS HEALTHC T; Vizzotti C, 2015, VACCINE, V33, pA227, DOI 10.1016/j.vaccine.2014.12.077; Weaver EH, 2015, INT J GYNECOL OBSTET, V130, P137, DOI 10.1016/j.ijgo.2015.02.026; Woodcock J, 2012, CLIN PHARMACOL THER, V91, P378, DOI 10.1038/clpt.2011.337; World Bank, 2014, HLTH EXP TOT GDP; Zapata-Giraldo Francisco F., 2013, Rev. salud pública, V15, P247; Zarante Ignacio, 2016, J Registry Manag, V41, P116	56	23	24	5	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	JUN	2019	22	6					739	749		10.1016/j.jval.2019.01.014	http://dx.doi.org/10.1016/j.jval.2019.01.014			11	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	IC4VW	31198192	Green Accepted, Bronze			2022-09-04	WOS:000470966200016
J	Gonzalez-Giraldo, Y; Forero, DA; Echeverria, V; Gonzalez, J; Avila-Rodriguez, M; Garcia-Segura, LM; Barret, GE				Gonzalez-Giraldo, Yeimy; Forero, Diego A.; Echeverria, Valentina; Gonzalez, Janneth; Avila-Rodriguez, Marco; Miguel Garcia-Segura, Luis; Barret, George E.			Neuroprotective effects of the catalytic subunit of telomerase: A potential therapeutic target in the central nervous system	AGEING RESEARCH REVIEWS			English	Review						Senescence; Oxidative stress; Telomeres; Telomerase; Neuroprotection	REVERSE-TRANSCRIPTASE; NEUROTROPHIC FACTOR; CELLULAR SENESCENCE; ESTROGEN-RECEPTOR; OXIDATIVE STRESS; DNA-DAMAGE; MOLECULAR-MECHANISMS; ALZHEIMERS-DISEASE; NUCLEAR EXPORT; NEONATAL-RATS	Senescence plays an important role in neurodegenerative diseases and involves key molecular changes induced by several mechanisms such as oxidative stress, telomere shortening and DNA damage. Potential therapeutic strategies directed to counteract these molecular changes are of great interest for the prevention of the neurodegenerative process. Telomerase is a ribonucleoprotein composed of a catalytic subunit (TERT) and a RNA subunit (TERC). It is known that the telomerase is involved in the maintenance of telomere length and is a highly expressed protein in embryonic stages and decreases in adult cells. In the last decade, a growing number of studies have shown that TERT has neuroprotective effects in cellular and animal models after a brain injury. Significantly, differences in TERT expression between controls and patients with major depressive disorder have been observed. More recently, TERT has been associated with the decrease in reactive oxygen species and DNA protection in mitochondria of neurons. In this review, we highlight the role of TERT in some neurodegenerative disorders and discuss some studies focusing on this protein as a potential target for neuroprotective therapies. (C) 2016 Elsevier B.V. All rights reserved.	[Gonzalez-Giraldo, Yeimy; Gonzalez, Janneth; Barret, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Forero, Diego A.] Univ Antonio Narino, Sch Med, Biomed Sci Res Grp, Lab Neuropsychiat Genet, Bogota, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion, Chile; [Avila-Rodriguez, Marco] Univ Tolima, Fac Ciencias Salud, Ibague, Tolima, Colombia; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Madrid, Spain; [Barret, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Barret, George E.] Univ Cient Sur, Lima, Peru		Barret, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Garcia-Segura, LM (corresponding author), CSIC, Inst Cajal, Madrid, Spain.	lmgs@cajal.csic.es; gsampaio@javeriana.edu.co	GONZALEZ, JANNETH/AAB-9948-2020; Garcia-Segura, Luis M/U-3711-2017; Valentina Echeverria Moran, BCh/E-7765-2013; Gonzalez, Yeimy/Y-1975-2019; González-Giraldo, Yeimy/Q-5652-2018; Barreto, George E./AAD-7420-2020; Barreto, George E./B-5747-2014; Forero, Diego A./O-9981-2019	GONZALEZ, JANNETH/0000-0003-4482-256X; Garcia-Segura, Luis M/0000-0002-2450-2916; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Gonzalez, Yeimy/0000-0002-2527-218X; González-Giraldo, Yeimy/0000-0002-2527-218X; Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Forero, Diego A./0000-0001-9175-3363; Avila-Rodriguez, Marco/0000-0003-4612-3236	Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program); VCTI-UAN; Colciencias; Pontificia Universidad Javeriana; IBRO	Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program); VCTI-UAN; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Pontificia Universidad Javeriana; IBRO	YG-G is supported by a PhD fellowship from Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program). DAF is supported by research grants from VCTI-UAN and Colciencias. GEB is supported by grants from Pontificia Universidad Javeriana and IBRO.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Andresen JH, 2009, J PERINAT MED, V37, P553, DOI 10.1515/JPM.2009.081; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Baek S, 2004, NEUROSCI LETT, V363, P94, DOI 10.1016/j.neulet.2004.03.059; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00340; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bersani FS, 2015, DRUG DISCOV TODAY, V20, P1305, DOI 10.1016/j.drudis.2015.06.016; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cai ZY, 2013, NEUROMOL MED, V15, P25, DOI 10.1007/s12017-012-8207-9; Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x; Caporaso GL, 2003, MOL CELL NEUROSCI, V23, P693, DOI 10.1016/S1044-7431(03)00103-9; Cen JP, 2015, GYNECOL ENDOCRINOL, V31, P582, DOI 10.3109/09513590.2015.1065478; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Cheng AW, 2007, J NEUROSCI, V27, P3722, DOI 10.1523/JNEUROSCI.0590-07.2007; Chinta SJ, 2013, J INTERN MED, V273, P429, DOI 10.1111/joim.12029; Chinta SJ, 2015, EXP GERONTOL, V68, P3, DOI 10.1016/j.exger.2014.09.018; Chung J, 2012, J CELL SCI, V125, P2684, DOI 10.1242/jcs.099267; Correia-Melo C, 2015, BBA-BIOENERGETICS, V1847, P1373, DOI 10.1016/j.bbabio.2015.05.017; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; De Felice B, 2014, J HUM GENET, V59, P555, DOI 10.1038/jhg.2014.72; Du BT, 2004, J ENDOCRINOL, V183, P605, DOI 10.1677/joe.1.05775; Eitan E., 2015, CEREBELLUM; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Eitan E, 2012, EMBO MOL MED, V4, P313, DOI 10.1002/emmm.201200212; Flanary BE, 2005, J NEUROSCI RES, V82, P160, DOI 10.1002/jnr.20636; Flanary BE, 2004, GLIA, V45, P75, DOI 10.1002/glia.10301; Forero D., 2016, J GERONTOL A; Forero DA, 2016, EXP GERONTOL, V75, P53, DOI 10.1016/j.exger.2016.01.002; Fridlyanskaya I, 2015, EXP GERONTOL, V72, P124, DOI 10.1016/j.exger.2015.09.021; Fu WM, 1999, J BIOL CHEM, V274, P7264, DOI 10.1074/jbc.274.11.7264; Fu WM, 2002, J NEUROSCI, V22, P10710; Fu WM, 2000, J MOL NEUROSCI, V14, P3, DOI 10.1385/JMN:14:1-2:003; Genazzani Andrea Riccardo, 2006, Neuropsychiatr Dis Treat, V2, P299, DOI 10.2147/nedt.2006.2.3.299; Goldstein JS, 2002, AGEING RES REV, V1, P17, DOI 10.1016/S0047-6374(01)00367-0; Gomez DE, 2012, INT J ONCOL, V41, P1561, DOI 10.3892/ijo.2012.1611; Gordon DM, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/390791; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Iannilli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066602; Imanishi T, 2005, J HYPERTENS, V23, P1699, DOI 10.1097/01.hjh.0000176788.12376.20; Ip FCF, 2014, NEUROSIGNALS, V22, P52, DOI 10.1159/000365290; Jacob T, 2009, J CARDIOVASC SURG, V50, P345; Jakob S, 2008, J BIOL CHEM, V283, P33155, DOI 10.1074/jbc.M805138200; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; Kanoh J, 2003, CELL MOL LIFE SCI, V60, P2295, DOI 10.1007/s00018-003-3245-y; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Li J, 2013, NEUROSCIENCE, V252, P346, DOI 10.1016/j.neuroscience.2013.08.015; Li J, 2011, INT J DEV NEUROSCI, V29, P867, DOI 10.1016/j.ijdevneu.2011.07.010; Lin PY, 2016, J PSYCHIATR RES, V76, P84, DOI 10.1016/j.jpsychires.2016.01.015; Liu JL, 2015, GENET MOL RES, V14, P8901, DOI 10.4238/2015.August.3.13; Liu JP, 2014, CLIN EXP PHARMACOL P, V41, P445, DOI 10.1111/1440-1681.12247; Liu Y, 2015, NEUROPHARMACOLOGY, V91, P87, DOI 10.1016/j.neuropharm.2014.11.028; Lustig Arthur J, 2015, J Cancer Epidemiol Treat, V1, P28; Melo A, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/467180; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Nicholls C, 2011, PROTEIN CELL, V2, P726, DOI 10.1007/s13238-011-1093-3; Niu CC, 2011, J NEUROPATH EXP NEUR, V70, P634, DOI 10.1097/NEN.0b013e318222b97b; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Ojeda D, 2014, J NEUROSCI RES, V92, P267, DOI 10.1002/jnr.23294; Polho GB, 2015, SCHIZOPHR RES, V165, P195, DOI 10.1016/j.schres.2015.04.025; Poole JC, 2001, GENE, V269, P1, DOI 10.1016/S0378-1119(01)00440-1; Qu Y, 2011, STROKE, V42, P3542, DOI 10.1161/STROKEAHA.111.626325; Rochette PJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000926; Safran M., 2010, DATABASE, V2010, DOI DOI 10.1093/DATABASE/BAQ020; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Shammas MA, 2011, CURR OPIN CLIN NUTR, V14, P28, DOI 10.1097/MCO.0b013e32834121b1; Sharma NK, 2012, NUCLEIC ACIDS RES, V40, P712, DOI 10.1093/nar/gkr758; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Speck-Hernandez CA, 2015, J GENET, V94, P305, DOI 10.1007/s12041-015-0513-1; Spilsbury A, 2015, J NEUROSCI, V35, P1659, DOI 10.1523/JNEUROSCI.2925-14.2015; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Szebeni A, 2014, INT J NEUROPSYCHOPH, V17, P1579, DOI 10.1017/S1461145714000698; Tan FCC, 2014, BIOGERONTOLOGY, V15, P643, DOI 10.1007/s10522-014-9532-1; Tedone E, 2015, J ALZHEIMERS DIS, V46, P761, DOI 10.3233/JAD-142808; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Wolf SA, 2011, BRAIN BEHAV IMMUN, V25, P971, DOI 10.1016/j.bbi.2010.10.014; Wolkowitz OM, 2012, MOL PSYCHIATR, V17, P164, DOI 10.1038/mp.2010.133; Xiao ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101251; Xu T, 2013, NEUROCHEM RES, V38, P1914, DOI 10.1007/s11064-013-1097-x; Zhang JW, 2016, AGEING RES REV, V25, P55, DOI 10.1016/j.arr.2015.11.006; Zhang P, 2014, BIOTECH HISTOCHEM, V89, P327, DOI 10.3109/10520295.2013.855323; Zhao FY, 2012, NEUROSCI LETT, V515, P39, DOI 10.1016/j.neulet.2012.03.014; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x; Zhu JH, 2009, CYTOTHERAPY, V11, P485, DOI 10.1080/14653240902887267	98	22	24	0	24	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1568-1637	1872-9649		AGEING RES REV	Ageing Res. Rev.	JUL	2016	28						37	45		10.1016/j.arr.2016.04.004	http://dx.doi.org/10.1016/j.arr.2016.04.004			9	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	DQ3JL	27095058				2022-09-04	WOS:000379098500004
J	Perez-Hernandez, G; Ehrenberg, N; Gomez-Duarte, I; Artaza, O; Cruz, D; Leyns, C; Lopez-Vazquez, J; Perman, G; Rios, V; Robles, W; Rojas-Araya, K; Saenz-Madrigal, R; Solis-Calvo, L				Perez-Hernandez, Galileo; Ehrenberg, Nieves; Gomez-Duarte, Ingrid; Artaza, Osvaldo; Cruz, Dionne; Leyns, Christine; Lopez-Vazquez, Julieta; Perman, Gastori; Rios, Victor; Robles, William; Rojas-Araya, Karol; Saenz-Madrigal, Rocio; Solis-Calvo, Luis			Pillars and lines of action for integrated and people- and community-centered health systems	REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article						Care; health care; health policy; health sector reform; health administration and planning; primary health care		This paper presents the position of the Latin American working group of the International Foundation for Integrated Care (IFIC). The working group brings together various Latin American actors and organizations in support of actions that facilitate the transformation of health systems in the region towards integrated systems that focus on people not as isolated individuals but as subjects of law in the complex social and environmental contexts where they live and interact. The working group proposes nine pillars of integrated care to be used as a conceptual framework for policy development and changes in practices: 1) shared vision and values; 2) population health; 3) people and communities as partners; 4) resilient communities; 5) capacities of human resources for health; 6) governance and leadership; 7) digital solutions; 8) aligned payment systems; and 9) public transparency. Based on these pillars, lines of work are proposed to strengthen alliances and networks, advocacy, research, and capacity-building, in order to help develop health and social systems that are effectively integrated and focused not only on people but also on communities in Latin America.	[Perez-Hernandez, Galileo; Ehrenberg, Nieves] Fdn Int Cuidados Integrados, Sheffield, S Yorkshire, England; [Gomez-Duarte, Ingrid; Rojas-Araya, Karol] Univ Costa Rica, Escuela Salud Publ, San Jose, Costa Rica; [Gomez-Duarte, Ingrid; Rojas-Araya, Karol; Saenz-Madrigal, Rocio; Solis-Calvo, Luis] Univ Costa Rica, Ctr Invest Cuidados Enfermeria & Salud, San Jose, Costa Rica; [Artaza, Osvaldo] Univ Amer, Fac Salud & Ciencias Sociales, Providencia, Chile; [Cruz, Dionne] Asociac Colombiana Salud Publ, Bogota, Colombia; [Leyns, Christine] Fdn VIDA, Plena, Bolivia; [Lopez-Vazquez, Julieta] Univ Veracruzana, Inst Salud Publ, Xalapa, Veracruz, Mexico; [Perman, Gastori] Inst Univ Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Rios, Victor] Univ Autonoma Metropolitana, Unidad Xochimilco, Ciudad De Mexico, Mexico; [Robles, William] Pontificia Univ Javeriana, Bogota, Colombia		Artaza, O (corresponding author), Univ Amer, Fac Salud & Ciencias Sociales, Providencia, Chile.	oartaza@udla.cl	Leyns, Christine/A-3778-2012					[Anonymous], 2018, Saúde debate, V42, P431, DOI 10.1590/0103-11042018s129; Artaza O, 2018, CUAD MED SOC, V58, P27; Artaza O, 2019, INT J INTEGR CARE, V19, DOI 10.5334/ijic.s3628; Artaza O, 2016, SALUD PUBLICA MEXICO, V58, P493, DOI 10.21149/spm.v58i5.8183; Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9; Bascolo E, 2018, REV PANAM SALUD PUBL, V42, DOI 10.26633/RPSP.2018.126; CEPAL, 2019, PAN SOC AM LAT; CEPAL-Comision Economica para America Latina y el Caribe, 2020, UN ACC TECN DIG ENFR; Cuba Fuentes María Sofía, 2016, Rev. perú. med. exp. salud publica, V33, P780; Etienne CF, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003509; Fernández Moreno Sara Yaneth, 2015, Rev Cubana Salud Pública, V41, P335; Toro-Palacio LF, 2012, REV PANAM SALUD PUBL, V31, P161, DOI 10.1590/S1020-49892012000200011; Garcia Farinas A, 2015, REV CUBANA SALUD PUB, V41; International Foundation for Integrated Care, INT FDN INTEGRATED C; Laurell A., 2014, MED SOCIAL, V9, P60; Lewis L., 2020, REALISING TRUE VALUE; OCDE, 2020, PAN SAL LAT CAR 2020, DOI [10.1787/740f9640-es, DOI 10.1787/740F9640-ES]; Organizacao Mundial da Saude (OMS), 2017, VIOL; Organizaci6n de las Naciones Unidas, 2012, RES A 67 L 36; Organizaci6n Mundial de la Salud, 2018, CONT COORD CAR PRACT; Organizaci6n Mundial de la Salud, 1978, C INT AT PRIM SAL AL; Organizaci6n Mundial de la Salud, 2018, DECL AST C MUND AT P; Organizaci6n Mundial de la Salud, 2010, INF SAL MUND 2010 FI; Organizaci6n Mundial de la Salud, 2016, MARC SERV SAL INT CE; Organizaci6n Panamericana de la Salud, 2019, IND BAS 2019 TEND SA; Organizaci6n Panamericana de la Salud, 2019, UN HLTH 21 CENT 40 Y; Organizacin Panamericana de la Salud, 2013, LEISHM AM REC TRA; Ranzani OT, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005639; Secretaria de Salud Mexico, 2020, AT PRIM SAL INT INT; UNFPA ICM OMS, 2014, EST PART MUND 2014; World Health Organization, 2015, PEOPL CENTR INT HLTH	31	0	0	0	0	PAN AMER HEALTH ORGANIZATION	WASHINGTON	525 23RD ST NW, WASHINGTON, DC 20037 USA	1020-4989			REV PANAM SALUD PUBL	Rev. Panam. Salud Publica		2022	46								e48	10.26633/RPSP.2022.48	http://dx.doi.org/10.26633/RPSP.2022.48			7	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	2D6DV	35702715	Green Published, gold			2022-09-04	WOS:000811636100001
J	Pirouzeh, R; Heidarzadeh-Esfahani, N; Morvaridzadeh, M; Izadi, A; Yosaee, S; Potter, E; Heshmati, J; Pizarro, AB; Omidi, A; Heshmati, S				Pirouzeh, Razieh; Heidarzadeh-Esfahani, Neda; Morvaridzadeh, Mojgan; Izadi, Azimeh; Yosaee, Somaye; Potter, Eric; Heshmati, Javad; Beatriz Pizarro, Ana; Omidi, Amirhosein; Heshmati, Shilan			Effect of DASH diet on oxidative stress parameters: A systematic review and meta-analysis of randomized clinical trials	DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS			English	Review						DASH diet; Glutathione (GSH); Malondialdehyde (MDA); Oxidative stress	STOP HYPERTENSION DASH; POLYCYSTIC-OVARY-SYNDROME; BLOOD-PRESSURE; VEGETABLE CONSUMPTION; CARDIOVASCULAR RISK; BODY-COMPOSITION; NITRIC-OXIDE; OBESE WOMEN; WEIGHT-LOSS; SALT	Background and aims: Oxidative stress (OS) is one of the main risk factors for several chronic diseases. The Dietary Approaches to Stop Hypertension (DASH) contain many antioxidants and may contribute to managing OS. Objective: To perform a systematic review and meta-analysis to examine the impacts of the DASH diet on OS parameters. Methods: A comprehensive electronic search in MEDLINE, Scopus, EMBASE, and the Cochrane Central Register of Controlled Trials was performed through September 2020 to find related studies evaluating the impact of the DASH diet on OS parameters. Standardized mean differences were pooled using random-effects meta-analysis. Results: Eight studies with a total of 317 subjects met our inclusion criteria. Four studies included in meta-analysis model with 200 participants (100 in treatment and 100 in control group). The DASH diet was associated with a statistically significant decrease in malondialdehyde (MDA) (SMD:-0.53; 95% CI:-0.89,-0.16; I-2 = 42.1%), and a significant increase in glutathione (GSH) (SMD: 0.83; 95% CI: 0.36, 1.03; I-2 = 42.1%). Meta-analysis found no statistically significant effect of DASH diet on nitric oxide (NO) (SMD:-1.40; 95% CI:-0.12, 1.93; I-2 = 92.6%) or total antioxidant capacity (TAC) levels (SMD: 0.95; 95% CI:-0.10, 1.99; I-2 = 87.6%). Conclusion: Our results demonstrated that a DASH diet could significantly increase GSH and decrease MDA levels. Furthermore, there is a trend to improve TAC, NO, and f2-isoprostanes by the adherence to the DASH diet. However, long-term, large sample size and well-designed randomized clinical trials are still needed to draw concrete conclusions about DASH diet's effects on OS parameters. (C) 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.	[Pirouzeh, Razieh] Iran Univ Med Sci, Sch Hlth, Dept Educ & Hlth Promot, Tehran, Iran; [Heidarzadeh-Esfahani, Neda; Morvaridzadeh, Mojgan; Heshmati, Javad; Omidi, Amirhosein] Kermanshah Univ Med Sci, Sch Nutr Sci & Food Technol, Dept Nutr Sci, Kermanshah 6715847141, Iran; [Izadi, Azimeh] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Biochem & Diet Therapy, Tabriz, Iran; [Yosaee, Somaye] Larestan Univ Med Sci, Sch Hlth, Dept Nutr, Larestan, Iran; [Potter, Eric] Baylor Scott & White Res Inst, Dallas, TX USA; [Beatriz Pizarro, Ana] Pontificia Univ Javeriana, Bogota, Colombia; [Heshmati, Shilan] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Dept Clin Nutr & Dietet, Natl Nutr & Food Technol,Res Inst, Tehran, Iran		Heidarzadeh-Esfahani, N; Omidi, A (corresponding author), Kermanshah Univ Med Sci, Sch Nutr Sci & Food Technol, Dept Nutr Sci, Kermanshah 6715847141, Iran.; Omidi, A (corresponding author), Kermanshah Univ Med Sci, Sch Nutr Sci & Food Technol, Dept Nutr Sci, Farabi Hosp,Fac Nutr Sci & Food Technol, Isar Sq, Kermanshah 6715847141, Iran.	R_pirouzeh@yahoo.com; neda.heidarzadeh@yahoo.com; morvaridzadeh.nut70@gmail.com; izadia@tbzmed.ac.ir; s_yousai2006@yahoo.com; Eric.potter@bswhealth.org; Javad.Heshmati@gmail.com; a.pizarro@javeriana.edu.co; Sh.heshmati73@gmail.com	heshmati, javad/H-6812-2019; heidarzadeh-esfahani, neda/AAW-2927-2021; Morvaridzadeh, Mojgan/GLU-6418-2022; Pizarro, Ana Beatriz/AAC-8021-2022	heshmati, javad/0000-0002-2676-0185; heidarzadeh-esfahani, neda/0000-0002-3740-2930; Morvaridzadeh, Mojgan/0000-0002-1771-4697; Pizarro, Ana Beatriz/0000-0003-4089-454X				Al-Solaiman Y, 2010, J HUM HYPERTENS, V24, P237, DOI 10.1038/jhh.2009.58; Al-Solaiman Y, 2009, J HUM HYPERTENS, V23, P826, DOI 10.1038/jhh.2009.32; Almoznino-Sarafian D, 2007, EUR J NUTR, V46, P230, DOI 10.1007/s00394-007-0655-x; Alvarez-Suarez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025878; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Asemi Z, 2014, NUTRITION, V30, P1287, DOI 10.1016/j.nut.2014.03.008; Asemi Z, 2013, NUTRITION, V29, P619, DOI 10.1016/j.nut.2012.11.020; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823; Azadi-Yazdi M, 2017, J HUM NUTR DIET, V30, P275, DOI 10.1111/jhn.12433; Bahareh Amirkalali, 2015, IRAN RED CRESCENT ME, V17; Bettermann EL, 2018, J NUTR, V148, P245, DOI 10.1093/jn/nxx045; BOEGEHOLD MA, 1993, AM J PHYSIOL, V264, pH1810, DOI 10.1152/ajpheart.1993.264.6.H1810; Callcott ET, 2018, FOOD FUNCT, V9, P5169, DOI [10.1039/C8FO01531G, 10.1039/c8fo01531g]; Chen X, 2001, HYPERTENSION, V38, P606, DOI 10.1161/hy09t1.094005; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Foroozanfard F, 2017, CLIN ENDOCRINOL, V87, P51, DOI 10.1111/cen.13333; Fowke JH, 2006, CARCINOGENESIS, V27, P2096, DOI 10.1093/carcin/bgl065; Gawel Stefan, 2004, Wiad Lek, V57, P453; Ghorabi S, 2019, DIABETES METAB SYND, V13, P1699, DOI 10.1016/j.dsx.2019.03.039; Guzik TJ, 2002, HYPERTENSION, V39, P1088, DOI 10.1161/01.HYP.0000018041.48432.B5; Higgins J.P., 2011, COCHRANE HDB SYSTEMA; Hummel SL, 2012, HYPERTENSION, V60, P1200, DOI 10.1161/HYPERTENSIONAHA.112.202705; Ishimitsu T, 1996, CLIN EXP HYPERTENS, V18, P659, DOI 10.3109/10641969609081773; John JH, 2002, LANCET, V359, P1969, DOI 10.1016/S0140-6736(02)98858-6; Laffer CL, 2006, HYPERTENSION, V47, P434, DOI 10.1161/01.HYP.0000202480.06735.82; Liberati A, 2009, BMJ-BRIT MED J, V62, pe1; Liese AD, 2011, CIRCULATION, V123, P1410, DOI 10.1161/CIRCULATIONAHA.110.955922; Lopes HF, 2003, HYPERTENSION, V41, P422, DOI 10.1161/01.HYP.0000053450.19998.11; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI 10.1089/ARS.2009.2695; Miller ER, 2005, ATHEROSCLEROSIS, V183, P175, DOI 10.1016/j.atherosclerosis.2005.04.001; Milne GL, 2015, BBA-MOL CELL BIOL L, V1851, P433, DOI 10.1016/j.bbalip.2014.10.007; Montezano AC, 2015, CAN J CARDIOL, V31, P631, DOI 10.1016/j.cjca.2015.02.008; Morvaridzadeh M, 2020, CYTOKINE, V135, DOI 10.1016/j.cyto.2020.155224; Piatti P, 2001, DIABETES CARE, V24, P875, DOI 10.2337/diacare.24.5.875; Rifai Luay, 2015, Proc (Bayl Univ Med Cent), V28, P151; Rodriguez-Moran M, 2008, ARCH DIS CHILD, V93, P676, DOI 10.1136/adc.2006.109371; Saneei P, 2014, NUTR METAB CARDIOVAS, V24, P1253, DOI 10.1016/j.numecd.2014.06.008; Services USDH Health N Lung BNHI, 2012, YOUR GUID LOW YOUR B; Shirani F, 2013, NUTRITION, V29, P939, DOI 10.1016/j.nut.2012.12.021; Sinha N, 2015, CURR HYPERTENS REV, V11, P132, DOI 10.2174/1573402111666150529130922; Soccio M, 2005, EUR J CLIN INVEST, V35, P305, DOI 10.1111/j.1365-2362.2005.01500.x; Soltani S, 2018, CLIN NUTR, V37, P542, DOI 10.1016/j.clnu.2017.02.018; Soltani S, 2016, OBES REV, V17, P442, DOI 10.1111/obr.12391; Vafa M, 2016, J MATERN-FETAL NEO M, V29, P461, DOI 10.3109/14767058.2015.1004052; Zade MR, 2016, LIVER INT, V36, P563, DOI 10.1111/liv.12990	48	6	6	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1871-4021	1878-0334		DIABETES METAB SYND	Diabetes Metab. Syndr.-Clin. Res. Rev.	NOV-DEC	2020	14	6					2131	2138		10.1016/j.dsx.2020.10.031	http://dx.doi.org/10.1016/j.dsx.2020.10.031			8	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	PN3SP	33395773				2022-09-04	WOS:000604402500010
J	Aschner, P; Chan, J; Owens, DR; Picard, S; Wang, E; Dain, MP; Pilorget, V; Echtay, A; Fonseca, V				Aschner, Pablo; Chan, Juliana; Owens, David R.; Picard, Sylvie; Wang, Edward; Dain, Marie-Paule; Pilorget, Valerie; Echtay, Akram; Fonseca, Vivian		EASIE Investigators	Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial	LANCET			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; BETA-CELL FUNCTION; GLYCEMIC CONTROL; THERAPY; METAANALYSIS; GLUCOSE; HYPERGLYCEMIA; SULFONYLUREA; MANAGEMENT; EFFICACY	Background In people with type 2 diabetes, a dipeptidyl peptidase-4 (DPP-4) inhibitor is one choice as second-line treatment after metformin, with basal insulin recommended as an alternative. We aimed to compare the efficacy, tolerability, and safety of insulin glargine and sitagliptin, a DPP-4 inhibitor, in patients whose disease was uncontrolled with metformin. Methods In this comparative, parallel, randomised, open-label trial, metformin-treated people aged 35-70 years with glycated haemoglobin A(1c) (HbA(1c)) of 7-11%, diagnosis of type 2 diabetes for at least 6 months, and body-mass index of 25-45 kg/m(2) were recruited from 17 countries. Participants were randomly assigned (1:1) to 24-week treatment with insulin glargine (titrated from an initial subcutaneous dose of 0.2 units per kg bodyweight to attain fasting plasma glucose of 4.0-5.5 mmol/L) or sitagliptin (oral dose of 100 mg daily). Randomisation (via a central interactive voice response system) was by random sequence generation and was stratified by centre. Patients and investigators were not masked to treatment assignment. The primary outcome was change in HbA(1c) from baseline to study end. Efficacy analysis included all randomly assigned participants who had received at least one dose of study drug and had at least one on-treatment assessment of any primary or secondary efficacy variable. This trial is registered at ClinicalTrials.gov, NCT00751114. Findings 732 people were screened and 515 were randomly assigned to insulin glargine (n=250) or sitagliptin (n=265). At study end, adjusted mean reduction in HbA(1c) was greater for patients on insulin glargine (n=227; -1.72%, SE 0.06) than for those on sitagliptin (n=253; -1.13%, SE 0.06) with a mean difference of -0.59% (95% CI -0.77 to -0.42, p<0.0001). The estimated rate of all symptomatic hypoglycaemic episodes was greater with insulin glargine than with sitagliptin (4.21 [SE 0.54] vs 0.50 [SE 0.09] events per patient-year; p<0.0001). Severe hypoglycaemia occurred in only three (1%) patients on insulin glargine and one (<1%) on sitagliptin. 15 (6%) of patients on insulin glargine versus eight (3%) on sitagliptin had at least one serious treatment-emergent adverse event. Interpretation Our results support the option of addition of basal insulin in patients with type 2 diabetes inadequately controlled by metformin. Long-term benefits might be expected from the achievement of optimum glycaemic control early in the course of the disease.	[Aschner, Pablo] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Chan, Juliana] Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Owens, David R.] Cardiff Univ, Ctr Endocrine & Diabet Sci, Cardiff, S Glam, Wales; [Picard, Sylvie] Point Medical Rond Point Nation, Dijon, France; [Wang, Edward] Sanofi, Bridgewater, NJ USA; [Dain, Marie-Paule; Pilorget, Valerie] Sanofi, Paris, France; [Echtay, Akram] Rafic Hariri Univ Hosp, Beirut, Lebanon; [Fonseca, Vivian] Tulane Univ, Med Ctr, New Orleans, LA 70118 USA		Aschner, P (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia.	paschner@cable.net.co	PICARD, Sylvie/AAI-6569-2020; Gönen, Mustafa Sait/AAH-5654-2019; Chan, Juliana/B-7918-2016; Bellido Guerrero, Diego/C-9446-2017	PICARD, Sylvie/0000-0003-0463-8063; Gönen, Mustafa Sait/0000-0002-1089-623X; Chan, Juliana/0000-0003-1325-1194; Bellido Guerrero, Diego/0000-0003-0631-2710; Tinahones, Francisco J/0000-0001-6871-4403	Sanofi; Amylin; AstraZeneca; Bayer Healthcare; Eli Lilly Co; Eli Lilly AMP; Co, GlaxoSmithKline; Merck-Serono; Merck; Sharpe Dohme; Takeda; Boehringer Ingelheim; Roche	Sanofi; Amylin; AstraZeneca(AstraZeneca); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Eli Lilly Co(Eli Lilly); Eli Lilly AMP; Co, GlaxoSmithKline; Merck-Serono(Merck & Company); Merck(Merck & Company); Sharpe Dohme; Takeda(Takeda Pharmaceutical Company Ltd); Boehringer Ingelheim(Boehringer Ingelheim); Roche(Roche Holding)	Sanofi.r PA has served on advisory boards for AstraZeneca, Eli Lilly & Co, GlaxoSmithKline, Janssen, Merck, Sharpe & Dohme, Novartis, and Sanofi and on speakers' bureaus for AstraZeneca, Eli Lilly & Co, Merck, Sharpe & Dohme, Novartis, and Sanofi. JC has served on advisory boards for Amylin, AstraZeneca, Bayer Healthcare, Eli Lilly & Co, GlaxoSmithKline, Merck-Serono, Merck, Sharpe & Dohme, Pfizer, and Sanofi and on speakers' bureaus for AstraZeneca, Bayer Healthcare, Eli Lilly & Co, GlaxoSmithKline, Merck-Serono, Merck, Sharpe & Dohme, Pfizer, Sanofi, and Takeda; she has received research support from Amylin, AstraZeneca, Bayer Healthcare, Eli Lilly & Co, GlaxoSmithKline, Merck-Serono, Merck, Sharpe & Dohme, Sanofi, and Takeda. DRO has served on advisory boards and speakers' bureaus for Roche and Sanofi and has received research support from Boehringer Ingelheim, Roche, and Sanofi. SP has served on advisory boards, as a board member, and as a consultant for Medtronics, Novo Nordisk, and Sanofi and on speakers' bureaus for Eli Lilly & Co, Lifescan, Medtronic, Merck-Serono, Novartis, Pierre Fabre, Novo Nordisk, Sanofi, and Solvay. EW, M-PD, and VP are employees of Sanofi. AE has served on an advisory board for Merck, Sharpe & Dohme and on speakers' bureaus for AstraZeneca, Eli Lilly & Co, Merck & Co, Merck, Sharpe & Dohme, Novartis, Novo Nordisk, and Sanofi. VF has served as a consultant and on speakers' bureaus for AstraZeneca, Daiichi Sankyo, Eli Lilly & Co, GlaxoSmithKline, Novo Nordisk, Pamlabs, Sanofi, Takeda, and Xoma.r The study was funded by Sanofi. Editorial support was provided by Tom Claus of PPSI (a PAREXEL Company; Hackensack, NJ, USA) and funded by Sanofi.	Ahren B, 2010, DIABETES METAB SYNDR, V3, P31, DOI 10.2147/DMSO.S7327; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Charbonnel B, 2006, DIABETES CARE, V29, P2638, DOI 10.2337/dc06-0706; Chen HS, 2008, DIABETES CARE, V31, P1927, DOI 10.2337/dc08-0075; Desouza CV, 2010, DIABETES CARE, V33, P1389, DOI 10.2337/dc09-2082; Fonseca V, 2011, DIABETES OBES METAB, V13, P814, DOI 10.1111/j.1463-1326.2011.01412.x; Gerstein HC, 2008, AM HEART J, V155, P26, DOI 10.1016/j.ahj.2007.09.009; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; *IDF CLIN GUID TAS, 2007, GUID MAN POSTM GLUC; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Noh YH, 2008, DIABETES-METAB RES, V24, P384, DOI 10.1002/dmrr.849; Pozzilli P, 2010, DIABETES-METAB RES, V26, P239, DOI 10.1002/dmrr.1092; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rodbard Helena W, 2007, Endocr Pract, V13 Suppl 1, P1; Rosenstock J, 2008, DIABETOLOGIA, V51, P408, DOI 10.1007/s00125-007-0911-x; Triplitt C, 2006, DIABETES CARE, V29, P2371, DOI 10.2337/dc06-0564; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wainstein J, 2012, DIABETES OBES METAB, V14, P409, DOI 10.1111/j.1463-1326.2011.01530.x; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X	25	83	88	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2262	2269		10.1016/S0140-6736(12)60439-5	http://dx.doi.org/10.1016/S0140-6736(12)60439-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683131				2022-09-04	WOS:000305511400033
J	Blom, DJ; Santos, RD; Daclin, V; Mercier, F; Ruiz, AJ; Danchin, N				Blom, Dirk J.; Santos, Raul D.; Daclin, Veronique; Mercier, Florence; Ruiz, Alvaro J.; Danchin, Nicolas		ICLPS study grp	The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International ChoLesterol management Practice Study	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY			English	Article						Cardiovascular disease; diabetes mellitus; dyslipidaemia; hypertension; observational study; risk factors	DIABETES-MELLITUS; IMPACT; COUNTRIES; MORTALITY; DISEASE	Background: Comprehensive control of multiple cardiovascular risk factors reduces cardiovascular risk but is difficult to achieve. Design: A multinational, cross-sectional, observational study. Methods: The International ChoLesterol management Practice Study (ICLPS) investigated achievement of European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guideline low-density lipoprotein cholesterol (LDL-C) targets in patients receiving lipid-modifying therapy in countries outside Western Europe. We examined the rate of, and association between, control of multiple risk factors in ICLPS participants with dyslipidaemia, diabetes and hypertension (N = 2377). Results: Mean (standard deviation) age of patients was 61.4 (10.4) years; 51.3% were male. Type 2 diabetes was the most common form of diabetes (prevalence, 96.9%). The prevalence of metabolic syndrome was 67.8%, obesity 40.4%, atherosclerotic disease 39.6% and coronary artery disease 33.5%. All patients were at high (38.2%) or very high (61.8%) cardiovascular risk according to ESC/EAS guidelines. Body mass index (BMI) was <25 kg/m(2) in 20.3% of patients, 62.8% had never smoked and 25.2% were former smokers. Overall, 12.2% achieved simultaneous control of LDL-C, diabetes and blood pressure. Risk factor control was similar across all participating countries. The proportion of patients achieving individual guideline-specified treatment targets was 43.9% for LDL-C, 55.5% for blood pressure and 39.3% for diabetes. Multiple correspondence analysis indicated that control of LDL-C, control of blood pressure, control of diabetes, BMI and smoking were associated. Conclusion: Comprehensive control of multiple cardiovascular risk factors in high-risk patients is suboptimal worldwide. Failure to control one risk factor is associated with poor control of other risk factors.	[Blom, Dirk J.] Univ Cape Town, Cape Town, South Africa; [Santos, Raul D.] Univ Sao Paulo, Med Sch Hosp, Heart Inst InCor, Sao Paulo, Brazil; [Santos, Raul D.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Daclin, Veronique] Sanofi Aventis, Paris, France; [Mercier, Florence] Stat Proc, Paris, France; [Ruiz, Alvaro J.] Pontificia Univ Javeriana, Bogota, Colombia; [Danchin, Nicolas] Hop Europeen Georges Pompidou, Cardiol, Paris, France		Blom, DJ (corresponding author), Univ Cape Town, Dept Med, Div Lipidol, 4th Floor,Chris Barnard Bldg,Anzio Rd, ZA-7925 Cape Town, South Africa.; Blom, DJ (corresponding author), Univ Cape Town, Hatter Inst Cardiovasc Res Africa, 4th Floor,Chris Barnard Bldg,Anzio Rd, ZA-7925 Cape Town, South Africa.	Dirk.blom@uct.ac.za	Santos, Raul D./A-1170-2010; Danchin, Nicolas/AAN-8291-2020	Santos, Raul D./0000-0002-9860-6582; Ruiz, Alvaro J/0000-0001-6528-4268	Sanofi	Sanofi	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Sanofi.	Aamir AH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025300; Bertoni AG, 2008, J DIABETES COMPLICAT, V22, P1, DOI 10.1016/j.jdiacomp.2006.10.003; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272; Chaturvedi N, 1998, BMJ-BRIT MED J, V316, P100; Danchin N, 2018, EUR J PREV CARDIOL, V25, P1087, DOI 10.1177/2047487318777079; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; Fan WJ, 2019, DIABETES OBES METAB, V21, P1121, DOI 10.1111/dom.13625; Germano G, 2012, EUR HEART J, V33, P137; Jaffiol C, 2013, DIABETES METAB, V39, P56, DOI 10.1016/j.diabet.2012.09.002; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kotseva K, 2019, EUR J PREV CARDIOL, V26, P824, DOI 10.1177/2047487318825350; Lechowicz Marta, 2015, Folia Med Cracov, V55, P15; Liu L, 2015, DIABETES-METAB RES, V31, P811, DOI 10.1002/dmrr.2757; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI 10.1016/j.atherosclerosis.2016.05.037; Rarau P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211068; Rawshani A, 2018, NEW ENGL J MED, V379, P633, DOI 10.1056/NEJMoa1800256; Schroeder EB, 2012, CIRC-CARDIOVASC QUAL, V5, P645, DOI 10.1161/CIRCOUTCOMES.111.963553; Song YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep36093; Tauras JA, 2013, INT J ENV RES PUB HE, V10, P4306, DOI 10.3390/ijerph10094306; Uthman OA, 2015, COCHRANE DB SYST REV, V8, pCD011163; Wan EYF, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006400; Wang CY, 2014, DIABETES RES CLIN PR, V106, pS309, DOI 10.1016/S0168-8227(14)70735-1; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Williams J, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020409; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	27	14	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-4873	2047-4881		EUR J PREV CARDIOL	Eur. J. Prev. Cardiol.	SEP	2020	27	13					1403	1411	2047487319871735	10.1177/2047487319871735	http://dx.doi.org/10.1177/2047487319871735		SEP 2019	9	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	NG0KQ	31533447	hybrid, Green Published			2022-09-04	WOS:000491829600001
J	Uddin, MS; Kabir, MT; Al Mamun, A; Abdel-Daim, MM; Barreto, GE; Ashraf, GM				Uddin, Md. Sahab; Kabir, Md. Tanvir; Al Mamun, Abdullah; Abdel-Daim, Mohamed M.; Barreto, George E.; Ashraf, Ghulam Md			APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis	MOLECULAR NEUROBIOLOGY			English	Review						APOE4; Senile plaques; Neurofibrillary tangles; Amyloid; Tauopathy; Alzheimer's disease	AMYLOID-BETA-PEPTIDE; APOLIPOPROTEIN-E POLYMORPHISM; TRANSGENIC MOUSE MODEL; BLOOD-BRAIN-BARRIER; GENOME-WIDE ASSOCIATION; A-BETA; ALPHA-SYNUCLEIN; PRECURSOR PROTEIN; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID	Alzheimer's disease (AD) is an immutable neurodegenerative disease featured by the two hallmark brain pathologies that are the extracellular amyloid ss (A ss) and intraneuronal tau protein. People carrying the APOE4 allele are at high risk of AD concerning the ones carrying the epsilon 3 allele, while the epsilon 2 allele abates risk. ApoE isoforms exert a central role in controlling the transport of brain lipid, neuronal signaling, mitochondrial function, glucose metabolism, and neuroinflammation. Regardless of widespread indispensable studies, the appropriate function of APOE in AD etiology stays ambiguous. Existing proof recommends that the disparate outcomes of ApoE isoforms on A accretion and clearance have a distinct function in AD pathogenesis. ApoE-lipoproteins combine diverse cell-surface receptors to transport lipids and moreover to lipophilic A peptide, that is believed to begin deadly events that generate neurodegeneration in the AD. ApoE has great influence in tau pathogenesis, tau-mediated neurodegeneration, and neuroinflammation, as well as -synucleinopathy, lipid metabolism, and synaptic plasticity despite the presence of A pathology. ApoE4 shows the deleterious effect for AD while the lack of ApoE4 is defensive. Therapeutic strategies primarily depend on APOE suggest to lessen the noxious effects of ApoE4 and reestablish the protective aptitudes of ApoE. This appraisal represents the critical interactions of APOE and AD pathology, existing facts on ApoE levels in the central nervous system (CNS), and the credible active stratagems for AD therapy by aiming ApoE. This review also highlighted utmost ApoE targeting therapeutic tactics that are crucial for controlling Alzheimer's pathogenesis.	[Uddin, Md. Sahab; Al Mamun, Abdullah] Southeast Univ, Dept Pharm, Dhaka, Bangladesh; [Kabir, Md. Tanvir] BRAC Univ, Dept Pharm, Dhaka, Bangladesh; [Abdel-Daim, Mohamed M.] Suez Canal Univ, Dept Pharmacol, Ismailia, Egypt; [Abdel-Daim, Mohamed M.] Yokohama City Univ, Dept Ophthalmol & Microtechnol, Yokohama, Kanagawa, Japan; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia		Uddin, MS (corresponding author), Southeast Univ, Dept Pharm, Dhaka, Bangladesh.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	msu-neuropharma@hotmail.com; ashraf.gm@gmail.com	Ashraf, Ghulam Md/H-9485-2012; , fvcx/AAE-2909-2021; Barreto, George E./AAD-7420-2020; Abdel-Daim, Mohamed M./B-2545-2013	Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Abdel-Daim, Mohamed M./0000-0002-4341-2713				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Agosta F, 2009, P NATL ACAD SCI USA, V106, P2018, DOI 10.1073/pnas.0812697106; Al-Wandi A, 2010, NEUROBIOL AGING, V31, P796, DOI 10.1016/j.neurobiolaging.2008.11.001; Ardura-Fabregat A, 2017, CNS DRUGS, V31, P1057, DOI 10.1007/s40263-017-0483-3; Austin SA, 2006, J NEUROSCI, V26, P10558, DOI 10.1523/JNEUROSCI.1799-06.2006; Austin SA, 2011, NEUROCHEM RES, V36, P994, DOI 10.1007/s11064-011-0439-9; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bar Roni, 2018, Alzheimers Dement (Amst), V10, P1, DOI 10.1016/j.dadm.2017.08.003; Beffert U, 1999, BRAIN RES, V843, P87, DOI 10.1016/S0006-8993(99)01894-6; Beffert U, 1998, J NEUROCHEM, V70, P1458; Bekris LM, 2008, J ALZHEIMERS DIS, V13, P255; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Benskey MJ, 2016, J NEUROCHEM, V137, P331, DOI 10.1111/jnc.13570; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bien-Ly N, 2012, J NEUROSCI, V32, P4803, DOI 10.1523/JNEUROSCI.0033-12.2012; Biere AL, 1995, NEUROBIOL DIS, V2, P177, DOI 10.1006/nbdi.1995.0019; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014; Bray NJ, 2004, HUM MOL GENET, V13, P2885, DOI 10.1093/hmg/ddh299; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; BURNS A, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B158; Buttini M, 2002, J NEUROSCI, V22, P10539; Castagnet PI, 2005, J NEUROCHEM, V94, P839, DOI 10.1111/j.1471-4159.2005.03247.x; CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599; Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Chan ES, 2016, SCI REP-UK, V6, DOI 10.1038/srep26119; Chan W, 1996, BIOCHEMISTRY-US, V35, P7123, DOI 10.1021/bi952852v; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chen HK, 2012, J BIOL CHEM, V287, P5253, DOI 10.1074/jbc.M111.276162; Chen RHC, 2013, J BIOL CHEM, V288, P7438, DOI 10.1074/jbc.M112.439497; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cummings JL, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0173-2; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Deming Y, 2017, ACTA NEUROPATHOL, V133, P839, DOI 10.1007/s00401-017-1685-y; Dodart JC, 2002, BRAIN RES, V955, P191, DOI 10.1016/S0006-8993(02)03437-6; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Emamzadeh FN, 2016, NEUROSCI LETT, V618, P146, DOI 10.1016/j.neulet.2016.02.042; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Fukumoto H, 2003, EXP NEUROL, V183, P249, DOI 10.1016/S0014-4886(03)00088-8; Gallardo G, 2008, NAT NEUROSCI, V11, P301, DOI 10.1038/nn2058; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Ghosal K, 2013, NEURODEGENER DIS, V12, P51, DOI 10.1159/000341299; Golabek AA, 1996, J BIOL CHEM, V271, P10602, DOI 10.1074/jbc.271.18.10602; Gureje O, 2006, ANN NEUROL, V59, P182, DOI 10.1002/ana.20694; Gureviciene I, 2007, NEUROBIOL DIS, V28, P83, DOI 10.1016/j.nbd.2007.06.016; Hamanaka H, 2000, HUM MOL GENET, V9, P353, DOI 10.1093/hmg/9.3.353; Handattu SP, 2013, J ALZHEIMERS DIS, V36, P335, DOI 10.3233/JAD-122377; Hao JA, 2010, NEUROPEPTIDES, V44, P305, DOI 10.1016/j.npep.2010.03.001; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hatami A, 2017, J BIOL CHEM, V292, P3172, DOI 10.1074/jbc.M116.755264; Hatters DM, 2006, J MOL BIOL, V361, P932, DOI 10.1016/j.jmb.2006.06.080; Hauser PS, 2013, CURR ALZHEIMER RES, V10, P809; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Hohman TJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188501; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hopkins PCR, 2011, J ALZHEIMERS DIS, V26, P239, DOI 10.3233/JAD-2011-102115; Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576; Hu J, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0001-3; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Huynh TPV, 2017, J LIPID RES, V58, P824, DOI 10.1194/jlr.R075481; Hwang KD, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0338-3; Irizarry MC, 2004, J NEUROCHEM, V90, P1132, DOI 10.1111/j.1471-4159.2004.02581.x; Irizarry MC, 2000, ANN NY ACAD SCI, V920, P171; Ito S, 2007, J NEUROCHEM, V103, P2482, DOI 10.1111/j.1471-4159.2007.04938.x; Ji Y, 2001, J ALZHEIMERS DIS, V3, P23, DOI 10.3233/JAD-2001-3105; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kim J, 2012, J EXP MED, V209, P2149, DOI 10.1084/jem.20121274; Kim J, 2011, J NEUROSCI, V31, P18007, DOI 10.1523/JNEUROSCI.3773-11.2011; Kim KW, 1999, NEUROSCI LETT, V277, P145, DOI 10.1016/S0304-3940(99)00867-8; Kivipelto M, 2002, ANN INTERN MED, V137, P149, DOI 10.7326/0003-4819-137-3-200208060-00006; Kline A, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt135; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; Kuszczyk MA, 2013, AM J PATHOL, V182, P1750, DOI 10.1016/j.ajpath.2013.01.034; LaDu MJ, 2001, NEUROCHEM INT, V39, P427, DOI 10.1016/S0197-0186(01)00050-X; Li XW, 2015, FASEB J, V29, P1754, DOI 10.1096/fj.14-262683; Liao F, 2014, J NEUROSCI, V34, P7281, DOI 10.1523/JNEUROSCI.0646-14.2014; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu CC, 2017, J NEUROSCI, V37, P4023, DOI 10.1523/JNEUROSCI.3442-16.2017; Liu CC, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3650; Liu S, 2014, J NEUROCHEM, V128, P577, DOI 10.1111/jnc.12484; Luz I, 2016, CURR ALZHEIMER RES, V13, P918, DOI 10.2174/1567205013666160404120817; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Mahley RW, 2012, J MED CHEM, V55, P8997, DOI 10.1021/jm3008618; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Martel CL, 1997, J NEUROCHEM, V69, P1995; Minami SS, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-16; Moser VA, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0077-17.2017; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Naiki H, 1997, BIOCHEMISTRY-US, V36, P6243, DOI 10.1021/bi9624705; Newport MT, 2015, ALZHEIMERS DEMENT, V11, P99, DOI 10.1016/j.jalz.2014.01.006; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; Nuriel T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01444-0; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Osei-Hwedieh DO, 2011, PHARMACOL THERAPEUT, V130, P83, DOI 10.1016/j.pharmthera.2010.12.003; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Pankiewicz JE, 2017, ONCOTARGET, V8, P39941, DOI 10.18632/oncotarget.17990; Pankiewicz JE, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0156-1; Pankiewicz JE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0075-0; Pirttila T, 1996, BRAIN RES, V722, P71, DOI 10.1016/0006-8993(96)00183-7; Qiao F, 2014, J ALZHEIMERS DIS, V41, P1165, DOI 10.3233/JAD-140375; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quiroga P, 1999, NEUROEPIDEMIOLOGY, V18, P48, DOI 10.1159/000026195; Rapp A, 2006, BIOCHIMIE, V88, P473, DOI 10.1016/j.biochi.2005.10.007; Rassas AA, 2012, NEUROL SCI, V33, P33, DOI 10.1007/s10072-011-0663-8; Raygani AV, 2005, NEUROSCI LETT, V375, P1, DOI 10.1016/j.neulet.2004.10.073; Rebeck GW, 2017, J LIPID RES, V58, P1493, DOI 10.1194/jlr.R075408; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Riemenschneider M, 2002, J NEUROL NEUROSUR PS, V72, P639, DOI 10.1136/jnnp.72.5.639; Ringman JM, 2012, ARCH NEUROL-CHICAGO, V69, P757, DOI 10.1001/archneurol.2012.277; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Ryan NS, 2010, BIOMARK MED, V4, P99, DOI 10.2217/BMM.09.92; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Sando SB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-9; Sen A, 2012, J BIOL CHEM, V287, P15947, DOI 10.1074/jbc.M111.312710; SEPEHRNIA B, 1989, AM J HUM GENET, V45, P586; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Shinohara M, 2010, J BIOL CHEM, V285, P22091, DOI 10.1074/jbc.M110.102277; Skerrett R, 2015, J BIOL CHEM, V290, P21591, DOI 10.1074/jbc.M115.652008; Srinivasan R, 2006, J NEUROL NEUROSUR PS, V77, P154, DOI 10.1136/jnnp.2005.063966; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; SVENNERHOLM L, 1994, J NEUROCHEM, V62, P1039; Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48; Tachibana M, 2016, EXP NEUROL, V277, P1, DOI 10.1016/j.expneurol.2015.12.003; Talwar P, 2016, J NEUROL SCI, V360, P179, DOI 10.1016/j.jns.2015.12.004; Teter B, 2002, J NEUROSCI RES, V68, P331, DOI 10.1002/jnr.10221; Uddin M.S., 2016, J ALZHEIMERS DIS PAR, V6, P1, DOI [10.4172/2161-0460.1000245, DOI 10.4172/2161-0460.1000245]; Uddin MS, 2018, ANN NEUROSCI, V25, P25, DOI 10.1159/000481812; Uddin MS, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00004; Uddin MS, 2016, ANN NEUROSCI, V23, P218, DOI 10.1159/000449482; Uddin MS, 2016, J NEUROL NEUROPHYSIO, V7, P1, DOI DOI 10.4172/2155-9562.1000397; Uddin MS, 2017, J INTELLECT DISABILI, V5, P137, DOI DOI 10.6000/2292-2598.2017.05.04.6; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; Vitek MP, 2012, NEURODEGENER DIS, V10, P122, DOI 10.1159/000334914; Wahrle SE, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-7; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; WEISGRABER KH, 1994, CURR OPIN STRUC BIOL, V4, P507, DOI 10.1016/S0959-440X(94)90212-7; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Wood SJ, 1996, CHEM BIOL, V3, P949, DOI 10.1016/S1074-5521(96)90183-0; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Yamauchi K, 2002, ANN CLIN LAB SCI, V32, P65; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Zhang L, 2015, PHARMACEUTICS, V7, P542, DOI 10.3390/pharmaceutics7040542; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006; Zhou W, 2006, NEUROSCIENCE, V143, P689, DOI 10.1016/j.neuroscience.2006.08.019; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	172	67	68	0	45	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2019	56	4					2450	2465		10.1007/s12035-018-1237-z	http://dx.doi.org/10.1007/s12035-018-1237-z			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU7XZ					2022-09-04	WOS:000465498200015
J	Rathmann, K; Pfortner, TK; Osorio, AM; Hurrelmann, K; Elgar, FJ; Bosakova, L; Richter, M				Rathmann, Katharina; Pfoertner, Timo-Kolja; Osorio, Ana M.; Hurrelmann, Klaus; Elgar, Frank J.; Bosakova, Lucia; Richter, Matthias			Adolescents' psychological health during the economic recession: does public spending buffer health inequalities among young people?	BMC PUBLIC HEALTH			English	Article						Health inequalities; Recession; Social spending; Adolescence; Multilevel analysis	FAMILY AFFLUENCE SCALE; MENTAL-HEALTH; CRISIS; COMPLAINTS; EUROPE; MULTILEVEL; COUNTRIES; CHILDREN; IMPACT; RISE	Background: Many OECD countries have replied to economic recessions with an adaption in public spending on social benefits for families and young people in need. So far, no study has examined the impact of public social spending during the recent economic recession on health, and social inequalities in health among young people. This study investigates whether an increase in public spending relates to a lower prevalence in health complaints and buffers health inequalities among adolescents. Methods: Data were obtained from the 2009/2010 "Health Behaviour in School-aged Children (HBSC)" study comprising 11 - 15-year-old adolescents from 27 European countries (N = 144,754). Socioeconomic position was measured by the Family Affluence Scale (FAS). Logistic multilevel models were conducted for the association between the absolute rate of public spending on family benefits per capita in 2010 and the relative change rate in family benefits (2006-2010) in relation to adolescent psychological health complaints in 2009/2010. Results: The absolute rate of public spending on family benefits in 2010 did not show a significant association with adolescents' psychological health complaints. Relative change rates of public spending on family benefits (2006-2010) were related to better health. Greater socioeconomic inequalities in psychological health complaints were found for countries with higher change rates in public spending on family benefits (2006-2010). Conclusions: The results partially support our hypothesis and highlight that policy initiatives in terms of an increase in family benefits might partially benefit adolescent health, but tend to widen social inequalities in adolescent health during the recent recession.	[Rathmann, Katharina; Pfoertner, Timo-Kolja; Richter, Matthias] Univ Halle Wittenberg, Fac Med, Inst Med Sociol, Magdeburger Str 8, D-06112 Halle, Germany; [Pfoertner, Timo-Kolja] Univ Cologne, Inst Med Sociol Hlth Serv Res & Rehabil Sci, Fac Human Sci, Cologne, Germany; [Pfoertner, Timo-Kolja] Univ Cologne, Fac Med, Cologne, Germany; [Osorio, Ana M.] Pontificia Univ Javeriana Cali, Cali, Colombia; [Hurrelmann, Klaus] Hertie Sch Governance Berlin, Berlin, Germany; [Elgar, Frank J.] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Bosakova, Lucia] PJ Safarik Univ Kosice, Fac Med, Dept Hlth Psychol, Kosice, Slovakia; [Bosakova, Lucia] Univ Econ Bratislava, Fac Business Econ Kosice, Dept Quantitat Methods, Bratislava, Slovakia; [Bosakova, Lucia] Palacky Univ Olomouc, Olomouc Univ Social Hlth Inst, Olomouc, Czech Republic		Rathmann, K (corresponding author), Univ Halle Wittenberg, Fac Med, Inst Med Sociol, Magdeburger Str 8, D-06112 Halle, Germany.	katharina.rathmann@medizin.uni-halle.de	Elgar, Frank/ABE-7450-2020; Pförtner, Timo-Kolja/AAE-1765-2021; Bosakova, Lucia/AAE-2085-2022; Hurrelmann, Klaus/AAB-7404-2019; Osorio Mejia, Ana Maria/K-7377-2016	Bosakova, Lucia/0000-0001-8381-7064; Richter, Matthias/0000-0003-3898-3332; Pfortner, Timo-Kolja/0000-0002-8188-894X; Osorio Mejia, Ana Maria/0000-0002-8318-6343; Rathmann, Katharina/0000-0002-2892-1624				Andersen A, 2008, J EPIDEMIOL COMMUN H, V62, P1092, DOI 10.1136/jech.2007.065169; [Anonymous], 2012, MULTILEVEL LONGITUDI; [Anonymous], 2014, 12 UNICEF OFF RES; Bambra C, 2010, J EPIDEMIOL COMMUN H, V64, P213, DOI 10.1136/jech.2009.090621; Boyce W, 2006, SOC INDIC RES, V78, P473, DOI 10.1007/s11205-005-1607-6; Catalano R, 2011, ANNU REV PUBL HEALTH, V32, P431, DOI 10.1146/annurev-publhealth-031210-101146; Chzhen Y, 2014, 201406 UNICEF OFF RE; Currie C, 2008, 20052006 HBSC WHO; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Currie C, 2009, INT J PUBLIC HEALTH, V54, P131, DOI 10.1007/s00038-009-5404-x; De Vogli R, 2013, J EPIDEMIOL COMMUN H, V67, P298, DOI 10.1136/jech-2012-202112; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Holstein BE, 2009, INT J PUBLIC HEALTH, V54, P260, DOI 10.1007/s00038-009-5418-4; Institute of Health Equity for the London Health Inequalities Network, 2012, IMP REC WELF CHANG H; International Labour Office, 2011, KEY IND LAB MARK KIL; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Lundberg M., 2012, CHILDREN YOUTH CRISI; Mcdaid D, 2011, HEALTH PROMOT INT, V26, pI108, DOI 10.1093/heapro/dar059; OECD, 2014, SOC GLANC 2014 OECD; OECD, 2012, SOC SPEND CRIS; Pfoertner TK, 2014, EUR J PUBLIC HEALTH, V24, P961, DOI 10.1093/eurpub/cku056; Rajmil L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003286; Rathmann K, 2015, MATURITAS, V80, P414, DOI 10.1016/j.maturitas.2015.01.008; Ravens-Sieberer U, 2008, EUR J PUBLIC HEALTH, V18, P294, DOI 10.1093/eurpub/ckn001; Richardson D, 2010, CHILD SOC, V24, P495, DOI 10.1111/j.1099-0860.2010.00334.x; Riva M, 2011, INT J PUBLIC HEALTH, V56, P3, DOI 10.1007/s00038-010-0220-x; Schoon I, 2012, CHILD DEV PERSPECT, V6, P335, DOI 10.1111/cdep.12003; Stanzani S., 2012, ITALIAN SOCIOL REV, V2, P191; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Stuckler D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3311; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Wahlbeck K, 2012, WORLD PSYCHIATRY, V11, P139; WHO, 2011, IMP EC CRIS MENT HLT; Zavras D, 2013, EUR J PUBLIC HEALTH, V23, P206, DOI 10.1093/eurpub/cks143	35	5	5	1	18	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2458			BMC PUBLIC HEALTH	BMC Public Health	AUG 24	2016	16								860	10.1186/s12889-016-3551-6	http://dx.doi.org/10.1186/s12889-016-3551-6			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DU1PQ	27553033	Green Published, gold			2022-09-04	WOS:000381981000005
J	Plaza, V; Bellido-Casado, J; Rodrigo, GJ; Solarte, I; Rodriguez-Trigo, G; Sepulveda, R; Neffen, H; Perpina, M				Plaza, Vicente; Bellido-Casado, Jesus; Rodrigo, Gustavo J.; Solarte, Ivan; Rodriguez-Trigo, Gema; Sepulveda, Ricardo; Neffen, Hugo; Perpina, Miguel			Impact of preventive treatment of adrenergic long- acting agonists beta(2) and inhaled glucocorticoids in the morbidity of 1543 episodes of severe exacerbation of asthma	ARCHIVOS DE BRONCONEUMOLOGIA			Spanish	Correction									[Plaza, Vicente; Bellido-Casado, Jesus] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Serv Neumol, E-08193 Barcelona, Spain; [Rodrigo, Gustavo J.] Hosp Cent Fuerzas Armadas, Dept Emergencia, Montevideo, Uruguay; [Rodrigo, Gustavo J.] Fac Med Claeh, Punta Del Este, Maldonado, Uruguay; [Solarte, Ivan] Univ Javeriana, Hosp San Ignacio, Unidad Med Resp, Bogota, Colombia; [Rodriguez-Trigo, Gema] Cornplejo Hosp Univ, Serv Neumol, La Coruna, Spain; [Rodriguez-Trigo, Gema] Hosp Clin San Carlos, Serv Neumol, Madrid, Spain; [Sepulveda, Ricardo] Inst Torax, Santiago, Chile; [Neffen, Hugo] Hosp Ninos O Allassia, Unidad Med Resp, Santa Fe, Argentina; [Perpina, Miguel] Hosp Univ La Fe, Serv Neumol, Valencia, Spain		Plaza, V (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Serv Neumol, E-08193 Barcelona, Spain.	vplaza@santpau.cat		SOLARTE, IVAN/0000-0002-0100-1940				Plaza V, 2009, ARCH BRONCONEUMOL, V45, P545, DOI 10.1016/j.arbres.2009.05.009	1	15	17	0	2	EDICIONES DOYMA S A	BARCELONA	TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN	0300-2896			ARCH BRONCONEUMOL	Arch. Bronconeumol.	AUG	2010	46	8					451	451		10.1016/j.arbres.2010.05.002	http://dx.doi.org/10.1016/j.arbres.2010.05.002			1	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Respiratory System	642GO	21320808				2022-09-04	WOS:000281193200015
J	Venegas-Sanabria, LC; Cavero-Redondo, I; Martinez-Vizcaino, V; Cano-Gutierrez, CA; Alvarez-Bueno, C				Carlos Venegas-Sanabria, Luis; Cavero-Redondo, Ivan; Martinez-Vizcaino, Vicente; Alberto Cano-Gutierrez, Carlos; Alvarez-Bueno, Celia			Effect of multicomponent exercise in cognitive impairment: a systematic review and meta-analysis	BMC GERIATRICS			English	Review						Cognitive impairment; Physical activity; Non-pharmacological treatment; Meta-analysis	NEUROTROPHIC FACTOR; PHYSICAL-EXERCISE; AEROBIC EXERCISE; ALZHEIMERS-DISEASE; OLDER-ADULTS; INTERVENTION; DEMENTIA; PROGRAM	Background Multicomponent physical exercise is the most recommended type of physical intervention in older adults. Experimental data suggest the relevance of the muscle-brain axis and the relationship between muscle contraction and release of brain-derived neurotrophic factor, however, the impact of this relationship on cognition remains unclear, especially in people with diagnosis of cognitive impairment. This study assesses the effect of multicomponent physical exercise on global cognition in people with mild cognitive impairment or dementia. Methods Randomized controlled trials published until January 2021 were searched across three electronic databases (PubMed, Scopus, and Cochrane Database). Data about exercises included in the multicomponent intervention (endurance, strength, balance, or flexibility), the inclusion of aerobic exercise, and the change in global cognition were extracted. The effect size was represented as a standardized mean difference. Risk of bias was assessed by the RoB2 tool. Results A total of 8 studies were included. The overall effect size suggested an effect of multicomponent exercise on global cognition. However, the subgroup analysis showed an effect only when aerobic exercise was included in the intervention. No effect when mild cognitive impairment and dementia were assessed separately was found. Conclusion This study suggests that multicomponent physical exercise could have an effect on global cognition in people with mild cognitive impairment or dementia only when aerobic exercise is included in the intervention. Our results support the inclusion of structured physical exercise programs in the management of people with cognitive impairment.	[Carlos Venegas-Sanabria, Luis; Cavero-Redondo, Ivan; Martinez-Vizcaino, Vicente; Alvarez-Bueno, Celia] Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain; [Carlos Venegas-Sanabria, Luis] Univ Rosario, Escuela Med & Ciencias Salud, Inst Rosarista Estudio Envejecimiento & Longevida, Bogota, Colombia; [Carlos Venegas-Sanabria, Luis] Hosp Univ Mayor, Mederi, Bogota, Colombia; [Cavero-Redondo, Ivan] Univ Amer, Rehabil Hlth Res Ctr CIRES, Santiago, Chile; [Cavero-Redondo, Ivan] Fac Enfermeria Cuenca, C Santa Teresa Jornet S-N, Cuenca, Ecuador; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile; [Alberto Cano-Gutierrez, Carlos] Pontificia Univ Javeriana, Med Sch, Aging Inst, Bogota, Colombia; [Alberto Cano-Gutierrez, Carlos] Hosp Univ San Ignacio, Dept Internal Med, Geriatr Unit, Bogota, Colombia; [Alvarez-Bueno, Celia] Univ Politecn & Artist Paraguay, Asuncion, Paraguay		Cavero-Redondo, I (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain.; Cavero-Redondo, I (corresponding author), Univ Amer, Rehabil Hlth Res Ctr CIRES, Santiago, Chile.; Cavero-Redondo, I (corresponding author), Fac Enfermeria Cuenca, C Santa Teresa Jornet S-N, Cuenca, Ecuador.	ivan.cavero@uclm.es						Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; [Anonymous], 2018, LANCET NEUROL, V17, P651, DOI [10.1016/S1474-4422(18)30256-4, 10.1016/S0140-6736(18)31258-3]; Arrieta H, 2020, MATURITAS, V131, P72, DOI 10.1016/j.maturitas.2019.10.014; Berg U, 2004, HORM RES, V62, P50, DOI 10.1159/000080759; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Bisbe M, 2020, J ALZHEIMERS DIS, V73, P769, DOI 10.3233/JAD-190552; Burns A, 2019, CURR OPIN PSYCHIATR, V32, P361, DOI 10.1097/YCO.0000000000000511; Burtscher J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126479; Cancela JM, 2016, J SCI MED SPORT, V19, P293, DOI 10.1016/j.jsams.2015.05.007; Christofoletti G, 2008, CLIN REHABIL, V22, P618, DOI 10.1177/0269215507086239; Cohen J, 1988, STAT POWER BEHAV SCI, V2nd; Correia PR, 2010, CLINICS, V65, P1123, DOI 10.1590/S1807-59322010001100012; Cress M.E., 2006, EUR REV AGING PHYS A, V3, P34, DOI [10.1007/s11556-006-0003-9, DOI 10.1007/S11556-006-0003-9]; Barreto PD, 2017, J AM GERIATR SOC, V65, pE123, DOI 10.1111/jgs.14947; Dent E, 2019, J NUTR HEALTH AGING, V23, P771, DOI 10.1007/s12603-019-1273-z; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Du Z, 2018, CLIN INTERV AGING, V13, P1593, DOI 10.2147/CIA.S169565; Duzel E, 2016, BRAIN, V139, P662, DOI 10.1093/brain/awv407; Feter N, 2019, PHYSIOL BEHAV, V201, P42, DOI 10.1016/j.physbeh.2018.12.002; Goncalves ID, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122184; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Izquierdo M, 2021, LANCET HEALTH LONGEV, V2, pE380; Tarazona-Santabalbina FJ, 2016, J AM MED DIR ASSOC, V17, P426, DOI 10.1016/j.jamda.2016.01.019; Jurakic ZG, 2017, AGING CLIN EXP RES, V29, P1295, DOI 10.1007/s40520-017-0740-9; Kemoun G, 2010, DEMENT GERIATR COGN, V29, P109, DOI 10.1159/000272435; Kwak YS, 2008, INT J SPORTS MED, V29, P471, DOI 10.1055/s-2007-964853; Lan YS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205562; Lee Ronald, 2017, Finance Dev, V54, P7; Liang JH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010744; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Martinez-Velilla N, 2019, JAMA INTERN MED, V179, P28, DOI 10.1001/jamainternmed.2018.4869; Phu S, 2015, J CLIN DENSITOM, V18, P488, DOI 10.1016/j.jocd.2015.04.011; Ruiz-Gonzalez D, 2021, NEUROSCI BIOBEHAV R, V128, P394, DOI 10.1016/j.neubiorev.2021.05.025; Shah H, 2016, LANCET NEUROL, V15, P1283, DOI 10.1016/S1474-4422(16)30235-6; Sharma K, 2019, MOL MED REP, V20, P1479, DOI 10.3892/mmr.2019.10374; Song D, 2018, INT J NURS STUD, V79, P155, DOI 10.1016/j.ijnurstu.2018.01.002; Steinberg M, 2009, INT J GERIATR PSYCH, V24, P680, DOI 10.1002/gps.2175; Stern Y, 2019, NEUROLOGY, V92, pE905, DOI [10.1212/WNL.0000000000007003, 10.1212/wnl.0000000000007003]; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Stettler C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1331; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061483; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; Tisher A, 2019, SEMIN NEUROL, V39, P167, DOI 10.1055/s-0039-1683408; Venegas-Sanabria LC, 2021, AGING MENT HEALTH, V25, P1977, DOI 10.1080/13607863.2020.1839862; Wang R, 2018, AGEING RES REV, V48, P109, DOI 10.1016/j.arr.2018.10.002; WHO, 2018, DEM PLAN WHO GUID; Zheng GH, 2016, BRIT J SPORT MED, V50, P1443, DOI 10.1136/bjsports-2015-095699	47	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2318		BMC GERIATR	BMC Geriatr.	JUL 25	2022	22	1							617	10.1186/s12877-022-03302-1	http://dx.doi.org/10.1186/s12877-022-03302-1			11	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	3E4DG	35879665	gold, Green Submitted, Green Published			2022-09-04	WOS:000829933800004
J	Baez, S; Pinasco, C; Roca, M; Ferrari, J; Couto, B; Garcia-Cordero, I; Ibanez, A; Cruz, F; Reyes, P; Matallana, D; Manes, F; Cetcovich, M; Torralva, T				Baez, Sandra; Pinasco, Clara; Roca, Maria; Ferrari, Jesica; Couto, Blas; Garcia-Cordero, Indira; Ibanez, Agustin; Cruz, Francy; Reyes, Pablo; Matallana, Diana; Manes, Facundo; Cetcovich, Marcelo; Torralva, Teresa			Brain structural correlates of executive and social cognition profiles in behavioral variant frontotemporal dementia and elderly bipolar disorder	NEUROPSYCHOLOGIA			English	Article						Behavioral variant frontotemporal dementia; Late-life bipolar disorder; Executive functions; Theory of mind; Structural neuroimaging	VOXEL-BASED MORPHOMETRY; GRAY-MATTER VOLUME; ALZHEIMERS-DISEASE; EUTHYMIC PATIENTS; FRONTAL VARIANT; BASAL GANGLIA; OLDER-ADULTS; VERBAL FLUENCY; MIND DEFICITS; LOBE	An early stage of behavioral variant frontotemporal dementia (bvFTD) often displays a mix of behavioral disturbances and personality changes hindering a differential diagnosis from elderly bipolar disorder (BD), making this process a big challenge. However, no studies have compared these pathologies from neuropsychological and neuroanatomical perspectives. The aim of the present study was to compare the executive functions (EF) and social cognition profiles as well as the structural neuroimaging of bvFTD and elderly patients with BD. First, we compared the executive and social cognition performances of 16 bvFTD patients, 13 BD patients and 22 healthy controls. Second, we compared grey matter volumes in both groups of patients and controls using voxel-based morphometry. Lastly, we examined the brain regions where atrophy might be associated with specific impairments in bvFTD and BD patients. Compared to controls, bvFTD patients showed deficits in working memory, abstraction capacity, inhibitory control, cognitive flexibility, verbal fluency and theory of mind (ToM). Patients with BD showed lower performance than controls in terms of abstraction capacity and verbal inhibitory control. In bvFTD patients, atrophy of frontal, temporal and insular cortices was related to EF deficits. Atrophy of the amygdala, the hippocampus, the parahippocampal gyrus, the putamen, the insula, the precuneus, the right temporo-parietal junction and superior temporal pole was associated to ToM impairments. No significant associations between atrophy and EF performance were observed in BD patients. BvFTD patients showed greater EF and ToM deficits than BD patients. Moreover, compared to BD, bvFTD patients exhibited a significant decrease in GM volume in frontal, temporal and parietal regions. Our results provide the first comparison of EF, social cognition and neuroanatomical profiles of bvFTD and elderly BD patients. These findings shed light on differential diagnosis of these disorders and may have important clinical implications.	[Baez, Sandra; Pinasco, Clara; Roca, Maria; Ferrari, Jesica; Couto, Blas; Garcia-Cordero, Indira; Ibanez, Agustin; Manes, Facundo; Cetcovich, Marcelo; Torralva, Teresa] Favaloro Univ, INECO Fdn, Inst Cognit & Translat Neurosci INCyT, Buenos Aires, DF, Argentina; [Baez, Sandra; Roca, Maria; Ibanez, Agustin; Manes, Facundo] Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina; [Baez, Sandra] Univ Andes, Dept Psicol, Bogota, Colombia; [Ibanez, Agustin] Univ Adolfo Ibanez, Sch Psychol, CSCN, Santiago, Chile; [Ibanez, Agustin] Univ Autonoma Caribe, Barranquilla, Colombia; [Ibanez, Agustin; Manes, Facundo] Australian Res Council Ctr Excellence Cognit & It, Sydney, NSW, Australia; [Cruz, Francy; Reyes, Pablo; Matallana, Diana] Pontificia Univ Javeriana, Fac Med, Bogota, Colombia; [Reyes, Pablo] Hosp Univ San Ignacio, Dept Radiol, Bogota, Colombia		Torralva, T (corresponding author), Inst Cognit Neurol INECO, Pacheco Melo 1860, RA-1126 Buenos Aires, DF, Argentina.	ttorralva@ineco.org.ar	Baez, Sandra/ABC-7150-2020; Ibanez, Agustin/H-7976-2015	Ibanez, Agustin/0000-0001-6758-5101; Matallana-Eslava, Diana L./0000-0001-6529-7077; Cruz-Sanabria, Francy/0000-0001-5807-6399	CONICET; CONICYT/FONDECYT Regular [1130920]; FONCyT-PICT [2012-0412, 2012-1309]; FONDAP [15150012]; INECO Foundation, Colciencias [697-2014]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICYT/FONDECYT Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONCyT-PICT(ANPCyTFONCyT); FONDAP; INECO Foundation, Colciencias	This work was partially supported by grants from CONICET, CONICYT/FONDECYT Regular (1130920), FONCyT-PICT 2012-0412, FONCyT-PICT 2012-1309, FONDAP 15150012 and the INECO Foundation, Colciencias 697-2014.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; AKISKAL HS, 1995, J AM ACAD CHILD PSY, V34, P754, DOI 10.1097/00004583-199506000-00016; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baez S., 2016, NEURODEGENER DIS; Baez S, 2016, CORTEX, V75, P20, DOI 10.1016/j.cortex.2015.11.007; Baez S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00262; Baez S, 2014, JAMA NEUROL, V71, P1172, DOI 10.1001/jamaneurol.2014.347; Baez S, 2014, PSYCHIAT RES, V216, P269, DOI 10.1016/j.psychres.2014.01.020; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Baron-Cohen S., 1997, J CHILD PSYCHOL PSYC, V34, P163; Beck A. T., 1966, BECK DEPRESSION INVE; Berk M, 2009, INT J NEUROPSYCHOPH, V12, P441, DOI 10.1017/S1461145708009498; Bodden ME, 2013, ADV COGN PSYCHOL, V9, P32, DOI 10.2478/v10053-008-0129-6; Bora E, 2005, ACTA PSYCHIAT SCAND, V112, P110, DOI 10.1111/j.1600-0447.2005.00570.x; Carlson GA, 2006, DEV PSYCHOPATHOL, V18, P939, DOI 10.1017/S0954579406060470; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Cohen AD, 2014, NEUROBIOL DIS, V72, P117, DOI 10.1016/j.nbd.2014.05.001; Colom F, 2002, MED CLIN-BARCELONA, V119, P366, DOI 10.1016/S0025-7753(02)73419-2; Couto B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00467; Delaloye C, 2011, INT J GERIATR PSYCH, V26, P1309, DOI 10.1002/gps.2683; Delaloye C, 2009, AM J GERIAT PSYCHIAT, V17, P1012, DOI 10.1097/JGP.0b013e3181b7f0e2; Depp CA, 2004, J NERV MENT DIS, V192, P796, DOI 10.1097/01.nmd.0000145055.45944.d6; Depp CA, 2004, BIPOLAR DISORD, V6, P343, DOI 10.1111/j.1399-5618.2004.00139.x; Depp CA, 2007, J AFFECT DISORDERS, V101, P201, DOI 10.1016/j.jad.2006.11.022; Depp CA, 2009, J NERV MENT DIS, V197, P471, DOI 10.1097/NMD.0b013e3181ab5c9b; Dos Santos V, 2011, J ALZHEIMERS DIS, V23, P411, DOI 10.3233/JAD-2010-100156; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; Duarte A, 2006, NEUROSCI LETT, V406, P60, DOI 10.1016/j.neulet.2006.07.029; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; ESLINGER PJ, 1993, NEUROPSYCHOLOGIA, V31, P17, DOI 10.1016/0028-3932(93)90077-D; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Fuster E., 2008, PREFRONTAL CORTEX; Garibotto V, 2011, NEUROBIOL AGING, V32, P875, DOI 10.1016/j.neurobiolaging.2009.05.004; Gildengers AG, 2007, AM J GERIAT PSYCHIAT, V15, P174, DOI 10.1097/JGP.0b013e31802dd367; Giovagnoli AR, 2008, NEUROPSYCHOLOGIA, V46, P1495, DOI 10.1016/j.neuropsychologia.2007.12.023; Gleichgerrcht E, 2011, J CLIN EXP NEUROPSYC, V33, P997, DOI 10.1080/13803395.2011.589375; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GRAYBIEL AM, CURR BIOL, V10, pR50; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Haldane M, 2008, J PSYCHOPHARMACOL, V22, P138, DOI 10.1177/0269881107082955; Haller S, 2011, J PSYCHIATR NEUROSCI, V36, P391, DOI 10.1503/jpn.100140; Hornberger M, 2008, NEUROLOGY, V71, P1481, DOI 10.1212/01.wnl.0000334299.72023.c8; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Irish M, 2014, BRAIN, V137, P1241, DOI 10.1093/brain/awu003; Irish M, 2014, HUM BRAIN MAPP, V35, P1422, DOI 10.1002/hbm.22263; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kerr N, 2003, J AFFECT DISORDERS, V73, P253, DOI 10.1016/S0165-0327(02)00008-3; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Lagarde J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080353; Liu W, 2004, NEUROLOGY, V62, P742, DOI 10.1212/01.WNL.0000113729.77161.C9; Martino DJ, 2008, J AFFECT DISORDERS, V105, P291, DOI 10.1016/j.jad.2007.05.014; Martino DJ, 2013, INT J GERIATR PSYCH, V28, P142, DOI 10.1002/gps.3801; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Montag C, 2010, J AFFECT DISORDERS, V123, P264, DOI 10.1016/j.jad.2009.08.017; Muller VI, 2015, BRAIN STRUCT FUNCT, V220, P2401, DOI 10.1007/s00429-014-0797-6; Murray RM, 2004, SCHIZOPHR RES, V71, P405, DOI 10.1016/j.schres.2004.03.002; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nugent AC, 2006, NEUROIMAGE, V30, P485, DOI 10.1016/j.neuroimage.2005.09.029; Oosterman JM, 2008, BRAIN COGNITION, V68, P128, DOI 10.1016/j.bandc.2008.03.006; Partington JE, 1949, PSYCHOL SERVICE CTR, V1, P9; Perry DC, 2014, BRAIN, V137, P1621, DOI 10.1093/brain/awu075; Perry RJ, 2000, NEUROLOGY, V54, P2277, DOI 10.1212/WNL.54.12.2277; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Placek K, 2016, NEUROLOGY, V87, P1813, DOI 10.1212/WNL.0000000000003250; POREBSKI OR, 1966, BRIT J MATH STAT PSY, V19, P215, DOI 10.1111/j.2044-8317.1966.tb00369.x; Premi E, 2013, BEHAV BRAIN RES, V245, P58, DOI 10.1016/j.bbr.2013.01.030; Pressman PS, 2014, BIOL PSYCHIAT, V75, P574, DOI 10.1016/j.biopsych.2013.11.006; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Rosen H. J., 2002, NEUROLOGY, V58, P108; Ruscheweyh R, 2013, HUM BRAIN MAPP, V34, P3333, DOI 10.1002/hbm.22146; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2006, SOC NEUROSCI-UK, V1, pI, DOI 10.1080/17470910601117463; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Serra L, 2015, NEUROBIOL AGING, V36, P592, DOI 10.1016/j.neurobiolaging.2014.10.010; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Stevens J., 1996, APPL MULTIVARIATE ST; Stopford CL, 2012, CORTEX, V48, P429, DOI 10.1016/j.cortex.2010.12.002; Stuss D. T., 2002, PRINCIPLES FRONTAL L; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Takahashi H, 2007, NEUROIMAGE, V34, P1643, DOI 10.1016/j.neuroimage.2006.11.008; Thames AD, 2012, NEUROPSYCHOLOGIA, V50, P390, DOI 10.1016/j.neuropsychologia.2011.12.010; Torralva T., 2009, J INT NEUROPSYCH SOC, V28, P1; Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031; Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041; Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Wesehler D., 1999, WESCHLER ABBREVIATED; Whitwell JL, 2009, BRAIN, V132, P2932, DOI 10.1093/brain/awp232; Wicklund AH, 2004, J CLIN EXP NEUROPSYC, V26, P347, DOI 10.1080/13803390490510077; Woolley JD, 2011, J CLIN PSYCHIAT, V72, P126, DOI 10.4088/JCP.10m06382oli	96	43	46	1	25	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	MAR 18	2019	126						159	169		10.1016/j.neuropsychologia.2017.02.012	http://dx.doi.org/10.1016/j.neuropsychologia.2017.02.012			11	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	IA2QV	28219620	Green Published			2022-09-04	WOS:000469407100020
J	Perez, MTP; Aristizabal, CPD; Vera-Marquez, AV; Bernate, SPP				Perdomo Perez, Monica Tatiana; Duque Aristizabal, Claudia Patricia; Victoria Vera-Marquez, Angela; Pena Bernate, Sandra Patricia			Evaluation of a qualification program to early childhood educational agents	ZONA PROXIMA			Spanish	Article						Early childhood education; Childhood; Social research (Unesco Thesaurus)	TEACHER; KINDERGARTEN; CLASSROOM; QUALITY	This evaluative research has measured the implementation of the qualification program "Hogares con Vivencias" which was directed to educational early childhood agents. An evaluative qualitative research was conducted from the formative perspective. It was used as instruments: Guide of questions, observation records and accompanying protocols in Community households. The results demonstrate that the educational agents valued the implementation in a positive way, in a learning level changes are achieved in knowledge and intentions of change in practices were identified. The findings contribute to acknowledge the relevance of processes significance in qualification programs to educators.	[Perdomo Perez, Monica Tatiana] Univ Ibague, Ibague, Colombia; [Perdomo Perez, Monica Tatiana] Univ Complutense Madrid, Psicol Social, Madrid, Spain; [Perdomo Perez, Monica Tatiana] Univ Ibague, Fac Humanidades Artes & Ciencias Sociales, Grp Invest Educ Salud & Soc, Ibague, Colombia; [Duque Aristizabal, Claudia Patricia] Univ Nacl Colombia, Bogota, Colombia; [Duque Aristizabal, Claudia Patricia] Univ Valle, Psicol, Cali, Colombia; [Duque Aristizabal, Claudia Patricia] Univ Tolima, Fac Ciencias Educ, Grp Invest Educ Social GES, Ibague, Colombia; [Victoria Vera-Marquez, Angela] Univ Ibague, Ibague, Colombia; [Victoria Vera-Marquez, Angela] Univ Norte, Desarrollo Social, Barranquilla, Colombia; [Victoria Vera-Marquez, Angela] Univ Rosario, Escuela Med & Ciencias Salud, Grp Invest Estudios Sociales Ciencias Tecnol & Pr, Bogota, Colombia; [Pena Bernate, Sandra Patricia] Pontificia Univ Javeriana, Ctr Ensenanza & Aprendizaje, Cali, Colombia		Perez, MTP (corresponding author), Univ Ibague, Ibague, Colombia.; Perez, MTP (corresponding author), Univ Complutense Madrid, Psicol Social, Madrid, Spain.; Perez, MTP (corresponding author), Univ Ibague, Fac Humanidades Artes & Ciencias Sociales, Grp Invest Educ Salud & Soc, Ibague, Colombia.	tatiana.perdomo@unibague.edu.co; cpduquea@ut.edu.co; angela.vera@urosario.edu.co; patriciabernate@gmail.com		Perdomo Perez, Monica Tatiana/0000-0002-1423-1366; Vera-Marquez, Angela Victoria/0000-0002-5829-0069				Aguirre E., 2000, SOCIALIZACION PRACTI; Aparicio J. A., 2008, THESIS; Baker JA, 2006, J SCHOOL PSYCHOL, V44, P211, DOI 10.1016/j.jsp.2006.02.002; Bakkenes I, 2010, LEARN INSTR, V20, P533, DOI 10.1016/j.learninstruc.2009.09.001; Barreneche A., 2007, INVESTIGACION DESARR, V15, P124; Bernal R, 2010, IMPORTANCIA PROGRAMA; Bronfenbrenner U., 2006, HDB CHILD PSYCHOL, P793, DOI DOI 10.1002/9780470147658.CHPSY0114; Bronfrenbrenner U., 1979, ECOLOGIA DESARROLLO; Castillo F., 2017, J PEDAGOGY, V8, P121, DOI [10.1515/jped-2017-0006, DOI 10.1515/JPED-2017-0006]; Castillo-Cedeno R, 2017, REV ELECTRON EDUCARE, V21, P1; Cennamo K., 2005, REAL WORLD INSTRUCTI; Chatterji M, 2003, DESIGNING USING TOOL; Chegwin A, 2011, REV ZONA PROXIMA, V15, P164; Clarke D, 2002, TEACH TEACH EDUC, V18, P947, DOI 10.1016/S0742-051X(02)00053-7; Curby TW, 2009, J EDUC PSYCHOL, V101, P912, DOI 10.1037/a0016647; Departamento Nacional de Planeacion DNP., 2007, AS SOC COL DIAGN PRO; Departamento Nacional de Planeacion DNP, 2011, DOC CONP SOC POL NAC; Fujimoto G, 2003, REV LATINOAMERICANA, V1, P3; Henao AMG, 2015, ZONA PROX, V22, P87; Gobernacion del Tolima & Universidad de Ibague, 2009, DIAGN POBL AT HOG CO; Hamre BK, 2005, CHILD DEV, V76, P949, DOI 10.1111/j.1467-8624.2005.00889.x; Hardre PL, 2010, EVAL PROGRAM PLANN, V33, P498, DOI 10.1016/j.evalprogplan.2009.12.004; Hoekstra A, 2011, J TEACH EDUC, V62, P76, DOI 10.1177/0022487110382917; Jaramillo L, 2009, ZONA PROX, V11, P86; Kirkpatrick D. L., 1994, EVALUATING TRAINING; La Paro KM, 2004, ELEM SCHOOL J, V104, P409, DOI 10.1086/499760; Mashburn AJ, 2008, APPL DEV SCI, V12, P113, DOI 10.1080/10888690802199392; Ministerio de Educacion Nacional, 2006, COL INF POL PUBL NIN; Ministerio de Educacion Nacional de Colombia (MEN), 2009, GUIA OP PREST SERV A; Morales Saavedra Soledad, 2010, Perfiles educativos, V32, P49; Otalora Y., 2007, RECUPERANDO SIGNIFIC; Pena S, 2009, HOGARES CON VIVENCIA; Perez-Escoda N, 2013, EDUC XX1, V16, P233, DOI 10.5944/educxx1.16.1.725; Pianta R. C., 2000, ENHANCING RELATIONSH; Pianta RC, 2004, SCHOOL PSYCHOL REV, V33, P444; Postholm M. B., 2016, CREATIVE ED, V7, P1314, DOI [10.4236/ce.2016.79136, DOI 10.4236/CE.2016.79136]; Pozo J. I., 1999, ENSEN CIENC, V17, P513; Puche R, 2009, DESARROLLO INFANTIL; Putnam R. T., 2000, ED RES, V29, P4, DOI DOI 10.3102/0013189X029001004; Riojas-Cortez M, 2013, J EARLY CHILD TEACH, V34, P36, DOI 10.1080/10901027.2013.758536; Rowe S. M., 2002, BLACKWELL HDB CHILDH, P539, DOI [10.1002/9780470996652.ch24, DOI 10.1002/9780470996652.CH24]; STERNBERG RJ, 2002, BLACKWELL HDB CHILDH, P600, DOI DOI 10.1002/9780470996652.CH27; Torrado M. E., 2006, REV INFANCIA ADOLESC, V1, P15; UNICEF, 2011, EST MUND INF; Vygotsky L.S., 1989, DESARROLLO PROCESOS; Wolf S, 2018, STUD EDUC EVAL, V59, P112, DOI 10.1016/j.stueduc.2018.05.001; Zinke L., 2016, REV BRASILEIRA EDUCA, V4, P132	47	0	0	0	0	UNIV NORTE, EDICIONES UNINORTE	BARRANQUILLA	KILOMETRO 5 VIA ANTIGUA PUERTO COLOMBIA, BARRANQUILLA, 00000, COLOMBIA	1657-2416	2145-9444		ZONA PROX	Zona Prox.	JAN-JUN	2019	30						1	19		10.14482/zp.30.372.21	http://dx.doi.org/10.14482/zp.30.372.21			19	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	IM0VH		hybrid			2022-09-04	WOS:000477707300002
J	Salazar, M; Consoli, F; Villegas, V; Caicedo, V; Maddaloni, V; Daniele, P; Caianiello, G; Pachon, S; Nunez, F; Limongelli, G; Pacileo, G; Marino, B; Bernal, JE; De Luca, A; Dallapiccola, B				Salazar, Marleny; Consoli, Federica; Villegas, Victoria; Caicedo, Victor; Maddaloni, Valeria; Daniele, Paola; Caianiello, Giuseppe; Pachon, Sonia; Nunez, Federico; Limongelli, Giuseppe; Pacileo, Giuseppe; Marino, Bruno; Bernal, Jaime E.; De Luca, Alessandro; Dallapiccola, Bruno			Search of somatic GATA4 and NKX2.5 gene mutations in sporadic septal heart defects	EUROPEAN JOURNAL OF MEDICAL GENETICS			English	Article						Congenital heart disease; Cardiac septal defect; Somatic mutations; GATA4; NKX2.5	CARDIAC-MALFORMATIONS; DISEASE; POLYMORPHISM; MOSAICISM	High prevalence of somatic mutations in the cardiac transcription factor genes NKX2.5 and GATA4 have been reported in the affected cardiovascular tissue of patients with isolated cardiac septal defects, suggesting a role of somatic mutations in the pathogenesis of these congenital heart defects (CHDs). However, all somatic mutations have been identified in DNA extracted from an archive of formalin-fixed cardiac tissues. In the present study, to address the hypothesis that somatic mutations are important in isolated CHDs, we analyzed the GATA4 and NKX2.5 genes in the fresh-frozen pathologic cardiac tissue specimen and corresponding non-diseased tissue obtained from a series of 62 CHD patients, including 35 patients with cardiac septal defects and 27 with other cardiac anomalies. We identified one variant and two common polymorphisms in the NKX2.5 gene, and six variants and two common polymorphisms in the GATA4 gene. All identified variants were seen in both the fresh-frozen pathologic cardiac tissue and the corresponding non-diseased tissue, which indicates that they all were constitutional variants. The present study has identified NKX2.5 and GATA4 constitutional variants in our CHD cohort, but was unable to replicate the previously published findings of high prevalence of somatically derived sequence mutations in patients with cardiac septal defects using fresh-frozen cardiac tissues rather than formalin-fixed tissues. (C) 2011 Elsevier Masson SAS. All rights reserved.	[Consoli, Federica; Daniele, Paola; De Luca, Alessandro] Casa Sollievo Sofferenza Hosp, IRCCS, San Giovanni Rotondo, Italy; [Salazar, Marleny] Univ Quindio, Armenia, Colombia; [Villegas, Victoria] Univ Rosario, Bogota, Colombia; [Caicedo, Victor; Pachon, Sonia; Nunez, Federico] Clin Shaio, Unidad Cirugia Cardiovasc, Bogota, Colombia; [Maddaloni, Valeria; Caianiello, Giuseppe; Limongelli, Giuseppe; Pacileo, Giuseppe] Univ Naples 2, Monaldi Hosp, Dept Cardiol, Naples, Italy; [Marino, Bruno] Sapienza Univ, Dept Pediat, Div Pediat Cardiol, Rome, Italy; [Bernal, Jaime E.] Pontificia Univ Javeriana, Inst Genet, Bogota, Colombia; [Dallapiccola, Bruno] Bambino Gesu Children Hosp, IRCCS, Rome, Italy		De Luca, A (corresponding author), Casa Sollievo Sofferenza Hosp, IRCCS, San Giovanni Rotondo, Italy.	a.deluca@css-mendel.it	Consoli, Federica/B-7747-2017; Daniele, Paola/AAB-9604-2019; De Luca, Alessandro/B-2179-2017; Villegas, Victoria E./G-8125-2016; Dallapiccola, Bruno/K-8692-2016; LImongelli, Giuseppe/K-4885-2018	Consoli, Federica/0000-0002-8256-586X; Daniele, Paola/0000-0001-5640-4184; De Luca, Alessandro/0000-0002-4408-8062; Villegas, Victoria E./0000-0003-4149-2307; maddaloni, valeria/0000-0001-5709-2936; Dallapiccola, Bruno/0000-0002-5031-1013; PACILEO, Giuseppe/0000-0001-5965-6184; Bernal Villegas, Jaime Eduardo/0000-0002-9733-5143; LImongelli, Giuseppe/0000-0002-8291-9517	Italian Ministry of Health [RC2009, RC2010]; FIRB [RBIP06PMF2_005]	Italian Ministry of Health(Ministry of Health, Italy); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	We would like to thank the patients who participated in this research. This research was supported by the Italian Ministry of Health grant RC2009 and RC2010 and FIRB RBIP06PMF2_005 (to A.D.).	Akcaboy MI, 2008, PEDIATR CARDIOL, V29, P126, DOI 10.1007/s00246-007-9058-2; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Dasgupta C, 2001, MUTAT RES-FUND MOL M, V479, P173, DOI 10.1016/S0027-5107(01)00160-9; De Luca A, 2010, CLIN GENET; Dentice M, 2006, J CLIN ENDOCR METAB, V91, P1428, DOI 10.1210/jc.2005-1350; Draus JM, 2009, J MED GENET, V46, P115, DOI 10.1136/jmg.2008.060277; Esposito G, 2009, AM J MED GENET A, V149A, P1574, DOI 10.1002/ajmg.a.32907; GIOLIPEREIRA L, 2008, INT J CARDIOL; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Jones AC, 2001, HUM MUTAT, V17, P233, DOI 10.1002/humu.8; Majumdar R, 2006, J THORAC CARDIOV SUR, V131, P1301, DOI 10.1016/j.jtcvs.2006.01.039; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Quach Nancy, 2004, BMC Clin Pathol, V4, P1, DOI 10.1186/1472-6890-4-1; Rauch A, 2004, AM J MED GENET A, V124A, P165, DOI 10.1002/ajmg.a.20323; Reamon-Buettner SM, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040907; Reamon-Buettner SM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025395; Reamon-Buettner SM, 2004, AM J PATHOL, V164, P2117, DOI 10.1016/S0002-9440(10)63770-4; Reamon-Buettner SM, 2004, J MED GENET, V41, P684, DOI 10.1136/jmg.2003.017483; Reamon-Buettner SM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-38; Reamon-Buettner SM, 2008, HUM MOL GENET, V17, P1397, DOI 10.1093/hmg/ddn027; Reamon-Buettner Stella Marie, 2006, Hum Mutat, V27, P118, DOI 10.1002/humu.9390; Reamon-Buettner Stella Marie, 2004, Hum Mutat, V24, P104, DOI 10.1002/humu.9255; Reamon-Buettner SM, 2009, HUM MOL GENET, V18, P3567, DOI 10.1093/hmg/ddp305; Schluterman MK, 2007, AM J MED GENET A, V143A, P817, DOI 10.1002/ajmg.a.31652; Tomita-Mitchell A, 2007, J MED GENET, V44, P779, DOI 10.1136/jmg.2007.052183; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	26	34	38	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1769-7212			EUR J MED GENET	Eur. J. Med. Genet.	MAY-JUN	2011	54	3					306	309		10.1016/j.ejmg.2011.01.004	http://dx.doi.org/10.1016/j.ejmg.2011.01.004			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	805QR	21276881	Green Published			2022-09-04	WOS:000293744600021
J	Molano, MF; Velasquez, VPL; Erben, MF; Gonzalez, DLN; Loaiza, AE; Echeverria, GA; Piro, OE; Tobon, YA; Ben Tayeb, K; Castano, JAG				Molano, Miguel F.; Lorett Velasquez, Vaneza P.; Erben, Mauricio F.; Nossa Gonzalez, Diana L.; Loaiza, Alix E.; Echeverria, Gustavo A.; Piro, Oscar E.; Tobon, Yeny A.; Ben Tayeb, Karima; Gomez Castano, Jovanny A.			Crystal structure, spectroscopic characterization and Hirshfeld surface analysis of aquadichlorido{N-[(pyridin-2-yl)methylidene]aniline}copper(II) monohydrate	ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS			English	Article						crystal structure; copper(II); five-coordinate complexes; distorted square pyramid	COMPLEXES	The reaction of N-phenyl-1-(pyridin-2-yl)methanimine with copper chloride dihydrate produced the title neutral complex, [CuCl2(C12H10N2)(H2O)]center dot H2O. The Cu-II ion is five-coordinated in a distorted square-pyramidal geometry, in which the two N atoms of the bidentate Schiff base, as well as one chloro and a water molecule, form the irregular base of the pyramidal structure. Meanwhile, the apical chloride ligand interacts through a strong hydrogen bond with a water molecule of crystallization. In the crystal, molecules are arranged in pairs, forming a stacking of symmetrical cyclic dimers that interact in turn through strong hydrogen bonds between the chloride ligands and both the coordinated and the crystallization water molecules. The molecular and electronic structures of the complex were also studied in detail using EPR (continuous and pulsed), FT-IR and Raman spectroscopy, as well as magnetization measurements. Likewise, Hirshfeld surface analysis was used to investigate the intermolecular interactions in the crystal packing.	[Molano, Miguel F.; Gomez Castano, Jovanny A.] Univ Pedag & Tecnol Colombia, Fac Ciencias, Grp Quim Fis Mol & Modelamiento Computac QUIMOL, Lab Quim Teor & Computac, Tunja 050030, Boyaca, Colombia; [Lorett Velasquez, Vaneza P.] Univ Antonio Narino, Fac Ciencias, Bogota, Colombia; [Erben, Mauricio F.; Nossa Gonzalez, Diana L.] Univ Nacl La Plata, Fac Ciencias Exactas, Ctr Quim Inorgan CEQUINOR, CC 962, RA-1900 La Plata, Argentina; [Loaiza, Alix E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Quim, Bogota 110231561, Colombia; [Echeverria, Gustavo A.; Piro, Oscar E.] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Fis, CC 67, RA-1900 La Plata, Argentina; [Echeverria, Gustavo A.; Piro, Oscar E.] Consejo Nacl Invest Cient & Tecn, IFLP, CC 67, RA-1900 La Plata, Argentina; [Tobon, Yeny A.; Ben Tayeb, Karima] Univ Lille, LASIR Lab Spectrochim Infrarouge & Raman, CNRS, UMR 8516, F-59000 Lille, France		Castano, JAG (corresponding author), Univ Pedag & Tecnol Colombia, Fac Ciencias, Grp Quim Fis Mol & Modelamiento Computac QUIMOL, Lab Quim Teor & Computac, Tunja 050030, Boyaca, Colombia.	jovanny.gomez@uptc.edu.co	Tobon, Yeny/B-9218-2013; Gómez Castaño, Jovanny A./X-7862-2019; Erben, Mauricio Federico/I-2120-2019	Tobon, Yeny/0000-0003-1858-8271; Gómez Castaño, Jovanny A./0000-0002-6654-1315; Erben, Mauricio Federico/0000-0001-8467-2784; ben tayeb, karima/0000-0002-4595-4225; Lorett Velasquez, Vaneza Paola/0000-0003-0482-4181	Direccion de Investigaciones de la UPTC [SGI2343]; Universidad Antonio Narino [2016231]; CONICET [PIP 11220130100651CO]; UNLP [11/X857]	Direccion de Investigaciones de la UPTC; Universidad Antonio Narino; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNLP(National University of La Plata)	Funding for this research was provided by: the Direccion de Investigaciones de la UPTC (contract No. SGI2343); Universidad Antonio Narino (contract No. 2016231); CONICET (contract No. (PIP 11220130100651CO)); and UNLP (grant No. (Grant to Project 11/X857)).	ADDISON AW, 1984, J CHEM SOC DALTON, P1349, DOI 10.1039/dt9840001349; Banerjee S, 2016, J CHEM SCI, V128, P165, DOI 10.1007/s12039-015-1017-5; Barwiolek M, 2016, J CHEM SCI, V128, P1057, DOI 10.1007/s12039-016-1116-y; Braymer JJ, 2012, INORG CHIM ACTA, V380, P261, DOI 10.1016/j.ica.2011.08.056; Chaviara AT, 2005, J INORG BIOCHEM, V99, P2102, DOI 10.1016/j.jinorgbio.2005.07.011; DeToma AS, 2012, CHEM SOC REV, V41, P608, DOI 10.1039/c1cs15112f; Dias PM, 2010, QUIM NOVA, V33, P2135, DOI 10.1590/S0100-40422010001000025; Farrugia LJ, 2012, J APPL CRYSTALLOGR, V45, P849, DOI 10.1107/S0021889812029111; Groom CR, 2016, ACTA CRYSTALLOGR B, V72, P171, DOI 10.1107/S2052520616003954; Gupta KC, 2008, COORDIN CHEM REV, V252, P1420, DOI 10.1016/j.ccr.2007.09.005; HOFER P, 1986, CHEM PHYS LETT, V132, P279, DOI 10.1016/0009-2614(86)80124-5; Macrae CF, 2020, J APPL CRYSTALLOGR, V53, P226, DOI 10.1107/S1600576719014092; McKinnon JJ, 2007, CHEM COMMUN, P3814, DOI 10.1039/b704980c; Rigaku OD, 2015, CRYSALIS PRO; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI 10.1107/S2053229614024218; Spackman MA, 2009, CRYSTENGCOMM, V11, P19, DOI 10.1039/b818330a; Trudu F, 2015, J APPL BIOMED, V13, P79, DOI 10.1016/j.jab.2015.03.003; Turner P, 2017, ROUTL ADV ETHNOGR, P17; Xavier V. S., 1998, MOL PHYS, V94, P269	19	3	3	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2056-9890			ACTA CRYSTALLOGR E	Acta Crystallogr. Sect. E.-Crystallogr. Commun.	FEB	2020	76		2				148	+		10.1107/S2056989019017213	http://dx.doi.org/10.1107/S2056989019017213			11	Crystallography	Emerging Sources Citation Index (ESCI)	Crystallography	KJ8TU	32071738	gold, Green Published			2022-09-04	WOS:000512329700007
J	Sathian, B; Asim, M; Banerjee, I; Pizarro, AB; Roy, B; Van Teijlingen, ER; do Nascimento, IB; Alhamad, HK				Sathian, Brijesh; Asim, Mohammad; Banerjee, Indrajit; Pizarro, Ana Beatriz; Roy, Bedanta; Van Teijlingen, Edwin R.; Borges do Nascimento, Israel Junior; Alhamad, Hanadi Khamis			Impact of COVID-19 on clinical trials and clinical research: A systematic review	NEPAL JOURNAL OF EPIDEMIOLOGY			English	Review						COVID-19; pandemic; clinical trial; SARS-CoV-2; research capacity; systematic review		Background: The World Health Organization has reported more than 31,186,000 confirmed cases of coronavirus disease-19 (COVID-19), including 962,343 deaths, worldwide as on September 21, 2020. The current COVID-19 pandemic is affecting clinical research activities in most parts of the world. The focus on developing a vaccine for SARS-CoV-2 and the treatment of COVID-19 is, in fact, disrupting many upcoming and/or ongoing clinical trials on other diseases around the globe. On March 18, 2020, the United States Food and Drug Administration (FDA) issued an updated guideline for the conduct of clinical trials during the current health emergency situation. The potential challenges, such as social distancing and quarantines, result in study participants' inaccessibility and trial personnel for in-person scheduled study visits and/or follow-up. Due to the sudden onset and wide-spread impact of COVID-19, its influence on the management of clinical trials and research necessitates urgent attention. Therefore, our systematic review ofthe literature aims to assess the impact of the COVID-19 pandemic on the conduction of clinical trials and research. The search for the relevant articles for review included the keywords "COVID-19" AND "clinical trial" in PubMed, MEDLINE, Embase, Google scholar and Google electronic databases. Key findings include: delaying subject enrollment and operational gaps in most ongoing clinical trials, which in turn has a negative impact on trial programmes and data integrity. Globally, most sites conducting clinical trials other than COVID-19 are experiencing a delay in timelines and a complete halt of operations in lieu of this pandemic, thus affecting clinical research outcomes.	[Sathian, Brijesh; Alhamad, Hanadi Khamis] Hamad Med Corp, Geriatr & Long Term Care Dept, Rumailah Hosp, POB 3050, Doha, Qatar; [Sathian, Brijesh; Van Teijlingen, Edwin R.] Bournemouth Univ, Ctr Midwifery Maternal & Perinatal Hlth, Bournemouth, Dorset, England; [Asim, Mohammad] Hamad Gen Hosp, Surg Dept, Trauma Surg, Doha, Qatar; [Banerjee, Indrajit] Sir Seewoosagur Ramgoolam Med Coll, Dept Pharmacol, Vacoas Phoenix, Mauritius; [Pizarro, Ana Beatriz] Pontificia Univ Javeriana, Cochrane Colombia, Bogota, Colombia; [Roy, Bedanta] QIUP, Dept Physiol, Fac Med, Ipoh, Negeri Perak, Malaysia; [Borges do Nascimento, Israel Junior] Univ Fed Minas Gerais, Univ Hosp, Belo Horizonte, MG, Brazil; [Borges do Nascimento, Israel Junior] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [Borges do Nascimento, Israel Junior] Med Coll Wisconsin, Milwaukee, WI 53226 USA		Sathian, B (corresponding author), Hamad Med Corp, Geriatr & Long Term Care Dept, Rumailah Hosp, POB 3050, Doha, Qatar.	drsathian@gmail.com	Banerjee, Indrajit/AAN-9512-2020; Sathian, Brijesh/G-7576-2014; Banerjee, Indrajit IB/C-2714-2014; Pizarro, Ana Beatriz/AAC-8021-2022; van Teijlingen, Edwin R/A-3727-2010	Banerjee, Indrajit/0000-0003-2880-4695; Sathian, Brijesh/0000-0003-0851-4762; Pizarro, Ana Beatriz/0000-0003-4089-454X; van Teijlingen, Edwin R/0000-0001-5523-8583; Borges do Nascimento, Israel Junior/0000-0001-5240-0493; Roy, Bedanta/0000-0003-2750-4949				[Anonymous], 2020, MANAGEMENT CLIN TRIA; DeMets DL, 2020, J CLIN EPIDEMIOL, V126, P167, DOI 10.1016/j.jclinepi.2020.07.001; Health Canada Notice, 2020, MAN CLIN TRIALS COVI; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; Holtz BE, 2021, TELEMED E-HEALTH, V27, P107, DOI 10.1089/tmj.2020.0168; McDermott MM, 2020, JAMA-J AM MED ASSOC, V323, P2135, DOI 10.1001/jama.2020.4689; Medidata, COVID 19 CLIN TRIALS; Medidata, IMP COVID 19 CLIN TR; Moher David, 2009, Ann Intern Med, V151, P264, DOI 10.1136/bmj.b2535; Moola S., 2020, JBI MANUAL EVIDENCE, DOI [10.46658/jbimes-20-08, DOI 10.46658/JBIMES-20-08]; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Smith AC, 2020, J TELEMED TELECARE, V26, P309, DOI 10.1177/1357633X20916567; Upadhaya S, 2020, NAT REV DRUG DISCOV, V19, P376, DOI 10.1038/d41573-020-00093-1; US Food & Drug Administration, FDA GUID COND CLIN T; van Dorn A, 2020, LANCET, V396, P523, DOI [10.1016/S0140-6736(20)31787-6, 10.1377/hblog20200702.963588/full]; Waterhouse DM, 2020, JCO ONCOL PRACT, V16, P417, DOI 10.1200/OP.20.00275	16	42	42	3	10	INT NEPAL EPIDEMIOLOGICAL ASSOC	POKHARA	DEPARTMENT OF COMMUNITY MEDICINE, MUNICIPAL COLLEGE OF MEDICAL SCIENCES, PO BOX 155 DEEP HEIGHTS, POKHARA, 00000, NEPAL	2091-0800			NEPAL J EPIDEMIOL	Nepal J. Epidemiol.		2020	10	3					878	887		10.3126/nje.v10i3.31622	http://dx.doi.org/10.3126/nje.v10i3.31622			10	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	NY7RL	33042591	Green Published, hybrid, Green Accepted			2022-09-04	WOS:000576581500002
J	Fisberg, RM; Leme, AC; de Mello, AV; Salles, C; Arroyo, A; Gomez, G; Kovalskys, I; Torres, RGP; Garcia, MCY; Sanabria, LYC; Herrera-Cuenca, M; Rigotti, A; Fisberg, M				Fisberg, Regina Mara; Leme, Ana Carolina; de Mello, Aline Veroneze; Salles, Cristiane; Arroyo, Angela; Gomez, Georgina; Kovalskys, Irina; Pareja Torres, Rossina Gabriella; Yepez Garcia, Martha Cecilia; Cortes Sanabria, Lilia Yadira; Herrera-Cuenca, Marianella; Rigotti, Attilio; Fisberg, Mauro		ELANS Grp	Top food sources of energy and nutrients-to-limit among Latin Americans: Latin American Study of Nutrition and Health Study (ELANS) 2014-2015	PROCEEDINGS OF THE NUTRITION SOCIETY			English	Meeting Abstract									[Fisberg, Regina Mara; Leme, Ana Carolina; de Mello, Aline Veroneze; Salles, Cristiane; Arroyo, Angela] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil; [Arroyo, Angela] Univ Valparaiso, Escuela Nutr & Dietet, Valparaiso, Chile; [Gomez, Georgina] Univ Costa Rica, Dept Bioquim, Escuela Med, San Jose, Costa Rica; [Kovalskys, Irina] Int Life Sci Inst, Comm Nutr & Wellbeing, Buenos Aires, DF, Argentina; [Pareja Torres, Rossina Gabriella] Inst Invest Nutr, Lima, Peru; [Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador; [Cortes Sanabria, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Fdn Bengoa, Ctr Estudios Desarrollo, Caracas, Venezuela; [Rigotti, Attilio] Pontificia Univ Catolica, Dept Nutr Diabet & Metab, Ctr Nutr Mol & Enfermedades Cron, Escuela Med, Santiago, Chile; [Fisberg, Mauro; ELANS Grp] Sabara Hosp Infantil, Fundacao Jose Luiz Egydio Setubal, Inst Pensi, Sao Paulo, Brazil				Fisberg, Mauro/E-7149-2010; Veroneze de Mello, Aline/AAY-8879-2021; Mello, Aline/AAX-6965-2021	Fisberg, Mauro/0000-0003-2992-3215; Mello, Aline/0000-0002-1958-6916					0	0	0	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0029-6651	1475-2719		P NUTR SOC	Proc. Nutr. Soc.		2020	79	OCE2					E305	E305		10.1017/S0029665120002530	http://dx.doi.org/10.1017/S0029665120002530			1	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	MH3ND		Bronze			2022-09-04	WOS:000546638800238
J	da Silva, J; Ventura, CAA; Vargens, OMD; Loyola, CMD; Albarracin, DGE; Diaz, J; Funes, GMR; Hernandez, MG; Torres, RMG; Rodriguez, RJO				da Silva, Jaqueline; Arena Ventura, Carla Aparecida; da Costa Vargens, Octavio Muniz; Douat Loyola, Cristina Maria; Eslava Albarracin, Daniel Gonzalo; Diaz, Jorge; Rodriguez Funes, Gladys Magdalena; Granados Hernandez, Mabell; Gallegos Torres, Ruth Magdalena; Oviedo Rodriguez, Ruth Jakeline			ILLICIT DRUG USE IN SEVEN LATIN AMERICAN COUNTRIES: CRITICAL PERSPECTIVES OF FAMILIES AND FAMILIARS	REVISTA LATINO-AMERICANA DE ENFERMAGEM			English	Article						street drugs; substance-related disorders; risk factors; protection; family; friends; health services accessibility; Latin America; multicenter study	ALCOHOL	This cross-sectional multi-centre study explored how family members and friends of illicit drug users perceived protective and risk factors, treatment facilities and policies and laws regarding illicit drug use. Family members and friends of illicit drug users were recruited in 10 urban health care outpatient units in 7 Latin American countries (Brazil, Colombia, Costa Rica, Ecuador, Guatemala, Honduras and Mexico) to complete a questionnaire. The majority of the respondents chose psycho-social factors over genetic or biological explanations as causes of drug problems. Respondents felt that families and governments were responsible for preventing drug problems. Church/religious institutions were most often mentioned in the context of accessible treatment. When asked about access to treatment facilities, the majority said that there were not enough. Shame about drug use, cost, and limited treatment options were most often cited as barriers to treatment.	[da Silva, Jaqueline; Douat Loyola, Cristina Maria] Univ Fed Rio de Janeiro, Escola Enfermagem Anna Nery, BR-21941 Rio De Janeiro, Brazil; [Arena Ventura, Carla Aparecida] Univ Sao Paulo, Escola Enfermagem Ribeirao Preto, WHO Collaborating Ctr Nursing Res Dev, BR-05508 Sao Paulo, Brazil; [da Costa Vargens, Octavio Muniz] Univ Estado Rio de Janeiro, Fac Enfermagem, Rio De Janeiro, Brazil; [Eslava Albarracin, Daniel Gonzalo] Pontificia Univ Javeriana, Fac Enfermeria, Bogota, Colombia; [Diaz, Jorge] Univ San Carlos, Guatemala City, Guatemala; [Granados Hernandez, Mabell] Univ Costa Rica, Escuela Enfermeria, San Pedro, Costa Rica; [Gallegos Torres, Ruth Magdalena] Univ Autonoma Queretaro, Queretaro, Mexico		da Silva, J (corresponding author), Univ Fed Rio de Janeiro, Escola Enfermagem Anna Nery, BR-21941 Rio De Janeiro, Brazil.	jackiedasilva@hotmail.com; caaventu@eerp.usp.br; omcvargens@uol.com.br; crisloyola@terra.com.br; dgeslava@javeriana.edu.co; jbdiazc@gmail.com; gmrfunes@yahoo.com; mabelmgranados@hotmail.com; isisrmg@uaq.mx; rutoviedo@hotmail.com	Ventura, Carla/B-2609-2014; ESLAVA, DANIEL G/U-5469-2018	Ventura, Carla/0000-0003-0379-913X; ESLAVA, DANIEL G/0000-0001-7257-4706; OVIEDO, RUTH/0000-0002-3584-7928	Canadian government; Organization of American States (OAS); Inter-American Drug Abuse Control Commission (CICAD); Centre for Addiction and Mental Health (CAMH), Canada	Canadian government; Organization of American States (OAS); Inter-American Drug Abuse Control Commission (CICAD); Centre for Addiction and Mental Health (CAMH), Canada	This research was conducted with support, advice and funding of the Canadian government, Organization of American States (OAS), Inter-American Drug Abuse Control Commission (CICAD), and Centre for Addiction and Mental Health (CAMH), Canada. We acknowledge the collaboration of other colleagues who contributed directly or indirectly in the development of this study.	Becona E., 2002, BASES CIENTIFICAS PR; Beyers JM, 2004, J ADOLESCENT HEALTH, V35, P3, DOI 10.1016/j.jadohealth.2003.08.015; Catford J, 2001, HEALTH PROMOT INT, V16, P107, DOI 10.1093/heapro/16.2.107; DEREMENTERIA I, 2001, PREVENIR DROGAS P PS; Dixon D, 1999, DRUG ALCOHOL REV, V18, P477; *FED LAT COM TER, QUE HAC FLACT 2001; France A., 2000, J YOUTH STUD, V3, P317, DOI DOI 10.1080/713684380; Mayhew Pat., 2003, COUNTING COSTS CRIME; McKay JR, 2005, ADDICTION, V100, P1594, DOI 10.1111/j.1360-0443.2005.01208.x; Meeks D., 2001, PREVENTION PROGRAMMI; MILLMAN RB, 1992, DEV BEHAV PEDIAT, P451; MRAZEK PG, 1994, REDUCING RISK MENTAL; Room R, 2005, DRUG ALCOHOL REV, V24, P143, DOI 10.1080/09595230500102434; Slovic P, 1980, SOC RISK ASSESSMENT, P181, DOI DOI 10.1007/978-1-4899-0445-4; Stockwell T., 2005, PREVENTING HARMFUL S; *UN GEN ASS, 1989, 198911 UN GEN ASS CO; United Nations International Drug Control Program (UNDCP), 2000, STUD DRUGS CRIM GUID; World Health Organization, 2006, WORLD HLTH REP WORK	18	8	9	0	7	UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO	RIBEIRAO PRETO	AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL	1518-8345			REV LAT-AM ENFERM	Rev. Latino-Am. Enfermagem	NOV-DEC	2009	17				SI		763	769		10.1590/S0104-11692009000700002	http://dx.doi.org/10.1590/S0104-11692009000700002			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	533FC	20011899	gold, Green Published, Green Submitted			2022-09-04	WOS:000272808100002
J	Baez, S; Pino, M; Berrio, M; Santamaria-Garcia, H; Sedeno, L; Garcia, AM; Fittipaldi, S; Ibanez, A				Baez, Sandra; Pino, Mariana; Berrio, Mildred; Santamaria-Garcia, Hernando; Sedeno, Lucas; Garcia, Adolfo M.; Fittipaldi, Sol; Ibanez, Agustin			Corticostriatal signatures of schadenfreude: evidence from Huntington's disease	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							VOXEL-BASED MORPHOMETRY; FRONTOTEMPORAL DEMENTIA; MATTER ATROPHY; MIND; PLEASURE; OTHERS; ENVY; PROGRESSION; ACTIVATION; COGNITION	Schadenfreude-pleasure at others' misfortunes-is a multidetermined social emotion which involves reward processing, mentalising and perspective-taking abilities. Patients with Huntington's disease (HD) exhibit reductions of this experience, suggesting a role of striatal degeneration in such impairment. However, no study has directly assessed the relationship between regional brain atrophy in HD and reduced schadenfreude. Here, we assessed whether grey matter (GM) atrophy in patients with HD correlates with ratings of schadenfreude. First, we compared the performance of 20 patients with HD and 23 controls on an experimental task designed to trigger schadenfreude and envy (another social emotion acting as a control condition). Second, we compared GM volume between groups. Third, we examined brain regions where atrophy might be associated with specific impairments in the patients. While both groups showed similar ratings of envy, patients with HD reported lower schadenfreude. The latter pattern was related to atrophy in regions of the reward system (ventral striatum) and the mentalising network (precuneus and superior parietal lobule). Our results shed light on the intertwining of reward and socioemotional processes in schadenfreude, while offering novel evidence about their neural correlates.	[Baez, Sandra; Santamaria-Garcia, Hernando; Sedeno, Lucas; Garcia, Adolfo M.; Fittipaldi, Sol; Ibanez, Agustin] Favaloro Univ, INECO Fdn, Inst Cognit & Translat Neurosci INCyT, Lab Expt Psychol & Neurosci LPEN, Buenos Aires, DF, Argentina; [Baez, Sandra] Univ Los Andes, Dept Psychol, Bogota, Colombia; [Baez, Sandra; Santamaria-Garcia, Hernando] Grp Invest Cerebro & Cognic Social, Bogota, Colombia; [Baez, Sandra; Santamaria-Garcia, Hernando; Sedeno, Lucas; Garcia, Adolfo M.; Fittipaldi, Sol; Ibanez, Agustin] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Pino, Mariana; Berrio, Mildred; Ibanez, Agustin] Univ Autonoma Caribe, Dept Psychol, Barranquilla, Colombia; [Santamaria-Garcia, Hernando] Pontificia Univ Javeriana, Bogota, Colombia; [Garcia, Adolfo M.] Natl Univ Cuyo UNCuyo, Fac Educ, Mendoza, Argentina; [Ibanez, Agustin] Univ Adolfo Ibanez, Sch Psychol, CSCN, Santiago, Chile; [Ibanez, Agustin] Australian Res Council, Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia		Ibanez, A (corresponding author), Inst Cognit Neurol INECO, Lab Expt Psychol & Neurosci LPEN, Inst Cognit & Translat Neurosci INCyT, Pacheco de Melo 1860, RA-1126 Buenos Aires, DF, Argentina.; Ibanez, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Pacheco de Melo 1860, RA-1126 Buenos Aires, DF, Argentina.	aibanez@ineco.org.ar	Ibanez, Agustin/H-7976-2015; Baez, Sandra/ABC-7150-2020; García, Adolfo/E-7150-2017	Ibanez, Agustin/0000-0001-6758-5101; García, Adolfo/0000-0002-6936-0114; Santamaria Garcia, Hernando/0000-0001-9422-3579	CONICET; CONICYT/FONDECYT Regular [1170010]; COLCIENCIAS [1115-545-31374, 392]; FONCyT-PICT [2012-0412, 2012-1309]; FONDAP [15150012]; HD Lorena Scarafiocca foundation; INECO Foundation	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICYT/FONDECYT Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); FONCyT-PICT(ANPCyTFONCyT); FONDAP; HD Lorena Scarafiocca foundation; INECO Foundation	This work was partially supported by grants from CONICET, CONICYT/FONDECYT Regular (1170010), COLCIENCIAS (1115-545-31374, contract: 392), FONCyT-PICT 2012-0412, FONCyT-PICT 2012-1309, FONDAP 15150012, the HD Lorena Scarafiocca foundation and the INECO Foundation.	Allain P, 2011, NEUROPSYCHOLOGY, V25, P741, DOI 10.1037/a0024408; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Baez S, 2017, NATURE HUMAN BEHAV, V1, P1; Baez S, 2016, CORTEX, V83, P78, DOI 10.1016/j.cortex.2016.07.009; Biglan KM, 2009, MOVEMENT DISORD, V24, P1763, DOI 10.1002/mds.22601; Boecker H, 1999, BRAIN, V122, P1651, DOI 10.1093/brain/122.9.1651; Brune M, 2011, MOVEMENT DISORD, V26, P671, DOI 10.1002/mds.23494; Bzdok D, 2012, BRAIN STRUCT FUNCT, V217, P783, DOI 10.1007/s00429-012-0380-y; Chester DS, 2013, SOC NEUROSCI-UK, V8, P640, DOI 10.1080/17470919.2013.846278; Cikara M, 2013, ANN NY ACAD SCI, V1299, P52, DOI 10.1111/nyas.12179; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Della Nave R, 2010, AM J NEURORADIOL, V31, P1675, DOI 10.3174/ajnr.A2128; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Dvash J, 2010, HUM BRAIN MAPP, V31, P1741, DOI 10.1002/hbm.20972; Eddy CM, 2012, ACTA NEUROL SCAND, V126, P376, DOI 10.1111/j.1600-0404.2012.01659.x; Enzi B, 2012, EXP NEUROL, V235, P256, DOI 10.1016/j.expneurol.2012.02.003; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Gao HM, 2014, PSYCHOL REP, V114, P439, DOI 10.2466/17.21.PR0.114k19w4; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/10628-000; Hennenlotter A, 2004, BRAIN, V127, P1446, DOI 10.1093/brain/awh165; IBANEZ A, 2017, BRAIN 3, V140, DOI DOI 10.1093/BRAIN/AWW316; Jech R, 2007, MOVEMENT DISORD, V22, P1783, DOI 10.1002/mds.21620; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; Larsen IU, 2016, AM J MED GENET B, V171, P1153, DOI 10.1002/ajmg.b.32501; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; Mahant N, 2003, NEUROLOGY, V61, P1085, DOI 10.1212/01.WNL.0000086373.32347.16; Melloni M, 2016, BRAIN, V139, P3022, DOI 10.1093/brain/aww231; Mossad SI, 2016, NEUROIMAGE, V134, P320, DOI 10.1016/j.neuroimage.2016.03.053; Muhlau M, 2007, J NEURAL TRANSM, V114, P367, DOI 10.1007/s00702-006-0571-x; MYERS RH, 1988, NEUROLOGY, V38, P341, DOI 10.1212/WNL.38.3.341; Nopoulos PC, 2010, NEUROBIOL DIS, V40, P544, DOI 10.1016/j.nbd.2010.07.014; O'Callaghan C, 2016, BRAIN, V139, P204, DOI 10.1093/brain/awv315; O'Callaghan C, 2014, J NEUROL NEUROSUR PS, V85, P371, DOI 10.1136/jnnp-2012-304558; OCALLAGHAN C, 2017, BRAIN 3, V140, DOI DOI 10.1093/BRAIN/AWW3150; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schippling S, 2009, BIOL PSYCHIAT, V65, P959, DOI 10.1016/j.biopsych.2008.12.026; Shamay-Tsoory SG, 2007, BRAIN, V130, P1663, DOI 10.1093/brain/awm093; Siesling S, 1998, MOVEMENT DISORD, V13, P915, DOI 10.1002/mds.870130609; Snowden JS, 2003, NEUROPSYCHOLOGIA, V41, P688, DOI 10.1016/S0028-3932(02)00221-X; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604	46	20	22	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JAN	2018	89	1					112	116		10.1136/jnnp-2017-316055	http://dx.doi.org/10.1136/jnnp-2017-316055			5	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	FQ3AE	28765320				2022-09-04	WOS:000418228400017
J	Lebeda, A; Kristkova, E; Khoury, CK; Carver, D; Sosa, CC				Lebeda, Ales; Kristkova, Eva; Khoury, Colin K.; Carver, Daniel; Sosa, Chrystian C.			Distribution and ecology of wild lettuces Lactuca serriola L. and Lactuca virosa L. in central Chile	HACQUETIA			English	Article						allochthonous species; elevational limits; germplasm conservation; opium lettuce; plant invasion; prickly lettuce	ALIEN PLANT INVASIONS; PATTERNS; BIODIVERSITY; ECOGEOGRAPHY; ASTERACEAE; REGION	Wild lettuces (Lactuca L.) provide valuable genetic resources for crop breeding, but are also significant invasive weeds. We explored the distributions, habitats, and ecological characteristics of populations of wild Lactuca species in central Chile. We documented two species - Lactuca serriola L. (prickly lettuce) and Lactuca virosa L. (opium/bitter lettuce) in 204 localities. These observations indicate that: i) both allochthonous (Euroasian) Lactuca species occur and are able to regenerate in central Chile; ii) L. serriola forms dense populations in urbanized areas; iii) both species can expand along transport corridors to high elevations; iv) the spread of L. virosa and persistence of dense populations in elevations above 2,000 m a.s.l. prove the invasiveness of this species in extreme climates; v) both species may contain novel traits of interest for germplasm conservation.	[Lebeda, Ales; Kristkova, Eva] Palacky Univ Olomouc, Fac Sci, Dept Bot, Olomouc, Czech Republic; [Khoury, Colin K.; Sosa, Chrystian C.] Int Ctr Trop Agr CIAT, Cali, Colombia; [Khoury, Colin K.; Carver, Daniel] ARS, USDA, Natl Lab Genet Resources Preservat, Ft Collins, CO USA; [Khoury, Colin K.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Carver, Daniel] Colorado State Univ, Geospatial Centroid, St Louis, CO USA; [Sosa, Chrystian C.] Pontificia Univ Javeriana Cali, Dept Ciencias Nat & Matemat, Cali, Colombia; [Sosa, Chrystian C.] Univ Quindio, Fac Ciencias Basicas & Tecnol, Programa Biol, Grp Invest Evoluc Ecol & Conservat EECO, Armenia, Colombia		Lebeda, A (corresponding author), Palacky Univ Olomouc, Fac Sci, Dept Bot, Olomouc, Czech Republic.	ales.lebeda@upol.cz	Khoury, Colin K./AAA-1864-2020	Khoury, Colin K./0000-0001-7893-5744	Ministry of Education, Youths and Sports, Czech Republic [MSM 6198959215]; Internal grant agency of Palacky University in Olomouc [IGA_ PrF_ 2019_004, IGA_ PrF_2020_003, IGA_PrF_2021_001]; USDA National Institute of Food and Agriculture [2019-67012-29733, 1019405]	Ministry of Education, Youths and Sports, Czech Republic; Internal grant agency of Palacky University in Olomouc; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Help of Dr. Marko Maras with translation of abstract to Slovenian language is greatly acknowledged. This research was supported by the following grants: Ministry of Education, Youths and Sports, Czech Republic (MSM 6198959215), Internal grant agency of Palacky University in Olomouc (IGA_ PrF_ 2019_004; IGA_ PrF_2020_003; IGA_PrF_2021_001), and the USDA National Institute of Food and Agriculture (grant no. 2019-67012-29733/project accession no. 1019405).	Alexander JM, 2016, J VEG SCI, V27, P217, DOI 10.1111/jvs.12388; Alexander JM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1446; Alexander JM, 2010, J BIOGEOGR, V37, P1951, DOI 10.1111/j.1365-2699.2010.02335.x; Alexander JM, 2009, ECOGRAPHY, V32, P334, DOI 10.1111/j.1600-0587.2008.05605.x; Alexander JM, 2009, DIVERS DISTRIB, V15, P502, DOI 10.1111/j.1472-4642.2008.00555.x; [Anonymous], 2020, GBIF OCC; Aschmann H., 1991, BIOGEOGRAPHY MEDITER, P33; Boukema I. W., 1990, CGN COLLECTION REV C; Braun U, 2019, MYCOL PROG, V18, P335, DOI 10.1007/s11557-018-1453-y; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Di Castri F., 1991, BIOGEOGRAPHY MEDITER, P3, DOI DOI 10.1017/CBO9780511525544.002; Dolezalova I., 2001, Plant Genetic Resources Newsletter, P41; Ferakova V, 1976, GENUS LACTUCA L EURO; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Figueroa JA, 2004, REV CHIL HIST NAT, V77, P465; Figueroa JA, 2020, URBAN ECOSYST, V23, P945, DOI 10.1007/s11252-020-00986-4; Fox M. D., 1990, Biological invasions in Europe and the Mediterranean Basin., P179; Fuentes N, 2014, PLANTAS INVASORAS CT; Fuentes N, 2015, PLANT ECOL DIVERS, V8, P371, DOI 10.1080/17550874.2014.984003; Fuentes N, 2013, BIOL INVASIONS, V15, P847, DOI 10.1007/s10530-012-0334-6; Gartner E, 2015, GAYANA BOT, V72, P192; Gay C., 1847, HIST FISICA POLITICA, V7; GBIF (Global Biodiversity Information Facility), 2019, GBIF OCC, DOI 10.15468/dl.onncjs; Global Crop Diversity Trust, 2019, GEN GLOB PORT PLANT; Grulich V., 2019, KLIC KE KVETENE CESK, V2, P1056; Guevara E., 2008, HOLE FILLED SEAMLESS; Guillerm J. L., 1991, Biogeography of mediterranean invasions., P379, DOI 10.1017/CBO9780511525544.030; Hauck L, 2016, GAYANA BOT, V73, P206; IUCN, 2019, WORLD DAT PROT AR; Kristkova E, 2014, ACTA BOT CROAT, V73, P1, DOI 10.2478/botcro-2013-0020; Lebeda A, 2007, GENET RESOUR CROP EV, V54, P555, DOI 10.1007/s10722-006-0012-6; Lebeda A, 2004, BOT REV, V70, P328, DOI 10.1663/0006-8101(2004)070[0328:GDOWLS]2.0.CO;2; Lebeda A, 2011, PLANT PATHOL, V60, P400, DOI 10.1111/j.1365-3059.2010.02399.x; Lebeda A, 2002, ADVANCES IN DOWNY MILDEW RESEARCH, P85, DOI 10.1007/0-306-47914-1_3; Lebeda A, 2001, GENET RESOUR CROP EV, V48, P153, DOI 10.1023/A:1011265614395; Lebeda A., 2019, N AM CROP WILD RELAT, V2, P131; Lebeda A., 2007, GENETIC RESOURCES CH, V3, P377; Lebeda A, 2008, EUR J PLANT PATHOL, V122, P127, DOI 10.1007/s10658-008-9291-4; Lebeda A, 2019, CROP SCI, V59, P2337, DOI 10.2135/cropsci2019.05.0350; Lebeda A, 2014, EUR J PLANT PATHOL, V138, P597, DOI 10.1007/s10658-013-0254-z; Lebeda A, 2012, GENET RESOUR CROP EV, V59, P1805, DOI 10.1007/s10722-012-9805-y; Lebeda A, 2012, BIOCHEM SYST ECOL, V42, P113, DOI 10.1016/j.bse.2012.02.008; Lebeda A, 2009, BIOCHEM SYST ECOL, V37, P597, DOI 10.1016/j.bse.2009.10.010; Lembrechts JJ, 2016, P NATL ACAD SCI USA, V113, P14061, DOI 10.1073/pnas.1608980113; Lembrechts JJ, 2017, ECOGRAPHY, V40, P353, DOI 10.1111/ecog.02200; Macaya Jorge, 1999, Gayana Botanica, V56, P141; MARTICORENA C, 1985, Gayana Botanica, V42, P1; McDougall KL, 2018, BIOL INVASIONS, V20, P3461, DOI 10.1007/s10530-018-1787-z; McDougall KL, 2011, MT RES DEV, V31, P380, DOI 10.1659/MRD-JOURNAL-D-11-00082.1; Mieslerova B, 2020, CRIT REV PLANT SCI, V39, P44, DOI 10.1080/07352689.2020.1752439; Montenegro G., 1991, Biogeography of mediterranean invasions., P103, DOI 10.1017/CBO9780511525544.012; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; Novoa Quezada P., 2013, FLORA REGION VALPARA; Novotna A, 2011, FLORA, V206, P473, DOI 10.1016/j.flora.2010.09.012; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Paiaro V, 2011, AUSTRAL ECOL, V36, P176, DOI 10.1111/j.1442-9993.2010.02134.x; Pauchard A, 2006, BIOL CONSERV, V127, P272, DOI 10.1016/j.biocon.2005.05.015; Pauchard A, 2004, BIOL INVASIONS, V6, P255, DOI 10.1023/B:BINV.0000022137.61633.09; Pauchard A, 2004, CONSERV BIOL, V18, P238, DOI 10.1111/j.1523-1739.2004.00300.x; Pauchard A., 2012, BIODIVERS CONSERV, P133; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Reiche C, 1910, FLORA CHILE; Rodriguez R, 2018, GAYANA BOT, V75, P1, DOI 10.4067/S0717-66432018000100001; Strother J. L., 2006, FLORA N AM N MEXICO, V19, P259; Teillier S, 2010, GAYANA BOT, V67, P27; Ugarte E., 2011, CHECK LIST, V7, P365, DOI [10.15560/7.3.365, DOI 10.15560/7.3.365]; USDA National Plant Germplasm System, 2019, GRIN GLOB ACC	67	0	0	3	3	SCIENDO	WARSAW	BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND	1581-4661	1854-9829		HACQUETIA	Hacquetia	JUN 1	2022	21	1					173	186		10.2478/hacq-2021-0019	http://dx.doi.org/10.2478/hacq-2021-0019			14	Plant Sciences; Ecology	Emerging Sources Citation Index (ESCI)	Plant Sciences; Environmental Sciences & Ecology	YX8UF		Green Submitted, gold			2022-09-04	WOS:000754370400009
J	Gantiva, C; Barrera-Valencia, M; Cadavid-Ruiz, N; Calderon-Delgado, L; Gelves-Ospina, M; Herrera, E; Mejia-Orduz, M; Montoya-Arenas, D; Suarez-Pico, P				Gantiva, Carlos; Barrera-Valencia, Mauricio; Cadavid-Ruiz, Natalia; Calderon-Delgado, Liliana; Gelves-Ospina, Melissa; Herrera, Eduar; Mejia-Orduz, Manuel; Montoya-Arenas, David; Suarez-Pico, Paola			Induction of Affective States with Pictures: Second Colombian Validation of the International Affective Pictures System (IAPS)	REVISTA LATINOAMERICANA DE PSICOLOGIA			Spanish	Article						Validation; emotion; motivation; attention; Colombia	EMOTION REGULATION; MOTIVATION	The aim of this study was to validate a second group of images of the International Affective Pictures System (IAPS) in Colombian population, in order to increase the bank of images that can be used in research in the fields of emotion, attention and memory, among others. 240 pictures belonging to sets 15, 16, 17 and 18 of the IAPS were validated in a sample of 1222 participants from five cities in the country (Bogota, Medellin, Cali, Barranquilla and Bucaramanga). To assess the emotional response to images in the valence, arousal and dominance dimensions, the Self-Assessment Manikin (SAM) was used. The results showed that the pictures were distributed as expected in the two-dimensional affective space composed of the valence and arousal dimensions. A positive emotional bias was identified in men and a negative emotional bias in women. The differences between regions and socioeconomic strata were presented only in arousal and dominance, not in valence. Together, the results suggest that these images can be used to induce affective states in the Colombian population in a controlled manner, which allows their use for the scientific and experimental study of different psychological processes, such as emotion, motivation and attention. (C) 2019 Fundacion Universitaria Konrad Lorenz.	[Gantiva, Carlos] Univ Los Andes, Bogota, Colombia; [Barrera-Valencia, Mauricio] Univ Antioquia, Medellin, Colombia; [Cadavid-Ruiz, Natalia] Pontificia Univ Javeriana, Cali, Colombia; [Calderon-Delgado, Liliana] Univ CES, Medellin, Colombia; [Gelves-Ospina, Melissa] Univ Costa CUC, Barranquilla, Colombia; [Herrera, Eduar] Univ Icesi, Cali, Colombia; [Mejia-Orduz, Manuel] Univ Pontificia Bolivariana, Bucaramanga, Colombia; [Montoya-Arenas, David] Univ San Buenaventura, Medellin, Colombia; [Montoya-Arenas, David] Univ Pontificia Bolivariana, Medellin, Colombia; [Suarez-Pico, Paola] Fdn Univ Konrad Lorenz, Bogota, Colombia		Gantiva, C (corresponding author), Univ Los Andes, Bogota, Colombia.	c.gantiva@uniandes.edu.co	Montoya Arenas, David Andrés/AAA-5988-2022; Gantiva, Carlos/N-3989-2014	Montoya Arenas, David Andrés/0000-0001-6647-4696; Barrera-Valencia, Mauricio/0000-0003-2095-0153; Gantiva, Carlos/0000-0002-9232-121X; Mejia, Manuel/0000-0001-9334-4459				Amstadter A, 2008, J ANXIETY DISORD, V22, P211, DOI 10.1016/j.janxdis.2007.02.004; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Camacho K., 2016, PSYCHOLOGIA-BOGOTA, V10, P55, DOI DOI 10.21500/19002386.2550; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dufey M, 2011, UNIV PSYCHOL, V10, P521, DOI 10.11144/Javeriana.upsy10-2.asce; Gantiva C, 2019, UNIV PSYCHOL, V18, DOI 10.11144/Javeriana.upsy18-1.mrfe; Gantiva C, 2021, J INTERPERS VIOLENCE, V36, P3438, DOI 10.1177/0886260518776999; Gantiva C, 2016, NICOTINE TOB RES, V18, P1324, DOI 10.1093/ntr/ntv257; GANTIVA DÍAZ CARLOS ANDRÉS, 2011, Act.Colom.Psicol., V14, P103; Gómez-Lugo Mayra, 2016, Suma Psicol., V23, P109, DOI 10.1016/j.sumpsi.2016.09.001; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gruhn D, 2008, BEHAV RES METHODS, V40, P512, DOI 10.3758/BRM.40.2.512; Hurtado-Parrado C, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00908; Irrazabal N, 2015, REV ARGENT CIENC COM, V7, P34; Lang P., 1999, A6 U FLOR; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lang PJ, 2010, EMOT REV, V2, P229, DOI 10.1177/1754073910361984; Lang Peter J., 2005, TECHNICAL REPORT A 8; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; LEDOUX J, 2000, SER AFFECTIVE SCI, P129; Michelini Yanina, 2016, Suma Psicol., V23, P42, DOI 10.1016/j.sumpsi.2016.01.001; Ministerio de Salud y Proteccion Social, 2015, ENC NAC SAL MENT 201, VI; MoltuE J., 1999, REV PSICOLOGIA GEN A, V52, P55, DOI DOI 10.6018/ANA-LESPS.29.3.153591; Niles AN, 2013, BEHAV RES THER, V51, P669, DOI 10.1016/j.brat.2013.06.005; Ribeiro Rafaela Larsen, 2004, Rev. psiquiatr. Rio Gd. Sul, V26, P190, DOI 10.1590/S0101-81082004000200008; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Rodríguez-Calvache Mónica V., 2017, TecnoL., V20, P83; Romo-Gonzalez T, 2018, UNIV PSYCHOL, V17, DOI [10.11144/javeriana.upsy.17-2.vnsi, 10.11144/Javeriana.upsy.17-2.vnsi]; Silva JR, 2011, TER PSICOL, V29, P251, DOI 10.4067/S0718-48082011000200012; Tobon C, 2015, SOC NEUROSCI-UK, V10, P153, DOI 10.1080/17470919.2014.969406; Verschuere B, 2001, PSYCHOL BELG, V41, P205; Vila J., 2001, REV PSICOLOGIA GEN A, V54, P635, DOI DOI 10.6018/analesps.29.3.153591; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053	36	3	4	3	5	FOUNDATION ADVANCEMENT PSYCHOLOGY	BOGOTA D C	APARTADO AEREO 92621, BOGOTA D C, COLOMBIA	0120-0534			REV LAT AM PSICOL	Rev. Latinoam. Psicol.		2019	51	2					93	112		10.14349/rlp.2019.v51.n2.5	http://dx.doi.org/10.14349/rlp.2019.v51.n2.5			20	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	KW7NT		gold			2022-09-04	WOS:000521372100005
J	Burwick, RM; Velasquez, JA; Valencia, CM; Bernal, YI; Silva, JL; Gutierrez-Marin, JH; Edna-Estrada, F; Trujillo-Otalvaro, J; Rincon, M; Tolosa, JE				Burwick, Richard M.; Velasquez, Jesus A.; Valencia, Catalina M.; Bernal, Yamile I.; Silva, Jaime L.; Gutierrez-Marin, Jorge H.; Edna-Estrada, Francisco; Trujillo-Otalvaro, Juliana; Rincon, Monica; Tolosa, Jorge E.			Preeclampsia with severe features, defining a subset of women with complement-associated disease	AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY			English	Meeting Abstract	38th Annual Meeting and Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine	JAN 29-FEB 03, 2018	Dallas, TX	Soc Maternal Fetal Med					[Burwick, Richard M.; Tolosa, Jorge E.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Portland, OR 97201 USA; [Burwick, Richard M.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Burwick, Richard M.; Velasquez, Jesus A.; Valencia, Catalina M.; Silva, Jaime L.; Gutierrez-Marin, Jorge H.; Edna-Estrada, Francisco; Rincon, Monica; Tolosa, Jorge E.] FUNDARED MATERNA, Bogota, Colombia; [Velasquez, Jesus A.] Univ Antioquia, Hosp Univ San Vicente Fdn, Medellin, Colombia; [Velasquez, Jesus A.; Tolosa, Jorge E.] Univ Antioquia, Dept Obstet & Ginecol, Medellin, Colombia; [Velasquez, Jesus A.; Tolosa, Jorge E.] Univ Antioquia, NACER Salud Sexual & Reprod, Medellin, Colombia; [Valencia, Catalina M.] Clin Colsanitas SA, Bogota, Colombia; [Bernal, Yamile I.] Clin Colsanitas SA, Lab Clin Sanitas, Grp Invest INPAC, Bogota, Colombia; [Silva, Jaime L.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Gutierrez-Marin, Jorge H.] Univ Pontificia Bolivariana, Clin Univ Bolivariana, Medellin, Colombia; [Edna-Estrada, Francisco] ESE Clin Maternidad Rafael Calvo, Grp Invest Maternidad Segura, Cartagena, Colombia; [Trujillo-Otalvaro, Juliana] Hosp Gen Medellin Luz Castro Gutierrez ESE, Medellin, Colombia; [Rincon, Monica] Oregon Hlth & Sci Univ, Portland, OR 97201 USA				Burwick, Richard/AAA-3365-2020	Burwick, Richard/0000-0002-2340-3772					0	0	0	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9378	1097-6868		AM J OBSTET GYNECOL	Am. J. Obstet. Gynecol.	JAN	2018	218	1		S		306	S193	S194						2	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Obstetrics & Gynecology	FT2CT					2022-09-04	WOS:000422946900307
J	Karkey, A; Jombart, T; Walker, AW; Thompson, CN; Torres, A; Dongol, S; Thieu, NTV; Thanh, DP; Ngoc, DTT; Vinh, PV; Singer, AC; Parkhill, J; Thwaites, G; Basnyat, B; Ferguson, N; Baker, S				Karkey, Abhilasha; Jombart, Thibaut; Walker, Alan W.; Thompson, Corinne N.; Torres, Andres; Dongol, Sabina; Nga Tran Vu Thieu; Duy Pham Thanh; Dung Tran Thi Ngoc; Phat Voong Vinh; Singer, Andrew C.; Parkhill, Julian; Thwaites, Guy; Basnyat, Buddha; Ferguson, Neil; Baker, Stephen			The Ecological Dynamics of Fecal Contamination and Salmonella Typhi and Salmonella Paratyphi A in Municipal Kathmandu Drinking Water	PLOS NEGLECTED TROPICAL DISEASES			English	Article							FEVER; NEPAL; GROUNDWATER; MICROBIOME; POLLUTION; PACKAGE; QUALITY; IMPACT; LINES	One of the UN sustainable development goals is to achieve universal access to safe and affordable drinking water by 2030. It is locations like Kathmandu, Nepal, a densely populated city in South Asia with endemic typhoid fever, where this goal is most pertinent. Aiming to understand the public health implications of water quality in Kathmandu we subjected weekly water samples from 10 sources for one year to a range of chemical and bacteriological analyses. We additionally aimed to detect the etiological agents of typhoid fever and longitudinally assess microbial diversity by 16S rRNA gene surveying. We found that the majority of water sources exhibited chemical and bacterial contamination exceeding WHO guidelines. Further analysis of the chemical and bacterial data indicated site-specific pollution, symptomatic of highly localized fecal contamination. Rainfall was found to be a key driver of this fecal contamination, correlating with nitrates and evidence of S. Typhi and S. Paratyphi A, for which DNA was detectable in 333 (77%) and 303 (70%) of 432 water samples, respectively. 16S rRNA gene surveying outlined a spectrum of fecal bacteria in the contaminated water, forming complex communities again displaying location-specific temporal signatures. Our data signify that the municipal water in Kathmandu is a predominant vehicle for the transmission of S. Typhi and S. Paratyphi A. This study represents the first extensive spatiotemporal investigation of water pollution in an endemic typhoid fever setting and implicates highly localized human waste as the major contributor to poor water quality in the Kathmandu Valley.	[Karkey, Abhilasha; Dongol, Sabina; Basnyat, Buddha] Univ Oxford, Clin Res Unit, Patan Acad Hlth Sci, Kathmandu, Nepal; [Jombart, Thibaut; Ferguson, Neil] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Walker, Alan W.; Parkhill, Julian] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Walker, Alan W.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Microbiol Grp, Aberdeen, Scotland; [Thompson, Corinne N.; Nga Tran Vu Thieu; Duy Pham Thanh; Dung Tran Thi Ngoc; Phat Voong Vinh; Thwaites, Guy; Baker, Stephen] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Thompson, Corinne N.; Thwaites, Guy; Baker, Stephen] Univ Oxford, Ctr Trop Med, Oxford, England; [Torres, Andres] Pontificia Univ Javeriana, Fac Ingn, Grp Invest Ciencia & Ingn Agua & Ambiente, Bogota, Colombia; [Singer, Andrew C.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Baker, Stephen] London Sch Hyg & Trop Med, London WC1, England		Baker, S (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam.; Baker, S (corresponding author), Univ Oxford, Ctr Trop Med, Oxford, England.; Baker, S (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	sbaker@oucru.org	Ferguson, Neil/B-8578-2008; Parkhill, Julian/G-4703-2011; Torres, Andres/R-7215-2019; Pham, Thanh Duy/AAX-3845-2020; Thwaites, Guy E/R-4993-2019; Walker, Alan W./AAE-8102-2019; Singer, Andrew/B-3398-2010	Ferguson, Neil/0000-0002-1154-8093; Parkhill, Julian/0000-0002-7069-5958; Pham, Thanh Duy/0000-0001-7029-9210; Thwaites, Guy E/0000-0002-2858-2087; Walker, Alan W./0000-0001-5099-8495; Baker, Stephen/0000-0003-1308-5755; Torres, Andres/0000-0001-8693-8611; Singer, Andrew/0000-0003-4705-6063	Medical Research Council Centre; National Institute for Health Research Health Protection Research Unit for Modelling Methodology; Wellcome Trust [098051]; Scottish Government Rural and Environmental Science and Analysis Service (RESAS); Royal Society [100087/Z/12/Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721] Funding Source: NIH RePORTER; Medical Research Council [MR/K010174/1, MR/K010174/1B, G0902420] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080, NF-SI-0513-10125, NF-SI-0508-10252] Funding Source: researchfish; Natural Environment Research Council [ceh020004] Funding Source: researchfish; MRC [MR/K010174/1, G0902420] Funding Source: UKRI; NERC [ceh020004] Funding Source: UKRI	Medical Research Council Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Health Protection Research Unit for Modelling Methodology; Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Government Rural and Environmental Science and Analysis Service (RESAS); Royal Society(Royal Society of LondonEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	TJ is funded by the Medical Research Council Centre for Outbreak Analysis and Modelling and the National Institute for Health Research Health Protection Research Unit for Modelling Methodology. Funding for AWW, JP and 454 pyrosequencing was provided by the Wellcome Trust (098051). AWW and The Rowett Institute of Nutrition and Health, University of Aberdeen, receive core-funding support from the Scottish Government Rural and Environmental Science and Analysis Service (RESAS). SB is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSIT D, V44, P139; [Anonymous], 1998, STANDARD METHODS EXA; [Anonymous], 2014, PRINCIPAL COMPONENT; Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Besemer K, 2009, APPL ENVIRON MICROB, V75, P7189, DOI 10.1128/AEM.01284-09; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Camargo JA, 2006, ENVIRON INT, V32, P831, DOI 10.1016/j.envint.2006.05.002; Cho JC, 1999, FEMS MICROBIOL LETT, V170, P257, DOI 10.1111/j.1574-6968.1999.tb13382.x; Cooper P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076573; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fransen M, 2013, ENVIRON RES, V122, P52, DOI 10.1016/j.envres.2012.12.005; Gaffield SJ, 2003, AM J PUBLIC HEALTH, V93, P1527, DOI 10.2105/AJPH.93.9.1527; Gibbons SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097435; Girones R, 2010, WATER RES, V44, P4325, DOI 10.1016/j.watres.2010.06.030; Hotellling H, 1933, J ED PSYCHOL, V24, P441; Institute for Integrated Development Studies (IIDS) Kathmandu, 2014, NEP EC OUTL 2013 14; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94, DOI 10.1111/brv.12083]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Karkey A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002391; Karkey A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013988; Karkey A, 2008, J INFECT DEV COUNTR, V2, P461; Karn SK, 2001, ENVIRON MANAGE, V28, P483; Krapac IG, 2002, ENVIRON POLLUT, V120, P475, DOI 10.1016/S0269-7491(02)00115-X; Lopes TJ, 1998, ENVIRON POLLUT, V101, P221, DOI 10.1016/S0269-7491(98)00048-7; McLellan SL, 2014, TRENDS MICROBIOL, V22, P697, DOI 10.1016/j.tim.2014.08.002; Mermin JH, 1997, PUBLIC HLTH, P1416; OLSON CL, 1979, PSYCHOL BULL, V86, P1350, DOI 10.1037/0033-2909.86.6.1350; Pajarillo EAB, 2015, APPL MICROBIOL BIOT, V99, P5647, DOI 10.1007/s00253-015-6408-5; Pajarillo EAB, 2014, J MICROBIOL, V52, P646, DOI 10.1007/s12275-014-4270-2; Pant BR, 2011, ENVIRON MONIT ASSESS, V178, P477, DOI 10.1007/s10661-010-1706-y; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pradhan R, 1990, ANCIENT NEPAL J DEP, V116-118, P10; Prest EI, 2014, WATER RES, V63, P179, DOI 10.1016/j.watres.2014.06.020; Rompre A, 2002, J MICROBIOL METH, V49, P31, DOI 10.1016/S0167-7012(01)00351-7; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sedgwick WT, 1910, J INFECT DIS, V7, P489, DOI 10.1093/infdis/7.4.489; Team R (2012) Development core, 2012, R LANG ENV STAT COMP; Tran VTN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-125; Vollaard AM, 2004, JAMA-J AM MED ASSOC, V291, P2607, DOI 10.1001/jama.291.21.2607; Warner NR, 2008, HYDROGEOL J, V16, P321, DOI 10.1007/s10040-007-0238-1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2011, WAT QUAL DRINK WHO G, V4th ed., DOI 10.1016/S1462-0758(00)00006-6	43	57	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2016	10	1							e0004346	10.1371/journal.pntd.0004346	http://dx.doi.org/10.1371/journal.pntd.0004346			18	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	DH1SR	26735696	Green Published, Green Submitted, Green Accepted, gold			2022-09-04	WOS:000372565700051
J	Oron, G; Armon, R; Mandelbaum, R; Manor, Y; Campos, C; Gillerman, L; Salgot, M; Gerba, C; Klein, I; Enriquez, C				Oron, G; Armon, R; Mandelbaum, R; Manor, Y; Campos, C; Gillerman, L; Salgot, M; Gerba, C; Klein, I; Enriquez, C			Secondary wastewater disposal for crop irrigation with minimal risks	WATER SCIENCE AND TECHNOLOGY			English	Article; Proceedings Paper	3rd International Symposium on Wastewater Reclamation, Recycling and Reuse held in Conjunction with the 1st IWA World Congress	JUL 03-06, 2000	PARIS, FRANCE			wastewater, reuse; pathogens; risks; onsurface drip; subsurface drip; effluent-soil-plant system	WATER; REUSE; SOIL; ADSORPTION; VIRUS; BACTERIOPHAGE; POLIOVIRUS-1; TRANSPORT; COLIPHAGE	A critical objective for any wastewater reuse program is to close the gap between supply of and demand for water and to minimize health and environmental hazards. Thus, the effects of treated effluent on crops, soils and community health must be considered carefully. When applying wastewater to soil-plant systems, it is to be noted that the passage of water through the soil reduces considerably the number of microorganisms carried out by the reclaimed wastewater. Nevertheless, there is a need to study the real rate of organism decay subject to water quality, soil and vegetable characteristics, and irrigation method; The aim of this work is to determine the fate of the fecal coliforms, coliphages F+ and CN13, and helminth eggs survival during the application of reclaimed wastewater in a vineyard orchard near the City of Arad (Israel) via onsurface and subsurface drip irrigation systems. Wastewater obtained from a stabilization pond, and soil samples were tested and an important decrease of microorganisms was reached in both cases, with the better values obtained with the sub-surface drip irrigation system.	Ben Gurion Univ Negev, Desert Res Inst, IL-84990 Sede Boqer, Israel; Technion Israel Inst Technol, Fac Civil Engn, IL-32000 Haifa, Israel; Volcani Ctr, IL-50250 Bet Dagan, Israel; Chaim Sheba Med Ctr, IL-52521 Tel Hashomer, Israel; Univ Javeriana, Fac Ciencias, Bogota 56710, Colombia; Univ Barcelona, Fac Farm, E-08028 Barcelona, Spain; Univ Arizona, Dept Soil & Water, Tucson, AZ 85721 USA		Oron, G (corresponding author), Ben Gurion Univ Negev, Desert Res Inst, IL-84990 Sede Boqer, Israel.		Salgot, Miquel/M-1841-2014; Campos, Claudia/AAF-6493-2019	Campos, Claudia/0000-0001-9137-9033; Armon, Robert/0000-0001-9112-951X				Adams MH., 1959, BACTERIOPHAGES, P592; ANGELAKIS A, 1997, BEN REUS WAT BIOS MA; APHA-AWWA-WPCF, 1995, STAND METH EX WAT WA; Asano T, 1996, WATER SCI TECHNOL, V33, P1, DOI 10.1016/0273-1223(96)00401-5; BALES RC, 1991, ENVIRON SCI TECHNOL, V25, P2088, DOI 10.1021/es00024a016; Bitton G., 1992, Environmental microbiology., P103; BRENNER A, 1995, WAT SCI TECH, V30, P219; CAI S, 1988, Biomedical and Environmental Sciences, V1, P332; CAMPOS C, 1999, THESIS U BARCELONA S, P123; CROOK J, 1998, WASTEWATER RECLAMATI, P27; GANNON J, 1991, APP ENV MICROBIOL, V57, P193; GANNON JT, 1991, APPL ENVIRON MICROB, V57, P190, DOI 10.1128/AEM.57.1.190-193.1991; GASPARD P, 1995, WAT SCI TECH, V27, P295; GERBA CP, 1981, ENVIRON SCI TECHNOL, V15, P940, DOI 10.1021/es00090a600; HURST CJ, 1980, APPL ENVIRON MICROB, V40, P1067, DOI 10.1128/AEM.40.6.1067-1079.1980; *ISQW, 1981, ISR STAND QUAL WAST; Jolis D, 1995, DESALINATION, V103, P1, DOI 10.1016/0011-9164(95)00081-X; LANCE JC, 1984, APPL ENVIRON MICROB, V47, P335, DOI 10.1128/AEM.47.2.335-337.1984; Meschke JS, 1998, WATER SCI TECHNOL, V38, P187, DOI 10.1016/S0273-1223(98)00823-3; NASSER AM, 1993, WATER SCI TECHNOL, V27, P331, DOI 10.2166/wst.1993.0567; Oron G, 1996, WATER SCI TECHNOL, V33, P95, DOI 10.1016/0273-1223(96)00411-8; ORON G, 1995, WATER RES, V29, P1069, DOI 10.1016/0043-1354(94)00257-8; ORON G, 1991, J IRRIG DRAIN ENG, V117, P25, DOI 10.1061/(ASCE)0733-9437(1991)117:1(25); PALMATEER GA, 1991, WATER RES, V25, P355, DOI 10.1016/0043-1354(91)90017-K; ROSE JB, 1991, WAT SCI TECH, V23, P209; WARD BK, 1982, APPL ENVIRON MICROB, V44, P1389, DOI 10.1128/AEM.44.6.1389-1394.1982	26	41	45	0	19	I W A PUBLISHING	LONDON	ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND	0273-1223			WATER SCI TECHNOL	Water Sci. Technol.		2001	43	10					139	146		10.2166/wst.2001.0603	http://dx.doi.org/10.2166/wst.2001.0603			8	Engineering, Environmental; Environmental Sciences; Water Resources	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Environmental Sciences & Ecology; Water Resources	450DH	11436773				2022-09-04	WOS:000169725900019
J	Nieto-Martinez, R; Gonzalez-Rivas, JP; Aschner, P; Barengo, NC; Mechanick, JI				Nieto-Martinez, Ramfis; Gonzalez-Rivas, Juan P.; Aschner, Pablo; Barengo, Noel C.; Mechanick, Jeffrey I.			Transculturalizing Diabetes Prevention in Latin America	ANNALS OF GLOBAL HEALTH			English	Review						FINDRISC; Latin America; prevention; type 2 diabetes; validation	LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; NUTRITION ALGORITHM; RISK SCORE; FOLLOW-UP; TYPE-2; PROGRAM; OBESITY; PREVALENCE; GUIDELINES	BACKGROUND Type 2 diabetes (T2D) imposes a heavy burden in developing countries, requiring effective primary prevention policies. Randomized clinical trials have identified successful strategies in T2D prevention. However, translating these results to real-life scenarios and adapting to ethnocultural differences is a major challenge. Transculturalization allows incorporating cultural factors to diabetes prevention strategies to optimize implementation of clinical trials results. The purpose of this paper is to review the transcultural adaptations developed for T2D prevention in Latin America (LA). METHODS A comprehensive literature review spanning 1960-2016 was performed, using" Diabetes,""Latin America,""Prevention,""Screening," and "Tools" as key words. RESULTS Two major tasks are underway in LA: adaptation of screening tools for high-risk individuals, and implementation of diabetes prevention programs. The Finnish Diabetes Risk Score (FINDRISC) is the most widely used screening tool to detect new cases of T2D and people with prediabetes, and it has been adapted (LA-FINDRISC) to include the waist circumference cutoff values appropriate for LA population (>= 94 cm for men and >= 90 cm for women). The validation of the LA-FINDRISC performance depends on the local characteristics. A LA-FINDRISC score >10 may be the best cutoff to identify individuals with impaired glucose regulation in population-based studies, but a higher score (>12-14) might be more appropriate in a clinical setting. A shorter version of the FINDRISC using only the 4 variables with highest impact has been developed and validated in Colombia (ColDRISC). The translation of the Diabetes Prevention Program study in a Latino population in Venezuela found a significant improvement in cardiometabolic risk factors. An adaptation of the Diabetes Prevention Study in the DEMOJUAN study in Barranquilla, Colombia, reduced 2-hour postload glucose. CONCLUSION Successful transculturalization strategies have been implemented in screening tools and prevention programs in LA.	[Nieto-Martinez, Ramfis] South Florida Vet Affairs Fdn Res & Educ, Miami VA Healthcare Syst, GRECC, Miami, FL 33125 USA; [Nieto-Martinez, Ramfis] Univ Ctr Occidental Lisandro Alvarado, Sch Med, Dept Physiol, Barquisimeto, Venezuela; [Nieto-Martinez, Ramfis] Cardiometab Unit 7, Barquisimeto, Venezuela; [Gonzalez-Rivas, Juan P.] Andes Clin Cardiometab Studies, Timotes, Venezuela; [Aschner, Pablo] Javeriana Univ, San Ignacio Univ Hosp, Colombian Diabet Assoc, Bogota, Colombia; [Barengo, Noel C.] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Barengo, Noel C.] Univ Helsinki, Dept Publ Hlth, Clinicum, Helsinki, Finland; [Mechanick, Jeffrey I.] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA		Nieto-Martinez, R (corresponding author), South Florida Vet Affairs Fdn Res & Educ, Miami VA Healthcare Syst, GRECC, Miami, FL 33125 USA.; Nieto-Martinez, R (corresponding author), Univ Ctr Occidental Lisandro Alvarado, Sch Med, Dept Physiol, Barquisimeto, Venezuela.; Nieto-Martinez, R (corresponding author), Cardiometab Unit 7, Barquisimeto, Venezuela.	nietoramfis@gmail.com	Martinez, Ramfis Nieto/I-7205-2019	Martinez, Ramfis Nieto/0000-0002-0575-7534				Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Aschner P, 2012, MINERVA ENDOCRINOL, V37, P114; Aschner P, 2014, DIABETES RES CLIN PR, V103, P238, DOI 10.1016/j.diabres.2013.11.010; Aschner P, 2011, DIABETES RES CLIN PR, V93, P243, DOI 10.1016/j.diabres.2011.05.002; Barengo NC, 2015, 8 WORLD C PREV DIAB; Barengo Noel C, 2013, Diabetes Metab Res Rev, DOI 10.1002/dmrr.2462; Galvis AB, 2014, J DIABETES METAB, V5, DOI 10.4172/2155-6156.1000423; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Cardona-Morrell M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-653; Danaei G, 2015, LANCET DIABETES ENDO, V3, P624, DOI 10.1016/S2213-8587(15)00129-1; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Florez H, 2012, VENEZUELA CIRCULATIO, V125, pAP162; Gabriel R, 2014, GLOBAL HLTH PERSPECT; Gao WG, 2010, DIABETIC MED, V27, P274, DOI 10.1111/j.1464-5491.2010.02943.x; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Gomez-Arbelaez D, 2015, WORLD J DIABETES, V6, P1337, DOI 10.4239/wjd.v6.i17.1337; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Guerrero-Romero F, 2010, REV PANAM SALUD PUBL, V27, P181, DOI 10.1590/S1020-49892010000300005; Hegazi RA, 2015, GLUCOSE INTAKE UTILI, P269; Heikes KE, 2008, DIABETES CARE, V31, P1040, DOI 10.2337/dc07-1150; Kengne AP, 2014, LANCET DIABETES ENDO, V2, P19, DOI 10.1016/S2213-8587(13)70103-7; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koksal Burcu, 2015, Open Access Maced J Med Sci, V3, P380, DOI 10.3889/oamjms.2015.093; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Kramer M.K., 2013, DIVERSITY EQUALITY H, V10, P73; Kutob RM, 2014, DIABETES EDUCATOR, V40, P191, DOI 10.1177/0145721714520722; Fuentes LL, 2010, REV MED CHILE, V138, P974, DOI /S0034-98872010000800005; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Lopez-Jaramillo P, 2015, IDENTIFICACION UNPUB; Mechanick JI, 2016, ENDOCR PRACT, V22, P476, DOI 10.4158/EP161229.GL; Mechanick JI, 2014, ENDOCR PRACT, V20, P692, DOI 10.4158/EP14166.PS; Mechanick JI, 2012, CURR DIABETES REP, V12, P180, DOI 10.1007/s11892-012-0253-z; Mezones-Holguin E, 2011, OBES J, V19; Mohan V, 2005, J Assoc Physicians India, V53, P759; Moura F, 2015, NUTRIENTS, V7, P7358, DOI 10.3390/nu7095342; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nieto Martinez RE, 2015, MED INTERNA, V31, P102; Nieto RE, 2013, DIABETES, V62, pA750; Nieto-Martinez R., 2015, MED INTERNA BUCUR, V31, P134; Nieto-Martinez R, 2015, 8 WORLD C PREV DIAB; Nieto-Martinez R, 2016, ENDOCRIN METAB CLIN, V45, P967, DOI 10.1016/j.ecl.2016.06.002; Nieto-Martinez R, 2014, NUTRIENTS, V6, P1333, DOI 10.3390/nu6041333; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; O'Brien MJ, 2017, AM J PREV MED, V52, P788, DOI 10.1016/j.amepre.2017.01.008; Ockene IS, 2012, AM J PUBLIC HEALTH, V102, P336, DOI 10.2105/AJPH.2011.300357; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Quitian H, 2015, VALUE HEALTH, V18, pA356, DOI 10.1016/j.jval.2015.09.668; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Ruggiero L, 2011, DIABETES EDUCATOR, V37, P564, DOI 10.1177/0145721711411107; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vignoli DA, 2015, 8 WORLD C PREV DIAB; Waugh NR, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17350; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097865; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	63	9	9	0	1	UBIQUITY PRESS LTD	LONDON	2N, 6 OSBORNE ST, LONDON, E1 6TD, ENGLAND	2214-9996			ANN GLOB HEALTH	Ann. Glob. Health	MAY-AUG	2017	83	3-4					432	443		10.1016/j.aogh.2017.07.001	http://dx.doi.org/10.1016/j.aogh.2017.07.001			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	FO9LN	29221516	gold			2022-09-04	WOS:000417209100004
J	Bustamante, IV; Carvalho, AMP; de Oliveira, EB; de Oliveira, HP; Figueroa, SDS; Vasquez, EMM; Cazenave, A; Chaname, E; Matallana, LSM; Castillo, JR				Bustamante, Ines V.; Pimenta Carvalho, Ana Maria; de Oliveira, Elias Barbosa; de Oliveira Junior, Hercilio Pereira; Santos Figueroa, Syntia Dinora; Montoya Vasquez, Erika Maria; Cazenave, Angelica; Chaname, Eva; Medina Matallana, Luz Stella; Ramirez Castillo, Julia			UNIVERSITY STUDENTS' PERCEIVED NORMS OF PEERS AND DRUG USE: A MULTICENTRIC STUDY IN FIVE LATIN AMERICAN COUNTRIES	REVISTA LATINO-AMERICANA DE ENFERMAGEM			English	Article						alcohol; tobacco; cannabis; cocaine	COLLEGE DRINKING; SUBSTANCE USE; ALCOHOL; MISPERCEPTIONS; PREVENTION	This cross-sectional study compared perceived peer drug use and actual drug use in a sample of Latin American university students. Students from nine universities in five countries (Brazil, Chile, Colombia, Honduras and Peru) completed a questionnaire that addressed the use of tobacco, alcohol, marijuana and cocaine. Analysis focused on comparing perceptions to actual drug use. The findings largely, but not completely, confirmed the idea that students overestimate peer drug use. The unexpected findings were those relating to alcohol. While students generally overestimated peer use of tobacco, marijuana and cocaine, they accurately estimated or underestimated peer use of alcohol. Apart from the anomalous findings with regard to alcohol, this study shows that perceived drug use relates to actual drug use in Latin America as it does elsewhere. The results also support the suggestion that interventions using normative feedback would be useful to strengthen drug use prevention programs aimed at youth in Latin America.	[Bustamante, Ines V.] Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm Carlos Vidal Layseca, Lima, Peru; [Pimenta Carvalho, Ana Maria] Univ Sao Paulo, Escola Enfermagem Ribeirao Preto, WHO Collaborating Ctr Nursing Res Dev, BR-05508 Sao Paulo, Brazil; [de Oliveira, Elias Barbosa] Univ Estado Rio de Janeiro, Fac Enfermagem, Rio De Janeiro, Brazil; [de Oliveira Junior, Hercilio Pereira] Univ Sao Paulo, Fac Med, BR-05508 Sao Paulo, Brazil; [Montoya Vasquez, Erika Maria] Univ Antioquia, Fac Nacl Salud Publ, Medellin, Colombia; [Cazenave, Angelica] Pontificia Univ Catolica Chile, Escuela Enfermeria, Santiago, Chile; [Cazenave, Angelica] Pontificia Univ Catolica Chile, Equipo Adicc, Santiago, Chile; [Cazenave, Angelica] Pontificia Univ Catolica Chile, Ctr Estudios Adicc, Santiago, Chile; [Chaname, Eva] Univ Peruana Cayetano Heredia, Fac Enfermeria, Lima, Peru; [Medina Matallana, Luz Stella] Pontificia Univ Javeriana, Fac Enfermeria, Bogota, Colombia; [Ramirez Castillo, Julia] Univ Concepcion, Dept Nursing, Concepcion, Chile		Bustamante, IV (corresponding author), Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm Carlos Vidal Layseca, Lima, Peru.	ibustama@jhsph.edu; anacar@eerp.usp.br; eliasbo@tutopia.com.br; hercilio@usp.br; syntiasantos@yahoo.com; eribertica@guajiros.udea.edu.co; keka.cazenave@gmail.com; echaname@gmail.com; lsmedina@javeriana.edu.co; jramirez@udev.cl	DE OLIVEIRA, ELIAS/AAE-6309-2019	Montoya Vasquez, Erika Maria/0000-0001-8582-6597	Canadian government; Organization of American States (OAS); Inter-American Drug Abuse Control Commission (CICAD); Centre for Addiction and Mental Health (CAMH), Canada	Canadian government; Organization of American States (OAS); Inter-American Drug Abuse Control Commission (CICAD); Centre for Addiction and Mental Health (CAMH), Canada	This research was conducted with support, advice and funding of the Canadian government, Organization of American States (OAS), Inter-American Drug Abuse Control Commission (CICAD), and Centre for Addiction and Mental Health (CAMH), Canada. We acknowledge the collaboration of other colleagues who contributed directly or indirectly in the development of this study.	Andrews JA, 2002, HEALTH PSYCHOL, V21, P349, DOI 10.1037//0278-6133.21.4.349; Borsari B, 2003, J STUD ALCOHOL, V64, P331, DOI 10.15288/jsa.2003.64.331; Carlini EA, 2002, LEVANTAMENTO DOMICIL; Chávez Luz María Carvajal, 2005, Rev. Latino-Am. Enfermagem, V13, P784, DOI 10.1590/S0104-11692005000700004; *CEDRO, 2006, EP DROG POBL URB PER; *COM NAC DES VID S, 2003, 2 ENC NAC PREV CONS; *CONACE, 2007, SEPT EST NAC DROG PO; JINEZ MLJ, 2009, REV LAT-AM ENFERM, V17, P369; Kilmer JR, 2006, J STUD ALCOHOL, V67, P277, DOI 10.15288/jsa.2006.67.277; Kypri K, 2003, J STUD ALCOHOL, V64, P829, DOI 10.15288/jsa.2003.64.829; Martens MR, 2006, J AM COLL HEALTH, V54, P295, DOI 10.3200/JACH.54.5.295-300; MATHERS CD, 2004, 18 WORLD BANK COUNTR; *MIN PROT SOC OMS, 2003, EST NAC SAL MENT COL; Neighbors C, 2006, J STUD ALCOHOL, V67, P290, DOI 10.15288/jsa.2006.67.290; Perkins HW, 2005, J STUD ALCOHOL, V66, P470, DOI 10.15288/jsa.2005.66.470; Perkins HW, 2002, J STUD ALCOHOL, P164, DOI 10.15288/jsas.2002.s14.164; Rehm J, 2006, DRUG ALCOHOL REV, V25, P503, DOI 10.1080/09595230600944453; Sale E, 2003, J DRUG EDUC, V33, P91, DOI 10.2190/LFJ0-ER64-1FVY-PA7L; WHO, 2020, GLOB REP EP BURD SEP; Wolfson S, 2000, PSYCHOL ADDICT BEHAV, V14, P295, DOI 10.1037/0893-164X.14.3.295	20	14	16	0	8	UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO	RIBEIRAO PRETO	AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL	1518-8345			REV LAT-AM ENFERM	Rev. Latino-Am. Enfermagem	NOV-DEC	2009	17				SI		838	843		10.1590/S0104-11692009000700013	http://dx.doi.org/10.1590/S0104-11692009000700013			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	533FC	20011910	gold, Green Submitted, Green Published			2022-09-04	WOS:000272808100013
J	Morales-Zamora, G; Espinosa, O; Puertas, E; Fernandez, JC; Hernandez, J; Zakzuk, V; Cepeda, M; Alvis-Guzman, N; Castaneda-Orjuela, C; Paternina-Caicedo, A				Morales-Zamora, Gilberto; Espinosa, Oscar; Puertas, Edwin; Fernandez, Juan Carlos; Hernandez, Jose; Zakzuk, Veronica; Cepeda, Magda; Alvis-Guzman, Nelson; Castaneda-Orjuela, Carlos; Paternina-Caicedo, Angel			Cost-Effectiveness Analysis of Strategies of COVID-19 Vaccination in Colombia: Comparison of High-Risk Prioritization and No Prioritization Strategies With the Absence of a Vaccination Plan	VALUE IN HEALTH REGIONAL ISSUES			English	Article						Colombia; cost-effectiveness; modeling; severe acute respiratory syndrome coronavirus 2; vaccination		Objectives: Our study compares two national COVID-19 vaccination plan strategies-high-risk prioritization and no prioritization-and estimates their cost-effectiveness compared with no vaccination, to generate possible recommendations for future vaccination plans. Methods: We developed a Markov discrete-time, compartmental, deterministic model stratified by Colombian departments, healthcare workers, comorbidities, and age groups and calibrated to seroprevalence, cases, and deaths. The model simulates three scenarios: no vaccination, no prioritization of vaccination, and prioritization of high-risk population. The study presents the perspective of the health system of Colombia, including the direct health costs financed by the government and the direct health outcomes related to the infection. We measured symptomatic cases, deaths, and costs for each of the three scenarios from the start of the vaccination rollout to February 20, 2023. Results: Both for the base-case and across multiple sensitivity analyses, the high-risk prioritization proves to be the most costeffective of the considered strategies. An increment of US$255 million results in an incremental cost-effectiveness ratio of US$3339 per disability-adjusted life-year avoided. The simulations show that prioritization of high-risk population reduces symptomatic cases by 3.4% and deaths by 20.1% compared with no vaccination. The no-prioritization strategy is still costeffective, with an incremental cost-effectiveness ratio of US$5223.66, but the sensitivity analysis the show potential risks of losing cost-effectiveness under the cost-effectiveness threshold (one gross domestic product per averted disability adjusted life-year). Conclusions: The high-risk prioritization strategy is consistently more cost-effective than the no-prioritization strategy across multiple scenarios. High-risk prioritization is the recommended strategy in low-resource settings to reduce the burden of disease.	[Paternina-Caicedo, Angel] Univ Sinu, Tv 54 41-117, Cartagena, Colombia; [Morales-Zamora, Gilberto] Inst Evaluac Tecnol Salud, Bogota, Colombia; [Espinosa, Oscar] Univ Nacl Colombia, Inst Evaluac Tecnol Salud, Bogota, Colombia; [Puertas, Edwin] Univ Tecnol Bolivar, Cartagena, Colombia; [Fernandez, Juan Carlos; Hernandez, Jose] Mutual Ser, Cartagena, Colombia; [Zakzuk, Veronica; Cepeda, Magda] Pontificia Univ Javeriana, Dept Epidemiol Clin & Bioestadist, Bogota, Colombia; [Alvis-Guzman, Nelson] Univ Cartagena, Cartagena, Colombia; [Castaneda-Orjuela, Carlos] Inst Nacl Salud, Observ Nacl Salud, Bogota, Colombia; [Paternina-Caicedo, Angel] Univ Sinu, Cartagena, Colombia; [Alvis-Guzman, Nelson] Univ Costa, Barranquilla, Colombia		Paternina-Caicedo, A (corresponding author), Univ Sinu, Tv 54 41-117, Cartagena, Colombia.; Paternina-Caicedo, A (corresponding author), Univ Sinu, Cartagena, Colombia.	apaterninac@unisinucartagena.edu.co	Espinosa, Oscar/GNH-4237-2022; Alvis-Guzman, Nelson/D-4913-2013; Puertas, Edwin/I-9169-2019	Espinosa, Oscar/0000-0003-4893-0509; Alvis-Guzman, Nelson/0000-0001-9458-864X; Puertas, Edwin/0000-0002-0758-1851	Ministerio of Ciencia, Tecnologa e Innovacion, Colombia [381-2020]	Ministerio of Ciencia, Tecnologa e Innovacion, Colombia	This project was conducted within the project "Development and evaluation of a mathematical and epidemiological model that supports decision making in response to the emergency due to SARS-CoV-2 and other causative agents of ARI in Colombia using Data Analytics and Machine Learning, which was financed by the Ministerio of Ciencia, Tecnologa e Innovacion, Colombia, under the call number 1015-2020 and contract number 381-2020.	Braun-Moscovici Y, 2021, ANN RHEUM DIS, V80, P1317, DOI 10.1136/annrheumdis-2021-220503; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Lei J, 2018, ANTIVIR RES, V149, P58, DOI 10.1016/j.antiviral.2017.11.001	5	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2212-1099			VALUE HEALTH REG ISS	Value Health Reg. Iss.	SEP	2022	31						101	110		10.1016/j.vhri.2022.04.004	http://dx.doi.org/10.1016/j.vhri.2022.04.004			10	Health Care Sciences & Services; Health Policy & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	1Y7LO	35640462	hybrid, Green Published			2022-09-04	WOS:000808321800002
J	Dobs, AS; Goldstein, BJ; Aschner, P; Horton, ES; Umpierrez, GE; Duran, L; Hill, JS; Chen, Y; Golm, GT; Langdon, RB; Williams-Herman, DE; Kaufman, KD; Amatruda, JM; Ferreira, JCA				Dobs, Adrian S.; Goldstein, Barry J.; Aschner, Pablo; Horton, Edward S.; Umpierrez, Guillermo E.; Duran, Lorraine; Hill, Julie S.; Chen, Yu; Golm, Gregory T.; Langdon, Ronald B.; Williams-Herman, Debora E.; Kaufman, Keith D.; Amatruda, John M.; Ferreira, Juan Camilo Arjona			Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes	JOURNAL OF DIABETES			English	Article						dipeptidyl peptidase-4 inhibitor; glycemic control; incretins; sitagliptin	DIPEPTIDYL PEPTIDASE-4 INHIBITOR; BETA-CELL FUNCTION; GLYCEMIC CONTROL; PLUS METFORMIN; PLASMA-GLUCOSE; DOUBLE-BLIND; PIOGLITAZONE; INCRETIN; TOLERABILITY; MULTICENTER	Background: New therapeutic approaches are needed to improve glycemic control in patients with type 2 diabetes (T2D), a progressive disorder that often requires combination therapy. The present study assessed the efficacy and safety of sitagliptin as add-on therapy to metformin and rosiglitazone in patients with T2D. Methods: The present study was a randomized double-blind placebo-controlled parallel-group 54-week study conducted at 41 sites across North and South America, Europe, and Asia in 278 patients with HbA1c ranging from >= 7.5% to <= 11.0% despite ongoing combination therapy with metformin (>= 1500 mg/day) and rosiglitazone (>= 4 mg/day). Patients were randomized (2: 1) to receive sitagliptin 100 mg or placebo once daily. The main outcome measure was change from baseline in HbA1c at Week 18. Results: Mean baseline HbA1c was 8.8%. The mean placebo-adjusted change from baseline in HbA1c with sitagliptin treatment was) 0.7% (P < 0.001) at Week 18 and) -0.8% (P < 0.001) at Week 54. There were also significant (P < 0.001) reductions in 2-h post-meal glucose and fasting plasma glucose compared with placebo at Weeks 18 and 54. Significantly higher proportions of sitagliptin-than placebo-treated patients had HbA1c<7.0% at Weeks 18 (22% vs 9%; P = 0.003) and 54 (26% vs 14%; P = 0.015). Changes in body weight and the rates of adverse events overall, hypoglycemia, and gastrointestinal adverse events were similar in the sitagliptin and placebo groups during the 54-week study. Conclusions: In patients with T2D, the addition of sitagliptin for 54 weeks to ongoing therapy with metformin and rosiglitazone improved glycemic control and was generally well tolerated compared with placebo.	[Dobs, Adrian S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Goldstein, Barry J.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Goldstein, Barry J.; Duran, Lorraine; Hill, Julie S.; Chen, Yu; Golm, Gregory T.; Langdon, Ronald B.; Williams-Herman, Debora E.; Kaufman, Keith D.; Amatruda, John M.; Ferreira, Juan Camilo Arjona] Merck Sharp & Dohme Corp, Whitehouse Stn, NJ USA; [Horton, Edward S.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Umpierrez, Guillermo E.] Emory Univ, Sch Med, Atlanta, GA USA; [Aschner, Pablo] Javeriana Univ, Sch Med, Bogota, Colombia; [Aschner, Pablo] Colombian Diabet Assoc, Bogota, Colombia		Ferreira, JCA (corresponding author), Merck Res Labs, 126 East Lincoln Ave,RY34-A232, Rahway, NJ 07065 USA.	juan.arjona@merck.com			Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA	This study was sponsored by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA. The authors thank Sheila Erespe (Merck & Co.) for editorial assistance.	Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Baetta R, 2011, DRUGS, V71, P1441, DOI 10.2165/11591400-000000000-00000; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bailey CJ, 2005, CLIN THER, V27, P1548, DOI 10.1016/j.clinthera.2005.10.012; Barnett A, 2007, CURR MED RES OPIN, V23, P1493, DOI 10.1185/030079907X199691; Bell DSH, 2011, DIABETES OBES METAB, V13, P800, DOI 10.1111/j.1463-1326.2011.01408.x; Charbonnel B, 2006, DIABETES CARE, V29, P2638, DOI 10.2337/dc06-0706; Cryer Philip E, 2008, Endocr Pract, V14, P750; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DeFronzo RA, 2009, DIABETES CARE, V32, P1649, DOI 10.2337/dc08-1984; Derosa G, 2010, DRUGS, V70, P1945, DOI 10.2165/11538100-000000000-00000; Goldstein BJ, 2007, DIABETES CARE, V30, P1979, DOI 10.2337/dc07-0627; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Hill NR, 2007, DRUG TODAY, V43, P443, DOI 10.1358/dot.2007.43.7.1119722; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Lebovitz HE, 2002, DIABETES-METAB RES, V18, pS23, DOI 10.1002/dmrr.252; Mannucci E, 2001, DIABETES CARE, V24, P489, DOI 10.2337/diacare.24.3.489; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ovalle F, 1998, Endocr Pract, V4, P146; Raz I, 2008, CURR MED RES OPIN, V24, P537, DOI [10.1185/030079908X260925, 10.1185/030079908X260925 ]; Richter B, 2008, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD006739., DOI 10.1002/14651858.CD006739]; Rosenstock J, 2006, DIABETES OBES METAB, V8, P650, DOI 10.1111/j.1463-1326.2006.00659.x; Rosenstock J, 2006, DIABETES CARE, V29, P554, DOI 10.2337/diacare.29.03.06.dc05-0695; Rosenstock J, 2006, CLIN THER, V28, P1556, DOI 10.1016/j.clinthera.2006.10.007; Wellington K, 2005, DRUGS, V65, P1581, DOI 10.2165/00003495-200565110-00013; Williams-Herman D, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-7; Woodcock J, 2010, NEW ENGL J MED, V363, P1489, DOI 10.1056/NEJMp1010788; Wu AH, 2008, HEART, V94, P1503, DOI 10.1136/hrt.2007.133876; YONEDA H, 1992, DIABETES CARE, V15, P1517, DOI 10.2337/diacare.15.11.1517; Yoon KH, 2011, INT J CLIN PRACT, V65, P154, DOI 10.1111/j.1742-1241.2010.02589.x	36	34	38	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1753-0393	1753-0407		J DIABETES	J. Diabetes	MAR	2013	5	1					68	79		10.1111/j.1753-0407.2012.00223.x	http://dx.doi.org/10.1111/j.1753-0407.2012.00223.x			12	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	087IG	22742523				2022-09-04	WOS:000314754200012
J	Silva, JL; Burwick, RM; Velasquez, JA; Lenis, V; Vargas, J; Bernal, Y; Valencia, CMM; Edna, F; Gutierrez, JH; Trujillo, J; Rincon, M; Tolosa, JE				Silva, Jaime L.; Burwick, Richard M.; Velasquez, Jesus A.; Lenis, Viviana; Vargas, Johanna; Bernal, Yamile; Valencia, Catalina Maria M.; Edna, Francisco; Gutierrez, Jorge H.; Trujillo, Juliana; Rincon, Monica; Tolosa, Jorge E.			CD59 in Hypertensive disorders of pregnancy and association with adverse outcomes: The COPA II study	AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY			English	Meeting Abstract	40th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine (SMFM)	FEB 03-08, 2020	Grapevine, TX	Soc Maternal Fetal Med					[Silva, Jaime L.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Burwick, Richard M.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Velasquez, Jesus A.; Lenis, Viviana] Univ Antioquia, Medellin, Colombia; [Vargas, Johanna; Bernal, Yamile] Lab Clin COLSANITAS, Bogota, Colombia; [Valencia, Catalina Maria M.] Med Fetal SAS, Medellin, Colombia; [Edna, Francisco] ESE Clin Maternidad Rafael Calvo, Cartagena, Colombia; [Gutierrez, Jorge H.] Univ Pontificia Bolivariana, Medellin, Colombia; [Trujillo, Juliana] Hosp Gen Medellin, Luz Castro de Gutierrez ESE, Medellin, Colombia; [Rincon, Monica; Tolosa, Jorge E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA										0	0	0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9378	1097-6868		AM J OBSTET GYNECOL	Am. J. Obstet. Gynecol.	JAN	2020	222	1		S		1007	S627	S627		10.1016/j.ajog.2019.11.1023	http://dx.doi.org/10.1016/j.ajog.2019.11.1023			1	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Obstetrics & Gynecology	JZ3JD		Bronze			2022-09-04	WOS:000504997301329
J	Van Nynatten, A; Janzen, FH; Brochu, K; Maldonado-Ocampo, JA; Crampton, WGR; Chang, BSW; Lovejoy, NR				Van Nynatten, Alexander; Janzen, Francesco H.; Brochu, Kristen; Maldonado-Ocampo, Javier A.; Crampton, William G. R.; Chang, Belinda S. W.; Lovejoy, Nathan R.			To see or not to see: molecular evolution of the rhodopsin visual pigment in neotropical electric fishes	PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES			English	Article						rhodopsin; Gymnotiformes; likelihood-based codon models; clade models of molecular evolution; evolution of fish vision; positive selection	CODON-SUBSTITUTION MODELS; FUNCTIONAL DIVERGENCE; DIM LIGHT; MUTATIONS; SITES; GENE; EYES; ADAPTATION; PERCEPTION; SELECTION	Functional variation in rhodopsin, the dim-light-specialized visual pigment, frequently occurs in species inhabiting light-limited environments. Variation in visual function can arise through two processes: relaxation of selection or adaptive evolution improving photon detection in a given environment. Here, we investigate the molecular evolution of rhodopsin in Gymnotiformes, an order of mostly nocturnal South American fishes that evolved sophisticated electrosensory capabilities. Our initial sequencing revealed a mutation associated with visual disease in humans. As these fishes are thought to have poor vision, this would be consistent with a possible sensory trade-off between the visual system and a novel electrosensory system. To investigate this, we surveyed rhodopsin from 147 gymnotiform species, spanning the order, and analysed patterns of molecular evolution. In contrast with our expectation, we detected strong selective constraint in gymnotiform rhodopsin, with rates of non-synonymous to synonymous substitutions lower in gymnotiforms than in other vertebrate lineages. In addition, we found evidence for positive selection on the branch leading to gymnotiforms and on a branch leading to a clade of deep-channel specialized gymnotiform species. We also found evidence that deleterious effects of a human disease-associated substitution are likely to be masked by epistatic substitutions at nearby sites. Our results suggest that rhodopsin remains an important component of the gymnotiform sensory system alongside electrolocation, and that photosensitivity of rhodopsin is well adapted for vision in dim-light environments.	[Van Nynatten, Alexander; Chang, Belinda S. W.; Lovejoy, Nathan R.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; [Van Nynatten, Alexander; Lovejoy, Nathan R.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [Janzen, Francesco H.] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; [Janzen, Francesco H.] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Brochu, Kristen] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Maldonado-Ocampo, Javier A.] Pontificia Univ Javeriana, Fac Ciendas, Dept Biol, Lab Ictiol,Unidad Ecol & Sistemit UNESIS, Bogota, Colombia; [Crampton, William G. R.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Chang, Belinda S. W.; Lovejoy, Nathan R.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON MSS 382, Canada; [Chang, Belinda S. W.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON MSS 382, Canada		Chang, BSW; Lovejoy, NR (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada.; Lovejoy, NR (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada.; Chang, BSW; Lovejoy, NR (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON MSS 382, Canada.; Chang, BSW (corresponding author), Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON MSS 382, Canada.	belinda.chang@utoronto.ca; lovejoy@utsc.utoronto.ca	Crampton, William/AAP-3608-2020	Chang, Belinda/0000-0002-6525-4429	NSERC Discovery grants; Vision Science Research Fellowship	NSERC Discovery grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vision Science Research Fellowship	Funding was provided by NSERC Discovery grants (to B.S.W.C. and N.R.L.) and a Vision Science Research Fellowship (to A.V.N.).	BASTIAN J, 1982, J COMP PHYSIOL, V147, P287, DOI 10.1007/BF00609662; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; BUNGE S, 1993, GENOMICS, V17, P230, DOI 10.1006/geno.1993.1309; Castiglione GM, 2018, ELIFE, V7, DOI 10.7554/eLife.35957; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Crampton WGR, 2019, J FISH BIOL, V95, P92, DOI 10.1111/jfb.13922; Crampton WGR, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P165; Crampton William G.R., 2008, P283; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Emerling CA, 2014, MOL PHYLOGENET EVOL, V78, P260, DOI 10.1016/j.ympev.2014.05.016; Erlandson SC, 2018, ANNU REV BIOPHYS, V47, P1, DOI 10.1146/annurev-biophys-070317-032931; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; FERNHOLM B, 1975, VISION RES, V15, P253, DOI 10.1016/0042-6989(75)90215-1; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Gower DJ, 2019, BIOL J LINN SOC, V126, P796, DOI 10.1093/biolinnean/blz003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunkel M, 2015, STRUCTURE, V23, P628, DOI 10.1016/j.str.2015.01.015; Gutierrez ED, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2835; Hauser FE, 2017, MOL BIOL EVOL, V34, P2650, DOI 10.1093/molbev/msx192; Hauser FE, 2016, VISUAL NEUROSCI, V33, DOI 10.1017/S0952523815000322; Hodos W, 1997, BRAIN BEHAV EVOLUT, V50, P189, DOI 10.1159/000113333; Jastrzebska B, 2017, BIOCHEMISTRY-US, V56, P61, DOI 10.1021/acs.biochem.6b00877; Keesey IW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09087-z; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kulathinal RJ, 2004, SCIENCE, V306, P1553, DOI 10.1126/science.1100522; Lavoue S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036287; Liu DW, 2019, MOL BIOL EVOL, V36, P447, DOI 10.1093/molbev/msy241; Liu DW, 2016, BRAIN BEHAV EVOLUT, V88, P204, DOI 10.1159/000450746; Mallory DP, 2018, BIOCHEMISTRY-US, V57, P5188, DOI 10.1021/acs.biochem.8b00403; Meredith RW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003432; Morrow JM, 2015, BIOCHEMISTRY-US, V54, P4507, DOI 10.1021/bi501377b; Muller J, 2018, ANNU REV EARTH PL SC, V46, P495, DOI 10.1146/annurev-earth-082517-010120; Munoz NE, 2012, BEHAV ECOL, V23, P457, DOI 10.1093/beheco/arr220; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Niemiller ML, 2013, EVOLUTION, V67, P732, DOI 10.1111/j.1558-5646.2012.01822.x; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Nummela S, 2013, J COMP PHYSIOL A, V199, P1077, DOI 10.1007/s00359-013-0846-2; Piechnick R, 2012, P NATL ACAD SCI USA, V109, P5247, DOI 10.1073/pnas.1117268109; Platt A, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-017-1085-x; Ploier B, 2016, NAT COMMUN, V7, P177, DOI [10.1038/ncommuns12832, DOI 10.1038/NCOMMUNS12832]; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rolland J, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.1796; ROSE GJ, 1993, J COMP PHYSIOL A, V171, P791, DOI 10.1007/BF00213075; Sadier A, 2018, ELIFE, V7, DOI 10.7554/eLife.37412; Shiriagin V, 2019, CHEM SENSES, V44, P23, DOI 10.1093/chemse/bjy062; Stieb SM, 2017, MOL ECOL, V26, P1323, DOI 10.1111/mec.13968; Sugawara T, 2010, MOL BIOL EVOL, V27, P506, DOI 10.1093/molbev/msp252; Takiyama T, 2015, BRAIN BEHAV EVOLUT, V86, P122, DOI 10.1159/000438448; Van Nynatten A, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0349; Wertheim JO, 2015, MOL BIOL EVOL, V32, P820, DOI 10.1093/molbev/msu400; Wu JW, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1523; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	61	2	2	4	33	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	0962-8452	1471-2954		P ROY SOC B-BIOL SCI	Proc. R. Soc. B-Biol. Sci.	JUL 10	2019	286	1906							20191182	10.1098/rspb.2019.1182	http://dx.doi.org/10.1098/rspb.2019.1182			7	Biology; Ecology; Evolutionary Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Environmental Sciences & Ecology; Evolutionary Biology	IJ3IL	31288710	Green Published, Bronze			2022-09-04	WOS:000475797600019
J	Davis, TME; Mulder, H; Lokhnygina, Y; Aschner, P; Chuang, LM; Grado, CAR; Standl, E; Peterson, ED; Holman, RR				Davis, Timothy M. E.; Mulder, Hillary; Lokhnygina, Yuliya; Aschner, Pablo; Chuang, Lee-Ming; Raffo Grado, Carlos A.; Standl, Eberhard; Peterson, Eric D.; Holman, Rury R.		TECOS Study Grp	Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)	DIABETES OBESITY & METABOLISM			English	Article						ethnicity; glycaemic control; sitagliptin; type 2 diabetes	TYPE-2 DIABETES-MELLITUS; ADD-ON THERAPY; GLUCOSE-TOLERANCE; PHARMACODYNAMIC EVALUATION; DPP-4 INHIBITOR; EFFICACY; LINAGLIPTIN; METFORMIN; INSULIN; ALPHA	Aim: Pooled efficacy studies suggest that glycaemic responses to dipeptidyl-peptidase 4 inhibitors in type 2 diabetes are greatest in Asians, who may also respond better to alpha-glucosidase inhibitors. We assessed the glycaemic impact of sitagliptin by race in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS), and whether this was enhanced in Asians with concomitant acarbose therapy. Materials and methods: TECOS enrolled 14 671 patients with type 2 diabetes, cardiovascular disease and HbA1c of 48-64 mmol/mol (6.5%-8.0%), and randomized them, double-blind, to sitagliptin or placebo. There were 3265 patients (22.3%) from Asian countries. Background glucose-lowering therapies were unaltered for the first 4 months post randomization unless clinically essential, facilitating comparison of sitagliptin-associated effects in self-identified East Asian, Other (South) Asian, White Caucasian, Hispanic, Black and Indigenous groups. Results: Median baseline HbA1c by race was 54 to 57 mmol/mol (7.1%-7.4%). Mean 4-month reduction in placebo-adjusted HbA1c was greatest in East Asians (-6.6 mmol/mol [-0.60%] vs <= 6.0 mmol/mol [<= 0.55%] in other groups), with significantly greater reduction vs the 2 largest groups (White Caucasians, Other Asians; P <.0001) after adjustment for covariates. After the first 4 months, East and Other Asians were more likely to initiate additional oral therapy (metformin and/or sulfonylureas) than insulin vs White Caucasians (P <.0001). Acarbose use increased in the Asian patients, but no glycaemic interaction with allocated study medication was observed (adjusted P = .12). Conclusions: The greatest initial reduction in HbA1c with sitagliptin in the TECOS population was in East Asians. No enhanced glycaemic effect was seen when sitagliptin was given with acarbose.	[Davis, Timothy M. E.] Univ Western Australia, Med Sch, Fremantle Hosp, Fremantle, WA, Australia; [Mulder, Hillary; Lokhnygina, Yuliya; Peterson, Eric D.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Aschner, Pablo] Pontificia Univ Javeriana, Sch Med, Hosp Univ San Ignacio, Bogota, Colombia; [Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Raffo Grado, Carlos A.] Univ Andres Bello, Vina Del Mar, Chile; [Standl, Eberhard] Munich Diabet Res Inst, Munich, Germany; [Holman, Rury R.] Univ Oxford, Diabet Trials Unit, Oxford, England		Davis, TME (corresponding author), Univ Western Australia, Fremantle Hosp, Fac Hlth & Med Sci, Med Sch, POB 480, Fremantle, WA 6959, Australia.	tim.davis@uwa.edu.au	Peterson, Eric David/ABF-5033-2021; Chuang, Lee-Ming/AAF-3324-2019; Hramiak, Irene/G-3305-2011	CHUANG, LEE-MING/0000-0003-0978-2662; Davis, Timothy/0000-0003-0749-7411; Mulder, Hillary/0000-0003-4838-582X	Merck Sharp Dohme Corp.	Merck Sharp Dohme Corp.(Merck & Company)	Funding for this research was provided by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey.	Ahren B, 2016, DIABETOLOGIA, V59, P907, DOI 10.1007/s00125-016-3899-2; Aso Y, 2012, TRANSL RES, V159, P25, DOI 10.1016/j.trsl.2011.09.005; Burden ML, 1994, PRACT DIAB INT, V11, P208, DOI DOI 10.1002/PDI.1960110508; Ceriello A, 2017, J DIABETES INVEST, V8, P19, DOI 10.1111/jdi.12528; Chen YH, 2015, J DIABETES INVEST, V6, P692, DOI 10.1111/jdi.12346; DAVIS TME, 1995, DIABETES RES CLIN PR, V27, P171, DOI 10.1016/0168-8227(95)01039-G; Del Prato S, 2016, NUTR METAB CARDIOVAS, V26, P886, DOI 10.1016/j.numecd.2016.06.015; Del Prato S, 2011, DIABETES OBES METAB, V13, P258, DOI 10.1111/j.1463-1326.2010.01350.x; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Foley JE, 2016, VASC HEALTH RISK MAN, V12, P9, DOI 10.2147/VHRM.S96971; Friedrich C, 2013, BRIT J CLIN PHARMACO, V76, P445, DOI 10.1111/bcp.12077; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Green JB, 2013, AM HEART J, V166, P983, DOI 10.1016/j.ahj.2013.09.003; Hara T, 1996, DIABETES CARE, V19, P642, DOI 10.2337/diacare.19.6.642; He YL, 2012, CLIN PHARMACOKINET, V51, P147, DOI 10.2165/11598080-000000000-00000; Henry CJK, 2008, BRIT J NUTR, V99, P840, DOI 10.1017/S0007114507831801; Horikawa Y, 2011, J DIABETES INVEST, V2, P200, DOI 10.1111/j.2040-1124.2010.00081.x; Hu EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1454; Joshi SR, 2015, EXPERT OPIN PHARMACO, V16, P597, DOI 10.1517/14656566.2015.1009894; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lim S, 2012, CLIN ENDOCRINOL, V77, P215, DOI 10.1111/j.1365-2265.2011.04240.x; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Mamza J, 2016, DIABETES TECHNOL THE, V18, P85, DOI 10.1089/dia.2015.0052; Monami M, 2016, ACTA DIABETOL, V53, P35, DOI 10.1007/s00592-015-0732-1; Nauck M, 2016, DIABETES OBES METAB, V18, P203, DOI 10.1111/dom.12591; Oh TJ, 2015, CLIN ENDOCRINOL, V83, P59, DOI 10.1111/cen.12623; Owens DR, 2011, DIABETIC MED, V28, P1352, DOI 10.1111/j.1464-5491.2011.03387.x; Perez-Escamilla R, 2011, AM J CLIN NUTR, V93, p1163S, DOI 10.3945/ajcn.110.003467; QUALMANN C, 1995, SCAND J GASTROENTERO, V30, P892, DOI 10.3109/00365529509101597; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Taskinen MR, 2011, DIABETES OBES METAB, V13, P65, DOI 10.1111/j.1463-1326.2010.01326.x; TURNER RC, 1995, DIABETES, V44, P1249; Weng JP, 2015, DIABETES-METAB RES, V31, P155, DOI 10.1002/dmrr.2576; Wu TZ, 2010, VITAM HORM, V84, P81, DOI [10.1016/S0083-6729(10)84015-4, 10.1016/B978-0-12-381517-0.00003-5]; Yabe D, 2015, J DIABETES COMPLICAT, V29, P413, DOI 10.1016/j.jdiacomp.2014.12.010; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	38	18	18	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	JUN	2018	20	6					1427	1434		10.1111/dom.13242	http://dx.doi.org/10.1111/dom.13242			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	GF4OS	29405540				2022-09-04	WOS:000431942800014
J	Londono, AF; Acevedo-Gutierrez, LY; Marin, D; Contreras, V; Diaz, FJ; Valbuena, G; Labruna, MB; Hidalgo, M; Arboleda, M; Mattar, S; Solari, S; Rodas, JD				Londono, Andres F.; Acevedo-Gutierrez, Leidy Y.; Marin, Diana; Contreras, Veronica; Diaz, Francisco J.; Valbuena, Gustavo; Labruna, Marcelo B.; Hidalgo, Marylin; Arboleda, Margarita; Mattar, Salim; Solari, Sergio; Rodas, Juan D.			Human prevalence of the spotted fever group (SFG) rickettsiae in endemic zones of Northwestern Colombia	TICKS AND TICK-BORNE DISEASES			English	Article						Rickettsia; Colombia; Equines; Birds	BRAZIL; BIRDS	In February 2006, an outbreak of human rickettsiosis occurred in the municipality of Necocli Colombia, with 35% of lethality. This episode was, followed by two more, one in the municipality of Los Cordobas in 2007 with a 54% of lethality and the other one in the municipality of Turbo in 2008 with 27% of lethality. The aim of this study was to perform serological tests in healthy persons to determine the seroprevalence of antibodies against spotted fever group (SFG) rickettsiae and develop a survey to study some infection risk-related factors. A cross-sectional study was performed in 2011 and 2012. A blood sample and survey of associated factors was performed in healthy persons. A prevalence of 32%-41% was found in healthy people. From the multivariate analysis, we found that people living more than 16 years in these sites had a 79% higher risk of being seropositive and a 46% higher risk when they reported having birds in their houses if the variable of having a horse was included in the model. In conclusion, this study shows endemicity of at least one spotted fever group Rickettsia in the study zone. (C) 2017 Elsevier GmbH. All rights reserved.	[Londono, Andres F.; Acevedo-Gutierrez, Leidy Y.; Rodas, Juan D.] Univ Antioquia U A, Ctr, Grp Invest Ciencias Vet, Calle 70 52-21, Medellin, Colombia; [Marin, Diana] Univ Pontificia Bolivariana, Medellin, Colombia; [Contreras, Veronica; Mattar, Salim] Univ Cordoba, Inst Invest Biol Trop, Monteria, Colombia; [Diaz, Francisco J.] Univ Antioquia, Grp Inmunovirol, Medellin, Colombia; [Valbuena, Gustavo] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Labruna, Marcelo B.] Univ Sao Paulo, Dept Med Vet Prevent & Saude Anim, Fac Med Vet & Zootecnia, Sao Paulo, Brazil; [Hidalgo, Marylin] Pontificia Univ Javeriana, Dept Microbiol, Bogota, Colombia; [Arboleda, Margarita] ICMT CES, Inst Colombiano Med Trop, Medellin, Colombia; [Solari, Sergio] CTUA, Inst Biol, Grp Mastozool, Medellin, Colombia		Rodas, JD (corresponding author), Univ Antioquia U A, Ctr, Grp Invest Ciencias Vet, Calle 70 52-21, Medellin, Colombia.	jdavid.rodas@udea.edu.co	GONZALEZ, JUAN DAVID RODAS/AAU-7011-2020; Barbarán, Andrés Felipe Londoño/AAB-8250-2020; Hidalgo, Marylin/AAF-5736-2019; Labruna, Marcelo B/B-6241-2013; Rodas, Juan David/AAM-6382-2020	GONZALEZ, JUAN DAVID RODAS/0000-0002-7054-9918; Barbarán, Andrés Felipe Londoño/0000-0002-4703-1387; Labruna, Marcelo B/0000-0002-9675-3132; Hidalgo, Marylin/0000-0001-8960-0616; Solari, Sergio/0000-0002-7002-2200; Arboleda, Margarita/0000-0002-4939-1212; Contreras Cogollo, Veronica/0000-0001-5380-2347; Marin Pineda, Diana/0000-0002-4715-8388	Colciencias [111549326228]; Universidad de Antioquia sustainability program	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Antioquia sustainability program	We thank Colciencias for their financial support through project No. 111549326228 [Ecological study of Rickettsia endemicity in Colombia] "Estudio ecologico de endemicidad por Rickettsia en Colombia". We are also grateful with the 2013/2014 Universidad de Antioquia sustainability program for their financial support.	Acosta J., 2006, Informe Quincenal - Epidemiologico Nacional, V11, P177; Correa F. K., 2009, MONOGRAFIA DE URABA, P23; Elfving K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008572; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Guarin G. W., 2011, IMPACTO VARIABILIDAD; Hervada Vidal Xurxo, 2004, Rev. Esp. Salud Publica, V78, P277, DOI 10.1590/s1135-57272004000200013; Hidalgo M., 2007, I NAC SALUD, V12, P371; Pacheco O., 2008, INF QUINC EPIDEMIOL, V13, P145; Pacheco RC, 2012, J MED ENTOMOL, V49, P710, DOI 10.1603/ME11217; Padmanabha H, 2009, VECTOR-BORNE ZOONOT, V9, P483, DOI 10.1089/vbz.2008.0092; PATINO L., 1937, American Journal of Tropical Medicine, V17, P639; Patino-Camargo L., 1941, Boletin de la Oficina Sanitaria Panamericana, V20, P1112; Pierre-Edouard F., 2007, RICKETTSIAL DIS, P1; Pinter A, 2008, CAD SAUDE PUBLICA, V24, P247, DOI 10.1590/S0102-311X2008000200003; Quintero J., 2013, BIOMEDICA, V33, P2, DOI DOI 10.7705/BI0MEDICA.V33I0.735; Wallace JW, 2016, VECTOR-BORNE ZOONOT, V16, P302, DOI 10.1089/vbz.2015.1887	16	10	11	0	2	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1877-959X	1877-9603		TICKS TICK-BORNE DIS	Ticks Tick-Borne Dis.		2017	8	4					477	482		10.1016/j.ttbdis.2017.02.006	http://dx.doi.org/10.1016/j.ttbdis.2017.02.006			6	Infectious Diseases; Microbiology; Parasitology	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Microbiology; Parasitology	EX3LI	28223058				2022-09-04	WOS:000403133200006
J	Vargas, LFC; Torregrosa, L; Guevara, O; Pedraza, M; Carrera, JA; Villarreal, RA; Vinck, EE; Cabrera, L; Ferrada, P; Chen, H				Cabrera Vargas, Luis Felipe; Torregrosa, Lilian; Guevara, Oscar; Pedraza, Mauricio; Carrera, Javier A.; Villarreal, Ricardo A.; Vinck, Eric E.; Cabrera, Laura; Ferrada, Paula; Chen, Herbert			Low-cost devices to prevent SARS-CoV-2 infection during open and laparoscopic surgery	AMERICAN JOURNAL OF SURGERY			English	Editorial Material									[Cabrera Vargas, Luis Felipe; Torregrosa, Lilian; Guevara, Oscar; Pedraza, Mauricio] Assoc Colombiana Cirugia, Covid19 Grp, Bogota, Colombia; [Cabrera Vargas, Luis Felipe; Pedraza, Mauricio; Carrera, Javier A.; Villarreal, Ricardo A.; Vinck, Eric E.] Univ Bosque, Dept Surg, Bogota, Colombia; [Cabrera Vargas, Luis Felipe] Fdn Santa Fe Bogota, Jose Felix Patino Dept Surg, Bogota, Colombia; [Torregrosa, Lilian] Pontificia Univ Javeriana, Bogota, Colombia; [Guevara, Oscar] Univ Nacl Colombia, Dept Hepatobiliary Surg, Calle 100 14-63 502, Bogota, Colombia; [Carrera, Javier A.] Fdn Santa Fe Bogota, Dept Colorectal Surg, Ave Cra 9 131a-20, Bogota, Colombia; [Villarreal, Ricardo A.] Cobos Med Ctr, Dept Gastrointestinal Surg, Cra 7b 1230-90, Bogota, Colombia; [Vinck, Eric E.] Fdn Clin Shaio, Dept Cardiac Surg, Bogota, Colombia; [Cabrera, Laura] Univ Bosque, Dept Med, Bogota, Colombia; [Ferrada, Paula] Virginia Commonwealth Univ, Med Ctr, Dept Surg, West Hosp, 16th Floor,1200 E Broad St, Richmond, VA 23219 USA; [Chen, Herbert] Univ Alabama Birmingham, Dept Surg, 701 19th St South,LHRB 112, Birmingham, AL 35294 USA		Pedraza, M (corresponding author), Univ Bosque, Dept Gen Surg, Bogota, Colombia.	Luis.felipe.cabrera@hotmail.com; lilian.torregrosa@gmail.com; oaguevarac@yahoo.com; mpedrazac@unbosque.edu.co; carrerasiachoque@yahoo.com; rivimed73@gmail.com; evinck518@gmail.com; cabreralaura.silva@gmail.com; pferrada@mcvh-vcu.edu; hchen@uabmc.edu		Cabrera Silva, Laura Alejandra/0000-0002-5411-8632; Pedraza Ciro, Mauricio/0000-0001-8726-5578; Torregrosa Almonacid, Lilian/0000-0002-5392-7083				Al-Balas M, 2020, AM J SURG, V219, P903, DOI 10.1016/j.amjsurg.2020.04.018; Brat Gabriel A, 2020, Ann Surg, DOI 10.1097/SLA.0000000000003926; DesCoteaux JG, 1996, SURG ENDOSC-ULTRAS, V10, P152; Diaz A, 2020, AM J SURG, V219, P900, DOI 10.1016/j.amjsurg.2020.04.014; Hua Zheng Min, 2020, ANN SURG; Mintz Y, 2020, ANN SURG, V272, pE7, DOI 10.1097/SLA.0000000000003965; Mintz Y, 2020, SURG ENDOSC, V34, P3298, DOI 10.1007/s00464-020-07652-y; Morris M, 2020, AM J SURG, V220, P558, DOI 10.1016/j.amjsurg.2020.05.027; Zheng MH, 2020, ANN SURG, V272, pE5, DOI 10.1097/SLA.0000000000003924	9	0	0	0	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	JAN	2021	221	1					55	58		10.1016/j.amjsurg.2020.07.014	http://dx.doi.org/10.1016/j.amjsurg.2020.07.014			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PI3LE	32736800	Green Published, Bronze			2022-09-04	WOS:000600995200017
J	Charpak, N; Tessier, R; Ruiz, JG; Hernandez, JT; Uriza, F; Villegas, J; Nadeau, L; Mercier, C; Maheu, F; Marin, J; Cortes, D; Gallego, JM; Maldonado, D				Charpak, Nathalie; Tessier, Rejean; Ruiz, Juan G.; Tiberio Hernandez, Jose; Uriza, Felipe; Villegas, Julieta; Nadeau, Line; Mercier, Catherine; Maheu, Francoise; Marin, Jorge; Cortes, Darwin; Miguel Gallego, Juan; Maldonado, Dario			Twenty-year Follow-up of Kangaroo Mother Care Versus Traditional Care	PEDIATRICS			English	Article							LOW-BIRTH-WEIGHT; HOME-ENVIRONMENT; PRETERM; OUTCOMES; CHILDREN; INFANTS; BORN	BACKGROUND AND OBJECTIVES: Kangaroo mother care (KMC) is a multifaceted intervention for preterm and low birth weight infants and their parents. Short-and mid-term benefits of KMC on survival, neurodevelopment, breastfeeding, and the quality of mother-infant bonding were documented in a randomized controlled trial (RCT) conducted in Colombia from 1993 to 1996. The aim of the present study was to evaluate the persistence of these results in young adulthood. METHODS: From 2012 to 2014, a total of 494 (69%) of the 716 participants of the original RCT known to be alive were identified; 441 (62% of the participants in the original RCT) were re-enrolled, and results for the 264 participants weighing <= 1800 g at birth were analyzed. The KMC and control groups were compared for health status and neurologic, cognitive, and social functioning with the use of neuroimaging, neurophysiological, and behavioral tests. RESULTS: The effects of KMC at 1 year on IQ and home environment were still present 20 years later in the most fragile individuals, and KMC parents were more protective and nurturing, reflected by reduced school absenteeism and reduced hyperactivity, aggressiveness, externalization, and socio-deviant conduct of young adults. Neuroimaging showed larger volume of the left caudate nucleus in the KMC group. CONCLUSIONS: This study indicates that KMC had significant, long-lasting social and behavioral protective effects 20 years after the intervention. Coverage with this efficient and scientifically based health care intervention should be extended to the 18 million infants born each year who are candidates for the method.	[Charpak, Nathalie; Villegas, Julieta] Fdn Canguro, Calle 44b 53-50, Bogota, Colombia; [Tessier, Rejean; Nadeau, Line; Mercier, Catherine] Univ Laval, Quebec City, PQ, Canada; [Ruiz, Juan G.; Uriza, Felipe] Pontificia Univ Javeriana, Bogota, Colombia; [Ruiz, Juan G.; Uriza, Felipe] Hosp Univ San Ignacio, Bogota, Colombia; [Tiberio Hernandez, Jose; Maldonado, Dario] Univ Los Andes, Bogota, Colombia; [Maheu, Francoise] Hop St Justine, Montreal, PQ, Canada; [Marin, Jorge] Hosp Univ Infantil San Jose, Bogota, Colombia; [Cortes, Darwin; Miguel Gallego, Juan] Univ Rosario, Bogota, Colombia		Charpak, N (corresponding author), Fdn Canguro, Calle 44b 53-50, Bogota, Colombia.	ncharpak@gmail.com	Ruiz, Juan Gabriel/AAZ-5882-2021; Gallego, Juan M./F-9009-2016; Cortes, Darwin/F-5161-2016	Ruiz, Juan Gabriel/0000-0003-3088-5834; Gallego, Juan M./0000-0002-8997-1107; Mercier, Catherine/0000-0002-2037-6916; Hernandez, Jose Tiberio/0000-0002-5035-4363; Cortes, Darwin/0000-0003-2280-9452; Uriza Carrasco, Luis Felipe/0000-0002-1923-3934; Maldonado, Dario/0000-0003-3544-208X	Grand Challenges Canada; Administrative Department of Science, Technology and Innovation (COLCIENCIAS), Colombia	Grand Challenges Canada(CGIAR); Administrative Department of Science, Technology and Innovation (COLCIENCIAS), Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	Supported by Grand Challenges Canada and the Administrative Department of Science, Technology and Innovation (COLCIENCIAS), Colombia.	Aarnoudse-Moens CSH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055994; Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Achenbach TM, 2001, INTEGRATED SYSTEM MU; Angulo D, 2015, MULTIFACETED VISUAL; AYLWARD GP, 1989, J PEDIATR-US, V115, P515, DOI 10.1016/S0022-3476(89)80273-2; Aylward GP, 2005, J DEV BEHAV PEDIATR, V26, P427, DOI 10.1097/00004703-200512000-00008; Baron IS, 2011, EARLY HUM DEV, V87, P115, DOI 10.1016/j.earlhumdev.2010.11.010; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Breeman LD, 2016, J CHILD PSYCHOL PSYC, V57, P132, DOI 10.1111/jcpp.12456; Cabrera NJ, 2000, CHILD DEV, V71, P127, DOI 10.1111/1467-8624.00126; Caldwell B. M., 2003, HOME OBSERVATION MEA; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Charpak N, 2001, PEDIATRICS, V108, P1072, DOI 10.1542/peds.108.5.1072; Conners CK, 2000, CONNERS CONTINUOUS P; Donders J, 2008, ASSESSMENT, V15, P123, DOI 10.1177/1073191107310926; Garcia-Alix A, 2004, REV NEUROLOGIA, V39, P548, DOI 10.33588/rn.3906.2004074; Hille ETM, 2007, PEDIATRICS, V120, pE587, DOI 10.1542/peds.2006-2407; Holmstrom G, 1998, BRIT J OPHTHALMOL, V82, P1265, DOI 10.1136/bjo.82.11.1265; Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; Nadeau L, 2004, DEV MED CHILD NEUROL, V46, P508, DOI 10.1017/S0012162204000854; Nosarti C., 2010, NEURODEVELOPMENTAL O; Pardo M.E., 2006, REV INTERAM PSICOL, V40, P289; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rizopoulos D, 2006, J STAT SOFTW, V17; Rollins JD, 2010, J PEDIATR-US, V156, P907, DOI 10.1016/j.jpeds.2010.01.009; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Sortor JM, 2003, OPTOMETRY VISION SCI, V80, P758, DOI 10.1097/00006324-200311000-00013; Spielberger C. D., 2002, REV INT PSICOLOGIA C, V2, P51; Tarabulsy GM, 2008, AM J ORTHOPSYCHIAT, V78, P322, DOI 10.1037/a0014070; Tessier R, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.2.e17; Tessier R, 2003, INFANT BEHAV DEV, V26, P384, DOI 10.1016/S0163-6383(03)00037-7; Tessier R, 2009, ACTA PAEDIATR, V98, P1444, DOI 10.1111/j.1651-2227.2009.01370.x; Treyvaud K, 2012, J EXP CHILD PSYCHOL, V112, P326, DOI 10.1016/j.jecp.2012.02.009; UN Inter-Agency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR; Weschler D, 1999, WECHSLER ABBREVIATED	37	88	90	1	29	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JAN	2017	139	1							e20162063	10.1542/peds.2016-2063	http://dx.doi.org/10.1542/peds.2016-2063			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	EH9WI	27965377	Green Published			2022-09-04	WOS:000392122000029
J	Ramirez-Velez, R; Perez-Sousa, MA; Garcia-Hermoso, A; Zambom-Ferraresi, F; Martinez-Velilla, N; de Asteasu, MLS; Cano-Gutierrez, CA; Rincon-Pabon, D; Izquierdo, M				Ramirez-Velez, Robinson; Perez-Sousa, Miguel Angel; Garcia-Hermoso, Antonio; Zambom-Ferraresi, Fabricio; Martinez-Velilla, Nicolas; Saez de Asteasu, Mikel L.; Cano-Gutierrez, Carlos A.; Rincon-Pabon, David; Izquierdo, Mikel			Relative Handgrip Strength Diminishes the Negative Effects of Excess Adiposity on Dependence in Older Adults: A Moderation Analysis	JOURNAL OF CLINICAL MEDICINE			English	Article						fat mass; obesity; muscle strength; physical function; functional dependence	MUSCLE STRENGTH; BODY-COMPOSITION; GRIP STRENGTH; HEALTH; WOMEN; MEN; ASSOCIATION; SARCOPENIA; OBESITY; MASS	The adverse effects of fat mass on functional dependence might be attenuated or worsened, depending on the level of muscular strength. The aim of this study was to determine (i) the detrimental effect of excess adiposity on dependence in activities of daily living (ADL), and (ii) whether relative handgrip strength (HGS) moderates the adverse effect of excess adiposity on dependence, and to provide the threshold of relative HGS from which the adverse effect could be improved or worsened. A total of 4169 participants (69.3 +/- 7.0 years old) from 244 municipalities were selected following a multistage area probability sampling design. Measurements included anthropometric/adiposity markers (weight, height, body mass index, waist circumference, and waist-to-height ratio (WHtR)), HGS, sarcopenia "proxy" (calf circumference), and ADL (Barthel Index scale). Moderation analyses were performed to identify associations between the independent variable (WHtR) and outcomes (dependence), as well as to determine whether relative HGS moderates the relationship between excess adiposity and dependence. The present study demonstrated that (i) the adverse effect of having a higher WHtR level on dependence in ADL was moderated by relative HGS, and (ii) two moderation thresholds of relative HGS were estimated: 0.35, below which the adverse effect of WHtR levels on dependency is aggravated, and 0.62, above which the adverse effect of fat on dependency could be improved. Because muscular strength represents a critically important and modifiable predictor of ADL, and the increase in adiposity is inherent in aging, our results underscore the importance of an optimal level of relative HGS in the older adult population.	[Ramirez-Velez, Robinson; Garcia-Hermoso, Antonio; Zambom-Ferraresi, Fabricio; Martinez-Velilla, Nicolas; Saez de Asteasu, Mikel L.; Izquierdo, Mikel] Univ Publ Navarra, Dept Hlth Sci, Navarrabiomed Biomed Res Ctr, IDISNA Navarras Hlth Res Inst, C Irunlarrea 3,Complejo Hosp Navarra, Navarra 31008, Spain; [Perez-Sousa, Miguel Angel] Univ Huelva, Fac Sport Sci, Ave Fuerzas Armadas S-N 21007, Huelva 21004, Spain; [Garcia-Hermoso, Antonio] Univ Santiago Chile, Fac Ciencias Med, Lab Ciencias Actividad Fis Deporte & Salud, USACH, Santiago 7500618, Chile; [Zambom-Ferraresi, Fabricio; Martinez-Velilla, Nicolas; Izquierdo, Mikel] Inst Salud Carlos III, CIBER Frailty & Hlth Aging CIBERFES, Navarra 28001, Spain; [Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Hosp Univ San Ignacio Aging Inst, Bogota 110111, Colombia; [Rincon-Pabon, David] Fdn Univ Area Andina, ZIPATEFI Zona Invest Posgrad Terapia Resp & Fisio, Pereira 110231, Colombia		Ramirez-Velez, R (corresponding author), Univ Publ Navarra, Dept Hlth Sci, Navarrabiomed Biomed Res Ctr, IDISNA Navarras Hlth Res Inst, C Irunlarrea 3,Complejo Hosp Navarra, Navarra 31008, Spain.	robin640@hotmail.com; perersousa@gmail.com; antonio.garciah@unavarra.es; fabriciogigante@hotmail.com; nicolas.martinez.velilla@navarra.es; mikel.lopez.saezdeasteasu@gmail.com; ccano@javeriana.edu.co; nicheunal@hotmail.com; mikel.izquierdo@gmail.com	Zambom-Ferraresi, Fabrício/AAA-4515-2022; Ferraresi, Fabricio/M-1906-2018; Perez-Sousa, Miguel A./M-5931-2019; Izquierdo, Mikel/A-4894-2010; Garcia-Hermoso, Antonio/AGK-7815-2022; García-Hermoso, Antonio/P-1857-2017; García-Hermoso, Antonio/ADU-2591-2022; Izquierdo, Mikel/O-8049-2019; Ramirez-Velez, Robinson/D-5311-2016; Martinez-Velilla, Nicolas/A-6942-2017	Zambom-Ferraresi, Fabrício/0000-0002-8377-9827; Ferraresi, Fabricio/0000-0002-8377-9827; Perez-Sousa, Miguel A./0000-0003-4392-6850; Izquierdo, Mikel/0000-0002-1506-4272; Garcia-Hermoso, Antonio/0000-0002-1397-7182; García-Hermoso, Antonio/0000-0002-1397-7182; Izquierdo, Mikel/0000-0002-1506-4272; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Ramirez-Velez, Robinson/0000-0003-3075-6960; Martinez-Velilla, Nicolas/0000-0001-9576-9960; Saez de Asteasu, Mikel Lopez/0000-0002-4111-5045; Rincon-Pabon, David/0000-0001-9678-2382	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia [764]; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER) [PI17/01814]; Universidad Publica de Navarra [420/2019]	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER); Universidad Publica de Navarra	This study is part of a larger project that has been funded by a Colciencias y Ministerio de Salud y la Proteccion Social de Colombia (The SABE Study ID 2013, no. 764). M.I. is also funded in part by a research grant PI17/01814 of the Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER). A.G.-H. is a Miguel Servet Fellow (Instituto de Salud Carlos III-FSE-CP18/0150). R.R.-V. was funded in part by a Postdoctoral Fellowship Resolution ID 420/2019 of the Universidad Publica de Navarra.	Akhmedov D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00371; Anton SD, 2015, AGEING RES REV, V24, P304, DOI 10.1016/j.arr.2015.09.005; Atlantis E, 2008, AM J CLIN NUTR, V88, P95; Barbat-Artigas S, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.06.003; Bollinger LM, 2017, GAIT POSTURE, V56, P100, DOI 10.1016/j.gaitpost.2017.05.003; Celis-Morales CA, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1651; Choquette S, 2010, J NUTR HEALTH AGING, V14, P190, DOI 10.1007/s12603-010-0047-4; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fuggle N, 2017, BEST PRACT RES CL RH, V31, P218, DOI 10.1016/j.berh.2017.11.007; Garcia-Hermoso A, 2020, SPORTS MED, V50, P1095, DOI 10.1007/s40279-020-01259-y; Garcia-Hermoso A, 2018, ARCH PHYS MED REHAB, V99, P2100, DOI 10.1016/j.apmr.2018.01.008; Gopinath B, 2017, MATURITAS, V106, P92, DOI 10.1016/j.maturitas.2017.09.009; Harris TB, 2000, ANN NY ACAD SCI, V904, P462; Hayes AF, 2017, BEHAV RES THER, V98, P39, DOI 10.1016/j.brat.2016.11.001; Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3; Keevil VL, 2015, J NUTR HEALTH AGING, V19, P3, DOI 10.1007/s12603-014-0492-6; Kim S, 2017, INNOV AGING, V1, DOI 10.1093/geroni/igx008; Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017; McGrath R, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.01.017; McGrath RP, 2018, SPORTS MED, V48, P1993, DOI 10.1007/s40279-018-0952-y; Mlinac ME, 2016, ARCH CLIN NEUROPSYCH, V31, P506, DOI 10.1093/arclin/acw049; Morais JA, 2018, EXP GERONTOL, V108, P262, DOI 10.1016/j.exger.2018.04.025; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Park S, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1140-0; Pataky Z, 2014, OBESITY, V22, P56, DOI 10.1002/oby.20514; Ramirez-Velez R, 2020, J AM MED DIR ASSOC, V21, P434, DOI 10.1016/j.jamda.2019.12.010; Ramirez-Velez R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112654; Ramirez-Velez R, 2019, J CACHEXIA SARCOPENI, V10, P278, DOI 10.1002/jcsm.12373; Rantanen Taina, 2002, Aging Clin Exp Res, V14, P10; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Sanchez-Perez A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001925; Schaap LA, 2005, CLIN ENDOCRINOL, V63, P152, DOI 10.1111/j.1365-2265.2005.02315.x; Stevens PJ, 2012, J NUTR HEALTH AGING, V16, P769, DOI 10.1007/s12603-012-0388-2; Straight CR, 2015, AM J LIFESTYLE MED, V9, P130, DOI 10.1177/1559827613510681; Swainson MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177175; Tallis J, 2017, J APPL PHYSIOL, V122, P170, DOI 10.1152/japplphysiol.00836.2016; Tomlinson DJ, 2016, BIOGERONTOLOGY, V17, P467, DOI 10.1007/s10522-015-9626-4; de Carvalho DHT, 2019, J GERONTOL A-BIOL, V74, P1105, DOI 10.1093/gerona/gly178; Valenzuela PL, 2019, COMPR PHYSIOL, V9, P1281, DOI 10.1002/cphy.c190002; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Verghese J, 2011, J GERONTOL A-BIOL, V66, P1083, DOI 10.1093/gerona/glr099; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Wang DXM, 2020, J CACHEXIA SARCOPENI, V11, P3, DOI 10.1002/jcsm.12502; Waters DL, 2008, J GERONTOL A-BIOL, V63, P536, DOI 10.1093/gerona/63.5.536; Zembron-Lacny A, 2019, AM J MENS HEALTH, V13, DOI 10.1177/1557988319841934	47	4	4	2	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	APR	2020	9	4							1152	10.3390/jcm9041152	http://dx.doi.org/10.3390/jcm9041152			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LL8RF	32316538	Green Published, gold			2022-09-04	WOS:000531821000259
J	Baron, E; Gago-Ferrero, P; Gorga, M; Rudolph, I; Mendoza, G; Zapata, AM; Diaz-Cruz, S; Barra, R; Ocampo-Duque, W; Paez, M; Darbra, RM; Eljarrat, E; Barcelo, D				Baron, Enrique; Gago-Ferrero, Pablo; Gorga, Marina; Rudolph, Ignacio; Mendoza, Gonzalo; Mauricio Zapata, Andres; Diaz-Cruz, Silvia; Barra, Ricardo; Ocampo-Duque, William; Paez, Martha; Maria Darbra, Rosa; Eljarrat, Ethel; Barcelo, Damia			Occurrence of hydrophobic organic pollutants (BFRs and UV-filters) in sediments from South America	CHEMOSPHERE			English	Article						BFR; Chile; Colombia; Sediments; South America; UV filter	POLYBROMINATED DIPHENYL ETHERS; PRESSURIZED LIQUID EXTRACTION; BROMINATED FLAME RETARDANTS; WASTE-WATER; CHROMATOGRAPHY; SAMPLES; HEXABROMOCYCLODODECANE; IDENTIFICATION; ESTUARY; SLUDGE	In the present study the occurrence of emerging hydrophobic organic pollutants in sediment samples from South America (Chile and Colombia) was investigated for the first time. Nineteen Chilean and thirteen Colombian sediment samples were analyzed in order to determine their content of brorninated flame retardants (BFRs) (including PBDEs and emerging BFRs) as well as UV filters (UV-F). Samples were collected from neighboring aquatic ecosystems highly urbanized and industrialized in Colombia (Magdalena River area) and Chile (Biobio region). Different analytical procedures were applied depending on the selected analytes, based on chromatographic and mass spectrometric methodologies (GC-MS and LC-MS-MS). In general, concentration levels of both BFRs (up to 2.43 and 143 ng g(-1)dw of PBDEs in Chile and Colombia, respectively) and UV-F (nd-2.96 and nd-54.4 ng g(-1) dw in Chile and Colombia, respectively) were in the low range of published data, and the contribution of BFRs was higher than that of UV-F for almost all the sampled sediments. (C) 2013 Elsevier Ltd. All rights reserved.	[Baron, Enrique; Gago-Ferrero, Pablo; Gorga, Marina; Diaz-Cruz, Silvia; Eljarrat, Ethel; Barcelo, Damia] CSIC, IDAEA, Dept Environm Chem, ES-08034 Barcelona, Spain; [Rudolph, Ignacio; Mendoza, Gonzalo; Barra, Ricardo] Univ Concepcion, Environm Sci Ctr EULA Chile, Aquat Syst Res Unit, Concepcion, Chile; [Mauricio Zapata, Andres; Ocampo-Duque, William] Pontificia Univ, Javeriana Secc, Fac Engn, Cali, Colombia; [Paez, Martha] Univ Valle, Dept Chem, Cali, Colombia; [Maria Darbra, Rosa] Univ Politecn Cataluna, ETSEIB, CERTEC, Dept Chem Engn, Barcelona, Spain; [Barcelo, Damia] Univ Girona, Catalan Inst Water Res ICRA, Girona, Spain		Eljarrat, E (corresponding author), CSIC, IDAEA, Dept Environm Chem, Jordi Girona 18-26, ES-08034 Barcelona, Spain.	eeeqam@cid.csic.es	Darbra, Rosa Mari/K-4971-2014; Barón, Enrique/AAO-4807-2021; Barón, Enrique/AAG-6504-2020; BARCELO, DAMIA/O-4558-2016; Barra, Ricardo O/A-5543-2009	Darbra, Rosa Mari/0000-0003-4076-6898; Barón, Enrique/0000-0001-7461-4599; Barón, Enrique/0000-0001-7461-4599; BARCELO, DAMIA/0000-0002-8873-0491; Barra, Ricardo O/0000-0002-1567-7722; Gorga Lopez, Marina/0000-0002-4669-5392; Gago-Ferrero, Pablo/0000-0002-5987-0399; ELJARRAT, ETHEL/0000-0002-0814-6579; Diaz Cruz, Silvia/0000-0003-3331-4076	Fundacion BBVA; Spanish Ministry of Economy and Competitiveness [CGL2007-64551/HID, 2007-64551/HID) and SCARCE]; Generalitat de Catalunya (Consolidated Research Group) [2009-SGR-965]	Fundacion BBVA(BBVA Foundation); Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya (Consolidated Research Group)(Generalitat de Catalunya)	This research project was founded by the Fundacion BBVA under the BROMACUA project, and by the Spanish Ministry of Economy and Competitiveness through the projects CEMAGUA (CGL2007-64551/HID) and SCARCE (Consolider Ingenio 2010 CSD2009-00065). This work was partly supported by the Generalitat de Catalunya (Consolidated Research Group: Water and Soil Quality Unit 2009-SGR-965). The authors would like to thank Dr. Goran Marsh (Department of Environmental Chemistry, Stockholm University, Sweden) for MonoBBPA, DiBBPA, and TriBBPA standards. Waters Corporation (USA) and Isolute (Sweden) are gratefully acknowledged for providing the solid-phase extraction cartridges. The authors want also to express their gratitude to Biotage and Merck for the gift of SPE cartridges and UPLC columns, respectively.	Balmer ME, 2005, ENVIRON SCI TECHNOL, V39, P953, DOI 10.1021/es040055r; Blackman A, 2009, J ENVIRON MANAGE, V90, P101, DOI 10.1016/j.jenvman.2007.08.010; Brausch JM, 2011, CHEMOSPHERE, V82, P1518, DOI 10.1016/j.chemosphere.2010.11.018; BYERS SC, 1978, HYDROBIOLOGIA, V58, P43, DOI 10.1007/BF00018894; Christen V, 2011, AQUAT TOXICOL, V102, P167, DOI 10.1016/j.aquatox.2011.01.013; Chu SG, 2005, J CHROMATOGR A, V1097, P25, DOI 10.1016/j.chroma.2005.08.007; Connely T., 2012, BIBL C NAC CHIL; Coronado M, 2008, AQUAT TOXICOL, V90, P182, DOI 10.1016/j.aquatox.2008.08.018; de la Cal A, 2003, J CHROMATOGR A, V1021, P165, DOI 10.1016/j.chroma.2003.09.023; Dodder NG, 2012, ENVIRON TOXICOL CHEM, V31, P2239, DOI 10.1002/etc.1957; Eljarrat E, 2004, ENVIRON SCI TECHNOL, V38, P2603, DOI 10.1021/es0301424; Eljarrat E, 2004, ANAL BIOANAL CHEM, V378, P610, DOI 10.1007/s00216-003-2220-7; Eljarrat E., 2005, ORGANOHALOGEN COMPD, V67, P459; Eljarrat E, 2009, ENVIRON SCI TECHNOL, V43, P1940, DOI 10.1021/es802919e; Fent K, 2008, CHIMIA, V62, P368, DOI 10.2533/chimia.2008.368; Fent K, 2010, ENVIRON POLLUT, V158, P1817, DOI 10.1016/j.envpol.2009.11.005; Fernie KJ, 2010, ENVIRON SCI TECHNOL, V44, P3520, DOI 10.1021/es100400n; Gago-Ferrero P, 2012, ANAL BIOANAL CHEM, V404, P2597, DOI 10.1007/s00216-012-6067-7; Gago-Ferrero P, 2011, CHEMOSPHERE, V84, P1158, DOI 10.1016/j.chemosphere.2011.04.003; Gago-Ferrero P, 2011, ANAL BIOANAL CHEM, V400, P2195, DOI 10.1007/s00216-011-4951-1; Guerra P, 2008, RAPID COMMUN MASS SP, V22, P916, DOI 10.1002/rcm.3443; Hoh E, 2005, ENVIRON SCI TECHNOL, V39, P2472, DOI 10.1021/es048508f; Jakab E, 2003, J ANAL APPL PYROL, V68-9, P83, DOI 10.1016/S0165-2370(03)00075-5; Kierkegaard A, 2004, ENVIRON SCI TECHNOL, V38, P3247, DOI 10.1021/es049867d; Kierkegaard A, 2009, J CHROMATOGR A, V1216, P364, DOI 10.1016/j.chroma.2008.05.058; Law RJ, 2006, CHEMOSPHERE, V64, P187, DOI 10.1016/j.chemosphere.2005.12.007; Li WH, 2007, WATER RES, V41, P3506, DOI 10.1016/j.watres.2007.05.039; Li YY, 2012, ENVIRON POLLUT, V171, P155, DOI 10.1016/j.envpol.2012.07.039; Negreira N, 2009, ANAL CHIM ACTA, V654, P162, DOI 10.1016/j.aca.2009.09.033; Pozo K, 2011, MAR POLLUT BULL, V62, P1572, DOI 10.1016/j.marpolbul.2011.04.037; Restrepo JD, 2006, J HYDROL, V316, P213, DOI 10.1016/j.jhydrol.2005.05.002; Rodil R, 2008, ANAL CHEM, V80, P1307, DOI 10.1021/ac702240u; Schlumpf M, 2010, CHEMOSPHERE, V81, P1171, DOI 10.1016/j.chemosphere.2010.09.079; Stapleton HM, 2008, ENVIRON SCI TECHNOL, V42, P6910, DOI 10.1021/es801070p; Tarazona I, 2010, J CHROMATOGR A, V1217, P4771, DOI 10.1016/j.chroma.2010.05.047; Van Ael E, 2012, ENVIRON INT, V48, P17, DOI 10.1016/j.envint.2012.06.017; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wu MH, 2013, ENVIRON SCI POLLUT R, V20, P2651, DOI 10.1007/s11356-012-1163-y; Zenker A, 2008, J CHROMATOGR A, V1202, P64, DOI 10.1016/j.chroma.2008.06.041; Zhang ZF, 2011, ENVIRON SCI TECHNOL, V45, P3909, DOI 10.1021/es2004057	40	74	80	10	120	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	JUL	2013	92	3					309	316		10.1016/j.chemosphere.2013.03.032	http://dx.doi.org/10.1016/j.chemosphere.2013.03.032			8	Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	161VE	23602656				2022-09-04	WOS:000320220600011
J	Aliev, G; Palacios, HH; Lipsitt, AE; Fischbach, K; Lamb, BT; Obrenovich, ME; Morales, L; Gasimov, E; Bragin, V				Aliev, Gjumrakch; Palacios, Hector H.; Lipsitt, Amanda E.; Fischbach, Kathryn; Lamb, Bruce T.; Obrenovich, Mark E.; Morales, Ludis; Gasimov, Eldar; Bragin, Valentin			Nitric Oxide as an Initiator of Brain Lesions During the Development of Alzheimer Disease	NEUROTOXICITY RESEARCH			English	Review						Alzheimer disease; Nitric oxide; Mitochondria; Nitric oxide synthase; Metabolism; Oxidative stress	FOCAL CEREBRAL-ISCHEMIA; MICROVASCULAR ENDOTHELIAL-CELLS; MITOCHONDRIA DNA DELETIONS; SYNTHASE GENE-EXPRESSION; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; MONOCLONAL-ANTIBODY; VASCULAR DISORDER; CORTICAL CULTURES; CEREBELLAR CORTEX	Nitric oxide (NO) is an important regulatory molecule for the host defense that plays a fundamental role in the cardiovascular, immune, and nervous systems. NO is synthesized through the conversion of l-arginine to l-citrulline by the enzyme NO synthase (NOS), which is found in three isoforms classified as neuronal (nNOS), inducible (iNOS), and endothelial (eNOS). Recent evidence supports the theory that this bioactive molecule has an influential role in the disruption of normal brain and vascular homeostasis, a condition known to elucidate chronic hypoperfusion which ultimately causes the development of brain lesions and the pathology that typify Alzheimer disease (AD). In addition, vascular NO activity appears to be a major contributor to this pathology before any overexpression of NOS isoforms is observed in the neuron, glia, and microglia of the brain tree, where the overexpression the NOS isoforms causes the formation of a large amount of NO. We hypothesize that since an imbalance between the NOS isoforms and endothelin-1 (ET-1), a human gene that encodes for blood vessel constriction, can cause antioxidant system insufficiency; by using pharmacological intervention with NO donors and/or NO suppressors, the brain lesions and the downstream progression of brain pathology and dementia in AD should be delayed or minimized.	[Aliev, Gjumrakch; Palacios, Hector H.; Fischbach, Kathryn] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Aliev, Gjumrakch; Palacios, Hector H.; Fischbach, Kathryn] Univ Texas San Antonio, Electron Microscopy Res Ctr, San Antonio, TX 78249 USA; [Aliev, Gjumrakch; Morales, Ludis] Javeriana Univ, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia; [Aliev, Gjumrakch; Bragin, Valentin] Stress Relief & Memory Training Ctr, Brooklyn, NY USA; [Lipsitt, Amanda E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Infect Dis, San Antonio, TX 78229 USA; [Lamb, Bruce T.] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Obrenovich, Mark E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Gasimov, Eldar] Azerbaijan Med Univ, Dept Cytol Histol & Embryol, Baku, Azerbaijan		Aliev, G (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	aliev03@gmail.com	Morales, Ludis/AAZ-7053-2020; Aliev, Gjumrakch/AAE-7734-2020; Aliev, Gjumrakch/K-7302-2017	Aliev, Gjumrakch/0000-0001-7373-3182; Gasimov, Eldar/0000-0002-5104-4260; Morales-Alvarez, Ludis/0000-0002-8541-9729	Alzheimer Association; Philip Morris USA Research Management Groups	Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Philip Morris USA Research Management Groups	Supported by grants from the Alzheimer Association and Philip Morris USA Research Management Groups.	Akar CA, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-12; Aliev G, 1996, CIRC RES, V79, P317, DOI 10.1161/01.RES.79.2.317; Aliev G, 2000, ANAT REC, V260, P16, DOI 10.1002/1097-0185(20000901)260:1<16::AID-AR20>3.0.CO;2-2; Aliev G, 2003, J BIOMED BIOTECHNOL, P162; Aliev G, 2003, NEUROTOX RES, V5, P491, DOI 10.1007/BF03033159; Aliev G., 2002, Journal of Submicroscopic Cytology and Pathology, V34, P37; Aliev G, 2002, ANN NY ACAD SCI, V977, P45, DOI 10.1111/j.1749-6632.2002.tb04798.x; ALIEV G, 1993, MICROVASC RES, V46, P65, DOI 10.1006/mvre.1993.1035; Aliev G, 1998, HISTOL HISTOPATHOL, V13, P797, DOI 10.14670/HH-13.797; Aliev G, 2008, NAT CLIN PRACT CARD, V5, P590, DOI 10.1038/ncpcardio1295; Aliev G, 2002, J ALZHEIMERS DIS, V4, P513; Aliev G, 2009, J CELL MOL MED, V13, P320, DOI 10.1111/j.1582-4934.2008.00324.x; Aliyev A, 2005, J NEUROL SCI, V229, P285, DOI 10.1016/j.jns.2004.11.040; Aliyev A, 2004, NEUROL RES, V26, P547, DOI 10.1179/01610425017613; Almeida A, 1999, BRAIN RES, V816, P580, DOI 10.1016/S0006-8993(98)01240-2; Alves E, 2009, NEUROSCIENCE, V158, P514, DOI 10.1016/j.neuroscience.2008.10.041; Andresen J, 2006, J APPL PHYSIOL, V100, P318, DOI 10.1152/japplphysiol.00937.2005; Bates TE, 1996, BIOCHEM BIOPH RES CO, V218, P40, DOI 10.1006/bbrc.1996.0008; Bayraktutan U, 2003, HYPERTENS RES, V26, P749, DOI 10.1291/hypres.26.749; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; Bellien J, 2008, FUND CLIN PHARMACOL, V22, P363, DOI 10.1111/j.1472-8206.2008.00610.x; Bera S, 2009, CELL MOL BIOL LETT, V14, P481, DOI 10.2478/s11658-009-0014-4; Bogumil R, 1998, BIOCHEMISTRY-US, V37, P4791, DOI 10.1021/bi972312t; Bras-Silva Carmen, 2008, Rev Port Cardiol, V27, P925; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BUISSON A, 1992, BRIT J PHARMACOL, V106, P766, DOI 10.1111/j.1476-5381.1992.tb14410.x; BUISSON A, 1993, J NEUROCHEM, V61, P690; Cao S, 2003, J BIOL CHEM, V278, P5894, DOI 10.1074/jbc.M212546200; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; CAZEVIEILLE C, 1993, FREE RADICAL BIO MED, V14, P389, DOI 10.1016/0891-5849(93)90088-C; Crow JP, 1997, J NEUROCHEM, V69, P1945; DAWSON DA, 1994, CEREBROVAS BRAIN MET, V6, P299; Dawson VL, 1996, P SOC EXP BIOL MED, V211, P33; DAWSON VL, 1994, NEUROPHARMACOLOGY, V33, P1425, DOI 10.1016/0028-3908(94)90045-0; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; de la Torre JC, 2002, J ALZHEIMERS DIS, V4, P497, DOI 10.3233/jad-2002-4606; de la Torre JC, 2005, J CEREBR BLOOD F MET, V25, P663, DOI 10.1038/sj.jcbfm.9600057; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; de la Torre JC, 2000, BRAIN RES REV, V34, P119, DOI 10.1016/S0165-0173(00)00043-6; Di Benedetto R, 2009, NEUROCHEM INT, V54, P37, DOI 10.1016/j.neuint.2008.10.002; Fabian RH, 2008, AM J PHYSIOL-HEART C, V295, pH1809, DOI 10.1152/ajpheart.00301.2007; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; FARACI FM, 1991, AM J PHYSIOL, V261, pH1038, DOI 10.1152/ajpheart.1991.261.4.H1038; FRADE JG, 2008, HIPPOCAMPUS, DOI DOI 10.1002/HIP0.20536; Gallagher PE, 2008, AM J PHYSIOL-CELL PH, V295, pC1169, DOI 10.1152/ajpcell.00145.2008; GARTHWAITE J, 1989, NEUROSCI LETT, V107, P151, DOI 10.1016/0304-3940(89)90808-2; Gates PE, 2009, EXP PHYSIOL, V94, P311, DOI 10.1113/expphysiol.2008.043349; Gorgone G, 2009, ATHEROSCLEROSIS, V206, P309, DOI 10.1016/j.atherosclerosis.2009.02.028; HAMADA Y, 1994, PEDIATR RES, V35, P10, DOI 10.1203/00006450-199401000-00003; Hamel E, 2008, EXP PHYSIOL, V93, P116, DOI 10.1113/expphysiol.2007.038729; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Harrison David G., 2003, Cardiology Clinics, V21, P289, DOI 10.1016/S0733-8651(03)00073-0; Hernanz R, 2008, J HYPERTENS, V26, P1944, DOI 10.1097/HJH.0b013e328308de55; Hosoi T, 2009, NEUROCHEM INT, V54, P1, DOI 10.1016/j.neuint.2008.09.017; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR1153, DOI 10.1152/ajpregu.1995.268.5.R1153; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; IADECOLA C, 1992, P NATL ACAD SCI USA, V89, P3913, DOI 10.1073/pnas.89.9.3913; Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373; Kara P, 1998, PROG BRAIN RES, V118, P183; Kaur C, 2008, CURR MED CHEM, V15, P3068, DOI 10.2174/092986708786848640; Kennedy JA, 2009, EUR J PHARMACOL, V602, P28, DOI 10.1016/j.ejphar.2008.11.029; KIMOTO M, 1993, ARCH BIOCHEM BIOPHYS, V300, P657, DOI 10.1006/abbi.1993.1091; KIMOTO M, 1995, J BIOCHEM-TOKYO, V117, P237, DOI 10.1093/jb/117.2.237; Kimura C, 2004, J PHYSIOL-LONDON, V554, P721, DOI 10.1113/jphysiol.2003.057059; Kone BC, 2000, ACTA PHYSIOL SCAND, V168, P27; Kumar VBS, 2009, J CELL PHYSIOL, V219, P123, DOI 10.1002/jcp.21659; LAFONCAZAL M, 1993, NEUROPHARMACOLOGY, V32, P1259, DOI 10.1016/0028-3908(93)90020-4; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Liclican EL, 2008, AM J PHYSIOL-RENAL, V295, pF1696, DOI 10.1152/ajprenal.90502.2008; Lin Y, 2008, BASIC CLIN PHARMACOL, V103, P124, DOI 10.1111/j.1742-7843.2008.00261.x; LIU JW, 1994, J BIOL CHEM, V269, P11691; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; NAKASHIMA MN, 1995, CELL MOL NEUROBIOL, V15, P341, DOI 10.1007/BF02089944; Obrenovich ME, 2006, NEUROTOX RES, V10, P43, DOI 10.1007/BF03033333; Okada D, 2004, NEUROSCIENCE, V125, P461, DOI 10.1016/j.neuroscience.2004.01.052; PARK CS, 1994, BIOCHEM BIOPH RES CO, V205, P85, DOI 10.1006/bbrc.1994.2633; Park Y, 2008, AM J PHYSIOL-HEART C, V295, pH1982, DOI 10.1152/ajpheart.01261.2007; Patel JD, 2007, J BIOMED MATER RES A, V80A, P381, DOI 10.1002/jbm.a.30907; Peebles KC, 2008, J APPL PHYSIOL, V105, P1060, DOI 10.1152/japplphysiol.90613.2008; Radenovic L, 2005, BRAIN RES BULL, V67, P133, DOI 10.1016/j.brainresbull.2005.06.019; RADI R, 1991, J BIOL CHEM, V266, P4244; RAVICHANDRAN LV, 1995, AM J PHYSIOL-HEART C, V268, pH2216, DOI 10.1152/ajpheart.1995.268.6.H2216; Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754; Reddy PH, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/31372; RENGASAMY A, 1993, J PHARMACOL EXP THER, V267, P1024; ROBINSON LJ, 1994, GENOMICS, V19, P350, DOI 10.1006/geno.1994.1068; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; SESSA WC, 1994, J VASC RES, V31, P131, DOI 10.1159/000159039; Seyidova D, 2004, IN VIVO, V18, P325; Shin T, 2000, J Vet Sci, V1, P77; Smith MA, 1997, J NEUROSCI, V17, P2653; Smith MA, 1998, FREE RADICAL BIO MED, V25, P898, DOI 10.1016/S0891-5849(98)00119-1; SMITH MA, 1996, ALZHEIMER DIS REV, V1, P63; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Styczynska M, 2008, FOLIA NEUROPATHOL, V46, P249; Szeto HH, 2008, ANN NY ACAD SCI, V1147, P112, DOI 10.1196/annals.1427.013; Takaki A, 2008, J CARDIOVASC PHARM, V52, P510, DOI 10.1097/FJC.0b013e318190358b; Thorns V, 1998, EXP NEUROL, V150, P14, DOI 10.1006/exnr.1997.6751; Viji RI, 2009, MOL CELL BIOCHEM, V323, P91, DOI 10.1007/s11010-008-9967-2; Walsh T, 2009, J AM GERIATR SOC, V57, P140, DOI 10.1111/j.1532-5415.2008.02051.x; Wang JY, 2006, CURR PHARM DESIGN, V12, P3521, DOI 10.2174/138161206778343109; WANG Q, 1995, J CEREBR BLOOD F MET, V15, P774, DOI 10.1038/jcbfm.1995.97; Wang SM, 2009, EXP NEUROL, V216, P499, DOI 10.1016/j.expneurol.2009.01.006; Weiner MF, 2009, CURR ALZHEIMER RES, V6, P52, DOI 10.2174/156720509787313952; Wever RMF, 1998, CIRCULATION, V97, P108, DOI 10.1161/01.CIR.97.1.108; Wood CE, 2006, J SOC GYNECOL INVEST, V13, P329, DOI 10.1016/j.jsgi.2006.04.001; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Xu ZQD, 1997, J CHEM NEUROANAT, V13, P169, DOI 10.1016/S0891-0618(97)00043-4; YANAGISAWA M, 1988, J HYPERTENS, V6, pS188, DOI 10.1097/00004872-198812040-00056; Yin C, 2009, CIRC RES, V104, P572, DOI 10.1161/CIRCRESAHA.108.193250; Yin T, 2008, CELL RES, V18, P792, DOI 10.1038/cr.2008.69; Zhang YD, 2008, NEUROPEPTIDES, V42, P593, DOI 10.1016/j.npep.2008.09.005; ZOCCOLELLA S, 2009, MOV DISORD	123	74	79	1	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	OCT	2009	16	3			SI		293	305		10.1007/s12640-009-9066-5	http://dx.doi.org/10.1007/s12640-009-9066-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	484AG	19526276				2022-09-04	WOS:000269014400011
J	Lepelletier, Y; Moura, IC; Hadj-Slimane, R; Renand, A; Fiorentino, S; Baudell, C; Shirvan, A; Barzilai, A; Hermine, O				Lepelletier, Yves; Moura, Ivan Cruz; Hadj-Slimane, Reda; Renand, Amedee; Fiorentino, Susana; Baudell, Cedric; Shirvan, Anat; Barzilai, Ari; Hermine, Olivier			Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						DC; neuropilin-1; semaphorin-3A; T cells; T cell proliferation	GROWTH CONE COLLAPSE; PRIMARY IMMUNE-RESPONSE; CHICK NERVOUS-SYSTEM; DENDRITIC CELLS; SPINAL-CORD; CHEMOREPULSIVE ACTIVITY; MESSENGER-RNA; SENSORY AXONS; LYMPH-NODES; F-ACTIN	Timely negative regulation of the immune system is critical to allow it to perform its duty while maintaining it under tight control to avoid overactivation. We previously reported that the neuronal receptor neuropilin-1 (NP-1) is expressed in human lymph nodes. However, the role of NP-1 interaction with its physiological ligand semaphorin-3A (Sema-3A) on immune cells remains elusive. Here we show that Sema-3A is expressed by activated DC and T cells, and that its secretion in DC/T cell cocultures is delayed. Sema-3A/NP-1 interaction down-modulated T cell activation since addition of Sema-3A in DC/T cell cocultures dramatically inhibited allogeneic T cell proliferation. More importantly, neutralization by blocking antibodies or by antagonist peptide of endogenous Sema-3A produced by DC/T cell cocultures resulted in a 130% increase in T cell proliferation. Sema-3A acted directly on T cells, since it could block anti-CD3/CD28-stimulated proliferation of T cells. Finally, immunomodulatory functions of Sema-3A relied on the blockage of actin cytoskeleton reorganization, affecting TCR polarization and interfering with early TCR signal transduction events such as ZAP-70 or focal adhesion kinase phosphorylation. Therefore, we propose that Sema-3A secretion and the resulting NP-1/Sema-3A interaction are involved in a late negative feedback loop controlling DC-induced T cell proliferation.	Univ Paris 05, Hop Necker, CNRS, UMR 8147,Fac Med,AP Hp, F-75743 Paris 15, France; TRAGEX Pharma, Paris, France; Pontificia Univ Javeriana, Fac Ciencia, Grp Inmunobiol, Bogota, Colombia; Pontificia Univ Javeriana, Fac Ciencia, Dept Microbiol, Bogota, Colombia; Rabin Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; Rabin Med Ctr, Dept Neurol, Petah Tiqwa, Israel; Sackler Sch Med, Petah Tiqwa, Israel; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, Tel Aviv, Israel		Hermine, O (corresponding author), Univ Paris 05, Hop Necker, CNRS, UMR 8147,Fac Med,AP Hp, 161 Rue Sevres, F-75743 Paris 15, France.	hermine@necker.fr	fiorentino, susana/R-8700-2016; lepelletier, yves/AAF-1546-2020; Renand, Amedee/A-9884-2018; Moura, Ivan C/A-9510-2013; Hermine, Olivier/Q-7072-2018; Cruz Moura, Ivan/A-9510-2013	fiorentino, susana/0000-0002-4664-0682; lepelletier, yves/0000-0001-7746-5170; Renand, Amedee/0000-0003-2265-549X; Moura, Ivan C/0000-0002-2977-0354; Hermine, Olivier/0000-0003-2574-3874; Cruz Moura, Ivan/0000-0002-8418-2803				Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Caplan S, 2000, IMMUNOL TODAY, V21, P223, DOI 10.1016/S0167-5699(00)01604-2; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Fritsche J, 1999, MOL CELL NEUROSCI, V14, P398, DOI 10.1006/mcne.1999.0777; Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x; Geissmann F, 1999, J IMMUNOL, V162, P4567; Giannoni E, 2003, J BIOL CHEM, V278, P36763, DOI 10.1074/jbc.M302686200; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grohmann U, 2003, TRENDS MOL MED, V9, P133, DOI 10.1016/S1471-4914(03)00026-1; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; Jin Z, 1997, J NEUROSCI, V17, P6256; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Masuda T, 2005, NEUROSCI RES, V51, P337, DOI 10.1016/j.neures.2005.01.007; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Moura IC, 2004, BLOOD, V103, P1838, DOI 10.1182/blood-2003-07-2440; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; Shirvan A, 2002, J BIOL CHEM, V277, P49799, DOI 10.1074/jbc.M204793200; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209	53	133	145	0	6	WILEY-V C H VERLAG GMBH	WEINHEIM	PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY	0014-2980			EUR J IMMUNOL	Eur. J. Immunol.	JUL	2006	36	7					1782	1793		10.1002/eji.200535601	http://dx.doi.org/10.1002/eji.200535601			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	067HI	16791896	Bronze			2022-09-04	WOS:000239292100016
J	McKee, GB; Perrin, PB; Agudelo, YR; Plaza, SLO; Quijano-Martinez, MC; Ohayagha, C; Kuzu, D; Cariello, AN; Arango-Lasprilla, JC				McKee, Grace B.; Perrin, Paul B.; Rodriguez Agudelo, Yaneth; Olivera Plaza, Silvia Leonor; Cristina Quijano-Martinez, Maria; Ohayagha, Chimdindu; Kuzu, Duygu; Cariello, Anna N.; Carlos Arango-Lasprilla, Juan			Relationship Satisfaction and Depression After Traumatic Brain Injury An Actor-Partner Interdependence Model of Patients and Caregivers in Mexico and Colombia	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						TBI (Traumatic Brain Injury); Depressive Symptoms; Family Caregivers; Latin America	MARITAL SATISFACTION; FAMILY CAREGIVERS; SYMPTOMS; VALIDITY; SEQUELAE; OUTCOMES; PROGRAM; IMPACT; PHQ-9	Objective Traumatic brain injury represents a major public health concern, particularly in low- and middle-income countries like in Latin America. Family members are often caregivers for individuals with traumatic brain injury, which can result in significant stress. Research is needed to examine depression and quality of the caregiving relationship in these dyads. This study examined relationship quality and depression longitudinally after traumatic brain injury within the caregiving relationship. Design Dyads (N= 109) composed of individuals with traumatic brain injury and their caregivers were recruited from three hospitals in Mexico and Colombia. They self-reported depression and relationship satisfaction during hospitalization and at 2 and 4 mos after hospitalization. Results A 2-lag Actor Partner Interdependence Model demonstrated that patients and caregivers reporting high relationship satisfaction at baseline experienced lower depression 2 mos later, which then predicted higher caregiver relationship satisfaction at 4 mos. Moreover, patients with high relationship satisfaction at baseline had caregivers with lower depression at 2 mos, which was then associated with patients' higher satisfaction at 4 mos. Conclusions Within individuals with traumatic brain injury and caregivers, depression and relationship satisfaction seem to be inversely related. Furthermore, patients' and caregivers' depression and relationship satisfaction impact each other over time, demonstrating interdependence within the caregiving relationship.	[McKee, Grace B.] Cent Virginia VA Hlth Care Syst, Adv Fellowship Program Mental Illness Res & Treat, Midatlant Mental Illness Res Educ & Clin Ctr MIRE, Richmond, VA USA; [McKee, Grace B.; Perrin, Paul B.; Ohayagha, Chimdindu; Kuzu, Duygu; Cariello, Anna N.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Perrin, Paul B.] Virginia Commonweath Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Rodriguez Agudelo, Yaneth] Natl Inst Neurol & Neurosurg, Neuropsychol Dept, Mexico City, DF, Mexico; [Olivera Plaza, Silvia Leonor] Univ Colombiana, Huila, Colombia; [Cristina Quijano-Martinez, Maria] Pontificia Univ Javeriana Cali, Dept Social Sci, Cali, Colombia; [Kuzu, Duygu] Istanbul Arel Univ, Istanbul, Turkey; [Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp Barakaldo, BioCruces Bizkaia Hlth Res Inst, Bizkaia, Spain; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, Ikerbasque, Bizkaia, Spain; [Carlos Arango-Lasprilla, Juan] Univ Basque Country, Dept Cell Biol & Histol, UPV EHU, Bizkaia, Spain		Arango-Lasprilla, JC (corresponding author), Basque Fdn Sci, Grp Psicol & Salud, BioCruces Bizkaia Hlth Res Inst, Ikerbasque, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain.			McKee, Grace/0000-0001-5823-203X; Kuzu, Duygu/0000-0002-1134-1551	Fogarty International Center of the National Institutes of Health [R21TW009746]; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; Medical Research Service of the Veterans Affairs Central Virginia Health Care System; Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC)	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment(US Department of Veterans Affairs); Medical Research Service of the Veterans Affairs Central Virginia Health Care System; Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC)(US Department of Veterans Affairs)	This study was funded by Grant #R21TW009746 from Fogarty International Center of the National Institutes of Health and in part by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Medical Research Service of the Veterans Affairs Central Virginia Health Care System, and the Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC).	Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; Arrieta J, 2017, J CLIN PSYCHOL, V73, P1076, DOI 10.1002/jclp.22390; Beach SRH, 2003, J SOC PERS RELAT, V20, P355, DOI 10.1177/0265407503020003005; Blais MC, 2009, BRAIN INJURY, V19, P1223; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Friedmann MS, 1997, FAM PROCESS, V36, P357, DOI 10.1111/j.1545-5300.1997.00357.x; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Harris JKJ, 2001, BRAIN INJURY, V15, P223; HENDRICK SS, 1988, J MARRIAGE FAM, V50, P93, DOI 10.2307/352430; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kouros CD, 2008, J FAM PSYCHOL, V22, P667, DOI 10.1037/0893-3200.22.5.667; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; Meyers MO, 2017, SUCCESS ACAD SURG, P3, DOI 10.1007/978-3-319-42897-0_1; Niemann Y.F., 2004, HDB CHICANA PSYCHOL, P79; Perrin PB, 2017, J CLIN PSYCHOL, V73, P279, DOI 10.1002/jclp.22324; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Proulx CM, 2007, J MARRIAGE FAM, V69, P576, DOI 10.1111/j.1741-3737.2007.00393.x; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Santiago-Rivera AL, 2002, COUNSELING LATINOS F, V17; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Whisman MA, 2001, MARITAL AND FAMILY PROCESSES IN DEPRESSION: A SCIENTIFIC FOUNDATION FOR CLINICAL PRACTICE, P3, DOI 10.1037/10350-001; Whisman MA, 2009, PSYCHOL AGING, V24, P184, DOI 10.1037/a0014759	30	2	2	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	NOV	2020	99	11					1032	1038		10.1097/PHM.0000000000001474	http://dx.doi.org/10.1097/PHM.0000000000001474			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	NX9HP	32452881	Green Accepted			2022-09-04	WOS:000576013100016
J	Fernandez, N; Puerto, A; Azuero, A; O'Kelly, F; Hannick, J; Rickard, M; Kirsch, A; Caldamone, A; Koyle, M				Fernandez, N.; Puerto, A.; Azuero, A.; O'Kelly, F.; Hannick, J.; Rickard, M.; Kirsch, A.; Caldamone, A.; Koyle, M.			Historical bibliometric analysis of the top cited articles on vesicoureteral reflux 1950-2016, and incorporation of a novel impact index	JOURNAL OF PEDIATRIC UROLOGY			English	Article						VUR; Bibliometric analysis; Impact factor	DEXTRANOMER/HYALURONIC ACID COPOLYMER; URINARY-TRACT-INFECTION; MANAGEMENT; CHILDREN; INJECTION	Introduction and objectives Vesicoureteral reflux (VUR) has been one of the defining conditions unique to pediatric urology since its inception. The clinical implications of this disease process depend on intrinsic patient factors such as age, genetics, epigenetics, voiding habits, anatomic anomalies, and extrinsic factors such as the pathogenicity of infectious agents. Knowledge about its natural history, the implications of conservative and surgical management, and their associated outcomes have evolved dramatically over time. This study aimed to use bibliometric analyses to summarize the evolution of VUR management overtime. In order to accomplish this, the most referenced articles for VUR since 1950 were identified, and a comprehensive analysis of their impact on the management and understanding of VUR was performed by creating a novel impact index. Methods A reference search was carried out for indexed citations through the portal 'Science Citation Index' in the subsection 'Web of Science Core Collection' using 'vesicoureteral reflux' as a MeSH term. References were analyzed and subcategorized according to various subtopics. A unique impact index was developed to adjust the number of publications for the time since publication, in order to define the impact of the paper amongst the most frequently I cited papers. Articles were analyzed and data were tabulated according to the number of citations, country and institute of origin, journal of publication, impact factor, and first authorship. Results Citation counts ranged from 43 to 510, and the mean number of citations per publication was 101.43. The most discussed topic was 'treatment'. The impact index showed that more recent publications have a higher impact. The author with the highest index impact had 271 citations in a period of 5 years. The top 150 articles were published across 23 countries, the majority being from the USA (Summary fig.). The most frequently cited institution had 12 publications. The journal with the highest publication referencing rate was the Journal of Urology. Conclusion The most cited articles were valuable sources of information to describe the historical evolution of the pathophysiology and management of VUR. After adjusting for time since publication, the most recent publications (i.e. those published after 1990) had a higher impact index. Combining traditional bibliometric analysis with this novel impact index may allow researchers to optimize future literature analyses, while also assisting clinicians in understanding best practices for patient management based on the available literature. [GRAPHICS] .	[Fernandez, N.; Hannick, J.; Rickard, M.; Koyle, M.] Hosp Sick Children, Div Pediat Urol, 555 Univ Ave, Toronto, ON, Canada; [Fernandez, N.; Puerto, A.; Azuero, A.] Pontificia Univ Javeriana, Div Pediat Urol, Hosp Univ San Ignacio, Bogota, Colombia; [O'Kelly, F.] Childrens Hosp Eastern Ontario, Dept Paediat Urol, Ottawa, ON, Canada; [Kirsch, A.] Childrens Healthcare Atlanta, Dept Pediat Urol, Atlanta, GA USA; [Kirsch, A.] Emory Univ, Sch Med, Atlanta, GA USA; [Caldamone, A.] Brown Univ, Hasbro Childrens Hosp, Dept Pediat Urol, Providence, RI 02912 USA		Fernandez, N (corresponding author), Hosp Sick Children, Div Pediat Urol, 555 Univ Ave, Toronto, ON, Canada.	Nicolas.fernandez@sickkids.ca	O’Kelly, Fardod/CAF-8854-2022; Fernandez, Jose Nicolas/C-2188-2015	Fernandez, Jose Nicolas/0000-0002-9675-5963; Azuero, Andres/0000-0002-4601-8383; O'Kelly, Fardod/0000-0002-4992-7689				Beall J, 2012, NATURE, V489, P179, DOI 10.1038/489179a; Curti M, 2001, HAEMATOLOGICA, V86, P1015; Delli K, 2017, ORAL DIS, V23, P1155, DOI 10.1111/odi.12714; Duyx B, 2017, J CLIN EPIDEMIOL, pS0895; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Garfield E., 1975, CURR CONTENTS, V51, P5; Hook O, 1999, SCAND J REHABIL MED, V31, P3, DOI 10.1080/003655099444669; HUTCH J A, 1955, J Urol, V74, P607; HUTCH JA, 1952, J UROLOGY, V68, P457, DOI 10.1016/S0022-5347(17)68223-5; Kirsch AJ, 2004, J UROLOGY, V171, P2413, DOI 10.1097/01.ju.0000127754.79866.7f; Kirsch AJ, 2003, J UROLOGY, V170, P211, DOI 10.1097/01.ju.0000072523.43060.a0; Laccourreye O, 2017, EUR ANN OTORHINOLARY; Lackgren G, 2001, J UROLOGY, V166, P1887, DOI 10.1016/S0022-5347(05)65713-8; Lippi G, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.24; Lopez PJ, 2014, CURR UROL REP, V15, DOI 10.1007/s11934-014-0447-9; MATOUSCHEK E, 1981, UROLOGE A, V20, P263; Memon AR, 2018, SCI ENG ETHICS, V24, P1617, DOI 10.1007/s11948-017-9955-6; O'Kelly F, 2017, J PEDIATR UROL, V13, DOI 10.1016/j.jpurol.2017.03.027; O'Kelly F, 2015, J PEDIATR UROL, V11, DOI 10.1016/j.jpurol.2014.11.022; Page MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000035.pub2; POLITANO VA, 1958, J UROLOGY, V79, P932, DOI 10.1016/S0022-5347(17)66369-9; Puri P, 2006, J UROLOGY, V176, P1856, DOI 10.1016/j.juro.2006.03.124; Ramin S, 2012, NUCL MED REV, V15, P132; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Rosenkrantz AB, 2017, ACAD RADIOL, V24, P891, DOI 10.1016/j.acra.2016.11.019; Royle P, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-74; Shaikh N, 2010, PEDIATRICS, V126, P1084, DOI 10.1542/peds.2010-0685; Simko I, 2015, PALGR COMMUN, V1, DOI 10.1057/palcomms.2015.11; Soygur T, 1999, UROLOGY, V54, P905, DOI 10.1016/S0090-4295(99)00291-5; Sweileh WM, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0476-7; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Waltman L, 2016, J INFORMETR, V10, P365, DOI 10.1016/j.joi.2016.02.007	33	11	11	1	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1477-5131	1873-4898		J PEDIATR UROL	J. Pediatr. Urol	OCT	2018	14	5					446	+		10.1016/j.jpurol.2018.04.004	http://dx.doi.org/10.1016/j.jpurol.2018.04.004			9	Pediatrics; Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Urology & Nephrology	HB8XJ	29776870				2022-09-04	WOS:000451374800037
J	Forero, DA; Gonzalez-Giraldo, Y; Lopez-Quintero, C; Castro-Vega, LJ; Barreto, GE; Perry, G				Forero, Diego A.; Gonzalez-Giraldo, Yeimy; Lopez-Quintero, Catalina; Castro-Vega, Luis J.; Barreto, George E.; Perry, George			Telomere length in Parkinson's disease: A meta-analysis	EXPERIMENTAL GERONTOLOGY			English	Article						Movement disorders; Epigenomics; Telomeres; Parkinson's disease; Meta-analysis	SOUTHERN BLOTS; RISK	Parkinson's disease (PD) is a common and severe movement disorder. Differences in telomere length (TL) have been reported as possible risk factors for several neuropsychiatric disorders, including PD. Results from published studies for TL in PD are inconsistent, highlighting the need for a meta-analysis. In the current work, a meta-analysis of published studies for TL in PD was carried out. PubMed, Web of Science and Google Scholar databases were used to identify relevant articles that reported TL in groups of PD patients and controls. A random-effects model was used for meta-analytical procedures. The meta-analysis included eight primary studies, derived from populations of European and Asian descent, and did not show a significant difference in TL between 956 PD patients and 1284 controls (p value: 0.246). Our results show that there is no consistent evidence of shorter telomeres in PD patients and suggest the importance of future studies on TL and PD that analyze other populations and also include assessment of TL from different brain regions. (C) 2016 Elsevier Inc. All rights reserved.	[Forero, Diego A.] Univ Antonio Narino, Sch Med, Lab NeuroPsychiat Genet, Biomed Sci Res Grp, Bogota, Colombia; [Gonzalez-Giraldo, Yeimy; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Lopez-Quintero, Catalina] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Castro-Vega, Luis J.] INSERM, UMR970, Paris Cardiovasc Res Ctr, F-75015 Paris, France; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Perry, George] Univ Texas San Antonio, Coll Sci, San Antonio, TX USA		Forero, DA (corresponding author), Univ Antonio Narino, Sch Med, Lab NeuroPsychiat Genet, Bogota, Colombia.	diego.forero@uan.edu.co	Barreto, George E./AAD-7420-2020; Castro-Vega, Luis Jaime/AAO-9988-2021; González-Giraldo, Yeimy/Q-5652-2018; Barreto, George E./B-5747-2014; Castro-Vega, Luis Jaime/L-5587-2019; Forero, Diego A./O-9981-2019; Perry, George/A-8611-2009; Gonzalez, Yeimy/Y-1975-2019	Barreto, George E./0000-0002-6644-1971; Castro-Vega, Luis Jaime/0000-0002-7232-9871; González-Giraldo, Yeimy/0000-0002-2527-218X; Barreto, George E./0000-0002-6644-1971; Forero, Diego A./0000-0001-9175-3363; Perry, George/0000-0002-6547-0172; Gonzalez, Yeimy/0000-0002-2527-218X	Colciencias; VCTI-UAN [20131079, 20131080]; Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program); National Institute on Drug Abuse [T32DA021129]; Pontificia Universidad Javeriana; NIH [G12-MD007591]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA021129, K05DA015799] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); VCTI-UAN; Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Pontificia Universidad Javeriana; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	DAF is supported by research grants from Colciencias and VCTI-UAN (grants # 20131079 and 20131080). YG-G is supported by a PhD fellowship from Centro de Estudios Interdisciplinarios Basicos y Aplicados CEIBA (Rodolfo Llinas Program). CLQ is supported by the National Institute on Drug Abuse (grant # T32DA021129, PI: J. Anthony). GEB work is supported by Pontificia Universidad Javeriana. GP is supported by a NIH grant (G12-MD007591). We thank corresponding authors that contributed with additional data from primary studies that were not available in the original articles.	Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Degerman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113387; Eerola J, 2010, J GERONTOL A-BIOL, V65, P1181, DOI 10.1093/gerona/glq125; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Elbers CC, 2014, J GERONTOL A-BIOL, V69, P527, DOI 10.1093/gerona/glt121; Forero DA, 2015, DRUG ALCOHOL DEPEN, V149, P259, DOI 10.1016/j.drugalcdep.2015.01.017; Guan JZ, 2008, J GERONTOL A-BIOL, V63, P467, DOI 10.1093/gerona/63.5.467; Hudson G, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.022; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lustig Arthur J, 2015, J Cancer Epidemiol Treat, V1, P28; Maeda T, 2012, J NEUROGENET, V26, P245, DOI 10.3109/01677063.2011.651665; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Oeckl P, 2014, NEUROREPORT, V25, P335, DOI 10.1097/WNR.0000000000000099; Schurks M, 2014, EUR J NEUROL, V21, P93, DOI 10.1111/ene.12252; Verstraeten A, 2015, TRENDS GENET, V31, P140, DOI 10.1016/j.tig.2015.01.004; von Elm E, 2007, PREV MED, V45, P247, DOI [10.1016/j.ypmed.2007.08.012, 10.1371/journal.pmed.0040297, 10.1016/S0140-6736(07)61602-X, 10.2471/BLT.07.045120, 10.1016/j.jclinepi.2007.11.008, 10.1371/journal.pmed.0040296]; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867; Watfa G, 2011, J NUTR HEALTH AGING, V15, P277, DOI 10.1007/s12603-010-0275-7	20	39	40	0	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	MAR	2016	75						53	55		10.1016/j.exger.2016.01.002	http://dx.doi.org/10.1016/j.exger.2016.01.002			3	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	DC4YZ	26772888	Green Accepted			2022-09-04	WOS:000369228100009
J	Zalko, J; Frachon, S; Morel, A; Deroin, T; Espinosa, F; Xiang, KL; Wang, W; Zhang, WG; Lang, SM; Dixon, L; Pinedo-Castro, M; Jabbour, F				Zalko, Julie; Frachon, Samuel; Morel, Antoine; Deroin, Thierry; Espinosa, Felipe; Xiang, Kun-Li; Wang, Wei; Zhang, Wen-Gen; Lang, Simon; Dixon, Lara; Pinedo-Castro, Myreya; Jabbour, Florian			Floral Organogenesis and Morphogenesis of Staphisagria (Ranunculaceae): Implications for the Evolution of Synorganized Floral Structures in Delphinieae	INTERNATIONAL JOURNAL OF PLANT SCIENCES			English	Article						Delphinieae; nectar spur; perianth; petal fusion; Staphisagria; synorganization	NIGELLA-DAMASCENA RANUNCULACEAE; FLOWER DEVELOPMENT; GENETIC DIVERSITY; PETAL IDENTITY; KNOX GENES; SPUR; POLLINATION; ACONITUM; FUSION; DIVERSIFICATION	Premise of research. Floral synorganization is a structural feature of many speciose angiosperm taxa and is considered a morphological innovation paving the way for evolutionary diversification. Staphisagria is sister to the remaining Delphinieae, the only lineage of Ranunculaceae characterized by zygomorphic flowers. We aim at providing a description of floral organogenesis and morphogenesis in both Staphisagria species, presenting the disparity of Delphinieae hyperorgans in a phylogenetic framework, and proposing a scenario of likely developmental pathways underlying the different types of hyperorgans in Delphinieae. Methodology. We carried out morphological, anatomical, and developmental studies on flowers of S. macrosperma and S. picta. Pivotal results. Synorganization is complex in Staphisagria and Delphinieae as a whole and involves flower dorsoventralization, the nesting of spurs, the postgenital fusion of petals, and the formation of a shared cavity. From a choripetalous ancestor, late and partial postgenital fusion among dorsal petals evolved once or twice in the tribe. Conclusions. The Delphinieae flower includes nested spurs and nested floral parlors. These key innovations, unique in angiosperms, probably led to the diversification of this species-rich tribe in the Northern Hemisphere. The lengths of the inner (nectariferous) spurs and the nested floral parlors determine the range of pollinators able to collect nectar. These traits could be used to revise the circumscription of taxonomic groups within the tribe and should be taken into account when examining the possible coevolution between Delphinieae flowers and their pollinators. Integrating this new knowledge about the hyperorgan will be essential for future research in taxonomy, evo-devo, and pollination ecology in Delphinieae.	[Zalko, Julie; Frachon, Samuel; Morel, Antoine; Deroin, Thierry; Espinosa, Felipe; Jabbour, Florian] Sorbonne Univ, Univ Antilles, Ctr Natl Rech Sci, Inst Syst,Evolut,Biodiversite,Museum Natl Hist,Ec, CP39,57 Rue Cuvier, F-75005 Paris, France; [Xiang, Kun-Li; Wang, Wei] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Xiang, Kun-Li; Wang, Wei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Wen-Gen] Jiangxi Agr Univ, Coll Forestry, Nanchang 330045, Jiangxi, Peoples R China; [Lang, Simon] Banque Graines, Musees & Jardins Bot & Zool, Museum Natl Hist Nat, 57 Rue Cuvier, F-75005 Paris, France; [Dixon, Lara] Conservatoire Bot Natl Mediterraneen Porquerolles, 34 Ave Gambetta, F-83400 Hyeres, France; [Pinedo-Castro, Myreya] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Lab Genet Poblac Mol Biol Evolut, Carrera 7a Numero 43-82, Bogota, DC, Colombia		Jabbour, F (corresponding author), Sorbonne Univ, Univ Antilles, Ctr Natl Rech Sci, Inst Syst,Evolut,Biodiversite,Museum Natl Hist,Ec, CP39,57 Rue Cuvier, F-75005 Paris, France.	fiabbour@mnhn.fr		Zalko, Julie/0000-0001-9755-2589	MNHN ATM Blanche; Institut de Systematique, Evolution, Biodiversite at the MNHN, Paris; National Geographic Society [9989-16]	MNHN ATM Blanche; Institut de Systematique, Evolution, Biodiversite at the MNHN, Paris; National Geographic Society(National Geographic Society)	We acknowledge the MNHN seed bank and the MNHN Ecole de Systematique garden, the Plateau Technique de Microscopie Electronique (UMR 7245 CNRS/MNHN; Geraldine Toutirais), and the Conservatoire Botanique National Mediterraneen de Porquerolles. The MNHN gives access to the collections in the framework of the RECOLNAT national research infrastructure. We thank Catherine Damerval for critical input on an earlier draft of the manuscript, Guillaume Leotard for providing his master of science thesis, Sonia Yakovlev for confirming the diploidy of Staphisagria picta, Andriy Novikov for taking the pictures of the transilluminated herbarium specimens, and Eugenie Carnero-Diaz and Isabel Le Disquet for taking pictures of the anatomical sections. We also thank Julie Kang (editor) and two anonymous reviewers for their critical and helpful comments. This work was funded by the MNHN ATM Blanche and by the Institut de Systematique, Evolution, Biodiversite at the MNHN, Paris. The field trip to Malawi was funded by the National Geographic Society (grant 9989-16 to F. Jabbour).	Aboucaya A, 1989, THESIS; [Anonymous], 1959, JB AKAD WISS LIT MN, V6, P270; [Anonymous], 1984, BOT MIKROTECHNIK; Anton S, 2015, PROTOPLASMA, V252, P1587, DOI 10.1007/s00709-015-0794-5; Bosch Maria, 1997, Lagascalia, V19, P545; Box MS, 2011, PLANT J, V68, P703, DOI 10.1111/j.1365-313X.2011.04721.x; Bruneton J, 1995, PHARMACOGNOSY PHYTOC; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carrive L, 2020, BOT J LINN SOC, V194, P23, DOI 10.1093/botlinnean/boaa031; Chang HL, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8110493; Chen YY, 2018, BOT LETT, V165, P368, DOI 10.1080/23818107.2018.1427145; Chortier M, 2016, TAXON, V65, P1313, DOI 10.12705/656.6; Damerval C, 2018, BOT LETT, V165, P396, DOI 10.1080/23818107.2017.1422437; Damerval C, 2017, NEW PHYTOL, V216, P361, DOI 10.1111/nph.14401; Davis PH., 1965, NEOGENE FLORA GEORGI, V1; Deroin T, 2015, MOD PHYTOL, V7, P13; Ding BZ, 1981, FLORA HENANENSIS, V1, P431; Endress PK, 2016, ANN BOT-LONDON, V117, P749, DOI 10.1093/aob/mcv119; Endress PK, 2011, AM J BOT, V98, P370, DOI 10.3732/ajb.1000299; Endress PK, 2010, ANN MO BOT GARD, V97, P541, DOI 10.3417/2009139; Endress PK, 2010, ANN BOT-LONDON, V106, P687, DOI 10.1093/aob/mcq171; Endress PK, 2009, AM J BOT, V96, P22, DOI 10.3732/ajb.0800047; Endress PK, 2001, J EXP ZOOL, V291, P105, DOI 10.1002/jez.1063; ENDRESS PK, 1990, BIOL J LINN SOC, V39, P153, DOI 10.1111/j.1095-8312.1990.tb00509.x; ERBAR C, 1991, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V112, P417; Erbar C, 1999, FLORA, V194, P317; Espinosa F, 2017, INT J PLANT SCI, V178, P546, DOI 10.1086/692764; F Jabbour, 2020, SYSTEMATIQUE EXPLORA, P171; Golz JF, 2002, CURR BIOL, V12, P515, DOI 10.1016/S0960-9822(02)00721-2; Goncalves B, 2013, PLANT J, V76, P223, DOI 10.1111/tpj.12284; Hileman LC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0348; Hill J, 1756, BRIT HERBAL HIST PLA, P44; Hong Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171038; HOOT SB, 1991, SYST BOT, V16, P741, DOI 10.2307/2418876; Huth E., 1895, BOT JB, V20, P322, DOI DOI 10.5962/BHL.TITLE.15558; Jabbour F, 2021, FLORA, V274, DOI 10.1016/j.flora.2020.151735; Jabbour F, 2015, BOT J LINN SOC, V178, P608, DOI 10.1111/boj.12297; Jabbour F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095727; Jabbour F, 2012, INT J PLANT SCI, V173, P1036, DOI 10.1086/667613; Jabbour Florian, 2011, PhytoKeys, V7, P21, DOI 10.3897/phytokeys.7.2010; Jabbour F, 2012, MOL PHYLOGENET EVOL, V62, P928, DOI 10.1016/j.ympev.2011.12.005; Jabbour F, 2011, TAXON, V60, P1029, DOI 10.1002/tax.604007; Jabbour F, 2009, ANN BOT-LONDON, V104, P809, DOI 10.1093/aob/mcp162; Jacquemart AL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53355-3; Johnson SD, 2001, NORD J BOT, V21, P599, DOI 10.1111/j.1756-1051.2001.tb00819.x; KOSUGE K, 1988, BOT MAG TOKYO, V101, P223, DOI 10.1007/BF02488601; KOSUGE K, 1989, Journal of Japanese Botany, V64, P65; Lee JY, 2005, PLANT CELL, V17, P25, DOI 10.1105/tpc.104.026666; Leotard G, 2002, THESIS; LEPPK E. E., 1964, IOWA STATE J SCI, V39, P1; Ley AC, 2012, BOT J LINN SOC, V168, P300, DOI 10.1111/j.1095-8339.2011.01202.x; Liao H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15658-2; Liao Wanjin, 2007, Shengwu Duoyangxing, V15, P618, DOI 10.1360/biodiv.070181; MACIOR LW, 1975, AM J BOT, V62, P1009, DOI 10.2307/2442116; MALYUTIN N I, 1987, Botanicheskii Zhurnal (St. Petersburg), V72, P683; Min Y, 2019, NEW PHYTOL, V221, P1090, DOI 10.1111/nph.15406; MUNZ PA, 1967, J ARNOLD ARBORETUM, V48, P249; Orellana MR, 2008, PLANTA MES 2008 3 PO; Payer JB, 1857, TRAITE ORGANOGENIE C, P247; Phillips HR, 2020, J EXP BOT, V71, P3390, DOI 10.1093/jxb/eraa125; Preston JC, 2019, PLANT J, V100, P158, DOI 10.1111/tpj.14436; Rebocho AB, 2017, CURR BIOL, V27, P2610, DOI 10.1016/j.cub.2017.07.064; Remane A., 1952, GRUNDLAGEN NATURLICH; Orellana MR, 2009, FOLIA GEOBOT, V44, P47, DOI 10.1007/s12224-009-9028-y; Orellana MR, 2009, GENETICA, V135, P221, DOI 10.1007/s10709-008-9271-9; Ronse De Craene L.P., 2010, FLORAL DIAGRAMS AID; SALVINIPLAWEN LV, 1979, Z ZOOL SYST EVOL, V17, P10; SATTLER R, 1973, ORGANOGENESIS FLOWER; SOKOLOFF D. D, 2018, BIOL SERBICA, V40, P16; Specht CD, 2009, ANNU REV ECOL EVOL S, V40, P217, DOI 10.1146/annurev.ecolsys.110308.120203; Tison J.-M., 2014, FLORA GALLICA FLORE; VERBEKE JA, 1992, ANNU REV PLANT PHYS, V43, P583, DOI 10.1146/annurev.pp.43.060192.003055; Verlaque R, 2001, BOCCONEA, V13, P189; Vlasankova A, 2017, NEW PHYTOL, V215, P1574, DOI 10.1111/nph.14677; VOGEL S, 1969, OSTERR BOT Z, V116, P244, DOI 10.1007/BF01379625; WAGNER GP, 1989, ANNU REV ECOL SYST, V20, P51, DOI 10.1146/annurev.es.20.110189.000411; Wang LL, 2017, ECOL EVOL, V7, P541, DOI 10.1002/ece3.2636; Wang PP, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2015.188, 10.1038/NPLANTS.2015.188]; Wang W, 2013, TAXON, V62, P713, DOI 10.12705/624.10; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Xiang KL, 2017, TAXON, V66, P554, DOI 10.12705/663.3; Yant L, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2778; Yao X, 2019, NEW PHYTOL, V223, P385, DOI 10.1111/nph.15799; Zhai W, 2019, MOL PHYLOGENET EVOL, V135, P12, DOI 10.1016/j.ympev.2019.02.024; Zhang R, 2020, NEW PHYTOL, V227, P1392, DOI 10.1111/nph.16633; Zhang R, 2013, P NATL ACAD SCI USA, V110, P5074, DOI 10.1073/pnas.1219690110; Zhao L, 2012, PLANT SYST EVOL, V298, P1057, DOI 10.1007/s00606-012-0616-6; Zhao L, 2011, BOT J LINN SOC, V166, P431, DOI 10.1111/j.1095-8339.2011.01142.x	88	5	5	4	25	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	1058-5893	1537-5315		INT J PLANT SCI	Int. J. Plant Sci.	JAN 1	2021	182	1					59	70		10.1086/711471	http://dx.doi.org/10.1086/711471		JAN 2021	12	Plant Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences	PI8MC		Green Submitted			2022-09-04	WOS:000594685500001
J	Gautier, JBO; Martindale, RG; Rugeles, SJ; Hurt, RT; Taylor, B; Heyland, DK; McClave, SA				Gautier, Juan B. Ochoa; Martindale, Robert G.; Rugeles, Saul J.; Hurt, Ryan T.; Taylor, Beth; Heyland, Daren K.; McClave, Stephen A.			How Much and What Type of Protein Should a Critically Ill Patient Receive?	NUTRITION IN CLINICAL PRACTICE			English	Review						protein; anabolism; catabolism; protein sparing effect of glucose; amino acid imbalance; critical illness; nutritional support	T-CELL DYSFUNCTION; AMERICAN-SOCIETY; NUTRITION; ENERGY; ARGININE; METABOLISM; INFECTION; THERAPY; BALANCE	Protein loss, manifested as loss of muscle mass, is observed universally in all critically ill patients. Depletion of muscle mass is associated with impaired function and poor outcomes. In extreme cases, protein malnutrition is manifested by respiratory failure, lack of wound healing, and immune dysfunction. Protecting muscle loss focused initially on meeting energy requirements. The assumption was that protein was being used (through oxidation) as an energy source. In healthy individuals, small amounts of glucose (approximately 400 calories) protect muscle loss and decrease amino acid oxidation (protein-sparing effect of glucose). Despite expectations of the benefits, the high provision of energy (above basal energy requirements) through the delivery of nonprotein calories has failed to demonstrate a clear benefit at curtailing protein loss. The protein-sparing effect of glucose is not clearly observed during illness. Increasing protein delivery beyond the normal nutrition requirements (0.8 g/k/d) has been investigated as an alternative solution. Over a dozen observational studies in critically ill patients suggest that higher protein delivery is beneficial at protecting muscle mass and associated with improved outcomes (decrease in mortality). Not surprisingly, new Society of Critical Care Medicine/American Society for Parenteral and Enteral Nutrition guidelines and expert recommendations suggest higher protein delivery (>1.2 g/kg/d) for critically ill patients. This article provides an introduction to the concepts that delineate the basic principles of modern medical nutrition therapy as it relates to the goal of achieving an optimal management of protein metabolism during critical care illness, highlighting successes achieved so far but also placing significant challenges limiting our success in perspective.	[Gautier, Juan B. Ochoa] Nestle HealthCare Nutr Inc, 12 Vreeland Rd, Florham Pk, NJ 07932 USA; [Martindale, Robert G.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Rugeles, Saul J.] Pontificia Univ Javeriana, Dept Surg, Bogota, DC, Colombia; [Hurt, Ryan T.] Mayo Clin, Dept Med, Rochester, MN USA; [Taylor, Beth] Barnes Jewish Hosp, Dept Food & Nutr, St Louis, MO 63110 USA; [Heyland, Daren K.] Queens Univ, Dept Med, Kingston, ON, Canada; [McClave, Stephen A.] Univ Louisville, Dept Med, Louisville, KY 40292 USA		Gautier, JBO (corresponding author), Nestle HealthCare Nutr Inc, 12 Vreeland Rd, Florham Pk, NJ 07932 USA.; Gautier, JBO (corresponding author), Geisinger Med Ctr, Dept Crit Care Med, 12 Vreeland Rd, Florham Pk, NJ 07932 USA.	juan.ochoa@us.nestle.com	Rugeles, Saúl/AAV-9510-2020	Rugeles, Saúl/0000-0003-0401-0743; Taylor, Beth/0000-0001-6944-2809	Nestle HealthCare Nutrition, Inc.	Nestle HealthCare Nutrition, Inc.(Nestle SA)	Financial support for the publication of the supplement in which this article appears was provided by Nestle HealthCare Nutrition, Inc.	Brooks RC, 2010, OBES REV, V11, P887, DOI 10.1111/j.1467-789X.2010.00733.x; Bryk JA, 2010, J TRAUMA, V68, P843, DOI 10.1097/TA.0b013e3181b026e4; Carpenter KJ, 2006, J NUTR, V136, P1; Dickerson RN, 2014, NUTR CLIN PRACT, V29, P786, DOI 10.1177/0884533614542439; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Drover JW, 2011, J AM COLL SURGEONS, V212, P385, DOI 10.1016/j.jamcollsurg.2010.10.016; Gautier JBO, 2016, JPEN-PARENTER ENTER, V40, P302, DOI 10.1177/0148607115581376; Gautier JBO, 2013, JAMA-J AM MED ASSOC, V309, P2165, DOI 10.1001/jama.2013.4867; Hoffer LJ, 2016, JPEN-PARENTER ENTER, V40, P460, DOI 10.1177/0148607115624084; Hoffer L John, 2014, Hepatobiliary Surg Nutr, V3, P172, DOI 10.3978/j.issn.2304-3881.2014.08.03; Jensen GL, 2010, CLIN NUTR, V29, P151, DOI 10.1016/j.clnu.2009.11.010; Kalm LM, 2005, J NUTR, V135, P1347, DOI 10.1093/jn/135.6.1347; Klein CJ, 1998, J AM DIET ASSOC, V98, P795, DOI 10.1016/S0002-8223(98)00179-5; LONG CL, 1976, METABOLISM, V25, P193, DOI 10.1016/0026-0495(76)90049-4; LONG CL, 1977, AM J CLIN NUTR, V30, P1301, DOI 10.1093/ajcn/30.8.1301; LONG CL, 1976, AM J CLIN NUTR, V29, P380, DOI 10.1093/ajcn/29.4.380; Makarenkova VP, 2006, J IMMUNOL, V176, P2085, DOI 10.4049/jimmunol.176.4.2085; McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1177/0148607115621863, 10.1097/CCM.0000000000001525]; MOORE FD, 1980, JPEN-PARENTER ENTER, V4, P228, DOI 10.1177/0148607180004003228; Nelson D.L., 2012, LEHNINGER PRINCIPLES, V6; Oben J, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-10; Pedberg J.S., 2012, EXP TRANSL STROKE ME, V4, P24, DOI [10.1186/2040-7378-4-24, DOI 10.1186/2040-7378-4-24]; Popovic PJ, 2007, J NUTR, V137, p1681S, DOI 10.1093/jn/137.6.1681S; Pribis JP, 2012, JPEN-PARENTER ENTER, V36, P53, DOI 10.1177/0148607111414579; Tattevin P, 2010, J INFECT DIS, V201, P956, DOI 10.1086/650996; Wang S, 2013, CRIT CARE, V17, DOI 10.1186/cc12850; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0701-z; Zhu XM, 2014, ANN SURG, V259, P171, DOI 10.1097/SLA.0b013e31828611f8	28	17	17	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-5336	1941-2452		NUTR CLIN PRACT	Nutr. Clin. Pract.	APR	2017	32			1			6S	14S		10.1177/0884533617693609	http://dx.doi.org/10.1177/0884533617693609			9	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	ET3QZ	28388376	Bronze			2022-09-04	WOS:000400195900002
J	Fry, BG; Vidal, N; van der Weerd, L; Kochva, E; Renjifo, C				Fry, Bryan G.; Vidal, Nicolas; van der Weerd, Louise; Kochva, Elazar; Renjifo, Carnila			Evolution and diversification of the Toxicofera reptile venom system	JOURNAL OF PROTEOMICS			English	Review							AMINO-ACID-SEQUENCE; NICOTINIC ACETYLCHOLINE-RECEPTORS; PRE-SYNAPTIC NEUROTOXIN; OXYURANUS-S-SCUTELLATUS; SNAKE-VENOM; DENDROASPIS-ANGUSTICEPS; KAPPA-BUNGAROTOXIN; CRYSTAL-STRUCTURE; COBRA VENOM; BROWN SNAKE	The diversification of the reptile venom system has been an area of major research but of great controversy. In this review we examine the historical and modem-day efforts of all aspects of the venom system including dentition, glands and secreted toxins and highlight areas of future research opportunities. We use multidisciplinary techniques, including magnetic resonance imaging of venom glands through to molecular phylogenetic reconstruction of toxin evolutionary history, to illustrate the diversity within this integrated weapons system and map the timing of toxin recruitment events over the toxicoferan organismal evolutionary tree. (c) 2009 Published by Elsevier B.V.	[Fry, Bryan G.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Melbourne, Vic 3010, Australia; [Vidal, Nicolas] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR 7138, F-75005 Paris, France; [van der Weerd, Louise] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [van der Weerd, Louise] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Kochva, Elazar] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Renjifo, Carnila] Pontificia Univ Javeriana, Fac Med, Dept Physiol Sci, Bogota, Colombia		Fry, BG (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Melbourne, Vic 3010, Australia.	bgf@unimelb.edu.au	van der Weerd, Louise/B-5421-2014	van der Weerd, Louise/0000-0002-5997-2125	Australian Research Counci; Australian Government Department of Education, Science and Training/EGIDE International Science Linkages	Australian Research Counci(Australian Research Council); Australian Government Department of Education, Science and Training/EGIDE International Science Linkages(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by Australian Research Council grants to BGF and an Australian Government Department of Education, Science and Training/EGIDE International Science Linkages grant to BGF and NV.	ANTHONY J, 1955, ANN SCI NAT ZOOL, V11; Aquilina JA, 2009, PROTEINS, V75, P478, DOI 10.1002/prot.22259; Banerjee Y, 2005, J BIOL CHEM, V280, P42601, DOI 10.1074/jbc.M508987200; Barbouche R, 1998, TOXICON, V36, P1939, DOI 10.1016/S0041-0101(98)00118-4; Beaman Kent R., 2006, Smithsonian Herpetological Information Service, V136, P1; Bilgrami S, 2004, J MOL BIOL, V341, P829, DOI 10.1016/j.jmb.2004.06.048; Bogert Charles Mitchill, 1943, BULL AMER MUS NAT HIST, V81, P285; Borgheresi RAMB, 2001, TOXICON, V39, P1211, DOI 10.1016/S0041-0101(00)00265-8; Boulenger G.A., 1893, CATALOGUE SNAKES BRI, VI; BROWN AM, 1987, CIRC RES, V61, P6; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Carsi JM, 2000, TOXICON, V38, P187, DOI 10.1016/S0041-0101(99)00141-5; Carsi JM, 1999, MOL PHARMACOL, V56, P933, DOI 10.1124/mol.56.5.933; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; COPE ED, 1900, CROCODILIANS LIZARDS, P153; Correa LC, 2008, BBA-PROTEINS PROTEOM, V1784, P591, DOI 10.1016/j.bbapap.2008.01.007; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; DEMARET JP, 1990, PROTEIN ENG, V4, P171, DOI 10.1093/protein/4.2.171; DEWEILLE JR, 1991, P NATL ACAD SCI USA, V88, P2437, DOI 10.1073/pnas.88.6.2437; DRYER SE, 1983, BRAIN RES, V289, P317, DOI 10.1016/0006-8993(83)90033-1; DUBOURDIEU DJ, 1987, TOXICON, V25, P333, DOI 10.1016/0041-0101(87)90262-5; Dubovskii PV, 2005, BIOCHEM J, V387, P807, DOI 10.1042/BJ20041814; DUFTON MJ, 1984, J MOL EVOL, V20, P128, DOI 10.1007/BF02257373; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; FAURE G, 1994, EUR J BIOCHEM, V223, P161, DOI 10.1111/j.1432-1033.1994.tb18978.x; FOHLMAN J, 1979, TOXICON, V17, P170, DOI 10.1016/0041-0101(79)90296-4; FOHLMAN J, 1977, FEBS LETT, V84, P367, DOI 10.1016/0014-5793(77)80726-6; FOHLMAN J, 1976, EUR J BIOCHEM, V68, P457, DOI 10.1111/j.1432-1033.1976.tb10833.x; Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x; Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012; Froy O, 1999, J MOL EVOL, V48, P187, DOI 10.1007/PL00006457; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Fry BG, 2002, RAPID COMMUN MASS SP, V16, P600, DOI 10.1002/rcm.613; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Grant GA, 1997, BIOCHEMISTRY-US, V36, P3353, DOI 10.1021/bi9629687; Hayashi MAF, 2004, PEPTIDES, V25, P1243, DOI 10.1016/j.peptides.2004.05.010; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Jackson K, 2003, ZOOL J LINN SOC-LOND, V137, P337, DOI 10.1046/j.1096-3642.2003.00052.x; Jackson K, 2002, J MORPHOL, V252, P291, DOI 10.1002/jmor.1106; Jackson K, 2007, TOXICON, V49, P975, DOI 10.1016/j.toxicon.2007.01.007; Jackson Kate, 1995, Amphibia-Reptilia, V16, P273, DOI 10.1163/156853895X00073; JOHNSON RG, 1956, EVOLUTION, V10, P56, DOI 10.2307/2406096; JOUBERT FJ, 1979, H-S Z PHYSIOL CHEM, V360, P1075, DOI 10.1515/bchm2.1979.360.2.1075; Juarez P, 2008, MOL BIOL EVOL, V25, P2391, DOI 10.1093/molbev/msn179; Kardong K.V., 1983, Memorias do Instituto Butantan (Sao Paulo), V46, P105; KARDONG KV, 1980, AM ZOOL, V20, P269; Kardong KV, 2002, J TOXICOL-TOXIN REV, V21, P1; Keogh JS, 1998, MOL PHYLOGENET EVOL, V10, P67, DOI 10.1006/mpev.1997.0471; Kochva E., 1978, P43; KOCHVA E, 1963, ACTA ANAT, V52, P49; Kochva E., 1965, COPEIA, V147-154; KWONG PD, 1995, STRUCTURE, V3, P1109, DOI 10.1016/S0969-2126(01)00246-5; Lawson R, 2005, MOL PHYLOGENET EVOL, V37, P581, DOI 10.1016/j.ympev.2005.07.016; LIND P, 1982, EUR J BIOCHEM, V124, P441; LIND P, 1982, EUR J BIOCHEM, V128, P71; MANCHEVA I, 1987, BIOL CHEM H-S, V368, P343, DOI 10.1515/bchm3.1987.368.1.343; MARX H, 1972, Fieldiana Zoology, V63, P1; MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; Patthy L, 2003, GENETICA, V118, P217, DOI 10.1023/A:1024182432483; PAWLAK J, 2008, FASEB J; POSSANI LD, 1992, TOXICON, V30, P1343, DOI 10.1016/0041-0101(92)90511-3; Ramazanova AS, 2008, TOXICON, V51, P524, DOI 10.1016/j.toxicon.2007.11.001; RODRIGUEZITHURRALDE D, 1984, ARCH BIOL MED EXP, V17, pR173; Soares MR, 2005, TOXICON, V46, P31, DOI 10.1016/j.toxicon.2005.03.006; Souza DHF, 1999, ARCH BIOCHEM BIOPHYS, V368, P285, DOI 10.1006/abbi.1999.1287; SU MJ, 1983, TOXICON, V21, P143, DOI 10.1016/0041-0101(83)90057-0; Taub A. M., 1967, Bulletin of the American Museum of Natural History, V138, P1; TENO AM, 1990, J BIOCHEM-TOKYO, V107, P821, DOI 10.1093/oxfordjournals.jbchem.a123132; TYLER MI, 1987, BIOCHIM BIOPHYS ACTA, V915, P210, DOI 10.1016/0167-4838(87)90302-5; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vidal N, 2002, CR BIOL, V325, P987, DOI 10.1016/S1631-0691(02)01509-3; Vidal N, 2002, J TOXICOL-TOXIN REV, V21, P21, DOI 10.1081/TXR-120004740; VIDAL N, 2008, ZOOTAXA, V1945, pS1; Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001; Vidal N, 2009, CR BIOL, V332, P129, DOI 10.1016/j.crvi.2008.07.010; VILJOEN CC, 1974, J BIOL CHEM, V249, P366; Vonk FJ, 2008, NATURE, V454, P630, DOI 10.1038/nature07178; Wagstaff SC, 2008, BIOCHEM BIOPH RES CO, V365, P650, DOI 10.1016/j.bbrc.2007.11.027; WILSON HI, 1995, N-S ARCH PHARMACOL, V352, P79; Wollberg M, 1998, HERPETOL J, V8, P137; Zhu SY, 2004, PROTEINS, V54, P361, DOI 10.1002/prot.10588	88	66	68	1	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1874-3919	1876-7737		J PROTEOMICS	J. Proteomics	MAR 6	2009	72	2			SI		127	136		10.1016/j.jprot.2009.01.009	http://dx.doi.org/10.1016/j.jprot.2009.01.009			10	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	424NX	19457354				2022-09-04	WOS:000264574500002
J	Borda, MG; Castellanos-Perilla, N; Tovar-Rios, DA; Ferreira, D; Duque, G; Aarsland, D				Borda, Miguel German; Castellanos-Perilla, Nicolas; Tovar-Rios, Diego Alejandro; Ferreira, Daniel; Duque, Gustavo; Aarsland, Dag			Tongue muscle mass is associated with total grey matter and hippocampal volumes in Dementia with Lewy Bodies	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Dementia; Intramuscular fat; Muscle; Dementia with Lewy Bodies; Sarcopenia	SYSTEMIC INFLAMMATION; FAT	Background: Age-related neurodegeneration, sarcopenia, and ectopic fat accumulation are conditions with shared pathways that remain poorly understood. We have measured muscle volume and fat accumulation in masseter and tongue muscle, and aim to explore their association with the total grey matter volume using MRI in older adults recently diagnosed with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). Methods: In this cross-sectional study, people newly diagnosed with mild AD (n=33) and DLB (n=20) underwent structural head MRI. Muscle volume and intramuscular fat (iMAT) of the tongue and masseter were computed using Slice-O-Matic software for segmentation. Total grey volume and hippocampal volumetric segmentation were performed with the FreeSurfer image analysis suite version 6.0. Independent regression models were employed to analyse the associations. Results: Tongue iMAT was higher and total grey volume lower in DLB compared to AD. In the DLB group, tongue muscle was positively associated with total grey matter volume Est 0.92 (SE 0.24 p-value 0.002), left-Est 0.01 (SE 0.0028 p-value 0,002), and right-Est 0.0088 (SE 0.0027 p-value: 0.005) hippocampal volume. There were no statistically significant results for AD. Conclusion: Tongue muscle volume was positively associated with hippocampal and total grey volume in DLB. Longitudinal designs are required to explore the extent and significance of this association.	[Borda, Miguel German; Castellanos-Perilla, Nicolas; Tovar-Rios, Diego Alejandro; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [Borda, Miguel German; Castellanos-Perilla, Nicolas] Pontificia Univ Javeriana, Ageing Inst, Med Sch, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Borda, Miguel German; Tovar-Rios, Diego Alejandro] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Tovar-Rios, Diego Alejandro] Univ Valle, Sch Stat, Santiago De Cali, Colombia; [Ferreira, Daniel] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Ctr Alzheimer Res, Stockholm, Sweden; [Duque, Gustavo] Univ Melbourne, Melbourne Med Sch, Dept Med Western Hlth, Melbourne, Vic, Australia; [Duque, Gustavo] Univ Melbourne, AIMSS, Gerosci & Osteosarcopenia Res Program, Melbourne, Vic, Australia; [Aarsland, Dag] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England; [Borda, Miguel German] Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, N-4068 Stavanger, Norway; [Duque, Gustavo] Western Hlth, Melbourne, Vic, Australia		Borda, MG (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, N-4068 Stavanger, Norway.	mmborda@gmail.com	Borda, Miguel German/AHB-5593-2022; Duque, Gustavo/G-6656-2015	Borda, Miguel German/0000-0001-5832-0603; Aarsland, Dag/0000-0001-6314-216X; Duque, Gustavo/0000-0001-8126-0637	Norwegian government through hospital owner Helse Vest (Western Norway Regional Health Authority) [911973]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London	Norwegian government through hospital owner Helse Vest (Western Norway Regional Health Authority); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London(General Electric)	This work was supported by the Norwegian government through hospital owner Helse Vest (Western Norway Regional Health Authority) number 911973. It is also funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, and King's College London.	Aarsland D., 2008, FREQUENCY CASE IDENT; Addison O, 2014, J NUTR HEALTH AGING, V18, P532, DOI 10.1007/s12603-014-0019-1; Alagiakrishnan K, 2013, ARCH GERONTOL GERIAT, V56, P1, DOI 10.1016/j.archger.2012.04.011; Barcellos N, 2020, EXP GERONTOL, V142, DOI 10.1016/j.exger.2020.111124; Beeri MS, 2021, J AM GERIATR SOC, V69, P1826, DOI 10.1111/jgs.17206; Borda M. G., 2021, J GERONTOL A-BIOL; Burns JM, 2010, ARCH NEUROL-CHICAGO, V67, P428, DOI 10.1001/archneurol.2010.38; Cao Q, 2020, J ALZHEIMERS DIS, V73, P1157, DOI 10.3233/JAD-191092; Cheng ST, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0721-2; Demontiero O, 2011, EXP GERONTOL, V46, P435, DOI 10.1016/j.exger.2011.01.001; Erickson KI, 2014, NEUROBIOL AGING, V35, pS20, DOI 10.1016/j.neurobiolaging.2014.03.034; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Garcia-Cifuentes E, 2017, J FRALITY AGING, V6, P141, DOI 10.14283/jfa.2017.17; Borda MG, 2021, J ALZHEIMERS DIS, V79, P1713, DOI 10.3233/JAD-200961; Borda MG, 2020, J AM GERIATR SOC, V68, P2257, DOI 10.1111/jgs.16709; Giil LM, 2020, J ALZHEIMERS DIS, V73, P1321, DOI 10.3233/JAD-190731; Hassan EB, 2018, CALCIFIED TISSUE INT, V103, P164, DOI 10.1007/s00223-018-0412-6; Kilgour AHM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-20; King E, 2017, ALZ DIS ASSOC DIS, V31, P346, DOI 10.1097/WAD.0000000000000211; Lee H, 2021, EUR RADIOL, V31, P2956, DOI 10.1007/s00330-020-07407-2; Lee JH, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00042; Marcus Robin L, 2012, J Aging Res, V2012, P629637, DOI 10.1155/2012/629637; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Osawa Y, 2021, J GERONTOL A-BIOL, V76, P286, DOI 10.1093/gerona/glaa095; Pedersen BK, 2019, NAT REV ENDOCRINOL, V15, P383, DOI 10.1038/s41574-019-0174-x; Peng TC, 2020, CLIN NUTR, V39, P2695, DOI 10.1016/j.clnu.2019.12.014; Ponti F, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00861; Raji MA, 2005, J AM GERIATR SOC, V53, P1462, DOI 10.1111/j.1532-5415.2005.53457.x; Skogseth R, 2017, J ALZHEIMERS DIS, V59, P1139, DOI 10.3233/JAD-170274; Voevodskaya O, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00264	31	0	0	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	MAY-JUN	2022	100								104647	10.1016/j.archger.2022.104647	http://dx.doi.org/10.1016/j.archger.2022.104647			6	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	1U8VI	35134612	hybrid, Green Published			2022-09-04	WOS:000805682800025
J	Baez-Villanueva, OM; Zambrano-Bigiarini, M; Beck, HE; McNamara, I; Ribbe, L; Nauditt, A; Birkel, C; Verbist, K; Giraldo-Osorio, JD; Thinh, NX				Baez-Villanueva, Oscar M.; Zambrano-Bigiarini, Mauricio; Beck, Hylke E.; McNamara, Ian; Ribbe, Lars; Nauditt, Alexandra; Birkel, Christian; Verbist, Koen; Giraldo-Osorio, Juan Diego; Nguyen Xuan Thinh			RF-MEP: A novel Random Forest method for merging gridded precipitation products and ground-based measurements	REMOTE SENSING OF ENVIRONMENT			English	Article						Bias correction; Merging; Precipitation; Precipitation products; Random Forest; RF-MEP	RAIN-GAUGE; SATELLITE RAINFALL; PASSIVE MICROWAVE; SCALE; PERFORMANCE; VALIDATION; CHILE; RADAR; INTERPOLATION; MODELS	The accurate representation of spatio-temporal patterns of precipitation is an essential input for numerous environmental applications. However, the estimation of precipitation patterns derived solely from rain gauges is subject to large uncertainties. We present the Random Forest based MErging Procedure (RF-MEP), which combines information from ground-based measurements, state-of-the-art precipitation products, and topography-related features to improve the representation of the spatio-temporal distribution of precipitation, especially in data-scarce regions. RF-MEP is applied over Chile for 2000-2016, using daily measurements from 258 rain gauges for model training and 111 stations for validation. Two merged datasets were computed: RF-MEP3P (based on PERSIANN-CDR, ERA-Interim, and CHIRPSv2) and RF-MEP5P (which additionally includes CMORPHv1 and TRMM 3B42v7). The performances of the two merged products and those used in their computation were compared against MSWEPv2.2, which is a state-of-the-art global merged product. A validation using ground-based measurements was applied at different temporal scales using both continuous and categorical indices of performance. RF-MEP3P and RF-MEP5P outperformed all the precipitation datasets used in their computation, the products derived using other merging techniques, and generally outperformed MSWEPv2.2. The merged P products showed improvements in the linear correlation, bias, and variability of precipitation at different temporal scales, as well as in the probability of detection, the false alarm ratio, the frequency bias, and the critical success index for different precipitation intensities. RF-MEP performed well even when the training dataset was reduced to 10% of the available rain gauges. Our results suggest that RF-MEP could be successfully applied to any other region and to correct other climatological variables, assuming that ground-based data are available.	[Baez-Villanueva, Oscar M.; McNamara, Ian; Ribbe, Lars; Nauditt, Alexandra] TH Koln, Inst Technol & Resources Management Trop & Subtro, Cologne, Germany; [Baez-Villanueva, Oscar M.; Nguyen Xuan Thinh] TU Dortmund Univ, Fac Spatial Planning, Dortmund, Germany; [Zambrano-Bigiarini, Mauricio] Univ la Frontera, Dept Civil Engn, Temuco, Chile; [Zambrano-Bigiarini, Mauricio] Univ Chile, Ctr Climate & Resilience Res, Santiago, Chile; [Beck, Hylke E.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Birkel, Christian] Univ Costa Rica, Geog Dept, San Jose, Costa Rica; [Birkel, Christian] Univ Aberdeen, Northern Rivers Inst, Aberdeen, Scotland; [Verbist, Koen] UNESCO Int Hydrol Programme, Paris, France; [Giraldo-Osorio, Juan Diego] Pontificia Univ Javeriana, Bogota, Colombia		Baez-Villanueva, OM (corresponding author), TH Koln, Inst Technol & Resources Management Trop & Subtro, Cologne, Germany.; Baez-Villanueva, OM (corresponding author), TU Dortmund Univ, Fac Spatial Planning, Dortmund, Germany.	obaezvil@th-koeln.de; mauricio.zambrano@ufrontera.cl; hylke.beck@gmail.com; ian.mcnamara@th-koeln.de; lars.ribbe@th-koeln.de; alexandra.nauditt@th-koeln.de; christian.birkel@ucr.ac.cr; k.verbist@unesco.org; j.giraldoo@javeriana.edu.co; nguyen.thinh@tu-dortmund.de	Beck, Hylke/ABD-9012-2020; Zambrano-Bigiarini, Mauricio/C-7855-2012; Baez-Villanueva, Oscar Manuel/ABG-1929-2020; Giraldo-Osorio, Juan Diego/F-8969-2016	Zambrano-Bigiarini, Mauricio/0000-0002-9536-643X; Giraldo-Osorio, Juan Diego/0000-0001-6205-3341; Verbist, Koen/0000-0002-9110-0263; Ribbe, Lars/0000-0003-3052-1782; Nauditt, Alexandra/0000-0002-9780-5280	Centers for Natural Resources and Development (CNRD); Conicyt-Fondecyt [11150861]; Center for Climate and Resilience Research (CR2) [Conicyt-FONDAP 15110009]; RSE editorial team	Centers for Natural Resources and Development (CNRD); Conicyt-Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Center for Climate and Resilience Research (CR2); RSE editorial team	The authors thank the Centers for Natural Resources and Development (CNRD) Ph.D. program for their financial support to the main author. The daily RF-MEP<INF>3P</INF> will be made available upon request for 2000-2016 at a spatial resolution of 0.05 degrees. In addition, Dr. Zambrano-Bigiarini thanks Conicyt-Fondecyt 11150861 for the financial support from 2016 to 2018 and the Center for Climate and Resilience Research (CR2, Conicyt-FONDAP 15110009) for providing the rain gauge data. We particularly thank Tim R. McVicar and the three anonymous reviewers, whose constructive comments helped to improve the quality of the final manuscript. We would also like to thank the RSE editorial team for their support.	Adhikary SK, 2015, HYDROL PROCESS, V29, P2582, DOI 10.1002/hyp.10389; Alvarez-Garreton C, 2018, HYDROL EARTH SYST SC, V22, P5817, DOI 10.5194/hess-22-5817-2018; [Anonymous], PUBL COMM LAND EROSI; [Anonymous], EUR J SOIL SCI; [Anonymous], T AM GEOPHYS UNION; [Anonymous], J HYDROENVIRON RES; [Anonymous], WATER RESOUR RES; [Anonymous], 2018, RASTER GEOGRAPHIC DA; Ashouri H, 2015, B AM METEOROL SOC, V96, P69, DOI 10.1175/BAMS-D-13-00068.1; Beck HE, 2019, B AM METEOROL SOC, V100, P473, DOI 10.1175/BAMS-D-17-0138.1; Beck HE, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.214; Beck HE, 2017, HYDROL EARTH SYST SC, V21, P6201, DOI 10.5194/hess-21-6201-2017; Beck HE, 2017, HYDROL EARTH SYST SC, V21, P589, DOI 10.5194/hess-21-589-2017; Beck HE, 2016, WATER RESOUR RES, V52, P3599, DOI 10.1002/2015WR018247; Biau G, 2016, TEST-SPAIN, V25, P197, DOI 10.1007/s11749-016-0481-7; Borga M, 1997, J HYDROL, V195, P160, DOI 10.1016/S0022-1694(96)03250-7; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; BREIMAN L, 2001, MACH LEARN, V0045; Chen Y, 2014, REMOTE SENS ENVIRON, V140, P279, DOI 10.1016/j.rse.2013.08.045; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Derin Y, 2014, J HYDROMETEOROL, V15, P1498, DOI 10.1175/JHM-D-13-0191.1; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dinku T, 2007, INT J REMOTE SENS, V28, P1503, DOI 10.1080/01431160600954688; Dinku T, 2011, INT J REMOTE SENS, V32, P5965, DOI 10.1080/01431161.2010.499381; Fu Y, 2016, THEOR APPL CLIMATOL, V123, P11, DOI 10.1007/s00704-014-1339-0; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.50; Gallant JC, 2012, INT ARCH PHOTOGRAMM, V39-B4, P275; Gao YC, 2013, HYDROL EARTH SYST SC, V17, P837, DOI 10.5194/hess-17-837-2013; Gebregiorgis A, 2011, J HYDROMETEOROL, V12, P1287, DOI 10.1175/JHM-D-10-05023.1; Goudenhoofdt E, 2009, HYDROL EARTH SYST SC, V13, P195, DOI 10.5194/hess-13-195-2009; Grimes DIF, 1999, J HYDROL, V222, P93, DOI 10.1016/S0022-1694(99)00092-X; Gupta HV, 2009, J HYDROL, V377, P80, DOI 10.1016/j.jhydrol.2009.08.003; Hengl T, 2014, GSIF GLOBAL SOIL INF; Hengl T, 2018, PEERJ, V6, DOI 10.7717/peerj.5518; Hirpa FA, 2010, J APPL METEOROL CLIM, V49, P1044, DOI 10.1175/2009JAMC2298.1; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Huffman GJ, 2010, SATELLITE RAINFALL APPLICATIONS FOR SURFACE HYDROLOGY, P3, DOI 10.1007/978-90-481-2915-7_1; HUTCHINSON MF, 1995, INT J GEOGR INF SYST, V9, P385, DOI 10.1080/02693799508902045; Jaagus J, 2010, INT J CLIMATOL, V30, P705, DOI 10.1002/joc.1929; Jarvis A., 2008, HOLE FILLED SRTM GLO; Jiang SH, 2012, J HYDROL, V452, P213, DOI 10.1016/j.jhydrol.2012.05.055; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Kling H, 2012, J HYDROL, V424, P264, DOI 10.1016/j.jhydrol.2012.01.011; Li M, 2010, J HYDROL, V385, P51, DOI 10.1016/j.jhydrol.2010.01.023; Li Z, 2013, J HYDROL, V500, P157, DOI 10.1016/j.jhydrol.2013.07.023; Lievens H, 2015, REMOTE SENS ENVIRON, V168, P146, DOI 10.1016/j.rse.2015.06.025; Ly S, 2011, HYDROL EARTH SYST SC, V15, P2259, DOI 10.5194/hess-15-2259-2011; Ma YZ, 2018, J GEOPHYS RES-ATMOS, V123, P814, DOI 10.1002/2017JD026648; Maggioni V, 2018, J HYDROL, V558, P214, DOI 10.1016/j.jhydrol.2018.01.039; Baez-Villanueva OM, 2018, ATMOS RES, V213, P34, DOI 10.1016/j.atmosres.2018.05.011; Manz B, 2016, J GEOPHYS RES-ATMOS, V121, P1190, DOI 10.1002/2015JD023788; McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012; McVicar TR, 2007, J HYDROL, V338, P196, DOI 10.1016/j.jhydrol.2007.02.018; McVicar TR, 2013, OECOLOGIA, V171, P335, DOI 10.1007/s00442-012-2416-7; Montecinos A, 2003, J CLIMATE, V16, P281, DOI [10.1175/1520-0442(2003)016<0281:SOTERR>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;0281:SOTERR&gt;2.0.CO;2]; Nie SP, 2015, J GEOPHYS RES-ATMOS, V120, P8671, DOI 10.1002/2015JD023347; Oliver MA, 2014, CATENA, V113, P56, DOI 10.1016/j.catena.2013.09.006; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Prein AF, 2017, INT J CLIMATOL, V37, P305, DOI 10.1002/joc.4706; Rabiei E, 2015, J HYDROL, V522, P544, DOI 10.1016/j.jhydrol.2015.01.020; Robertson AW, 2014, EARTH PERSPECT, V1, P12, DOI [DOI 10.1186/2194-6434-1-12, 10.1186/2194-6434-1-12]; Roy MH, 2012, J NONPARAMETR STAT, V24, P993, DOI 10.1080/10485252.2012.715161; Rozante JR, 2010, WEATHER FORECAST, V25, P885, DOI 10.1175/2010WAF2222325.1; Schneider U., 2008, GLOBAL PRECIPITATION; SEO DJ, 1990, WATER RESOUR RES, V26, P469, DOI 10.1029/WR026i003p00469; Shen Y, 2014, INT J REMOTE SENS, V35, P6843, DOI 10.1080/01431161.2014.960612; Sinclair S, 2005, ATMOS SCI LETT, V6, P19, DOI 10.1002/asl.85; Sorooshian S, 2000, B AM METEOROL SOC, V81, P2035, DOI 10.1175/1520-0477(2000)081<2035:EOPSSE>2.3.CO;2; Tang L, 2014, J GEOPHYS RES-ATMOS, V119, P4546, DOI 10.1002/2013JD020933; Team R.C., 2018, R LANG ENV STAT COMP; Thiemig V, 2013, J HYDROL, V499, P324, DOI 10.1016/j.jhydrol.2013.07.012; Thiemig V, 2012, J HYDROMETEOROL, V13, P1760, DOI 10.1175/JHM-D-12-032.1; Valdes-Pineda R, 2014, J HYDROL, V519, P2538, DOI 10.1016/j.jhydrol.2014.04.016; Verbist K, 2010, J APPL METEOROL CLIM, V49, P1938, DOI 10.1175/2010JAMC2372.1; Verdin A, 2016, IEEE T GEOSCI REMOTE, V54, P2552, DOI 10.1109/TGRS.2015.2502956; Villarini G, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009214; Villarini G, 2008, ADV WATER RESOUR, V31, P1015, DOI 10.1016/j.advwatres.2008.04.007; Wang CG, 2018, J HYDROL, V564, P342, DOI 10.1016/j.jhydrol.2018.06.064; Woldemeskel FM, 2013, J HYDROL, V499, P167, DOI 10.1016/j.jhydrol.2013.06.039; Wu JH, 2008, MA COMPUT SCI ENG, P113; Xie PP, 2017, J HYDROMETEOROL, V18, P1617, DOI [10.1175/JHM-D-16-0168.1, 10.1175/jhm-d-16-0168.1]; Xie PP, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016118; Yang ZW, 2017, J GEOPHYS RES-ATMOS, V122, P5267, DOI 10.1002/2016JD026177; Zambrano-Bigiarini M., 2017, HYDROTSM TIME SERIES; Zambrano-Bigiarini M, 2018, PROC SPIE, V10782, DOI 10.1117/12.2513645; Zambrano-Bigiarini M, 2017, HYDROL EARTH SYST SC, V21, P1295, DOI 10.5194/hess-21-1295-2017; Zhao YY, 2016, REMOTE SENS ENVIRON, V183, P170, DOI 10.1016/j.rse.2016.05.016	87	53	56	24	83	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	MAR 15	2020	239								111606	10.1016/j.rse.2019.111606	http://dx.doi.org/10.1016/j.rse.2019.111606			19	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	KT0IO		hybrid			2022-09-04	WOS:000518694400006
J	Craig, JM; Carvalho, TP; Chakrabarty, P; Derouen, V; Ortega, H; Petry, P; Reis, RE; Tagliacollo, VA; Albert, JS				Craig, Jack M.; Carvalho, Tiago P.; Chakrabarty, Prosanta; Derouen, Valerie; Ortega, Hernan; Petry, Paulo; Reis, Roberto E.; Tagliacollo, Victor A.; Albert, James S.			Using community phylogenetics to assess phylogenetic structure in the Fitzcarrald region of Western Amazonia	NEOTROPICAL ICHTHYOLOGY			English	Article						Biodiversity; Biogeography; Community phylogenetics; Phylogenetic structure	RIVER-BASINS; FISH ASSEMBLAGES; MAJOR GROUPS; TELEOSTEI; BIODIVERSITY; DIVERSITY; CATFISHES; PATTERNS; HYPOPTOPOMATINAE; NEOPLECOSTOMINAE	Here we explore the use of community phylogenetics as a tool to document patterns of biodiversity in the Fitzcarrald region, a remote area in Southwestern Amazonia. For these analyses, we subdivide the region into basin-wide assemblages encompassing the headwaters of four Amazonian tributaries (Urubamba, Yurua, Purus and Las Piedras basins), and habitat types: river channels, terra firme (nonfloodplain) streams, and floodplain lakes. We present a robust, well-documented collection of fishes from the region including 272 species collected from 132 field sites over 63 field days and four years, comprising the most extensive collection of fishes from this region to date. We conduct a preliminary community phylogenetic analysis based on this collection and recover results largely statistically indistinguishable from the random expectation, with only a few instances of phylogenetic structure. Based on these results, and of those published in other recent biogeographic studies, we conclude that the Fitzcarrald fish species pool accumulated over a period of several million years, plausibly as a result of dispersal from the larger species pool of Greater Amazonia.	[Craig, Jack M.; Albert, James S.] Univ Louisiana Lafayette, Dept Biol, 300 E St Mary Blvd, Lafayette, LA 70504 USA; [Carvalho, Tiago P.] Pontificia Univ Javeriana, Dept Biol, Unidad Ecol & Sistemat UNESIS, Carrera 7 43-82, Bogota, DC, Colombia; [Chakrabarty, Prosanta; Derouen, Valerie] Louisiana State Univ, Museum Nat Sci, 119 Foster Hall, Baton Rouge, LA 70803 USA; [Chakrabarty, Prosanta; Derouen, Valerie] Louisiana State Univ, Dept Biol Sci, 119 Foster Hall, Baton Rouge, LA 70803 USA; [Ortega, Hernan] Univ Nacl Mayor San Marcos, Museo Hist Nat, Av Arenales 1256, Lima, Peru; [Petry, Paulo] Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA; [Petry, Paulo] Nature Conservancy, Arlington Cty, VA USA; [Reis, Roberto E.] Pontificia Univ Catolica Rio Grande do Sul, PUCRS, Av Ipiranga 6681, BR-90619900 Porto Alegre, RS, Brazil; [Tagliacollo, Victor A.] Univ Sao Paulo, Museu Zool, Av Nazare 481, BR-04263000 Sao Paulo, SP, Brazil		Craig, JM (corresponding author), Univ Louisiana Lafayette, Dept Biol, 300 E St Mary Blvd, Lafayette, LA 70504 USA.	jack.m.craig@gmail.com; pitiago@javeriana.edu.co; prosanta@lsu.edu; vderou1@lsu.edu; hortega.musm@gmail.com; ppetry@tnc.org; reis@pucrs.br; vatagliacollo@gmail.com; jalbert@louisiana.edu	Tagliacollo, Victor A/C-9798-2012; Reis, Roberto/A-7030-2012; Chakrabarty, Prosanta/E-3307-2010	Tagliacollo, Victor A/0000-0003-1493-9409; Reis, Roberto/0000-0003-3746-6894; Petry, Paulo/0000-0003-1104-5709; Carvalho, Tiago/0000-0001-5901-1634; Chakrabarty, Prosanta/0000-0003-0565-0312; Albert, James/0000-0001-5477-1749	United States National Science Foundation [0741450, 1354511]; CNPq [306455/2014-5]; FAPESP [2018/20806-3]	United States National Science Foundation(National Science Foundation (NSF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We thank Maria Aldea, Julio Araujo, Junior Chuctaya, Isabel Corahua, Jessica Espino, Steven Ivanyisky, Fernando Jerep, Emmanuel Maxime, Diana Lopez, Edson Pereira, Blanca Rengifo, Giannina Trevejo, and Roberto Quispe for assistance and comradery in the field, and Jon Armbruster, Maxwell Bernt, William Crampton, Michael Goulding, Damian Green, Lesley Kim, Nathan Lujan, John Lundberg, Hernan Lopez-Fernandez, William Pearse, Diogo Provete, Brandon Waltz, Peter van der Sleen, and Kirk Winemiller for discussions and comments on the manuscript. Thanks to A. Urbano-Bonilla for proofreading the abstract in Spanish. This work was undertaken with support from United States National Science Foundation awards 0741450 to J.S.A., P.P., and R.E.R, and 1354511 to P.C. and J.S.A. R.E.R. is partially funded by CNPq (process #306455/2014-5). VAT is supported by FAPESP (process #2018/20806-3).	Abreu JMS, 2019, NEOTROP ICHTHYOL, V17, DOI 10.1590/1982-0224-20180156; Albert J.S., 2001, MISCELLANEOUS PUBLIC, V190, P1; Albert JS, 2006, J S AM EARTH SCI, V21, P14, DOI 10.1016/j.jsames.2005.07.010; Albert JS, 2011, ANIMALS-BASEL, V1, P205, DOI 10.3390/ani1020205; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert JS, 2012, FISHES FITZCARRALD P; Amador L, 2019, ECOL EVOL, V9, P11040, DOI 10.1002/ece3.5593; Araujo-Lima C, 1997, SO FRUITFUL FISH ECO; Arrington DA, 2005, OECOLOGIA, V144, P157, DOI 10.1007/s00442-005-0014-7; Barfknecht DF, 2020, PLANT ECOL, V221, P167, DOI 10.1007/s11258-020-01002-7; BARTHEM R, 1997, CATFISH CONNECTION; Belmaker J, 2008, ECOLOGY, V89, P2829, DOI 10.1890/07-1464.1; Betancur-R R, 2013, PLOS CURR, V5, P1, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Bloom DD, 2017, J BIOGEOGR, V44, P1927, DOI 10.1111/jbi.12954; Bower LM, 2019, ECOL EVOL, V9, P13862, DOI 10.1002/ece3.5823; Caldas FLS, 2019, COPEIA, V107, P567, DOI 10.1643/CH-18-109; Caley MJ, 1997, ECOLOGY, V78, P70; Carvalho Tiago P., 2012, Check List, V8, P973; Carvalho Tiago P., 2011, Check List, V7, P413; Carvalho Tiago P., 2009, Check List, V5, P673; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chiachio MC, 2008, MOL PHYLOGENET EVOL, V49, P606, DOI 10.1016/j.ympev.2008.08.013; Craig JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224599; Cramer CA, 2011, MOL PHYLOGENET EVOL, V59, P43, DOI 10.1016/j.ympev.2011.01.002; Crampton WGR, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P165; Dagosta FCP, 2019, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090.431.1.1; de Pinna Mario C.C., 1998, P279; de Souza LS, 2012, CYBIUM, V36, P31; Dexter KG, 2017, P NATL ACAD SCI USA, V114, P2645, DOI 10.1073/pnas.1613655114; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Espurt N, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P89; Ewers RM, 2013, ECOL LETT, V16, P1221, DOI 10.1111/ele.12160; Floeter SR, 2018, BIOL REV, V93, P131, DOI 10.1111/brv.12336; Garcia-Navas V, 2019, ORG DIVERS EVOL, V19, P637, DOI 10.1007/s13127-019-00411-5; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; Hawkins BA, 2014, J BIOGEOGR, V41, P23, DOI 10.1111/jbi.12171; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kennedy JD, 2017, EVOLUTION, V71, P38, DOI 10.1111/evo.13080; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leprieur F, 2016, ECOGRAPHY, V39, P825, DOI 10.1111/ecog.01638; Lessard JP, 2009, ECOLOGY, V90, P2664, DOI 10.1890/09-0503.1; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Losos JB, 1996, ECOLOGY, V77, P1344, DOI 10.2307/2265532; Lovejoy NR, 2010, MOL PHYLOGENET EVOL, V54, P278, DOI 10.1016/j.ympev.2009.09.017; Lujan NK, 2013, J BIOGEOGR, V40, P1715, DOI 10.1111/jbi.12131; Lujan NK, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-124; Lundberg John G., 1998, P13; Mirande JM, 2009, CLADISTICS, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Marki PZ, 2015, EVOLUTION, V69, P1874, DOI 10.1111/evo.12695; Mastrogianni A, 2019, FOREST ECOL MANAG, V446, P226, DOI 10.1016/j.foreco.2019.05.044; Melo BF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00107; Mendonca FP, 2005, COPEIA, P751, DOI 10.1643/0045-8511(2005)005[0751:RBHCAF]2.0.CO;2; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1554/0014-3820(2001)055[0561:POOTRO]2.0.CO;2; Oberdorff T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav8681; Orti G, 1997, SYST BIOL, V46, P75, DOI 10.2307/2413637; Palumbi Stephen R., 1996, P205; Paradis Emmanuel, 2019, Bioinformatics, V35, P526, DOI 10.1093/bioinformatics/bty633; Pearse W.D., 2014, MODERN PHYLOGENETIC, P451; Pearse WD, 2019, GLOBAL ECOL BIOGEOGR, V28, P1499, DOI 10.1111/geb.12938; Pearse WD, 2013, ECOLOGY, V94, P2861, DOI 10.1890/12-1676.1; Picq S, 2014, J BIOGEOGR, V41, P1520, DOI 10.1111/jbi.12309; Pugedo ML, 2016, GENETICA, V144, P341, DOI 10.1007/s10709-016-9903-4; Qin TJ, 2020, PLANT BIOLOGY, V22, P591, DOI 10.1111/plb.13101; Rambaut A., 2018, FIGTREE TREE FIGURE; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Roa-Fuentes CA, 2015, NEOTROP ICHTHYOL, V13, P165, DOI 10.1590/1982-0224-20140045; Roxo FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105564; Santorelli S, 2014, ECOL EVOL, V4, P2146, DOI 10.1002/ece3.1026; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Schaefer S, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P259; Stewart DJ, 2002, COPEIA, P333; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Sullivan JP, 2013, P ACAD NAT SCI PHILA, V162, P89, DOI 10.1635/053.162.0106; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Tagliacollo VA, 2016, MOL PHYLOGENET EVOL, V95, P20, DOI 10.1016/j.ympev.2015.11.007; Tagliacollo VA, 2015, J BIOGEOGR, V42, P2349, DOI 10.1111/jbi.12594; Team RDC, 2020, R A LANGUAGE ENV STA; Thomaz AT, 2015, J BIOGEOGR, V42, P2389, DOI 10.1111/jbi.12597; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Van der Sleen P, 2017, FIELD GUIDE FISHES A, DOI [10.1111/faf.12317, DOI 10.1111/FAF.12317]; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; Westoby M, 1998, ECOLOGY, V79, P1825, DOI 10.1890/0012-9658(1998)079[1825:TRBLAR]2.0.CO;2; Willis SC, 2010, MOL ECOL, V19, P1014, DOI 10.1111/j.1365-294X.2010.04540.x; Zheng Y, 2019, ECOL EVOL, V9, P13320, DOI 10.1002/ece3.5787; 2011, HIST BIOG NEOTR, P1	90	3	4	1	2	SOC BRASILEIRA ICTIOLOGIA	SAO PAULO	UNIV SAO PAULO, DEPT FISIOLOGIA-IB, RUA DO MATAO, TRAVESSA 14 N 321, SAO PAULO, SP 05508-900, BRAZIL	1679-6225			NEOTROP ICHTHYOL	Neotrop. Ichthyol.		2020	18	2							200004	10.1590/1982-0224-2020-0004	http://dx.doi.org/10.1590/1982-0224-2020-0004			16	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	MH3UK		gold, Green Published			2022-09-04	WOS:000546658300001
J	Areiza-Mazo, N; Robles, J; Zamudio-Rodriguez, JA; Giraldez, L; Echeverria, V; Barrera-Bailon, B; Aliev, G; Sahebkar, A; Ashraf, GM; Barreto, GE				Areiza-Mazo, Natalia; Robles, Jorge; Zamudio-Rodriguez, Jairo A.; Giraldez, Lisandro; Echeverria, Valentina; Barrera-Bailon, Biviana; Aliev, Gjumrakch; Sahebkar, Amirhossein; Ashraf, Ghufam Md; Barreto, George E.			Extracts of Physalis peruviana Protect Astrocytic Cells Under Oxidative Stress With Rotenone	FRONTIERS IN CHEMISTRY			English	Article						Physalis peruviana; uchuva; phenolics; astrocytes; oxidative stress; rotenone	ANTIINFLAMMATORY ACTIVITY; IN-VITRO; NEURODEGENERATIVE DISEASES; ANTIOXIDANT CAPACITY; BRAIN-INJURY; SUCROSE ESTERS; T98G CELLS; FRUIT; RATS; L.	The use of medicinal plants to counteract the oxidative damage in neurodegenerative diseases has steadily increased over the last few years. However, the rationale for using these natural compounds and their therapeutic benefit are not well explored. In this study, we evaluated the effect of different Physalis peruviana extracts on astrocytic cells (T98G) subjected to oxidative damage induced by rotenone. Extracts of fresh and dehydrated fruits of the plant with different polarities were prepared and tested in vitro. Our results demonstrated that the ethanolic extract of fresh fruits (EF) and acetone-dehydrated fruit extract (AD) increased cell viability, reduced the formation of reactive oxygen species (ROS) and preserved mitochondrial membrane potential. In contrast, we observed a significant reduction in mitochondrial mass when rotenone-treated cells were co-treated with EF and AD. These effects were accompanied by a reduction in the percentage of cells with fragmented/condensed nuclei and increased expression of endogenous antioxidant defense survival proteins such as ERK1/2. In conclusion, our findings suggest that ethanolic and acetone extracts from P. peruviana are potential medicinal plant extracts to overcome oxidative damage induced by neurotoxic compounds.	[Areiza-Mazo, Natalia; Zamudio-Rodriguez, Jairo A.; Barrera-Bailon, Biviana; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Robles, Jorge] Pontificia Univ Javeriana, Fac Ciencias, Dept Quim, Bogota, Colombia; [Giraldez, Lisandro] Univ Estadual Sudoeste Bahia, Dept Quim & Exatas, Jequie, Brazil; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Concepcion, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA USA; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran; [Ashraf, Ghufam Md] King Abdulaziz Univ, King Fand Med Res Ctr, Jeddah, Saudi Arabia		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.	gesbarreto@gmail.com	Rodriguez, Jairo Alberto Zamudio/AAQ-7186-2021; Sahebkar, Amirhossein/B-5124-2018; Ashraf, Ghulam Md/H-9485-2012; Valentina Echeverria Moran, BCh/E-7765-2013; Robles-Camargo, Jorge/AAF-6768-2019; Barreto, George E./AAD-7420-2020; Aliev, Gjumrakch/K-7302-2017; Aliev, Gjumrakch/AAE-7734-2020; Barrera-Bailon, Biviana/K-6107-2017	Rodriguez, Jairo Alberto Zamudio/0000-0003-3412-8320; Ashraf, Ghulam Md/0000-0002-9820-2078; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Robles-Camargo, Jorge/0000-0002-6782-5619; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Barrera-Bailon, Biviana/0000-0001-8607-5174	Pontificia Universidad Javeriana, Bogota, Colombia; Colciencias by the Young Researchers program	Pontificia Universidad Javeriana, Bogota, Colombia; Colciencias by the Young Researchers program	This work was supported by the Pontificia Universidad Javeriana, Bogota, Colombia, and Colciencias by the Young Researchers program.	Moneim AEA, 2014, BIOL TRACE ELEM RES, V160, P392, DOI 10.1007/s12011-014-0066-9; Abeti R, 2015, PHARMACOL RES, V99, P377, DOI 10.1016/j.phrs.2015.05.007; Akinrinmade O, 2017, ACTA NEUROBIOL EXP, V77, P94, DOI 10.21307/ane-2017-040; Al-Olayan E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/381413; Amri Z, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1842-9; [Anonymous], 2013, ASSAY GUIDANCE MANUA; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bernal CA, 2018, CARBOHYD RES, V461, P4, DOI 10.1016/j.carres.2018.03.003; Blach-Olszewska Z, 2015, CURR PHARM DESIGN, V21, P3582, DOI 10.2174/1381612821666150710144829; Bornsek SM, 2012, FOOD CHEM, V134, P1878, DOI 10.1016/j.foodchem.2012.03.092; Brewer GJ, 2010, J NUTR BIOCHEM, V21, P991, DOI 10.1016/j.jnutbio.2009.08.005; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cortés Díaz G. M, 2015, Ciencia en Desarrollo, V6, P87; Cui K, 2004, PROG NEURO-PSYCHOPH, V28, P771, DOI 10.1016/j.pnpbp.2004.05.023; Debnath T, 2011, FOOD CHEM, V128, P697, DOI 10.1016/j.foodchem.2011.03.090; Denzer I, 2016, PHARMACOL RES, V103, P80, DOI 10.1016/j.phrs.2015.11.019; Dkhil MA, 2014, FOOD CHEM TOXICOL, V74, P98, DOI 10.1016/j.fct.2014.09.013; Echeverria V, 2017, CURR MED CHEM, V24, P411, DOI 10.2174/0929867323666161101140908; Essa MM, 2012, NEUROCHEM RES, V37, P1829, DOI 10.1007/s11064-012-0799-9; Etzbach L, 2018, FOOD CHEM, V245, P508, DOI 10.1016/j.foodchem.2017.10.120; Faria A, 2005, J AGR FOOD CHEM, V53, P6896, DOI 10.1021/jf0511300; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Forbes-Hernandez TY, 2016, CRIT REV FOOD SCI, V56, pS46, DOI 10.1080/10408398.2015.1051919; Fortalezas S, 2010, NUTRIENTS, V2, P214, DOI 10.3390/nu2020214; Franco LA, 2014, PLANTA MED, V80, P1605, DOI 10.1055/s-0034-1383192; Garzon D, 2016, J MOL NEUROSCI, V58, P483, DOI 10.1007/s12031-016-0719-6; Gasiorowski K, 2018, MOL NEUROBIOL, V55, P1463, DOI 10.1007/s12035-017-0419-4; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147; Hassanien MFR, 2011, FOOD REV INT, V27, P259, DOI 10.1080/87559129.2011.563391; Horn R. C., 2015, Journal of Agricultural Science (Toronto), V7, P137, DOI 10.5539/jas.v7n12p137; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Jeong HR, 2013, J MED FOOD, V16, P968, DOI 10.1089/jmf.2013.2881; Kim HG, 2010, BRIT J NUTR, V104, P8, DOI 10.1017/S0007114510000218; Kolosova NG, 2006, NEUROBIOL AGING, V27, P1289, DOI 10.1016/j.neurobiolaging.2005.07.022; Lan YH, 2009, FOOD CHEM, V116, P462, DOI 10.1016/j.foodchem.2009.02.061; LEE HY, 2017, BMC COMPLEM ALTERN M, V17; Li B., 2013, INT J FOOD NUTR SAF, V3, P15; Limusa S.A, 1979, METODOS INVESTIGACIO; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Martinez W, 2010, IMMUNOPHARM IMMUNOT, V32, P63, DOI [10.3109/08923970903143957, 10.1080/08923970903143957]; Mena P, 2012, FOOD CHEM, V133, P108, DOI 10.1016/j.foodchem.2011.12.079; Moneim AEA, 2016, TOXICOL IND HEALTH, V32, P1064, DOI 10.1177/0748233714545502; Nones J, 2010, NEUROCHEM RES, V35, P955, DOI 10.1007/s11064-010-0144-0; Oviedo-Solis CI, 2017, FOOD SCI NUTR, V5, P1004, DOI 10.1002/fsn3.487; Paiva CN, 2014, ANTIOXID REDOX SIGN, V20, P1000, DOI 10.1089/ars.2013.5447; Parrado-Fernandez C, 2016, BBA-MOL BASIS DIS, V1862, P2110, DOI 10.1016/j.bbadis.2016.08.002; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Queiroz M, 2017, FITOTERAPIA, V120, P146, DOI 10.1016/j.fitote.2017.06.010; Ramadan MF, 2011, FOOD RES INT, V44, P1830, DOI 10.1016/j.foodres.2010.12.042; Rendeiro C, 2015, NEUROCHEM INT, V89, P126, DOI 10.1016/j.neuint.2015.08.002; Rodriguez-Amaya DB, 2010, J FOOD COMPOS ANAL, V23, P726, DOI 10.1016/j.jfca.2010.03.008; Ruszkiewicz J, 2015, NEUROCHEM INT, V88, P66, DOI 10.1016/j.neuint.2014.12.012; Sang-Ngern M, 2016, BIOORG MED CHEM LETT, V26, P2755, DOI 10.1016/j.bmcl.2016.04.077; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sheikha KM., 2015, PACIFIC SCI REV NATU, V17, P103, DOI DOI 10.1016/J.PSRA.2016.02.002; Spencer JPE, 2008, BRIT J NUTR, V99, pES60, DOI 10.1017/S0007114508965776; Subash S, 2014, NEURAL REGEN RES, V9, P1557, DOI 10.4103/1673-5374.139483; Swarnkar S, 2012, ARCH TOXICOL, V86, P1387, DOI 10.1007/s00204-012-0853-z; Tang Y, 2015, J ETHNOPHARMACOL, V169, P18, DOI 10.1016/j.jep.2015.04.003; Tavares L, 2013, EUR J NUTR, V52, P225, DOI 10.1007/s00394-012-0307-7; Toro RM, 2014, NAT PROD COMMUN, V9, P1573; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Vauzour D, 2008, GENES NUTR, V3, P115, DOI 10.1007/s12263-008-0091-4; Vepsalainen S, 2013, J NUTR BIOCHEM, V24, P360, DOI 10.1016/j.jnutbio.2012.07.006; Vuong T, 2010, BRIT J NUTR, V104, P656, DOI 10.1017/S0007114510001170; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Xu YM, 2017, J NAT PROD, V80, P1981, DOI 10.1021/acs.jnatprod.6b01129; Yen CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-46; Yildiz G, 2015, J FOOD SCI TECH MYS, V52, P2320, DOI 10.1007/s13197-014-1280-3	77	14	15	1	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2646			FRONT CHEM	Front. Chem.	JUL 20	2018	6								276	10.3389/fchem.2018.00276	http://dx.doi.org/10.3389/fchem.2018.00276			13	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	GN7YO	30175092	Green Published, gold			2022-09-04	WOS:000439366800001
J	Ferrari, GLD; Kovalskys, I; Fisberg, M; Gomez, G; Rigotti, A; Cortes, LY; Yepez, MC; Pareja, RG; Herrera-Cuenca, M; Zimberg, IZ; Guajardo, V; Pratt, M; Pires, C; Sole, D				de Moraes Ferrari, Gerson Luis; Kovalskys, Irina; Fisberg, Mauro; Gomez, Georgina; Rigotti, Attilio; Yadira Cortes, Lilia; Cecilia Yepez, Martha; Pareja, Rossina G.; Herrera-Cuenca, Marianella; Zimberg, Iona Z.; Guajardo, Viviana; Pratt, Michael; Pires, Carlos; Sole, Dirceu			Epidemiology Of Self-reported Physical Activity In Eight Latin American Countries: Findings From Elans Study	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Meeting Abstract	Annual Meeting of the American-College-of-Sports-Medicine (ACSM)	MAY 29-JUN 02, 2018	Minneapolis, MN	Amer Coll Sports Med					[de Moraes Ferrari, Gerson Luis] CELAFISCS UNIFESP, Itu, Brazil; [Kovalskys, Irina; Guajardo, Viviana] Int Life Sci Inst, Buenos Aires, DF, Argentina; [Fisberg, Mauro; Zimberg, Iona Z.; Sole, Dirceu] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Gomez, Georgina] Univ Costa Rica, San Jose, Costa Rica; [Rigotti, Attilio] Dept Nutr Diabet & Metab, Santiago, Chile; [Yadira Cortes, Lilia] Pontificia Univ Javeriana, Bogota, Colombia; [Cecilia Yepez, Martha] Univ San Francisco Quito, Quito, Ecuador; [Pareja, Rossina G.] Inst Invest Nutr, Lima, Peru; [Herrera-Cuenca, Marianella] Univ Cent Venezuela, Caracas, Venezuela; [Pratt, Michael] Hubert Dept Global Hlth, Atlanta, GA USA; [Pires, Carlos] Univ Tras Os Montes & Alto Douro, Ctr Math 13, Vila Real, Portugal				Cortes, Lilia Yadira/AAF-2960-2019; Gomez, Georgina/AAR-7272-2020; Pires, Carlos/N-9271-2014; Solé, Dirceu/D-7789-2013; Fisberg, Mauro/E-7149-2010; Ferrari, Gerson/ABG-6635-2021	Gomez, Georgina/0000-0003-3514-2984; Pires, Carlos/0000-0001-9190-1119; Fisberg, Mauro/0000-0003-2992-3215; Ferrari, Gerson/0000-0003-3177-6576; Kovalskys, Irina/0000-0001-8481-5415					0	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	MAY	2018	50	5		1		892	204	204						1	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Sport Sciences	HJ0RR					2022-09-04	WOS:000456870500630
J	Dzyurkevich, MS; Babkov, DA; Shtyrlin, NV; Mayka, OY; Iksanova, AG; Vassiliev, PM; Balakin, KV; Spasov, AA; Tarasov, VV; Barreto, G; Shtyrlin, YG; Aliev, G				Dzyurkevich, Mikhail S.; Babkov, Denis A.; Shtyrlin, Nikita V.; Mayka, Olga Yu.; Iksanova, Alfiya G.; Vassiliev, Pavel M.; Balakin, Konstantin V.; Spasov, Alexander A.; Tarasov, Vadim V.; Barreto, George; Shtyrlin, Yurii G.; Aliev, Gjumrakch			Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus	SCIENTIFIC REPORTS			English	Article							GLUCOSE	Glucokinase is one of the promising targets for glucose-lowering agents, and the development of GK activators are now considered as one of the most promising strategies for the treatment of type 2 diabetes mellitus. In this work, a series of novel symmetric molecular constructs, in which two pyridoxine moieties are connected via sulfur-containing linkers, have been synthesized and tested in vitro for glucokinase activation potential. The enzyme activation rates by two most active compounds at 100 mu M (similar to 150% and 130%) were comparable to that of the reference agent PF-04937319 (similar to 154%). Both leading compounds demonstrated low cytotoxicity and excellent safety profile in acute toxicity experiment in rats after oral administration with LD50 exceeding 2000 mg/kg of body weight. Binding mode of the active compounds in comparison with the reference agent was studied using molecular docking. The leading compounds represent viable preclinical candidates for the treatment of type 2 diabetes mellitus, as well as a promising starting point for the design of structural analogs with improved activity.	[Dzyurkevich, Mikhail S.; Shtyrlin, Nikita V.; Iksanova, Alfiya G.; Balakin, Konstantin V.; Shtyrlin, Yurii G.] Kazan Volga Reg Fed Univ, Kremlyovskaya 18, Kazan 420008, Russia; [Babkov, Denis A.; Mayka, Olga Yu.; Vassiliev, Pavel M.; Spasov, Alexander A.] Volgograd State Med Univ, Pavshikh Bortsov Sq 1, Volgograd 400131, Russia; [Balakin, Konstantin V.] IM Sechenov First Moscow State Med Univ, Trubetskaya St 8,Bld 2, Moscow 119991, Russia; [Tarasov, Vadim V.] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, Moscow 119991, Russia; [Barreto, George] Pontificia Univ Javeriana, Fac Ciencias, Depto Nutr & Bioquim, Bogota, Colombia; [Barreto, George] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res & Consulting LLC, 7733 Louis Pasteur Dr Suite 328, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, E Johns Crossing 175, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia		Aliev, G (corresponding author), GALLY Int Biomed Res & Consulting LLC, 7733 Louis Pasteur Dr Suite 328, San Antonio, TX 78229 USA.; Aliev, G (corresponding author), Univ Atlanta, Sch Hlth Sci & Healthcare Adm, E Johns Crossing 175, Johns Creek, GA 30097 USA.; Aliev, G (corresponding author), Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia.	aliev03@gmail.com	Aliev, Gjumrakch/AAE-7734-2020; Shtyrlin, Nikita V/K-5872-2017; Iksanova, Alfiya/E-9523-2014; Spasov, Alexander A/D-9417-2016; Iksanova, Alfiya/ABA-3656-2020; Dzyurkevich, Mikhail/K-5915-2017; Aliev, Gjumrakch/K-7302-2017; Vassiliev, Pavel M/R-9283-2016; Babkov, Denis/B-6502-2017; Barreto, George E./AAD-7420-2020; Shtyrlin, Yurii/K-5856-2017	Aliev, Gjumrakch/0000-0001-7373-3182; Shtyrlin, Nikita V/0000-0001-7926-5121; Iksanova, Alfiya/0000-0003-0474-6638; Spasov, Alexander A/0000-0002-7185-4826; Iksanova, Alfiya/0000-0003-0474-6638; Vassiliev, Pavel M/0000-0002-8188-5052; Babkov, Denis/0000-0002-9645-3324; Barreto, George E./0000-0002-6644-1971; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994; Shtyrlin, Yurii/0000-0002-2777-719X	Russian Government Program of Competitive Growth of Kazan Federal University	Russian Government Program of Competitive Growth of Kazan Federal University	The work was carried out according to Russian Government Program of Competitive Growth of Kazan Federal University and the RF State task No 115042410204 "Search for new activators of glucokinase and study of their action in streptozotocin-nicotinamide model of diabetes mellitus."	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Amin NB, 2015, DIABETES OBES METAB, V17, P751, DOI 10.1111/dom.12474; [Anonymous], 2016, GLOBAL REPORT DIABET; Cheruvallath ZS, 2013, BIOORG MED CHEM LETT, V23, P2166, DOI 10.1016/j.bmcl.2013.01.093; Filipski KJ, 2012, PHARM PAT ANAL, V1, P301, DOI [10.4155/ppa.12.26, 10.4155/PPA.12.26]; Gonzalez-Reyes RE, 2016, CURR PHARM DESIGN, V22, P812, DOI 10.2174/1381612822666151209152013; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Jurado-Coronel JC, 2016, CNS NEUROL DISORD-DR, V15, P292, DOI 10.2174/1871527315666160202125519; Kanthlal S. K., 2014, RES J PHARM, V8, P6; Katz L, 2016, DIABETES OBES METAB, V18, P191, DOI 10.1111/dom.12586; Maksimov ML, 2016, CURR PHARM DESIGN, V22, P895, DOI 10.2174/1381612822666151209153047; Matschinsky FM, 2010, F1000 MED REP, V2; Pugachev MV, 2013, BIOORGAN MED CHEM, V21, P4388, DOI 10.1016/j.bmc.2013.04.051; Rittie L, 2005, METH MOLEC MED, V117, P83; Shtyrlin NV, 2010, RUSS J ORG CHEM+, V46, P561, DOI 10.1134/S1070428010040202; Shtyrlin NV, 2009, RUSS J ORG CHEM+, V45, P1266, DOI 10.1134/S1070428009080314; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vassiliev P. M., 2016, TARGET ORIENTED SEAR, P126; Xu HR, 2016, DRUG DES DEV THER, V10, P1619, DOI 10.2147/DDDT.S105021; Zelent B, 2011, BIOCHEM J, V440, P203, DOI 10.1042/BJ20110440; Zhi JG, 2016, J CLIN PHARMACOL, V56, DOI 10.1002/jcph.589	21	9	10	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 22	2017	7								16072	10.1038/s41598-017-16405-2	http://dx.doi.org/10.1038/s41598-017-16405-2			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN6JG	29167582	gold, Green Published			2022-09-04	WOS:000416119600005
J	Noguera, MC; Schwegler, A; Gomes, V; Briceno, I; Alvarez, L; Uricoechea, D; Amorim, A; Benavides, E; Silvera, C; Charris, M; Bernal, JE; Gusmao, L				Claudia Noguera, Maria; Schwegler, Armin; Gomes, Veronica; Briceno, Ignacio; Alvarez, Luis; Uricoechea, Daniel; Amorim, Antonio; Benavides, Escilda; Silvera, Carlos; Charris, Marlon; Bernal, Jaime E.; Gusmao, Leonor			Colombia's racial crucible: Y chromosome evidence from six admixed communities in the Department of Bolivar	ANNALS OF HUMAN BIOLOGY			English	Article						African ancestry; Colombia; male lineages; palenque; population genetics; Y-SNP haplogroups	MATERNAL LINEAGES; GUINEA-BISSAU; POPULATION; VERDE; DIVERSITY; ORIGIN; LEGACY; DNA	Objectives: To determine the African, European and Native-American paternal contributions in genetic samples from the Department of Bolivar (Colombia) with the aims of establishing (1) possible population substructures, and (2) the proportion of biological African heritage in admixed populations of European, Amerindian, and African descent. Methods: Y-SNPs were typed in samples from six communities, including Palenque (renowned for its African linguistic and cultural heritage). Results: Findings reveal a high diversity of Y-haplogroups. With the exception of Palenque, the sum of European male lineages uniformly exceeded 57%. In Palenque, African lineages accounted for 57.7% of its chromosomes, with European male lineages constituting a mere 38.5%. In Pinillos, a significant proportion (23.8%) of the chromosomes belongs to the Native American haplogroup Q1a3a*-M3. Genetic differentiation analyses reveal significant divergences in most pairwise comparisons among the Bolivar municipalities, and the same holds between Bolivar and other South American populations. Conclusions: Heterogeneous patterns of admixture reveal a genetic substructure within the Department of Bolivar. On the paternal side, five out of the six communities studied exhibit a predominantly European gene pool. The exception is Palenque, where European input (38%) is more significant than we had expected.	[Claudia Noguera, Maria; Briceno, Ignacio; Bernal, Jaime E.] Pontificia Univ Javeriana, Inst Genet Humana, Fac Med, Bogota, Colombia; [Claudia Noguera, Maria; Briceno, Ignacio; Uricoechea, Daniel] Univ Sabana, Fac Med, Lab Genet Humana, Bogota, Colombia; [Gomes, Veronica; Alvarez, Luis; Amorim, Antonio; Gusmao, Leonor] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, P-4100 Oporto, Portugal; [Schwegler, Armin] Univ Calif Irvine, Dept Spanish & Portuguese, Irvine, CA USA; [Amorim, Antonio] Univ Porto, Fac Sci, P-4100 Oporto, Portugal; [Benavides, Escilda] Univ Sinu, Fac Med, Seccional Cartagena, Colombia; [Silvera, Carlos] Univ Norte, Dept Med, Barranquilla, Colombia; [Charris, Marlon] Univ Cartagena, Grp Genet & Biol Mol, Cartagena, Colombia; [Gusmao, Leonor] State Univ Rio de Janeiro UERJ, LDD, Rio De Janeiro, Brazil		Noguera, MC (corresponding author), Pontificia Univ Javeriana, Inst Genet Humana, Fac Med, Cra 7 40-62 Edif 32, Bogota, Colombia.	mariacno-guera@gmail.com	Gusmao, Leonor/B-3122-2013; Gusmão, Leonor/L-8931-2019; Alvarez, Luis/J-6022-2013; Amorim, Antonio/A-7938-2008; Briceno Balcazar, Ignacio/N-3337-2017	Gusmao, Leonor/0000-0003-0432-6481; Gusmão, Leonor/0000-0003-0432-6481; Alvarez, Luis/0000-0003-1311-4536; Amorim, Antonio/0000-0002-7518-6247; Briceno Balcazar, Ignacio/0000-0001-7300-6401; Gomes, Veronica/0000-0003-2815-6376; Noguera Santamaria, Maria Claudia/0000-0002-2421-8579; Bernal Villegas, Jaime Eduardo/0000-0002-9733-5143	FCT, the Portuguese Foundation for Science and Technology; FCT [SFRH/BPD/76207/2011, SFRH/BPD/65000/2009]	FCT, the Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, and is partially supported by FCT, the Portuguese Foundation for Science and Technology. VG and LA are supported by FCT (grants SFRH/BPD/76207/2011 and SFRH/BPD/65000/2009). The authors report no conflicts of interest. The authors alone are responsible for the content of this article.	Acosta MA, 2009, FORENSIC SCI INT-GEN, V3, pE59, DOI 10.1016/j.fsigen.2008.06.006; Arrazola R., 1970, PALENQUE PRIMER PUEB; Beleza S, 2006, ANN HUM GENET, V70, P181, DOI 10.1111/j.1529-8817.2005.00221.x; Beleza S, 2005, HUM GENET, V117, P366, DOI 10.1007/s00439-005-1290-3; Blanco-Verea A, 2010, FORENSIC SCI INT-GEN, V4, P187, DOI 10.1016/j.fsigen.2009.08.008; Brion M, 2005, INT J LEGAL MED, V119, P10, DOI 10.1007/s00414-004-0439-2; Capelli C, 2009, EUR J HUM GENET, V17, P848, DOI 10.1038/ejhg.2008.258; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; Carvalho AM, PORTUGUESE IN PRESS; Carvalho M, 2010, DOCUMENTOS, P115; Carvalho M, 2011, FORENSIC SCI INT-GEN, V5, P114, DOI 10.1016/j.fsigen.2010.10.007; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; de la Serna Herrera J.M., 2011, VICISITUDES NEGRO AF, P101; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gomes V, 2010, HUM GENET, V127, P603, DOI 10.1007/s00439-010-0808-5; Goncalves R, 2003, HUM GENET, V113, P467, DOI 10.1007/s00439-003-1007-4; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Gonzalez M, 2013, EUR J HUM GENET, V21, P324, DOI 10.1038/ejhg.2012.167; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Maglia G, 2012, PALENQUE COLOMBIA OR, P57; Middleton D, 2000, HUM IMMUNOL, V61, P1048, DOI 10.1016/S0198-8859(00)00178-6; Navarrete M. C., 2012, PALENQUE COLOMBIA OR, P257; Navarrete M. C., 2008, SAN BASILIO PALENQUE; Navarrete MC, 2008, HIST CARIBE, V13, P7; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Rosa A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-124; Salzano F. M., 1988, S AM INDIANS CASE ST; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Schwegler A., 2012, PALENQUE COLOMBIA OR, P107; Silva DA, 2006, AM J HUM BIOL, V18, P829, DOI 10.1002/ajhb.20567; Silverman H, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P3, DOI 10.1007/978-0-387-74907-5_1; Stefflova K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014495; Toscanini U, 2011, AM J PHYS ANTHROPOL, V146, P188, DOI 10.1002/ajpa.21562; Trombetta B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016073; Wheat David, 2009, THESIS VANDERBILT U; Zuluaga Gomez, 2010, THESIS VANDERBILT U	38	23	24	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0301-4460	1464-5033		ANN HUM BIOL	Ann. Hum. Biol.	SEP-OCT	2014	41	5					453	459		10.3109/03014460.2013.852244	http://dx.doi.org/10.3109/03014460.2013.852244			7	Anthropology; Biology; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anthropology; Life Sciences & Biomedicine - Other Topics; Public, Environmental & Occupational Health	AN2PL	24215508				2022-09-04	WOS:000340427700009
S	Quiroga, LM; Arias, J; Bellemore, AC; Pacheco, R; Packer, AL; Vivas, I; Voutssas, J; Allard, SL; Barreau, D		Bryans, JB		Quiroga, LM; Arias, J; Bellemore, AC; Pacheco, R; Packer, AL; Vivas, I; Voutssas, J; Allard, SL; Barreau, D			Digital libraries in action: The Latin American and Caribbean experience	ASIST 2003: PROCEEDINGS OF THE 66TH ASIST ANNUAL MEETING, VOL 40, 2003: HUMANIZING INFORMATION TECHNOLOGY: FROM IDEAS TO BITS AND BACK	PROCEEDINGS OF THE ASIST ANNUAL MEETING		English	Article; Proceedings Paper	66th Annual Meeting of the American-Society-for-Information-Science-and-Technology	OCT 19-22, 2003	Long Beach, CA	Amer Soc Informat Sci & Technol				Knowledge acquisition and dissemination can facilitate innovation and provide the engine for economic growth and development. Creating and sharing knowledge can be hindered when multiple languages are spoken in geographically diverse regions that are bound together by cultural proximity. Digital libraries help provide the information infrastructure and technology to overcome these challenges and facilitate knowledge sharing by encouraging collaboration and providing information access. This interactive panel session features experts who are working on the frontlines building and implementing programs that utilize DLs to meet these goals in Latin America and the Caribbean. These projects address technical issues related to cross-lingual access, interoperability, and usability as well as organizational issues related to sharing and integrating research and development streams.	Univ Hawaii, Honolulu, HI 96822 USA; Javeriana Univ, Informat Sci Program, Bogota, Colombia; Univ Fed Santa Catarina, Project LATTES, BR-88040900 Florianopolis, SC, Brazil; WHO, PAHO, BIREME, Latin Amer & Caribbean Ctr Hlth Sci Informat, Sao Paulo, Brazil; Univ Nacl Autonoma Mexico, Digital Lib Project, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Adm Comp Serv, Mexico City 04510, DF, Mexico; Univ Kentucky, Coll Commun & Informat Studies, Lexington, KY 40506 USA; Univ N Carolina, Sch Lib & Informat Sci, Chapel Hill, NC 27599 USA		Quiroga, LM (corresponding author), Univ Hawaii, POST Bldg,1680 East West Rd, Honolulu, HI 96822 USA.	lquiroga@hawaii.edu; ariasj@javeriana.edu.co; acabezas@conicyt.cl; pacheco@eps.ufsc.br; abel@brm.bireme.br; marins@servidor.unam.mx; voutssas@servidor.unam.mx; slalla0@uky.edu; barreau@ils.unc.edu	Lopez-Gijon, Javier/F-7686-2012; Packer, Abel Laerte L/J-9350-2012; Packer, Abel/C-1705-2009	Packer, Abel Laerte L/0000-0001-9610-5728; Allard, Suzie/0000-0001-9421-3848					0	0	0	1	7	INFORMATION TODAY INC	MEDFORD	143 OLD MARLTON PIKE, MEDFORD, NJ 08055 USA	0044-7870		1-57387-197-4	P ASIST ANNU			2003	40						498	499		10.1002/meet.1450400194	http://dx.doi.org/10.1002/meet.1450400194			2	Computer Science, Information Systems; Information Science & Library Science	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Information Science & Library Science	BBZ20		Bronze			2022-09-04	WOS:000228354100094
J	Suarez-Ortegon, MF; McLachlan, S; Fernandez-Real, JM; Tuomainen, TP; Aregbesola, A; Wild, SH				Suarez-Ortegon, Milton-Fabian; McLachlan, Stela; Fernandez-Real, Jose-Manuel; Tuomainen, Tomi-Pekka; Aregbesola, Alex; Wild, Sarah H.			Serum ferritin and incident cardiometabolic diseases in Scottish adults	CARDIOVASCULAR DIABETOLOGY			English	Article						Metabolic syndrome; Iron metabolism; Obesity; Type 2 diabetes; Cardiovascular disease; Cerebrovascular disease	RISK; MORTALITY; METAANALYSIS; ASSOCIATION; TRENDS	Background Iron stores, estimated as ferritin levels, and type 2 diabetes (T2D) have been associated previously, while findings regarding coronary heart disease (CHD) and cerebrovascular disease (CEVD) are still inconclusive. No study has focused on simultaneous evaluation of associations between iron stores and the above cardiometabolic diseases (CMD) in the same population. We aim to evaluate the association between serum ferritin and risk of T2D, CHD and CEVD in Scottish population over a wide range of ferritin levels. Methods Longitudinal study in 6,497 participants of the 1995 and 1998 Scottish health surveys, who were followed-up until 2011. Cox regression models were conducted adjusting for age, sex/menopausal status, fibrinogen, GGT levels, smoking, alcohol consumption, total cholesterol, HDL-cholesterol, blood pressure, and BMI. Ferritin was used as continuous (sex/menopausal status-specific Z score) and categorical variable (sex/menopausal status-specific quartiles, quintiles and sextiles). Results During follow-up, 4.9% of the participants developed T2D, 5.3% CHD, and 2.3% CEVD. By using ferritin quartiles, serum ferritin was positively associated with T2D, CHD and CEVD but only the association with T2D remained after adjustment for covariates [Quartile 4 v. 1: adjusted HR 95% CI 1.59 (1.10-2.34); P = 0.006]. When ferritin sextiles were used (6 v. 1), the ferritin-CEVD association became slightly stronger and significant [adjusted HR 95% CI 2.08 (1.09-3.94); P = 0.024]. Conclusions Iron stores relate differently to each CMD. Serum ferritin levels were positively and independently associated with incident T2D, and with incident CEVD if higher cut-off points for high ferritin levels were considered.	[Suarez-Ortegon, Milton-Fabian] Pontificia Univ Javeriana Secc Cali, Fac Ciencias Salud, Dept Alimentac & Nutr, Calle 18 118-250, Cali, Colombia; [Suarez-Ortegon, Milton-Fabian] Pontificia Univ Javeriana Secc Cali, Fac Ciencias Salud, Grp Invest Ciencias Basicas & Clin Salud, Cali, Colombia; [McLachlan, Stela; Wild, Sarah H.] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland; [Fernandez-Real, Jose-Manuel] Univ Girona, Dept Diabet Endocrinol & Nutr, Inst Invest Biomed Girona IdIBGi, CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Girona, Spain; [Fernandez-Real, Jose-Manuel] Univ Girona, Inst Salud Carlos III ISCIII, Girona, Spain; [Fernandez-Real, Jose-Manuel] Univ Girona, Sch Med, Dept Med Sci, Girona, Spain; [Tuomainen, Tomi-Pekka; Aregbesola, Alex] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Aregbesola, Alex] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Paediat & Child Hlth, Winnipeg, MB, Canada; [Aregbesola, Alex] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada		Suarez-Ortegon, MF (corresponding author), Pontificia Univ Javeriana Secc Cali, Fac Ciencias Salud, Dept Alimentac & Nutr, Calle 18 118-250, Cali, Colombia.; Suarez-Ortegon, MF (corresponding author), Pontificia Univ Javeriana Secc Cali, Fac Ciencias Salud, Grp Invest Ciencias Basicas & Clin Salud, Cali, Colombia.; Fernandez-Real, JM (corresponding author), Univ Girona, Dept Diabet Endocrinol & Nutr, Inst Invest Biomed Girona IdIBGi, CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Girona, Spain.; Fernandez-Real, JM (corresponding author), Univ Girona, Inst Salud Carlos III ISCIII, Girona, Spain.; Fernandez-Real, JM (corresponding author), Univ Girona, Sch Med, Dept Med Sci, Girona, Spain.	fabian.suarezuv@gmail.com; jmfreal@idibgi.org	Fernández-Real, Jose Manuel/AGH-3599-2022	Fernández-Real, Jose Manuel/0000-0002-7442-9323				Akter S, 2017, J DIABETES INVEST, V8, P462, DOI 10.1111/jdi.12617; Bhatnagar P, 2016, HEART, V102, P1945, DOI 10.1136/heartjnl-2016-309573; Council S., 1992, ALL DUNB NAT FITN SU; Das De S, 2015, ATHEROSCLEROSIS, V238, P296, DOI 10.1016/j.atherosclerosis.2014.12.018; Franklin SS, 1997, CIRCULATION, V96, P308; Garcia-Casal MN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196576; Gray L, 2010, INT J EPIDEMIOL, V39, P345, DOI 10.1093/ije/dyp155; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hotchkiss JW, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1088; Jehn ML, 2007, AM J EPIDEMIOL, V165, P1047, DOI 10.1093/aje/kwk093; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Knuiman MW, 2003, AM J EPIDEMIOL, V158, P144, DOI 10.1093/aje/kwg121; Kunutsor SK, 2013, DIABETES-METAB RES, V29, P308, DOI 10.1002/dmrr.2394; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; LOHMAN TG, 1986, EXERCISE SPORT SCI R, V14, P325; Lohmann T.G., 1988, ANTHROPOMETRIC STAND; Lunneborg CE., 2005, JONCKHEERE TERPSTRA; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Podmore C, 2016, DIABETES CARE, V39, P572, DOI 10.2337/dc15-0257; Read SH, 2019, DIABETOLOGIA, V62, P418, DOI 10.1007/s00125-018-4796-7; Read SH, 2016, DIABETOLOGIA, V59, P2106, DOI 10.1007/s00125-016-4054-9; Scicchitano P, 2014, J FUNCT FOODS, V6, P11, DOI 10.1016/j.jff.2013.12.006; SCOTLAND S, 1995, SCOTTISH HLTH SURVEY; Shaw A, 2000, SCOTTISH HLTH SURVEY; van der A DL, 2005, STROKE, V36, P1637, DOI 10.1161/01.STR.0000173172.82880.72; WHO, 2011, WHO TECH REP SER, V959, P1; World Health Organization, 2004, INT STAT CLASS DIS R, V10th	27	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1475-2840		CARDIOVASC DIABETOL	Cardiovasc. Diabetol.	FEB 16	2022	21	1							26	10.1186/s12933-022-01450-7	http://dx.doi.org/10.1186/s12933-022-01450-7			11	Cardiac & Cardiovascular Systems; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Endocrinology & Metabolism	ZB4KG	35172838	gold, Green Published, Green Accepted			2022-09-04	WOS:000756812200001
J	Priebe, S; Borrero, AA; Bird, V; Kulenovic, AD; Giacco, D; Restrepo, CG; Hanna, F; Jayacodi, S; Musisi, S; Morgan, C; Nakasujja, N; Sabitova, A; Sandford, S; Sewankambo, N; Restrepo, JMU				Priebe, Stefan; Borrero, Alvaro Arenas; Bird, Victoria; Kulenovic, Alma Dzubur; Giacco, Domenico; Restrepo, Carlos Gomez; Hanna, Fahmy; Jayacodi, Sandrasagary; Musisi, Seggane; Morgan, Craig; Nakasujja, Noeline; Sabitova, Alina; Sandford, Stephen; Sewankambo, Nelson; Uribe Restrepo, Jose Miguel			Possibilities for the future of global mental health: a scenario planning approach	BMC PSYCHIATRY			English	Article						Global mental health; Future scenarios; Scenario planning; Global health research	DISTRESS	Background: Global mental health is a widely used term describing initiatives in policies, research and practice to improve the mental health of people worldwide. It has been gaining momentum over the last 10 years, reflected in increasing funding opportunities, training programmes, and publications. In light of the rising importance of global mental health and the various uncertainties about its future directions, this paper explores what the future may hold for global mental health in 30 years' time. Method: A scenario planning method was used, involving a workshop with experts from four continents and a range of backgrounds, including clinical and academic psychiatry, psychology, art and music therapy, service user advisory role, funder of global health research and post-graduate students. Results: Six distinct scenarios that describe potential future situations were developed: universal standards for care; worldwide coordination of research; making use of diversity; focus on social factors; globalised care through technology; mental health as a currency in global politics. Conclusions: These scenarios consider different social, economic, scientific and technological drivers and focus on distinct aspects. Some reflect a global application of possible trends in mental health, whilst others apply general global developments to mental health care. They are not fixed forecasts, but instead may help to promote discussion and debate about further developments and decisions.	[Priebe, Stefan; Bird, Victoria; Giacco, Domenico; Sabitova, Alina] Queen Mary Univ London, Newham Ctr Mental Hlth, Unit Social & Community Psychiat, WHO Collaborating Ctr Mental Hlth Serv Dev, London E13 8SP, England; [Borrero, Alvaro Arenas; Restrepo, Carlos Gomez; Uribe Restrepo, Jose Miguel] Pontificia Univ Javeriana, Dept Social & Prevent Med, Bogota, Colombia; [Kulenovic, Alma Dzubur] Univ Sarajevo, Clin Ctr, Sarajevo, Bosnia & Herceg; [Giacco, Domenico; Jayacodi, Sandrasagary; Sandford, Stephen] East London NHS Fdn Trust, London, England; [Hanna, Fahmy] WHO, Dept Mental Hlth & Subst Abuse, Geneva, Switzerland; [Musisi, Seggane; Nakasujja, Noeline; Sewankambo, Nelson] Makerere Univ, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Morgan, Craig] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Sabitova, Alina] Astana Med Univ, Astana, Kazakhstan		Priebe, S (corresponding author), Queen Mary Univ London, Newham Ctr Mental Hlth, Unit Social & Community Psychiat, WHO Collaborating Ctr Mental Hlth Serv Dev, London E13 8SP, England.	s.priebe@qmul.ac.uk	Morgan, Craig/B-2100-2010; Bird, Victoria/N-1165-2013	Morgan, Craig/0000-0002-1386-2369; Uribe Restrepo, Jose Miguel/0000-0003-4284-7886; Priebe, Stefan/0000-0001-9864-3394; Gomez-Restrepo, Carlos/0000-0002-9013-5384; Bird, Victoria/0000-0002-2053-7679; Giacco, Domenico/0000-0001-7809-8800	Global Health Research Programme of the National Institute of Health Research in the United Kingdom (NIHR) [GHR 16/137/97]; Department of Health and Social Care disclaimer	Global Health Research Programme of the National Institute of Health Research in the United Kingdom (NIHR); Department of Health and Social Care disclaimer	This project was funded by the Global Health Research Programme of the National Institute of Health Research in the United Kingdom (NIHR) (ref: GHR 16/137/97). The NIHR had no role in the study design; the collection, analysis and interpretation of data; the writing of the report; or the decision to submit the paper for publication.; Department of Health and Social Care disclaimer.; The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Amer M, 2013, FUTURES, V46, P23, DOI 10.1016/j.futures.2012.10.003; [Anonymous], 2017, BMJ; Fenton S, 1996, SOCIOL HEALTH ILL, V18, P66, DOI 10.1111/1467-9566.ep10934418; Giacco D, 2016, LANCET PSYCHIAT, V0366, P1; Jocalyn Clark, 2005, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V5, P585; Kohrt BA, 2014, INT J EPIDEMIOL, V43, P365, DOI 10.1093/ije/dyt227; Ling T, 2000, Br Homeopath J, V89 Suppl 1, pS3; Nielsen G A, 1996, Radiol Manage, V18, P43; Patel V, 2010, JAMA-J AM MED ASSOC, V303, P1976, DOI 10.1001/jama.2010.616; Priebe S, 2016, EPIDEMIOL PSYCH SCI, V25, P521, DOI 10.1017/S2045796016000147; Rhoods S, 2018, LEARN PUBL, P1; *UNAIDS, 2005, AIDS AFR 3 SCEN 2025; Vollmar HC, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0083-1; Vollmar HC, 2014, HEALTH POLICY, V114, P254, DOI 10.1016/j.healthpol.2013.07.023; Wack P, 1985, HARVARD BUS REV, P73	15	2	2	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-244X		BMC PSYCHIATRY	BMC Psychiatry	DEC 11	2019	19	1							392	10.1186/s12888-019-2381-3	http://dx.doi.org/10.1186/s12888-019-2381-3			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	KJ3GB	31829152	Green Published, gold			2022-09-04	WOS:000511944100003
J	Ramirez-Velez, R; Perez-Sousa, MA; Izquierdo, M; Cano-Gutierrez, CA; Gonzalez-Jimenez, E; Schmidt-RioValle, J; Gonzalez-Ruiz, K; Correa-Rodriguez, M				Ramirez-Velez, Robinson; Angel Perez-Sousa, Miguel; Izquierdo, Mikel; Cano-Gutierrez, Carlos A.; Gonzalez-Jimenez, Emilio; Schmidt-RioValle, Jacqueline; Gonzalez-Ruiz, Katherine; Correa-Rodriguez, Maria			Validation of Surrogate Anthropometric Indices in Older Adults: What Is the Best Indicator of High Cardiometabolic Risk Factor Clustering? (vol 11, 1701, 2019)	NUTRIENTS			English	Correction									[Ramirez-Velez, Robinson; Izquierdo, Mikel] IDISNA Navarras Hlth Res Inst, Navarrabiomed Biomed Res Ctr, Publ Univ Navarra, Dept Hlth Sci, C Irunlarrea 3,Complejo Hosp Navarra, Navarra 31008, Spain; [Angel Perez-Sousa, Miguel] Univ Huelva, Fac Sport Sci, Ave Fuerzas Armadas S-N, Huelva 21004, Spain; [Izquierdo, Mikel] Inst Salud Carlos III, CIBERFES, Madrid 28029, Spain; [Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Aging Inst, Hosp Univ San Ignacio, Bogota 110111, Colombia; [Gonzalez-Jimenez, Emilio; Schmidt-RioValle, Jacqueline; Correa-Rodriguez, Maria] Univ Granada, Fac Hlth Sci, Dept Nursing, Ave Ilustrac 60, Granada 18016, Spain; [Gonzalez-Ruiz, Katherine] Univ Manuela Beltran, Fac Salud, Grp Ejercicio Fisico & Deportes Vicerrectoria Inv, Bogota 110231, Colombia		Ramirez-Velez, R (corresponding author), IDISNA Navarras Hlth Res Inst, Navarrabiomed Biomed Res Ctr, Publ Univ Navarra, Dept Hlth Sci, C Irunlarrea 3,Complejo Hosp Navarra, Navarra 31008, Spain.	robin640@hotmail.com; perersousa@gmail.com; mikel.izquierdo@gmail.com; ccano@javeriana.edu.co; emigoji@ugr.es; jschmidt@ugr.es; katherine.gonzalez@docentes.umb.edu.co; macoro@ugr.es	Perez-Sousa, Miguel A./M-5931-2019; González-Ruíz, Katherine/AGI-4611-2022; Correa-Rodriguez, Maria/G-1793-2018; Ramírez-Vélez, Robinson/D-5311-2016; Izquierdo, Mikel/A-4894-2010; Izquierdo, Mikel/O-8049-2019; Gonzalez-Jimenez, Emilio/I-6039-2017	Perez-Sousa, Miguel A./0000-0003-4392-6850; González-Ruíz, Katherine/0000-0001-7518-0761; Correa-Rodriguez, Maria/0000-0001-9165-4349; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Izquierdo, Mikel/0000-0002-1506-4272; Izquierdo, Mikel/0000-0002-1506-4272; Gonzalez-Jimenez, Emilio/0000-0001-5103-6028; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Schmidt-Riovalle, Jacqueline/0000-0003-2775-0058				Ramirez-Velez R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081701	1	0	0	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6643		NUTRIENTS	Nutrients	OCT	2019	11	10							2413	10.3390/nu11102413	http://dx.doi.org/10.3390/nu11102413			2	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	JP4HG	31658785	Green Published, gold			2022-09-04	WOS:000498227300154
J	Borda, MG; Santacruz, JM; Aarsland, D; Camargo-Casas, S; Cano-Gutierrez, CA; Suarez-Monsalve, S; Campos-Fajardo, S; Perez-Zepeda, MU				German Borda, Miguel; Manuel Santacruz, Jose; Aarsland, Dag; Camargo-Casas, Sandy; Alberto Cano-Gutierrez, Carlos; Suarez-Monsalve, Silvia; Campos-Fajardo, Santiago; Ulises Perez-Zepeda, Mario			Association of depressive symptoms and subjective memory complaints with the incidence of cognitive impairment in older adults with high blood pressure	EUROPEAN GERIATRIC MEDICINE			English	Article						Aged; Depressive symptoms; Cognition disorders; Cognitive impairment; Hypertension; Subjective memory complaint	LATE-LIFE DEPRESSION; VASCULAR-DISEASE; MEXICAN HEALTH; DEMENTIA; RISK; VALIDATION; QUESTIONNAIRE; HYPERTENSION; PREVALENCE	Key Summary PointsAimThis study aims to uncover the association between frecuent conditions in older persons, according to their blood pressure: memory complaints, depression and incident cognitive impairment.FindingsIndividuals with depressive symptoms and/or subjective memory complaints have a higher risk of developing incident cognitive impairment when high blood pressure is present.MessageThere are several treatable risk factors, which could be managed through counseling regarding healthy lifestyle habits, including HBP prevention which could importantly impact outcomes in older persons. AbstractPurposeHigh blood pressure is a relevant risk factor for vascular damage, leading to the development of depressive symptoms and dementia in older adults. Moreover, subjective memory complaints are recognized as an early marker of cognitive impairment. However, it has been established that subjective memory complaints could also be a reflection of depressive symptoms. The objective of this paper is to assess the impact of depressive symptoms and subjective memory complaints on the incidence of cognitive impairment in older adults with high blood pressure.MethodsThis is a secondary analysis of the Mexican Health and Aging Study, a representative cohort composed by individuals aged 50years. Participants with cognitive impairment in 2012 were excluded since the outcome was incident cognitive impairment in 2015. Four groups were created according to depressive symptomatology and subjective memory complaints status; analyses were stratified according to blood pressure status. The odds incident cognitive impairment was estimated through logistic regression models.ResultsA total of 6327 participants were included, from which 6.44% developed cognitive impairment. No differences were seen regarding the development of cognitive impairment in participants without high blood pressure. However, increased risk was evident in those with both high blood pressure and depressive symptoms (OR=2.1, 95% CI 1.09-4.09, p=0.026) as with high blood pressure, depressive symptoms and subjective memory complaints (OR=1.91, 9% CI 1.4-3.2, p=0.001).ConclusionIndividuals with depressive symptoms and/or subjective memory complaints have a higher risk of developing incident cognitive impairment when high blood pressure is present. Our results suggest that a sequence of events related to altered cerebral vascular dynamics is possible.	[German Borda, Miguel; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med SESAM, Stavanger, Norway; [German Borda, Miguel; Camargo-Casas, Sandy; Alberto Cano-Gutierrez, Carlos; Suarez-Monsalve, Silvia; Campos-Fajardo, Santiago; Ulises Perez-Zepeda, Mario] Pontificia Univ Javeriana, Med Sch, Ageing Inst, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [German Borda, Miguel] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Alberto Cano-Gutierrez, Carlos] Hosp Univ San Ignacio, Internal Med Dept, Geriatr Unit, Bogota, Colombia; [Manuel Santacruz, Jose] Hosp Univ San Ignacio, Intellectus, Cognit & Memory Ctr, Bogota, Colombia; [Manuel Santacruz, Jose] Hosp Univ San Ignacio, Psychiat Dept, Bogota, Colombia; [Aarsland, Dag] Kings Coll London, Dept Old Age Psychiat, London, England; [Ulises Perez-Zepeda, Mario] Inst Nacl Geriatria, Geriatr Epidemiol Res Dept, Blvd Adolfo Lopez Mateo 2767, Mexico City 10200, DF, Mexico; [Ulises Perez-Zepeda, Mario] Dalhousie Univ, Dept Med, Geriatr Med Res Unit, Halifax, NS, Canada; [Manuel Santacruz, Jose] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Bellaterra, Spain		Perez-Zepeda, MU (corresponding author), Pontificia Univ Javeriana, Med Sch, Ageing Inst, Semillero Neurociencias & Envejecimiento, Bogota, Colombia.; Perez-Zepeda, MU (corresponding author), Inst Nacl Geriatria, Geriatr Epidemiol Res Dept, Blvd Adolfo Lopez Mateo 2767, Mexico City 10200, DF, Mexico.; Perez-Zepeda, MU (corresponding author), Dalhousie Univ, Dept Med, Geriatr Med Res Unit, Halifax, NS, Canada.	mperez@inger.gob.mx	Borda, Miguel Germán/AAK-9029-2020; Santacruz, Jose/AAW-8280-2020; Borda, Miguel German/AHB-5593-2022; Perez-Zepeda, Mario/B-7265-2011	Borda, Miguel Germán/0000-0001-5832-0603; Santacruz, Jose/0000-0001-5051-3056; Borda, Miguel German/0000-0001-5832-0603; Perez-Zepeda, Mario/0000-0003-4374-976X; Aarsland, Dag/0000-0001-6314-216X; Suarez, Silvia/0000-0001-8845-7686; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Campos-Fajardo, Santiago/0000-0001-7723-5578	National Institutes of Health/National Institute on Aging [NIH R01AG018016]; Sealy Center on Aging at the University of Texas Medical Branch in Galveston; Health of Older Minorities training Grant from the National Institute on Aging [T32AG00270]; NATIONAL INSTITUTE ON AGING [R01AG018016] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Sealy Center on Aging at the University of Texas Medical Branch in Galveston; Health of Older Minorities training Grant from the National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The MHAS was sponsored by the National Institutes of Health/National Institute on Aging (Grant NIH R01AG018016), as well as the Sealy Center on Aging at the University of Texas Medical Branch in Galveston and by the Health of Older Minorities T32AG00270 training Grant from the National Institute on Aging.	Aguilar-Navarro SG, 2007, SALUD PUBLICA MEXICO, V49, P256, DOI 10.1590/S0036-36342007000400005; Alexopoulos GS, 2009, WORLD PSYCHIATRY, V8, P140; [Anonymous], 2000, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890423349; Balash Y, 2013, ACTA NEUROL SCAND, V127, P344, DOI 10.1111/ane.12038; Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Bhalla RK, 2006, AM J GERIAT PSYCHIAT, V14, P419, DOI 10.1097/01.JGP.0000203130.45421.69; Binder N, 2016, NEW ENGL J MED, V375, P92, DOI 10.1056/NEJMc1604823; Brommelhoff JA, 2009, PSYCHOL AGING, V24, P373, DOI 10.1037/a0015713; Cano-Gutierrez C, 2015, J AGING HEALTH, V27, P1046, DOI 10.1177/0898264315573518; Cheng S, 2012, HYPERTENSION, V60, P1393, DOI 10.1161/HYPERTENSIONAHA.112.201780; Cipolla M.J., 2009, CEREBRAL CIRCULATION; Downer B, 2016, J AGING HEALTH, V28, P1239, DOI 10.1177/0898264316656508; Fladby T, 2017, J ALZHEIMERS DIS, V60, P97, DOI 10.3233/JAD-170231; Frankish H, 2017, LANCET, V390, P2614, DOI 10.1016/S0140-6736(17)31756-7; Geda YE, 2014, AM J PSYCHIAT, V171, P572, DOI 10.1176/appi.ajp.2014.13060821; GLOSSER G, 1993, J AM GERIATR SOC, V41, P931, DOI 10.1111/j.1532-5415.1993.tb06758.x; Gutierrez-Robledo LM, 2002, J GERONTOL A-BIOL, V57, pM162, DOI 10.1093/gerona/57.3.M162; Hernandez-Hernandez R, 2010, J HYPERTENS, V28, P24, DOI 10.1097/HJH.0b013e328332c353; Ismail Z, 2014, NEURODEGENER DIS MAN, V4, P119, DOI [10.2217/NMT.14.5, 10.2217/nmt.14.5]; Jacinto AF, 2014, CLINICS, V69, P194, DOI 10.6061/clinics/2014(03)09; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; McLeod KJ, 2017, GERONTOL GERIATR MED, V3, DOI 10.1177/2333721417733216; Mejia-Arango S, 2015, SALUD PUBLICA MEXICO, V57, pS90; Mejia-Arango S, 2011, J AGING HEALTH, V23, P1050, DOI 10.1177/0898264311421199; Miguel Gutierrez-Robledo L, 2015, DEMENCIAS MEXICO NEC; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Montenegro Pena M, 2015, QUEJAS SUBJETIVAS ME; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Reppermund S, 2014, BRIT J PSYCHIAT, V205, P315, DOI 10.1192/bjp.bp.113.142109; Rizzi L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/908915; Salloway S, 1996, NEUROLOGY, V46, P1567, DOI 10.1212/WNL.46.6.1567; Singh-Manoux A, 2017, JAMA PSYCHIAT, V74, P712, DOI 10.1001/jamapsychiatry.2017.0660; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Steffens DC, 2017, JAMA PSYCHIAT, V74, P673, DOI 10.1001/jamapsychiatry.2017.0658; Taragano FE, 2009, J CLIN PSYCHIAT, V70, P584, DOI 10.4088/JCP.08m04181; Thomas AJ, 2004, J AFFECT DISORDERS, V79, P81, DOI 10.1016/S0165-0327(02)00349-x; Wang X, 2019, IEEE T SIGNAL PROCES, V67, P221, DOI 10.1109/TSP.2018.2880722; Wong R, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyu263; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	40	10	13	4	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1878-7649	1878-7657		EUR GERIATR MED	Eur. Geriatr. Med.	JUN	2019	10	3					413	420		10.1007/s41999-019-00185-1	http://dx.doi.org/10.1007/s41999-019-00185-1			8	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	HZ7NR	31186819	Green Accepted			2022-09-04	WOS:000469041000009
J	Tarasov, VV; Kudryashov, NV; Chubarev, VN; Kalinina, TS; Barreto, GE; Ashraf, GM; Aliev, G				Tarasov, Vadim V.; Kudryashov, Nikita V.; Chubarev, Vladimir N.; Kalinina, Tatiana S.; Barreto, George E.; Ashraf, Ghulam Md; Aliev, Gjumrakch			Pharmacological Aspects of Neuro-Immune Interactions	CURRENT PHARMACEUTICAL DESIGN			English	Review						Amantadine; amitriptyline; interferon; neurogenesis; neuro-immune interaction; oseltamivir; panavir; semax	MIGRATION INHIBITORY FACTOR; ADULT HIPPOCAMPAL NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; RAT BASAL FOREBRAIN; INDUCED PAW EDEMA; PARKINSONS-DISEASE; INTERFERON-ALPHA; PRECURSOR CELLS; GM1 GANGLIOSIDE; OXIDATIVE STRESS	The use of systematic approach for the analysis of mechanism of action of drugs at different levels of biological organization of organisms is an important task in experimental and clinical pharmacology for drug designing and increasing the efficacy and safety of drugs. The analysis of published data on pharmacological effects of psychotropic drugs possessing immunomodulatory and/or antiviral properties have shown a correlation between central effects of examined drugs associated with the impact on the processes of neurogenesis of adult brain and survival of neurons, and their ability to alter levels of key proinflammatory cytokines. The changes that occur as a result of the influence of pharmacological agents at one of the systems should inevitably lead to the functional reorganization at another. Integrative mechanisms underlying the neuro-immune interactions may explain the "pleiotropic" pharmacological effects of some antiviral and immunomodulatory drugs. Amantadine, which was originally considered as an antiviral agent, was approved as anti-parkinsonic drug after its wide medical use. The prolonged administration of interferon alpha caused depression in 30-45% of patients, thus limiting its clinical use. The antiviral drug "Oseltamivir" may provoke the development of central side effects, including abnormal behavior, delirium, impaired perception and suicides. Anti-herpethetical drug "Panavir" shows pronounced neuroprotective properties. The purpose of this review is to analyze the experimental and clinical data related to central effects of drugs with antiviral or/and immunotropic activity, and to discover the relationship of these effects with changes in reactivity of immune system and proinflammatory response.	[Tarasov, Vadim V.; Kudryashov, Nikita V.; Chubarev, Vladimir N.] IM Sechenov First Moscow State Med Univ, Pharmaceut Fac, Dept Pharmacol, Off 211,8-2 Trubetskaya St, Moscow 119991, Russia; [Kudryashov, Nikita V.; Kalinina, Tatiana S.] Res Zakusov Inst Pharmacol, Fed State Budgetary Inst, Baltiyskaya Str 8, Moscow 125315, Russia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, E Johns Crossing 175, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia		Tarasov, VV (corresponding author), IM Sechenov First Moscow State Med Univ, Pharmaceut Fac, Dept Pharmacol, Off 211,8-2 Trubetskaya St, Moscow 119991, Russia.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA.	tarasov-v-v@mail.ru; aliev03@gmail.com	Kudryashov, Nikita/AAD-7238-2020; Aliev, Gjumrakch/AAE-7734-2020; Kalinina, Tatiana S/A-4799-2016; Chubarev, Vladimir N/J-4321-2017; Ashraf, Ghulam Md/H-9485-2012; Barreto, George E./AAD-7420-2020	Aliev, Gjumrakch/0000-0001-7373-3182; Chubarev, Vladimir N/0000-0002-7047-1436; Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994; Kalinina, Tatiana/0000-0002-0178-3567	Russian Scientific Foundation [14-2300160P]; Pontificia Universidad Javeriana	Russian Scientific Foundation(Russian Science Foundation (RSF)); Pontificia Universidad Javeriana	This work supported by the Russian Scientific Foundation ((www.rscf.ru, Pocck Hay H Phi oH, Grant No 14-2300160P: Directed design, synthesis, and study of biological activity of multi-target compounds as innovative drugs for treatment of neurodegenerative diseases). GEB work is supported by Pontificia Universidad Javeriana. GMA gratefully acknowledges the facilities provided by King Fahad Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia.	Agapova TY, 2007, NEUROSCI LETT, V417, P201, DOI 10.1016/j.neulet.2007.02.042; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; [Anonymous], 2007, NATURE, V446, P358, DOI 10.1038/446358a; [Anonymous], NEUROSCI BEHAV PHYSL; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Berger F, 2013, THERANOSTICS, V3, P932, DOI 10.7150/thno.7445; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Bigi A, 2013, GLYCOBIOLOGY, V23, P1499, DOI 10.1093/glycob/cwt078; Blach-Olszewska Z, 2015, CURR PHARM DESIGN, V21, P3582, DOI 10.2174/1381612821666150710144829; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Boldyrev AA, 2004, BIOCHEM BIOPH RES CO, V324, P133, DOI 10.1016/j.bbrc.2004.09.019; Bowen KK, 2011, NEUROREPORT, V22, P126, DOI 10.1097/WNR.0b013e3283430a44; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Bull SJ, 2009, MOL PSYCHIATR, V14, P1095, DOI 10.1038/mp.2008.48; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021638; Conboy L, 2011, MOL PSYCHIATR, V16, P533, DOI 10.1038/mp.2010.15; Crain SM, 2004, BRAIN RES, V995, P260, DOI 10.1016/j.brainres.2003.09.068; Crespo FA, 2006, J LEUKOCYTE BIOL, V79, P586, DOI 10.1189/jlb.0705395; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; Dolotov OV, 2006, BRAIN RES, V1117, P54, DOI 10.1016/j.brainres.2006.07.108; Dolotov OV, 2006, J NEUROCHEM, V97, P82, DOI 10.1111/j.1471-4159.2006.03658.x; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Gao RB, 2013, BIOCHEM BIOPH RES CO, V431, P788, DOI 10.1016/j.bbrc.2013.01.019; Gonzalez-Perez Oscar, 2010, J Stem Cells, V5, P23, DOI jsc.2010.5.1.23; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Grivennikov IA, 2008, RESTOR NEUROL NEUROS, V26, P35; Guijarro A, 2006, PROG BRAIN RES, V153, P367, DOI 10.1016/S0079-6123(06)53022-5; Hajhashemi V, 2010, CLINICS, V65, P1183, DOI 10.1590/S1807-59322010001100022; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Heinonen S, 2010, CLIN INFECT DIS, V51, P887, DOI 10.1086/656408; Inzelberg R, 2006, MOVEMENT DISORD, V21, P1375, DOI 10.1002/mds.20968; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Izumi Y, 2008, HUM EXP TOXICOL, V27, P911, DOI 10.1177/0960327109102367; Kalinina TS, 2005, BEHAV PHARMACOL, V16, pS93, DOI 10.1097/00008877-200509001-00293; Kalinina TS, 2005, B EXP BIOL MED+, V140, P55, DOI 10.1007/s10517-005-0410-3; Kaloustian S, 2009, APOPTOSIS, V14, P1308, DOI 10.1007/s10495-009-0395-x; Kaneko N, 2006, NEUROPSYCHOPHARMACOL, V31, P2619, DOI 10.1038/sj.npp.1301137; Katsanos GS, 2008, J BIOL REG HOMEOS AG, V22, P93; Khonsari N, 1994, TEHRAN U MED J, V52, P16; Klimova R. R., 2009, Antibiotiki i Khimioterapiya, V54, P18; Kolbukhina L., 2009, CYTOKINES INFLAMMATI, V8, P49; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Ledeen RW, 2015, TRENDS BIOCHEM SCI, V40, P407, DOI 10.1016/j.tibs.2015.04.005; Leon LR, 2006, J THERM BIOL, V31, P67, DOI 10.1016/j.jtherbio.2005.11.023; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Li HW, 2008, FASEB J, V22, P3175, DOI 10.1096/fj.08-108662; Lotrich FE, 2007, J PSYCHOSOM RES, V63, P131, DOI 10.1016/j.jpsychores.2007.05.013; Manjunatha Narayana, 2011, Ind Psychiatry J, V20, P83, DOI 10.4103/0972-6748.102479; Mao XL, 2011, MOL PHARMACOL, V79, P672, DOI 10.1124/mol.110.068122; Maxwell SRJ, 2007, BRIT MED J, V334, P1232, DOI 10.1136/bmj.39240.497025.80; Medvedeva EV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-228; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moon HY, 2012, P NATL ACAD SCI USA, V109, P13094, DOI 10.1073/pnas.1205535109; Nishibori M, 1996, NEUROSCI LETT, V213, P193; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Onali P, 2010, J PHARMACOL EXP THER, V332, P255, DOI 10.1124/jpet.109.159939; Ossola B, 2011, NEUROPHARMACOLOGY, V61, P574, DOI 10.1016/j.neuropharm.2011.04.030; [Острова Ирина Васильевна Ostrova I.V.], 2010, [Общая реаниматология, Obshchaya reanimatologiya], VVI, P25; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; RABIN BS, 1989, CRIT REV IMMUNOL, V9, P279; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Sadeghi H, 2011, EUR J PHARMACOL, V667, P396, DOI 10.1016/j.ejphar.2011.05.053; Safarova ER, 2003, B EXP BIOL MED+, V135, P268, DOI 10.1023/A:1024141232307; Sanders VM, 2012, BRAIN BEHAV IMMUN, V26, P195, DOI 10.1016/j.bbi.2011.08.001; SCHWAB RS, 1969, J AMER MED ASSOC, V208, P1168, DOI 10.1001/jama.208.7.1168; Shadrina MI, 2001, NEUROSCI LETT, V308, P115, DOI 10.1016/S0304-3940(01)01994-2; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; SHEN KF, 1990, BRAIN RES, V531, P1, DOI 10.1016/0006-8993(90)90751-V; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Storozhevykh TP, 2007, B EXP BIOL MED+, V143, P601, DOI 10.1007/s10517-007-0192-x; Stovbun SV, 2014, MOSC U PHYS B+, V69, P542, DOI 10.3103/S0027134914060150; Straub RH, 2004, TRENDS PHARMACOL SCI, V25, P640, DOI 10.1016/j.tips.2004.10.007; Toovey S, 2012, ADV THER, V29, P826, DOI 10.1007/s12325-012-0050-8; Tracey KJ, 2001, FASEB J, V15, P1575, DOI 10.1096/fj.01-0148hyp; Turrin NP, 2004, CURR OPIN CLIN NUTR, V7, P419, DOI 10.1097/01.mco.0000134373.16557.92; Uchakina ON, 2006, FASEB J, V20, pA1128; Vale S, 2008, EXP BIOL MED, V233, P941, DOI 10.3181/0707-MR-193; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Vikman KS, 2001, BRAIN RES, V896, P18, DOI 10.1016/S0006-8993(00)03238-8; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; WENK GL, 1995, EUR J PHARM-ENVIRON, V293, P267, DOI 10.1016/0926-6917(95)00028-3; Wu MD, 2013, BRAIN BEHAV IMMUN, V32, P9, DOI 10.1016/j.bbi.2013.03.003; Xiong M, 2009, BRAIN RES BULL, V79, P351, DOI 10.1016/j.brainresbull.2009.03.011; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Zheng LS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00005	93	6	7	0	9	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2018	24	1					15	21		10.2174/1381612823666170829135115	http://dx.doi.org/10.2174/1381612823666170829135115			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GA6QL	28875850				2022-09-04	WOS:000428458200003
J	Barreno, M; Sisa, I; Garcia, MCY; Shen, H; Villar, M; Kovalskys, I; Fisberg, M; Gomez, G; Rigotti, A; Cortes, LY; Pareja, RG; Herrera-Cuenca, M; Guajardo, V				Barreno, Mishell; Sisa, Ivan; Garcia, Martha Cecilia Yepez; Shen, Hua; Villar, Monica; Kovalskys, Irina; Fisberg, Mauro; Gomez, Georgina; Rigotti, Attilio; Cortes, Lilia Yadira; Pareja, Rossina G.; Herrera-Cuenca, Marianella; Guajardo, Viviana		ELANS Study Grp	Association between built environment and physical activity in Latin American countries: a multicentre cross-sectional study	BMJ OPEN			English	Article						epidemiology; health policy; public health	ACTIVITY QUESTIONNAIRE; GREEN SPACES; HEALTH; MORTALITY; IMPACT	Objective To assess the association between the physical activity level and the built environment by accessibility, microinfrastructure and security in Latin America (LA). Design We conducted a multicentre cross-sectional study to collect physical activity and built environment data. The levels of physical activity were calculated through the International Physical Activity Questionnaire survey. Using the Neighbourhood Environment Walkability Scale-Abbreviated, characteristics of the built environment were measured through three domains: accessibility, microinfrastructure and security. To estimate the association of the built environment and physical activity, we used mixed effects logistic regression analysis. In addition, likelihood ratio test to account for clustered effect within countries and/or cities was used. Setting Eight countries in LA. Participants Adults aged 15-65 years (n=9218) living in urban areas and consented to participate of the Latin American Study of Nutrition and Health. Results Most of the population in LA had access to a grocery store (97.2%), public transport stop (91.5%) and children's playground (81.6%). Metropolitan parks were more accessible in Ecuador (59.8%) and Colombia (59.2%) than in Venezuela (33.5%). Individuals located within 20 min of walking from sport facilities or children's playground areas were more likely to perform moderate-to-high physical activity OR 1.20 (95% CI 1.06 to 1.36) and OR 1.25 (95% CI 1.02 to 1.53), respectively. Only 14.5% of the population from the region considered that their neighbourhood had an adequate design for walking or cycling. Likewise, among adults living in LA, only 39.75% had the perception of living in a safe neighbourhood. Conclusions This multicentre study shows that currently, LA built environment does not promote physical activity in the region. Our findings provide the rationale to push forward, at regional and national levels, policies and interventions that will help to achieve a safe, healthy and friendly built environment to encourage participation in active recreation and sports in leisure time.	[Barreno, Mishell; Sisa, Ivan; Garcia, Martha Cecilia Yepez; Villar, Monica] Univ San Francisco Quito USFQ, Colegio Ciencias Salud, Quito, Ecuador; [Shen, Hua] Univ Calgary, Dept Math & Stat, Calgary, AB, Canada; [Kovalskys, Irina; Guajardo, Viviana] Pontificia Univ Catolica Argentina, Fac Ciencias Med, Carrera Nutr, Buenos Aires, DF, Argentina; [Fisberg, Mauro] Fundacao Jose Egydio Setubal, Sabara Hosp Infantil, Inst Pensi, Sao Paulo, Brazil; [Fisberg, Mauro] Univ Fed Sao Paulo, Dept Pediat, Escola Paulista Med, Sao Paulo, Brazil; [Gomez, Georgina] Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose, Costa Rica; [Rigotti, Attilio] Pontificia Univ Catolica, Escuela Med, Dept Nutr Diabet & Metabolismo, Ctr Nutr Mol & Enfermedades Cron, Santiago, Chile; [Cortes, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Pareja, Rossina G.] Inst Invest Nutr, Lima, Peru; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Fdn Bengoa, Ctr Estudios Desarrollo, Caracas, Venezuela		Sisa, I (corresponding author), Univ San Francisco Quito USFQ, Colegio Ciencias Salud, Quito, Ecuador.	isisa@usfq.edu.ec	; Fisberg, Mauro/E-7149-2010; Pareja, Rossina/D-9892-2018	Cortes, Lilia Yadira/0000-0003-2789-3219; Fisberg, Mauro/0000-0003-2992-3215; Pareja, Rossina/0000-0001-7523-3181; Kovalskys, Irina/0000-0001-8481-5415; Gomez, Georgina/0000-0003-3514-2984; Yepez, Martha Cecilia/0000-0003-4119-238X; Sisa, Ivan/0000-0002-7503-9044	Coca Cola Company (Atlanta, GA, USA) [207000014]	Coca Cola Company (Atlanta, GA, USA)	The fieldwork was originally supported by a scientific grant from the Coca Cola Company (Atlanta, GA, USA) #207000014.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Briceño-León Roberto, 2005, Cad. Saúde Pública, V21, P1629; Cain KL, 2014, SOC SCI MED, V116, P82, DOI 10.1016/j.socscimed.2014.06.042; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Cerin E, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-84; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dadvand P, 2015, P NATL ACAD SCI USA, V112, P7937, DOI 10.1073/pnas.1503402112; Ferrari GLD, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8048-7; Devarajan R, 2020, OBES REV, V21, DOI 10.1111/obr.12938; Dumith SC, 2011, PREV MED, V53, P24, DOI 10.1016/j.ypmed.2011.02.017; Fisberg M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2765-y; Garin Noe, 2014, Clin Pract Epidemiol Ment Health, V10, P103, DOI 10.2174/1745017901410010103; Gascon M, 2016, ENVIRON INT, V86, P60, DOI 10.1016/j.envint.2015.10.013; Giles-Corti B, 2016, LANCET, V388, P2912, DOI 10.1016/S0140-6736(16)30066-6; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS259, DOI 10.1123/jpah.7.s2.s259; HHS, PHYS ACTIVITY GUIDEL, V2 nd; Janke K, 2016, J HEALTH ECON, V47, P34, DOI 10.1016/j.jhealeco.2016.01.006; Kane JC, 2018, LANCET PSYCHIAT, V5, P864, DOI 10.1016/S2215-0366(18)30301-8; Kerr J, 2013, J PHYS ACT HEALTH, V10, P581, DOI 10.1123/jpah.10.4.581; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; MacMillan F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020217; McPhee JS, 2016, BIOGERONTOLOGY, V17, P567, DOI 10.1007/s10522-016-9641-0; Muller MM, 2018, GLOB CRIME, V19, P171, DOI 10.1080/17440572.2018.1543916; OECD, GROWTH LAT AM; Robson Sean, 2014, Rand Health Q, V3, P6; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Salinas Judith, 2003, Rev Panam Salud Publica, V14, P281, DOI 10.1590/S1020-49892003000900015; Sallis JF, 2020, ANNU REV PUBL HEALTH, V41, P119, DOI 10.1146/annurev-publhealth-040218-043657; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Salvo D, 2017, PREV MED, V103, pS27, DOI 10.1016/j.ypmed.2016.09.007; Salvo D, 2014, PREV MED, V69, pS86, DOI 10.1016/j.ypmed.2014.10.014; Salvo D, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140047; Sarmiento O, 2010, J PHYS ACT HEALTH, V7, pS163, DOI 10.1123/jpah.7.s2.s163; Sisa I, 2021, PUBLIC HEALTH NUTR, V24, P2577, DOI 10.1017/S1368980020000646; Starnes HA, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0126-8; UN, 2020, GOAL 13 CLIM ACT, DOI DOI 10.4324/9781351067478-8; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; WHO, 2010, B WHO URB HLTH; WKC, 2013, URB HEART EV REP; World Health Organization, 2002, GLOB STRAT DIET PHYS; World Health Organization, 2018, MOR ACT PEOPL HEALTH	45	0	0	3	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	NOV	2021	11	11							e046271	10.1136/bmjopen-2020-046271	http://dx.doi.org/10.1136/bmjopen-2020-046271			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WS7XX	34732475	Green Published, gold			2022-09-04	WOS:000715392500020
J	Montes-Correa, AC; Saboya-Acosta, LP; Jimenez-Bolano, JD; Angarita-Sierra, T; Briceno-Perez, V; Nunez, S; Renjifo, JM; Schargel, WE; Daza, JD; Hoogmoed, MS				Montes-Correa, Andres Camilo; Saboya-Acosta, Liliana P.; Jimenez-Bolano, Juan David; Angarita-Sierra, Teddy; Briceno-Perez, Vladimir; Nunez, Samuel; Renjifo, Juan Manuel; Schargel, Walter E.; Daza, Juan D.; Hoogmoed, Marinus S.			Extended diagnosis of the type species of Pseudogonatodes Ruthven 1915 (Gekkota: Sphaerodactylidae)	ZOOTAXA			English	Article						Caribbean; distribution range; ground dwelling geckos; morphology; osteology; Sierra Nevada de Santa Marta	SQUAMATA SPHAERODACTYLIDAE; GECKO; SAURIA; GENUS; SKULL	Pseudogonatodes furvus is an endemic gecko from the region of the Sierra Nevada de Santa Marta, an isolated massif located in the continental Caribbean region of Colombia. Pseudogonatodes furvus is the type species of the genus, and its morphology and natural history remain poorly known. This lizard was described based on two specimens. After its description, the species has only been mentioned in a handful of taxonomic studies of Pseudogonatodes, in which a few morphological characters of P. furvus have been mentioned. One other paper reported two new localities, without providing new information on the external morphology, especially the lepidosis of the newly obtained specimens. Here we review the external morphology of P. furvus, based on examination of the holotype and six additional specimens. We provide an extended diagnosis and definition, description of holotype, variation, comparisons with other Pseudogonatodes, geographic distribution (adding a fourth locality to the known distribution for the species), and conservation status. Additionally, we describe osteological features for the diagnosis of the genus.	[Montes-Correa, Andres Camilo; Saboya-Acosta, Liliana P.; Jimenez-Bolano, Juan David; Nunez, Samuel; Renjifo, Juan Manuel] Univ Magdalena, Grp Invest Manejo & Conservac Fauna Flora & Ecosi, Fac Ciencias Basicas, Santa Marta, Magdalena, Colombia; [Saboya-Acosta, Liliana P.] Pontificia Univ Javeriana, Programa Doctorado Estudios Ambientales & Rurales, Fac Estudios Ambientales & Rurales, Bogota, Cundinamarca, Colombia; [Angarita-Sierra, Teddy] Univ Manuela Beltran, Invest, Ave Circunvalar 60-00, Bogota, Cundinamarca, Colombia; [Angarita-Sierra, Teddy] Fdn Invest Biodiversidad & Conservac, Yoluka, Cra 68B 23-88, Bogota, Cundinamarca, Colombia; [Briceno-Perez, Vladimir] Univ Nacl Colombia, Grp Invest Biol Organismos Tropicales BIOTUN, Inst Ciencias Nat, Bogota, Cundinamarca, Colombia; [Schargel, Walter E.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Daza, Juan D.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA; [Hoogmoed, Marinus S.] Museu Paraense Emilio Goeldi, Campus Pesquisa,Ave Perimetral 1901, BR-66077830 Belem, Para, Brazil		Montes-Correa, AC (corresponding author), Univ Magdalena, Grp Invest Manejo & Conservac Fauna Flora & Ecosi, Fac Ciencias Basicas, Santa Marta, Magdalena, Colombia.	andresc.montes@gmail.com; liliana.saboya.acosta@gmail.com; juand.daza@gmail.com; tgangaritas@unal.edu.co; vbricenop@unal.edu.co; samuelnunez2000@gmail.com; juanmanuel.renjifo@gmail.com; schargel@uta.edu	Angarita-Sierra, Teddy/V-8188-2019; saboya, liliana patricia/B-8853-2016	Angarita-Sierra, Teddy/0000-0002-5978-9312; Montes-Correa, Andres Camilo/0000-0003-3561-0426; saboya, liliana patricia/0000-0002-0499-6664	Department of Biological Sciences at Sam Houston State University; NSF [DEB 1657656]	Department of Biological Sciences at Sam Houston State University; NSF(National Science Foundation (NSF))	The authors are grateful for the access to the material and assistance during visits to the following collections (museum acronyms): E.N. Arnold and C. McCarthy (BMNH), R.J. Guerrero (CBUMAG), E.J. Censky (CM), M.L. Calderon-Espinosa (ICN), the late Gloria Moreira (INPA), W.E. Duellman and J.E. Simmons (KU), J.W. Wright and J.A. Seigel (LACM), D.A. Rossman (LSUMNS), J.E. Cadle and J.P. Rosado (MCZ), U. Galatti (MPEG), E. Meneses-Pelayo (MHN-UIS), J. Manzanilla (MIZA), Raffael Ernst (MTKD), J.M. Hoyos (MUJ), H. Greene (MVZ), R.W. McDiarmid and S.W. Gotte (NMNH), R.A. Nussbaum and G. Schneider (UMMZ). We thank to J. Rosado (MCZ) and A.M. Bauer (Villanova University) for access to HRCT data, and to K. de Queiroz, R.W. McDiarmid, R.W. Heyer, G. Zug, A. Wynn, K. Tighe, and S. Gotte (NMNH) for access to comparative material and digital Xrays system. We are grateful to OVert: Open Exploration of Vertebrate Diversity in 3D for facilitating access to specimens online. Marinus S. Hoogmoed (formerly Rijksmuseum van Natuurlijke Historie, RMNH) has pleasant memories of the fieldwork in Rancho Grande, Venezuela with the late Scott J. Maness and Robert Godshalk. Juan D. Daza received funding from the Department of Biological Sciences at Sam Houston State University and an NSF grant DEB 1657656. Andres C. Montes-Correa thanks C. Koch (Museum Alexander Koenig, Bonn, Germany) for her invaluable collaboration with information, morphological data and photographs of the specimens under her responsibility. Finally, thanks to A. Llinas-Pizarro, J.P. Ramirez, A.J. Lopez-Caro, G. Rivas, and L.F. Esqueda for their comments on the manuscript.	Alberto Rueda-Solano Luis, 2014, Herpetology Notes, V7, P609; [Anonymous], Pseudogonatodes sp.2: COLOMBIA: Cundinamarca; [Anonymous], Pseudogonatodes sp.1: COLOMBIA; [Anonymous], PSEUDOGONATODES PSEUDOGONATODES; [Anonymous], Pseudogonatodes sp. 7: VENEZUELA; [Anonymous], PSEUDOGONATODES LUNU; [Anonymous], PSEUDOGONATODES PSEUDOGONATODES, V15, P185; [Anonymous], PSEUDOGONATODES MANE; [Anonymous], Pseudogonatodes sp.4: COLOMBIA: Caldas: La Dorada,; Avila-Pires T.C.S., 1995, Zoologische Verhandelingen (Leiden), V299, P1; Avila-Pires T.C.S., 2000, ZOOL MEDED, V73, P209; AYALA S C, 1984, Papeis Avulsos de Zoologia (Sao Paulo), V35, P135; AYALA S C, 1986, Caldasia, V15, P555; Bauer AM, 2018, S AM J HERPETOL, V13, P102, DOI 10.2994/SAJH-D-17-00113.1; Bernal-Carlo A., 2005, NOVEDADES COLOMBIANA, V8, P9; Bernstein J.M., 2016, IRCF REPTILES AMPHIB, V23, P40; Boulenger GA, 1914, P ZOOL SOC LOND, V1914, P813; Cadena CD, 2007, MOL PHYLOGENET EVOL, V44, P993, DOI 10.1016/j.ympev.2006.12.012; Caicedo J., 2015, IUCN RED LIST THREAT, V2015; Montes-Correa AC, 2018, PHYLLOMEDUSA, V17, P61, DOI 10.11606/issn.2316-9079.v17i1p61-72; Caro LM, 2013, J EVOLUTION BIOL, V26, P357, DOI 10.1111/jeb.12055; Carvajal-Cogollo J.E., 2012, COLOMBIA DIVERSIDAD, P791; Darlington P. J., 1931, Bulletin of the Museum of Comparative Zoology, V71, P349; Daza JD, 2008, J MORPHOL, V269, P1340, DOI 10.1002/jmor.10664; Daza Juan D., 2012, Breviora, P1; DIXON J R, 1975, Milwaukee Public Museum Contributions in Biology and Geology, V4, P1; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Dunn E.R, 1944, CALDASIA, V3, P73; ESQUEDA LUIS FELIPE, 2016, Saber, V28, P18; Gamble C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035982, 10.1371/journal.pone.0039429]; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Gamble T, 2015, BIOL J LINN SOC, V115, P896, DOI 10.1111/bij.12536; Gamble T, 2011, ZOOL J LINN SOC-LOND, V163, P1244, DOI 10.1111/j.1096-3642.2011.00741.x; GASC J-P, 1981, Terre et la Vie, V35, P273; Granda-Rodriguez H.D., 2020, INSIGHTS NATURAL HIS; Harris Dennis M., 1994, Herpetological Monographs, V8, P226, DOI 10.2307/1467082; HARRIS DM, 1987, HERPETOLOGICA, V43, P182; Herrero D., 2015, MOROCCOHERPS ANFIBIO; Holdridge L. R., 1967, Life zone ecology.; Hoogmoed M.S., 1973, Biogeographica, V4, P1; HUEY RB, 1970, COPEIA, P538; Kluge Arnold G., 1995, American Museum Novitates, V3139, P1; Koch C, 2018, ZOOTAXA, V4385, P1, DOI 10.11646/zootaxa.4385.1.1; Calderon-Espinosa ML, 2016, ZOOTAXA, V4067, P215, DOI 10.11646/zootaxa.4067.2.6; MECHLER B, 1968, Revue Suisse de Zoologie, V75, P305; Meiri S, 2018, DIVERS DISTRIB, V24, P262, DOI 10.1111/ddi.12678; Noble G. K., 1921, Annals of the New York Academy of Sciences, V29, P133; Parker H.W, 1926, ANN MAGAZINE NATURAL, V9, P291, DOI [10.1080/00222932608633413, DOI 10.1080/00222932608633413]; Parker HW., 1935, P ZOOL SOC LOND, V1935, P505, DOI DOI 10.1111/J.1096-3642.1935.TB01678.X; Peters J. A, 1970, Bull. U.S. natn. Mus., VNo. 297, P1; Pseudogonatodes sp.3: COLOMBIA, UISMHNR3795 UISMHNR3795; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rangel-Ch J.O., 2012, BIODIVERSIDAD MUNICI; Rivas GA, 2013, S AM J HERPETOL, V8, P5, DOI 10.2994/SAJH-D-12-18212.1; RIVERO JUAN A., 1963, CARIBBEAN J SCI, V3, P103; Roux J., 1927, VERHANDLUNGEN NATURF, V38, P252; Ruiz C. P., 1994, REV COLOMBIANA ACAD, VXIX, P153; Ruthven A.G., 1922, MUSEUM OF ZOOLOGY, V8, P1; Ruthven A.G., 1915, OCCAS PAP MUS ZOOL U, V19, P1; Sanchez-C H., 1995, COLOMBIA DIVERSIDAD, P277; Sanchez-Pacheco SJ, 2018, CLADISTICS, V34, P260, DOI 10.1111/cla.12203; Sanchez-Pacheco SJ, 2017, ZOOKEYS, P149, DOI 10.3897/zookeys.691.13595; Sentzen U.J, 1796, ZOOLOGISCHES ARCHIV ZOOLOGISCHES ARCHIV, V2, P66; Shreve Benjamin, 1947, BULL MUS COMP ZOOL [HARVARD UNIV], V99, P519; Uetz P, 2019, REPTILE DATABASE; VANZOLINI P E, 1968, Arquivos de Zoologia do Estado de Sao Paulo, V17, P85; VANZOLINI P. E., 1967, PAPEIS AVULSOS ZOOL S PAULO, V21, P1	67	0	0	0	0	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	JAN 20	2021	4915	1					41	59		10.11646/zootaxa.4915.1.3	http://dx.doi.org/10.11646/zootaxa.4915.1.3			19	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	TI1VG	33756583				2022-09-04	WOS:000672572300003
J	Mohammadi, A; Blesso, CN; Barreto, GE; Banach, M; Majeed, M; Sahebkar, A				Mohammadi, Asadollah; Blesso, Christopher N.; Barreto, George E.; Banach, Maciej; Majeed, Muhammed; Sahebkar, Amirhossein			Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Review						Dietary polyphenols; Curcumin; Macrophage; Immune system; Inflammation; Cytokine	NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NITRIC-OXIDE SYNTHASE; FATTY LIVER-DISEASE; PROINFLAMMATORY CYTOKINE PRODUCTION; INDUCED INFLAMMATORY RESPONSE; RANDOMIZED CONTROLLED-TRIAL; PROSTAGLANDIN E-2 SYNTHESIS; QUALITY-OF-LIFE; MOLECULAR-MECHANISMS	Monocytes and macrophages are important cells of the innate immune system that have diverse functions, including defense against invading pathogens, removal of dead cells by phagocytosis, antigen presentation in the context of MHC class I and class II molecules, and production of various pro-inflammatory cytokines and chemokines such as IL-1 beta, IL-6, TNF-alpha and MCP-1. In addition, pro-inflammatory (M1) and anti-inflammatory (M2) macrophages clearly play important roles in the progression of several inflammatory diseases. Therefore, therapies that target macrophage polarization and function by either blocking their trafficking to sites of inflammation, or skewing M1 to M2 phenotype polarization may hold clinical promise in several inflammatory diseases. Dietary-derived polyphenols have potent natural anti-oxidative properties. Within this group of polyphenols, curcumin has been shown to suppress macrophage inflammatory responses. Curcumin significantly reduces co-stimulatory molecules and also inhibits MAPK activation and the translocation of NF-kappa B p65. Curcumin can also polarize/repolarize macrophages toward the M2 phenotype. Curcumin-treated macrophages have been shown to be highly efficient at antigen capture and endocytosis via the mannose receptor. These novel findings provide new perspectives for the understanding of the immunopharmacological role of curcumin, as well as its therapeutic potential for impacting macrophage polarization and function in the context of inflammation-related disease. However, the precise effects of curcumin on the migration, differentiation, polarization and immunostimulatory functions of macrophages remain unknown. Therefore, in this review, we summarized whether curcumin can influence macrophage polarization, surface molecule expression, cytokine and chemokine production and their underlying pathways in the prevention of inflammatory diseases. (C) 2018 Elsevier Inc. All rights reserved.	[Mohammadi, Asadollah] Kurdistan Univ Med Sci, Cellular & Mol Res Ctr, Sanandaj, Iran; [Blesso, Christopher N.] Univ Connecticut, Dept Nutr Sci, Storrs, CT USA; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Banach, Maciej] Med Univ Lodz, WAM Univ Hosp Lodz, Dept Hypertens, Zeromskiego 113, Lodz, Poland; [Banach, Maciej] PMMHRI, Lodz, Poland; [Majeed, Muhammed] Sabinsa Corp, East Windsor, NJ USA; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Univ Western Australia, Sch Med, Perth, WA, Australia		Sahebkar, A (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, POB 91779-48564, Mashhad, Razavi Khorasan, Iran.	sahebkara@mums.ac.ir	Barreto, George E./AAD-7420-2020; Banach, Maciej/A-1271-2009; Blesso, Christopher/AAK-3357-2020; Mohammadi, Asadollah/E-1411-2018; Sahebkar, Amirhossein/B-5124-2018	Barreto, George E./0000-0002-6644-1971; Banach, Maciej/0000-0001-6690-6874; Mohammadi, Asadollah/0000-0002-6695-0506; 				Abdollahi E, 2018, J CELL PHYSIOL, V233, P830, DOI 10.1002/jcp.25778; Abe Y, 1999, PHARMACOL RES, V39, P41, DOI 10.1006/phrs.1998.0404; Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Ali SO, 2016, BASIC CLIN PHARMACOL, V118, P369, DOI 10.1111/bcpt.12502; Aluwi MFFM, 2016, BIOORG MED CHEM LETT, V26, P2531, DOI 10.1016/j.bmcl.2016.03.092; Amano C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137207; Antoine F, 2013, INT IMMUNOPHARMACOL, V17, P1101, DOI 10.1016/j.intimp.2013.09.024; Areiza-Mazo N, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00276; Bai XY, 2016, RESPIROLOGY, V21, P951, DOI 10.1111/resp.12762; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Barreto GE, 2012, NUTR NEUROSCI, V15, P92, DOI 10.1179/12Z.00000000034; Ben PL, 2011, INT IMMUNOPHARMACOL, V11, P179, DOI 10.1016/j.intimp.2010.11.013; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Bhaumik S, 2000, FEBS LETT, V483, P78, DOI 10.1016/S0014-5793(00)02089-5; Bisht K, 2009, BIOCHEM BIOPH RES CO, V379, P632, DOI 10.1016/j.bbrc.2008.12.135; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Bromelow KV, 2001, J IMMUNOL METHODS, V247, P1, DOI 10.1016/S0022-1759(00)00311-2; BROUET I, 1995, BIOCHEM BIOPH RES CO, V206, P533, DOI 10.1006/bbrc.1995.1076; Buckley RJ, 2016, PLACENTA, V47, P73, DOI 10.1016/j.placenta.2016.09.004; Bukhari SNA, 2014, BIOORGAN MED CHEM, V22, P4151, DOI 10.1016/j.bmc.2014.05.052; Cao FJ, 2015, INT J CLIN EXP PATHO, V8, P6037; Cao HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106007; Cao JT, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00062; Cao JT, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0266-2; Casey SC, 2015, SEMIN CANCER BIOL, V35, pS199, DOI 10.1016/j.semcancer.2015.02.007; Castro CN, 2014, CLIN EXP IMMUNOL, V177, P149, DOI 10.1111/cei.12322; Chan MMY, 1998, BIOCHEM PHARMACOL, V55, P1955, DOI 10.1016/S0006-2952(98)00114-2; Chauhan PS, 2017, INFLAMMATION, V40, P248, DOI 10.1007/s10753-016-0475-3; Chauhan PS, 2014, INT IMMUNOPHARMACOL, V21, P63, DOI 10.1016/j.intimp.2014.03.021; Chen FY, 2015, BIOCHEM BIOPH RES CO, V467, P872, DOI 10.1016/j.bbrc.2015.10.051; Chen FY, 2014, J CARDIOVASC PHARM, V63, P544, DOI 10.1097/FJC.0000000000000079; Chen JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10278; Cheng CI, 2015, CELL SIGNAL, V27, P283, DOI 10.1016/j.cellsig.2014.11.012; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Chistiakov DA, 2015, INT J CARDIOL, V184, P436, DOI 10.1016/j.ijcard.2015.03.055; Chong L, 2014, INFLAMMATION, V37, P1476, DOI 10.1007/s10753-014-9873-6; Chuengsamarn S, 2012, DIABETES CARE, V35, P2121, DOI 10.2337/dc12-0116; Chung SH, 2012, MOL VIS, V18, P1966; Cianciulli A, 2016, INT IMMUNOPHARMACOL, V36, P282, DOI 10.1016/j.intimp.2016.05.007; Cipriani B, 2001, J IMMUNOL, V167, P3454, DOI 10.4049/jimmunol.167.6.3454; Coban D, 2012, MOL NUTR FOOD RES, V56, P1270, DOI 10.1002/mnfr.201100818; Derosa G, 2016, PHARMACOL RES, V111, P394, DOI 10.1016/j.phrs.2016.07.004; Devi YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125627; Ding FJ, 2016, EXP THER MED, V12, P823, DOI 10.3892/etm.2016.3413; Doumiati S, 2012, J MOL RECOGNIT, V25, P623, DOI 10.1002/jmr.2194; Echeverria V, 2017, CURR MED CHEM, V24, P411, DOI 10.2174/0929867323666161101140908; El-Bahr SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-368; Esmaily H, 2015, CHIN J INTEGR MED, V21, P332, DOI 10.1007/s11655-015-2160-z; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fan CL, 2006, J ETHNOPHARMACOL, V105, P251, DOI 10.1016/j.jep.2005.11.009; Farhood B, 2019, J CELL PHYSIOL, V234, P5728, DOI 10.1002/jcp.27442; Fu YM, 2008, MOL PHARMACOL, V73, P399, DOI 10.1124/mol.107.039818; Gafner S, 2004, PHYTOCHEMISTRY, V65, P2849, DOI 10.1016/j.phytochem.2004.08.008; Ganjali S, 2014, SCIENTIFICWORLDJOURN, V2014; Ganjali S, 2017, PHARMACOL RES, V119, P208, DOI 10.1016/j.phrs.2017.02.008; Ganz T, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0037-2016; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Gao SS, 2015, J MOL CELL CARDIOL, V85, P131, DOI 10.1016/j.yjmcc.2015.04.025; Gao XH, 2004, BIOCHEM PHARMACOL, V68, P51, DOI 10.1016/j.bcp.2004.03.015; Gautam SC, 2007, ADV EXP MED BIOL, V595, P321; Ghandadi M, 2017, CURR PHARM DESIGN, V23, P921, DOI 10.2174/1381612822666161006151605; Ghosh S, 2015, FOOD CHEM TOXICOL, V83, P111, DOI 10.1016/j.fct.2015.05.022; Gong P, 2016, PLACENTA, V41, P45, DOI 10.1016/j.placenta.2016.03.002; Gonzales AM, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-17; Grabiec AM, 2016, SEMIN IMMUNOPATHOL, V38, P409, DOI 10.1007/s00281-016-0555-3; Guimaraes MR, 2013, ARCH ORAL BIOL, V58, P1309, DOI 10.1016/j.archoralbio.2013.07.005; Gullo F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00500; Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x; Hasan ST, 2014, ATHEROSCLEROSIS, V232, P40, DOI 10.1016/j.atherosclerosis.2013.10.016; He GL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147721; He GL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-49; Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165; Huang R, 2016, DISCOV MED, V21, P447; Huang SS, 2016, EUR J PHARMACOL, V779, P22, DOI 10.1016/j.ejphar.2016.02.067; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Jacob A, 2007, PPAR RES, V2007, DOI 10.1155/2007/89369; Jagetia GC, 2007, J CLIN IMMUNOL, V27, P19, DOI 10.1007/s10875-006-9066-7; Jain K, 2013, BRAZ J INFECT DIS, V17, P579, DOI 10.1016/j.bjid.2013.03.004; Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jiang ZL, 2016, J ASTHMA ALLERGY, V9, P101, DOI 10.2147/JAA.S104508; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Jurado-Coronel JC, 2016, CNS NEUROL DISORD-DR, V15, P292, DOI 10.2174/1871527315666160202125519; Kang BY, 1999, EUR J PHARMACOL, V384, P191, DOI 10.1016/S0014-2999(99)00690-1; Kang BY, 1999, BRIT J PHARMACOL, V128, P380, DOI 10.1038/sj.bjp.0702803; Karaman M, 2012, ALLERGOL IMMUNOPATH, V40, P210, DOI 10.1016/j.aller.2011.04.006; Karaman M, 2011, ARCH MED RES, V42, P79, DOI 10.1016/j.arcmed.2011.01.011; Karimian MS, 2017, CYTOKINE GROWTH F R, V33, P55, DOI 10.1016/j.cytogfr.2016.10.001; Karlstetter M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-125; Karuppagounder V, 2016, CYTOKINE, V84, P1, DOI 10.1016/j.cyto.2016.05.001; Kim DH, 2011, ALLERGY RHINOL, V2, pE51, DOI 10.2500/ar.2011.2.0016; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Kinney SRM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132467; Kobayashi T, 1997, BIOCHEM PHARMACOL, V54, P819, DOI 10.1016/S0006-2952(97)00220-7; Komohara Y, 2016, ADV DRUG DELIVER REV, V99, P180, DOI 10.1016/j.addr.2015.11.009; Kong FQ, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00369; Kumari A, 2015, CYTOKINE, V76, P334, DOI 10.1016/j.cyto.2015.07.022; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Kunwittaya S, 2014, EXCLI J, V13, P287; Kurup VP, 2008, MOL NUTR FOOD RES, V52, P1031, DOI 10.1002/mnfr.200700293; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Lai AY, 2012, FUTUR NEUROL, V7, P165, DOI 10.2217/FNL.12.6; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Lee KH, 2011, MOLECULES, V16, P9728, DOI 10.3390/molecules16119728; Lee WH, 2016, PHARM RES-DORDR, V33, P315, DOI 10.1007/s11095-015-1789-9; Lelli D, 2017, PHARMACOL RES, V115, P133, DOI 10.1016/j.phrs.2016.11.017; Li L, 2004, CIRC RES, V94, P892, DOI 10.1161/01.RES.0000124920.09738.26; Li MY, 2014, BIOCHEM BIOPH RES CO, V446, P626, DOI 10.1016/j.bbrc.2014.03.023; Li MY, 2014, MOL MED REP, V10, P3261, DOI 10.3892/mmr.2014.2615; Li Xinjian, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P137; Liu LY, 2015, CLIN EXP PHARMACOL P, V42, P520, DOI 10.1111/1440-1681.12384; Liu TR, 2014, INFLAMM RES, V63, P841, DOI 10.1007/s00011-014-0758-9; Lubbad A, 2009, MOL CELL BIOCHEM, V322, P127, DOI 10.1007/s11010-008-9949-4; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Maradana MR, 2013, MOL NUTR FOOD RES, V57, P1550, DOI 10.1002/mnfr.201200791; Martin CJ, 2014, CURR OPIN MICROBIOL, V17, P17, DOI 10.1016/j.mib.2013.10.007; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; Mayer BA, 2011, ARTERIOSCL THROM VAS, V31, P2240, DOI 10.1161/ATVBAHA.111.234294; Mazo NA, 2017, CURR PHARM DESIGN, V23, P4180, DOI 10.2174/1381612823666170316142803; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Memvanga PB, 2013, J CONTROL RELEASE, V172, P904, DOI 10.1016/j.jconrel.2013.09.001; Mills CD, 2001, CRIT REV IMMUNOL, V21, P399, DOI 10.1615/critrevimmunol.v21.i5.10; Mimche PN, 2012, J ANTIMICROB CHEMOTH, V67, P1895, DOI 10.1093/jac/dks132; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirzaei H, 2017, BIOMED PHARMACOTHER, V85, P102, DOI 10.1016/j.biopha.2016.11.098; Mirzaei H, 2016, INT J CANCER, V139, P1683, DOI 10.1002/ijc.30224; Mohammadi A, 2013, PHYTOTHER RES, V27, P374, DOI 10.1002/ptr.4715; Mohammadi A, 2017, BIOMED PHARMACOTHER, V85, P457, DOI 10.1016/j.biopha.2016.11.050; Momtazi AA, 2016, REV PHYSIOL BIOCH P, V171, P1, DOI 10.1007/112_2016_3; Momtazi AA, 2016, CURR PHARM DESIGN, V22, P4386, DOI 10.2174/1381612822666160527113501; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001; Mukherjee S, 2016, INT J CANCER, V139, P2838, DOI 10.1002/ijc.30398; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Na LX, 2013, MOL NUTR FOOD RES, V57, P1569, DOI 10.1002/mnfr.201200131; Nagamatsu T, 2010, AM J REPROD IMMUNOL, V63, P460, DOI 10.1111/j.1600-0897.2010.00813.x; Nagaraju GP, 2015, CANCER LETT, V357, P557, DOI 10.1016/j.canlet.2014.12.007; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; Nakagawa Y, 2015, PHARMACOL THERAPEUT, V154, P21, DOI 10.1016/j.pharmthera.2015.06.010; Nakamura Tatsufumi, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P137; Nandakumar DN, 2006, ANTIMICROB AGENTS CH, V50, P1859, DOI 10.1128/AAC.50.5.1859-1860.2006; Nayak AP, 2010, COLLOID SURFACE B, V81, P263, DOI 10.1016/j.colsurfb.2010.07.020; Neto Zoraima, 2013, J Parasitol Res, V2013, P429736, DOI 10.1155/2013/429736; Ning F, 2016, AM J REPROD IMMUNOL, V75, P298, DOI 10.1111/aji.12477; Padmanaban G, 2016, TRENDS PHARMACOL SCI, V37, P1, DOI 10.1016/j.tips.2015.09.007; Pan MH, 2000, BIOCHEM PHARMACOL, V60, P1665, DOI 10.1016/S0006-2952(00)00489-5; Pan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079084; Pan Y, 2013, J NUTR BIOCHEM, V24, P146, DOI 10.1016/j.jnutbio.2012.03.012; Pan Y, 2012, BRIT J PHARMACOL, V166, P1169, DOI 10.1111/j.1476-5381.2012.01854.x; Panahi Y, 2018, J CELL PHYSIOL, V233, P141, DOI 10.1002/jcp.25756; Panahi Y, 2017, DRUG RES, V67, P244, DOI 10.1055/s-0043-100019; Panahi Y, 2017, INFLAMMOPHARMACOLOGY, V25, P25, DOI 10.1007/s10787-016-0301-4; Panahi Y, 2016, J CARDIOVASC PHARM, V68, P223, DOI 10.1097/FJC.0000000000000406; Panahi Y, 2016, NUTRITION, V32, P1116, DOI 10.1016/j.nut.2016.03.018; Panahi Y, 2016, BIOMED PHARMACOTHER, V82, P578, DOI 10.1016/j.biopha.2016.05.037; Panahi Y, 2015, CLIN NUTR, V34, P1101, DOI 10.1016/j.clnu.2014.12.019; Panahi Yunes, 2016, Journal of Dietary Supplements, V13, P93, DOI 10.3109/19390211.2014.952865; Panahi Y, 2015, PHYTOTHER RES, V29, P17, DOI 10.1002/ptr.5211; Panahi Y, 2014, COMPLEMENT THER MED, V22, P851, DOI 10.1016/j.ctim.2014.07.006; Panahi Y, 2014, PHYTOTHER RES, V28, P1625, DOI 10.1002/ptr.5174; Panahi Y, 2012, ANN CLIN BIOCHEM, V49, P580, DOI 10.1258/acb.2012.012040; Panahi Y, 2012, BRIT J NUTR, V108, P1272, DOI 10.1017/S0007114511006544; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Park SH, 2003, DNA CELL BIOL, V22, P131, DOI 10.1089/104454903321515931; Patel U, 2017, DRUG DISCOV TODAY, V22, P186, DOI 10.1016/j.drudis.2016.08.006; Porta C, 2015, SEMIN IMMUNOL, V27, P237, DOI 10.1016/j.smim.2015.10.003; Prasad S, 2014, BIOTECHNOL ADV, V32, P1053, DOI 10.1016/j.biotechadv.2014.04.004; Putta S, 2017, CURR PHARM DESIGN, V23, P6321, DOI 10.2174/1381612823666170519151801; Rahimifard M, 2017, AGEING RES REV, V36, P11, DOI 10.1016/j.arr.2017.02.004; Rahmani S, 2016, PHYTOTHER RES, V30, P1540, DOI 10.1002/ptr.5659; Rajasingh J, 2006, BIOCHEM BIOPH RES CO, V340, P359, DOI 10.1016/j.bbrc.2005.12.014; Ramezani M, 2018, J CELL PHYSIOL, V233, P880, DOI 10.1002/jcp.25795; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Reddy RC, 2005, BIOCHEM BIOPH RES CO, V326, P472, DOI 10.1016/j.bbrc.2004.11.051; Rezaee R, 2017, PHARMACOL RES, V117, P218, DOI 10.1016/j.phrs.2016.12.037; Rushworth SA, 2006, BIOCHEM BIOPH RES CO, V341, P1007, DOI 10.1016/j.bbrc.2006.01.065; Sahebkar A, 2017, J CACHEXIA SARCOPENI, V8, P19, DOI 10.1002/jcsm.12140; Sahebkar A, 2016, PAIN MED, V17, P1192, DOI 10.1093/pm/pnv024; Sahebkar A, 2016, PHARMACOL RES, V107, P234, DOI 10.1016/j.phrs.2016.03.026; Sahebkar A, 2015, J FUNCT FOODS, V18, P898, DOI 10.1016/j.jff.2015.01.005; Sahebkar A, 2014, PHYTOTHER RES, V28, P633, DOI 10.1002/ptr.5045; Sahebkar A, 2014, NAT REV CARDIOL, V11, P12, DOI 10.1038/nrcardio.2013.139-c1; Sahebkar A, 2013, PHYTOTHER RES, V27, P1883, DOI 10.1002/ptr.4952; Sahebkar A, 2010, FERTIL STERIL, V94, pE75, DOI 10.1016/j.fertnstert.2010.07.1071; Serghides L, 2001, J IMMUNOL, V166, P6742, DOI 10.4049/jimmunol.166.11.6742; Shan B, 2012, J ENDOCRINOL, V214, P389, DOI 10.1530/JOE-12-0207; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shin HS, 2015, J ETHNOPHARMACOL, V175, P21, DOI 10.1016/j.jep.2015.08.038; Shiri Sadaf, 2015, Asian Pac J Cancer Prev, V16, P3917; Shirley SA, 2008, BIOCHEM BIOPH RES CO, V374, P431, DOI 10.1016/j.bbrc.2008.07.051; Shishodia S, 2013, BIOFACTORS, V39, P37, DOI 10.1002/biof.1041; Sica A, 2015, CELL MOL LIFE SCI, V72, P4111, DOI 10.1007/s00018-015-1995-y; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Singh SK, 2017, CURR DRUG METAB, V18, P112, DOI 10.2174/1389200217666161201112206; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Srivastava RM, 2011, INT IMMUNOPHARMACOL, V11, P331, DOI 10.1016/j.intimp.2010.08.014; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Subhashini, 2016, INT IMMUNOPHARMACOL, V31, P200, DOI 10.1016/j.intimp.2015.12.025; Subhashini, 2013, INT IMMUNOPHARMACOL, V17, P733, DOI 10.1016/j.intimp.2013.08.008; Suzuki H, 2016, IMMUNOL LETT, V176, P18, DOI 10.1016/j.imlet.2016.05.009; Teymouri M, 2017, BIOFACTORS, V43, P331, DOI 10.1002/biof.1344; Tomita M, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-8; Torres-Castro I, 2016, IMMUNOL LETT, V176, P81, DOI 10.1016/j.imlet.2016.06.001; Tu CT, 2012, FOOD CHEM TOXICOL, V50, P3343, DOI 10.1016/j.fct.2012.05.050; Tu CT, 2012, INT IMMUNOPHARMACOL, V12, P151, DOI 10.1016/j.intimp.2011.11.005; Varalakshmi C, 2008, INT IMMUNOPHARMACOL, V8, P688, DOI 10.1016/j.intimp.2008.01.008; Vathsala PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029442; Veillat V, 2009, FERTIL STERIL, V91, P2148, DOI 10.1016/j.fertnstert.2008.05.017; Vizzutti F, 2010, LAB INVEST, V90, P104, DOI 10.1038/labinvest.2009.112; Waknine-Grinberg JH, 2010, EXP PARASITOL, V125, P141, DOI 10.1016/j.exppara.2010.01.005; Woo HM, 2007, LIFE SCI, V80, P926, DOI 10.1016/j.lfs.2006.11.030; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Wu SH, 2016, ANN ALLERG ASTHMA IM, V117, P697, DOI 10.1016/j.anai.2016.09.427; Wurm T, 2012, NUCLEIC ACIDS RES, V40, P5910, DOI 10.1093/nar/gks244; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang CW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-22; Ye N, 2014, J MED CHEM, V57, P6930, DOI 10.1021/jm5004733; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P62, DOI 10.1016/j.bcp.2006.03.022; Young NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111559; Youreva V, 2013, CAN J PHYSIOL PHARM, V91, P241, DOI 10.1139/cjpp-2012-0267; Yu S, 2016, CELL STRESS CHAPERON, V21, P697, DOI 10.1007/s12192-016-0695-3; Yun JM, 2011, J NUTR BIOCHEM, V22, P450, DOI 10.1016/j.jnutbio.2010.03.014; Zabihi NA, 2017, CURR PHARM DESIGN, V23, P969, DOI 10.2174/1381612822666161010115235; Zhang L, 2006, J ALZHEIMERS DIS, V10, P1; Zhang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065896; Zhao CG, 2010, EUR J MED CHEM, V45, P5773, DOI 10.1016/j.ejmech.2010.09.037; Zhao CG, 2010, BIOORGAN MED CHEM, V18, P2388, DOI 10.1016/j.bmc.2010.03.001; Zhao F, 2015, MOL MED REP, V11, P3087, DOI 10.3892/mmr.2014.3079; Zhao JF, 2012, MOL NUTR FOOD RES, V56, P691, DOI 10.1002/mnfr.201100735; Zhong K, 2015, CELL BIOCHEM BIOPHYS, V73, P175, DOI 10.1007/s12013-015-0664-y; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhou JJ, 2017, INFLAMM RES, V66, P177, DOI 10.1007/s00011-016-1004-4; Zhou YY, 2015, CELL PHYSIOL BIOCHEM, V36, P631, DOI 10.1159/000430126; Zhuang PW, 2017, J ETHNOPHARMACOL, V198, P194, DOI 10.1016/j.jep.2016.11.052; Zingg JM, 2012, J CELL BIOCHEM, V113, P833, DOI 10.1002/jcb.23411	246	54	57	5	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	APR	2019	66						1	16		10.1016/j.jnutbio.2018.12.005	http://dx.doi.org/10.1016/j.jnutbio.2018.12.005			16	Biochemistry & Molecular Biology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Nutrition & Dietetics	HT3SW	30660832				2022-09-04	WOS:000464484500001
J	Forero, DA; Gonzalez-Giraldo, Y; Lopez-Quintero, C; Castro-Vega, LJ; Barreto, GE; Perry, G				Forero, Diego A.; Gonzalez-Giraldo, Yeimy; Lopez-Quintero, Catalina; Castro-Vega, Luis J.; Barreto, George E.; Perry, George			Meta-analysis of Telomere Length in Alzheimer's Disease	JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES			English	Article						Dementia; Epigenomics; Telomeres; Alzheimer's disease; Meta-analysis	MILD COGNITIVE IMPAIRMENT; BUCCAL CELLS; ASSOCIATION; DISORDERS; PATHOLOGY; GENETICS; STRESS; BLOOD	Alzheimer's disease (AD) is a common and severe neurodegenerative disorder. Human telomeres are fundamental for the maintenance of genomic stability and play prominent roles in both cellular senescence and organismal aging. Regulation of telomere length (TL) is the result of the complex interplay between environmental and genetic factors. Alterations in TL are increasingly being studied as a possible risk factor for AD, and published studies on TL in AD show discrepant results, highlighting the need for a meta-analysis. In the current study, we carried out a meta-analysis of published studies of TL in AD patients and healthy controls. PubMed, Web of Science and Google Scholar databases (from inception to September 2015) were used to identify relevant articles reporting TL in humans with AD, from which we retrieved data such as sample size, experimental methods, and mean TL for cases and controls. A random-effects model was used for meta-analytical procedures. The meta-analysis included 13 primary studies and demonstrated a significant difference in TL between 860 AD patients and 2,022 controls, with a standardized mean difference of -0.984 (confidence interval: -1.433 to -0.535; p value: <.001). Our results show a consistent evidence of shorter telomeres in AD patients and highlight the importance of the analysis of epigenomic markers associated with neurodegeneration and with the risk for common and severe neurological diseases, such as AD.	[Forero, Diego A.] Univ Antonio Narino, Sch Med, Biomed Sci Res Grp, Lab Neuropsychiat Genet, Bogota, Colombia; [Gonzalez-Giraldo, Yeimy; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Lopez-Quintero, Catalina] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Castro-Vega, Luis J.] Paris Cardiovasc Res Ctr, INSERM, UMR970, Paris, France; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Perry, George] Univ Texas San Antonio, Coll Sci, San Antonio, TX USA		Forero, DA (corresponding author), Univ Antonio Narino, Sch Med, Lab NeuroPsychiat Genet, Bogota, Colombia.	diego.forero@uan.edu.co	Gonzalez, Yeimy/Y-1975-2019; Barreto, George E./B-5747-2014; González-Giraldo, Yeimy/Q-5652-2018; Perry, George/A-8611-2009; Barreto, George E./AAD-7420-2020; Forero, Diego A./O-9981-2019; Castro-Vega, Luis Jaime/AAO-9988-2021; Castro-Vega, Luis Jaime/L-5587-2019	Gonzalez, Yeimy/0000-0002-2527-218X; Barreto, George E./0000-0002-6644-1971; González-Giraldo, Yeimy/0000-0002-2527-218X; Perry, George/0000-0002-6547-0172; Barreto, George E./0000-0002-6644-1971; Forero, Diego A./0000-0001-9175-3363; Castro-Vega, Luis Jaime/0000-0002-7232-9871; 	Colciencias; VCTI-UAN [20131079, 20131080]; Centro de Estudios Interdisciplinarios Basicos y Aplicados (CEIBA; Rodolfo Llinas Program); National Institute on Drug Abuse [T32DA021129]; Pontificia Universidad Javeriana; National Institutes of Health [G12-MD007591]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA021129] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); VCTI-UAN; Centro de Estudios Interdisciplinarios Basicos y Aplicados (CEIBA; Rodolfo Llinas Program); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Pontificia Universidad Javeriana; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	D.A.F. is supported by research grants from Colciencias and VCTI-UAN (grants # 20131079 and 20131080). Y.G.-G. is supported by a PhD fellowship from Centro de Estudios Interdisciplinarios Basicos y Aplicados (CEIBA; Rodolfo Llinas Program). C.L.-Q. is supported by the National Institute on Drug Abuse (grant # T32DA021129, PI: J. Anthony). G.E.B. work is supported by Pontificia Universidad Javeriana. G.P. is supported by a National Institutes of Health grant (G12-MD007591).	Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bin Wei Y, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv002; Cai ZY, 2013, NEUROMOL MED, V15, P25, DOI 10.1007/s12017-012-8207-9; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Cheng AW, 2007, J NEUROSCI, V27, P3722, DOI 10.1523/JNEUROSCI.0590-07.2007; Colpo GD, 2015, J AFFECT DISORDERS, V186, P241, DOI 10.1016/j.jad.2015.06.034; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Elbers CC, 2014, J GERONTOL A-BIOL, V69, P527, DOI 10.1093/gerona/glt121; Forero DA, 2006, J CELL MOL MED, V10, P796, DOI 10.1111/j.1582-4934.2006.tb00439.x; Forero DA, 2014, WORLD J PSYCHIATR, V4, P69, DOI 10.5498/wjp.v4.i4.69; Franco Sonia, 2006, Alzheimers Dement, V2, P164, DOI 10.1016/j.jalz.2006.03.001; Guan JZ, 2012, GERONTOLOGY, V58, P62, DOI 10.1159/000327821; Hochstrasser T, 2012, EXP GERONTOL, V47, P160, DOI 10.1016/j.exger.2011.11.012; Honig LS, 2012, ARCH NEUROL-CHICAGO, V69, P1332, DOI 10.1001/archneurol.2012.1541; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; King KS, 2014, JAMA NEUROL, V71, P1247, DOI 10.1001/jamaneurol.2014.1926; Kota LN, 2015, J NEUROPSYCH CLIN N, V27, pE92, DOI 10.1176/appi.neuropsych.13100240; Koziel JE, 2011, J CELL MOL MED, V15, P457, DOI 10.1111/j.1582-4934.2011.01276.x; Lindqvist D, 2015, NEUROSCI BIOBEHAV R, V55, P333, DOI 10.1016/j.neubiorev.2015.05.007; Lukens JN, 2009, ALZHEIMERS DEMENT, V5, P463, DOI 10.1016/j.jalz.2009.05.666; Mathur S, 2014, J ALZHEIMERS DIS, V39, P35, DOI 10.3233/JAD-130866; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Moverare-Skrtic S, 2012, EXP GERONTOL, V47, P179, DOI 10.1016/j.exger.2011.12.005; Mundstock E, 2015, AGEING RES REV, V22, P72, DOI 10.1016/j.arr.2015.02.004; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Rolyan H, 2011, BRAIN, V134, P2044, DOI 10.1093/brain/awr133; Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028; Schutte NS, 2016, STRESS HEALTH, V32, P313, DOI 10.1002/smi.2607; Spilsbury A, 2015, J NEUROSCI, V35, P1659, DOI 10.1523/JNEUROSCI.2925-14.2015; Takata Y, 2012, J GERONTOL A-BIOL, V67, P330, DOI 10.1093/gerona/glr185; Tedone E, 2015, J ALZHEIMERS DIS, V46, P761, DOI 10.3233/JAD-142808; Thomas P, 2008, MECH AGEING DEV, V129, P183, DOI 10.1016/j.mad.2007.12.004; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Wikgren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034292; Wikgren M, 2012, NEUROBIOL AGING, V33, P335, DOI 10.1016/j.neurobiolaging.2010.03.004; Zekry D, 2010, J NEUROL SCI, V299, P108, DOI 10.1016/j.jns.2010.07.019; Zhan YQ, 2015, JAMA NEUROL, V72, P1202, DOI 10.1001/jamaneurol.2015.1513; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052; Zhou QG, 2011, J NEUROSCI, V31, P12258, DOI 10.1523/JNEUROSCI.0805-11.2011	40	121	131	0	32	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5006	1758-535X		J GERONTOL A-BIOL	J. Gerontol. Ser. A-Biol. Sci. Med. Sci.	AUG	2016	71	8					1069	1073		10.1093/gerona/glw053	http://dx.doi.org/10.1093/gerona/glw053			5	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	DV9BX	27091133	Green Published, Bronze			2022-09-04	WOS:000383235400011
J	Rojas, MA; Lozano, JM; Rojas, MX; Laughon, M; Bose, CL; Rondon, MA; Charry, L; Bastidas, JA; Perez, LA; Rojas, C; Ovalle, O; Celis, LA; Garcia-Harker, J; Jaramillo, ML				Rojas, Mario Augusto; Manuel Lozano, Juan; Ximena Rojas, Maria; Laughon, Matthew; Bose, Carl Lewis; Alonso Rondon, Martin; Charry, Laura; Alberto Bastidas, Jaime; Alfonso Perez, Luis; Rojas, Catherine; Ovalle, Oscar; Astrid Celis, Luz; Garcia-Harker, Jorge; Lucia Jaramillo, Martha		Colombian Neonatal Res Network	Very Early Surfactant Without Mandatory Ventilation in Premature Infants Treated With Early Continuous Positive Airway Pressure: A Randomized, Controlled Trial	PEDIATRICS			English	Article						very early surfactant; early nasal continuous positive airway pressure; respiratory distress syndrome; preterm infant; mandatory ventilation	CHRONIC LUNG-DISEASE; BRONCHOPULMONARY DYSPLASIA; RISK-FACTORS; MECHANISMS; INJURY	BACKGROUND. Chronic lung disease is one of the most frequent and serious complications of premature birth. Because mechanical ventilation is a major risk factor for chronic lung disease, the early application of nasal continuous positive airway pressure has been used as a strategy for avoiding mechanical ventilation in premature infants. Surfactant therapy improves the short-term respiratory status of premature infants, but its use is traditionally limited to infants being mechanically ventilated. Administration of very early surfactant during a brief period of intubation to infants treated with nasal continuous positive airway pressure may improve their outcome and further decrease the need for mechanical ventilation. OBJECTIVE. Our goal was to determine if very early surfactant therapy without mandatory ventilation improves outcome and decreases the need for mechanical ventilation when used in very premature infants treated with nasal continuous positive airway pressure soon after birth. DESIGN/METHODS. Eight centers in Colombia participated in this randomized, controlled trial. Infants born between 27 and 31(6/7) weeks' gestation with evidence of respiratory distress and treated with supplemental oxygen in the delivery room were randomly assigned within the first hour of life to intubation, very early surfactant, extubation, and nasal continuous positive airway pressure (treatment group) or nasal continuous airway pressure alone (ontrol group). The primary outcome was the need for subsequent mechanical ventilation using predefined criteria. RESULTS. From January 1, 2004, to December 31, 2006, 279 infants were randomly assigned, 141 to the treatment group and 138 to the control group. The need for mechanical ventilation was lower in the treatment group (26%) compared with the control group (39%). Air- leak syndrome occurred less frequently in the treatment group (2%) compared with the control group (9%). The percentage of patients receiving surfactant after the first hour of life was also significantly less in the treatment group (12%) compared with the control group (26%). The incidence of chronic lung disease (oxygen treatment at 36 weeks' postmenstrual age) was 49% in the treatment group compared with 59% in the control group. All other outcomes, including mortality, intraventricular hemorrhage, and periventricular leukomalacia were similar between the groups. CONCLUSIONS. In premature infants treated with nasal continuous positive airway pressure early after birth, the addition of very early surfactant therapy without mandatory ventilation decreased the need for subsequent mechanical ventilation, decreased the incidence of air-leak syndrome, and seemed to be safe. Reduction in the need for mechanical ventilation is an important outcome when medical resources are limited and may result in less chronic lung disease in both developed and developing countries. Pediatrics 2009; 123: 137-142	[Rojas, Mario Augusto] Vanderbilt Univ, Div Neonatal Perinatal Med, Dept Pediat, Nashville, TN 37232 USA; [Manuel Lozano, Juan; Ximena Rojas, Maria; Alonso Rondon, Martin; Charry, Laura] Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Laughon, Matthew; Bose, Carl Lewis] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Alberto Bastidas, Jaime] Clin Los Farallones Remedios, Cali, Colombia; [Astrid Celis, Luz] Hosp Univ Santander, Dept Pediat, Bucaramanga, Colombia; [Rojas, Catherine] Policlin Olaya, Bogota, Colombia; [Ovalle, Oscar] Saludcoop, Bogota, Colombia; [Astrid Celis, Luz] Hosp Univ Simon Bolivar, Dept Pediat, Bogota, Colombia; [Garcia-Harker, Jorge] Clin San Luis, Bucaramanga, Colombia; [Lucia Jaramillo, Martha] Fdn Valle Lili, Cali, Colombia		Rojas, MA (corresponding author), Vanderbilt Univ, Div Neonatal Perinatal Med, Dept Pediat, 11111 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.	mario.a.rojas@vanderbilt.edu	Rojas-Reyes, Maria Ximena/AAD-6800-2019; RONDON, MARTIN/AAD-5855-2019	Rojas-Reyes, Maria Ximena/0000-0001-5752-7653; RONDON, MARTIN/0000-0002-3885-5448; Charry, Laura/0000-0002-4457-6824	Vanderbilt University, Universidad Javeriana; University of North Carolina, Fisher & Paykel Healthcare; Abbott Laboratories	Vanderbilt University, Universidad Javeriana; University of North Carolina, Fisher & Paykel Healthcare; Abbott Laboratories(Abbott Laboratories)	This research was supported by Vanderbilt University, Universidad Javeriana, University of North Carolina, Fisher & Paykel Healthcare, and Abbott Laboratories.	AVERY ME, 1987, PEDIATRICS, V79, P26; Bancalari E, 2001, BIOL NEONATE, V80, P7, DOI 10.1159/000047170; Bjorklund LJ, 1997, PEDIATR RES, V42, P348; Blackmon L, 2005, PEDIATRICS, V115, P1118, DOI 10.1542/peds.2005-0452; BOWERMAN RA, 1984, RADIOLOGY, V151, P383, DOI 10.1148/radiology.151.2.6709907; BRUCE MC, 1992, AM REV RESPIR DIS, V146, P204, DOI 10.1164/ajrccm/146.1.204; Dani C, 2004, PEDIATRICS, V113, pE560, DOI 10.1542/peds.113.6.e560; Darlow B.A., 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000501; GERHARDT T, 1979, PEDIATRICS, V63, P537; HERNANDEZ LA, 1989, J APPL PHYSIOL, V66, P2364, DOI 10.1152/jappl.1989.66.5.2364; Jobe AH, 1998, EARLY HUM DEV, V53, P81, DOI 10.1016/S0378-3782(98)00045-0; Kattwinkel J, 2000, TXB NEONATAL RESUSCI, V4th ed.; Korhonen P, 1999, EARLY HUM DEV, V54, P245, DOI 10.1016/S0378-3782(98)00101-7; Lannon C, 2004, PEDIATRICS, V114, P494, DOI 10.1542/peds.114.2.494; LOZANO JM, 1992, ARCH DIS CHILD, V67, P299, DOI 10.1136/adc.67.3.299; Manktelow BN, 2001, ARCH DIS CHILD-FETAL, V85, pF33, DOI 10.1136/fn.85.1.F33; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; PARKER JC, 1993, CRIT CARE MED, V21, P131, DOI 10.1097/00003246-199301000-00024; PARKER RA, 1992, PEDIATRICS, V90, P663; Reininger Ann, 2005, J Perinatol, V25, P703, DOI 10.1038/sj.jp.7211381; Soll R., 2001, COCHRANE LIB; SOLL RF, 2000, COCHRANE DB SYST REV; Van Marter LJ, 2000, PEDIATRICS, V105, P1194, DOI 10.1542/peds.105.6.1194; VANMARTER LJ, 1992, J PEDIATR-US, V120, P938, DOI 10.1016/S0022-3476(05)81968-7; Verder H, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.2.e24; VERDER H, 1994, NEW ENGL J MED, V331, P1051, DOI 10.1056/NEJM199410203311603	26	135	146	0	12	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JAN	2009	123	1					137	142		10.1542/peds.2007-3501	http://dx.doi.org/10.1542/peds.2007-3501			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	388UZ	19117872				2022-09-04	WOS:000262046400020
J	Jaramillo-Jimenez, A; Suarez-Revelo, JX; Ochoa-Gomez, JF; Arroyave, JAC; Bocanegra, Y; Lopera, F; Buritica, O; Pineda-Salazar, DA; Gomez, LM; Quintero, CAT; Borda, MG; Bonanni, L; Ffytche, DH; Bronnick, K; Aarsland, D				Jaramillo-Jimenez, Alberto; Ximena Suarez-Revelo, Jazmin; Fredy Ochoa-Gomez, John; Carmona Arroyave, Jairo Alexander; Bocanegra, Yamile; Lopera, Francisco; Buritica, Omar; Antonio Pineda-Salazar, David; Moreno Gomez, Leonardo; Tobon Quintero, Carlos Andres; German Borda, Miguel; Bonanni, Laura; Ffytche, Dominic H.; Bronnick, Kolbjorn; Aarsland, Dag			Resting-state EEG alpha/theta ratio related to neuropsychological test performance in Parkinson's Disease	CLINICAL NEUROPHYSIOLOGY			English	Article						Electroencephalography; Parkinson's Disease; Alpha rhythm; Theta rhythm; Neuropsychological tests	CLINICAL DIAGNOSTIC-CRITERIA; MILD COGNITIVE IMPAIRMENT; LEWY BODIES; DEMENTIA; DYSFUNCTION; PROGRESSION; VALIDATION; DYNAMICS; SPECTRUM; DEFICITS	Objective: To determine possible associations of hemispheric-regional alpha/theta ratio (alpha/theta) with neuropsychological test performance in Parkinson's Disease (PD) non-demented patients. Methods: 36 PD were matched to 36 Healthy Controls (HC). The alpha/theta in eight hemispheric regions was computed from the relative power spectral density of the resting-state quantitative electroencephalogram (qEEG). Correlations between alpha/theta and performance in several neuropsychological tests were conducted, significant findings were included in a moderation analysis. Results: The alpha/theta in all regions was lower in PD than in HC, with larger effect sizes in the posterior regions. Right parietal, and right and left occipital alpha/theta had significant positive correlations with performance in Judgement of Line Orientation Test (JLOT) in PD. Adjusted moderation analysis indicated that right, but not left, occipital alpha/theta influenced the JLOT performance related to PD. Conclusions: Reduction of the occipital alpha/theta, in particular on the right side, was associated with visuospatial performance impairment in PD. Significance: Visuospatial impairment in PD, which is highly correlated with the subsequent development of dementia, is reflected in alpha/theta in the right posterior regions. The right occipital alpha/theta may represent a useful qEEG marker for evaluating the presence of early signs of cognitive decline in PD and the subsequent risk of dementia. (C) 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.	[Jaramillo-Jimenez, Alberto; German Borda, Miguel; Bronnick, Kolbjorn; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, N-4068 Stavanger, Norway; [Jaramillo-Jimenez, Alberto; German Borda, Miguel; Bronnick, Kolbjorn] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Jaramillo-Jimenez, Alberto; Ximena Suarez-Revelo, Jazmin; Fredy Ochoa-Gomez, John; Carmona Arroyave, Jairo Alexander; Bocanegra, Yamile; Lopera, Francisco; Buritica, Omar; Antonio Pineda-Salazar, David; Tobon Quintero, Carlos Andres] Univ Antioquia, Sch Med, Grp Neurociencias Antioquia, Medellin, Colombia; [Jaramillo-Jimenez, Alberto; Ximena Suarez-Revelo, Jazmin; Fredy Ochoa-Gomez, John; Carmona Arroyave, Jairo Alexander; Bocanegra, Yamile; Antonio Pineda-Salazar, David; Tobon Quintero, Carlos Andres] Univ Antioquia, Sch Med, Grp Neuropsicol & Conducta, Medellin, Colombia; [Jaramillo-Jimenez, Alberto] Univ Antioquia, Sch Med, Semillero Invest SINAPSIS, Medellin, Colombia; [Jaramillo-Jimenez, Alberto] Univ Antioquia, Sch Med, Semillero Invest NeuroCo, Medellin, Colombia; [Jaramillo-Jimenez, Alberto] Sch Engn, Medellin, Colombia; [Moreno Gomez, Leonardo] Pablo Tobon Uribe Hosp, Neurol Unit, Medellin, Colombia; [Tobon Quintero, Carlos Andres] IPS Univ, Area Invest & Innovac, Inst Prestadora Serv Salud, Medellin, Colombia; [German Borda, Miguel] Pontificia Univ Javeriana, Med Sch, Ageing Inst, Semillero Neurociencias & Envejecimiento, Bogota, Colombia; [Bonanni, Laura] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Bonanni, Laura] Univ G dAnnunzio, Aging Res Ctr, Chieti, Italy; [Ffytche, Dominic H.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England; [Ffytche, Dominic H.; Aarsland, Dag] Kings Coll London, Inst Psychiat Psychol & Neurosci, KCL PARCOG Grp, London, England		Jaramillo-Jimenez, A (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med SESAM, PB 8100, N-4068 Stavanger, Norway.	alberto.jaramilloj@udea.edu.co	Borda, Miguel German/AHB-5593-2022; Carmona, Jairo/AAV-3962-2021; ffytche, Dominic/ABD-8214-2021; LOPERA, FRANCISCO/AAR-5968-2021	Borda, Miguel German/0000-0001-5832-0603; Carmona, Jairo/0000-0002-1196-4652; Aarsland, Dag/0000-0001-6314-216X; Jaramillo-Jimenez, Alberto/0000-0001-5374-6410	Research Development Committee (CODI) - Universidad de Antioquia (University of Antioquia), Colombia [PRG-2014-768]; Norwegian government, through hospital owner Helse Vest (Western Norway Regional Health Authority)	Research Development Committee (CODI) - Universidad de Antioquia (University of Antioquia), Colombia; Norwegian government, through hospital owner Helse Vest (Western Norway Regional Health Authority)	This work was supported by the Research Development Committee (CODI) - Universidad de Antioquia (University of Antioquia), Colombia, under the research project: "Procesamiento del lenguaje de accion en pacientes con enfermedad ganglio-basal desde una perspectiva neuropsicologica y neurofisiologica" (grant reference PRG-2014-768). In addition, this paper represents independent research supported by the Norwegian government, through hospital owner Helse Vest (Western Norway Regional Health Authority).	Aarsland D, 2017, NAT REV NEUROL, V13, P217, DOI 10.1038/nrneurol.2017.27; Agrell B, 1998, AGE AGEING, V27, P399, DOI 10.1093/ageing/27.3.399; Al-Qazzaz NK, 2014, SCI WORLD J, DOI 10.1155/2014/906038; Armstrong Melissa J, 2019, Continuum (Minneap Minn), V25, P128, DOI 10.1212/CON.0000000000000685; Babadi B, 2014, IEEE T BIO-MED ENG, V61, P1555, DOI 10.1109/TBME.2014.2311996; Babiloni C, 2020, NEUROBIOL AGING, V85, P58, DOI 10.1016/j.neurobiolaging.2019.09.008; Babiloni C, 2019, NEUROBIOL AGING, V73, P9, DOI 10.1016/j.neurobiolaging.2018.08.010; Ballinger EC, 2016, NEURON, V91, P1199, DOI 10.1016/j.neuron.2016.09.006; BENTON AL, 1978, ARCH NEUROL-CHICAGO, V35, P364, DOI 10.1001/archneur.1978.00500300038006; Bigdely-Shamlo N, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00016; Bohnen NI, 2015, JAMA NEUROL, V72, P194, DOI 10.1001/jamaneurol.2014.2757; Bonanni L, 2008, BRAIN, V131, P690, DOI 10.1093/brain/awm322; Bonanni L, 2016, J ALZHEIMERS DIS, V54, P1649, DOI 10.3233/JAD-160435; Bousleiman H, 2014, ANN CLIN TRANSL NEUR, V1, P884, DOI 10.1002/acn3.129; Arroyave JAC, 2019, FUTUR NEUROL, V14, DOI 10.2217/fnl-2018-0048; Casals-Coll M, 2013, NEUROLOGIA, V28, P33, DOI 10.1016/j.nrl.2012.02.010; Caviness JN, 2016, EUR J NEUROL, V23, P387, DOI 10.1111/ene.12878; Cozac VV, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/9060649; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eichelberger D, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/3659784; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Ffytche DH, 2017, J NEUROL NEUROSUR PS, V88, P325, DOI 10.1136/jnnp-2016-314832; Franciotti R, 2020, NEUROBIOL AGING, V93, P55, DOI 10.1016/j.neurobiolaging.2020.04.023; George JS, 2013, NEUROIMAGE-CLIN, V3, P261, DOI 10.1016/j.nicl.2013.07.013; Geraedts VJ, 2018, NEUROLOGY, V91, P871, DOI 10.1212/WNL.0000000000006473; Gil L, 2015, INT J GERIATR PSYCH, V30, P655, DOI 10.1002/gps.4199; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Golden CJ, 1978, STROOP COLOR WORD TE; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kehagia AA, 2013, NEURODEGENER DIS, V11, P79, DOI 10.1159/000341998; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; MAHONEY F I, 1965, Md State Med J, V14, P61; Massa F, 2020, PARKINSONISM RELAT D, V75, P70, DOI 10.1016/j.parkreldis.2020.05.007; Mitra PP, 2007, OBSERVED BRAIN DYNAM, DOI [10.1093/acprof:oso/9780195178081.003.0012, DOI 10.1093/ACPROF:OSO/9780195178081.003.0012]; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Prerau MJ, 2017, PHYSIOLOGY, V32, P60, DOI 10.1152/physiol.00062.2015; Rentz DM, 2010, ANN NEUROL, V67, P353, DOI 10.1002/ana.21904; Roberts JA, 2018, BRAIN, V141, P1583, DOI 10.1093/brain/awy136; Schmidt MT, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00060; Suarez-Revelo J, 2016, IEEE ENG MED BIO, P961, DOI 10.1109/EMBC.2016.7590861; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; Tranel D, 2008, NEUROPSYCHOLOGY, V22, P553, DOI 10.1037/0894-4105.22.5.553; Tranel D, 2009, J CLIN EXP NEUROPSYC, V31, P219, DOI 10.1080/13803390802317542; van der Hiele K, 2007, CLIN NEUROPHYSIOL, V118, P1931, DOI 10.1016/j.clinph.2007.05.070; van der Zande JJ, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00190; Watson GS, 2013, ALZHEIMERS DEMENT, V9, P609, DOI 10.1016/j.jalz.2012.07.006; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Suarez-Revelo JX, 2018, COMM COM INF SC, V916, P290, DOI 10.1007/978-3-030-00353-1_26; Yuvaraj R, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-12	52	5	5	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	MAR	2021	132	3					756	764		10.1016/j.clinph.2021.01.001	http://dx.doi.org/10.1016/j.clinph.2021.01.001		FEB 2021	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QL5DQ	33571883				2022-09-04	WOS:000621097800009
J	Soler-Font, M; Ramada, JM; Montero-Moraga, JM; Palencia-Sanchez, F; Merelles, A; Macdonald, EB; Serra, C				Soler-Font, Merce; Maria Ramada, Jose; Maria Montero-Moraga, Jose; Palencia-Sanchez, Francisco; Merelles, Antoni; Macdonald, Ewan B.; Serra, Consol			What is meant by case management for the return-to-work of workers with musculoskeletal disorders? A scoping review	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Review						Case manager; sickness absence; workplace; services; description	EASY EARLY ACCESS; SICKNESS ABSENCE; VOCATIONAL-REHABILITATION; INJURED WORKERS; HEALTH; SERVICE; INCAPACITY; SUPPORT; IMPACT; COSTS	BACKGROUND: Case management interventions have shown to be effective to prevent musculoskeletal pain and disability, but a single definition has not been achieved, nor an agreed profile for case managers. OBJECTIVE: To describe the elements that define case management and case managers tasks for return-to-work of workers with musculoskeletal disorders (MSDs). METHODS: A comprehensive computerized search of articles published in English until February 16, 2021 was carried out in several bibliographic databases. Grey literature was obtained through a search of 13 key websites. A peer-review screening of titles and abstracts was carried out. Full text in-depth analysis of the selected articles was performed for data extraction and synthesis of results. RESULTS: We identified 2,422 documents. After full-text screening 31 documents were included for analysis. These were mostly European and North American and had an experimental design. Fifteen documents were published between 2010 to 2021 and of these 7 studies were published from 2015. Fifteen elements were identified being the commonest "return-towork programme" (44.4%) and "multidisciplinary assessment/interdisciplinary intervention" (44.4%). Of 18 tasks found, the most frequent was "establishing goals and planning return-to-work rehabilitation" (57.7%). Eighteen referral services were identified. CONCLUSIONS: Despite there were several elements frequently reported, some elements with scientific evidence of their importance to deal with MSDs (e.g. early return-to-work) were almost not mentioned. This study proposes key points for the description of case management and case managers tasks.	[Soler-Font, Merce; Maria Ramada, Jose; Merelles, Antoni; Serra, Consol] Univ Pompeu Fabra, Ctr Res Occupat Hlth CiSAL, Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Soler-Font, Merce; Maria Ramada, Jose; Serra, Consol] CIBER Epidemiol & Publ Hlth, Madrid, Spain; [Maria Ramada, Jose; Serra, Consol] Occupat Hlth Serv, Parc Salut Mar, Barcelona, Spain; [Maria Montero-Moraga, Jose] Univ Pompeu Fabra, Publ Hlth & Prevent Med Training Unit, Publ Hlth Agcy Barcelona, Parc Salut Mar, Barcelona, Spain; [Palencia-Sanchez, Francisco] Pontificia Univ Javerina, Fac Med, Dept Med Prevent & Social, Bogota, Colombia; [Merelles, Antoni] Univ Valencia, Nursing & Podiatry Fac, Nursing Dept, Valencia, Spain; [Macdonald, Ewan B.] Univ Glasgow, Hlth Working Lives Grp, Glasgow, Lanark, Scotland		Soler-Font, M (corresponding author), Hosp del Mar Med Res Inst IMIM, Barcelona Biomed Res Pk PRBB,Dr Aiguader 88, Barcelona 08003, Spain.	merce.soler@upf.edu		Ramada Rodilla, Jose Maria/0000-0002-3854-1596	Instituto de Salud Carlos III-FEDER [PI14/01959, PI17/00779]	Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos IIIEuropean Commission)	We want to thank Andrew N March for providing a grammatical revision of the text, and Anna Amat for her collaboration during the first part of this scoping review. The work was supported by the Instituto de Salud Carlos III-FEDER (reference number PI14/01959 and PI17/00779). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Aas RW, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008160.pub2; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Beaumont D, 2002, OCCUP MED-OXFORD, V52, P293, DOI 10.1093/occmed/52.6.293; Beemster TT, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0861-4; Belin A., 2016, REHABILITATION RETUR; Bevan S, 2009, FIT WORK MUSCULOSKEL; Bishop A, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-232; Brown J, 2015, SCAND J WORK ENV HEA, V41, P204, DOI 10.5271/sjweh.3480; BSRM Working Party Report, 2003, BSRM WORKING PARTY R, V2nd; Bultmann U, 2009, J OCCUP REHABIL, V19, P81, DOI 10.1007/s10926-009-9162-7; Caroly S, 2010, APPL ERGON, V41, P591, DOI 10.1016/j.apergo.2009.12.016; Carrolli C, 2010, DISABIL REHABIL, V32, P607, DOI 10.3109/09638280903186301; Chamberlain MA, 2009, J REHABIL MED, V41, P856, DOI 10.2340/16501977-0457; Coggon D, 2013, OCCUP ENVIRON MED, V70, P575, DOI 10.1136/oemed-2012-101316; Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013; Davis F N, 1999, Case Manager, V10, P55, DOI 10.1016/S1061-9259(99)80108-8; Demou E, 2016, WORK, V53, P597, DOI 10.3233/WOR-152137; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; European Agency for Safety and Health at Work (EUOSHA), 2007, WORK REL NECK UPP LI, P72; Feuerstein M, 2003, J OCCUP ENVIRON MED, V45, P803, DOI 10.1097/01.jom.0000079091.95532.92; Feuerstein M, 1998, AM PAIN SOC B, V8, P9; Fisker A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-93; Green JF, 1996, J BACK MUSCULOSKELET, V7, P167, DOI 10.3233/BMR-1996-7307; Hanson M, 2006, COSTS BENEFITS ACTIV; Harrison J, 2009, STANDARDS BEST PRACT; Hogelund J, 2006, J HEALTH ECON, V25, P500, DOI 10.1016/j.jhealeco.2005.07.007; Iles RA, 2012, J OCCUP REHABIL, V22, P478, DOI 10.1007/s10926-012-9364-2; Kamper SJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000963.pub3; Kersbergen AL, 1996, NURS OUTLOOK, V44, P169, DOI 10.1016/S0029-6554(96)80037-6; Lee K, 2009, GLOB INST, P1; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Li-Tsang CWP, 2008, J OCCUP REHABIL, V18, P299, DOI 10.1007/s10926-008-9138-z; Lowe J, 2011, PROF CASE MANAG, V16, P316, DOI 10.1097/NCM.0b013e318230ec72; Maki S, 1998, PL S REHAB HEALTH, P325; Marin TJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002193.pub2; McCluskey S, 2006, OCCUP MED-OXFORD, V56, P237, DOI 10.1093/occmed/kql003; Mullahy CM, 2015, CARE MANAGEMENT, V21, P7; Murad MS, 2013, SCAND J OCCUP THER, V20, P101, DOI 10.3109/11038128.2012.720276; New York Academy of Medicine, 2016, WHAT IS GREY LIT FIL; Nicholas MK, 2020, J OCCUP REHABIL, V30, P93, DOI 10.1007/s10926-019-09849-y; Nicholson PJ, 2001, OCCUP MED-OXFORD, V51, P423, DOI 10.1093/occmed/51.7.423; Okunribido O, 2010, AGING WORK RELATED M, pRR799; Pransky GS, 2006, SPINE, V31, P690, DOI 10.1097/01.brs.0000202761.20896.02; Provine KN, 2008, PROF CASE MANAG, V13, P292, DOI 10.1097/01.PCAMA.0000336696.31188.e1; RUPP K, 1994, SOC SECUR BULL, V57, P3; Russo Domenica, 2002, Occup Ther Int, V9, P57, DOI 10.1002/oti.156; Schaafsma FG, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001822.pub3; Scholz SM, 2016, J OCCUP REHABIL, V26, P319, DOI 10.1007/s10926-015-9615-0; Schultz IZ, 2008, J OCCUP REHABIL, V18, P140, DOI 10.1007/s10926-008-9130-7; Schultz IZ, 2007, J OCCUP REHABIL, V17, P327, DOI 10.1007/s10926-007-9071-6; Serra C, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6683-7; Smedley J, 2013, OCCUP MED-OXFORD, V63, P89, DOI 10.1093/occmed/kqs223; Soler-Font M., 2018, PI1700779 FIS CISAL; Stapelfeldt CM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-112; Stephens B, 2007, SPINE, V32, P2898, DOI 10.1097/BRS.0b013e31815b64b6; van Vilsteren M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006955.pub3; Vermeulen SJ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-60; Vogel N, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011618.pub2; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Warren J, 2014, J PUBLIC HEALTH-UK, V36, P117, DOI 10.1093/pubmed/fds100	60	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2021	70	4					1069	1087		10.3233/WOR-205172	http://dx.doi.org/10.3233/WOR-205172			19	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XU8JX	34842208	Green Published			2022-09-04	WOS:000734505400008
J	Carver, D; Sosa, CC; Khoury, CK; Achicanoy, HA; Diaz, MV; Sotelo, S; Castaneda-Alvarez, NP; Ramirez-Villegas, J				Carver, Daniel; Sosa, Chrystian C.; Khoury, Colin K.; Achicanoy, Harold A.; Diaz, Maria Victoria; Sotelo, Steven; Castaneda-Alvarez, Nora P.; Ramirez-Villegas, Julian			GapAnalysis: an R package to calculate conservation indicators using spatial information	ECOGRAPHY			English	Article						biodiversity indicators; crop wild relatives; ex situ conservation; gap analysis; in situ conservation	SITU CONSERVATION; PLATFORM	Effective assessments of the current status of biodiversity conservation are needed to support planning, policy and action, from local to global levels. Of particular use would be well documented, reproducible methods based on openly accessible data and tools. Such methods should provide an accurate estimate of the state of conservation of diversity, identifying gaps in current conservation systems, while providing a benchmark against which to measure success, including determining when conservation goals have been met. Here we introduce GapAnalysis, an open source R package developed to support the assessment of the state of conservation of taxa, both ex situ (in genebanks, botanic gardens and other repositories) and in situ (in protected natural areas). The eco-geographic variation maintained in conservation repositories and that present within protected natural areas is compared with the full extent of eco-geographic variation predicted within species' native ranges. Eco-geographic conservation gaps are identified, and taxa are then prioritized for further action. The package enables users to quickly determine conservation status, gaps and priorities for as few as one to as many as thousands of taxa, for any wild flora or fauna for which occurrence data and species distribution models are available. To demonstrate the use of GapAnalysis, we provide case studies for wild plant taxa in the genera Capsicum L. and Cucurbita L, with an accompanying online R tutorial for three of the Cucurbita species.	[Carver, Daniel] Colorado State Univ, Geospatial Centroid, Ft Collins, CO USA; [Carver, Daniel; Khoury, Colin K.] ARS, USDA, Natl Lab Genet Resources Preservat, Ft Collins, CO USA; [Sosa, Chrystian C.; Khoury, Colin K.; Diaz, Maria Victoria; Sotelo, Steven; Ramirez-Villegas, Julian] Int Ctr Trop Agr CIAT, Cali, Colombia; [Sosa, Chrystian C.] Pontificia Univ Javeriana Cali, Dept Ciencias Nat & Matemat, Cali, Colombia; [Sosa, Chrystian C.] Univ Quindio, Fac Ciencias Basicas & Tecnol, Programa Biol, Grp Invest Evoluc Ecol & Conservac EECO, Armenia, Colombia; [Khoury, Colin K.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Castaneda-Alvarez, Nora P.] Global Crop Diversity Trust, Bonn, Germany; [Ramirez-Villegas, Julian] CGIAR Res Program Climate Change Agr & Food Secur, Cali, Colombia		Ramirez-Villegas, J (corresponding author), Int Ctr Trop Agr CIAT, Cali, Colombia.; Ramirez-Villegas, J (corresponding author), CGIAR Res Program Climate Change Agr & Food Secur, Cali, Colombia.	j.r.villegas@cgiar.org	Khoury, Colin K./AAA-1864-2020; Arango, Chrystian Camilo Sosa/N-3989-2019; Castaneda-Alvarez, Nora P./I-8026-2015	Khoury, Colin K./0000-0001-7893-5744; Arango, Chrystian Camilo Sosa/0000-0002-3734-3248; Carver, Daniel/0000-0002-1344-6357; Sotelo, Steven/0000-0002-9621-1456; Castaneda-Alvarez, Nora P./0000-0003-1827-4782; Ramirez-Villegas, Julian/0000-0002-8044-583X; Achicanoy, Harold/0000-0002-3432-3655	Government of Norway; Biodiversity Indicators Partnership - UN Environment; European Commission; Swiss Federal Office for the Environment; United States Department of Agriculture; CGIAR Genebank Platform; Global Crop Diversity Trust; USDA National Institute of Food and Agriculture [2019-67012-29733, 1019405]	Government of Norway; Biodiversity Indicators Partnership - UN Environment; European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss Federal Office for the Environment; United States Department of Agriculture(United States Department of Agriculture (USDA)); CGIAR Genebank Platform(CGIAR); Global Crop Diversity Trust; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Work contributing to this method was supported by the Government of Norway; the Biodiversity Indicators Partnership, an initiative supported by UN Environment, the European Commission and the Swiss Federal Office for the Environment; the United States Department of Agriculture; the CGIAR Genebank Platform; and the Global Crop Diversity Trust. C.K.K. was supported by grant no. 2019-67012-29733/project accession no. 1019405 from the USDA National Institute of Food and Agriculture. The funders played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The USDA is an equal opportunity employer and provider. The data used to construct Fig. 2 are available in Dryad Digital Repository: 'https://doi.org/10.5061/dryad.t4b8gtj1x'.	ALTIERI MA, 1987, ECON BOT, V41, P86, DOI 10.1007/BF02859354; [Anonymous], 2010, AICH BIOD TARG; Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Bellon MR, 2004, WORLD DEV, V32, P159, DOI 10.1016/j.worlddev.2003.04.007; Castaneda-Alvarez NP, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.22, 10.1038/NPLANTS.2016.22]; CBD, 2020, PREP POST 2020 BIOD; Chamberlain S., 2020, SPOCC INTERFACE SPEC; Chamberlain S, 2020, RGBIF INTERFACE GLOB; Chamberlain Scott A, 2013, F1000Res, V2, P191, DOI 10.12688/f1000research.2-191.v1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Convention on Biological Diversity (CBD, 2020, TARGETS; Convention on Biological Diversity (CBD), 2018, STRAT PLAN IND; Elith J, 2017, SPECIES DISTRIBUTION; FAO, 2015, 2 GLOB ASS AN GEN RE; FAO, 2002, INT TREAT PLANT GEN; Fick S.E., 2017, J CLIMATOL, V37, P4302, DOI [DOI 10.1002/JOC.5086, DOI 10.1016/j.ppees.2013.02.001]; Frances AL, 2018, N AM CROP WILD RELAT, P189, DOI [10.1007/978-3-319-95101-0_7, DOI 10.1007/978-3-319-95101-0_7]; Guevara E., 2008, HOLE FILLED SEAMLESS; Hanson JO, 2017, P NATL ACAD SCI USA, V114, P12755, DOI 10.1073/pnas.1711009114; Hoban S, 2020, BIOL CONSERV, V248, DOI 10.1016/j.biocon.2020.108654; Hoban S, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.0102; Hoban S, 2018, BIOL CONSERV, V225, P10, DOI 10.1016/j.biocon.2018.06.017; Hoban S, 2015, BIOL CONSERV, V187, P182, DOI 10.1016/j.biocon.2015.04.023; IUCN, 2019, WORLD DAT PROT AR; Kass JM, 2018, METHODS ECOL EVOL, V9, P1151, DOI 10.1111/2041-210X.12945; Khoury CK, 2020, P NATL ACAD SCI USA, V117, P33351, DOI 10.1073/pnas.2007029117; Khoury CK, 2020, PLANTS PEOPLE PLANET, V2, P269, DOI 10.1002/ppp3.10085; Khoury CK, 2020, DIVERS DISTRIB, V26, P209, DOI 10.1111/ddi.13008; Khoury CK, 2019, ECOL INDIC, V98, P420, DOI 10.1016/j.ecolind.2018.11.016; Khoury CK, 2019, DATA BRIEF, V22, P90, DOI 10.1016/j.dib.2018.11.125; Kindt R, 2019, BIODIVERSITYR PACKAG; Lebeda A, 2019, CROP SCI, V59, P2337, DOI 10.2135/cropsci2019.05.0350; Lee CKF, 2019, ECOGRAPHY, V42, P1050, DOI 10.1111/ecog.04143; MA, 2005, ECOSYSTEMS HUMAN WEL; McGowan P.J.K., 2018, Conserv. Lett., V12; Mezghani N, 2019, CROP SCI, V59, P2317, DOI 10.2135/cropsci2019.05.0333; Myrans H, 2020, DIVERS DISTRIB, V26, P1727, DOI 10.1111/ddi.13166; Naimi B, 2016, ECOGRAPHY, V39, P368, DOI 10.1111/ecog.01881; Norton SL, 2017, AUST J BOT, V65, P638, DOI 10.1071/BT16236; Obreza M., 2019, **DATA OBJECT**; Phillips Steven, 2017, CRAN; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Ramirez-Villegas J, 2020, DIVERS DISTRIB, V26, P730, DOI 10.1111/ddi.13046; Ramirez-Villegas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013497; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; The Nature Conservancy Geospatial Conservation Atlas, 2019, TERRESTRIAL ECOREGIO; UNEP-WCMC, 2020, WORLD DAT OTH EFF AR; UNEP-WCMC, 2019, US MAN WORLD DAT PRO; United Nations, 2020, SUSTAINABLE DEV GOAL; Zizka A, 2019, METHODS ECOL EVOL, V10, P744, DOI 10.1111/2041-210X.13152	50	5	5	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-7590	1600-0587		ECOGRAPHY	Ecography	JUL	2021	44	7					1000	1009		10.1111/ecog.05430	http://dx.doi.org/10.1111/ecog.05430		MAY 2021	10	Biodiversity Conservation; Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation; Environmental Sciences & Ecology	TC2AV		gold, Green Published			2022-09-04	WOS:000646576800001
J	Mazo, NA; Echeverria, V; Cabezas, R; Avila-Rodriguez, M; Tarasov, VV; Yarla, NS; Aliev, G; Barreto, GE				Mazo, Natalia Areiza; Echeverria, Valentina; Cabezas, Ricardo; Avila-Rodriguez, Marco; Tarasov, Vadim V.; Yarla, Nagendra S.; Aliev, Gjumrakch; Barreto, George E.			Medicinal Plants as Protective Strategies Against Parkinson's Disease	CURRENT PHARMACEUTICAL DESIGN			English	Review						Parkinson's Disease; phytochemicals; neuroprotective fruits; signaling pathways; transcription factors; dopaminergic neurons	COCOA FLAVANOL CONSUMPTION; INDUCED OXIDATIVE STRESS; NF-KAPPA-B; NUCLEAR-FACTOR; NEURODEGENERATIVE DISEASES; MICROGLIAL ACTIVATION; DIETARY ANTIOXIDANTS; COGNITIVE FUNCTION; ELDERLY SUBJECTS; BLOOD-PRESSURE	Parkinson's disease is a neurodegenerative disease caused by the loss of dopaminergic neurons in the substantia nigra pars compacta region. An important mechanism contributing to its development is oxidative stress, induced by the imbalance between the endogenous antioxidant defenses and free radicals production. Naturally occurring bioactive compounds exhibit high antioxidant capacity that may help reducing oxidative stress and even reverse the damage induced by ROS. Fruits are particularly rich in phytochemicals with antioxidant effect, and their properties against the development of neurodegenerative diseases are of great interest. This review discusses how the fruits bioactive compounds and synthetic analogs have been assessed for their ability to regulate molecular pathways involved in neuronal survival such as MAPK, Nrf2, and NF-kappa B, thus elucidating the possible therapeutic and neuroprotective actions of these compounds.	[Mazo, Natalia Areiza; Cabezas, Ricardo; Avila-Rodriguez, Marco; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Echeverria, Valentina] Univ San Sebastian, Lientur 1457, Concepcion 4030000, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA; [Tarasov, Vadim V.] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, 2-4 Bolshaya Pirogovskaya St, Moscow 119991, Russia; [Yarla, Nagendra S.] GITAM Univ, Inst Sci, Dept Biochem & Bioinformat, Visakhapatnam 530045, Andhra Pradesh, India; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiologically Act Cpds, Chernogolovka 142432, Russia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Mazo, NA (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Echeverria, V (corresponding author), Univ San Sebastian, Lientur 1457, Concepcion 4030000, Chile.	gsampaio@javeriana.edu.co; echeverria.valentina@gmail.com	Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./B-5747-2014; Barreto, George E./AAD-7420-2020; Valentina Echeverria Moran, BCh/E-7765-2013	Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Avila-Rodriguez, Marco/0000-0003-4612-3236; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994	Universidad San Sebastian, Chile; Pontificia Universidad Javeriana, Bogota, Colombia	Universidad San Sebastian, Chile; Pontificia Universidad Javeriana, Bogota, Colombia	GEB work is supported by Pontificia Universidad Javeriana, Bogota, Colombia. VE is supported by Universidad San Sebastian, Chile.	Abeti R, 2015, PHARMACOL RES, V99, P377, DOI 10.1016/j.phrs.2015.05.007; Ansari MN, 2008, FUND CLIN PHARMACOL, V22, P305, DOI 10.1111/j.1472-8206.2008.00580.x; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00340; Barreto GE, 2012, NUTR NEUROSCI, V15, P92, DOI 10.1179/12Z.00000000034; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Blach-Olszewska Z, 2015, CURR PHARM DESIGN, V21, P3582, DOI 10.2174/1381612821666150710144829; Blasa M, 2010, BIOACTIVE FOODS IN PROMOTING HEALTH: FRUITS AND VEGETABLES, P37, DOI 10.1016/B978-0-12-374628-3.00003-7; Blesa J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00091; Bornsek SM, 2012, FOOD CHEM, V134, P1878, DOI 10.1016/j.foodchem.2012.03.092; Cabezas R, 2014, DIET NUTR DEMENTIA C; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Choi DK, 2011, MOLECULES, V16, P1021, DOI 10.3390/molecules16021021; Cui YJ, 2010, BIOL PHARM BULL, V33, P1814, DOI 10.1248/bpb.33.1814; Davinelli S, 2015, J AM COLL NUTR, V34, P28, DOI 10.1080/07315724.2015.1080108; Deng G., 2014, POLYPHENOLS HUM HEAL, V1, P47, DOI [10.1016/B978-0-12-398456-2.00005-0, DOI 10.1016/B978-0-12-398456-2.00005-0]; Denzer I, 2016, PHARMACOL RES, V103, P80, DOI 10.1016/j.phrs.2015.11.019; Desideri G, 2012, HYPERTENSION, V60, P794, DOI 10.1161/HYPERTENSIONAHA.112.193060; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Dey A, 2015, STUDIES NATURAL PROD, V44, P447; dos Santos AB, 2015, NEUROCHEM RES, V40, P421, DOI 10.1007/s11064-014-1488-7; dos Santos AB, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00273; Ebrahimi A, 2012, AGEING RES REV, V11, P329, DOI 10.1016/j.arr.2012.01.006; Echeverria V, 2016, CURR PHARM DESIGN, V22, P1324, DOI 10.2174/138161282210160304112511; Erlund I, 2004, NUTR RES, V24, P851, DOI 10.1016/j.nutres.2004.07.005; Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920; Esposito E, 2002, NEUROBIOL AGING, V23, P719, DOI 10.1016/S0197-4580(02)00078-7; Essa MM, 2012, NEUROCHEM RES, V37, P1829, DOI 10.1007/s11064-012-0799-9; Fahrig T, 2005, MOL PHARMACOL, V67, P1544, DOI 10.1124/mol.104.008177; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Forman HJ, 2015, FREE RADICAL BIO MED, V78, P233, DOI 10.1016/j.freeradbiomed.2014.10.504; Fujishita K, 2009, CELL MOL NEUROBIOL, V29, P1121, DOI 10.1007/s10571-009-9403-5; Goyarzu F, 2004, NUTR NEUROSCI, V7, P75, DOI 10.1080/10284150410001710410; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147; Halliwell Barry, 2014, Biomed J, V37, P99, DOI 10.4103/2319-4170.128725; Ihara H, 2012, BIOSCI BIOTECH BIOCH, V76, P1843, DOI 10.1271/bbb.120215; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jellinger KA, 2015, EXPERT REV NEUROTHER, V15, P1105, DOI 10.1586/14737175.2015.1079486; Joseph JA, 2007, ANN NY ACAD SCI, V1100, P470, DOI 10.1196/annals.1395.052; Jurado-Coronel JC, 2016, CNS NEUROL DISORD-DR, V15, P292, DOI 10.2174/1871527315666160202125519; Kim HG, 2010, BRIT J NUTR, V104, P8, DOI 10.1017/S0007114510000218; Krikorian R, 2012, J AGR FOOD CHEM, V60, P5736, DOI 10.1021/jf300277g; Krikorian R, 2010, J AGR FOOD CHEM, V58, P3996, DOI 10.1021/jf9029332; Lau FC, 2007, J NEUROSCI RES, V85, P1010, DOI 10.1002/jnr.21205; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Mastroiacovo D, 2015, AM J CLIN NUTR, V101, P538, DOI 10.3945/ajcn.114.092189; Meng XL, 2008, CHEM-BIOL INTERACT, V174, P51, DOI 10.1016/j.cbi.2008.04.015; Mythri RB, 2012, RECENT PATENTS ENDOC, V6, P181, DOI 10.2174/187221412802481793; Mythri RB, 2011, NEUROCHEM RES, V36, P1452, DOI 10.1007/s11064-011-0471-9; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Petrucci S, 2015, MOVEMENT DISORDERS: GENETICS AND MODELS, 2ND EDITION, P243, DOI 10.1016/B978-0-12-405195-9.00015-9; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Qiao HM, 2012, BRAIN RES, V1448, P71, DOI 10.1016/j.brainres.2012.02.003; Rojanathammanee L, 2013, J NUTR, V143, P597, DOI 10.3945/jn.112.169516; Campos-Esparza MR, 2009, CELL CALCIUM, V45, P358, DOI 10.1016/j.ceca.2008.12.007; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ruszkiewicz J, 2015, NEUROCHEM INT, V88, P66, DOI 10.1016/j.neuint.2014.12.012; Sandoval-Acuna C, 2014, ARCH BIOCHEM BIOPHYS, V559, P75, DOI 10.1016/j.abb.2014.05.017; Schroeder EK, 2009, ANTIOXID REDOX SIGN, V11, P469, DOI [10.1089/ars.2008.2215, 10.1089/ARS.2008.2215]; Seifried HE, 2007, J NUTR BIOCHEM, V18, P567, DOI 10.1016/j.jnutbio.2006.10.007; Shih PH, 2010, J NUTR BIOCHEM, V21, P598, DOI 10.1016/j.jnutbio.2009.03.008; Shukitt-Hale B, 2008, NUTR NEUROSCI, V11, P172, DOI 10.1179/147683008X301487; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Sokolov AN, 2013, NEUROSCI BIOBEHAV R, V37, P2445, DOI 10.1016/j.neubiorev.2013.06.013; Spencer JPE, 2008, BRIT J NUTR, V99, pES60, DOI 10.1017/S0007114508965776; Spencer JPE, 2012, MOL ASPECTS MED, V33, P83, DOI 10.1016/j.mam.2011.10.016; Spencer JPE, 2009, CHEM SOC REV, V38, P1152, DOI 10.1039/b800422f; Sun AG, 2016, INT J NEUROSCI, V126, P318, DOI 10.3109/00207454.2014.986673; Vafeiadou K, 2009, ARCH BIOCHEM BIOPHYS, V484, P100, DOI 10.1016/j.abb.2009.01.016; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vauzour D, 2015, NEUROCHEM INT, V89, P63, DOI 10.1016/j.neuint.2015.08.004; Vauzour D, 2008, GENES NUTR, V3, P115, DOI 10.1007/s12263-008-0091-4; Vuong T, 2010, BRIT J NUTR, V104, P656, DOI 10.1017/S0007114510001170; Wang YJ, 2009, NEUROTOX RES, V15, P3, DOI 10.1007/s12640-009-9000-x; Zeng XB, 2014, MOLECULES, V19, P7368, DOI 10.3390/molecules19067368; Zhang L, 2013, BRAIN RES BULL, V96, P45, DOI 10.1016/j.brainresbull.2013.04.009; Zhang XY, 2013, PROG NEURO-PSYCHOPH, V46, P197, DOI 10.1016/j.pnpbp.2013.03.003	85	23	23	1	14	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2017	23	28					4180	4188		10.2174/1381612823666170316142803	http://dx.doi.org/10.2174/1381612823666170316142803			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FL6PC	28302024				2022-09-04	WOS:000414366900012
J	Renjifo, C; Smith, EN; Hodgson, WC; Renjifo, JM; Sanchez, A; Acosta, R; Maldonado, JH; Riveros, A				Renjifo, Camila; Smith, Eric N.; Hodgson, Wayne C.; Renjifo, Juan M.; Sanchez, Armando; Acosta, Rodrigo; Maldonado, Jairo H.; Riveros, Alain			Neuromuscular activity of the venoms of the Colombian coral snakes Micrurus dissoleucus and Micrurus mipartitus: An evolutionary perspective	TOXICON			English	Article						Micrurus; Neurotoxic; Myotoxic; Chick biventer cervicis; Venom	BAYESIAN PHYLOGENETIC INFERENCE; NIGROCINCTUS VENOM; BETA-BUNGAROTOXIN; ANTIVENOMS; ELAPIDAE; RATTLESNAKES; MYONECROSIS; DIVERSITY; HELLERI; VIPER	The venoms of coral snakes (genus Micrurus) are known to induce a broad spectrum of pharmacological activities. While some studies have investigated their potential human effects, little is known about their mechanism of action in terms of the ecological diversity and evolutionary relationships among the group. In the current study we investigated the neuromuscular blockade of the venom of two sister species Micrurus mipartitus and Micrurus dissoleucus, which exhibit divergent ecological characteristics in Colombia, by using the chick biventer cervicis nerve-muscle preparation. We also undertook a phylogenetic analysis of these species and their congeners, in order to provide an evolutionary framework for the American coral snakes. The venom of M. mipartitus caused a concentration-dependant inhibition (3-10 mu g/ml) of nerve-mediated twitches and significantly inhibited contractile responses to exogenous ACh (1 mM), but not KCl (40 mM), indicating a postsynaptic mechanism of action. The inhibition of indirect twitches at the lower venom dose (3 mu g/ml) showed to be triphasic and the effect was further attenuated when PLA2 was inhibited. M. dissoleucus venom (10-50 mu g/ml) failed to produce a complete blockade of nerve-mediated twitches within a 3 h time period and significantly inhibited contractile responses to exogenous ACh (1 mM) and KCl (40 mM), indicating both postsynaptic and myotoxic mechanisms of action. Myotoxic activity was confirmed by morphological studies of the envenomed tissues. Our results demonstrate a hitherto unsuspected diversity of pharmacological actions in closely related species which exhibit divergent ecological characteristics; these results have important implications for both the clinical management of Coral snake envenomings and the design of Micrurus antivenom. (C) 2011 Elsevier Ltd. All rights reserved.	[Renjifo, Camila; Sanchez, Armando; Riveros, Alain] Pontificia Univ Javeriana, Fac Med, Dept Ciencias Fisiol, Bogota, Colombia; [Smith, Eric N.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Hodgson, Wayne C.] Monash Univ, Dept Pharmacol, Monash Venom Grp, Clayton, Vic 3168, Australia; [Renjifo, Juan M.] Univ Magdalena, Dept Biol, Santa Marta, Colombia; [Acosta, Rodrigo] Clin Marly, Dept Patol, Bogota, Colombia; [Maldonado, Jairo H.] Serpentario, Nilo, Tolima, Colombia; [Riveros, Alain] Univ Militar Nueva Granada, Fac Med, Lab Fisiol, Bogota, Colombia		Renjifo, C (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Alistair Reid Venom Res Unit, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	renjifo@liv.ac.uk		Sanchez, Armando/0000-0001-5506-638X; Hodgson, Wayne/0000-0002-9919-0144; Riveros-Rivera, Alain/0000-0002-0011-0758	University of Oklahoma through NSF [DEB-9200779, DEB-9505518]; University of Texas at Arlington through NSF [DEB-9705277, DEB-0102383]; Circulo Herpetologico de Panama; KU; Clodomiro Picado; LSU; TNHC; CAS; ROM; Institut Bioclon; NSF [DEB-0416000, 0416160]	University of Oklahoma through NSF; University of Texas at Arlington through NSF; Circulo Herpetologico de Panama; KU; Clodomiro Picado; LSU; TNHC; CAS(Chinese Academy of Sciences); ROM; Institut Bioclon; NSF(National Science Foundation (NSF))	ENS is grateful to acknowledge several researchers who provided tissues under their care, obtained during sponsored research, including Laurie Vitt (University of Oklahoma, obtained through NSF grants DEB-9200779 and DEB-9505518), Roy W. McDiarmid and Steve W. Gotte, USNM, Carl J. Franklin and Jonathan Campbell (University of Texas at Arlington, obtained through NSF grants DEB-9705277 and DEB-0102383), Cesar Jaramillo (Circulo Herpetologico de Panama), William Duellman (KU), Mahmood Sasa M. (Clodomiro Picado), Fred Sheldon and Donna Dittmann (LSU), Travis LaDuc (TNHC), Jens Vindum (CAS), and Robert Murphy (ROM). Todd A. Castoe and Matthew Ingrasci kindly generated and edited some of the DNA sequences. Jeffrey Streicher kindly assisted with the Bayesian reconstruction. For help in obtaining permits to Aleyda Martinez and Mauricio Rivera (Ministerio de Ambiente, Vivienda y Desarrollo Territorial, Colombia), Juan M. Daza and Vivian P. Paez (Universidad de Antioquia), Andrew J. Crawford and Nelsy R. Pinto (Universidad de Los Andes, Colombia), and Andrea Acevedo. Collecting and exportation permits were issued by the Secretaria de Medio Ambiente y Recursos Naturales (Mexico, to Oscar Flores-Villela), Ministerio de Ambiente y Energia (Costa Rica, to Mahmood Sasa), the US Fish and Wildlife service (USA, to ENS), Texas Parks and Wildlife (USA, to Carl J. Franklin and ENS), and the Ministerio de Ambiente, Vivienda y Desarrollo Territorial (Colombia, Res. No. 0445, 14 March 2008, to ENS). The use of Colombian samples for phylogenetic analyses was possible under the Genetic Resources Access permit to ENS (Ministerio de Ambiente, Vivienda y Desarrollo Territorial de Colombia, Res. No. 0445,14 March 2008).; Bioactivity experiments were part of Camila Renjifo's undergraduate thesis work at the Departamento de Ciencias Fisiologicas, Pontificia Universidad Javeriana. Phylogenetic analysis of this project was provided by a grant from Institut Bioclon (to ENS), an NSF Collaborative Research grant to Christopher L Parkinson and ENS (DEB-0416000. 0416160), and startup package to Christopher L Parkinson (UCF) and ENS (UTA).	Ayerbe S., 1990, NOVEDADES COLOMBIANA, V2, P30; Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; BARROS ACS, 1994, TOXICON, V32, P445, DOI 10.1016/0041-0101(94)90296-8; Benabib M, 1997, EVOLUTION, V51, P1262, DOI 10.1111/j.1558-5646.1997.tb03973.x; BRAZIL O V, 1983, Memorias do Instituto Butantan (Sao Paulo), V47-48, P13; Camargo Thiago Magalhaes, 2011, J Venom Res, V2, P24; Casewell NR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000851; Casewell NR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-564; Castoe TA, 2007, ZOOL J LINN SOC-LOND, V151, P809, DOI 10.1111/j.1096-3642.2007.00350.x; Cecchini AL, 2005, COMP BIOCHEM PHYS A, V140, P125, DOI 10.1016/j.cbpb.2004.11.012; CHANG CC, 1977, N-S ARCH PHARMACOL, V299, P155, DOI 10.1007/BF00498557; CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9; da Silva N, 2001, HERPETOLOGICA, V57, P1; da Silva NJ, 2001, COMP BIOCHEM PHYS C, V128, P425, DOI 10.1016/S1532-0456(00)00215-5; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; de Oliveira JS, 2000, BIOCHEM BIOPH RES CO, V267, P887, DOI 10.1006/bbrc.1999.2033; de Roodt AR, 2004, J TOXICOL-CLIN TOXIC, V42, P171, DOI 10.1081/CLT-120030943; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flores-Villela O, 2000, SYST BIOL, V49, P713, DOI 10.1080/106351500750049798; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Galan JA, 2004, TOXICON, V43, P791, DOI 10.1016/j.toxicon.2004.03.009; GINSBORG BL, 1960, BRIT J PHARM CHEMOTH, V15, P410, DOI 10.1111/j.1476-5381.1960.tb01264.x; Goularte F C, 1999, Acta Physiol Pharmacol Ther Latinoam, V49, P290; GOULARTE FC, 1995, TOXICON, V33, P679, DOI 10.1016/0041-0101(94)00178-B; Gutberlet Ronald L. Jr, 2004, P634; GUTIERREZ JM, 1980, TOXICON, V18, P633, DOI 10.1016/0041-0101(80)90091-4; GUTIERREZ JM, 1983, TOXICON, V21, P777, DOI 10.1016/0041-0101(83)90066-1; GUTIERREZ JM, 1986, BRIT J EXP PATHOL, V67, P1; Gutierrez JM, 2009, J PROTEOMICS, V72, P165, DOI 10.1016/j.jprot.2009.01.008; Harris J.B., 1991, P91; Harvey A L, 1990, Int Rev Neurobiol, V32, P201; HARVEY AL, 1994, TOXICON, V32, P257, DOI 10.1016/0041-0101(94)90078-7; Hodgson WC, 2002, CLIN EXP PHARMACOL P, V29, P807, DOI 10.1046/j.1440-1681.2002.03740.x; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; KUMAZAWA Y, 1993, J MOL EVOL, V37, P380, DOI 10.1007/BF00178868; Kuruppu S, 2005, TOXICON, V45, P383, DOI 10.1016/j.toxicon.2004.11.016; Lamar W.W., 2004, VENOMOUS REPTILES W, VVolume 2; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; Manock SR, 2008, T ROY SOC TROP MED H, V102, P1127, DOI 10.1016/j.trstmh.2008.03.026; Montecucco C, 2000, TRENDS BIOCHEM SCI, V25, P266, DOI 10.1016/S0968-0004(00)01556-5; Nicholas KB, 1997, GENEDOC TOOL EDITING; Nunez V, 2009, J PROTEOMICS, V73, P57, DOI 10.1016/j.jprot.2009.07.013; OTERO R, 1992, TOXICON, V30, P611, DOI 10.1016/0041-0101(92)90855-Y; Passos P, 2005, ZOOTAXA, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Rey-Suarez P., 2011, J PROTEOMICS; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roze J.A., 1983, Memorias do Instituto Butantan (Sao Paulo), V46, P305; Roze J.A., 1996, BIOL CORAL SNAKE VEN; Roze J.A., 1987, B MUSEO REGIONALE SC, V5, P573; ROZE JANIS A., 1967, AMER MUS NOVITATES, V2287, P1; Ruthven A.G, 1922, U MICHIGAN MUSEUM ZO, V8, P1; Sanz L, 2006, J PROTEOME RES, V5, P2098, DOI 10.1021/pr0602500; Sasa M., 2001, JOINT ANN M HERP LEA; Serafim FG, 2002, TOXICON, V40, P167, DOI 10.1016/S0041-0101(01)00217-3; Shashidharamurthy R, 2002, MOL CELL BIOCHEM, V229, P93, DOI 10.1023/A:1017972511272; SLOWINSKI JB, 1995, J HERPETOL, V29, P325, DOI 10.2307/1564981; SU MJ, 1984, TOXICON, V22, P631, DOI 10.1016/0041-0101(84)90003-5; Swofford D., 2002, MAC VERS, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; Tanaka GD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000622; Vieira R.J., 2007, TOXICOLOGY, V45, P31; Visser LE, 2008, T ROY SOC TROP MED H, V102, P445, DOI 10.1016/j.trstmh.2007.11.006; Vital Brazil O., 1990, MEM I BUTANTAN, V52, P32; Warrell D.A., 2004, VENOMOUS REPTILES W, P728; WARRELL DA, 1989, T ROY SOC TROP MED H, V83, P732, DOI 10.1016/0035-9203(89)90311-8; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; YU BZ, 1993, BIOCHEMISTRY-US, V32, P6485, DOI 10.1021/bi00076a024	69	22	24	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	JAN	2012	59	1					132	142		10.1016/j.toxicon.2011.10.017	http://dx.doi.org/10.1016/j.toxicon.2011.10.017			11	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	890IC	22108621				2022-09-04	WOS:000300137300017
J	Gomez, AM; Imitola, A; Henao, D; Garcia-Jaramillo, M; Gimenez, M; Vinals, C; Grassi, B; Torres, M; Zuluaga, I; Munoz, OM; Rondon, M; Leon-Vargas, F; Conget, I				Gomez, Ana M.; Imitola, Angelica; Henao, Diana; Garcia-Jaramillo, Maira; Gimenez, Marga; Vinals, Clara; Grassi, Bruno; Torres, Mariana; Zuluaga, Isabella; Munoz, Oscar Mauricio; Rondon, Martin; Leon-Vargas, Fabian; Conget, Ignacio			Factors associated with clinically significant hypoglycemia in patients with type 1 diabetes using sensor-augmented pump therapy with predictive low-glucose management: A multicentric study on iberoamerica	DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS			English	Article						Hypoglycemia Insulin infusion system; Sensor-augmented pump therapy (SAPT) with predictive low-glucose management (PLGM); Type 1 diabetes	ALL-CAUSE MORTALITY; GLYCEMIC CONTROL; CARDIOVASCULAR-DISEASE; IMPACT; ADULTS; REDUCTION; ALGORITHM; EFFICACY; SAFETY; RISK	Background and aims: Despite using sensor-augmented pump therapy (SAPT) with predictive lowglucose management (PLGM), hypoglycemia is still an issue in patients with type 1 Diabetes (T1D). Our aim was to determine factors associated with clinically significant hypoglycemia (<54 mg/dl) in persons with T1D treated with PLGM-SAPT. Method: ology: This is a multicentric prospective real-life study performed in Colombia, Chile and Spain. Patients with T1D treated with PLGM-SAPT, using sensor >= 70% of time, were included. Data regarding pump and sensor use patterns and carbohydrate intake from 28 consecutive days were collected. A bivariate and multivariate Poisson regression analysis was carried out, to evaluate the association between the number of events of <54 mg/dl with the clinical variables and patterns of sensor and pump use. Results: 188 subjects were included (41 +/- 13.8 years-old, 23 +/- 12 years disease duration, A1c 7.2% +/- 0.9). The median of events <54 mg/dl was four events/patient/month (IQR 1-10), 77% of these events occurred during day time. Multivariate analysis showed that the number of events of hypoglycemia were higher in patients with previous severe hypoglycemia (IRR1.38; 95% CI 1.19-1.61; p 0.001), high glycemic variability defined as Coefficient of Variation (CV%) 0.001) and hypoglycemia unawareness. A protector effect was identified for adequate sensor calibration (IRR 0.77; 95%CI 0.66-0.90; p:0.001), and the use of bolus wizard 60% (IRR 0.74; 95%CI 0.58-0.95; p:0.017). Conclusion: In spite of using advanced SAPT, clinically significant hypoglycemia is still a non-negligible risk. Only the identification and intervention of modifiable factors could help to prevent and reduce hypoglycemia in clinical practice (C) 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.	[Gomez, Ana M.; Imitola, Angelica; Henao, Diana; Torres, Mariana; Zuluaga, Isabella; Munoz, Oscar Mauricio] Pontificia Univ Javeriana, Carrera 7 40-62, Bogota, Colombia; [Gomez, Ana M.; Imitola, Angelica; Henao, Diana] Hosp Univ San Ignacio, Endocrinol Unit, Carrera 7 40-62, Bogota, Colombia; [Garcia-Jaramillo, Maira] Univ EAN, Calle 79 11-45, Bogota, Colombia; [Gimenez, Marga; Vinals, Clara; Conget, Ignacio] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Endocrinol & Nutr Dept, Diabet Unit, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Grassi, Bruno] Pontificia Univ Catolica Chile, Santiago, Chile; [Munoz, Oscar Mauricio] Hosp Univ San Ignacio, Dept Internal Med, Bogota, Colombia; [Munoz, Oscar Mauricio; Rondon, Martin] Pontificia Univ Javeriana, Dept Clin Epidmiol & Biostat, Carrera 7 40-62, Bogota, Colombia; [Leon-Vargas, Fabian] Univ Antonio Narino, Calle 22S 12D-81, Bogota, Colombia		Gomez, AM (corresponding author), Pontificia Univ Javeriana, Carrera 7 40-62, Bogota, Colombia.; Gomez, AM (corresponding author), Pontificia Univ Javeriana, Endocrinol Unit, Hosp Univ San Ignacio, Carrera 7 40-62, Bogota, Colombia.	anagomez@javeriana.edu.co; angelicaimitolam@gmail.com; fucshenao@hotmail.com; magarcia@universidadean.edu.co; gimenez@clinic.cat; vinals@clinic.cat; bagrassi@gmail.com; marianatorres@javeriana.edu.co; isabella_zuluaga@javeriana.edu.co; o.munoz@javeriana.edu.co; martin.rondon@javeriana.edu.co; fabianleon@uan.edu.co; iconget@javeriana.edu.co	Garcia Jaramillo, Maira/AAE-8251-2022	Garcia Jaramillo, Maira/0000-0001-6008-9068; Henao-Carrillo, Diana Cristina/0000-0002-1353-148X; Munoz, Oscar/0000-0001-5401-0018; Vinals, Clara/0000-0002-6888-0396; RONDON, MARTIN/0000-0002-3885-5448				Abraham MB, 2018, DIABETES CARE, V41, P303, DOI 10.2337/dc17-1604; Abraham MB, 2016, DIABETES TECHNOL THE, V18, P543, DOI 10.1089/dia.2016.0141; Battelino T, 2019, DIABETES CARE, V42, P1593, DOI 10.2337/dci19-0028; Biester T, 2017, DIABETES TECHNOL THE, V19, P173, DOI 10.1089/dia.2016.0349; Bohn B, 2015, DIABETES CARE, V38, P1536, DOI 10.2337/dc15-0030; Bosi E, 2019, LANCET DIABETES ENDO, V7, P462, DOI 10.1016/S2213-8587(19)30150-0; Choudhary P, 2016, DIABETES TECHNOL THE, V18, P288, DOI 10.1089/dia.2015.0324; Danne T, 2017, DIABETES CARE, V40, P1631, DOI 10.2337/dc17-1600; Deeb Asma, 2017, J Diabetes Sci Technol, V11, P753, DOI 10.1177/1932296816679850; Fidler Carrie, 2011, J Med Econ, V14, P646, DOI 10.3111/13696998.2011.610852; Frier BM, 2004, DIABETES RES CLIN PR, V65, pS47, DOI 10.1016/j.diabres.2004.07.008; Jaramillo MG, 2020, DIABETES TECHNOL THE, V22, pA154; Gill G, 2009, DIABETOLOGIA, V52, P42, DOI 10.1007/s00125-008-1177-7; Gomez AM, 2019, DIABETES METAB SYND, V13, P2625, DOI 10.1016/j.dsx.2019.07.024; Beato-Vibora PI, 2018, DIABETES TECHNOL THE, V20, P738, DOI 10.1089/dia.2018.0199; Jansa M, 2015, MED CLIN-BARCELONA, V144, P440, DOI 10.1016/j.medcli.2013.11.036; Khunti K, 2015, DIABETES CARE, V38, P316, DOI 10.2337/dc14-0920; Lane W, 2017, JAMA-J AM MED ASSOC, V318, P33, DOI 10.1001/jama.2017.7115; Lu CL, 2016, DIABETES CARE, V39, P1571, DOI 10.2337/dc15-2418; Lung TWC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113635; Gomez AM, 2019, DIABETES TECHNOL THE, V21, P430, DOI 10.1089/dia.2019.0075; Gomez AM, 2018, ENDOCRINOL DIAB NUTR, V65, P451, DOI 10.1016/j.endinu.2018.03.009; Marques JLB, 1997, DIABETIC MED, V14, P648, DOI 10.1002/(SICI)1096-9136(199708)14:8<648::AID-DIA418>3.0.CO;2-1; Monnier L, 2020, DIABETES CARE, V43, P821, DOI 10.2337/dc19-1549; Oyer DS, 2013, CURR DIABETES REV, V9, P195, DOI 10.2174/15733998113099990059; Snell-Bergeon JK, 2012, DIABETES TECHNOL THE, V14, pS51, DOI 10.1089/dia.2012.0031; Thomakos P, 2021, EXP CLIN ENDOCR DIAB, V129, P385, DOI 10.1055/a-0889-7598; Weiss R, 2015, DIABETES TECHNOL THE, V17, P542, DOI 10.1089/dia.2014.0306; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865; Yun JS, 2019, CARDIOVASC DIABETOL, V18, P103, DOI 10.1186/s12933-019-0909-y	30	1	1	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1871-4021	1878-0334		DIABETES METAB SYND	Diabetes Metab. Syndr.-Clin. Res. Rev.	JAN-FEB	2021	15	1					267	272		10.1016/j.dsx.2021.01.002	http://dx.doi.org/10.1016/j.dsx.2021.01.002		JAN 2021	6	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	QR0LA	33477103				2022-09-04	WOS:000624905300053
J	Valenzuela-Alcaraz, B; Serafini, A; Sepulveda-Martinez, A; Casals, G; Rodriguez-Lopez, M; Garcia-Otero, L; Cruz-Lemini, M; Bijnens, B; Sitges, M; Balasch, J; Gratacos, E; Crispi, F				Valenzuela-Alcaraz, B.; Serafini, A.; Sepulveda-Martinez, A.; Casals, G.; Rodriguez-Lopez, M.; Garcia-Otero, L.; Cruz-Lemini, M.; Bijnens, B.; Sitges, M.; Balasch, J.; Gratacos, E.; Crispi, F.			Postnatal persistence of fetal cardiovascular remodelling associated with assisted reproductive technologies: a cohort study	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Article						Assisted reproductive technologies; blood pressure; carotid intima-media thickness; echocardiography; heart; postnatal	IN-VITRO FERTILIZATION; TERM HEALTH OUTCOMES; CHILDREN BORN; AMERICAN-SOCIETY; VASCULAR DYSFUNCTION; WRITING GROUP; IVF; ECHOCARDIOGRAPHY; RECOMMENDATIONS; QUANTIFICATION	Objective To assess the postnatal persistence of fetal cardiovascular remodelling associated with assisted reproductive technologies (ART) in children at 3 years of age. Design A cohort study of children conceived by ART. Setting Maternal-Fetal Medicine Unit, Hospital Clinic Barcelona, Spain. Population sample Eighty singleton pregnancies conceived by ART and 80 spontaneously conceived (controls) followed from fetal life up to childhood. Methods Cardiovascular evaluation was performed at 3 years of corrected age, including echocardiography, carotid intima-media (cIMT) by ultrasound, and blood pressure. Main outcome measures Postnatal persistence of cardiovascular changes in children conceived by ART. Results Compared with controls, children conceived by ART showed larger atria (right atrial area: control 4.9 cm(2) (0.9) versus ART 5.5 cm(2) (0.9), P < 0.001), more globular ventricles (right ventricular sphericity index: control mean 1.8 (SD 0.5) versus ART 1.6 (0.2), P < 0.001), and signs of systolic (tricuspid annular plane systolic excursion: control 18 mm (2) versus ART 16 mm (3), P < 0.001) and diastolic dysfunction (isovolumic relaxation time: control 68 ms (12) versus ART 79 ms (12), P < 0.001). ART children also presented increased systolic blood pressure (control 90 mmHg (6) versus ART 94 mmHg (5), P < 0.003) and cIMT (control 0.52 mu m (0.14) versus ART 0.60 mu m (0.16), P < 0.001) as compared with those spontaneously conceived. Conclusions Cardiovascular changes previously reported in ART fetuses persist postnatally at 3 years of age. These results underscore the importance of future studies for assessing the long-term cardiovascular health associated with ART.	[Valenzuela-Alcaraz, B.; Serafini, A.; Sepulveda-Martinez, A.; Casals, G.; Rodriguez-Lopez, M.; Garcia-Otero, L.; Cruz-Lemini, M.; Balasch, J.; Gratacos, E.; Crispi, F.] Univ Barcelona, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Hosp Clin, Fetal I D Fetal Med Res Ctr,CIBER ER, Barcelona, Spain; [Valenzuela-Alcaraz, B.; Serafini, A.; Sepulveda-Martinez, A.; Casals, G.; Rodriguez-Lopez, M.; Garcia-Otero, L.; Cruz-Lemini, M.; Balasch, J.; Gratacos, E.; Crispi, F.] Univ Barcelona, Inst Clin Gynecol Obstet & Neonatol, IDIBAPS, Hosp St Joan Deu,CIBER ER, Barcelona, Spain; [Valenzuela-Alcaraz, B.; Cruz-Lemini, M.] UNAM, Children & Womens Specialty Hosp, Unidad Invest Neurodesarrollo, Fetal Med & Surg Res Unit,Fetal Med Mexico,Inst N, Queretaro, Mexico; [Sepulveda-Martinez, A.] Univ Chile, Hosp Clin, Dept Obstet & Gynaecol, Fetal Med Unit, Santiago, Chile; [Rodriguez-Lopez, M.] Pontificia Univ Javeriana, Fac Ciencias Salud, Dept Salud Publ & Epidemiol, Cali, Colombia; [Rodriguez-Lopez, M.] Pontificia Univ Javeriana, Fac Ciencias Salud, Dept Clin Med, Cali, Colombia; [Bijnens, B.] Univ Pompeu Fabra, ICREA, Barcelona, Spain; [Sitges, M.] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi i Sunyer, Cardiol Dept,Cardiovasc Inst, Barcelona, Spain		Gratacos, E (corresponding author), BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Sabino de Arana 1, Barcelona 08028, Spain.	gratacos@clinic.cat	Rodriguez-Lopez, Merida/N-9273-2017; Sepulveda-Martinez, Alvaro/H-6546-2014; Gratacos, Eduard/AAR-4939-2020; Bijnens, Bart H/C-2955-2008; Bijnens, Bart/AAE-7186-2021; Cruz-Lemini, Monica/A-4163-2015	Rodriguez-Lopez, Merida/0000-0001-8245-0811; Sepulveda-Martinez, Alvaro/0000-0002-8364-2732; Gratacos, Eduard/0000-0002-7405-7224; Bijnens, Bart H/0000-0003-3130-6937; Bijnens, Bart/0000-0003-3130-6937; Garcia-Otero, Laura/0000-0003-2766-5048; Cruz-Lemini, Monica/0000-0002-6807-3578	Instituto de Salud Carlos III [PI14/00226, INT16/00168, PI15/00130]; Instituto de Salud Carlos III (ISCIII general evaluation subdirectorate); Instituto de Salud Carlos III (European Regional Development Fund (FEDER)); Instituto de Salud Carlos III (Erasmus Programme of the European Union) [2013-0040]; "La Caixa" Foundation; Cerebra, the Foundation for the Brain Injured Infant and Young People; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya [SGR n_928, 2013_FI0667, 2016FI_B01184]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (ISCIII general evaluation subdirectorate); Instituto de Salud Carlos III (European Regional Development Fund (FEDER)); Instituto de Salud Carlos III (Erasmus Programme of the European Union); "La Caixa" Foundation(La Caixa Foundation); Cerebra, the Foundation for the Brain Injured Infant and Young People; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya)	This project has been funded with support of the Instituto de Salud Carlos III ((PI14/00226, INT16/00168 and PI15/00130) integrated in the National R&D Plan and cofinanced by the ISCIII general evaluation subdirectorate, by the European Regional Development Fund (FEDER acronym in spanish) and by Erasmus Programme of the European Union (Framework Agreement number: 2013-0040)). Research leading to these results received funding from "La Caixa" Foundation; Cerebra, the Foundation for the Brain Injured Infant and Young People and the support of the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya (grant SGR n_928, 2013_FI0667, 2016FI_B01184).	Balasch J, 2012, CURR OPIN OBSTET GYN, V24, P187, DOI 10.1097/GCO.0b013e3283517908; Belva F, 2008, HUM REPROD, V23, P2227, DOI 10.1093/humrep/den254; Bontekoe S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008950.pub2; Calhaz-Jorge C, 2016, HUM REPROD, V31, P1638, DOI 10.1093/humrep/dew151; Ceelen M, 2007, J CLIN ENDOCR METAB, V92, P3417, DOI 10.1210/jc.2006-2896; Coates A, 2017, FERTIL STERIL, V107, P723, DOI [10.1016/.fertnstert.2016.12.022, 10.1016/j.fertnstert.2016.12.022]; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Guo XY, 2017, FERTIL STERIL, V107, P622, DOI 10.1016/j.fertnstert.2016.12.007; Hart R, 2013, HUM REPROD UPDATE, V19, P244, DOI 10.1093/humupd/dmt002; Hart R, 2013, HUM REPROD UPDATE, V19, P232, DOI 10.1093/humupd/dms062; Henningsen AKA, 2011, FERTIL STERIL, V95, P959, DOI 10.1016/j.fertnstert.2010.07.1075; Kleijkers SHM, 2014, HUM REPROD, V29, P661, DOI 10.1093/humrep/deu025; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liu H, 2015, JAMA PEDIATR, V169, P603, DOI 10.1001/jamapediatrics.2015.0214; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Pinborg A, 2013, HUM REPROD UPDATE, V19, P87, DOI 10.1093/humupd/dms044; Pontesilli M, 2015, REPROD BIOMED ONLINE, V30, P258, DOI 10.1016/j.rbmo.2014.11.006; Rexhaj E, 2013, J CLIN INVEST, V123, P5052, DOI 10.1172/JCI68943; Sakka SD, 2010, FERTIL STERIL, V94, P1693, DOI 10.1016/j.fertnstert.2009.09.049; Scherrer U, 2015, EUR HEART J, V36, P1583, DOI 10.1093/eurheartj/ehv145; Scherrer U, 2012, CIRCULATION, V125, P1890, DOI 10.1161/CIRCULATIONAHA.111.071183; Seggers J, 2014, HUM REPROD, V29, P502, DOI 10.1093/humrep/det396; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Valenzuela-Alcaraz B, 2013, CIRCULATION, V128, P1442, DOI 10.1161/CIRCULATIONAHA.113.002428; von Arx R, 2015, J APPL PHYSIOL, V118, P1200, DOI 10.1152/japplphysiol.00533.2014; Zhou J, 2014, CELL PHYSIOL BIOCHEM, V34, P988, DOI 10.1159/000366315	27	22	22	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	JAN	2019	126	2			SI		291	298		10.1111/1471-0528.15246	http://dx.doi.org/10.1111/1471-0528.15246			8	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	HD9HE	29673050	Green Accepted			2022-09-04	WOS:000452871600034
J	Bustacara, AM; Saavedra, JEC; Jimenez, MAP				Molano Bustacara, Alejandra; Cuellar Saavedra, Jose Edwin; Perez Jimenez, Miguel Angel			Emotional integrity. How to be spiritual in a skeptical world	HALLAZGOS-REVISTA DE INVESITIGACIONES			Spanish	Article						spirituality; secularity; emotional integrity; cognitive theory; meaning of life		The theme of this work is spirituality in a secularized world. It is proposed that Solomon's theory of emotional integrity makes explicit a form of spirituality that does not make it dependent on religion. Thus, it is a good tool to understand spirituality in a world with several forms of religiosity, atheism and agnosticism. This spirituality assumes a cognitivist conception of the three emotions that are traditionally recognized as ethical and spiritual: happiness, gratitude and love. According to this conception, emotions in general are judgments and its content is an object evaluated in some way. These three emotions have other emotional states as intentional objects, that is why they are called "meta-emotions". Being spiritual involves an assessment of our life as a whole, affectionately evaluated from a specific present. As such, spirituality is the key to construct each person's meaning of life. Affective spirituality is within the framework of the emotional integrity theory. This theory states that human beings are capable of endless number of emotions. In this regard, the ability to have an integral affective life is the possibility to forge what we are, to face the challenges of life; it is how we construct the meaning of our own lives.	[Molano Bustacara, Alejandra] Univ Los Andes, Fac Derecho, Santiago, Chile; [Molano Bustacara, Alejandra] Univ Los Andes, Derecho, Santiago, Chile; [Molano Bustacara, Alejandra; Cuellar Saavedra, Jose Edwin] Pontificia Univ Javeriana, Bogota, Colombia; [Molano Bustacara, Alejandra] Univ Los Andes, Santiago, Chile; [Molano Bustacara, Alejandra] Univ El Bosque, Bogota, Colombia; [Molano Bustacara, Alejandra; Cuellar Saavedra, Jose Edwin] Pontificia Univ Javeriana, Inst Bioet, Bogota, Colombia; [Molano Bustacara, Alejandra] Escuela Judicial Lara Bonilla, Programas Educ Continuada Argumentac, Bogota, Colombia; [Molano Bustacara, Alejandra] Univ Rosario, Bogota, Colombia; [Molano Bustacara, Alejandra] Pontificia Univ Javeriana, Proyecto Invest Aspectos Eticos Teoria Cognit Emo, Bogota, Colombia; [Cuellar Saavedra, Jose Edwin] Pontificia Univ Javeriana, Bioet, Bogota, Colombia; [Cuellar Saavedra, Jose Edwin] Pontificia Univ Javeriana, Gest Ambiental, Bogota, Colombia; [Cuellar Saavedra, Jose Edwin] Pontificia Univ Javeriana, Filosofia, Bogota, Colombia; [Cuellar Saavedra, Jose Edwin] Univ Nacl Cuyo, Bioet, Mendoza, Argentina; [Cuellar Saavedra, Jose Edwin] Univ Nacl Colombia, Filosofia Polit, Bogota, Colombia; [Perez Jimenez, Miguel Angel] Pontificia Univ Javeriana, Dept Filosofia, Bogota, Colombia; [Perez Jimenez, Miguel Angel] Univ Granada, Filosofia, Granada, Spain; [Perez Jimenez, Miguel Angel] Pontificia Univ Javeriana, Filosofia, Bogota, Colombia; [Perez Jimenez, Miguel Angel] Univ Granada, Filosofia Lenguaje, Granada, Spain; [Perez Jimenez, Miguel Angel] Pontificia Univ Javeriana Colciencias A, Grp Invest Problemas Filosofia, Bogota, Colombia		Bustacara, AM (corresponding author), Univ Los Andes, Fac Derecho, Santiago, Chile.; Bustacara, AM (corresponding author), Univ Los Andes, Derecho, Santiago, Chile.; Bustacara, AM (corresponding author), Pontificia Univ Javeriana, Bogota, Colombia.; Bustacara, AM (corresponding author), Univ Los Andes, Santiago, Chile.; Bustacara, AM (corresponding author), Univ El Bosque, Bogota, Colombia.; Bustacara, AM (corresponding author), Pontificia Univ Javeriana, Inst Bioet, Bogota, Colombia.; Bustacara, AM (corresponding author), Escuela Judicial Lara Bonilla, Programas Educ Continuada Argumentac, Bogota, Colombia.; Bustacara, AM (corresponding author), Univ Rosario, Bogota, Colombia.; Bustacara, AM (corresponding author), Pontificia Univ Javeriana, Proyecto Invest Aspectos Eticos Teoria Cognit Emo, Bogota, Colombia.	na.molano45@uniandes.edu.co; cuellarj@javeriana.edu.co; miguel.perez@javeriana.edu.co		Perez Jimenez, Miguel Angel/0000-0002-1154-8026				Averill J., 1980, EMOTION THEORY RES E, V1, P339; BEDFORD E, 1957, P ARISTOTELIAN SOC, V57, P281; Bishop J., 2012, PASSION DEATH SPIRIT, P245, DOI [10.1007/978-94-007-4650-3_18, DOI 10.1007/978-94-007-4650-3_18]; Cornelius R., 2006, SCI EMOTION; Darwin C., 2009, EXPRESS EMOT MAN; Deigh J., 2010, OXFORD HDB PHILOS EM, P17; Deonna J., 2012, EMOTIONS PHILOS INTR; Doring SA, 2003, PHILOS QUART, V53, P214, DOI 10.1111/1467-9213.00307; Ekman P, 2007, EMOTIONS REVEALED RE, V2nd; FRIJDA NH, 1993, COGNITION EMOTION, V7, P357, DOI 10.1080/02699939308409193; Goldie P., 2000, EMOTIONS; Goleman D., 2008, DESTRUCTIVE EMOTIONS; Helm BW, 2009, EMOT REV, V1, P248, DOI 10.1177/1754073909103593; James W., 1884, MIND, VIX, P188, DOI [DOI 10.1093/MIND/OS-IX.34.188, 10.1093/mind/os-IX.34.188]; Kenny D. A., 2003, ACTION EMOTION WILL, V2nd, DOI [10.4324/9780203711460, DOI 10.4324/9780203711460]; LAZARUS R, 2000, PASION RAZON COMPREN; Maiese M, 2014, PHENOMENOL COGN SCI, V13, P513, DOI 10.1007/s11097-014-9373-z; Mesquita B., 2016, HDB EMOTIONS, P393; Mulligan Kevin., 2010, OXFORD HDB PHILOS EM, P475; Nussbaum Martha C., 2001, MONARCHY FEAR; Prinz Jesse, 2006, GUT REACTIONS; Scarantino A., 2016, HDB EMOTIONS, P3; Solomon R, 2006, ETHICS LIVING WELL; Solomon R. C., 1992, ETHICS EXCELLENCE; SOLOMON RC, 1976, PASSIONS EMOTIONS ME; Solomon Robert C., 2007, ETICA EMOCIONAL TEOR; Tooby J., 2000, HDB EMOTIONS, P114; Vendrell, 2009, CONTRASTES REV INT F, V14, P217; Weidler M., 2012, PASSION DEATH SPIRIT, P223	29	0	0	0	1	UNIV SANTO TOMAS	BOGOTA	CRA 9 NRO 51 11, BOGOTA, 00000, COLOMBIA	1794-3841			HALLAZGOS	Hallazgos	JAN-JUN	2018	15	29					73	85		10.15332/s1794-3841.2018.0029.03	http://dx.doi.org/10.15332/s1794-3841.2018.0029.03			13	Area Studies	Emerging Sources Citation Index (ESCI)	Area Studies	GT7PM					2022-09-04	WOS:000444720600004
J	Aschner, P; Aguilar-Salinas, C; Aguirre, L; Franco, L; Gagliardino, JJ; de Lapertosa, SG; Seclen, S; Vinocour, M				Aschner, Pablo; Aguilar-Salinas, Carlos; Aguirre, Loreto; Franco, Laercio; Jose Gagliardino, Juan; Gorban de Lapertosa, Sylvia; Seclen, Segundo; Vinocour, Mary		IDF Diabet Atlas	Diabetes in South and Central America: An update	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Diabetes; South and Central America; Glycemic control; HbA1c; Prevalance; Impaired Glucose Tolerance	SOCIOECONOMIC GRADIENTS; LATIN-AMERICA; RISK-FACTORS; PREVALENCE; OBESITY; URBAN; HOSPITALIZATION; COUNTRIES; IMPROVE; DISEASE	The estimated population of the South and Central America (SACA) Region is 467.6 million and 64% is in the age range of 20-79 years but the population pyramid and age distribution are changing. The average prevalence of diabetes in the Region is 8.0% and is expected to reach 9.8% by the year 2035. Prevalence is much lower in rural settings than in urban and the differences attributed to lifestyle changes may be a target for intervention. The indigenous population is a particularly vulnerable group needing special attention. On average, 24% of the adult cases with diabetes are undiagnosed but in some countries this is still as high as 50%. Health expenditure due to diabetes in the Region is around 9% of the global total. Inadequate glycemic control, defined as HbA1c >7%, is a strong predictor of chronic complications which increase resource use in the Region and less than half of the patients enrolled in diabetes care programmes are at target. Fifty percent or more of the adult population is overweight/obese and around one third of the adult population has metabolic syndrome using regional cutoffs for waist circumference. The number of people with IGT is almost equal to those with diabetes presenting an additional challenge for prevention. Children with type 1 diabetes represent only 0.2% of the total population with diabetes but the incidence may be increasing. In many places they have limited access to insulin, and even when available, it is not used appropriately. The available epidemiological data provide the background to act in developing national diabetes programmes which integrate diabetes care with cardiovascular prevention and promote diabetes prevention as well. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Aschner, Pablo] Javeriana Univ, Sch Med, Bogota, Colombia; [Aschner, Pablo] San Ignacio Univ Hosp, Bogota, Colombia; [Aguilar-Salinas, Carlos] Natl Inst Med Sci & Nutr, Mexico City, DF, Mexico; [Aguirre, Loreto] Adich OPS, Chilean Diabet Assoc, Santiago, Spain; [Franco, Laercio] Univ Sao Paulo, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil; [Jose Gagliardino, Juan] UNLP CONICET, Ctr Expt & Appl Endocrinol CENEXA, La Plata, Buenos Aires, Argentina; [Jose Gagliardino, Juan] UNLP CONICET, PAHO WHO Collaborating Ctr Diabet, La Plata, Buenos Aires, Argentina; [Gorban de Lapertosa, Sylvia] Nordeste Natl Univ, Sch Med, Corrientes, Argentina; [Seclen, Segundo] Peruvian Univ Cayetano Heredia, Diabet Hypertens & Lipids Unit, Lima, Peru; [Vinocour, Mary] Univ Costa Rica, Sch Med, San Jose, Costa Rica		Aschner, P (corresponding author), Javeriana Univ, Sch Med, San Ignacio Univ Hosp, Colombian Diabet Assoc, Bogota, Colombia.	paschner@cable.net.co	Seclen, Segundo Nicolas/GNM-5418-2022; Franco, Laercio Joel/H-3814-2013; Salinas, Carlos A Aguilar/AAL-4491-2020	Franco, Laercio Joel/0000-0002-9820-3425; Seclen Santisteban, Segundo Nicolas/0000-0002-2431-099X	Lilly Diabetes; Merck and Co., Inc.; Novo Nordisk A/S; Novo Nordisk Changing Diabetes(R) initiative; Pfizer, Inc.; Sanofi Diabetes	Lilly Diabetes; Merck and Co., Inc.(Merck & Company); Novo Nordisk A/S(Novo Nordisk); Novo Nordisk Changing Diabetes(R) initiative; Pfizer, Inc.(Pfizer); Sanofi Diabetes	The 6th edition of the IDF Diabetes Atlas was supported by the following sponsors: Lilly Diabetes, Merck and Co., Inc., Novo Nordisk A/S supported through an unrestricted grant by the Novo Nordisk Changing Diabetes (R) initiative, Pfizer, Inc., and Sanofi Diabetes.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; [Anonymous], 2013, IDF DIABETES ATLAS; Aschner P, 2010, AV DIABETOL, V26, P95, DOI 10.1016/S1134-3230(10)62005-4; Aschner P, 2011, DIABETES RES CLIN PR, V93, P243, DOI 10.1016/j.diabres.2011.05.002; Aschner P, 2009, J CLIN HYPERTENS, V11, P769, DOI 10.1111/j.1559-4572.2008.00051.x; Caporale JE, 2011, VALUE HEALTH, V14, pS20, DOI 10.1016/j.jval.2011.05.018; Carrasco E, 2004, REV MED CHILE, V132, P1189; Carrasco E, 2006, DIABETES METAB RES R, V22; Carrasco E, 2006, REV MED CHILE, V134, P1258; Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435; Commendatore V, 2013, INT J CLIN PRACT, V67, p)); Dal Fabbro A, 2013, ETHN DIS IN PRESS; De Maio FG, 2012, GLOB PUBLIC HEALTH, V7, P635, DOI 10.1080/17441692.2012.663399; Escobedo J, 2009, DIABETIC MED, V26, P864, DOI 10.1111/j.1464-5491.2009.02795.x; Fleischer NL, 2011, AM J PUBLIC HEALTH, V101, P294, DOI 10.2105/AJPH.2009.190165; Gagliardino JJ, 2006, DIABETES RES CLIN PR, V72, P284, DOI 10.1016/j.diabres.2006.02.004; Gagliardino J J, 2001, Rev Panam Salud Publica, V10, P309, DOI 10.1590/S1020-49892001001100003; Gagliardino JJ, 2013, DIABETIC MED, V30, P1102, DOI 10.1111/dme.12230; Gagliardino JJ, 2004, DIABETES RES CLIN PR, V65, P51, DOI 10.1016/j.diabres.2003.11.011; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Guariguata L, 2011, DIABETES RES CLIN PR, V94, P322, DOI 10.1016/j.diabres.2011.10.040; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Linetzky B, 2013, INT J PUBLIC HEALTH, V58, P277, DOI 10.1007/s00038-012-0371-z; Ministerio de Salud de Peru, 2006, ENC NAC IND NUTR BIO; Ministry of Health Chile, 2009, ENC NAC SAL; Ringborg A, 2009, INT J CLIN PRACT, V63, P997, DOI 10.1111/j.1742-1241.2009.02098.x; Rosas Guzman J, 2009, REV ALAD, V17, P146; Stewart GL, 2007, REV PANAM SALUD PUBL, V22, P12, DOI 10.1590/S1020-49892007000600002; The World Bank, GDP CURR US; United Nations Department of Economic and Social Affairs, 2012, WORLD POP PROSP 2012; WHO, GLOB HLTH EXP DAT	32	49	58	1	21	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	FEB	2014	103	2					238	243		10.1016/j.diabres.2013.11.010	http://dx.doi.org/10.1016/j.diabres.2013.11.010			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	AD2TC	24439209				2022-09-04	WOS:000333087200011
J	Estrada-Villegas, S; Perez-Torres, J; McGill, BJ; Stevens, RD				Estrada-Villegas, Sergio; Perez-Torres, Jairo; McGill, Brian J.; Stevens, Richard D.			Environmental Seasonality Regulates Community Evenness in Neotropical Bat Communities	FRONTIERS IN ECOLOGY AND EVOLUTION			English	Article						Shannon-Weiner evenness; sampling coverage; climatic variability; Atlantic Forest; South America; Chiroptera; ATLANTIC BATS	SPECIES RICHNESS; AVIAN COMMUNITIES; CONSUMERS GUIDE; DIVERSITY; CHIROPTERA; VESPERTILIONIDAE; DETERMINANTS; BIODIVERSITY; ORGANIZATION; COMPONENTS	Evenness is a key community property that provides insights into resource acquisition and ecosystem functioning. However, it is unclear how other community properties influence evenness after integrating the effect of environmental gradients. Using 49 neotropical bat communities, we tested the hypothesis that evenness increases in communities that have low species richness and low biomass because the negative effect of richness and biomass on evenness is regulated by environmental seasonality. We selected among path models to determine how temperature seasonality, the most important gradient across study sites, affected richness and biomass as drivers of evenness. Employing three indices of evenness, we found that more seasonal climate reduces species richness, and lower richness increases evenness. Moreover, a decline in biomass with increasing seasonality also increases evenness. A decrease in resource specialization and rarity as sites become more seasonal may explain the negative relationship between seasonality, richness and evenness. Moreover, the negative effect of biomass on richness and evenness may be due to an expansion of niche space and a positive effect of smaller body size on diversification rates, which may allow more species packing and greater richness. We believe our results bring us closer to a unified theory of which factors control evenness in a community.	[Estrada-Villegas, Sergio] Yale Univ, Yale Sch Environm, New Haven, CT USA; [Estrada-Villegas, Sergio] New York Bot Garden, Bronx, NY USA; [Estrada-Villegas, Sergio] Smithsonian Trop Res Inst, Balboa, Panama; [Perez-Torres, Jairo] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Bogota, Colombia; [McGill, Brian J.] Univ Maine, Sch Biol & Ecol, Orono, ME USA; [Stevens, Richard D.] Texas Tech Univ, Dept Nat Resources Management, Lubbock, TX USA; [Stevens, Richard D.] Museum Texas Tech Univ, Nat Sci Res Lab, Lubbock, TX USA		Estrada-Villegas, S (corresponding author), New York Bot Garden, Bronx, NY USA.; Estrada-Villegas, S (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	sergio.estradavillegas@yale.edu						Alroy J, 2019, GLOBAL ECOL BIOGEOGR, V28, P784, DOI 10.1111/geb.12892; BARQUEZ RUBÉN M., 2017, Pap. Avulsos Zool., V57, P287, DOI 10.11606/0031-1049.2017.57.22; Bernard E, 2001, J TROP ECOL, V17, P115, DOI 10.1017/S0266467401001079; Buzas Martin A., 1996, Biodiversity Letters, V3, P40, DOI 10.2307/2999767; Canals M, 2005, ACTA CHIROPTEROL, V7, P65, DOI 10.3161/1733-5329(2005)7[65:RSOHAL]2.0.CO;2; Cardoso V., 2018, MORCEGOS PARQUE ESTA; Chao AN, 2014, ANNU REV ECOL EVOL S, V45, P297, DOI 10.1146/annurev-ecolsys-120213-091540; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; COTGREAVE P, 1994, J ANIM ECOL, V63, P365, DOI 10.2307/5554; Drobner U, 1998, OIKOS, V82, P295, DOI 10.2307/3546969; Estrada-Villegas S, 2012, OIKOS, V121, P927, DOI 10.1111/j.1600-0706.2011.19837.x; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Gaston K. J, 1994, RARITY; Hanya G, 2011, ECOGRAPHY, V34, P1009, DOI 10.1111/j.1600-0587.2010.06775.x; Haynes Michelle A., 2004, Mammalian Species, P1; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Isaac NJB, 2005, AM NAT, V165, P600, DOI 10.1086/429148; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jost L., 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; KARR JR, 1971, ECOL MONOGR, V41, P207, DOI 10.2307/1942366; Gimenez AL, 2020, MAMMALIA, V84, P150, DOI 10.1515/mammalia-2019-0024; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; MacArthur R.H., 1972, pvii; Magurran AE, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0856; Maureaud A, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1189; Mies Rob, 1996, Mammalian Species, V526, P1; Mittelbach G.G., 2019, COMMUNITY ECOL, V2nd; Moratelli R, 2011, MAMM BIOL, V76, P592, DOI 10.1016/j.mambio.2011.01.003; Mulder CPH, 2004, OIKOS, V107, P50, DOI 10.1111/j.0030-1299.2004.13110.x; Muylaert RDL, 2017, ECOLOGY, V98, P3227, DOI 10.1002/ecy.2007; Nogueira MR, 2012, AM MUS NOVIT, P1; Oprea Monik, 2009, Mammalian Species, DOI 10.1644/844.1; Ortega Jorge, 2008, Mammalian Species, P1, DOI 10.1644/818.1; Passy SI, 2017, HYDROBIOLOGIA, V787, P243, DOI 10.1007/s10750-016-2968-3; Perez-Torres J., 2004, THESIS PONTIFICIA U; Pielou E.C., 1975, ECOLOGICAL DIVERSITY; Reid F.A., 2009, FIELD GUIDE MAMMALS; Rojas D, 2012, J BIOGEOGR, V39, P1948, DOI 10.1111/j.1365-2699.2012.02709.x; Rolland J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001775; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROTENBERRY JT, 1978, ECOLOGY, V59, P693, DOI 10.2307/1938772; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Santos Mery, 2003, Mammalian Species, V722, P1, DOI 10.1644/722; Scholl JP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1334; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Steudel B, 2012, ECOL LETT, V15, P1397, DOI 10.1111/j.1461-0248.2012.01863.x; Stevens RD, 2002, ECOLOGY, V83, P545, DOI 10.2307/2680034; Stevens RD, 2013, BIOTROPICA, V45, P764, DOI 10.1111/btp.12056; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Straube F.C., 2002, CHIROPTERA NEOTROPIC, V8, P150, DOI DOI 10.1017/CB09781107415324.004; Su Q, 2018, PEERJ, V6, DOI 10.7717/peerj.4951; Tavares Valeria da Cunha, 2010, Mammalian Species, P119, DOI 10.1644/859.1; Tejedor A, 2011, B AM MUS NAT HIST, P1; Tello JS, 2010, ECOGRAPHY, V33, P796, DOI 10.1111/j.1600-0587.2009.05991.x; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; TRAMER E J, 1969, Ecology (Washington D C), V50, P927, DOI 10.2307/1933715; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; Velazco PM, 2019, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090.429.1.1; Verde Rair de Sousa, 2017, Oecologia Australis, V21, P191, DOI 10.4257/oeco.2017.2102.09; Weiher E, 1999, OIKOS, V87, P355, DOI 10.2307/3546751; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wilsey B, 2007, PLANT ECOL, V190, P259, DOI 10.1007/s11258-006-9206-4; Wilson D.E., 1974, MAMMALIAN SPECIES, V39, P1, DOI [DOI 10.2307/3503847, 10.2307/3503847]; WINEMILLER KO, 1990, ECOL MONOGR, V60, P27, DOI 10.2307/1943025	69	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-701X			FRONT ECOL EVOL	Front. Ecol. Evol.	MAR 22	2022	10								839384	10.3389/fevo.2022.839384	http://dx.doi.org/10.3389/fevo.2022.839384			8	Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	0I7XY		gold			2022-09-04	WOS:000779630200001
J	Gomez, G; Fisberg, RM; Previdelli, AN; Kovalskys, I; Fisberg, M; Herrera-Cuenca, M; Sanabria, LYC; Yepez, MC; Pareja, RG; Rigotti, A				Gomez, Georgina; Fisberg, Regina Mara; Previdelli, Agatha Nogueria; Kovalskys, Irina; Fisberg, Mauro; Herrera-Cuenca, Marianella; Cortes Sanabria, Lilia Yadira; Cecilia Yepez, Martha; Pareja, Rossina G.; Rigotti, Attilio			Dietary diversity in eight Latin American countries: Results from ELANS Study	PROCEEDINGS OF THE NUTRITION SOCIETY			English	Meeting Abstract									[Gomez, Georgina] Univ Cost Rica, San Jose, Costa Rica; [Fisberg, Regina Mara] Univ Costa Rica, Sao Paulo, Brazil; [Previdelli, Agatha Nogueria] Univ Sao Judas Tadeu, Sao Paulo, Brazil; [Kovalskys, Irina] Int Life Sci Inst, Buenos Aires, DF, Argentina; [Fisberg, Mauro] Inst Pensi, Sao Paulo, Brazil; [Fisberg, Mauro] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Herrera-Cuenca, Marianella] Univ Cent Venezuela, Caracas, Venezuela; [Cortes Sanabria, Lilia Yadira] Pontificia Univ Javeriana, Bogota, Colombia; [Cecilia Yepez, Martha] Univ San Francisco Quito, Quito, Ecuador; [Pareja, Rossina G.] Inst Invest Nutr, Lima, Peru; [Rigotti, Attilio] Pontificia Univ Catolica, Santiago, Chile				Fisberg, Mauro/E-7149-2010	Fisberg, Mauro/0000-0003-2992-3215					0	0	0	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0029-6651	1475-2719		P NUTR SOC	Proc. Nutr. Soc.		2020	79	OCE2					E703	E703		10.1017/S0029665120006527	http://dx.doi.org/10.1017/S0029665120006527			1	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	MH3ND		Bronze			2022-09-04	WOS:000546638800636
J	Albert, RM; Bamford, MK; Stanistreet, IG; Stollhofen, H; Rivera-Rondon, CA; Njau, JK; Blumenschine, RJ				Albert, R. M.; Bamford, M. K.; Stanistreet, I. G.; Stollhofen, H.; Rivera-Rondon, Carlos A.; Njau, J. K.; Blumenschine, R. J.			River-fed wetland palaeovegetation and palaeoecology at the HWK W site, Bed I, Olduvai Gorge	REVIEW OF PALAEOBOTANY AND PALYNOLOGY			English	Article						Hominins; Tuff ID-IE interval palaeofacies; Paleovegetation; Phytoliths; Macroplant fossils; Diatoms	OKAVANGO FAN; ARCHAEOLOGICAL RECORD; PHYTOLITH ASSEMBLAGES; PLIO-PLEISTOCENE; FLK NORTH; LAND-USE; 1.84 MA; TANZANIA; BASIN; CLASSIFICATION	Palaeolandscape studies are an essential tool for understanding adaptation and use of plant- and water-related affordances by hominins. A number of high-resolution palaeolandscape analyses have been carried out at Olduvai Gorge (northern Tanzania) over the last two decades but none have focused on the Tuff ID-IE stratigraphic interval (1.83-1.84 Ma). At locality HWK W, this interval presents earthy facies, including siliceous earth, earthy claystone, sandy earth, and earthy sandstone facies varieties, which are rare for Bed I. These facies have been interpreted at other stratigraphic levels to represent densely vegetated wetlands. Additionally, the HWK W site has yielded quantities of fossil bone and tools eroding to the surface. Within the Tuff ID-IE interval, and during regression periods of Palaeolake Olduvai, fluvial and wetland facies were deposited. During this period, the phytoliths and plant macrofossils show that the vegetation was dominated by palms, associated with a mix of C-3 and C-4 grasses as well as sedges. The variation in phytolith types within these facies implies a locally diverse palaeoenvironmental micro-mosaic, with stacked transgressive sequences, varying from vegetated fluvial channels to vegetated levees and then backswamp subenvironments. Diatoms are particularly rich at Trench T155 and are associated with sponge spicules, indicating the presence of freshwater palaeowetlands with clear water. The extensive diatom valve fragmentation and the differences among trenches suggest that the diatom depositional environment was a heterogeneous river-fed palaeowetland or a vegetated fluvial channel affected by periodic droughts. A diverse fauna was recovered, comprising autochthonous hippopotamus and crocodile elements as well as herbivores drawn to the freshwater resource. Oldowan lithic artifacts were also recovered and some bone was processed through percussion and cutting by early hominins, likely Homo habilis. Overall, the first landscape reconstruction undertaken at HWK W locality during the Tuff ID-IE interval shows a dynamic and richly vegetated area that would have provided hominins with fresh water, scavengeable carcasses, as well as with edible plant affordances (palm fruits, starch-rich rhizomes from sedges and Typha). The presence of palms suggests the area supported a diversity of trees, affording hominins refuge from predators. (C) 2018 Elsevier B.V. All rights reserved.	[Albert, R. M.] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain; [Albert, R. M.] Univ Barcelona, Dept Hist & Archaeol, ERAAUB, C Montalegre 6-8, Barcelona 08001, Spain; [Albert, R. M.; Bamford, M. K.; Blumenschine, R. J.] Univ Witwatersrand, Evolutionary Studies Inst, P Bag 3, ZA-2050 Johannesburg, South Africa; [Albert, R. M.; Bamford, M. K.; Blumenschine, R. J.] Univ Witwatersrand, Sch Geosci, P Bag 3, ZA-2050 Johannesburg, South Africa; [Stanistreet, I. G.] Univ Liverpool, Dept Earth Ocean & Ecol Sci, Brownlow St,POB 147, Liverpool L69 3GP, Merseyside, England; [Stanistreet, I. G.; Njau, J. K.] Stone Age Inst, Bloomington, IN 47407 USA; [Stollhofen, H.] Friedrich Alexander Univ FAU Erlangen Nurnberg, GeoZentrum Nordbayern, Schlossgarten 5, D-91054 Erlangen, Germany; [Rivera-Rondon, Carlos A.] Pontificia Univ Javeriana, Dept Biol, UNESIS, Cra 7 40-62, Bogota 110231, Colombia; [Njau, J. K.] Indiana Univ, Dept Earth & Atmospher Sci, 1001 East 10th St, Bloomington, IN 47405 USA; [Blumenschine, R. J.] Paleontol Sci Trust PAST, Johannesburg, South Africa		Albert, RM (corresponding author), Univ Barcelona, Dept Hist & Archaeol, ERAAUB, C Montalegre 6-8, Barcelona 08001, Spain.	rmalbert@ub.edu	Rivera-Rondon, Carlos A/B-6162-2014; Albert, Rosa Maria/F-2937-2016	Rivera-Rondon, Carlos A/0000-0001-5025-6141; Albert, Rosa Maria/0000-0003-1722-9445; Stollhofen, Harald/0000-0002-2782-3440	Spanish Ministry of Economy and Competitivity [HAR2013-42054, HAR2016-75216]; PAST (Palaeontological Scientific Trust, South Africa); German Science Foundation (DFG) [STO 275/9]; Pontificia Universidad Javeriana [IDPPTA 7630]	Spanish Ministry of Economy and Competitivity(Spanish Government); PAST (Palaeontological Scientific Trust, South Africa); German Science Foundation (DFG)(German Research Foundation (DFG)); Pontificia Universidad Javeriana	This project was funded by the Spanish Ministry of Economy and Competitivity to RMA (HAR2013-42054 and HAR2016-75216). Funding from PAST (Palaeontological Scientific Trust, South Africa) for fieldwork over several years as well as other PAST funding to MB and IGS for traveling is gratefully acknowledged. Financial support from German Science Foundation (DFG STO 275/9) to HS and from Pontificia Universidad Javeriana (IDPPTA 7630) to CARR was also received. We thank the Tanzania Commission for Science and Technology (COSTECH), the Ngorongoro Conservation Area Authority (NCAA), and Tanzanian Department of Antiquities for granting permission to work in the Olduvai area, and NNHM (the National Natural History Museum of Tanzania, Arusha) for logistical support and curational management of Olduvai material. We also thank Irene Esteban, Dan Cabanes and Jose Antonio Ruiz for their help in the preparation, study and statistical analysis of samples.	Albert RM, 2015, PALAEOGEOGR PALAEOCL, V426, P34, DOI 10.1016/j.palaeo.2015.02.022; Albert RM, 1999, J ARCHAEOL SCI, V26, P1249, DOI 10.1006/jasc.1999.0355; Albert RM, 2006, QUATERN INT, V148, P78, DOI 10.1016/j.quaint.2005.11.026; Albert RM, 2001, PHYTOLITHS: APPLICATIONS IN EARTH SCIENCES AND HUMAN HISTORY, P251; Alexandre A, 1997, PALAEOGEOGR PALAEOCL, V136, P213, DOI 10.1016/S0031-0182(97)00089-8; Arraiz H, 2017, PALAEOGEOGR PALAEOCL, V488, P9, DOI 10.1016/j.palaeo.2017.04.025; Ashley GM, 2010, QUATERNARY RES, V74, P333, DOI 10.1016/j.yqres.2010.08.006; Ashley GM, 2009, PALAEOGEOGR PALAEOCL, V272, P1, DOI 10.1016/j.palaeo.2008.10.016; Bamford MK, 2008, PALAEOGEOGR PALAEOCL, V257, P280, DOI 10.1016/j.palaeo.2007.09.003; Bamford MK, 2012, J HUM EVOL, V63, P351, DOI 10.1016/j.jhevol.2011.07.001; Bamford MK, 2006, QUATERN INT, V148, P95, DOI 10.1016/j.quaint.2005.11.027; Barboni D, 2014, QUATERN INT, P322; Barboni D, 2007, PALAEOGEOGR PALAEOCL, V246, P454, DOI 10.1016/j.palaeo.2006.10.012; Barboni D, 2010, QUATERNARY RES, V74, P344, DOI 10.1016/j.yqres.2010.09.005; Barboni D, 2009, REV PALAEOBOT PALYNO, V158, P29, DOI 10.1016/j.revpalbo.2009.07.002; Binford L.R., 2001, CONSTRUCTING FRAMES, P563; Blumenschine R., 2009, CUTTING EDGE NEW APP, P1; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Blumenschine RJ, 1998, J HUM EVOL, V34, P565, DOI 10.1006/jhev.1998.0216; Blumenschine RJ, 2012, J HUM EVOL, V63, P364, DOI 10.1016/j.jhevol.2011.10.001; Blumenschine RJ, 2012, J HUM EVOL, V63, P384, DOI 10.1016/j.jhevol.2011.05.003; Bonnefille R., 1984, NATL GEOGRAPHIC SOC, V17, P227; Bremond L, 2005, J BIOGEOGR, V32, P311, DOI 10.1111/j.1365-2699.2004.01162.x; Bunn HT, 1982, MEAT EATING HUMAN EV; Cabanes D, 2011, J ARCHAEOL SCI, V38, P2480, DOI 10.1016/j.jas.2011.05.020; CALJON AG, 1991, HYDROBIOLOGIA, V226, P179, DOI 10.1007/BF00006859; Collura LV, 2017, QUATERN INT, V434, P142, DOI 10.1016/j.quaint.2015.12.070; de la Torre I, 2018, J HUM EVOL, V120, P140, DOI 10.1016/j.jhevol.2017.07.018; Deino AL, 2012, J HUM EVOL, V63, P251, DOI 10.1016/j.jhevol.2012.05.004; Deocampo DM, 2002, QUATERNARY RES, V57, P271, DOI 10.1006/qres.2001.2317; Dransfield J, 1986, FLORA TROPICAL E AFR, P55; Esteban I, 2017, REV PALAEOBOT PALYNO, V245, P69, DOI 10.1016/j.revpalbo.2017.05.001; Honaine MF, 2009, AUST J BOT, V57, P512, DOI 10.1071/BT09041; Fernandez-Jalvo Y, 1998, J HUM EVOL, V34, P137, DOI 10.1006/jhev.1997.0188; GASSE F, 1995, PALAEOGEOGR PALAEOCL, V117, P31, DOI 10.1016/0031-0182(94)00122-O; GASSE F, 1983, Revue d'Hydrobiologie Tropicale, V16, P3; GASSE F, 1983, HYDROBIOLOGIA, V103, P85, DOI 10.1007/BF00028433; Gasse F., 1980, REV ALGOLOGIQUE MEMO, P249; Gibson JJ., 1977, PERCEIVING ACTING KN, V1, P67, DOI DOI 10.2307/1421838; Habermann JM, 2016, J HUM EVOL, V90, P74, DOI 10.1016/j.jhevol.2015.09.011; Hay R., 1976, GEOLOGY OLDUVAI GORG, DOI DOI 10.1525/9780520334229; ISAAC GL, 1978, J ANTHROPOL RES, V34, P311; Kappelman J, 1997, J HUM EVOL, V32, P229, DOI 10.1006/jhev.1996.0105; KAPPELMAN J, 1984, PALAEOGEOGR PALAEOCL, V48, P171, DOI 10.1016/0031-0182(84)90043-9; Katz O, 2010, J ARCHAEOL SCI, V37, P1557, DOI 10.1016/j.jas.2010.01.016; Kelly Robert, 1995, LIFEWAYS HUNTER GATH; Kent PE, 1941, GEOL MAG, V78, P173, DOI 10.1017/s0016756800071867; Kondo R., 1994, OPAL PHYTOLITHS NZ; Krammer K., 2004, SUSSWASSERFLORA MITT, V2/4, P468; Krammer K., 1991, SUSSWASSERFLORA MITT, V3/2, P576; Lange-Bertalot H, NON TRADITIONAL REF, V2, P526; LEAKEY LSB, 1959, NATURE, V184, P491, DOI 10.1038/184491a0; Leakey M., 1971, OLDUVAI GORGE, V3, P1960; Liutkus CM, 2003, J SEDIMENT RES, V73, P691, DOI 10.1306/021303730691; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Albert RM, 2012, J HUM EVOL, V63, P342, DOI 10.1016/j.jhevol.2011.05.010; Albert RM, 2009, QUATERN INT, V193, P41, DOI 10.1016/j.quaint.2007.06.008; McCarthy IS, 1988, PALAEOECOL AFR, V19, P3; MCCARTHY TS, 1993, Z GEOMORPHOL, V37, P273; MCCARTHY TS, 1991, SEDIMENTOLOGY, V38, P471, DOI 10.1111/j.1365-3091.1991.tb00362.x; MCHENRY L. J., 2005, STRATIGRAPHY, V2, P101; McHenry LJ, 2016, QUATERNARY RES, V85, P147, DOI 10.1016/j.yqres.2015.10.005; McHenry LJ, 2012, J HUM EVOL, V63, P284, DOI 10.1016/j.jhevol.2011.04.010; Mulholland SC, 1992, PHYTOLITH SYSTEMATIC; Neumann K, 2017, QUATERN INT, V434, P15, DOI 10.1016/j.quaint.2015.11.039; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; PETERS CR, 1995, J HUM EVOL, V29, P321, DOI 10.1006/jhev.1995.1062; Piperno D. R., 1988, PHYTOLITH ANAL ARCHA; Piperno DR, 2006, PHYTOLITHS COMPREHEN; Reck H., 1951, OLDUVAI GORGE, P5; Reck H, 1914, GES NATURFORSCH FREU, V3, P81; RENBERG I, 1990, Journal of Paleolimnology, V4, P87; ROSEN AM, 1994, J ARCHAEOL SCI, V21, P125, DOI 10.1006/jasc.1994.1013; Runge F, 1999, REV PALAEOBOT PALYNO, V107, P23, DOI 10.1016/S0034-6667(99)00018-4; Ryves DB, 2009, QUATERNARY SCI REV, V28, P120, DOI 10.1016/j.quascirev.2008.08.021; SANGSTER AG, 1969, ANN BOT-LONDON, V33, P315, DOI 10.1093/oxfordjournals.aob.a084285; Seago JL, 2002, J TORREY BOT SOC, V129, P1, DOI 10.2307/3088677; SIKES NE, 1994, J HUM EVOL, V27, P25, DOI 10.1006/jhev.1994.1034; Stanistreet IG, 2018, J HUM EVOL, V116, P27, DOI 10.1016/j.jhevol.2017.11.011; Stanistreet IG, 2012, J HUM EVOL, V63, P300, DOI 10.1016/j.jhevol.2012.03.001; STANISTREET IG, 1993, SEDIMENT GEOL, V85, P135, DOI 10.1016/0037-0738(93)90079-K; STANISTREET IG, 1993, SEDIMENT GEOL, V85, P115, DOI 10.1016/0037-0738(93)90078-J; Stromberg C.A.E., 2003, THESIS; Stromberg CAE, 2004, PALAEOGEOGR PALAEOCL, V207, P239, DOI 10.1016/j.palaeo.2003.09.028; Team R.C., 2017, R LANG ENV STAT COMP; Tomlinson P. B., 1961, ANATOMY MONOCOTYLEDO; Tsartsidou G, 2007, J ARCHAEOL SCI, V34, P1262, DOI 10.1016/j.jas.2006.10.017; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Twiss PC., 1992, PHYTOLITH SYSTEMATIC, P113, DOI [DOI 10.1007/978-1-4899-1155-1_6, 10.1007/978-1-4899-1155-1_6]	89	13	13	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0034-6667	1879-0615		REV PALAEOBOT PALYNO	Rev. Palaeobot. Palynology	DEC	2018	259						223	241		10.1016/j.revpalbo.2018.09.010	http://dx.doi.org/10.1016/j.revpalbo.2018.09.010			19	Plant Sciences; Paleontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Plant Sciences; Paleontology	HE7MO					2022-09-04	WOS:000453622000020
J	Gutierrez-Gomez, S; Wahl, L; Blecher, R; Olewnik, L; Iwanaga, J; Maulucci, CM; Dumont, AS; Tubbs, RS				Gutierrez-Gomez, Santiago; Wahl, Lauren; Blecher, Ronen; Olewnik, Lukasz; Iwanaga, Joe; Maulucci, Christopher M.; Dumont, Aaron S.; Tubbs, R. Shane			Sacral fractures: An updated and comprehensive review	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Review						Sacral fractures; Biomechanics; Classification systems; Treatment options		Sacral fractures are often underdiagnosed but are relatively frequent in the setting of pelvic ring injury. Causes include traumatic insults and osteoporosis. Sacral fractures have become more frequent owing to the growth of the elderly population worldwide as osteoporosis is an age-related disease. Misdiagnosed and neglected sacral fractures can result in chronic back pain, spine deformity, and instability. Unfortunately, the wide range of classification systems hinders adequate communication among clinicians. Therefore, a complete understanding of the pathology, and communication within the interdisciplinary team, are necessary to ensure adequate treatment and satisfactory clinical outcomes. The aim of this manuscript is to present the current knowledge available regarding classification systems, clinical assessment, decision-making factors, and current treatment options. (C) 2020 Elsevier Ltd. All rights reserved.	[Gutierrez-Gomez, Santiago] Pontificia Univ Javeriana, Bogota, Colombia; [Gutierrez-Gomez, Santiago] Ctr Res & Training Neurosurg CIEN, Bogota, Colombia; [Gutierrez-Gomez, Santiago] Samaritan Univ Hosp, Neurosurg, Bogota, Colombia; [Wahl, Lauren] Univ Colorado, Dept Cell & Dev Biol, Boulder, CO 80309 USA; [Blecher, Ronen] Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA USA; [Olewnik, Lukasz] Med Univ Lodz, Dept Normal & Clin Anat, Lodz, Poland; [Iwanaga, Joe; Maulucci, Christopher M.; Dumont, Aaron S.; Tubbs, R. Shane] Tulane Univ, Sch Med, Tulane Ctr Clin Neurosci, Dept Neurosurg, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Tubbs, R. Shane] St Georges Univ, Dept Anat Sci, St Georges, Grenada; [Tubbs, R. Shane] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Iwanaga, Joe] Kurume Univ, Dept Anat, Div Gross & Clin Anat, Sch Med, Kurume, Fukuoka, Japan		Iwanaga, J (corresponding author), Tulane Univ, Sch Med, Tulane Ctr Clin Neurosci, Dept Neurosurg, 1430 Tulane Ave, New Orleans, LA 70112 USA.; Iwanaga, J (corresponding author), Kurume Univ, Dept Anat, Div Gross & Clin Anat, Sch Med, Kurume, Fukuoka, Japan.	iwanagajoeca@gmail.com	Iwanaga, Joe/ABC-7040-2021	Iwanaga, Joe/0000-0002-8502-7952; Gutierrez-Gomez, Santiago/0000-0003-1326-8308				Abdelgawad AA, 2016, J PEDIATR ORTHOPED, V36, P117, DOI 10.1097/BPO.0000000000000416; Acevedo Gonzalez JC, 2017, REV COL ORT TRAUM, V21, P55, DOI [10.1016/j. rccot.2017.03.002, DOI 10.1016/J.RCCOT.2017.03.002]; Acevedo J, 2004, REV ESP DOL, V38, P168, DOI 10.1016/S0048- 7120(04)73452-0.; ALLEN BL, 1984, SPINE, V9, P388, DOI 10.1097/00007632-198405000-00011; Alvis-Miranda HR, 2014, J CRANIOVERTEBRAL JU, V5, P110, DOI 10.4103/0974-8237.142303; Ames CP, 2012, J NEUROSURG-SPINE, V16, P547, DOI 10.3171/2012.2.SPINE11320; Bakker G, 2018, J KOREAN NEUROSURG S, V61, P258, DOI 10.3340/jkns.2017.0188; Beckmann N, 2017, EMERG RADIOL, V24, P255, DOI 10.1007/s10140-016-1476-0; Beckmann NM, 2017, EMERG RADIOL, V24, P605, DOI 10.1007/s10140-017-1533-3; Bederman SS, 2017, CLIN SPINE SURG, V30, pE49, DOI 10.1097/BSD.0b013e3182a3572b; Bederman SS, 2013, SPINE, V38, pE1028, DOI 10.1097/BRS.0b013e318297960a; Bellabarba C., 2016, GLOB SPINE J, DOI [10.1055/s-0036-1582696, DOI 10.1055/S-0036-1582696]; Bellabarba C, 2006, SPINE, V31, pS80, DOI 10.1097/01.brs.0000217949.31762.be; Bishop JA, 2017, J ORTHOP TRAUMA, V31, P636, DOI 10.1097/BOT.0000000000000972; Brazis PW, 2011, LOCALIZATION CLIN NE; Burns Camden B, 2016, Spine Deform, V4, P10, DOI 10.1016/j.jspd.2015.07.008; Bydon M, 2014, SPINE, V39, pE1103, DOI 10.1097/BRS.0000000000000448; Bydon M, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS1474; DENIS F, 1988, CLIN ORTHOP RELAT R, P67; Dilogo IH, 2017, J ORTHOP SURG-HONG K, V25, DOI 10.1177/2309499017690985; Ebraheim NA, 1996, SPINE, V21, P2390, DOI 10.1097/00007632-199610150-00020; Elder BD, 2017, SPINE, V42, pE142, DOI 10.1097/BRS.0000000000001722; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Frey ME, 2017, PAIN PHYSICIAN, V20, pE1063; Gupta AC, 2014, AM J NEURORADIOL, V35, P2202, DOI 10.3174/ajnr.A4027; Haroun HS, 2018, MOJ ANAT PHYSL, V5, P87, DOI 10.15406/mojap.2018.05.00169.; Hart RA, 2007, J ORTHOP TRAUMA, V21, P369, DOI 10.1097/BOT.0b013e31806dd959; Hoernschemeyer DG, 2017, SPINE J, V17, P875, DOI 10.1016/j.spinee.2017.02.001; Hsu SD, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101217; Hu XB, 2017, EUR SPINE J, V26, P720, DOI 10.1007/s00586-016-4639-5; Ilyas H, 2015, J SPINAL DISORD TECH, V28, pE199, DOI 10.1097/BSD.0000000000000222; Kannus P, 2000, OSTEOPOROSIS INT, V11, P443, DOI 10.1007/s001980070112; Katsuura Y, 2018, SURG RADIOL ANAT, V40, P521, DOI 10.1007/s00276-017-1955-3; Kebaish KM, 2010, SPINE, V35, P2245, DOI 10.1097/BRS.0b013e3181f5cfae; Kepler CK, 2017, J ORTHOP TRAUMA, V31, pS75, DOI 10.1097/BOT.0000000000000951; Konig MA, 2012, EUR SPINE J, V21, P829, DOI 10.1007/s00586-011-2125-7; Kuklo TR, 2006, SPINE, V31, P1047, DOI 10.1097/01.brs.0000214940.11096.c8; Laratta Joseph L, 2017, J Spine Surg, V3, P732, DOI 10.21037/jss.2017.11.11; Le Huec JC, 2019, EUR SPINE J, V28, P1889, DOI 10.1007/s00586-019-06083-1; Lehman RA, 2012, SPINE J, V12, P612, DOI 10.1016/j.spinee.2012.01.009; Lehmann W, 2012, EUR J TRAUMA EMERG S, V38, P517, DOI 10.1007/s00068-012-0225-7; Lindado Pacheco Carlos Alberto, 2019, Univ. Med., V60, P78, DOI 10.11144/javeriana.umed60-1.artr; Merrill RK, 2017, GLOB SPINE J, V7, P536, DOI 10.1177/2192568217699405; MORONEY SP, 1988, J BIOMECH, V21, P769, DOI 10.1016/0021-9290(88)90285-0; Nonne Daniela, 2018, J Med Case Rep, V12, P186, DOI 10.1186/s13256-018-1668-1; Nork SE, 2001, J ORTHOP TRAUMA, V15, P238, DOI 10.1097/00005131-200105000-00002; Ohya J, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.2.FocusVid.1690; Onen MR, 2015, J CLIN NEUROSCI, V22, P1601, DOI 10.1016/j.jocn.2015.03.039; Park YS, 2017, CLIN SPINE SURG, V30, pE877, DOI 10.1097/BSD.0000000000000520; Pearson JM, 2018, ADV ORTHOP, V2018, DOI 10.1155/2018/5023908; Pecina M, 2007, EUR SPINE J, V16, P299, DOI 10.1007/s00586-006-0223-8; Rodrigues-Pinto R, 2017, GLOB SPINE J, V7, P609, DOI 10.1177/2192568217701097; Rommens PM, 2012, EUR J TRAUMA EMERG S, V38, P499, DOI 10.1007/s00068-012-0224-8; Rommens PM, 2013, INJURY, V44, P1733, DOI 10.1016/j.injury.2013.06.023; ROYCAMILLE R, 1985, SPINE, V10, P838, DOI 10.1097/00007632-198511000-00011; Rozo OL, 2009, CONDICIONES SALUD TR; Sasaji Tatsuro, 2017, Case Rep Orthop, V2017, P7396564, DOI 10.1155/2017/7396564; Sasso Rick C, 2009, Instr Course Lect, V58, P645; Schildhauer TA, 2003, J ORTHOP TRAUMA, V17, P22, DOI 10.1097/00005131-200301000-00004; Schildhauer TA, 2002, J SPINAL DISORD TECH, V15, P199, DOI 10.1097/00024720-200206000-00005; Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P447, DOI 10.1097/00005131-200608000-00001; Schroeder GD, 2016, GLOB SPINE J, V6, P686, DOI 10.1055/s-0036-1580611; Siebler JC, 2010, J ORTHOP TRAUMA, V24, P297, DOI 10.1097/BOT.0b013e3181ccb645; Smith JS, 2015, J NEUROSURG-SPINE, V23, P349, DOI 10.3171/2014.12.SPINE14777; Strange-Vognsen H H, 1991, J Orthop Trauma, V5, P200, DOI 10.1097/00005131-199105020-00014; Talmadge J, 2014, J VASC INTERV RADIOL, V25, P911, DOI 10.1016/j.jvir.2014.02.007; Wagner D, 2015, EUR J TRAUMA EMERG S, V41, P349, DOI 10.1007/s00068-015-0530-z; Wang MY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/8/E17; Yilmaz E, 2018, WORLD NEUROSURG, V113, pE296, DOI 10.1016/j.wneu.2018.02.009; Yoder K, 2015, J MAN MANIP THER, V23, P84, DOI 10.1179/2042618613Y.0000000055; Zhao Y, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0713-5	71	0	1	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAR	2021	52	3					366	375		10.1016/j.injury.2020.11.015	http://dx.doi.org/10.1016/j.injury.2020.11.015		MAR 2021	10	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	RA2PA	33187674				2022-09-04	WOS:000631259400009
J	Ramirez-Velez, R; Perez-Sousa, MA; Venegas-Sanabria, LC; Cano-Gutierrez, CA; Hernandez-Quinonez, PA; Rincon-Pabon, D; Garcia-Hermoso, A; Zambom-Ferraresi, F; de Asteasu, MLS; Izquierdo, M				Ramirez-Velez, Robinson; Perez-Sousa, Miguel A.; Venegas-Sanabria, Luis C.; Cano-Gutierrez, Carlos A.; Hernandez-Quinonez, Paula A.; Rincon-Pabon, David; Garcia-Hermoso, Antonio; Zambom-Ferraresi, Fabricio; Saez de Asteasu, Mikel L.; Izquierdo, Mikel			Normative Values for the Short Physical Performance Battery (SPPB) and Their Association With Anthropometric Variables in Older Colombian Adults. The SABE Study, 2015	FRONTIERS IN MEDICINE			English	Article						physical function; mobility; older people; reference values; latinos	LOWER-EXTREMITY FUNCTION; ELDERLY-PEOPLE; MUSCLE MASS; GAIT SPEED; DISABILITY; HEALTH; RELIABILITY; VALIDITY; FRAILTY; WOMEN	Background: The short physical performance battery (SPPB) is a physical performance test of lower extremity function designed for non-disabled older adults. We aimed to establish reference values for community-dwelling Colombian adults aged 60 years or older in terms of (1) the total score; (2) the three subtest scores (walking speed, standing balance performance, and five times sit-to-stand test); and (3) the time to complete the five times sit-to-stand test, s and the walking speed test. Additionally, we sought to explore how much of the variance in the SPPB subtest scores could be explained by anthropometric variables (age, body mass, height, body mass index, and calf circumference). Methods: Participants were men and women aged 60 years or older who participated in the Health and Well-being and Aging Survey in Colombia, 2015. A sample of 4,211 participants (57.3% women) completed the SPPB test, and their anthropometric variables were evaluated. Age-specific percentiles were calculated using the LMS method (3rd, 10th, 25th, 50th, 75th, 90th, and 97th percentiles). Results: The mean SPPB total score for the entire sample was 8.73 (2.0) points. On average, the total SPPB score was 0.85 points greater in men than in women (p < 0.001). Significant sex differences were observed in all three age groups tested (60-69, 70-79, and 80+ years). In the full sample, our findings suggested that age, body mass, height, body mass index, and calf circumference are significant contributors to walking speed (p < 0.001) after controlling for confounding factors, including ethnicity, socioeconomic status, and urbanicity. Conclusions: Percentile values are of interest to identify target populations for primary prevention and to estimate the proportion of high or low values for SPPB measures in community-dwelling Colombians aged at least 60 years.	[Ramirez-Velez, Robinson; Garcia-Hermoso, Antonio; Zambom-Ferraresi, Fabricio; Saez de Asteasu, Mikel L.; Izquierdo, Mikel] Navarrabiomed Univ Publ Navarra UPNA, CHN, Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain; [Perez-Sousa, Miguel A.] Univ Huelva, Fac Sport Sci, Huelva, Spain; [Venegas-Sanabria, Luis C.; Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Inst Aging, Bogota, Colombia; [Hernandez-Quinonez, Paula A.] Univ Santo Tomas, GICAEDS Grp, Fac Phys Culture Sport & Recreat, Bogota, Colombia; [Rincon-Pabon, David] Fdn Univ Area Andina, ZIPATEFI Zona Invest Posgrad Terapia Resp & Fisto, Pereira, Colombia; [Garcia-Hermoso, Antonio] Univ Santiago Chile, Lab Ciencias Act Fis Deporte & Salud, Santiago, Chile; [Izquierdo, Mikel] Inst Salud Carlos III, CIBER Frailty & Hlth Aging CIBERFES, Madrid, Spain		Ramirez-Velez, R (corresponding author), Navarrabiomed Univ Publ Navarra UPNA, CHN, Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain.	robin640@hotmail.com	Izquierdo, Mikel/O-8049-2019; Zambom-Ferraresi, Fabrício/AAA-4515-2022; García-Hermoso, Antonio/P-1857-2017; Perez-Sousa, Miguel A./M-5931-2019; Ferraresi, Fabricio/M-1906-2018; Garcia-Hermoso, Antonio/AGK-7815-2022; García-Hermoso, Antonio/ADU-2591-2022; Izquierdo, Mikel/A-4894-2010	Izquierdo, Mikel/0000-0002-1506-4272; Zambom-Ferraresi, Fabrício/0000-0002-8377-9827; García-Hermoso, Antonio/0000-0002-1397-7182; Perez-Sousa, Miguel A./0000-0003-4392-6850; Ferraresi, Fabricio/0000-0002-8377-9827; Garcia-Hermoso, Antonio/0000-0002-1397-7182; Izquierdo, Mikel/0000-0002-1506-4272; Saez de Asteasu, Mikel Lopez/0000-0002-4111-5045; Rincon-Pabon, David/0000-0001-9678-2382; Venegas-Sanabria, Luis Carlos/0000-0001-8260-9108; Cano-Gutierrez, Carlos/0000-0001-5680-7880	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia [764]; Universidad Publica de Navarra [420/2019]; Ministerio de Economia, Industria y Competitividad de Espana (ISCIII, FEDER) [PI17/01814]	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia; Universidad Publica de Navarra; Ministerio de Economia, Industria y Competitividad de Espana (ISCIII, FEDER)	This study is part of a larger project that has been funded by a Colciencias y Ministerio de Salud y la Proteccion Social de Colombia (The SABE Study ID 2013, no. 764). RR-V was funded in part by a Postdoctoral Fellowship Resolution ID 420/2019 of the Universidad Publica de Navarra. MI was funded in part by a research grant PI17/01814 of the Ministerio de Economia, Industria y Competitividad de Espana (ISCIII, FEDER).	Aadahl M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000192; da Camara SMA, 2013, GERIATR GERONTOL INT, V13, P421, DOI 10.1111/j.1447-0594.2012.00920.x; BASSEY EJ, 1993, CLIN SCI, V84, P331, DOI 10.1042/cs0840331; Bautmans Ivan, 2004, BMC Geriatr, V4, P6, DOI 10.1186/1471-2318-4-6; Bergland A, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1234-8; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Cabrero-Garcia J, 2012, ATEN PRIM, V44, P540, DOI 10.1016/j.aprim.2012.02.007; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; Charles A, 2019, ARCH GERONTOL GERIAT, V85, DOI 10.1016/j.archger.2019.103913; Cohen J, 1988, STAT POWER BEHAV SCI, V2nd; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Gomez JF, 2013, COLOMB MEDICA, V44, P165; Fisher S, 2009, AGING CLIN EXP RES, V21, P445, DOI 10.1007/BF03327444; Freiberger E, 2012, AGE AGEING, V41, P712, DOI 10.1093/ageing/afs099; Freire AN, 2012, J AGING HEALTH, V24, P863, DOI 10.1177/0898264312438551; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Garcia-Hermoso A, 2018, ARCH PHYS MED REHAB, V99, P2100, DOI 10.1016/j.apmr.2018.01.008; Gomez Fernando, 2016, Curr Gerontol Geriatr Res, V2016, P7910205; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hicks GE, 2005, J GERONTOL A-BIOL, V60, P882, DOI 10.1093/gerona/60.7.882; Ibrahim A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185641; Jadczak Agathe D, 2018, JBI Database System Rev Implement Rep, V16, P752, DOI 10.11124/JBISRIR-2017-003551; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; Judge JO, 1996, J AM GERIATR SOC, V44, P1332, DOI 10.1111/j.1532-5415.1996.tb01404.x; Kidd T, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1196-x; Kjaer IGH, 2016, BMC SPORTS SCI MED R, V8, DOI 10.1186/s13102-016-0059-4; Mbada CE, 2009, MED PRIN PRACT, V18, P345, DOI 10.1159/000226285; Mijnarends DM, 2013, J AM MED DIR ASSOC, V14, P170, DOI 10.1016/j.jamda.2012.10.009; Pan H, 1997, USERS GUIDE LMSCHART; Pavasini R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0763-7; Ramirez-Velez R, 2019, J CACHEXIA SARCOPENI, V10, P278, DOI 10.1002/jcsm.12373; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Sverdrup K, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0724-4; Thaweewannakij T, 2013, PHYS THER, V93, P1312, DOI 10.2522/ptj.20120411; Verghese J, 2010, AGE AGEING, V39, P382, DOI 10.1093/ageing/afp226; Veronese N, 2014, REJUV RES, V17, P276, DOI 10.1089/rej.2013.1491; Visser M, 1998, J GERONTOL A-BIOL, V53, pM214, DOI 10.1093/gerona/53A.3.M214; Westman AW, 2019, ARCH PHYS MED REHAB, V100, P185, DOI 10.1016/j.apmr.2018.06.003; Woo J, 2007, OBESITY, V15, P1886, DOI 10.1038/oby.2007.223	45	14	15	2	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	FEB 20	2020	7								52	10.3389/fmed.2020.00052	http://dx.doi.org/10.3389/fmed.2020.00052			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KT3VJ	32154258	Green Published, gold			2022-09-04	WOS:000518944300001
J	Ramirez-Velez, R; Perez-Sousa, MA; Gonzalez-Ruiz, K; Cano-Gutierrez, CA; Schmidt-RioValle, J; Correa-Rodriguez, M; Izquierdo, M; Romero-Garcia, JA; Campos-Rodriguez, AY; Triana-Reina, HR; Gonzalez-Jimenez, E				Ramirez-Velez, Robinson; Angel Perez-Sousa, Miguel; Gonzalez-Ruiz, Katherine; Cano-Gutierrez, Carlos A.; Schmidt-RioValle, Jacqueline; Correa-Rodriguez, Maria; Izquierdo, Mikel; Astolfo Romero-Garcia, Jesus; Yolanda Campos-Rodriguez, Adriana; Reynaldo Triana-Reina, Hector; Gonzalez-Jimenez, Emilio			Obesity- and Lipid-Related Parameters in the Identification of Older Adults with a High Risk of Prediabetes According to the American Diabetes Association: An Analysis of the 2015 Health, Well-Being, and Aging Study	NUTRIENTS			English	Article						adiposity; prediabetes; lipids; anthropometric measure; elderly	CARDIOVASCULAR-DISEASE; UNITED-STATES; INDEX; ATHEROSCLEROSIS; METAANALYSIS; PREVALENCE	This study evaluated the predictive ability of 11 obesity- and lipid-related parameters, including body mass index (BMI), waist circumference (WC), waist-to-height ratio (WtHR), body roundness index (BRI), "A" body-shape index (ABSI), conicity index (C), visceral adiposity index (VAI), triglyceride-to-glucose fasting index (TyG), triglyceride-to-glucose fasting related to BMI (TyG-BMI), triglyceride-to-glucose fasting related to WC (TyG-WC), and triglyceride-to-glucose fasting related to WtHR (TyG-WtHR), to identify patients from an elderly Colombian population with a high risk of prediabetes according to the 2016 American Diabetes Association criteria. The data were obtained from the 2015 Colombian Health and Wellbeing and Aging Survey. A total of 3307 elderly Colombian individuals (aged over 60 years) were included. Anthropometric data, fasting plasma glucose, blood lipid profiles, family history, and health-related behaviors were assessed, and prediabetes was defined as a fasting plasma glucose of 100 to 125 mg/dL. The areas under the receiver operating characteristic (ROC) curves (AUCs) were calculated for each anthropometric indicator, using the prediabetes classification to identify their sensitivity and specificity, and these indicated that the prevalence of prediabetes was 25.3% in this population. After adjusting for potential confounding factors, the TyG index was strongly associated with the odds of having prediabetes in both sexes, and multivariate logistic regression analysis showed that the ORs for prediabetes increased across quartiles (p < 0.001). The TyG index was best able to identify prediabetes in either sex (AUC and optimal cut-off = 0.700 and 8.72, and 0.695 and 8.92 for men and women, respectively), suggesting that compared to the other parameters, the TyG index has the best discriminative power to predict prediabetes in the whole population. Thus, we propose the TyG index be used as a complementary marker for assessing prediabetes in older adults.	[Ramirez-Velez, Robinson; Izquierdo, Mikel] Univ Publ Navarra, Navarrabiomed Univ Publ Navarra UPNA, Inst Invest Sanitaria Navarra IdiSNA, Dept Hlth Sci,CHN, Navarra 31008, Spain; [Ramirez-Velez, Robinson; Izquierdo, Mikel] Inst Salud Carlos III, CIBERFES, Madrid 28029, Spain; [Angel Perez-Sousa, Miguel] Univ Huelva, Fac Sport Sci, Ave Fuerzas Armadas S-N, Huelva 21007, Spain; [Gonzalez-Ruiz, Katherine] Univ Manuela Beltran, Vicerrectoria Invest, Grp Ejercicio Fis & Deportes, Bogota 110231, DC, Colombia; [Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Aging Inst, Bogota 110111, Colombia; [Schmidt-RioValle, Jacqueline; Correa-Rodriguez, Maria; Gonzalez-Jimenez, Emilio] Univ Granada, Dept Nursing, Av Ilustrac 60, Granada 18016, Spain; [Izquierdo, Mikel; Astolfo Romero-Garcia, Jesus; Yolanda Campos-Rodriguez, Adriana; Reynaldo Triana-Reina, Hector] Univ Santo Tomas, Fac Phys Culture Sport & Recreat, GICAEDS Grp, Bogota 110311, Colombia		Ramirez-Velez, R (corresponding author), Univ Publ Navarra, Navarrabiomed Univ Publ Navarra UPNA, Inst Invest Sanitaria Navarra IdiSNA, Dept Hlth Sci,CHN, Navarra 31008, Spain.; Ramirez-Velez, R (corresponding author), Inst Salud Carlos III, CIBERFES, Madrid 28029, Spain.	robin640@hotmail.com; perezsousa@gmail.com; katherine.gonzalez@docentes.umb.edu.co; ccano@javeriana.edu.co; jschmidt@ugr.es; macoro@ugr.es; mikel.izquierdo@gmail.com; astolforomero@usantotomas.edu.co; adrianacampos@usantotomas.edu.co; hectortriana@usantotomas.edu.co; emigoji@ugr.es	Izquierdo, Mikel/O-8049-2019; González-Ruíz, Katherine/AGI-4611-2022; Perez-Sousa, Miguel A./M-5931-2019; Izquierdo, Mikel/A-4894-2010; Ramírez-Vélez, Robinson/D-5311-2016; Correa-Rodriguez, Maria/G-1793-2018; Gonzalez-Jimenez, Emilio/I-6039-2017	Izquierdo, Mikel/0000-0002-1506-4272; González-Ruíz, Katherine/0000-0001-7518-0761; Perez-Sousa, Miguel A./0000-0003-4392-6850; Izquierdo, Mikel/0000-0002-1506-4272; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Correa-Rodriguez, Maria/0000-0001-9165-4349; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Schmidt-Riovalle, Jacqueline/0000-0003-2775-0058; Gonzalez-Jimenez, Emilio/0000-0001-5103-6028; TRIANA R, HECTOR REYNALDO/0000-0002-6334-7082	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia [764, 2013]; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER) [PI17/01814]	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER)(Spanish Government)	This study is part of a larger project that has been funded by a Colciencias y Ministerio de Salud y la Proteccion Social de Colombia (The SABE Study ID 2013, no. 764). Mikel Izquierdo is funded in part by a research grant PI17/01814 of the Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER).	Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Barcelo A, 2007, DIABETES RES CLIN PR, V78, P418, DOI 10.1016/j.diabres.2007.06.008; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Buysschaert M, 2011, MED CLIN N AM, V95, P289, DOI 10.1016/j.mcna.2010.11.002; Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Claridge-Chang A, 2016, NAT METHODS, V13, P108, DOI 10.1038/nmeth.3729; Cohen J, 1988, STAT POWER BEHAV SCI, V2nd; Du TT, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0146-3; Er LK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149731; Fujita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128972; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Gomez Fernando, 2016, Curr Gerontol Geriatr Res, V2016, P7910205; Gu Z, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0927-x; Gu Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18854-1; Guerrero-Romero F, 2010, J CLIN ENDOCR METAB, V95, P3347, DOI 10.1210/jc.2010-0288; Hardy DS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168282; Huang YL, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5953; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kurihara O, 2013, DIABETES CARE, V36, P729, DOI 10.2337/dc12-1635; Lambrinoudaki I, 2018, HEART LUNG CIRC, V27, P716, DOI 10.1016/j.hlc.2017.05.142; Lee EY, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0324-2; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Li R, 2018, J DIABETES INVEST, V9, P411, DOI 10.1111/jdi.12708; Lim J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212963; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Nasr Gamela, 2010, J Cardiovasc Dis Res, V1, P116, DOI 10.4103/0975-3583.70903; Nwose E U, 2017, BMC Res Notes, V10, P730, DOI 10.1186/s13104-017-3017-7; Qiu MY, 2015, HYPERTENSION, V65, P525, DOI 10.1161/HYPERTENSIONAHA.114.04632; Ramirez-Velez R, 2019, J CACHEXIA SARCOPENI, V10, P278, DOI 10.1002/jcsm.12373; Rodriguez-Segade S, 2019, ACTA DIABETOL, V56, P1023, DOI 10.1007/s00592-019-01342-5; Salgado JF, 2018, EUR J PSYCHOL APPL L, V10, P35, DOI 10.5093/ejpalc2018a5; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Spruijt-Metz D, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0475-3; Thomas DM, 2013, OBESITY, V21, P2264, DOI 10.1002/oby.20408; VALDEZ R, 1991, J CLIN EPIDEMIOL, V44, P955, DOI 10.1016/0895-4356(91)90059-I; Vilanova MB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015158; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilson ML, 2017, NURS CLIN N AM, V52, P665, DOI 10.1016/j.cnur.2017.07.011; Yang X Y, 2016, Zhonghua Yu Fang Yi Xue Za Zhi, V50, P328, DOI 10.3760/cma.j.issn.0253-9624.2016.04.009; Yip WCY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111273; Zhang SJ, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0409-6; Zheng S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1020-8	44	23	23	2	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6643		NUTRIENTS	Nutrients	NOV	2019	11	11							2654	10.3390/nu11112654	http://dx.doi.org/10.3390/nu11112654			21	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	JV3OC	31689977	Green Published, gold			2022-09-04	WOS:000502274600105
J	Rosenthal, VD; Chaparro, GJ; Servolo-Medeiros, EA; Souza-Fram, D; Escudero, DVD; Gualtero-Trujillo, SM; Morfin-Otero, R; Gonzalez-Diaz, E; Rodriguez-Noriega, E; Altuzar-Figueroa, MA; Aguirre-Avalos, G; Mijangos-Mendez, JC; Corona-Jimenez, F; Hernandez-Chena, BE; Abu-Jarad, MR; Diaz-Hernandez, EM; Miranda-Novales, MG; Vazquez-Rosales, JG; Aguilar-De-Moros, D; Castano-Guerra, E; Munoz-Gutierrez, G; Mejia, N; Acebo-Arcentales, JJ; Di-Silvestre, G				Daniel Rosenthal, Victor; Jorge Chaparro, Gustavo; Servolo-Medeiros, Eduardo Alexandrino; Souza-Fram, Dayana; da Silva Escudero, Daniela Vieira; Milena Gualtero-Trujillo, Sandra; Morfin-Otero, Rayo; Gonzalez-Diaz, Esteban; Rodriguez-Noriega, Eduardo; Angel Altuzar-Figueroa, Miguel; Aguirre-Avalos, Guadalupe; Cesar Mijangos-Mendez, Julio; Corona-Jimenez, Federico; Estela Hernandez-Chena, Blanca; Rajab Abu-Jarad, Mohamed; Maria Diaz-Hernandez, Evelia; Guadalupe Miranda-Novales, Maria; Guillermo Vazquez-Rosales, Jose; Aguilar-De-Moros, Daisy; Castano-Guerra, Elizabeth; Munoz-Gutierrez, Gabriel; Mejia, Nepomuceno; Johana Acebo-Arcentales, Jenia; Di-Silvestre, Gabriela			An eight-year multicenter study on short-term peripheral intravenous catheter-related bloodstream infection rates in 100 intensive care units of 9 countries in Latin America: Argentina, Brazil, Colombia, Costa Rica, Dominican Republic, Ecuador, Mexico, Panama, and Venezuela. Findings of the International Nosocomial Infection Control Consortium (INICC)	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							MULTIDIMENSIONAL APPROACH; IMPACT; IMPLEMENTATION; COMPLICATIONS; INTERVENTION; STRATEGY; BUNDLE	Background: Data on short-term peripheral intravenous catheter-related bloodstream infections per 1,000 peripheral venous catheter days (PIVCR BSIs per 1,000 PVC days) rates from Latin America are not available, so they have not been thoroughly studied. Methods: International Nosocomial Infection Control Consortium (INICC) members conducted a prospective, surveillance study on PIVCR BSIs from January 2010 to March 2018 in 100 intensive care units (ICUs) among 41 hospitals, in 26 cities of 9 countries in Latin America (Argentina, Brazil, Colombia, Costa Rica, Dominican-Republic, Ecuador, Mexico, Panama, and Venezuela). The Centers for Disease Control and Prevention (CDC) National Health Safety Network (NHSN) definitions were applied, and INICC methodology and INICC Surveillance Online System software were used. Results: In total, 10,120 ICU patients were followed for 40,078 bed days and 38,262 PVC days. In addition, 79 PIVCR BSIs were identified, with a rate of 2.06 per 1,000 PVC days (95% confidence interval [CI], 1.635-2.257). The average length of stay (ALOS) of patients without a PIVCR BSI was 3.95 days, and the ALOS was 5.29 days for patients with a PIVCR BSI. The crude extra ALOS was 1.34 days (RR, 1.33; 95% CI, 1.0975-1.6351; P = .040). The mortality rate in patients without PIVCR BSI was 3.67%, and this rate was 6.33% in patients with a PIVCR BSI. The crude extra mortality was 1.70 times higher. The microorganism profile showed 48.5% gram-positive bacteria (coagulase-negative Staphylococci 25.7%) and 48.5% gram-negative bacteria: Acinetobacter spp, Escherichia coli, and Klebsiella spp (8.5% each one), Pseudomonas aeruginosa (5.7%), and Candida spp (2.8%). The resistances of Pseudomonas aeruginosa were 0% to amikacin and 50% to meropenem. The resistance of Acinetobacter baumanii to amikacin was 0%, and the resistance of coagulase-negative Staphylococcus to oxacillin was 75%. Conclusions: Our PIVCR BSI rates were higher than rates from more economically developed countries and were similar to those of countries with limited resources.	[Daniel Rosenthal, Victor] Int Nosocomial Infect Control Consortium INICC, Buenos Aires, DF, Argentina; [Jorge Chaparro, Gustavo] Inst Med Platense SA, Adult Intens Care Unit, La Plata, Buenos Aires, Argentina; [Servolo-Medeiros, Eduardo Alexandrino; Souza-Fram, Dayana; da Silva Escudero, Daniela Vieira] Hosp Sao Paulo Escola Paulista Med Unifesp, Sao Paulo, Brazil; [Milena Gualtero-Trujillo, Sandra] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Morfin-Otero, Rayo; Gonzalez-Diaz, Esteban; Rodriguez-Noriega, Eduardo] Antiguo Hosp Civil Guadalajara, Adult Infect Dis, Guadalajara, Spain; [Angel Altuzar-Figueroa, Miguel] Hosp Gen Zona UMAA 1 Oaxaca Demetrio Mayoral Pard, Oaxaca De Juarez, Oaxaca, Mexico; [Aguirre-Avalos, Guadalupe; Cesar Mijangos-Mendez, Julio; Corona-Jimenez, Federico] Hosp Civil Guadalajara Fray Antonio Alcalde, Intens Care Unit, Guadalajara, Jalisco, Mexico; [Estela Hernandez-Chena, Blanca; Rajab Abu-Jarad, Mohamed; Maria Diaz-Hernandez, Evelia] Hosp Gen Reg 6 IMSS, Madero City, Mexico; [Guadalupe Miranda-Novales, Maria; Guillermo Vazquez-Rosales, Jose] Hosp Pediat Ctr Med Nacl Siglo XXI IMSS, Mexico City, DF, Mexico; [Aguilar-De-Moros, Daisy; Castano-Guerra, Elizabeth] Hosp Nino Dr Jose Renan Esquivel, Panama City, Panama; [Munoz-Gutierrez, Gabriel] Hosp Clin Bibl, San Jose De Costa Rica, Costa Rica; [Mejia, Nepomuceno] Hosp Gen Plaza Salud, Santo Domingo, Dominican Rep; [Johana Acebo-Arcentales, Jenia] Hosp Oncol Solon Espinoza Ayala, Quito, Ecuador; [Di-Silvestre, Gabriela] Hosp Clin Caracas, Caracas, Venezuela		Rosenthal, VD (corresponding author), Int Nosocomial Infect Control Consortium INICC, Buenos Aires, DF, Argentina.	victor_rosenthal@inicc.org		Mijangos-Mendez, Julio Cesar/0000-0002-9640-3036; Aguirre-Avalos, Guadalupe/0000-0001-7950-1024; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815; Castano Guerra, Elizabeth/0000-0001-9119-8697; ROSENTHAL, VICTOR DANIEL/0000-0001-9138-4801	INICC Foundation	INICC Foundation	The funding for the activities carried out at INICC headquarters were provided by the corresponding author, Victor D. Rosenthal, and the INICC Foundation.	Al-Abdely Hail M, 2017, J Infect Prev, V18, P25, DOI 10.1177/1757177416669424; Alexandrou Evan, 2018, J Hosp Med, V13, DOI 10.12788/jhm.3039; Alkhawaja S, 2020, J VASC ACCESS, V21, P481, DOI 10.1177/1129729819888426; Alvarez-Moreno CA, 2016, AM J INFECT CONTROL, V44, pE235, DOI 10.1016/j.ajic.2016.03.043; [Anonymous], 2018, INT J AD MED; [Anonymous], CDC definition of bloodstream infection event (central-line-associated bloodstream infection and non-central-line-associated bloodstream infection); [Anonymous], 2016, J ASS VASC ACCESS; [Anonymous], 2018, J ASS VASC ACCESS; Aygun G, 2006, DIAGN MICR INFEC DIS, V54, P165, DOI 10.1016/j.diagmicrobio.2005.09.006; Rosenthal VD, 2018, INFECT CONT HOSP EP, V39, P445, DOI 10.1017/ice.2017.298; Rosenthal VD, 2016, AM J INFECT CONTROL, V44, pE81, DOI 10.1016/j.ajic.2016.01.005; Rosenthal VD, 2013, INFECT CONT HOSP EP, V34, P229, DOI 10.1086/669511; Freixas N, 2013, CLIN MICROBIOL INFEC, V19, P838, DOI 10.1111/1469-0691.12049; Higuera F, 2005, CRIT CARE MED, V33, P2022, DOI 10.1097/01.CCM.0000178190.89663.E5; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jaggi N, 2013, INT J INFECT DIS, V17, pE1218, DOI 10.1016/j.ijid.2013.07.007; Leblebicioglu H, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-10; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Ruiz-Giardin JM, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4505-2; Mermel LA, 2017, CLIN INFECT DIS, V65, P1757, DOI 10.1093/cid/cix562; Miliani K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168637; Pujol M, 2007, J HOSP INFECT, V67, P22, DOI 10.1016/j.jhin.2007.06.017; Ray-Barruel G, 2019, INFECT DIS HEALTH, V24, P152, DOI 10.1016/j.idh.2019.03.001; Rhodes D, 2016, J HOSP INFECT, V94, P86, DOI 10.1016/j.jhin.2016.05.020; Ripa M, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00892-18, 10.1128/aac.00892-18]; Rosenthal VD, 2012, INFECTION, V40, P415, DOI 10.1007/s15010-012-0246-5; Rosenthal VD., 2020, J INFECT PUBLIC HEAL; Rosenthal VD, 2006, ANN INTERN MED, V145, P582, DOI 10.7326/0003-4819-145-8-200610170-00007; Rosenthal VD, 2010, INFECT CONT HOSP EP, V31, P1264, DOI 10.1086/657140; Rosenthal VD, 2021, J VASC ACCESS, V22, P34, DOI 10.1177/1129729820917259; Rosenthal VD, 2020, AM J INFECT CONTROL, V48, P423, DOI 10.1016/j.ajic.2019.08.023; Rosenthal VD, 2020, INFECT CONT HOSP EP, V41, P553, DOI 10.1017/ice.2020.20; Salibe P, 2018, J HOSP INFECT, V100, pE178, DOI 10.1016/j.jhin.2018.06.010; Salm F, 2016, INFECT CONT HOSP EP, V37, P798, DOI 10.1017/ice.2016.72; Sato A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2536-0; Soifer NE, 1998, ARCH INTERN MED, V158, P473, DOI 10.1001/archinte.158.5.473; Worth LJ, 2018, J HOSP INFECT, V99, P55, DOI 10.1016/j.jhin.2017.11.021; Zhang Li, 2016, J Infect Prev, V17, P207, DOI 10.1177/1757177416655472	38	4	3	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	SEP	2021	42	9					1098	1104	PII S0899823X20013732	10.1017/ice.2020.1373	http://dx.doi.org/10.1017/ice.2020.1373			7	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	US6GA	33441207				2022-09-04	WOS:000697524100012
J	Christidi, F; Migliaccio, R; Santamaria-Garcia, H; Santangelo, G; Trojsi, F				Christidi, Foteini; Migliaccio, Raffaella; Santamaria-Garcia, Hernando; Santangelo, Gabriella; Trojsi, Francesca			Social Cognition Dysfunctions in Neurodegenerative Diseases: Neuroanatomical Correlates and Clinical Implications	BEHAVIOURAL NEUROLOGY			English	Review							FACIAL EMOTION RECOGNITION; VARIANT FRONTOTEMPORAL DEMENTIA; AMYOTROPHIC-LATERAL-SCLEROSIS; SUBTHALAMIC NUCLEUS STIMULATION; RESTING STATE NETWORKS; QUALITY-OF-LIFE; BEHAVIORAL-VARIANT; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; FUNCTIONAL CONNECTIVITY	Social cognitive function, involved in the perception, processing, and interpretation of social information, has been shown to be crucial for successful communication and interpersonal relationships, thereby significantly impacting mental health, well-being, and quality of life. In this regard, assessment of social cognition, mainly focusing on four key domains, such as theory of mind (ToM), emotional empathy, and social perception and behavior, has been increasingly evaluated in clinical settings, given the potential implications of impairments of these skills for therapeutic decision-making. With regard to neurodegenerative diseases (NDs), most disorders, characterized by variable disease phenotypes and progression, although similar for the unfavorable prognosis, are associated to impairments of social cognitive function, with consequent negative effects on patients' management. Specifically, in some NDs these deficits may represent core diagnostic criteria, such as for behavioral variant frontotemporal dementia (bvFTD), or may emerge during the disease course as critical aspects, such as for Parkinson's and Alzheimer's diseases. On this background, we aimed to revise the most updated evidence on the neurobiological hypotheses derived from network-based approaches, clinical manifestations, and assessment tools of social cognitive dysfunctions in NDs, also prospecting potential benefits on patients' well-being, quality of life, and outcome derived from potential therapeutic perspectives of these deficits.	[Christidi, Foteini] Univ Athens, Aeginit Hosp, Med Sch, Dept Neurol 1, Athens, Greece; [Migliaccio, Raffaella] Sorbonne Univ, INSERM U 1127, CNRS, UMR 7225, F-75013 Paris, France; [Migliaccio, Raffaella] Univ Pierre & Marie Curie Paris 6, Inst Cerveau & Moelle Epiniere ICM, UMRS 1127, F-75013 Paris, France; [Santamaria-Garcia, Hernando] Pontificia Univ Javeriana Bogota, Bogota, Colombia; [Santamaria-Garcia, Hernando] Hosp Univ San Ignacio, Ctr Memoria & Cognic Intellectus, Bogota, Colombia; [Santangelo, Gabriella] Univ Campania Luigi Vanvitelli, Dept Psychol, Caserta, Italy; [Trojsi, Francesca] Univ Campania Luigi Vanvitelli, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy		Trojsi, F (corresponding author), Univ Campania Luigi Vanvitelli, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy.	francesca.trojsi@unicampania.it	Trojsi, Francesca/AHD-9665-2022	Migliaccio, Raffaella/0000-0002-6960-8474; Trojsi, Francesca/0000-0002-3790-8018; Santamaria Garcia, Hernando/0000-0001-9422-3579				Abrahams S, 2014, AMYOTROPH LAT SCL FR, V15, P9, DOI 10.3109/21678421.2013.805784; Abram SV, 2017, HUM BRAIN MAPP, V38, P1111, DOI 10.1002/hbm.23439; Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012; Adenzato M, 2010, NEUROPSYCHOLOGIA, V48, P2, DOI 10.1016/j.neuropsychologia.2009.08.001; Adolfi F, 2017, CORTEX, V88, P124, DOI 10.1016/j.cortex.2016.12.019; Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 1998, NEUROPSYCHOLOGY, V12, P253, DOI 10.1037/0894-4105.12.2.253; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Aho-Ozhan HEA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164655; ALBERT MS, 1991, ARCH NEUROL-CHICAGO, V48, P791, DOI 10.1001/archneur.1991.00530200027013; Albuquerque L, 2014, PARKINSONISM RELAT D, V20, P166, DOI 10.1016/j.parkreldis.2013.10.010; ALLENDER J, 1989, INT J NEUROSCI, V46, P147, DOI 10.3109/00207458908986252; [Anonymous], 1990, CONCEPT NEUROSCI; Ariatti A, 2008, NEUROL SCI, V29, P219, DOI 10.1007/s10072-008-0971-9; Baez S., 2017, NEUROPSYCHOLOGIA; Baez S, 2017, NATURE HUMAN BEHAV, V1, P1; Baez S, 2017, CURR TOP BEHAV NEURO, V30, P379, DOI 10.1007/7854_2016_443; Baez S, 2016, NEURODEGENER DIS, V16, P206, DOI 10.1159/000441918; Baez S, 2016, CORTEX, V75, P20, DOI 10.1016/j.cortex.2015.11.007; Baez S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00262; Baez S, 2014, JAMA NEUROL, V71, P1172, DOI 10.1001/jamaneurol.2014.347; Baggio HC, 2012, NEUROPSYCHOLOGIA, V50, P2121, DOI 10.1016/j.neuropsychologia.2012.05.020; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barsuglia JP, 2014, ARCH CLIN NEUROPSYCH, V29, P793, DOI 10.1093/arclin/acu050; BEATTY WW, 1989, B PSYCHONOMIC SOC, V27, P361; Beeldman E, 2016, J NEUROL NEUROSUR PS, V87, P611, DOI 10.1136/jnnp-2015-310734; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Bejanin A, 2017, SOC NEUROSCI-UK, V12, P287, DOI 10.1080/17470919.2016.1168314; Berlim MT, 2012, WORLD J BIOL PSYCHIA, V13, P474, DOI 10.3109/15622975.2011.615861; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Bickart KC, 2014, J NEUROL NEUROSUR PS, V85, P438, DOI 10.1136/jnnp-2012-304656; Biseul I, 2005, NEUROPSYCHOLOGIA, V43, P1054, DOI 10.1016/j.neuropsychologia.2004.10.006; BLONDER LX, 1989, BRAIN LANG, V36, P193, DOI 10.1016/0093-934X(89)90061-8; Bodden ME, 2010, PARKINSONISM RELAT D, V16, P466, DOI 10.1016/j.parkreldis.2010.04.014; Bora E, 2016, J GERIATR PSYCH NEUR, V29, P205, DOI 10.1177/0891988716640375; Bora E, 2015, BEHAV BRAIN RES, V292, P515, DOI 10.1016/j.bbr.2015.07.012; Bora E, 2015, J NEUROL NEUROSUR PS, V86, P714, DOI 10.1136/jnnp-2014-309445; Bowers D., 1999, FLORIDA AFFECT BATTE; Buhl C, 2013, DEMENT GER COGN D EX, V3, P376, DOI 10.1159/000355123; Burke T, 2016, AMYOTROPH LAT SCL FR, V17, P467, DOI 10.1080/21678421.2016.1177088; Burnham H, 2004, DEMENT GERIATR COGN, V18, P75, DOI 10.1159/000077813; Burrell JR, 2016, LANCET, V388, P919, DOI 10.1016/S0140-6736(16)00737-6; Cacioppo S, 2014, PSYCHOL BULL, V140, P1464, DOI 10.1037/a0037618; Cadieux NL, 1997, J INT NEUROPSYCH SOC, V3, P411, DOI 10.1017/S1355617797004116; CAEKEBEKE JFV, 1991, J NEUROL NEUROSUR PS, V54, P145, DOI 10.1136/jnnp.54.2.145; Caminiti SP, 2015, NEUROIMAGE-CLIN, V9, P484, DOI 10.1016/j.nicl.2015.08.012; Carluer L, 2015, CORTEX, V65, P19, DOI 10.1016/j.cortex.2014.12.010; Cavallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025948; Cerami C, 2014, AMYOTROPH LAT SCL FR, V15, P21, DOI 10.3109/21678421.2013.785568; Cohen MH, 2016, NEUROPSYCHOLOGIA, V81, P245, DOI 10.1016/j.neuropsychologia.2015.12.031; Consonni M, 2016, CORTEX, V81, P162, DOI 10.1016/j.cortex.2016.04.014; Costa A., 2013, BEHAV NEUROLOGY, V27; Cotter J, 2018, NEUROSCI BIOBEHAV R, V84, P92, DOI 10.1016/j.neubiorev.2017.11.014; Couto B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00467; Coyle-Gilchrist ITS, 2016, NEUROLOGY, V86, P1736, DOI 10.1212/WNL.0000000000002638; Crespi C, 2014, CORTEX, V53, P1, DOI 10.1016/j.cortex.2014.01.002; Cristofori I, 2016, J NEUROSCI, V36, P2757, DOI 10.1523/JNEUROSCI.2975-15.2016; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Day GS, 2013, JAMA NEUROL, V70, P1249, DOI 10.1001/jamaneurol.2013.3258; de Oliveira-Souza R, 2008, NEUROIMAGE, V40, P1202, DOI 10.1016/j.neuroimage.2007.12.054; De Risi M, 2018, INT J NEUROSCI, V128, P71, DOI 10.1080/00207454.2017.1366475; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; Decety J, 2014, TRENDS COGN SCI, V18, P337, DOI 10.1016/j.tics.2014.04.008; Dermody N, 2016, J ALZHEIMERS DIS, V53, P801, DOI 10.3233/JAD-160175; Diez-Cirarda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142234; Dodell-Feder D, 2011, NEUROIMAGE, V55, P705, DOI 10.1016/j.neuroimage.2010.12.040; Dodich A, 2016, J ALZHEIMERS DIS, V50, P1011, DOI 10.3233/JAD-150605; Drapier D, 2008, NEUROPSYCHOLOGIA, V46, P2796, DOI 10.1016/j.neuropsychologia.2008.05.006; Duval C, 2012, BRAIN, V135, P228, DOI 10.1093/brain/awr309; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Eckart JA, 2012, NEUROPSYCHOLOGIA, V50, P786, DOI 10.1016/j.neuropsychologia.2012.01.012; Ekman P., 1976, PICTURES FACIAL AFFE; Enrici I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131470; Enticott PG, 2008, NEUROPSYCHOLOGIA, V46, P2851, DOI 10.1016/j.neuropsychologia.2008.04.022; Enticott PG, 2011, J ECT, V27, P41, DOI 10.1097/YCT.0b013e3181f07948; Eslinger P. J., 2012, BEHAV NEUROLOGY, V25; Farb NAS, 2013, CORTEX, V49, P1856, DOI 10.1016/j.cortex.2012.09.008; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Fishman I, 2014, JAMA PSYCHIAT, V71, P751, DOI 10.1001/jamapsychiatry.2014.83; Freedman M, 2013, ALZ DIS ASSOC DIS, V27, P56, DOI 10.1097/WAD.0b013e31824ea5db; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Froming K., 2006, COMPREHENSIVE AFFECT; Fukai M, 2017, PSYCHIAT RES-NEUROIM, V267, P45, DOI 10.1016/j.pscychresns.2017.06.015; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Garcia-Cordero I, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0006; Ghosh BCP, 2009, J NEUROL NEUROSUR PS, V80, P1143, DOI 10.1136/jnnp.2008.155846; Ghosh BCP, 2012, BRAIN, V135, P2089, DOI 10.1093/brain/aws128; Gibbons ZC, 2007, NEUROPSYCHOLOGIA, V45, P1196, DOI 10.1016/j.neuropsychologia.2006.10.008; Girardi A, 2011, NEUROPSYCHOLOGY, V25, P53, DOI 10.1037/a0020357; Gleichgerrcht E, 2010, J INT NEUROPSYCH SOC, V16, P687, DOI 10.1017/S1355617710000482; Goodkind MS, 2015, EMOTION, V15, P416, DOI 10.1037/a0039261; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grace J, 2001, PSYCHOL ASSESS RESOU; GRAFMAN J, 1990, ARCH NEUROL-CHICAGO, V47, P553, DOI 10.1001/archneur.1990.00530050077015; Gray HA, 2010, NEUROPSYCHOLOGY, V24, P176, DOI 10.1037/a0018104; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Grossman AB, 2007, AMYOTROPH LATERAL SC, V8, P56, DOI 10.1080/17482960601044106; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Henry JD, 2014, NEUROPSYCHOLOGIA, V56, P53, DOI 10.1016/j.neuropsychologia.2013.12.024; Henry JD, 2009, PSYCHOL AGING, V24, P239, DOI 10.1037/a0013423; Herrera E, 2011, J NEUROL SCI, V310, P237, DOI 10.1016/j.jns.2011.06.034; Hill CA, 2017, NAT NEUROSCI, V20, P1142, DOI 10.1038/nn.4602; Hipp G, 2014, J NEUROL SCI, V338, P178, DOI 10.1016/j.jns.2013.12.047; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Hyde DC, 2015, HUM BRAIN MAPP, V36, P4831, DOI 10.1002/hbm.22953; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; IBANEZ A, 2017, BRAIN 3, V140, DOI DOI 10.1093/BRAIN/AWW316; Ibanez A, 2014, WORLD PSYCHIATRY, V13, P148, DOI 10.1002/wps.20125; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; Ille R, 2016, J NEUROL SCI, V361, P72, DOI 10.1016/j.jns.2015.12.007; Kaat LD, 2007, NEUROLOGY, V69, P723, DOI 10.1212/01.wnl.0000267643.24870.26; Kazui H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161092; Keller J., 2017, BRAIN IMAGING BEHAV; Kempnich CL, 2017, J INT NEUROPSYCH SOC, V23, P314, DOI 10.1017/S1355617717000145; Kertesz A, 2000, J INT NEUROPSYCH SOC, V6, P460, DOI 10.1017/S1355617700644041; Kertesz A, 2010, J NEUROL SCI, V289, P138, DOI 10.1016/j.jns.2009.08.036; Keuken MC, 2011, BRAIN RES, V1383, P196, DOI 10.1016/j.brainres.2011.01.073; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kluger BM, 2007, NEUROCASE, V13, P165, DOI 10.1080/13554790701448192; Korner S, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0340-2; Korponay C, 2017, SOC COGN AFFECT NEUR, V12, P1169, DOI 10.1093/scan/nsx042; Kovacs AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106558; Kumfor F, 2017, CORTEX, V93, P166, DOI 10.1016/j.cortex.2017.05.022; Kumfor F, 2014, BRAIN, V137, P3061, DOI 10.1093/brain/awu246; Kumfor F, 2014, J NEUROL NEUROSUR PS, V85, P1076, DOI 10.1136/jnnp-2013-307098; Kumfor F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067457; Kumfor F, 2012, NEUROPSYCHOL REV, V22, P280, DOI 10.1007/s11065-012-9201-6; Kumfor F, 2011, SOC NEUROSCI-UK, V6, P502, DOI 10.1080/17470919.2011.620779; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lanata SC, 2016, J NEUROL NEUROSUR PS, V87, P501, DOI 10.1136/jnnp-2015-310697; Lavenu I, 1999, ALZ DIS ASSOC DIS, V13, P96, DOI 10.1097/00002093-199904000-00007; Le Jeune F, 2008, BRAIN, V131, P1599, DOI 10.1093/brain/awn084; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee KH, 2004, PSYCHOL MED, V34, P391, DOI 10.1017/S0033291703001284; Levenson RW, 2014, ANNU REV CLIN PSYCHO, V10, P581, DOI 10.1146/annurev-clinpsy-032813-153653; Liljegren M, 2015, JAMA NEUROL, V72, P295, DOI 10.1001/jamaneurol.2014.3781; Lin CY, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/9287092; Lindau M, 2000, DEMENT GERIATR COGN, V11, P286, DOI 10.1159/000017251; Lule D, 2013, J NEUROL, V260, P2836, DOI 10.1007/s00415-013-7068-y; Madeley P., 1995, BEHAV NEUROLOGY, V8; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McKinlay A, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S49104; Meier SL, 2010, BRAIN, V133, P3444, DOI 10.1093/brain/awq254; Melloni M, 2016, BRAIN, V139, P3022, DOI 10.1093/brain/aww231; Mendez MF, 2010, J AM ACAD PSYCHIATRY, V38, P318; Moll J, 2011, NEUROIMAGE, V54, P1735, DOI 10.1016/j.neuroimage.2010.08.026; Montuschi A, 2015, J NEUROL NEUROSUR PS, V86, P168, DOI 10.1136/jnnp-2013-307223; Moreau N, 2016, NEUROPSYCHOLOGY, V30, P312, DOI 10.1037/neu0000220; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mukherjee P, 2014, SCHIZOPHRENIA BULL, V40, P152, DOI 10.1093/schbul/sbt086; Nobis L, 2017, J NEURAL TRANSM, V124, P1067, DOI 10.1007/s00702-017-1739-2; O'Callaghan C, 2016, BRAIN, V139, P204, DOI 10.1093/brain/awv315; Omar R, 2011, NEUROIMAGE, V56, P1814, DOI 10.1016/j.neuroimage.2011.03.002; Ossenkoppele R, 2015, BRAIN, V138, P2732, DOI 10.1093/brain/awv191; Palmieri A, 2010, J NEUROL, V257, P1970, DOI 10.1007/s00415-010-5640-2; Papps B, 2005, NEUROPSYCHOLOGIA, V43, P1107, DOI 10.1016/j.neuropsychologia.2004.11.027; Parker KJ, 2017, P NATL ACAD SCI USA, V114, P8119, DOI 10.1073/pnas.1705521114; Patriquin MA, 2016, HUM BRAIN MAPP, V37, P3957, DOI 10.1002/hbm.23288; Pell MD, 2005, COGNITIVE BRAIN RES, V23, P327, DOI 10.1016/j.cogbrainres.2004.11.004; Peron J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009919; Peron J, 2010, NEUROPSYCHOLOGY, V24, P1, DOI 10.1037/a0017433; Peron J, 2009, NEUROPSYCHOLOGIA, V47, P406, DOI 10.1016/j.neuropsychologia.2008.09.008; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pietschnig J, 2016, INT PSYCHOGERIATR, V28, P1165, DOI 10.1017/S104161021600034X; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Poletti M, 2013, PSYCHIAT CLIN NEUROS, V67, P273, DOI 10.1111/pcn.12045; Poletti M, 2012, NEUROSCI BIOBEHAV R, V36, P2147, DOI 10.1016/j.neubiorev.2012.07.004; Poletti M, 2012, J NEUROPSYCH CLIN N, V24, pE7, DOI 10.1176/appi.neuropsych.11010021; Pontieri FE, 2012, PARKINSONISM RELAT D, V18, P871, DOI 10.1016/j.parkreldis.2012.04.023; Ramanan S, 2017, CORTEX, V88, P8, DOI 10.1016/j.cortex.2016.11.014; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Robert G, 2014, J NEUROL NEUROSUR PS, V85, P1153, DOI 10.1136/jnnp-2013-307025; Roca M, 2010, COGN BEHAV NEUROL, V23, P152, DOI 10.1097/WNN.0b013e3181e078de; Rosen HJ, 2002, BRAIN, V125, P2286, DOI 10.1093/brain/awf225; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Rytty R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00461; Saenz A, 2013, EUR J NEUROL, V20, P571, DOI 10.1111/ene.12040; Santamar-Garcia H, 2016, J ALZHEIMERS DIS, V54, P957, DOI 10.3233/JAD-160501; Santamaria-Garcia H, 2017, BRAIN, V140, P3357, DOI 10.1093/brain/awx269; Santangelo G, 2014, PSYCHIAT CLIN NEUROS, V68, P242, DOI 10.1111/pcn.12116; Santangelo G, 2012, MOVEMENT DISORD, V27, P98, DOI 10.1002/mds.23949; Savage SA, 2014, AMYOTROPH LAT SCL FR, V15, P39, DOI 10.3109/21678421.2013.809763; Saxe R, 2006, BRAIN RES, V1079, P57, DOI 10.1016/j.brainres.2006.01.001; Schmolck H, 2007, NEUROLOGY, V69, P2232, DOI 10.1212/01.wnl.0000296001.16603.b3; Schneider D, 2014, NEUROIMAGE, V101, P268, DOI 10.1016/j.neuroimage.2014.07.014; Schrag A, 2003, MOVEMENT DISORD, V18, P1464, DOI 10.1002/mds.10583; Schroeter ML, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00011; Schroeter ML, 2012, BRAIN, V135, DOI 10.1093/brain/aws030; Schroeter ML, 2012, BRAIN, V135, P201, DOI 10.1093/brain/awr311; Schulte-Ruther M, 2017, AUTISM RES, V10, P298, DOI 10.1002/aur.1654; Sedda A, 2017, BEHAV BRAIN RES, V330, P30, DOI 10.1016/j.bbr.2017.05.003; Sedda A, 2014, CURR OPIN NEUROL, V27, P659, DOI 10.1097/WCO.0000000000000147; Sedeno L, 2016, J INT NEUROPSYCH SOC, V22, P250, DOI 10.1017/S1355617715000703; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Seeley WW, 2012, NEUROSCIENTIST, V18, P373, DOI 10.1177/1073858411410354; Seeley WW, 2010, BRAIN STRUCT FUNCT, V214, P465, DOI 10.1007/s00429-010-0263-z; Shany-Ur T, 2014, BRAIN, V137, P2368, DOI 10.1093/brain/awu161; Shany-Ur T, 2012, CORTEX, V48, P1329, DOI 10.1016/j.cortex.2011.08.003; Shimokawa A, 2003, DEMENT GERIATR COGN, V15, P163, DOI 10.1159/000068479; Snowden JS, 2008, NEUROPSYCHOLOGIA, V46, P2638, DOI 10.1016/j.neuropsychologia.2008.04.018; Spoletini I, 2008, AM J GERIAT PSYCHIAT, V16, P389, DOI 10.1097/JGP.0b013e318165dbce; Staios M, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00178, 10.3389/fnhum.2013.00464]; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Strong MJ, 2017, AMYOTROPH LAT SCL FR, V18, P153, DOI 10.1080/21678421.2016.1267768; Sturm VE, 2015, CORTEX, V64, P55, DOI 10.1016/j.cortex.2014.10.002; Teng E, 2007, DEMENT GERIATR COGN, V23, P271, DOI 10.1159/000100829; Timmermann M, 2017, PSYCHONEUROENDOCRINO, V85, P158, DOI 10.1016/j.psyneuen.2017.07.483; Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031; Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041; Trojsi F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01934; Tsermentseli S, 2012, CORTEX, V48, P166, DOI 10.1016/j.cortex.2011.02.004; Valk SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700489; Van den Stock J., 2017, CORTEX; Van den Stock J, 2015, NEUROPSYCHOLOGIA, V75, P496, DOI 10.1016/j.neuropsychologia.2015.06.035; van der Hulst EJ, 2015, J NEUROL NEUROSUR PS, V86, P1208, DOI 10.1136/jnnp-2014-309290; von dem Hagen EAH, 2013, SOC COGN AFFECT NEUR, V8, P694, DOI 10.1093/scan/nss053; Wabnegger A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136110; Warren JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4827; Watermeyer TJ, 2015, J NEUROL, V262, P1681, DOI 10.1007/s00415-015-7761-0; Werner KH, 2007, NEUROLOGY, V69, P148, DOI 10.1212/01.wnl.0000265589.32060.d3; Whitwell JL, 2005, DEMENT GERIATR COGN, V20, P238, DOI 10.1159/000087343; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; Witgert M, 2010, EUR J NEUROL, V17, P103, DOI 10.1111/j.1468-1331.2009.02801.x; Wolters EC, 2009, PARKINSONISM RELAT D, V15, pS6, DOI 10.1016/S1353-8020(09)70770-9; Xi CH, 2015, BEHAV BRAIN RES, V279, P226, DOI 10.1016/j.bbr.2014.11.035; Yao SX, 2018, NEUROPSYCHOPHARMACOL, V43, P294, DOI 10.1038/npp.2017.189; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137; Yu RL, 2012, PARKINSONISM RELAT D, V18, P21, DOI 10.1016/j.parkreldis.2011.08.003; Zamboni G, 2008, NEUROLOGY, V71, P736, DOI 10.1212/01.wnl.0000324920.96835.95; Zimmerman EK, 2007, COGN BEHAV NEUROL, V20, P79, DOI 10.1097/WNN.0b013e31804c700b	243	51	51	1	17	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2018	2018								1849794	10.1155/2018/1849794	http://dx.doi.org/10.1155/2018/1849794			18	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GE9IB	29854017	Green Published, Green Submitted, gold			2022-09-04	WOS:000431542300001
J	Schneider-Maunoury, L; Lefebvre, V; Ewers, RM; Medina-Rangel, GF; Peres, CA; Somarriba, E; Urbina-Cardona, N; Pfeifer, M				Schneider-Maunoury, Laure; Lefebvre, Veronique; Ewers, Robert M.; Medina-Rangel, Guido. F.; Peres, Carlos A.; Somarriba, Eduardo; Urbina-Cardona, Nicolas; Pfeifer, Marion			Abundance signals of amphibians and reptiles indicate strong edge effects in Neotropical fragmented forest landscapes	BIOLOGICAL CONSERVATION			English	Article						Forest fragmentation; Edge influence; Species abundance; tropical forest; Herpetofauna	LEAF-AREA INDEX; DRY TROPICAL FOREST; HABITAT FRAGMENTATION; ATLANTIC FOREST; RAIN-FOREST; CONSERVATION; EXTINCTION; DIVERSITY; RESPONSES; VULNERABILITY	Fragmentation and habitat loss contribute considerably to global declines of amphibians and reptiles. However, few studies focus on forest edges, created during the fragmentation process, as proximate drivers of the local demographic structure of populations. Here, we use abundance data of amphibians and reptiles to study their responses to forest edges in nine fragmented forested landscapes of the Neotropics. Species-specific abundance data were collected in plots established at varying distances from their respective nearest forest edge. We tested for edge effects on the abundance of species, and used curve clustering techniques to group species with similar edge responses, i.e. species with either increasing or decreasing abundance from the matrix towards the forest interior. We also grouped species that showed no change in abundance with respect to the nearest forest edge and those whose abundance response was unimodal, peaking in either forest habitat or the surrounding matrix habitat. We found that 96% of all amphibians and 90% of all reptiles showed an edge response, with the abundance of 74.5% of amphibians and 57.3% of reptiles decreasing with increasing proximity to forest edges. However, species-specific edge effects were not always consistent, with some species having opposite edge responses when measured in different landscapes. The depth of edge effects exhibited by forest species, i.e. species that increased in abundance in the forest interior, extended up to one kilometre away from forest edges. We show that the median edge effect on forest species extends to 250 m within the forest interior, indicating that tropical forest patches with a mean diameter < 500 m (minimum area approximate to 78 ha) are unsuitable for half of forest-dependent species considered in this study. (C) 2016 Elsevier Ltd. All rights reserved.	[Schneider-Maunoury, Laure; Lefebvre, Veronique; Ewers, Robert M.] Imperial Coll, Silwood Pk Campus,Buckhusrt Rd, Ascot SL5 7PY, Berks, England; [Medina-Rangel, Guido. F.] Univ Nacl Colombia, Inst Ciencias Natur, Grp Biodiversidad & Conservat Reptiles, Ciudad Univ,Edificio 425, Bogota, DC, Colombia; [Peres, Carlos A.] Univ East Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Somarriba, Eduardo] Ctr Agronom Trop Invest & Ensenanza, Sede Cent, Programa Agroforesteria & Agr Sostenible, Cartago 30501, Turrialba, Costa Rica; [Urbina-Cardona, Nicolas] Pontificia Univ Javeriana, Sch Rural & Environm Studies, Ecol & Terr Dept, Bogota, DC, Colombia; [Pfeifer, Marion] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Schneider-Maunoury, Laure] Ecole Normale Super Paris, 45 Rue Ulm, F-75005 Paris, France		Schneider-Maunoury, L (corresponding author), Imperial Coll, Silwood Pk Campus,Buckhusrt Rd, Ascot SL5 7PY, Berks, England.; Schneider-Maunoury, L (corresponding author), Ecole Normale Super Paris, 45 Rue Ulm, F-75005 Paris, France.	laure.schneider-maunoury@ens.fr; v.lefebvre@imperial.ac.uk; r.ewers@imperial.ac.uk; gfmedinar@unal.edu.co; c.peres@uea.ac.uk; esomarri@catie.ac.cr; urbina-j@javeriana.edu.co; marion.pfeifer@newcastle.ac.uk	Peres, Carlos A./B-1276-2013; Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./ABE-8361-2020; Urbina-Cardona, J. Nicolas/B-5447-2008	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; Urbina-Cardona, J. Nicolas/0000-0002-4174-8467; Pfeifer, Marion/0000-0002-6775-3141; Medina-Rangel, Guido Fabian/0000-0002-9609-590X	French Ministry for Higher Education and Research; Ecole Normale Superieure de Paris; European Research Council [281986]; The British Council [GII111] Funding Source: researchfish	French Ministry for Higher Education and Research; Ecole Normale Superieure de Paris; European Research Council(European Research Council (ERC)European Commission); The British Council	LSM's Master thesis work was funded by the French Ministry for Higher Education and Research and the Ecole Normale Superieure de Paris. MP, VL and RME were supported by European Research Council Project number 281986. This paper is a contribution to the global BIOFRAG project.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Ashcroft MB, 2012, INT J CLIMATOL, V32, P2134, DOI 10.1002/joc.2428; Banks-Leite C, 2012, ECOLOGY, V93, P2560, DOI 10.1890/11-2054.1; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Biek R., 2002, NW SCI, V76, P1689; Blaustein AR, 2007, BIOSCIENCE, V57, P437, DOI 10.1641/B570517; Bonan G.B, 2008, ECOLOGICAL CLIMATOLO; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Cadenasso ML, 1997, CAN J FOREST RES, V27, P774, DOI 10.1139/cjfr-27-5-774; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Carvajal-Cogollo JE, 2015, BIODIVERS CONSERV, V24, P1109, DOI 10.1007/s10531-014-0845-9; Carvajal-Cogollo JE, 2008, TROP CONSERV SCI, V1, P397, DOI 10.1177/194008290800100407; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Demaynadier PG, 1998, CONSERV BIOL, V12, P340, DOI 10.1046/j.1523-1739.1998.96412.x; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Didham R. K., 2010, ENCY LIFE SCI; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Dixo M, 2009, ORYX, V43, P435, DOI 10.1017/S0030605309431508; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Medina-Rangel GF, 2011, REV BIOL TROP, V59, P935; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fletcher RJ, 2005, J ANIM ECOL, V74, P342, DOI 10.1111/j.1365-2656.2005.00930.x; Gaffney S. J., 2004, PROBABILITIC CURVE A; Gardner TA, 2007, BIOL CONSERV, V138, P166, DOI 10.1016/j.biocon.2007.04.017; Gardner TA, 2007, CONSERV BIOL, V21, P775, DOI 10.1111/j.1523-1739.2007.00659.x; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gibbs JP, 1998, LANDSCAPE ECOL, V13, P263, DOI 10.1023/A:1008056424692; Hansen MC, 2013, SCIENCE, V342, P850, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hardwick SR, 2015, AGR FOREST METEOROL, V201, P187, DOI 10.1016/j.agrformet.2014.11.010; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Harris L., 1992, FOREST FRAGMENTATION; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; HOBBS RJ, 1992, TRENDS ECOL EVOL, V7, P389, DOI 10.1016/0169-5347(92)90010-9; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Holt RD, 2005, OIKOS, V108, P3, DOI 10.1111/j.0030-1299.2005.13145.x; Houlahan JE, 2006, WETLANDS, V26, P79, DOI 10.1672/0277-5212(2006)26[79:TEOALU]2.0.CO;2; Isaacs-Cubides PJ, 2011, NAT CONSERVACAO, V9, P39, DOI 10.4322/natcon.2011.004; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lehtinen RM, 2003, BIODIVERS CONSERV, V12, P1357, DOI 10.1023/A:1023673301850; Matthews TJ, 2014, DIVERS DISTRIB, V20, P1136, DOI 10.1111/ddi.12227; Maurer CR, 2003, IEEE T PATTERN ANAL, V25, P265, DOI 10.1109/TPAMI.2003.1177156; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Mendenhall CD, 2014, ECOLOGY, V95, P856, DOI 10.1890/12-2017.1; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Meyer F., 1990, Journal of Visual Communication and Image Representation, V1, P21, DOI 10.1016/1047-3203(90)90014-M; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Pfeifer M, 2016, REMOTE SENS ENVIRON, V176, P84, DOI 10.1016/j.rse.2016.01.014; Pfeifer M, 2014, ECOL EVOL, V4, P1524, DOI 10.1002/ece3.1036; Pfeifer M, 2014, REMOTE SENS-BASEL, V6, P1973, DOI 10.3390/rs6031973; Pfeifer M, 2012, REMOTE SENS ENVIRON, V118, P103, DOI 10.1016/j.rse.2011.11.009; Pineda E, 2004, BIOL CONSERV, V117, P499, DOI 10.1016/j.biocon.2003.08.009; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Pryke JS, 2012, LANDSCAPE ECOL, V27, P73, DOI 10.1007/s10980-011-9668-1; Reino L, 2009, BIOL CONSERV, V142, P824, DOI 10.1016/j.biocon.2008.12.011; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Ries L, 2010, OIKOS, V119, P1636, DOI 10.1111/j.1600-0706.2010.18414.x; Samways MJ, 2010, BIODIVERS CONSERV, V19, P2949, DOI 10.1007/s10531-009-9715-2; Santos-Barrera G, 2011, REV MEX BIODIVERS, V82, P679; Sartorius SS, 1999, BIOL CONSERV, V90, P91, DOI 10.1016/S0006-3207(99)00019-1; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schlaepfer MA, 2001, CONSERV BIOL, V15, P1079, DOI 10.1046/j.1523-1739.2001.0150041079.x; Stork NE, 2009, CONSERV BIOL, V23, P1438, DOI 10.1111/j.1523-1739.2009.01335.x; Stuart L. C., 1955, BRIEF REV GUATEMALAN; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Suaz-Ortuno I, 2008, CONSERV BIOL, V22, P362, DOI 10.1111/j.1523-1739.2008.00883.x; Toral E, 2002, CONSERV BIOL, V16, P735, DOI 10.1046/j.1523-1739.2002.00250.x; Urbina-Cardona J.N., 2012, EVERGREENS TYPES ECO, P514; Urbina-Cardona JN, 2006, BIOL CONSERV, V132, P61, DOI 10.1016/j.biocon.2006.03.014; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; WILSON DS, 1994, AM NAT, V144, P692, DOI 10.1086/285702; Young R. P., 2008, AMPHIBIANS REPTILES, P90	84	36	38	1	68	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0006-3207	1873-2917		BIOL CONSERV	Biol. Conserv.	AUG	2016	200						207	215		10.1016/j.biocon.2016.06.011	http://dx.doi.org/10.1016/j.biocon.2016.06.011			9	Biodiversity Conservation; Ecology; Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation; Environmental Sciences & Ecology	DT2QK		Green Published, Green Accepted, Green Submitted			2022-09-04	WOS:000381325300024
J	Lizarralde, G; Bornstein, L; Robertson, M; Gould, K; Herazo, B; Petter, AM; Paez, H; Diaz, JH; Olivera, A; Gonzalez, G; Lopez, O; Lopez, A; Ascui, H; Burdiles, R; Bouchereau, K				Lizarralde, Gonzalo; Bornstein, Lisa; Robertson, Melanie; Gould, Kevin; Herazo, Benjamin; Petter, Anne-Marie; Paez, Holmes; Diaz, Julia Helena; Olivera, Andres; Gonzalez, Gonzalo; Lopez, Oswaldo; Lopez, Adriana; Ascui, Hernan; Burdiles, Roberto; Bouchereau, Karine			Does climate change cause disasters? How citizens, academics, and leaders explain climate-related risk and disasters in Latin America and the Caribbean	INTERNATIONAL JOURNAL OF DISASTER RISK REDUCTION			English	Article						Climate change; Risk; Disasters; Vulnerability; Latin America; Caribbean	POLITICAL-ECONOMY; CHANGE ADAPTATION; ANTHROPOLOGY; VULNERABILITY; EARTHQUAKE; JUSTICE; HAZARDS; IMPACT; STATE	For decades, social scientists have attempted to reveal the real causes behind disasters. While some scholars have recently focused almost exclusively on people's vulnerabilities, the majority recognize that disasters result from a combination of people's choices and hazards. Agencies and government officials, on the other hand, have often downplayed the political component of disasters (particularly those linked to global warming), preferring to focus on the technical and managerial aspects of climate response. This study explores how activists in informal settlements, academics, and governments in the Global South explain climate-related risk and disasters. The study is based on interviews, workshops, and group meetings in Haiti, Cuba, Chile, and Colombia, and on a fouryear analysis of implementation activities where community leaders were given financial resources to create risk reduction initiatives. Results show that there are significant mismatches between understandings of climate effects by people in informal settlements and decision-makers. Besides, whereas some scholars tend to focus on an anthropocentric view of risk and consider climate a component of "the hazard," residents perceive it as a factor of their vulnerability and a threat to their territories and ecosystems. These results challenge some popular definitions of climate risk and suggest that modern epistemologies of disasters are inappropriate to set up effective risk reduction in the Global South. Understanding local narratives of risk is crucial for the integration of climate and social agendas in the region.	[Lizarralde, Gonzalo; Herazo, Benjamin; Petter, Anne-Marie] Univ Montreal, Fac Built Environm, Montreal, PQ, Canada; [Bornstein, Lisa] McGill Univ, Sch Urban Planning, Montreal, PQ, Canada; [Robertson, Melanie] Int Dev Res Ctr IDRC, Ottawa, ON, Canada; [Gould, Kevin] Concordia Univ, Montreal, PQ, Canada; [Paez, Holmes; Diaz, Julia Helena] Pontificia Univ Javeriana, Bogota, Colombia; [Olivera, Andres; Gonzalez, Gonzalo] Univ Cent Marta Abreu, Santa Clara, Cuba; [Lopez, Oswaldo; Lopez, Adriana] Univ Valle, Cali, Colombia; [Ascui, Hernan; Burdiles, Roberto] Univ Bio Bio, Concepcion, Chile; [Bouchereau, Karine] Univ Etat Haiti, Port Au Prince, Haiti		Lizarralde, G (corresponding author), Univ Montreal, Fac Built Environm, Montreal, PQ, Canada.	gonzalo.lizarralde@umontreal.ca		lopez bernal, oswaldo/0000-0003-3781-2582; Diaz Ramirez, Julia Helena/0000-0003-4400-8779; Herazo, Benjamin/0000-0001-8605-8147; Lopez-Valencia, Adriana Patricia/0000-0003-1857-7580; Lizarralde, Gonzalo/0000-0001-6645-9269; Gonzalez Camacho, Gonzalo/0000-0002-4754-0480	Canada's International Development Research Centre (IDRC) [108501]; Social Sciences and Humanities Research Council of Canada (SSHRC); Fonds de recherche du Quebec (FRQSC)	Canada's International Development Research Centre (IDRC); Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); Fonds de recherche du Quebec (FRQSC)	This research project was supported by Canada's International Development Research Centre (IDRC), Grant#108501. Project: Climate change adaptation in informal settings: Understanding and reinforcing bottom-up initiatives in Latin America and the Caribbean. It also received support from the Social Sciences and Humanities Research Council of Canada (SSHRC) and the Fonds de recherche du Quebec (FRQSC). We acknowledge the special contribution of our partners in Colombia, Cuba, Chile and Haiti. Special thanks to the citizens, local leaders and government and NGO officials who participated in the study.	Alexander D., 2018, NATURAL DISASTERS, V1st ed.; [Anonymous], 2006, THESIS; [Anonymous], 2020, INT J DISASTER RISK, DOI DOI 10.33885/SF.2020.50.1257; Aragon-Duran E, 2020, INT J DISAST RISK RE, V50, DOI 10.1016/j.ijdrr.2020.101712; Araya-Munoz D, 2017, SCI TOTAL ENVIRON, V576, P508, DOI 10.1016/j.scitotenv.2016.10.077; Arevalo-Pena M.L., 2020, REV CIEN SOC, P81; Atkinson P., 2014, ETHNOGRAPHIC IMAGINA; Bankoff G, 2001, DISASTERS, V25, P19, DOI 10.1111/1467-7717.00159; Barrios R.E., 2020, DISASTER DISASTER EC; Barrios RE, 2017, ANNU REV ANTHROPOL, V46, P151, DOI 10.1146/annurev-anthro-102116-041635; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Blaikie PM, 1994, RISK NATURAL HAZARDS; Borie M, 2019, GLOBAL ENVIRON CHANG, V54, P203, DOI 10.1016/j.gloenvcha.2019.01.001; Bornstein L., 2018, INT J DISASTER RESIL, V4, P43; Bornstein Lisa, 2008, J PEACEBUILDING DEV, V4, P1; Brown B., 2020, POWER VULNERABILITY; Budds J, 2004, SINGAPORE J TROP GEO, V25, P322, DOI 10.1111/j.0129-7619.2004.00189.x; CALLICOTT JB, 1984, AM PHILOS QUART, V21, P299; Cannon T, 2010, NAT HAZARDS, V55, P621, DOI 10.1007/s11069-010-9499-4; Cantero C., 2019, QUINTO PODER 0411; Cardona O.D., 2002, INT WORK C VULN DIS; CITMA, 2020, PLAN EST ENFR CAMB C; Daudier V., 2020, NOUVELLISTE 0110; Dubois L, 2012, HAITI AFTERSHOCKS HI; Duque J.A. Diaz, 2015, 2 C MED AMB DES HUM; Edwards J, 2018, AUST J EMERG MANAG, V33, P22; Engle J, 2018, PROG PLANN, V124, P1, DOI 10.1016/j.progress.2017.04.001; Faas AJ, 2020, HUM ORGAN, V79, P333; Faas AJ, 2015, HUM ORGAN, V74, P287, DOI 10.17730/0018-7259-74.4.287; Fabricant Nicole, 2013, LATIN AM CARIBBEAN E, V8, P159, DOI DOI 10.1080/17442222.2013.805618; Fairclough Norman, 1997, DISCOURSE SOCIAL INT, V2, P258, DOI DOI 10.4135/9781446289068.N17; Fernandez A.G., 2020, REV CIEN SOC, P7; FORTMANN L, 1995, WORLD DEV, V23, P1053, DOI 10.1016/0305-750X(95)00024-7; Franco E, 1996, ESTADO SOC GESTION D; Gallard J., 2019, DISASTERS, V43; Geffard R., 2019, NOUVELLISTE 0204; Gould KA, 2016, J POLIT ECOL, V23, P93, DOI 10.2458/v23i1.20181; Gros JG, 2000, LAT AM RES REV, V35, P211; Hammersley M., 1994, ETHNOGRAPHY PARTICIP, P248; Hammersley M, 2015, BLACKWELL ENCY SOCIO, DOI 10.1002/9781405165518.wbeose070.pub2; Haraway D., 1989, PRIMATE VISIONS GEND; Hewitt K, 1983, INTERPRETATIONS CALA, P3; Hewitt K, 2013, JAMBA-J DISASTER RIS, V5, DOI 10.4102/jamba.v5i2.91; Hoffman S.M., 2002, CATASTROPHE CULTURE; ILO, 2016, IND PEOPL CLIM CHANG; Inostroza L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162464; Jean Y.-R., 2012, CADRE COORDINATION L; Jonas S., 1976, CLASS QUAKE GUATEMAL; Kelman I., 2017, DONT BLAME CLIMATE C; Kelman I., 2017, ROUTLEDGE HDB DISAST; Kelman I, 2019, PROG DISASTER SCI, V2, DOI 10.1016/j.pdisas.2019.100008; Kelman I, 2010, COMM ENV DISAST RISK, V4, P23, DOI 10.1108/S2040-7262(2010)0000004008; Klein N., 2010, SHOCK DOCTRINE RISE; Klepp S, 2018, ROUT ADV CLIMATE, P3; Koensler A, 2013, J POLIT ECOL, V20, P286, DOI 10.2458/v20i1.21767; Laennec H., 2015, NOUVELLISTE 0121; Lambert R., 2019, NOUVELLISTE 1106; Latour B., 2012, WE HAVE NEVER BEEN M; Lavell A., 2004, RED ESTUDIOS SOCIALE; Lavell A, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P25; Lizarralde G, 2015, INVISIBLE HOUSES: RETHINKING AND DESIGNING LOW-COST HOUSING IN DEVELOPING COUNTRIES, P1; Lizarralde G., 2020, ONLINE DEBATE IS ADA; Lizarralde G, 2020, DISASTER PREV MANAG, V29, P909, DOI 10.1108/DPM-01-2020-0011; Lyons M, 2009, WORLD DEV, V37, P385, DOI 10.1016/j.worlddev.2008.01.006; MacLennan M., 2012, CLIM LAW, V3, P283; Marin M., 2019, COMUNICACION LABERIN; Martinez-Alier J, 2016, J PEASANT STUD, V43, P731, DOI 10.1080/03066150.2016.1141198; Mika Kasia., 2018, DISASTERS VULNERABIL; Ministerio de Ciencia Tecnologia y Medio Ambiente-CITMA, 2016, ESTR AMB NAC 2016 20; Moezzi M, 2017, ENERGY RES SOC SCI, V31, P1, DOI 10.1016/j.erss.2017.06.034; Mu?oz L., 2019, TRIALOG, V134, P14; Musset A., 2010, CIUDAD SOC JUSTICIA; Newell P., 2020, TRANSFORMATIVE CLIMA; Nightingale AJ, 2020, CLIM DEV, V12, P343, DOI 10.1080/17565529.2019.1624495; Nisbet MC, 2009, ENVIRONMENT, V51, P12, DOI 10.3200/ENVT.51.2.12-23; O'Brien G, 2006, DISASTERS, V30, P64, DOI 10.1111/j.1467-9523.2006.00307.x; OKEEFE P, 1976, NATURE, V260, P566, DOI 10.1038/260566a0; OLIVERSMITH A, 1991, DISASTERS, V15, P12, DOI 10.1111/j.1467-7717.1991.tb00423.x; OliverSmith A, 1996, ANNU REV ANTHROPOL, V25, P303, DOI 10.1146/annurev.anthro.25.1.303; Organisation des femmes Haitiennes, 2019, NOUVELLISTE 0222; P?ez H., 2019, TRIALOG, V134, P9; Paez H., 2019, J PLANNING BUILDING, V3, P9; Parra Ahumada A., 2019, DIARIO CONCEPCI 1125; Paschen JA, 2014, RES POLICY, V43, P1083, DOI 10.1016/j.respol.2013.12.006; Lopez-Valencia AP, 2019, NAT HAZARDS, V99, P217, DOI 10.1007/s11069-019-03736-8; Pelling M., 2003, NATURAL DISASTERS DE; Perry R.W., 2007, HDB DISASTER RES, P1, DOI DOI 10.1007/978-0-387-32353-4_1; Petter AM, 2020, CITIES, V104, DOI 10.1016/j.cities.2020.102805; Pierre H., 2018, NOUVELLISTE 1018; Ramirez-Villegas J, 2012, CLIMATIC CHANGE, V115, P611, DOI 10.1007/s10584-012-0500-y; Roe E., 1994, NARRATIVE POLICY ANA; ROE EM, 1991, WORLD DEV, V19, P287, DOI 10.1016/0305-750X(91)90177-J; Saavedra J., 2020, REV CIEN SOC, P131; Salih M.A., 2014, LOCAL CLIMATE CHANGE; Salinas V., 2020, REV ESTUD SOC, V66, P107, DOI [10.17141/iconos.66.2020.4012, DOI 10.17141/ICONOS.66.2020.4012]; Sanchez Bustos S., 2019, COOPERATIVA OPINION; Schipper L, 2006, DISASTERS, V30, P19, DOI 10.1111/j.1467-9523.2006.00304.x; Schlosberg D, 2014, WIRES CLIM CHANGE, V5, P359, DOI 10.1002/wcc.275; Schuller M, 2009, POLAR-POLIT LEG ANTH, V32, P84, DOI DOI 10.1111/J.1555-2934.2009.01025.X; Scoville-Simonds M, 2020, WORLD DEV, V125, DOI 10.1016/j.worlddev.2019.104683; Senat J.D., 2020, NOUVELLISTE 0113; Shue Henry, 2014, CLIMATE JUSTICE VULN; Sliwinsky A., 2010, REBUILDING DISASTERS, P188; Sovacool BK, 2015, NAT CLIM CHANGE, V5, P616, DOI 10.1038/nclimate2665; Stone R., 2018, SCIENCE, V359; Szasz A., 2014, WORLDS RELIG ARE RES; Temper L, 2015, J POLIT ECOL, V22, P255, DOI 10.2458/v22i1.21108; Thomas T.S., 2018, CLIMATE CHANGE AGR C; van Aalst MK, 2006, DISASTERS, V30, P5, DOI 10.1111/j.1467-9523.2006.00303.x; Vivir Redaccion, 2020, EL ESPECTADOR; von Meding J., 2020, OPEN DEMOCRACY; WilchesChaux G., 1993, DESASTRES SON NATURA, P11; Wisner B, 2001, DISASTERS, V25, P251, DOI 10.1111/1467-7717.00176; Wisner B., 2016, OXFORD RES ENCY; Yin R.K., 2014, CASE STUDY RES DESIG; Yin R.K., 2003, CASE STUDY RES DESIG, Vthird	116	3	3	2	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2212-4209			INT J DISAST RISK RE	Int. J. Disaster Risk Reduct.	MAY	2021	58								102173	10.1016/j.ijdrr.2021.102173	http://dx.doi.org/10.1016/j.ijdrr.2021.102173		APR 2021	14	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geology; Meteorology & Atmospheric Sciences; Water Resources	SB0QZ		hybrid			2022-09-04	WOS:000649709300006
J	Perez-Sousa, MA; del Pozo-Cruz, J; Cano-Gutierrez, CA; Ferrebuz, AJ; Sandoval-Cuellar, C; Izquierdo, M; Hernandez-Quinonez, PA; Ramirez-Velez, R				Perez-Sousa, Miguel angel; del Pozo-Cruz, Jesus; Cano-Gutierrez, Carlos A.; Ferrebuz, Atilio J.; Sandoval-Cuellar, Carolina; Izquierdo, Mikel; Hernandez-Quinonez, Paula A.; Ramirez-Velez, Robinson			Glucose Levels as a Mediator of the Detrimental Effect of Abdominal Obesity on Relative Handgrip Strength in Older Adults	JOURNAL OF CLINICAL MEDICINE			English	Article						fat mass; obesity; muscle strength; physical function; diabetes	GRIP STRENGTH; MUSCLE STRENGTH; SKELETAL-MUSCLE; TYPE-2; RISK; ASSOCIATION; HEALTH; DISEASE; HYPERGLYCEMIA; PERFORMANCE	Excess central adiposity accelerates the decline of muscle strength in older people. Additionally, hyperglycemia, independent of associated comorbidities, is related to the loss of muscle mass and strength, and contributes to functional impairment in older adults. We studied the mediation effect of glucose levels, in the relationship between abdominal obesity and relative handgrip strength (HGS). A total of 1571 participants (60.0% women, mean age 69.1 +/- 7.0 years) from 86 municipalities were selected following a multistage area probability sampling design. Measurements included demographic and anthropometric/adiposity markers (weight, height, body mass index, and waist circumference). HGS was measured using a digital dynamometer for three sets and the mean value was recorded. The values were normalized to body weight (relative HGS). Fasting glucose was analyzed by enzymatic colorimetric methods. Mediation analyses were performed to identify associations between the independent variable (abdominal obesity) and outcomes (relative HGS), as well as to determine whether fasting glucose levels mediated the relationship between excess adiposity and relative HGS. A total of 1239 (78.8%) had abdominal obesity. Abdominal obesity had a negative effect on fasting glucose (beta = 9.04, 95%CI = 5.87 to 12.21); while fasting glucose to relative HGS was inversely related (beta = -0.003, 95%CI = -0.005 to -0.001),p< 0.001. The direct effect of abdominal obesity on relative HGS was statistically significant (beta = -0.069, 95%CI = -0.082 to -0.057),p< 0.001. Lastly, fasting glucose levels mediates the detrimental effect of abdominal obesity on relative HGS (indirect effect beta = -0.002, 95%CI = -0.004 to -0.001),p< 0.001. Our results suggest that the glucose level could worsen the association between abdominal obesity status and lower HGS. Thus, it is plausible to consider fasting glucose levels when assessing older adults with excess adiposity and/or suspected loss of muscle mass.	[Perez-Sousa, Miguel angel] Univ Huelva, Fac Sport Sci, Ave Fuerzas Armadas S-N 21007, Huelva 21004, Spain; [del Pozo-Cruz, Jesus] Univ Seville, Dept Phys Educ & Sport, Seville 41092, Spain; [Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Aging Inst, Bogota 110111, Colombia; [Ferrebuz, Atilio J.; Sandoval-Cuellar, Carolina] Univ Boyaca, Fac Ciencias Salud, Tunja 150003, Colombia; [Izquierdo, Mikel; Ramirez-Velez, Robinson] Univ Publ Navarra UPNA, IdiSNA, Complejo Hosp Navarra CHN, Navarrabiomed, Pamplona 31008, Spain; [Izquierdo, Mikel; Ramirez-Velez, Robinson] Inst Salud Carlos III, CIBER Frailty & Hlth Aging CIBERFES, Madrid 28029, Spain; [Izquierdo, Mikel; Hernandez-Quinonez, Paula A.] Univ Santo Tomas, Fac Phys Culture Sport & Recreat, GICAEDS Grp, Bogota 110311, Colombia		Ramirez-Velez, R (corresponding author), Univ Publ Navarra UPNA, IdiSNA, Complejo Hosp Navarra CHN, Navarrabiomed, Pamplona 31008, Spain.; Ramirez-Velez, R (corresponding author), Inst Salud Carlos III, CIBER Frailty & Hlth Aging CIBERFES, Madrid 28029, Spain.	perezsousa@gmail.com; jpozo2@us.es; ccano@javeriana.edu.co; ajferrebuz@uniboyaca.edu.co; carolinasandoval@uniboyaca.edu.co; mikel.izquierdo@gmail.com; paulahernandezq@usantotomas.edu.co; robin640@hotmail.com	Perez-Sousa, Miguel A./M-5931-2019; Sandoval-Cuellar, Carolina/AAP-8957-2021; Izquierdo, Mikel/A-4894-2010; Izquierdo, Mikel/O-8049-2019; Ramirez-Velez, Robinson/D-5311-2016	Perez-Sousa, Miguel A./0000-0003-4392-6850; Izquierdo, Mikel/0000-0002-1506-4272; Izquierdo, Mikel/0000-0002-1506-4272; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Sandoval-Cuellar, Carolina/0000-0003-1576-4380; Ramirez-Velez, Robinson/0000-0003-3075-6960; Ferrebuz, Atilio/0000-0002-7396-2775	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia [764]; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER) [PI17/01814]; Universidad Publica de Navarra [420/2019]	Colciencias y Ministerio de Salud y la Proteccion Social de Colombia; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER)(Spanish Government); Universidad Publica de Navarra	This study is part of a larger project that has been funded by a Colciencias y Ministerio de Salud y la Proteccion Social de Colombia (The SABE Study ID 2013, no. 764). M.I. is also funded in part by a research grant PI17/01814 of the Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER). R.R.-V. was funded in part by a Postdoctoral Fellowship Resolution ID 420/2019 of the Universidad Publica de Navarra.	Al-Sofiani ME, 2019, J DIABETES COMPLICAT, V33, P451, DOI 10.1016/j.jdiacomp.2019.03.007; Bailey DP, 2015, J PHYS ACT HEALTH, V12, P1148, DOI 10.1123/jpah.2014-0311; Barrett-Connor E, 1998, DIABETES CARE, V21, P1236, DOI 10.2337/diacare.21.8.1236; Bohannon RW, 2019, CLIN INTERV AGING, V14, P1681, DOI 10.2147/CIA.S194543; Brand Caroline, 2018, Motriz: rev. educ. fis., V24, pe101811, DOI 10.1590/s1980-6574201800040015; Cetinus E, 2005, DIABETES RES CLIN PR, V70, P278, DOI 10.1016/j.diabres.2005.03.028; Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Chun SW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222040; Cohen J, 1988, STAT POWER BEHAV SCI, V2nd; Corriere M, 2013, CURR DIABETES REP, V13, P805, DOI 10.1007/s11892-013-0425-5; Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6; Dodds R, 2013, AGE AGEING, V42, P794, DOI 10.1093/ageing/aft124; Eaton SB, 2017, RES Q EXERCISE SPORT, V88, P1, DOI 10.1080/02701367.2016.1268519; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Garcia-Hermoso A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173932; Giglio Bruna M, 2018, Clin Nutr Res, V7, P112, DOI 10.7762/cnr.2018.7.2.112; Hamasaki H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07438-8; Hayes AF, 2017, INTRO MEDIATION MODE; Hong S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188650; Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Lee MR, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010984; Lee PG, 2017, DIABETES CARE, V40, P444, DOI 10.2337/dc16-1732; Lee WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160876; Leenders M, 2013, J AM MED DIR ASSOC, V14, P585, DOI 10.1016/j.jamda.2013.02.006; Li JJ, 2016, METABOLISM, V65, P883, DOI 10.1016/j.metabol.2016.03.011; Lopez-Jaramillo P, 2014, INT J CARDIOL, V174, P458, DOI 10.1016/j.ijcard.2014.04.013; Mamtani MR, 2005, ARCH MED RES, V36, P581, DOI 10.1016/j.arcmed.2005.03.049; McGrath R, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.01.017; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Mizgier ML, 2014, OBES REV, V15, P587, DOI 10.1111/obr.12166; Murai J, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0755-3; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Nwose E U, 2017, BMC Res Notes, V10, P730, DOI 10.1186/s13104-017-3017-7; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Ohlendieck K, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/893876; Palacios-Chavez M, 2016, ENDOCRINOL NUTR, V63, P220, DOI 10.1016/j.endonu.2015.12.008; Park SW, 2007, DIABETES CARE, V30, P1507, DOI 10.2337/dc06-2537; Park SW, 2006, DIABETES, V55, P1813, DOI 10.2337/db05-1183; Pedersen BK, 2011, J EXP BIOL, V214, P337, DOI 10.1242/jeb.048074; Peterson MD, 2017, J GERONTOL A-BIOL, V72, P1525, DOI 10.1093/gerona/glx031; Peterson MD, 2016, J AM MED DIR ASSOC, V17, P933, DOI 10.1016/j.jamda.2016.06.007; Ramirez-Velez R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112654; Ramirez-Velez R, 2019, J CACHEXIA SARCOPENI, V10, P278, DOI 10.1002/jcsm.12373; Ross R, 2020, NAT REV ENDOCRINOL, V16, P177, DOI 10.1038/s41574-019-0310-7; Ryan AS, 2011, NEUROREHAB NEURAL RE, V25, P865, DOI 10.1177/1545968311408920; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Shi J, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00703; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Son YJ, 2016, ENDOCRINOL METAB, V31, P127, DOI 10.3803/EnM.2016.31.1.127; Tramunt B, 2020, DIABETOLOGIA, V63, P453, DOI 10.1007/s00125-019-05040-3; de Carvalho DHT, 2019, J GERONTOL A-BIOL, V74, P1105, DOI 10.1093/gerona/gly178; van Agtmaal MJM, 2018, DIABETES CARE, V41, P2535, DOI 10.2337/dc18-1132; van der Kooi ALLF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137739; Villareal DT, 2005, OBES RES, V13, P1849, DOI 10.1038/oby.2005.228; Virtanen KA, 2002, J CLIN ENDOCR METAB, V87, P3902, DOI 10.1210/jc.87.8.3902; Wang DXM, 2020, J CACHEXIA SARCOPENI, V11, P3, DOI 10.1002/jcsm.12502; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Westphal Sydney A, 2008, Clin Cornerstone, V9, P23, DOI 10.1016/S1098-3597(08)60025-3; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2019, WHO GUID INT CAR OLD	62	4	4	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	AUG	2020	9	8							2323	10.3390/jcm9082323	http://dx.doi.org/10.3390/jcm9082323			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM4UC	32707776	gold, Green Published			2022-09-04	WOS:000568092100001
J	Mishchenko, DV; Neganova, ME; Klimanova, EN; Sashenkova, TE; Klochkov, SG; Shevtsova, EF; Vystorop, IV; Tarasov, VV; Chubarev, VN; Samsonova, AN; Ashraf, GM; Barreto, G; Yarla, NS; Aliev, G				Mishchenko, Denis V.; Neganova, Margarita E.; Klimanova, Elena N.; Sashenkova, Tatyana E.; Klochkov, Sergey G.; Shevtsova, Elena F.; Vystorop, Igor V.; Tarasov, Vadim V.; Chubarev, Vladimir N.; Samsonova, Anna N.; Ashraf, Ghulam Md; Barreto, George; Yarla, Nagendra Sastry; Aliev, Gjumrakch			Chemosensitizing Activity of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids for Combination Chemotherapy of Lymphatic Leukemia	CURRENT CANCER DRUG TARGETS			English	Article						HDAC inhibitory activity; hydroxamic acid; chemosensitizing property; lymphatic leukemia; histone deacetylases; combination chemotherapy	NITRIC-OXIDE	Background: Anti-tumor effect of hydroxamic acid derivatives is largely connected with its properties as efficient inhibitors of histone deacetylases, and other metalloenzymes involved in carcinogenesis. Objective: The work was aimed to (i) determine the anti-tumor and chemosensitizing activity of the novel racemic spirocyclic hydroxamic acids using experimental drug sensitive leukemia P388 of mice, and (ii) determine the structure-activity relationships as metal chelating and HDAC inhibitory agents. Method: Outbreed male rat of 200-220 g weights were used in biochemical experiments. In vivo experiments were performed using the BDF1 hybrid male mice of 22-24 g weight. Lipid peroxidation, Fe (II) -chelating activity, HDAC fluorescent activity, anti-tumor and anti-metastatic activity, acute toxicity techniques were used in this study. Results: Chemosensitizing properties of water soluble cyclic hydroxamic acids (CHA) are evaluated using in vitro activities and in vivo methods and found significant results. These compounds possess iron (II) chelating properties, and slightly inhibit lipid peroxidation. CHA prepared from triacetonamine (la-e) are more effective Fe (II) ions cheaters, as compared to CHA prepared from 1-methylpiperidone (2a-e). The histone deacetylase (HDAC) inhibitory activity, lipophilicity and acute toxicity were influenced by the length amino acids (size) (Glycine<Alanine<Valine<Leucine <Phenylalanine). All compounds bearing spiro-N-methylpiperidine ring (2a-e) are non-toxic up to 1250 mg/kg dose, while compounds bearing spiro-tetramethylpiperidine ring (la-e) exhibit moderate toxicity which increases with increasing lipophility, but not excite at 400 mg/kg. Conclusion: It was shown that the use of combination of non-toxic doses of cisplatin (cPt) or cyclophosphamide with CHA in most cases result in the appearance of a considerable anti-tumor effect of cytostatics. The highest chemosensitizing activity with respect to leukemia P388 is demonstrated by the CHA derivatives of Valine lc or 2c.	[Mishchenko, Denis V.; Klimanova, Elena N.; Sashenkova, Tatyana E.; Vystorop, Igor V.] Russian Acad Sci, Inst Problems Chem Phys, Chernogolovka 142432, Russia; [Mishchenko, Denis V.] Moscow Reg State Univ, Moscow 105005, Russia; [Neganova, Margarita E.; Klochkov, Sergey G.; Shevtsova, Elena F.; Samsonova, Anna N.; Aliev, Gjumrakch] Russian Acad Sci, Inst Physiologically Act Cpds, Chernogolovka 142432, Russia; [Tarasov, Vadim V.; Chubarev, Vladimir N.] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, Moscow 119991, Russia; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Barreto, George; Aliev, Gjumrakch] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George; Aliev, Gjumrakch] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Yarla, Nagendra Sastry; Aliev, Gjumrakch] GALLY Int Biomed Res Inst Inc, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA; Univ Atlanta, Sch Hlth Sci & Healthcare Adm, E Johns Crossing 175, Johns Creek, GA 30097 USA		Aliev, G (corresponding author), GALLY Int Biomed Res Inst Inc, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA.	aliev03@gmail.com	Ashraf, Ghulam Md/H-9485-2012; Mischenko, Denis/AAH-7960-2019; Barreto, George E./AAD-7420-2020; Mischenko, Denis V/H-3054-2011; Klimanova, Elena/AAH-8076-2019; Shevtsova, Elena/G-6288-2017; Neganova, Margarita E/L-8499-2017; Klochkov, S. G./F-4087-2017; Aliev, Gjumrakch/AAE-7734-2020; Chubarev, Vladimir N/J-4321-2017	Ashraf, Ghulam Md/0000-0002-9820-2078; Barreto, George E./0000-0002-6644-1971; Mischenko, Denis V/0000-0003-3779-3211; Klochkov, S. G./0000-0002-0299-9183; Aliev, Gjumrakch/0000-0001-7373-3182; Chubarev, Vladimir N/0000-0002-7047-1436; Elena, Shevtsova/0000-0003-2887-1185; , Klimanova Elena/0000-0001-6319-3151; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994	RSF [14-23-00160P]; scientific projects of IPAC [48.8., 48.9]	RSF(Russian Science Foundation (RSF)); scientific projects of IPAC	This research was supported in part by RSF project #14-23-00160P and the scientific projects of IPAC (topics 48.8. and 48.9). Authors' also very grateful for the animal facilities were provided by Center for preclinical trials of IPAC RAS.	ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Arrighetti Noemi, 2015, Critical Reviews in Oncogenesis, V20, P83; Bartel C, 2011, J BIOL INORG CHEM, V16, P1205, DOI 10.1007/s00775-011-0809-4; Bogatyrenko TN, 2011, RUSS CHEM B+, V60, P1162, DOI 10.1007/s11172-011-0182-z; Buss JL, 2004, CURR TOP MED CHEM, V4, P1623, DOI 10.2174/1568026043387269; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Granik V. G., 1997, RUSS CHEM REV, V66, P717; Hirst D, 2010, CURR PHARM DESIGN, V16, P411, DOI 10.2174/138161210790232185; MARMION CJ, 2000, HYDROXAMIC ACIDS ARE, P1153; Mironov A.N., 2012, HDB PRECLINICAL DRUG, V1, P670; Perez CA, 2009, J INORG BIOCHEM, V103, P326, DOI 10.1016/j.jinorgbio.2008.11.003; Pontiki E, 2012, MED RES REV, V32, P1, DOI 10.1002/med.20200; Saban N, 2009, CANCER CHEMOTH PHARM, V64, P213, DOI 10.1007/s00280-009-0991-z; Tetko IV, 2002, J CHEM INF COMP SCI, V42, P1136, DOI 10.1021/ci025515j; Vystorop IV, 2013, RUSS CHEM B+, V62, P1272, DOI 10.1007/s11172-013-0176-0; Vystorop IV, 2010, RUSS CHEM B+, V59, P127, DOI 10.1007/s11172-010-0055-x; Wegener D, 2003, ANAL BIOCHEM, V321, P202, DOI 10.1016/S0003-2697(03)00426-3; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543	18	5	5	0	5	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1568-0096	1873-5576		CURR CANCER DRUG TAR	Curr. Cancer Drug Targets		2018	18	4					365	371		10.2174/1568009617666170623104030	http://dx.doi.org/10.2174/1568009617666170623104030			7	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	GD1MO	28669342				2022-09-04	WOS:000430264200006
J	Rosenthal, VD; Ramachandran, B; Duenas, L; Alvarez-Moreno, C; Navoa-Ng, JA; Armas-Ruiz, A; Ersoz, G; Matta-Cortes, L; Pawar, M; Yalcin, AN; Rodriguez-Ferrer, M; de Casares, ACB; Linares, C; Villanueva, VD; Campuzano, R; Kaya, A; Rendon-Campo, LF; Gupta, A; Turhan, O; Barahona-Guzman, N; de Jesus-Machuca, L; Tolentino, MCV; Mena-Brito, J; Kuyucu, N; Astudillo, Y; Saini, N; Gunay, N; Sarmiento-Villa, G; Gumus, E; Lagares-Guzman, A; Dursun, O				Rosenthal, Victor D.; Ramachandran, Bala; Duenas, Lourdes; Alvarez-Moreno, Carlos; Navoa-Ng, J. A.; Armas-Ruiz, Alberto; Ersoz, Gulden; Matta-Cortes, Lorena; Pawar, Mandakini; Yalcin, Ata Nevzat; Rodriguez-Ferrer, Marena; Bran de Casares, Ana Concepcion; Linares, Claudia; Villanueva, Victoria D.; Campuzano, Roberto; Kaya, Ali; Fernando Rendon-Campo, Luis; Gupta, Amit; Turhan, Ozge; Barahona-Guzman, Nayide; de Jesus-Machuca, Lilian; Tolentino, Maria Corazon V.; Mena-Brito, Jorge; Kuyucu, Necdet; Astudillo, Yamileth; Saini, Narinder; Gunay, Nurgul; Sarmiento-Villa, Guillermo; Gumus, Eylul; Lagares-Guzman, Alfredo; Dursun, Oguz			Findings of the International Nosocomial Infection Control Consortium (INICC), Part I: Effectiveness of a Multidimensional Infection Control Approach on Catheter-Associated Urinary Tract Infection Rates in Pediatric Intensive Care Units of 6 Developing Countries	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							BLOOD-STREAM INFECTIONS; PERFORMANCE FEEDBACK; HAND HYGIENE; EDUCATION; ARGENTINA; IMPACT; HOSPITALS; MORTALITY; RISK; ERA	DESIGN. A before-after prospective surveillance study to assess the impact of a multidimensional infection control approach for the reduction of catheter-associated urinary tract infection (CAUTI) rates. SETTING. Pediatric intensive care units (PICUs) of hospital members of the International Nosocomial Infection Control Consortium (INICC) from 10 cities of the following 6 developing countries: Colombia, El Salvador, India, Mexico, Philippines, and Turkey. PATIENTS. PICU inpatients. METHODS. We performed a prospective active surveillance to determine rates of CAUTI among 3,877 patients hospitalized in 10 PICUs for a total of 27,345 bed-days. The study was divided into a baseline period (phase 1) and an intervention period (phase 2). In phase 1, surveillance was performed without the implementation of the multidimensional approach. In phase 2, we implemented a multidimensional infection control approach that included outcome surveillance, process surveillance, feedback on CAUTI rates, feedback on performance, education, and a bundle of preventive measures. The rates of CAUTI obtained in phase 1 were compared with the rates obtained in phase 2, after interventions were implemented. RESULTS. During the study period, we recorded 8,513 urinary catheter (UC) days, including 1,513 UC-days in phase 1 and 7,000 UCdays in phase 2. In phase 1, the CAUTI rate was 5.9 cases per 1,000 UC-days, and in phase 2, after implementing the multidimensional infection control approach for CAUTI prevention, the rate of CAUTI decreased to 2.6 cases per 1,000 UC-days (relative risk, 0.43 [95% confidence interval, 0.21-1.0]), indicating a rate reduction of 57%. CONCLUSIONS. Our findings demonstrated that implementing a multidimensional infection control approach is associated with a significant reduction in the CAUTI rate of PICUs in developing countries. Infect Control Hosp Epidemiol 2012;33(7):696-703	[Rosenthal, Victor D.] Int Nosocomial Infect Control Consortium, Buenos Aires, DF, Argentina; [Ramachandran, Bala] KK Childs Trust Hosp, Chennai, Tamil Nadu, India; [Duenas, Lourdes; Bran de Casares, Ana Concepcion; de Jesus-Machuca, Lilian] Hosp Nacl Ninos Benjamin Bloom, San Salvador, El Salvador; [Alvarez-Moreno, Carlos; Linares, Claudia] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Navoa-Ng, J. A.; Villanueva, Victoria D.; Tolentino, Maria Corazon V.] St Lukes Med Ctr, Quezon City, Philippines; [Armas-Ruiz, Alberto; Campuzano, Roberto; Mena-Brito, Jorge] Ctr Med La Raza IMSS, Mexico City, DF, Mexico; [Ersoz, Gulden; Kaya, Ali; Kuyucu, Necdet] Mersin Univ, Fac Med, Mersin, Turkey; [Matta-Cortes, Lorena; Fernando Rendon-Campo, Luis; Astudillo, Yamileth] Corp Comfenalco Valle Univ Libre, Santiago De Cali, Colombia; [Pawar, Mandakini; Gupta, Amit; Saini, Narinder] Pushpanjali Crosslay Hosp, Ghaziabad, India; [Yalcin, Ata Nevzat; Turhan, Ozge; Gunay, Nurgul; Gumus, Eylul; Dursun, Oguz] Akdeniz Univ, TR-07058 Antalya, Turkey; [Rodriguez-Ferrer, Marena; Barahona-Guzman, Nayide; Sarmiento-Villa, Guillermo; Lagares-Guzman, Alfredo] Univ Simon Bolivar, Barranquilla, Colombia		Rosenthal, VD (corresponding author), Ave Corrientes 4580,Piso 12 D,C1195AAR, Buenos Aires, DF, Argentina.	victor_rosenthal@inicc.org	ersoz, gulden/A-4255-2018; Yalcin, Ata Nevzat/B-4818-2008; Moreno, carlos Arturo alvarez/P-6678-2016; dursun, oguz/C-1604-2016; Dursun, Oğuz/L-6205-2019; Turhan, Özge/C-1007-2016; Matta Cortes, Lorena/I-9030-2016	Yalcin, Ata Nevzat/0000-0002-7243-7354; Moreno, carlos Arturo alvarez/0000-0001-5419-4494; dursun, oguz/0000-0001-5482-3780; Dursun, Oğuz/0000-0001-5482-3780; Matta Cortes, Lorena/0000-0002-5215-3215; Barahona G., Nayide/0000-0003-3559-6900; ROSENTHAL, VICTOR DANIEL/0000-0001-9138-4801; Rodriguez Ferrer, Marena Luz/0000-0002-8053-8454; Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318	Foundation to Fight against Nosocomial Infections	Foundation to Fight against Nosocomial Infections	Financial support. The funding for the activities carried out at INICC headquarters were provided by V.D.R. and Foundation to Fight against Nosocomial Infections.	Bagshaw SM, 2006, CURR OPIN INFECT DIS, V19, P67, DOI 10.1097/01.qco.0000200292.37909.e0; Bi XC, 2009, J CHEMOTHERAPY, V21, P661, DOI 10.1179/joc.2009.21.6.661; Chant C, 2011, CRIT CARE MED, V39, P1167, DOI 10.1097/CCM.0b013e31820a8581; Ciavarella DJ, 2009, INFECT CONT HOSP EP, V30, P404, DOI 10.1086/596730; Clec'h C, 2007, INFECT CONT HOSP EP, V28, P1367, DOI 10.1086/523279; Crouzet J, 2007, J HOSP INFECT, V67, P253, DOI 10.1016/j.jhin.2007.08.014; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Gray M, 2010, AACN ADV CRIT CARE, V21, P247, DOI 10.1097/NCI.0b013e3181db53cb; Hameed A, 2010, BR J HOSP MED LOND, V71, P151; Hameed A, 2010, BRIT J HOSP MED, V71, P148, DOI 10.12968/hmed.2010.71.3.46978; Higuera F, 2005, CRIT CARE MED, V33, P2022, DOI 10.1097/01.CCM.0000178190.89663.E5; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Lo Evelyn, 2008, Infect Control Hosp Epidemiol, V29 Suppl 1, pS41, DOI 10.1086/591066; Mahmood Zeeshan, 2008, J Pak Med Assoc, V58, P653; Malt Greg, 2007, Int J Nurs Pract, V13, P348, DOI 10.1111/j.1440-172X.2007.00649.x; Marra AR, 2011, AM J INFECT CONTROL, V39, P817, DOI 10.1016/j.ajic.2011.01.013; Rosenthal VD, 2011, INFECTION, V39, P439, DOI 10.1007/s15010-011-0136-2; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P392, DOI 10.1016/j.ajic.2004.08.009; Rosenthal VD, 2004, INFECT CONT HOSP EP, V25, P47, DOI 10.1086/502291; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P85, DOI 10.1067/mic.2003.63; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P405, DOI 10.1067/mic.2003.52; Rosenthal VD, 2011, AM J INFECT CONTROL; Rosenthal VD, 2008, AM J INFECT CONTROL, V36, P627, DOI [10.1016/j.ajic.2008.10.009, 10.1016/j.ajic.2008.06.003]; Rosenthal VD, 2006, ANN INTERN MED, V145, P582, DOI 10.7326/0003-4819-145-8-200610170-00007; Rosenthal VD, 2011, J INFECTION, V62, P136, DOI 10.1016/j.jinf.2010.12.004; Rosenthal VD, 2010, INFECT CONT HOSP EP, V31, P1264, DOI 10.1086/657140; Sax H, 2009, AM J INFECT CONTROL, V37, P827, DOI 10.1016/j.ajic.2009.07.003; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; Trautner BW, 2010, CURR OPIN INFECT DIS, V23, P76, DOI 10.1097/QCO.0b013e328334dda8; Tsuchida T, 2008, INT J NURS STUD, V45, P352, DOI 10.1016/j.ijnurstu.2006.10.006; Willson M, 2009, J WOUND OSTOMY CONT, V36, P137, DOI 10.1097/01.WON.0000347655.56851.04; World Bank, 2007, WORLD BANK ASSISTANCE TO AGRICULTURE IN SUB-SAHARAN AFRICA: AN IEG REVIEW, P1, DOI 10.1596/978-0-8213-7350-7; Xie DS, 2011, BRAZ J INFECT DIS, V15, P296, DOI 10.1590/S1413-86702011000300021; Yildirim M, 2007, MYCOSES, V50, P189, DOI 10.1111/j.0933-7407.2006.01348.x	34	46	47	0	27	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	JUL	2012	33	7					696	703		10.1086/666341	http://dx.doi.org/10.1086/666341			8	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	955DW	22669231				2022-09-04	WOS:000304998300008
J	Hill, MJ; Roman, MO; Schaaf, CB; Hutley, L; Brannstrom, C; Etter, A; Hanan, NP				Hill, Michael J.; Roman, Miguel O.; Schaaf, Crystal B.; Hutley, Lindsay; Brannstrom, Christian; Etter, Andres; Hanan, Niall P.			Characterizing vegetation cover in global savannas with an annual foliage clumping index derived from the MODIS BRDF product	REMOTE SENSING OF ENVIRONMENT			English	Article						Savanna; Clumping index; Canopy; Woody cover; Global; Physiognomy; Shadow	LEAF-AREA INDEX; BIDIRECTIONAL REFLECTANCE; LAND-COVER; SEMIARID SAVANNA; TREE COVER; SURFACE; CANOPY; ALBEDO; RETRIEVAL; SYSTEM	The global savanna biome is characterized by enormous diversity in the physiognomy and spatial structure of the vegetation. The foliage clumping index can be calculated from bidirectional reflectance distribution function (BRDF) data. It measures the response of the darkspot reflectance to increased shadow associated with clumped vegetation and is related to leaf area index. Clumping index theoretically declines with increasing woody cover until the tree canopy begins to become uniform. In this study, clumping index is calculated for Moderate Resolution Imaging Spectroradiometer BRDF data for the Australian tropical savanna, the tropical savannas of South America, and the tropical savannas of east, west and southern Africa and compared with site-based measurements of tree canopy cover, and with area-based classifications of land cover. There were differences in sensitivity of clumping index between red and near-infrared reflectance channels, and between savanna systems with markedly different woody vegetation physiognomy. Clumping index was broadly related to foliage cover from historical site data in Australia and in West Africa and Kenya, but not in Southern Africa nor with detailed site-based demographic data in the cerrado of Brazil. However, clumping index decreased with proportion of woody cover in land cover datasets for east Africa, Australia and the Colombian Llanos. There was overlap in the range of clumping index values for forest, cerrado and campo land covers in Brazil. Clumping index was generally negatively correlated with percentage tree cover from the MODIS Vegetation Continuous Fields product, but regional differences in the relationship were evident. There were large differences in the frequency distributions of clumping index from savanna, woody savanna and grassland land cover classes between global ecoregions. The clumping index shows differing sensitivity to savanna woody cover for red and NIR reflectance, and requires regional calibration for application as a universal indicator. (C) 2011 Elsevier Inc. All rights reserved.	[Hill, Michael J.] Univ N Dakota, Grand Forks, ND 58202 USA; [Roman, Miguel O.] NASA, Goddard Space Flight Ctr, Terr Informat Syst Branch, Greenbelt, MD 20771 USA; [Schaaf, Crystal B.] Boston Univ, Ctr Remote Sensing, Dept Geog & Environm, Boston, MA 02215 USA; [Hutley, Lindsay] Charles Darwin Univ, Sch Environm & Life Sci, Darwin, NT 0909, Australia; [Brannstrom, Christian] Texas A&M Univ, Dept Geog, College Stn, TX USA; [Etter, Andres] Univ Javeriana, Fac Estudios Ambientales & Rurales, Grp Ecol & Terr, Bogota, DC, Colombia; [Hanan, Niall P.] Colorado State Univ, Nat Resources & Environm Lab, Ft Collins, CO 80523 USA		Hill, MJ (corresponding author), Univ N Dakota, Clifford Hall,Stop 9011, Grand Forks, ND 58202 USA.	hillmj@aero.und.edu	Roman, Miguel O/D-4764-2012; Hutley, Lindsay B/A-7925-2011; Etter, Andrés/E-1860-2011	Roman, Miguel O/0000-0003-3953-319X; Hutley, Lindsay B/0000-0001-5533-9886; Etter, Andrés/0000-0003-0665-9300; Hill, Michael/0000-0003-4570-7467; Hanan, Niall/0000-0002-9130-5306; Brannstrom, Christian/0000-0002-6619-2020; Schaaf, Crystal/0000-0002-9150-2975				Agren G.I., 1996, GLOBAL CHANGE EFFECT, P69; Aranibar JN, 2004, GLOBAL CHANGE BIOL, V10, P359, DOI 10.1111/j.1365-2486.2003.00698.x; Armston JD, 2007, REMOTE SENS ENVIRON, V107, P287, DOI 10.1016/j.rse.2006.11.003; Asner GP, 2003, REMOTE SENS ENVIRON, V87, P521, DOI 10.1016/j.rse.2003.08.006; ASSAD ED, 1994, LAND COVER EVALUATIO; Augustine DJ, 2003, PLANT ECOL, V167, P319, DOI 10.1023/A:1023927512590; *AUSLIG, 1990, ATL AUSTR RES VEG; Barrett DJ, 2005, AUST J BOT, V53, P689, DOI 10.1071/BT04139; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; BRANNSTROM C, 2007, GEOCARTO INT, V23, P109; Brannstrom C, 2009, AMBIO, V38, P141, DOI 10.1579/0044-7447-38.3.141; Bucini G, 2007, GLOBAL ECOL BIOGEOGR, V16, P593, DOI 10.1111/j.1466-8238.2007.00325.x; Chen JM, 2005, REMOTE SENS ENVIRON, V97, P447, DOI 10.1016/j.rse.2005.05.003; Chen JM, 2003, REMOTE SENS ENVIRON, V84, P516, DOI 10.1016/S0034-4257(02)00150-5; CHEN JM, 1992, PLANT CELL ENVIRON, V15, P421, DOI 10.1111/j.1365-3040.1992.tb00992.x; Chen JM, 1996, AGR FOREST METEOROL, V80, P135, DOI 10.1016/0168-1923(95)02291-0; Chopping M, 2008, REMOTE SENS ENVIRON, V112, P2051, DOI 10.1016/j.rse.2007.07.024; Chopping M, 2008, REMOTE SENS ENVIRON, V112, P19, DOI 10.1016/j.rse.2006.04.023; Couteron P, 1997, PLANT ECOL, V132, P211, DOI 10.1023/A:1009723906370; de Bie S, 1998, J BIOGEOGR, V25, P883, DOI 10.1046/j.1365-2699.1998.00229.x; DESCHAMPS PY, 1994, IEEE T GEOSCI REMOTE, V32, P598, DOI 10.1109/36.297978; Devineau JL, 1999, J TROP ECOL, V15, P497, DOI 10.1017/S0266467499000978; DIGREGORIO A, 1998, CLASSIFICATION CONCE; Etter A, 2011, ECOSYSTEM FUNCTION S, P383; ETTER A, 1998, INFORME NACL ESTADO; Ferreira JN, 2007, OECOLOGIA, V153, P417, DOI 10.1007/s00442-007-0747-6; Filippi AM, 2009, GISCI REMOTE SENS, V46, P1, DOI 10.2747/1548-1603.46.1.1; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gao F, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005190; Gao F, 2003, REMOTE SENS ENVIRON, V86, P198, DOI 10.1016/S0034-4257(03)00100-7; Gatebe CK, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002397; Goldstein G, 2008, TREE PHYSIOL, V28, P395, DOI 10.1093/treephys/28.3.395; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Hansen MC, 2003, EARTH INTERACT, V7; Hansen MC, 2002, REMOTE SENS ENVIRON, V83, P303, DOI 10.1016/S0034-4257(02)00079-2; Hill M. J., 2011, ECOSYSTEM FUNCTION S, P3; Hill MJ, 2008, CAN J REMOTE SENS, V34, pS247, DOI 10.5589/m08-042; HILL MJ, 2011, REMOTE SENS IN PRESS; Jansen LJM, 2003, LAND USE POLICY, V20, P131, DOI 10.1016/S0264-8377(02)00081-9; Jansen LJM, 2002, AGR ECOSYST ENVIRON, V91, P89, DOI 10.1016/S0167-8809(01)00243-2; Lacaze R, 2002, REMOTE SENS ENVIRON, V79, P84, DOI 10.1016/S0034-4257(01)00241-3; Leblanc SG, 2005, CAN J REMOTE SENS, V31, P364, DOI 10.5589/m05-020; Levick SR, 2009, BIOL CONSERV, V142, P1693, DOI 10.1016/j.biocon.2009.03.004; LI XW, 1992, IEEE T GEOSCI REMOTE, V30, P276, DOI 10.1109/36.134078; Lucas RM, 2006, REMOTE SENS ENVIRON, V100, P407, DOI 10.1016/j.rse.2005.10.019; Lucas RM, 2006, REMOTE SENS ENVIRON, V100, P388, DOI 10.1016/j.rse.2005.09.020; Lucht W, 2000, IEEE T GEOSCI REMOTE, V38, P977, DOI 10.1109/36.841980; Ludwig JA, 1999, LANDSCAPE ECOL, V14, P557, DOI 10.1023/A:1008112122193; Maignan F, 2004, REMOTE SENS ENVIRON, V90, P210, DOI 10.1016/j.rse.2003.12.006; Morisette JT, 2002, REMOTE SENS ENVIRON, V83, P77, DOI 10.1016/S0034-4257(02)00088-3; Ni WG, 1999, IEEE T GEOSCI REMOTE, V37, P987, DOI 10.1109/36.752217; NORMAN P, 2003, 1 BUR RUR SCI NAT FO; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pinty B, 2002, IEEE T GEOSCI REMOTE, V40, P1560, DOI 10.1109/TGRS.2002.801148; Pisek J, 2010, ISPRS J PHOTOGRAMM, V65, P341, DOI 10.1016/j.isprsjprs.2010.03.002; Prior LD, 2003, FUNCT ECOL, V17, P504, DOI 10.1046/j.1365-2435.2003.00761.x; Privette JL, 2004, GLOBAL CHANGE BIOL, V10, P281, DOI 10.1111/j.1365-2486.2004.00740.x; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; Roman MO, 2010, REMOTE SENS ENVIRON, V114, P738, DOI 10.1016/j.rse.2009.11.014; Roman MO, 2009, REMOTE SENS ENVIRON, V113, P2476, DOI 10.1016/j.rse.2009.07.009; ROUJEAN JL, 1992, J GEOPHYS RES-ATMOS, V97, P20455, DOI 10.1029/92JD01411; Sandmeier S, 1998, REMOTE SENS ENVIRON, V66, P222, DOI 10.1016/S0034-4257(98)00060-1; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sano EE, 2010, ENVIRON MONIT ASSESS, V166, P113, DOI 10.1007/s10661-009-0988-4; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Schaaf C, 2008, ADVANCES IN LAND REMOTE SENSING: SYSTEM, MODELING, INVERSION AND APPLICATION, P219, DOI 10.1007/978-1-4020-6450-0_9; WALTHALL C, 2000, REMOTE SENSING REV, V18, P503, DOI DOI 10.1080/02757250009532399; Wang ZS, 2011, REMOTE SENS ENVIRON, V115, P1595, DOI 10.1016/j.rse.2011.02.010; Wanner W, 1997, J GEOPHYS RES-ATMOS, V102, P17143, DOI 10.1029/96JD03295; WANNER W, 1995, J GEOPHYS RES-ATMOS, V100, P21077, DOI 10.1029/95JD02371; Widlowski JL, 2001, GEOPHYS RES LETT, V28, P4639, DOI 10.1029/2001GL013490; Williams RJ, 1997, ECOLOGY, V78, P2542, DOI 10.1890/0012-9658(1997)078[2542:LPOWSI]2.0.CO;2; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x	74	39	42	2	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	AUG 15	2011	115	8					2008	2024		10.1016/j.rse.2011.04.003	http://dx.doi.org/10.1016/j.rse.2011.04.003			17	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	785NJ					2022-09-04	WOS:000292235400019
J	Medina, A; Altamar, G; Fernandez-Avila, DG; Leal, J; Castro, E; Rivera, A; Gomez, A; Garcia, L; Lancheros, A; Paez, R; Velez, L; Rivera, MC; Chaparro, W; Suarez, D; Rodriguez, C; Filizzola, V; Martinez, S; Riveros, E; Olarte, C; Morales, D; Rosero, O; Castro, CA				Medina, Adriana; Altamar, Geraldine; Fernandez-Avila, Daniel G.; Leal, Jaime; Castro, Edgar; Rivera, Alejandra; Gomez, Amparo; Garcia, Luisa; Lancheros, Andres; Paez, Rodolfo; Velez, Lina; Claudia Rivera, Maria; Chaparro, Walter; Suarez, Daniel; Rodriguez, Cesar; Filizzola, Viviana; Martinez, Saul; Riveros, Emilio; Olarte, Carlos; Morales, Diana; Rosero, Oscar; Alberto Castro, Carlos			Clinical characteristics and impact of treatment gap of fragility fractures in Colombia: experience of 10 Fracture Liaison Services (FLS)	JOURNAL OF GERONTOLOGY AND GERIATRICS			English	Article						osteoporosis; fractures bone; hip fractures; mortality; registries; therapy	OSTEOPOROSIS; PREVALENCE	Background & aims. Fragility fractures are those caused by low-energy trauma or falls from standing height. The mortality after the first year of suffering a hip fracture ranges from 15 to 30%. This problem has been addressed through the creation of interdisciplinary programs for fragility fracture early diagnosis and prevention. Describing the clinical characteristics of a cohort of patients diagnosed with fragility fractures in 10 fracture liaison services in Colombia. Methods. Led by the Asociacion Colombiana de Osteoporosis y Metabolismo Mineral, this is a cross-sectional descriptive study, in patients with a diagnosis of fragility fracture in 10 fracture liaison services. Demographic and clinical variables were described for one year from the diagnosis of the fracture. Results. were analyzed 1699 records of patient fractures between 50 and 101 years of age, 1334 were women (76.5%), 581/1484 (39.1%) had previous fragility fractures, 570/1599 (35.7%) had a previous diagnosis of osteoporosis. Of these, 70/1051 (7%) received anti-osteoporosis medication, and 311/733 (42.4%) received it post-fracture. Of the total records with information, 65/707 (9.2%) died the following year of the fracture. Conclusions. Fracture prevention programs in institutions allow for detecting patients with fragility fractures, clinical characteristics of these, in addition to strengthening the conditions of a centralized national registry, based on the parameters of the International Osteoporosis Foundation - Capture the Fracture program, through strategies with multidisciplinary personnel.	[Medina, Adriana] Fdn Univ Ciencias Salud, Hosp San Jose, Endocrinol Serv, Asociac Colombiana Osteoporosis & Metab Mineral A, Kr 19 8A-32, Bogota, Colombia; [Altamar, Geraldine] Hosp Univ Valle, Geriatr Serv, Cali, Colombia; [Fernandez-Avila, Daniel G.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Rheumatol Unit, Bogota, Colombia; [Leal, Jaime; Gomez, Amparo; Garcia, Luisa] Hosp Univ La Samaritana, Orthoped Serv, Bogota, Colombia; [Castro, Edgar] Hosp Caldas, Geriatr Serv, Manizales, Colombia; [Rivera, Alejandra] Hosp San Jose, Endocrinol Serv, Bogota, Colombia; [Lancheros, Andres] Hosp Univ La Samaritana, Endocrinol Serv, Bogota, Colombia; [Paez, Rodolfo] Fdn Univ Ciencias Salud, Hosp San Jose, Orthoped Serv, Bogota, Colombia; [Velez, Lina] Hosp Univ San Vicente Fdn, Orthoped Serv, Medellin, Colombia; [Claudia Rivera, Maria; Chaparro, Walter] Hosp Univ Clin San Rafael, Endocrinol Serv, Bogota, Colombia; [Suarez, Daniel] Hosp Univ Clin San Rafael, Gynecol & Obstet Serv, Bogota, Colombia; [Rodriguez, Cesar] Hosp San Blas, Orthoped Serv, Bogota, Colombia; [Filizzola, Viviana] Hosp San Blas, Endocrinol Serv, Bogota, Colombia; [Martinez, Saul; Riveros, Emilio] Hosp Santa Clara, Orthoped Serv, Bogota, Colombia; [Olarte, Carlos] Hosp Univ Fdn Santa Fe Bogota, Orthoped Serv, Bogota, Colombia; [Morales, Diana] Hosp Univ Fdn Santa Fe Bogota, Geriatr Serv, Bogota, Colombia; [Rosero, Oscar] Asociac Colombiana Osteoporosis & Metab Mineral A, Bogota, Colombia; [Alberto Castro, Carlos] Fdn Univ Ciencias Salud, SIIES Consultores SAS, Bogota, Colombia		Medina, A (corresponding author), Fdn Univ Ciencias Salud, Hosp San Jose, Endocrinol Serv, Asociac Colombiana Osteoporosis & Metab Mineral A, Kr 19 8A-32, Bogota, Colombia.	adrimedor@hotmail.com	Leal, Jaime/FWB-9375-2022; Leal, Jaime Andrés/AGX-1915-2022	Leal, Jaime/0000-0002-0667-1134; rosero, francisco oscar/0000-0002-1002-4546	Asociacion Colombiana de Osteoporosis y Metabolismo Mineral (ACOMM); Lilly laboratories	Asociacion Colombiana de Osteoporosis y Metabolismo Mineral (ACOMM); Lilly laboratories	This study was funded by the Asociacion Colombiana de Osteoporosis y Metabolismo Mineral (ACOMM) and by Lilly laboratories (2019). The authors and FLSs did not receive any fees for their participation in this study. None of the authors declares conflicts of interest.	Alarcon T, 2015, REV ESP SALUD PUBLIC, V89, P117, DOI 10.4321/S1135-57272015000100013; Butista K., 2018, REV REPERTORIO MED C, V27, P30; Clark P, 2009, OSTEOPOROSIS INT, V20, P275, DOI 10.1007/s00198-008-0657-4; Cohn MR, 2018, J ORTHOP TRAUMA, V32, P480, DOI 10.1097/BOT.0000000000001244; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; Cuddihy MT, 2002, ARCH INTERN MED, V162, P421, DOI 10.1001/archinte.162.4.421; Dang DY, 2019, J AM ACAD ORTHOP SUR, V27, pE85, DOI 10.5435/JAAOS-D-17-00103; Dell R, 2011, OSTEOPOROSIS INT, V22, pS457, DOI 10.1007/s00198-011-1712-0; Fernandez-Avila DG, 2019, ARCH OSTEOPOROS, V14, DOI 10.1007/s11657-019-0646-6; Hermoso de Mendoza M.T., 2003, Anales Sis San Navarra, V26, P29, DOI 10.4321/s1137-66272003000600004; Huntjens Kirsten M B, 2014, J Bone Joint Surg Am, V96, pe29, DOI 10.2106/JBJS.L.00223; IOF, 2015, GAPS SOL BON HLTH GL; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Lim JY, 2019, ANN GERIATR MED RES, V23, P1, DOI 10.4235/agmr.19.0011; Marsh D, 2011, OSTEOPOROSIS INT, V22, P2051, DOI 10.1007/s00198-011-1642-x; Medina-Orjuela Adriana, 2018, Rev.Colomb.Reumatol., V25, P184, DOI 10.1016/j.rcreu.2018.02.006; Nikkel LE, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6246; Nordstrom P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h696; Ong T, 2018, AGE AGEING, V47, P17, DOI 10.1093/ageing/afx079; Sanchez-Riera L, 2017, BEST PRACT RES CL RH, V31, P169, DOI 10.1016/j.berh.2017.10.001; Vallejo-González Santiago, 2020, Acta Med Colomb, V45, P16, DOI 10.36104/amc.2020.1319; WATTS NB, 1991, J FAM PRACTICE, V32, P261	22	0	0	0	0	PACINI EDITORE	PISA	VIA DELLA GHERARDESCA-ZONA INDUSTRIALE OSPEDALETTO, 56121 PISA, ITALY	2499-6564			J GERONTOL GERIATR	J. Gerontol. Geriatr.	JUN	2021	69	3					147	154		10.36150/2499-6564-N307	http://dx.doi.org/10.36150/2499-6564-N307			8	Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	XQ8DJ		hybrid			2022-09-04	WOS:000731772800001
J	Rivera, LMS; Avila, DF; Molano, WB; Arroyave, DJ; Ramirez, AJB; Maldonado, AD; Izquierdo, JH; Jauregui, E; Munoz, MCL; Restrepo, JP; Charry, JSS				Saldarriaga Rivera, Lina Maria; Fernandez Avila, Daniel; Bautista Molano, Wilson; Jaramillo Arroyave, Daniel; Bautista Ramirez, Alain Jasaf; Diaz Maldonado, Adriana; Hernan Izquierdo, Jorge; Jauregui, Edwin; Latorre Munoz, Maria Constanza; Pablo Restrepo, Juan; Segura Charry, Juan Sebastian			Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology	REUMATOLOGIA CLINICA			Spanish	Article						Immunosuppression; Immunomodulation; Treatment; SARS-CoV-2/COVID-19	SYSTEMIC-LUPUS-ERYTHEMATOSUS; MYCOPHENOLATE-MOFETIL; RISK; ARTHRITIS; METHOTREXATE; LEFLUNOMIDE; PNEUMONIA; TOXICITY; COVID-19; EFFICACY	Objective: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. Materials and methods: The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. Results: A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. Conclusion: The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19. (C) 2020 Elsevier Espana, S.L.U. and Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.	[Saldarriaga Rivera, Lina Maria] Univ Tecnol Pereira, Hosp Univ San Jorge, Clin Los Rosales, Unidad Reumatol,Dept Med Interna, Pereira, Colombia; [Fernandez Avila, Daniel] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Fac Med, Unidad Reumatol,Dept Med Interna, Bogota, Colombia; [Bautista Molano, Wilson] Univ Bosque, Hosp Univ Fdn Santa Fe Bogota, Secc Reumatol, Bogota, Colombia; [Jaramillo Arroyave, Daniel] Univ CES, IPS Univ Antioquia, Serv Reumatol, Medellin, Colombia; [Bautista Ramirez, Alain Jasaf] Hosp Santa Sofia, Dept Med Interna, Unidad Reumatol, Manizales, Colombia; [Diaz Maldonado, Adriana] Fdn HOMI, Inst Roosevelt, Care Kids, Unidad Reumatol Pediat, Bogota, Colombia; [Hernan Izquierdo, Jorge] Clin Occidente SA, Unidad Reumatol, Cali, Colombia; [Jauregui, Edwin] Riesgo Fractura SA CAYRE IPS, Epidemiol Clin, Unidad Reumatol, Bogota, Colombia; [Latorre Munoz, Maria Constanza] Country Med Ctr, Unidad Reumatol, Bogota, Colombia; [Pablo Restrepo, Juan] Consultorio Privado Clin Cent Quindio, Armenia, Colombia; [Segura Charry, Juan Sebastian] Clin Medilaser, Unidad Reumatol, Neiva, Colombia		Rivera, LMS (corresponding author), Univ Tecnol Pereira, Hosp Univ San Jorge, Clin Los Rosales, Unidad Reumatol,Dept Med Interna, Pereira, Colombia.	vasculitisreumato@gmail.com	Rodriguez, Juan Sebastian Charry/AAL-9545-2021; Rodriguez, Juan Sebastian Charry/AAM-3783-2021; Bautista-Molano, Wilson/Y-8316-2019	Rodriguez, Juan Sebastian Charry/0000-0002-3199-6723; Rodriguez, Juan Sebastian Charry/0000-0002-6321-4474; Bautista-Molano, Wilson/0000-0003-0684-9542; Fernandez-Avila, Daniel/0000-0003-1490-1822				Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; AMOS RS, 1986, BMJ-BRIT MED J, V293, P420, DOI 10.1136/bmj.293.6544.420; Australian Rheumatology Association, 2020, ADV GPS OTH HLTH PRO; Bernatsky S, 2007, RHEUMATOLOGY, V46, P1157, DOI 10.1093/rheumatology/kem076; Bird P, 2013, J RHEUMATOL, V40, P228, DOI 10.3899/jrheum.120922; BUSSEL JB, 1995, IMMUNOL INVEST, V24, P451, DOI 10.3109/08820139509062794; BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110; Cao W, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa102; Clinical Trials.gov, 2020, STUD EV SAF EFF TOC; ClinicalTrials.gov, 2020, BAR SYMPT PAT INF CO; ClinicalTrials.gov, 2020, TREATM MOD SEV COR D; ClinicalTrials.gov, 2020, COLCH COR SARS COV2; ClinicalTrials.gov, 2020, TOFACITINIB SARS COV; ClinicalTrials.gov, 2020, EFF SAF TOC TREATM S; ClinicalTrials.gov, 2020, EFF INTR IMM THER SE; ClinicalTrials.gov, SAF EFF BAR COVID 19; Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Day Michael, 2020, BMJ, V368, pm1086, DOI 10.1136/bmj.m1086; Day M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1168; Deodhar A, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1882-2; EMA, 2020, EUR MED AG ROACTEMRA; European League Against Rheumatism, 2020, EULAR EULAR GUID PAT; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Favalli EG, 2020, LANCET INFECT DIS, V20, P1012, DOI 10.1016/S1473-3099(20)30262-0; Favalli EG, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102523; Feldmann M, 2020, LANCET, V395, P1407, DOI 10.1016/S0140-6736(20)30858-8; Fernandez-Ávila Daniel G., 2020, Rev.Colomb.Reumatol., V27, P177, DOI 10.1016/j.rcreu.2019.04.001; Fessler BJ, 2002, BEST PRACT RES CL RH, V16, P281, DOI 10.1053/berh.2001.0226; FitzGerald GA, 2020, SCIENCE, V367, P1434, DOI 10.1126/science.abb8034; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Genestier L, 1998, J CLIN INVEST, V102, P322, DOI 10.1172/JCI2676; Germano V, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-77; Gomez-Marin Jorge E., 2020, Infect., V24, P1, DOI 10.22354/in.v24i3.896; Greenberg SB, 2002, CRIT CARE CLIN, V18, P931, DOI 10.1016/S0749-0704(02)00022-2; Hu SCS, 2016, J AM ACAD DERMATOL, V75, P49, DOI 10.1016/j.jaad.2015.12.059; INGLOT AD, 1969, J GEN VIROL, V4, P203, DOI 10.1099/0022-1317-4-2-203; Jones G, 2010, CLIN MED INSIGHTS-AR, V3, P81, DOI 10.4137/CMAMD.S4864; Kalb RE, 2015, JAMA DERMATOL, V151, P961, DOI 10.1001/jamadermatol.2015.0718; Kang I, 2003, CURR OPIN RHEUMATOL, V15, P528, DOI 10.1097/00002281-200309000-00002; Kobashigawa J, 1998, TRANSPLANTATION, V66, P507, DOI 10.1097/00007890-199808270-00016; Kotch C, 2019, EXPERT REV CLIN IMMU, V15, P813, DOI 10.1080/1744666X.2019.1629904; Le RQ, 2018, ONCOLOGIST, V23, P943, DOI 10.1634/theoncologist.2018-0028; Lee GE, 2018, J MICROBIOL BIOTECHN, V28, P1716, DOI 10.4014/jmb.1807.06054; Lee YH, 2011, RHEUMATOL INT, V31, P1493, DOI 10.1007/s00296-010-1526-y; Lew TWK, 2003, JAMA-J AM MED ASSOC, V290, P374, DOI 10.1001/jama.290.3.374; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305; Luo P, 2020, J MED VIROL, V92, P814, DOI 10.1002/jmv.25801; Mola EM, 2013, REUMATOL CLIN, V9, P5, DOI 10.1016/j.reuma.2012.05.001; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Ministerio de Salud y Proteccion Social de Colombia, 0018 MIN SAL PROT SO; National Health Services, 2020, CLIN GUID MAN RHEUM; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Panek JJ, 2005, J CHEM INF MODEL, V45, P39, DOI 10.1021/ci049754d; Papp KA, 2017, BRIT J DERMATOL, V177, P1537, DOI 10.1111/bjd.15723; Pierce LR, 2003, TRANSFUS MED REV, V17, P241, DOI 10.1016/S0887-7963(03)00038-5; Qiao WL, 2015, CARDIOLOGY, V131, P97, DOI 10.1159/000375362; Ramos-Casals M, 2013, REV CLIN ESP, V213, P42, DOI 10.1016/j.rce.2012.10.004; Richardson P, 2020, LANCET, V395, pE30, DOI 10.1016/S0140-6736(20)30304-4; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101613; Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2; Sarmiento JM, 2000, CLIN TRANSPLANT, V14, P136, DOI 10.1034/j.1399-0012.2000.140206.x; SINGH G, 1989, ARTHRITIS RHEUM, V32, P837; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Smitten AL, 2008, J RHEUMATOL, V35, P387; Smolen JS, 2019, J RHEUMATOL, V46, P7, DOI 10.3899/jrheum.171361; Steurer J, 2011, SKELETAL RADIOL, V40, P959, DOI 10.1007/s00256-011-1145-z; Strand V, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0880-2; Teichmann LL, 2008, RHEUMATOLOGY, V47, P1256, DOI 10.1093/rheumatology/ken234; Terkeltaub RA, 2011, ARTHRITIS RHEUM-US, V63, P2226, DOI 10.1002/art.30389; US Food and Drug Administration, 2020, FDA ADV PAT US NONST; Vallet H, 2011, J RHEUMATOL, V38, P965, DOI 10.3899/jrheum.100818; Wingfield T, 2011, RHEUMATOLOGY, V50, P1725, DOI 10.1093/rheumatology/ker210; Wu KK, 2020, J DERMATOL TREAT, V31, P359, DOI 10.1080/09546634.2019.1597246; Xu M., 2020, CELL RES, P269, DOI DOI 10.1038/s41422-020-0282-0; Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954	77	2	2	1	2	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1699-258X	1885-1398		REUMATOL CLIN	Reumatol. Clin.	NOV-DEC	2020	16	6					437	446		10.1016/j.reuma.2020.06.011	http://dx.doi.org/10.1016/j.reuma.2020.06.011			10	Rheumatology	Emerging Sources Citation Index (ESCI)	Rheumatology	OH7UX	32800760	Green Published, Bronze			2022-09-04	WOS:000582800100001
J	Sychev, DA; Ashraf, GM; Svistunov, AA; Maksimov, ML; Tarasov, VV; Chubarev, VN; Otdelenov, VA; Denisenko, NP; Barreto, GE; Aliev, G				Sychev, Dmitrij A.; Ashraf, Ghulam Md; Svistunov, Andrey A.; Maksimov, Maksim L.; Tarasov, Vadim V.; Chubarev, Vladimir N.; Otdelenov, Vitalij A.; Denisenko, Natal'ja P.; Barreto, George E.; Aliev, Gjumrakch			The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo	DRUG DESIGN DEVELOPMENT AND THERAPY			English	Review						cytochrome CYP450; drug interaction; drug metabolism; phenotyping	HUMAN LIVER-MICROSOMES; CYP2C9-ASTERISK-3 ALLELE; METABOLIZING-ENZYMES; HEALTHY-VOLUNTEERS; HUMAN HEPATOCYTES; CYP3A ACTIVITY; PHARMACOKINETICS; LOSARTAN; CYP2C9; INDUCTION	Cytochrome (CYP) 450 isoenzymes are the basic enzymes involved in Phase I biotransformation. The most important role in biotransformation belongs to CYP3A4, CYP2D6, CYP2C9, CYP2C19 and CYP1A2. Inhibition and induction of CYP isoenzymes caused by drugs are important and clinically relevant pharmacokinetic mechanisms of drug interaction. Investigation of the activity of CYP isoenzymes by using phenotyping methods (such as the determination of the concentration of specific substrates and metabolites in biological fluids) during drug administration provides the prediction of negative side effects caused by drug interaction. In clinical practice, the process of phenotyping of CYP isoenzymes and some endogenous substrates in the ratio of cortisol to 6 beta-hydroxycortisol in urine for the evaluation of CYP3A4 activity has been deemed to be a quite promising, safe and minimally invasive method for patients nowadays.	[Sychev, Dmitrij A.; Otdelenov, Vitalij A.; Denisenko, Natal'ja P.] Russian Med Acad Postgrad Educ Studies, Moscow, Russia; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Svistunov, Andrey A.; Tarasov, Vadim V.; Chubarev, Vladimir N.] Sechenov First Moscow State Med Univ, Moscow, Russia; [Maksimov, Maksim L.] Kazan State Med Acad, Russian Med Acad Continuous Profess Educ, Minist Healthcare Russian Federat, Fed State Budgetary Educ Inst Further Profess Edu, Branch Campus, Kazan, Russia; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr 330, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka, Russia		Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr 330, San Antonio, TX 78229 USA.	aliev03@gmail.com	Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./AAD-7420-2020; Ashraf, Ghulam Md/H-9485-2012; Maksimov, Maksim/AAU-3086-2021; Chubarev, Vladimir N/J-4321-2017; Aliev, Gjumrakch/K-7302-2017; скворцова, вера/AAL-2668-2020; Denisenko, Natalia/O-8728-2017	Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Ashraf, Ghulam Md/0000-0002-9820-2078; Chubarev, Vladimir N/0000-0002-7047-1436; скворцова, вера/0000-0002-8032-0308; Dmitry, Sychev/0000-0002-4496-3680; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994	Russian Science Foundation [PHF 14-23-00160Pi]	Russian Science Foundation(Russian Science Foundation (RSF))	Gjumrakch Aliev's work was supported by a grant from the Russian Science Foundation (directed design, synthesis and study of biological activity of multitarget compounds as innovative drugs for the treatment of neurodegenerative diseases: PHF 14-23-00160 Pi). Gjumrakch Aliev is also grateful for the equipment of Center for Collective Use, Institute of Physiologically Active Compounds of Russian Academy of Sciences Chernogolovka, Russia, that was used for this review.	Akiyoshi T, 2013, DRUG METAB PHARMACOK, V28, P411, DOI 10.2133/dmpk.DMPK-12-RG-134; Ayari I, 2013, MOL MED REP, V7, P280, DOI 10.3892/mmr.2012.1164; Azzalis LA, 2012, DRUG CHEM TOXICOL, V35, P324, DOI 10.3109/01480545.2011.619192; Backman JT, 1996, CLIN PHARMACOL THER, V59, P7, DOI 10.1016/S0009-9236(96)90018-1; Bae JW, 2009, ARCH PHARM RES, V32, P269, DOI 10.1007/s12272-009-1232-z; Berka K, 2011, J PHYS CHEM A, V115, P11248, DOI 10.1021/jp204488j; Bertilsson L, 1997, BRIT J CLIN PHARMACO, V44, P186, DOI 10.1046/j.1365-2125.1997.00630.x; Bibi Z, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-27; Bjorkhem-Bergman L, 2013, DRUG METAB DISPOS, V41, P1488, DOI 10.1124/dmd.113.052316; Brewer L, 2013, PHARM MED, V27, P9, DOI [10.1007/s40290-013-0008-4, DOI 10.1007/s40290-013-0008-4]; Chan AT, 2009, GASTROENTEROLOGY, V136, P2127, DOI 10.1053/j.gastro.2009.02.045; Chen G, 2006, METHOD FIND EXP CLIN, V28, P19, DOI 10.1358/mf.2006.28.1.962773; Chesne C, 1998, XENOBIOTICA, V28, P1, DOI 10.1080/004982598239704; Coller JK, 2002, BRIT J CLIN PHARMACO, V54, P157, DOI 10.1046/j.1365-2125.2002.01614.x; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; de Andres F, 2014, BIOANALYSIS, V6, P683, DOI 10.4155/bio.14.20; Diczfalusy U, 2011, BRIT J CLIN PHARMACO, V71, P183, DOI 10.1111/j.1365-2125.2010.03773.x; Dorado P, 2014, PHARMACOGENOMICS, V15, P1417, DOI [10.2217/pgs.14.85, 10.2217/PGS.14.85]; Eagling VA, 1997, BRIT J CLIN PHARMACO, V44, P190, DOI 10.1046/j.1365-2125.1997.00644.x; Ekhart C, 2008, PHARMACOGENET GENOM, V18, P515, DOI 10.1097/FPC.0b013e3282fc9766; Feghali M, 2015, SEMIN PERINATOL, V39, P512, DOI 10.1053/j.semperi.2015.08.003; FLEISHAKER JC, 1995, J PHARM SCI, V84, P292, DOI 10.1002/jps.2600840305; Fontana RJ, 1999, GASTROENTEROLOGY, V117, P89, DOI 10.1016/S0016-5085(99)70554-8; Fowler S, 2008, AAPS J, V10, P410, DOI 10.1208/s12248-008-9042-7; GARFINKEL D, 1958, ARCH BIOCHEM BIOPHYS, V77, P493, DOI 10.1016/0003-9861(58)90095-X; Gray J., 2009, CLIN PHARMACOL THER, V85, P125; Griskevicius L, 2003, EUR J CLIN PHARMACOL, V59, P103, DOI 10.1007/s00228-003-0590-6; Guo YJ, 2005, DRUG METAB DISPOS, V33, P749, DOI 10.1124/dmd.105.003616; Haertter Sebastian, 2013, Drug Metabolism and Drug Interactions, V28, P209, DOI 10.1515/dmdi-2013-0032; Hakooz N, 2007, CURR DRUG METAB, V8, P9, DOI 10.2174/138920007779315080; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Hodgson E, TXB MODERN TOXICOLOG; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Jiang XL, 2009, DRUG METAB DISPOS, V37, P443, DOI 10.1124/dmd.108.025056; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Karjalainen MJ, 2008, BASIC CLIN PHARMACOL, V103, P157, DOI 10.1111/j.1742-7843.2008.00252.x; Kasichayanula S, 2014, BRIT J CLIN PHARMACO, V78, P1122, DOI 10.1111/bcp.12425; Katoh M, 2000, PHARMACEUT RES, V17, P1189, DOI 10.1023/A:1007568811691; Kaukonen KM, 1998, EUR J CLIN PHARMACOL, V53, P445, DOI 10.1007/s002280050405; Kidd RS, 1999, PHARMACOGENETICS, V9, P71, DOI 10.1097/00008571-199902000-00010; Kirchheiner J, 2002, PHARMACOGENETICS, V12, P101, DOI 10.1097/00008571-200203000-00004; KLINGENBERG M, 1958, ARCH BIOCHEM BIOPHYS, V75, P376, DOI 10.1016/0003-9861(58)90436-3; Leil TA, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.18; Marde Arrhen Yvonne, 2013, Br J Clin Pharmacol, V75, P1536, DOI 10.1111/bcp.12016; McCrea JB, 1999, CLIN PHARMACOL THER, V65, P348, DOI 10.1016/S0009-9236(99)70114-1; Michaut A, 2014, LIVER INT, V34, pE171, DOI 10.1111/liv.12514; Morin S, 2001, EUR J CLIN PHARMACOL, V56, P793, DOI 10.1007/s002280000240; Murry DJ., 2007, J PHARM PRACT, V20, P206, DOI DOI 10.1177/0897190007304821; Niemi M, 2002, CLIN PHARMACOL THER, V72, P326, DOI 10.1067/mcp.2002.127495; Niioka T, 2007, EUR J CLIN PHARMACOL, V63, P1031, DOI 10.1007/s00228-007-0331-3; O'Hara GE, 2012, J CLIN PHARMACOL, V52, P171, DOI 10.1177/0091270011399574; Ogu C C, 2000, Proc (Bayl Univ Med Cent), V13, P421; Ohno M, 2009, BIOL PHARM BULL, V32, P813, DOI 10.1248/bpb.32.813; Peng CC, 2011, CLIN PHARMACOL THER, V89, P888, DOI 10.1038/clpt.2011.53; Pinto N, 2011, CURR DRUG METAB, V12, P487, DOI 10.2174/138920011795495321; Preskorn Sheldon H, 2007, J Psychiatr Pract, V13, P5, DOI 10.1097/00131746-200701000-00002; Prueksaritanont T, 2013, AAPS J, V15, P629, DOI 10.1208/s12248-013-9470-x; Rae JM, 2001, J PHARMACOL EXP THER, V299, P849; Rahimi R, 2012, EXPERT OPIN DRUG MET, V8, P691, DOI 10.1517/17425255.2012.680886; Rana R, 2010, DRUG METAB DISPOS, V38, P591, DOI 10.1124/dmd.109.030387; Ritter JM, 2008, TXB CLIN PHARM THERA, V5th; Rodrigues AD, 1997, DRUG METAB DISPOS, V25, P623; Roy J., 2011, INTRO PHARM SCI; Sekino K, 2003, EUR J CLIN PHARMACOL, V59, P589, DOI 10.1007/s00228-003-0664-5; Shin KH, 2013, CLIN PHARMACOL THER, V94, P601, DOI 10.1038/clpt.2013.128; Sirim D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-34; Spina E, 2008, CLIN THER, V30, P1206, DOI 10.1016/S0149-2918(08)80047-1; STEARNS RA, 1995, DRUG METAB DISPOS, V23, P207; Teo YL, 2015, BRIT J CLIN PHARMACO, V79, P241, DOI 10.1111/bcp.12496; Thunell S, 2007, BRIT J CLIN PHARMACO, V64, P668, DOI 10.1111/j.0306-5251.2007.02955.x; Tompkins LM, 2007, J BIOCHEM MOL TOXIC, V21, P176, DOI 10.1002/jbt.20180; Tutton R, 2014, PHARMACOGENOMICS, V15, P297, DOI 10.2217/pgs.13.198; VARHE A, 1994, CLIN PHARMACOL THER, V56, P601, DOI 10.1038/clpt.1994.184; VERONESE ME, 1991, BIOCHEM BIOPH RES CO, V175, P1112, DOI 10.1016/0006-291X(91)91680-B; Wadelius M, 1997, CLIN PHARMACOL THER, V62, P400, DOI 10.1016/S0009-9236(97)90118-1; Wedemeyer RS, 2014, DRUG SAFETY, V37, P201, DOI 10.1007/s40264-014-0144-0; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Wu XJ, 2014, EUR J CLIN PHARMACOL, V70, P57, DOI 10.1007/s00228-013-1573-x; Yang SH, 2011, ACTA PHARMACOL SIN, V32, P967, DOI 10.1038/aps.2011.32; Yasar U, 2002, CLIN PHARMACOL THER, V71, P89, DOI 10.1067/mcp.2002.121216; YUN CH, 1995, DRUG METAB DISPOS, V23, P285; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang Yi-fan, 2005, Yaoxue Xuebao, V40, P796	84	52	57	2	17	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-8881			DRUG DES DEV THER	Drug Des. Dev. Ther.		2018	12						1147	1156		10.2147/DDDT.S149069	http://dx.doi.org/10.2147/DDDT.S149069			10	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GF0UC	29780235	Green Published, Green Submitted, gold			2022-09-04	WOS:000431645600001
J	Cassiani-Miranda, CA; Campo-Arias, A; Tirado-Otalvaro, AF; Botero-Tobon, LA; Upegui-Arango, LD; Rodriguez-Verdugo, MS; Botero-Tobon, ME; Arismendy-Lopez, YA; Robles-Fonnegra, WA; Nino, L; Scoppetta, O				Cassiani-Miranda, Carlos Arturo; Campo-Arias, Adalberto; Tirado-Otalvaro, Andres Felipe; Botero-Tobon, Luz Adriana; Upegui-Arango, Luz Dary; Rodriguez-Verdugo, Maria Soledad; Botero-Tobon, Maria Elena; Arismendy-Lopez, Yinneth Andrea; Robles-Fonnegra, William Alberto; Nino, Levinson; Scoppetta, Orlando			Stigmatisation associated with COVID-19 in the general Colombian population	INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY			English	Article						Social stigma; fear; Coronavirus infections (source MeSH)	MENTAL-HEALTH; STIGMA; DISCRIMINATION; PREJUDICE; IMPACT; CARE; FEAR	Background: As the COVID-19 pandemic progresses, the fear of infection increases and, with it, the stigma-discrimination, which makes it an additional problem of the epidemic. However, studies about stigma associated with coronavirus are scarce worldwide. Aims: To determine the association between stigmatisation and fear of COVID-19 in the general population of Colombia. Method: A cross-sectional study was carried out. A total of 1,687 adults between 18 and 76 years old (M = 36.3; SD = 12.5), 41.1% health workers, filled out an online questionnaire on Stigma-Discrimination and the COVID-5 Fear Scale, adapted by the research team. Results: The proportion of high fear of COVID-19 was 34.1%; When comparing the affirmative answers to the questionnaire on stigma-discrimination towards COVID-19, it was found that the difference was significantly higher in the general population compared to health workers in most of the questions evaluated, which indicates a high level of stigmatisation in that group. An association between high fear of COVID-19 and stigma was evidenced in 63.6% of the questions in the questionnaire. Conclusion: Stigma-discrimination towards COVID-19 is frequent in the Colombian population and is associated with high levels of fear towards said disease, mainly people who are not health workers.	[Cassiani-Miranda, Carlos Arturo; Arismendy-Lopez, Yinneth Andrea] Univ Santander, UDES Neurosci Res Grp, Fac Hlth Sci, Med Program, Calle 70 55-210, Bucaramanga 680001, Santander, Colombia; [Cassiani-Miranda, Carlos Arturo; Campo-Arias, Adalberto; Tirado-Otalvaro, Andres Felipe; Botero-Tobon, Luz Adriana; Upegui-Arango, Luz Dary; Rodriguez-Verdugo, Maria Soledad; Botero-Tobon, Maria Elena; Arismendy-Lopez, Yinneth Andrea; Nino, Levinson] Int Network Stigma Reduct RED ESTIGMA, Bogota, Colombia; [Campo-Arias, Adalberto] Univ Magdalena, Hlth Psychol & Psychiat Res Grp, Med Program, Fac Hlth Sci, Santa Marta, Colombia; [Tirado-Otalvaro, Andres Felipe] Univ Pontificia Bolivariana, Fac Nursing, Care Res Grp, Medellin, Colombia; [Upegui-Arango, Luz Dary] Rhein Westfal TH Aachen, Univ Hosp, Inst Med Psychol & Med Sociol, Aachen, Germany; [Rodriguez-Verdugo, Maria Soledad] Univ Sonora, Mental Hlth & Addict Dept, Hermosillo, Sonora, Mexico; [Robles-Fonnegra, William Alberto] Pontificia Univ Javeriana, Dept Prevent & Social Med, Bogota, Colombia; [Nino, Levinson] Ctr Innovat Culture & Soc CENICS, Bogota, Colombia; [Scoppetta, Orlando] Univ Catolica Colombia, Fac Psychol, GAEM Grp Res Methods Appl Behav Sci, Bogota, Colombia		Cassiani-Miranda, CA (corresponding author), Univ Santander, UDES Neurosci Res Grp, Fac Hlth Sci, Med Program, Calle 70 55-210, Bucaramanga 680001, Santander, Colombia.	ca.cassiani@mail.udes.edu.co		Campo-Arias, Adalberto/0000-0003-2201-7404; Arismendy Lopez, Yinneth Andrea/0000-0002-7363-6777	Research Vice-rectory of Universidad del Magdalena [266]	Research Vice-rectory of Universidad del Magdalena	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was financed by the The Research Vice-rectory of Universidad del Magdalena through Resolution No 266 of 2020.	Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, NATURE, V580, P165, DOI 10.1038/d41586-020-01009-0; [Anonymous], 2003, J ADV NURS, V42, P546; Cassiani-Miranda CA, 2020, INDIAN J PSYCHIAT, V62, P610, DOI 10.4103/psychiatry.IndianJPsychiatry_506_20; Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9; Bruns DP, 2020, J TRANSCULT NURS, V31, P326, DOI 10.1177/1043659620917724; Budenz A, 2020, J MENT HEALTH, V29, P191, DOI 10.1080/09638237.2019.1677878; Budhwani H, 2019, HEALTH EQUITY, V3, P73, DOI 10.1089/heq.2018.0079; Campo-Arias Adalberto, 2015, rev.colomb.psiquiatr., V44, P243, DOI 10.1016/j.rcp.2015.04.003; Carey JW, 1997, PUBLIC HEALTH REP, V112, P66; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Cox WTL, 2012, PERSPECT PSYCHOL SCI, V7, P427, DOI 10.1177/1745691612455204; Devakumar D, 2020, LANCET, V395, P1194, DOI 10.1016/S0140-6736(20)30792-3; Dubey S, 2020, DIABETES METAB SYND, V14, P779, DOI 10.1016/j.dsx.2020.05.035; Eaton LA, 2020, J BEHAV MED, V43, P341, DOI 10.1007/s10865-020-00157-y; Fischer LS, 2019, DISASTER MED PUBLIC, V13, P989, DOI 10.1017/dmp.2018.157; Goffman E., 2009, ESTIGMA IDENTIDAD DE; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5; Herek GM, 2002, J LAW MED ETHICS, V30, P594, DOI 10.1111/j.1748-720X.2002.tb00428.x; Ho CLL, 2017, J PSYCHOSOC NURS MEN, V55, P38, DOI 10.3928/02793695-20170905-01; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812; Karamouzian M, 2018, SEX HEALTH, V15, P46, DOI 10.1071/SH17089; KATZ I, 1991, POLIT PSYCHOL, V12, P125, DOI 10.2307/3791349; Keys HM, 2019, ANTHROPOL MED, V26, P123, DOI 10.1080/13648470.2017.1368829; Klik KA, 2019, SOC SCI MED, V222, P35, DOI 10.1016/j.socscimed.2018.12.001; Lin C.Y., 2020, SOCIAL HLTH BEHAV, V3, P1, DOI [10.4103/SHB.SHB_11_20, DOI 10.4103/SHB.SHB_11_20]; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Logie CH, 2020, AIDS BEHAV, V24, P2003, DOI 10.1007/s10461-020-02856-8; Lupia T, 2020, J GLOB ANTIMICROB RE, V21, P22, DOI 10.1016/j.jgar.2020.02.021; MacLeod JS, 2003, EPILEPSY BEHAV, V4, P112, DOI 10.1016/S1525-5050(03)00007-6; Major B, 2002, ADV EXP SOC PSYCHOL, V34, P251, DOI 10.1016/S0065-2601(02)80007-7; Migliori, 2020, DEMYSTIFY COVID 19 R, DOI [10.5588/ijtld.20.0233, DOI 10.5588/IJTLD.20.0233]; Monterrosa-Castro A., 2020, MEDUNAB, V23, P195, DOI [10.29375/01237047.3890, DOI 10.29375/01237047.3890, https://doi.org/10.29375/01237047.3890, DOI 10.29375/01237047]; Ng E, 2020, AM J TROP MED HYG, V102, P1158, DOI 10.4269/ajtmh.20-0285; Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008; Orozco K., 2018, REV U IND SANTANDER, V50; Pachankis JE, 2018, PERS SOC PSYCHOL B, V44, P451, DOI 10.1177/0146167217741313; Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750; Pescosolido BA, 2015, ANNU REV SOCIOL, V41, P87, DOI 10.1146/annurev-soc-071312-145702; Phelan JC, 2008, SOC SCI MED, V67, P358, DOI 10.1016/j.socscimed.2008.03.022; Ransing R, 2020, BRAIN BEHAV IMMUN, V88, P32, DOI 10.1016/j.bbi.2020.05.049; Ransing R, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102085; Rao D, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1244-y; Ren SY, 2020, WORLD J CLIN CASES, V8, P652, DOI 10.12998/wjcc.v8.i4.652; Scheff T.J., 1971, BEING MENTALLY ILL S, P236; Schulze B, 2003, SOC SCI MED, V56, P299, DOI 10.1016/S0277-9536(02)00028-X; Shoib S, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102223; Singh R, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102222; Stangl AL, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1271-3; Taylor L, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3088; Turner-Musa J, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020168; Upegui A Luz D, 2014, Rev. Univ. Ind. Santander. Salud, V46, P22; Upegui-Arango Luz Dary, 2019, An. Fac. med., V80, P12, DOI 10.15381/anales.v80i1.15656; Villa S, 2020, CLIN MICROBIOL INFEC, V26, P1450, DOI 10.1016/j.cmi.2020.08.001; Wang MM, 2020, EUR J HEALTH ECON, V21, P665, DOI 10.1007/s10198-020-01202-y; Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689; Weiner B., 1995, JUDGMENTS RESPONSIBI, P326; Yoshioka T, 2020, J EPIDEMIOL, V30, P372, DOI 10.2188/jea.JE20200247	61	14	14	1	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0020-7640	1741-2854		INT J SOC PSYCHIATR	Int. J. Soc. Psychiatr.	SEP	2021	67	6					728	736	0020764020972445	10.1177/0020764020972445	http://dx.doi.org/10.1177/0020764020972445		NOV 2020	9	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	YR7SD	33161822	hybrid, Green Published			2022-09-04	WOS:000618427400001
J	Del Rio, JP; Molina, S; Hidalgo-Lanussa, O; Garcia-Segura, LM; Barreto, GE				Pablo Del Rio, Juan; Molina, Santiago; Hidalgo-Lanussa, Oscar; Miguel Garcia-Segura, Luis; Barreto, George E.			Tibolone as Hormonal Therapy and Neuroprotective Agent	TRENDS IN ENDOCRINOLOGY AND METABOLISM			English	Review							QUALITY-OF-LIFE; HEALTHY POSTMENOPAUSAL WOMEN; ESTROGEN PLUS PROGESTIN; CORONARY-HEART-DISEASE; REPLACEMENT THERAPY; DOUBLE-BLIND; BREAST-CANCER; NITRIC-OXIDE; IN-VITRO; CLINICAL RECOMMENDATIONS	Tibolone (TIB), a selective tissue estrogenic activity regulator (STEAR) in clinical use by postmenopausal women, activates hormonal receptors in a tissue-specific manner. Estrogenic activity is present mostly in the brain, vagina, and bone, while the inactive forms predominate in the endometrium and breast. Conflicting literature on TIB's actions has been observed. While it has benefits for vasomotor symptoms, bone demineralization, and sexual health, a higher relative risk of hormone-sensitive cancer has been reported. In the brain, TIB can improve mood and cognition, neuroinflammation, and reactive gliosis. This review aims to discuss the systemic effects of TIB on peri- and post-menopausal women and its role in the brain. We suggest that TIB is a hormonal therapy with promising neuroprotective properties.	[Pablo Del Rio, Juan] Reprod Hlth Res Inst, Santiago, Chile; [Pablo Del Rio, Juan] Univ Chile, Clin Psiquiatr Univ, Hosp Clin, Translat Psychiat Lab, Santiago, Chile; [Pablo Del Rio, Juan] Millennium Nucleus Improve Mental Hlth Adolescent, Santiago, Chile; [Molina, Santiago] Tallahassee Community Coll, Tallahassee, FL USA; [Hidalgo-Lanussa, Oscar] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota, Colombia; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Madrid, Spain; [Miguel Garcia-Segura, Luis] Inst Salud Carlos III, Ctr Invest Biomed Red Fragilidad & Envejecimiento, Madrid, Spain; [Barreto, George E.] Univ Limerick, Sch Nat Sci, Dept Biol Sci, Limerick, Ireland; [Barreto, George E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland		Barreto, GE (corresponding author), Univ Limerick, Sch Nat Sci, Dept Biol Sci, Limerick, Ireland.; Barreto, GE (corresponding author), Univ Limerick, Hlth Res Inst, Limerick, Ireland.	George.Barreto@ul.ie		Barreto, George E./0000-0002-6644-1971				Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Akgul C, 2002, INT J FERTIL WOMEN M, V47, P13; Albertazzi P, 2000, MATURITAS, V36, P223, DOI 10.1016/S0378-5122(00)00147-X; Aldred S, 1999, BRAIN RES BULL, V48, P291, DOI 10.1016/S0361-9230(98)00172-5; Alnouti Y, 2011, XENOBIOTICA, V41, P187, DOI 10.3109/00498254.2010.535923; Anagnostis P, 2017, MATURITAS, V99, P27, DOI 10.1016/j.maturitas.2017.02.009; Anagnostis P, 2016, INT J CLIN PRACT, V70, P967, DOI 10.1111/ijcp.12903; Andrabi SS, 2017, J ENVIRON PATHOL TOX, V36, P191, DOI 10.1615/JEnvironPatholToxicolOncol.2017017156; Archer DF, 2007, J CLIN ENDOCR METAB, V92, P911, DOI 10.1210/jc.2006-2207; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Baez E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00146; Bala M, 2017, PHARMACOL RES, V124, P64, DOI 10.1016/j.phrs.2017.07.024; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barrionuevo P, 2019, J CLIN ENDOCR METAB, V104, P1623, DOI 10.1210/jc.2019-00192; Beltran-Campos V, 2015, NEUROLOGIA, V30, P401, DOI 10.1016/j.nrl.2014.03.002; Berlanga C, 2003, J WOMEN HEALTH GEN-B, V12, P33, DOI 10.1089/154099903321154121; Bhawna G, 2013, J OBSTET GYN INDIA, V63, P194, DOI 10.1007/s13224-012-0297-7; Blumel JE, 2010, REV MED CHILE, V138, P645, DOI /S0034-98872010000500017; Bodine PVN, 2002, STEROIDS, V67, P681, DOI 10.1016/S0039-128X(02)00021-1; Borrow AP, 2017, VITAM HORM, V103, P27, DOI 10.1016/bs.vh.2016.08.004; Brusselaers N, 2018, ANN ONCOL, V29, P1771, DOI 10.1093/annonc/mdy212; Bundred NJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3097; Campisi R, 2007, CARDIOVASC DRUG REV, V25, P132, DOI 10.1111/j.1527-3466.2007.00007.x; Carswell HVO, 2004, AM J PHYSIOL-HEART C, V287, pH1501, DOI 10.1152/ajpheart.00227.2004; Cicinelli E, 2002, FERTIL STERIL, V78, P464, DOI 10.1016/S0015-0282(02)03295-8; Clarkson TB, 2006, EUR HEART J, V27, P635, DOI 10.1093/eurheartj/ehi724; Clarkson TB, 2004, MATURITAS, V48, pS24, DOI 10.1016/j.maturitas.2004.02.011; Collaborative Grp Hormonal Factors, 2019, LANCET, V394, P1159, DOI 10.1016/S0140-6736(19)31709-X; Colombo D, 2008, ARZNEIMITTELFORSCH, V58, P86, DOI 10.1055/s-0031-1296473; Coylewright M, 2008, HYPERTENSION, V51, P952, DOI 10.1161/HYPERTENSIONAHA.107.105742; Crespo-Castrillo A, 2018, MOL NEUROBIOL, V55, P8651, DOI 10.1007/s12035-018-1008-x; CRONA N, 1988, MATURITAS, V9, P303, DOI 10.1016/0378-5122(88)90095-3; CRONA N, 1983, ACTA ENDOCRINOL-COP, V102, P451, DOI 10.1530/acta.0.1020451; Cummings SR, 2008, NEW ENGL J MED, V359, P697, DOI 10.1056/NEJMoa0800743; Davis SR, 1997, J CLIN ENDOCR METAB, V82, P702; de Gooyer ME, 2001, MOL CELL ENDOCRINOL, V183, P55, DOI 10.1016/S0303-7207(01)00606-2; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; De Marinis E, 2011, IUBMB LIFE, V63, P140, DOI 10.1002/iub.426; Delmas PD, 2008, OSTEOPOROSIS INT, V19, P1153, DOI 10.1007/s00198-007-0545-3; Doren M, 2001, FERTIL STERIL, V75, P554, DOI 10.1016/S0015-0282(00)01768-4; Eden J, 2005, GYNECOL ENDOCRINOL, V21, P22, DOI 10.1080/09513590400030020; Eilertsen AL, 2019, BLOOD COAGUL FIBRIN, V30, P17, DOI 10.1097/MBC.0000000000000784; Eilertsen AL, 2007, THROMB RES, V120, P371, DOI 10.1016/j.thromres.2006.10.013; Escande A, 2009, J STEROID BIOCHEM, V116, P8, DOI 10.1016/j.jsbmb.2009.03.008; Espinosa-Raya J, 2012, HORM BEHAV, V61, P76, DOI 10.1016/j.yhbeh.2011.10.005; Cruz NAE, 2019, EXP CLIN ENDOCR DIAB, V127, P396, DOI 10.1055/a-0659-9928; Falany JL, 2004, J STEROID BIOCHEM, V88, P383, DOI 10.1016/j.jsbmb.2004.01.005; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; FARISH E, 1984, MATURITAS, V6, P297, DOI 10.1016/0378-5122(84)90046-X; Farmer R., 2005, MILLION WOMEN STUDY; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; Fluck E, 2002, J CLIN PSYCHOPHARM, V22, P62, DOI 10.1097/00004714-200202000-00010; Formoso G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008536.pub3; Frey Benicio N, 2008, Menopause Int, V14, P123, DOI 10.1258/mi.2008.008019; Frick KM, 2018, CURR OPIN BEHAV SCI, V23, P65, DOI 10.1016/j.cobeha.2018.03.011; Gallagher JC, 2001, J CLIN ENDOCR METAB, V86, P4717, DOI 10.1210/jc.86.10.4717; Garay RP, 2019, EXPERT OPIN PHARMACO, V20, P1837, DOI 10.1080/14656566.2019.1645122; Garefalakis M, 2008, CLIN INTERV AGING, V3, P1; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; Genazzani Andrea Riccardo, 2006, Neuropsychiatr Dis Treat, V2, P299, DOI 10.2147/nedt.2006.2.3.299; Genazzani AR, 2006, MENOPAUSE, V13, P57, DOI 10.1097/01.gme.0000191372.79052.d3; GENAZZANI AR, 1988, GYNECOL OBSTET INVES, V26, P153, DOI 10.1159/000293687; Gibbs RB, 2002, NEUROSCIENCE, V113, P907, DOI 10.1016/S0306-4522(02)00239-7; Gilglioni EH, 2013, J GERONTOL A-BIOL, V68, P510, DOI 10.1093/gerona/gls210; Godsland IF, 2001, FERTIL STERIL, V75, P898, DOI 10.1016/S0015-0282(01)01699-5; Gompel A, 2002, FERTIL STERIL, V78, P351, DOI 10.1016/S0015-0282(02)03203-X; Gordon JL, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01319; Gordon JL, 2018, JAMA PSYCHIAT, V75, P149, DOI 10.1001/jamapsychiatry.2017.3998; Grigorova M, 2006, PSYCHONEUROENDOCRINO, V31, P935, DOI 10.1016/j.psyneuen.2006.05.004; Guidolin D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111817; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Haenggi W, 1999, GYNECOL ENDOCRINOL, V13, P202, DOI 10.3109/09513599909167556; Hammar ML, 2007, BJOG-INT J OBSTET GY, V114, P1522, DOI 10.1111/j.1471-0528.2007.01537.x; Hampson E, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0972-1; Hidalgo-Lanussa O, 2020, J NEUROENDOCRINOL, V32, DOI 10.1111/jne.12776; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Hodis HN, 2011, BRAIN RES, V1379, P244, DOI 10.1016/j.brainres.2010.10.076; Hofling M, 2005, GYNECOL ENDOCRINOL, V20, P110, DOI 10.1080/09513590400021151; Hoibraaten E, 2000, THROMB HAEMOSTASIS, V84, P961; Huang AJ, 2018, MENOPAUSE, V25, P1286, DOI 10.1097/GME.0000000000001230; Huang KE, 2010, CLIMACTERIC, V13, P317, DOI 10.3109/13697131003681458; Huber J, 2002, BJOG-INT J OBSTET GY, V109, P886, DOI 10.1111/j.1471-0528.2002.01338.x; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Jamin C, 2006, Gynecol Obstet Fertil, V34, P224, DOI 10.1016/j.gyobfe.2006.01.027; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kenemans P, 2005, MATURITAS, V51, P21, DOI 10.1016/j.maturitas.2005.02.011; Kenemans P, 2009, LANCET ONCOL, V10, P135, DOI 10.1016/S1470-2045(08)70341-3; KHANNA M, 1995, J BIOL CHEM, V270, P20162, DOI 10.1074/jbc.270.34.20162; KICOVIC P M, 1982, Reproduccion, V6, P81; Kloosterboer HJ, 2011, CLIMACTERIC, V14, P609, DOI 10.3109/13697137.2011.580639; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kloosterboer HJ, 2004, MATURITAS, V49, pS5, DOI 10.1016/j.maturitas.2004.06.022; Koh KK, 2003, ARTERIOSCL THROM VAS, V23, P1889, DOI 10.1161/01.ATV.0000091502.96745.95; Kubista E, 2007, CLIN CANCER RES, V13, P4185, DOI 10.1158/1078-0432.CCR-06-2700; Kulkarni J, 2018, J AFFECT DISORDERS, V236, P88, DOI 10.1016/j.jad.2018.04.103; Laan E, 2001, Climacteric, V4, P28, DOI 10.1080/713605033; Liyou NE, 2003, J HISTOCHEM CYTOCHEM, V51, P1655, DOI 10.1177/002215540305101209; Lokkegaard ECL, 2018, INT J CANCER, V142, P2435, DOI 10.1002/ijc.31267; Manson JE, 2017, JAMA-J AM MED ASSOC, V318, P927, DOI 10.1001/jama.2017.11217; Maran A, 2006, BONE, V39, P523, DOI 10.1016/j.bone.2006.03.006; Marques LD, 2015, REV BRAS GINECOL OBS, V37, P233, DOI 10.1590/SO100-720320150005333; Mattson MP, 2002, PHYSIOL REV, V82, P637, DOI 10.1152/physrev.00004.2002; Mayyas F, 2017, CLIN EXP HYPERTENS, V39, P126, DOI 10.1080/10641963.2016.1226894; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Mendoza N, 2013, GYNECOL ENDOCRINOL, V29, P1, DOI 10.3109/09513590.2012.705378; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001; Miller E, 2018, EUR J DRUG METAB PH, V43, P415, DOI 10.1007/s13318-017-0458-2; Modelska K, 2002, J CLIN ENDOCR METAB, V87, P16, DOI 10.1210/jc.87.1.16; Morris EP, 1999, BRIT J OBSTET GYNAEC, V106, P954, DOI 10.1111/j.1471-0528.1999.tb08436.x; Muka T, 2016, JAMA CARDIOL, V1, P767, DOI 10.1001/jamacardio.2016.2415; Nardi A, 2009, J STEROID BIOCHEM, V115, P68, DOI 10.1016/j.jsbmb.2009.02.017; NathorstBoos J, 1997, MATURITAS, V26, P15, DOI 10.1016/S0378-5122(96)01069-9; Neri-Gomez T, 2017, NEURAL REGEN RES, V12, P588, DOI 10.4103/1673-5374.205098; NICE, 2015, MEN DIAGN MAN NICE G; Nijland EA, 2007, MATURITAS, V58, P164, DOI 10.1016/j.maturitas.2007.07.005; Norris LA, 2002, MATURITAS, V43, P125, DOI 10.1016/S0378-5122(02)00202-5; Notelovitz Morris, 2007, MedGenMed, V9, P2; Del Rio JP, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00141; PALACIOS S, 1995, MATURITAS, V22, P155, DOI 10.1016/0378-5122(95)00930-J; Palomba S, 2008, FERTIL STERIL, V90, P165, DOI 10.1016/j.fertnstert.2007.05.061; Pinkerton JV, 2017, MENOPAUSE, V24, P728, DOI 10.1097/GME.0000000000000921; Pinkerton JV, 2016, MENOPAUSE, V23, P215, DOI 10.1097/GME.0000000000000523; Pinto-Almazan R, 2018, NEURAL REGEN RES, V13, P440, DOI 10.4103/1673-5374.228726; Pinto-Almazan R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8630764; Pinto-Almazan R, 2014, REV NEUROLOGIA, V58, P441, DOI 10.33588/rn.5810.2013357; Polisseni AF, 2013, MATURITAS, V74, P172, DOI 10.1016/j.maturitas.2012.11.001; Pugazhenthi S, 2017, PROG MOL BIOL TRANSL, V146, P243, DOI 10.1016/bs.pmbts.2016.12.016; Quinn MM, 2018, FERTIL STERIL, V110, P790, DOI 10.1016/j.fertnstert.2018.07.1152; Reddy DS, 2016, TRENDS PHARMACOL SCI, V37, P543, DOI 10.1016/j.tips.2016.04.003; Rice MS, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0750-0; Rizner TL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00030; Roman M, 2016, CANCER EPIDEM BIOMAR, V25, P1464, DOI 10.1158/1055-9965.EPI-16-0240; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sadarangani A, 2005, BIOL RES, V38, P245, DOI 10.4067/S0716-97602005000200014; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Seeger H, 2007, MATURITAS, V58, P42, DOI 10.1016/j.maturitas.2007.04.011; Seeley Tony, 2006, J Br Menopause Soc, V12, P81, DOI 10.1258/136218006777525730; Sherman ME, 1997, MODERN PATHOL, V10, P963; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Simin J, 2017, EUR J CANCER, V84, P60, DOI 10.1016/j.ejca.2017.07.012; Simoncini T, 2004, J CLIN ENDOCR METAB, V89, P4594, DOI 10.1210/jc.2003-032189; Sjogren LL, 2016, MATURITAS, V91, P25, DOI 10.1016/j.maturitas.2016.05.013; Speth RC, 2018, AM J PHYSIOL-HEART C, V315, pH1765, DOI 10.1152/ajpheart.00041.2018; Stark J, 2015, GYNECOL ENDOCRINOL, V31, P31, DOI 10.3109/09513590.2014.943727; Steckelbroeck S, 2006, J PHARMACOL EXP THER, V316, P1300, DOI 10.1124/jpet.105.091587; Swanson SG, 2006, MENOPAUSE, V13, P917, DOI 10.1097/01.gme.0000247016.41007.c9; Swegle JM, 2004, ANN PHARMACOTHER, V38, P874, DOI 10.1345/aph.1D462; TAX L, 1987, MATURITAS, P3; Tenkorang MA, 2018, STEROIDS, V133, P21, DOI 10.1016/j.steroids.2017.12.010; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Tsilidis KK, 2011, CANCER CAUSE CONTROL, V22, P1075, DOI 10.1007/s10552-011-9782-z; Van Acker ZP, 2019, MOL NEUROBIOL, V56, P2101, DOI 10.1007/s12035-018-1212-8; van Rooijen M, 2004, AM J OBSTET GYNECOL, V190, P332, DOI 10.1016/S00020-9378(03)00950-5; Vassalle C, 2011, GYNECOL ENDOCRINOL, V27, P163, DOI 10.3109/09513590.2010.488770; Vegeto E., 2019, ENDOCR REV, V41; Vergouwen MDI, 2000, BRAIN RES, V878, P88, DOI 10.1016/S0006-8993(00)02713-X; Verheul HAM, 2006, J STEROID BIOCHEM, V102, P195, DOI 10.1016/j.jsbmb.2006.09.037; Verheul HAM, 2007, DRUG METAB DISPOS, V35, P1105, DOI 10.1124/dmd.106.014118; Verheul HAM, 2007, DRUG METAB DISPOS, V35, P1112, DOI 10.1124/dmd.106.014159; Verheul HAM, 2007, REPROD SCI, V14, P160, DOI 10.1177/1933719106298684; Volker W, 2001, Climacteric, V4, P203, DOI 10.1080/713605098; Vos RME, 2002, DRUG METAB DISPOS, V30, P106, DOI 10.1124/dmd.30.2.106; Wang M, 2006, STEROIDS, V71, P343, DOI 10.1016/j.steroids.2005.11.003; Weiser M, 2019, JAMA PSYCHIAT, V76, P1009, DOI 10.1001/jamapsychiatry.2019.1842; Wise PM, 2002, TRENDS ENDOCRIN MET, V13, P229, DOI 10.1016/S1043-2760(02)00611-2; Zandberg P, 1998, ARTERIOSCL THROM VAS, V18, P1844, DOI 10.1161/01.ATV.18.12.1844; Ziaei S, 2010, CLIMACTERIC, V13, P147, DOI 10.1080/13697130903009195; Zoma W, 2001, AM J OBSTET GYNECOL, V184, P544, DOI 10.1067/mob.2001.111098	172	5	5	1	7	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1043-2760	1879-3061		TRENDS ENDOCRIN MET	Trends Endocrinol. Metab.	OCT	2020	31	10					742	759		10.1016/j.tem.2020.04.007	http://dx.doi.org/10.1016/j.tem.2020.04.007			18	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	NY2DB	32507541				2022-09-04	WOS:000576205700005
J	Guirado, L; Crispi, F; Soveral, I; Valenzuela-Alcaraz, B; Rodriguez-Lopez, M; Garcia-Otero, L; Torres, X; Sepulveda-Martinez, A; Escobar-Diaz, MC; Martinez, JM; Friedberg, MK; Gratacos, E; Gomez, O				Guirado, Laura; Crispi, Fatima; Soveral, Iris; Valenzuela-Alcaraz, Brenda; Rodriguez-Lopez, Merida; Garcia-Otero, Laura; Torres, Ximena; Sepulveda-Martinez, Alvaro; Clara Escobar-Diaz, Maria; Maria Martinez, Josep; Friedberg, Mark K.; Gratacos, Eduard; Gomez, Olga			Nomograms of Fetal Right Ventricular Fractional Area Change by 2D Echocardiography	FETAL DIAGNOSIS AND THERAPY			English	Article						Cardiac function; Right ventricular; Fetal echocardiography; Fractional area change; Prenatal	MYOCARDIAL TISSUE DOPPLER; EUROPEAN ASSOCIATION; CARDIAC DIMENSIONS; PULSATILITY INDEX; AMERICAN SOCIETY; REFERENCE RANGES; GESTATIONAL-AGE; RIGHT HEART; PRETERM; DISEASE	Objectives: Fetal right ventricular (RV) function assessment is challenging due to the RV geometry and limitations of in utero assessment. Postnatally, 2D echocardiographic RV fractional area change (FAC) is used to assess RV global systolic function by calculating the percentage of change in RV area from systole to diastole. Reports on FAC are scarce in prenatal life, and nomograms throughout pregnancy are not available. Our aims were (1) to study prenatal RV FAC feasibility and reproducibility and (2) to construct nomograms for RV FAC and end-diastolic (ED) and end-systolic (ES) RV areas from 18 to 41 weeks of gestation. Methods: Prospective cohort study including 602 low-risk singleton pregnancies undergoing a fetal echocardiography from 18 to 41 weeks of gestation. RV ED and ES areas were measured following standard recommendations for ventricular dimensions and establishing strict landmarks to identify the different phases of the cardiac cycle. RV FAC was calculated as: ([ED area - ES area]/ED area) x 100. RV FAC intra- and inter-observer reproducibility was evaluated in 45 fetuses by calculating the intraclass correlation coefficient (ICC). Parametric regressions were tested to model each parameter against gestational age (GA) and estimated fetal weight (EFW). Results: RV areas and FAC were successfully obtained in similar to 99% of fetuses with acceptable reproducibility throughout gestation (RV ED area inter-observer ICC [95% CI] 0.96 [0.93-0.98], RV ES area 0.97 [0.94-0.98], and FAC 0.69 [0.44-0.83]). Nomograms were constructed for RV ED and ES areas and FAC. RV areas showed a quadratic and logarithmic increase with GA and EFW, respectively. In contrast, RV FAC showed a slight quadratic decrease throughout gestation (mean RV FAC ranged from 36% at 18 weeks of gestation [10-90th centiles: 25-47%, respectively] to 29% at 41 weeks [10-90th centiles: 18-40%, respectively]). The best models for RV areas and FAC were a second-degree polynomial. Conclusions: RV FAC is a feasible and reproducible parameter to assess RV global systolic function in fetal life. We provide reference ranges adjusted by GA and EFW that can be used as normal references for the assessment of RV function in prenatal conditions.	[Guirado, Laura; Crispi, Fatima; Soveral, Iris; Valenzuela-Alcaraz, Brenda; Rodriguez-Lopez, Merida; Garcia-Otero, Laura; Torres, Ximena; Sepulveda-Martinez, Alvaro; Maria Martinez, Josep; Gratacos, Eduard; Gomez, Olga] Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER,BCNatal, Inst Invest Biomed August Pi I Sunyer,Fetal Med R, Inst Clin Ginecol Obstet & Neonatol,Hosp Clin,Bar, Barcelona, Spain; [Guirado, Laura; Crispi, Fatima; Soveral, Iris; Valenzuela-Alcaraz, Brenda; Rodriguez-Lopez, Merida; Garcia-Otero, Laura; Torres, Ximena; Sepulveda-Martinez, Alvaro; Maria Martinez, Josep; Gratacos, Eduard; Gomez, Olga] Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, Inst Invest Biomed August Pi I Sunyer, Inst Clin Ginecol Obstet & Neonatol,Hosp St Joan, Barcelona, Spain; [Rodriguez-Lopez, Merida] Pontificia Univ Javeriana Secc Cali, Cali, Colombia; [Sepulveda-Martinez, Alvaro] Univ Chile, Dept Obstet & Gynecol, Fetal Med Unit, Hosp Clin, Santiago, Chile; [Clara Escobar-Diaz, Maria] Hosp St Joan Deu, Pediat Cardiol, Barcelona, Spain; [Friedberg, Mark K.] Hosp Sick Children, Labatt Family Heart Ctr, Div Cardiol, Toronto, ON, Canada; [Friedberg, Mark K.] Univ Toronto, Toronto, ON, Canada		Crispi, F (corresponding author), Hosp Clin Barcelona, Barcelona Ctr Maternal Fetal & Neonatal Med, BCNatal, Fetal Med Res Ctr, Sabino de Arana St 1, ES-08028 Barcelona, Spain.; Crispi, F (corresponding author), Hosp St Joan Deu, Sabino de Arana St 1, ES-08028 Barcelona, Spain.	fcrispi@clinic.cat	Sepulveda-Martinez, Alvaro/H-6546-2014; Rodriguez-Lopez, Merida/N-9273-2017	Sepulveda-Martinez, Alvaro/0000-0002-8364-2732; Rodriguez-Lopez, Merida/0000-0001-8245-0811; Gratacos, Eduard/0000-0002-7405-7224; Friedberg, Mark/0000-0002-4108-5560; Garcia-Otero, Laura/0000-0003-2766-5048; Soveral, Iris/0000-0002-3571-1780; Crispi, Fatima/0000-0002-7422-5240	Erasmus+ Programme of the European Union [2013-0040]; Hospital Clinic de Barcelona (Ajut Josep Font, Barcelona, Spain); "la Caixa" Foundation [LCF/PR/GN14/10270005, LCF/PR/GN18/10310003]; Instituto de Salud Carlos III [PI14/00226, PI15/00263, PI15/00130, INT16/00168, PI17/00675]; integrados en el Plan Nacional de I+D+I y cofinanciados por el ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa"; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR 2017 SGR grant [1531]; FI AGAUR [2016FI_B01184]; La Caixa Foundation (Spain); AGAUR 2014 SGR grant [928]; Instituto de Salud Carlos III as part of the Plan Nacional de I+D+I [PI14/00226, PI15/00263, PI15/00130, INT16/00168]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional "Otra manera de hacer Europa" (Spain)	Erasmus+ Programme of the European Union; Hospital Clinic de Barcelona (Ajut Josep Font, Barcelona, Spain); "la Caixa" Foundation(La Caixa Foundation); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); integrados en el Plan Nacional de I+D+I y cofinanciados por el ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa"; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR 2017 SGR grant; FI AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); La Caixa Foundation (Spain)(La Caixa Foundation); AGAUR 2014 SGR grant; Instituto de Salud Carlos III as part of the Plan Nacional de I+D+I(Instituto de Salud Carlos III); ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional "Otra manera de hacer Europa" (Spain)	This project has been funded with support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040). This publication reflects the views only of the author, and the Commission cannot be held responsible for any use, which may be made of the information contained therein. Additionally, the research leading to these results have received funding from Hospital Clinic de Barcelona (Ajut Josep Font, Barcelona, Spain), "la Caixa" Foundation (LCF/PR/GN14/10270005, LCF/PR/GN18/10310003), the Instituto de Salud Carlos III (PI14/00226, PI15/00263, PI15/00130, INT16/00168, PI17/00675), integrados en el Plan Nacional de I+D+I y cofinanciados por el ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa," Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK), and AGAUR 2017 SGR grant no 1531. L.G.-O. has received grant from FI AGAUR (2016FI_B01184). This study was supported by La Caixa Foundation (Spain); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR 2014 SGR grant no 928; and Instituto de Salud Carlos III (PI14/00226, PI15/00263, PI15/00130, and INT16/00168) as part of the Plan Nacional de I+D+I and co-funded by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional "Otra manera de hacer Europa" (Spain).	Anavekar NS, 2007, ECHOCARDIOGR-J CARD, V24, P452, DOI 10.1111/j.1540-8175.2007.00424.x; [Anonymous], 2006, Ultrasound Obstet Gynecol, V27, P107, DOI 10.1002/uog.2677; ARDUINI D, 1990, J PERINAT MED, V18, P165, DOI 10.1515/jpme.1990.18.3.165; Baschat AA, 2003, ULTRASOUND OBST GYN, V21, P124, DOI 10.1002/uog.20; Bijnens B, 2012, FETAL DIAGN THER, V32, P5, DOI 10.1159/000335649; Breatnach CR, 2017, ARCH DIS CHILD-FETAL, V102, pF446, DOI 10.1136/archdischild-2016-311189; Carvalho JS, 2013, ULTRASOUND OBST GYN, V41, P348, DOI 10.1002/uog.12403; Chaoui R, 1998, ULTRASOUND OBST GYN, V11, P173, DOI 10.1046/j.1469-0705.1998.11030173.x; Comas M, 2011, ULTRASOUND OBST GYN, V37, P57, DOI 10.1002/uog.8870; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; Day TG, 2019, ULTRASOUND OBST GYN, V54, P575, DOI 10.1002/uog.20233; DeKoninck P, 2014, ULTRASOUND OBST GYN, V43, P432, DOI 10.1002/uog.12561; Devore GR, 2019, ULTRASOUND OBST GYN, V53, P219, DOI 10.1002/uog.19048; DeVore GR, 2018, J ULTRASOUND MED; DeVore GR, 2018, J ULTRAS MED, V37, P1129, DOI 10.1002/jum.14455; Donofrio MT, 2014, CIRCULATION, V129, P2183, DOI 10.1161/01.cir.0000437597.44550.5d; Erickson CT, 2019, EARLY HUM DEV, V129, P23, DOI 10.1016/j.earlhumdev.2018.12.015; Eschbach SJ, 2017, ULTRASOUND OBST GYN, V49, P737, DOI 10.1002/uog.16008; Figueras F, 2008, EUR J OBSTET GYN R B, V136, P20, DOI 10.1016/j.ejogrb.2006.12.015; Foschi M, 2017, J CARDIOVASC DEV DIS, V4, DOI 10.3390/jcdd4040018; Gardiner HM, 2006, INT J CARDIOL, V113, P39, DOI 10.1016/j.ijcard.2005.10.029; Goldinfeld M, 2004, PRENATAL DIAG, V24, P799, DOI 10.1002/pd.880; Gomez O, 2008, ULTRASOUND OBST GYN, V32, P128, DOI 10.1002/uog.5315; Guirado L, 2018, ULTRASOUND OBST GYN, V51, P349, DOI 10.1002/uog.17456; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; HADLOCK FP, 1987, AM J OBSTET GYNECOL, V156, P955, DOI 10.1016/0002-9378(87)90365-6; Hamilton-Craig CR, 2016, IJC HEART VASC, V12, P38, DOI 10.1016/j.ijcha.2016.05.007; Howley LW, 2017, J AM SOC ECHOCARDIOG, V30, P579, DOI 10.1016/j.echo.2017.01.002; Jain A, 2014, J AM SOC ECHOCARDIOG, V27, P1293, DOI 10.1016/j.echo.2014.08.018; James AT, 2016, EARLY HUM DEV, V92, P19, DOI 10.1016/j.earlhumdev.2015.10.015; Karatza AA, 2002, HEART, V88, P271, DOI 10.1136/heart.88.3.271; Korinek J, 2005, J AM SOC ECHOCARDIOG, V18, P1247, DOI 10.1016/j.echo.2005.03.024; Krishnan A, 2016, J AM SOC ECHOCARDIOG, V29, P1197, DOI 10.1016/j.echo.2016.08.019; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee JZ, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2017-000667; Levy PT, 2015, J AM SOC ECHOCARDIOG, V28, P559, DOI 10.1016/j.echo.2015.01.024; Lewandowski AJ, 2013, CIRCULATION, V128, P713, DOI 10.1161/CIRCULATIONAHA.113.002583; Mielke G, 2001, CIRCULATION, V103, P1662, DOI 10.1161/01.CIR.103.12.1662; Patey O, 2019, ULTRASOUND OBST GYN, V54, P634, DOI 10.1002/uog.20187; Patey O, 2017, J AM SOC ECHOCARDIOG, V30, P485, DOI 10.1016/j.echo.2017.01.011; Portnoy SG, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0578-8; Prins KW, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011464; Rajagopal S, 2014, J AM SOC ECHOCARDIOG, V27, P657, DOI 10.1016/j.echo.2014.02.001; ROBINSON HP, 1979, BRIT J OBSTET GYNAEC, V86, P525, DOI 10.1111/j.1471-0528.1979.tb10804.x; Rolf N, 2019, J PERINAT MED, V47, P68, DOI 10.1515/jpm-2018-0031; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Schneider C, 2005, ULTRASOUND OBST GYN, V26, P599, DOI 10.1002/uog.2597; Selly JB, 2015, ARCH CARDIOVASC DIS, V108, P5, DOI 10.1016/j.acvd.2014.07.054; TAN J, 1992, AM J CARDIOL, V70, P1459, DOI 10.1016/0002-9149(92)90300-N; Valenzuela-Alcaraz B, 2013, CIRCULATION, V128, P1442, DOI 10.1161/CIRCULATIONAHA.113.002428; Van Mieghem T, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.051; Venkatachalam S, 2017, ECHOCARDIOGR-J CARD, V34, P1930, DOI 10.1111/echo.13651; Voges I, 2018, HEART FAIL CLIN, V14, P283, DOI 10.1016/j.hfc.2018.02.005; World Health Organization, 2015, INT STAT CLASS DIS R, VFifth; Yagel S, 2001, ULTRASOUND OBST GYN, V17, P367, DOI 10.1046/j.1469-0705.2001.00414.x; Zhang J, 2016, CARDIOVASC ULTRASOUN, V14, DOI 10.1186/s12947-016-0056-5	58	3	3	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-3837	1421-9964		FETAL DIAGN THER	Fetal Diagn. Ther.	MAY	2020	47	5					399	410		10.1159/000503228	http://dx.doi.org/10.1159/000503228			12	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	LU6ME	31822009				2022-09-04	WOS:000537866600007
J	Styczynski, A; Burgado, J; Walteros, D; Usme-Ciro, J; Laiton, K; Farias, AP; Nakazawa, Y; Chapman, C; Davidson, W; Mauldin, M; Morgan, C; Martinez-Ceron, J; Patina, E; Sepulveda, LLL; Torres, CP; Suarez, AEC; Olaya, GP; Riveros, CE; Cepeda, DY; Lopez, LA; Espinosa, DG; Lozada, FAG; Li, Y; Satheshkumar, PS; Reynolds, M; Gracia-Romero, M; Petersen, B				Styczynski, Ashley; Burgado, Jillybeth; Walteros, Diana; Usme-Ciro, Jose; Laiton, Katherine; Pinilla Farias, Alejandra; Nakazawa, Yoshinori; Chapman, Christina; Davidson, Whitni; Mauldin, Matthew; Morgan, Clint; Martinez-Ceron, Juan; Patina, Edilson; Lopez Sepulveda, Leidy Laura; Patricia Torres, Claudia; Cruz Suarez, Anyely Eliana; Paez Olaya, Gina; Elkin Riveros, Carlos; Yaneth Cepeda, Diana; Acosta Lopez, Leydi; Gomez Espinosa, Daniela; Gutierrez Lozada, Faiber Antonio; Li, Yu; Satheshkumar, P. S.; Reynolds, Mary; Gracia-Romero, Martha; Petersen, Brett			Seroprevalence and Risk Factors Possibly Associated with Emerging Zoonotic Vaccinia Virus in a Farming Community, Colombia	EMERGING INFECTIOUS DISEASES			English	Article							MOLECULAR CHARACTERIZATION; INFECTION; OUTBREAK; HUMANS; CATTLE; PAULO; MILK; TRANSMISSION; POXVIRUS; STRAIN	In 2014, vaccinia virus (VACV) infections were identified among farmworkers in Caqueta Department, Colombia; additional cases were identified in Cundinamarca Department in 2015. VACV, an orthopoxvirus (OPXV) used in the smallpox vaccine, has caused sporadic bovine and human outbreaks in countries such as Brazil and India. In response to the emergence of this disease in Colombia, we surveyed and collected blood from 134 farmworkers and household members from 56 farms in Cundinamarca Department. We tested serum samples for OPXV antibodies and correlated risk factors with seropositivity by using multivariate analyses. Fifty-two percent of farmworkers had OPXV antibodies; this percentage decreased to 31% when we excluded persons who would have been eligible for smallpox vaccination. The major risk factors for seropositivity were municipality, age, smallpox vaccination scar, duration of time working on a farm, and animals having vaccinia-like lesions. This investigation provides evidence for possible emergence of VACV as a zoonosis in South America.	[Styczynski, Ashley; Burgado, Jillybeth; Nakazawa, Yoshinori; Chapman, Christina; Davidson, Whitni; Mauldin, Matthew; Morgan, Clint; Li, Yu; Satheshkumar, P. S.; Reynolds, Mary; Petersen, Brett] Ctr Dis Control & Prevent, Atlanta, GA USA; [Walteros, Diana; Usme-Ciro, Jose; Laiton, Katherine; Pinilla Farias, Alejandra; Gracia-Romero, Martha] Inst Nacl Salud, Bogota, Colombia; [Usme-Ciro, Jose] Univ Cooperat Colombia, Santa Marta, Colombia; [Martinez-Ceron, Juan; Patina, Edilson; Lopez Sepulveda, Leidy Laura] Univ Antioquia, Medellin, Colombia; [Patricia Torres, Claudia; Cruz Suarez, Anyely Eliana; Paez Olaya, Gina; Elkin Riveros, Carlos] Secretaria Salud Cundinamarca, Bogota, Colombia; [Yaneth Cepeda, Diana] Hosp Nuestra Senora Pilar Medina, Medina, Colombia; [Acosta Lopez, Leydi] Vigilancia Salud Publ, Bogota, Colombia; [Gomez Espinosa, Daniela] Univ Javeriana, Bogota, Colombia; [Gutierrez Lozada, Faiber Antonio] Secretaria Salud Caqueta, Florencia, Colombia; [Styczynski, Ashley] Stanford Univ, Infect Dis, 300 Pasteur Dr,Lane Bldg 134, Palo Alto, CA 94305 USA		Styczynski, A (corresponding author), Stanford Univ, Infect Dis, 300 Pasteur Dr,Lane Bldg 134, Palo Alto, CA 94305 USA.	ashley.styczynski@gmail.com	Usme, Jose/AAZ-1173-2021	Mauldin, Matt/0000-0002-3807-2339; Reynolds, Mary/0000-0001-7882-4614; Martinez Ceron, Juan Manuel/0000-0002-8906-9420; Styczynski, Ashley/0000-0002-4682-8087				Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324; Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428; Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1; Abrahao JS, 2015, EMERG INFECT DIS, V21, P695, DOI 10.3201/eid2104.140351; Assis FL, 2013, EMERG INFECT DIS, V19, P2045, DOI 10.3201/eid1912.120937; Carroll DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023086; Costa GB, 2015, EMERG INFECT DIS, V21, P2244, DOI 10.3201/eid2112.141249; da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223; Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603; de Oliveira TML, 2018, TRANSBOUND EMERG DIS, V65, pe40, DOI 10.1111/tbed.12666; Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026; Fenner F., 1988, SMALLPOX ITS ERADICA; Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365; Gomez Pando V, 1967, Bol Oficina Sanit Panam, V63, P111; Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005; Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018; Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773; LOPES ODS, 1965, AM J TROP MED HYG, V14, P156; de Oliveira TML, 2015, FOODBORNE PATHOG DIS, V12, P898, DOI 10.1089/fpd.2015.1974; de Oliveira TML, 2010, FOODBORNE PATHOG DIS, V7, P1491, DOI 10.1089/fpd.2010.0597; LUM GS, 1967, AM J TROP MED HYG, V16, P332, DOI 10.4269/ajtmh.1967.16.332; Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845; Medaglia MLG, 2015, J VIROL, V89, P11909, DOI 10.1128/JVI.01833-15; Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647; Megid J, 2012, EMERG INFECT DIS, V18, P189, DOI 10.3201/eid1801.110692; Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004; Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5; PERES MG, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10020051; Quiner CA, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-017-0100-1; Rehfeld IS, 2017, J DAIRY SCI, V100, P7051, DOI 10.3168/jds.2017-12560; Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756; Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007; Singh RX, 2006, REV SCI TECH OIE, V25, P981, DOI 10.20506/rst.25.3.1708; Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0; Smithson C, 2014, COMPUTATION, V2, P182, DOI 10.3390/computation2040182; Trindade GD, 2003, EMERG INFECT DIS, V9, P155; Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486; Usme-Ciro JA, 2017, EMERG INFECT DIS, V23, P649, DOI 10.3201/eid2304.161041; Yadav S, 2010, ARCH VIROL, V155, P255, DOI 10.1007/s00705-009-0562-y	41	8	8	0	4	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1080-6040	1080-6059		EMERG INFECT DIS	Emerg. Infect. Dis	DEC	2019	25	12					2169	2176		10.3201/eid2512.181114	http://dx.doi.org/10.3201/eid2512.181114			8	Immunology; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases	JX9ES	31743085	gold, Green Published			2022-09-04	WOS:000504030700001
J	Cabezas, R; Avila-Rodriguez, M; Vega-Vela, NE; Echeverria, V; Gonzalez, J; Hidalgo, OA; Santos, AB; Aliev, G; Barreto, GE				Cabezas, Ricardo; Avila-Rodriguez, Marco; Vega-Vela, Nelson E.; Echeverria, Valentina; Gonzalez, Janneth; Hidalgo, Oscar A.; Santos, Altair B.; Aliev, Gjumrakch; Barreto, George E.			Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor	MEDICINAL CHEMISTRY			English	Article						Astrocyte; growth factors; metabolism; mitochondria; neuroprotection; platelet derived growth factor	BLOOD-BRAIN-BARRIER; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; SIGNALING PATHWAY; FACTOR-I; PDGF; NEUROPROTECTION; CELLS; DISRUPTION; PLASTICITY	Astrocytes exert multiple functions in the brain such as the development of blood-brain barrier characteristics, the promotion of neurovascular coupling, attraction of cells through the release of chemokines, clearance of toxic substances and generation of antioxidant molecules and growth factors. In this aspect, astrocytes secrete several growth factors (BDNF, GDNF, NGF, and others) that are fundamental for cell viability, oxidant protection, genetic expression and modulation of metabolic functions. The platelet derived growth factor (PDGF), which is expressed by many SNC cells, including astrocytes, is an important molecule that has shown neuroprotective potential, improvement of wound healing, regulation of calcium metabolism and mitochondrial function. Here we explore some of these astrocyte-driven functions of growth factors and their possible therapeutic uses in the context of neurodegeneration.	[Cabezas, Ricardo; Avila-Rodriguez, Marco; Vega-Vela, Nelson E.; Gonzalez, Janneth; Hidalgo, Oscar A.; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Echeverria, Valentina] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33647 USA; [Echeverria, Valentina] Univ San Sebastian, Lientur 1457, Concepcion 4030000, Chile; [Santos, Altair B.] Univ Estadual Sudoeste Bahia, Dept Biol Sci, Itapetinga, Brazil; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.	aliev03@gmail.com; gsampaio@javeriana.edu.co	Valentina Echeverria Moran, BCh/E-7765-2013; GONZALEZ, JANNETH/AAB-9948-2020; Barreto, George E./B-5747-2014; Aliev, Gjumrakch/K-7302-2017; Brito dos Santos, Altair/J-9949-2015; Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./AAD-7420-2020	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; GONZALEZ, JANNETH/0000-0003-4482-256X; Barreto, George E./0000-0002-6644-1971; Brito dos Santos, Altair/0000-0002-9253-3183; Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Vega, Nelson/0000-0003-2404-6858; Avila-Rodriguez, Marco/0000-0003-4612-3236; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X	PUJ [4509, 5024, 5608]; Colciencias project [528, 511]; "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA	PUJ; Colciencias project(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA	This work was supported in part by grants PUJ IDs 4509, 5024 and 5608 to GEB, Colciencias project (convocatoria 528) to RC and Colciencias project (convocatoria 511) to MA. Part of the experimental work was performed using the equipment of Center for collective use of IPAC RAS (Agreement No 14.621.21.0008, ID RFMEFI62114X0008). G. Aliev work also is supported by the "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Arena CB, 2014, TECHNOLOGY, V2, P206, DOI 10.1142/S2339547814500186; Aryal M, 2014, ADV DRUG DELIVER REV, V72, P94, DOI 10.1016/j.addr.2014.01.008; Ball SG, 2012, STEM CELLS, V30, P548, DOI 10.1002/stem.1015; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bonkowski D, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-8; Burkhalter J, 2003, J NEUROSCI, V23, P8212; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Chen LW, 2012, NEUROPHARMACOLOGY, V63, P719, DOI 10.1016/j.neuropharm.2012.05.019; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; CHENG B, 1995, J NEUROSCI, V15, P7095; Chinta SJ, 2008, BBA-GEN SUBJECTS, V1780, P1362, DOI 10.1016/j.bbagen.2008.02.005; Clemmons DR, 2012, ENDOCRIN METAB CLIN, V41, P425, DOI 10.1016/j.ecl.2012.04.017; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Funa K, 2014, J NEUROIMMUNE PHARM, V9, P168, DOI 10.1007/s11481-013-9479-z; Geetha T, 2013, J BIOL CHEM, V288, P23807, DOI 10.1074/jbc.M112.436279; Genis Laura, 2014, F1000Res, V3, P28, DOI 10.12688/f1000research.3-28.v2; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gosslau A, 2001, COMP BIOCHEM PHYS A, V128, P241, DOI 10.1016/S1095-6433(00)00303-2; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hauser RA, 2011, INT J NEUROSCI, V121, P53, DOI 10.3109/00207454.2011.620195; HEDBERG KM, 1993, CELL MOTIL CYTOSKEL, V24, P139, DOI 10.1002/cm.970240207; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Iqbal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030764; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jankovic J, 2012, CURR OPIN NEUROL, V25, P433, DOI 10.1097/WCO.0b013e3283542fc2; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Kang SW, 2007, CELL MOL LIFE SCI, V64, P533, DOI 10.1007/s00018-007-6437-z; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Klein P, 2014, EMBO J, V33, P341, DOI 10.1002/embj.201284290; Krupinski J, 1997, STROKE, V28, P564, DOI 10.1161/01.STR.28.3.564; Lee H, 2014, FRONT BIOSCI-LANDMRK, V19, P272, DOI 10.2741/4206; Lehwald N, 2012, GASTROENTEROLOGY, V143, P754, DOI 10.1053/j.gastro.2012.05.048; Li L, 2010, CHINESE MED J-PEKING, V123, P2502, DOI 10.3760/cma.j.issn.0366-6999.2010.18.002; Llado J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00181; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Markham A, 2012, EUR J NEUROSCI, V35, P366, DOI 10.1111/j.1460-9568.2011.07965.x; Masserini Massimo, 2013, ISRN Biochem, V2013, P238428, DOI 10.1155/2013/238428; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; McDannold N, 2004, MAGN RESON MED, V51, P913, DOI 10.1002/mrm.20060; McDonald TJ, 2007, REV ENDOCR METAB DIS, V8, P71, DOI 10.1007/s11154-007-9044-2; NOBES CD, 1995, J CELL SCI, V108, P225; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Pang Y, 2010, PEDIATR RES, V67, P579, DOI 10.1203/PDR.0b013e3181dc240f; Parpura V, 2011, BBA-MOL CELL RES, V1813, P984, DOI 10.1016/j.bbamcr.2010.11.006; Peng FW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047572; Peng FW, 2010, J BIOL CHEM, V285, P21615, DOI 10.1074/jbc.M110.107003; Peterson AL, 2008, NEUROTHERAPEUTICS, V5, P270, DOI 10.1016/j.nurt.2008.02.003; Proschel C, 2014, EMBO MOL MED, V6, P504, DOI 10.1002/emmm.201302878; Ramaswamy S, 2009, PARKINSONISM RELAT D, V15, pS176, DOI 10.1016/S1353-8020(09)70809-0; RIDEFELT P, 1995, GROWTH FACTORS, V12, P191, DOI 10.3109/08977199509036879; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Ruusala A, 1998, J CELL SCI, V111, P111; Safi R, 2012, J MOL NEUROSCI, V46, P654, DOI 10.1007/s12031-011-9654-8; Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011; Sano Y, 2007, CELL STRUCT FUNCT, V32, P139, DOI 10.1247/csf.07015; Shin Hye Won, 2009, Korean J Hepatol, V15, P486, DOI 10.3350/kjhep.2009.15.4.486; Simon AR, 2002, AM J PHYSIOL-LUNG C, V282, pL1296, DOI 10.1152/ajplung.00315.2001; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Sullivan AM, 2011, CYTOKINE GROWTH F R, V22, P157, DOI 10.1016/j.cytogfr.2011.05.001; Tang ZS, 2010, J EXP MED, V207, P867, DOI 10.1084/jem.20091704; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Timmer M, 2004, EXP NEUROL, V187, P118, DOI 10.1016/j.expneurol.2004.01.013; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang Z, 2010, BBA-REV CANCER, V1806, P122, DOI 10.1016/j.bbcan.2010.04.003; Wright GL, 2008, FASEB J, V22, P3264, DOI 10.1096/fj.08-106468; Yasuda T, 2010, EXPERT REV NEUROTHER, V10, P915, DOI [10.1586/ern.10.55, 10.1586/ERN.10.55]; Yin F, 2013, BIOCHEM SOC T, V41, P101, DOI 10.1042/BST20120260; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zechariah A, 2013, STROKE, V44, P1690, DOI 10.1161/STROKEAHA.111.000240; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302; Zhu XH, 2009, TOXICOL APPL PHARM, V240, P286, DOI 10.1016/j.taap.2009.06.020; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	91	24	24	0	10	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1573-4064	1875-6638		MED CHEM	Med. Chem.		2016	12	3					204	210		10.2174/1573406411666151019120444	http://dx.doi.org/10.2174/1573406411666151019120444			7	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DI7ML	26477707				2022-09-04	WOS:000373684700002
J	Martin-Jimenez, C; Gaitan-Vaca, DM; Areiza, N; Echeverria, V; Ashraf, GM; Gonzalez, J; Sahebkar, A; Garcia-Segura, LM; Barreto, GE				Martin-Jimenez, Cynthia; Milena Gaitan-Vaca, Diana; Areiza, Natalia; Echeverria, Valentina; Ashraf, Ghulam Md; Gonzalez, Janneth; Sahebkar, Amirhossein; Miguel Garcia-Segura, Luis; Barreto, George E.			Astrocytes Mediate Protective Actions of Estrogenic Compounds after Traumatic Brain Injury	NEUROENDOCRINOLOGY			English	Article						Astrocytes; Neuroprotection; Estrogenic compounds; Traumatic brain injury	SPINAL-CORD-INJURY; RECEPTOR MODULATORS SERMS; CENTRAL-NERVOUS-SYSTEM; INDUCED UP-REGULATION; GLUTAMATE TRANSPORTER EXPRESSION; HORMONE-REPLACEMENT THERAPY; CEREBRAL-ARTERY OCCLUSION; ALPHA ER-ALPHA; SELECTIVE ESTROGEN; REACTIVE ASTROCYTES	Traumatic brain injury (TBI) is a serious public health problem. It may result in severe neurological disabilities and in a variety of cellular metabolic alterations for which available therapeutic strategies are limited. In the last decade, the use of estrogenic compounds, which activate protective mechanisms in astrocytes, has been explored as a potential experimental therapeutic approach. Previous works have suggested estradiol (E2) as a neuroprotective hormone that acts in the brain by binding to estrogen receptors (ERs). Several steroidal and nonsteroidal estrogenic compounds can imitate the effects of estradiol on ERs. These include hormonal estrogens, phytoestrogens and synthetic estrogens, such as selective ER modulators or tibolone. Current evidence of the role of astrocytes in mediating protective actions of estrogenic compounds after TBI is reviewed in this paper. We conclude that the use of estrogenic compounds to modulate astrocytic properties is a promising therapeutic approach for the treatment of TBI. (c) 2018 S. Karger AG, Basel	[Martin-Jimenez, Cynthia; Milena Gaitan-Vaca, Diana; Areiza, Natalia; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Cra 7 40-62, Bogota, DC, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Cs Salud, Concepcion, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL USA; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Madrid, Spain; [Miguel Garcia-Segura, Luis] Inst Salud Carlos III, CIBERFES, Madrid, Spain		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Cra 7 40-62, Bogota, DC, Colombia.; Garcia-Segura, LM (corresponding author), CSIC, Inst Cajal, Madrid, Spain.	lmgs@cajal.csic.es; gsampaio@javeriana.edu.co	Valentina Echeverria Moran, BCh/E-7765-2013; GONZALEZ, JANNETH/AAB-9948-2020; Garcia-Segura, Luis M/U-3711-2017; martin, cynthia/AAC-6016-2021; Sahebkar, Amirhossein/B-5124-2018; Barreto, George E./AAD-7420-2020; Ashraf, Ghulam Md/H-9485-2012	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; GONZALEZ, JANNETH/0000-0003-4482-256X; Garcia-Segura, Luis M/0000-0002-2450-2916; Barreto, George E./0000-0002-6644-1971; Ashraf, Ghulam Md/0000-0002-9820-2078	Colciencias grant [824-2017]	Colciencias grant(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work is in part funded by Colciencias grant (Contract No. 824-2017) to G.E.B.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Aoki E, 2009, EXP MOL PATHOL, V86, P57, DOI 10.1016/j.yexmp.2008.10.004; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Arimoto JM, 2013, ENDOCRINOLOGY, V154, P2101, DOI 10.1210/en.2012-2046; Aschner M, 2000, NEUROTOXICOLOGY, V21, P1101; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Azcoitia I, 1998, NEUROREPORT, V9, P3075, DOI 10.1097/00001756-199809140-00029; Azcoitia I, 1999, J NEUROSCI RES, V58, P815, DOI 10.1002/(SICI)1097-4547(19991215)58:6<815::AID-JNR8>3.0.CO;2-R; Azcoitia I, 1999, GLIA, V26, P260; Azcoitia I, 1999, J NEUROCYTOL, V28, P699, DOI 10.1023/A:1007025219044; Azcoitia I, 2006, GYNECOL ENDOCRINOL, V22, P63, DOI 10.1080/09513590500519161; Bagheri M, 2012, BRAIN RES, V1429, P145, DOI 10.1016/j.brainres.2011.10.020; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Blurton-Jones M, 2001, J COMP NEUROL, V433, P115, DOI 10.1002/cne.1129; Bolborea M, 2013, TRENDS NEUROSCI, V36, P91, DOI 10.1016/j.tins.2012.12.008; Born G, 1999, ESTROGENS ANTIESTROG, V135; Bourque M, 2012, FRONT NEUROENDOCRIN, V33, P169, DOI 10.1016/j.yfrne.2012.02.003; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Braissant O, 2013, J INHERIT METAB DIS, V36, P595, DOI 10.1007/s10545-012-9546-2; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Brambilla R, 2009, J NEUROCHEM, V110, P765, DOI 10.1111/j.1471-4159.2009.06190.x; Brinton RD, 2004, J ALZHEIMERS DIS, V6, pS27; Brinton RD, 2002, DRUG DEVELOP RES, V56, P380, DOI 10.1002/ddr.10090; Buchanan CD, 2000, BIOL REPROD, V62, P1710, DOI 10.1095/biolreprod62.6.1710; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cerciat M, 2010, GLIA, V58, P93, DOI 10.1002/glia.20904; Chandra K., 2015, INT J PHARM PHYTOCHE, V7, P383; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Ciriza I, 2004, J NEUROBIOL, V61, P209, DOI 10.1002/neu.20043; Colangelo AM, 2014, NEUROSCI LETT, V565, P59, DOI 10.1016/j.neulet.2014.01.014; Colodner KJ, 2005, J NEUROPATH EXP NEUR, V64, P163, DOI 10.1093/jnen/64.2.163; Colon JM, 2018, EXP NEUROL, V299, P109, DOI 10.1016/j.expneurol.2017.10.006; Cook LG, 2008, NEUROREHABILITATION, V23, P467; Crespo-Castrillo A, 2018, MOL NEUROBIOL, V55, P8651, DOI 10.1007/s12035-018-1008-x; Cveji J., 2012, STUDIES NATURAL PROD, V38, P1; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Dehghan Fatemeh, 2015, Iranian Biomedical Journal, V19, P165, DOI 10.7508/ibj.2015.03.006; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Dhandapani KM, 2003, ENDOCRINE, V21, P59, DOI 10.1385/ENDO:21:1:59; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Donahue JE, 2000, BRAIN RES, V856, P142, DOI 10.1016/S0006-8993(99)02413-0; DonCarlos Lydia L, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS113, DOI 10.1016/j.psyneuen.2009.04.012; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; dos Santos AQ, 2006, ARCH BIOCHEM BIOPHYS, V453, P161, DOI 10.1016/j.abb.2006.06.025; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Duncan SR, 2018, ESTROGEN EFFECTS TRA; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; Escobedo LVS, 2013, WORLD J EMERG MED, V4, P252, DOI [10.5847/wjem.j.1920-8642.2013.04.002, 10.5847/wjem.j.issn.1920-8642.2013.04.002]; Espinosa-Raya J, 2012, HORM BEHAV, V61, P76, DOI 10.1016/j.yhbeh.2011.10.005; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Figiel M, 2003, EXP NEUROL, V183, P124, DOI 10.1016/S0014-4886(03)00134-1; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Fluck E, 2002, J CLIN PSYCHOPHARM, V22, P62, DOI 10.1097/00004714-200202000-00010; Rodriguez NEF, 2013, BRAIN RES BULL, V98, P64, DOI 10.1016/j.brainresbull.2013.07.007; Fuente-Martin E, 2013, REV ENDOCR METAB DIS, V14, P331, DOI 10.1007/s11154-013-9263-7; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Garcia-Segura LM, 2006, GLIA, V54, P485, DOI 10.1002/glia.20404; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Gavillet M, 2008, GLIA, V56, P975, DOI 10.1002/glia.20671; Gee JR, 2005, INT J BIOCHEM CELL B, V37, P1145, DOI 10.1016/j.biocel.2004.10.004; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; Goldstein JS, 2002, AGEING RES REV, V1, P17, DOI 10.1016/S0047-6374(01)00367-0; Gonzalez-Giraldo Y, 2018, MOL NEUROBIOL, V55, P4453, DOI 10.1007/s12035-017-0667-3; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Graham DI, 2002, GREENFIELDS NEUROPAT, P823; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Guo JB, 2012, FREE RADICAL BIO MED, V52, P2151, DOI 10.1016/j.freeradbiomed.2012.03.005; Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Horner PJ, 2000, J NEUROSCI, V20, P2218; Hosli E, 2000, INT J DEV NEUROSCI, V18, P101, DOI 10.1016/S0736-5748(99)00074-X; Hung KL, 2011, NEUROPHARMACOLOGY, V61, P293, DOI 10.1016/j.neuropharm.2011.04.016; Iglesias J, 2017, MOL NEUROBIOL, V54, P2518, DOI 10.1007/s12035-016-9833-2; Ismailoglu O, 2013, AM J MED SCI, V345, P39, DOI 10.1097/MAJ.0b013e3182522651; Jakab RL, 2001, J COMP NEUROL, V430, P396, DOI 10.1002/1096-9861(20010212)430:3<396::AID-CNE1039>3.0.CO;2-0; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; Karki P, 2013, J BIOL CHEM, V288, P28975, DOI 10.1074/jbc.M113.483826; Khaksari M, 2015, BRAIN RES, V1618, P1, DOI 10.1016/j.brainres.2015.05.017; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Khan MM, 2015, J STEROID BIOCHEM, V146, P38, DOI 10.1016/j.jsbmb.2014.05.001; Kim JV, 2006, J IMMUNOL, V177, P5269, DOI 10.4049/jimmunol.177.8.5269; Kim JH, 2014, ENDOCR J, V61, P1055, DOI 10.1507/endocrj.EJ14-0262; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; Klinge CM, 2017, J BIOENERG BIOMEMBR, V49, P307, DOI 10.1007/s10863-017-9704-1; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Kubik LL, 2015, TOXICOL SCI, V144, P7, DOI 10.1093/toxsci/kfu254; LANGUB MC, 1992, ENDOCRINOLOGY, V130, P364, DOI 10.1210/en.130.1.364; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Levi G, 1983, Brain Res, V312, P227; Levison SW, 2000, GLIA, V32, P328, DOI 10.1002/1098-1136(200012)32:3<328::AID-GLIA110>3.0.CO;2-7; Li LB, 2006, J NEUROCHEM, V97, P759, DOI 10.1111/j.1471-4159.2006.03743.x; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Littleton-Kearney MT, 2002, CNS DRUG REV, V8, P309; Liu MH, 2009, NUTR NEUROSCI, V12, P123, DOI 10.1179/147683009X423274; Liu RZ, 2017, INT J MOL MED, V39, P1021, DOI 10.3892/ijmm.2017.2915; Lopez M, 2015, TRENDS ENDOCRIN MET, V26, P411, DOI 10.1016/j.tem.2015.06.003; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; Lu H, 2009, J NEUROL SCI, V278, P91, DOI 10.1016/j.jns.2008.12.007; Ma WW, 2013, NEUROCHEM RES, V38, P1315, DOI 10.1007/s11064-013-1019-y; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Mehta SH, 2003, NEUROENDOCRINOLOGY, V77, P44, DOI 10.1159/000068332; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Micevych P, 2010, NEUROENDOCRINOLOGY, V91, P211, DOI 10.1159/000289568; Mickley KR, 2004, NEUROENDOCRINOLOGY, V79, P305, DOI 10.1159/000079710; Milner TA, 2001, J COMP NEUROL, V429, P355; Mirkin S, 2015, MATURITAS, V80, P52, DOI 10.1016/j.maturitas.2014.10.010; Molaie AM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00176; MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201; Moreira AC, 2014, J STEROID BIOCHEM, V143, P61, DOI 10.1016/j.jsbmb.2014.01.016; Moreira PI, 2011, J STEROID BIOCHEM, V123, P8, DOI 10.1016/j.jsbmb.2010.09.004; Moreira PI, 2005, NEUROPHARMACOLOGY, V48, P435, DOI 10.1016/j.neuropharm.2004.10.012; Moreira PI, 2004, BIOCHEM PHARMACOL, V68, P195, DOI 10.1016/j.bcp.2004.03.019; Morissette M, 2008, MOL CELL ENDOCRINOL, V290, P60, DOI 10.1016/j.mce.2008.04.008; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; MUCKE L, 1993, FASEB J, V7, P1226, DOI 10.1096/fasebj.7.13.8405808; Mullier A, 2010, J COMP NEUROL, V518, P943, DOI 10.1002/cne.22273; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Navarrete M, 2011, CELL, V146, P675, DOI 10.1016/j.cell.2011.08.006; Neary JT, 2009, TRENDS NEUROSCI, V32, P189, DOI 10.1016/j.tins.2009.01.002; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Ohab JJ, 2008, NEUROSCIENTIST, V14, P369, DOI 10.1177/1073858407309545; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; Osterstock G, 2014, ENDOCRINOLOGY, V155, P1887, DOI 10.1210/en.2013-1336; Paintlia MK, 2013, J BIOL CHEM, V288, P3831, DOI 10.1074/jbc.M112.405654; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Paterni I, 2014, STEROIDS, V90, P13, DOI 10.1016/j.steroids.2014.06.012; Pawlak J, 2005, GLIA, V50, P270, DOI 10.1002/glia.20162; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez-Alvarez A, 2013, CURR DRUG TARGETS, V14, P1220; Persichini T, 2010, NEUROSCI LETT, V470, P145, DOI 10.1016/j.neulet.2009.12.074; Picazo O, 2003, BRAIN RES, V990, P20, DOI 10.1016/S0006-8993(03)03380-8; Picazo O, 2010, CELL MOL NEUROBIOL, V30, P675, DOI 10.1007/s10571-009-9490-3; Pinkerton JV, 2014, J STEROID BIOCHEM, V142, P142, DOI 10.1016/j.jsbmb.2013.12.011; Pinto-Almazan R, 2014, REV NEUROLOGIA, V58, P441, DOI 10.33588/rn.5810.2013357; Prevot V, 2018, ENDOCR REV, V39, P333, DOI 10.1210/er.2017-00235; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qin HW, 2008, J IMMUNOL, V181, P3167, DOI 10.4049/jimmunol.181.5.3167; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Rossberg MI, 2000, STROKE, V31, P3041, DOI 10.1161/01.STR.31.12.3041; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rzemieniec J, 2015, J STEROID BIOCHEM, V146, P26, DOI 10.1016/j.jsbmb.2014.05.005; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SANTAGATI S, 1994, J NEUROCHEM, V63, P2058; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303; de Medeiros ARS, 2012, REGUL PEPTIDES, V179, P55, DOI 10.1016/j.regpep.2012.08.015; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sato K, 2008, J PHARMACOL SCI, V107, P226, DOI 10.1254/jphs.08039SC; Savaskan E, 2001, BRAIN RES, V908, P113, DOI 10.1016/S0006-8993(01)02610-5; Shi RF, 2014, NEUROCHEM INT, V65, P14, DOI 10.1016/j.neuint.2013.12.002; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Shy H, 2000, INT J DEV NEUROSCI, V18, P289, DOI 10.1016/S0736-5748(99)00097-0; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simpkins JW, 2008, MOL CELL ENDOCRINOL, V290, P51, DOI 10.1016/j.mce.2008.04.013; Simpkins JW, 2008, BRAIN RES REV, V57, P421, DOI 10.1016/j.brainresrev.2007.04.007; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Sirotkin AV, 2014, EUR J PHARMACOL, V741, P230, DOI 10.1016/j.ejphar.2014.07.057; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Stanikova D, 2018, PSYCHONEUROENDOCRINO, V87, P196, DOI 10.1016/j.psyneuen.2017.10.025; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Streit WJ, 2000, J NEUROSCI RES, V61, P10, DOI 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E; Suzumura A, 2013, CURR PROTEIN PEPT SC, V14, P16, DOI 10.2174/1389203711314010004; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Thiede A, 2012, BBA-BIOENERGETICS, V1817, P1747, DOI 10.1016/j.bbabio.2012.02.034; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Toklu H.Z., 2015, BRAIN NEUROTRAUMA MO; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Verderame M, 2018, STEROIDS, V134, P1, DOI 10.1016/j.steroids.2018.04.001; Verheul HAM, 2006, J STEROID BIOCHEM, V102, P195, DOI 10.1016/j.jsbmb.2006.09.037; Verkhratsky A., 2013, GLIAL PHYSL PATHOPHY, DOI [10.1002/9781118402061, DOI 10.1002/9781118402061]; de Almeida LMV, 2007, CELL MOL NEUROBIOL, V27, P661, DOI 10.1007/s10571-007-9152-2; Volterra A, 2004, GLIA, V47, P249, DOI 10.1002/glia.20080; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Vuceljic Marina, 2006, Vojnosanit Pregl, V63, P545, DOI 10.2298/VSP0606545V; Wang H, 2005, FREE RADICAL BIO MED, V38, P1112, DOI 10.1016/j.freeradbiomed.2005.01.010; Wang YP, 2014, J FORMOS MED ASSOC, V113, P155, DOI 10.1016/j.jfma.2012.04.003; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wicher G, 2015, J STEROID BIOCHEM, V145, P21, DOI 10.1016/j.jsbmb.2014.09.022; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang L, 2002, MOL BRAIN RES, V103, P1; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7; Zhao LQ, 2006, J PHARMACOL EXP THER, V319, P1124, DOI 10.1124/jpet.106.109504; Zhao LQ, 2005, BRAIN RES REV, V49, P472, DOI 10.1016/j.brainresrev.2005.01.009; Zhou WX, 2002, NEUROENDOCRINOLOGY, V75, P24, DOI 10.1159/000048218; Zhou XM, 2014, J SURG RES, V189, P159, DOI 10.1016/j.jss.2014.01.062; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	272	20	21	1	12	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-3835	1423-0194		NEUROENDOCRINOLOGY	Neuroendocrinology		2019	108	2					142	160		10.1159/000495078	http://dx.doi.org/10.1159/000495078			19	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	HO5PL	30391959	Bronze			2022-09-04	WOS:000460980100007
J	Jurado-Coronel, JC; Avila-Rodriguez, M; Echeverria, V; Hidalgo, OA; Gonzalez, J; Aliev, G; Barreto, GE				Jurado-Coronel, Juan C.; Avila-Rodriguez, Marco; Echeverria, Valentina; Alejandro Hidalgo, Oscar; Gonzalez, Janneth; Aliev, Gjumrakch; Barreto, George E.			Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Parkinson Disease; Green tea; (-)-epigallocatechin-3-gallate; oxidative stress; antioxidant; neuroprotection	EPIGALLOCATECHIN GALLATE EGCG; OXIDATIVE STRESS; POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; ALZHEIMERS-DISEASE; POTENTIAL ROLE; L-THEANINE; BLACK TEA; NEUROPROTECTION; ANTIOXIDANTS; CONSUMPTION	Green tea is a beverage consumed around the world that is believed to have substantial health benefits such as reducing the risk of cancer, cardiovascular diseases, diabetes and neurodegeneration. This beverage is prepared from the leaves (steamed and dried) of the Camellia sinesis plant and contains strong antioxidant and neuroprotective phenolic compounds from which the most important is (-)-Epigallocatechin-3-gallate. Parkinson's disease (PD) is the second more common neurodegenerative disorders, after Alzheimer's disease and is characterized by degeneration of dopaminergic neurons in the pars compact of the substantia nigra of the basal ganglia. It has been shown in pre-clinical and clinical studies that green tea may be able to prevent PD, but its optimal dose or a possible mechanism explaining its health benefit in PD has not been properly established. In this review, we discuss the potential role of green tea's phenolic compounds and their therapeutic effectin modulating key signaling pathways in the PD brain.	[Jurado-Coronel, Juan C.; Alejandro Hidalgo, Oscar; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Bogota, Colombia; [Avila-Rodriguez, Marco] Univ Tolima, Fac Ciencias Salud, Ibague, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion, Chile; [Echeverria, Valentina] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33647 USA; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiologically Act Cpds, Chernogolovka 142432, Russia; [Barreto, George E.] Univ Autonoma Chile, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Bogota, Colombia.; Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,330, San Antonio, TX 78229 USA.	aliev03@gmail.com; gsampaio@javeriana.edu.co	Aliev, Gjumrakch/K-7302-2017; Valentina Echeverria Moran, BCh/E-7765-2013; GONZALEZ, JANNETH/AAB-9948-2020; Barreto, George E./AAD-7420-2020; Barreto, George E./B-5747-2014; Aliev, Gjumrakch/AAE-7734-2020	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; GONZALEZ, JANNETH/0000-0003-4482-256X; Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Jurado, Juan/0000-0003-4167-8726; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X; Avila-Rodriguez, Marco/0000-0003-4612-3236	PUJ [5544]; Colciencias (Programa Jovenes Investigadores) [226]; GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA	PUJ; Colciencias (Programa Jovenes Investigadores)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA	This work was in part funded by PUJ grant #5544, and Colciencias (No. 226 de 2014, Programa Jovenes Investigadores) to GEB. G. Aliev work is supported by the GALLY International Biomedical Research Consulting LLC, San Antonio, Texas, USA. Part of the experimental work was performed using the equipment of Center for collective use of IPAC RAS (Agreement. 14.621.21.0008, ID RFMEFI62114X0008). We are also very thankful for Ms. Galina Alieva editorial work throughout preparation of this manuscript.	Apetz N, 2014, CNS NEUROL DISORD-DR, V13, P1175, DOI 10.2174/1871527313666140917110635; Asano K, 2011, J AGR FOOD CHEM, V59, P13360, DOI 10.1021/jf204016k; Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052; Assuncao M, 2010, FREE RADICAL BIO MED, V48, P831, DOI 10.1016/j.freeradbiomed.2010.01.003; Barreto GE, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00340; Barreto GE, 2012, NUTR NEUROSCI, V15, P92, DOI 10.1179/12Z.00000000034; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Barreto George Emilio Sampaio, 2005, Acta Cir Bras, V20 Suppl 1, P72; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Checkoway H, 2002, AM J EPIDEMIOL, V155, P732, DOI 10.1093/aje/155.8.732; Choi JY, 2002, NEUROTOXICOLOGY, V23, P367, DOI 10.1016/S0161-813X(02)00079-7; Chung WG, 2007, BRAIN RES, V1176, P133, DOI 10.1016/j.brainres.2007.07.083; De Andrade DVG, 2008, BRAIN RES, V1198, P188, DOI 10.1016/j.brainres.2008.01.006; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; de Oliveria DM, 2009, NEUROCHEM RES, V34, P215, DOI 10.1007/s11064-008-9749-y; Deschamps V, 2001, NEUROEPIDEMIOLOGY, V20, P7, DOI 10.1159/000054752; dos Santos AB, 2015, NEUROCHEM RES, V40, P421, DOI 10.1007/s11064-014-1488-7; dos Santos AB, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00273; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Guo SH, 2007, BIOL PSYCHIAT, V62, P1353, DOI 10.1016/j.biopsych.2007.04.020; Heber D, 2014, J NUTR, V144, P1385, DOI 10.3945/jn.114.191007; Heese Traci, 2009, AANA J, V77, P445; Hellenbrand W, 1996, NEUROLOGY, V47, P636, DOI 10.1212/WNL.47.3.636; Higuchi A, 2003, TOXICOLOGY, V183, P143, DOI 10.1016/S0300-483X(02)00512-7; Horn PJ, 2010, PSYCHOSOMATICS, V51, P176, DOI 10.1176/appi.psy.51.2.176; Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706; Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Kalfon L, 2007, J NEUROCHEM, V100, P992, DOI 10.1111/j.1471-4159.2006.04265.x; Kim JS, 2010, J CLIN NEUROSCI, V17, P1165, DOI 10.1016/j.jocn.2010.01.042; Kimura M, 2002, EUR J CLIN NUTR, V56, P1186, DOI 10.1038/sj.ejcn.1601471; Kumamoto M, 2001, BIOSCI BIOTECH BIOCH, V65, P126, DOI 10.1271/bbb.65.126; Kumazaki M, 2013, J NUTR BIOCHEM, V24, P1849, DOI 10.1016/j.jnutbio.2013.04.006; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lardner AL, 2014, NUTR NEUROSCI, V17, P145, DOI 10.1179/1476830513Y.0000000079; Leaver KR, 2009, BRAIN RES BULL, V80, P397, DOI 10.1016/j.brainresbull.2009.08.013; Levites Y, 2002, BIOCHEM PHARMACOL, V63, P21, DOI 10.1016/S0006-2952(01)00813-9; Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Li HY, 2014, NUTRITION, V30, P337, DOI 10.1016/j.nut.2013.08.021; Liberatore GT, 1999, NAT MED, V5, P1403; Lin SM, 2010, NUTRITION, V26, P1195, DOI 10.1016/j.nut.2009.11.022; Linazasoro Gurutz J, 2002, Expert Rev Neurother, V2, P403, DOI 10.1586/14737175.2.3.403; Liu G, 2014, BRIT J NUTR, V112, P1043, DOI 10.1017/S0007114514001731; Liu J, 2014, FREE RADICAL RES, V48, P898, DOI 10.3109/10715762.2014.920955; Lopez-Gutierrez N, 2015, FOOD CHEM, V173, P607, DOI 10.1016/j.foodchem.2014.10.092; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Mak JCW, 2012, CLIN EXP PHARMACOL P, V39, P265, DOI 10.1111/j.1440-1681.2012.05673.x; Mandel S, 2004, FREE RADICAL BIO MED, V37, P304, DOI 10.1016/j.freeradbiomed.2004.04.012; Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; Manohar M, 2013, J NUTR BIOCHEM, V24, P940, DOI 10.1016/j.jnutbio.2012.06.013; Mazzio E, 2013, PHYTOTHER RES, V27, P818, DOI 10.1002/ptr.4795; Mazzio E, 2001, NEUROTOXICOLOGY, V22, P283, DOI 10.1016/S0161-813X(01)00017-1; Mazzio EA, 1998, PLANTA MED, V64, P603, DOI 10.1055/s-2006-957530; Miyazawa T, 2000, BIOFACTORS, V13, P55, DOI 10.1002/biof.5520130110; Moldzio R, 2010, J NEURAL TRANSM, V117, P5, DOI 10.1007/s00702-009-0284-z; Morris MC, 2002, JAMA-J AM MED ASSOC, V287, P3230, DOI 10.1001/jama.287.24.3230; Nie GJ, 2002, REDOX REP, V7, P171, DOI 10.1179/135100002125000424; Obrenovich ME, 2011, CNS NEUROL DISORD-DR, V10, P192; Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102460; Polanski W, 2011, EXPERT REV NEUROTHER, V11, P845, DOI [10.1586/ERN.11.1, 10.1586/ern.11.1]; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Roberts RA, 2009, TOXICOL SCI, V112, P4, DOI 10.1093/toxsci/kfp179; Robinson R, 2001, LANCET, V358, P391, DOI 10.1016/S0140-6736(01)05594-5; Schroeder EK, 2009, ANTIOXID REDOX SIGN, V11, P469, DOI [10.1089/ars.2008.2215, 10.1089/ARS.2008.2215]; Shimizu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085520; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; Sutherland BA, 2006, J NUTR BIOCHEM, V17, P291, DOI 10.1016/j.jnutbio.2005.10.005; Tai KK, 2010, NEUROSCI LETT, V482, P183, DOI 10.1016/j.neulet.2010.06.018; Tanabe N, 2008, INT J EPIDEMIOL, V37, P1030, DOI 10.1093/ije/dyn211; Tian B, 2007, ASIA PAC J CLIN NUTR, V16, P153; Vignes M, 2006, BRAIN RES, V1110, P102, DOI 10.1016/j.brainres.2006.06.062; Virmani A, 2013, MOL NEUROBIOL, V48, P353, DOI 10.1007/s12035-013-8498-3; Wagner AE, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/835970; Walker JM, 2015, J ALZHEIMERS DIS, V44, P561, DOI 10.3233/JAD-140981; WANG ZY, 1994, CANCER RES, V54, P3428; Weinreb O, 2004, J NUTR BIOCHEM, V15, P506, DOI 10.1016/j.jnutbio.2004.05.002; Weinreb O, 2007, FREE RADICAL BIO MED, V43, P546, DOI 10.1016/j.freeradbiomed.2007.05.011; Weinreb O, 2009, GENES NUTR, V4, P283, DOI 10.1007/s12263-009-0143-4; Werba JP, 2015, CURR PHARM DESIGN, V21, P1213, DOI 10.2174/1381612820666141013135045; Wise LE, 2012, PHARMACOL BIOCHEM BE, V103, P245, DOI 10.1016/j.pbb.2012.08.008; Yiannakopoulou EC, 2014, PHARMACOLOGY, V94, P245, DOI 10.1159/000369170; Yin C, 2011, PHYTOTHER RES, V25, P1636, DOI 10.1002/ptr.3456; Zhang QY, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-84; Zhu WL, 2012, PHARMACOL RES, V65, P74, DOI 10.1016/j.phrs.2011.09.007	90	28	29	2	56	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2016	15	3					292	300		10.2174/1871527315666160202125519	http://dx.doi.org/10.2174/1871527315666160202125519			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DI9DH	26831259				2022-09-04	WOS:000373801100004
J	Gagliardino, JJ; Aschner, P; Baik, SH; Chan, J; Chantelot, JM; Ilkova, H; Ramachandran, A				Gagliardino, J. J.; Aschner, P.; Baik, S. H.; Chan, J.; Chantelot, J. M.; Ilkova, H.; Ramachandran, A.		IDMPS Investigators	Patients' education, and its impact on care outcomes, resource consumption and working conditions: Data from the International Diabetes Management Practices Study (IDMPS)	DIABETES & METABOLISM			English	Article						Diabetes; Education; Developing countries; Costs	CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; SELF-MANAGEMENT; HEALTH-CARE; TYPE-2; PROGRAM; PEOPLE; MELLITUS; INTERVENTION; METAANALYSIS	Aim. - To evaluate the impact of diabetes education provided to patients with type 2 diabetes mellitus (T2DM) in non-controlled studies ("real-world conditions") on quality of care, resource consumption and conditions of employment. Methods. - This cross-sectional study and longitudinal follow-up describe the data (demographic and socioeconomic profiles, clinical characteristics, treatment of hyperglycaemia and associated cardiovascular risk factors, resource consumption) collected during the second phase (2006) of the International Diabetes Management Practices Study (IDMPS). Patients received diabetes education directly from the practice nurse, dietitian or educator, or were referred to ad hoc group-education programmes; all programmes emphasized healthy lifestyle changes, self-care and active participation in disease control and treatment. Educated vs non-educated T2DM patients (n = 5692 in each group), paired by age, gender and diabetes duration, were randomly recruited for the IDMPS by participating primary-care physicians from 27 countries in Eastern Europe, Asia, Latin America and Africa. Outcome measures included clinical (body weight, height, waist circumference, blood pressure, foot evaluation), metabolic (HbA(1c) levels, blood lipid profile) and biochemical control measures. Treatment goals were defined according to American Diabetes Association guidelines. Results. - T2DM patients' education significantly improved the percentage of patients achieving target values set by international guidelines. Educated patients increased their insulin use and self-care performance, had a lower rate of chronic complications and a modest increase in cost of care, and probably higher salaries and slightly better productivity. Conclusion. - Diabetes education is an efficient tool for improving, care outcomes without having a major impact on healthcare costs. (C) 2011 Elsevier Masson SAS. All rights reserved.	[Gagliardino, J. J.] Natl Univ La Plata, PAHO WHO Collaborating Ctr Diabet, Ctr Expt & Appl Endocrinol, La Plata Natl Sci & Tech Res Council, La Plata, Buenos Aires, Argentina; [Aschner, P.] Javeriana Univ, Endocrinol Unit, Bogota, Colombia; [Baik, S. H.] Korea Univ, Dept Internal Med, Guro Hosp, Seoul, South Korea; [Chan, J.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chantelot, J. M.] Sanofi Aventis, Dept Intercontinental Med Affairs, Paris, France; [Ilkova, H.] Istanbul Univ, Dept Internal Med, Cerrahpasa Med Fac, Istanbul, Turkey; [Ramachandran, A.] Dr A Ramachandrans Diabet Hosp, India Diabet Res Fdn, Madras, Tamil Nadu, India		Gagliardino, JJ (corresponding author), Natl Univ La Plata, PAHO WHO Collaborating Ctr Diabet, Ctr Expt & Appl Endocrinol, La Plata Natl Sci & Tech Res Council, La Plata, Buenos Aires, Argentina.	cenexa@speedy.com.ar	Chan, Juliana/B-7918-2016	Chan, Juliana/0000-0003-1325-1194	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	The IDMPS is an epidemiological survey entirely funded by Sanofi-Aventis. J.-M. C. is an employee of Sanofi-Aventis, a sponsor of the IDMPS. All the other authors are members of the IDMPS steering committee, and have received honoraria and traveling sponsorships related to the IDMPS.	Albu JB, 2010, OBESITY, V18, P1046, DOI 10.1038/oby.2009.339; Berger M, 1996, ANN INTERN MED, V124, P153, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00014; Bolin K, 2009, DIABETIC MED, V26, P928, DOI 10.1111/j.1464-5491.2009.02786.x; Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435; Cleveringa FGW, 2010, DIABETES CARE, V33, P258, DOI 10.2337/dc09-1232; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Davies MJ, 2006, DIABETOLOGIA, V49, P535; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gagliardino JJ, 2001, DIABETES CARE, V24, P1001, DOI 10.2337/diacare.24.6.1001; Glasgow RE, 1997, DIABETES CARE, V20, P556, DOI 10.2337/diacare.20.4.556; Hannan EL, 2008, JACC-CARDIOVASC INTE, V1, P211, DOI 10.1016/j.jcin.2008.01.008; Heller SR, 2009, DIABETES CARE, V32, pS357, DOI 10.2337/dc09-S339; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; *INT DIAB FED, 2007, IDF DIAB ATL PREV ES; KRONSBEIN P, 1988, LANCET, V2, P1407; Lagger G, 2010, ED THER PATIENT THER, V2, pS117; Lorig K, 2002, LANCET, V359, P814, DOI 10.1016/S0140-6736(02)07959-X; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; Martin S, 2007, EXP CLIN ENDOCR DIAB, V115, P495, DOI 10.1055/s-2007-981470; Menard J, 2007, DIABETES METAB, V33, P54, DOI 10.1016/j.diabet.2006.09.001; Moher M, 2001, BMJ-BRIT MED J, V322, P1338, DOI 10.1136/bmj.322.7298.1338; Nathan DM, 2006, DIABETOLOGIA, V49, P1711, DOI 10.1007/s00125-006-0316-2; National Institute for Clinical Excellence, 2003, 60 NICE, V60; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Petersen M, 2008, DIABETES CARE, V31, P596, DOI 10.2337/dc08-9017; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; RUBIN RJ, 1994, J CLIN ENDOCR METAB, V78, pA809, DOI 10.1210/jcem.78.4.8157701; Rutten G, 2005, DIABETIC MED, V22, P671, DOI 10.1111/j.1464-5491.2005.01497.x; Scifres CM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.873; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Skinner T, 2003, DIABETES SPECTRUM, V16, P75, DOI DOI 10.2337/DIASPECT.16.2.75; Trento M, 2004, DIABETES CARE, V27, P670, DOI 10.2337/diacare.27.3.670; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Dam HA, 2003, PATIENT ED COUNS; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695; Wilson S, 2000, BMJ-BRIT MED J, V321, P24, DOI 10.1136/bmj.321.7252.24	42	45	46	0	26	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	1262-3636	1878-1780		DIABETES METAB	Diabetes Metab.	APR	2012	38	2					128	134		10.1016/j.diabet.2011.09.002	http://dx.doi.org/10.1016/j.diabet.2011.09.002			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	939WC	22019715				2022-09-04	WOS:000303849100004
J	Gagliardino, JJ; Aschner, P; Baik, SH; Chan, J; Hancu, N; Ilkova, H; Ramachandran, A				Gagliardino, J. J.; Aschner, P.; Baik, S. H.; Chan, J.; Hancu, N.; Ilkova, H.; Ramachandran, A.			International diabetes management practices study (IDMPS): outcomes comparison between educated and non educated people with type 2 diabetes	DIABETOLOGIA			English	Meeting Abstract	45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes	SEP 30-OCT 02, 2009	Vienna, AUSTRIA	European Assoc Study Diabet					[Gagliardino, J. J.] CENEXA UNLP CONICET LA PLATA, La Plata, Buenos Aires, Argentina; [Aschner, P.] Javeriana Univ, Sch Med, Endocrinol Unit, Bogota, Colombia; [Baik, S. H.] Korea Univ, Guro Hosp, Div Endocrinol, Seoul, South Korea; [Chan, J.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Hancu, N.] Iuliu Hatieganu Univ Med, Diabet Ctr & Clin, Cluj Napoca, Romania; [Ilkova, H.] Istanbul Univ, Cerrahpasa Med Fac, Dept Internal Med, Istanbul, Turkey; [Ramachandran, A.] Dr A Ramachandrans Diabet Hosp, India Diabet Res Fdn, Madras, Tamil Nadu, India				Chan, Juliana/B-7918-2016	Chan, Juliana/0000-0003-1325-1194					0	0	0	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X			DIABETOLOGIA	Diabetologia	SEP	2009	52					990	S389	S389						1	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	487HK					2022-09-04	WOS:000269262400988
J	Saldarriaga-Rivera, LM; Bautista-Molano, W; Junca-Ramirez, A; Fernandez-Aldana, AR; Fernandez-Avila, DG; Jaimes, DA; Jauregui, EA; Segura-Charry, JS; Romero-Sanchez, C; Felipe-Diaz, OJ				Saldarriaga-Rivera, Lina M.; Bautista-Molano, Wilson; Junca-Ramirez, Alejandro; Fernandez-Aldana, Andres R.; Fernandez-Avila, Daniel G.; Jaimes, Diego A.; Jauregui, Edwin A.; Segura-Charry, Juan S.; Romero-Sanchez, Consuelo; Felipe-Diaz, Oscar J.			2021 clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with peripheral spondyloarthritis. Colombian Association of Rheumatology	REUMATOLOGIA CLINICA			English	Article						Spondyloarthritis; Clinical practice guideline; Treatment; Monitoring	ACTIVE PSORIATIC-ARTHRITIS; ANKYLOSING-SPONDYLITIS PATIENTS; MODIFYING ANTIRHEUMATIC DRUGS; FACTOR-ALPHA AGENTS; ANTERIOR UVEITIS; DISEASE-ACTIVITY; INADEQUATE RESPONSE; COST-EFFECTIVENESS; HEALTH-CARE; TREATMENT RECOMMENDATIONS	Background: Peripheral spondyloarthritis is a chronic inflammatory disease in which clinical presentation is related to the presence of arthritis, enthesitis and/or dactylitis. This term is used interchangeably with some of its subtypes such as psoriatic arthritis, reactive arthritis, and undifferentiated spondyloarthritis. Objective: To develop and formulate a set of specific recommendations based on the best available evidence for the diagnosis, treatment and monitoring of adult patients with peripheral spondyloarthritis. Objective: To develop and formulate a set of specific recommendations based on the best available evidence for the diagnosis, treatment and monitoring of adult patients with peripheral spondyloarthritis. Methods: A working group was established, clinical questions were formulated, outcomes were graded, and a systematic search for evidence was conducted. The guideline panel was multidisciplinary (including patient representatives) and balanced. Following the formal expert consensus method, the GRADE methodology "Grading of Recommendations Assessment, Development and Evaluation" was used to assess the quality of the evidence and generate the recommendations. The Clinical Practice Guideline includes ten recommendations; related to monitoring of disease activity (n = 1) and treatment (n = 9). Results: In patients with peripheral spondyloarthritis, the use of methotrexate or sulfasalazine as the first line of treatment is suggested, and local injections of glucocorticoids is recommended conditionally. In patients with failure to cDMARDs, an anti TNFce. or an anti IL17A is recommended. In case of failure to bDMARDs, it is suggested to use another bDMARD or JAK inhibitor. In patients with peripheral spondyloarthritis associated to inflammatory bowel disease, it is recommended to start treatment with cDMARDs; in the absence of response, the use of an anti TNF alpha over an anti-IL-17 or an anti-IL-12-23 is recommended as a second line of treatment. In patients with psoriatic arthritis, the combined use of methotrexate with bDMARD is conditionally recommended for optimization of dosing. To assess disease activity in Psoriatic Arthritis, the use of DAPSA or MDA is suggested for patient monitoring. Conclusions: This set of recommendations provides an updated guide on the diagnosis and treatment of peripheral spondyloarthritis. (C) 2021 Elsevier Espana, S.L.U. and Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.	[Saldarriaga-Rivera, Lina M.] Univ Tecnol Pereira, Hosp Univ San Jorge, Fac Med, Univ Vis Amer,Clin Los Rosales, Pereira, Colombia; [Bautista-Molano, Wilson] Univ El Bosque, Hosp Univ Fdn Santa Fe Bogota, Bogota, Colombia; [Junca-Ramirez, Alejandro] Bienestar IPS, Serv Reumatol, IPS Especializada, Colsanitas, Bogota, Colombia; [Fernandez-Aldana, Andres R.] Inmunar SAS, Serv Reumatol 1, Ibague, Colombia; [Fernandez-Avila, Daniel G.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Fac Med, Bogota, Colombia; [Jaimes, Diego A.] Univ Sabana, Clin IPS, Bogota, Colombia; [Jauregui, Edwin A.] Riesgo Fractura SA Cayre IPS, Serv Reumatol, Bogota, Colombia; [Segura-Charry, Juan S.] Clin Medilaser, Serv Reumatol, Neiva, Colombia; [Segura-Charry, Juan S.] Clin IPS, Bogota, Colombia; [Romero-Sanchez, Consuelo] Hosp Mil Cent, Serv Reumatol & Inmunol, Bogota, Colombia; [Felipe-Diaz, Oscar J.] Medicarte SA Clin Las Vegas, Serv Reumatol, Bogota, Colombia		Saldarriaga-Rivera, LM (corresponding author), Univ Tecnol Pereira, Hosp Univ San Jorge, Fac Med, Univ Vis Amer,Clin Los Rosales, Pereira, Colombia.	vasculitisreumato@gmail.com		Bautista-Molano, Wilson/0000-0003-0684-9542	Abbvie; Amgen; Janssen; Novartis; Pfizer	Abbvie(AbbVie); Amgen(Amgen); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Pfizer(Pfizer)	The development of these CPG was possible thanks of the unrestricted support of the following institutions that jointly funded this effort: Abbvie, Amgen, Janssen, Novartis and Pfizer. The technical work of the process to develop these CPG was independently conducted by the GDT.	Aiello E, 2019, VALUE HEALTH REG ISS, V20, P86, DOI 10.1016/j.vhri.2019.03.002; Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2089; Ash Z, 2012, ANN RHEUM DIS, V71, P319, DOI 10.1136/ard.2011.150995; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bautista-Molano W, 2018, J RHEUMATOL, V45, P206, DOI 10.3899/jrheum.170520; Bautista-Molano W, 2016, CLIN RHEUMATOL, V35, P1759, DOI 10.1007/s10067-016-3184-2; Behrens F, 2015, RHEUMATOLOGY, V54, P915, DOI 10.1093/rheumatology/keu415; Betts KA, 2016, CURR MED RES OPIN, V32, P721, DOI 10.1185/03007995.2016.1140026; Bolge SC, 2017, PATIENT PREFER ADHER, V11, P661, DOI 10.2147/PPA.S121032; Braun J, 2005, ARTHRITIS RHEUM, V52, P2447, DOI 10.1002/art.21197; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Ca  nete Crespillo J, 2015, SOC ESP REUMATOL; Calvo-Rio V, MULTICENTER STUDY 15; Carron P, 2020, RMD OPEN, V6, DOI 10.1136/rmdopen-2019-001136; Cawson MR, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-26; Coates LC, 2016, ARTHRITIS RHEUMATOL, V68, P1060, DOI 10.1002/art.39573; Conti F, 2007, ANN RHEUM DIS, V66, P1393, DOI 10.1136/ard.2007.073569; Corbett M, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21560; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; D'Angiolella LS, 2018, PHARMACOECONOMICS, V36, P567, DOI 10.1007/s40273-018-0618-5; de Winter JJ, 2019, RMD OPEN, V5, DOI 10.1136/rmdopen-2018-000802; del Rio-Martinez P, 2016, SEMIN ARTHRITIS RHEU, V45, P400, DOI 10.1016/j.semarthrit.2015.09.001; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Dressler C, 2019, J EUR ACAD DERMATOL, V33, P1249, DOI 10.1111/jdv.15482; Duarte C, 2017, ACTA REUMATOL PORT, V42, P112; El-Shabrawi Y, 2002, OPHTHALMOLOGY, V109, P2342, DOI 10.1016/S0161-6420(02)01292-7; Fei JZ, 2020, RHEUMATOLOGY, V59, P69, DOI 10.1093/rheumatology/kez202; Gao Xin, 2012, J Med Econ, V15, P1054, DOI 10.3111/13696998.2012.692341; Gisondi P, 2005, EUR J DERMATOL, V15, P279; Gomez-Gomez A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008045; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hamilton L, 2017, RHEUMATOLOGY, V56, P313, DOI 10.1093/rheumatology/kew223; Helliwell PS, 2014, ARTHRIT CARE RES, V66, P749, DOI 10.1002/acr.22204; Heuft-Dorenbosch L, 2004, ARTHRIT RHEUM-ARTHR, V51, P154, DOI 10.1002/art.20233; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hoes JN, 2009, ANN RHEUM DIS, V68, P1833, DOI 10.1136/ard.2008.100008; Kaeley GS, 2018, SEMIN ARTHRITIS RHEU, V48, P263, DOI 10.1016/j.semarthrit.2018.02.002; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P1777, DOI 10.1136/annrheumdis-2012-202035; Kawalec P, 2016, RHEUMATOL INT, V36, P1223, DOI 10.1007/s00296-016-3514-3; Kelly A, 2018, ARTHRIT CARE RES, V70, P525, DOI 10.1002/acr.23329; Kerschbaumer A, 2020, ANN RHEUM DIS, V79, P778, DOI [10.1136/annrheumdis-2020-217163, 10.1136/annrheumdis-2020-eular.6514]; Kim M, 2016, AM J OPHTHALMOL, V170, P32, DOI 10.1016/j.ajo.2016.07.016; Kingsley GH, 2015, PSORIASIS-TARGETS TH, V5, P71, DOI 10.2147/PTT.S52893; Lee S, 2019, J KOREAN MED SCI, V34; Lie E, 2017, ANN RHEUM DIS, V76, P1515, DOI 10.1136/annrheumdis-2016-210931; Loft ND, 2020, J EUR ACAD DERMATOL, V34, P1151, DOI 10.1111/jdv.16073; Londoño John, 2018, Rev.Colomb.Reumatol., V25, P245, DOI 10.1016/j.rcreu.2018.08.003; McDonough AK, 2008, CURR OPIN RHEUMATOL, V20, P131, DOI 10.1097/BOR.0b013e3282f51031; McInnes IB, 2020, LANCET, V395, P1496, DOI 10.1016/S0140-6736(20)30564-X; McInnes IB, 2018, J COMP EFFECT RES, V7, P1107, DOI 10.2217/cer-2018-0075; Mease PJ, 2020, ANN RHEUM DIS, V79, P123, DOI 10.1136/annrheumdis-2019-215386; Mesquida M, 2016, ARTHRITIS RHEUM, V68; Narula N, 2016, AM J GASTROENTEROL, V111, P477, DOI 10.1038/ajg.2016.7; Nota I, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-333; Olivieri I, 2008, RHEUMATOLOGY, V47, P1664, DOI 10.1093/rheumatology/ken320; Orden LY, 2014, GUIA METODOLOGICA EL; Paccou J, 2011, RHEUMATOLOGY, V50, P714, DOI 10.1093/rheumatology/keq377; Pasma A, 2015, J RHEUMATOL, V42, P379, DOI 10.3899/jrheum.140693; Pisu M, 2005, RHEUMATOLOGY, V44, P781, DOI 10.1093/rheumatology/keh594; Poole CD, 2010, RHEUMATOLOGY, V49, P1949, DOI 10.1093/rheumatology/keq182; Reyes-Cordero G, 2021, REUMATOL CLIN, V17, P37, DOI 10.1016/j.reuma.2019.03.010; Ritchlin C, 2014, ANN RHEUM DIS, V73, P990, DOI 10.1136/annrheumdis-2013-204655; Robson JC, 2018, RHEUMATOL INT, V38, P675, DOI 10.1007/s00296-017-3855-6; Rohekar S, 2015, J RHEUMATOL, V42, P665, DOI 10.3899/jrheum.141001; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P696, DOI 10.1136/ard.2008.092585; Ruyssen-Witrand A, 2020, RMD OPEN, V6, DOI 10.1136/rmdopen-2019-001117; Salaffi F, 2005, CLIN EXP RHEUMATOL, V23, P819; Salaffi F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/528105; Schunemann HJ, 2017, J CLIN EPIDEMIOL, V81, P101, DOI 10.1016/j.jclinepi.2016.09.009; Schunemann HJ, 2016, J CLIN EPIDEMIOL, V76, P89, DOI 10.1016/j.jclinepi.2016.01.032; Schweikert B, 2018, VALUE HEALTH, V21, pS319, DOI 10.1016/j.jval.2018.09.1902; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Simon ST, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub3; Singh JA, 2019, ARTHRIT CARE RES, V71, P2, DOI 10.1002/acr.23789; Smolen JS, 2018, ANN RHEUM DIS, V77, P3, DOI 10.1136/annrheumdis-2017-211734; Song GG, 2018, Z RHEUMATOL, V77, P613, DOI 10.1007/s00393-017-0355-8; Song GG, 2019, CLIN DRUG INVEST, V39, P421, DOI 10.1007/s40261-019-00765-w; Soriano ER, 2006, J RHEUMATOL, V33, P1422; Squires H, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21680; Stidham RW, 2014, ALIMENT PHARM THER, V39, P1349, DOI 10.1111/apt.12749; Stidham RW, 2014, ALIMENT PHARM THER, V39, P660, DOI 10.1111/apt.12644; Stolwijk C, 2016, ARTHRIT CARE RES, V68, P1320, DOI 10.1002/acr.22831; Tam LS, 2019, INT J RHEUM DIS, V22, P340, DOI 10.1111/1756-185X.13510; Ungprasert P, 2016, SEMIN ARTHRITIS RHEU, V45, P428, DOI 10.1016/j.semarthrit.2015.09.004; van Denderen JC, 2014, J RHEUMATOL, V41, P1843, DOI 10.3899/jrheum.131289; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; van Mens LJJ, 2018, ANN RHEUM DIS, V77, P251, DOI 10.1136/annrheumdis-2017-211998; Wendling D, 2014, JOINT BONE SPINE, V81, P6, DOI 10.1016/j.jbspin.2013.12.002; Wervers K, 2018, ARTHRIT CARE RES, V70, P1764, DOI 10.1002/acr.23571; Wijnen BFM, 2016, EXPERT REV PHARM OUT, V16, P723, DOI 10.1080/14737167.2016.1246961; Williams JG, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20440; Wilsdon TD, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012722.pub2; Yazgan S, 2017, INT OPHTHALMOL, V37, P139, DOI 10.1007/s10792-016-0239-y; Zhang Y, 2019, J CLIN EPIDEMIOL, V111, P83, DOI 10.1016/j.jclinepi.2018.05.011; Zink A, 2006, J RHEUMATOL, V33, P86	97	0	0	0	0	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1699-258X	1885-1398		REUMATOL CLIN	Reumatol. Clin.	JAN	2022	18	1					5	14		10.1016/j.reumae.2021.09.002	http://dx.doi.org/10.1016/j.reumae.2021.09.002			10	Rheumatology	Emerging Sources Citation Index (ESCI)	Rheumatology	YV9TF	35033487				2022-09-04	WOS:000753064900002
J	Gomez, LF; Sarmiento, OL; Parra, DC; Schmid, TL; Pratt, M; Jacoby, E; Neiman, A; Cervero, R; Mosquera, J; Rutt, C; Ardila, M; Pinzon, JD				Gomez, Luis F.; Sarmiento, Olga L.; Parra, Diana C.; Schmid, Thomas L.; Pratt, Michael; Jacoby, Enrique; Neiman, Andrea; Cervero, Robert; Mosquera, Janeth; Rutt, Candance; Ardila, Mauricio; Pinzon, Jose D.			Characteristics of the Built Environment Associated With Leisure-Time Physical Activity Among Adults in Bogota, Colombia: A Multilevel Study	JOURNAL OF PHYSICAL ACTIVITY & HEALTH			English	Article						urban health; active living; public parks	HEALTH; WALKING; PREVENTION; LIFE	Background: Even though there is increasing evidence that the built environment (BE) has an influence on leisure-time physical activity (LTPA), little is known about this relationship in developing countries. The objective of this study was to assess the associations between objective built environment characteristics and LTPA. Methods: A cross-sectional multilevel study was conducted in 27 neighborhoods in which 1315 adults aged 18-65 years were surveyed. An adapted version of the IPAQ (long version) was used to assess LTPA. Objective BE characteristics were obtained using Geographic Information Systems. Associations were assessed using multilevel polytomous logistic regression. Results: Compared with inactive people, those who resided in neighborhoods with the highest tertile dedicated to parks (7.4% to 25.2%) were more likely to be regularly active (POR = 2.05, 95% CI = 1.13-3.72; P = 0.021). Those who resided in neighborhoods with presence of TransMilenio stations (mass public transportation system) were more likely to be irregularly active (POR = 1.27,95% CI = 1.07-1.50, P = 0.009) as compared with inactive people. Conclusions: These findings showed that park density and availability of TransMilenio stations at neighborhood level are positively associated with LTPA. Public health efforts to address physical inactivity should consider the potential influences of urban planning and mass public transportation systems on health.	[Gomez, Luis F.; Mosquera, Janeth] Fdn FES Social, Div Salud, Bogota, Colombia; [Gomez, Luis F.] Univ Javeriana, Fac Med, Bogota, Colombia; [Sarmiento, Olga L.] Univ Los Andes, Dept Social Med, Bogota, Colombia; [Parra, Diana C.] Washington Univ, Prevent Res Ctr St Louis, St Louis, MO 63130 USA; [Parra, Diana C.] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA; [Schmid, Thomas L.; Pratt, Michael; Neiman, Andrea; Rutt, Candance] Ctr Dis Control & Prevent, Div Nutr & Phys Act, Atlanta, GA USA; [Jacoby, Enrique] Pan Amer World Hlth Org, Noncommunicable Dis Unit, Dept Healthy Eating & Act Living, Washington, DC USA; [Cervero, Robert] Univ Calif Berkeley, Dept City & Reg Planning, Berkeley, CA 94720 USA; [Pinzon, Jose D.] Corp Univ Ctr Ciudad, Ctr Estudios Urbanos, Bogota, Colombia		Gomez, LF (corresponding author), Fdn FES Social, Div Salud, Bogota, Colombia.		Parra, Diana C/D-7633-2013; Sarmiento, Olga L/AAS-4165-2020; Parra, Diana C/B-7761-2015	Parra, Diana C/0000-0002-9797-6231; Sarmiento, Olga L/0000-0002-9190-3568; Parra, Diana C/0000-0002-9797-6231; Gomez Gutierrez, Luis Fernando/0000-0003-1834-3012; Mosquera Becerra, Janeth/0000-0001-9516-7011				Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Cervero R, 1997, TRANSPORT RES D-TR E, V2, P199, DOI 10.1016/S1361-9209(97)00009-6; Cervero R, 2009, INT J SUSTAIN TRANSP, V3, P203, DOI 10.1080/15568310802178314; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; *DEP ADM NAC EST, CENS 2005; Duncan M, 2005, PREV MED, V40, P363, DOI 10.1016/j.ypmed.2004.06.017; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; GOMESCASERES TM, 2003, SOCIOLOGA UNPUB; GONZALES M, 2002, INF QUINA EPIDEMIOL, V7, P205; Handy S, 2006, J AM PLANN ASSOC, V72, P55, DOI 10.1080/01944360608976724; Humpel N, 2004, ANN BEHAV MED, V27, P60, DOI 10.1207/s15324796abm2701_8; *I COL BIEN FAM, 2005, ENC NAC SIT NUTR COL; *INT PHYS ACT QUES, 2002, INT PHYS STUD; Lee IM, 2003, MED SCI SPORT EXER, V35, P1823, DOI 10.1249/01.MSS.0000093620.27893.23; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Lobelo Felipe, 2006, Rev. salud pública, V8, P28, DOI 10.1590/S0124-00642006000500003; Parra D, 2007, INDOOR BUILT ENVIRON, V16, P344, DOI 10.1177/1420326X07080462; RAUDENBUSH S, 2005, HIERARCHICAL LINEAR; Raudenbush S.W., 2002, HIERARCHICAL LINEAR; Rose G. A., 1992, STRATEGY PREVENTIVE; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Schnohr P, 2005, SCAND J MED SCI SPOR, V15, P107, DOI 10.1111/j.1600-0838.2004.00394.x; Stewart KJ, 2002, JAMA-J AM MED ASSOC, V288, P1622, DOI 10.1001/jama.288.13.1622; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wendel-Vos GCW, 2004, QUAL LIFE RES, V13, P667, DOI 10.1023/B:QURE.0000021313.51397.33; Willis G.B., 2005, COGNITIVE INTERVIEWI, DOI DOI 10.4135/9781412983655; World Health Organization, 2004, 57 WORLD HLTH ASS GL; World Health Organization, 2005, PREV CHRON DIS VIT I	31	61	63	1	31	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1543-3080	1543-5474		J PHYS ACT HEALTH	J. Phys. Act. Health	JUL	2010	7			2			S196	S203		10.1123/jpah.7.s2.s196	http://dx.doi.org/10.1123/jpah.7.s2.s196			8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	632TQ	20702907				2022-09-04	WOS:000280451800009
J	Arrieta, LAA; Vergara, TA; Tuesca, R; Acosta, SR; Lozano, KCF; Aschner, P; Gabriel, R; De la Rosa, S; Castillo, JPN; Barengo, NC				Anillo Arrieta, Luis A.; Acosta Vergara, Tania; Tuesca, Rafael; Rodriguez Acosta, Sandra; Florez Lozano, Karen C.; Aschner, Pablo; Gabriel, Rafael; De la Rosa, Sandra; Nieto Castillo, Julieth P.; Barengo, Noel C.			Health-related quality of life (HRQoL) in a population at risk of type 2 diabetes: a cross-sectional study in two Latin American cities	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article						Health related quality of life; Hyperglycemia; Type 2 diabetes; Risk factors	IMPAIRED GLUCOSE-METABOLISM; PHYSICAL-ACTIVITY QUESTIONNAIRE; SHORT-FORM; MELLITUS; RELIABILITY; EUROQOL; SCORE; DEPRESSION; TOLERANCE; CONTINUUM	Purpose The purpose of this study was to describe the health-related quality of life (HRQoL) characteristics in a population at risk of developing type 2 diabetes in Barranquilla and Bogota, Colombia. Methods A cross-sectional study with 1135 participants older than 30 years-of-age recruited in Bogota D.C., and Barranquilla by cluster sampling in 2018 to 2019. The Finnish Diabetes Risk Score (FINDRISC) was used to detect participants at risk of developing type 2 diabetes (T2D). HRQoL was assessed using the EQ-5D-3L questionnaire. Unadjusted and adjusted logistic regression models were used to calculate odds ratios (OR) and their corresponding 95% confidence intervals CI). Results Moderate or extreme problems appeared more frequently in the dimensions of Pain/Discomfort (60.8%) and Anxiety/Depression (30.8%). The mean score of the EQ-VAS was 74.3 (+/- 17.3), significantly larger in the state of complete health (11111) compared with those with problems in more than one of the quality-of-life dimensions. Being female and living in Bogota D.C., were associated with greater odds of reporting problems in the Pain (OR 1.6; 95% CI 1.2-2.2) and Discomfort dimensions (OR 1.6; 95% CI 1.2-2.0) respectively and Anxiety/Depression (OR 1.9; 95% CI 1.3-2.7), (OR 9.1; 95% CI 6.6-12.4), respectively. Conclusions As living place and sex were associated with dimensions of Pain/Discomfort and Anxiety/Depression in the HRQoL in people at risk of T2D, greater attention should be paid to these determinants of HRQoL to design and reorient strategies with a territorial and gender perspective to achieve better health outcomes. Plain English summary Diabetes is one of the four non-communicable diseases with increasing prevalence in the world, which has made it a serious public health problem. In Colombia, in 2019 diabetes affected 8.4% of the Colombian adult population and more than one million Colombian adults of this age group have hidden or undetected diabetes. This disease is not only characterized by increased premature mortality, loss of productivity, and economic impact, but it also involves a deterioration in the quality of life of people with diabetes with their respective families. However, very Little is known about health-related quality of life (HRQoL) in a population at risk or with prediabetes. This study has evaluated the quality of life in patients at risk of diabetes and their behavior with some variables as sociodemographic, lifestyle, history, and established their difference in two territories of the Colombian Caribbean. The results of this study indicate that the HRQoL of people at risk of type 2 diabetes is affected by factors such as gender, city, dysglycemia, medication for hypertension and education level. Therefore, greater attention should be paid to these determinants of HRQL to design and implement strategies that reduce this risk of developing type 2 diabetes, prevent prediabetes and improve the quality of life in prediabetic or diabetic patients.	[Anillo Arrieta, Luis A.; Florez Lozano, Karen C.] Univ Norte, Dept Math & Stat, Div Basic Sci, Barranquilla, Colombia; [Anillo Arrieta, Luis A.; Acosta Vergara, Tania; Tuesca, Rafael; De la Rosa, Sandra; Nieto Castillo, Julieth P.] Univ Norte, Dept Publ Hlth, Div Hlth Sci, Barranquilla, Colombia; [Tuesca, Rafael] Univ Ctr CIFE, Dept Interdisciplinary Res, Cuernavacas Morelos, Mexico; [Rodriguez Acosta, Sandra] Univ Norte, Dept Econ, Div Humanities & Sci Div Social, Barranquilla, Colombia; [Aschner, Pablo] Assoc Colombiana Diabet, Bogota, Colombia; [Aschner, Pablo] Javeriana Univ, Bogota, Colombia; [Aschner, Pablo] San Ignacio Univ Hosp, Bogota, Colombia; [Gabriel, Rafael] Inst Salud Carlos III, Natl Sch Publ Hlth, Dept Int Hlth, Madrid, Spain; [Gabriel, Rafael] World Community Prevent Diabet WCPD Fdn, Madrid, Spain; [Barengo, Noel C.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Translat Med, Miami, FL 33199 USA; [Barengo, Noel C.] Univ Helsinki, Fac Med, Dept Publ Hlth, Helsinki, Finland; [Barengo, Noel C.] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Hlth Policy & Management, Miami, FL 33199 USA		Arrieta, LAA (corresponding author), Univ Norte, Dept Math & Stat, Div Basic Sci, Barranquilla, Colombia.; Arrieta, LAA (corresponding author), Univ Norte, Dept Publ Hlth, Div Hlth Sci, Barranquilla, Colombia.	laanillo@uninorte.edu.co		Rodriguez Acosta, Sandra/0000-0002-8770-4400; Tuesca, Rafael/0000-0003-3095-7199	Colombian National Program for Science, Technology, and Health Innovation (COLCIENCIAS)	Colombian National Program for Science, Technology, and Health Innovation (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This project was financed by the Colombian National Program for Science, Technology, and Health Innovation (COLCIENCIAS) in line with the theme focused on chronic non-transmutable diseases. This was in response to the 744 Call for projects in science, technology, and health innovation of 2016 in association with the Universidad del Norte of Barranquilla and the Colombian Diabetes Association.	Abedini MR, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-1277-8; Acosta T, 2021, FRONT PUBLIC HEALTH, V8, P89484, DOI 10.3389/fpubh.2020.589484; Adriaanse MC, 2008, DIABETIC MED, V25, P843, DOI 10.1111/j.1464-5491.2008.02464.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], METHODS EC EVALUATIO; Brown WJ, 2004, J SCI MED SPORT, V7, P205, DOI 10.1016/S1440-2440(04)80010-0; Bustamante D., 2006, FORMULATION KNOWLEDG; Cefalu WT, 2016, DIABETES CARE, V39, P1186, DOI 10.2337/dc16-0873; Chittleborough CR, 2006, QUAL LIFE RES, V15, P687, DOI 10.1007/s11136-005-3570-8; Clouet F, 2001, DIABETES METAB, V27, P711; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DANE, PROYECC POBL 2018 20; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Gomez-Arbelaez D, 2015, WORLD J DIABETES, V6, P1337, DOI 10.4239/wjd.v6.i17.1337; Grandy S, 2008, INT J CLIN PRACT, V62, P562, DOI 10.1111/j.1742-1241.2008.01703.x; Herdman M, 2001, Aten Primaria, V28, P425; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Hunger M, 2014, QUAL LIFE RES, V23, P2515, DOI 10.1007/s11136-014-0689-5; IETS [Instituto de Evaluacion Tecnologica en Salud], 2014, GUID EC EV HEALTHC T; Javanbakht M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044526; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee WJ, 2012, J KOREAN MED SCI, V27, P255, DOI 10.3346/jkms.2012.27.3.255; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; Makrilakis K, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0261-3; Marin A, 2012, MINERVA ENDOCRINOL, P37; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; National Institute for Health and Clinical Excellence (NICE), 2013, GUID METH TECHN APPR; Neumann A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0150-z; Noncommunicable diseases, 2013, GLOB ACT PLAN PREV C; Pardini R., 2001, REV BRAS 101 NCIA MO, V9, P45, DOI 10.18511/rbcm.v9i3.393; Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458; Richardson G, 2004, HEALTH ECON, V13, P1203, DOI 10.1002/hec.901; Rojas-Reyes María X., 2017, Rev. salud pública, V19, P340, DOI 10.15446/rsap.v19n3.54226; Ruiz M., 2005, PHARMACOECONOMICS SP, V2, P31; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Schunk M, 2012, DIABETIC MED, V29, P646, DOI 10.1111/j.1464-5491.2011.03465.x; Seppala T, 2013, PRIM CARE DIABETES, V7, P223, DOI 10.1016/j.pcd.2013.03.001; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Solano MR, 2009, HUMAN DEV QUALITY LI; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Tapp RJ, 2006, DIABETES RES CLIN PR, V74, P154, DOI 10.1016/j.diabres.2006.03.012; Trikkalinou A, 2017, WORLD J DIABETES, V8, P120, DOI 10.4239/wjd.v8.i4.120; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Urzua AM, 2011, REV MED CHILE, V139, P313, DOI /S0034-98872011000300005; Utami, 2020, J APPL PHARM SCI, V10, P75, DOI [10.7324/JAPS.2020.103009, DOI 10.7324/JAPS.2020.103009]; Vaatainen S, 2014, QUAL LIFE RES, V23, P1935, DOI 10.1007/s11136-014-0638-3; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2006, DEF DIAGN DIAB MELL	54	1	1	2	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1477-7525		HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	DEC 20	2021	19	1							269	10.1186/s12955-021-01894-7	http://dx.doi.org/10.1186/s12955-021-01894-7			12	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	XS5GD	34930297	Green Published, gold			2022-09-04	WOS:000732936400004
J	Kawahara, AY; Breinholt, JW; Espeland, M; Storer, C; Plotkin, D; Dexter, KM; Toussaint, EFA; St Laurent, RA; Brehm, G; Vargas, S; Forero, D; Pierce, NE; Lohman, DJ				Kawahara, Akito; Breinholt, Jesse; Espeland, Marianne; Storer, Caroline; Plotkin, David; Dexter, Kelly; Toussaint, Emmanuel; St Laurent, Ryan; Brehm, Gunnar; Vargas, Sergio; Forero, Dimitri; Pierce, Naomi; Lohman, David			Phylogenetics of moth-like butterflies (Papilionoidea: Hedylidae) based on a new 13-locus target capture probe set	MOLECULAR PHYLOGENETICS AND EVOLUTION			English	Article						Anchored hybrid enrichment; Exon capture; Lepidoptera systematics; Papilionoidea; Phylogenomics	ULTRASONIC HEARING; LEPIDOPTERA; GENOMES; PERFORMANCE; HEDYLOIDEA; RADIATION; GENE; TREE	The Neotropical moth-like butterflies (Hedylidae) are perhaps the most unusual butterfly family. In addition to being species-poor, this family is predominantly nocturnal and has anti-bat ultrasound hearing organs. Evolutionary relationships among the 36 described species are largely unexplored. A new, target capture, anchored hybrid enrichment probe set ('BUTTERFLY2.0') was developed to infer relationships of hedylids and some of their butterfly relatives. The probe set includes 13 genes that have historically been used in butterfly phylogenetics. Our dataset comprised of up to 10,898 aligned base pairs from 22 hedylid species and 19 out-groups. Eleven of the thirteen loci were successfully captured from all samples, and the remaining loci were captured from >= 94% of samples. The inferred phylogeny was consistent with recent molecular studies by placing Hedylidae sister to Hesperiidae, and the tree had robust support for 80% of nodes. Our results are also consistent with morphological studies, with Macrosoma tipulata as the sister species to all remaining hedylids, followed by M. semiermis sister to the remaining species in the genus. We tested the hypothesis that nocturnally evolved once from diurnally in Hedylidae, and demonstrate that the ancestral condition was likely diurnal, with a shift to nocturnally early in the diversification of this family. The BUTTERFLY2.0 probe set includes standard butterfly phylogenetics markers, captures sequences from decades-old museum specimens, and is a cost-effective technique to infer phylogenetic relationships of the butterfly tree of life.	[Kawahara, Akito; Breinholt, Jesse; Espeland, Marianne; Storer, Caroline; Plotkin, David; Dexter, Kelly; Toussaint, Emmanuel; St Laurent, Ryan] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Kawahara, Akito; Plotkin, David] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Kawahara, Akito; St Laurent, Ryan] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Breinholt, Jesse] RAPiD Genom, 747 SW 2nd Ave,IMB 14, Gainesville, FL 32601 USA; [Espeland, Marianne] Zool Res Museum Alexander Koenig, Arthropoda Dept, Adenauer Allee 160, D-53113 Bonn, Germany; [Brehm, Gunnar] Friedrich Schiller Univ Jena, Phylet Museum, Inst Zool & Evolutionary Biol, D-07743 Jena, Germany; [Vargas, Sergio; Forero, Dimitri] Pontificia Univ Javeriana, Dept Biol, Lab Entomol, Bogota, Colombia; [Pierce, Naomi] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Pierce, Naomi] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Lohman, David] CUNY, Dept Biol, New York, NY 10031 USA; [Lohman, David] CUNY, Grad Ctr, PhD Program Biol, New York, NY 10016 USA; [Lohman, David] Natl Museum Philippines, Entomol Sect, Manila 1000, Philippines		Kawahara, AY (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	kawahara@flmnh.ufl.edu	Forero, Dimitri/P-4860-2016; Breinholt, Jesse/F-4330-2014	Forero, Dimitri/0000-0002-6358-757X; Vargas, Sergio/0000-0002-6716-905X; Espeland, Marianne/0000-0002-6800-4783; St Laurent, Ryan/0000-0001-6439-5249; Lohman, David/0000-0002-0689-2906; Breinholt, Jesse/0000-0002-3867-2430	DEB [1541500, 1541557, 1541560]; DBI [1601369]; Direct For Biological Sciences [1541500] Funding Source: National Science Foundation; Division Of Environmental Biology [1541557] Funding Source: National Science Foundation	DEB; DBI; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the members of the Kawahara Lab and curators and collection managers of the Florida Museum of Natural History, McGuire Center for Lepidoptera and Biodiversity. Stacey Huber took photographs of specimens in Fig. 2. Geoff Martin (NHM) and Patricia Gentili-Poole (USNM) allowed access to type specimens and photographs. Jesse Barber and members of his lab (Boise State University) accompanied field trips and helped collect some specimens that were sequenced. RAPiD Genomics (Gainesville, FL, USA) is acknowledged for conducting library preps and DNA sequencing. The University of Florida HiPerGator provided computational resources. AYK, DJL, JWB, ME and NEP acknowledge funding from DEB 1541500, 1541557, and 1541560; financial support for images included in this paper were provided by DBI 1601369 to AYK.	Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gkq1079, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094, 10.1093/nar/gkn723]; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Breinholt JW, 2018, SYST BIOL, V67, P78, DOI 10.1093/sysbio/syx048; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Cho S, 2016, PEERJ, V4, DOI 10.7717/peerj.2160; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Espeland M, 2018, CURR BIOL, V28, P770, DOI 10.1016/j.cub.2018.01.061; Fullard JH, 2004, J EVOLUTION BIOL, V17, P856, DOI 10.1111/j.1420-9101.2004.00722.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; ICZN, 1999, INT COD ZOOL NOM, V4; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawahara AY, 2018, ORG DIVERS EVOL, V18, P13, DOI 10.1007/s13127-017-0350-6; Kawahara AY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0970; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kozak KM, 2015, SYST BIOL, V64, P505, DOI 10.1093/sysbio/syv007; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leveque Antoine, 2007, Entomologiste (Paris), V63, P197; Lourido G. M, 2011, THESIS; Maddison WP, 2018, MESQUITE MODULAR SYS; Mirarab S, 2015, BIOINFORMATICS, V31, P44, DOI 10.1093/bioinformatics/btv234; Mitter KT, 2011, SYST ENTOMOL, V36, P139, DOI 10.1111/j.1365-3113.2010.00549.x; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; PROUT L. B., 1932, MACROLEPIDOPTERA WOR, V8, P1; Prout L. B., 1910, GENERA INSECTORUM, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rubin J. J, SCI ADV; Sayyari E, 2016, MOL BIOL EVOL, V33, P1654, DOI 10.1093/molbev/msw079; Scoble M.J., 1986, Bulletin of the British Museum (Natural History) Entomology, V53, P251; SCOBLE MJ, 1990, ENTOMOL SCAND, V21, P113; SCOBLE MJ, 1990, ENTOMOL SCAND, V21, P121; SCOBLE MJ, 1990, J NAT HIST, V24, P159, DOI 10.1080/00222939000770101; Shen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057125; Simonsen TJ, 2011, CLADISTICS, V27, P113, DOI 10.1111/j.1096-0031.2010.00326.x; St Laurent RA, 2018, SYST ENTOMOL, V43, P729, DOI 10.1111/syen.12301; Toussaint EFA, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1216-z; Triant DA, 2018, CURR OPIN INSECT SCI, V25, P99, DOI 10.1016/j.cois.2017.12.004; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2016, ZOOKEYS, P129, DOI 10.3897/zookeys.596.8399; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yack JE, 2007, J COMP PHYSIOL A, V193, P577, DOI 10.1007/s00359-007-0213-2; Yack JE, 2007, ARTHROPOD STRUCT DEV, V36, P11, DOI 10.1016/j.asd.2006.07.001; Yack JE, 2000, NATURE, V403, P265, DOI 10.1038/35002247	51	19	19	1	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1055-7903	1095-9513		MOL PHYLOGENET EVOL	Mol. Phylogenet. Evol.	OCT	2018	127						600	605		10.1016/j.ympev.2018.06.002	http://dx.doi.org/10.1016/j.ympev.2018.06.002			6	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	GV3UB	29902572				2022-09-04	WOS:000446021300052
J	Cadena, C; Carlone, L; Carrillo, H; Latif, Y; Scaramuzza, D; Neira, J; Reid, I; Leonard, JJ				Cadena, Cesar; Carlone, Luca; Carrillo, Henry; Latif, Yasir; Scaramuzza, Davide; Neira, Jose; Reid, Ian; Leonard, John J.			Past, Present, and Future of Simultaneous Localization and Mapping: Toward the Robust-Perception Age	IEEE TRANSACTIONS ON ROBOTICS			English	Article						Factor graphs; localization; mapping; maximum a posteriori estimation; perception; robots; sensing; simultaneous localization and mapping (SLAM)	VISUAL ODOMETRY; DATA ASSOCIATION; HAND-HELD; SLAM; TIME; UNCERTAINTY; NAVIGATION; OPTIMIZATION; EXPLORATION; SENSOR	Simultaneous localization and mapping (SLAM) consists in the concurrent construction of a model of the environment (the map), and the estimation of the state of the robot moving within it. The SLAM community has made astonishing progress over the last 30 years, enabling large-scale real-world applications and witnessing a steady transition of this technology to industry. We survey the current state of SLAM and consider future directions. We start by presenting what is now the de-facto standard formulation for SLAM. We then review related work, covering a broad set of topics including robustness and scalability in long-term mapping, metric and semantic representations for mapping, theoretical performance guarantees, active SLAM and exploration, and other new frontiers. This paper simultaneously serves as a position paper and tutorial to those who are users of SLAM. By looking at the published research with a critical eye, we delineate open challenges and new research issues, that still deserve careful scientific investigation. The paper also contains the authors' take on two questions that often animate discussions during robotics conferences: Do robots need SLAM? and Is SLAM solved?	[Cadena, Cesar] ETH, Autonomous Syst Lab, CH-8092 Zurich, Switzerland; [Carlone, Luca] MIT, Lab Informat & Decis Syst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Carrillo, Henry] Univ Sergio Arboleda, Escuela Ciencias Exactas & Ingn, Bogota, Colombia; [Carrillo, Henry] Pontificia Univ Javeriana, Bogota, Colombia; [Latif, Yasir; Reid, Ian] Univ Adelaide, Sch Comp Sci, Adelaide, SA 5005, Australia; [Latif, Yasir; Reid, Ian] Australian Ctr Robot Vis, Brisbane, Qld 4000, Australia; [Scaramuzza, Davide] Univ Zurich, Robot & Percept Grp, CH-8006 Zurich, Switzerland; [Neira, Jose] Univ Zaragoza, Dept Informat & Ingn Sistemas, Zaragoza 50029, Spain; [Leonard, John J.] MIT, Marine Robot Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA		Cadena, C (corresponding author), ETH, Autonomous Syst Lab, CH-8092 Zurich, Switzerland.	cesarc@ethz.ch; lcarlone@mit.edu; henry.carrillo@usa.edu.co; yasir.latif@adelaide.edu.au; sdavide@ifi.uzh.ch; jneira@unizar.es; ian.reid@adelaide.edu.au; jleonard@mit.edu	Neira, Jose/AAM-6571-2020; Cadena, Cesar/AAM-4987-2020; Neira Parra, Jose/F-8887-2013	Cadena, Cesar/0000-0002-2972-6011; Reid, Ian/0000-0001-7790-6423; Carrillo Lindado, Henry David/0000-0002-1088-8942; Neira Parra, Jose/0000-0003-0668-977X	ARC [DP130104413, CE140100016, FL130100102]; NCCR Robotics; EU-FP7-ICT-Project TRADR [609763];  [MINECO-FEDER DPI2015-68905-P];  [Grupo DGA T04-FSE];  [PUJ 6601];  [EU-H2020-688652];  [SERI-15.0284]	ARC(Australian Research Council); NCCR Robotics; EU-FP7-ICT-Project TRADR; ; ; ; ; 	This work was supported in part by the following: Grant MINECO-FEDER DPI2015-68905-P, Grant Grupo DGA T04-FSE; ARC Grants DP130104413, Grant CE140100016 and Grant FL130100102; NCCR Robotics; Grant PUJ 6601; EU-FP7-ICT-Project TRADR 609763, Grant EU-H2020-688652, and Grant SERI-15.0284. This paper was presented in part at the workshop "The problem of mobile sensors: Setting future goals and indicators of progress for SLAM" at the Robotics: Science and System Conference, Rome, Italy, July 2015. Additional material for this paper, including an extended list of references (bibtex) and a table of pointers to online datasets for SLAM, can be found at https://slam-future.github.io/	Absil PA, 2008, OPTIMIZATION ALGORITHMS ON MATRIX MANIFOLDS, P1; Ackerman E., 2014, IEEE SPECTR; Agarwal S, 2010, LECT NOTES COMPUT SC, V6312, P29, DOI 10.1007/978-3-642-15552-9_3; Agarwal Sameer, 2016, CERES SOLVER; Anandan P., 1999, P WORKSH VIS ALG THE, P267; Anderson S, 2015, AUTON ROBOT, V39, P221, DOI 10.1007/s10514-015-9455-y; Anderson S, 2014, IEEE INT CONF ROBOT, P373, DOI 10.1109/ICRA.2014.6906884; [Anonymous], 2007, COMP VIS 2007 ICCV 2; [Anonymous], 2004, P IEEE RSJ INT C INT, V3, P2155; [Anonymous], 1986, FDN OPTIMUM EXPT DES; Aragues R, 2012, IEEE T ROBOT, V28, P840, DOI 10.1109/TRO.2012.2192012; Aulinas J, 2008, FRONT ARTIF INTEL AP, V184, P363, DOI 10.3233/978-1-58603-925-7-363; Bailey T, 2006, IEEE ROBOT AUTOM MAG, V13, P108, DOI 10.1109/MRA.2006.1678144; BAJCSY R, 1988, P IEEE, V76, P996, DOI 10.1109/5.5968; Bao SY, 2012, PROC CVPR IEEE, P2703, DOI 10.1109/CVPR.2012.6247992; Barto A. G., 1981, GOAL SEEKING COMPONE; Bibby C., 2007, P ROBOTICS SCI SYSTE, P105; Bibby C., 2010, P IEEE INT C ROB AUT, P1050; Binford T. O., 1971, P IEEE C SYST CONTR, P116; Bishop TE, 2012, IEEE T PATTERN ANAL, V34, P972, DOI 10.1109/TPAMI.2011.168; Blanco JL, 2008, INT J ROBOT RES, V27, P73, DOI 10.1177/0278364907082610; Bloomenthal J., 1997, INTRO IMPLICIT SURFA; Bodis-Szomoru A., 2015, COMPUT VIS IMAGE UND, V66, P91; Bosse M, 2004, INT J ROBOT RES, V23, P1113, DOI 10.1177/0278364904049393; Bosse M, 2009, IEEE INT C ROB AUT, P4312, DOI [10.1109/robot.2009.5152851, DOI 10.1109/ROBOT.2009.5152851, 10.1109/ROBOT.2009.5152851]; Bosse M, 2012, IEEE T ROBOT, V28, P1104, DOI 10.1109/TRO.2012.2200990; Bosse M, 2009, ROBOT AUTON SYST, V57, P1211, DOI 10.1016/j.robot.2009.07.009; Bourgault F, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P540, DOI 10.1109/IRDS.2002.1041446; Brand C., 2014, P IEEE RSJ INT C INT, P2153; Burgard W, 2005, IEEE T ROBOT, V21, P376, DOI 10.1109/TRO.2004.839232; Cadena C., 2015, PROBLEM MOBILE SENSO; Cadena C., 2016, P ROB SCI SYST C, P377; Cadena C, 2015, IEEE INT CONF ROBOT, P4859, DOI 10.1109/ICRA.2015.7139874; Carlevaris-Bianco N, 2013, IEEE INT CONF ROBOT, P5748, DOI 10.1109/ICRA.2013.6631403; Carlone L, 2016, IEEE T ROBOT, V32, P545, DOI 10.1109/TRO.2016.2544304; Carlone L, 2015, IEEE INT C INT ROBOT, P125, DOI 10.1109/IROS.2015.7353364; Carlone L, 2015, IEEE INT CONF ROBOT, P4597, DOI 10.1109/ICRA.2015.7139836; Carlone L, 2015, IEEE INT CONF ROBOT, P4589, DOI 10.1109/ICRA.2015.7139835; Carlone L, 2014, IEEE INT C INT ROBOT, P2667, DOI 10.1109/IROS.2014.6942927; Carlone L, 2014, J INTELL ROBOT SYST, V75, P291, DOI 10.1007/s10846-013-9981-9; Carlone L, 2014, INT J ROBOT RES, V33, P965, DOI 10.1177/0278364914523689; Carlone L, 2014, IEEE T ROBOT, V30, P475, DOI 10.1109/TRO.2013.2291626; Carlone L, 2013, IEEE INT CONF ROBOT, P965, DOI 10.1109/ICRA.2013.6630690; Carr JC, 2001, COMP GRAPH, P67; Carrillo H, 2015, IEEE INT CONF ROBOT, P1476, DOI 10.1109/ICRA.2015.7139384; Carrillo H, 2015, IEEE INT CONF ROBOT, P487, DOI 10.1109/ICRA.2015.7139224; Carrillo H, 2013, IEEE INT CONF ROBOT, P3653, DOI 10.1109/ICRA.2013.6631090; Carrillo H, 2012, IEEE INT C INT ROBOT, P2504, DOI 10.1109/IROS.2012.6385927; Carrillo H, 2012, IEEE INT CONF ROBOT, P2080, DOI 10.1109/ICRA.2012.6224890; Castle R, 2007, IEEE INT CONF ROBOT, P4102, DOI 10.1109/ROBOT.2007.364109; Censi A, 2015, IEEE INT CONF ROBOT, P3319, DOI 10.1109/ICRA.2015.7139657; Chiuso A, 2008, COMMUN INF SYST, V8, P185; Choudhary S., 2015, P IEEE INT C ROB AUT, P5261; Churchill W, 2013, INT J ROBOT RES, V32, P1645, DOI 10.1177/0278364913499193; Cieslewski T, 2015, IEEE INT CONF ROBOT, P6241, DOI 10.1109/ICRA.2015.7140075; Civera J, 2011, IEEE INT C INT ROBOT, P1277, DOI 10.1109/IROS.2011.6048293; Cohen A, 2012, PROC CVPR IEEE, P1514, DOI 10.1109/CVPR.2012.6247841; Costante G, 2016, IEEE ROBOT AUTOM LET, V1, P18, DOI 10.1109/LRA.2015.2505717; Cummins M, 2008, INT J ROBOT RES, V27, P647, DOI 10.1177/0278364908090961; Cunningham A, 2013, IEEE INT CONF ROBOT, P5220, DOI 10.1109/ICRA.2013.6631323; Curless B., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P303; Dame A, 2013, PROC CVPR IEEE, P1288, DOI 10.1109/CVPR.2013.170; Dansereau D. G., 2013, P SPIE C COMP IM, V8657, P1; Dansereau DG, 2016, COMPUT VIS IMAGE UND, V145, P160, DOI 10.1016/j.cviu.2015.12.008; Davison AJ, 2007, IEEE T PATTERN ANAL, V29, P1052, DOI 10.1109/TPAMI.2007.1049; Dayoub F, 2011, ROBOT AUTON SYST, V59, P285, DOI 10.1016/j.robot.2011.02.013; Dellaert F., 2012, GTRIMCPR2012002; Dellaert F, 2006, INT J ROBOT RES, V25, P1181, DOI 10.1177/0278364906072768; Dellaert F, 2010, IEEE INT C INT ROBOT, P2566, DOI 10.1109/IROS.2010.5650422; Dissanayake G., 2011, 2011 IEEE 6th International Conference on Industrial and Information Systems (ICIIS 2011), P477, DOI 10.1109/ICIINFS.2011.6038117; Dong FC, 2013, INT J ROBOT RES, V32, P206, DOI 10.1177/0278364912469420; Dong J, 2015, IEEE INT CONF ROBOT, P5807, DOI 10.1109/ICRA.2015.7140012; Dube R, 2016, IEEE INT CONF ROBOT, P4792, DOI 10.1109/ICRA.2016.7487683; Durrant-Whyte H, 2006, IEEE ROBOT AUTOM MAG, V13, P99, DOI 10.1109/MRA.2006.1638022; DurrantWhyte HF, 1996, INT J ROBOT RES, V15, P407, DOI 10.1177/027836499601500501; Eigen D, 2015, IEEE I CONF COMP VIS, P2650, DOI 10.1109/ICCV.2015.304; ELFES A, 1987, IEEE T ROBOTIC AUTOM, V3, P249, DOI 10.1109/JRA.1987.1087096; Engel J, 2014, LECT NOTES COMPUT SC, V8690, P834, DOI 10.1007/978-3-319-10605-2_54; Eustice RM, 2006, INT J ROBOT RES, V25, P1223, DOI 10.1177/0278364906072512; Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4; Fairfield N, 2007, J FIELD ROBOT, V24, P3, DOI 10.1002/rob.20165; Fairfield N, 2010, SPRINGER TRAC ADV RO, V62, P173; Feder H. J. S., 1999, THESIS; Ferris B, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2480; Flint A, 2011, IEEE I CONF COMP VIS, P2228, DOI 10.1109/ICCV.2011.6126501; Foley J., 1992, COMPUTER GRAPHICS PR; Folkesson J, 2007, J FIELD ROBOT, V24, P51, DOI 10.1002/rob.20174; Forster C., IEEE T ROBO IN PRESS; Forster  C., IEEE T ROBOT; Fox D, 2006, P IEEE, V94, P1325, DOI 10.1109/JPROC.2006.876927; Fraundorfer F, 2012, IEEE ROBOT AUTOM MAG, V19, P78, DOI 10.1109/MRA.2012.2182810; Fredriksson J., 2012, AS C COMP VIS; Frese U, 2010, KUNSTL INTELL, V24, P255, DOI 10.1007/s13218-010-0047-x; Furgale P, 2012, IEEE INT CONF ROBOT, P2088, DOI 10.1109/ICRA.2012.6225005; Gallego G., 2016, CORR, P1; Garg R, 2016, LECT NOTES COMPUT SC, V9912, P740, DOI 10.1007/978-3-319-46484-8_45; Garg R, 2013, PROC CVPR IEEE, P1272, DOI 10.1109/CVPR.2013.168; Gibson J.J., 1979, ECOLOGICAL APPROACH, P127; Golovin D, 2011, J ARTIF INTELL RES, V42, P427; Govindu VM, 2001, PROC CVPR IEEE, P218; Grasa OG, 2014, IEEE T MED IMAGING, V33, P135, DOI 10.1109/TMI.2013.2282997; Grisetti G., 2007, ROBOTICS SCI SYSTEMS, V3, P65; Grisetti G, 2010, IEEE INTEL TRANSP SY, V2, P31, DOI 10.1109/MITS.2010.939925; Grisetti G, 2010, IEEE INT CONF ROBOT, P273, DOI 10.1109/ROBOT.2010.5509407; Grisetti G, 2009, IEEE T INTELL TRANSP, V10, P428, DOI 10.1109/TITS.2009.2026444; Gutmann J.-S., 1999, Proceedings 1999 IEEE International Symposium on Computational Intelligence in Robotics and Automation. CIRA'99 (Cat. No.99EX375), P318, DOI 10.1109/CIRA.1999.810068; Hane C, 2013, PROC CVPR IEEE, P97, DOI 10.1109/CVPR.2013.20; Hartley R, 2013, INT J COMPUT VISION, V103, P267, DOI 10.1007/s11263-012-0601-0; Henry P., 2014, EXPT ROBOTICS, P477, DOI DOI 10.1007/978-3-642-28572-1_33; Hesch JA, 2014, INT J ROBOT RES, V33, P182, DOI 10.1177/0278364913509675; Ho KL, 2006, ROBOT AUTON SYST, V54, P740, DOI 10.1016/j.robot.2006.04.016; Huang GQ, 2013, 2013 EUROPEAN CONFERENCE ON MOBILE ROBOTS (ECMR 2013), P150, DOI 10.1109/ECMR.2013.6698835; Huang GQP, 2011, IEEE INT C INT ROBOT, P65, DOI 10.1109/IROS.2011.6048760; Huang SD, 2016, INT J ADV ROBOT SYST, V13, DOI 10.1177/1729881416669482; Huang SD, 2012, IEEE INT CONF ROBOT, P2074, DOI 10.1109/ICRA.2012.6224876; Huber P. J., 2004, ROBUST STAT, V523; Montoya JI, 2006, CUADERNOS HISPANOAM, P81; IEEE RAS Map Data Representation Working Group, 2016, IEEE STAND ROB MAP D; Ila V, 2010, IEEE T ROBOT, V26, P78, DOI 10.1109/TRO.2009.2034435; Indelman V, 2016, IEEE CONTR SYST MAG, V36, P41, DOI 10.1109/MCS.2015.2512031; Indelman V, 2015, INT J ROBOT RES, V34, P849, DOI 10.1177/0278364914561102; Jachnik J, 2012, INT SYM MIX AUGMENT, P91, DOI 10.1109/ISMAR.2012.6402544; Johannsson H, 2013, IEEE INT CONF ROBOT, P54, DOI 10.1109/ICRA.2013.6630556; Johnson J, 2015, PROC CVPR IEEE, P3668, DOI 10.1109/CVPR.2015.7298990; Jorge VA, 2015, IEEE INT CONF ROBOT, P2125, DOI 10.1109/ICRA.2015.7139479; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Kaess M, 2015, IEEE INT CONF ROBOT, P4605, DOI 10.1109/ICRA.2015.7139837; Kaess M, 2012, INT J ROBOT RES, V31, P216, DOI 10.1177/0278364911430419; Kaess M, 2008, IEEE T ROBOT, V24, P1365, DOI 10.1109/TRO.2008.2006706; Keidar M, 2014, INT J ROBOT RES, V33, P215, DOI 10.1177/0278364913494911; Kelly A, 2013, MOBILE ROBOTICS: MATHEMATICS, MODELS, AND METHODS, P1; Kendall A, 2015, IEEE I CONF COMP VIS, P2938, DOI 10.1109/ICCV.2015.336; Khosoussi K, 2015, ROBOTICS: SCIENCE AND SYSTEMS XI; Kim A, 2013, IEEE T ROBOT, V29, P719, DOI 10.1109/TRO.2012.2235699; Kim H, 2016, LECT NOTES COMPUT SC, V9910, P349, DOI 10.1007/978-3-319-46466-4_21; Kim JH, 2016, IEEE INT CONF ROBOT, P1308, DOI 10.1109/ICRA.2016.7487263; Kim V. G., 2014, ACM T GRAPHIC, V33; Klein George, 2007, P1; Klingensmith M., 2015, P ROB SCI SYST C, P367; Knuth J, 2013, IEEE INT CONF ROBOT, P1534, DOI 10.1109/ICRA.2013.6630774; Knuth J, 2013, ROBOT AUTON SYST, V61, P229, DOI 10.1016/j.robot.2012.11.001; Kottas D. G., 2012, P INT S EXP ROB, P303; Krajnik T, 2014, IEEE INT C INT ROBOT, P4537, DOI 10.1109/IROS.2014.6943205; Kretzschmar H, 2011, IEEE INT C INT ROBOT, P865, DOI 10.1109/IROS.2011.6048060; Kristensen R, 2016, ARBEJDSPAPIR DOGMEPR, P1; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Kueng B, 2016, 2016 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2016), P16, DOI 10.1109/IROS.2016.7758089; Kummerle Rainer, 2011, IEEE International Conference on Robotics and Automation, P3607; Kundu A, 2014, LECT NOTES COMPUT SC, V8694, P703, DOI 10.1007/978-3-319-10599-4_45; Lai K, 2010, INT J ROBOT RES, V29, P1019, DOI 10.1177/0278364910369190; Latif Y, 2013, INT J ROBOT RES, V32, P1611, DOI 10.1177/0278364913498910; Lazaro MT, 2013, IEEE INT C INT ROBOT, P1069, DOI 10.1109/IROS.2013.6696483; Leung C, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P5026, DOI 10.1109/IROS.2006.282530; Leung C, 2006, ROBOT AUTON SYST, V54, P898, DOI 10.1016/j.robot.2006.05.008; Levinson J.S., 2011, THESIS; Li CH, 2015, IEEE INT SYMP CIRC S, P718, DOI 10.1109/ISCAS.2015.7168734; Lichtsteiner Patrick, 2008, IEEE Journal of Solid-State Circuits, V43, P566, DOI 10.1109/JSSC.2007.914337; Lim JJ, 2013, IEEE I CONF COMP VIS, P2992, DOI 10.1109/ICCV.2013.372; Liu FY, 2015, PROC CVPR IEEE, P5162, DOI 10.1109/CVPR.2015.7299152; Liu MJ, 2012, IEEE INT C INT ROBOT, P1898, DOI 10.1109/IROS.2012.6385742; Lowry S, 2016, IEEE T ROBOT, V32, P1, DOI 10.1109/TRO.2015.2496823; Lu F, 1997, AUTON ROBOT, V4, P333, DOI 10.1023/A:1008854305733; Lu Y, 2015, IEEE T ROBOT, V31, P736, DOI 10.1109/TRO.2015.2424032; Lynen S., 2015, RSS; MacKay DJC., 2002, INFORM THEORY INFERE; Magnabosco M, 2013, ROBOT AUTON SYST, V61, P195, DOI 10.1016/j.robot.2012.09.023; Maimone M, 2007, J FIELD ROBOT, V24, P169, DOI 10.1002/rob.20184; Marques L, 2002, THIN SOLID FILMS, V418, P51, DOI 10.1016/S0040-6090(02)00593-X; Martinec D., 2007, P IEEE C COMP VIS PA, DOI DOI 10.1109/CVPR.2007.383115; Mozos OM, 2007, ROBOT AUTON SYST, V55, P391, DOI 10.1016/j.robot.2006.12.003; Martinez-Cantin R, 2009, AUTON ROBOT, V27, P93, DOI 10.1007/s10514-009-9130-2; Mazuran M, 2016, INT J ROBOT RES, V35, P50, DOI 10.1177/0278364915581629; Mendel J. M, 1995, LESSONS ESTIMATION T; Merrell P, 2011, IEEE T VIS COMPUT GR, V17, P715, DOI 10.1109/TVCG.2010.112; Milford MJ, 2012, IEEE INT CONF ROBOT, P1643, DOI 10.1109/ICRA.2012.6224623; Mourikis AI, 2007, IEEE INT CONF ROBOT, P3565, DOI 10.1109/ROBOT.2007.364024; Mueggler E, 2015, ROBOTICS: SCIENCE AND SYSTEMS XI; Mueller E, 2015, IEEE DECIS CONTR P, P992, DOI 10.1109/CDC.2015.7402002; Mur-Artal R, 2015, IEEE T ROBOT, V31, P1147, DOI 10.1109/TRO.2015.2463671; Neira J, 2001, IEEE T ROBOTIC AUTOM, V17, P890, DOI 10.1109/70.976019; Nerurkar ED, 2009, IEEE INT CONF ROBOT, P1375; Newcombe RA, 2015, PROC CVPR IEEE, P343, DOI 10.1109/CVPR.2015.7298631; Newcombe RA, 2011, IEEE I CONF COMP VIS, P2320, DOI 10.1109/ICCV.2011.6126513; Newcombe RA, 2011, INT SYM MIX AUGMENT, P127, DOI 10.1109/ISMAR.2011.6092378; Newman P, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P1802, DOI 10.1109/ROBOT.2002.1014803; Ng R., 2005, CSTR200502 STANF U D; Ni K, 2010, IEEE INT C INT ROBOT, P2558, DOI 10.1109/IROS.2010.5650197; Niessner M, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2508363.2508374; Nister D., 2006, 2006 IEEE COMPUTER S, P2161; Nuchter A, 2009, SPRINGER TRAC ADV RO, V52, P1; Olson E, 2006, IEEE INT CONF ROBOT, P2262, DOI 10.1109/ROBOT.2006.1642040; Olson E, 2013, INT J ROBOT RES, V32, P826, DOI 10.1177/0278364913479413; Open Geospatial Consortium (OGC), 2016, OGC INDOORGML STAND; Open Geospatial Consortium (OGC), 2016, CITYGML 2 0 0; Patil S, 2015, SPRINGER TRAC ADV RO, V107, P515, DOI 10.1007/978-3-319-16595-0_30; Patron-Perez A, 2015, INT J COMPUT VISION, V113, P208, DOI 10.1007/s11263-015-0811-3; Paull L, 2015, IEEE INT CONF ROBOT, P509, DOI 10.1109/ICRA.2015.7139227; Peters JR, 2015, SIAM J CONTROL OPTIM, V53, P3534, DOI 10.1137/140957743; Phillips CJ, 2015, IEEE INT CONF ROBOT, P1352, DOI 10.1109/ICRA.2015.7139366; Pillai S., 2015, P ROB SCI SYST C, P310; Piovan G, 2013, AUTOMATICA, V49, P206, DOI 10.1016/j.automatica.2012.09.014; Pizzoli M, 2014, IEEE INT CONF ROBOT, P2609, DOI 10.1109/ICRA.2014.6907233; Posch C, 2008, IEEE INT SYMP CIRC S, P2130, DOI 10.1109/ISCAS.2008.4541871; Pronobis A, 2012, IEEE INT CONF ROBOT, P3515, DOI 10.1109/ICRA.2012.6224637; Rebecq H., IEEE ROBOT IN PRESS; Renyi A., 1960, P 4 BERK S MATH STAT; Requicha A. A. G., 1980, Computing Surveys, V12, P437; Riazuelo L, 2014, ROBOT AUTON SYST, V62, P401, DOI 10.1016/j.robot.2013.11.007; Robotics Kuka, 2016, KUKA NAVIGATION SOLU; Rosen DM, 2015, IEEE INT CONF ROBOT, P5822, DOI 10.1109/ICRA.2015.7140014; Rosen DM, 2013, IEEE INT CONF ROBOT, P1025, DOI 10.1109/ICRA.2013.6630699; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sabatta D, 2010, IEEE INT CONF ROBOT, P1008, DOI 10.1109/ROBOT.2010.5509382; Saeedi S, 2016, J FIELD ROBOT, V33, P3, DOI 10.1002/rob.21620; Salas-Moreno RF, 2013, PROC CVPR IEEE, P1352, DOI 10.1109/CVPR.2013.178; Scaramuzza D, 2011, IEEE ROBOT AUTOM MAG, V18, P80, DOI 10.1109/MRA.2011.943233; Sengupta S, 2015, IEEE INT CONF ROBOT, P1874, DOI 10.1109/ICRA.2015.7139442; Shah JJ., 1995, PARAMETRIC FEATURE B; SHAPIRO V, 2002, HDB COMPUTER AIDED G, V20, P473, DOI DOI 10.1016/B978-044451104-1/50021-6; Shen C, 2004, ACM T GRAPHIC, V23, P896, DOI 10.1145/1015706.1015816; Shoudong Huang, 2010, 2010 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2010), P3011, DOI 10.1109/IROS.2010.5652603; Sibley G., 2009, P ROB SCI SYST C, P177; Singer A, 2011, SIAM J IMAGING SCI, V4, P543, DOI 10.1137/090767777; Singer A, 2011, APPL COMPUT HARMON A, V30, P20, DOI 10.1016/j.acha.2010.02.001; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Smith BM, 2009, IEEE I CONF COMP VIS, P341, DOI 10.1109/ICCV.2009.5459270; Soatto S., 2016, CORR, P1; Soatto S., 2011, ARXIV11102053, P1; Song L., 2010, P 27 INT C MACH LEAR; Srinaga Nikhil N, 2015, 2015 IEEE APPL EL C, P1, DOI [10.1109/AEMC.2015.7509236, DOI 10.1109/AEMC.2015.7509236]; Stachniss C., 2005, ROBOTICS SCI SYSTEMS, V2, P65; Stachniss C, 2016, SPRINGER HANDBOOK OF ROBOTICS, P1153; Stachniss C, 2009, SPRINGER TRAC ADV RO, V55, P3; Strasdat H, 2012, IMAGE VISION COMPUT, V30, P65, DOI 10.1016/j.imavis.2012.02.009; Strasdat H, 2011, IEEE I CONF COMP VIS, P2352, DOI 10.1109/ICCV.2011.6126517; Strub C, 2014, J IEEE I C DEVELOP L, P26, DOI 10.1109/DEVLRN.2014.6982950; Sunderhauf N, 2012, IEEE INT CONF ROBOT, P1254, DOI 10.1109/ICRA.2012.6224709; Svoboda, 2013, ROBOTICS SCI SYSTEMS, P328; Thrun S., 2005, PROBABILISTIC ROBOTI; Thrun S., 1995, HDB BRAIN SCI NEURAL; Thrun S, 2006, INT J ROBOT RES, V25, P403, DOI 10.1177/0278364906065387; Tipaldi GD, 2010, IEEE INT CONF ROBOT, P3616, DOI 10.1109/ROBOT.2010.5509864; Tong CH, 2013, INT J ROBOT RES, V32, P507, DOI 10.1177/0278364913478672; Triggs B., 1999, VISION ALGORITHMS TH, P298, DOI [10.1007/3-540-44480-7_21, DOI 10.1007/3-540-44480-7_21]; Tron R., 2012, P 51 IEEE C DEC CONT, P2052, DOI [10.1109/CDC.2012.6426677, DOI 10.1109/CDC.2012.6426677]; Valencia R, 2012, IEEE INT C INT ROBOT, P1885, DOI 10.1109/IROS.2012.6385637; Valentin J, 2015, PROC CVPR IEEE, P4400, DOI 10.1109/CVPR.2015.7299069; Vallivaara I, 2010, 2010 IEEE International Conference on Multisensor Fusion and Integration for Intelligent Systems (MFI 2010), P14, DOI 10.1109/MFI.2010.5604465; Vallve J, 2015, ROBOT AUTON SYST, V69, P68, DOI 10.1016/j.robot.2014.08.009; van den Berg J, 2012, INT J ROBOT RES, V31, P1263, DOI 10.1177/0278364912456319; Vineet V, 2015, IEEE INT CONF ROBOT, P75, DOI 10.1109/ICRA.2015.7138983; Wahlstrom Niklas, 2015, IFAC - Papers Online, V48, P1059, DOI 10.1016/j.ifacol.2015.12.271; Wang CC, 2007, INT J ROBOT RES, V26, P889, DOI 10.1177/0278364907081229; Wang LH, 2013, INF INFERENCE, V2, P145, DOI 10.1093/imaiai/iat005; Wang SJ, 2014, INT CONF ACOUST SPEE; Wang Z., 2011, SIMULTANEOUS LOCALIZ; Whelan T, 2012, RSS WORKSH RGB D ADV; Whelan T, 2015, ROBOTICS: SCIENCE AND SYSTEMS XI; Williams S, 2014, INT J ROBOT RES, V33, P1544, DOI 10.1177/0278364914531056; Wolcott RW, 2014, IEEE INT C INT ROBOT, P176, DOI 10.1109/IROS.2014.6942558; Wood R., 2015, ROBOBEES PROJECT; Yamauchi B, 1997, 1997 IEEE INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN ROBOTICS AND AUTOMATION - CIRA '97, PROCEEDINGS, P146, DOI 10.1109/CIRA.1997.613851; Yu KT, 2015, IEEE INT C INT ROBOT, P1208, DOI 10.1109/IROS.2015.7353523; Zhang J, 2016, IEEE INT CONF ROBOT, P809, DOI 10.1109/ICRA.2016.7487211; Zhang ST, 2012, MED IMAGE ANAL, V16, P265, DOI 10.1016/j.media.2011.08.004; Zhao L, 2013, IEEE INT C INT ROBOT, P24, DOI 10.1109/IROS.2013.6696327	266	1326	1446	154	922	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1552-3098	1941-0468		IEEE T ROBOT	IEEE Trans. Robot.	DEC	2016	32	6					1309	1332		10.1109/TRO.2016.2624754	http://dx.doi.org/10.1109/TRO.2016.2624754			24	Robotics	Science Citation Index Expanded (SCI-EXPANDED)	Robotics	EE8BO		Green Submitted, Green Accepted, Green Published			2022-09-04	WOS:000389849700001
J	Shenk, JC; Liu, JK; Fischbach, K; Xu, K; Puchowicz, M; Obrenovich, ME; Gasimov, E; Alvarez, LM; Ames, BN; LaManna, JC; Aliev, G				Shenk, Justin C.; Liu, Jiankang; Fischbach, Kathryn; Xu, Kui; Puchowicz, Michel; Obrenovich, Mark E.; Gasimov, Eldar; Morales Alvarez, Ludis; Ames, Bruce N.; LaManna, Joseph C.; Aliev, Gjumrakch			The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	5th International Congress on Vascular Dementia	NOV 08-11, 2007	Budapest, HUNGARY			ApoE4; Alzheimer's disease; Cerebral blood flow; Electron microscopy; Vascular and mitochondrial damage; Mitochondrial antioxidant and cognitive performance	CEREBRAL-BLOOD-FLOW; MITOCHONDRIA DNA DELETIONS; APOLIPOPROTEIN-E GENOTYPE; OXIDATIVE STRESS; ATHEROSCLEROTIC LESIONS; VASCULAR HYPOPERFUSION; NITRIC-OXIDE; CHOLESTEROL TRANSPORT; AMYLOID DEPOSITION; BRAIN MICROVESSELS	We measured age-dependent effects of human ApoE4 on cerebral blood flow (CBF) using ApoE4 transgenic mice compared to age-matched wild-type (WT) mice by use of [C-14] iodoantipyrene autoradiography. ApoE4 associated factors reduce CBF gradually to create brain hypoperfusion when compared to WT, and the differences in CBF are greatest as animals age from 6-weeks to 12-months. Transmission electron microscopy with colloidal gold immunocytochemistry showed structural damage in young and aged microvessel endothelium of ApoE4 animals extended to the cytoplasm of perivascular cells, perivascular nerve terminals and hippocampal neurons and glial cells. These abnormalities coexist with mitochondrial structural alteration and mitochondrial DNA overproliferation and/or deletion in all brain cellular compartments. Spatial memory and temporal memory tests showed a trend in improving cognitive function in ApoE4 mice fed selective mitochondrial antioxidants acetyl-l-carnitine and R-alpha-lipoic acid. Our findings indicate that ApoE4 genotypeinduced mitochondrial changes and associated structural damage may explain age-dependent pathology seen in AD, indicating potential for novel treatment strategies in the near future. (C) 2009 Elsevier B.V. All rights reserved.	[Aliev, Gjumrakch] Univ Texas San Antonio, Dept Biol, Coll Sci, San Antonio, TX 78249 USA; [Shenk, Justin C.; Fischbach, Kathryn; Aliev, Gjumrakch] Univ Texas San Antonio, Elect Microscopy Res Ctr, San Antonio, TX 78249 USA; [Liu, Jiankang; Ames, Bruce N.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Xu, Kui; Puchowicz, Michel; LaManna, Joseph C.] Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA; [Obrenovich, Mark E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Gasimov, Eldar] Baku Med Univ, Dept Cytol Histol & Embryol, Baku AZ1025, Azerbaijan; [Morales Alvarez, Ludis] Univ Javeriana, Dept Biochem & Nutr, Bogota, Colombia		Aliev, G (corresponding author), Univ Texas San Antonio, Dept Biol, Coll Sci, 1 UTSA Circle, San Antonio, TX 78249 USA.	aliev03@gmail.com	LaManna, Joseph C/C-3347-2012; Aliev, Gjumrakch/K-7302-2017; Liu, Jiankang/A-1610-2011; Sancheti, Harsh/H-3538-2012; LaManna, Joseph/D-3860-2013; Aliev, Gjumrakch/AAE-7734-2020	LaManna, Joseph C/0000-0002-0159-4512; LaManna, Joseph/0000-0002-0159-4512; Aliev, Gjumrakch/0000-0001-7373-3182; Gasimov, Eldar/0000-0002-5104-4260; Morales-Alvarez, Ludis/0000-0002-8541-9729	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060655] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 60655, R25 GM060655, R25 GM060655-07] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aliev G., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P225; Aliev G, 2007, ATHEROSCLEROSIS SUPP, V8, P105, DOI 10.1016/S1567-5688(07)71367-3; Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018; Aliev G, 2003, NEUROTOX RES, V5, P491, DOI 10.1007/BF03033159; Aliev G, 2002, ANN NY ACAD SCI, V977, P45, DOI 10.1111/j.1749-6632.2002.tb04798.x; Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977; Aliev G, 2002, BRAIN PATHOL, V12, P21; Aliev G, 2001, EXP MOL PATHOL, V71, P40, DOI 10.1006/exmp.2001.2380; Aliev G, 2009, J CELL MOL MED, V13, P320, DOI 10.1111/j.1582-4934.2008.00324.x; Aliyev A, 2005, J NEUROL SCI, V229, P285, DOI 10.1016/j.jns.2004.11.040; Aliyev A, 2004, NEUROL RES, V26, P547, DOI 10.1179/01610425017613; Alves TCTF, 2005, J NEUROIMAGING, V15, P150, DOI 10.1177/1051228404272880; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Blain Jean-Francois, 2004, Expert Rev Neurother, V4, P823, DOI 10.1586/14737175.4.5.823; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; de la Torre JC, 2002, J ALZHEIMERS DIS, V4, P497, DOI 10.3233/jad-2002-4606; de la Torre JC, 2005, J CEREBR BLOOD F MET, V25, P663, DOI 10.1038/sj.jcbfm.9600057; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; de la Torre JC, 2000, BRAIN RES REV, V34, P119, DOI 10.1016/S0165-0173(00)00043-6; de la Torre JC, 2000, NEUROBIOL AGING, V21, P331, DOI 10.1016/S0197-4580(00)00111-1; Etiene Dannie, 1998, J Alzheimers Dis, V1, P119; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fisher A, 1998, J NEUROCHEM, V70, P1991; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Genis I, 1998, ADV BEHAV BIOL, V49, P251; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Jagust WJ, 1997, ANN NY ACAD SCI, V826, P254, DOI 10.1111/j.1749-6632.1997.tb48477.x; JAGUST WJ, 1988, NEUROLOGY, V38, P909, DOI 10.1212/WNL.38.6.909; Kalaria RN, 1999, ALZ DIS ASSOC DIS, V13, pS115, DOI 10.1097/00002093-199912003-00017; Kalaria RN, 1999, ANN NY ACAD SCI, V893, P113, DOI 10.1111/j.1749-6632.1999.tb07821.x; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Liu JK, 2002, P NATL ACAD SCI USA, V99, P1876, DOI 10.1073/pnas.261709098; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Meguro K, 1999, BRAIN, V122, P1519, DOI 10.1093/brain/122.8.1519; Moreira PI, 2007, AUTOPHAGY, V3, P614, DOI 10.4161/auto.4872; Moretra PI, 2007, J NEUROPATH EXP NEUR, V66, P525, DOI 10.1097/01.jnen.0000240476.73532.b0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Obrenovich ME, 2006, NEUROTOX RES, V10, P43, DOI 10.1007/BF03033333; Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Puchowicz MA, 2005, ADV EXP MED BIOL, V566, P99; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; ROBERTS S, 1981, J EXP PSYCHOL ANIM B, V7, P242, DOI 10.1037/0097-7403.7.3.242; SCHENK F, 1985, EXP BRAIN RES, V58, P11; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sparks DL, 1997, ANN NY ACAD SCI, V826, P128, DOI 10.1111/j.1749-6632.1997.tb48466.x; Trogan E, 2002, P NATL ACAD SCI USA, V99, P2234, DOI 10.1073/pnas.042683999; Walker LC, 1997, AM J PATHOL, V151, P1371; WEISGRABER KH, 1994, CURR OPIN STRUC BIOL, V4, P507, DOI 10.1016/S0959-440X(94)90212-7; 2002, CAUSES EARLY DETECTI	58	74	75	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	AUG 15	2009	283	1-2			1		199	206		10.1016/j.jns.2009.03.002	http://dx.doi.org/10.1016/j.jns.2009.03.002			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	478SU	19342064	Green Accepted			2022-09-04	WOS:000268609400043
J	Ramirez-Velez, R; Perez-Sousa, MA; Izquierdo, M; Cano-Gutierrez, CA; Gonzalez-Jimenez, E; Schmidt-RioValle, J; Gonzalez-Ruiz, K; Correa-Rodriguez, M				Ramirez-Velez, Robinson; Angel Perez-Sousa, Miguel; Izquierdo, Mikel; Cano-Gutierrez, Carlos A.; Gonzalez-Jimenez, Emilio; Schmidt-RioValle, Jacqueline; Gonzalez-Ruiz, Katherine; Correa-Rodriguez, Maria			Validation of Surrogate Anthropometric Indices in Older Adults: What Is the Best Indicator of High Cardiometabolic Risk Factor Clustering?	NUTRIENTS			English	Article						anthropometric indices; diagnosis criteria; metabolic syndrome; cardiometabolic risk; elderly	TO-HEIGHT RATIO; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; SCREENING TOOL; PREDICTOR; INSULIN; STROKE; BMI	The present study evaluated the ability of five obesity-related parameters, including a body shape index (ABSI), conicity index (CI), body roundness index (BRI), body mass index (BMI), and waist-to-height ratio (WtHR) for predicting increased cardiometabolic risk in a population of elderly Colombians. A cross-sectional study was conducted on 1502 participants (60.3% women, mean age 70 +/- 7.6 years) and subjects' weight, height, waist circumference, serum lipid indices, blood pressure, and fasting plasma glucose were measured. A cardiometabolic risk index (CMRI) was calculated using the participants' systolic and diastolic blood pressure, triglycerides, high-density lipoprotein and fasting glucose levels, and waist circumference. Following the International Diabetes Federation definition, metabolic syndrome was defined as having three or more metabolic abnormalities. All surrogate anthropometric indices correlated significantly with CMRI (p < 0.01). Receiver operating characteristic curve analysis of how well the anthropometric indices identified high cardiometabolic risk showed that WtHR and BRI were the most accurate indices. The best WtHR and BRI cut-off points in men were 0.56 (area under curve, AUC 0.77) and 4.71 (AUC 0.77), respectively. For women, the WtHR and BRI cut-off points were 0.63 (AUC 0.77) and 6.20 (AUC 0.77), respectively. In conclusion, BRI and WtHR have a moderate discriminating power for detecting high cardiometabolic risk in older Colombian adults, supporting the idea that both anthropometric indices are useful screening tools for use in the elderly.	[Ramirez-Velez, Robinson; Izquierdo, Mikel] Univ Publ Navarra, Navarrabiomed Biomed Res Ctr, Dept Hlth Sci, IDISNA Navarras Hlth Res Inst, C Irunlarrea 3,Complejo Hosp Navarra, Navarra 31008, Spain; [Angel Perez-Sousa, Miguel] Univ Huelva, Fac Sport Sci, Ave Fuerzas Armadas S-N, Huelva 21007, Spain; [Izquierdo, Mikel] Inst Salud Carlos III, CIBERFES, Madrid 28029, Spain; [Cano-Gutierrez, Carlos A.] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Aging Inst, Bogota 110111, Colombia; [Gonzalez-Jimenez, Emilio; Schmidt-RioValle, Jacqueline; Correa-Rodriguez, Maria] Univ Granada, Fac Hlth Sci, Dept Nursing, Av Ilustrac 60, Granada 18016, Spain; [Gonzalez-Ruiz, Katherine] Univ Manuela Beltran, Fac Salud, Invest, Grp Ejercicio Fis & Deportes, Bogota 110231, DC, Colombia		Ramirez-Velez, R (corresponding author), Univ Publ Navarra, Navarrabiomed Biomed Res Ctr, Dept Hlth Sci, IDISNA Navarras Hlth Res Inst, C Irunlarrea 3,Complejo Hosp Navarra, Navarra 31008, Spain.	robin640@hotmail.com	Ramírez-Vélez, Robinson/D-5311-2016; Perez-Sousa, Miguel A./M-5931-2019; González-Ruíz, Katherine/AGI-4611-2022; Correa-Rodriguez, Maria/G-1793-2018; Izquierdo, Mikel/A-4894-2010; Izquierdo, Mikel/O-8049-2019; Gonzalez-Jimenez, Emilio/I-6039-2017	Ramírez-Vélez, Robinson/0000-0003-3075-6960; Perez-Sousa, Miguel A./0000-0003-4392-6850; González-Ruíz, Katherine/0000-0001-7518-0761; Correa-Rodriguez, Maria/0000-0001-9165-4349; Izquierdo, Mikel/0000-0002-1506-4272; Izquierdo, Mikel/0000-0002-1506-4272; Schmidt-Riovalle, Jacqueline/0000-0003-2775-0058; Cano-Gutierrez, Carlos/0000-0001-5680-7880; Gonzalez-Jimenez, Emilio/0000-0001-5103-6028	Colciencias; Ministerio de Salud y la Proteccion Social de Colombia [764]; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER) [PI17/01814]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Ministerio de Salud y la Proteccion Social de Colombia; Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER)	This study is part of a larger project that has been funded by the Colciencias y Ministerio de Salud y la Proteccion Social de Colombia (The SABE Study ID 2013, no. 764). Mikel Izquierdo is funded in part by a research grant PI17/01814 of the Ministerio de Economia, Industria y Competitividad (ISCIII, FEDER).	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amirabdollahian F, 2018, J OBES, V2018, DOI 10.1155/2018/8370304; Aronow WS, 2012, BLOOD PRESSURE, V21, P3, DOI 10.3109/08037051.2011.615902; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Boden-Albala B, 2008, STROKE, V39, P30, DOI 10.1161/STROKEAHA.107.496588; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Chang Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2150-2; Chien KL, 2007, ATHEROSCLEROSIS, V194, P214, DOI 10.1016/j.atherosclerosis.2006.07.033; Correa-Rodriguez M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111742; Davila EP, 2013, PREV MED, V56, P30, DOI 10.1016/j.ypmed.2012.10.027; DeBoer MD, 2015, DIABETOLOGIA, V58, P2745, DOI 10.1007/s00125-015-3759-5; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dobbelsteyn CJ, 2001, INT J OBESITY, V25, P652, DOI 10.1038/sj.ijo.0801582; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Gomez F., 2016, CURR GERONTOL GERIAT, V2016, DOI [10.1155/2016/7910205, DOI 10.1155/2016/7910205]; Haghighatdoost F, 2014, NUTRITION, V30, P636, DOI 10.1016/j.nut.2013.10.021; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Knowles KM, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/931402; Krakauer NY, 2018, METAB SYNDR RELAT D, V16, P160, DOI 10.1089/met.2017.0166; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kutner M. H., 2003, APPL LINEAR REGRESSI; Li G, 2020, CLIN NUTR, V39, P893, DOI 10.1016/j.clnu.2019.03.029; Li G, 2019, NUTRITION, V57, P194, DOI 10.1016/j.nut.2018.05.004; Liu PJ, 2017, PUBLIC HEALTH NUTR, V20, P984, DOI [10.1017/s1368980016003281, 10.1017/S1368980016003281]; Maessen MFH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107212; Mantzoros CS, 1996, HORM METAB RES, V28, P32, DOI 10.1055/s-2007-979126; Marquez-Sandoval F, 2011, PUBLIC HEALTH NUTR, V14, P1702, DOI 10.1017/S1368980010003320; Mente A, 2010, J AM COLL CARDIOL, V55, P2390, DOI 10.1016/j.jacc.2009.12.053; Perez-Sousa MA, 2019, J CACHEXIA SARCOPENI, V10, P1009, DOI 10.1002/jcsm.12444; Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694; Ramirez-Velez R, 2019, J CACHEXIA SARCOPENI, V10, P278, DOI 10.1002/jcsm.12373; Ramirez-Velez R, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040412; Ramirez-Velez R, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101093; Stefanescu A, 2020, J INT MED RES, V48, DOI 10.1177/0300060519848854; Thomas DM, 2013, OBESITY, V21, P2264, DOI 10.1002/oby.20408; Tian SM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004642; Tune JD, 2017, TRANSL RES, V183, P57, DOI 10.1016/j.trsl.2017.01.001; VALDEZ R, 1991, J CLIN EPIDEMIOL, V44, P955, DOI 10.1016/0895-4356(91)90059-I; Wang HY, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016062	40	17	17	0	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6643		NUTRIENTS	Nutrients	AUG	2019	11	8							1701	10.3390/nu11081701	http://dx.doi.org/10.3390/nu11081701			16	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	IV8HH	31344803	Green Published, gold			2022-09-04	WOS:000484506000124
J	Dzyurkevich, MS; Babkov, DA; Shtyrlin, NV; Mayka, OY; Iksanova, AG; Vassiliev, PM; Balakin, KV; Spasov, AA; Tarasov, VV; Barreto, G; Shtyrlin, YG; Aliev, G				Dzyurkevich, Mikhail S.; Babkov, Denis A.; Shtyrlin, Nikita V.; Mayka, Olga Yu.; Iksanova, Alfiya G.; Vassiliev, Pavel M.; Balakin, Konstantin V.; Spasov, Alexander A.; Tarasov, Vadim V.; Barreto, George; Shtyrlin, Yurii G.; Aliev, Gjumrakch			Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus (vol 7, 16072, 2017)	SCIENTIFIC REPORTS			English	Correction									[Dzyurkevich, Mikhail S.; Shtyrlin, Nikita V.; Iksanova, Alfiya G.; Balakin, Konstantin V.; Shtyrlin, Yurii G.] Kazan Volga Reg Fed Univ, Kremlyovskaya 18, Kazan 420008, Russia; [Babkov, Denis A.; Mayka, Olga Yu.; Vassiliev, Pavel M.; Spasov, Alexander A.] Volgograd State Med Univ, Pavshikh Bortsov Sq 1, Volgograd 400131, Russia; [Balakin, Konstantin V.] IM Sechenov First Moscow State Med Univ, Trubetskaya St 8,Bld 2, Moscow 119991, Russia; [Tarasov, Vadim V.] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, Moscow 119991, Russia; [Barreto, George] Pontificia Univ Javeriana, Fac Med, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Barreto, George] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res & Consulting LLC, 7733 Louis Pasteur Dr,Suite 328, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm Atlanta, E Johns Crossing 175, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia		Aliev, G (corresponding author), GALLY Int Biomed Res & Consulting LLC, 7733 Louis Pasteur Dr,Suite 328, San Antonio, TX 78229 USA.; Aliev, G (corresponding author), Univ Atlanta, Sch Hlth Sci & Healthcare Adm Atlanta, E Johns Crossing 175, Johns Creek, GA 30097 USA.; Aliev, G (corresponding author), Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia.	aliev03@gmail.com	Aliev, Gjumrakch/AAE-7734-2020; Iksanova, Alfiya/ABA-3656-2020; Aliev, Gjumrakch/K-7302-2017; Iksanova, Alfiya/E-9523-2014; Babkov, Denis/B-6502-2017; Barreto, George E./AAD-7420-2020; Vassiliev, Pavel M/R-9283-2016; Dzyurkevich, Mikhail/K-5915-2017; Spasov, Alexander A/D-9417-2016; Shtyrlin, Nikita V/K-5872-2017; Maika, Olga/B-7692-2017	Aliev, Gjumrakch/0000-0001-7373-3182; Iksanova, Alfiya/0000-0003-0474-6638; Iksanova, Alfiya/0000-0003-0474-6638; Babkov, Denis/0000-0002-9645-3324; Barreto, George E./0000-0002-6644-1971; Vassiliev, Pavel M/0000-0002-8188-5052; Spasov, Alexander A/0000-0002-7185-4826; Shtyrlin, Nikita V/0000-0001-7926-5121; Maika, Olga/0000-0003-3559-004X				Dzyurkevich MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16405-2	1	0	0	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 19	2018	8								6489	10.1038/s41598-018-24838-6	http://dx.doi.org/10.1038/s41598-018-24838-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3EK	29670171	Green Published, gold			2022-09-04	WOS:000430385800005
J	Sanchez-Garrido, N; Cesari, M; Sgaravatti, A; Zengarini, E; Moreira, V; Borda, MG; Zuniga-Gil, C; Perez-Zepeda, MU				Sanchez-Garrido, Natalia; Cesari, Matteo; Sgaravatti, Aldo; Zengarini, Elisa; Moreira, Virgilio; Borda, Miguel-German; Zuniga-Gil, Clemente; Ulises Perez-Zepeda, Mario			The Chimeric Nihilism of Geriatrics	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							INTERVENTION		[Sanchez-Garrido, Natalia; Ulises Perez-Zepeda, Mario] Inst Nacl Geriatria, Geriatr Epidemiol Res Dept, Mexico City, DF, Mexico; [Cesari, Matteo] Ctr Hosp Univ Toulouse, Gerontopole, Toulouse, France; [Cesari, Matteo] Univ Toulouse III Paul Sabatier, Toulouse, France; [Sgaravatti, Aldo] Univ Republica, Dept Geriatr, Montevideo, Uruguay; [Zengarini, Elisa] Univ Perugia, Dept Med, Inst Gerontol & Geriatr, Perugia, Italy; [Moreira, Virgilio] Univ Estado Rio De Janeiro, Dept Internal Med, Rio De Janeiro, Brazil; [Borda, Miguel-German] Pontificia Univ Javeriana, Inst Aging, Bogota, Colombia; [Zuniga-Gil, Clemente] Univ Autonoma Baja California, Internal Med & Geriatr Dept, Tijuana, Baja California, Mexico		Sanchez-Garrido, N (corresponding author), Inst Nacl Geriatria, Geriatr Epidemiol Res Dept, Mexico City, DF, Mexico.		Borda, Miguel Germán/AAK-9029-2020; Moreira, Virgilio G/Q-1776-2015; Perez-Zepeda, Mario/B-7265-2011; Zengarini, Elisa/AAB-7535-2019; Borda, Miguel German/AHB-5593-2022; Cesari, Matteo/A-4649-2008	Borda, Miguel Germán/0000-0001-5832-0603; Perez-Zepeda, Mario/0000-0003-4374-976X; Zengarini, Elisa/0000-0002-0875-6561; Borda, Miguel German/0000-0001-5832-0603; Cesari, Matteo/0000-0002-0348-3664; Sanchez Garrido, Natalia/0000-0001-9308-9662				Camus Albert, 1942, MYTHE SISYPHE; Cervantes Miguel de., 2013, DON QUIJOTE MANCHA; Fairhall N, 2014, AGE AGEING, V43, P616, DOI 10.1093/ageing/aft204; Graves R, 1955, LES MYTHS GRECS; Holt R, 2013, AGE AGEING, V42, P721, DOI 10.1093/ageing/aft120; Martire LM, 2010, J AM GERIATR SOC, V58, P23, DOI 10.1111/j.1532-5415.2009.02610.x; Nietzche F, 1901, DER WILLE ZUR MACHT	7	5	5	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	NOV	2016	64	11					E213	E214		10.1111/jgs.14348	http://dx.doi.org/10.1111/jgs.14348			2	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	EC7QO	27676177				2022-09-04	WOS:000388335600016
J	Sletto, B; Stiphany, K; Winslow, JF; Roberts, A; Torrado, M; Reyes, A; Reyes, A; Yunda, J; Wirsching, C; Choi, K; Tajchman, K				Sletto, Bjorn; Stiphany, Kristine; Winslow, Jane Futrell; Roberts, Andrea; Torrado, Marla; Reyes, Alejandra; Reyes, Ariadna; Yunda, Juan; Wirsching, Christina; Choi, Kwangyul; Tajchman, Kristina			Demystifying Academic Writing in the Doctoral Program: Writing Workshops, Peer Reviews, and Scholarly Identities	PLANNING PRACTICE AND RESEARCH			English	Article; Early Access						Doctoral studies; scholarly identity; planning education; writing pedagogy; curriculum development	STUDENTS; FACULTY; WRITERS; SUPERVISION; COMMUNITY; GEOGRAPHY; SUPPORT; SCHOOL; PHD	This article discusses a course at The University of Texas at Austinwhich sought to facilitate doctoral students' development of scholarly articles while simultaneously fostering their sense of scholarly identity. The article was co-authored by the instructor and two cohorts of doctoral students based on immediate as well as retrospective learning outcome assessments. The social constructivist approach to writing pedagogy fostered students' scholarly identities and demystified the publication process. However, efforts should be made to maintain the practice of writing, sharing, and reviewing and the course should more explicitly foster critical reflections on the relationship between writing, scholarly identity, and knowledge production.	[Sletto, Bjorn; Wirsching, Christina; Tajchman, Kristina] Univ Texas Austin, Sch Architecture, Austin, TX 78712 USA; [Stiphany, Kristine] Texas Tech Univ, Dept Architecture, Lubbock, TX 79409 USA; [Winslow, Jane Futrell; Roberts, Andrea] Texas A&M Univ, Dept Landscape Architecture & Urban Planning, College Stn, TX USA; [Torrado, Marla] Austin Community Design & Dev Ctr, Planning & Engagement, Austin, TX USA; [Reyes, Alejandra] Univ California, Sch Social Ecol, Munk Sch Global Affairs, Irvine, ON, Canada; [Reyes, Ariadna] Univ Penn, Perry World House, Philadelphia, PA 19104 USA; [Yunda, Juan] Pontificia Univ Javeriana, Sch Architecture & Design, Bogota, Colombia; [Choi, Kwangyul] Univ Calgary, Sch Architecture Planning & Landscape, Calgary, AB, Canada		Sletto, B (corresponding author), Univ Texas Austin, Sch Architecture, Austin, TX 78712 USA.	bjorn@utexas.edu	; ROBERTS, ANDREA/U-3097-2017	Choi, Kwangyul/0000-0002-4839-0314; Yunda, Juan/0000-0002-3459-6880; Winslow, Jane Futrell/0000-0002-2459-8049; Reyes, Ariadna/0000-0002-8849-3772; ROBERTS, ANDREA/0000-0001-9979-6026				Adamek ME, 2015, J TEACH SOC WORK, V35, P213, DOI 10.1080/08841233.2014.995333; Aitchison C., 2014, WRITING GROUPS DOCTO, P3; Aitchison C, 2006, TEACH HIGH EDUC, V11, P265, DOI 10.1080/13562510600680574; Austin AE, 2002, J HIGH EDUC, V73, P94, DOI 10.1353/jhe.2002.0001; Baker VL, 2010, STUD HIGH EDUC, V35, P807, DOI 10.1080/03075070903501887; Barnacle R, 2014, STUD HIGH EDUC, V39, P1139, DOI 10.1080/03075079.2013.777405; Bartkowski J. P., 2015, AM SOCIOL, V46, P99; Bleske BE, 2014, AM J PHARM EDUC, V78, DOI 10.5688/ajpe78113; Boote DN, 2012, RESHAPING DOCTORAL EDUCATION: INTERNATIONAL APPROACHES AND PEDAGOGIES, P26; Boud D, 2005, STUD HIGH EDUC, V30, P501, DOI 10.1080/03075070500249138; Broadhurst K, 2014, QUAL SOC WORK, V13, P595, DOI 10.1177/1473325014544936; Brooks M, 2012, J PLAN EDUC RES, V32, P491, DOI 10.1177/0739456X12447976; Caffarella RS, 2000, STUD HIGH EDUC, V25, P39, DOI 10.1080/030750700116000; Carter N, 2012, EDUC ACTION RES, V20, P407, DOI 10.1080/09650792.2012.697403; Carter S., 2014, DEV GENERIC SUPPORT; Chandrasoma R., 2004, J LANG IDENTITY EDUC, V3, P171, DOI DOI 10.1207/S15327701JLIE0303_1; Cotterall S, 2011, TEACH HIGH EDUC, V16, P413, DOI 10.1080/13562517.2011.560381; Cumbie S, 2005, J NURS SCHOLARSHIP, V37, P289, DOI 10.1111/j.1547-5069.2005.00049.x; Cuthbert D, 2009, HIGH EDUC RES DEV, V28, P137, DOI 10.1080/07294360902725025; Danby S, 2012, RESHAPING DOCTORAL EDUCATION: INTERNATIONAL APPROACHES AND PEDAGOGIES, P3; Dowling R, 2012, J GEOGR HIGHER EDUC, V36, P293, DOI 10.1080/03098265.2011.638368; Ferguson T, 2009, J GEOGR HIGHER EDUC, V33, P285, DOI 10.1080/03098260902734968; Foote KE, 2010, J GEOGR HIGHER EDUC, V34, P7, DOI 10.1080/03098260902954087; Forsyth A, 1999, J PLAN EDUC RES, V19, P98, DOI 10.1177/0739456X9901900110; Frankel K., 2013, J ED, V193, P31, DOI [10.1177/002205741319300104, DOI 10.1177/002205741319300104]; Gergen K., 1995, CONSTRUCTIVISM ED, P29; Golde C., 2001, SURVEY DOCTORAL ED C; Guerin C, 2013, STUD CONTIN EDUC, V35, P65, DOI 10.1080/0158037X.2012.684375; Hamin EM, 2000, J PLAN EDUC RES, V20, P88; HIRSCHMAN AO, 1970, WORLD POLIT, V22, P329, DOI 10.2307/2009600; Ivanic R, 1998, WRITING IDENTITY DIS; Kamler B, 2004, TEACH HIGH EDUC, V9, P195, DOI 10.1080/1356251042000195358; Lassig CJ, 2013, STUD CONTIN EDUC, V35, P299, DOI 10.1080/0158037X.2012.746226; Lee A, 2003, STUD HIGH EDUC, V28, P187, DOI 10.1080/0307507032000058109; Lee A., 2009, CHANGING PRACTICES D, P87; Lee A, 2008, TEACH HIGH EDUC, V13, P511, DOI 10.1080/13562510802334723; Maghelal PK, 2008, J PLAN EDUC RES, V28, P108, DOI 10.1177/0739456X08321794; Maher D, 2008, STUD CONTIN EDUC, V30, P263, DOI 10.1080/01580370802439870; Maher MA, 2013, J HIGH EDUC, V84, P121, DOI 10.1353/jhe.2013.0004; Maki PeggyL., 2006, ASSESSMENT DOCTORAL; Manathunga C, 2010, INT J ACAD DEV, V15, P33, DOI 10.1080/13601440903529893; McAlpine L, 2012, INNOV EDUC TEACH INT, V49, P351, DOI 10.1080/14703297.2012.728875; Morss K, 2001, STUD HIGH EDUC, V26, P35, DOI 10.1080/03075070020030706; Murray R, 2008, PHYSIOTHERAPY, V94, P29, DOI 10.1016/j.physio.2007.06.004; Parker R, 2009, TEACH HIGH EDUC, V14, P43, DOI 10.1080/13562510802602533; Reybold L. E., 2003, INNOVATIVE HIGHER ED, P235, DOI [10.1023/A:1024024430041, DOI 10.1023/A:1024024430041]; Rinfrette ES, 2015, J TEACH SOC WORK, V35, P65, DOI 10.1080/08841233.2014.990077; Silvia P.J., 2007, WRITE LOT PRACTICAL; Solem MN, 2004, ANN ASSOC AM GEOGR, V94, P889; Stiftel B, 2009, J PLAN EDUC RES, V28, P323, DOI 10.1177/0739456X08325174; The Association of Collegiate Schools of Planning (ACSP), JPER WRIT WORKSH NEW; Thompson C., 2009, PORTAL J MULTIDISCIP, V6, P1, DOI DOI 10.5130/PORTAL.V6I1.775; Ward Mary-Helen, 2008, INT J EMERGING TECHN, V6, P60; Wilkinson A, 2015, INNOV EDUC TEACH INT, V52, P99, DOI 10.1080/14703297.2014.978350	54	0	0	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-7459	1360-0583		PLAN PRACT RES	Plan. Pract. Res.												10.1080/02697459.2020.1748331	http://dx.doi.org/10.1080/02697459.2020.1748331		APR 2020	14	Regional & Urban Planning	Emerging Sources Citation Index (ESCI)	Public Administration	LF6WB					2022-09-04	WOS:000527557200001
J	Leszek, J; Ashraf, GM; Tse, WH; Zhang, J; Gasiorowski, K; Avila-Rodriguez, MF; Tarasov, VV; Barreto, GE; Klochkov, SG; Bachurin, SO; Aliev, G				Leszek, Jerzy; Ashraf, Ghulam Md; Tse, Wai Hei; Zhang, Jin; Gasiorowski, Kazimierz; Fidel Avila-Rodriguez, Marco; Tarasov, Vadim V.; Barreto, George E.; Klochkov, Sergey G.; Bachurin, Sergey O.; Aliev, Gjumrakch			Nanotechnology for Alzheimer Disease	CURRENT ALZHEIMER RESEARCH			English	Review						Alzheimer's disease; dementia; drug delivery; nanoparticles; neuroprotection; neurofibrillary tangles	GLYCOL)-MODIFIED GELATIN NANOPARTICLES; OXIDATIVE STRESS; GOLD NANOPARTICLES; ULTRASENSITIVE DETECTION; DRUG-DELIVERY; BRAIN; AGGREGATION; CELLS; CYTOTOXICITY; THERAPY	Background: Alzheimer disease (AD) typically affects behavior, memory and thinking. The change in brain have been reported to begin approx. 10-20 years before the appearance of actual symptoms and diagnosis of AD. An early stage diagnosis and treatment of this lethal disease is the prime challenge, which is mainly halted by the lack of validated biomarkers. Method: Recent nanotechnological advancements have the potential to offer large scale effective diagnostic and therapeutic options. Targeted drug (e.g. Rivastigmine) delivery with the help of nanoparticles (NPs) in the range of 1-100 nm diameters can effectively cross the blood brain barrier with minimized side effects. Moreover, biocompatible nanomaterials with increased magnetic and optical properties can act as excellent alternative agents for an early diagnosis. With the high volume of research coming in support of the effective usage of NP based drug delivery in critical environment of CNS, it is quite likely that this approach can end up providing remarkable breakthroughs in early stage diagnosis and therapy of AD. Conclusion: In the current review, we have presented a comprehensive outlook on the current challenges in diagnosis and therapy of AD, with an emphasis on the effective options provided by biocompatible NPs as imaging contrast agents and drug carriers.	[Leszek, Jerzy] Wroclaw Med Univ, Dept Psychiat, Wroclaw, Poland; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Tse, Wai Hei; Zhang, Jin] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Zhang, Jin] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON, Canada; [Gasiorowski, Kazimierz] Wroclaw Med Univ, Dept Basic Med Sci, Wroclaw, Poland; [Fidel Avila-Rodriguez, Marco; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Tarasov, Vadim V.] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, Moscow 119991, Russia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Klochkov, Sergey G.; Bachurin, Sergey O.; Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Moscow Region, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA		Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.	aliev03@gmail.com	Zhang, Jin/AAG-3490-2019; Barreto, George E./AAD-7420-2020; Barreto, George E./B-5747-2014; Aliev, Gjumrakch/AAE-7734-2020; Ashraf, Ghulam Md/H-9485-2012; Sergey, Bachurin/I-1708-2018; Klochkov, S. G./F-4087-2017	Zhang, Jin/0000-0002-6875-8008; Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Ashraf, Ghulam Md/0000-0002-9820-2078; Klochkov, S. G./0000-0002-0299-9183; Tse, Wai Hei (Andrew)/0000-0002-4187-8720; Avila-Rodriguez, Marco/0000-0003-4612-3236; Leszek, Jerzy/0000-0002-2316-2470; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994	Russian Science Foundation (RSCF) [14-23-00160]	Russian Science Foundation (RSCF)(Russian Science Foundation (RSF))	This work was supported by the grant from the Russian Science Foundation (RSCF: No. 14-23-00160).	Ahmad A, 2012, PHYTOMEDICINE, V19, P639, DOI 10.1016/j.phymed.2012.02.012; Ahmad A, 2012, CAN J NEUROL SCI, V39, P311, DOI 10.1017/S0317167100013433; Ahmad MZ, 2014, CNS NEUROL DISORD-DR, V13, P1315, DOI 10.2174/1871527313666141023100618; Ali A, 2015, CURR DRUG METAB, V16, P376, DOI 10.2174/1389200216666141208153303; Aliev G, 2014, CURR MED CHEM, V21, P2208, DOI 10.2174/0929867321666131227161303; Aliev G., 2011, SYSTEMS BIOL FREE RA, P2325; Aliev G, 2015, CNS NEUROL DISORD-DR, V14, P1235, DOI 10.2174/1871527314666150821102631; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Ansari SA, 2017, CURR OPIN PSYCHIATR, V30, P128, DOI 10.1097/YCO.0000000000000310; Ashraf GM, 2016, CNS NEUROL DISORD-DR, V15, P321, DOI 10.2174/1871527315666160202124900; Ashraf GM, 2014, CNS NEUROL DISORD-DR, V13, P1280, DOI 10.2174/1871527313666140917095514; Ashraf GM, 2015, CURR DRUG METAB, V16, P719, DOI 10.2174/138920021608151107125757; Ausaf Ahmad, 2013, Medicinal Plants - International Journal of Phytomedicines and Related Industries, V5, P194, DOI 10.5958/j.0975-6892.5.4.031; Azarmi S, 2006, J PHARM PHARM SCI, V9, P124; Bakry R, 2007, INT J NANOMED, V2, P639; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bastus NG, 2007, MAT SCI ENG C-BIO S, V27, P1236, DOI 10.1016/j.msec.2006.08.003; Baum L, 2004, J ALZHEIMERS DIS, V6, P367; Bhat SA, 2017, CURR TOP MED CHEM, V17, P1371, DOI 10.2174/1568026616666161222121229; Blach-Olszewska Z, 2015, CURR PHARM DESIGN, V21, P3582, DOI 10.2174/1381612821666150710144829; Brambilla D, 2011, NANOMED-NANOTECHNOL, V7, P521, DOI 10.1016/j.nano.2011.03.008; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Butterfield DA, 2002, FREE RADICAL RES, V36, P1307, DOI 10.1080/1071576021000049890; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Davis D. A., 2006, NANOSCAPE, V3, P13; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434; Dugan LL, 1996, NEUROBIOL DIS, V3, P129, DOI 10.1006/nbdi.1996.0013; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Etame AB, 2012, NANOMED-NANOTECHNOL, V8, P1133, DOI 10.1016/j.nano.2012.02.003; Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321; Fazili NA, 2015, CURR DRUG METAB, V16, P346, DOI 10.2174/1389200215999141125115749; Galimberti Daniela, 2011, Ther Adv Neurol Disord, V4, P203, DOI 10.1177/1756285611404470; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Gupta AK, 2004, J CONTROL RELEASE, V95, P197, DOI 10.1016/j.jconrel.2003.11.006; Haes AJ, 2004, NANO LETT, V4, P1029, DOI 10.1021/nl049670j; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; Hegde ML, 2009, J ALZHEIMERS DIS, V17, P457, DOI 10.3233/JAD-2009-1068; Hodes G, 2007, ADV MATER, V19, P639, DOI 10.1002/adma.200601173; Hsieh SC, 2013, COLLOID SURFACE B, V112, P525, DOI 10.1016/j.colsurfb.2013.08.029; Huang HM, 2000, LIFE SCI, V66, P1525, DOI 10.1016/S0024-3205(00)00470-7; Huang XD, 2004, ANN NY ACAD SCI, V1012, P153, DOI 10.1196/annals.1306.012; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jabir NR, 2012, INT J NANOMED, V7, P4391, DOI 10.2147/IJN.S33838; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Joshi SA, 2010, EUR J PHARM BIOPHARM, V76, P189, DOI 10.1016/j.ejpb.2010.07.007; Kadowaki H, 2005, CELL DEATH DIFFER, V12, P19, DOI 10.1038/sj.cdd.4401528; Kaul G, 2002, PHARM RES-DORDR, V19, P1061, DOI 10.1023/A:1016486910719; Kaul G, 2004, J DRUG TARGET, V12, P585, DOI 10.1080/10611860400013451; Keating CD, 2005, P NATL ACAD SCI USA, V102, P2263, DOI 10.1073/pnas.0500024102; Khan TA, 2016, CNS NEUROL DISORD-DR, V15, P310, DOI 10.2174/1871527315666160202124518; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Kogan MJ, 2006, NANO LETT, V6, P110, DOI 10.1021/nl0516862; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; KRUSIC PJ, 1991, SCIENCE, V254, P1183, DOI 10.1126/science.254.5035.1183; Lee CM, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/28/285102; Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028; Madan J, 2011, ANTI-CANCER DRUG, V22, P543, DOI 10.1097/CAD.0b013e32834159b8; Mahajan YR, 2011, NANOTECH INSIGHTS, V2, P17; Marty B, 2012, J CEREBR BLOOD F MET, V32, P1948, DOI 10.1038/jcbfm.2012.100; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Mirza Z, 2014, CNS NEUROL DISORD-DR, V13, P213, DOI 10.2174/18715273113126660144; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h; Nikalje A. P., 2015, NIKALJE MED CHEM, V5, P81, DOI [10.4172/2161-0444.1000247, DOI 10.4172/2161-0444.1000247]; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Pai AS, 2006, PEPTIDES, V27, P2858, DOI 10.1016/j.peptides.2006.04.022; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Parveen S, 2012, NANOMED-NANOTECHNOL, V8, P147, DOI 10.1016/j.nano.2011.05.016; Rao KSJ, 1999, ALZHEIMERS REP, V2, P241; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Rocha S, 2008, BIOPHYS CHEM, V137, P35, DOI 10.1016/j.bpc.2008.06.010; Saraiva AM, 2010, MACROMOL BIOSCI, V10, P1152, DOI 10.1002/mabi.200900448; Shemetov AA, 2012, ACS NANO, V6, P4585, DOI 10.1021/nn300415x; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; SIMKO M., 2010, NANOTRUST DOSSIERS, P1; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Soursou G, 2015, CURR DRUG METAB, V16, P705, DOI 10.2174/138920021608151107125049; Suh AR, 2006, MICROSC MICROANAL, V12, P620; Suh WH, 2006, ADV MATER, V18, P1832, DOI 10.1002/adma.200600222; Suh WH, 2009, PROG NEUROBIOL, V87, P133, DOI 10.1016/j.pneurobio.2008.09.009; Thakur G., 2011, INT J ALZHEIMERS DIS, DOI 10.4061/2011/502386; Wilson B, 2008, BRAIN RES, V1200, P159, DOI 10.1016/j.brainres.2008.01.039; Xiao LH, 2010, BIOMATERIALS, V31, P91, DOI 10.1016/j.biomaterials.2009.09.014; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yang Z, 2010, NANOMED-NANOTECHNOL, V6, P427, DOI 10.1016/j.nano.2009.11.007; Ye YJ, 2013, INT J PHARMACEUT, V458, P110, DOI 10.1016/j.ijpharm.2013.10.005	100	28	29	1	38	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2050	1875-5828		CURR ALZHEIMER RES	Curr. Alzheimer Res.		2017	14	11					1182	1189		10.2174/1567205014666170203125008	http://dx.doi.org/10.2174/1567205014666170203125008			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FJ5DT	28164767				2022-09-04	WOS:000412767100006
J	Medina, AG; Bassyouni, A; Bee, Y; Beshyah, S; Kshanti, I; Omar, M; Sari, R; Chan, V; Jain, A; Siddiqui, N				Medina, Ana Gomez; Bassyouni, Atef; Bee, Yong; Beshyah, Salem; Kshanti, Ida; Omar, Mak; Sari, Ramazan; Chan, Vicky; Jain, Anand; Siddiqui, Nazrul			Self-reported hypoglycemic rates and insulin regimen among 7289 insulin-treated adult patients with diabetes: An International survey in 9 countries	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Meeting Abstract									[Medina, Ana Gomez] Javeriana Univ, Bogota, Colombia; [Bassyouni, Atef] Natl Inst Diabet & Endocrinol, Cairo, Egypt; [Bee, Yong] Singapore Gen Hosp, Singapore, Singapore; [Beshyah, Salem] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates; [Kshanti, Ida] Fatmawati Hosp, Jakarta, Indonesia; [Omar, Mak] Univ KwaZulu Natal, Durban, South Africa; [Sari, Ramazan] Akdeniz Univ, Fac Med, Antalya, Turkey; [Chan, Vicky; Jain, Anand] Novo Nordisk, Zurich, Switzerland; [Siddiqui, Nazrul] Mymensingh Med Coll Hosp, Mymensingh, Bangladesh				Beshyah, Salem A/I-1533-2019	Beshyah, Salem A/0000-0003-3650-9741					0	0	0	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	OCT	2016	120			1		PD-69	S113	S113						1	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	FN6GZ					2022-09-04	WOS:000416113300332
J	Patino, B; Acon-Solano, C; Pereira, M; Enciso-Olivera, L; Otero-de la Hoz, D; Cordero, HM; Spirko, P; Solano-Vega, J; Arevalo-Zambrano, M; Heider, U; Ruiz-Patino, A; Sossa, CL; Pena, AM; Chalela, CM; Karduss, A; Leon-Basantes, G; Abello, V; Espinosa, DL; Guerrero, P; Guerrero, A; Herrera, JM; Osuna, M; Perdomo, I; Rosales, C; Omana, P; Villarroya, N; Rodriguez-Sanjuan, V; Sandoval-Sus, J				Patino, Bonell; Acon-Solano, Cristina; Pereira, Mario; Enciso-Olivera, Leonardo; Otero-de la Hoz, Diana; Cordero, Humberto Martinez; Spirko, Paola; Solano-Vega, Julio; Arevalo-Zambrano, Monica; Heider, Ulrike; Ruiz-Patino, Alejandro; Sossa, Claudia Lucia; Pena, Angela Maria; Chalela, Claudia Marcela; Karduss, Amado; Leon-Basantes, Guillermo; Abello, Virginia; Espinosa, Daniel Lorenzo; Guerrero, Paola; Guerrero, Alvaro; Herrera, Juan Manuel; Osuna, Monica; Perdomo, Ivan; Rosales, Carmen; Omana, Paola; Villarroya, Natalia; Rodriguez-Sanjuan, Victor; Sandoval-Sus, Jose			Brentuximab Vedotin As Consolidation Therapy Post Hematopoietic Stem Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma: A Real World Analysis of the Colombian Experience	BLOOD			English	Meeting Abstract	61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)	DEC 07-10, 2019	Orlando, FL	Amer Soc Hematol					[Patino, Bonell; Acon-Solano, Cristina; Pereira, Mario; Enciso-Olivera, Leonardo; Otero-de la Hoz, Diana; Cordero, Humberto Martinez; Spirko, Paola] Inst Nacl Cancerol, Bogota, Colombia; [Solano-Vega, Julio; Arevalo-Zambrano, Monica; Heider, Ulrike] Hosp Univ San Ignacio, Bogota, Colombia; [Ruiz-Patino, Alejandro] Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; [Sossa, Claudia Lucia; Pena, Angela Maria] Univ Autonoma Bucaramanga, Fac Hlth Sci, Bucaramanga, Colombia; [Sossa, Claudia Lucia; Pena, Angela Maria; Chalela, Claudia Marcela] Clin FOSCAL, Hematol & Hematopoiet Stem Cell Transplantat Unit, Floridablanca, Colombia; [Karduss, Amado] Inst Cancerol Amer, Medellin, Colombia; [Leon-Basantes, Guillermo; Abello, Virginia; Espinosa, Daniel Lorenzo] Fdn Univ Ciencias Salud, Hosp San Jose, Bogota, Colombia; [Guerrero, Paola; Guerrero, Alvaro; Herrera, Juan Manuel] Ctr Med Imbanaco, Cali, Colombia; [Osuna, Monica; Perdomo, Ivan] Clin Los Nogales, Bogota, Colombia; [Rosales, Carmen] Clin Country, Bogota, Colombia; [Omana, Paola] Ctr Invest Oncol Clin San Diego CIOSAD, Bogota, Colombia; [Villarroya, Natalia; Rodriguez-Sanjuan, Victor] Inst Trasplante Medula Osea Costa, Barranquilla, Colombia; [Sandoval-Sus, Jose] Mem Healthcare Syst, Moffitt Canc Ctr, Moffitt Malignant Hematol & Cellular Therapy, Pembroke Pines, FL USA				Patiño-Escobar, Bonell/GPG-1865-2022	Patiño-Escobar, Bonell/0000-0003-2622-4822; Martinez-Cordero, Humberto/0000-0002-7920-5951					0	0	0	0	0	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	NOV 13	2019	134			1		5275				10.1182/blood-2019-129295	http://dx.doi.org/10.1182/blood-2019-129295			4	Hematology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Hematology	NZ5SD		Bronze			2022-09-04	WOS:000577164605348
J	Weijs, PJM; Dickerson, RN; Heyland, DK; Moore, FA; Rugeles, SJ; McClave, SA				Weijs, Peter J. M.; Dickerson, Roland N.; Heyland, Daren K.; Moore, Frederick A.; Rugeles, Saul J.; McClave, Stephen A.			Experimental and Outcome-Based Approaches to Protein Requirements in the Intensive Care Unit	NUTRITION IN CLINICAL PRACTICE			English	Review						protein; intensive care unit; critical illness; nitrogen; energy	CRITICALLY-ILL PATIENTS; ENTERAL NUTRITION; NITROGEN REQUIREMENTS; CRITICAL ILLNESS; SEPTIC PATIENTS; ENERGY; MORTALITY; RECOMMENDATIONS; PROVISION; INFUSION	Insight into protein requirements of intensive care unit (ICU) patients is urgently needed, but at present, it is unrealistic to define protein requirements for different diagnostic groups of critical illness or at different stages of illness. No large randomized controlled trials have randomized protein delivery, adequately addressed energy intake, and evaluated relevant clinical outcomes. As a pragmatic approach, experimental studies have focused on protein requirements of heterogeneous ICU patients. Data are scarce and the absolute value of protein requirements therefore is an approximation. Experimental studies indicate a protein requirement of >1.2 g/kg protein, which is supported by several outcome-based observational studies. Protein intake levels of up to 2.0-2.5 g/kg appear to be safe. A higher level of personalized treatment, within 1.2 and 2.5 g/kg, must involve identification of patients with low muscle protein mass that might benefit most from adequate protein nutrition in the ICU.	[Weijs, Peter J. M.] Vrije Univ Amsterdam, Dept Internal Med, Med Ctr, Nutr & Dietet, Amsterdam, Netherlands; [Weijs, Peter J. M.] Amsterdam Univ Appl Sci, Fac Sports & Nutr, Nutr & Dietet, Amsterdam, Netherlands; [Weijs, Peter J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care Med, Amsterdam, Netherlands; [Weijs, Peter J. M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Dickerson, Roland N.] Univ Tennessee, Dept Clin Pharm, Coll Pharm, Memphis, TN USA; [Heyland, Daren K.] Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON, Canada; [Heyland, Daren K.] Queens Univ, Dept Crit Care Med, Kingston, ON, Canada; [Moore, Frederick A.] Univ Florida, Coll Med, Dept Surg, Div Acute Care Surg, Gainesville, FL USA; [Moore, Frederick A.] Univ Florida, Coll Med, Ctr Sepsis & Crit Illness Res, Gainesville, FL USA; [Rugeles, Saul J.] Pontificia Univ Javeriana, Med Sch, Hosp Univ San Ignacio, Dept Surg, Bogota, Colombia; [McClave, Stephen A.] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40292 USA		Weijs, PJM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Lector Weight Management,Nutr & Dietet, POB 7057, NL-1007 MB Amsterdam, Netherlands.	p.weijs@vumc.nl	Rugeles, Saúl/AAV-9510-2020	Rugeles, Saúl/0000-0003-0401-0743; Dickerson, Roland/0000-0002-2086-6317; Weijs, Peter/0000-0001-8281-0426	Nestle HealthCare Nutrition, Inc.	Nestle HealthCare Nutrition, Inc.(Nestle SA)	Financial support for the publication of the supplement in which this article appears was provided by Nestle HealthCare Nutrition, Inc.	Alberda Cathy, 2009, Intensive Care Med, V35, P1728, DOI 10.1007/s00134-009-1567-4; Allingstrup MJ, 2012, CLIN NUTR, V31, P462, DOI 10.1016/j.clnu.2011.12.006; Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021; Casaer MP, 2013, AM J RESP CRIT CARE, V187, P247, DOI 10.1164/rccm.201206-0999OC; Deutz NEP, 2014, CLIN NUTR, V33, P929, DOI 10.1016/j.clnu.2014.04.007; Dickerson RN, 2015, JPEN-PARENTER ENTER, V39, P282, DOI 10.1177/0148607113506939; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Doig GS, 2015, INTENS CARE MED, V41, P1197, DOI 10.1007/s00134-015-3827-9; Elke G, 2015, NEW ENGL J MED, V373, P1174, DOI 10.1056/NEJMc1509259; Elke G, 2014, CRIT CARE, V18, DOI 10.1186/cc13720; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2832; FAO/WHO/UNU, 2007, WHO TECHN REP SER, V935; Ferrie S, 2016, JPEN-PARENTER ENTER, V40, P795, DOI 10.1177/0148607115618449; Fraipont V, 2013, JPEN-PARENTER ENTER, V37, P705, DOI 10.1177/0148607113505868; Herridge Margaret S, 2011, N Engl J Med, V364, P1293, DOI 10.1056/NEJMoa1011802; Heyland DK, 2017, NUTR CLIN PRACT, V32, p58S, DOI 10.1177/0884533617691245; Hoffer LJ, 2012, AM J CLIN NUTR, V96, P591, DOI 10.3945/ajcn.111.032078; Hoffer LJ, 2011, AM J CLIN NUTR, V94, P1396, DOI 10.3945/ajcn.111.023390; Ishibashi N, 1998, CRIT CARE MED, V26, P1529, DOI 10.1097/00003246-199809000-00020; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Kruizenga H, 2016, AM J CLIN NUTR, V103, P1026, DOI 10.3945/ajcn.115.126615; LARSSON J, 1990, BRIT J SURG, V77, P413, DOI 10.1002/bjs.1800770418; Liebau F, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0844-6; Looijaard WG, 2017, ADEQUATE PROTEIN NUT; McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1177/0148607115621863, 10.1097/CCM.0000000000001525]; McClave SA, 2015, CURR OPIN CLIN NUTR, V18, P155, DOI 10.1097/MCO.0000000000000144; Meijer RI, 2016, LANCET DIABETES ENDO, V4, P958, DOI 10.1016/S2213-8587(15)00520-3; Millward DJ, 2012, BRIT J NUTR, V108, pS3, DOI 10.1017/S0007114512002450; Monk DN, 1996, ANN SURG, V223, P395, DOI 10.1097/00000658-199604000-00008; Nicolo M, 2016, JPEN-PARENTER ENTER, V40, P45, DOI 10.1177/0148607115583675; Phillips SM, 2017, NUTR CLIN PRACT, V32, p112S, DOI 10.1177/0884533616686719; Puthucheary ZA, 2014, JAMA-J AM MED ASSOC, V311, P622, DOI 10.1001/jama.2013.285426; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Rand WM, 2003, AM J CLIN NUTR, V77, P109, DOI 10.1093/ajcn/77.1.109; Rugeles SJ, 2013, INDIAN J CRIT CARE M, V17, P343, DOI 10.4103/0972-5229.123438; SHAW JHF, 1987, ANN SURG, V205, P288, DOI 10.1097/00000658-198703000-00012; Singer P, 2014, CLIN NUTR, V33, P246, DOI 10.1016/j.clnu.2013.12.004; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; van Schijndel RJMS, 2009, NETH J MED, V67, P388; van Schijndel RJM S, 2007, E SPEN J, V2, P69; van Schijndel RJMS, 2009, CRIT CARE, V13, DOI 10.1186/cc7993; Weijs PJM, 2015, J THORAC DIS, V7, pE209, DOI 10.3978/j.issn.2072-1439.2015.08.23; Weijs PJM, 2016, CLIN NUTR, V35, P394, DOI 10.1016/j.clnu.2015.02.016; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0701-z; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/cc13189; Weijs PJM, 2014, CURR OPIN CLIN NUTR, V17, P183, DOI 10.1097/MCO.0000000000000029; Weijs PJM, 2012, JPEN-PARENTER ENTER, V36, P60, DOI 10.1177/0148607111415109; Weijs PJ, 2016, PROTEIN INTAKE NUTR	48	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-5336	1941-2452		NUTR CLIN PRACT	Nutr. Clin. Pract.	APR	2017	32			1			77S	85S		10.1177/0884533617692774	http://dx.doi.org/10.1177/0884533617692774			9	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	ET3QZ	28388371	Bronze			2022-09-04	WOS:000400195900009
J	Busso, D; David, A; Penailillo, R; Echeverria, G; Rigotti, A; Kovalskys, I; Gomez, G; Sanabria, LYC; Garcia, MCY; Pareja, RG; Herrera-Cuenca, M; Fisberg, M				Busso, Dolores; David, Andrea; Penailillo, Reyna; Echeverria, Guadalupe; Rigotti, Attilio; Kovalskys, Irina; Gomez, Georgina; Cortes Sanabria, Lilia Yadira; Yepez Garcia, Martha Cecilia; Pareja, Rossina G.; Herrera-Cuenca, Marianella; Fisberg, Mauro		ELANS Study Grp	Intake of Vitamin E and C in Women of Reproductive Age: Results from the Latin American Study of Nutrition and Health (ELANS)	NUTRIENTS			English	Article						women of reproductive age; Latin America; intake; vitamin E; vitamin C	TOCOPHEROL TRANSFER PROTEIN; ALPHA-TOCOPHEROL; E SUPPLEMENTATION; PREGNANT-WOMEN; E-DEFICIENCY; FOOD; REQUIREMENTS; INTERVENTION; PREVALENCE; PROFILE	Vitamin E was identified as a lipophilic compound essential to maintain rat pregnancy. Low vitamin E intake during early pregnancy associates with congenital malformations and embryonic loss in animals and with miscarriage and intrauterine growth restriction in humans. Vitamin E protects cell membranes from lipoperoxidation and exerts non-antioxidant activities. Its function can be restored by vitamin C; thus, intake and circulating levels of both micronutrients are frequently analyzed together. Although substantial vitamin E inadequacy was reported worldwide, its consumption in Latin America (LatAm) is mostly unknown. Using data from the Latin American Study of Nutrition and Health (Estudio Latinoamericano de Nutricion y Salud, ELANS), we evaluated vitamin E and C intake in women of reproductive age (WRA) from eight LatAm countries and identified their main food sources. Two non-consecutive 24-h dietary recalls in 3704 women aged from 15 to 49 years and living in urban locations showed low average intake of vitamin E (7.9 mg/day vs. estimated average requirement (EAR) of 12 mg/day) and adequate overall vitamin C consumption (95.5 mg/day vs. EAR of 60 mg/day). The mean regional inadequacy was 89.6% for vitamin E and 36.3% for vitamin C. The primary food sources of vitamin E were fats and oils, as well as vegetables. Vitamin C intake was explained mainly by the consumption of fruit juices, fruits, and vegetables. Combined deficient intake of both vitamins was observed in 33.7% of LatAm women. Although the implications of low antioxidant vitamins' consumption in WRA are still unclear, the combined deficient intake of both vitamins observed in one-third of ELANS participants underscores the need for further research on this topic.	[Busso, Dolores; Penailillo, Reyna] Univ Los Andes, Biomed Res & Innovat Ctr, Sch Med, Santiago 7550000, Chile; [David, Andrea; Echeverria, Guadalupe; Rigotti, Attilio] Pontificia Univ Catolica Chile, Sch Med, Dept Nutr Diabet & Metab, Santiago 8320000, Chile; [Echeverria, Guadalupe; Rigotti, Attilio] Pontificia Univ Catolica Chile, Ctr Mol Nutr & Chron Dis, Sch Med, Santiago 8320000, Chile; [Kovalskys, Irina] Pontificia Univ Catolica Argentina, Fac Ciencias Med, Carrera Nutr, C1059ABF, Buenos Aires, DF, Argentina; [Gomez, Georgina] Univ Costa Rica, Dept Bioquim, Escuela Med, San Jose 94088, Costa Rica; [Cortes Sanabria, Lilia Yadira] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Bogota 110111, Colombia; [Yepez Garcia, Martha Cecilia] Univ San Francisco Quito, Colegio Ciencias Salud, Quito 171200841, Ecuador; [Pareja, Rossina G.] Inst Invest Nutr, Lima 15026, Peru; [Herrera-Cuenca, Marianella] Univ Cent Venezuela CENDES UCV, Ctr Estudios Desarrollo, Caracas 1010, Venezuela; [Herrera-Cuenca, Marianella] Fdn Bengoa, Caracas 1010, Venezuela; [Fisberg, Mauro] Fundacao Jose Luiz Egydio Setubal, Inst Pensi, Hosp Infantil Sabara, BR-04023062 Sao Paulo, Brazil; [Fisberg, Mauro] Univ Fed Sao Paulo, Ctr Excelencia Nutr & Dificuldades Alimentaes CEN, Inst Pensi, Fundacao Jose Luiz Egydio Setubal,Dept Pediat, BR-01239040 Sao Paulo, Brazil		Busso, D (corresponding author), Univ Los Andes, Biomed Res & Innovat Ctr, Sch Med, Santiago 7550000, Chile.	dbusso@uandes.cl; andreadavidn@hotmail.com; reyna.penailillo@gmail.com; gecheverria@bio.puc.cl; arigotti@med.puc.cl; ikovalskys@ilsi.org.ar; georgina.gomez@ucr.ac.cr; ycortes@javeriana.edu.co; myepez@usfq.edu.ec; rpareja@iin.sld.pe; marianella.herrera@ucv.ve; mfisberg.dped@epm.br	Fisberg, Mauro/E-7149-2010; Pareja, Rossina/D-9892-2018	Fisberg, Mauro/0000-0003-2992-3215; Kovalskys, Irina/0000-0001-8481-5415; Gomez, Georgina/0000-0003-3514-2984; Penailillo, Reyna/0000-0001-5300-1208; Cortes, Lilia Yadira/0000-0003-2789-3219; Yepez, Martha Cecilia/0000-0003-4119-238X; Pareja, Rossina/0000-0001-7523-3181; Herrera-Cuenca, Marianella/0000-0003-0162-3480; Echeverria, Guadalupe/0000-0002-2915-0171	Agencia Nacional de Investigacion y Desarrollo from the Government of Chile through Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1180347]; Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	Agencia Nacional de Investigacion y Desarrollo from the Government of Chile through Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT); Coca Cola Company; Instituto Pensi/Hospital Infantil Sabara; International Life Science Institute of Argentina; Universidad de Costa Rica; Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa; Universidad San Francisco de Quito; Instituto de Investigacion Nutricional de Peru	The research reported in this review was funded by Agencia Nacional de Investigacion y Desarrollo from the Government of Chile, through grant from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) #1180347 to Dolores Busso. The ELANS and researchers (PIs and advisory board) were supported by a scientific grant from the Coca Cola Company as well as funds from Instituto Pensi/Hospital Infantil Sabara, International Life Science Institute of Argentina, Universidad de Costa Rica, Pontificia Universidad Catolica de Chile, Pontificia Universidad Javeriana, Universidad Central de Venezuela (CENDES-UCV)/Fundacion Bengoa, Universidad San Francisco de Quito, and Instituto de Investigacion Nutricional de Peru.	Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4149; Alvarez JJ, 1996, J LIPID RES, V37, P299; Bailey RL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5967; Bastani P, 2011, INT J GEN MED, V4, P461, DOI 10.2147/IJGM.S20107; Brauchla M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020420; Brigelius-Flohe R, 2009, FREE RADICAL BIO MED, V46, P543, DOI 10.1016/j.freeradbiomed.2008.12.007; Bruno RS, 2005, AM J CLIN NUTR, V81, P95; Busso D, 2021, PUBLIC HEALTH NUTR, V24, P385, DOI 10.1017/S1368980020002608; Clark J, 2016, FOOD SCI NUTR, V4, P848, DOI 10.1002/fsn3.353; Clark J, 2012, J ACAD NUTR DIET, V112, P297, DOI 10.1016/j.jada.2011.08.033; Committee W.E., 1995, WHO EXP COMM PHYS ST; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dror DK, 2011, FOOD NUTR BULL, V32, P124, DOI 10.1177/156482651103200206; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Fares S, 2014, PEDIATR NEONATOL, V55, P196, DOI 10.1016/j.pedneo.2013.09.006; Fisberg M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2765-y; Food Agriculture and Organization of the United Nations & Family Health International 360, 2016, MIN DIET DIV WOM GUI; Gomez Georgina, 2020, Nutrients, V12, P1994, DOI 10.3390/nu12071994; Hauth JC, 2010, OBSTET GYNECOL, V116, P653, DOI 10.1097/AOG.0b013e3181ed721d; Herrera E, 2004, EUR J CLIN NUTR, V58, P1231, DOI 10.1038/sj.ejcn.1601954; Herrera-Cuenca Marianella, 2021, Nutrients, V13, P45, DOI 10.3390/nu13010045; Institute of Medicine, 2000, ANTIOXIDANTS RELATED, DOI [10.17226/9810, DOI 10.17226/9810]; Jauniaux E, 2004, J CLIN ENDOCR METAB, V89, P1452, DOI 10.1210/jc.2003-031332; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Kaempf-Rotzoll DE, 2003, PLACENTA, V24, P439, DOI 10.1053/plac.2002.0966; Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599; Kositamongkol S, 2011, J PERINATOL, V31, P471, DOI 10.1038/jp.2010.155; Kovalskys I, 2018, PUBLIC HEALTH NUTR, V21, P2535, DOI 10.1017/S1368980018001222; Kovalskys I, 2015, NUTRIENTS, V7, P7914, DOI 10.3390/nu7095373; Lean SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186287; Lewandowska M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092838; Maras JE, 2004, J AM DIET ASSOC, V104, P567, DOI 10.1016/j.jada.2004.01.004; Mattill H.A., 1924, J BIOL CHEM, V44, P137, DOI [10.1016/S0021-9258(18)86276-7, DOI 10.1016/S0021-9258(18)86276-7]; McDougall M, 2017, FREE RADICAL BIO MED, V110, P250, DOI 10.1016/j.freeradbiomed.2017.06.012; Medicine I.O, 2006, DIETARY REFERENCE IN, P1344, DOI 10.17226/11537; Miller GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047402; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Niki E, 2012, ANN NUTR METAB, V61, P207, DOI 10.1159/000343106; Olza J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070697; Peter S, 2015, INT J VITAM NUTR RES, V85, P261, DOI 10.1024/0300-9831/a000281; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Previdelli AN, 2019, NUTR RES, V68, P9, DOI 10.1016/j.nutres.2019.05.007; Rengaraj D, 2015, INT J MOL SCI, V16, P9910, DOI 10.3390/ijms16059910; Rigotti A, 2007, MOL ASPECTS MED, V28, P423, DOI 10.1016/j.mam.2007.01.002; Rumbold A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004069.pub3; Santander N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05422-w; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schleicher RL, 2009, AM J CLIN NUTR, V90, P1252, DOI 10.3945/ajcn.2008.27016; Shamim AA, 2015, AM J CLIN NUTR, V101, P294, DOI 10.3945/ajcn.114.094920; Simsek M, 1998, CELL BIOCHEM FUNCT, V16, P227; Sure B, 1924, J BIOL CHEM, V58, P693; Traber MG, 2017, AM J CLIN NUTR, V105, P571, DOI 10.3945/ajcn.116.138495; Traber MG, 2014, ADV NUTR, V5, P503, DOI 10.3945/an.114.006254; US Departs of Agriculture and Health and Human Services, 2020, DIET GUID AM 2020 20, V9th; US Institute of Medicine, 2000, DIET REF INT VIT C V, P528, DOI [10.1016/S0002-8223(00)00189-9, DOI 10.1016/S0002-8223(00)00189-9]; Violet PC, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133309; WHO, 2019, BUILDING CLIMATE RES, DOI [10.18356/63e608ce-en, DOI 10.18356/63E608CE-EN]; Zingg JM, 2015, ANNU REV NUTR, V35, P135, DOI 10.1146/annurev-nutr-071714-034347; Zingg JM, 2004, CURR MED CHEM, V11, P1113, DOI 10.2174/0929867043365332	60	1	1	3	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6643		NUTRIENTS	Nutrients	JUN	2021	13	6							1954	10.3390/nu13061954	http://dx.doi.org/10.3390/nu13061954			16	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	SZ6KN	34200192	gold, Green Published			2022-09-04	WOS:000666671800001
J	Tabak, AG; Anderson, J; Aschner, P; Liu, M; Saremi, A; Stella, P; Tinahones, FJ; Wysham, C; Meier, JJ				Tabak, Adam G.; Anderson, John; Aschner, Pablo; Liu, Minzhi; Saremi, Aramesh; Stella, Peter; Tinahones, Francisco J.; Wysham, Carol; Meier, Juris J.			Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis	DIABETES THERAPY			English	Article						Hypoglycemia; iGlarLixi; Insulin therapy; Type 2 diabetes; Weight control	PEPTIDE-1 RECEPTOR AGONIST; PLUS LIXISENATIDE; THERAPY; METFORMIN; LIXILAN; TRIALS; DRUGS	Introduction Basal-bolus (BB) regimens are generally used to intensify basal insulin therapy in patients with type 2 diabetes (T2D) not meeting glycemic targets. However, drawbacks include multiple injection burden and risk of weight gain and hypoglycemia. A once-daily titratable fixed-ratio combination of insulin glargine 100 U/mL and lixisenatide (iGlarLixi) may provide a simple, well-tolerated, and efficacious alternative. We compared these treatments in a post hoc propensity score matched analysis using randomized trial data. Methods From the LixiLan-L study, 195 patients who had been randomized to iGlarLixi were matched for age, sex, race, T2D duration, baseline body mass index, glycated hemoglobin (HbA1c), fasting plasma glucose, insulin dose, and metformin use to 195 patients who had been randomized to a BB regimen in the GetGoal Duo-2 trial. Results At study end, estimated treatment differences for reduction in HbA1c and weight change, and ratio of hypoglycemia events per patient-year (BB vs iGlarLixi) were - 0.28% (standard error 0.08, P = 0.0002), - 1.32 kg (standard error 0.30, P < 0.0001), and 2.85 (P < 0.0001), respectively, all favoring iGlarLixi over BB. Also, proportions of patients reaching individual and composite goals (HbA1c < 7% [< 53 mmol/mol], no weight gain, and no hypoglycemia) were higher in the iGlarLixi compared with the BB treatment group. Gastrointestinal side effects were more common with iGlarLixi. Conclusions In patients with T2D inadequately controlled on basal insulin, iGlarLixi offers an effective alternative to BB regimen for reducing HbA1c, without increased risk of hypoglycemia and weight gain. Plain Language Summary Plain language summary available for this article.	[Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Med 1, Budapest, Hungary; [Anderson, John] Frist Clin, Nashville, TN USA; [Aschner, Pablo] Javeriana Univ, San Ignacio Univ Hosp, Bogota, Colombia; [Liu, Minzhi] BDM Consulting Inc, Somerset, NJ USA; [Saremi, Aramesh] Sanofi, Bridgewater, NJ USA; [Stella, Peter] Sanofi Aventis, Budapest, Hungary; [Tinahones, Francisco J.] Inst Salud Carlos III Univ Malaga, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Inst Invest Biomed Malaga IBIMA, Hosp Univ Virgen Victoria,Serv Endocrinol & Nutr, Malaga, Spain; [Wysham, Carol] Rockwood Clin, Spokane, WA USA; [Meier, Juris J.] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany		Tabak, AG (corresponding author), Semmelweis Univ, Fac Med, Dept Med 1, Budapest, Hungary.	tabak.adam@med.semmelweis-univ.hu	Tinahones, Francisco José/AAB-2882-2020	Tabak, Adam/0000-0002-6234-3936; Tinahones, Francisco J/0000-0001-6871-4403	Sanofi	Sanofi	This study and the Rapid Service Fee were funded by Sanofi.	Aroda VR, 2016, DIABETES CARE, V39, P1972, DOI 10.2337/dc16-1495; Berard L, 2018, DIABETES OBES METAB, V20, P301, DOI 10.1111/dom.13064; Billings LK, 2018, DIABETES CARE, V41, P1009, DOI 10.2337/dc17-1114; Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; Dalal MR, 2016, DIABETES RES CLIN PR, V121, P17, DOI 10.1016/j.diabres.2016.08.004; Diamant M, 2014, DIABETES CARE, V37, P2763, DOI 10.2337/dc14-0876; Dungan KM, 2016, DIABETES OBES METAB, V18, P49, DOI 10.1111/dom.12575; Esposito K, 2012, DIABETES OBES METAB, V14, P228, DOI 10.1111/j.1463-1326.2011.01512.x; Hermansen K, 2006, DIABETES CARE, V29, P1269, DOI 10.2337/dc05-1365; Hutchins V, 2011, CURR MED RES OPIN, V27, P1157, DOI 10.1185/03007995.2011.570745; International Hypoglycaemia Study Group, 2017, DIABETES CARE, V40, P155, DOI [10.2337/dc16-2215, DOI 10.2337/DC16-2215, DOI 10.2337/dc16-2215]; Kitsios GD, 2015, CRIT CARE MED, V43, P1870, DOI 10.1097/CCM.0000000000001135; Maiorino MI, 2018, DIABETES OBES METAB, V20, P2309, DOI 10.1111/dom.13343; Maiorino MI, 2017, DIABETES CARE, V40, P614, DOI 10.2337/dc16-1957; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Porcellati F, 2015, DIABETES METAB, V41, pS16; Rosenstock J, 2018, DIABETES OBES METAB, V20, P2821, DOI 10.1111/dom.13462; Rosenstock J, 2016, DIABETES CARE, V39, P2026, DOI 10.2337/dc16-0917; Rosenstock J, 2016, DIABETES CARE, V39, P1318, DOI 10.2337/dc16-0014; Yabe D, 2016, J DIABETES COMPLICAT, V30, P1385, DOI 10.1016/j.jdiacomp.2016.05.018	20	10	11	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-6953	1869-6961		DIABETES THER	Diabetes Ther.	JAN	2020	11	1					305	318		10.1007/s13300-019-00735-7	http://dx.doi.org/10.1007/s13300-019-00735-7		DEC 2019	14	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	KP4PJ	31848983	Green Published, gold			2022-09-04	WOS:000504136600001
J	Gabriel, R; Acosta, T; Florez, K; Anillo, L; Navarro, E; Boukichou, N; Acosta-Reyes, J; Barengo, NC; Lindstrom, J; Tuomilehto, JO; Aschner, P				Gabriel, Rafael; Acosta, Tania; Florez, Karen; Anillo, Luis; Navarro, Edgar; Boukichou, Nisa; Acosta-Reyes, Jorge; Barengo, Noel C.; Lindstrom, Jaana; Tuomilehto, Jaakko O.; Aschner, Pablo			Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Diabetes; FINDRISC; Glucose impairment; OGTT; Community and opportunistic; screening; Primary care settings	PREVENTION; GLUCOSE	Aims: /hypothesis. To determine the best cut-off threshold value of the Finnish Diabetes Risk Score (FIN-DRISC) for the detection of diabetes and non-diabetic hyperglycaemia in people 35 years or older at primary health care settings in Europe. Methods: Cross-sectional study in 11,444 adults from primary health care centres using community and opportunistic screening approaches. All participants completed the FIN-DRISC questionnaire and underwent a 2-hour oral glucose tolerance test (OGTT). The FIN-DRISC performance was assessed by the area under the curve (AUC) using receiver operating characteristics (ROC) analysis. The sensitivity, specificity, Youden acute accent s index, posi-tive and negative prediction values for different FINDRISC cut-offs were calculated. Results: The optimal FINDRISC value for detecting both diabetes or glucose impairment in the community -screened sample was 14 point with the associated AUC 0.75,5 (95 %CI 0.73,7-0.77,3). The optimal score in the opportunistic screening sample was 16 with the associated AUC only 0.60,4 (95% CI 0.56, 4-0.64, 4). Conclusions/interpretation: The FINDRISC is a non-invasive tool useful for detecting people with unknown diabetes and glucose impairment in people visiting primary health centres in Europe. (c) 2021 Elsevier B.V. All rights reserved.	[Gabriel, Rafael; Tuomilehto, Jaakko O.] Inst Salud Carlos III, Natl Sch Publ Hlth, Dept Int Hlth, Madrid, Spain; [Gabriel, Rafael; Tuomilehto, Jaakko O.; Aschner, Pablo] World Community Prevent Diabet WCPD Fdn, Madrid, Spain; [Acosta, Tania; Anillo, Luis; Navarro, Edgar; Acosta-Reyes, Jorge] Univ Norte, Dept Publ Hlth, Barranquilla, Colombia; [Florez, Karen; Anillo, Luis] Univ Norte, Dept Matemat & Estadist, Barranquilla, Colombia; [Boukichou, Nisa] Assoc Invest Prevenc Diabet & Enfermedades Cardio, Madrid, Spain; [Barengo, Noel C.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Translat Med, Miami, FL 33199 USA; [Barengo, Noel C.; Tuomilehto, Jaakko O.] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Lindstrom, Jaana; Tuomilehto, Jaakko O.] Finnish Inst Hlth & Welf, Dept Publ Hlth Solut, Helsinki, Finland; [Tuomilehto, Jaakko O.] King Abdulaziz Univ, Diabet Res Grp, Jeddah, Saudi Arabia; [Aschner, Pablo] Javeriana Univ, Bogota, Colombia; [Aschner, Pablo] San Ignacio Univ, Bogota, Colombia		Gabriel, R (corresponding author), Inst Salud Carlos III, Natl Sch Publ Hlth, Dept Int Hlth, Madrid, Spain.	rgabriel@isciii.es	Lechuga, Edgar Navarro/ABB-2780-2021; Acosta-Reyes, Jorge/D-1906-2011	Acosta-Reyes, Jorge/0000-0003-4303-3243; Boukichou Abdelkader, Nisa/0000-0002-7427-531X	European Commission; General Directorate SANCO [2004310]	European Commission(European CommissionEuropean Commission Joint Research Centre); General Directorate SANCO	The DE-PLAN project was funded by the European Commission. General Directorate SANCO (Grant Agreement: 2004310).	Salinero-Fort MA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007195; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bernabe-Ortiz A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8790235; Carrillo-Larco RM, 2019, DIABETIC MED, V36, P1573, DOI 10.1111/dme.14114; Davidson MB, 1999, JAMA-J AM MED ASSOC, V281, P1203, DOI 10.1001/jama.281.13.1203; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Nieto-Martinez R, 2017, ANN GLOB HEALTH, V83, P432, DOI 10.1016/j.aogh.2017.07.001; Ramachandran A, 2005, DIABETES RES CLIN PR, V70, P63, DOI 10.1016/j.diabres.2005.02.016; Rodriguez Garrido DP, TRABAJO PRESENTADO O; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schwarz PEH, 2008, EXP CLIN ENDOCR DIAB, V116, P167, DOI 10.1055/s-2007-992115; World Health Organization Department of Noncommunicable Disease Surveillance, 1999, DEF DIAGN CLASS DIAB; Cos FX, 2015, DIABETES RES CLIN PR, V109, P149, DOI 10.1016/j.diabres.2015.04.016; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097865	14	0	0	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	AUG	2021	178								108976	10.1016/j.diabres.2021.108976	http://dx.doi.org/10.1016/j.diabres.2021.108976		JUL 2021	7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	UM3PQ	34302911	Green Accepted			2022-09-04	WOS:000693246300036
J	Ribeiro, IM; Souto, PCS; Borbely, AU; Tanabe, ELL; Cadavid, A; Alvarez, AM; Bueno, J; Agudelo, O; Robles, RG; Ayala-Ramirez, P; Sacerdoti, F; Szasz, T; Damiano, AE; Ibarra, C; Escudero, C; Lima, VV; Giachini, FR				Ribeiro, Isabela Moreti; Souza Souto, Paula Cristina; Borbely, Alexandre U.; Lira Tanabe, Eloiza Lopes; Cadavid, Angela; Alvarez, Angela M.; Bueno, Julio; Agudelo, Olga; Garcia Robles, Reggie; Ayala-Ramirez, Paola; Sacerdoti, Flavia; Szasz, Theodora; Damiano, Alicia E.; Ibarra, Cristina; Escudero, Carlos; Lima, Victor V.; Giachini, Fernanda R.		RIVATREM	The limited knowledge of placental damage due to neglected infections: ongoing problems in Latin America	SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE			English	Review						Microbiome; placenta; dysbiosis; infection; pregnancy complications; placental diseases	HEMOLYTIC-UREMIC SYNDROME; TO-CHILD TRANSMISSION; CONGENITAL VISCERAL LEISHMANIASIS; PLASMODIUM-FALCIPARUM MALARIA; ESCHERICHIA-COLI; CUTANEOUS-LEISHMANIASIS; VIRUS-INFECTIONS; TRANSPLACENTAL TRANSMISSION; COMPLEMENT ACTIVATION; VERTICAL TRANSMISSION	The placenta works as a selective barrier, protecting the fetus from potential infections that may affect the maternal organism during pregnancy. In this review, we will discuss several challenging infections that are common within Latin American countries and that may affect the maternal-fetal interface and pose risks to fetal development. Specifically, we will focus on emerging infectious diseases including the arboviruses, malaria, leishmaniasis, and the bacterial foodborne disease caused by Shiga toxin-producingEscherichia coli. We will also highlight some topics of interest currently being studied by research groups that comprise an international effort aimed at filling the knowledge gaps in this field. These topics address the relationship between exposure to microorganisms and placental abnormalities, congenital anomalies, and complications of pregnancy.	[Ribeiro, Isabela Moreti; Souza Souto, Paula Cristina; Lima, Victor V.; Giachini, Fernanda R.] Univ Fed Mato Grosso, Inst Hlth Sci & Hlth, Lab Vasc Biol & Histopathol, Barra Do Garcas, Brazil; [Borbely, Alexandre U.; Lira Tanabe, Eloiza Lopes] Univ Fed Alagoas, Inst Hlth & Biol Sci, Cell Biol Lab, Penedo, Alagoas, Brazil; [Cadavid, Angela; Alvarez, Angela M.; Bueno, Julio] Univ Antioquia, Grp Reprod, Fac Med, Medellin, Colombia; [Agudelo, Olga] Univ Antioquia, Grp Salud & Comunidad, Fac Med, Medellin, Colombia; [Garcia Robles, Reggie] Pontificia Univ Javeriana, Fac Med, Physiol Sci Dept, Bogota, Colombia; [Ayala-Ramirez, Paola] Pontificia Univ Javeriana, Fac Med, Human Genet Inst, Bogota, Colombia; [Sacerdoti, Flavia] Univ Buenos Aires, Fac Med, CONICET Dept Fisiol, Lab Fisiopatogenia,Inst Fisiol & Biofis Bernardo, Buenos Aires, DF, Argentina; [Szasz, Theodora] Augusta Univ, Dept Physiol, Augusta, GA USA; [Damiano, Alicia E.; Ibarra, Cristina] Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol, Buenos Aires, DF, Argentina; [Damiano, Alicia E.] Univ Buenos Aires, Fac Med, CONICET, Lab Biol Reprod,Inst Fisiol & Biofis Bernardo Hou, Buenos Aires, DF, Argentina; [Escudero, Carlos] Univ Bio Bio, Basic Sci Dept, Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Vasc Physiol Lab,Fac Sci, Chillan, Chile		Giachini, FR (corresponding author), Univ Fed Mato Grosso, Campus Univ Araguaia,Av Valdon Varjon 6390, BR-78607059 Barra Do Garcas, Brazil.	fernandagiachini@hotmail.com	Borbely, Alexandre/GPW-8010-2022; Alvarez, Angela/Z-3244-2019; Borbely, Alexandre Urban/Q-2884-2019; Giachini, Fernanda R/J-7958-2012; da Saúde, Programa Ciências/ABF-1705-2020	Borbely, Alexandre/0000-0001-6737-0901; Alvarez, Angela/0000-0002-9056-9764; Giachini, Fernanda R/0000-0003-2688-7204; Ayala Ramirez, Paola/0000-0002-0141-1149; Sacerdoti, Flavia/0000-0002-8480-756X				Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389; Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.18655, 10.1001/jama.2016.19328]; Adibi JJ, 2016, CELL HOST MICROBE, V20, P9, DOI 10.1016/j.chom.2016.06.013; Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Agudelo OM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-122; Aisemberg J, 2007, P NATL ACAD SCI USA, V104, P7534, DOI 10.1073/pnas.0702279104; Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578; Alimi TO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1052-1; Arango EM, 2013, AM J TROP MED HYG, V89, P178, DOI 10.4269/ajtmh.12-0669; Arumugasaamy N, 2018, ANN BIOMED ENG, V46, P1963, DOI 10.1007/s10439-018-2090-y; Avila-Garcia M, 2013, AM J TROP MED HYG, V89, P354, DOI 10.4269/ajtmh.12-0716; Baergen RN, 2011, MANUAL OF PATHOLOGY OF THE HUMAN PLACENTA, SECOND EDITION, P459, DOI 10.1007/978-1-4419-7494-5_25; Bailey MS, 2007, CLIN DERMATOL, V25, P203, DOI 10.1016/j.clindermatol.2006.05.008; Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2; Bastos MM, 2012, REV VIRTUAL QUIM, V4, P257, DOI 10.5935/1984-6835.20120021; Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028; Baud D, 2011, CLIN MICROBIOL INFEC, V17, P1312, DOI 10.1111/j.1469-0691.2011.03604.x; Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Berger BA, 2017, TRENDS PARASITOL, V33, P935, DOI 10.1016/j.pt.2017.08.012; Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499; Boehme CC, 2006, EMERG INFECT DIS, V12, P359, DOI 10.3201/eid1202.050449d; Boeuf P, 2008, J INFECT DIS, V197, P757, DOI 10.1086/526521; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005; Bruel A, 2017, CLIN J AM SOC NEPHRO, V12, P1237, DOI 10.2215/CJN.00280117; Burdet J, 2013, BRIT J PHARMACOL, V168, P946, DOI 10.1111/j.1476-5381.2012.02239.x; Burdet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015127; Burton GJ, 2016, PHYSIOL REV, V96, P1509, DOI 10.1152/physrev.00029.2015; Caldas AJM, 2003, ACTA TROP, V88, P39, DOI 10.1016/S0001-706X(03)00160-8; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957; Carmona-Fonseca J, 2013, AM J TROP MED HYG, V88, P1093, DOI 10.4269/ajtmh.12-0363; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Carvalho FR, 2019, ACTA TROP, V192, P49, DOI 10.1016/j.actatropica.2019.01.020; Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4; Chart H, 2002, J MED MICROBIOL, V51, P522, DOI 10.1099/0022-1317-51-6-522; Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059; Conroy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004953; Conroy AL, 2013, CELL HOST MICROBE, V13, P215, DOI 10.1016/j.chom.2013.01.010; Conroy AL, 2011, TRENDS PARASITOL, V27, P294, DOI 10.1016/j.pt.2011.02.005; Contopoulos-Ioannidis D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006510; CORDOVEZ A, 1992, J CLIN MICROBIOL, V30, P2153; Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114; Costa AAUML, 2005, ACTA TROP, V96, P9, DOI 10.1016/j.actatropica.2005.06.016; Costa MA, 2016, REPROD BIOMED ONLINE, V32, P14, DOI 10.1016/j.rbmo.2015.10.005; Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; D'Oliveira Junior Argemiro, 2002, Rev. Soc. Bras. Med. Trop., V35, P7, DOI 10.1590/S0037-86822002000100002; de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266; de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Dotters-Katz SK, 2015, OBSTET GYNECOL SURV, V70, P453, DOI 10.1097/OGX.0000000000000184; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duaso J, 2011, PLACENTA, V32, P356, DOI 10.1016/j.placenta.2011.02.005; Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167; ELTOUM IA, 1992, AM J TROP MED HYG, V46, P57, DOI 10.4269/ajtmh.1992.46.57; Escobar M, 2017, EMERG INFECT DIS, V23, P1777, DOI 10.3201/eid2311.170480; Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849; Filho ACM, 2014, AM J TROP MED HYG, V90, P371, DOI 10.4269/ajtmh.13-0285; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403; Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Nunes PCG, 2016, J MED VIROL, V88, P1448, DOI 10.1002/jmv.24479; Gurung P, 2015, CELL MICROBIOL, V17, P1286, DOI 10.1111/cmi.12484; Hermanns K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0199-6; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Ibarra C, 2013, IUBMB LIFE, V65, P827, DOI 10.1002/iub.1206; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461; Kallur SD, 2019, TROP DOCT, V49, P7, DOI 10.1177/0049475518800638; Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428; KARMALI MA, 1983, LANCET, V2, P1299; Pangrazio KK, 2009, VET PARASITOL, V165, P327, DOI 10.1016/j.vetpar.2009.07.013; Kemp MW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00574; Krishnan L, 1996, J IMMUNOL, V156, P644; Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065; Lenglet Y, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P578; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18; Lopez-Perez M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1125-9; Low GC, 1926, LANCET, V2, P1209; Scalise ML, 2019, REPRODUCTION, V157, P297, DOI 10.1530/REP-18-0581; Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003; Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459; Mescouto-Borges MRM, 2013, BRAZ J INFECT DIS, V17, P263, DOI 10.1016/j.bjid.2012.10.017; Malaria, 2019, MALARIA; Maspi N, 2016, PATHOG GLOB HEALTH, V110, P247, DOI 10.1080/20477724.2016.1232042; McDonald CR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01460; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Meinecke CK, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.5.e65; Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mitropoulos P, 2010, J AM ACAD DERMATOL, V63, P309, DOI 10.1016/j.jaad.2009.06.088; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Morgan DJ, 2007, CLIN INFECT DIS, V45, P478, DOI 10.1086/520017; Muehlenbachs A, 2010, J INFECT DIS, V202, P1608, DOI 10.1086/656723; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nations WHOFaAOotU, 2018, SHIG TOX PROD ESCH C; Naucke TJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-67; Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; Nunes P, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040319; NUWAYRISALTI N, 1985, INT J PARASITOL, V15, P497, DOI 10.1016/0020-7519(85)90043-8; NYAKUNDI PM, 1988, T ROY SOC TROP MED H, V82, P564, DOI 10.1016/0035-9203(88)90508-1; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Ojha CR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02340; Pagliano P, 2005, J ANTIMICROB CHEMOTH, V55, P229, DOI 10.1093/jac/dkh538; Pagliano Pasquale, 2016, Infez Med, V24, P265; PAHO, 2019, EP REP AM; Paixao ES, 2018, EMERG INFECT DIS, V24, P1748, DOI 10.3201/eid2409.170361; Paixao ES, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28387-w; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; Park AY, 2002, J IMMUNOL, V168, P5771, DOI 10.4049/jimmunol.168.11.5771; Petitt M, 2017, CURR OPIN VIROL, V27, P48, DOI 10.1016/j.coviro.2017.11.008; Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; Raa H, 2009, TRAFFIC, V10, P868, DOI 10.1111/j.1600-0854.2009.00919.x; Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f; Ramos R, 2018, PEDIATR INFECT DIS J, V37, P94, DOI 10.1097/INF.0000000000001690; Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Repetto HA, 1997, KIDNEY INT, V52, P1708, DOI 10.1038/ki.1997.508; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Ribeiro CF, 2017, INT J INFECT DIS, V55, P109, DOI 10.1016/j.ijid.2017.01.002; Ribeiro CF, 2013, J PEDIATR-US, V163, P1514, DOI 10.1016/j.jpeds.2013.06.040; Riera C, 1996, PARASITOL TODAY, V12, P412, DOI 10.1016/0169-4758(96)90062-9; Rivas M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0002-2013; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11; Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]; Rodriguez-Morales AJ, 2018, TRAVEL MED INFECT DI, V25, P20, DOI 10.1016/j.tmaid.2018.06.006; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2017, INDIAN J MED RES, V146, P328, DOI 10.4103/ijmr.IJMR_1304_17; Romero I, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000819; Romero R, 2002, NEOREVIEWS, V3, pe73, DOI DOI 10.1542/NEO.3-5-E73; Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA; Rosypal AC, 2005, J PARASITOL, V91, P970, DOI 10.1645/GE-483R.1; Sacerdoti F, 2015, PLACENTA, V36, P674, DOI 10.1016/j.placenta.2015.03.005; Sacerdoti F, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6040111; Sacerdoti F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/384645; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Salles TS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2830-8; Schneider H, 2010, INT J DEV BIOL, V54, P367, DOI 10.1387/ijdb.082773hs; Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5; Scott P, 2016, NAT REV IMMUNOL, V16, P581, DOI 10.1038/nri.2016.72; Senanayake M. P., 2009, CEYLON MEDICAL JOURNAL, V54, P47; SHARMA JB, 1992, INT J GYNECOL OBSTET, V39, P291, DOI 10.1016/0020-7292(92)90260-P; Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086; Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114; Silva FL, 2009, VET PARASITOL, V160, P55, DOI 10.1016/j.vetpar.2008.10.079; Slimane TB, 2014, VET PARASITOL, V206, P282, DOI 10.1016/j.vetpar.2014.10.020; Souza RM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002071; STEELE BT, 1984, LANCET, V1, P511; Stritt A, 2013, CLIN INFECT DIS, V56, P114, DOI 10.1093/cid/cis851; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4; SYMMERS WS, 1960, LANCET, V1, P127; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Tanaka H, 2000, J REPROD MED, V45, P442; Thomas DE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-799; Torres AG, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6040100; Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009; Ulinski T, 2005, PEDIATR NEPHROL, V20, P1334, DOI 10.1007/s00467-005-1871-3; Varela G, 2008, REV ARGENT MICROBIOL, V40, P93; Villamil-Gomez WE, 2017, J CLIN VIROL, V95, P52, DOI 10.1016/j.jcv.2017.08.010; von Stebut E, 2003, J EXP MED, V198, P191, DOI 10.1084/jem.20030159; Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006; Walker PGT, 2014, LANCET GLOB HEALTH, V2, pE460, DOI 10.1016/S2214-109X(14)70256-6; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Weisblum Y, 2017, J VIROL, V91, DOI [10.1128/JVI.01905-16, 10.1128/jvi.01905-16]; WHO, 2019, WHOCDSGMP201810; Wilder-Smith A, 2019, CURR OPIN INFECT DIS, V32, P394, DOI 10.1097/QCO.0000000000000573; Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031; World Health Organization, 2017, ESAPWP248; Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363; Yoshimura K, 2002, J SOC GYNECOL INVEST, V9, P22, DOI 10.1016/S1071-5576(01)00143-5; Yoshimura K, 2000, INFECT IMMUN, V68, P2254, DOI 10.1128/IAI.68.4.2254-2258.2000; Zeldovich VB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002804; Zinchuk A, 2010, ANN TROP PAEDIATR, V30, P161, DOI 10.1179/146532810X12703902516400; Zulu MZ, 2019, J INNATE IMMUN, V11, P447, DOI 10.1159/000497416	190	0	0	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1939-6368	1939-6376		SYST BIOL REPROD MED	Syst. Biol. Reprod. Med.	MAY 3	2020	66	3					151	169		10.1080/19396368.2020.1753850	http://dx.doi.org/10.1080/19396368.2020.1753850			19	Andrology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Reproductive Biology	NE8KK	32482148	Green Published, hybrid			2022-09-04	WOS:000562853200001
J	Ahumada, V; Garcia, E; Dennis, R; Rojas, MX; Rondon, MA; Perez, A; Penaranda, A; Barragan, AM; Jimenez, S; Kennedy, MW; Caraballo, L				Ahumada, V.; Garcia, E.; Dennis, R.; Rojas, M. X.; Rondon, M. A.; Perez, A.; Penaranda, A.; Barragan, A. M.; Jimenez, S.; Kennedy, M. W.; Caraballo, L.			IgE responses to Ascaris and mite tropomyosins are risk factors for asthma	CLINICAL AND EXPERIMENTAL ALLERGY			English	Article						allergen; ascariasis; Ascaris; asthma; IgE; mite; recombinant allergens; tropomyosin	SKIN-TEST REACTIVITY; ALLERGIC SENSITIZATION; CROSS-REACTIVITY; CHILDHOOD ASTHMA; SCHOOL-CHILDREN; ABA-1 ALLERGEN; RURAL AREA; P 10; LUMBRICOIDES; INFECTION	BackgroundThe relationship between helminthiases and allergy is a matter of considerable interest and research. In the tropics, house dust mite exposure, a known risk factor for asthma, is frequently concurrent with helminth infections. It remains to be defined whether infection with the common roundworm Ascaris or its bystander immunological effects influence the prevalence and pathogenesis of asthma independently of mite sensitization. ObjectiveTo investigate the relationship between the IgE responses to Ascaris and its purified allergens and the risk of asthma in a tropical country. MethodsA nested case-control study was performed in 356 subjects who reported current and past asthma symptoms (asthmatics) and 435 controls that had never experienced such symptoms. They were tested for serum levels of total IgE and specific IgE to Ascaris extract, Asc s 1 (ABA-1), Asc l 3 (tropomyosin) and GST (glutathione transferase). In addition, specific IgE to Dermatophagoides pteronyssinus, Blomia tropicalis and their tropomyosins Der p 10 and Blo t 10 was measured. Sensitization was defined as a positive specific IgE result to any extract or recombinant allergen. ResultsSensitization to Ascaris and D. pteronyssinus was independently associated with asthma after adjustment for age, gender, socio-economic stratum, city and other IgE levels (adjusted ORs: 2.17; 95% CI 1.37-3.42 and 2.46; 95% CI 1.54-3.92), respectively. There was also a significant association with sensitization to the highly allergenic and cross-reactive tropomyosins Asc l 3, Blo t 10 and Der p10 (aORs: 1.76; 95% CI 1.21-2.57, 1.64; 95% CI 1.14-2.35 and 1.51; 95% CI 1.02-2.24), respectively. Conclusion and Clinical RelevanceIgE responses to Ascaris are associated with asthma symptoms in a population living in the tropics. Sensitization to the cross-reactive Ascaris and mite tropomyosins partially underlies this finding. These results have potential relevance in asthma diagnosis and management.	[Ahumada, V.; Jimenez, S.; Caraballo, L.] Univ Cartagena, Immunol Res Inst, Cartagena, Colombia; [Garcia, E.; Penaranda, A.] Fdn Santafe Bogota, Div Pediat Allergy & Otorhinolaryngol, Bogota, Colombia; [Dennis, R.; Barragan, A. M.] Fdn Cardioinfantil, Res Dept, Inst Cardiol, Bogota, Colombia; [Dennis, R.; Rojas, M. X.; Rondon, M. A.] Pontificia Univ Javeriana, Sch Med, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [Perez, A.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, Houston, TX 77030 USA; [Perez, A.] Michael & Susan Dell Ctr Hlth Living, Austin, TX USA; [Barragan, A. M.] Univ Rosario, Hlth Sci Res Ctr CICS, Bogota, Colombia; [Jimenez, S.; Caraballo, L.] Fdn Dev Med & Biol Sci Fundemeb, Cartagena, Colombia; [Kennedy, M. W.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Kennedy, M. W.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland		Caraballo, L (corresponding author), Univ Cartagena, Immunol Res Inst, Cartagena, Colombia.	lcaraballog@unicartagena.edu.co	Rojas-Reyes, Maria Ximena/AAD-6800-2019; Barragan, Ana M./AAC-2380-2022; Peñaranda, Augusto/GOE-5385-2022; RONDON, MARTIN/AAD-5855-2019	Rojas-Reyes, Maria Ximena/0000-0001-5752-7653; Barragan, Ana M./0000-0002-4646-4324; RONDON, MARTIN/0000-0002-3885-5448; Dennis, Rodolfo J/0000-0003-3215-9721; Penaranda, Augusto/0000-0003-1598-8472; Perez, Adriana/0000-0002-6859-9916; Ahumada, Velky/0000-0003-0905-7276	Colciencias [540-2008, 602-2009]; University of Cartagena; Wellcome Trust (UK); Colciencias (Young Researcher Program)	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); University of Cartagena; Wellcome Trust (UK)(Wellcome Trust); Colciencias (Young Researcher Program)	We thank all the research subjects for their voluntary participation in the study. This work was supported by Colciencias (Grants 540-2008, 602-2009) and the University of Cartagena. Construction of an expression system for ABA-1 and its characterization as an allergen in the context of infection was funded through grants from the Wellcome Trust (UK) to MK. VA. was supported by Colciencias (Young Researcher Program 2010).	Acevedo N, 2008, ALLERGY, V63, P15; Acevedo N, 2011, PARASITE IMMUNOL, V33, P309, DOI 10.1111/j.1365-3024.2011.01288.x; Acevedo N, 2011, INT ARCH ALLERGY IMM, V154, P195, DOI 10.1159/000321106; Acevedo N, 2009, ALLERGY, V64, P1635, DOI 10.1111/j.1398-9995.2009.02084.x; Acevedo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078353; Acevedo N, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-13; Alcantara-Neves NM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-114; Alvarado Beatriz Eugenia, 2006, Biomed., V26, P81; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Asturias JA, 1998, BBA-GENE STRUCT EXPR, V1397, P27, DOI 10.1016/S0167-4781(98)00006-2; Becker S, 2012, EUR ARCH OTO-RHINO-L, V269, P1291, DOI 10.1007/s00405-011-1826-1; Bronnert M, 2012, CLIN EXP ALLERGY, V42, P1406, DOI 10.1111/j.1365-2222.2012.04035.x; Caraballo L, 1998, J INVEST ALLERG CLIN, V8, P281; Caraballo L, 2013, ASCARIS: THE NEGLECTED PARASITE, P21, DOI 10.1016/B978-0-12-396978-1.00002-1; Caraballo L, 2011, WORLD ALLERGY ORGAN, V4, P77, DOI 10.1097/WOX.0b013e3182167e04; Charlier J, 2008, VET PARASITOL, V153, P44, DOI 10.1016/j.vetpar.2008.01.035; CHRISTIE JF, 1990, IMMUNOLOGY, V69, P596; Cooper PJ, 2003, J ALLERGY CLIN IMMUN, V111, P995, DOI 10.1067/mai.2003.1348; Cooper PJ, 2000, J INFECT DIS, V182, P1207, DOI 10.1086/315830; Cooper PJ, 2003, AM J RESP CRIT CARE, V168, P313, DOI 10.1164/rccm.200211-1320OC; Dagoye D, 2003, AM J RESP CRIT CARE, V167, P1369, DOI 10.1164/rccm.200210-1204OC; Dennis R, 2004, ANN ALLERG ASTHMA IM, V93, P568, DOI 10.1016/S1081-1206(10)61265-3; Dennis RJ, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-17; Dold S, 1998, J ALLERGY CLIN IMMUN, V102, P414, DOI 10.1016/S0091-6749(98)70129-0; FRASER EM, 1993, INT ARCH ALLERGY IMM, V100, P283, DOI 10.1159/000236425; Giraldo-Gómez Jorge M, 2005, Rev. salud pública, V7, P327, DOI 10.1590/S0124-00642005000300008; Hagel I, 2007, ACTA TROP, V103, P231, DOI 10.1016/j.actatropica.2007.06.010; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V119, P654, DOI 10.1016/j.jaci.2006.12.609; KENNEDY MW, 1995, BIOCHEMISTRY-US, V34, P6700, DOI 10.1021/bi00020a015; Knudson Angélica, 2012, Rev. salud pública, V14, P681; LEE TDG, 1993, INT ARCH ALLERGY IMM, V102, P185, DOI 10.1159/000236570; MARRETTA J, 1979, IMMUNOLOGY, V37, P609; McSharry C, 1999, INFECT IMMUN, V67, P484, DOI 10.1128/IAI.67.2.484-489.1999; Meenan NAG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001040; Moncayo AL, 2013, CLIN EXP ALLERGY, V43, P60, DOI 10.1111/cea.12040; Palmer LJ, 2002, AM J RESP CRIT CARE, V165, P1489, DOI 10.1164/rccm.2107020; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Resch Y, 2011, CLIN EXP ALLERGY, V41, P1468, DOI 10.1111/j.1365-2222.2011.03798.x; Roepstorff A, 1998, PARASITOL RES, V84, P537, DOI 10.1007/s004360050444; Santiago HC, 2011, J ALLERGY CLIN IMMUN, V127, P479, DOI 10.1016/j.jaci.2010.11.007; Santos ABR, 2008, J ALLERGY CLIN IMMUN, V121, P1040, DOI 10.1016/j.jaci.2007.12.1147; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Simons E, 2011, CAN J PUBLIC HEALTH, V102, P35, DOI 10.1007/BF03404874; STROMBERG BE, 1980, J IMMUNOL, V125, P833; Takeuchi H, 2008, CLIN EXP ALLERGY, V38, P276, DOI 10.1111/j.1365-2222.2007.02890.x; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; Vlaminck J, 2014, PARASITOLOGY, V28, P1; Weghofer M, 2008, EUR J CLIN INVEST, V38, P959, DOI 10.1111/j.1365-2362.2008.02048.x; Westritschnig K, 2003, CLIN EXP ALLERGY, V33, P22, DOI 10.1046/j.1365-2222.2003.01540.x; Yi FC, 2002, CLIN EXP ALLERGY, V32, P1203, DOI 10.1046/j.1365-2745.2002.01449.x; Zakzuk J, 2013, PEDIAT ALLERG IMM-UK, V24, P788, DOI 10.1111/pai.12161; Zheng YW, 2011, CHINESE MED J-PEKING, V124, P4350, DOI 10.3760/cma.j.issn.0366-6999.2011.24.039	52	51	52	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0954-7894	1365-2222		CLIN EXP ALLERGY	Clin. Exp. Allergy	JUL	2015	45	7					1189	1200		10.1111/cea.12513	http://dx.doi.org/10.1111/cea.12513			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CK6UL	25702830				2022-09-04	WOS:000356363700006
J	Sharma, A; Tobar-Tosse, F; Dakal, TC; Liu, HD; Biswas, A; Menon, A; Paruchuri, A; Katsonis, P; Lichtarge, O; Gromiha, MM; Ludwig, M; Schmidt-Wolf, IGH; Holz, FG; Loeffler, KU; Herwig-Carl, MC				Sharma, Amit; Tobar-Tosse, Fabian; Dakal, Tikam Chand; Liu, Hongde; Biswas, Arijit; Menon, Athira; Paruchuri, Anoosha; Katsonis, Panagiotis; Lichtarge, Olivier; Gromiha, M. Michael; Ludwig, Michael; Schmidt-Wolf, Ingo G. H.; Holz, Frank G.; Loeffler, Karin U.; Herwig-Carl, Martina C.			PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPAR gamma-DNMT1 Interactions in the Genome	CANCERS			English	Article						cancer; repetitive sequences; evolutionary action score; uveal melanoma; Alu repeats; PPAR gamma; DNMT1	PROLIFERATOR-ACTIVATED RECEPTORS; UVEAL MELANOMAS; PROTEIN; CANCER; GAMMA; CHROMOSOME-3; MUTATION; SERVER; BAP1; 1P	Background: PPAR gamma (peroxisome proliferator-activated receptor gamma) is involved in the pathology of numerous diseases, including UM and other types of cancer. Emerging evidence suggests that an interaction between PPAR gamma and DNMTs (DNA methyltransferase) plays a role in cancer that is yet to be defined. Methods: The configuration of the repeating elements was performed with CAP3 and MAFFT, and the structural modelling was conducted with HDOCK. An evolutionary action scores algorithm was used to identify oncogenic variants. A systematic bioinformatic appraisal of PPAR gamma and DNMT1 was performed across 29 tumor types and UM available in The Cancer Genome Atlas (TCGA). Results: PPAR-responsive elements (PPREs) enriched with Alu repeats are associated with different genomic regions, particularly the promotor region of DNMT1. PPAR gamma -DNMT1 co-expression is significantly associated with several cancers. C-terminals of PPAR gamma and DNMT1 appear to be the potential protein-protein interaction sites where disease-specific mutations may directly impair the respective protein functions. Furthermore, PPAR gamma expression could be identified as an additional prognostic marker for UM. Conclusions: We hypothesize that the function of PPAR gamma requires an additional contribution of Alu repeats which may directly influence the DNMT1 network. Regarding UM, PPAR gamma appears to be an additional discriminatory prognostic marker, in particular in disomy 3 tumors.	[Sharma, Amit; Holz, Frank G.; Loeffler, Karin U.; Herwig-Carl, Martina C.] Univ Hosp Bonn, Dept Ophthalmol, D-53127 Bonn, Germany; [Sharma, Amit] Univ Bonn, Dept Neurosurg, D-53127 Bonn, Germany; [Tobar-Tosse, Fabian] Pontificia Univ Javeriana Cali, Dept Basic Sci Hlth, Cali 760031, Colombia; [Dakal, Tikam Chand; Menon, Athira] Mohanlal Sukhadia Univ Udaipur, Dept Biotechnol, Udaipur 313001, Rajasthan, India; [Liu, Hongde] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Peoples R China; [Biswas, Arijit] Univ Hosp Bonn, Inst Expt Hematol & Transfus Med, D-53127 Bonn, Germany; [Paruchuri, Anoosha] Ohio State Univ, Div Med Oncol, Dept Internal Med, Columbus, OH 43210 USA; [Paruchuri, Anoosha] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Katsonis, Panagiotis; Lichtarge, Olivier] Baylor Coll Med, Computat & Integrat Biomed Res Ctr, Houston, TX 77030 USA; [Gromiha, M. Michael] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch BioSci, Dept Biotechnol, Chennai 600036, Tamil Nadu, India; [Ludwig, Michael] Univ Hosp Bonn, Dept Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Schmidt-Wolf, Ingo G. H.; Herwig-Carl, Martina C.] Univ Hosp Bonn, Dept Integrated Oncol, CIO Bonn, D-53127 Bonn, Germany		Sharma, A (corresponding author), Univ Hosp Bonn, Dept Ophthalmol, D-53127 Bonn, Germany.; Sharma, A (corresponding author), Univ Bonn, Dept Neurosurg, D-53127 Bonn, Germany.	amit.sharma@ukbonn.de; ftobar@javerianacali.edu.co; tc.dakal@mlsu.ac.in; liuhongde@seu.edu.cn; arijit.biswas@ukbonn.de; aathimenon143@gmail.com; Anoosha.Paruchuri@osumc.edu; katsonis@bcm.edu; lichtarg@bcm.edu; gromiha@iitm.ac.in; mludwig@uni-bonn.de; Ingo.Schmidt-Wolf@ukbonn.de; Frank.Holz@ukbonn.de; Karinloeffler@uni-bonn.de; Martina.Herwig@ukbonn.de	Herwig-Carl, Martina/AAI-2618-2019; Tobar-Tosse, Fabian/P-1710-2014	Herwig-Carl, Martina/0000-0002-5943-7675; Biswas, Arijit/0000-0002-4103-5854; Liu, Hongde/0000-0001-8768-764X; Michael, Gromiha/0000-0002-1776-4096; Tobar-Tosse, Fabian/0000-0001-5334-4286; Sharma, Amit/0000-0002-2216-5389	German Research Foundation (DFG) [HE 5775/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG; HE 5775/5-1).	Abdel-Rahman MH, 2011, MODERN PATHOL, V24, P954, DOI 10.1038/modpathol.2011.51; Ceccarelli V, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2020.194481; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cross NA, 2006, EYE, V20, P476, DOI 10.1038/sj.eye.6701906; Fang L, 2016, PPAR RES, V2016, DOI 10.1155/2016/6042162; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gionfriddo G, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010174; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hart C, 2016, J EUR ACAD DERMATOL, V30, pE119, DOI 10.1111/jdv.13391; Hausler T, 2005, INT J CANCER, V116, P909, DOI 10.1002/ijc.21086; Herwig MC, 2013, EXP EYE RES, V107, P52, DOI 10.1016/j.exer.2012.11.012; Katsonis P, 2014, GENOME RES, V24, P2050, DOI 10.1101/gr.176214.114; Kilic E, 2005, INVEST OPHTH VIS SCI, V46, P2253, DOI 10.1167/iovs.04-1460; Loponte S, 2019, CANCERS, V11, DOI 10.3390/cancers11101574; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Mazzarella L, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.554; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pathak S, 2010, MOL CELL ENDOCRINOL, V314, P110, DOI 10.1016/j.mce.2009.08.005; Pazienza V, 2012, PPAR RES, V2012, DOI 10.1155/2012/461784; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sanchez-Garcia R, 2019, BIOINFORMATICS, V35, P470, DOI 10.1093/bioinformatics/bty647; Sharma A, 2018, CLIN GENET, V93, P952, DOI 10.1111/cge.13136; Sharma A, 2021, CANCER INVEST, V39, P257, DOI 10.1080/07357907.2021.1872593; Sharma A, 2020, INT J MOL SCI, V21, P3910, DOI 10.3390/ijms21113910; Sharma A, 2020, CANCER SCI, V111, P1385, DOI 10.1111/cas.14319; Sharma A, 2020, CURR GENOMICS, V21, P34, DOI 10.2174/1389202921666200102163422; Sharma A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54865-w; Sharma A, 2019, CANCERS, V11, DOI 10.3390/cancers11101600; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang RZ, 2019, J MOL CELL CARDIOL, V128, P11, DOI 10.1016/j.yjmcc.2019.01.009; Tudzarova S, 2015, MOL BIOL CELL, V26, P3129, DOI 10.1091/mbc.E14-11-1550; Viswakarma N, 2010, PPAR RES, V2010, DOI 10.1155/2010/250126; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yan YM, 2017, NUCLEIC ACIDS RES, V45, pW365, DOI 10.1093/nar/gkx407; Yu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30053; Zhang W, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0081-z	40	1	1	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6694		CANCERS	Cancers	AUG	2021	13	16							3993	10.3390/cancers13163993	http://dx.doi.org/10.3390/cancers13163993			12	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	UF8XN	34439147	Green Published, gold			2022-09-04	WOS:000688851300001
J	Baez, S; Herrera, E; Garcia, AM; Huepe, D; Santamaria-Garcia, H; Ibanez, A				Baez, Sandra; Herrera, Eduar; Garcia, Adolfo M.; Huepe, David; Santamaria-Garcia, Hernando; Ibanez, Agustin			Increased moral condemnation of accidental harm in institutionalized adolescents	SCIENTIFIC REPORTS			English	Article							HIGH-FUNCTIONING AUTISM; FRONTOTEMPORAL DEMENTIA; EXECUTIVE FUNCTION; EMOTION RECOGNITION; EARLY DEPRIVATION; INTENTIONAL HARM; FALSE BELIEF; EYES TEST; MIND; JUDGMENT	Social deprivation, as faced by children in institutional rearing, involves socio-cognitive deficits that may persist into adolescence. In particular, two relevant domains which prove sensitive to pre-adult neurodevelopment are theory of mind (ToM) and moral judgment (a complex skill which partially depend upon ToM). However, no study has assessed moral evaluation in adolescents with a history of institutional care, let alone its relationship with ToM skills. The present study aims to bridge this gap, focusing on moral evaluation of harmful actions in institutionalized adolescents (IAs). Relative to adolescents raised with their biological families, IAs exhibited less willingness to exculpate protagonists for accidental harms, suggesting an under-reliance on information about a person's (innocent) intentions. Moreover, such abnormalities in IAs were associated with ToM impairments. Taken together, our findings extend previous findings of delayed ToM under social deprivation, further showing that the development of moral cognition is also vulnerable to the impact of institutionalization. These results could pave the way for novel research on the role of institutional rearing in ToM and moral development during adolescence.	[Baez, Sandra] Univ Los Andes, Bogota, Colombia; [Herrera, Eduar] Univ Icesi, Dept Estudios Psicol, Cali, Colombia; [Garcia, Adolfo M.; Ibanez, Agustin] Favaloro Univ, INECO Fdn, Inst Cognit & Translat Neurosci INCYT, Lab Expt Psychol & Neurosci LPEN, Buenos Aires, DF, Argentina; [Garcia, Adolfo M.; Ibanez, Agustin] Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina; [Garcia, Adolfo M.] Natl Univ Cuyo UNCuyo, Fac Educ, Mendoza, Argentina; [Huepe, David; Ibanez, Agustin] Univ Adolfo Ibanez, Sch Psychol, CSCN, Santiago, Chile; [Santamaria-Garcia, Hernando] Intellectus Hosp Univ San Ignacio, Ctr Memoria & Cognic, Bogota, Colombia; [Santamaria-Garcia, Hernando] Pontificia Univ Javeriana, Physiol Psychiat & Aging Inst, Bogota, Colombia; [Ibanez, Agustin] ACR Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Ibanez, Agustin] Univ Autonoma Caribe, Barranquilla, Colombia		Ibanez, A (corresponding author), Favaloro Univ, INECO Fdn, Inst Cognit & Translat Neurosci INCYT, Lab Expt Psychol & Neurosci LPEN, Buenos Aires, DF, Argentina.; Ibanez, A (corresponding author), Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina.; Ibanez, A (corresponding author), Univ Adolfo Ibanez, Sch Psychol, CSCN, Santiago, Chile.; Ibanez, A (corresponding author), ACR Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia.; Ibanez, A (corresponding author), Univ Autonoma Caribe, Barranquilla, Colombia.	aibanez@ineco.org.ar	Baez, Sandra/ABC-7150-2020; Ibanez, Agustin/H-7976-2015; García, Adolfo/E-7150-2017	Ibanez, Agustin/0000-0001-6758-5101; García, Adolfo/0000-0002-6936-0114; Herrera, Eduar/0000-0001-9409-245X; Santamaria Garcia, Hernando/0000-0001-9422-3579; Huepe, David/0000-0001-8351-5314	CONICET; CONICYT/FONDECYT Regular [1170010]; FONCyT-PICT [2017-1818, 2017-1820]; FONDAP [15150012]; INECO Foundation; COLCIENCIAS [211774454967-Contrato 709-2016]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICYT/FONDECYT Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONCyT-PICT(ANPCyTFONCyT); FONDAP; INECO Foundation; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was partially supported by grants from CONICET, CONICYT/FONDECYT Regular (1170010), FONCyT-PICT 2017-1818, FONCyT-PICT 2017-1820, FONDAP 15150012, the INECO Foundation, and COLCIENCIAS 211774454967-Contrato 709-2016.	Baez S, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0118; Baez S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179336; Baez S, 2016, NEURODEGENER DIS, V16, P206, DOI 10.1159/000441918; Baez S, 2016, CORTEX, V75, P20, DOI 10.1016/j.cortex.2015.11.007; Baez S, 2015, NEUROPSYCHOLOGIA, V68, P158, DOI 10.1016/j.neuropsychologia.2015.01.012; Baez S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00262; Baez S, 2014, JAMA NEUROL, V71, P1172, DOI 10.1001/jamaneurol.2014.347; Baez S, 2014, PSYCHIAT RES, V216, P269, DOI 10.1016/j.psychres.2014.01.020; Baez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057664; Baez S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00302; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Baron-Cohen S., 1997, J CHILD PSYCHOL PSYC, V34, P163; Bos KJ, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.016.2009; Bull R, 2008, COGNITION, V107, P663, DOI 10.1016/j.cognition.2007.07.015; Buon M, 2016, PSYCHON B REV, V23, P1660, DOI 10.3758/s13423-016-1042-5; Carlo G, 1998, J ADOLESCENT RES, V13, P363, DOI 10.1177/0743554898134001; Carlson SM, 2004, DEV PSYCHOL, V40, P1105, DOI 10.1037/0012-1649.40.6.1105; Cicchetti D, 2003, DEV PSYCHOPATHOL, V15, P1067, DOI 10.1017/S0954579403000440; Colvert E, 2008, J ABNORM CHILD PSYCH, V36, P1057, DOI 10.1007/s10802-008-9232-x; Cushman F, 2008, COGNITION, V108, P353, DOI 10.1016/j.cognition.2008.03.006; DAVIS MH, 1994, J PERS, V62, P369, DOI 10.1111/j.1467-6494.1994.tb00302.x; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Djeriouat H, 2014, PERS INDIV DIFFER, V67, P11, DOI 10.1016/j.paid.2013.12.026; Doherty M. J., 2008, THEORY MIND CHILDREN; Fries ABW, 2004, DEV PSYCHOPATHOL, V16, P355, DOI 10.1017/S0954579404044554; Germine L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129612; Gonzalez-Gadea ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00850; Hesse E, 2016, BRAIN, V139, P54, DOI 10.1093/brain/awv336; Hurtado E, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-69; Escobar MJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05354; Koenig AL, 2004, SOC DEV, V13, P87, DOI 10.1111/j.1467-9507.2004.00258.x; MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167; Melloni M, 2016, BRAIN, V139, P3022, DOI 10.1093/brain/aww231; Moran JM, 2011, P NATL ACAD SCI USA, V108, P2688, DOI 10.1073/pnas.1011734108; Oakley BFM, 2016, J ABNORM PSYCHOL, V125, P818, DOI 10.1037/abn0000182; Patil I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05299-9; Patil I, 2017, SCI REP-UK, V7, DOI 10.1038/srep45967; Patil I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00501; Piaget Jean., 1965, MORAL JUDGMENT CHILD; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Raven J. C., 1960, GUIDE USING STANDARD; Santamaria-Garcia H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06775-y; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; SHULTZ TR, 1986, CHILD DEV, V57, P177, DOI 10.2307/1130649; Tarullo AR, 2007, SOC DEV, V16, P57, DOI 10.1111/j.1467-9507.2007.00372.x; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; Treadway MT, 2014, NAT NEUROSCI, V17, P1270, DOI 10.1038/nn.3781; Yagmurlu B, 2005, J APPL DEV PSYCHOL, V26, P521, DOI 10.1016/j.appdev.2005.06.004; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104; Young L, 2012, J ABNORM PSYCHOL, V121, P659, DOI 10.1037/a0027489; Young L, 2010, NEURON, V65, P845, DOI 10.1016/j.neuron.2010.03.003; Young L, 2009, NEUROPSYCHOLOGIA, V47, P2065, DOI 10.1016/j.neuropsychologia.2009.03.020; YUILL N, 1988, DEV PSYCHOL, V24, P358, DOI 10.1037/0012-1649.24.3.358	54	4	4	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 2	2018	8								11609	10.1038/s41598-018-29956-9	http://dx.doi.org/10.1038/s41598-018-29956-9			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GP2AN	30072749	gold, Green Published			2022-09-04	WOS:000440621000026
J	Waylen, KA; Martin-Ortega, J; Blackstock, KL; Brown, I; Uribe, BEA; Hernandez, SB; Bertoni, MB; Bustos, ML; Bayer, AXC; Semerena, RIE; Quijano, MAF; Ferrelli, F; Fidalgo, GL; Lopez, IH; Cisneros, MAH; London, S; Velez, DLM; Ocampo-Diaz, N; Ortiz-Guerrero, CE; Pascale, JC; Perillo, GME; Piccolo, MC; Martinez, LNP; Rojas, ML; Scordo, F; Vitale, V; Zilio, MI				Waylen, Kerry A.; Martin-Ortega, Julia; Blackstock, Kirsty L.; Brown, Iain; Avendano Uribe, Bryan E.; Basurto Hernandez, Saul; Belen Bertoni, Maria; Lujan Bustos, M.; Cruz Bayer, Alejandra Xochitl; Escalante Semerena, Roberto Ivan; Farah Quijano, Maria Adelaida; Ferrelli, Federico; Luis Fidalgo, Guillermo; Hernandez Lopez, Israel; Huamantinco Cisneros, Maria Andrea; London, Silvia; Maya Velez, Diana L.; Ocampo-Diaz, Natalia; Ortiz-Guerrero, Cesar E.; Carlos Pascale, Juan; Perillo, Gerardo M. E.; Cintia Piccolo, M.; Pinzon Martinez, Lina N.; Rojas, Mara L.; Scordo, Facundo; Vitale, Valeria; Zilio, Mariana I.			Can scenario-planning support community-based natural resource management? Experiences from three countries in Latin America	ECOLOGY AND SOCIETY			English	Article						Argentina; climate change; Colombia; community-based conservation; futures thinking; Mexico; participation; scenario methods; wicked problems	BIODIVERSITY CONSERVATION; MODELS; FUTURE; SUSTAINABILITY; PARTICIPATION; CHALLENGES; KNOWLEDGE; LESSONS; HISTORY; SYSTEMS	Community-based natural resource management (CBNRM) is a concept critical to managing social-ecological systems but whose implementation needs strengthening. Scenario planning is one approach that may offer benefits relevant to CBNRM but whose potential is not yet well understood. Therefore, we designed, trialed, and evaluated a scenario-planning method intended to support CBNRM in three cases, located in Colombia, Mexico, and Argentina. Implementing scenario planning was judged as worthwhile in all three cases, although aspects of it were challenging to facilitate. The benefits generated were relevant to strengthening CBNRM: encouraging the participation of local people and using their knowledge, enhanced consideration of and adaptation to future change, and supporting the development of systems thinking. Tracing exactly when and how these benefits arose was challenging, but two elements of the method seemed particularly useful. First, using a systematic approach to discuss how drivers of change may affect local social-ecological systems helped to foster systems thinking and identify connections between issues. Second, explicitly focusing on how to use and respond to scenarios helped identify specific practical activities, or "response options," that would support CBNRM despite the pressures of future change. Discussions about response options also highlighted the need for support by other actors, e.g., policy groups: this raised the question of when and how other actors and other sources of knowledge should be involved in scenario planning, so as to encourage their buy-in to actions identified by the process. We suggest that other CBNRM initiatives may benefit from adapting and applying scenario planning. However, these initiatives should be carefully monitored because further research is required to understand how and when scenario-planning methods may produce benefits, as well as their strengths and weaknesses versus other methods.	[Waylen, Kerry A.; Martin-Ortega, Julia; Blackstock, Kirsty L.] Univ Leeds, James Hutton Inst, Social Econ & Geog Sci Grp, Leeds LS2 9JT, W Yorkshire, England; [Martin-Ortega, Julia] Univ Leeds, Sch Earth & Environm & water@ leeds, Sustainabil Res Inst, Leeds LS2 9JT, W Yorkshire, England; [Brown, Iain] Univ Birmingham, James Hutton Inst, Informat & Computat Sci Grp, Birmingham, W Midlands, England; [Avendano Uribe, Bryan E.] Univ Birmingham, Pontificia Univ Javeriana, Sch Environm & rural studies, Dept Rural Dev, Birmingham, W Midlands, England; [Basurto Hernandez, Saul; Cruz Bayer, Alejandra Xochitl; Escalante Semerena, Roberto Ivan] Univ Birmingham, Fac Econ, Natl Autonomous Univ Mexico UNAM, Birmingham, W Midlands, England; [Basurto Hernandez, Saul] Univ Birmingham, Dept Econ, Birmingham, W Midlands, England; [Belen Bertoni, Maria] Univ Buenos Aires, Dept Antropol, Buenos Aires, DF, Argentina; [Lujan Bustos, M.; Huamantinco Cisneros, Maria Andrea; Cintia Piccolo, M.; Scordo, Facundo] Consejo Nacl Invest Cient & Tecn, Inst Argentino Oceanografia, RA-1033 Buenos Aires, DF, Argentina; [Lujan Bustos, M.; Carlos Pascale, Juan; Cintia Piccolo, M.] Univ Nacl Sur, Dept Geografia Turismo, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Farah Quijano, Maria Adelaida] Pontificia Univ Javeriana Fac Environm & Rural St, Bogota, Colombia; [Ferrelli, Federico] Consejo Nacl Invest Cient & Tecn, IADO, Consejo Nacl Invest Cientjo Tecn, Inst Argentino Oceanografia, RA-1033 Buenos Aires, DF, Argentina; [Ferrelli, Federico] Univ Nacl Sur, Dept Geografia & Turismo, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Luis Fidalgo, Guillermo; Vitale, Valeria] Fdn Aquamarina, Pinamar, Argentina; [Hernandez Lopez, Israel] ERA, Estudios Rurales Asesoria Campesina, Vienna, Austria; [London, Silvia; Rojas, Mara L.; Vitale, Valeria] Univ Nacl Sur, Dept Econ, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [London, Silvia; Rojas, Mara L.] Inst Invest Econ & Soci Sur, Vienna, Austria; [Maya Velez, Diana L.; Ocampo-Diaz, Natalia; Ortiz-Guerrero, Cesar E.; Pinzon Martinez, Lina N.] Pontificia Univ Javeriana, Bogota, Colombia; [Perillo, Gerardo M. E.] Consejo Nacl Invest Cient & Tecn, Inst Argentino Oceanografia, Bahia Blanca, Buenos Aires, Argentina; [Perillo, Gerardo M. E.] Univ Nacl Sur, Dept Geologia, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Scordo, Facundo] Univ Nacl Sur, Dept Geografia Turismo, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Zilio, Mariana I.] Consejo Nacl Invest Cient & Tecn, Inst Invest Econ & Sociales Sur, RA-1033 Buenos Aires, DF, Argentina; [Zilio, Mariana I.] Univ Nacl Sur, Dept Econ, RA-8000 Bahia Blanca, Buenos Aires, Argentina		Waylen, KA (corresponding author), Univ Leeds, James Hutton Inst, Social Econ & Geog Sci Grp, Leeds LS2 9JT, W Yorkshire, England.		Waylen, Kerry/B-1867-2008; Perillo, GME/AAV-3784-2021; Brown, Iain M/M-7580-2017	Perillo, GME/0000-0002-1200-5138; Brown, Iain M/0000-0002-3469-5598; Avendano-Uribe, Bryann/0000-0003-4454-2656; Zilio, Mariana I./0000-0003-3902-554X; London, Silvia/0000-0002-4597-0233; Waylen, Kerry/0000-0002-6593-2795; Basurto Hernandez, Saul/0000-0002-3585-5784; Scordo, Facundo/0000-0001-6182-7368; Martin-Ortega, Julia/0000-0003-0002-6772; Farah Quijano, Maria Adelaida/0000-0002-6221-6742	European Union [282845]; Rural and Environment Science and Analytical Services Division of the Scottish Government	European Union(European Commission); Rural and Environment Science and Analytical Services Division of the Scottish Government	The research leading to these results received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 282845 for project COMET-LA and was also partly funded by the Rural and Environment Science and Analytical Services Division of the Scottish Government. We thank the community members of the Mexican, Argentinean, and Colombian cases, whose enthusiasm and willingness to engage made this work possible.	Armitage D, 2005, ENVIRON MANAGE, V35, P703, DOI 10.1007/s00267-004-0076-z; Beach DM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07379-200161; Bengston DN, 2012, ECOL SOC, V17, DOI 10.5751/ES-04794-170210; Best A, 2010, EVID POLICY, V6, P145, DOI 10.1332/174426410X502284; Borjeson L, 2006, FUTURES, V38, P723, DOI 10.1016/j.futures.2005.12.002; Bradfield R, 2005, FUTURES, V37, P795, DOI 10.1016/j.futures.2005.01.003; Checkland P., 1999, RETHINKING MANAGEMEN, P45; Delgado Serrano M. M., 2013, D1 1 LOCALLY ADAPTED; Dressler W, 2010, ENVIRON CONSERV, V37, P5, DOI 10.1017/S0376892910000044; Mendez-Lopez ME, 2014, J ENVIRON MANAGE, V145, P321, DOI 10.1016/j.jenvman.2014.06.028; Enfors EI, 2008, ECOL SOC, V13; Escalante Semerena R. I., 2014, D3 3 STAKEHOLDER VIS; Escalante Semerena R. I., 2012, DELIVERABLE D3 1 STA; Fabricus C., 2004, RIGHTS RESOURCES RUR; Farah M. A., 2014, D2 3 STAKEHOLDER VIS; Farah M. A., 2012, DELIVERABLE D2 1 STA; Farrell L. A, 2010, THESIS; Game ET, 2014, CONSERV LETT, V7, P271, DOI 10.1111/conl.12050; Glenn J. C., 2010, 2010 STATE OF FUTURE; Godet M., 2001, CREATING FUTURES SCE; Hagmann J, 2002, CONSERV ECOL, V5; Haller T., 2008, Journal of Environment & Development, V17, P118, DOI 10.1177/1070496508316853; Hunt DVL, 2012, SUSTAINABILITY-BASEL, V4, P740, DOI 10.3390/su4040740; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; London S., 2012, STAKEHOLDER VISION S; Lynam T, 2007, ECOL SOC, V12; Martin-Ortega J., 2014, D5 A PARTICIPATORY R; Mietzner D., 2004, P EU US SCI SEM NEW, P48; Mistry J, 2014, ENVIRON SCI POLICY, V44, P126, DOI 10.1016/j.envsci.2014.05.007; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; Mwangi E, 2012, INT J COMMONS, V6, P79, DOI 10.18352/ijc.374; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Ostrom E, 2010, ENVIRON CONSERV, V37, P451, DOI 10.1017/S0376892910000834; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pert PL, 2010, AUST GEOGR, V41, P285, DOI 10.1080/00049182.2010.498037; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Reed MS, 2008, BIOL CONSERV, V141, P2417, DOI 10.1016/j.biocon.2008.07.014; Rogers KH, 2013, ECOL SOC, V18, DOI 10.5751/ES-05330-180231; Rojas M., 2014, D4 3 STAKEHOLDER VIS; Rounsevell MDA, 2010, WIRES CLIM CHANGE, V1, P606, DOI 10.1002/wcc.63; Saunders FP, 2014, INT J COMMONS, V8, P636, DOI 10.18352/ijc.477; Scholte P, 2003, AMBIO, V32, P58, DOI 10.1639/0044-7447(2003)032[0058:IAPTBU]2.0.CO;2; Schreckenberg K., 2010, SOCIAL ASSESSMENT CO; Shackleton CM, 2010, ENVIRON CONSERV, V37, P1, DOI 10.1017/S0376892910000366; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; Van Der Heijden K., 2012, TRANSFORMATIVE SCENA; van Notten PWF, 2003, FUTURES, V35, P423, DOI 10.1016/S0016-3287(02)00090-3; Waylen K. A., 2014, COMET LA SCENARIO PL; Waylen KA, 2013, HUM ECOL, V41, P575, DOI 10.1007/s10745-013-9594-8; Western D., 1994, NATURAL CONNECTIONS; Wollenberg E, 2000, LANDSCAPE URBAN PLAN, V47, P65, DOI 10.1016/S0169-2046(99)00071-7; Wright G, 2009, INT J FORECASTING, V25, P813, DOI 10.1016/j.ijforecast.2009.05.019	52	13	14	0	28	RESILIENCE ALLIANCE	WOLFVILLE	ACADIA UNIV, BIOLOGY DEPT, WOLFVILLE, NS B0P 1X0, CANADA	1708-3087			ECOL SOC	Ecol. Soc.		2015	20	4							28	10.5751/ES-07926-200428	http://dx.doi.org/10.5751/ES-07926-200428			15	Ecology; Environmental Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology	DA2MM		Green Published, gold			2022-09-04	WOS:000367628900017
J	Oberdorff, T; Jezequel, C; Campero, M; Carvajal-Vallejos, F; Cornu, JF; Dias, MS; Duponchelle, F; Maldonado-Ocampo, JA; Ortega, H; Renno, JF; Tedesco, PA				Oberdorff, T.; Jezequel, C.; Campero, M.; Carvajal-Vallejos, F.; Cornu, J. F.; Dias, M. S.; Duponchelle, F.; Maldonado-Ocampo, J. A.; Ortega, H.; Renno, J. F.; Tedesco, P. A.			Opinion Paper: how vulnerable are Amazonian freshwater fishes to ongoing climatechange?	JOURNAL OF APPLIED ICHTHYOLOGY			English	Article; Proceedings Paper	4th International Conference of the Research Network on Amazonian Ichthyofauna	SEP 30-OCT 02, 2014	Cochabamba, BOLIVIA	Univ San Simon, French Res Inst Dev, Unit Limnol & Aquat Resources			ARAPAIMA-GIGAS; SHIFTS; BASIN	With around 15% of all described freshwater fish species in the world, the Amazon Basin is by far the most fish species-rich freshwater ecosystem on the planet. In this opinion paper, a rough evaluation is given on just how vulnerable Amazonian freshwater fishes are to ongoing climate change. And to argue that current anthropogenic threats through rapid expansion of human infrastructure and economic activities in the basin could be a far greater threat to fish communities than those anticipated by any future climate change. Conservation actions in the Amazon Basin should focus preferentially on reducing the impacts of present-day anthropogenic threats.	[Oberdorff, T.; Jezequel, C.; Duponchelle, F.; Renno, J. F.; Tedesco, P. A.] UCBN, UPMC, IRD 207, IRD,UMR BOREA MNHN,CNRS 7208, F-75231 Paris, France; [Oberdorff, T.; Jezequel, C.; Campero, M.] UMSS, FCyT, ULRA, Cochabamba, Bolivia; [Carvajal-Vallejos, F.] FAUNAGUA Inst Invest Aplicadas Recursos Agua, Cochabamba, Bolivia; [Cornu, J. F.] Univ Montpellier, CNRS IRD UM2, Inst Sci Evolut, UMR ISEM, F-34059 Montpellier, France; [Dias, M. S.] Univ Fed Santa Catarina, Lab Biogeog & Macroecol Marinha, BR-88040900 Florianopolis, SC, Brazil; [Maldonado-Ocampo, J. A.] Pontificia Univ Javeriana, Fac Ciencias, Dept Biol, Unidad Ecol & Sistemat UNESIS, Bogota, Colombia; [Ortega, H.] Univ Nacl Mayor San Marcos, Museo Hist Nat, Dept Ictiol, Lima 14, Peru		Oberdorff, T (corresponding author), UCBN, UPMC, IRD 207, IRD,UMR BOREA MNHN,CNRS 7208, F-75231 Paris, France.	thierry.oberdorff@ird.fr	CELINE, JEZEQUEL/AAI-8090-2020; Tedesco, Pablo A/F-7088-2013; Renno, Jean-François/L-1082-2017; oberdorff, thierry/I-3109-2016; Duponchelle, Fabrice/K-1998-2016; Oberdorff, Thierry/AGD-5797-2022; Carvajal-Vallejos, Fernando M./R-7302-2019; Dias, Murilo Sversut/G-5549-2010; Carvajal-Vallejos, Fernando M./AGO-7079-2022	CELINE, JEZEQUEL/0000-0003-0687-1467; Tedesco, Pablo A/0000-0001-5972-5928; oberdorff, thierry/0000-0001-7323-2599; Duponchelle, Fabrice/0000-0003-0497-2264; Oberdorff, Thierry/0000-0001-7323-2599; Dias, Murilo Sversut/0000-0002-7213-5284; Carvajal-Vallejos, Fernando M./0000-0002-9110-490X; Maldonado Ocampo, Javier Alejandro/0000-0003-3024-237X; Renno, Jean-Francois/0000-0002-9071-0086; Campero, Melina/0000-0001-7878-4261; Ortega, Hernan/0000-0002-4396-2598	IRD through the EU "BIOFRESH" [226874]; IRD through the EU "AMAZONFISH" [ELAC2014/DCC-0210]; Brazilian government (Science without Borders program, MCTI/MEC)	IRD through the EU "BIOFRESH"; IRD through the EU "AMAZONFISH"; Brazilian government (Science without Borders program, MCTI/MEC)	This work is a contribution to the Laboratoire Mixte International - Evolution et Domestication de l'Ichtyofaune Amazonienne (LMI - EDIA - IRD) and was financially supported by the IRD through the EU "BIOFRESH" (FP7-ENV-2008, Contract no 226874) and "AMAZONFISH" (ELAC2014/DCC-0210) projects. M. S. D. received a PhD grant from the Brazilian government (Science without Borders program, MCTI/MEC). This opinion paper is an extended English version of a book chapter published in Spanish and presented at the COP20 in Lima Peru in 2014: 'El Peru frente al cambio climatico - Resultados de investigaciones franco-peruanas'. Ed. Scientifica A. Gregoire. IRD. ISBN 978-2-7099-1906-7.	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Brosse S, 2013, HYDROBIOLOGIA, V700, P343, DOI 10.1007/s10750-012-1242-6; Carvajal-Vallejos FM, 2014, HYDROBIOLOGIA, V732, P19, DOI 10.1007/s10750-014-1841-5; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; Comte L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6053; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Freitas CEC, 2013, HYDROBIOLOGIA, V705, P159, DOI 10.1007/s10750-012-1394-4; Goulding M., 1979, ECOLOGIA PESCA RIO M; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hrbek T, 2005, ANIM CONSERV, V8, P297, DOI 10.1017/S1367943005002210; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Hugueny B, 2011, GLOBAL ECOL BIOGEOGR, V20, P449, DOI 10.1111/j.1466-8238.2010.00614.x; Junk WJ, 2007, AQUAT ECOSYST HEALTH, V10, P153, DOI 10.1080/14634980701351023; Knorr G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048873; Leadley P, 2014, BIOSCIENCE, V64, P665, DOI 10.1093/biosci/biu093; Lowe-McConnell R. H., 1987, ECOLOGICAL STUDIES T; Miranda-Chumacero G, 2012, BIOINVASIONS REC, V1, P129, DOI 10.3391/bir.2012.1.2.09; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Oberdorff Thierry, 2011, International Journal of Ecology, V2011, DOI 10.1155/2011/967631; Pachauri R.K., 2007, CLIMATE CHANGE 2007, P104; Pelicice FM, 2015, FISH FISH, V16, P697, DOI 10.1111/faf.12089; Petrere M, 2004, REV FISH BIOL FISHER, V14, P403, DOI 10.1007/s11160-004-8362-7; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Reis RE, 2003, CHECKLIST FRESHWATER; Saupe EE, 2015, GLOBAL ECOL BIOGEOGR, V24, P1159, DOI 10.1111/geb.12333; Stewart DJ, 2013, COPEIA, P38, DOI 10.1643/CI-12-013; Stewart DJ, 2013, COPEIA, P470, DOI 10.1643/CI-12-017; Tedesco PA, 2013, J APPL ECOL, V50, P1105, DOI 10.1111/1365-2664.12125; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Winemiller KO, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P225	33	24	25	1	44	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0175-8659	1439-0426		J APPL ICHTHYOL	J. Appl. Ichthyol.	DEC	2015	31			4			4	9		10.1111/jai.12971	http://dx.doi.org/10.1111/jai.12971			6	Fisheries; Marine & Freshwater Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Fisheries; Marine & Freshwater Biology	DD6BM					2022-09-04	WOS:000370008700002
J	Coppus, R; Romijn, JE; Mendez-Toribio, M; Murcia, C; Thomas, E; Guariguata, MR; Herold, M; Verchot, L				Coppus, R.; Romijn, J. E.; Mendez-Toribio, M.; Murcia, C.; Thomas, E.; Guariguata, M. R.; Herold, M.; Verchot, L.			What is out there? a typology of land restoration projects in Latin America and the Caribbean	ENVIRONMENTAL RESEARCH COMMUNICATIONS			English	Article						typology; forest landscape restoration; ecological restoration; Latin America and the Caribbean; regional assessment; comparative analysis	SCALE FOREST RESTORATION; ECOLOGICAL RESTORATION; ECOSYSTEM SERVICES; AGRICULTURAL LANDSCAPES; BIODIVERSITY; CONSERVATION; GOVERNANCE; GUIDE	Restoring degraded lands is high on the international agenda and the number of restoration projects in Latin America and the Caribbean (LAC) has increased considerably over the past decades. However, the variety of approaches used have not been systematically documented and analyzed. We aimed to develop a restoration typology as a function of the geographical and socio-economical setting, planning, timeframe, finances, implementation, monitoring and potential impact, which will help to discern broad patterns and identify gaps in project implementation in LAC. We categorized 97 restoration projects using Multiple Correspondence Analysis and a Hierarchical Clustering on Principal Components. Three main restoration types emerged from the clustering, with the main defining variables being: (1) project area under restoration, (2) amount of funding received, (3) source of funding and (4) monitoring efforts. The first type are large-scale projects, which receive high amounts of funding provided by international donors, and with a well-established monitoring plan; the second type are projects financed with private money, typically lacking a sound monitoring program; and the third type represents small projects with low amounts of funding, financed with public funds from national governments, often with a rudimentary monitoring plan. The typology enables a comparative analysis of the status and trends of restoration activities across Latin America. We conclude that, despite growing awareness and recognition that integrated approaches are needed to revert complex and interconnected socio-economic and environmental issues like land degradation, the socio-economic dimension remains underexposed in the majority of restoration projects, whereas monitoring is still regarded as an extra cost instead of a necessary investment.	[Coppus, R.; Verchot, L.] Int Ctr Trop Agr CIAT, Cali 6713, Colombia; [Romijn, J. E.; Herold, M.] Wageningen Univ Res, Lab Geoinformat Sci & Remote Sensing, Droevendaalsesteeg 3, NL-6708 PB Wageningen, Netherlands; [Mendez-Toribio, M.] Ctr Reg Bajio, Inst Ecol, AC Red Diversidad Biol Occidente Mexicano, Patzcuaro 61600, Michoacan, Mexico; [Murcia, C.] Pontificia Univ Javeriana Secc Cali, Dept Ciencias Nat & Matemat, Cali, Colombia; [Murcia, C.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Thomas, E.] Biovers Int, Ave La Molina 1895, Lima, Peru; [Guariguata, M. R.] Ctr Int Forestry Res CIFOR, Ave La Molina 1895, Lima, Peru		Coppus, R (corresponding author), Int Ctr Trop Agr CIAT, Cali 6713, Colombia.	r.coppus@cgiar.org	Herold, Martin/F-8553-2012	Herold, Martin/0000-0003-0246-6886; thomas, evert/0000-0002-7838-6228	USAID - Global Climate Change Program; CGIAR Research Program on Forests, Trees and Agroforestry	USAID - Global Climate Change Program(CGIAR); CGIAR Research Program on Forests, Trees and Agroforestry(CGIAR)	The authors gratefully acknowledge the support of USAID - Global Climate Change Program and the CGIAR Research Program on Forests, Trees and Agroforestry. Thanks also due to Hugo Andres Dorado Betancourt for helping with the statistical analyses.	Adams C, 2016, BIOTROPICA, V48, P731, DOI 10.1111/btp.12385; [Anonymous], **DATA OBJECT**, DOI DOI 10.7910/DVN/B9OUOZ; [Anonymous], 2018, GLOB PARTN FOR LANDS; Aronson J, 2017, ANN MO BOT GARD, V102, P188, DOI 10.3417/2017003; Aronson J, 2010, RESTOR ECOL, V18, P143, DOI 10.1111/j.1526-100X.2009.00638.x; Bai ZG, 2008, SOIL USE MANAGE, V24, P223, DOI 10.1111/j.1475-2743.2008.00169.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Bartholomew DJ, 2008, ANAL MULTIVARIATE SO; Brancalion PHS, 2016, BIOTROPICA, V48, P856, DOI 10.1111/btp.12383; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Ceccon E, 2015, RESTOR ECOL, V23, P331, DOI 10.1111/rec.12228; Cerron J, 2017, LECCIONES APRENDIDAS; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chazdon RL, 2016, BIOTROPICA, V48, P716, DOI 10.1111/btp.12381; Chazdon RL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501639; Convention on Biological Diversity (CBD), 2011, HIGH LEV PAN RES AIC; Crouzeilles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11666; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; De Sy V, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124004; Duchelle AE, 2014, WORLD DEV, V55, P53, DOI 10.1016/j.worlddev.2013.01.014; Economics of Land Degradation (ELD), 2015, VALUE LAND PROSPEROU; Estrada-Carmona N, 2014, LANDSCAPE URBAN PLAN, V129, P1, DOI 10.1016/j.landurbplan.2014.05.001; Evans K, 2018, CONSERV BIOL, V32, P525, DOI 10.1111/cobi.13110; Global Environmental Facility (GEF), 2018, FORESTS; Harvey CA, 2008, CONSERV BIOL, V22, P8, DOI 10.1111/j.1523-1739.2007.00863.x; Hobbs RJ, 1996, RESTOR ECOL, V4, P93, DOI 10.1111/j.1526-100X.1996.tb00112.x; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Husson F., 2010, PRINCIPAL COMPONENT; Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services, 2021, ANNEX 2 DECISION IPB; International Union for Conservation of Nature (IUCN), 2011, BONN CHALLENGE; IUCN, 2014, GUID REST OPP ASS ME; Laestadius L., 2015, Unasylva (English ed.), V66, P11; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lamb D, 2014, LARGE SCALE FOREST R, DOI [10.4324/9780203071649, DOI 10.4324/9780203071649]; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; McConnachie MM, 2013, RESTOR ECOL, V21, P544, DOI 10.1111/rec.12038; Mcdonald T, 2016, INT STANDARDS PRACTI, VFirst; Meli P, 2017, RESTOR ECOL, V25, P156, DOI 10.1111/rec.12473; Meli P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171368; Mendez-Toribio M, 2018, DOCUMENTOS OCASIONAL; Menz MHM, 2013, SCIENCE, V339, P526, DOI 10.1126/science.1228334; Murcia C, 2014, DOCUMENTOS OCASIONAL; Murcia C, 2016, CONSERV LETT, V9, P213, DOI 10.1111/conl.12199; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pacheco P, 2012, ANN ASSOC AM GEOGR, V102, P1366, DOI 10.1080/00045608.2012.678040; Palmer MA, 2009, SCIENCE, V325, P575, DOI 10.1126/science.1172976; Pinto SR, 2014, FORESTS, V5, P2212, DOI 10.3390/f5092212; Pirard R, 2014, FORESTS, V5, P404, DOI 10.3390/f5030404; Pistorius T, 2014, FORESTS, V5, P482, DOI 10.3390/f5030482; R Development Core Team, 2022, R LANGUAGE ENV STAT; Reed J, 2016, GLOBAL CHANGE BIOL, V22, P2540, DOI 10.1111/gcb.13284; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Roman-Cuesta RM, 2016, BIOGEOSCIENCES, V13, P4253, DOI 10.5194/bg-13-4253-2016; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8349, DOI 10.1073/pnas.1210595110; Scherr S J, 2017, BUSINESS SUSTAINABLE; Sourial N, 2010, J CLIN EPIDEMIOL, V63, P638, DOI 10.1016/j.jclinepi.2009.08.008; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; United Nations, 2014, FOR ACT STAT ACT PLA; United Nations (UN), 2015, SOC DEV GOALS GOAL; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010	61	10	10	1	2	IOP Publishing Ltd	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2515-7620			ENVIRON RES COMMUN	Environ. Res. Commun.	MAY 1	2019	1	4							041004	10.1088/2515-7620/ab2102	http://dx.doi.org/10.1088/2515-7620/ab2102			13	Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	NC7VC		Green Published, gold			2022-09-04	WOS:000561421700001
J	Sahebkar, A; Simental-Mendia, LE; Pirro, M; Montecucco, F; Carbone, F; Banach, M; Barreto, GE; Butler, AE				Sahebkar, Amirhossein; Simental-Mendia, Luis E.; Pirro, Matteo; Montecucco, Fabrizio; Carbone, Federico; Banach, Maciej; Barreto, George E.; Butler, Alexandra E.			Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials	ANNALS OF MEDICINE			English	Review						Fibrates; cystatin C; fenofibrate	LIPID ASSOCIATION RECOMMENDATIONS; PATIENT-CENTERED MANAGEMENT; RENAL-FUNCTION; FENOFIBRATE TREATMENT; PLASMA HOMOCYSTEINE; RISK-FACTOR; THERAPY; DYSLIPIDEMIA; DISEASE; INHIBITORS	Aims: To assess the effect of fibrates on circulating cystatin C levels.Material and methods: Clinical studies evaluating the effect of a fibrate on circulating cystatin C levels were searched in PubMed-Medline, SCOPUS, Web of Science, and Google Scholar databases. A random-effect model and generic inverse variance method were used for quantitative data synthesis, sensitivity analysis conducted using the leave-one-out method, and weighted random-effects meta-regression performed to evaluate potential confounders on cystatin C levels.Results: This meta-analysis of data from nine published studies (16 treatment arms) involved a total of 2195 subjects. In a single-arm analysis of clinical trials (without control group; eight studies comprising 14 treatment arms), fibrate therapy increased circulating cystatin C concentrations (WMD: 0.07mg/dL, 95% CI: 0.04, 0.10, p<.001; I-2=82.66%). When the analysis was restricted to randomized controlled trials (four studies comprising six treatment arms), again elevation of circulating cystatin C levels was observed (WMD: 0.06mg/L, 95% CI: 0.03, 0.09, p<.001; I-2=42.98%). Elevated cystatin C levels were only seen with fenofibrate and not with other fibrates.Conclusions: The results suggest that fenofibrate treatment adversely affects cystatin C levels and might partially explain the limited efficacy of fenofibrate in reducing cardiovascular events.Key messageFenofibrate treatment adversely affects cystatin C levels and might partially explain the limited efficacy of fenofibrate in reducing cardiovascular events.	[Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran; [Simental-Mendia, Luis E.] Mexican Social Secur Inst, Biomed Res Unit, Durango, Mexico; [Pirro, Matteo] Univ Perugia, Dept Med, Unit Internal Med, Perugia, Italy; [Montecucco, Fabrizio; Carbone, Federico] Univ Genoa, Dept Internal Med, Clin Internal Med 1, Genoa, Italy; [Montecucco, Fabrizio] Osped Policlin San Martino, Genoa, Italy; [Montecucco, Fabrizio] Univ Genoa, CEBR, Genoa, Italy; [Banach, Maciej] Med Univ Lodz, WAM Univ Hosp Lodz, Dept Hypertens, Lodz, Poland; [Banach, Maciej] PMMHRI, Lodz, Poland; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile; [Butler, Alexandra E.] Antidoping Lab Qatar, Life Sci & Res Div, POB 27775,Sports City Rd, Doha, Qatar		Butler, AE (corresponding author), Antidoping Lab Qatar, Life Sci & Res Div, POB 27775,Sports City Rd, Doha, Qatar.	abutler@adlqatar.qa	Barreto, George E./AAD-7420-2020; Banach, Maciej/A-1271-2009; Carbone, Federico/G-3650-2013; Pirro, Matteo/AAC-2318-2022; Sahebkar, Amirhossein/B-5124-2018; Montecucco, Fabrizio/K-8543-2016	Barreto, George E./0000-0002-6644-1971; Banach, Maciej/0000-0001-6690-6874; Carbone, Federico/0000-0003-2957-4078; Pirro, Matteo/0000-0002-5527-4821; Montecucco, Fabrizio/0000-0003-0823-8729				Ansquer JC, 2008, AM J KIDNEY DIS, V51, P904, DOI 10.1053/j.ajkd.2008.01.014; Atkin SL, 2017, J DIABETES COMPLICAT, V31, P1458, DOI 10.1016/j.jdiacomp.2017.05.016; BOBEK LA, 1992, CRIT REV ORAL BIOL M, V3, P307, DOI 10.1177/10454411920030040101; BOSTOM A, 1995, ATHEROSCLEROSIS, V116, P59, DOI 10.1016/0021-9150(95)05522-X; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Davidson MH, 2007, AM J CARDIOL, V99, p3C, DOI 10.1016/j.amjcard.2006.11.016; Derosa G, 2015, PHARMACOL RES, V102, P63, DOI 10.1016/j.phrs.2015.09.012; Dierkes J, 1999, LANCET, V354, P219, DOI 10.1016/S0140-6736(99)02153-4; Dierkes J, 2001, ATHEROSCLEROSIS, V158, P161, DOI 10.1016/S0021-9150(00)00766-8; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Forsblom C, 2010, DIABETES CARE, V33, P215, DOI 10.2337/dc09-0621; Foucher C, 2015, CARDIOVASC THER, V33, P329, DOI 10.1111/1755-5922.12148; Fruchart JC, 2008, AM J CARDIOL, V102, p1K, DOI [10.1016/j.amjcard.2008.10.002, 10.1016/S0002-9149(08)01833-X]; Garcia-Carretero R, 2018, DIABETES METAB SYND, V12, P625, DOI 10.1016/j.dsx.2018.04.001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Higgins J.P.T.G.S., 2009, HDB SYSTEMATIC REV I; Ishibashi S, 2018, J CLIN LIPIDOL, V12, P173, DOI 10.1016/j.jacl.2017.10.006; Jacobson TA, 2015, J CLIN LIPIDOL, V9, P129, DOI 10.1016/j.jacl.2015.02.003; Jun M, 2012, J AM COLL CARDIOL, V60, P2061, DOI 10.1016/j.jacc.2012.07.049; McKeage K, 2011, DRUGS, V71, P1917, DOI 10.2165/11208090-000000000-00000; Menon V, 2007, ANN INTERN MED, V147, P19, DOI 10.7326/0003-4819-147-1-200707030-00004; Mychaleckyj JC, 2012, DIABETES CARE, V35, P1008, DOI 10.2337/dc11-1811; Ncube V, 2012, ANN CLIN BIOCHEM, V49, P491, DOI 10.1258/acb.2012.011163; Nordestgaard BG, 2016, CIRC RES, V118, P547, DOI 10.1161/CIRCRESAHA.115.306249; Randers E, 1999, CLIN CHEM LAB MED, V37, P389, DOI 10.1515/CCLM.1999.064; Sahebkar A, 2014, DIABETES OBES METAB, V16, P780, DOI 10.1111/dom.12277; Sahebkar A, 2016, CURR MED CHEM, V23, P4490, DOI 10.2174/0929867323666161007155310; Sahebkar A, 2016, PHARMACOL RES, V111, P163, DOI 10.1016/j.phrs.2016.06.011; Sahebkar A, 2015, THROMB HAEMOSTASIS, V114, P546, DOI 10.1160/TH14-11-0937; Sahebkar A, 2014, PROG LIPID RES, V56, P47, DOI 10.1016/j.plipres.2014.07.002; Sahebkar A, 2014, EXPERT OPIN PHARMACO, V15, P493, DOI 10.1517/14656566.2014.876992; Sahebkar A, 2013, ATHEROSCLEROSIS, V230, P110, DOI 10.1016/j.atherosclerosis.2013.06.026; Sahebkar A, 2013, DNA CELL BIOL, V32, P188, DOI 10.1089/dna.2012.1947; Serban C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09902; Shipman KE, 2016, WORLD J DIABETES, V7, P74, DOI 10.4239/wjd.v7.i5.74; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Westphal S, 2001, LANCET, V358, P39, DOI 10.1016/S0140-6736(00)05271-5; Zi MT, 2018, IMMUNOL LETT, V196, P80, DOI 10.1016/j.imlet.2018.01.006	38	3	3	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0785-3890	1365-2060		ANN MED	Ann. Med.		2018	50	6					485	493		10.1080/07853890.2018.1495338	http://dx.doi.org/10.1080/07853890.2018.1495338			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HK9CQ	29957074				2022-09-04	WOS:000458287100003
